 mechanisms of pharmacological action|mesh-ancestor
92111915|NCT04392063|Protective Agents|protective agents|mesh-ancestor
92111916|NCT04392063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111917|NCT04392063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92111918|NCT01903798|Mycophenolic Acid|mycophenolic acid|mesh-list
92111919|NCT01903798|Prednisolone|prednisolone|mesh-list
92111920|NCT01903798|Rilonacept|rilonacept|mesh-list
92111921|NCT01903798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92111922|NCT01903798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111923|NCT01903798|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92111924|NCT01903798|Antitubercular Agents|antitubercular agents|mesh-ancestor
92111925|NCT01903798|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92111926|NCT01903798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111927|NCT01903798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111928|NCT01903798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111929|NCT01903798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92111930|NCT01903798|Glucocorticoids|glucocorticoids|mesh-ancestor
92111931|NCT01903798|Hormones|hormones|mesh-ancestor
92111932|NCT01903798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111933|NCT01903798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111934|NCT01903798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92111935|NCT01945138|Insulin|insulin|mesh-list
92111936|NCT01945138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92111937|NCT01945138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92111938|NCT01945138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111939|NCT01734785|Empagliflozin|empagliflozin|mesh-list
92111940|NCT01734785|Linagliptin|linagliptin|mesh-list
92111941|NCT01734785|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92070043|NCT00985738|Dutasteride|dutasteride|mesh-list
92111942|NCT01734785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111943|NCT01734785|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92111944|NCT01734785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111945|NCT01734785|Incretins|incretins|mesh-ancestor
92111947|NCT01734785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111948|NCT01734785|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92111949|NCT01734785|Protease Inhibitors|protease inhibitors|mesh-ancestor
92111950|NCT01734785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111951|NCT03821415|Estradiol|estradiol|mesh-list
92111952|NCT03821415|Estrogens|estrogens|mesh-ancestor
92111953|NCT03821415|Hormones|hormones|mesh-ancestor
92111954|NCT03821415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92111955|NCT03821415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111956|NCT01734395|Galantamine|galantamine|mesh-list
92111957|NCT01734395|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92111958|NCT01734395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92111959|NCT01734395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111960|NCT01734395|Cholinergic Agents|cholinergic agents|mesh-ancestor
92142831|NCT03896737|Leprostatic Agents|leprostatic agents|mesh-ancestor
92111961|NCT01734395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92111962|NCT01734395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111963|NCT01734395|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92111964|NCT01734395|Autonomic Agents|autonomic agents|mesh-ancestor
92111965|NCT01734395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92111966|NCT01734395|Nootropic Agents|nootropic agents|mesh-ancestor
92111967|NCT01945294|Interferons|interferons|mesh-list
92111968|NCT01945294|Ribavirin|ribavirin|mesh-list
92111969|NCT01945294|Interferon-alpha|interferon-alpha|mesh-list
92111970|NCT01945294|Interferon alpha-2|interferon alpha-2|mesh-list
92111971|NCT01945294|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92111972|NCT01945294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111973|NCT01945294|Antiviral Agents|antiviral agents|mesh-ancestor
92111974|NCT01945294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92111975|NCT01945294|Antimetabolites|antimetabolites|mesh-ancestor
92111976|NCT01945294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111977|NCT01945294|Immunologic Factors|immunologic factors|mesh-ancestor
92111978|NCT01945294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111979|NCT04392297|Antibodies|antibodies|mesh-list
92111980|NCT04392297|Immunoglobulin G|immunoglobulin g|mesh-list
92111981|NCT04392297|Immunologic Factors|immunologic factors|mesh-ancestor
92111982|NCT04392297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92111983|NCT01947946|Benralizumab|benralizumab|mesh-list
92111984|NCT01947946|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92111985|NCT01947946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92111986|NCT02954055|Paclitaxel|paclitaxel|mesh-list
92111987|NCT02954055|Vinorelbine|vinorelbine|mesh-list
92111988|NCT02954055|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92111989|NCT02954055|Cyclophosphamide|cyclophosphamide|mesh-list
92111990|NCT02954055|Capecitabine|capecitabine|mesh-list
92111991|NCT02954055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92111992|NCT02954055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92111993|NCT02954055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92111994|NCT02954055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92111995|NCT02954055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92111996|NCT02954055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92111997|NCT02954055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92111998|NCT02954055|Immunologic Factors|immunologic factors|mesh-ancestor
92111999|NCT02954055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112000|NCT02954055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112001|NCT02954055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92112002|NCT02954055|Alkylating Agents|alkylating agents|mesh-ancestor
92112003|NCT02954055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92112004|NCT02954055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92112005|NCT02954055|Antimetabolites|antimetabolites|mesh-ancestor
92112006|NCT03313180|Nintedanib|nintedanib|mesh-list
92112007|NCT03313180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112008|NCT03313180|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92112009|NCT03313180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112010|NCT03313180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112011|NCT03275506|Bevacizumab|bevacizumab|mesh-list
92112012|NCT03275506|Pembrolizumab|pembrolizumab|mesh-list
92112013|NCT03275506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112014|NCT03275506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112015|NCT03275506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92112016|NCT03275506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92112017|NCT03275506|Growth Substances|growth substances|mesh-ancestor
92112018|NCT03275506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112019|NCT03275506|Growth Inhibitors|growth inhibitors|mesh-ancestor
92112020|NCT03275506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112021|NCT03275506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112022|NCT03820245|Lycopene|lycopene|mesh-list
92112023|NCT03820245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112024|NCT03820245|Antioxidants|antioxidants|mesh-ancestor
92112025|NCT03820245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112026|NCT03820245|Protective Agents|protective agents|mesh-ancestor
92112027|NCT03820245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112028|NCT03820245|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92112029|NCT03820245|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92112030|NCT03820245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112031|NCT01597505|Vancomycin|vancomycin|mesh-list
92112032|NCT01597505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92112033|NCT01597505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112034|NCT03826485|Pranlukast|pranlukast|mesh-list
92112035|NCT03826485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92112036|NCT03826485|Respiratory System Agents|respiratory system agents|mesh-ancestor
92112037|NCT03826485|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92112038|NCT03826485|Hormone Antagonists|hormone antagonists|mesh-ancestor
92116532|NCT03288402|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92115128|NCT01724021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112039|NCT03826485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112040|NCT03826485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112041|NCT03823989|Mitomycins|mitomycins|mesh-list
92112042|NCT03823989|Mitomycin|mitomycin|mesh-list
92112043|NCT03823989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92112044|NCT03823989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112045|NCT03823989|Alkylating Agents|alkylating agents|mesh-ancestor
92115129|NCT01724021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112046|NCT03823989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116612|NCT03282162|Oxytocin|oxytocin|mesh-list
92112047|NCT03823989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92112048|NCT03823989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112049|NCT03826875|Fluoxetine|fluoxetine|mesh-list
92112050|NCT03826875|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92097504|NCT01133158|Hormones|hormones|mesh-ancestor
92112051|NCT03826875|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92112052|NCT03826875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92097673|NCT00634179|Glucocorticoids|glucocorticoids|mesh-ancestor
92115130|NCT01724021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92115131|NCT01724021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115132|NCT01724021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112053|NCT03826875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112054|NCT03826875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112055|NCT03826875|Serotonin Agents|serotonin agents|mesh-ancestor
92112056|NCT03826875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112057|NCT03826875|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92112058|NCT03826875|Antidepressive Agents|antidepressive agents|mesh-ancestor
92112059|NCT03826875|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098715|NCT01158820|Diphenhydramine|diphenhydramine|mesh-list
92112060|NCT03826875|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92098953|NCT03449940|Diclofenac|diclofenac|mesh-list
92112061|NCT03826875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92099242|NCT01238536|Lidocaine|lidocaine|mesh-list
92112062|NCT03826875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112063|NCT01951066|Dexamethasone|dexamethasone|mesh-list
92112064|NCT01951066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112065|NCT01951066|Antiemetics|antiemetics|mesh-ancestor
92112066|NCT01951066|Autonomic Agents|autonomic agents|mesh-ancestor
92112067|NCT01951066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112068|NCT01951066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112069|NCT01951066|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112070|NCT01951066|Glucocorticoids|glucocorticoids|mesh-ancestor
92112071|NCT01951066|Hormones|hormones|mesh-ancestor
92112072|NCT01951066|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112073|NCT01951066|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92112074|NCT01951066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112075|NCT02916771|Dexamethasone|dexamethasone|mesh-list
92112076|NCT02916771|Lenalidomide|lenalidomide|mesh-list
92112077|NCT02916771|Ixazomib|ixazomib|mesh-list
92112078|NCT02916771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112079|NCT02916771|Antiemetics|antiemetics|mesh-ancestor
92112080|NCT02916771|Autonomic Agents|autonomic agents|mesh-ancestor
92112081|NCT02916771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112082|NCT02916771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112083|NCT02916771|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112084|NCT02916771|Glucocorticoids|glucocorticoids|mesh-ancestor
92112085|NCT02916771|Hormones|hormones|mesh-ancestor
92112086|NCT02916771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112087|NCT02916771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92112088|NCT02916771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112089|NCT02916771|Immunologic Factors|immunologic factors|mesh-ancestor
92112090|NCT02916771|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92112091|NCT02916771|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92112092|NCT02916771|Growth Substances|growth substances|mesh-ancestor
92112093|NCT02916771|Growth Inhibitors|growth inhibitors|mesh-ancestor
92112094|NCT02916771|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112095|NCT02916771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112096|NCT02916771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112097|NCT05735626|Capsaicin|capsaicin|mesh-list
92112098|NCT05735626|Piperine|piperine|mesh-list
92112099|NCT05735626|Antipruritics|antipruritics|mesh-ancestor
92112100|NCT05735626|Dermatologic Agents|dermatologic agents|mesh-ancestor
92112101|NCT05735626|Sensory System Agents|sensory system agents|mesh-ancestor
92112102|NCT05735626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112103|NCT05735626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112104|NCT05735626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92112105|NCT05735626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112106|NCT05735626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112107|NCT01951768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92112108|NCT01951768|Gentamicins|gentamicins|mesh-list
92112109|NCT01951768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112110|NCT01951768|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92112111|NCT01951768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112112|NCT01951768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112113|NCT05735470|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92112114|NCT05735470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112115|NCT03825861|Folfirinox|folfirinox|mesh-list
92112116|NCT03825861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112117|NCT01760447|Metformin|metformin|mesh-list
92112118|NCT01760447|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92112119|NCT01760447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92115133|NCT01724021|Glucocorticoids|glucocorticoids|mesh-ancestor
92112120|NCT01760447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112121|NCT01760447|Incretins|incretins|mesh-ancestor
92112122|NCT01760447|Hormones|hormones|mesh-ancestor
92112123|NCT01760447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112124|NCT01760447|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92112125|NCT01760447|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112126|NCT01760447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112127|NCT01760447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112128|NCT01915108|Remifentanil|remifentanil|mesh-list
92112129|NCT01915108|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92112130|NCT01915108|Narcotics|narcotics|mesh-ancestor
92112131|NCT01915108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112132|NCT01915108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112133|NCT01915108|Analgesics|analgesics|mesh-ancestor
92112134|NCT01915108|Sensory System Agents|sensory system agents|mesh-ancestor
92112135|NCT01915108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112136|NCT03825471|Analgesics, Opioid|analgesics, opioid|mesh-list
92112137|NCT03825471|Anesthetics|anesthetics|mesh-list
92112138|NCT03825471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112139|NCT03825471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112140|NCT03825471|Narcotics|narcotics|mesh-ancestor
92112141|NCT03825471|Analgesics|analgesics|mesh-ancestor
92112142|NCT03825471|Sensory System Agents|sensory system agents|mesh-ancestor
92112143|NCT03825471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112144|NCT01917136|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92112145|NCT01917136|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92112146|NCT01917136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112147|NCT01450215|Lenalidomide|lenalidomide|mesh-list
92112148|NCT01450215|Immunologic Factors|immunologic factors|mesh-ancestor
92112149|NCT01450215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112150|NCT01450215|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92112151|NCT01450215|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92112152|NCT01450215|Growth Substances|growth substances|mesh-ancestor
92112153|NCT01450215|Growth Inhibitors|growth inhibitors|mesh-ancestor
92112154|NCT01450215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112155|NCT02915523|Avelumab|avelumab|mesh-list
92112156|NCT02915523|Entinostat|entinostat|mesh-list
92112157|NCT02915523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112158|NCT02915523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112159|NCT02915523|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92112160|NCT02915523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112161|NCT02915523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112162|NCT01917214|Sunitinib|sunitinib|mesh-list
92112163|NCT01917214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112164|NCT01917214|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92112165|NCT01917214|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92112166|NCT01917214|Growth Substances|growth substances|mesh-ancestor
92112167|NCT01917214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112168|NCT01917214|Growth Inhibitors|growth inhibitors|mesh-ancestor
92112169|NCT01917214|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92112170|NCT01917214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112171|NCT01917214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112173|NCT01955434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92112174|NCT01955434|Immunologic Factors|immunologic factors|mesh-ancestor
92112175|NCT01955434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112176|NCT01955434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112177|NCT01955434|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92112178|NCT01955434|Alkylating Agents|alkylating agents|mesh-ancestor
92112179|NCT01955434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112180|NCT01955434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112181|NCT01955434|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92112182|NCT01732913|Rituximab|rituximab|mesh-list
92112183|NCT01732913|Idelalisib|idelalisib|mesh-list
92112184|NCT01732913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112185|NCT01732913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112186|NCT01732913|Immunologic Factors|immunologic factors|mesh-ancestor
92112187|NCT01732913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112188|NCT01732913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112189|NCT01732913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112190|NCT01732913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112191|NCT03824925|Zinc|zinc|mesh-list
92112192|NCT03824925|Zinc Sulfate|zinc sulfate|mesh-list
92112193|NCT03824925|Trace Elements|trace elements|mesh-ancestor
92112194|NCT03824925|Micronutrients|micronutrients|mesh-ancestor
92112195|NCT03824925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112196|NCT03824925|Astringents|astringents|mesh-ancestor
92112197|NCT03824925|Dermatologic Agents|dermatologic agents|mesh-ancestor
92112198|NCT03825081|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92112199|NCT03825081|Pilocarpine|pilocarpine|mesh-list
92112200|NCT03825081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92112201|NCT03825081|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92018671|NCT04397107|Antiviral Agents|antiviral agents|mesh-ancestor
92112202|NCT03825081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92112203|NCT03825081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92112204|NCT03825081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112205|NCT03825081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020818|NCT02431533|Calcium|calcium|mesh-list
92112206|NCT03825081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112207|NCT03825081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112208|NCT03825081|Miotics|miotics|mesh-ancestor
92112209|NCT03825081|Autonomic Agents|autonomic agents|mesh-ancestor
92112210|NCT03825081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112211|NCT03825081|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92021712|NCT05613361|Colistin|colistin|mesh-list
92112212|NCT03825081|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92112213|NCT03825081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92112214|NCT02912715|Paclitaxel|paclitaxel|mesh-list
92022372|NCT05696977|Cyclosporins|cyclosporins|mesh-list
92112215|NCT02912715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024998|NCT04279561|Edetic Acid|edetic acid|mesh-list
92112216|NCT02912715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112217|NCT02912715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92112218|NCT02912715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92112219|NCT02912715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92115134|NCT01724021|Hormones|hormones|mesh-ancestor
92116613|NCT03282162|Oxytocics|oxytocics|mesh-ancestor
92030253|NCT02775435|Paclitaxel|paclitaxel|mesh-list
92112220|NCT02912715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035754|NCT01852162|Dabigatran|dabigatran|mesh-list
92112221|NCT01920802|Olanzapine|olanzapine|mesh-list
92112222|NCT01920802|Iloperidone|iloperidone|mesh-list
92112223|NCT01920802|Antiemetics|antiemetics|mesh-ancestor
92112224|NCT01920802|Autonomic Agents|autonomic agents|mesh-ancestor
92112225|NCT01920802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116697|NCT01748175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112226|NCT01920802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112227|NCT01920802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112228|NCT01920802|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92112229|NCT01920802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92112230|NCT01920802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112231|NCT01920802|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112232|NCT01920802|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92112233|NCT01920802|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92112234|NCT01920802|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92112235|NCT01920802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112236|NCT01920802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112238|NCT01451229|Higenamine|higenamine|mesh-list
92112239|NCT01451229|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92112240|NCT01451229|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92112241|NCT01451229|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112242|NCT01451229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112243|NCT01451229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112244|NCT01451229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112245|NCT01451229|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92112246|NCT01451229|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92112247|NCT01451229|Analgesics|analgesics|mesh-ancestor
92112248|NCT01451229|Sensory System Agents|sensory system agents|mesh-ancestor
92112249|NCT01451229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112250|NCT01451229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112251|NCT01451229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112252|NCT01451229|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92112253|NCT01451229|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92112254|NCT01451229|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92112255|NCT01451229|Protective Agents|protective agents|mesh-ancestor
92112256|NCT03054519|Metformin|metformin|mesh-list
92112257|NCT03054519|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92112258|NCT03054519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112259|NCT01921894|Vitamin D|vitamin d|mesh-list
92112260|NCT01921894|Cholecalciferol|cholecalciferol|mesh-list
92112261|NCT01921894|Vitamins|vitamins|mesh-ancestor
92112262|NCT01921894|Micronutrients|micronutrients|mesh-ancestor
92112263|NCT01921894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112264|NCT01921894|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92112265|NCT01921894|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92112266|NCT01452009|Travoprost|travoprost|mesh-list
92112267|NCT01452009|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92112268|NCT01452009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92112269|NCT01452009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92112270|NCT03824379|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92112271|NCT03824379|Magnesium citrate|magnesium citrate|mesh-list
92112272|NCT03824379|Cathartics|cathartics|mesh-ancestor
92112273|NCT03824379|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112274|NCT03824379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112275|NCT01957930|Insulin|insulin|mesh-list
92043810|NCT05650775|Adderall|adderall|mesh-list
92044860|NCT03760484|Fidaxomicin|fidaxomicin|mesh-list
92045622|NCT01630135|Xhance|xhance|mesh-list
92112276|NCT01957930|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92112277|NCT01957930|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046675|NCT04844099|Artenimol|artenimol|mesh-list
92116773|NCT03280212|Tranexamic Acid|tranexamic acid|mesh-list
92112278|NCT01957930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112279|NCT01732757|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92112280|NCT01732757|Dextrans|dextrans|mesh-list
92112281|NCT01732757|Alcaftadine|alcaftadine|mesh-list
92112282|NCT01732757|Anticoagulants|anticoagulants|mesh-ancestor
92112283|NCT01732757|Plasma Substitutes|plasma substitutes|mesh-ancestor
92112284|NCT01732757|Blood Substitutes|blood substitutes|mesh-ancestor
92054852|NCT01821729|Losartan|losartan|mesh-list
92112285|NCT01732757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92112286|NCT01732757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92057853|NCT02023151|Omalizumab|omalizumab|mesh-list
92112287|NCT01732757|Analgesics|analgesics|mesh-ancestor
92112288|NCT01732757|Sensory System Agents|sensory system agents|mesh-ancestor
92116853|NCT01230411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112289|NCT01732757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059924|NCT01778985|Estrogens|estrogens|mesh-list
92063848|NCT04405960|Micronutrients|micronutrients|mesh-ancestor
92065261|NCT01590771|Hormones|hormones|mesh-ancestor
92112290|NCT01732757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142908|NCT03912805|Botulinum Toxins|botulinum toxins|mesh-list
92069935|NCT00988858|Pemetrexed|pemetrexed|mesh-list
92142987|NCT04726878|Analgesics|analgesics|mesh-ancestor
92073745|NCT03364348|Antibodies|antibodies|mesh-list
92143064|NCT03588091|Trastuzumab|trastuzumab|mesh-list
92112291|NCT01732757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112292|NCT01732757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112293|NCT01732757|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92112294|NCT01732757|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92112295|NCT01732757|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92112296|NCT01732757|Histamine Antagonists|histamine antagonists|mesh-ancestor
92112298|NCT01732757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084332|NCT00619060|Niacin|niacin|mesh-list
92143218|NCT03891355|Autonomic Agents|autonomic agents|mesh-ancestor
92143368|NCT04514328|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92090103|NCT01913639|Vitamins|vitamins|mesh-ancestor
92112299|NCT01732757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112300|NCT01758731|Cetuximab|cetuximab|mesh-list
92094154|NCT03031756|Glycine|glycine|mesh-list
92112301|NCT01758731|Olaparib|olaparib|mesh-list
92095391|NCT01025830|Lamivudine|lamivudine|mesh-list
92112302|NCT01758731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112303|NCT01758731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112304|NCT01758731|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92112305|NCT01758731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112306|NCT01758731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112307|NCT01452477|Tanshinone|tanshinone|mesh-list
92112308|NCT01452477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112309|NCT01452477|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92112310|NCT01452477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92112311|NCT01452477|Analgesics|analgesics|mesh-ancestor
92112312|NCT01452477|Sensory System Agents|sensory system agents|mesh-ancestor
92112313|NCT01452477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112314|NCT01452477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112315|NCT01452477|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112316|NCT01452477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112317|NCT01452477|Anticoagulants|anticoagulants|mesh-ancestor
92112318|NCT01452477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92112319|NCT01452477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112320|NCT01452477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92112321|NCT01452477|Immunologic Factors|immunologic factors|mesh-ancestor
92112322|NCT01452633|Bupivacaine|bupivacaine|mesh-list
92112323|NCT01452633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92112324|NCT01452633|Anesthetics|anesthetics|mesh-ancestor
92112325|NCT01452633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112326|NCT01452633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112327|NCT01452633|Sensory System Agents|sensory system agents|mesh-ancestor
92112328|NCT01452633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112329|NCT01606319|Acetaminophen|acetaminophen|mesh-list
92112330|NCT01606319|Ibuprofen|ibuprofen|mesh-list
92112331|NCT01606319|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92112332|NCT01606319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92112333|NCT01606319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92112334|NCT01606319|Analgesics|analgesics|mesh-ancestor
92112335|NCT01606319|Sensory System Agents|sensory system agents|mesh-ancestor
92112336|NCT01606319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112337|NCT01606319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112338|NCT01606319|Antipyretics|antipyretics|mesh-ancestor
92112339|NCT01606319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112340|NCT01606319|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92112341|NCT01606319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112342|NCT01606319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112343|NCT01452711|Lansoprazole|lansoprazole|mesh-list
92112344|NCT01452711|Dexlansoprazole|dexlansoprazole|mesh-list
92112345|NCT01452711|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92112346|NCT01452711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112347|NCT01452711|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92112348|NCT01452711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112349|NCT01452711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112350|NCT02630121|Phenylephrine|phenylephrine|mesh-list
92112351|NCT02630121|Oxymetazoline|oxymetazoline|mesh-list
92112352|NCT02630121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92112353|NCT02630121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92112354|NCT02630121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112355|NCT02630121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112356|NCT02630121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112357|NCT02630121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112358|NCT02630121|Sympathomimetics|sympathomimetics|mesh-ancestor
92112359|NCT02630121|Autonomic Agents|autonomic agents|mesh-ancestor
92112360|NCT02630121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112361|NCT02630121|Nasal Decongestants|nasal decongestants|mesh-ancestor
92112362|NCT02630121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92112363|NCT02630121|Respiratory System Agents|respiratory system agents|mesh-ancestor
92112365|NCT02630121|Mydriatics|mydriatics|mesh-ancestor
92112366|NCT02630121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92112367|NCT02630121|Protective Agents|protective agents|mesh-ancestor
92112368|NCT02956785|Dinoprostone|dinoprostone|mesh-list
92112369|NCT02956785|Oxytocics|oxytocics|mesh-ancestor
92112370|NCT02956785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92112371|NCT02956785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112372|NCT01452867|Chlorhexidine|chlorhexidine|mesh-list
92112373|NCT01452867|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92112374|NCT01452867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112375|NCT01452867|Disinfectants|disinfectants|mesh-ancestor
92112376|NCT02910531|Thioctic Acid|thioctic acid|mesh-list
92112377|NCT02910531|Antioxidants|antioxidants|mesh-ancestor
92143369|NCT04514328|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92112378|NCT02910531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112379|NCT02910531|Protective Agents|protective agents|mesh-ancestor
92112380|NCT02910531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112381|NCT02910531|Vitamin B Complex|vitamin b complex|mesh-ancestor
92112382|NCT02910531|Vitamins|vitamins|mesh-ancestor
92112383|NCT02910531|Micronutrients|micronutrients|mesh-ancestor
92112384|NCT02947581|Albendazole|albendazole|mesh-list
92112385|NCT02947581|Praziquantel|praziquantel|mesh-list
92112386|NCT02947581|Anthelmintics|anthelmintics|mesh-ancestor
92112387|NCT02947581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92112388|NCT02947581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112389|NCT02947581|Anticestodal Agents|anticestodal agents|mesh-ancestor
92112390|NCT02947581|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92112391|NCT02947581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92112392|NCT02947581|Tubulin Modulators|tubulin modulators|mesh-ancestor
92112393|NCT02947581|Antimitotic Agents|antimitotic agents|mesh-ancestor
92112394|NCT02947581|Mitosis Modulators|mitosis modulators|mesh-ancestor
92112395|NCT02947581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112396|NCT02947581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112397|NCT05606757|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92112398|NCT05606757|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92112399|NCT05606757|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92112400|NCT05606757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112401|NCT05606757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112402|NCT05606757|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92112403|NCT05606757|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92112404|NCT05606757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112405|NCT05606757|Cholinergic Agents|cholinergic agents|mesh-ancestor
92112406|NCT05606757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112407|NCT01453881|Beclomethasone|beclomethasone|mesh-list
92112408|NCT01453881|Formoterol Fumarate|formoterol fumarate|mesh-list
92112409|NCT01453881|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92112410|NCT01453881|Autonomic Agents|autonomic agents|mesh-ancestor
92112411|NCT01453881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112412|NCT01453881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112413|NCT01453881|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92112414|NCT01453881|Respiratory System Agents|respiratory system agents|mesh-ancestor
92112415|NCT01453881|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92112416|NCT01453881|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92112417|NCT01453881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92112418|NCT01453881|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112419|NCT01453881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112420|NCT01453881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112421|NCT01453881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112422|NCT01453881|Glucocorticoids|glucocorticoids|mesh-ancestor
92112423|NCT01453881|Hormones|hormones|mesh-ancestor
92112424|NCT01453881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112425|NCT04391361|Atropine|atropine|mesh-list
92112426|NCT04391361|Scopolamine|scopolamine|mesh-list
92112427|NCT04391361|Dexmedetomidine|dexmedetomidine|mesh-list
92112428|NCT04391361|Edaravone|edaravone|mesh-list
92112429|NCT04391361|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92112430|NCT04391361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92112431|NCT04391361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112432|NCT04391361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112433|NCT04391361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92112434|NCT04391361|Analgesics|analgesics|mesh-ancestor
92112435|NCT04391361|Sensory System Agents|sensory system agents|mesh-ancestor
92112436|NCT04391361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112437|NCT04391361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92112438|NCT04391361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92112440|NCT04391361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112441|NCT04391361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112442|NCT04391361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112443|NCT04391361|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92112444|NCT04391361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92112445|NCT04391361|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92112446|NCT04391361|Autonomic Agents|autonomic agents|mesh-ancestor
92112447|NCT04391361|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92112448|NCT04391361|Respiratory System Agents|respiratory system agents|mesh-ancestor
92112449|NCT04391361|Mydriatics|mydriatics|mesh-ancestor
92112450|NCT04391361|Parasympatholytics|parasympatholytics|mesh-ancestor
92112451|NCT04391361|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92112452|NCT04391361|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92112453|NCT04391361|Cholinergic Agents|cholinergic agents|mesh-ancestor
92112454|NCT04391361|Antiemetics|antiemetics|mesh-ancestor
92112455|NCT04391361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112456|NCT04391361|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92112457|NCT04391361|Antioxidants|antioxidants|mesh-ancestor
92112458|NCT04391361|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92112459|NCT04391361|Protective Agents|protective agents|mesh-ancestor
92112460|NCT03035331|Pembrolizumab|pembrolizumab|mesh-list
92112461|NCT03035331|Vaccines|vaccines|mesh-list
92112462|NCT03035331|Immunologic Factors|immunologic factors|mesh-ancestor
92112463|NCT03035331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112464|NCT03035331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112465|NCT03035331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112466|NCT03035331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112467|NCT03035331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112468|NCT04273191|Brexanolone|brexanolone|mesh-list
92112469|NCT04273191|Neurosteroids|neurosteroids|mesh-ancestor
92070568|NCT03827278|Amebicides|amebicides|mesh-ancestor
92112485|NCT01455597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112486|NCT01455597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112487|NCT01453101|Fludarabine|fludarabine|mesh-list
92112488|NCT01453101|Fludarabine phosphate|fludarabine phosphate|mesh-list
92112489|NCT01453101|Bortezomib|bortezomib|mesh-list
92112490|NCT01453101|Melphalan|melphalan|mesh-list
92112491|NCT01453101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112492|NCT01453101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92112493|NCT01453101|Antimetabolites|antimetabolites|mesh-ancestor
92112494|NCT01453101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112495|NCT01453101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92112496|NCT01453101|Immunologic Factors|immunologic factors|mesh-ancestor
92112497|NCT01453101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112498|NCT01453101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92112499|NCT01453101|Alkylating Agents|alkylating agents|mesh-ancestor
92112500|NCT01453101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92112501|NCT02085447|Haloperidol|haloperidol|mesh-list
92112502|NCT02085447|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92112503|NCT02085447|Haloperidol decanoate|haloperidol decanoate|mesh-list
92112504|NCT02085447|Antipsychotic Agents|antipsychotic agents|mesh-list
92112505|NCT02085447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92112506|NCT02085447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112507|NCT02085447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112508|NCT02085447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112509|NCT02085447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92112510|NCT02085447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92112511|NCT02085447|Serotonin Agents|serotonin agents|mesh-ancestor
92112512|NCT02085447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112513|NCT02085447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112514|NCT02085447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92112515|NCT02085447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92112516|NCT02085447|Dopamine Agents|dopamine agents|mesh-ancestor
92112517|NCT02085447|Antiemetics|antiemetics|mesh-ancestor
92112518|NCT02085447|Autonomic Agents|autonomic agents|mesh-ancestor
92112519|NCT02085447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112520|NCT02085447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112521|NCT02085447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92112522|NCT04847193|Xanthohumol|xanthohumol|mesh-list
92112523|NCT04847193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112524|NCT04847193|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92112525|NCT04847193|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92112526|NCT04847193|Growth Substances|growth substances|mesh-ancestor
92112527|NCT04847193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112528|NCT04847193|Growth Inhibitors|growth inhibitors|mesh-ancestor
92070649|NCT03043924|Estradiol|estradiol|mesh-list
92112544|NCT04273035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92112545|NCT04273035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92112546|NCT04273035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112547|NCT04273035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112549|NCT04273035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92112550|NCT04273035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112551|NCT04273035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92112552|NCT04273035|Anesthetics, General|anesthetics, general|mesh-ancestor
92112553|NCT04273035|Anesthetics|anesthetics|mesh-ancestor
92112554|NCT04273035|GABA Modulators|gaba modulators|mesh-ancestor
92112555|NCT04273035|GABA Agents|gaba agents|mesh-ancestor
92112556|NCT04273035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112557|NCT04273035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112558|NCT02836899|Nitric Oxide|nitric oxide|mesh-list
92112559|NCT02836899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92112560|NCT02836899|Autonomic Agents|autonomic agents|mesh-ancestor
92112561|NCT02836899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112562|NCT02836899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112563|NCT02836899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92112564|NCT02836899|Respiratory System Agents|respiratory system agents|mesh-ancestor
92112565|NCT02836899|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92112566|NCT02836899|Antioxidants|antioxidants|mesh-ancestor
92112567|NCT02836899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112568|NCT02836899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112569|NCT02836899|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92112570|NCT02836899|Vasodilator Agents|vasodilator agents|mesh-ancestor
92112571|NCT02836899|Gasotransmitters|gasotransmitters|mesh-ancestor
92112572|NCT02836899|Protective Agents|protective agents|mesh-ancestor
92112573|NCT02902029|Atezolizumab|atezolizumab|mesh-list
92112574|NCT02902029|Vemurafenib|vemurafenib|mesh-list
92112575|NCT02902029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112576|NCT02902029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112577|NCT02902029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112578|NCT02902029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112579|NCT02902029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92112580|NCT02902029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112581|NCT02933697|Apixaban|apixaban|mesh-list
92112582|NCT02933697|Phenprocoumon|phenprocoumon|mesh-list
92112583|NCT02933697|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92112584|NCT02933697|Antithrombins|antithrombins|mesh-ancestor
92112585|NCT02933697|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92112586|NCT02933697|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112587|NCT02933697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112588|NCT02933697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112589|NCT02933697|Anticoagulants|anticoagulants|mesh-ancestor
92112590|NCT01455129|Tiotropium Bromide|tiotropium bromide|mesh-list
92112591|NCT01455129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92112592|NCT01455129|Autonomic Agents|autonomic agents|mesh-ancestor
92112593|NCT01455129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112594|NCT01455129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112595|NCT01455129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92112596|NCT01455129|Respiratory System Agents|respiratory system agents|mesh-ancestor
92112597|NCT01455129|Parasympatholytics|parasympatholytics|mesh-ancestor
92112598|NCT01455129|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92112599|NCT01455129|Cholinergic Agents|cholinergic agents|mesh-ancestor
92112600|NCT01455129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112601|NCT01455129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112602|NCT02784171|Pembrolizumab|pembrolizumab|mesh-list
92112603|NCT02784171|Pemetrexed|pemetrexed|mesh-list
92112604|NCT02784171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112605|NCT02784171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112606|NCT02784171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112607|NCT02784171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112608|NCT02784171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112609|NCT02784171|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92112610|NCT02784171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92112611|NCT01455441|Liraglutide|liraglutide|mesh-list
92112612|NCT01455441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92112613|NCT01455441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112614|NCT01455441|Incretins|incretins|mesh-ancestor
92112615|NCT01455441|Hormones|hormones|mesh-ancestor
92112616|NCT01455441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112617|NCT01455831|Tinzaparin|tinzaparin|mesh-list
92112618|NCT01455831|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92112619|NCT01455831|Dalteparin|dalteparin|mesh-list
92112620|NCT01455831|Anticoagulants|anticoagulants|mesh-ancestor
92112621|NCT01455831|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92112623|NCT01455831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112624|NCT04840641|Efavirenz|efavirenz|mesh-list
92112625|NCT04840641|Floxacillin|floxacillin|mesh-list
92112626|NCT04840641|Losartan|losartan|mesh-list
92112627|NCT04840641|Metoprolol|metoprolol|mesh-list
92112628|NCT04840641|Midazolam|midazolam|mesh-list
92112629|NCT04840641|Caffeine|caffeine|mesh-list
92112630|NCT04840641|Omeprazole|omeprazole|mesh-list
92112631|NCT04840641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92112632|NCT04840641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92112633|NCT04840641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112634|NCT04840641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112635|NCT04840641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92112636|NCT04840641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92112637|NCT04840641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112638|NCT04840641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92112639|NCT04840641|Anesthetics, General|anesthetics, general|mesh-ancestor
92112640|NCT04840641|Anesthetics|anesthetics|mesh-ancestor
92112641|NCT04840641|GABA Modulators|gaba modulators|mesh-ancestor
92112642|NCT04840641|GABA Agents|gaba agents|mesh-ancestor
92112643|NCT04840641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112644|NCT04840641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112645|NCT04840641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92112646|NCT04840641|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92112647|NCT04840641|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92112648|NCT04840641|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92112649|NCT04840641|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92112650|NCT04840641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92112651|NCT04840641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112652|NCT04840641|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92112653|NCT04840641|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92112654|NCT04840641|Purinergic Agents|purinergic agents|mesh-ancestor
92112655|NCT04840641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92112656|NCT04840641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112657|NCT04840641|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92112658|NCT04840641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92112659|NCT04840641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92112660|NCT04840641|Antiviral Agents|antiviral agents|mesh-ancestor
92112661|NCT04840641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112662|NCT04840641|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92112663|NCT04840641|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92112664|NCT04840641|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92112665|NCT04840641|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92112666|NCT04840641|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92112667|NCT04840641|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92112668|NCT04840641|Sympatholytics|sympatholytics|mesh-ancestor
92112669|NCT04840641|Autonomic Agents|autonomic agents|mesh-ancestor
92112670|NCT04840641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112671|NCT04840641|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92112672|NCT04840641|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92112673|NCT04840641|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92112674|NCT04840641|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112675|NCT04840641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92112676|NCT01455909|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92112677|NCT01455909|Exenatide|exenatide|mesh-list
92112678|NCT01455909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92112679|NCT01455909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112680|NCT01455909|Incretins|incretins|mesh-ancestor
92112681|NCT01455909|Hormones|hormones|mesh-ancestor
92112682|NCT01455909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112683|NCT01455909|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92112684|NCT01455909|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112685|NCT01455909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112686|NCT01455909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112687|NCT01455909|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92112688|NCT04844619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92112689|NCT04844619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92112691|NCT02555787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92112692|NCT02555787|Immunologic Factors|immunologic factors|mesh-ancestor
92112693|NCT02555787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938453|NCT01352741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112694|NCT02555787|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92112695|NCT02555787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112696|NCT02555787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112698|NCT01730729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92112699|NCT01730729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92112700|NCT01730729|Dopamine Agonists|dopamine agonists|mesh-ancestor
92112701|NCT01730729|Dopamine Agents|dopamine agents|mesh-ancestor
92112702|NCT01730729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112703|NCT01730729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112704|NCT01730729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112705|NCT01756157|Complement C1s|complement c1s|mesh-list
92112706|NCT01756157|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92112707|NCT01756157|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92112708|NCT01756157|Immunologic Factors|immunologic factors|mesh-ancestor
92143446|NCT03589495|Acetylcysteine|acetylcysteine|mesh-list
92112709|NCT01756157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112710|NCT01756157|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92112711|NCT01756157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92112712|NCT04846491|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92112713|NCT04846491|Interferon-alpha|interferon-alpha|mesh-list
92112714|NCT04846491|Antiviral Agents|antiviral agents|mesh-ancestor
92112715|NCT04846491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112716|NCT04846491|Immunologic Factors|immunologic factors|mesh-ancestor
92112717|NCT04846491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112718|NCT01756079|Ribavirin|ribavirin|mesh-list
92112719|NCT01756079|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92112720|NCT01756079|Antimetabolites|antimetabolites|mesh-ancestor
92112721|NCT01756079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112722|NCT01756079|Antiviral Agents|antiviral agents|mesh-ancestor
92112723|NCT01756079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112724|NCT04272645|Atezolizumab|atezolizumab|mesh-list
92112725|NCT04272645|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112726|NCT04272645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112727|NCT04272645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92112728|NCT04272645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112729|NCT04390815|Insulin|insulin|mesh-list
92112730|NCT04390815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92112731|NCT04390815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92112732|NCT04390815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112733|NCT01456611|Diclofenac|diclofenac|mesh-list
92112734|NCT01456611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92112735|NCT01456611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92112736|NCT01456611|Analgesics|analgesics|mesh-ancestor
92112737|NCT01456611|Sensory System Agents|sensory system agents|mesh-ancestor
92112738|NCT01456611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112739|NCT01456611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112740|NCT01456611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112741|NCT01456611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112742|NCT01456611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92112743|NCT01456611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112744|NCT01456611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112745|NCT01456689|Midazolam|midazolam|mesh-list
92112746|NCT01456689|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92112747|NCT01456689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92112748|NCT01456689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112749|NCT01456689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112750|NCT01456689|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92112751|NCT01456689|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92112752|NCT01456689|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112753|NCT01456689|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92112754|NCT01456689|Anesthetics, General|anesthetics, general|mesh-ancestor
92112755|NCT01456689|Anesthetics|anesthetics|mesh-ancestor
92112756|NCT01456689|GABA Modulators|gaba modulators|mesh-ancestor
92112757|NCT01456689|GABA Agents|gaba agents|mesh-ancestor
92112758|NCT01456689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112759|NCT01456689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112760|NCT05827159|Naltrexone|naltrexone|mesh-list
92112761|NCT05827159|Gabapentin|gabapentin|mesh-list
92112762|NCT05827159|Analgesics|analgesics|mesh-ancestor
92112763|NCT05827159|Sensory System Agents|sensory system agents|mesh-ancestor
92112764|NCT05827159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112765|NCT05827159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112766|NCT05827159|Anticonvulsants|anticonvulsants|mesh-ancestor
92112767|NCT05827159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92112768|NCT05827159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92112769|NCT05827159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112770|NCT05827159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92112771|NCT05827159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92112772|NCT05827159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92112773|NCT05827159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112774|NCT05827159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112775|NCT05827159|Antimanic Agents|antimanic agents|mesh-ancestor
92112776|NCT05827159|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92112777|NCT05827159|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92112779|NCT05827081|Leuprolide|leuprolide|mesh-list
92112780|NCT05827081|Goserelin|goserelin|mesh-list
92112781|NCT05827081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112782|NCT05827081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92112783|NCT05827081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92112784|NCT05827081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112785|NCT05827081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112786|NCT05827081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92112787|NCT05827081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92112788|NCT05827081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112789|NCT05827081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112790|NCT05827081|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92112791|NCT05827081|Fertility Agents|fertility agents|mesh-ancestor
92112792|NCT05827081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92112793|NCT05827081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92112794|NCT05827042|Tenecteplase|tenecteplase|mesh-list
92112795|NCT05827042|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92112796|NCT05827042|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92112797|NCT05827042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112798|NCT05826990|Cefepime|cefepime|mesh-list
92112799|NCT05826990|Enmetazobactam|enmetazobactam|mesh-list
92112800|NCT05826990|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92112801|NCT05826990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112802|NCT05826990|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92112803|NCT05826990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112804|NCT05826990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112805|NCT05826821|Pirfenidone|pirfenidone|mesh-list
92112806|NCT05826821|Analgesics|analgesics|mesh-ancestor
92112807|NCT05826821|Sensory System Agents|sensory system agents|mesh-ancestor
92112808|NCT05826821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112809|NCT05826821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112810|NCT05826821|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92112811|NCT05826821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92112812|NCT05826821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112813|NCT05826821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92112814|NCT05826821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112815|NCT05826444|Calcium|calcium|mesh-list
92112816|NCT05826444|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92112817|NCT05826444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112818|NCT05826249|Ritonavir|ritonavir|mesh-list
92112819|NCT05826249|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92112820|NCT05826249|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92112821|NCT05826249|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112822|NCT05826249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112823|NCT05826249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112824|NCT05826249|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92112825|NCT05826249|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92112826|NCT05826249|Antiviral Agents|antiviral agents|mesh-ancestor
92112827|NCT05826249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112828|NCT05826249|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92112829|NCT05826249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92112830|NCT05826015|Paclitaxel|paclitaxel|mesh-list
92112831|NCT05826015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92112832|NCT05826015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112833|NCT05826015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92112834|NCT05826015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92112835|NCT05826015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92112836|NCT05826015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112837|NCT05825963|Psyllium|psyllium|mesh-list
92112838|NCT05825963|Cathartics|cathartics|mesh-ancestor
92112839|NCT05825963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112840|NCT05825872|Lidocaine|lidocaine|mesh-list
92112841|NCT05825872|Bupivacaine|bupivacaine|mesh-list
91938455|NCT01352741|Narcotics|narcotics|mesh-ancestor
92112842|NCT05825872|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92112843|NCT05825872|Anesthetics, Local|anesthetics, local|mesh-ancestor
92112844|NCT05825872|Anesthetics|anesthetics|mesh-ancestor
92112845|NCT05825872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112846|NCT05825872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112847|NCT05825872|Sensory System Agents|sensory system agents|mesh-ancestor
92112848|NCT05825872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112849|NCT05825872|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92112850|NCT05825872|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92112851|NCT05825872|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92112852|NCT05825872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92112853|NCT05825872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112854|NCT05825625|Atezolizumab|atezolizumab|mesh-list
92112855|NCT05825625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112856|NCT05825625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112857|NCT05825625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143447|NCT03589495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92112858|NCT05825625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112859|NCT05825599|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92112860|NCT05825599|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92112861|NCT05825586|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92112862|NCT05825586|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92112863|NCT05825430|Bupivacaine|bupivacaine|mesh-list
92112864|NCT05825430|Anesthetics|anesthetics|mesh-list
92112865|NCT05825430|Anesthetics, General|anesthetics, general|mesh-list
92112866|NCT05825430|Anesthetics, Local|anesthetics, local|mesh-ancestor
92112867|NCT05825430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112868|NCT05825430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112869|NCT05825430|Sensory System Agents|sensory system agents|mesh-ancestor
92112870|NCT05825430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112871|NCT05825417|Selexipag|selexipag|mesh-list
92112872|NCT05825417|Riociguat|riociguat|mesh-list
92112873|NCT05825417|Enzyme Activators|enzyme activators|mesh-ancestor
92112874|NCT05825417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112875|NCT05825417|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92112876|NCT05825378|Dexamethasone|dexamethasone|mesh-list
92112877|NCT05825378|Ropivacaine|ropivacaine|mesh-list
92112878|NCT05825378|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112879|NCT05825378|Antiemetics|antiemetics|mesh-ancestor
92112880|NCT05825378|Autonomic Agents|autonomic agents|mesh-ancestor
92112881|NCT05825378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112882|NCT05825378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112883|NCT05825378|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112884|NCT05825378|Glucocorticoids|glucocorticoids|mesh-ancestor
92112885|NCT05825378|Hormones|hormones|mesh-ancestor
92112886|NCT05825378|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112887|NCT05825378|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92112888|NCT05825378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112889|NCT05825378|Anesthetics, Local|anesthetics, local|mesh-ancestor
92112890|NCT05825378|Anesthetics|anesthetics|mesh-ancestor
92112891|NCT05825378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112892|NCT05825378|Sensory System Agents|sensory system agents|mesh-ancestor
92112893|NCT05825235|Pramipexole|pramipexole|mesh-list
92112894|NCT05825235|Antioxidants|antioxidants|mesh-ancestor
92112895|NCT05825235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112896|NCT05825235|Protective Agents|protective agents|mesh-ancestor
92112897|NCT05825235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112898|NCT05825235|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92112899|NCT05825235|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92112900|NCT05825235|Dopamine Agonists|dopamine agonists|mesh-ancestor
92112901|NCT05825235|Dopamine Agents|dopamine agents|mesh-ancestor
92112902|NCT05825235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112903|NCT05825092|Methyltestosterone|methyltestosterone|mesh-list
92112904|NCT05825092|Testosterone|testosterone|mesh-list
92112905|NCT05825092|Testosterone undecanoate|testosterone undecanoate|mesh-list
92112906|NCT05825092|Testosterone enanthate|testosterone enanthate|mesh-list
92112907|NCT05825092|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92112908|NCT05825092|Androgens|androgens|mesh-ancestor
92112909|NCT05825092|Hormones|hormones|mesh-ancestor
92112910|NCT05825092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112911|NCT05825092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112912|NCT05825092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92112913|NCT05825092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112914|NCT05825092|Anabolic Agents|anabolic agents|mesh-ancestor
92112916|NCT05824897|Vitamins|vitamins|mesh-ancestor
92112917|NCT05824897|Micronutrients|micronutrients|mesh-ancestor
92112918|NCT05824897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112919|NCT05824897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92112920|NCT05824871|Bedaquiline|bedaquiline|mesh-list
92112921|NCT05824871|Antitubercular Agents|antitubercular agents|mesh-ancestor
92112922|NCT05824871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92112923|NCT05824871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92112924|NCT05824832|Dexamethasone|dexamethasone|mesh-list
92112925|NCT05824832|Dexamethasone acetate|dexamethasone acetate|mesh-list
92112927|NCT05824832|Buprenorphine|buprenorphine|mesh-list
92112928|NCT05824832|BB 1101|bb 1101|mesh-list
92112929|NCT05824832|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92112930|NCT05824832|Antiemetics|antiemetics|mesh-ancestor
92112931|NCT05824832|Autonomic Agents|autonomic agents|mesh-ancestor
92112932|NCT05824832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112933|NCT05824832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112934|NCT05824832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92112935|NCT05824832|Glucocorticoids|glucocorticoids|mesh-ancestor
92112936|NCT05824832|Hormones|hormones|mesh-ancestor
92115208|NCT01721759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92112937|NCT05824832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92112938|NCT05824832|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92112939|NCT05824832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92112940|NCT05824832|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112941|NCT05824832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112942|NCT05824832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112943|NCT05824832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92112944|NCT05824832|Narcotics|narcotics|mesh-ancestor
92112945|NCT05824832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112946|NCT05824832|Analgesics|analgesics|mesh-ancestor
92112947|NCT05824832|Sensory System Agents|sensory system agents|mesh-ancestor
92112948|NCT05824832|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92112949|NCT05824832|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92112950|NCT05824832|Sympatholytics|sympatholytics|mesh-ancestor
92112951|NCT05824832|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92112952|NCT05824832|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92112953|NCT05824832|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92112954|NCT05824832|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112955|NCT05824832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112956|NCT05824806|Hyaluronic Acid|hyaluronic acid|mesh-list
92112957|NCT05824806|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92112958|NCT05824806|Immunologic Factors|immunologic factors|mesh-ancestor
92112959|NCT05824806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112960|NCT05824806|Viscosupplements|viscosupplements|mesh-ancestor
92112961|NCT05824806|Protective Agents|protective agents|mesh-ancestor
92112962|NCT05824767|Angiotensin II|angiotensin ii|mesh-list
92112963|NCT05824767|Giapreza|giapreza|mesh-list
92112964|NCT05824767|Angiotensinogen|angiotensinogen|mesh-list
92112965|NCT05824767|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92112966|NCT05824767|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92112967|NCT05824767|Protease Inhibitors|protease inhibitors|mesh-ancestor
92112968|NCT05824767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92112969|NCT05824767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112970|NCT05824728|Levetiracetam|levetiracetam|mesh-list
92112971|NCT05824728|Anticonvulsants|anticonvulsants|mesh-ancestor
92112972|NCT05824728|Nootropic Agents|nootropic agents|mesh-ancestor
92112973|NCT05823844|Suvorexant|suvorexant|mesh-list
92112974|NCT05823844|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92112975|NCT05823844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92112976|NCT05823844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112977|NCT05823844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112978|NCT05823844|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92112979|NCT05823844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112980|NCT05823844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112981|NCT05823662|Silodosin|silodosin|mesh-list
92112982|NCT05823662|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92112983|NCT05823662|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92112984|NCT05823662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92112985|NCT05823662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92112986|NCT05823662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92112987|NCT05823662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92112988|NCT05823662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112989|NCT05823662|Urological Agents|urological agents|mesh-ancestor
92112991|NCT05823363|Anesthetics, Local|anesthetics, local|mesh-ancestor
92112992|NCT05823363|Anesthetics|anesthetics|mesh-ancestor
92112993|NCT05823363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92112994|NCT05823363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92112995|NCT05823363|Sensory System Agents|sensory system agents|mesh-ancestor
92112996|NCT05823363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92112997|NCT05822076|Ropivacaine|ropivacaine|mesh-list
92112998|NCT05822076|Anesthetics, Local|anesthetics, local|mesh-ancestor
92112999|NCT05822076|Anesthetics|anesthetics|mesh-ancestor
92113000|NCT05822076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113001|NCT05822076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113002|NCT05822076|Sensory System Agents|sensory system agents|mesh-ancestor
92113003|NCT05822076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113005|NCT05821543|Sibutramine|sibutramine|mesh-list
92113006|NCT05821543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92113007|NCT05821543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113008|NCT05821543|Antidepressive Agents|antidepressive agents|mesh-ancestor
92113009|NCT05821543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113010|NCT05821543|Appetite Depressants|appetite depressants|mesh-ancestor
92113011|NCT05821543|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92113012|NCT05811949|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92113013|NCT05811949|Dermatologic Agents|dermatologic agents|mesh-ancestor
92113014|NCT05811949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113015|NCT05811949|Immunologic Factors|immunologic factors|mesh-ancestor
92113016|NCT05811949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113017|NCT05810233|Ascorbic Acid|ascorbic acid|mesh-list
92113018|NCT05810233|Vitamins|vitamins|mesh-ancestor
92113019|NCT05810233|Micronutrients|micronutrients|mesh-ancestor
92113020|NCT05810233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113021|NCT05810233|Antioxidants|antioxidants|mesh-ancestor
92113022|NCT05810233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113023|NCT05810233|Protective Agents|protective agents|mesh-ancestor
92113024|NCT05801978|Vaccines|vaccines|mesh-list
92113025|NCT05801978|Immunologic Factors|immunologic factors|mesh-ancestor
92113026|NCT05801978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113027|NCT05800639|Anesthetics|anesthetics|mesh-list
92113028|NCT05800639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113029|NCT05800639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113030|NCT05776108|Cabotegravir|cabotegravir|mesh-list
92113031|NCT05776108|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92113032|NCT05776108|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92113033|NCT05776108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113034|NCT05776108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113035|NCT05776108|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92113036|NCT05776108|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92113037|NCT05776108|Antiviral Agents|antiviral agents|mesh-ancestor
92113038|NCT05776108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113039|NCT05753618|Lenograstim|lenograstim|mesh-list
92113040|NCT05753618|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92113041|NCT05753618|Immunologic Factors|immunologic factors|mesh-ancestor
92113042|NCT05753618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113043|NCT05752461|Enoxaparin|enoxaparin|mesh-list
92113044|NCT05752461|Enoxaparin sodium|enoxaparin sodium|mesh-list
92113045|NCT05752461|Anticoagulants|anticoagulants|mesh-ancestor
92113046|NCT05752461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92113047|NCT05752461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92113048|NCT05752461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113049|NCT05750992|Fentanyl|fentanyl|mesh-list
92113050|NCT05750992|Meperidine|meperidine|mesh-list
92113051|NCT05750992|Bupivacaine|bupivacaine|mesh-list
92113052|NCT05750992|Anesthetics, Local|anesthetics, local|mesh-ancestor
92113053|NCT05750992|Anesthetics|anesthetics|mesh-ancestor
92113054|NCT05750992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113055|NCT05750992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113056|NCT05750992|Sensory System Agents|sensory system agents|mesh-ancestor
92113057|NCT05750992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113058|NCT05750992|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92113059|NCT05750992|Narcotics|narcotics|mesh-ancestor
92113060|NCT05750992|Analgesics|analgesics|mesh-ancestor
92113061|NCT05750992|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92113062|NCT05750992|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113063|NCT05750992|Anesthetics, General|anesthetics, general|mesh-ancestor
92113064|NCT05733546|Psilocybin|psilocybin|mesh-list
92113065|NCT05733546|Hallucinogens|hallucinogens|mesh-ancestor
92113066|NCT05733546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113068|NCT05724550|Neostigmine|neostigmine|mesh-list
92113069|NCT05724550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92113070|NCT05724550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113071|NCT05724550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113072|NCT05724550|Cholinergic Agents|cholinergic agents|mesh-ancestor
92113073|NCT05724550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113074|NCT05724550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113075|NCT05724550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92113076|NCT05724550|Autonomic Agents|autonomic agents|mesh-ancestor
92113077|NCT05724550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113078|NCT05659329|Gentamicins|gentamicins|mesh-list
92113079|NCT05659329|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92113080|NCT05659329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113081|NCT05659329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92113082|NCT05659329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113083|NCT05659329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113084|NCT05653258|Dasatinib|dasatinib|mesh-list
92113085|NCT05653258|Quercetin|quercetin|mesh-list
92113086|NCT05653258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113087|NCT05653258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92113088|NCT05653258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113089|NCT05653258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113090|NCT05653258|Antioxidants|antioxidants|mesh-ancestor
92113091|NCT05653258|Protective Agents|protective agents|mesh-ancestor
92143448|NCT03589495|Antiviral Agents|antiviral agents|mesh-ancestor
92113092|NCT05653258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113093|NCT05632627|Cannabidiol|cannabidiol|mesh-list
92113094|NCT05632627|Anticonvulsants|anticonvulsants|mesh-ancestor
92113095|NCT05586802|Anastrozole|anastrozole|mesh-list
92113096|NCT05586802|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92113097|NCT05586802|Testosterone|testosterone|mesh-list
92113098|NCT05586802|Androgens|androgens|mesh-ancestor
92113099|NCT05586802|Hormones|hormones|mesh-ancestor
92113100|NCT05586802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113101|NCT05586802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113102|NCT05586802|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92113103|NCT05586802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113104|NCT05586802|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92113105|NCT05586802|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92113106|NCT05586802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113107|NCT05586802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113108|NCT05586802|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92113109|NCT05586802|Hormone Antagonists|hormone antagonists|mesh-ancestor
92113110|NCT05586802|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92113111|NCT05504291|Carboplatin|carboplatin|mesh-list
92113112|NCT05504291|Etoposide|etoposide|mesh-list
92113113|NCT05504291|Vincristine|vincristine|mesh-list
92113114|NCT05504291|Etoposide phosphate|etoposide phosphate|mesh-list
92113115|NCT05504291|Melphalan|melphalan|mesh-list
92113116|NCT05504291|Mechlorethamine|mechlorethamine|mesh-list
92113117|NCT05504291|Podophyllotoxin|podophyllotoxin|mesh-list
92113118|NCT05504291|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92113119|NCT05504291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113120|NCT05504291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113121|NCT05504291|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113122|NCT05504291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92113123|NCT05504291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92113124|NCT05504291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113125|NCT05504291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113126|NCT05504291|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113127|NCT05504291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113128|NCT05504291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113129|NCT05504291|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92113130|NCT05504291|Alkylating Agents|alkylating agents|mesh-ancestor
92113131|NCT05504291|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92113132|NCT05504291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113133|NCT05504291|Immunologic Factors|immunologic factors|mesh-ancestor
92113134|NCT05504291|Keratolytic Agents|keratolytic agents|mesh-ancestor
92113135|NCT05504291|Dermatologic Agents|dermatologic agents|mesh-ancestor
92113136|NCT05496036|Pembrolizumab|pembrolizumab|mesh-list
92113137|NCT05496036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113138|NCT05496036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113139|NCT05496036|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113140|NCT05496036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113142|NCT05487859|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92113143|NCT05487859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113144|NCT05487859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113145|NCT05487859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92113146|NCT05487859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113147|NCT05413304|Temozolomide|temozolomide|mesh-list
92113148|NCT05413304|Dialysis Solutions|dialysis solutions|mesh-list
92113149|NCT05413304|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92113150|NCT05413304|Alkylating Agents|alkylating agents|mesh-ancestor
92113151|NCT05413304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113152|NCT05413304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113153|NCT05413304|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92113154|NCT05375084|Nivolumab|nivolumab|mesh-list
92113155|NCT05375084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113156|NCT05375084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113157|NCT05375084|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113158|NCT05375084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113159|NCT05359237|Vincristine|vincristine|mesh-list
92113160|NCT05359237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113161|NCT05359237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113162|NCT05359237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113163|NCT05359237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113164|NCT05359237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113165|NCT05359237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113166|NCT05346354|Ravulizumab|ravulizumab|mesh-list
92113167|NCT05346354|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92113168|NCT05346354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113169|NCT05346354|Immunologic Factors|immunologic factors|mesh-ancestor
92113170|NCT05346354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113171|NCT05331664|Moxifloxacin|moxifloxacin|mesh-list
92113172|NCT05331664|Polymyxins|polymyxins|mesh-list
92113173|NCT05331664|Trimethoprim|trimethoprim|mesh-list
92113174|NCT05331664|Prednisolone|prednisolone|mesh-list
92113175|NCT05331664|Prednisolone acetate|prednisolone acetate|mesh-list
92113176|NCT05331664|Triamcinolone|triamcinolone|mesh-list
92113177|NCT05331664|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92113178|NCT05331664|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92113179|NCT05331664|Atropine|atropine|mesh-list
92113180|NCT05331664|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92113181|NCT05331664|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92113182|NCT05331664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92113183|NCT05331664|Glucocorticoids|glucocorticoids|mesh-ancestor
92113184|NCT05331664|Hormones|hormones|mesh-ancestor
92113185|NCT05331664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113186|NCT05331664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113187|NCT05331664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92113188|NCT05331664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113189|NCT05331664|Autonomic Agents|autonomic agents|mesh-ancestor
92113190|NCT05331664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113191|NCT05331664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92113192|NCT05331664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113193|NCT05331664|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92113194|NCT05331664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92113195|NCT05331664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113196|NCT05331664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113197|NCT05331664|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92113198|NCT05331664|Contraceptive Agents|contraceptive agents|mesh-ancestor
92113199|NCT05331664|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92113200|NCT05331664|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92113201|NCT05331664|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92113202|NCT05331664|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92113203|NCT05331664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113204|NCT05331664|Immunologic Factors|immunologic factors|mesh-ancestor
92113205|NCT05331664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92113206|NCT05331664|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92113207|NCT05331664|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92113208|NCT05331664|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92113209|NCT05331664|Respiratory System Agents|respiratory system agents|mesh-ancestor
92113210|NCT05331664|Mydriatics|mydriatics|mesh-ancestor
92113211|NCT05331664|Parasympatholytics|parasympatholytics|mesh-ancestor
92113212|NCT05331664|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92113213|NCT05331664|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92113214|NCT05331664|Cholinergic Agents|cholinergic agents|mesh-ancestor
92113215|NCT05331664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113216|NCT05331664|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92113218|NCT05331664|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92113220|NCT05331664|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92113221|NCT05331664|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92113222|NCT05331664|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92113223|NCT05331664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92113225|NCT05325632|Trastuzumab|trastuzumab|mesh-list
92113226|NCT05325632|Pertuzumab|pertuzumab|mesh-list
92113227|NCT05325632|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113228|NCT05325632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113229|NCT05325632|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113230|NCT05325632|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113231|NCT05325632|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113232|NCT05325632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113233|NCT05325632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113234|NCT05320068|Vancomycin|vancomycin|mesh-list
92113235|NCT05320068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92113236|NCT05320068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113237|NCT05285644|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92113238|NCT05285644|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92113239|NCT05277402|Pembrolizumab|pembrolizumab|mesh-list
92113240|NCT05277402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113241|NCT05277402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113242|NCT05277402|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113243|NCT05277402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113244|NCT05223647|Carboplatin|carboplatin|mesh-list
92113245|NCT05223647|Etoposide|etoposide|mesh-list
92113246|NCT05223647|Durvalumab|durvalumab|mesh-list
92113247|NCT05223647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113248|NCT05223647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113249|NCT05223647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92113250|NCT05223647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92113251|NCT05223647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113252|NCT05223647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113253|NCT05223647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113254|NCT05204160|Pembrolizumab|pembrolizumab|mesh-list
92113255|NCT05204160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113256|NCT05204160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113257|NCT05204160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113258|NCT05204160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113259|NCT05161637|Bupivacaine|bupivacaine|mesh-list
92113260|NCT05161637|Ropivacaine|ropivacaine|mesh-list
92113261|NCT05161637|Anesthetics, Local|anesthetics, local|mesh-ancestor
92113262|NCT05161637|Anesthetics|anesthetics|mesh-ancestor
92113263|NCT05161637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113264|NCT05161637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113265|NCT05161637|Sensory System Agents|sensory system agents|mesh-ancestor
92113266|NCT05161637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113267|NCT05151744|Ranibizumab|ranibizumab|mesh-list
92113268|NCT05151744|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92113269|NCT05151744|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92113270|NCT05151744|Growth Substances|growth substances|mesh-ancestor
92113271|NCT05151744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113272|NCT05151744|Growth Inhibitors|growth inhibitors|mesh-ancestor
92113273|NCT05151744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113274|NCT05136677|Carboplatin|carboplatin|mesh-list
92113275|NCT05136677|Nivolumab|nivolumab|mesh-list
92113276|NCT05136677|Pemetrexed|pemetrexed|mesh-list
92113277|NCT05136677|Ipilimumab|ipilimumab|mesh-list
92113278|NCT05136677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113279|NCT05136677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113280|NCT05136677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113281|NCT05136677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113282|NCT05136677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113283|NCT05136677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92113284|NCT05136677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92113285|NCT05101096|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92113286|NCT05101096|Immunoconjugates|immunoconjugates|mesh-ancestor
92113287|NCT05101096|Immunologic Factors|immunologic factors|mesh-ancestor
92113288|NCT05101096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113289|NCT05080322|Fluticasone|fluticasone|mesh-list
92113290|NCT05080322|Xhance|xhance|mesh-list
92113291|NCT05080322|Azelastine|azelastine|mesh-list
92113292|NCT05080322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92113293|NCT05080322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92113295|NCT05080322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113296|NCT05080322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113297|NCT05080322|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92113298|NCT05080322|Respiratory System Agents|respiratory system agents|mesh-ancestor
92113299|NCT05080322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92113300|NCT05080322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92113301|NCT05080322|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92113302|NCT05080322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113303|NCT05080322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113304|NCT05080322|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92113305|NCT05080322|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92113306|NCT05080322|Histamine Antagonists|histamine antagonists|mesh-ancestor
92113307|NCT05080322|Histamine Agents|histamine agents|mesh-ancestor
92113308|NCT05080322|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113309|NCT05071313|Vaccines|vaccines|mesh-list
92113310|NCT05071313|Immunologic Factors|immunologic factors|mesh-ancestor
92113311|NCT05071313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113312|NCT05065424|Atropine|atropine|mesh-list
92113313|NCT05065424|Fentanyl|fentanyl|mesh-list
92113314|NCT05065424|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92113315|NCT05065424|Narcotics|narcotics|mesh-ancestor
92113316|NCT05065424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113317|NCT05065424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113318|NCT05065424|Analgesics|analgesics|mesh-ancestor
92113319|NCT05065424|Sensory System Agents|sensory system agents|mesh-ancestor
92113320|NCT05065424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113321|NCT05065424|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92113322|NCT05065424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113323|NCT05065424|Anesthetics, General|anesthetics, general|mesh-ancestor
92113324|NCT05065424|Anesthetics|anesthetics|mesh-ancestor
92113325|NCT05065424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113326|NCT05065424|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92113327|NCT05065424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92113328|NCT05065424|Autonomic Agents|autonomic agents|mesh-ancestor
92113329|NCT05065424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92113330|NCT05065424|Respiratory System Agents|respiratory system agents|mesh-ancestor
92113331|NCT05065424|Mydriatics|mydriatics|mesh-ancestor
92113332|NCT05065424|Parasympatholytics|parasympatholytics|mesh-ancestor
92113333|NCT05065424|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92113334|NCT05065424|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92113335|NCT05065424|Cholinergic Agents|cholinergic agents|mesh-ancestor
92113336|NCT05065424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113337|NCT05041257|Maytansine|maytansine|mesh-list
92113338|NCT05041257|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92113339|NCT05041257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113340|NCT05041257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113341|NCT05041257|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113342|NCT05041257|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113343|NCT05041257|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113344|NCT05041257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113345|NCT05041257|Immunoconjugates|immunoconjugates|mesh-ancestor
92113346|NCT05041257|Immunologic Factors|immunologic factors|mesh-ancestor
92113347|NCT05041257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113348|NCT05015439|Cannabidiol|cannabidiol|mesh-list
92113349|NCT05015439|Anticonvulsants|anticonvulsants|mesh-ancestor
92113350|NCT05013502|Empagliflozin|empagliflozin|mesh-list
92113351|NCT05013502|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92113352|NCT05013502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113353|NCT05013502|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92113354|NCT05013502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113355|NCT04989803|Cyclophosphamide|cyclophosphamide|mesh-list
92113356|NCT04989803|Fludarabine|fludarabine|mesh-list
92113357|NCT04989803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113358|NCT04989803|Immunologic Factors|immunologic factors|mesh-ancestor
92113359|NCT04989803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113360|NCT04989803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92113361|NCT04989803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92113362|NCT04989803|Alkylating Agents|alkylating agents|mesh-ancestor
92113363|NCT04989803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113364|NCT04989803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113365|NCT04989803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92113366|NCT04922333|Risedronic Acid|risedronic acid|mesh-list
92113367|NCT04922333|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92113368|NCT04922333|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113369|NCT04922333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113370|NCT04922333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92113371|NCT04922333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113372|NCT04922333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92113374|NCT04911166|Interleukin-12|interleukin-12|mesh-list
92113375|NCT04911166|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113376|NCT04911166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113377|NCT04911166|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113378|NCT04911166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113379|NCT04911166|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92113380|NCT04911166|Immunologic Factors|immunologic factors|mesh-ancestor
92113381|NCT04911166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113382|NCT04911166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92113383|NCT04911166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92113384|NCT04911166|Growth Substances|growth substances|mesh-ancestor
92113385|NCT04911166|Growth Inhibitors|growth inhibitors|mesh-ancestor
92113386|NCT04903353|Risperidone|risperidone|mesh-list
92113387|NCT04903353|Aripiprazole|aripiprazole|mesh-list
92113388|NCT04903353|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92113389|NCT04903353|Serotonin Agents|serotonin agents|mesh-ancestor
92113390|NCT04903353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113391|NCT04903353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113392|NCT04903353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113393|NCT04903353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92113394|NCT04903353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92113395|NCT04903353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113396|NCT04903353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113397|NCT04903353|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92113398|NCT04903353|Dopamine Agents|dopamine agents|mesh-ancestor
92113399|NCT04903353|Antidepressive Agents|antidepressive agents|mesh-ancestor
92113400|NCT04903353|Dopamine Agonists|dopamine agonists|mesh-ancestor
92113401|NCT04903353|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92113402|NCT04903353|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92113403|NCT04903353|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92113404|NCT04903353|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92113405|NCT04856904|Trifarotene|trifarotene|mesh-list
92113406|NCT04856904|Dermatologic Agents|dermatologic agents|mesh-ancestor
92113407|NCT04831047|Phenylephrine|phenylephrine|mesh-list
92113408|NCT04831047|Oxymetazoline|oxymetazoline|mesh-list
92113409|NCT04831047|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92113410|NCT04831047|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92113411|NCT04831047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92113412|NCT04831047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92113413|NCT04831047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92113414|NCT04831047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113415|NCT04831047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113416|NCT04831047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113417|NCT04831047|Sympathomimetics|sympathomimetics|mesh-ancestor
92113418|NCT04831047|Autonomic Agents|autonomic agents|mesh-ancestor
92113419|NCT04831047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113420|NCT04831047|Nasal Decongestants|nasal decongestants|mesh-ancestor
92113421|NCT04831047|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92113422|NCT04831047|Respiratory System Agents|respiratory system agents|mesh-ancestor
92113423|NCT04831047|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92113424|NCT04831047|Mydriatics|mydriatics|mesh-ancestor
92113425|NCT04831047|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92113426|NCT04831047|Protective Agents|protective agents|mesh-ancestor
92113427|NCT04775680|Antibodies|antibodies|mesh-list
92113428|NCT04775680|Immunologic Factors|immunologic factors|mesh-ancestor
92113429|NCT04775680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113430|NCT04767022|Paclitaxel|paclitaxel|mesh-list
92113431|NCT04767022|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92113432|NCT04767022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113433|NCT04767022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113434|NCT04767022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113435|NCT04767022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113436|NCT04767022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113437|NCT04767022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113438|NCT04764162|Choline|choline|mesh-list
92113439|NCT04764162|Lipotropic Agents|lipotropic agents|mesh-ancestor
92113440|NCT04764162|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92113442|NCT04764162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113443|NCT04764162|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92113444|NCT04764162|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92113445|NCT04764162|Nootropic Agents|nootropic agents|mesh-ancestor
92113446|NCT04747314|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92113447|NCT04747314|Aripiprazole|aripiprazole|mesh-list
92113448|NCT04747314|Mirtazapine|mirtazapine|mesh-list
92113449|NCT04747314|Bupropion|bupropion|mesh-list
92113450|NCT04747314|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92113451|NCT04747314|Sertraline|sertraline|mesh-list
92113452|NCT04747314|Antidepressive Agents|antidepressive agents|mesh-list
92113453|NCT04747314|Escitalopram|escitalopram|mesh-list
92113454|NCT04747314|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92113455|NCT04747314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92113456|NCT04747314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113457|NCT04747314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113458|NCT04747314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113459|NCT04747314|Serotonin Agents|serotonin agents|mesh-ancestor
92113460|NCT04747314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113461|NCT04747314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113462|NCT04747314|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92113463|NCT04747314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113464|NCT04747314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92113465|NCT04747314|Dopamine Agents|dopamine agents|mesh-ancestor
92113466|NCT04747314|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92113467|NCT04747314|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92113468|NCT04747314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113469|NCT04747314|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92113470|NCT04747314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92113471|NCT04747314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113472|NCT04747314|Dopamine Agonists|dopamine agonists|mesh-ancestor
92113473|NCT04747314|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92113474|NCT04747314|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92113475|NCT04747314|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92113476|NCT04747314|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92113477|NCT04747314|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92113478|NCT04747314|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92113479|NCT04747314|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92113480|NCT04747314|Analgesics|analgesics|mesh-ancestor
92113481|NCT04747314|Sensory System Agents|sensory system agents|mesh-ancestor
92113482|NCT04747314|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92113483|NCT04747314|Histamine Antagonists|histamine antagonists|mesh-ancestor
92113484|NCT04747314|Histamine Agents|histamine agents|mesh-ancestor
92113485|NCT04747314|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92113486|NCT04747314|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92113487|NCT04747314|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92113488|NCT04747314|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92113489|NCT04747314|Adrenergic Agents|adrenergic agents|mesh-ancestor
92113490|NCT04747314|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92113491|NCT04731363|Erythritol|erythritol|mesh-list
92113492|NCT04731363|Vasodilator Agents|vasodilator agents|mesh-ancestor
92113493|NCT04700514|Dexmedetomidine|dexmedetomidine|mesh-list
92113494|NCT04700514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92113495|NCT04700514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113496|NCT04700514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113497|NCT04700514|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92113498|NCT04700514|Analgesics|analgesics|mesh-ancestor
92113499|NCT04700514|Sensory System Agents|sensory system agents|mesh-ancestor
92113500|NCT04700514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113501|NCT04700514|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92113502|NCT04700514|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92113503|NCT04700514|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92113504|NCT04700514|Adrenergic Agents|adrenergic agents|mesh-ancestor
92113505|NCT04700514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113506|NCT04700514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113507|NCT04669145|Ropivacaine|ropivacaine|mesh-list
92113508|NCT04669145|Anesthetics, Local|anesthetics, local|mesh-ancestor
92113509|NCT04669145|Anesthetics|anesthetics|mesh-ancestor
92113510|NCT04669145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113511|NCT04669145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113512|NCT04669145|Sensory System Agents|sensory system agents|mesh-ancestor
92113513|NCT04669145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113515|NCT04650074|Ketamine|ketamine|mesh-list
92113516|NCT04650074|Anesthetics, Local|anesthetics, local|mesh-ancestor
92113517|NCT04650074|Anesthetics|anesthetics|mesh-ancestor
92113518|NCT04650074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113519|NCT04650074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113520|NCT04650074|Sensory System Agents|sensory system agents|mesh-ancestor
92113521|NCT04650074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113522|NCT04650074|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92113523|NCT04650074|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92113524|NCT04650074|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92113525|NCT04650074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113526|NCT04650074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113528|NCT04650074|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92113529|NCT04650074|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113530|NCT04650074|Anesthetics, General|anesthetics, general|mesh-ancestor
92113531|NCT04650074|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92113532|NCT04650074|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92113533|NCT04650074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113535|NCT04620304|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92113536|NCT04620304|Antiviral Agents|antiviral agents|mesh-ancestor
92113537|NCT04620304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113538|NCT04579380|Trastuzumab|trastuzumab|mesh-list
92113539|NCT04579380|Fulvestrant|fulvestrant|mesh-list
92113540|NCT04579380|Tucatinib|tucatinib|mesh-list
92113541|NCT04579380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113542|NCT04579380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113543|NCT04579380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92113544|NCT04579380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92113545|NCT04579380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92113546|NCT04579380|Hormone Antagonists|hormone antagonists|mesh-ancestor
92113547|NCT04579380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113548|NCT04579380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113549|NCT04579380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92113550|NCT04579380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113551|NCT04579380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113552|NCT04578886|Guanfacine|guanfacine|mesh-list
92113553|NCT04578886|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92113554|NCT04578886|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92113555|NCT04578886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92113556|NCT04578886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92113557|NCT04578886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92113558|NCT04578886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113559|NCT04578886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113560|NCT04578886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113561|NCT04550585|Insulin|insulin|mesh-list
92113562|NCT04550585|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92113563|NCT04550585|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92113564|NCT04550585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113565|NCT04545515|Ivacaftor|ivacaftor|mesh-list
92113566|NCT04545515|Elexacaftor|elexacaftor|mesh-list
92113567|NCT04545515|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92113568|NCT04545515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113569|NCT04545515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113570|NCT04512066|Risperidone|risperidone|mesh-list
92113571|NCT04512066|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92113572|NCT04512066|Serotonin Agents|serotonin agents|mesh-ancestor
92113573|NCT04512066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113574|NCT04512066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113575|NCT04512066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113576|NCT04512066|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92113577|NCT04512066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92113578|NCT04512066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113579|NCT04512066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113580|NCT04512066|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92113581|NCT04512066|Dopamine Agents|dopamine agents|mesh-ancestor
92113583|NCT04449549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113584|NCT04449549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113585|NCT04449549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113586|NCT04449549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113587|NCT04449549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113588|NCT04449549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113589|NCT04447027|Dexamethasone|dexamethasone|mesh-list
92113591|NCT04447027|Azacitidine|azacitidine|mesh-list
92113593|NCT04447027|Cc-486|cc-486|mesh-list
92113594|NCT04447027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92113595|NCT04447027|Antiemetics|antiemetics|mesh-ancestor
92113596|NCT04447027|Autonomic Agents|autonomic agents|mesh-ancestor
92113597|NCT04447027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113598|NCT04447027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113599|NCT04447027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92113600|NCT04447027|Glucocorticoids|glucocorticoids|mesh-ancestor
92113602|NCT04447027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113603|NCT04447027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92113604|NCT04447027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113605|NCT04447027|Immunologic Factors|immunologic factors|mesh-ancestor
92113606|NCT04447027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92113607|NCT04447027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92113608|NCT04447027|Growth Substances|growth substances|mesh-ancestor
92113609|NCT04447027|Growth Inhibitors|growth inhibitors|mesh-ancestor
92113610|NCT04447027|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92113611|NCT04447027|Antimetabolites|antimetabolites|mesh-ancestor
92113612|NCT04447027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113613|NCT04447027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113614|NCT04447027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92113615|NCT04447027|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92113616|NCT04421092|Lidocaine|lidocaine|mesh-list
92113617|NCT04421092|Anesthetics, Local|anesthetics, local|mesh-ancestor
92113618|NCT04421092|Anesthetics|anesthetics|mesh-ancestor
92113619|NCT04421092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113620|NCT04421092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113621|NCT04421092|Sensory System Agents|sensory system agents|mesh-ancestor
92113622|NCT04421092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113623|NCT04421092|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92113624|NCT04421092|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92113625|NCT04421092|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92113626|NCT04421092|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113627|NCT04421092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113628|NCT04406727|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92113629|NCT04406727|UB-421|ub-421|mesh-list
92113630|NCT04406727|Antiviral Agents|antiviral agents|mesh-ancestor
92113631|NCT04406727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113632|NCT04364945|Dexmedetomidine|dexmedetomidine|mesh-list
92113633|NCT04364945|Remifentanil|remifentanil|mesh-list
92113634|NCT04364945|Sevoflurane|sevoflurane|mesh-list
92113635|NCT04364945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92113636|NCT04364945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113637|NCT04364945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113638|NCT04364945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92113639|NCT04364945|Analgesics|analgesics|mesh-ancestor
92113640|NCT04364945|Sensory System Agents|sensory system agents|mesh-ancestor
92113641|NCT04364945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113642|NCT04364945|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92113643|NCT04364945|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92113644|NCT04364945|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92113645|NCT04364945|Adrenergic Agents|adrenergic agents|mesh-ancestor
92113646|NCT04364945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113647|NCT04364945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113648|NCT04364945|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92113649|NCT04364945|Narcotics|narcotics|mesh-ancestor
92113650|NCT04364945|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92113651|NCT04364945|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92113652|NCT04364945|Anesthetics, General|anesthetics, general|mesh-ancestor
92113653|NCT04364945|Anesthetics|anesthetics|mesh-ancestor
92113655|NCT04256941|Fulvestrant|fulvestrant|mesh-list
92113656|NCT04256941|Palbociclib|palbociclib|mesh-list
92113657|NCT04256941|Anastrozole|anastrozole|mesh-list
92113658|NCT04256941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113659|NCT04256941|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92113660|NCT04256941|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92113661|NCT04256941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113662|NCT04256941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113663|NCT04256941|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92113664|NCT04256941|Hormone Antagonists|hormone antagonists|mesh-ancestor
92113665|NCT04256941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113666|NCT04256941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113667|NCT04256941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92113668|NCT04256941|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92113669|NCT04256941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92113671|NCT04235608|Sevoflurane|sevoflurane|mesh-list
92113684|NCT04232306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113685|NCT04232306|Sensory System Agents|sensory system agents|mesh-ancestor
92113686|NCT04232306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113687|NCT04161027|Pregabalin|pregabalin|mesh-list
92113688|NCT04161027|Analgesics|analgesics|mesh-ancestor
92113689|NCT04161027|Sensory System Agents|sensory system agents|mesh-ancestor
92113690|NCT04161027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113691|NCT04161027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113692|NCT04161027|Anticonvulsants|anticonvulsants|mesh-ancestor
92113693|NCT04161027|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92113694|NCT04161027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113695|NCT04161027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113696|NCT04161027|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92113697|NCT04161027|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92113698|NCT04161027|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92113699|NCT04161027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113700|NCT04161027|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113701|NCT04126135|Nicotine|nicotine|mesh-list
92113702|NCT04126135|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92113703|NCT04126135|Autonomic Agents|autonomic agents|mesh-ancestor
92113704|NCT04126135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113705|NCT04126135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113706|NCT04126135|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92113707|NCT04126135|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92113708|NCT04126135|Cholinergic Agents|cholinergic agents|mesh-ancestor
92113709|NCT04126135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113710|NCT04126135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113711|NCT04025554|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92113712|NCT04025554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92113713|NCT04019964|Nivolumab|nivolumab|mesh-list
92113714|NCT04019964|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113715|NCT04019964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113716|NCT04019964|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113717|NCT04019964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113718|NCT04011345|Folic Acid|folic acid|mesh-list
92113719|NCT04011345|Hematinics|hematinics|mesh-ancestor
92113720|NCT04011345|Vitamin B Complex|vitamin b complex|mesh-ancestor
92113721|NCT04011345|Vitamins|vitamins|mesh-ancestor
92113722|NCT04011345|Micronutrients|micronutrients|mesh-ancestor
92113723|NCT04011345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113724|NCT03990571|Avelumab|avelumab|mesh-list
92113725|NCT03990571|Axitinib|axitinib|mesh-list
92113726|NCT03990571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92113727|NCT03990571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113728|NCT03990571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113729|NCT03990571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92113730|NCT03990571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113731|NCT03990571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113732|NCT03990571|Immunologic Factors|immunologic factors|mesh-ancestor
92113733|NCT03990571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113753|NCT03936777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113754|NCT03936777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113755|NCT03936777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113756|NCT03936777|Serotonin Agents|serotonin agents|mesh-ancestor
92113757|NCT03936777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113758|NCT03927521|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92113759|NCT03927521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92113760|NCT03927521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113761|NCT03889756|Midazolam|midazolam|mesh-list
92113762|NCT03889756|Ketamine|ketamine|mesh-list
92113763|NCT03889756|Analgesics|analgesics|mesh-ancestor
92113764|NCT03889756|Sensory System Agents|sensory system agents|mesh-ancestor
92113765|NCT03889756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113766|NCT03889756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113767|NCT03889756|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92113768|NCT03889756|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113769|NCT03889756|Anesthetics, General|anesthetics, general|mesh-ancestor
92113770|NCT03889756|Anesthetics|anesthetics|mesh-ancestor
92113771|NCT03889756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113772|NCT03889756|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92113773|NCT03889756|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92113775|NCT03889756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113776|NCT03889756|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92113777|NCT03889756|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92113778|NCT03889756|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92113779|NCT03889756|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92113780|NCT03889756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113781|NCT03889756|GABA Modulators|gaba modulators|mesh-ancestor
92113782|NCT03889756|GABA Agents|gaba agents|mesh-ancestor
92113783|NCT03882580|Antineoplastic Agents|antineoplastic agents|mesh-list
92113784|NCT03881696|Omalizumab|omalizumab|mesh-list
92113785|NCT03881696|Immunomodulating Agents|immunomodulating agents|mesh-list
92113786|NCT03881696|Immunologic Factors|immunologic factors|mesh-list
92113787|NCT03881696|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92113788|NCT03881696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113789|NCT03881696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92113790|NCT03881696|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92113791|NCT03881696|Respiratory System Agents|respiratory system agents|mesh-ancestor
92113792|NCT03864406|Darunavir|darunavir|mesh-list
92113793|NCT03864406|Cobicistat|cobicistat|mesh-list
92113794|NCT03864406|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92113795|NCT03864406|Rivaroxaban|rivaroxaban|mesh-list
92113796|NCT03864406|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92113797|NCT03864406|Antithrombins|antithrombins|mesh-ancestor
92113798|NCT03864406|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92113799|NCT03864406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92113800|NCT03864406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113801|NCT03864406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113802|NCT03864406|Anticoagulants|anticoagulants|mesh-ancestor
92113803|NCT03864406|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92113804|NCT03864406|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92113805|NCT03864406|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92113806|NCT03864406|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92113808|NCT03864406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113809|NCT03864406|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92113810|NCT03864406|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92113811|NCT03845114|Insulin|insulin|mesh-list
92113812|NCT03845114|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92113813|NCT03845114|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92113814|NCT03845114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113815|NCT03778502|Rivaroxaban|rivaroxaban|mesh-list
92113816|NCT03778502|Apixaban|apixaban|mesh-list
92113817|NCT03778502|Edoxaban|edoxaban|mesh-list
92113818|NCT03778502|Dabigatran|dabigatran|mesh-list
92113819|NCT03778502|Anticoagulants|anticoagulants|mesh-list
92113820|NCT03778502|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92113821|NCT03778502|Antithrombins|antithrombins|mesh-ancestor
92113822|NCT03778502|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92071935|NCT02913196|Hormones|hormones|mesh-ancestor
92113823|NCT03778502|Protease Inhibitors|protease inhibitors|mesh-ancestor
92113824|NCT03778502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113825|NCT03778502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113826|NCT03775200|Psilocybin|psilocybin|mesh-list
92113827|NCT03775200|Hallucinogens|hallucinogens|mesh-ancestor
92113828|NCT03775200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113829|NCT03775200|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113830|NCT03698669|Analgesics, Opioid|analgesics, opioid|mesh-list
92113831|NCT03698669|Narcotics|narcotics|mesh-ancestor
92113832|NCT03698669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113833|NCT03698669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113835|NCT03698669|Sensory System Agents|sensory system agents|mesh-ancestor
92113836|NCT03698669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113837|NCT03689855|Atezolizumab|atezolizumab|mesh-list
92113838|NCT03689855|Ramucirumab|ramucirumab|mesh-list
92113839|NCT03689855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113840|NCT03689855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113841|NCT03689855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113842|NCT03689855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113843|NCT03635996|Etripamil|etripamil|mesh-list
92113844|NCT03635996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92113845|NCT03635996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92113846|NCT03635996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113847|NCT03635996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92113848|NCT03635996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113850|NCT03613181|Capecitabine|capecitabine|mesh-list
92113851|NCT03613181|Methotrexate|methotrexate|mesh-list
92113852|NCT03613181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92113853|NCT03613181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113854|NCT03613181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92113855|NCT03613181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92113856|NCT03613181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92113857|NCT03613181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113858|NCT03613181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92113859|NCT03613181|Antimetabolites|antimetabolites|mesh-ancestor
92113860|NCT03613181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92113861|NCT03613181|Abortifacient Agents|abortifacient agents|mesh-ancestor
92113862|NCT03613181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92113863|NCT03613181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113864|NCT03613181|Dermatologic Agents|dermatologic agents|mesh-ancestor
92113865|NCT03613181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113866|NCT03613181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92113867|NCT03613181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113868|NCT03613181|Immunologic Factors|immunologic factors|mesh-ancestor
92113869|NCT03613181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92113870|NCT03613181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92113871|NCT03468478|Mycophenolic Acid|mycophenolic acid|mesh-list
92113872|NCT03468478|Sirolimus|sirolimus|mesh-list
92113873|NCT03468478|Everolimus|everolimus|mesh-list
92113874|NCT03468478|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92113875|NCT03468478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92113876|NCT03468478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113877|NCT03468478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113878|NCT03468478|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92113879|NCT03468478|Immunologic Factors|immunologic factors|mesh-ancestor
92113880|NCT03468478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113881|NCT03468478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113882|NCT03468478|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92113883|NCT03468478|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92113884|NCT03468478|Antitubercular Agents|antitubercular agents|mesh-ancestor
92113885|NCT03468478|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92113886|NCT03468478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113887|NCT03468478|Antifungal Agents|antifungal agents|mesh-ancestor
92113888|NCT03409367|Emollients|emollients|mesh-list
92113889|NCT03409367|Petrolatum|petrolatum|mesh-list
92113890|NCT03409367|Dermatologic Agents|dermatologic agents|mesh-ancestor
92113891|NCT03168464|Nivolumab|nivolumab|mesh-list
92113892|NCT03168464|Ipilimumab|ipilimumab|mesh-list
92113893|NCT03168464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113894|NCT03168464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113895|NCT03168464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113896|NCT03168464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113897|NCT03164447|UB-421|ub-421|mesh-list
92072012|NCT02620072|Insulin|insulin|mesh-list
92113899|NCT03164447|Antiviral Agents|antiviral agents|mesh-ancestor
92113900|NCT03164447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92113901|NCT03054792|Fluoroazomycin arabinoside|fluoroazomycin arabinoside|mesh-list
92113902|NCT03054792|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92113903|NCT03054792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113904|NCT02875262|Deferoxamine|deferoxamine|mesh-list
92113905|NCT02875262|Siderophores|siderophores|mesh-ancestor
92113906|NCT02875262|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92113907|NCT02875262|Chelating Agents|chelating agents|mesh-ancestor
92113908|NCT02875262|Sequestering Agents|sequestering agents|mesh-ancestor
92113909|NCT02875262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113910|NCT02818920|Pembrolizumab|pembrolizumab|mesh-list
92113911|NCT02818920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92113912|NCT02818920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113913|NCT02818920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92113914|NCT02818920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113915|NCT02811510|Dronabinol|dronabinol|mesh-list
92113916|NCT02811510|Hallucinogens|hallucinogens|mesh-ancestor
92113917|NCT02811510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113918|NCT02811510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92113919|NCT02811510|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92113920|NCT02811510|Analgesics|analgesics|mesh-ancestor
92113921|NCT02811510|Sensory System Agents|sensory system agents|mesh-ancestor
92113922|NCT02811510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113923|NCT02811510|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92113924|NCT02811510|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92113925|NCT02811510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113926|NCT02811510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113927|NCT02811510|Hormones|hormones|mesh-ancestor
92113928|NCT02811510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92113929|NCT02786264|Dexmedetomidine|dexmedetomidine|mesh-list
92113930|NCT02786264|Propofol|propofol|mesh-list
92113931|NCT02786264|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92113932|NCT02786264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113933|NCT02786264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113934|NCT02786264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92113935|NCT02786264|Analgesics|analgesics|mesh-ancestor
92113936|NCT02786264|Sensory System Agents|sensory system agents|mesh-ancestor
92113937|NCT02786264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113938|NCT02786264|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92113939|NCT02786264|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92113940|NCT02786264|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92113941|NCT02786264|Adrenergic Agents|adrenergic agents|mesh-ancestor
92113942|NCT02786264|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113943|NCT02786264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113944|NCT02786264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113945|NCT02786264|Anesthetics, General|anesthetics, general|mesh-ancestor
92113946|NCT02786264|Anesthetics|anesthetics|mesh-ancestor
92113947|NCT02778971|Flutemetamol|flutemetamol|mesh-list
92113948|NCT02778971|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92113949|NCT02778971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113950|NCT02444546|Sargramostim|sargramostim|mesh-list
92113951|NCT02444546|Immunologic Factors|immunologic factors|mesh-ancestor
92113952|NCT02444546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113953|NCT01948505|Acetaminophen|acetaminophen|mesh-list
92113954|NCT01948505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92113955|NCT01948505|Analgesics|analgesics|mesh-ancestor
92113956|NCT01948505|Sensory System Agents|sensory system agents|mesh-ancestor
92113957|NCT01948505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113958|NCT01948505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113959|NCT01948505|Antipyretics|antipyretics|mesh-ancestor
92113960|NCT01916005|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92113961|NCT01916005|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92113962|NCT01916005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113963|NCT01160926|Cediranib|cediranib|mesh-list
92113964|NCT01160926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92113965|NCT01160926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92113966|NCT01160926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92113967|NCT01160926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113968|NCT01126957|Fentanyl|fentanyl|mesh-list
92113969|NCT01126957|Ketamine|ketamine|mesh-list
92113970|NCT01126957|Propofol|propofol|mesh-list
91938478|NCT00911963|Ribavirin|ribavirin|mesh-list
92113971|NCT01126957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92113972|NCT01126957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92113973|NCT01126957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113974|NCT01126957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92113975|NCT01126957|Anesthetics, General|anesthetics, general|mesh-ancestor
92113977|NCT01126957|Analgesics|analgesics|mesh-ancestor
92113978|NCT01126957|Sensory System Agents|sensory system agents|mesh-ancestor
92113979|NCT01126957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92113980|NCT01126957|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92113981|NCT01126957|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92113982|NCT01126957|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92113983|NCT01126957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92113984|NCT01126957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92113985|NCT01126957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92113986|NCT01126957|Narcotics|narcotics|mesh-ancestor
92113987|NCT01126957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92113988|NCT00811122|Corticosterone|corticosterone|mesh-list
92113989|NCT00811122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92113990|NCT00651885|Treprostinil|treprostinil|mesh-list
92113991|NCT00651885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92113992|NCT01457001|Vitamin D|vitamin d|mesh-list
92113993|NCT01457001|Vitamins|vitamins|mesh-ancestor
92113994|NCT01457001|Micronutrients|micronutrients|mesh-ancestor
92113995|NCT01457001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92113996|NCT01457001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92113997|NCT02846883|Plasma-lyte 148|plasma-lyte 148|mesh-list
92113998|NCT02846883|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92113999|NCT02846883|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92114000|NCT01457469|Nicotine|nicotine|mesh-list
92114001|NCT01457469|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92114002|NCT01457469|Autonomic Agents|autonomic agents|mesh-ancestor
92114003|NCT01457469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114004|NCT01457469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114005|NCT01457469|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92114006|NCT01457469|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92114007|NCT01457469|Cholinergic Agents|cholinergic agents|mesh-ancestor
92114008|NCT01457469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114009|NCT01457469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114010|NCT01457547|Edetic Acid|edetic acid|mesh-list
92114011|NCT01457547|Vaccines|vaccines|mesh-list
92114012|NCT01457547|Pentetic Acid|pentetic acid|mesh-list
92114013|NCT01457547|Immunologic Factors|immunologic factors|mesh-ancestor
92114014|NCT01457547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114015|NCT01457547|Antidotes|antidotes|mesh-ancestor
92114016|NCT01457547|Protective Agents|protective agents|mesh-ancestor
92114017|NCT01457547|Chelating Agents|chelating agents|mesh-ancestor
92114018|NCT01457547|Sequestering Agents|sequestering agents|mesh-ancestor
92114019|NCT01457547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114020|NCT01457547|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92114021|NCT01457547|Anticoagulants|anticoagulants|mesh-ancestor
92114022|NCT01457547|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92114023|NCT01457859|Triclosan|triclosan|mesh-list
92114024|NCT01457859|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92114025|NCT01457859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114026|NCT01457859|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92114027|NCT01457859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92114028|NCT01457859|Antimetabolites|antimetabolites|mesh-ancestor
92114029|NCT01457859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114030|NCT01457859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92114031|NCT01890993|Liraglutide|liraglutide|mesh-list
92114032|NCT01890993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114033|NCT01890993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114034|NCT01890993|Incretins|incretins|mesh-ancestor
92114035|NCT01890993|Hormones|hormones|mesh-ancestor
92114036|NCT01890993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114037|NCT01457937|Interferons|interferons|mesh-list
92114038|NCT01457937|Ribavirin|ribavirin|mesh-list
92114039|NCT01457937|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92114040|NCT01457937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114041|NCT01457937|Antiviral Agents|antiviral agents|mesh-ancestor
92114042|NCT01457937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114043|NCT01457937|Antimetabolites|antimetabolites|mesh-ancestor
92114044|NCT01457937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114045|NCT04272255|Scopolamine|scopolamine|mesh-list
92114046|NCT04272255|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92114047|NCT04272255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92114048|NCT04272255|Antiemetics|antiemetics|mesh-ancestor
92114049|NCT04272255|Autonomic Agents|autonomic agents|mesh-ancestor
92114050|NCT04272255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114051|NCT04272255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114052|NCT04272255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92114054|NCT04272255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92114055|NCT04272255|Cholinergic Agents|cholinergic agents|mesh-ancestor
92114056|NCT04272255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114057|NCT04272255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114058|NCT04272255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92114059|NCT04272255|Parasympatholytics|parasympatholytics|mesh-ancestor
92114061|NCT01458015|Tapentadol|tapentadol|mesh-list
92114062|NCT01458015|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92114063|NCT01458015|Narcotics|narcotics|mesh-ancestor
92114064|NCT01458015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114065|NCT01458015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114066|NCT01458015|Analgesics|analgesics|mesh-ancestor
92114067|NCT01458015|Sensory System Agents|sensory system agents|mesh-ancestor
92114068|NCT01458015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114069|NCT01458015|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92114070|NCT01458015|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92114071|NCT01458015|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92114072|NCT01458015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114073|NCT01458015|Adrenergic Agents|adrenergic agents|mesh-ancestor
92114074|NCT01458015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114075|NCT05026125|Remifentanil|remifentanil|mesh-list
92114076|NCT05026125|Anesthetics|anesthetics|mesh-list
92114077|NCT05026125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114078|NCT05026125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114079|NCT05026125|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92114080|NCT05026125|Narcotics|narcotics|mesh-ancestor
92114081|NCT05026125|Analgesics|analgesics|mesh-ancestor
92114082|NCT05026125|Sensory System Agents|sensory system agents|mesh-ancestor
92114083|NCT05026125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114084|NCT01891227|Capecitabine|capecitabine|mesh-list
92114085|NCT01891227|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92114086|NCT01891227|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114087|NCT01891227|Antimetabolites|antimetabolites|mesh-ancestor
92114088|NCT01891227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114089|NCT01891227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114090|NCT01891227|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92114091|NCT01891227|Alkylating Agents|alkylating agents|mesh-ancestor
92114092|NCT04391439|Methylprednisolone|methylprednisolone|mesh-list
92114093|NCT04391439|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92114094|NCT04391439|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92114095|NCT04391439|Prednisolone|prednisolone|mesh-list
92114096|NCT04391439|Prednisolone acetate|prednisolone acetate|mesh-list
92114097|NCT04391439|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92114098|NCT04391439|Prednisolone phosphate|prednisolone phosphate|mesh-list
92114099|NCT04391439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92114100|NCT04391439|Antiemetics|antiemetics|mesh-ancestor
92114101|NCT04391439|Autonomic Agents|autonomic agents|mesh-ancestor
92114102|NCT04391439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114103|NCT04391439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114104|NCT04391439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92114105|NCT04391439|Glucocorticoids|glucocorticoids|mesh-ancestor
92114106|NCT04391439|Hormones|hormones|mesh-ancestor
92114107|NCT04391439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114108|NCT04391439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92114109|NCT04391439|Protective Agents|protective agents|mesh-ancestor
92114110|NCT04391439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92114111|NCT04391439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114112|NCT02884245|Estrogens|estrogens|mesh-list
92114113|NCT02884245|Hormones|hormones|mesh-ancestor
92114114|NCT02884245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114115|NCT02884245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114116|NCT01891461|Hemostatics|hemostatics|mesh-list
92114117|NCT01891461|Coagulants|coagulants|mesh-ancestor
92114118|NCT02842749|Everolimus|everolimus|mesh-list
92114119|NCT02842749|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92114120|NCT02842749|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114121|NCT02842749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938484|NCT01657292|Octenidine|octenidine|mesh-list
92114122|NCT02842749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114123|NCT02842749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114124|NCT02842749|Immunologic Factors|immunologic factors|mesh-ancestor
92114125|NCT02842749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114126|NCT02842749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114127|NCT04272567|Norepinephrine|norepinephrine|mesh-list
92114128|NCT04272567|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92114129|NCT04272567|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92114130|NCT04272567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92114131|NCT04272567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114132|NCT04272567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114133|NCT04272567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114134|NCT04272567|Sympathomimetics|sympathomimetics|mesh-ancestor
92114135|NCT04272567|Autonomic Agents|autonomic agents|mesh-ancestor
92114136|NCT04272567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114137|NCT04272567|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92114138|NCT01891851|Ritonavir|ritonavir|mesh-list
92114139|NCT01891851|Simeprevir|simeprevir|mesh-list
92114140|NCT01891851|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92114141|NCT01891851|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92114142|NCT01891851|Protease Inhibitors|protease inhibitors|mesh-ancestor
92114143|NCT01891851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114144|NCT01891851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114145|NCT01891851|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92114146|NCT01891851|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92114147|NCT01891851|Antiviral Agents|antiviral agents|mesh-ancestor
92114148|NCT01891851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114149|NCT01891851|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92114150|NCT01891851|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92114151|NCT01459419|Antibodies|antibodies|mesh-list
92114152|NCT01459419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92114153|NCT01459419|Immunologic Factors|immunologic factors|mesh-ancestor
92114154|NCT01459419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114155|NCT01892241|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92114156|NCT01892241|Entecavir|entecavir|mesh-list
92114157|NCT01892241|Antiviral Agents|antiviral agents|mesh-ancestor
92114158|NCT01892241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114159|NCT04391127|Hydroxychloroquine|hydroxychloroquine|mesh-list
92114160|NCT04391127|Ivermectin|ivermectin|mesh-list
92114161|NCT04391127|Antimalarials|antimalarials|mesh-ancestor
92114162|NCT04391127|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92114163|NCT04391127|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92114164|NCT04391127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114165|NCT04391127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114166|NCT04391127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114167|NCT04391127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114168|NCT05024253|Tranexamic Acid|tranexamic acid|mesh-list
92114169|NCT05024253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92114170|NCT05024253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92114171|NCT05024253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114172|NCT05024253|Hemostatics|hemostatics|mesh-ancestor
92114173|NCT05024253|Coagulants|coagulants|mesh-ancestor
92114174|NCT01459809|Metformin|metformin|mesh-list
92114175|NCT01459809|Glimepiride|glimepiride|mesh-list
92114176|NCT01459809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114177|NCT01459809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114178|NCT01459809|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92114179|NCT01459809|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114180|NCT01459809|Immunologic Factors|immunologic factors|mesh-ancestor
92114181|NCT01459887|Prednisone|prednisone|mesh-list
92114182|NCT01459887|Cyclophosphamide|cyclophosphamide|mesh-list
92114183|NCT01459887|Doxorubicin|doxorubicin|mesh-list
92114184|NCT01459887|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92114185|NCT01459887|Vincristine|vincristine|mesh-list
92114186|NCT01459887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114187|NCT01459887|Immunologic Factors|immunologic factors|mesh-ancestor
92114188|NCT01459887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114189|NCT01459887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114190|NCT01459887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92114191|NCT01459887|Alkylating Agents|alkylating agents|mesh-ancestor
92114192|NCT01459887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114193|NCT01459887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114194|NCT01459887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92114195|NCT01459887|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92114196|NCT01459887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92114197|NCT01459887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92114198|NCT01459887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114199|NCT01459887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92114200|NCT01459887|Glucocorticoids|glucocorticoids|mesh-ancestor
92114201|NCT01459887|Hormones|hormones|mesh-ancestor
92114202|NCT01459887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114203|NCT01459887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92114204|NCT01459887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92114205|NCT01459887|Tubulin Modulators|tubulin modulators|mesh-ancestor
92114206|NCT01459887|Antimitotic Agents|antimitotic agents|mesh-ancestor
92114207|NCT01459887|Mitosis Modulators|mitosis modulators|mesh-ancestor
92114208|NCT02876211|Vitamin D|vitamin d|mesh-list
92114209|NCT02876211|Vitamins|vitamins|mesh-ancestor
92114210|NCT02876211|Micronutrients|micronutrients|mesh-ancestor
92114211|NCT02876211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114212|NCT02876211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92114213|NCT02682147|Sildenafil Citrate|sildenafil citrate|mesh-list
92114214|NCT02682147|Vasodilator Agents|vasodilator agents|mesh-ancestor
92114215|NCT02682147|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92114216|NCT02682147|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92114217|NCT02682147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114218|NCT02682147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114219|NCT02682147|Urological Agents|urological agents|mesh-ancestor
92114220|NCT01892787|Formoterol Fumarate|formoterol fumarate|mesh-list
92114221|NCT01892787|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92114222|NCT01892787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92114223|NCT01892787|Autonomic Agents|autonomic agents|mesh-ancestor
92114224|NCT01892787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114225|NCT01892787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114226|NCT01892787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92114227|NCT01892787|Respiratory System Agents|respiratory system agents|mesh-ancestor
92114228|NCT01892787|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92114229|NCT01892787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92114230|NCT01892787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92114231|NCT01892787|Adrenergic Agents|adrenergic agents|mesh-ancestor
92114232|NCT01892787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114233|NCT01892787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114234|NCT01893723|Remifentanil|remifentanil|mesh-list
92114235|NCT01893723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92114236|NCT01893723|Narcotics|narcotics|mesh-ancestor
92114237|NCT01893723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114238|NCT01893723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114239|NCT01893723|Analgesics|analgesics|mesh-ancestor
92114240|NCT01893723|Sensory System Agents|sensory system agents|mesh-ancestor
92114241|NCT01893723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114242|NCT01453959|Fludrocortisone|fludrocortisone|mesh-list
92114243|NCT01453959|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92114244|NCT02669901|Naloxone|naloxone|mesh-list
92114245|NCT02669901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92114246|NCT02669901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114247|NCT02669901|Sensory System Agents|sensory system agents|mesh-ancestor
92114248|NCT02669901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114249|NCT01893099|Sorafenib|sorafenib|mesh-list
92114250|NCT01893099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114251|NCT01893099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114252|NCT01893099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114253|NCT01893099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114254|NCT02327403|Abatacept|abatacept|mesh-list
92114255|NCT02327403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92114256|NCT02327403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114257|NCT02327403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114258|NCT02327403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114259|NCT02327403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114260|NCT02327403|Immunologic Factors|immunologic factors|mesh-ancestor
92114261|NCT02327403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114262|NCT02327403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114263|NCT01893177|Vaccines|vaccines|mesh-list
92114264|NCT01893177|Immunologic Factors|immunologic factors|mesh-ancestor
92114265|NCT01893177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114266|NCT05740150|Taurolidine|taurolidine|mesh-list
92114267|NCT05740150|Heparin|heparin|mesh-list
92114268|NCT05740150|Calcium heparin|calcium heparin|mesh-list
92114269|NCT05740150|Anticoagulants|anticoagulants|mesh-ancestor
92114270|NCT05740150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114271|NCT05740150|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92114272|NCT05740150|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92114273|NCT05740150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114274|NCT05740150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92114275|NCT05740150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114277|NCT05734612|Gout Suppressants|gout suppressants|mesh-ancestor
92114278|NCT05734612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114279|NCT05734612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92114280|NCT05734612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92114281|NCT05734612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92114282|NCT05734612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114283|NCT05734612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114284|NCT02349867|Gemcitabine|gemcitabine|mesh-list
92114285|NCT02349867|Sorafenib|sorafenib|mesh-list
92114286|NCT02349867|Vorinostat|vorinostat|mesh-list
92114287|NCT02349867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114288|NCT02349867|Antimetabolites|antimetabolites|mesh-ancestor
92114289|NCT02349867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114290|NCT02349867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114291|NCT02349867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114292|NCT02349867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114293|NCT02349867|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92114294|NCT02630043|Oxaliplatin|oxaliplatin|mesh-list
92114295|NCT02630043|Tolcapone|tolcapone|mesh-list
92114296|NCT02630043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114297|NCT02630043|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92114298|NCT02630043|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92114299|NCT02630043|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92114300|NCT02630043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114301|NCT02630043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114302|NCT02629419|Amphotericin B|amphotericin b|mesh-list
92114303|NCT02629419|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92114304|NCT02629419|Amebicides|amebicides|mesh-ancestor
92114305|NCT02629419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92114306|NCT02629419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92114307|NCT02629419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114308|NCT02629419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114309|NCT02629419|Antifungal Agents|antifungal agents|mesh-ancestor
92114310|NCT02334735|Vaccines|vaccines|mesh-list
92114311|NCT02334735|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92114312|NCT02334735|Poly ICLC|poly iclc|mesh-list
92114313|NCT02334735|Immunologic Factors|immunologic factors|mesh-ancestor
92114314|NCT02334735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114315|NCT02334735|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92114316|NCT02334735|Interferon Inducers|interferon inducers|mesh-ancestor
92114317|NCT02329600|Triamcinolone|triamcinolone|mesh-list
92114318|NCT02329600|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92114319|NCT02329600|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92114320|NCT02329600|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92114321|NCT02329600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92114322|NCT02329600|Glucocorticoids|glucocorticoids|mesh-ancestor
92114323|NCT02329600|Hormones|hormones|mesh-ancestor
92114324|NCT02329600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114325|NCT02329600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114326|NCT02329600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114327|NCT02329600|Immunologic Factors|immunologic factors|mesh-ancestor
92114328|NCT02329600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114329|NCT02329600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114330|NCT02620761|Fenoldopam|fenoldopam|mesh-list
92114331|NCT02620761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92114332|NCT02620761|Vasodilator Agents|vasodilator agents|mesh-ancestor
92114333|NCT02620761|Dopamine Agonists|dopamine agonists|mesh-ancestor
92114334|NCT02620761|Dopamine Agents|dopamine agents|mesh-ancestor
92114335|NCT02620761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114336|NCT02620761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114337|NCT02620761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114338|NCT02615691|Factor VIII|factor viii|mesh-list
92114339|NCT02615691|BAX 855|bax 855|mesh-list
92114340|NCT02615691|Coagulants|coagulants|mesh-ancestor
92114341|NCT04758273|Vaccines|vaccines|mesh-list
92114342|NCT04758273|Immunologic Factors|immunologic factors|mesh-ancestor
92114343|NCT04758273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114344|NCT01729871|Vitamin K|vitamin k|mesh-list
92114345|NCT01729871|Rivaroxaban|rivaroxaban|mesh-list
92114346|NCT01729871|Vitamins|vitamins|mesh-ancestor
92114347|NCT01729871|Micronutrients|micronutrients|mesh-ancestor
92114348|NCT01729871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114349|NCT01729871|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92114350|NCT01729871|Antithrombins|antithrombins|mesh-ancestor
92114351|NCT01729871|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92114352|NCT01729871|Protease Inhibitors|protease inhibitors|mesh-ancestor
92114353|NCT01729871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114354|NCT01729871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114355|NCT01729871|Anticoagulants|anticoagulants|mesh-ancestor
92114356|NCT01729871|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92114357|NCT01729871|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92114358|NCT01729871|Hemostatics|hemostatics|mesh-ancestor
92114359|NCT01729871|Coagulants|coagulants|mesh-ancestor
92114360|NCT02611323|Rituximab|rituximab|mesh-list
92114361|NCT02611323|Obinutuzumab|obinutuzumab|mesh-list
92114362|NCT02611323|Venetoclax|venetoclax|mesh-list
92114363|NCT02611323|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92114364|NCT02611323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114365|NCT02611323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114366|NCT02611323|Immunologic Factors|immunologic factors|mesh-ancestor
92114367|NCT02611323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114368|NCT02611323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114369|NCT02611323|Immunoconjugates|immunoconjugates|mesh-ancestor
92114370|NCT02608359|Abiraterone Acetate|abiraterone acetate|mesh-list
92114371|NCT02608359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114372|NCT02608359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92114373|NCT02608359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114374|NCT02608359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114375|NCT02608359|Hormone Antagonists|hormone antagonists|mesh-ancestor
92114376|NCT02608359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114377|NCT02608359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114378|NCT02608359|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92114380|NCT01729559|Enoxaparin|enoxaparin|mesh-list
92114381|NCT01729559|Calcium heparin|calcium heparin|mesh-list
92114382|NCT01729559|Enoxaparin sodium|enoxaparin sodium|mesh-list
92114383|NCT01729559|Anticoagulants|anticoagulants|mesh-ancestor
92114384|NCT01729559|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92114385|NCT01729559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92114386|NCT01729559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114387|NCT01926496|Imiquimod|imiquimod|mesh-list
92114388|NCT01926496|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92114389|NCT01926496|Immunologic Factors|immunologic factors|mesh-ancestor
92114390|NCT01926496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114391|NCT01926496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114392|NCT01926496|Interferon Inducers|interferon inducers|mesh-ancestor
92114393|NCT01728779|Nelfinavir|nelfinavir|mesh-list
92114394|NCT01728779|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92114395|NCT01728779|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92114396|NCT01728779|Protease Inhibitors|protease inhibitors|mesh-ancestor
92114397|NCT01728779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114398|NCT01728779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114399|NCT01728779|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92114400|NCT01728779|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92114401|NCT01728779|Antiviral Agents|antiviral agents|mesh-ancestor
92114402|NCT01728779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114403|NCT01927120|Sirolimus|sirolimus|mesh-list
92114404|NCT01927120|Aldesleukin|aldesleukin|mesh-list
92114405|NCT01927120|Tacrolimus|tacrolimus|mesh-list
92114406|NCT01927120|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114407|NCT01927120|Immunologic Factors|immunologic factors|mesh-ancestor
92114408|NCT01927120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114409|NCT01927120|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92114410|NCT01927120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114411|NCT01927120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114412|NCT01927120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114413|NCT01927120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114414|NCT01927120|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92114415|NCT01927120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114416|NCT01927120|Antifungal Agents|antifungal agents|mesh-ancestor
92114417|NCT01927120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92114418|NCT01927120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92114419|NCT01927120|Antiviral Agents|antiviral agents|mesh-ancestor
92114420|NCT02600949|Pembrolizumab|pembrolizumab|mesh-list
92114421|NCT02600949|Imiquimod|imiquimod|mesh-list
92114422|NCT02600949|Vaccines|vaccines|mesh-list
92114423|NCT02600949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114424|NCT02600949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114425|NCT02600949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92114426|NCT02600949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114427|NCT02600949|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92114428|NCT02600949|Immunologic Factors|immunologic factors|mesh-ancestor
92114429|NCT02600949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114430|NCT02600949|Interferon Inducers|interferon inducers|mesh-ancestor
92114432|NCT01728623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114433|NCT01728623|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114434|NCT01728623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114435|NCT01728623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114436|NCT02573337|Lidocaine|lidocaine|mesh-list
92114437|NCT02573337|Anesthetics, Local|anesthetics, local|mesh-ancestor
92114438|NCT02573337|Anesthetics|anesthetics|mesh-ancestor
92114439|NCT02573337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114440|NCT02573337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114441|NCT02573337|Sensory System Agents|sensory system agents|mesh-ancestor
92114442|NCT02573337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114443|NCT02573337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92114444|NCT02573337|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92114445|NCT02573337|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92114446|NCT02573337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92114447|NCT02573337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114448|NCT01728077|Brivaracetam|brivaracetam|mesh-list
92114449|NCT01728077|Anticonvulsants|anticonvulsants|mesh-ancestor
92114450|NCT01606007|Metformin|metformin|mesh-list
92114451|NCT01606007|Dapagliflozin|dapagliflozin|mesh-list
92114452|NCT01606007|Saxagliptin|saxagliptin|mesh-list
92114453|NCT01606007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114454|NCT01606007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114455|NCT01606007|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92114456|NCT01606007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114457|NCT01606007|Incretins|incretins|mesh-ancestor
92114458|NCT01606007|Hormones|hormones|mesh-ancestor
92114459|NCT01606007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114460|NCT01606007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92114461|NCT01606007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92114462|NCT01606007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114463|NCT02304783|Acetaminophen|acetaminophen|mesh-list
92114464|NCT02304783|Piroxicam|piroxicam|mesh-list
92114465|NCT02304783|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92114466|NCT02304783|Analgesics|analgesics|mesh-ancestor
92114467|NCT02304783|Sensory System Agents|sensory system agents|mesh-ancestor
92114468|NCT02304783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114469|NCT02304783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114470|NCT02304783|Antipyretics|antipyretics|mesh-ancestor
92114471|NCT02304783|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92114472|NCT02304783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92114473|NCT02304783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114474|NCT02304783|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92114475|NCT02304783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114476|NCT02304783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114477|NCT02553447|Vitamin D|vitamin d|mesh-list
92114478|NCT02553447|Cholecalciferol|cholecalciferol|mesh-list
92114479|NCT02553447|Vitamins|vitamins|mesh-ancestor
92114480|NCT02553447|Micronutrients|micronutrients|mesh-ancestor
92114481|NCT02553447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114482|NCT02553447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92114483|NCT02553447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92114484|NCT01928290|Leucovorin|leucovorin|mesh-list
92114485|NCT01928290|Tetrahydrofolates|tetrahydrofolates|mesh-list
92114486|NCT01928290|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92114487|NCT01928290|Fluorouracil|fluorouracil|mesh-list
92114488|NCT01928290|Oxaliplatin|oxaliplatin|mesh-list
92114489|NCT01928290|Trastuzumab|trastuzumab|mesh-list
92114490|NCT01928290|Irinotecan|irinotecan|mesh-list
92114491|NCT01928290|Levoleucovorin|levoleucovorin|mesh-list
92114492|NCT01928290|Antimetabolites|antimetabolites|mesh-ancestor
92114493|NCT01928290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114494|NCT01928290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114495|NCT01928290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114496|NCT01928290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114497|NCT01928290|Immunologic Factors|immunologic factors|mesh-ancestor
92114498|NCT01928290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114499|NCT01928290|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114500|NCT01928290|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92114502|NCT01928290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114503|NCT01928290|Antidotes|antidotes|mesh-ancestor
92114504|NCT01928290|Protective Agents|protective agents|mesh-ancestor
92114505|NCT01928290|Vitamin B Complex|vitamin b complex|mesh-ancestor
92114506|NCT01928290|Vitamins|vitamins|mesh-ancestor
92114507|NCT01928290|Micronutrients|micronutrients|mesh-ancestor
92114508|NCT02282319|Dexmedetomidine|dexmedetomidine|mesh-list
92114509|NCT02282319|Chloroprocaine|chloroprocaine|mesh-list
92114510|NCT02282319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92114511|NCT02282319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114512|NCT02282319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114513|NCT02282319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92114514|NCT02282319|Analgesics|analgesics|mesh-ancestor
92114515|NCT02282319|Sensory System Agents|sensory system agents|mesh-ancestor
92114516|NCT02282319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114517|NCT02282319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92114518|NCT02282319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92114519|NCT02282319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92114520|NCT02282319|Adrenergic Agents|adrenergic agents|mesh-ancestor
92114521|NCT02282319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114522|NCT02282319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114523|NCT02282319|Anesthetics, Local|anesthetics, local|mesh-ancestor
92114524|NCT02282319|Anesthetics|anesthetics|mesh-ancestor
92114525|NCT02772081|Poractant alfa|poractant alfa|mesh-list
92114526|NCT02772081|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92114527|NCT02772081|Respiratory System Agents|respiratory system agents|mesh-ancestor
92114528|NCT02278965|Metformin|metformin|mesh-list
92114529|NCT02278965|Biguanides|biguanides|mesh-list
92114530|NCT02278965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114531|NCT02278965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114532|NCT02766465|Sirolimus|sirolimus|mesh-list
92114533|NCT02766465|Methotrexate|methotrexate|mesh-list
92114534|NCT02766465|Fludarabine|fludarabine|mesh-list
92114535|NCT02766465|Melphalan|melphalan|mesh-list
92114536|NCT02766465|Busulfan|busulfan|mesh-list
92114537|NCT02766465|Alemtuzumab|alemtuzumab|mesh-list
92114538|NCT02766465|Tacrolimus|tacrolimus|mesh-list
92114539|NCT02766465|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92114540|NCT02766465|Thymoglobulin|thymoglobulin|mesh-list
92114541|NCT02766465|Lenograstim|lenograstim|mesh-list
92114542|NCT02766465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92114543|NCT02766465|Abortifacient Agents|abortifacient agents|mesh-ancestor
92114544|NCT02766465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92114545|NCT02766465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114546|NCT02766465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114547|NCT02766465|Antimetabolites|antimetabolites|mesh-ancestor
92114548|NCT02766465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114549|NCT02766465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114550|NCT02766465|Dermatologic Agents|dermatologic agents|mesh-ancestor
92114551|NCT02766465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114552|NCT02766465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92114553|NCT02766465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114554|NCT02766465|Immunologic Factors|immunologic factors|mesh-ancestor
92114555|NCT02766465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114556|NCT02766465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92114557|NCT02766465|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92114558|NCT02766465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114559|NCT02766465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114560|NCT02766465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92114561|NCT02766465|Antifungal Agents|antifungal agents|mesh-ancestor
92114562|NCT02766465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92114563|NCT02766465|Alkylating Agents|alkylating agents|mesh-ancestor
92114564|NCT02766465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92114565|NCT02766465|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92114566|NCT02766465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114567|NCT02757885|Cyclophosphamide|cyclophosphamide|mesh-list
92114568|NCT02757885|Thiotepa|thiotepa|mesh-list
92114569|NCT02757885|Fludarabine|fludarabine|mesh-list
92114570|NCT02757885|Fludarabine phosphate|fludarabine phosphate|mesh-list
92114571|NCT02757885|Hydroxyurea|hydroxyurea|mesh-list
92114572|NCT02757885|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92114573|NCT02757885|Thymoglobulin|thymoglobulin|mesh-list
92114574|NCT02757885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114575|NCT02757885|Immunologic Factors|immunologic factors|mesh-ancestor
92114576|NCT02757885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114577|NCT02757885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114578|NCT02757885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92114580|NCT02757885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114581|NCT02757885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114582|NCT02757885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92114583|NCT02757885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114584|NCT02757885|Antimetabolites|antimetabolites|mesh-ancestor
92114585|NCT02757885|Antisickling Agents|antisickling agents|mesh-ancestor
92114586|NCT02757885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114587|NCT02757885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92114588|NCT01928446|Lithium Carbonate|lithium carbonate|mesh-list
92114589|NCT01928446|Antidepressive Agents|antidepressive agents|mesh-ancestor
92114590|NCT01928446|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92114591|NCT01928446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114592|NCT01928446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114593|NCT01928446|Antimanic Agents|antimanic agents|mesh-ancestor
92114594|NCT01928446|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92114595|NCT01928446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114596|NCT01928446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114597|NCT02983383|Anesthetics|anesthetics|mesh-list
92114598|NCT02983383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114599|NCT02983383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114600|NCT02753283|Vitamin D|vitamin d|mesh-list
92114601|NCT02753283|Zoledronic Acid|zoledronic acid|mesh-list
92114602|NCT02753283|Denosumab|denosumab|mesh-list
92114603|NCT02753283|Calcium|calcium|mesh-list
92114604|NCT02753283|Vitamins|vitamins|mesh-ancestor
92114605|NCT02753283|Micronutrients|micronutrients|mesh-ancestor
92114606|NCT02753283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114607|NCT02753283|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92114608|NCT02753283|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92114609|NCT02748369|Glucagon|glucagon|mesh-list
92114610|NCT02748369|Hormones|hormones|mesh-list
92114611|NCT02748369|Somatostatin|somatostatin|mesh-list
92114612|NCT02748369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114614|NCT02748369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92114615|NCT01928680|Capecitabine|capecitabine|mesh-list
92114616|NCT01928680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114617|NCT01928680|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114618|NCT01928680|Antimetabolites|antimetabolites|mesh-ancestor
92114619|NCT01928680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114620|NCT01929460|Ciprofloxacin|ciprofloxacin|mesh-list
92114621|NCT01929460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114622|NCT01929460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114623|NCT01929460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92114624|NCT01929460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92114625|NCT01929460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114626|NCT01929460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114627|NCT01929460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114628|NCT01929460|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92114629|NCT01929460|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92114630|NCT02248701|Methyltestosterone|methyltestosterone|mesh-list
92114631|NCT02248701|Finasteride|finasteride|mesh-list
92114632|NCT02248701|Testosterone|testosterone|mesh-list
92114633|NCT02248701|Testosterone undecanoate|testosterone undecanoate|mesh-list
92114634|NCT02248701|Testosterone enanthate|testosterone enanthate|mesh-list
92114635|NCT02248701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92114636|NCT02248701|Androgens|androgens|mesh-ancestor
92114637|NCT02248701|Hormones|hormones|mesh-ancestor
92114638|NCT02248701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114639|NCT02248701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938490|NCT00907907|Mycophenolic Acid|mycophenolic acid|mesh-list
92114640|NCT02248701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92114642|NCT02248701|Anabolic Agents|anabolic agents|mesh-ancestor
92114643|NCT02248701|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92114644|NCT02248701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92114645|NCT02248701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114646|NCT02248701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114647|NCT02248701|Hormone Antagonists|hormone antagonists|mesh-ancestor
92114648|NCT02248701|Urological Agents|urological agents|mesh-ancestor
92114649|NCT02283814|Topiramate|topiramate|mesh-list
92114650|NCT02283814|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92114651|NCT02283814|Anticonvulsants|anticonvulsants|mesh-ancestor
92114652|NCT02283814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114653|NCT02283814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114654|NCT02283814|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92114655|NCT02283814|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92114656|NCT02283814|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92114657|NCT02283814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114658|NCT05739682|Anti-Infective Agents|anti-infective agents|mesh-list
92114659|NCT05739682|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92114660|NCT05739682|Epinephrine|epinephrine|mesh-list
92114661|NCT05739682|Anesthetics|anesthetics|mesh-list
92114663|NCT05739682|Anesthetics, Local|anesthetics, local|mesh-list
92114664|NCT05739682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114665|NCT05739682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114666|NCT05739682|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92114667|NCT05739682|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92114668|NCT05739682|Adrenergic Agents|adrenergic agents|mesh-ancestor
92114669|NCT05739682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114670|NCT05739682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114671|NCT05739682|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92114672|NCT05739682|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92114673|NCT05739682|Autonomic Agents|autonomic agents|mesh-ancestor
92114674|NCT05739682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114675|NCT05739682|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92114676|NCT05739682|Respiratory System Agents|respiratory system agents|mesh-ancestor
92114677|NCT05739682|Mydriatics|mydriatics|mesh-ancestor
92114678|NCT05739682|Sympathomimetics|sympathomimetics|mesh-ancestor
92114679|NCT05739682|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92114680|NCT05739682|Sensory System Agents|sensory system agents|mesh-ancestor
92114681|NCT02462421|Canagliflozin|canagliflozin|mesh-list
92114682|NCT02462421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92114683|NCT02462421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114684|NCT02462421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114685|NCT02462421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114686|NCT02727387|Cyclophosphamide|cyclophosphamide|mesh-list
92114687|NCT02727387|Temozolomide|temozolomide|mesh-list
92114688|NCT02727387|Melphalan|melphalan|mesh-list
92114689|NCT02727387|Busulfan|busulfan|mesh-list
92114690|NCT02727387|Ifosfamide|ifosfamide|mesh-list
92114691|NCT02727387|Irinotecan|irinotecan|mesh-list
92114692|NCT02727387|Etoposide|etoposide|mesh-list
92114693|NCT02727387|Vincristine|vincristine|mesh-list
92114694|NCT02727387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114695|NCT02727387|Immunologic Factors|immunologic factors|mesh-ancestor
92114696|NCT02727387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114697|NCT02727387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92114698|NCT02727387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92114699|NCT02727387|Alkylating Agents|alkylating agents|mesh-ancestor
92114700|NCT02727387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114701|NCT02727387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114702|NCT02727387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92114703|NCT02727387|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92114704|NCT02727387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92114705|NCT02727387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114706|NCT02727387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92114707|NCT02727387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92114708|NCT02727387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92114709|NCT02727387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92114710|NCT02727387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92114711|NCT01753115|Ciprofloxacin|ciprofloxacin|mesh-list
92114712|NCT01753115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114713|NCT01753115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938501|NCT03140553|Docetaxel|docetaxel|mesh-list
92114714|NCT01753115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92114715|NCT01753115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92114716|NCT01753115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114717|NCT01753115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114718|NCT01753115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114719|NCT01753115|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92114720|NCT01753115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92114721|NCT02445651|Acetylcysteine|acetylcysteine|mesh-list
92114722|NCT02445651|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92114723|NCT02445651|Antiviral Agents|antiviral agents|mesh-ancestor
92114724|NCT02445651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114725|NCT02445651|Expectorants|expectorants|mesh-ancestor
92114726|NCT02445651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92114727|NCT02445651|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92114728|NCT02445651|Antioxidants|antioxidants|mesh-ancestor
92114729|NCT02445651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114730|NCT02445651|Protective Agents|protective agents|mesh-ancestor
92114731|NCT02445651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114732|NCT02445651|Antidotes|antidotes|mesh-ancestor
92114733|NCT05719714|Dapagliflozin|dapagliflozin|mesh-list
92114734|NCT05719714|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92114735|NCT05719714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114736|NCT05719714|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92114745|NCT02721537|Niacinamide|niacinamide|mesh-list
92114746|NCT02721537|Niacin|niacin|mesh-list
92114747|NCT02721537|Nicotinic Acids|nicotinic acids|mesh-list
92114748|NCT02721537|Vitamin B Complex|vitamin b complex|mesh-ancestor
92114749|NCT02721537|Vitamins|vitamins|mesh-ancestor
92114750|NCT02721537|Micronutrients|micronutrients|mesh-ancestor
92114751|NCT02721537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114752|NCT02721537|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92114753|NCT02721537|Antimetabolites|antimetabolites|mesh-ancestor
92114754|NCT02721537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114755|NCT02721537|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92114756|NCT02721537|Vasodilator Agents|vasodilator agents|mesh-ancestor
92114758|NCT02185209|Metronidazole|metronidazole|mesh-list
92114759|NCT02185209|Penicillin V|penicillin v|mesh-list
92114760|NCT02185209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114761|NCT02185209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114762|NCT02185209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92114763|NCT02185209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92114764|NCT01894035|Iloprost|iloprost|mesh-list
92114765|NCT01894035|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92114766|NCT01894035|Vasodilator Agents|vasodilator agents|mesh-ancestor
92114767|NCT01727141|Glycopyrrolate|glycopyrrolate|mesh-list
92114768|NCT01727141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92114769|NCT01727141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92114770|NCT01727141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92114771|NCT01727141|Cholinergic Agents|cholinergic agents|mesh-ancestor
92114772|NCT01727141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114773|NCT01727141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114774|NCT01727141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114775|NCT02716311|Cetuximab|cetuximab|mesh-list
92114776|NCT02716311|Afatinib|afatinib|mesh-list
92114777|NCT02716311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114778|NCT02716311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114779|NCT02716311|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114780|NCT02716311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114781|NCT02716311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114782|NCT05439694|Tranexamic Acid|tranexamic acid|mesh-list
92114783|NCT05439694|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92114784|NCT05439694|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92114785|NCT05439694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114786|NCT05439694|Hemostatics|hemostatics|mesh-ancestor
92114787|NCT05439694|Coagulants|coagulants|mesh-ancestor
92114788|NCT02714439|Proflavine|proflavine|mesh-list
92114789|NCT02714439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92114790|NCT02714439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114791|NCT02165007|Sirolimus|sirolimus|mesh-list
92114792|NCT02165007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92114793|NCT02165007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114794|NCT02165007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92114795|NCT02165007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114796|NCT02165007|Antifungal Agents|antifungal agents|mesh-ancestor
92114797|NCT02165007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114798|NCT02165007|Immunologic Factors|immunologic factors|mesh-ancestor
92114799|NCT02165007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114800|NCT02290444|Hormones|hormones|mesh-list
92114801|NCT02290444|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92114802|NCT02290444|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92114803|NCT02290444|beta-Endorphin|beta-endorphin|mesh-list
92114804|NCT02290444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114805|NCT02290444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114806|NCT02290444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114807|NCT02290444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114808|NCT01726517|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92114809|NCT01726517|Antiviral Agents|antiviral agents|mesh-ancestor
92114810|NCT01726517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114811|NCT01752023|Itraconazole|itraconazole|mesh-list
92114812|NCT01752023|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92114813|NCT01752023|Cisplatin|cisplatin|mesh-list
92114814|NCT01752023|Gemcitabine|gemcitabine|mesh-list
92114815|NCT01752023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114816|NCT01752023|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114817|NCT01752023|Antimetabolites|antimetabolites|mesh-ancestor
92143526|NCT04818372|Dexamethasone|dexamethasone|mesh-list
92114818|NCT01752023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114819|NCT01752023|Antifungal Agents|antifungal agents|mesh-ancestor
92114820|NCT01752023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114821|NCT01752023|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92114822|NCT01752023|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92114823|NCT01752023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114824|NCT01752023|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92114825|NCT01752023|Hormone Antagonists|hormone antagonists|mesh-ancestor
92114826|NCT01752023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114827|NCT01752023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114828|NCT01752023|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92114829|NCT02986906|Triamcinolone|triamcinolone|mesh-list
92114830|NCT02986906|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92114831|NCT02986906|Glucocorticoids|glucocorticoids|mesh-ancestor
92114832|NCT02986906|Hormones|hormones|mesh-ancestor
92114833|NCT02986906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114834|NCT02986906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114835|NCT05658562|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92114836|NCT05658562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114837|NCT05658562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114838|NCT01726049|Sildenafil Citrate|sildenafil citrate|mesh-list
92114839|NCT01726049|Vasodilator Agents|vasodilator agents|mesh-ancestor
92114840|NCT01726049|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92114841|NCT01726049|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92114842|NCT01726049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114843|NCT01726049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114844|NCT01726049|Urological Agents|urological agents|mesh-ancestor
92114846|NCT02162667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114847|NCT02162667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114848|NCT01605617|Fesoterodine|fesoterodine|mesh-list
92114849|NCT01605617|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92114850|NCT01605617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92114851|NCT01605617|Cholinergic Agents|cholinergic agents|mesh-ancestor
92114852|NCT01605617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114853|NCT01605617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114854|NCT01605617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114855|NCT01605617|Urological Agents|urological agents|mesh-ancestor
92114856|NCT05402020|Tiotropium Bromide|tiotropium bromide|mesh-list
92114858|NCT05402020|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92114859|NCT05402020|Autonomic Agents|autonomic agents|mesh-ancestor
92114860|NCT05402020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114861|NCT05402020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114862|NCT05402020|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92114863|NCT05402020|Respiratory System Agents|respiratory system agents|mesh-ancestor
92114864|NCT05402020|Parasympatholytics|parasympatholytics|mesh-ancestor
92114865|NCT05402020|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92114866|NCT05402020|Cholinergic Agents|cholinergic agents|mesh-ancestor
92114867|NCT05402020|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114868|NCT05402020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114869|NCT02284828|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92114870|NCT02284828|Anticonvulsants|anticonvulsants|mesh-ancestor
92114871|NCT02284828|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92114872|NCT02284828|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92114873|NCT02284828|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92114874|NCT02284828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114875|NCT01751867|Decitabine|decitabine|mesh-list
92114876|NCT01751867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92114877|NCT01751867|Antimetabolites|antimetabolites|mesh-ancestor
92114878|NCT01751867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114879|NCT01751867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114880|NCT01751867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114881|NCT02418195|Ketamine|ketamine|mesh-list
92114882|NCT02418195|Analgesics|analgesics|mesh-ancestor
92114883|NCT02418195|Sensory System Agents|sensory system agents|mesh-ancestor
92114884|NCT02418195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92114885|NCT02418195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072991|NCT01464034|Hormones|hormones|mesh-ancestor
92114886|NCT02418195|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92114887|NCT02418195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92114888|NCT02418195|Anesthetics, General|anesthetics, general|mesh-ancestor
92114889|NCT02418195|Anesthetics|anesthetics|mesh-ancestor
92114890|NCT02418195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92114891|NCT02418195|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92114892|NCT02418195|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92114893|NCT02418195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92114894|NCT02418195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114895|NCT05633914|Paclitaxel|paclitaxel|mesh-list
92114896|NCT05633914|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92114897|NCT05633914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114898|NCT05633914|Tubulin Modulators|tubulin modulators|mesh-ancestor
92114899|NCT05633914|Antimitotic Agents|antimitotic agents|mesh-ancestor
92114900|NCT05633914|Mitosis Modulators|mitosis modulators|mesh-ancestor
92114901|NCT05633914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114902|NCT05383612|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92114903|NCT05383612|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92114904|NCT05382364|Tucatinib|tucatinib|mesh-list
92114905|NCT05382364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114906|NCT05382364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114907|NCT05382364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114908|NCT05382364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114909|NCT02712801|Ritonavir|ritonavir|mesh-list
92114910|NCT02712801|Lopinavir|lopinavir|mesh-list
92114911|NCT02712801|Lamivudine|lamivudine|mesh-list
92114912|NCT02712801|Zidovudine|zidovudine|mesh-list
92114913|NCT02712801|Nevirapine|nevirapine|mesh-list
92114914|NCT02712801|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92114915|NCT02712801|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92114916|NCT02712801|Protease Inhibitors|protease inhibitors|mesh-ancestor
92114917|NCT02712801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114918|NCT02712801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114919|NCT02712801|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92114920|NCT02712801|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92114921|NCT02712801|Antiviral Agents|antiviral agents|mesh-ancestor
92114922|NCT02712801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92114923|NCT02712801|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92114924|NCT02712801|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92114925|NCT02712801|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92114926|NCT02712801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92114927|NCT02712801|Antimetabolites|antimetabolites|mesh-ancestor
92114928|NCT02712801|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92114929|NCT02712801|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92114930|NCT02712723|Letrozole|letrozole|mesh-list
92114931|NCT02712723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114932|NCT02712723|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92114933|NCT02712723|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92114934|NCT02712723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114935|NCT02712723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114936|NCT02712723|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92114937|NCT02712723|Hormone Antagonists|hormone antagonists|mesh-ancestor
92114938|NCT02712723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114939|NCT02712723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114940|NCT02156739|Edetic Acid|edetic acid|mesh-list
92114941|NCT02156739|Pentetic Acid|pentetic acid|mesh-list
92114942|NCT02156739|Antidotes|antidotes|mesh-ancestor
92114943|NCT02156739|Protective Agents|protective agents|mesh-ancestor
92114944|NCT02156739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114945|NCT02156739|Chelating Agents|chelating agents|mesh-ancestor
92114946|NCT02156739|Sequestering Agents|sequestering agents|mesh-ancestor
92114947|NCT02156739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114948|NCT02156739|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92114949|NCT02156739|Anticoagulants|anticoagulants|mesh-ancestor
92114950|NCT02156739|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92114951|NCT02402439|Pancrelipase|pancrelipase|mesh-list
92114952|NCT02402439|Pancreatin|pancreatin|mesh-list
92114953|NCT02402439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92114954|NCT01751087|Vitamins|vitamins|mesh-list
92114955|NCT01751087|Vitamin B 12|vitamin b 12|mesh-list
92114956|NCT01751087|Misoprostol|misoprostol|mesh-list
92114957|NCT01751087|Mifepristone|mifepristone|mesh-list
92114958|NCT01751087|Micronutrients|micronutrients|mesh-ancestor
92114959|NCT01751087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114960|NCT01751087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92114961|NCT01751087|Abortifacient Agents|abortifacient agents|mesh-ancestor
92114963|NCT01751087|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92114964|NCT01751087|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92114965|NCT01751087|Oxytocics|oxytocics|mesh-ancestor
92114966|NCT01751087|Vitamin B Complex|vitamin b complex|mesh-ancestor
92114967|NCT01751087|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92114968|NCT01751087|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92114969|NCT01751087|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92114970|NCT01751087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92114971|NCT01751087|Contraceptive Agents|contraceptive agents|mesh-ancestor
92114972|NCT01751087|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92114973|NCT01751087|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92114974|NCT01751087|Hormone Antagonists|hormone antagonists|mesh-ancestor
92114975|NCT01751087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92114976|NCT01751087|Luteolytic Agents|luteolytic agents|mesh-ancestor
92114977|NCT01751087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92114978|NCT01751087|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92114979|NCT02143401|Sorafenib|sorafenib|mesh-list
92114980|NCT02143401|Navitoclax|navitoclax|mesh-list
92114981|NCT02143401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938538|NCT05277896|Anesthetics|anesthetics|mesh-ancestor
92114982|NCT02143401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92114983|NCT02143401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92114984|NCT02143401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114985|NCT02401503|Venetoclax|venetoclax|mesh-list
92114986|NCT02401503|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92114987|NCT02401503|Obinutuzumab|obinutuzumab|mesh-list
92114988|NCT02401503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92114989|NCT02401503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92114990|NCT02401503|Alkylating Agents|alkylating agents|mesh-ancestor
92114991|NCT02401503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92114992|NCT02401503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92114993|NCT02395497|Antibodies|antibodies|mesh-list
92114994|NCT02395497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92114995|NCT02395497|Tacrolimus|tacrolimus|mesh-list
92114996|NCT02395497|Immunologic Factors|immunologic factors|mesh-ancestor
92114997|NCT02395497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92114998|NCT02395497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92114999|NCT02395497|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92115000|NCT02395497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115001|NCT02395497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115002|NCT02393157|Carboplatin|carboplatin|mesh-list
92115003|NCT02393157|Etoposide|etoposide|mesh-list
92115004|NCT02393157|Ifosfamide|ifosfamide|mesh-list
92115005|NCT02393157|Obinutuzumab|obinutuzumab|mesh-list
92115006|NCT02393157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115007|NCT02393157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92115008|NCT02393157|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92115009|NCT02393157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92115010|NCT02393157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115011|NCT02393157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115012|NCT02393157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92115013|NCT02393157|Alkylating Agents|alkylating agents|mesh-ancestor
92115014|NCT02393157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115015|NCT01750697|Rituximab|rituximab|mesh-list
92115016|NCT01750697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115017|NCT01750697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115018|NCT01750697|Immunologic Factors|immunologic factors|mesh-ancestor
92115019|NCT01750697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115020|NCT01750697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115021|NCT02127723|Hyaluronic Acid|hyaluronic acid|mesh-list
92115022|NCT02127723|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92115023|NCT02127723|Immunologic Factors|immunologic factors|mesh-ancestor
92115024|NCT02127723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115025|NCT02127723|Viscosupplements|viscosupplements|mesh-ancestor
92115026|NCT02127723|Protective Agents|protective agents|mesh-ancestor
92115028|NCT05586711|Estrogens|estrogens|mesh-ancestor
92115029|NCT05586711|Hormones|hormones|mesh-ancestor
92115030|NCT05586711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115031|NCT05586711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115032|NCT05317858|Pembrolizumab|pembrolizumab|mesh-list
92115033|NCT05317858|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115034|NCT05317858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115035|NCT05317858|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115036|NCT05317858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115037|NCT01724489|Hormones|hormones|mesh-list
92115038|NCT01724489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115039|NCT01724489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115040|NCT01996293|Lamotrigine|lamotrigine|mesh-list
92115041|NCT01996293|Anticonvulsants|anticonvulsants|mesh-ancestor
92115042|NCT01996293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92115043|NCT01996293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115044|NCT01996293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115045|NCT01996293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92115046|NCT01996293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115047|NCT01996293|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92115048|NCT01996293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92115049|NCT01996293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115050|NCT01996293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115051|NCT01996293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92115052|NCT02986750|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92115053|NCT02986750|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92115054|NCT05304364|Naltrexone|naltrexone|mesh-list
92115055|NCT05304364|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92115056|NCT05304364|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92115057|NCT05304364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115058|NCT05304364|Sensory System Agents|sensory system agents|mesh-ancestor
92115059|NCT05304364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115060|NCT01724177|Lenalidomide|lenalidomide|mesh-list
92115061|NCT01724177|Immunologic Factors|immunologic factors|mesh-ancestor
92115062|NCT01724177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115063|NCT01724177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92115064|NCT01724177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92115065|NCT01724177|Growth Substances|growth substances|mesh-ancestor
92115066|NCT01724177|Growth Inhibitors|growth inhibitors|mesh-ancestor
92096499|NCT01059994|Sildenafil Citrate|sildenafil citrate|mesh-list
92115067|NCT01724177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115068|NCT01991457|Fludarabine|fludarabine|mesh-list
92098051|NCT03461718|GABA Modulators|gaba modulators|mesh-ancestor
92143527|NCT04818372|Lenalidomide|lenalidomide|mesh-list
92143761|NCT05119452|Adalimumab|adalimumab|mesh-list
92115069|NCT01991457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115070|NCT02117817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92143762|NCT05119452|Infliximab|infliximab|mesh-list
92115071|NCT02117817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115072|NCT05529784|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92115073|NCT05529784|Immunologic Factors|immunologic factors|mesh-ancestor
92115074|NCT05529784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115075|NCT05524246|Pravastatin|pravastatin|mesh-list
92115076|NCT05524246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92115077|NCT05524246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92115078|NCT05524246|Antimetabolites|antimetabolites|mesh-ancestor
92115079|NCT05524246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115080|NCT05524246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92115081|NCT05524246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92115082|NCT05524246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115083|NCT02685735|Gabapentin|gabapentin|mesh-list
92115084|NCT02685735|Analgesics|analgesics|mesh-ancestor
92115085|NCT02685735|Sensory System Agents|sensory system agents|mesh-ancestor
92115086|NCT02685735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115087|NCT02685735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115088|NCT02685735|Anticonvulsants|anticonvulsants|mesh-ancestor
92115089|NCT02685735|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92115090|NCT02685735|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92115091|NCT02685735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115092|NCT02685735|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115093|NCT02685735|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92115094|NCT02685735|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92115095|NCT02685735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115096|NCT02685735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115135|NCT01724021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115136|NCT01724021|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115137|NCT01724021|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92115138|NCT01724021|Tubulin Modulators|tubulin modulators|mesh-ancestor
92115139|NCT01724021|Antimitotic Agents|antimitotic agents|mesh-ancestor
92115140|NCT01724021|Mitosis Modulators|mitosis modulators|mesh-ancestor
92115141|NCT01724021|Antiemetics|antiemetics|mesh-ancestor
92115142|NCT01724021|Autonomic Agents|autonomic agents|mesh-ancestor
92115143|NCT01724021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115144|NCT01724021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115145|NCT01724021|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92115146|NCT01724021|Protective Agents|protective agents|mesh-ancestor
92115147|NCT01724021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92115148|NCT01724021|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92115149|NCT01724021|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92115150|NCT01724021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115151|NCT05197504|Bevacizumab|bevacizumab|mesh-list
92115152|NCT05197504|Atezolizumab|atezolizumab|mesh-list
92115153|NCT05197504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115154|NCT05197504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115155|NCT05197504|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92115156|NCT05197504|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92115157|NCT05197504|Growth Substances|growth substances|mesh-ancestor
92115158|NCT05197504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115159|NCT05197504|Growth Inhibitors|growth inhibitors|mesh-ancestor
92115160|NCT05197504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115161|NCT05197504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115162|NCT02293096|Metoprolol|metoprolol|mesh-list
92115163|NCT02293096|Dextromethorphan|dextromethorphan|mesh-list
92115164|NCT02293096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92115165|NCT02293096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92115166|NCT02293096|Sympatholytics|sympatholytics|mesh-ancestor
92115167|NCT02293096|Autonomic Agents|autonomic agents|mesh-ancestor
92115168|NCT02293096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115169|NCT02293096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115170|NCT02293096|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92115171|NCT02293096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92115172|NCT02293096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92115173|NCT02293096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92115174|NCT02293096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115175|NCT02293096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115176|NCT02293096|Antitussive Agents|antitussive agents|mesh-ancestor
92115177|NCT02293096|Respiratory System Agents|respiratory system agents|mesh-ancestor
92115178|NCT02293096|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92115179|NCT02293096|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92115180|NCT01722071|Oxytocin|oxytocin|mesh-list
92115181|NCT01722071|Oxytocics|oxytocics|mesh-ancestor
92115182|NCT01722071|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92115183|NCT01722071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115184|NCT04223752|Tazobactam|tazobactam|mesh-list
92115185|NCT04223752|Ceftolozane|ceftolozane|mesh-list
92115186|NCT04223752|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92115187|NCT04223752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92115188|NCT04223752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115189|NCT04223752|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92115190|NCT04223752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115191|NCT04223752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115192|NCT04223752|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92115193|NCT04187404|Nivolumab|nivolumab|mesh-list
92115194|NCT04187404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115195|NCT04187404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115196|NCT04187404|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115197|NCT04187404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115198|NCT04155580|Decitabine|decitabine|mesh-list
92115199|NCT04155580|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92115200|NCT04155580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115201|NCT04155580|Antimetabolites|antimetabolites|mesh-ancestor
92115202|NCT04155580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115203|NCT04155580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115204|NCT04155580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115205|NCT01721759|Nivolumab|nivolumab|mesh-list
92115206|NCT01721759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115207|NCT01721759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115209|NCT01721759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115210|NCT04776850|Mycophenolic Acid|mycophenolic acid|mesh-list
92115211|NCT04776850|Dexamethasone|dexamethasone|mesh-list
92115212|NCT04776850|Dexamethasone acetate|dexamethasone acetate|mesh-list
92115213|NCT04776850|Cyclophosphamide|cyclophosphamide|mesh-list
92115214|NCT04776850|Busulfan|busulfan|mesh-list
92115216|NCT04776850|Fludarabine|fludarabine|mesh-list
92115217|NCT04776850|Fludarabine phosphate|fludarabine phosphate|mesh-list
92115218|NCT04776850|Bortezomib|bortezomib|mesh-list
92115219|NCT04776850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92115220|NCT04776850|Tacrolimus|tacrolimus|mesh-list
92115221|NCT04776850|Thymoglobulin|thymoglobulin|mesh-list
92115222|NCT04776850|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92115223|NCT04776850|Antibodies|antibodies|mesh-list
92115224|NCT04776850|Immunoglobulins|immunoglobulins|mesh-list
92115225|NCT04776850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92115226|NCT04776850|gamma-Globulins|gamma-globulins|mesh-list
92115227|NCT04776850|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92115228|NCT04776850|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92115229|NCT04776850|BB 1101|bb 1101|mesh-list
92115230|NCT04776850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115231|NCT04776850|Immunologic Factors|immunologic factors|mesh-ancestor
92115232|NCT04776850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115233|NCT04776850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115234|NCT04776850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92115235|NCT04776850|Alkylating Agents|alkylating agents|mesh-ancestor
92115236|NCT04776850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115237|NCT04776850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115238|NCT04776850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92115239|NCT04776850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115240|NCT04776850|Antiemetics|antiemetics|mesh-ancestor
92115241|NCT04776850|Autonomic Agents|autonomic agents|mesh-ancestor
92115242|NCT04776850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115243|NCT04776850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115244|NCT04776850|Glucocorticoids|glucocorticoids|mesh-ancestor
92115245|NCT04776850|Hormones|hormones|mesh-ancestor
92115246|NCT04776850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115247|NCT04776850|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115248|NCT04776850|Protease Inhibitors|protease inhibitors|mesh-ancestor
92115249|NCT04776850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115250|NCT04776850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115251|NCT04776850|Antimetabolites|antimetabolites|mesh-ancestor
92115252|NCT04776850|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92115253|NCT04776850|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92115254|NCT04776850|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92115255|NCT04776850|Antitubercular Agents|antitubercular agents|mesh-ancestor
92115256|NCT04776850|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92115257|NCT04776850|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115258|NCT04132648|Curcumin|curcumin|mesh-list
92115259|NCT04132648|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92115260|NCT04132648|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92115261|NCT04132648|Analgesics|analgesics|mesh-ancestor
92115262|NCT04132648|Sensory System Agents|sensory system agents|mesh-ancestor
92115263|NCT04132648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115264|NCT04132648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115265|NCT04132648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115266|NCT04132648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115267|NCT04132648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115268|NCT04132648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115269|NCT04132648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938550|NCT05249972|Calcitriol|calcitriol|mesh-list
92115270|NCT02331940|Tiotropium Bromide|tiotropium bromide|mesh-list
92115271|NCT02331940|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92115272|NCT02331940|Autonomic Agents|autonomic agents|mesh-ancestor
92115273|NCT02331940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115274|NCT02331940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115275|NCT02331940|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92115276|NCT02331940|Respiratory System Agents|respiratory system agents|mesh-ancestor
92115277|NCT02331940|Parasympatholytics|parasympatholytics|mesh-ancestor
92115278|NCT02331940|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92115279|NCT02331940|Cholinergic Agents|cholinergic agents|mesh-ancestor
92115280|NCT02331940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115281|NCT02331940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115282|NCT04095208|Nivolumab|nivolumab|mesh-list
92115283|NCT04095208|Relatlimab|relatlimab|mesh-list
92115284|NCT04095208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115285|NCT04095208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115287|NCT04095208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115288|NCT05117554|Midazolam|midazolam|mesh-list
92115289|NCT05117554|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92115290|NCT05117554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92115291|NCT05117554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115292|NCT05117554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115293|NCT05117554|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92115294|NCT05117554|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92115295|NCT05117554|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115296|NCT05117554|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92115297|NCT05117554|Anesthetics, General|anesthetics, general|mesh-ancestor
92115298|NCT05117554|Anesthetics|anesthetics|mesh-ancestor
92115299|NCT05117554|GABA Modulators|gaba modulators|mesh-ancestor
92115300|NCT05117554|GABA Agents|gaba agents|mesh-ancestor
92115301|NCT05117554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115302|NCT05117554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115303|NCT04093570|Decitabine|decitabine|mesh-list
92115304|NCT04093570|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92115305|NCT04093570|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115306|NCT04093570|Antimetabolites|antimetabolites|mesh-ancestor
92115307|NCT04093570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115308|NCT04093570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115309|NCT04093570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115310|NCT04034056|Obinutuzumab|obinutuzumab|mesh-list
92115311|NCT04034056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115312|NCT04034056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115313|NCT02292082|Cefazolin|cefazolin|mesh-list
92115314|NCT02292082|Dexamethasone|dexamethasone|mesh-list
92115315|NCT02292082|Methylprednisolone|methylprednisolone|mesh-list
92115316|NCT02292082|Midazolam|midazolam|mesh-list
92115317|NCT02292082|Morphine|morphine|mesh-list
92115318|NCT02292082|Bupivacaine|bupivacaine|mesh-list
92115319|NCT02292082|Propofol|propofol|mesh-list
92115320|NCT02292082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115321|NCT02292082|Antiemetics|antiemetics|mesh-ancestor
92115322|NCT02292082|Autonomic Agents|autonomic agents|mesh-ancestor
92115323|NCT02292082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115324|NCT02292082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115325|NCT02292082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115326|NCT02292082|Glucocorticoids|glucocorticoids|mesh-ancestor
92115327|NCT02292082|Hormones|hormones|mesh-ancestor
92115328|NCT02292082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115329|NCT02292082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115330|NCT02292082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115331|NCT02292082|Anesthetics, Local|anesthetics, local|mesh-ancestor
92115332|NCT02292082|Anesthetics|anesthetics|mesh-ancestor
92115333|NCT02292082|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115334|NCT02292082|Sensory System Agents|sensory system agents|mesh-ancestor
92115335|NCT02292082|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92115336|NCT02292082|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92115337|NCT02292082|Anesthetics, General|anesthetics, general|mesh-ancestor
92115338|NCT02292082|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92115339|NCT02292082|Narcotics|narcotics|mesh-ancestor
92115340|NCT02292082|Analgesics|analgesics|mesh-ancestor
92115341|NCT02292082|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92115342|NCT02292082|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92115343|NCT02292082|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92115344|NCT02292082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115345|NCT02292082|GABA Modulators|gaba modulators|mesh-ancestor
92115347|NCT02292082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115348|NCT02292082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115349|NCT02292082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92115350|NCT02292082|Protective Agents|protective agents|mesh-ancestor
92115351|NCT02292082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92115352|NCT02292082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115353|NCT05072704|Sufentanil|sufentanil|mesh-list
92115354|NCT05072704|Dexmedetomidine|dexmedetomidine|mesh-list
92115355|NCT05072704|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92115356|NCT05072704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115357|NCT05072704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115358|NCT05072704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92115359|NCT05072704|Analgesics|analgesics|mesh-ancestor
92115360|NCT05072704|Sensory System Agents|sensory system agents|mesh-ancestor
92115361|NCT05072704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115362|NCT05072704|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92115363|NCT05072704|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92115364|NCT05072704|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92115367|NCT05072704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115368|NCT05072704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92115369|NCT05072704|Narcotics|narcotics|mesh-ancestor
92115370|NCT05072704|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92115371|NCT05072704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92115372|NCT05072704|Anesthetics, General|anesthetics, general|mesh-ancestor
92115373|NCT05072704|Anesthetics|anesthetics|mesh-ancestor
92115374|NCT04678336|Cyclophosphamide|cyclophosphamide|mesh-list
92115375|NCT04678336|Fludarabine|fludarabine|mesh-list
92115376|NCT04678336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115377|NCT04678336|Immunologic Factors|immunologic factors|mesh-ancestor
92115378|NCT04678336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115379|NCT04678336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115380|NCT04678336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92115381|NCT04678336|Alkylating Agents|alkylating agents|mesh-ancestor
92115382|NCT04678336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115383|NCT04678336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115384|NCT04678336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92115386|NCT03195478|Ipilimumab|ipilimumab|mesh-list
92115387|NCT03195478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115388|NCT03195478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115389|NCT03195478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115390|NCT03195478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115391|NCT04607122|Landiolol|landiolol|mesh-list
92115392|NCT04607122|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92115393|NCT04607122|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92115394|NCT04607122|Adrenergic Agents|adrenergic agents|mesh-ancestor
92115395|NCT04607122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115396|NCT04607122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115397|NCT04607122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115398|NCT04607122|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92115399|NCT03099382|Docetaxel|docetaxel|mesh-list
92115400|NCT03099382|Irinotecan|irinotecan|mesh-list
92115401|NCT03099382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115402|NCT03099382|Tubulin Modulators|tubulin modulators|mesh-ancestor
92115403|NCT03099382|Antimitotic Agents|antimitotic agents|mesh-ancestor
92115404|NCT03099382|Mitosis Modulators|mitosis modulators|mesh-ancestor
92115405|NCT03099382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115406|NCT03099382|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92115407|NCT03099382|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92115408|NCT03099382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115409|NCT04590664|Verteporfin|verteporfin|mesh-list
92115410|NCT04590664|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92115411|NCT04590664|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073518|NCT04389580|Dermatologic Agents|dermatologic agents|mesh-ancestor
92115412|NCT04494412|Zanamivir|zanamivir|mesh-list
92115413|NCT04494412|Antiviral Agents|antiviral agents|mesh-ancestor
92115414|NCT04494412|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115415|NCT04494412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115416|NCT04494412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115417|NCT03583528|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92115418|NCT03583528|Edotreotide|edotreotide|mesh-list
92115419|NCT03583528|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92115420|NCT03583528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115421|NCT02180724|Acalabrutinib|acalabrutinib|mesh-list
92115422|NCT02180724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115423|NCT01949337|Prednisone|prednisone|mesh-list
92115424|NCT01949337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115425|NCT01949337|Glucocorticoids|glucocorticoids|mesh-ancestor
92115426|NCT01949337|Hormones|hormones|mesh-ancestor
92115427|NCT01949337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115428|NCT01949337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115429|NCT01949337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115430|NCT01949337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115431|NCT03578146|Rivaroxaban|rivaroxaban|mesh-list
92115432|NCT03578146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92115433|NCT03578146|Antithrombins|antithrombins|mesh-ancestor
92115434|NCT03578146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92115435|NCT03578146|Protease Inhibitors|protease inhibitors|mesh-ancestor
92115436|NCT03578146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115437|NCT03578146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115438|NCT03578146|Anticoagulants|anticoagulants|mesh-ancestor
92115439|NCT04355832|Glucagon|glucagon|mesh-list
92115440|NCT04355832|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92115441|NCT04355832|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115442|NCT04355832|Hormones|hormones|mesh-ancestor
92115443|NCT04355832|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115444|NCT04355832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115445|NCT04355832|Incretins|incretins|mesh-ancestor
92115446|NCT02518594|Progesterone|progesterone|mesh-list
92115447|NCT02518594|Progestins|progestins|mesh-ancestor
92115448|NCT02518594|Hormones|hormones|mesh-ancestor
92115449|NCT02518594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115450|NCT02518594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115451|NCT01516593|Cytarabine|cytarabine|mesh-list
92115452|NCT01516593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115453|NCT01516593|Antimetabolites|antimetabolites|mesh-ancestor
92115454|NCT01516593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115455|NCT01516593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115456|NCT01516593|Antiviral Agents|antiviral agents|mesh-ancestor
92115457|NCT01516593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115458|NCT01516593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115459|NCT01516593|Immunologic Factors|immunologic factors|mesh-ancestor
92115460|NCT01516593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115461|NCT04273932|Lithium Carbonate|lithium carbonate|mesh-list
92115462|NCT04273932|Antidepressive Agents|antidepressive agents|mesh-ancestor
92115463|NCT04273932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115464|NCT04273932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115465|NCT04273932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115466|NCT04273932|Antimanic Agents|antimanic agents|mesh-ancestor
92115467|NCT04273932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92115468|NCT04273932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115469|NCT04273932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115470|NCT02042391|Cytarabine|cytarabine|mesh-list
92115471|NCT02042391|Prednisone|prednisone|mesh-list
92115472|NCT02042391|Cyclophosphamide|cyclophosphamide|mesh-list
92115473|NCT02042391|Rituximab|rituximab|mesh-list
92115474|NCT02042391|Oxaliplatin|oxaliplatin|mesh-list
92115475|NCT02042391|Doxorubicin|doxorubicin|mesh-list
92115476|NCT02042391|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92115477|NCT02042391|Vincristine|vincristine|mesh-list
92115478|NCT02042391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115479|NCT02042391|Immunologic Factors|immunologic factors|mesh-ancestor
92115480|NCT02042391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115481|NCT02042391|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115482|NCT02042391|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92115483|NCT02042391|Alkylating Agents|alkylating agents|mesh-ancestor
92115484|NCT02042391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115485|NCT02042391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115486|NCT02042391|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92115487|NCT02042391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115488|NCT02042391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115489|NCT02042391|Glucocorticoids|glucocorticoids|mesh-ancestor
92115490|NCT02042391|Hormones|hormones|mesh-ancestor
92115491|NCT02042391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115492|NCT02042391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115493|NCT02042391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115495|NCT02042391|Antiviral Agents|antiviral agents|mesh-ancestor
92115496|NCT02042391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115497|NCT02042391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92115498|NCT02042391|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92115499|NCT02042391|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92115500|NCT02042391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115501|NCT02042391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92115502|NCT02042391|Tubulin Modulators|tubulin modulators|mesh-ancestor
92115503|NCT02042391|Antimitotic Agents|antimitotic agents|mesh-ancestor
92115504|NCT02042391|Mitosis Modulators|mitosis modulators|mesh-ancestor
92115506|NCT02461836|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115507|NCT02461836|Antimetabolites|antimetabolites|mesh-ancestor
92115508|NCT02461836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115509|NCT02461836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115510|NCT02034981|Crizotinib|crizotinib|mesh-list
92115511|NCT02034981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115512|NCT02034981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92115513|NCT02034981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115514|NCT02034981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115515|NCT01986946|Hydromorphone|hydromorphone|mesh-list
92115516|NCT01986946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92115517|NCT01986946|Narcotics|narcotics|mesh-ancestor
92115518|NCT01986946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143763|NCT05119452|Golimumab|golimumab|mesh-list
92115536|NCT02427724|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92115537|NCT02427724|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92115538|NCT02427724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115539|NCT02427724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115540|NCT03437200|Nivolumab|nivolumab|mesh-list
92115541|NCT03437200|Ipilimumab|ipilimumab|mesh-list
92115542|NCT03437200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115543|NCT03437200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115544|NCT03437200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92115545|NCT03437200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115546|NCT01903473|Sirolimus|sirolimus|mesh-list
92115547|NCT01903473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92115548|NCT01903473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115549|NCT01903473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92115550|NCT01903473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115551|NCT01903473|Antifungal Agents|antifungal agents|mesh-ancestor
92115552|NCT01903473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115553|NCT01903473|Immunologic Factors|immunologic factors|mesh-ancestor
91938554|NCT05249972|Betamethasone benzoate|betamethasone benzoate|mesh-list
92115554|NCT01903473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115556|NCT02715726|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92115557|NCT02715726|Simvastatin|simvastatin|mesh-list
92115558|NCT02715726|Ezetimibe|ezetimibe|mesh-list
92115559|NCT02715726|Alirocumab|alirocumab|mesh-list
92115560|NCT02715726|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92115561|NCT02715726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92115562|NCT02715726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92115563|NCT02715726|Antimetabolites|antimetabolites|mesh-ancestor
92115564|NCT02715726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115565|NCT02715726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92115566|NCT02715726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92115567|NCT02715726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115568|NCT02715726|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92115569|NCT02715726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92115570|NCT02715726|Protease Inhibitors|protease inhibitors|mesh-ancestor
92115571|NCT02715726|Immunologic Factors|immunologic factors|mesh-ancestor
92115572|NCT02715726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115573|NCT01893567|Clobetasol|clobetasol|mesh-list
92115574|NCT01893567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115575|NCT01893567|Glucocorticoids|glucocorticoids|mesh-ancestor
92115576|NCT01893567|Hormones|hormones|mesh-ancestor
92115577|NCT01893567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115578|NCT01893567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115579|NCT01485861|Prednisone|prednisone|mesh-list
92115580|NCT01485861|Prednisolone|prednisolone|mesh-list
92115581|NCT01485861|Ipatasertib|ipatasertib|mesh-list
92115582|NCT01485861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115583|NCT01485861|Glucocorticoids|glucocorticoids|mesh-ancestor
92115584|NCT01485861|Hormones|hormones|mesh-ancestor
92115585|NCT01485861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115586|NCT01485861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115587|NCT01485861|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115588|NCT01485861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115589|NCT01485861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92115590|NCT01485861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115591|NCT01485861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115592|NCT04249596|Tianeptine|tianeptine|mesh-list
92115593|NCT04249596|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92115594|NCT04249596|Antidepressive Agents|antidepressive agents|mesh-ancestor
92115595|NCT04249596|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115596|NCT01476501|Vitamin D|vitamin d|mesh-list
92115597|NCT01476501|Cholecalciferol|cholecalciferol|mesh-list
92115598|NCT01476501|Vitamins|vitamins|mesh-ancestor
92115599|NCT01476501|Micronutrients|micronutrients|mesh-ancestor
92115600|NCT01476501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115601|NCT01476501|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92115602|NCT01476501|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92115603|NCT03426124|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92115604|NCT03426124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92115605|NCT03426124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115606|NCT02464020|Vancomycin|vancomycin|mesh-list
92115607|NCT02464020|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92115608|NCT02464020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115609|NCT04756089|Oxytocin|oxytocin|mesh-list
92115610|NCT04756089|Oxytocics|oxytocics|mesh-ancestor
92115611|NCT04756089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92115619|NCT03397888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115620|NCT03397888|Anticoagulants|anticoagulants|mesh-ancestor
92115621|NCT01886859|Lenalidomide|lenalidomide|mesh-list
92115622|NCT01886859|Immunologic Factors|immunologic factors|mesh-ancestor
91938570|NCT05249972|Vitamins|vitamins|mesh-ancestor
92115623|NCT01886859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115624|NCT01886859|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92115625|NCT01886859|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92115626|NCT01886859|Growth Substances|growth substances|mesh-ancestor
92115627|NCT01886859|Growth Inhibitors|growth inhibitors|mesh-ancestor
92115628|NCT01886859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115630|NCT01989910|Raltegravir Potassium|raltegravir potassium|mesh-list
92115631|NCT01989910|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92115632|NCT01989910|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92115633|NCT01989910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115634|NCT01989910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115635|NCT01989910|Antiviral Agents|antiviral agents|mesh-ancestor
92115636|NCT01989910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115637|NCT01989910|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92115638|NCT01989910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92115639|NCT01989910|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92115640|NCT01989910|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92115641|NCT01989910|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92115642|NCT01989910|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92115643|NCT01989910|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92115644|NCT01989910|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92115645|NCT01989910|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92115646|NCT01989910|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92115647|NCT02464722|Epinephrine|epinephrine|mesh-list
92115648|NCT02464722|Dexmedetomidine|dexmedetomidine|mesh-list
92115649|NCT02464722|Remifentanil|remifentanil|mesh-list
92115650|NCT02464722|Propofol|propofol|mesh-list
92115651|NCT02464722|Rocuronium|rocuronium|mesh-list
92115652|NCT02464722|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92115653|NCT02464722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115654|NCT02464722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115655|NCT02464722|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92115656|NCT02464722|Analgesics|analgesics|mesh-ancestor
92115657|NCT02464722|Sensory System Agents|sensory system agents|mesh-ancestor
92115658|NCT02464722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115659|NCT02464722|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92115660|NCT02464722|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92115661|NCT02464722|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92115662|NCT02464722|Adrenergic Agents|adrenergic agents|mesh-ancestor
92115663|NCT02464722|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115664|NCT02464722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115665|NCT02464722|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92115666|NCT02464722|Anesthetics, General|anesthetics, general|mesh-ancestor
92115667|NCT02464722|Anesthetics|anesthetics|mesh-ancestor
92115668|NCT02464722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92115669|NCT02464722|Narcotics|narcotics|mesh-ancestor
92115670|NCT02464722|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92115671|NCT02464722|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92115672|NCT02464722|Autonomic Agents|autonomic agents|mesh-ancestor
92115673|NCT02464722|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92115674|NCT02464722|Respiratory System Agents|respiratory system agents|mesh-ancestor
92115675|NCT02464722|Mydriatics|mydriatics|mesh-ancestor
92115676|NCT02464722|Sympathomimetics|sympathomimetics|mesh-ancestor
92115677|NCT02464722|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92115678|NCT02464722|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92115679|NCT02464722|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92115680|NCT02464722|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92115681|NCT01991548|Insulin|insulin|mesh-list
92115682|NCT01991548|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92115683|NCT01991548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115684|NCT03298854|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92115685|NCT03298854|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92115686|NCT03298854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115687|NCT01878669|Acetylcysteine|acetylcysteine|mesh-list
92115688|NCT01878669|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92115689|NCT01878669|Antiviral Agents|antiviral agents|mesh-ancestor
92115690|NCT01878669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115691|NCT01878669|Expectorants|expectorants|mesh-ancestor
92115692|NCT01878669|Respiratory System Agents|respiratory system agents|mesh-ancestor
92115693|NCT01878669|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92115694|NCT01878669|Antioxidants|antioxidants|mesh-ancestor
92115695|NCT01878669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115696|NCT01878669|Protective Agents|protective agents|mesh-ancestor
92115697|NCT01878669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115699|NCT02461914|Warfarin|warfarin|mesh-list
92115700|NCT02461914|Anticoagulants|anticoagulants|mesh-ancestor
92115701|NCT01991860|Amisulpride|amisulpride|mesh-list
92115702|NCT01991860|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92115703|NCT01991860|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92115704|NCT01991860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115705|NCT01991860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115706|NCT01991860|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92115707|NCT01991860|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92115708|NCT01991860|Dopamine Agents|dopamine agents|mesh-ancestor
92115709|NCT01991860|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115710|NCT01991860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115711|NCT01991860|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92115712|NCT01991860|Antidepressive Agents|antidepressive agents|mesh-ancestor
92115713|NCT01873131|Timolol|timolol|mesh-list
92115714|NCT01873131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115715|NCT01873131|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92115717|NCT01873131|Adrenergic Agents|adrenergic agents|mesh-ancestor
92115718|NCT01873131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115719|NCT01873131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115720|NCT01873131|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92115721|NCT01873131|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92115722|NCT02463552|Naproxen|naproxen|mesh-list
92115723|NCT02463552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92115724|NCT02463552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92115725|NCT02463552|Analgesics|analgesics|mesh-ancestor
92115726|NCT02463552|Sensory System Agents|sensory system agents|mesh-ancestor
92115727|NCT02463552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115728|NCT02463552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115729|NCT02463552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115730|NCT02463552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115731|NCT02463552|Gout Suppressants|gout suppressants|mesh-ancestor
92115732|NCT02463552|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92115733|NCT02463552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115734|NCT02463552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115735|NCT01992016|Ranolazine|ranolazine|mesh-list
92115736|NCT01992016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92115737|NCT01992016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115738|NCT01992016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115739|NCT01871571|Leucovorin|leucovorin|mesh-list
92115740|NCT01871571|Bevacizumab|bevacizumab|mesh-list
92115741|NCT01871571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92115742|NCT01871571|Fluorouracil|fluorouracil|mesh-list
92115743|NCT01871571|Oxaliplatin|oxaliplatin|mesh-list
92115744|NCT01871571|Antibodies|antibodies|mesh-list
92115745|NCT01871571|Immunoglobulins|immunoglobulins|mesh-list
92115746|NCT01871571|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92115747|NCT01871571|Levoleucovorin|levoleucovorin|mesh-list
92115748|NCT01871571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115749|NCT01871571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92115750|NCT01871571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92115751|NCT01871571|Growth Substances|growth substances|mesh-ancestor
92115752|NCT01871571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115753|NCT01871571|Growth Inhibitors|growth inhibitors|mesh-ancestor
92115754|NCT01871571|Immunologic Factors|immunologic factors|mesh-ancestor
92115755|NCT01871571|Antimetabolites|antimetabolites|mesh-ancestor
92115756|NCT01871571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115757|NCT01871571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115758|NCT01871571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115759|NCT01871571|Antidotes|antidotes|mesh-ancestor
92115760|NCT01871571|Protective Agents|protective agents|mesh-ancestor
92115761|NCT01871571|Vitamin B Complex|vitamin b complex|mesh-ancestor
92115762|NCT01871571|Vitamins|vitamins|mesh-ancestor
92115763|NCT01871571|Micronutrients|micronutrients|mesh-ancestor
92115764|NCT02461368|Triamcinolone|triamcinolone|mesh-list
92115765|NCT02461368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92115766|NCT02461368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92115767|NCT02461368|Lidocaine|lidocaine|mesh-list
92115768|NCT02461368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92115770|NCT02461368|Anesthetics|anesthetics|mesh-ancestor
92115771|NCT02461368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115772|NCT02461368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115773|NCT02461368|Sensory System Agents|sensory system agents|mesh-ancestor
92115776|NCT02461368|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92115777|NCT02461368|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92115778|NCT02461368|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115779|NCT02461368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115780|NCT02461368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115781|NCT02461368|Glucocorticoids|glucocorticoids|mesh-ancestor
92115782|NCT02461368|Hormones|hormones|mesh-ancestor
92115783|NCT02461368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115784|NCT02461368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115785|NCT02461368|Immunologic Factors|immunologic factors|mesh-ancestor
92115786|NCT02461368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115787|NCT01422759|Spironolactone|spironolactone|mesh-list
92115788|NCT01422759|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92115789|NCT01422759|Hormone Antagonists|hormone antagonists|mesh-ancestor
92115790|NCT01422759|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115791|NCT01422759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115792|NCT01422759|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92115793|NCT01422759|Diuretics|diuretics|mesh-ancestor
92115794|NCT01422759|Natriuretic Agents|natriuretic agents|mesh-ancestor
92115795|NCT01992172|Sunscreening Agents|sunscreening agents|mesh-list
92115796|NCT01992172|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92115797|NCT01992172|Protective Agents|protective agents|mesh-ancestor
92115798|NCT01992172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115799|NCT01992172|Dermatologic Agents|dermatologic agents|mesh-ancestor
92115800|NCT03296982|Enoxaparin|enoxaparin|mesh-list
92115801|NCT03296982|Edoxaban|edoxaban|mesh-list
92115802|NCT03296982|Anticoagulants|anticoagulants|mesh-ancestor
92115803|NCT03296982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92115804|NCT03296982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92115805|NCT03296982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115806|NCT03296982|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92115807|NCT03296982|Antithrombins|antithrombins|mesh-ancestor
92115808|NCT03296982|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92115809|NCT03296982|Protease Inhibitors|protease inhibitors|mesh-ancestor
92115810|NCT03296982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115811|NCT01895829|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92115812|NCT01895829|Hematinics|hematinics|mesh-ancestor
92115813|NCT01895829|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92115814|NCT01895829|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92115815|NCT03298698|Prednisone|prednisone|mesh-list
92115816|NCT03298698|Prednisolone|prednisolone|mesh-list
92115817|NCT03298698|Rituximab|rituximab|mesh-list
92115818|NCT03298698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92115819|NCT03298698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115820|NCT03298698|Immunologic Factors|immunologic factors|mesh-ancestor
92115821|NCT03298698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115822|NCT03298698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115823|NCT03298698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115824|NCT03298698|Glucocorticoids|glucocorticoids|mesh-ancestor
92115825|NCT03298698|Hormones|hormones|mesh-ancestor
92115826|NCT03298698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115827|NCT03298698|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115828|NCT03389620|Dexamethasone|dexamethasone|mesh-list
92115829|NCT03389620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115830|NCT03389620|Antiemetics|antiemetics|mesh-ancestor
92115831|NCT03389620|Autonomic Agents|autonomic agents|mesh-ancestor
92115832|NCT03389620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115833|NCT03389620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115834|NCT03389620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115835|NCT03389620|Glucocorticoids|glucocorticoids|mesh-ancestor
92115836|NCT03389620|Hormones|hormones|mesh-ancestor
92115837|NCT03389620|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115838|NCT03389620|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115839|NCT03389620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115840|NCT02463942|Doxycycline|doxycycline|mesh-list
92115841|NCT02463942|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92115842|NCT02463942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115843|NCT02463942|Antimalarials|antimalarials|mesh-ancestor
92115844|NCT02463942|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92115845|NCT02463942|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92115846|NCT03298542|Golimumab|golimumab|mesh-list
92115847|NCT03298542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92115848|NCT03298542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115849|NCT03298542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115850|NCT03298542|Immunologic Factors|immunologic factors|mesh-ancestor
92143764|NCT05119452|Certolizumab Pegol|certolizumab pegol|mesh-list
92115862|NCT01852071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073969|NCT04779892|Infliximab|infliximab|mesh-list
92115863|NCT01852071|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115864|NCT01852071|Immunologic Factors|immunologic factors|mesh-ancestor
92115865|NCT01852071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115866|NCT01852071|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92115867|NCT01852071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115868|NCT01852071|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92115869|NCT04084548|Lidocaine|lidocaine|mesh-list
92115870|NCT04084548|Ketamine|ketamine|mesh-list
92115871|NCT04084548|Anesthetics, Local|anesthetics, local|mesh-ancestor
92115872|NCT04084548|Anesthetics|anesthetics|mesh-ancestor
92115873|NCT04084548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92115874|NCT04084548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115875|NCT04084548|Sensory System Agents|sensory system agents|mesh-ancestor
92115876|NCT04084548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115877|NCT04084548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92115878|NCT04084548|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92115879|NCT04084548|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92115880|NCT04084548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115881|NCT04084548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115882|NCT04084548|Analgesics|analgesics|mesh-ancestor
92115883|NCT04084548|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92115884|NCT04084548|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92115885|NCT04084548|Anesthetics, General|anesthetics, general|mesh-ancestor
92115886|NCT04084548|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92115887|NCT04084548|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92115888|NCT04084548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115889|NCT02059642|Metadoxine|metadoxine|mesh-list
92115890|NCT02059642|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92115891|NCT03296358|Dexamethasone|dexamethasone|mesh-list
92115892|NCT03296358|Prednisolone|prednisolone|mesh-list
92115893|NCT03296358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115894|NCT03296358|Antiemetics|antiemetics|mesh-ancestor
92115895|NCT03296358|Autonomic Agents|autonomic agents|mesh-ancestor
92115896|NCT03296358|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115897|NCT03296358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115898|NCT03296358|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92115899|NCT03296358|Glucocorticoids|glucocorticoids|mesh-ancestor
92115900|NCT03296358|Hormones|hormones|mesh-ancestor
92115901|NCT03296358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92115902|NCT03296358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92115903|NCT03296358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115904|NCT04756323|Vaccines|vaccines|mesh-list
92115905|NCT04756323|Immunologic Factors|immunologic factors|mesh-ancestor
92115906|NCT04756323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115907|NCT00469755|Nicotinic Acids|nicotinic acids|mesh-list
92115908|NCT00469755|Adapalene|adapalene|mesh-list
92115909|NCT00469755|Tazarotene|tazarotene|mesh-list
92115910|NCT00469755|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92115911|NCT00469755|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92115913|NCT00469755|Sensory System Agents|sensory system agents|mesh-ancestor
92115914|NCT00469755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115915|NCT00469755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115916|NCT00469755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115917|NCT00469755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92115918|NCT00469755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92115919|NCT00469755|Keratolytic Agents|keratolytic agents|mesh-ancestor
92115920|NCT00469755|Vitamin B Complex|vitamin b complex|mesh-ancestor
92115921|NCT00469755|Vitamins|vitamins|mesh-ancestor
92115922|NCT00469755|Micronutrients|micronutrients|mesh-ancestor
92115923|NCT00453531|Acetylcholine|acetylcholine|mesh-list
92115924|NCT00453531|Vasodilator Agents|vasodilator agents|mesh-ancestor
92115925|NCT00453531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92115926|NCT00453531|Cholinergic Agents|cholinergic agents|mesh-ancestor
92115927|NCT00453531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115928|NCT00453531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115929|NCT00453531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115930|NCT03295968|Ibuprofen|ibuprofen|mesh-list
92115931|NCT03295968|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92115932|NCT03295968|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92115933|NCT03295968|Analgesics|analgesics|mesh-ancestor
92115934|NCT03295968|Sensory System Agents|sensory system agents|mesh-ancestor
92115935|NCT03295968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115936|NCT03295968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115937|NCT03295968|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92115941|NCT03295968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115943|NCT03298074|Apatinib|apatinib|mesh-list
92115944|NCT03298074|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92115945|NCT03298074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115946|NCT03298074|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92115947|NCT03298074|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92115948|NCT03298074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115949|NCT03298074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115950|NCT03298074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92115951|NCT01992874|Niacinamide|niacinamide|mesh-list
92115952|NCT01992874|Vitamin B Complex|vitamin b complex|mesh-ancestor
92115953|NCT01992874|Vitamins|vitamins|mesh-ancestor
92115954|NCT01992874|Micronutrients|micronutrients|mesh-ancestor
92115955|NCT01992874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115956|NCT04755543|Fluorouracil|fluorouracil|mesh-list
92115957|NCT04755543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115958|NCT04755543|Antimetabolites|antimetabolites|mesh-ancestor
92115959|NCT04755543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115960|NCT04755543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92115961|NCT04755543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92115962|NCT04755543|Immunologic Factors|immunologic factors|mesh-ancestor
92115963|NCT04755543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115964|NCT01993108|Naltrexone|naltrexone|mesh-list
92115965|NCT01993108|Methylphenidate|methylphenidate|mesh-list
92115966|NCT01993108|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92115967|NCT01993108|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92115968|NCT01993108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115969|NCT01993108|Sensory System Agents|sensory system agents|mesh-ancestor
92115970|NCT01993108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92115971|NCT01993108|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92115972|NCT01993108|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92115973|NCT01993108|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92115974|NCT01993108|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92115975|NCT01993108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115976|NCT01993108|Dopamine Agents|dopamine agents|mesh-ancestor
92115977|NCT01993108|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115978|NCT02307526|Bromides|bromides|mesh-list
92115979|NCT02307526|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92115980|NCT02307526|Anticonvulsants|anticonvulsants|mesh-ancestor
92115981|NCT02307526|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92115982|NCT02307526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115983|NCT02307526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115984|NCT02307526|Cholinergic Agents|cholinergic agents|mesh-ancestor
92115985|NCT02307526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92115986|NCT02307526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115987|NCT01371201|Sunitinib|sunitinib|mesh-list
92115988|NCT01371201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92115989|NCT01371201|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92115990|NCT01371201|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92115991|NCT01371201|Growth Substances|growth substances|mesh-ancestor
92115992|NCT01371201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92115993|NCT01371201|Growth Inhibitors|growth inhibitors|mesh-ancestor
92115994|NCT01371201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92115995|NCT01371201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92115996|NCT01371201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92115997|NCT00436527|Metronidazole|metronidazole|mesh-list
92115998|NCT00436527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92115999|NCT00436527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116000|NCT00436527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92116001|NCT00436527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92116002|NCT02307916|Mitogens|mitogens|mesh-list
92116003|NCT02307916|Mitosis Modulators|mitosis modulators|mesh-ancestor
92116004|NCT02307916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116005|NCT00419367|Vorinostat|vorinostat|mesh-list
92116006|NCT00419367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116007|NCT00419367|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92116008|NCT00419367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116009|NCT00419367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116010|NCT01994746|Glucagon|glucagon|mesh-list
92116011|NCT01994746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92116012|NCT01994746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92116013|NCT01994746|Hormones|hormones|mesh-ancestor
92116014|NCT01994746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116015|NCT01994746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116022|NCT04034238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116023|NCT04034238|Immunoconjugates|immunoconjugates|mesh-ancestor
92116024|NCT04034238|Immunologic Factors|immunologic factors|mesh-ancestor
92116025|NCT04034238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116026|NCT00291525|Warfarin|warfarin|mesh-list
92116027|NCT00291525|Anticoagulants|anticoagulants|mesh-ancestor
92116028|NCT01337349|Pentoxifylline|pentoxifylline|mesh-list
92116029|NCT01337349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92116030|NCT01337349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116031|NCT01337349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116032|NCT01337349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92116033|NCT01337349|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92116034|NCT01337349|Protective Agents|protective agents|mesh-ancestor
92116035|NCT01337349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116036|NCT01337349|Vasodilator Agents|vasodilator agents|mesh-ancestor
92116037|NCT01337349|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92116038|NCT01337349|Antioxidants|antioxidants|mesh-ancestor
92116039|NCT01999348|Timolol|timolol|mesh-list
92116040|NCT01999348|Bimatoprost|bimatoprost|mesh-list
92116041|NCT01999348|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92116042|NCT01999348|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92116043|NCT01999348|Adrenergic Agents|adrenergic agents|mesh-ancestor
92116044|NCT01999348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116045|NCT01999348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116046|NCT01999348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116047|NCT01999348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92116048|NCT01999348|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92116049|NCT00280761|Fluorouracil|fluorouracil|mesh-list
92116050|NCT00280761|Capecitabine|capecitabine|mesh-list
92116051|NCT00280761|Antimetabolites|antimetabolites|mesh-ancestor
92116052|NCT00280761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116053|NCT00280761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92116054|NCT00280761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116055|NCT00280761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116056|NCT00280761|Immunologic Factors|immunologic factors|mesh-ancestor
92116057|NCT00280761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116058|NCT02463318|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92116059|NCT02463318|Melatonin|melatonin|mesh-list
92116060|NCT02463318|Antioxidants|antioxidants|mesh-ancestor
92116061|NCT02463318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116062|NCT02463318|Protective Agents|protective agents|mesh-ancestor
92116063|NCT02463318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116064|NCT02463318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116065|NCT02463318|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92116066|NCT02463318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116067|NCT01436968|Valacyclovir|valacyclovir|mesh-list
92116068|NCT01436968|Antiviral Agents|antiviral agents|mesh-ancestor
92116069|NCT01436968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116070|NCT02462772|Cabotegravir|cabotegravir|mesh-list
92116071|NCT02462772|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92116072|NCT02462772|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92116073|NCT02462772|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92116074|NCT02462772|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92116075|NCT02462772|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92116076|NCT02462772|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92116077|NCT02462772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116078|NCT02462772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116079|NCT02462772|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92116080|NCT02462772|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92116081|NCT02462772|Antiviral Agents|antiviral agents|mesh-ancestor
92116082|NCT02462772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116083|NCT02716194|Factor VIII|factor viii|mesh-list
92116084|NCT02716194|Coagulants|coagulants|mesh-ancestor
92116085|NCT02461056|Ibuprofen|ibuprofen|mesh-list
92116086|NCT02461056|Hydromorphone|hydromorphone|mesh-list
92116087|NCT02461056|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92116088|NCT02461056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116089|NCT02461056|Analgesics|analgesics|mesh-ancestor
92116090|NCT02461056|Sensory System Agents|sensory system agents|mesh-ancestor
92116091|NCT02461056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116092|NCT02461056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116093|NCT02461056|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116094|NCT02461056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116095|NCT02461056|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92116096|NCT02461056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143765|NCT05119452|Etanercept|etanercept|mesh-list
92116097|NCT02461056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116098|NCT02461056|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92116100|NCT02461056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116101|NCT01173172|Boron|boron|mesh-list
92116102|NCT01173172|Trace Elements|trace elements|mesh-ancestor
92116103|NCT01173172|Micronutrients|micronutrients|mesh-ancestor
92116104|NCT01173172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116105|NCT00003270|Cyclosporine|cyclosporine|mesh-list
92116106|NCT00003270|Methylprednisolone|methylprednisolone|mesh-list
92116107|NCT00003270|Cyclophosphamide|cyclophosphamide|mesh-list
92116108|NCT00003270|Busulfan|busulfan|mesh-list
92116109|NCT00003270|Cyclosporins|cyclosporins|mesh-list
92116110|NCT00003270|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92116111|NCT00003270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116112|NCT00003270|Immunologic Factors|immunologic factors|mesh-ancestor
92116113|NCT00003270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116114|NCT00003270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116115|NCT00003270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92116116|NCT00003270|Alkylating Agents|alkylating agents|mesh-ancestor
92116117|NCT00003270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116118|NCT00003270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116119|NCT00003270|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92116120|NCT00003270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116121|NCT00003270|Antifungal Agents|antifungal agents|mesh-ancestor
92116122|NCT00003270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116123|NCT00003270|Dermatologic Agents|dermatologic agents|mesh-ancestor
92116124|NCT00003270|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92116126|NCT00003270|Antiemetics|antiemetics|mesh-ancestor
92116127|NCT00003270|Autonomic Agents|autonomic agents|mesh-ancestor
92116128|NCT00003270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116129|NCT00003270|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92116130|NCT00003270|Glucocorticoids|glucocorticoids|mesh-ancestor
92116131|NCT00003270|Hormones|hormones|mesh-ancestor
92116132|NCT00003270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116133|NCT00003270|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92116134|NCT00003270|Protective Agents|protective agents|mesh-ancestor
92116135|NCT02005354|Nitrous Oxide|nitrous oxide|mesh-list
92116136|NCT02005354|Anesthetics|anesthetics|mesh-list
92116137|NCT02005354|Anesthetics, Local|anesthetics, local|mesh-list
92116138|NCT02005354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116139|NCT02005354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116140|NCT02005354|Sensory System Agents|sensory system agents|mesh-ancestor
92116141|NCT02005354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116142|NCT02005354|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92116144|NCT02005354|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116145|NCT02005354|Analgesics|analgesics|mesh-ancestor
92116146|NCT03290820|Aspirin|aspirin|mesh-list
92116147|NCT03290820|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92116148|NCT03290820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116149|NCT03290820|Analgesics|analgesics|mesh-ancestor
92116150|NCT03290820|Sensory System Agents|sensory system agents|mesh-ancestor
92116151|NCT03290820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116152|NCT03290820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116153|NCT03290820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116154|NCT03290820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116155|NCT03290820|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92116156|NCT03290820|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92116157|NCT03290820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116158|NCT03290820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92116159|NCT03290820|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92116160|NCT03290820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116161|NCT03290820|Antipyretics|antipyretics|mesh-ancestor
92116162|NCT03295110|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92116163|NCT03773484|Analgesics, Opioid|analgesics, opioid|mesh-list
92116164|NCT03773484|Narcotics|narcotics|mesh-ancestor
92116165|NCT03773484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116166|NCT03773484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116167|NCT03773484|Analgesics|analgesics|mesh-ancestor
92116168|NCT03773484|Sensory System Agents|sensory system agents|mesh-ancestor
92116169|NCT03773484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116171|NCT03283410|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92116172|NCT03283410|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116173|NCT03283410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116174|NCT03283410|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92116175|NCT03283410|Anesthetics, General|anesthetics, general|mesh-ancestor
92116176|NCT03283410|Anesthetics|anesthetics|mesh-ancestor
92116182|NCT04318704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116183|NCT04318704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116184|NCT04318704|Vasodilator Agents|vasodilator agents|mesh-ancestor
92116185|NCT04318704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92116186|NCT04318704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92116187|NCT03283176|Folic Acid|folic acid|mesh-list
92116188|NCT03283176|Vitamin B 12|vitamin b 12|mesh-list
92116189|NCT03283176|Hydroxocobalamin|hydroxocobalamin|mesh-list
92116190|NCT03283176|Vitamins|vitamins|mesh-ancestor
92116191|NCT03283176|Micronutrients|micronutrients|mesh-ancestor
92116192|NCT03283176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116193|NCT03283176|Hematinics|hematinics|mesh-ancestor
92116194|NCT03283176|Vitamin B Complex|vitamin b complex|mesh-ancestor
92116195|NCT03290430|Nicotine|nicotine|mesh-list
92116196|NCT03290430|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92116197|NCT03290430|Autonomic Agents|autonomic agents|mesh-ancestor
92116198|NCT03290430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116199|NCT03290430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116200|NCT03290430|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92116201|NCT03290430|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92116202|NCT03290430|Cholinergic Agents|cholinergic agents|mesh-ancestor
92116203|NCT03290430|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116204|NCT03290430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116205|NCT03294798|Interferons|interferons|mesh-list
92116206|NCT03294798|Interferon-alpha|interferon-alpha|mesh-list
92116208|NCT03294798|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92116209|NCT03294798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116210|NCT03294798|Antiviral Agents|antiviral agents|mesh-ancestor
92116211|NCT03294798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116212|NCT03294798|Immunologic Factors|immunologic factors|mesh-ancestor
92116213|NCT03294798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116214|NCT04488744|Nicotine|nicotine|mesh-list
92116215|NCT04488744|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92116217|NCT04488744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116218|NCT04488744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116219|NCT04488744|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92116220|NCT04488744|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92116221|NCT04488744|Cholinergic Agents|cholinergic agents|mesh-ancestor
92116222|NCT04488744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116223|NCT04488744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116224|NCT02005666|Clindamycin|clindamycin|mesh-list
92116225|NCT02005666|Clindamycin palmitate|clindamycin palmitate|mesh-list
92116226|NCT02005666|Clindamycin phosphate|clindamycin phosphate|mesh-list
92116227|NCT02005666|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92116228|NCT02005666|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116229|NCT02005666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116230|NCT02005666|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92116231|NCT02005666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116232|NCT02005666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116233|NCT02005666|Dermatologic Agents|dermatologic agents|mesh-ancestor
92116234|NCT03283020|Naltrexone|naltrexone|mesh-list
92116235|NCT03283020|Remifentanil|remifentanil|mesh-list
92116236|NCT03283020|Methylnaltrexone|methylnaltrexone|mesh-list
92116237|NCT03283020|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92116238|NCT03283020|Narcotics|narcotics|mesh-ancestor
92116239|NCT03283020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116240|NCT03283020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116241|NCT03283020|Analgesics|analgesics|mesh-ancestor
92116242|NCT03283020|Sensory System Agents|sensory system agents|mesh-ancestor
92116243|NCT03283020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116244|NCT03283020|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92116245|NCT03283020|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92116246|NCT00494182|Paclitaxel|paclitaxel|mesh-list
92116247|NCT00494182|Carboplatin|carboplatin|mesh-list
92116248|NCT00494182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92116249|NCT00494182|Sorafenib|sorafenib|mesh-list
92116250|NCT00494182|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92116251|NCT00494182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116252|NCT00494182|Tubulin Modulators|tubulin modulators|mesh-ancestor
92116253|NCT00494182|Antimitotic Agents|antimitotic agents|mesh-ancestor
92116254|NCT00494182|Mitosis Modulators|mitosis modulators|mesh-ancestor
92116255|NCT00494182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116256|NCT00494182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92116257|NCT00494182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116258|NCT02006056|Ondansetron|ondansetron|mesh-list
92116259|NCT02006056|Antiemetics|antiemetics|mesh-ancestor
92116260|NCT02006056|Autonomic Agents|autonomic agents|mesh-ancestor
92116261|NCT02006056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116270|NCT02006056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116271|NCT03290196|Bupivacaine|bupivacaine|mesh-list
92116272|NCT03290196|Anesthetics, Local|anesthetics, local|mesh-ancestor
92116273|NCT03290196|Anesthetics|anesthetics|mesh-ancestor
92116274|NCT03290196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116275|NCT03290196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116276|NCT03290196|Sensory System Agents|sensory system agents|mesh-ancestor
92116277|NCT03290196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116279|NCT02006836|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92116280|NCT02006836|Metformin|metformin|mesh-list
92116281|NCT02006836|Insulin Aspart|insulin aspart|mesh-list
92116282|NCT02006836|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92116283|NCT02006836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116284|NCT02068846|Ciprofloxacin|ciprofloxacin|mesh-list
92116286|NCT02068846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116287|NCT02068846|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92116288|NCT02068846|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92116289|NCT02068846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116290|NCT02068846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116291|NCT02068846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116292|NCT02068846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92116293|NCT02068846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92116294|NCT03294486|Flucytosine|flucytosine|mesh-list
92116295|NCT03294486|Antifungal Agents|antifungal agents|mesh-ancestor
92116296|NCT03294486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116297|NCT03294486|Antimetabolites|antimetabolites|mesh-ancestor
92116298|NCT03294486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116299|NCT03294252|Leucovorin|leucovorin|mesh-list
92116300|NCT03294252|Folic Acid|folic acid|mesh-list
92116301|NCT03294252|Fluorouracil|fluorouracil|mesh-list
92116302|NCT03294252|Oxaliplatin|oxaliplatin|mesh-list
92116303|NCT03294252|Levoleucovorin|levoleucovorin|mesh-list
92116304|NCT03294252|Antimetabolites|antimetabolites|mesh-ancestor
92116305|NCT03294252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116306|NCT03294252|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92116307|NCT03294252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116308|NCT03294252|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116309|NCT03294252|Immunologic Factors|immunologic factors|mesh-ancestor
92116310|NCT03294252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116311|NCT03294252|Antidotes|antidotes|mesh-ancestor
92116312|NCT03294252|Protective Agents|protective agents|mesh-ancestor
92116313|NCT03294252|Vitamin B Complex|vitamin b complex|mesh-ancestor
92116314|NCT03294252|Vitamins|vitamins|mesh-ancestor
92116315|NCT03294252|Micronutrients|micronutrients|mesh-ancestor
92116316|NCT03294252|Hematinics|hematinics|mesh-ancestor
92116317|NCT03294174|Ropivacaine|ropivacaine|mesh-list
92116318|NCT03294174|Anesthetics, Local|anesthetics, local|mesh-ancestor
92074414|NCT01473381|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92116319|NCT03294174|Anesthetics|anesthetics|mesh-ancestor
92116320|NCT03294174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116321|NCT03294174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116322|NCT03294174|Sensory System Agents|sensory system agents|mesh-ancestor
92116323|NCT03294174|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116324|NCT03289338|Zoledronic Acid|zoledronic acid|mesh-list
92116325|NCT03289338|Methylprednisolone|methylprednisolone|mesh-list
92116326|NCT03289338|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92116327|NCT03289338|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92116328|NCT03289338|Prednisolone|prednisolone|mesh-list
92116329|NCT03289338|Prednisolone acetate|prednisolone acetate|mesh-list
92116330|NCT03289338|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92116331|NCT03289338|Prednisolone phosphate|prednisolone phosphate|mesh-list
92116332|NCT03289338|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116333|NCT03289338|Antiemetics|antiemetics|mesh-ancestor
92116334|NCT03289338|Autonomic Agents|autonomic agents|mesh-ancestor
92116335|NCT03289338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116336|NCT03289338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116337|NCT03289338|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92116338|NCT03289338|Glucocorticoids|glucocorticoids|mesh-ancestor
92116339|NCT03289338|Hormones|hormones|mesh-ancestor
92116340|NCT03289338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116341|NCT03289338|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92116342|NCT03289338|Protective Agents|protective agents|mesh-ancestor
92116343|NCT03289338|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92116344|NCT03289338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116345|NCT03289338|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92116346|NCT02069704|Leucovorin|leucovorin|mesh-list
92116347|NCT02069704|Folic Acid|folic acid|mesh-list
92116361|NCT02069704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116362|NCT02069704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92116363|NCT02069704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116364|NCT02069704|Immunologic Factors|immunologic factors|mesh-ancestor
92116365|NCT02069704|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92116366|NCT02069704|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92116367|NCT02069704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116369|NCT02069704|Protective Agents|protective agents|mesh-ancestor
92116370|NCT02069704|Vitamin B Complex|vitamin b complex|mesh-ancestor
92116372|NCT02069704|Micronutrients|micronutrients|mesh-ancestor
92116373|NCT02069704|Hematinics|hematinics|mesh-ancestor
92116374|NCT02314546|Lidocaine|lidocaine|mesh-list
92116375|NCT02314546|Midazolam|midazolam|mesh-list
92116376|NCT02314546|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92116377|NCT02314546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92116378|NCT02314546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116379|NCT02314546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116380|NCT02314546|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92116381|NCT02314546|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92116382|NCT02314546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92116383|NCT02314546|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92116384|NCT02314546|Anesthetics, General|anesthetics, general|mesh-ancestor
92116385|NCT02314546|Anesthetics|anesthetics|mesh-ancestor
92116386|NCT02314546|GABA Modulators|gaba modulators|mesh-ancestor
92116387|NCT02314546|GABA Agents|gaba agents|mesh-ancestor
92116388|NCT02314546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116389|NCT02314546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116390|NCT02314546|Anesthetics, Local|anesthetics, local|mesh-ancestor
92116391|NCT02314546|Sensory System Agents|sensory system agents|mesh-ancestor
92116392|NCT02314546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116393|NCT02314546|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92116394|NCT02314546|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92116395|NCT02314546|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92116396|NCT02314546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92116397|NCT03289260|Imiquimod|imiquimod|mesh-list
92116398|NCT03289260|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92116399|NCT03289260|Immunologic Factors|immunologic factors|mesh-ancestor
92116400|NCT03289260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116401|NCT03289260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116402|NCT03289260|Interferon Inducers|interferon inducers|mesh-ancestor
92116404|NCT03289182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92116405|NCT03289182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116406|NCT03289182|Immunologic Factors|immunologic factors|mesh-ancestor
92116407|NCT03289182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116408|NCT03289182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116409|NCT03289026|Aripiprazole|aripiprazole|mesh-list
92116410|NCT03289026|Antidepressive Agents|antidepressive agents|mesh-ancestor
92116411|NCT03289026|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92116412|NCT03289026|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92116413|NCT03289026|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92116414|NCT03289026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116415|NCT03289026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116416|NCT03289026|Dopamine Agonists|dopamine agonists|mesh-ancestor
92116417|NCT03289026|Dopamine Agents|dopamine agents|mesh-ancestor
92116418|NCT03289026|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116419|NCT03289026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116420|NCT03289026|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92116421|NCT03289026|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92116422|NCT03289026|Serotonin Agents|serotonin agents|mesh-ancestor
92116424|NCT03289026|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92116425|NCT03289026|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92116426|NCT03289026|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92116427|NCT02460510|Mannitol|mannitol|mesh-list
92116428|NCT02460510|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92116429|NCT02460510|Diuretics|diuretics|mesh-ancestor
92116430|NCT02460510|Natriuretic Agents|natriuretic agents|mesh-ancestor
92116431|NCT02460510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116432|NCT02334436|Botulinum Toxins|botulinum toxins|mesh-list
92116433|NCT02334436|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92116434|NCT02334436|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92116435|NCT02334436|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92116436|NCT02334436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92116437|NCT02334436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116438|NCT02334436|Cholinergic Agents|cholinergic agents|mesh-ancestor
92116440|NCT02334436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116448|NCT03288870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116449|NCT03282474|Sofosbuvir|sofosbuvir|mesh-list
92116450|NCT03282474|Antiviral Agents|antiviral agents|mesh-ancestor
92116451|NCT03282474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116452|NCT02460354|Metformin|metformin|mesh-list
92116453|NCT02460354|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92116454|NCT02460354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116455|NCT02008942|Aspirin|aspirin|mesh-list
92116456|NCT02008942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92116457|NCT02008942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116458|NCT02008942|Analgesics|analgesics|mesh-ancestor
92116459|NCT02008942|Sensory System Agents|sensory system agents|mesh-ancestor
92116460|NCT02008942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116461|NCT02008942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116462|NCT02008942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116463|NCT02008942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116464|NCT02008942|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92116465|NCT02008942|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92116466|NCT02008942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116467|NCT02008942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92116468|NCT02008942|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92116469|NCT02008942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116470|NCT02008942|Antipyretics|antipyretics|mesh-ancestor
92116471|NCT03288636|Ritonavir|ritonavir|mesh-list
92116472|NCT03288636|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92116473|NCT03288636|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92116474|NCT03288636|Protease Inhibitors|protease inhibitors|mesh-ancestor
92116475|NCT03288636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116476|NCT03288636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116477|NCT03288636|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92116478|NCT03288636|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92116479|NCT03288636|Antiviral Agents|antiviral agents|mesh-ancestor
92116480|NCT03288636|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116481|NCT03288636|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92116482|NCT03288636|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92116483|NCT03293472|Bupivacaine|bupivacaine|mesh-list
92116484|NCT03293472|Ropivacaine|ropivacaine|mesh-list
92116485|NCT03293472|Anesthetics, Local|anesthetics, local|mesh-ancestor
92116486|NCT03293472|Anesthetics|anesthetics|mesh-ancestor
92116487|NCT03293472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116488|NCT03293472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116489|NCT03293472|Sensory System Agents|sensory system agents|mesh-ancestor
92116490|NCT03293472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116491|NCT02071810|Opicapone|opicapone|mesh-list
92116492|NCT02071810|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92116493|NCT02071810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116494|NCT02071810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116495|NCT02071810|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92116496|NCT02071810|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92116497|NCT02715258|Bexagliflozin|bexagliflozin|mesh-list
92116498|NCT02715258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92116499|NCT02715258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116500|NCT01959490|Paclitaxel|paclitaxel|mesh-list
92116501|NCT01959490|Docetaxel|docetaxel|mesh-list
92116502|NCT01959490|Cyclophosphamide|cyclophosphamide|mesh-list
92116503|NCT01959490|Bevacizumab|bevacizumab|mesh-list
92116504|NCT01959490|Carboplatin|carboplatin|mesh-list
92116505|NCT01959490|Doxorubicin|doxorubicin|mesh-list
92116506|NCT01959490|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92116507|NCT01959490|Trastuzumab|trastuzumab|mesh-list
92116508|NCT01959490|Pertuzumab|pertuzumab|mesh-list
92116509|NCT01959490|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92116510|NCT01959490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116511|NCT01959490|Tubulin Modulators|tubulin modulators|mesh-ancestor
92116512|NCT01959490|Antimitotic Agents|antimitotic agents|mesh-ancestor
92116513|NCT01959490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92116514|NCT01959490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116515|NCT01959490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116516|NCT01959490|Immunologic Factors|immunologic factors|mesh-ancestor
92116517|NCT01959490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116519|NCT01959490|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92116520|NCT01959490|Alkylating Agents|alkylating agents|mesh-ancestor
92116521|NCT01959490|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92116522|NCT01959490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92116523|NCT01959490|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92116524|NCT01959490|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92116536|NCT03288402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116537|NCT03288402|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92116538|NCT03288402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92116539|NCT03288402|Purinergic Agents|purinergic agents|mesh-ancestor
92116540|NCT03288402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116541|NCT02011516|Baclofen|baclofen|mesh-list
92116542|NCT02011516|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92116543|NCT02011516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116544|NCT02011516|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92116545|NCT02011516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116546|NCT02011516|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92116547|NCT02011516|GABA Agonists|gaba agonists|mesh-ancestor
92116548|NCT02011516|GABA Agents|gaba agents|mesh-ancestor
92116549|NCT02011516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074640|NCT02197156|Acetaminophen|acetaminophen|mesh-list
92116550|NCT02011516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116551|NCT04349410|Interferons|interferons|mesh-list
92116552|NCT04349410|Interferon-alpha|interferon-alpha|mesh-list
92116553|NCT04349410|Interferon alpha-2|interferon alpha-2|mesh-list
92116554|NCT04349410|Remdesivir|remdesivir|mesh-list
92116555|NCT04349410|Azithromycin|azithromycin|mesh-list
92116556|NCT04349410|Hydroxychloroquine|hydroxychloroquine|mesh-list
92116557|NCT04349410|Doxycycline|doxycycline|mesh-list
92116558|NCT04349410|Clindamycin|clindamycin|mesh-list
92116559|NCT04349410|Clindamycin palmitate|clindamycin palmitate|mesh-list
92116560|NCT04349410|Clindamycin phosphate|clindamycin phosphate|mesh-list
92116561|NCT04349410|Primaquine|primaquine|mesh-list
92116562|NCT04349410|Methylprednisolone|methylprednisolone|mesh-list
92116563|NCT04349410|Losartan|losartan|mesh-list
92116564|NCT04349410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116565|NCT04349410|Antiviral Agents|antiviral agents|mesh-ancestor
92116566|NCT04349410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116567|NCT04349410|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116568|NCT04349410|Antiemetics|antiemetics|mesh-ancestor
92116569|NCT04349410|Autonomic Agents|autonomic agents|mesh-ancestor
92116570|NCT04349410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116571|NCT04349410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116572|NCT04349410|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92116573|NCT04349410|Glucocorticoids|glucocorticoids|mesh-ancestor
92116574|NCT04349410|Hormones|hormones|mesh-ancestor
92116575|NCT04349410|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116576|NCT04349410|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92116577|NCT04349410|Protective Agents|protective agents|mesh-ancestor
92116578|NCT04349410|Immunologic Factors|immunologic factors|mesh-ancestor
92116579|NCT04349410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116580|NCT04349410|Antimalarials|antimalarials|mesh-ancestor
92116581|NCT04349410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92116582|NCT04349410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92116583|NCT04349410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116584|NCT04349410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116585|NCT04349410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116586|NCT04349410|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92116587|NCT04349410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92116588|NCT04349410|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92116589|NCT04349410|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92116590|NCT04349410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92116591|NCT04349410|Antimetabolites|antimetabolites|mesh-ancestor
92116592|NCT03287388|Rocuronium|rocuronium|mesh-list
92116593|NCT03287388|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92116594|NCT03287388|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92116595|NCT03287388|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92116596|NCT03287388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116597|NCT03287388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116598|NCT03293004|Vitamins|vitamins|mesh-list
92116599|NCT03293004|Ascorbic Acid|ascorbic acid|mesh-list
92116600|NCT03293004|Micronutrients|micronutrients|mesh-ancestor
92116601|NCT03293004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116602|NCT03293004|Antioxidants|antioxidants|mesh-ancestor
92116603|NCT03293004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116604|NCT03293004|Protective Agents|protective agents|mesh-ancestor
92116605|NCT03292848|Brexpiprazole|brexpiprazole|mesh-list
92116606|NCT03292848|Serotonin Agents|serotonin agents|mesh-ancestor
92116607|NCT03292848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116608|NCT03292848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116609|NCT03292848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116610|NCT03292848|Dopamine Agonists|dopamine agonists|mesh-ancestor
92116611|NCT03292848|Dopamine Agents|dopamine agents|mesh-ancestor
92116622|NCT03287076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116623|NCT02460276|Rituximab|rituximab|mesh-list
92074717|NCT00189436|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92116624|NCT02460276|Lenalidomide|lenalidomide|mesh-list
92116625|NCT02460276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92116626|NCT02460276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116627|NCT02460276|Immunologic Factors|immunologic factors|mesh-ancestor
92116628|NCT02460276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116629|NCT02460276|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116630|NCT02460276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92116631|NCT02460276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92116632|NCT02460276|Growth Substances|growth substances|mesh-ancestor
92116633|NCT02460276|Growth Inhibitors|growth inhibitors|mesh-ancestor
92116635|NCT02460432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92116636|NCT02460432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116637|NCT02460432|Tubulin Modulators|tubulin modulators|mesh-ancestor
92116638|NCT02460432|Antimitotic Agents|antimitotic agents|mesh-ancestor
92116639|NCT02460432|Mitosis Modulators|mitosis modulators|mesh-ancestor
92116640|NCT02460432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116641|NCT03282006|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
92116642|NCT03282006|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92116643|NCT03282006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116644|NCT03282006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116645|NCT03281928|Potassium Citrate|potassium citrate|mesh-list
92116646|NCT03281928|Diuretics|diuretics|mesh-ancestor
92116647|NCT03281928|Natriuretic Agents|natriuretic agents|mesh-ancestor
92116648|NCT03281928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116649|NCT03281928|Expectorants|expectorants|mesh-ancestor
92116650|NCT03281928|Respiratory System Agents|respiratory system agents|mesh-ancestor
92116651|NCT03286764|Peppermint oil|peppermint oil|mesh-list
92116652|NCT03286764|Antiemetics|antiemetics|mesh-ancestor
92116653|NCT03286764|Autonomic Agents|autonomic agents|mesh-ancestor
92116654|NCT03286764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116655|NCT03286764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116656|NCT03286764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92116657|NCT03286764|Parasympatholytics|parasympatholytics|mesh-ancestor
92116658|NCT03281694|Nicotine|nicotine|mesh-list
92116659|NCT03281694|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92116660|NCT03281694|Autonomic Agents|autonomic agents|mesh-ancestor
92116661|NCT03281694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116662|NCT03281694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116663|NCT03281694|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92116664|NCT03281694|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92116665|NCT03281694|Cholinergic Agents|cholinergic agents|mesh-ancestor
91938596|NCT03832647|Salicylic Acid|salicylic acid|mesh-list
92116666|NCT03281694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116667|NCT03281694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116668|NCT03286452|Anti-Infective Agents|anti-infective agents|mesh-list
92116669|NCT03286452|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92116670|NCT03291054|Pembrolizumab|pembrolizumab|mesh-list
92116671|NCT03291054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92116672|NCT03291054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116673|NCT03291054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92116674|NCT03291054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116676|NCT03286296|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92116677|NCT03286296|Immunologic Factors|immunologic factors|mesh-ancestor
92116678|NCT03286296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116679|NCT03285906|Apatinib|apatinib|mesh-list
92116680|NCT03285906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116681|NCT03285906|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92116682|NCT03285906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116683|NCT03285906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116684|NCT01895205|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92116685|NCT01895205|Hematinics|hematinics|mesh-ancestor
92116686|NCT01748175|Triamcinolone|triamcinolone|mesh-list
92116687|NCT01748175|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92116688|NCT01748175|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92116689|NCT01748175|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92116690|NCT01748175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116691|NCT01748175|Glucocorticoids|glucocorticoids|mesh-ancestor
92116692|NCT01748175|Hormones|hormones|mesh-ancestor
92116693|NCT01748175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116694|NCT01748175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116695|NCT01748175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116696|NCT01748175|Immunologic Factors|immunologic factors|mesh-ancestor
92116698|NCT01748175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116700|NCT04755387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92116701|NCT04755387|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92116702|NCT04755387|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92116703|NCT04755387|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92116704|NCT04755387|Purinergic Agents|purinergic agents|mesh-ancestor
92116705|NCT04755387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116706|NCT04755387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116707|NCT04755387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116708|NCT04046328|Cholestyramine Resin|cholestyramine resin|mesh-list
92116709|NCT04046328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92116710|NCT04046328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92116711|NCT04046328|Antimetabolites|antimetabolites|mesh-ancestor
92116712|NCT04046328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116713|NCT04046328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92116714|NCT03285360|Fluorides|fluorides|mesh-list
92116715|NCT03285360|Fluorides, Topical|fluorides, topical|mesh-list
92116716|NCT03285360|Cariostatic Agents|cariostatic agents|mesh-ancestor
92116717|NCT03285360|Protective Agents|protective agents|mesh-ancestor
92116718|NCT03285360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116719|NCT00160173|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92116720|NCT00160173|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92116721|NCT00160173|Estradiol|estradiol|mesh-list
92116722|NCT00160173|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92116723|NCT00160173|Estrogens|estrogens|mesh-ancestor
92116724|NCT00160173|Hormones|hormones|mesh-ancestor
92116725|NCT00160173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116726|NCT00160173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116727|NCT00160173|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92116728|NCT00160173|Contraceptive Agents|contraceptive agents|mesh-ancestor
92116729|NCT00160173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92116730|NCT00160173|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92116731|NCT00136695|Anastrozole|anastrozole|mesh-list
92116732|NCT00136695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92116733|NCT00136695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116734|NCT00136695|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92116735|NCT00136695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92116736|NCT00136695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116737|NCT00136695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116738|NCT00136695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92116739|NCT00136695|Hormone Antagonists|hormone antagonists|mesh-ancestor
92116740|NCT00136695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116741|NCT00136695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116742|NCT04782375|Antiviral Agents|antiviral agents|mesh-list
92116743|NCT04782375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116745|NCT02459574|Sotalol|sotalol|mesh-list
92116746|NCT02459574|Flecainide|flecainide|mesh-list
92116747|NCT02459574|Propafenone|propafenone|mesh-list
92116748|NCT02459574|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92116749|NCT02459574|Calcium Channel Blockers|calcium channel blockers|mesh-list
92116750|NCT02459574|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92116751|NCT02459574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116752|NCT02459574|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92116753|NCT02459574|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92116754|NCT02459574|Adrenergic Agents|adrenergic agents|mesh-ancestor
92116755|NCT02459574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116756|NCT02459574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116757|NCT02459574|Vasodilator Agents|vasodilator agents|mesh-ancestor
92116758|NCT02459574|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92116759|NCT02459574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92116760|NCT02459574|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92116761|NCT02459574|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92116762|NCT02459574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92116763|NCT02459574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116764|NCT02459574|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92116765|NCT02459574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92116766|NCT02459574|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92116768|NCT02459574|Autonomic Agents|autonomic agents|mesh-ancestor
92116769|NCT02459574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116770|NCT02459574|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92116771|NCT04168866|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92116772|NCT04168866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116776|NCT03280212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116777|NCT03280212|Hemostatics|hemostatics|mesh-ancestor
92116778|NCT03280212|Coagulants|coagulants|mesh-ancestor
92116779|NCT03536520|Acetazolamide|acetazolamide|mesh-list
92116780|NCT03536520|Anticonvulsants|anticonvulsants|mesh-ancestor
92116781|NCT03536520|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92116782|NCT03536520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116783|NCT03536520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116784|NCT03536520|Diuretics|diuretics|mesh-ancestor
92116785|NCT03536520|Natriuretic Agents|natriuretic agents|mesh-ancestor
92116786|NCT03536520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116787|NCT01673217|Doxorubicin|doxorubicin|mesh-list
92116788|NCT01673217|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92116789|NCT01673217|Decitabine|decitabine|mesh-list
92116790|NCT01673217|Azacitidine|azacitidine|mesh-list
92116791|NCT01673217|Vaccines|vaccines|mesh-list
92116792|NCT01673217|Sargramostim|sargramostim|mesh-list
92116793|NCT01673217|Freund's Adjuvant|freund's adjuvant|mesh-list
92116794|NCT01673217|Immunologic Factors|immunologic factors|mesh-ancestor
92116795|NCT01673217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116796|NCT01673217|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92116797|NCT01673217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116798|NCT01673217|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92116799|NCT01673217|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92116800|NCT01673217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116801|NCT01673217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116802|NCT01673217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92116803|NCT01673217|Antimetabolites|antimetabolites|mesh-ancestor
92116804|NCT01673217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92116805|NCT03475134|Cyclophosphamide|cyclophosphamide|mesh-list
92116806|NCT03475134|Nivolumab|nivolumab|mesh-list
92116807|NCT03475134|Fludarabine|fludarabine|mesh-list
92116808|NCT03475134|Interleukin-2|interleukin-2|mesh-list
92116809|NCT03475134|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116810|NCT03475134|Immunologic Factors|immunologic factors|mesh-ancestor
92116811|NCT03475134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116812|NCT03475134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116813|NCT03475134|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92116814|NCT03475134|Alkylating Agents|alkylating agents|mesh-ancestor
92116815|NCT03475134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116816|NCT03475134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116817|NCT03475134|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92116818|NCT03475134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92116819|NCT03475134|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92116820|NCT03475134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116822|NCT03475134|Sensory System Agents|sensory system agents|mesh-ancestor
92116823|NCT03475134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116824|NCT01668849|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92116825|NCT01668849|Fentanyl|fentanyl|mesh-list
92116826|NCT01668849|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92116827|NCT01668849|Narcotics|narcotics|mesh-ancestor
92116828|NCT01668849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116829|NCT01668849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116830|NCT01668849|Analgesics|analgesics|mesh-ancestor
92116831|NCT01668849|Sensory System Agents|sensory system agents|mesh-ancestor
92116832|NCT01668849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116833|NCT01668849|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92116834|NCT01668849|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92116835|NCT01668849|Anesthetics, General|anesthetics, general|mesh-ancestor
92116836|NCT01668849|Anesthetics|anesthetics|mesh-ancestor
92116837|NCT01668849|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92116838|NCT01668849|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116839|NCT01668849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116840|NCT01668849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116841|NCT01252719|Vancomycin|vancomycin|mesh-list
92116842|NCT01252719|Oritavancin|oritavancin|mesh-list
92116843|NCT01252719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92116844|NCT01252719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116845|NCT01230411|Ibuprofen|ibuprofen|mesh-list
92116846|NCT01230411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92116847|NCT01230411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92116848|NCT01230411|Analgesics|analgesics|mesh-ancestor
92116849|NCT01230411|Sensory System Agents|sensory system agents|mesh-ancestor
92116850|NCT01230411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116851|NCT01230411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116852|NCT01230411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116856|NCT01230411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116857|NCT03283800|Copper|copper|mesh-list
92116858|NCT03283800|Trace Elements|trace elements|mesh-ancestor
92116859|NCT03283800|Micronutrients|micronutrients|mesh-ancestor
92116860|NCT03283800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116861|NCT01962688|Diuretics|diuretics|mesh-list
92116862|NCT01962688|Natriuretic Agents|natriuretic agents|mesh-ancestor
92116863|NCT01962688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116864|NCT03274596|Vitamin E|vitamin e|mesh-list
92116865|NCT03274596|Vitamins|vitamins|mesh-ancestor
92116866|NCT03274596|Micronutrients|micronutrients|mesh-ancestor
92116867|NCT03274596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116868|NCT03274596|Antioxidants|antioxidants|mesh-ancestor
92116869|NCT03274596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116870|NCT03274596|Protective Agents|protective agents|mesh-ancestor
92116871|NCT01963078|Oxytocin|oxytocin|mesh-list
92116872|NCT01963078|Oxytocics|oxytocics|mesh-ancestor
92116873|NCT01963078|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92116874|NCT01963078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116875|NCT03269760|Zolpidem|zolpidem|mesh-list
92116876|NCT03269760|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92116877|NCT03269760|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92116878|NCT03269760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92116879|NCT03269760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116880|NCT03269760|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92116881|NCT03269760|GABA Agonists|gaba agonists|mesh-ancestor
92116882|NCT03269760|GABA Agents|gaba agents|mesh-ancestor
92116883|NCT03269760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116884|NCT03269760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116885|NCT03269916|Hormones|hormones|mesh-list
92116886|NCT03269916|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92116887|NCT03269916|Estrogens|estrogens|mesh-list
92116888|NCT03269916|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116889|NCT03269916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116890|NCT02346916|Capsaicin|capsaicin|mesh-list
92116891|NCT02346916|Antipruritics|antipruritics|mesh-ancestor
92116892|NCT02346916|Dermatologic Agents|dermatologic agents|mesh-ancestor
92116893|NCT02346916|Sensory System Agents|sensory system agents|mesh-ancestor
92116894|NCT02346916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116895|NCT02346916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116896|NCT02458482|Albuterol|albuterol|mesh-list
92116897|NCT02458482|Ipratropium|ipratropium|mesh-list
92116898|NCT02458482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92116899|NCT02458482|Autonomic Agents|autonomic agents|mesh-ancestor
92116900|NCT02458482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92116901|NCT02458482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116902|NCT02458482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92116903|NCT02458482|Respiratory System Agents|respiratory system agents|mesh-ancestor
92116904|NCT02458482|Tocolytic Agents|tocolytic agents|mesh-ancestor
92116905|NCT02458482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92116906|NCT02458482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92116907|NCT02458482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92116908|NCT02458482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92116909|NCT02458482|Adrenergic Agents|adrenergic agents|mesh-ancestor
92116910|NCT02458482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92116911|NCT02458482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116912|NCT02458482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92116913|NCT02458482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92116914|NCT03273192|Adalimumab|adalimumab|mesh-list
92116915|NCT03273192|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92116916|NCT03273192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92116917|NCT03273192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116918|NCT03269604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92116919|NCT03269604|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92116920|NCT03269604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116921|NCT03269604|Antitubercular Agents|antitubercular agents|mesh-ancestor
92116922|NCT02349178|Cyclophosphamide|cyclophosphamide|mesh-list
92116923|NCT02349178|Etoposide|etoposide|mesh-list
92116924|NCT02349178|Clofarabine|clofarabine|mesh-list
92116925|NCT02349178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92116926|NCT02349178|Immunologic Factors|immunologic factors|mesh-ancestor
92116927|NCT02349178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116928|NCT02349178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92116929|NCT02349178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92116930|NCT02349178|Alkylating Agents|alkylating agents|mesh-ancestor
92116931|NCT02349178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116945|NCT05075460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116946|NCT05075460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116947|NCT05075460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116948|NCT01966978|Insulin|insulin|mesh-list
92116949|NCT01966978|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92116950|NCT01966978|Metformin|metformin|mesh-list
92116951|NCT01966978|Insulin Aspart|insulin aspart|mesh-list
92116952|NCT01966978|Insulin, Long-Acting|insulin, long-acting|mesh-list
92116953|NCT01966978|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92116954|NCT01966978|Liraglutide|liraglutide|mesh-list
92116955|NCT01966978|Insulin Detemir|insulin detemir|mesh-list
92116956|NCT01966978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92116957|NCT01966978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116958|NCT01966978|Incretins|incretins|mesh-ancestor
92116959|NCT01966978|Hormones|hormones|mesh-ancestor
92116960|NCT01966978|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116961|NCT03269214|Phenytoin|phenytoin|mesh-list
92116962|NCT03269214|Anticonvulsants|anticonvulsants|mesh-ancestor
92116963|NCT03269214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92116964|NCT03269214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92116965|NCT03269214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92116966|NCT03269214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116967|NCT03269214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92116968|NCT03269214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92116970|NCT03269058|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92116971|NCT03269058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116972|NCT03269058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92116973|NCT03269058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116974|NCT05074602|Fluconazole|fluconazole|mesh-list
92116975|NCT05074602|Antifungal Agents|antifungal agents|mesh-ancestor
92116976|NCT05074602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92116977|NCT05074602|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92116978|NCT05074602|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92116979|NCT05074602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116980|NCT05074602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116981|NCT05074602|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92116982|NCT05074602|Hormone Antagonists|hormone antagonists|mesh-ancestor
92116983|NCT05074602|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116984|NCT05074602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116985|NCT05074602|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92116986|NCT05074602|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92116988|NCT02457312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92116989|NCT02457312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92116990|NCT02457312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92116991|NCT02457312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92116992|NCT02457312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92116993|NCT02457312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92116994|NCT02457312|Hormone Antagonists|hormone antagonists|mesh-ancestor
92116995|NCT02457312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92116996|NCT02457312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92116997|NCT03268902|Niacinamide|niacinamide|mesh-list
92116998|NCT03268902|Niacin|niacin|mesh-list
92116999|NCT03268902|Nicotinic Acids|nicotinic acids|mesh-list
92117000|NCT03268902|Azithromycin|azithromycin|mesh-list
92075119|NCT00049036|Prednisone|prednisone|mesh-list
92117001|NCT03268902|Nitazoxanide|nitazoxanide|mesh-list
92117002|NCT03268902|Vitamins|vitamins|mesh-ancestor
92117003|NCT03268902|Micronutrients|micronutrients|mesh-ancestor
92117004|NCT03268902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117005|NCT03268902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92117006|NCT03268902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117007|NCT03268902|Vitamin B Complex|vitamin b complex|mesh-ancestor
92117008|NCT03268902|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92117009|NCT03268902|Antimetabolites|antimetabolites|mesh-ancestor
92117010|NCT03268902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117011|NCT03268902|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92117012|NCT03268902|Vasodilator Agents|vasodilator agents|mesh-ancestor
92117013|NCT03268902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92117014|NCT02458716|Leuprolide|leuprolide|mesh-list
92117015|NCT02458716|Bicalutamide|bicalutamide|mesh-list
92117016|NCT02458716|Androgens|androgens|mesh-list
92117017|NCT02458716|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92117018|NCT02458716|Hormones|hormones|mesh-ancestor
92117019|NCT02458716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117038|NCT03268278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92117039|NCT03268278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92117040|NCT03268278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117041|NCT03268278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117042|NCT03268278|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92117043|NCT03268278|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92117044|NCT03268278|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117045|NCT03268278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117046|NCT03268278|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92117047|NCT03268278|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92117048|NCT03268278|Autonomic Agents|autonomic agents|mesh-ancestor
92117049|NCT03268278|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92117050|NCT03268278|Respiratory System Agents|respiratory system agents|mesh-ancestor
92117051|NCT03268278|Mydriatics|mydriatics|mesh-ancestor
92117052|NCT03268278|Sympathomimetics|sympathomimetics|mesh-ancestor
92117053|NCT03268278|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92117054|NCT03268278|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92117055|NCT03268278|Narcotics|narcotics|mesh-ancestor
92117056|NCT03268278|Analgesics|analgesics|mesh-ancestor
92117057|NCT03268278|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92117058|NCT05045586|Hyaluronic Acid|hyaluronic acid|mesh-list
92117059|NCT05045586|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92117060|NCT05045586|Immunologic Factors|immunologic factors|mesh-ancestor
92117061|NCT05045586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117062|NCT05045586|Viscosupplements|viscosupplements|mesh-ancestor
92117063|NCT05045586|Protective Agents|protective agents|mesh-ancestor
92117064|NCT03263520|Nandrolone Decanoate|nandrolone decanoate|mesh-list
92117065|NCT03263520|Dexamethasone|dexamethasone|mesh-list
92117066|NCT03263520|Dexamethasone acetate|dexamethasone acetate|mesh-list
92117067|NCT03263520|Nandrolone|nandrolone|mesh-list
92117068|NCT03263520|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
92117069|NCT03263520|BB 1101|bb 1101|mesh-list
92117070|NCT03263520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117071|NCT03263520|Antiemetics|antiemetics|mesh-ancestor
92117072|NCT03263520|Autonomic Agents|autonomic agents|mesh-ancestor
92117073|NCT03263520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117074|NCT03263520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117075|NCT03263520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117076|NCT03263520|Glucocorticoids|glucocorticoids|mesh-ancestor
92117077|NCT03263520|Hormones|hormones|mesh-ancestor
92117078|NCT03263520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117079|NCT03263520|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92117080|NCT03263520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117081|NCT03263520|Protease Inhibitors|protease inhibitors|mesh-ancestor
92117082|NCT03263520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117083|NCT03263520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117084|NCT03263520|Androgens|androgens|mesh-ancestor
92117085|NCT03263520|Anabolic Agents|anabolic agents|mesh-ancestor
92117086|NCT03263520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92117087|NCT02456844|Leucovorin|leucovorin|mesh-list
92117088|NCT02456844|Flurbiprofen|flurbiprofen|mesh-list
92117089|NCT02456844|Methotrexate|methotrexate|mesh-list
92117090|NCT02456844|Digoxin|digoxin|mesh-list
92117091|NCT02456844|Midazolam|midazolam|mesh-list
92117092|NCT02456844|Pravastatin|pravastatin|mesh-list
92117093|NCT02456844|Montelukast|montelukast|mesh-list
92117094|NCT02456844|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92117095|NCT02456844|Abortifacient Agents|abortifacient agents|mesh-ancestor
92117096|NCT02456844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92117097|NCT02456844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117098|NCT02456844|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92117099|NCT02456844|Antimetabolites|antimetabolites|mesh-ancestor
92117100|NCT02456844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117101|NCT02456844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117102|NCT02456844|Dermatologic Agents|dermatologic agents|mesh-ancestor
92117103|NCT02456844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117104|NCT02456844|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92117105|NCT02456844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92117106|NCT02456844|Immunologic Factors|immunologic factors|mesh-ancestor
92117107|NCT02456844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117108|NCT02456844|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92117109|NCT02456844|Antidotes|antidotes|mesh-ancestor
92117110|NCT02456844|Protective Agents|protective agents|mesh-ancestor
92117111|NCT02456844|Vitamin B Complex|vitamin b complex|mesh-ancestor
92117112|NCT02456844|Vitamins|vitamins|mesh-ancestor
92117113|NCT02456844|Micronutrients|micronutrients|mesh-ancestor
92117114|NCT02456844|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92117115|NCT02456844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92117130|NCT02456844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117131|NCT02456844|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92117132|NCT02456844|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92117133|NCT02456844|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92117134|NCT02456844|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92117135|NCT02456844|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92117136|NCT02456844|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92117137|NCT02456844|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92117138|NCT02456844|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92117139|NCT02456844|Analgesics|analgesics|mesh-ancestor
92117140|NCT02456844|Sensory System Agents|sensory system agents|mesh-ancestor
92117141|NCT02456844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117142|NCT02456844|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117143|NCT02456844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117144|NCT02456844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117145|NCT02456844|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92117146|NCT03263208|Cyclophosphamide|cyclophosphamide|mesh-list
92117147|NCT03263208|Fludarabine|fludarabine|mesh-list
92117148|NCT03263208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92117149|NCT03263208|Immunologic Factors|immunologic factors|mesh-ancestor
92117150|NCT03263208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117151|NCT03263208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117152|NCT03263208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92117153|NCT03263208|Alkylating Agents|alkylating agents|mesh-ancestor
92117154|NCT03263208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117155|NCT03263208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117156|NCT03263208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92117157|NCT04630002|Ritonavir|ritonavir|mesh-list
92117158|NCT04630002|Darunavir|darunavir|mesh-list
92117159|NCT04630002|Etravirine|etravirine|mesh-list
92117160|NCT04630002|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92117161|NCT04630002|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92117162|NCT04630002|Protease Inhibitors|protease inhibitors|mesh-ancestor
92117163|NCT04630002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117164|NCT04630002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117165|NCT04630002|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92117166|NCT04630002|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92117167|NCT04630002|Antiviral Agents|antiviral agents|mesh-ancestor
92117168|NCT04630002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117169|NCT04630002|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92117170|NCT04630002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92117171|NCT04630002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92117172|NCT04630002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92117173|NCT03259542|Itraconazole|itraconazole|mesh-list
92117174|NCT03259542|Mifepristone|mifepristone|mesh-list
92117175|NCT03259542|Antifungal Agents|antifungal agents|mesh-ancestor
92117176|NCT03259542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117177|NCT03259542|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92117178|NCT03259542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92117179|NCT03259542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117180|NCT03259542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117181|NCT03259542|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92117182|NCT03259542|Hormone Antagonists|hormone antagonists|mesh-ancestor
92117183|NCT03259542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117184|NCT03259542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117185|NCT03259542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92117186|NCT03259542|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92117188|NCT03259542|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92117189|NCT03259542|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92117190|NCT03259542|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92117191|NCT03259542|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92117192|NCT03259542|Contraceptive Agents|contraceptive agents|mesh-ancestor
92117193|NCT03259542|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92117194|NCT03259542|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92117195|NCT03259542|Luteolytic Agents|luteolytic agents|mesh-ancestor
92117196|NCT03259542|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92117197|NCT03259542|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92117199|NCT03267654|Gefitinib|gefitinib|mesh-list
92117200|NCT03267654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117201|NCT03267654|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117202|NCT03267654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117277|NCT03258372|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92117203|NCT03267654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117204|NCT03263052|Tacrolimus|tacrolimus|mesh-list
92117205|NCT03263052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92117206|NCT03263052|Immunologic Factors|immunologic factors|mesh-ancestor
92117207|NCT03263052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117208|NCT03263052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92117209|NCT03263052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117210|NCT03263052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117211|NCT03267030|Eryaspase|eryaspase|mesh-list
92117212|NCT03267030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117213|NCT03259152|Denosumab|denosumab|mesh-list
92117214|NCT03259152|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92117215|NCT03259152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117216|NCT02456142|Morphine|morphine|mesh-list
92117217|NCT02456142|Bupivacaine|bupivacaine|mesh-list
92117218|NCT02456142|Anesthetics, Local|anesthetics, local|mesh-ancestor
92117219|NCT02456142|Anesthetics|anesthetics|mesh-ancestor
92117220|NCT02456142|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117221|NCT02456142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117222|NCT02456142|Sensory System Agents|sensory system agents|mesh-ancestor
92117223|NCT02456142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117224|NCT02456142|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92117225|NCT02456142|Narcotics|narcotics|mesh-ancestor
92117226|NCT02456142|Analgesics|analgesics|mesh-ancestor
92117227|NCT03262740|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92075313|NCT05818982|Irinotecan|irinotecan|mesh-list
92117228|NCT03262740|Norethindrone|norethindrone|mesh-list
92117229|NCT03262740|Norethindrone Acetate|norethindrone acetate|mesh-list
92117230|NCT03262740|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
92117232|NCT03262740|Branebrutinib|branebrutinib|mesh-list
92117233|NCT03262740|Estrogens|estrogens|mesh-ancestor
92117234|NCT03262740|Hormones|hormones|mesh-ancestor
92117235|NCT03262740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117236|NCT03262740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117237|NCT03262740|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92117238|NCT03262740|Contraceptive Agents|contraceptive agents|mesh-ancestor
92117239|NCT03262740|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92117240|NCT03262740|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92117241|NCT03262740|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92117242|NCT03262740|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92117243|NCT03262740|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92117244|NCT03262740|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92117245|NCT03262740|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
92117246|NCT03262740|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117247|NCT03262740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117248|NCT03262740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117249|NCT03266562|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92117250|NCT03266562|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92117251|NCT03266562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117252|NCT03258684|Thiamine|thiamine|mesh-list
92117253|NCT03258684|Hydrocortisone|hydrocortisone|mesh-list
92117254|NCT03258684|Vitamins|vitamins|mesh-ancestor
92117255|NCT03258684|Micronutrients|micronutrients|mesh-ancestor
92117256|NCT03258684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938604|NCT03832647|Analgesics|analgesics|mesh-ancestor
92117257|NCT03258684|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117258|NCT03258684|Vitamin B Complex|vitamin b complex|mesh-ancestor
92117259|NCT03266250|Anesthetics|anesthetics|mesh-list
92117260|NCT03266250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117261|NCT03266250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117262|NCT03258372|Rifampin|rifampin|mesh-list
92117263|NCT03258372|Mifepristone|mifepristone|mesh-list
92117264|NCT03258372|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92117266|NCT03258372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92117267|NCT03258372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117268|NCT03258372|Leprostatic Agents|leprostatic agents|mesh-ancestor
92117269|NCT03258372|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92117270|NCT03258372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117271|NCT03258372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117272|NCT03258372|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92117273|NCT03258372|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92117274|NCT03258372|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92117275|NCT03258372|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92117276|NCT03258372|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92117286|NCT03258372|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92117287|NCT03258372|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92117288|NCT03258372|Hormone Antagonists|hormone antagonists|mesh-ancestor
92117289|NCT03258372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117290|NCT03258372|Luteolytic Agents|luteolytic agents|mesh-ancestor
92117291|NCT03258372|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92117292|NCT03258372|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92117294|NCT02456454|Risperidone|risperidone|mesh-list
92117295|NCT02456454|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92117296|NCT02456454|Serotonin Agents|serotonin agents|mesh-ancestor
92117297|NCT02456454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117298|NCT02456454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117299|NCT02456454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117300|NCT02456454|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92117301|NCT02456454|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92117302|NCT02456454|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117303|NCT02456454|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92117304|NCT02456454|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92117305|NCT02456454|Dopamine Agents|dopamine agents|mesh-ancestor
92117306|NCT02456454|Anticonvulsants|anticonvulsants|mesh-ancestor
92117307|NCT02456454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117308|NCT02456454|GABA Agents|gaba agents|mesh-ancestor
92117309|NCT02456454|Antimanic Agents|antimanic agents|mesh-ancestor
92117310|NCT03258294|Melatonin|melatonin|mesh-list
92117311|NCT03258294|Antioxidants|antioxidants|mesh-ancestor
92117312|NCT03258294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117313|NCT03258294|Protective Agents|protective agents|mesh-ancestor
92117314|NCT03258294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117315|NCT03258294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117316|NCT03265782|Acetaminophen|acetaminophen|mesh-list
92117317|NCT03265782|Ibuprofen|ibuprofen|mesh-list
92117318|NCT03265782|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117319|NCT03265782|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117320|NCT03265782|Analgesics|analgesics|mesh-ancestor
92117321|NCT03265782|Sensory System Agents|sensory system agents|mesh-ancestor
92117322|NCT03265782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117323|NCT03265782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117324|NCT03265782|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117325|NCT03265782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117326|NCT03265782|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92117327|NCT03265782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938605|NCT03832647|Sensory System Agents|sensory system agents|mesh-ancestor
92117328|NCT03265782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117329|NCT03265782|Antipyretics|antipyretics|mesh-ancestor
92117330|NCT03798054|Insulin|insulin|mesh-list
92117331|NCT03798054|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92117332|NCT03798054|Metformin|metformin|mesh-list
92117333|NCT03798054|Insulin Glargine|insulin glargine|mesh-list
92117334|NCT03798054|Lixisenatide|lixisenatide|mesh-list
92117335|NCT03798054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92117336|NCT03798054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92117337|NCT03798054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117338|NCT03798054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117339|NCT03265470|Fentanyl|fentanyl|mesh-list
92117340|NCT03265470|Dexmedetomidine|dexmedetomidine|mesh-list
92117341|NCT03265470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92117342|NCT03265470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117343|NCT03265470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117344|NCT03265470|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117345|NCT03265470|Analgesics|analgesics|mesh-ancestor
92117346|NCT03265470|Sensory System Agents|sensory system agents|mesh-ancestor
92117347|NCT03265470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117348|NCT03265470|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92117349|NCT03265470|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92117350|NCT03265470|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92117351|NCT03265470|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117352|NCT03265470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117353|NCT03265470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117354|NCT03265470|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92117355|NCT03265470|Narcotics|narcotics|mesh-ancestor
92117356|NCT03265470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92117357|NCT03265470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92117358|NCT03265470|Anesthetics, General|anesthetics, general|mesh-ancestor
92117359|NCT03265470|Anesthetics|anesthetics|mesh-ancestor
92117360|NCT02019940|Riluzole|riluzole|mesh-list
92117365|NCT02019940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117366|NCT02019940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117367|NCT02019940|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92117368|NCT02019940|Protective Agents|protective agents|mesh-ancestor
92117369|NCT01229943|Bevacizumab|bevacizumab|mesh-list
92117370|NCT01229943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92117371|NCT01229943|Everolimus|everolimus|mesh-list
92117372|NCT01229943|Octreotide|octreotide|mesh-list
92117373|NCT01229943|Endothelial Growth Factors|endothelial growth factors|mesh-list
92117374|NCT01229943|Antibodies|antibodies|mesh-list
92117375|NCT01229943|Immunoglobulins|immunoglobulins|mesh-list
92117376|NCT01229943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92117377|NCT01229943|Immunoglobulin G|immunoglobulin g|mesh-list
92117378|NCT01229943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117379|NCT01229943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92117380|NCT01229943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92117381|NCT01229943|Growth Substances|growth substances|mesh-ancestor
92117382|NCT01229943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117383|NCT01229943|Growth Inhibitors|growth inhibitors|mesh-ancestor
92117384|NCT01229943|Immunologic Factors|immunologic factors|mesh-ancestor
92117385|NCT01229943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92117386|NCT01229943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117387|NCT01229943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117388|NCT01229943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117389|NCT01229943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92117390|NCT01229943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117391|NCT01229943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92117392|NCT02020408|Raclopride|raclopride|mesh-list
92117393|NCT02020408|Amphetamine|amphetamine|mesh-list
92117394|NCT02020408|Dextroamphetamine|dextroamphetamine|mesh-list
92117395|NCT02020408|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92117396|NCT02020408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117397|NCT02020408|Sympathomimetics|sympathomimetics|mesh-ancestor
92117398|NCT02020408|Autonomic Agents|autonomic agents|mesh-ancestor
92117399|NCT02020408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117400|NCT02020408|Dopamine Agents|dopamine agents|mesh-ancestor
92117401|NCT02020408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117402|NCT02020408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117403|NCT02020408|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117404|NCT02020408|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92117405|NCT02020408|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92117406|NCT02020408|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117407|NCT02020408|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92117408|NCT02020408|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92117409|NCT02020408|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92117410|NCT02020408|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117411|NCT02020408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92117412|NCT02020408|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92117413|NCT01219257|Adalimumab|adalimumab|mesh-list
92117414|NCT01219257|Infliximab|infliximab|mesh-list
92117415|NCT01219257|Golimumab|golimumab|mesh-list
92117416|NCT01219257|Etanercept|etanercept|mesh-list
92117417|NCT01219257|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92117418|NCT01219257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117419|NCT01219257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117420|NCT01219257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92117421|NCT01219257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117422|NCT01219257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117423|NCT01219257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117424|NCT01219257|Analgesics|analgesics|mesh-ancestor
92117425|NCT01219257|Sensory System Agents|sensory system agents|mesh-ancestor
92117426|NCT01219257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117427|NCT01219257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117428|NCT01219257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92117429|NCT01219257|Immunologic Factors|immunologic factors|mesh-ancestor
92117430|NCT01615887|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92117431|NCT01615887|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92117432|NCT01615887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117433|NCT01615887|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92117434|NCT01615887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92117435|NCT01615887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117436|NCT01615887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117437|NCT01615887|Dopamine Agents|dopamine agents|mesh-ancestor
92117438|NCT01615887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117439|NCT04389801|Deferoxamine|deferoxamine|mesh-list
92117444|NCT04389801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117445|NCT01606995|Rivaroxaban|rivaroxaban|mesh-list
92117446|NCT01606995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92117447|NCT01606995|Antithrombins|antithrombins|mesh-ancestor
92117448|NCT01606995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92117449|NCT01606995|Protease Inhibitors|protease inhibitors|mesh-ancestor
92117450|NCT01606995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117451|NCT01606995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117453|NCT03548220|Mitapivat|mitapivat|mesh-list
92117454|NCT03548220|Enzyme Activators|enzyme activators|mesh-ancestor
92117455|NCT03548220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117456|NCT03257670|Lidocaine|lidocaine|mesh-list
92117457|NCT03257670|Anesthetics, Local|anesthetics, local|mesh-ancestor
92117458|NCT03257670|Anesthetics|anesthetics|mesh-ancestor
92117459|NCT03257670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117460|NCT03257670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117461|NCT03257670|Sensory System Agents|sensory system agents|mesh-ancestor
92117462|NCT03257670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117463|NCT03257670|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92117464|NCT03257670|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92117465|NCT03257670|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92117466|NCT03257670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117467|NCT03257670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117468|NCT03265002|Psyllium|psyllium|mesh-list
92117469|NCT03265002|Calcium polycarbophil|calcium polycarbophil|mesh-list
92117470|NCT03265002|Cathartics|cathartics|mesh-ancestor
92117471|NCT03265002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117472|NCT03265002|Antidiarrheals|antidiarrheals|mesh-ancestor
92117473|NCT03257514|Thioctic Acid|thioctic acid|mesh-list
92117474|NCT03257514|Antioxidants|antioxidants|mesh-ancestor
92117475|NCT03257514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117476|NCT03257514|Protective Agents|protective agents|mesh-ancestor
92117477|NCT03257514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117478|NCT03257514|Vitamin B Complex|vitamin b complex|mesh-ancestor
92117479|NCT03257514|Vitamins|vitamins|mesh-ancestor
92117480|NCT03257514|Micronutrients|micronutrients|mesh-ancestor
92117481|NCT04781751|Insulin|insulin|mesh-list
92117482|NCT04781751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92117483|NCT04781751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117484|NCT04643379|Carboplatin|carboplatin|mesh-list
92117485|NCT04643379|Pembrolizumab|pembrolizumab|mesh-list
92117486|NCT04643379|Olaparib|olaparib|mesh-list
92117487|NCT04643379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117488|NCT04643379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92117489|NCT04643379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92117490|NCT04643379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117491|NCT04643379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92117492|NCT04643379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117493|NCT04781439|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92117494|NCT04781439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117495|NCT03261024|Nickel|nickel|mesh-list
92117496|NCT03261024|Trace Elements|trace elements|mesh-ancestor
92117497|NCT03261024|Micronutrients|micronutrients|mesh-ancestor
92117498|NCT03261024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117499|NCT04777383|Atropine|atropine|mesh-list
92117500|NCT04777383|Phenylephrine|phenylephrine|mesh-list
92117501|NCT04777383|Oxymetazoline|oxymetazoline|mesh-list
92117502|NCT04777383|Norepinephrine|norepinephrine|mesh-list
92117503|NCT04777383|Acetylcholine|acetylcholine|mesh-list
92117504|NCT04777383|Neostigmine|neostigmine|mesh-list
92117505|NCT04777383|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92117506|NCT04777383|Mydriatics|mydriatics|mesh-ancestor
92117507|NCT04777383|Autonomic Agents|autonomic agents|mesh-ancestor
92117508|NCT04777383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117509|NCT04777383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117510|NCT04777383|Sympathomimetics|sympathomimetics|mesh-ancestor
92117511|NCT04777383|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92117512|NCT04777383|Nasal Decongestants|nasal decongestants|mesh-ancestor
92117513|NCT04777383|Respiratory System Agents|respiratory system agents|mesh-ancestor
92117514|NCT04777383|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92117515|NCT04777383|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92117516|NCT04777383|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92117517|NCT04777383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117518|NCT04777383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117519|NCT04777383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117520|NCT04777383|Protective Agents|protective agents|mesh-ancestor
92117521|NCT04777383|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92117538|NCT03257124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117539|NCT02089113|Dexamethasone|dexamethasone|mesh-list
92117540|NCT02089113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117541|NCT02089113|Antiemetics|antiemetics|mesh-ancestor
92117542|NCT02089113|Autonomic Agents|autonomic agents|mesh-ancestor
92117543|NCT02089113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117544|NCT02089113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117545|NCT02089113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117546|NCT02089113|Glucocorticoids|glucocorticoids|mesh-ancestor
92117547|NCT02089113|Hormones|hormones|mesh-ancestor
92117548|NCT02089113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117549|NCT02089113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92117550|NCT02089113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117551|NCT04780659|Vaccines|vaccines|mesh-list
92117552|NCT04780659|Immunologic Factors|immunologic factors|mesh-ancestor
92117553|NCT04780659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117554|NCT03260634|Voriconazole|voriconazole|mesh-list
92117555|NCT03260634|Antifungal Agents|antifungal agents|mesh-ancestor
92117556|NCT03260634|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117557|NCT03260634|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92117558|NCT03260634|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92117559|NCT03260634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117560|NCT03260634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117561|NCT03260634|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92117562|NCT03260634|Hormone Antagonists|hormone antagonists|mesh-ancestor
92117563|NCT03260634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117564|NCT03260634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117565|NCT03260634|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92117567|NCT04777227|Anesthetics, Local|anesthetics, local|mesh-ancestor
92117568|NCT04777227|Anesthetics|anesthetics|mesh-ancestor
92117569|NCT04777227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117570|NCT04777227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117571|NCT04777227|Sensory System Agents|sensory system agents|mesh-ancestor
92117572|NCT04777227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117573|NCT04777227|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92117574|NCT04777227|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92117575|NCT04777227|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92117576|NCT04777227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117577|NCT04777227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117578|NCT03260556|Pirfenidone|pirfenidone|mesh-list
92117579|NCT03260556|Analgesics|analgesics|mesh-ancestor
92117580|NCT03260556|Sensory System Agents|sensory system agents|mesh-ancestor
92117581|NCT03260556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117582|NCT03260556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117583|NCT03260556|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117584|NCT03260556|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117585|NCT03260556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117586|NCT03260556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117587|NCT03260556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117588|NCT02712996|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92117589|NCT02712996|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92117590|NCT02712996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117591|NCT02712996|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92117592|NCT02712996|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92117593|NCT02712996|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117594|NCT02712996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117595|NCT02712996|Dopamine Agents|dopamine agents|mesh-ancestor
92117596|NCT02712996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117597|NCT03252366|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92117598|NCT03252366|Hemostatics|hemostatics|mesh-ancestor
92117599|NCT03252366|Coagulants|coagulants|mesh-ancestor
92117600|NCT04346277|Antibodies|antibodies|mesh-list
92075686|NCT05565222|Meropenem|meropenem|mesh-list
92117601|NCT04346277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92117602|NCT04346277|Immunologic Factors|immunologic factors|mesh-ancestor
92117603|NCT04346277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117605|NCT04780347|Capecitabine|capecitabine|mesh-list
92117606|NCT04780347|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92117607|NCT04780347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92117608|NCT04780347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117609|NCT04780347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92117610|NCT04780347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92117612|NCT04780347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117613|NCT04780347|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92117614|NCT04780347|Antimetabolites|antimetabolites|mesh-ancestor
92117615|NCT02455596|Interferons|interferons|mesh-list
92117616|NCT02455596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117617|NCT02455596|Antiviral Agents|antiviral agents|mesh-ancestor
92117618|NCT02455596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117619|NCT02455440|Propofol|propofol|mesh-list
92117620|NCT02455440|Sevoflurane|sevoflurane|mesh-list
92117621|NCT02455440|Esmolol|esmolol|mesh-list
92117622|NCT02455440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92117623|NCT02455440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117624|NCT02455440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117625|NCT02455440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92117626|NCT02455440|Anesthetics, General|anesthetics, general|mesh-ancestor
92117627|NCT02455440|Anesthetics|anesthetics|mesh-ancestor
92117628|NCT02455440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92117629|NCT02455440|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92117630|NCT02455440|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92117631|NCT02455440|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92117632|NCT02455440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92117633|NCT02455440|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117634|NCT02455440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117635|NCT02455440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117636|NCT03260166|Niacinamide|niacinamide|mesh-list
92117638|NCT03260166|Nicotinic Acids|nicotinic acids|mesh-list
92117639|NCT03260166|Vitamin B Complex|vitamin b complex|mesh-ancestor
92117640|NCT03260166|Vitamins|vitamins|mesh-ancestor
92117641|NCT03260166|Micronutrients|micronutrients|mesh-ancestor
92117642|NCT03260166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117643|NCT03260166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92117644|NCT03260166|Antimetabolites|antimetabolites|mesh-ancestor
92117645|NCT03260166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117646|NCT03260166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92117647|NCT03260166|Vasodilator Agents|vasodilator agents|mesh-ancestor
92117648|NCT03260010|Fosfomycin|fosfomycin|mesh-list
92117649|NCT03260010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92117650|NCT03260010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117651|NCT00992901|Atropine|atropine|mesh-list
92117652|NCT00992901|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92117653|NCT00992901|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92117654|NCT00992901|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92117655|NCT00992901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92117656|NCT00992901|Autonomic Agents|autonomic agents|mesh-ancestor
92117657|NCT00992901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117658|NCT00992901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117659|NCT00992901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92117660|NCT00992901|Respiratory System Agents|respiratory system agents|mesh-ancestor
92117661|NCT00992901|Mydriatics|mydriatics|mesh-ancestor
92117662|NCT00992901|Parasympatholytics|parasympatholytics|mesh-ancestor
92117663|NCT00992901|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92117664|NCT00992901|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92117665|NCT00992901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92117666|NCT00992901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117667|NCT00992901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117668|NCT00992901|Incretins|incretins|mesh-ancestor
92117669|NCT00992901|Hormones|hormones|mesh-ancestor
92117670|NCT00992901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117671|NCT03260088|Immunoglobulins|immunoglobulins|mesh-list
92117672|NCT03260088|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92117673|NCT03260088|Antibodies|antibodies|mesh-list
92117674|NCT03260088|Immunoglobulin G|immunoglobulin g|mesh-list
92117675|NCT03260088|Immunologic Factors|immunologic factors|mesh-ancestor
92117676|NCT03260088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117677|NCT03480672|Pembrolizumab|pembrolizumab|mesh-list
92117678|NCT03480672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92117679|NCT03480672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117680|NCT03480672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92117681|NCT03480672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117682|NCT04776135|Edaravone|edaravone|mesh-list
92117683|NCT04776135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92117684|NCT04776135|Antioxidants|antioxidants|mesh-ancestor
92117685|NCT04776135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117686|NCT04776135|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92117687|NCT04776135|Protective Agents|protective agents|mesh-ancestor
92117688|NCT04776135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117701|NCT03474276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117702|NCT03474276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117703|NCT04779255|Acetaminophen|acetaminophen|mesh-list
92117704|NCT04779255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117705|NCT04779255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117706|NCT04779255|Analgesics|analgesics|mesh-ancestor
92117707|NCT04779255|Sensory System Agents|sensory system agents|mesh-ancestor
92117708|NCT04779255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117709|NCT04779255|Antipyretics|antipyretics|mesh-ancestor
92117710|NCT04779567|Acetaminophen|acetaminophen|mesh-list
92117711|NCT04779567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117712|NCT04779567|Analgesics|analgesics|mesh-ancestor
92117713|NCT04779567|Sensory System Agents|sensory system agents|mesh-ancestor
92117714|NCT04779567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117715|NCT04779567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117716|NCT04779567|Antipyretics|antipyretics|mesh-ancestor
92117717|NCT02352844|Everolimus|everolimus|mesh-list
92117718|NCT02352844|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92117719|NCT02352844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117720|NCT02352844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117721|NCT02352844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117722|NCT02352844|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92117723|NCT02352844|Immunologic Factors|immunologic factors|mesh-ancestor
92117724|NCT02352844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117725|NCT02352844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117726|NCT03255642|Clonazepam|clonazepam|mesh-list
92117727|NCT03255642|Melatonin|melatonin|mesh-list
92117728|NCT03255642|Antioxidants|antioxidants|mesh-ancestor
92117729|NCT03255642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117730|NCT03255642|Protective Agents|protective agents|mesh-ancestor
92117731|NCT03255642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117732|NCT03255642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117733|NCT03255642|Anticonvulsants|anticonvulsants|mesh-ancestor
92117734|NCT03255642|GABA Modulators|gaba modulators|mesh-ancestor
92117735|NCT03255642|GABA Agents|gaba agents|mesh-ancestor
92117736|NCT03255642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117737|NCT03562377|Vaccines|vaccines|mesh-list
92117738|NCT03562377|Immunologic Factors|immunologic factors|mesh-ancestor
92117739|NCT03562377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117740|NCT02352922|Bupivacaine|bupivacaine|mesh-list
92117741|NCT02352922|Anesthetics, Local|anesthetics, local|mesh-ancestor
92117742|NCT02352922|Anesthetics|anesthetics|mesh-ancestor
92117743|NCT02352922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117744|NCT02352922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117745|NCT02352922|Sensory System Agents|sensory system agents|mesh-ancestor
92117746|NCT02352922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117747|NCT03255330|Dipyrone|dipyrone|mesh-list
92117748|NCT03255330|Gabapentin|gabapentin|mesh-list
92117749|NCT03255330|Tramadol|tramadol|mesh-list
92117750|NCT03255330|Analgesics|analgesics|mesh-ancestor
92117751|NCT03255330|Sensory System Agents|sensory system agents|mesh-ancestor
92117752|NCT03255330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117753|NCT03255330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117754|NCT03255330|Anticonvulsants|anticonvulsants|mesh-ancestor
92117755|NCT03255330|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92117757|NCT03255330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117758|NCT03255330|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92117759|NCT03255330|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92117760|NCT03255330|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92117761|NCT03255330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117762|NCT03255330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117763|NCT03255330|Antimanic Agents|antimanic agents|mesh-ancestor
92117764|NCT03255330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92117765|NCT03255330|Narcotics|narcotics|mesh-ancestor
92117766|NCT03255330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117767|NCT03255330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117768|NCT03255330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117769|NCT03255330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92117770|NCT03255330|Antipyretics|antipyretics|mesh-ancestor
92117771|NCT02353780|Etanercept|etanercept|mesh-list
92117772|NCT02353780|Infliximab|infliximab|mesh-list
92117773|NCT02353780|Certolizumab Pegol|certolizumab pegol|mesh-list
92117774|NCT02353780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92117775|NCT02353780|Abatacept|abatacept|mesh-list
92117776|NCT02353780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92117777|NCT02353780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92117778|NCT02353780|Analgesics|analgesics|mesh-ancestor
92117779|NCT02353780|Sensory System Agents|sensory system agents|mesh-ancestor
92117823|NCT03245970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117824|NCT03245970|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92117825|NCT03245970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117826|NCT03245970|Vasodilator Agents|vasodilator agents|mesh-ancestor
92117827|NCT03245970|Tocolytic Agents|tocolytic agents|mesh-ancestor
92117828|NCT03245970|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92117829|NCT03245970|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92117830|NCT03245970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92117831|NCT03245970|Sympatholytics|sympatholytics|mesh-ancestor
92117832|NCT03245970|Autonomic Agents|autonomic agents|mesh-ancestor
92117833|NCT03245970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117834|NCT03245970|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92117835|NCT03245970|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92117836|NCT03245970|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92117837|NCT03245970|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117838|NCT03245970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117839|NCT03245970|Sympathomimetics|sympathomimetics|mesh-ancestor
92117840|NCT03245970|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92117841|NCT03245970|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92117843|NCT02454348|Arginine Vasopressin|arginine vasopressin|mesh-list
92117844|NCT02454348|Norepinephrine|norepinephrine|mesh-list
92117845|NCT02454348|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92117846|NCT02454348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92117847|NCT02454348|Adrenergic Agents|adrenergic agents|mesh-ancestor
92117848|NCT02454348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117849|NCT02454348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117850|NCT02454348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117851|NCT02454348|Sympathomimetics|sympathomimetics|mesh-ancestor
92117852|NCT02454348|Autonomic Agents|autonomic agents|mesh-ancestor
92117853|NCT02454348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117854|NCT02454348|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92117855|NCT02454348|Hemostatics|hemostatics|mesh-ancestor
92117856|NCT02454348|Coagulants|coagulants|mesh-ancestor
92117857|NCT02454348|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92117858|NCT02454348|Natriuretic Agents|natriuretic agents|mesh-ancestor
92117859|NCT02455908|Aldesleukin|aldesleukin|mesh-list
92117860|NCT02455908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117861|NCT02455908|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92117862|NCT02455908|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92117863|NCT02455908|Antiviral Agents|antiviral agents|mesh-ancestor
92117864|NCT02455908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117866|NCT03245424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117867|NCT03245424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117868|NCT03245424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117869|NCT03251040|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92117870|NCT03251040|Hemostatics|hemostatics|mesh-ancestor
92117871|NCT03251040|Coagulants|coagulants|mesh-ancestor
92117872|NCT04754763|Propolis|propolis|mesh-list
92117873|NCT04754763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117874|NCT02454894|Lidocaine|lidocaine|mesh-list
92117875|NCT02454894|Anesthetics, Local|anesthetics, local|mesh-ancestor
92117877|NCT02454894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117878|NCT02454894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117879|NCT02454894|Sensory System Agents|sensory system agents|mesh-ancestor
92117880|NCT02454894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117881|NCT02454894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92117882|NCT02454894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92117883|NCT02454894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92117884|NCT02454894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117885|NCT02454894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117886|NCT03250962|Decitabine|decitabine|mesh-list
92117887|NCT03250962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92117888|NCT03250962|Antimetabolites|antimetabolites|mesh-ancestor
92117889|NCT03250962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117890|NCT03250962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117891|NCT03250962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117892|NCT04774029|Lidocaine|lidocaine|mesh-list
92117893|NCT04774029|Anesthetics, Local|anesthetics, local|mesh-ancestor
92117894|NCT04774029|Anesthetics|anesthetics|mesh-ancestor
92117895|NCT04774029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117896|NCT04774029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117897|NCT04774029|Sensory System Agents|sensory system agents|mesh-ancestor
92117898|NCT04774029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117899|NCT04774029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92143766|NCT05119452|Antirheumatic Agents|antirheumatic agents|mesh-list
92117900|NCT04774029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92117901|NCT04774029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92117902|NCT04774029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92117903|NCT04774029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117904|NCT03245346|Anesthetics|anesthetics|mesh-list
92117905|NCT03245346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92117906|NCT03245346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117908|NCT03244956|Dabrafenib|dabrafenib|mesh-list
92117909|NCT03244956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117910|NCT03244956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117911|NCT03244956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117912|NCT03244956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117913|NCT03244488|Mecamylamine|mecamylamine|mesh-list
92117914|NCT03244488|Scopolamine|scopolamine|mesh-list
92117915|NCT03244488|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92117916|NCT03244488|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92117917|NCT03244488|Antiemetics|antiemetics|mesh-ancestor
92117918|NCT03244488|Autonomic Agents|autonomic agents|mesh-ancestor
92117919|NCT03244488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117920|NCT03244488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117921|NCT03244488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117922|NCT03244488|Mydriatics|mydriatics|mesh-ancestor
92117923|NCT03244488|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92117924|NCT03244488|Cholinergic Agents|cholinergic agents|mesh-ancestor
92117925|NCT03244488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92117926|NCT03244488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117927|NCT03244488|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92117928|NCT03244488|Parasympatholytics|parasympatholytics|mesh-ancestor
92117929|NCT03244488|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92117930|NCT03244488|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92117931|NCT03244488|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92117932|NCT03254784|Deucravacitinib|deucravacitinib|mesh-list
92117933|NCT03254784|Dermatologic Agents|dermatologic agents|mesh-ancestor
92117934|NCT03254784|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117935|NCT03254784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117936|NCT03254784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117937|NCT03245658|Nabiximols|nabiximols|mesh-list
92117938|NCT03245658|Analgesics|analgesics|mesh-ancestor
92117939|NCT03245658|Sensory System Agents|sensory system agents|mesh-ancestor
92117940|NCT03245658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117941|NCT03245658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117942|NCT03245190|Chiauranib|chiauranib|mesh-list
92117943|NCT03245190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117944|NCT03245190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92117945|NCT03245190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117946|NCT03245190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117947|NCT01969708|Bevacizumab|bevacizumab|mesh-list
92117948|NCT01969708|Aflibercept|aflibercept|mesh-list
92117949|NCT01969708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92117950|NCT01969708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92117951|NCT01969708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92117952|NCT01969708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92117953|NCT01969708|Growth Substances|growth substances|mesh-ancestor
92117954|NCT01969708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117955|NCT01969708|Growth Inhibitors|growth inhibitors|mesh-ancestor
92117956|NCT03243864|Ceftazidime|ceftazidime|mesh-list
92117957|NCT03243864|Avibactam|avibactam|mesh-list
92117958|NCT03243864|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92117959|NCT03243864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92117960|NCT03243864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92117961|NCT03243864|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92117962|NCT03243864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117963|NCT03243864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117964|NCT03250494|Dexamethasone|dexamethasone|mesh-list
92117965|NCT03250494|Dexamethasone acetate|dexamethasone acetate|mesh-list
92117966|NCT03250494|BB 1101|bb 1101|mesh-list
92117967|NCT03250494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92117968|NCT03250494|Antiemetics|antiemetics|mesh-ancestor
92117969|NCT03250494|Autonomic Agents|autonomic agents|mesh-ancestor
92117970|NCT03250494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92117971|NCT03250494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117972|NCT03250494|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117973|NCT03250494|Glucocorticoids|glucocorticoids|mesh-ancestor
92117975|NCT03250494|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92117980|NCT03250494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117981|NCT03254628|Misoprostol|misoprostol|mesh-list
92117983|NCT03254628|Oxytocics|oxytocics|mesh-ancestor
92117984|NCT03254628|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92117985|NCT03254628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92117986|NCT03254628|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92117987|NCT03254628|Abortifacient Agents|abortifacient agents|mesh-ancestor
92117988|NCT03254628|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92117989|NCT03254628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92117990|NCT01970176|Tadalafil|tadalafil|mesh-list
92117991|NCT01970176|Vasodilator Agents|vasodilator agents|mesh-ancestor
92117992|NCT01970176|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92117993|NCT01970176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92117994|NCT01970176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92117995|NCT01970176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92117996|NCT01970176|Urological Agents|urological agents|mesh-ancestor
92117997|NCT02024386|Riociguat|riociguat|mesh-list
92117998|NCT02024386|Enzyme Activators|enzyme activators|mesh-ancestor
92117999|NCT02024386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118000|NCT03250338|Cytarabine|cytarabine|mesh-list
92118001|NCT03250338|Fludarabine|fludarabine|mesh-list
92118002|NCT03250338|Mitoxantrone|mitoxantrone|mesh-list
92118003|NCT03250338|Idarubicin|idarubicin|mesh-list
92118004|NCT03250338|Crenolanib|crenolanib|mesh-list
92118005|NCT03250338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118006|NCT03250338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92118007|NCT03250338|Antimetabolites|antimetabolites|mesh-ancestor
92118008|NCT03250338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118009|NCT03250338|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118010|NCT03250338|Immunologic Factors|immunologic factors|mesh-ancestor
92118011|NCT03250338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118012|NCT03250338|Antiviral Agents|antiviral agents|mesh-ancestor
92118013|NCT03250338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118014|NCT03250338|Analgesics|analgesics|mesh-ancestor
92118015|NCT03250338|Sensory System Agents|sensory system agents|mesh-ancestor
92118016|NCT03250338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118017|NCT03250338|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92118018|NCT03250338|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92118019|NCT03250338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118020|NCT03250338|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92118021|NCT01971580|Ambrisentan|ambrisentan|mesh-list
92118022|NCT01971580|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92118023|NCT00354562|Docetaxel|docetaxel|mesh-list
92118024|NCT00354562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118025|NCT00354562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92118026|NCT00354562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92118027|NCT00354562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92118028|NCT00354562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118029|NCT03250104|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92118030|NCT03250104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118032|NCT00838383|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92118033|NCT00838383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118034|NCT02355886|Gabapentin|gabapentin|mesh-list
92118035|NCT02355886|Analgesics|analgesics|mesh-ancestor
92118036|NCT02355886|Sensory System Agents|sensory system agents|mesh-ancestor
92118037|NCT02355886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118038|NCT02355886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118039|NCT02355886|Anticonvulsants|anticonvulsants|mesh-ancestor
92118040|NCT02355886|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92118041|NCT02355886|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92118042|NCT02355886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118043|NCT02355886|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92118044|NCT02355886|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92118045|NCT02355886|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92118046|NCT02355886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118047|NCT02355886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118048|NCT02355886|Antimanic Agents|antimanic agents|mesh-ancestor
92118049|NCT03247413|Dexamethasone|dexamethasone|mesh-list
92118050|NCT03247413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118051|NCT03247413|Antiemetics|antiemetics|mesh-ancestor
92118052|NCT03247413|Autonomic Agents|autonomic agents|mesh-ancestor
92118053|NCT03247413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118054|NCT03247413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076133|NCT04926571|Hormones|hormones|mesh-ancestor
92118055|NCT03247413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118056|NCT03247413|Glucocorticoids|glucocorticoids|mesh-ancestor
92118058|NCT03247413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118059|NCT03247413|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118060|NCT03247413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118061|NCT02356198|Hydromorphone|hydromorphone|mesh-list
92118062|NCT02356198|Bupivacaine|bupivacaine|mesh-list
92118063|NCT02356198|Anesthetics, Local|anesthetics, local|mesh-ancestor
92118064|NCT02356198|Anesthetics|anesthetics|mesh-ancestor
92118065|NCT02356198|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118066|NCT02356198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118067|NCT02356198|Sensory System Agents|sensory system agents|mesh-ancestor
92118068|NCT02356198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118069|NCT02356198|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92118070|NCT02356198|Narcotics|narcotics|mesh-ancestor
92118071|NCT02356198|Analgesics|analgesics|mesh-ancestor
92118072|NCT03254004|Pembrolizumab|pembrolizumab|mesh-list
92118073|NCT03254004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92118074|NCT03254004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118075|NCT03254004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92118076|NCT03254004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118077|NCT04778865|Vitamin D|vitamin d|mesh-list
92118079|NCT04778865|Cholecalciferol|cholecalciferol|mesh-list
92118080|NCT04778865|Vitamins|vitamins|mesh-list
92118081|NCT04778865|Micronutrients|micronutrients|mesh-ancestor
92118082|NCT04778865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118083|NCT04778865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92118084|NCT04778865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92118085|NCT02025634|Acetaminophen|acetaminophen|mesh-list
92118086|NCT02025634|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92118087|NCT02025634|Analgesics|analgesics|mesh-ancestor
92118088|NCT02025634|Sensory System Agents|sensory system agents|mesh-ancestor
92118089|NCT02025634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118090|NCT02025634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118091|NCT02025634|Antipyretics|antipyretics|mesh-ancestor
92118092|NCT04773951|Antibodies|antibodies|mesh-list
92118093|NCT04773951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92118094|NCT04773951|Immunologic Factors|immunologic factors|mesh-ancestor
92118095|NCT04773951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118096|NCT04773717|Ascorbic Acid|ascorbic acid|mesh-list
92118097|NCT04773717|Antioxidants|antioxidants|mesh-ancestor
92118098|NCT04773717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118099|NCT04773717|Protective Agents|protective agents|mesh-ancestor
92118100|NCT04773717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118101|NCT04773717|Vitamins|vitamins|mesh-ancestor
92118102|NCT04773717|Micronutrients|micronutrients|mesh-ancestor
92118103|NCT04444167|Lenvatinib|lenvatinib|mesh-list
92118104|NCT04444167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118105|NCT04444167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92118106|NCT04444167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118107|NCT04444167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118108|NCT03243006|Acetaminophen|acetaminophen|mesh-list
92118109|NCT03243006|Tramadol|tramadol|mesh-list
92118110|NCT03243006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92118111|NCT03243006|Analgesics|analgesics|mesh-ancestor
92118112|NCT03243006|Sensory System Agents|sensory system agents|mesh-ancestor
92118113|NCT03243006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118114|NCT03243006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118115|NCT03243006|Antipyretics|antipyretics|mesh-ancestor
92118116|NCT03243006|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92118117|NCT03243006|Narcotics|narcotics|mesh-ancestor
92118118|NCT03243006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118119|NCT03249402|Levonorgestrel|levonorgestrel|mesh-list
92118120|NCT03249402|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92118121|NCT03249402|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92118122|NCT03249402|Estradiol|estradiol|mesh-list
92118123|NCT03249402|Estrogens|estrogens|mesh-ancestor
92118124|NCT03249402|Hormones|hormones|mesh-ancestor
92118125|NCT03249402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118126|NCT03249402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118127|NCT03249402|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92118128|NCT03249402|Contraceptive Agents|contraceptive agents|mesh-ancestor
92118129|NCT03249402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92118130|NCT03249402|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92118131|NCT03249402|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92118132|NCT03249402|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92118133|NCT03249402|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92118134|NCT03249402|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92118144|NCT03242460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118145|NCT03242460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118146|NCT03242460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92118147|NCT03242460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118148|NCT03242460|Antiemetics|antiemetics|mesh-ancestor
92118149|NCT03242460|Autonomic Agents|autonomic agents|mesh-ancestor
92118150|NCT03242460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118151|NCT03242460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118152|NCT03242460|Glucocorticoids|glucocorticoids|mesh-ancestor
92118153|NCT03242460|Hormones|hormones|mesh-ancestor
92118154|NCT03242460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118155|NCT03242460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118156|NCT03242460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92118157|NCT03242460|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92118158|NCT03242460|Growth Substances|growth substances|mesh-ancestor
92118159|NCT03242460|Growth Inhibitors|growth inhibitors|mesh-ancestor
92118160|NCT01972516|Tivozanib|tivozanib|mesh-list
92118161|NCT01972516|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92118162|NCT01972516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118163|NCT01972516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118164|NCT03242616|Pemetrexed|pemetrexed|mesh-list
92118165|NCT03242616|Vinorelbine|vinorelbine|mesh-list
92118166|NCT03242616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118167|NCT03242616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118168|NCT03242616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118169|NCT03242616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92118170|NCT03242616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92118171|NCT03242616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92118172|NCT03242616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92118173|NCT03242616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92118174|NCT03242616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92118175|NCT01748825|Adavosertib|adavosertib|mesh-list
92118176|NCT01748825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118177|NCT01748825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118178|NCT03253224|Magnesium Sulfate|magnesium sulfate|mesh-list
92118179|NCT03253224|Analgesics|analgesics|mesh-ancestor
92118180|NCT03253224|Sensory System Agents|sensory system agents|mesh-ancestor
92118181|NCT03253224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118182|NCT03253224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118183|NCT03253224|Anesthetics|anesthetics|mesh-ancestor
92118184|NCT03253224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118185|NCT03253224|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92118186|NCT03253224|Anticonvulsants|anticonvulsants|mesh-ancestor
92118187|NCT03253224|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92118188|NCT03253224|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118189|NCT03253224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118190|NCT03253224|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92118191|NCT03253224|Tocolytic Agents|tocolytic agents|mesh-ancestor
92118192|NCT03253224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92118194|NCT00789399|Fondaparinux|fondaparinux|mesh-list
92118195|NCT00789399|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92118196|NCT00789399|Antithrombins|antithrombins|mesh-ancestor
92118197|NCT00789399|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92118198|NCT00789399|Protease Inhibitors|protease inhibitors|mesh-ancestor
92118199|NCT00789399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118200|NCT00789399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118201|NCT00789399|Anticoagulants|anticoagulants|mesh-ancestor
92118202|NCT00789399|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92118203|NCT00789399|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92118204|NCT01720667|Levetiracetam|levetiracetam|mesh-list
92118205|NCT01720667|Phenobarbital|phenobarbital|mesh-list
92118206|NCT01720667|Anticonvulsants|anticonvulsants|mesh-ancestor
92118207|NCT01720667|Nootropic Agents|nootropic agents|mesh-ancestor
92118208|NCT01720667|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92118209|NCT01720667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118210|NCT01720667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118211|NCT01720667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92118212|NCT01720667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92118213|NCT01720667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118214|NCT01720667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118215|NCT01720667|GABA Modulators|gaba modulators|mesh-ancestor
92118216|NCT01720667|GABA Agents|gaba agents|mesh-ancestor
92118217|NCT01720667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92118218|NCT01720667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92118219|NCT01720667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92118221|NCT04773093|Anesthetics, Local|anesthetics, local|mesh-ancestor
92118222|NCT04773093|Anesthetics|anesthetics|mesh-ancestor
92118223|NCT04773093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118224|NCT04773093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938614|NCT00901979|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92118226|NCT04773093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118227|NCT04773093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92118228|NCT04773093|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92118229|NCT04773093|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92118230|NCT04773093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118231|NCT04773093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118232|NCT01720043|Bortezomib|bortezomib|mesh-list
92118233|NCT01720043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118234|NCT02455362|Morphine|morphine|mesh-list
92118235|NCT02455362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92118236|NCT02455362|Narcotics|narcotics|mesh-ancestor
92118237|NCT02455362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118238|NCT02455362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118239|NCT02455362|Analgesics|analgesics|mesh-ancestor
92118240|NCT02455362|Sensory System Agents|sensory system agents|mesh-ancestor
92118241|NCT02455362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118242|NCT03242304|Hydrocortisone|hydrocortisone|mesh-list
92118243|NCT03242304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118244|NCT03253068|Pembrolizumab|pembrolizumab|mesh-list
92118245|NCT03253068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92118246|NCT03253068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118247|NCT03253068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92118248|NCT03253068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118249|NCT01718483|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92118250|NCT01718483|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92118251|NCT01718483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118252|NCT01718483|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92118253|NCT01718483|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92118254|NCT01718483|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118255|NCT01718483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118256|NCT01718483|Dopamine Agents|dopamine agents|mesh-ancestor
92118257|NCT01718483|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118258|NCT03249168|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92118259|NCT03249168|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92118260|NCT03249168|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92118261|NCT03249168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118262|NCT03249168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118263|NCT03249168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118264|NCT03249168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118265|NCT03249168|Analgesics|analgesics|mesh-ancestor
92118266|NCT03249168|Sensory System Agents|sensory system agents|mesh-ancestor
92118267|NCT03249168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118268|NCT03249168|Antidepressive Agents|antidepressive agents|mesh-ancestor
92118269|NCT03249168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92118270|NCT03249168|Dopamine Agents|dopamine agents|mesh-ancestor
92118271|NCT03248856|Triamcinolone|triamcinolone|mesh-list
92118272|NCT03248856|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92118273|NCT03248856|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92118274|NCT03248856|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92118275|NCT03248856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118276|NCT03248856|Glucocorticoids|glucocorticoids|mesh-ancestor
92118277|NCT03248856|Hormones|hormones|mesh-ancestor
92405129|NCT01434849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118278|NCT03248856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118279|NCT03248856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118280|NCT03248856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118281|NCT03248856|Immunologic Factors|immunologic factors|mesh-ancestor
92118282|NCT03248856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118283|NCT03248856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118284|NCT03241602|Lidocaine|lidocaine|mesh-list
92118285|NCT03241602|Anesthetics, Local|anesthetics, local|mesh-ancestor
92118286|NCT03241602|Anesthetics|anesthetics|mesh-ancestor
92118287|NCT03241602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118288|NCT03241602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118289|NCT03241602|Sensory System Agents|sensory system agents|mesh-ancestor
92118290|NCT03241602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118291|NCT03241602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92118292|NCT03241602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92118293|NCT03241602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91938617|NCT00901979|Incretins|incretins|mesh-ancestor
92118294|NCT03241602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118295|NCT03241602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118296|NCT00734877|Thalidomide|thalidomide|mesh-list
92118297|NCT00734877|Dexamethasone|dexamethasone|mesh-list
92118298|NCT00734877|Dexamethasone acetate|dexamethasone acetate|mesh-list
92118299|NCT00734877|Cyclophosphamide|cyclophosphamide|mesh-list
92118300|NCT00734877|Melphalan|melphalan|mesh-list
92118301|NCT00734877|Cisplatin|cisplatin|mesh-list
92118302|NCT00734877|Etoposide|etoposide|mesh-list
92118303|NCT00734877|Etoposide phosphate|etoposide phosphate|mesh-list
92118304|NCT00734877|Doxorubicin|doxorubicin|mesh-list
92118305|NCT00734877|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92118306|NCT00734877|Bortezomib|bortezomib|mesh-list
92118307|NCT00734877|BB 1101|bb 1101|mesh-list
92118308|NCT00734877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118309|NCT00734877|Immunologic Factors|immunologic factors|mesh-ancestor
92118310|NCT00734877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118311|NCT00734877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92118312|NCT00734877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92118313|NCT00734877|Alkylating Agents|alkylating agents|mesh-ancestor
92118314|NCT00734877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118315|NCT00734877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118316|NCT00734877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92118317|NCT00734877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118318|NCT00734877|Antiemetics|antiemetics|mesh-ancestor
92118319|NCT00734877|Autonomic Agents|autonomic agents|mesh-ancestor
92118320|NCT00734877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118321|NCT00734877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118322|NCT00734877|Glucocorticoids|glucocorticoids|mesh-ancestor
92118323|NCT00734877|Hormones|hormones|mesh-ancestor
92118324|NCT00734877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118325|NCT00734877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118326|NCT00734877|Protease Inhibitors|protease inhibitors|mesh-ancestor
92118327|NCT00734877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118328|NCT00734877|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92118329|NCT00734877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92118330|NCT00734877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92118331|NCT00734877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92118332|NCT00734877|Leprostatic Agents|leprostatic agents|mesh-ancestor
92118333|NCT00734877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92118334|NCT00734877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118335|NCT00734877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92118336|NCT00734877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92118337|NCT00734877|Growth Substances|growth substances|mesh-ancestor
92118338|NCT00734877|Growth Inhibitors|growth inhibitors|mesh-ancestor
92118339|NCT02357290|Acetylcysteine|acetylcysteine|mesh-list
92118340|NCT02357290|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92118341|NCT02357290|Antiviral Agents|antiviral agents|mesh-ancestor
92118342|NCT02357290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118343|NCT02357290|Expectorants|expectorants|mesh-ancestor
92118344|NCT02357290|Respiratory System Agents|respiratory system agents|mesh-ancestor
92118345|NCT02357290|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92118346|NCT02357290|Antioxidants|antioxidants|mesh-ancestor
92118347|NCT02357290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118348|NCT02357290|Protective Agents|protective agents|mesh-ancestor
92118349|NCT02357290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118350|NCT02357290|Antidotes|antidotes|mesh-ancestor
92076439|NCT04313712|Ibogaine|ibogaine|mesh-list
92118351|NCT02477202|Levonorgestrel|levonorgestrel|mesh-list
92118352|NCT02477202|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92118353|NCT02477202|Contraceptive Agents|contraceptive agents|mesh-ancestor
92118354|NCT02477202|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92118355|NCT02477202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118356|NCT02477202|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92118357|NCT02477202|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92118358|NCT02477202|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92118359|NCT00687765|Temozolomide|temozolomide|mesh-list
92118360|NCT00687765|Iniparib|iniparib|mesh-list
92118361|NCT00687765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92118362|NCT00687765|Alkylating Agents|alkylating agents|mesh-ancestor
92118363|NCT00687765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118364|NCT00687765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143767|NCT05119452|Tofacitinib|tofacitinib|mesh-list
92118365|NCT00687765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92118366|NCT00687765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118367|NCT03248544|Vitamin D|vitamin d|mesh-list
92118369|NCT03248544|Vitamins|vitamins|mesh-ancestor
92118370|NCT03248544|Micronutrients|micronutrients|mesh-ancestor
92118371|NCT03248544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118372|NCT03248544|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92118373|NCT03248544|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92118374|NCT00984399|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92118375|NCT00984399|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92118376|NCT00984399|Estradiol|estradiol|mesh-list
92118377|NCT00984399|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92118378|NCT00984399|Estrogens|estrogens|mesh-ancestor
92118379|NCT00984399|Hormones|hormones|mesh-ancestor
92118380|NCT00984399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118381|NCT00984399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118382|NCT00984399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92118383|NCT00984399|Contraceptive Agents|contraceptive agents|mesh-ancestor
92118384|NCT00984399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92118385|NCT00984399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92118386|NCT03248700|Vitamins|vitamins|mesh-list
92118387|NCT03248700|Vitamin A|vitamin a|mesh-list
92118388|NCT03248700|Retinol palmitate|retinol palmitate|mesh-list
92118389|NCT03248700|Retinol acetate|retinol acetate|mesh-list
92118390|NCT03248700|Micronutrients|micronutrients|mesh-ancestor
92118391|NCT03248700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118392|NCT03248700|Antioxidants|antioxidants|mesh-ancestor
92118393|NCT03248700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118394|NCT03248700|Protective Agents|protective agents|mesh-ancestor
92118395|NCT03248700|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92118396|NCT03248700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118397|NCT03248700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92118398|NCT03248700|Immunologic Factors|immunologic factors|mesh-ancestor
92118399|NCT03238482|Fluticasone|fluticasone|mesh-list
92118401|NCT03238482|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92118402|NCT03238482|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92118403|NCT03238482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118404|NCT03238482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92118406|NCT03238482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118407|NCT03238482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118408|NCT03238482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92118409|NCT03238482|Respiratory System Agents|respiratory system agents|mesh-ancestor
92118410|NCT03238482|Dermatologic Agents|dermatologic agents|mesh-ancestor
92118411|NCT03238482|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92118412|NCT03238482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92118413|NCT03238482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92118414|NCT03238482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92118415|NCT03238482|Adrenergic Agents|adrenergic agents|mesh-ancestor
92118416|NCT03238482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118417|NCT03238482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118418|NCT03238482|Glucocorticoids|glucocorticoids|mesh-ancestor
92118419|NCT03238482|Hormones|hormones|mesh-ancestor
92118420|NCT03238482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118421|NCT03238482|Sympathomimetics|sympathomimetics|mesh-ancestor
92118422|NCT02454504|Neostigmine|neostigmine|mesh-list
92118423|NCT02454504|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92118424|NCT02454504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118425|NCT02454504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118426|NCT02454504|Cholinergic Agents|cholinergic agents|mesh-ancestor
92118427|NCT02454504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118428|NCT02454504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118429|NCT02454504|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92118430|NCT02454504|Autonomic Agents|autonomic agents|mesh-ancestor
92118431|NCT02454504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118432|NCT03240822|Antibodies|antibodies|mesh-list
92118433|NCT03240822|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92118434|NCT03240822|Tacrolimus|tacrolimus|mesh-list
92118435|NCT03240822|Immunologic Factors|immunologic factors|mesh-ancestor
92118436|NCT03240822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118437|NCT03240822|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118438|NCT03240822|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92118439|NCT03240822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118440|NCT03240822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118441|NCT03238560|Montelukast|montelukast|mesh-list
92118442|NCT03238560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92118443|NCT03238560|Respiratory System Agents|respiratory system agents|mesh-ancestor
92118444|NCT03238560|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92118445|NCT03238560|Hormone Antagonists|hormone antagonists|mesh-ancestor
92118446|NCT03238560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118447|NCT03238560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118448|NCT03238560|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92118449|NCT03238560|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92118450|NCT03238560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118451|NCT04486092|Valproic Acid|valproic acid|mesh-list
92118452|NCT04486092|Anticonvulsants|anticonvulsants|mesh-ancestor
92118453|NCT04486092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118454|NCT04486092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118455|NCT04486092|GABA Agents|gaba agents|mesh-ancestor
92118456|NCT04486092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118457|NCT04486092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118458|NCT04486092|Antimanic Agents|antimanic agents|mesh-ancestor
92118459|NCT04486092|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92118460|NCT04486092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118461|NCT04486092|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92118462|NCT03238638|Pembrolizumab|pembrolizumab|mesh-list
92118463|NCT03238638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92118464|NCT03238638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118465|NCT03238638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92118466|NCT03238638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118467|NCT00668655|Metronidazole|metronidazole|mesh-list
92118468|NCT00668655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118469|NCT00668655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92118470|NCT00668655|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92118471|NCT00668655|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92118472|NCT02454426|Vortioxetine|vortioxetine|mesh-list
92118473|NCT02454426|Antidepressive Agents|antidepressive agents|mesh-ancestor
92118474|NCT02454426|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92118475|NCT02454426|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92118476|NCT02454426|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92118477|NCT02454426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118478|NCT02454426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118479|NCT02454426|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92118480|NCT02454426|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92118481|NCT02454426|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118482|NCT02454426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118483|NCT02454426|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118484|NCT02454426|Serotonin Agents|serotonin agents|mesh-ancestor
92118485|NCT02454426|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92118486|NCT02454426|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92118487|NCT02454426|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92118488|NCT02454426|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92118489|NCT03238092|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92118490|NCT03238092|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92118491|NCT03238092|Estradiol|estradiol|mesh-list
92118492|NCT03238092|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92118493|NCT03238092|Testosterone|testosterone|mesh-list
92118494|NCT03238092|Estrogens|estrogens|mesh-ancestor
92118495|NCT03238092|Hormones|hormones|mesh-ancestor
92118496|NCT03238092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118497|NCT03238092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118498|NCT03238092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92118499|NCT03238092|Contraceptive Agents|contraceptive agents|mesh-ancestor
92118500|NCT03238092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92118501|NCT03238092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92118503|NCT03247998|Remifentanil|remifentanil|mesh-list
92118504|NCT03247998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118505|NCT03247998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118506|NCT03247998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92118507|NCT03247998|Narcotics|narcotics|mesh-ancestor
92118508|NCT03247998|Analgesics|analgesics|mesh-ancestor
92118509|NCT03247998|Sensory System Agents|sensory system agents|mesh-ancestor
92118510|NCT03247998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118511|NCT03248076|Fentanyl|fentanyl|mesh-list
92118512|NCT03248076|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92118513|NCT03248076|Narcotics|narcotics|mesh-ancestor
92118514|NCT03248076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118515|NCT03248076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118516|NCT03248076|Analgesics|analgesics|mesh-ancestor
92118517|NCT03248076|Sensory System Agents|sensory system agents|mesh-ancestor
92118518|NCT03248076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118519|NCT03248076|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92118520|NCT03248076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92118521|NCT03248076|Anesthetics, General|anesthetics, general|mesh-ancestor
92118522|NCT03248076|Anesthetics|anesthetics|mesh-ancestor
92118523|NCT03240120|Tinzaparin|tinzaparin|mesh-list
92118524|NCT03240120|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92118525|NCT03240120|Dalteparin|dalteparin|mesh-list
92118526|NCT03240120|Dabigatran|dabigatran|mesh-list
92118527|NCT03240120|Antithrombins|antithrombins|mesh-ancestor
92118528|NCT03240120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92118529|NCT03240120|Protease Inhibitors|protease inhibitors|mesh-ancestor
92118530|NCT03240120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118531|NCT03240120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118532|NCT03240120|Anticoagulants|anticoagulants|mesh-ancestor
92118533|NCT03240120|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92118534|NCT03240120|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92118535|NCT03237936|Cyclosporine|cyclosporine|mesh-list
92118536|NCT03237936|Cyclosporins|cyclosporins|mesh-list
92118537|NCT03237936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118538|NCT03237936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118539|NCT03237936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118540|NCT03237936|Immunologic Factors|immunologic factors|mesh-ancestor
92118541|NCT03237936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118542|NCT03237936|Antifungal Agents|antifungal agents|mesh-ancestor
92118543|NCT03237936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118544|NCT03237936|Dermatologic Agents|dermatologic agents|mesh-ancestor
92118545|NCT03237936|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92118546|NCT03237936|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92118547|NCT03247920|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92118548|NCT03247920|Amoxicillin|amoxicillin|mesh-list
92118549|NCT03247920|Clavulanic Acid|clavulanic acid|mesh-list
92118550|NCT03247920|Clavulanic Acids|clavulanic acids|mesh-list
92118551|NCT03247920|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92118552|NCT03247920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118553|NCT03247920|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92118554|NCT03247920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118555|NCT03247920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118556|NCT03239964|Dexamethasone|dexamethasone|mesh-list
92118557|NCT03239964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118558|NCT03239964|Antiemetics|antiemetics|mesh-ancestor
92118559|NCT03239964|Autonomic Agents|autonomic agents|mesh-ancestor
92118560|NCT03239964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118561|NCT03239964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118562|NCT03239964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118563|NCT03239964|Glucocorticoids|glucocorticoids|mesh-ancestor
92118564|NCT03239964|Hormones|hormones|mesh-ancestor
92118565|NCT03239964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118566|NCT03239964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118567|NCT03239964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118568|NCT03239886|Imatinib Mesylate|imatinib mesylate|mesh-list
92118569|NCT03239886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118570|NCT03239886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92118571|NCT03239886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118572|NCT03239886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118573|NCT03102723|Cangrelor|cangrelor|mesh-list
92118574|NCT03102723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92118575|NCT03102723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92118576|NCT03102723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92118577|NCT03102723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92118578|NCT03102723|Purinergic Agents|purinergic agents|mesh-ancestor
92118579|NCT03102723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118580|NCT03102723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118581|NCT03102723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118583|NCT03237312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118584|NCT03237312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118586|NCT03241914|Megestrol Acetate|megestrol acetate|mesh-list
92118587|NCT03241914|Levonorgestrel|levonorgestrel|mesh-list
92118588|NCT03241914|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92118589|NCT03241914|Contraceptive Agents|contraceptive agents|mesh-ancestor
92118590|NCT03241914|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92118591|NCT03241914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118592|NCT03241914|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92118593|NCT03241914|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92118594|NCT03241914|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92118595|NCT03241914|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92118596|NCT03241914|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118597|NCT03241914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118598|NCT03241914|Appetite Stimulants|appetite stimulants|mesh-ancestor
92118599|NCT03241914|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92118600|NCT00057681|Valproic Acid|valproic acid|mesh-list
92118601|NCT00057681|Risperidone|risperidone|mesh-list
92118602|NCT00057681|Lithium Carbonate|lithium carbonate|mesh-list
92118603|NCT00057681|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92118604|NCT00057681|Serotonin Agents|serotonin agents|mesh-ancestor
92118605|NCT00057681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118606|NCT00057681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118607|NCT00057681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118608|NCT00057681|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92118609|NCT00057681|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92118610|NCT00057681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118611|NCT00057681|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92118612|NCT00057681|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92118613|NCT00057681|Dopamine Agents|dopamine agents|mesh-ancestor
92118614|NCT00057681|Antidepressive Agents|antidepressive agents|mesh-ancestor
92118615|NCT00057681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118616|NCT00057681|Antimanic Agents|antimanic agents|mesh-ancestor
92118617|NCT00057681|Anticonvulsants|anticonvulsants|mesh-ancestor
92118618|NCT00057681|GABA Agents|gaba agents|mesh-ancestor
92118619|NCT03234816|Norepinephrine|norepinephrine|mesh-list
92118620|NCT03234816|Bupivacaine|bupivacaine|mesh-list
92118621|NCT03234816|Anesthetics, Local|anesthetics, local|mesh-ancestor
92118622|NCT03234816|Anesthetics|anesthetics|mesh-ancestor
92118623|NCT03234816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118624|NCT03234816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118625|NCT03234816|Sensory System Agents|sensory system agents|mesh-ancestor
92118626|NCT03234816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118627|NCT03234816|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92118628|NCT03234816|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92118629|NCT03234816|Adrenergic Agents|adrenergic agents|mesh-ancestor
92118630|NCT03234816|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118631|NCT03234816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118632|NCT03234816|Sympathomimetics|sympathomimetics|mesh-ancestor
92118633|NCT03234816|Autonomic Agents|autonomic agents|mesh-ancestor
92118634|NCT03234816|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92118635|NCT03247452|Ascorbic Acid|ascorbic acid|mesh-list
92118636|NCT03247452|Antioxidants|antioxidants|mesh-ancestor
92118637|NCT03247452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118638|NCT03247452|Protective Agents|protective agents|mesh-ancestor
92118639|NCT03247452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118640|NCT03247452|Vitamins|vitamins|mesh-ancestor
92118641|NCT03247452|Micronutrients|micronutrients|mesh-ancestor
92118642|NCT03247140|Amlodipine|amlodipine|mesh-list
92118643|NCT03247140|Telmisartan|telmisartan|mesh-list
92118644|NCT03247140|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92118645|NCT03247140|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92118646|NCT03247140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92118647|NCT03247140|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92118648|NCT03247140|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118649|NCT03247140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118650|NCT03247140|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92076734|NCT03780543|Tenofovir|tenofovir|mesh-list
92118651|NCT03247140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118652|NCT03247140|Vasodilator Agents|vasodilator agents|mesh-ancestor
92118653|NCT03247140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92118654|NCT03247140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92118655|NCT03247140|Antimetabolites|antimetabolites|mesh-ancestor
92118656|NCT03247140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92118657|NCT03247140|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92118658|NCT03247140|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118659|NCT03247140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92118660|NCT03247140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92118661|NCT03237546|Anesthetics|anesthetics|mesh-list
92118662|NCT03237546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118663|NCT03237546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118665|NCT03247296|Sofosbuvir|sofosbuvir|mesh-list
92118666|NCT03247296|Antimetabolites|antimetabolites|mesh-ancestor
92118667|NCT03247296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118669|NCT03247296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118671|NCT03247218|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92118672|NCT03247218|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92118673|NCT03247218|Dopamine Agents|dopamine agents|mesh-ancestor
92118674|NCT03247218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118675|NCT03247218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118676|NCT03247218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118677|NCT03247218|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92118678|NCT03247218|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92118679|NCT03237624|Chitosan|chitosan|mesh-list
92118680|NCT03237624|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92118681|NCT03237624|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92118682|NCT03237624|Antimetabolites|antimetabolites|mesh-ancestor
92118683|NCT03237624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118684|NCT03237624|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92118685|NCT03237624|Chelating Agents|chelating agents|mesh-ancestor
92118686|NCT03237624|Sequestering Agents|sequestering agents|mesh-ancestor
92118687|NCT03237624|Hemostatics|hemostatics|mesh-ancestor
92118688|NCT03237624|Coagulants|coagulants|mesh-ancestor
92118689|NCT03234660|Dexmedetomidine|dexmedetomidine|mesh-list
92118690|NCT03234660|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92118691|NCT03234660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118692|NCT03234660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118693|NCT03234660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92118694|NCT03234660|Analgesics|analgesics|mesh-ancestor
92118695|NCT03234660|Sensory System Agents|sensory system agents|mesh-ancestor
92118696|NCT03234660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118697|NCT03234660|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92118698|NCT03234660|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92118699|NCT03234660|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92118700|NCT03234660|Adrenergic Agents|adrenergic agents|mesh-ancestor
92118701|NCT03234660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118702|NCT03234660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118703|NCT04485780|Botulinum Toxins|botulinum toxins|mesh-list
92118704|NCT04485780|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92118705|NCT04485780|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92118706|NCT04485780|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92118707|NCT04485780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92118708|NCT04485780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118709|NCT04485780|Cholinergic Agents|cholinergic agents|mesh-ancestor
92118710|NCT04485780|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118711|NCT04485780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118712|NCT04485780|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92118713|NCT04485780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118714|NCT00059475|polysaccharide-K|polysaccharide-k|mesh-list
92118715|NCT00059475|Interleukin-2|interleukin-2|mesh-list
92118716|NCT00059475|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92118717|NCT00059475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118718|NCT00059475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92118719|NCT00059475|Analgesics|analgesics|mesh-ancestor
92118720|NCT00059475|Sensory System Agents|sensory system agents|mesh-ancestor
92118721|NCT00059475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118722|NCT00059475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118723|NCT00059475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92118724|NCT00059475|Immunologic Factors|immunologic factors|mesh-ancestor
92118725|NCT00059475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92118727|NCT00059475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118728|NCT00059475|Interferon Inducers|interferon inducers|mesh-ancestor
92118729|NCT00059475|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92118730|NCT00059475|Protective Agents|protective agents|mesh-ancestor
92118731|NCT02453802|Tranylcypromine|tranylcypromine|mesh-list
92118732|NCT02453802|Rivaroxaban|rivaroxaban|mesh-list
92118733|NCT02453802|Tranexamic Acid|tranexamic acid|mesh-list
92118734|NCT02453802|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92118735|NCT02453802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92118736|NCT02453802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118737|NCT02453802|Hemostatics|hemostatics|mesh-ancestor
92118738|NCT02453802|Coagulants|coagulants|mesh-ancestor
92118739|NCT02453802|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92118740|NCT02453802|Antithrombins|antithrombins|mesh-ancestor
92118741|NCT02453802|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92118742|NCT02453802|Protease Inhibitors|protease inhibitors|mesh-ancestor
92118743|NCT02453802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118744|NCT02453802|Anticoagulants|anticoagulants|mesh-ancestor
92118745|NCT02453802|Antidepressive Agents|antidepressive agents|mesh-ancestor
92118747|NCT02453802|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92118748|NCT02453802|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92118749|NCT02453802|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92118750|NCT02453802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118751|NCT02453802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118752|NCT02028676|Lamivudine|lamivudine|mesh-list
92118753|NCT02028676|Zidovudine|zidovudine|mesh-list
92118754|NCT02028676|Efavirenz|efavirenz|mesh-list
92118755|NCT02028676|Nevirapine|nevirapine|mesh-list
92118756|NCT02028676|Abacavir|abacavir|mesh-list
92118757|NCT02028676|Dideoxynucleosides|dideoxynucleosides|mesh-list
92118758|NCT02028676|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92118759|NCT02028676|Trimethoprim|trimethoprim|mesh-list
92118760|NCT02028676|Sulfamethoxazole|sulfamethoxazole|mesh-list
92118761|NCT02028676|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92118762|NCT02028676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92118763|NCT02028676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92118764|NCT02028676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118765|NCT02028676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118766|NCT02028676|Antiviral Agents|antiviral agents|mesh-ancestor
92118767|NCT02028676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118768|NCT02028676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92118769|NCT02028676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92118770|NCT02028676|Antimetabolites|antimetabolites|mesh-ancestor
92118771|NCT02028676|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92118772|NCT02028676|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92118773|NCT02028676|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92118774|NCT02028676|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92118775|NCT02028676|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92118776|NCT02028676|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92118777|NCT02028676|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92118778|NCT02028676|Antimalarials|antimalarials|mesh-ancestor
92118779|NCT02028676|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92118780|NCT02028676|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92118781|NCT02028676|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92118782|NCT02028676|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92118783|NCT02028676|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92118784|NCT02028676|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92118785|NCT03233880|Azithromycin|azithromycin|mesh-list
92118786|NCT03233880|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92118787|NCT03233880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118788|NCT00061893|Celecoxib|celecoxib|mesh-list
92118789|NCT00061893|Cyclophosphamide|cyclophosphamide|mesh-list
92118790|NCT00061893|Ifosfamide|ifosfamide|mesh-list
92118791|NCT00061893|Doxorubicin|doxorubicin|mesh-list
92118792|NCT00061893|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92118793|NCT00061893|Etoposide|etoposide|mesh-list
92118794|NCT00061893|Vincristine|vincristine|mesh-list
92118795|NCT00061893|Vinblastine|vinblastine|mesh-list
92118796|NCT00061893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118797|NCT00061893|Immunologic Factors|immunologic factors|mesh-ancestor
92118798|NCT00061893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118799|NCT00061893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92118800|NCT00061893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076887|NCT03458221|Everolimus|everolimus|mesh-list
92118802|NCT00061893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118803|NCT00061893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118804|NCT00061893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92118805|NCT00061893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92118806|NCT00061893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92118807|NCT00061893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92118808|NCT00061893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118809|NCT00061893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92118810|NCT00061893|Tubulin Modulators|tubulin modulators|mesh-ancestor
92118811|NCT00061893|Antimitotic Agents|antimitotic agents|mesh-ancestor
92118812|NCT00061893|Mitosis Modulators|mitosis modulators|mesh-ancestor
92118813|NCT00061893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92118814|NCT00061893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92118815|NCT00061893|Analgesics|analgesics|mesh-ancestor
92118816|NCT00061893|Sensory System Agents|sensory system agents|mesh-ancestor
92118817|NCT00061893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118818|NCT00061893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118819|NCT00061893|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92118820|NCT00061893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92118821|NCT02957019|Rituximab|rituximab|mesh-list
92118822|NCT02957019|Interleukin-2|interleukin-2|mesh-list
92118823|NCT02957019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92118824|NCT02957019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118825|NCT02957019|Immunologic Factors|immunologic factors|mesh-ancestor
92118826|NCT02957019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118827|NCT02957019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92118828|NCT02957019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92118829|NCT02957019|Analgesics|analgesics|mesh-ancestor
92118830|NCT02957019|Sensory System Agents|sensory system agents|mesh-ancestor
92118831|NCT02957019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118832|NCT02028754|Levofloxacin|levofloxacin|mesh-list
92118833|NCT02028754|Prednisolone|prednisolone|mesh-list
92118834|NCT02028754|Prednisolone acetate|prednisolone acetate|mesh-list
92118835|NCT02028754|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92118836|NCT02028754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118837|NCT02028754|Glucocorticoids|glucocorticoids|mesh-ancestor
92118838|NCT02028754|Hormones|hormones|mesh-ancestor
92118839|NCT02028754|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118840|NCT02028754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118841|NCT02028754|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118842|NCT02028754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118843|NCT02028754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118844|NCT02028754|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92118845|NCT02028754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118846|NCT02028754|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92118847|NCT02028754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92118848|NCT02028754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92118849|NCT02028754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118850|NCT02028754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118851|NCT02028754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92118852|NCT02028754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92118854|NCT02453490|Fluorouracil|fluorouracil|mesh-list
92118855|NCT02453490|Raltitrexed|raltitrexed|mesh-list
92118856|NCT02453490|Antimetabolites|antimetabolites|mesh-ancestor
92118857|NCT02453490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118858|NCT02453490|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92118859|NCT02453490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118860|NCT02453490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92118861|NCT02453490|Immunologic Factors|immunologic factors|mesh-ancestor
92118862|NCT02453490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118863|NCT02453490|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92118864|NCT02453490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118865|NCT01974700|Levetiracetam|levetiracetam|mesh-list
92118866|NCT01974700|Anticonvulsants|anticonvulsants|mesh-ancestor
92118867|NCT01974700|Nootropic Agents|nootropic agents|mesh-ancestor
92118868|NCT04753203|Capecitabine|capecitabine|mesh-list
92118869|NCT04753203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92118870|NCT04753203|Antimetabolites|antimetabolites|mesh-ancestor
92118871|NCT04753203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118872|NCT04753203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118873|NCT03236610|Tenofovir|tenofovir|mesh-list
92118874|NCT03236610|Entecavir|entecavir|mesh-list
92118875|NCT03236610|Antiviral Agents|antiviral agents|mesh-ancestor
92118876|NCT03236610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118877|NCT03236610|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92118878|NCT03236610|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92118879|NCT03236610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118880|NCT03236610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118881|NCT03236610|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92118882|NCT03236610|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92118883|NCT05287893|Pyronaridine|pyronaridine|mesh-list
92118884|NCT05287893|Antimalarials|antimalarials|mesh-ancestor
92118885|NCT05287893|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92118886|NCT05287893|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92118887|NCT05287893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118888|NCT02357758|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92118889|NCT02357758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118890|NCT02357836|Itraconazole|itraconazole|mesh-list
92118891|NCT02357836|Antifungal Agents|antifungal agents|mesh-ancestor
92118892|NCT02357836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118893|NCT02357836|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92118894|NCT02357836|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92118895|NCT02357836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118896|NCT02357836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118897|NCT02357836|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92118898|NCT02357836|Hormone Antagonists|hormone antagonists|mesh-ancestor
92118899|NCT02357836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118900|NCT02357836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118901|NCT02357836|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92118902|NCT02359006|Minocycline|minocycline|mesh-list
92118903|NCT02359006|Tetracycline|tetracycline|mesh-list
92118904|NCT02359006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92118905|NCT02359006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118906|NCT02359006|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92118907|NCT02359006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118908|NCT02359006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118909|NCT04485702|Midazolam|midazolam|mesh-list
92118910|NCT04485702|Ketamine|ketamine|mesh-list
92118911|NCT04485702|Analgesics|analgesics|mesh-ancestor
92118912|NCT04485702|Sensory System Agents|sensory system agents|mesh-ancestor
92118913|NCT04485702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118914|NCT04485702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118915|NCT04485702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92118916|NCT04485702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92118917|NCT04485702|Anesthetics, General|anesthetics, general|mesh-ancestor
92118918|NCT04485702|Anesthetics|anesthetics|mesh-ancestor
92118919|NCT04485702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92118920|NCT04485702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92118921|NCT04485702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92118922|NCT04485702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118923|NCT04485702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118924|NCT04485702|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92118925|NCT04485702|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92118926|NCT04485702|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92118927|NCT04485702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92118928|NCT04485702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92118929|NCT04485702|GABA Modulators|gaba modulators|mesh-ancestor
92118930|NCT04485702|GABA Agents|gaba agents|mesh-ancestor
92118931|NCT00068367|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92118932|NCT00068367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118933|NCT00068367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92118934|NCT00068367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118935|NCT00068367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118936|NCT03233412|Imiquimod|imiquimod|mesh-list
92118937|NCT03233412|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92118938|NCT03233412|Immunologic Factors|immunologic factors|mesh-ancestor
92118939|NCT03233412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118940|NCT03233412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118941|NCT03233412|Interferon Inducers|interferon inducers|mesh-ancestor
92118942|NCT01976416|Hydroxyurea|hydroxyurea|mesh-list
92118943|NCT01976416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118944|NCT01976416|Antisickling Agents|antisickling agents|mesh-ancestor
92118945|NCT01976416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118946|NCT01976416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118947|NCT01976416|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92118948|NCT01976572|Candesartan|candesartan|mesh-list
92118949|NCT01976572|Candesartan cilexetil|candesartan cilexetil|mesh-list
92077033|NCT03060434|Acetaminophen|acetaminophen|mesh-list
92118950|NCT01976572|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92118951|NCT01976572|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92118952|NCT01976572|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92118953|NCT01976572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118954|NCT01976650|Dexamethasone|dexamethasone|mesh-list
92118955|NCT01976650|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92118956|NCT01976650|Antiemetics|antiemetics|mesh-ancestor
92118957|NCT01976650|Autonomic Agents|autonomic agents|mesh-ancestor
92118958|NCT01976650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92118959|NCT01976650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118960|NCT01976650|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92118961|NCT01976650|Glucocorticoids|glucocorticoids|mesh-ancestor
92118962|NCT01976650|Hormones|hormones|mesh-ancestor
92118963|NCT01976650|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92118964|NCT01976650|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92118965|NCT01976650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92118966|NCT01978600|Timolol|timolol|mesh-list
92118967|NCT01978600|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92118968|NCT01978600|Brinzolamide|brinzolamide|mesh-list
92118969|NCT01978600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92118970|NCT01978600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118971|NCT01978600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92118972|NCT01978600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92118973|NCT01978600|Adrenergic Agents|adrenergic agents|mesh-ancestor
92118974|NCT01978600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92118975|NCT01978600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118976|NCT01978600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92118977|NCT01978600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92118978|NCT01978600|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92118979|NCT01978600|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92118980|NCT01978600|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92118981|NCT01978600|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92118982|NCT03236220|Acetylcysteine|acetylcysteine|mesh-list
92118983|NCT03236220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92118984|NCT03236220|Antiviral Agents|antiviral agents|mesh-ancestor
92118985|NCT03236220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92118986|NCT03236220|Expectorants|expectorants|mesh-ancestor
92118987|NCT03236220|Respiratory System Agents|respiratory system agents|mesh-ancestor
92118988|NCT03236220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92118989|NCT03236220|Antioxidants|antioxidants|mesh-ancestor
92118990|NCT03236220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118991|NCT03236220|Protective Agents|protective agents|mesh-ancestor
92118992|NCT03236220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92118993|NCT03236220|Antidotes|antidotes|mesh-ancestor
92118994|NCT03232632|Flutemetamol|flutemetamol|mesh-list
92118995|NCT03232632|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92118996|NCT03232632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92118997|NCT01747499|Azacitidine|azacitidine|mesh-list
92118998|NCT01747499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92118999|NCT01747499|Antimetabolites|antimetabolites|mesh-ancestor
92119000|NCT01747499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119001|NCT01747499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119002|NCT01747499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119003|NCT00071721|Valproic Acid|valproic acid|mesh-list
92119004|NCT00071721|Anticonvulsants|anticonvulsants|mesh-ancestor
92119005|NCT00071721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119006|NCT00071721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119007|NCT00071721|GABA Agents|gaba agents|mesh-ancestor
92119008|NCT00071721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119009|NCT00071721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119010|NCT00071721|Antimanic Agents|antimanic agents|mesh-ancestor
92119011|NCT00071721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92119012|NCT00071721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119013|NCT00071721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119014|NCT03107208|Insulin Glargine|insulin glargine|mesh-list
92119015|NCT03107208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92119016|NCT03107208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119017|NCT05606055|Tenofovir|tenofovir|mesh-list
92119018|NCT05606055|Emtricitabine|emtricitabine|mesh-list
92119019|NCT05606055|Antiviral Agents|antiviral agents|mesh-ancestor
92119020|NCT05606055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119021|NCT05606055|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92119022|NCT05606055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92119023|NCT05606055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405130|NCT01434849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119024|NCT05606055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119025|NCT05606055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92119026|NCT05606055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92119027|NCT01896609|Interferons|interferons|mesh-list
92119028|NCT01896609|Ribavirin|ribavirin|mesh-list
92119029|NCT01896609|Interferon-alpha|interferon-alpha|mesh-list
92119030|NCT01896609|Interferon alpha-2|interferon alpha-2|mesh-list
92119031|NCT01896609|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92119032|NCT01896609|Nitazoxanide|nitazoxanide|mesh-list
92119033|NCT01896609|Complement Factor H|complement factor h|mesh-list
92119034|NCT01896609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119036|NCT01896609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119037|NCT01896609|Antimetabolites|antimetabolites|mesh-ancestor
92119038|NCT01896609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119039|NCT01896609|Immunologic Factors|immunologic factors|mesh-ancestor
92119040|NCT01896609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119041|NCT01896609|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92119042|NCT01896609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119043|NCT01896609|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92119045|NCT03232554|Trace Elements|trace elements|mesh-ancestor
92119046|NCT03232554|Micronutrients|micronutrients|mesh-ancestor
92119047|NCT03232554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119048|NCT03232398|Warfarin|warfarin|mesh-list
92119049|NCT03232398|Apixaban|apixaban|mesh-list
92119053|NCT03232398|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92119054|NCT03232398|Protease Inhibitors|protease inhibitors|mesh-ancestor
92119055|NCT03232398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119056|NCT03232398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119057|NCT02362048|Pembrolizumab|pembrolizumab|mesh-list
92119058|NCT02362048|Acalabrutinib|acalabrutinib|mesh-list
92119059|NCT02362048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119060|NCT02362048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119061|NCT02362048|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92119062|NCT02362048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119063|NCT00158223|Pimozide|pimozide|mesh-list
92119064|NCT00158223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92119065|NCT00158223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92119066|NCT00158223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119067|NCT00158223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119068|NCT00158223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119069|NCT00158223|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92119070|NCT00158223|Dopamine Agents|dopamine agents|mesh-ancestor
92119071|NCT00158223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119072|NCT00158223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119073|NCT00158223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92119074|NCT03228576|Everolimus|everolimus|mesh-list
92119075|NCT03228576|Tacrolimus|tacrolimus|mesh-list
92119076|NCT03228576|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119077|NCT03228576|Immunologic Factors|immunologic factors|mesh-ancestor
92119078|NCT03228576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119079|NCT03228576|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92119080|NCT03228576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119081|NCT03228576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119082|NCT03228576|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92119083|NCT03228576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92119084|NCT03228576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119085|NCT00158379|Paclitaxel|paclitaxel|mesh-list
92119086|NCT00158379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92119087|NCT00158379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119088|NCT00158379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92119089|NCT00158379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92119090|NCT00158379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92119091|NCT00158379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119093|NCT03228498|Lipotropic Agents|lipotropic agents|mesh-ancestor
92119094|NCT03228498|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92119095|NCT03228498|Antimetabolites|antimetabolites|mesh-ancestor
92119096|NCT03228498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119097|NCT03228498|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119098|NCT03228498|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92119099|NCT03228498|Nootropic Agents|nootropic agents|mesh-ancestor
92119100|NCT03232320|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92119101|NCT03232320|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92119102|NCT03232320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119103|NCT03232320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119104|NCT03232320|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92119105|NCT03232320|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119106|NCT03232320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119107|NCT03232320|Cholinergic Agents|cholinergic agents|mesh-ancestor
92119108|NCT03232320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119110|NCT02364076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119111|NCT02364076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119112|NCT02364076|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92119113|NCT02364076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119114|NCT02453022|Omeprazole|omeprazole|mesh-list
92119115|NCT02453022|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92119116|NCT02453022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119117|NCT02453022|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92119118|NCT02453022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119119|NCT02453022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119120|NCT00163293|Ciclesonide|ciclesonide|mesh-list
92119121|NCT00163293|Glucocorticoids|glucocorticoids|mesh-ancestor
92119122|NCT00163293|Hormones|hormones|mesh-ancestor
92119123|NCT00163293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119124|NCT00163293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119125|NCT00163293|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92119126|NCT02365870|Rotigotine|rotigotine|mesh-list
92119127|NCT02365870|Dopamine Agonists|dopamine agonists|mesh-ancestor
92119129|NCT02365870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119130|NCT02365870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119131|NCT02365870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119132|NCT03228108|Amoxicillin|amoxicillin|mesh-list
92119133|NCT03228108|Ciprofloxacin|ciprofloxacin|mesh-list
92119134|NCT03228108|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92119135|NCT03228108|Clavulanic Acids|clavulanic acids|mesh-list
92119136|NCT03228108|Clavulanic Acid|clavulanic acid|mesh-list
92119137|NCT03228108|Fosfomycin|fosfomycin|mesh-list
92119138|NCT03228108|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92119139|NCT03228108|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
92119140|NCT03228108|Trimethoprim|trimethoprim|mesh-list
92119141|NCT03228108|Sulfamethoxazole|sulfamethoxazole|mesh-list
92119142|NCT03228108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119143|NCT03228108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119144|NCT03228108|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92119145|NCT03228108|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92119146|NCT03228108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119147|NCT03228108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119148|NCT03228108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119149|NCT03228108|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92119150|NCT03228108|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119151|NCT03228108|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92119152|NCT03228108|Antimalarials|antimalarials|mesh-ancestor
92119153|NCT03228108|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92119154|NCT03228108|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92119155|NCT03228108|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92119156|NCT03228108|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92119157|NCT03228108|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92119158|NCT03228108|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92119160|NCT00078897|Antioxidants|antioxidants|mesh-ancestor
92119161|NCT00078897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119162|NCT00078897|Protective Agents|protective agents|mesh-ancestor
92119163|NCT00078897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119164|NCT00078897|Trace Elements|trace elements|mesh-ancestor
92119165|NCT00078897|Micronutrients|micronutrients|mesh-ancestor
92119166|NCT03228030|Thiamine|thiamine|mesh-list
92119167|NCT03228030|Vitamin B Complex|vitamin b complex|mesh-ancestor
92119168|NCT03228030|Vitamins|vitamins|mesh-ancestor
92119169|NCT03228030|Micronutrients|micronutrients|mesh-ancestor
92119170|NCT03228030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119171|NCT01717313|Metformin|metformin|mesh-list
92119172|NCT01717313|Glimepiride|glimepiride|mesh-list
92119173|NCT01717313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92119174|NCT01717313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119175|NCT01717313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92119176|NCT01717313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119177|NCT01717313|Immunologic Factors|immunologic factors|mesh-ancestor
92119178|NCT00081861|Bevacizumab|bevacizumab|mesh-list
92119179|NCT00081861|Rituximab|rituximab|mesh-list
92119180|NCT00081861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119181|NCT00081861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119182|NCT00081861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92119183|NCT00081861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92119185|NCT00081861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119186|NCT00081861|Growth Inhibitors|growth inhibitors|mesh-ancestor
92119187|NCT00081861|Immunologic Factors|immunologic factors|mesh-ancestor
92119188|NCT00081861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119189|NCT03120234|Fentanyl|fentanyl|mesh-list
92119190|NCT03120234|Dexmedetomidine|dexmedetomidine|mesh-list
92119191|NCT03120234|Ketamine|ketamine|mesh-list
92119192|NCT03120234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92119193|NCT03120234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119194|NCT03120234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119195|NCT03120234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92119196|NCT03120234|Analgesics|analgesics|mesh-ancestor
92119197|NCT03120234|Sensory System Agents|sensory system agents|mesh-ancestor
92119198|NCT03120234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119199|NCT03120234|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92119200|NCT03120234|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92119201|NCT03120234|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92119202|NCT03120234|Adrenergic Agents|adrenergic agents|mesh-ancestor
92119203|NCT03120234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119204|NCT03120234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119205|NCT03120234|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92119206|NCT03120234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92119207|NCT03120234|Anesthetics, General|anesthetics, general|mesh-ancestor
92119208|NCT03120234|Anesthetics|anesthetics|mesh-ancestor
92119209|NCT03120234|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92119210|NCT03120234|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92119211|NCT03120234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92119212|NCT03120234|Narcotics|narcotics|mesh-ancestor
92119213|NCT03120234|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92119214|NCT03230682|Antidepressive Agents|antidepressive agents|mesh-list
92119215|NCT03230682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119216|NCT03232710|Aripiprazole|aripiprazole|mesh-list
92119217|NCT03232710|Antidepressive Agents|antidepressive agents|mesh-ancestor
92119218|NCT03232710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119219|NCT03232710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92119220|NCT03232710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92119221|NCT03232710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119222|NCT03232710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119223|NCT03232710|Dopamine Agonists|dopamine agonists|mesh-ancestor
92119224|NCT03232710|Dopamine Agents|dopamine agents|mesh-ancestor
92119225|NCT03232710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119226|NCT03232710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119227|NCT03232710|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92119228|NCT03232710|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92119229|NCT03232710|Serotonin Agents|serotonin agents|mesh-ancestor
92119230|NCT03232710|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92119231|NCT03232710|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92119232|NCT03232710|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92119233|NCT03232710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92119234|NCT03227484|Empagliflozin|empagliflozin|mesh-list
92119235|NCT03227484|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92119236|NCT03227484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119237|NCT03227484|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92119238|NCT03227484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119239|NCT02038894|Propofol|propofol|mesh-list
92119240|NCT02038894|Sevoflurane|sevoflurane|mesh-list
92119241|NCT02038894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92119242|NCT02038894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119243|NCT02038894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119244|NCT02038894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92119245|NCT02038894|Anesthetics, General|anesthetics, general|mesh-ancestor
92119246|NCT02038894|Anesthetics|anesthetics|mesh-ancestor
92119247|NCT02038894|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92119248|NCT02038894|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92119249|NCT01375374|Lacosamide|lacosamide|mesh-list
92119250|NCT01375374|Levetiracetam|levetiracetam|mesh-list
92119251|NCT01375374|Anticonvulsants|anticonvulsants|mesh-ancestor
92119252|NCT01375374|Nootropic Agents|nootropic agents|mesh-ancestor
92119253|NCT01375374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92119254|NCT01375374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92119255|NCT01375374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119256|NCT01375374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119257|NCT04348786|Amoxicillin|amoxicillin|mesh-list
92119258|NCT04348786|Doxycycline|doxycycline|mesh-list
92119259|NCT04348786|Levofloxacin|levofloxacin|mesh-list
92119260|NCT04348786|Esomeprazole|esomeprazole|mesh-list
92119262|NCT04348786|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92119263|NCT04348786|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119264|NCT04348786|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119265|NCT04348786|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92119266|NCT04348786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119267|NCT04348786|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92119268|NCT04348786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119269|NCT04348786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119270|NCT04348786|Antimalarials|antimalarials|mesh-ancestor
92119271|NCT04348786|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92119272|NCT04348786|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92119273|NCT04348786|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92119274|NCT04348786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92119275|NCT04348786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92119276|NCT04348786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119277|NCT04348786|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92119278|NCT04348786|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119279|NCT04348786|Antacids|antacids|mesh-ancestor
92119280|NCT04348786|Antidiarrheals|antidiarrheals|mesh-ancestor
92119281|NCT02369068|Triamcinolone|triamcinolone|mesh-list
92119282|NCT02369068|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92119283|NCT02369068|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92119284|NCT02369068|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92119285|NCT02369068|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92119286|NCT02369068|Glucocorticoids|glucocorticoids|mesh-ancestor
92119287|NCT02369068|Hormones|hormones|mesh-ancestor
92119288|NCT02369068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119289|NCT02369068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119290|NCT02369068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119291|NCT02369068|Immunologic Factors|immunologic factors|mesh-ancestor
92119292|NCT02369068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119293|NCT02369068|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92119294|NCT02369068|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119295|NCT02369068|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92119296|NCT02369068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119297|NCT02369068|Cholinergic Agents|cholinergic agents|mesh-ancestor
92119298|NCT02369068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119299|NCT02452632|Ipragliflozin|ipragliflozin|mesh-list
92119300|NCT02452632|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92119301|NCT02452632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119302|NCT02452632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92119303|NCT02452632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119304|NCT02371252|Alendronate|alendronate|mesh-list
92119305|NCT02371252|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92119306|NCT02371252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119307|NCT03221946|Diclofenac|diclofenac|mesh-list
92119308|NCT03221946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92119309|NCT03221946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92119310|NCT03221946|Analgesics|analgesics|mesh-ancestor
92119311|NCT03221946|Sensory System Agents|sensory system agents|mesh-ancestor
92119312|NCT03221946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119313|NCT03221946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119314|NCT03221946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92119315|NCT03221946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119316|NCT03221946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92119317|NCT03221946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119318|NCT03221946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119319|NCT03229746|Hydroxychloroquine|hydroxychloroquine|mesh-list
92119320|NCT03229746|Vincristine|vincristine|mesh-list
92119321|NCT03229746|Azathioprine|azathioprine|mesh-list
92119322|NCT03229746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92119323|NCT03229746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119324|NCT03229746|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077410|NCT00139477|Metformin|metformin|mesh-list
92119325|NCT03229746|Antimitotic Agents|antimitotic agents|mesh-ancestor
92119326|NCT03229746|Mitosis Modulators|mitosis modulators|mesh-ancestor
92119327|NCT03229746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119328|NCT03229746|Antimalarials|antimalarials|mesh-ancestor
92119329|NCT03229746|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92119330|NCT03229746|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92119331|NCT03229746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119332|NCT03229746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119333|NCT03229746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119335|NCT03229746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92119336|NCT03229746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119337|NCT03229746|Immunologic Factors|immunologic factors|mesh-ancestor
92119338|NCT03229746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119340|NCT02040298|Antipruritics|antipruritics|mesh-ancestor
92119341|NCT02040298|Dermatologic Agents|dermatologic agents|mesh-ancestor
92119342|NCT02040298|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92119343|NCT02040298|Histamine Antagonists|histamine antagonists|mesh-ancestor
92119344|NCT02040298|Histamine Agents|histamine agents|mesh-ancestor
92119345|NCT02040298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119346|NCT02040298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119347|NCT02040298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119348|NCT02040298|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92119349|NCT03229668|Pregabalin|pregabalin|mesh-list
92119350|NCT03229668|Analgesics|analgesics|mesh-ancestor
92119351|NCT03229668|Sensory System Agents|sensory system agents|mesh-ancestor
92119352|NCT03229668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119353|NCT03229668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119354|NCT03229668|Anticonvulsants|anticonvulsants|mesh-ancestor
92119355|NCT03229668|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92119356|NCT03229668|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119357|NCT03229668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119358|NCT03229668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92119359|NCT03229668|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92119360|NCT03229668|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92119361|NCT03229668|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119362|NCT03229668|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119363|NCT03230058|Voriconazole|voriconazole|mesh-list
92119364|NCT03230058|Natamycin|natamycin|mesh-list
92119365|NCT03230058|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92119366|NCT03230058|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92119367|NCT03230058|Antifungal Agents|antifungal agents|mesh-ancestor
92119368|NCT03230058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119369|NCT03230058|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92119370|NCT03230058|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119371|NCT03230058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119372|NCT03230058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119373|NCT03230058|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92119374|NCT03230058|Hormone Antagonists|hormone antagonists|mesh-ancestor
92119375|NCT03230058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119376|NCT03230058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119377|NCT03230058|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92119378|NCT03230058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92119379|NCT03230058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119380|NCT01985542|Immunomodulating Agents|immunomodulating agents|mesh-list
92119381|NCT01985542|Immunologic Factors|immunologic factors|mesh-ancestor
92119382|NCT01985542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119383|NCT03229824|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92119384|NCT03229824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119387|NCT00081939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119388|NCT00081939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119389|NCT00081939|Immunologic Factors|immunologic factors|mesh-ancestor
92119390|NCT00081939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119391|NCT00081939|Leprostatic Agents|leprostatic agents|mesh-ancestor
92119392|NCT00081939|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119393|NCT00081939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119394|NCT00081939|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92119395|NCT00081939|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92119396|NCT00081939|Growth Substances|growth substances|mesh-ancestor
92119397|NCT00081939|Growth Inhibitors|growth inhibitors|mesh-ancestor
92119398|NCT02373124|N-Methylaspartate|n-methylaspartate|mesh-list
92119399|NCT02373124|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92119401|NCT02373124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119402|NCT02373124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119403|NCT02373124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119404|NCT03221634|Pembrolizumab|pembrolizumab|mesh-list
92119405|NCT03221634|Daratumumab|daratumumab|mesh-list
92119406|NCT03221634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119407|NCT03221634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119408|NCT03221634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92119409|NCT03221634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119410|NCT05003037|Carboplatin|carboplatin|mesh-list
92119411|NCT05003037|Pemetrexed|pemetrexed|mesh-list
92119412|NCT05003037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119413|NCT05003037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119414|NCT05003037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119415|NCT05003037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92119416|NCT05003037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92119417|NCT02374060|Dexamethasone|dexamethasone|mesh-list
92119418|NCT02374060|Triamcinolone|triamcinolone|mesh-list
92119419|NCT02374060|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92119420|NCT02374060|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92119421|NCT02374060|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92119422|NCT02374060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92119423|NCT02374060|Antiemetics|antiemetics|mesh-ancestor
92119424|NCT02374060|Autonomic Agents|autonomic agents|mesh-ancestor
92119425|NCT02374060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119426|NCT02374060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119427|NCT02374060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119428|NCT02374060|Glucocorticoids|glucocorticoids|mesh-ancestor
92119429|NCT02374060|Hormones|hormones|mesh-ancestor
92119430|NCT02374060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119431|NCT02374060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92119432|NCT02374060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119433|NCT02374060|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119436|NCT02374060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119437|NCT03221166|Thalidomide|thalidomide|mesh-list
92119438|NCT03221166|Infliximab|infliximab|mesh-list
92119439|NCT03221166|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92119440|NCT03221166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92119441|NCT03221166|Dermatologic Agents|dermatologic agents|mesh-ancestor
92119442|NCT03221166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119443|NCT03221166|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119444|NCT03221166|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119446|NCT03221166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119447|NCT03221166|Leprostatic Agents|leprostatic agents|mesh-ancestor
92119448|NCT03221166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119449|NCT03221166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119450|NCT03221166|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92119451|NCT03221166|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92119452|NCT03221166|Growth Substances|growth substances|mesh-ancestor
92119453|NCT03221166|Growth Inhibitors|growth inhibitors|mesh-ancestor
92119454|NCT03221166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119455|NCT03220932|Bevacizumab|bevacizumab|mesh-list
92119456|NCT03220932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119457|NCT03220932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119458|NCT03220932|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92119459|NCT03220932|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92119460|NCT03220932|Growth Substances|growth substances|mesh-ancestor
92119461|NCT03220932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119462|NCT03220932|Growth Inhibitors|growth inhibitors|mesh-ancestor
92119463|NCT02042872|Zoledronic Acid|zoledronic acid|mesh-list
92119464|NCT02042872|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92119465|NCT02042872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119466|NCT04484688|Bisoprolol|bisoprolol|mesh-list
92119467|NCT04484688|Perindopril|perindopril|mesh-list
92119468|NCT04484688|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92119469|NCT04484688|Sympatholytics|sympatholytics|mesh-ancestor
92119470|NCT04484688|Autonomic Agents|autonomic agents|mesh-ancestor
92119471|NCT04484688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119472|NCT04484688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119473|NCT04484688|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92119474|NCT04484688|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92119475|NCT04484688|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92119476|NCT04484688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92119477|NCT04484688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119478|NCT04484688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119479|NCT04484688|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92119480|NCT04484688|Protease Inhibitors|protease inhibitors|mesh-ancestor
92119481|NCT04484688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119482|NCT00082017|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92119483|NCT00082017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119484|NCT00082017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92119485|NCT00082017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119486|NCT00082017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119488|NCT00082329|Lenograstim|lenograstim|mesh-list
92119489|NCT00082329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92119490|NCT00082329|Immunologic Factors|immunologic factors|mesh-ancestor
92119491|NCT00082329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119492|NCT00082329|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92119493|NCT00082329|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92119494|NCT00082329|Antiviral Agents|antiviral agents|mesh-ancestor
92119495|NCT00082329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119496|NCT02451462|Zoledronic Acid|zoledronic acid|mesh-list
92119497|NCT02451462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92119498|NCT02451462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119499|NCT03207204|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92119500|NCT03207204|Carbamide Peroxide|carbamide peroxide|mesh-list
92119501|NCT03207204|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92119502|NCT03207204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119503|NCT02451306|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92119504|NCT02451306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92119505|NCT02451306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119506|NCT02451306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92119507|NCT02451306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92119508|NCT02451306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119509|NCT02451306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119510|NCT00167661|Alemtuzumab|alemtuzumab|mesh-list
92119511|NCT00167661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119512|NCT00167661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119517|NCT03220542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119518|NCT03220542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119519|NCT03220542|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92119520|NCT03220542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119521|NCT03220542|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92119522|NCT03220542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119523|NCT03220542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119524|NCT03220542|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92119525|NCT03220542|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92119526|NCT03220542|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119527|NCT03220542|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92119528|NCT03220542|Protective Agents|protective agents|mesh-ancestor
92119529|NCT03220542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119530|NCT03220542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119531|NCT03220152|Tenofovir|tenofovir|mesh-list
92119532|NCT03220152|Emtricitabine|emtricitabine|mesh-list
92119533|NCT03220152|Antiviral Agents|antiviral agents|mesh-ancestor
92119534|NCT03220152|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119535|NCT03220152|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92119536|NCT03220152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92119537|NCT03220152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119538|NCT03220152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119539|NCT03220152|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92119540|NCT03220152|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92119541|NCT03220464|Interferons|interferons|mesh-list
92119542|NCT03220464|Interferon-gamma|interferon-gamma|mesh-list
92119543|NCT03220464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119544|NCT03220464|Antiviral Agents|antiviral agents|mesh-ancestor
92119545|NCT03220464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119546|NCT03206658|Spironolactone|spironolactone|mesh-list
92119547|NCT03206658|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92119548|NCT03206658|Hormone Antagonists|hormone antagonists|mesh-ancestor
92119549|NCT03206658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119550|NCT03206658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119551|NCT03206658|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92119552|NCT03206658|Diuretics|diuretics|mesh-ancestor
92119553|NCT03206658|Natriuretic Agents|natriuretic agents|mesh-ancestor
92119554|NCT00170157|Ipilimumab|ipilimumab|mesh-list
92119555|NCT00170157|Leuprolide|leuprolide|mesh-list
92119556|NCT00170157|Goserelin|goserelin|mesh-list
92119557|NCT00170157|Bicalutamide|bicalutamide|mesh-list
92119558|NCT00170157|Flutamide|flutamide|mesh-list
92119559|NCT00170157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119560|NCT00170157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119561|NCT00170157|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92119562|NCT00170157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119563|NCT00170157|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92119564|NCT00170157|Fertility Agents|fertility agents|mesh-ancestor
92119565|NCT00170157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92119566|NCT00170157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119567|NCT00170157|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92119568|NCT00170157|Androgen Antagonists|androgen antagonists|mesh-ancestor
92119569|NCT00170157|Hormone Antagonists|hormone antagonists|mesh-ancestor
92119570|NCT00170157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119571|NCT03206346|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
92119572|NCT03206346|Antiviral Agents|antiviral agents|mesh-ancestor
92119573|NCT03206346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119574|NCT00170625|Topotecan|topotecan|mesh-list
92119575|NCT00170625|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92119576|NCT00170625|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92119577|NCT00170625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119578|NCT00170625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119579|NCT00170625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119580|NCT02043652|Chloroquine|chloroquine|mesh-list
92119581|NCT02043652|Primaquine|primaquine|mesh-list
92119582|NCT02043652|Amebicides|amebicides|mesh-ancestor
92119583|NCT02043652|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92119584|NCT02043652|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92119585|NCT02043652|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119586|NCT02043652|Antimalarials|antimalarials|mesh-ancestor
92119587|NCT02043652|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119588|NCT01898169|Nicotine|nicotine|mesh-list
92119589|NCT01898169|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92119590|NCT01898169|Autonomic Agents|autonomic agents|mesh-ancestor
92119591|NCT01898169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143920|NCT03155035|Anticestodal Agents|anticestodal agents|mesh-ancestor
92119592|NCT01898169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119593|NCT01898169|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92119594|NCT01898169|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92119595|NCT01898169|Cholinergic Agents|cholinergic agents|mesh-ancestor
92119596|NCT01898169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119597|NCT01898169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119598|NCT03227016|Topotecan|topotecan|mesh-list
92119599|NCT03227016|Veliparib|veliparib|mesh-list
92119600|NCT03227016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92119601|NCT03227016|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92119602|NCT03227016|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92119603|NCT03227016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119604|NCT03227016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119605|NCT03227016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119606|NCT04748991|Amiodarone|amiodarone|mesh-list
92119607|NCT04748991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92119608|NCT04748991|Vasodilator Agents|vasodilator agents|mesh-ancestor
92119609|NCT04748991|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92119610|NCT04748991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119611|NCT04748991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119612|NCT04748991|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92119613|NCT04748991|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92119614|NCT04748991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119615|NCT04748991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119616|NCT04748991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92119617|NCT04748991|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92119618|NCT04748991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92119619|NCT03230136|Anesthetics|anesthetics|mesh-list
92119620|NCT03230136|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077715|NCT01493427|Travoprost|travoprost|mesh-list
92119621|NCT03230136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119622|NCT00176865|Cyclosporine|cyclosporine|mesh-list
92119623|NCT00176865|Mycophenolic Acid|mycophenolic acid|mesh-list
92119624|NCT00176865|Fludarabine|fludarabine|mesh-list
92119625|NCT00176865|Melphalan|melphalan|mesh-list
92119626|NCT00176865|Alemtuzumab|alemtuzumab|mesh-list
92119627|NCT00176865|Cyclosporins|cyclosporins|mesh-list
92119628|NCT00176865|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92119629|NCT00176865|Immunoglobulins|immunoglobulins|mesh-list
92119630|NCT00176865|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92119631|NCT00176865|gamma-Globulins|gamma-globulins|mesh-list
92119632|NCT00176865|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92119633|NCT00176865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119634|NCT00176865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119635|NCT00176865|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119636|NCT00176865|Immunologic Factors|immunologic factors|mesh-ancestor
92119637|NCT00176865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119638|NCT00176865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119639|NCT00176865|Antifungal Agents|antifungal agents|mesh-ancestor
92119640|NCT00176865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119641|NCT00176865|Dermatologic Agents|dermatologic agents|mesh-ancestor
92119642|NCT00176865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119643|NCT00176865|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92119644|NCT00176865|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92119645|NCT00176865|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92119646|NCT00176865|Antitubercular Agents|antitubercular agents|mesh-ancestor
92119647|NCT00176865|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119648|NCT00176865|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92119649|NCT00176865|Alkylating Agents|alkylating agents|mesh-ancestor
92119650|NCT00176865|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92119651|NCT00176865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119652|NCT02451072|Ketanserin|ketanserin|mesh-list
92119653|NCT02451072|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92119654|NCT02451072|Hallucinogens|hallucinogens|mesh-ancestor
92119655|NCT02451072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119656|NCT02451072|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119657|NCT02451072|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92119658|NCT02451072|Serotonin Agents|serotonin agents|mesh-ancestor
92119659|NCT02451072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119660|NCT02451072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119661|NCT02451072|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92119662|NCT02451072|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92119663|NCT02451072|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92119664|NCT03226626|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92119665|NCT03226626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119666|NCT02450994|Dexamethasone|dexamethasone|mesh-list
92119667|NCT02450994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92119668|NCT02450994|Antiemetics|antiemetics|mesh-ancestor
92119669|NCT02450994|Autonomic Agents|autonomic agents|mesh-ancestor
92119670|NCT02450994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119671|NCT02450994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119672|NCT02450994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119673|NCT02450994|Glucocorticoids|glucocorticoids|mesh-ancestor
92119674|NCT02450994|Hormones|hormones|mesh-ancestor
92119675|NCT02450994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119676|NCT02450994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92119677|NCT02450994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119678|NCT00177255|Docetaxel|docetaxel|mesh-list
92119679|NCT00177255|Capecitabine|capecitabine|mesh-list
92119680|NCT00177255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119681|NCT00177255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92119682|NCT00177255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92119683|NCT00177255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92119684|NCT00177255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119685|NCT00177255|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92119686|NCT00177255|Antimetabolites|antimetabolites|mesh-ancestor
92119687|NCT02401048|Durvalumab|durvalumab|mesh-list
92119688|NCT02401048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119689|NCT02401048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119690|NCT02046382|Acetaminophen|acetaminophen|mesh-list
92119691|NCT02046382|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92119692|NCT02046382|Analgesics|analgesics|mesh-ancestor
92119693|NCT02046382|Sensory System Agents|sensory system agents|mesh-ancestor
92119694|NCT02046382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119695|NCT02046382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119696|NCT02046382|Antipyretics|antipyretics|mesh-ancestor
92119697|NCT03205176|Olaparib|olaparib|mesh-list
92119698|NCT03205176|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92119699|NCT03205176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119700|NCT03205176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119701|NCT03205176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119702|NCT02046772|Morphine|morphine|mesh-list
92119704|NCT02046772|Anesthetics, Local|anesthetics, local|mesh-ancestor
92119705|NCT02046772|Anesthetics|anesthetics|mesh-ancestor
92119706|NCT02046772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119707|NCT02046772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119708|NCT02046772|Sensory System Agents|sensory system agents|mesh-ancestor
92119709|NCT02046772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119710|NCT02046772|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92119711|NCT02046772|Narcotics|narcotics|mesh-ancestor
92119712|NCT02046772|Analgesics|analgesics|mesh-ancestor
92119713|NCT00178503|Methylphenidate|methylphenidate|mesh-list
92119714|NCT00178503|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92119715|NCT00178503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119716|NCT00178503|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92119717|NCT00178503|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92119718|NCT00178503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119719|NCT00178503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119720|NCT00178503|Dopamine Agents|dopamine agents|mesh-ancestor
92119721|NCT00178503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119722|NCT02376010|Warfarin|warfarin|mesh-list
92119723|NCT02376010|Rivaroxaban|rivaroxaban|mesh-list
92119724|NCT02376010|Anticoagulants|anticoagulants|mesh-ancestor
92119725|NCT02376010|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92119726|NCT02376010|Antithrombins|antithrombins|mesh-ancestor
92119728|NCT02376010|Protease Inhibitors|protease inhibitors|mesh-ancestor
92119729|NCT02376010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119730|NCT02376010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119731|NCT00085293|Decitabine|decitabine|mesh-list
92119732|NCT00085293|Azacitidine|azacitidine|mesh-list
92119733|NCT00085293|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92119734|NCT00085293|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92119735|NCT00085293|Antimetabolites|antimetabolites|mesh-ancestor
92119736|NCT00085293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119737|NCT00085293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119738|NCT00085293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119739|NCT00085293|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92119740|NCT02402062|Sunitinib|sunitinib|mesh-list
92119741|NCT02402062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119742|NCT02402062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92119743|NCT02402062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92119744|NCT02402062|Growth Substances|growth substances|mesh-ancestor
92119745|NCT02402062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119746|NCT02402062|Growth Inhibitors|growth inhibitors|mesh-ancestor
92119747|NCT02402062|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92119748|NCT02402062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119749|NCT02402062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119750|NCT02450838|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92119751|NCT02450838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92119752|NCT02450838|Immunologic Factors|immunologic factors|mesh-ancestor
92119753|NCT02450838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119754|NCT02450838|Antacids|antacids|mesh-ancestor
92119755|NCT02450838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119756|NCT02450838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92119757|NCT03214302|Tenofovir|tenofovir|mesh-list
92119758|NCT03214302|Antiviral Agents|antiviral agents|mesh-ancestor
92119759|NCT03214302|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119760|NCT03214302|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92119761|NCT03214302|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92119762|NCT03214302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119763|NCT03214302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119764|NCT03214302|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92119765|NCT03214302|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92119766|NCT00085839|Paclitaxel|paclitaxel|mesh-list
92119767|NCT00085839|Carboplatin|carboplatin|mesh-list
92119768|NCT00085839|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92119769|NCT00085839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92119770|NCT00085839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119771|NCT00085839|Tubulin Modulators|tubulin modulators|mesh-ancestor
92119772|NCT00085839|Antimitotic Agents|antimitotic agents|mesh-ancestor
92119773|NCT00085839|Mitosis Modulators|mitosis modulators|mesh-ancestor
92119774|NCT00085839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119775|NCT00085839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92119776|NCT00085839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119777|NCT03204474|Lacosamide|lacosamide|mesh-list
92119778|NCT03204474|Anticonvulsants|anticonvulsants|mesh-ancestor
92119779|NCT03204474|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92119780|NCT03204474|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92119781|NCT03204474|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119782|NCT03204474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119783|NCT03204318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92119784|NCT03204318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92119785|NCT03204318|Norethindrone|norethindrone|mesh-list
92119786|NCT03204318|Norethindrone Acetate|norethindrone acetate|mesh-list
92119787|NCT03204318|Estradiol|estradiol|mesh-list
92119788|NCT03204318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92119789|NCT03204318|Relugolix|relugolix|mesh-list
92119790|NCT03204318|Estrogens|estrogens|mesh-ancestor
92119791|NCT03204318|Hormones|hormones|mesh-ancestor
92119792|NCT03204318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119793|NCT03204318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119794|NCT03204318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92119795|NCT03204318|Contraceptive Agents|contraceptive agents|mesh-ancestor
92119796|NCT03204318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92119797|NCT03204318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92119798|NCT03204318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92119799|NCT03204318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92119800|NCT03204318|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92119801|NCT03204318|Androgen Antagonists|androgen antagonists|mesh-ancestor
92119802|NCT03204318|Hormone Antagonists|hormone antagonists|mesh-ancestor
92119803|NCT03204006|Dexmedetomidine|dexmedetomidine|mesh-list
92119804|NCT03204006|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92119805|NCT03204006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119806|NCT03204006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119807|NCT03204006|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92119808|NCT03204006|Analgesics|analgesics|mesh-ancestor
92119809|NCT03204006|Sensory System Agents|sensory system agents|mesh-ancestor
92119810|NCT03204006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119811|NCT03204006|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92119812|NCT03204006|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92119813|NCT03204006|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92119814|NCT03204006|Adrenergic Agents|adrenergic agents|mesh-ancestor
92119815|NCT03204006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119816|NCT03204006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119818|NCT03226080|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92119819|NCT03226080|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92119820|NCT03226080|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92119821|NCT03226080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119822|NCT03226080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119823|NCT03225924|Prednisone|prednisone|mesh-list
92119824|NCT03225924|Cyclophosphamide|cyclophosphamide|mesh-list
92119825|NCT03225924|Rituximab|rituximab|mesh-list
92119826|NCT03225924|Doxorubicin|doxorubicin|mesh-list
92119827|NCT03225924|Vincristine|vincristine|mesh-list
92119828|NCT03225924|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119829|NCT03225924|Immunologic Factors|immunologic factors|mesh-ancestor
92119830|NCT03225924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119831|NCT03225924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119832|NCT03225924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92119833|NCT03225924|Alkylating Agents|alkylating agents|mesh-ancestor
92119834|NCT03225924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119835|NCT03225924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119836|NCT03225924|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92119837|NCT03225924|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119838|NCT03225924|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92119839|NCT03225924|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92119840|NCT03225924|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92119841|NCT03225924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119842|NCT03225924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92119843|NCT03225924|Glucocorticoids|glucocorticoids|mesh-ancestor
92119844|NCT03225924|Hormones|hormones|mesh-ancestor
92119845|NCT03225924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92119846|NCT03225924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92119847|NCT03225924|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92119848|NCT03225924|Tubulin Modulators|tubulin modulators|mesh-ancestor
92119849|NCT03225924|Antimitotic Agents|antimitotic agents|mesh-ancestor
92119850|NCT03225924|Mitosis Modulators|mitosis modulators|mesh-ancestor
92119851|NCT03119532|Metronidazole|metronidazole|mesh-list
92119852|NCT03119532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119853|NCT03119532|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119854|NCT03119532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92119855|NCT03119532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92119856|NCT02404168|Lamotrigine|lamotrigine|mesh-list
92119857|NCT02404168|Anticonvulsants|anticonvulsants|mesh-list
92119858|NCT02404168|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92119859|NCT02404168|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119860|NCT02404168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119861|NCT02404168|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92119862|NCT02404168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119863|NCT02404168|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92119864|NCT02404168|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92119865|NCT02404168|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119866|NCT02404168|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119867|NCT02404168|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92119869|NCT04733937|Chelating Agents|chelating agents|mesh-ancestor
92119870|NCT04733937|Sequestering Agents|sequestering agents|mesh-ancestor
92119871|NCT04733937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119872|NCT02051452|Methylphenidate|methylphenidate|mesh-list
92119873|NCT02051452|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92119874|NCT02051452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119875|NCT02051452|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92119876|NCT02051452|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92119877|NCT02051452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119878|NCT02051452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119879|NCT02051452|Dopamine Agents|dopamine agents|mesh-ancestor
92119880|NCT02051452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119881|NCT00180687|Bupivacaine|bupivacaine|mesh-list
92119882|NCT00180687|Coal Tar|coal tar|mesh-list
92119883|NCT00180687|Anesthetics, Local|anesthetics, local|mesh-ancestor
92119884|NCT00180687|Anesthetics|anesthetics|mesh-ancestor
92119885|NCT00180687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119886|NCT00180687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119887|NCT00180687|Sensory System Agents|sensory system agents|mesh-ancestor
92119888|NCT00180687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119889|NCT00180687|Keratolytic Agents|keratolytic agents|mesh-ancestor
92119890|NCT00180687|Dermatologic Agents|dermatologic agents|mesh-ancestor
92119891|NCT00087633|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92119892|NCT00087633|Antiviral Agents|antiviral agents|mesh-ancestor
92119893|NCT00087633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119894|NCT02384044|Listerine|listerine|mesh-list
92119895|NCT02384044|Sodium Fluoride|sodium fluoride|mesh-list
92119896|NCT02384044|Cariostatic Agents|cariostatic agents|mesh-ancestor
92119897|NCT02384044|Protective Agents|protective agents|mesh-ancestor
92119898|NCT02384044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119899|NCT02384044|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92119900|NCT02384044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119901|NCT02384200|Vancomycin|vancomycin|mesh-list
92119902|NCT02384200|Gentamicins|gentamicins|mesh-list
92119903|NCT02384200|Ceftriaxone|ceftriaxone|mesh-list
92119904|NCT02384200|Ampicillin|ampicillin|mesh-list
92119906|NCT02384200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92119907|NCT02384200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92119908|NCT02384200|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92119909|NCT02384200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119910|NCT02384200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119911|NCT02384200|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92119912|NCT02051686|Tranexamic Acid|tranexamic acid|mesh-list
92119913|NCT02051686|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92119914|NCT02051686|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92119915|NCT02051686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119916|NCT02051686|Hemostatics|hemostatics|mesh-ancestor
92119917|NCT02051686|Coagulants|coagulants|mesh-ancestor
92119918|NCT00182793|Cyclophosphamide|cyclophosphamide|mesh-list
92119919|NCT00182793|Melphalan|melphalan|mesh-list
92119920|NCT00182793|Thiotepa|thiotepa|mesh-list
92078014|NCT00237718|Vitamin E|vitamin e|mesh-list
92119921|NCT00182793|Carboplatin|carboplatin|mesh-list
92119922|NCT00182793|Trastuzumab|trastuzumab|mesh-list
92119923|NCT00182793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92119924|NCT00182793|Immunologic Factors|immunologic factors|mesh-ancestor
92119925|NCT00182793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119926|NCT00182793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92119927|NCT00182793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92119928|NCT00182793|Alkylating Agents|alkylating agents|mesh-ancestor
92119929|NCT00182793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119930|NCT00182793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119931|NCT00182793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92119932|NCT00182793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92119934|NCT00183339|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92119935|NCT00183339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92119936|NCT00183339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119937|NCT00183339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119938|NCT00183339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119939|NCT00183339|Serotonin Agents|serotonin agents|mesh-ancestor
92119940|NCT00183339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119941|NCT00183339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92119942|NCT00183339|Antidepressive Agents|antidepressive agents|mesh-ancestor
92119943|NCT00183339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92119944|NCT00183339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92119945|NCT00183339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92119946|NCT00183339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92119947|NCT00183729|Memantine|memantine|mesh-list
92119948|NCT00183729|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92119949|NCT00183729|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92119950|NCT00183729|Dopamine Agents|dopamine agents|mesh-ancestor
92119951|NCT00183729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92119952|NCT00183729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119953|NCT00183729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119954|NCT00183729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92119955|NCT00183729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92119956|NCT00186069|Magnesium Sulfate|magnesium sulfate|mesh-list
92119957|NCT00186069|Analgesics|analgesics|mesh-ancestor
92119958|NCT00186069|Sensory System Agents|sensory system agents|mesh-ancestor
92119959|NCT00186069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119960|NCT00186069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119961|NCT00186069|Anesthetics|anesthetics|mesh-ancestor
92119962|NCT00186069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119963|NCT00186069|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92119964|NCT00186069|Anticonvulsants|anticonvulsants|mesh-ancestor
92119965|NCT00186069|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92119966|NCT00186069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92119967|NCT00186069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92119968|NCT00186069|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92119969|NCT00186069|Tocolytic Agents|tocolytic agents|mesh-ancestor
92119970|NCT00186069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92119971|NCT01742897|Fentanyl|fentanyl|mesh-list
92119972|NCT01742897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92119973|NCT01742897|Narcotics|narcotics|mesh-ancestor
92119974|NCT01742897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119975|NCT01742897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119976|NCT01742897|Analgesics|analgesics|mesh-ancestor
92119977|NCT01742897|Sensory System Agents|sensory system agents|mesh-ancestor
92119978|NCT01742897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119979|NCT01742897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92119980|NCT01742897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92119981|NCT01742897|Anesthetics, General|anesthetics, general|mesh-ancestor
92119982|NCT01742897|Anesthetics|anesthetics|mesh-ancestor
92119983|NCT04554485|Blinatumomab|blinatumomab|mesh-list
92119984|NCT04554485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92119985|NCT01741259|Meperidine|meperidine|mesh-list
92119986|NCT01741259|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92119987|NCT01741259|Narcotics|narcotics|mesh-ancestor
92119988|NCT01741259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92119989|NCT01741259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92119990|NCT01741259|Analgesics|analgesics|mesh-ancestor
92119991|NCT01741259|Sensory System Agents|sensory system agents|mesh-ancestor
92119992|NCT01741259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92119993|NCT01741259|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92119994|NCT01715129|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92119995|NCT01715129|Luteolytic Agents|luteolytic agents|mesh-ancestor
92119996|NCT01715129|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92119997|NCT01715129|Contraceptive Agents|contraceptive agents|mesh-ancestor
92119998|NCT01715129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92119999|NCT01715129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120000|NCT01715129|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92120001|NCT01715129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92120002|NCT01715129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120004|NCT02387554|Amlodipine|amlodipine|mesh-list
92120005|NCT02387554|Chlorthalidone|chlorthalidone|mesh-list
92120006|NCT02387554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92120007|NCT02387554|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92120008|NCT02387554|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120009|NCT02387554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120010|NCT02387554|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92120011|NCT02387554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120012|NCT02387554|Vasodilator Agents|vasodilator agents|mesh-ancestor
92120013|NCT02387554|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92120014|NCT02387554|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92120015|NCT02387554|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92120016|NCT02387554|Diuretics|diuretics|mesh-ancestor
92120017|NCT02387554|Natriuretic Agents|natriuretic agents|mesh-ancestor
92120018|NCT02387554|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92120019|NCT02387710|Tiagabine|tiagabine|mesh-list
92120020|NCT02387710|Anticonvulsants|anticonvulsants|mesh-ancestor
92120021|NCT02387710|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92120022|NCT02387710|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92120023|NCT02387710|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120024|NCT02387710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120025|NCT02387710|GABA Agents|gaba agents|mesh-ancestor
92120026|NCT02387710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120027|NCT02387710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120028|NCT01740791|Velpatasvir|velpatasvir|mesh-list
92120029|NCT01740791|Antiviral Agents|antiviral agents|mesh-ancestor
92120030|NCT01740791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120031|NCT01740323|Curcumin|curcumin|mesh-list
92120032|NCT01740323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92120033|NCT01740323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120034|NCT01740323|Analgesics|analgesics|mesh-ancestor
92120035|NCT01740323|Sensory System Agents|sensory system agents|mesh-ancestor
92120036|NCT01740323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120037|NCT01740323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120038|NCT01740323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120039|NCT01740323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120040|NCT01740323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120041|NCT01740323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120042|NCT01740323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120043|NCT00090051|Cyclophosphamide|cyclophosphamide|mesh-list
92120047|NCT00090051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92120048|NCT00090051|Immunologic Factors|immunologic factors|mesh-ancestor
92120049|NCT00090051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120050|NCT00090051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120051|NCT00090051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92120052|NCT00090051|Alkylating Agents|alkylating agents|mesh-ancestor
92120053|NCT00090051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120054|NCT00090051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120055|NCT00090051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92120056|NCT00090051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120057|NCT00090051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92120058|NCT00090051|Antimetabolites|antimetabolites|mesh-ancestor
92120059|NCT01740089|Ribavirin|ribavirin|mesh-list
92120060|NCT01740089|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92120061|NCT01740089|Antimetabolites|antimetabolites|mesh-ancestor
92120062|NCT01740089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120063|NCT01740089|Antiviral Agents|antiviral agents|mesh-ancestor
92120064|NCT01740089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120065|NCT01739933|Dexmedetomidine|dexmedetomidine|mesh-list
92120066|NCT01739933|Propofol|propofol|mesh-list
92120067|NCT01739933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92120068|NCT01739933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078165|NCT00273754|Caffeine|caffeine|mesh-list
92120069|NCT01739933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120070|NCT01739933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120071|NCT01739933|Analgesics|analgesics|mesh-ancestor
92120072|NCT01739933|Sensory System Agents|sensory system agents|mesh-ancestor
92120073|NCT01739933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120074|NCT01739933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92120075|NCT01739933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92120076|NCT01739933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92120077|NCT01739933|Adrenergic Agents|adrenergic agents|mesh-ancestor
92120078|NCT01739933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120079|NCT01739933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120080|NCT01739933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92120081|NCT01739933|Anesthetics, General|anesthetics, general|mesh-ancestor
92120082|NCT01739933|Anesthetics|anesthetics|mesh-ancestor
92120083|NCT00094497|Doxorubicin|doxorubicin|mesh-list
92120085|NCT00094497|Mitotane|mitotane|mesh-list
92120086|NCT00094497|Streptozocin|streptozocin|mesh-list
92120087|NCT00094497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120088|NCT00094497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92120089|NCT00094497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92120090|NCT00094497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92120091|NCT00094497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120092|NCT00094497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120093|NCT00094497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92120094|NCT00094497|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92120095|NCT00094887|Nitric Oxide|nitric oxide|mesh-list
92120096|NCT00094887|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92120097|NCT00094887|Autonomic Agents|autonomic agents|mesh-ancestor
92120098|NCT00094887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120099|NCT00094887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120100|NCT00094887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92120101|NCT00094887|Respiratory System Agents|respiratory system agents|mesh-ancestor
92120102|NCT00094887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92120103|NCT00094887|Antioxidants|antioxidants|mesh-ancestor
92120104|NCT00094887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120105|NCT00094887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120106|NCT00094887|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92120107|NCT00094887|Vasodilator Agents|vasodilator agents|mesh-ancestor
92120108|NCT00094887|Gasotransmitters|gasotransmitters|mesh-ancestor
92120109|NCT00094887|Protective Agents|protective agents|mesh-ancestor
92120110|NCT01712399|Mavrilimumab|mavrilimumab|mesh-list
92120111|NCT01712399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120112|NCT00097695|Icatibant|icatibant|mesh-list
92120113|NCT00097695|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92120114|NCT00097695|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120115|NCT00097695|Analgesics|analgesics|mesh-ancestor
92120116|NCT00097695|Sensory System Agents|sensory system agents|mesh-ancestor
92120117|NCT00097695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120118|NCT00097695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120119|NCT00097695|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120120|NCT00097695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144074|NCT02570503|Ropivacaine|ropivacaine|mesh-list
92120121|NCT00097695|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92120122|NCT00097695|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92120123|NCT00097695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120124|NCT00097695|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92120125|NCT00097695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92120126|NCT00097695|Immunologic Factors|immunologic factors|mesh-ancestor
92120127|NCT02096679|Osimertinib|osimertinib|mesh-list
92120128|NCT02096679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120129|NCT02096679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92120130|NCT02096679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120131|NCT02096679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120132|NCT00195039|Antibodies|antibodies|mesh-list
92120133|NCT00195039|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92120134|NCT00195039|Immunologic Factors|immunologic factors|mesh-ancestor
92120135|NCT00195039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120136|NCT04645719|Magnesium Sulfate|magnesium sulfate|mesh-list
92120137|NCT04645719|Analgesics|analgesics|mesh-ancestor
92120138|NCT04645719|Sensory System Agents|sensory system agents|mesh-ancestor
92120139|NCT04645719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120140|NCT04645719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120141|NCT04645719|Anesthetics|anesthetics|mesh-ancestor
92120142|NCT04645719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120143|NCT04645719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92120144|NCT04645719|Anticonvulsants|anticonvulsants|mesh-ancestor
92120145|NCT04645719|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92120146|NCT04645719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120147|NCT04645719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120148|NCT04645719|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92120149|NCT04645719|Tocolytic Agents|tocolytic agents|mesh-ancestor
92120150|NCT04645719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120151|NCT02054338|Paclitaxel|paclitaxel|mesh-list
92120152|NCT02054338|Gemcitabine|gemcitabine|mesh-list
92120153|NCT02054338|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92120154|NCT02054338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120155|NCT02054338|Tubulin Modulators|tubulin modulators|mesh-ancestor
92120156|NCT02054338|Antimitotic Agents|antimitotic agents|mesh-ancestor
92120157|NCT02054338|Mitosis Modulators|mitosis modulators|mesh-ancestor
92120158|NCT02054338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120159|NCT02054338|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92120160|NCT02054338|Antimetabolites|antimetabolites|mesh-ancestor
92120161|NCT00198081|Celecoxib|celecoxib|mesh-list
92120162|NCT00198081|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92120163|NCT00198081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92120164|NCT00198081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120165|NCT00198081|Analgesics|analgesics|mesh-ancestor
92120166|NCT00198081|Sensory System Agents|sensory system agents|mesh-ancestor
92120167|NCT00198081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120168|NCT00198081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120169|NCT00198081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120170|NCT00198081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120171|NCT00198081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92120172|NCT00198081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120173|NCT00198081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120174|NCT00100659|Interferons|interferons|mesh-list
92120175|NCT00100659|Ribavirin|ribavirin|mesh-list
92120176|NCT00100659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120177|NCT00100659|Antiviral Agents|antiviral agents|mesh-ancestor
92120178|NCT00100659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120179|NCT00100659|Antimetabolites|antimetabolites|mesh-ancestor
92120180|NCT00100659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120181|NCT00101361|Oxandrolone|oxandrolone|mesh-list
92120182|NCT00101361|Androgens|androgens|mesh-ancestor
92120183|NCT00101361|Hormones|hormones|mesh-ancestor
92120184|NCT00101361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120185|NCT00101361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120186|NCT00101361|Anabolic Agents|anabolic agents|mesh-ancestor
92120187|NCT03225690|Morphine|morphine|mesh-list
92120188|NCT03225690|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92120189|NCT03225690|Narcotics|narcotics|mesh-ancestor
92120190|NCT03225690|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120191|NCT03225690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120192|NCT03225690|Analgesics|analgesics|mesh-ancestor
92120193|NCT03225690|Sensory System Agents|sensory system agents|mesh-ancestor
92120194|NCT03225690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120197|NCT02389738|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92120198|NCT02389738|Alkylating Agents|alkylating agents|mesh-ancestor
92120199|NCT02389738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120200|NCT02389738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120201|NCT02389738|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92120202|NCT02389738|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92120203|NCT02389738|Purinergic Agonists|purinergic agonists|mesh-ancestor
92120204|NCT02389738|Purinergic Agents|purinergic agents|mesh-ancestor
92120205|NCT02389738|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120206|NCT02389738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120207|NCT00200343|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92120208|NCT00200343|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92120209|NCT00200343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120210|NCT00201123|Interferons|interferons|mesh-list
92120211|NCT00201123|Interferon-gamma|interferon-gamma|mesh-list
92120212|NCT00201123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120213|NCT00201123|Antiviral Agents|antiviral agents|mesh-ancestor
92120214|NCT00201123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120216|NCT01712009|Naproxen|naproxen|mesh-list
92405131|NCT01434849|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92078318|NCT04079218|Estradiol|estradiol|mesh-list
92120217|NCT01712009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92120218|NCT01712009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120220|NCT01712009|Sensory System Agents|sensory system agents|mesh-ancestor
92120221|NCT01712009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120222|NCT01712009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120223|NCT01712009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120224|NCT01712009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120225|NCT01712009|Gout Suppressants|gout suppressants|mesh-ancestor
92120226|NCT01712009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92120227|NCT01712009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120228|NCT01712009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120229|NCT01712009|Antipruritics|antipruritics|mesh-ancestor
92120230|NCT01712009|Dermatologic Agents|dermatologic agents|mesh-ancestor
92120231|NCT01712009|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92120232|NCT01712009|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92120233|NCT01712009|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92120234|NCT01712009|Histamine Antagonists|histamine antagonists|mesh-ancestor
92120235|NCT01712009|Histamine Agents|histamine agents|mesh-ancestor
92120236|NCT01712009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120238|NCT03212352|Mifepristone|mifepristone|mesh-list
92120239|NCT03212352|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92120240|NCT03212352|Abortifacient Agents|abortifacient agents|mesh-ancestor
92120241|NCT03212352|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120242|NCT03212352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120243|NCT03212352|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92120244|NCT03212352|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120245|NCT03212352|Oxytocics|oxytocics|mesh-ancestor
92120246|NCT03212352|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92120247|NCT03212352|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92120248|NCT03212352|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92120249|NCT03212352|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92120250|NCT03212352|Contraceptive Agents|contraceptive agents|mesh-ancestor
92120251|NCT03212352|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92120252|NCT03212352|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92120253|NCT03212352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92120254|NCT03212352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120255|NCT03212352|Luteolytic Agents|luteolytic agents|mesh-ancestor
92120256|NCT03212352|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92120257|NCT03212352|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92120258|NCT00201825|Docetaxel|docetaxel|mesh-list
92120259|NCT00201825|Capecitabine|capecitabine|mesh-list
92120260|NCT00201825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120261|NCT00201825|Tubulin Modulators|tubulin modulators|mesh-ancestor
92120262|NCT00201825|Antimitotic Agents|antimitotic agents|mesh-ancestor
92120263|NCT00201825|Mitosis Modulators|mitosis modulators|mesh-ancestor
92120264|NCT00201825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120265|NCT00201825|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92120266|NCT00201825|Antimetabolites|antimetabolites|mesh-ancestor
92120267|NCT02390050|Bexagliflozin|bexagliflozin|mesh-list
92120268|NCT02390050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92120269|NCT02390050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120270|NCT01711853|Dabigatran|dabigatran|mesh-list
92120271|NCT01711853|Antithrombins|antithrombins|mesh-ancestor
92120272|NCT01711853|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92120273|NCT01711853|Protease Inhibitors|protease inhibitors|mesh-ancestor
92120274|NCT01711853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120275|NCT01711853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120276|NCT01711853|Anticoagulants|anticoagulants|mesh-ancestor
92120277|NCT00202449|Prazosin|prazosin|mesh-list
92120278|NCT00202449|Paroxetine|paroxetine|mesh-list
92120279|NCT00202449|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92120280|NCT00202449|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92120281|NCT00202449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120282|NCT00202449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120283|NCT00202449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120284|NCT00202449|Serotonin Agents|serotonin agents|mesh-ancestor
92120285|NCT00202449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120286|NCT00202449|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92120287|NCT00202449|Antidepressive Agents|antidepressive agents|mesh-ancestor
92120288|NCT00202449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92120289|NCT00202449|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92120290|NCT00202449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92120291|NCT00202449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120292|NCT00202449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92120293|NCT00202449|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92120294|NCT00202449|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92120295|NCT00202449|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92120296|NCT00202449|Adrenergic Agents|adrenergic agents|mesh-ancestor
92120297|NCT03203304|Nivolumab|nivolumab|mesh-list
92120298|NCT03203304|Ipilimumab|ipilimumab|mesh-list
92120299|NCT03203304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120300|NCT03203304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120301|NCT03203304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92120302|NCT03203304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120303|NCT03225456|Oxytocin|oxytocin|mesh-list
92120304|NCT03225456|Oxytocics|oxytocics|mesh-ancestor
92120305|NCT03225456|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120306|NCT03225456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120307|NCT00203229|Lamotrigine|lamotrigine|mesh-list
92120308|NCT00203229|Anticonvulsants|anticonvulsants|mesh-ancestor
92120309|NCT00203229|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92120310|NCT00203229|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120311|NCT00203229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120312|NCT00203229|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92120313|NCT00203229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120314|NCT00203229|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92120315|NCT00203229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92120316|NCT00203229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120317|NCT00203229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92120318|NCT00203229|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92120319|NCT00203931|Pemetrexed|pemetrexed|mesh-list
92120320|NCT00203931|Cetuximab|cetuximab|mesh-list
92120321|NCT00203931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120322|NCT00203931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120323|NCT00203931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120324|NCT00203931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92120325|NCT00203931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92120326|NCT00203931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120327|NCT02412982|Enoxaparin|enoxaparin|mesh-list
92120328|NCT02412982|Enoxaparin sodium|enoxaparin sodium|mesh-list
92120329|NCT02412982|Anticoagulants|anticoagulants|mesh-ancestor
92120330|NCT02412982|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92120331|NCT02412982|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92120332|NCT02412982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120333|NCT03203616|Trastuzumab|trastuzumab|mesh-list
92120334|NCT03203616|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92120335|NCT03203616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120336|NCT03203616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120337|NCT03203616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92120338|NCT03203616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92120339|NCT03203616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92120340|NCT03203616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120341|NCT03203616|Immunotoxins|immunotoxins|mesh-ancestor
92120342|NCT03203616|Immunoconjugates|immunoconjugates|mesh-ancestor
92120343|NCT03203616|Immunologic Factors|immunologic factors|mesh-ancestor
92120344|NCT03203616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120347|NCT02450214|Sensory System Agents|sensory system agents|mesh-ancestor
92120348|NCT02450214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120349|NCT02450214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120350|NCT02450214|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92120351|NCT02450214|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92120352|NCT02450214|Anesthetics, General|anesthetics, general|mesh-ancestor
92120353|NCT02450214|Anesthetics|anesthetics|mesh-ancestor
92120354|NCT02450214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120355|NCT02450214|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92120356|NCT02450214|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92120357|NCT02450214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120358|NCT02450214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120360|NCT02450682|Apixaban|apixaban|mesh-list
92120361|NCT02450682|Anticoagulants|anticoagulants|mesh-ancestor
92120362|NCT02450682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92120363|NCT02450682|Antithrombins|antithrombins|mesh-ancestor
92120364|NCT02450682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92120365|NCT02450682|Protease Inhibitors|protease inhibitors|mesh-ancestor
92120366|NCT02450682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120367|NCT02450682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120368|NCT01740401|Cyclophosphamide|cyclophosphamide|mesh-list
92120369|NCT01740401|Ipilimumab|ipilimumab|mesh-list
92120370|NCT01740401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92120371|NCT01740401|Immunologic Factors|immunologic factors|mesh-ancestor
92120372|NCT01740401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120373|NCT01740401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120374|NCT01740401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92120375|NCT01740401|Alkylating Agents|alkylating agents|mesh-ancestor
92120376|NCT01740401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120377|NCT01740401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120378|NCT01740401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92120379|NCT01740401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120380|NCT01740401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92120381|NCT03202836|Tocolytic Agents|tocolytic agents|mesh-list
92120382|NCT03202836|Progesterone|progesterone|mesh-list
92120383|NCT03202836|Progestins|progestins|mesh-ancestor
92120384|NCT03202836|Hormones|hormones|mesh-ancestor
92120385|NCT03202836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120386|NCT03202836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120387|NCT03202836|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120388|NCT03203070|Dipyrone|dipyrone|mesh-list
92120389|NCT03203070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92120390|NCT03203070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120391|NCT03203070|Analgesics|analgesics|mesh-ancestor
92120392|NCT03203070|Sensory System Agents|sensory system agents|mesh-ancestor
92120393|NCT03203070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120394|NCT03203070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120395|NCT03203070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120396|NCT03203070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120397|NCT03203070|Antipyretics|antipyretics|mesh-ancestor
92120398|NCT03209856|Vitamin D|vitamin d|mesh-list
92120399|NCT03209856|Calcitriol|calcitriol|mesh-list
92120400|NCT03209856|Vitamins|vitamins|mesh-ancestor
92120401|NCT03209856|Micronutrients|micronutrients|mesh-ancestor
92120402|NCT03209856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120403|NCT03209856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92120404|NCT03209856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92120405|NCT03209856|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92120406|NCT03209856|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120407|NCT03209856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120408|NCT03209856|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92120409|NCT02413918|Iloperidone|iloperidone|mesh-list
92120410|NCT02413918|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92120411|NCT02413918|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92120412|NCT02413918|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120413|NCT02413918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120414|NCT02413918|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92120415|NCT03209622|Nicotine|nicotine|mesh-list
92120416|NCT03209622|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92120417|NCT03209622|Autonomic Agents|autonomic agents|mesh-ancestor
92120418|NCT03209622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120419|NCT03209622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120420|NCT03209622|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92120421|NCT03209622|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92120422|NCT03209622|Cholinergic Agents|cholinergic agents|mesh-ancestor
92120423|NCT03209622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120424|NCT03209622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120425|NCT00099021|Pioglitazone|pioglitazone|mesh-list
92120426|NCT00099021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92120427|NCT00099021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120428|NCT00354874|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92120429|NCT00354874|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92120430|NCT00354874|Autonomic Agents|autonomic agents|mesh-ancestor
92120431|NCT00354874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120432|NCT00354874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120433|NCT00354874|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92120434|NCT00354874|Respiratory System Agents|respiratory system agents|mesh-ancestor
92120435|NCT00354874|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92120436|NCT00354874|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92120437|NCT00354874|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92120438|NCT00354874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92120440|NCT00354874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120441|NCT03209466|Chlorhexidine|chlorhexidine|mesh-list
92120442|NCT03209466|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92120443|NCT03209466|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92120444|NCT03209466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120445|NCT03209466|Disinfectants|disinfectants|mesh-ancestor
92120446|NCT03209466|Dermatologic Agents|dermatologic agents|mesh-ancestor
92120447|NCT03834688|Rituximab|rituximab|mesh-list
92120448|NCT03834688|Venetoclax|venetoclax|mesh-list
92120449|NCT03834688|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92120450|NCT03834688|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120451|NCT03834688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120452|NCT03834688|Immunologic Factors|immunologic factors|mesh-ancestor
92120453|NCT03834688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120454|NCT03834688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120455|NCT03834688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92120456|NCT03834688|Alkylating Agents|alkylating agents|mesh-ancestor
92120457|NCT03834688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120458|NCT01710527|Metformin|metformin|mesh-list
92120459|NCT01710527|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92120460|NCT01710527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120461|NCT00354952|Azithromycin|azithromycin|mesh-list
92120462|NCT00354952|Clarithromycin|clarithromycin|mesh-list
92120463|NCT00354952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92120464|NCT00354952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120465|NCT00354952|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92120466|NCT00354952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120467|NCT00354952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120468|NCT00354952|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92120469|NCT00354952|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92120471|NCT04943848|Vaccines|vaccines|mesh-list
92120472|NCT04943848|Immunologic Factors|immunologic factors|mesh-ancestor
92120473|NCT04943848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120474|NCT04943848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92120475|NCT04943848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120476|NCT04943848|Trace Elements|trace elements|mesh-ancestor
92120477|NCT04943848|Micronutrients|micronutrients|mesh-ancestor
92120478|NCT01706939|Carboplatin|carboplatin|mesh-list
92120479|NCT01706939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120480|NCT04938232|Nivolumab|nivolumab|mesh-list
92120481|NCT04938232|Ipilimumab|ipilimumab|mesh-list
92120482|NCT04938232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120483|NCT04938232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120484|NCT04938232|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92120485|NCT04938232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120486|NCT03209232|Infliximab|infliximab|mesh-list
92120487|NCT03209232|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92120488|NCT03209232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120489|NCT03209232|Dermatologic Agents|dermatologic agents|mesh-ancestor
92120490|NCT03209232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120491|NCT03209232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120492|NCT04485312|Chlorhexidine|chlorhexidine|mesh-list
92120493|NCT04485312|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92120494|NCT04485312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120495|NCT04485312|Disinfectants|disinfectants|mesh-ancestor
92120496|NCT01709903|Fluticasone|fluticasone|mesh-list
92120497|NCT01709903|Xhance|xhance|mesh-list
92120498|NCT01709903|Glycopyrrolate|glycopyrrolate|mesh-list
92120499|NCT01709903|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92120500|NCT01709903|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92120501|NCT01709903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120502|NCT01709903|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92120503|NCT01709903|Autonomic Agents|autonomic agents|mesh-ancestor
92120504|NCT01709903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120505|NCT01709903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120506|NCT01709903|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92120507|NCT01709903|Respiratory System Agents|respiratory system agents|mesh-ancestor
92120508|NCT01709903|Dermatologic Agents|dermatologic agents|mesh-ancestor
92120509|NCT01709903|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92120510|NCT01709903|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92120511|NCT01709903|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92120512|NCT01709903|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92120513|NCT01709903|Adrenergic Agents|adrenergic agents|mesh-ancestor
92120514|NCT01709903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120515|NCT01709903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120516|NCT01709903|Glucocorticoids|glucocorticoids|mesh-ancestor
92120517|NCT01709903|Hormones|hormones|mesh-ancestor
92120518|NCT01709903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120519|NCT01709903|Sympathomimetics|sympathomimetics|mesh-ancestor
92120520|NCT01709903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92120521|NCT01709903|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92120522|NCT01709903|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92120523|NCT01709903|Cholinergic Agents|cholinergic agents|mesh-ancestor
92120524|NCT03202446|Cyclophosphamide|cyclophosphamide|mesh-list
92120525|NCT03202446|Chitosan|chitosan|mesh-list
92120526|NCT03202446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92120527|NCT03202446|Immunologic Factors|immunologic factors|mesh-ancestor
92120528|NCT03202446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120529|NCT03202446|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120530|NCT03202446|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92120531|NCT03202446|Alkylating Agents|alkylating agents|mesh-ancestor
92120532|NCT03202446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120533|NCT03202446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120534|NCT03202446|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92120535|NCT03202446|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92120536|NCT03202446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92120537|NCT03202446|Antimetabolites|antimetabolites|mesh-ancestor
92120538|NCT03202446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92120539|NCT03202446|Chelating Agents|chelating agents|mesh-ancestor
92120540|NCT03202446|Sequestering Agents|sequestering agents|mesh-ancestor
92120541|NCT03202446|Hemostatics|hemostatics|mesh-ancestor
92120542|NCT03202446|Coagulants|coagulants|mesh-ancestor
92120543|NCT05718934|Glycopyrrolate|glycopyrrolate|mesh-list
92120544|NCT05718934|Neostigmine|neostigmine|mesh-list
92120545|NCT05718934|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92120546|NCT05718934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120547|NCT05718934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120548|NCT05718934|Cholinergic Agents|cholinergic agents|mesh-ancestor
92120549|NCT05718934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120550|NCT05718934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120551|NCT05718934|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92120552|NCT05718934|Autonomic Agents|autonomic agents|mesh-ancestor
92120553|NCT05718934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120554|NCT05718934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92120555|NCT05718934|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92120556|NCT05718934|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92120557|NCT03208764|Nitric Oxide|nitric oxide|mesh-list
92120558|NCT03208764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92120559|NCT03208764|Autonomic Agents|autonomic agents|mesh-ancestor
92120560|NCT03208764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120561|NCT03208764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120562|NCT03208764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92120563|NCT03208764|Respiratory System Agents|respiratory system agents|mesh-ancestor
92120564|NCT03208764|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92120565|NCT03208764|Antioxidants|antioxidants|mesh-ancestor
92120566|NCT03208764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120567|NCT03208764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120568|NCT03208764|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92120569|NCT03208764|Vasodilator Agents|vasodilator agents|mesh-ancestor
92120570|NCT03208764|Gasotransmitters|gasotransmitters|mesh-ancestor
92120571|NCT03208764|Protective Agents|protective agents|mesh-ancestor
92120572|NCT05718856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92120573|NCT05718856|Antibodies|antibodies|mesh-list
92120574|NCT05718856|Immunoglobulins|immunoglobulins|mesh-list
92120575|NCT05718856|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92120576|NCT05718856|Immunologic Factors|immunologic factors|mesh-ancestor
92120577|NCT05718856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120578|NCT05718856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120579|NCT03208998|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92120580|NCT03208998|Antiviral Agents|antiviral agents|mesh-ancestor
92120581|NCT03208998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120582|NCT03208452|Magnesium Sulfate|magnesium sulfate|mesh-list
92120583|NCT03208452|Analgesics|analgesics|mesh-ancestor
92120584|NCT03208452|Sensory System Agents|sensory system agents|mesh-ancestor
92120585|NCT03208452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120586|NCT03208452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120587|NCT03208452|Anesthetics|anesthetics|mesh-ancestor
92120588|NCT03208452|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120589|NCT03208452|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92078701|NCT00332644|Bupropion|bupropion|mesh-list
92120590|NCT03208452|Anticonvulsants|anticonvulsants|mesh-ancestor
92120591|NCT03208452|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92120592|NCT03208452|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120593|NCT03208452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120594|NCT03208452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92120595|NCT03208452|Tocolytic Agents|tocolytic agents|mesh-ancestor
92120596|NCT03208452|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120597|NCT05718310|Nitroglycerin|nitroglycerin|mesh-list
92120598|NCT05718310|Vasodilator Agents|vasodilator agents|mesh-ancestor
92120599|NCT03224208|Vemurafenib|vemurafenib|mesh-list
92120600|NCT03224208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120601|NCT03224208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92120602|NCT03224208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120603|NCT03224208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120605|NCT05718232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120606|NCT05718232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92120607|NCT05718232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120608|NCT05718232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120609|NCT00355966|Misoprostol|misoprostol|mesh-list
92120610|NCT00355966|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92120611|NCT00355966|Abortifacient Agents|abortifacient agents|mesh-ancestor
92120612|NCT00355966|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120613|NCT00355966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120614|NCT00355966|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92120615|NCT00355966|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120616|NCT00355966|Oxytocics|oxytocics|mesh-ancestor
92120617|NCT03208218|Lenalidomide|lenalidomide|mesh-list
92120618|NCT03208218|Immunologic Factors|immunologic factors|mesh-ancestor
92120619|NCT03208218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120620|NCT03208218|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92120621|NCT03208218|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92120622|NCT03208218|Growth Substances|growth substances|mesh-ancestor
92120623|NCT03208218|Growth Inhibitors|growth inhibitors|mesh-ancestor
92120624|NCT03208218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120625|NCT05372380|Atorvastatin|atorvastatin|mesh-list
92120626|NCT05372380|Ezetimibe|ezetimibe|mesh-list
92120627|NCT05372380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92120628|NCT05372380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92120629|NCT05372380|Antimetabolites|antimetabolites|mesh-ancestor
92120630|NCT05372380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120631|NCT05372380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92120632|NCT05372380|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92120633|NCT05372380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120634|NCT02451774|Pentoxifylline|pentoxifylline|mesh-list
92120635|NCT02451774|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92120636|NCT02451774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120637|NCT02451774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120638|NCT02451774|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92120639|NCT02451774|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92120640|NCT02451774|Protective Agents|protective agents|mesh-ancestor
92120641|NCT02451774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120642|NCT02451774|Vasodilator Agents|vasodilator agents|mesh-ancestor
92120643|NCT02451774|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92120644|NCT02451774|Antioxidants|antioxidants|mesh-ancestor
92120645|NCT00355576|Minocycline|minocycline|mesh-list
92120646|NCT00355576|Celecoxib|celecoxib|mesh-list
92120647|NCT00355576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92120648|NCT00355576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120649|NCT00355576|Analgesics|analgesics|mesh-ancestor
92120650|NCT00355576|Sensory System Agents|sensory system agents|mesh-ancestor
92120651|NCT00355576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120652|NCT00355576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120653|NCT00355576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120654|NCT00355576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120655|NCT00355576|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92120656|NCT00355576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92120657|NCT00355576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120658|NCT00355576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120659|NCT00355576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92120660|NCT00355576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120661|NCT03195582|Chlorhexidine|chlorhexidine|mesh-list
92120662|NCT03195582|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92120663|NCT03195582|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92120664|NCT03195582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120665|NCT03195582|Disinfectants|disinfectants|mesh-ancestor
92120666|NCT03195582|Dermatologic Agents|dermatologic agents|mesh-ancestor
92120667|NCT02448264|Berotralstat|berotralstat|mesh-list
92120668|NCT02448264|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92120669|NCT02448264|Protease Inhibitors|protease inhibitors|mesh-ancestor
92120670|NCT02448264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120671|NCT02448264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120672|NCT02451852|Osimertinib|osimertinib|mesh-list
92120673|NCT02451852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120674|NCT02451852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92120675|NCT02451852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120676|NCT02451852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120677|NCT00421642|Adalimumab|adalimumab|mesh-list
92120678|NCT00421642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92120679|NCT00421642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120680|NCT00421642|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120681|NCT03200964|Anesthetics|anesthetics|mesh-list
92120682|NCT03200964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120683|NCT03200964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120684|NCT04484844|Listerine|listerine|mesh-list
92120685|NCT04484844|Fluorides|fluorides|mesh-list
92120686|NCT04484844|Sodium Fluoride|sodium fluoride|mesh-list
92120687|NCT04484844|Cariostatic Agents|cariostatic agents|mesh-ancestor
92120688|NCT04484844|Protective Agents|protective agents|mesh-ancestor
92120689|NCT04484844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120690|NCT04484844|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92120691|NCT04484844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120692|NCT03119454|Betamethasone|betamethasone|mesh-list
92120693|NCT03119454|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
92120694|NCT03119454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120695|NCT03119454|Glucocorticoids|glucocorticoids|mesh-ancestor
92120696|NCT03119454|Hormones|hormones|mesh-ancestor
92120697|NCT03119454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120698|NCT03119454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120699|NCT03119454|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92120700|NCT03119454|Respiratory System Agents|respiratory system agents|mesh-ancestor
92120701|NCT04485156|Rifampin|rifampin|mesh-list
92120702|NCT04485156|Isoniazid|isoniazid|mesh-list
92120703|NCT04485156|Pyrazinamide|pyrazinamide|mesh-list
92120704|NCT04485156|Ethambutol|ethambutol|mesh-list
92120705|NCT04485156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92120706|NCT04485156|Antitubercular Agents|antitubercular agents|mesh-ancestor
92120707|NCT04485156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92120708|NCT04485156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120709|NCT04485156|Leprostatic Agents|leprostatic agents|mesh-ancestor
92120710|NCT04485156|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92120711|NCT04485156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120712|NCT04485156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120713|NCT04485156|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92120714|NCT04485156|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92120715|NCT04485156|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92120716|NCT04485156|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92120717|NCT04485156|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92120718|NCT04485156|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92120719|NCT04485156|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92120720|NCT04485156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92120721|NCT04485156|Antimetabolites|antimetabolites|mesh-ancestor
92120722|NCT04485156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92120724|NCT04637620|Antidepressive Agents|antidepressive agents|mesh-ancestor
92120725|NCT04637620|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92120726|NCT04637620|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92120727|NCT04637620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92120728|NCT04637620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92120729|NCT04637620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120730|NCT04637620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120731|NCT04637620|Serotonin Agents|serotonin agents|mesh-ancestor
92120732|NCT04637620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120733|NCT00355108|Tranexamic Acid|tranexamic acid|mesh-list
92120734|NCT00355108|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92120735|NCT00355108|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92405132|NCT01434849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92078844|NCT01490697|Cycloserine|cycloserine|mesh-list
92120736|NCT00355108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120737|NCT00355108|Hemostatics|hemostatics|mesh-ancestor
92120738|NCT00355108|Coagulants|coagulants|mesh-ancestor
92120739|NCT05271604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92120740|NCT05271604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120741|NCT05271604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120742|NCT05271604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120743|NCT04614766|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92120744|NCT04614766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120745|NCT04614766|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92120746|NCT03200886|Triamcinolone|triamcinolone|mesh-list
92120747|NCT03200886|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92120748|NCT03200886|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92120749|NCT03200886|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92120750|NCT03200886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120751|NCT03200886|Glucocorticoids|glucocorticoids|mesh-ancestor
92120752|NCT03200886|Hormones|hormones|mesh-ancestor
92120753|NCT03200886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120754|NCT03200886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120755|NCT03200886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92120756|NCT03200886|Immunologic Factors|immunologic factors|mesh-ancestor
92120757|NCT03200886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120758|NCT03200886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120759|NCT05717764|Capecitabine|capecitabine|mesh-list
92120760|NCT05717764|Mitoxantrone|mitoxantrone|mesh-list
92120761|NCT05717764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92120762|NCT05717764|Antimetabolites|antimetabolites|mesh-ancestor
92120763|NCT05717764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120764|NCT05717764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120765|NCT05717764|Analgesics|analgesics|mesh-ancestor
92120766|NCT05717764|Sensory System Agents|sensory system agents|mesh-ancestor
92120767|NCT05717764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120768|NCT05717764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120769|NCT05717764|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92120770|NCT05717764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92120771|NCT05717764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120772|NCT03118830|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92120773|NCT03118830|Cetrorelix|cetrorelix|mesh-list
92120774|NCT03118830|Hormones|hormones|mesh-list
92120775|NCT03118830|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92120776|NCT03118830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120777|NCT03118830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120778|NCT03118830|Luteolytic Agents|luteolytic agents|mesh-ancestor
92120779|NCT03118830|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92120780|NCT03118830|Contraceptive Agents|contraceptive agents|mesh-ancestor
92120781|NCT03118830|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120782|NCT03118830|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92120783|NCT03118830|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92120784|NCT03118830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120785|NCT03118830|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92120786|NCT03118830|Fertility Agents|fertility agents|mesh-ancestor
92120787|NCT03118830|Hormone Antagonists|hormone antagonists|mesh-ancestor
92120788|NCT03223506|Acetaminophen|acetaminophen|mesh-list
92120789|NCT03223506|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120790|NCT03223506|Analgesics|analgesics|mesh-ancestor
92120791|NCT03223506|Sensory System Agents|sensory system agents|mesh-ancestor
92120792|NCT03223506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120793|NCT03223506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120794|NCT03223506|Antipyretics|antipyretics|mesh-ancestor
92120795|NCT04535362|Nicotine|nicotine|mesh-list
92120796|NCT04535362|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92120797|NCT04535362|Autonomic Agents|autonomic agents|mesh-ancestor
92120798|NCT04535362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120799|NCT04535362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120800|NCT04535362|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92120801|NCT04535362|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92120802|NCT04535362|Cholinergic Agents|cholinergic agents|mesh-ancestor
92120803|NCT04535362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120804|NCT04535362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120805|NCT03223896|Naloxone|naloxone|mesh-list
92120806|NCT03223896|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92120807|NCT03223896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120808|NCT03223896|Sensory System Agents|sensory system agents|mesh-ancestor
92120809|NCT03223896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120810|NCT02447796|Dexmedetomidine|dexmedetomidine|mesh-list
92120812|NCT02447796|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92120813|NCT02447796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120814|NCT02447796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120815|NCT02447796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92120816|NCT02447796|Analgesics|analgesics|mesh-ancestor
92120817|NCT02447796|Sensory System Agents|sensory system agents|mesh-ancestor
92120818|NCT02447796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120819|NCT02447796|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92120820|NCT02447796|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92120821|NCT02447796|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92120822|NCT02447796|Adrenergic Agents|adrenergic agents|mesh-ancestor
92120823|NCT02447796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120824|NCT02447796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120825|NCT02447796|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92120826|NCT02447796|Anesthetics, General|anesthetics, general|mesh-ancestor
92120827|NCT02447796|Anesthetics|anesthetics|mesh-ancestor
92120828|NCT05225116|Lenvatinib|lenvatinib|mesh-list
92120829|NCT05225116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120830|NCT05225116|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92120831|NCT05225116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120832|NCT05225116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120833|NCT03838042|Nivolumab|nivolumab|mesh-list
92120834|NCT03838042|Entinostat|entinostat|mesh-list
92120835|NCT03838042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120836|NCT03838042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120837|NCT03838042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92120838|NCT03838042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120839|NCT03838042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92120840|NCT03838042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120841|NCT03200184|Sofosbuvir|sofosbuvir|mesh-list
92120842|NCT03200184|Antiviral Agents|antiviral agents|mesh-ancestor
92120843|NCT03200184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120844|NCT03222960|Propolis|propolis|mesh-list
92120845|NCT03222960|Fluorides|fluorides|mesh-list
92120846|NCT03222960|Cariostatic Agents|cariostatic agents|mesh-ancestor
92120847|NCT03222960|Protective Agents|protective agents|mesh-ancestor
92120848|NCT03222960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120849|NCT03222960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120850|NCT05681260|Cytarabine|cytarabine|mesh-list
92120851|NCT05681260|Dexamethasone|dexamethasone|mesh-list
92120852|NCT05681260|Dexamethasone acetate|dexamethasone acetate|mesh-list
92120853|NCT05681260|Prednisone|prednisone|mesh-list
92120854|NCT05681260|Cyclophosphamide|cyclophosphamide|mesh-list
92120855|NCT05681260|Ifosfamide|ifosfamide|mesh-list
92120856|NCT05681260|Doxorubicin|doxorubicin|mesh-list
92120857|NCT05681260|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92120858|NCT05681260|Methotrexate|methotrexate|mesh-list
92120859|NCT05681260|Etoposide|etoposide|mesh-list
92120860|NCT05681260|Vincristine|vincristine|mesh-list
92120861|NCT05681260|Bortezomib|bortezomib|mesh-list
92120862|NCT05681260|Daunorubicin|daunorubicin|mesh-list
92120863|NCT05681260|Asparaginase|asparaginase|mesh-list
92120864|NCT05681260|Mercaptopurine|mercaptopurine|mesh-list
92120865|NCT05681260|Vindesine|vindesine|mesh-list
92120866|NCT05681260|Pegaspargase|pegaspargase|mesh-list
92120867|NCT05681260|BB 1101|bb 1101|mesh-list
92120868|NCT05681260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92120869|NCT05681260|Immunologic Factors|immunologic factors|mesh-ancestor
92120870|NCT05681260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120871|NCT05681260|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92120872|NCT05681260|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92120873|NCT05681260|Alkylating Agents|alkylating agents|mesh-ancestor
92120874|NCT05681260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120875|NCT05681260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120876|NCT05681260|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92120877|NCT05681260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92120878|NCT05681260|Antiemetics|antiemetics|mesh-ancestor
92120880|NCT05681260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120881|NCT05681260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120882|NCT05681260|Glucocorticoids|glucocorticoids|mesh-ancestor
92078990|NCT01462929|Cholinergic Agents|cholinergic agents|mesh-ancestor
92120884|NCT05681260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92120885|NCT05681260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92120886|NCT05681260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92120887|NCT05681260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120888|NCT05681260|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92120889|NCT05681260|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92120890|NCT05681260|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92120891|NCT05681260|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92120892|NCT05681260|Abortifacient Agents|abortifacient agents|mesh-ancestor
92120893|NCT05681260|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92120894|NCT05681260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92120895|NCT05681260|Antimetabolites|antimetabolites|mesh-ancestor
92120896|NCT05681260|Dermatologic Agents|dermatologic agents|mesh-ancestor
92120897|NCT05681260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92120898|NCT05681260|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92120899|NCT05681260|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92120900|NCT05681260|Antiviral Agents|antiviral agents|mesh-ancestor
92120901|NCT05681260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120902|NCT05681260|Tubulin Modulators|tubulin modulators|mesh-ancestor
92120903|NCT05681260|Antimitotic Agents|antimitotic agents|mesh-ancestor
92120904|NCT05681260|Mitosis Modulators|mitosis modulators|mesh-ancestor
92120905|NCT03193086|Alemtuzumab|alemtuzumab|mesh-list
92120906|NCT03193086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120907|NCT03193086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120908|NCT03199950|Haloperidol|haloperidol|mesh-list
92120909|NCT03199950|Haloperidol decanoate|haloperidol decanoate|mesh-list
92120910|NCT03199950|Antiemetics|antiemetics|mesh-ancestor
92120911|NCT03199950|Autonomic Agents|autonomic agents|mesh-ancestor
92120912|NCT03199950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120913|NCT03199950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120914|NCT03199950|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120915|NCT03199950|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92120916|NCT03199950|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92120917|NCT03199950|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120918|NCT03199950|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92120919|NCT03199950|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92120920|NCT03199950|Dopamine Agents|dopamine agents|mesh-ancestor
92120921|NCT03199950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120922|NCT03199950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120923|NCT03199950|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92120924|NCT05156632|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92120925|NCT05156632|Vaccines|vaccines|mesh-list
92120926|NCT05156632|Immunologic Factors|immunologic factors|mesh-ancestor
92120927|NCT05156632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120928|NCT05156632|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92120929|NCT05156632|Antacids|antacids|mesh-ancestor
92120930|NCT05156632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120931|NCT05156632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92120932|NCT03118362|Plasma-lyte 148|plasma-lyte 148|mesh-list
92120933|NCT03118362|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92120934|NCT03118362|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92120935|NCT02447016|Tenofovir|tenofovir|mesh-list
92120936|NCT02447016|Emtricitabine|emtricitabine|mesh-list
92120937|NCT02447016|Efavirenz|efavirenz|mesh-list
92120938|NCT02447016|Rilpivirine|rilpivirine|mesh-list
92120939|NCT02447016|Antiviral Agents|antiviral agents|mesh-ancestor
92120940|NCT02447016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120941|NCT02447016|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92120942|NCT02447016|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92120943|NCT02447016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120944|NCT02447016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120945|NCT02447016|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92120946|NCT02447016|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92120947|NCT02447016|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92120948|NCT02447016|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92120949|NCT02447016|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92120950|NCT02447016|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92120951|NCT02447016|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92120952|NCT02447016|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92120955|NCT02447094|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92120956|NCT02447094|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92120957|NCT02447094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120958|NCT02446860|Nivolumab|nivolumab|mesh-list
92120959|NCT02446860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92120960|NCT02446860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92120961|NCT02446860|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92405133|NCT01434862|Pramlintide|pramlintide|mesh-list
92120962|NCT02446860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120963|NCT02449746|Immunoglobulins|immunoglobulins|mesh-list
92120964|NCT02449746|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92120965|NCT02449746|Antibodies|antibodies|mesh-list
92120966|NCT02449746|gamma-Globulins|gamma-globulins|mesh-list
92120967|NCT02449746|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92120968|NCT02449746|Immunologic Factors|immunologic factors|mesh-ancestor
92120969|NCT02449746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120970|NCT02446782|Clindamycin|clindamycin|mesh-list
92120971|NCT02446782|Cefazolin|cefazolin|mesh-list
92120972|NCT02446782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92120973|NCT02446782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92120974|NCT02446782|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92120975|NCT02446782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92120976|NCT02446782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120977|NCT04745260|Fentanyl|fentanyl|mesh-list
92120978|NCT04745260|Midazolam|midazolam|mesh-list
92120979|NCT04745260|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92120980|NCT04745260|Narcotics|narcotics|mesh-ancestor
92120981|NCT04745260|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92120982|NCT04745260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92120983|NCT04745260|Analgesics|analgesics|mesh-ancestor
92120984|NCT04745260|Sensory System Agents|sensory system agents|mesh-ancestor
92120985|NCT04745260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92120986|NCT04745260|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92120987|NCT04745260|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92120988|NCT04745260|Anesthetics, General|anesthetics, general|mesh-ancestor
92120989|NCT04745260|Anesthetics|anesthetics|mesh-ancestor
92120990|NCT04745260|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92120991|NCT04745260|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92120992|NCT04745260|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92120993|NCT04745260|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92120994|NCT04745260|GABA Modulators|gaba modulators|mesh-ancestor
92120995|NCT04745260|GABA Agents|gaba agents|mesh-ancestor
92120996|NCT04745260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92120997|NCT04745260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92120998|NCT03199482|Dexamethasone|dexamethasone|mesh-list
92120999|NCT03199482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121000|NCT03199482|Antiemetics|antiemetics|mesh-ancestor
92121001|NCT03199482|Autonomic Agents|autonomic agents|mesh-ancestor
92121002|NCT03199482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121003|NCT03199482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121004|NCT03199482|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121005|NCT03199482|Glucocorticoids|glucocorticoids|mesh-ancestor
92121006|NCT03199482|Hormones|hormones|mesh-ancestor
92121007|NCT03199482|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121008|NCT03199482|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121009|NCT03199482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121010|NCT02446704|Temozolomide|temozolomide|mesh-list
92121011|NCT02446704|Olaparib|olaparib|mesh-list
92121012|NCT02446704|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92121013|NCT02446704|Alkylating Agents|alkylating agents|mesh-ancestor
92121014|NCT02446704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121015|NCT02446704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121016|NCT02446704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92121017|NCT02446704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121018|NCT01605227|Prednisone|prednisone|mesh-list
92121019|NCT01605227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121020|NCT01605227|Glucocorticoids|glucocorticoids|mesh-ancestor
92121021|NCT01605227|Hormones|hormones|mesh-ancestor
92121022|NCT01605227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121023|NCT01605227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121024|NCT01605227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121025|NCT01605227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121026|NCT02446548|Losartan|losartan|mesh-list
92121027|NCT02446548|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92121028|NCT02446548|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92121029|NCT02446548|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92121030|NCT02446548|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92121031|NCT02446548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121032|NCT04291768|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92121033|NCT04291768|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92121034|NCT04291768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121035|NCT04291768|Antitubercular Agents|antitubercular agents|mesh-ancestor
92121036|NCT03199170|Morphine|morphine|mesh-list
92121037|NCT03199170|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92121038|NCT03199170|Narcotics|narcotics|mesh-ancestor
92121039|NCT03199170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121040|NCT03199170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121041|NCT03199170|Analgesics|analgesics|mesh-ancestor
92121042|NCT03199170|Sensory System Agents|sensory system agents|mesh-ancestor
92121043|NCT03199170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121044|NCT03118128|Metformin|metformin|mesh-list
92121045|NCT03118128|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92121046|NCT03118128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121047|NCT05100472|Androgens|androgens|mesh-list
92121048|NCT05100472|Hormones|hormones|mesh-ancestor
92121049|NCT05100472|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121050|NCT05100472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121051|NCT05087914|Naproxen|naproxen|mesh-list
92121052|NCT05087914|Levodopa|levodopa|mesh-list
92121053|NCT05087914|Carbidopa|carbidopa|mesh-list
92121054|NCT05087914|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92121055|NCT05087914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92121056|NCT05087914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121057|NCT05087914|Analgesics|analgesics|mesh-ancestor
92121058|NCT05087914|Sensory System Agents|sensory system agents|mesh-ancestor
92121059|NCT05087914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121060|NCT05087914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121061|NCT05087914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121063|NCT05087914|Gout Suppressants|gout suppressants|mesh-ancestor
92121064|NCT05087914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92121065|NCT05087914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121066|NCT05087914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121067|NCT05087914|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92121068|NCT05087914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92121069|NCT05087914|Dopamine Agents|dopamine agents|mesh-ancestor
92121070|NCT05087914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121071|NCT05087914|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92121072|NCT05087914|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92121073|NCT05087914|Immunologic Factors|immunologic factors|mesh-ancestor
92121074|NCT05087914|Dopamine Agonists|dopamine agonists|mesh-ancestor
92121075|NCT03194724|Vitamin A|vitamin a|mesh-list
92121076|NCT03194724|Vitamins|vitamins|mesh-ancestor
92121077|NCT03194724|Micronutrients|micronutrients|mesh-ancestor
92121078|NCT03194724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121079|NCT05637970|Hemostatics|hemostatics|mesh-list
92121080|NCT05637970|Coagulants|coagulants|mesh-ancestor
92121081|NCT03198702|Botulinum Toxins|botulinum toxins|mesh-list
92121082|NCT03198702|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92121083|NCT03198702|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92121084|NCT03198702|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92121085|NCT03198702|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121086|NCT03198702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121087|NCT03198702|Cholinergic Agents|cholinergic agents|mesh-ancestor
92121088|NCT03198702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121089|NCT03198702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121090|NCT03198702|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92121091|NCT03198702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121092|NCT01709513|Atorvastatin|atorvastatin|mesh-list
92121093|NCT01709513|Ezetimibe|ezetimibe|mesh-list
92121094|NCT01709513|Alirocumab|alirocumab|mesh-list
92121095|NCT01709513|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92121096|NCT01709513|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92121097|NCT01709513|Antimetabolites|antimetabolites|mesh-ancestor
92121098|NCT01709513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121099|NCT01709513|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92121100|NCT01709513|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92121102|NCT01709513|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92121103|NCT01709513|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92121104|NCT01709513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92121105|NCT02446158|Chlorhexidine|chlorhexidine|mesh-list
92121106|NCT02446158|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92121107|NCT02446158|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92121108|NCT02446158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121112|NCT05631886|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92121113|NCT05631886|Paclitaxel|paclitaxel|mesh-list
92121114|NCT05631886|Antibodies|antibodies|mesh-list
92121115|NCT05631886|Immunoglobulins|immunoglobulins|mesh-list
92121116|NCT05631886|Antibodies, Blocking|antibodies, blocking|mesh-list
92121117|NCT05631886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121118|NCT05631886|Immunologic Factors|immunologic factors|mesh-ancestor
92121119|NCT05631886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121120|NCT05631886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121121|NCT05631886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92121122|NCT05631886|Alkylating Agents|alkylating agents|mesh-ancestor
92121123|NCT05631886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121124|NCT05631886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121125|NCT05631886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92121126|NCT05631886|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92121127|NCT05631886|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121128|NCT05631886|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121129|NCT05631886|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121130|NCT02446002|Lofexidine|lofexidine|mesh-list
92121131|NCT02446002|Clonidine|clonidine|mesh-list
92121132|NCT02446002|Naltrexone|naltrexone|mesh-list
92121133|NCT02446002|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92121134|NCT02446002|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92121135|NCT02446002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121136|NCT02446002|Sensory System Agents|sensory system agents|mesh-ancestor
92121137|NCT02446002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121138|NCT02446002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92121139|NCT02446002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92121140|NCT02446002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92121141|NCT02446002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92121142|NCT02446002|Adrenergic Agents|adrenergic agents|mesh-ancestor
92121143|NCT02446002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121144|NCT02446002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121146|NCT02446002|Sympatholytics|sympatholytics|mesh-ancestor
92121147|NCT02446002|Autonomic Agents|autonomic agents|mesh-ancestor
92121148|NCT01605071|Estradiol|estradiol|mesh-list
92121149|NCT01605071|Estrogens|estrogens|mesh-ancestor
92121150|NCT01605071|Hormones|hormones|mesh-ancestor
92121151|NCT01605071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121152|NCT01605071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121153|NCT04345198|Epinephrine|epinephrine|mesh-list
92121154|NCT04345198|Racepinephrine|racepinephrine|mesh-list
92121155|NCT04345198|Epinephryl borate|epinephryl borate|mesh-list
92121156|NCT04345198|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92121157|NCT04345198|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92121158|NCT04345198|Adrenergic Agents|adrenergic agents|mesh-ancestor
92121159|NCT04345198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121160|NCT04345198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121161|NCT04345198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121162|NCT04345198|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92121163|NCT04345198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92121164|NCT04345198|Autonomic Agents|autonomic agents|mesh-ancestor
92121165|NCT04345198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121166|NCT04345198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92121167|NCT04345198|Respiratory System Agents|respiratory system agents|mesh-ancestor
92121168|NCT04345198|Mydriatics|mydriatics|mesh-ancestor
92121169|NCT04345198|Sympathomimetics|sympathomimetics|mesh-ancestor
92121170|NCT04345198|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92121171|NCT03192618|Leucovorin|leucovorin|mesh-list
92121172|NCT03192618|Oxaliplatin|oxaliplatin|mesh-list
92121173|NCT03192618|Calcium|calcium|mesh-list
92121174|NCT03192618|Levoleucovorin|levoleucovorin|mesh-list
92121175|NCT03192618|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92121176|NCT03192618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121177|NCT03192618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121178|NCT03192618|Antidotes|antidotes|mesh-ancestor
92121179|NCT03192618|Protective Agents|protective agents|mesh-ancestor
92121180|NCT03192618|Vitamin B Complex|vitamin b complex|mesh-ancestor
92121181|NCT03192618|Vitamins|vitamins|mesh-ancestor
92121182|NCT03192618|Micronutrients|micronutrients|mesh-ancestor
92121183|NCT04113226|Rituximab|rituximab|mesh-list
92121184|NCT04113226|Lenalidomide|lenalidomide|mesh-list
92121185|NCT04113226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121186|NCT04113226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121187|NCT04113226|Immunologic Factors|immunologic factors|mesh-ancestor
92121188|NCT04113226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121189|NCT04113226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121190|NCT04113226|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92121191|NCT04113226|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92121192|NCT04113226|Growth Substances|growth substances|mesh-ancestor
92121193|NCT04113226|Growth Inhibitors|growth inhibitors|mesh-ancestor
92121194|NCT02444364|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92121195|NCT02444364|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92121196|NCT02444364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121197|NCT02444364|Incretins|incretins|mesh-ancestor
92121198|NCT02444364|Hormones|hormones|mesh-ancestor
92121199|NCT02444364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121200|NCT02444364|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92121201|NCT02444364|Protease Inhibitors|protease inhibitors|mesh-ancestor
92121202|NCT02444364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121203|NCT02444364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121204|NCT05039476|Vitamin A|vitamin a|mesh-list
92121205|NCT05039476|Vitamins|vitamins|mesh-ancestor
92121206|NCT05039476|Micronutrients|micronutrients|mesh-ancestor
92121207|NCT05039476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121208|NCT00356356|Etanercept|etanercept|mesh-list
92121209|NCT00356356|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92121210|NCT00356356|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121211|NCT00356356|Analgesics|analgesics|mesh-ancestor
92121212|NCT00356356|Sensory System Agents|sensory system agents|mesh-ancestor
92121213|NCT00356356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121214|NCT00356356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121215|NCT00356356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121216|NCT00356356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121217|NCT00356356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121218|NCT00356356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121219|NCT00356356|Immunologic Factors|immunologic factors|mesh-ancestor
92121220|NCT02443818|Sirolimus|sirolimus|mesh-list
92121221|NCT02443818|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92121222|NCT02443818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121223|NCT02443818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121224|NCT02443818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121225|NCT02443818|Antifungal Agents|antifungal agents|mesh-ancestor
92121226|NCT02443818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121227|NCT02443818|Immunologic Factors|immunologic factors|mesh-ancestor
92121228|NCT02443818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121229|NCT01705691|Paclitaxel|paclitaxel|mesh-list
92121230|NCT01705691|Cyclophosphamide|cyclophosphamide|mesh-list
92121231|NCT01705691|Doxorubicin|doxorubicin|mesh-list
92121232|NCT01705691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92121233|NCT01705691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121234|NCT01705691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121235|NCT01705691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121236|NCT01705691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121237|NCT01705691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121238|NCT01705691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121239|NCT01705691|Immunologic Factors|immunologic factors|mesh-ancestor
92121240|NCT01705691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121241|NCT01705691|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121242|NCT01705691|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92121243|NCT01705691|Alkylating Agents|alkylating agents|mesh-ancestor
92121244|NCT01705691|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92121245|NCT01705691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121246|NCT01705691|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92121247|NCT01705691|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92121248|NCT01705691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121249|NCT02450058|Paclitaxel|paclitaxel|mesh-list
92121250|NCT02450058|Cyclophosphamide|cyclophosphamide|mesh-list
92121251|NCT02450058|Fluorouracil|fluorouracil|mesh-list
92121253|NCT02450058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92121254|NCT02450058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121255|NCT02450058|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121256|NCT02450058|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121257|NCT02450058|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121258|NCT02450058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121259|NCT02450058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121260|NCT02450058|Immunologic Factors|immunologic factors|mesh-ancestor
92121261|NCT02450058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121262|NCT02450058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121263|NCT02450058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92121264|NCT02450058|Alkylating Agents|alkylating agents|mesh-ancestor
92121265|NCT02450058|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92121266|NCT02450058|Antimetabolites|antimetabolites|mesh-ancestor
92121267|NCT02450058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92121268|NCT02450058|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121269|NCT02450058|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92121270|NCT02450058|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92121271|NCT02450058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121272|NCT02445300|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92121273|NCT02445300|Laxatives|laxatives|mesh-ancestor
92121274|NCT02445300|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121275|NCT02445066|Vitamin D|vitamin d|mesh-list
92121276|NCT02445066|Cholecalciferol|cholecalciferol|mesh-list
92121277|NCT02445066|Vitamins|vitamins|mesh-ancestor
92121278|NCT02445066|Micronutrients|micronutrients|mesh-ancestor
92121279|NCT02445066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121280|NCT02445066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92121281|NCT02445066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92121282|NCT03197298|Clopidogrel|clopidogrel|mesh-list
92121283|NCT03197298|Ticagrelor|ticagrelor|mesh-list
92121284|NCT03197298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92121285|NCT03197298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92121286|NCT03197298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92121287|NCT03197298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92121288|NCT03197298|Purinergic Agents|purinergic agents|mesh-ancestor
92121289|NCT03197298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121290|NCT03197298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121291|NCT03197298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121292|NCT00357448|Interleukin-2|interleukin-2|mesh-list
92121293|NCT00357448|Denileukin diftitox|denileukin diftitox|mesh-list
92121294|NCT00357448|Immunotoxins|immunotoxins|mesh-list
92121295|NCT00357448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121296|NCT00357448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121297|NCT00357448|Analgesics|analgesics|mesh-ancestor
92121298|NCT00357448|Sensory System Agents|sensory system agents|mesh-ancestor
92121299|NCT00357448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121300|NCT00357448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121301|NCT00357448|Immunoconjugates|immunoconjugates|mesh-ancestor
92121302|NCT00357448|Immunologic Factors|immunologic factors|mesh-ancestor
92121303|NCT05715658|Dabigatran|dabigatran|mesh-list
92121304|NCT05715658|Antithrombins|antithrombins|mesh-ancestor
92121305|NCT05715658|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92121306|NCT05715658|Protease Inhibitors|protease inhibitors|mesh-ancestor
92121307|NCT05715658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121308|NCT05715658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121309|NCT05715658|Anticoagulants|anticoagulants|mesh-ancestor
92121310|NCT02443194|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92121311|NCT02443194|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92121312|NCT02443194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92121313|NCT02443194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121314|NCT02443194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121315|NCT02443194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121316|NCT02443194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121317|NCT02443194|Analgesics|analgesics|mesh-ancestor
92121318|NCT02443194|Sensory System Agents|sensory system agents|mesh-ancestor
92121319|NCT02443194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121320|NCT02443194|Antidepressive Agents|antidepressive agents|mesh-ancestor
92121321|NCT02443194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92121322|NCT02443194|Dopamine Agents|dopamine agents|mesh-ancestor
92121323|NCT03193944|Vitamin D|vitamin d|mesh-list
92121324|NCT03193944|Ergocalciferols|ergocalciferols|mesh-list
92121325|NCT03193944|Cholecalciferol|cholecalciferol|mesh-list
92121326|NCT03193944|Vitamins|vitamins|mesh-list
92121327|NCT03193944|Micronutrients|micronutrients|mesh-ancestor
92121328|NCT03193944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121329|NCT03193944|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92121330|NCT03193944|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92121331|NCT00357604|Ritonavir|ritonavir|mesh-list
92121332|NCT00357604|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92121333|NCT00357604|Moxifloxacin|moxifloxacin|mesh-list
92121334|NCT00357604|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92121335|NCT00357604|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92121336|NCT00357604|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92121337|NCT00357604|Norgestimate|norgestimate|mesh-list
92121338|NCT00357604|Norgestrel|norgestrel|mesh-list
92121339|NCT00357604|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92121340|NCT00357604|Estradiol|estradiol|mesh-list
92121341|NCT00357604|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92079487|NCT00398476|Xhance|xhance|mesh-list
92121342|NCT00357604|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92121343|NCT00357604|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92121346|NCT00357604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121347|NCT00357604|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92121348|NCT00357604|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92121349|NCT00357604|Antiviral Agents|antiviral agents|mesh-ancestor
92121350|NCT00357604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121351|NCT00357604|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92121352|NCT00357604|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92121353|NCT00357604|Estrogens|estrogens|mesh-ancestor
92121354|NCT00357604|Hormones|hormones|mesh-ancestor
92121355|NCT00357604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121356|NCT00357604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121357|NCT00357604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92121358|NCT00357604|Contraceptive Agents|contraceptive agents|mesh-ancestor
92121359|NCT00357604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92121360|NCT00357604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92121361|NCT00357604|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92121362|NCT00357604|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92121363|NCT00357604|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92121364|NCT00357604|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92121365|NCT00357604|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92121366|NCT00357604|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92121367|NCT00357604|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92121368|NCT00357604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121369|NCT03193788|Folic Acid|folic acid|mesh-list
92121370|NCT03193788|Vitamin B 12|vitamin b 12|mesh-list
92121371|NCT03193788|Dexamethasone|dexamethasone|mesh-list
92121372|NCT03193788|Pemetrexed|pemetrexed|mesh-list
92121373|NCT03193788|Vitamins|vitamins|mesh-ancestor
92121374|NCT03193788|Micronutrients|micronutrients|mesh-ancestor
92121375|NCT03193788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121376|NCT03193788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121377|NCT03193788|Antiemetics|antiemetics|mesh-ancestor
92121378|NCT03193788|Autonomic Agents|autonomic agents|mesh-ancestor
92121379|NCT03193788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121380|NCT03193788|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121381|NCT03193788|Glucocorticoids|glucocorticoids|mesh-ancestor
92121382|NCT03193788|Hormones|hormones|mesh-ancestor
92121383|NCT03193788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121384|NCT03193788|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121385|NCT03193788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121386|NCT03193788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121387|NCT03193788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121388|NCT03193788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92121389|NCT03193788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92121390|NCT03193788|Hematinics|hematinics|mesh-ancestor
92121391|NCT03193788|Vitamin B Complex|vitamin b complex|mesh-ancestor
92121392|NCT02442648|Rituximab|rituximab|mesh-list
92121393|NCT02442648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121394|NCT02442648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121395|NCT02442648|Immunologic Factors|immunologic factors|mesh-ancestor
92121396|NCT02442648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121397|NCT02442648|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121398|NCT00356824|Artesunate|artesunate|mesh-list
92121399|NCT00356824|Amodiaquine|amodiaquine|mesh-list
92121400|NCT00356824|Antimalarials|antimalarials|mesh-ancestor
92121401|NCT00356824|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92121402|NCT00356824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92121403|NCT00356824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121404|NCT00356824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121405|NCT00356824|Antiviral Agents|antiviral agents|mesh-ancestor
92121406|NCT00356824|Schistosomicides|schistosomicides|mesh-ancestor
92121407|NCT00356824|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92121408|NCT00356824|Anthelmintics|anthelmintics|mesh-ancestor
92121409|NCT01705145|Ivacaftor|ivacaftor|mesh-list
92121410|NCT01705145|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92121411|NCT01705145|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121412|NCT01705145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121413|NCT03716934|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92121414|NCT04483830|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
92121415|NCT04483830|Anticoagulants|anticoagulants|mesh-ancestor
92121416|NCT04483830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92121417|NCT04483830|Antimetabolites|antimetabolites|mesh-ancestor
92079513|NCT01436643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121418|NCT04483830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121419|NCT04483830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92121421|NCT04483830|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92121422|NCT04483830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92121423|NCT04483830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121424|NCT02442492|Sildenafil Citrate|sildenafil citrate|mesh-list
92121425|NCT02442492|Vasodilator Agents|vasodilator agents|mesh-ancestor
92121426|NCT02442492|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92121427|NCT02442492|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92121428|NCT02442492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121429|NCT02442492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121430|NCT02442492|Urological Agents|urological agents|mesh-ancestor
92121431|NCT01704755|Ribavirin|ribavirin|mesh-list
92121432|NCT01704755|Antimetabolites|antimetabolites|mesh-ancestor
92121433|NCT01704755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121434|NCT01704755|Antiviral Agents|antiviral agents|mesh-ancestor
92121435|NCT01704755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121436|NCT05165550|Elsulfavirine|elsulfavirine|mesh-list
92121437|NCT05165550|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92121438|NCT05165550|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92121439|NCT05165550|Antiviral Agents|antiviral agents|mesh-ancestor
92121440|NCT05165550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121441|NCT04166669|Itraconazole|itraconazole|mesh-list
92121442|NCT04166669|Rifampin|rifampin|mesh-list
92121443|NCT04166669|Antifungal Agents|antifungal agents|mesh-ancestor
92121444|NCT04166669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121445|NCT04166669|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92121446|NCT04166669|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92121447|NCT04166669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121448|NCT04166669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121449|NCT04166669|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92121450|NCT04166669|Hormone Antagonists|hormone antagonists|mesh-ancestor
92121451|NCT04166669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121452|NCT04166669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121453|NCT04166669|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92121454|NCT04166669|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92121455|NCT04166669|Antitubercular Agents|antitubercular agents|mesh-ancestor
92121456|NCT04166669|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92121457|NCT04166669|Leprostatic Agents|leprostatic agents|mesh-ancestor
92121458|NCT04166669|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92121459|NCT04166669|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92121460|NCT04166669|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92121461|NCT04166669|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92121462|NCT04166669|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92121463|NCT04166669|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92121464|NCT04166669|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92121465|NCT03193710|Remifentanil|remifentanil|mesh-list
92121466|NCT03193710|Propofol|propofol|mesh-list
92121467|NCT03193710|Sevoflurane|sevoflurane|mesh-list
92121468|NCT03193710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938659|NCT03692715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121469|NCT03193710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121470|NCT03193710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121471|NCT03193710|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92121472|NCT03193710|Anesthetics, General|anesthetics, general|mesh-ancestor
92121473|NCT03193710|Anesthetics|anesthetics|mesh-ancestor
92121474|NCT03193710|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92121475|NCT03193710|Narcotics|narcotics|mesh-ancestor
92121476|NCT03193710|Analgesics|analgesics|mesh-ancestor
92121477|NCT03193710|Sensory System Agents|sensory system agents|mesh-ancestor
92121478|NCT03193710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121479|NCT03193710|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92121480|NCT03193710|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92121481|NCT01704599|Vitamins|vitamins|mesh-list
92121482|NCT01704599|Folic Acid|folic acid|mesh-list
92121483|NCT01704599|Vitamin B 12|vitamin b 12|mesh-list
92121484|NCT01704599|Pyridoxine|pyridoxine|mesh-list
92121485|NCT01704599|Vitamin B 6|vitamin b 6|mesh-list
92121486|NCT01704599|Vitamin B Complex|vitamin b complex|mesh-list
92121487|NCT01704599|Adalimumab|adalimumab|mesh-list
92121488|NCT01704599|Micronutrients|micronutrients|mesh-ancestor
92121489|NCT01704599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121490|NCT01704599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92121491|NCT01704599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121492|NCT01704599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121493|NCT01704599|Hematinics|hematinics|mesh-ancestor
92121494|NCT03196362|Metformin|metformin|mesh-list
92121495|NCT03196362|Pioglitazone|pioglitazone|mesh-list
92121496|NCT03196362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92121497|NCT03196362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121499|NCT02449278|Cyclophosphamide|cyclophosphamide|mesh-list
92121500|NCT02449278|Doxorubicin|doxorubicin|mesh-list
92121501|NCT02449278|Vincristine|vincristine|mesh-list
92121502|NCT02449278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121503|NCT02449278|Immunologic Factors|immunologic factors|mesh-ancestor
92121504|NCT02449278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121505|NCT02449278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121506|NCT02449278|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92121507|NCT02449278|Alkylating Agents|alkylating agents|mesh-ancestor
92121508|NCT02449278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121509|NCT02449278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121510|NCT02449278|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92121511|NCT02449278|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121512|NCT02449278|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92121513|NCT02449278|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92121514|NCT02449278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121515|NCT02449278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121516|NCT02449278|Glucocorticoids|glucocorticoids|mesh-ancestor
92121517|NCT02449278|Hormones|hormones|mesh-ancestor
92121518|NCT02449278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121519|NCT02449278|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121520|NCT02449278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92121521|NCT02449278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121522|NCT02449278|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121523|NCT02449278|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121524|NCT03599518|Gefitinib|gefitinib|mesh-list
92121525|NCT03599518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121526|NCT03599518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92121527|NCT03599518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121528|NCT03599518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121529|NCT03099486|Leucovorin|leucovorin|mesh-list
92121530|NCT03099486|Antidotes|antidotes|mesh-ancestor
92121531|NCT03099486|Protective Agents|protective agents|mesh-ancestor
92121532|NCT03099486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121533|NCT03099486|Vitamin B Complex|vitamin b complex|mesh-ancestor
92121534|NCT03099486|Vitamins|vitamins|mesh-ancestor
92121535|NCT03099486|Micronutrients|micronutrients|mesh-ancestor
92121536|NCT00358228|Rimonabant|rimonabant|mesh-list
92121537|NCT00358228|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92121538|NCT00358228|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92121539|NCT00358228|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92121540|NCT00358228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121541|NCT00358228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121542|NCT00358228|Hormones|hormones|mesh-ancestor
92121543|NCT00358228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121544|NCT00358228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121545|NCT05710198|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92121546|NCT05710198|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92121547|NCT05710198|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92121548|NCT05710198|Nootropic Agents|nootropic agents|mesh-ancestor
92121549|NCT05709028|Fosfomycin|fosfomycin|mesh-list
92121550|NCT05709028|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92121551|NCT05709028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121552|NCT01336530|Oxethazaine|oxethazaine|mesh-list
92121553|NCT01336530|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92121555|NCT01336530|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92121556|NCT01336530|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92121557|NCT01336530|Immunologic Factors|immunologic factors|mesh-ancestor
92121558|NCT01336530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121559|NCT01336530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121560|NCT01336530|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121562|NCT01336530|Anesthetics|anesthetics|mesh-ancestor
92121563|NCT01336530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121564|NCT01336530|Sensory System Agents|sensory system agents|mesh-ancestor
92121565|NCT01336530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121566|NCT00777348|Reproterol|reproterol|mesh-list
92121567|NCT00777348|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92121568|NCT00777348|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92121569|NCT00777348|Adrenergic Agents|adrenergic agents|mesh-ancestor
92121570|NCT00777348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079663|NCT01793272|Pentoxifylline|pentoxifylline|mesh-list
92121571|NCT00777348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121572|NCT00777348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121573|NCT00777348|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92121575|NCT00777348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121576|NCT00777348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92121577|NCT00777348|Respiratory System Agents|respiratory system agents|mesh-ancestor
92121578|NCT03836560|Nicotine|nicotine|mesh-list
92121579|NCT03836560|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92121580|NCT03836560|Autonomic Agents|autonomic agents|mesh-ancestor
92121581|NCT03836560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121582|NCT03836560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121583|NCT03836560|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92121584|NCT03836560|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92121585|NCT03836560|Cholinergic Agents|cholinergic agents|mesh-ancestor
92121586|NCT03836560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121587|NCT03836560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121588|NCT04483596|Melatonin|melatonin|mesh-list
92121589|NCT04483596|Antioxidants|antioxidants|mesh-ancestor
92121590|NCT04483596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121591|NCT04483596|Protective Agents|protective agents|mesh-ancestor
92121592|NCT04483596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121593|NCT04483596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121594|NCT05721586|Listerine|listerine|mesh-list
92121595|NCT05721586|Fluorides|fluorides|mesh-list
92121596|NCT05721586|Fluorides, Topical|fluorides, topical|mesh-list
92121597|NCT05721586|Sodium Fluoride|sodium fluoride|mesh-list
92121598|NCT05721586|Cariostatic Agents|cariostatic agents|mesh-ancestor
92121599|NCT05721586|Protective Agents|protective agents|mesh-ancestor
92121600|NCT05721586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121601|NCT05721586|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92121602|NCT05721586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121603|NCT02978482|Durvalumab|durvalumab|mesh-list
92121604|NCT02978482|Tremelimumab|tremelimumab|mesh-list
92121605|NCT02978482|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92121606|NCT02978482|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121607|NCT02978482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121608|NCT02978482|Immunologic Factors|immunologic factors|mesh-ancestor
92121609|NCT02978482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121610|NCT00357682|Aspirin|aspirin|mesh-list
92121611|NCT00357682|Esomeprazole|esomeprazole|mesh-list
92121612|NCT00357682|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92121613|NCT00357682|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121614|NCT00357682|Analgesics|analgesics|mesh-ancestor
92121615|NCT00357682|Sensory System Agents|sensory system agents|mesh-ancestor
92121616|NCT00357682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121617|NCT00357682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121618|NCT00357682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121619|NCT00357682|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121620|NCT00357682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92121621|NCT00357682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92121622|NCT00357682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121623|NCT00357682|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92121624|NCT00357682|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92121625|NCT00357682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121626|NCT00357682|Antipyretics|antipyretics|mesh-ancestor
92121627|NCT00357682|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92121628|NCT00357682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121629|NCT00357682|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92121631|NCT00105027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92121632|NCT00105027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92121633|NCT00105027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92121634|NCT00105027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121635|NCT00105027|Glucocorticoids|glucocorticoids|mesh-ancestor
92121637|NCT00105027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121638|NCT00105027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121639|NCT00105027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121640|NCT00105027|Immunologic Factors|immunologic factors|mesh-ancestor
92121641|NCT00105027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121642|NCT00105027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121643|NCT03145012|Ranitidine|ranitidine|mesh-list
92121644|NCT03145012|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92079737|NCT00416494|Growth Substances|growth substances|mesh-ancestor
92121645|NCT03145012|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92121646|NCT03145012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121647|NCT03145012|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92121648|NCT03145012|Histamine Antagonists|histamine antagonists|mesh-ancestor
92121649|NCT03145012|Histamine Agents|histamine agents|mesh-ancestor
92121650|NCT03145012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939437|NCT04875767|Coal Tar|coal tar|mesh-list
92121651|NCT03145012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121652|NCT03145012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121653|NCT03832660|Valsartan|valsartan|mesh-list
92121654|NCT03832660|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92121655|NCT03832660|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92121656|NCT03832660|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92121657|NCT03832660|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92121658|NCT03832660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121659|NCT00030147|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92121660|NCT00030147|Estradiol|estradiol|mesh-list
92121661|NCT00030147|Estrogens|estrogens|mesh-ancestor
92121662|NCT00030147|Hormones|hormones|mesh-ancestor
92121663|NCT00030147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121664|NCT00030147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121665|NCT00030147|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92121666|NCT00030147|Hormone Antagonists|hormone antagonists|mesh-ancestor
92121667|NCT00030147|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92121668|NCT00030147|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92121669|NCT00030147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92121670|NCT02709486|Tanezumab|tanezumab|mesh-list
92121671|NCT02709486|Analgesics|analgesics|mesh-ancestor
92121672|NCT02709486|Sensory System Agents|sensory system agents|mesh-ancestor
92121673|NCT02709486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121674|NCT02709486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121675|NCT00106431|Romidepsin|romidepsin|mesh-list
92121676|NCT00106431|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121677|NCT00106431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121678|NCT00106431|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92121679|NCT00106431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121680|NCT00106431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121681|NCT03107416|Bumetanide|bumetanide|mesh-list
92121682|NCT03107416|Diuretics|diuretics|mesh-ancestor
92121683|NCT03107416|Natriuretic Agents|natriuretic agents|mesh-ancestor
92121684|NCT03107416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121685|NCT03107416|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92121686|NCT03107416|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121687|NCT03107416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121688|NCT02439996|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92121689|NCT02439996|gamma-Globulins|gamma-globulins|mesh-list
92121690|NCT02439996|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92121691|NCT02439996|Immunologic Factors|immunologic factors|mesh-ancestor
92121692|NCT02439996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121693|NCT03833596|Prednisone|prednisone|mesh-list
92121694|NCT03833596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121695|NCT03833596|Glucocorticoids|glucocorticoids|mesh-ancestor
92121696|NCT03833596|Hormones|hormones|mesh-ancestor
92121697|NCT03833596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121698|NCT03833596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121699|NCT03833596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121700|NCT03833596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121702|NCT02831998|Chlorhexidine|chlorhexidine|mesh-list
92121703|NCT02831998|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92121704|NCT02831998|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92121705|NCT02831998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121706|NCT02831998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121707|NCT02831998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121708|NCT02831998|Disinfectants|disinfectants|mesh-ancestor
92121709|NCT02831998|Dermatologic Agents|dermatologic agents|mesh-ancestor
92121710|NCT02434614|Cisplatin|cisplatin|mesh-list
92121711|NCT02434614|Docetaxel|docetaxel|mesh-list
92121712|NCT02434614|Fluorouracil|fluorouracil|mesh-list
92121713|NCT02434614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121714|NCT02434614|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121715|NCT02434614|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121716|NCT02434614|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121717|NCT02434614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121718|NCT02434614|Antimetabolites|antimetabolites|mesh-ancestor
92121719|NCT02434614|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92121721|NCT02434614|Immunologic Factors|immunologic factors|mesh-ancestor
92121722|NCT02434614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121723|NCT05720260|Durvalumab|durvalumab|mesh-list
92121724|NCT05720260|Fulvestrant|fulvestrant|mesh-list
92121725|NCT05720260|Goserelin|goserelin|mesh-list
92144075|NCT02570503|Anesthetics, Local|anesthetics, local|mesh-ancestor
92121726|NCT05720260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121727|NCT05720260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121728|NCT05720260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121729|NCT05720260|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92121730|NCT05720260|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92121731|NCT05720260|Hormone Antagonists|hormone antagonists|mesh-ancestor
92121732|NCT05720260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121733|NCT05720260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121734|NCT05720026|Docetaxel|docetaxel|mesh-list
92121735|NCT05720026|Trastuzumab|trastuzumab|mesh-list
92121736|NCT05720026|Pertuzumab|pertuzumab|mesh-list
92121737|NCT05720026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121738|NCT05720026|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121739|NCT05720026|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121740|NCT05720026|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121741|NCT05720026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121742|NCT05720026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121743|NCT04483674|Tenofovir|tenofovir|mesh-list
92121744|NCT04483674|Emtricitabine|emtricitabine|mesh-list
92121745|NCT04483674|Antiviral Agents|antiviral agents|mesh-ancestor
92121746|NCT04483674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121747|NCT04483674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92121748|NCT04483674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92121749|NCT04483674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121750|NCT04483674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121751|NCT04483674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92121752|NCT04483674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92121753|NCT02438982|Rituximab|rituximab|mesh-list
92121754|NCT02438982|Tacrolimus|tacrolimus|mesh-list
92121755|NCT02438982|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92121756|NCT02438982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121757|NCT02438982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121758|NCT02438982|Immunologic Factors|immunologic factors|mesh-ancestor
92121759|NCT02438982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121760|NCT02438982|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121761|NCT02438982|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121762|NCT02438982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121763|NCT02438982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121764|NCT02425774|Prucalopride|prucalopride|mesh-list
92121765|NCT02425774|Laxatives|laxatives|mesh-ancestor
92121766|NCT02425774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938662|NCT03558789|Lactoferrin|lactoferrin|mesh-list
92121767|NCT02425774|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92121768|NCT02425774|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92121769|NCT02425774|Serotonin Agents|serotonin agents|mesh-ancestor
92121770|NCT02425774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121771|NCT02425774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121772|NCT02425774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121773|NCT02420002|Nitrous Oxide|nitrous oxide|mesh-list
92121774|NCT02420002|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92121775|NCT02420002|Anesthetics, General|anesthetics, general|mesh-ancestor
92121776|NCT02420002|Anesthetics|anesthetics|mesh-ancestor
92121777|NCT02420002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121778|NCT02420002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121779|NCT02420002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121780|NCT02420002|Analgesics|analgesics|mesh-ancestor
92121781|NCT02420002|Sensory System Agents|sensory system agents|mesh-ancestor
92121782|NCT02420002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121783|NCT03187626|Botulinum Toxins|botulinum toxins|mesh-list
92121784|NCT03187626|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92121785|NCT03187626|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92121786|NCT03187626|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92121787|NCT03187626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121788|NCT03187626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121789|NCT03187626|Cholinergic Agents|cholinergic agents|mesh-ancestor
92121790|NCT03187626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121791|NCT03187626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121792|NCT03187626|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92121793|NCT03187626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121794|NCT03117894|Acetaminophen|acetaminophen|mesh-list
92121795|NCT03117894|Etoricoxib|etoricoxib|mesh-list
92121796|NCT03117894|Morphine|morphine|mesh-list
92121797|NCT03117894|Remifentanil|remifentanil|mesh-list
92121798|NCT03117894|Ondansetron|ondansetron|mesh-list
92121799|NCT03117894|Propofol|propofol|mesh-list
92121800|NCT03117894|Ropivacaine|ropivacaine|mesh-list
92121801|NCT03117894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92121802|NCT03117894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121803|NCT03117894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121804|NCT03117894|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92121805|NCT03117894|Anesthetics, General|anesthetics, general|mesh-ancestor
92121806|NCT03117894|Anesthetics|anesthetics|mesh-ancestor
92121807|NCT03117894|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92121808|NCT03117894|Narcotics|narcotics|mesh-ancestor
92121809|NCT03117894|Analgesics|analgesics|mesh-ancestor
92121810|NCT03117894|Sensory System Agents|sensory system agents|mesh-ancestor
92121811|NCT03117894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121812|NCT03117894|Anesthetics, Local|anesthetics, local|mesh-ancestor
92121813|NCT03117894|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121814|NCT03117894|Antipyretics|antipyretics|mesh-ancestor
92121815|NCT03117894|Antiemetics|antiemetics|mesh-ancestor
92121816|NCT03117894|Autonomic Agents|autonomic agents|mesh-ancestor
92121817|NCT03117894|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92121818|NCT03117894|Antipruritics|antipruritics|mesh-ancestor
92121819|NCT03117894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92121820|NCT03117894|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92121821|NCT03117894|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92121822|NCT03117894|Serotonin Agents|serotonin agents|mesh-ancestor
92121823|NCT03117894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121824|NCT03117894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121825|NCT03117894|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92121826|NCT03117894|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121827|NCT03117894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92121828|NCT03117894|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92121829|NCT03117894|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92121830|NCT03117894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121831|NCT00357292|Azithromycin|azithromycin|mesh-list
92121832|NCT00357292|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92121833|NCT00357292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121834|NCT05625802|Ropivacaine|ropivacaine|mesh-list
92121835|NCT05625802|Anesthetics, Local|anesthetics, local|mesh-ancestor
92121836|NCT05625802|Anesthetics|anesthetics|mesh-ancestor
92121837|NCT05625802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121838|NCT05625802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121839|NCT05625802|Sensory System Agents|sensory system agents|mesh-ancestor
92121840|NCT05625802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121842|NCT03187548|Caseins|caseins|mesh-list
92121843|NCT03187548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92121844|NCT03187548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121846|NCT03187548|Sequestering Agents|sequestering agents|mesh-ancestor
92121847|NCT03187548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121848|NCT02042326|Sirolimus|sirolimus|mesh-list
92121849|NCT02042326|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92121850|NCT02042326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121851|NCT02042326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121852|NCT02042326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121853|NCT02042326|Antifungal Agents|antifungal agents|mesh-ancestor
92121854|NCT02042326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121855|NCT02042326|Immunologic Factors|immunologic factors|mesh-ancestor
92121856|NCT02042326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121858|NCT05718544|Dexmedetomidine|dexmedetomidine|mesh-list
92121859|NCT05718544|Esketamine|esketamine|mesh-list
92121860|NCT05718544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92121861|NCT05718544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121862|NCT05718544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121863|NCT05718544|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92121864|NCT05718544|Analgesics|analgesics|mesh-ancestor
92121865|NCT05718544|Sensory System Agents|sensory system agents|mesh-ancestor
92121866|NCT05718544|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121867|NCT05718544|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92079974|NCT00455962|Estradiol|estradiol|mesh-list
92121868|NCT05718544|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92121869|NCT05718544|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92121870|NCT05718544|Adrenergic Agents|adrenergic agents|mesh-ancestor
92121871|NCT05718544|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121872|NCT05718544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121873|NCT05718544|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92121874|NCT05718544|Narcotics|narcotics|mesh-ancestor
92121875|NCT05718544|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92121876|NCT05718544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92121877|NCT05718544|Anesthetics, General|anesthetics, general|mesh-ancestor
92121878|NCT05718544|Anesthetics|anesthetics|mesh-ancestor
92121879|NCT05718544|Antidepressive Agents|antidepressive agents|mesh-ancestor
92121880|NCT05718544|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92121881|NCT05616598|Ribavirin|ribavirin|mesh-list
92121882|NCT05616598|Sofosbuvir|sofosbuvir|mesh-list
92121883|NCT05616598|Simeprevir|simeprevir|mesh-list
92121884|NCT05616598|Antimetabolites|antimetabolites|mesh-ancestor
92121885|NCT05616598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121886|NCT05616598|Antiviral Agents|antiviral agents|mesh-ancestor
92121887|NCT05616598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92121888|NCT05616598|Protease Inhibitors|protease inhibitors|mesh-ancestor
92121889|NCT05616598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121890|NCT03187392|Lidocaine|lidocaine|mesh-list
92121891|NCT03187392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92121892|NCT03187392|Anesthetics|anesthetics|mesh-ancestor
92121893|NCT03187392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121894|NCT03187392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121895|NCT03187392|Sensory System Agents|sensory system agents|mesh-ancestor
92121896|NCT03187392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92121897|NCT03187392|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92121898|NCT03187392|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92121899|NCT03187392|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92121900|NCT03187392|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121901|NCT03187392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121902|NCT01464268|Riboflavin|riboflavin|mesh-list
92121903|NCT01464268|Dextrans|dextrans|mesh-list
92121904|NCT01464268|Vitamin B Complex|vitamin b complex|mesh-ancestor
92121905|NCT01464268|Vitamins|vitamins|mesh-ancestor
92121906|NCT01464268|Micronutrients|micronutrients|mesh-ancestor
92121907|NCT01464268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121908|NCT01464268|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92121909|NCT01464268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92121910|NCT01464268|Anticoagulants|anticoagulants|mesh-ancestor
92121911|NCT01464268|Plasma Substitutes|plasma substitutes|mesh-ancestor
92121912|NCT01464268|Blood Substitutes|blood substitutes|mesh-ancestor
92121914|NCT00215787|Dexlansoprazole|dexlansoprazole|mesh-list
92121915|NCT00215787|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92121916|NCT00215787|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938666|NCT00890591|Olmesartan|olmesartan|mesh-list
92121917|NCT00215787|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92121918|NCT00215787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121919|NCT00215787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121921|NCT05716906|Antioxidants|antioxidants|mesh-ancestor
92121922|NCT05716906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121923|NCT05716906|Protective Agents|protective agents|mesh-ancestor
92121924|NCT05716906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121925|NCT05716906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92121926|NCT00216099|Folic Acid|folic acid|mesh-list
92121927|NCT00216099|Vitamin B 12|vitamin b 12|mesh-list
92121928|NCT00216099|Hydroxocobalamin|hydroxocobalamin|mesh-list
92121929|NCT00216099|Pemetrexed|pemetrexed|mesh-list
92121930|NCT00216099|Vitamins|vitamins|mesh-ancestor
92121931|NCT00216099|Micronutrients|micronutrients|mesh-ancestor
92121932|NCT00216099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121933|NCT00216099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121934|NCT00216099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121935|NCT00216099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121936|NCT00216099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92121937|NCT00216099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92121938|NCT00216099|Hematinics|hematinics|mesh-ancestor
92121939|NCT00216099|Vitamin B Complex|vitamin b complex|mesh-ancestor
92121940|NCT04565925|Sildenafil Citrate|sildenafil citrate|mesh-list
92121941|NCT04565925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121942|NCT04565925|Vasodilator Agents|vasodilator agents|mesh-ancestor
92121943|NCT04565925|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92121944|NCT04565925|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92121945|NCT04565925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121946|NCT04565925|Urological Agents|urological agents|mesh-ancestor
92121947|NCT00039195|Prednisone|prednisone|mesh-list
92121948|NCT00039195|Cyclophosphamide|cyclophosphamide|mesh-list
92121949|NCT00039195|Ifosfamide|ifosfamide|mesh-list
92121950|NCT00039195|Rituximab|rituximab|mesh-list
92121951|NCT00039195|Carboplatin|carboplatin|mesh-list
92121952|NCT00039195|Doxorubicin|doxorubicin|mesh-list
92121953|NCT00039195|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92121954|NCT00039195|Etoposide|etoposide|mesh-list
92121955|NCT00039195|Vincristine|vincristine|mesh-list
92121956|NCT00039195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92121957|NCT00039195|Immunologic Factors|immunologic factors|mesh-ancestor
92121958|NCT00039195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121960|NCT00039195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92121961|NCT00039195|Alkylating Agents|alkylating agents|mesh-ancestor
92121962|NCT00039195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121963|NCT00039195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92121964|NCT00039195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92121965|NCT00039195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92121966|NCT00039195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92121967|NCT00039195|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92121968|NCT00039195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92121969|NCT00039195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92121970|NCT00039195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92121971|NCT00039195|Glucocorticoids|glucocorticoids|mesh-ancestor
92121972|NCT00039195|Hormones|hormones|mesh-ancestor
92121973|NCT00039195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92121974|NCT00039195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92121975|NCT00039195|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92121976|NCT00039195|Tubulin Modulators|tubulin modulators|mesh-ancestor
92121977|NCT00039195|Antimitotic Agents|antimitotic agents|mesh-ancestor
92121978|NCT00039195|Mitosis Modulators|mitosis modulators|mesh-ancestor
92121979|NCT05591170|Cholecalciferol|cholecalciferol|mesh-list
92121980|NCT05591170|Vitamin D|vitamin d|mesh-list
92121981|NCT05591170|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92121982|NCT05591170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121983|NCT05591170|Vitamins|vitamins|mesh-ancestor
92121984|NCT05591170|Micronutrients|micronutrients|mesh-ancestor
92121985|NCT05591170|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92121986|NCT00218439|Paroxetine|paroxetine|mesh-list
92121987|NCT00218439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92121988|NCT00218439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92121989|NCT00218439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92121990|NCT00218439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92121991|NCT00218439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92121992|NCT00218439|Serotonin Agents|serotonin agents|mesh-ancestor
92121993|NCT00218439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92121994|NCT00218439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92121995|NCT00218439|Antidepressive Agents|antidepressive agents|mesh-ancestor
92121996|NCT00218439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92121997|NCT00218439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92121998|NCT00218439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92121999|NCT00218439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122000|NCT04344730|Dexamethasone|dexamethasone|mesh-list
92122001|NCT04344730|Dexamethasone acetate|dexamethasone acetate|mesh-list
92122002|NCT04344730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122003|NCT04344730|Antiemetics|antiemetics|mesh-ancestor
92122004|NCT04344730|Autonomic Agents|autonomic agents|mesh-ancestor
92122005|NCT04344730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122006|NCT04344730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122007|NCT04344730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122008|NCT04344730|Glucocorticoids|glucocorticoids|mesh-ancestor
92122009|NCT04344730|Hormones|hormones|mesh-ancestor
92122010|NCT04344730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122011|NCT04344730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122012|NCT04344730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122013|NCT05716672|Lazertinib|lazertinib|mesh-list
92122014|NCT05716672|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122015|NCT05716672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122016|NCT05716672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122017|NCT00358384|Betamethasone|betamethasone|mesh-list
92122018|NCT00358384|Betamethasone Valerate|betamethasone valerate|mesh-list
92122019|NCT00358384|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92122020|NCT00358384|Betamethasone benzoate|betamethasone benzoate|mesh-list
92122021|NCT00358384|Calcipotriene|calcipotriene|mesh-list
92122022|NCT00358384|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92122023|NCT00358384|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122024|NCT00358384|Glucocorticoids|glucocorticoids|mesh-ancestor
92122025|NCT00358384|Hormones|hormones|mesh-ancestor
92122026|NCT00358384|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122027|NCT00358384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122028|NCT00358384|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92122029|NCT00358384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92122030|NCT00358384|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122031|NCT02959060|Rifampin|rifampin|mesh-list
92122032|NCT02959060|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92122033|NCT02959060|Antitubercular Agents|antitubercular agents|mesh-ancestor
92122034|NCT02959060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122035|NCT02959060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122036|NCT02959060|Leprostatic Agents|leprostatic agents|mesh-ancestor
92122037|NCT02959060|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92122038|NCT02959060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122039|NCT02959060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122040|NCT02959060|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92122041|NCT02959060|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92122042|NCT02959060|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92122043|NCT02959060|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92122044|NCT02959060|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92122045|NCT02959060|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92122046|NCT00109005|Lenalidomide|lenalidomide|mesh-list
92122047|NCT00109005|Immunologic Factors|immunologic factors|mesh-ancestor
92122048|NCT00109005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122049|NCT00109005|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92122050|NCT00109005|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92122051|NCT00109005|Growth Substances|growth substances|mesh-ancestor
92122052|NCT00109005|Growth Inhibitors|growth inhibitors|mesh-ancestor
92122053|NCT00109005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122054|NCT05552950|Antiviral Agents|antiviral agents|mesh-list
92122055|NCT05552950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122056|NCT05547100|Olanzapine|olanzapine|mesh-list
92122057|NCT05547100|Antiemetics|antiemetics|mesh-ancestor
92122058|NCT05547100|Autonomic Agents|autonomic agents|mesh-ancestor
92122059|NCT05547100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122060|NCT05547100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122061|NCT05547100|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122062|NCT05547100|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92122063|NCT05547100|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92122064|NCT05547100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122065|NCT05547100|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92122066|NCT05547100|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92122067|NCT05547100|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92122068|NCT05547100|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122069|NCT05547100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122070|NCT05547100|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122071|NCT05547100|Serotonin Agents|serotonin agents|mesh-ancestor
92122073|NCT00109473|Hormones|hormones|mesh-list
92122074|NCT00109473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122075|NCT00109473|Glucocorticoids|glucocorticoids|mesh-ancestor
92122076|NCT00109473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122077|NCT00109473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122078|NCT00109473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122079|NCT00109473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122081|NCT05136976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122082|NCT05136976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122083|NCT05136976|Immunologic Factors|immunologic factors|mesh-ancestor
92122084|NCT05136976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122085|NCT05136976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122086|NCT00044655|Olanzapine|olanzapine|mesh-list
92122087|NCT00044655|Risperidone|risperidone|mesh-list
92122088|NCT00044655|Aripiprazole|aripiprazole|mesh-list
92122089|NCT00044655|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92122090|NCT00044655|Ziprasidone|ziprasidone|mesh-list
92122091|NCT00044655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92122092|NCT00044655|Serotonin Agents|serotonin agents|mesh-ancestor
92122093|NCT00044655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122094|NCT00044655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122095|NCT00044655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080193|NCT00381862|Oxaliplatin|oxaliplatin|mesh-list
92122096|NCT00044655|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92122097|NCT00044655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92122098|NCT00044655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122099|NCT00044655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92122100|NCT00044655|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92122101|NCT00044655|Dopamine Agents|dopamine agents|mesh-ancestor
92122102|NCT00044655|Antiemetics|antiemetics|mesh-ancestor
92122103|NCT00044655|Autonomic Agents|autonomic agents|mesh-ancestor
92122104|NCT00044655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122105|NCT00044655|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122106|NCT00044655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92144076|NCT02570503|Anesthetics|anesthetics|mesh-ancestor
92122107|NCT00044655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92122108|NCT00044655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122109|NCT00044655|Antidepressive Agents|antidepressive agents|mesh-ancestor
92122110|NCT00044655|Dopamine Agonists|dopamine agonists|mesh-ancestor
92122111|NCT00044655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92122112|NCT00044655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92122113|NCT00044655|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92122114|NCT00044655|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92122115|NCT05130892|Tranilast|tranilast|mesh-list
92122116|NCT05130892|Colchicine|colchicine|mesh-list
92122117|NCT05130892|Gout Suppressants|gout suppressants|mesh-ancestor
92122118|NCT05130892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122119|NCT05130892|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122120|NCT05130892|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122121|NCT05130892|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122122|NCT05130892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122123|NCT05130892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122124|NCT05130892|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92122125|NCT05130892|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92122126|NCT05130892|Analgesics|analgesics|mesh-ancestor
92122127|NCT05130892|Sensory System Agents|sensory system agents|mesh-ancestor
92122128|NCT05130892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122129|NCT05130892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122130|NCT05130892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122131|NCT05130892|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92122132|NCT05130892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122133|NCT05130892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92122134|NCT05130892|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92122135|NCT05130892|Histamine Antagonists|histamine antagonists|mesh-ancestor
92122136|NCT05130892|Histamine Agents|histamine agents|mesh-ancestor
92122137|NCT05130892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122138|NCT05130892|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92122139|NCT05130892|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92122140|NCT00223665|Leuprolide|leuprolide|mesh-list
92122141|NCT00223665|Flutamide|flutamide|mesh-list
92122142|NCT00223665|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92122143|NCT00223665|Fertility Agents|fertility agents|mesh-ancestor
92122144|NCT00223665|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92122145|NCT00223665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122146|NCT00223665|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122147|NCT00223665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122148|NCT00223665|Androgen Antagonists|androgen antagonists|mesh-ancestor
92122149|NCT00223665|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122150|NCT00223665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122151|NCT05311540|Zinc Sulfate|zinc sulfate|mesh-list
92122152|NCT05311540|Astringents|astringents|mesh-ancestor
92122153|NCT05311540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122154|NCT05311540|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122155|NCT00223821|Oxybutynin|oxybutynin|mesh-list
92122156|NCT00223821|Parasympatholytics|parasympatholytics|mesh-ancestor
92122157|NCT00223821|Autonomic Agents|autonomic agents|mesh-ancestor
92122158|NCT00223821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122159|NCT00223821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122160|NCT00223821|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92122161|NCT00223821|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92122162|NCT00223821|Cholinergic Agents|cholinergic agents|mesh-ancestor
92122163|NCT00223821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122164|NCT00223821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122165|NCT00223821|Urological Agents|urological agents|mesh-ancestor
92122166|NCT00359164|Bevacizumab|bevacizumab|mesh-list
92122167|NCT00359164|Verteporfin|verteporfin|mesh-list
92122168|NCT00359164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122169|NCT00359164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080275|NCT00383266|Carboplatin|carboplatin|mesh-list
92122170|NCT00359164|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92122171|NCT00359164|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92122172|NCT00359164|Growth Substances|growth substances|mesh-ancestor
92122173|NCT00359164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122174|NCT00359164|Growth Inhibitors|growth inhibitors|mesh-ancestor
92122175|NCT00359164|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92122176|NCT00359164|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122178|NCT00224289|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92122179|NCT00224289|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92122180|NCT00045435|Cyclosporine|cyclosporine|mesh-list
92122181|NCT00045435|Mycophenolic Acid|mycophenolic acid|mesh-list
92122185|NCT00045435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122186|NCT00045435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92122187|NCT00045435|Antimetabolites|antimetabolites|mesh-ancestor
92122188|NCT00045435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122189|NCT00045435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92122190|NCT00045435|Immunologic Factors|immunologic factors|mesh-ancestor
92122191|NCT00045435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122192|NCT00045435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122193|NCT00045435|Antifungal Agents|antifungal agents|mesh-ancestor
92122194|NCT00045435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122195|NCT00045435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122196|NCT00045435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122197|NCT00045435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92122198|NCT00045435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92122199|NCT00045435|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92122200|NCT00045435|Antitubercular Agents|antitubercular agents|mesh-ancestor
92122201|NCT00045435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122202|NCT00111657|Rasburicase|rasburicase|mesh-list
92122203|NCT00111657|Gout Suppressants|gout suppressants|mesh-ancestor
92122204|NCT00111657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122206|NCT05292586|Formoterol Fumarate|formoterol fumarate|mesh-list
92122207|NCT05292586|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92122208|NCT05292586|Autonomic Agents|autonomic agents|mesh-ancestor
92122209|NCT05292586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122210|NCT05292586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122211|NCT05292586|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92122212|NCT05292586|Respiratory System Agents|respiratory system agents|mesh-ancestor
91938669|NCT00890591|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92122213|NCT05292586|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92122214|NCT05292586|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92122216|NCT05292586|Adrenergic Agents|adrenergic agents|mesh-ancestor
92122217|NCT05292586|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122218|NCT05292586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122219|NCT05292586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122220|NCT05292586|Glucocorticoids|glucocorticoids|mesh-ancestor
92122221|NCT05292586|Hormones|hormones|mesh-ancestor
92122222|NCT05292586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122223|NCT02097303|Prednisone|prednisone|mesh-list
92122224|NCT02097303|Abiraterone Acetate|abiraterone acetate|mesh-list
92122225|NCT02097303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92122226|NCT02097303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122227|NCT02097303|Glucocorticoids|glucocorticoids|mesh-ancestor
92122228|NCT02097303|Hormones|hormones|mesh-ancestor
92122229|NCT02097303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122230|NCT02097303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122231|NCT02097303|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122232|NCT02097303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122233|NCT02097303|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92122234|NCT02097303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122235|NCT02097303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122236|NCT02097303|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122237|NCT02097303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92122239|NCT00703326|Ramucirumab|ramucirumab|mesh-list
92122240|NCT00703326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122241|NCT00703326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122242|NCT00703326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122243|NCT00703326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122244|NCT00703326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122245|NCT02097537|Methacholine Chloride|methacholine chloride|mesh-list
92122247|NCT02097537|Autonomic Agents|autonomic agents|mesh-ancestor
92122248|NCT02097537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122249|NCT02097537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122250|NCT02097537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92122251|NCT02097537|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92122252|NCT02097537|Respiratory System Agents|respiratory system agents|mesh-ancestor
92122253|NCT02097537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92122254|NCT02097537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92122255|NCT02097537|Cholinergic Agents|cholinergic agents|mesh-ancestor
92122256|NCT02097537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122257|NCT02097537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122258|NCT02097849|Interferons|interferons|mesh-list
92122259|NCT02097849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92122260|NCT02097849|Vaccines|vaccines|mesh-list
92122261|NCT02097849|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92122263|NCT02097849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122264|NCT02097849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122265|NCT02097849|Antiviral Agents|antiviral agents|mesh-ancestor
92122266|NCT02097849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122267|NCT02097849|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122268|NCT02097849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92122269|NCT00047697|Donepezil|donepezil|mesh-list
92122270|NCT00047697|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92122271|NCT00047697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122272|NCT00047697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122273|NCT00047697|Cholinergic Agents|cholinergic agents|mesh-ancestor
92122274|NCT00047697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122275|NCT00047697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122276|NCT00047697|Nootropic Agents|nootropic agents|mesh-ancestor
92122277|NCT05094154|Penicillins|penicillins|mesh-list
92122278|NCT05094154|Cephalosporins|cephalosporins|mesh-list
92122279|NCT05094154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122280|NCT05094154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122281|NCT02437812|Metformin|metformin|mesh-list
92122282|NCT02437812|Paclitaxel|paclitaxel|mesh-list
92122283|NCT02437812|Carboplatin|carboplatin|mesh-list
92122284|NCT02437812|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92122285|NCT02437812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122286|NCT02437812|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122287|NCT02437812|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122288|NCT02437812|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122289|NCT02437812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122290|NCT02437812|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92122291|NCT02437812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122292|NCT00112593|Cyclosporine|cyclosporine|mesh-list
92122293|NCT00112593|Mycophenolic Acid|mycophenolic acid|mesh-list
92122294|NCT00112593|Fludarabine|fludarabine|mesh-list
92122295|NCT00112593|Fludarabine phosphate|fludarabine phosphate|mesh-list
92122296|NCT00112593|Cyclosporins|cyclosporins|mesh-list
92122297|NCT00112593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122298|NCT00112593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92122299|NCT00112593|Antimetabolites|antimetabolites|mesh-ancestor
92122300|NCT00112593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122301|NCT00112593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92122302|NCT00112593|Immunologic Factors|immunologic factors|mesh-ancestor
92122303|NCT00112593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122304|NCT00112593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122305|NCT00112593|Antifungal Agents|antifungal agents|mesh-ancestor
92122306|NCT00112593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122307|NCT00112593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122308|NCT00112593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122309|NCT00112593|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92122310|NCT00112593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92122311|NCT00112593|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92122312|NCT00112593|Antitubercular Agents|antitubercular agents|mesh-ancestor
92122313|NCT00112593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122314|NCT05280106|Citric Acid|citric acid|mesh-list
92122315|NCT05280106|Sodium Citrate|sodium citrate|mesh-list
92122316|NCT05280106|Dialysis Solutions|dialysis solutions|mesh-list
92122317|NCT05280106|Anticoagulants|anticoagulants|mesh-ancestor
92122318|NCT05280106|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92122319|NCT05280106|Chelating Agents|chelating agents|mesh-ancestor
92122320|NCT05280106|Sequestering Agents|sequestering agents|mesh-ancestor
92122321|NCT05280106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122322|NCT05280106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92122323|NCT00112671|Sorafenib|sorafenib|mesh-list
92122324|NCT00112671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122325|NCT00112671|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122326|NCT00112671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122327|NCT00112671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122328|NCT05279092|Dexamethasone|dexamethasone|mesh-list
92122329|NCT05279092|Methylprednisolone|methylprednisolone|mesh-list
92122330|NCT05279092|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92122331|NCT05279092|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92122332|NCT05279092|Prednisolone|prednisolone|mesh-list
92122333|NCT05279092|Prednisolone acetate|prednisolone acetate|mesh-list
92122334|NCT05279092|Dexamethasone acetate|dexamethasone acetate|mesh-list
92122335|NCT05279092|Bupivacaine|bupivacaine|mesh-list
92122336|NCT05279092|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92122337|NCT05279092|Prednisolone phosphate|prednisolone phosphate|mesh-list
92122338|NCT05279092|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92122339|NCT05279092|BB 1101|bb 1101|mesh-list
92122340|NCT05279092|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122343|NCT05279092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122344|NCT05279092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122345|NCT05279092|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122346|NCT05279092|Glucocorticoids|glucocorticoids|mesh-ancestor
92122347|NCT05279092|Hormones|hormones|mesh-ancestor
92122348|NCT05279092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122349|NCT05279092|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122350|NCT05279092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122351|NCT05279092|Anesthetics, Local|anesthetics, local|mesh-ancestor
92122353|NCT05279092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122354|NCT05279092|Sensory System Agents|sensory system agents|mesh-ancestor
92122355|NCT05279092|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92122356|NCT05279092|Protective Agents|protective agents|mesh-ancestor
92122357|NCT05279092|Protease Inhibitors|protease inhibitors|mesh-ancestor
92122358|NCT05279092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122359|NCT05279092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122360|NCT02437656|Metformin|metformin|mesh-list
92122361|NCT02437656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92122362|NCT02437656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122363|NCT05273632|Tranexamic Acid|tranexamic acid|mesh-list
92122364|NCT05273632|Oxytocin|oxytocin|mesh-list
92122366|NCT05273632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92122367|NCT05273632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122368|NCT05273632|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92122369|NCT05273632|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92122370|NCT05273632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122371|NCT05273632|Hemostatics|hemostatics|mesh-ancestor
92122372|NCT05273632|Coagulants|coagulants|mesh-ancestor
92122373|NCT02429622|Paclitaxel|paclitaxel|mesh-list
92122374|NCT02429622|Nedaplatin|nedaplatin|mesh-list
92122375|NCT02429622|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92122376|NCT02429622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122377|NCT02429622|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122378|NCT02429622|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122379|NCT02429622|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122380|NCT02429622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122381|NCT02429466|Guadecitabine|guadecitabine|mesh-list
92122382|NCT02429466|Azacitidine|azacitidine|mesh-list
92122383|NCT02429466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122384|NCT02429466|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92122385|NCT02429466|Antimetabolites|antimetabolites|mesh-ancestor
92122386|NCT02429466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122387|NCT02429466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122388|NCT02429388|Sodium Channel Blockers|sodium channel blockers|mesh-list
92122389|NCT02429388|Spironolactone|spironolactone|mesh-list
92122390|NCT02429388|Diuretics|diuretics|mesh-list
92122391|NCT02429388|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-list
92122392|NCT02429388|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92122393|NCT02429388|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122394|NCT02429388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122395|NCT02429388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122396|NCT02429388|Natriuretic Agents|natriuretic agents|mesh-ancestor
92122397|NCT02429388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122398|NCT02429388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122399|NCT02429232|Pioglitazone|pioglitazone|mesh-list
92122400|NCT02429232|Linagliptin|linagliptin|mesh-list
92122401|NCT02429232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92122402|NCT02429232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122403|NCT02429232|Incretins|incretins|mesh-ancestor
92122405|NCT02429232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122406|NCT02429232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92122407|NCT02429232|Protease Inhibitors|protease inhibitors|mesh-ancestor
92122408|NCT02429232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122409|NCT02429232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122410|NCT03189732|Metformin|metformin|mesh-list
92122411|NCT03189732|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92122412|NCT03189732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122413|NCT02437032|Menotropins|menotropins|mesh-list
92122414|NCT02437032|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92122415|NCT02437032|Fertility Agents|fertility agents|mesh-ancestor
92122416|NCT02437032|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92122417|NCT02437032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122418|NCT05232994|Metformin|metformin|mesh-list
92122419|NCT05232994|Esomeprazole|esomeprazole|mesh-list
92122421|NCT05232994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122422|NCT05232994|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92122423|NCT05232994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122424|NCT05232994|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92122425|NCT05232994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122426|NCT05232994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122427|NCT02436798|Ondansetron|ondansetron|mesh-list
92122428|NCT02436798|Antiemetics|antiemetics|mesh-ancestor
92122429|NCT02436798|Autonomic Agents|autonomic agents|mesh-ancestor
92122430|NCT02436798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122431|NCT02436798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122432|NCT02436798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122433|NCT02436798|Antipruritics|antipruritics|mesh-ancestor
92122434|NCT02436798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122435|NCT02436798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92122436|NCT02436798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92122437|NCT02436798|Serotonin Agents|serotonin agents|mesh-ancestor
92122438|NCT02436798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122439|NCT02436798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122440|NCT03185130|Diphenhydramine|diphenhydramine|mesh-list
92122441|NCT03185130|Promethazine|promethazine|mesh-list
92122442|NCT03185130|Prochlorperazine|prochlorperazine|mesh-list
92122443|NCT03185130|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92122444|NCT03185130|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92122445|NCT03185130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122446|NCT03185130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122447|NCT03185130|Anesthetics, Local|anesthetics, local|mesh-ancestor
92122448|NCT03185130|Anesthetics|anesthetics|mesh-ancestor
92122449|NCT03185130|Sensory System Agents|sensory system agents|mesh-ancestor
92122450|NCT03185130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122451|NCT03185130|Antiemetics|antiemetics|mesh-ancestor
92122452|NCT03185130|Autonomic Agents|autonomic agents|mesh-ancestor
92122453|NCT03185130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122454|NCT03185130|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92122455|NCT03185130|Histamine Antagonists|histamine antagonists|mesh-ancestor
92122456|NCT03185130|Histamine Agents|histamine agents|mesh-ancestor
92122457|NCT03185130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122458|NCT03185130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122459|NCT03185130|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92122460|NCT03185130|Antipruritics|antipruritics|mesh-ancestor
92122461|NCT03185130|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122462|NCT03185130|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92122463|NCT03185130|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92122464|NCT03185130|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92122465|NCT03185130|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92122466|NCT03185130|Dopamine Agents|dopamine agents|mesh-ancestor
92122467|NCT00358618|Propofol|propofol|mesh-list
92122468|NCT00358618|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92122469|NCT00358618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122470|NCT00358618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122471|NCT00358618|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92122472|NCT00358618|Anesthetics, General|anesthetics, general|mesh-ancestor
92122473|NCT00358618|Anesthetics|anesthetics|mesh-ancestor
92122478|NCT02428764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92122479|NCT02428764|Antimetabolites|antimetabolites|mesh-ancestor
92122480|NCT02428764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122481|NCT02428764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122482|NCT00358696|Tenofovir|tenofovir|mesh-list
92122483|NCT00358696|Antiviral Agents|antiviral agents|mesh-ancestor
92122484|NCT00358696|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122486|NCT00358696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92122487|NCT00358696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122488|NCT00358696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122489|NCT00358696|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92122490|NCT00358696|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92122491|NCT05429476|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92122492|NCT05429476|Plasminogen|plasminogen|mesh-list
92122493|NCT05429476|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92122494|NCT05429476|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92122495|NCT05429476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122496|NCT00360178|Amlodipine|amlodipine|mesh-list
92122497|NCT00360178|Valsartan|valsartan|mesh-list
92122498|NCT00360178|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92122499|NCT00360178|Candesartan|candesartan|mesh-list
92122500|NCT00360178|Candesartan cilexetil|candesartan cilexetil|mesh-list
92122501|NCT00360178|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92122502|NCT00360178|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92122503|NCT00360178|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122504|NCT00360178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122505|NCT00360178|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92122506|NCT00360178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122507|NCT00360178|Vasodilator Agents|vasodilator agents|mesh-ancestor
92122508|NCT00360178|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92122509|NCT00360178|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92122510|NCT00360178|Diuretics|diuretics|mesh-ancestor
92122511|NCT00360178|Natriuretic Agents|natriuretic agents|mesh-ancestor
92122512|NCT00360178|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92122513|NCT00421720|Sufentanil|sufentanil|mesh-list
92122514|NCT00421720|Remifentanil|remifentanil|mesh-list
92122515|NCT00421720|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92122516|NCT00421720|Narcotics|narcotics|mesh-ancestor
92122517|NCT00421720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122518|NCT00421720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122519|NCT00421720|Analgesics|analgesics|mesh-ancestor
92122520|NCT00421720|Sensory System Agents|sensory system agents|mesh-ancestor
92122521|NCT00421720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122522|NCT00421720|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92122523|NCT00421720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92122524|NCT00421720|Anesthetics, General|anesthetics, general|mesh-ancestor
92122525|NCT00421720|Anesthetics|anesthetics|mesh-ancestor
92122529|NCT05008276|Dextrans|dextrans|mesh-list
92122530|NCT05008276|Anticoagulants|anticoagulants|mesh-ancestor
92122531|NCT05008276|Plasma Substitutes|plasma substitutes|mesh-ancestor
92122532|NCT05008276|Blood Substitutes|blood substitutes|mesh-ancestor
92122533|NCT00358930|Beta-lapachone|beta-lapachone|mesh-list
92122534|NCT00358930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122535|NCT00358930|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92122536|NCT00358930|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92122537|NCT00358930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122538|NCT00358930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122539|NCT00358930|Antiviral Agents|antiviral agents|mesh-ancestor
92122540|NCT04492306|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92122541|NCT04492306|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92122542|NCT04492306|Protective Agents|protective agents|mesh-ancestor
92122543|NCT04492306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122544|NCT04492306|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92122545|NCT04492306|Antioxidants|antioxidants|mesh-ancestor
92122546|NCT04492306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122547|NCT04941898|Factor VIII|factor viii|mesh-list
92122549|NCT04941898|Coagulants|coagulants|mesh-ancestor
92122551|NCT04468360|Brexanolone|brexanolone|mesh-list
92122552|NCT04468360|Anesthetics|anesthetics|mesh-ancestor
92122553|NCT04468360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122554|NCT04468360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122555|NCT04468360|Neurosteroids|neurosteroids|mesh-ancestor
92122556|NCT04468360|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122557|NCT04468360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122558|NCT04468360|GABA Modulators|gaba modulators|mesh-ancestor
92122559|NCT04468360|GABA Agents|gaba agents|mesh-ancestor
92122560|NCT02977312|Imatinib Mesylate|imatinib mesylate|mesh-list
92122561|NCT02977312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122562|NCT02977312|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122563|NCT02977312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122564|NCT02977312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122565|NCT04907110|Niacinamide|niacinamide|mesh-list
92122566|NCT04907110|Vitamin B Complex|vitamin b complex|mesh-ancestor
92122567|NCT04907110|Vitamins|vitamins|mesh-ancestor
92122568|NCT04907110|Micronutrients|micronutrients|mesh-ancestor
92122569|NCT04907110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122570|NCT04394416|Imatinib Mesylate|imatinib mesylate|mesh-list
92122571|NCT04394416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122572|NCT04394416|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122573|NCT04394416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122574|NCT04394416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122575|NCT04887298|Annamycin|annamycin|mesh-list
92122576|NCT04887298|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92122577|NCT04887298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122578|NCT02977000|Propranolol|propranolol|mesh-list
92122579|NCT02977000|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92122580|NCT02977000|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92122581|NCT02977000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92122582|NCT02977000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122583|NCT02977000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122584|NCT02977000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122585|NCT02977000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92122586|NCT02977000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92122587|NCT02977000|Vasodilator Agents|vasodilator agents|mesh-ancestor
92122588|NCT02975986|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
92122589|NCT02975986|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92122590|NCT02975986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122591|NCT00112827|Cyclophosphamide|cyclophosphamide|mesh-list
92122592|NCT00112827|Melphalan|melphalan|mesh-list
92122593|NCT00112827|Lenalidomide|lenalidomide|mesh-list
92122594|NCT00112827|Lenograstim|lenograstim|mesh-list
92122595|NCT00112827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92122596|NCT00112827|Immunologic Factors|immunologic factors|mesh-ancestor
92122597|NCT00112827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122598|NCT00112827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122599|NCT00112827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92122600|NCT00112827|Alkylating Agents|alkylating agents|mesh-ancestor
92122601|NCT00112827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122602|NCT00112827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122603|NCT00112827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92122604|NCT00112827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92122605|NCT00112827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92122606|NCT00112827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92122607|NCT00112827|Growth Substances|growth substances|mesh-ancestor
92122608|NCT00112827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92122609|NCT04752111|Esmolol|esmolol|mesh-list
92122610|NCT04752111|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92122611|NCT04752111|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92122612|NCT04752111|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92122613|NCT04752111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92122614|NCT04752111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122615|NCT04752111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122616|NCT04752111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122617|NCT04343170|Folic Acid|folic acid|mesh-list
92122618|NCT04343170|Vitamin B 12|vitamin b 12|mesh-list
92122619|NCT04343170|Hydroxocobalamin|hydroxocobalamin|mesh-list
92122620|NCT04343170|Epoetin Alfa|epoetin alfa|mesh-list
92122621|NCT04343170|Vitamins|vitamins|mesh-ancestor
92122622|NCT04343170|Micronutrients|micronutrients|mesh-ancestor
92080715|NCT00529126|Anesthetics|anesthetics|mesh-ancestor
92122623|NCT04343170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122624|NCT04343170|Hematinics|hematinics|mesh-ancestor
92122625|NCT04343170|Vitamin B Complex|vitamin b complex|mesh-ancestor
92122626|NCT00226239|Docetaxel|docetaxel|mesh-list
92122627|NCT00226239|Cetuximab|cetuximab|mesh-list
92122628|NCT00226239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122629|NCT00226239|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122630|NCT00226239|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122631|NCT00226239|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122632|NCT00226239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122633|NCT00226239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122634|NCT00227019|Vitamins|vitamins|mesh-list
92122635|NCT00227019|Folic Acid|folic acid|mesh-list
92122636|NCT00227019|Vitamin B 12|vitamin b 12|mesh-list
92122637|NCT00227019|Vitamin B Complex|vitamin b complex|mesh-list
92122638|NCT00227019|Dexamethasone|dexamethasone|mesh-list
92122639|NCT00227019|Bevacizumab|bevacizumab|mesh-list
92122640|NCT00227019|Pemetrexed|pemetrexed|mesh-list
92122641|NCT00227019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122642|NCT00227019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122643|NCT00227019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92122644|NCT00227019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92122645|NCT00227019|Growth Substances|growth substances|mesh-ancestor
92122646|NCT00227019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122647|NCT00227019|Growth Inhibitors|growth inhibitors|mesh-ancestor
92122648|NCT00227019|Micronutrients|micronutrients|mesh-ancestor
92122649|NCT00227019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92122650|NCT00227019|Antiemetics|antiemetics|mesh-ancestor
92122651|NCT00227019|Autonomic Agents|autonomic agents|mesh-ancestor
92122652|NCT00227019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122653|NCT00227019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122654|NCT00227019|Glucocorticoids|glucocorticoids|mesh-ancestor
92122655|NCT00227019|Hormones|hormones|mesh-ancestor
92122656|NCT00227019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122657|NCT00227019|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92122658|NCT00227019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122659|NCT00227019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122660|NCT00227019|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92122661|NCT00227019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92122662|NCT00227019|Hematinics|hematinics|mesh-ancestor
92122663|NCT00113217|Bevacizumab|bevacizumab|mesh-list
92122664|NCT00113217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122665|NCT00113217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122666|NCT00113217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92122667|NCT00113217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92122668|NCT00113217|Growth Substances|growth substances|mesh-ancestor
92122669|NCT00113217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122670|NCT00113217|Growth Inhibitors|growth inhibitors|mesh-ancestor
92122672|NCT04718116|Tapentadol|tapentadol|mesh-list
92122673|NCT04718116|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92122674|NCT04718116|Narcotics|narcotics|mesh-ancestor
92122675|NCT04718116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122676|NCT04718116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122677|NCT04718116|Analgesics|analgesics|mesh-ancestor
92122678|NCT04718116|Sensory System Agents|sensory system agents|mesh-ancestor
92122679|NCT04718116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122680|NCT04718116|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92122681|NCT04718116|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92122682|NCT04718116|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122683|NCT04718116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122684|NCT04718116|Adrenergic Agents|adrenergic agents|mesh-ancestor
92122685|NCT04718116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122686|NCT04429503|Aflibercept|aflibercept|mesh-list
92122687|NCT04429503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92122688|NCT04429503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92122689|NCT04429503|Growth Substances|growth substances|mesh-ancestor
92122690|NCT04429503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122691|NCT04429503|Growth Inhibitors|growth inhibitors|mesh-ancestor
92122692|NCT04429503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122693|NCT04276792|Analgesics, Opioid|analgesics, opioid|mesh-list
92122694|NCT04276792|Narcotics|narcotics|mesh-ancestor
92122695|NCT04276792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122696|NCT04276792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122697|NCT04276792|Analgesics|analgesics|mesh-ancestor
92122698|NCT04276792|Sensory System Agents|sensory system agents|mesh-ancestor
92122699|NCT04276792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122700|NCT00053703|Olanzapine|olanzapine|mesh-list
92122701|NCT00053703|Risperidone|risperidone|mesh-list
92122703|NCT00053703|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92122704|NCT00053703|Serotonin Agents|serotonin agents|mesh-ancestor
92122705|NCT00053703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122706|NCT00053703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122707|NCT00053703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122708|NCT00053703|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92122709|NCT00053703|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92122710|NCT00053703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122711|NCT00053703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92122712|NCT00053703|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92122713|NCT00053703|Dopamine Agents|dopamine agents|mesh-ancestor
92122714|NCT00053703|Antiemetics|antiemetics|mesh-ancestor
92122715|NCT00053703|Autonomic Agents|autonomic agents|mesh-ancestor
92122716|NCT00053703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122717|NCT00053703|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92122718|NCT00053703|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92122719|NCT00053703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92122720|NCT00053703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122721|NCT02975440|Rifampin|rifampin|mesh-list
92122722|NCT02975440|Midazolam|midazolam|mesh-list
92122723|NCT02975440|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92122724|NCT02975440|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92122725|NCT02975440|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122726|NCT02975440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122727|NCT02975440|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92122728|NCT02975440|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92122729|NCT02975440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92122730|NCT02975440|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92122731|NCT02975440|Anesthetics, General|anesthetics, general|mesh-ancestor
92122732|NCT02975440|Anesthetics|anesthetics|mesh-ancestor
92122733|NCT02975440|GABA Modulators|gaba modulators|mesh-ancestor
92122734|NCT02975440|GABA Agents|gaba agents|mesh-ancestor
92122735|NCT02975440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122736|NCT02975440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122737|NCT02975440|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92122738|NCT02975440|Antitubercular Agents|antitubercular agents|mesh-ancestor
92122739|NCT02975440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122740|NCT02975440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122741|NCT02975440|Leprostatic Agents|leprostatic agents|mesh-ancestor
92122742|NCT02975440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92122743|NCT02975440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122744|NCT02975440|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92122745|NCT02975440|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92122746|NCT02975440|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92122747|NCT02975440|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92122748|NCT02975440|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92122749|NCT02975440|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92122751|NCT00231309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92122752|NCT00231309|Immunologic Factors|immunologic factors|mesh-ancestor
92122753|NCT00231309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122754|NCT04267120|Pembrolizumab|pembrolizumab|mesh-list
92122755|NCT04267120|Lenvatinib|lenvatinib|mesh-list
92122756|NCT04267120|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122757|NCT04267120|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122758|NCT04267120|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92122759|NCT04267120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122760|NCT04267120|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122761|NCT04267120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122762|NCT04265872|Pembrolizumab|pembrolizumab|mesh-list
92122763|NCT04265872|Bortezomib|bortezomib|mesh-list
92122764|NCT04265872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122765|NCT04265872|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122766|NCT04265872|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92122767|NCT04265872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122768|NCT00232479|Carboplatin|carboplatin|mesh-list
92122769|NCT00232479|Docetaxel|docetaxel|mesh-list
92122770|NCT00232479|Trastuzumab|trastuzumab|mesh-list
92122771|NCT00232479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122772|NCT00232479|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122773|NCT00232479|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122774|NCT00232479|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122775|NCT00232479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080863|NCT04075149|Diuretics|diuretics|mesh-ancestor
92122776|NCT00232479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122777|NCT04710628|Pembrolizumab|pembrolizumab|mesh-list
92122778|NCT04710628|Lenvatinib|lenvatinib|mesh-list
92122779|NCT04710628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122780|NCT04710628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122781|NCT04710628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92122782|NCT04710628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122783|NCT04710628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122784|NCT04710628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122785|NCT00233103|Sertraline|sertraline|mesh-list
92122786|NCT00233103|Antidepressive Agents|antidepressive agents|mesh-ancestor
92122787|NCT00233103|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92122788|NCT00233103|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92122789|NCT00233103|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92122790|NCT00233103|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122791|NCT00233103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122792|NCT00233103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122793|NCT00233103|Serotonin Agents|serotonin agents|mesh-ancestor
92122794|NCT00233103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122795|NCT00703014|Progesterone|progesterone|mesh-list
92122796|NCT00703014|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92122797|NCT00703014|Ganirelix|ganirelix|mesh-list
92122798|NCT00703014|Progestins|progestins|mesh-ancestor
92122799|NCT00703014|Hormones|hormones|mesh-ancestor
92122800|NCT00703014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122801|NCT00703014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122802|NCT00703014|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122803|NCT02433522|Rituximab|rituximab|mesh-list
92122804|NCT02433522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92122805|NCT02433522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122806|NCT02433522|Immunologic Factors|immunologic factors|mesh-ancestor
92122807|NCT02433522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122808|NCT02433522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92122810|NCT00118131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122811|NCT00118131|Tubulin Modulators|tubulin modulators|mesh-ancestor
92122812|NCT00118131|Antimitotic Agents|antimitotic agents|mesh-ancestor
92122813|NCT00118131|Mitosis Modulators|mitosis modulators|mesh-ancestor
92122814|NCT00118131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122815|NCT02433912|Acetaminophen|acetaminophen|mesh-list
92122816|NCT02433912|Chlorhexidine|chlorhexidine|mesh-list
92122817|NCT02433912|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92122818|NCT02433912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92122819|NCT02433912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122820|NCT02433912|Disinfectants|disinfectants|mesh-ancestor
92122821|NCT02433912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122822|NCT02433912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92122823|NCT02433912|Analgesics|analgesics|mesh-ancestor
92122824|NCT02433912|Sensory System Agents|sensory system agents|mesh-ancestor
92122825|NCT02433912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122826|NCT02433912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122827|NCT02433912|Antipyretics|antipyretics|mesh-ancestor
92122828|NCT02436486|Moxifloxacin|moxifloxacin|mesh-list
92122829|NCT02436486|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92122830|NCT02436486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122831|NCT02436486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122832|NCT02436486|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92122833|NCT02436486|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92122834|NCT02436486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122835|NCT02436486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122836|NCT02436486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92122837|NCT02436486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122838|NCT02436486|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92122839|NCT02436486|Serotonin Agents|serotonin agents|mesh-ancestor
92122840|NCT02436486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122841|NCT04342858|Listerine|listerine|mesh-list
92122842|NCT04342858|Fluorides|fluorides|mesh-list
92122843|NCT04342858|Sodium Fluoride|sodium fluoride|mesh-list
92122844|NCT04342858|Fluorides, Topical|fluorides, topical|mesh-list
92122845|NCT04342858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122846|NCT04342858|Cariostatic Agents|cariostatic agents|mesh-ancestor
92122847|NCT04342858|Protective Agents|protective agents|mesh-ancestor
92122848|NCT04342858|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92122849|NCT04342858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080944|NCT00542308|Zalutumumab|zalutumumab|mesh-list
92122850|NCT02429076|Propofol|propofol|mesh-list
92122851|NCT02429076|Sevoflurane|sevoflurane|mesh-list
92122852|NCT02429076|Methylphenidate|methylphenidate|mesh-list
92122853|NCT02429076|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92122854|NCT02429076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122855|NCT02429076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122856|NCT02429076|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92122857|NCT02429076|Anesthetics, General|anesthetics, general|mesh-ancestor
92122858|NCT02429076|Anesthetics|anesthetics|mesh-ancestor
92122859|NCT02429076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92122860|NCT02429076|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92122861|NCT02429076|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92122862|NCT02429076|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92122863|NCT02429076|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92122864|NCT02429076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122865|NCT02429076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122866|NCT02429076|Dopamine Agents|dopamine agents|mesh-ancestor
92122867|NCT02429076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122868|NCT00255177|Mifepristone|mifepristone|mesh-list
92122869|NCT00255177|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92122870|NCT00255177|Abortifacient Agents|abortifacient agents|mesh-ancestor
92122871|NCT00255177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92122872|NCT00255177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122873|NCT00255177|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92122874|NCT00255177|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92122875|NCT00255177|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92122876|NCT00255177|Contraceptive Agents|contraceptive agents|mesh-ancestor
92122877|NCT00255177|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92122878|NCT00255177|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92122879|NCT00255177|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122880|NCT00255177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122881|NCT00255177|Luteolytic Agents|luteolytic agents|mesh-ancestor
92122882|NCT00255177|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92122883|NCT00255177|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92122884|NCT04670224|Anesthetics|anesthetics|mesh-list
92122885|NCT04670224|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122886|NCT04670224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122887|NCT00361114|Pyrimethamine|pyrimethamine|mesh-list
92122888|NCT00361114|Sulfadoxine|sulfadoxine|mesh-list
92122889|NCT00361114|Dapsone|dapsone|mesh-list
92122890|NCT00361114|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92122891|NCT00361114|Chlorproguanil|chlorproguanil|mesh-list
92122892|NCT00361114|Antimalarials|antimalarials|mesh-ancestor
92122893|NCT00361114|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92122894|NCT00361114|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92122895|NCT00361114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92122896|NCT00361114|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92122897|NCT00361114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122898|NCT00361114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122899|NCT00361114|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92122900|NCT00361114|Leprostatic Agents|leprostatic agents|mesh-ancestor
92122901|NCT00361114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92122902|NCT00702624|Hormones|hormones|mesh-list
92122903|NCT00702624|Progesterone|progesterone|mesh-list
92122904|NCT00702624|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92122905|NCT00702624|Ganirelix|ganirelix|mesh-list
92122906|NCT00702624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122907|NCT00702624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122908|NCT00702624|Progestins|progestins|mesh-ancestor
92122909|NCT00702624|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122910|NCT03915496|Abrocitinib|abrocitinib|mesh-list
92122911|NCT03915496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92122912|NCT03915496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122913|NCT03915496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122914|NCT00702546|Hormones|hormones|mesh-list
92122915|NCT00702546|Progesterone|progesterone|mesh-list
92122916|NCT00702546|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92122917|NCT00702546|Ganirelix|ganirelix|mesh-list
92122918|NCT00702546|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122919|NCT00702546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122921|NCT00702546|Hormone Antagonists|hormone antagonists|mesh-ancestor
92122922|NCT04648930|Omalizumab|omalizumab|mesh-list
92122923|NCT04648930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92081026|NCT00499408|Vitamin D|vitamin d|mesh-list
92122924|NCT04648930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92122925|NCT04648930|Respiratory System Agents|respiratory system agents|mesh-ancestor
92122926|NCT01372410|Tiotropium Bromide|tiotropium bromide|mesh-list
92122927|NCT01372410|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92122928|NCT01372410|Autonomic Agents|autonomic agents|mesh-ancestor
92122929|NCT01372410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122930|NCT01372410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122931|NCT01372410|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92122932|NCT01372410|Respiratory System Agents|respiratory system agents|mesh-ancestor
92122933|NCT01372410|Parasympatholytics|parasympatholytics|mesh-ancestor
92122934|NCT01372410|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92122935|NCT01372410|Cholinergic Agents|cholinergic agents|mesh-ancestor
92122936|NCT01372410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92122937|NCT01372410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122938|NCT02428686|Epoetin Alfa|epoetin alfa|mesh-list
92122939|NCT02428686|Hematinics|hematinics|mesh-ancestor
92122940|NCT02432976|Insulin|insulin|mesh-list
92122941|NCT02432976|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92122942|NCT02432976|Exenatide|exenatide|mesh-list
92122943|NCT02432976|Insulin Lispro|insulin lispro|mesh-list
92122944|NCT02432976|Incretins|incretins|mesh-list
92122945|NCT02432976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92122946|NCT02432976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122947|NCT02432976|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92122948|NCT02432976|Hormones|hormones|mesh-ancestor
92122949|NCT02432976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92122950|NCT02428374|Clopidogrel|clopidogrel|mesh-list
92122951|NCT02428374|Ticagrelor|ticagrelor|mesh-list
92122952|NCT02428374|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92122953|NCT02428374|Simvastatin|simvastatin|mesh-list
92122954|NCT02428374|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92122955|NCT02428374|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92122956|NCT02428374|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92122957|NCT02428374|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92122958|NCT02428374|Purinergic Agents|purinergic agents|mesh-ancestor
92122959|NCT02428374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144380|NCT03873337|Nicotine|nicotine|mesh-list
92122960|NCT02428374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122961|NCT02428374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122962|NCT02428374|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92122963|NCT02428374|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92122965|NCT02428374|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92122966|NCT02428374|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92122967|NCT02428374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92122968|NCT04614610|Lidocaine|lidocaine|mesh-list
92122969|NCT04614610|Anesthetics, Local|anesthetics, local|mesh-ancestor
92122970|NCT04614610|Anesthetics|anesthetics|mesh-ancestor
92122971|NCT04614610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92122972|NCT04614610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122973|NCT04614610|Sensory System Agents|sensory system agents|mesh-ancestor
92122974|NCT04614610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92122975|NCT04614610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92122976|NCT04614610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92122977|NCT04614610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92122978|NCT04614610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92122979|NCT04614610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92122980|NCT02428218|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92122981|NCT02428218|Dermatologic Agents|dermatologic agents|mesh-ancestor
92122982|NCT02428218|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92122983|NCT02428218|Immunologic Factors|immunologic factors|mesh-ancestor
92122984|NCT02428218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122985|NCT04606576|Insulin|insulin|mesh-list
92122986|NCT04606576|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92122987|NCT04606576|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92122988|NCT04606576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122990|NCT02428062|Dopamine|dopamine|mesh-list
92122991|NCT02428062|Epinephrine|epinephrine|mesh-list
92122992|NCT02428062|Oxymetazoline|oxymetazoline|mesh-list
92122993|NCT02428062|Norepinephrine|norepinephrine|mesh-list
92122994|NCT02428062|Ephedrine|ephedrine|mesh-list
92122995|NCT02428062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92122996|NCT02428062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92122997|NCT02428062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92122998|NCT02428062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92122999|NCT02428062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92123000|NCT02428062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123001|NCT02428062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123002|NCT02428062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92123003|NCT02428062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92123004|NCT02428062|Autonomic Agents|autonomic agents|mesh-ancestor
92123005|NCT02428062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123006|NCT02428062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92123007|NCT02428062|Respiratory System Agents|respiratory system agents|mesh-ancestor
92123009|NCT02428062|Sympathomimetics|sympathomimetics|mesh-ancestor
92123010|NCT02428062|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92123011|NCT02428062|Nasal Decongestants|nasal decongestants|mesh-ancestor
92123012|NCT02428062|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92123013|NCT02428062|Protective Agents|protective agents|mesh-ancestor
92123014|NCT02428062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92123015|NCT02428062|Dopamine Agents|dopamine agents|mesh-ancestor
92123016|NCT04594798|Prednisone|prednisone|mesh-list
92123017|NCT04594798|Cyclophosphamide|cyclophosphamide|mesh-list
92123018|NCT04594798|Rituximab|rituximab|mesh-list
92123019|NCT04594798|Doxorubicin|doxorubicin|mesh-list
92123020|NCT04594798|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92123021|NCT04594798|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123022|NCT04594798|Immunologic Factors|immunologic factors|mesh-ancestor
92123023|NCT04594798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123024|NCT04594798|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123025|NCT04594798|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123026|NCT04594798|Alkylating Agents|alkylating agents|mesh-ancestor
92123027|NCT04594798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123028|NCT04594798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123029|NCT04594798|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92123030|NCT04594798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123031|NCT04594798|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92123032|NCT04594798|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92123033|NCT04594798|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123034|NCT04594798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123035|NCT04594798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123036|NCT04594798|Glucocorticoids|glucocorticoids|mesh-ancestor
92123037|NCT04594798|Hormones|hormones|mesh-ancestor
92123038|NCT04594798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123039|NCT04594798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123040|NCT04594798|Immunoconjugates|immunoconjugates|mesh-ancestor
92123041|NCT02432664|Midazolam|midazolam|mesh-list
92123042|NCT02432664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92123043|NCT02432664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92123044|NCT02432664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123045|NCT02432664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123046|NCT02432664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92123047|NCT02432664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92123048|NCT02432664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92123049|NCT02432664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92123050|NCT02432664|Anesthetics, General|anesthetics, general|mesh-ancestor
92123051|NCT02432664|Anesthetics|anesthetics|mesh-ancestor
92123052|NCT02432664|GABA Modulators|gaba modulators|mesh-ancestor
92123053|NCT02432664|GABA Agents|gaba agents|mesh-ancestor
92123054|NCT02432664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123055|NCT02432664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123056|NCT03189186|Pembrolizumab|pembrolizumab|mesh-list
92123057|NCT03189186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123058|NCT03189186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123059|NCT03189186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92123060|NCT03189186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123061|NCT00361894|Enoxaparin|enoxaparin|mesh-list
92123062|NCT00361894|Rivaroxaban|rivaroxaban|mesh-list
92123063|NCT00361894|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92123064|NCT00361894|Antithrombins|antithrombins|mesh-ancestor
92123065|NCT00361894|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92123066|NCT00361894|Protease Inhibitors|protease inhibitors|mesh-ancestor
92123067|NCT00361894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123068|NCT00361894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123069|NCT00361894|Anticoagulants|anticoagulants|mesh-ancestor
92123070|NCT00361894|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92123071|NCT00361894|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92123072|NCT03185988|Trastuzumab|trastuzumab|mesh-list
92081180|NCT00557362|Natamycin|natamycin|mesh-list
92123073|NCT03185988|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123074|NCT03185988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123075|NCT04550494|Talazoparib|talazoparib|mesh-list
92123076|NCT04550494|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92123077|NCT04550494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123078|NCT04550494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123079|NCT04550494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123081|NCT00361348|Anticoagulants|anticoagulants|mesh-ancestor
92123082|NCT00361348|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92123083|NCT00361348|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92123084|NCT00361348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123085|NCT02431728|Melatonin|melatonin|mesh-list
92123086|NCT02431728|Antioxidants|antioxidants|mesh-ancestor
92123087|NCT02431728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123088|NCT02431728|Protective Agents|protective agents|mesh-ancestor
92123089|NCT02431728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123090|NCT02431728|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123091|NCT04343326|Menthol|menthol|mesh-list
92123092|NCT04343326|Antipruritics|antipruritics|mesh-ancestor
92123093|NCT04343326|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123094|NCT00362206|Simvastatin|simvastatin|mesh-list
92123095|NCT00362206|Pravastatin|pravastatin|mesh-list
92123096|NCT00362206|Fenofibrate|fenofibrate|mesh-list
92123097|NCT00362206|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92123098|NCT00362206|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92123099|NCT00362206|Antimetabolites|antimetabolites|mesh-ancestor
92123100|NCT00362206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123101|NCT00362206|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92123102|NCT00362206|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92123103|NCT00362206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123104|NCT02314468|Glycerol|glycerol|mesh-list
92123105|NCT02314468|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92123106|NCT02314468|Protective Agents|protective agents|mesh-ancestor
92123107|NCT02314468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123108|NCT01704287|Paclitaxel|paclitaxel|mesh-list
92123109|NCT01704287|Carboplatin|carboplatin|mesh-list
92123110|NCT01704287|Pembrolizumab|pembrolizumab|mesh-list
92123111|NCT01704287|Temozolomide|temozolomide|mesh-list
92123112|NCT01704287|Dacarbazine|dacarbazine|mesh-list
92123113|NCT01704287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92123114|NCT01704287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123116|NCT01704287|Antimitotic Agents|antimitotic agents|mesh-ancestor
92123117|NCT01704287|Mitosis Modulators|mitosis modulators|mesh-ancestor
92123118|NCT01704287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123119|NCT01704287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123120|NCT01704287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92123121|NCT01704287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123122|NCT01704287|Alkylating Agents|alkylating agents|mesh-ancestor
92123123|NCT00362752|Norfloxacin|norfloxacin|mesh-list
92123124|NCT00362752|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92123125|NCT00362752|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123126|NCT00362752|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92123127|NCT00362752|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123128|NCT00362752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123129|NCT00362752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123130|NCT00362752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123131|NCT00362752|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92123132|NCT00362752|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92123133|NCT00118209|Prednisone|prednisone|mesh-list
92123134|NCT00118209|Cyclophosphamide|cyclophosphamide|mesh-list
92123135|NCT00118209|Rituximab|rituximab|mesh-list
92123136|NCT00118209|Doxorubicin|doxorubicin|mesh-list
92123137|NCT00118209|Etoposide|etoposide|mesh-list
92123138|NCT00118209|Vincristine|vincristine|mesh-list
92123139|NCT00118209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123140|NCT00118209|Immunologic Factors|immunologic factors|mesh-ancestor
92123141|NCT00118209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123142|NCT00118209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123143|NCT00118209|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123144|NCT00118209|Alkylating Agents|alkylating agents|mesh-ancestor
92123145|NCT00118209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123146|NCT00118209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123147|NCT00118209|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92123148|NCT00118209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123149|NCT00118209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92123150|NCT00118209|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92123151|NCT00118209|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123152|NCT00118209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123153|NCT00118209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123154|NCT00118209|Glucocorticoids|glucocorticoids|mesh-ancestor
92123155|NCT00118209|Hormones|hormones|mesh-ancestor
92123156|NCT00118209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123157|NCT00118209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123158|NCT00118209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92123159|NCT00118209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92123160|NCT00118209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92123161|NCT00118209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92123162|NCT01897779|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92123163|NCT01897779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123164|NCT01897779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123165|NCT01897779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92123166|NCT01897779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123167|NCT04342156|Hydroxychloroquine|hydroxychloroquine|mesh-list
92123168|NCT04342156|Antimalarials|antimalarials|mesh-ancestor
92123169|NCT04342156|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92123170|NCT04342156|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92123171|NCT04342156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123172|NCT04342156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123173|NCT04342156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123174|NCT04342156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123175|NCT01682837|Potassium Citrate|potassium citrate|mesh-list
92123176|NCT01682837|Magnesium citrate|magnesium citrate|mesh-list
92123177|NCT01682837|Citric Acid|citric acid|mesh-list
92123178|NCT01682837|Sodium Citrate|sodium citrate|mesh-list
92123179|NCT01682837|Anticoagulants|anticoagulants|mesh-ancestor
92123180|NCT01682837|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92123181|NCT01682837|Chelating Agents|chelating agents|mesh-ancestor
92123182|NCT01682837|Sequestering Agents|sequestering agents|mesh-ancestor
92123183|NCT01682837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123184|NCT01682837|Diuretics|diuretics|mesh-ancestor
92123185|NCT01682837|Natriuretic Agents|natriuretic agents|mesh-ancestor
92123186|NCT01682837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123187|NCT01682837|Expectorants|expectorants|mesh-ancestor
92123188|NCT01682837|Respiratory System Agents|respiratory system agents|mesh-ancestor
92123189|NCT01682837|Cathartics|cathartics|mesh-ancestor
92123190|NCT01682837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123191|NCT02213068|Mycophenolic Acid|mycophenolic acid|mesh-list
92123192|NCT02213068|Abatacept|abatacept|mesh-list
92123193|NCT02213068|Tacrolimus|tacrolimus|mesh-list
92123194|NCT02213068|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123195|NCT02213068|Immunologic Factors|immunologic factors|mesh-ancestor
92123196|NCT02213068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123197|NCT02213068|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92123198|NCT02213068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123199|NCT02213068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123200|NCT02213068|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92123201|NCT02213068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123202|NCT02213068|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92123203|NCT02213068|Antitubercular Agents|antitubercular agents|mesh-ancestor
92123204|NCT02213068|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92123205|NCT02213068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123206|NCT02213068|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92123207|NCT02213068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123208|NCT02213068|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123209|NCT00702234|Progesterone|progesterone|mesh-list
92123210|NCT00702234|Progestins|progestins|mesh-ancestor
92123211|NCT00702234|Hormones|hormones|mesh-ancestor
92123212|NCT00702234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123213|NCT00702234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123214|NCT04483284|Chlorotrianisene|chlorotrianisene|mesh-list
92123215|NCT04483284|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92123216|NCT04483284|Estrogens|estrogens|mesh-ancestor
92123217|NCT04483284|Hormones|hormones|mesh-ancestor
92123218|NCT04483284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123219|NCT04483284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123220|NCT04483284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123222|NCT00235833|Adalimumab|adalimumab|mesh-list
92123223|NCT00235833|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92123224|NCT00235833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123225|NCT00235833|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081307|NCT00513292|Paclitaxel|paclitaxel|mesh-list
92123226|NCT00255801|Doxorubicin|doxorubicin|mesh-list
92123227|NCT00255801|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92123228|NCT00255801|Bexarotene|bexarotene|mesh-list
92123229|NCT00255801|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92123230|NCT00255801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123231|NCT00255801|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92123232|NCT00255801|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123233|NCT00255801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123234|NCT00255801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123235|NCT02431416|Hormones|hormones|mesh-list
92123236|NCT02431416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123237|NCT02431416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123238|NCT04751955|Capecitabine|capecitabine|mesh-list
92123239|NCT04751955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92123240|NCT04751955|Antimetabolites|antimetabolites|mesh-ancestor
92123241|NCT04751955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123242|NCT04751955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123243|NCT01682759|Metformin|metformin|mesh-list
92123244|NCT01682759|Insulin Glargine|insulin glargine|mesh-list
92123245|NCT01682759|Glimepiride|glimepiride|mesh-list
92123246|NCT01682759|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92123247|NCT01682759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123248|NCT01682759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92123249|NCT01682759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123250|NCT01682759|Immunologic Factors|immunologic factors|mesh-ancestor
92123251|NCT01682681|Topiramate|topiramate|mesh-list
92123252|NCT01682681|Anticonvulsants|anticonvulsants|mesh-ancestor
92123253|NCT01682681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92123254|NCT01682681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123255|NCT01682603|Botulinum Toxins|botulinum toxins|mesh-list
92123256|NCT01682603|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92123257|NCT01682603|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92123258|NCT01682603|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92123259|NCT01682603|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123260|NCT01682603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123261|NCT01682603|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123262|NCT01682603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123263|NCT01682603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123264|NCT01682603|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92123265|NCT01682603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123266|NCT03183024|Benralizumab|benralizumab|mesh-list
92123267|NCT03183024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92123268|NCT03183024|Respiratory System Agents|respiratory system agents|mesh-ancestor
92123269|NCT00240981|Testosterone|testosterone|mesh-list
92123270|NCT00240981|Androgens|androgens|mesh-ancestor
92123271|NCT00240981|Hormones|hormones|mesh-ancestor
92123272|NCT00240981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123273|NCT00240981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123274|NCT01682213|Dabrafenib|dabrafenib|mesh-list
92123275|NCT01682213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123276|NCT01682213|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92123277|NCT01682213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123278|NCT01682213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123279|NCT04134923|Corticosterone|corticosterone|mesh-list
92123280|NCT04134923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123281|NCT02126553|Lenalidomide|lenalidomide|mesh-list
92123282|NCT02126553|Immunologic Factors|immunologic factors|mesh-ancestor
92123283|NCT02126553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123284|NCT02126553|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92123285|NCT02126553|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92123286|NCT02126553|Growth Substances|growth substances|mesh-ancestor
92123287|NCT02126553|Growth Inhibitors|growth inhibitors|mesh-ancestor
92123288|NCT02126553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123289|NCT01703741|Testosterone|testosterone|mesh-list
92123290|NCT01703741|Androgens|androgens|mesh-ancestor
92123292|NCT01703741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123293|NCT01703741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123294|NCT02425176|Botulinum Toxins|botulinum toxins|mesh-list
92123295|NCT02425176|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92123297|NCT02425176|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92123298|NCT02425176|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92123299|NCT02425176|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123300|NCT02425176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123301|NCT02425176|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123302|NCT02425176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123303|NCT02425176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123304|NCT02425176|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92123305|NCT02425176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123306|NCT02430714|Lenvatinib|lenvatinib|mesh-list
92123307|NCT02430714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123308|NCT02430714|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92123309|NCT02430714|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123310|NCT02430714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123311|NCT02425254|Acetaminophen|acetaminophen|mesh-list
92123312|NCT02425254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92123313|NCT02425254|Analgesics|analgesics|mesh-ancestor
92123314|NCT02425254|Sensory System Agents|sensory system agents|mesh-ancestor
92123315|NCT02425254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123316|NCT02425254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123317|NCT02425254|Antipyretics|antipyretics|mesh-ancestor
92123318|NCT02426736|Dexamethasone|dexamethasone|mesh-list
92123319|NCT02426736|Bupivacaine|bupivacaine|mesh-list
92123320|NCT02426736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123321|NCT02426736|Antiemetics|antiemetics|mesh-ancestor
92123322|NCT02426736|Autonomic Agents|autonomic agents|mesh-ancestor
92123323|NCT02426736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123324|NCT02426736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123325|NCT02426736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123326|NCT02426736|Glucocorticoids|glucocorticoids|mesh-ancestor
92123327|NCT02426736|Hormones|hormones|mesh-ancestor
92123328|NCT02426736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123329|NCT02426736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123330|NCT02426736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123331|NCT02426736|Anesthetics, Local|anesthetics, local|mesh-ancestor
92123332|NCT02426736|Anesthetics|anesthetics|mesh-ancestor
92123333|NCT02426736|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123334|NCT02426736|Sensory System Agents|sensory system agents|mesh-ancestor
92123335|NCT03182634|Fulvestrant|fulvestrant|mesh-list
92123336|NCT03182634|Olaparib|olaparib|mesh-list
92123337|NCT03182634|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123338|NCT03182634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123339|NCT03182634|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92123340|NCT03182634|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92123341|NCT03182634|Hormone Antagonists|hormone antagonists|mesh-ancestor
92123342|NCT03182634|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123343|NCT03182634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123344|NCT03182634|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92123345|NCT03182634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123346|NCT03182634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123347|NCT03182322|Insulin|insulin|mesh-list
92123348|NCT03182322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92123349|NCT03182322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123350|NCT03185364|Sildenafil Citrate|sildenafil citrate|mesh-list
92123351|NCT03185364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123352|NCT03185364|Vasodilator Agents|vasodilator agents|mesh-ancestor
92123353|NCT03185364|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92123354|NCT03185364|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92123355|NCT03185364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123356|NCT03185364|Urological Agents|urological agents|mesh-ancestor
92123357|NCT02424552|Vitamin D|vitamin d|mesh-list
92123359|NCT02424552|Vitamins|vitamins|mesh-ancestor
92123360|NCT02424552|Micronutrients|micronutrients|mesh-ancestor
92123361|NCT02424552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123362|NCT02424552|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92123363|NCT02424552|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92123364|NCT03182088|Norepinephrine|norepinephrine|mesh-list
92123365|NCT03182088|Bupivacaine|bupivacaine|mesh-list
92123366|NCT03182088|Anesthetics, Local|anesthetics, local|mesh-ancestor
92123367|NCT03182088|Anesthetics|anesthetics|mesh-ancestor
92123368|NCT03182088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123369|NCT03182088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123370|NCT03182088|Sensory System Agents|sensory system agents|mesh-ancestor
92123371|NCT03182088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123372|NCT03182088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92123373|NCT03182088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92123374|NCT03182088|Adrenergic Agents|adrenergic agents|mesh-ancestor
92123375|NCT03182088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123376|NCT03182088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123377|NCT03182088|Sympathomimetics|sympathomimetics|mesh-ancestor
92123378|NCT03182088|Autonomic Agents|autonomic agents|mesh-ancestor
92123379|NCT03182088|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92123380|NCT02425878|Ulipristal acetate|ulipristal acetate|mesh-list
92123381|NCT02425878|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92123382|NCT02425878|Contraceptive Agents|contraceptive agents|mesh-ancestor
92123383|NCT02425878|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92123384|NCT02425878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123385|NCT02425878|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92123386|NCT02425722|Linaclotide|linaclotide|mesh-list
92123387|NCT02425722|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92123388|NCT02425722|Enzyme Activators|enzyme activators|mesh-ancestor
92123389|NCT02425722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123390|NCT02425722|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123391|NCT03609580|Tamsulosin|tamsulosin|mesh-list
92123392|NCT03609580|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92123393|NCT03609580|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92123394|NCT03609580|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92123395|NCT03609580|Adrenergic Agents|adrenergic agents|mesh-ancestor
92123396|NCT03609580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123397|NCT03609580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123398|NCT03609580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123399|NCT03609580|Urological Agents|urological agents|mesh-ancestor
92123400|NCT02061514|Propofol|propofol|mesh-list
92123401|NCT02061514|Desflurane|desflurane|mesh-list
92123402|NCT02061514|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92123403|NCT02061514|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123404|NCT02061514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123405|NCT02061514|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92123406|NCT02061514|Anesthetics, General|anesthetics, general|mesh-ancestor
92123407|NCT02061514|Anesthetics|anesthetics|mesh-ancestor
92123408|NCT02061514|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92123409|NCT03183492|Vaccines|vaccines|mesh-list
92123410|NCT03183492|Immunologic Factors|immunologic factors|mesh-ancestor
92123411|NCT03183492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123412|NCT02424318|Topiramate|topiramate|mesh-list
92123413|NCT02424318|Anticonvulsants|anticonvulsants|mesh-ancestor
92123414|NCT02424318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92123415|NCT02424318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123416|NCT03179280|Insulin|insulin|mesh-list
92123417|NCT03179280|Insulin Aspart|insulin aspart|mesh-list
92123419|NCT03179280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123420|NCT01681433|Prednisone|prednisone|mesh-list
92123421|NCT01681433|Abiraterone Acetate|abiraterone acetate|mesh-list
92123422|NCT01681433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123423|NCT01681433|Glucocorticoids|glucocorticoids|mesh-ancestor
92123424|NCT01681433|Hormones|hormones|mesh-ancestor
92123425|NCT01681433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123426|NCT01681433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123427|NCT01681433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123428|NCT01681433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123429|NCT01681433|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92123430|NCT01681433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123431|NCT01681433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123432|NCT01681433|Hormone Antagonists|hormone antagonists|mesh-ancestor
92123433|NCT01681433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92123434|NCT01703117|Riluzole|riluzole|mesh-list
92123435|NCT01703117|Anticonvulsants|anticonvulsants|mesh-ancestor
92123436|NCT01703117|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92123437|NCT01703117|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92123438|NCT01703117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123439|NCT01703117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123440|NCT01703117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123441|NCT01703117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92123442|NCT01703117|Protective Agents|protective agents|mesh-ancestor
92123443|NCT01702961|Cytarabine|cytarabine|mesh-list
92123444|NCT01702961|Etoposide|etoposide|mesh-list
92123446|NCT01702961|Melphalan|melphalan|mesh-list
92123447|NCT01702961|Carmustine|carmustine|mesh-list
92123448|NCT01702961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92123449|NCT01702961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123450|NCT01702961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92123451|NCT01702961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123452|NCT01702961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123453|NCT01702961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123454|NCT01702961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92123455|NCT01702961|Antimetabolites|antimetabolites|mesh-ancestor
92123456|NCT01702961|Antiviral Agents|antiviral agents|mesh-ancestor
92123457|NCT01702961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123458|NCT01702961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123459|NCT01702961|Immunologic Factors|immunologic factors|mesh-ancestor
92123460|NCT01702961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123461|NCT01702961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123462|NCT01702961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123463|NCT01702961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123464|NCT01702961|Alkylating Agents|alkylating agents|mesh-ancestor
92123465|NCT01702961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92123466|NCT01702025|Aminophylline|aminophylline|mesh-list
92123467|NCT01702025|Methazolamide|methazolamide|mesh-list
92123468|NCT01702025|Theophylline|theophylline|mesh-list
92123469|NCT01702025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92123470|NCT01702025|Autonomic Agents|autonomic agents|mesh-ancestor
92123471|NCT01702025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123472|NCT01702025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123473|NCT01702025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92123474|NCT01702025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92123475|NCT01702025|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92123476|NCT01702025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123477|NCT01702025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123478|NCT01702025|Vasodilator Agents|vasodilator agents|mesh-ancestor
92123479|NCT01702025|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92123480|NCT01702025|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92123481|NCT01702025|Purinergic Agents|purinergic agents|mesh-ancestor
92123483|NCT01702025|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92123484|NCT01702025|Protective Agents|protective agents|mesh-ancestor
92123485|NCT01702025|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92123487|NCT01702025|Natriuretic Agents|natriuretic agents|mesh-ancestor
92123488|NCT01592747|Memantine|memantine|mesh-list
92123489|NCT01592747|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92123490|NCT01592747|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92123491|NCT01592747|Dopamine Agents|dopamine agents|mesh-ancestor
92123492|NCT01592747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123493|NCT01592747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123494|NCT01592747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123495|NCT01592747|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92123496|NCT01592747|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92123497|NCT02425488|Coal Tar|coal tar|mesh-list
92123498|NCT02425488|Keratolytic Agents|keratolytic agents|mesh-ancestor
92123499|NCT02425488|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123500|NCT02426112|Azithromycin|azithromycin|mesh-list
92123501|NCT02426112|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92123502|NCT02426112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123503|NCT03117192|Zinc Sulfate|zinc sulfate|mesh-list
92123504|NCT03117192|Astringents|astringents|mesh-ancestor
92123505|NCT03117192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123506|NCT03117192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123507|NCT04768439|Vitamin D|vitamin d|mesh-list
92123508|NCT04768439|Ergocalciferols|ergocalciferols|mesh-list
92123509|NCT04768439|Cholecalciferol|cholecalciferol|mesh-list
92123510|NCT04768439|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
92123511|NCT04768439|Calcitriol|calcitriol|mesh-list
92123512|NCT04768439|Vitamins|vitamins|mesh-list
92123513|NCT04768439|Micronutrients|micronutrients|mesh-ancestor
92123514|NCT04768439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123515|NCT04768439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92123516|NCT04768439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92123517|NCT04768439|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92123518|NCT04768439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123519|NCT04768439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123520|NCT04768439|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92123521|NCT02421042|Lenvatinib|lenvatinib|mesh-list
92123522|NCT02421042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123523|NCT02421042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92123525|NCT02421042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123526|NCT03181464|Lidocaine|lidocaine|mesh-list
92123527|NCT03181464|Anesthetics, Local|anesthetics, local|mesh-ancestor
92123528|NCT03181464|Anesthetics|anesthetics|mesh-ancestor
92123529|NCT03181464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123530|NCT03181464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123531|NCT03181464|Sensory System Agents|sensory system agents|mesh-ancestor
92123532|NCT03181464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123533|NCT03181464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92123534|NCT03181464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92123535|NCT03181464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92123536|NCT03181464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123537|NCT03181464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123538|NCT02423928|Cyclophosphamide|cyclophosphamide|mesh-list
92123539|NCT02423928|Ipilimumab|ipilimumab|mesh-list
92123540|NCT02423928|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123541|NCT02423928|Immunologic Factors|immunologic factors|mesh-ancestor
92123542|NCT02423928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123543|NCT02423928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123544|NCT02423928|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123545|NCT02423928|Alkylating Agents|alkylating agents|mesh-ancestor
92123546|NCT02423928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123547|NCT02423928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123548|NCT02423928|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92123549|NCT02423928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123550|NCT02423928|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92123551|NCT02416128|Prednisolone|prednisolone|mesh-list
92123552|NCT02416128|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92123553|NCT02416128|Methylprednisolone|methylprednisolone|mesh-list
92123554|NCT02416128|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92123555|NCT02416128|Prednisolone acetate|prednisolone acetate|mesh-list
92123556|NCT02416128|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92123557|NCT02416128|Prednisolone phosphate|prednisolone phosphate|mesh-list
92123558|NCT02416128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123559|NCT02416128|Glucocorticoids|glucocorticoids|mesh-ancestor
92123561|NCT02416128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123562|NCT02416128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123563|NCT02416128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123564|NCT02416128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123565|NCT02416128|Antiemetics|antiemetics|mesh-ancestor
92123566|NCT02416128|Autonomic Agents|autonomic agents|mesh-ancestor
92123567|NCT02416128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123568|NCT02416128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123569|NCT02416128|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92123570|NCT02416128|Protective Agents|protective agents|mesh-ancestor
92123571|NCT03106740|Minocycline|minocycline|mesh-list
92123572|NCT03106740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92123573|NCT03106740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123574|NCT03106818|Ketorolac|ketorolac|mesh-list
92123575|NCT03106818|Magnesium Sulfate|magnesium sulfate|mesh-list
92123576|NCT03106818|Bupivacaine|bupivacaine|mesh-list
92123577|NCT03106818|Anesthetics, Local|anesthetics, local|mesh-list
92123578|NCT03106818|Anesthetics|anesthetics|mesh-list
92123579|NCT03106818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123580|NCT03106818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123581|NCT03106818|Sensory System Agents|sensory system agents|mesh-ancestor
92123582|NCT03106818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123583|NCT03106818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92123584|NCT03106818|Analgesics|analgesics|mesh-ancestor
92123585|NCT03106818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92123586|NCT03106818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123587|NCT03106818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123588|NCT03106818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92123589|NCT03106818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123590|NCT03106818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123591|NCT03106818|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92123592|NCT03106818|Anticonvulsants|anticonvulsants|mesh-ancestor
92123593|NCT03106818|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92123594|NCT03106818|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123595|NCT03106818|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92123596|NCT03106818|Tocolytic Agents|tocolytic agents|mesh-ancestor
92123598|NCT01592045|Aldesleukin|aldesleukin|mesh-list
92123599|NCT01592045|Molgramostim|molgramostim|mesh-list
92123600|NCT01592045|Dinutuximab|dinutuximab|mesh-list
92123601|NCT01592045|Isotretinoin|isotretinoin|mesh-list
92081873|NCT04033575|Listerine|listerine|mesh-list
92123602|NCT01592045|Sargramostim|sargramostim|mesh-list
92123603|NCT01592045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123604|NCT01592045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92123605|NCT01592045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92123606|NCT01592045|Antiviral Agents|antiviral agents|mesh-ancestor
92123607|NCT01592045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123608|NCT01592045|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123609|NCT01592045|Immunologic Factors|immunologic factors|mesh-ancestor
92123610|NCT01592045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123611|NCT03178656|Sorafenib|sorafenib|mesh-list
92123612|NCT03178656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123613|NCT03178656|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92123614|NCT03178656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123615|NCT03178656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123616|NCT01590797|Metformin|metformin|mesh-list
92123617|NCT01590797|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92123618|NCT01590797|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92123619|NCT01590797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123620|NCT01590797|Incretins|incretins|mesh-ancestor
92123621|NCT01590797|Hormones|hormones|mesh-ancestor
92123622|NCT01590797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123623|NCT01590797|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92123624|NCT01590797|Protease Inhibitors|protease inhibitors|mesh-ancestor
92123625|NCT01590797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123626|NCT01590797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123627|NCT02415192|Amlodipine|amlodipine|mesh-list
92123628|NCT02415192|Valsartan|valsartan|mesh-list
92123629|NCT02415192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92123630|NCT02415192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92123631|NCT02415192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123632|NCT02415192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123633|NCT02415192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92123634|NCT02415192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123635|NCT02415192|Vasodilator Agents|vasodilator agents|mesh-ancestor
92123636|NCT02415192|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92123637|NCT02415192|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92123638|NCT02415270|Menthol|menthol|mesh-list
92123639|NCT02415270|Nicotine|nicotine|mesh-list
92123640|NCT02415270|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92123641|NCT02415270|Autonomic Agents|autonomic agents|mesh-ancestor
92123642|NCT02415270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123643|NCT02415270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123644|NCT02415270|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92123645|NCT02415270|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92123646|NCT02415270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123647|NCT02415270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123648|NCT02415270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123653|NCT02415114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123654|NCT02415114|Protective Agents|protective agents|mesh-ancestor
92123655|NCT02415114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123656|NCT02415114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123657|NCT02415114|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92123658|NCT03178422|Nicotine|nicotine|mesh-list
92123659|NCT03178422|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92123660|NCT03178422|Autonomic Agents|autonomic agents|mesh-ancestor
92123661|NCT03178422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123662|NCT03178422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123663|NCT03178422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92123664|NCT03178422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92123665|NCT03178422|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123666|NCT03178422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123667|NCT03178422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123668|NCT02420496|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92123669|NCT02420496|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92123670|NCT02420496|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123671|NCT02414880|Rocuronium|rocuronium|mesh-list
92123672|NCT02414880|Neostigmine|neostigmine|mesh-list
92123673|NCT02414880|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92123674|NCT02414880|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92123675|NCT02414880|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92123676|NCT02414880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123677|NCT02414880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123678|NCT02414880|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92123679|NCT02414880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123680|NCT02414880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123681|NCT02414880|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123682|NCT02414880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123683|NCT02414880|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92123684|NCT02414880|Autonomic Agents|autonomic agents|mesh-ancestor
92123685|NCT02423694|Dexetimide|dexetimide|mesh-list
92123686|NCT02423694|Citalopram|citalopram|mesh-list
92123687|NCT02423694|Escitalopram|escitalopram|mesh-list
92123688|NCT02423694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92123689|NCT02423694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92123690|NCT02423694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123691|NCT02423694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123692|NCT02423694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123693|NCT02423694|Serotonin Agents|serotonin agents|mesh-ancestor
92123694|NCT02423694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123695|NCT02423694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92123696|NCT02423694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92123697|NCT02423694|Parasympatholytics|parasympatholytics|mesh-ancestor
92123698|NCT02423694|Autonomic Agents|autonomic agents|mesh-ancestor
92123699|NCT02423694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123700|NCT02423694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92123701|NCT02423694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92123702|NCT02423694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123703|NCT02423694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92123704|NCT02423694|Antidepressive Agents|antidepressive agents|mesh-ancestor
92123705|NCT02423694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92123706|NCT02420418|Acetylcysteine|acetylcysteine|mesh-list
92123707|NCT02420418|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92123708|NCT02420418|Antiviral Agents|antiviral agents|mesh-ancestor
92123709|NCT02420418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123710|NCT02420418|Expectorants|expectorants|mesh-ancestor
92123711|NCT02420418|Respiratory System Agents|respiratory system agents|mesh-ancestor
92123712|NCT02420418|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92123713|NCT02420418|Antioxidants|antioxidants|mesh-ancestor
92123714|NCT02420418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123715|NCT02420418|Protective Agents|protective agents|mesh-ancestor
92123716|NCT02420418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123717|NCT02420418|Antidotes|antidotes|mesh-ancestor
92123718|NCT02414802|Calcium, Dietary|calcium, dietary|mesh-list
92123719|NCT02414802|Heparin|heparin|mesh-list
92123720|NCT02414802|Calcium heparin|calcium heparin|mesh-list
92123721|NCT02414802|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92123722|NCT02414802|Tinzaparin|tinzaparin|mesh-list
92123723|NCT02414802|Dalteparin|dalteparin|mesh-list
92123724|NCT02414802|Calcium|calcium|mesh-list
92123725|NCT02414802|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92123726|NCT02414802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123727|NCT02414802|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92123730|NCT02414802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92123731|NCT02414802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123732|NCT01701401|Sofosbuvir|sofosbuvir|mesh-list
92123733|NCT01701401|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92123734|NCT01701401|Ledipasvir|ledipasvir|mesh-list
92123735|NCT01701401|Antiviral Agents|antiviral agents|mesh-ancestor
92123736|NCT01701401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92123737|NCT04482504|Vitamin D|vitamin d|mesh-list
92123738|NCT04482504|Vitamins|vitamins|mesh-ancestor
92123740|NCT04482504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123741|NCT04482504|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92123742|NCT02414568|Prednisone|prednisone|mesh-list
92123743|NCT02414568|Doxorubicin|doxorubicin|mesh-list
92123744|NCT02414568|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92123745|NCT02414568|Vinblastine|vinblastine|mesh-list
92123746|NCT02414568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92123747|NCT02414568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123748|NCT02414568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92123749|NCT02414568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92123750|NCT02414568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123751|NCT02414568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123752|NCT02414568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123753|NCT02414568|Glucocorticoids|glucocorticoids|mesh-ancestor
92123754|NCT02414568|Hormones|hormones|mesh-ancestor
92123755|NCT02414568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123756|NCT02414568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123757|NCT02414568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92123758|NCT02414568|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123759|NCT02414568|Alkylating Agents|alkylating agents|mesh-ancestor
92123760|NCT02414568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92123761|NCT02414568|Tubulin Modulators|tubulin modulators|mesh-ancestor
92123762|NCT02414568|Antimitotic Agents|antimitotic agents|mesh-ancestor
92123763|NCT02414568|Mitosis Modulators|mitosis modulators|mesh-ancestor
92123764|NCT04348877|Antibodies|antibodies|mesh-list
92123765|NCT04348877|Immunologic Factors|immunologic factors|mesh-ancestor
92123766|NCT04348877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123767|NCT03176628|Niacinamide|niacinamide|mesh-list
92123768|NCT03176628|Vitamin B Complex|vitamin b complex|mesh-ancestor
92123769|NCT03176628|Vitamins|vitamins|mesh-ancestor
92123770|NCT03176628|Micronutrients|micronutrients|mesh-ancestor
92123771|NCT03176628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123772|NCT02414490|Immunoglobulins|immunoglobulins|mesh-list
92123773|NCT02414490|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92123774|NCT02414490|Antibodies|antibodies|mesh-list
92123775|NCT02414490|gamma-Globulins|gamma-globulins|mesh-list
92123776|NCT02414490|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91938687|NCT03140787|Lidocaine|lidocaine|mesh-list
92123777|NCT02414490|Immunologic Factors|immunologic factors|mesh-ancestor
92123778|NCT02414490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123779|NCT01590017|Cisplatin|cisplatin|mesh-list
92123780|NCT01590017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123781|NCT01700621|Vaccines|vaccines|mesh-list
92123782|NCT01700621|Immunologic Factors|immunologic factors|mesh-ancestor
92123783|NCT01700621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123784|NCT03178500|Clomiphene|clomiphene|mesh-list
92123785|NCT03178500|Enclomiphene|enclomiphene|mesh-list
92123786|NCT03178500|Zuclomiphene|zuclomiphene|mesh-list
92123787|NCT03178500|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92123788|NCT03178500|Hormone Antagonists|hormone antagonists|mesh-ancestor
92123789|NCT03178500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123790|NCT03178500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123791|NCT03178500|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92123792|NCT03178500|Fertility Agents|fertility agents|mesh-ancestor
92123793|NCT03178500|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92123794|NCT03178500|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92123795|NCT03178500|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92123796|NCT01700387|Topiramate|topiramate|mesh-list
92123797|NCT01700387|Botulinum Toxins|botulinum toxins|mesh-list
92123798|NCT01700387|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92123799|NCT01700387|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92123800|NCT01700387|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92123801|NCT01700387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123802|NCT01700387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123803|NCT01700387|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123804|NCT01700387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123805|NCT01700387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123806|NCT01700387|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92123807|NCT01700387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123808|NCT01700387|Anticonvulsants|anticonvulsants|mesh-ancestor
92123809|NCT01700387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92123810|NCT01699685|Glycopyrrolate|glycopyrrolate|mesh-list
92123811|NCT01699685|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92123812|NCT01699685|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92123813|NCT01699685|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92123814|NCT01699685|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123815|NCT01699685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123816|NCT01699685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123817|NCT01699685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123818|NCT01587989|Methotrexate|methotrexate|mesh-list
92123819|NCT01587989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92123820|NCT01587989|Abortifacient Agents|abortifacient agents|mesh-ancestor
92123821|NCT01587989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92123822|NCT01587989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123823|NCT01587989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92123824|NCT01587989|Antimetabolites|antimetabolites|mesh-ancestor
92123825|NCT01587989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123826|NCT01587989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123827|NCT01587989|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123828|NCT01587989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123829|NCT01587989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92123830|NCT01587989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123831|NCT01587989|Immunologic Factors|immunologic factors|mesh-ancestor
92123832|NCT01587989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123833|NCT01587989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92123834|NCT01697969|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92123835|NCT01697969|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92123836|NCT01697969|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92123837|NCT01697969|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92123838|NCT01697969|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92123840|NCT01697969|Sensory System Agents|sensory system agents|mesh-ancestor
92123841|NCT01697969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123842|NCT01697969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123843|NCT01697969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92123844|NCT01697969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123845|NCT01697969|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92123846|NCT01697969|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92123847|NCT01697969|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92123848|NCT01697969|Histamine Antagonists|histamine antagonists|mesh-ancestor
92123849|NCT01697969|Histamine Agents|histamine agents|mesh-ancestor
92123850|NCT01697969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123851|NCT01697969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123852|NCT01586819|Botulinum Toxins|botulinum toxins|mesh-list
92123853|NCT01586819|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92123854|NCT01586819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123855|NCT01586819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123856|NCT01586819|Cholinergic Agents|cholinergic agents|mesh-ancestor
92123857|NCT01586819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123858|NCT01586819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123859|NCT01697579|Ondansetron|ondansetron|mesh-list
92123860|NCT01697579|Fosaprepitant|fosaprepitant|mesh-list
92123861|NCT01697579|Aprepitant|aprepitant|mesh-list
92123862|NCT01697579|Serotonin|serotonin|mesh-list
92123863|NCT01697579|Antiemetics|antiemetics|mesh-ancestor
92123864|NCT01697579|Autonomic Agents|autonomic agents|mesh-ancestor
92123865|NCT01697579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123866|NCT01697579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123867|NCT01697579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123868|NCT01697579|Antipruritics|antipruritics|mesh-ancestor
92123869|NCT01697579|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123870|NCT01697579|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92123871|NCT01697579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92123872|NCT01697579|Serotonin Agents|serotonin agents|mesh-ancestor
92123873|NCT01697579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123874|NCT01697579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123875|NCT01697579|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92123876|NCT01697579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92123877|NCT01586195|Vemurafenib|vemurafenib|mesh-list
92123878|NCT01586195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123879|NCT01586195|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92123880|NCT01586195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144847|NCT03627715|Immunologic Factors|immunologic factors|mesh-ancestor
92123881|NCT01586195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123882|NCT01697345|Testosterone|testosterone|mesh-list
92123883|NCT01697345|Androgens|androgens|mesh-ancestor
92123884|NCT01697345|Hormones|hormones|mesh-ancestor
92123885|NCT01697345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92123886|NCT01697345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123887|NCT03467386|Cyclophosphamide|cyclophosphamide|mesh-list
92123888|NCT03467386|Tacrolimus|tacrolimus|mesh-list
92123889|NCT03467386|Lenograstim|lenograstim|mesh-list
92123890|NCT03467386|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123891|NCT03467386|Immunologic Factors|immunologic factors|mesh-ancestor
92123892|NCT03467386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123893|NCT03467386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92123894|NCT03467386|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92123895|NCT03467386|Alkylating Agents|alkylating agents|mesh-ancestor
92123896|NCT03467386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123897|NCT03467386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123898|NCT03467386|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92123899|NCT03467386|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92123900|NCT03467386|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92123901|NCT03467386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123902|NCT03465592|Nivolumab|nivolumab|mesh-list
92123903|NCT03465592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123904|NCT03465592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123905|NCT03465592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92123906|NCT03465592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123907|NCT02441062|Edotreotide|edotreotide|mesh-list
92123908|NCT02441062|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92123909|NCT02441062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123910|NCT02442700|Pitavastatin|pitavastatin|mesh-list
92123911|NCT02442700|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92123912|NCT02442700|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92123913|NCT02442700|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92123914|NCT02442700|Antimetabolites|antimetabolites|mesh-ancestor
91938691|NCT03140787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123915|NCT02442700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123916|NCT02442700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92123917|NCT02442700|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92123919|NCT00619528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123920|NCT00619528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123921|NCT00568672|Olanzapine|olanzapine|mesh-list
92123922|NCT00568672|Antiemetics|antiemetics|mesh-ancestor
92123923|NCT00568672|Autonomic Agents|autonomic agents|mesh-ancestor
92123924|NCT00568672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123925|NCT00568672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123926|NCT00568672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123927|NCT00568672|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92123928|NCT00568672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92123929|NCT00568672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123930|NCT00568672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92123931|NCT00568672|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92123932|NCT00568672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92123933|NCT00568672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123934|NCT00568672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123935|NCT00568672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123936|NCT00568672|Serotonin Agents|serotonin agents|mesh-ancestor
92123937|NCT02448862|Fentanyl|fentanyl|mesh-list
92123938|NCT02448862|Analgesics|analgesics|mesh-list
92123939|NCT02448862|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92123940|NCT02448862|Narcotics|narcotics|mesh-ancestor
92123941|NCT02448862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123942|NCT02448862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123943|NCT02448862|Sensory System Agents|sensory system agents|mesh-ancestor
92123944|NCT02448862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123945|NCT02448862|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92123946|NCT02448862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92123947|NCT02448862|Anesthetics, General|anesthetics, general|mesh-ancestor
92123948|NCT02448862|Anesthetics|anesthetics|mesh-ancestor
92123949|NCT01697267|Rituximab|rituximab|mesh-list
92123950|NCT01697267|Azathioprine|azathioprine|mesh-list
92123951|NCT01697267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92123952|NCT01697267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92123953|NCT01697267|Immunologic Factors|immunologic factors|mesh-ancestor
92123954|NCT01697267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123957|NCT01697267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123958|NCT01697267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92123959|NCT01697267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92123960|NCT00362986|Sunscreening Agents|sunscreening agents|mesh-list
92123961|NCT00362986|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92123962|NCT00362986|Protective Agents|protective agents|mesh-ancestor
92123963|NCT00362986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123964|NCT00362986|Dermatologic Agents|dermatologic agents|mesh-ancestor
92123965|NCT00363376|Zonisamide|zonisamide|mesh-list
92123966|NCT00363376|Olanzapine|olanzapine|mesh-list
92123967|NCT00363376|Antiemetics|antiemetics|mesh-ancestor
92123968|NCT00363376|Autonomic Agents|autonomic agents|mesh-ancestor
92123969|NCT00363376|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123970|NCT00363376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123971|NCT00363376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92123972|NCT00363376|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92123973|NCT00363376|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92123974|NCT00363376|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92123975|NCT00363376|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92123976|NCT00363376|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92123977|NCT00363376|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92123978|NCT00363376|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92123979|NCT00363376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92123980|NCT00363376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92123981|NCT00363376|Serotonin Agents|serotonin agents|mesh-ancestor
92123982|NCT00363376|Anticonvulsants|anticonvulsants|mesh-ancestor
92123983|NCT00363376|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92123984|NCT00363376|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92123986|NCT02451202|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91938696|NCT03140787|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92123987|NCT02451202|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92123988|NCT02451202|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92123989|NCT02451202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123990|NCT02451202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123991|NCT02452060|Ketamine|ketamine|mesh-list
92123992|NCT02452060|Analgesics|analgesics|mesh-ancestor
92123993|NCT02452060|Sensory System Agents|sensory system agents|mesh-ancestor
92123994|NCT02452060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92123995|NCT02452060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92123996|NCT02452060|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92123997|NCT02452060|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92123998|NCT02452060|Anesthetics, General|anesthetics, general|mesh-ancestor
92123999|NCT02452060|Anesthetics|anesthetics|mesh-ancestor
92124000|NCT02452060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124001|NCT02452060|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92124002|NCT02452060|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92124003|NCT02452060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124004|NCT02452060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124005|NCT01696955|Cetuximab|cetuximab|mesh-list
92124006|NCT01696955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92124007|NCT01696955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124008|NCT02452528|Diphenhydramine|diphenhydramine|mesh-list
92124009|NCT02452528|Promethazine|promethazine|mesh-list
92124010|NCT02452528|Tenofovir|tenofovir|mesh-list
92124011|NCT02452528|Entecavir|entecavir|mesh-list
92124012|NCT02452528|Antiviral Agents|antiviral agents|mesh-ancestor
92124013|NCT02452528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124014|NCT02452528|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92124015|NCT02452528|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92124016|NCT02452528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124017|NCT02452528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124018|NCT02452528|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92124019|NCT02452528|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92124020|NCT02452528|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92124021|NCT02452528|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92124022|NCT02452528|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124023|NCT02452528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124024|NCT02452528|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124025|NCT02452528|Anesthetics|anesthetics|mesh-ancestor
92124026|NCT02452528|Sensory System Agents|sensory system agents|mesh-ancestor
92124027|NCT02452528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124028|NCT02452528|Antiemetics|antiemetics|mesh-ancestor
92124029|NCT02452528|Autonomic Agents|autonomic agents|mesh-ancestor
92124030|NCT02452528|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92124031|NCT02452528|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92124032|NCT02452528|Histamine Antagonists|histamine antagonists|mesh-ancestor
92124033|NCT02452528|Histamine Agents|histamine agents|mesh-ancestor
92124034|NCT02452528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124035|NCT02452528|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92124036|NCT02452528|Antipruritics|antipruritics|mesh-ancestor
92124037|NCT02452528|Dermatologic Agents|dermatologic agents|mesh-ancestor
92124038|NCT02702388|Lenvatinib|lenvatinib|mesh-list
92124039|NCT02702388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124040|NCT02702388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92124041|NCT02702388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124042|NCT02702388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124043|NCT02456896|Oxcarbazepine|oxcarbazepine|mesh-list
92124044|NCT02456896|Anticonvulsants|anticonvulsants|mesh-ancestor
92124045|NCT02456896|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92124046|NCT02456896|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92124047|NCT02456896|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124048|NCT02456896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124049|NCT02456896|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92124050|NCT02456896|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92124051|NCT01696877|Cyclophosphamide|cyclophosphamide|mesh-list
92124052|NCT01696877|Molgramostim|molgramostim|mesh-list
92124053|NCT01696877|Sargramostim|sargramostim|mesh-list
92124054|NCT01696877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124055|NCT01696877|Immunologic Factors|immunologic factors|mesh-ancestor
92124056|NCT01696877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124057|NCT01696877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92124058|NCT01696877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92124059|NCT01696877|Alkylating Agents|alkylating agents|mesh-ancestor
92124060|NCT01696877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124061|NCT01696877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124062|NCT01696877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92124064|NCT02416102|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92124065|NCT02416102|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92124066|NCT02416102|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92124067|NCT02416102|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92124068|NCT02416102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124069|NCT02414256|Anesthetics|anesthetics|mesh-list
92124070|NCT02414256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124071|NCT02414256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124073|NCT02458690|Norepinephrine|norepinephrine|mesh-list
92124074|NCT02458690|Antidepressive Agents|antidepressive agents|mesh-list
92124075|NCT02458690|Serotonin|serotonin|mesh-list
92124076|NCT02458690|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92124077|NCT02458690|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-list
92124078|NCT02458690|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92124079|NCT02458690|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124080|NCT02458690|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124081|NCT02458690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124082|NCT02458690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124083|NCT02458690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124084|NCT02458690|Sympathomimetics|sympathomimetics|mesh-ancestor
92124085|NCT02458690|Autonomic Agents|autonomic agents|mesh-ancestor
92124086|NCT02458690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124087|NCT02458690|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92124088|NCT02458690|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92124089|NCT02458690|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92124090|NCT02458690|Dopamine Agents|dopamine agents|mesh-ancestor
92124091|NCT02458690|Protective Agents|protective agents|mesh-ancestor
92124092|NCT02458690|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92124093|NCT02458690|Serotonin Agents|serotonin agents|mesh-ancestor
92124094|NCT02458690|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92124095|NCT02458690|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124096|NCT02458768|Menotropins|menotropins|mesh-list
92124097|NCT02458768|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92124098|NCT02458768|Fertility Agents|fertility agents|mesh-ancestor
92124099|NCT02458768|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92124100|NCT02458768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124101|NCT02418676|Insulin|insulin|mesh-list
92124102|NCT02418676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92124103|NCT02418676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124104|NCT02419638|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92124105|NCT02419638|Dermatologic Agents|dermatologic agents|mesh-ancestor
92124106|NCT02419638|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124108|NCT02419638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124109|NCT02422836|Sunscreening Agents|sunscreening agents|mesh-list
92124110|NCT02422836|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92124111|NCT02422836|Protective Agents|protective agents|mesh-ancestor
92124112|NCT02422836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124113|NCT02422836|Dermatologic Agents|dermatologic agents|mesh-ancestor
92124114|NCT03179514|Vasodilator Agents|vasodilator agents|mesh-list
92124115|NCT03179514|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92124116|NCT03179514|Lipid Regulating Agents|lipid regulating agents|mesh-list
92124117|NCT00707304|Lactoferrin|lactoferrin|mesh-list
92124118|NCT00707304|Talactoferrin alfa|talactoferrin alfa|mesh-list
92124119|NCT00707304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124120|NCT00707304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124121|NCT02423980|Glucagon|glucagon|mesh-list
92124122|NCT02423980|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92124123|NCT02423980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082394|NCT00211185|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124124|NCT02423980|Hormones|hormones|mesh-ancestor
92124125|NCT02423980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124126|NCT02423980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124128|NCT03176316|Naloxone|naloxone|mesh-list
92124129|NCT03176316|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92124130|NCT03176316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124131|NCT03176316|Sensory System Agents|sensory system agents|mesh-ancestor
92124132|NCT03176316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124133|NCT02419170|Cyclophosphamide|cyclophosphamide|mesh-list
92124134|NCT02419170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124135|NCT02419170|Immunologic Factors|immunologic factors|mesh-ancestor
92124136|NCT02419170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124137|NCT02419170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92124138|NCT02419170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92124139|NCT02419170|Alkylating Agents|alkylating agents|mesh-ancestor
92124140|NCT02419170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124141|NCT02419170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124142|NCT02419170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92124144|NCT02974426|Carboplatin|carboplatin|mesh-list
92124145|NCT02974426|Pemetrexed|pemetrexed|mesh-list
92124146|NCT02974426|Vinorelbine|vinorelbine|mesh-list
92124147|NCT02974426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124148|NCT02974426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124149|NCT02974426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124150|NCT02974426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92124151|NCT02974426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92124152|NCT02974426|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92124153|NCT02974426|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124154|NCT02974426|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124155|NCT02974426|Mitosis Modulators|mitosis modulators|mesh-ancestor
92124156|NCT02413554|Rivastigmine|rivastigmine|mesh-list
92124157|NCT02413554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92124158|NCT02413554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124159|NCT02413554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124160|NCT02413554|Cholinergic Agents|cholinergic agents|mesh-ancestor
92124161|NCT02413554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124162|NCT02413554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124163|NCT02413554|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92124164|NCT02413554|Protective Agents|protective agents|mesh-ancestor
92124165|NCT02422602|Rivaroxaban|rivaroxaban|mesh-list
92124166|NCT02422602|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92124167|NCT02422602|Antithrombins|antithrombins|mesh-ancestor
92124168|NCT02422602|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92124169|NCT02422602|Protease Inhibitors|protease inhibitors|mesh-ancestor
92124170|NCT02422602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124171|NCT02422602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124172|NCT02422602|Anticoagulants|anticoagulants|mesh-ancestor
92124173|NCT02465632|Clindamycin|clindamycin|mesh-list
92124174|NCT02465632|Clindamycin palmitate|clindamycin palmitate|mesh-list
92124175|NCT02465632|Clindamycin phosphate|clindamycin phosphate|mesh-list
92124176|NCT02465632|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92124177|NCT02465632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92124178|NCT02465632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124179|NCT02465632|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92124180|NCT02465632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124181|NCT02465632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124182|NCT02465632|Dermatologic Agents|dermatologic agents|mesh-ancestor
92124183|NCT02703636|Rivastigmine|rivastigmine|mesh-list
92145148|NCT00005803|Alkylating Agents|alkylating agents|mesh-ancestor
92124184|NCT02703636|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92124185|NCT02703636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124186|NCT02703636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124187|NCT02703636|Cholinergic Agents|cholinergic agents|mesh-ancestor
92124188|NCT02703636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124189|NCT02703636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124190|NCT02703636|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92124191|NCT02703636|Protective Agents|protective agents|mesh-ancestor
92124192|NCT02422056|Tranexamic Acid|tranexamic acid|mesh-list
92124193|NCT02422056|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92124194|NCT02422056|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92124195|NCT02422056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124196|NCT02422056|Hemostatics|hemostatics|mesh-ancestor
92124197|NCT02422056|Coagulants|coagulants|mesh-ancestor
92124198|NCT02466958|Milnacipran|milnacipran|mesh-list
92124199|NCT02466958|Levomilnacipran|levomilnacipran|mesh-list
92124200|NCT02466958|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92124201|NCT02466958|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92124202|NCT02466958|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124203|NCT02466958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124204|NCT02466958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124205|NCT02466958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124206|NCT02466958|Antidepressive Agents|antidepressive agents|mesh-ancestor
92124207|NCT02466958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92124208|NCT02466958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92124209|NCT02466958|Analgesics|analgesics|mesh-ancestor
92124210|NCT02466958|Sensory System Agents|sensory system agents|mesh-ancestor
92124211|NCT02466958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124213|NCT02467504|Loxoprofen|loxoprofen|mesh-list
92124214|NCT02467504|Hematinics|hematinics|mesh-ancestor
92124215|NCT02467504|Vitamin B Complex|vitamin b complex|mesh-ancestor
92124216|NCT02467504|Vitamins|vitamins|mesh-ancestor
92124217|NCT02467504|Micronutrients|micronutrients|mesh-ancestor
92124218|NCT02467504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124219|NCT02467504|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92124220|NCT02467504|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92124221|NCT02467504|Analgesics|analgesics|mesh-ancestor
92124222|NCT02467504|Sensory System Agents|sensory system agents|mesh-ancestor
92124223|NCT02467504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124224|NCT02467504|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92124225|NCT02467504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92124226|NCT02413086|Chitosan|chitosan|mesh-list
92124227|NCT02413086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92124228|NCT02413086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92124229|NCT02413086|Antimetabolites|antimetabolites|mesh-ancestor
92124230|NCT02413086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124231|NCT02413086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92124232|NCT02413086|Chelating Agents|chelating agents|mesh-ancestor
92124233|NCT02413086|Sequestering Agents|sequestering agents|mesh-ancestor
92124234|NCT02413086|Hemostatics|hemostatics|mesh-ancestor
92124235|NCT02413086|Coagulants|coagulants|mesh-ancestor
92124236|NCT02468830|Mirabegron|mirabegron|mesh-list
92124237|NCT02468830|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92124238|NCT02468830|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92124239|NCT02468830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124240|NCT02468830|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124241|NCT02468830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124242|NCT02468830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124243|NCT02468830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124244|NCT02468830|Urological Agents|urological agents|mesh-ancestor
92124245|NCT02470234|Methylphenidate|methylphenidate|mesh-list
92124246|NCT02470234|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92124247|NCT02470234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124248|NCT02470234|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92124249|NCT02470234|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92124250|NCT02470234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124251|NCT02470234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124252|NCT02470234|Dopamine Agents|dopamine agents|mesh-ancestor
92124253|NCT02470234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124254|NCT02418702|Ketamine|ketamine|mesh-list
92124255|NCT02418702|Analgesics|analgesics|mesh-ancestor
92124256|NCT02418702|Sensory System Agents|sensory system agents|mesh-ancestor
92124257|NCT02418702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124258|NCT02418702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124259|NCT02418702|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92124260|NCT02418702|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92124261|NCT02418702|Anesthetics, General|anesthetics, general|mesh-ancestor
92124262|NCT02418702|Anesthetics|anesthetics|mesh-ancestor
92124263|NCT02418702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124264|NCT02418702|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92124265|NCT02418702|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92124266|NCT02418702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124267|NCT02418702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124268|NCT02412930|Tramadol|tramadol|mesh-list
92124269|NCT02412930|Bupivacaine|bupivacaine|mesh-list
92124270|NCT02412930|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124271|NCT02412930|Anesthetics|anesthetics|mesh-ancestor
92124272|NCT02412930|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124273|NCT02412930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124274|NCT02412930|Sensory System Agents|sensory system agents|mesh-ancestor
92124275|NCT02412930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124276|NCT02412930|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124277|NCT02412930|Narcotics|narcotics|mesh-ancestor
92124278|NCT02412930|Analgesics|analgesics|mesh-ancestor
92124279|NCT02432716|Insulin|insulin|mesh-list
92124280|NCT02432716|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92124281|NCT02432716|Insulin glulisine|insulin glulisine|mesh-list
92124282|NCT02432716|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92124283|NCT02432716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124284|NCT02418624|Carboplatin|carboplatin|mesh-list
92124285|NCT02418624|Olaparib|olaparib|mesh-list
92124286|NCT02418624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124287|NCT02418624|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92124289|NCT02418624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124290|NCT02440204|Remifentanil|remifentanil|mesh-list
92124291|NCT02440204|Sevoflurane|sevoflurane|mesh-list
92124292|NCT02440204|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124293|NCT02440204|Narcotics|narcotics|mesh-ancestor
92124294|NCT02440204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124295|NCT02440204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124296|NCT02440204|Analgesics|analgesics|mesh-ancestor
92124297|NCT02440204|Sensory System Agents|sensory system agents|mesh-ancestor
92124298|NCT02440204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124299|NCT02440204|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92124300|NCT02440204|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92124301|NCT02440204|Anesthetics, General|anesthetics, general|mesh-ancestor
92124302|NCT02440204|Anesthetics|anesthetics|mesh-ancestor
92124303|NCT02410590|Atropine|atropine|mesh-list
92124304|NCT02410590|Rocuronium|rocuronium|mesh-list
92124305|NCT02410590|Cisatracurium|cisatracurium|mesh-list
92124306|NCT02410590|Succinylcholine|succinylcholine|mesh-list
92124307|NCT02410590|Neostigmine|neostigmine|mesh-list
92124308|NCT02410590|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92124309|NCT02410590|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92124310|NCT02410590|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92124311|NCT02410590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124312|NCT02410590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124313|NCT02410590|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92124314|NCT02410590|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92124315|NCT02410590|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92124316|NCT02410590|Autonomic Agents|autonomic agents|mesh-ancestor
92124317|NCT02410590|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92124318|NCT02410590|Respiratory System Agents|respiratory system agents|mesh-ancestor
92124319|NCT02410590|Mydriatics|mydriatics|mesh-ancestor
92124320|NCT02410590|Parasympatholytics|parasympatholytics|mesh-ancestor
92124321|NCT02410590|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92124322|NCT02410590|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92124323|NCT02410590|Cholinergic Agents|cholinergic agents|mesh-ancestor
92124324|NCT02410590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124325|NCT02410590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124326|NCT02410590|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92124327|NCT02410590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124328|NCT02410590|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92124329|NCT02410590|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92124330|NCT02517580|Vitamin K|vitamin k|mesh-list
92124331|NCT02517580|Vitamin K 2|vitamin k 2|mesh-list
92124332|NCT02517580|Vitamins|vitamins|mesh-ancestor
92124333|NCT02517580|Micronutrients|micronutrients|mesh-ancestor
92124334|NCT02517580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124335|NCT02517580|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92124336|NCT02517580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92124337|NCT02517580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124338|NCT02517580|Hemostatics|hemostatics|mesh-ancestor
92124339|NCT02517580|Coagulants|coagulants|mesh-ancestor
92124340|NCT02522104|Hydroxyurea|hydroxyurea|mesh-list
92124341|NCT02522104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124342|NCT02522104|Antisickling Agents|antisickling agents|mesh-ancestor
92124343|NCT02522104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124344|NCT02522104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124345|NCT02522104|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92124346|NCT02412150|Dexmedetomidine|dexmedetomidine|mesh-list
92124348|NCT02412150|Desflurane|desflurane|mesh-list
92124349|NCT02412150|Anesthetics|anesthetics|mesh-list
92124350|NCT02412150|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
92124351|NCT02412150|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92124352|NCT02412150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124353|NCT02412150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124354|NCT02412150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92124355|NCT02412150|Analgesics|analgesics|mesh-ancestor
92124356|NCT02412150|Sensory System Agents|sensory system agents|mesh-ancestor
92124357|NCT02412150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124358|NCT02412150|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92124359|NCT02412150|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92124360|NCT02412150|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124361|NCT02412150|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124362|NCT02412150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124363|NCT02412150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124364|NCT02412150|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124366|NCT02412150|Anesthetics, General|anesthetics, general|mesh-ancestor
92124367|NCT02523196|Cholic Acids|cholic acids|mesh-list
92124368|NCT02523196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92124369|NCT02418078|Anesthetics|anesthetics|mesh-list
92124370|NCT02418078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124371|NCT02418078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124372|NCT03175926|Budesonide|budesonide|mesh-list
92124373|NCT03175926|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92124374|NCT03175926|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92124375|NCT03175926|Autonomic Agents|autonomic agents|mesh-ancestor
92124376|NCT03175926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124377|NCT03175926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124378|NCT03175926|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92124379|NCT03175926|Respiratory System Agents|respiratory system agents|mesh-ancestor
92124380|NCT03175926|Glucocorticoids|glucocorticoids|mesh-ancestor
92124381|NCT03175926|Hormones|hormones|mesh-ancestor
92124382|NCT03175926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124383|NCT02524054|Furosemide|furosemide|mesh-list
92124384|NCT02524054|Diuretics|diuretics|mesh-ancestor
92124385|NCT02524054|Natriuretic Agents|natriuretic agents|mesh-ancestor
92124386|NCT02524054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124387|NCT02524054|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92124388|NCT02524054|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124389|NCT02524054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124390|NCT03106662|Cyclophosphamide|cyclophosphamide|mesh-list
92124391|NCT03106662|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124392|NCT03106662|Immunologic Factors|immunologic factors|mesh-ancestor
92124393|NCT03106662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124394|NCT03106662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92124395|NCT03106662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92124396|NCT03106662|Alkylating Agents|alkylating agents|mesh-ancestor
92124397|NCT03106662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124398|NCT03106662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124399|NCT03106662|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92124400|NCT02417610|Hyaluronic Acid|hyaluronic acid|mesh-list
92124401|NCT02417610|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92124402|NCT02417610|Immunologic Factors|immunologic factors|mesh-ancestor
92124403|NCT02417610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124404|NCT02417610|Viscosupplements|viscosupplements|mesh-ancestor
92124405|NCT02417610|Protective Agents|protective agents|mesh-ancestor
92124406|NCT03116490|Anesthetics|anesthetics|mesh-list
92124407|NCT03116490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124408|NCT03116490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124409|NCT02417298|Ketamine|ketamine|mesh-list
92124410|NCT02417298|Analgesics|analgesics|mesh-ancestor
92124411|NCT02417298|Sensory System Agents|sensory system agents|mesh-ancestor
92124412|NCT02417298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124413|NCT02417298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124414|NCT02417298|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92124415|NCT02417298|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92124416|NCT02417298|Anesthetics, General|anesthetics, general|mesh-ancestor
92124417|NCT02417298|Anesthetics|anesthetics|mesh-ancestor
92124418|NCT02417298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124419|NCT02417298|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92124420|NCT02417298|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92124421|NCT02417298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124422|NCT02417298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124423|NCT02525536|Trebananib|trebananib|mesh-list
92124424|NCT02525536|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92124425|NCT02525536|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92124426|NCT02525536|Growth Substances|growth substances|mesh-ancestor
92124427|NCT02525536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124428|NCT02525536|Growth Inhibitors|growth inhibitors|mesh-ancestor
92124429|NCT02525536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124430|NCT02411994|Artesunate|artesunate|mesh-list
92124431|NCT02411994|Lumefantrine|lumefantrine|mesh-list
92124433|NCT02411994|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92124434|NCT02411994|Pyronaridine|pyronaridine|mesh-list
92124435|NCT02411994|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92124436|NCT02411994|Antimalarials|antimalarials|mesh-ancestor
92124437|NCT02411994|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92124438|NCT02411994|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92124439|NCT02411994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124440|NCT02411994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124441|NCT02411994|Antiviral Agents|antiviral agents|mesh-ancestor
92124442|NCT02411994|Schistosomicides|schistosomicides|mesh-ancestor
92124443|NCT02411994|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92124444|NCT02411994|Anthelmintics|anthelmintics|mesh-ancestor
92124445|NCT02530294|Glycopyrrolate|glycopyrrolate|mesh-list
92124446|NCT02530294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92124447|NCT02530294|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92124448|NCT02530294|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92124449|NCT02530294|Cholinergic Agents|cholinergic agents|mesh-ancestor
92124450|NCT02530294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124451|NCT02530294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124452|NCT02530294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124453|NCT03177720|Ciprofloxacin|ciprofloxacin|mesh-list
92124454|NCT03177720|Imipenem|imipenem|mesh-list
92124455|NCT03177720|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92124456|NCT03177720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124457|NCT03177720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92124458|NCT03177720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92124459|NCT03177720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124460|NCT03177720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124461|NCT03177720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124462|NCT03177720|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92124463|NCT03177720|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92124464|NCT02411604|Tacrolimus|tacrolimus|mesh-list
92124465|NCT02411604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124466|NCT02411604|Immunologic Factors|immunologic factors|mesh-ancestor
92124467|NCT02411604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124468|NCT02411604|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92124469|NCT02411604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124470|NCT02411604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124471|NCT03175380|BCG Vaccine|bcg vaccine|mesh-list
92124472|NCT03175380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92124473|NCT03175380|Immunologic Factors|immunologic factors|mesh-ancestor
92124474|NCT03175380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124475|NCT02530528|Chlorhexidine|chlorhexidine|mesh-list
92124476|NCT02530528|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92124477|NCT02530528|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92124478|NCT02530528|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124479|NCT02530528|Disinfectants|disinfectants|mesh-ancestor
92124480|NCT02530528|Dermatologic Agents|dermatologic agents|mesh-ancestor
92124481|NCT03174756|Chlorhexidine|chlorhexidine|mesh-list
92124482|NCT03174756|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92124483|NCT03174756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124484|NCT03174756|Disinfectants|disinfectants|mesh-ancestor
92124485|NCT03174678|Dexmedetomidine|dexmedetomidine|mesh-list
92124486|NCT03174678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92124487|NCT03174678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124488|NCT03174678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124489|NCT03174678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92124490|NCT03174678|Analgesics|analgesics|mesh-ancestor
92124491|NCT03174678|Sensory System Agents|sensory system agents|mesh-ancestor
92124492|NCT03174678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124493|NCT03174678|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92124494|NCT03174678|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92124495|NCT03174678|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124496|NCT03174678|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124497|NCT03174678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124498|NCT03174678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124499|NCT02409498|Bupivacaine|bupivacaine|mesh-list
92124500|NCT02409498|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124501|NCT02409498|Anesthetics|anesthetics|mesh-ancestor
92082772|NCT04198233|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92124502|NCT02409498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124505|NCT02409498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124509|NCT02409186|Nimotuzumab|nimotuzumab|mesh-list
92124510|NCT02409186|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92124511|NCT02409186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124512|NCT02409186|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124513|NCT02409186|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124514|NCT02409186|Mitosis Modulators|mitosis modulators|mesh-ancestor
92124515|NCT02409186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124516|NCT02409186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92124517|NCT02410746|Ibuprofen|ibuprofen|mesh-list
92124518|NCT02410746|Morphine|morphine|mesh-list
92124519|NCT02410746|Levobupivacaine|levobupivacaine|mesh-list
92124520|NCT02410746|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124521|NCT02410746|Narcotics|narcotics|mesh-ancestor
92124522|NCT02410746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124523|NCT02410746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124524|NCT02410746|Analgesics|analgesics|mesh-ancestor
92124525|NCT02410746|Sensory System Agents|sensory system agents|mesh-ancestor
92124526|NCT02410746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124527|NCT02410746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92124528|NCT02410746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92124529|NCT02410746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92124530|NCT02410746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92124531|NCT02410746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92124532|NCT02410746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124533|NCT02410746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124534|NCT02410746|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124535|NCT02410746|Anesthetics|anesthetics|mesh-ancestor
92124536|NCT03177174|Docetaxel|docetaxel|mesh-list
92124537|NCT03177174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124538|NCT03177174|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124539|NCT03177174|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124540|NCT03177174|Mitosis Modulators|mitosis modulators|mesh-ancestor
92124541|NCT03177174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124542|NCT03177252|Lidocaine|lidocaine|mesh-list
92124543|NCT03177252|Bupivacaine|bupivacaine|mesh-list
92124544|NCT03177252|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124545|NCT03177252|Anesthetics|anesthetics|mesh-ancestor
92124546|NCT03177252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124547|NCT03177252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124548|NCT03177252|Sensory System Agents|sensory system agents|mesh-ancestor
92124549|NCT03177252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124550|NCT03177252|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92124551|NCT03177252|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92124552|NCT03177252|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92124553|NCT03177252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124554|NCT03177252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124555|NCT02703324|Insulin Lispro|insulin lispro|mesh-list
92124556|NCT02703324|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92124557|NCT02703324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124558|NCT02408562|Becaplermin|becaplermin|mesh-list
92124559|NCT02408562|Anticoagulants|anticoagulants|mesh-ancestor
92124560|NCT02408562|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
92124561|NCT02408562|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92124562|NCT02408562|Growth Substances|growth substances|mesh-ancestor
92124563|NCT02408562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124567|NCT02701764|Pregabalin|pregabalin|mesh-list
92124568|NCT02701764|Analgesics|analgesics|mesh-ancestor
92124569|NCT02701764|Sensory System Agents|sensory system agents|mesh-ancestor
92124570|NCT02701764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124571|NCT02701764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124572|NCT02701764|Anticonvulsants|anticonvulsants|mesh-ancestor
92124573|NCT02701764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92124574|NCT02701764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124575|NCT02701764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124576|NCT02701764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92124577|NCT02701764|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92124578|NCT02701764|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92124579|NCT02701764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124580|NCT02701764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92124581|NCT03174288|Spironolactone|spironolactone|mesh-list
92124582|NCT03174288|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92124583|NCT03174288|Hormone Antagonists|hormone antagonists|mesh-ancestor
92124584|NCT03174288|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124585|NCT03174288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124586|NCT03174288|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92124588|NCT03174288|Natriuretic Agents|natriuretic agents|mesh-ancestor
92124589|NCT02532010|Cytarabine|cytarabine|mesh-list
92124590|NCT02532010|Decitabine|decitabine|mesh-list
92124591|NCT02532010|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92124592|NCT02532010|Antimetabolites|antimetabolites|mesh-ancestor
92124593|NCT02532010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124594|NCT02532010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124595|NCT02532010|Antiviral Agents|antiviral agents|mesh-ancestor
92124596|NCT02532010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124597|NCT02532010|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124598|NCT02532010|Immunologic Factors|immunologic factors|mesh-ancestor
92124599|NCT02532010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124600|NCT02532010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124601|NCT02406300|Bupivacaine|bupivacaine|mesh-list
92124602|NCT02406300|Ropivacaine|ropivacaine|mesh-list
92124603|NCT02406300|Levobupivacaine|levobupivacaine|mesh-list
92124604|NCT02406300|Sevoflurane|sevoflurane|mesh-list
92124605|NCT02406300|Desflurane|desflurane|mesh-list
92124606|NCT02406300|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124607|NCT02406300|Anesthetics|anesthetics|mesh-ancestor
92124608|NCT02406300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124609|NCT02406300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124610|NCT02406300|Sensory System Agents|sensory system agents|mesh-ancestor
92124611|NCT02406300|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124612|NCT02406300|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92124613|NCT02406300|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92124614|NCT02406300|Anesthetics, General|anesthetics, general|mesh-ancestor
92124615|NCT02538016|Tolvaptan|tolvaptan|mesh-list
92124616|NCT02538016|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92124617|NCT02538016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124618|NCT02538016|Natriuretic Agents|natriuretic agents|mesh-ancestor
92124619|NCT02538016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124620|NCT02406144|Dexamethasone|dexamethasone|mesh-list
92124621|NCT02406144|Lenalidomide|lenalidomide|mesh-list
92124622|NCT02406144|Ixazomib|ixazomib|mesh-list
92124623|NCT02406144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92124624|NCT02406144|Antiemetics|antiemetics|mesh-ancestor
92124625|NCT02406144|Autonomic Agents|autonomic agents|mesh-ancestor
92124626|NCT02406144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124627|NCT02406144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124628|NCT02406144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92124629|NCT02406144|Glucocorticoids|glucocorticoids|mesh-ancestor
92124630|NCT02406144|Hormones|hormones|mesh-ancestor
92124631|NCT02406144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124632|NCT02406144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92124633|NCT02406144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124634|NCT02406144|Immunologic Factors|immunologic factors|mesh-ancestor
92124635|NCT02406144|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92124636|NCT02406144|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92124637|NCT02406144|Growth Substances|growth substances|mesh-ancestor
92124638|NCT02406144|Growth Inhibitors|growth inhibitors|mesh-ancestor
92124639|NCT02406144|Protease Inhibitors|protease inhibitors|mesh-ancestor
92124640|NCT02406144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124641|NCT02406144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124642|NCT02416752|Remifentanil|remifentanil|mesh-list
92124643|NCT02416752|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124644|NCT02416752|Narcotics|narcotics|mesh-ancestor
92124645|NCT02416752|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145227|NCT00350701|Anabolic Agents|anabolic agents|mesh-ancestor
92124646|NCT02416752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124647|NCT02416752|Analgesics|analgesics|mesh-ancestor
92124648|NCT02416752|Sensory System Agents|sensory system agents|mesh-ancestor
92124649|NCT02416752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124650|NCT02405910|Paclitaxel|paclitaxel|mesh-list
92124651|NCT02405910|Gemcitabine|gemcitabine|mesh-list
92124652|NCT02405910|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92124653|NCT02405910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124654|NCT02405910|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124655|NCT02405910|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124656|NCT02405910|Mitosis Modulators|mitosis modulators|mesh-ancestor
92124657|NCT02405910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124658|NCT02405910|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92124660|NCT02539108|Vaccines|vaccines|mesh-list
92124661|NCT02539108|Immunologic Factors|immunologic factors|mesh-ancestor
92124662|NCT02539108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124663|NCT02406066|Oxazepam|oxazepam|mesh-list
92124664|NCT02406066|Metyrapone|metyrapone|mesh-list
92124665|NCT02406066|Antimetabolites|antimetabolites|mesh-ancestor
92124666|NCT02406066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124667|NCT02406066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124668|NCT02406066|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92124669|NCT02406066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124670|NCT02406066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124672|NCT02406066|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92124673|NCT02406066|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92124674|NCT02406066|GABA Modulators|gaba modulators|mesh-ancestor
92124675|NCT02406066|GABA Agents|gaba agents|mesh-ancestor
92124676|NCT02406066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124677|NCT02408328|Caffeine|caffeine|mesh-list
92124678|NCT02408328|Caffeine citrate|caffeine citrate|mesh-list
92124679|NCT02408328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124680|NCT02408328|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92124681|NCT02408328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124682|NCT02408328|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92124683|NCT02408328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124684|NCT02408328|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92124685|NCT02408328|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92124686|NCT02408328|Purinergic Agents|purinergic agents|mesh-ancestor
92124687|NCT02408328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124688|NCT02539342|Calcium|calcium|mesh-list
92124689|NCT02539342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92124690|NCT02539342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124691|NCT02405988|Remifentanil|remifentanil|mesh-list
92124692|NCT02405988|Naloxone|naloxone|mesh-list
92124693|NCT02405988|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92124694|NCT02405988|Narcotics|narcotics|mesh-ancestor
92124695|NCT02405988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124696|NCT02405988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124697|NCT02405988|Analgesics|analgesics|mesh-ancestor
92124698|NCT02405988|Sensory System Agents|sensory system agents|mesh-ancestor
92124699|NCT02405988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124700|NCT02405988|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92124701|NCT02542150|Ethanol|ethanol|mesh-list
92124702|NCT02542150|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92124703|NCT02542150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124704|NCT02542150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124705|NCT02542150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124706|NCT02542462|Vaccines|vaccines|mesh-list
92124707|NCT02542462|Immunologic Factors|immunologic factors|mesh-ancestor
92124708|NCT02542462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124709|NCT03173898|Anesthetics|anesthetics|mesh-list
92124710|NCT03173898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124711|NCT03173898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124712|NCT02408172|Metoprolol|metoprolol|mesh-list
92124713|NCT02408172|Amlodipine|amlodipine|mesh-list
92124714|NCT02408172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92124715|NCT02408172|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92124716|NCT02408172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92124717|NCT02408172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124718|NCT02408172|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92124719|NCT02408172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124720|NCT02408172|Vasodilator Agents|vasodilator agents|mesh-ancestor
92124721|NCT02408172|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92124722|NCT02408172|Sympatholytics|sympatholytics|mesh-ancestor
92124723|NCT02408172|Autonomic Agents|autonomic agents|mesh-ancestor
92124724|NCT02408172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124725|NCT02408172|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92124726|NCT02408172|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92124727|NCT02408172|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92124728|NCT02408172|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124729|NCT02408172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124730|NCT04481100|Itraconazole|itraconazole|mesh-list
92124731|NCT04481100|Antifungal Agents|antifungal agents|mesh-ancestor
92124732|NCT04481100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124733|NCT04481100|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92124734|NCT04481100|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92124735|NCT04481100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124736|NCT04481100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124737|NCT04481100|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92124738|NCT04481100|Hormone Antagonists|hormone antagonists|mesh-ancestor
92124739|NCT04481100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124740|NCT04481100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124741|NCT04481100|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92124743|NCT02405598|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92124744|NCT02405598|Autonomic Agents|autonomic agents|mesh-ancestor
92124745|NCT02405598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124746|NCT02405598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124747|NCT02405598|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92124748|NCT02405598|Respiratory System Agents|respiratory system agents|mesh-ancestor
92124749|NCT02405598|Tocolytic Agents|tocolytic agents|mesh-ancestor
92124750|NCT02405598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92124751|NCT02405598|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92124752|NCT02405598|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92124753|NCT02405598|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124754|NCT02405598|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124755|NCT02405598|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124756|NCT02405598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124757|NCT03173508|Acetazolamide|acetazolamide|mesh-list
92124758|NCT03173508|Anticonvulsants|anticonvulsants|mesh-ancestor
92124759|NCT03173508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92124760|NCT03173508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124761|NCT03173508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124762|NCT03173508|Diuretics|diuretics|mesh-ancestor
92124763|NCT03173508|Natriuretic Agents|natriuretic agents|mesh-ancestor
92124764|NCT03173508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124765|NCT03173430|Blinatumomab|blinatumomab|mesh-list
92124766|NCT03173430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124768|NCT02407782|Permethrin|permethrin|mesh-list
92124769|NCT02407782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92124770|NCT02407782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124771|NCT02407782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124772|NCT02407782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124773|NCT02405364|Dexamethasone|dexamethasone|mesh-list
92124774|NCT02405364|Lenalidomide|lenalidomide|mesh-list
92124775|NCT02405364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92124776|NCT02405364|Antiemetics|antiemetics|mesh-ancestor
92124777|NCT02405364|Autonomic Agents|autonomic agents|mesh-ancestor
92124778|NCT02405364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124779|NCT02405364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124780|NCT02405364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92124781|NCT02405364|Glucocorticoids|glucocorticoids|mesh-ancestor
92124782|NCT02405364|Hormones|hormones|mesh-ancestor
92124783|NCT02405364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124784|NCT02405364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92124785|NCT02405364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124786|NCT02405364|Immunologic Factors|immunologic factors|mesh-ancestor
92124787|NCT02405364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92124788|NCT02405364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92124789|NCT02405364|Growth Substances|growth substances|mesh-ancestor
92124790|NCT02405364|Growth Inhibitors|growth inhibitors|mesh-ancestor
92124791|NCT02405130|Epinephrine|epinephrine|mesh-list
92124792|NCT02405130|Racepinephrine|racepinephrine|mesh-list
92124793|NCT02405130|Epinephryl borate|epinephryl borate|mesh-list
92124794|NCT02405130|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92124795|NCT02405130|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124796|NCT02405130|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124797|NCT02405130|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124798|NCT02405130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124799|NCT02405130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124800|NCT02405130|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92124801|NCT02405130|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92124802|NCT02405130|Autonomic Agents|autonomic agents|mesh-ancestor
92083089|NCT01822561|Eplerenone|eplerenone|mesh-list
92124803|NCT02405130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124804|NCT02405130|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92124805|NCT02405130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92124806|NCT02405130|Mydriatics|mydriatics|mesh-ancestor
92124807|NCT02405130|Sympathomimetics|sympathomimetics|mesh-ancestor
92124808|NCT02405130|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92124809|NCT03171090|Anesthetics|anesthetics|mesh-list
92124810|NCT03171090|Anesthetics, Local|anesthetics, local|mesh-list
92124811|NCT03171090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124812|NCT03171090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124813|NCT03171090|Sensory System Agents|sensory system agents|mesh-ancestor
92124814|NCT03171090|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124815|NCT02407470|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92124816|NCT02407470|Immunologic Factors|immunologic factors|mesh-ancestor
92124817|NCT02407470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124818|NCT02407470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92124819|NCT02407626|Propofol|propofol|mesh-list
92124820|NCT02407626|Sevoflurane|sevoflurane|mesh-list
92124821|NCT02407626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92124822|NCT02407626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124823|NCT02407626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124824|NCT02407626|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92124825|NCT02407626|Anesthetics, General|anesthetics, general|mesh-ancestor
92124826|NCT02407626|Anesthetics|anesthetics|mesh-ancestor
92124827|NCT02407626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92124828|NCT02407626|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92124829|NCT02407392|Acetic Acid|acetic acid|mesh-list
92124830|NCT02407392|Retinol acetate|retinol acetate|mesh-list
92124831|NCT02407392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92124832|NCT02407392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124833|NCT02407392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92124834|NCT02407392|Immunologic Factors|immunologic factors|mesh-ancestor
92124835|NCT02407392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124836|NCT02407392|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92124837|NCT02407392|Protective Agents|protective agents|mesh-ancestor
92124838|NCT02407392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124839|NCT02551432|Paclitaxel|paclitaxel|mesh-list
92124840|NCT02551432|Pembrolizumab|pembrolizumab|mesh-list
92124841|NCT02551432|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92124842|NCT02551432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124843|NCT02551432|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124844|NCT02551432|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124845|NCT02551432|Mitosis Modulators|mitosis modulators|mesh-ancestor
92124846|NCT02551432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124847|NCT02551432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92124848|NCT02551432|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92124849|NCT02407548|Vitamin E|vitamin e|mesh-list
92124850|NCT02407548|Coenzyme Q10|coenzyme q10|mesh-list
92124851|NCT02407548|Ubiquinone|ubiquinone|mesh-list
92124852|NCT02407548|Vitamins|vitamins|mesh-ancestor
92124853|NCT02407548|Micronutrients|micronutrients|mesh-ancestor
92124854|NCT02407548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124855|NCT02407548|Antioxidants|antioxidants|mesh-ancestor
92124856|NCT02407548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124857|NCT02407548|Protective Agents|protective agents|mesh-ancestor
92124858|NCT01695317|Acetylcarnitine|acetylcarnitine|mesh-list
92124859|NCT01695317|Vitamin B Complex|vitamin b complex|mesh-ancestor
92124860|NCT01695317|Vitamins|vitamins|mesh-ancestor
92124861|NCT01695317|Micronutrients|micronutrients|mesh-ancestor
92124862|NCT01695317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124863|NCT01695317|Nootropic Agents|nootropic agents|mesh-ancestor
92124864|NCT02551744|Pantoprazole|pantoprazole|mesh-list
92124865|NCT02551744|Famotidine|famotidine|mesh-list
92124866|NCT02551744|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92124867|NCT02551744|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
92124868|NCT02551744|Histamine|histamine|mesh-list
92124869|NCT02551744|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92124870|NCT02551744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92124871|NCT02551744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124872|NCT02551744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124873|NCT02551744|Histamine Antagonists|histamine antagonists|mesh-ancestor
92124874|NCT02551744|Histamine Agents|histamine agents|mesh-ancestor
92124875|NCT02551744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124876|NCT02551744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124877|NCT02551744|Histamine Agonists|histamine agonists|mesh-ancestor
92124878|NCT04743544|Voriconazole|voriconazole|mesh-list
92124879|NCT04743544|Antifungal Agents|antifungal agents|mesh-ancestor
92124880|NCT04743544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124881|NCT04743544|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92124882|NCT04743544|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92124883|NCT04743544|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124884|NCT04743544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124885|NCT04743544|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92124886|NCT04743544|Hormone Antagonists|hormone antagonists|mesh-ancestor
92124887|NCT04743544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92124888|NCT04743544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124889|NCT04743544|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92124891|NCT04481802|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92124892|NCT04481802|Immunologic Factors|immunologic factors|mesh-ancestor
92124893|NCT04481802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124894|NCT04481802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124895|NCT04481802|Antiviral Agents|antiviral agents|mesh-ancestor
92124896|NCT04481802|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124897|NCT04481802|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92124898|NCT02551822|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92124899|NCT02551822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124900|NCT02551822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124901|NCT02407314|Aspirin|aspirin|mesh-list
92124902|NCT02407314|Ticagrelor|ticagrelor|mesh-list
92124903|NCT02407314|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92124904|NCT02407314|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92124905|NCT02407314|Analgesics|analgesics|mesh-ancestor
92124906|NCT02407314|Sensory System Agents|sensory system agents|mesh-ancestor
92124907|NCT02407314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124908|NCT02407314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124909|NCT02407314|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92124910|NCT02407314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92124911|NCT02407314|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92124912|NCT02407314|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92124913|NCT02407314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124914|NCT02407314|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92124915|NCT02407314|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92124916|NCT02407314|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92124917|NCT02407314|Antipyretics|antipyretics|mesh-ancestor
92124918|NCT02407314|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92124919|NCT02407314|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92124920|NCT02407314|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92124921|NCT02407314|Purinergic Agents|purinergic agents|mesh-ancestor
92124922|NCT02407314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124923|NCT02407080|Interferons|interferons|mesh-list
92124924|NCT02407080|Interferon-alpha|interferon-alpha|mesh-list
92124925|NCT02407080|Interferon alpha-2|interferon alpha-2|mesh-list
92124926|NCT02407080|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92124927|NCT02407080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124928|NCT02407080|Antiviral Agents|antiviral agents|mesh-ancestor
92124929|NCT02407080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92124930|NCT02407080|Immunologic Factors|immunologic factors|mesh-ancestor
92124931|NCT02407080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124932|NCT04743622|Latanoprost|latanoprost|mesh-list
92124933|NCT04743622|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92124934|NCT04743622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92124935|NCT02701296|Epinephrine|epinephrine|mesh-list
92124936|NCT02701296|Ropivacaine|ropivacaine|mesh-list
92124937|NCT02701296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92124938|NCT02701296|Anesthetics|anesthetics|mesh-ancestor
92124939|NCT02701296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92124940|NCT02701296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124941|NCT02701296|Sensory System Agents|sensory system agents|mesh-ancestor
92124942|NCT02701296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124943|NCT02701296|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92124944|NCT02701296|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92124945|NCT02701296|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124946|NCT02701296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124947|NCT02701296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124948|NCT02701296|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92124949|NCT02701296|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92124950|NCT02701296|Autonomic Agents|autonomic agents|mesh-ancestor
92124951|NCT02701296|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92124952|NCT02701296|Respiratory System Agents|respiratory system agents|mesh-ancestor
92124953|NCT02701296|Mydriatics|mydriatics|mesh-ancestor
92083218|NCT04025775|Insulin|insulin|mesh-list
92124954|NCT02701296|Sympathomimetics|sympathomimetics|mesh-ancestor
92124955|NCT02701296|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92124956|NCT02558374|Timolol|timolol|mesh-list
92124958|NCT02558374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92124959|NCT02558374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124960|NCT02558374|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92124961|NCT02558374|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92124962|NCT02558374|Adrenergic Agents|adrenergic agents|mesh-ancestor
92124963|NCT02558374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124964|NCT02558374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124965|NCT02558374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92124966|NCT02558374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92124968|NCT01582451|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92124969|NCT01582451|Insulin Glargine|insulin glargine|mesh-list
92124970|NCT01582451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92124971|NCT01582451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124972|NCT03115320|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92124973|NCT03115320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92124974|NCT03115320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124975|NCT03168828|Trospium chloride|trospium chloride|mesh-list
92124976|NCT03168828|Parasympatholytics|parasympatholytics|mesh-ancestor
92124977|NCT03168828|Autonomic Agents|autonomic agents|mesh-ancestor
92124978|NCT03168828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92124979|NCT03168828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92124980|NCT03168828|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92124981|NCT03168828|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92124982|NCT03168828|Cholinergic Agents|cholinergic agents|mesh-ancestor
92124983|NCT03168828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92124984|NCT03168828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124985|NCT03168828|Urological Agents|urological agents|mesh-ancestor
92124986|NCT02562898|Paclitaxel|paclitaxel|mesh-list
92124987|NCT02562898|Gemcitabine|gemcitabine|mesh-list
92124988|NCT02562898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92124989|NCT02562898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92124990|NCT02562898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92124991|NCT02562898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92124992|NCT02562898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92124993|NCT02562898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92124994|NCT02562898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92124995|NCT02562898|Antimetabolites|antimetabolites|mesh-ancestor
92124996|NCT03168594|Cisplatin|cisplatin|mesh-list
92124997|NCT03168594|Irinotecan|irinotecan|mesh-list
92124998|NCT03168594|Etoposide|etoposide|mesh-list
92124999|NCT03168594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125000|NCT03168594|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92125001|NCT03168594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125002|NCT03168594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125003|NCT03168594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125004|NCT03168594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125005|NCT03168594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92125006|NCT02563834|Insulin|insulin|mesh-list
92125007|NCT02563834|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92125008|NCT02563834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125009|NCT02564926|Dapagliflozin|dapagliflozin|mesh-list
92125010|NCT02564926|Glimepiride|glimepiride|mesh-list
92125011|NCT02564926|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92125012|NCT02564926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125013|NCT02564926|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92125014|NCT02564926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125015|NCT02564926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92125016|NCT02564926|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125017|NCT02564926|Immunologic Factors|immunologic factors|mesh-ancestor
92125018|NCT02567968|Caffeine|caffeine|mesh-list
92125019|NCT02567968|Caffeine citrate|caffeine citrate|mesh-list
92125020|NCT02567968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125021|NCT02567968|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92125022|NCT02567968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125023|NCT02567968|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92125024|NCT02567968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125025|NCT02567968|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92125026|NCT02567968|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92125028|NCT02567968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125030|NCT02571634|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92125031|NCT02571634|Narcotics|narcotics|mesh-ancestor
92125032|NCT02571634|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125033|NCT02571634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125034|NCT02571634|Analgesics|analgesics|mesh-ancestor
92125035|NCT02571634|Sensory System Agents|sensory system agents|mesh-ancestor
92125036|NCT02571634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125037|NCT02571634|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92125038|NCT02571634|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92125039|NCT02571634|Anesthetics, General|anesthetics, general|mesh-ancestor
92125040|NCT02571634|Anesthetics|anesthetics|mesh-ancestor
92125041|NCT02404038|NuvaRing|nuvaring|mesh-list
92125042|NCT02404038|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92125043|NCT02404038|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92125044|NCT02404038|Contraceptive Agents|contraceptive agents|mesh-ancestor
92125045|NCT02404038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92125046|NCT02404038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125047|NCT02404038|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92125048|NCT02404038|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92125049|NCT02404038|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92125050|NCT02404038|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92125051|NCT02404038|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92125052|NCT02404038|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92125053|NCT02404038|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92125054|NCT02404038|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92125055|NCT02574598|Docetaxel|docetaxel|mesh-list
92125056|NCT02574598|Pembrolizumab|pembrolizumab|mesh-list
92125057|NCT02574598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125058|NCT02574598|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125059|NCT02574598|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125060|NCT02574598|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125061|NCT02574598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125062|NCT02574598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125063|NCT02574598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92125064|NCT02574832|Lidocaine|lidocaine|mesh-list
92125065|NCT02574832|Fentanyl|fentanyl|mesh-list
92125066|NCT02574832|Anesthetics, Local|anesthetics, local|mesh-ancestor
92125067|NCT02574832|Anesthetics|anesthetics|mesh-ancestor
92125068|NCT02574832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125069|NCT02574832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125070|NCT02574832|Sensory System Agents|sensory system agents|mesh-ancestor
92125071|NCT02574832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125072|NCT02574832|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92125073|NCT02574832|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92125074|NCT02574832|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92125075|NCT02574832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125076|NCT02574832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125077|NCT02574832|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92125078|NCT02574832|Narcotics|narcotics|mesh-ancestor
92125079|NCT02574832|Analgesics|analgesics|mesh-ancestor
92125080|NCT02574832|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92125081|NCT02574832|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92125082|NCT02574832|Anesthetics, General|anesthetics, general|mesh-ancestor
92125083|NCT02406690|Leuprolide|leuprolide|mesh-list
92125084|NCT02406690|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92125085|NCT02406690|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92125086|NCT02406690|Estradiol|estradiol|mesh-list
92125087|NCT02406690|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92125088|NCT02406690|Progesterone|progesterone|mesh-list
92125089|NCT02406690|Estrogens|estrogens|mesh-ancestor
92125090|NCT02406690|Hormones|hormones|mesh-ancestor
92125091|NCT02406690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125092|NCT02406690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125093|NCT02406690|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91938709|NCT03317223|Amoxicillin|amoxicillin|mesh-list
92125094|NCT02406690|Contraceptive Agents|contraceptive agents|mesh-ancestor
92125095|NCT02406690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92125096|NCT02406690|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92125097|NCT02406690|Progestins|progestins|mesh-ancestor
92125098|NCT02406690|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92125099|NCT02406690|Fertility Agents|fertility agents|mesh-ancestor
92125100|NCT02406690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92125101|NCT02406690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125102|NCT04440696|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
92125105|NCT04440696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125106|NCT02974348|Acetaminophen|acetaminophen|mesh-list
92125107|NCT02974348|Amoxicillin|amoxicillin|mesh-list
92125108|NCT02974348|Artesunate|artesunate|mesh-list
92125109|NCT02974348|Lumefantrine|lumefantrine|mesh-list
92125110|NCT02974348|Piperaquine|piperaquine|mesh-list
92125111|NCT02974348|Artenimol|artenimol|mesh-list
92125112|NCT02974348|Mefloquine|mefloquine|mesh-list
92125113|NCT02974348|Quinine|quinine|mesh-list
92125114|NCT02974348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125115|NCT02974348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125116|NCT02974348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92125117|NCT02974348|Analgesics|analgesics|mesh-ancestor
92125118|NCT02974348|Sensory System Agents|sensory system agents|mesh-ancestor
92125119|NCT02974348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125120|NCT02974348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125121|NCT02974348|Antipyretics|antipyretics|mesh-ancestor
92125122|NCT02974348|Antimalarials|antimalarials|mesh-ancestor
92125123|NCT02974348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92125124|NCT02974348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92125125|NCT02974348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125126|NCT02974348|Antiviral Agents|antiviral agents|mesh-ancestor
92125127|NCT02974348|Schistosomicides|schistosomicides|mesh-ancestor
92125128|NCT02974348|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92125129|NCT02974348|Anthelmintics|anthelmintics|mesh-ancestor
92125130|NCT02974348|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92125131|NCT02974348|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92125132|NCT03170310|Apatinib|apatinib|mesh-list
91938722|NCT02284906|Pioglitazone|pioglitazone|mesh-list
92125133|NCT03170310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125134|NCT03170310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92125135|NCT03170310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125136|NCT03170310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125138|NCT00364000|Sevelamer|sevelamer|mesh-list
92125139|NCT00364000|Calcium acetate|calcium acetate|mesh-list
92125140|NCT00364000|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92125141|NCT00364000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125142|NCT00364000|Chelating Agents|chelating agents|mesh-ancestor
92125143|NCT00364000|Sequestering Agents|sequestering agents|mesh-ancestor
92125144|NCT00364000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125145|NCT00422188|Deoxycholic Acid|deoxycholic acid|mesh-list
92125146|NCT00422188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92125147|NCT00422188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125148|NCT02403804|Betaine|betaine|mesh-list
92125149|NCT02403804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125150|NCT02403804|Lipotropic Agents|lipotropic agents|mesh-ancestor
92125151|NCT02403804|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92125152|NCT02403804|Antimetabolites|antimetabolites|mesh-ancestor
92125153|NCT02403804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125154|NCT02403804|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92125155|NCT03169764|Leucovorin|leucovorin|mesh-list
92125156|NCT03169764|Cyclophosphamide|cyclophosphamide|mesh-list
92125157|NCT03169764|Bevacizumab|bevacizumab|mesh-list
92125158|NCT03169764|Fluorouracil|fluorouracil|mesh-list
92125159|NCT03169764|Capecitabine|capecitabine|mesh-list
92125160|NCT03169764|Nivolumab|nivolumab|mesh-list
92125161|NCT03169764|Cetuximab|cetuximab|mesh-list
92125162|NCT03169764|Fulvestrant|fulvestrant|mesh-list
92125163|NCT03169764|Avelumab|avelumab|mesh-list
92125164|NCT03169764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125165|NCT03169764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125166|NCT03169764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125167|NCT03169764|Immunologic Factors|immunologic factors|mesh-ancestor
92125168|NCT03169764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125169|NCT03169764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125170|NCT03169764|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92125171|NCT03169764|Alkylating Agents|alkylating agents|mesh-ancestor
92125172|NCT03169764|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92125173|NCT03169764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125174|NCT03169764|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92125175|NCT03169764|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92125176|NCT03169764|Growth Substances|growth substances|mesh-ancestor
92125177|NCT03169764|Growth Inhibitors|growth inhibitors|mesh-ancestor
92125178|NCT03169764|Antimetabolites|antimetabolites|mesh-ancestor
92125179|NCT03169764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92125180|NCT03169764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92125181|NCT03169764|Antidotes|antidotes|mesh-ancestor
92125182|NCT03169764|Protective Agents|protective agents|mesh-ancestor
92125183|NCT03169764|Vitamin B Complex|vitamin b complex|mesh-ancestor
92125184|NCT03169764|Vitamins|vitamins|mesh-ancestor
92125186|NCT03169764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92125187|NCT03169764|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92125188|NCT03169764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92125189|NCT03169764|Hormone Antagonists|hormone antagonists|mesh-ancestor
92125190|NCT03169764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125191|NCT03874936|Dexamethasone|dexamethasone|mesh-list
92125192|NCT03874936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92125193|NCT03874936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125194|NCT03874936|Antiemetics|antiemetics|mesh-ancestor
92125195|NCT03874936|Autonomic Agents|autonomic agents|mesh-ancestor
92125196|NCT03874936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125197|NCT03874936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125198|NCT03874936|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125199|NCT03874936|Glucocorticoids|glucocorticoids|mesh-ancestor
92125200|NCT03874936|Hormones|hormones|mesh-ancestor
92125201|NCT03874936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125202|NCT03874936|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92125203|NCT03874936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125204|NCT02399592|Bevacizumab|bevacizumab|mesh-list
92125205|NCT02399592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125206|NCT02399592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125207|NCT02399592|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92125208|NCT02399592|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92125209|NCT02399592|Growth Substances|growth substances|mesh-ancestor
92125210|NCT02399592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125211|NCT02399592|Growth Inhibitors|growth inhibitors|mesh-ancestor
92125212|NCT03801304|Atezolizumab|atezolizumab|mesh-list
92125213|NCT03801304|Vinorelbine|vinorelbine|mesh-list
92125214|NCT03801304|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92125215|NCT03801304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125216|NCT03801304|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125217|NCT03801304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125218|NCT03801304|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125219|NCT03801304|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125220|NCT03801304|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125221|NCT03801304|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125222|NCT02696850|Budesonide|budesonide|mesh-list
92125223|NCT02696850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125224|NCT02696850|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92125225|NCT02696850|Autonomic Agents|autonomic agents|mesh-ancestor
92125226|NCT02696850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125227|NCT02696850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125228|NCT02696850|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92125229|NCT02696850|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125230|NCT02696850|Glucocorticoids|glucocorticoids|mesh-ancestor
92125231|NCT02696850|Hormones|hormones|mesh-ancestor
92125232|NCT02696850|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125233|NCT00365170|Insulin|insulin|mesh-list
92125234|NCT00365170|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92125235|NCT00365170|Insulin Aspart|insulin aspart|mesh-list
92125236|NCT00365170|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92125237|NCT00365170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125238|NCT02403648|Glucagon|glucagon|mesh-list
92125239|NCT02403648|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92125240|NCT02403648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125241|NCT02403648|Hormones|hormones|mesh-ancestor
92125242|NCT02403648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125243|NCT02403648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125244|NCT02403648|Incretins|incretins|mesh-ancestor
92125245|NCT02396862|Factor VIII|factor viii|mesh-list
92125246|NCT02396862|Coagulants|coagulants|mesh-ancestor
92125247|NCT02377492|Vasopressins|vasopressins|mesh-list
92125248|NCT02377492|Arginine Vasopressin|arginine vasopressin|mesh-list
92125249|NCT02377492|Hemostatics|hemostatics|mesh-ancestor
92125250|NCT02377492|Coagulants|coagulants|mesh-ancestor
92125251|NCT02377492|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91938780|NCT00966953|Triclosan|triclosan|mesh-list
92125252|NCT02377492|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92125253|NCT02377492|Natriuretic Agents|natriuretic agents|mesh-ancestor
92125254|NCT02377492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125255|NCT02594644|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92125256|NCT02594644|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92125257|NCT02594644|Dermatologic Agents|dermatologic agents|mesh-ancestor
92125258|NCT02601976|Ribavirin|ribavirin|mesh-list
92125259|NCT02601976|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92125260|NCT02601976|Antimetabolites|antimetabolites|mesh-ancestor
92145228|NCT04277247|Botulinum Toxins|botulinum toxins|mesh-list
92125261|NCT02601976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125262|NCT02601976|Antiviral Agents|antiviral agents|mesh-ancestor
92125263|NCT02601976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125265|NCT02603926|Brexanolone|brexanolone|mesh-list
92125266|NCT02603926|Anesthetics|anesthetics|mesh-ancestor
92125267|NCT02603926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125268|NCT02603926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125269|NCT02603926|Neurosteroids|neurosteroids|mesh-ancestor
92125270|NCT02603926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125271|NCT02603926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125272|NCT02603926|GABA Modulators|gaba modulators|mesh-ancestor
92125273|NCT02603926|GABA Agents|gaba agents|mesh-ancestor
92125274|NCT00365560|Tiotropium Bromide|tiotropium bromide|mesh-list
92125275|NCT00365560|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92125276|NCT00365560|Autonomic Agents|autonomic agents|mesh-ancestor
92125277|NCT00365560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125278|NCT00365560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125279|NCT00365560|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92125280|NCT00365560|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125281|NCT00365560|Parasympatholytics|parasympatholytics|mesh-ancestor
92125282|NCT00365560|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92125283|NCT00365560|Cholinergic Agents|cholinergic agents|mesh-ancestor
92125284|NCT00365560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125285|NCT00365560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125287|NCT02395926|Lipotropic Agents|lipotropic agents|mesh-ancestor
92125288|NCT02395926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92125289|NCT02395926|Antimetabolites|antimetabolites|mesh-ancestor
92125290|NCT02395926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125291|NCT02395926|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125292|NCT02395926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92125293|NCT02395926|Nootropic Agents|nootropic agents|mesh-ancestor
92125294|NCT02402868|Ketamine|ketamine|mesh-list
92125295|NCT02402868|Analgesics|analgesics|mesh-ancestor
92125296|NCT02402868|Sensory System Agents|sensory system agents|mesh-ancestor
92125297|NCT02402868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125298|NCT02402868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125299|NCT02402868|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92125300|NCT02402868|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92125301|NCT02402868|Anesthetics, General|anesthetics, general|mesh-ancestor
92125303|NCT02402868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125304|NCT02402868|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92125305|NCT02402868|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92125306|NCT02402868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125307|NCT02402868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125308|NCT02402712|Docetaxel|docetaxel|mesh-list
92125309|NCT02402712|Trastuzumab|trastuzumab|mesh-list
92125310|NCT02402712|Pertuzumab|pertuzumab|mesh-list
92125311|NCT02402712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125312|NCT02402712|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125313|NCT02402712|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125314|NCT02402712|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125315|NCT02402712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125316|NCT02402712|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125317|NCT02395458|Amoxicillin|amoxicillin|mesh-list
92125318|NCT02395458|Metronidazole|metronidazole|mesh-list
92125319|NCT02395458|Clarithromycin|clarithromycin|mesh-list
92125320|NCT02395458|Omeprazole|omeprazole|mesh-list
92125321|NCT02395458|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125322|NCT02395458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125323|NCT02395458|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92125324|NCT02395458|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92125325|NCT02395458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92125326|NCT02395458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125327|NCT02395458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92125328|NCT02395458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125329|NCT02395458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125330|NCT02395458|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92125331|NCT02395458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92125332|NCT02395458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92125333|NCT02402400|Ticagrelor|ticagrelor|mesh-list
92125334|NCT02402400|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92125335|NCT02402400|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92125336|NCT02402400|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92125338|NCT02402400|Purinergic Agents|purinergic agents|mesh-ancestor
92125339|NCT02402400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125340|NCT02402400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125341|NCT02402400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125343|NCT02610868|Botulinum Toxins|botulinum toxins|mesh-list
92125344|NCT02610868|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92125345|NCT02610868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125346|NCT02610868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125347|NCT02610868|Cholinergic Agents|cholinergic agents|mesh-ancestor
92125348|NCT02610868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125349|NCT02610868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125350|NCT02610868|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92125351|NCT02395068|Irinotecan|irinotecan|mesh-list
92125352|NCT02395068|Nimotuzumab|nimotuzumab|mesh-list
92125353|NCT02395068|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92125354|NCT02395068|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125355|NCT02395068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125356|NCT02395068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125357|NCT02395068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125358|NCT02395068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125359|NCT02616250|Ivermectin|ivermectin|mesh-list
92125360|NCT02616250|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92125361|NCT02616250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92125362|NCT02616250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125363|NCT02616250|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92125364|NCT02616250|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92125365|NCT02616250|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92125366|NCT02616250|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92125367|NCT02616250|Adrenergic Agents|adrenergic agents|mesh-ancestor
92125368|NCT02616250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125369|NCT02616250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125370|NCT02616250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125371|NCT02698410|Temozolomide|temozolomide|mesh-list
92125372|NCT02698410|Lanreotide|lanreotide|mesh-list
92125373|NCT02698410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92125374|NCT02698410|Alkylating Agents|alkylating agents|mesh-ancestor
92125375|NCT02698410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125376|NCT02698410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125377|NCT00365638|Simvastatin|simvastatin|mesh-list
92125378|NCT00365638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92125379|NCT00365638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92125380|NCT00365638|Antimetabolites|antimetabolites|mesh-ancestor
92125381|NCT00365638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125382|NCT00365638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92125383|NCT00365638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92125384|NCT00365638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125385|NCT02699892|Rituximab|rituximab|mesh-list
92125386|NCT02699892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125387|NCT02699892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125388|NCT02699892|Immunologic Factors|immunologic factors|mesh-ancestor
92125389|NCT02699892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125390|NCT02699892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125391|NCT05731258|Doxorubicin|doxorubicin|mesh-list
92125392|NCT05731258|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92125393|NCT05731258|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92125394|NCT05731258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125395|NCT05731258|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92125396|NCT05731258|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125397|NCT05731258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125398|NCT05731258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125399|NCT04340908|Dapagliflozin|dapagliflozin|mesh-list
92125400|NCT04340908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92125401|NCT04340908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125402|NCT04340908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92125403|NCT04340908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125404|NCT05730634|Atorvastatin|atorvastatin|mesh-list
92125405|NCT05730634|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92125406|NCT05730634|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92125407|NCT05730634|Antimetabolites|antimetabolites|mesh-ancestor
92125408|NCT05730634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125409|NCT05730634|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92125410|NCT05730634|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92125411|NCT05730634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125413|NCT05705830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92125414|NCT05705830|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92125415|NCT05705830|Serotonin Agents|serotonin agents|mesh-ancestor
92125416|NCT05705830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125417|NCT05705830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125418|NCT05705830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125419|NCT05705830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92125420|NCT05705830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125421|NCT05745714|Cytarabine|cytarabine|mesh-list
92125422|NCT05745714|Dexamethasone|dexamethasone|mesh-list
92125423|NCT05745714|Cyclophosphamide|cyclophosphamide|mesh-list
92125424|NCT05745714|Venetoclax|venetoclax|mesh-list
92125425|NCT05745714|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125426|NCT05745714|Immunologic Factors|immunologic factors|mesh-ancestor
92125427|NCT05745714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125428|NCT05745714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125429|NCT05745714|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92125430|NCT05745714|Alkylating Agents|alkylating agents|mesh-ancestor
92125431|NCT05745714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125432|NCT05745714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125433|NCT05745714|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92125434|NCT05745714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125435|NCT05745714|Antiemetics|antiemetics|mesh-ancestor
92125436|NCT05745714|Autonomic Agents|autonomic agents|mesh-ancestor
92125437|NCT05745714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125438|NCT05745714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125439|NCT05745714|Glucocorticoids|glucocorticoids|mesh-ancestor
92125440|NCT05745714|Hormones|hormones|mesh-ancestor
92125441|NCT05745714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125442|NCT05745714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92125443|NCT05745714|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92125444|NCT05745714|Antimetabolites|antimetabolites|mesh-ancestor
92125445|NCT05745714|Antiviral Agents|antiviral agents|mesh-ancestor
92125446|NCT05745714|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125447|NCT02974270|Leuprolide|leuprolide|mesh-list
92125448|NCT02974270|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92125449|NCT02974270|Fertility Agents|fertility agents|mesh-ancestor
92125450|NCT02974270|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92125451|NCT02974270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125452|NCT02974270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92125453|NCT02974270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125454|NCT04050540|Doxycycline|doxycycline|mesh-list
92125455|NCT04050540|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125456|NCT04050540|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125457|NCT04050540|Antimalarials|antimalarials|mesh-ancestor
92125458|NCT04050540|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92125459|NCT04050540|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92125460|NCT03167268|Lycopene|lycopene|mesh-list
92125461|NCT03167268|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125462|NCT03167268|Antioxidants|antioxidants|mesh-ancestor
92125463|NCT03167268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125464|NCT03167268|Protective Agents|protective agents|mesh-ancestor
92125465|NCT03167268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125466|NCT03167268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92125467|NCT03167268|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92125468|NCT03167268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125469|NCT04544098|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92125470|NCT04544098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92125471|NCT04544098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125472|NCT04485052|Azacitidine|azacitidine|mesh-list
92125473|NCT04485052|Decitabine|decitabine|mesh-list
92125474|NCT04485052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92125475|NCT04485052|Antimetabolites|antimetabolites|mesh-ancestor
92125476|NCT04485052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125477|NCT04485052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125478|NCT04485052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125479|NCT02393898|Paclitaxel|paclitaxel|mesh-list
92125480|NCT02393898|Bevacizumab|bevacizumab|mesh-list
92125481|NCT02393898|Carboplatin|carboplatin|mesh-list
92125482|NCT02393898|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125483|NCT02393898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125484|NCT02393898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125485|NCT02393898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125486|NCT02393898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125487|NCT02393898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125488|NCT02393898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125489|NCT02393898|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92125490|NCT02393898|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92125491|NCT02393898|Growth Substances|growth substances|mesh-ancestor
92125492|NCT02393898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125493|NCT02393898|Growth Inhibitors|growth inhibitors|mesh-ancestor
92125494|NCT04340128|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92125495|NCT04340128|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92125496|NCT04340128|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92125497|NCT04340128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125498|NCT04258852|Nicotine|nicotine|mesh-list
92125499|NCT04258852|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92125500|NCT04258852|Autonomic Agents|autonomic agents|mesh-ancestor
92125501|NCT04258852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125502|NCT04258852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125503|NCT04258852|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92125504|NCT04258852|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92125505|NCT04258852|Cholinergic Agents|cholinergic agents|mesh-ancestor
92125506|NCT04258852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125507|NCT04258852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125508|NCT04145674|Methadone|methadone|mesh-list
92125509|NCT04145674|D-methadone|d-methadone|mesh-list
92125510|NCT04145674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92125511|NCT04145674|Narcotics|narcotics|mesh-ancestor
92125512|NCT04145674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125513|NCT04145674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125514|NCT04145674|Analgesics|analgesics|mesh-ancestor
92125515|NCT04145674|Sensory System Agents|sensory system agents|mesh-ancestor
92125516|NCT04145674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125517|NCT04145674|Antitussive Agents|antitussive agents|mesh-ancestor
92125518|NCT04145674|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125519|NCT04145674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92125520|NCT02394054|Vasopressins|vasopressins|mesh-list
92125521|NCT02394054|Arginine Vasopressin|arginine vasopressin|mesh-list
91938803|NCT05247320|Sotalol|sotalol|mesh-list
92125522|NCT02394054|Hemostatics|hemostatics|mesh-ancestor
92125523|NCT02394054|Coagulants|coagulants|mesh-ancestor
92125524|NCT02394054|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92125525|NCT02394054|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92125526|NCT02394054|Natriuretic Agents|natriuretic agents|mesh-ancestor
92125527|NCT02394054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125528|NCT02393664|Bupivacaine|bupivacaine|mesh-list
92125529|NCT02393664|Propofol|propofol|mesh-list
92125530|NCT02393664|Sevoflurane|sevoflurane|mesh-list
92125531|NCT02393664|Rocuronium|rocuronium|mesh-list
92125532|NCT02393664|Anesthetics, Local|anesthetics, local|mesh-ancestor
92125533|NCT02393664|Anesthetics|anesthetics|mesh-ancestor
92125534|NCT02393664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125535|NCT02393664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125536|NCT02393664|Sensory System Agents|sensory system agents|mesh-ancestor
92125537|NCT02393664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125538|NCT02393664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92125539|NCT02393664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92125540|NCT02393664|Anesthetics, General|anesthetics, general|mesh-ancestor
92125541|NCT02393664|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92125542|NCT02393664|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92125543|NCT02393664|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92125544|NCT02393664|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92125545|NCT02393664|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92125546|NCT02397642|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92125547|NCT02397642|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92125548|NCT02397642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125549|NCT02397486|Vitamin E|vitamin e|mesh-list
92125550|NCT02397486|Pentoxifylline|pentoxifylline|mesh-list
92125551|NCT02397486|Vitamins|vitamins|mesh-ancestor
92125552|NCT02397486|Micronutrients|micronutrients|mesh-ancestor
92125553|NCT02397486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125554|NCT02397486|Antioxidants|antioxidants|mesh-ancestor
92125555|NCT02397486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083823|NCT01609933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92125556|NCT02397486|Protective Agents|protective agents|mesh-ancestor
92125557|NCT02397486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92125558|NCT02397486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125559|NCT02397486|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92125560|NCT02397486|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92125561|NCT02397486|Vasodilator Agents|vasodilator agents|mesh-ancestor
92125562|NCT02397486|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92125565|NCT02393586|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92125566|NCT02393586|Clavulanic Acids|clavulanic acids|mesh-list
92125567|NCT02393586|Clavulanic Acid|clavulanic acid|mesh-list
92125568|NCT02393586|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125569|NCT02393586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125570|NCT02393586|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92125571|NCT02393586|Antitubercular Agents|antitubercular agents|mesh-ancestor
92125572|NCT02393586|Leprostatic Agents|leprostatic agents|mesh-ancestor
92125573|NCT02393586|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92125574|NCT02393586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125575|NCT02393586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125576|NCT02393586|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92125577|NCT02393586|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92125578|NCT02393586|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92125579|NCT02393586|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92125580|NCT02393586|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92125581|NCT02393586|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92125582|NCT02393586|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92125583|NCT02393430|Rebamipide|rebamipide|mesh-list
92125584|NCT02393430|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92125585|NCT02393430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125586|NCT02393430|Antioxidants|antioxidants|mesh-ancestor
92125587|NCT02393430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125588|NCT02393430|Protective Agents|protective agents|mesh-ancestor
92125589|NCT02393430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125590|NCT02393430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125591|NCT03453892|Pembrolizumab|pembrolizumab|mesh-list
92125592|NCT03453892|Nivolumab|nivolumab|mesh-list
92125593|NCT03453892|Ipilimumab|ipilimumab|mesh-list
92125594|NCT03453892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125595|NCT03453892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125596|NCT03453892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92125597|NCT03453892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125598|NCT00367120|Amoxicillin|amoxicillin|mesh-list
92125599|NCT00367120|Azithromycin|azithromycin|mesh-list
92125600|NCT00367120|Clavulanic Acid|clavulanic acid|mesh-list
92125601|NCT00367120|Clavulanic Acids|clavulanic acids|mesh-list
92125602|NCT00367120|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92125603|NCT00367120|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125604|NCT00367120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125605|NCT00367120|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92125606|NCT00367120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125607|NCT00367120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125608|NCT03103750|Calcitriol|calcitriol|mesh-list
92125609|NCT03103750|Amphetamine|amphetamine|mesh-list
92125610|NCT03103750|Dextroamphetamine|dextroamphetamine|mesh-list
92125611|NCT03103750|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92125612|NCT03103750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125613|NCT03103750|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92125614|NCT03103750|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125615|NCT03103750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125616|NCT03103750|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92125617|NCT03103750|Vitamins|vitamins|mesh-ancestor
92125618|NCT03103750|Micronutrients|micronutrients|mesh-ancestor
92125619|NCT03103750|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92125620|NCT03103750|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92125621|NCT03103750|Sympathomimetics|sympathomimetics|mesh-ancestor
92125622|NCT03103750|Autonomic Agents|autonomic agents|mesh-ancestor
92125623|NCT03103750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125624|NCT03103750|Dopamine Agents|dopamine agents|mesh-ancestor
92125625|NCT03103750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125626|NCT03103750|Adrenergic Agents|adrenergic agents|mesh-ancestor
92125627|NCT03103750|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92125628|NCT03103750|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92125629|NCT03103750|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92125630|NCT02397330|Morphine|morphine|mesh-list
92125631|NCT02397330|Bupivacaine|bupivacaine|mesh-list
92083900|NCT02454322|Tocolytic Agents|tocolytic agents|mesh-ancestor
92125632|NCT02397330|Anesthetics, Local|anesthetics, local|mesh-ancestor
92125633|NCT02397330|Anesthetics|anesthetics|mesh-ancestor
92125634|NCT02397330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125636|NCT02397330|Sensory System Agents|sensory system agents|mesh-ancestor
92125637|NCT02397330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125638|NCT02397330|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92125642|NCT03081052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92125643|NCT03081052|Autonomic Agents|autonomic agents|mesh-ancestor
92125644|NCT03081052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125645|NCT03081052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125646|NCT03081052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92125647|NCT03081052|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125648|NCT03081052|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92125649|NCT03081052|Antioxidants|antioxidants|mesh-ancestor
92125650|NCT03081052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125651|NCT03081052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125652|NCT03081052|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92125653|NCT03081052|Vasodilator Agents|vasodilator agents|mesh-ancestor
92125654|NCT03081052|Gasotransmitters|gasotransmitters|mesh-ancestor
92125655|NCT03081052|Protective Agents|protective agents|mesh-ancestor
92125656|NCT02393196|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92125657|NCT02393196|Plasma Substitutes|plasma substitutes|mesh-ancestor
92125658|NCT02393196|Blood Substitutes|blood substitutes|mesh-ancestor
92125659|NCT03015610|Lansoprazole|lansoprazole|mesh-list
92125660|NCT03015610|Dexlansoprazole|dexlansoprazole|mesh-list
92125661|NCT03015610|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92125662|NCT03015610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125663|NCT03015610|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92125664|NCT03015610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125665|NCT03015610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125666|NCT00422344|Sunitinib|sunitinib|mesh-list
92125667|NCT00422344|Everolimus|everolimus|mesh-list
92125668|NCT00422344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125669|NCT00422344|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92125670|NCT00422344|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92125671|NCT00422344|Growth Substances|growth substances|mesh-ancestor
92125672|NCT00422344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125673|NCT00422344|Growth Inhibitors|growth inhibitors|mesh-ancestor
92125674|NCT00422344|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92125675|NCT00422344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125676|NCT00422344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125677|NCT00422344|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92125678|NCT00422344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125679|NCT00422344|Immunologic Factors|immunologic factors|mesh-ancestor
92125681|NCT02876302|Cyclophosphamide|cyclophosphamide|mesh-list
92125682|NCT02876302|Doxorubicin|doxorubicin|mesh-list
92125683|NCT02876302|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125684|NCT02876302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125685|NCT02876302|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125686|NCT02876302|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125687|NCT02876302|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125688|NCT02876302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125689|NCT02876302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125690|NCT02876302|Immunologic Factors|immunologic factors|mesh-ancestor
92125691|NCT02876302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125692|NCT02876302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125693|NCT02876302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92125694|NCT02876302|Alkylating Agents|alkylating agents|mesh-ancestor
92125695|NCT02876302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92125696|NCT02876302|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92125697|NCT02876302|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92125698|NCT02876302|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125699|NCT02876302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125700|NCT00367276|Drospirenone|drospirenone|mesh-list
92125701|NCT00367276|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92125702|NCT00367276|Hormone Antagonists|hormone antagonists|mesh-ancestor
92125703|NCT00367276|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125704|NCT00367276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125705|NCT00367276|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92125706|NCT00367276|Diuretics|diuretics|mesh-ancestor
92125710|NCT02546986|Cc-486|cc-486|mesh-list
92125711|NCT02546986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125712|NCT02546986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125713|NCT02546986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92125714|NCT02546986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125715|NCT02546986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92125716|NCT02546986|Antimetabolites|antimetabolites|mesh-ancestor
92125717|NCT02546986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125718|NCT02689206|Glycine|glycine|mesh-list
92125719|NCT02689206|Glycine Agents|glycine agents|mesh-ancestor
92125720|NCT02689206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125721|NCT02689206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125722|NCT02689206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125723|NCT01695239|Adalimumab|adalimumab|mesh-list
92125724|NCT01695239|Ixekizumab|ixekizumab|mesh-list
92125725|NCT01695239|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92125726|NCT01695239|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125727|NCT01695239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125728|NCT01695239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92125729|NCT02163694|Paclitaxel|paclitaxel|mesh-list
92125730|NCT02163694|Carboplatin|carboplatin|mesh-list
92125731|NCT02163694|Veliparib|veliparib|mesh-list
92125732|NCT02163694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125733|NCT02163694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125734|NCT02163694|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125735|NCT02163694|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125736|NCT02163694|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125737|NCT02163694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125738|NCT02163694|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92125739|NCT02163694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125740|NCT01587352|Vorinostat|vorinostat|mesh-list
92125741|NCT01587352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125742|NCT01587352|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92125743|NCT01587352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125744|NCT01587352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125745|NCT00703222|Interleukin-2|interleukin-2|mesh-list
92125746|NCT00703222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125747|NCT00703222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92125748|NCT00703222|Analgesics|analgesics|mesh-ancestor
92125749|NCT00703222|Sensory System Agents|sensory system agents|mesh-ancestor
92125750|NCT00703222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125751|NCT00703222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125752|NCT04449250|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92125753|NCT04449250|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92125754|NCT04449250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125755|NCT04449250|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92125756|NCT04449250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92125757|NCT04449250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125758|NCT04449250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125759|NCT04449250|Dopamine Agents|dopamine agents|mesh-ancestor
92125760|NCT04449250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125761|NCT04317430|Niclosamide|niclosamide|mesh-list
92125762|NCT04317430|Anticestodal Agents|anticestodal agents|mesh-ancestor
92125763|NCT04317430|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92125764|NCT04317430|Anthelmintics|anthelmintics|mesh-ancestor
92125765|NCT04317430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92125766|NCT04317430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125767|NCT04317430|Antinematodal Agents|antinematodal agents|mesh-ancestor
92125768|NCT04277884|Firibastat|firibastat|mesh-list
92125769|NCT04277884|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92125773|NCT00367822|Ropinirole|ropinirole|mesh-list
92125774|NCT00367822|Lisuride|lisuride|mesh-list
92125775|NCT00367822|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92125776|NCT00367822|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92125777|NCT00367822|Dopamine Agonists|dopamine agonists|mesh-ancestor
92125778|NCT00367822|Dopamine Agents|dopamine agents|mesh-ancestor
92125779|NCT00367822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125780|NCT00367822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125781|NCT00367822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125782|NCT00367822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92125783|NCT00367822|Serotonin Agents|serotonin agents|mesh-ancestor
92125785|NCT03189706|Temozolomide|temozolomide|mesh-list
92125786|NCT03189706|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92125787|NCT03189706|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125788|NCT03189706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125789|NCT03189706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125790|NCT03189706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125791|NCT03189706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92125792|NCT03189706|Alkylating Agents|alkylating agents|mesh-ancestor
92125794|NCT02643862|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92125795|NCT02643862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92125796|NCT02643862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125797|NCT01694771|Tiotropium Bromide|tiotropium bromide|mesh-list
92125798|NCT01694771|Olodaterol|olodaterol|mesh-list
92125799|NCT01694771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92125801|NCT01694771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125802|NCT01694771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125803|NCT01694771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92125804|NCT01694771|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125805|NCT01694771|Parasympatholytics|parasympatholytics|mesh-ancestor
92125806|NCT01694771|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92125807|NCT01694771|Cholinergic Agents|cholinergic agents|mesh-ancestor
92125808|NCT01694771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125809|NCT01694771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125810|NCT02651272|Macitentan|macitentan|mesh-list
92125811|NCT02651272|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92125812|NCT02651272|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92125813|NCT02651272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125814|NCT02651272|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92125815|NCT01582061|Pasireotide|pasireotide|mesh-list
92125816|NCT01582061|Hormones|hormones|mesh-ancestor
92125817|NCT01582061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125818|NCT01582061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125819|NCT01693523|Minocycline|minocycline|mesh-list
92125820|NCT01693523|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125821|NCT01693523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125822|NCT03924323|Escitalopram|escitalopram|mesh-list
92125823|NCT03924323|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92125824|NCT03924323|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92125825|NCT03924323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125826|NCT03924323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125827|NCT03924323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125828|NCT03924323|Serotonin Agents|serotonin agents|mesh-ancestor
92125829|NCT03924323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125830|NCT01581281|Topiramate|topiramate|mesh-list
92125831|NCT01581281|Amitriptyline|amitriptyline|mesh-list
92125832|NCT01581281|Anticonvulsants|anticonvulsants|mesh-ancestor
92125833|NCT01581281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92125834|NCT01581281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125835|NCT01581281|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92125836|NCT01581281|Antidepressive Agents|antidepressive agents|mesh-ancestor
92125837|NCT01581281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92125838|NCT01581281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92125839|NCT01581281|Analgesics|analgesics|mesh-ancestor
92125840|NCT01581281|Sensory System Agents|sensory system agents|mesh-ancestor
92125841|NCT01581281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125842|NCT01581281|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92125843|NCT01581281|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92125844|NCT01581281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92125845|NCT01581281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125846|NCT01581281|Adrenergic Agents|adrenergic agents|mesh-ancestor
92125847|NCT01581281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125848|NCT01580969|Minocycline|minocycline|mesh-list
92125849|NCT01580969|Bevacizumab|bevacizumab|mesh-list
92125850|NCT01580969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125851|NCT01580969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125852|NCT01580969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92125853|NCT01580969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92125854|NCT01580969|Growth Substances|growth substances|mesh-ancestor
92125855|NCT01580969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084125|NCT00608062|Estradiol|estradiol|mesh-list
92125856|NCT01580969|Growth Inhibitors|growth inhibitors|mesh-ancestor
92125857|NCT01580969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92125858|NCT01580969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125859|NCT02696226|Aspirin|aspirin|mesh-list
92125860|NCT02696226|Warfarin|warfarin|mesh-list
92125861|NCT02696226|Clopidogrel|clopidogrel|mesh-list
92125862|NCT02696226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92125863|NCT02696226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92125864|NCT02696226|Analgesics|analgesics|mesh-ancestor
92125865|NCT02696226|Sensory System Agents|sensory system agents|mesh-ancestor
92125866|NCT02696226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125867|NCT02696226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125868|NCT02696226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125869|NCT02696226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125870|NCT02696226|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92125871|NCT02696226|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92125872|NCT02696226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125873|NCT02696226|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92125874|NCT02696226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92125875|NCT02696226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125876|NCT02696226|Antipyretics|antipyretics|mesh-ancestor
92125877|NCT02696226|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92125878|NCT02696226|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92125879|NCT02696226|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92125880|NCT02696226|Purinergic Agents|purinergic agents|mesh-ancestor
92125881|NCT02696226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92125882|NCT02696226|Anticoagulants|anticoagulants|mesh-ancestor
92125883|NCT04547777|D2C7-(scdsFv)-PE38KDEL|d2c7-(scdsfv)-pe38kdel|mesh-list
92125884|NCT04547777|Immunoconjugates|immunoconjugates|mesh-ancestor
92125885|NCT04547777|Immunologic Factors|immunologic factors|mesh-ancestor
92125886|NCT04547777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125887|NCT03167112|Leucovorin|leucovorin|mesh-list
92125888|NCT03167112|Fluorouracil|fluorouracil|mesh-list
92125889|NCT03167112|Oxaliplatin|oxaliplatin|mesh-list
92125890|NCT03167112|Irinotecan|irinotecan|mesh-list
92125891|NCT03167112|Antimetabolites|antimetabolites|mesh-ancestor
92125892|NCT03167112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125893|NCT03167112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92125894|NCT03167112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125895|NCT03167112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125896|NCT03167112|Immunologic Factors|immunologic factors|mesh-ancestor
92125897|NCT03167112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125898|NCT03167112|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92125899|NCT03167112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125900|NCT03167112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125901|NCT03167112|Antidotes|antidotes|mesh-ancestor
92125902|NCT03167112|Protective Agents|protective agents|mesh-ancestor
92125903|NCT03167112|Vitamin B Complex|vitamin b complex|mesh-ancestor
92125904|NCT03167112|Vitamins|vitamins|mesh-ancestor
92125905|NCT03167112|Micronutrients|micronutrients|mesh-ancestor
92125906|NCT01578785|Glatiramer Acetate|glatiramer acetate|mesh-list
92125907|NCT01578785|(T,G)-A-L|(t,g)-a-l|mesh-list
92125908|NCT01578785|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92125909|NCT01578785|Immunologic Factors|immunologic factors|mesh-ancestor
92125910|NCT01578785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125911|NCT01578785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125912|NCT01578785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92125913|NCT03167034|Acetazolamide|acetazolamide|mesh-list
92125914|NCT03167034|Anticonvulsants|anticonvulsants|mesh-ancestor
92125915|NCT03167034|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92125916|NCT03167034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125917|NCT03167034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125918|NCT03167034|Diuretics|diuretics|mesh-ancestor
92125919|NCT03167034|Natriuretic Agents|natriuretic agents|mesh-ancestor
92125920|NCT03167034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125921|NCT01578551|Metformin|metformin|mesh-list
92125922|NCT01578551|Biguanides|biguanides|mesh-list
92125923|NCT01578551|Paclitaxel|paclitaxel|mesh-list
92125924|NCT01578551|Bevacizumab|bevacizumab|mesh-list
92125925|NCT01578551|Carboplatin|carboplatin|mesh-list
92125926|NCT01578551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92125927|NCT01578551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125928|NCT01578551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92125929|NCT01578551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92125930|NCT01578551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92125931|NCT01578551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125932|NCT01578551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125933|NCT01578551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92125934|NCT01578551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92125935|NCT01578551|Growth Substances|growth substances|mesh-ancestor
92125936|NCT01578551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125937|NCT01578551|Growth Inhibitors|growth inhibitors|mesh-ancestor
92125938|NCT01578551|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92125939|NCT01692197|Cytarabine|cytarabine|mesh-list
92125940|NCT01692197|Dexamethasone|dexamethasone|mesh-list
92125941|NCT01692197|Idarubicin|idarubicin|mesh-list
92125942|NCT01692197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125943|NCT01692197|Antiemetics|antiemetics|mesh-ancestor
92125944|NCT01692197|Autonomic Agents|autonomic agents|mesh-ancestor
92125945|NCT01692197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125946|NCT01692197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125947|NCT01692197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92125948|NCT01692197|Glucocorticoids|glucocorticoids|mesh-ancestor
92125949|NCT01692197|Hormones|hormones|mesh-ancestor
92125950|NCT01692197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92125951|NCT01692197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92125952|NCT01692197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125953|NCT01692197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92125954|NCT01692197|Antimetabolites|antimetabolites|mesh-ancestor
92125955|NCT01692197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125956|NCT01692197|Antiviral Agents|antiviral agents|mesh-ancestor
92125957|NCT01692197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92125958|NCT01692197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92125959|NCT01692197|Immunologic Factors|immunologic factors|mesh-ancestor
92125960|NCT01692197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92125961|NCT01692197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92125962|NCT01692197|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92125963|NCT01692197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92125964|NCT03166644|Sufentanil|sufentanil|mesh-list
92125965|NCT03166644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92125966|NCT03166644|Narcotics|narcotics|mesh-ancestor
92125967|NCT03166644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92125968|NCT03166644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125969|NCT03166644|Analgesics|analgesics|mesh-ancestor
92125970|NCT03166644|Sensory System Agents|sensory system agents|mesh-ancestor
92125971|NCT03166644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125972|NCT03166644|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92125973|NCT03166644|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92125974|NCT03166644|Anesthetics, General|anesthetics, general|mesh-ancestor
92125975|NCT03166644|Anesthetics|anesthetics|mesh-ancestor
92125976|NCT01691885|Fluticasone|fluticasone|mesh-list
92125977|NCT01691885|Xhance|xhance|mesh-list
92125978|NCT01691885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92125979|NCT01691885|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92125980|NCT01691885|Autonomic Agents|autonomic agents|mesh-ancestor
92125981|NCT01691885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92125982|NCT01691885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125983|NCT01691885|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92125984|NCT01691885|Respiratory System Agents|respiratory system agents|mesh-ancestor
92125985|NCT01691885|Dermatologic Agents|dermatologic agents|mesh-ancestor
92125986|NCT01691885|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92125987|NCT03166800|Ubiquinone|ubiquinone|mesh-list
92125988|NCT03166800|Micronutrients|micronutrients|mesh-ancestor
92125989|NCT03166800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125990|NCT03166254|Pembrolizumab|pembrolizumab|mesh-list
92125991|NCT03166254|Vaccines|vaccines|mesh-list
92125992|NCT03166254|Poly ICLC|poly iclc|mesh-list
92125993|NCT03166254|Immunologic Factors|immunologic factors|mesh-ancestor
92125994|NCT03166254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92125995|NCT03166254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92125996|NCT03166254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92125997|NCT03166254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92125998|NCT03166254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92125999|NCT03166254|Interferon Inducers|interferon inducers|mesh-ancestor
92126000|NCT02651428|Taurolidine|taurolidine|mesh-list
92126001|NCT02651428|Heparin|heparin|mesh-list
92126002|NCT02651428|Calcium heparin|calcium heparin|mesh-list
92126003|NCT02651428|Anticoagulants|anticoagulants|mesh-ancestor
92126004|NCT02651428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126005|NCT02651428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92126006|NCT02651428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92126007|NCT02651428|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126008|NCT02651428|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92126009|NCT02651428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126010|NCT02686164|Lenvatinib|lenvatinib|mesh-list
92126011|NCT02686164|Midazolam|midazolam|mesh-list
92126012|NCT02686164|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92126013|NCT02686164|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92126014|NCT02686164|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126015|NCT02686164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126016|NCT02686164|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92126017|NCT02686164|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92126018|NCT02686164|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92126019|NCT02686164|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92126020|NCT02686164|Anesthetics, General|anesthetics, general|mesh-ancestor
92126022|NCT02686164|GABA Modulators|gaba modulators|mesh-ancestor
92126023|NCT02686164|GABA Agents|gaba agents|mesh-ancestor
92126024|NCT02686164|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126025|NCT02686164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126026|NCT02686164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126027|NCT02686164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126028|NCT02686164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126032|NCT02651584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126033|NCT02651584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126034|NCT02651584|Analgesics|analgesics|mesh-ancestor
92126035|NCT02651584|Sensory System Agents|sensory system agents|mesh-ancestor
92126036|NCT02651584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126037|NCT02651584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92126038|NCT02685072|Progesterone|progesterone|mesh-list
92126039|NCT02685072|Progestins|progestins|mesh-ancestor
92126040|NCT02685072|Hormones|hormones|mesh-ancestor
92126041|NCT02685072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938881|NCT00871481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126042|NCT02685072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126043|NCT02653144|Dexamethasone|dexamethasone|mesh-list
92126044|NCT02653144|Dexmedetomidine|dexmedetomidine|mesh-list
92126045|NCT02653144|Ropivacaine|ropivacaine|mesh-list
92126046|NCT02653144|Anesthetics|anesthetics|mesh-list
92126047|NCT02653144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126048|NCT02653144|Antiemetics|antiemetics|mesh-ancestor
92126049|NCT02653144|Autonomic Agents|autonomic agents|mesh-ancestor
92126050|NCT02653144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126051|NCT02653144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126052|NCT02653144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126053|NCT02653144|Glucocorticoids|glucocorticoids|mesh-ancestor
92126054|NCT02653144|Hormones|hormones|mesh-ancestor
92126055|NCT02653144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126056|NCT02653144|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92126057|NCT02653144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126058|NCT02653144|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92126059|NCT02653144|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126060|NCT02653144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92126061|NCT02653144|Analgesics|analgesics|mesh-ancestor
92126062|NCT02653144|Sensory System Agents|sensory system agents|mesh-ancestor
92126063|NCT02653144|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92126064|NCT02653144|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92126065|NCT02653144|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92126066|NCT02653144|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126067|NCT02653144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126068|NCT02653144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126069|NCT02653144|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126070|NCT00118365|Eflornithine|eflornithine|mesh-list
92126071|NCT00118365|Sulindac|sulindac|mesh-list
92126072|NCT00118365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126073|NCT00118365|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92126074|NCT00118365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92126075|NCT00118365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92126076|NCT00118365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126077|NCT00118365|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92126078|NCT00118365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126079|NCT00118365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126080|NCT00118365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92126081|NCT00118365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92126082|NCT00118365|Analgesics|analgesics|mesh-ancestor
92126083|NCT00118365|Sensory System Agents|sensory system agents|mesh-ancestor
92126084|NCT00118365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126085|NCT00118365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126086|NCT00118365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126087|NCT00118365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126088|NCT00118365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92126089|NCT03165240|Eplerenone|eplerenone|mesh-list
92126090|NCT03165240|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92126091|NCT03165240|Hormone Antagonists|hormone antagonists|mesh-ancestor
92126092|NCT03165240|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126093|NCT03165240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126094|NCT03165240|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92126096|NCT03165240|Natriuretic Agents|natriuretic agents|mesh-ancestor
92126097|NCT03165240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92126098|NCT01587079|Tiotropium Bromide|tiotropium bromide|mesh-list
92126099|NCT01587079|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92126100|NCT01587079|Autonomic Agents|autonomic agents|mesh-ancestor
92126101|NCT01587079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126102|NCT01587079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126103|NCT01587079|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92126104|NCT01587079|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126105|NCT01587079|Parasympatholytics|parasympatholytics|mesh-ancestor
92126106|NCT01587079|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92126107|NCT01587079|Cholinergic Agents|cholinergic agents|mesh-ancestor
92126108|NCT01587079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126109|NCT01587079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126110|NCT03028909|Oseltamivir|oseltamivir|mesh-list
92126111|NCT03028909|MEDI8852|medi8852|mesh-list
92126112|NCT03028909|Antiviral Agents|antiviral agents|mesh-ancestor
92126113|NCT03028909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126114|NCT03028909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938905|NCT05083689|Lubricant Eye Drops|lubricant eye drops|mesh-list
92126115|NCT03028909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126116|NCT02654860|Acetaminophen|acetaminophen|mesh-list
92126117|NCT02654860|Bupivacaine|bupivacaine|mesh-list
92126118|NCT02654860|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126119|NCT02654860|Anesthetics|anesthetics|mesh-ancestor
92126120|NCT02654860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126121|NCT02654860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126122|NCT02654860|Sensory System Agents|sensory system agents|mesh-ancestor
92126123|NCT02654860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126124|NCT02654860|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92126125|NCT02654860|Analgesics|analgesics|mesh-ancestor
92126126|NCT02654860|Antipyretics|antipyretics|mesh-ancestor
92126127|NCT01587001|Acetylcysteine|acetylcysteine|mesh-list
92126128|NCT01587001|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92126129|NCT01587001|Antiviral Agents|antiviral agents|mesh-ancestor
92126130|NCT01587001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126131|NCT01587001|Expectorants|expectorants|mesh-ancestor
92126132|NCT01587001|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126133|NCT01587001|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92126134|NCT01587001|Antioxidants|antioxidants|mesh-ancestor
92126135|NCT01587001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126136|NCT01587001|Protective Agents|protective agents|mesh-ancestor
92126137|NCT01587001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126138|NCT01587001|Antidotes|antidotes|mesh-ancestor
92126139|NCT01568047|Levodopa|levodopa|mesh-list
92126140|NCT01568047|Carbidopa|carbidopa|mesh-list
92126141|NCT01568047|Opicapone|opicapone|mesh-list
92126142|NCT01568047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92126143|NCT01568047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92126144|NCT01568047|Dopamine Agents|dopamine agents|mesh-ancestor
92126145|NCT01568047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126146|NCT01568047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126147|NCT01568047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126148|NCT01568047|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92126149|NCT01568047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126150|NCT01568047|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92126151|NCT04782258|Tolvaptan|tolvaptan|mesh-list
92126152|NCT04782258|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92126153|NCT04782258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126154|NCT04782258|Natriuretic Agents|natriuretic agents|mesh-ancestor
92126155|NCT04782258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126156|NCT01688921|Vaccines|vaccines|mesh-list
92126157|NCT01688921|Immunologic Factors|immunologic factors|mesh-ancestor
92126158|NCT01688921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126159|NCT00118755|Bevacizumab|bevacizumab|mesh-list
92126160|NCT00118755|Capecitabine|capecitabine|mesh-list
92126161|NCT00118755|Oxaliplatin|oxaliplatin|mesh-list
92126162|NCT00118755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126163|NCT00118755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126164|NCT00118755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92126165|NCT00118755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92126166|NCT00118755|Growth Substances|growth substances|mesh-ancestor
92126167|NCT00118755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126168|NCT00118755|Growth Inhibitors|growth inhibitors|mesh-ancestor
92126169|NCT00118755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92126170|NCT00118755|Antimetabolites|antimetabolites|mesh-ancestor
92126171|NCT00118755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126172|NCT01541371|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92126173|NCT01541371|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92126174|NCT01541371|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92126175|NCT01541371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126176|NCT01541371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126177|NCT01541371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92126178|NCT01541371|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92126179|NCT01541371|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92126180|NCT01541371|Serotonin Agents|serotonin agents|mesh-ancestor
92126181|NCT01541371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126182|NCT01541371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126183|NCT01541371|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92126184|NCT01541371|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92126185|NCT01541371|Dopamine Agents|dopamine agents|mesh-ancestor
92126186|NCT02662036|Bupivacaine|bupivacaine|mesh-list
92126187|NCT02662036|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126188|NCT02662036|Anesthetics|anesthetics|mesh-ancestor
92126189|NCT02662036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126190|NCT02662036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126191|NCT02662036|Sensory System Agents|sensory system agents|mesh-ancestor
92126192|NCT02662036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126193|NCT01687673|Sirolimus|sirolimus|mesh-list
92126194|NCT01687673|Sorafenib|sorafenib|mesh-list
92126195|NCT01687673|Temsirolimus|temsirolimus|mesh-list
92126196|NCT01687673|MTOR Inhibitors|mtor inhibitors|mesh-list
92126197|NCT01687673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126198|NCT01687673|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126199|NCT01687673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126200|NCT01687673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126201|NCT01687673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92126202|NCT01687673|Immunologic Factors|immunologic factors|mesh-ancestor
92126203|NCT01687673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126204|NCT01687673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92126205|NCT01687673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126206|NCT01687673|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92126207|NCT01687673|Antifungal Agents|antifungal agents|mesh-ancestor
92126208|NCT00121251|Gemcitabine|gemcitabine|mesh-list
92126209|NCT00121251|Capecitabine|capecitabine|mesh-list
92126210|NCT00121251|Sorafenib|sorafenib|mesh-list
92126211|NCT00121251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92126212|NCT00121251|Antimetabolites|antimetabolites|mesh-ancestor
92126213|NCT00121251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126214|NCT00121251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126215|NCT00121251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126216|NCT00121251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126217|NCT02664220|Povidone-Iodine|povidone-iodine|mesh-list
92126218|NCT02664220|Povidone|povidone|mesh-list
92126219|NCT02664220|Plasma Substitutes|plasma substitutes|mesh-ancestor
92126220|NCT02664220|Blood Substitutes|blood substitutes|mesh-ancestor
92126221|NCT02664220|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92126222|NCT02664220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126223|NCT04339348|Lidocaine|lidocaine|mesh-list
92126224|NCT04339348|Prilocaine|prilocaine|mesh-list
92126225|NCT04339348|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92126226|NCT04339348|Misoprostol|misoprostol|mesh-list
92126227|NCT04339348|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126228|NCT04339348|Anesthetics|anesthetics|mesh-ancestor
92126229|NCT04339348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126230|NCT04339348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126231|NCT04339348|Sensory System Agents|sensory system agents|mesh-ancestor
92126232|NCT04339348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126233|NCT04339348|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92126234|NCT04339348|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92126235|NCT04339348|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92126236|NCT04339348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126237|NCT04339348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126238|NCT04339348|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92126239|NCT04339348|Abortifacient Agents|abortifacient agents|mesh-ancestor
92126240|NCT04339348|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92126241|NCT04339348|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92126242|NCT04339348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126243|NCT04339348|Oxytocics|oxytocics|mesh-ancestor
92126244|NCT04339348|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92126245|NCT02664922|Ketamine|ketamine|mesh-list
92126246|NCT02664922|Remifentanil|remifentanil|mesh-list
92126247|NCT02664922|Propofol|propofol|mesh-list
92126248|NCT02664922|Sevoflurane|sevoflurane|mesh-list
92126249|NCT02664922|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92126250|NCT02664922|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126251|NCT02664922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126252|NCT02664922|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92126253|NCT02664922|Anesthetics, General|anesthetics, general|mesh-ancestor
92126254|NCT02664922|Anesthetics|anesthetics|mesh-ancestor
92126255|NCT02664922|Analgesics|analgesics|mesh-ancestor
92126256|NCT02664922|Sensory System Agents|sensory system agents|mesh-ancestor
92126257|NCT02664922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126258|NCT02664922|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92126259|NCT02664922|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92126260|NCT02664922|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92126261|NCT02664922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126262|NCT02664922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126263|NCT02664922|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92126265|NCT02664922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92126266|NCT02664922|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92126267|NCT02666950|Cytarabine|cytarabine|mesh-list
92126268|NCT02666950|Adavosertib|adavosertib|mesh-list
92126269|NCT02666950|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92126270|NCT02666950|Antimetabolites|antimetabolites|mesh-ancestor
92126271|NCT02666950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126272|NCT02666950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126273|NCT02666950|Antiviral Agents|antiviral agents|mesh-ancestor
92126274|NCT02666950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126275|NCT02666950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92126276|NCT02666950|Immunologic Factors|immunologic factors|mesh-ancestor
92126277|NCT02666950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126278|NCT02666950|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126279|NCT02668432|Amiodarone|amiodarone|mesh-list
92126280|NCT02668432|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92126281|NCT02668432|Vasodilator Agents|vasodilator agents|mesh-ancestor
92126282|NCT02668432|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92126283|NCT02668432|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126284|NCT02668432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126285|NCT02668432|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92126286|NCT02668432|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92126287|NCT02668432|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92126288|NCT02668432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126289|NCT02668432|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92126290|NCT02668432|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92126291|NCT02668432|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92126292|NCT01687283|Fluticasone|fluticasone|mesh-list
92126294|NCT01687283|Budesonide|budesonide|mesh-list
92126295|NCT01687283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126296|NCT01687283|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92126297|NCT01687283|Autonomic Agents|autonomic agents|mesh-ancestor
92126298|NCT01687283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126299|NCT01687283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126300|NCT01687283|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92126301|NCT01687283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126302|NCT01687283|Dermatologic Agents|dermatologic agents|mesh-ancestor
92126303|NCT01687283|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92126304|NCT01687283|Glucocorticoids|glucocorticoids|mesh-ancestor
92126305|NCT01687283|Hormones|hormones|mesh-ancestor
92126306|NCT01687283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126307|NCT02684370|Ustekinumab|ustekinumab|mesh-list
92126308|NCT02684370|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92126309|NCT02684370|Dermatologic Agents|dermatologic agents|mesh-ancestor
92126310|NCT02684370|Immunologic Factors|immunologic factors|mesh-ancestor
92126311|NCT02684370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126312|NCT02669914|Durvalumab|durvalumab|mesh-list
92126313|NCT02669914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126314|NCT02669914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126315|NCT01686581|Botulinum Toxins|botulinum toxins|mesh-list
92126316|NCT01686581|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92126317|NCT01686581|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92126318|NCT01686581|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92126319|NCT01686581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126320|NCT01686581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126321|NCT01686581|Cholinergic Agents|cholinergic agents|mesh-ancestor
92126322|NCT01686581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126323|NCT01686581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126324|NCT01686581|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92126325|NCT01686581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126326|NCT04739410|Ivermectin|ivermectin|mesh-list
92126327|NCT04739410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92126328|NCT04739410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126329|NCT02691936|Estrogens|estrogens|mesh-list
92126330|NCT02691936|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92126331|NCT02691936|Hormones|hormones|mesh-ancestor
92126332|NCT02691936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145303|NCT00245037|Mycophenolic Acid|mycophenolic acid|mesh-list
92126333|NCT02691936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126334|NCT04707742|Povidone-Iodine|povidone-iodine|mesh-list
92126335|NCT04707742|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92126336|NCT04707742|Cetylpyridinium|cetylpyridinium|mesh-list
92126337|NCT04707742|Povidone|povidone|mesh-list
92126338|NCT04707742|Plasma Substitutes|plasma substitutes|mesh-ancestor
92126339|NCT04707742|Blood Substitutes|blood substitutes|mesh-ancestor
92126340|NCT04707742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92126341|NCT04707742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126342|NCT02680054|Insulin|insulin|mesh-list
92126343|NCT02680054|Insulin Aspart|insulin aspart|mesh-list
92126344|NCT02680054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126345|NCT02680054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126346|NCT00367978|Amlodipine|amlodipine|mesh-list
92126347|NCT00367978|Benazepril|benazepril|mesh-list
92126348|NCT00367978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92126349|NCT00367978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92126350|NCT00367978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126351|NCT00367978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126352|NCT00367978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92126353|NCT00367978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126354|NCT00367978|Vasodilator Agents|vasodilator agents|mesh-ancestor
92126355|NCT00367978|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92126356|NCT00367978|Protease Inhibitors|protease inhibitors|mesh-ancestor
92126357|NCT00367978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126358|NCT00368056|Eszopiclone|eszopiclone|mesh-list
92126359|NCT00368056|Zopiclone|zopiclone|mesh-list
92126360|NCT00368056|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92126361|NCT00368056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126362|NCT00368056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126363|NCT01685801|Ivacaftor|ivacaftor|mesh-list
92126364|NCT01685801|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92126365|NCT01685801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126366|NCT01685801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126367|NCT01684943|Insulin|insulin|mesh-list
92126368|NCT01684943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126369|NCT01684943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126370|NCT04739566|Trametinib|trametinib|mesh-list
92126371|NCT04739566|Dabrafenib|dabrafenib|mesh-list
92126372|NCT04739566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126373|NCT04739566|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126374|NCT04739566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126375|NCT04739566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126376|NCT05339542|Methylprednisolone|methylprednisolone|mesh-list
92126377|NCT05339542|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92126378|NCT05339542|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92126379|NCT05339542|Prednisolone|prednisolone|mesh-list
92126380|NCT05339542|Prednisolone acetate|prednisolone acetate|mesh-list
92126381|NCT05339542|Lidocaine|lidocaine|mesh-list
92126382|NCT05339542|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92126383|NCT05339542|Prednisolone phosphate|prednisolone phosphate|mesh-list
92126384|NCT05339542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126385|NCT05339542|Anesthetics|anesthetics|mesh-ancestor
92126386|NCT05339542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126387|NCT05339542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126388|NCT05339542|Sensory System Agents|sensory system agents|mesh-ancestor
92126389|NCT05339542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126392|NCT05339542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92126393|NCT05339542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126394|NCT05339542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126395|NCT05339542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126397|NCT05339542|Autonomic Agents|autonomic agents|mesh-ancestor
92126398|NCT05339542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126399|NCT05339542|Glucocorticoids|glucocorticoids|mesh-ancestor
92126400|NCT05339542|Hormones|hormones|mesh-ancestor
92126401|NCT05339542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126402|NCT05339542|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92126403|NCT05339542|Protective Agents|protective agents|mesh-ancestor
92126404|NCT05339542|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92126405|NCT05339542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126406|NCT03162900|Moxifloxacin|moxifloxacin|mesh-list
92126407|NCT03162900|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92126408|NCT03162900|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126409|NCT03162900|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92126410|NCT03162900|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92126411|NCT03162900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126412|NCT03162900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126413|NCT03162900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126414|NCT05257018|Doxorubicin|doxorubicin|mesh-list
92126415|NCT05257018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92126416|NCT05257018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126417|NCT05257018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92126418|NCT05257018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92126419|NCT05257018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126420|NCT05257018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126421|NCT00368602|Timolol|timolol|mesh-list
92126422|NCT00368602|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92126423|NCT00368602|Adrenergic Antagonists|adrenergic antagonists|mesh-list
92126424|NCT00368602|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126425|NCT00368602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126426|NCT00368602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126427|NCT00368602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126428|NCT00368602|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92126429|NCT00368602|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92126430|NCT01683071|Bupivacaine|bupivacaine|mesh-list
92126431|NCT01683071|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126432|NCT01683071|Anesthetics|anesthetics|mesh-ancestor
92126433|NCT01683071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126434|NCT01683071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126435|NCT01683071|Sensory System Agents|sensory system agents|mesh-ancestor
92126436|NCT01683071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126437|NCT04707508|Metformin|metformin|mesh-list
92126438|NCT04707508|Valsartan|valsartan|mesh-list
92126439|NCT04707508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126440|NCT04707508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126441|NCT04707508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92126442|NCT04707508|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92126443|NCT04707508|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92126444|NCT04707508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126445|NCT01567865|Vaccines|vaccines|mesh-list
92126446|NCT01567865|Immunologic Factors|immunologic factors|mesh-ancestor
92126447|NCT01567865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126448|NCT05049226|Vaccines|vaccines|mesh-list
92126449|NCT05049226|Immunologic Factors|immunologic factors|mesh-ancestor
92126450|NCT05049226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126451|NCT01567163|Docetaxel|docetaxel|mesh-list
92126452|NCT01567163|Ramucirumab|ramucirumab|mesh-list
92126453|NCT01567163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126454|NCT01567163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92126455|NCT01567163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92126456|NCT01567163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92126457|NCT01567163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126458|NCT05002114|Cannabidiol|cannabidiol|mesh-list
92126459|NCT05002114|Anticonvulsants|anticonvulsants|mesh-ancestor
92126463|NCT04338802|Nintedanib|nintedanib|mesh-list
92084710|NCT00640822|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92126464|NCT04338802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126465|NCT04338802|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126466|NCT04338802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126467|NCT04338802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126468|NCT04395508|Trastuzumab|trastuzumab|mesh-list
92126469|NCT04395508|Pertuzumab|pertuzumab|mesh-list
92126470|NCT04395508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126471|NCT04395508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126472|NCT00368914|Sirolimus|sirolimus|mesh-list
92126473|NCT00368914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92126474|NCT00368914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126475|NCT00368914|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92126476|NCT00368914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126477|NCT00368914|Antifungal Agents|antifungal agents|mesh-ancestor
92126478|NCT00368914|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92126479|NCT00368914|Immunologic Factors|immunologic factors|mesh-ancestor
92126480|NCT00368914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126482|NCT01567085|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92126483|NCT01567085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92126484|NCT01567085|Immunologic Factors|immunologic factors|mesh-ancestor
92126485|NCT01567085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126486|NCT04344184|Ascorbic Acid|ascorbic acid|mesh-list
92126487|NCT04344184|Vitamins|vitamins|mesh-ancestor
92126488|NCT04344184|Micronutrients|micronutrients|mesh-ancestor
92126489|NCT04344184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126490|NCT04344184|Antioxidants|antioxidants|mesh-ancestor
92126491|NCT04344184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126492|NCT04344184|Protective Agents|protective agents|mesh-ancestor
92126493|NCT01566773|Bromides|bromides|mesh-list
92126494|NCT01566773|Tiotropium Bromide|tiotropium bromide|mesh-list
92126495|NCT01566773|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92126496|NCT01566773|Autonomic Agents|autonomic agents|mesh-ancestor
92126497|NCT01566773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126498|NCT01566773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126499|NCT01566773|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92126500|NCT01566773|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126501|NCT01566773|Parasympatholytics|parasympatholytics|mesh-ancestor
92126502|NCT01566773|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92126503|NCT01566773|Cholinergic Agents|cholinergic agents|mesh-ancestor
92126504|NCT01566773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126505|NCT01566773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126506|NCT01566773|Anticonvulsants|anticonvulsants|mesh-ancestor
92126507|NCT04134442|Bupivacaine|bupivacaine|mesh-list
92126508|NCT04134442|Anesthetics, Local|anesthetics, local|mesh-ancestor
92126509|NCT04134442|Anesthetics|anesthetics|mesh-ancestor
92126510|NCT04134442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126511|NCT04134442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126512|NCT04134442|Sensory System Agents|sensory system agents|mesh-ancestor
92126513|NCT04134442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126514|NCT04103476|Bazedoxifene|bazedoxifene|mesh-list
92126515|NCT04103476|Estrogens|estrogens|mesh-list
92126516|NCT04103476|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92126517|NCT04103476|Hormones|hormones|mesh-ancestor
92126518|NCT04103476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126519|NCT04103476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126520|NCT04103476|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92126521|NCT04103476|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92126522|NCT04103476|Hormone Antagonists|hormone antagonists|mesh-ancestor
92126523|NCT04103476|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92126524|NCT01566149|Mometasone Furoate|mometasone furoate|mesh-list
92126525|NCT01566149|Formoterol Fumarate|formoterol fumarate|mesh-list
92126526|NCT01566149|Mometasone Furoate, Formoterol Fumarate Drug Combination|mometasone furoate, formoterol fumarate drug combination|mesh-list
92126527|NCT01566149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92126528|NCT01566149|Autonomic Agents|autonomic agents|mesh-ancestor
92126529|NCT01566149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126530|NCT01566149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126531|NCT01566149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92126532|NCT01566149|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126533|NCT01566149|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92126534|NCT01566149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92126535|NCT01566149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92126536|NCT01566149|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126537|NCT01566149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126538|NCT01566149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126539|NCT01566149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126541|NCT01566149|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92126542|NCT03417388|Aspirin|aspirin|mesh-list
92126543|NCT03417388|Losartan|losartan|mesh-list
92126544|NCT03417388|Lisinopril|lisinopril|mesh-list
92126545|NCT03417388|Atorvastatin|atorvastatin|mesh-list
92126546|NCT03417388|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92126547|NCT03417388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92126548|NCT03417388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92126549|NCT03417388|Analgesics|analgesics|mesh-ancestor
92126550|NCT03417388|Sensory System Agents|sensory system agents|mesh-ancestor
92126551|NCT03417388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126552|NCT03417388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126553|NCT03417388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126554|NCT03417388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126556|NCT03417388|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92126557|NCT03417388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126558|NCT03417388|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92126559|NCT03417388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92126560|NCT03417388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126561|NCT03417388|Antipyretics|antipyretics|mesh-ancestor
92126562|NCT03417388|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92126563|NCT03417388|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92126564|NCT03417388|Antimetabolites|antimetabolites|mesh-ancestor
92126565|NCT03417388|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92126566|NCT03417388|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92126567|NCT03417388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92126568|NCT03417388|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92126569|NCT03417388|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92126570|NCT03417388|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92126571|NCT03417388|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92126572|NCT03417388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92126573|NCT03417388|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92126574|NCT03417388|Protective Agents|protective agents|mesh-ancestor
92126575|NCT02691702|Melatonin|melatonin|mesh-list
92126576|NCT02691702|Antioxidants|antioxidants|mesh-ancestor
92126577|NCT02691702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126578|NCT02691702|Protective Agents|protective agents|mesh-ancestor
92126579|NCT02691702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126580|NCT02691702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126581|NCT01564277|Allopurinol|allopurinol|mesh-list
92126582|NCT01564277|Rasburicase|rasburicase|mesh-list
92126583|NCT01564277|Antimetabolites|antimetabolites|mesh-ancestor
92126584|NCT01564277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126585|NCT01564277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126586|NCT01564277|Gout Suppressants|gout suppressants|mesh-ancestor
92126587|NCT01564277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126588|NCT01564277|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92126589|NCT01564277|Antioxidants|antioxidants|mesh-ancestor
92126590|NCT01564277|Protective Agents|protective agents|mesh-ancestor
92126591|NCT01564277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126592|NCT01563185|Ibuprofen|ibuprofen|mesh-list
92126593|NCT01563185|Famotidine|famotidine|mesh-list
92126594|NCT01563185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92126595|NCT01563185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92126596|NCT01563185|Analgesics|analgesics|mesh-ancestor
92126597|NCT01563185|Sensory System Agents|sensory system agents|mesh-ancestor
92126598|NCT01563185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126599|NCT01563185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126600|NCT01563185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126601|NCT01563185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126602|NCT01563185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92126603|NCT01563185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126604|NCT01563185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126605|NCT01563185|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92126606|NCT01563185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126607|NCT01563185|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92126608|NCT01563185|Histamine Antagonists|histamine antagonists|mesh-ancestor
92126609|NCT01563185|Histamine Agents|histamine agents|mesh-ancestor
92126610|NCT01563185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126611|NCT02974660|Protamines|protamines|mesh-list
92126612|NCT02974660|Heparin Antagonists|heparin antagonists|mesh-ancestor
92126613|NCT02974660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126614|NCT02974660|Coagulants|coagulants|mesh-ancestor
92126615|NCT03305848|Nitroglycerin|nitroglycerin|mesh-list
92126616|NCT03305848|Vasodilator Agents|vasodilator agents|mesh-ancestor
92126617|NCT01563029|Fluticasone|fluticasone|mesh-list
92126618|NCT01563029|Xhance|xhance|mesh-list
92126619|NCT01563029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126620|NCT01563029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92126621|NCT01563029|Autonomic Agents|autonomic agents|mesh-ancestor
92126622|NCT01563029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126623|NCT01563029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126624|NCT01563029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92126625|NCT01563029|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126626|NCT01563029|Dermatologic Agents|dermatologic agents|mesh-ancestor
92126627|NCT01563029|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92126628|NCT03293368|Triamcinolone|triamcinolone|mesh-list
92126629|NCT03293368|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92126630|NCT03293368|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92126631|NCT03293368|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92126632|NCT03293368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126633|NCT03293368|Glucocorticoids|glucocorticoids|mesh-ancestor
92126635|NCT03293368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126636|NCT03293368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126637|NCT03293368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92126638|NCT03293368|Immunologic Factors|immunologic factors|mesh-ancestor
92126639|NCT03293368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126640|NCT03293368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126641|NCT03273712|Octreotide|octreotide|mesh-list
92126642|NCT03273712|Edotreotide|edotreotide|mesh-list
92126643|NCT03273712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126644|NCT03273712|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92126645|NCT03273712|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126646|NCT03273712|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92126647|NCT03273712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126648|NCT04113317|Lenograstim|lenograstim|mesh-list
92126649|NCT04113317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92126650|NCT04113317|Immunologic Factors|immunologic factors|mesh-ancestor
92126651|NCT04113317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126652|NCT04341844|Methylene Blue|methylene blue|mesh-list
92126653|NCT04341844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126654|NCT04341844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126655|NCT01561313|Adalimumab|adalimumab|mesh-list
92126656|NCT01561313|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92126657|NCT01561313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126658|NCT01561313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126659|NCT04111133|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92126660|NCT04111133|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92126661|NCT04111133|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126662|NCT04111133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126663|NCT04111133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126664|NCT04111133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126665|NCT01561079|Buprenorphine|buprenorphine|mesh-list
92126666|NCT01561079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92126667|NCT01561079|Narcotics|narcotics|mesh-ancestor
92126668|NCT01561079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126669|NCT01561079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126670|NCT01561079|Analgesics|analgesics|mesh-ancestor
92126671|NCT01561079|Sensory System Agents|sensory system agents|mesh-ancestor
92126672|NCT01561079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126673|NCT01561079|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92126674|NCT01559675|Hydrocortisone|hydrocortisone|mesh-list
92126675|NCT01559675|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92126676|NCT01559675|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92126677|NCT01559675|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92126678|NCT01559675|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92126679|NCT01559675|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92126680|NCT01559675|Methylprednisolone|methylprednisolone|mesh-list
92126681|NCT01559675|Prednisolone|prednisolone|mesh-list
92126682|NCT01559675|Prednisolone acetate|prednisolone acetate|mesh-list
92126683|NCT01559675|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92126684|NCT01559675|Prednisolone phosphate|prednisolone phosphate|mesh-list
92126685|NCT01559675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126686|NCT01559675|Glucocorticoids|glucocorticoids|mesh-ancestor
92405134|NCT01434862|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92126688|NCT01559675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126689|NCT01559675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126690|NCT01559675|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92126691|NCT01559675|Protective Agents|protective agents|mesh-ancestor
92126692|NCT01559675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92126693|NCT01559675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126694|NCT01559675|Antiemetics|antiemetics|mesh-ancestor
92126695|NCT01559675|Autonomic Agents|autonomic agents|mesh-ancestor
92126696|NCT01559675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126697|NCT01559675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126698|NCT01374906|Pasireotide|pasireotide|mesh-list
92126700|NCT01374906|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126701|NCT01374906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126702|NCT00362596|Acyclovir|acyclovir|mesh-list
92126703|NCT00362596|Antiviral Agents|antiviral agents|mesh-ancestor
92126705|NCT02974504|Linagliptin|linagliptin|mesh-list
92126706|NCT02974504|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126707|NCT02974504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126708|NCT02974504|Incretins|incretins|mesh-ancestor
92126709|NCT02974504|Hormones|hormones|mesh-ancestor
92126710|NCT02974504|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126711|NCT02974504|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92126712|NCT02974504|Protease Inhibitors|protease inhibitors|mesh-ancestor
92126713|NCT02974504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126714|NCT02974504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126715|NCT03013504|Cyclophosphamide|cyclophosphamide|mesh-list
92126716|NCT03013504|Docetaxel|docetaxel|mesh-list
92126717|NCT03013504|Trastuzumab|trastuzumab|mesh-list
92126718|NCT03013504|Epirubicin|epirubicin|mesh-list
92126719|NCT03013504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92126720|NCT03013504|Immunologic Factors|immunologic factors|mesh-ancestor
92126721|NCT03013504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126722|NCT03013504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126723|NCT03013504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92126724|NCT03013504|Alkylating Agents|alkylating agents|mesh-ancestor
92126725|NCT03013504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126726|NCT03013504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126727|NCT03013504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92126728|NCT03013504|Tubulin Modulators|tubulin modulators|mesh-ancestor
92126729|NCT03013504|Antimitotic Agents|antimitotic agents|mesh-ancestor
92126730|NCT03013504|Mitosis Modulators|mitosis modulators|mesh-ancestor
92126731|NCT03013504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126732|NCT03013504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92126733|NCT03013504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92126734|NCT03013504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92126735|NCT03013504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126736|NCT02683746|rGLP-1 protein|rglp-1 protein|mesh-list
92126737|NCT02683746|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92126738|NCT02683746|Incretins|incretins|mesh-ancestor
92126739|NCT02683746|Hormones|hormones|mesh-ancestor
92126740|NCT02683746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126741|NCT02683746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126742|NCT01559129|Pomalidomide|pomalidomide|mesh-list
92126743|NCT01559129|Immunologic Factors|immunologic factors|mesh-ancestor
92126744|NCT01559129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126745|NCT01559129|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92126746|NCT01559129|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92126747|NCT01559129|Growth Substances|growth substances|mesh-ancestor
91938942|NCT03079921|Propranolol|propranolol|mesh-list
92126748|NCT01559129|Growth Inhibitors|growth inhibitors|mesh-ancestor
92126749|NCT01559129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126750|NCT02691468|Silicon|silicon|mesh-list
92126751|NCT02691468|Trace Elements|trace elements|mesh-ancestor
92126752|NCT02691468|Micronutrients|micronutrients|mesh-ancestor
92126753|NCT02691468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126754|NCT03162120|Metoprolol|metoprolol|mesh-list
92126755|NCT03162120|Flecainide|flecainide|mesh-list
92126756|NCT03162120|Ranolazine|ranolazine|mesh-list
92126757|NCT03162120|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92126758|NCT03162120|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92126759|NCT03162120|Sympatholytics|sympatholytics|mesh-ancestor
92126760|NCT03162120|Autonomic Agents|autonomic agents|mesh-ancestor
92126761|NCT03162120|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126762|NCT03162120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126763|NCT03162120|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92126764|NCT03162120|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92126765|NCT03162120|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92126766|NCT03162120|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126767|NCT03162120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126768|NCT03162120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126769|NCT03162120|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92126770|NCT03162120|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126771|NCT03162120|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92126772|NCT02683668|Tiotropium Bromide|tiotropium bromide|mesh-list
92126773|NCT02683668|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92126774|NCT02683668|Autonomic Agents|autonomic agents|mesh-ancestor
92126775|NCT02683668|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126776|NCT02683668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126777|NCT02683668|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92126778|NCT02683668|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126779|NCT02683668|Parasympatholytics|parasympatholytics|mesh-ancestor
92126780|NCT02683668|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92126781|NCT02683668|Cholinergic Agents|cholinergic agents|mesh-ancestor
92126782|NCT02683668|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126783|NCT02683668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126784|NCT03114228|Midostaurin|midostaurin|mesh-list
92126785|NCT03114228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126786|NCT03114228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126787|NCT03114228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126788|NCT03114228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126789|NCT02678286|Meloxicam|meloxicam|mesh-list
92126790|NCT02678286|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92126791|NCT02678286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92126792|NCT02678286|Analgesics|analgesics|mesh-ancestor
92126793|NCT02678286|Sensory System Agents|sensory system agents|mesh-ancestor
92145304|NCT00245037|Methotrexate|methotrexate|mesh-list
92126794|NCT02678286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126795|NCT02678286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126796|NCT02678286|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126797|NCT02678286|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126798|NCT02678286|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92126799|NCT02678286|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92126800|NCT02678286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126801|NCT02678286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126802|NCT03164694|Carboplatin|carboplatin|mesh-list
92126803|NCT03164694|Pemetrexed|pemetrexed|mesh-list
92126804|NCT03164694|Apatinib|apatinib|mesh-list
92126805|NCT03164694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126806|NCT03164694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126807|NCT03164694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126808|NCT03164694|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91938953|NCT03079921|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91938954|NCT04473989|Teriparatide|teriparatide|mesh-list
91938956|NCT04473989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126809|NCT03164694|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92126810|NCT03164694|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126812|NCT04775550|Lenalidomide|lenalidomide|mesh-list
92126813|NCT04775550|Bortezomib|bortezomib|mesh-list
92126814|NCT04775550|Daratumumab|daratumumab|mesh-list
92126815|NCT04775550|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126816|NCT04775550|Antiemetics|antiemetics|mesh-ancestor
92126817|NCT04775550|Autonomic Agents|autonomic agents|mesh-ancestor
92126818|NCT04775550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126819|NCT04775550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126820|NCT04775550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92126821|NCT04775550|Glucocorticoids|glucocorticoids|mesh-ancestor
92126822|NCT04775550|Hormones|hormones|mesh-ancestor
92126823|NCT04775550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126824|NCT04775550|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92126825|NCT04775550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126826|NCT04775550|Immunologic Factors|immunologic factors|mesh-ancestor
92126827|NCT04775550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92126828|NCT04775550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92126829|NCT04775550|Growth Substances|growth substances|mesh-ancestor
92126830|NCT04775550|Growth Inhibitors|growth inhibitors|mesh-ancestor
92126831|NCT02930902|Paclitaxel|paclitaxel|mesh-list
92126832|NCT02930902|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92126833|NCT02930902|Gemcitabine|gemcitabine|mesh-list
92126834|NCT02930902|Pembrolizumab|pembrolizumab|mesh-list
92126835|NCT02930902|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92126836|NCT02930902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126837|NCT02930902|Tubulin Modulators|tubulin modulators|mesh-ancestor
92126838|NCT02930902|Antimitotic Agents|antimitotic agents|mesh-ancestor
92126839|NCT02930902|Mitosis Modulators|mitosis modulators|mesh-ancestor
92126840|NCT02930902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126841|NCT02930902|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92126842|NCT02930902|Antimetabolites|antimetabolites|mesh-ancestor
92126843|NCT02930902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126844|NCT02930902|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92126845|NCT02905318|Palbociclib|palbociclib|mesh-list
92126846|NCT02905318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126847|NCT02905318|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126848|NCT02905318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126849|NCT02905318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126850|NCT02767804|Crizotinib|crizotinib|mesh-list
92126852|NCT02767804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126853|NCT02767804|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92126854|NCT02767804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126855|NCT02767804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126856|NCT02741128|Vaccines|vaccines|mesh-list
92126857|NCT02741128|Immunologic Factors|immunologic factors|mesh-ancestor
92126858|NCT02741128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126859|NCT01566721|Trastuzumab|trastuzumab|mesh-list
92126860|NCT01566721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126861|NCT01566721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126862|NCT01541215|Metformin|metformin|mesh-list
92126863|NCT01541215|Liraglutide|liraglutide|mesh-list
91938975|NCT04473911|Mycophenolic Acid|mycophenolic acid|mesh-list
91938976|NCT04473911|Sirolimus|sirolimus|mesh-list
91938977|NCT04473911|Cyclophosphamide|cyclophosphamide|mesh-list
91938978|NCT04473911|Melphalan|melphalan|mesh-list
91938979|NCT04473911|Fludarabine|fludarabine|mesh-list
91938980|NCT04473911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938982|NCT04473911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938983|NCT04473911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92126864|NCT01541215|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126865|NCT01541215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126866|NCT01541215|Incretins|incretins|mesh-ancestor
92126867|NCT01541215|Hormones|hormones|mesh-ancestor
92126868|NCT01541215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126869|NCT01585987|Ipilimumab|ipilimumab|mesh-list
92126870|NCT01585987|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126871|NCT01585987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126872|NCT01585987|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92126873|NCT01585987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126874|NCT01585831|Testosterone|testosterone|mesh-list
92126875|NCT01585831|Androgens|androgens|mesh-ancestor
92126876|NCT01585831|Hormones|hormones|mesh-ancestor
92126877|NCT01585831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126878|NCT01585831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126879|NCT01565941|Insulin|insulin|mesh-list
92126880|NCT01565941|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92126881|NCT01565941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126882|NCT01565941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126883|NCT01558271|Liraglutide|liraglutide|mesh-list
92126884|NCT01558271|Dulaglutide|dulaglutide|mesh-list
92126885|NCT01558271|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92126886|NCT01558271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126887|NCT01558271|Incretins|incretins|mesh-ancestor
92126888|NCT01558271|Hormones|hormones|mesh-ancestor
92126889|NCT01558271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92126890|NCT01565707|Solifenacin Succinate|solifenacin succinate|mesh-list
92126891|NCT01565707|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92126892|NCT01565707|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92126893|NCT01565707|Cholinergic Agents|cholinergic agents|mesh-ancestor
92126894|NCT01565707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126895|NCT01565707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126896|NCT01565707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126897|NCT01565707|Urological Agents|urological agents|mesh-ancestor
92126898|NCT01557569|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92126899|NCT01557569|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92126900|NCT01557569|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92126901|NCT01557569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92126902|NCT01557569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126903|NCT01557569|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126904|NCT01557569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126905|NCT01557569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126906|NCT04756271|Antibodies|antibodies|mesh-list
92126907|NCT04756271|Antibodies, Blocking|antibodies, blocking|mesh-list
92126908|NCT04756271|Immunologic Factors|immunologic factors|mesh-ancestor
92126909|NCT04756271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126910|NCT01538719|Rilonacept|rilonacept|mesh-list
92126911|NCT01538719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126912|NCT01537783|Chlorhexidine|chlorhexidine|mesh-list
92126913|NCT01537783|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92126914|NCT01537783|Mupirocin|mupirocin|mesh-list
92126915|NCT01537783|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92126916|NCT01537783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92126917|NCT01537783|Disinfectants|disinfectants|mesh-ancestor
92126918|NCT01537783|Dermatologic Agents|dermatologic agents|mesh-ancestor
92126919|NCT01537783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92126920|NCT01537783|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92126921|NCT01537783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126922|NCT01537783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126924|NCT01556165|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92126925|NCT01556165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92126926|NCT01556165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126927|NCT01556165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92126928|NCT01556165|Protective Agents|protective agents|mesh-ancestor
92126929|NCT01556165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126930|NCT01537549|Thioctic Acid|thioctic acid|mesh-list
92126931|NCT01537549|Acetylcarnitine|acetylcarnitine|mesh-list
92126932|NCT01537549|Antioxidants|antioxidants|mesh-ancestor
92126933|NCT01537549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126934|NCT01537549|Protective Agents|protective agents|mesh-ancestor
92126935|NCT01537549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126936|NCT01537549|Vitamin B Complex|vitamin b complex|mesh-ancestor
92126941|NCT01555931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92126942|NCT01555931|Contraceptive Agents|contraceptive agents|mesh-ancestor
92126943|NCT01555931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92126944|NCT01555931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126945|NCT01555931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92126946|NCT01555931|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92126947|NCT01555931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92126948|NCT01583179|Buprenorphine|buprenorphine|mesh-list
92126949|NCT01583179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92126950|NCT01583179|Narcotics|narcotics|mesh-ancestor
92126951|NCT01583179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126952|NCT01583179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126953|NCT01583179|Analgesics|analgesics|mesh-ancestor
92126954|NCT01583179|Sensory System Agents|sensory system agents|mesh-ancestor
92126955|NCT01583179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126956|NCT01583179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92126957|NCT01582945|Ketamine|ketamine|mesh-list
92126958|NCT01582945|Analgesics|analgesics|mesh-ancestor
92126959|NCT01582945|Sensory System Agents|sensory system agents|mesh-ancestor
92126960|NCT01582945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92126961|NCT01582945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126962|NCT01582945|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92126963|NCT01582945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92126964|NCT01582945|Anesthetics, General|anesthetics, general|mesh-ancestor
92126965|NCT01582945|Anesthetics|anesthetics|mesh-ancestor
92126966|NCT01582945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92126967|NCT01582945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92126968|NCT01582945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92126969|NCT01582945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126970|NCT01582945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126971|NCT01565083|Trastuzumab|trastuzumab|mesh-list
92126972|NCT01565083|Pertuzumab|pertuzumab|mesh-list
92126973|NCT01565083|Vinorelbine|vinorelbine|mesh-list
92126974|NCT01565083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92126975|NCT01565083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92126976|NCT01565083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92126977|NCT01565083|Tubulin Modulators|tubulin modulators|mesh-ancestor
92126978|NCT01565083|Antimitotic Agents|antimitotic agents|mesh-ancestor
92126979|NCT01565083|Mitosis Modulators|mitosis modulators|mesh-ancestor
92126980|NCT01565083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126981|NCT01555151|Mometasone Furoate|mometasone furoate|mesh-list
92126982|NCT01555151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92126983|NCT01555151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92126984|NCT01555151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91939015|NCT05088057|Docetaxel|docetaxel|mesh-list
92126985|NCT01537081|Phenylpropanolamine|phenylpropanolamine|mesh-list
92126987|NCT01537081|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92126988|NCT01537081|Expectorants|expectorants|mesh-ancestor
92126989|NCT01537081|Respiratory System Agents|respiratory system agents|mesh-ancestor
92126990|NCT01537081|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92126991|NCT01537081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92126992|NCT01537081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92126993|NCT01537081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92126994|NCT01537081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92126995|NCT01537081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92126997|NCT01537081|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92126998|NCT01537081|Sympathomimetics|sympathomimetics|mesh-ancestor
92126999|NCT01537081|Autonomic Agents|autonomic agents|mesh-ancestor
92127000|NCT01537081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127001|NCT01537081|Nasal Decongestants|nasal decongestants|mesh-ancestor
92127002|NCT01537081|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92127003|NCT01555073|Celecoxib|celecoxib|mesh-list
92127004|NCT01555073|Pregabalin|pregabalin|mesh-list
92127005|NCT01555073|Analgesics|analgesics|mesh-ancestor
92127006|NCT01555073|Sensory System Agents|sensory system agents|mesh-ancestor
92127007|NCT01555073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127008|NCT01555073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127009|NCT01555073|Anticonvulsants|anticonvulsants|mesh-ancestor
92127010|NCT01555073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92127011|NCT01555073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92127012|NCT01555073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127013|NCT01555073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92127014|NCT01555073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92127015|NCT01555073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92145305|NCT00245037|Fludarabine phosphate|fludarabine phosphate|mesh-list
92127016|NCT01555073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127017|NCT01555073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92127018|NCT01555073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92127019|NCT01555073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127020|NCT01555073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127021|NCT01555073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127022|NCT01555073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92127023|NCT01555073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92127024|NCT01555073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127025|NCT01582243|Vildagliptin|vildagliptin|mesh-list
92127026|NCT01582243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92127027|NCT01582243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127028|NCT01582243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92127029|NCT01582243|Protease Inhibitors|protease inhibitors|mesh-ancestor
92127030|NCT01582243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127031|NCT01582243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127032|NCT01536535|Prednisone|prednisone|mesh-list
92127033|NCT01536535|Mesalamine|mesalamine|mesh-list
92127034|NCT01536535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127035|NCT01536535|Glucocorticoids|glucocorticoids|mesh-ancestor
92127036|NCT01536535|Hormones|hormones|mesh-ancestor
92127037|NCT01536535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127038|NCT01536535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127039|NCT01536535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92127040|NCT01536535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127041|NCT01536535|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92127042|NCT01536535|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127043|NCT01536535|Analgesics|analgesics|mesh-ancestor
92127044|NCT01536535|Sensory System Agents|sensory system agents|mesh-ancestor
92127045|NCT01536535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127046|NCT01536535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127047|NCT01553747|Eluxadoline|eluxadoline|mesh-list
92127048|NCT01553747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127049|NCT01536379|Belimumab|belimumab|mesh-list
92127050|NCT01536379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127051|NCT01536379|Immunologic Factors|immunologic factors|mesh-ancestor
92127052|NCT01536379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127053|NCT01536067|Bortezomib|bortezomib|mesh-list
92127054|NCT01536067|Ofatumumab|ofatumumab|mesh-list
92127055|NCT01536067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127056|NCT04410211|Midazolam|midazolam|mesh-list
92127057|NCT04410211|Sevoflurane|sevoflurane|mesh-list
92127058|NCT04410211|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92127059|NCT04410211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92127060|NCT04410211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127061|NCT04410211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127062|NCT04410211|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92127063|NCT04410211|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92127064|NCT04410211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92127065|NCT04410211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92127068|NCT04410211|GABA Modulators|gaba modulators|mesh-ancestor
92127069|NCT04410211|GABA Agents|gaba agents|mesh-ancestor
92127070|NCT04410211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127071|NCT04410211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127072|NCT04410211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92127073|NCT04410211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92127074|NCT01582009|Everolimus|everolimus|mesh-list
92127075|NCT01582009|Panobinostat|panobinostat|mesh-list
92127076|NCT01582009|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92127077|NCT01582009|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92127078|NCT01582009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92127079|NCT01582009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127080|NCT01582009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127081|NCT01582009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127082|NCT01582009|Immunologic Factors|immunologic factors|mesh-ancestor
92127083|NCT01582009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127084|NCT01582009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127085|NCT01553591|Eluxadoline|eluxadoline|mesh-list
92127086|NCT01553591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127087|NCT01581931|Metformin|metformin|mesh-list
92127088|NCT01581931|Linagliptin|linagliptin|mesh-list
92127089|NCT01581931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92127090|NCT01581931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127091|NCT01581931|Incretins|incretins|mesh-ancestor
92127092|NCT01581931|Hormones|hormones|mesh-ancestor
92127093|NCT01581931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127094|NCT01581931|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92127095|NCT01581931|Protease Inhibitors|protease inhibitors|mesh-ancestor
92127096|NCT01581931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127097|NCT01581931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127098|NCT01581307|Leucovorin|leucovorin|mesh-list
92127099|NCT01581307|Folic Acid|folic acid|mesh-list
92127100|NCT01581307|Fluorouracil|fluorouracil|mesh-list
92127101|NCT01581307|Oxaliplatin|oxaliplatin|mesh-list
92127102|NCT01581307|Levoleucovorin|levoleucovorin|mesh-list
92127103|NCT01581307|Antimetabolites|antimetabolites|mesh-ancestor
92127104|NCT01581307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127105|NCT01581307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127106|NCT01581307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127107|NCT01581307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127108|NCT01581307|Immunologic Factors|immunologic factors|mesh-ancestor
92127109|NCT01581307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127110|NCT01581307|Antidotes|antidotes|mesh-ancestor
92127111|NCT01581307|Protective Agents|protective agents|mesh-ancestor
92127112|NCT01581307|Vitamin B Complex|vitamin b complex|mesh-ancestor
92127113|NCT01581307|Vitamins|vitamins|mesh-ancestor
92127114|NCT01581307|Micronutrients|micronutrients|mesh-ancestor
92127115|NCT01581307|Hematinics|hematinics|mesh-ancestor
92127116|NCT01580995|Valacyclovir|valacyclovir|mesh-list
92127117|NCT01580995|Antiviral Agents|antiviral agents|mesh-ancestor
92127118|NCT01580995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127119|NCT01553279|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92127120|NCT01553279|Immunologic Factors|immunologic factors|mesh-ancestor
92127121|NCT01553279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127122|NCT01562743|Rotigotine|rotigotine|mesh-list
92127123|NCT01562743|Dopamine Agonists|dopamine agonists|mesh-ancestor
92127124|NCT01562743|Dopamine Agents|dopamine agents|mesh-ancestor
92127125|NCT01562743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127126|NCT01562743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127127|NCT01562743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127128|NCT03028571|Trimethaphan|trimethaphan|mesh-list
92127129|NCT03028571|Trimethaphan camsylate|trimethaphan camsylate|mesh-list
92127130|NCT03028571|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92127131|NCT03028571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92127132|NCT03028571|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92127133|NCT03028571|Autonomic Agents|autonomic agents|mesh-ancestor
92127134|NCT03028571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127135|NCT03028571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127136|NCT03028571|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92127137|NCT03028571|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92127138|NCT03028571|Cholinergic Agents|cholinergic agents|mesh-ancestor
92127139|NCT03028571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127140|NCT03028571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127141|NCT03028571|Vasodilator Agents|vasodilator agents|mesh-ancestor
92127143|NCT01535443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92127144|NCT01535443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127145|NCT01535443|Analgesics|analgesics|mesh-ancestor
92127146|NCT01535443|Sensory System Agents|sensory system agents|mesh-ancestor
92127147|NCT01535443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127148|NCT01535443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127149|NCT01535443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127150|NCT01535443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127151|NCT01535287|Dexmedetomidine|dexmedetomidine|mesh-list
92127152|NCT01535287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92127153|NCT01535287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127154|NCT01535287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127155|NCT01535287|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127156|NCT01535287|Analgesics|analgesics|mesh-ancestor
92127157|NCT01535287|Sensory System Agents|sensory system agents|mesh-ancestor
92127158|NCT01535287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127159|NCT01535287|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92127160|NCT01535287|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92127161|NCT01535287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92127162|NCT01535287|Adrenergic Agents|adrenergic agents|mesh-ancestor
92127163|NCT01535287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127164|NCT01535287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127165|NCT01549613|Vancomycin|vancomycin|mesh-list
92127166|NCT01549613|Daptomycin|daptomycin|mesh-list
92127168|NCT01549613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127169|NCT04106219|Cyclophosphamide|cyclophosphamide|mesh-list
92127170|NCT04106219|Topotecan|topotecan|mesh-list
92127171|NCT04106219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127173|NCT04106219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127174|NCT04106219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127175|NCT04106219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92127176|NCT04106219|Alkylating Agents|alkylating agents|mesh-ancestor
92127177|NCT04106219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127178|NCT04106219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127179|NCT04106219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92127180|NCT04106219|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92127181|NCT04106219|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92127182|NCT04106219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127183|NCT04739189|Butyl phosphorotrithioate|butyl phosphorotrithioate|mesh-list
92127184|NCT04739189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127185|NCT04739189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127186|NCT01546883|Dabigatran|dabigatran|mesh-list
92127187|NCT01546883|Antithrombins|antithrombins|mesh-ancestor
92127188|NCT01546883|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92127189|NCT01546883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92127190|NCT01546883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127191|NCT01546883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127192|NCT01546883|Anticoagulants|anticoagulants|mesh-ancestor
92127193|NCT01580293|Factor VIII|factor viii|mesh-list
92127194|NCT01580293|Coagulants|coagulants|mesh-ancestor
92127195|NCT01546649|Leuprolide|leuprolide|mesh-list
92127196|NCT01546649|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92127197|NCT01546649|Fertility Agents|fertility agents|mesh-ancestor
92127198|NCT01546649|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127199|NCT01546649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127200|NCT01546649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92127201|NCT01546649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127202|NCT02985983|Brodalumab|brodalumab|mesh-list
92127203|NCT02985983|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127204|NCT01544309|Atorvastatin|atorvastatin|mesh-list
92127205|NCT01544309|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92127206|NCT01544309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92127207|NCT01544309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92127208|NCT01544309|Antimetabolites|antimetabolites|mesh-ancestor
92127209|NCT01544309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127210|NCT01544309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92127211|NCT01544309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92127212|NCT01544309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127213|NCT01544153|Nicotine|nicotine|mesh-list
92127214|NCT01544153|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92085480|NCT02992912|Antibodies|antibodies|mesh-list
92127215|NCT01544153|Autonomic Agents|autonomic agents|mesh-ancestor
92127216|NCT01544153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405135|NCT01434862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92127217|NCT01544153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127218|NCT01544153|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92127219|NCT01544153|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92127220|NCT01544153|Cholinergic Agents|cholinergic agents|mesh-ancestor
92127221|NCT01544153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127222|NCT01544153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127223|NCT01543685|Celecoxib|celecoxib|mesh-list
92127224|NCT01543685|Indomethacin|indomethacin|mesh-list
92127225|NCT01543685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92127226|NCT01543685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127227|NCT01543685|Analgesics|analgesics|mesh-ancestor
92127228|NCT01543685|Sensory System Agents|sensory system agents|mesh-ancestor
92127229|NCT01543685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127230|NCT01543685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127231|NCT01543685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127232|NCT01543685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127233|NCT01543685|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92127234|NCT01543685|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92127235|NCT01543685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127236|NCT01543685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127237|NCT01543685|Gout Suppressants|gout suppressants|mesh-ancestor
92127238|NCT01543685|Tocolytic Agents|tocolytic agents|mesh-ancestor
92127239|NCT01543685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127240|NCT01540565|Veliparib|veliparib|mesh-list
92127241|NCT01540565|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92127242|NCT01540565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127243|NCT01540565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127244|NCT01540565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127245|NCT01540487|Metformin|metformin|mesh-list
92127248|NCT01540487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127249|NCT01540487|Incretins|incretins|mesh-ancestor
92127250|NCT01540487|Hormones|hormones|mesh-ancestor
92127251|NCT01540487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127252|NCT01540487|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92127253|NCT01540487|Protease Inhibitors|protease inhibitors|mesh-ancestor
92127254|NCT01540487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127255|NCT01540487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127256|NCT01539317|Lidocaine|lidocaine|mesh-list
92127257|NCT01539317|Anesthetics, Local|anesthetics, local|mesh-ancestor
92127258|NCT01539317|Anesthetics|anesthetics|mesh-ancestor
92127259|NCT01539317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127260|NCT01539317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127261|NCT01539317|Sensory System Agents|sensory system agents|mesh-ancestor
92127262|NCT01539317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127263|NCT01539317|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92127264|NCT01539317|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92127265|NCT01539317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92127266|NCT01539317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92127267|NCT01539317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127268|NCT01539083|Thalidomide|thalidomide|mesh-list
92127269|NCT01539083|Dexamethasone|dexamethasone|mesh-list
92127270|NCT01539083|Prednisolone|prednisolone|mesh-list
92127271|NCT01539083|Cyclophosphamide|cyclophosphamide|mesh-list
92127272|NCT01539083|Bortezomib|bortezomib|mesh-list
92127273|NCT01539083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127274|NCT01539083|Immunologic Factors|immunologic factors|mesh-ancestor
92127275|NCT01539083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127276|NCT01539083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127277|NCT01539083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92127278|NCT01539083|Alkylating Agents|alkylating agents|mesh-ancestor
91939017|NCT05088057|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127279|NCT01539083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127280|NCT01539083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127281|NCT01539083|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92127282|NCT01539083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127283|NCT01539083|Antiemetics|antiemetics|mesh-ancestor
92127284|NCT01539083|Autonomic Agents|autonomic agents|mesh-ancestor
92127285|NCT01539083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127286|NCT01539083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127287|NCT01539083|Glucocorticoids|glucocorticoids|mesh-ancestor
92127288|NCT01539083|Hormones|hormones|mesh-ancestor
92127289|NCT01539083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127290|NCT01539083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92127292|NCT01539083|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92127293|NCT01539083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127294|NCT01539083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92127295|NCT01539083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92127296|NCT01539083|Growth Substances|growth substances|mesh-ancestor
92127297|NCT01539083|Growth Inhibitors|growth inhibitors|mesh-ancestor
92127298|NCT01537133|Fluticasone|fluticasone|mesh-list
92127299|NCT01537133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127300|NCT01537133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92127301|NCT01537133|Autonomic Agents|autonomic agents|mesh-ancestor
92127302|NCT01537133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127303|NCT01537133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127304|NCT01537133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92127305|NCT01537133|Respiratory System Agents|respiratory system agents|mesh-ancestor
92127306|NCT01537133|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127307|NCT01537133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92127308|NCT01536587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92127309|NCT01536587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92127310|NCT01536587|Autonomic Agents|autonomic agents|mesh-ancestor
92127311|NCT01536587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127312|NCT01536587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127313|NCT01536587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92127314|NCT01536587|Respiratory System Agents|respiratory system agents|mesh-ancestor
92127315|NCT01536587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92127316|NCT01536587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92127317|NCT01536587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92127318|NCT01536587|Adrenergic Agents|adrenergic agents|mesh-ancestor
92127319|NCT01536587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127320|NCT01536587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127321|NCT02985905|Zinc Sulfate|zinc sulfate|mesh-list
92127323|NCT02985905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127324|NCT02985905|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127325|NCT01535261|Ranibizumab|ranibizumab|mesh-list
92127326|NCT01535261|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92127327|NCT01535261|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92127328|NCT01535261|Growth Substances|growth substances|mesh-ancestor
92127329|NCT01535261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127330|NCT01535261|Growth Inhibitors|growth inhibitors|mesh-ancestor
92127331|NCT01535261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127332|NCT01534637|Gemcitabine|gemcitabine|mesh-list
92127333|NCT01534637|Fluorouracil|fluorouracil|mesh-list
92127334|NCT01534637|Capecitabine|capecitabine|mesh-list
92127336|NCT01534637|Antiemetics|antiemetics|mesh-list
92127337|NCT01534637|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127338|NCT01534637|Antimetabolites|antimetabolites|mesh-ancestor
92127339|NCT01534637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127340|NCT01534637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127341|NCT01534637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127342|NCT01534637|Immunologic Factors|immunologic factors|mesh-ancestor
92127343|NCT01534637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127344|NCT01534637|Autonomic Agents|autonomic agents|mesh-ancestor
92127345|NCT01534637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127346|NCT01534637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127347|NCT01534637|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92127348|NCT01534637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127349|NCT02655016|Niraparib|niraparib|mesh-list
92127350|NCT02655016|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92127351|NCT02655016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127352|NCT02655016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127353|NCT02655016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127354|NCT01533935|Tiotropium Bromide|tiotropium bromide|mesh-list
92127355|NCT01533935|Olodaterol|olodaterol|mesh-list
92127356|NCT01533935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92127357|NCT01533935|Autonomic Agents|autonomic agents|mesh-ancestor
92127358|NCT01533935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127359|NCT01533935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127360|NCT01533935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92127361|NCT01533935|Respiratory System Agents|respiratory system agents|mesh-ancestor
92127362|NCT01533935|Parasympatholytics|parasympatholytics|mesh-ancestor
92127363|NCT01533935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92127364|NCT01533935|Cholinergic Agents|cholinergic agents|mesh-ancestor
92127365|NCT01533935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127366|NCT01533935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127367|NCT01532687|Gemcitabine|gemcitabine|mesh-list
92127368|NCT01532687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127369|NCT01532687|Antimetabolites|antimetabolites|mesh-ancestor
92127370|NCT01532687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127371|NCT01532687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127372|NCT02677116|Doxorubicin|doxorubicin|mesh-list
92127373|NCT02677116|Irinotecan|irinotecan|mesh-list
92127374|NCT02677116|Vincristine|vincristine|mesh-list
92127375|NCT02677116|Ifosfamide|ifosfamide|mesh-list
92127376|NCT02677116|Olaratumab|olaratumab|mesh-list
92127377|NCT02677116|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92127378|NCT02677116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127379|NCT02677116|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92127380|NCT02677116|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92127381|NCT02677116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127382|NCT02677116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127383|NCT02677116|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92127384|NCT02677116|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92127385|NCT02677116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92127386|NCT02677116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92127387|NCT02677116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92127388|NCT02677116|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92127389|NCT02677116|Alkylating Agents|alkylating agents|mesh-ancestor
92127390|NCT02689518|Aflibercept|aflibercept|mesh-list
92127391|NCT02689518|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92127392|NCT02689518|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92127393|NCT02689518|Growth Substances|growth substances|mesh-ancestor
92127394|NCT02689518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127395|NCT02689518|Growth Inhibitors|growth inhibitors|mesh-ancestor
92127396|NCT02689518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127397|NCT02681094|Dapagliflozin|dapagliflozin|mesh-list
92127398|NCT02681094|Saxagliptin|saxagliptin|mesh-list
92127477|NCT03163914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127399|NCT02681094|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92127400|NCT02681094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127401|NCT02681094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92127402|NCT02681094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127403|NCT02681094|Incretins|incretins|mesh-ancestor
92127404|NCT02681094|Hormones|hormones|mesh-ancestor
92127405|NCT02681094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127406|NCT02681094|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92127407|NCT02681094|Protease Inhibitors|protease inhibitors|mesh-ancestor
92127408|NCT02681094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127409|NCT03164304|Magnesium Sulfate|magnesium sulfate|mesh-list
92127410|NCT03164304|Analgesics|analgesics|mesh-ancestor
92127411|NCT03164304|Sensory System Agents|sensory system agents|mesh-ancestor
92127412|NCT03164304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127413|NCT03164304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127414|NCT03164304|Anesthetics|anesthetics|mesh-ancestor
92127415|NCT03164304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127416|NCT03164304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92127417|NCT03164304|Anticonvulsants|anticonvulsants|mesh-ancestor
92127418|NCT03164304|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92127419|NCT03164304|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92127420|NCT03164304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127421|NCT03164304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92127422|NCT03164304|Tocolytic Agents|tocolytic agents|mesh-ancestor
92127423|NCT03164304|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127424|NCT02689284|Pembrolizumab|pembrolizumab|mesh-list
92127425|NCT02689284|Margetuximab|margetuximab|mesh-list
92127426|NCT02689284|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92127427|NCT02689284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92127429|NCT02689284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92127430|NCT02689284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127431|NCT02689284|Immunologic Factors|immunologic factors|mesh-ancestor
92127432|NCT02689284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127433|NCT03165396|Propofol|propofol|mesh-list
92127434|NCT03165396|Sevoflurane|sevoflurane|mesh-list
92127435|NCT03165396|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92127436|NCT03165396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127437|NCT03165396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127438|NCT03165396|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92127439|NCT03165396|Anesthetics, General|anesthetics, general|mesh-ancestor
92127440|NCT03165396|Anesthetics|anesthetics|mesh-ancestor
92127441|NCT03165396|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92127442|NCT03165396|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92127443|NCT03164382|Sorafenib|sorafenib|mesh-list
92127444|NCT03164382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127445|NCT03164382|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92127446|NCT03164382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127447|NCT03164382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127448|NCT03161340|Sirolimus|sirolimus|mesh-list
92127449|NCT03161340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92127450|NCT03161340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127451|NCT03161340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92127452|NCT03161340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127453|NCT03161340|Antifungal Agents|antifungal agents|mesh-ancestor
92127454|NCT03161340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127455|NCT03161340|Immunologic Factors|immunologic factors|mesh-ancestor
92127456|NCT03161340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127457|NCT03161574|Fluorouracil|fluorouracil|mesh-list
92127458|NCT03161574|Oxaliplatin|oxaliplatin|mesh-list
92127459|NCT03161574|Irinotecan|irinotecan|mesh-list
92127460|NCT03161574|Antimetabolites|antimetabolites|mesh-ancestor
92127461|NCT03161574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127462|NCT03161574|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127463|NCT03161574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127464|NCT03161574|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127465|NCT03161574|Immunologic Factors|immunologic factors|mesh-ancestor
92127466|NCT03161574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127467|NCT03161574|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92127468|NCT03161574|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92127469|NCT03161574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127470|NCT03163914|Phenylephrine|phenylephrine|mesh-list
92127471|NCT03163914|Epinephrine|epinephrine|mesh-list
92127472|NCT03163914|Oxymetazoline|oxymetazoline|mesh-list
92127473|NCT03163914|Norepinephrine|norepinephrine|mesh-list
92127474|NCT03163914|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92127478|NCT03163914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127479|NCT03163914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127480|NCT03163914|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92127481|NCT03163914|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92127482|NCT03163914|Autonomic Agents|autonomic agents|mesh-ancestor
92127483|NCT03163914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127484|NCT03163914|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92127485|NCT03163914|Respiratory System Agents|respiratory system agents|mesh-ancestor
92127486|NCT03163914|Mydriatics|mydriatics|mesh-ancestor
92127487|NCT03163914|Sympathomimetics|sympathomimetics|mesh-ancestor
92127488|NCT03163914|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92127489|NCT03163914|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92127490|NCT03163914|Nasal Decongestants|nasal decongestants|mesh-ancestor
92127491|NCT03163914|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92127492|NCT03163914|Protective Agents|protective agents|mesh-ancestor
92127493|NCT03160872|Hormones|hormones|mesh-list
92127494|NCT03160872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127495|NCT03160872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127497|NCT03163680|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92127498|NCT03163680|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127499|NCT03163680|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92127500|NCT03163680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127501|NCT03163680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127502|NCT04574232|Triamcinolone|triamcinolone|mesh-list
92127503|NCT04574232|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92127504|NCT04574232|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92127505|NCT04574232|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92127506|NCT04574232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127507|NCT04574232|Glucocorticoids|glucocorticoids|mesh-ancestor
92127508|NCT04574232|Hormones|hormones|mesh-ancestor
92127509|NCT04574232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127510|NCT04574232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127511|NCT04574232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127512|NCT04574232|Immunologic Factors|immunologic factors|mesh-ancestor
92127513|NCT04574232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127514|NCT04574232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127515|NCT05071716|Rifaximin|rifaximin|mesh-list
92127516|NCT05071716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92127517|NCT05071716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127518|NCT05071716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127519|NCT02680002|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92127520|NCT02680002|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92127521|NCT02680002|Immunologic Factors|immunologic factors|mesh-ancestor
92127522|NCT02680002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127523|NCT04557384|Ramucirumab|ramucirumab|mesh-list
92127524|NCT04557384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127525|NCT04548648|Isavuconazole|isavuconazole|mesh-list
92127526|NCT04548648|Acalabrutinib|acalabrutinib|mesh-list
92127527|NCT04548648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127528|NCT04548648|Antifungal Agents|antifungal agents|mesh-ancestor
92127529|NCT04548648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127530|NCT04443348|Paclitaxel|paclitaxel|mesh-list
92127531|NCT04443348|Cyclophosphamide|cyclophosphamide|mesh-list
92127532|NCT04443348|Carboplatin|carboplatin|mesh-list
92127533|NCT04443348|Doxorubicin|doxorubicin|mesh-list
92127534|NCT04443348|Pembrolizumab|pembrolizumab|mesh-list
92127535|NCT04443348|Capecitabine|capecitabine|mesh-list
92127536|NCT04443348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92127537|NCT04443348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127538|NCT04443348|Tubulin Modulators|tubulin modulators|mesh-ancestor
92127539|NCT04443348|Antimitotic Agents|antimitotic agents|mesh-ancestor
92127540|NCT04443348|Mitosis Modulators|mitosis modulators|mesh-ancestor
92127541|NCT04443348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127542|NCT04443348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127543|NCT04443348|Immunologic Factors|immunologic factors|mesh-ancestor
92127544|NCT04443348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127545|NCT04443348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127546|NCT04443348|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92127547|NCT04443348|Alkylating Agents|alkylating agents|mesh-ancestor
92127548|NCT04443348|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92127549|NCT04443348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92127550|NCT04443348|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92127551|NCT04443348|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92127552|NCT04443348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127553|NCT04443348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92127554|NCT04443348|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92127555|NCT04443348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127556|NCT04443348|Antimetabolites|antimetabolites|mesh-ancestor
92127557|NCT03161184|Sulfamethazine|sulfamethazine|mesh-list
92127558|NCT03161184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127559|NCT05231850|Tislelizumab|tislelizumab|mesh-list
92127560|NCT05231850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92127561|NCT05231850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127562|NCT03163212|Lactoferrin|lactoferrin|mesh-list
92127563|NCT03163212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127564|NCT05007678|Leflunomide|leflunomide|mesh-list
92127565|NCT05007678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127566|NCT05007678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127567|NCT05007678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127568|NCT05007678|Immunologic Factors|immunologic factors|mesh-ancestor
92127569|NCT05007678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127570|NCT03161106|Lactulose|lactulose|mesh-list
92127571|NCT03161106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127572|NCT02671500|Sofosbuvir|sofosbuvir|mesh-list
92127573|NCT02671500|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92127574|NCT02671500|Velpatasvir|velpatasvir|mesh-list
92127575|NCT02671500|Antiviral Agents|antiviral agents|mesh-ancestor
92127576|NCT02671500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127577|NCT02671266|Oxytocin|oxytocin|mesh-list
92127578|NCT02671266|Oxytocics|oxytocics|mesh-ancestor
92127579|NCT02671266|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127580|NCT02671266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127581|NCT03160404|Zolpidem|zolpidem|mesh-list
92127582|NCT03160404|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92127583|NCT03160404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92127584|NCT03160404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127585|NCT03160404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127586|NCT03160404|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92127587|NCT03160404|GABA Agonists|gaba agonists|mesh-ancestor
92127588|NCT03160404|GABA Agents|gaba agents|mesh-ancestor
92127589|NCT03160404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127590|NCT03160404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127591|NCT03162588|Epoetin Alfa|epoetin alfa|mesh-list
92127592|NCT03162588|Hematinics|hematinics|mesh-ancestor
92127593|NCT03320070|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92127594|NCT03320070|Hormones|hormones|mesh-ancestor
92127595|NCT03320070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127596|NCT03320070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127597|NCT04977336|Acetaminophen|acetaminophen|mesh-list
92127598|NCT04977336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127599|NCT04977336|Analgesics|analgesics|mesh-ancestor
92127600|NCT04977336|Sensory System Agents|sensory system agents|mesh-ancestor
92127601|NCT04977336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127602|NCT04977336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127603|NCT04977336|Antipyretics|antipyretics|mesh-ancestor
92127604|NCT03284424|Pembrolizumab|pembrolizumab|mesh-list
92127605|NCT03284424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92127606|NCT03284424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127607|NCT03284424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92127608|NCT03284424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127609|NCT02674854|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92127610|NCT02674854|Latanoprost|latanoprost|mesh-list
92127611|NCT02674854|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92127612|NCT04036188|Vitamin D|vitamin d|mesh-list
92127613|NCT04036188|Cholecalciferol|cholecalciferol|mesh-list
92127614|NCT04036188|Triamcinolone|triamcinolone|mesh-list
92127615|NCT04036188|Vitamins|vitamins|mesh-ancestor
92127616|NCT04036188|Micronutrients|micronutrients|mesh-ancestor
92127617|NCT04036188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127618|NCT04036188|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92127619|NCT04036188|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92127620|NCT04036188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127621|NCT04036188|Glucocorticoids|glucocorticoids|mesh-ancestor
92127622|NCT04036188|Hormones|hormones|mesh-ancestor
92127623|NCT04036188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127624|NCT02388516|Vitamin D|vitamin d|mesh-list
92127625|NCT02388516|Cholecalciferol|cholecalciferol|mesh-list
92127626|NCT02388516|Vitamins|vitamins|mesh-ancestor
92127627|NCT02388516|Micronutrients|micronutrients|mesh-ancestor
92127628|NCT02388516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127629|NCT02388516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92127630|NCT02388516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92127631|NCT02669862|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92127632|NCT02135874|Cytarabine|cytarabine|mesh-list
92127633|NCT02135874|Dexamethasone|dexamethasone|mesh-list
92127634|NCT02135874|Dexamethasone acetate|dexamethasone acetate|mesh-list
92127635|NCT02135874|Rituximab|rituximab|mesh-list
92127636|NCT02135874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92127637|NCT02135874|Vincristine|vincristine|mesh-list
92127638|NCT02135874|Sorafenib|sorafenib|mesh-list
92127639|NCT02135874|Idarubicin|idarubicin|mesh-list
92127640|NCT02135874|Clofarabine|clofarabine|mesh-list
92127641|NCT02135874|Antibodies|antibodies|mesh-list
92127642|NCT02135874|Immunoglobulins|immunoglobulins|mesh-list
92127643|NCT02135874|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92127644|NCT02135874|BB 1101|bb 1101|mesh-list
92127645|NCT02135874|Immunologic Factors|immunologic factors|mesh-ancestor
92127646|NCT02135874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127647|NCT02135874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127649|NCT02135874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127650|NCT02135874|Antiemetics|antiemetics|mesh-ancestor
92127651|NCT02135874|Autonomic Agents|autonomic agents|mesh-ancestor
92127652|NCT02135874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127653|NCT02135874|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127654|NCT02135874|Glucocorticoids|glucocorticoids|mesh-ancestor
92127655|NCT02135874|Hormones|hormones|mesh-ancestor
92127656|NCT02135874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127657|NCT02135874|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92127658|NCT02135874|Protease Inhibitors|protease inhibitors|mesh-ancestor
92127659|NCT02135874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127660|NCT02135874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127661|NCT02135874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127662|NCT02135874|Antimetabolites|antimetabolites|mesh-ancestor
92127663|NCT02135874|Antiviral Agents|antiviral agents|mesh-ancestor
92127664|NCT02135874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127665|NCT02135874|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127666|NCT02135874|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92127667|NCT02135874|Tubulin Modulators|tubulin modulators|mesh-ancestor
92127668|NCT02135874|Antimitotic Agents|antimitotic agents|mesh-ancestor
92127669|NCT02135874|Mitosis Modulators|mitosis modulators|mesh-ancestor
92127670|NCT02135874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92127671|NCT02135874|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92127672|NCT02135874|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92127673|NCT02135874|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92127675|NCT01531673|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92127676|NCT01531673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92127677|NCT01531673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127678|NCT01531205|Leuprolide|leuprolide|mesh-list
92127679|NCT01531205|Goserelin|goserelin|mesh-list
92127680|NCT01531205|Bicalutamide|bicalutamide|mesh-list
92127681|NCT01531205|Androgens|androgens|mesh-list
92127682|NCT01531205|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92127683|NCT01531205|Fertility Agents|fertility agents|mesh-ancestor
92127684|NCT01531205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127685|NCT01531205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127686|NCT01531205|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92127687|NCT01531205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127688|NCT01531205|Hormones|hormones|mesh-ancestor
92127689|NCT01531205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127690|NCT01531205|Androgen Antagonists|androgen antagonists|mesh-ancestor
92127691|NCT01531205|Hormone Antagonists|hormone antagonists|mesh-ancestor
92127692|NCT02985671|Acetaminophen|acetaminophen|mesh-list
92127693|NCT02985671|Diclofenac|diclofenac|mesh-list
92127694|NCT02985671|Orphenadrine|orphenadrine|mesh-list
92127695|NCT02985671|Caffeine|caffeine|mesh-list
92127696|NCT02985671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127697|NCT02985671|Analgesics|analgesics|mesh-ancestor
92127698|NCT02985671|Sensory System Agents|sensory system agents|mesh-ancestor
92127699|NCT02985671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127700|NCT02985671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127701|NCT02985671|Antipyretics|antipyretics|mesh-ancestor
92127702|NCT02985671|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92127703|NCT02985671|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92127704|NCT02985671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127705|NCT02985671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127706|NCT02985671|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92127707|NCT02985671|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92127708|NCT02985671|Purinergic Agents|purinergic agents|mesh-ancestor
92127709|NCT02985671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127936|NCT00130923|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92127710|NCT02985671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92127711|NCT02985671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127712|NCT02985671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127713|NCT02985671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92127714|NCT02985671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92127715|NCT02985671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92127716|NCT02985671|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92127717|NCT02985671|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92127718|NCT02985671|Parasympatholytics|parasympatholytics|mesh-ancestor
92127719|NCT02985671|Autonomic Agents|autonomic agents|mesh-ancestor
92127720|NCT02985671|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92127721|NCT02985671|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92127722|NCT02985671|Cholinergic Agents|cholinergic agents|mesh-ancestor
92127723|NCT02985671|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
92127724|NCT02985671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92127726|NCT01529645|Immunologic Factors|immunologic factors|mesh-ancestor
92127727|NCT01529645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127728|NCT01528787|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92127729|NCT01528787|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92127730|NCT01528709|Atorvastatin|atorvastatin|mesh-list
92127731|NCT01528709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92127732|NCT01528709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92127733|NCT01528709|Antimetabolites|antimetabolites|mesh-ancestor
92127734|NCT01528709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127735|NCT01528709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92127736|NCT01528709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92127737|NCT01528709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127738|NCT01527383|Vaccines|vaccines|mesh-list
92127739|NCT01527383|Immunologic Factors|immunologic factors|mesh-ancestor
92127740|NCT01527383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127741|NCT01526057|Rituximab|rituximab|mesh-list
92127742|NCT01526057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92127743|NCT01526057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127744|NCT01526057|Immunologic Factors|immunologic factors|mesh-ancestor
92127745|NCT01526057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127746|NCT01526057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127747|NCT01525901|Mitogens|mitogens|mesh-list
92127748|NCT01525901|Mecasermin|mecasermin|mesh-list
92127749|NCT01525901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127750|NCT01525901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92127751|NCT01525901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127752|NCT01525901|Growth Substances|growth substances|mesh-ancestor
92127753|NCT00123123|Chlorhexidine|chlorhexidine|mesh-list
92127754|NCT00123123|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92127755|NCT00123123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92127756|NCT00123123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127757|NCT00123123|Disinfectants|disinfectants|mesh-ancestor
92127758|NCT00123123|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127759|NCT00242385|Protease Inhibitors|protease inhibitors|mesh-list
92127760|NCT00242385|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92127761|NCT00242385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127762|NCT00242385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127763|NCT00242385|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92127764|NCT00242385|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92127765|NCT00242619|Rosiglitazone|rosiglitazone|mesh-list
92127766|NCT00242619|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92127767|NCT00242619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127768|NCT01899027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92127769|NCT01899027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92127770|NCT01899027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92127771|NCT01899027|Antimetabolites|antimetabolites|mesh-ancestor
92127772|NCT01899027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127773|NCT01899027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92127774|NCT01899027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92127775|NCT01899027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127776|NCT00264381|Dalteparin|dalteparin|mesh-list
92127777|NCT00264381|Tinzaparin|tinzaparin|mesh-list
92127778|NCT00264381|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92127779|NCT00264381|Anticoagulants|anticoagulants|mesh-ancestor
92127780|NCT00264381|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92127781|NCT00264381|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92127782|NCT00264381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127783|NCT00246441|Paroxetine|paroxetine|mesh-list
92127784|NCT00246441|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92127785|NCT00246441|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92127786|NCT00246441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92127787|NCT00246441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127788|NCT00246441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127789|NCT00246441|Serotonin Agents|serotonin agents|mesh-ancestor
92127790|NCT00246441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127791|NCT00246441|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92127792|NCT00246441|Antidepressive Agents|antidepressive agents|mesh-ancestor
92127793|NCT00246441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92127794|NCT00246441|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92127795|NCT00246441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92127797|NCT00246519|Atenolol|atenolol|mesh-list
92127798|NCT00246519|Metoprolol|metoprolol|mesh-list
92127799|NCT00246519|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92127800|NCT00246519|Trichlormethiazide|trichlormethiazide|mesh-list
92127801|NCT00246519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92127802|NCT00246519|Diuretics|diuretics|mesh-ancestor
92127803|NCT00246519|Natriuretic Agents|natriuretic agents|mesh-ancestor
92127804|NCT00246519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127805|NCT00246519|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92127806|NCT00246519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92127807|NCT00246519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127808|NCT00246519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92127810|NCT00246519|Autonomic Agents|autonomic agents|mesh-ancestor
92127811|NCT00246519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127812|NCT00246519|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92127813|NCT00246519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92127814|NCT00246519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92127815|NCT00246519|Adrenergic Agents|adrenergic agents|mesh-ancestor
92127816|NCT00246519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127817|NCT00248547|Dexamethasone|dexamethasone|mesh-list
92127818|NCT00248547|Ondansetron|ondansetron|mesh-list
92127819|NCT00248547|Aprepitant|aprepitant|mesh-list
92127820|NCT00248547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127821|NCT00248547|Antiemetics|antiemetics|mesh-ancestor
92127822|NCT00248547|Autonomic Agents|autonomic agents|mesh-ancestor
92127823|NCT00248547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127824|NCT00248547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127825|NCT00248547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92127826|NCT00248547|Glucocorticoids|glucocorticoids|mesh-ancestor
92127827|NCT00248547|Hormones|hormones|mesh-ancestor
92127828|NCT00248547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92127829|NCT00248547|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92127830|NCT00248547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127831|NCT00248547|Antipruritics|antipruritics|mesh-ancestor
92127832|NCT00248547|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127833|NCT00248547|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92127834|NCT00248547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92127835|NCT00248547|Serotonin Agents|serotonin agents|mesh-ancestor
92127836|NCT00248547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127837|NCT00248547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127838|NCT00248547|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92127839|NCT01524887|Immunoglobulins|immunoglobulins|mesh-list
92127840|NCT01524887|Antibodies|antibodies|mesh-list
92127841|NCT01524887|gamma-Globulins|gamma-globulins|mesh-list
92127842|NCT01524887|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92127843|NCT01524887|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92127844|NCT01524887|Immunologic Factors|immunologic factors|mesh-ancestor
92127845|NCT01524887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127846|NCT00266799|Doxorubicin|doxorubicin|mesh-list
92127847|NCT00266799|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92127848|NCT00266799|Capecitabine|capecitabine|mesh-list
92127849|NCT00266799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92127850|NCT00266799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127851|NCT00266799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92127852|NCT00266799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92127853|NCT00266799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127854|NCT00266799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127855|NCT00266799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127856|NCT00266799|Antimetabolites|antimetabolites|mesh-ancestor
92127857|NCT00249249|Atorvastatin|atorvastatin|mesh-list
92127858|NCT00249249|Pitavastatin|pitavastatin|mesh-list
92127859|NCT00249249|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92127860|NCT00249249|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92127861|NCT00249249|Antimetabolites|antimetabolites|mesh-ancestor
92127937|NCT00130923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92127862|NCT00249249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127863|NCT00249249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92127864|NCT00249249|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92127865|NCT00249249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127866|NCT01522235|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92127867|NCT01522235|gamma-Globulins|gamma-globulins|mesh-list
92127868|NCT01522235|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92127869|NCT01522235|Immunologic Factors|immunologic factors|mesh-ancestor
92127870|NCT01522235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127871|NCT00125931|Pentazocine|pentazocine|mesh-list
92127872|NCT00125931|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92127873|NCT00125931|Narcotics|narcotics|mesh-ancestor
92127874|NCT00125931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127875|NCT00125931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127876|NCT00125931|Analgesics|analgesics|mesh-ancestor
92127877|NCT00125931|Sensory System Agents|sensory system agents|mesh-ancestor
92127878|NCT00125931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127879|NCT00125931|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92127880|NCT00125931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92127881|NCT00267111|Tetracaine|tetracaine|mesh-list
92127882|NCT00267111|Anesthetics, Local|anesthetics, local|mesh-ancestor
92127883|NCT00267111|Anesthetics|anesthetics|mesh-ancestor
92127884|NCT00267111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127885|NCT00267111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127887|NCT00267111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127888|NCT01521923|Certolizumab Pegol|certolizumab pegol|mesh-list
92127889|NCT01521923|Methotrexate|methotrexate|mesh-list
92127890|NCT01521923|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92127891|NCT01521923|Abortifacient Agents|abortifacient agents|mesh-ancestor
92127892|NCT01521923|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127893|NCT01521923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127894|NCT01521923|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127895|NCT01521923|Antimetabolites|antimetabolites|mesh-ancestor
92127896|NCT01521923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086129|NCT03588429|Isoflurane|isoflurane|mesh-list
92127897|NCT01521923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127898|NCT01521923|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127899|NCT01521923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127900|NCT01521923|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92127901|NCT01521923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127902|NCT01521923|Immunologic Factors|immunologic factors|mesh-ancestor
92127903|NCT01521923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127904|NCT01521923|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92127905|NCT01521923|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92127906|NCT01521923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127907|NCT05240781|Sirolimus|sirolimus|mesh-list
92127908|NCT05240781|Temsirolimus|temsirolimus|mesh-list
92127909|NCT05240781|MTOR Inhibitors|mtor inhibitors|mesh-list
92127910|NCT05240781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92127911|NCT05240781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127912|NCT05240781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92127913|NCT05240781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127914|NCT05240781|Antifungal Agents|antifungal agents|mesh-ancestor
92127915|NCT05240781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127916|NCT05240781|Immunologic Factors|immunologic factors|mesh-ancestor
92127917|NCT05240781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127918|NCT05240781|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92127919|NCT05240781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127920|NCT05240781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127921|NCT01520987|Opicapone|opicapone|mesh-list
92127922|NCT01520987|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92127923|NCT01520987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127924|NCT01520987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127925|NCT01520987|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92127926|NCT01520987|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92127927|NCT00130923|Risperidone|risperidone|mesh-list
92127928|NCT00130923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92127929|NCT00130923|Serotonin Agents|serotonin agents|mesh-ancestor
92127930|NCT00130923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92127931|NCT00130923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127932|NCT00130923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127933|NCT00130923|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92127934|NCT00130923|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92127935|NCT00130923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92127943|NCT04117581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127944|NCT04117581|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92127945|NCT04117581|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92127946|NCT00272337|Aspirin|aspirin|mesh-list
92127947|NCT00272337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92127948|NCT00272337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92127949|NCT00272337|Analgesics|analgesics|mesh-ancestor
92127950|NCT00272337|Sensory System Agents|sensory system agents|mesh-ancestor
92127951|NCT00272337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92127952|NCT00272337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127953|NCT00272337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92127954|NCT00272337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127955|NCT00272337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92127956|NCT00272337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92127957|NCT00272337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127958|NCT00272337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92127959|NCT00272337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92127960|NCT00272337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127961|NCT00272337|Antipyretics|antipyretics|mesh-ancestor
92127962|NCT01562275|Ipatasertib|ipatasertib|mesh-list
92127963|NCT01562275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127964|NCT01562275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92127965|NCT01562275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127966|NCT01562275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127967|NCT01535053|Calcium, Dietary|calcium, dietary|mesh-list
92127968|NCT01535053|Leucovorin|leucovorin|mesh-list
92127969|NCT01535053|Folic Acid|folic acid|mesh-list
92127970|NCT01535053|Dactinomycin|dactinomycin|mesh-list
92127971|NCT01535053|Methotrexate|methotrexate|mesh-list
92086207|NCT03586869|Leucovorin|leucovorin|mesh-list
92127972|NCT01535053|Calcium|calcium|mesh-list
92127973|NCT01535053|Levoleucovorin|levoleucovorin|mesh-list
92127974|NCT01535053|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92127975|NCT01535053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92127976|NCT01535053|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92127977|NCT01535053|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92127978|NCT01535053|Abortifacient Agents|abortifacient agents|mesh-ancestor
92127979|NCT01535053|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92127980|NCT01535053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92127981|NCT01535053|Antimetabolites|antimetabolites|mesh-ancestor
92127982|NCT01535053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92127983|NCT01535053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92127984|NCT01535053|Dermatologic Agents|dermatologic agents|mesh-ancestor
92127985|NCT01535053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92127986|NCT01535053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92127987|NCT01535053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92127988|NCT01535053|Immunologic Factors|immunologic factors|mesh-ancestor
92127989|NCT01535053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92127990|NCT01535053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92127991|NCT01535053|Antidotes|antidotes|mesh-ancestor
92127992|NCT01535053|Protective Agents|protective agents|mesh-ancestor
92127993|NCT01535053|Vitamin B Complex|vitamin b complex|mesh-ancestor
92127994|NCT01535053|Vitamins|vitamins|mesh-ancestor
92127995|NCT01535053|Micronutrients|micronutrients|mesh-ancestor
92127996|NCT01535053|Hematinics|hematinics|mesh-ancestor
92127997|NCT01535053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92127998|NCT01535053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92127999|NCT01535053|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92128000|NCT01535053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92128001|NCT03027635|Ciprofloxacin|ciprofloxacin|mesh-list
92128002|NCT03027635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92128003|NCT03027635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128004|NCT03027635|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92128005|NCT03027635|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92128006|NCT03027635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128007|NCT03027635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128008|NCT03027635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128009|NCT03027635|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92128010|NCT03027635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92128011|NCT01520363|Dextromethorphan|dextromethorphan|mesh-list
92128012|NCT01520363|Antitussive Agents|antitussive agents|mesh-ancestor
92128013|NCT01520363|Respiratory System Agents|respiratory system agents|mesh-ancestor
92128014|NCT01520363|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92128015|NCT01520363|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92128016|NCT01520363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128017|NCT01520363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128018|NCT01520363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128019|NCT01578499|Methotrexate|methotrexate|mesh-list
92128020|NCT01578499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92128022|NCT01578499|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92128023|NCT01578499|Abortifacient Agents|abortifacient agents|mesh-ancestor
92128024|NCT01578499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92128025|NCT01578499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128026|NCT01578499|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92128027|NCT01578499|Antimetabolites|antimetabolites|mesh-ancestor
92128028|NCT01578499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128029|NCT01578499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128030|NCT01578499|Dermatologic Agents|dermatologic agents|mesh-ancestor
92128031|NCT01578499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128032|NCT01578499|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92128033|NCT01578499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128034|NCT01578499|Immunologic Factors|immunologic factors|mesh-ancestor
92128035|NCT01578499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128036|NCT01578499|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92128037|NCT01578499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92128038|NCT01578499|Immunotoxins|immunotoxins|mesh-ancestor
92128039|NCT01578499|Immunoconjugates|immunoconjugates|mesh-ancestor
92128040|NCT01561963|Rifampin|rifampin|mesh-list
92128041|NCT01561963|Apremilast|apremilast|mesh-list
92128042|NCT01561963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92128043|NCT01561963|Antitubercular Agents|antitubercular agents|mesh-ancestor
92128044|NCT01561963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92128045|NCT01561963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128046|NCT01561963|Leprostatic Agents|leprostatic agents|mesh-ancestor
92128047|NCT01561963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92128049|NCT01561963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128050|NCT01561963|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92128051|NCT01561963|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92128052|NCT01561963|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92128053|NCT01561963|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92128054|NCT01561963|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92128055|NCT01561963|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92128056|NCT01561963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92128057|NCT01561963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92128058|NCT01561963|Analgesics|analgesics|mesh-ancestor
92128059|NCT01561963|Sensory System Agents|sensory system agents|mesh-ancestor
92128060|NCT01561963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128061|NCT01561963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128062|NCT01561963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128063|NCT01561963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128064|NCT01561963|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92128065|NCT01561963|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92128066|NCT04852003|Morphine|morphine|mesh-list
92128067|NCT04852003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92128068|NCT04852003|Narcotics|narcotics|mesh-ancestor
92128069|NCT04852003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128070|NCT04852003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128071|NCT04852003|Analgesics|analgesics|mesh-ancestor
92128072|NCT04852003|Sensory System Agents|sensory system agents|mesh-ancestor
92128073|NCT04852003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128074|NCT01534351|Tamsulosin|tamsulosin|mesh-list
92128075|NCT01534351|Finasteride|finasteride|mesh-list
92128076|NCT01534351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92128077|NCT01534351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92128079|NCT01534351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92128080|NCT01534351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128081|NCT01534351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128082|NCT01534351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128083|NCT01534351|Urological Agents|urological agents|mesh-ancestor
92128084|NCT01534351|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92128085|NCT01534351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92128086|NCT01534351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128087|NCT01534351|Hormone Antagonists|hormone antagonists|mesh-ancestor
92128088|NCT01534351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128089|NCT01534195|Prednisolone|prednisolone|mesh-list
92128090|NCT01534195|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92128091|NCT01534195|Methylprednisolone|methylprednisolone|mesh-list
92145306|NCT00245037|Fludarabine|fludarabine|mesh-list
92128092|NCT01534195|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92128093|NCT01534195|Prednisolone acetate|prednisolone acetate|mesh-list
92128094|NCT01534195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92128095|NCT01534195|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92128096|NCT01534195|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92128097|NCT01534195|Prednisolone phosphate|prednisolone phosphate|mesh-list
92128098|NCT01534195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128099|NCT01534195|Glucocorticoids|glucocorticoids|mesh-ancestor
92128100|NCT01534195|Hormones|hormones|mesh-ancestor
92128101|NCT01534195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128102|NCT01534195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128103|NCT01534195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92128104|NCT01534195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128105|NCT01534195|Antiemetics|antiemetics|mesh-ancestor
92128106|NCT01534195|Autonomic Agents|autonomic agents|mesh-ancestor
92128107|NCT01534195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128108|NCT01534195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128109|NCT01534195|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92128110|NCT01534195|Protective Agents|protective agents|mesh-ancestor
92128111|NCT01560949|Gemcitabine|gemcitabine|mesh-list
91939074|NCT04876534|Hormones|hormones|mesh-ancestor
92128113|NCT01560949|Oxaliplatin|oxaliplatin|mesh-list
92128114|NCT01560949|Irinotecan|irinotecan|mesh-list
92128115|NCT01560949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92128116|NCT01560949|Antimetabolites|antimetabolites|mesh-ancestor
92128117|NCT01560949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128118|NCT01560949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086362|NCT03156153|Bumetanide|bumetanide|mesh-list
92128119|NCT01560949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128121|NCT01560949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128122|NCT01560949|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92128123|NCT01560949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92128124|NCT01560949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128125|NCT03113448|Capsaicin|capsaicin|mesh-list
92128126|NCT03113448|Antipruritics|antipruritics|mesh-ancestor
92128127|NCT03113448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92128128|NCT03113448|Sensory System Agents|sensory system agents|mesh-ancestor
92128129|NCT03113448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128130|NCT03113448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128131|NCT01533493|Memantine|memantine|mesh-list
92128132|NCT01533493|Methylphenidate|methylphenidate|mesh-list
92128133|NCT01533493|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92128134|NCT01533493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128135|NCT01533493|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92128136|NCT01533493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92128137|NCT01533493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128138|NCT01533493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128139|NCT01533493|Dopamine Agents|dopamine agents|mesh-ancestor
92128140|NCT01533493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128141|NCT01533493|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92128142|NCT01533493|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92128143|NCT01533493|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92128144|NCT01533493|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92128145|NCT02388048|Ofatumumab|ofatumumab|mesh-list
92128146|NCT02388048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128147|NCT02387892|Vitamin D|vitamin d|mesh-list
92128148|NCT02387892|Cholecalciferol|cholecalciferol|mesh-list
92128149|NCT02387892|Vitamins|vitamins|mesh-ancestor
92128150|NCT02387892|Micronutrients|micronutrients|mesh-ancestor
92128151|NCT02387892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128152|NCT02387892|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92128153|NCT02387892|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92128154|NCT00133575|Vaccines|vaccines|mesh-list
92128155|NCT00133575|Immunologic Factors|immunologic factors|mesh-ancestor
92128156|NCT00133575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128157|NCT00134043|Vorinostat|vorinostat|mesh-list
92128158|NCT00134043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128159|NCT00134043|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92128160|NCT00134043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128161|NCT00134043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128162|NCT03715998|Ramipril|ramipril|mesh-list
92128163|NCT03715998|Firibastat|firibastat|mesh-list
92128164|NCT03715998|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92128165|NCT03715998|Protease Inhibitors|protease inhibitors|mesh-ancestor
92128166|NCT03715998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128167|NCT03715998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128168|NCT03715998|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92128169|NCT01790529|Metronidazole|metronidazole|mesh-list
92128170|NCT01790529|Cefuroxime|cefuroxime|mesh-list
92128172|NCT01790529|Anesthetics|anesthetics|mesh-list
92128173|NCT01790529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128174|NCT01790529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128175|NCT01790529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128176|NCT01790529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92128177|NCT01790529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92128178|NCT01790529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92128179|NCT01533181|Topotecan|topotecan|mesh-list
92128180|NCT01533181|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92128181|NCT01533181|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92128182|NCT01533181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128183|NCT01533181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128184|NCT01533181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128185|NCT04641507|Tadalafil|tadalafil|mesh-list
92128186|NCT04641507|Tamsulosin|tamsulosin|mesh-list
92128187|NCT04641507|Vasodilator Agents|vasodilator agents|mesh-ancestor
92128188|NCT04641507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92128190|NCT04641507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128191|NCT04641507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086431|NCT03586947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128192|NCT04641507|Urological Agents|urological agents|mesh-ancestor
92128193|NCT04641507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92128194|NCT04641507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92128195|NCT04641507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92128196|NCT04641507|Adrenergic Agents|adrenergic agents|mesh-ancestor
92128197|NCT04641507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128198|NCT04641507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128200|NCT04489173|Antimetabolites|antimetabolites|mesh-ancestor
92128201|NCT04489173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128202|NCT04489173|Antiviral Agents|antiviral agents|mesh-ancestor
92128203|NCT04489173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128204|NCT00512070|Olanzapine|olanzapine|mesh-list
92128205|NCT00512070|Melatonin|melatonin|mesh-list
92128206|NCT00512070|Antioxidants|antioxidants|mesh-ancestor
92128207|NCT00512070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128208|NCT00512070|Protective Agents|protective agents|mesh-ancestor
92128209|NCT00512070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128210|NCT00512070|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128211|NCT00512070|Antiemetics|antiemetics|mesh-ancestor
92128212|NCT00512070|Autonomic Agents|autonomic agents|mesh-ancestor
92128213|NCT00512070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128214|NCT00512070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128215|NCT00512070|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92128216|NCT00512070|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92128217|NCT00512070|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128218|NCT00512070|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92128219|NCT00512070|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92128220|NCT00512070|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128221|NCT00512070|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128222|NCT00512070|Serotonin Agents|serotonin agents|mesh-ancestor
92128223|NCT05668026|Venetoclax|venetoclax|mesh-list
92128224|NCT05668026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128225|NCT05661552|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92128226|NCT05661552|Ezetimibe|ezetimibe|mesh-list
92128227|NCT05661552|Evolocumab|evolocumab|mesh-list
92128228|NCT05661552|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92128229|NCT05661552|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92128230|NCT05661552|Antimetabolites|antimetabolites|mesh-ancestor
92128231|NCT05661552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128232|NCT05661552|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92128233|NCT05661552|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92128234|NCT05661552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128235|NCT05661552|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92128236|NCT05661552|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92128237|NCT05661552|Protease Inhibitors|protease inhibitors|mesh-ancestor
92128238|NCT03534102|Analgesics, Opioid|analgesics, opioid|mesh-list
92128239|NCT03534102|Narcotics|narcotics|mesh-ancestor
92128240|NCT03534102|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128241|NCT03534102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128242|NCT03534102|Analgesics|analgesics|mesh-ancestor
92128243|NCT03534102|Sensory System Agents|sensory system agents|mesh-ancestor
92128244|NCT03534102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128245|NCT04051203|Methylprednisolone|methylprednisolone|mesh-list
92128246|NCT04051203|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92128247|NCT04051203|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92128248|NCT04051203|Prednisolone|prednisolone|mesh-list
92128249|NCT04051203|Prednisolone acetate|prednisolone acetate|mesh-list
92128250|NCT04051203|Lidocaine|lidocaine|mesh-list
92128251|NCT04051203|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92128252|NCT04051203|Prednisolone phosphate|prednisolone phosphate|mesh-list
92128253|NCT04051203|Anesthetics, Local|anesthetics, local|mesh-ancestor
92128254|NCT04051203|Anesthetics|anesthetics|mesh-ancestor
92128255|NCT04051203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128256|NCT04051203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128257|NCT04051203|Sensory System Agents|sensory system agents|mesh-ancestor
92128258|NCT04051203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128259|NCT04051203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92128260|NCT04051203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92128261|NCT04051203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92128262|NCT04051203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128263|NCT04051203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128264|NCT04051203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128265|NCT04051203|Antiemetics|antiemetics|mesh-ancestor
92128266|NCT04051203|Autonomic Agents|autonomic agents|mesh-ancestor
92128267|NCT04051203|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128268|NCT04051203|Glucocorticoids|glucocorticoids|mesh-ancestor
92128269|NCT04051203|Hormones|hormones|mesh-ancestor
92128270|NCT04051203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128271|NCT04051203|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92128272|NCT04051203|Protective Agents|protective agents|mesh-ancestor
92128273|NCT04051203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92128274|NCT04051203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128275|NCT00144963|Dexamethasone|dexamethasone|mesh-list
92128276|NCT00144963|Vincristine|vincristine|mesh-list
92128277|NCT00144963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128278|NCT00144963|Antiemetics|antiemetics|mesh-ancestor
92128279|NCT00144963|Autonomic Agents|autonomic agents|mesh-ancestor
92128280|NCT00144963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128281|NCT00144963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128282|NCT00144963|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128283|NCT00144963|Glucocorticoids|glucocorticoids|mesh-ancestor
92128284|NCT00144963|Hormones|hormones|mesh-ancestor
92128285|NCT00144963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128286|NCT00144963|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92128287|NCT00144963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128288|NCT00144963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92128289|NCT00144963|Tubulin Modulators|tubulin modulators|mesh-ancestor
92128290|NCT00144963|Antimitotic Agents|antimitotic agents|mesh-ancestor
92128291|NCT00144963|Mitosis Modulators|mitosis modulators|mesh-ancestor
92128292|NCT00144963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128293|NCT02662764|Sufentanil|sufentanil|mesh-list
92128295|NCT02662764|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92128296|NCT02662764|Narcotics|narcotics|mesh-ancestor
92128297|NCT02662764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128298|NCT02662764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128299|NCT02662764|Analgesics|analgesics|mesh-ancestor
92128300|NCT02662764|Sensory System Agents|sensory system agents|mesh-ancestor
92128301|NCT02662764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128302|NCT02662764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92128303|NCT02662764|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92128304|NCT02662764|Anesthetics, General|anesthetics, general|mesh-ancestor
92128305|NCT02662764|Anesthetics|anesthetics|mesh-ancestor
92128306|NCT01519817|Vaccines|vaccines|mesh-list
92128307|NCT01519817|Immunologic Factors|immunologic factors|mesh-ancestor
92128308|NCT01519817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128309|NCT02985593|KHK4083|khk4083|mesh-list
92128310|NCT02985593|Dermatologic Agents|dermatologic agents|mesh-ancestor
92128311|NCT03478956|Etrolizumab|etrolizumab|mesh-list
92128312|NCT03478956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128313|NCT03478956|Immunologic Factors|immunologic factors|mesh-ancestor
92128314|NCT03478956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128315|NCT05549154|Vitamin D|vitamin d|mesh-list
92128316|NCT05549154|Ergocalciferols|ergocalciferols|mesh-list
92128317|NCT05549154|Cholecalciferol|cholecalciferol|mesh-list
92128318|NCT05549154|Vitamins|vitamins|mesh-list
92128319|NCT05549154|Micronutrients|micronutrients|mesh-ancestor
92128320|NCT05549154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128321|NCT05549154|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92128322|NCT05549154|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92128324|NCT01518257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92128325|NCT01518257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92128326|NCT01518257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92128327|NCT01518257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128328|NCT01518257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128329|NCT01518257|Cholinergic Agents|cholinergic agents|mesh-ancestor
92128330|NCT01518257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128331|NCT01518257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128332|NCT01518257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92128333|NCT01518257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128334|NCT02391636|Oxytocin|oxytocin|mesh-list
92128335|NCT02391636|Carbetocin|carbetocin|mesh-list
92128336|NCT02391636|Oxytocics|oxytocics|mesh-ancestor
92128338|NCT02391636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128339|NCT01514357|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92128340|NCT01514357|Natriuretic Agents|natriuretic agents|mesh-ancestor
92128341|NCT01514357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128342|NCT02383212|Paclitaxel|paclitaxel|mesh-list
92128343|NCT02383212|Docetaxel|docetaxel|mesh-list
92128344|NCT02383212|Cyclophosphamide|cyclophosphamide|mesh-list
92128345|NCT02383212|Carboplatin|carboplatin|mesh-list
92128347|NCT02383212|Cemiplimab|cemiplimab|mesh-list
92128348|NCT02383212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92128349|NCT02383212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128350|NCT02383212|Tubulin Modulators|tubulin modulators|mesh-ancestor
92128351|NCT02383212|Antimitotic Agents|antimitotic agents|mesh-ancestor
92128352|NCT02383212|Mitosis Modulators|mitosis modulators|mesh-ancestor
92128353|NCT02383212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128354|NCT02383212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128355|NCT02383212|Immunologic Factors|immunologic factors|mesh-ancestor
92128356|NCT02383212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128357|NCT02383212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128358|NCT02383212|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92128359|NCT02383212|Alkylating Agents|alkylating agents|mesh-ancestor
92128360|NCT02383212|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92128361|NCT02383212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128362|NCT02383212|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92128363|NCT02383212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92128364|NCT02383212|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92128365|NCT01531387|Hydroxyurea|hydroxyurea|mesh-list
92128366|NCT01531387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128367|NCT01531387|Antisickling Agents|antisickling agents|mesh-ancestor
92128368|NCT01531387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128369|NCT01531387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128370|NCT01531387|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92128371|NCT01531153|Galantamine|galantamine|mesh-list
92128372|NCT01531153|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92128373|NCT01531153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128374|NCT01531153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128375|NCT01531153|Cholinergic Agents|cholinergic agents|mesh-ancestor
92128376|NCT01531153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128377|NCT01531153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128378|NCT01531153|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92128379|NCT01531153|Autonomic Agents|autonomic agents|mesh-ancestor
92128380|NCT01531153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128381|NCT01531153|Nootropic Agents|nootropic agents|mesh-ancestor
92128382|NCT03027973|Tranexamic Acid|tranexamic acid|mesh-list
92128383|NCT03027973|Ulipristal acetate|ulipristal acetate|mesh-list
92128384|NCT03027973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92128385|NCT03027973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92128386|NCT03027973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128388|NCT03027973|Coagulants|coagulants|mesh-ancestor
92128389|NCT03027973|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92128390|NCT03027973|Contraceptive Agents|contraceptive agents|mesh-ancestor
92128391|NCT03027973|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92128392|NCT03027973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128393|NCT03027973|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92128394|NCT01529749|Raltegravir Potassium|raltegravir potassium|mesh-list
92128395|NCT01529749|Losartan|losartan|mesh-list
92128396|NCT01529749|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92128397|NCT01529749|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92128398|NCT01529749|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92128399|NCT01529749|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92128400|NCT01529749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128402|NCT01529749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92128403|NCT01529749|Antiviral Agents|antiviral agents|mesh-ancestor
92128404|NCT01529749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128405|NCT01529749|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92128406|NCT01529749|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92128407|NCT01529749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128408|NCT01529515|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92128409|NCT01529515|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92128410|NCT01529515|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92128411|NCT01529515|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92128412|NCT01528969|Sorbitol|sorbitol|mesh-list
92128413|NCT01528969|Cathartics|cathartics|mesh-ancestor
92128414|NCT01528969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128415|NCT01514201|Temozolomide|temozolomide|mesh-list
92128416|NCT01514201|Veliparib|veliparib|mesh-list
92128417|NCT01514201|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92128418|NCT01514201|Alkylating Agents|alkylating agents|mesh-ancestor
92128419|NCT01514201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128420|NCT01514201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128421|NCT01514201|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92128422|NCT01514201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128423|NCT02666664|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|8-hydroxy-2,2,14,14-tetramethylpentadecanedioic acid|mesh-list
92128424|NCT02666664|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92128425|NCT02666664|Antimetabolites|antimetabolites|mesh-ancestor
92128426|NCT02666664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128427|NCT02666664|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92128428|NCT02666664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128429|NCT02666664|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92128430|NCT02666664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128431|NCT01528735|Ribavirin|ribavirin|mesh-list
92128432|NCT01528735|Antimetabolites|antimetabolites|mesh-ancestor
92128433|NCT01528735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128434|NCT01528735|Antiviral Agents|antiviral agents|mesh-ancestor
92128435|NCT01528735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128436|NCT02386488|Vortioxetine|vortioxetine|mesh-list
92128437|NCT02386488|Antidepressive Agents|antidepressive agents|mesh-ancestor
92128438|NCT02386488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128439|NCT02386488|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92128440|NCT02386488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92128441|NCT02386488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128442|NCT02386488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128443|NCT02386488|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92128444|NCT02386488|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92128445|NCT02386488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128446|NCT02386488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128447|NCT02386488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128448|NCT02386488|Serotonin Agents|serotonin agents|mesh-ancestor
92128449|NCT02386488|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92128450|NCT02386488|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92128451|NCT02386488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92128452|NCT02386488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92128454|NCT02661594|Amisulpride|amisulpride|mesh-list
92128455|NCT02661594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92128456|NCT02661594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128457|NCT02661594|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92128458|NCT02661594|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92128459|NCT02661594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128460|NCT02661594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128461|NCT02661594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128462|NCT02661594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128463|NCT02661594|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92128464|NCT02661594|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92128465|NCT02661594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128466|NCT02661594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128467|NCT02661594|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92128468|NCT02661594|Dopamine Agents|dopamine agents|mesh-ancestor
92128469|NCT02661594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128470|NCT02661594|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92128471|NCT02661594|Antidepressive Agents|antidepressive agents|mesh-ancestor
92128472|NCT02386566|Natalizumab|natalizumab|mesh-list
92128473|NCT02386566|Immunologic Factors|immunologic factors|mesh-ancestor
92128474|NCT02386566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128475|NCT01528345|Fulvestrant|fulvestrant|mesh-list
92128476|NCT01528345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92128477|NCT01528345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128478|NCT01528345|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92128479|NCT01528345|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92128481|NCT01528345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128482|NCT01528345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128483|NCT01511939|Diclofenac|diclofenac|mesh-list
92128484|NCT01511939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92128485|NCT01511939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92128486|NCT01511939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92128487|NCT01511939|Analgesics|analgesics|mesh-ancestor
92128489|NCT01511939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128490|NCT01511939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086727|NCT01272232|Liraglutide|liraglutide|mesh-list
92128491|NCT01511939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128492|NCT01511939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92128493|NCT01511939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128494|NCT01511939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128495|NCT02391480|Venetoclax|venetoclax|mesh-list
92128496|NCT02391480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128497|NCT01576705|Leucovorin|leucovorin|mesh-list
92128498|NCT01576705|Folic Acid|folic acid|mesh-list
92128499|NCT01576705|Hormones|hormones|mesh-list
92128500|NCT01576705|Levoleucovorin|levoleucovorin|mesh-list
92128501|NCT01576705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128502|NCT01576705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128503|NCT01576705|Antidotes|antidotes|mesh-ancestor
92128504|NCT01576705|Protective Agents|protective agents|mesh-ancestor
92128505|NCT01576705|Vitamin B Complex|vitamin b complex|mesh-ancestor
92128506|NCT01576705|Vitamins|vitamins|mesh-ancestor
92128507|NCT01576705|Micronutrients|micronutrients|mesh-ancestor
92128508|NCT01576705|Hematinics|hematinics|mesh-ancestor
92128509|NCT02666430|Insulin Glargine|insulin glargine|mesh-list
92128510|NCT02666430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92128511|NCT02666430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128512|NCT02382666|Rolapitant|rolapitant|mesh-list
92128513|NCT02382666|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92128514|NCT02382666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128515|NCT02382666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128516|NCT02382666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128517|NCT00145041|Vincristine|vincristine|mesh-list
92128518|NCT00145041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92128519|NCT00145041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128520|NCT00145041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92128521|NCT00145041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92128522|NCT00145041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92128523|NCT00145041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128524|NCT04123561|Dexamethasone|dexamethasone|mesh-list
92128525|NCT04123561|Dexamethasone acetate|dexamethasone acetate|mesh-list
92128526|NCT04123561|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92128527|NCT04123561|BB 1101|bb 1101|mesh-list
92128528|NCT04123561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128529|NCT04123561|Antiemetics|antiemetics|mesh-ancestor
92128530|NCT04123561|Autonomic Agents|autonomic agents|mesh-ancestor
92128531|NCT04123561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128532|NCT04123561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128533|NCT04123561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128534|NCT04123561|Glucocorticoids|glucocorticoids|mesh-ancestor
92128535|NCT04123561|Hormones|hormones|mesh-ancestor
92128536|NCT04123561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128537|NCT04123561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92128538|NCT04123561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128539|NCT04123561|Protease Inhibitors|protease inhibitors|mesh-ancestor
92128540|NCT04123561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128541|NCT04123561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128542|NCT01510769|Febuxostat|febuxostat|mesh-list
92128543|NCT01510769|Lesinurad|lesinurad|mesh-list
92128544|NCT01510769|Gout Suppressants|gout suppressants|mesh-ancestor
92128545|NCT01510769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128546|NCT01510769|Uricosuric Agents|uricosuric agents|mesh-ancestor
92128547|NCT02382354|Remifentanil|remifentanil|mesh-list
92128548|NCT02382354|Propofol|propofol|mesh-list
92128549|NCT02382354|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92128550|NCT02382354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128551|NCT02382354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128552|NCT02382354|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92128558|NCT02382354|Sensory System Agents|sensory system agents|mesh-ancestor
92128559|NCT02382354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128561|NCT01510145|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92128562|NCT03027167|Aspirin|aspirin|mesh-list
92128563|NCT03027167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92128565|NCT03027167|Analgesics|analgesics|mesh-ancestor
92086798|NCT01275352|Natriuretic Agents|natriuretic agents|mesh-ancestor
92128566|NCT03027167|Sensory System Agents|sensory system agents|mesh-ancestor
92128567|NCT03027167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128568|NCT03027167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128569|NCT03027167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128570|NCT03027167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128571|NCT03027167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92128572|NCT03027167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92128573|NCT03027167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128574|NCT03027167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92128575|NCT03027167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92128576|NCT03027167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128577|NCT03027167|Antipyretics|antipyretics|mesh-ancestor
92128578|NCT02382198|Glycopyrrolate|glycopyrrolate|mesh-list
92128579|NCT02382198|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92128580|NCT02382198|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92128581|NCT02382198|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92128582|NCT02382198|Cholinergic Agents|cholinergic agents|mesh-ancestor
92128583|NCT02382198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128584|NCT02382198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128585|NCT02382198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128586|NCT02382432|Meperidine|meperidine|mesh-list
92128587|NCT02382432|Dexmedetomidine|dexmedetomidine|mesh-list
92128588|NCT02382432|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92128589|NCT02382432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128590|NCT02382432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128591|NCT02382432|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92128592|NCT02382432|Analgesics|analgesics|mesh-ancestor
92128593|NCT02382432|Sensory System Agents|sensory system agents|mesh-ancestor
92128594|NCT02382432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128595|NCT02382432|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92128596|NCT02382432|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92128597|NCT02382432|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92128598|NCT02382432|Adrenergic Agents|adrenergic agents|mesh-ancestor
92128599|NCT02382432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128600|NCT02382432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128601|NCT02382432|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92128602|NCT02382432|Narcotics|narcotics|mesh-ancestor
92128603|NCT02382432|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92128604|NCT00145587|Antibodies|antibodies|mesh-list
92128605|NCT00145587|Immunologic Factors|immunologic factors|mesh-ancestor
92128606|NCT00145587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128607|NCT04298463|Vancomycin|vancomycin|mesh-list
92128608|NCT04298463|Daptomycin|daptomycin|mesh-list
92128609|NCT04298463|Teicoplanin|teicoplanin|mesh-list
92128610|NCT04298463|Dalbavancin|dalbavancin|mesh-list
92128611|NCT04298463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92128612|NCT04298463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128613|NCT02381964|Coenzyme Q10|coenzyme q10|mesh-list
92128614|NCT02381964|Vitamins|vitamins|mesh-ancestor
92128615|NCT02381964|Micronutrients|micronutrients|mesh-ancestor
92128616|NCT02381964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128617|NCT01509053|Aripiprazole|aripiprazole|mesh-list
92128618|NCT01509053|Antidepressive Agents|antidepressive agents|mesh-ancestor
92128619|NCT01509053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128620|NCT01509053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92128621|NCT01509053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92128622|NCT01509053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128623|NCT01509053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128624|NCT01509053|Dopamine Agonists|dopamine agonists|mesh-ancestor
92128625|NCT01509053|Dopamine Agents|dopamine agents|mesh-ancestor
92128626|NCT01509053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128627|NCT01509053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128628|NCT01509053|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92128629|NCT01509053|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92128630|NCT01509053|Serotonin Agents|serotonin agents|mesh-ancestor
92128631|NCT01509053|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92128632|NCT01509053|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92128633|NCT01509053|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92128634|NCT01509053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92128636|NCT01560403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128637|NCT01560403|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92128638|NCT01560403|Protective Agents|protective agents|mesh-ancestor
92128639|NCT01560403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128640|NCT02100579|Bupivacaine|bupivacaine|mesh-list
92128641|NCT02100579|Anesthetics, Local|anesthetics, local|mesh-ancestor
92128642|NCT02100579|Anesthetics|anesthetics|mesh-ancestor
92128643|NCT02100579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128644|NCT02100579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128645|NCT02100579|Sensory System Agents|sensory system agents|mesh-ancestor
92128646|NCT02100579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128647|NCT04251351|Acetaminophen|acetaminophen|mesh-list
92128648|NCT04251351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92128649|NCT04251351|Analgesics|analgesics|mesh-ancestor
92128650|NCT04251351|Sensory System Agents|sensory system agents|mesh-ancestor
92128651|NCT04251351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128652|NCT04251351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128653|NCT04251351|Antipyretics|antipyretics|mesh-ancestor
92128655|NCT02390700|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92128656|NCT02390700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128657|NCT02390700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128658|NCT02390700|Immunologic Factors|immunologic factors|mesh-ancestor
92128659|NCT02390700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128660|NCT00284739|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92128661|NCT00284739|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92128662|NCT00284739|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92128663|NCT00284739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128664|NCT01527487|Cyclophosphamide|cyclophosphamide|mesh-list
92128665|NCT01527487|Docetaxel|docetaxel|mesh-list
92128666|NCT01527487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128667|NCT01527487|Immunologic Factors|immunologic factors|mesh-ancestor
92128668|NCT01527487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128669|NCT01527487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128670|NCT01527487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92128671|NCT01527487|Alkylating Agents|alkylating agents|mesh-ancestor
92128672|NCT01527487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128673|NCT01527487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128674|NCT01527487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92128675|NCT01527487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92128676|NCT01527487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92128677|NCT01527487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92128678|NCT01506947|Darbepoetin alfa|darbepoetin alfa|mesh-list
92128679|NCT01506947|Hematinics|hematinics|mesh-ancestor
92128680|NCT00149643|Fluoxetine|fluoxetine|mesh-list
92128681|NCT00149643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92128682|NCT00149643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92128683|NCT00149643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128684|NCT00149643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128685|NCT00149643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128686|NCT00149643|Serotonin Agents|serotonin agents|mesh-ancestor
92128687|NCT00149643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128688|NCT00149643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92128689|NCT00149643|Antidepressive Agents|antidepressive agents|mesh-ancestor
92128690|NCT00149643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128691|NCT00149643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92128692|NCT00149643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92128693|NCT00149643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128694|NCT02381730|Aflibercept|aflibercept|mesh-list
92128695|NCT02381730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91939099|NCT00851045|Calcium|calcium|mesh-list
92128696|NCT02381730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92128698|NCT02381730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128699|NCT02381730|Growth Inhibitors|growth inhibitors|mesh-ancestor
92128700|NCT02381730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128701|NCT00149799|Escitalopram|escitalopram|mesh-list
92128702|NCT00149799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92128703|NCT00149799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92128704|NCT00149799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128705|NCT00149799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128706|NCT00149799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128707|NCT00149799|Serotonin Agents|serotonin agents|mesh-ancestor
92128708|NCT00149799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128709|NCT02390544|Melphalan|melphalan|mesh-list
92145307|NCT00245037|Busulfan|busulfan|mesh-list
92128710|NCT02390544|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92128711|NCT02390544|Alkylating Agents|alkylating agents|mesh-ancestor
92128712|NCT02390544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128713|NCT02390544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128714|NCT02390544|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92128715|NCT02390544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128716|NCT02390544|Immunologic Factors|immunologic factors|mesh-ancestor
92128717|NCT02390544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128718|NCT01790997|Aspirin|aspirin|mesh-list
92128719|NCT01790997|Clopidogrel|clopidogrel|mesh-list
92128720|NCT01790997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92128721|NCT01790997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92128722|NCT01790997|Analgesics|analgesics|mesh-ancestor
92128723|NCT01790997|Sensory System Agents|sensory system agents|mesh-ancestor
92128724|NCT01790997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128725|NCT01790997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128726|NCT01790997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128727|NCT01790997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128728|NCT01790997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92128729|NCT01790997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92128730|NCT01790997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128731|NCT01790997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92128732|NCT01790997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92128733|NCT01790997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128734|NCT01790997|Antipyretics|antipyretics|mesh-ancestor
92128735|NCT01790997|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92128736|NCT01790997|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92128737|NCT01790997|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92128738|NCT01790997|Purinergic Agents|purinergic agents|mesh-ancestor
92128739|NCT01790997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128741|NCT02385474|Cariostatic Agents|cariostatic agents|mesh-ancestor
92128742|NCT02385474|Protective Agents|protective agents|mesh-ancestor
92128743|NCT02385474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128744|NCT02390310|Lidocaine|lidocaine|mesh-list
92128745|NCT02390310|Prilocaine|prilocaine|mesh-list
92128746|NCT02390310|Anesthetics|anesthetics|mesh-list
92128747|NCT02390310|Anesthetics, Local|anesthetics, local|mesh-ancestor
92128748|NCT02390310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128749|NCT02390310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128750|NCT02390310|Sensory System Agents|sensory system agents|mesh-ancestor
92128751|NCT02390310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128752|NCT02390310|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92128753|NCT02390310|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92128754|NCT02390310|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92128755|NCT02390310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128756|NCT02390310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128757|NCT02381184|Clomiphene|clomiphene|mesh-list
92128758|NCT02381184|Enclomiphene|enclomiphene|mesh-list
92128759|NCT02381184|Zuclomiphene|zuclomiphene|mesh-list
92128760|NCT02381184|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92128761|NCT02381184|Hormone Antagonists|hormone antagonists|mesh-ancestor
92128762|NCT02381184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128763|NCT02381184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128764|NCT02381184|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92128765|NCT02381184|Fertility Agents|fertility agents|mesh-ancestor
92128766|NCT02381184|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92128767|NCT02381184|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92128768|NCT02381184|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92128769|NCT02381028|Emollients|emollients|mesh-list
92128770|NCT02381028|Dermatologic Agents|dermatologic agents|mesh-ancestor
92128771|NCT00326781|Nicotine|nicotine|mesh-list
92128772|NCT00326781|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92128773|NCT00326781|Autonomic Agents|autonomic agents|mesh-ancestor
92128774|NCT00326781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128775|NCT00326781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128776|NCT00326781|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92128777|NCT00326781|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92128778|NCT00326781|Cholinergic Agents|cholinergic agents|mesh-ancestor
92128779|NCT00326781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128780|NCT00326781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128782|NCT02385396|Inositol|inositol|mesh-list
92128783|NCT02385396|Hematinics|hematinics|mesh-ancestor
92128784|NCT02385396|Vitamin B Complex|vitamin b complex|mesh-ancestor
92128785|NCT02385396|Vitamins|vitamins|mesh-ancestor
92128786|NCT02385396|Micronutrients|micronutrients|mesh-ancestor
92128787|NCT02385396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128788|NCT05445414|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92128789|NCT05445414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128790|NCT02979405|Phenylephrine|phenylephrine|mesh-list
92128791|NCT02979405|Oxymetazoline|oxymetazoline|mesh-list
92087021|NCT01764997|Adalimumab|adalimumab|mesh-list
92128792|NCT02979405|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92128793|NCT02979405|Mydriatics|mydriatics|mesh-ancestor
92128794|NCT02979405|Autonomic Agents|autonomic agents|mesh-ancestor
92128795|NCT02979405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128796|NCT02979405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128797|NCT02979405|Sympathomimetics|sympathomimetics|mesh-ancestor
92128798|NCT02979405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92128799|NCT02979405|Nasal Decongestants|nasal decongestants|mesh-ancestor
92128800|NCT02979405|Respiratory System Agents|respiratory system agents|mesh-ancestor
92128801|NCT02979405|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92128802|NCT02979405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92128803|NCT02979405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92128804|NCT02979405|Adrenergic Agents|adrenergic agents|mesh-ancestor
92128805|NCT02979405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128806|NCT02979405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128807|NCT02979405|Protective Agents|protective agents|mesh-ancestor
92128808|NCT01791231|Canagliflozin|canagliflozin|mesh-list
92128809|NCT01791231|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92128810|NCT01791231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128811|NCT01791231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92128812|NCT01791231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128813|NCT01791309|Panitumumab|panitumumab|mesh-list
92128814|NCT01791309|Vemurafenib|vemurafenib|mesh-list
92128815|NCT01791309|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92128816|NCT01791309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128817|NCT01791309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92128818|NCT01791309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128819|NCT01791309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128820|NCT00329433|Heparin|heparin|mesh-list
92128821|NCT00329433|Desirudin|desirudin|mesh-list
92128822|NCT00329433|Anticoagulants|anticoagulants|mesh-ancestor
92128823|NCT00329433|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92128824|NCT00329433|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92128825|NCT00329433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128826|NCT03105960|Chlorhexidine|chlorhexidine|mesh-list
92128827|NCT03105960|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92128828|NCT03105960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128829|NCT03105960|Disinfectants|disinfectants|mesh-ancestor
92128830|NCT02389842|Palbociclib|palbociclib|mesh-list
92128831|NCT02389842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128832|NCT02389842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92128833|NCT02389842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128834|NCT02389842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128835|NCT04932096|Melatonin|melatonin|mesh-list
92128836|NCT04932096|Antioxidants|antioxidants|mesh-ancestor
92128837|NCT04932096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128838|NCT04932096|Protective Agents|protective agents|mesh-ancestor
92128839|NCT04932096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128840|NCT04932096|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128841|NCT00289653|Nicotine|nicotine|mesh-list
92128842|NCT00289653|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92128843|NCT00289653|Autonomic Agents|autonomic agents|mesh-ancestor
92128844|NCT00289653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128845|NCT00289653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128846|NCT00289653|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92128847|NCT00289653|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92128848|NCT00289653|Cholinergic Agents|cholinergic agents|mesh-ancestor
92128849|NCT00289653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128850|NCT00289653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128851|NCT00291135|Letrozole|letrozole|mesh-list
92128852|NCT00291135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128853|NCT00291135|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92128854|NCT00291135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92128855|NCT00291135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128856|NCT00291135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128857|NCT00291135|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92128858|NCT00291135|Hormone Antagonists|hormone antagonists|mesh-ancestor
92128859|NCT00291135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128860|NCT00291135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128861|NCT02103855|Abatacept|abatacept|mesh-list
92128862|NCT02103855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92128863|NCT02103855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128864|NCT02103855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92128865|NCT02103855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128866|NCT02103855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128867|NCT02103855|Immunologic Factors|immunologic factors|mesh-ancestor
92128868|NCT02103855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128869|NCT02103855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128870|NCT03706053|Midodrine|midodrine|mesh-list
92128871|NCT03706053|Sympathomimetics|sympathomimetics|mesh-ancestor
92128872|NCT03706053|Autonomic Agents|autonomic agents|mesh-ancestor
92128873|NCT03706053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128874|NCT03706053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128875|NCT03706053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92128876|NCT03706053|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92128877|NCT03706053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92128878|NCT03706053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92128879|NCT03706053|Adrenergic Agents|adrenergic agents|mesh-ancestor
92128880|NCT03706053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128881|NCT03706053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128882|NCT01504841|Etravirine|etravirine|mesh-list
92128883|NCT01504841|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92128884|NCT01504841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92128885|NCT01504841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128886|NCT01504841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128887|NCT01504841|Antiviral Agents|antiviral agents|mesh-ancestor
92128888|NCT01504841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92128890|NCT00330915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128891|NCT00330915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128892|NCT00330915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128893|NCT00330915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92128894|NCT00330915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92128895|NCT03026933|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92128896|NCT03026933|Calcium|calcium|mesh-list
92128897|NCT03026933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92128898|NCT03026933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128899|NCT03026933|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92128900|NCT03026933|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92128901|NCT03026933|Antimetabolites|antimetabolites|mesh-ancestor
92128902|NCT03026933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128903|NCT03026933|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92128904|NCT03026933|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92128905|NCT03026933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128906|NCT01502423|Adalimumab|adalimumab|mesh-list
92128907|NCT01502423|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92128908|NCT01502423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128909|NCT01502423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128910|NCT04861584|Gemcitabine|gemcitabine|mesh-list
92128911|NCT04861584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128912|NCT04861584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92128913|NCT04861584|Antimetabolites|antimetabolites|mesh-ancestor
92128914|NCT04861584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128916|NCT02388750|Antiemetics|antiemetics|mesh-ancestor
92128917|NCT02388750|Autonomic Agents|autonomic agents|mesh-ancestor
92128918|NCT02388750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128919|NCT02388750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128920|NCT02388750|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92128921|NCT02388750|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92128922|NCT02388750|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92128923|NCT02388750|Serotonin Agents|serotonin agents|mesh-ancestor
92128924|NCT02388750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128925|NCT02388750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128926|NCT02388594|Cyclophosphamide|cyclophosphamide|mesh-list
92128927|NCT02388594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128928|NCT02388594|Immunologic Factors|immunologic factors|mesh-ancestor
92128929|NCT02388594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128930|NCT02388594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92128931|NCT02388594|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92128932|NCT02388594|Alkylating Agents|alkylating agents|mesh-ancestor
92128933|NCT02388594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128934|NCT02388594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128935|NCT02388594|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92128936|NCT01500317|Oxycodone|oxycodone|mesh-list
92128937|NCT01500317|Tapentadol|tapentadol|mesh-list
92128938|NCT01500317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92128939|NCT01500317|Narcotics|narcotics|mesh-ancestor
92128940|NCT01500317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128941|NCT01500317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128943|NCT01500317|Sensory System Agents|sensory system agents|mesh-ancestor
92128944|NCT01500317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128945|NCT01500317|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92128946|NCT01500317|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92128947|NCT01500317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92128948|NCT01500317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128949|NCT01500317|Adrenergic Agents|adrenergic agents|mesh-ancestor
92128950|NCT01500317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128951|NCT02379546|Desflurane|desflurane|mesh-list
92128952|NCT02379546|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92128953|NCT02379546|Anesthetics, General|anesthetics, general|mesh-ancestor
92128954|NCT02379546|Anesthetics|anesthetics|mesh-ancestor
92128955|NCT02379546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128956|NCT02379546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128958|NCT00332163|Panitumumab|panitumumab|mesh-list
92128959|NCT00332163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92128960|NCT00332163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92128961|NCT00332163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128962|NCT00332163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128963|NCT00332163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92128964|NCT00332163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92128965|NCT02379000|Triamcinolone|triamcinolone|mesh-list
92128966|NCT02379000|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92128967|NCT02379000|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92128968|NCT02379000|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92128969|NCT02379000|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92128970|NCT02379000|Glucocorticoids|glucocorticoids|mesh-ancestor
92128971|NCT02379000|Hormones|hormones|mesh-ancestor
92128972|NCT02379000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92128973|NCT02379000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128974|NCT02379000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92128975|NCT02379000|Immunologic Factors|immunologic factors|mesh-ancestor
92128976|NCT02379000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92128977|NCT02379000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128978|NCT00333177|Risperidone|risperidone|mesh-list
92128979|NCT00333177|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92128980|NCT00333177|Serotonin Agents|serotonin agents|mesh-ancestor
92128981|NCT00333177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92128982|NCT00333177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92128983|NCT00333177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128984|NCT00333177|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92128985|NCT00333177|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92128986|NCT00333177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92128987|NCT00333177|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92128988|NCT00333177|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92128989|NCT00333177|Dopamine Agents|dopamine agents|mesh-ancestor
92128990|NCT02379156|Midodrine|midodrine|mesh-list
92128991|NCT02379156|Sympathomimetics|sympathomimetics|mesh-ancestor
92128992|NCT02379156|Autonomic Agents|autonomic agents|mesh-ancestor
92128993|NCT02379156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92128994|NCT02379156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92128995|NCT02379156|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92128996|NCT02379156|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92128997|NCT02379156|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92128998|NCT02379156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92128999|NCT02379156|Adrenergic Agents|adrenergic agents|mesh-ancestor
92129000|NCT02379156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129001|NCT02379156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129002|NCT00335283|Lansoprazole|lansoprazole|mesh-list
92129003|NCT00335283|Dexlansoprazole|dexlansoprazole|mesh-list
92129004|NCT00335283|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92129005|NCT00335283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129006|NCT00335283|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92129007|NCT00335283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129008|NCT00335283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129009|NCT01500083|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92129010|NCT01500083|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129011|NCT01500083|Alkylating Agents|alkylating agents|mesh-ancestor
92087248|NCT03804268|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92129012|NCT01500083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129013|NCT01500083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129014|NCT02779257|Diazoxide|diazoxide|mesh-list
92129015|NCT02779257|Pasireotide|pasireotide|mesh-list
92129016|NCT02779257|Hormones|hormones|mesh-ancestor
92129017|NCT02779257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129018|NCT02779257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129019|NCT02779257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92129020|NCT02779257|Vasodilator Agents|vasodilator agents|mesh-ancestor
92129021|NCT00295503|Bevacizumab|bevacizumab|mesh-list
92129022|NCT00295503|Pemetrexed|pemetrexed|mesh-list
92129023|NCT00295503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129024|NCT00295503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129025|NCT00295503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92129026|NCT00295503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129027|NCT00295503|Growth Substances|growth substances|mesh-ancestor
92129028|NCT00295503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129029|NCT00295503|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129030|NCT00295503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129031|NCT00295503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129032|NCT00295503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92129033|NCT00295503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129034|NCT02371590|Lenalidomide|lenalidomide|mesh-list
92129035|NCT02371590|Obinutuzumab|obinutuzumab|mesh-list
92129036|NCT02371590|Immunologic Factors|immunologic factors|mesh-ancestor
92129037|NCT02371590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129038|NCT02371590|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92129039|NCT02371590|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129040|NCT02371590|Growth Substances|growth substances|mesh-ancestor
92129041|NCT02371590|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129042|NCT02371590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129043|NCT02371590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129044|NCT00298155|Ketoconazole|ketoconazole|mesh-list
92129045|NCT00298155|Goserelin|goserelin|mesh-list
92129046|NCT00298155|Bicalutamide|bicalutamide|mesh-list
92129048|NCT00298155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92129049|NCT00298155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129050|NCT00298155|Antifungal Agents|antifungal agents|mesh-ancestor
92129051|NCT00298155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129052|NCT00298155|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92129053|NCT00298155|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92129054|NCT00298155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129055|NCT00298155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129056|NCT00298155|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92129057|NCT00298155|Hormone Antagonists|hormone antagonists|mesh-ancestor
92129058|NCT00298155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129059|NCT00298155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129060|NCT00298155|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92129061|NCT00298155|Androgen Antagonists|androgen antagonists|mesh-ancestor
92129062|NCT00298155|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92129063|NCT01499849|Dexamethasone|dexamethasone|mesh-list
92129064|NCT01499849|Granisetron|granisetron|mesh-list
92129065|NCT01499849|Rolapitant|rolapitant|mesh-list
92129066|NCT01499849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129067|NCT01499849|Antiemetics|antiemetics|mesh-ancestor
92129068|NCT01499849|Autonomic Agents|autonomic agents|mesh-ancestor
92129069|NCT01499849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129070|NCT01499849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129071|NCT01499849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129072|NCT01499849|Glucocorticoids|glucocorticoids|mesh-ancestor
92129073|NCT01499849|Hormones|hormones|mesh-ancestor
92129074|NCT01499849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129075|NCT01499849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92129076|NCT01499849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129077|NCT01499849|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92129078|NCT01499849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92129079|NCT01499849|Serotonin Agents|serotonin agents|mesh-ancestor
92129080|NCT01499849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129081|NCT01499849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129082|NCT01499849|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92087322|NCT00768118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129085|NCT00298233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129086|NCT00298233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129087|NCT00298233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129088|NCT02376972|Rifaximin|rifaximin|mesh-list
92129089|NCT02376972|Metronidazole|metronidazole|mesh-list
92129090|NCT02376972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92129091|NCT02376972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129092|NCT02376972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129093|NCT02376972|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92129094|NCT02376972|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92129095|NCT02378532|Chloroquine|chloroquine|mesh-list
92129096|NCT02378532|Temozolomide|temozolomide|mesh-list
92129097|NCT02378532|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129098|NCT02378532|Alkylating Agents|alkylating agents|mesh-ancestor
92129099|NCT02378532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129100|NCT02378532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129101|NCT02378532|Amebicides|amebicides|mesh-ancestor
92129102|NCT02378532|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92129103|NCT02378532|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92129104|NCT02378532|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129105|NCT02378532|Antimalarials|antimalarials|mesh-ancestor
92129106|NCT02378532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129107|NCT01498679|Fluticasone|fluticasone|mesh-list
92129109|NCT01498679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129110|NCT01498679|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92129111|NCT01498679|Autonomic Agents|autonomic agents|mesh-ancestor
92129112|NCT01498679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129113|NCT01498679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129114|NCT01498679|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92129115|NCT01498679|Respiratory System Agents|respiratory system agents|mesh-ancestor
92129116|NCT01498679|Dermatologic Agents|dermatologic agents|mesh-ancestor
92129117|NCT01498679|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92129118|NCT01000467|Probucol|probucol|mesh-list
92129119|NCT01000467|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92129120|NCT01000467|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92129121|NCT01000467|Antimetabolites|antimetabolites|mesh-ancestor
92129122|NCT01000467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129123|NCT01000467|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92129124|NCT01000467|Antioxidants|antioxidants|mesh-ancestor
92129125|NCT01000467|Protective Agents|protective agents|mesh-ancestor
92129126|NCT01000467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129127|NCT00198315|Bleomycin|bleomycin|mesh-list
92129128|NCT00198315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92129129|NCT00198315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129130|NCT01559389|Solifenacin Succinate|solifenacin succinate|mesh-list
92129131|NCT01559389|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92129132|NCT01559389|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92129133|NCT01559389|Cholinergic Agents|cholinergic agents|mesh-ancestor
92129134|NCT01559389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129135|NCT01559389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129136|NCT01559389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129137|NCT01559389|Urological Agents|urological agents|mesh-ancestor
92129138|NCT01526551|Vaccines|vaccines|mesh-list
92129139|NCT01526551|Immunologic Factors|immunologic factors|mesh-ancestor
92129140|NCT01526551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129141|NCT04540692|Paclitaxel|paclitaxel|mesh-list
92129142|NCT04540692|Docetaxel|docetaxel|mesh-list
92129143|NCT04540692|Cyclophosphamide|cyclophosphamide|mesh-list
92129144|NCT04540692|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129145|NCT04540692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129146|NCT04540692|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129147|NCT04540692|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129148|NCT04540692|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129149|NCT04540692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129150|NCT04540692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92129151|NCT04540692|Immunologic Factors|immunologic factors|mesh-ancestor
92129152|NCT04540692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129153|NCT04540692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129154|NCT04540692|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129155|NCT04540692|Alkylating Agents|alkylating agents|mesh-ancestor
92129156|NCT04540692|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92129157|NCT00343083|Paclitaxel|paclitaxel|mesh-list
92129158|NCT00343083|Carboplatin|carboplatin|mesh-list
92129159|NCT00343083|Cetuximab|cetuximab|mesh-list
92129160|NCT00343083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129161|NCT00343083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129165|NCT00343083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129166|NCT00343083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129167|NCT02376426|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92129168|NCT02376426|Antiviral Agents|antiviral agents|mesh-ancestor
92129169|NCT02376426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129170|NCT00343785|Cyclosporine|cyclosporine|mesh-list
92129171|NCT00343785|Cyclophosphamide|cyclophosphamide|mesh-list
92129172|NCT00343785|Methotrexate|methotrexate|mesh-list
92129173|NCT00343785|Cyclosporins|cyclosporins|mesh-list
92129174|NCT00343785|Thymoglobulin|thymoglobulin|mesh-list
92129175|NCT00343785|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92129176|NCT00343785|Immunoglobulins|immunoglobulins|mesh-list
92129177|NCT00343785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92129178|NCT00343785|Immunologic Factors|immunologic factors|mesh-ancestor
92129179|NCT00343785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129180|NCT00343785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129181|NCT00343785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129182|NCT00343785|Alkylating Agents|alkylating agents|mesh-ancestor
92129183|NCT00343785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129184|NCT00343785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129185|NCT00343785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92129186|NCT00343785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92129187|NCT00343785|Abortifacient Agents|abortifacient agents|mesh-ancestor
92129188|NCT00343785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92129189|NCT00343785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129190|NCT00343785|Antimetabolites|antimetabolites|mesh-ancestor
92129191|NCT00343785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92129192|NCT00343785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129193|NCT00343785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92129194|NCT00343785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129195|NCT00343785|Antifungal Agents|antifungal agents|mesh-ancestor
92129196|NCT00343785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129197|NCT00343785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92129198|NCT00343863|Dexamethasone|dexamethasone|mesh-list
92129199|NCT00343863|Cyclophosphamide|cyclophosphamide|mesh-list
92129200|NCT00343863|Doxorubicin|doxorubicin|mesh-list
92129201|NCT00343863|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92129202|NCT00343863|Ondansetron|ondansetron|mesh-list
92129203|NCT00343863|Palonosetron|palonosetron|mesh-list
92129204|NCT00343863|Antiemetics|antiemetics|mesh-list
92129205|NCT00343863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92129206|NCT00343863|Immunologic Factors|immunologic factors|mesh-ancestor
92129207|NCT00343863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129208|NCT00343863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129209|NCT00343863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129210|NCT00343863|Alkylating Agents|alkylating agents|mesh-ancestor
92129211|NCT00343863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129212|NCT00343863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129213|NCT00343863|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92129214|NCT00343863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129215|NCT00343863|Autonomic Agents|autonomic agents|mesh-ancestor
92129216|NCT00343863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129217|NCT00343863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129218|NCT00343863|Glucocorticoids|glucocorticoids|mesh-ancestor
92129219|NCT00343863|Hormones|hormones|mesh-ancestor
92129220|NCT00343863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129221|NCT00343863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92129222|NCT00343863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92129223|NCT00343863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92129224|NCT00343863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129225|NCT00343863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129226|NCT00343863|Antipruritics|antipruritics|mesh-ancestor
92129227|NCT00343863|Dermatologic Agents|dermatologic agents|mesh-ancestor
92129228|NCT00343863|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92129229|NCT00343863|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92129230|NCT00343863|Serotonin Agents|serotonin agents|mesh-ancestor
92129231|NCT00343863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129232|NCT00344175|Simvastatin|simvastatin|mesh-list
92129233|NCT00344175|Pitavastatin|pitavastatin|mesh-list
92129234|NCT00344175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92129235|NCT00344175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92129236|NCT00344175|Antimetabolites|antimetabolites|mesh-ancestor
92087470|NCT04384744|Hormones|hormones|mesh-list
92129237|NCT00344175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129238|NCT00344175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92129239|NCT00344175|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92129241|NCT00345033|Aripiprazole|aripiprazole|mesh-list
92129242|NCT00345033|Antidepressive Agents|antidepressive agents|mesh-ancestor
92129243|NCT00345033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92129244|NCT00345033|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92129245|NCT00345033|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92129246|NCT00345033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129247|NCT00345033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129248|NCT00345033|Dopamine Agonists|dopamine agonists|mesh-ancestor
92129250|NCT00345033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129251|NCT00345033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129252|NCT00345033|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92129253|NCT00345033|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92129254|NCT00345033|Serotonin Agents|serotonin agents|mesh-ancestor
92129255|NCT00345033|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92129256|NCT00345033|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92129257|NCT00345033|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92129258|NCT00345033|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92129259|NCT00345969|Testosterone|testosterone|mesh-list
92129260|NCT00345969|Androgens|androgens|mesh-ancestor
92129261|NCT00345969|Hormones|hormones|mesh-ancestor
91945320|NCT03529175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129262|NCT00345969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129263|NCT00345969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129264|NCT01498445|Decitabine|decitabine|mesh-list
92129265|NCT01498445|Dasatinib|dasatinib|mesh-list
92129266|NCT01498445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129267|NCT01498445|Antimetabolites|antimetabolites|mesh-ancestor
92129268|NCT01498445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129269|NCT01498445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129270|NCT01498445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129271|NCT01498445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92129272|NCT01525615|Tiotropium Bromide|tiotropium bromide|mesh-list
92129273|NCT01525615|Olodaterol|olodaterol|mesh-list
92129274|NCT01525615|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92129275|NCT01525615|Autonomic Agents|autonomic agents|mesh-ancestor
92129276|NCT01525615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129277|NCT01525615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129278|NCT01525615|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92129279|NCT01525615|Respiratory System Agents|respiratory system agents|mesh-ancestor
92129280|NCT01525615|Parasympatholytics|parasympatholytics|mesh-ancestor
92129281|NCT01525615|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92129282|NCT01525615|Cholinergic Agents|cholinergic agents|mesh-ancestor
92129283|NCT01525615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129284|NCT01525615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129285|NCT00309465|Insulin|insulin|mesh-list
92129286|NCT00309465|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92129287|NCT00309465|Insulin Glargine|insulin glargine|mesh-list
92129288|NCT00309465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92129289|NCT00309465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129290|NCT01791699|Moxonidine|moxonidine|mesh-list
92129291|NCT01791699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92129292|NCT00302133|Naltrexone|naltrexone|mesh-list
92129293|NCT00302133|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92129294|NCT00302133|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92129295|NCT00302133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129296|NCT00302133|Sensory System Agents|sensory system agents|mesh-ancestor
92129297|NCT00302133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129298|NCT01525225|Metformin|metformin|mesh-list
92129299|NCT01525225|Saxagliptin|saxagliptin|mesh-list
92129300|NCT01525225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92129301|NCT01525225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129302|NCT01525225|Incretins|incretins|mesh-ancestor
92129303|NCT01525225|Hormones|hormones|mesh-ancestor
92129304|NCT01525225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129305|NCT01525225|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92129306|NCT01525225|Protease Inhibitors|protease inhibitors|mesh-ancestor
92129307|NCT01525225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129308|NCT01525225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129309|NCT00304161|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92129310|NCT00304161|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92129311|NCT00304161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92129312|NCT00304161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92129313|NCT00304161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129315|NCT00304161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129316|NCT00304161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129317|NCT02660580|Adalimumab|adalimumab|mesh-list
92129318|NCT02660580|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92129319|NCT02660580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129320|NCT02660580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129321|NCT01524991|Gemcitabine|gemcitabine|mesh-list
92129322|NCT01524991|Ipilimumab|ipilimumab|mesh-list
92129323|NCT01524991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129324|NCT01524991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129325|NCT01524991|Antimetabolites|antimetabolites|mesh-ancestor
92129326|NCT01524991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129327|NCT01524991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129328|NCT01524991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92129329|NCT04039230|Talazoparib|talazoparib|mesh-list
92129330|NCT04039230|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92129331|NCT04039230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92129332|NCT04039230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129333|NCT04039230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129334|NCT04039230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129336|NCT04039230|Immunologic Factors|immunologic factors|mesh-ancestor
92129337|NCT04039230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129338|NCT01524913|Hyaluronic Acid|hyaluronic acid|mesh-list
92129339|NCT01524913|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92129340|NCT01524913|Immunologic Factors|immunologic factors|mesh-ancestor
92129341|NCT01524913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129342|NCT01524913|Viscosupplements|viscosupplements|mesh-ancestor
92129343|NCT01524913|Protective Agents|protective agents|mesh-ancestor
92129344|NCT02376192|Phenylephrine|phenylephrine|mesh-list
92129345|NCT02376192|Oxymetazoline|oxymetazoline|mesh-list
92129346|NCT02376192|Ephedrine|ephedrine|mesh-list
92129347|NCT02376192|Bupivacaine|bupivacaine|mesh-list
92129348|NCT02376192|Anesthetics, Local|anesthetics, local|mesh-ancestor
92129349|NCT02376192|Anesthetics|anesthetics|mesh-ancestor
92129350|NCT02376192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129351|NCT02376192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129352|NCT02376192|Sensory System Agents|sensory system agents|mesh-ancestor
92129353|NCT02376192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129354|NCT02376192|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92129355|NCT02376192|Mydriatics|mydriatics|mesh-ancestor
92129356|NCT02376192|Autonomic Agents|autonomic agents|mesh-ancestor
92129357|NCT02376192|Sympathomimetics|sympathomimetics|mesh-ancestor
92129358|NCT02376192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92129359|NCT02376192|Nasal Decongestants|nasal decongestants|mesh-ancestor
92129360|NCT02376192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92129361|NCT02376192|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92129362|NCT02376192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92129363|NCT02376192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92129364|NCT02376192|Adrenergic Agents|adrenergic agents|mesh-ancestor
92129365|NCT02376192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129366|NCT02376192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129367|NCT02376192|Protective Agents|protective agents|mesh-ancestor
92129368|NCT02376192|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92129369|NCT02037126|Diphenhydramine|diphenhydramine|mesh-list
92129370|NCT02037126|Promethazine|promethazine|mesh-list
92129371|NCT02037126|Psilocybin|psilocybin|mesh-list
92129372|NCT02037126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92129373|NCT02037126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92129374|NCT02037126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129375|NCT02037126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129376|NCT02037126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92129377|NCT02037126|Anesthetics|anesthetics|mesh-ancestor
92129378|NCT02037126|Sensory System Agents|sensory system agents|mesh-ancestor
92129379|NCT02037126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129380|NCT02037126|Antiemetics|antiemetics|mesh-ancestor
92129381|NCT02037126|Autonomic Agents|autonomic agents|mesh-ancestor
92129382|NCT02037126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129383|NCT02037126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92129384|NCT02037126|Histamine Antagonists|histamine antagonists|mesh-ancestor
92129385|NCT02037126|Histamine Agents|histamine agents|mesh-ancestor
92129386|NCT02037126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129387|NCT02037126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129388|NCT02037126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92129389|NCT02037126|Antipruritics|antipruritics|mesh-ancestor
92129390|NCT02037126|Dermatologic Agents|dermatologic agents|mesh-ancestor
92129391|NCT02037126|Hallucinogens|hallucinogens|mesh-ancestor
92129394|NCT02375880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129395|NCT02375880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129396|NCT02375880|Antimetabolites|antimetabolites|mesh-ancestor
92129397|NCT02375880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129398|NCT01524679|Interferons|interferons|mesh-list
92129399|NCT01524679|Interferon-alpha|interferon-alpha|mesh-list
92129400|NCT01524679|Interferon alpha-2|interferon alpha-2|mesh-list
92129401|NCT01524679|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92129402|NCT01524679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129403|NCT01524679|Antiviral Agents|antiviral agents|mesh-ancestor
92129404|NCT01524679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129405|NCT01524679|Immunologic Factors|immunologic factors|mesh-ancestor
92129406|NCT01524679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129407|NCT02365272|Amikacin|amikacin|mesh-list
92129408|NCT02365272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92129409|NCT02365272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129410|NCT02369250|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92129411|NCT02369250|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92129412|NCT02369250|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92129413|NCT02369250|Antimetabolites|antimetabolites|mesh-ancestor
92129414|NCT02369250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129415|NCT02369250|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92129416|NCT02369250|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92129417|NCT02369250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129419|NCT04645602|Lenvatinib|lenvatinib|mesh-list
92129420|NCT04645602|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129421|NCT04645602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129422|NCT04645602|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92129423|NCT04645602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129424|NCT04645602|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92129425|NCT04645602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129426|NCT01880541|Anesthetics|anesthetics|mesh-list
92129427|NCT01880541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129428|NCT01880541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129429|NCT02368860|Capecitabine|capecitabine|mesh-list
92129430|NCT02368860|Oxaliplatin|oxaliplatin|mesh-list
92129431|NCT02368860|Irinotecan|irinotecan|mesh-list
92129432|NCT02368860|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129433|NCT02368860|Antimetabolites|antimetabolites|mesh-ancestor
92129434|NCT02368860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129435|NCT02368860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129436|NCT02368860|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92129437|NCT02368860|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129438|NCT02368860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129439|NCT02375646|Heparin|heparin|mesh-list
92129440|NCT02375646|Enoxaparin|enoxaparin|mesh-list
92129441|NCT02375646|Warfarin|warfarin|mesh-list
92129442|NCT02375646|Anticoagulants|anticoagulants|mesh-ancestor
92129443|NCT02375646|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92129444|NCT02375646|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92129445|NCT02375646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129446|NCT01524289|Anacetrapib|anacetrapib|mesh-list
92129447|NCT01524289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92129448|NCT01524289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92129449|NCT01524289|Antimetabolites|antimetabolites|mesh-ancestor
92129450|NCT01524289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129451|NCT01524289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92129452|NCT01498289|Leucovorin|leucovorin|mesh-list
92129453|NCT01498289|Docetaxel|docetaxel|mesh-list
92129454|NCT01498289|Fluorouracil|fluorouracil|mesh-list
92129455|NCT01498289|Oxaliplatin|oxaliplatin|mesh-list
92129456|NCT01498289|Irinotecan|irinotecan|mesh-list
92129457|NCT01498289|Calcium|calcium|mesh-list
92129458|NCT01498289|Levoleucovorin|levoleucovorin|mesh-list
92129459|NCT01498289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129460|NCT01498289|Tubulin Modulators|tubulin modulators|mesh-ancestor
92087696|NCT05742568|Amoxicillin|amoxicillin|mesh-list
92129461|NCT01498289|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129462|NCT01498289|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129463|NCT01498289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129464|NCT01498289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92129465|NCT01498289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129466|NCT01498289|Antimetabolites|antimetabolites|mesh-ancestor
92129467|NCT01498289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129468|NCT01498289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92129469|NCT01498289|Immunologic Factors|immunologic factors|mesh-ancestor
92129470|NCT01498289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92129471|NCT01498289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129472|NCT01498289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129474|NCT01498289|Protective Agents|protective agents|mesh-ancestor
92129475|NCT01498289|Vitamin B Complex|vitamin b complex|mesh-ancestor
92129476|NCT01498289|Vitamins|vitamins|mesh-ancestor
92129477|NCT01498289|Micronutrients|micronutrients|mesh-ancestor
92129478|NCT02364882|Sildenafil Citrate|sildenafil citrate|mesh-list
92129479|NCT02364882|Vasodilator Agents|vasodilator agents|mesh-ancestor
92129480|NCT02364882|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92129481|NCT02364882|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92129482|NCT02364882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129483|NCT02364882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129484|NCT02364882|Urological Agents|urological agents|mesh-ancestor
92129486|NCT02364804|Antiemetics|antiemetics|mesh-ancestor
92129487|NCT02364804|Autonomic Agents|autonomic agents|mesh-ancestor
92129488|NCT02364804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129489|NCT02364804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129490|NCT02364804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129491|NCT02364804|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92129492|NCT02364804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129493|NCT02364804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129494|NCT01524133|Sertraline|sertraline|mesh-list
92129495|NCT01524133|Antidepressive Agents|antidepressive agents|mesh-ancestor
92129496|NCT01524133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92129497|NCT01524133|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92129498|NCT01524133|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92129499|NCT01524133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92129500|NCT01524133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129501|NCT01524133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129502|NCT01524133|Serotonin Agents|serotonin agents|mesh-ancestor
92129503|NCT01524133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129504|NCT02368470|Gemifloxacin|gemifloxacin|mesh-list
92129505|NCT02368470|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92129506|NCT02368470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129507|NCT02368470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129508|NCT02368470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129509|NCT02368470|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92129510|NCT02368470|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129511|NCT02368470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129512|NCT04561206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92129513|NCT04561206|Nivolumab|nivolumab|mesh-list
92129514|NCT04561206|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92129515|NCT04561206|Antibodies|antibodies|mesh-list
92129516|NCT04561206|Immunoglobulins|immunoglobulins|mesh-list
92129517|NCT04561206|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92129518|NCT04561206|Immunoconjugates|immunoconjugates|mesh-list
92129519|NCT04561206|Immunologic Factors|immunologic factors|mesh-ancestor
92129520|NCT04561206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129521|NCT04561206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129522|NCT04561206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92129523|NCT04561206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129524|NCT04561206|Immunotoxins|immunotoxins|mesh-ancestor
92129525|NCT04110301|Lenalidomide|lenalidomide|mesh-list
92129526|NCT04110301|Antibodies|antibodies|mesh-list
92129527|NCT04110301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92129528|NCT04110301|Immunologic Factors|immunologic factors|mesh-ancestor
92129529|NCT04110301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129530|NCT04110301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92129531|NCT04110301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129532|NCT04110301|Growth Substances|growth substances|mesh-ancestor
92129533|NCT04110301|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129534|NCT04110301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129535|NCT05800600|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92129536|NCT05800600|Hematinics|hematinics|mesh-ancestor
92129537|NCT05800587|Paclitaxel|paclitaxel|mesh-list
92129538|NCT05800587|Etoposide|etoposide|mesh-list
92129539|NCT05800587|Docetaxel|docetaxel|mesh-list
92129540|NCT05800587|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92129541|NCT05800587|Carboplatin|carboplatin|mesh-list
92129542|NCT05800587|Gemcitabine|gemcitabine|mesh-list
92129543|NCT05800587|Irinotecan|irinotecan|mesh-list
92129544|NCT05800587|Pemetrexed|pemetrexed|mesh-list
92129545|NCT05800587|Topotecan|topotecan|mesh-list
92129546|NCT05800587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129547|NCT05800587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129548|NCT05800587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129549|NCT05800587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129551|NCT05800587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129552|NCT05800587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129553|NCT05800587|Antimetabolites|antimetabolites|mesh-ancestor
92129554|NCT05800587|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92129555|NCT05800587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129556|NCT05800587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129557|NCT05800587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92129559|NCT05800587|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129560|NCT05800418|Ramucirumab|ramucirumab|mesh-list
92129561|NCT05800418|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92129562|NCT05800418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129563|NCT05800418|Immunologic Factors|immunologic factors|mesh-ancestor
92129564|NCT05800418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129565|NCT05800366|Prednisone|prednisone|mesh-list
92129566|NCT05800366|Methylprednisolone|methylprednisolone|mesh-list
92129567|NCT05800366|Prednisolone|prednisolone|mesh-list
92129568|NCT05800366|Cyclophosphamide|cyclophosphamide|mesh-list
92129569|NCT05800366|Rituximab|rituximab|mesh-list
92129570|NCT05800366|Doxorubicin|doxorubicin|mesh-list
92129571|NCT05800366|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92129572|NCT05800366|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92129573|NCT05800366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92129574|NCT05800366|Immunologic Factors|immunologic factors|mesh-ancestor
92129575|NCT05800366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129576|NCT05800366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129577|NCT05800366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129578|NCT05800366|Alkylating Agents|alkylating agents|mesh-ancestor
92129579|NCT05800366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129580|NCT05800366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129581|NCT05800366|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92129582|NCT05800366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129583|NCT05800366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92129584|NCT05800366|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92129585|NCT05800366|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129586|NCT05800366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129587|NCT05800366|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129588|NCT05800366|Glucocorticoids|glucocorticoids|mesh-ancestor
92129589|NCT05800366|Hormones|hormones|mesh-ancestor
92129590|NCT05800366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129591|NCT05800366|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92129592|NCT05800366|Antiemetics|antiemetics|mesh-ancestor
92129593|NCT05800366|Autonomic Agents|autonomic agents|mesh-ancestor
92129594|NCT05800366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129595|NCT05800366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129596|NCT05800366|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92129597|NCT05800366|Protective Agents|protective agents|mesh-ancestor
92129598|NCT05800366|Immunoconjugates|immunoconjugates|mesh-ancestor
92129599|NCT05800340|Paclitaxel|paclitaxel|mesh-list
92129600|NCT05800340|Carboplatin|carboplatin|mesh-list
92129601|NCT05800340|Pemetrexed|pemetrexed|mesh-list
92129602|NCT05800340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129603|NCT05800340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129604|NCT05800340|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129605|NCT05800340|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129606|NCT05800340|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129607|NCT05800340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129608|NCT05800340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129609|NCT05800340|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92129610|NCT05800340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129611|NCT05800301|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92129612|NCT05800301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129613|NCT05800301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087842|NCT00790192|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92129614|NCT05800288|Propofol|propofol|mesh-list
92129615|NCT05800288|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92129636|NCT05800106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129637|NCT05800106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129638|NCT05800106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92129639|NCT05800106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129640|NCT05800106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129641|NCT05800080|Oxaliplatin|oxaliplatin|mesh-list
92129642|NCT05800080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129643|NCT05800054|Docetaxel|docetaxel|mesh-list
92129644|NCT05800054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129645|NCT05800054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129648|NCT05800054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129649|NCT05800041|Cyclophosphamide|cyclophosphamide|mesh-list
92129650|NCT05800041|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92129651|NCT05800041|Immunologic Factors|immunologic factors|mesh-ancestor
92129652|NCT05800041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129653|NCT05800041|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129654|NCT05800041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92129655|NCT05800041|Alkylating Agents|alkylating agents|mesh-ancestor
92129656|NCT05800041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129657|NCT05800041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129658|NCT05800041|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92129660|NCT05800015|Carboplatin|carboplatin|mesh-list
92129661|NCT05800015|Pemetrexed|pemetrexed|mesh-list
92129662|NCT05800015|Cemiplimab|cemiplimab|mesh-list
92129663|NCT05800015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129664|NCT05800015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129665|NCT05800015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129666|NCT05800015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129667|NCT05800015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129668|NCT05800015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129669|NCT05800015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129670|NCT05800015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92129671|NCT05800015|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129672|NCT05800015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129673|NCT05799924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92129674|NCT05799924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92129675|NCT05799924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92129676|NCT05799924|Analgesics|analgesics|mesh-ancestor
92129677|NCT05799924|Sensory System Agents|sensory system agents|mesh-ancestor
92129678|NCT05799924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129679|NCT05799924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129680|NCT05799924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92129681|NCT05799755|Nintedanib|nintedanib|mesh-list
92129682|NCT05799755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129683|NCT05799755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92129684|NCT05799755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129685|NCT05799755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129686|NCT05799729|Ketamine|ketamine|mesh-list
92129687|NCT05799729|Analgesics|analgesics|mesh-ancestor
92129688|NCT05799729|Sensory System Agents|sensory system agents|mesh-ancestor
92129689|NCT05799729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087925|NCT05709184|Vancomycin|vancomycin|mesh-list
92129690|NCT05799729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129691|NCT05799729|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92129692|NCT05799729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92129693|NCT05799729|Anesthetics, General|anesthetics, general|mesh-ancestor
92129694|NCT05799729|Anesthetics|anesthetics|mesh-ancestor
92129695|NCT05799729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129696|NCT05799729|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92129697|NCT05799729|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92129698|NCT05799729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129699|NCT05799729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129700|NCT05799612|Interferons|interferons|mesh-list
92129701|NCT05799612|Interferon-alpha|interferon-alpha|mesh-list
92129702|NCT05799612|Interferon alpha-2|interferon alpha-2|mesh-list
92129703|NCT05799612|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92129704|NCT05799612|Paclitaxel|paclitaxel|mesh-list
92129705|NCT05799612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129706|NCT05799612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129707|NCT05799612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129708|NCT05799612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129709|NCT05799612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129710|NCT05799612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129711|NCT05799612|Antiviral Agents|antiviral agents|mesh-ancestor
92129712|NCT05799612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129713|NCT05799612|Immunologic Factors|immunologic factors|mesh-ancestor
92129714|NCT05799612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129715|NCT05799469|Cisplatin|cisplatin|mesh-list
92129716|NCT05799469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129717|NCT05799443|Irinotecan|irinotecan|mesh-list
92129718|NCT05799443|Cetuximab|cetuximab|mesh-list
92129719|NCT05799443|Tislelizumab|tislelizumab|mesh-list
92129720|NCT05799443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92129721|NCT05799443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129722|NCT05799443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129723|NCT05799443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129724|NCT05799443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129725|NCT05799443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129727|NCT05799300|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129728|NCT05799300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129729|NCT05799105|Omeprazole|omeprazole|mesh-list
92129730|NCT05799105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92129731|NCT05799105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129732|NCT05799105|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92129733|NCT05799105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129734|NCT05799105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129735|NCT05799053|Peppermint oil|peppermint oil|mesh-list
92129736|NCT05799053|Antiemetics|antiemetics|mesh-ancestor
92129737|NCT05799053|Autonomic Agents|autonomic agents|mesh-ancestor
92129738|NCT05799053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129739|NCT05799053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129740|NCT05799053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129741|NCT05799053|Parasympatholytics|parasympatholytics|mesh-ancestor
92129742|NCT05798936|Ethanol|ethanol|mesh-list
92129743|NCT05798936|Polidocanol|polidocanol|mesh-list
92129744|NCT05798936|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92129745|NCT05798936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129746|NCT05798936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129747|NCT05798936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129748|NCT05798936|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92129749|NCT05798936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92129750|NCT05798871|Erythritol|erythritol|mesh-list
92129751|NCT05798871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92129752|NCT05798819|Paclitaxel|paclitaxel|mesh-list
92129753|NCT05798819|Bevacizumab|bevacizumab|mesh-list
92129754|NCT05798819|Carboplatin|carboplatin|mesh-list
92129755|NCT05798819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92129756|NCT05798819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129757|NCT05798819|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129758|NCT05798819|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129759|NCT05798819|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129760|NCT05798819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129761|NCT05798819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129762|NCT05798819|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92129763|NCT05798819|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129764|NCT05798819|Growth Substances|growth substances|mesh-ancestor
92129765|NCT05798819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129766|NCT05798819|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129767|NCT05798728|Misoprostol|misoprostol|mesh-list
92129768|NCT05798728|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92129769|NCT05798728|Abortifacient Agents|abortifacient agents|mesh-ancestor
92129770|NCT05798728|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92129771|NCT05798728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129772|NCT05798728|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92129773|NCT05798728|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129774|NCT05798728|Oxytocics|oxytocics|mesh-ancestor
92129775|NCT05798715|Metformin|metformin|mesh-list
92129776|NCT05798715|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92129777|NCT05798715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92129778|NCT05798715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129779|NCT05798715|Incretins|incretins|mesh-ancestor
92129780|NCT05798715|Hormones|hormones|mesh-ancestor
92129781|NCT05798715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129782|NCT05798715|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92129783|NCT05798715|Protease Inhibitors|protease inhibitors|mesh-ancestor
92129784|NCT05798715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129785|NCT05798715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129786|NCT05796167|Pimavanserin|pimavanserin|mesh-list
92129787|NCT05796167|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92129788|NCT05796167|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92129789|NCT05796167|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92129790|NCT05796167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92129791|NCT05796167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129792|NCT05796167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129793|NCT05796167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92129794|NCT05796167|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92129795|NCT05796167|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92129797|NCT05796167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129798|NCT05796167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129803|NCT05795491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129804|NCT05795491|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92129805|NCT05795491|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92129806|NCT05795491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129807|NCT05795491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129808|NCT05795491|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92129809|NCT05795491|Hormone Antagonists|hormone antagonists|mesh-ancestor
92129810|NCT05795491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129811|NCT05795491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129812|NCT05795491|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92129813|NCT05795491|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92129814|NCT05795491|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92129815|NCT05795491|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92129816|NCT05788627|Lactulose|lactulose|mesh-list
92129817|NCT05788627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129818|NCT05777135|Propofol|propofol|mesh-list
92129819|NCT05777135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92129820|NCT05777135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129821|NCT05777135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129822|NCT05777135|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92129823|NCT05777135|Anesthetics, General|anesthetics, general|mesh-ancestor
92129824|NCT05777135|Anesthetics|anesthetics|mesh-ancestor
92129825|NCT05771883|Lenalidomide|lenalidomide|mesh-list
92129826|NCT05771883|Immunologic Factors|immunologic factors|mesh-ancestor
92129827|NCT05771883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129828|NCT05771883|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92129829|NCT05771883|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92129830|NCT05771883|Growth Substances|growth substances|mesh-ancestor
92129831|NCT05771883|Growth Inhibitors|growth inhibitors|mesh-ancestor
92129832|NCT05771883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129833|NCT05767892|Carboplatin|carboplatin|mesh-list
92129834|NCT05767892|Pemetrexed|pemetrexed|mesh-list
92129835|NCT05767892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129836|NCT05767892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129837|NCT05767892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129838|NCT05767892|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92129839|NCT05767892|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129840|NCT05753956|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92129841|NCT05753956|Hallucinogens|hallucinogens|mesh-ancestor
92129842|NCT05753956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129843|NCT05753956|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92129844|NCT05753956|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92129845|NCT05753956|Serotonin Agents|serotonin agents|mesh-ancestor
92129846|NCT05753956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129847|NCT05753956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129848|NCT05753956|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92129849|NCT05730816|Magnesium Sulfate|magnesium sulfate|mesh-list
92129850|NCT05730816|Analgesics|analgesics|mesh-ancestor
92129851|NCT05730816|Sensory System Agents|sensory system agents|mesh-ancestor
92129852|NCT05730816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129853|NCT05730816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129854|NCT05730816|Anesthetics|anesthetics|mesh-ancestor
92129855|NCT05730816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129856|NCT05730816|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92129857|NCT05730816|Anticonvulsants|anticonvulsants|mesh-ancestor
92129858|NCT05730816|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92129859|NCT05730816|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92129860|NCT05730816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129861|NCT05730816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92129862|NCT05730816|Tocolytic Agents|tocolytic agents|mesh-ancestor
92129863|NCT05730816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92129865|NCT05702333|Dobutamine|dobutamine|mesh-list
92129866|NCT05702333|Dopamine|dopamine|mesh-list
92129867|NCT05702333|Epinephrine|epinephrine|mesh-list
92129868|NCT05702333|Norepinephrine|norepinephrine|mesh-list
92129869|NCT05702333|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92129870|NCT05702333|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92129871|NCT05702333|Adrenergic Agents|adrenergic agents|mesh-ancestor
92129872|NCT05702333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129873|NCT05702333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129874|NCT05702333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129875|NCT05702333|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92129876|NCT05702333|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92129878|NCT05702333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129879|NCT05702333|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92129880|NCT05702333|Respiratory System Agents|respiratory system agents|mesh-ancestor
92129881|NCT05702333|Mydriatics|mydriatics|mesh-ancestor
92129882|NCT05702333|Sympathomimetics|sympathomimetics|mesh-ancestor
92129883|NCT05702333|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92129884|NCT05702333|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92129885|NCT05702333|Vasodilator Agents|vasodilator agents|mesh-ancestor
92129886|NCT05702333|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92129887|NCT05702333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92129888|NCT05702333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129889|NCT05702333|Protective Agents|protective agents|mesh-ancestor
92129890|NCT05702333|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92129891|NCT05702333|Dopamine Agents|dopamine agents|mesh-ancestor
92129892|NCT05671913|Ketamine|ketamine|mesh-list
92129893|NCT05671913|Analgesics|analgesics|mesh-ancestor
92129894|NCT05671913|Sensory System Agents|sensory system agents|mesh-ancestor
92129895|NCT05671913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129896|NCT05671913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129897|NCT05671913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92129898|NCT05671913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92129899|NCT05671913|Anesthetics, General|anesthetics, general|mesh-ancestor
92129900|NCT05671913|Anesthetics|anesthetics|mesh-ancestor
92129901|NCT05671913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129902|NCT05671913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92129903|NCT05671913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92129904|NCT05671913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129905|NCT05671913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129906|NCT05668936|Moxifloxacin|moxifloxacin|mesh-list
92129907|NCT05668936|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92129908|NCT05668936|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92129909|NCT05668936|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92129910|NCT05668936|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92129911|NCT05668936|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92129912|NCT05668936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129913|NCT05668936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129914|NCT05668936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129915|NCT05668936|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92129916|NCT05668936|Contraceptive Agents|contraceptive agents|mesh-ancestor
92129917|NCT05668936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92129918|NCT05668936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129919|NCT05668936|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92129920|NCT05668936|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92129921|NCT05668936|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92129922|NCT05668676|Prednisone|prednisone|mesh-list
92129923|NCT05668676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92129924|NCT05668676|Glucocorticoids|glucocorticoids|mesh-ancestor
92129925|NCT05668676|Hormones|hormones|mesh-ancestor
92129926|NCT05668676|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92129927|NCT05668676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129928|NCT05668676|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92129929|NCT05668676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129930|NCT05657990|Tamsulosin|tamsulosin|mesh-list
92129931|NCT05657990|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92129932|NCT05657990|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92129933|NCT05657990|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92129934|NCT05657990|Adrenergic Agents|adrenergic agents|mesh-ancestor
92129935|NCT05657990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92129936|NCT05657990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129937|NCT05657990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129938|NCT05657990|Urological Agents|urological agents|mesh-ancestor
92129939|NCT05627752|Docetaxel|docetaxel|mesh-list
92129940|NCT05627752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129941|NCT05627752|Tubulin Modulators|tubulin modulators|mesh-ancestor
92129942|NCT05627752|Antimitotic Agents|antimitotic agents|mesh-ancestor
92129943|NCT05627752|Mitosis Modulators|mitosis modulators|mesh-ancestor
92129944|NCT05627752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129945|NCT05609942|Azacitidine|azacitidine|mesh-list
92129946|NCT05609942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92129947|NCT05609942|Antimetabolites|antimetabolites|mesh-ancestor
92129948|NCT05609942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129949|NCT05609942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129950|NCT05609942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129953|NCT05590676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129954|NCT05559814|Peppermint oil|peppermint oil|mesh-list
92129955|NCT05559814|Antiemetics|antiemetics|mesh-ancestor
92129956|NCT05559814|Autonomic Agents|autonomic agents|mesh-ancestor
92129957|NCT05559814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92129958|NCT05559814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129959|NCT05559814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92129960|NCT05559814|Parasympatholytics|parasympatholytics|mesh-ancestor
92129961|NCT05505292|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92129962|NCT05505292|Lifitegrast|lifitegrast|mesh-list
92129963|NCT05505292|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92129964|NCT05491317|Pembrolizumab|pembrolizumab|mesh-list
92129965|NCT05491317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129966|NCT05491317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129967|NCT05491317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92129968|NCT05491317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129969|NCT05438420|Pembrolizumab|pembrolizumab|mesh-list
92129970|NCT05438420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92129971|NCT05438420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92129972|NCT05438420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92129973|NCT05438420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129974|NCT05419466|Melatonin|melatonin|mesh-list
92129975|NCT05419466|Antioxidants|antioxidants|mesh-ancestor
92129976|NCT05419466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129977|NCT05419466|Protective Agents|protective agents|mesh-ancestor
92129978|NCT05419466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129979|NCT05419466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129980|NCT05382481|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92129981|NCT05382481|Dalteparin|dalteparin|mesh-list
92129982|NCT05382481|Anticoagulants|anticoagulants|mesh-ancestor
92129983|NCT05382481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92129984|NCT05382481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92129985|NCT05382481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129986|NCT05353283|Tenofovir|tenofovir|mesh-list
92129987|NCT05353283|Antiviral Agents|antiviral agents|mesh-ancestor
92129989|NCT05353283|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92129990|NCT05353283|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92129991|NCT05353283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92129992|NCT05353283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92129993|NCT05353283|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92129994|NCT05353283|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92129995|NCT05323786|Anesthetics|anesthetics|mesh-list
92129996|NCT05323786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92129997|NCT05323786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92129998|NCT05262387|Insulin Lispro|insulin lispro|mesh-list
92129999|NCT05262387|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92130000|NCT05262387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130001|NCT05252416|Carboplatin|carboplatin|mesh-list
92130002|NCT05252416|Fulvestrant|fulvestrant|mesh-list
92130003|NCT05252416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130004|NCT05252416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130005|NCT05252416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92130006|NCT05252416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92130007|NCT05252416|Hormone Antagonists|hormone antagonists|mesh-ancestor
92130008|NCT05252416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130009|NCT05252416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130010|NCT05233228|Nicotine|nicotine|mesh-list
92130011|NCT05233228|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92130012|NCT05233228|Autonomic Agents|autonomic agents|mesh-ancestor
92130013|NCT05233228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130014|NCT05233228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130015|NCT05233228|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92130016|NCT05233228|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92130017|NCT05233228|Cholinergic Agents|cholinergic agents|mesh-ancestor
92130018|NCT05233228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130019|NCT05233228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130020|NCT05221554|Tacrine|tacrine|mesh-list
92130021|NCT05221554|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92130022|NCT05221554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130023|NCT05221554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130024|NCT05221554|Cholinergic Agents|cholinergic agents|mesh-ancestor
92130025|NCT05221554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130026|NCT05221554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130027|NCT05221554|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92130029|NCT05221554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130030|NCT05221554|Nootropic Agents|nootropic agents|mesh-ancestor
92130031|NCT05162937|Antibodies|antibodies|mesh-list
92130032|NCT05162937|Immunologic Factors|immunologic factors|mesh-ancestor
92130033|NCT05162937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130034|NCT05152147|Fluorouracil|fluorouracil|mesh-list
92130035|NCT05152147|Capecitabine|capecitabine|mesh-list
92130036|NCT05152147|Oxaliplatin|oxaliplatin|mesh-list
92130037|NCT05152147|Trastuzumab|trastuzumab|mesh-list
92130038|NCT05152147|Tislelizumab|tislelizumab|mesh-list
92130039|NCT05152147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130040|NCT05152147|Antimetabolites|antimetabolites|mesh-ancestor
92130041|NCT05152147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130042|NCT05152147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130043|NCT05152147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130044|NCT05152147|Immunologic Factors|immunologic factors|mesh-ancestor
92130045|NCT05152147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130046|NCT05152147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130047|NCT04985500|Bupivacaine|bupivacaine|mesh-list
92130048|NCT04985500|Anesthetics, Local|anesthetics, local|mesh-ancestor
92130049|NCT04985500|Anesthetics|anesthetics|mesh-ancestor
92130050|NCT04985500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130051|NCT04985500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130052|NCT04985500|Sensory System Agents|sensory system agents|mesh-ancestor
92130053|NCT04985500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130054|NCT04973670|Sivelestat|sivelestat|mesh-list
92130055|NCT04973670|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92130056|NCT04973670|Protease Inhibitors|protease inhibitors|mesh-ancestor
92130057|NCT04973670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130058|NCT04973670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130059|NCT04967248|Fulvestrant|fulvestrant|mesh-list
92130060|NCT04967248|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130061|NCT04967248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130062|NCT04967248|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92130063|NCT04967248|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92130064|NCT04967248|Hormone Antagonists|hormone antagonists|mesh-ancestor
92130065|NCT04967248|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130066|NCT04967248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130067|NCT04929626|Magnesium Sulfate|magnesium sulfate|mesh-list
92130069|NCT04929626|Analgesics|analgesics|mesh-ancestor
92130070|NCT04929626|Sensory System Agents|sensory system agents|mesh-ancestor
92130071|NCT04929626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130072|NCT04929626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130073|NCT04929626|Anesthetics|anesthetics|mesh-ancestor
92130074|NCT04929626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130075|NCT04929626|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92130076|NCT04929626|Anticonvulsants|anticonvulsants|mesh-ancestor
92130077|NCT04929626|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92130078|NCT04929626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92130079|NCT04929626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130080|NCT04929626|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92130081|NCT04929626|Tocolytic Agents|tocolytic agents|mesh-ancestor
92130082|NCT04929626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130083|NCT04929626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92130084|NCT04929626|Autonomic Agents|autonomic agents|mesh-ancestor
92130085|NCT04929626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92130086|NCT04929626|Respiratory System Agents|respiratory system agents|mesh-ancestor
92130087|NCT04929626|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92130088|NCT04929626|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92130089|NCT04929626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92130090|NCT04929626|Adrenergic Agents|adrenergic agents|mesh-ancestor
92130091|NCT04929626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130093|NCT04908202|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130094|NCT04908202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92130095|NCT04908202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130096|NCT04908202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130097|NCT04905316|Durvalumab|durvalumab|mesh-list
92130098|NCT04905316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130099|NCT04905316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130100|NCT04879849|Pembrolizumab|pembrolizumab|mesh-list
92130101|NCT04879849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130102|NCT04879849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130103|NCT04879849|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130104|NCT04879849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130108|NCT04826198|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92130109|NCT04826198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130110|NCT04826198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130111|NCT04826198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130112|NCT04808934|Rivaroxaban|rivaroxaban|mesh-list
92130113|NCT04808934|Apixaban|apixaban|mesh-list
92130114|NCT04808934|Dabigatran|dabigatran|mesh-list
92130115|NCT04808934|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92130116|NCT04808934|Antithrombins|antithrombins|mesh-ancestor
92130117|NCT04808934|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92130118|NCT04808934|Protease Inhibitors|protease inhibitors|mesh-ancestor
92130119|NCT04808934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130120|NCT04808934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130121|NCT04808934|Anticoagulants|anticoagulants|mesh-ancestor
92130122|NCT04754230|Tranexamic Acid|tranexamic acid|mesh-list
92130123|NCT04754230|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92130124|NCT04754230|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92130125|NCT04754230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130126|NCT04754230|Hemostatics|hemostatics|mesh-ancestor
92130127|NCT04754230|Coagulants|coagulants|mesh-ancestor
92130128|NCT04733118|Trastuzumab|trastuzumab|mesh-list
92130130|NCT04733118|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92130131|NCT04733118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130132|NCT04733118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130133|NCT04733118|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130134|NCT04733118|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130135|NCT04733118|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130136|NCT04733118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130138|NCT04733118|Immunoconjugates|immunoconjugates|mesh-ancestor
92130139|NCT04733118|Immunologic Factors|immunologic factors|mesh-ancestor
92130140|NCT04733118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130141|NCT04699461|Idelalisib|idelalisib|mesh-list
92130142|NCT04699461|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92130143|NCT04699461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130144|NCT04699461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130145|NCT04699461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130146|NCT04699461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130147|NCT04659928|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92130148|NCT04659928|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92130149|NCT04659928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130150|NCT04653337|Norepinephrine|norepinephrine|mesh-list
92130151|NCT04653337|Serotonin|serotonin|mesh-list
92130152|NCT04653337|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
92130153|NCT04653337|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92130154|NCT04653337|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92130155|NCT04653337|Adrenergic Agents|adrenergic agents|mesh-ancestor
92130156|NCT04653337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130157|NCT04653337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130158|NCT04653337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130159|NCT04653337|Sympathomimetics|sympathomimetics|mesh-ancestor
92130160|NCT04653337|Autonomic Agents|autonomic agents|mesh-ancestor
92130161|NCT04653337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130162|NCT04653337|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92130163|NCT04653337|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92130164|NCT04653337|Serotonin Agents|serotonin agents|mesh-ancestor
92130165|NCT04653337|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92130166|NCT04653337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92130167|NCT04561739|Sirolimus|sirolimus|mesh-list
92130168|NCT04561739|Paclitaxel|paclitaxel|mesh-list
92130169|NCT04561739|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130170|NCT04561739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130171|NCT04561739|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130172|NCT04561739|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130173|NCT04561739|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130174|NCT04561739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130175|NCT04561739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92130176|NCT04561739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130177|NCT04561739|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92130178|NCT04561739|Antifungal Agents|antifungal agents|mesh-ancestor
92130179|NCT04561739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130180|NCT04561739|Immunologic Factors|immunologic factors|mesh-ancestor
92130181|NCT04561739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130182|NCT04539626|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92130183|NCT04539626|Estradiol|estradiol|mesh-list
92130184|NCT04539626|Estrogens|estrogens|mesh-list
92130185|NCT04539626|Hormones|hormones|mesh-ancestor
92130186|NCT04539626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130187|NCT04539626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130188|NCT04539626|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92130189|NCT04539626|Contraceptive Agents|contraceptive agents|mesh-ancestor
92130190|NCT04539626|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130191|NCT04539626|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92130192|NCT04539626|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92130193|NCT04539626|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92130194|NCT04521348|Antibodies|antibodies|mesh-list
92130195|NCT04521348|Immunoglobulins|immunoglobulins|mesh-list
92130196|NCT04521348|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92130197|NCT04521348|Immunologic Factors|immunologic factors|mesh-ancestor
92130198|NCT04521348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130199|NCT04521348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92130200|NCT04521348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130201|NCT04521348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130202|NCT04512534|Antibodies|antibodies|mesh-list
92130203|NCT04512534|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92130204|NCT04512534|Immunologic Factors|immunologic factors|mesh-ancestor
92130205|NCT04512534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130206|NCT04512534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130207|NCT04512534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130208|NCT04486118|Lisinopril|lisinopril|mesh-list
92130209|NCT04486118|Benazepril|benazepril|mesh-list
92130210|NCT04486118|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92130211|NCT04486118|Protease Inhibitors|protease inhibitors|mesh-ancestor
92130212|NCT04486118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130213|NCT04486118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130214|NCT04486118|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92130215|NCT04486118|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92130216|NCT04486118|Protective Agents|protective agents|mesh-ancestor
92130217|NCT04486118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130218|NCT04442581|Pembrolizumab|pembrolizumab|mesh-list
92130219|NCT04442581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130220|NCT04442581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130221|NCT04442581|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130222|NCT04442581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130223|NCT04436731|Phentolamine|phentolamine|mesh-list
92130224|NCT04436731|Phenylephrine|phenylephrine|mesh-list
92130225|NCT04436731|Oxymetazoline|oxymetazoline|mesh-list
92130226|NCT04436731|Norepinephrine|norepinephrine|mesh-list
92130227|NCT04436731|Dexmedetomidine|dexmedetomidine|mesh-list
92130228|NCT04436731|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92130229|NCT04436731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130230|NCT04436731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130231|NCT04436731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92130232|NCT04436731|Analgesics|analgesics|mesh-ancestor
92130233|NCT04436731|Sensory System Agents|sensory system agents|mesh-ancestor
92130234|NCT04436731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130235|NCT04436731|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92130236|NCT04436731|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92130237|NCT04436731|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92130238|NCT04436731|Adrenergic Agents|adrenergic agents|mesh-ancestor
92130239|NCT04436731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130240|NCT04436731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130241|NCT04436731|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92130243|NCT04436731|Autonomic Agents|autonomic agents|mesh-ancestor
92130244|NCT04436731|Sympathomimetics|sympathomimetics|mesh-ancestor
92130245|NCT04436731|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92130246|NCT04436731|Nasal Decongestants|nasal decongestants|mesh-ancestor
92130247|NCT04436731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92130248|NCT04436731|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92130249|NCT04436731|Protective Agents|protective agents|mesh-ancestor
92130250|NCT04436731|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92130251|NCT04436731|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92130252|NCT04436731|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92130253|NCT04423068|Contraceptive Agents|contraceptive agents|mesh-list
92130254|NCT04423068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130255|NCT04423068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130256|NCT04420598|Trastuzumab|trastuzumab|mesh-list
92130257|NCT04420598|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92130258|NCT04420598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130259|NCT04420598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130260|NCT04420598|Immunoconjugates|immunoconjugates|mesh-ancestor
92130262|NCT04420598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130263|NCT04411654|Sirolimus|sirolimus|mesh-list
92130264|NCT04411654|Prednisone|prednisone|mesh-list
92130265|NCT04411654|Methylprednisolone|methylprednisolone|mesh-list
92130266|NCT04411654|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92130267|NCT04411654|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92130268|NCT04411654|Prednisolone|prednisolone|mesh-list
92130269|NCT04411654|Prednisolone acetate|prednisolone acetate|mesh-list
92130270|NCT04411654|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92130271|NCT04411654|Prednisolone phosphate|prednisolone phosphate|mesh-list
92130272|NCT04411654|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130273|NCT04411654|Glucocorticoids|glucocorticoids|mesh-ancestor
92130275|NCT04411654|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130276|NCT04411654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130277|NCT04411654|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130278|NCT04411654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130279|NCT04411654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92130280|NCT04411654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130281|NCT04411654|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92130282|NCT04411654|Antifungal Agents|antifungal agents|mesh-ancestor
92088517|NCT01969721|Autonomic Agents|autonomic agents|mesh-ancestor
92130283|NCT04411654|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130284|NCT04411654|Immunologic Factors|immunologic factors|mesh-ancestor
92130285|NCT04411654|Antiemetics|antiemetics|mesh-ancestor
92130286|NCT04411654|Autonomic Agents|autonomic agents|mesh-ancestor
92130287|NCT04411654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130288|NCT04411654|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130289|NCT04411654|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92130290|NCT04411654|Protective Agents|protective agents|mesh-ancestor
92130291|NCT04381832|Docetaxel|docetaxel|mesh-list
92130292|NCT04381832|Quemliclustat|quemliclustat|mesh-list
92130293|NCT04381832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130294|NCT04381832|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130295|NCT04381832|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130296|NCT04381832|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130297|NCT04381832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130298|NCT04381832|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130299|NCT04381832|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130300|NCT04364230|Poly ICLC|poly iclc|mesh-list
92130301|NCT04364230|Immunologic Factors|immunologic factors|mesh-ancestor
92130302|NCT04364230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130303|NCT04364230|Interferon Inducers|interferon inducers|mesh-ancestor
92130304|NCT04268706|Fludarabine|fludarabine|mesh-list
92130305|NCT04268706|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92130306|NCT04268706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130307|NCT04268706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130308|NCT04268706|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92130309|NCT04268706|Alkylating Agents|alkylating agents|mesh-ancestor
92130310|NCT04223609|Oxycodone|oxycodone|mesh-list
92130311|NCT04223609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92130312|NCT04223609|Narcotics|narcotics|mesh-ancestor
92130313|NCT04223609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130314|NCT04223609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130315|NCT04223609|Analgesics|analgesics|mesh-ancestor
92130316|NCT04223609|Sensory System Agents|sensory system agents|mesh-ancestor
92130317|NCT04223609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130318|NCT04120415|Vedolizumab|vedolizumab|mesh-list
92130319|NCT04120415|Vaccines|vaccines|mesh-list
92130320|NCT04120415|Immunologic Factors|immunologic factors|mesh-ancestor
92130321|NCT04120415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130322|NCT04120415|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130323|NCT04118920|Insulin|insulin|mesh-list
92130324|NCT04118920|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92130325|NCT04118920|Lubricant Eye Drops|lubricant eye drops|mesh-list
92130326|NCT04118920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92130327|NCT04118920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130328|NCT04118920|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92130329|NCT04118920|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92130330|NCT04083144|Varenicline|varenicline|mesh-list
92130331|NCT04083144|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92130332|NCT04083144|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92130333|NCT04083144|Cholinergic Agents|cholinergic agents|mesh-ancestor
92130334|NCT04083144|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130335|NCT04083144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130336|NCT04083144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130337|NCT04055818|Niacinamide|niacinamide|mesh-list
92130338|NCT04055818|Niacin|niacin|mesh-list
92130342|NCT04055818|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130343|NCT04055818|Antimetabolites|antimetabolites|mesh-ancestor
92130344|NCT04055818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130345|NCT04055818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130346|NCT04055818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130347|NCT04055818|Vitamin B Complex|vitamin b complex|mesh-ancestor
92130348|NCT04055818|Vitamins|vitamins|mesh-ancestor
92130349|NCT04055818|Micronutrients|micronutrients|mesh-ancestor
92130350|NCT04055818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130351|NCT04055818|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92130352|NCT04055818|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92130353|NCT04055818|Vasodilator Agents|vasodilator agents|mesh-ancestor
92130354|NCT04047953|Paclitaxel|paclitaxel|mesh-list
92130355|NCT04047953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92130356|NCT04047953|Oxaliplatin|oxaliplatin|mesh-list
92130357|NCT04047953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130358|NCT04047953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130359|NCT04047953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130360|NCT04047953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92088595|NCT01959503|Hemostatics|hemostatics|mesh-ancestor
92130361|NCT04047953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130362|NCT04047953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130363|NCT03981900|Tofacitinib|tofacitinib|mesh-list
92130364|NCT03981900|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92130365|NCT03981900|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92130366|NCT03981900|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130367|NCT03981900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130369|NCT03958877|Interferon-beta|interferon-beta|mesh-list
92130370|NCT03958877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130371|NCT03958877|Antiviral Agents|antiviral agents|mesh-ancestor
92130372|NCT03958877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130373|NCT03958877|Immunologic Factors|immunologic factors|mesh-ancestor
92130374|NCT03958877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130375|NCT03954067|Pembrolizumab|pembrolizumab|mesh-list
92130376|NCT03954067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130377|NCT03954067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130378|NCT03954067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130379|NCT03954067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130380|NCT03941288|Cannabidiol|cannabidiol|mesh-list
92130381|NCT03941288|Anticonvulsants|anticonvulsants|mesh-ancestor
92130382|NCT03925727|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92130383|NCT03925727|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92130384|NCT03864419|Prednisone|prednisone|mesh-list
92130385|NCT03864419|Cyclophosphamide|cyclophosphamide|mesh-list
92130386|NCT03864419|Rituximab|rituximab|mesh-list
92130387|NCT03864419|Doxorubicin|doxorubicin|mesh-list
92130388|NCT03864419|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92130389|NCT03864419|Methotrexate|methotrexate|mesh-list
92130390|NCT03864419|Etoposide|etoposide|mesh-list
92130391|NCT03864419|Vincristine|vincristine|mesh-list
92130392|NCT03864419|Daunorubicin|daunorubicin|mesh-list
92130393|NCT03864419|Podophyllotoxin|podophyllotoxin|mesh-list
92130394|NCT03864419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92130395|NCT03864419|Antibodies|antibodies|mesh-list
92130396|NCT03864419|Immunoglobulins|immunoglobulins|mesh-list
92130397|NCT03864419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92130398|NCT03864419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130399|NCT03864419|Immunologic Factors|immunologic factors|mesh-ancestor
92130400|NCT03864419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130401|NCT03864419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130402|NCT03864419|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92130403|NCT03864419|Alkylating Agents|alkylating agents|mesh-ancestor
92130404|NCT03864419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130405|NCT03864419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130406|NCT03864419|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92130407|NCT03864419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92130408|NCT03864419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92130409|NCT03864419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92130410|NCT03864419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130411|NCT03864419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130412|NCT03864419|Glucocorticoids|glucocorticoids|mesh-ancestor
92130413|NCT03864419|Hormones|hormones|mesh-ancestor
92130414|NCT03864419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130415|NCT03864419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130416|NCT03864419|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92130417|NCT03864419|Abortifacient Agents|abortifacient agents|mesh-ancestor
92130418|NCT03864419|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130419|NCT03864419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130420|NCT03864419|Antimetabolites|antimetabolites|mesh-ancestor
92130421|NCT03864419|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130422|NCT03864419|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92130423|NCT03864419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92130424|NCT03864419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130425|NCT03864419|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130426|NCT03864419|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130427|NCT03864419|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130428|NCT03864419|Keratolytic Agents|keratolytic agents|mesh-ancestor
92130430|NCT03859427|Lenalidomide|lenalidomide|mesh-list
92130431|NCT03859427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130432|NCT03859427|Antiemetics|antiemetics|mesh-ancestor
92130433|NCT03859427|Autonomic Agents|autonomic agents|mesh-ancestor
92130434|NCT03859427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130435|NCT03859427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130436|NCT03859427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130437|NCT03859427|Glucocorticoids|glucocorticoids|mesh-ancestor
92130438|NCT03859427|Hormones|hormones|mesh-ancestor
92130439|NCT03859427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130440|NCT03859427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130441|NCT03859427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130442|NCT03859427|Immunologic Factors|immunologic factors|mesh-ancestor
92130443|NCT03859427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92130444|NCT03859427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92130445|NCT03859427|Growth Substances|growth substances|mesh-ancestor
92130446|NCT03859427|Growth Inhibitors|growth inhibitors|mesh-ancestor
92130447|NCT03856671|Metronidazole|metronidazole|mesh-list
92130449|NCT03856671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130450|NCT03856671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92130451|NCT03856671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92130452|NCT03856671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92130453|NCT03856671|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92130454|NCT03856671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130455|NCT03856671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130456|NCT03728361|Nivolumab|nivolumab|mesh-list
92130457|NCT03728361|Temozolomide|temozolomide|mesh-list
92130458|NCT03728361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130459|NCT03728361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130460|NCT03728361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130461|NCT03728361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130462|NCT03728361|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92130463|NCT03728361|Alkylating Agents|alkylating agents|mesh-ancestor
92130464|NCT03662685|Coal Tar|coal tar|mesh-list
92130465|NCT03662685|Keratolytic Agents|keratolytic agents|mesh-ancestor
92130466|NCT03662685|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130467|NCT03617328|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92130468|NCT03617328|Poly ICLC|poly iclc|mesh-list
92130469|NCT03617328|Immunologic Factors|immunologic factors|mesh-ancestor
92130470|NCT03617328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130471|NCT03617328|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92130472|NCT03617328|Interferon Inducers|interferon inducers|mesh-ancestor
92130473|NCT03391934|Leucovorin|leucovorin|mesh-list
92130474|NCT03391934|Fluorouracil|fluorouracil|mesh-list
92130475|NCT03391934|Irinotecan|irinotecan|mesh-list
92130476|NCT03391934|Cetuximab|cetuximab|mesh-list
92130477|NCT03391934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130478|NCT03391934|Antimetabolites|antimetabolites|mesh-ancestor
92130479|NCT03391934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130480|NCT03391934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130481|NCT03391934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130482|NCT03391934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130483|NCT03391934|Immunologic Factors|immunologic factors|mesh-ancestor
92130484|NCT03391934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92130485|NCT03391934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92130486|NCT03391934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130487|NCT03391934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130488|NCT03391934|Antidotes|antidotes|mesh-ancestor
92130489|NCT03391934|Protective Agents|protective agents|mesh-ancestor
92130490|NCT03391934|Vitamin B Complex|vitamin b complex|mesh-ancestor
92130491|NCT03391934|Vitamins|vitamins|mesh-ancestor
92130492|NCT03391934|Micronutrients|micronutrients|mesh-ancestor
92130493|NCT03333343|Gefitinib|gefitinib|mesh-list
92130494|NCT03333343|Trametinib|trametinib|mesh-list
92130495|NCT03333343|Nazartinib|nazartinib|mesh-list
92130496|NCT03333343|Naporafenib|naporafenib|mesh-list
92130497|NCT03333343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130498|NCT03333343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92130500|NCT03333343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130502|NCT03326947|Fluorouracil|fluorouracil|mesh-list
92130503|NCT03326947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130504|NCT03326947|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130505|NCT03326947|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130506|NCT03326947|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130507|NCT03326947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130508|NCT03326947|Antimetabolites|antimetabolites|mesh-ancestor
92130509|NCT03326947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130510|NCT03326947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130511|NCT03326947|Immunologic Factors|immunologic factors|mesh-ancestor
92130512|NCT03326947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130513|NCT03304639|Pembrolizumab|pembrolizumab|mesh-list
92130514|NCT03304639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130515|NCT03304639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130516|NCT03304639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130517|NCT03304639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130519|NCT03289234|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92130520|NCT03289234|Antioxidants|antioxidants|mesh-ancestor
92130521|NCT03289234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130522|NCT03289234|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92130523|NCT03289234|Protective Agents|protective agents|mesh-ancestor
92130524|NCT03289234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130525|NCT03289208|Edaravone|edaravone|mesh-list
92130526|NCT03289208|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92130527|NCT03289208|Antioxidants|antioxidants|mesh-ancestor
92130528|NCT03289208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130529|NCT03289208|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92130530|NCT03289208|Protective Agents|protective agents|mesh-ancestor
92130531|NCT03289208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130532|NCT03244059|Belimumab|belimumab|mesh-list
92130533|NCT03244059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130534|NCT03244059|Immunologic Factors|immunologic factors|mesh-ancestor
92130535|NCT03244059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130536|NCT03036566|Lithium Carbonate|lithium carbonate|mesh-list
92130537|NCT03036566|Antidepressive Agents|antidepressive agents|mesh-ancestor
92130538|NCT03036566|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92130539|NCT03036566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130540|NCT03036566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130541|NCT03036566|Antimanic Agents|antimanic agents|mesh-ancestor
92130542|NCT03036566|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92130543|NCT03036566|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130544|NCT03036566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130545|NCT03010228|Aluminum sulfate|aluminum sulfate|mesh-list
92130546|NCT03010228|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92130547|NCT03010228|Immunologic Factors|immunologic factors|mesh-ancestor
92130548|NCT03010228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130549|NCT03006302|Cyclophosphamide|cyclophosphamide|mesh-list
92130550|NCT03006302|Pembrolizumab|pembrolizumab|mesh-list
92130551|NCT03006302|Immunologic Factors|immunologic factors|mesh-ancestor
92130552|NCT03006302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130553|NCT03006302|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130554|NCT03006302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130555|NCT03006302|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92130556|NCT03006302|Alkylating Agents|alkylating agents|mesh-ancestor
92130557|NCT03006302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130558|NCT03006302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130559|NCT03006302|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92130560|NCT03006302|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130561|NCT03006302|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130562|NCT02927249|Aspirin|aspirin|mesh-list
92130563|NCT02927249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92130564|NCT02927249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92130565|NCT02927249|Analgesics|analgesics|mesh-ancestor
92130566|NCT02927249|Sensory System Agents|sensory system agents|mesh-ancestor
92130567|NCT02927249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130568|NCT02927249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130569|NCT02927249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130570|NCT02927249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130571|NCT02927249|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92130572|NCT02927249|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92130573|NCT02927249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130574|NCT02927249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92130575|NCT02927249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92130576|NCT02927249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130578|NCT02918864|Oxytocin|oxytocin|mesh-list
92130579|NCT02918864|Oxytocics|oxytocics|mesh-ancestor
92130580|NCT02918864|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130581|NCT02918864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130582|NCT02890368|Interferons|interferons|mesh-list
92130583|NCT02890368|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92130584|NCT02890368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92130585|NCT02890368|Immunoglobulin G|immunoglobulin g|mesh-list
92130586|NCT02890368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130587|NCT02890368|Antiviral Agents|antiviral agents|mesh-ancestor
92130588|NCT02890368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130589|NCT02890368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130590|NCT02890368|Immunologic Factors|immunologic factors|mesh-ancestor
92130591|NCT02890368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130592|NCT02890368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130593|NCT02754141|Nivolumab|nivolumab|mesh-list
92130594|NCT02754141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130595|NCT02754141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130596|NCT02754141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130597|NCT02754141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130598|NCT02659059|Paclitaxel|paclitaxel|mesh-list
92130599|NCT02659059|Cisplatin|cisplatin|mesh-list
92130600|NCT02659059|Carboplatin|carboplatin|mesh-list
92130601|NCT02659059|Nivolumab|nivolumab|mesh-list
92130602|NCT02659059|Pemetrexed|pemetrexed|mesh-list
92130603|NCT02659059|Ipilimumab|ipilimumab|mesh-list
92130604|NCT02659059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130605|NCT02659059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130606|NCT02659059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130607|NCT02659059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130608|NCT02659059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130609|NCT02659059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130610|NCT02659059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130611|NCT02659059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130612|NCT02659059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130613|NCT02659059|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92130614|NCT02659059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92130615|NCT01997840|Dexamethasone|dexamethasone|mesh-list
92130616|NCT01997840|Dexamethasone acetate|dexamethasone acetate|mesh-list
92130617|NCT01997840|Pomalidomide|pomalidomide|mesh-list
92130618|NCT01997840|Ricolinostat|ricolinostat|mesh-list
92130619|NCT01997840|BB 1101|bb 1101|mesh-list
92130620|NCT01997840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130621|NCT01997840|Antiemetics|antiemetics|mesh-ancestor
92130622|NCT01997840|Autonomic Agents|autonomic agents|mesh-ancestor
92130623|NCT01997840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130624|NCT01997840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130625|NCT01997840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130626|NCT01997840|Glucocorticoids|glucocorticoids|mesh-ancestor
92130627|NCT01997840|Hormones|hormones|mesh-ancestor
92130628|NCT01997840|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130629|NCT01997840|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130630|NCT01997840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130631|NCT01997840|Protease Inhibitors|protease inhibitors|mesh-ancestor
92130632|NCT01997840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130633|NCT01997840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130634|NCT01997840|Immunologic Factors|immunologic factors|mesh-ancestor
92130635|NCT01997840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92130636|NCT01997840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92130637|NCT01997840|Growth Substances|growth substances|mesh-ancestor
92130638|NCT01997840|Growth Inhibitors|growth inhibitors|mesh-ancestor
92130639|NCT01997840|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92130640|NCT01505569|Etoposide|etoposide|mesh-list
92130641|NCT01505569|Carboplatin|carboplatin|mesh-list
92130642|NCT01505569|Melphalan|melphalan|mesh-list
92130643|NCT01505569|Busulfan|busulfan|mesh-list
92130644|NCT01505569|Ifosfamide|ifosfamide|mesh-list
92130645|NCT01505569|Thiotepa|thiotepa|mesh-list
92130646|NCT01505569|Lenograstim|lenograstim|mesh-list
92130648|NCT01505569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130649|NCT01505569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130650|NCT01505569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130651|NCT01505569|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92130652|NCT01505569|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92130653|NCT01505569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130654|NCT01505569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92130655|NCT01505569|Alkylating Agents|alkylating agents|mesh-ancestor
92130656|NCT01505569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92130657|NCT01505569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130658|NCT01505569|Immunologic Factors|immunologic factors|mesh-ancestor
92130659|NCT01505569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130660|NCT01505569|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92130661|NCT01505569|Protective Agents|protective agents|mesh-ancestor
92130662|NCT02375178|Biguanides|biguanides|mesh-list
92130663|NCT02375178|Chlorhexidine|chlorhexidine|mesh-list
92130664|NCT02375178|Polihexanide|polihexanide|mesh-list
92130665|NCT02375178|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92130666|NCT02375178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088889|NCT00830362|Propranolol|propranolol|mesh-list
92130667|NCT02375178|Disinfectants|disinfectants|mesh-ancestor
92130668|NCT02375178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92130669|NCT02375178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130671|NCT02375100|Tramadol|tramadol|mesh-list
92130672|NCT02375100|Analgesics|analgesics|mesh-list
92130673|NCT02375100|Bupivacaine|bupivacaine|mesh-list
92130674|NCT02375100|Anesthetics, Local|anesthetics, local|mesh-ancestor
92130675|NCT02375100|Anesthetics|anesthetics|mesh-ancestor
92130676|NCT02375100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130677|NCT02375100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130678|NCT02375100|Sensory System Agents|sensory system agents|mesh-ancestor
92130679|NCT02375100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130680|NCT02375100|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92130681|NCT02375100|Antipyretics|antipyretics|mesh-ancestor
92130682|NCT02375100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92130683|NCT02375100|Narcotics|narcotics|mesh-ancestor
92130684|NCT02364258|Atorvastatin|atorvastatin|mesh-list
92130685|NCT02364258|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92130686|NCT02364258|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92130687|NCT02364258|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92130688|NCT02364258|Antimetabolites|antimetabolites|mesh-ancestor
92130689|NCT02364258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130690|NCT02364258|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92130691|NCT02364258|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92130692|NCT02364258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130693|NCT02375022|Endostar protein|endostar protein|mesh-list
92130694|NCT02375022|Endostatins|endostatins|mesh-list
92130695|NCT02375022|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92130696|NCT02375022|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92130697|NCT02375022|Growth Substances|growth substances|mesh-ancestor
92130698|NCT02375022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130699|NCT02375022|Growth Inhibitors|growth inhibitors|mesh-ancestor
92130700|NCT02375022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130701|NCT01497899|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92130702|NCT01497899|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92130703|NCT01497899|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92130705|NCT01497899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130706|NCT01497275|Rituximab|rituximab|mesh-list
92130707|NCT01497275|Bortezomib|bortezomib|mesh-list
92130708|NCT01497275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130709|NCT01497275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130710|NCT01497275|Immunologic Factors|immunologic factors|mesh-ancestor
92130711|NCT01497275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130712|NCT01497275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130713|NCT01557517|Clobetasol|clobetasol|mesh-list
92130714|NCT01557517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130715|NCT01557517|Glucocorticoids|glucocorticoids|mesh-ancestor
92130716|NCT01557517|Hormones|hormones|mesh-ancestor
92130717|NCT01557517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130718|NCT01557517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130719|NCT02363556|Misoprostol|misoprostol|mesh-list
92130720|NCT02363556|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92130721|NCT02363556|Abortifacient Agents|abortifacient agents|mesh-ancestor
92130722|NCT02363556|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130723|NCT02363556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130724|NCT02363556|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92130725|NCT02363556|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130726|NCT02363556|Oxytocics|oxytocics|mesh-ancestor
92130727|NCT01497197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92130728|NCT01497197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130729|NCT01497197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130730|NCT01557283|Etanercept|etanercept|mesh-list
92145308|NCT00245037|Phenytoin|phenytoin|mesh-list
92130731|NCT01557283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92130732|NCT01557283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92130733|NCT01557283|Analgesics|analgesics|mesh-ancestor
92130734|NCT01557283|Sensory System Agents|sensory system agents|mesh-ancestor
92130735|NCT01557283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130736|NCT01557283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130737|NCT01557283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130738|NCT01557283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130739|NCT01557283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130740|NCT01557283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130741|NCT01557283|Immunologic Factors|immunologic factors|mesh-ancestor
92130742|NCT02374632|Octreotide|octreotide|mesh-list
92130743|NCT02374632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130744|NCT02374632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130745|NCT02374632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130746|NCT02363400|Cisplatin|cisplatin|mesh-list
92130747|NCT02363400|Epirubicin|epirubicin|mesh-list
92130748|NCT02363400|Mitomycins|mitomycins|mesh-list
92130749|NCT02363400|Mitomycin|mitomycin|mesh-list
92130750|NCT02363400|Tegafur|tegafur|mesh-list
92130751|NCT02363400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130752|NCT02363400|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92130753|NCT02363400|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92130754|NCT02363400|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92130755|NCT02363400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130756|NCT02363400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130757|NCT02363400|Alkylating Agents|alkylating agents|mesh-ancestor
92130758|NCT02363400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92130759|NCT02363400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130760|NCT02363400|Antimetabolites|antimetabolites|mesh-ancestor
92130761|NCT00350025|Paclitaxel|paclitaxel|mesh-list
92130762|NCT00350025|Cetuximab|cetuximab|mesh-list
92130763|NCT00350025|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130764|NCT00350025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130765|NCT00350025|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130766|NCT00350025|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130767|NCT00350025|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130768|NCT00350025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130769|NCT00350025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130770|NCT01496807|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92130771|NCT01496807|Ipilimumab|ipilimumab|mesh-list
92130772|NCT01496807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130773|NCT01496807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130774|NCT01496807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92130775|NCT01496807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130776|NCT01496807|Antiviral Agents|antiviral agents|mesh-ancestor
92130777|NCT01496807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130778|NCT02374320|Bupivacaine|bupivacaine|mesh-list
92130779|NCT02374320|Anesthetics, Local|anesthetics, local|mesh-ancestor
92130780|NCT02374320|Anesthetics|anesthetics|mesh-ancestor
92130781|NCT02374320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130782|NCT02374320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130783|NCT02374320|Sensory System Agents|sensory system agents|mesh-ancestor
92130784|NCT02374320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130786|NCT01496183|Antiemetics|antiemetics|mesh-ancestor
92130787|NCT01496183|Autonomic Agents|autonomic agents|mesh-ancestor
92130788|NCT01496183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130789|NCT01496183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130790|NCT01496183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130791|NCT01496183|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92130792|NCT01496183|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92130793|NCT01496183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130794|NCT01496183|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92130795|NCT01496183|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92130796|NCT01496183|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92130797|NCT01496183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92130798|NCT01496183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130799|NCT01496183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130800|NCT01496183|Serotonin Agents|serotonin agents|mesh-ancestor
92130801|NCT01495793|Rotigotine|rotigotine|mesh-list
92130802|NCT01495793|Dopamine Agonists|dopamine agonists|mesh-ancestor
92130803|NCT01495793|Dopamine Agents|dopamine agents|mesh-ancestor
92130804|NCT01495793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130805|NCT01495793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130806|NCT01495793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130810|NCT02374008|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130811|NCT02374008|Antiemetics|antiemetics|mesh-ancestor
92130812|NCT02374008|Autonomic Agents|autonomic agents|mesh-ancestor
92130813|NCT02374008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130814|NCT02374008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130815|NCT02374008|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130816|NCT02374008|Glucocorticoids|glucocorticoids|mesh-ancestor
92130817|NCT02374008|Hormones|hormones|mesh-ancestor
92130818|NCT02374008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130819|NCT02374008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130820|NCT02374008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130821|NCT02374008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130822|NCT02374008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130823|NCT02374008|Anesthetics, Local|anesthetics, local|mesh-ancestor
92130824|NCT02374008|Anesthetics|anesthetics|mesh-ancestor
92130825|NCT02374008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130826|NCT02374008|Sensory System Agents|sensory system agents|mesh-ancestor
92130827|NCT02374008|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92130828|NCT02374008|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92130829|NCT02374008|Analgesics|analgesics|mesh-ancestor
92130830|NCT02374008|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130831|NCT02374008|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92130833|NCT04505280|Anesthetics, Local|anesthetics, local|mesh-ancestor
92130834|NCT04505280|Anesthetics|anesthetics|mesh-ancestor
92130835|NCT04505280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92130836|NCT04505280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130837|NCT04505280|Sensory System Agents|sensory system agents|mesh-ancestor
92130838|NCT04505280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130839|NCT04505280|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92130840|NCT04505280|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92130841|NCT04505280|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92130842|NCT04505280|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92130843|NCT04505280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130844|NCT02366676|Hyaluronic Acid|hyaluronic acid|mesh-list
92130845|NCT02366676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92130846|NCT02366676|Immunologic Factors|immunologic factors|mesh-ancestor
92130847|NCT02366676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130848|NCT02366676|Viscosupplements|viscosupplements|mesh-ancestor
92130849|NCT02366676|Protective Agents|protective agents|mesh-ancestor
92130850|NCT02373384|Allopurinol|allopurinol|mesh-list
92130851|NCT02373384|Potassium Citrate|potassium citrate|mesh-list
92130852|NCT02373384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130853|NCT02373384|Antimetabolites|antimetabolites|mesh-ancestor
92130854|NCT02373384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130855|NCT02373384|Gout Suppressants|gout suppressants|mesh-ancestor
92130856|NCT02373384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130857|NCT02373384|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92130858|NCT02373384|Antioxidants|antioxidants|mesh-ancestor
92130859|NCT02373384|Protective Agents|protective agents|mesh-ancestor
92130860|NCT02373384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130861|NCT02373384|Diuretics|diuretics|mesh-ancestor
92130862|NCT02373384|Natriuretic Agents|natriuretic agents|mesh-ancestor
92130863|NCT02373384|Expectorants|expectorants|mesh-ancestor
92130864|NCT02373384|Respiratory System Agents|respiratory system agents|mesh-ancestor
92130865|NCT01494467|Azelaic acid|azelaic acid|mesh-list
92130866|NCT01494467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130867|NCT01494467|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130868|NCT02881086|Cytarabine|cytarabine|mesh-list
92130869|NCT02881086|Dexamethasone|dexamethasone|mesh-list
92130870|NCT02881086|Prednisolone|prednisolone|mesh-list
92130871|NCT02881086|Cyclophosphamide|cyclophosphamide|mesh-list
92130872|NCT02881086|Rituximab|rituximab|mesh-list
92130873|NCT02881086|Methotrexate|methotrexate|mesh-list
92130874|NCT02881086|Fludarabine|fludarabine|mesh-list
92130875|NCT02881086|Vincristine|vincristine|mesh-list
92130876|NCT02881086|Doxorubicin|doxorubicin|mesh-list
92130877|NCT02881086|Daunorubicin|daunorubicin|mesh-list
92130878|NCT02881086|Asparaginase|asparaginase|mesh-list
92130879|NCT02881086|Mercaptopurine|mercaptopurine|mesh-list
92130880|NCT02881086|Idarubicin|idarubicin|mesh-list
92130881|NCT02881086|Pegaspargase|pegaspargase|mesh-list
92130882|NCT02881086|Vindesine|vindesine|mesh-list
92130883|NCT02881086|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92130884|NCT02881086|Immunologic Factors|immunologic factors|mesh-ancestor
92130885|NCT02881086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130886|NCT02881086|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92130887|NCT02881086|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92130888|NCT02881086|Alkylating Agents|alkylating agents|mesh-ancestor
92130889|NCT02881086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130890|NCT02881086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130891|NCT02881086|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92130892|NCT02881086|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92130893|NCT02881086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92130894|NCT02881086|Antiemetics|antiemetics|mesh-ancestor
92130895|NCT02881086|Autonomic Agents|autonomic agents|mesh-ancestor
92130896|NCT02881086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130897|NCT02881086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92130898|NCT02881086|Glucocorticoids|glucocorticoids|mesh-ancestor
92130900|NCT02881086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130901|NCT02881086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92130902|NCT02881086|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92130903|NCT02881086|Abortifacient Agents|abortifacient agents|mesh-ancestor
92130904|NCT02881086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130905|NCT02881086|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92130906|NCT02881086|Antimetabolites|antimetabolites|mesh-ancestor
92130907|NCT02881086|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130908|NCT02881086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130909|NCT02881086|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92130910|NCT02881086|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92130911|NCT02881086|Antiviral Agents|antiviral agents|mesh-ancestor
92130912|NCT02881086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130913|NCT02881086|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92130914|NCT02881086|Tubulin Modulators|tubulin modulators|mesh-ancestor
92130915|NCT02881086|Antimitotic Agents|antimitotic agents|mesh-ancestor
92130916|NCT02881086|Mitosis Modulators|mitosis modulators|mesh-ancestor
92130917|NCT02881086|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92130918|NCT02881086|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92130919|NCT02881086|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92130921|NCT03922542|Vitamin B Complex|vitamin b complex|mesh-ancestor
92130923|NCT03922542|Micronutrients|micronutrients|mesh-ancestor
92130924|NCT03922542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130925|NCT03922542|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92130926|NCT03922542|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130927|NCT01493687|Azelaic acid|azelaic acid|mesh-list
92130928|NCT01493687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130929|NCT01493687|Dermatologic Agents|dermatologic agents|mesh-ancestor
92130930|NCT02362308|Eplerenone|eplerenone|mesh-list
92130931|NCT02362308|Spironolactone|spironolactone|mesh-list
92130932|NCT02362308|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92130933|NCT02362308|Mineralocorticoids|mineralocorticoids|mesh-list
92130934|NCT02362308|Hormone Antagonists|hormone antagonists|mesh-ancestor
92130935|NCT02362308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130936|NCT02362308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130937|NCT02362308|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92130938|NCT02362308|Diuretics|diuretics|mesh-ancestor
92130939|NCT02362308|Natriuretic Agents|natriuretic agents|mesh-ancestor
92130940|NCT02362308|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92130941|NCT02362308|Hormones|hormones|mesh-ancestor
92130942|NCT02366208|Adefovir|adefovir|mesh-list
92130943|NCT02366208|Thymalfasin|thymalfasin|mesh-list
92130944|NCT02366208|Antiviral Agents|antiviral agents|mesh-ancestor
92130945|NCT02366208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92130946|NCT02366208|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92130947|NCT02366208|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92130948|NCT02366208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130949|NCT02366208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130950|NCT02366208|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92130951|NCT02366208|Immunologic Factors|immunologic factors|mesh-ancestor
92130952|NCT02366208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130953|NCT02373462|Olmesartan|olmesartan|mesh-list
92130954|NCT02373462|Antihypertensive Agents|antihypertensive agents|mesh-list
92130955|NCT02373462|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92130956|NCT02373462|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92130957|NCT02373462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130958|NCT01523587|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92130959|NCT01523587|Afatinib|afatinib|mesh-list
92130960|NCT01523587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92130961|NCT01523587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92130962|NCT01523587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92130963|NCT01523587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130965|NCT00310401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92130966|NCT00310401|Autonomic Agents|autonomic agents|mesh-ancestor
92130967|NCT00310401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92130968|NCT00310401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130969|NCT00310401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92130970|NCT00310401|Respiratory System Agents|respiratory system agents|mesh-ancestor
92130971|NCT00310401|Tocolytic Agents|tocolytic agents|mesh-ancestor
92130973|NCT00310401|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92130974|NCT00310401|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92130975|NCT00310401|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92130976|NCT00310401|Adrenergic Agents|adrenergic agents|mesh-ancestor
92130977|NCT00310401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92130978|NCT00310401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92130979|NCT00310791|Levonorgestrel|levonorgestrel|mesh-list
92130980|NCT00310791|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92130981|NCT00310791|Hormones|hormones|mesh-list
92130982|NCT00310791|Estradiol|estradiol|mesh-list
92130983|NCT00310791|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92130984|NCT00310791|Estrogens|estrogens|mesh-list
92130985|NCT00310791|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92130986|NCT00310791|Progestins|progestins|mesh-list
92130987|NCT00310791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92130988|NCT00310791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92130989|NCT00310791|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92130990|NCT00310791|Contraceptive Agents|contraceptive agents|mesh-ancestor
92130991|NCT00310791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92130992|NCT00310791|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92130993|NCT00310791|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92130994|NCT00310791|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92130995|NCT00310791|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92130996|NCT00310791|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92130997|NCT00310791|Immunologic Factors|immunologic factors|mesh-ancestor
92130998|NCT02362152|Diclofenac|diclofenac|mesh-list
92130999|NCT02362152|Fluorouracil|fluorouracil|mesh-list
92131000|NCT02362152|Imiquimod|imiquimod|mesh-list
92131001|NCT02362152|Antimetabolites|antimetabolites|mesh-ancestor
92131002|NCT02362152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131003|NCT02362152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92131004|NCT02362152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131005|NCT02362152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131006|NCT02362152|Immunologic Factors|immunologic factors|mesh-ancestor
92131007|NCT02362152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131008|NCT02362152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92131009|NCT02362152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131010|NCT02362152|Analgesics|analgesics|mesh-ancestor
92131011|NCT02362152|Sensory System Agents|sensory system agents|mesh-ancestor
92131012|NCT02362152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131013|NCT02362152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131014|NCT02362152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131015|NCT02362152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92131016|NCT02362152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131017|NCT02362152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92131018|NCT02362152|Interferon Inducers|interferon inducers|mesh-ancestor
92131019|NCT01493531|Allopurinol|allopurinol|mesh-list
92131020|NCT01493531|Lesinurad|lesinurad|mesh-list
92131021|NCT01493531|Antimetabolites|antimetabolites|mesh-ancestor
92131022|NCT01493531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131023|NCT01493531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131024|NCT01493531|Gout Suppressants|gout suppressants|mesh-ancestor
92131025|NCT01493531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131026|NCT01493531|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92131027|NCT01493531|Antioxidants|antioxidants|mesh-ancestor
92131028|NCT01493531|Protective Agents|protective agents|mesh-ancestor
92131029|NCT01493531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131030|NCT01493531|Uricosuric Agents|uricosuric agents|mesh-ancestor
92131031|NCT02105415|Ketamine|ketamine|mesh-list
92131032|NCT02105415|Propofol|propofol|mesh-list
92131033|NCT02105415|Etomidate|etomidate|mesh-list
92131034|NCT02105415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92131035|NCT02105415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131036|NCT02105415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131037|NCT02105415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92131038|NCT02105415|Anesthetics, General|anesthetics, general|mesh-ancestor
92131039|NCT02105415|Anesthetics|anesthetics|mesh-ancestor
92131040|NCT02105415|Analgesics|analgesics|mesh-ancestor
92131041|NCT02105415|Sensory System Agents|sensory system agents|mesh-ancestor
92131042|NCT02105415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131043|NCT02105415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92145309|NCT00245037|Cyclosporins|cyclosporins|mesh-list
92131044|NCT02105415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92131045|NCT02105415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92131046|NCT02105415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131047|NCT02105415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131049|NCT01523275|Mitomycin|mitomycin|mesh-list
92131050|NCT01523275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92131051|NCT01523275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131052|NCT01523275|Alkylating Agents|alkylating agents|mesh-ancestor
92131053|NCT01523275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131054|NCT01523275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92131055|NCT01523275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131056|NCT00304707|Bupropion|bupropion|mesh-list
92131057|NCT00304707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92131058|NCT00304707|Antidepressive Agents|antidepressive agents|mesh-ancestor
92131059|NCT00304707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92131060|NCT00304707|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92131061|NCT00304707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92131062|NCT00304707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131063|NCT00304707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131064|NCT00304707|Dopamine Agents|dopamine agents|mesh-ancestor
92131065|NCT00304707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131066|NCT00304707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131067|NCT00304707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92131068|NCT00304707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92131069|NCT00304707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131070|NCT04409483|Ritonavir|ritonavir|mesh-list
92131071|NCT04409483|Lopinavir|lopinavir|mesh-list
92131072|NCT04409483|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92131073|NCT04409483|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92131074|NCT04409483|Protease Inhibitors|protease inhibitors|mesh-ancestor
92131075|NCT04409483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131076|NCT04409483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131077|NCT04409483|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92131078|NCT04409483|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92131079|NCT04409483|Antiviral Agents|antiviral agents|mesh-ancestor
92131080|NCT04409483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131081|NCT04409483|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92131082|NCT04409483|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92131083|NCT02365740|Insulin|insulin|mesh-list
92131084|NCT02365740|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92131085|NCT02365740|Hormones|hormones|mesh-list
92131086|NCT02365740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92131087|NCT02365740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131088|NCT02365740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131089|NCT02437110|Ritonavir|ritonavir|mesh-list
92131090|NCT02437110|Darunavir|darunavir|mesh-list
92131091|NCT02437110|Tenofovir|tenofovir|mesh-list
92131092|NCT02437110|Dolutegravir|dolutegravir|mesh-list
92131093|NCT02437110|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92131094|NCT02437110|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92131095|NCT02437110|Protease Inhibitors|protease inhibitors|mesh-ancestor
92131096|NCT02437110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131097|NCT02437110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131098|NCT02437110|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92131099|NCT02437110|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92131100|NCT02437110|Antiviral Agents|antiviral agents|mesh-ancestor
92131101|NCT02437110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131102|NCT02437110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92131103|NCT02437110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92131104|NCT02437110|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92131105|NCT02437110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92131106|NCT02437110|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92131107|NCT02437110|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92131108|NCT05267847|Anesthetics|anesthetics|mesh-list
92131109|NCT05267847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131110|NCT05267847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131111|NCT05267457|Vanadium|vanadium|mesh-list
91939192|NCT05235542|Irinotecan|irinotecan|mesh-list
92131112|NCT05267457|Trace Elements|trace elements|mesh-ancestor
92131113|NCT05267457|Micronutrients|micronutrients|mesh-ancestor
92131114|NCT05267457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131115|NCT00351039|Bevacizumab|bevacizumab|mesh-list
92131116|NCT00351039|Pemetrexed|pemetrexed|mesh-list
92131117|NCT00351039|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92131118|NCT00351039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131119|NCT00351039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131120|NCT00351039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131121|NCT00351039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131122|NCT00351039|Growth Substances|growth substances|mesh-ancestor
92131123|NCT00351039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131124|NCT00351039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131125|NCT00351039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131126|NCT00351039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131127|NCT00351039|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92131128|NCT00351039|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92131129|NCT00351039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92131130|NCT02373072|Trimethobenzamide|trimethobenzamide|mesh-list
92131131|NCT02373072|Antiemetics|antiemetics|mesh-ancestor
92131132|NCT02373072|Autonomic Agents|autonomic agents|mesh-ancestor
92131133|NCT02373072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131134|NCT02373072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131135|NCT02373072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131137|NCT02372916|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131138|NCT02372916|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131139|NCT02372916|Growth Substances|growth substances|mesh-ancestor
92131140|NCT02372916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131141|NCT02372916|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131142|NCT02372916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131143|NCT02361528|Sargramostim|sargramostim|mesh-list
92131144|NCT02361528|Immunologic Factors|immunologic factors|mesh-ancestor
92131145|NCT02361528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131146|NCT01572727|Paclitaxel|paclitaxel|mesh-list
92131147|NCT01572727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92131148|NCT01572727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131149|NCT01572727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92131150|NCT01572727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92131151|NCT01572727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92131152|NCT01572727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131153|NCT02359266|Vitamin D|vitamin d|mesh-list
92131154|NCT02359266|Cholecalciferol|cholecalciferol|mesh-list
92131155|NCT02359266|Vitamins|vitamins|mesh-ancestor
92131156|NCT02359266|Micronutrients|micronutrients|mesh-ancestor
92131157|NCT02359266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131158|NCT02359266|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92131159|NCT02359266|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92131160|NCT02359500|Octreotide|octreotide|mesh-list
92131161|NCT02359500|Edotreotide|edotreotide|mesh-list
92131162|NCT02359500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131163|NCT02359500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92131164|NCT02359500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131165|NCT02359500|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92131166|NCT02359500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131167|NCT02372526|Orlistat|orlistat|mesh-list
92131168|NCT02372526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131169|NCT02372526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131170|NCT02372526|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92131171|NCT02372526|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92131173|NCT02985697|Dexmedetomidine|dexmedetomidine|mesh-list
92131174|NCT02985697|Nitrous Oxide|nitrous oxide|mesh-list
92131175|NCT02985697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92131176|NCT02985697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131177|NCT02985697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131178|NCT02985697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131179|NCT02985697|Analgesics|analgesics|mesh-ancestor
92131180|NCT02985697|Sensory System Agents|sensory system agents|mesh-ancestor
92131181|NCT02985697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131182|NCT02985697|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92131183|NCT02985697|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92131184|NCT02985697|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92131185|NCT02985697|Adrenergic Agents|adrenergic agents|mesh-ancestor
92131186|NCT02985697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131187|NCT02985697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131188|NCT02985697|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92131189|NCT02985697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92131190|NCT02985697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92131191|NCT02985697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92131192|NCT02985697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92131193|NCT02985697|Anesthetics, General|anesthetics, general|mesh-ancestor
92131197|NCT02985697|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92131198|NCT02372760|Lidocaine|lidocaine|mesh-list
92131199|NCT02372760|Anesthetics|anesthetics|mesh-list
92131200|NCT02372760|Anesthetics, Local|anesthetics, local|mesh-ancestor
92131201|NCT02372760|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131202|NCT02372760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131203|NCT02372760|Sensory System Agents|sensory system agents|mesh-ancestor
92131204|NCT02372760|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131205|NCT02372760|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92131206|NCT02372760|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92131207|NCT02372760|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92131208|NCT02372760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131209|NCT02372760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131210|NCT00352911|Mifepristone|mifepristone|mesh-list
92131211|NCT00352911|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92131212|NCT00352911|Abortifacient Agents|abortifacient agents|mesh-ancestor
92131213|NCT00352911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92131214|NCT00352911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131215|NCT00352911|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92131216|NCT00352911|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92131217|NCT00352911|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92131218|NCT00352911|Contraceptive Agents|contraceptive agents|mesh-ancestor
92131219|NCT00352911|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92131220|NCT00352911|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92131221|NCT00352911|Hormone Antagonists|hormone antagonists|mesh-ancestor
92131222|NCT00352911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131223|NCT00352911|Luteolytic Agents|luteolytic agents|mesh-ancestor
92131224|NCT00352911|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92131225|NCT00352911|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92131226|NCT00353301|Sirolimus|sirolimus|mesh-list
92131227|NCT00353301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92131228|NCT00353301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131229|NCT00353301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92131230|NCT00353301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131231|NCT00353301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131232|NCT00353301|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92131233|NCT00353301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131234|NCT00353301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92131235|NCT00353301|Antifungal Agents|antifungal agents|mesh-ancestor
92131236|NCT00353301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131237|NCT00353301|Immunologic Factors|immunologic factors|mesh-ancestor
92131238|NCT00353301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131239|NCT02372604|Cetirizine|cetirizine|mesh-list
92131240|NCT02372604|Levocetirizine|levocetirizine|mesh-list
92131241|NCT02372604|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92131242|NCT02372604|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92131243|NCT02372604|Histamine Antagonists|histamine antagonists|mesh-ancestor
92131244|NCT02372604|Histamine Agents|histamine agents|mesh-ancestor
92131245|NCT02372604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131246|NCT02372604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131247|NCT02372604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131248|NCT02372604|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92131249|NCT01792323|Insulin Lispro|insulin lispro|mesh-list
92131250|NCT01792323|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92131251|NCT01792323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131252|NCT02358642|Lisinopril|lisinopril|mesh-list
92131253|NCT02358642|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92131254|NCT02358642|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92131255|NCT02358642|Protease Inhibitors|protease inhibitors|mesh-ancestor
92131256|NCT02358642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131257|NCT02358642|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92131258|NCT02358642|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92131259|NCT02358642|Protective Agents|protective agents|mesh-ancestor
92131260|NCT02358642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131261|NCT03160248|Apremilast|apremilast|mesh-list
92131262|NCT03160248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92131263|NCT03160248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131264|NCT03160248|Analgesics|analgesics|mesh-ancestor
92131265|NCT03160248|Sensory System Agents|sensory system agents|mesh-ancestor
92131266|NCT03160248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131267|NCT03160248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131268|NCT03160248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131269|NCT03160248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131270|NCT03160248|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92131271|NCT03160248|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92131272|NCT03160248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131273|NCT03160248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131275|NCT01522651|Ranolazine|ranolazine|mesh-list
92131276|NCT01522651|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92131277|NCT01522651|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131278|NCT01522651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131279|NCT01522651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92131280|NCT02372292|Furosemide|furosemide|mesh-list
92131281|NCT02372292|Diuretics|diuretics|mesh-ancestor
92131282|NCT02372292|Natriuretic Agents|natriuretic agents|mesh-ancestor
92131283|NCT02372292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131284|NCT02372292|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92131285|NCT02372292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131286|NCT02372292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131287|NCT01554241|Vitamin D|vitamin d|mesh-list
92131288|NCT01554241|Cholecalciferol|cholecalciferol|mesh-list
92131289|NCT01554241|Vitamins|vitamins|mesh-ancestor
92131290|NCT01554241|Micronutrients|micronutrients|mesh-ancestor
92131291|NCT01554241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131292|NCT01554241|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92131293|NCT01554241|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92131294|NCT02353026|Artesunate|artesunate|mesh-list
92131295|NCT02353026|Antimalarials|antimalarials|mesh-ancestor
92131296|NCT02353026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92131297|NCT02353026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92131298|NCT02353026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131299|NCT02353026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131300|NCT02353026|Antiviral Agents|antiviral agents|mesh-ancestor
92131301|NCT02353026|Schistosomicides|schistosomicides|mesh-ancestor
92131302|NCT02353026|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92131303|NCT02353026|Anthelmintics|anthelmintics|mesh-ancestor
92131304|NCT01521559|Aflibercept|aflibercept|mesh-list
92131305|NCT01521559|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131306|NCT01521559|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131307|NCT01521559|Growth Substances|growth substances|mesh-ancestor
92131308|NCT01521559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131309|NCT01521559|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131310|NCT01521559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131311|NCT04438980|Methylprednisolone|methylprednisolone|mesh-list
92131312|NCT04438980|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92131313|NCT04438980|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92131314|NCT04438980|Prednisolone|prednisolone|mesh-list
92131315|NCT04438980|Prednisolone acetate|prednisolone acetate|mesh-list
92131316|NCT04438980|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92131317|NCT04438980|Prednisolone phosphate|prednisolone phosphate|mesh-list
92131318|NCT04438980|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131319|NCT04438980|Antiemetics|antiemetics|mesh-ancestor
92131320|NCT04438980|Autonomic Agents|autonomic agents|mesh-ancestor
92131321|NCT04438980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131322|NCT04438980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131323|NCT04438980|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131325|NCT04438980|Hormones|hormones|mesh-ancestor
92131326|NCT04438980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131327|NCT04438980|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92131328|NCT04438980|Protective Agents|protective agents|mesh-ancestor
92131329|NCT04438980|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92131330|NCT04438980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131331|NCT03824847|Clarithromycin|clarithromycin|mesh-list
92131332|NCT03824847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92131333|NCT03824847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131334|NCT03824847|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92131335|NCT03824847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131336|NCT03824847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131337|NCT03824847|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92131338|NCT03824847|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92131339|NCT01554163|Celecoxib|celecoxib|mesh-list
92131340|NCT01554163|Etoricoxib|etoricoxib|mesh-list
92131341|NCT01554163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92131342|NCT01554163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131343|NCT01554163|Analgesics|analgesics|mesh-ancestor
92131344|NCT01554163|Sensory System Agents|sensory system agents|mesh-ancestor
92131345|NCT01554163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131346|NCT01554163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131347|NCT01554163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131348|NCT01554163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131349|NCT01554163|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92131350|NCT01554163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92131351|NCT01554163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131352|NCT01554163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131353|NCT02360826|Simvastatin|simvastatin|mesh-list
92131354|NCT02360826|Pravastatin|pravastatin|mesh-list
92131355|NCT02360826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92131356|NCT02360826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92131357|NCT02360826|Antimetabolites|antimetabolites|mesh-ancestor
92131358|NCT02360826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131359|NCT02360826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92131360|NCT02360826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92131361|NCT02360826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131362|NCT02361060|Atropine|atropine|mesh-list
92131363|NCT02361060|Neostigmine|neostigmine|mesh-list
92131364|NCT02361060|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92131365|NCT02361060|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92131366|NCT02361060|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92131367|NCT02361060|Autonomic Agents|autonomic agents|mesh-ancestor
92131368|NCT02361060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131369|NCT02361060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131370|NCT02361060|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92131371|NCT02361060|Respiratory System Agents|respiratory system agents|mesh-ancestor
92131372|NCT02361060|Mydriatics|mydriatics|mesh-ancestor
92131373|NCT02361060|Parasympatholytics|parasympatholytics|mesh-ancestor
92131374|NCT02361060|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92131375|NCT02361060|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92131376|NCT02361060|Cholinergic Agents|cholinergic agents|mesh-ancestor
92131377|NCT02361060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131378|NCT02361060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131379|NCT02361060|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92131380|NCT02361060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131381|NCT02361060|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92131382|NCT02360982|Fentanyl|fentanyl|mesh-list
92131383|NCT02360982|Propofol|propofol|mesh-list
92131384|NCT02360982|Bupivacaine|bupivacaine|mesh-list
92131385|NCT02360982|Rocuronium|rocuronium|mesh-list
92131386|NCT02360982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92131387|NCT02360982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131388|NCT02360982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131389|NCT02360982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92131390|NCT02360982|Anesthetics, General|anesthetics, general|mesh-ancestor
92131391|NCT02360982|Anesthetics|anesthetics|mesh-ancestor
92131392|NCT02360982|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92131393|NCT02360982|Narcotics|narcotics|mesh-ancestor
92131394|NCT02360982|Analgesics|analgesics|mesh-ancestor
92131395|NCT02360982|Sensory System Agents|sensory system agents|mesh-ancestor
92131396|NCT02360982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131398|NCT02360982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92131399|NCT02360982|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92131400|NCT02360982|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92131401|NCT02360982|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92131402|NCT03786237|ON 01910|on 01910|mesh-list
92131403|NCT03786237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131404|NCT03786237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92131405|NCT03786237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131406|NCT03786237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131407|NCT01553851|Trametinib|trametinib|mesh-list
92131408|NCT01553851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131409|NCT01553851|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92131410|NCT01553851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131411|NCT01553851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131412|NCT02358018|Edotreotide|edotreotide|mesh-list
92131413|NCT02358018|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92131414|NCT02358018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089642|NCT01363349|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92131415|NCT01552915|Methylphenidate|methylphenidate|mesh-list
92131416|NCT01552915|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92131417|NCT01552915|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92131418|NCT01552915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131419|NCT01552915|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92131420|NCT01552915|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92131421|NCT01552915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131422|NCT01552915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131423|NCT01552915|Dopamine Agents|dopamine agents|mesh-ancestor
92131424|NCT01552915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131425|NCT02352714|Lidocaine|lidocaine|mesh-list
92131426|NCT02352714|Anesthetics, Local|anesthetics, local|mesh-ancestor
92131427|NCT02352714|Anesthetics|anesthetics|mesh-ancestor
92131428|NCT02352714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131429|NCT02352714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131430|NCT02352714|Sensory System Agents|sensory system agents|mesh-ancestor
92131431|NCT02352714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131432|NCT02352714|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92131433|NCT02352714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92131434|NCT02352714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92131435|NCT02352714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131436|NCT02352714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131437|NCT03911557|Durvalumab|durvalumab|mesh-list
92131438|NCT03911557|Tremelimumab|tremelimumab|mesh-list
92131439|NCT03911557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131440|NCT03911557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131441|NCT00356031|Bevacizumab|bevacizumab|mesh-list
92131442|NCT00356031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131443|NCT00356031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131444|NCT00356031|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131445|NCT00356031|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131446|NCT00356031|Growth Substances|growth substances|mesh-ancestor
92131447|NCT00356031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131448|NCT00356031|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131449|NCT02038842|Vaccines|vaccines|mesh-list
92131450|NCT02038842|Immunologic Factors|immunologic factors|mesh-ancestor
92131451|NCT02038842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131452|NCT01790139|Simethicone|simethicone|mesh-list
92131453|NCT01790139|Antifoaming Agents|antifoaming agents|mesh-ancestor
92131454|NCT01790139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131455|NCT01790139|Emollients|emollients|mesh-ancestor
92131456|NCT01790139|Dermatologic Agents|dermatologic agents|mesh-ancestor
92131457|NCT02360592|Interferons|interferons|mesh-list
92131458|NCT02360592|Interferon-alpha|interferon-alpha|mesh-list
92131459|NCT02360592|Interferon alpha-2|interferon alpha-2|mesh-list
92131460|NCT02360592|Entecavir|entecavir|mesh-list
92131461|NCT02360592|Interleukin-2|interleukin-2|mesh-list
92131462|NCT02360592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131463|NCT02360592|Antiviral Agents|antiviral agents|mesh-ancestor
92131464|NCT02360592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131465|NCT02360592|Immunologic Factors|immunologic factors|mesh-ancestor
92131466|NCT02360592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131467|NCT02360592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131468|NCT02360592|Analgesics|analgesics|mesh-ancestor
92131469|NCT02360592|Sensory System Agents|sensory system agents|mesh-ancestor
92131470|NCT02360592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131471|NCT02360202|Clobetasol|clobetasol|mesh-list
92131472|NCT02360202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131473|NCT02360202|Glucocorticoids|glucocorticoids|mesh-ancestor
92131474|NCT02360202|Hormones|hormones|mesh-ancestor
92131475|NCT02360202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131476|NCT02360202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131477|NCT00322101|Cyclosporine|cyclosporine|mesh-list
92131478|NCT00322101|Mycophenolic Acid|mycophenolic acid|mesh-list
92131479|NCT00322101|Cyclophosphamide|cyclophosphamide|mesh-list
92131480|NCT00322101|Busulfan|busulfan|mesh-list
92131481|NCT00322101|Methotrexate|methotrexate|mesh-list
92131482|NCT00322101|Fludarabine|fludarabine|mesh-list
92131483|NCT00322101|Fludarabine phosphate|fludarabine phosphate|mesh-list
92131484|NCT00322101|Tacrolimus|tacrolimus|mesh-list
92131485|NCT00322101|Cyclosporins|cyclosporins|mesh-list
92131486|NCT00322101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131487|NCT00322101|Immunologic Factors|immunologic factors|mesh-ancestor
92131488|NCT00322101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131489|NCT00322101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131490|NCT00322101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92089715|NCT01692301|Vasodilator Agents|vasodilator agents|mesh-ancestor
92131491|NCT00322101|Alkylating Agents|alkylating agents|mesh-ancestor
92131492|NCT00322101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131493|NCT00322101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131494|NCT00322101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92131495|NCT00322101|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92131496|NCT00322101|Abortifacient Agents|abortifacient agents|mesh-ancestor
92131497|NCT00322101|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92131498|NCT00322101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92131499|NCT00322101|Antimetabolites|antimetabolites|mesh-ancestor
92131500|NCT00322101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92131501|NCT00322101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131502|NCT00322101|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92131503|NCT00322101|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92131504|NCT00322101|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92131505|NCT00322101|Antifungal Agents|antifungal agents|mesh-ancestor
92131506|NCT00322101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131507|NCT00322101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92131508|NCT00322101|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92131509|NCT00322101|Antitubercular Agents|antitubercular agents|mesh-ancestor
92131510|NCT00322101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92131511|NCT02360046|Hydrocortisone|hydrocortisone|mesh-list
92131512|NCT02360046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131513|NCT01552681|Immunoglobulins|immunoglobulins|mesh-list
92131514|NCT01552681|Immunologic Factors|immunologic factors|mesh-ancestor
92131515|NCT01552681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131516|NCT02352402|Ticagrelor|ticagrelor|mesh-list
92131517|NCT02352402|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92131518|NCT02352402|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92131519|NCT02352402|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92131520|NCT02352402|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92131521|NCT02352402|Purinergic Agents|purinergic agents|mesh-ancestor
92131522|NCT02352402|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131523|NCT02352402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131524|NCT02352402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131525|NCT02357472|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92131526|NCT02357472|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92131527|NCT02357472|Immunologic Factors|immunologic factors|mesh-ancestor
92131528|NCT02357472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131529|NCT00322335|PENTA|penta|mesh-list
92131530|NCT00322335|Anticoagulants|anticoagulants|mesh-ancestor
92131531|NCT00322335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92131532|NCT00322335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92131533|NCT00322335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131534|NCT03153852|Glycolic acid|glycolic acid|mesh-list
92131535|NCT03153852|Keratolytic Agents|keratolytic agents|mesh-ancestor
92131536|NCT03153852|Dermatologic Agents|dermatologic agents|mesh-ancestor
92131537|NCT04751175|Dexamethasone|dexamethasone|mesh-list
92131538|NCT04751175|Ketamine|ketamine|mesh-list
92131539|NCT04751175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131540|NCT04751175|Antiemetics|antiemetics|mesh-ancestor
92131541|NCT04751175|Autonomic Agents|autonomic agents|mesh-ancestor
92131542|NCT04751175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131543|NCT04751175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131544|NCT04751175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131545|NCT04751175|Glucocorticoids|glucocorticoids|mesh-ancestor
92131546|NCT04751175|Hormones|hormones|mesh-ancestor
92131547|NCT04751175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131548|NCT04751175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92131549|NCT04751175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131550|NCT04751175|Analgesics|analgesics|mesh-ancestor
92131551|NCT04751175|Sensory System Agents|sensory system agents|mesh-ancestor
92131552|NCT04751175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92131553|NCT04751175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92131554|NCT04751175|Anesthetics, General|anesthetics, general|mesh-ancestor
92131555|NCT04751175|Anesthetics|anesthetics|mesh-ancestor
92131556|NCT04751175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131557|NCT04751175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92131558|NCT04751175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92131559|NCT04751175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131560|NCT04751175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131561|NCT01792557|Phenol|phenol|mesh-list
92131562|NCT01792557|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92131563|NCT01792557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131564|NCT01792557|Disinfectants|disinfectants|mesh-ancestor
92131565|NCT01792557|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92131566|NCT01792557|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92131567|NCT01792713|Sertaconazole|sertaconazole|mesh-list
92131568|NCT01792713|Antifungal Agents|antifungal agents|mesh-ancestor
92131569|NCT01792713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131570|NCT02352168|Budesonide|budesonide|mesh-list
92131571|NCT02352168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131572|NCT02352168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92131573|NCT02352168|Autonomic Agents|autonomic agents|mesh-ancestor
92131574|NCT02352168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131575|NCT02352168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131576|NCT02352168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92131577|NCT02352168|Respiratory System Agents|respiratory system agents|mesh-ancestor
92131578|NCT02352168|Glucocorticoids|glucocorticoids|mesh-ancestor
92131580|NCT02352168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131581|NCT02357004|Carvedilol|carvedilol|mesh-list
92131582|NCT02357004|Chlorthalidone|chlorthalidone|mesh-list
92131583|NCT02357004|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92131584|NCT02357004|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92131585|NCT02357004|Adrenergic Agents|adrenergic agents|mesh-ancestor
92131586|NCT02357004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131587|NCT02357004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131588|NCT02357004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131589|NCT02357004|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92131590|NCT02357004|Antioxidants|antioxidants|mesh-ancestor
92131591|NCT02357004|Protective Agents|protective agents|mesh-ancestor
92131592|NCT02357004|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92131593|NCT02357004|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131594|NCT02357004|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92131595|NCT02357004|Vasodilator Agents|vasodilator agents|mesh-ancestor
92131596|NCT02357004|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92131597|NCT02357004|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92131598|NCT02357004|Diuretics|diuretics|mesh-ancestor
92131599|NCT02357004|Natriuretic Agents|natriuretic agents|mesh-ancestor
92131600|NCT02357004|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92131601|NCT01570387|Dexamethasone|dexamethasone|mesh-list
92131602|NCT01570387|Dexamethasone acetate|dexamethasone acetate|mesh-list
92131603|NCT01570387|Pomalidomide|pomalidomide|mesh-list
92131604|NCT01570387|BB 1101|bb 1101|mesh-list
92131605|NCT01570387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131606|NCT01570387|Antiemetics|antiemetics|mesh-ancestor
92131607|NCT01570387|Autonomic Agents|autonomic agents|mesh-ancestor
92131608|NCT01570387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131609|NCT01570387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131610|NCT01570387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131611|NCT01570387|Glucocorticoids|glucocorticoids|mesh-ancestor
92131612|NCT01570387|Hormones|hormones|mesh-ancestor
92131613|NCT01570387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131614|NCT01570387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92131615|NCT01570387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131616|NCT01570387|Protease Inhibitors|protease inhibitors|mesh-ancestor
92131617|NCT01570387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131618|NCT01570387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131619|NCT01570387|Immunologic Factors|immunologic factors|mesh-ancestor
92131620|NCT01570387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131621|NCT01570387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131622|NCT01570387|Growth Substances|growth substances|mesh-ancestor
92131623|NCT01570387|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131624|NCT02348424|Solithromycin|solithromycin|mesh-list
92131625|NCT02348424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92131626|NCT02348424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131627|NCT01570309|Ergocalciferols|ergocalciferols|mesh-list
92131628|NCT01570309|Vitamin D|vitamin d|mesh-list
92131629|NCT01570309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92131630|NCT01570309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131631|NCT01570309|Vitamins|vitamins|mesh-ancestor
92131632|NCT01570309|Micronutrients|micronutrients|mesh-ancestor
92131633|NCT01570309|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92131634|NCT02356146|Tacrolimus|tacrolimus|mesh-list
92131635|NCT02356146|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131636|NCT02356146|Immunologic Factors|immunologic factors|mesh-ancestor
92131637|NCT02356146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131638|NCT02356146|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92131639|NCT02356146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131640|NCT02356146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131641|NCT01519921|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92131642|NCT01519921|Antiviral Agents|antiviral agents|mesh-ancestor
92131643|NCT01519921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131644|NCT01519765|Misoprostol|misoprostol|mesh-list
92131645|NCT01519765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92131646|NCT01519765|Abortifacient Agents|abortifacient agents|mesh-ancestor
92131647|NCT01519765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92131648|NCT01519765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131649|NCT01519765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92131650|NCT01519765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131651|NCT01519765|Oxytocics|oxytocics|mesh-ancestor
92131652|NCT03147066|Flurbiprofen|flurbiprofen|mesh-list
92131653|NCT03147066|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92131654|NCT03147066|Dezocine|dezocine|mesh-list
92131655|NCT03147066|Analgesics|analgesics|mesh-ancestor
92131656|NCT03147066|Sensory System Agents|sensory system agents|mesh-ancestor
92131657|NCT03147066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131658|NCT03147066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131659|NCT03147066|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92131660|NCT03147066|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131661|NCT03147066|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131662|NCT03147066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131663|NCT03147066|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92131664|NCT03147066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131665|NCT03147066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131666|NCT03147066|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92131667|NCT03147066|Narcotics|narcotics|mesh-ancestor
92131668|NCT03147066|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131669|NCT02351622|Dexamethasone|dexamethasone|mesh-list
92131670|NCT02351622|Caffeic acid|caffeic acid|mesh-list
92131671|NCT02351622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131672|NCT02351622|Antiemetics|antiemetics|mesh-ancestor
92131673|NCT02351622|Autonomic Agents|autonomic agents|mesh-ancestor
92131674|NCT02351622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131675|NCT02351622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131676|NCT02351622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131677|NCT02351622|Glucocorticoids|glucocorticoids|mesh-ancestor
92131678|NCT02351622|Hormones|hormones|mesh-ancestor
92131679|NCT02351622|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131680|NCT02351622|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92131681|NCT02351622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131682|NCT02351622|Antioxidants|antioxidants|mesh-ancestor
92131683|NCT02351622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131684|NCT02351622|Protective Agents|protective agents|mesh-ancestor
92131685|NCT01552603|Pancrelipase|pancrelipase|mesh-list
92131686|NCT01552603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131687|NCT02348190|Heparin|heparin|mesh-list
92131688|NCT02348190|Anticoagulants|anticoagulants|mesh-ancestor
92131689|NCT02348190|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92131690|NCT02348190|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92131691|NCT02348190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131692|NCT01552369|Valganciclovir|valganciclovir|mesh-list
92131693|NCT01552369|Antiviral Agents|antiviral agents|mesh-ancestor
92131694|NCT01552369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131695|NCT02351232|Liraglutide|liraglutide|mesh-list
92131696|NCT02351232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92131697|NCT02351232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131698|NCT02351232|Incretins|incretins|mesh-ancestor
92131699|NCT02351232|Hormones|hormones|mesh-ancestor
92131700|NCT02351232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131701|NCT02355756|Maxadilan protein, insect|maxadilan protein, insect|mesh-list
92131702|NCT02355756|Vasodilator Agents|vasodilator agents|mesh-ancestor
92131703|NCT03150030|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92131704|NCT03150030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131705|NCT02355678|Acetaminophen|acetaminophen|mesh-list
92131706|NCT02355678|Dexamethasone|dexamethasone|mesh-list
92131707|NCT02355678|Propacetamol|propacetamol|mesh-list
92131708|NCT02355678|Tramadol|tramadol|mesh-list
92131709|NCT02355678|Anesthetics|anesthetics|mesh-list
92131710|NCT02355678|Anesthetics, Local|anesthetics, local|mesh-list
92131711|NCT02355678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131713|NCT02355678|Autonomic Agents|autonomic agents|mesh-ancestor
92131714|NCT02355678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131715|NCT02355678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131716|NCT02355678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131717|NCT02355678|Glucocorticoids|glucocorticoids|mesh-ancestor
92131718|NCT02355678|Hormones|hormones|mesh-ancestor
92131719|NCT02355678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131720|NCT02355678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92131721|NCT02355678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131722|NCT02355678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131723|NCT02355678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131724|NCT02355678|Analgesics|analgesics|mesh-ancestor
92131725|NCT02355678|Sensory System Agents|sensory system agents|mesh-ancestor
92131726|NCT02355678|Antipyretics|antipyretics|mesh-ancestor
92131727|NCT02355678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92131728|NCT02355678|Narcotics|narcotics|mesh-ancestor
92131729|NCT02355678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92131730|NCT02355678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131731|NCT02351310|Betamethasone|betamethasone|mesh-list
92131732|NCT02351310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131733|NCT02351310|Glucocorticoids|glucocorticoids|mesh-ancestor
92131734|NCT02351310|Hormones|hormones|mesh-ancestor
92131735|NCT02351310|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131736|NCT02351310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131737|NCT02351310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92131738|NCT02351310|Respiratory System Agents|respiratory system agents|mesh-ancestor
92131740|NCT02347878|Antiemetics|antiemetics|mesh-ancestor
92131741|NCT02347878|Autonomic Agents|autonomic agents|mesh-ancestor
92131742|NCT02347878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131743|NCT02347878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131744|NCT02347878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131745|NCT02347878|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92131746|NCT02347878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131747|NCT02347878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131748|NCT02355522|Lidocaine|lidocaine|mesh-list
92131749|NCT02355522|Anesthetics, Local|anesthetics, local|mesh-ancestor
92131750|NCT02355522|Anesthetics|anesthetics|mesh-ancestor
92131751|NCT02355522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131752|NCT02355522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131753|NCT02355522|Sensory System Agents|sensory system agents|mesh-ancestor
92131754|NCT02355522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131755|NCT02355522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92131756|NCT02355522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92131757|NCT02355522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92131758|NCT02355522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131759|NCT02355522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131760|NCT02355054|Choline|choline|mesh-list
92131761|NCT02355054|Lipotropic Agents|lipotropic agents|mesh-ancestor
92131762|NCT02355054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92131763|NCT02355054|Antimetabolites|antimetabolites|mesh-ancestor
92131764|NCT02355054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131765|NCT02355054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92131766|NCT02355054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92131767|NCT02355054|Nootropic Agents|nootropic agents|mesh-ancestor
92131768|NCT04478448|Favipiravir|favipiravir|mesh-list
92131769|NCT04478448|Antiviral Agents|antiviral agents|mesh-ancestor
92131770|NCT04478448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131771|NCT04478526|Norepinephrine|norepinephrine|mesh-list
92131772|NCT04478526|Serotonin|serotonin|mesh-list
92131773|NCT04478526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92131774|NCT04478526|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-list
92131775|NCT04478526|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92131776|NCT04478526|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92131777|NCT04478526|Adrenergic Agents|adrenergic agents|mesh-ancestor
92131778|NCT04478526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131779|NCT04478526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131780|NCT04478526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131781|NCT04478526|Sympathomimetics|sympathomimetics|mesh-ancestor
92131782|NCT04478526|Autonomic Agents|autonomic agents|mesh-ancestor
92131783|NCT04478526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131784|NCT04478526|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92131785|NCT04478526|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92131786|NCT04478526|Serotonin Agents|serotonin agents|mesh-ancestor
92131787|NCT04478526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92131788|NCT04478526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131789|NCT01552057|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92131790|NCT01552057|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92131791|NCT01552057|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92131792|NCT01552057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92131793|NCT01552057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131794|NCT01552057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131795|NCT01552057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131796|NCT01552057|Analgesics|analgesics|mesh-ancestor
92131797|NCT01552057|Sensory System Agents|sensory system agents|mesh-ancestor
92131798|NCT01552057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131799|NCT01552057|Antidepressive Agents|antidepressive agents|mesh-ancestor
92131800|NCT01552057|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92131801|NCT01552057|Dopamine Agents|dopamine agents|mesh-ancestor
92131804|NCT02350686|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92131805|NCT02350686|Antimetabolites|antimetabolites|mesh-ancestor
92131806|NCT02350686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131807|NCT02350686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131808|NCT03159078|Imipenem|imipenem|mesh-list
92131809|NCT03159078|Polymyxins|polymyxins|mesh-list
92131810|NCT03159078|Polymyxin B|polymyxin b|mesh-list
92131811|NCT03159078|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92131812|NCT03159078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131813|NCT01551745|Bevacizumab|bevacizumab|mesh-list
92131814|NCT01551745|Vaccines|vaccines|mesh-list
92131815|NCT01551745|Immunologic Factors|immunologic factors|mesh-ancestor
92131816|NCT01551745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131817|NCT01551745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131818|NCT01551745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131819|NCT01551745|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131820|NCT01551745|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131821|NCT01551745|Growth Substances|growth substances|mesh-ancestor
92131822|NCT01551745|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131823|NCT02350530|Bevacizumab|bevacizumab|mesh-list
92131824|NCT02350530|Fluorouracil|fluorouracil|mesh-list
92131825|NCT02350530|Oxaliplatin|oxaliplatin|mesh-list
92131826|NCT02350530|Irinotecan|irinotecan|mesh-list
92131827|NCT02350530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131828|NCT02350530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131829|NCT02350530|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131830|NCT02350530|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131831|NCT02350530|Growth Substances|growth substances|mesh-ancestor
92131832|NCT02350530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131833|NCT02350530|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131834|NCT02350530|Antimetabolites|antimetabolites|mesh-ancestor
92131835|NCT02350530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131836|NCT02350530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92131837|NCT02350530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131838|NCT02350530|Immunologic Factors|immunologic factors|mesh-ancestor
92131839|NCT02350530|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92131840|NCT02350530|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92131841|NCT02350530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131842|NCT01569841|Insulin|insulin|mesh-list
92131843|NCT01569841|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92131844|NCT01569841|Insulin Glargine|insulin glargine|mesh-list
92131845|NCT01569841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92131846|NCT01569841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131847|NCT01550965|Adalimumab|adalimumab|mesh-list
92131848|NCT01550965|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92131849|NCT01550965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131850|NCT01550965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92131851|NCT05265819|Hormones|hormones|mesh-list
92131852|NCT05265819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131853|NCT05265819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131854|NCT02353494|Piperaquine|piperaquine|mesh-list
92131856|NCT02353494|Antimalarials|antimalarials|mesh-ancestor
92131857|NCT02353494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92131858|NCT02353494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92131859|NCT02353494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131860|NCT02353260|Docetaxel|docetaxel|mesh-list
92131861|NCT02353260|Fluorouracil|fluorouracil|mesh-list
92131862|NCT02353260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131863|NCT02353260|Tubulin Modulators|tubulin modulators|mesh-ancestor
92131864|NCT02353260|Antimitotic Agents|antimitotic agents|mesh-ancestor
92131865|NCT02353260|Mitosis Modulators|mitosis modulators|mesh-ancestor
92131866|NCT02353260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131867|NCT02353260|Antimetabolites|antimetabolites|mesh-ancestor
92131868|NCT02353260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92131869|NCT02353260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131870|NCT02353260|Immunologic Factors|immunologic factors|mesh-ancestor
92131871|NCT02353260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131872|NCT03158610|Capecitabine|capecitabine|mesh-list
92131873|NCT03158610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92131875|NCT03158610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131876|NCT03158610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131877|NCT00323739|Bevacizumab|bevacizumab|mesh-list
92131878|NCT00323739|Everolimus|everolimus|mesh-list
92131879|NCT00323739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92131880|NCT00323739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131881|NCT00323739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131882|NCT00323739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131884|NCT00323739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131885|NCT00323739|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131887|NCT00323739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92131888|NCT00323739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131889|NCT00323739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131890|NCT00323739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92131891|NCT00323739|Immunologic Factors|immunologic factors|mesh-ancestor
92131892|NCT02350218|Alprostadil|alprostadil|mesh-list
92131893|NCT02350218|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92131894|NCT02350218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92131895|NCT02350218|Urological Agents|urological agents|mesh-ancestor
92131896|NCT00390429|Docetaxel|docetaxel|mesh-list
92131897|NCT00390429|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92131898|NCT00390429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131899|NCT00390429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92131900|NCT00390429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92131901|NCT00390429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92131902|NCT00390429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131903|NCT00390429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92131904|NCT00390429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92131905|NCT02349828|Acyclovir|acyclovir|mesh-list
92131906|NCT02349828|Antiviral Agents|antiviral agents|mesh-ancestor
92131907|NCT02349828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131908|NCT02353182|Dexmedetomidine|dexmedetomidine|mesh-list
92131909|NCT02353182|Remifentanil|remifentanil|mesh-list
92131910|NCT02353182|Bupivacaine|bupivacaine|mesh-list
92131911|NCT02353182|Ropivacaine|ropivacaine|mesh-list
92131912|NCT02353182|Anesthetics, Local|anesthetics, local|mesh-ancestor
92131913|NCT02353182|Anesthetics|anesthetics|mesh-ancestor
92131914|NCT02353182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131915|NCT02353182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131916|NCT02353182|Sensory System Agents|sensory system agents|mesh-ancestor
92131917|NCT02353182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131918|NCT02353182|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92131919|NCT02353182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92131920|NCT02353182|Analgesics|analgesics|mesh-ancestor
92131921|NCT02353182|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92131922|NCT02353182|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92131923|NCT02353182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92131924|NCT02353182|Adrenergic Agents|adrenergic agents|mesh-ancestor
92131925|NCT02353182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92131926|NCT02353182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131927|NCT02353182|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92131928|NCT02353182|Narcotics|narcotics|mesh-ancestor
92131929|NCT02349516|Squalamine|squalamine|mesh-list
92131930|NCT02349516|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92131931|NCT02349516|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92131932|NCT02349516|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92131933|NCT02349516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131934|NCT02349516|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92131935|NCT02349516|Protective Agents|protective agents|mesh-ancestor
92131936|NCT02349516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131937|NCT02349516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92131938|NCT02349516|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92131939|NCT02349516|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92131940|NCT02349516|Growth Substances|growth substances|mesh-ancestor
92131941|NCT02349516|Growth Inhibitors|growth inhibitors|mesh-ancestor
92131942|NCT02349594|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92131943|NCT02349594|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92131944|NCT02349594|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92131945|NCT02349594|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92131946|NCT02346084|Maraviroc|maraviroc|mesh-list
92131947|NCT02346084|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92131948|NCT02346084|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92090169|NCT01910519|Vaccines|vaccines|mesh-list
92131949|NCT02346084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131950|NCT02346084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92131951|NCT02346084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92131952|NCT02346084|Antiviral Agents|antiviral agents|mesh-ancestor
92131953|NCT02346084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92131954|NCT02346084|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92131955|NCT03149250|Hemostatics|hemostatics|mesh-list
92131956|NCT03149250|Coagulants|coagulants|mesh-ancestor
92131957|NCT00391443|Bosentan|bosentan|mesh-list
92131958|NCT00391443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92131959|NCT00391443|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92145310|NCT00245037|Lenograstim|lenograstim|mesh-list
92131960|NCT00391443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131961|NCT02343432|Triamcinolone|triamcinolone|mesh-list
92131962|NCT02343432|Bupivacaine|bupivacaine|mesh-list
92131963|NCT02343432|Anesthetics, Local|anesthetics, local|mesh-ancestor
92131964|NCT02343432|Anesthetics|anesthetics|mesh-ancestor
92131965|NCT02343432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131966|NCT02343432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131967|NCT02343432|Sensory System Agents|sensory system agents|mesh-ancestor
92131968|NCT02343432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131969|NCT02343432|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92131970|NCT02343432|Glucocorticoids|glucocorticoids|mesh-ancestor
92131971|NCT02343432|Hormones|hormones|mesh-ancestor
92131972|NCT02343432|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92131973|NCT02349282|Vitamin D|vitamin d|mesh-list
92131974|NCT02349282|Cholecalciferol|cholecalciferol|mesh-list
92131975|NCT02349282|Calcifediol|calcifediol|mesh-list
92131976|NCT02349282|Vitamins|vitamins|mesh-ancestor
92131977|NCT02349282|Micronutrients|micronutrients|mesh-ancestor
92131978|NCT02349282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131979|NCT02349282|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92131980|NCT02349282|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92131981|NCT02349204|Zaleplon|zaleplon|mesh-list
92131982|NCT02349204|Anticonvulsants|anticonvulsants|mesh-ancestor
92131983|NCT02349204|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92131984|NCT02349204|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92131985|NCT02349204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131986|NCT02349204|GABA Modulators|gaba modulators|mesh-ancestor
92131987|NCT02349204|GABA Agents|gaba agents|mesh-ancestor
92131988|NCT02349204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939217|NCT00838799|Analgesics|analgesics|mesh-ancestor
92131989|NCT02349204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92131990|NCT02345616|Nitric Oxide|nitric oxide|mesh-list
92131991|NCT02345616|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92131992|NCT02345616|Autonomic Agents|autonomic agents|mesh-ancestor
92131993|NCT02345616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92131994|NCT02345616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92131995|NCT02345616|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92131996|NCT02345616|Respiratory System Agents|respiratory system agents|mesh-ancestor
92131997|NCT02345616|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92131998|NCT02345616|Antioxidants|antioxidants|mesh-ancestor
92131999|NCT02345616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132000|NCT02345616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132001|NCT02345616|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92132002|NCT02345616|Vasodilator Agents|vasodilator agents|mesh-ancestor
92132003|NCT02345616|Gasotransmitters|gasotransmitters|mesh-ancestor
92132004|NCT02345616|Protective Agents|protective agents|mesh-ancestor
92132005|NCT00391989|Dasatinib|dasatinib|mesh-list
92132006|NCT00391989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132007|NCT00391989|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92132008|NCT00391989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132009|NCT00391989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132011|NCT03148704|Antiemetics|antiemetics|mesh-ancestor
92132012|NCT03148704|Autonomic Agents|autonomic agents|mesh-ancestor
92132013|NCT03148704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132014|NCT03148704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132015|NCT03148704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132016|NCT03148704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92132017|NCT03148704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92132018|NCT03148704|Serotonin Agents|serotonin agents|mesh-ancestor
92132019|NCT03148704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132020|NCT03148704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132021|NCT01795287|Anesthetics|anesthetics|mesh-list
92132022|NCT01795287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132023|NCT01795287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132024|NCT04976283|Pioglitazone|pioglitazone|mesh-list
92132025|NCT04976283|Empagliflozin|empagliflozin|mesh-list
92132026|NCT04976283|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92132027|NCT04976283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132028|NCT04976283|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92132029|NCT04976283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132030|NCT02345304|Digoxin|digoxin|mesh-list
92132031|NCT02345304|Midazolam|midazolam|mesh-list
92132032|NCT02345304|Omeprazole|omeprazole|mesh-list
92132033|NCT02345304|Warfarin|warfarin|mesh-list
92132034|NCT02345304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92132035|NCT02345304|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92132036|NCT02345304|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132037|NCT02345304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132038|NCT02345304|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92132039|NCT02345304|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92132040|NCT02345304|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92132041|NCT02345304|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92132042|NCT02345304|Anesthetics, General|anesthetics, general|mesh-ancestor
92132043|NCT02345304|Anesthetics|anesthetics|mesh-ancestor
92132044|NCT02345304|GABA Modulators|gaba modulators|mesh-ancestor
92132045|NCT02345304|GABA Agents|gaba agents|mesh-ancestor
92132046|NCT02345304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132047|NCT02345304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132048|NCT02345304|Anticoagulants|anticoagulants|mesh-ancestor
92132049|NCT02345304|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92132050|NCT02345304|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132051|NCT02345304|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92132052|NCT02345304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132053|NCT02345304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92132054|NCT02345304|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92132055|NCT02345304|Protective Agents|protective agents|mesh-ancestor
92132056|NCT01569295|Rituximab|rituximab|mesh-list
92132057|NCT01569295|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92132058|NCT01569295|Idelalisib|idelalisib|mesh-list
92132059|NCT01569295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92132060|NCT01569295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132061|NCT01569295|Immunologic Factors|immunologic factors|mesh-ancestor
92132062|NCT01569295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132063|NCT01569295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132064|NCT01569295|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92132065|NCT01569295|Alkylating Agents|alkylating agents|mesh-ancestor
92132066|NCT01569295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132067|NCT01569295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132068|NCT03112278|Salicylic Acid|salicylic acid|mesh-list
92132069|NCT03112278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132070|NCT03112278|Antifungal Agents|antifungal agents|mesh-ancestor
92132071|NCT03112278|Keratolytic Agents|keratolytic agents|mesh-ancestor
92132072|NCT03112278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132073|NCT02345148|Esketamine|esketamine|mesh-list
92132074|NCT02345148|Antidepressive Agents|antidepressive agents|mesh-ancestor
92132075|NCT02345148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92132076|NCT00394329|Beclomethasone|beclomethasone|mesh-list
92132077|NCT00394329|Albuterol|albuterol|mesh-list
92132078|NCT00394329|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92132079|NCT00394329|Autonomic Agents|autonomic agents|mesh-ancestor
92132080|NCT00394329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132081|NCT00394329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132082|NCT00394329|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92132083|NCT00394329|Respiratory System Agents|respiratory system agents|mesh-ancestor
92132084|NCT00394329|Tocolytic Agents|tocolytic agents|mesh-ancestor
92132085|NCT00394329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92132086|NCT00394329|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92132087|NCT00394329|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92132088|NCT00394329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92132089|NCT00394329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92132090|NCT00394329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132091|NCT00394329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132092|NCT00394329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132093|NCT00394329|Glucocorticoids|glucocorticoids|mesh-ancestor
92132094|NCT00394329|Hormones|hormones|mesh-ancestor
92132095|NCT00394329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132096|NCT03146052|Simethicone|simethicone|mesh-list
92132097|NCT03146052|Bisacodyl|bisacodyl|mesh-list
92132098|NCT03146052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132099|NCT03146052|Cathartics|cathartics|mesh-ancestor
92132100|NCT03146052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132101|NCT03146052|Laxatives|laxatives|mesh-ancestor
92132102|NCT03146052|Antifoaming Agents|antifoaming agents|mesh-ancestor
92132103|NCT03146052|Emollients|emollients|mesh-ancestor
92132104|NCT03146052|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132105|NCT01549951|Prednisone|prednisone|mesh-list
92132106|NCT01549951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132107|NCT01549951|Glucocorticoids|glucocorticoids|mesh-ancestor
92132108|NCT01549951|Hormones|hormones|mesh-ancestor
92132109|NCT01549951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132110|NCT01549951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132111|NCT01549951|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92132112|NCT01549951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132113|NCT03148314|Misoprostol|misoprostol|mesh-list
92132114|NCT03148314|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92132115|NCT03148314|Abortifacient Agents|abortifacient agents|mesh-ancestor
92132116|NCT03148314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92132117|NCT03148314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132118|NCT03148314|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92132119|NCT03148314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132120|NCT03148314|Oxytocics|oxytocics|mesh-ancestor
92132121|NCT01517893|Simvastatin|simvastatin|mesh-list
92132122|NCT01517893|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92132123|NCT01517893|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92132124|NCT01517893|Antimetabolites|antimetabolites|mesh-ancestor
92132125|NCT01517893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132126|NCT01517893|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92132127|NCT01517893|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92132128|NCT01517893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132129|NCT02344992|Insulin Lispro|insulin lispro|mesh-list
92132130|NCT02344992|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92132131|NCT02344992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132132|NCT01489891|Lidocaine|lidocaine|mesh-list
92132133|NCT01489891|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132134|NCT01489891|Anesthetics|anesthetics|mesh-ancestor
92132135|NCT01489891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132136|NCT01489891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132137|NCT01489891|Sensory System Agents|sensory system agents|mesh-ancestor
92132138|NCT01489891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132139|NCT01489891|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92132140|NCT01489891|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92132141|NCT01489891|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92132142|NCT01489891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92132143|NCT01489891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132145|NCT02342574|Antifungal Agents|antifungal agents|mesh-ancestor
92132146|NCT02342574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132147|NCT03148002|Lactulose|lactulose|mesh-list
92132148|NCT03148002|Sennosides|sennosides|mesh-list
92132149|NCT03148002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132150|NCT03148002|Laxatives|laxatives|mesh-ancestor
92132151|NCT02342184|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92132152|NCT02342184|Immunologic Factors|immunologic factors|mesh-ancestor
92132153|NCT02342184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132155|NCT00396201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92132156|NCT00396201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92132157|NCT00396201|Antiviral Agents|antiviral agents|mesh-ancestor
92132158|NCT00396201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132159|NCT03145896|Vitamin D|vitamin d|mesh-list
92132160|NCT03145896|Vitamins|vitamins|mesh-ancestor
92132161|NCT03145896|Micronutrients|micronutrients|mesh-ancestor
92132162|NCT03145896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132163|NCT03145896|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92132164|NCT02341872|Calcium|calcium|mesh-list
92132165|NCT02341872|Fluorides|fluorides|mesh-list
92132166|NCT02341872|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92132167|NCT02341872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132168|NCT02341872|Cariostatic Agents|cariostatic agents|mesh-ancestor
92132169|NCT02341872|Protective Agents|protective agents|mesh-ancestor
92132170|NCT00360399|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92132171|NCT00360399|Escitalopram|escitalopram|mesh-list
92132172|NCT00360399|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92132173|NCT00360399|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92132174|NCT00360399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92132175|NCT00360399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132176|NCT00360399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132177|NCT00360399|Serotonin Agents|serotonin agents|mesh-ancestor
92132178|NCT00360399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132179|NCT00360399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132180|NCT00360399|Antidepressive Agents|antidepressive agents|mesh-ancestor
92132181|NCT00360399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92132182|NCT00360399|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92132183|NCT00360399|Analgesics|analgesics|mesh-ancestor
92132184|NCT00360399|Sensory System Agents|sensory system agents|mesh-ancestor
92132185|NCT00360399|Dopamine Agents|dopamine agents|mesh-ancestor
92132186|NCT02341794|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92132187|NCT02341794|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92132188|NCT02341794|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92132190|NCT02341794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132191|NCT02341794|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92132192|NCT02341794|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92132193|NCT02341794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132194|NCT02344602|Febuxostat|febuxostat|mesh-list
92132195|NCT02344602|Gout Suppressants|gout suppressants|mesh-ancestor
92132196|NCT02344602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132197|NCT02348268|Analgesics|analgesics|mesh-list
92132198|NCT02348268|Sensory System Agents|sensory system agents|mesh-ancestor
92132199|NCT02348268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132200|NCT02348268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132201|NCT02348346|Titanium dioxide|titanium dioxide|mesh-list
92132202|NCT02348346|Sunscreening Agents|sunscreening agents|mesh-ancestor
92132203|NCT02348346|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92132204|NCT02348346|Protective Agents|protective agents|mesh-ancestor
92132205|NCT02348346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132206|NCT02348346|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132207|NCT02348346|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92132208|NCT00361257|Minocycline|minocycline|mesh-list
92132209|NCT00361257|Tetracycline|tetracycline|mesh-list
92132210|NCT00361257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92132211|NCT00361257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132212|NCT00361257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92132213|NCT00361257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132214|NCT00361257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132215|NCT02341404|Hydroxyflutamide|hydroxyflutamide|mesh-list
92132216|NCT02341404|Androgen Antagonists|androgen antagonists|mesh-ancestor
92132217|NCT02341404|Hormone Antagonists|hormone antagonists|mesh-ancestor
92132218|NCT02341404|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132219|NCT02341404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132220|NCT02341638|Aspirin|aspirin|mesh-list
92132221|NCT02341638|Itraconazole|itraconazole|mesh-list
92132222|NCT02341638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132223|NCT02341638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132224|NCT02341638|Analgesics|analgesics|mesh-ancestor
92132225|NCT02341638|Sensory System Agents|sensory system agents|mesh-ancestor
92132226|NCT02341638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132227|NCT02341638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132228|NCT02341638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132229|NCT02341638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132230|NCT02341638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92132231|NCT02341638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92132232|NCT02341638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132233|NCT02341638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92132234|NCT02341638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92132235|NCT02341638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132236|NCT02341638|Antipyretics|antipyretics|mesh-ancestor
92132237|NCT02341638|Antifungal Agents|antifungal agents|mesh-ancestor
92132238|NCT02341638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132239|NCT02341638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92132240|NCT02341638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92132241|NCT02341638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92132242|NCT02341638|Hormone Antagonists|hormone antagonists|mesh-ancestor
92132243|NCT02341638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132244|NCT02341638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92132245|NCT02337192|Chlorhexidine|chlorhexidine|mesh-list
92132246|NCT02337192|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92132247|NCT02337192|Curcumin|curcumin|mesh-list
92132248|NCT02337192|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92132249|NCT02337192|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92132250|NCT02337192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132251|NCT02337192|Disinfectants|disinfectants|mesh-ancestor
92132252|NCT02337192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132253|NCT02337192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132254|NCT02337192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132255|NCT02337192|Analgesics|analgesics|mesh-ancestor
92132256|NCT02337192|Sensory System Agents|sensory system agents|mesh-ancestor
92132257|NCT02337192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132258|NCT02337192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132259|NCT02337192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132260|NCT02337192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132261|NCT02337192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132262|NCT02337192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132342|NCT04594746|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92132263|NCT02337192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132264|NCT02337192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92132265|NCT03111966|Grazoprevir|grazoprevir|mesh-list
92132266|NCT03111966|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92132267|NCT03111966|Antiviral Agents|antiviral agents|mesh-ancestor
92132268|NCT03111966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132269|NCT02343666|Plerixafor|plerixafor|mesh-list
92132270|NCT02343666|Carmustine|carmustine|mesh-list
92132271|NCT02343666|O(6)-benzylguanine|o(6)-benzylguanine|mesh-list
92132272|NCT02343666|Lenograstim|lenograstim|mesh-list
92132273|NCT02343666|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92132274|NCT02343666|Immunologic Factors|immunologic factors|mesh-ancestor
92132275|NCT02343666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132276|NCT02343666|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92132277|NCT02343666|Alkylating Agents|alkylating agents|mesh-ancestor
92132278|NCT02343666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132279|NCT02343666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132280|NCT02343666|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92132281|NCT02343666|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92132282|NCT02343666|Antiviral Agents|antiviral agents|mesh-ancestor
92132283|NCT02343666|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132284|NCT02343666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132285|NCT02332356|Adalimumab|adalimumab|mesh-list
92132286|NCT02332356|Infliximab|infliximab|mesh-list
92132287|NCT02332356|Azathioprine|azathioprine|mesh-list
92132288|NCT02332356|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92132289|NCT02332356|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132290|NCT02332356|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132291|NCT02332356|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132292|NCT02332356|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132293|NCT02332356|Antimetabolites|antimetabolites|mesh-ancestor
92132294|NCT02332356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132295|NCT02332356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92132296|NCT02332356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132297|NCT02332356|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92132298|NCT02332356|Immunologic Factors|immunologic factors|mesh-ancestor
92132299|NCT02332356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132300|NCT02340936|Lenalidomide|lenalidomide|mesh-list
92132301|NCT02340936|Immunologic Factors|immunologic factors|mesh-ancestor
92132302|NCT02340936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132303|NCT02340936|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92132304|NCT02340936|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92132305|NCT02340936|Growth Substances|growth substances|mesh-ancestor
92132306|NCT02340936|Growth Inhibitors|growth inhibitors|mesh-ancestor
92132307|NCT02340936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132308|NCT02332044|Bepotastine besilate|bepotastine besilate|mesh-list
92132309|NCT02332044|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92132310|NCT02337036|Tacrolimus|tacrolimus|mesh-list
92132311|NCT02337036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92132312|NCT02337036|Immunologic Factors|immunologic factors|mesh-ancestor
92132313|NCT02337036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132314|NCT02337036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92132315|NCT02337036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132316|NCT02337036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132317|NCT02336568|Oxytocin|oxytocin|mesh-list
92132318|NCT02336568|Oxytocics|oxytocics|mesh-ancestor
92132319|NCT02336568|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92132320|NCT02336568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132321|NCT05253768|Glycerol|glycerol|mesh-list
92132322|NCT05253768|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92090542|NCT03216304|Antimetabolites|antimetabolites|mesh-ancestor
92132323|NCT05253768|Protective Agents|protective agents|mesh-ancestor
92132324|NCT05253768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132325|NCT04630938|Lidocaine|lidocaine|mesh-list
92132326|NCT04630938|Morphine|morphine|mesh-list
92132327|NCT04630938|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132328|NCT04630938|Anesthetics|anesthetics|mesh-ancestor
92132329|NCT04630938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132330|NCT04630938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132331|NCT04630938|Sensory System Agents|sensory system agents|mesh-ancestor
92132332|NCT04630938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132333|NCT04630938|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92132334|NCT04630938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92132335|NCT04630938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92132336|NCT04630938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92132337|NCT04630938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132344|NCT04594746|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92132345|NCT04594746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92132346|NCT04594746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132347|NCT04594746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92132348|NCT04594746|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92132349|NCT04594746|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92132350|NCT04594746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132351|NCT04594746|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92132352|NCT04594746|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92132353|NCT04594746|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92132354|NCT02790138|Ciprofloxacin|ciprofloxacin|mesh-list
92132355|NCT02790138|Vedolizumab|vedolizumab|mesh-list
92132356|NCT02790138|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92132357|NCT02790138|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132358|NCT02790138|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92132359|NCT02790138|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92132360|NCT02790138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132361|NCT02790138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132362|NCT02790138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132363|NCT02790138|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92132364|NCT02790138|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92132365|NCT02790138|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132367|NCT02339844|Antidepressive Agents|antidepressive agents|mesh-ancestor
92132368|NCT02339844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92132369|NCT02339844|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92132370|NCT02339844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92132371|NCT02339844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132372|NCT02339844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132373|NCT02339844|Dopamine Agonists|dopamine agonists|mesh-ancestor
92132374|NCT02339844|Dopamine Agents|dopamine agents|mesh-ancestor
92132375|NCT02339844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132376|NCT02339844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132377|NCT02339844|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92132378|NCT02339844|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92132379|NCT02339844|Serotonin Agents|serotonin agents|mesh-ancestor
92132380|NCT02339844|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92132381|NCT02339844|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92132382|NCT02339844|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92132383|NCT02339844|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92132384|NCT00397839|Ibandronic Acid|ibandronic acid|mesh-list
92132385|NCT00397839|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92132386|NCT00397839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132387|NCT02331576|Fentanyl|fentanyl|mesh-list
92132388|NCT02331576|Ropivacaine|ropivacaine|mesh-list
92132389|NCT02331576|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132390|NCT02331576|Anesthetics|anesthetics|mesh-ancestor
92132391|NCT02331576|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132392|NCT02331576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132393|NCT02331576|Sensory System Agents|sensory system agents|mesh-ancestor
92132394|NCT02331576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132395|NCT02331576|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92132396|NCT02331576|Narcotics|narcotics|mesh-ancestor
92132397|NCT02331576|Analgesics|analgesics|mesh-ancestor
92132398|NCT02331576|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92132399|NCT02331576|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92132400|NCT02331576|Anesthetics, General|anesthetics, general|mesh-ancestor
92132401|NCT00400803|Bevacizumab|bevacizumab|mesh-list
92132402|NCT00400803|Carboplatin|carboplatin|mesh-list
92132403|NCT00400803|Gemcitabine|gemcitabine|mesh-list
92132404|NCT00400803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92132405|NCT00400803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132406|NCT00400803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92132407|NCT00400803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92132408|NCT00400803|Growth Substances|growth substances|mesh-ancestor
92132409|NCT00400803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132410|NCT00400803|Growth Inhibitors|growth inhibitors|mesh-ancestor
92132411|NCT00400803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92132412|NCT00400803|Antimetabolites|antimetabolites|mesh-ancestor
92132413|NCT00400803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132415|NCT04681443|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92132416|NCT04681443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132417|NCT04681443|Disinfectants|disinfectants|mesh-ancestor
92132418|NCT04681443|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92132419|NCT04681443|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92132420|NCT02339142|Methylprednisolone|methylprednisolone|mesh-list
92132421|NCT02339142|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92132422|NCT02339142|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92132423|NCT02339142|Prednisolone|prednisolone|mesh-list
92132424|NCT02339142|Prednisolone acetate|prednisolone acetate|mesh-list
92132425|NCT02339142|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92132426|NCT02339142|Prednisolone phosphate|prednisolone phosphate|mesh-list
92132427|NCT02339142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132428|NCT02339142|Antiemetics|antiemetics|mesh-ancestor
92132429|NCT02339142|Autonomic Agents|autonomic agents|mesh-ancestor
92132430|NCT02339142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132431|NCT02339142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132433|NCT02339142|Glucocorticoids|glucocorticoids|mesh-ancestor
92132434|NCT02339142|Hormones|hormones|mesh-ancestor
92132435|NCT02339142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132436|NCT02339142|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92132437|NCT02339142|Protective Agents|protective agents|mesh-ancestor
92132438|NCT02339142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92132439|NCT02339142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132440|NCT00362817|Carboplatin|carboplatin|mesh-list
92132441|NCT00362817|Temozolomide|temozolomide|mesh-list
92132442|NCT00362817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132443|NCT00362817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92132444|NCT00362817|Alkylating Agents|alkylating agents|mesh-ancestor
92132445|NCT00362817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132446|NCT02330952|Prednisone|prednisone|mesh-list
92132447|NCT02330952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132448|NCT02330952|Glucocorticoids|glucocorticoids|mesh-ancestor
92132449|NCT02330952|Hormones|hormones|mesh-ancestor
92132450|NCT02330952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132451|NCT02330952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132452|NCT02330952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92132453|NCT02330952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132454|NCT02338830|Progesterone|progesterone|mesh-list
92132455|NCT02338830|Progestins|progestins|mesh-ancestor
92132456|NCT02338830|Hormones|hormones|mesh-ancestor
92132457|NCT02338830|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132458|NCT02338830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132459|NCT00364377|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92132460|NCT00364377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92132461|NCT00364377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132462|NCT00364377|Incretins|incretins|mesh-ancestor
92132463|NCT00364377|Hormones|hormones|mesh-ancestor
92132464|NCT00364377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132465|NCT00364377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92132466|NCT00364377|Protease Inhibitors|protease inhibitors|mesh-ancestor
92132467|NCT00364377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132468|NCT00364377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132469|NCT04175886|Tofacitinib|tofacitinib|mesh-list
92132470|NCT04175886|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92132471|NCT04175886|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92132472|NCT04175886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132473|NCT04175886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090691|NCT01901393|Ibuprofen|ibuprofen|mesh-list
92132474|NCT02338674|Tenofovir|tenofovir|mesh-list
92132475|NCT02338674|Telbivudine|telbivudine|mesh-list
92132476|NCT02338674|Antiviral Agents|antiviral agents|mesh-ancestor
92132477|NCT02338674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132478|NCT02338674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92132479|NCT02338674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92132480|NCT02338674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132481|NCT02338674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132482|NCT02338674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92132483|NCT02338674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92132485|NCT02338518|Etoposide|etoposide|mesh-list
92132486|NCT02338518|Epirubicin|epirubicin|mesh-list
92132487|NCT02338518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132488|NCT02338518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92132489|NCT02338518|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92132490|NCT02338518|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92132491|NCT02338518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132492|NCT02338518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132493|NCT02338518|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92132494|NCT01826838|Dasatinib|dasatinib|mesh-list
92132495|NCT01826838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132496|NCT01826838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92132497|NCT01826838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132498|NCT01826838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132500|NCT00365391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92132501|NCT00365391|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92132502|NCT00365391|Antibodies|antibodies|mesh-list
92132503|NCT00365391|Immunoglobulins|immunoglobulins|mesh-list
92132504|NCT00365391|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92132505|NCT00365391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132506|NCT00365391|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92132507|NCT00365391|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92132508|NCT00365391|Growth Substances|growth substances|mesh-ancestor
92132509|NCT00365391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132510|NCT00365391|Growth Inhibitors|growth inhibitors|mesh-ancestor
92132511|NCT00365391|Immunologic Factors|immunologic factors|mesh-ancestor
92132512|NCT00365391|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92132513|NCT00365391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132514|NCT00365391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132515|NCT03105180|Mannitol|mannitol|mesh-list
92132516|NCT03105180|Sorbitol|sorbitol|mesh-list
92132517|NCT03105180|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92132518|NCT03105180|Diuretics|diuretics|mesh-ancestor
92132519|NCT03105180|Natriuretic Agents|natriuretic agents|mesh-ancestor
92132520|NCT03105180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132521|NCT03105180|Cathartics|cathartics|mesh-ancestor
92132522|NCT03105180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132523|NCT02331030|Ropivacaine|ropivacaine|mesh-list
92132524|NCT02331030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132525|NCT02331030|Anesthetics|anesthetics|mesh-ancestor
92132526|NCT02331030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132527|NCT02331030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132528|NCT02331030|Sensory System Agents|sensory system agents|mesh-ancestor
92132529|NCT02331030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132530|NCT04270929|Folfirinox|folfirinox|mesh-list
92132531|NCT04270929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132532|NCT00401817|Bevacizumab|bevacizumab|mesh-list
92132533|NCT00401817|Rituximab|rituximab|mesh-list
92132534|NCT00401817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92132535|NCT00401817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132536|NCT00401817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92132537|NCT00401817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92132538|NCT00401817|Growth Substances|growth substances|mesh-ancestor
92132539|NCT00401817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132540|NCT00401817|Growth Inhibitors|growth inhibitors|mesh-ancestor
92132541|NCT00401817|Immunologic Factors|immunologic factors|mesh-ancestor
92132543|NCT04417179|Bupivacaine|bupivacaine|mesh-list
92132544|NCT04417179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132545|NCT04417179|Anesthetics|anesthetics|mesh-ancestor
92132546|NCT04417179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132547|NCT04417179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132548|NCT04417179|Sensory System Agents|sensory system agents|mesh-ancestor
92132549|NCT04417179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132550|NCT02330796|Bucillamine|bucillamine|mesh-list
92132551|NCT02330796|Colchicine|colchicine|mesh-list
92132552|NCT02330796|Gout Suppressants|gout suppressants|mesh-ancestor
92132553|NCT02330796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132554|NCT02330796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92132555|NCT02330796|Antimitotic Agents|antimitotic agents|mesh-ancestor
92132556|NCT02330796|Mitosis Modulators|mitosis modulators|mesh-ancestor
92132557|NCT02330796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132558|NCT02330796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132559|NCT02330796|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132560|NCT02330796|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132561|NCT02330796|Analgesics|analgesics|mesh-ancestor
92132562|NCT02330796|Sensory System Agents|sensory system agents|mesh-ancestor
92132563|NCT02330796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132564|NCT02330796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132565|NCT02330796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132566|NCT02330796|Antioxidants|antioxidants|mesh-ancestor
92132567|NCT02330796|Protective Agents|protective agents|mesh-ancestor
92132568|NCT02330640|Clopidogrel|clopidogrel|mesh-list
92132569|NCT02330640|Ticagrelor|ticagrelor|mesh-list
92132570|NCT02330640|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92132571|NCT02330640|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92132572|NCT02330640|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92132573|NCT02330640|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92132574|NCT02330640|Purinergic Agents|purinergic agents|mesh-ancestor
92132575|NCT02330640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132576|NCT02330640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132577|NCT02330640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132578|NCT02335398|Methadone|methadone|mesh-list
92132579|NCT02335398|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92132580|NCT02335398|Narcotics|narcotics|mesh-ancestor
92132581|NCT02335398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132582|NCT02335398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132583|NCT02335398|Analgesics|analgesics|mesh-ancestor
92132584|NCT02335398|Sensory System Agents|sensory system agents|mesh-ancestor
92132585|NCT02335398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132586|NCT02335398|Antitussive Agents|antitussive agents|mesh-ancestor
92132587|NCT02335398|Respiratory System Agents|respiratory system agents|mesh-ancestor
92132588|NCT02338206|Hormones|hormones|mesh-list
92132589|NCT02338206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132590|NCT02338206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132591|NCT02338050|Immunotoxin HA22|immunotoxin ha22|mesh-list
92132592|NCT02338050|Immunotoxins|immunotoxins|mesh-ancestor
92132593|NCT02338050|Immunoconjugates|immunoconjugates|mesh-ancestor
92132594|NCT02338050|Immunologic Factors|immunologic factors|mesh-ancestor
92132595|NCT02338050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132596|NCT02338050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132597|NCT02330406|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92132599|NCT02330406|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92132600|NCT02330406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132601|NCT02330406|Incretins|incretins|mesh-ancestor
92132602|NCT02330406|Hormones|hormones|mesh-ancestor
92132603|NCT02330406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132604|NCT02330406|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92132605|NCT02330406|Protease Inhibitors|protease inhibitors|mesh-ancestor
92132606|NCT02330406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132607|NCT02330406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132608|NCT03906708|Carbon Monoxide|carbon monoxide|mesh-list
92132609|NCT03906708|Antimetabolites|antimetabolites|mesh-ancestor
92132610|NCT03906708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132611|NCT03906708|Gasotransmitters|gasotransmitters|mesh-ancestor
92132612|NCT03906708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132613|NCT03906708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132614|NCT02337972|Povidone-Iodine|povidone-iodine|mesh-list
92132615|NCT02337972|Povidone|povidone|mesh-list
92132616|NCT02337972|Plasma Substitutes|plasma substitutes|mesh-ancestor
92132617|NCT02337972|Blood Substitutes|blood substitutes|mesh-ancestor
92132618|NCT02337972|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92132619|NCT02337972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132620|NCT02335164|Hemagglutinins|hemagglutinins|mesh-list
92132621|NCT02335164|Agglutinins|agglutinins|mesh-ancestor
92132622|NCT02335164|Immunologic Factors|immunologic factors|mesh-ancestor
92132623|NCT02335164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090836|NCT01738646|Bevacizumab|bevacizumab|mesh-list
92132624|NCT02335164|Coagulants|coagulants|mesh-ancestor
92132625|NCT00365859|Aripiprazole|aripiprazole|mesh-list
92132626|NCT00365859|Antidepressive Agents|antidepressive agents|mesh-ancestor
92132627|NCT00365859|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92132628|NCT00365859|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92132629|NCT00365859|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92132630|NCT00365859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132631|NCT00365859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132632|NCT00365859|Dopamine Agonists|dopamine agonists|mesh-ancestor
92132633|NCT00365859|Dopamine Agents|dopamine agents|mesh-ancestor
92132634|NCT00365859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132635|NCT00365859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132636|NCT00365859|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92132637|NCT00365859|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92132638|NCT00365859|Serotonin Agents|serotonin agents|mesh-ancestor
92132639|NCT00365859|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92132640|NCT00365859|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92132641|NCT00365859|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92132642|NCT00365859|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92132643|NCT02337426|Temozolomide|temozolomide|mesh-list
92132644|NCT02337426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92132645|NCT02337426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92132646|NCT02337426|Alkylating Agents|alkylating agents|mesh-ancestor
92132647|NCT02337426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132648|NCT02337426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132649|NCT02337426|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132650|NCT02337426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92132651|NCT02337426|Immunologic Factors|immunologic factors|mesh-ancestor
92132652|NCT02337426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132654|NCT03664830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92132655|NCT03664830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92132656|NCT03664830|Antiviral Agents|antiviral agents|mesh-ancestor
92132657|NCT03664830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132658|NCT00407355|Ranibizumab|ranibizumab|mesh-list
92132659|NCT00407355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92132660|NCT00407355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92132661|NCT00407355|Growth Substances|growth substances|mesh-ancestor
92132662|NCT00407355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132663|NCT00407355|Growth Inhibitors|growth inhibitors|mesh-ancestor
92132664|NCT00407355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132665|NCT02334462|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92132666|NCT02334462|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92132667|NCT02334462|Immunologic Factors|immunologic factors|mesh-ancestor
92132668|NCT02334462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132669|NCT02334462|Antacids|antacids|mesh-ancestor
92132670|NCT02334462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132671|NCT02334462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132672|NCT03144882|Curcumin|curcumin|mesh-list
92132673|NCT03144882|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132674|NCT03144882|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132675|NCT03144882|Analgesics|analgesics|mesh-ancestor
92132676|NCT03144882|Sensory System Agents|sensory system agents|mesh-ancestor
92132677|NCT03144882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132678|NCT03144882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132679|NCT03144882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132680|NCT03144882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132681|NCT03144882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132682|NCT03144882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132683|NCT03144882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132684|NCT01793259|Methotrexate|methotrexate|mesh-list
92132685|NCT01793259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92132686|NCT01793259|Abortifacient Agents|abortifacient agents|mesh-ancestor
92132687|NCT01793259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92132688|NCT01793259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132689|NCT01793259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92132690|NCT01793259|Antimetabolites|antimetabolites|mesh-ancestor
92132691|NCT01793259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132692|NCT01793259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132693|NCT01793259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92132694|NCT01793259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132695|NCT01793259|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92132696|NCT01793259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92132697|NCT01793259|Immunologic Factors|immunologic factors|mesh-ancestor
92132698|NCT01793259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132699|NCT01793259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92132700|NCT02329626|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92132701|NCT02329626|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92132702|NCT02329626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132703|NCT03111810|Prednisolone|prednisolone|mesh-list
92132704|NCT03111810|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92132705|NCT03111810|Methylprednisolone|methylprednisolone|mesh-list
92132706|NCT03111810|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92132707|NCT03111810|Prednisolone acetate|prednisolone acetate|mesh-list
92132708|NCT03111810|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92132709|NCT03111810|Prednisolone phosphate|prednisolone phosphate|mesh-list
92132710|NCT03111810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132711|NCT03111810|Glucocorticoids|glucocorticoids|mesh-ancestor
92132712|NCT03111810|Hormones|hormones|mesh-ancestor
92132713|NCT03111810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92132714|NCT03111810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132715|NCT03111810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92132716|NCT03111810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132717|NCT03111810|Antiemetics|antiemetics|mesh-ancestor
92132718|NCT03111810|Autonomic Agents|autonomic agents|mesh-ancestor
92132719|NCT03111810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132720|NCT03111810|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132721|NCT03111810|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92132722|NCT03111810|Protective Agents|protective agents|mesh-ancestor
92132723|NCT02334150|Sufentanil|sufentanil|mesh-list
92132726|NCT02334150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132727|NCT02334150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132728|NCT02334150|Analgesics|analgesics|mesh-ancestor
92132729|NCT02334150|Sensory System Agents|sensory system agents|mesh-ancestor
92132730|NCT02334150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132731|NCT02334150|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92132732|NCT02334150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92132733|NCT02334150|Anesthetics, General|anesthetics, general|mesh-ancestor
92132734|NCT02334150|Anesthetics|anesthetics|mesh-ancestor
92132735|NCT02326428|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92132736|NCT02326428|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92132737|NCT02326428|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92132738|NCT02326428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132739|NCT04477590|Metformin|metformin|mesh-list
92132740|NCT04477590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92132741|NCT04477590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132742|NCT02333838|Fludarabine|fludarabine|mesh-list
92132743|NCT02333838|Fludarabine phosphate|fludarabine phosphate|mesh-list
92132744|NCT02333838|Busulfan|busulfan|mesh-list
92132745|NCT02333838|Thiotepa|thiotepa|mesh-list
92132746|NCT02333838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132747|NCT02333838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92132748|NCT02333838|Antimetabolites|antimetabolites|mesh-ancestor
92132749|NCT02333838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132750|NCT02333838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92132751|NCT02333838|Immunologic Factors|immunologic factors|mesh-ancestor
92132752|NCT02333838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132753|NCT02333838|Alkylating Agents|alkylating agents|mesh-ancestor
92132754|NCT02333838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92132755|NCT02333838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92132756|NCT02326584|Cytarabine|cytarabine|mesh-list
92132757|NCT02326584|Daunorubicin|daunorubicin|mesh-list
92132758|NCT02326584|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92132759|NCT02326584|Antimetabolites|antimetabolites|mesh-ancestor
92132760|NCT02326584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132761|NCT02326584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132762|NCT02326584|Antiviral Agents|antiviral agents|mesh-ancestor
92132763|NCT02326584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132764|NCT02326584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92132765|NCT02326584|Immunologic Factors|immunologic factors|mesh-ancestor
92132766|NCT02326584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132767|NCT02326584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92132768|NCT02326584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92132769|NCT02326584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92132770|NCT02326584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132771|NCT03111342|Lidocaine|lidocaine|mesh-list
92132772|NCT03111342|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132773|NCT03111342|Anesthetics|anesthetics|mesh-ancestor
92132774|NCT03111342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132775|NCT03111342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132776|NCT03111342|Sensory System Agents|sensory system agents|mesh-ancestor
92132777|NCT03111342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132778|NCT03111342|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92132779|NCT03111342|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92132780|NCT03111342|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92132781|NCT03111342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92132782|NCT03111342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132783|NCT03111420|Clopidogrel|clopidogrel|mesh-list
92132784|NCT03111420|Ticagrelor|ticagrelor|mesh-list
92132785|NCT03111420|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92132786|NCT03111420|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92132787|NCT03111420|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92132788|NCT03111420|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92132789|NCT03111420|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92132790|NCT03111420|Purinergic Agents|purinergic agents|mesh-ancestor
92132791|NCT03111420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132792|NCT03111420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132793|NCT03111420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132794|NCT02333682|Vitamin D|vitamin d|mesh-list
92132795|NCT02333682|Cholecalciferol|cholecalciferol|mesh-list
92132796|NCT02333682|Calcifediol|calcifediol|mesh-list
92132797|NCT02333682|Vitamins|vitamins|mesh-ancestor
92132798|NCT02333682|Micronutrients|micronutrients|mesh-ancestor
92132799|NCT02333682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132800|NCT02333682|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92132801|NCT02333682|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92132802|NCT02328456|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92132803|NCT02328456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92132804|NCT02326350|Aspirin|aspirin|mesh-list
92132805|NCT02326350|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132806|NCT02326350|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132807|NCT02326350|Analgesics|analgesics|mesh-ancestor
92132808|NCT02326350|Sensory System Agents|sensory system agents|mesh-ancestor
92132809|NCT02326350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132810|NCT02326350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132811|NCT02326350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132812|NCT02326350|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132813|NCT02326350|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92132814|NCT02326350|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92132815|NCT02326350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132816|NCT02326350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92132817|NCT02326350|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92132818|NCT02326350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132819|NCT02326350|Antipyretics|antipyretics|mesh-ancestor
92132821|NCT02326194|Immunologic Factors|immunologic factors|mesh-ancestor
92132822|NCT02326194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132823|NCT02326038|Methylphenidate|methylphenidate|mesh-list
92132824|NCT02326038|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92132825|NCT02326038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132826|NCT02326038|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92132827|NCT02326038|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92132828|NCT02326038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92132829|NCT02326038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132830|NCT02326038|Dopamine Agents|dopamine agents|mesh-ancestor
92132831|NCT02326038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132832|NCT00970866|Folic Acid|folic acid|mesh-list
92132833|NCT00970866|Micronutrients|micronutrients|mesh-list
92132834|NCT00970866|Trace Elements|trace elements|mesh-list
92132835|NCT00970866|Hematinics|hematinics|mesh-ancestor
92132836|NCT00970866|Vitamin B Complex|vitamin b complex|mesh-ancestor
92132837|NCT00970866|Vitamins|vitamins|mesh-ancestor
92132838|NCT00970866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132839|NCT03145584|Bupivacaine|bupivacaine|mesh-list
92132840|NCT03145584|Anesthetics, Local|anesthetics, local|mesh-ancestor
92132841|NCT03145584|Anesthetics|anesthetics|mesh-ancestor
92132842|NCT03145584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132843|NCT03145584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132844|NCT03145584|Sensory System Agents|sensory system agents|mesh-ancestor
92132845|NCT03145584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132846|NCT03145194|Ticagrelor|ticagrelor|mesh-list
92132847|NCT03145194|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92132848|NCT03145194|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92132849|NCT03145194|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92132850|NCT03145194|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92132852|NCT03145194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132853|NCT03145194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132854|NCT03145194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132855|NCT05076942|Cisplatin|cisplatin|mesh-list
92132856|NCT05076942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132857|NCT03143946|Vitamins|vitamins|mesh-list
92132858|NCT03143946|Micronutrients|micronutrients|mesh-ancestor
92132859|NCT03143946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132860|NCT02039700|Lesinurad|lesinurad|mesh-list
92132861|NCT02039700|Gout Suppressants|gout suppressants|mesh-ancestor
92132862|NCT02039700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132863|NCT02039700|Uricosuric Agents|uricosuric agents|mesh-ancestor
92132864|NCT05076474|Orlistat|orlistat|mesh-list
92132865|NCT05076474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132866|NCT05076474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132867|NCT05076474|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92132868|NCT05076474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92132869|NCT02328144|Metronidazole|metronidazole|mesh-list
92132870|NCT02328144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132871|NCT02328144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92132872|NCT02328144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92132873|NCT02328144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92132874|NCT02327676|Emtricitabine|emtricitabine|mesh-list
92132875|NCT02327676|Antiviral Agents|antiviral agents|mesh-ancestor
92132876|NCT02327676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132877|NCT02327676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92145385|NCT01276353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132878|NCT02327676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92132879|NCT02327676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132880|NCT02327676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132881|NCT02327676|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92132882|NCT02327676|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92132883|NCT02333058|Treosulfan|treosulfan|mesh-list
92132884|NCT02333058|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92132885|NCT02333058|Alkylating Agents|alkylating agents|mesh-ancestor
92132886|NCT02333058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132887|NCT02333058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132888|NCT03111186|Acetaminophen|acetaminophen|mesh-list
92132889|NCT03111186|Ibuprofen|ibuprofen|mesh-list
92132890|NCT03111186|Oxycodone|oxycodone|mesh-list
92132891|NCT03111186|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132892|NCT03111186|Analgesics|analgesics|mesh-ancestor
92132893|NCT03111186|Sensory System Agents|sensory system agents|mesh-ancestor
92132894|NCT03111186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132895|NCT03111186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132896|NCT03111186|Antipyretics|antipyretics|mesh-ancestor
92132897|NCT03111186|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132898|NCT03111186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132899|NCT03111186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132900|NCT03111186|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92132901|NCT03111186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132902|NCT03111186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132903|NCT03111186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92132904|NCT03111186|Narcotics|narcotics|mesh-ancestor
92132905|NCT03111186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132906|NCT02332512|Apatinib|apatinib|mesh-list
92132907|NCT02332512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132908|NCT02332512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92132909|NCT02332512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132910|NCT02332512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132911|NCT02327754|FYX-051|fyx-051|mesh-list
92132912|NCT02327754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132913|NCT02327754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132914|NCT03142620|Vitamin D|vitamin d|mesh-list
92132915|NCT03142620|Cholecalciferol|cholecalciferol|mesh-list
92132916|NCT03142620|Amoxicillin|amoxicillin|mesh-list
92132917|NCT03142620|Clarithromycin|clarithromycin|mesh-list
92132918|NCT03142620|Clavulanic Acid|clavulanic acid|mesh-list
92132919|NCT03142620|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92132920|NCT03142620|Esomeprazole|esomeprazole|mesh-list
92132921|NCT03142620|Vitamins|vitamins|mesh-ancestor
92132922|NCT03142620|Micronutrients|micronutrients|mesh-ancestor
92132923|NCT03142620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132924|NCT03142620|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92132925|NCT03142620|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92132926|NCT03142620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92132927|NCT03142620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92132928|NCT03142620|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92132929|NCT03142620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132930|NCT03142620|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92132931|NCT03142620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132932|NCT03142620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132933|NCT03142620|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92132934|NCT03142620|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92132935|NCT03142620|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92132936|NCT03142620|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92132937|NCT03110952|alpha-Tocopherol|alpha-tocopherol|mesh-list
92132938|NCT03110952|Vaccines|vaccines|mesh-list
92132939|NCT03110952|Immunologic Factors|immunologic factors|mesh-ancestor
92132940|NCT03110952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132941|NCT03110952|Antioxidants|antioxidants|mesh-ancestor
92132942|NCT03110952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132943|NCT03110952|Protective Agents|protective agents|mesh-ancestor
92132944|NCT03110952|Vitamins|vitamins|mesh-ancestor
92132945|NCT03110952|Micronutrients|micronutrients|mesh-ancestor
92132946|NCT03143244|Ketorolac|ketorolac|mesh-list
92132947|NCT03143244|Midazolam|midazolam|mesh-list
92132948|NCT03143244|Dexmedetomidine|dexmedetomidine|mesh-list
92132949|NCT03143244|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92132950|NCT03143244|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132951|NCT03143244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132952|NCT03143244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92132953|NCT03143244|Analgesics|analgesics|mesh-ancestor
92132954|NCT03143244|Sensory System Agents|sensory system agents|mesh-ancestor
92132955|NCT03143244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92132956|NCT03143244|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92132957|NCT03143244|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92132958|NCT03143244|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92132959|NCT03143244|Adrenergic Agents|adrenergic agents|mesh-ancestor
92132960|NCT03143244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92132961|NCT03143244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132962|NCT03143244|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92132963|NCT03143244|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92132964|NCT03143244|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92132965|NCT03143244|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92132966|NCT03143244|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92132967|NCT03143244|Anesthetics, General|anesthetics, general|mesh-ancestor
92132968|NCT03143244|Anesthetics|anesthetics|mesh-ancestor
92132969|NCT03143244|GABA Modulators|gaba modulators|mesh-ancestor
92132970|NCT03143244|GABA Agents|gaba agents|mesh-ancestor
92132971|NCT03143244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92132972|NCT03143244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92132973|NCT03143244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92132974|NCT03143244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92132975|NCT03143244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132976|NCT03838692|Ponatinib|ponatinib|mesh-list
92132977|NCT03838692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132978|NCT03838692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92132979|NCT03838692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92132980|NCT03838692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92132981|NCT03774186|Pancrelipase|pancrelipase|mesh-list
92132982|NCT03774186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92132983|NCT03505944|Venetoclax|venetoclax|mesh-list
92132984|NCT03505944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132985|NCT01489189|Ranibizumab|ranibizumab|mesh-list
92132986|NCT01489189|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92132987|NCT01489189|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92132988|NCT01489189|Growth Substances|growth substances|mesh-ancestor
92132989|NCT01489189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132990|NCT01489189|Growth Inhibitors|growth inhibitors|mesh-ancestor
92132991|NCT01489189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92132992|NCT01549873|Propofol|propofol|mesh-list
92132993|NCT01549873|Desflurane|desflurane|mesh-list
92132994|NCT01549873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92132995|NCT01549873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92132996|NCT01549873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92132997|NCT01549873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92132998|NCT01549873|Anesthetics, General|anesthetics, general|mesh-ancestor
92132999|NCT01549873|Anesthetics|anesthetics|mesh-ancestor
92133000|NCT01549873|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92133001|NCT04106401|Carbon Monoxide|carbon monoxide|mesh-list
92133002|NCT04106401|Antimetabolites|antimetabolites|mesh-ancestor
92133003|NCT04106401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133005|NCT04106401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133006|NCT04106401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133007|NCT01488487|Everolimus|everolimus|mesh-list
92133008|NCT01488487|Pasireotide|pasireotide|mesh-list
92133009|NCT01488487|Somatostatin|somatostatin|mesh-list
92133010|NCT01488487|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92133011|NCT01488487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133012|NCT01488487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133013|NCT01488487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133014|NCT01488487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133015|NCT01488487|Immunologic Factors|immunologic factors|mesh-ancestor
92133016|NCT01488487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133017|NCT01488487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133018|NCT01488487|Hormones|hormones|mesh-ancestor
92133019|NCT01488487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133020|NCT03027115|Tamsulosin|tamsulosin|mesh-list
92133021|NCT03027115|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92133022|NCT03027115|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92133023|NCT03027115|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92133024|NCT03027115|Adrenergic Agents|adrenergic agents|mesh-ancestor
92133025|NCT03027115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133026|NCT03027115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133027|NCT03027115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133028|NCT03027115|Urological Agents|urological agents|mesh-ancestor
92133029|NCT03026881|Paclitaxel|paclitaxel|mesh-list
92133030|NCT03026881|Apatinib|apatinib|mesh-list
92133032|NCT03026881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92133033|NCT03026881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133034|NCT03026881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92133035|NCT03026881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92133036|NCT03026881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92133037|NCT03026881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133038|NCT03026881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133039|NCT03026881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133040|NCT03026881|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92133041|NCT01516879|Atorvastatin|atorvastatin|mesh-list
92133042|NCT01516879|Ezetimibe|ezetimibe|mesh-list
92133043|NCT01516879|Evolocumab|evolocumab|mesh-list
92133044|NCT01516879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92133045|NCT01516879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92133046|NCT01516879|Antimetabolites|antimetabolites|mesh-ancestor
92133047|NCT01516879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133048|NCT01516879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92133049|NCT01516879|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92133050|NCT01516879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133051|NCT01516879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92133052|NCT01516879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92133053|NCT01516879|Protease Inhibitors|protease inhibitors|mesh-ancestor
92133054|NCT01515865|Midodrine|midodrine|mesh-list
92133055|NCT01515865|Sympathomimetics|sympathomimetics|mesh-ancestor
92133056|NCT01515865|Autonomic Agents|autonomic agents|mesh-ancestor
92133057|NCT01515865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133058|NCT01515865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133059|NCT01515865|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92133060|NCT01515865|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92133061|NCT01515865|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92133062|NCT01515865|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92133063|NCT01515865|Adrenergic Agents|adrenergic agents|mesh-ancestor
92133064|NCT01515865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133065|NCT01515865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133066|NCT01547299|Leuprolide|leuprolide|mesh-list
92133067|NCT01547299|Dutasteride|dutasteride|mesh-list
92133068|NCT01547299|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92133069|NCT01547299|Fertility Agents|fertility agents|mesh-ancestor
92133070|NCT01547299|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92133071|NCT01547299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133072|NCT01547299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92133073|NCT01547299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133074|NCT01547299|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92133075|NCT01547299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92133076|NCT01547299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133077|NCT01547299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133078|NCT01547299|Hormone Antagonists|hormone antagonists|mesh-ancestor
92133079|NCT01547299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133080|NCT04072107|Capecitabine|capecitabine|mesh-list
92133081|NCT04072107|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92133082|NCT04072107|Antimetabolites|antimetabolites|mesh-ancestor
92133083|NCT04072107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133084|NCT04072107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133085|NCT00411411|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92133086|NCT00411411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133087|NCT00411411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133088|NCT00411411|Incretins|incretins|mesh-ancestor
92133089|NCT00411411|Hormones|hormones|mesh-ancestor
92133090|NCT00411411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133091|NCT00411411|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92133092|NCT00411411|Protease Inhibitors|protease inhibitors|mesh-ancestor
92133093|NCT00411411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133094|NCT00411411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133095|NCT01794273|Phenylephrine|phenylephrine|mesh-list
92133096|NCT01794273|Oxymetazoline|oxymetazoline|mesh-list
92133097|NCT01794273|Ephedrine|ephedrine|mesh-list
92133098|NCT01794273|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92133099|NCT01794273|Mydriatics|mydriatics|mesh-ancestor
92133100|NCT01794273|Autonomic Agents|autonomic agents|mesh-ancestor
92133101|NCT01794273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133102|NCT01794273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133103|NCT01794273|Sympathomimetics|sympathomimetics|mesh-ancestor
92133104|NCT01794273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92133105|NCT01794273|Nasal Decongestants|nasal decongestants|mesh-ancestor
92133106|NCT01794273|Respiratory System Agents|respiratory system agents|mesh-ancestor
92133107|NCT01794273|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92133108|NCT01794273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92133110|NCT01794273|Adrenergic Agents|adrenergic agents|mesh-ancestor
92133111|NCT01794273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133112|NCT01794273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133113|NCT01794273|Protective Agents|protective agents|mesh-ancestor
92133114|NCT01794273|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92133115|NCT02109939|Psychotropic Drugs|psychotropic drugs|mesh-list
92133116|NCT01795599|Mifepristone|mifepristone|mesh-list
92133117|NCT01795599|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92133118|NCT01795599|Abortifacient Agents|abortifacient agents|mesh-ancestor
92133119|NCT01795599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92133120|NCT01795599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133121|NCT01795599|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92133122|NCT01795599|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92133123|NCT01795599|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92133124|NCT01795599|Contraceptive Agents|contraceptive agents|mesh-ancestor
92133125|NCT01795599|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92133126|NCT01795599|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92133127|NCT01795599|Hormone Antagonists|hormone antagonists|mesh-ancestor
92133128|NCT01795599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133129|NCT01795599|Luteolytic Agents|luteolytic agents|mesh-ancestor
92133130|NCT01795599|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92133131|NCT01795599|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92133132|NCT01794351|Resveratrol|resveratrol|mesh-list
92133133|NCT01794351|Antioxidants|antioxidants|mesh-ancestor
92133134|NCT01794351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133135|NCT01794351|Protective Agents|protective agents|mesh-ancestor
92133136|NCT01794351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133137|NCT01794351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133138|NCT01794351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92133139|NCT04409431|Epinephrine|epinephrine|mesh-list
92133140|NCT04409431|Racepinephrine|racepinephrine|mesh-list
92133141|NCT04409431|Epinephryl borate|epinephryl borate|mesh-list
92133142|NCT04409431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92133143|NCT04409431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92133144|NCT04409431|Adrenergic Agents|adrenergic agents|mesh-ancestor
92133145|NCT04409431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133146|NCT04409431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133147|NCT04409431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133148|NCT04409431|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92133149|NCT04409431|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92133151|NCT04409431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133152|NCT04409431|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92133153|NCT04409431|Respiratory System Agents|respiratory system agents|mesh-ancestor
92133154|NCT04409431|Mydriatics|mydriatics|mesh-ancestor
92133155|NCT04409431|Sympathomimetics|sympathomimetics|mesh-ancestor
92133156|NCT04409431|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92133157|NCT01794507|Dexamethasone|dexamethasone|mesh-list
92133158|NCT01794507|Bortezomib|bortezomib|mesh-list
92133159|NCT01794507|Venetoclax|venetoclax|mesh-list
92133160|NCT01794507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133161|NCT01794507|Antiemetics|antiemetics|mesh-ancestor
92133162|NCT01794507|Autonomic Agents|autonomic agents|mesh-ancestor
92133163|NCT01794507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133164|NCT01794507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133165|NCT01794507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92133166|NCT01794507|Glucocorticoids|glucocorticoids|mesh-ancestor
92133167|NCT01794507|Hormones|hormones|mesh-ancestor
92133168|NCT01794507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133169|NCT01794507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92133170|NCT01794507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133171|NCT00412425|Palonosetron|palonosetron|mesh-list
92133172|NCT00412425|Antiemetics|antiemetics|mesh-ancestor
92133173|NCT00412425|Autonomic Agents|autonomic agents|mesh-ancestor
92133174|NCT00412425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133175|NCT00412425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133176|NCT00412425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92133177|NCT00412425|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92133178|NCT00412425|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92133179|NCT00412425|Serotonin Agents|serotonin agents|mesh-ancestor
92133180|NCT00412425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133181|NCT00412425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133182|NCT01492361|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92133183|NCT01492361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92133184|NCT01492361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92133185|NCT05287503|Ambroxol|ambroxol|mesh-list
92133186|NCT05287503|Expectorants|expectorants|mesh-ancestor
92133187|NCT05287503|Respiratory System Agents|respiratory system agents|mesh-ancestor
92133188|NCT00415857|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92133189|NCT00415857|Imatinib Mesylate|imatinib mesylate|mesh-list
92133190|NCT00415857|Vaccines|vaccines|mesh-list
92133191|NCT00415857|Sargramostim|sargramostim|mesh-list
92133192|NCT00415857|Immunologic Factors|immunologic factors|mesh-ancestor
92133193|NCT00415857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133194|NCT00415857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133195|NCT00415857|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133196|NCT00415857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133197|NCT00415857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133198|NCT00415857|Antiviral Agents|antiviral agents|mesh-ancestor
92133199|NCT00415857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133200|NCT03491631|Apatinib|apatinib|mesh-list
92133201|NCT03491631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133202|NCT03491631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133203|NCT03491631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133204|NCT03491631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133205|NCT04271007|Mometasone Furoate|mometasone furoate|mesh-list
92133206|NCT04271007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133207|NCT04271007|Dermatologic Agents|dermatologic agents|mesh-ancestor
92133208|NCT04271007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92133209|NCT05287035|Dexamethasone|dexamethasone|mesh-list
92133210|NCT05287035|Dexamethasone acetate|dexamethasone acetate|mesh-list
92133211|NCT05287035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133212|NCT05287035|Antiemetics|antiemetics|mesh-ancestor
92133213|NCT05287035|Autonomic Agents|autonomic agents|mesh-ancestor
92133214|NCT05287035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133215|NCT05287035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133216|NCT05287035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92133217|NCT05287035|Glucocorticoids|glucocorticoids|mesh-ancestor
92133218|NCT05287035|Hormones|hormones|mesh-ancestor
92133219|NCT05287035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133220|NCT05287035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92133221|NCT05287035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133222|NCT00416793|Carboplatin|carboplatin|mesh-list
92133223|NCT00416793|Bortezomib|bortezomib|mesh-list
92133224|NCT00416793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133225|NCT00417417|Rilonacept|rilonacept|mesh-list
92133226|NCT00417417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133227|NCT00419445|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
92133228|NCT00419445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92133229|NCT00419445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91939249|NCT03134729|Ropivacaine|ropivacaine|mesh-list
92133230|NCT00419445|Cholinergic Agents|cholinergic agents|mesh-ancestor
92133231|NCT00419445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133232|NCT00419445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133233|NCT00419445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133235|NCT00420459|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133236|NCT00420459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133237|NCT00420459|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92133238|NCT00420459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92133239|NCT00420459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133240|NCT00420459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133241|NCT00420459|Dopamine Agonists|dopamine agonists|mesh-ancestor
92133242|NCT00420459|Dopamine Agents|dopamine agents|mesh-ancestor
92133243|NCT00420459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133244|NCT00420459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133245|NCT00420459|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92133246|NCT00420459|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92133247|NCT00420459|Serotonin Agents|serotonin agents|mesh-ancestor
92133248|NCT00420459|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92133249|NCT00420459|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92133250|NCT00420459|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92133251|NCT00420459|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92133253|NCT00420771|Analgesics|analgesics|mesh-ancestor
92133254|NCT00420771|Sensory System Agents|sensory system agents|mesh-ancestor
92133255|NCT00420771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133256|NCT00420771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133257|NCT00420771|Anticonvulsants|anticonvulsants|mesh-ancestor
92133258|NCT00420771|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92133260|NCT00420771|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133261|NCT00420771|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133262|NCT00420771|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92133263|NCT00420771|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92133264|NCT00420771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133265|NCT00420771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133266|NCT00420771|Antimanic Agents|antimanic agents|mesh-ancestor
92133267|NCT00426153|Octreotide|octreotide|mesh-list
92133268|NCT00426153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92133269|NCT00426153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92133270|NCT00426153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133271|NCT04750317|Tofacitinib|tofacitinib|mesh-list
92133272|NCT04750317|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92133273|NCT04750317|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133274|NCT04750317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133275|NCT04750317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133276|NCT01996449|Amlodipine|amlodipine|mesh-list
92133277|NCT01996449|Eplerenone|eplerenone|mesh-list
92133278|NCT01996449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92133279|NCT01996449|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92133280|NCT01996449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133281|NCT01996449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133282|NCT01996449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92133283|NCT01996449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133284|NCT01996449|Vasodilator Agents|vasodilator agents|mesh-ancestor
92133285|NCT01996449|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92133286|NCT01996449|Hormone Antagonists|hormone antagonists|mesh-ancestor
92133287|NCT01996449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133288|NCT01996449|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92133289|NCT01996449|Diuretics|diuretics|mesh-ancestor
92133290|NCT01996449|Natriuretic Agents|natriuretic agents|mesh-ancestor
92133291|NCT00426855|Bortezomib|bortezomib|mesh-list
92133292|NCT00426855|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92133293|NCT00426855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133294|NCT00426855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92133295|NCT00426855|Alkylating Agents|alkylating agents|mesh-ancestor
92133296|NCT00426855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133297|NCT01491737|Trastuzumab|trastuzumab|mesh-list
92133298|NCT01491737|Pertuzumab|pertuzumab|mesh-list
92133299|NCT01491737|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92133300|NCT01491737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133302|NCT01491737|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92133303|NCT01491737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133304|NCT01491737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133305|NCT01491737|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92133306|NCT01491737|Hormone Antagonists|hormone antagonists|mesh-ancestor
92133307|NCT01491737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133308|NCT01491737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133310|NCT00427557|Fludarabine|fludarabine|mesh-list
92133311|NCT00427557|Fludarabine phosphate|fludarabine phosphate|mesh-list
92133312|NCT00427557|Melphalan|melphalan|mesh-list
92133313|NCT00427557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133314|NCT00427557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133315|NCT00427557|Immunologic Factors|immunologic factors|mesh-ancestor
92133316|NCT00427557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133317|NCT00427557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92133318|NCT00427557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92133319|NCT00427557|Antimetabolites|antimetabolites|mesh-ancestor
92133320|NCT00427557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133321|NCT00427557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133322|NCT00427557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92133323|NCT00427557|Alkylating Agents|alkylating agents|mesh-ancestor
92133324|NCT00427557|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92133325|NCT01487863|Abiraterone Acetate|abiraterone acetate|mesh-list
92133326|NCT01487863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133327|NCT01487863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92133328|NCT01487863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133329|NCT01487863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133330|NCT01487863|Hormone Antagonists|hormone antagonists|mesh-ancestor
92133331|NCT01487863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133332|NCT01487863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133333|NCT01487863|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92133334|NCT04088305|Vancomycin|vancomycin|mesh-list
92133335|NCT04088305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92133336|NCT04088305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133337|NCT00427791|Rituximab|rituximab|mesh-list
92133338|NCT00427791|Etoposide|etoposide|mesh-list
92133339|NCT00427791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133340|NCT00427791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133341|NCT00427791|Immunologic Factors|immunologic factors|mesh-ancestor
92133342|NCT00427791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133343|NCT00427791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92133344|NCT00427791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92133345|NCT00427791|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92133346|NCT00427791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92133347|NCT00427791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133348|NCT00427791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133349|NCT01487161|Triamcinolone|triamcinolone|mesh-list
92133350|NCT01487161|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92133351|NCT01487161|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92133352|NCT01487161|FX006|fx006|mesh-list
92133354|NCT01487161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133355|NCT01487161|Glucocorticoids|glucocorticoids|mesh-ancestor
92133356|NCT01487161|Hormones|hormones|mesh-ancestor
92133357|NCT01487161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133358|NCT01487161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133359|NCT01487161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133360|NCT01487161|Immunologic Factors|immunologic factors|mesh-ancestor
92133361|NCT01487161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133362|NCT01487161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133363|NCT00429507|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92133364|NCT00429507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92133365|NCT00429507|Analgesics|analgesics|mesh-ancestor
92133366|NCT00429507|Sensory System Agents|sensory system agents|mesh-ancestor
92133367|NCT00429507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133368|NCT00429507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133369|NCT01794897|Valacyclovir|valacyclovir|mesh-list
92133370|NCT01794897|Antiviral Agents|antiviral agents|mesh-ancestor
92133371|NCT01794897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133372|NCT01794975|Ketamine|ketamine|mesh-list
92133373|NCT01794975|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92133374|NCT01794975|Analgesics|analgesics|mesh-ancestor
92133375|NCT01794975|Sensory System Agents|sensory system agents|mesh-ancestor
92133376|NCT01794975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133377|NCT01794975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133378|NCT01794975|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92133379|NCT01794975|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92133380|NCT01794975|Anesthetics, General|anesthetics, general|mesh-ancestor
92133381|NCT01794975|Anesthetics|anesthetics|mesh-ancestor
92133382|NCT01794975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133383|NCT01794975|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92133384|NCT01794975|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92133385|NCT01794975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133386|NCT01794975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133387|NCT01794975|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92133388|NCT01794975|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92133389|NCT01794975|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133390|NCT01794975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92133391|NCT05285787|Menaquinone 7|menaquinone 7|mesh-list
92133392|NCT05285787|Hemostatics|hemostatics|mesh-ancestor
92133393|NCT05285787|Coagulants|coagulants|mesh-ancestor
92133394|NCT01491035|Vortioxetine|vortioxetine|mesh-list
92133395|NCT01491035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133396|NCT01491035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133397|NCT01491035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92133398|NCT01491035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92133399|NCT01491035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133400|NCT01491035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133401|NCT01491035|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92133402|NCT01491035|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92133403|NCT01491035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133404|NCT01491035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133405|NCT01491035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133406|NCT01491035|Serotonin Agents|serotonin agents|mesh-ancestor
92133407|NCT01491035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92133408|NCT01491035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92133409|NCT01491035|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92133410|NCT01491035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92133411|NCT00375999|Docetaxel|docetaxel|mesh-list
92133412|NCT00375999|Epirubicin|epirubicin|mesh-list
92133413|NCT00375999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133414|NCT00375999|Tubulin Modulators|tubulin modulators|mesh-ancestor
92133415|NCT00375999|Antimitotic Agents|antimitotic agents|mesh-ancestor
92133416|NCT00375999|Mitosis Modulators|mitosis modulators|mesh-ancestor
92133417|NCT00375999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133418|NCT00375999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92133419|NCT00375999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92133420|NCT00375999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92133421|NCT00375999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133422|NCT04409327|Dactolisib|dactolisib|mesh-list
92133423|NCT04409327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133424|NCT01488071|Vortioxetine|vortioxetine|mesh-list
92133425|NCT01488071|Agomelatine|agomelatine|mesh-list
92133426|NCT01488071|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133427|NCT01488071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133428|NCT01488071|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92133429|NCT01488071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92133430|NCT01488071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133431|NCT01488071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133432|NCT01488071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92133433|NCT01488071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92133434|NCT01488071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133435|NCT01488071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133436|NCT01488071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133437|NCT01488071|Serotonin Agents|serotonin agents|mesh-ancestor
92133438|NCT01488071|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92133439|NCT01488071|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92133440|NCT01488071|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92133441|NCT01488071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92133442|NCT01488071|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92133443|NCT01485887|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92133444|NCT01485887|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92133445|NCT01485887|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92133446|NCT01485887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133447|NCT01485887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133448|NCT01485887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133449|NCT01485887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133450|NCT01485887|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92133451|NCT01485887|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133452|NCT01485887|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133454|NCT01484951|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92133455|NCT01484951|Brinzolamide|brinzolamide|mesh-list
92133456|NCT01484951|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92133457|NCT01484951|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92133458|NCT01484951|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92133459|NCT01484951|Adrenergic Agents|adrenergic agents|mesh-ancestor
92133460|NCT01484951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133461|NCT01484951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133462|NCT01484951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133463|NCT01484951|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92133464|NCT01484951|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92133465|NCT01484951|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92133466|NCT01484951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133467|NCT01484873|Exenatide|exenatide|mesh-list
92133468|NCT01484873|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133469|NCT01484873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133470|NCT01484873|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92133471|NCT01484873|Incretins|incretins|mesh-ancestor
92133472|NCT01484873|Hormones|hormones|mesh-ancestor
92133473|NCT01484873|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133474|NCT01486927|Factor VIII|factor viii|mesh-list
92133475|NCT01486927|Coagulants|coagulants|mesh-ancestor
92133476|NCT00379197|Naltrexone|naltrexone|mesh-list
92133477|NCT00379197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92133478|NCT00379197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92133479|NCT00379197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133480|NCT00379197|Sensory System Agents|sensory system agents|mesh-ancestor
92133481|NCT00379197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133482|NCT01513759|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92133483|NCT01513759|Plasminogen|plasminogen|mesh-list
92133484|NCT01513759|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92133485|NCT01513759|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92133486|NCT01513759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133487|NCT01484561|Tofacitinib|tofacitinib|mesh-list
92133488|NCT01484561|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92133489|NCT01484561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133490|NCT01484561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133491|NCT01484561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133492|NCT01483625|Tiotropium Bromide|tiotropium bromide|mesh-list
92133493|NCT01483625|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92133494|NCT01483625|Autonomic Agents|autonomic agents|mesh-ancestor
92133495|NCT01483625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133496|NCT01483625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133497|NCT01483625|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92133498|NCT01483625|Respiratory System Agents|respiratory system agents|mesh-ancestor
92133499|NCT01483625|Parasympatholytics|parasympatholytics|mesh-ancestor
92133500|NCT01483625|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92133501|NCT01483625|Cholinergic Agents|cholinergic agents|mesh-ancestor
92133502|NCT01483625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133503|NCT01483625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133504|NCT01485991|Simeprevir|simeprevir|mesh-list
92133505|NCT01485991|Antiviral Agents|antiviral agents|mesh-ancestor
92133506|NCT01485991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133507|NCT01485991|Protease Inhibitors|protease inhibitors|mesh-ancestor
92133508|NCT01485991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133509|NCT01485991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133510|NCT00379821|Azithromycin|azithromycin|mesh-list
92133511|NCT00379821|Artesunate|artesunate|mesh-list
92133512|NCT00379821|Chloroquine|chloroquine|mesh-list
92133513|NCT00379821|Atovaquone|atovaquone|mesh-list
92133514|NCT00379821|Proguanil|proguanil|mesh-list
92133515|NCT00379821|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92133516|NCT00379821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92133517|NCT00379821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133518|NCT00379821|Antimalarials|antimalarials|mesh-ancestor
92133519|NCT00379821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92133520|NCT00379821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92133521|NCT00379821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133522|NCT00379821|Antiviral Agents|antiviral agents|mesh-ancestor
92133523|NCT00379821|Schistosomicides|schistosomicides|mesh-ancestor
92133524|NCT00379821|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92133525|NCT00379821|Anthelmintics|anthelmintics|mesh-ancestor
92133526|NCT00379821|Amebicides|amebicides|mesh-ancestor
92133527|NCT00379821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92133528|NCT00379821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133529|NCT00379821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133530|NCT00379821|Antimetabolites|antimetabolites|mesh-ancestor
92133531|NCT01482767|Interferons|interferons|mesh-list
92133532|NCT01482767|Ribavirin|ribavirin|mesh-list
92133533|NCT01482767|Interferon-alpha|interferon-alpha|mesh-list
92133534|NCT01482767|Interferon alpha-2|interferon alpha-2|mesh-list
92133535|NCT01482767|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92133536|NCT01482767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133537|NCT01482767|Antiviral Agents|antiviral agents|mesh-ancestor
92133538|NCT01482767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133539|NCT01482767|Antimetabolites|antimetabolites|mesh-ancestor
92133540|NCT01482767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133541|NCT01482767|Immunologic Factors|immunologic factors|mesh-ancestor
92133542|NCT01482767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133544|NCT00435591|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92133545|NCT00435591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133546|NCT00435591|Natriuretic Agents|natriuretic agents|mesh-ancestor
92133547|NCT00435591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133548|NCT00439335|Vaccines|vaccines|mesh-list
92133549|NCT00439335|Immunologic Factors|immunologic factors|mesh-ancestor
92133550|NCT00439335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133551|NCT01545817|Everolimus|everolimus|mesh-list
92133552|NCT01545817|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92133553|NCT01545817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133554|NCT01545817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133555|NCT01545817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133556|NCT01545817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133557|NCT01545817|Immunologic Factors|immunologic factors|mesh-ancestor
92133558|NCT01545817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133559|NCT01545817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133560|NCT01512979|Metformin|metformin|mesh-list
92133561|NCT01512979|Linagliptin|linagliptin|mesh-list
92133562|NCT01512979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133563|NCT01512979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133564|NCT01512979|Incretins|incretins|mesh-ancestor
92133565|NCT01512979|Hormones|hormones|mesh-ancestor
92133566|NCT01512979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133567|NCT01512979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92133568|NCT01512979|Protease Inhibitors|protease inhibitors|mesh-ancestor
92133569|NCT01512979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133570|NCT01512979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133571|NCT00383565|Romidepsin|romidepsin|mesh-list
92133572|NCT00383565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92133573|NCT00383565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133574|NCT00383565|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92133575|NCT00383565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133576|NCT00383565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133577|NCT01512745|Apatinib|apatinib|mesh-list
92133578|NCT01512745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133579|NCT01512745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133580|NCT01512745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939256|NCT03134651|Propofol|propofol|mesh-list
92133581|NCT01512745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133582|NCT01478321|Bevacizumab|bevacizumab|mesh-list
92133583|NCT01478321|Temozolomide|temozolomide|mesh-list
92133584|NCT01478321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133585|NCT01478321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133586|NCT01478321|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92133587|NCT01478321|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92133588|NCT01478321|Growth Substances|growth substances|mesh-ancestor
92133589|NCT01478321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133590|NCT01478321|Growth Inhibitors|growth inhibitors|mesh-ancestor
92133591|NCT01478321|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92133592|NCT01478321|Alkylating Agents|alkylating agents|mesh-ancestor
92133593|NCT01478321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133594|NCT01544491|Everolimus|everolimus|mesh-list
92133595|NCT01544491|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92133596|NCT01544491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133597|NCT01544491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133598|NCT01544491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133599|NCT01544491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133600|NCT01544491|Immunologic Factors|immunologic factors|mesh-ancestor
92133601|NCT01544491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133602|NCT01544491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133603|NCT00383643|Sodium Oxybate|sodium oxybate|mesh-list
92133604|NCT00383643|Zolpidem|zolpidem|mesh-list
92133605|NCT00383643|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92133606|NCT00383643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92133607|NCT00383643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133608|NCT00383643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133609|NCT00383643|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92133610|NCT00383643|GABA Agonists|gaba agonists|mesh-ancestor
92133611|NCT00383643|GABA Agents|gaba agents|mesh-ancestor
92133612|NCT00383643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133613|NCT00383643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133614|NCT00383643|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92133615|NCT00383643|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92133616|NCT00383643|Anesthetics, General|anesthetics, general|mesh-ancestor
92133617|NCT00383643|Anesthetics|anesthetics|mesh-ancestor
92133618|NCT00439413|Selegiline|selegiline|mesh-list
92133619|NCT00439413|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133620|NCT00439413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133621|NCT00439413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92133622|NCT00439413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92133623|NCT00439413|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92133624|NCT00439413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133625|NCT00439413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133626|NCT00439413|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92133627|NCT00439413|Protective Agents|protective agents|mesh-ancestor
92133628|NCT00439413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133630|NCT01477853|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92133631|NCT01477853|Glimepiride|glimepiride|mesh-list
92133632|NCT01477853|Atorvastatin|atorvastatin|mesh-list
92133633|NCT01477853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133634|NCT01477853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133635|NCT01477853|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92133636|NCT01477853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92133637|NCT01477853|Antimetabolites|antimetabolites|mesh-ancestor
92133638|NCT01477853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133639|NCT01477853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92133640|NCT01477853|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92133641|NCT01477853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133642|NCT01477853|Incretins|incretins|mesh-ancestor
92133643|NCT01477853|Hormones|hormones|mesh-ancestor
92133644|NCT01477853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133645|NCT01477853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92133646|NCT01477853|Protease Inhibitors|protease inhibitors|mesh-ancestor
92133647|NCT01477853|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92133648|NCT01477853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133649|NCT01477853|Immunologic Factors|immunologic factors|mesh-ancestor
92133650|NCT00440505|Nicotine|nicotine|mesh-list
92133651|NCT00440505|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92133652|NCT00440505|Autonomic Agents|autonomic agents|mesh-ancestor
92133653|NCT00440505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133654|NCT00440505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133655|NCT00440505|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92133656|NCT00440505|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92133657|NCT00440505|Cholinergic Agents|cholinergic agents|mesh-ancestor
92133658|NCT00440505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133659|NCT00440505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133660|NCT00441285|Albendazole|albendazole|mesh-list
92133661|NCT00441285|Praziquantel|praziquantel|mesh-list
92133662|NCT00441285|Anthelmintics|anthelmintics|mesh-ancestor
92133663|NCT00441285|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92133664|NCT00441285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133665|NCT00441285|Anticestodal Agents|anticestodal agents|mesh-ancestor
92133666|NCT00441285|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92133667|NCT00441285|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92133668|NCT00441285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92133669|NCT00441285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92133670|NCT00441285|Mitosis Modulators|mitosis modulators|mesh-ancestor
92133671|NCT00441285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133672|NCT00441285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133674|NCT01796613|Desogestrel|desogestrel|mesh-list
92133675|NCT01796613|Etonogestrel|etonogestrel|mesh-list
92133676|NCT01796613|NuvaRing|nuvaring|mesh-list
92133677|NCT01796613|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92133678|NCT01796613|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92133679|NCT01796613|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92133680|NCT01796613|Contraceptive Agents|contraceptive agents|mesh-ancestor
92133681|NCT01796613|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92133682|NCT01796613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133683|NCT01796613|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92133684|NCT01796613|Estrogens|estrogens|mesh-ancestor
92133685|NCT01796613|Hormones|hormones|mesh-ancestor
92133686|NCT01796613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133687|NCT01796613|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92133688|NCT01796613|Progestins|progestins|mesh-ancestor
92133689|NCT00442611|Abatacept|abatacept|mesh-list
92133690|NCT00442611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92133691|NCT00442611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133692|NCT00442611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133693|NCT00442611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133694|NCT00442611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133695|NCT00442611|Immunologic Factors|immunologic factors|mesh-ancestor
92133696|NCT00442611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133698|NCT01511107|Amoxicillin|amoxicillin|mesh-list
92133699|NCT01511107|Clavulanic Acid|clavulanic acid|mesh-list
92133700|NCT01511107|Clavulanic Acids|clavulanic acids|mesh-list
92133701|NCT01511107|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92133702|NCT01511107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92133703|NCT01511107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133704|NCT01511107|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92133705|NCT01511107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133706|NCT01511107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133707|NCT00387621|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92133708|NCT00387621|Natriuretic Agents|natriuretic agents|mesh-ancestor
92133709|NCT00387621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133716|NCT00442689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133717|NCT00442689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133718|NCT00442689|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92133719|NCT00442689|Contraceptive Agents|contraceptive agents|mesh-ancestor
92133720|NCT00442689|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92133721|NCT00442689|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92133722|NCT00442689|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92133723|NCT00442689|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92133724|NCT00442689|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92133725|NCT00442689|Hormone Antagonists|hormone antagonists|mesh-ancestor
92133726|NCT00442689|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92133727|NCT00442689|Diuretics|diuretics|mesh-ancestor
92133728|NCT00442689|Natriuretic Agents|natriuretic agents|mesh-ancestor
92133729|NCT00442689|Androgen Antagonists|androgen antagonists|mesh-ancestor
92133731|NCT00442689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133732|NCT01484977|Lacosamide|lacosamide|mesh-list
92133733|NCT01484977|Anticonvulsants|anticonvulsants|mesh-ancestor
92133734|NCT01484977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92133735|NCT01484977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92133736|NCT01484977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133737|NCT01484977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133738|NCT00442767|Insulin|insulin|mesh-list
92133739|NCT00442767|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92133740|NCT00442767|Pramlintide|pramlintide|mesh-list
92133741|NCT00442767|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92133742|NCT00442767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133743|NCT00442767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133744|NCT00442767|Appetite Depressants|appetite depressants|mesh-ancestor
92133745|NCT00442767|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92133746|NCT00442767|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92133747|NCT00442767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133748|NCT00445263|Tirofiban|tirofiban|mesh-list
92133749|NCT00445263|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92133750|NCT00445263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92133751|NCT00445263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133752|NCT00445263|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92133753|NCT00389493|Risperidone|risperidone|mesh-list
92133754|NCT00389493|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92133755|NCT00389493|Serotonin Agents|serotonin agents|mesh-ancestor
92133756|NCT00389493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133757|NCT00389493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133758|NCT00389493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133759|NCT00389493|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92133760|NCT00389493|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92133761|NCT00389493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133762|NCT00389493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133763|NCT00389493|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92133764|NCT00389493|Dopamine Agents|dopamine agents|mesh-ancestor
92133765|NCT04388709|Interferons|interferons|mesh-list
92133766|NCT04388709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133767|NCT04388709|Antiviral Agents|antiviral agents|mesh-ancestor
92133768|NCT04388709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92133769|NCT00389805|Pemetrexed|pemetrexed|mesh-list
92133770|NCT00389805|Bortezomib|bortezomib|mesh-list
92133771|NCT00389805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133772|NCT00389805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133773|NCT00389805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133774|NCT00389805|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92133775|NCT00389805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92133776|NCT00456807|Vaccines|vaccines|mesh-list
92133777|NCT00456807|Immunologic Factors|immunologic factors|mesh-ancestor
92133778|NCT00456807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133779|NCT00456885|Exenatide|exenatide|mesh-list
92133780|NCT00456885|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133781|NCT00456885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133782|NCT00456885|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92133783|NCT00456885|Incretins|incretins|mesh-ancestor
92133784|NCT00456885|Hormones|hormones|mesh-ancestor
92133785|NCT00456885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133786|NCT01475825|Mipomersen|mipomersen|mesh-list
92133787|NCT01475825|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92133788|NCT01475825|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92133789|NCT01475825|Antimetabolites|antimetabolites|mesh-ancestor
92133790|NCT01475825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133791|NCT01475825|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92133793|NCT00457197|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133794|NCT00457197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133795|NCT00457197|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92133796|NCT00457197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92133797|NCT00457197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92133798|NCT00457197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133799|NCT01484431|Tadalafil|tadalafil|mesh-list
92133800|NCT01484431|Vasodilator Agents|vasodilator agents|mesh-ancestor
92133801|NCT01484431|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92133802|NCT01484431|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92133803|NCT01484431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939271|NCT05202080|Analgesics, Opioid|analgesics, opioid|mesh-list
92133804|NCT01484431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133805|NCT01484431|Urological Agents|urological agents|mesh-ancestor
92133806|NCT00445887|Levonorgestrel|levonorgestrel|mesh-list
92133807|NCT00445887|Norgestrel|norgestrel|mesh-list
92133808|NCT00445887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92133809|NCT00445887|Contraceptive Agents|contraceptive agents|mesh-ancestor
92133810|NCT00445887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92133811|NCT00445887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133812|NCT00445887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92133813|NCT00445887|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92133814|NCT00445887|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92133815|NCT00445887|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92133816|NCT01473953|Liraglutide|liraglutide|mesh-list
92133817|NCT01473953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133818|NCT01473953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133819|NCT01473953|Incretins|incretins|mesh-ancestor
92133820|NCT01473953|Hormones|hormones|mesh-ancestor
92092082|NCT01592708|Hormones|hormones|mesh-ancestor
92133821|NCT01473953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133822|NCT00457977|Vaccines|vaccines|mesh-list
92133823|NCT00457977|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92133824|NCT00457977|Immunologic Factors|immunologic factors|mesh-ancestor
92133825|NCT00457977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133826|NCT01473563|Pemetrexed|pemetrexed|mesh-list
92133827|NCT01473563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133828|NCT01473563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133829|NCT01473563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133830|NCT01473563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92133831|NCT01473563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92133832|NCT01795209|Ranibizumab|ranibizumab|mesh-list
92133833|NCT01795209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92133834|NCT01795209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92133835|NCT01795209|Growth Substances|growth substances|mesh-ancestor
92133836|NCT01795209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133837|NCT01795209|Growth Inhibitors|growth inhibitors|mesh-ancestor
92133838|NCT01795209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133840|NCT01484275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133841|NCT01484197|Maleic acid|maleic acid|mesh-list
92133842|NCT01484197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133843|NCT01484197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133844|NCT01473407|Epoetin Alfa|epoetin alfa|mesh-list
92133845|NCT01473407|Hematinics|hematinics|mesh-ancestor
92133846|NCT04082897|Atezolizumab|atezolizumab|mesh-list
92133847|NCT04082897|Venetoclax|venetoclax|mesh-list
92133848|NCT04082897|Obinutuzumab|obinutuzumab|mesh-list
92133849|NCT04082897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92133850|NCT04082897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133851|NCT04082897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133852|NCT04082897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133853|NCT01544179|Pemetrexed|pemetrexed|mesh-list
92133854|NCT01544179|Gefitinib|gefitinib|mesh-list
92133855|NCT01544179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133856|NCT01544179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133857|NCT01544179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133858|NCT01544179|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92133859|NCT01544179|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92133860|NCT01544179|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133861|NCT01483651|Insulin|insulin|mesh-list
92133862|NCT01483651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92133863|NCT01483651|Glucagon|glucagon|mesh-list
92133864|NCT01483651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133865|NCT01483651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133866|NCT01483651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92133867|NCT01483651|Hormones|hormones|mesh-ancestor
92133868|NCT01483651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133869|NCT01464307|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92133870|NCT01464307|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92133871|NCT01464307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133872|NCT01464307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133873|NCT01464307|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92133874|NCT01464307|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133875|NCT01464307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133876|NCT01464307|Cholinergic Agents|cholinergic agents|mesh-ancestor
92133877|NCT01464307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133878|NCT01482169|Adenosine|adenosine|mesh-list
92133879|NCT01482169|Regadenoson|regadenoson|mesh-list
92133880|NCT01482169|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92133881|NCT01482169|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92133882|NCT01482169|Purinergic Agonists|purinergic agonists|mesh-ancestor
92133883|NCT01482169|Purinergic Agents|purinergic agents|mesh-ancestor
92133884|NCT01482169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133885|NCT01482169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133886|NCT01482169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133887|NCT01482169|Analgesics|analgesics|mesh-ancestor
92133888|NCT01482169|Sensory System Agents|sensory system agents|mesh-ancestor
92133889|NCT01482169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133890|NCT01482169|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92133891|NCT01482169|Vasodilator Agents|vasodilator agents|mesh-ancestor
92133892|NCT01481779|Insulin Lispro|insulin lispro|mesh-list
92133893|NCT01481779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92133894|NCT01481779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133895|NCT01509547|Varenicline|varenicline|mesh-list
92133896|NCT01509547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92133897|NCT01509547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92133898|NCT01509547|Cholinergic Agents|cholinergic agents|mesh-ancestor
92133899|NCT01509547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133900|NCT01509547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133901|NCT01509547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133902|NCT01509079|Vitamin D|vitamin d|mesh-list
92133903|NCT01509079|Ergocalciferols|ergocalciferols|mesh-list
92133904|NCT01509079|Cholecalciferol|cholecalciferol|mesh-list
92133905|NCT01509079|Vitamins|vitamins|mesh-list
92133906|NCT01509079|Micronutrients|micronutrients|mesh-ancestor
92133907|NCT01509079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133908|NCT01509079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92133909|NCT01509079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92133911|NCT04650217|Carbidopa|carbidopa|mesh-list
92133912|NCT04650217|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92133913|NCT04650217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92133914|NCT04650217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92133915|NCT04650217|Dopamine Agents|dopamine agents|mesh-ancestor
92133916|NCT04650217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133917|NCT04650217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133918|NCT04650217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133919|NCT04650217|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92133920|NCT04650217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133921|NCT04650217|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92133922|NCT04650217|Immunologic Factors|immunologic factors|mesh-ancestor
92133923|NCT04650217|Dopamine Agonists|dopamine agonists|mesh-ancestor
92133924|NCT01462435|Celecoxib|celecoxib|mesh-list
92133925|NCT01462435|Diclofenac|diclofenac|mesh-list
92133926|NCT01462435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92133927|NCT01462435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92133928|NCT01462435|Analgesics|analgesics|mesh-ancestor
92133929|NCT01462435|Sensory System Agents|sensory system agents|mesh-ancestor
92133930|NCT01462435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133931|NCT01462435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133932|NCT01462435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133933|NCT01462435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92133934|NCT01462435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92133935|NCT01462435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92133936|NCT01462435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133937|NCT01462435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133938|NCT01472081|Nivolumab|nivolumab|mesh-list
92133939|NCT01472081|Ipilimumab|ipilimumab|mesh-list
92133940|NCT01472081|Sunitinib|sunitinib|mesh-list
92133941|NCT01472081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92133942|NCT01472081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133943|NCT01472081|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92133944|NCT01472081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133945|NCT01472081|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92133946|NCT01472081|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92133947|NCT01472081|Growth Substances|growth substances|mesh-ancestor
92133948|NCT01472081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133949|NCT01472081|Growth Inhibitors|growth inhibitors|mesh-ancestor
92133950|NCT01472081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133951|NCT01472081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133952|NCT01471691|Ranibizumab|ranibizumab|mesh-list
92133953|NCT01471691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92133954|NCT01471691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92133955|NCT01471691|Growth Substances|growth substances|mesh-ancestor
92133956|NCT01471691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133957|NCT01471691|Growth Inhibitors|growth inhibitors|mesh-ancestor
92133958|NCT01471691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92133959|NCT01471379|Milnacipran|milnacipran|mesh-list
92133960|NCT01471379|Levomilnacipran|levomilnacipran|mesh-list
92133961|NCT01471379|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92133962|NCT01471379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92133963|NCT01471379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133964|NCT01471379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133965|NCT01471379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92133966|NCT01471379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133967|NCT01471379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92133968|NCT01471379|Analgesics|analgesics|mesh-ancestor
92133969|NCT01471379|Sensory System Agents|sensory system agents|mesh-ancestor
92133970|NCT01471379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92133971|NCT01471379|Antidepressive Agents|antidepressive agents|mesh-ancestor
92133972|NCT01471379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92133973|NCT01470989|Triamcinolone|triamcinolone|mesh-list
92133974|NCT01470989|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92133975|NCT01470989|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92133976|NCT01470989|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92133977|NCT01470989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92133979|NCT01470989|Hormones|hormones|mesh-ancestor
92133980|NCT01470989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92133981|NCT01470989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92133982|NCT01470989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92133983|NCT01470989|Immunologic Factors|immunologic factors|mesh-ancestor
92133984|NCT01470989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133985|NCT01470989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133986|NCT01470599|Tofacitinib|tofacitinib|mesh-list
92133987|NCT01470599|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92133988|NCT01470599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92133989|NCT01470599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92133990|NCT01470599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133991|NCT01469819|Lubiprostone|lubiprostone|mesh-list
92133992|NCT01469819|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92133993|NCT01469819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92133994|NCT01469819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92133995|NCT04618523|Artesunate|artesunate|mesh-list
92133996|NCT04618523|Lumefantrine|lumefantrine|mesh-list
92133997|NCT04618523|Artemether|artemether|mesh-list
92133998|NCT04618523|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92133999|NCT04618523|Amodiaquine|amodiaquine|mesh-list
92134000|NCT04618523|Antimalarials|antimalarials|mesh-ancestor
92134001|NCT04618523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92134002|NCT04618523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92134003|NCT04618523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134004|NCT04618523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134005|NCT04618523|Antiviral Agents|antiviral agents|mesh-ancestor
92134006|NCT04618523|Schistosomicides|schistosomicides|mesh-ancestor
92134007|NCT04618523|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92134008|NCT04618523|Anthelmintics|anthelmintics|mesh-ancestor
92134009|NCT01507831|Alirocumab|alirocumab|mesh-list
92134010|NCT01507831|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92134011|NCT01507831|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92134012|NCT01507831|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92134013|NCT01507831|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92134014|NCT01507831|Antimetabolites|antimetabolites|mesh-ancestor
92134015|NCT01507831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134016|NCT01507831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92134017|NCT01507831|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134019|NCT01507831|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92134020|NCT01507831|Immunologic Factors|immunologic factors|mesh-ancestor
92134021|NCT01507831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134022|NCT01479439|Losartan|losartan|mesh-list
92134023|NCT01479439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92134024|NCT01479439|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92134025|NCT01479439|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92134026|NCT01479439|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92134027|NCT01479439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134029|NCT01478971|Hematinics|hematinics|mesh-ancestor
92134030|NCT01507051|Vitamin K|vitamin k|mesh-list
92134031|NCT01507051|Vitamin K 1|vitamin k 1|mesh-list
92134032|NCT01507051|Warfarin|warfarin|mesh-list
92134033|NCT01507051|Rivaroxaban|rivaroxaban|mesh-list
92134034|NCT01507051|Vitamins|vitamins|mesh-ancestor
92134035|NCT01507051|Micronutrients|micronutrients|mesh-ancestor
92134036|NCT01507051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134037|NCT01507051|Anticoagulants|anticoagulants|mesh-ancestor
92134038|NCT01507051|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92134039|NCT01507051|Antithrombins|antithrombins|mesh-ancestor
92134040|NCT01507051|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92134041|NCT01507051|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134042|NCT01507051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134043|NCT01507051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134044|NCT01507051|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92134045|NCT01507051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92134046|NCT01507051|Hemostatics|hemostatics|mesh-ancestor
92134047|NCT01507051|Coagulants|coagulants|mesh-ancestor
92134049|NCT04079257|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92134050|NCT04079257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134051|NCT04079257|Immunologic Factors|immunologic factors|mesh-ancestor
92134052|NCT04079257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134053|NCT01478113|Amphetamine|amphetamine|mesh-list
92134054|NCT01478113|Adderall|adderall|mesh-list
92134055|NCT01478113|Dextroamphetamine|dextroamphetamine|mesh-list
92134056|NCT01478113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92134057|NCT01478113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134058|NCT01478113|Sympathomimetics|sympathomimetics|mesh-ancestor
92134059|NCT01478113|Autonomic Agents|autonomic agents|mesh-ancestor
92134060|NCT01478113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134061|NCT01478113|Dopamine Agents|dopamine agents|mesh-ancestor
92134062|NCT01478113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134063|NCT01478113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134064|NCT01478113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92134065|NCT01478113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92134066|NCT01478113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92134067|NCT01478113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134068|NCT01478113|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92134069|NCT01506271|Imipenem|imipenem|mesh-list
92134070|NCT01506271|Relebactam|relebactam|mesh-list
92134071|NCT01506271|Cilastatin|cilastatin|mesh-list
92134072|NCT01506271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134073|NCT01506271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134074|NCT01506271|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134075|NCT01506271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134076|NCT01506271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134077|NCT01506271|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92134078|NCT01506193|Vaccines|vaccines|mesh-list
92134079|NCT01506193|Immunologic Factors|immunologic factors|mesh-ancestor
92134080|NCT01506193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134081|NCT01505881|Warfarin|warfarin|mesh-list
92134082|NCT01505881|Dabigatran|dabigatran|mesh-list
92134083|NCT01505881|Anticoagulants|anticoagulants|mesh-ancestor
92134084|NCT01505881|Antithrombins|antithrombins|mesh-ancestor
92134085|NCT01505881|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92134086|NCT01505881|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134087|NCT01505881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134088|NCT01505881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134089|NCT01505647|Vaccines|vaccines|mesh-list
92134090|NCT01505647|Immunologic Factors|immunologic factors|mesh-ancestor
92134091|NCT01505647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134092|NCT01477333|Treprostinil|treprostinil|mesh-list
92134093|NCT01477333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92134094|NCT01505491|Adalimumab|adalimumab|mesh-list
92134095|NCT01505491|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92134096|NCT01505491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134097|NCT01505491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134098|NCT01504867|Aspirin|aspirin|mesh-list
92134099|NCT01504867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92134100|NCT01504867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92134101|NCT01504867|Analgesics|analgesics|mesh-ancestor
92134102|NCT01504867|Sensory System Agents|sensory system agents|mesh-ancestor
92134103|NCT01504867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134104|NCT01504867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134105|NCT01504867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134106|NCT01504867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134107|NCT01504867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92134108|NCT01504867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92134109|NCT01504867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134110|NCT01504867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92134111|NCT01504867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92134112|NCT01504867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134113|NCT01504867|Antipyretics|antipyretics|mesh-ancestor
92134114|NCT01476475|Insulin|insulin|mesh-list
92134115|NCT01476475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92134116|NCT01476475|Metformin|metformin|mesh-list
92134117|NCT01476475|Insulin Glargine|insulin glargine|mesh-list
92134118|NCT01476475|Lixisenatide|lixisenatide|mesh-list
92134119|NCT01476475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92134120|NCT01476475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134121|NCT01460719|Vaccines|vaccines|mesh-list
92134122|NCT01460719|Immunologic Factors|immunologic factors|mesh-ancestor
92134123|NCT01460719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134124|NCT00527943|Vorapaxar|vorapaxar|mesh-list
92134125|NCT00527943|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92134126|NCT00448227|Famciclovir|famciclovir|mesh-list
92134127|NCT00448227|Antiviral Agents|antiviral agents|mesh-ancestor
92134128|NCT00448227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134129|NCT00448227|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92134130|NCT00448227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134131|NCT00448227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134132|NCT00529191|Atorvastatin|atorvastatin|mesh-list
92134133|NCT00529191|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92134134|NCT00529191|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92134135|NCT00529191|Antimetabolites|antimetabolites|mesh-ancestor
92134136|NCT00529191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134137|NCT00529191|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92134138|NCT00529191|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92134139|NCT00529191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134140|NCT00449007|Bupropion|bupropion|mesh-list
92134141|NCT00449007|Fluoxetine|fluoxetine|mesh-list
92134142|NCT00449007|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92134143|NCT00449007|Antidepressive Agents|antidepressive agents|mesh-ancestor
92134144|NCT00449007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92134145|NCT00449007|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92134146|NCT00449007|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92134147|NCT00449007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134148|NCT00449007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134149|NCT00449007|Dopamine Agents|dopamine agents|mesh-ancestor
92134150|NCT00449007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134151|NCT00449007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134152|NCT00449007|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92134153|NCT00449007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134154|NCT00449007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134155|NCT00449007|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92134156|NCT00449007|Serotonin Agents|serotonin agents|mesh-ancestor
92134157|NCT03331731|Pembrolizumab|pembrolizumab|mesh-list
92134158|NCT03331731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134159|NCT03331731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134160|NCT03331731|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92134161|NCT03331731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134162|NCT00460551|Zalutumumab|zalutumumab|mesh-list
92134163|NCT00460551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134164|NCT00460551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134165|NCT01468181|Dulaglutide|dulaglutide|mesh-list
92134166|NCT01468181|Biguanides|biguanides|mesh-list
92134168|NCT01468181|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92134169|NCT01468181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92134170|NCT01468181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134171|NCT01468181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134172|NCT01468181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134173|NCT01693562|Durvalumab|durvalumab|mesh-list
92134174|NCT01693562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134175|NCT01693562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134176|NCT00461097|Immunomodulating Agents|immunomodulating agents|mesh-list
92134177|NCT00461097|Immunologic Factors|immunologic factors|mesh-ancestor
92134178|NCT00461097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134179|NCT00531453|Thalidomide|thalidomide|mesh-list
92134180|NCT00531453|Dexamethasone|dexamethasone|mesh-list
92134181|NCT00531453|Dexamethasone acetate|dexamethasone acetate|mesh-list
92134182|NCT00531453|Cyclophosphamide|cyclophosphamide|mesh-list
92134184|NCT00531453|BB 1101|bb 1101|mesh-list
92134185|NCT00531453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134186|NCT00531453|Immunologic Factors|immunologic factors|mesh-ancestor
92134187|NCT00531453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134188|NCT00531453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134189|NCT00531453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92134190|NCT00531453|Alkylating Agents|alkylating agents|mesh-ancestor
92134191|NCT00531453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134192|NCT00531453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134193|NCT00531453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92134194|NCT00531453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134195|NCT00531453|Antiemetics|antiemetics|mesh-ancestor
92134196|NCT00531453|Autonomic Agents|autonomic agents|mesh-ancestor
92134197|NCT00531453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134198|NCT00531453|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92134199|NCT00531453|Glucocorticoids|glucocorticoids|mesh-ancestor
92134200|NCT00531453|Hormones|hormones|mesh-ancestor
92134201|NCT00531453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134202|NCT00531453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92134203|NCT00531453|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134204|NCT00531453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134205|NCT00531453|Leprostatic Agents|leprostatic agents|mesh-ancestor
92134206|NCT00531453|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134207|NCT00531453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134208|NCT00531453|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92134209|NCT00531453|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92134210|NCT00531453|Growth Substances|growth substances|mesh-ancestor
92134211|NCT00531453|Growth Inhibitors|growth inhibitors|mesh-ancestor
92134213|NCT00531843|Fondaparinux|fondaparinux|mesh-list
92134214|NCT00531843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92134215|NCT00531843|Antithrombins|antithrombins|mesh-ancestor
92134216|NCT00531843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92134217|NCT00531843|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134218|NCT00531843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134219|NCT00531843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134220|NCT00531843|Anticoagulants|anticoagulants|mesh-ancestor
92134221|NCT00531843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92134222|NCT00531843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92134223|NCT02073461|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92134224|NCT02073461|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134225|NCT01590758|Pexiganan|pexiganan|mesh-list
92134226|NCT01590758|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134227|NCT01590758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134228|NCT00534417|Capecitabine|capecitabine|mesh-list
92134229|NCT00534417|Fulvestrant|fulvestrant|mesh-list
92134230|NCT00534417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92134231|NCT00534417|Antimetabolites|antimetabolites|mesh-ancestor
92134232|NCT00534417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134233|NCT00534417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134234|NCT00534417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92134235|NCT00534417|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92134236|NCT00534417|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92134237|NCT00534417|Hormone Antagonists|hormone antagonists|mesh-ancestor
92134238|NCT00534417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134239|NCT00534417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134240|NCT01692626|Pimecrolimus|pimecrolimus|mesh-list
92134241|NCT01692626|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92134242|NCT01692626|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92134243|NCT01692626|Analgesics|analgesics|mesh-ancestor
92134244|NCT01692626|Sensory System Agents|sensory system agents|mesh-ancestor
92134245|NCT01692626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134246|NCT01692626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134247|NCT01692626|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134248|NCT01692626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134249|NCT01692626|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134250|NCT01692626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134252|NCT01692626|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92134254|NCT01692626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134255|NCT00535587|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92134256|NCT00535587|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92134257|NCT00535587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134258|NCT00535587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134259|NCT00535587|Cholinergic Agents|cholinergic agents|mesh-ancestor
92134260|NCT00535587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134261|NCT00535587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134262|NCT01475461|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92134263|NCT01475461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92134264|NCT01475461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134265|NCT01475461|Incretins|incretins|mesh-ancestor
92134266|NCT01475461|Hormones|hormones|mesh-ancestor
92134267|NCT01475461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134268|NCT01475461|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92134269|NCT01475461|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134270|NCT01475461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134271|NCT01475461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134272|NCT01589822|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92134273|NCT01589822|Hemostatics|hemostatics|mesh-ancestor
92134274|NCT01589822|Coagulants|coagulants|mesh-ancestor
92134275|NCT01475071|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92134276|NCT01475071|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92134277|NCT01475071|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92134278|NCT01475071|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134279|NCT01474993|Sulforaphane|sulforaphane|mesh-list
92134280|NCT01474993|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92134281|NCT01474993|Protective Agents|protective agents|mesh-ancestor
92134282|NCT01474993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134283|NCT01474993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134284|NCT01691768|Tenofovir|tenofovir|mesh-list
92134285|NCT01691768|Antiviral Agents|antiviral agents|mesh-ancestor
92134286|NCT01691768|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134287|NCT01691768|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92134288|NCT01691768|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92134289|NCT01691768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134290|NCT01691768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134291|NCT01691768|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92134292|NCT01691768|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92134293|NCT01503229|Prednisone|prednisone|mesh-list
92134294|NCT01503229|Cortisone|cortisone|mesh-list
92134295|NCT01503229|Abiraterone Acetate|abiraterone acetate|mesh-list
92134296|NCT01503229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134297|NCT01503229|Glucocorticoids|glucocorticoids|mesh-ancestor
92134298|NCT01503229|Hormones|hormones|mesh-ancestor
92134299|NCT01503229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134300|NCT01503229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134301|NCT01503229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92134302|NCT01503229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134303|NCT01503229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92134304|NCT01503229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134305|NCT01503229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134306|NCT01503229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92134307|NCT01503229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134308|NCT01460407|Clarithromycin|clarithromycin|mesh-list
92134309|NCT01460407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134310|NCT01460407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134311|NCT01460407|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92134312|NCT01460407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134313|NCT01460407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134314|NCT01460407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92134315|NCT01460407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134316|NCT01502371|Mometasone Furoate|mometasone furoate|mesh-list
92134317|NCT01502371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134318|NCT01502371|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134319|NCT01502371|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92134320|NCT01588496|Evolocumab|evolocumab|mesh-list
92134321|NCT01588496|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92134322|NCT01588496|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92134323|NCT01588496|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92134324|NCT01588496|Antimetabolites|antimetabolites|mesh-ancestor
91939275|NCT05202080|Analgesics|analgesics|mesh-ancestor
92134325|NCT01588496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134326|NCT01588496|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92134327|NCT01588496|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134328|NCT01588496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134329|NCT01588496|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92134330|NCT01502293|Interleukin-12|interleukin-12|mesh-list
92134331|NCT01502293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92134332|NCT01502293|Immunologic Factors|immunologic factors|mesh-ancestor
92134333|NCT01502293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134334|NCT01502293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92134335|NCT01502293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92134336|NCT01502293|Growth Substances|growth substances|mesh-ancestor
92134337|NCT01502293|Growth Inhibitors|growth inhibitors|mesh-ancestor
92134338|NCT01502293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134339|NCT01588184|Bevacizumab|bevacizumab|mesh-list
92134340|NCT01588184|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134341|NCT01588184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134342|NCT01588184|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92134343|NCT01588184|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92134344|NCT01588184|Growth Substances|growth substances|mesh-ancestor
92134345|NCT01588184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134346|NCT01588184|Growth Inhibitors|growth inhibitors|mesh-ancestor
92134347|NCT01564862|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92134348|NCT01564862|Vortioxetine|vortioxetine|mesh-list
92134349|NCT01564862|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92134350|NCT01564862|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92134351|NCT01564862|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134352|NCT01564862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134353|NCT01564862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134354|NCT01564862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134355|NCT01564862|Analgesics|analgesics|mesh-ancestor
92134356|NCT01564862|Sensory System Agents|sensory system agents|mesh-ancestor
92134357|NCT01564862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134358|NCT01564862|Antidepressive Agents|antidepressive agents|mesh-ancestor
92134359|NCT01564862|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92134360|NCT01564862|Dopamine Agents|dopamine agents|mesh-ancestor
92134361|NCT01564862|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92134362|NCT01564862|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92134363|NCT01564862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134364|NCT01564862|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92134365|NCT01564862|Serotonin Agents|serotonin agents|mesh-ancestor
92134366|NCT01564862|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92134367|NCT01564862|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92134368|NCT01564862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92134369|NCT01564862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92134370|NCT04857164|Pembrolizumab|pembrolizumab|mesh-list
92134371|NCT04857164|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134372|NCT04857164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134373|NCT04857164|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92134374|NCT04857164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134375|NCT01467479|Interferons|interferons|mesh-list
92134376|NCT01467479|Ribavirin|ribavirin|mesh-list
92134377|NCT01467479|Interferon-alpha|interferon-alpha|mesh-list
92134378|NCT01467479|Interferon alpha-2|interferon alpha-2|mesh-list
92134379|NCT01467479|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92134380|NCT01467479|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92134381|NCT01467479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134382|NCT01467479|Antiviral Agents|antiviral agents|mesh-ancestor
92134383|NCT01467479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134384|NCT01467479|Antimetabolites|antimetabolites|mesh-ancestor
92134385|NCT01467479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134386|NCT01467479|Immunologic Factors|immunologic factors|mesh-ancestor
92134387|NCT01467479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134388|NCT01466387|Vaccines|vaccines|mesh-list
92134389|NCT01466387|Immunologic Factors|immunologic factors|mesh-ancestor
92134390|NCT01466387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134391|NCT00535743|Bromides|bromides|mesh-list
92134392|NCT00535743|Rocuronium|rocuronium|mesh-list
92134393|NCT00535743|Anticonvulsants|anticonvulsants|mesh-ancestor
92134394|NCT00535743|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92134395|NCT00535743|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92134396|NCT00535743|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92134397|NCT00535743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134398|NCT00535743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134399|NCT01564784|Cytarabine|cytarabine|mesh-list
92134400|NCT01564784|Fludarabine|fludarabine|mesh-list
92134403|NCT01564784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134404|NCT01564784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92134405|NCT01564784|Antimetabolites|antimetabolites|mesh-ancestor
92134406|NCT01564784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134407|NCT01564784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134408|NCT01564784|Immunologic Factors|immunologic factors|mesh-ancestor
92134409|NCT01564784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134410|NCT01564784|Antiviral Agents|antiviral agents|mesh-ancestor
92134411|NCT01564784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134412|NCT01564784|Analgesics|analgesics|mesh-ancestor
92134413|NCT01564784|Sensory System Agents|sensory system agents|mesh-ancestor
92134414|NCT01564784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134415|NCT01564784|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92134416|NCT01564784|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92134417|NCT01564784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134418|NCT01564784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134419|NCT01564784|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92134420|NCT01564784|Immunotoxins|immunotoxins|mesh-ancestor
92134421|NCT01564784|Immunoconjugates|immunoconjugates|mesh-ancestor
92134422|NCT00536601|Cyclophosphamide|cyclophosphamide|mesh-list
92134423|NCT00536601|Melphalan|melphalan|mesh-list
92134424|NCT00536601|Busulfan|busulfan|mesh-list
92134425|NCT00536601|Thiotepa|thiotepa|mesh-list
92134426|NCT00536601|Carmustine|carmustine|mesh-list
92134427|NCT00536601|Carboplatin|carboplatin|mesh-list
92134428|NCT00536601|Etoposide|etoposide|mesh-list
92134429|NCT00536601|Etoposide phosphate|etoposide phosphate|mesh-list
92134430|NCT00536601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134431|NCT00536601|Immunologic Factors|immunologic factors|mesh-ancestor
92134432|NCT00536601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134433|NCT00536601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134434|NCT00536601|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92134435|NCT00536601|Alkylating Agents|alkylating agents|mesh-ancestor
92134436|NCT00536601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134437|NCT00536601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134438|NCT00536601|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92134439|NCT00536601|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92134440|NCT00536601|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92134441|NCT00536601|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92134442|NCT00536601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134443|NCT00536913|Budesonide|budesonide|mesh-list
92134444|NCT00536913|Formoterol Fumarate|formoterol fumarate|mesh-list
92134445|NCT00536913|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92134446|NCT00536913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134447|NCT00536913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92134448|NCT00536913|Autonomic Agents|autonomic agents|mesh-ancestor
92134449|NCT00536913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134450|NCT00536913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134451|NCT00536913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92134452|NCT00536913|Respiratory System Agents|respiratory system agents|mesh-ancestor
92134453|NCT00536913|Glucocorticoids|glucocorticoids|mesh-ancestor
92134454|NCT00536913|Hormones|hormones|mesh-ancestor
92134455|NCT00536913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134456|NCT00536913|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92134457|NCT00536913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92134458|NCT00536913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92134459|NCT00536913|Adrenergic Agents|adrenergic agents|mesh-ancestor
92134460|NCT00536913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134461|NCT00536913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134462|NCT00462423|Bevacizumab|bevacizumab|mesh-list
92134463|NCT00462423|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92134464|NCT00462423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134465|NCT00462423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134466|NCT00462423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92134467|NCT00462423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92134468|NCT00462423|Growth Substances|growth substances|mesh-ancestor
92134469|NCT00462423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134470|NCT00462423|Growth Inhibitors|growth inhibitors|mesh-ancestor
92134472|NCT00461331|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92134473|NCT00461331|Insulin Aspart|insulin aspart|mesh-list
92134474|NCT00461331|Insulin, Long-Acting|insulin, long-acting|mesh-list
92134475|NCT00461331|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92134476|NCT00461331|Insulin Lispro|insulin lispro|mesh-list
92134477|NCT00461331|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92134478|NCT00461331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134483|NCT00462735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134484|NCT00462735|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92134485|NCT00462735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134486|NCT00462735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134487|NCT00462735|Immunologic Factors|immunologic factors|mesh-ancestor
92134488|NCT00462735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134489|NCT00462735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134490|NCT00462735|Antisickling Agents|antisickling agents|mesh-ancestor
92134491|NCT00462735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134492|NCT00462735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92134493|NCT01690988|Ketamine|ketamine|mesh-list
92134494|NCT01690988|Analgesics|analgesics|mesh-ancestor
92134495|NCT01690988|Sensory System Agents|sensory system agents|mesh-ancestor
92134496|NCT01690988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134497|NCT01690988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134498|NCT01690988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92134506|NCT01690988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134507|NCT00463437|Vaccines|vaccines|mesh-list
92134508|NCT00463437|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92134509|NCT00463437|Immunologic Factors|immunologic factors|mesh-ancestor
92134510|NCT00463437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134511|NCT01466153|Rituximab|rituximab|mesh-list
92134512|NCT01466153|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92134513|NCT01466153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134514|NCT01466153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134515|NCT01466153|Immunologic Factors|immunologic factors|mesh-ancestor
92134516|NCT01466153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134517|NCT01466153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134518|NCT01466153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92134519|NCT01466153|Alkylating Agents|alkylating agents|mesh-ancestor
92134520|NCT01466153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134521|NCT00464685|Dexamethasone|dexamethasone|mesh-list
92134522|NCT00464685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134523|NCT00464685|Antiemetics|antiemetics|mesh-ancestor
92134524|NCT00464685|Autonomic Agents|autonomic agents|mesh-ancestor
92134525|NCT00464685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134526|NCT00464685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134527|NCT00464685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92134528|NCT00464685|Glucocorticoids|glucocorticoids|mesh-ancestor
92134529|NCT00464685|Hormones|hormones|mesh-ancestor
92134530|NCT00464685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134531|NCT00464685|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92134532|NCT00464685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134533|NCT01465997|Lacosamide|lacosamide|mesh-list
92134534|NCT01465997|Carbamazepine|carbamazepine|mesh-list
92134535|NCT01465997|Anticonvulsants|anticonvulsants|mesh-ancestor
92134536|NCT01465997|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92134537|NCT01465997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92134539|NCT01465997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134540|NCT01465997|Antimanic Agents|antimanic agents|mesh-ancestor
92134541|NCT01465997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92134542|NCT01465997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134543|NCT01465997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134544|NCT01465997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92134545|NCT01465997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92134546|NCT01465997|Analgesics|analgesics|mesh-ancestor
91939282|NCT05155124|Cetuximab|cetuximab|mesh-list
92134547|NCT01465997|Sensory System Agents|sensory system agents|mesh-ancestor
92134548|NCT01465997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134549|NCT01465997|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92134550|NCT01465997|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92134552|NCT00538863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92134553|NCT00538863|Narcotics|narcotics|mesh-ancestor
92134554|NCT00538863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134555|NCT00538863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134556|NCT00538863|Analgesics|analgesics|mesh-ancestor
92134557|NCT00538863|Sensory System Agents|sensory system agents|mesh-ancestor
92134558|NCT00538863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134559|NCT00538863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92134560|NCT00538863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92134561|NCT00538863|Anesthetics, General|anesthetics, general|mesh-ancestor
92134562|NCT00538863|Anesthetics|anesthetics|mesh-ancestor
92134570|NCT01465763|Tofacitinib|tofacitinib|mesh-list
92134571|NCT01465763|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92134572|NCT01465763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92134573|NCT01465763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134574|NCT01465763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134575|NCT00540579|Gemcitabine|gemcitabine|mesh-list
92134576|NCT00540579|Pomalidomide|pomalidomide|mesh-list
92134577|NCT00540579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92134578|NCT00540579|Antimetabolites|antimetabolites|mesh-ancestor
92134579|NCT00540579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134580|NCT00540579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134581|NCT00540579|Immunologic Factors|immunologic factors|mesh-ancestor
92134582|NCT00540579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134583|NCT00540579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92134584|NCT00540579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92134585|NCT00540579|Growth Substances|growth substances|mesh-ancestor
92134586|NCT00540579|Growth Inhibitors|growth inhibitors|mesh-ancestor
92134587|NCT01690520|Cyclosporine|cyclosporine|mesh-list
92134588|NCT01690520|Mycophenolic Acid|mycophenolic acid|mesh-list
92134589|NCT01690520|Cyclophosphamide|cyclophosphamide|mesh-list
92134590|NCT01690520|Thiotepa|thiotepa|mesh-list
92134591|NCT01690520|Fludarabine|fludarabine|mesh-list
92134592|NCT01690520|Fludarabine phosphate|fludarabine phosphate|mesh-list
92134593|NCT01690520|Cyclosporins|cyclosporins|mesh-list
92134594|NCT01690520|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134595|NCT01690520|Immunologic Factors|immunologic factors|mesh-ancestor
92134596|NCT01690520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134597|NCT01690520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134598|NCT01690520|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92134599|NCT01690520|Alkylating Agents|alkylating agents|mesh-ancestor
92134600|NCT01690520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134601|NCT01690520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134602|NCT01690520|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92134603|NCT01690520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92134604|NCT01690520|Antimetabolites|antimetabolites|mesh-ancestor
92134605|NCT01690520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134606|NCT01690520|Antifungal Agents|antifungal agents|mesh-ancestor
92134607|NCT01690520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134608|NCT01690520|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134609|NCT01690520|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92134610|NCT01690520|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92134611|NCT01690520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92134612|NCT01690520|Antitubercular Agents|antitubercular agents|mesh-ancestor
92134613|NCT01690520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134614|NCT04081337|Tirzepatide|tirzepatide|mesh-list
92134615|NCT04081337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92134616|NCT04081337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134617|NCT04081337|Incretins|incretins|mesh-ancestor
92134618|NCT04081337|Hormones|hormones|mesh-ancestor
92134619|NCT04081337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134620|NCT00541671|Promethazine|promethazine|mesh-list
92134621|NCT00541671|Antipruritics|antipruritics|mesh-ancestor
92134622|NCT00541671|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134623|NCT00541671|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92134624|NCT00541671|Histamine Antagonists|histamine antagonists|mesh-ancestor
92134625|NCT00541671|Histamine Agents|histamine agents|mesh-ancestor
92134626|NCT00541671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134627|NCT00541671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134629|NCT00541671|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92134630|NCT01563536|Ritonavir|ritonavir|mesh-list
92134631|NCT01563536|Ribavirin|ribavirin|mesh-list
92134632|NCT01563536|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92134633|NCT01563536|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92134634|NCT01563536|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134635|NCT01563536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134636|NCT01563536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134637|NCT01563536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92134638|NCT01563536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92134639|NCT01563536|Antiviral Agents|antiviral agents|mesh-ancestor
92134640|NCT01563536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134641|NCT01563536|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92134642|NCT01563536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134643|NCT01563536|Antimetabolites|antimetabolites|mesh-ancestor
92134644|NCT01690052|Pilocarpine|pilocarpine|mesh-list
92134645|NCT01690052|Cevimeline|cevimeline|mesh-list
92134646|NCT01690052|Miotics|miotics|mesh-ancestor
92134647|NCT01690052|Autonomic Agents|autonomic agents|mesh-ancestor
92134648|NCT01690052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134649|NCT01690052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134653|NCT01690052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134654|NCT01690052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134655|NCT01690052|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92134656|NCT01689974|Ipilimumab|ipilimumab|mesh-list
92134657|NCT01689974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134658|NCT01689974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134659|NCT01689974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92134660|NCT01689974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134661|NCT04750083|Carboplatin|carboplatin|mesh-list
92134662|NCT04750083|Pembrolizumab|pembrolizumab|mesh-list
92134663|NCT04750083|Pemetrexed|pemetrexed|mesh-list
92134664|NCT04750083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134665|NCT04750083|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134666|NCT04750083|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92134667|NCT04750083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134668|NCT04750083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134669|NCT04750083|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92134670|NCT04750083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92134671|NCT02954991|Nivolumab|nivolumab|mesh-list
92134672|NCT02954991|Mocetinostat|mocetinostat|mesh-list
92134673|NCT02954991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134674|NCT02954991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134675|NCT02954991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92134676|NCT02954991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134677|NCT02954991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92134678|NCT02954991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134679|NCT02892591|Oxycodone|oxycodone|mesh-list
92134680|NCT02892591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92134681|NCT02892591|Narcotics|narcotics|mesh-ancestor
92134682|NCT02892591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134683|NCT02892591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134684|NCT02892591|Analgesics|analgesics|mesh-ancestor
92134685|NCT02892591|Sensory System Agents|sensory system agents|mesh-ancestor
92134686|NCT02892591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134687|NCT00470301|Paclitaxel|paclitaxel|mesh-list
92134688|NCT00470301|Cyclophosphamide|cyclophosphamide|mesh-list
92134689|NCT00470301|Doxorubicin|doxorubicin|mesh-list
92134690|NCT00470301|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92134691|NCT00470301|Tipifarnib|tipifarnib|mesh-list
92134692|NCT00470301|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92134693|NCT00470301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134694|NCT00470301|Tubulin Modulators|tubulin modulators|mesh-ancestor
92134695|NCT00470301|Antimitotic Agents|antimitotic agents|mesh-ancestor
92134696|NCT00470301|Mitosis Modulators|mitosis modulators|mesh-ancestor
92134697|NCT00470301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134698|NCT00470301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134699|NCT00470301|Immunologic Factors|immunologic factors|mesh-ancestor
92134700|NCT00470301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134701|NCT00470301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134702|NCT00470301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92134703|NCT00470301|Alkylating Agents|alkylating agents|mesh-ancestor
92134704|NCT00470301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92134705|NCT00470301|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92134706|NCT00470301|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92134707|NCT00470301|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92134708|NCT00470301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134709|NCT00544713|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92134710|NCT00544713|Lubricant Eye Drops|lubricant eye drops|mesh-list
92134711|NCT00544713|Glycerol|glycerol|mesh-list
92134712|NCT00544713|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92134713|NCT00544713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92134714|NCT00544713|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92134715|NCT00544713|Protective Agents|protective agents|mesh-ancestor
92134716|NCT00544713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134717|NCT00544713|Laxatives|laxatives|mesh-ancestor
92134718|NCT00544713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92134719|NCT00545181|Metronidazole|metronidazole|mesh-list
92134720|NCT00545181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134721|NCT00545181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134722|NCT00545181|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92134723|NCT00545181|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92134724|NCT01797315|Sirolimus|sirolimus|mesh-list
92134725|NCT01797315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134726|NCT01797315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134727|NCT01797315|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92134728|NCT01797315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134730|NCT01797315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134731|NCT01797315|Immunologic Factors|immunologic factors|mesh-ancestor
92134732|NCT01797315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134733|NCT00471705|Miltefosine|miltefosine|mesh-list
92134734|NCT00471705|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92134735|NCT00471705|Antifungal Agents|antifungal agents|mesh-ancestor
92134736|NCT00471705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134737|NCT00471705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134738|NCT00471705|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92134739|NCT00471705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92134740|NCT00472797|Interferon beta-1a|interferon beta-1a|mesh-list
92134741|NCT00472797|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92134742|NCT00472797|Immunologic Factors|immunologic factors|mesh-ancestor
92134743|NCT00472797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134744|NCT00472797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134745|NCT00472797|Antiviral Agents|antiviral agents|mesh-ancestor
92134746|NCT00472797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134747|NCT01458535|Ritonavir|ritonavir|mesh-list
92134748|NCT01458535|Ribavirin|ribavirin|mesh-list
92134749|NCT01458535|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92134750|NCT01458535|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92134751|NCT01458535|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134752|NCT01458535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134753|NCT01458535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134754|NCT01458535|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92134755|NCT01458535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92134756|NCT01458535|Antiviral Agents|antiviral agents|mesh-ancestor
92134757|NCT01458535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134758|NCT01458535|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92134759|NCT01458535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134760|NCT01458535|Antimetabolites|antimetabolites|mesh-ancestor
92134761|NCT01464827|Ritonavir|ritonavir|mesh-list
92134762|NCT01464827|Ribavirin|ribavirin|mesh-list
92134763|NCT01464827|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92134764|NCT01464827|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92134765|NCT01464827|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134766|NCT01464827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134767|NCT01464827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134768|NCT01464827|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92134769|NCT01464827|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92134770|NCT01464827|Antiviral Agents|antiviral agents|mesh-ancestor
92134771|NCT01464827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134772|NCT01464827|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92134773|NCT01464827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134774|NCT01464827|Antimetabolites|antimetabolites|mesh-ancestor
92134775|NCT01463111|Lamotrigine|lamotrigine|mesh-list
92134776|NCT01463111|Valproic Acid|valproic acid|mesh-list
92134777|NCT01463111|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92134778|NCT01463111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134779|NCT01463111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134780|NCT01463111|Antimanic Agents|antimanic agents|mesh-ancestor
92134781|NCT01463111|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92134782|NCT01463111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134783|NCT01463111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134784|NCT01463111|Anticonvulsants|anticonvulsants|mesh-ancestor
92134785|NCT01463111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92134786|NCT01463111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134787|NCT01463111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92134789|NCT01463111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92134790|NCT01463111|GABA Agents|gaba agents|mesh-ancestor
92134791|NCT01463111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134792|NCT01463033|Levetiracetam|levetiracetam|mesh-list
92134793|NCT01463033|Anticonvulsants|anticonvulsants|mesh-ancestor
92134794|NCT01463033|Nootropic Agents|nootropic agents|mesh-ancestor
92134796|NCT01461551|Sevoflurane|sevoflurane|mesh-list
92134797|NCT01461551|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92134798|NCT01461551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92134799|NCT01461551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134800|NCT01461551|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92134801|NCT01461551|Anesthetics, General|anesthetics, general|mesh-ancestor
92134802|NCT01461551|Anesthetics|anesthetics|mesh-ancestor
92134803|NCT01461551|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92134804|NCT01461551|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92134805|NCT01460381|Quinidine|quinidine|mesh-list
92134806|NCT01460381|Quinidine gluconate|quinidine gluconate|mesh-list
92134807|NCT01460381|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92134808|NCT01460381|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92134810|NCT01460381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134811|NCT01460381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134812|NCT01460381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134813|NCT01460381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92134814|NCT01460381|Antimalarials|antimalarials|mesh-ancestor
92134815|NCT01460381|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92134816|NCT01460381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92134817|NCT01460381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134818|NCT01460381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134819|NCT01460381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92134820|NCT01460381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92134821|NCT01460381|Cholinergic Agents|cholinergic agents|mesh-ancestor
92134822|NCT01460381|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92134823|NCT01460381|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92134824|NCT01460381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134825|NCT01460381|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92134826|NCT01460381|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134827|NCT00546897|Lenalidomide|lenalidomide|mesh-list
92134828|NCT00546897|Immunologic Factors|immunologic factors|mesh-ancestor
92134829|NCT00546897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134830|NCT00546897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92134831|NCT00546897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92134832|NCT00546897|Growth Substances|growth substances|mesh-ancestor
92134833|NCT00546897|Growth Inhibitors|growth inhibitors|mesh-ancestor
92134834|NCT00546897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134835|NCT00474123|Simvastatin|simvastatin|mesh-list
92134836|NCT00474123|Ezetimibe|ezetimibe|mesh-list
92134837|NCT00474123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92134838|NCT00474123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92134839|NCT00474123|Antimetabolites|antimetabolites|mesh-ancestor
92134840|NCT00474123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134841|NCT00474123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92134842|NCT00474123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92134843|NCT00474123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134844|NCT00474201|Ritonavir|ritonavir|mesh-list
92134845|NCT00474201|Lopinavir|lopinavir|mesh-list
92134846|NCT00474201|Gemfibrozil|gemfibrozil|mesh-list
92134847|NCT00474201|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92134848|NCT00474201|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92134849|NCT00474201|Protease Inhibitors|protease inhibitors|mesh-ancestor
92134850|NCT00474201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134851|NCT00474201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134852|NCT00474201|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92134853|NCT00474201|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92134854|NCT00474201|Antiviral Agents|antiviral agents|mesh-ancestor
92134855|NCT00474201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134856|NCT00474201|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92134857|NCT00474201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92134858|NCT00474201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92134859|NCT00474201|Antimetabolites|antimetabolites|mesh-ancestor
92134860|NCT00474201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92134861|NCT00474201|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92134863|NCT00549393|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92134864|NCT00549393|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92134865|NCT00549393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134866|NCT00549393|Disinfectants|disinfectants|mesh-ancestor
92134867|NCT00549393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92134868|NCT00549783|Botulinum Toxins|botulinum toxins|mesh-list
92134869|NCT00549783|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92134870|NCT00549783|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92134871|NCT00549783|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92134872|NCT00549783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134873|NCT00549783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134874|NCT00549783|Cholinergic Agents|cholinergic agents|mesh-ancestor
92134875|NCT00549783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92134876|NCT00549783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134877|NCT00549783|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92134878|NCT00549783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134879|NCT00475215|Rocuronium|rocuronium|mesh-list
92134880|NCT00475215|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92134881|NCT00475215|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92134882|NCT00475215|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92134883|NCT00475215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134884|NCT00475215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134886|NCT02733159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92134887|NCT02733159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134888|NCT02733159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92134889|NCT02733159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134890|NCT00477087|Molgramostim|molgramostim|mesh-list
92134891|NCT00477087|Mitoxantrone|mitoxantrone|mesh-list
92134892|NCT00477087|Sargramostim|sargramostim|mesh-list
92134893|NCT00477087|Immunologic Factors|immunologic factors|mesh-ancestor
92134894|NCT00477087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134895|NCT00477087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134896|NCT00477087|Analgesics|analgesics|mesh-ancestor
92134897|NCT00477087|Sensory System Agents|sensory system agents|mesh-ancestor
92134898|NCT00477087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134899|NCT00477087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92134900|NCT00477087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92134901|NCT00477087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134902|NCT00477087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134903|NCT04409912|Sirolimus|sirolimus|mesh-list
92134904|NCT04409912|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92134905|NCT04409912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134906|NCT04409912|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92134907|NCT04409912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92134908|NCT04409912|Antifungal Agents|antifungal agents|mesh-ancestor
92134909|NCT04409912|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92134910|NCT04409912|Immunologic Factors|immunologic factors|mesh-ancestor
92134911|NCT04409912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134912|NCT01473589|Vitamin D|vitamin d|mesh-list
92134913|NCT01473589|Teriparatide|teriparatide|mesh-list
92134914|NCT01473589|Calcium|calcium|mesh-list
92134915|NCT01473589|Vitamins|vitamins|mesh-ancestor
92134916|NCT01473589|Micronutrients|micronutrients|mesh-ancestor
92134917|NCT01473589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134918|NCT01473589|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92134919|NCT01473589|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92134920|NCT00478335|Calcitonin|calcitonin|mesh-list
92134921|NCT00478335|Salmon calcitonin|salmon calcitonin|mesh-list
92134922|NCT00478335|Indomethacin|indomethacin|mesh-list
92134923|NCT00478335|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92134924|NCT00478335|Amiloride|amiloride|mesh-list
92134925|NCT00478335|Sildenafil Citrate|sildenafil citrate|mesh-list
92134926|NCT00478335|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92134927|NCT00478335|Katacalcin|katacalcin|mesh-list
92134928|NCT00478335|Vasodilator Agents|vasodilator agents|mesh-ancestor
92134929|NCT00478335|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92134930|NCT00478335|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92134931|NCT00478335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92134932|NCT00478335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92134933|NCT00478335|Urological Agents|urological agents|mesh-ancestor
92134934|NCT00478335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92134935|NCT00478335|Diuretics|diuretics|mesh-ancestor
92134936|NCT00478335|Natriuretic Agents|natriuretic agents|mesh-ancestor
92134937|NCT00478335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134938|NCT00478335|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92134939|NCT00478335|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92134940|NCT00478335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92134941|NCT00478335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92134942|NCT00478335|Analgesics|analgesics|mesh-ancestor
92134943|NCT00478335|Sensory System Agents|sensory system agents|mesh-ancestor
92134944|NCT00478335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92134945|NCT00478335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92134946|NCT00478335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92134947|NCT00478335|Gout Suppressants|gout suppressants|mesh-ancestor
92134948|NCT00478335|Tocolytic Agents|tocolytic agents|mesh-ancestor
92134949|NCT00478335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92134950|NCT00478335|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92134951|NCT00478335|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92134952|NCT00478335|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92134953|NCT00478335|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92134954|NCT00478335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92134955|NCT00478335|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92134956|NCT00478335|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92134957|NCT00478569|Hormones|hormones|mesh-list
92134958|NCT00478569|Parathyroid Hormone|parathyroid hormone|mesh-list
92134959|NCT00478569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134960|NCT00478569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134961|NCT00478569|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92134962|NCT00479037|Strontium ranelate|strontium ranelate|mesh-list
92134963|NCT00479037|Hormones|hormones|mesh-list
92134964|NCT00479037|Parathyroid Hormone|parathyroid hormone|mesh-list
92134965|NCT00479037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134966|NCT00479037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134967|NCT00479037|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92134968|NCT00479037|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92134969|NCT02985229|Misoprostol|misoprostol|mesh-list
92134970|NCT02985229|Mifepristone|mifepristone|mesh-list
92134971|NCT02985229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92134972|NCT02985229|Abortifacient Agents|abortifacient agents|mesh-ancestor
92134973|NCT02985229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92134974|NCT02985229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92134975|NCT02985229|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92134976|NCT02985229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92134977|NCT02985229|Oxytocics|oxytocics|mesh-ancestor
92134978|NCT02985229|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92134979|NCT02985229|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92134980|NCT02985229|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92134981|NCT02985229|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92134982|NCT02985229|Contraceptive Agents|contraceptive agents|mesh-ancestor
92134983|NCT02985229|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92134984|NCT02985229|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92134985|NCT02985229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92134986|NCT02985229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92134987|NCT02985229|Luteolytic Agents|luteolytic agents|mesh-ancestor
92134988|NCT02985229|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92134989|NCT02985229|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92134990|NCT00479115|Plerixafor|plerixafor|mesh-list
92134991|NCT00479115|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92134992|NCT00479115|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92134993|NCT00479115|Antiviral Agents|antiviral agents|mesh-ancestor
92134994|NCT00479115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92134995|NCT01472965|Ethanol|ethanol|mesh-list
92134996|NCT01472965|Heparin|heparin|mesh-list
92134997|NCT01472965|Calcium heparin|calcium heparin|mesh-list
92134998|NCT01472965|Anticoagulants|anticoagulants|mesh-ancestor
92134999|NCT01472965|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92135000|NCT01472965|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92135001|NCT01472965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135003|NCT01472965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135004|NCT01472965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135005|NCT01472965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135007|NCT00480987|Oxaliplatin|oxaliplatin|mesh-list
92135008|NCT00480987|Fludarabine|fludarabine|mesh-list
92135009|NCT00480987|Fludarabine phosphate|fludarabine phosphate|mesh-list
92135010|NCT00480987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135011|NCT00480987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92135012|NCT00480987|Antimetabolites|antimetabolites|mesh-ancestor
92135013|NCT00480987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135014|NCT00480987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135015|NCT00480987|Immunologic Factors|immunologic factors|mesh-ancestor
92135016|NCT00480987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135017|NCT00480987|Antiviral Agents|antiviral agents|mesh-ancestor
92135018|NCT00480987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135019|NCT01457053|Torsemide|torsemide|mesh-list
92135020|NCT01457053|Furosemide|furosemide|mesh-list
92135021|NCT01457053|Bumetanide|bumetanide|mesh-list
92135022|NCT01457053|Diuretics|diuretics|mesh-list
92135023|NCT01457053|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-list
92135024|NCT01457053|Natriuretic Agents|natriuretic agents|mesh-ancestor
92135025|NCT01457053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135026|NCT01457053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135027|NCT01457053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135028|NCT01457053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135030|NCT04082767|Dexmedetomidine|dexmedetomidine|mesh-list
92135031|NCT04082767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92135032|NCT04082767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135033|NCT04082767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135034|NCT04082767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92135035|NCT04082767|Analgesics|analgesics|mesh-ancestor
92135036|NCT04082767|Sensory System Agents|sensory system agents|mesh-ancestor
92135037|NCT04082767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135038|NCT04082767|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92135039|NCT04082767|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92135040|NCT04082767|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92135041|NCT04082767|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135042|NCT04082767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135043|NCT04082767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135044|NCT04082767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92135045|NCT04082767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92135046|NCT04082767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92135047|NCT04082767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135048|NCT04082767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92135049|NCT04082767|Anesthetics, General|anesthetics, general|mesh-ancestor
92135050|NCT04082767|Anesthetics|anesthetics|mesh-ancestor
92135051|NCT04082767|GABA Modulators|gaba modulators|mesh-ancestor
92135052|NCT04082767|GABA Agents|gaba agents|mesh-ancestor
92135053|NCT00481845|Anastrozole|anastrozole|mesh-list
92135054|NCT00481845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135055|NCT00481845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135056|NCT00481845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92135057|NCT00481845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92135058|NCT00481845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135059|NCT00481845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135061|NCT00481845|Hormone Antagonists|hormone antagonists|mesh-ancestor
92135062|NCT00481845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135063|NCT00481845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135064|NCT01472185|Ranolazine|ranolazine|mesh-list
92135065|NCT01472185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92135066|NCT01472185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135067|NCT01472185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135068|NCT00482625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92135069|NCT00482625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135070|NCT00482625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135071|NCT00482625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939288|NCT00927641|Analgesics|analgesics|mesh-ancestor
92135072|NCT00482625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135073|NCT00553839|Ketamine|ketamine|mesh-list
92135074|NCT00553839|Analgesics|analgesics|mesh-ancestor
92135075|NCT00553839|Sensory System Agents|sensory system agents|mesh-ancestor
92135076|NCT00553839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135077|NCT00553839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135078|NCT00553839|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92135079|NCT00553839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92135081|NCT00553839|Anesthetics|anesthetics|mesh-ancestor
92135082|NCT00553839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135083|NCT00553839|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92135084|NCT00553839|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92135085|NCT00553839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135086|NCT00553839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135087|NCT00554463|Etoposide|etoposide|mesh-list
92135088|NCT00554463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135089|NCT00554463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92135090|NCT00554463|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92135091|NCT00554463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92135092|NCT00554463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135093|NCT00554463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135094|NCT04082533|Hydrocortisone|hydrocortisone|mesh-list
92135095|NCT04082533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135096|NCT00554853|Pioglitazone|pioglitazone|mesh-list
92135097|NCT00554853|Nitroglycerin|nitroglycerin|mesh-list
92135098|NCT00554853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92093318|NCT01591382|Anesthetics, General|anesthetics, general|mesh-ancestor
92135099|NCT00554853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135100|NCT00554853|Vasodilator Agents|vasodilator agents|mesh-ancestor
92135101|NCT00556491|Minocycline|minocycline|mesh-list
92135102|NCT00556491|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92135103|NCT00556491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135104|NCT02685969|Flutemetamol|flutemetamol|mesh-list
92135105|NCT02685969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92135106|NCT02685969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135107|NCT00483561|Etoposide|etoposide|mesh-list
92135108|NCT00483561|Gefitinib|gefitinib|mesh-list
92135109|NCT00483561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92135110|NCT00483561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135111|NCT00483561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92135112|NCT00483561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92135113|NCT00483561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135114|NCT00483561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135115|NCT00483561|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135116|NCT00485433|Epinephrine|epinephrine|mesh-list
92135117|NCT00485433|Bupivacaine|bupivacaine|mesh-list
92135118|NCT00485433|Anesthetics, Local|anesthetics, local|mesh-ancestor
92135119|NCT00485433|Anesthetics|anesthetics|mesh-ancestor
92135120|NCT00485433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135121|NCT00485433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135122|NCT00485433|Sensory System Agents|sensory system agents|mesh-ancestor
92135123|NCT00485433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135124|NCT00485433|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92135125|NCT00485433|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92135126|NCT00485433|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135127|NCT00485433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135128|NCT00485433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135129|NCT00485433|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92135130|NCT00485433|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92135131|NCT00485433|Autonomic Agents|autonomic agents|mesh-ancestor
92135132|NCT00485433|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92135133|NCT00485433|Respiratory System Agents|respiratory system agents|mesh-ancestor
92135134|NCT00485433|Mydriatics|mydriatics|mesh-ancestor
92135135|NCT00485433|Sympathomimetics|sympathomimetics|mesh-ancestor
92135136|NCT00485433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92135137|NCT02850081|Atorvastatin|atorvastatin|mesh-list
92135138|NCT02850081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92135139|NCT02850081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92135140|NCT02850081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92135141|NCT02850081|Antimetabolites|antimetabolites|mesh-ancestor
92135142|NCT02850081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135143|NCT02850081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92135144|NCT02850081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135145|NCT01456039|Romidepsin|romidepsin|mesh-list
92135146|NCT01456039|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92135147|NCT01456039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135148|NCT01456039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92135149|NCT01456039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135150|NCT01456039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135151|NCT01455415|Pregabalin|pregabalin|mesh-list
92135152|NCT01455415|Analgesics|analgesics|mesh-ancestor
92135153|NCT01455415|Sensory System Agents|sensory system agents|mesh-ancestor
92135154|NCT01455415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135155|NCT01455415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135156|NCT01455415|Anticonvulsants|anticonvulsants|mesh-ancestor
92135157|NCT01455415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92135158|NCT01455415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135159|NCT01455415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135160|NCT01455415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92135161|NCT01455415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92135162|NCT01455415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92135163|NCT01455415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135164|NCT01455415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135165|NCT01471171|Bromides|bromides|mesh-list
92135166|NCT01471171|Anticonvulsants|anticonvulsants|mesh-ancestor
92135167|NCT01471093|Rebamipide|rebamipide|mesh-list
92135168|NCT01471093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92135169|NCT01471093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92135170|NCT01471093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92135171|NCT01471093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135172|NCT01471093|Antioxidants|antioxidants|mesh-ancestor
92135173|NCT01471093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135174|NCT01471093|Protective Agents|protective agents|mesh-ancestor
92135175|NCT01471093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135176|NCT01471093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135177|NCT01471015|Darbepoetin alfa|darbepoetin alfa|mesh-list
92135178|NCT01471015|Hematinics|hematinics|mesh-ancestor
92135179|NCT01470469|Guanfacine|guanfacine|mesh-list
92135180|NCT01470469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135181|NCT01470469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92135182|NCT01470469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92135183|NCT01470469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92135184|NCT01470469|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135185|NCT01470469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135186|NCT01470469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135187|NCT01470469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135188|NCT01470001|Solifenacin Succinate|solifenacin succinate|mesh-list
92135189|NCT01470001|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92135190|NCT01470001|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92135191|NCT01470001|Cholinergic Agents|cholinergic agents|mesh-ancestor
92135192|NCT01470001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135193|NCT01470001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135194|NCT01470001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135195|NCT01470001|Urological Agents|urological agents|mesh-ancestor
92135196|NCT01469377|Cariprazine|cariprazine|mesh-list
92135197|NCT01469377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92135198|NCT01469377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92135199|NCT01469377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135200|NCT01469377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135201|NCT01469377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135202|NCT01469221|Apaziquone|apaziquone|mesh-list
92135203|NCT01469221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135204|NCT01453855|Travoprost|travoprost|mesh-list
92135205|NCT01453855|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92135206|NCT01453855|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92135207|NCT01453855|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135208|NCT01469065|Nicotinic Acids|nicotinic acids|mesh-list
92135209|NCT01469065|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1H-imidazol-1-yl)propanamido)nicotinic acid|6-(3-cyclopentyl-2-(4-(trifluoromethyl)-1h-imidazol-1-yl)propanamido)nicotinic acid|mesh-list
92135210|NCT01469065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135211|NCT01469065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135212|NCT01469065|Vitamin B Complex|vitamin b complex|mesh-ancestor
92135213|NCT01469065|Vitamins|vitamins|mesh-ancestor
92135214|NCT01469065|Micronutrients|micronutrients|mesh-ancestor
92135215|NCT01469065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135216|NCT01586156|Carvedilol|carvedilol|mesh-list
92135217|NCT01586156|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92135218|NCT01586156|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92135219|NCT01586156|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135220|NCT01586156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135221|NCT01586156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135222|NCT01586156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135223|NCT01586156|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135224|NCT01586156|Antioxidants|antioxidants|mesh-ancestor
92135225|NCT01586156|Protective Agents|protective agents|mesh-ancestor
92135226|NCT01586156|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92135227|NCT01586156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135228|NCT01586156|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92135229|NCT01586156|Vasodilator Agents|vasodilator agents|mesh-ancestor
92135230|NCT01586156|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92135231|NCT01586156|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92135232|NCT01459913|Interferons|interferons|mesh-list
92135233|NCT01459913|Ribavirin|ribavirin|mesh-list
92135234|NCT01459913|Interferon-alpha|interferon-alpha|mesh-list
92135235|NCT01459913|Interferon alpha-2|interferon alpha-2|mesh-list
92135236|NCT01459913|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92135237|NCT01459913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135238|NCT01459913|Antiviral Agents|antiviral agents|mesh-ancestor
92135239|NCT01459913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135240|NCT01459913|Antimetabolites|antimetabolites|mesh-ancestor
92135241|NCT01459913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135242|NCT01459913|Immunologic Factors|immunologic factors|mesh-ancestor
92135243|NCT01459913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135244|NCT01458587|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92135245|NCT01458587|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92135246|NCT01458587|Dermatologic Agents|dermatologic agents|mesh-ancestor
92135247|NCT01458275|Ciclesonide|ciclesonide|mesh-list
92135248|NCT01458275|Glucocorticoids|glucocorticoids|mesh-ancestor
92135250|NCT01458275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135251|NCT01458275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135252|NCT01458275|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92135253|NCT02334527|Palbociclib|palbociclib|mesh-list
92135254|NCT02334527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135255|NCT02334527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135256|NCT02334527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135257|NCT02334527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135258|NCT01688726|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92135259|NCT01688726|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92135260|NCT01457339|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92135261|NCT01457339|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92135262|NCT01457339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135263|NCT01457339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92135264|NCT01457339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92135265|NCT01457339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135266|NCT01457339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135267|NCT01457339|Dopamine Agents|dopamine agents|mesh-ancestor
92135268|NCT01457339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135269|NCT01456169|Chlorthalidone|chlorthalidone|mesh-list
92135270|NCT01456169|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92135271|NCT01456169|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92135272|NCT01456169|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92135273|NCT01456169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135274|NCT01456169|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135275|NCT01456169|Diuretics|diuretics|mesh-ancestor
92135276|NCT01456169|Natriuretic Agents|natriuretic agents|mesh-ancestor
92135277|NCT01456169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135278|NCT01456169|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92135279|NCT01456169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135280|NCT01453595|Dactolisib|dactolisib|mesh-list
92135281|NCT01453595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135282|NCT01585298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92135283|NCT01585298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92135284|NCT01585298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135285|NCT01585298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135286|NCT01585298|Immunologic Factors|immunologic factors|mesh-ancestor
92135287|NCT01585298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135288|NCT04124198|Nimorazole|nimorazole|mesh-list
92135289|NCT04124198|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92135290|NCT04124198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92135291|NCT04124198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92135292|NCT04124198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135294|NCT01453205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92135295|NCT01453205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135296|NCT01453205|Immunologic Factors|immunologic factors|mesh-ancestor
92135297|NCT01453205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135298|NCT01453205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135299|NCT01453049|Glimepiride|glimepiride|mesh-list
92135300|NCT01453049|Rosiglitazone|rosiglitazone|mesh-list
92135301|NCT01453049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92135302|NCT01453049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135303|NCT01453049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135304|NCT01453049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135305|NCT01453049|Immunologic Factors|immunologic factors|mesh-ancestor
92135306|NCT01452347|Warfarin|warfarin|mesh-list
92135307|NCT01452347|Dabigatran|dabigatran|mesh-list
92135308|NCT01452347|Anticoagulants|anticoagulants|mesh-ancestor
92135309|NCT01452347|Antithrombins|antithrombins|mesh-ancestor
92135310|NCT01452347|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92135311|NCT01452347|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135312|NCT01452347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135313|NCT01452347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135314|NCT01451723|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92135315|NCT01451723|Antioxidants|antioxidants|mesh-ancestor
92135316|NCT01451723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135317|NCT01451723|Protective Agents|protective agents|mesh-ancestor
92135318|NCT01451723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135319|NCT01451723|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92135320|NCT01451723|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92135321|NCT01451723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135322|NCT01451723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92135323|NCT01451645|Colchicine|colchicine|mesh-list
92135324|NCT01451645|Allopurinol|allopurinol|mesh-list
92135325|NCT01451645|Gout Suppressants|gout suppressants|mesh-ancestor
92135326|NCT01451645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135327|NCT01451645|Tubulin Modulators|tubulin modulators|mesh-ancestor
92135328|NCT01451645|Antimitotic Agents|antimitotic agents|mesh-ancestor
92135329|NCT01451645|Mitosis Modulators|mitosis modulators|mesh-ancestor
92135330|NCT01451645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135331|NCT01451645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135332|NCT01451645|Antimetabolites|antimetabolites|mesh-ancestor
92135333|NCT01451645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135334|NCT01451645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92135335|NCT01451645|Antioxidants|antioxidants|mesh-ancestor
92135336|NCT01451645|Protective Agents|protective agents|mesh-ancestor
92135337|NCT01451645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135342|NCT01450007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135343|NCT01450007|Antiemetics|antiemetics|mesh-ancestor
92135344|NCT01450007|Autonomic Agents|autonomic agents|mesh-ancestor
92135345|NCT01450007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135346|NCT01450007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135347|NCT01450007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135348|NCT01450007|Glucocorticoids|glucocorticoids|mesh-ancestor
92135349|NCT01450007|Hormones|hormones|mesh-ancestor
92135350|NCT01450007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135351|NCT01450007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135352|NCT01450007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135353|NCT01450007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135354|NCT01450007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135355|NCT01450007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135356|NCT01450007|Anesthetics, Local|anesthetics, local|mesh-ancestor
92135357|NCT01450007|Anesthetics|anesthetics|mesh-ancestor
92135358|NCT01450007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135359|NCT01450007|Sensory System Agents|sensory system agents|mesh-ancestor
92135360|NCT01496365|Pregabalin|pregabalin|mesh-list
92135361|NCT01496365|Analgesics|analgesics|mesh-ancestor
92135362|NCT01496365|Sensory System Agents|sensory system agents|mesh-ancestor
92135363|NCT01496365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939292|NCT00927641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135364|NCT01496365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135365|NCT01496365|Anticonvulsants|anticonvulsants|mesh-ancestor
92135366|NCT01496365|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92135367|NCT01496365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135368|NCT01496365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135369|NCT01496365|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92135370|NCT01496365|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92135371|NCT01496365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92135372|NCT01496365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135373|NCT01496365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135374|NCT01468987|Insulin|insulin|mesh-list
92135375|NCT01468987|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92135376|NCT01468987|Insulin Glargine|insulin glargine|mesh-list
92135377|NCT01468987|Insulin Lispro|insulin lispro|mesh-list
92135378|NCT01468987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135379|NCT01468987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135380|NCT01687712|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92135381|NCT01687712|Hormones|hormones|mesh-ancestor
92135382|NCT01687712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135383|NCT01687712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135384|NCT01603628|Botulinum Toxins|botulinum toxins|mesh-list
92135385|NCT01603628|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92135386|NCT01603628|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92135387|NCT01603628|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92135388|NCT01603628|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135389|NCT01603628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135390|NCT01603628|Cholinergic Agents|cholinergic agents|mesh-ancestor
92135391|NCT01603628|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135392|NCT01603628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135393|NCT01603628|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92135394|NCT01603628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135395|NCT01453153|Gemcitabine|gemcitabine|mesh-list
92135396|NCT01453153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92135397|NCT01453153|Antimetabolites|antimetabolites|mesh-ancestor
92135398|NCT01453153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135399|NCT01453153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135400|NCT01584440|Quinidine|quinidine|mesh-list
92135401|NCT01584440|Dextromethorphan|dextromethorphan|mesh-list
92135402|NCT01584440|Antitussive Agents|antitussive agents|mesh-ancestor
92135403|NCT01584440|Respiratory System Agents|respiratory system agents|mesh-ancestor
92135404|NCT01584440|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92135405|NCT01584440|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92135406|NCT01584440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135407|NCT01584440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135408|NCT01584440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135409|NCT01584440|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92135410|NCT01584440|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92135411|NCT01584440|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135412|NCT01584440|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92135413|NCT01584440|Antimalarials|antimalarials|mesh-ancestor
92135416|NCT01584440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135417|NCT01584440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135418|NCT01584440|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92135419|NCT01584440|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92135420|NCT01584440|Cholinergic Agents|cholinergic agents|mesh-ancestor
92135421|NCT01584440|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92135422|NCT01584440|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92135423|NCT01584440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135424|NCT01584440|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92135425|NCT01584440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92135427|NCT01687478|Fluoxetine|fluoxetine|mesh-list
92135428|NCT01687478|Antiemetics|antiemetics|mesh-ancestor
92135429|NCT01687478|Autonomic Agents|autonomic agents|mesh-ancestor
92135430|NCT01687478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135431|NCT01687478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135432|NCT01687478|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135433|NCT01687478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92135434|NCT01687478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92135435|NCT01687478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135436|NCT01687478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135437|NCT01687478|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92135438|NCT01687478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92135439|NCT01687478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135440|NCT01687478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135441|NCT01687478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135442|NCT01687478|Serotonin Agents|serotonin agents|mesh-ancestor
92135443|NCT01687478|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92135444|NCT01687478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92135445|NCT01687478|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92135446|NCT01687478|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92135447|NCT01687478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135448|NCT01468909|Paclitaxel|paclitaxel|mesh-list
92135449|NCT01468909|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92135450|NCT01468909|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92135451|NCT01468909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135452|NCT01468909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92135453|NCT01468909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92135454|NCT01468909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92135455|NCT01468909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135456|NCT01687166|Acifluorfen|acifluorfen|mesh-list
92135457|NCT01687166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135458|NCT01687166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135459|NCT01561976|Metformin|metformin|mesh-list
92135460|NCT01561976|Glimepiride|glimepiride|mesh-list
92135461|NCT01561976|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135462|NCT01561976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135463|NCT01561976|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92135464|NCT01561976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135465|NCT01561976|Immunologic Factors|immunologic factors|mesh-ancestor
92135466|NCT01686932|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92135467|NCT01686932|Vildagliptin|vildagliptin|mesh-list
92135468|NCT01686932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135469|NCT01686932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135470|NCT01686932|Incretins|incretins|mesh-ancestor
92135471|NCT01686932|Hormones|hormones|mesh-ancestor
92135472|NCT01686932|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135473|NCT01686932|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92135474|NCT01686932|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135475|NCT01686932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135476|NCT01686932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135478|NCT01468207|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92135479|NCT01468207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135480|NCT01468207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135481|NCT03026725|Calcium|calcium|mesh-list
92135482|NCT03026725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92135483|NCT03026725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135484|NCT01686152|Imiquimod|imiquimod|mesh-list
92135485|NCT01686152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92135486|NCT01686152|Immunologic Factors|immunologic factors|mesh-ancestor
92135487|NCT01686152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135488|NCT01686152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135489|NCT01686152|Interferon Inducers|interferon inducers|mesh-ancestor
92135490|NCT01561898|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92135493|NCT01561898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135494|NCT01561898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135495|NCT01561898|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135496|NCT01561898|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92135497|NCT01561898|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92135499|NCT01561898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135500|NCT01561898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135501|NCT01561898|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92135502|NCT01561898|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92135503|NCT01561898|Dopamine Agents|dopamine agents|mesh-ancestor
92135504|NCT01452529|Hydrocodone|hydrocodone|mesh-list
92135505|NCT01452529|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92135506|NCT01452529|Narcotics|narcotics|mesh-ancestor
92135507|NCT01452529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135508|NCT01452529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135510|NCT01452529|Sensory System Agents|sensory system agents|mesh-ancestor
92135511|NCT01452529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135512|NCT01452529|Antitussive Agents|antitussive agents|mesh-ancestor
92135513|NCT01452529|Respiratory System Agents|respiratory system agents|mesh-ancestor
92135514|NCT01560416|Fulvestrant|fulvestrant|mesh-list
92135515|NCT01560416|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135516|NCT01560416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135517|NCT01560416|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92135518|NCT01560416|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92135519|NCT01560416|Hormone Antagonists|hormone antagonists|mesh-ancestor
92135520|NCT01560416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135521|NCT01560416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135522|NCT01685606|Immunomodulating Agents|immunomodulating agents|mesh-list
92135523|NCT01685606|Immunologic Factors|immunologic factors|mesh-ancestor
92135524|NCT01685606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135525|NCT01685372|Vaccines|vaccines|mesh-list
92135526|NCT01685372|Immunologic Factors|immunologic factors|mesh-ancestor
92135527|NCT01685372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135528|NCT01685138|Ceritinib|ceritinib|mesh-list
92135529|NCT01685138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135530|NCT01685138|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135531|NCT01685138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135532|NCT01685138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135533|NCT01685060|Ceritinib|ceritinib|mesh-list
92135534|NCT01685060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135535|NCT01685060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135536|NCT01685060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135537|NCT01685060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135538|NCT03887936|Testosterone|testosterone|mesh-list
92135539|NCT03887936|Androgens|androgens|mesh-ancestor
92135540|NCT03887936|Hormones|hormones|mesh-ancestor
92135541|NCT03887936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135542|NCT03887936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135543|NCT01684202|Tolvaptan|tolvaptan|mesh-list
92135544|NCT01684202|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92135545|NCT01684202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135546|NCT01684202|Natriuretic Agents|natriuretic agents|mesh-ancestor
92135547|NCT01684202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135548|NCT01559090|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92135549|NCT01559090|Immunologic Factors|immunologic factors|mesh-ancestor
92135550|NCT01559090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135551|NCT01683266|Insulin|insulin|mesh-list
92135552|NCT01683266|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92135553|NCT01683266|Insulin Glargine|insulin glargine|mesh-list
92135554|NCT01683266|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135555|NCT01683266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135556|NCT01467661|Anagrelide|anagrelide|mesh-list
92135557|NCT01467661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92135558|NCT01467661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92135559|NCT01467661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135560|NCT01467661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92135561|NCT01577186|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92135562|NCT01577186|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92135563|NCT01577186|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92135564|NCT01577186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135565|NCT01577186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135566|NCT01577186|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92135567|NCT01577186|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92135568|NCT01577186|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92135569|NCT01577186|Serotonin Agents|serotonin agents|mesh-ancestor
92135570|NCT01577186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135571|NCT01577186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135572|NCT01577186|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92135573|NCT01577186|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92135574|NCT01577186|Dopamine Agents|dopamine agents|mesh-ancestor
92135576|NCT01559012|Analgesics|analgesics|mesh-ancestor
92135577|NCT01559012|Sensory System Agents|sensory system agents|mesh-ancestor
92135578|NCT01559012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135579|NCT01559012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135580|NCT01559012|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135582|NCT01559012|Autonomic Agents|autonomic agents|mesh-ancestor
92135583|NCT01559012|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92135584|NCT01559012|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92135585|NCT01559012|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92135586|NCT01559012|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135587|NCT01559012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135588|NCT01559012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135589|NCT01451827|Tolvaptan|tolvaptan|mesh-list
92135590|NCT01451827|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92135591|NCT01451827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135592|NCT01451827|Natriuretic Agents|natriuretic agents|mesh-ancestor
92135593|NCT01451827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135594|NCT01557920|Propofol|propofol|mesh-list
92135595|NCT01557920|Sevoflurane|sevoflurane|mesh-list
92135596|NCT01557920|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92135597|NCT01557920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135598|NCT01557920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135599|NCT01557920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92135600|NCT01557920|Anesthetics, General|anesthetics, general|mesh-ancestor
92135601|NCT01557920|Anesthetics|anesthetics|mesh-ancestor
92135602|NCT01557920|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92135603|NCT01557920|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92135604|NCT01467583|PENTA|penta|mesh-list
92135605|NCT01467583|Fondaparinux|fondaparinux|mesh-list
92135606|NCT01467583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92135607|NCT01467583|Antithrombins|antithrombins|mesh-ancestor
92135608|NCT01467583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92135609|NCT01467583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135610|NCT01467583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135611|NCT01467583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135612|NCT01467583|Anticoagulants|anticoagulants|mesh-ancestor
92135613|NCT01467583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92135614|NCT01467583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92135615|NCT01576718|Fluticasone|fluticasone|mesh-list
92135616|NCT01576718|Xhance|xhance|mesh-list
92135617|NCT01576718|Albuterol|albuterol|mesh-list
92135618|NCT01576718|Adrenergic Agonists|adrenergic agonists|mesh-list
92135619|NCT01576718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135620|NCT01576718|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92135621|NCT01576718|Autonomic Agents|autonomic agents|mesh-ancestor
92135622|NCT01576718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135623|NCT01576718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135624|NCT01576718|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92135625|NCT01576718|Respiratory System Agents|respiratory system agents|mesh-ancestor
92135626|NCT01576718|Dermatologic Agents|dermatologic agents|mesh-ancestor
92135627|NCT01576718|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92135628|NCT01576718|Tocolytic Agents|tocolytic agents|mesh-ancestor
92135629|NCT01576718|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92135630|NCT01576718|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92135631|NCT01576718|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92135632|NCT01576718|Adrenergic Agents|adrenergic agents|mesh-ancestor
92135633|NCT01576718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135634|NCT01576718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135635|NCT01493557|Pantoprazole|pantoprazole|mesh-list
92135637|NCT01493557|Antithrombins|antithrombins|mesh-ancestor
92135638|NCT01493557|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92135639|NCT01493557|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135640|NCT01493557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135641|NCT01493557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135642|NCT01493557|Anticoagulants|anticoagulants|mesh-ancestor
92135643|NCT01493557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92135644|NCT01493557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135645|NCT01493557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92135646|NCT01451749|Donepezil|donepezil|mesh-list
92135647|NCT01451749|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92135648|NCT01451749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135649|NCT01451749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135650|NCT01451749|Cholinergic Agents|cholinergic agents|mesh-ancestor
92135651|NCT01451749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135652|NCT01451749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135653|NCT01451749|Nootropic Agents|nootropic agents|mesh-ancestor
92135654|NCT01576484|Alirocumab|alirocumab|mesh-list
92135655|NCT01576484|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92135656|NCT01576484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92135657|NCT01576484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92135658|NCT01576484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92135659|NCT01576484|Antimetabolites|antimetabolites|mesh-ancestor
92135660|NCT01576484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135661|NCT01576484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92135662|NCT01576484|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135663|NCT01576484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135664|NCT01576484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92135665|NCT01576484|Immunologic Factors|immunologic factors|mesh-ancestor
92135666|NCT01576484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135668|NCT01467505|Ribavirin|ribavirin|mesh-list
92135669|NCT01467505|Interferon-alpha|interferon-alpha|mesh-list
92135670|NCT01467505|Interferon alpha-2|interferon alpha-2|mesh-list
92135671|NCT01467505|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92135672|NCT01467505|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92135673|NCT01467505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135674|NCT01467505|Antiviral Agents|antiviral agents|mesh-ancestor
92135675|NCT01467505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135676|NCT01467505|Antimetabolites|antimetabolites|mesh-ancestor
92135677|NCT01467505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135678|NCT01467505|Immunologic Factors|immunologic factors|mesh-ancestor
92135679|NCT01467505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135680|NCT01449929|Ritonavir|ritonavir|mesh-list
92135681|NCT01449929|Darunavir|darunavir|mesh-list
92135682|NCT01449929|Dolutegravir|dolutegravir|mesh-list
92135683|NCT01449929|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92135684|NCT01449929|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92135685|NCT01449929|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135686|NCT01449929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135687|NCT01449929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135688|NCT01449929|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92135689|NCT01449929|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92135690|NCT01449929|Antiviral Agents|antiviral agents|mesh-ancestor
92135691|NCT01449929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135692|NCT01449929|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92135693|NCT01449929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92135694|NCT01449929|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92135695|NCT01449929|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92135696|NCT01451515|Cytarabine|cytarabine|mesh-list
92135697|NCT01451515|Dexamethasone|dexamethasone|mesh-list
92135698|NCT01451515|Prednisone|prednisone|mesh-list
92135699|NCT01451515|Prednisolone|prednisolone|mesh-list
92135700|NCT01451515|Hydrocortisone|hydrocortisone|mesh-list
92135701|NCT01451515|Cyclophosphamide|cyclophosphamide|mesh-list
92135702|NCT01451515|Doxorubicin|doxorubicin|mesh-list
92135703|NCT01451515|Methotrexate|methotrexate|mesh-list
92135704|NCT01451515|Etoposide|etoposide|mesh-list
92135705|NCT01451515|Vincristine|vincristine|mesh-list
92135706|NCT01451515|Daunorubicin|daunorubicin|mesh-list
92135707|NCT01451515|Asparaginase|asparaginase|mesh-list
92135708|NCT01451515|Mercaptopurine|mercaptopurine|mesh-list
92135709|NCT01451515|Clofarabine|clofarabine|mesh-list
92135710|NCT01451515|Pegaspargase|pegaspargase|mesh-list
92135711|NCT01451515|Thioguanine|thioguanine|mesh-list
92135712|NCT01451515|Antimetabolites|antimetabolites|mesh-list
92135713|NCT01451515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135714|NCT01451515|Immunologic Factors|immunologic factors|mesh-ancestor
92135715|NCT01451515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135716|NCT01451515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135717|NCT01451515|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92135718|NCT01451515|Alkylating Agents|alkylating agents|mesh-ancestor
92135719|NCT01451515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135720|NCT01451515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135722|NCT01451515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135723|NCT01451515|Antiemetics|antiemetics|mesh-ancestor
92135724|NCT01451515|Autonomic Agents|autonomic agents|mesh-ancestor
92135725|NCT01451515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135726|NCT01451515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135727|NCT01451515|Glucocorticoids|glucocorticoids|mesh-ancestor
92135728|NCT01451515|Hormones|hormones|mesh-ancestor
92135729|NCT01451515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135730|NCT01451515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135731|NCT01451515|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92135732|NCT01451515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92135733|NCT01451515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92135734|NCT01451515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135735|NCT01451515|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92135736|NCT01451515|Abortifacient Agents|abortifacient agents|mesh-ancestor
92135737|NCT01451515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92135738|NCT01451515|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92135739|NCT01451515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92135740|NCT01451515|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92135741|NCT01451515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92135742|NCT01451515|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92135743|NCT01451515|Antiviral Agents|antiviral agents|mesh-ancestor
92135744|NCT01451515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135745|NCT01451515|Tubulin Modulators|tubulin modulators|mesh-ancestor
92135746|NCT01451515|Antimitotic Agents|antimitotic agents|mesh-ancestor
92135747|NCT01451515|Mitosis Modulators|mitosis modulators|mesh-ancestor
92135748|NCT01576406|Crizotinib|crizotinib|mesh-list
92135749|NCT01576406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135750|NCT01576406|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135751|NCT01576406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135752|NCT01576406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135753|NCT01576172|Prednisone|prednisone|mesh-list
92135754|NCT01576172|Cortisone|cortisone|mesh-list
92135755|NCT01576172|Abiraterone Acetate|abiraterone acetate|mesh-list
92135756|NCT01576172|Veliparib|veliparib|mesh-list
92135757|NCT01576172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135758|NCT01576172|Glucocorticoids|glucocorticoids|mesh-ancestor
92135759|NCT01576172|Hormones|hormones|mesh-ancestor
92135760|NCT01576172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135761|NCT01576172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135762|NCT01576172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135763|NCT01576172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135764|NCT01576172|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92135765|NCT01576172|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135766|NCT01576172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135767|NCT01576172|Hormone Antagonists|hormone antagonists|mesh-ancestor
92135768|NCT01576172|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92135769|NCT01576172|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92135770|NCT01542788|Sofosbuvir|sofosbuvir|mesh-list
92135771|NCT01542788|Antiviral Agents|antiviral agents|mesh-ancestor
92135772|NCT01542788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135773|NCT01541930|Metronidazole|metronidazole|mesh-list
92135774|NCT01541930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135775|NCT01541930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92135777|NCT01541930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92135778|NCT03028298|Sildenafil Citrate|sildenafil citrate|mesh-list
92135779|NCT03028298|Citric Acid|citric acid|mesh-list
92135780|NCT03028298|Sodium Citrate|sodium citrate|mesh-list
92135781|NCT03028298|Anticoagulants|anticoagulants|mesh-ancestor
92135782|NCT03028298|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92135784|NCT03028298|Sequestering Agents|sequestering agents|mesh-ancestor
92135785|NCT03028298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135786|NCT03028298|Vasodilator Agents|vasodilator agents|mesh-ancestor
92135787|NCT03028298|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92135788|NCT03028298|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92135789|NCT03028298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135790|NCT03028298|Urological Agents|urological agents|mesh-ancestor
92135791|NCT01540838|Acetaminophen|acetaminophen|mesh-list
92135792|NCT01540838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92135793|NCT01540838|Analgesics|analgesics|mesh-ancestor
92135794|NCT01540838|Sensory System Agents|sensory system agents|mesh-ancestor
92135795|NCT01540838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135796|NCT01540838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135797|NCT01540838|Antipyretics|antipyretics|mesh-ancestor
92135798|NCT01451203|Certolizumab Pegol|certolizumab pegol|mesh-list
92135799|NCT01451203|Methotrexate|methotrexate|mesh-list
92135800|NCT01451203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92135801|NCT01451203|Abortifacient Agents|abortifacient agents|mesh-ancestor
92135802|NCT01451203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92135803|NCT01451203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135804|NCT01451203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92135805|NCT01451203|Antimetabolites|antimetabolites|mesh-ancestor
92135806|NCT01451203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135807|NCT01451203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135808|NCT01451203|Dermatologic Agents|dermatologic agents|mesh-ancestor
91939297|NCT05200364|Bevacizumab|bevacizumab|mesh-list
92135809|NCT01451203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135810|NCT01451203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92135811|NCT01451203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135812|NCT01451203|Immunologic Factors|immunologic factors|mesh-ancestor
92135813|NCT01451203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135814|NCT01451203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92135815|NCT01451203|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92135816|NCT01451203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135819|NCT01556438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135820|NCT01556438|Antiemetics|antiemetics|mesh-ancestor
92135821|NCT01556438|Autonomic Agents|autonomic agents|mesh-ancestor
92135822|NCT01556438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135823|NCT01556438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135824|NCT01556438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135825|NCT01556438|Glucocorticoids|glucocorticoids|mesh-ancestor
92135826|NCT01556438|Hormones|hormones|mesh-ancestor
92135827|NCT01556438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135828|NCT01556438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92135829|NCT01556438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135830|NCT02073487|Paclitaxel|paclitaxel|mesh-list
92135831|NCT02073487|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92135832|NCT02073487|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92135833|NCT02073487|Trastuzumab|trastuzumab|mesh-list
92135834|NCT02073487|Lapatinib|lapatinib|mesh-list
92135835|NCT02073487|Pertuzumab|pertuzumab|mesh-list
92135836|NCT02073487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92135837|NCT02073487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135838|NCT02073487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92135839|NCT02073487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92135840|NCT02073487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92135841|NCT02073487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135842|NCT02073487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92135843|NCT02073487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92135844|NCT02073487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135845|NCT02073487|Immunotoxins|immunotoxins|mesh-ancestor
92135846|NCT02073487|Immunoconjugates|immunoconjugates|mesh-ancestor
92135847|NCT02073487|Immunologic Factors|immunologic factors|mesh-ancestor
92135848|NCT02073487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135849|NCT01466491|Lidocaine|lidocaine|mesh-list
92135850|NCT01466491|Anesthetics, Local|anesthetics, local|mesh-ancestor
92094071|NCT02245438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92135851|NCT01466491|Anesthetics|anesthetics|mesh-ancestor
92135852|NCT01466491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92135853|NCT01466491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135854|NCT01466491|Sensory System Agents|sensory system agents|mesh-ancestor
92135855|NCT01466491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135856|NCT01466491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92135857|NCT01466491|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92135858|NCT01466491|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92135859|NCT01466491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92135860|NCT01466491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135861|NCT01466179|Blinatumomab|blinatumomab|mesh-list
92135862|NCT01466179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135863|NCT01493089|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92135864|NCT01493089|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92135865|NCT01493089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135866|NCT01493089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135867|NCT01450813|Bromides|bromides|mesh-list
92135868|NCT01450813|Rocuronium|rocuronium|mesh-list
92135869|NCT01450813|Anticonvulsants|anticonvulsants|mesh-ancestor
92135870|NCT01450813|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92135871|NCT01450813|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92135872|NCT01450813|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92135873|NCT01450813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135874|NCT01450813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135875|NCT01539512|Rituximab|rituximab|mesh-list
92135876|NCT01539512|Idelalisib|idelalisib|mesh-list
92135877|NCT01539512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92135878|NCT01539512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135879|NCT01539512|Immunologic Factors|immunologic factors|mesh-ancestor
92135880|NCT01539512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135883|NCT01539512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135884|NCT01449955|Sirolimus|sirolimus|mesh-list
92135885|NCT01449955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92135886|NCT01449955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135887|NCT01449955|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92135888|NCT01449955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135889|NCT01449955|Antifungal Agents|antifungal agents|mesh-ancestor
92135890|NCT01449955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92135891|NCT01449955|Immunologic Factors|immunologic factors|mesh-ancestor
92135892|NCT01449955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135893|NCT01574612|Acyclovir|acyclovir|mesh-list
92135894|NCT01574612|Hydrocortisone|hydrocortisone|mesh-list
92135895|NCT01574612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92135896|NCT01574612|Antiviral Agents|antiviral agents|mesh-ancestor
92135897|NCT01574612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135898|NCT01573910|Moxifloxacin|moxifloxacin|mesh-list
92135899|NCT01573910|Ofloxacin|ofloxacin|mesh-list
92135900|NCT01573910|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92135901|NCT01573910|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92135902|NCT01573910|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92135903|NCT01573910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135904|NCT01573910|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92135905|NCT01573910|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92135906|NCT01573910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135907|NCT01573910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135908|NCT01573910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135909|NCT01573910|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92135910|NCT01573910|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92135911|NCT01573910|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92135912|NCT01491919|Lisinopril|lisinopril|mesh-list
92135913|NCT01491919|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92135914|NCT01491919|Protease Inhibitors|protease inhibitors|mesh-ancestor
92135915|NCT01491919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135916|NCT01491919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135917|NCT01491919|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92135918|NCT01491919|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92135919|NCT01491919|Protective Agents|protective agents|mesh-ancestor
92135920|NCT01491919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135921|NCT01573442|Testosterone|testosterone|mesh-list
92135922|NCT01573442|Androgens|androgens|mesh-ancestor
92135923|NCT01573442|Hormones|hormones|mesh-ancestor
92135924|NCT01573442|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094147|NCT00944554|Varenicline|varenicline|mesh-list
92135925|NCT01573442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135926|NCT02319369|Azacitidine|azacitidine|mesh-list
92135927|NCT02319369|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92135928|NCT02319369|Antimetabolites|antimetabolites|mesh-ancestor
92135929|NCT02319369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135930|NCT02319369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135931|NCT02319369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135932|NCT01491841|Rituximab|rituximab|mesh-list
92135933|NCT01491841|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92135934|NCT01491841|Pixantrone|pixantrone|mesh-list
92135935|NCT01491841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92135936|NCT01491841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92135937|NCT01491841|Immunologic Factors|immunologic factors|mesh-ancestor
92135938|NCT01491841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135939|NCT01491841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92135940|NCT01491841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92135941|NCT01491841|Alkylating Agents|alkylating agents|mesh-ancestor
92135942|NCT01491841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135943|NCT01491841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92135944|NCT01491841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92135945|NCT01491841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135946|NCT00297063|Rosiglitazone|rosiglitazone|mesh-list
92135947|NCT00297063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135948|NCT00297063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135949|NCT01553318|Ketotifen|ketotifen|mesh-list
92135950|NCT01553318|Antipruritics|antipruritics|mesh-ancestor
92135951|NCT01553318|Dermatologic Agents|dermatologic agents|mesh-ancestor
92135952|NCT01553318|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92135953|NCT01553318|Histamine Antagonists|histamine antagonists|mesh-ancestor
92135954|NCT01553318|Histamine Agents|histamine agents|mesh-ancestor
92135955|NCT01553318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135956|NCT01553318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135957|NCT01553318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135958|NCT01553318|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92135959|NCT01572740|Liraglutide|liraglutide|mesh-list
92135960|NCT01572740|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92135961|NCT01572740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135962|NCT01572740|Incretins|incretins|mesh-ancestor
92135963|NCT01572740|Hormones|hormones|mesh-ancestor
92135964|NCT01572740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92135965|NCT01491607|Vaccines|vaccines|mesh-list
92135966|NCT01491607|Immunologic Factors|immunologic factors|mesh-ancestor
92135967|NCT01491607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135968|NCT02338713|Calcium Carbonate|calcium carbonate|mesh-list
92135969|NCT02338713|Antacids|antacids|mesh-ancestor
92135970|NCT02338713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135971|NCT02338713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135972|NCT00557349|Omeprazole|omeprazole|mesh-list
92135973|NCT00557349|Famotidine|famotidine|mesh-list
92135974|NCT00557349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92135975|NCT00557349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92135976|NCT00557349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92135977|NCT00557349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92135978|NCT00557349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135979|NCT00557349|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92135980|NCT00557349|Histamine Antagonists|histamine antagonists|mesh-ancestor
92135981|NCT00557349|Histamine Agents|histamine agents|mesh-ancestor
92135982|NCT00557349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135983|NCT00557349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135984|NCT01553084|Nicotine|nicotine|mesh-list
92135985|NCT01553084|Varenicline|varenicline|mesh-list
92135986|NCT01553084|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92135988|NCT01553084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92135989|NCT01553084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92135990|NCT01553084|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92135991|NCT01553084|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92135992|NCT01553084|Cholinergic Agents|cholinergic agents|mesh-ancestor
92135993|NCT01553084|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92135994|NCT01553084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92135995|NCT01552928|Moxifloxacin|moxifloxacin|mesh-list
92135996|NCT01552928|Anagrelide|anagrelide|mesh-list
92135997|NCT01552928|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92135998|NCT01552928|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92135999|NCT01552928|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136000|NCT01552928|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136001|NCT01552928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136002|NCT01552928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136003|NCT01552928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136004|NCT01552928|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92136005|NCT01552928|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92136006|NCT01552928|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92136007|NCT01448707|Ritonavir|ritonavir|mesh-list
92136008|NCT01448707|Darunavir|darunavir|mesh-list
92136009|NCT01448707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92136010|NCT01448707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92136011|NCT01448707|Protease Inhibitors|protease inhibitors|mesh-ancestor
92136012|NCT01448707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136013|NCT01448707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136014|NCT01448707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92136015|NCT01448707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92136016|NCT01448707|Antiviral Agents|antiviral agents|mesh-ancestor
92136017|NCT01448707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136018|NCT01448707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92136019|NCT01448707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92136020|NCT01536704|Nicotine|nicotine|mesh-list
92136021|NCT01536704|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92136022|NCT01536704|Autonomic Agents|autonomic agents|mesh-ancestor
92136023|NCT01536704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136024|NCT01536704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136025|NCT01536704|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92136026|NCT01536704|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92136027|NCT01536704|Cholinergic Agents|cholinergic agents|mesh-ancestor
92136028|NCT01536704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136029|NCT01536704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136030|NCT04108676|Fluzoparib|fluzoparib|mesh-list
92136031|NCT04108676|Omeprazole|omeprazole|mesh-list
92136032|NCT04108676|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92136033|NCT04108676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136034|NCT04108676|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92136035|NCT04108676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136036|NCT04108676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136037|NCT04108676|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92136038|NCT04108676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136039|NCT01552772|Aripiprazole|aripiprazole|mesh-list
92136040|NCT01552772|Antidepressive Agents|antidepressive agents|mesh-ancestor
92136041|NCT01552772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136042|NCT01552772|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92136043|NCT01552772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92136044|NCT01552772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136045|NCT01552772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136046|NCT01552772|Dopamine Agonists|dopamine agonists|mesh-ancestor
92136047|NCT01552772|Dopamine Agents|dopamine agents|mesh-ancestor
92136048|NCT01552772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136049|NCT01552772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136050|NCT01552772|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92136051|NCT01552772|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92136052|NCT01552772|Serotonin Agents|serotonin agents|mesh-ancestor
92136053|NCT01552772|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92136054|NCT01552772|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92136055|NCT01552772|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92136056|NCT01552772|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92136057|NCT01552694|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92136058|NCT01552694|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92136059|NCT01552694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136060|NCT01552694|Incretins|incretins|mesh-ancestor
92136061|NCT01552694|Hormones|hormones|mesh-ancestor
92136062|NCT01552694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136063|NCT01552694|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92136064|NCT01552694|Protease Inhibitors|protease inhibitors|mesh-ancestor
92136065|NCT01552694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136066|NCT01552694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136067|NCT01464931|Denosumab|denosumab|mesh-list
92136068|NCT01464931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92136069|NCT01464931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136070|NCT01536392|Ondansetron|ondansetron|mesh-list
92136071|NCT01536392|Granisetron|granisetron|mesh-list
92136072|NCT01536392|Antiemetics|antiemetics|mesh-ancestor
92136073|NCT01536392|Autonomic Agents|autonomic agents|mesh-ancestor
92136074|NCT01536392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136075|NCT01536392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136076|NCT01536392|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136077|NCT01536392|Antipruritics|antipruritics|mesh-ancestor
92136078|NCT01536392|Dermatologic Agents|dermatologic agents|mesh-ancestor
92136079|NCT01536392|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92136080|NCT01536392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92136081|NCT01536392|Serotonin Agents|serotonin agents|mesh-ancestor
92136082|NCT01536392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136083|NCT01536392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136085|NCT04767295|Carboplatin|carboplatin|mesh-list
92136086|NCT04767295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92136087|NCT04767295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136088|NCT04767295|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136089|NCT04767295|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136090|NCT04767295|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136091|NCT04767295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136092|NCT02118831|Bevacizumab|bevacizumab|mesh-list
92136093|NCT02118831|Ranibizumab|ranibizumab|mesh-list
92136094|NCT02118831|Aflibercept|aflibercept|mesh-list
92136095|NCT02118831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136096|NCT02118831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136097|NCT02118831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136098|NCT02118831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136099|NCT02118831|Growth Substances|growth substances|mesh-ancestor
92136100|NCT02118831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136101|NCT02118831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136102|NCT00490269|Dronabinol|dronabinol|mesh-list
92136103|NCT00490269|Hallucinogens|hallucinogens|mesh-ancestor
92136104|NCT00490269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136105|NCT00490269|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136106|NCT00490269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92136107|NCT00490269|Analgesics|analgesics|mesh-ancestor
92136108|NCT00490269|Sensory System Agents|sensory system agents|mesh-ancestor
92136109|NCT00490269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136110|NCT00490269|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92136111|NCT00490269|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92136112|NCT00490269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136113|NCT00490269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136114|NCT00490269|Hormones|hormones|mesh-ancestor
92136115|NCT00490269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136116|NCT05621499|Lenvatinib|lenvatinib|mesh-list
92136117|NCT05621499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136118|NCT05621499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136119|NCT05621499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136120|NCT05621499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136121|NCT01490125|Glycopyrrolate|glycopyrrolate|mesh-list
92136122|NCT01490125|Albuterol|albuterol|mesh-list
92136123|NCT01490125|Tiotropium Bromide|tiotropium bromide|mesh-list
92136124|NCT01490125|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92136125|NCT01490125|Autonomic Agents|autonomic agents|mesh-ancestor
92136126|NCT01490125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136127|NCT01490125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136128|NCT01490125|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92136129|NCT01490125|Respiratory System Agents|respiratory system agents|mesh-ancestor
92136130|NCT01490125|Parasympatholytics|parasympatholytics|mesh-ancestor
92136131|NCT01490125|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92136132|NCT01490125|Cholinergic Agents|cholinergic agents|mesh-ancestor
92136133|NCT01490125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136134|NCT01490125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136135|NCT01490125|Tocolytic Agents|tocolytic agents|mesh-ancestor
92136136|NCT01490125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92136137|NCT01490125|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92136138|NCT01490125|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92136139|NCT01490125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92136140|NCT01490125|Adrenergic Agents|adrenergic agents|mesh-ancestor
92136141|NCT01490125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92136142|NCT01490125|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92136143|NCT00491751|Ascorbic Acid|ascorbic acid|mesh-list
92136144|NCT00491751|Atorvastatin|atorvastatin|mesh-list
92136145|NCT00491751|Vitamins|vitamins|mesh-ancestor
92136146|NCT00491751|Micronutrients|micronutrients|mesh-ancestor
92136147|NCT00491751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136148|NCT00491751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92136149|NCT00491751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92136150|NCT00491751|Antimetabolites|antimetabolites|mesh-ancestor
92136151|NCT00491751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136152|NCT00491751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92136153|NCT00491751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92136154|NCT00491751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136155|NCT00491751|Antioxidants|antioxidants|mesh-ancestor
92136156|NCT00491751|Protective Agents|protective agents|mesh-ancestor
92136157|NCT01420549|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92136158|NCT01420549|Simvastatin|simvastatin|mesh-list
92136159|NCT01420549|Ezetimibe|ezetimibe|mesh-list
92136160|NCT01420549|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92136161|NCT01420549|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92136162|NCT01420549|Antimetabolites|antimetabolites|mesh-ancestor
92136163|NCT01420549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136164|NCT01420549|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92136165|NCT01420549|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92136166|NCT01420549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136167|NCT01440595|Ribavirin|ribavirin|mesh-list
92136168|NCT01440595|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92136169|NCT01440595|Grazoprevir|grazoprevir|mesh-list
92136170|NCT01440595|Antimetabolites|antimetabolites|mesh-ancestor
92136171|NCT01440595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136172|NCT01440595|Antiviral Agents|antiviral agents|mesh-ancestor
92136173|NCT01440595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136174|NCT05560035|Lidocaine|lidocaine|mesh-list
92136175|NCT05560035|Anesthetics, Local|anesthetics, local|mesh-ancestor
92136176|NCT05560035|Anesthetics|anesthetics|mesh-ancestor
92136177|NCT05560035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136178|NCT05560035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136179|NCT05560035|Sensory System Agents|sensory system agents|mesh-ancestor
92136180|NCT05560035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136181|NCT05560035|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92136182|NCT05560035|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92136183|NCT05560035|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92136184|NCT05560035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136185|NCT05560035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136186|NCT00497055|Aripiprazole|aripiprazole|mesh-list
92136187|NCT00497055|Antidepressive Agents|antidepressive agents|mesh-ancestor
92136188|NCT00497055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136189|NCT00497055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92136190|NCT00497055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92136191|NCT00497055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136192|NCT00497055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136193|NCT00497055|Dopamine Agonists|dopamine agonists|mesh-ancestor
92136194|NCT00497055|Dopamine Agents|dopamine agents|mesh-ancestor
92136195|NCT00497055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136196|NCT00497055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136197|NCT00497055|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92136198|NCT00497055|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92136199|NCT00497055|Serotonin Agents|serotonin agents|mesh-ancestor
92136200|NCT00497055|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92136201|NCT00497055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92136202|NCT00497055|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92136203|NCT00497055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92136204|NCT00498615|Fasudil|fasudil|mesh-list
92136205|NCT00498615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92136206|NCT00498615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136207|NCT00498615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136208|NCT00498615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92136209|NCT00498615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136210|NCT00498615|Vasodilator Agents|vasodilator agents|mesh-ancestor
92136211|NCT00498615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136212|NCT00498615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136213|NCT00498927|Temozolomide|temozolomide|mesh-list
92136214|NCT00498927|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136215|NCT00498927|Alkylating Agents|alkylating agents|mesh-ancestor
92136216|NCT00498927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136217|NCT00498927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136218|NCT05555901|Bevacizumab|bevacizumab|mesh-list
92136219|NCT05555901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136220|NCT05555901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136221|NCT05555901|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136222|NCT05555901|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136223|NCT05555901|Growth Substances|growth substances|mesh-ancestor
92136224|NCT05555901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136225|NCT05555901|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136226|NCT00499473|Sunitinib|sunitinib|mesh-list
92136227|NCT00499473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136228|NCT00499473|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136229|NCT00499473|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136230|NCT00499473|Growth Substances|growth substances|mesh-ancestor
92136231|NCT00499473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136232|NCT00499473|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136233|NCT00499473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136234|NCT00499473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136235|NCT00499473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136236|NCT00501891|Bevacizumab|bevacizumab|mesh-list
92136237|NCT00501891|Temozolomide|temozolomide|mesh-list
92136238|NCT00501891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136239|NCT00501891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136240|NCT00501891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136241|NCT00501891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136242|NCT00501891|Growth Substances|growth substances|mesh-ancestor
92136243|NCT00501891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136244|NCT00501891|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136245|NCT00501891|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136246|NCT00501891|Alkylating Agents|alkylating agents|mesh-ancestor
92136247|NCT00501891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136248|NCT01798017|Misoprostol|misoprostol|mesh-list
92136249|NCT01798017|Mifepristone|mifepristone|mesh-list
92136250|NCT01798017|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92136251|NCT01798017|Abortifacient Agents|abortifacient agents|mesh-ancestor
92136252|NCT01798017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92136253|NCT01798017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136254|NCT01798017|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92136255|NCT01798017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136257|NCT01798017|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92136258|NCT01798017|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92136259|NCT01798017|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92136260|NCT01798017|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92136261|NCT01798017|Contraceptive Agents|contraceptive agents|mesh-ancestor
92136262|NCT01798017|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92136263|NCT01798017|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92136264|NCT01798017|Hormone Antagonists|hormone antagonists|mesh-ancestor
92136265|NCT01798017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136266|NCT01798017|Luteolytic Agents|luteolytic agents|mesh-ancestor
92136267|NCT01798017|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92136268|NCT01798017|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92136269|NCT00502905|Fludarabine|fludarabine|mesh-list
92136270|NCT00502905|Fludarabine phosphate|fludarabine phosphate|mesh-list
92136272|NCT00502905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136273|NCT00502905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92136274|NCT00502905|Antimetabolites|antimetabolites|mesh-ancestor
92136275|NCT00502905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136276|NCT00502905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136277|NCT00502905|Immunologic Factors|immunologic factors|mesh-ancestor
92136278|NCT00502905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136279|NCT00502905|Alkylating Agents|alkylating agents|mesh-ancestor
92136280|NCT00502905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136281|NCT00502905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92136282|NCT05418777|Trimethoprim|trimethoprim|mesh-list
92136283|NCT05418777|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92136284|NCT05418777|Sulfamethoxazole|sulfamethoxazole|mesh-list
92136285|NCT05418777|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92136286|NCT05418777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136287|NCT05418777|Antimalarials|antimalarials|mesh-ancestor
92136288|NCT05418777|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92136289|NCT05418777|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92136290|NCT05418777|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92136291|NCT05418777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136292|NCT05418777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136293|NCT05418777|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92136294|NCT05418777|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92094527|NCT03023020|Antipyretics|antipyretics|mesh-ancestor
92136295|NCT05418777|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92136296|NCT05418777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92136297|NCT00505635|Interferons|interferons|mesh-list
92136298|NCT00505635|Interferon-alpha|interferon-alpha|mesh-list
92136299|NCT00505635|Interferon alpha-2|interferon alpha-2|mesh-list
92136300|NCT00505635|Thalidomide|thalidomide|mesh-list
92136301|NCT00505635|Cisplatin|cisplatin|mesh-list
92136302|NCT00505635|Temozolomide|temozolomide|mesh-list
92136303|NCT00505635|Interleukin-2|interleukin-2|mesh-list
92136304|NCT00505635|Vinblastine|vinblastine|mesh-list
92136305|NCT00505635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136306|NCT00505635|Antiviral Agents|antiviral agents|mesh-ancestor
92136307|NCT00505635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136308|NCT00505635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136309|NCT00505635|Alkylating Agents|alkylating agents|mesh-ancestor
92136310|NCT00505635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136311|NCT00505635|Immunologic Factors|immunologic factors|mesh-ancestor
92136312|NCT00505635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136313|NCT00505635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92136314|NCT00505635|Analgesics|analgesics|mesh-ancestor
92136315|NCT00505635|Sensory System Agents|sensory system agents|mesh-ancestor
92136316|NCT00505635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136317|NCT00505635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136318|NCT00505635|Leprostatic Agents|leprostatic agents|mesh-ancestor
92136319|NCT00505635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92136320|NCT00505635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136321|NCT00505635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136322|NCT00505635|Growth Substances|growth substances|mesh-ancestor
92136323|NCT00505635|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136324|NCT00505635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92136325|NCT00505635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136326|NCT00505635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136327|NCT00505635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136328|NCT01842165|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92136329|NCT01842165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92136330|NCT01842165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136332|NCT04479813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92136333|NCT04474899|Amlodipine|amlodipine|mesh-list
92136334|NCT04474899|Moxonidine|moxonidine|mesh-list
92136335|NCT04474899|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92136336|NCT04474899|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92136337|NCT04474899|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136338|NCT04474899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136339|NCT04474899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92136340|NCT04474899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136341|NCT04474899|Vasodilator Agents|vasodilator agents|mesh-ancestor
92136342|NCT00511173|Warfarin|warfarin|mesh-list
92136343|NCT00511173|Anticoagulants|anticoagulants|mesh-ancestor
92136345|NCT01447927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92136346|NCT01447927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136347|NCT04037397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92136348|NCT00513747|Rituximab|rituximab|mesh-list
92136349|NCT00513747|Fludarabine|fludarabine|mesh-list
92136350|NCT00513747|Fludarabine phosphate|fludarabine phosphate|mesh-list
92136351|NCT00513747|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136352|NCT00513747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136353|NCT00513747|Immunologic Factors|immunologic factors|mesh-ancestor
92136354|NCT00513747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136355|NCT00513747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136356|NCT00513747|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92136357|NCT00513747|Antimetabolites|antimetabolites|mesh-ancestor
92136358|NCT00513747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136359|NCT00513747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136360|NCT00514137|Sunitinib|sunitinib|mesh-list
92136361|NCT00514137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136362|NCT00514137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136363|NCT00514137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136364|NCT00514137|Growth Substances|growth substances|mesh-ancestor
92136365|NCT00514137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136366|NCT00514137|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136367|NCT00514137|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136368|NCT00514137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136369|NCT00514137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136370|NCT00514215|Molgramostim|molgramostim|mesh-list
92136371|NCT00514215|Sargramostim|sargramostim|mesh-list
92136372|NCT00514215|Immunologic Factors|immunologic factors|mesh-ancestor
92136373|NCT00514215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136374|NCT00514215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136376|NCT03912909|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92136377|NCT03912909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136378|NCT03912909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92136379|NCT03912909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136381|NCT02130063|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92136382|NCT02130063|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92136383|NCT02130063|Trace Elements|trace elements|mesh-ancestor
92136384|NCT02130063|Micronutrients|micronutrients|mesh-ancestor
92136385|NCT02130063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136386|NCT02130063|Hematinics|hematinics|mesh-ancestor
92136387|NCT00515697|Ramucirumab|ramucirumab|mesh-list
92136388|NCT00515697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136389|NCT00516165|Everolimus|everolimus|mesh-list
92136390|NCT00516165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92136391|NCT00516165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136392|NCT00516165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136393|NCT00516165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136394|NCT00516165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136395|NCT00516165|Immunologic Factors|immunologic factors|mesh-ancestor
91939305|NCT00835991|Metformin|metformin|mesh-list
92136396|NCT00516165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136397|NCT00516165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136398|NCT03631173|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92136399|NCT03631173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136400|NCT03419481|Pembrolizumab|pembrolizumab|mesh-list
92136401|NCT03419481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136402|NCT03419481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136403|NCT03419481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92136404|NCT03419481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136405|NCT02132169|Cetirizine|cetirizine|mesh-list
92136406|NCT02132169|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92136407|NCT02132169|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92136408|NCT02132169|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92136409|NCT02132169|Histamine Antagonists|histamine antagonists|mesh-ancestor
92136410|NCT02132169|Histamine Agents|histamine agents|mesh-ancestor
92136411|NCT02132169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136412|NCT02132169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136413|NCT02132169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136414|NCT03174405|Avelumab|avelumab|mesh-list
92136415|NCT03174405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136416|NCT03174405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136417|NCT00522795|Paclitaxel|paclitaxel|mesh-list
92136418|NCT00522795|Cisplatin|cisplatin|mesh-list
92136419|NCT00522795|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92136420|NCT00522795|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92136421|NCT00522795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136422|NCT00522795|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136423|NCT00522795|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136424|NCT00522795|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136425|NCT00522795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136426|NCT03121677|Poly I-C|poly i-c|mesh-list
92136427|NCT03121677|Rituximab|rituximab|mesh-list
92136428|NCT03121677|Nivolumab|nivolumab|mesh-list
92136429|NCT03121677|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92136430|NCT03121677|Poly ICLC|poly iclc|mesh-list
92136431|NCT03121677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136432|NCT03121677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136433|NCT03121677|Immunologic Factors|immunologic factors|mesh-ancestor
92136434|NCT03121677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136435|NCT03121677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136436|NCT03121677|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92136437|NCT03121677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136438|NCT03121677|Interferon Inducers|interferon inducers|mesh-ancestor
92136439|NCT03121677|Laxatives|laxatives|mesh-ancestor
92136440|NCT03121677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136441|NCT03121677|Antiviral Agents|antiviral agents|mesh-ancestor
92136442|NCT03121677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136443|NCT02871687|Simvastatin|simvastatin|mesh-list
92136444|NCT02871687|Pravastatin|pravastatin|mesh-list
92136445|NCT02871687|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92136447|NCT02871687|Antimetabolites|antimetabolites|mesh-ancestor
92136448|NCT02871687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136449|NCT02871687|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92136450|NCT02871687|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92136451|NCT02871687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136452|NCT00525057|Dalteparin|dalteparin|mesh-list
92136453|NCT00525057|Tinzaparin|tinzaparin|mesh-list
92136454|NCT00525057|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92136455|NCT00525057|Anticoagulants|anticoagulants|mesh-ancestor
92136456|NCT00525057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92136457|NCT00525057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92136458|NCT00525057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136459|NCT00525135|Valproic Acid|valproic acid|mesh-list
92136460|NCT00525135|Anticonvulsants|anticonvulsants|mesh-ancestor
92136461|NCT00525135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136462|NCT00525135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136463|NCT00525135|GABA Agents|gaba agents|mesh-ancestor
92136464|NCT00525135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136465|NCT00525135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136466|NCT00525135|Antimanic Agents|antimanic agents|mesh-ancestor
92136467|NCT00525135|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92136468|NCT00525135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136469|NCT00525135|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136470|NCT00525525|Bevacizumab|bevacizumab|mesh-list
92136471|NCT00525525|Temozolomide|temozolomide|mesh-list
92136472|NCT00525525|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92136473|NCT00525525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136474|NCT00525525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136475|NCT00525525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136476|NCT00525525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136477|NCT00525525|Growth Substances|growth substances|mesh-ancestor
92136478|NCT00525525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136479|NCT00525525|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136480|NCT00525525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136481|NCT00525525|Alkylating Agents|alkylating agents|mesh-ancestor
92136482|NCT00525525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136483|NCT00525525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136484|NCT00525525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136485|NCT00525603|Cyclophosphamide|cyclophosphamide|mesh-list
92136490|NCT00525603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136491|NCT00525603|Immunologic Factors|immunologic factors|mesh-ancestor
92136492|NCT00525603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136493|NCT00525603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136494|NCT00525603|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136495|NCT00525603|Alkylating Agents|alkylating agents|mesh-ancestor
92136496|NCT00525603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136497|NCT00525603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136498|NCT00525603|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92136499|NCT00525603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136500|NCT00525603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92136501|NCT00525603|Antimetabolites|antimetabolites|mesh-ancestor
92136502|NCT00398307|Cisplatin|cisplatin|mesh-list
92136503|NCT00398307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136504|NCT00564447|Azithromycin|azithromycin|mesh-list
92136505|NCT00564447|Moxifloxacin|moxifloxacin|mesh-list
92136506|NCT00564447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92136507|NCT00564447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136508|NCT00564447|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136509|NCT00564447|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136510|NCT00564447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136511|NCT00564447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136512|NCT00564447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136513|NCT00564681|Botulinum Toxins|botulinum toxins|mesh-list
92136514|NCT00564681|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92136515|NCT00564681|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92136516|NCT00564681|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92136517|NCT00564681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136518|NCT00564681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136520|NCT00564681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136521|NCT00564681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136522|NCT00564681|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92136523|NCT00564681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136524|NCT00525837|Varenicline|varenicline|mesh-list
92136525|NCT00525837|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92136526|NCT00525837|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92136527|NCT00525837|Cholinergic Agents|cholinergic agents|mesh-ancestor
92136528|NCT00525837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136529|NCT00525837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136530|NCT00525837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136531|NCT00527475|Ranibizumab|ranibizumab|mesh-list
92136532|NCT00527475|Verteporfin|verteporfin|mesh-list
92136533|NCT00527475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136534|NCT00527475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136535|NCT00527475|Growth Substances|growth substances|mesh-ancestor
92136536|NCT00527475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136537|NCT00527475|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136538|NCT00527475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136539|NCT00527475|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92136540|NCT00527475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92136541|NCT01798251|Capecitabine|capecitabine|mesh-list
92136542|NCT01798251|Oxaliplatin|oxaliplatin|mesh-list
92136543|NCT01798251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92136544|NCT01798251|Antimetabolites|antimetabolites|mesh-ancestor
92136545|NCT01798251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136546|NCT01798251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136547|NCT02121483|Empagliflozin|empagliflozin|mesh-list
92136548|NCT02121483|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92136549|NCT02121483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136550|NCT02121483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92136551|NCT02121483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136553|NCT01572038|Docetaxel|docetaxel|mesh-list
92136554|NCT01572038|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92136555|NCT01572038|Trastuzumab|trastuzumab|mesh-list
92136556|NCT01572038|Pertuzumab|pertuzumab|mesh-list
92136557|NCT01572038|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92136558|NCT01572038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136559|NCT01572038|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136560|NCT01572038|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136561|NCT01572038|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136562|NCT01572038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136563|NCT01572038|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136564|NCT01448213|Fluorometholone|fluorometholone|mesh-list
92136565|NCT01448213|Prednisolone|prednisolone|mesh-list
92136566|NCT01448213|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92136567|NCT01448213|Methylprednisolone|methylprednisolone|mesh-list
92136568|NCT01448213|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92136569|NCT01448213|Prednisolone acetate|prednisolone acetate|mesh-list
92136570|NCT01448213|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92136571|NCT01448213|Prednisolone phosphate|prednisolone phosphate|mesh-list
92136572|NCT01448213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136573|NCT01448213|Glucocorticoids|glucocorticoids|mesh-ancestor
92136574|NCT01448213|Hormones|hormones|mesh-ancestor
92136575|NCT01448213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136576|NCT01448213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136577|NCT01448213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92136578|NCT01448213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136579|NCT01448213|Antiemetics|antiemetics|mesh-ancestor
92136580|NCT01448213|Autonomic Agents|autonomic agents|mesh-ancestor
92136581|NCT01448213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136582|NCT01448213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136583|NCT01448213|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92136584|NCT01448213|Protective Agents|protective agents|mesh-ancestor
92136585|NCT01448213|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92136586|NCT01448057|Acetaminophen|acetaminophen|mesh-list
92136587|NCT01448057|Dimethindene|dimethindene|mesh-list
92136588|NCT01448057|Phenylephrine|phenylephrine|mesh-list
92136589|NCT01448057|Oxymetazoline|oxymetazoline|mesh-list
92136590|NCT01448057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92136591|NCT01448057|Analgesics|analgesics|mesh-ancestor
92136592|NCT01448057|Sensory System Agents|sensory system agents|mesh-ancestor
92136593|NCT01448057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136594|NCT01448057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136596|NCT01448057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136597|NCT01448057|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92136598|NCT01448057|Mydriatics|mydriatics|mesh-ancestor
92136599|NCT01448057|Autonomic Agents|autonomic agents|mesh-ancestor
92136600|NCT01448057|Sympathomimetics|sympathomimetics|mesh-ancestor
92136601|NCT01448057|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92136602|NCT01448057|Nasal Decongestants|nasal decongestants|mesh-ancestor
92136603|NCT01448057|Respiratory System Agents|respiratory system agents|mesh-ancestor
92136604|NCT01448057|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92136605|NCT01448057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92136606|NCT01448057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92136607|NCT01448057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92136608|NCT01448057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136609|NCT01448057|Protective Agents|protective agents|mesh-ancestor
92136610|NCT01448057|Antipruritics|antipruritics|mesh-ancestor
92136611|NCT01448057|Dermatologic Agents|dermatologic agents|mesh-ancestor
92136612|NCT01448057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92136613|NCT01448057|Histamine Antagonists|histamine antagonists|mesh-ancestor
92136614|NCT01448057|Histamine Agents|histamine agents|mesh-ancestor
92136615|NCT01448057|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92136616|NCT05246631|Dexamethasone|dexamethasone|mesh-list
92136617|NCT05246631|Dexamethasone acetate|dexamethasone acetate|mesh-list
92136618|NCT05246631|Haloperidol|haloperidol|mesh-list
92136619|NCT05246631|Haloperidol decanoate|haloperidol decanoate|mesh-list
92136620|NCT05246631|BB 1101|bb 1101|mesh-list
92136621|NCT05246631|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136622|NCT05246631|Antiemetics|antiemetics|mesh-ancestor
92136623|NCT05246631|Autonomic Agents|autonomic agents|mesh-ancestor
92136624|NCT05246631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136625|NCT05246631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136626|NCT05246631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136627|NCT05246631|Glucocorticoids|glucocorticoids|mesh-ancestor
92136628|NCT05246631|Hormones|hormones|mesh-ancestor
92136629|NCT05246631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136630|NCT05246631|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92136631|NCT05246631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136632|NCT05246631|Protease Inhibitors|protease inhibitors|mesh-ancestor
92136633|NCT05246631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136634|NCT05246631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136635|NCT05246631|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92136636|NCT05246631|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92136637|NCT05246631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136638|NCT05246631|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136639|NCT05246631|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92136640|NCT05246631|Dopamine Agents|dopamine agents|mesh-ancestor
92136641|NCT05246631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136642|NCT05246631|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92136643|NCT01447433|Calcium Carbonate|calcium carbonate|mesh-list
92136644|NCT01447433|Calcium|calcium|mesh-list
92136645|NCT01447433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92136646|NCT01447433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136647|NCT01447433|Antacids|antacids|mesh-ancestor
92136648|NCT01447433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136649|NCT01447433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136650|NCT01798875|Metformin|metformin|mesh-list
92136651|NCT01798875|Contraceptive Agents|contraceptive agents|mesh-list
92136652|NCT01798875|Contraceptives, Oral|contraceptives, oral|mesh-list
92136653|NCT01798875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92136654|NCT01798875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136655|NCT01798875|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92136656|NCT01798875|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92136657|NCT05362851|Celecoxib|celecoxib|mesh-list
92136658|NCT05362851|Tramadol|tramadol|mesh-list
92136659|NCT05362851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92136660|NCT05362851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92136661|NCT05362851|Analgesics|analgesics|mesh-ancestor
92136662|NCT05362851|Sensory System Agents|sensory system agents|mesh-ancestor
92136663|NCT05362851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136664|NCT05362851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136665|NCT05362851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136666|NCT05362851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136667|NCT05362851|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92136668|NCT05362851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92136669|NCT05362851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136670|NCT05362851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136671|NCT05362851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92136672|NCT05362851|Narcotics|narcotics|mesh-ancestor
92136673|NCT05362851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136674|NCT04408235|Enoxaparin|enoxaparin|mesh-list
92136675|NCT04408235|Anticoagulants|anticoagulants|mesh-ancestor
92136676|NCT04408235|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92136677|NCT04408235|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92136678|NCT04408235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136679|NCT03517137|Cyclophosphamide|cyclophosphamide|mesh-list
92136680|NCT03517137|Dacarbazine|dacarbazine|mesh-list
92136681|NCT03517137|Etoposide|etoposide|mesh-list
92136682|NCT03517137|Doxorubicin|doxorubicin|mesh-list
92136683|NCT03517137|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92136684|NCT03517137|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92136685|NCT03517137|Vinblastine|vinblastine|mesh-list
92136686|NCT03517137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136687|NCT03517137|Immunologic Factors|immunologic factors|mesh-ancestor
92136688|NCT03517137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136689|NCT03517137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136690|NCT03517137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136691|NCT03517137|Alkylating Agents|alkylating agents|mesh-ancestor
92136692|NCT03517137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136693|NCT03517137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136694|NCT03517137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92136695|NCT03517137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92136696|NCT03517137|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136697|NCT03517137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136698|NCT03517137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136699|NCT03517137|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92136700|NCT03517137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136701|NCT03517137|Immunotoxins|immunotoxins|mesh-ancestor
92136702|NCT03517137|Immunoconjugates|immunoconjugates|mesh-ancestor
92136703|NCT03517137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136704|NCT03517137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136705|NCT03517137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136706|NCT01446809|Doxorubicin|doxorubicin|mesh-list
92136707|NCT01446809|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92136709|NCT01446809|Isophosphamide mustard|isophosphamide mustard|mesh-list
92136710|NCT01446809|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92136711|NCT01446809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136712|NCT01446809|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136713|NCT01446809|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136714|NCT01446809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136715|NCT01446809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136716|NCT01446809|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136718|NCT03357159|Cyclophosphamide|cyclophosphamide|mesh-list
92136719|NCT03357159|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92136720|NCT03357159|Immunoglobulins|immunoglobulins|mesh-list
92136721|NCT03357159|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92136722|NCT03357159|Antibodies|antibodies|mesh-list
92136723|NCT03357159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136724|NCT03357159|Immunologic Factors|immunologic factors|mesh-ancestor
92136725|NCT03357159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136726|NCT03357159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136727|NCT03357159|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136728|NCT03357159|Alkylating Agents|alkylating agents|mesh-ancestor
92136729|NCT03357159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136730|NCT03357159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136731|NCT03357159|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92136732|NCT04387929|Antibodies|antibodies|mesh-list
92136733|NCT04387929|Immunologic Factors|immunologic factors|mesh-ancestor
92136734|NCT04387929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136735|NCT05361291|Dexamethasone|dexamethasone|mesh-list
92136736|NCT05361291|Lidocaine|lidocaine|mesh-list
92136737|NCT05361291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136738|NCT05361291|Antiemetics|antiemetics|mesh-ancestor
92136739|NCT05361291|Autonomic Agents|autonomic agents|mesh-ancestor
92136740|NCT05361291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136741|NCT05361291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136742|NCT05361291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92136743|NCT05361291|Glucocorticoids|glucocorticoids|mesh-ancestor
92136744|NCT05361291|Hormones|hormones|mesh-ancestor
92136745|NCT05361291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136746|NCT05361291|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92136747|NCT05361291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136748|NCT05361291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136749|NCT05361291|Anesthetics, Local|anesthetics, local|mesh-ancestor
92136751|NCT05361291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136752|NCT05361291|Sensory System Agents|sensory system agents|mesh-ancestor
92136753|NCT05361291|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92136754|NCT05361291|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92136755|NCT05361291|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92136756|NCT05361291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136757|NCT01445951|Insulin|insulin|mesh-list
92136758|NCT01445951|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92136759|NCT01445951|Insulin Aspart|insulin aspart|mesh-list
92136760|NCT01445951|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92136761|NCT01445951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136762|NCT03169101|Nicotine|nicotine|mesh-list
92136763|NCT03169101|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92136764|NCT03169101|Autonomic Agents|autonomic agents|mesh-ancestor
92136765|NCT03169101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136766|NCT03169101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136767|NCT03169101|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92136768|NCT03169101|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92136770|NCT03169101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136771|NCT03169101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136772|NCT05219877|Levofloxacin|levofloxacin|mesh-list
92136773|NCT05219877|Ofloxacin|ofloxacin|mesh-list
92136774|NCT05219877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92136775|NCT05219877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136776|NCT05219877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92136777|NCT05219877|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136778|NCT05219877|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136779|NCT05219877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136780|NCT05219877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136781|NCT05219877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136782|NCT05219877|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92136783|NCT05219877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92136784|NCT00513435|Saracatinib|saracatinib|mesh-list
92136785|NCT00513435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136787|NCT00513435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136788|NCT05214339|Bevacizumab|bevacizumab|mesh-list
92136789|NCT05214339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136790|NCT05214339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136791|NCT05214339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136792|NCT05214339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136793|NCT05214339|Growth Substances|growth substances|mesh-ancestor
92136794|NCT05214339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136795|NCT05214339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136796|NCT01444781|Vaccines|vaccines|mesh-list
92136797|NCT01444781|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92136798|NCT01444781|Immunologic Factors|immunologic factors|mesh-ancestor
92145615|NCT03508921|Antimalarials|antimalarials|mesh-ancestor
92136799|NCT01444781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136800|NCT02471391|Venetoclax|venetoclax|mesh-list
92136801|NCT02471391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136802|NCT02431845|Fluoxetine|fluoxetine|mesh-list
92136803|NCT02431845|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92136804|NCT02431845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92136805|NCT02431845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136806|NCT02431845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136807|NCT02431845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136808|NCT02431845|Serotonin Agents|serotonin agents|mesh-ancestor
92136809|NCT02431845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136810|NCT02431845|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92136811|NCT02431845|Antidepressive Agents|antidepressive agents|mesh-ancestor
92136812|NCT02431845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136813|NCT02431845|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92136814|NCT02431845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92136815|NCT02431845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136816|NCT05065671|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92136817|NCT05065671|Tolcapone|tolcapone|mesh-list
92136818|NCT05065671|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92136819|NCT05065671|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92136820|NCT05065671|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136821|NCT05065671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136822|NCT05065671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92136823|NCT05065671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136824|NCT05065671|Analgesics|analgesics|mesh-ancestor
92136825|NCT05065671|Sensory System Agents|sensory system agents|mesh-ancestor
92136826|NCT05065671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136827|NCT05065671|Antidepressive Agents|antidepressive agents|mesh-ancestor
92136828|NCT05065671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136829|NCT05065671|Dopamine Agents|dopamine agents|mesh-ancestor
92136830|NCT05065671|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92136831|NCT05065671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92136832|NCT05065671|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92136833|NCT05065671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136834|NCT01443923|Interferons|interferons|mesh-list
92136836|NCT01443923|Interferon-alpha|interferon-alpha|mesh-list
92136837|NCT01443923|Interferon alpha-2|interferon alpha-2|mesh-list
92136838|NCT01443923|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92136839|NCT01443923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136840|NCT01443923|Antiviral Agents|antiviral agents|mesh-ancestor
92136841|NCT01443923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136842|NCT01443923|Antimetabolites|antimetabolites|mesh-ancestor
92136843|NCT01443923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136844|NCT01443923|Immunologic Factors|immunologic factors|mesh-ancestor
92136845|NCT01443923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136846|NCT00569673|Docetaxel|docetaxel|mesh-list
92136847|NCT00569673|Trabectedin|trabectedin|mesh-list
92136848|NCT00569673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136849|NCT00569673|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136850|NCT00569673|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136851|NCT00569673|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136852|NCT00569673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136853|NCT00569673|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136854|NCT00569673|Alkylating Agents|alkylating agents|mesh-ancestor
92136855|NCT01551212|Everolimus|everolimus|mesh-list
92136856|NCT01551212|Tacrolimus|tacrolimus|mesh-list
92136857|NCT01551212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136858|NCT01551212|Immunologic Factors|immunologic factors|mesh-ancestor
92136859|NCT01551212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136860|NCT01551212|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92136861|NCT01551212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136862|NCT01551212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136863|NCT01551212|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92136864|NCT01551212|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92136865|NCT01551212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136866|NCT00573261|Pregabalin|pregabalin|mesh-list
92136867|NCT00573261|Analgesics|analgesics|mesh-ancestor
92136868|NCT00573261|Sensory System Agents|sensory system agents|mesh-ancestor
92136869|NCT00573261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136870|NCT00573261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136871|NCT00573261|Anticonvulsants|anticonvulsants|mesh-ancestor
92136872|NCT00573261|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92136873|NCT00573261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92136874|NCT00573261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136875|NCT00573261|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92136876|NCT00573261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92136877|NCT00573261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92136878|NCT00573261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136879|NCT00573261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92136880|NCT04268199|Bortezomib|bortezomib|mesh-list
92136881|NCT04268199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136882|NCT04514211|Propofol|propofol|mesh-list
92136883|NCT04514211|Sevoflurane|sevoflurane|mesh-list
92136884|NCT04514211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92136885|NCT04514211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92136886|NCT04514211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136887|NCT04514211|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92136888|NCT04514211|Anesthetics, General|anesthetics, general|mesh-ancestor
92136889|NCT04514211|Anesthetics|anesthetics|mesh-ancestor
92136890|NCT04514211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92136891|NCT04514211|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92136892|NCT00574197|Mycophenolic Acid|mycophenolic acid|mesh-list
92136893|NCT00574197|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92136894|NCT00574197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136895|NCT00574197|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92136896|NCT00574197|Antitubercular Agents|antitubercular agents|mesh-ancestor
92136897|NCT00574197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92136898|NCT00574197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136899|NCT00574197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136900|NCT00574197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136902|NCT00574587|Cyclophosphamide|cyclophosphamide|mesh-list
92136903|NCT00574587|Doxorubicin|doxorubicin|mesh-list
92136904|NCT00574587|Trastuzumab|trastuzumab|mesh-list
92136905|NCT00574587|Vorinostat|vorinostat|mesh-list
92136906|NCT00574587|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92136907|NCT00574587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136908|NCT00574587|Tubulin Modulators|tubulin modulators|mesh-ancestor
92136909|NCT00574587|Antimitotic Agents|antimitotic agents|mesh-ancestor
92136910|NCT00574587|Mitosis Modulators|mitosis modulators|mesh-ancestor
92136911|NCT00574587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136912|NCT00574587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92136913|NCT00574587|Immunologic Factors|immunologic factors|mesh-ancestor
92136914|NCT00574587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136915|NCT00574587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136916|NCT00574587|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92136917|NCT00574587|Alkylating Agents|alkylating agents|mesh-ancestor
92136918|NCT00574587|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92136919|NCT00574587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92136920|NCT00574587|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136921|NCT00574587|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136922|NCT00574587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136923|NCT00574587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136924|NCT00574587|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92136925|NCT00603993|Adalimumab|adalimumab|mesh-list
92136926|NCT00603993|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92136927|NCT00603993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136928|NCT00603993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136929|NCT00575367|Azithromycin|azithromycin|mesh-list
92136930|NCT00575367|Moxifloxacin|moxifloxacin|mesh-list
92136931|NCT00575367|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92136932|NCT00575367|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92136933|NCT00575367|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92136934|NCT00575367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92136935|NCT00575367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92136936|NCT00575367|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92136937|NCT00575367|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92136938|NCT00575367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136939|NCT00575367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136940|NCT00575367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136941|NCT00575367|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92136942|NCT00575367|Contraceptive Agents|contraceptive agents|mesh-ancestor
92136943|NCT00575367|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92136944|NCT00575367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136945|NCT00575367|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92136946|NCT00575367|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92136947|NCT00575367|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92136949|NCT00604461|Carboplatin|carboplatin|mesh-list
92136951|NCT00604461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92136952|NCT00604461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92136953|NCT00604461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92136954|NCT00604461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92136955|NCT00604461|Growth Substances|growth substances|mesh-ancestor
92136956|NCT00604461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136957|NCT00604461|Growth Inhibitors|growth inhibitors|mesh-ancestor
92136958|NCT00604461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136959|NCT00604461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136960|NCT00604461|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92136961|NCT00604461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92136962|NCT04417569|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92136963|NCT04417569|Estradiol|estradiol|mesh-list
92136964|NCT04417569|Progesterone|progesterone|mesh-list
92136965|NCT04417569|Hormones|hormones|mesh-ancestor
92136966|NCT04417569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92136967|NCT04417569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136968|NCT04417569|Estrogens|estrogens|mesh-ancestor
92136969|NCT04417569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92136970|NCT04417569|Progestins|progestins|mesh-ancestor
92136971|NCT01550744|Ustekinumab|ustekinumab|mesh-list
92136972|NCT01550744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92136973|NCT00606489|Ibuprofen|ibuprofen|mesh-list
92136974|NCT00606489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92136975|NCT00606489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92136976|NCT00606489|Analgesics|analgesics|mesh-ancestor
92136977|NCT00606489|Sensory System Agents|sensory system agents|mesh-ancestor
92136978|NCT00606489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136979|NCT00606489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136980|NCT00606489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136981|NCT00606489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92136982|NCT00606489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92136983|NCT00606489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92136984|NCT00606489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92136985|NCT00578331|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92136986|NCT00578331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92136987|NCT00578331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92136988|NCT00578331|Analgesics|analgesics|mesh-ancestor
92136989|NCT00578331|Sensory System Agents|sensory system agents|mesh-ancestor
92136990|NCT00578331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92136991|NCT00578331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92136992|NCT00578331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92136994|NCT00578331|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92136995|NCT00578331|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92136996|NCT00578331|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92136997|NCT00578331|Histamine Antagonists|histamine antagonists|mesh-ancestor
92136998|NCT00578331|Histamine Agents|histamine agents|mesh-ancestor
92136999|NCT00578331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137000|NCT00578331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137001|NCT00607113|Bevacizumab|bevacizumab|mesh-list
92137002|NCT00607113|Everolimus|everolimus|mesh-list
92137003|NCT00607113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137004|NCT00607113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137005|NCT00607113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92137006|NCT00607113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92137007|NCT00607113|Growth Substances|growth substances|mesh-ancestor
92137008|NCT00607113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137009|NCT00607113|Growth Inhibitors|growth inhibitors|mesh-ancestor
92137010|NCT00607113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92137011|NCT00607113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92137012|NCT00607113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137013|NCT00607113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137014|NCT00607113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137015|NCT00607113|Immunologic Factors|immunologic factors|mesh-ancestor
92137016|NCT01549964|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92137017|NCT01549964|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92137018|NCT01549964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137019|NCT01549964|Incretins|incretins|mesh-ancestor
92137020|NCT01549964|Hormones|hormones|mesh-ancestor
92137021|NCT01549964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137022|NCT01549964|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92137023|NCT01549964|Protease Inhibitors|protease inhibitors|mesh-ancestor
92137024|NCT01549964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145616|NCT03508921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92137025|NCT01549964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137026|NCT00579111|Fludarabine|fludarabine|mesh-list
92137027|NCT00579111|Busulfan|busulfan|mesh-list
92137028|NCT00579111|Alemtuzumab|alemtuzumab|mesh-list
92137029|NCT00579111|Tacrolimus|tacrolimus|mesh-list
92137030|NCT00579111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137031|NCT00579111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137032|NCT00579111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137033|NCT00579111|Immunologic Factors|immunologic factors|mesh-ancestor
92137034|NCT00579111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137035|NCT00579111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92137036|NCT00579111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137037|NCT00579111|Alkylating Agents|alkylating agents|mesh-ancestor
92137038|NCT00579111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92137039|NCT00579111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92137040|NCT00579111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137041|NCT04363437|Colchicine|colchicine|mesh-list
92137042|NCT04363437|Gout Suppressants|gout suppressants|mesh-ancestor
92137043|NCT04363437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137044|NCT04363437|Tubulin Modulators|tubulin modulators|mesh-ancestor
92137045|NCT04363437|Antimitotic Agents|antimitotic agents|mesh-ancestor
92137046|NCT04363437|Mitosis Modulators|mitosis modulators|mesh-ancestor
92405136|NCT01434862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137047|NCT04363437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137048|NCT04363437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137049|NCT01570244|Levonorgestrel|levonorgestrel|mesh-list
92137050|NCT01570244|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92137051|NCT01570244|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92137052|NCT01570244|Contraceptive Agents|contraceptive agents|mesh-ancestor
92137053|NCT01570244|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92137054|NCT01570244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137055|NCT01570244|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92137056|NCT01570244|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92137057|NCT01570244|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92137058|NCT01570244|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92137059|NCT01570244|Estrogens|estrogens|mesh-ancestor
92137060|NCT01570244|Hormones|hormones|mesh-ancestor
92137061|NCT01570244|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137063|NCT00579813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92137064|NCT00579813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137065|NCT01549886|Rituximab|rituximab|mesh-list
92137066|NCT01549886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137067|NCT01549886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137068|NCT01549886|Immunologic Factors|immunologic factors|mesh-ancestor
92137069|NCT01549886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137070|NCT01549886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137071|NCT00610311|Aldesleukin|aldesleukin|mesh-list
92137072|NCT00610311|Cyclophosphamide|cyclophosphamide|mesh-list
92137073|NCT00610311|Fludarabine|fludarabine|mesh-list
92137074|NCT00610311|Fludarabine phosphate|fludarabine phosphate|mesh-list
92137075|NCT00610311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137076|NCT00610311|Immunologic Factors|immunologic factors|mesh-ancestor
92137077|NCT00610311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137078|NCT00610311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137079|NCT00610311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92137080|NCT00610311|Alkylating Agents|alkylating agents|mesh-ancestor
92137081|NCT00610311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137082|NCT00610311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137083|NCT00610311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92137084|NCT00610311|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92137085|NCT00610311|Antimetabolites|antimetabolites|mesh-ancestor
92137086|NCT00610311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92137087|NCT00610311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92137088|NCT00610311|Antiviral Agents|antiviral agents|mesh-ancestor
92137089|NCT00610311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137090|NCT04233567|Infigratinib|infigratinib|mesh-list
92137091|NCT04233567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137092|NCT00581061|Solifenacin Succinate|solifenacin succinate|mesh-list
92137093|NCT00581061|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92137094|NCT00581061|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92137095|NCT00581061|Cholinergic Agents|cholinergic agents|mesh-ancestor
92137096|NCT00581061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137097|NCT00581061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137098|NCT00581061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137099|NCT00581061|Urological Agents|urological agents|mesh-ancestor
92137105|NCT01549652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137106|NCT01549652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137107|NCT01549652|Analgesics|analgesics|mesh-ancestor
92137108|NCT01549652|Sensory System Agents|sensory system agents|mesh-ancestor
92137109|NCT01549652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137110|NCT01549652|Antiemetics|antiemetics|mesh-ancestor
92137111|NCT01549652|Autonomic Agents|autonomic agents|mesh-ancestor
92137112|NCT01549652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137113|NCT01549652|Antipruritics|antipruritics|mesh-ancestor
92137114|NCT01549652|Dermatologic Agents|dermatologic agents|mesh-ancestor
92137115|NCT01549652|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92137116|NCT01549652|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92137117|NCT01549652|Serotonin Agents|serotonin agents|mesh-ancestor
92137118|NCT01549652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137119|NCT01549652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137120|NCT01549652|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92137121|NCT01569464|Rotigotine|rotigotine|mesh-list
92137122|NCT01569464|Dopamine Agonists|dopamine agonists|mesh-ancestor
92137123|NCT01569464|Dopamine Agents|dopamine agents|mesh-ancestor
92137124|NCT01569464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137125|NCT01569464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137126|NCT01569464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137127|NCT01534520|Lidocaine|lidocaine|mesh-list
92137128|NCT01534520|Anesthetics, Local|anesthetics, local|mesh-ancestor
92137129|NCT01534520|Anesthetics|anesthetics|mesh-ancestor
92137130|NCT01534520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137131|NCT01534520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137132|NCT01534520|Sensory System Agents|sensory system agents|mesh-ancestor
92137133|NCT01534520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137134|NCT01534520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92137135|NCT01534520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92137136|NCT01534520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92137137|NCT01534520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137138|NCT01534520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137140|NCT00611325|Bortezomib|bortezomib|mesh-list
92137141|NCT00611325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137142|NCT00611325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137143|NCT00611325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92137144|NCT00611325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92137145|NCT00611325|Growth Substances|growth substances|mesh-ancestor
92137146|NCT00611325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137147|NCT00611325|Growth Inhibitors|growth inhibitors|mesh-ancestor
92137148|NCT00611403|Cyclosporine|cyclosporine|mesh-list
92137149|NCT00611403|Lubricant Eye Drops|lubricant eye drops|mesh-list
92137150|NCT00611403|Cyclosporins|cyclosporins|mesh-list
92137151|NCT00611403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137152|NCT00611403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137153|NCT00611403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137154|NCT00611403|Immunologic Factors|immunologic factors|mesh-ancestor
92137155|NCT00611403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137156|NCT00611403|Antifungal Agents|antifungal agents|mesh-ancestor
92137157|NCT00611403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137158|NCT00611403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92137159|NCT00611403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137160|NCT00611403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92137161|NCT00611403|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92137162|NCT00611403|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92137163|NCT01534208|Enclomiphene|enclomiphene|mesh-list
92137164|NCT01534208|Clomiphene|clomiphene|mesh-list
92137165|NCT01534208|Zuclomiphene|zuclomiphene|mesh-list
92137166|NCT01534208|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92137167|NCT01534208|Hormone Antagonists|hormone antagonists|mesh-ancestor
92137168|NCT01534208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137169|NCT01534208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137170|NCT01534208|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92137171|NCT01534208|Fertility Agents|fertility agents|mesh-ancestor
92137172|NCT01534208|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92137173|NCT01534208|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92137174|NCT01534208|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92137175|NCT01548638|Galantamine|galantamine|mesh-list
92137176|NCT01548638|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92137177|NCT01548638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137178|NCT01548638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137179|NCT01548638|Cholinergic Agents|cholinergic agents|mesh-ancestor
92137180|NCT01548638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137181|NCT01548638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137182|NCT01548638|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92137183|NCT01548638|Autonomic Agents|autonomic agents|mesh-ancestor
92137184|NCT01548638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137185|NCT01548638|Nootropic Agents|nootropic agents|mesh-ancestor
92137186|NCT00612339|Bevacizumab|bevacizumab|mesh-list
92137187|NCT00612339|Temozolomide|temozolomide|mesh-list
92137188|NCT00612339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137189|NCT00612339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137190|NCT00612339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92137191|NCT00612339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92137192|NCT00612339|Growth Substances|growth substances|mesh-ancestor
92137193|NCT00612339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137194|NCT00612339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92137195|NCT00612339|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92137196|NCT00612339|Alkylating Agents|alkylating agents|mesh-ancestor
92137197|NCT00612339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137198|NCT01533428|Capsaicin|capsaicin|mesh-list
92137199|NCT01533428|Antipruritics|antipruritics|mesh-ancestor
92137200|NCT01533428|Dermatologic Agents|dermatologic agents|mesh-ancestor
92137201|NCT01533428|Sensory System Agents|sensory system agents|mesh-ancestor
92137202|NCT01533428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137203|NCT01533428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137204|NCT04066725|Aspirin|aspirin|mesh-list
92137205|NCT04066725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92137206|NCT04066725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137207|NCT04066725|Analgesics|analgesics|mesh-ancestor
92137208|NCT04066725|Sensory System Agents|sensory system agents|mesh-ancestor
92137209|NCT04066725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137210|NCT04066725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137211|NCT04066725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137212|NCT04066725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137213|NCT04066725|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92137214|NCT04066725|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92137215|NCT04066725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137216|NCT04066725|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92137217|NCT04066725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92137218|NCT04066725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137219|NCT04066725|Antipyretics|antipyretics|mesh-ancestor
92137220|NCT01517984|Mycophenolic Acid|mycophenolic acid|mesh-list
92137221|NCT01517984|Prednisone|prednisone|mesh-list
92137222|NCT01517984|Tacrolimus|tacrolimus|mesh-list
92137223|NCT01517984|Thymoglobulin|thymoglobulin|mesh-list
92137224|NCT01517984|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92137225|NCT01517984|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92137226|NCT01517984|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92137227|NCT01517984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137229|NCT01517984|Hormones|hormones|mesh-ancestor
92137230|NCT01517984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137231|NCT01517984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137232|NCT01517984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92137233|NCT01517984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137234|NCT01517984|Immunologic Factors|immunologic factors|mesh-ancestor
92137235|NCT01517984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137236|NCT01517984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137237|NCT01517984|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92137238|NCT01517984|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92137239|NCT01517984|Antitubercular Agents|antitubercular agents|mesh-ancestor
92137240|NCT01517984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92137241|NCT01517984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137242|NCT00612573|Doxycycline|doxycycline|mesh-list
92137243|NCT00612573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92137244|NCT00612573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137245|NCT00612573|Antimalarials|antimalarials|mesh-ancestor
92137246|NCT00612573|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92137247|NCT00612573|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92137248|NCT00614445|Pyridoxine|pyridoxine|mesh-list
92137249|NCT00614445|Vitamin B 6|vitamin b 6|mesh-list
92137250|NCT00614445|Doxylamine|doxylamine|mesh-list
92137251|NCT00614445|Doxylamine succinate|doxylamine succinate|mesh-list
92137252|NCT00614445|Vitamin B Complex|vitamin b complex|mesh-ancestor
92137254|NCT00614445|Micronutrients|micronutrients|mesh-ancestor
92137255|NCT00614445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137256|NCT00614445|Antiemetics|antiemetics|mesh-ancestor
92137257|NCT00614445|Autonomic Agents|autonomic agents|mesh-ancestor
92145617|NCT03508921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92137258|NCT00614445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137259|NCT00614445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137260|NCT00614445|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92137261|NCT00614445|Histamine Antagonists|histamine antagonists|mesh-ancestor
92137262|NCT00614445|Histamine Agents|histamine agents|mesh-ancestor
92137263|NCT00614445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137264|NCT00614445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137265|NCT00583011|Anesthetics|anesthetics|mesh-list
92137266|NCT00583011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137267|NCT00583011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137268|NCT01547390|Aspirin|aspirin|mesh-list
92137269|NCT01547390|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92137270|NCT01547390|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137271|NCT01547390|Analgesics|analgesics|mesh-ancestor
92137272|NCT01547390|Sensory System Agents|sensory system agents|mesh-ancestor
92405137|NCT01434862|Appetite Depressants|appetite depressants|mesh-ancestor
92137273|NCT01547390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137274|NCT01547390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137275|NCT01547390|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137276|NCT01547390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137277|NCT01547390|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92137278|NCT01547390|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92137279|NCT01547390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137280|NCT01547390|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92137281|NCT01547390|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92137282|NCT01547390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137284|NCT01546922|Hydrocortisone|hydrocortisone|mesh-list
92137285|NCT01546922|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137286|NCT00615927|Imatinib Mesylate|imatinib mesylate|mesh-list
92137287|NCT00615927|Hydroxyurea|hydroxyurea|mesh-list
92137288|NCT00615927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137289|NCT00615927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92137290|NCT00615927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137291|NCT00615927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137292|NCT00615927|Antisickling Agents|antisickling agents|mesh-ancestor
92137293|NCT00615927|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92137294|NCT01532648|Budesonide|budesonide|mesh-list
92137295|NCT01532648|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137296|NCT01532648|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92137297|NCT01532648|Autonomic Agents|autonomic agents|mesh-ancestor
92137298|NCT01532648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137299|NCT01532648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137300|NCT01532648|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92137301|NCT01532648|Respiratory System Agents|respiratory system agents|mesh-ancestor
92137302|NCT01532648|Glucocorticoids|glucocorticoids|mesh-ancestor
92137304|NCT01532648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137305|NCT00617097|Ketorolac|ketorolac|mesh-list
92137306|NCT00617097|Lidocaine|lidocaine|mesh-list
92137307|NCT00617097|Anesthetics, Local|anesthetics, local|mesh-ancestor
92137308|NCT00617097|Anesthetics|anesthetics|mesh-ancestor
92137309|NCT00617097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137310|NCT00617097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137311|NCT00617097|Sensory System Agents|sensory system agents|mesh-ancestor
92137312|NCT00617097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137313|NCT00617097|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92137314|NCT00617097|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92137315|NCT00617097|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92137316|NCT00617097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137317|NCT00617097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137318|NCT00617097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92137319|NCT00617097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137320|NCT00617097|Analgesics|analgesics|mesh-ancestor
92137321|NCT00617097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137322|NCT00617097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137323|NCT00617097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92137324|NCT00617097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137325|NCT01532414|Enclomiphene|enclomiphene|mesh-list
92137326|NCT01532414|Clomiphene|clomiphene|mesh-list
92137327|NCT01532414|Zuclomiphene|zuclomiphene|mesh-list
92137328|NCT01532414|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92137329|NCT01532414|Hormone Antagonists|hormone antagonists|mesh-ancestor
92137330|NCT01532414|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137331|NCT01532414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137332|NCT01532414|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92137333|NCT01532414|Fertility Agents|fertility agents|mesh-ancestor
92137334|NCT01532414|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92137335|NCT01532414|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92137336|NCT01532414|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92137338|NCT01441973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137339|NCT02074709|Bupivacaine|bupivacaine|mesh-list
92137340|NCT02074709|Anesthetics, Local|anesthetics, local|mesh-ancestor
92137341|NCT02074709|Anesthetics|anesthetics|mesh-ancestor
92137342|NCT02074709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137343|NCT02074709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137344|NCT02074709|Sensory System Agents|sensory system agents|mesh-ancestor
92137345|NCT02074709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137346|NCT03571191|Denosumab|denosumab|mesh-list
92095576|NCT01032850|Sorafenib|sorafenib|mesh-list
92137347|NCT03571191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92137348|NCT03571191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137349|NCT01575899|Amoxicillin|amoxicillin|mesh-list
92137350|NCT01575899|Clarithromycin|clarithromycin|mesh-list
92137351|NCT01575899|Levofloxacin|levofloxacin|mesh-list
92137352|NCT01575899|Ofloxacin|ofloxacin|mesh-list
92137353|NCT01575899|Clavulanic Acid|clavulanic acid|mesh-list
92137354|NCT01575899|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92137356|NCT01575899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92137357|NCT01575899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137358|NCT01575899|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92137359|NCT01575899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137360|NCT01575899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137361|NCT01575899|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92137362|NCT01575899|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92137363|NCT01575899|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92137364|NCT01575899|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92137365|NCT01575899|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92137366|NCT01575899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137367|NCT01575899|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92137368|NCT01575899|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92137369|NCT01575899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137370|NCT01575899|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92137371|NCT01575899|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92137372|NCT01440881|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92137373|NCT01440881|Natriuretic Agents|natriuretic agents|mesh-ancestor
92137374|NCT01440881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137375|NCT00620061|Lubiprostone|lubiprostone|mesh-list
92137376|NCT00620061|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92137377|NCT00620061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137378|NCT00620061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137379|NCT04122443|Acetaminophen|acetaminophen|mesh-list
92137380|NCT04122443|Oxycodone|oxycodone|mesh-list
92137381|NCT04122443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137382|NCT04122443|Analgesics|analgesics|mesh-ancestor
92137383|NCT04122443|Sensory System Agents|sensory system agents|mesh-ancestor
92137384|NCT04122443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137385|NCT04122443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137386|NCT04122443|Antipyretics|antipyretics|mesh-ancestor
92137387|NCT04122443|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92137388|NCT04122443|Narcotics|narcotics|mesh-ancestor
92137389|NCT04122443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137390|NCT00587769|Bupropion|bupropion|mesh-list
92137391|NCT00587769|Varenicline|varenicline|mesh-list
92137392|NCT00587769|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92137393|NCT00587769|Antidepressive Agents|antidepressive agents|mesh-ancestor
92137394|NCT00587769|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92137395|NCT00587769|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92137396|NCT00587769|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92137397|NCT00587769|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137398|NCT00587769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137399|NCT00587769|Dopamine Agents|dopamine agents|mesh-ancestor
92137400|NCT00587769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137401|NCT00587769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137402|NCT00587769|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92137403|NCT00587769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92137404|NCT00587769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137405|NCT00587769|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92137406|NCT00587769|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92137410|NCT00623181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137411|NCT03433833|Digoxin|digoxin|mesh-list
92137412|NCT03433833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92137413|NCT03433833|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92137414|NCT03433833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137415|NCT03433833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137416|NCT03433833|Protective Agents|protective agents|mesh-ancestor
92137417|NCT03433833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137418|NCT01574651|Glycopyrrolate|glycopyrrolate|mesh-list
92137419|NCT01574651|Formoterol Fumarate|formoterol fumarate|mesh-list
92137420|NCT01574651|Tiotropium Bromide|tiotropium bromide|mesh-list
92137421|NCT01574651|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92137422|NCT01574651|Autonomic Agents|autonomic agents|mesh-ancestor
92137423|NCT01574651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137424|NCT01574651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137425|NCT01574651|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92137426|NCT01574651|Respiratory System Agents|respiratory system agents|mesh-ancestor
92137427|NCT01574651|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92137428|NCT01574651|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92137429|NCT01574651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92137430|NCT01574651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92137431|NCT01574651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137432|NCT01574651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137433|NCT01574651|Parasympatholytics|parasympatholytics|mesh-ancestor
92137434|NCT01574651|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92137435|NCT01574651|Cholinergic Agents|cholinergic agents|mesh-ancestor
92137436|NCT01574651|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92137437|NCT01574651|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92137438|NCT03179163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92137439|NCT03179163|Enalapril|enalapril|mesh-list
92137440|NCT03179163|Captopril|captopril|mesh-list
92137441|NCT03179163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92137442|NCT03179163|Diuretics|diuretics|mesh-ancestor
92137443|NCT03179163|Natriuretic Agents|natriuretic agents|mesh-ancestor
92137444|NCT03179163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137445|NCT03179163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92137446|NCT03179163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137447|NCT03179163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137448|NCT03179163|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92137449|NCT03179163|Protease Inhibitors|protease inhibitors|mesh-ancestor
92137450|NCT03179163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137451|NCT01440803|Teriparatide|teriparatide|mesh-list
92137452|NCT01440803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92137453|NCT01440803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137454|NCT01440803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92137455|NCT05247177|Dexmedetomidine|dexmedetomidine|mesh-list
92137456|NCT05247177|Ketamine|ketamine|mesh-list
92137457|NCT05247177|Anesthetics|anesthetics|mesh-list
92137458|NCT05247177|Sevoflurane|sevoflurane|mesh-list
92137459|NCT05247177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137460|NCT05247177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137461|NCT05247177|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92137462|NCT05247177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137463|NCT05247177|Analgesics|analgesics|mesh-ancestor
92137464|NCT05247177|Sensory System Agents|sensory system agents|mesh-ancestor
92137465|NCT05247177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137466|NCT05247177|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92137467|NCT05247177|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92137468|NCT05247177|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92137469|NCT05247177|Adrenergic Agents|adrenergic agents|mesh-ancestor
92137470|NCT05247177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137471|NCT05247177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137472|NCT05247177|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92137473|NCT05247177|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92137474|NCT05247177|Anesthetics, General|anesthetics, general|mesh-ancestor
92137475|NCT05247177|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92137476|NCT05247177|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92137477|NCT05247177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92137478|NCT05247177|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92137479|NCT00624195|Etravirine|etravirine|mesh-list
92137480|NCT00624195|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92137481|NCT00624195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92137482|NCT00624195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92137483|NCT00624195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137484|NCT00624195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137485|NCT00624195|Antiviral Agents|antiviral agents|mesh-ancestor
92137486|NCT00624195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137487|NCT01516970|Ritonavir|ritonavir|mesh-list
92137488|NCT01516970|Lopinavir|lopinavir|mesh-list
92137489|NCT01516970|Darunavir|darunavir|mesh-list
92137490|NCT01516970|Zidovudine|zidovudine|mesh-list
92137491|NCT01516970|Efavirenz|efavirenz|mesh-list
92137492|NCT01516970|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92137493|NCT01516970|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92137494|NCT01516970|Protease Inhibitors|protease inhibitors|mesh-ancestor
92137495|NCT01516970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095724|NCT01895777|Dabigatran|dabigatran|mesh-list
92137496|NCT01516970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137497|NCT01516970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91939324|NCT00835367|Amlodipine|amlodipine|mesh-list
92137499|NCT01516970|Antiviral Agents|antiviral agents|mesh-ancestor
92137500|NCT01516970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137501|NCT01516970|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92137502|NCT01516970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92137503|NCT01516970|Antimetabolites|antimetabolites|mesh-ancestor
92137504|NCT01516970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92137505|NCT01516970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92137506|NCT01516970|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92137507|NCT01516970|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92137508|NCT01516970|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92137509|NCT01516970|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92137510|NCT01516970|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92137511|NCT02140593|Rocuronium|rocuronium|mesh-list
92137512|NCT02140593|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92137513|NCT02140593|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92137514|NCT02140593|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92137515|NCT02140593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137516|NCT02140593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137517|NCT01516892|Botulinum Toxins|botulinum toxins|mesh-list
92137518|NCT01516892|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92137519|NCT01516892|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92137520|NCT01516892|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92137521|NCT01516892|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137522|NCT01516892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137523|NCT01516892|Cholinergic Agents|cholinergic agents|mesh-ancestor
92137524|NCT01516892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137525|NCT01516892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137526|NCT01516892|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92137527|NCT01516892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137529|NCT00668811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137530|NCT00668811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92137531|NCT00668811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92137532|NCT00668811|Growth Substances|growth substances|mesh-ancestor
92137533|NCT00668811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137534|NCT00668811|Growth Inhibitors|growth inhibitors|mesh-ancestor
92137535|NCT00668811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92137536|NCT00668811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137537|NCT00668811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137538|NCT02776605|Prednisone|prednisone|mesh-list
92137539|NCT02776605|Methotrexate|methotrexate|mesh-list
92137540|NCT02776605|Vincristine|vincristine|mesh-list
92137541|NCT02776605|Daunorubicin|daunorubicin|mesh-list
92137542|NCT02776605|Mercaptopurine|mercaptopurine|mesh-list
92137543|NCT02776605|Ponatinib|ponatinib|mesh-list
92137544|NCT02776605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137545|NCT02776605|Glucocorticoids|glucocorticoids|mesh-ancestor
92137546|NCT02776605|Hormones|hormones|mesh-ancestor
92137547|NCT02776605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137548|NCT02776605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137549|NCT02776605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92137550|NCT02776605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137551|NCT02776605|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92137552|NCT02776605|Abortifacient Agents|abortifacient agents|mesh-ancestor
92137553|NCT02776605|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92137554|NCT02776605|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92137555|NCT02776605|Antimetabolites|antimetabolites|mesh-ancestor
92137556|NCT02776605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137557|NCT02776605|Dermatologic Agents|dermatologic agents|mesh-ancestor
92137559|NCT02776605|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92137560|NCT02776605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137561|NCT02776605|Immunologic Factors|immunologic factors|mesh-ancestor
92137562|NCT02776605|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137563|NCT02776605|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92137564|NCT02776605|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92137565|NCT02776605|Tubulin Modulators|tubulin modulators|mesh-ancestor
92137566|NCT02776605|Antimitotic Agents|antimitotic agents|mesh-ancestor
92137567|NCT02776605|Mitosis Modulators|mitosis modulators|mesh-ancestor
92137568|NCT02776605|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92137569|NCT02776605|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92137570|NCT02776605|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92137571|NCT02776605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92137572|NCT00627861|Metoprolol|metoprolol|mesh-list
92137573|NCT00627861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92137574|NCT00627861|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92137575|NCT00627861|Sympatholytics|sympatholytics|mesh-ancestor
92137576|NCT00627861|Autonomic Agents|autonomic agents|mesh-ancestor
92137577|NCT00627861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137578|NCT00627861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137579|NCT00627861|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92137580|NCT00627861|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92137581|NCT00627861|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92137582|NCT00627861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92137583|NCT00627861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137584|NCT00627861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137585|NCT00669279|Atenolol|atenolol|mesh-list
92137586|NCT00669279|Carvedilol|carvedilol|mesh-list
92137587|NCT00669279|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92137588|NCT00669279|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92137589|NCT00669279|Adrenergic Agents|adrenergic agents|mesh-ancestor
92137590|NCT00669279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137591|NCT00669279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137592|NCT00669279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137593|NCT00669279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92137594|NCT00669279|Antioxidants|antioxidants|mesh-ancestor
92137595|NCT00669279|Protective Agents|protective agents|mesh-ancestor
92137596|NCT00669279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92137597|NCT00669279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137598|NCT00669279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92137599|NCT00669279|Vasodilator Agents|vasodilator agents|mesh-ancestor
92137600|NCT00669279|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92137601|NCT00669279|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92137602|NCT00669279|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92137603|NCT00669279|Sympatholytics|sympatholytics|mesh-ancestor
92137604|NCT00669279|Autonomic Agents|autonomic agents|mesh-ancestor
92137605|NCT00669279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137606|NCT00669279|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92137607|NCT02394795|Calcium, Dietary|calcium, dietary|mesh-list
92137608|NCT02394795|Leucovorin|leucovorin|mesh-list
92137609|NCT02394795|Bevacizumab|bevacizumab|mesh-list
92137610|NCT02394795|Panitumumab|panitumumab|mesh-list
92137611|NCT02394795|Oxaliplatin|oxaliplatin|mesh-list
92137612|NCT02394795|Fluorouracil|fluorouracil|mesh-list
92137613|NCT02394795|Calcium|calcium|mesh-list
92137614|NCT02394795|Levoleucovorin|levoleucovorin|mesh-list
92137615|NCT02394795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137616|NCT02394795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137617|NCT02394795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92137618|NCT02394795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92137619|NCT02394795|Growth Substances|growth substances|mesh-ancestor
92137620|NCT02394795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137621|NCT02394795|Growth Inhibitors|growth inhibitors|mesh-ancestor
92137622|NCT02394795|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92137623|NCT02394795|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92137624|NCT02394795|Antimetabolites|antimetabolites|mesh-ancestor
92137625|NCT02394795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137626|NCT02394795|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92137627|NCT02394795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137628|NCT02394795|Immunologic Factors|immunologic factors|mesh-ancestor
92137629|NCT02394795|Antidotes|antidotes|mesh-ancestor
92137630|NCT02394795|Protective Agents|protective agents|mesh-ancestor
92137631|NCT02394795|Vitamin B Complex|vitamin b complex|mesh-ancestor
92137632|NCT02394795|Vitamins|vitamins|mesh-ancestor
92137633|NCT02394795|Micronutrients|micronutrients|mesh-ancestor
92137634|NCT01546688|Zonisamide|zonisamide|mesh-list
92137636|NCT01546688|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92137637|NCT01546688|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137638|NCT01546688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137639|NCT01546688|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92137640|NCT01546688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137641|NCT04409522|Melatonin|melatonin|mesh-list
92137642|NCT04409522|Antioxidants|antioxidants|mesh-ancestor
92405138|NCT01434862|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92137643|NCT04409522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137644|NCT04409522|Protective Agents|protective agents|mesh-ancestor
92137645|NCT04409522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137646|NCT04409522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137648|NCT00672243|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92137649|NCT00672243|Temsirolimus|temsirolimus|mesh-list
92137650|NCT00672243|MTOR Inhibitors|mtor inhibitors|mesh-list
92137651|NCT00672243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137652|NCT00672243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92137653|NCT00672243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137654|NCT00672243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137655|NCT00672243|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92137656|NCT00672243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137657|NCT00672243|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92137658|NCT00672243|Antifungal Agents|antifungal agents|mesh-ancestor
92137659|NCT00672243|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137660|NCT00672243|Immunologic Factors|immunologic factors|mesh-ancestor
92137661|NCT00672243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137662|NCT04105946|Dexmedetomidine|dexmedetomidine|mesh-list
92137663|NCT04105946|Remifentanil|remifentanil|mesh-list
92137664|NCT04105946|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92137665|NCT04105946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137666|NCT04105946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137667|NCT04105946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137668|NCT04105946|Analgesics|analgesics|mesh-ancestor
92137669|NCT04105946|Sensory System Agents|sensory system agents|mesh-ancestor
92137670|NCT04105946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137671|NCT04105946|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92137672|NCT04105946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92137673|NCT04105946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92137674|NCT04105946|Adrenergic Agents|adrenergic agents|mesh-ancestor
92137675|NCT04105946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137676|NCT04105946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137677|NCT04105946|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92137678|NCT04105946|Narcotics|narcotics|mesh-ancestor
92137679|NCT01440569|Darunavir|darunavir|mesh-list
92137680|NCT01440569|Cobicistat|cobicistat|mesh-list
92137681|NCT01440569|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92137682|NCT01440569|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92137683|NCT01440569|Protease Inhibitors|protease inhibitors|mesh-ancestor
92137684|NCT01440569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137685|NCT01440569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137686|NCT01440569|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92137687|NCT01440569|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92137688|NCT01440569|Antiviral Agents|antiviral agents|mesh-ancestor
92137689|NCT01440569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137690|NCT01440569|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92137691|NCT01440569|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92137692|NCT00629499|Paclitaxel|paclitaxel|mesh-list
92137693|NCT00629499|Cyclophosphamide|cyclophosphamide|mesh-list
92137694|NCT00629499|Trastuzumab|trastuzumab|mesh-list
92137695|NCT00629499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92137696|NCT00629499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137697|NCT00629499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92137698|NCT00629499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92137699|NCT00629499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92137700|NCT00629499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137701|NCT00629499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137702|NCT00629499|Immunologic Factors|immunologic factors|mesh-ancestor
92137703|NCT00629499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137704|NCT00629499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137705|NCT00629499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92137706|NCT00629499|Alkylating Agents|alkylating agents|mesh-ancestor
92137707|NCT00629499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92137708|NCT00629499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137709|NCT00631449|Raltegravir Potassium|raltegravir potassium|mesh-list
92137711|NCT00631449|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92137712|NCT00631449|Antiviral Agents|antiviral agents|mesh-ancestor
92137714|NCT00631449|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92137715|NCT00631449|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92137716|NCT00631449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405139|NCT01434862|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92137717|NCT00631449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137718|NCT01546142|Deoxycholic Acid|deoxycholic acid|mesh-list
92137719|NCT01546142|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92137720|NCT01546142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137721|NCT00632619|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92137722|NCT00632619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137723|NCT01440101|Natalizumab|natalizumab|mesh-list
92137724|NCT01440101|Immunologic Factors|immunologic factors|mesh-ancestor
92137725|NCT01440101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137726|NCT01530464|Ambrisentan|ambrisentan|mesh-list
92137727|NCT01530464|Aminophylline|aminophylline|mesh-list
92137728|NCT01530464|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92137729|NCT01530464|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92137730|NCT01530464|Autonomic Agents|autonomic agents|mesh-ancestor
92137731|NCT01530464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137732|NCT01530464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137733|NCT01530464|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92137734|NCT01530464|Respiratory System Agents|respiratory system agents|mesh-ancestor
92137735|NCT01530464|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92137736|NCT01530464|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92137737|NCT01530464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137738|NCT01530464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137739|NCT01530464|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92137740|NCT01530464|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92137741|NCT01530464|Purinergic Agents|purinergic agents|mesh-ancestor
92137742|NCT01530464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137743|NCT01530464|Protective Agents|protective agents|mesh-ancestor
92137744|NCT00633399|Ziprasidone|ziprasidone|mesh-list
92137745|NCT00633399|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92137746|NCT00633399|Serotonin Agents|serotonin agents|mesh-ancestor
92137747|NCT00633399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137748|NCT00633399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137749|NCT00633399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137750|NCT00633399|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92137751|NCT00633399|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92137752|NCT00633399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137753|NCT00633399|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92137754|NCT00633399|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92137755|NCT00633399|Dopamine Agents|dopamine agents|mesh-ancestor
92137757|NCT01077843|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
92137758|NCT01077843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92137759|NCT01077843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92137760|NCT01077843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137761|NCT01077843|Analgesics|analgesics|mesh-ancestor
92137762|NCT01077843|Sensory System Agents|sensory system agents|mesh-ancestor
92137763|NCT01077843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137764|NCT01077843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137765|NCT01077843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137766|NCT01077843|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92137767|NCT01077843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137768|NCT01077843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137769|NCT00673959|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92137770|NCT00673959|Lubricant Eye Drops|lubricant eye drops|mesh-list
92137771|NCT00673959|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92137772|NCT00635817|Leuprolide|leuprolide|mesh-list
92137773|NCT00635817|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92137774|NCT00635817|Fertility Agents|fertility agents|mesh-ancestor
92137775|NCT00635817|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92137776|NCT00635817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137777|NCT00635817|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92137778|NCT00635817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137779|NCT01439945|Magnesium Oxide|magnesium oxide|mesh-list
92137780|NCT01439945|Antacids|antacids|mesh-ancestor
92137781|NCT01439945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137782|NCT01439945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137783|NCT00651963|Ezetimibe|ezetimibe|mesh-list
92137784|NCT00651963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92137785|NCT00651963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92137786|NCT00651963|Antimetabolites|antimetabolites|mesh-ancestor
92137787|NCT00651963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137788|NCT00651963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92137790|NCT00674115|Omeprazole, sodium bicarbonate drug combination|omeprazole, sodium bicarbonate drug combination|mesh-list
92137791|NCT00674115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92137792|NCT00674115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137793|NCT00674115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92137794|NCT00674115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137795|NCT00674115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137797|NCT02142153|Antifungal Agents|antifungal agents|mesh-ancestor
92137798|NCT02142153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137799|NCT00674583|Vaccines|vaccines|mesh-list
92137800|NCT00674583|Immunologic Factors|immunologic factors|mesh-ancestor
92137801|NCT00674583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137802|NCT01420081|Gedatolisib|gedatolisib|mesh-list
92137803|NCT01420081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92137804|NCT01420081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137805|NCT01420081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137806|NCT01439867|Cinacalcet|cinacalcet|mesh-list
92137807|NCT01439867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92137808|NCT01439867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137809|NCT01439867|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92137810|NCT01439867|Hormone Antagonists|hormone antagonists|mesh-ancestor
92137811|NCT01439867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137812|NCT00637923|Ribavirin|ribavirin|mesh-list
92137813|NCT00637923|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92137814|NCT00637923|Nitazoxanide|nitazoxanide|mesh-list
92137815|NCT00637923|Antimetabolites|antimetabolites|mesh-ancestor
92137816|NCT00637923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137817|NCT00637923|Antiviral Agents|antiviral agents|mesh-ancestor
92137818|NCT00637923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137819|NCT00637923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92137820|NCT01439711|Letrozole|letrozole|mesh-list
92137821|NCT01439711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137822|NCT01439711|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92137823|NCT01439711|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92137824|NCT01439711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137825|NCT01439711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137826|NCT01439711|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92137827|NCT01439711|Hormone Antagonists|hormone antagonists|mesh-ancestor
92137828|NCT01439711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137829|NCT01439711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137830|NCT01439555|Simvastatin|simvastatin|mesh-list
92137831|NCT01439555|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92137832|NCT01439555|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92137833|NCT01439555|Antimetabolites|antimetabolites|mesh-ancestor
92137834|NCT01439555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137835|NCT01439555|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92137836|NCT01439555|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92137837|NCT01439555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137838|NCT00674739|Imiquimod|imiquimod|mesh-list
92137839|NCT00674739|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92137840|NCT00674739|Immunologic Factors|immunologic factors|mesh-ancestor
92137841|NCT00674739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137843|NCT00674739|Interferon Inducers|interferon inducers|mesh-ancestor
92137844|NCT00675909|Midazolam|midazolam|mesh-list
92137845|NCT00675909|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92137846|NCT00675909|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92137847|NCT00675909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137848|NCT00675909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137849|NCT00675909|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92137850|NCT00675909|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92137851|NCT00675909|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92137852|NCT00675909|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92137853|NCT00675909|Anesthetics, General|anesthetics, general|mesh-ancestor
92137854|NCT00675909|Anesthetics|anesthetics|mesh-ancestor
92137855|NCT00675909|GABA Modulators|gaba modulators|mesh-ancestor
92137856|NCT00675909|GABA Agents|gaba agents|mesh-ancestor
92137857|NCT00675909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137858|NCT00675909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137859|NCT03027908|Fluorides|fluorides|mesh-list
92137860|NCT03027908|Cariostatic Agents|cariostatic agents|mesh-ancestor
92137861|NCT03027908|Protective Agents|protective agents|mesh-ancestor
92137862|NCT03027908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137864|NCT00638937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137866|NCT00638937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137867|NCT01439009|Tolvaptan|tolvaptan|mesh-list
92137868|NCT01439009|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92137869|NCT01439009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137870|NCT01439009|Natriuretic Agents|natriuretic agents|mesh-ancestor
92137871|NCT01439009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137872|NCT00675987|Losartan|losartan|mesh-list
92137873|NCT00675987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92137874|NCT00675987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92137875|NCT00675987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92137876|NCT00675987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92137877|NCT00675987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137878|NCT00639717|Etanercept|etanercept|mesh-list
92137879|NCT00639717|Methoxsalen|methoxsalen|mesh-list
92137880|NCT00639717|Tacrolimus|tacrolimus|mesh-list
92137881|NCT00639717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92137882|NCT00639717|Immunologic Factors|immunologic factors|mesh-ancestor
92137883|NCT00639717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137884|NCT00639717|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92137885|NCT00639717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137886|NCT00639717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137887|NCT00639717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92137888|NCT00639717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137889|NCT00639717|Analgesics|analgesics|mesh-ancestor
92137890|NCT00639717|Sensory System Agents|sensory system agents|mesh-ancestor
92137891|NCT00639717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137892|NCT00639717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137893|NCT00639717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137894|NCT00639717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137895|NCT00639717|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92137896|NCT00639717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92137897|NCT01571453|Vortioxetine|vortioxetine|mesh-list
92137898|NCT01571453|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92137899|NCT01571453|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92137900|NCT01571453|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92137901|NCT01571453|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92137902|NCT01571453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137903|NCT01571453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137904|NCT01571453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137905|NCT01571453|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92137906|NCT01571453|Antidepressive Agents|antidepressive agents|mesh-ancestor
92137907|NCT01571453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92137908|NCT01571453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92137909|NCT01571453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92137910|NCT01571453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92137911|NCT01571453|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92137912|NCT01571453|Serotonin Agents|serotonin agents|mesh-ancestor
92137913|NCT01571453|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92137914|NCT01571453|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92137915|NCT01571453|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92137916|NCT01571453|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92137918|NCT04120961|Bivalirudin|bivalirudin|mesh-list
92137919|NCT04120961|Antithrombins|antithrombins|mesh-ancestor
92137920|NCT04120961|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92137921|NCT04120961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92137922|NCT04120961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137923|NCT04120961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137924|NCT04120961|Anticoagulants|anticoagulants|mesh-ancestor
92137925|NCT04120961|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92137926|NCT04120961|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92137927|NCT04410263|Dimercaprol|dimercaprol|mesh-list
92137928|NCT04410263|Chelating Agents|chelating agents|mesh-ancestor
92137929|NCT04410263|Sequestering Agents|sequestering agents|mesh-ancestor
92137930|NCT04410263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137931|NCT01444651|Tadalafil|tadalafil|mesh-list
92137932|NCT01444651|Vasodilator Agents|vasodilator agents|mesh-ancestor
92137933|NCT01444651|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92137934|NCT01444651|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92137935|NCT01444651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92137936|NCT01444651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137937|NCT01444651|Urological Agents|urological agents|mesh-ancestor
92137938|NCT01570751|Insulin|insulin|mesh-list
92137942|NCT01570751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137943|NCT01419535|Mifepristone|mifepristone|mesh-list
92137944|NCT01419535|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92137945|NCT01419535|Abortifacient Agents|abortifacient agents|mesh-ancestor
92137946|NCT01419535|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92137947|NCT01419535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137948|NCT01419535|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92137949|NCT01419535|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92137950|NCT01419535|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92137951|NCT01419535|Contraceptive Agents|contraceptive agents|mesh-ancestor
92137952|NCT01419535|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92137953|NCT01419535|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92137954|NCT01419535|Hormone Antagonists|hormone antagonists|mesh-ancestor
92137955|NCT01419535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92137956|NCT01419535|Luteolytic Agents|luteolytic agents|mesh-ancestor
92137957|NCT01419535|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92137958|NCT01419535|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92137959|NCT01438151|Infliximab|infliximab|mesh-list
92137960|NCT01438151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92137961|NCT01438151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137962|NCT01438151|Dermatologic Agents|dermatologic agents|mesh-ancestor
92137963|NCT01438151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92137964|NCT01438151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137965|NCT02141451|Rituximab|rituximab|mesh-list
92137966|NCT02141451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92137967|NCT02141451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92137968|NCT02141451|Immunologic Factors|immunologic factors|mesh-ancestor
92137969|NCT02141451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137970|NCT02141451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137971|NCT01418365|Metronidazole|metronidazole|mesh-list
92137972|NCT01418365|Mesalamine|mesalamine|mesh-list
92137973|NCT01418365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92137974|NCT01418365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92137975|NCT01418365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92137976|NCT01418365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92137977|NCT01418365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92137978|NCT01418365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92137979|NCT01418365|Analgesics|analgesics|mesh-ancestor
92137980|NCT01418365|Sensory System Agents|sensory system agents|mesh-ancestor
92137981|NCT01418365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92137982|NCT01418365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137983|NCT01418365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92137984|NCT01418365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92137985|NCT02075125|Ticagrelor|ticagrelor|mesh-list
92137986|NCT02075125|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92137987|NCT02075125|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92137988|NCT02075125|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92137989|NCT02075125|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92137990|NCT02075125|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92137991|NCT02075125|Purinergic Agents|purinergic agents|mesh-ancestor
92137992|NCT02075125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92137993|NCT02075125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137994|NCT02075125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92137996|NCT00678015|Antioxidants|antioxidants|mesh-ancestor
92137997|NCT00678015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92137998|NCT00678015|Protective Agents|protective agents|mesh-ancestor
92137999|NCT00678015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138000|NCT00678015|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92138001|NCT00678015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138003|NCT00678015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92138004|NCT00678015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138005|NCT00678015|Analgesics|analgesics|mesh-ancestor
92138006|NCT00678015|Sensory System Agents|sensory system agents|mesh-ancestor
92138007|NCT00678015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138008|NCT00678015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138009|NCT00678015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138010|NCT01437995|Fluticasone|fluticasone|mesh-list
92138012|NCT01437995|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92138013|NCT01437995|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92138014|NCT01437995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138015|NCT01437995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92138016|NCT01437995|Autonomic Agents|autonomic agents|mesh-ancestor
92138017|NCT01437995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138018|NCT01437995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138019|NCT01437995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138020|NCT01437995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92138021|NCT01437995|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138022|NCT01437995|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92138023|NCT01437995|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92138024|NCT01437995|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92138025|NCT01437995|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138026|NCT01437995|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138027|NCT01437995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138028|NCT01437995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138029|NCT01437995|Glucocorticoids|glucocorticoids|mesh-ancestor
92138030|NCT01437995|Hormones|hormones|mesh-ancestor
92138031|NCT01437995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138032|NCT01437995|Sympathomimetics|sympathomimetics|mesh-ancestor
92138033|NCT00641745|Risperidone|risperidone|mesh-list
92138034|NCT00641745|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92138035|NCT00641745|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92138036|NCT00641745|Serotonin Agents|serotonin agents|mesh-ancestor
92138037|NCT00641745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138038|NCT00641745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138039|NCT00641745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138040|NCT00641745|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92138041|NCT00641745|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92138042|NCT00641745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138043|NCT00641745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92138044|NCT00641745|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92138045|NCT00641745|Dopamine Agents|dopamine agents|mesh-ancestor
92138046|NCT00641745|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92138047|NCT00641745|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92138048|NCT00641745|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92138049|NCT00641745|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138050|NCT00641745|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92138051|NCT00641745|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92138052|NCT01799109|Magnesium Sulfate|magnesium sulfate|mesh-list
92138053|NCT01799109|Albuterol|albuterol|mesh-list
92138054|NCT01799109|Analgesics|analgesics|mesh-ancestor
92138055|NCT01799109|Sensory System Agents|sensory system agents|mesh-ancestor
92138056|NCT01799109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138057|NCT01799109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138058|NCT01799109|Anesthetics|anesthetics|mesh-ancestor
92138059|NCT01799109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138060|NCT01799109|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92138061|NCT01799109|Anticonvulsants|anticonvulsants|mesh-ancestor
92138062|NCT01799109|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92138063|NCT01799109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138064|NCT01799109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138065|NCT01799109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92138066|NCT01799109|Tocolytic Agents|tocolytic agents|mesh-ancestor
92138067|NCT01799109|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138068|NCT01799109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92138069|NCT01799109|Autonomic Agents|autonomic agents|mesh-ancestor
92138070|NCT01799109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138071|NCT01799109|Respiratory System Agents|respiratory system agents|mesh-ancestor
91939336|NCT02276560|Paclitaxel|paclitaxel|mesh-list
92138072|NCT01799109|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92138073|NCT01799109|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92138074|NCT01799109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138075|NCT01799109|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138076|NCT01799109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138077|NCT00588159|Diphenhydramine|diphenhydramine|mesh-list
92138078|NCT00588159|Promethazine|promethazine|mesh-list
92138079|NCT00588159|Gabapentin|gabapentin|mesh-list
92138080|NCT00588159|Analgesics|analgesics|mesh-ancestor
92138081|NCT00588159|Sensory System Agents|sensory system agents|mesh-ancestor
92138082|NCT00588159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138083|NCT00588159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138084|NCT00588159|Anticonvulsants|anticonvulsants|mesh-ancestor
92138085|NCT00588159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92138086|NCT00588159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92138087|NCT00588159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138088|NCT00588159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92138089|NCT00588159|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92138090|NCT00588159|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92138091|NCT00588159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138092|NCT00588159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138093|NCT00588159|Antimanic Agents|antimanic agents|mesh-ancestor
92138094|NCT00588159|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92138095|NCT00588159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92138096|NCT00588159|Anesthetics, Local|anesthetics, local|mesh-ancestor
92138097|NCT00588159|Anesthetics|anesthetics|mesh-ancestor
92138098|NCT00588159|Antiemetics|antiemetics|mesh-ancestor
92138099|NCT00588159|Autonomic Agents|autonomic agents|mesh-ancestor
92138100|NCT00588159|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138101|NCT00588159|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92138102|NCT00588159|Histamine Antagonists|histamine antagonists|mesh-ancestor
92138103|NCT00588159|Histamine Agents|histamine agents|mesh-ancestor
92138104|NCT00588159|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92138105|NCT00588159|Antipruritics|antipruritics|mesh-ancestor
92138106|NCT00588159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138107|NCT01439347|Vincristine|vincristine|mesh-list
92138108|NCT01439347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138109|NCT01439347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138110|NCT01439347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138111|NCT01439347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92138112|NCT01439347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92138113|NCT01439347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138114|NCT00680823|Ropivacaine|ropivacaine|mesh-list
92138115|NCT00680823|Anesthetics, Local|anesthetics, local|mesh-ancestor
92138116|NCT00680823|Anesthetics|anesthetics|mesh-ancestor
92138117|NCT00680823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138118|NCT00680823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138119|NCT00680823|Sensory System Agents|sensory system agents|mesh-ancestor
92138120|NCT00680823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138121|NCT00589329|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92138122|NCT00589329|Metronidazole|metronidazole|mesh-list
92138123|NCT00589329|Erythromycin|erythromycin|mesh-list
92138124|NCT00589329|Erythromycin Estolate|erythromycin estolate|mesh-list
92138125|NCT00589329|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92138126|NCT00589329|Erythromycin stearate|erythromycin stearate|mesh-list
92138127|NCT00589329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138128|NCT00589329|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92138129|NCT00589329|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92138130|NCT00589329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138131|NCT00589329|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92138132|NCT00589329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138133|NCT00589329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138134|NCT01438957|Dexmedetomidine|dexmedetomidine|mesh-list
92138135|NCT01438957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92138136|NCT01438957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138137|NCT01438957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138138|NCT01438957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138139|NCT01438957|Analgesics|analgesics|mesh-ancestor
92138140|NCT01438957|Sensory System Agents|sensory system agents|mesh-ancestor
92138141|NCT01438957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138142|NCT01438957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92138143|NCT01438957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92138144|NCT01438957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138145|NCT01438957|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138146|NCT01438957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138147|NCT01438957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138149|NCT00589563|Cyclophosphamide|cyclophosphamide|mesh-list
92138151|NCT00589563|Methotrexate|methotrexate|mesh-list
92138152|NCT00589563|Fludarabine|fludarabine|mesh-list
92138153|NCT00589563|Fludarabine phosphate|fludarabine phosphate|mesh-list
92138154|NCT00589563|Etoposide|etoposide|mesh-list
92138155|NCT00589563|Tacrolimus|tacrolimus|mesh-list
92138156|NCT00589563|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92138157|NCT00589563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138158|NCT00589563|Immunologic Factors|immunologic factors|mesh-ancestor
92138159|NCT00589563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138160|NCT00589563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138161|NCT00589563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92138162|NCT00589563|Alkylating Agents|alkylating agents|mesh-ancestor
92138163|NCT00589563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138164|NCT00589563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138165|NCT00589563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92138166|NCT00589563|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92138167|NCT00589563|Abortifacient Agents|abortifacient agents|mesh-ancestor
92138168|NCT00589563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138169|NCT00589563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92138170|NCT00589563|Antimetabolites|antimetabolites|mesh-ancestor
92138171|NCT00589563|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138172|NCT00589563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138173|NCT00589563|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92138174|NCT00589563|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138175|NCT00589563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138176|NCT00589563|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92138177|NCT00589563|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92138178|NCT00589563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92138179|NCT00589563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92138180|NCT00589563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138181|NCT00589563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92138182|NCT00589563|Antifungal Agents|antifungal agents|mesh-ancestor
92138183|NCT00645333|Docetaxel|docetaxel|mesh-list
92138184|NCT00645333|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|3-(4-((4-chlorophenyl)sulfonyl)-4-(2,5-difluorophenyl)cyclohexyl)propanoic acid|mesh-list
92138185|NCT00645333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138186|NCT00645333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138187|NCT00645333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92138188|NCT00645333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92138189|NCT00645333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138190|NCT00645333|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92138191|NCT00645333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138192|NCT00646581|Insulin|insulin|mesh-list
92138193|NCT00646581|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92138194|NCT00646581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92138195|NCT00646581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138196|NCT00648375|Propranolol|propranolol|mesh-list
92138197|NCT00648375|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92138198|NCT00648375|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92138199|NCT00648375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138200|NCT00648375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138201|NCT00648375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138202|NCT00648375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138203|NCT00648375|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92138204|NCT00648375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92138205|NCT00648375|Vasodilator Agents|vasodilator agents|mesh-ancestor
92138206|NCT00654069|Niacin|niacin|mesh-list
92138207|NCT00654069|Niacinamide|niacinamide|mesh-list
92138208|NCT00654069|Nicotinic Acids|nicotinic acids|mesh-list
92138209|NCT00654069|Oxycodone|oxycodone|mesh-list
92138210|NCT00654069|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92138211|NCT00654069|Narcotics|narcotics|mesh-ancestor
92138212|NCT00654069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138213|NCT00654069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138214|NCT00654069|Analgesics|analgesics|mesh-ancestor
92138215|NCT00654069|Sensory System Agents|sensory system agents|mesh-ancestor
92138216|NCT00654069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138217|NCT00654069|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92138218|NCT00654069|Antimetabolites|antimetabolites|mesh-ancestor
92138219|NCT00654069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138220|NCT00654069|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92138222|NCT00654069|Vitamin B Complex|vitamin b complex|mesh-ancestor
92138223|NCT00654069|Vitamins|vitamins|mesh-ancestor
92138224|NCT00654069|Micronutrients|micronutrients|mesh-ancestor
92138225|NCT00654147|Ritonavir|ritonavir|mesh-list
92138226|NCT00654147|Lopinavir|lopinavir|mesh-list
92138227|NCT00654147|Tenofovir|tenofovir|mesh-list
92138228|NCT00654147|Emtricitabine|emtricitabine|mesh-list
92138229|NCT00654147|Raltegravir Potassium|raltegravir potassium|mesh-list
92138230|NCT00654147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92138231|NCT00654147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92138232|NCT00654147|Protease Inhibitors|protease inhibitors|mesh-ancestor
92138233|NCT00654147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138234|NCT00654147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138235|NCT00654147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92138236|NCT00654147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92138237|NCT00654147|Antiviral Agents|antiviral agents|mesh-ancestor
92138238|NCT00654147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138239|NCT00654147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92138240|NCT00654147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92138241|NCT00654147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92138242|NCT00654147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138243|NCT00654147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92138244|NCT00654147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92138247|NCT01438489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138249|NCT00654927|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92138250|NCT00654927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138251|NCT00654927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138252|NCT00655083|MEN 11420|men 11420|mesh-list
92138253|NCT00655083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92138254|NCT00655083|Autonomic Agents|autonomic agents|mesh-ancestor
92138255|NCT00655083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138256|NCT00655083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138257|NCT00655083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138258|NCT00655083|Respiratory System Agents|respiratory system agents|mesh-ancestor
92138259|NCT01418209|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92138260|NCT01418209|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92138261|NCT01418209|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92138262|NCT01418209|Estradiol|estradiol|mesh-list
92138263|NCT01418209|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92138264|NCT01418209|Progesterone|progesterone|mesh-list
92138265|NCT01418209|Estrogens|estrogens|mesh-ancestor
92138266|NCT01418209|Hormones|hormones|mesh-ancestor
92138267|NCT01418209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138268|NCT01418209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138269|NCT01418209|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92138270|NCT01418209|Contraceptive Agents|contraceptive agents|mesh-ancestor
92138271|NCT01418209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138272|NCT01418209|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92138273|NCT01418209|Progestins|progestins|mesh-ancestor
92138274|NCT01418209|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92138275|NCT01418209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92138276|NCT01418209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138277|NCT01418209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138278|NCT01418209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138279|NCT01418209|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92138280|NCT01418209|Antidepressive Agents|antidepressive agents|mesh-ancestor
92138281|NCT01418209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92138282|NCT00655473|Dalcetrapib|dalcetrapib|mesh-list
92138283|NCT00655473|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92138284|NCT00655473|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92138285|NCT00655473|Antimetabolites|antimetabolites|mesh-ancestor
92138286|NCT00655473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138287|NCT00655473|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92138288|NCT01570361|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92138289|NCT01417195|Menotropins|menotropins|mesh-list
92138290|NCT01417195|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92138291|NCT01417195|Hormones|hormones|mesh-ancestor
91939341|NCT02276560|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138292|NCT01417195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138293|NCT01417195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138294|NCT01417195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92138295|NCT01417195|Fertility Agents|fertility agents|mesh-ancestor
92138296|NCT01417195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138297|NCT00656487|Rimonabant|rimonabant|mesh-list
92138298|NCT00656487|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92138299|NCT00656487|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92138300|NCT00656487|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92138301|NCT00656487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138302|NCT00656487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138303|NCT00656487|Hormones|hormones|mesh-ancestor
92138304|NCT00656487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138305|NCT00656487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138306|NCT01438411|Cholic Acids|cholic acids|mesh-list
92138307|NCT01438411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138308|NCT01438177|Chloroquine|chloroquine|mesh-list
92138309|NCT01438177|Cyclophosphamide|cyclophosphamide|mesh-list
92138310|NCT01438177|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92138311|NCT01438177|Bortezomib|bortezomib|mesh-list
92138312|NCT01438177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138313|NCT01438177|Immunologic Factors|immunologic factors|mesh-ancestor
92138314|NCT01438177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138315|NCT01438177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138316|NCT01438177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92138317|NCT01438177|Alkylating Agents|alkylating agents|mesh-ancestor
92138318|NCT01438177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138319|NCT01438177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138320|NCT01438177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92138321|NCT01438177|Amebicides|amebicides|mesh-ancestor
92138322|NCT01438177|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92138323|NCT01438177|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92138324|NCT01438177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138325|NCT01438177|Antimalarials|antimalarials|mesh-ancestor
92138326|NCT01442779|Interferons|interferons|mesh-list
92138327|NCT01442779|Interferon-alpha|interferon-alpha|mesh-list
92138328|NCT01442779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138329|NCT01442779|Antiviral Agents|antiviral agents|mesh-ancestor
92138330|NCT01442779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138331|NCT01442779|Immunologic Factors|immunologic factors|mesh-ancestor
92138332|NCT01442779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138333|NCT01436201|Dulaglutide|dulaglutide|mesh-list
92138334|NCT01436201|Digoxin|digoxin|mesh-list
92138335|NCT01436201|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92138336|NCT01436201|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92138337|NCT01436201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138338|NCT01436201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138339|NCT01436201|Protective Agents|protective agents|mesh-ancestor
92138340|NCT01436201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138341|NCT01436201|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92138342|NCT01437397|Bromides|bromides|mesh-list
92138343|NCT01437397|Formoterol Fumarate|formoterol fumarate|mesh-list
92138344|NCT01437397|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92138345|NCT01437397|Autonomic Agents|autonomic agents|mesh-ancestor
92138346|NCT01437397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138347|NCT01437397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138348|NCT01437397|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138349|NCT01437397|Respiratory System Agents|respiratory system agents|mesh-ancestor
92138350|NCT01437397|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92138351|NCT01437397|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92138352|NCT01437397|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138353|NCT01437397|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138354|NCT01437397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138355|NCT01437397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138356|NCT01437397|Anticonvulsants|anticonvulsants|mesh-ancestor
92138357|NCT04070833|Vitamin D|vitamin d|mesh-list
92138358|NCT04070833|Ergocalciferols|ergocalciferols|mesh-list
92138359|NCT04070833|Cholecalciferol|cholecalciferol|mesh-list
92138360|NCT04070833|Vitamins|vitamins|mesh-list
92138361|NCT04070833|Micronutrients|micronutrients|mesh-ancestor
92138362|NCT04070833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138363|NCT04070833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92138364|NCT04070833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92138365|NCT01442155|Capecitabine|capecitabine|mesh-list
92138366|NCT01442155|Oxaliplatin|oxaliplatin|mesh-list
92138367|NCT01442155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92138368|NCT01442155|Antimetabolites|antimetabolites|mesh-ancestor
92138369|NCT01442155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138370|NCT01442155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138371|NCT01416181|Natalizumab|natalizumab|mesh-list
92138372|NCT01416181|Immunologic Factors|immunologic factors|mesh-ancestor
92138373|NCT01416181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138374|NCT03026023|Ribavirin|ribavirin|mesh-list
92138375|NCT03026023|Grazoprevir|grazoprevir|mesh-list
92138376|NCT03026023|Antimetabolites|antimetabolites|mesh-ancestor
92138377|NCT03026023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138378|NCT03026023|Antiviral Agents|antiviral agents|mesh-ancestor
92138379|NCT03026023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138380|NCT01441765|Pidilizumab|pidilizumab|mesh-list
92138381|NCT01441765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138382|NCT01441765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138383|NCT01419665|Rituximab|rituximab|mesh-list
92138384|NCT01419665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138385|NCT01419665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138386|NCT01419665|Immunologic Factors|immunologic factors|mesh-ancestor
92138387|NCT01419665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138388|NCT01419665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138389|NCT01436305|Mycophenolic Acid|mycophenolic acid|mesh-list
92138390|NCT01436305|Methylprednisolone|methylprednisolone|mesh-list
92138392|NCT01436305|Abatacept|abatacept|mesh-list
92138393|NCT01436305|Tacrolimus|tacrolimus|mesh-list
92138394|NCT01436305|Basiliximab|basiliximab|mesh-list
92138395|NCT01436305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138396|NCT01436305|Immunologic Factors|immunologic factors|mesh-ancestor
92138397|NCT01436305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138398|NCT01436305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92138399|NCT01436305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138400|NCT01436305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138401|NCT01436305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92138402|NCT01436305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138403|NCT01436305|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92138404|NCT01436305|Antitubercular Agents|antitubercular agents|mesh-ancestor
92138405|NCT01436305|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92138406|NCT01436305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138407|NCT01436305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138408|NCT01436305|Antiemetics|antiemetics|mesh-ancestor
92138409|NCT01436305|Autonomic Agents|autonomic agents|mesh-ancestor
92138410|NCT01436305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138411|NCT01436305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138412|NCT01436305|Glucocorticoids|glucocorticoids|mesh-ancestor
92138413|NCT01436305|Hormones|hormones|mesh-ancestor
92138414|NCT01436305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138415|NCT01436305|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92138416|NCT01436305|Protective Agents|protective agents|mesh-ancestor
92138417|NCT01436305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138418|NCT01436305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92138419|NCT01436305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138420|NCT01436149|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92138421|NCT01436149|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92138422|NCT01436149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138423|NCT01436149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92138424|NCT01436149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92138425|NCT01436149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138426|NCT01436149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138427|NCT01436149|Dopamine Agents|dopamine agents|mesh-ancestor
92138428|NCT01436149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138429|NCT01415401|Timolol|timolol|mesh-list
92138430|NCT01415401|Brinzolamide|brinzolamide|mesh-list
92138431|NCT01415401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138432|NCT01415401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138434|NCT01415401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92138435|NCT01415401|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138436|NCT01415401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138437|NCT01415401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138438|NCT01415401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92138439|NCT01415401|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92138440|NCT01415401|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92138442|NCT01414855|Cyclophosphamide|cyclophosphamide|mesh-list
92138443|NCT01414855|Doxorubicin|doxorubicin|mesh-list
92138444|NCT01414855|Vincristine|vincristine|mesh-list
92138445|NCT01414855|Obinutuzumab|obinutuzumab|mesh-list
92138446|NCT01414855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138447|NCT01414855|Immunologic Factors|immunologic factors|mesh-ancestor
92138448|NCT01414855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138449|NCT01414855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138450|NCT01414855|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92138451|NCT01414855|Alkylating Agents|alkylating agents|mesh-ancestor
92138452|NCT01414855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138453|NCT01414855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138454|NCT01414855|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92138455|NCT01414855|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92138456|NCT01414855|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92138457|NCT01414855|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92138458|NCT01414855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138459|NCT01414855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138460|NCT01414855|Glucocorticoids|glucocorticoids|mesh-ancestor
92138461|NCT01414855|Hormones|hormones|mesh-ancestor
92138462|NCT01414855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138463|NCT01414855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92138464|NCT01414855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138465|NCT01414855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138466|NCT01414855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92138467|NCT01414855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92138468|NCT01414855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138469|NCT02074735|Choline|choline|mesh-list
92138470|NCT02074735|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92138471|NCT02074735|Lipotropic Agents|lipotropic agents|mesh-ancestor
92138472|NCT02074735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92138474|NCT02074735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138475|NCT02074735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138476|NCT02074735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92138477|NCT02074735|Nootropic Agents|nootropic agents|mesh-ancestor
92138478|NCT01527110|Zanamivir|zanamivir|mesh-list
92138479|NCT01527110|Antiviral Agents|antiviral agents|mesh-ancestor
92138480|NCT01527110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138481|NCT01527110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138482|NCT01527110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138483|NCT01441063|Zidovudine|zidovudine|mesh-list
92138484|NCT01441063|Valganciclovir|valganciclovir|mesh-list
92138485|NCT01441063|Antimetabolites|antimetabolites|mesh-ancestor
92138486|NCT01441063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138487|NCT01441063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92138488|NCT01441063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138489|NCT01441063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138490|NCT01441063|Antiviral Agents|antiviral agents|mesh-ancestor
92138491|NCT01441063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138492|NCT01441063|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92138493|NCT01441063|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92138494|NCT01436071|Fluticasone|fluticasone|mesh-list
92138495|NCT01436071|Xhance|xhance|mesh-list
92138496|NCT01436071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138497|NCT01436071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92138498|NCT01436071|Autonomic Agents|autonomic agents|mesh-ancestor
92138499|NCT01436071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138500|NCT01436071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138501|NCT01436071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138502|NCT01436071|Respiratory System Agents|respiratory system agents|mesh-ancestor
92138503|NCT01436071|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138504|NCT01436071|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92138505|NCT01514864|Dasatinib|dasatinib|mesh-list
92138506|NCT01514864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138507|NCT01514864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92138508|NCT01514864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138509|NCT01514864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138511|NCT01514240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92138512|NCT01514240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138514|NCT01514240|Sensory System Agents|sensory system agents|mesh-ancestor
92138515|NCT01514240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138516|NCT01514240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138517|NCT01514240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138518|NCT01514240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138519|NCT01435759|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92138520|NCT01435759|Antidepressive Agents|antidepressive agents|mesh-list
92138521|NCT01435759|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92138522|NCT01435759|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92138523|NCT01435759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138524|NCT01435759|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92138525|NCT01435759|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92138526|NCT01435759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138527|NCT01435759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138528|NCT01435759|Dopamine Agents|dopamine agents|mesh-ancestor
92138529|NCT01435759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138530|NCT04061239|Cytarabine|cytarabine|mesh-list
92138531|NCT04061239|Azacitidine|azacitidine|mesh-list
92138532|NCT04061239|Daunorubicin|daunorubicin|mesh-list
92138533|NCT04061239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92138534|NCT04061239|Antimetabolites|antimetabolites|mesh-ancestor
92138535|NCT04061239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138536|NCT04061239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138537|NCT04061239|Antiviral Agents|antiviral agents|mesh-ancestor
92138538|NCT04061239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138539|NCT04061239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138540|NCT04061239|Immunologic Factors|immunologic factors|mesh-ancestor
92138541|NCT04061239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138542|NCT04061239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138543|NCT04061239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92138544|NCT04061239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92138545|NCT04061239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92138546|NCT01393405|Methotrexate|methotrexate|mesh-list
92138547|NCT01393405|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92138548|NCT01393405|Abortifacient Agents|abortifacient agents|mesh-ancestor
92138549|NCT01393405|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138550|NCT01393405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138551|NCT01393405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92138552|NCT01393405|Antimetabolites|antimetabolites|mesh-ancestor
92138553|NCT01393405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138554|NCT01393405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138555|NCT01393405|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138556|NCT01393405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138557|NCT01393405|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92138558|NCT01393405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138559|NCT01393405|Immunologic Factors|immunologic factors|mesh-ancestor
92138560|NCT01393405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138561|NCT01393405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138562|NCT01419197|Trastuzumab|trastuzumab|mesh-list
92138563|NCT01419197|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92138564|NCT01419197|Maytansine|maytansine|mesh-list
92138565|NCT01419197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138566|NCT01419197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138567|NCT01419197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138568|NCT01419197|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138569|NCT01419197|Antimitotic Agents|antimitotic agents|mesh-ancestor
92138570|NCT01419197|Mitosis Modulators|mitosis modulators|mesh-ancestor
92138571|NCT01419197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138572|NCT01419197|Immunotoxins|immunotoxins|mesh-ancestor
92138573|NCT01419197|Immunoconjugates|immunoconjugates|mesh-ancestor
92138574|NCT01419197|Immunologic Factors|immunologic factors|mesh-ancestor
92138575|NCT01419197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138576|NCT01414075|Iron|iron|mesh-list
92138577|NCT01414075|Trace Elements|trace elements|mesh-ancestor
92138578|NCT01414075|Micronutrients|micronutrients|mesh-ancestor
92138579|NCT01414075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138581|NCT01513460|Tiotropium Bromide|tiotropium bromide|mesh-list
92138582|NCT01513460|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92138584|NCT01513460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138585|NCT01513460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138586|NCT01513460|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138587|NCT01513460|Respiratory System Agents|respiratory system agents|mesh-ancestor
92138589|NCT01513460|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92138590|NCT01513460|Cholinergic Agents|cholinergic agents|mesh-ancestor
92138591|NCT01513460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138592|NCT01513460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138593|NCT01513460|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92138594|NCT01513460|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92138595|NCT01418339|Aripiprazole|aripiprazole|mesh-list
92138596|NCT01418339|Antidepressive Agents|antidepressive agents|mesh-ancestor
92138597|NCT01418339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92138598|NCT01418339|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92138599|NCT01418339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92138600|NCT01418339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138601|NCT01418339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138602|NCT01418339|Dopamine Agonists|dopamine agonists|mesh-ancestor
92138603|NCT01418339|Dopamine Agents|dopamine agents|mesh-ancestor
92138604|NCT01418339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138605|NCT01418339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138606|NCT01418339|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92138607|NCT01418339|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92138608|NCT01418339|Serotonin Agents|serotonin agents|mesh-ancestor
92138609|NCT01418339|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92138610|NCT01418339|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92138611|NCT01418339|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92138612|NCT01418339|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92138613|NCT01417481|Glycine|glycine|mesh-list
92138614|NCT01417481|Glycine Agents|glycine agents|mesh-ancestor
92138615|NCT01417481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138616|NCT01417481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138617|NCT01417481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138618|NCT01392469|Imatinib Mesylate|imatinib mesylate|mesh-list
92138619|NCT01392469|Bosentan|bosentan|mesh-list
92138620|NCT01392469|Sildenafil Citrate|sildenafil citrate|mesh-list
92138621|NCT01392469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138622|NCT01392469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92138623|NCT01392469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138624|NCT01392469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138625|NCT01392469|Vasodilator Agents|vasodilator agents|mesh-ancestor
92138626|NCT01392469|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92138627|NCT01392469|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92138628|NCT01392469|Urological Agents|urological agents|mesh-ancestor
92138629|NCT01392469|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92138630|NCT01392469|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92138631|NCT01435577|Tapentadol|tapentadol|mesh-list
92138632|NCT01435577|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92138633|NCT01435577|Narcotics|narcotics|mesh-ancestor
92138634|NCT01435577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138635|NCT01435577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138636|NCT01435577|Analgesics|analgesics|mesh-ancestor
92138637|NCT01435577|Sensory System Agents|sensory system agents|mesh-ancestor
92138638|NCT01435577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138639|NCT01435577|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92138640|NCT01435577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92138641|NCT01435577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138642|NCT01435577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138643|NCT01435577|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138644|NCT01435577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138645|NCT04039087|Sildenafil Citrate|sildenafil citrate|mesh-list
92138646|NCT04039087|Vasodilator Agents|vasodilator agents|mesh-ancestor
92138647|NCT04039087|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92138648|NCT04039087|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92138649|NCT04039087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138650|NCT04039087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138651|NCT04039087|Urological Agents|urological agents|mesh-ancestor
92138653|NCT01411891|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92138654|NCT01411891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138655|NCT01411891|Disinfectants|disinfectants|mesh-ancestor
92138656|NCT01416389|Lenograstim|lenograstim|mesh-list
92138657|NCT01416389|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92138658|NCT01416389|Immunologic Factors|immunologic factors|mesh-ancestor
92138659|NCT01416389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138661|NCT04497155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92138662|NCT04497155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138663|NCT04497155|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138664|NCT04497155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138665|NCT04497155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138666|NCT04497155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138667|NCT04497155|Sympathomimetics|sympathomimetics|mesh-ancestor
92138668|NCT04497155|Autonomic Agents|autonomic agents|mesh-ancestor
92138669|NCT04497155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138670|NCT04497155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92138671|NCT01544348|Omalizumab|omalizumab|mesh-list
92138672|NCT01544348|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92138673|NCT01544348|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92138674|NCT01544348|Respiratory System Agents|respiratory system agents|mesh-ancestor
92138675|NCT01416155|Natalizumab|natalizumab|mesh-list
92138676|NCT01416155|Immunologic Factors|immunologic factors|mesh-ancestor
92138677|NCT01416155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138678|NCT01415921|Bromides|bromides|mesh-list
92138679|NCT01415921|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92138680|NCT01415921|Anticonvulsants|anticonvulsants|mesh-ancestor
92138681|NCT01415921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92138682|NCT01415921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138683|NCT01415921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138684|NCT01415921|Cholinergic Agents|cholinergic agents|mesh-ancestor
92138685|NCT01415921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138686|NCT01415921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138687|NCT01415531|Nebivolol|nebivolol|mesh-list
92138688|NCT01415531|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92138689|NCT01415531|Vasodilator Agents|vasodilator agents|mesh-ancestor
92138690|NCT01415531|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92138691|NCT01415531|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92138692|NCT01415531|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138693|NCT01415531|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138694|NCT01415531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138695|NCT01415531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138696|NCT01415531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138697|NCT01544114|Naproxen|naproxen|mesh-list
92138698|NCT01544114|Esomeprazole|esomeprazole|mesh-list
92138699|NCT01544114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92138700|NCT01544114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138701|NCT01544114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92138702|NCT01544114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138780|NCT02823990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138703|NCT01544114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138704|NCT01544114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92138705|NCT01544114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138706|NCT01544114|Analgesics|analgesics|mesh-ancestor
92138707|NCT01544114|Sensory System Agents|sensory system agents|mesh-ancestor
92138708|NCT01544114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138709|NCT01544114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138710|NCT01544114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138711|NCT01544114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138712|NCT01544114|Gout Suppressants|gout suppressants|mesh-ancestor
92138713|NCT01544114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92138714|NCT01410799|Hormones|hormones|mesh-list
92138715|NCT01410799|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
92138716|NCT01410799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138717|NCT01410799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138718|NCT01432171|Lacosamide|lacosamide|mesh-list
92138719|NCT01432171|Anticonvulsants|anticonvulsants|mesh-ancestor
92138720|NCT01432171|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92138721|NCT01432171|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92138722|NCT01432171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138723|NCT01432171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138724|NCT04046263|Ferric Compounds|ferric compounds|mesh-list
92138725|NCT04046263|Hematinics|hematinics|mesh-ancestor
92138726|NCT01414205|Obinutuzumab|obinutuzumab|mesh-list
92138727|NCT01414205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138728|NCT01414205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138729|NCT01413503|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92138730|NCT01413503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138731|NCT01413503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138732|NCT01413503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138734|NCT01413191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92138735|NCT01413191|Immunologic Factors|immunologic factors|mesh-ancestor
92138736|NCT01413191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138737|NCT05021562|Niraparib|niraparib|mesh-list
92138738|NCT05021562|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92138739|NCT05021562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138740|NCT05021562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138741|NCT05021562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138742|NCT01412957|Panitumumab|panitumumab|mesh-list
92138743|NCT01412957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138744|NCT01412957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138745|NCT04973826|Aztreonam|aztreonam|mesh-list
92138746|NCT04973826|Avibactam|avibactam|mesh-list
92138747|NCT04973826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92138748|NCT04973826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138749|NCT04973826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92138750|NCT04973826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138751|NCT04973826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138752|NCT05387616|Obinutuzumab|obinutuzumab|mesh-list
92138753|NCT05387616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138754|NCT05387616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138755|NCT03025841|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92138756|NCT03025841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92138757|NCT03025841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138758|NCT01432457|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92138759|NCT01432457|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92138760|NCT01432457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92138761|NCT01432457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138762|NCT01432457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138763|NCT01432457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138764|NCT01432457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138765|NCT01432457|Antidepressive Agents|antidepressive agents|mesh-ancestor
92138766|NCT01432457|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92138767|NCT05062278|Hydroxyurea|hydroxyurea|mesh-list
92138768|NCT05062278|Vinblastine|vinblastine|mesh-list
92138769|NCT05062278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138770|NCT05062278|Antisickling Agents|antisickling agents|mesh-ancestor
92138771|NCT05062278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138772|NCT05062278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138773|NCT05062278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138774|NCT05062278|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138775|NCT05062278|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138781|NCT02823990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138782|NCT02823990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138783|NCT02823990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92138784|NCT02823990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138785|NCT02823990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138786|NCT02823990|Analgesics|analgesics|mesh-ancestor
92138787|NCT02823990|Sensory System Agents|sensory system agents|mesh-ancestor
92138788|NCT02823990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138789|NCT02427126|Aspirin|aspirin|mesh-list
92138790|NCT02427126|Apixaban|apixaban|mesh-list
92138791|NCT02427126|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92138792|NCT02427126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138794|NCT02427126|Sensory System Agents|sensory system agents|mesh-ancestor
92138795|NCT02427126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138796|NCT02427126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138797|NCT02427126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138798|NCT02427126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138799|NCT02427126|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92138800|NCT02427126|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92138801|NCT02427126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138802|NCT02427126|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92138803|NCT02427126|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92138804|NCT02427126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138805|NCT02427126|Antipyretics|antipyretics|mesh-ancestor
92138806|NCT02427126|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92138807|NCT02427126|Antithrombins|antithrombins|mesh-ancestor
92138808|NCT02427126|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92138809|NCT02427126|Protease Inhibitors|protease inhibitors|mesh-ancestor
92138810|NCT02427126|Anticoagulants|anticoagulants|mesh-ancestor
92138811|NCT04807920|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92138812|NCT04807920|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92138813|NCT04807920|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92138814|NCT04807920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138815|NCT04807920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138816|NCT04807920|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92138817|NCT04807920|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92138818|NCT04807920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138819|NCT04807920|Cholinergic Agents|cholinergic agents|mesh-ancestor
92138820|NCT04807920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138821|NCT00658515|Dalcetrapib|dalcetrapib|mesh-list
92138822|NCT00658515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92138823|NCT00658515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92138824|NCT00658515|Antimetabolites|antimetabolites|mesh-ancestor
92138825|NCT00658515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138826|NCT00658515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92138827|NCT04797312|Sufentanil|sufentanil|mesh-list
92138828|NCT04797312|Remifentanil|remifentanil|mesh-list
92138829|NCT04797312|Analgesics, Opioid|analgesics, opioid|mesh-list
92138830|NCT04797312|Anesthetics|anesthetics|mesh-ancestor
92138831|NCT04797312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138832|NCT04797312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138833|NCT04797312|Narcotics|narcotics|mesh-ancestor
92138834|NCT04797312|Analgesics|analgesics|mesh-ancestor
92138835|NCT04797312|Sensory System Agents|sensory system agents|mesh-ancestor
92138836|NCT04797312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138837|NCT04797312|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92138838|NCT04797312|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92138839|NCT04797312|Anesthetics, General|anesthetics, general|mesh-ancestor
92138840|NCT05080140|Ezetimibe|ezetimibe|mesh-list
92138841|NCT05080140|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92138842|NCT05080140|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92138843|NCT05080140|Antimetabolites|antimetabolites|mesh-ancestor
92138844|NCT05080140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138845|NCT05080140|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92138846|NCT01390441|Acetaminophen|acetaminophen|mesh-list
92138847|NCT01390441|Loratadine|loratadine|mesh-list
92138848|NCT01390441|Methylprednisolone|methylprednisolone|mesh-list
92138849|NCT01390441|Rituximab|rituximab|mesh-list
92138850|NCT01390441|Methotrexate|methotrexate|mesh-list
92138851|NCT01390441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138852|NCT01390441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138853|NCT01390441|Immunologic Factors|immunologic factors|mesh-ancestor
92138854|NCT01390441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138855|NCT01390441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138856|NCT01390441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92138857|NCT01390441|Abortifacient Agents|abortifacient agents|mesh-ancestor
92138858|NCT01390441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138859|NCT01390441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92138860|NCT01390441|Antimetabolites|antimetabolites|mesh-ancestor
92138861|NCT01390441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138862|NCT01390441|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138863|NCT01390441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138864|NCT01390441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92138865|NCT01390441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138866|NCT01390441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138867|NCT01390441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138868|NCT01390441|Analgesics|analgesics|mesh-ancestor
92138869|NCT01390441|Sensory System Agents|sensory system agents|mesh-ancestor
92138870|NCT01390441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138872|NCT01390441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138873|NCT01390441|Antiemetics|antiemetics|mesh-ancestor
92138874|NCT01390441|Autonomic Agents|autonomic agents|mesh-ancestor
92138875|NCT01390441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138876|NCT01390441|Glucocorticoids|glucocorticoids|mesh-ancestor
92138877|NCT01390441|Hormones|hormones|mesh-ancestor
92138878|NCT01390441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138879|NCT01390441|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92138880|NCT01390441|Protective Agents|protective agents|mesh-ancestor
92138881|NCT01390441|Antipruritics|antipruritics|mesh-ancestor
92138882|NCT01390441|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92138883|NCT01390441|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92138884|NCT01390441|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92138885|NCT01390441|Histamine Antagonists|histamine antagonists|mesh-ancestor
92138886|NCT01390441|Histamine Agents|histamine agents|mesh-ancestor
92138887|NCT01390441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138888|NCT03142542|Udenafil|udenafil|mesh-list
92138889|NCT03142542|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92138890|NCT03142542|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92138891|NCT03142542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138892|NCT03142542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138893|NCT03025867|Niraparib|niraparib|mesh-list
92138894|NCT03025867|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92138895|NCT03025867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138896|NCT03025867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138897|NCT03025867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138898|NCT01412879|Leucovorin|leucovorin|mesh-list
92138899|NCT01412879|Cytarabine|cytarabine|mesh-list
92138900|NCT01412879|Dexamethasone|dexamethasone|mesh-list
92138901|NCT01412879|Cyclophosphamide|cyclophosphamide|mesh-list
92138902|NCT01412879|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92138903|NCT01412879|Rituximab|rituximab|mesh-list
92138904|NCT01412879|Doxorubicin|doxorubicin|mesh-list
92138905|NCT01412879|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92138906|NCT01412879|Methotrexate|methotrexate|mesh-list
92138907|NCT01412879|Vincristine|vincristine|mesh-list
92138908|NCT01412879|Levoleucovorin|levoleucovorin|mesh-list
92138909|NCT01412879|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92138910|NCT01412879|Immunologic Factors|immunologic factors|mesh-ancestor
92138911|NCT01412879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138912|NCT01412879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92138913|NCT01412879|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92138914|NCT01412879|Alkylating Agents|alkylating agents|mesh-ancestor
92138915|NCT01412879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138916|NCT01412879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92138917|NCT01412879|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92138918|NCT01412879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92138919|NCT01412879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92138920|NCT01412879|Antiemetics|antiemetics|mesh-ancestor
92138921|NCT01412879|Autonomic Agents|autonomic agents|mesh-ancestor
92138922|NCT01412879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138923|NCT01412879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92138924|NCT01412879|Glucocorticoids|glucocorticoids|mesh-ancestor
92138925|NCT01412879|Hormones|hormones|mesh-ancestor
92138926|NCT01412879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138927|NCT01412879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92138928|NCT01412879|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92138929|NCT01412879|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92138930|NCT01412879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92138931|NCT01412879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138932|NCT01412879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92138933|NCT01412879|Abortifacient Agents|abortifacient agents|mesh-ancestor
92139009|NCT01430455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92138934|NCT01412879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92138935|NCT01412879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92138936|NCT01412879|Antimetabolites|antimetabolites|mesh-ancestor
92138937|NCT01412879|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138938|NCT01412879|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92138939|NCT01412879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92138940|NCT01412879|Antiviral Agents|antiviral agents|mesh-ancestor
92138941|NCT01412879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138942|NCT01412879|Antidotes|antidotes|mesh-ancestor
92138943|NCT01412879|Protective Agents|protective agents|mesh-ancestor
92138944|NCT01412879|Vitamin B Complex|vitamin b complex|mesh-ancestor
92138945|NCT01412879|Vitamins|vitamins|mesh-ancestor
92138946|NCT01412879|Micronutrients|micronutrients|mesh-ancestor
92138947|NCT01412879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92138948|NCT01412879|Tubulin Modulators|tubulin modulators|mesh-ancestor
92138949|NCT01412879|Antimitotic Agents|antimitotic agents|mesh-ancestor
92138950|NCT01412879|Mitosis Modulators|mitosis modulators|mesh-ancestor
92138951|NCT03143010|Dexmedetomidine|dexmedetomidine|mesh-list
92138952|NCT03143010|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92138953|NCT03143010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92138954|NCT03143010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138955|NCT03143010|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92138956|NCT03143010|Analgesics|analgesics|mesh-ancestor
92138957|NCT03143010|Sensory System Agents|sensory system agents|mesh-ancestor
92138958|NCT03143010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92138959|NCT03143010|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92138960|NCT03143010|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92138961|NCT03143010|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92138962|NCT03143010|Adrenergic Agents|adrenergic agents|mesh-ancestor
92138963|NCT03143010|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92138964|NCT03143010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138965|NCT03142776|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92138966|NCT03142776|Clarithromycin|clarithromycin|mesh-list
92138967|NCT03142776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138968|NCT03142776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92138969|NCT03142776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138970|NCT03142776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138971|NCT03142776|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92138972|NCT03142776|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92138974|NCT01430611|Immunologic Factors|immunologic factors|mesh-ancestor
92138975|NCT01430611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138976|NCT03140826|Meropenem|meropenem|mesh-list
92138977|NCT03140826|Tazobactam|tazobactam|mesh-list
92138978|NCT03140826|Piperacillin|piperacillin|mesh-list
92138979|NCT03140826|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92138980|NCT03140826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92138981|NCT03140826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92138982|NCT03140826|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92138983|NCT03140826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138984|NCT03140826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138985|NCT01389973|Ustekinumab|ustekinumab|mesh-list
92138986|NCT01389973|Dermatologic Agents|dermatologic agents|mesh-ancestor
92138987|NCT04529460|Antibodies|antibodies|mesh-list
92138988|NCT04529460|Immunologic Factors|immunologic factors|mesh-ancestor
92138989|NCT04529460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138990|NCT04032067|Finasteride|finasteride|mesh-list
92138991|NCT04032067|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92138992|NCT04032067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92138993|NCT04032067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92138994|NCT04032067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92138995|NCT04032067|Hormone Antagonists|hormone antagonists|mesh-ancestor
92138996|NCT04032067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92138997|NCT04032067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92138998|NCT04032067|Urological Agents|urological agents|mesh-ancestor
92138999|NCT00659295|Insulin Detemir|insulin detemir|mesh-list
92139000|NCT00659295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92139001|NCT00659295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139002|NCT01430455|Tranylcypromine|tranylcypromine|mesh-list
92139003|NCT01430455|Antidepressive Agents|antidepressive agents|mesh-ancestor
92139004|NCT01430455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139005|NCT01430455|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92139006|NCT01430455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139007|NCT01430455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139008|NCT01430455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92139010|NCT01430455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139011|NCT01430455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139012|NCT04051957|Isosorbide|isosorbide|mesh-list
92139013|NCT04051957|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92139014|NCT04051957|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92139015|NCT04051957|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92139016|NCT04051957|Diuretics|diuretics|mesh-ancestor
92139017|NCT04051957|Natriuretic Agents|natriuretic agents|mesh-ancestor
92139018|NCT04051957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139019|NCT04051957|Vasodilator Agents|vasodilator agents|mesh-ancestor
92139020|NCT04051957|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92139021|NCT04051957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139022|NCT05084196|Melatonin|melatonin|mesh-list
92139023|NCT05084196|Antioxidants|antioxidants|mesh-ancestor
92139024|NCT05084196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139025|NCT05084196|Protective Agents|protective agents|mesh-ancestor
92139026|NCT05084196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139027|NCT05084196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139028|NCT00591123|Leucovorin|leucovorin|mesh-list
92139029|NCT00591123|Fluorouracil|fluorouracil|mesh-list
92139030|NCT00591123|Oxaliplatin|oxaliplatin|mesh-list
92139031|NCT00591123|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92139033|NCT00591123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139034|NCT00591123|Antimetabolites|antimetabolites|mesh-ancestor
92139035|NCT00591123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139036|NCT00591123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92139037|NCT00591123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139038|NCT00591123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139039|NCT00591123|Immunologic Factors|immunologic factors|mesh-ancestor
92139040|NCT00591123|Antidotes|antidotes|mesh-ancestor
92139041|NCT00591123|Protective Agents|protective agents|mesh-ancestor
92139042|NCT00591123|Vitamin B Complex|vitamin b complex|mesh-ancestor
92139043|NCT00591123|Vitamins|vitamins|mesh-ancestor
92139044|NCT00591123|Micronutrients|micronutrients|mesh-ancestor
92139045|NCT00591123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92139046|NCT00591123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139047|NCT04149990|Valsartan|valsartan|mesh-list
92139048|NCT04149990|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92139049|NCT04149990|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92139050|NCT04149990|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92139051|NCT04149990|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92139052|NCT04149990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139053|NCT00591825|Cycloserine|cycloserine|mesh-list
92139054|NCT00591825|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92139055|NCT00591825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139056|NCT00591825|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92139057|NCT00591825|Antitubercular Agents|antitubercular agents|mesh-ancestor
92139058|NCT00591825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92139059|NCT00591825|Antimetabolites|antimetabolites|mesh-ancestor
92139060|NCT00591825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139061|NCT01429285|Hydromorphone|hydromorphone|mesh-list
92139062|NCT01429285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92139063|NCT01429285|Narcotics|narcotics|mesh-ancestor
92139064|NCT01429285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139065|NCT01429285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139066|NCT01429285|Analgesics|analgesics|mesh-ancestor
92139067|NCT01429285|Sensory System Agents|sensory system agents|mesh-ancestor
92139068|NCT01429285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139069|NCT00594945|Clonazepam|clonazepam|mesh-list
92139070|NCT00594945|Anticonvulsants|anticonvulsants|mesh-ancestor
92139071|NCT00594945|GABA Modulators|gaba modulators|mesh-ancestor
92139072|NCT00594945|GABA Agents|gaba agents|mesh-ancestor
92139073|NCT00594945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139074|NCT00594945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139075|NCT00594945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139076|NCT00595101|Latanoprost|latanoprost|mesh-list
92139077|NCT00595101|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92139078|NCT00595101|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92139079|NCT00660075|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92139080|NCT00660075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92139081|NCT00660075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139082|NCT00660075|Incretins|incretins|mesh-ancestor
92139083|NCT00660075|Hormones|hormones|mesh-ancestor
91939367|NCT00924833|Carvedilol|carvedilol|mesh-list
92139084|NCT00660075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139085|NCT00660075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92139086|NCT00660075|Protease Inhibitors|protease inhibitors|mesh-ancestor
92139087|NCT00660075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139088|NCT00660075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139089|NCT05174052|Dapagliflozin|dapagliflozin|mesh-list
92139090|NCT05174052|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92139091|NCT05174052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139092|NCT05174052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92139093|NCT05174052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139094|NCT01429051|Fentanyl|fentanyl|mesh-list
92139095|NCT01429051|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92139096|NCT01429051|Narcotics|narcotics|mesh-ancestor
92139097|NCT01429051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139098|NCT01429051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139099|NCT01429051|Analgesics|analgesics|mesh-ancestor
92139100|NCT01429051|Sensory System Agents|sensory system agents|mesh-ancestor
92139101|NCT01429051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139102|NCT01429051|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92139103|NCT01429051|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92139104|NCT01429051|Anesthetics, General|anesthetics, general|mesh-ancestor
92139105|NCT01429051|Anesthetics|anesthetics|mesh-ancestor
92139106|NCT03968562|Doxycycline|doxycycline|mesh-list
92139107|NCT03968562|Petrolatum|petrolatum|mesh-list
92139108|NCT03968562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92139109|NCT03968562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139110|NCT03968562|Antimalarials|antimalarials|mesh-ancestor
92139111|NCT03968562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92139112|NCT03968562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92139113|NCT03968562|Emollients|emollients|mesh-ancestor
92139114|NCT03968562|Dermatologic Agents|dermatologic agents|mesh-ancestor
92139115|NCT03425292|Bevacizumab|bevacizumab|mesh-list
92139116|NCT03425292|Nivolumab|nivolumab|mesh-list
92139117|NCT03425292|Ipilimumab|ipilimumab|mesh-list
92139118|NCT03425292|Temozolomide|temozolomide|mesh-list
92139119|NCT03425292|Lomustine|lomustine|mesh-list
92139120|NCT03425292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139121|NCT03425292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139122|NCT03425292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92139123|NCT03425292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92139124|NCT03425292|Growth Substances|growth substances|mesh-ancestor
92139125|NCT03425292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139126|NCT03425292|Growth Inhibitors|growth inhibitors|mesh-ancestor
92139127|NCT03425292|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92139128|NCT03425292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139129|NCT03425292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139130|NCT03425292|Alkylating Agents|alkylating agents|mesh-ancestor
92139132|NCT00596271|Immunologic Factors|immunologic factors|mesh-ancestor
92139133|NCT00596271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139134|NCT03139422|Tranexamic Acid|tranexamic acid|mesh-list
92139135|NCT03139422|Calcium Dobesilate|calcium dobesilate|mesh-list
92139136|NCT03139422|Calcium|calcium|mesh-list
92139137|NCT03139422|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92139138|NCT03139422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139140|NCT03139422|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92139141|NCT03139422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139142|NCT03139422|Hemostatics|hemostatics|mesh-ancestor
92139143|NCT03139422|Coagulants|coagulants|mesh-ancestor
92139144|NCT01428583|Naltrexone|naltrexone|mesh-list
92139145|NCT01428583|Oxycodone|oxycodone|mesh-list
92139146|NCT01428583|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92139147|NCT01428583|Narcotics|narcotics|mesh-ancestor
92139148|NCT01428583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139149|NCT01428583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139150|NCT01428583|Analgesics|analgesics|mesh-ancestor
92139151|NCT01428583|Sensory System Agents|sensory system agents|mesh-ancestor
92139152|NCT01428583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139153|NCT01428583|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92139154|NCT01428583|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92139155|NCT00660543|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92139156|NCT00660543|Hematinics|hematinics|mesh-ancestor
92139157|NCT00660543|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92139158|NCT00660543|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92139159|NCT01428193|Flutamide|flutamide|mesh-list
92139160|NCT01428193|Estradiol|estradiol|mesh-list
92139161|NCT01428193|Progesterone|progesterone|mesh-list
92139162|NCT01428193|Estrogens|estrogens|mesh-ancestor
92139163|NCT01428193|Hormones|hormones|mesh-ancestor
92139164|NCT01428193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139165|NCT01428193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139166|NCT01428193|Progestins|progestins|mesh-ancestor
92139167|NCT01428193|Androgen Antagonists|androgen antagonists|mesh-ancestor
92139168|NCT01428193|Hormone Antagonists|hormone antagonists|mesh-ancestor
92139169|NCT01428193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92139170|NCT01428193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139171|NCT03864276|Propofol|propofol|mesh-list
92139172|NCT03864276|Desflurane|desflurane|mesh-list
92139173|NCT03864276|Anesthetics|anesthetics|mesh-ancestor
92139174|NCT03864276|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139175|NCT03864276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139176|NCT03864276|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92139177|NCT03864276|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92139178|NCT03864276|Anesthetics, General|anesthetics, general|mesh-ancestor
92139179|NCT03864276|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92139180|NCT05083026|Antibodies|antibodies|mesh-list
92139181|NCT05083026|Antibodies, Blocking|antibodies, blocking|mesh-list
92139182|NCT05083026|Immunologic Factors|immunologic factors|mesh-ancestor
92139183|NCT05083026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139184|NCT03141918|Curcumin|curcumin|mesh-list
92139185|NCT03141918|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92139186|NCT03141918|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92139187|NCT03141918|Analgesics|analgesics|mesh-ancestor
92139188|NCT03141918|Sensory System Agents|sensory system agents|mesh-ancestor
92139189|NCT03141918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139190|NCT03141918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139191|NCT03141918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92139192|NCT03141918|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139193|NCT03141918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139194|NCT03141918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139195|NCT03141918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139196|NCT01427803|Naproxen|naproxen|mesh-list
92139197|NCT01427803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92139198|NCT01427803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92139199|NCT01427803|Analgesics|analgesics|mesh-ancestor
92139200|NCT01427803|Sensory System Agents|sensory system agents|mesh-ancestor
92139201|NCT01427803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139202|NCT01427803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139203|NCT01427803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92139204|NCT01427803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139205|NCT01427803|Gout Suppressants|gout suppressants|mesh-ancestor
92139206|NCT01427803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92139207|NCT01427803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139208|NCT01427803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139209|NCT03139500|Midazolam|midazolam|mesh-list
92139210|NCT03139500|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92139211|NCT03139500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92139212|NCT03139500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139213|NCT03139500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139214|NCT03139500|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92139215|NCT03139500|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92139216|NCT03139500|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139217|NCT03139500|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92139218|NCT03139500|Anesthetics, General|anesthetics, general|mesh-ancestor
92139220|NCT03139500|GABA Modulators|gaba modulators|mesh-ancestor
92139221|NCT03139500|GABA Agents|gaba agents|mesh-ancestor
92139222|NCT03139500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139223|NCT03139500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139224|NCT00661479|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92139225|NCT00661479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92139226|NCT00661479|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92139227|NCT00661479|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92139228|NCT00661479|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92139229|NCT00661479|Adrenergic Agents|adrenergic agents|mesh-ancestor
92139230|NCT00661479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139231|NCT00661479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139232|NCT00661479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139234|NCT04476966|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92139235|NCT04476966|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92139236|NCT04476966|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92139237|NCT04476966|Adrenergic Agents|adrenergic agents|mesh-ancestor
92139238|NCT04476966|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139239|NCT04476966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139240|NCT04476966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139246|NCT03821610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139247|NCT03821610|Immunologic Factors|immunologic factors|mesh-ancestor
92139248|NCT03821610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139249|NCT03821610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139250|NCT03821610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139251|NCT03821610|Alkylating Agents|alkylating agents|mesh-ancestor
92139252|NCT03821610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139253|NCT03821610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139254|NCT03821610|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92139255|NCT03821610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139256|NCT00683163|Ibandronic Acid|ibandronic acid|mesh-list
92139257|NCT00683163|Parathyroid Hormone|parathyroid hormone|mesh-list
92139258|NCT00683163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92139259|NCT00683163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139260|NCT00683163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92139261|NCT04044001|Isoniazid|isoniazid|mesh-list
92139262|NCT04044001|Pyrazinamide|pyrazinamide|mesh-list
92139263|NCT04044001|Ethambutol|ethambutol|mesh-list
92139264|NCT04044001|Dolutegravir|dolutegravir|mesh-list
92139265|NCT04044001|Antitubercular Agents|antitubercular agents|mesh-ancestor
92139266|NCT04044001|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92139267|NCT04044001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139268|NCT04044001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139269|NCT04044001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139270|NCT04044001|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92139271|NCT04044001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92139272|NCT04044001|Antimetabolites|antimetabolites|mesh-ancestor
92139273|NCT04044001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92139274|NCT04044001|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92139275|NCT04044001|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92139276|NCT04044001|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92139277|NCT04044001|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92139278|NCT04044001|Antiviral Agents|antiviral agents|mesh-ancestor
92139280|NCT00684723|L 647318|l 647318|mesh-list
92139281|NCT00684723|Dihydromevinolin|dihydromevinolin|mesh-list
92139282|NCT00684723|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92139283|NCT00684723|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92139284|NCT00684723|Antimetabolites|antimetabolites|mesh-ancestor
92139285|NCT00684723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139286|NCT00684723|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92139287|NCT00684723|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92139288|NCT00684723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139289|NCT01405027|Interferons|interferons|mesh-list
92139290|NCT01405027|Ribavirin|ribavirin|mesh-list
92139291|NCT01405027|Interferon-alpha|interferon-alpha|mesh-list
92139292|NCT01405027|Interferon alpha-2|interferon alpha-2|mesh-list
92139293|NCT01405027|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92139294|NCT01405027|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92139295|NCT01405027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139296|NCT01405027|Antiviral Agents|antiviral agents|mesh-ancestor
92139297|NCT01405027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139298|NCT01405027|Antimetabolites|antimetabolites|mesh-ancestor
92139299|NCT01405027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139300|NCT01405027|Immunologic Factors|immunologic factors|mesh-ancestor
92139301|NCT01405027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139302|NCT00663039|Oxytocin|oxytocin|mesh-list
92139303|NCT00663039|Oxytocics|oxytocics|mesh-ancestor
92139304|NCT00663039|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92139305|NCT00663039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139306|NCT04387539|Sofosbuvir|sofosbuvir|mesh-list
92139307|NCT04387539|Simeprevir|simeprevir|mesh-list
92139308|NCT04387539|Antiviral Agents|antiviral agents|mesh-ancestor
92139309|NCT04387539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139311|NCT04387539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139312|NCT04387539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139313|NCT00664755|Nicotine|nicotine|mesh-list
92139314|NCT00664755|Varenicline|varenicline|mesh-list
92139315|NCT00664755|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92139316|NCT00664755|Autonomic Agents|autonomic agents|mesh-ancestor
92139317|NCT00664755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139318|NCT00664755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139319|NCT00664755|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92139320|NCT00664755|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92139321|NCT00664755|Cholinergic Agents|cholinergic agents|mesh-ancestor
92139322|NCT00664755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139323|NCT00664755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139324|NCT01525628|Tolbutamide|tolbutamide|mesh-list
92139330|NCT01525628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139331|NCT01525628|Antiviral Agents|antiviral agents|mesh-ancestor
92139332|NCT01525628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139333|NCT01525628|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92139334|NCT01525628|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92139335|NCT01525628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139336|NCT01525628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139337|NCT01525628|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92139338|NCT01525628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92139339|NCT01525628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139340|NCT01525628|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92139341|NCT01525628|Anesthetics, General|anesthetics, general|mesh-ancestor
92139343|NCT01525628|GABA Modulators|gaba modulators|mesh-ancestor
92139344|NCT01525628|GABA Agents|gaba agents|mesh-ancestor
92139346|NCT01525628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139347|NCT01525628|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92139348|NCT01525628|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92139349|NCT01525628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139350|NCT01525628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92139351|NCT01525628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92139352|NCT01525628|Antimetabolites|antimetabolites|mesh-ancestor
92139353|NCT01525628|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92139354|NCT01525628|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92139355|NCT01525628|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92139356|NCT01525628|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92139357|NCT01525628|Purinergic Agents|purinergic agents|mesh-ancestor
92139358|NCT01525628|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92139359|NCT00665457|Celecoxib|celecoxib|mesh-list
92139360|NCT00665457|Cyclophosphamide|cyclophosphamide|mesh-list
92139361|NCT00665457|Docetaxel|docetaxel|mesh-list
92139362|NCT00665457|Doxorubicin|doxorubicin|mesh-list
92139363|NCT00665457|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92139364|NCT00665457|Capecitabine|capecitabine|mesh-list
92139365|NCT00665457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139366|NCT00665457|Immunologic Factors|immunologic factors|mesh-ancestor
92139367|NCT00665457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139368|NCT00665457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139369|NCT00665457|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139370|NCT00665457|Alkylating Agents|alkylating agents|mesh-ancestor
92139371|NCT00665457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139372|NCT00665457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139373|NCT00665457|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92139374|NCT00665457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92139375|NCT00665457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92139376|NCT00665457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92139377|NCT00665457|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92139378|NCT00665457|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92139379|NCT00665457|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92139380|NCT00665457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139381|NCT00665457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92139383|NCT00665457|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92139384|NCT00665457|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92139385|NCT00665457|Analgesics|analgesics|mesh-ancestor
92139386|NCT00665457|Sensory System Agents|sensory system agents|mesh-ancestor
92139387|NCT00665457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139388|NCT00665457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92139389|NCT00665457|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92139390|NCT00665457|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92139391|NCT02320695|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92139392|NCT02320695|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
92139393|NCT02320695|Bacitracin|bacitracin|mesh-list
92139394|NCT02320695|Neomycin|neomycin|mesh-list
92139395|NCT02320695|Polymyxin B|polymyxin b|mesh-list
92139396|NCT02320695|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92139397|NCT02320695|Ethanol|ethanol|mesh-list
92139398|NCT02320695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139399|NCT02320695|Antitubercular Agents|antitubercular agents|mesh-ancestor
92139400|NCT02320695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92139401|NCT02320695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139402|NCT02320695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139403|NCT02320695|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92139404|NCT02320695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139405|NCT02320695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139406|NCT01426009|Bromides|bromides|mesh-list
92139407|NCT01426009|Tiotropium Bromide|tiotropium bromide|mesh-list
92139409|NCT01426009|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92139410|NCT01426009|Autonomic Agents|autonomic agents|mesh-ancestor
92139411|NCT01426009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139412|NCT01426009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139413|NCT01426009|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92139414|NCT01426009|Respiratory System Agents|respiratory system agents|mesh-ancestor
92139416|NCT01426009|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92139417|NCT01426009|Cholinergic Agents|cholinergic agents|mesh-ancestor
92139418|NCT01426009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139419|NCT01426009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139420|NCT01426009|Anticonvulsants|anticonvulsants|mesh-ancestor
92139421|NCT01543958|Sevelamer|sevelamer|mesh-list
92139422|NCT01543958|Chelating Agents|chelating agents|mesh-ancestor
92139423|NCT01543958|Sequestering Agents|sequestering agents|mesh-ancestor
92139424|NCT01543958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139425|NCT04880928|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92139426|NCT04880928|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92139427|NCT01411085|Risperidone|risperidone|mesh-list
92139428|NCT01411085|Desipramine|desipramine|mesh-list
92139429|NCT01411085|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92139430|NCT01411085|Serotonin Agents|serotonin agents|mesh-ancestor
92139431|NCT01411085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139432|NCT01411085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139433|NCT01411085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139434|NCT01411085|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92139435|NCT01411085|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92139436|NCT01411085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139437|NCT01411085|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139438|NCT01411085|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92139439|NCT01411085|Dopamine Agents|dopamine agents|mesh-ancestor
92139440|NCT01411085|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92139441|NCT01411085|Antidepressive Agents|antidepressive agents|mesh-ancestor
92139442|NCT01411085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139443|NCT01411085|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92139444|NCT01411085|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92139445|NCT01411085|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92139446|NCT01411085|Adrenergic Agents|adrenergic agents|mesh-ancestor
92139447|NCT01404949|Arsenic Trioxide|arsenic trioxide|mesh-list
92139448|NCT01404949|Tretinoin|tretinoin|mesh-list
92139449|NCT01404949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139450|NCT01404949|Keratolytic Agents|keratolytic agents|mesh-ancestor
92139451|NCT01404949|Dermatologic Agents|dermatologic agents|mesh-ancestor
92139452|NCT01431521|Pioglitazone|pioglitazone|mesh-list
92139453|NCT01431521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92139454|NCT01431521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139455|NCT00601965|Escitalopram|escitalopram|mesh-list
92139456|NCT00601965|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92139457|NCT00601965|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91939381|NCT00924833|Vasodilator Agents|vasodilator agents|mesh-ancestor
92139458|NCT00601965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92139459|NCT00601965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139460|NCT00601965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139461|NCT00601965|Serotonin Agents|serotonin agents|mesh-ancestor
92139462|NCT00601965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139463|NCT04751994|Sorbitol|sorbitol|mesh-list
92139464|NCT04751994|Cathartics|cathartics|mesh-ancestor
92139465|NCT04751994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92139466|NCT00687453|Insulin Glargine|insulin glargine|mesh-list
92139467|NCT00687453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92139468|NCT00687453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139469|NCT00602043|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92139470|NCT00602043|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92139471|NCT00602043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139472|NCT02998437|Amoxicillin|amoxicillin|mesh-list
92139473|NCT02998437|Clarithromycin|clarithromycin|mesh-list
92139474|NCT02998437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92139475|NCT02998437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139476|NCT02998437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92139477|NCT02998437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139478|NCT02998437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139479|NCT02998437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92139480|NCT02998437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92139481|NCT02618148|Estrogens|estrogens|mesh-list
92139482|NCT02618148|Hormones|hormones|mesh-ancestor
92139559|NCT00705003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139483|NCT02618148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139484|NCT02618148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139485|NCT04680936|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92139487|NCT01404325|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92139488|NCT01404325|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92139490|NCT01404325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139491|NCT01404325|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139492|NCT01404325|Immunologic Factors|immunologic factors|mesh-ancestor
92139493|NCT01404325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139494|NCT01404325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139495|NCT00602355|Sertraline|sertraline|mesh-list
92139496|NCT00602355|Antidepressive Agents|antidepressive agents|mesh-ancestor
92139497|NCT00602355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139498|NCT00602355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92139499|NCT00602355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92139500|NCT00602355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92139501|NCT00602355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139502|NCT00602355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139503|NCT00602355|Serotonin Agents|serotonin agents|mesh-ancestor
92139504|NCT00602355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139505|NCT01425463|Glycine|glycine|mesh-list
92139506|NCT01425463|Glycine Agents|glycine agents|mesh-ancestor
92139507|NCT01425463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139508|NCT01425463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139509|NCT01425463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139510|NCT02144259|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92139511|NCT02144259|Medroxyprogesterone|medroxyprogesterone|mesh-list
92139512|NCT02144259|Etonogestrel|etonogestrel|mesh-list
92139513|NCT02144259|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92139514|NCT02144259|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92139515|NCT02144259|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92139516|NCT02144259|Contraceptive Agents|contraceptive agents|mesh-ancestor
92139517|NCT02144259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92139518|NCT02144259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139519|NCT02144259|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92139520|NCT02144259|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92139521|NCT02144259|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92139522|NCT02144259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92139523|NCT02144259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139524|NCT04655586|Heparin|heparin|mesh-list
92139525|NCT04655586|Protein C|protein c|mesh-list
92139526|NCT04655586|Anticoagulants|anticoagulants|mesh-list
92139527|NCT04655586|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92139528|NCT04655586|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92139529|NCT04655586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139530|NCT01388647|Carboplatin|carboplatin|mesh-list
92139531|NCT01388647|Trastuzumab|trastuzumab|mesh-list
92139532|NCT01388647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139533|NCT01388647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139535|NCT03140982|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92139536|NCT03140982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139537|NCT03140982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139538|NCT03140982|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92139539|NCT03140982|Anesthetics, General|anesthetics, general|mesh-ancestor
92139540|NCT03140982|Anesthetics|anesthetics|mesh-ancestor
92139541|NCT05392686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92139542|NCT05392686|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92139543|NCT05392686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139544|NCT05392686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139545|NCT05392686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139546|NCT05392686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139547|NCT00705003|Melatonin|melatonin|mesh-list
92139548|NCT00705003|Buspirone|buspirone|mesh-list
92139549|NCT00705003|Antioxidants|antioxidants|mesh-ancestor
92139550|NCT00705003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139551|NCT00705003|Protective Agents|protective agents|mesh-ancestor
92139552|NCT00705003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139553|NCT00705003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139554|NCT00705003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92139555|NCT00705003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92139556|NCT00705003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139557|NCT00705003|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92139558|NCT00705003|Serotonin Agents|serotonin agents|mesh-ancestor
92139562|NCT03110640|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139563|NCT03110640|Immunologic Factors|immunologic factors|mesh-ancestor
92139564|NCT03110640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139565|NCT03110640|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139566|NCT03110640|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139567|NCT03110640|Alkylating Agents|alkylating agents|mesh-ancestor
92139568|NCT03110640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139569|NCT03110640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139570|NCT03110640|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92139571|NCT00690495|Propofol|propofol|mesh-list
92139572|NCT00690495|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92139573|NCT00690495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139574|NCT00690495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139575|NCT00690495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92139576|NCT00690495|Anesthetics, General|anesthetics, general|mesh-ancestor
92139577|NCT00690495|Anesthetics|anesthetics|mesh-ancestor
92139578|NCT00691197|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92139579|NCT00691197|Glycerol|glycerol|mesh-list
92139580|NCT00691197|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92139581|NCT00691197|Protective Agents|protective agents|mesh-ancestor
92139582|NCT00691197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139583|NCT00691197|Laxatives|laxatives|mesh-ancestor
92139584|NCT00691197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92139585|NCT02997969|Vaccines|vaccines|mesh-list
92139586|NCT02997969|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92139587|NCT02997969|Immunologic Factors|immunologic factors|mesh-ancestor
92139588|NCT02997969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139589|NCT02997969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92139590|NCT04351230|Trastuzumab|trastuzumab|mesh-list
92139591|NCT04351230|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92139593|NCT04351230|Immunoconjugates|immunoconjugates|mesh-list
92139594|NCT04351230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139595|NCT04351230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139596|NCT04351230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92139597|NCT04351230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92139598|NCT04351230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92139599|NCT04351230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92139600|NCT04351230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139601|NCT04351230|Immunotoxins|immunotoxins|mesh-ancestor
92139602|NCT04351230|Immunologic Factors|immunologic factors|mesh-ancestor
92139603|NCT04351230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139604|NCT05392374|TIC10 compound|tic10 compound|mesh-list
92139605|NCT05392374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139606|NCT04028388|Docetaxel|docetaxel|mesh-list
92139607|NCT04028388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139608|NCT04028388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92139609|NCT04028388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92139610|NCT04028388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92139611|NCT04028388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139612|NCT01402063|Temozolomide|temozolomide|mesh-list
92139613|NCT01402063|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
92139614|NCT01402063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139615|NCT01402063|Alkylating Agents|alkylating agents|mesh-ancestor
92139616|NCT01402063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139617|NCT01402063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139618|NCT01796301|Teriparatide|teriparatide|mesh-list
92139619|NCT01796301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92139620|NCT01796301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139621|NCT01796301|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92139622|NCT00868179|Dabigatran|dabigatran|mesh-list
92139623|NCT00868179|Antithrombins|antithrombins|mesh-ancestor
92139624|NCT00868179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92139625|NCT00868179|Protease Inhibitors|protease inhibitors|mesh-ancestor
92139626|NCT00868179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139627|NCT00868179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139628|NCT00868179|Anticoagulants|anticoagulants|mesh-ancestor
92139629|NCT01204905|Raltegravir Potassium|raltegravir potassium|mesh-list
92139630|NCT01204905|Maraviroc|maraviroc|mesh-list
92139631|NCT01204905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92139632|NCT01204905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92139633|NCT01204905|Antiviral Agents|antiviral agents|mesh-ancestor
92139634|NCT01204905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139635|NCT01204905|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92139636|NCT01204905|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92139637|NCT01204905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139638|NCT01204905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139639|NCT01204905|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92139640|NCT01204905|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92139641|NCT01204905|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92139642|NCT00691665|Fluticasone|fluticasone|mesh-list
92139644|NCT00691665|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92139645|NCT00691665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92139646|NCT00691665|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92139647|NCT00691665|Autonomic Agents|autonomic agents|mesh-ancestor
92139648|NCT00691665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139649|NCT00691665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139650|NCT00691665|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92139651|NCT00691665|Respiratory System Agents|respiratory system agents|mesh-ancestor
92139652|NCT00691665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92139653|NCT00691665|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92139654|NCT00691665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92139655|NCT00691665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92139656|NCT00691665|Analgesics|analgesics|mesh-ancestor
92139657|NCT00691665|Sensory System Agents|sensory system agents|mesh-ancestor
92139658|NCT00691665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139659|NCT00691665|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92139660|NCT00691665|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92139661|NCT00691665|Histamine Antagonists|histamine antagonists|mesh-ancestor
92139662|NCT00691665|Histamine Agents|histamine agents|mesh-ancestor
92139663|NCT00691665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139664|NCT00691665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139665|NCT01388335|Warfarin|warfarin|mesh-list
92139666|NCT01388335|Anticoagulants|anticoagulants|mesh-ancestor
92139667|NCT00713583|Levodopa|levodopa|mesh-list
92139668|NCT00713583|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92139669|NCT00713583|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92139670|NCT00713583|Dopamine Agents|dopamine agents|mesh-ancestor
92139671|NCT00713583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139672|NCT00713583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139673|NCT00713583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139674|NCT03359460|Lenalidomide|lenalidomide|mesh-list
92139675|NCT03359460|Immunologic Factors|immunologic factors|mesh-ancestor
92139676|NCT03359460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139677|NCT03359460|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92139679|NCT03359460|Growth Substances|growth substances|mesh-ancestor
92139680|NCT03359460|Growth Inhibitors|growth inhibitors|mesh-ancestor
92139681|NCT03359460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139682|NCT03025477|Paclitaxel|paclitaxel|mesh-list
92139683|NCT03025477|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92139684|NCT03025477|Cisplatin|cisplatin|mesh-list
92139685|NCT03025477|Carboplatin|carboplatin|mesh-list
92139686|NCT03025477|Epirubicin|epirubicin|mesh-list
92139687|NCT03025477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92139688|NCT03025477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139689|NCT03025477|Tubulin Modulators|tubulin modulators|mesh-ancestor
92139690|NCT03025477|Antimitotic Agents|antimitotic agents|mesh-ancestor
92139691|NCT03025477|Mitosis Modulators|mitosis modulators|mesh-ancestor
92139692|NCT03025477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139693|NCT03025477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92139694|NCT03025477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92139695|NCT03025477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92139696|NCT03025477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139697|NCT03147378|Docetaxel|docetaxel|mesh-list
92139698|NCT03147378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139699|NCT03147378|Tubulin Modulators|tubulin modulators|mesh-ancestor
92139700|NCT03147378|Antimitotic Agents|antimitotic agents|mesh-ancestor
92139701|NCT03147378|Mitosis Modulators|mitosis modulators|mesh-ancestor
92139702|NCT03147378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139703|NCT00159744|Olanzapine|olanzapine|mesh-list
92139704|NCT00159744|Asenapine|asenapine|mesh-list
92139705|NCT00159744|Antiemetics|antiemetics|mesh-ancestor
92139706|NCT00159744|Autonomic Agents|autonomic agents|mesh-ancestor
92139707|NCT00159744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139708|NCT00159744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139709|NCT00159744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92139710|NCT00159744|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92139711|NCT00159744|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92139712|NCT00159744|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139713|NCT00159744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139714|NCT00159744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92139715|NCT00159744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92139716|NCT00159744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92139717|NCT00159744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139718|NCT00159744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139719|NCT00159744|Serotonin Agents|serotonin agents|mesh-ancestor
92139720|NCT04041973|Lumefantrine|lumefantrine|mesh-list
92139722|NCT04041973|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92139723|NCT04041973|Antimalarials|antimalarials|mesh-ancestor
92139724|NCT04041973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92139725|NCT04041973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92139726|NCT04041973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139727|NCT02914470|Atezolizumab|atezolizumab|mesh-list
92139728|NCT02914470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92139729|NCT02914470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139730|NCT02914470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139731|NCT02914470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139732|NCT05088330|Daratumumab|daratumumab|mesh-list
92139733|NCT05088330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139734|NCT00695097|Rituximab|rituximab|mesh-list
92139735|NCT00695097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139736|NCT00695097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139737|NCT00695097|Immunologic Factors|immunologic factors|mesh-ancestor
92139738|NCT00695097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139739|NCT00695097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139740|NCT01795911|Interferons|interferons|mesh-list
92139741|NCT01795911|Ribavirin|ribavirin|mesh-list
92139742|NCT01795911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139744|NCT01795911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139745|NCT01795911|Antimetabolites|antimetabolites|mesh-ancestor
92139746|NCT01795911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139747|NCT03137316|Hormones|hormones|mesh-list
92139748|NCT03137316|Parathyroid Hormone|parathyroid hormone|mesh-list
92139749|NCT03137316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139750|NCT03137316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139751|NCT03137316|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92139752|NCT03137082|Guanfacine|guanfacine|mesh-list
92139753|NCT03137082|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92139754|NCT03137082|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92139755|NCT03137082|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92139756|NCT03137082|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92139757|NCT03137082|Adrenergic Agents|adrenergic agents|mesh-ancestor
92139758|NCT03137082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139759|NCT03137082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139760|NCT03137082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139761|NCT05088174|Cyclosporine|cyclosporine|mesh-list
92139762|NCT05088174|Cyclosporins|cyclosporins|mesh-list
92139763|NCT05088174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139764|NCT05088174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139765|NCT05088174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139766|NCT05088174|Immunologic Factors|immunologic factors|mesh-ancestor
92139767|NCT05088174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139768|NCT05088174|Antifungal Agents|antifungal agents|mesh-ancestor
92139769|NCT05088174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139770|NCT05088174|Dermatologic Agents|dermatologic agents|mesh-ancestor
92139771|NCT05088174|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139772|NCT05088174|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92139773|NCT03041688|Decitabine|decitabine|mesh-list
92139774|NCT03041688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92139775|NCT03041688|Antimetabolites|antimetabolites|mesh-ancestor
92139776|NCT03041688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139777|NCT03041688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139778|NCT03041688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139779|NCT00695409|Cytarabine|cytarabine|mesh-list
92139780|NCT00695409|Rituximab|rituximab|mesh-list
92139781|NCT00695409|Etoposide|etoposide|mesh-list
92139782|NCT00695409|Etoposide phosphate|etoposide phosphate|mesh-list
92139783|NCT00695409|Melphalan|melphalan|mesh-list
92139784|NCT00695409|Carmustine|carmustine|mesh-list
92139785|NCT00695409|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92139786|NCT00695409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139787|NCT00695409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139788|NCT00695409|Immunologic Factors|immunologic factors|mesh-ancestor
92139789|NCT00695409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139790|NCT00695409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139791|NCT00695409|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92139792|NCT00695409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92139793|NCT00695409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92139795|NCT00695409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139796|NCT00695409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92139798|NCT00695409|Antiviral Agents|antiviral agents|mesh-ancestor
92139799|NCT00695409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139800|NCT00695409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139801|NCT00695409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92139802|NCT00695409|Alkylating Agents|alkylating agents|mesh-ancestor
92139803|NCT00695409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92139805|NCT03469050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92139806|NCT03469050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139807|NCT03469050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92139808|NCT05087706|Bicalutamide|bicalutamide|mesh-list
92139809|NCT05087706|Leuprolide|leuprolide|mesh-list
92139810|NCT05087706|Androgen Antagonists|androgen antagonists|mesh-ancestor
92139811|NCT05087706|Hormone Antagonists|hormone antagonists|mesh-ancestor
92139812|NCT05087706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139813|NCT05087706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139814|NCT05087706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139815|NCT05087706|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92139816|NCT05087706|Fertility Agents|fertility agents|mesh-ancestor
92139817|NCT05087706|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92139818|NCT05087706|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92139819|NCT02990403|Aspirin|aspirin|mesh-list
92139820|NCT02990403|Prednisone|prednisone|mesh-list
92139821|NCT02990403|Heparin|heparin|mesh-list
92139822|NCT02990403|Dydrogesterone|dydrogesterone|mesh-list
92139823|NCT02990403|Immunoglobulins|immunoglobulins|mesh-list
92139824|NCT02990403|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92139825|NCT02990403|Antibodies|antibodies|mesh-list
92139826|NCT02990403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92139827|NCT02990403|Glucocorticoids|glucocorticoids|mesh-ancestor
92139828|NCT02990403|Hormones|hormones|mesh-ancestor
92139829|NCT02990403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139830|NCT02990403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139831|NCT02990403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92139832|NCT02990403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139833|NCT02990403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92139834|NCT02990403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92139835|NCT02990403|Analgesics|analgesics|mesh-ancestor
92139836|NCT02990403|Sensory System Agents|sensory system agents|mesh-ancestor
92139837|NCT02990403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139838|NCT02990403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92139839|NCT02990403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92139840|NCT02990403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92139841|NCT02990403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139842|NCT02990403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92139843|NCT02990403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92139844|NCT02990403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139845|NCT02990403|Antipyretics|antipyretics|mesh-ancestor
92139846|NCT02990403|Anticoagulants|anticoagulants|mesh-ancestor
92139847|NCT02990403|Immunologic Factors|immunologic factors|mesh-ancestor
92139848|NCT02990403|Progestins|progestins|mesh-ancestor
92139849|NCT00697203|Pravastatin|pravastatin|mesh-list
92139850|NCT00697203|Dalcetrapib|dalcetrapib|mesh-list
92139851|NCT00697203|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92139852|NCT00697203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92139853|NCT00697203|Antimetabolites|antimetabolites|mesh-ancestor
92139854|NCT00697203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139855|NCT00697203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92139856|NCT00697203|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92139857|NCT00697203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139859|NCT05086848|Fluorouracil|fluorouracil|mesh-list
92139860|NCT05086848|Irinotecan|irinotecan|mesh-list
92139861|NCT05086848|Antimetabolites|antimetabolites|mesh-ancestor
92139862|NCT05086848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139863|NCT05086848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92139864|NCT05086848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139865|NCT05086848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139866|NCT05086848|Immunologic Factors|immunologic factors|mesh-ancestor
92139867|NCT05086848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139869|NCT05086848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92139870|NCT05086848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139871|NCT05086848|Antidotes|antidotes|mesh-ancestor
92139872|NCT05086848|Protective Agents|protective agents|mesh-ancestor
92139873|NCT05086848|Vitamin B Complex|vitamin b complex|mesh-ancestor
92139874|NCT05086848|Vitamins|vitamins|mesh-ancestor
92139878|NCT00830895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92139879|NCT00830895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139880|NCT00830895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139881|NCT00830895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92139882|NCT00830895|Immunologic Factors|immunologic factors|mesh-ancestor
92139883|NCT00830895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139884|NCT00830895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139885|NCT01158417|Resveratrol|resveratrol|mesh-list
92139886|NCT01158417|Antioxidants|antioxidants|mesh-ancestor
92139887|NCT01158417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139888|NCT01158417|Protective Agents|protective agents|mesh-ancestor
92139889|NCT01158417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139890|NCT01158417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139891|NCT01158417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92139892|NCT05086614|Thymalfasin|thymalfasin|mesh-list
92139893|NCT05086614|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92139894|NCT05086614|Immunologic Factors|immunologic factors|mesh-ancestor
92139895|NCT05086614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139896|NCT01795131|Vitamin B 12|vitamin b 12|mesh-list
92139897|NCT01795131|Hydroxocobalamin|hydroxocobalamin|mesh-list
92139899|NCT01795131|Micronutrients|micronutrients|mesh-ancestor
92139900|NCT01795131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139901|NCT01795131|Vitamin B Complex|vitamin b complex|mesh-ancestor
92139902|NCT01795131|Hematinics|hematinics|mesh-ancestor
92139903|NCT03137004|Docetaxel|docetaxel|mesh-list
92139904|NCT03137004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139906|NCT03137004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92139907|NCT03137004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92139908|NCT03137004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139909|NCT03113994|Calcium, Dietary|calcium, dietary|mesh-list
92139910|NCT03113994|Vitamin D|vitamin d|mesh-list
92139911|NCT03113994|Coenzyme Q10|coenzyme q10|mesh-list
92139912|NCT03113994|Ubiquinone|ubiquinone|mesh-list
92139913|NCT03113994|Calcium Carbonate|calcium carbonate|mesh-list
92139914|NCT03113994|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92139915|NCT03113994|Calcium|calcium|mesh-list
92139916|NCT03113994|Vitamins|vitamins|mesh-ancestor
92139917|NCT03113994|Micronutrients|micronutrients|mesh-ancestor
92139918|NCT03113994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139919|NCT03113994|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92139920|NCT03113994|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92139921|NCT03113994|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92139922|NCT03113994|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92139923|NCT03113994|Antimetabolites|antimetabolites|mesh-ancestor
92139924|NCT03113994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139925|NCT03113994|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92139926|NCT03113994|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92139927|NCT03113994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139928|NCT03113994|Antacids|antacids|mesh-ancestor
92139929|NCT03113994|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92139930|NCT02003742|Tamsulosin|tamsulosin|mesh-list
92139931|NCT02003742|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92139932|NCT02003742|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92139933|NCT02003742|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92139935|NCT02003742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139936|NCT02003742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139937|NCT02003742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139938|NCT02003742|Urological Agents|urological agents|mesh-ancestor
92139939|NCT03134118|Nivolumab|nivolumab|mesh-list
92139940|NCT03134118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139941|NCT03134118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139942|NCT03134118|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92139943|NCT03134118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139944|NCT05085912|Ethanol|ethanol|mesh-list
92139945|NCT05085912|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92139946|NCT05085912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92139947|NCT05085912|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139948|NCT05085912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139949|NCT02339415|Edoxaban|edoxaban|mesh-list
92139950|NCT02339415|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92139951|NCT02339415|Antithrombins|antithrombins|mesh-ancestor
92139952|NCT02339415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92139953|NCT02339415|Protease Inhibitors|protease inhibitors|mesh-ancestor
92139954|NCT02339415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92139955|NCT02339415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139958|NCT02998047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92139959|NCT02998047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139960|NCT03110172|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92139961|NCT03110172|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92139962|NCT03110172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92139963|NCT03110172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92139964|NCT03110172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92139965|NCT03110172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92139966|NCT03110172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139967|NCT03110172|Analgesics|analgesics|mesh-ancestor
92139968|NCT03110172|Sensory System Agents|sensory system agents|mesh-ancestor
92139969|NCT03110172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139970|NCT03110172|Antidepressive Agents|antidepressive agents|mesh-ancestor
92139971|NCT03110172|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92139972|NCT03110172|Dopamine Agents|dopamine agents|mesh-ancestor
92139974|NCT01400503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92139975|NCT00706719|Enclomiphene|enclomiphene|mesh-list
92139976|NCT00706719|Clomiphene|clomiphene|mesh-list
92139977|NCT00706719|Zuclomiphene|zuclomiphene|mesh-list
92139978|NCT00706719|Testosterone|testosterone|mesh-list
92139979|NCT00706719|Androgens|androgens|mesh-ancestor
92139980|NCT00706719|Hormones|hormones|mesh-ancestor
92139981|NCT00706719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92139982|NCT00706719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139983|NCT00706719|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92139984|NCT00706719|Hormone Antagonists|hormone antagonists|mesh-ancestor
92139985|NCT00706719|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92139986|NCT00706719|Fertility Agents|fertility agents|mesh-ancestor
92139987|NCT00706719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92139988|NCT00706719|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92139989|NCT00706719|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92139990|NCT05079672|Dexmedetomidine|dexmedetomidine|mesh-list
92139991|NCT05079672|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92139992|NCT05079672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92139993|NCT05079672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92139994|NCT05079672|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92139995|NCT05079672|Analgesics|analgesics|mesh-ancestor
92139996|NCT05079672|Sensory System Agents|sensory system agents|mesh-ancestor
92139997|NCT05079672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92139998|NCT05079672|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92139999|NCT05079672|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92140000|NCT05079672|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92140001|NCT05079672|Adrenergic Agents|adrenergic agents|mesh-ancestor
92140002|NCT05079672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140003|NCT05079672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140004|NCT04766827|Paclitaxel|paclitaxel|mesh-list
92140005|NCT04766827|Docetaxel|docetaxel|mesh-list
92140006|NCT04766827|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92140007|NCT04766827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92140008|NCT04766827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140009|NCT04766827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92140010|NCT04766827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92140011|NCT04766827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92140012|NCT04766827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140013|NCT02960568|Primaquine|primaquine|mesh-list
92140014|NCT02960568|Antimalarials|antimalarials|mesh-ancestor
92140015|NCT02960568|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92140016|NCT02960568|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92140017|NCT02960568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140018|NCT02996409|Lidocaine|lidocaine|mesh-list
92140019|NCT02996409|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140020|NCT02996409|Anesthetics|anesthetics|mesh-ancestor
92140021|NCT02996409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140022|NCT02996409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140023|NCT02996409|Sensory System Agents|sensory system agents|mesh-ancestor
92140024|NCT02996409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140025|NCT02996409|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92140026|NCT02996409|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92140027|NCT02996409|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92140028|NCT02996409|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140029|NCT02996409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140030|NCT02864004|Apomorphine|apomorphine|mesh-list
92140031|NCT02864004|Emetics|emetics|mesh-ancestor
92140032|NCT02864004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140034|NCT02864004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140035|NCT02864004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140036|NCT02864004|Dopamine Agonists|dopamine agonists|mesh-ancestor
92140037|NCT02864004|Dopamine Agents|dopamine agents|mesh-ancestor
92140038|NCT02864004|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140039|NCT02864004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140040|NCT01421719|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92140041|NCT01421719|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92140042|NCT01421719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140043|NCT01421719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140044|NCT01421719|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92140045|NCT01421719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140046|NCT01421719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140047|NCT01421719|Cholinergic Agents|cholinergic agents|mesh-ancestor
92140048|NCT01421719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140049|NCT02721654|Plasma-lyte 148|plasma-lyte 148|mesh-list
92140050|NCT02721654|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92140051|NCT02721654|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92140053|NCT01421641|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140054|NCT01421641|Anesthetics|anesthetics|mesh-ancestor
92140055|NCT01421641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140056|NCT01421641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140057|NCT01421641|Sensory System Agents|sensory system agents|mesh-ancestor
92140058|NCT01421641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140059|NCT01421641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92140060|NCT01421641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92140061|NCT01421641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92140062|NCT01421641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140063|NCT01421641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140064|NCT05068206|Bevacizumab|bevacizumab|mesh-list
92140065|NCT05068206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140066|NCT05068206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140067|NCT05068206|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140068|NCT05068206|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140069|NCT05068206|Growth Substances|growth substances|mesh-ancestor
92140070|NCT05068206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140071|NCT05068206|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140072|NCT05063370|Simendan|simendan|mesh-list
92140073|NCT05063370|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92140074|NCT05063370|Vasodilator Agents|vasodilator agents|mesh-ancestor
92140075|NCT05063370|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92140076|NCT05063370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92140077|NCT05063370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140078|NCT05063370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140079|NCT05063370|Protective Agents|protective agents|mesh-ancestor
92140080|NCT05063370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140081|NCT01421017|Cyclophosphamide|cyclophosphamide|mesh-list
92140082|NCT01421017|Imiquimod|imiquimod|mesh-list
92140083|NCT01421017|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140084|NCT01421017|Immunologic Factors|immunologic factors|mesh-ancestor
92140085|NCT01421017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140086|NCT01421017|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140087|NCT01421017|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92140088|NCT01421017|Alkylating Agents|alkylating agents|mesh-ancestor
92140089|NCT01421017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140090|NCT01421017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140091|NCT01421017|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92140092|NCT01421017|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92140093|NCT01421017|Interferon Inducers|interferon inducers|mesh-ancestor
92140094|NCT04951050|Sirolimus|sirolimus|mesh-list
92140095|NCT04951050|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140096|NCT04951050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140097|NCT04951050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92140098|NCT04951050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140099|NCT04951050|Antifungal Agents|antifungal agents|mesh-ancestor
92140100|NCT04951050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140101|NCT04951050|Immunologic Factors|immunologic factors|mesh-ancestor
92140102|NCT04951050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140103|NCT05089344|Clomiphene|clomiphene|mesh-list
92140104|NCT05089344|Enclomiphene|enclomiphene|mesh-list
92140105|NCT05089344|Zuclomiphene|zuclomiphene|mesh-list
92140106|NCT05089344|Hormones|hormones|mesh-list
92140107|NCT05089344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140108|NCT05089344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140109|NCT05089344|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92140110|NCT05089344|Hormone Antagonists|hormone antagonists|mesh-ancestor
92140111|NCT05089344|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92140112|NCT05089344|Fertility Agents|fertility agents|mesh-ancestor
92140113|NCT05089344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92140114|NCT05089344|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92140115|NCT05089344|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92140116|NCT01400113|Asenapine|asenapine|mesh-list
92140117|NCT01400113|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92140123|NCT01399723|Penicillins|penicillins|mesh-list
92140124|NCT01399723|Penicillin G|penicillin g|mesh-list
92140125|NCT01399723|Penicillin G Benzathine|penicillin g benzathine|mesh-list
92140126|NCT01399723|Penicillin G Procaine|penicillin g procaine|mesh-list
92140127|NCT01399723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140128|NCT01399723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140129|NCT04771962|Sevoflurane|sevoflurane|mesh-list
92140131|NCT04771962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92140132|NCT04771962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92140133|NCT04771962|Anesthetics, General|anesthetics, general|mesh-ancestor
92140134|NCT04771962|Anesthetics|anesthetics|mesh-ancestor
92140135|NCT04771962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140136|NCT04771962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140137|NCT04726098|Dexamethasone|dexamethasone|mesh-list
92140138|NCT04726098|Dexamethasone acetate|dexamethasone acetate|mesh-list
92140139|NCT04726098|BB 1101|bb 1101|mesh-list
92140140|NCT04726098|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140141|NCT04726098|Antiemetics|antiemetics|mesh-ancestor
92140142|NCT04726098|Autonomic Agents|autonomic agents|mesh-ancestor
92140143|NCT04726098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140144|NCT04726098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140145|NCT04726098|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140146|NCT04726098|Glucocorticoids|glucocorticoids|mesh-ancestor
92140147|NCT04726098|Hormones|hormones|mesh-ancestor
92140148|NCT04726098|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140149|NCT04726098|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92140150|NCT04726098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140151|NCT04726098|Protease Inhibitors|protease inhibitors|mesh-ancestor
92140152|NCT04726098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140153|NCT04726098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140159|NCT05088720|Misoprostol|misoprostol|mesh-list
92140160|NCT05088720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92140161|NCT05088720|Abortifacient Agents|abortifacient agents|mesh-ancestor
92140162|NCT05088720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92140163|NCT05088720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140164|NCT05088720|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92140165|NCT05088720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140167|NCT01383499|Bromides|bromides|mesh-list
92140168|NCT01383499|Tiotropium Bromide|tiotropium bromide|mesh-list
92140169|NCT01383499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92140170|NCT01383499|Autonomic Agents|autonomic agents|mesh-ancestor
92140171|NCT01383499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140172|NCT01383499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140173|NCT01383499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92140174|NCT01383499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92140175|NCT01383499|Parasympatholytics|parasympatholytics|mesh-ancestor
92140176|NCT01383499|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92140177|NCT01383499|Cholinergic Agents|cholinergic agents|mesh-ancestor
92140178|NCT01383499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140179|NCT01383499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140180|NCT01383499|Anticonvulsants|anticonvulsants|mesh-ancestor
92140181|NCT05084118|Landiolol|landiolol|mesh-list
92140182|NCT05084118|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92140183|NCT05084118|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92140184|NCT05084118|Adrenergic Agents|adrenergic agents|mesh-ancestor
92140185|NCT05084118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140186|NCT05084118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140187|NCT05084118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140188|NCT05084118|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92140189|NCT03025009|Insulin|insulin|mesh-list
92140190|NCT03025009|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92140191|NCT03025009|Insulin Glargine|insulin glargine|mesh-list
92140192|NCT03025009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92140193|NCT03025009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140194|NCT03135912|Terbinafine|terbinafine|mesh-list
92140195|NCT03135912|Antifungal Agents|antifungal agents|mesh-ancestor
92140196|NCT03135912|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140197|NCT03135912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140198|NCT03135912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140199|NCT01397461|Retapamulin|retapamulin|mesh-list
92140200|NCT01397461|Ozenoxacin|ozenoxacin|mesh-list
92140201|NCT01397461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140202|NCT01397461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140203|NCT01397461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92140204|NCT01397461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140205|NCT01397461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140206|NCT01397461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140207|NCT04335084|Vitamin D|vitamin d|mesh-list
92140208|NCT04335084|Vitamins|vitamins|mesh-list
92140209|NCT04335084|Hydroxychloroquine|hydroxychloroquine|mesh-list
92140210|NCT04335084|Micronutrients|micronutrients|mesh-ancestor
92140211|NCT04335084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140212|NCT04335084|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92140214|NCT04335084|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92140215|NCT04335084|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92140216|NCT04335084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140217|NCT04335084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140218|NCT04335084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140219|NCT04335084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140220|NCT02996019|Etrolizumab|etrolizumab|mesh-list
92140221|NCT02996019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140222|NCT02996019|Immunologic Factors|immunologic factors|mesh-ancestor
92140223|NCT02996019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140224|NCT02997501|Osimertinib|osimertinib|mesh-list
92140225|NCT02997501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140226|NCT02997501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92140227|NCT02997501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140228|NCT02997501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140229|NCT02998827|Thalidomide|thalidomide|mesh-list
92140230|NCT02998827|Infliximab|infliximab|mesh-list
92140231|NCT02998827|Azathioprine|azathioprine|mesh-list
92140232|NCT02998827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92140233|NCT02998827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140234|NCT02998827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92140235|NCT02998827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140236|NCT02998827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140237|NCT02998827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140238|NCT02998827|Immunologic Factors|immunologic factors|mesh-ancestor
92140239|NCT02998827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140240|NCT02998827|Leprostatic Agents|leprostatic agents|mesh-ancestor
92140241|NCT02998827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140242|NCT02998827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140243|NCT02998827|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140244|NCT02998827|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140245|NCT02998827|Growth Substances|growth substances|mesh-ancestor
92140246|NCT02998827|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140247|NCT02998827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140248|NCT02998827|Antimetabolites|antimetabolites|mesh-ancestor
92140249|NCT02998827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140250|NCT02998827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92140251|NCT02995707|Thalidomide|thalidomide|mesh-list
92140252|NCT02995707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140253|NCT02995707|Immunologic Factors|immunologic factors|mesh-ancestor
92140254|NCT02995707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140255|NCT02995707|Leprostatic Agents|leprostatic agents|mesh-ancestor
92140256|NCT02995707|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140257|NCT02995707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140258|NCT02995707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140259|NCT02995707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140260|NCT02995707|Growth Substances|growth substances|mesh-ancestor
92140261|NCT02995707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140262|NCT02995707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140264|NCT01270035|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92140265|NCT01270035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140266|NCT01270035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140267|NCT01396447|Cariprazine|cariprazine|mesh-list
92140268|NCT01396447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92140269|NCT01396447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92140270|NCT01396447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140271|NCT01396447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140272|NCT01396447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92140273|NCT05738148|Vasopressins|vasopressins|mesh-list
92140276|NCT05738148|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92140277|NCT05738148|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92140278|NCT05738148|Adrenergic Agents|adrenergic agents|mesh-ancestor
92140279|NCT05738148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140280|NCT05738148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140281|NCT05738148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140282|NCT05738148|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92140283|NCT05738148|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92140284|NCT05738148|Autonomic Agents|autonomic agents|mesh-ancestor
92140285|NCT05738148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140286|NCT05738148|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92140287|NCT05738148|Respiratory System Agents|respiratory system agents|mesh-ancestor
92140288|NCT05738148|Mydriatics|mydriatics|mesh-ancestor
92140289|NCT05738148|Sympathomimetics|sympathomimetics|mesh-ancestor
92140290|NCT05738148|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92140291|NCT05738148|Hemostatics|hemostatics|mesh-ancestor
92140292|NCT05738148|Coagulants|coagulants|mesh-ancestor
92140293|NCT05738148|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92140294|NCT05738148|Natriuretic Agents|natriuretic agents|mesh-ancestor
92140295|NCT00704379|Sertraline|sertraline|mesh-list
92140296|NCT00704379|Antidepressive Agents|antidepressive agents|mesh-ancestor
92140297|NCT00704379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92140298|NCT00704379|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92140299|NCT00704379|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92140300|NCT00704379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140301|NCT00704379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140302|NCT00704379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140303|NCT00704379|Serotonin Agents|serotonin agents|mesh-ancestor
92140304|NCT00704379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140305|NCT02991495|Vaccines|vaccines|mesh-list
92140306|NCT02991495|Immunologic Factors|immunologic factors|mesh-ancestor
92140307|NCT02991495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140308|NCT04449042|Anesthetics|anesthetics|mesh-list
92140309|NCT04449042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140310|NCT04449042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140311|NCT04341090|Apatinib|apatinib|mesh-list
92140312|NCT04341090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140313|NCT04341090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92140314|NCT04341090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140315|NCT04341090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140316|NCT00707655|Zalutumumab|zalutumumab|mesh-list
92140317|NCT00707655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140318|NCT00707655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140319|NCT04413396|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92140320|NCT04413396|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140321|NCT04089150|Leucovorin|leucovorin|mesh-list
92140322|NCT04089150|Paclitaxel|paclitaxel|mesh-list
92140323|NCT04089150|Gemcitabine|gemcitabine|mesh-list
92140324|NCT04089150|Fluorouracil|fluorouracil|mesh-list
92140325|NCT04089150|Capecitabine|capecitabine|mesh-list
92140326|NCT04089150|Oxaliplatin|oxaliplatin|mesh-list
92140327|NCT04089150|Irinotecan|irinotecan|mesh-list
92140328|NCT04089150|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92140329|NCT04089150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140330|NCT04089150|Tubulin Modulators|tubulin modulators|mesh-ancestor
92140331|NCT04089150|Antimitotic Agents|antimitotic agents|mesh-ancestor
92140332|NCT04089150|Mitosis Modulators|mitosis modulators|mesh-ancestor
92140333|NCT04089150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140334|NCT04089150|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92140336|NCT04089150|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140337|NCT04089150|Immunologic Factors|immunologic factors|mesh-ancestor
92140338|NCT04089150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140339|NCT04089150|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92140340|NCT04089150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92140341|NCT04089150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140342|NCT04089150|Antidotes|antidotes|mesh-ancestor
92140343|NCT04089150|Protective Agents|protective agents|mesh-ancestor
92140344|NCT04089150|Vitamin B Complex|vitamin b complex|mesh-ancestor
92140345|NCT04089150|Vitamins|vitamins|mesh-ancestor
92140346|NCT04089150|Micronutrients|micronutrients|mesh-ancestor
92140347|NCT02076919|Acrizanib|acrizanib|mesh-list
92140348|NCT02076919|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92140349|NCT02076919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92140350|NCT02076919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92140351|NCT02076919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140352|NCT02076919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145996|NCT01677559|Antimitotic Agents|antimitotic agents|mesh-ancestor
92140354|NCT02076997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92140355|NCT02076997|Abortifacient Agents|abortifacient agents|mesh-ancestor
92140356|NCT02076997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92140357|NCT02076997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140358|NCT02076997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92140359|NCT02076997|Antimetabolites|antimetabolites|mesh-ancestor
92140360|NCT02076997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140361|NCT02076997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140362|NCT02076997|Dermatologic Agents|dermatologic agents|mesh-ancestor
92140363|NCT02076997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140364|NCT02076997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92140365|NCT02076997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140366|NCT02076997|Immunologic Factors|immunologic factors|mesh-ancestor
92140367|NCT02076997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140368|NCT02076997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92140370|NCT05365165|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92140371|NCT05365165|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92140372|NCT05365165|Anesthetics, General|anesthetics, general|mesh-ancestor
92140373|NCT05365165|Anesthetics|anesthetics|mesh-ancestor
92140374|NCT05365165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140375|NCT05365165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140376|NCT03925350|Niraparib|niraparib|mesh-list
92140377|NCT03925350|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92140378|NCT03925350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140379|NCT03925350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140380|NCT03925350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140381|NCT00707967|Vaccines|vaccines|mesh-list
92140382|NCT00707967|Immunologic Factors|immunologic factors|mesh-ancestor
92140383|NCT00707967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140384|NCT02994381|Ozanimod|ozanimod|mesh-list
92140385|NCT02994381|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92140386|NCT02994381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140387|NCT02994381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140388|NCT02994381|Immunologic Factors|immunologic factors|mesh-ancestor
92140389|NCT02994381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140390|NCT00716079|Metoprolol|metoprolol|mesh-list
92140391|NCT00716079|Clonidine|clonidine|mesh-list
92140392|NCT00716079|Labetalol|labetalol|mesh-list
92140393|NCT00716079|Hydralazine|hydralazine|mesh-list
92140394|NCT00716079|Nicardipine|nicardipine|mesh-list
92140395|NCT00716079|Phentolamine|phentolamine|mesh-list
92140396|NCT00716079|Urapidil|urapidil|mesh-list
92140397|NCT00716079|Enalaprilat|enalaprilat|mesh-list
92140398|NCT00716079|Esmolol|esmolol|mesh-list
92140399|NCT00716079|Glycerol|glycerol|mesh-list
92140400|NCT00716079|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92140401|NCT00716079|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92140402|NCT00716079|Sympatholytics|sympatholytics|mesh-ancestor
92140403|NCT00716079|Autonomic Agents|autonomic agents|mesh-ancestor
92140404|NCT00716079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140405|NCT00716079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140406|NCT00716079|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92140407|NCT00716079|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92140408|NCT00716079|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92140409|NCT00716079|Adrenergic Agents|adrenergic agents|mesh-ancestor
92140410|NCT00716079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140411|NCT00716079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140412|NCT00716079|Analgesics|analgesics|mesh-ancestor
92140413|NCT00716079|Sensory System Agents|sensory system agents|mesh-ancestor
92140414|NCT00716079|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92140415|NCT00716079|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92140416|NCT00716079|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92140417|NCT00716079|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92140418|NCT00716079|Protective Agents|protective agents|mesh-ancestor
92140419|NCT00716079|Sympathomimetics|sympathomimetics|mesh-ancestor
92140420|NCT00716079|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92140421|NCT00716079|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92140422|NCT00716079|Vasodilator Agents|vasodilator agents|mesh-ancestor
92140423|NCT00716079|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92140424|NCT00716079|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140425|NCT00716079|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92140426|NCT00716079|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92140427|NCT00716079|Serotonin Agents|serotonin agents|mesh-ancestor
92140428|NCT00716079|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92140429|NCT00716079|Protease Inhibitors|protease inhibitors|mesh-ancestor
92140432|NCT01270191|Isophane Insulin, Human|isophane insulin, human|mesh-list
92140433|NCT01270191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92140434|NCT01270191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140435|NCT01270191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92140436|NCT01270191|Incretins|incretins|mesh-ancestor
92140437|NCT01270191|Hormones|hormones|mesh-ancestor
92140438|NCT01270191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140439|NCT02999919|Bupivacaine|bupivacaine|mesh-list
92140440|NCT02999919|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140441|NCT02999919|Anesthetics|anesthetics|mesh-ancestor
92140442|NCT02999919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140443|NCT02999919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140444|NCT02999919|Sensory System Agents|sensory system agents|mesh-ancestor
92140445|NCT02999919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140446|NCT04526652|Dexmedetomidine|dexmedetomidine|mesh-list
92140447|NCT04526652|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92140448|NCT04526652|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140449|NCT04526652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140450|NCT04526652|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92140451|NCT04526652|Analgesics|analgesics|mesh-ancestor
92140452|NCT04526652|Sensory System Agents|sensory system agents|mesh-ancestor
92140453|NCT04526652|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140454|NCT04526652|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92140455|NCT04526652|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92140456|NCT04526652|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92140457|NCT04526652|Adrenergic Agents|adrenergic agents|mesh-ancestor
92140458|NCT04526652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140459|NCT04526652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140460|NCT01381549|Imipenem|imipenem|mesh-list
92140461|NCT01381549|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92140462|NCT01381549|Cilastatin|cilastatin|mesh-list
92140463|NCT01381549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140464|NCT01381549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140465|NCT01381549|Protease Inhibitors|protease inhibitors|mesh-ancestor
92140466|NCT01381549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140467|NCT01381549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140468|NCT00159432|Bevacizumab|bevacizumab|mesh-list
92140469|NCT00159432|Capecitabine|capecitabine|mesh-list
92140470|NCT00159432|Oxaliplatin|oxaliplatin|mesh-list
92140471|NCT00159432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140472|NCT00159432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140473|NCT00159432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140474|NCT00159432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140475|NCT00159432|Growth Substances|growth substances|mesh-ancestor
92140476|NCT00159432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140477|NCT00159432|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140478|NCT00159432|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92140479|NCT00159432|Antimetabolites|antimetabolites|mesh-ancestor
92140480|NCT00159432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140481|NCT02969850|Vitamin D|vitamin d|mesh-list
92140482|NCT02969850|Calcium|calcium|mesh-list
92140483|NCT02969850|Vitamins|vitamins|mesh-ancestor
92140484|NCT02969850|Micronutrients|micronutrients|mesh-ancestor
92140485|NCT02969850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140486|NCT02969850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92140487|NCT02969850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92140488|NCT02339766|Morphine|morphine|mesh-list
92140489|NCT02339766|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92140490|NCT02339766|Narcotics|narcotics|mesh-ancestor
92140491|NCT02339766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140492|NCT02339766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140493|NCT02339766|Analgesics|analgesics|mesh-ancestor
92140494|NCT02339766|Sensory System Agents|sensory system agents|mesh-ancestor
92140495|NCT02339766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140496|NCT04287660|Clarithromycin|clarithromycin|mesh-list
92140497|NCT04287660|Dexamethasone|dexamethasone|mesh-list
92140498|NCT04287660|Lenalidomide|lenalidomide|mesh-list
92140499|NCT04287660|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140500|NCT04287660|Antiemetics|antiemetics|mesh-ancestor
92140501|NCT04287660|Autonomic Agents|autonomic agents|mesh-ancestor
92140502|NCT04287660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140503|NCT04287660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140504|NCT04287660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140505|NCT04287660|Glucocorticoids|glucocorticoids|mesh-ancestor
92140506|NCT04287660|Hormones|hormones|mesh-ancestor
92140507|NCT04287660|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140508|NCT04287660|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92140509|NCT04287660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140510|NCT04287660|Immunologic Factors|immunologic factors|mesh-ancestor
92140511|NCT04287660|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140512|NCT04287660|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140513|NCT04287660|Growth Substances|growth substances|mesh-ancestor
92140514|NCT04287660|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140515|NCT04287660|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140516|NCT04287660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140517|NCT04287660|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92140518|NCT04287660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140519|NCT04287660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140520|NCT04287660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92140521|NCT04287660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92140523|NCT01396057|Ranibizumab|ranibizumab|mesh-list
92140524|NCT01396057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140525|NCT01396057|Antiemetics|antiemetics|mesh-ancestor
92140526|NCT01396057|Autonomic Agents|autonomic agents|mesh-ancestor
92140527|NCT01396057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140528|NCT01396057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140529|NCT01396057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140530|NCT01396057|Glucocorticoids|glucocorticoids|mesh-ancestor
92140532|NCT01396057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140533|NCT01396057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92140534|NCT01396057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140535|NCT01396057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140536|NCT01396057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140537|NCT01396057|Growth Substances|growth substances|mesh-ancestor
92140538|NCT01396057|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140539|NCT02419560|Venetoclax|venetoclax|mesh-list
92140540|NCT02419560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140541|NCT04011163|Morphine|morphine|mesh-list
92140542|NCT04011163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92140543|NCT04011163|Narcotics|narcotics|mesh-ancestor
92140544|NCT04011163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140545|NCT04011163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140546|NCT04011163|Analgesics|analgesics|mesh-ancestor
92140547|NCT04011163|Sensory System Agents|sensory system agents|mesh-ancestor
92140548|NCT04011163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140549|NCT00704847|Calcitonin|calcitonin|mesh-list
92140550|NCT00704847|Salmon calcitonin|salmon calcitonin|mesh-list
92140551|NCT00704847|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92140552|NCT00704847|Katacalcin|katacalcin|mesh-list
92140553|NCT00704847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92140554|NCT00704847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140555|NCT00704847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92140556|NCT00704847|Vasodilator Agents|vasodilator agents|mesh-ancestor
92140557|NCT03393468|Dapivirine|dapivirine|mesh-list
92140558|NCT03393468|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92140559|NCT03393468|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92140560|NCT03393468|Antiviral Agents|antiviral agents|mesh-ancestor
92140561|NCT03393468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140562|NCT05091606|Anesthetics|anesthetics|mesh-list
92140563|NCT05091606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140564|NCT05091606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140565|NCT01395901|Ondansetron|ondansetron|mesh-list
92140566|NCT01395901|Palonosetron|palonosetron|mesh-list
92140567|NCT01395901|Antiemetics|antiemetics|mesh-ancestor
92140568|NCT01395901|Autonomic Agents|autonomic agents|mesh-ancestor
92140569|NCT01395901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140570|NCT01395901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140571|NCT01395901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140572|NCT01395901|Antipruritics|antipruritics|mesh-ancestor
92140573|NCT01395901|Dermatologic Agents|dermatologic agents|mesh-ancestor
92140574|NCT01395901|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92140575|NCT01395901|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92140576|NCT01395901|Serotonin Agents|serotonin agents|mesh-ancestor
92140577|NCT01395901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140578|NCT01395901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140579|NCT01395823|Vitamin D|vitamin d|mesh-list
92140580|NCT01395823|Ergocalciferols|ergocalciferols|mesh-list
92140581|NCT01395823|Vitamins|vitamins|mesh-ancestor
92140582|NCT01395823|Micronutrients|micronutrients|mesh-ancestor
92140583|NCT01395823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140584|NCT01395823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92140585|NCT01395823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92140588|NCT02993991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140589|NCT02993991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140590|NCT02993991|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92140591|NCT02993991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140592|NCT02993991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140593|NCT00158184|Oxycodone|oxycodone|mesh-list
92140594|NCT00158184|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92140595|NCT00158184|Narcotics|narcotics|mesh-ancestor
92140596|NCT00158184|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140597|NCT00158184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140598|NCT00158184|Analgesics|analgesics|mesh-ancestor
92140599|NCT00158184|Sensory System Agents|sensory system agents|mesh-ancestor
92140600|NCT00158184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140601|NCT02405520|Vaccines|vaccines|mesh-list
92140602|NCT02405520|Immunologic Factors|immunologic factors|mesh-ancestor
92140603|NCT02405520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140604|NCT02993835|Iron|iron|mesh-list
92140605|NCT02993835|Trace Elements|trace elements|mesh-ancestor
92140606|NCT02993835|Micronutrients|micronutrients|mesh-ancestor
92140607|NCT02993835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140608|NCT05091138|Buprenorphine|buprenorphine|mesh-list
92140609|NCT05091138|Bupivacaine|bupivacaine|mesh-list
92140610|NCT05091138|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140611|NCT05091138|Anesthetics|anesthetics|mesh-ancestor
92140612|NCT05091138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140613|NCT05091138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140614|NCT05091138|Sensory System Agents|sensory system agents|mesh-ancestor
92140615|NCT05091138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140616|NCT05091138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92140617|NCT05091138|Narcotics|narcotics|mesh-ancestor
92140618|NCT05091138|Analgesics|analgesics|mesh-ancestor
92140619|NCT05091138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92140620|NCT02999295|Nivolumab|nivolumab|mesh-list
92140621|NCT02999295|Ramucirumab|ramucirumab|mesh-list
92140622|NCT02999295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140623|NCT02999295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140624|NCT02999295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92140625|NCT02999295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140626|NCT02998905|Aspirin|aspirin|mesh-list
92140627|NCT02998905|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92140628|NCT02998905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92140629|NCT02998905|Analgesics|analgesics|mesh-ancestor
92140630|NCT02998905|Sensory System Agents|sensory system agents|mesh-ancestor
92140631|NCT02998905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140632|NCT02998905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140633|NCT02998905|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140634|NCT02998905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140635|NCT02998905|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92140636|NCT02998905|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92140637|NCT02998905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140638|NCT02998905|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92140639|NCT02998905|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92140640|NCT02998905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140642|NCT05735184|Cytarabine|cytarabine|mesh-list
92140643|NCT05735184|Azacitidine|azacitidine|mesh-list
92140644|NCT05735184|Daunorubicin|daunorubicin|mesh-list
92140645|NCT05735184|Venetoclax|venetoclax|mesh-list
92140646|NCT05735184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92140647|NCT05735184|Antimetabolites|antimetabolites|mesh-ancestor
92140648|NCT05735184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140649|NCT05735184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140650|NCT05735184|Antiviral Agents|antiviral agents|mesh-ancestor
92140651|NCT05735184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140652|NCT05735184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140653|NCT05735184|Immunologic Factors|immunologic factors|mesh-ancestor
92140654|NCT05735184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140655|NCT05735184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140656|NCT05735184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92140657|NCT05735184|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92140658|NCT05735184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92140659|NCT02993367|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92140660|NCT02993367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92140661|NCT02993367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92140662|NCT02993367|Protective Agents|protective agents|mesh-ancestor
92140663|NCT02993367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140664|NCT05094492|Fluorides|fluorides|mesh-list
92140668|NCT05094492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140669|NCT01380691|Phenylethyl Alcohol|phenylethyl alcohol|mesh-list
92140670|NCT01380691|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92140671|NCT01380691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140673|NCT05094414|Valacyclovir|valacyclovir|mesh-list
92140674|NCT05094414|Antiviral Agents|antiviral agents|mesh-ancestor
92140675|NCT05094414|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140676|NCT04386447|Oxytocin|oxytocin|mesh-list
92140677|NCT04386447|Oxytocics|oxytocics|mesh-ancestor
92140678|NCT04386447|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92140679|NCT04386447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140680|NCT02993133|Mycophenolic Acid|mycophenolic acid|mesh-list
92140681|NCT02993133|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92140682|NCT02993133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140683|NCT02993133|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92140684|NCT02993133|Antitubercular Agents|antitubercular agents|mesh-ancestor
92140685|NCT02993133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92140686|NCT02993133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140687|NCT02993133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140688|NCT02993133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140689|NCT01380535|Methoxsalen|methoxsalen|mesh-list
92140690|NCT01380535|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92140691|NCT01380535|Dermatologic Agents|dermatologic agents|mesh-ancestor
92140692|NCT00725361|Ambrisentan|ambrisentan|mesh-list
92140693|NCT00725361|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92140694|NCT02816424|TEMPO|tempo|mesh-list
92140695|NCT02816424|Antioxidants|antioxidants|mesh-ancestor
92140696|NCT02816424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140697|NCT02816424|Protective Agents|protective agents|mesh-ancestor
92140698|NCT02816424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140699|NCT01275885|Cholecalciferol|cholecalciferol|mesh-list
92140700|NCT01275885|Vitamin D|vitamin d|mesh-list
92140701|NCT01275885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92140702|NCT01275885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140703|NCT01275885|Vitamins|vitamins|mesh-ancestor
92140704|NCT01275885|Micronutrients|micronutrients|mesh-ancestor
92140705|NCT01275885|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92140706|NCT02794896|Fentanyl|fentanyl|mesh-list
92140707|NCT02794896|Propofol|propofol|mesh-list
92140708|NCT02794896|Sevoflurane|sevoflurane|mesh-list
92140709|NCT02794896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92140710|NCT02794896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140711|NCT02794896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140712|NCT02794896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92140713|NCT02794896|Anesthetics, General|anesthetics, general|mesh-ancestor
92140714|NCT02794896|Anesthetics|anesthetics|mesh-ancestor
92140715|NCT02794896|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92140716|NCT02794896|Narcotics|narcotics|mesh-ancestor
92140717|NCT02794896|Analgesics|analgesics|mesh-ancestor
92140718|NCT02794896|Sensory System Agents|sensory system agents|mesh-ancestor
92140719|NCT02794896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140720|NCT02794896|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92140721|NCT02794896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92140722|NCT02794896|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92140723|NCT01271283|Lenalidomide|lenalidomide|mesh-list
92140724|NCT01271283|Immunologic Factors|immunologic factors|mesh-ancestor
92140725|NCT01271283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140726|NCT01271283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140727|NCT01271283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140728|NCT01271283|Growth Substances|growth substances|mesh-ancestor
92140729|NCT01271283|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140730|NCT01271283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140731|NCT01271439|Cetuximab|cetuximab|mesh-list
92140732|NCT01271439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140733|NCT01271439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140734|NCT01271517|Insulin, Isophane|insulin, isophane|mesh-list
91939396|NCT05142254|Antisickling Agents|antisickling agents|mesh-ancestor
92140735|NCT01271517|Isophane Insulin, Human|isophane insulin, human|mesh-list
92140736|NCT01271517|Isophane insulin, beef|isophane insulin, beef|mesh-list
92140737|NCT01271517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92140738|NCT01271517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140739|NCT05090592|Atropine|atropine|mesh-list
92140740|NCT05090592|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92140741|NCT05090592|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92140742|NCT05090592|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92140743|NCT05090592|Autonomic Agents|autonomic agents|mesh-ancestor
92140744|NCT05090592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140745|NCT05090592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140746|NCT05090592|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92140747|NCT05090592|Respiratory System Agents|respiratory system agents|mesh-ancestor
92140748|NCT05090592|Mydriatics|mydriatics|mesh-ancestor
92140749|NCT05090592|Parasympatholytics|parasympatholytics|mesh-ancestor
92140750|NCT05090592|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92140751|NCT05090592|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92140752|NCT05090592|Cholinergic Agents|cholinergic agents|mesh-ancestor
92140753|NCT05090592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140754|NCT05090592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140755|NCT02992665|Ionophores|ionophores|mesh-list
92140756|NCT02992665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140757|NCT02992665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140758|NCT05093478|Lidocaine|lidocaine|mesh-list
92140759|NCT05093478|Capsaicin|capsaicin|mesh-list
92140760|NCT05093478|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140761|NCT05093478|Anesthetics|anesthetics|mesh-ancestor
92140762|NCT05093478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140763|NCT05093478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140764|NCT05093478|Sensory System Agents|sensory system agents|mesh-ancestor
92140765|NCT05093478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140766|NCT05093478|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92140767|NCT05093478|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92140768|NCT05093478|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92140769|NCT05093478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92140770|NCT05093478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140771|NCT05093478|Antipruritics|antipruritics|mesh-ancestor
92140772|NCT05093478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92140773|NCT00725751|Interferons|interferons|mesh-list
92140774|NCT00725751|Ribavirin|ribavirin|mesh-list
92140775|NCT00725751|Interferon-alpha|interferon-alpha|mesh-list
92140776|NCT00725751|Interferon alpha-2|interferon alpha-2|mesh-list
92140777|NCT00725751|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92140778|NCT00725751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140779|NCT00725751|Antiviral Agents|antiviral agents|mesh-ancestor
92140780|NCT00725751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92140781|NCT00725751|Antimetabolites|antimetabolites|mesh-ancestor
92140782|NCT00725751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140783|NCT00725751|Immunologic Factors|immunologic factors|mesh-ancestor
92140784|NCT00725751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140785|NCT05364385|Budesonide|budesonide|mesh-list
92140786|NCT05364385|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92140787|NCT05364385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140788|NCT05364385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92140789|NCT05364385|Autonomic Agents|autonomic agents|mesh-ancestor
92140790|NCT05364385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140791|NCT05364385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140793|NCT05364385|Respiratory System Agents|respiratory system agents|mesh-ancestor
92140794|NCT05364385|Glucocorticoids|glucocorticoids|mesh-ancestor
92140795|NCT05364385|Hormones|hormones|mesh-ancestor
92140796|NCT05364385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140797|NCT00726375|Etanercept|etanercept|mesh-list
92140798|NCT00726375|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92140799|NCT00726375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92140800|NCT00726375|Analgesics|analgesics|mesh-ancestor
92140801|NCT00726375|Sensory System Agents|sensory system agents|mesh-ancestor
92140802|NCT00726375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140803|NCT00726375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140804|NCT00726375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140805|NCT00726375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92140806|NCT00726375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140807|NCT00726375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92140808|NCT00726375|Immunologic Factors|immunologic factors|mesh-ancestor
92140809|NCT02693184|Vitamin D|vitamin d|mesh-list
92140810|NCT02693184|Calcium|calcium|mesh-list
92140811|NCT02693184|Vitamins|vitamins|mesh-ancestor
92140812|NCT02693184|Micronutrients|micronutrients|mesh-ancestor
92140813|NCT02693184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140814|NCT02693184|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92140815|NCT02693184|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92140816|NCT05363059|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92140817|NCT05363059|Antihypertensive Agents|antihypertensive agents|mesh-list
92140818|NCT05363059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140819|NCT01394185|Dronabinol|dronabinol|mesh-list
92140820|NCT01394185|Hallucinogens|hallucinogens|mesh-ancestor
92140821|NCT01394185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140822|NCT01394185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92140823|NCT01394185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92140824|NCT01394185|Analgesics|analgesics|mesh-ancestor
92140825|NCT01394185|Sensory System Agents|sensory system agents|mesh-ancestor
92140826|NCT01394185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140827|NCT01394185|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92140828|NCT01394185|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92140829|NCT01394185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140830|NCT01394185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140831|NCT01394185|Hormones|hormones|mesh-ancestor
92140832|NCT01394185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140833|NCT04361851|Pembrolizumab|pembrolizumab|mesh-list
92140834|NCT04361851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140835|NCT04361851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140836|NCT04361851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92140837|NCT04361851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140838|NCT04407715|Anesthetics|anesthetics|mesh-list
92140839|NCT04407715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140840|NCT04407715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140841|NCT00727857|Metformin|metformin|mesh-list
92140842|NCT00727857|Pioglitazone|pioglitazone|mesh-list
92140843|NCT00727857|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92140844|NCT00727857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140845|NCT05092152|Propofol|propofol|mesh-list
92140846|NCT05092152|Esketamine|esketamine|mesh-list
92140847|NCT05092152|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92140848|NCT05092152|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140849|NCT05092152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140850|NCT05092152|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92140851|NCT05092152|Anesthetics, General|anesthetics, general|mesh-ancestor
92140852|NCT05092152|Anesthetics|anesthetics|mesh-ancestor
92140853|NCT05092152|Antidepressive Agents|antidepressive agents|mesh-ancestor
92140854|NCT05092152|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92140855|NCT05081700|Ocrelizumab|ocrelizumab|mesh-list
92140856|NCT05081700|Immunologic Factors|immunologic factors|mesh-ancestor
92140857|NCT05081700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140858|NCT05001360|Nivolumab|nivolumab|mesh-list
92140859|NCT05001360|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92140860|NCT05001360|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140861|NCT05001360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140862|NCT05001360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140863|NCT05022810|Acetaminophen|acetaminophen|mesh-list
92140864|NCT05022810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92140865|NCT05022810|Analgesics|analgesics|mesh-ancestor
92140866|NCT05022810|Sensory System Agents|sensory system agents|mesh-ancestor
92140867|NCT05022810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140868|NCT05022810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140869|NCT05022810|Antipyretics|antipyretics|mesh-ancestor
92140870|NCT01525550|Sunitinib|sunitinib|mesh-list
92140871|NCT01525550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140872|NCT01525550|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140873|NCT01525550|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140874|NCT01525550|Growth Substances|growth substances|mesh-ancestor
92140875|NCT01525550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140876|NCT01525550|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140877|NCT01525550|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92140878|NCT01525550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92140879|NCT01525550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140880|NCT04730232|Paclitaxel|paclitaxel|mesh-list
92140881|NCT04730232|Tislelizumab|tislelizumab|mesh-list
92140882|NCT04730232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92140883|NCT04730232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140884|NCT04730232|Tubulin Modulators|tubulin modulators|mesh-ancestor
92140885|NCT04730232|Antimitotic Agents|antimitotic agents|mesh-ancestor
92140886|NCT04730232|Mitosis Modulators|mitosis modulators|mesh-ancestor
92140887|NCT04730232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140888|NCT04730232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140889|NCT04701918|Pembrolizumab|pembrolizumab|mesh-list
92140890|NCT04701918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140891|NCT04701918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140892|NCT04701918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92140893|NCT04701918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140894|NCT04540848|Bupivacaine|bupivacaine|mesh-list
92140895|NCT04540848|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140896|NCT04540848|Anesthetics|anesthetics|mesh-ancestor
92140897|NCT04540848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140898|NCT04540848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140899|NCT04540848|Sensory System Agents|sensory system agents|mesh-ancestor
92140900|NCT04540848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140901|NCT04793100|Aflibercept|aflibercept|mesh-list
92140902|NCT04793100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140903|NCT04793100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140904|NCT04793100|Growth Substances|growth substances|mesh-ancestor
92140905|NCT04793100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140906|NCT04793100|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140907|NCT04793100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140908|NCT04760028|Anesthetics|anesthetics|mesh-list
92140909|NCT04760028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140910|NCT04760028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140911|NCT05366101|Valsartan|valsartan|mesh-list
92140912|NCT05366101|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92140913|NCT05366101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92140914|NCT05366101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92140915|NCT05366101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92140916|NCT05366101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140917|NCT04993560|Vaccines|vaccines|mesh-list
92140918|NCT04993560|Immunologic Factors|immunologic factors|mesh-ancestor
92140919|NCT04993560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140920|NCT05365555|Anesthetics|anesthetics|mesh-list
92140921|NCT05365555|Ropivacaine|ropivacaine|mesh-list
92140922|NCT05365555|Anesthetics, Local|anesthetics, local|mesh-list
92140923|NCT05365555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140924|NCT05365555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140925|NCT05365555|Sensory System Agents|sensory system agents|mesh-ancestor
92140926|NCT05365555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140927|NCT01525238|Dapagliflozin|dapagliflozin|mesh-list
92140928|NCT01525238|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92140929|NCT01525238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140930|NCT01525238|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92140931|NCT01525238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140932|NCT05374356|Morphine|morphine|mesh-list
92140933|NCT05374356|Bupivacaine|bupivacaine|mesh-list
92140934|NCT05374356|Anesthetics, Local|anesthetics, local|mesh-ancestor
92140935|NCT05374356|Anesthetics|anesthetics|mesh-ancestor
92140936|NCT05374356|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92140937|NCT05374356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140938|NCT05374356|Sensory System Agents|sensory system agents|mesh-ancestor
92140939|NCT05374356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140940|NCT05374356|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92140941|NCT05374356|Narcotics|narcotics|mesh-ancestor
92140942|NCT05374356|Analgesics|analgesics|mesh-ancestor
92140943|NCT00717405|Bevacizumab|bevacizumab|mesh-list
92140944|NCT00717405|Trastuzumab|trastuzumab|mesh-list
92140945|NCT00717405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92140946|NCT00717405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140947|NCT00717405|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140948|NCT00717405|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140949|NCT00717405|Growth Substances|growth substances|mesh-ancestor
92140950|NCT00717405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140951|NCT00717405|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140952|NCT01276977|Zolmitriptan|zolmitriptan|mesh-list
92140953|NCT01276977|Eletriptan|eletriptan|mesh-list
92140954|NCT01276977|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92140955|NCT01276977|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92140956|NCT01276977|Serotonin Agents|serotonin agents|mesh-ancestor
92140957|NCT01276977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92140958|NCT01276977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140959|NCT01276977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140960|NCT03832699|Dydrogesterone|dydrogesterone|mesh-list
92140961|NCT03832699|Progesterone|progesterone|mesh-list
92140962|NCT03832699|Progestins|progestins|mesh-ancestor
92140963|NCT03832699|Hormones|hormones|mesh-ancestor
92140964|NCT03832699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140965|NCT03832699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140966|NCT01277289|Dexamethasone|dexamethasone|mesh-list
92140967|NCT01277289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92140968|NCT01277289|Antiemetics|antiemetics|mesh-ancestor
92140969|NCT01277289|Autonomic Agents|autonomic agents|mesh-ancestor
92140970|NCT01277289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92140971|NCT01277289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140972|NCT01277289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92140973|NCT01277289|Glucocorticoids|glucocorticoids|mesh-ancestor
92140974|NCT01277289|Hormones|hormones|mesh-ancestor
92140975|NCT01277289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92140976|NCT01277289|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92140977|NCT01277289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140978|NCT01525082|Bevacizumab|bevacizumab|mesh-list
92140979|NCT01525082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92140980|NCT01525082|Capecitabine|capecitabine|mesh-list
92140981|NCT01525082|Temozolomide|temozolomide|mesh-list
92140982|NCT01525082|Antibodies|antibodies|mesh-list
92140983|NCT01525082|Immunoglobulins|immunoglobulins|mesh-list
92140984|NCT01525082|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92140985|NCT01525082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92140986|NCT01525082|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92140987|NCT01525082|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92140988|NCT01525082|Growth Substances|growth substances|mesh-ancestor
92140989|NCT01525082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92140990|NCT01525082|Growth Inhibitors|growth inhibitors|mesh-ancestor
92140991|NCT01525082|Immunologic Factors|immunologic factors|mesh-ancestor
92140992|NCT01525082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92140993|NCT01525082|Antimetabolites|antimetabolites|mesh-ancestor
92140994|NCT01525082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92140995|NCT01525082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92140996|NCT01525082|Alkylating Agents|alkylating agents|mesh-ancestor
92140997|NCT03599791|Fluticasone|fluticasone|mesh-list
92140998|NCT03599791|Xhance|xhance|mesh-list
92140999|NCT03599791|Azelastine|azelastine|mesh-list
92141000|NCT03599791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141001|NCT03599791|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92141002|NCT03599791|Autonomic Agents|autonomic agents|mesh-ancestor
92141003|NCT03599791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141004|NCT03599791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141005|NCT03599791|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141006|NCT03599791|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141007|NCT03599791|Dermatologic Agents|dermatologic agents|mesh-ancestor
92141008|NCT03599791|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92141009|NCT03599791|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92141010|NCT03599791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141011|NCT03599791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141012|NCT03599791|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92141013|NCT03599791|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92141014|NCT03599791|Histamine Antagonists|histamine antagonists|mesh-ancestor
92141015|NCT03599791|Histamine Agents|histamine agents|mesh-ancestor
92141016|NCT03599791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141017|NCT01488578|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92141018|NCT01488578|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92141019|NCT01488578|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92141020|NCT01488578|Cholinergic Agents|cholinergic agents|mesh-ancestor
92141021|NCT01488578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141022|NCT01488578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141023|NCT01488578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141024|NCT01488578|Urological Agents|urological agents|mesh-ancestor
92141025|NCT00720369|Ubiquinone|ubiquinone|mesh-list
92141026|NCT00720369|Coenzyme Q10|coenzyme q10|mesh-list
92141027|NCT00720369|Micronutrients|micronutrients|mesh-ancestor
92141028|NCT00720369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141029|NCT00720369|Vitamins|vitamins|mesh-ancestor
92141030|NCT01524770|Dulaglutide|dulaglutide|mesh-list
92141031|NCT01524770|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141032|NCT01524770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141033|NCT04088864|Cyclophosphamide|cyclophosphamide|mesh-list
92141034|NCT04088864|Fludarabine|fludarabine|mesh-list
92141035|NCT04088864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92141036|NCT04088864|Immunologic Factors|immunologic factors|mesh-ancestor
92141037|NCT04088864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141039|NCT04088864|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92141040|NCT04088864|Alkylating Agents|alkylating agents|mesh-ancestor
92141041|NCT04088864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141042|NCT04088864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141043|NCT04088864|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92141044|NCT02991339|Dexamethasone|dexamethasone|mesh-list
92141045|NCT02991339|Dexamethasone acetate|dexamethasone acetate|mesh-list
92141046|NCT02991339|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92141047|NCT02991339|BB 1101|bb 1101|mesh-list
92141048|NCT02991339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141049|NCT02991339|Antiemetics|antiemetics|mesh-ancestor
92141050|NCT02991339|Autonomic Agents|autonomic agents|mesh-ancestor
92141051|NCT02991339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141052|NCT02991339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141053|NCT02991339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141054|NCT02991339|Glucocorticoids|glucocorticoids|mesh-ancestor
92141055|NCT02991339|Hormones|hormones|mesh-ancestor
92141056|NCT02991339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141057|NCT02991339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92141058|NCT02991339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141059|NCT02991339|Protease Inhibitors|protease inhibitors|mesh-ancestor
92141060|NCT02991339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141061|NCT02991339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141062|NCT04018105|Metformin|metformin|mesh-list
92141063|NCT04018105|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141064|NCT04018105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141065|NCT05632549|Biotin|biotin|mesh-list
92141066|NCT05632549|Vitamin B Complex|vitamin b complex|mesh-ancestor
92141067|NCT05632549|Vitamins|vitamins|mesh-ancestor
92141068|NCT05632549|Micronutrients|micronutrients|mesh-ancestor
92141069|NCT05632549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141070|NCT00721617|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92141071|NCT00721617|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92141072|NCT00721617|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92141073|NCT00721617|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92141074|NCT03597997|Propofol|propofol|mesh-list
92141075|NCT03597997|Sevoflurane|sevoflurane|mesh-list
92141076|NCT03597997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92141077|NCT03597997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141078|NCT03597997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141079|NCT03597997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92141080|NCT03597997|Anesthetics, General|anesthetics, general|mesh-ancestor
92141081|NCT03597997|Anesthetics|anesthetics|mesh-ancestor
92141082|NCT03597997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92141083|NCT03597997|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92141084|NCT01277835|Lidocaine|lidocaine|mesh-list
92141085|NCT01277835|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141086|NCT01277835|Anesthetics|anesthetics|mesh-ancestor
92141087|NCT01277835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141088|NCT01277835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141089|NCT01277835|Sensory System Agents|sensory system agents|mesh-ancestor
92141090|NCT01277835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141091|NCT01277835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92141092|NCT01277835|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92141093|NCT01277835|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92141094|NCT01277835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141095|NCT01277835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141096|NCT01431287|Tiotropium Bromide|tiotropium bromide|mesh-list
92141097|NCT01431287|Olodaterol|olodaterol|mesh-list
92141098|NCT01431287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92141099|NCT01431287|Autonomic Agents|autonomic agents|mesh-ancestor
92141100|NCT01431287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141101|NCT01431287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141102|NCT01431287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141103|NCT01431287|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141104|NCT01431287|Parasympatholytics|parasympatholytics|mesh-ancestor
92141105|NCT01431287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92141106|NCT01431287|Cholinergic Agents|cholinergic agents|mesh-ancestor
92141107|NCT01431287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141108|NCT01431287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141109|NCT05632159|Anesthetics|anesthetics|mesh-list
92141110|NCT05632159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141111|NCT05632159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141112|NCT04017013|Lidocaine|lidocaine|mesh-list
92141113|NCT04017013|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141114|NCT04017013|Anesthetics|anesthetics|mesh-ancestor
92141115|NCT04017013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141116|NCT04017013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141117|NCT04017013|Sensory System Agents|sensory system agents|mesh-ancestor
92141118|NCT04017013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141119|NCT04017013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92141120|NCT04017013|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92141121|NCT04017013|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92141122|NCT04017013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141123|NCT04017013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141124|NCT01277913|Vitamin D|vitamin d|mesh-list
92141125|NCT01277913|Ergocalciferols|ergocalciferols|mesh-list
92141126|NCT01277913|Cholecalciferol|cholecalciferol|mesh-list
92141127|NCT01277913|Vitamins|vitamins|mesh-list
92141128|NCT01277913|Micronutrients|micronutrients|mesh-ancestor
92141129|NCT01277913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141130|NCT01277913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92141131|NCT01277913|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92141132|NCT05631847|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92141133|NCT05631847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92141134|NCT05631847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92141135|NCT05631847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141136|NCT00729807|Pentamidine|pentamidine|mesh-list
92141137|NCT00729807|Antifungal Agents|antifungal agents|mesh-ancestor
92141138|NCT00729807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141139|NCT00729807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92141140|NCT00729807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92141141|NCT00729807|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92141142|NCT03590119|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92141143|NCT03590119|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92141144|NCT03590119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141145|NCT03592693|Vitamins|vitamins|mesh-list
92141146|NCT03592693|Hydrocortisone|hydrocortisone|mesh-list
92141147|NCT03592693|Micronutrients|micronutrients|mesh-ancestor
92141148|NCT03592693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141149|NCT03592693|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141150|NCT00730353|Paclitaxel|paclitaxel|mesh-list
92141151|NCT00730353|Sunitinib|sunitinib|mesh-list
92141152|NCT00730353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92141153|NCT00730353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141154|NCT00730353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92141155|NCT00730353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92141156|NCT00730353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92141157|NCT00730353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141158|NCT00730353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92141159|NCT00730353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92141160|NCT00730353|Growth Substances|growth substances|mesh-ancestor
92141161|NCT00730353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141162|NCT00730353|Growth Inhibitors|growth inhibitors|mesh-ancestor
92141163|NCT00730353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92141164|NCT00730353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141165|NCT01272531|Valproic Acid|valproic acid|mesh-list
92141166|NCT01272531|Lithium Carbonate|lithium carbonate|mesh-list
92141167|NCT01272531|Anticonvulsants|anticonvulsants|mesh-ancestor
92141168|NCT01272531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141169|NCT01272531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141170|NCT01272531|GABA Agents|gaba agents|mesh-ancestor
92141171|NCT01272531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141172|NCT01272531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141173|NCT01272531|Antimanic Agents|antimanic agents|mesh-ancestor
92141174|NCT01272531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92141175|NCT01272531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141176|NCT01272531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92141177|NCT01272531|Antidepressive Agents|antidepressive agents|mesh-ancestor
92141180|NCT01272609|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92141181|NCT01272609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92141182|NCT01272609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141183|NCT01272609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141184|NCT01272609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141185|NCT01272609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92141186|NCT01272609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92141188|NCT03595189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92141189|NCT03595189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141190|NCT03595189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141191|NCT01410227|Factor VIII|factor viii|mesh-list
92141192|NCT01410227|Coagulants|coagulants|mesh-ancestor
92141193|NCT04007029|Cyclophosphamide|cyclophosphamide|mesh-list
92141194|NCT04007029|Fludarabine|fludarabine|mesh-list
92141195|NCT04007029|Fludarabine phosphate|fludarabine phosphate|mesh-list
92141196|NCT04007029|Immunoglobulins|immunoglobulins|mesh-list
92141197|NCT04007029|Immunoglobulin G|immunoglobulin g|mesh-list
92141198|NCT04007029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92141199|NCT04007029|Immunologic Factors|immunologic factors|mesh-ancestor
92141200|NCT04007029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141202|NCT04007029|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92141203|NCT04007029|Alkylating Agents|alkylating agents|mesh-ancestor
92141204|NCT04007029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141205|NCT04007029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141206|NCT04007029|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92141207|NCT04007029|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92141208|NCT04007029|Antimetabolites|antimetabolites|mesh-ancestor
92141209|NCT01274559|Niacin|niacin|mesh-list
92141210|NCT01274559|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92141211|NCT01274559|Antimetabolites|antimetabolites|mesh-ancestor
92141212|NCT01274559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141213|NCT01274559|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92141214|NCT01274559|Vasodilator Agents|vasodilator agents|mesh-ancestor
92141215|NCT01274559|Vitamin B Complex|vitamin b complex|mesh-ancestor
92141216|NCT01274559|Vitamins|vitamins|mesh-ancestor
92141217|NCT01274559|Micronutrients|micronutrients|mesh-ancestor
92141218|NCT01274559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141219|NCT01409993|Sildenafil Citrate|sildenafil citrate|mesh-list
92141220|NCT01409993|Vasodilator Agents|vasodilator agents|mesh-ancestor
92141221|NCT01409993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92141222|NCT01409993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92141223|NCT01409993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141224|NCT01409993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141225|NCT01409993|Urological Agents|urological agents|mesh-ancestor
92141226|NCT01409915|Molgramostim|molgramostim|mesh-list
92141227|NCT01409915|Sargramostim|sargramostim|mesh-list
92141228|NCT01409915|Immunologic Factors|immunologic factors|mesh-ancestor
92141229|NCT01409915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141230|NCT01409915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141231|NCT01272921|Bupivacaine|bupivacaine|mesh-list
92141232|NCT01272921|Ropivacaine|ropivacaine|mesh-list
92141233|NCT01272921|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141234|NCT01272921|Anesthetics|anesthetics|mesh-ancestor
92141235|NCT01272921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141236|NCT01272921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141237|NCT01272921|Sensory System Agents|sensory system agents|mesh-ancestor
92141238|NCT01272921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141239|NCT01409837|Lisinopril|lisinopril|mesh-list
92141240|NCT01409837|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92141241|NCT01409837|Protease Inhibitors|protease inhibitors|mesh-ancestor
92141242|NCT01409837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141243|NCT01409837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141244|NCT01409837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92141245|NCT01409837|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92141246|NCT01409837|Protective Agents|protective agents|mesh-ancestor
92141247|NCT01409837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141249|NCT01278459|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92141250|NCT01278459|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92141251|NCT01278459|Antimetabolites|antimetabolites|mesh-ancestor
92141252|NCT01278459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141253|NCT01278459|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92141254|NCT01278459|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92141255|NCT01278459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141257|NCT00731055|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92141258|NCT00731055|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92141259|NCT00731055|Cholinergic Agents|cholinergic agents|mesh-ancestor
92141260|NCT00731055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141261|NCT00731055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141262|NCT00731055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141263|NCT03594565|Fluticasone|fluticasone|mesh-list
92141264|NCT03594565|Xhance|xhance|mesh-list
92141265|NCT03594565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141266|NCT03594565|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92141267|NCT03594565|Autonomic Agents|autonomic agents|mesh-ancestor
92141268|NCT03594565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141269|NCT03594565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141270|NCT03594565|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141271|NCT03594565|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141272|NCT03594565|Dermatologic Agents|dermatologic agents|mesh-ancestor
92141273|NCT03594565|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92141274|NCT01430585|Letrozole|letrozole|mesh-list
92141275|NCT01430585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141276|NCT01430585|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92141277|NCT01430585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92141278|NCT01430585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141279|NCT01430585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141280|NCT01430585|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92141281|NCT01430585|Hormone Antagonists|hormone antagonists|mesh-ancestor
92141282|NCT01430585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141283|NCT01430585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141284|NCT04005859|Lidocaine|lidocaine|mesh-list
92141285|NCT04005859|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141286|NCT04005859|Anesthetics|anesthetics|mesh-ancestor
92141287|NCT04005859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141288|NCT04005859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141289|NCT04005859|Sensory System Agents|sensory system agents|mesh-ancestor
92141290|NCT04005859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141291|NCT04005859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92141292|NCT04005859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92141293|NCT04005859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92141294|NCT04005859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141295|NCT04005859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141296|NCT05633719|Carboplatin|carboplatin|mesh-list
92141297|NCT05633719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141298|NCT01408901|Molgramostim|molgramostim|mesh-list
92141299|NCT01408901|Sargramostim|sargramostim|mesh-list
92141300|NCT01408901|Immunologic Factors|immunologic factors|mesh-ancestor
92141301|NCT01408901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141302|NCT01408901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141303|NCT02080195|Mycophenolic Acid|mycophenolic acid|mesh-list
92141304|NCT02080195|Cyclophosphamide|cyclophosphamide|mesh-list
92141305|NCT02080195|Fludarabine|fludarabine|mesh-list
92141306|NCT02080195|Tacrolimus|tacrolimus|mesh-list
92141307|NCT02080195|Thymoglobulin|thymoglobulin|mesh-list
92141308|NCT02080195|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92141309|NCT02080195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92141310|NCT02080195|Immunologic Factors|immunologic factors|mesh-ancestor
92141311|NCT02080195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141312|NCT02080195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92141313|NCT02080195|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92141314|NCT02080195|Alkylating Agents|alkylating agents|mesh-ancestor
92141315|NCT02080195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141316|NCT02080195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141317|NCT02080195|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92141318|NCT02080195|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92141319|NCT02080195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141320|NCT02080195|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92141321|NCT02080195|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92141322|NCT02080195|Antitubercular Agents|antitubercular agents|mesh-ancestor
92141323|NCT02080195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92141324|NCT02080195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141326|NCT04044131|Cathartics|cathartics|mesh-ancestor
92141327|NCT04044131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141328|NCT01428713|Tranexamic Acid|tranexamic acid|mesh-list
92141329|NCT01428713|Contraceptive Agents|contraceptive agents|mesh-list
92141330|NCT01428713|Contraceptives, Oral|contraceptives, oral|mesh-list
92141331|NCT01428713|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92141332|NCT01428713|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92141333|NCT01428713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92141334|NCT01428713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141335|NCT01428713|Hemostatics|hemostatics|mesh-ancestor
92141336|NCT01428713|Coagulants|coagulants|mesh-ancestor
92141337|NCT01428713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92141338|NCT01428713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141339|NCT01428713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92141340|NCT03976375|Docetaxel|docetaxel|mesh-list
92141341|NCT03976375|Pembrolizumab|pembrolizumab|mesh-list
92141342|NCT03976375|Lenvatinib|lenvatinib|mesh-list
92141343|NCT03976375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141344|NCT03976375|Tubulin Modulators|tubulin modulators|mesh-ancestor
92141345|NCT03976375|Antimitotic Agents|antimitotic agents|mesh-ancestor
92141346|NCT03976375|Mitosis Modulators|mitosis modulators|mesh-ancestor
92141347|NCT03976375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141348|NCT03976375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92141349|NCT03976375|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92141350|NCT03976375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92141351|NCT03976375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141352|NCT01408043|Plerixafor|plerixafor|mesh-list
92141353|NCT01408043|Etoposide|etoposide|mesh-list
92141354|NCT01408043|Etoposide phosphate|etoposide phosphate|mesh-list
92145997|NCT01677559|Mitosis Modulators|mitosis modulators|mesh-ancestor
92141355|NCT01408043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92141356|NCT01408043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141357|NCT01408043|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92141358|NCT01408043|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92141359|NCT01408043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141360|NCT01408043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141361|NCT01408043|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92141362|NCT01408043|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92141363|NCT01408043|Antiviral Agents|antiviral agents|mesh-ancestor
92141364|NCT01408043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141365|NCT00219349|Escitalopram|escitalopram|mesh-list
92141366|NCT00219349|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92141367|NCT00219349|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92141368|NCT00219349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141369|NCT00219349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141370|NCT00219349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141371|NCT00219349|Serotonin Agents|serotonin agents|mesh-ancestor
92141372|NCT00219349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141373|NCT00218257|Progesterone|progesterone|mesh-list
92141374|NCT00218257|Progestins|progestins|mesh-ancestor
92141375|NCT00218257|Hormones|hormones|mesh-ancestor
92141376|NCT00218257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141377|NCT00218257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141378|NCT01523366|Clopidogrel|clopidogrel|mesh-list
92141379|NCT01523366|Ticagrelor|ticagrelor|mesh-list
92141380|NCT01523366|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92141381|NCT01523366|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92141382|NCT01523366|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92141383|NCT01523366|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92141384|NCT01523366|Purinergic Agents|purinergic agents|mesh-ancestor
92141385|NCT01523366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141386|NCT01523366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141387|NCT01523366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141388|NCT03024697|Anesthetics|anesthetics|mesh-list
92141389|NCT03024697|Anesthetics, Local|anesthetics, local|mesh-list
92141390|NCT03024697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141391|NCT03024697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141392|NCT03024697|Sensory System Agents|sensory system agents|mesh-ancestor
92141393|NCT03024697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141394|NCT01427933|Ramucirumab|ramucirumab|mesh-list
92141395|NCT01427933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141396|NCT00217087|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92141397|NCT00217087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141398|NCT00217087|Dermatologic Agents|dermatologic agents|mesh-ancestor
92141399|NCT00217087|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92141401|NCT03780127|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92141402|NCT03780127|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92141403|NCT03780127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141404|NCT03780127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141405|NCT03780127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141407|NCT03780127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141408|NCT01406873|Mexiletine|mexiletine|mesh-list
92141409|NCT01406873|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92141410|NCT01406873|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92141411|NCT01406873|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92141412|NCT01406873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141413|NCT01406873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141414|NCT01406795|Heparin|heparin|mesh-list
92141415|NCT01406795|Anticoagulants|anticoagulants|mesh-ancestor
92141416|NCT01406795|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92141417|NCT01406795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92141418|NCT01406795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141419|NCT01406015|Spironolactone|spironolactone|mesh-list
92141420|NCT01406015|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92141421|NCT01406015|Hormone Antagonists|hormone antagonists|mesh-ancestor
92141422|NCT01406015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141423|NCT01406015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141424|NCT01406015|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92141425|NCT01406015|Diuretics|diuretics|mesh-ancestor
92141426|NCT01406015|Natriuretic Agents|natriuretic agents|mesh-ancestor
92141427|NCT00215137|Escitalopram|escitalopram|mesh-list
92141428|NCT00215137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92141429|NCT00215137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92141430|NCT00215137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141431|NCT00215137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141432|NCT00215137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141433|NCT00215137|Serotonin Agents|serotonin agents|mesh-ancestor
92141434|NCT00215137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141435|NCT04406779|Hormones|hormones|mesh-list
92141436|NCT04406779|Autoantibodies|autoantibodies|mesh-list
92141437|NCT04406779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141438|NCT04406779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141439|NCT04406779|Immunologic Factors|immunologic factors|mesh-ancestor
92141440|NCT00214201|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92141441|NCT00214201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141442|NCT00214201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141443|NCT03598075|Pramlintide|pramlintide|mesh-list
92141444|NCT03598075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141445|NCT03598075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141446|NCT03597919|Vaccines|vaccines|mesh-list
92141447|NCT03597919|Immunologic Factors|immunologic factors|mesh-ancestor
92141448|NCT03597919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141449|NCT04001413|Durvalumab|durvalumab|mesh-list
92141450|NCT04001413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92141451|NCT04001413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141452|NCT01677858|Dexamethasone|dexamethasone|mesh-list
92141453|NCT01677858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141454|NCT01677858|Antiemetics|antiemetics|mesh-ancestor
92141455|NCT01677858|Autonomic Agents|autonomic agents|mesh-ancestor
92141456|NCT01677858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141457|NCT01677858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141458|NCT01677858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141459|NCT01677858|Glucocorticoids|glucocorticoids|mesh-ancestor
92141460|NCT01677858|Hormones|hormones|mesh-ancestor
92141461|NCT01677858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141462|NCT01677858|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92141464|NCT03027284|Gemcitabine|gemcitabine|mesh-list
92141465|NCT03027284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141466|NCT03027284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92141467|NCT03027284|Antimetabolites|antimetabolites|mesh-ancestor
92141468|NCT03027284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141469|NCT03592069|Amoxicillin|amoxicillin|mesh-list
92141470|NCT03592069|Metronidazole|metronidazole|mesh-list
92141471|NCT03592069|Clarithromycin|clarithromycin|mesh-list
92141472|NCT03592069|Esomeprazole|esomeprazole|mesh-list
92141473|NCT03592069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92141474|NCT03592069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141475|NCT03592069|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92141477|NCT03592069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92141478|NCT03592069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141479|NCT03592069|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92141480|NCT03592069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141481|NCT03592069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141482|NCT03592069|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92141483|NCT03592069|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92141484|NCT03592069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92141486|NCT03591991|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92141487|NCT03591991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141488|NCT03591991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141489|NCT03591991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141490|NCT03591913|Misoprostol|misoprostol|mesh-list
92141491|NCT03591913|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92141492|NCT03591913|Abortifacient Agents|abortifacient agents|mesh-ancestor
92141493|NCT03591913|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92141494|NCT03591913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141495|NCT03591913|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92141496|NCT03591913|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141497|NCT03591913|Oxytocics|oxytocics|mesh-ancestor
92141498|NCT04198129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92141499|NCT04198129|Amoxicillin|amoxicillin|mesh-list
92141500|NCT04198129|Clindamycin|clindamycin|mesh-list
92141501|NCT04198129|Clindamycin palmitate|clindamycin palmitate|mesh-list
92141502|NCT04198129|Clindamycin phosphate|clindamycin phosphate|mesh-list
92141503|NCT04198129|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92141504|NCT04198129|Ampicillin|ampicillin|mesh-list
92141506|NCT04198129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92141507|NCT04198129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141508|NCT04198129|Antitubercular Agents|antitubercular agents|mesh-ancestor
92141509|NCT04198129|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92141510|NCT04198129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141511|NCT04198129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141512|NCT04198129|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92141513|NCT03591757|Tolcapone|tolcapone|mesh-list
92141514|NCT03591757|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92141515|NCT03591757|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92141516|NCT03591757|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92141517|NCT03591757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141518|NCT03591757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141519|NCT04438434|Chlorhexidine|chlorhexidine|mesh-list
92141520|NCT04438434|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92141521|NCT04438434|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92141522|NCT04438434|Hyaluronic Acid|hyaluronic acid|mesh-list
92141523|NCT04438434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92141524|NCT04438434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141525|NCT04438434|Disinfectants|disinfectants|mesh-ancestor
92141526|NCT04438434|Dermatologic Agents|dermatologic agents|mesh-ancestor
92141527|NCT04438434|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92141528|NCT04438434|Immunologic Factors|immunologic factors|mesh-ancestor
92141529|NCT04438434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141530|NCT04438434|Viscosupplements|viscosupplements|mesh-ancestor
92141531|NCT04438434|Protective Agents|protective agents|mesh-ancestor
92141532|NCT03591679|Oxytocin|oxytocin|mesh-list
92141533|NCT03591679|Oxytocics|oxytocics|mesh-ancestor
92141534|NCT03591679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92141535|NCT03591679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141536|NCT04197817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92141537|NCT04197817|Antibodies|antibodies|mesh-list
92141538|NCT04197817|Immunoglobulins|immunoglobulins|mesh-list
92141539|NCT04197817|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92141540|NCT04197817|Immunologic Factors|immunologic factors|mesh-ancestor
92141541|NCT04197817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141542|NCT04197817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141544|NCT04585854|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92141545|NCT04585854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141546|NCT04585854|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92141547|NCT04585854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141548|NCT04585854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141549|NCT04585854|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92141550|NCT04585854|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92141552|NCT04585854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141553|NCT03481842|Axitinib|axitinib|mesh-list
92141554|NCT03481842|Afatinib|afatinib|mesh-list
92141555|NCT03481842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141556|NCT03481842|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92141557|NCT03481842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141558|NCT03481842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141559|NCT04197739|Amikacin|amikacin|mesh-list
92141560|NCT04197739|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92141561|NCT04197739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141562|NCT03449706|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92141563|NCT03449706|Antiviral Agents|antiviral agents|mesh-ancestor
92141564|NCT03449706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141565|NCT04197349|Sumatriptan|sumatriptan|mesh-list
92141566|NCT04197349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92141567|NCT04197349|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92141568|NCT04197349|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92141569|NCT04197349|Serotonin Agents|serotonin agents|mesh-ancestor
92141570|NCT04197349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141571|NCT04197349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141572|NCT04197349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141573|NCT03982225|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92141574|NCT03982225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92141575|NCT03982225|Antimetabolites|antimetabolites|mesh-ancestor
92141576|NCT03982225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141577|NCT03982225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92141578|NCT03422094|Nivolumab|nivolumab|mesh-list
92141579|NCT03422094|Ipilimumab|ipilimumab|mesh-list
92141580|NCT03422094|Poly ICLC|poly iclc|mesh-list
92141581|NCT03422094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92141582|NCT03422094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141583|NCT03422094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92141584|NCT03422094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141585|NCT03422094|Interferon Inducers|interferon inducers|mesh-ancestor
92141586|NCT03422094|Immunologic Factors|immunologic factors|mesh-ancestor
92141587|NCT03422094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141588|NCT04356534|Antibodies|antibodies|mesh-list
92141589|NCT04356534|Immunologic Factors|immunologic factors|mesh-ancestor
92141590|NCT04356534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141591|NCT03591289|Bromides|bromides|mesh-list
92141592|NCT03591289|Rocuronium|rocuronium|mesh-list
92141593|NCT03591289|Anticonvulsants|anticonvulsants|mesh-ancestor
92141594|NCT03591289|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92141595|NCT03591289|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92141596|NCT03591289|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92141597|NCT03591289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141598|NCT03591289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141599|NCT05338866|Capecitabine|capecitabine|mesh-list
92141600|NCT05338866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92141601|NCT05338866|Antimetabolites|antimetabolites|mesh-ancestor
92141602|NCT05338866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141603|NCT05338866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141604|NCT02471118|Adalimumab|adalimumab|mesh-list
92141605|NCT02471118|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92141606|NCT02471118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141607|NCT02471118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92141608|NCT04197115|Vitamins|vitamins|mesh-list
92141609|NCT04197115|Ascorbic Acid|ascorbic acid|mesh-list
92141610|NCT04197115|Vitamin B Complex|vitamin b complex|mesh-list
92141611|NCT04197115|Hydrocortisone|hydrocortisone|mesh-list
92141612|NCT04197115|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92141613|NCT04197115|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92141614|NCT04197115|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92141615|NCT04197115|Micronutrients|micronutrients|mesh-ancestor
92141616|NCT04197115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141617|NCT04197115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141618|NCT04197115|Antioxidants|antioxidants|mesh-ancestor
92141619|NCT04197115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141620|NCT04197115|Protective Agents|protective agents|mesh-ancestor
92141621|NCT02467452|Tiotropium Bromide|tiotropium bromide|mesh-list
92141622|NCT02467452|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92141623|NCT02467452|Autonomic Agents|autonomic agents|mesh-ancestor
92141624|NCT02467452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141626|NCT02467452|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141627|NCT02467452|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141628|NCT02467452|Parasympatholytics|parasympatholytics|mesh-ancestor
92141629|NCT02467452|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92141630|NCT02467452|Cholinergic Agents|cholinergic agents|mesh-ancestor
92141631|NCT02467452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141632|NCT02467452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141633|NCT03590587|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92141634|NCT03590587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141635|NCT03590587|Glucocorticoids|glucocorticoids|mesh-ancestor
92141636|NCT03590587|Hormones|hormones|mesh-ancestor
92141637|NCT03590587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141638|NCT03590587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141640|NCT03590431|Cadexomer iodine|cadexomer iodine|mesh-list
92141641|NCT03590431|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92141642|NCT03590431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141643|NCT03590431|Trace Elements|trace elements|mesh-ancestor
92141644|NCT03590431|Micronutrients|micronutrients|mesh-ancestor
92141645|NCT03590431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141646|NCT03980665|Arsenic Trioxide|arsenic trioxide|mesh-list
92141647|NCT03980665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141648|NCT03971461|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92141649|NCT03971461|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92141650|NCT03971461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141651|NCT05102448|Methotrexate|methotrexate|mesh-list
92141652|NCT05102448|Tofacitinib|tofacitinib|mesh-list
92141653|NCT05102448|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92141654|NCT05102448|Abortifacient Agents|abortifacient agents|mesh-ancestor
92141655|NCT05102448|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92141656|NCT05102448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141657|NCT05102448|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92141658|NCT05102448|Antimetabolites|antimetabolites|mesh-ancestor
92141659|NCT05102448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141660|NCT05102448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141661|NCT05102448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92141662|NCT05102448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141663|NCT05102448|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92141664|NCT05102448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92141665|NCT05102448|Immunologic Factors|immunologic factors|mesh-ancestor
92141666|NCT05102448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92141667|NCT05102448|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92141668|NCT05102448|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92141669|NCT05102448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92141670|NCT03599323|Clotrimazole|clotrimazole|mesh-list
92141671|NCT03599323|Miconazole|miconazole|mesh-list
92141672|NCT03599323|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92141673|NCT03599323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141674|NCT03599323|Antifungal Agents|antifungal agents|mesh-ancestor
92141675|NCT03599323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92141676|NCT03599323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92141677|NCT03599323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141678|NCT03599323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141679|NCT03599323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92141680|NCT03599323|Hormone Antagonists|hormone antagonists|mesh-ancestor
92141681|NCT03599323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141682|NCT03599323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141683|NCT03599323|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92141684|NCT03599323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92141685|NCT04195867|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92141686|NCT04195867|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92141687|NCT04195867|Autonomic Agents|autonomic agents|mesh-ancestor
92141688|NCT04195867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141689|NCT04195867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141690|NCT04195867|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141691|NCT04195867|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141692|NCT04195867|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92141693|NCT04195867|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92141694|NCT04195867|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92141696|NCT04195867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141697|NCT04195867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141699|NCT05102058|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92141700|NCT05102058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141701|NCT05102058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141702|NCT05102058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92141703|NCT05102058|Analgesics|analgesics|mesh-ancestor
92141704|NCT05102058|Sensory System Agents|sensory system agents|mesh-ancestor
92141705|NCT05102058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141706|NCT05102058|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92141707|NCT05102058|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92141708|NCT05102058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92141709|NCT05102058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92141710|NCT05102058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141711|NCT05102058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141712|NCT03956797|Anesthetics|anesthetics|mesh-list
92141713|NCT03956797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141714|NCT03956797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141715|NCT03598777|Botulinum Toxins|botulinum toxins|mesh-list
92141716|NCT03598777|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92141717|NCT03598777|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92141718|NCT03598777|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92141719|NCT03598777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141720|NCT03598777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141721|NCT03598777|Cholinergic Agents|cholinergic agents|mesh-ancestor
92141722|NCT03598777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141723|NCT03598777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141724|NCT03598777|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92141725|NCT03598777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141726|NCT04195243|Dapagliflozin|dapagliflozin|mesh-list
92141727|NCT04195243|Empagliflozin|empagliflozin|mesh-list
92141728|NCT04195243|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92141729|NCT04195243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141730|NCT04195243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141731|NCT04195243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141732|NCT04195321|Phenylephrine|phenylephrine|mesh-list
92141738|NCT04195321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141739|NCT04195321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141740|NCT04195321|Sympathomimetics|sympathomimetics|mesh-ancestor
92141741|NCT04195321|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92141742|NCT04195321|Nasal Decongestants|nasal decongestants|mesh-ancestor
92141743|NCT04195321|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141744|NCT04195321|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92141745|NCT04195321|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92141746|NCT04195321|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92141747|NCT04195321|Adrenergic Agents|adrenergic agents|mesh-ancestor
92141748|NCT04195321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141749|NCT04195321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141750|NCT04195321|Protective Agents|protective agents|mesh-ancestor
92141751|NCT03965845|Palbociclib|palbociclib|mesh-list
92141752|NCT03965845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141753|NCT03965845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92141754|NCT03965845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141755|NCT03965845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141756|NCT04766359|Paclitaxel|paclitaxel|mesh-list
92141757|NCT04766359|Cisplatin|cisplatin|mesh-list
92141758|NCT04766359|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92141759|NCT04766359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92141760|NCT04766359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141761|NCT04766359|Tubulin Modulators|tubulin modulators|mesh-ancestor
92141762|NCT04766359|Antimitotic Agents|antimitotic agents|mesh-ancestor
92141763|NCT04766359|Mitosis Modulators|mitosis modulators|mesh-ancestor
92141764|NCT04766359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141765|NCT04020601|Ropivacaine|ropivacaine|mesh-list
92141766|NCT04020601|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141767|NCT04020601|Anesthetics|anesthetics|mesh-ancestor
92141768|NCT04020601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141769|NCT04020601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141770|NCT04020601|Sensory System Agents|sensory system agents|mesh-ancestor
92141771|NCT04020601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141773|NCT03964051|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92141774|NCT03964051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141775|NCT03964051|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141776|NCT03973489|Methamphetamine|methamphetamine|mesh-list
92141777|NCT03973489|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92141778|NCT03973489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141779|NCT03973489|Sympathomimetics|sympathomimetics|mesh-ancestor
92141780|NCT03973489|Autonomic Agents|autonomic agents|mesh-ancestor
92141781|NCT03973489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141782|NCT03973489|Dopamine Agents|dopamine agents|mesh-ancestor
92141783|NCT03973489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141784|NCT03973489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141785|NCT03973489|Adrenergic Agents|adrenergic agents|mesh-ancestor
92141786|NCT03973489|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92141787|NCT03973489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92141788|NCT03973489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141789|NCT03973489|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92141790|NCT04193137|Captopril|captopril|mesh-list
92141791|NCT04193137|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92141792|NCT04193137|Protease Inhibitors|protease inhibitors|mesh-ancestor
92141793|NCT04193137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141794|NCT04193137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141795|NCT04193137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92141796|NCT05060484|Vaccines|vaccines|mesh-list
92141797|NCT05060484|Immunologic Factors|immunologic factors|mesh-ancestor
92141798|NCT05060484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141799|NCT04193059|Paclitaxel|paclitaxel|mesh-list
92141800|NCT04193059|Docetaxel|docetaxel|mesh-list
92141801|NCT04193059|Cyclophosphamide|cyclophosphamide|mesh-list
92141802|NCT04193059|Carboplatin|carboplatin|mesh-list
92141803|NCT04193059|Trastuzumab|trastuzumab|mesh-list
92141804|NCT04193059|Epirubicin|epirubicin|mesh-list
92141805|NCT04193059|Pertuzumab|pertuzumab|mesh-list
92141806|NCT04193059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92141807|NCT04193059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141808|NCT04193059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92141809|NCT04193059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92141810|NCT04193059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92141811|NCT04193059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141812|NCT04193059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92141813|NCT04193059|Immunologic Factors|immunologic factors|mesh-ancestor
92141814|NCT04193059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141815|NCT04193059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92141816|NCT04193059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92141817|NCT04193059|Alkylating Agents|alkylating agents|mesh-ancestor
92141818|NCT04193059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92141819|NCT04193059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92141820|NCT04193059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92141821|NCT04193059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92141822|NCT04193059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92141823|NCT04193059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141824|NCT04028869|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92141825|NCT04028869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141826|NCT05092074|Sofosbuvir|sofosbuvir|mesh-list
92141827|NCT05092074|Velpatasvir|velpatasvir|mesh-list
92141828|NCT05092074|Antiviral Agents|antiviral agents|mesh-ancestor
92141829|NCT05092074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141830|NCT02080273|Listerine|listerine|mesh-list
92141831|NCT02080273|Sodium Fluoride|sodium fluoride|mesh-list
92141832|NCT02080273|Cariostatic Agents|cariostatic agents|mesh-ancestor
92141833|NCT02080273|Protective Agents|protective agents|mesh-ancestor
92141834|NCT02080273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141835|NCT02080273|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92141836|NCT02080273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141837|NCT04199143|Nitrous Oxide|nitrous oxide|mesh-list
92141838|NCT04199143|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92141839|NCT04199143|Anesthetics, General|anesthetics, general|mesh-ancestor
92141840|NCT04199143|Anesthetics|anesthetics|mesh-ancestor
92141841|NCT04199143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141842|NCT04199143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141843|NCT04199143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92141844|NCT04199143|Analgesics|analgesics|mesh-ancestor
92141845|NCT04199143|Sensory System Agents|sensory system agents|mesh-ancestor
92141846|NCT04199143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141848|NCT04616274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141849|NCT04613622|Venetoclax|venetoclax|mesh-list
92141850|NCT04613622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141851|NCT04515186|Miltefosine|miltefosine|mesh-list
92141852|NCT04515186|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92141853|NCT04515186|Antifungal Agents|antifungal agents|mesh-ancestor
92141854|NCT04515186|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141855|NCT04515186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141856|NCT04515186|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92141857|NCT04515186|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92141858|NCT04021225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92141859|NCT04021225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92141860|NCT05096676|Oxytocin|oxytocin|mesh-list
92141861|NCT05096676|Oxytocics|oxytocics|mesh-ancestor
92141862|NCT05096676|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92141863|NCT05096676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141864|NCT03948763|Pembrolizumab|pembrolizumab|mesh-list
92141865|NCT03948763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92141866|NCT03948763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141867|NCT03948763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92141868|NCT03948763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141869|NCT05096520|Lidocaine|lidocaine|mesh-list
92141870|NCT05096520|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141871|NCT05096520|Anesthetics|anesthetics|mesh-ancestor
92141872|NCT05096520|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141873|NCT05096520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141874|NCT05096520|Sensory System Agents|sensory system agents|mesh-ancestor
92141875|NCT05096520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141876|NCT05096520|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92141877|NCT05096520|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92141878|NCT05096520|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92141879|NCT05096520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92141880|NCT05096520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141881|NCT03832465|Levofloxacin|levofloxacin|mesh-list
92141883|NCT03832465|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92141884|NCT03832465|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92141885|NCT03832465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141886|NCT03832465|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92141887|NCT03832465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92141888|NCT03832465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92141889|NCT03832465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141890|NCT03832465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141891|NCT03832465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141892|NCT03832465|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92141893|NCT03832465|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92141894|NCT04190173|Prucalopride|prucalopride|mesh-list
92141895|NCT04190173|Laxatives|laxatives|mesh-ancestor
92141896|NCT04190173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141897|NCT04190173|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92141898|NCT04190173|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92141899|NCT04190173|Serotonin Agents|serotonin agents|mesh-ancestor
92141900|NCT04190173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141901|NCT04190173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141902|NCT04190173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141903|NCT01272219|Liraglutide|liraglutide|mesh-list
92141904|NCT01272219|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92141905|NCT01272219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141906|NCT01272219|Incretins|incretins|mesh-ancestor
92141907|NCT01272219|Hormones|hormones|mesh-ancestor
92141908|NCT01272219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141909|NCT04198363|Amoxicillin|amoxicillin|mesh-list
92141910|NCT04198363|Clarithromycin|clarithromycin|mesh-list
92141911|NCT04198363|Potassium Citrate|potassium citrate|mesh-list
92141912|NCT04198363|Esomeprazole|esomeprazole|mesh-list
92141913|NCT04198363|Bismuth|bismuth|mesh-list
92141914|NCT04198363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141915|NCT04198363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92141916|NCT04198363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141917|NCT04198363|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92141918|NCT04198363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141919|NCT04198363|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92141920|NCT04198363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141921|NCT04198363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92141922|NCT04198363|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92141923|NCT04198363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92141925|NCT04198363|Diuretics|diuretics|mesh-ancestor
92141926|NCT04198363|Natriuretic Agents|natriuretic agents|mesh-ancestor
92141927|NCT04198363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141928|NCT04198363|Expectorants|expectorants|mesh-ancestor
92141929|NCT04198363|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141930|NCT04020133|Epinephrine|epinephrine|mesh-list
92141931|NCT04020133|Bupivacaine|bupivacaine|mesh-list
92141932|NCT04020133|Anesthetics, Local|anesthetics, local|mesh-ancestor
92141933|NCT04020133|Anesthetics|anesthetics|mesh-ancestor
92141934|NCT04020133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92141935|NCT04020133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141936|NCT04020133|Sensory System Agents|sensory system agents|mesh-ancestor
92141937|NCT04020133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141938|NCT04020133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92141939|NCT04020133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92141940|NCT04020133|Adrenergic Agents|adrenergic agents|mesh-ancestor
92141941|NCT04020133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92141942|NCT04020133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141943|NCT04020133|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92141944|NCT04020133|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92141945|NCT04020133|Autonomic Agents|autonomic agents|mesh-ancestor
92141946|NCT04020133|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92141947|NCT04020133|Respiratory System Agents|respiratory system agents|mesh-ancestor
92141948|NCT04020133|Mydriatics|mydriatics|mesh-ancestor
92141949|NCT04020133|Sympathomimetics|sympathomimetics|mesh-ancestor
92141950|NCT04020133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92141951|NCT04565574|Rifampin|rifampin|mesh-list
92141952|NCT04565574|Rabeprazole|rabeprazole|mesh-list
92141953|NCT04565574|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92141954|NCT04565574|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141955|NCT04565574|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92141956|NCT04565574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141957|NCT04565574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141958|NCT04565574|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92141959|NCT04565574|Antitubercular Agents|antitubercular agents|mesh-ancestor
92141960|NCT04565574|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92141961|NCT04565574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141962|NCT04565574|Leprostatic Agents|leprostatic agents|mesh-ancestor
92141963|NCT04565574|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92141964|NCT04565574|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92141965|NCT04565574|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92141966|NCT04565574|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92141967|NCT04565574|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92141968|NCT04565574|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92141969|NCT04565574|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92141970|NCT01270971|Tavaborole|tavaborole|mesh-list
92141971|NCT01270971|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92141972|NCT01270971|Antifungal Agents|antifungal agents|mesh-ancestor
92141973|NCT01270971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92141974|NCT04026841|Antibodies|antibodies|mesh-list
92141975|NCT04026841|Immunologic Factors|immunologic factors|mesh-ancestor
92141976|NCT04026841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141977|NCT04128774|Dexamethasone|dexamethasone|mesh-list
92141978|NCT04128774|Dexamethasone acetate|dexamethasone acetate|mesh-list
92141979|NCT04128774|BB 1101|bb 1101|mesh-list
92141980|NCT04128774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92141981|NCT04128774|Antiemetics|antiemetics|mesh-ancestor
92141982|NCT04128774|Autonomic Agents|autonomic agents|mesh-ancestor
92141983|NCT04128774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92141984|NCT04128774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141985|NCT04128774|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92141986|NCT04128774|Glucocorticoids|glucocorticoids|mesh-ancestor
92141987|NCT04128774|Hormones|hormones|mesh-ancestor
92141988|NCT04128774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92141989|NCT04128774|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92141990|NCT04128774|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92141991|NCT04128774|Protease Inhibitors|protease inhibitors|mesh-ancestor
92141992|NCT04128774|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92141993|NCT04128774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92141994|NCT00732225|Hyaluronic Acid|hyaluronic acid|mesh-list
92141995|NCT00732225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92141996|NCT00732225|Immunologic Factors|immunologic factors|mesh-ancestor
92141997|NCT00732225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92141998|NCT00732225|Viscosupplements|viscosupplements|mesh-ancestor
92141999|NCT00732225|Protective Agents|protective agents|mesh-ancestor
92142000|NCT04026685|Phenylephrine|phenylephrine|mesh-list
92142001|NCT04026685|Oxymetazoline|oxymetazoline|mesh-list
92142002|NCT04026685|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92142003|NCT04026685|Mydriatics|mydriatics|mesh-ancestor
92142004|NCT04026685|Autonomic Agents|autonomic agents|mesh-ancestor
92142005|NCT04026685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142006|NCT04026685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142007|NCT04026685|Sympathomimetics|sympathomimetics|mesh-ancestor
92142008|NCT04026685|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92142009|NCT04026685|Nasal Decongestants|nasal decongestants|mesh-ancestor
92142010|NCT04026685|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142011|NCT04026685|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92142012|NCT04026685|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92142013|NCT04026685|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92142014|NCT04026685|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142015|NCT04026685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142016|NCT04026685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142017|NCT04026685|Protective Agents|protective agents|mesh-ancestor
92142019|NCT00751179|Rocuronium|rocuronium|mesh-list
92142020|NCT00751179|Succinylcholine|succinylcholine|mesh-list
92142021|NCT00751179|Anticonvulsants|anticonvulsants|mesh-ancestor
92142022|NCT00751179|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92142023|NCT00751179|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92142024|NCT00751179|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92142025|NCT00751179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142026|NCT00751179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142027|NCT00751179|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92142028|NCT01273233|Vaccines|vaccines|mesh-list
92142029|NCT01273233|Immunologic Factors|immunologic factors|mesh-ancestor
92142030|NCT01273233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142031|NCT01277211|NuvaRing|nuvaring|mesh-list
92142032|NCT01277211|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92142033|NCT01277211|Contraceptive Agents|contraceptive agents|mesh-ancestor
92142034|NCT01277211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92142035|NCT01277211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142036|NCT04022161|Nitric Oxide|nitric oxide|mesh-list
92142037|NCT04022161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92142038|NCT04022161|Autonomic Agents|autonomic agents|mesh-ancestor
92142039|NCT04022161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142040|NCT04022161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142041|NCT04022161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92142042|NCT04022161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142043|NCT04022161|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92142044|NCT04022161|Antioxidants|antioxidants|mesh-ancestor
92142045|NCT04022161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142046|NCT04022161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142047|NCT04022161|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92142048|NCT04022161|Vasodilator Agents|vasodilator agents|mesh-ancestor
92142049|NCT04022161|Gasotransmitters|gasotransmitters|mesh-ancestor
92142050|NCT04022161|Protective Agents|protective agents|mesh-ancestor
92142051|NCT01676220|Insulin|insulin|mesh-list
92142052|NCT01676220|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92142053|NCT01676220|Insulin Glargine|insulin glargine|mesh-list
92142054|NCT01676220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92142055|NCT01676220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142056|NCT01275105|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92142057|NCT01275105|Phenylephrine|phenylephrine|mesh-list
92142058|NCT01275105|Oxymetazoline|oxymetazoline|mesh-list
92142059|NCT01275105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92142060|NCT01275105|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92142061|NCT01275105|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92142062|NCT01275105|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92142063|NCT01275105|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142064|NCT01275105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142065|NCT01275105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142066|NCT01275105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142067|NCT01275105|Sympathomimetics|sympathomimetics|mesh-ancestor
92142068|NCT01275105|Autonomic Agents|autonomic agents|mesh-ancestor
92142069|NCT01275105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142070|NCT01275105|Nasal Decongestants|nasal decongestants|mesh-ancestor
92142071|NCT01275105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92142072|NCT01275105|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142073|NCT01275105|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92142074|NCT01275105|Mydriatics|mydriatics|mesh-ancestor
92142075|NCT01275105|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92142076|NCT01275105|Protective Agents|protective agents|mesh-ancestor
92142077|NCT01270347|Levofloxacin|levofloxacin|mesh-list
92142078|NCT01270347|Ofloxacin|ofloxacin|mesh-list
92142079|NCT01270347|Tobramycin|tobramycin|mesh-list
92142080|NCT01270347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92142081|NCT01270347|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92142082|NCT01270347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142083|NCT01270347|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92142084|NCT01270347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142085|NCT01270347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142086|NCT01270347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142087|NCT01270347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142088|NCT01270347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142089|NCT01270347|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92142090|NCT01270347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92142091|NCT03608436|Bromides|bromides|mesh-list
92142092|NCT03608436|Rocuronium|rocuronium|mesh-list
92142093|NCT03608436|Anticonvulsants|anticonvulsants|mesh-ancestor
92142094|NCT03608436|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92142095|NCT03608436|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92142096|NCT03608436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92142097|NCT03608436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142098|NCT03608436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142099|NCT04025671|Naloxone|naloxone|mesh-list
92142100|NCT04025671|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92142101|NCT04025671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142102|NCT04025671|Sensory System Agents|sensory system agents|mesh-ancestor
92142103|NCT04025671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142104|NCT03412188|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92142105|NCT03412188|gamma-Globulins|gamma-globulins|mesh-list
92142106|NCT03412188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142107|NCT03412188|Immunologic Factors|immunologic factors|mesh-ancestor
92142108|NCT03412188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142109|NCT03412188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142110|NCT03412188|Glucocorticoids|glucocorticoids|mesh-ancestor
92142111|NCT03412188|Hormones|hormones|mesh-ancestor
92142112|NCT03412188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142113|NCT03412188|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92142114|NCT03412188|Protective Agents|protective agents|mesh-ancestor
92142115|NCT03412188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142116|NCT01278849|Vadimezan|vadimezan|mesh-list
92142117|NCT01278849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142118|NCT04949412|Vitamin D|vitamin d|mesh-list
92142119|NCT04949412|Vitamins|vitamins|mesh-ancestor
92142120|NCT04949412|Micronutrients|micronutrients|mesh-ancestor
92142121|NCT04949412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142122|NCT04949412|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92142123|NCT04022473|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92142124|NCT04022473|Dermatologic Agents|dermatologic agents|mesh-ancestor
92142125|NCT04022473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142126|NCT04022473|Immunologic Factors|immunologic factors|mesh-ancestor
92142127|NCT04022473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142128|NCT01485614|Metformin|metformin|mesh-list
92142129|NCT01485614|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92142130|NCT01485614|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92142131|NCT01485614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142132|NCT01485614|Incretins|incretins|mesh-ancestor
92142133|NCT01485614|Hormones|hormones|mesh-ancestor
92142134|NCT01485614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142135|NCT01485614|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92142136|NCT01485614|Protease Inhibitors|protease inhibitors|mesh-ancestor
92142137|NCT01485614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142138|NCT01485614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142139|NCT00722553|Vitamins|vitamins|mesh-list
92142140|NCT00722553|Folic Acid|folic acid|mesh-list
92142141|NCT00722553|Vitamin B 12|vitamin b 12|mesh-list
92142142|NCT00722553|Vitamin B Complex|vitamin b complex|mesh-list
92142143|NCT00722553|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92142145|NCT00722553|Micronutrients|micronutrients|mesh-ancestor
92142146|NCT00722553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142147|NCT00722553|Hematinics|hematinics|mesh-ancestor
92142148|NCT00722553|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92142149|NCT00722553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142150|NCT00722553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142151|NCT00722553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142152|NCT03022747|Allopurinol|allopurinol|mesh-list
92142153|NCT03022747|Antimetabolites|antimetabolites|mesh-ancestor
92142154|NCT03022747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142155|NCT03022747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142156|NCT03022747|Gout Suppressants|gout suppressants|mesh-ancestor
92142157|NCT03022747|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142158|NCT03022747|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92142159|NCT03022747|Antioxidants|antioxidants|mesh-ancestor
92142160|NCT03022747|Protective Agents|protective agents|mesh-ancestor
92142161|NCT03022747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142162|NCT03928015|Analgesics|analgesics|mesh-list
92142163|NCT03928015|Dronabinol|dronabinol|mesh-list
92142164|NCT03928015|Sensory System Agents|sensory system agents|mesh-ancestor
92142165|NCT03928015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142166|NCT03928015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142167|NCT03928015|Hallucinogens|hallucinogens|mesh-ancestor
92142168|NCT03928015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92142169|NCT03928015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92142170|NCT03928015|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92142171|NCT03928015|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92142172|NCT03928015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142173|NCT03928015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142174|NCT03928015|Hormones|hormones|mesh-ancestor
92142175|NCT03928015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142176|NCT00735969|Ribavirin|ribavirin|mesh-list
92142177|NCT00735969|Antimetabolites|antimetabolites|mesh-ancestor
92142178|NCT00735969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142179|NCT00735969|Antiviral Agents|antiviral agents|mesh-ancestor
92142180|NCT00735969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142181|NCT03229512|Sildenafil Citrate|sildenafil citrate|mesh-list
92142182|NCT03229512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142183|NCT03229512|Vasodilator Agents|vasodilator agents|mesh-ancestor
92142184|NCT03229512|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92142185|NCT03229512|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92142186|NCT03229512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142187|NCT03229512|Urological Agents|urological agents|mesh-ancestor
92142188|NCT01279083|Timolol|timolol|mesh-list
92142189|NCT01279083|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92142190|NCT01279083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142191|NCT01279083|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92142192|NCT01279083|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92142193|NCT01279083|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142194|NCT01279083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142195|NCT01279083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142196|NCT01279083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92142197|NCT01279083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92142198|NCT03022201|Domperidone|domperidone|mesh-list
92142199|NCT03022201|Antiemetics|antiemetics|mesh-ancestor
92142200|NCT03022201|Autonomic Agents|autonomic agents|mesh-ancestor
92142201|NCT03022201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142202|NCT03022201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142203|NCT03022201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142204|NCT03022201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92142205|NCT03022201|Dopamine Agents|dopamine agents|mesh-ancestor
92142206|NCT03022201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142207|NCT03022201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142208|NCT04716114|Cytarabine|cytarabine|mesh-list
92142209|NCT04716114|Fludarabine|fludarabine|mesh-list
92142210|NCT04716114|Azacitidine|azacitidine|mesh-list
92142211|NCT04716114|Homoharringtonine|homoharringtonine|mesh-list
92142212|NCT04716114|Aclarubicin|aclarubicin|mesh-list
92142213|NCT04716114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142214|NCT04716114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92142215|NCT04716114|Antimetabolites|antimetabolites|mesh-ancestor
92142216|NCT04716114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142217|NCT04716114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142218|NCT04716114|Immunologic Factors|immunologic factors|mesh-ancestor
92142219|NCT04716114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142220|NCT04716114|Antiviral Agents|antiviral agents|mesh-ancestor
92142221|NCT04716114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142222|NCT04716114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142223|NCT04716114|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142224|NCT04716114|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92142225|NCT04716114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92142226|NCT04716114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142227|NCT04716114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142229|NCT00752973|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92142230|NCT00752973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142231|NCT00752973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142232|NCT00752973|Cholinergic Agents|cholinergic agents|mesh-ancestor
92142233|NCT00752973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142234|NCT00752973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142235|NCT04025593|Prednisone|prednisone|mesh-list
92142236|NCT04025593|Cyclophosphamide|cyclophosphamide|mesh-list
92142237|NCT04025593|Rituximab|rituximab|mesh-list
92142238|NCT04025593|Doxorubicin|doxorubicin|mesh-list
92142239|NCT04025593|Vincristine|vincristine|mesh-list
92142240|NCT04025593|Lenalidomide|lenalidomide|mesh-list
92142241|NCT04025593|Decitabine|decitabine|mesh-list
92142242|NCT04025593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142243|NCT04025593|Immunologic Factors|immunologic factors|mesh-ancestor
92142244|NCT04025593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142245|NCT04025593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142246|NCT04025593|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92142247|NCT04025593|Alkylating Agents|alkylating agents|mesh-ancestor
92142248|NCT04025593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142249|NCT04025593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142250|NCT04025593|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92142251|NCT04025593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92142252|NCT04025593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92142253|NCT04025593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142254|NCT04025593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142255|NCT04025593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142256|NCT04025593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142258|NCT04025593|Hormones|hormones|mesh-ancestor
92142259|NCT04025593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142260|NCT04025593|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142261|NCT04025593|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142262|NCT04025593|Tubulin Modulators|tubulin modulators|mesh-ancestor
92142263|NCT04025593|Antimitotic Agents|antimitotic agents|mesh-ancestor
92142264|NCT04025593|Mitosis Modulators|mitosis modulators|mesh-ancestor
92142265|NCT04025593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92142266|NCT04025593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92142267|NCT04025593|Growth Substances|growth substances|mesh-ancestor
92142268|NCT04025593|Growth Inhibitors|growth inhibitors|mesh-ancestor
92142269|NCT04025593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92142270|NCT04025593|Antimetabolites|antimetabolites|mesh-ancestor
92142271|NCT01279707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92142272|NCT01279707|Epratuzumab|epratuzumab|mesh-list
92142273|NCT01279707|Veltuzumab|veltuzumab|mesh-list
92142274|NCT01279707|Antibodies|antibodies|mesh-list
92142278|NCT01279707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142279|NCT01279707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142280|NCT02957292|Levonorgestrel|levonorgestrel|mesh-list
92142281|NCT02957292|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92142282|NCT02957292|Contraceptive Agents|contraceptive agents|mesh-ancestor
92142283|NCT02957292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92142284|NCT02957292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142285|NCT02957292|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92142286|NCT02957292|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92142287|NCT02957292|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92142288|NCT02595060|Molgramostim|molgramostim|mesh-list
92142289|NCT02595060|Sargramostim|sargramostim|mesh-list
92142290|NCT02595060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142291|NCT02595060|Immunologic Factors|immunologic factors|mesh-ancestor
92142292|NCT02595060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142294|NCT01273779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142295|NCT03023124|Doxorubicin|doxorubicin|mesh-list
92142296|NCT03023124|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92142297|NCT03023124|Dacarbazine|dacarbazine|mesh-list
92142298|NCT03023124|Trabectedin|trabectedin|mesh-list
92142299|NCT03023124|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92142300|NCT03023124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142301|NCT03023124|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142302|NCT03023124|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142303|NCT03023124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142304|NCT03023124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142305|NCT03023124|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92142306|NCT03023124|Alkylating Agents|alkylating agents|mesh-ancestor
92142308|NCT03022123|Cyclophosphamide|cyclophosphamide|mesh-list
92142309|NCT03022123|Doxorubicin|doxorubicin|mesh-list
92142310|NCT03022123|Vincristine|vincristine|mesh-list
92142311|NCT03022123|Epirubicin|epirubicin|mesh-list
92142312|NCT03022123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142313|NCT03022123|Immunologic Factors|immunologic factors|mesh-ancestor
92142314|NCT03022123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142315|NCT03022123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142316|NCT03022123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92142317|NCT03022123|Alkylating Agents|alkylating agents|mesh-ancestor
92142318|NCT03022123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142319|NCT03022123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142320|NCT03022123|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92142321|NCT03022123|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92142322|NCT03022123|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142323|NCT03022123|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142324|NCT03022123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142325|NCT03022123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142327|NCT03022123|Hormones|hormones|mesh-ancestor
92142328|NCT03022123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142329|NCT03022123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142330|NCT03022123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142331|NCT03022123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92142332|NCT03022123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92142333|NCT03022123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92142334|NCT00722865|Bevacizumab|bevacizumab|mesh-list
92142335|NCT00722865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92142336|NCT00722865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142337|NCT00722865|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92142338|NCT00722865|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92142339|NCT00722865|Growth Substances|growth substances|mesh-ancestor
92142340|NCT00722865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142341|NCT00722865|Growth Inhibitors|growth inhibitors|mesh-ancestor
92142342|NCT02700529|Ubenimex|ubenimex|mesh-list
92142343|NCT02700529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92142344|NCT02700529|Immunologic Factors|immunologic factors|mesh-ancestor
92142345|NCT02700529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142346|NCT02700529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92142347|NCT02700529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142348|NCT02700529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92142349|NCT02700529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142350|NCT02700529|Protease Inhibitors|protease inhibitors|mesh-ancestor
92142351|NCT02700529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142352|NCT02700529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142353|NCT02700529|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92142354|NCT02700529|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92142355|NCT02700529|Antiviral Agents|antiviral agents|mesh-ancestor
92142359|NCT04146493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92142360|NCT04146493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142361|NCT00723099|Cyclosporine|cyclosporine|mesh-list
92142362|NCT00723099|Mycophenolic Acid|mycophenolic acid|mesh-list
92142363|NCT00723099|Cyclophosphamide|cyclophosphamide|mesh-list
92142364|NCT00723099|Fludarabine|fludarabine|mesh-list
92142365|NCT00723099|Fludarabine phosphate|fludarabine phosphate|mesh-list
92142366|NCT00723099|Cyclosporins|cyclosporins|mesh-list
92142367|NCT00723099|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142368|NCT00723099|Immunologic Factors|immunologic factors|mesh-ancestor
92142369|NCT00723099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142370|NCT00723099|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142371|NCT00723099|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92142372|NCT00723099|Alkylating Agents|alkylating agents|mesh-ancestor
92142373|NCT00723099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142375|NCT00723099|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92142376|NCT00723099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92142377|NCT00723099|Antimetabolites|antimetabolites|mesh-ancestor
92142378|NCT00723099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142379|NCT00723099|Antifungal Agents|antifungal agents|mesh-ancestor
92142380|NCT00723099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142381|NCT00723099|Dermatologic Agents|dermatologic agents|mesh-ancestor
92142382|NCT00723099|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92142383|NCT00723099|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92142384|NCT00723099|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92142385|NCT00723099|Antitubercular Agents|antitubercular agents|mesh-ancestor
92142386|NCT00723099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92142388|NCT01508936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92142389|NCT01508936|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142390|NCT04146259|Alfacalcidol|alfacalcidol|mesh-list
92142391|NCT04146259|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92142392|NCT04146259|Calcium Carbonate|calcium carbonate|mesh-list
92142393|NCT04146259|Calcium|calcium|mesh-list
92142394|NCT04146259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92142395|NCT04146259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142396|NCT04146259|Antacids|antacids|mesh-ancestor
92142397|NCT04146259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142398|NCT04146259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142399|NCT04146259|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92142400|NCT04146259|Vitamins|vitamins|mesh-ancestor
92142401|NCT04146259|Micronutrients|micronutrients|mesh-ancestor
92142402|NCT05100186|Dexamethasone|dexamethasone|mesh-list
92142403|NCT05100186|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142404|NCT05100186|Antiemetics|antiemetics|mesh-ancestor
92142405|NCT05100186|Autonomic Agents|autonomic agents|mesh-ancestor
92142406|NCT05100186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142407|NCT05100186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142408|NCT05100186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142409|NCT05100186|Glucocorticoids|glucocorticoids|mesh-ancestor
92142410|NCT05100186|Hormones|hormones|mesh-ancestor
92142411|NCT05100186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142412|NCT05100186|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142413|NCT05100186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142414|NCT04323462|Insulin|insulin|mesh-list
92142415|NCT04323462|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92142416|NCT04323462|Insulin Glargine|insulin glargine|mesh-list
92142417|NCT04323462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92142418|NCT04323462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142419|NCT00723177|Ibudilast|ibudilast|mesh-list
92142420|NCT00723177|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92142421|NCT00723177|Autonomic Agents|autonomic agents|mesh-ancestor
92142422|NCT00723177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142423|NCT00723177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142424|NCT00723177|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92142425|NCT00723177|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142426|NCT00723177|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92142427|NCT00723177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142428|NCT00723177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142429|NCT00723177|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92142430|NCT00723177|Vasodilator Agents|vasodilator agents|mesh-ancestor
92142431|NCT04318392|Dimercaprol|dimercaprol|mesh-list
92142432|NCT04318392|Chelating Agents|chelating agents|mesh-ancestor
92142433|NCT04318392|Sequestering Agents|sequestering agents|mesh-ancestor
92142434|NCT04318392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142435|NCT04698434|Esketamine|esketamine|mesh-list
92142436|NCT04698434|Antidepressive Agents|antidepressive agents|mesh-ancestor
92142440|NCT04142749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142441|NCT04142749|Schistosomicides|schistosomicides|mesh-ancestor
92142442|NCT04142749|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92142443|NCT04142749|Anthelmintics|anthelmintics|mesh-ancestor
92142444|NCT04142749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92142445|NCT04142749|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92142446|NCT04142749|Protective Agents|protective agents|mesh-ancestor
92142447|NCT04142749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142448|NCT04142749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142449|NCT04142749|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92142450|NCT04142749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92142451|NCT04142749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142452|NCT04142749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142453|NCT01508702|Lesinurad|lesinurad|mesh-list
92142454|NCT01508702|Gout Suppressants|gout suppressants|mesh-ancestor
92142455|NCT01508702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142456|NCT01508702|Uricosuric Agents|uricosuric agents|mesh-ancestor
92142457|NCT04024813|Seladelpar|seladelpar|mesh-list
92142458|NCT04024813|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92142459|NCT04024813|Antimetabolites|antimetabolites|mesh-ancestor
92142460|NCT04024813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142461|NCT04024813|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92142462|NCT01276041|Paclitaxel|paclitaxel|mesh-list
92142463|NCT01276041|Trastuzumab|trastuzumab|mesh-list
92142464|NCT01276041|Pertuzumab|pertuzumab|mesh-list
92142465|NCT01276041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142466|NCT01276041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142467|NCT01276041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92142468|NCT01276041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92142469|NCT01276041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92142470|NCT01276041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142471|NCT01276041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92142473|NCT04150770|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92142474|NCT04150770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142475|NCT04150770|Dermatologic Agents|dermatologic agents|mesh-ancestor
92142476|NCT04150770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142477|NCT04150770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142478|NCT04026438|Potassium phosphate|potassium phosphate|mesh-list
92142479|NCT04026438|Cariostatic Agents|cariostatic agents|mesh-ancestor
92142480|NCT04026438|Protective Agents|protective agents|mesh-ancestor
92142481|NCT04026438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142482|NCT01275339|Tadalafil|tadalafil|mesh-list
92142483|NCT01275339|Vasodilator Agents|vasodilator agents|mesh-ancestor
92142484|NCT01275339|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92142485|NCT01275339|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92142486|NCT01275339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142487|NCT01275339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142488|NCT01275339|Urological Agents|urological agents|mesh-ancestor
92142489|NCT01520402|Warfarin|warfarin|mesh-list
92142490|NCT01520402|Anticoagulants|anticoagulants|mesh-list
92142491|NCT00738543|Povidone-Iodine|povidone-iodine|mesh-list
92142492|NCT00738543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92142493|NCT00738543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142494|NCT05108220|Cannabidiol|cannabidiol|mesh-list
92142495|NCT05108220|Anticonvulsants|anticonvulsants|mesh-ancestor
92142496|NCT03027674|Nifedipine|nifedipine|mesh-list
92142497|NCT03027674|Sildenafil Citrate|sildenafil citrate|mesh-list
92142498|NCT03027674|Vasodilator Agents|vasodilator agents|mesh-ancestor
92142499|NCT03027674|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92142500|NCT03027674|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92142501|NCT03027674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142502|NCT03027674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142503|NCT03027674|Urological Agents|urological agents|mesh-ancestor
92142504|NCT03027674|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92142505|NCT03027674|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142506|NCT03027674|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92142507|NCT03027674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142508|NCT03027674|Tocolytic Agents|tocolytic agents|mesh-ancestor
92142509|NCT03027674|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92142510|NCT04144153|Analgesics, Opioid|analgesics, opioid|mesh-list
92142511|NCT04144153|Anesthetics|anesthetics|mesh-list
92142512|NCT04144153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142513|NCT04144153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142514|NCT04144153|Narcotics|narcotics|mesh-ancestor
92142515|NCT04144153|Analgesics|analgesics|mesh-ancestor
92142516|NCT04144153|Sensory System Agents|sensory system agents|mesh-ancestor
92142517|NCT04144153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142518|NCT04094948|Clenbuterol|clenbuterol|mesh-list
92142519|NCT04094948|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92142520|NCT04094948|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92142521|NCT04094948|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142522|NCT04094948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142523|NCT04094948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142524|NCT04094948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142525|NCT04094948|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92142526|NCT04094948|Autonomic Agents|autonomic agents|mesh-ancestor
92142527|NCT04094948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142528|NCT04094948|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92142529|NCT04094948|Respiratory System Agents|respiratory system agents|mesh-ancestor
92142530|NCT04094948|Sympathomimetics|sympathomimetics|mesh-ancestor
92142531|NCT04023565|Perindopril|perindopril|mesh-list
92142532|NCT04023565|Moxonidine|moxonidine|mesh-list
92142533|NCT04023565|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92142534|NCT04023565|Protease Inhibitors|protease inhibitors|mesh-ancestor
92142535|NCT04023565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142536|NCT04023565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142537|NCT04023565|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92142538|NCT01506908|Nicotine|nicotine|mesh-list
92142539|NCT01506908|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92142540|NCT01506908|Autonomic Agents|autonomic agents|mesh-ancestor
92142541|NCT01506908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142542|NCT01506908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142543|NCT01506908|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92142544|NCT01506908|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92142545|NCT01506908|Cholinergic Agents|cholinergic agents|mesh-ancestor
92142546|NCT01506908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142547|NCT01506908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142548|NCT01519778|Tedizolid|tedizolid|mesh-list
92142549|NCT01519778|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92142550|NCT01519778|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142551|NCT04144933|Acetaminophen|acetaminophen|mesh-list
92142552|NCT04144933|Dexamethasone|dexamethasone|mesh-list
92142553|NCT04144933|Lidocaine|lidocaine|mesh-list
92142554|NCT04144933|Magnesium Sulfate|magnesium sulfate|mesh-list
92142555|NCT04144933|Sufentanil|sufentanil|mesh-list
92142556|NCT04144933|Dexmedetomidine|dexmedetomidine|mesh-list
92142557|NCT04144933|Ketamine|ketamine|mesh-list
92142558|NCT04144933|Gabapentin|gabapentin|mesh-list
92142559|NCT04144933|Dsuvia|dsuvia|mesh-list
92142560|NCT04144933|Analgesics, Opioid|analgesics, opioid|mesh-list
92142561|NCT04144933|Ondansetron|ondansetron|mesh-list
92142562|NCT04144933|Sevoflurane|sevoflurane|mesh-list
92142563|NCT04144933|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92142564|NCT04144933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142565|NCT04144933|Antiemetics|antiemetics|mesh-ancestor
92142566|NCT04144933|Autonomic Agents|autonomic agents|mesh-ancestor
92142567|NCT04144933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142568|NCT04144933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142569|NCT04144933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142570|NCT04144933|Glucocorticoids|glucocorticoids|mesh-ancestor
92142571|NCT04144933|Hormones|hormones|mesh-ancestor
92142572|NCT04144933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142573|NCT04144933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142574|NCT04144933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142575|NCT04144933|Anesthetics, Local|anesthetics, local|mesh-ancestor
92142576|NCT04144933|Anesthetics|anesthetics|mesh-ancestor
92142577|NCT04144933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142578|NCT04144933|Sensory System Agents|sensory system agents|mesh-ancestor
92142579|NCT04144933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92142580|NCT04144933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92142581|NCT04144933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92142582|NCT04144933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142583|NCT04144933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142584|NCT04144933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92142585|NCT04144933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92142586|NCT04144933|Analgesics|analgesics|mesh-ancestor
92142587|NCT04144933|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92142588|NCT04144933|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92142589|NCT04144933|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92142590|NCT04144933|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142591|NCT04144933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142592|NCT04144933|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92142593|NCT04144933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92142595|NCT04144933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92142596|NCT04144933|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92142597|NCT04144933|Antipyretics|antipyretics|mesh-ancestor
92142598|NCT04144933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92142599|NCT04144933|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92142600|NCT04144933|Anticonvulsants|anticonvulsants|mesh-ancestor
92142601|NCT04144933|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92142602|NCT04144933|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92142603|NCT04144933|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92142604|NCT04144933|Antimanic Agents|antimanic agents|mesh-ancestor
92142605|NCT04144933|Narcotics|narcotics|mesh-ancestor
92142606|NCT04144933|Antipruritics|antipruritics|mesh-ancestor
92142607|NCT04144933|Dermatologic Agents|dermatologic agents|mesh-ancestor
92142608|NCT04144933|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92142609|NCT04144933|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92142610|NCT04144933|Serotonin Agents|serotonin agents|mesh-ancestor
92142611|NCT04144933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92142612|NCT04144933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92142613|NCT04144933|Tocolytic Agents|tocolytic agents|mesh-ancestor
92142614|NCT04144933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92142615|NCT04144933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92142616|NCT04149067|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92142617|NCT04149067|Dapagliflozin|dapagliflozin|mesh-list
92142618|NCT04149067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92142619|NCT04149067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142620|NCT04149067|Incretins|incretins|mesh-ancestor
92142622|NCT04149067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142623|NCT04149067|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92142625|NCT04149067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142626|NCT04149067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142627|NCT04149067|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92142628|NCT04022941|Sodium Benzoate|sodium benzoate|mesh-list
92142629|NCT04022941|Antifungal Agents|antifungal agents|mesh-ancestor
92142630|NCT04022941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142631|NCT05087862|Anesthetics|anesthetics|mesh-list
92142632|NCT05087862|Anesthetics, Local|anesthetics, local|mesh-list
92142633|NCT05087862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142634|NCT05087862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142635|NCT05087862|Sensory System Agents|sensory system agents|mesh-ancestor
92142636|NCT05087862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142637|NCT01519700|Lenograstim|lenograstim|mesh-list
92142638|NCT01519700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92142639|NCT01519700|Immunologic Factors|immunologic factors|mesh-ancestor
92142640|NCT01519700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142641|NCT04143685|Misoprostol|misoprostol|mesh-list
92142642|NCT04143685|Oxytocin|oxytocin|mesh-list
92142643|NCT04143685|Oxytocics|oxytocics|mesh-ancestor
92142644|NCT04143685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92142645|NCT04143685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142646|NCT04143685|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92142647|NCT04143685|Abortifacient Agents|abortifacient agents|mesh-ancestor
92142648|NCT04143685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92142649|NCT04143685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142650|NCT04148599|Lidocaine|lidocaine|mesh-list
92142651|NCT04148599|Dexmedetomidine|dexmedetomidine|mesh-list
92142652|NCT04148599|Anesthetics, Local|anesthetics, local|mesh-ancestor
92142653|NCT04148599|Anesthetics|anesthetics|mesh-ancestor
92142654|NCT04148599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142655|NCT04148599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142656|NCT04148599|Sensory System Agents|sensory system agents|mesh-ancestor
92142657|NCT04148599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142658|NCT04148599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92142659|NCT04148599|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92142660|NCT04148599|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92142661|NCT04148599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142662|NCT04148599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142663|NCT04148599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92142664|NCT04148599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92142665|NCT04148599|Analgesics|analgesics|mesh-ancestor
92142666|NCT04148599|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92142667|NCT04148599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92142668|NCT04148599|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92142669|NCT04148599|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142670|NCT04148599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142671|NCT04930458|Listerine|listerine|mesh-list
92142677|NCT04930458|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92142678|NCT04930458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142679|NCT04930458|Cariostatic Agents|cariostatic agents|mesh-ancestor
92142680|NCT04930458|Protective Agents|protective agents|mesh-ancestor
92142681|NCT04930458|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92142682|NCT04930458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142683|NCT04930458|Chelating Agents|chelating agents|mesh-ancestor
92142684|NCT04930458|Sequestering Agents|sequestering agents|mesh-ancestor
92142685|NCT04930458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142687|NCT04917588|Anesthetics, Local|anesthetics, local|mesh-ancestor
92142688|NCT04917588|Anesthetics|anesthetics|mesh-ancestor
92142689|NCT04917588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142690|NCT04917588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142691|NCT04917588|Sensory System Agents|sensory system agents|mesh-ancestor
92142692|NCT04917588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142693|NCT04917588|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92142694|NCT04917588|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92142695|NCT04917588|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92142696|NCT04917588|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142697|NCT04917588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142698|NCT05101356|Antineoplastic Agents|antineoplastic agents|mesh-list
92142700|NCT05101356|Sargramostim|sargramostim|mesh-list
92142701|NCT05101356|Immunologic Factors|immunologic factors|mesh-ancestor
92142702|NCT05101356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142703|NCT04022317|Insulin|insulin|mesh-list
92142704|NCT04022317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92142705|NCT04022317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142706|NCT05099250|Magnesium Sulfate|magnesium sulfate|mesh-list
92142707|NCT05099250|Bupivacaine|bupivacaine|mesh-list
92142708|NCT05099250|Anesthetics, Local|anesthetics, local|mesh-ancestor
92142709|NCT05099250|Anesthetics|anesthetics|mesh-ancestor
92142710|NCT05099250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142711|NCT05099250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142712|NCT05099250|Sensory System Agents|sensory system agents|mesh-ancestor
92142713|NCT05099250|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142714|NCT05099250|Analgesics|analgesics|mesh-ancestor
92142715|NCT05099250|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92142716|NCT05099250|Anticonvulsants|anticonvulsants|mesh-ancestor
92142717|NCT05099250|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92142718|NCT05099250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142719|NCT05099250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142720|NCT05099250|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92142721|NCT05099250|Tocolytic Agents|tocolytic agents|mesh-ancestor
92142722|NCT05099250|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92142723|NCT04143451|Imiquimod|imiquimod|mesh-list
92142724|NCT04143451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92142725|NCT04143451|Immunologic Factors|immunologic factors|mesh-ancestor
92142726|NCT04143451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142727|NCT04143451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142728|NCT04143451|Interferon Inducers|interferon inducers|mesh-ancestor
92142729|NCT05105412|Gemcitabine|gemcitabine|mesh-list
92142730|NCT05105412|Lenalidomide|lenalidomide|mesh-list
92142731|NCT05105412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92142732|NCT05105412|Antimetabolites|antimetabolites|mesh-ancestor
92142733|NCT05105412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142734|NCT05105412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142735|NCT05105412|Immunologic Factors|immunologic factors|mesh-ancestor
92142736|NCT05105412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142737|NCT05105412|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92142738|NCT05105412|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92142739|NCT05105412|Growth Substances|growth substances|mesh-ancestor
92142740|NCT05105412|Growth Inhibitors|growth inhibitors|mesh-ancestor
92142741|NCT04766047|Dexmedetomidine|dexmedetomidine|mesh-list
92142742|NCT04766047|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92142743|NCT04766047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142744|NCT04766047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142745|NCT04766047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92142746|NCT04766047|Analgesics|analgesics|mesh-ancestor
92142747|NCT04766047|Sensory System Agents|sensory system agents|mesh-ancestor
92142748|NCT04766047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142749|NCT04766047|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92142750|NCT04766047|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92142751|NCT04766047|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92142752|NCT04766047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92142753|NCT04766047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142754|NCT04766047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142755|NCT02080819|Levodopa|levodopa|mesh-list
92142756|NCT02080819|Carbidopa|carbidopa|mesh-list
92142757|NCT02080819|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92142758|NCT02080819|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92142759|NCT02080819|Dopamine Agents|dopamine agents|mesh-ancestor
92142760|NCT02080819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142761|NCT02080819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142762|NCT02080819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142763|NCT02080819|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92142764|NCT02080819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142765|NCT05104788|Carboplatin|carboplatin|mesh-list
92142766|NCT05104788|Pemetrexed|pemetrexed|mesh-list
92142767|NCT05104788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142768|NCT05104788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142769|NCT05104788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142770|NCT05104788|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92142771|NCT05104788|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92142772|NCT04405843|Ivermectin|ivermectin|mesh-list
92142773|NCT04405843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92142774|NCT04405843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142775|NCT04316364|Paclitaxel|paclitaxel|mesh-list
92142776|NCT04316364|Carboplatin|carboplatin|mesh-list
92142777|NCT04316364|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142778|NCT04316364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142779|NCT04316364|Tubulin Modulators|tubulin modulators|mesh-ancestor
92142780|NCT04316364|Antimitotic Agents|antimitotic agents|mesh-ancestor
92142781|NCT04316364|Mitosis Modulators|mitosis modulators|mesh-ancestor
92142782|NCT04316364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142783|NCT03916003|Primaquine|primaquine|mesh-list
92142784|NCT03916003|Antimalarials|antimalarials|mesh-ancestor
92142785|NCT03916003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92142786|NCT03916003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92142787|NCT03916003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142788|NCT04781478|Chlorhexidine|chlorhexidine|mesh-list
92142789|NCT04781478|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92142790|NCT04781478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142791|NCT04781478|Disinfectants|disinfectants|mesh-ancestor
92142792|NCT04018872|Itraconazole|itraconazole|mesh-list
92142793|NCT04018872|Antifungal Agents|antifungal agents|mesh-ancestor
92142794|NCT04018872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142795|NCT04018872|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92142796|NCT04018872|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92142797|NCT04018872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142798|NCT04018872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142799|NCT04018872|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92142800|NCT04018872|Hormone Antagonists|hormone antagonists|mesh-ancestor
92142801|NCT04018872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142802|NCT04018872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142803|NCT04018872|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92142804|NCT03896737|Thalidomide|thalidomide|mesh-list
92142805|NCT03896737|Dexamethasone|dexamethasone|mesh-list
92142806|NCT03896737|Dexamethasone acetate|dexamethasone acetate|mesh-list
92142807|NCT03896737|Cyclophosphamide|cyclophosphamide|mesh-list
92142808|NCT03896737|Bortezomib|bortezomib|mesh-list
92142809|NCT03896737|Daratumumab|daratumumab|mesh-list
92142810|NCT03896737|BB 1101|bb 1101|mesh-list
92142811|NCT03896737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142812|NCT03896737|Immunologic Factors|immunologic factors|mesh-ancestor
92142813|NCT03896737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142814|NCT03896737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142815|NCT03896737|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92142816|NCT03896737|Alkylating Agents|alkylating agents|mesh-ancestor
92142817|NCT03896737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142818|NCT03896737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142819|NCT03896737|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92142820|NCT03896737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142822|NCT03896737|Autonomic Agents|autonomic agents|mesh-ancestor
92142823|NCT03896737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142824|NCT03896737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142825|NCT03896737|Glucocorticoids|glucocorticoids|mesh-ancestor
92142826|NCT03896737|Hormones|hormones|mesh-ancestor
92142827|NCT03896737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142828|NCT03896737|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142832|NCT03896737|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92142833|NCT03896737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142834|NCT03896737|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92142835|NCT03896737|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92142836|NCT03896737|Growth Substances|growth substances|mesh-ancestor
92142837|NCT03896737|Growth Inhibitors|growth inhibitors|mesh-ancestor
92142838|NCT05076786|Carboplatin|carboplatin|mesh-list
92142839|NCT05076786|Etoposide|etoposide|mesh-list
92142840|NCT05076786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142841|NCT05076786|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142842|NCT05076786|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142843|NCT05076786|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142844|NCT05076786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142845|NCT05076786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142846|NCT03476317|Vancomycin|vancomycin|mesh-list
92142847|NCT03476317|Ciprofloxacin|ciprofloxacin|mesh-list
92142848|NCT03476317|Neomycin|neomycin|mesh-list
92142849|NCT03476317|Fluconazole|fluconazole|mesh-list
92142850|NCT03476317|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92142851|NCT03476317|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92142852|NCT03476317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142853|NCT03476317|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92142854|NCT03476317|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92142855|NCT03476317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142856|NCT03476317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142857|NCT03476317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142858|NCT03476317|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92142859|NCT03476317|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92142860|NCT03476317|Antifungal Agents|antifungal agents|mesh-ancestor
92142861|NCT03476317|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92142862|NCT03476317|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92142863|NCT03476317|Hormone Antagonists|hormone antagonists|mesh-ancestor
92142864|NCT03476317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142865|NCT03476317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142866|NCT03476317|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92142867|NCT03476317|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92142868|NCT03476317|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92142869|NCT03476317|Laxatives|laxatives|mesh-ancestor
92142870|NCT03476317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142871|NCT02658084|Trastuzumab|trastuzumab|mesh-list
92142872|NCT02658084|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92142873|NCT02658084|Vinorelbine|vinorelbine|mesh-list
92142874|NCT02658084|Maytansine|maytansine|mesh-list
92142875|NCT02658084|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92142876|NCT02658084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142877|NCT02658084|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92142878|NCT02658084|Tubulin Modulators|tubulin modulators|mesh-ancestor
92142879|NCT02658084|Antimitotic Agents|antimitotic agents|mesh-ancestor
92142880|NCT02658084|Mitosis Modulators|mitosis modulators|mesh-ancestor
92142881|NCT02658084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142882|NCT02658084|Immunotoxins|immunotoxins|mesh-ancestor
92142883|NCT02658084|Immunoconjugates|immunoconjugates|mesh-ancestor
92142884|NCT02658084|Immunologic Factors|immunologic factors|mesh-ancestor
92142885|NCT02658084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142886|NCT03588871|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92142887|NCT03588871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92142888|NCT03588871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142889|NCT03588715|Interferons|interferons|mesh-list
92142890|NCT03588715|Interferon-alpha|interferon-alpha|mesh-list
92142891|NCT03588715|Interferon alpha-2|interferon alpha-2|mesh-list
92142892|NCT03588715|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92142893|NCT03588715|Antibodies, Blocking|antibodies, blocking|mesh-list
92142894|NCT03588715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142895|NCT03588715|Antiviral Agents|antiviral agents|mesh-ancestor
92142896|NCT03588715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142897|NCT03588715|Immunologic Factors|immunologic factors|mesh-ancestor
92142898|NCT03588715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142899|NCT04528758|Rhodamine 6G|rhodamine 6g|mesh-list
92142900|NCT04528758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142901|NCT04140409|Octreotide|octreotide|mesh-list
92142902|NCT04140409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142903|NCT04140409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92142904|NCT04140409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142905|NCT04527432|Antibodies|antibodies|mesh-list
92142906|NCT04527432|Immunologic Factors|immunologic factors|mesh-ancestor
92142907|NCT04527432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142909|NCT03912805|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92142910|NCT03912805|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92142911|NCT03912805|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92142912|NCT03912805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92142913|NCT03912805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142914|NCT03912805|Cholinergic Agents|cholinergic agents|mesh-ancestor
92142915|NCT03912805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92142916|NCT03912805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142917|NCT03912805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92142918|NCT03912805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142919|NCT04642950|Sargramostim|sargramostim|mesh-list
92142920|NCT04642950|Immunologic Factors|immunologic factors|mesh-ancestor
92142921|NCT04642950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142922|NCT04374240|Tretazicar|tretazicar|mesh-list
92142923|NCT04374240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142924|NCT05109390|Cyclosporine|cyclosporine|mesh-list
92142925|NCT05109390|Simethicone|simethicone|mesh-list
92142926|NCT05109390|Omeprazole|omeprazole|mesh-list
92142927|NCT05109390|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
92142928|NCT05109390|Calcium Carbonate|calcium carbonate|mesh-list
92142929|NCT05109390|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92142930|NCT05109390|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
92142931|NCT05109390|Antacids|antacids|mesh-list
92142932|NCT05109390|Tacrolimus|tacrolimus|mesh-list
92142933|NCT05109390|Cyclosporins|cyclosporins|mesh-list
92142934|NCT05109390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142935|NCT05109390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92142936|NCT05109390|Immunologic Factors|immunologic factors|mesh-ancestor
92142937|NCT05109390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92142938|NCT05109390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142939|NCT05109390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142940|NCT05109390|Antifungal Agents|antifungal agents|mesh-ancestor
92142941|NCT05109390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92142942|NCT05109390|Dermatologic Agents|dermatologic agents|mesh-ancestor
92142943|NCT05109390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142944|NCT05109390|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92142945|NCT05109390|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92142946|NCT05109390|Antifoaming Agents|antifoaming agents|mesh-ancestor
92142947|NCT05109390|Emollients|emollients|mesh-ancestor
92142948|NCT04030182|Vitamin D|vitamin d|mesh-list
92142949|NCT04030182|Vitamins|vitamins|mesh-ancestor
92142950|NCT04030182|Micronutrients|micronutrients|mesh-ancestor
92142951|NCT04030182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142952|NCT04030182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92142953|NCT05109312|Acetaminophen|acetaminophen|mesh-list
92142954|NCT05109312|Ibuprofen|ibuprofen|mesh-list
92142955|NCT05109312|Bupivacaine|bupivacaine|mesh-list
92142956|NCT05109312|Anesthetics, Local|anesthetics, local|mesh-ancestor
92142957|NCT05109312|Anesthetics|anesthetics|mesh-ancestor
92142958|NCT05109312|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142959|NCT05109312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142960|NCT05109312|Sensory System Agents|sensory system agents|mesh-ancestor
92142961|NCT05109312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142962|NCT05109312|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92142963|NCT05109312|Analgesics|analgesics|mesh-ancestor
92142964|NCT05109312|Antipyretics|antipyretics|mesh-ancestor
92142965|NCT05109312|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92142966|NCT05109312|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92142967|NCT05109312|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92142968|NCT05109312|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92142969|NCT05109312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92142970|NCT05109312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142972|NCT03661632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92142973|NCT03661632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92142974|NCT03661632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92142975|NCT03661632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142976|NCT04748250|Phytoestrogens|phytoestrogens|mesh-list
92142977|NCT04748250|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92142978|NCT04748250|Estrogens|estrogens|mesh-ancestor
92142979|NCT04748250|Hormones|hormones|mesh-ancestor
92142980|NCT04748250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92142981|NCT04748250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142983|NCT04726878|Oxycodone|oxycodone|mesh-list
92142984|NCT04726878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92142985|NCT04726878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92142986|NCT04726878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92142988|NCT04726878|Sensory System Agents|sensory system agents|mesh-ancestor
92142989|NCT04726878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92142990|NCT04726878|Antipyretics|antipyretics|mesh-ancestor
92142991|NCT04726878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92142992|NCT04726878|Narcotics|narcotics|mesh-ancestor
92142993|NCT04525638|Nivolumab|nivolumab|mesh-list
92142994|NCT04525638|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92142995|NCT04525638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92142997|NCT04525638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92142998|NCT04525638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92142999|NCT04525638|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92143000|NCT01482962|Gemcitabine|gemcitabine|mesh-list
92143001|NCT01482962|Romidepsin|romidepsin|mesh-list
92143002|NCT01482962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92143003|NCT01482962|Antimetabolites|antimetabolites|mesh-ancestor
92143004|NCT01482962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143005|NCT01482962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143006|NCT01482962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92143007|NCT01482962|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92143008|NCT01482962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143009|NCT04701060|Apatinib|apatinib|mesh-list
92143010|NCT04701060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143011|NCT04701060|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143012|NCT04701060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143013|NCT04701060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143014|NCT05116098|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92143015|NCT05116098|Antioxidants|antioxidants|mesh-ancestor
92143016|NCT05116098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143017|NCT05116098|Protective Agents|protective agents|mesh-ancestor
92143018|NCT05116098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143019|NCT05116098|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92143020|NCT05116098|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92143021|NCT05116098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143022|NCT05116098|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92143023|NCT04464408|Favipiravir|favipiravir|mesh-list
92143024|NCT04464408|Antiviral Agents|antiviral agents|mesh-ancestor
92143025|NCT04464408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143026|NCT04339218|Carboplatin|carboplatin|mesh-list
92143027|NCT04339218|Pembrolizumab|pembrolizumab|mesh-list
92143028|NCT04339218|Pemetrexed|pemetrexed|mesh-list
92143029|NCT04339218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143030|NCT04339218|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143031|NCT04339218|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92143032|NCT04339218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143033|NCT04339218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143034|NCT04339218|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92143035|NCT04339218|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92143036|NCT03895801|Prednisone|prednisone|mesh-list
92143037|NCT03895801|Glucocorticoids|glucocorticoids|mesh-list
92143038|NCT03895801|Vilobelimab|vilobelimab|mesh-list
92143039|NCT03895801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143040|NCT03895801|Hormones|hormones|mesh-ancestor
92143041|NCT03895801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143042|NCT03895801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143043|NCT03895801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92143044|NCT03895801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143045|NCT03895801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92143046|NCT03895801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92143047|NCT03895801|Immunologic Factors|immunologic factors|mesh-ancestor
92143048|NCT03021421|Bupivacaine|bupivacaine|mesh-list
92143049|NCT03021421|Anesthetics, Local|anesthetics, local|mesh-ancestor
92143050|NCT03021421|Anesthetics|anesthetics|mesh-ancestor
92143051|NCT03021421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143052|NCT03021421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143053|NCT03021421|Sensory System Agents|sensory system agents|mesh-ancestor
92143054|NCT03021421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143055|NCT04521582|Amlodipine|amlodipine|mesh-list
92143056|NCT04521582|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92143057|NCT04521582|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92143058|NCT04521582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92143059|NCT04521582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143060|NCT04521582|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143061|NCT04521582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143062|NCT04521582|Vasodilator Agents|vasodilator agents|mesh-ancestor
92143063|NCT03588091|Docetaxel|docetaxel|mesh-list
92143065|NCT03588091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143066|NCT03588091|Tubulin Modulators|tubulin modulators|mesh-ancestor
92143067|NCT03588091|Antimitotic Agents|antimitotic agents|mesh-ancestor
92143068|NCT03588091|Mitosis Modulators|mitosis modulators|mesh-ancestor
92143069|NCT03588091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143070|NCT03588091|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143071|NCT05065554|Rituximab|rituximab|mesh-list
92143072|NCT05065554|Acalabrutinib|acalabrutinib|mesh-list
92143073|NCT05065554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143074|NCT05065554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143075|NCT05065554|Immunologic Factors|immunologic factors|mesh-ancestor
92143076|NCT05065554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143077|NCT05065554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143078|NCT04436172|Anesthetics|anesthetics|mesh-list
92143079|NCT04436172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143080|NCT04436172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143081|NCT03587779|Sevoflurane|sevoflurane|mesh-list
92143082|NCT03587779|Desflurane|desflurane|mesh-list
92143083|NCT03587779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92143084|NCT03587779|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92143085|NCT03587779|Anesthetics, General|anesthetics, general|mesh-ancestor
92143086|NCT03587779|Anesthetics|anesthetics|mesh-ancestor
92143087|NCT03587779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143088|NCT03587779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143089|NCT04405921|Azithromycin|azithromycin|mesh-list
92143090|NCT04405921|Hydroxychloroquine|hydroxychloroquine|mesh-list
92143091|NCT04405921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143092|NCT04405921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143093|NCT04405921|Antimalarials|antimalarials|mesh-ancestor
92143094|NCT04405921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92143095|NCT04405921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92143096|NCT04405921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143097|NCT04405921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143098|NCT04405921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143099|NCT04516902|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92143100|NCT04516902|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92143101|NCT04516902|Hallucinogens|hallucinogens|mesh-ancestor
92143102|NCT04516902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143103|NCT04516902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92143104|NCT04516902|Serotonin Agents|serotonin agents|mesh-ancestor
92143105|NCT04516902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143106|NCT04516902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143107|NCT04516902|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92143108|NCT04516902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92143109|NCT04516902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92143110|NCT04516902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92143111|NCT04516902|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92143112|NCT04516902|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92143113|NCT03581149|Ascorbic Acid|ascorbic acid|mesh-list
92143114|NCT03581149|Magnesium citrate|magnesium citrate|mesh-list
92143115|NCT03581149|Picosulfate sodium|picosulfate sodium|mesh-list
92143116|NCT03581149|Laxatives|laxatives|mesh-list
92143117|NCT03581149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143118|NCT03581149|Antioxidants|antioxidants|mesh-ancestor
92143119|NCT03581149|Protective Agents|protective agents|mesh-ancestor
92143120|NCT03581149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143121|NCT03581149|Vitamins|vitamins|mesh-ancestor
92143122|NCT03581149|Micronutrients|micronutrients|mesh-ancestor
92143123|NCT03581149|Cathartics|cathartics|mesh-ancestor
92143124|NCT03581149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143125|NCT04765267|Vitamin D|vitamin d|mesh-list
92143126|NCT04765267|Cholecalciferol|cholecalciferol|mesh-list
92143127|NCT04765267|Zinc Sulfate|zinc sulfate|mesh-list
92143128|NCT04765267|Vitamins|vitamins|mesh-ancestor
92143129|NCT04765267|Micronutrients|micronutrients|mesh-ancestor
92143130|NCT04765267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143131|NCT04765267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92143132|NCT04765267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143134|NCT04765267|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143135|NCT05583409|Osimertinib|osimertinib|mesh-list
92143136|NCT05583409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143137|NCT05583409|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143138|NCT05583409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143139|NCT05583409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143140|NCT03020953|Estrogens|estrogens|mesh-list
92143141|NCT03020953|Hormones|hormones|mesh-ancestor
92143219|NCT03891355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143142|NCT03020953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143143|NCT03020953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143144|NCT05583175|Venetoclax|venetoclax|mesh-list
92143145|NCT05583175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143146|NCT03891901|Isoniazid|isoniazid|mesh-list
92143147|NCT03891901|Rifabutin|rifabutin|mesh-list
92143148|NCT03891901|Imatinib Mesylate|imatinib mesylate|mesh-list
92143149|NCT03891901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143150|NCT03891901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143151|NCT03891901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143152|NCT03891901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143153|NCT03891901|Antitubercular Agents|antitubercular agents|mesh-ancestor
92143154|NCT03891901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143155|NCT03891901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143156|NCT03891901|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92143157|NCT03891901|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92143158|NCT03891901|Antimetabolites|antimetabolites|mesh-ancestor
92143159|NCT03891901|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92143160|NCT03891901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92143161|NCT03580681|Vitamin E|vitamin e|mesh-list
92143162|NCT03580681|Vitamins|vitamins|mesh-ancestor
92143163|NCT03580681|Micronutrients|micronutrients|mesh-ancestor
92143164|NCT03580681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143165|NCT03580681|Antioxidants|antioxidants|mesh-ancestor
92143166|NCT03580681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143167|NCT03580681|Protective Agents|protective agents|mesh-ancestor
92143168|NCT03452826|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92143169|NCT03452826|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92143170|NCT03452826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143171|NCT03452826|Antitubercular Agents|antitubercular agents|mesh-ancestor
92143172|NCT05040126|Linezolid|linezolid|mesh-list
92143173|NCT05040126|Bedaquiline|bedaquiline|mesh-list
92143174|NCT05040126|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143175|NCT05040126|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143176|NCT05040126|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92143177|NCT05040126|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143178|NCT05040126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143179|NCT05040126|Antitubercular Agents|antitubercular agents|mesh-ancestor
92143180|NCT03217201|Methamphetamine|methamphetamine|mesh-list
92143181|NCT03217201|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92143182|NCT03217201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143183|NCT03217201|Sympathomimetics|sympathomimetics|mesh-ancestor
92143184|NCT03217201|Autonomic Agents|autonomic agents|mesh-ancestor
92143185|NCT03217201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143186|NCT03217201|Dopamine Agents|dopamine agents|mesh-ancestor
92143187|NCT03217201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143188|NCT03217201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143189|NCT03217201|Adrenergic Agents|adrenergic agents|mesh-ancestor
92143190|NCT03217201|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92143191|NCT03217201|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92143192|NCT03217201|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92143193|NCT03217201|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92143194|NCT03069300|Acetylcysteine|acetylcysteine|mesh-list
92143195|NCT03069300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92143196|NCT03069300|Antiviral Agents|antiviral agents|mesh-ancestor
92143197|NCT03069300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143198|NCT03069300|Expectorants|expectorants|mesh-ancestor
92143199|NCT03069300|Respiratory System Agents|respiratory system agents|mesh-ancestor
92143200|NCT03069300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92143201|NCT03069300|Antioxidants|antioxidants|mesh-ancestor
92143202|NCT03069300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143203|NCT03069300|Protective Agents|protective agents|mesh-ancestor
92143204|NCT03069300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143205|NCT03069300|Antidotes|antidotes|mesh-ancestor
92143206|NCT05582317|Simvastatin|simvastatin|mesh-list
92143207|NCT05582317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92143208|NCT05582317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92143209|NCT05582317|Antimetabolites|antimetabolites|mesh-ancestor
92143210|NCT05582317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143211|NCT05582317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92143212|NCT05582317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92143213|NCT05582317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143214|NCT03891355|Dexamethasone|dexamethasone|mesh-list
92143215|NCT03891355|Lenalidomide|lenalidomide|mesh-list
92143216|NCT03891355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143217|NCT03891355|Antiemetics|antiemetics|mesh-ancestor
92143220|NCT03891355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143221|NCT03891355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143222|NCT03891355|Glucocorticoids|glucocorticoids|mesh-ancestor
92143223|NCT03891355|Hormones|hormones|mesh-ancestor
92143224|NCT03891355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143225|NCT03891355|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92143226|NCT03891355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143227|NCT03891355|Immunologic Factors|immunologic factors|mesh-ancestor
92143228|NCT03891355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92143229|NCT03891355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92143230|NCT03891355|Growth Substances|growth substances|mesh-ancestor
92143231|NCT03891355|Growth Inhibitors|growth inhibitors|mesh-ancestor
92143232|NCT05582083|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92143233|NCT05582083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143234|NCT05582083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143235|NCT05582083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143236|NCT03954132|Cholinergic Agents|cholinergic agents|mesh-list
92143237|NCT03954132|Muscarinic Antagonists|muscarinic antagonists|mesh-list
92143238|NCT03954132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143239|NCT03954132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143240|NCT03954132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143241|NCT03954132|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92143242|NCT03580291|Mycophenolic Acid|mycophenolic acid|mesh-list
92143243|NCT03580291|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92143244|NCT03580291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143245|NCT03580291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92143246|NCT03580291|Antitubercular Agents|antitubercular agents|mesh-ancestor
92143247|NCT03580291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143248|NCT03580291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143249|NCT03580291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143250|NCT03580291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143251|NCT02936388|Cisplatin|cisplatin|mesh-list
92143252|NCT02936388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143253|NCT03586141|Chrysarobin|chrysarobin|mesh-list
92143254|NCT03586141|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92143255|NCT03586141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92143256|NCT03586141|Analgesics|analgesics|mesh-ancestor
92143257|NCT03586141|Sensory System Agents|sensory system agents|mesh-ancestor
92143258|NCT03586141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143259|NCT03586141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143260|NCT03586141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143261|NCT03586141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143262|NCT03020563|Bupivacaine|bupivacaine|mesh-list
92143263|NCT03020563|Anesthetics, Local|anesthetics, local|mesh-ancestor
92143264|NCT03020563|Anesthetics|anesthetics|mesh-ancestor
92143265|NCT03020563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143266|NCT03020563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143267|NCT03020563|Sensory System Agents|sensory system agents|mesh-ancestor
92143268|NCT03020563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143269|NCT04591626|Insulin Glargine|insulin glargine|mesh-list
92143270|NCT04591626|Dulaglutide|dulaglutide|mesh-list
92143271|NCT04591626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92143272|NCT04591626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143273|NCT04518306|Amlodipine|amlodipine|mesh-list
92143274|NCT04518306|Telmisartan|telmisartan|mesh-list
92143275|NCT04518306|Indapamide|indapamide|mesh-list
92143276|NCT04518306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92143277|NCT04518306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92143278|NCT04518306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92143279|NCT04518306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143280|NCT04518306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143281|NCT04518306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143282|NCT04518306|Vasodilator Agents|vasodilator agents|mesh-ancestor
92143283|NCT04518306|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92143284|NCT04518306|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92143286|NCT04518306|Natriuretic Agents|natriuretic agents|mesh-ancestor
92143287|NCT04518306|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92143288|NCT03580135|Propolis|propolis|mesh-list
92143289|NCT03580135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143290|NCT01890252|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92143291|NCT03901573|Atezolizumab|atezolizumab|mesh-list
92143292|NCT03901573|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92143367|NCT05118984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143293|NCT03901573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143294|NCT03901573|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143295|NCT03901573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143296|NCT03585829|Prednisolone|prednisolone|mesh-list
92143297|NCT03585829|Hydrocortisone|hydrocortisone|mesh-list
92143298|NCT03585829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143299|NCT03585829|Glucocorticoids|glucocorticoids|mesh-ancestor
92143300|NCT03585829|Hormones|hormones|mesh-ancestor
92143301|NCT03585829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143302|NCT03585829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143303|NCT03585829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92143304|NCT03585829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143305|NCT05701969|Melatonin|melatonin|mesh-list
92143306|NCT05701969|Antioxidants|antioxidants|mesh-ancestor
92143307|NCT05701969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143308|NCT05701969|Protective Agents|protective agents|mesh-ancestor
92143309|NCT05701969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143310|NCT05701969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143311|NCT03585751|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92143312|NCT03585751|Simvastatin|simvastatin|mesh-list
92143313|NCT03585751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143314|NCT03585751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92143315|NCT03585751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92143316|NCT03585751|Antimetabolites|antimetabolites|mesh-ancestor
92143317|NCT03585751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143318|NCT03585751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92143319|NCT03585751|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92143320|NCT03585751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143321|NCT03583333|Linezolid|linezolid|mesh-list
92143322|NCT03583333|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143323|NCT03583333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143324|NCT03583333|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92143325|NCT03583333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143326|NCT03583333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143327|NCT03585673|Docetaxel|docetaxel|mesh-list
92143328|NCT03585673|Oxaliplatin|oxaliplatin|mesh-list
92143329|NCT03585673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143330|NCT03585673|Tubulin Modulators|tubulin modulators|mesh-ancestor
92143331|NCT03585673|Antimitotic Agents|antimitotic agents|mesh-ancestor
92143332|NCT03585673|Mitosis Modulators|mitosis modulators|mesh-ancestor
92143333|NCT03585673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143334|NCT01602510|Lamotrigine|lamotrigine|mesh-list
92143335|NCT01602510|Anticonvulsants|anticonvulsants|mesh-ancestor
91939424|NCT00834743|Metformin|metformin|mesh-list
92143336|NCT01602510|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92143337|NCT01602510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92143338|NCT01602510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143339|NCT01602510|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143340|NCT01602510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143341|NCT01602510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92143342|NCT01602510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92143343|NCT01602510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143344|NCT01602510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92143345|NCT01602510|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92143346|NCT03899467|Androgens|androgens|mesh-list
92143347|NCT03899467|Androgen Receptor Antagonists|androgen receptor antagonists|mesh-list
92143348|NCT03899467|Hormones|hormones|mesh-ancestor
92143349|NCT03899467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143350|NCT03899467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143351|NCT03899467|Androgen Antagonists|androgen antagonists|mesh-ancestor
92143352|NCT03899467|Hormone Antagonists|hormone antagonists|mesh-ancestor
92143354|NCT05701813|Vitamin B Complex|vitamin b complex|mesh-ancestor
92143355|NCT05701813|Vitamins|vitamins|mesh-ancestor
92143356|NCT05701813|Micronutrients|micronutrients|mesh-ancestor
92143357|NCT05701813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143358|NCT03586219|Analgesics, Opioid|analgesics, opioid|mesh-list
92143359|NCT03586219|Narcotics|narcotics|mesh-ancestor
92143360|NCT03586219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143361|NCT03586219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143362|NCT03586219|Analgesics|analgesics|mesh-ancestor
92143363|NCT03586219|Sensory System Agents|sensory system agents|mesh-ancestor
92143364|NCT03586219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143365|NCT05118984|Azithromycin|azithromycin|mesh-list
92143366|NCT05118984|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143370|NCT04514328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143371|NCT02802852|Lenograstim|lenograstim|mesh-list
92143372|NCT02802852|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92143373|NCT02802852|Immunologic Factors|immunologic factors|mesh-ancestor
92143374|NCT02802852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143375|NCT03158389|Sirolimus|sirolimus|mesh-list
92143376|NCT03158389|Atezolizumab|atezolizumab|mesh-list
92143377|NCT03158389|Palbociclib|palbociclib|mesh-list
92143378|NCT03158389|Temsirolimus|temsirolimus|mesh-list
92143379|NCT03158389|MTOR Inhibitors|mtor inhibitors|mesh-list
92143380|NCT03158389|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92143381|NCT03158389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143382|NCT03158389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143383|NCT03158389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143384|NCT03158389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143385|NCT03158389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143386|NCT03158389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92143387|NCT03158389|Immunologic Factors|immunologic factors|mesh-ancestor
92143388|NCT03158389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143389|NCT03158389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143390|NCT03158389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143391|NCT03158389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92143392|NCT03158389|Antifungal Agents|antifungal agents|mesh-ancestor
92143393|NCT01236456|Cyclophosphamide|cyclophosphamide|mesh-list
92143394|NCT01236456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92143395|NCT01236456|Immunologic Factors|immunologic factors|mesh-ancestor
92143396|NCT01236456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143397|NCT01236456|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143398|NCT01236456|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92143399|NCT01236456|Alkylating Agents|alkylating agents|mesh-ancestor
92143400|NCT01236456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143401|NCT01236456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143402|NCT01236456|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92143403|NCT05118048|Chrysarobin|chrysarobin|mesh-list
92143404|NCT05118048|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92143405|NCT05118048|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92143406|NCT05118048|Analgesics|analgesics|mesh-ancestor
92143407|NCT05118048|Sensory System Agents|sensory system agents|mesh-ancestor
92143408|NCT05118048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143409|NCT05118048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143410|NCT05118048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143411|NCT05118048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143412|NCT04405375|Dexamethasone|dexamethasone|mesh-list
92143413|NCT04405375|Etoposide|etoposide|mesh-list
92143414|NCT04405375|Pegaspargase|pegaspargase|mesh-list
92143415|NCT04405375|Gemcitabine|gemcitabine|mesh-list
92143416|NCT04405375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143417|NCT04405375|Antiemetics|antiemetics|mesh-ancestor
92143418|NCT04405375|Autonomic Agents|autonomic agents|mesh-ancestor
92143419|NCT04405375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143420|NCT04405375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143421|NCT04405375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143422|NCT04405375|Glucocorticoids|glucocorticoids|mesh-ancestor
92143423|NCT04405375|Hormones|hormones|mesh-ancestor
92143424|NCT04405375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143425|NCT04405375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92143426|NCT04405375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143427|NCT04405375|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92143428|NCT04405375|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92143429|NCT04405375|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92143430|NCT04405375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143431|NCT04405375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143432|NCT04405375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92143433|NCT04405375|Antimetabolites|antimetabolites|mesh-ancestor
92143435|NCT03158857|Antiviral Agents|antiviral agents|mesh-ancestor
92143436|NCT03158857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143437|NCT03029611|Paclitaxel|paclitaxel|mesh-list
92143438|NCT03029611|Carboplatin|carboplatin|mesh-list
92143439|NCT03029611|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92143440|NCT03029611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92143441|NCT03029611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143442|NCT03029611|Tubulin Modulators|tubulin modulators|mesh-ancestor
92143443|NCT03029611|Antimitotic Agents|antimitotic agents|mesh-ancestor
92143444|NCT03029611|Mitosis Modulators|mitosis modulators|mesh-ancestor
92143445|NCT03029611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143449|NCT03589495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143450|NCT03589495|Expectorants|expectorants|mesh-ancestor
92143451|NCT03589495|Respiratory System Agents|respiratory system agents|mesh-ancestor
92143452|NCT03589495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92143453|NCT03589495|Antioxidants|antioxidants|mesh-ancestor
92143454|NCT03589495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143455|NCT03589495|Protective Agents|protective agents|mesh-ancestor
92143456|NCT03589495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143457|NCT03589495|Antidotes|antidotes|mesh-ancestor
92143458|NCT03159559|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92143459|NCT03159559|Alprostadil|alprostadil|mesh-list
92143460|NCT03159559|Clopidogrel|clopidogrel|mesh-list
92143461|NCT03159559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143462|NCT03159559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143463|NCT03159559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92143464|NCT03159559|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92143465|NCT03159559|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92143466|NCT03159559|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92143467|NCT03159559|Purinergic Agents|purinergic agents|mesh-ancestor
92143468|NCT03159559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143469|NCT03159559|Vasodilator Agents|vasodilator agents|mesh-ancestor
92143470|NCT03159559|Urological Agents|urological agents|mesh-ancestor
92143471|NCT03159403|Oritavancin|oritavancin|mesh-list
92143472|NCT03159403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143473|NCT03159403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143474|NCT03583567|Chlorpheniramine|chlorpheniramine|mesh-list
92143475|NCT03583567|Ranitidine|ranitidine|mesh-list
92143476|NCT03583567|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92143477|NCT03583567|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92143478|NCT03583567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143479|NCT03583567|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92143480|NCT03583567|Histamine Antagonists|histamine antagonists|mesh-ancestor
92143481|NCT03583567|Histamine Agents|histamine agents|mesh-ancestor
92143482|NCT03583567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143483|NCT03583567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939425|NCT00834743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92143484|NCT03583567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143486|NCT03583567|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143487|NCT03583567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92143488|NCT03583567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92143489|NCT03583489|Ondansetron|ondansetron|mesh-list
92143490|NCT03583489|Antiemetics|antiemetics|mesh-ancestor
92143491|NCT03583489|Autonomic Agents|autonomic agents|mesh-ancestor
92143492|NCT03583489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143493|NCT03583489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143494|NCT03583489|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143495|NCT03583489|Antipruritics|antipruritics|mesh-ancestor
92143496|NCT03583489|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143497|NCT03583489|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92143498|NCT03583489|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92143499|NCT03583489|Serotonin Agents|serotonin agents|mesh-ancestor
92143500|NCT03583489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143501|NCT03583489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143502|NCT03158935|Aldesleukin|aldesleukin|mesh-list
92143504|NCT03158935|Pembrolizumab|pembrolizumab|mesh-list
92143505|NCT03158935|Fludarabine|fludarabine|mesh-list
92143506|NCT03158935|Interleukin-2|interleukin-2|mesh-list
92143507|NCT03158935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92143508|NCT03158935|Immunologic Factors|immunologic factors|mesh-ancestor
92143509|NCT03158935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143510|NCT03158935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143511|NCT03158935|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92143512|NCT03158935|Alkylating Agents|alkylating agents|mesh-ancestor
92143513|NCT03158935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143514|NCT03158935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143515|NCT03158935|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92143516|NCT03158935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143517|NCT03158935|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92143518|NCT03158935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92143519|NCT03158935|Analgesics|analgesics|mesh-ancestor
92143520|NCT03158935|Sensory System Agents|sensory system agents|mesh-ancestor
92143521|NCT03158935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143522|NCT03158935|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92143523|NCT03158935|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92143524|NCT03158935|Antiviral Agents|antiviral agents|mesh-ancestor
92143525|NCT03158935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143528|NCT04818372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143529|NCT04818372|Antiemetics|antiemetics|mesh-ancestor
92143530|NCT04818372|Autonomic Agents|autonomic agents|mesh-ancestor
92143531|NCT04818372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143532|NCT04818372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143533|NCT04818372|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143534|NCT04818372|Glucocorticoids|glucocorticoids|mesh-ancestor
92143535|NCT04818372|Hormones|hormones|mesh-ancestor
92143536|NCT04818372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143537|NCT04818372|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92143538|NCT04818372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143539|NCT04818372|Immunologic Factors|immunologic factors|mesh-ancestor
92143540|NCT04818372|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92143541|NCT04818372|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92143542|NCT04818372|Growth Substances|growth substances|mesh-ancestor
92143543|NCT04818372|Growth Inhibitors|growth inhibitors|mesh-ancestor
92143544|NCT01462578|Azacitidine|azacitidine|mesh-list
92143545|NCT01462578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92143546|NCT01462578|Antimetabolites|antimetabolites|mesh-ancestor
92143547|NCT01462578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143548|NCT01462578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143549|NCT01462578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143550|NCT03059173|Inositol|inositol|mesh-list
92143551|NCT03059173|Clomiphene|clomiphene|mesh-list
92143552|NCT03059173|Enclomiphene|enclomiphene|mesh-list
92143553|NCT03059173|Zuclomiphene|zuclomiphene|mesh-list
92143554|NCT03059173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92143555|NCT03059173|Hormone Antagonists|hormone antagonists|mesh-ancestor
92143556|NCT03059173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143557|NCT03059173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143558|NCT03059173|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92143559|NCT03059173|Fertility Agents|fertility agents|mesh-ancestor
92143560|NCT03059173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92143561|NCT03059173|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92143562|NCT03059173|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92143563|NCT03059173|Vitamin B Complex|vitamin b complex|mesh-ancestor
92143564|NCT03059173|Vitamins|vitamins|mesh-ancestor
92143565|NCT03059173|Micronutrients|micronutrients|mesh-ancestor
92143566|NCT05122338|Lidocaine|lidocaine|mesh-list
92143567|NCT05122338|Ropivacaine|ropivacaine|mesh-list
92143568|NCT05122338|Esketamine|esketamine|mesh-list
92143569|NCT05122338|Anesthetics, Local|anesthetics, local|mesh-ancestor
92143570|NCT05122338|Anesthetics|anesthetics|mesh-ancestor
92143571|NCT05122338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143572|NCT05122338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143573|NCT05122338|Sensory System Agents|sensory system agents|mesh-ancestor
92143574|NCT05122338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143575|NCT05122338|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92143576|NCT05122338|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92143577|NCT05122338|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92143578|NCT05122338|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92143579|NCT05122338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143580|NCT05122338|Antidepressive Agents|antidepressive agents|mesh-ancestor
92143581|NCT05122338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92143582|NCT03157843|Heparin|heparin|mesh-list
92143583|NCT03157843|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92143584|NCT03157843|Tinzaparin|tinzaparin|mesh-list
92143585|NCT03157843|Dalteparin|dalteparin|mesh-list
92143586|NCT03157843|Anticoagulants|anticoagulants|mesh-ancestor
92143587|NCT03157843|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92143588|NCT03157843|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92143589|NCT03157843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143590|NCT03589027|Ritonavir|ritonavir|mesh-list
92143591|NCT03589027|Darunavir|darunavir|mesh-list
92143592|NCT03589027|Rilpivirine|rilpivirine|mesh-list
92143593|NCT03589027|Levonorgestrel|levonorgestrel|mesh-list
92143594|NCT03589027|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92143595|NCT03589027|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92143596|NCT03589027|Protease Inhibitors|protease inhibitors|mesh-ancestor
92143597|NCT03589027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143598|NCT03589027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143599|NCT03589027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92143600|NCT03589027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92143601|NCT03589027|Antiviral Agents|antiviral agents|mesh-ancestor
92143602|NCT03589027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143603|NCT03589027|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92146144|NCT04912518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92143604|NCT03589027|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92143605|NCT03589027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92143606|NCT03589027|Contraceptive Agents|contraceptive agents|mesh-ancestor
92143607|NCT03589027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92143608|NCT03589027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143609|NCT03589027|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92143610|NCT03589027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92143611|NCT03589027|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92143612|NCT03589027|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92143613|NCT03589027|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92143614|NCT03874494|Aripiprazole|aripiprazole|mesh-list
92143615|NCT03874494|Brexpiprazole|brexpiprazole|mesh-list
92143616|NCT03874494|Antidepressive Agents|antidepressive agents|mesh-ancestor
92143617|NCT03874494|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92143618|NCT03874494|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92143619|NCT03874494|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92143620|NCT03874494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143621|NCT03874494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143622|NCT03874494|Dopamine Agonists|dopamine agonists|mesh-ancestor
92143623|NCT03874494|Dopamine Agents|dopamine agents|mesh-ancestor
92143624|NCT03874494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143625|NCT03874494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143626|NCT03874494|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92143627|NCT03874494|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92143628|NCT03874494|Serotonin Agents|serotonin agents|mesh-ancestor
92143629|NCT03874494|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92143630|NCT03874494|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92143631|NCT03874494|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92143632|NCT03874494|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92143633|NCT03156439|Huperzine A|huperzine a|mesh-list
92143634|NCT03156439|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92143635|NCT03156439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143636|NCT03156439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143637|NCT03156439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92143638|NCT03156439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143639|NCT03156439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143640|NCT03156439|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92143641|NCT03156439|Protective Agents|protective agents|mesh-ancestor
92143642|NCT04436328|Anti-Infective Agents|anti-infective agents|mesh-list
92143643|NCT04436328|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92143645|NCT03156361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92143646|NCT03156361|Insulin Lispro|insulin lispro|mesh-list
92143647|NCT03156361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92143648|NCT03156361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143649|NCT05690035|Tislelizumab|tislelizumab|mesh-list
92143650|NCT05690035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143651|NCT05690035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143653|NCT05002530|Ergocalciferols|ergocalciferols|mesh-list
92143654|NCT05002530|Cholecalciferol|cholecalciferol|mesh-list
92143655|NCT05002530|Vitamins|vitamins|mesh-list
92143656|NCT05002530|Tretinoin|tretinoin|mesh-list
92143657|NCT05002530|Isotretinoin|isotretinoin|mesh-list
92143658|NCT05002530|Micronutrients|micronutrients|mesh-ancestor
92143659|NCT05002530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143660|NCT05002530|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92143661|NCT05002530|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143662|NCT05002530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143663|NCT05002530|Keratolytic Agents|keratolytic agents|mesh-ancestor
92143664|NCT05002530|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143665|NCT03583021|Neostigmine|neostigmine|mesh-list
92143666|NCT03583021|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92143667|NCT03583021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143668|NCT03583021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143669|NCT03583021|Cholinergic Agents|cholinergic agents|mesh-ancestor
92143670|NCT03583021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143671|NCT03583021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143672|NCT03583021|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92143673|NCT03583021|Autonomic Agents|autonomic agents|mesh-ancestor
92143674|NCT03583021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143675|NCT03155971|Paclitaxel|paclitaxel|mesh-list
92143676|NCT03155971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92143677|NCT03155971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143678|NCT03155971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92143679|NCT03155971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92143680|NCT03155971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92143681|NCT03155971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143682|NCT03582319|Formaldehyde|formaldehyde|mesh-list
92143683|NCT03582319|Disinfectants|disinfectants|mesh-ancestor
92143684|NCT03582319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143685|NCT00307242|Adefovir|adefovir|mesh-list
92143686|NCT00307242|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92143687|NCT00307242|Antiviral Agents|antiviral agents|mesh-ancestor
92143688|NCT00307242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143689|NCT00307242|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92143690|NCT00307242|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92143691|NCT00307242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143692|NCT00307242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143693|NCT03582007|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92143694|NCT03582007|Murepavadin|murepavadin|mesh-list
92143695|NCT03582007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143696|NCT05120622|Tremelimumab|tremelimumab|mesh-list
92143697|NCT05120622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143698|NCT02895373|Alprostadil|alprostadil|mesh-list
92143699|NCT02895373|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92143700|NCT02895373|Vasodilator Agents|vasodilator agents|mesh-ancestor
92143701|NCT02895373|Urological Agents|urological agents|mesh-ancestor
92143702|NCT05698771|Niacinamide|niacinamide|mesh-list
92143703|NCT05698771|Niacin|niacin|mesh-list
92143704|NCT05698771|Nicotinic Acids|nicotinic acids|mesh-list
92143705|NCT05698771|Vitamin B Complex|vitamin b complex|mesh-ancestor
92143706|NCT05698771|Vitamins|vitamins|mesh-ancestor
92143707|NCT05698771|Micronutrients|micronutrients|mesh-ancestor
92143708|NCT05698771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143710|NCT05698771|Antimetabolites|antimetabolites|mesh-ancestor
92143711|NCT05698771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143712|NCT05698771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92143713|NCT05698771|Vasodilator Agents|vasodilator agents|mesh-ancestor
92143714|NCT05698147|Rituximab|rituximab|mesh-list
92143715|NCT05698147|Methotrexate|methotrexate|mesh-list
92143716|NCT05698147|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143717|NCT05698147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143718|NCT05698147|Immunologic Factors|immunologic factors|mesh-ancestor
92143719|NCT05698147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143720|NCT05698147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143721|NCT05698147|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92143722|NCT05698147|Abortifacient Agents|abortifacient agents|mesh-ancestor
92143723|NCT05698147|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92143724|NCT05698147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92143725|NCT05698147|Antimetabolites|antimetabolites|mesh-ancestor
92143726|NCT05698147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143727|NCT05698147|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143728|NCT05698147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143729|NCT05698147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92143730|NCT05698147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92143731|NCT05698147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92143733|NCT03156907|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92143734|NCT03156907|Narcotics|narcotics|mesh-ancestor
92143735|NCT03156907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143736|NCT03156907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143737|NCT03156907|Analgesics|analgesics|mesh-ancestor
92143738|NCT03156907|Sensory System Agents|sensory system agents|mesh-ancestor
92143739|NCT03156907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143740|NCT03156907|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92143741|NCT03156829|Betamethasone|betamethasone|mesh-list
92143742|NCT03156829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143743|NCT03156829|Glucocorticoids|glucocorticoids|mesh-ancestor
92143744|NCT03156829|Hormones|hormones|mesh-ancestor
92143745|NCT03156829|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143746|NCT03156829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143747|NCT03156829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92143748|NCT03156829|Respiratory System Agents|respiratory system agents|mesh-ancestor
92143749|NCT05229276|Bone wax|bone wax|mesh-list
92143750|NCT05229276|Hemostatics|hemostatics|mesh-ancestor
92143751|NCT05229276|Coagulants|coagulants|mesh-ancestor
92143752|NCT03581773|Folic Acid|folic acid|mesh-list
92143753|NCT03581773|Hematinics|hematinics|mesh-ancestor
92143754|NCT03581773|Vitamin B Complex|vitamin b complex|mesh-ancestor
92143755|NCT03581773|Vitamins|vitamins|mesh-ancestor
92143756|NCT03581773|Micronutrients|micronutrients|mesh-ancestor
92143757|NCT03581773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143758|NCT04425174|Anesthetics|anesthetics|mesh-list
92143759|NCT04425174|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143760|NCT04425174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143768|NCT05119452|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92143769|NCT05119452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143770|NCT05119452|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143771|NCT05119452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143772|NCT05119452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92143773|NCT05119452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92143774|NCT05119452|Analgesics|analgesics|mesh-ancestor
92143775|NCT05119452|Sensory System Agents|sensory system agents|mesh-ancestor
92143776|NCT05119452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143777|NCT05119452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143778|NCT05119452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92143779|NCT05119452|Immunologic Factors|immunologic factors|mesh-ancestor
92143780|NCT05119452|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92143781|NCT05119452|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143782|NCT05119452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939430|NCT00834587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143783|NCT05119452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143784|NCT02788591|Esomeprazole|esomeprazole|mesh-list
92143785|NCT02788591|Omeprazole|omeprazole|mesh-list
92143786|NCT02788591|Pantoprazole|pantoprazole|mesh-list
92143787|NCT02788591|Lansoprazole|lansoprazole|mesh-list
92143788|NCT02788591|Sucralfate|sucralfate|mesh-list
92143789|NCT02788591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92143790|NCT02788591|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92143791|NCT02788591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143792|NCT02788591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143793|NCT02788591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143794|NCT05229042|Ricolinostat|ricolinostat|mesh-list
92143795|NCT05229042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143796|NCT05229042|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92143797|NCT05229042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143798|NCT05229042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143799|NCT01670305|Photosensitizing Agents|photosensitizing agents|mesh-list
92143800|NCT01670305|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143801|NCT03267498|Nivolumab|nivolumab|mesh-list
92143802|NCT03267498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143803|NCT03267498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92143804|NCT03267498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92143805|NCT03267498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143807|NCT03076164|Trametinib|trametinib|mesh-list
92143808|NCT03076164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143809|NCT03076164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92143810|NCT03076164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143811|NCT03076164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143812|NCT03155893|Moxifloxacin|moxifloxacin|mesh-list
92143813|NCT03155893|Adafosbuvir|adafosbuvir|mesh-list
92143814|NCT03155893|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92143816|NCT03155893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143817|NCT03155893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92143818|NCT03155893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92143819|NCT03155893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143820|NCT03155893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143821|NCT03155893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143822|NCT03155893|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92143823|NCT03155893|Contraceptive Agents|contraceptive agents|mesh-ancestor
92143824|NCT03155893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92143825|NCT03155893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143826|NCT03155893|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92143827|NCT03155893|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92143828|NCT03155893|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92143829|NCT03155893|Antiviral Agents|antiviral agents|mesh-ancestor
92143830|NCT01670773|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92143831|NCT01670773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92143832|NCT01670773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92143833|NCT01670773|Analgesics|analgesics|mesh-ancestor
92143834|NCT01670773|Sensory System Agents|sensory system agents|mesh-ancestor
92143835|NCT01670773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143836|NCT01670773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143837|NCT01670773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143838|NCT01670773|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143839|NCT05228418|Naltrexone|naltrexone|mesh-list
92143840|NCT05228418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92143841|NCT05228418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92143842|NCT05228418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143843|NCT05228418|Sensory System Agents|sensory system agents|mesh-ancestor
92143844|NCT05228418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143845|NCT01676233|Insulin|insulin|mesh-list
92143846|NCT01676233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92143847|NCT01676233|Insulin Glargine|insulin glargine|mesh-list
92143848|NCT01676233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92143849|NCT01676233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143850|NCT01670929|Progesterone|progesterone|mesh-list
92143851|NCT01670929|Progestins|progestins|mesh-ancestor
92143852|NCT01670929|Hormones|hormones|mesh-ancestor
92143853|NCT01670929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143854|NCT01670929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143855|NCT02673996|Phenylephrine|phenylephrine|mesh-list
92143856|NCT02673996|Isoproterenol|isoproterenol|mesh-list
92143857|NCT02673996|Oxymetazoline|oxymetazoline|mesh-list
92143858|NCT02673996|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92143859|NCT02673996|Mydriatics|mydriatics|mesh-ancestor
92143860|NCT02673996|Autonomic Agents|autonomic agents|mesh-ancestor
92143861|NCT02673996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143862|NCT02673996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143863|NCT02673996|Sympathomimetics|sympathomimetics|mesh-ancestor
92143864|NCT02673996|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92143865|NCT02673996|Nasal Decongestants|nasal decongestants|mesh-ancestor
92143866|NCT02673996|Respiratory System Agents|respiratory system agents|mesh-ancestor
92143867|NCT02673996|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92143868|NCT02673996|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92143869|NCT02673996|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92143870|NCT02673996|Adrenergic Agents|adrenergic agents|mesh-ancestor
92143871|NCT02673996|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143872|NCT02673996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143873|NCT02673996|Protective Agents|protective agents|mesh-ancestor
92143874|NCT02673996|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92143875|NCT02673996|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92143876|NCT02673996|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92143877|NCT04746937|Nitazoxanide|nitazoxanide|mesh-list
92143878|NCT04746937|Norfloxacin|norfloxacin|mesh-list
92143879|NCT04746937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92143880|NCT04746937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143881|NCT04746937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92143882|NCT04746937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92143883|NCT04746937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92143884|NCT04746937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143885|NCT04746937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143886|NCT04746937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143887|NCT04746937|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92143888|NCT04746937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92143889|NCT05220319|Methylprednisolone|methylprednisolone|mesh-list
92143890|NCT05220319|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92143891|NCT05220319|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92143892|NCT05220319|Prednisolone|prednisolone|mesh-list
92143893|NCT05220319|Prednisolone acetate|prednisolone acetate|mesh-list
92143894|NCT05220319|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92143895|NCT05220319|Prednisolone phosphate|prednisolone phosphate|mesh-list
92143896|NCT05220319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143897|NCT05220319|Antiemetics|antiemetics|mesh-ancestor
92143898|NCT05220319|Autonomic Agents|autonomic agents|mesh-ancestor
92143899|NCT05220319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143900|NCT05220319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143901|NCT05220319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143902|NCT05220319|Glucocorticoids|glucocorticoids|mesh-ancestor
92143903|NCT05220319|Hormones|hormones|mesh-ancestor
92143904|NCT05220319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143905|NCT05220319|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92143906|NCT05220319|Protective Agents|protective agents|mesh-ancestor
92143907|NCT05220319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92143908|NCT05220319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143909|NCT03155035|Vitamin D|vitamin d|mesh-list
92143910|NCT03155035|Albendazole|albendazole|mesh-list
92143911|NCT03155035|Calcium|calcium|mesh-list
92143912|NCT03155035|Vitamins|vitamins|mesh-ancestor
92143913|NCT03155035|Micronutrients|micronutrients|mesh-ancestor
92143914|NCT03155035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143915|NCT03155035|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143916|NCT03155035|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92143917|NCT03155035|Anthelmintics|anthelmintics|mesh-ancestor
92143918|NCT03155035|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92143919|NCT03155035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92143921|NCT03155035|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92143922|NCT03155035|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92143923|NCT03155035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92143924|NCT03155035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92143925|NCT03155035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92143926|NCT03155035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143927|NCT03155035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92143928|NCT04497870|Peppermint oil|peppermint oil|mesh-list
92143929|NCT04497870|Menthol|menthol|mesh-list
92143930|NCT04497870|Antipruritics|antipruritics|mesh-ancestor
92143931|NCT04497870|Dermatologic Agents|dermatologic agents|mesh-ancestor
92143932|NCT04497870|Antiemetics|antiemetics|mesh-ancestor
92143933|NCT04497870|Autonomic Agents|autonomic agents|mesh-ancestor
92143934|NCT04497870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143935|NCT04497870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143936|NCT04497870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92143937|NCT04497870|Parasympatholytics|parasympatholytics|mesh-ancestor
92143938|NCT03154723|Vitamin A|vitamin a|mesh-list
92143939|NCT03154723|Vitamins|vitamins|mesh-ancestor
92143940|NCT03154723|Micronutrients|micronutrients|mesh-ancestor
92143941|NCT03154723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143942|NCT04080908|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92143943|NCT04080908|Hematinics|hematinics|mesh-ancestor
92143944|NCT04080908|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92143945|NCT04080908|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92143946|NCT02653482|Dapagliflozin|dapagliflozin|mesh-list
92143947|NCT02653482|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92143948|NCT02653482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143949|NCT02653482|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92143950|NCT02653482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143951|NCT03154567|Yohimbine|yohimbine|mesh-list
92143952|NCT03154567|Mydriatics|mydriatics|mesh-ancestor
92143953|NCT03154567|Autonomic Agents|autonomic agents|mesh-ancestor
92143954|NCT03154567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143955|NCT03154567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143956|NCT03154567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92143957|NCT03154567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92143958|NCT03154567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92143959|NCT03154567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92143960|NCT03154567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92143961|NCT03154567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143962|NCT03154567|Urological Agents|urological agents|mesh-ancestor
92143963|NCT04310748|Anesthetics|anesthetics|mesh-list
92143964|NCT04310748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92143965|NCT04310748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143966|NCT03154645|Ibuprofen|ibuprofen|mesh-list
92143967|NCT03154645|Acetazolamide|acetazolamide|mesh-list
92143968|NCT03154645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92143969|NCT03154645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92143970|NCT03154645|Analgesics|analgesics|mesh-ancestor
92143971|NCT03154645|Sensory System Agents|sensory system agents|mesh-ancestor
92143972|NCT03154645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92143973|NCT03154645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143974|NCT03154645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92143975|NCT03154645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92143976|NCT03154645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92143977|NCT03154645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92143978|NCT03154645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92143979|NCT03154645|Anticonvulsants|anticonvulsants|mesh-ancestor
92143980|NCT03154645|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92143981|NCT03154645|Diuretics|diuretics|mesh-ancestor
92143982|NCT03154645|Natriuretic Agents|natriuretic agents|mesh-ancestor
92143983|NCT01631292|Vitamin D|vitamin d|mesh-list
92143984|NCT01631292|Ergocalciferols|ergocalciferols|mesh-list
92143985|NCT01631292|Cholecalciferol|cholecalciferol|mesh-list
92143986|NCT01631292|Vitamins|vitamins|mesh-list
92143987|NCT01631292|Micronutrients|micronutrients|mesh-ancestor
92143988|NCT01631292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143989|NCT01631292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92143990|NCT01631292|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92143991|NCT01671709|Montelukast|montelukast|mesh-list
92143992|NCT01671709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92143993|NCT01671709|Respiratory System Agents|respiratory system agents|mesh-ancestor
92143994|NCT01671709|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92143995|NCT01671709|Hormone Antagonists|hormone antagonists|mesh-ancestor
92143996|NCT01671709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92143997|NCT01671709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92143998|NCT01671709|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92143999|NCT01671709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92144000|NCT01671709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144001|NCT05222256|Simendan|simendan|mesh-list
92144002|NCT05222256|Epinephrine|epinephrine|mesh-list
92144003|NCT05222256|Racepinephrine|racepinephrine|mesh-list
92144004|NCT05222256|Epinephryl borate|epinephryl borate|mesh-list
92144005|NCT05222256|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92144006|NCT05222256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92144007|NCT05222256|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144008|NCT05222256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144009|NCT05222256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144010|NCT05222256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144011|NCT05222256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92144012|NCT05222256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92144014|NCT05222256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144015|NCT05222256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92144016|NCT05222256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92144017|NCT05222256|Mydriatics|mydriatics|mesh-ancestor
92144018|NCT05222256|Sympathomimetics|sympathomimetics|mesh-ancestor
92144019|NCT05222256|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92144020|NCT05222256|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92144021|NCT05222256|Vasodilator Agents|vasodilator agents|mesh-ancestor
92144022|NCT05222256|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92144023|NCT05222256|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92144024|NCT05222256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144025|NCT05222256|Protective Agents|protective agents|mesh-ancestor
92144026|NCT01671787|Tenofovir|tenofovir|mesh-list
92144027|NCT01671787|Antiviral Agents|antiviral agents|mesh-ancestor
92144028|NCT01671787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144029|NCT01671787|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92144030|NCT01671787|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92144031|NCT01671787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144032|NCT01671787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144033|NCT01671787|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92144034|NCT01671787|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92144035|NCT05229510|Ribavirin|ribavirin|mesh-list
92144036|NCT05229510|Antimetabolites|antimetabolites|mesh-ancestor
92144037|NCT05229510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144038|NCT05229510|Antiviral Agents|antiviral agents|mesh-ancestor
92144039|NCT05229510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144040|NCT01362348|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92144041|NCT01362348|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92144042|NCT03154489|Acenocoumarol|acenocoumarol|mesh-list
92144043|NCT03154489|Anticoagulants|anticoagulants|mesh-ancestor
92144044|NCT00698022|Risperidone|risperidone|mesh-list
92144045|NCT00698022|Mifepristone|mifepristone|mesh-list
92144046|NCT00698022|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92144047|NCT00698022|Serotonin Agents|serotonin agents|mesh-ancestor
92144048|NCT00698022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144049|NCT00698022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144050|NCT00698022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144051|NCT00698022|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92144052|NCT00698022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92144053|NCT00698022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144054|NCT00698022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92144055|NCT00698022|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92144056|NCT00698022|Dopamine Agents|dopamine agents|mesh-ancestor
92144057|NCT00698022|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92144058|NCT00698022|Abortifacient Agents|abortifacient agents|mesh-ancestor
92144059|NCT00698022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92144060|NCT00698022|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92144061|NCT00698022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92144062|NCT00698022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92144063|NCT00698022|Contraceptive Agents|contraceptive agents|mesh-ancestor
92144064|NCT00698022|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92144065|NCT00698022|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92144066|NCT00698022|Hormone Antagonists|hormone antagonists|mesh-ancestor
92144067|NCT00698022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144068|NCT00698022|Luteolytic Agents|luteolytic agents|mesh-ancestor
92144069|NCT00698022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92144070|NCT00698022|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92144072|NCT02570503|Clonidine|clonidine|mesh-list
92144073|NCT02570503|Epinephrine|epinephrine|mesh-list
92144077|NCT02570503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144078|NCT02570503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144079|NCT02570503|Sensory System Agents|sensory system agents|mesh-ancestor
92144080|NCT02570503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144081|NCT02570503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92144082|NCT02570503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92144083|NCT02570503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144084|NCT02570503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144085|NCT02570503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144086|NCT02570503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92144087|NCT02570503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92144088|NCT02570503|Autonomic Agents|autonomic agents|mesh-ancestor
92144089|NCT02570503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92144090|NCT02570503|Respiratory System Agents|respiratory system agents|mesh-ancestor
92144091|NCT02570503|Mydriatics|mydriatics|mesh-ancestor
92144092|NCT02570503|Sympathomimetics|sympathomimetics|mesh-ancestor
92144093|NCT02570503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92144094|NCT02570503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92144095|NCT02570503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144096|NCT02570503|Analgesics|analgesics|mesh-ancestor
92144097|NCT02570503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144098|NCT02570503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144099|NCT02570503|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92144100|NCT02570503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144101|NCT02570503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92144102|NCT02570503|Sympatholytics|sympatholytics|mesh-ancestor
92144103|NCT02570503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92144104|NCT02492269|Dexmedetomidine|dexmedetomidine|mesh-list
92144105|NCT02492269|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92144106|NCT02492269|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144107|NCT02492269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144108|NCT02492269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144109|NCT02492269|Analgesics|analgesics|mesh-ancestor
92144110|NCT02492269|Sensory System Agents|sensory system agents|mesh-ancestor
92144111|NCT02492269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144112|NCT02492269|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92144113|NCT02492269|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92144114|NCT02492269|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92144115|NCT02492269|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144116|NCT02492269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144117|NCT02492269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144118|NCT05561179|Hyaluronic Acid|hyaluronic acid|mesh-list
92144119|NCT05561179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92144120|NCT05561179|Immunologic Factors|immunologic factors|mesh-ancestor
92144121|NCT05561179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144122|NCT05561179|Viscosupplements|viscosupplements|mesh-ancestor
92144123|NCT05561179|Protective Agents|protective agents|mesh-ancestor
92144125|NCT02467153|Cholecalciferol|cholecalciferol|mesh-list
92144126|NCT02467153|Vitamins|vitamins|mesh-ancestor
92144127|NCT02467153|Micronutrients|micronutrients|mesh-ancestor
92144128|NCT02467153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144129|NCT02467153|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92144130|NCT02467153|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92144131|NCT04933903|Nivolumab|nivolumab|mesh-list
92144132|NCT04933903|Ipilimumab|ipilimumab|mesh-list
92144133|NCT04933903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144134|NCT04933903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144135|NCT04933903|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144136|NCT04933903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144137|NCT03153163|Trastuzumab|trastuzumab|mesh-list
92144138|NCT03153163|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92144139|NCT03153163|Maytansine|maytansine|mesh-list
92144140|NCT03153163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144141|NCT03153163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144142|NCT03153163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92144143|NCT03153163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92144144|NCT03153163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92144145|NCT03153163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92144146|NCT03153163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144147|NCT03153163|Immunotoxins|immunotoxins|mesh-ancestor
92144148|NCT03153163|Immunoconjugates|immunoconjugates|mesh-ancestor
92144149|NCT03153163|Immunologic Factors|immunologic factors|mesh-ancestor
92144150|NCT03153163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144151|NCT03153085|Ipilimumab|ipilimumab|mesh-list
92146145|NCT04912518|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144152|NCT03153085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144153|NCT03153085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144154|NCT03153085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144155|NCT03153085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144156|NCT03589339|Pembrolizumab|pembrolizumab|mesh-list
92144157|NCT03589339|Nivolumab|nivolumab|mesh-list
92144158|NCT03589339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144159|NCT03589339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144160|NCT03589339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144161|NCT03589339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144162|NCT03463525|Osimertinib|osimertinib|mesh-list
92144163|NCT03463525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144164|NCT03463525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92144165|NCT03463525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144166|NCT03463525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144167|NCT01675128|Irinotecan|irinotecan|mesh-list
92144168|NCT01675128|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92144169|NCT01675128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92144170|NCT01675128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144171|NCT01675128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144172|NCT01675128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144173|NCT02626507|Fulvestrant|fulvestrant|mesh-list
92144174|NCT02626507|Goserelin|goserelin|mesh-list
92144175|NCT02626507|Palbociclib|palbociclib|mesh-list
92144176|NCT02626507|Gedatolisib|gedatolisib|mesh-list
92144177|NCT02626507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92144178|NCT02626507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144179|NCT02626507|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92144180|NCT02626507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92144181|NCT02626507|Hormone Antagonists|hormone antagonists|mesh-ancestor
92144182|NCT02626507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144183|NCT02626507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144184|NCT02626507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92144185|NCT02626507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144186|NCT02626507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144187|NCT03413995|Rucaparib|rucaparib|mesh-list
92144188|NCT03413995|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92144189|NCT03413995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144190|NCT03413995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144191|NCT03413995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144192|NCT04508244|Propranolol|propranolol|mesh-list
92144193|NCT04508244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92144194|NCT04508244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92144195|NCT04508244|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144196|NCT04508244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144197|NCT04508244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144198|NCT04508244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144199|NCT04508244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92144200|NCT04508244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92144201|NCT04508244|Vasodilator Agents|vasodilator agents|mesh-ancestor
92144202|NCT03243175|Apixaban|apixaban|mesh-list
92144203|NCT03243175|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92144204|NCT03243175|Antithrombins|antithrombins|mesh-ancestor
92144205|NCT03243175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92144206|NCT03243175|Protease Inhibitors|protease inhibitors|mesh-ancestor
92144207|NCT03243175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144208|NCT03243175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144209|NCT03243175|Anticoagulants|anticoagulants|mesh-ancestor
92144210|NCT04764955|Vitamin D|vitamin d|mesh-list
92144211|NCT04764955|Cholecalciferol|cholecalciferol|mesh-list
92144212|NCT04764955|Vitamins|vitamins|mesh-ancestor
92144213|NCT04764955|Micronutrients|micronutrients|mesh-ancestor
92144214|NCT04764955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144215|NCT04764955|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92144216|NCT04764955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92144217|NCT03126331|Nivolumab|nivolumab|mesh-list
92144218|NCT03126331|Ipilimumab|ipilimumab|mesh-list
92144219|NCT03126331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144220|NCT03126331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144221|NCT03126331|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144222|NCT03126331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144224|NCT01674127|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92144225|NCT01674127|Sympatholytics|sympatholytics|mesh-ancestor
92144226|NCT01674127|Autonomic Agents|autonomic agents|mesh-ancestor
92144227|NCT01674127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144228|NCT01674127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144229|NCT01674127|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92144230|NCT01674127|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92144231|NCT01674127|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92144232|NCT01674127|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144233|NCT01674127|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144234|NCT01674127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144235|NCT02081443|Ticagrelor|ticagrelor|mesh-list
92144236|NCT02081443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92144237|NCT02081443|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92144238|NCT02081443|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92144239|NCT02081443|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92144240|NCT02081443|Purinergic Agents|purinergic agents|mesh-ancestor
92144241|NCT02081443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144242|NCT02081443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144243|NCT02081443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144245|NCT01674205|Immunologic Factors|immunologic factors|mesh-ancestor
92144246|NCT01674205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144247|NCT02646475|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92144248|NCT02646475|Angiotensin II|angiotensin ii|mesh-list
92144249|NCT02646475|Angiotensinogen|angiotensinogen|mesh-list
92144250|NCT02646475|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92144251|NCT02646475|Vasodilator Agents|vasodilator agents|mesh-ancestor
92144252|NCT02646475|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92144253|NCT02646475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92144254|NCT02646475|Protease Inhibitors|protease inhibitors|mesh-ancestor
92144255|NCT02646475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144256|NCT02646475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144257|NCT03151057|Idelalisib|idelalisib|mesh-list
92144258|NCT03151057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144259|NCT03151057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144260|NCT03151057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144261|NCT01674283|Glucagon|glucagon|mesh-list
92144262|NCT01674283|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92144264|NCT01674283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144265|NCT01674283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144266|NCT04404517|Adalimumab|adalimumab|mesh-list
92144267|NCT04404517|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92144268|NCT04404517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144269|NCT04404517|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144270|NCT01674517|Montelukast|montelukast|mesh-list
92144271|NCT01674517|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92144272|NCT01674517|Respiratory System Agents|respiratory system agents|mesh-ancestor
92144273|NCT01674517|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92144274|NCT01674517|Hormone Antagonists|hormone antagonists|mesh-ancestor
92144275|NCT01674517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144276|NCT01674517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144277|NCT01674517|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92144278|NCT01674517|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92144279|NCT01674517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144280|NCT01923649|Lanreotide|lanreotide|mesh-list
92144281|NCT01923649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144282|NCT01670071|Risperidone|risperidone|mesh-list
92144283|NCT01670071|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92144284|NCT01670071|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92144285|NCT01670071|Serotonin Agents|serotonin agents|mesh-ancestor
92144286|NCT01670071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144287|NCT01670071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144288|NCT01670071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144289|NCT01670071|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92144290|NCT01670071|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92144291|NCT01670071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144292|NCT01670071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92144293|NCT01670071|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92144294|NCT01670071|Dopamine Agents|dopamine agents|mesh-ancestor
92144295|NCT01670071|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92144296|NCT01670071|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92144297|NCT01427309|Vaccines|vaccines|mesh-list
92144298|NCT01427309|Immunologic Factors|immunologic factors|mesh-ancestor
92144299|NCT01427309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144300|NCT01426373|Deoxycholic Acid|deoxycholic acid|mesh-list
92144301|NCT01426373|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92144302|NCT01426373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92144303|NCT03855007|Hydroxychloroquine|hydroxychloroquine|mesh-list
92144304|NCT03855007|Prednisone|prednisone|mesh-list
92144305|NCT03855007|Methotrexate|methotrexate|mesh-list
92144306|NCT03855007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144307|NCT03855007|Glucocorticoids|glucocorticoids|mesh-ancestor
92144308|NCT03855007|Hormones|hormones|mesh-ancestor
92144309|NCT03855007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144310|NCT03855007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144311|NCT03855007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92144312|NCT03855007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144313|NCT03855007|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92144314|NCT03855007|Abortifacient Agents|abortifacient agents|mesh-ancestor
92144315|NCT03855007|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92144316|NCT03855007|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92144317|NCT03855007|Antimetabolites|antimetabolites|mesh-ancestor
92144318|NCT03855007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144319|NCT03855007|Dermatologic Agents|dermatologic agents|mesh-ancestor
92144320|NCT03855007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144321|NCT03855007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92144322|NCT03855007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144323|NCT03855007|Immunologic Factors|immunologic factors|mesh-ancestor
92144324|NCT03855007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144325|NCT03855007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92144326|NCT03855007|Antimalarials|antimalarials|mesh-ancestor
92144327|NCT03855007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92144328|NCT03855007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92144329|NCT03855007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144330|NCT03852901|Empagliflozin|empagliflozin|mesh-list
92144331|NCT03852901|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92144332|NCT03852901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144333|NCT03852901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92144334|NCT03852901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144336|NCT01675999|Cetuximab|cetuximab|mesh-list
92144337|NCT01675999|Fluorouracil|fluorouracil|mesh-list
92144338|NCT01675999|Oxaliplatin|oxaliplatin|mesh-list
92144339|NCT01675999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144340|NCT01675999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144341|NCT01675999|Antimetabolites|antimetabolites|mesh-ancestor
92144342|NCT01675999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144343|NCT01675999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92144344|NCT01675999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144345|NCT01675999|Immunologic Factors|immunologic factors|mesh-ancestor
92144346|NCT01675999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144347|NCT01675999|Antidotes|antidotes|mesh-ancestor
92144348|NCT01675999|Protective Agents|protective agents|mesh-ancestor
92144349|NCT01675999|Vitamin B Complex|vitamin b complex|mesh-ancestor
92144350|NCT01675999|Vitamins|vitamins|mesh-ancestor
92144351|NCT01675999|Micronutrients|micronutrients|mesh-ancestor
92144352|NCT01425359|Ranolazine|ranolazine|mesh-list
92144353|NCT01425359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92144354|NCT01425359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92144355|NCT01425359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144356|NCT04404751|Folic Acid|folic acid|mesh-list
92144357|NCT04404751|Vitamin B 12|vitamin b 12|mesh-list
92144358|NCT04404751|Hydroxocobalamin|hydroxocobalamin|mesh-list
92144359|NCT04404751|Iron|iron|mesh-list
92144360|NCT04404751|Vitamins|vitamins|mesh-ancestor
92144361|NCT04404751|Micronutrients|micronutrients|mesh-ancestor
92144362|NCT04404751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144363|NCT04404751|Trace Elements|trace elements|mesh-ancestor
92144364|NCT04404751|Hematinics|hematinics|mesh-ancestor
92144365|NCT04404751|Vitamin B Complex|vitamin b complex|mesh-ancestor
92144366|NCT01403051|Calcium, Dietary|calcium, dietary|mesh-list
92144367|NCT01403051|Vitamin D|vitamin d|mesh-list
92144368|NCT01403051|Ergocalciferols|ergocalciferols|mesh-list
92144369|NCT01403051|Cholecalciferol|cholecalciferol|mesh-list
92144370|NCT01403051|Vitamins|vitamins|mesh-list
92144371|NCT01403051|Calcium Carbonate|calcium carbonate|mesh-list
92144372|NCT01403051|Calcium|calcium|mesh-list
92144373|NCT01403051|Micronutrients|micronutrients|mesh-ancestor
92144374|NCT01403051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144375|NCT01403051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92144376|NCT01403051|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92144377|NCT01403051|Antacids|antacids|mesh-ancestor
92144378|NCT01403051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144379|NCT01403051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92144381|NCT03873337|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92144382|NCT03873337|Autonomic Agents|autonomic agents|mesh-ancestor
92144383|NCT03873337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144384|NCT03873337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144385|NCT03873337|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92144386|NCT03873337|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92144387|NCT03873337|Cholinergic Agents|cholinergic agents|mesh-ancestor
92144388|NCT03873337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144389|NCT03873337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144391|NCT03841357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144392|NCT03841357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144393|NCT03841357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144394|NCT03841357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144395|NCT03841357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144396|NCT03841357|Immunologic Factors|immunologic factors|mesh-ancestor
92144397|NCT03841357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144398|NCT03841357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144399|NCT04115748|Adalimumab|adalimumab|mesh-list
92144400|NCT04115748|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92144401|NCT04115748|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144402|NCT04115748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144403|NCT03838159|Paclitaxel|paclitaxel|mesh-list
92144404|NCT03838159|Carboplatin|carboplatin|mesh-list
92144405|NCT03838159|Nivolumab|nivolumab|mesh-list
92144406|NCT03838159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92144407|NCT03838159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144408|NCT03838159|Tubulin Modulators|tubulin modulators|mesh-ancestor
92144409|NCT03838159|Antimitotic Agents|antimitotic agents|mesh-ancestor
92144410|NCT03838159|Mitosis Modulators|mitosis modulators|mesh-ancestor
92144411|NCT03838159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144412|NCT03838159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144413|NCT03838159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144415|NCT04747015|Oxytocics|oxytocics|mesh-ancestor
92144416|NCT04747015|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92144417|NCT04747015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144418|NCT04747171|Dexmedetomidine|dexmedetomidine|mesh-list
92144419|NCT04747171|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92144420|NCT04747171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144421|NCT04747171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144422|NCT04747171|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144423|NCT04747171|Analgesics|analgesics|mesh-ancestor
92144424|NCT04747171|Sensory System Agents|sensory system agents|mesh-ancestor
92144425|NCT04747171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144426|NCT04747171|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92144427|NCT04747171|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92144428|NCT04747171|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92144429|NCT04747171|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144430|NCT04747171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144431|NCT04747171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144432|NCT02082769|Allopurinol|allopurinol|mesh-list
92144433|NCT02082769|Febuxostat|febuxostat|mesh-list
92144434|NCT02082769|Antimetabolites|antimetabolites|mesh-ancestor
92144435|NCT02082769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144436|NCT02082769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144437|NCT02082769|Gout Suppressants|gout suppressants|mesh-ancestor
92144438|NCT02082769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144439|NCT02082769|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92144440|NCT02082769|Antioxidants|antioxidants|mesh-ancestor
92144441|NCT02082769|Protective Agents|protective agents|mesh-ancestor
92144442|NCT02082769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144443|NCT03751423|Fentanyl|fentanyl|mesh-list
92144444|NCT03751423|Ketamine|ketamine|mesh-list
92144445|NCT03751423|Morphine|morphine|mesh-list
92144446|NCT03751423|Analgesics|analgesics|mesh-ancestor
92144447|NCT03751423|Sensory System Agents|sensory system agents|mesh-ancestor
92144448|NCT03751423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144449|NCT03751423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144450|NCT03751423|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92144451|NCT03751423|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92144452|NCT03751423|Anesthetics, General|anesthetics, general|mesh-ancestor
92144453|NCT03751423|Anesthetics|anesthetics|mesh-ancestor
92144454|NCT03751423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144455|NCT03751423|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92144456|NCT03751423|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92144457|NCT03751423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144458|NCT03751423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144459|NCT03751423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92144460|NCT03751423|Narcotics|narcotics|mesh-ancestor
92144461|NCT03751423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92144462|NCT03745729|Allopurinol|allopurinol|mesh-list
92144463|NCT03745729|Antimetabolites|antimetabolites|mesh-ancestor
92144464|NCT03745729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144465|NCT03745729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144466|NCT03745729|Gout Suppressants|gout suppressants|mesh-ancestor
92144467|NCT03745729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144468|NCT03745729|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92144469|NCT03745729|Antioxidants|antioxidants|mesh-ancestor
92144470|NCT03745729|Protective Agents|protective agents|mesh-ancestor
92144471|NCT03745729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144472|NCT04904952|Acetylcysteine|acetylcysteine|mesh-list
92144473|NCT04904952|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92144474|NCT04904952|Antiviral Agents|antiviral agents|mesh-ancestor
92144475|NCT04904952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144476|NCT04904952|Expectorants|expectorants|mesh-ancestor
92144477|NCT04904952|Respiratory System Agents|respiratory system agents|mesh-ancestor
92144478|NCT04904952|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92144479|NCT04904952|Antioxidants|antioxidants|mesh-ancestor
92144480|NCT04904952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144481|NCT04904952|Protective Agents|protective agents|mesh-ancestor
92144482|NCT04904952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144483|NCT04904952|Antidotes|antidotes|mesh-ancestor
92144484|NCT03661411|Aspirin|aspirin|mesh-list
92144485|NCT03661411|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92144486|NCT03661411|Clopidogrel|clopidogrel|mesh-list
92144487|NCT03661411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92144488|NCT03661411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144489|NCT03661411|Analgesics|analgesics|mesh-ancestor
92144490|NCT03661411|Sensory System Agents|sensory system agents|mesh-ancestor
92144491|NCT03661411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144492|NCT03661411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144493|NCT03661411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144494|NCT03661411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144495|NCT03661411|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92144496|NCT03661411|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92144497|NCT03661411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144498|NCT03661411|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92144499|NCT03661411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92144500|NCT03661411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144501|NCT03661411|Antipyretics|antipyretics|mesh-ancestor
92144502|NCT03661411|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92144503|NCT03661411|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92144504|NCT03661411|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92144505|NCT03661411|Purinergic Agents|purinergic agents|mesh-ancestor
92144506|NCT03661411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144507|NCT05048784|Sotorasib|sotorasib|mesh-list
92144508|NCT05048784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144509|NCT05048784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144510|NCT05048784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144511|NCT05048784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144512|NCT03742297|Dexamethasone|dexamethasone|mesh-list
92144513|NCT03742297|Prednisone|prednisone|mesh-list
92144514|NCT03742297|Lenalidomide|lenalidomide|mesh-list
92144515|NCT03742297|Bortezomib|bortezomib|mesh-list
92144516|NCT03742297|Melphalan|melphalan|mesh-list
92144517|NCT03742297|Daratumumab|daratumumab|mesh-list
92144518|NCT03742297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144519|NCT03742297|Antiemetics|antiemetics|mesh-ancestor
92144520|NCT03742297|Autonomic Agents|autonomic agents|mesh-ancestor
92144521|NCT03742297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144522|NCT03742297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144523|NCT03742297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92144524|NCT03742297|Glucocorticoids|glucocorticoids|mesh-ancestor
92144525|NCT03742297|Hormones|hormones|mesh-ancestor
92144526|NCT03742297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144527|NCT03742297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92144528|NCT03742297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144529|NCT03742297|Immunologic Factors|immunologic factors|mesh-ancestor
92144530|NCT03742297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92144531|NCT03742297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92144532|NCT03742297|Growth Substances|growth substances|mesh-ancestor
92144533|NCT03742297|Growth Inhibitors|growth inhibitors|mesh-ancestor
92144534|NCT03742297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92144535|NCT03742297|Alkylating Agents|alkylating agents|mesh-ancestor
92144536|NCT03742297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144537|NCT03742297|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92144538|NCT03742297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144540|NCT01677403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92144541|NCT01677403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144542|NCT03742141|Glycopyrrolate|glycopyrrolate|mesh-list
92144543|NCT03742141|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92144544|NCT03742141|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92144545|NCT03742141|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92144546|NCT03742141|Cholinergic Agents|cholinergic agents|mesh-ancestor
92144547|NCT03742141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144548|NCT03742141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144549|NCT03742141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144550|NCT03441750|Metformin|metformin|mesh-list
92144551|NCT03441750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92144552|NCT03441750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144553|NCT03826693|Nitrous Oxide|nitrous oxide|mesh-list
92144554|NCT03826693|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92144555|NCT03826693|Anesthetics, General|anesthetics, general|mesh-ancestor
92144556|NCT03826693|Anesthetics|anesthetics|mesh-ancestor
92144557|NCT03826693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144558|NCT03826693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144559|NCT03826693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144560|NCT03826693|Analgesics|analgesics|mesh-ancestor
92144561|NCT03826693|Sensory System Agents|sensory system agents|mesh-ancestor
92144562|NCT03826693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144563|NCT03660553|Insulin|insulin|mesh-list
92144564|NCT03660553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92144565|NCT03660553|Insulin Glargine|insulin glargine|mesh-list
92144566|NCT03660553|Insulin Aspart|insulin aspart|mesh-list
92144567|NCT03660553|Insulin Lispro|insulin lispro|mesh-list
92144568|NCT03660553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92144569|NCT03660553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144570|NCT04527744|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92144571|NCT04527744|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92144572|NCT04527744|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92144573|NCT04527744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144574|NCT04527744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144575|NCT04527744|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92144576|NCT04527744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92144577|NCT04527744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144578|NCT04527744|Cholinergic Agents|cholinergic agents|mesh-ancestor
92144579|NCT04527744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144580|NCT03825757|Aspirin|aspirin|mesh-list
92144581|NCT03825757|Salicylic Acid|salicylic acid|mesh-list
92144582|NCT03825757|Salicylates|salicylates|mesh-list
92144583|NCT03825757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144584|NCT03825757|Antifungal Agents|antifungal agents|mesh-ancestor
92144585|NCT03825757|Keratolytic Agents|keratolytic agents|mesh-ancestor
92144586|NCT03825757|Dermatologic Agents|dermatologic agents|mesh-ancestor
92144587|NCT03825757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92144588|NCT03825757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144589|NCT03825757|Analgesics|analgesics|mesh-ancestor
92144590|NCT03825757|Sensory System Agents|sensory system agents|mesh-ancestor
92144591|NCT03825757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144592|NCT03825757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144593|NCT03825757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144594|NCT03825757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144595|NCT03825757|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92144596|NCT03825757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144597|NCT03825757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144598|NCT03825757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92144599|NCT03825757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92144600|NCT03825757|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92144601|NCT03825757|Antipyretics|antipyretics|mesh-ancestor
92144602|NCT03657433|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92144603|NCT03657433|Hematinics|hematinics|mesh-ancestor
92144604|NCT03657433|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92144605|NCT03657433|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92144606|NCT04827030|Ropivacaine|ropivacaine|mesh-list
92144607|NCT04827030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92144608|NCT04827030|Anesthetics|anesthetics|mesh-ancestor
92144609|NCT04827030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144610|NCT04827030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144611|NCT04827030|Sensory System Agents|sensory system agents|mesh-ancestor
92144612|NCT04827030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144613|NCT03820141|Trastuzumab|trastuzumab|mesh-list
92144614|NCT03820141|Durvalumab|durvalumab|mesh-list
92144615|NCT03820141|Pertuzumab|pertuzumab|mesh-list
92144616|NCT03820141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144617|NCT03820141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144618|NCT03651895|Metformin|metformin|mesh-list
92144619|NCT03651895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92144620|NCT03651895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144621|NCT03818191|Acamprosate|acamprosate|mesh-list
92144622|NCT03818191|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92144623|NCT02398656|Tenecteplase|tenecteplase|mesh-list
92144624|NCT02398656|Clopidogrel|clopidogrel|mesh-list
92144625|NCT02398656|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92144626|NCT02398656|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92144627|NCT02398656|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92144628|NCT02398656|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92144629|NCT02398656|Purinergic Agents|purinergic agents|mesh-ancestor
92144630|NCT02398656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144631|NCT02398656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144632|NCT02398656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144633|NCT02398656|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92144634|NCT02398656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92144635|NCT03807037|Tocotrienols|tocotrienols|mesh-list
92144636|NCT03807037|Vitamin E|vitamin e|mesh-list
92144637|NCT03807037|Tocopherols|tocopherols|mesh-list
92144638|NCT03807037|Tocovid|tocovid|mesh-list
92144639|NCT03807037|Antioxidants|antioxidants|mesh-ancestor
92144640|NCT03807037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144641|NCT03807037|Protective Agents|protective agents|mesh-ancestor
92144642|NCT03807037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144643|NCT03807037|Vitamins|vitamins|mesh-ancestor
92144644|NCT03807037|Micronutrients|micronutrients|mesh-ancestor
92144645|NCT03805399|Sirolimus|sirolimus|mesh-list
92144646|NCT03805399|Paclitaxel|paclitaxel|mesh-list
92144647|NCT03805399|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92144648|NCT03805399|Capecitabine|capecitabine|mesh-list
92144649|NCT03805399|Everolimus|everolimus|mesh-list
92144650|NCT03805399|Apatinib|apatinib|mesh-list
92144651|NCT03805399|Temsirolimus|temsirolimus|mesh-list
92144652|NCT03805399|MTOR Inhibitors|mtor inhibitors|mesh-list
92144653|NCT03805399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92144654|NCT03805399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92144655|NCT03805399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144657|NCT03805399|Antimitotic Agents|antimitotic agents|mesh-ancestor
92144658|NCT03805399|Mitosis Modulators|mitosis modulators|mesh-ancestor
92144659|NCT03805399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144660|NCT03805399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92144661|NCT03805399|Antimetabolites|antimetabolites|mesh-ancestor
92144662|NCT03805399|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92144663|NCT03805399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144664|NCT03805399|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144665|NCT03805399|Immunologic Factors|immunologic factors|mesh-ancestor
92144666|NCT03805399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144667|NCT03805399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92144668|NCT03805399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144669|NCT03805399|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92144670|NCT03805399|Antifungal Agents|antifungal agents|mesh-ancestor
92144671|NCT03725059|Paclitaxel|paclitaxel|mesh-list
92144672|NCT03725059|Cyclophosphamide|cyclophosphamide|mesh-list
92144673|NCT03725059|Doxorubicin|doxorubicin|mesh-list
92144674|NCT03725059|Pembrolizumab|pembrolizumab|mesh-list
92144675|NCT03725059|Epirubicin|epirubicin|mesh-list
92144676|NCT03725059|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92144677|NCT03725059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144678|NCT03725059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92144679|NCT03725059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92144680|NCT03725059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92144681|NCT03725059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144682|NCT03725059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144683|NCT03725059|Immunologic Factors|immunologic factors|mesh-ancestor
92144684|NCT03725059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144685|NCT03725059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144686|NCT03725059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92144687|NCT03725059|Alkylating Agents|alkylating agents|mesh-ancestor
92144688|NCT03725059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92144689|NCT03725059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92144690|NCT03725059|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92144691|NCT03725059|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92144692|NCT03725059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144693|NCT03725059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144694|NCT03725059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92144695|NCT02652624|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92144697|NCT02652624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144698|NCT02652624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92144699|NCT02652624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92144700|NCT03637075|Insulin|insulin|mesh-list
92144701|NCT03637075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92144702|NCT03637075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144703|NCT04403503|Thrombin|thrombin|mesh-list
92144704|NCT04403503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92144705|NCT04403503|Hemostatics|hemostatics|mesh-ancestor
92144706|NCT04403503|Coagulants|coagulants|mesh-ancestor
92144707|NCT00249795|Irbesartan|irbesartan|mesh-list
92144708|NCT00249795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92144709|NCT00249795|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92144710|NCT00249795|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92144711|NCT00249795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144712|NCT04404127|Basiliximab|basiliximab|mesh-list
92144713|NCT04404127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144714|NCT04404127|Immunologic Factors|immunologic factors|mesh-ancestor
92144715|NCT04404127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144717|NCT02651220|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92144718|NCT02651220|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92144719|NCT02651220|Dermatologic Agents|dermatologic agents|mesh-ancestor
92144720|NCT02651220|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92144721|NCT02651220|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144723|NCT02651220|Sensory System Agents|sensory system agents|mesh-ancestor
92144724|NCT02651220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144725|NCT02651220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144726|NCT02651220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144727|NCT02651220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144728|NCT01279551|Lidocaine|lidocaine|mesh-list
92144729|NCT01279551|Nitroglycerin|nitroglycerin|mesh-list
92144731|NCT01279551|Anesthetics|anesthetics|mesh-ancestor
92144732|NCT01279551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144733|NCT01279551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144734|NCT01279551|Sensory System Agents|sensory system agents|mesh-ancestor
92144735|NCT01279551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144736|NCT01279551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92144737|NCT01279551|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92144738|NCT01279551|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92144739|NCT01279551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92144740|NCT01279551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144741|NCT01279551|Vasodilator Agents|vasodilator agents|mesh-ancestor
92144742|NCT03738696|Bupivacaine|bupivacaine|mesh-list
92144743|NCT03738696|Ropivacaine|ropivacaine|mesh-list
92144744|NCT03738696|Anesthetics, Local|anesthetics, local|mesh-ancestor
92144745|NCT03738696|Anesthetics|anesthetics|mesh-ancestor
92144746|NCT03738696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144747|NCT03738696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144748|NCT03738696|Sensory System Agents|sensory system agents|mesh-ancestor
92144749|NCT03738696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144750|NCT00780403|Cetirizine|cetirizine|mesh-list
92144751|NCT00780403|Desloratadine|desloratadine|mesh-list
92144752|NCT00780403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92144753|NCT00780403|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92144754|NCT00780403|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92144755|NCT00780403|Histamine Antagonists|histamine antagonists|mesh-ancestor
92144756|NCT00780403|Histamine Agents|histamine agents|mesh-ancestor
92144757|NCT00780403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144758|NCT00780403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144759|NCT00780403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144760|NCT00780403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92144761|NCT00780403|Cholinergic Agents|cholinergic agents|mesh-ancestor
92144762|NCT04209504|Bupivacaine|bupivacaine|mesh-list
92144763|NCT04209504|Ropivacaine|ropivacaine|mesh-list
92144764|NCT04209504|Anesthetics, Local|anesthetics, local|mesh-ancestor
92144765|NCT04209504|Anesthetics|anesthetics|mesh-ancestor
92144766|NCT04209504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144767|NCT04209504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144768|NCT04209504|Sensory System Agents|sensory system agents|mesh-ancestor
92144769|NCT04209504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144770|NCT03704610|Infliximab|infliximab|mesh-list
92144771|NCT03704610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92144772|NCT03704610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144773|NCT03704610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92144774|NCT03704610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92144775|NCT03704610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144776|NCT01979796|Nicotine|nicotine|mesh-list
92144777|NCT01979796|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92144778|NCT01979796|Autonomic Agents|autonomic agents|mesh-ancestor
92144779|NCT01979796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144780|NCT01979796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144781|NCT01979796|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92144782|NCT01979796|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92144783|NCT01979796|Cholinergic Agents|cholinergic agents|mesh-ancestor
92144784|NCT01979796|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144785|NCT01979796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144786|NCT03630211|Cyclophosphamide|cyclophosphamide|mesh-list
92144787|NCT03630211|Thiotepa|thiotepa|mesh-list
92144788|NCT03630211|Rituximab|rituximab|mesh-list
92144789|NCT03630211|Alemtuzumab|alemtuzumab|mesh-list
92144790|NCT03630211|Thymoglobulin|thymoglobulin|mesh-list
92144792|NCT03630211|Immunoglobulins|immunoglobulins|mesh-list
92144793|NCT03630211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92144794|NCT03630211|gamma-Globulins|gamma-globulins|mesh-list
92144795|NCT03630211|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92144796|NCT03630211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144797|NCT03630211|Immunologic Factors|immunologic factors|mesh-ancestor
92144798|NCT03630211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144799|NCT03630211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144800|NCT03630211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92144801|NCT03630211|Alkylating Agents|alkylating agents|mesh-ancestor
92144802|NCT03630211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144803|NCT03630211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144804|NCT03630211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92144805|NCT03630211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144807|NCT03628339|Midazolam|midazolam|mesh-list
92144808|NCT03628339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92144809|NCT03628339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92144810|NCT03628339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144811|NCT03628339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144812|NCT03628339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92144813|NCT03628339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92144814|NCT03628339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92144815|NCT03628339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92144816|NCT03628339|Anesthetics, General|anesthetics, general|mesh-ancestor
92144817|NCT03628339|Anesthetics|anesthetics|mesh-ancestor
92144818|NCT03628339|GABA Modulators|gaba modulators|mesh-ancestor
92144819|NCT03628339|GABA Agents|gaba agents|mesh-ancestor
92144820|NCT03628339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144821|NCT03628339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144822|NCT03628339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144823|NCT03792763|Denosumab|denosumab|mesh-list
92144824|NCT03792763|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92144825|NCT03792763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92144826|NCT03792763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144827|NCT04412694|Dexamethasone|dexamethasone|mesh-list
92144828|NCT04412694|Dexamethasone acetate|dexamethasone acetate|mesh-list
92144829|NCT04412694|BB 1101|bb 1101|mesh-list
92144830|NCT04412694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144831|NCT04412694|Antiemetics|antiemetics|mesh-ancestor
92144832|NCT04412694|Autonomic Agents|autonomic agents|mesh-ancestor
92144833|NCT04412694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144834|NCT04412694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144835|NCT04412694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92144836|NCT04412694|Glucocorticoids|glucocorticoids|mesh-ancestor
92144837|NCT04412694|Hormones|hormones|mesh-ancestor
92144838|NCT04412694|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144839|NCT04412694|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92144840|NCT04412694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144841|NCT04412694|Protease Inhibitors|protease inhibitors|mesh-ancestor
92144842|NCT04412694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144843|NCT04412694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144844|NCT03627715|Propagermanium|propagermanium|mesh-list
92144845|NCT03627715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144846|NCT03627715|Interferon Inducers|interferon inducers|mesh-ancestor
92144848|NCT03627715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144849|NCT00246753|Lapatinib|lapatinib|mesh-list
92144850|NCT00246753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144851|NCT00246753|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92144852|NCT00246753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144853|NCT00246753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144854|NCT02083861|Oxymetazoline|oxymetazoline|mesh-list
92144855|NCT02083861|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92144856|NCT02083861|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92144857|NCT02083861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92144858|NCT02083861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144859|NCT02083861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144860|NCT02083861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144861|NCT02083861|Sympathomimetics|sympathomimetics|mesh-ancestor
92144862|NCT02083861|Autonomic Agents|autonomic agents|mesh-ancestor
92144863|NCT02083861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144864|NCT02083861|Nasal Decongestants|nasal decongestants|mesh-ancestor
92144865|NCT02083861|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92144866|NCT02083861|Respiratory System Agents|respiratory system agents|mesh-ancestor
92144867|NCT00246129|Alemtuzumab|alemtuzumab|mesh-list
92144868|NCT00246129|Daclizumab|daclizumab|mesh-list
92144869|NCT00246129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92144870|NCT00246129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144871|NCT00246129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144872|NCT00246129|Immunologic Factors|immunologic factors|mesh-ancestor
92144873|NCT00246129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144875|NCT01274247|Anesthetics, Local|anesthetics, local|mesh-ancestor
92144876|NCT01274247|Anesthetics|anesthetics|mesh-ancestor
92144877|NCT01274247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144878|NCT01274247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144879|NCT01274247|Sensory System Agents|sensory system agents|mesh-ancestor
92144880|NCT01274247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144881|NCT03783715|Ketoprofen|ketoprofen|mesh-list
92144882|NCT03783715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92144883|NCT03783715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92144884|NCT03783715|Analgesics|analgesics|mesh-ancestor
92144885|NCT03783715|Sensory System Agents|sensory system agents|mesh-ancestor
92144886|NCT03783715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144887|NCT03783715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144888|NCT03783715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144889|NCT03783715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92144890|NCT03783715|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92144891|NCT03783715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144892|NCT03783715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144893|NCT01279629|Tazarotene|tazarotene|mesh-list
92144894|NCT01279629|Calcipotriene|calcipotriene|mesh-list
92144895|NCT01279629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92144896|NCT01279629|Keratolytic Agents|keratolytic agents|mesh-ancestor
92144897|NCT01274325|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92144898|NCT01274325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92144899|NCT01274325|Autonomic Agents|autonomic agents|mesh-ancestor
92144900|NCT01274325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144901|NCT01274325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144902|NCT01274325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92144903|NCT01274325|Respiratory System Agents|respiratory system agents|mesh-ancestor
92144904|NCT01274325|Glucocorticoids|glucocorticoids|mesh-ancestor
92144905|NCT01274325|Hormones|hormones|mesh-ancestor
92144906|NCT01274325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144907|NCT01274325|Sympathomimetics|sympathomimetics|mesh-ancestor
92144908|NCT04502394|Acalabrutinib|acalabrutinib|mesh-list
92144909|NCT04502394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144910|NCT01274403|Thalidomide|thalidomide|mesh-list
92144911|NCT01274403|Prednisone|prednisone|mesh-list
92144912|NCT01274403|Melphalan|melphalan|mesh-list
92144913|NCT01274403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92144914|NCT01274403|Glucocorticoids|glucocorticoids|mesh-ancestor
92144915|NCT01274403|Hormones|hormones|mesh-ancestor
92144916|NCT01274403|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144917|NCT01274403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144918|NCT01274403|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92144919|NCT01274403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144920|NCT01274403|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92144921|NCT01274403|Alkylating Agents|alkylating agents|mesh-ancestor
92144922|NCT01274403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144923|NCT01274403|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92144924|NCT01274403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92144925|NCT01274403|Immunologic Factors|immunologic factors|mesh-ancestor
92144926|NCT01274403|Leprostatic Agents|leprostatic agents|mesh-ancestor
92144927|NCT01274403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92144928|NCT01274403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92144929|NCT01274403|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92144930|NCT01274403|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92144931|NCT01274403|Growth Substances|growth substances|mesh-ancestor
92144932|NCT01274403|Growth Inhibitors|growth inhibitors|mesh-ancestor
92144933|NCT03700099|Docetaxel|docetaxel|mesh-list
92144934|NCT03700099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144935|NCT03700099|Tubulin Modulators|tubulin modulators|mesh-ancestor
92144936|NCT03700099|Antimitotic Agents|antimitotic agents|mesh-ancestor
92144937|NCT03700099|Mitosis Modulators|mitosis modulators|mesh-ancestor
92144938|NCT03700099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144939|NCT01274481|Iloprost|iloprost|mesh-list
92144940|NCT01274481|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92144941|NCT01274481|Vasodilator Agents|vasodilator agents|mesh-ancestor
92144942|NCT00245583|Topiramate|topiramate|mesh-list
92144943|NCT00245583|Anticonvulsants|anticonvulsants|mesh-ancestor
92144944|NCT00245583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92144945|NCT00245583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144946|NCT01379989|Carboplatin|carboplatin|mesh-list
92144947|NCT01379989|Doxorubicin|doxorubicin|mesh-list
92144948|NCT01379989|Trabectedin|trabectedin|mesh-list
92144949|NCT01379989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144950|NCT01379989|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92144951|NCT01379989|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92144952|NCT01379989|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92144953|NCT01379989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144954|NCT01379989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144955|NCT01379989|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92144956|NCT01379989|Alkylating Agents|alkylating agents|mesh-ancestor
92144957|NCT00754845|Letrozole|letrozole|mesh-list
92144958|NCT00754845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144959|NCT00754845|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92144960|NCT00754845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92144961|NCT00754845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144962|NCT00754845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144963|NCT00754845|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92144964|NCT00754845|Hormone Antagonists|hormone antagonists|mesh-ancestor
92144965|NCT00754845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92144966|NCT00754845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144967|NCT02652156|Bupivacaine|bupivacaine|mesh-list
92144968|NCT02652156|Ropivacaine|ropivacaine|mesh-list
92144969|NCT02652156|Anesthetics, Local|anesthetics, local|mesh-ancestor
92144970|NCT02652156|Anesthetics|anesthetics|mesh-ancestor
92144971|NCT02652156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144972|NCT02652156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144973|NCT02652156|Sensory System Agents|sensory system agents|mesh-ancestor
92144974|NCT02652156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144975|NCT03699865|Nicotine|nicotine|mesh-list
92144976|NCT03699865|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92144977|NCT03699865|Autonomic Agents|autonomic agents|mesh-ancestor
92144978|NCT03699865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92144979|NCT03699865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144980|NCT03699865|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92144981|NCT03699865|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92144982|NCT03699865|Cholinergic Agents|cholinergic agents|mesh-ancestor
92144983|NCT03699865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92144984|NCT03699865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144985|NCT00754923|Sorafenib|sorafenib|mesh-list
92144986|NCT00754923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92144987|NCT00754923|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92144988|NCT00754923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92144989|NCT00754923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92144990|NCT03696199|Anesthetics|anesthetics|mesh-list
92144991|NCT03696199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144992|NCT03696199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92144993|NCT00746421|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92144994|NCT00746421|Antidepressive Agents|antidepressive agents|mesh-ancestor
92144995|NCT00746421|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92144996|NCT00746421|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92144997|NCT00746421|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92146224|NCT01462370|Antipyretics|antipyretics|mesh-ancestor
92144998|NCT00746421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92144999|NCT00746421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145000|NCT02117076|Gabapentin|gabapentin|mesh-list
92145001|NCT02117076|Analgesics|analgesics|mesh-ancestor
92145002|NCT02117076|Sensory System Agents|sensory system agents|mesh-ancestor
91939485|NCT00833495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145003|NCT02117076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145004|NCT02117076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145005|NCT02117076|Anticonvulsants|anticonvulsants|mesh-ancestor
92145006|NCT02117076|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92145007|NCT02117076|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92145008|NCT02117076|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145009|NCT02117076|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92145010|NCT02117076|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92145011|NCT02117076|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92145012|NCT02117076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145013|NCT02117076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145014|NCT02117076|Antimanic Agents|antimanic agents|mesh-ancestor
92145015|NCT01274793|Mosapride|mosapride|mesh-list
92145016|NCT01274793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145017|NCT01274793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145018|NCT01274793|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92145019|NCT01274793|Serotonin Agents|serotonin agents|mesh-ancestor
92145020|NCT01274793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145021|NCT01274793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145022|NCT00746889|Triamcinolone|triamcinolone|mesh-list
92145023|NCT00746889|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92145024|NCT00746889|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92145025|NCT00746889|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92145026|NCT00746889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145027|NCT00746889|Glucocorticoids|glucocorticoids|mesh-ancestor
92145028|NCT00746889|Hormones|hormones|mesh-ancestor
92145029|NCT00746889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145030|NCT00746889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145031|NCT00746889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145032|NCT00746889|Immunologic Factors|immunologic factors|mesh-ancestor
92145033|NCT00746889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145034|NCT00746889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145035|NCT01675050|Cyproheptadine|cyproheptadine|mesh-list
92145036|NCT01675050|Antipruritics|antipruritics|mesh-ancestor
92145037|NCT01675050|Dermatologic Agents|dermatologic agents|mesh-ancestor
92145038|NCT01675050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145039|NCT01675050|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92145040|NCT01675050|Histamine Antagonists|histamine antagonists|mesh-ancestor
92145041|NCT01675050|Histamine Agents|histamine agents|mesh-ancestor
92145042|NCT01675050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145043|NCT01675050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145044|NCT01675050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145045|NCT01675050|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92145046|NCT01675050|Serotonin Agents|serotonin agents|mesh-ancestor
92145047|NCT01675050|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92145048|NCT00756093|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92145049|NCT00756093|Lubricant Eye Drops|lubricant eye drops|mesh-list
92145050|NCT00756093|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92145051|NCT00816582|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92145052|NCT00816582|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92145053|NCT00816582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145054|NCT03771313|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92145055|NCT03771313|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92145056|NCT03771313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145057|NCT03704688|Trametinib|trametinib|mesh-list
92145058|NCT03704688|Ponatinib|ponatinib|mesh-list
92145059|NCT03704688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145060|NCT03704688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92145061|NCT03704688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145062|NCT03704688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145063|NCT03600649|Cyclophosphamide|cyclophosphamide|mesh-list
92145064|NCT03600649|Topotecan|topotecan|mesh-list
92145065|NCT03600649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145066|NCT03600649|Immunologic Factors|immunologic factors|mesh-ancestor
92145067|NCT03600649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145068|NCT03600649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145069|NCT03600649|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145070|NCT03600649|Alkylating Agents|alkylating agents|mesh-ancestor
92146299|NCT00794313|Analgesics|analgesics|mesh-ancestor
92145071|NCT03600649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145072|NCT03600649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145073|NCT03600649|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92145074|NCT03600649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92145075|NCT03600649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92145076|NCT03600649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145077|NCT00244881|Cediranib|cediranib|mesh-list
92145078|NCT00244881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145079|NCT00244881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145080|NCT00244881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145081|NCT00244881|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92145082|NCT00530517|Sumatriptan|sumatriptan|mesh-list
92145083|NCT00530517|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92145084|NCT00530517|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92145085|NCT00530517|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92145086|NCT00530517|Serotonin Agents|serotonin agents|mesh-ancestor
92145087|NCT00530517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145088|NCT00530517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145089|NCT00530517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145090|NCT03765541|Cytarabine|cytarabine|mesh-list
92145091|NCT03765541|Dexamethasone|dexamethasone|mesh-list
92145092|NCT03765541|Azacitidine|azacitidine|mesh-list
92145093|NCT03765541|Amsacrine|amsacrine|mesh-list
92145094|NCT03765541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145096|NCT03765541|Autonomic Agents|autonomic agents|mesh-ancestor
92145097|NCT03765541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145098|NCT03765541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145099|NCT03765541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145100|NCT03765541|Glucocorticoids|glucocorticoids|mesh-ancestor
92145101|NCT03765541|Hormones|hormones|mesh-ancestor
92145102|NCT03765541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145103|NCT03765541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92145104|NCT03765541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145105|NCT03765541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145106|NCT03765541|Antimetabolites|antimetabolites|mesh-ancestor
92145107|NCT03765541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145108|NCT03765541|Antiviral Agents|antiviral agents|mesh-ancestor
92145109|NCT03765541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145110|NCT03765541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145111|NCT03765541|Immunologic Factors|immunologic factors|mesh-ancestor
92145112|NCT03765541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145113|NCT05123976|Olanzapine|olanzapine|mesh-list
92145114|NCT05123976|Antiemetics|antiemetics|mesh-ancestor
92145115|NCT05123976|Autonomic Agents|autonomic agents|mesh-ancestor
92145116|NCT05123976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145117|NCT05123976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145118|NCT05123976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145119|NCT05123976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92145120|NCT05123976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92145121|NCT05123976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145122|NCT05123976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92145123|NCT05123976|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92145124|NCT05123976|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92145125|NCT05123976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145126|NCT05123976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145127|NCT05123976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145128|NCT05123976|Serotonin Agents|serotonin agents|mesh-ancestor
92145129|NCT00005803|Cytarabine|cytarabine|mesh-list
92145130|NCT00005803|Cyclosporine|cyclosporine|mesh-list
92145131|NCT00005803|Mycophenolic Acid|mycophenolic acid|mesh-list
92145132|NCT00005803|Cyclophosphamide|cyclophosphamide|mesh-list
92145133|NCT00005803|Melphalan|melphalan|mesh-list
92145134|NCT00005803|Mechlorethamine|mechlorethamine|mesh-list
92145135|NCT00005803|Carmustine|carmustine|mesh-list
92145136|NCT00005803|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92145137|NCT00005803|Fludarabine|fludarabine|mesh-list
92145138|NCT00005803|Fludarabine phosphate|fludarabine phosphate|mesh-list
92145139|NCT00005803|Etoposide|etoposide|mesh-list
92145140|NCT00005803|Etoposide phosphate|etoposide phosphate|mesh-list
92145141|NCT00005803|Podophyllotoxin|podophyllotoxin|mesh-list
92145142|NCT00005803|Cyclosporins|cyclosporins|mesh-list
92145143|NCT00005803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145144|NCT00005803|Immunologic Factors|immunologic factors|mesh-ancestor
92145145|NCT00005803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145146|NCT00005803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145147|NCT00005803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145149|NCT00005803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145150|NCT00005803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145152|NCT00005803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145153|NCT00005803|Antimetabolites|antimetabolites|mesh-ancestor
92145154|NCT00005803|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92145155|NCT00005803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92145156|NCT00005803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92145157|NCT00005803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145158|NCT00005803|Antiviral Agents|antiviral agents|mesh-ancestor
92145159|NCT00005803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145160|NCT00005803|Antifungal Agents|antifungal agents|mesh-ancestor
92145161|NCT00005803|Dermatologic Agents|dermatologic agents|mesh-ancestor
92145162|NCT00005803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92145163|NCT00005803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92145164|NCT00005803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92145165|NCT00005803|Antitubercular Agents|antitubercular agents|mesh-ancestor
92145166|NCT00005803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92145167|NCT00005803|Keratolytic Agents|keratolytic agents|mesh-ancestor
92145168|NCT00005803|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145169|NCT00005803|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145170|NCT00005803|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145171|NCT00244725|Warfarin|warfarin|mesh-list
92145172|NCT00244725|Anticoagulants|anticoagulants|mesh-ancestor
92145173|NCT02649894|Silver Nitrate|silver nitrate|mesh-list
92145174|NCT02649894|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92145175|NCT02649894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145176|NCT04185012|Benralizumab|benralizumab|mesh-list
92145177|NCT04185012|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92145178|NCT04185012|Respiratory System Agents|respiratory system agents|mesh-ancestor
92145179|NCT01275183|Raltegravir Potassium|raltegravir potassium|mesh-list
92145180|NCT01275183|Cisplatin|cisplatin|mesh-list
92145181|NCT01275183|Docetaxel|docetaxel|mesh-list
92145182|NCT01275183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145183|NCT01275183|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145184|NCT01275183|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145185|NCT01275183|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145186|NCT01275183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145187|NCT01275183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92145188|NCT01275183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92145189|NCT01275183|Antiviral Agents|antiviral agents|mesh-ancestor
92145190|NCT01275183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145191|NCT01275183|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92145192|NCT01275183|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92145193|NCT01275183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145194|NCT05126004|Acetylcysteine|acetylcysteine|mesh-list
92145195|NCT05126004|Azacitidine|azacitidine|mesh-list
92145196|NCT05126004|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92145197|NCT05126004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145198|NCT05126004|Antimetabolites|antimetabolites|mesh-ancestor
92145199|NCT05126004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145200|NCT05126004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145201|NCT05126004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145202|NCT05126004|Antiviral Agents|antiviral agents|mesh-ancestor
92145203|NCT05126004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145204|NCT05126004|Expectorants|expectorants|mesh-ancestor
92145205|NCT05126004|Respiratory System Agents|respiratory system agents|mesh-ancestor
92145206|NCT05126004|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92145207|NCT05126004|Antioxidants|antioxidants|mesh-ancestor
91939492|NCT00830219|Ropinirole|ropinirole|mesh-list
92145208|NCT05126004|Protective Agents|protective agents|mesh-ancestor
92145209|NCT05126004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145210|NCT05126004|Antidotes|antidotes|mesh-ancestor
92145211|NCT03672643|Crizotinib|crizotinib|mesh-list
92145212|NCT03672643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145213|NCT03672643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92145214|NCT03672643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145215|NCT03672643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145216|NCT00350701|Methyltestosterone|methyltestosterone|mesh-list
92145217|NCT00350701|Testosterone|testosterone|mesh-list
92145218|NCT00350701|Testosterone undecanoate|testosterone undecanoate|mesh-list
92145219|NCT00350701|Testosterone enanthate|testosterone enanthate|mesh-list
92145220|NCT00350701|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92145221|NCT00350701|Androgens|androgens|mesh-ancestor
92145222|NCT00350701|Hormones|hormones|mesh-ancestor
92145223|NCT00350701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145224|NCT00350701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145225|NCT00350701|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92145226|NCT00350701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145229|NCT04277247|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92145230|NCT04277247|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92145231|NCT04277247|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92145232|NCT04277247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145233|NCT04277247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145234|NCT04277247|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145235|NCT04277247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145236|NCT04277247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145237|NCT04277247|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92145238|NCT04277247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145239|NCT01505114|Tenofovir|tenofovir|mesh-list
92145240|NCT01505114|Emtricitabine|emtricitabine|mesh-list
92145241|NCT01505114|Maraviroc|maraviroc|mesh-list
92145242|NCT01505114|Antiviral Agents|antiviral agents|mesh-ancestor
92145243|NCT01505114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145244|NCT01505114|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92145245|NCT01505114|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92145246|NCT01505114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145247|NCT01505114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145248|NCT01505114|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92145249|NCT01505114|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92145250|NCT01505114|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92145251|NCT01505114|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92145252|NCT01505114|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92145253|NCT04761757|Antidepressive Agents|antidepressive agents|mesh-list
92145254|NCT04761757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92145255|NCT04187898|Cyclophosphamide|cyclophosphamide|mesh-list
92145256|NCT04187898|Docetaxel|docetaxel|mesh-list
92145257|NCT04187898|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145258|NCT04187898|Immunologic Factors|immunologic factors|mesh-ancestor
92145259|NCT04187898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145260|NCT04187898|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145261|NCT04187898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145262|NCT04187898|Alkylating Agents|alkylating agents|mesh-ancestor
92145263|NCT04187898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145264|NCT04187898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145265|NCT04187898|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92145266|NCT04187898|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145267|NCT04187898|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145268|NCT04187898|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145269|NCT00243867|Paclitaxel|paclitaxel|mesh-list
92145270|NCT00243867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92145271|NCT00243867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145272|NCT00243867|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145273|NCT00243867|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145274|NCT00243867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145275|NCT00243867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145276|NCT01679899|Vildagliptin|vildagliptin|mesh-list
92145277|NCT01679899|Gliclazide|gliclazide|mesh-list
92145278|NCT01679899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92145279|NCT01679899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939509|NCT02274766|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92145280|NCT01679899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92145281|NCT01679899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92145282|NCT01679899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145283|NCT01679899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145284|NCT01276821|Epinephrine|epinephrine|mesh-list
92145285|NCT01276821|Racepinephrine|racepinephrine|mesh-list
92145286|NCT01276821|Epinephryl borate|epinephryl borate|mesh-list
92145287|NCT01276821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92145288|NCT01276821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92145289|NCT01276821|Adrenergic Agents|adrenergic agents|mesh-ancestor
92145290|NCT01276821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145291|NCT01276821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145292|NCT01276821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145293|NCT01276821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92145294|NCT01276821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92145295|NCT01276821|Autonomic Agents|autonomic agents|mesh-ancestor
92145296|NCT01276821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145297|NCT01276821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92145298|NCT01276821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92145299|NCT01276821|Mydriatics|mydriatics|mesh-ancestor
92145300|NCT01276821|Sympathomimetics|sympathomimetics|mesh-ancestor
92145301|NCT01276821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92145302|NCT00245037|Cyclosporine|cyclosporine|mesh-list
92145311|NCT00245037|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92145312|NCT00245037|Abortifacient Agents|abortifacient agents|mesh-ancestor
92145313|NCT00245037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92145314|NCT00245037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145315|NCT00245037|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145316|NCT00245037|Antimetabolites|antimetabolites|mesh-ancestor
92145317|NCT00245037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145318|NCT00245037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145319|NCT00245037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92145320|NCT00245037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145321|NCT00245037|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92145322|NCT00245037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145323|NCT00245037|Immunologic Factors|immunologic factors|mesh-ancestor
92145324|NCT00245037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145325|NCT00245037|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92145326|NCT00245037|Antifungal Agents|antifungal agents|mesh-ancestor
92145327|NCT00245037|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145328|NCT00245037|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92145329|NCT00245037|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92145330|NCT00245037|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92145331|NCT00245037|Antitubercular Agents|antitubercular agents|mesh-ancestor
92145332|NCT00245037|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92145333|NCT00245037|Alkylating Agents|alkylating agents|mesh-ancestor
92145334|NCT00245037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145335|NCT00245037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92145336|NCT00245037|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92145337|NCT00245037|Anticonvulsants|anticonvulsants|mesh-ancestor
92145338|NCT00245037|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92145339|NCT00245037|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92145340|NCT00245037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145341|NCT00245037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92145342|NCT00245037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92145343|NCT00241839|Allopurinol|allopurinol|mesh-list
92145344|NCT00241839|Chlorthalidone|chlorthalidone|mesh-list
92145345|NCT00241839|Antimetabolites|antimetabolites|mesh-ancestor
92145346|NCT00241839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145347|NCT00241839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145348|NCT00241839|Gout Suppressants|gout suppressants|mesh-ancestor
92145349|NCT00241839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145350|NCT00241839|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92145351|NCT00241839|Antioxidants|antioxidants|mesh-ancestor
92145352|NCT00241839|Protective Agents|protective agents|mesh-ancestor
92145353|NCT00241839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145354|NCT00241839|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92145355|NCT00241839|Diuretics|diuretics|mesh-ancestor
92145356|NCT00241839|Natriuretic Agents|natriuretic agents|mesh-ancestor
92145357|NCT00241839|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92145358|NCT00241839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145359|NCT05347381|Dexamethasone|dexamethasone|mesh-list
92145360|NCT05347381|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145361|NCT05347381|Antiemetics|antiemetics|mesh-ancestor
92145362|NCT05347381|Autonomic Agents|autonomic agents|mesh-ancestor
92145363|NCT05347381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145364|NCT05347381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145365|NCT05347381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145366|NCT05347381|Glucocorticoids|glucocorticoids|mesh-ancestor
92145367|NCT05347381|Hormones|hormones|mesh-ancestor
92145368|NCT05347381|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145369|NCT05347381|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92145370|NCT05347381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145371|NCT02651688|Enclomiphene|enclomiphene|mesh-list
92145372|NCT02651688|Clomiphene|clomiphene|mesh-list
92145373|NCT02651688|Zuclomiphene|zuclomiphene|mesh-list
92145374|NCT02651688|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92145375|NCT02651688|Hormone Antagonists|hormone antagonists|mesh-ancestor
92145376|NCT02651688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145377|NCT02651688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145378|NCT02651688|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92145379|NCT02651688|Fertility Agents|fertility agents|mesh-ancestor
92145380|NCT02651688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92145381|NCT02651688|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92145382|NCT02651688|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92145383|NCT01276353|Donepezil|donepezil|mesh-list
92145384|NCT01276353|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92145386|NCT01276353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145387|NCT01276353|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145388|NCT01276353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145389|NCT01276353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145390|NCT01276353|Nootropic Agents|nootropic agents|mesh-ancestor
92145391|NCT03809013|Trastuzumab|trastuzumab|mesh-list
92145392|NCT03809013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92145393|NCT03809013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145394|NCT03807921|Aspirin|aspirin|mesh-list
92145395|NCT03807921|Warfarin|warfarin|mesh-list
92145396|NCT03807921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92145397|NCT03807921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92145398|NCT03807921|Analgesics|analgesics|mesh-ancestor
92145399|NCT03807921|Sensory System Agents|sensory system agents|mesh-ancestor
92145400|NCT03807921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145401|NCT03807921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145402|NCT03807921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145403|NCT03807921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145404|NCT03807921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92145405|NCT03807921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92145406|NCT03807921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145407|NCT03807921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92145408|NCT03807921|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92145409|NCT03807921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145410|NCT03807921|Antipyretics|antipyretics|mesh-ancestor
92145411|NCT03807921|Anticoagulants|anticoagulants|mesh-ancestor
92145412|NCT01675609|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92145413|NCT01675609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92145414|NCT01675609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92145415|NCT01675609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92145416|NCT01675609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92145417|NCT01675609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92145418|NCT01675609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145419|NCT01675609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145420|NCT01675609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145421|NCT01673659|Mometasone Furoate|mometasone furoate|mesh-list
92145422|NCT01673659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145423|NCT01673659|Dermatologic Agents|dermatologic agents|mesh-ancestor
92145424|NCT01673659|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92145425|NCT00762177|Triclosan|triclosan|mesh-list
92145426|NCT00762177|Fluorides|fluorides|mesh-list
92145427|NCT00762177|Tin Fluorides|tin fluorides|mesh-list
92145428|NCT00762177|Cariostatic Agents|cariostatic agents|mesh-ancestor
92145429|NCT00762177|Protective Agents|protective agents|mesh-ancestor
92145430|NCT00762177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145431|NCT00762177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92145432|NCT00762177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145433|NCT00762177|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92145434|NCT00762177|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92145435|NCT00762177|Antimetabolites|antimetabolites|mesh-ancestor
92145436|NCT00762177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145437|NCT00762177|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92145438|NCT03458455|Pembrolizumab|pembrolizumab|mesh-list
92145439|NCT03458455|Nivolumab|nivolumab|mesh-list
92145440|NCT03458455|Ipilimumab|ipilimumab|mesh-list
92145441|NCT03458455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92145442|NCT03458455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145443|NCT03458455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92145444|NCT03458455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145445|NCT02536794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92145446|NCT02536794|Durvalumab|durvalumab|mesh-list
92145447|NCT02536794|Ipilimumab|ipilimumab|mesh-list
92145448|NCT02536794|Tremelimumab|tremelimumab|mesh-list
92145449|NCT02536794|Antibodies|antibodies|mesh-list
92145450|NCT02536794|Immunoglobulins|immunoglobulins|mesh-list
92145451|NCT02536794|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92145452|NCT02536794|Immunologic Factors|immunologic factors|mesh-ancestor
92145453|NCT02536794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145454|NCT02536794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145455|NCT02536794|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92145456|NCT02536794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145457|NCT00777855|Rifampin|rifampin|mesh-list
92145458|NCT00777855|Warfarin|warfarin|mesh-list
92145459|NCT00777855|Anticoagulants|anticoagulants|mesh-ancestor
92145460|NCT00777855|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92145461|NCT00777855|Antitubercular Agents|antitubercular agents|mesh-ancestor
92145462|NCT00777855|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92145463|NCT00777855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145464|NCT00777855|Leprostatic Agents|leprostatic agents|mesh-ancestor
92145465|NCT00777855|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92145466|NCT00777855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145467|NCT00777855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145468|NCT00777855|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92145469|NCT00777855|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92145470|NCT00777855|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92145471|NCT00777855|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92145472|NCT00777855|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92145473|NCT00777855|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92145474|NCT03523429|Blinatumomab|blinatumomab|mesh-list
92145475|NCT03523429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145476|NCT05125380|Acetic Acid|acetic acid|mesh-list
92145477|NCT05125380|Retinol acetate|retinol acetate|mesh-list
92145478|NCT05125380|Lugol's solution|lugol's solution|mesh-list
92145479|NCT05125380|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92145480|NCT05125380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145481|NCT05125380|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92145482|NCT05125380|Immunologic Factors|immunologic factors|mesh-ancestor
92145483|NCT05125380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145484|NCT05125380|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92145485|NCT05125380|Protective Agents|protective agents|mesh-ancestor
92145486|NCT05125380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145487|NCT05125380|Hemostatics|hemostatics|mesh-ancestor
92145488|NCT05125380|Coagulants|coagulants|mesh-ancestor
92145489|NCT00762645|Travoprost|travoprost|mesh-list
92145490|NCT00762645|Pilocarpine|pilocarpine|mesh-list
92145491|NCT00762645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92145493|NCT00762645|Autonomic Agents|autonomic agents|mesh-ancestor
92145494|NCT00762645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145495|NCT00762645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145496|NCT00762645|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92145497|NCT00762645|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92145498|NCT00762645|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145499|NCT00762645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145500|NCT00762645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145501|NCT02403193|Spartalizumab|spartalizumab|mesh-list
92145502|NCT02403193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92145503|NCT02403193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145504|NCT02403193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92145505|NCT02403193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145506|NCT03807297|Dexmedetomidine|dexmedetomidine|mesh-list
92145507|NCT03807297|Nitrous Oxide|nitrous oxide|mesh-list
92145508|NCT03807297|Propofol|propofol|mesh-list
92145509|NCT03807297|Sevoflurane|sevoflurane|mesh-list
92145510|NCT03807297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92145511|NCT03807297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145512|NCT03807297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145513|NCT03807297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92145514|NCT03807297|Analgesics|analgesics|mesh-ancestor
92145515|NCT03807297|Sensory System Agents|sensory system agents|mesh-ancestor
92145516|NCT03807297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145517|NCT03807297|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92145518|NCT03807297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92145519|NCT03807297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92145520|NCT03807297|Adrenergic Agents|adrenergic agents|mesh-ancestor
92145521|NCT03807297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145522|NCT03807297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145523|NCT03807297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92145524|NCT03807297|Anesthetics, General|anesthetics, general|mesh-ancestor
92145525|NCT03807297|Anesthetics|anesthetics|mesh-ancestor
92145526|NCT03807297|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92145527|NCT03807297|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92145528|NCT03573349|Ketamine|ketamine|mesh-list
92145529|NCT03573349|Analgesics|analgesics|mesh-ancestor
92145530|NCT03573349|Sensory System Agents|sensory system agents|mesh-ancestor
92145531|NCT03573349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145532|NCT03573349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145533|NCT03573349|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92145534|NCT03573349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92145535|NCT03573349|Anesthetics, General|anesthetics, general|mesh-ancestor
92145536|NCT03573349|Anesthetics|anesthetics|mesh-ancestor
92145537|NCT03573349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145538|NCT03573349|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92145539|NCT03573349|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92145540|NCT03573349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145541|NCT03573349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145542|NCT05387148|Cannabidiol|cannabidiol|mesh-list
92145543|NCT05387148|Anticonvulsants|anticonvulsants|mesh-ancestor
92145544|NCT03809637|Pemetrexed|pemetrexed|mesh-list
92145545|NCT03809637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145546|NCT03809637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145547|NCT03809637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145548|NCT03809637|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92145549|NCT03809637|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92145551|NCT03513445|Morphine|morphine|mesh-list
92145552|NCT03513445|Ropivacaine|ropivacaine|mesh-list
92145553|NCT03513445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92145554|NCT03513445|Narcotics|narcotics|mesh-ancestor
92145555|NCT03513445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145556|NCT03513445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145557|NCT03513445|Analgesics|analgesics|mesh-ancestor
92145558|NCT03513445|Sensory System Agents|sensory system agents|mesh-ancestor
92145559|NCT03513445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145560|NCT03513445|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92145561|NCT03513445|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92145562|NCT03513445|Adrenergic Agents|adrenergic agents|mesh-ancestor
92145563|NCT03513445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145564|NCT03513445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145565|NCT03513445|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92145566|NCT03513445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92145567|NCT03513445|Autonomic Agents|autonomic agents|mesh-ancestor
92145568|NCT03513445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92145569|NCT03513445|Respiratory System Agents|respiratory system agents|mesh-ancestor
92145570|NCT03513445|Mydriatics|mydriatics|mesh-ancestor
92145571|NCT03513445|Sympathomimetics|sympathomimetics|mesh-ancestor
92145572|NCT03513445|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92145573|NCT03513445|Anesthetics, Local|anesthetics, local|mesh-ancestor
92145574|NCT03513445|Anesthetics|anesthetics|mesh-ancestor
92145575|NCT03802071|Doxorubicin|doxorubicin|mesh-list
92145577|NCT03802071|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92145578|NCT03802071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145579|NCT03802071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92145580|NCT03802071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92145581|NCT03802071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145582|NCT03802071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145583|NCT03802071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92145584|NCT03809793|Acipimox|acipimox|mesh-list
92145585|NCT03809793|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92145586|NCT03809793|Antimetabolites|antimetabolites|mesh-ancestor
92145587|NCT03809793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145588|NCT03809793|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92145589|NCT00758667|Mesna|mesna|mesh-list
92145590|NCT00758667|Protective Agents|protective agents|mesh-ancestor
92145591|NCT00758667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145592|NCT05041920|Omeprazole|omeprazole|mesh-list
92145593|NCT05041920|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92145594|NCT05041920|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145595|NCT05041920|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92145596|NCT05041920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145597|NCT05041920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145598|NCT03508921|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92145599|NCT03508921|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92145600|NCT03508921|Trimethoprim|trimethoprim|mesh-list
92145601|NCT03508921|Sulfamethoxazole|sulfamethoxazole|mesh-list
92145602|NCT03508921|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92145603|NCT03508921|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92145604|NCT03508921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145605|NCT03508921|Antitubercular Agents|antitubercular agents|mesh-ancestor
92145606|NCT03508921|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92145607|NCT03508921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145608|NCT03508921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145609|NCT03508921|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92145610|NCT03508921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145611|NCT03508921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145612|NCT03508921|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145613|NCT03508921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145614|NCT03508921|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92145618|NCT03508921|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92145619|NCT03508921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145620|NCT03508921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92145621|NCT03508921|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92145622|NCT03508921|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92145623|NCT03506113|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92145624|NCT03506113|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92145625|NCT03506113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145626|NCT03506113|Antitubercular Agents|antitubercular agents|mesh-ancestor
92145627|NCT04412850|Magnesium Sulfate|magnesium sulfate|mesh-list
92145629|NCT04412850|Sensory System Agents|sensory system agents|mesh-ancestor
92145630|NCT04412850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145631|NCT04412850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145632|NCT04412850|Anesthetics|anesthetics|mesh-ancestor
92145633|NCT04412850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145634|NCT04412850|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92145635|NCT04412850|Anticonvulsants|anticonvulsants|mesh-ancestor
92145636|NCT04412850|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92145637|NCT04412850|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145638|NCT04412850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145639|NCT04412850|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92145640|NCT04412850|Tocolytic Agents|tocolytic agents|mesh-ancestor
92145641|NCT04412850|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92145642|NCT00778167|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92145644|NCT00778167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145645|NCT00778167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92145646|NCT00778167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145647|NCT00778167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145648|NCT00778167|Immunologic Factors|immunologic factors|mesh-ancestor
92145649|NCT00778167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145650|NCT00778869|Infliximab|infliximab|mesh-list
92145651|NCT00778869|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92145652|NCT00778869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145653|NCT00778869|Dermatologic Agents|dermatologic agents|mesh-ancestor
92145654|NCT00778869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145655|NCT00778869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145656|NCT05008536|Fludarabine|fludarabine|mesh-list
92145657|NCT05008536|Cyclophosphamide|cyclophosphamide|mesh-list
92145658|NCT05008536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145659|NCT05008536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145660|NCT05008536|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145661|NCT05008536|Immunologic Factors|immunologic factors|mesh-ancestor
92145662|NCT05008536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145663|NCT05008536|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145664|NCT05008536|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145665|NCT05008536|Alkylating Agents|alkylating agents|mesh-ancestor
92145666|NCT05008536|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92145667|NCT04345419|Remdesivir|remdesivir|mesh-list
92145668|NCT04345419|Antimetabolites|antimetabolites|mesh-ancestor
92145669|NCT04345419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145670|NCT04345419|Antiviral Agents|antiviral agents|mesh-ancestor
92145671|NCT04345419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145672|NCT01480076|4-Aminopyridine|4-aminopyridine|mesh-list
92145673|NCT01480076|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92145674|NCT01480076|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145675|NCT01480076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145676|NCT00759525|Glycyrrhetinic Acid|glycyrrhetinic acid|mesh-list
92145677|NCT00759525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145678|NCT00759603|Rituximab|rituximab|mesh-list
92145679|NCT00759603|Lenalidomide|lenalidomide|mesh-list
92145680|NCT00759603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92145681|NCT00759603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145682|NCT00759603|Immunologic Factors|immunologic factors|mesh-ancestor
92145683|NCT00759603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145684|NCT00759603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145685|NCT00759603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92145686|NCT00759603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92145687|NCT00759603|Growth Substances|growth substances|mesh-ancestor
92145688|NCT00759603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92145689|NCT03809325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92145690|NCT03809325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92145691|NCT03809325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92145692|NCT03809325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146374|NCT00768261|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145693|NCT03809325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145694|NCT03809325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92145695|NCT03809325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92145696|NCT03809325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92145697|NCT03809325|Serotonin Agents|serotonin agents|mesh-ancestor
92145698|NCT03809325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145699|NCT03809325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145700|NCT03809325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92145701|NCT03809325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92145704|NCT03510390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92145705|NCT03510390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145706|NCT03806673|Bupivacaine|bupivacaine|mesh-list
92145707|NCT03806673|Anesthetics, Local|anesthetics, local|mesh-ancestor
92145708|NCT03806673|Anesthetics|anesthetics|mesh-ancestor
92145709|NCT03806673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145710|NCT03806673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145711|NCT03806673|Sensory System Agents|sensory system agents|mesh-ancestor
92145712|NCT03806673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145714|NCT03291990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145716|NCT03291990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145717|NCT03291990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145718|NCT03806595|Lidocaine|lidocaine|mesh-list
92145719|NCT03806595|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92145720|NCT03806595|Anesthetics, Local|anesthetics, local|mesh-ancestor
92145721|NCT03806595|Anesthetics|anesthetics|mesh-ancestor
92145722|NCT03806595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145723|NCT03806595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145724|NCT03806595|Sensory System Agents|sensory system agents|mesh-ancestor
92145725|NCT03806595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145726|NCT03806595|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92145727|NCT03806595|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92145728|NCT03806595|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92145729|NCT03806595|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145730|NCT03806595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145731|NCT03807999|Paclitaxel|paclitaxel|mesh-list
92145732|NCT03807999|Gemcitabine|gemcitabine|mesh-list
92145733|NCT03807999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92145734|NCT03807999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145735|NCT03807999|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145736|NCT03807999|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145737|NCT03807999|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145738|NCT03807999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145739|NCT03807999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145740|NCT03807999|Antimetabolites|antimetabolites|mesh-ancestor
92145741|NCT04762147|Acetaminophen|acetaminophen|mesh-list
92145742|NCT04762147|Fentanyl|fentanyl|mesh-list
92145743|NCT04762147|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92145744|NCT04762147|Narcotics|narcotics|mesh-ancestor
92145745|NCT04762147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145746|NCT04762147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145747|NCT04762147|Analgesics|analgesics|mesh-ancestor
92145748|NCT04762147|Sensory System Agents|sensory system agents|mesh-ancestor
92145749|NCT04762147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145750|NCT04762147|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92145751|NCT04762147|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92145752|NCT04762147|Anesthetics, General|anesthetics, general|mesh-ancestor
92145753|NCT04762147|Anesthetics|anesthetics|mesh-ancestor
92145754|NCT04762147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92145755|NCT04762147|Antipyretics|antipyretics|mesh-ancestor
92145756|NCT04273737|Amantadine|amantadine|mesh-list
92145757|NCT04273737|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92145758|NCT04273737|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92145759|NCT04273737|Antiviral Agents|antiviral agents|mesh-ancestor
92145760|NCT04273737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145761|NCT04273737|Dopamine Agents|dopamine agents|mesh-ancestor
92145762|NCT04273737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145763|NCT04273737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145764|NCT04273737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145765|NCT04273737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92145766|NCT04273737|Analgesics|analgesics|mesh-ancestor
92145767|NCT04273737|Sensory System Agents|sensory system agents|mesh-ancestor
92145768|NCT04273737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145769|NCT02963064|Antibodies|antibodies|mesh-list
92145771|NCT02963064|Immunologic Factors|immunologic factors|mesh-ancestor
92146607|NCT03482167|Niacinamide|niacinamide|mesh-list
92145772|NCT02963064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145773|NCT04183062|Gemcitabine|gemcitabine|mesh-list
92145774|NCT04183062|Docetaxel|docetaxel|mesh-list
92145775|NCT04183062|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145776|NCT04183062|Antimetabolites|antimetabolites|mesh-ancestor
92145777|NCT04183062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145778|NCT04183062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145779|NCT04183062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145780|NCT04183062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145781|NCT04183062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145782|NCT04325880|Tamsulosin|tamsulosin|mesh-list
92145783|NCT04325880|Solifenacin Succinate|solifenacin succinate|mesh-list
92145784|NCT04325880|Mirabegron|mirabegron|mesh-list
92145785|NCT04325880|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92145786|NCT04325880|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92145787|NCT04325880|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92145788|NCT04325880|Adrenergic Agents|adrenergic agents|mesh-ancestor
92145789|NCT04325880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145790|NCT04325880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145791|NCT04325880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145792|NCT04325880|Urological Agents|urological agents|mesh-ancestor
92145793|NCT04325880|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92145794|NCT04325880|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92145795|NCT04325880|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145796|NCT04325880|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92145797|NCT04325880|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92145798|NCT04325880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92145799|NCT04846218|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92145800|NCT04846218|Progesterone|progesterone|mesh-list
92145801|NCT04846218|Progestins|progestins|mesh-ancestor
92145802|NCT04846218|Hormones|hormones|mesh-ancestor
92145803|NCT04846218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145804|NCT04846218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145805|NCT04846218|Luteolytic Agents|luteolytic agents|mesh-ancestor
92145806|NCT04846218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92145807|NCT04846218|Contraceptive Agents|contraceptive agents|mesh-ancestor
92145808|NCT04846218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92145809|NCT04846218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92145810|NCT04846218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92145811|NCT04846218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145812|NCT04152486|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92145813|NCT04152486|Antiviral Agents|antiviral agents|mesh-ancestor
92145814|NCT04152486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145815|NCT02512692|Gemcitabine|gemcitabine|mesh-list
92145816|NCT02512692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145817|NCT02512692|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145818|NCT02512692|Antimetabolites|antimetabolites|mesh-ancestor
92145819|NCT02512692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145820|NCT01594398|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92145821|NCT01594398|Exemestane|exemestane|mesh-list
92145822|NCT01594398|Entinostat|entinostat|mesh-list
92145823|NCT01594398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145824|NCT01594398|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92145825|NCT01594398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145826|NCT01594398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145827|NCT01594398|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92145828|NCT01594398|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92145829|NCT01594398|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92145830|NCT01594398|Hormone Antagonists|hormone antagonists|mesh-ancestor
92145831|NCT01594398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92145832|NCT01594398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145833|NCT01594398|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92145834|NCT00782379|Mycophenolic Acid|mycophenolic acid|mesh-list
92145835|NCT00782379|Cyclophosphamide|cyclophosphamide|mesh-list
92145836|NCT00782379|Busulfan|busulfan|mesh-list
92145837|NCT00782379|Fludarabine|fludarabine|mesh-list
92145838|NCT00782379|Fludarabine phosphate|fludarabine phosphate|mesh-list
92145839|NCT00782379|Tacrolimus|tacrolimus|mesh-list
92145840|NCT00782379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145841|NCT00782379|Immunologic Factors|immunologic factors|mesh-ancestor
92145842|NCT00782379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145843|NCT00782379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145844|NCT00782379|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145845|NCT00782379|Alkylating Agents|alkylating agents|mesh-ancestor
92145846|NCT00782379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145847|NCT00782379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145848|NCT00782379|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92145849|NCT00782379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145850|NCT00782379|Antimetabolites|antimetabolites|mesh-ancestor
92145851|NCT00782379|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92145852|NCT00782379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145853|NCT00782379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92145854|NCT00782379|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92145855|NCT00782379|Antitubercular Agents|antitubercular agents|mesh-ancestor
92145856|NCT00782379|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92145857|NCT00782379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92145858|NCT04572828|Naproxen|naproxen|mesh-list
92145859|NCT04572828|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92145860|NCT04572828|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92145861|NCT04572828|Analgesics|analgesics|mesh-ancestor
92145862|NCT04572828|Sensory System Agents|sensory system agents|mesh-ancestor
92145863|NCT04572828|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145864|NCT04572828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145865|NCT04572828|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145866|NCT04572828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145867|NCT04572828|Gout Suppressants|gout suppressants|mesh-ancestor
92145868|NCT04572828|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92145869|NCT04572828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145870|NCT04572828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145871|NCT05134350|Omeprazole|omeprazole|mesh-list
92145872|NCT05134350|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92145873|NCT05134350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92145874|NCT05134350|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92145875|NCT05134350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145876|NCT05134350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145877|NCT05134194|Gemcitabine|gemcitabine|mesh-list
92145878|NCT05134194|Capecitabine|capecitabine|mesh-list
92145879|NCT05134194|Vinorelbine|vinorelbine|mesh-list
92145880|NCT05134194|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145881|NCT05134194|Antimetabolites|antimetabolites|mesh-ancestor
92145882|NCT05134194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145883|NCT05134194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145884|NCT05134194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92145885|NCT05134194|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145886|NCT05134194|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145887|NCT05134194|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145888|NCT00761085|Morphine|morphine|mesh-list
92145889|NCT00761085|Methadone|methadone|mesh-list
92145890|NCT00761085|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92145891|NCT00761085|Narcotics|narcotics|mesh-ancestor
92145892|NCT00761085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145893|NCT00761085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145894|NCT00761085|Analgesics|analgesics|mesh-ancestor
92145895|NCT00761085|Sensory System Agents|sensory system agents|mesh-ancestor
92145896|NCT00761085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145897|NCT00761085|Antitussive Agents|antitussive agents|mesh-ancestor
92145898|NCT00761085|Respiratory System Agents|respiratory system agents|mesh-ancestor
92145899|NCT02145039|Cyclophosphamide|cyclophosphamide|mesh-list
92145900|NCT02145039|Fludarabine|fludarabine|mesh-list
92145901|NCT02145039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92145902|NCT02145039|Immunologic Factors|immunologic factors|mesh-ancestor
92145903|NCT02145039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145904|NCT02145039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92145905|NCT02145039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92145906|NCT02145039|Alkylating Agents|alkylating agents|mesh-ancestor
92145907|NCT02145039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145908|NCT02145039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145909|NCT02145039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92145910|NCT03806049|Paclitaxel|paclitaxel|mesh-list
92145911|NCT03806049|Bevacizumab|bevacizumab|mesh-list
92145912|NCT03806049|Carboplatin|carboplatin|mesh-list
92145913|NCT03806049|Niraparib|niraparib|mesh-list
92145914|NCT03806049|Dostarlimab|dostarlimab|mesh-list
92145915|NCT03806049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92145916|NCT03806049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145917|NCT03806049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145918|NCT03806049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145919|NCT03806049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145920|NCT03806049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146608|NCT03482167|Vitamin B Complex|vitamin b complex|mesh-ancestor
92145921|NCT03806049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92145922|NCT03806049|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92145923|NCT03806049|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92145924|NCT03806049|Growth Substances|growth substances|mesh-ancestor
92145925|NCT03806049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145926|NCT03806049|Growth Inhibitors|growth inhibitors|mesh-ancestor
92145927|NCT03806049|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92145928|NCT03806049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145930|NCT00089479|Docetaxel|docetaxel|mesh-list
92145931|NCT00089479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92145932|NCT00089479|Antimetabolites|antimetabolites|mesh-ancestor
92145933|NCT00089479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145934|NCT00089479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145935|NCT00089479|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145936|NCT00089479|Antimitotic Agents|antimitotic agents|mesh-ancestor
92145937|NCT00089479|Mitosis Modulators|mitosis modulators|mesh-ancestor
92145938|NCT01463306|Pregabalin|pregabalin|mesh-list
92145939|NCT01463306|Analgesics|analgesics|mesh-ancestor
92145940|NCT01463306|Sensory System Agents|sensory system agents|mesh-ancestor
92145941|NCT01463306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145942|NCT01463306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145943|NCT01463306|Anticonvulsants|anticonvulsants|mesh-ancestor
92145944|NCT01463306|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92145945|NCT01463306|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145946|NCT01463306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145947|NCT01463306|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92145948|NCT01463306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92145949|NCT01463306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92145950|NCT01463306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92145951|NCT01463306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92145952|NCT05055726|Benzydamine|benzydamine|mesh-list
92145953|NCT05055726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92145954|NCT00765375|Botulinum Toxins|botulinum toxins|mesh-list
92145955|NCT00765375|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92145956|NCT00765375|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92145957|NCT00765375|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92145958|NCT00765375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92145959|NCT00765375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145960|NCT00765375|Cholinergic Agents|cholinergic agents|mesh-ancestor
92145961|NCT00765375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92145962|NCT00765375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145963|NCT00765375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92145964|NCT00765375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145965|NCT03451591|Cilostazol|cilostazol|mesh-list
92145966|NCT03451591|Isosorbide|isosorbide|mesh-list
92145967|NCT03451591|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92145968|NCT03451591|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92145969|NCT03451591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92145970|NCT03451591|Autonomic Agents|autonomic agents|mesh-ancestor
92145971|NCT03451591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92145972|NCT03451591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92145973|NCT03451591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92145974|NCT03451591|Respiratory System Agents|respiratory system agents|mesh-ancestor
92145975|NCT03451591|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92145976|NCT03451591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92145977|NCT03451591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145978|NCT03451591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92145979|NCT03451591|Vasodilator Agents|vasodilator agents|mesh-ancestor
92145980|NCT03451591|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92145981|NCT03451591|Protective Agents|protective agents|mesh-ancestor
92145982|NCT03451591|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92145983|NCT03451591|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92145984|NCT03451591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92145985|NCT03451591|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92145986|NCT03451591|Diuretics|diuretics|mesh-ancestor
92145987|NCT03451591|Natriuretic Agents|natriuretic agents|mesh-ancestor
92145988|NCT03451591|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92145989|NCT05744115|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92145990|NCT05744115|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92145991|NCT05744115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145992|NCT01677559|Paclitaxel|paclitaxel|mesh-list
92145993|NCT01677559|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92145994|NCT01677559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92145995|NCT01677559|Tubulin Modulators|tubulin modulators|mesh-ancestor
92145998|NCT01677559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92145999|NCT05132712|Losartan|losartan|mesh-list
92146000|NCT05132712|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92146001|NCT05132712|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92146002|NCT05132712|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92146003|NCT05132712|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92146004|NCT05132712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146005|NCT02149173|Deoxyglucose|deoxyglucose|mesh-list
92146006|NCT02149173|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92146007|NCT02149173|Fluorides|fluorides|mesh-list
92146008|NCT02149173|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92146009|NCT02149173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146010|NCT02149173|Cariostatic Agents|cariostatic agents|mesh-ancestor
92146011|NCT02149173|Protective Agents|protective agents|mesh-ancestor
92146012|NCT02149173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146013|NCT02149173|Antimetabolites|antimetabolites|mesh-ancestor
92146014|NCT02149173|Antiviral Agents|antiviral agents|mesh-ancestor
92146015|NCT02149173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146016|NCT04789434|Tislelizumab|tislelizumab|mesh-list
92146017|NCT04789434|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92146018|NCT04789434|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146019|NCT04789434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146020|NCT04789434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146021|NCT03805503|Chloroprocaine|chloroprocaine|mesh-list
92146022|NCT03805503|Procaine|procaine|mesh-list
92146023|NCT03805503|Anesthetics, Local|anesthetics, local|mesh-ancestor
92146024|NCT03805503|Anesthetics|anesthetics|mesh-ancestor
92146025|NCT03805503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146026|NCT03805503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146027|NCT03805503|Sensory System Agents|sensory system agents|mesh-ancestor
92146028|NCT03805503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146029|NCT01504412|Pregabalin|pregabalin|mesh-list
92146030|NCT01504412|Analgesics|analgesics|mesh-ancestor
92146031|NCT01504412|Sensory System Agents|sensory system agents|mesh-ancestor
92146032|NCT01504412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146033|NCT01504412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146034|NCT01504412|Anticonvulsants|anticonvulsants|mesh-ancestor
92146035|NCT01504412|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92146036|NCT01504412|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146037|NCT01504412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146038|NCT01504412|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92146039|NCT01504412|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92146040|NCT01504412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92146041|NCT01504412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146042|NCT01504412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92146043|NCT04702464|Fluconazole|fluconazole|mesh-list
92146044|NCT04702464|Antifungal Agents|antifungal agents|mesh-ancestor
92146045|NCT04702464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146046|NCT04702464|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92146047|NCT04702464|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92146048|NCT04702464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146049|NCT04702464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146050|NCT04702464|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92146051|NCT04702464|Hormone Antagonists|hormone antagonists|mesh-ancestor
92146052|NCT04702464|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146053|NCT04702464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146054|NCT04702464|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92146055|NCT04702464|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92146056|NCT00088465|Olanzapine|olanzapine|mesh-list
92146057|NCT00088465|Antiemetics|antiemetics|mesh-ancestor
92146058|NCT00088465|Autonomic Agents|autonomic agents|mesh-ancestor
92146059|NCT00088465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146060|NCT00088465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146061|NCT00088465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92146062|NCT00088465|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92146063|NCT00088465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92146064|NCT00088465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146065|NCT00088465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92146066|NCT00088465|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92146067|NCT00088465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92146068|NCT00088465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146069|NCT00088465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146070|NCT00088465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146071|NCT00088465|Serotonin Agents|serotonin agents|mesh-ancestor
92146072|NCT04405674|Paclitaxel|paclitaxel|mesh-list
92146073|NCT04405674|Bevacizumab|bevacizumab|mesh-list
92146074|NCT04405674|Carboplatin|carboplatin|mesh-list
92146075|NCT04405674|Pemetrexed|pemetrexed|mesh-list
92146076|NCT04405674|Tislelizumab|tislelizumab|mesh-list
92146077|NCT04405674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92146078|NCT04405674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146079|NCT04405674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92146080|NCT04405674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92146081|NCT04405674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92146082|NCT04405674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146083|NCT04405674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146084|NCT04405674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146085|NCT04405674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146086|NCT04405674|Growth Substances|growth substances|mesh-ancestor
92146087|NCT04405674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146088|NCT04405674|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146089|NCT04405674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146090|NCT04405674|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92146091|NCT04405674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92146092|NCT00088153|Progesterone|progesterone|mesh-list
92146093|NCT00088153|Estrogens|estrogens|mesh-list
92146094|NCT00088153|Progestins|progestins|mesh-ancestor
92146095|NCT00088153|Hormones|hormones|mesh-ancestor
92146096|NCT00088153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146097|NCT00088153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146098|NCT02074358|Apixaban|apixaban|mesh-list
92146099|NCT02074358|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92146100|NCT02074358|Antithrombins|antithrombins|mesh-ancestor
92146101|NCT02074358|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92146102|NCT02074358|Protease Inhibitors|protease inhibitors|mesh-ancestor
92146103|NCT02074358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146104|NCT02074358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146105|NCT02074358|Anticoagulants|anticoagulants|mesh-ancestor
92146106|NCT05743725|Magnesium Sulfate|magnesium sulfate|mesh-list
92146107|NCT05743725|Dexmedetomidine|dexmedetomidine|mesh-list
92146108|NCT05743725|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146109|NCT05743725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146110|NCT05743725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146111|NCT05743725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146112|NCT05743725|Analgesics|analgesics|mesh-ancestor
92146113|NCT05743725|Sensory System Agents|sensory system agents|mesh-ancestor
92146114|NCT05743725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146115|NCT05743725|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92146116|NCT05743725|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92146117|NCT05743725|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92146118|NCT05743725|Adrenergic Agents|adrenergic agents|mesh-ancestor
92146119|NCT05743725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146120|NCT05743725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146121|NCT05743725|Anesthetics|anesthetics|mesh-ancestor
92146122|NCT05743725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92146123|NCT05743725|Anticonvulsants|anticonvulsants|mesh-ancestor
92146124|NCT05743725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92146125|NCT05743725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146126|NCT05743725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92146127|NCT05743725|Tocolytic Agents|tocolytic agents|mesh-ancestor
92146128|NCT05743725|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92146129|NCT05547321|Pembrolizumab|pembrolizumab|mesh-list
92146130|NCT05547321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146131|NCT05547321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146132|NCT05547321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92146133|NCT05547321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146134|NCT04912518|Dexmedetomidine|dexmedetomidine|mesh-list
92146135|NCT04912518|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146136|NCT04912518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939540|NCT02370238|Tubulin Modulators|tubulin modulators|mesh-ancestor
92146137|NCT04912518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146138|NCT04912518|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146139|NCT04912518|Analgesics|analgesics|mesh-ancestor
92146140|NCT04912518|Sensory System Agents|sensory system agents|mesh-ancestor
92146141|NCT04912518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146142|NCT04912518|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92146143|NCT04912518|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92146146|NCT04912518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146147|NCT04912518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146149|NCT00087685|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92146150|NCT00087685|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146151|NCT00087685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146152|NCT00087685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146153|NCT00087685|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146154|NCT00087685|Immunologic Factors|immunologic factors|mesh-ancestor
92146155|NCT00087685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146156|NCT00087685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146157|NCT04094558|Lactulose|lactulose|mesh-list
92146158|NCT04094558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92146159|NCT01502228|Sunitinib|sunitinib|mesh-list
92146160|NCT01502228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146161|NCT01502228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146162|NCT01502228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146163|NCT01502228|Growth Substances|growth substances|mesh-ancestor
92146164|NCT01502228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146165|NCT01502228|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146166|NCT01502228|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146167|NCT01502228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146168|NCT01502228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146169|NCT05011812|Ritonavir|ritonavir|mesh-list
92146170|NCT05011812|Midazolam|midazolam|mesh-list
92146171|NCT05011812|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92146172|NCT05011812|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146173|NCT05011812|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146174|NCT05011812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146175|NCT05011812|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92146176|NCT05011812|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92146177|NCT05011812|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92146178|NCT05011812|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92146179|NCT05011812|Anesthetics, General|anesthetics, general|mesh-ancestor
92146180|NCT05011812|Anesthetics|anesthetics|mesh-ancestor
92146181|NCT05011812|GABA Modulators|gaba modulators|mesh-ancestor
92146182|NCT05011812|GABA Agents|gaba agents|mesh-ancestor
92146183|NCT05011812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146184|NCT05011812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146185|NCT05011812|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92146186|NCT05011812|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92146187|NCT05011812|Protease Inhibitors|protease inhibitors|mesh-ancestor
92146188|NCT05011812|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146189|NCT05011812|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92146190|NCT05011812|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92146191|NCT05011812|Antiviral Agents|antiviral agents|mesh-ancestor
92146192|NCT05011812|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146193|NCT05011812|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92146194|NCT05011812|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92146195|NCT05535231|Curcumin|curcumin|mesh-list
92146196|NCT05535231|Turmeric extract|turmeric extract|mesh-list
92146197|NCT05535231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92146198|NCT05535231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146199|NCT05535231|Analgesics|analgesics|mesh-ancestor
92146200|NCT05535231|Sensory System Agents|sensory system agents|mesh-ancestor
92146201|NCT05535231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146202|NCT05535231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146203|NCT05535231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146204|NCT05535231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146205|NCT05535231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146206|NCT05535231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146207|NCT05535231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146208|NCT05535231|Antioxidants|antioxidants|mesh-ancestor
92146209|NCT05535231|Protective Agents|protective agents|mesh-ancestor
92146211|NCT01502072|Antimetabolites|antimetabolites|mesh-ancestor
92146212|NCT01502072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146213|NCT01502072|Antiviral Agents|antiviral agents|mesh-ancestor
92146214|NCT01502072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146215|NCT01462370|Acetaminophen|acetaminophen|mesh-list
92146216|NCT01462370|Ibuprofen|ibuprofen|mesh-list
92146217|NCT01462370|Etoricoxib|etoricoxib|mesh-list
92146218|NCT01462370|Caffeine|caffeine|mesh-list
92146219|NCT01462370|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146220|NCT01462370|Analgesics|analgesics|mesh-ancestor
92146221|NCT01462370|Sensory System Agents|sensory system agents|mesh-ancestor
92146222|NCT01462370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146223|NCT01462370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146225|NCT01462370|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92146226|NCT01462370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146227|NCT01462370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146228|NCT01462370|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92146229|NCT01462370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146230|NCT01462370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146231|NCT01462370|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92146232|NCT01462370|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92146233|NCT01462370|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92146234|NCT01462370|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92146235|NCT01462370|Purinergic Agents|purinergic agents|mesh-ancestor
92146236|NCT01462370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146237|NCT01462370|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92146238|NCT05743179|Zoledronic Acid|zoledronic acid|mesh-list
92146239|NCT05743179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92146240|NCT05743179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146241|NCT01479764|Glycopyrrolate|glycopyrrolate|mesh-list
92146242|NCT01479764|Neostigmine|neostigmine|mesh-list
92146243|NCT01479764|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92146244|NCT01479764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146245|NCT01479764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146246|NCT01479764|Cholinergic Agents|cholinergic agents|mesh-ancestor
92146247|NCT01479764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146248|NCT01479764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146249|NCT01479764|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92146250|NCT01479764|Autonomic Agents|autonomic agents|mesh-ancestor
92146251|NCT01479764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146252|NCT01479764|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92146253|NCT01479764|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92146254|NCT01479764|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92146255|NCT01479530|Rasagiline|rasagiline|mesh-list
92146256|NCT01479530|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92146257|NCT01479530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146258|NCT01479530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146259|NCT01479530|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92146260|NCT01479530|Protective Agents|protective agents|mesh-ancestor
92146261|NCT01479530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146262|NCT01479374|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92146263|NCT01479374|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92146264|NCT01479374|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92146265|NCT01479374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92146266|NCT01479374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146267|NCT01479374|Analgesics|analgesics|mesh-ancestor
92146268|NCT01479374|Sensory System Agents|sensory system agents|mesh-ancestor
92146269|NCT01479374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146270|NCT01479374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146271|NCT01479374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146272|NCT01479374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146273|NCT01479374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92146274|NCT01479374|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92146275|NCT01479374|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92146276|NCT01479374|Histamine Antagonists|histamine antagonists|mesh-ancestor
92146277|NCT01479374|Histamine Agents|histamine agents|mesh-ancestor
92146278|NCT01479374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146279|NCT01479374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146280|NCT00087529|Rituximab|rituximab|mesh-list
92146281|NCT00087529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146282|NCT00087529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146283|NCT00087529|Immunologic Factors|immunologic factors|mesh-ancestor
92146284|NCT00087529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146285|NCT00087529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146286|NCT00794313|Topiramate|topiramate|mesh-list
92146287|NCT00794313|Amantadine|amantadine|mesh-list
92146288|NCT00794313|Anticonvulsants|anticonvulsants|mesh-ancestor
92146289|NCT00794313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92146290|NCT00794313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146291|NCT00794313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92146292|NCT00794313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92146293|NCT00794313|Antiviral Agents|antiviral agents|mesh-ancestor
92146294|NCT00794313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146295|NCT00794313|Dopamine Agents|dopamine agents|mesh-ancestor
92146296|NCT00794313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146297|NCT00794313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146298|NCT00794313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146300|NCT00794313|Sensory System Agents|sensory system agents|mesh-ancestor
92146301|NCT00794313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146302|NCT05743101|Levofloxacin|levofloxacin|mesh-list
92146303|NCT05743101|Ofloxacin|ofloxacin|mesh-list
92146304|NCT05743101|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92146305|NCT05743101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146306|NCT05743101|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92146307|NCT05743101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92146308|NCT05743101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92146309|NCT05743101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146310|NCT05743101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146311|NCT05743101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146312|NCT05743101|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92146313|NCT05743101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92146314|NCT01500434|Aspirin|aspirin|mesh-list
92146315|NCT01500434|Ticlopidine|ticlopidine|mesh-list
92146316|NCT01500434|Clopidogrel|clopidogrel|mesh-list
92146317|NCT01500434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92146318|NCT01500434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146319|NCT01500434|Analgesics|analgesics|mesh-ancestor
92146320|NCT01500434|Sensory System Agents|sensory system agents|mesh-ancestor
92146321|NCT01500434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146322|NCT01500434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146323|NCT01500434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146324|NCT01500434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146325|NCT01500434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92146326|NCT01500434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92146327|NCT01500434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146328|NCT01500434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92146329|NCT01500434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92146330|NCT01500434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146331|NCT01500434|Antipyretics|antipyretics|mesh-ancestor
92146332|NCT01500434|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92146333|NCT01500434|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92146334|NCT01500434|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92146335|NCT01500434|Purinergic Agents|purinergic agents|mesh-ancestor
92146336|NCT01500434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146337|NCT01500434|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92146338|NCT01500434|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92146339|NCT00087139|Epothilones|epothilones|mesh-list
92146340|NCT00087139|Epothilone B|epothilone b|mesh-list
92146341|NCT00087139|Tubulin Modulators|tubulin modulators|mesh-ancestor
92146342|NCT00087139|Antimitotic Agents|antimitotic agents|mesh-ancestor
92146343|NCT00087139|Mitosis Modulators|mitosis modulators|mesh-ancestor
92146344|NCT00087139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146345|NCT00087139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146346|NCT00794547|Calcitriol|calcitriol|mesh-list
92146347|NCT00794547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92146348|NCT00794547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146349|NCT00794547|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92146350|NCT00794547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146351|NCT00794547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146352|NCT00794547|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92146353|NCT00794547|Vitamins|vitamins|mesh-ancestor
92146354|NCT00794547|Micronutrients|micronutrients|mesh-ancestor
92146355|NCT00794547|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92146356|NCT03493165|Everolimus|everolimus|mesh-list
92146357|NCT03493165|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92146358|NCT03493165|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146359|NCT03493165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146360|NCT03493165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146361|NCT03493165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146362|NCT03493165|Immunologic Factors|immunologic factors|mesh-ancestor
92146363|NCT03493165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146364|NCT03493165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146366|NCT00786825|Hormones|hormones|mesh-ancestor
92146367|NCT00786825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146368|NCT00786825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146369|NCT00768261|Memantine|memantine|mesh-list
92146370|NCT00768261|Donepezil|donepezil|mesh-list
92146371|NCT00768261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92146372|NCT00768261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146373|NCT00768261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146375|NCT00768261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146376|NCT00768261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146377|NCT00768261|Nootropic Agents|nootropic agents|mesh-ancestor
92146378|NCT00768261|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92146379|NCT00768261|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92146380|NCT00768261|Dopamine Agents|dopamine agents|mesh-ancestor
92146381|NCT00768261|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92146382|NCT00768261|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92146383|NCT03804723|Prednisone|prednisone|mesh-list
92146384|NCT03804723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146385|NCT03804723|Glucocorticoids|glucocorticoids|mesh-ancestor
92146386|NCT03804723|Hormones|hormones|mesh-ancestor
92146387|NCT03804723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146388|NCT03804723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146389|NCT03804723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92146390|NCT03804723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146391|NCT00797277|Lorazepam|lorazepam|mesh-list
92146392|NCT00797277|Haloperidol|haloperidol|mesh-list
92146393|NCT00797277|Olanzapine|olanzapine|mesh-list
92146394|NCT00797277|Haloperidol decanoate|haloperidol decanoate|mesh-list
92146395|NCT00797277|Antiemetics|antiemetics|mesh-ancestor
92146396|NCT00797277|Autonomic Agents|autonomic agents|mesh-ancestor
92146397|NCT00797277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146398|NCT00797277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146399|NCT00797277|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92146400|NCT00797277|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92146401|NCT00797277|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92146402|NCT00797277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146403|NCT00797277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92146404|NCT00797277|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92146405|NCT00797277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92146406|NCT00797277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146407|NCT00797277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146408|NCT00797277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146409|NCT00797277|Serotonin Agents|serotonin agents|mesh-ancestor
92146410|NCT00797277|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92146411|NCT00797277|Dopamine Agents|dopamine agents|mesh-ancestor
92146412|NCT00797277|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92146413|NCT00797277|Anticonvulsants|anticonvulsants|mesh-ancestor
92146414|NCT00797277|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146415|NCT00797277|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92146416|NCT00797277|GABA Modulators|gaba modulators|mesh-ancestor
92146417|NCT00797277|GABA Agents|gaba agents|mesh-ancestor
92146418|NCT03837015|Estradiol|estradiol|mesh-list
92146419|NCT03837015|Estrogens|estrogens|mesh-ancestor
92146420|NCT03837015|Hormones|hormones|mesh-ancestor
92146421|NCT03837015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146422|NCT03837015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146423|NCT01500278|Adalimumab|adalimumab|mesh-list
92146424|NCT01500278|Certolizumab Pegol|certolizumab pegol|mesh-list
92146425|NCT01500278|Methotrexate|methotrexate|mesh-list
92146426|NCT01500278|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92146427|NCT01500278|Abortifacient Agents|abortifacient agents|mesh-ancestor
92146428|NCT01500278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92146429|NCT01500278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146430|NCT01500278|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146431|NCT01500278|Antimetabolites|antimetabolites|mesh-ancestor
92146432|NCT01500278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146433|NCT01500278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146434|NCT01500278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92146435|NCT01500278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146436|NCT01500278|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92146437|NCT01500278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146438|NCT01500278|Immunologic Factors|immunologic factors|mesh-ancestor
92146439|NCT01500278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146440|NCT01500278|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92146441|NCT01500278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92146442|NCT01500278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146445|NCT00086281|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92146446|NCT00086281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146447|NCT00086281|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92146448|NCT00086281|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92146449|NCT00086281|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92146450|NCT00086281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146451|NCT00086281|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92146452|NCT00086281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146453|NCT00086281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146454|NCT00086281|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92146455|NCT00086281|GABA Agonists|gaba agonists|mesh-ancestor
92146456|NCT00086281|GABA Agents|gaba agents|mesh-ancestor
92146457|NCT00086281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146458|NCT00787761|Cyclophosphamide|cyclophosphamide|mesh-list
92146459|NCT00787761|Busulfan|busulfan|mesh-list
92146460|NCT00787761|Methotrexate|methotrexate|mesh-list
92146461|NCT00787761|Fludarabine|fludarabine|mesh-list
92146462|NCT00787761|Fludarabine phosphate|fludarabine phosphate|mesh-list
92146463|NCT00787761|Tacrolimus|tacrolimus|mesh-list
92146464|NCT00787761|Thymoglobulin|thymoglobulin|mesh-list
92146465|NCT00787761|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92146466|NCT00787761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146467|NCT00787761|Immunologic Factors|immunologic factors|mesh-ancestor
92146468|NCT00787761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146469|NCT00787761|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146470|NCT00787761|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92146471|NCT00787761|Alkylating Agents|alkylating agents|mesh-ancestor
92146472|NCT00787761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146473|NCT00787761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146474|NCT00787761|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92146475|NCT00787761|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92146476|NCT00787761|Abortifacient Agents|abortifacient agents|mesh-ancestor
92146477|NCT00787761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92146478|NCT00787761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146479|NCT00787761|Antimetabolites|antimetabolites|mesh-ancestor
92146480|NCT00787761|Dermatologic Agents|dermatologic agents|mesh-ancestor
92146481|NCT00787761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146482|NCT00787761|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92146483|NCT00787761|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92146484|NCT00787761|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92146485|NCT01478828|Lovastatin|lovastatin|mesh-list
92146486|NCT01478828|L 647318|l 647318|mesh-list
92146487|NCT01478828|Dihydromevinolin|dihydromevinolin|mesh-list
92146488|NCT01478828|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92146489|NCT01478828|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92146490|NCT01478828|Antimetabolites|antimetabolites|mesh-ancestor
92146491|NCT01478828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146492|NCT01478828|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92146493|NCT01478828|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92146494|NCT01478828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146495|NCT00085423|Aldesleukin|aldesleukin|mesh-list
92146496|NCT00085423|Cyclophosphamide|cyclophosphamide|mesh-list
92146497|NCT00085423|Fludarabine|fludarabine|mesh-list
92146498|NCT00085423|Fludarabine phosphate|fludarabine phosphate|mesh-list
92146499|NCT00085423|Interleukin-2|interleukin-2|mesh-list
92146500|NCT00085423|Molgramostim|molgramostim|mesh-list
92146501|NCT00085423|Sargramostim|sargramostim|mesh-list
92146502|NCT00085423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146503|NCT00085423|Immunologic Factors|immunologic factors|mesh-ancestor
92146504|NCT00085423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146506|NCT00085423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92146507|NCT00085423|Alkylating Agents|alkylating agents|mesh-ancestor
92146508|NCT00085423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146509|NCT00085423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146510|NCT00085423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92146511|NCT00085423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146513|NCT00085423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146514|NCT00085423|Analgesics|analgesics|mesh-ancestor
92146515|NCT00085423|Sensory System Agents|sensory system agents|mesh-ancestor
92146516|NCT00085423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146517|NCT00085423|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92146518|NCT00085423|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92146519|NCT00085423|Antiviral Agents|antiviral agents|mesh-ancestor
92146520|NCT00085423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146521|NCT04079192|Umirolimus|umirolimus|mesh-list
92146522|NCT04079192|Paclitaxel|paclitaxel|mesh-list
92146523|NCT04079192|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92146524|NCT04079192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146525|NCT04079192|Tubulin Modulators|tubulin modulators|mesh-ancestor
92146526|NCT04079192|Antimitotic Agents|antimitotic agents|mesh-ancestor
92146527|NCT04079192|Mitosis Modulators|mitosis modulators|mesh-ancestor
92146528|NCT04079192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146529|NCT04079192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146530|NCT04079192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146531|NCT04079192|Immunologic Factors|immunologic factors|mesh-ancestor
92146532|NCT04079192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146533|NCT03087877|Acetaminophen|acetaminophen|mesh-list
92146534|NCT03087877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146535|NCT03087877|Analgesics|analgesics|mesh-ancestor
92146536|NCT03087877|Sensory System Agents|sensory system agents|mesh-ancestor
92146537|NCT03087877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146538|NCT03087877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146539|NCT03087877|Antipyretics|antipyretics|mesh-ancestor
92146540|NCT05742477|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92146541|NCT05742477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146542|NCT03447379|Aspirin|aspirin|mesh-list
92146543|NCT03447379|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92146544|NCT03447379|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146545|NCT03447379|Analgesics|analgesics|mesh-ancestor
92146546|NCT03447379|Sensory System Agents|sensory system agents|mesh-ancestor
92146547|NCT03447379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146548|NCT03447379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146549|NCT03447379|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146550|NCT03447379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146551|NCT03447379|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92146552|NCT03447379|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92146553|NCT03447379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146554|NCT03447379|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92146555|NCT03447379|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92146556|NCT03447379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146557|NCT03447379|Antipyretics|antipyretics|mesh-ancestor
92146558|NCT03803553|Fluorouracil|fluorouracil|mesh-list
92146559|NCT03803553|Nivolumab|nivolumab|mesh-list
92146560|NCT03803553|Irinotecan|irinotecan|mesh-list
92146561|NCT03803553|Cetuximab|cetuximab|mesh-list
92146562|NCT03803553|Antimetabolites|antimetabolites|mesh-ancestor
92146563|NCT03803553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146564|NCT03803553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146565|NCT03803553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146566|NCT03803553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146567|NCT03803553|Immunologic Factors|immunologic factors|mesh-ancestor
92146568|NCT03803553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146569|NCT03803553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146570|NCT03803553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92146571|NCT03803553|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92146572|NCT03803553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92146573|NCT03803553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146574|NCT05740449|Decitabine|decitabine|mesh-list
92146575|NCT05740449|Venetoclax|venetoclax|mesh-list
92146576|NCT05740449|Navitoclax|navitoclax|mesh-list
92146577|NCT05740449|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146578|NCT05740449|Antimetabolites|antimetabolites|mesh-ancestor
92146579|NCT05740449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146580|NCT05740449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146581|NCT05740449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146582|NCT01677949|Cyclophosphamide|cyclophosphamide|mesh-list
92146583|NCT01677949|Etoposide|etoposide|mesh-list
92146584|NCT01677949|Clofarabine|clofarabine|mesh-list
92146585|NCT01677949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146586|NCT01677949|Immunologic Factors|immunologic factors|mesh-ancestor
92146587|NCT01677949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146588|NCT01677949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146589|NCT01677949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92146591|NCT01677949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146592|NCT01677949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146593|NCT01677949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92146594|NCT01677949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92146595|NCT01677949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92146596|NCT01677949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92146597|NCT01677949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146598|NCT01677949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146599|NCT01677949|Antimetabolites|antimetabolites|mesh-ancestor
92146600|NCT03483883|Gemcitabine|gemcitabine|mesh-list
92146601|NCT03483883|Avelumab|avelumab|mesh-list
92146602|NCT03483883|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146603|NCT03483883|Antimetabolites|antimetabolites|mesh-ancestor
92146604|NCT03483883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146605|NCT03483883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146606|NCT03483883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146611|NCT03482167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146612|NCT00799227|Dexamethasone|dexamethasone|mesh-list
92146613|NCT00799227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146614|NCT00799227|Antiemetics|antiemetics|mesh-ancestor
92146615|NCT00799227|Autonomic Agents|autonomic agents|mesh-ancestor
92146616|NCT00799227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146617|NCT00799227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146618|NCT00799227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92146619|NCT00799227|Glucocorticoids|glucocorticoids|mesh-ancestor
92146620|NCT00799227|Hormones|hormones|mesh-ancestor
92146621|NCT00799227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146622|NCT00799227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92146623|NCT00799227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146624|NCT03439267|Calcium|calcium|mesh-list
92146625|NCT03439267|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92146626|NCT03439267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146627|NCT00770133|Ketotifen|ketotifen|mesh-list
92146628|NCT00770133|Naphazoline|naphazoline|mesh-list
92146629|NCT00770133|Antipruritics|antipruritics|mesh-ancestor
92146630|NCT00770133|Dermatologic Agents|dermatologic agents|mesh-ancestor
92146631|NCT00770133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92146632|NCT00770133|Histamine Antagonists|histamine antagonists|mesh-ancestor
92146633|NCT00770133|Histamine Agents|histamine agents|mesh-ancestor
92146634|NCT00770133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146635|NCT00770133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146636|NCT00770133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146637|NCT00770133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92146638|NCT00770133|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92146639|NCT00770133|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92146640|NCT00770133|Adrenergic Agents|adrenergic agents|mesh-ancestor
92146641|NCT00770133|Nasal Decongestants|nasal decongestants|mesh-ancestor
92146642|NCT00770133|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92146643|NCT00770133|Respiratory System Agents|respiratory system agents|mesh-ancestor
92146644|NCT00770757|Pomalidomide|pomalidomide|mesh-list
92146645|NCT00770757|Immunologic Factors|immunologic factors|mesh-ancestor
92146646|NCT00770757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146647|NCT00770757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146648|NCT00770757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146649|NCT00770757|Growth Substances|growth substances|mesh-ancestor
92146650|NCT00770757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146651|NCT00770757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146652|NCT01425281|Everolimus|everolimus|mesh-list
92146653|NCT01425281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92146654|NCT01425281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146656|NCT01425281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146657|NCT01425281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146658|NCT01425281|Immunologic Factors|immunologic factors|mesh-ancestor
92146659|NCT01425281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146660|NCT01425281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146661|NCT04384653|Furosemide|furosemide|mesh-list
92146662|NCT04384653|Diuretics|diuretics|mesh-ancestor
92146663|NCT04384653|Natriuretic Agents|natriuretic agents|mesh-ancestor
92146664|NCT04384653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146665|NCT04384653|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92146666|NCT04384653|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146667|NCT04384653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146668|NCT04113720|Dexmedetomidine|dexmedetomidine|mesh-list
92146669|NCT04113720|Levobupivacaine|levobupivacaine|mesh-list
92146670|NCT04113720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146671|NCT04113720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146672|NCT04113720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146673|NCT04113720|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146674|NCT04113720|Analgesics|analgesics|mesh-ancestor
92146675|NCT04113720|Sensory System Agents|sensory system agents|mesh-ancestor
92146676|NCT04113720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146677|NCT04113720|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92146678|NCT04113720|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92146679|NCT04113720|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92146680|NCT04113720|Adrenergic Agents|adrenergic agents|mesh-ancestor
92146681|NCT04113720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146682|NCT04113720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146683|NCT04113720|Anesthetics, Local|anesthetics, local|mesh-ancestor
92146686|NCT01402817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146687|NCT01402817|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146688|NCT01402817|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146689|NCT01402817|Growth Substances|growth substances|mesh-ancestor
92146690|NCT01402817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146691|NCT01402817|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146692|NCT01402817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146693|NCT01402817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146694|NCT01402817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146695|NCT01425203|Ribavirin|ribavirin|mesh-list
92146696|NCT01425203|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92146697|NCT01425203|Antimetabolites|antimetabolites|mesh-ancestor
92146698|NCT01425203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146699|NCT01425203|Antiviral Agents|antiviral agents|mesh-ancestor
92146700|NCT01425203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146701|NCT04215120|Epoetin Alfa|epoetin alfa|mesh-list
92146702|NCT04215120|Hematinics|hematinics|mesh-ancestor
92146703|NCT00081289|Leucovorin|leucovorin|mesh-list
92146704|NCT00081289|Folic Acid|folic acid|mesh-list
92146705|NCT00081289|Fluorouracil|fluorouracil|mesh-list
92146706|NCT00081289|Capecitabine|capecitabine|mesh-list
92146707|NCT00081289|Oxaliplatin|oxaliplatin|mesh-list
92146708|NCT00081289|Irinotecan|irinotecan|mesh-list
92146709|NCT00081289|Levoleucovorin|levoleucovorin|mesh-list
92146710|NCT00081289|Antimetabolites|antimetabolites|mesh-ancestor
92146711|NCT00081289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146712|NCT00081289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92146713|NCT00081289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146714|NCT00081289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146715|NCT00081289|Immunologic Factors|immunologic factors|mesh-ancestor
92146716|NCT00081289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146717|NCT00081289|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92146718|NCT00081289|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92146719|NCT00081289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146720|NCT00081289|Antidotes|antidotes|mesh-ancestor
92146721|NCT00081289|Protective Agents|protective agents|mesh-ancestor
92146722|NCT00081289|Vitamin B Complex|vitamin b complex|mesh-ancestor
92146723|NCT00081289|Vitamins|vitamins|mesh-ancestor
92146724|NCT00081289|Micronutrients|micronutrients|mesh-ancestor
92146725|NCT00081289|Hematinics|hematinics|mesh-ancestor
92146726|NCT01478594|Bevacizumab|bevacizumab|mesh-list
92146727|NCT01478594|Tivozanib|tivozanib|mesh-list
92146728|NCT01478594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146729|NCT01478594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146730|NCT01478594|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146731|NCT01478594|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146732|NCT01478594|Growth Substances|growth substances|mesh-ancestor
92146733|NCT01478594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146734|NCT01478594|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146735|NCT01478594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146736|NCT01478594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146737|NCT01478594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146739|NCT01424813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92146740|NCT01424813|Autonomic Agents|autonomic agents|mesh-ancestor
92146741|NCT01424813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146742|NCT01424813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146743|NCT01424813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92146744|NCT01424813|Respiratory System Agents|respiratory system agents|mesh-ancestor
92146745|NCT01424813|Tocolytic Agents|tocolytic agents|mesh-ancestor
92146746|NCT01424813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92146747|NCT01424813|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92146748|NCT01424813|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92146749|NCT01424813|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92146750|NCT01424813|Adrenergic Agents|adrenergic agents|mesh-ancestor
92146751|NCT01424813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146752|NCT01424813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146753|NCT03480061|Dexmedetomidine|dexmedetomidine|mesh-list
92146754|NCT03480061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92146755|NCT03480061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146756|NCT03480061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146757|NCT03480061|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146758|NCT03480061|Analgesics|analgesics|mesh-ancestor
92146759|NCT03480061|Sensory System Agents|sensory system agents|mesh-ancestor
92146760|NCT03480061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146761|NCT03480061|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92146762|NCT03480061|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92146763|NCT03480061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92146764|NCT03480061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92146765|NCT03480061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146766|NCT03480061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146767|NCT03389022|Ketamine|ketamine|mesh-list
92146768|NCT03389022|Analgesics|analgesics|mesh-ancestor
92146769|NCT03389022|Sensory System Agents|sensory system agents|mesh-ancestor
92146770|NCT03389022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146771|NCT03389022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146772|NCT03389022|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92146773|NCT03389022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92146774|NCT03389022|Anesthetics, General|anesthetics, general|mesh-ancestor
92146775|NCT03389022|Anesthetics|anesthetics|mesh-ancestor
92146776|NCT03389022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146777|NCT03389022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92146778|NCT03389022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92146779|NCT03389022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146780|NCT03389022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146781|NCT00080899|Fenretinide|fenretinide|mesh-list
92146782|NCT00080899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146783|NCT00080899|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92146784|NCT00080899|Protective Agents|protective agents|mesh-ancestor
92146785|NCT00080899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146786|NCT03627858|Beclomethasone|beclomethasone|mesh-list
92146787|NCT03627858|Glycopyrrolate|glycopyrrolate|mesh-list
92146788|NCT03627858|Formoterol Fumarate|formoterol fumarate|mesh-list
92146789|NCT03627858|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92146790|NCT03627858|Autonomic Agents|autonomic agents|mesh-ancestor
92146791|NCT03627858|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146792|NCT03627858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146793|NCT03627858|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92146794|NCT03627858|Respiratory System Agents|respiratory system agents|mesh-ancestor
92146795|NCT03627858|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92146796|NCT03627858|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92146797|NCT03627858|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92146798|NCT03627858|Adrenergic Agents|adrenergic agents|mesh-ancestor
92146799|NCT03627858|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92146800|NCT03627858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146802|NCT03627858|Glucocorticoids|glucocorticoids|mesh-ancestor
92146803|NCT03627858|Hormones|hormones|mesh-ancestor
92146804|NCT03627858|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146805|NCT03627858|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92146806|NCT03627858|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92146807|NCT03627858|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92146808|NCT03627858|Cholinergic Agents|cholinergic agents|mesh-ancestor
92146809|NCT03086785|Apatinib|apatinib|mesh-list
92146810|NCT03086785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146811|NCT03086785|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146812|NCT03086785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146813|NCT03086785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146814|NCT03259698|Tenofovir|tenofovir|mesh-list
92146815|NCT03259698|Emtricitabine|emtricitabine|mesh-list
92146816|NCT03259698|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92146817|NCT03259698|Antiviral Agents|antiviral agents|mesh-ancestor
92146818|NCT03259698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146819|NCT03259698|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92146820|NCT03259698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92146821|NCT03259698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146822|NCT03259698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146823|NCT03259698|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92146824|NCT03259698|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92146825|NCT00089635|Panitumumab|panitumumab|mesh-list
92146826|NCT00089635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146827|NCT00089635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146828|NCT03445728|Nicorandil|nicorandil|mesh-list
92146829|NCT03445728|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92146830|NCT03445728|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92146831|NCT03445728|Vasodilator Agents|vasodilator agents|mesh-ancestor
92146832|NCT03445728|Vitamin B Complex|vitamin b complex|mesh-ancestor
92146834|NCT03445728|Micronutrients|micronutrients|mesh-ancestor
92146835|NCT03445728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146836|NCT02795520|OTS167|ots167|mesh-list
92146837|NCT02795520|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92146838|NCT02795520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146839|NCT02795520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146840|NCT03159000|Lidocaine|lidocaine|mesh-list
92146841|NCT03159000|Bupivacaine|bupivacaine|mesh-list
92146844|NCT03159000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92146845|NCT03159000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146846|NCT03159000|Sensory System Agents|sensory system agents|mesh-ancestor
92146847|NCT03159000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146848|NCT03159000|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92146849|NCT03159000|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92146850|NCT03159000|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92146851|NCT03159000|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92146852|NCT03159000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146853|NCT00086671|Antibodies|antibodies|mesh-list
92146854|NCT00086671|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92146855|NCT00086671|Immunologic Factors|immunologic factors|mesh-ancestor
92146856|NCT00086671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146857|NCT02464878|Etanercept|etanercept|mesh-list
92146858|NCT02464878|Thymoglobulin|thymoglobulin|mesh-list
92146859|NCT02464878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92146860|NCT02464878|Basiliximab|basiliximab|mesh-list
92146861|NCT02464878|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92146862|NCT02464878|Protein C Inhibitor|protein c inhibitor|mesh-list
92146863|NCT02464878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92146864|NCT02464878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146865|NCT02464878|Analgesics|analgesics|mesh-ancestor
92146866|NCT02464878|Sensory System Agents|sensory system agents|mesh-ancestor
92146867|NCT02464878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146868|NCT02464878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146869|NCT02464878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146870|NCT02464878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146871|NCT02464878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92146872|NCT02464878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92146873|NCT02464878|Immunologic Factors|immunologic factors|mesh-ancestor
92146874|NCT02464878|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92146875|NCT02464878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92146876|NCT02464878|Protease Inhibitors|protease inhibitors|mesh-ancestor
92146877|NCT02464878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146878|NCT02464878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146879|NCT02010606|Bevacizumab|bevacizumab|mesh-list
92146880|NCT02010606|Temozolomide|temozolomide|mesh-list
92146881|NCT02010606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146882|NCT02010606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146883|NCT02010606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146884|NCT02010606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146885|NCT02010606|Growth Substances|growth substances|mesh-ancestor
92146886|NCT02010606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146887|NCT02010606|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146888|NCT02010606|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92146889|NCT02010606|Alkylating Agents|alkylating agents|mesh-ancestor
92146890|NCT02010606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146892|NCT00084253|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92146893|NCT00084253|Lamivudine|lamivudine|mesh-list
92146894|NCT00084253|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92146895|NCT00084253|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92146896|NCT00084253|Protease Inhibitors|protease inhibitors|mesh-ancestor
92146897|NCT00084253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146898|NCT00084253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146899|NCT00084253|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92146900|NCT00084253|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92146901|NCT00084253|Antiviral Agents|antiviral agents|mesh-ancestor
92146902|NCT00084253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146903|NCT00084253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92146904|NCT00084253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92146905|NCT00084253|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92146906|NCT00084253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92146907|NCT02951364|Sofosbuvir|sofosbuvir|mesh-list
92146908|NCT02951364|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92146909|NCT02951364|Ledipasvir|ledipasvir|mesh-list
92146910|NCT02951364|Antiviral Agents|antiviral agents|mesh-ancestor
92146911|NCT02951364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146912|NCT01678417|Rituximab|rituximab|mesh-list
92146913|NCT01678417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146914|NCT01678417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146915|NCT01678417|Immunologic Factors|immunologic factors|mesh-ancestor
92146916|NCT01678417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146917|NCT01678417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92146918|NCT00083941|Interleukin-2|interleukin-2|mesh-list
92146919|NCT00083941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146920|NCT00083941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92146921|NCT00083941|Analgesics|analgesics|mesh-ancestor
92146922|NCT00083941|Sensory System Agents|sensory system agents|mesh-ancestor
92146923|NCT00083941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146924|NCT00083941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146925|NCT02856438|Dexamethasone|dexamethasone|mesh-list
92146926|NCT02856438|Lenalidomide|lenalidomide|mesh-list
92146927|NCT02856438|Elotuzumab|elotuzumab|mesh-list
92146928|NCT02856438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92146929|NCT02856438|Antiemetics|antiemetics|mesh-ancestor
92146930|NCT02856438|Autonomic Agents|autonomic agents|mesh-ancestor
92146931|NCT02856438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92146932|NCT02856438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146933|NCT02856438|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92146934|NCT02856438|Glucocorticoids|glucocorticoids|mesh-ancestor
92146935|NCT02856438|Hormones|hormones|mesh-ancestor
92146936|NCT02856438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146937|NCT02856438|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92146938|NCT02856438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146939|NCT02856438|Immunologic Factors|immunologic factors|mesh-ancestor
92146940|NCT02856438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92146941|NCT02856438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92146942|NCT02856438|Growth Substances|growth substances|mesh-ancestor
92146943|NCT02856438|Growth Inhibitors|growth inhibitors|mesh-ancestor
92146944|NCT01678495|Plasminogen|plasminogen|mesh-list
92146945|NCT01678495|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92146946|NCT01678495|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92146947|NCT01678495|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92146948|NCT01678495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146949|NCT01678573|Abiraterone Acetate|abiraterone acetate|mesh-list
92146950|NCT01678573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146951|NCT01678573|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92146952|NCT01678573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92146953|NCT01678573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146954|NCT01678573|Hormone Antagonists|hormone antagonists|mesh-ancestor
92146955|NCT01678573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146956|NCT01678573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146957|NCT01678573|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92146958|NCT01678651|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92146960|NCT01678651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92146961|NCT01678651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146962|NCT03084523|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92146963|NCT03084523|Hematinics|hematinics|mesh-ancestor
92146964|NCT03084523|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92146965|NCT03084523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92146966|NCT04094090|Riboflavin|riboflavin|mesh-list
92146967|NCT04094090|Vitamin B Complex|vitamin b complex|mesh-ancestor
92146968|NCT04094090|Vitamins|vitamins|mesh-ancestor
92146969|NCT04094090|Micronutrients|micronutrients|mesh-ancestor
92146970|NCT04094090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146971|NCT04094090|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92146972|NCT04094090|Dermatologic Agents|dermatologic agents|mesh-ancestor
92146973|NCT04670796|Trastuzumab|trastuzumab|mesh-list
92146974|NCT04670796|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146975|NCT04670796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146976|NCT01019616|Paclitaxel|paclitaxel|mesh-list
92146977|NCT01019616|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92146978|NCT01019616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146979|NCT01019616|Tubulin Modulators|tubulin modulators|mesh-ancestor
92146980|NCT01019616|Antimitotic Agents|antimitotic agents|mesh-ancestor
92146981|NCT01019616|Mitosis Modulators|mitosis modulators|mesh-ancestor
92146982|NCT01019616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92146983|NCT03086395|Obinutuzumab|obinutuzumab|mesh-list
92146984|NCT03086395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92146985|NCT03086395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92146986|NCT03083197|Azithromycin|azithromycin|mesh-list
92146987|NCT03083197|Doxycycline|doxycycline|mesh-list
92146988|NCT03083197|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92146989|NCT03083197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92146990|NCT03083197|Antimalarials|antimalarials|mesh-ancestor
92146991|NCT03083197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92146992|NCT03083197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92146993|NCT03086239|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92146994|NCT03086239|Immunoconjugates|immunoconjugates|mesh-ancestor
92146996|NCT03086239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92146997|NCT01678963|Squalamine|squalamine|mesh-list
92146998|NCT01678963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92146999|NCT01678963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147000|NCT01678963|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92147001|NCT01678963|Protective Agents|protective agents|mesh-ancestor
92147002|NCT01678963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147003|NCT01678963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147004|NCT01678963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92147005|NCT01678963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92147006|NCT01678963|Growth Substances|growth substances|mesh-ancestor
92147007|NCT01678963|Growth Inhibitors|growth inhibitors|mesh-ancestor
92147008|NCT00790335|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92147009|NCT00790335|Plasminogen|plasminogen|mesh-list
92147010|NCT00790335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92147011|NCT00790335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92147012|NCT00790335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147013|NCT05136534|Anesthetics|anesthetics|mesh-list
92147014|NCT05136534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147015|NCT05136534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147016|NCT05135442|Bortezomib|bortezomib|mesh-list
92147017|NCT05135442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147018|NCT05130684|Paclitaxel|paclitaxel|mesh-list
92147019|NCT05130684|Cisplatin|cisplatin|mesh-list
92147020|NCT05130684|Nivolumab|nivolumab|mesh-list
92147021|NCT05130684|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92147022|NCT05130684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147023|NCT05130684|Tubulin Modulators|tubulin modulators|mesh-ancestor
92147024|NCT05130684|Antimitotic Agents|antimitotic agents|mesh-ancestor
92147025|NCT05130684|Mitosis Modulators|mitosis modulators|mesh-ancestor
92147026|NCT05130684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147027|NCT05130684|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92147028|NCT05130684|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92147029|NCT04402411|Analgesics, Opioid|analgesics, opioid|mesh-list
92147030|NCT04402411|Narcotics|narcotics|mesh-ancestor
92147031|NCT04402411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147032|NCT04402411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147033|NCT04402411|Analgesics|analgesics|mesh-ancestor
92147034|NCT04402411|Sensory System Agents|sensory system agents|mesh-ancestor
92147035|NCT04402411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147036|NCT05265507|Glycopyrrolate|glycopyrrolate|mesh-list
92147037|NCT05265507|Ondansetron|ondansetron|mesh-list
92147038|NCT05265507|Antiemetics|antiemetics|mesh-ancestor
92147039|NCT05265507|Autonomic Agents|autonomic agents|mesh-ancestor
92147040|NCT05265507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147041|NCT05265507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147042|NCT05265507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92147044|NCT05265507|Dermatologic Agents|dermatologic agents|mesh-ancestor
92147045|NCT05265507|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92147046|NCT05265507|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92147047|NCT05265507|Serotonin Agents|serotonin agents|mesh-ancestor
92147048|NCT05265507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147049|NCT05265507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147050|NCT05265507|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92147051|NCT05265507|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92147052|NCT05265507|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92147053|NCT05265507|Cholinergic Agents|cholinergic agents|mesh-ancestor
92147054|NCT05135286|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92147055|NCT05135286|Carbachol|carbachol|mesh-list
92147056|NCT05135286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92147057|NCT05135286|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92147058|NCT05135286|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92147059|NCT05135286|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92147060|NCT05135286|Adrenergic Agents|adrenergic agents|mesh-ancestor
92147061|NCT05135286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147062|NCT05135286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147063|NCT05135286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147064|NCT05135286|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92147065|NCT05135286|Miotics|miotics|mesh-ancestor
92147066|NCT05135286|Autonomic Agents|autonomic agents|mesh-ancestor
92147067|NCT05135286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147068|NCT05135286|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92147069|NCT05135286|Cholinergic Agents|cholinergic agents|mesh-ancestor
92147070|NCT05135286|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92147071|NCT05135286|Analgesics|analgesics|mesh-ancestor
92147072|NCT05135286|Sensory System Agents|sensory system agents|mesh-ancestor
92147078|NCT03089671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147079|NCT03089671|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92147080|NCT03089671|Dermatologic Agents|dermatologic agents|mesh-ancestor
92147081|NCT05136924|Varenicline|varenicline|mesh-list
92147082|NCT05136924|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92147083|NCT05136924|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92147084|NCT05136924|Cholinergic Agents|cholinergic agents|mesh-ancestor
92147085|NCT05136924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147086|NCT05136924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147087|NCT05136924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147088|NCT00791037|Cyclophosphamide|cyclophosphamide|mesh-list
92147089|NCT00791037|Sargramostim|sargramostim|mesh-list
92147090|NCT00791037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92147091|NCT00791037|Immunologic Factors|immunologic factors|mesh-ancestor
92147092|NCT00791037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147093|NCT00791037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147094|NCT00791037|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92147095|NCT00791037|Alkylating Agents|alkylating agents|mesh-ancestor
92147096|NCT00791037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147097|NCT00791037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147098|NCT00791037|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92147099|NCT04403191|Ondansetron|ondansetron|mesh-list
92147100|NCT04403191|Antiemetics|antiemetics|mesh-ancestor
92147101|NCT04403191|Autonomic Agents|autonomic agents|mesh-ancestor
92147102|NCT04403191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147103|NCT04403191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147104|NCT04403191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92147105|NCT04403191|Antipruritics|antipruritics|mesh-ancestor
92147106|NCT04403191|Dermatologic Agents|dermatologic agents|mesh-ancestor
92147107|NCT04403191|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92147108|NCT04403191|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92147109|NCT04403191|Serotonin Agents|serotonin agents|mesh-ancestor
92147110|NCT04403191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147111|NCT04403191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147112|NCT04383093|Tadalafil|tadalafil|mesh-list
92147113|NCT04383093|Tamsulosin|tamsulosin|mesh-list
92147114|NCT04383093|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147115|NCT04383093|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92147116|NCT04383093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92147117|NCT04383093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147118|NCT04383093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147119|NCT04383093|Urological Agents|urological agents|mesh-ancestor
92147120|NCT04383093|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92147121|NCT04383093|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92147122|NCT04383093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92147123|NCT04383093|Adrenergic Agents|adrenergic agents|mesh-ancestor
92147124|NCT04383093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147125|NCT04383093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147126|NCT05301660|Nicotine|nicotine|mesh-list
92147127|NCT05301660|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92147128|NCT05301660|Autonomic Agents|autonomic agents|mesh-ancestor
92147129|NCT05301660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147130|NCT05301660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147131|NCT05301660|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92147132|NCT05301660|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92147133|NCT05301660|Cholinergic Agents|cholinergic agents|mesh-ancestor
92147134|NCT05301660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147135|NCT05301660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147136|NCT01401959|Trastuzumab|trastuzumab|mesh-list
92147137|NCT01401959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92147138|NCT01401959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147139|NCT04767035|Midazolam|midazolam|mesh-list
92147140|NCT04767035|Ketamine|ketamine|mesh-list
92147141|NCT04767035|Analgesics|analgesics|mesh-ancestor
92147142|NCT04767035|Sensory System Agents|sensory system agents|mesh-ancestor
92147143|NCT04767035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147144|NCT04767035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147145|NCT04767035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92147146|NCT04767035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92147147|NCT04767035|Anesthetics, General|anesthetics, general|mesh-ancestor
92147148|NCT04767035|Anesthetics|anesthetics|mesh-ancestor
92147149|NCT04767035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147150|NCT04767035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92147151|NCT04767035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92147152|NCT04767035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147153|NCT04767035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147154|NCT04767035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92147155|NCT04767035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92147156|NCT04767035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92147157|NCT04767035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92147158|NCT04767035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147159|NCT04767035|GABA Modulators|gaba modulators|mesh-ancestor
92147160|NCT04767035|GABA Agents|gaba agents|mesh-ancestor
92147161|NCT03081169|Heparin|heparin|mesh-list
92147162|NCT03081169|Enoxaparin|enoxaparin|mesh-list
92147163|NCT03081169|Enoxaparin sodium|enoxaparin sodium|mesh-list
92147164|NCT03081169|Anticoagulants|anticoagulants|mesh-ancestor
92147165|NCT03081169|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92147166|NCT03081169|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92147167|NCT03081169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147168|NCT03803163|Treprostinil|treprostinil|mesh-list
92147169|NCT03803163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92147170|NCT05287308|Paclitaxel|paclitaxel|mesh-list
92147171|NCT05287308|Docetaxel|docetaxel|mesh-list
92147172|NCT05287308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92147173|NCT05287308|Cyclophosphamide|cyclophosphamide|mesh-list
92147174|NCT05287308|Doxorubicin|doxorubicin|mesh-list
92147176|NCT05287308|Pirarubicin|pirarubicin|mesh-list
92147177|NCT05287308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92147178|NCT05287308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147179|NCT05287308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92147180|NCT05287308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92147181|NCT05287308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92147182|NCT05287308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147183|NCT05287308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92147184|NCT05287308|Immunologic Factors|immunologic factors|mesh-ancestor
92147185|NCT05287308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147186|NCT05287308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147187|NCT05287308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92147188|NCT05287308|Alkylating Agents|alkylating agents|mesh-ancestor
92147189|NCT05287308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92147190|NCT05287308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92147191|NCT05287308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92147192|NCT05287308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92147193|NCT05287308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147195|NCT00801723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147196|NCT00801723|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92147197|NCT00801723|Autonomic Agents|autonomic agents|mesh-ancestor
92147198|NCT00801723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147199|NCT00801723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147200|NCT00801723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92147201|NCT00801723|Respiratory System Agents|respiratory system agents|mesh-ancestor
92147202|NCT00801723|Glucocorticoids|glucocorticoids|mesh-ancestor
92147203|NCT00801723|Hormones|hormones|mesh-ancestor
92147204|NCT00801723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147205|NCT05346211|Curcumin|curcumin|mesh-list
92147206|NCT05346211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92147207|NCT05346211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92147208|NCT05346211|Analgesics|analgesics|mesh-ancestor
92147209|NCT05346211|Sensory System Agents|sensory system agents|mesh-ancestor
92147210|NCT05346211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147211|NCT05346211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147212|NCT05346211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147213|NCT05346211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147214|NCT05346211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147215|NCT05346211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147216|NCT05346211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147217|NCT05694897|Magnesium Sulfate|magnesium sulfate|mesh-list
92147218|NCT05694897|Bupivacaine|bupivacaine|mesh-list
92147219|NCT05694897|Anesthetics, Local|anesthetics, local|mesh-ancestor
92147220|NCT05694897|Anesthetics|anesthetics|mesh-ancestor
92147221|NCT05694897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147222|NCT05694897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147223|NCT05694897|Sensory System Agents|sensory system agents|mesh-ancestor
92147224|NCT05694897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147225|NCT05694897|Analgesics|analgesics|mesh-ancestor
92147226|NCT05694897|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92147227|NCT05694897|Anticonvulsants|anticonvulsants|mesh-ancestor
92147228|NCT05694897|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92147229|NCT05694897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147230|NCT05694897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147231|NCT05694897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92147232|NCT05694897|Tocolytic Agents|tocolytic agents|mesh-ancestor
92147233|NCT05694897|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92147234|NCT01478048|Dexamethasone|dexamethasone|mesh-list
92147235|NCT01478048|Dexamethasone acetate|dexamethasone acetate|mesh-list
92147236|NCT01478048|Bortezomib|bortezomib|mesh-list
92147237|NCT01478048|Elotuzumab|elotuzumab|mesh-list
92147238|NCT01478048|BB 1101|bb 1101|mesh-list
92147239|NCT01478048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147240|NCT01478048|Antiemetics|antiemetics|mesh-ancestor
92147241|NCT01478048|Autonomic Agents|autonomic agents|mesh-ancestor
92147242|NCT01478048|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147243|NCT01478048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147244|NCT01478048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92147245|NCT01478048|Glucocorticoids|glucocorticoids|mesh-ancestor
92147246|NCT01478048|Hormones|hormones|mesh-ancestor
92147247|NCT01478048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147248|NCT01478048|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92147249|NCT01478048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147250|NCT01478048|Protease Inhibitors|protease inhibitors|mesh-ancestor
92147251|NCT01478048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147252|NCT01478048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147253|NCT04585776|Insulin|insulin|mesh-list
92147254|NCT04585776|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147255|NCT04585776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147256|NCT01401647|Lidocaine|lidocaine|mesh-list
92147257|NCT01401647|Amiodarone|amiodarone|mesh-list
92147258|NCT01401647|Anesthetics, Local|anesthetics, local|mesh-ancestor
92147259|NCT01401647|Anesthetics|anesthetics|mesh-ancestor
92147260|NCT01401647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147261|NCT01401647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147262|NCT01401647|Sensory System Agents|sensory system agents|mesh-ancestor
92147263|NCT01401647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147264|NCT01401647|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92147265|NCT01401647|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92147267|NCT01401647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147268|NCT01401647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147269|NCT01401647|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147270|NCT01401647|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92147271|NCT01401647|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92147272|NCT01401647|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92147273|NCT01401647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147274|NCT01401647|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92147275|NCT01401647|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92147276|NCT01401647|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92147277|NCT01423253|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92147278|NCT01423253|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92147279|NCT01423253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92147280|NCT01423253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147281|NCT01423253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147282|NCT01423253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147283|NCT01423253|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92147284|NCT01423253|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92147285|NCT01423253|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92147286|NCT01423253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92147287|NCT01423253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147288|NCT01423253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147289|NCT01423253|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92147290|NCT01423253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92147291|NCT01423253|Serotonin Agents|serotonin agents|mesh-ancestor
92147292|NCT01423253|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92147293|NCT01423253|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92147294|NCT01423253|Dopamine Agents|dopamine agents|mesh-ancestor
92147295|NCT03088891|Antioxidants|antioxidants|mesh-list
92147296|NCT03088891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147297|NCT03088891|Protective Agents|protective agents|mesh-ancestor
92147298|NCT03088891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147299|NCT01477892|Remifentanil|remifentanil|mesh-list
92147300|NCT01477892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92147301|NCT01477892|Narcotics|narcotics|mesh-ancestor
92147302|NCT01477892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147303|NCT01477892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147304|NCT01477892|Analgesics|analgesics|mesh-ancestor
92147762|NCT01459718|Sequestering Agents|sequestering agents|mesh-ancestor
92147305|NCT01477892|Sensory System Agents|sensory system agents|mesh-ancestor
92147306|NCT01477892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147307|NCT00801801|Docetaxel|docetaxel|mesh-list
92147308|NCT00801801|Sorafenib|sorafenib|mesh-list
92147309|NCT00801801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147310|NCT00801801|Tubulin Modulators|tubulin modulators|mesh-ancestor
92147311|NCT00801801|Antimitotic Agents|antimitotic agents|mesh-ancestor
92147312|NCT00801801|Mitosis Modulators|mitosis modulators|mesh-ancestor
92147313|NCT00801801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147314|NCT00801801|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92147315|NCT00801801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147317|NCT01499576|Retinol acetate|retinol acetate|mesh-list
92147318|NCT01499576|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147319|NCT01499576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147320|NCT01499576|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92147321|NCT01499576|Immunologic Factors|immunologic factors|mesh-ancestor
92147322|NCT01499576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147323|NCT01499576|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92147324|NCT01499576|Protective Agents|protective agents|mesh-ancestor
92147325|NCT01499576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147326|NCT04546074|Pembrolizumab|pembrolizumab|mesh-list
92147327|NCT04546074|Imatinib Mesylate|imatinib mesylate|mesh-list
92147328|NCT04546074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92147329|NCT04546074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147330|NCT04546074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92147331|NCT04546074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147332|NCT04546074|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92147333|NCT04546074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147334|NCT00802113|Fludarabine|fludarabine|mesh-list
92147335|NCT00802113|Busulfan|busulfan|mesh-list
92147336|NCT00802113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92147337|NCT00802113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147338|NCT00802113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147339|NCT00802113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92147340|NCT00802113|Immunologic Factors|immunologic factors|mesh-ancestor
92147341|NCT00802113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147342|NCT00802113|Alkylating Agents|alkylating agents|mesh-ancestor
92147343|NCT00802113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92147344|NCT00802113|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92147346|NCT03084601|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92147347|NCT03084601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147348|NCT00791973|Fluticasone|fluticasone|mesh-list
92147349|NCT00791973|Xhance|xhance|mesh-list
92147350|NCT00791973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147351|NCT00791973|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92147352|NCT00791973|Autonomic Agents|autonomic agents|mesh-ancestor
92147353|NCT00791973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147354|NCT00791973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147355|NCT00791973|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92147356|NCT00791973|Respiratory System Agents|respiratory system agents|mesh-ancestor
92147357|NCT00791973|Dermatologic Agents|dermatologic agents|mesh-ancestor
92147358|NCT00791973|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92147359|NCT00773955|Acetic Acid|acetic acid|mesh-list
92147360|NCT00773955|Retinol acetate|retinol acetate|mesh-list
92147361|NCT00773955|Gossypol acetic acid|gossypol acetic acid|mesh-list
92147362|NCT00773955|Gossypol|gossypol|mesh-list
92147363|NCT00773955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147364|NCT00773955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147365|NCT00773955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92147366|NCT00773955|Immunologic Factors|immunologic factors|mesh-ancestor
92147367|NCT00773955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147368|NCT00773955|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92147369|NCT00773955|Protective Agents|protective agents|mesh-ancestor
92147370|NCT00773955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147371|NCT00773955|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92147372|NCT00773955|Contraceptive Agents|contraceptive agents|mesh-ancestor
92147373|NCT00773955|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92147374|NCT00773955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92147375|NCT00773955|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92147376|NCT00773955|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
92147377|NCT00773955|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
92147378|NCT01421459|Insulin Glargine|insulin glargine|mesh-list
92147379|NCT01421459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147380|NCT01421459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147381|NCT01498952|Sorafenib|sorafenib|mesh-list
92147382|NCT01498952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147383|NCT01498952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92147384|NCT01498952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147385|NCT01498952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147386|NCT04499196|Glucocorticoids|glucocorticoids|mesh-list
92147388|NCT04499196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147389|NCT04499196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147391|NCT04608266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92147392|NCT04608266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147393|NCT04608266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147394|NCT04608266|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92147395|NCT04608266|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92147396|NCT00774267|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92147397|NCT00774267|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92147398|NCT00774267|Hormone Antagonists|hormone antagonists|mesh-ancestor
92147399|NCT00774267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147400|NCT00774267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147401|NCT00774267|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92147402|NCT00774267|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92147403|NCT00774267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92147404|NCT04460352|Leucovorin|leucovorin|mesh-list
92147405|NCT04460352|Paclitaxel|paclitaxel|mesh-list
92147406|NCT04460352|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92147407|NCT04460352|Carboplatin|carboplatin|mesh-list
92147408|NCT04460352|Fluorouracil|fluorouracil|mesh-list
92147409|NCT04460352|Oxaliplatin|oxaliplatin|mesh-list
92147410|NCT04460352|Calcium|calcium|mesh-list
92147411|NCT04460352|Levoleucovorin|levoleucovorin|mesh-list
92147412|NCT04460352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92147413|NCT04460352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147414|NCT04460352|Tubulin Modulators|tubulin modulators|mesh-ancestor
92147415|NCT04460352|Antimitotic Agents|antimitotic agents|mesh-ancestor
92147416|NCT04460352|Mitosis Modulators|mitosis modulators|mesh-ancestor
92147417|NCT04460352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147418|NCT04460352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92147419|NCT04460352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147420|NCT04460352|Antimetabolites|antimetabolites|mesh-ancestor
92147421|NCT04460352|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92147422|NCT04460352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92147423|NCT04460352|Immunologic Factors|immunologic factors|mesh-ancestor
92147424|NCT04460352|Antidotes|antidotes|mesh-ancestor
92147425|NCT04460352|Protective Agents|protective agents|mesh-ancestor
92147426|NCT04460352|Vitamin B Complex|vitamin b complex|mesh-ancestor
92147427|NCT04460352|Vitamins|vitamins|mesh-ancestor
92147428|NCT04460352|Micronutrients|micronutrients|mesh-ancestor
92147429|NCT03083353|Isradipine|isradipine|mesh-list
92147430|NCT03083353|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92147431|NCT03083353|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92147432|NCT03083353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147433|NCT03083353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147434|NCT03083353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92147435|NCT03083353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147436|NCT03083353|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147438|NCT01421303|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92147439|NCT01421303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92147440|NCT01421303|Analgesics|analgesics|mesh-ancestor
92147441|NCT01421303|Sensory System Agents|sensory system agents|mesh-ancestor
92147442|NCT01421303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147443|NCT01421303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147444|NCT01421303|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147445|NCT01421303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147446|NCT01421303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92147447|NCT01421303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92147448|NCT01421303|Immunologic Factors|immunologic factors|mesh-ancestor
92147449|NCT03703375|Gemcitabine|gemcitabine|mesh-list
92147450|NCT03703375|Azacitidine|azacitidine|mesh-list
92147451|NCT03703375|Romidepsin|romidepsin|mesh-list
92147452|NCT03703375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92147453|NCT03703375|Antimetabolites|antimetabolites|mesh-ancestor
92147454|NCT03703375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147455|NCT03703375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147456|NCT03703375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147457|NCT03703375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92147458|NCT03703375|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92147459|NCT05303688|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92147460|NCT05303688|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92147461|NCT05303688|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92147463|NCT05303688|Sensory System Agents|sensory system agents|mesh-ancestor
92147464|NCT05303688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147465|NCT05303688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147466|NCT05303688|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147467|NCT05303688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147468|NCT04383717|Azithromycin|azithromycin|mesh-list
92147469|NCT04383717|Hydroxychloroquine|hydroxychloroquine|mesh-list
92147470|NCT04383717|Levamisole|levamisole|mesh-list
92147471|NCT04383717|Inosine Pranobex|inosine pranobex|mesh-list
92147472|NCT04383717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147473|NCT04383717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147474|NCT04383717|Antimalarials|antimalarials|mesh-ancestor
92147475|NCT04383717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92147476|NCT04383717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92147477|NCT04383717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147478|NCT04383717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147479|NCT04383717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147480|NCT04383717|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92147481|NCT04383717|Immunologic Factors|immunologic factors|mesh-ancestor
92147482|NCT04383717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147483|NCT04383717|Antinematodal Agents|antinematodal agents|mesh-ancestor
92147484|NCT04383717|Anthelmintics|anthelmintics|mesh-ancestor
92147485|NCT04383717|Antiviral Agents|antiviral agents|mesh-ancestor
92147486|NCT01400243|Nicotine|nicotine|mesh-list
92147487|NCT01400243|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92147488|NCT01400243|Autonomic Agents|autonomic agents|mesh-ancestor
92147489|NCT01400243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147490|NCT01400243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147491|NCT01400243|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92147492|NCT01400243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92147493|NCT01400243|Cholinergic Agents|cholinergic agents|mesh-ancestor
92147494|NCT01400243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147495|NCT01400243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147496|NCT05685277|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92147497|NCT05685277|Ramipril|ramipril|mesh-list
92147498|NCT05685277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92147499|NCT05685277|Diuretics|diuretics|mesh-ancestor
92147500|NCT05685277|Natriuretic Agents|natriuretic agents|mesh-ancestor
92147501|NCT05685277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147502|NCT05685277|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92147503|NCT05685277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147504|NCT05685277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147505|NCT05685277|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92147506|NCT05685277|Protease Inhibitors|protease inhibitors|mesh-ancestor
92147507|NCT05685277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147508|NCT00809055|Caffeine|caffeine|mesh-list
92147509|NCT00809055|Caffeine citrate|caffeine citrate|mesh-list
92147510|NCT00809055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147511|NCT00809055|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92147512|NCT00809055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147513|NCT00809055|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92147514|NCT00809055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147515|NCT00809055|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92147516|NCT00809055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92147517|NCT00809055|Purinergic Agents|purinergic agents|mesh-ancestor
92147518|NCT00809055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147519|NCT01421225|Insulin|insulin|mesh-list
92147520|NCT01421225|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92147521|NCT01421225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147522|NCT01421225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147523|NCT03082885|Thymalfasin|thymalfasin|mesh-list
92147524|NCT03082885|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92147525|NCT03082885|Immunologic Factors|immunologic factors|mesh-ancestor
92147526|NCT03082885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147527|NCT04382781|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92147528|NCT04382781|Immunologic Factors|immunologic factors|mesh-ancestor
92147529|NCT04382781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147530|NCT05688631|Antioxidants|antioxidants|mesh-list
92147531|NCT05688631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147532|NCT05688631|Protective Agents|protective agents|mesh-ancestor
92147533|NCT05688631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147534|NCT04348032|Apatinib|apatinib|mesh-list
92147535|NCT04348032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147536|NCT04348032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92147537|NCT04348032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147538|NCT04348032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147539|NCT05007873|Decitabine|decitabine|mesh-list
92147540|NCT05007873|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92147541|NCT05007873|Dasatinib|dasatinib|mesh-list
92147542|NCT05007873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92147543|NCT05007873|Antimetabolites|antimetabolites|mesh-ancestor
92147544|NCT05007873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147545|NCT05007873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147546|NCT05007873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147547|NCT05007873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92147548|NCT01474772|Pregabalin|pregabalin|mesh-list
92147549|NCT01474772|Analgesics|analgesics|mesh-ancestor
92147550|NCT01474772|Sensory System Agents|sensory system agents|mesh-ancestor
92147551|NCT01474772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147552|NCT01474772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147553|NCT01474772|Anticonvulsants|anticonvulsants|mesh-ancestor
92147554|NCT01474772|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92147555|NCT01474772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147556|NCT01474772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147557|NCT01474772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92147558|NCT01474772|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92147559|NCT01474772|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92147560|NCT01474772|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147561|NCT01474772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147562|NCT03082339|Cortisone|cortisone|mesh-list
92147563|NCT03082339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147564|NCT03801759|Adefovir|adefovir|mesh-list
92147565|NCT03801759|Digoxin|digoxin|mesh-list
92147566|NCT03801759|Furosemide|furosemide|mesh-list
92147567|NCT03801759|Diuretics|diuretics|mesh-ancestor
92147568|NCT03801759|Natriuretic Agents|natriuretic agents|mesh-ancestor
92147569|NCT03801759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147570|NCT03801759|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92147571|NCT03801759|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147572|NCT03801759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147573|NCT03801759|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92147574|NCT03801759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92147575|NCT03801759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147576|NCT03801759|Protective Agents|protective agents|mesh-ancestor
92147577|NCT03801759|Antiviral Agents|antiviral agents|mesh-ancestor
92147578|NCT03801759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147579|NCT03801759|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92147580|NCT03801759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92147581|NCT01421147|Insulin Lispro|insulin lispro|mesh-list
92147582|NCT01421147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147583|NCT01421147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147584|NCT03082573|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92147585|NCT03082573|Hormones|hormones|mesh-ancestor
92147586|NCT03082573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147587|NCT03082573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147588|NCT01497938|Insulin|insulin|mesh-list
92147589|NCT01497938|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147590|NCT01497938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147591|NCT03092154|Hypolipidemic Agents|hypolipidemic agents|mesh-list
92147592|NCT03092154|Antimetabolites|antimetabolites|mesh-ancestor
92147593|NCT03092154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147594|NCT03092154|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92147595|NCT04301310|Rifampin|rifampin|mesh-list
92147596|NCT04301310|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92147597|NCT04301310|Antitubercular Agents|antitubercular agents|mesh-ancestor
92147598|NCT04301310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147599|NCT04301310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147600|NCT04301310|Leprostatic Agents|leprostatic agents|mesh-ancestor
92147601|NCT04301310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92147602|NCT04301310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147603|NCT04301310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147604|NCT04301310|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92147605|NCT04301310|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92147606|NCT04301310|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92147607|NCT04301310|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92147608|NCT04301310|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92147609|NCT04301310|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92147610|NCT03026894|Salicylic Acid|salicylic acid|mesh-list
92147611|NCT03026894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147612|NCT03026894|Antifungal Agents|antifungal agents|mesh-ancestor
92147613|NCT03026894|Keratolytic Agents|keratolytic agents|mesh-ancestor
92147614|NCT03026894|Dermatologic Agents|dermatologic agents|mesh-ancestor
92147616|NCT00804609|Morphine|morphine|mesh-list
92147617|NCT00804609|Anesthetics|anesthetics|mesh-list
92147618|NCT00804609|Anesthetics, Local|anesthetics, local|mesh-ancestor
92147619|NCT00804609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147620|NCT00804609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147621|NCT00804609|Sensory System Agents|sensory system agents|mesh-ancestor
92147622|NCT00804609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147623|NCT00804609|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92147624|NCT00804609|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92147625|NCT00804609|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92147626|NCT00804609|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147627|NCT00804609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147628|NCT00804609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92147629|NCT00804609|Narcotics|narcotics|mesh-ancestor
92147630|NCT00804609|Analgesics|analgesics|mesh-ancestor
92147631|NCT03082183|Rifampin|rifampin|mesh-list
92147632|NCT03082183|BI 425809|bi 425809|mesh-list
92147633|NCT03082183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92147634|NCT03082183|Antitubercular Agents|antitubercular agents|mesh-ancestor
92147635|NCT03082183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147636|NCT03082183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147637|NCT03082183|Leprostatic Agents|leprostatic agents|mesh-ancestor
92147638|NCT03082183|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92147639|NCT03082183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147640|NCT03082183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147641|NCT03082183|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92147642|NCT03082183|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92147643|NCT03082183|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92147644|NCT03082183|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92147645|NCT03082183|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92147646|NCT03082183|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92147647|NCT03082183|Nootropic Agents|nootropic agents|mesh-ancestor
92147648|NCT03361735|Leuprolide|leuprolide|mesh-list
92147649|NCT03361735|Goserelin|goserelin|mesh-list
92147650|NCT03361735|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92147651|NCT03361735|Hormones|hormones|mesh-list
92147652|NCT03361735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147653|NCT03361735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147654|NCT03361735|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92147655|NCT03361735|Fertility Agents|fertility agents|mesh-ancestor
92147656|NCT03361735|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92147657|NCT03361735|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92147658|NCT03361735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147660|NCT00804999|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92147661|NCT00804999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147662|NCT04283604|Methylphenidate|methylphenidate|mesh-list
92147663|NCT04283604|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92147664|NCT04283604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147665|NCT04283604|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92147666|NCT04283604|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92147667|NCT04283604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92147668|NCT04283604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147669|NCT04283604|Dopamine Agents|dopamine agents|mesh-ancestor
92147670|NCT04283604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147671|NCT00810303|Efavirenz|efavirenz|mesh-list
92147672|NCT00810303|Ezetimibe|ezetimibe|mesh-list
92147673|NCT00810303|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92147674|NCT00810303|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92147675|NCT00810303|Antimetabolites|antimetabolites|mesh-ancestor
92147676|NCT00810303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147677|NCT00810303|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92147678|NCT00810303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92147679|NCT00810303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92147680|NCT00810303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147681|NCT00810303|Antiviral Agents|antiviral agents|mesh-ancestor
92147682|NCT00810303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147683|NCT00810303|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92147684|NCT00810303|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92147685|NCT00810303|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92147686|NCT00810303|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92147687|NCT00810303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92147688|NCT00810303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92147689|NCT04401085|Antibodies|antibodies|mesh-list
92147690|NCT04401085|Immunologic Factors|immunologic factors|mesh-ancestor
92147691|NCT04401085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147692|NCT05645107|Immunoglobulins|immunoglobulins|mesh-list
92147693|NCT05645107|gamma-Globulins|gamma-globulins|mesh-list
92147694|NCT05645107|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92147695|NCT05645107|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92147696|NCT05645107|Immunologic Factors|immunologic factors|mesh-ancestor
92147697|NCT05645107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147698|NCT04227756|Psilocybin|psilocybin|mesh-list
92147699|NCT04227756|Mescaline|mescaline|mesh-list
92147700|NCT04227756|Hallucinogens|hallucinogens|mesh-ancestor
92147701|NCT04227756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147702|NCT04227756|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147703|NCT04227756|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92147704|NCT04227756|Serotonin Agents|serotonin agents|mesh-ancestor
92147705|NCT04227756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147706|NCT04227756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147707|NCT01460342|Tadalafil|tadalafil|mesh-list
92147708|NCT01460342|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147709|NCT01460342|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92147710|NCT01460342|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92147711|NCT01460342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147712|NCT01460342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147713|NCT01460342|Urological Agents|urological agents|mesh-ancestor
92147715|NCT00775671|Nebivolol|nebivolol|mesh-list
92147716|NCT00775671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92147717|NCT00775671|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92147718|NCT00775671|Sympatholytics|sympatholytics|mesh-ancestor
92147719|NCT00775671|Autonomic Agents|autonomic agents|mesh-ancestor
92147720|NCT00775671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147721|NCT00775671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147722|NCT00775671|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92147723|NCT00775671|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92147724|NCT00775671|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92147725|NCT00775671|Adrenergic Agents|adrenergic agents|mesh-ancestor
92147726|NCT00775671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147727|NCT00775671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147728|NCT00775671|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147729|NCT00775671|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92147730|NCT00775671|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92147731|NCT00775671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92147733|NCT03800745|Laxatives|laxatives|mesh-ancestor
92147734|NCT03800745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92147735|NCT01459796|Rilonacept|rilonacept|mesh-list
92147736|NCT01459796|Allopurinol|allopurinol|mesh-list
92147737|NCT01459796|Antimetabolites|antimetabolites|mesh-ancestor
92147738|NCT01459796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147739|NCT01459796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147740|NCT01459796|Gout Suppressants|gout suppressants|mesh-ancestor
92147741|NCT01459796|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147742|NCT01459796|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92147743|NCT01459796|Antioxidants|antioxidants|mesh-ancestor
92147744|NCT01459796|Protective Agents|protective agents|mesh-ancestor
92147745|NCT01459796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147746|NCT01459796|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147747|NCT04721691|Cannabidiol|cannabidiol|mesh-list
92147748|NCT04721691|Anticonvulsants|anticonvulsants|mesh-ancestor
92147749|NCT04760821|Trimetazidine|trimetazidine|mesh-list
92147750|NCT04760821|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147751|NCT04382079|Propolis|propolis|mesh-list
92147752|NCT04382079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147753|NCT05688007|Hormones|hormones|mesh-list
92147754|NCT05688007|Parathyroid Hormone|parathyroid hormone|mesh-list
92147755|NCT05688007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147756|NCT05688007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147757|NCT05688007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92147758|NCT01459718|Deferasirox|deferasirox|mesh-list
92147759|NCT01459718|Deferoxamine|deferoxamine|mesh-list
92147760|NCT01459718|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92147761|NCT01459718|Chelating Agents|chelating agents|mesh-ancestor
92147763|NCT01459718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147764|NCT01459718|Siderophores|siderophores|mesh-ancestor
92147765|NCT04918407|Empagliflozin|empagliflozin|mesh-list
92147766|NCT04918407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147767|NCT04918407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147768|NCT04918407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92147769|NCT04918407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147771|NCT04989660|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92147772|NCT04989660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147773|NCT04989660|Disinfectants|disinfectants|mesh-ancestor
92147774|NCT04989660|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92147775|NCT04989660|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92147776|NCT02970318|Rituximab|rituximab|mesh-list
92147777|NCT02970318|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92147778|NCT02970318|Acalabrutinib|acalabrutinib|mesh-list
92147779|NCT02970318|Idelalisib|idelalisib|mesh-list
92147780|NCT02970318|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92147781|NCT02970318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147782|NCT02970318|Immunologic Factors|immunologic factors|mesh-ancestor
92147783|NCT02970318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147784|NCT02970318|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147785|NCT02970318|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92147786|NCT02970318|Alkylating Agents|alkylating agents|mesh-ancestor
92147787|NCT02970318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147788|NCT02970318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147789|NCT03081325|Immunomodulating Agents|immunomodulating agents|mesh-list
92147790|NCT03081325|Immunologic Factors|immunologic factors|mesh-ancestor
92147791|NCT03081325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147792|NCT04384731|Poractant alfa|poractant alfa|mesh-list
92147793|NCT04384731|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92147794|NCT04384731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92147795|NCT05042466|Psilocybin|psilocybin|mesh-list
92147796|NCT05042466|Hallucinogens|hallucinogens|mesh-ancestor
92147797|NCT05042466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147798|NCT05042466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92147799|NCT05615467|Metformin|metformin|mesh-list
92147800|NCT05615467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147801|NCT05615467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147802|NCT03800433|Pentoxifylline|pentoxifylline|mesh-list
92147803|NCT03800433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92147804|NCT03800433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147805|NCT03800433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147806|NCT03800433|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92147807|NCT03800433|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92147808|NCT03800433|Protective Agents|protective agents|mesh-ancestor
92147809|NCT03800433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147810|NCT03800433|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147811|NCT03800433|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92147813|NCT03395899|Bevacizumab|bevacizumab|mesh-list
92147814|NCT03395899|Atezolizumab|atezolizumab|mesh-list
92147815|NCT03395899|Ipatasertib|ipatasertib|mesh-list
92147816|NCT03395899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92147817|NCT03395899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147818|NCT03395899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92147819|NCT03395899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92147820|NCT03395899|Growth Substances|growth substances|mesh-ancestor
92147821|NCT03395899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147822|NCT03395899|Growth Inhibitors|growth inhibitors|mesh-ancestor
92147823|NCT03395899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92147824|NCT03395899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147825|NCT03395899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92147826|NCT03395899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147827|NCT02900976|Rituximab|rituximab|mesh-list
92147828|NCT02900976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92147829|NCT02900976|Antibodies|antibodies|mesh-list
92147830|NCT02900976|Immunoglobulins|immunoglobulins|mesh-list
92147831|NCT02900976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92147832|NCT02900976|Immunologic Factors|immunologic factors|mesh-ancestor
92147833|NCT02900976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147834|NCT02900976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147835|NCT02900976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147836|NCT05602597|Itraconazole|itraconazole|mesh-list
92147837|NCT05602597|Fluconazole|fluconazole|mesh-list
92147838|NCT05602597|Rifampin|rifampin|mesh-list
92147839|NCT05602597|Rabeprazole|rabeprazole|mesh-list
92147840|NCT05602597|Antifungal Agents|antifungal agents|mesh-ancestor
92147841|NCT05602597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147842|NCT05602597|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92147843|NCT05602597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92147844|NCT05602597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147845|NCT05602597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147846|NCT05602597|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92147847|NCT05602597|Hormone Antagonists|hormone antagonists|mesh-ancestor
92147848|NCT05602597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147849|NCT05602597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147850|NCT05602597|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92147851|NCT05602597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92147852|NCT05602597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92147853|NCT05602597|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92147854|NCT05602597|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92147855|NCT05602597|Antitubercular Agents|antitubercular agents|mesh-ancestor
92147856|NCT05602597|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147857|NCT05602597|Leprostatic Agents|leprostatic agents|mesh-ancestor
92147858|NCT05602597|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92147859|NCT05602597|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92147860|NCT05602597|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92147872|NCT04608201|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92147873|NCT04608201|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92147874|NCT04608201|Cholinergic Agents|cholinergic agents|mesh-ancestor
92147875|NCT04608201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92147876|NCT04608201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147889|NCT04110444|Sildenafil Citrate|sildenafil citrate|mesh-list
92147890|NCT04110444|Vasodilator Agents|vasodilator agents|mesh-ancestor
92147891|NCT04110444|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92147892|NCT04110444|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92147893|NCT04110444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147894|NCT04110444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147895|NCT04110444|Urological Agents|urological agents|mesh-ancestor
92147896|NCT04951986|Levofloxacin|levofloxacin|mesh-list
92147897|NCT04951986|Rifampin|rifampin|mesh-list
92147898|NCT04951986|Isoniazid|isoniazid|mesh-list
92147899|NCT04951986|Pyrazinamide|pyrazinamide|mesh-list
92147900|NCT04951986|Ethambutol|ethambutol|mesh-list
92147901|NCT04951986|Prednisone|prednisone|mesh-list
92147902|NCT04951986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147903|NCT04951986|Glucocorticoids|glucocorticoids|mesh-ancestor
92147904|NCT04951986|Hormones|hormones|mesh-ancestor
92147905|NCT04951986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92147906|NCT04951986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147907|NCT04951986|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92147908|NCT04951986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92147909|NCT04951986|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92147910|NCT04951986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147911|NCT04951986|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92147912|NCT04951986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92147913|NCT04951986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92147914|NCT04951986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147915|NCT04951986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147916|NCT04951986|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92147917|NCT04951986|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92147918|NCT04951986|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92147919|NCT04951986|Antitubercular Agents|antitubercular agents|mesh-ancestor
92147920|NCT04951986|Leprostatic Agents|leprostatic agents|mesh-ancestor
92147921|NCT04951986|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92147922|NCT04951986|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92147923|NCT04951986|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92147924|NCT04951986|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92147925|NCT04951986|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92147926|NCT04951986|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92147927|NCT04951986|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92147928|NCT04951986|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92147930|NCT04951986|Antimetabolites|antimetabolites|mesh-ancestor
92147931|NCT04951986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92147933|NCT04278859|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92147934|NCT04278859|Immunologic Factors|immunologic factors|mesh-ancestor
92147935|NCT04278859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147936|NCT04484337|Cabotegravir|cabotegravir|mesh-list
92147937|NCT04484337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92147938|NCT04484337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92147939|NCT04484337|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92147940|NCT04484337|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92147941|NCT04484337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147942|NCT04484337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147943|NCT04484337|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92147944|NCT04484337|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92147945|NCT04484337|Antiviral Agents|antiviral agents|mesh-ancestor
92147946|NCT04484337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92147947|NCT04484337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92147948|NCT04484337|Analgesics|analgesics|mesh-ancestor
92147949|NCT04484337|Sensory System Agents|sensory system agents|mesh-ancestor
92147950|NCT04484337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147951|NCT04484337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147952|NCT04484337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147953|NCT01474538|Insulin|insulin|mesh-list
92147954|NCT01474538|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92147955|NCT01474538|Insulin Aspart|insulin aspart|mesh-list
92147956|NCT01474538|Insulin Lispro|insulin lispro|mesh-list
92147957|NCT01474538|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92147958|NCT01474538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147959|NCT04278703|Oxycodone|oxycodone|mesh-list
92147960|NCT04278703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92147961|NCT04278703|Narcotics|narcotics|mesh-ancestor
92147962|NCT04278703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147963|NCT04278703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147964|NCT04278703|Analgesics|analgesics|mesh-ancestor
92147965|NCT04278703|Sensory System Agents|sensory system agents|mesh-ancestor
92147966|NCT04278703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147967|NCT02647788|Acetaminophen|acetaminophen|mesh-list
92147968|NCT02647788|Ibuprofen|ibuprofen|mesh-list
92147969|NCT02647788|Codeine|codeine|mesh-list
92147970|NCT02647788|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92147971|NCT02647788|Analgesics|analgesics|mesh-ancestor
92147972|NCT02647788|Sensory System Agents|sensory system agents|mesh-ancestor
92147973|NCT02647788|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147974|NCT02647788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147975|NCT02647788|Antipyretics|antipyretics|mesh-ancestor
92147976|NCT02647788|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92147977|NCT02647788|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92147978|NCT02647788|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92147979|NCT02647788|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92147980|NCT02647788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92147981|NCT02647788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92147982|NCT02647788|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92147983|NCT02647788|Narcotics|narcotics|mesh-ancestor
92147984|NCT02647788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147985|NCT02647788|Antitussive Agents|antitussive agents|mesh-ancestor
92147986|NCT02647788|Respiratory System Agents|respiratory system agents|mesh-ancestor
92147987|NCT04382859|Bupivacaine|bupivacaine|mesh-list
92147988|NCT04382859|Anesthetics, Local|anesthetics, local|mesh-ancestor
92147989|NCT04382859|Anesthetics|anesthetics|mesh-ancestor
92147990|NCT04382859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147991|NCT04382859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147992|NCT04382859|Sensory System Agents|sensory system agents|mesh-ancestor
92147993|NCT04382859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92147994|NCT03318133|Anesthetics|anesthetics|mesh-list
92147995|NCT03318133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92147996|NCT03318133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92147998|NCT04520217|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92147999|NCT04520217|Antidepressive Agents|antidepressive agents|mesh-ancestor
92148000|NCT04520217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92148001|NCT04520217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92148002|NCT04520217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92148003|NCT04520217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148004|NCT04520217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148005|NCT04520217|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148006|NCT04520217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148007|NCT04520217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148008|NCT04134663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92148009|NCT04134663|Oxytocin|oxytocin|mesh-list
92148010|NCT04134663|Oxytocics|oxytocics|mesh-ancestor
92148011|NCT04134663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92148012|NCT04134663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148013|NCT05431764|Gemcitabine|gemcitabine|mesh-list
92148014|NCT05431764|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92148015|NCT05431764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148016|NCT05431764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148017|NCT05431764|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148018|NCT05431764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92148019|NCT05431764|Antimetabolites|antimetabolites|mesh-ancestor
92148020|NCT04311411|Liraglutide|liraglutide|mesh-list
92148021|NCT04311411|Tirzepatide|tirzepatide|mesh-list
92148022|NCT04311411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92148023|NCT04311411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148024|NCT04311411|Incretins|incretins|mesh-ancestor
92148025|NCT04311411|Hormones|hormones|mesh-ancestor
92148026|NCT04311411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148027|NCT00843531|Everolimus|everolimus|mesh-list
92148028|NCT00843531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92148029|NCT00843531|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92148030|NCT00843531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92148031|NCT00843531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148032|NCT00843531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148033|NCT00843531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148034|NCT00843531|Immunologic Factors|immunologic factors|mesh-ancestor
92148035|NCT00843531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148036|NCT00843531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148037|NCT00812877|Calcium|calcium|mesh-list
92148038|NCT00812877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92148039|NCT00812877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148040|NCT00813111|Epinephrine|epinephrine|mesh-list
92148041|NCT00813111|Bupivacaine|bupivacaine|mesh-list
92148042|NCT00813111|Anesthetics, Local|anesthetics, local|mesh-ancestor
92148043|NCT00813111|Anesthetics|anesthetics|mesh-ancestor
92148044|NCT00813111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148045|NCT00813111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148046|NCT00813111|Sensory System Agents|sensory system agents|mesh-ancestor
92148047|NCT00813111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148048|NCT00813111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92148049|NCT00813111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148050|NCT00813111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148051|NCT00813111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148052|NCT00813111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148053|NCT00813111|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92148054|NCT00813111|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92148055|NCT00813111|Autonomic Agents|autonomic agents|mesh-ancestor
92148056|NCT00813111|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92148057|NCT00813111|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148058|NCT00813111|Mydriatics|mydriatics|mesh-ancestor
92148059|NCT00813111|Sympathomimetics|sympathomimetics|mesh-ancestor
92148060|NCT00813111|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92148062|NCT00845481|Betamethasone|betamethasone|mesh-list
92148063|NCT00845481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148064|NCT00845481|Glucocorticoids|glucocorticoids|mesh-ancestor
92148065|NCT00845481|Hormones|hormones|mesh-ancestor
92148066|NCT00845481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148067|NCT00845481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148068|NCT00845481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92148069|NCT00845481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148070|NCT00845481|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92148071|NCT00845481|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92148072|NCT00845481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148073|NCT00845481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148074|NCT00845481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92148075|NCT00845481|Vitamins|vitamins|mesh-ancestor
92148076|NCT00845481|Micronutrients|micronutrients|mesh-ancestor
92148077|NCT00845481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92148078|NCT03641001|Micronutrients|micronutrients|mesh-list
92148079|NCT03641001|Trace Elements|trace elements|mesh-list
92148080|NCT03641001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148081|NCT01421069|Etanercept|etanercept|mesh-list
92148082|NCT01421069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92148083|NCT01421069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92148084|NCT01421069|Analgesics|analgesics|mesh-ancestor
92148085|NCT01421069|Sensory System Agents|sensory system agents|mesh-ancestor
92148086|NCT01421069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148087|NCT01421069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148088|NCT01421069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148089|NCT01421069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148090|NCT01421069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92148091|NCT01421069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148092|NCT01421069|Immunologic Factors|immunologic factors|mesh-ancestor
92148093|NCT04276233|Albuterol|albuterol|mesh-list
92148094|NCT04276233|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92148095|NCT04276233|Autonomic Agents|autonomic agents|mesh-ancestor
92148096|NCT04276233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148097|NCT04276233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148098|NCT04276233|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92148099|NCT04276233|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148100|NCT04276233|Tocolytic Agents|tocolytic agents|mesh-ancestor
92148101|NCT04276233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92148102|NCT04276233|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92148103|NCT04276233|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92148104|NCT04276233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148105|NCT04276233|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148106|NCT04276233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148107|NCT04276233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148108|NCT04681430|Gabexate|gabexate|mesh-list
92148109|NCT04681430|Camostat|camostat|mesh-list
92148110|NCT04681430|Protease Inhibitors|protease inhibitors|mesh-ancestor
92148111|NCT04681430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148112|NCT04681430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148113|NCT04681430|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92148114|NCT04681430|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92148115|NCT04681430|Anticoagulants|anticoagulants|mesh-ancestor
92148116|NCT03309475|Psychotropic Drugs|psychotropic drugs|mesh-list
92148117|NCT00814671|Rifampin|rifampin|mesh-list
92148118|NCT00814671|Rifapentine|rifapentine|mesh-list
92148119|NCT00814671|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92148120|NCT00814671|Antitubercular Agents|antitubercular agents|mesh-ancestor
92148121|NCT00814671|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148122|NCT00814671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148124|NCT00814671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92148125|NCT00814671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148126|NCT00814671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148127|NCT00814671|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92148128|NCT00814671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92148129|NCT00814671|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92148130|NCT00814671|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92148131|NCT00814671|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92148132|NCT00814671|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92148134|NCT03379051|Venetoclax|venetoclax|mesh-list
92148135|NCT03379051|Immunologic Factors|immunologic factors|mesh-ancestor
92148136|NCT03379051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148137|NCT03379051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92148138|NCT03379051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92148139|NCT03379051|Growth Substances|growth substances|mesh-ancestor
92148140|NCT03379051|Growth Inhibitors|growth inhibitors|mesh-ancestor
92148141|NCT03379051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148142|NCT01473836|Metronidazole|metronidazole|mesh-list
92148143|NCT01473836|Ceftriaxone|ceftriaxone|mesh-list
92148144|NCT01473836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148145|NCT01473836|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148146|NCT01473836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92148147|NCT01473836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92148148|NCT03340909|Prednisolone|prednisolone|mesh-list
92148149|NCT03340909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148150|NCT03340909|Glucocorticoids|glucocorticoids|mesh-ancestor
92148151|NCT03340909|Hormones|hormones|mesh-ancestor
92148152|NCT03340909|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148153|NCT03340909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148154|NCT03340909|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92148155|NCT03340909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148156|NCT05686915|Cobalt|cobalt|mesh-list
92148157|NCT05686915|Chromium|chromium|mesh-list
92148158|NCT05686915|Trace Elements|trace elements|mesh-ancestor
92148159|NCT05686915|Micronutrients|micronutrients|mesh-ancestor
92148160|NCT05686915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148161|NCT03674151|Povidone|povidone|mesh-list
92148162|NCT03674151|Plasma Substitutes|plasma substitutes|mesh-ancestor
92148163|NCT03674151|Blood Substitutes|blood substitutes|mesh-ancestor
92148164|NCT03643965|Budesonide|budesonide|mesh-list
92148165|NCT03643965|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148166|NCT03643965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92148167|NCT03643965|Autonomic Agents|autonomic agents|mesh-ancestor
92148467|NCT01457924|Immunologic Factors|immunologic factors|mesh-ancestor
92148168|NCT03643965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148169|NCT03643965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148170|NCT03643965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92148171|NCT03643965|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148172|NCT03643965|Glucocorticoids|glucocorticoids|mesh-ancestor
92148173|NCT03643965|Hormones|hormones|mesh-ancestor
92148174|NCT03643965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148175|NCT02979522|Doxorubicin|doxorubicin|mesh-list
92148176|NCT02979522|Dacarbazine|dacarbazine|mesh-list
92148177|NCT02979522|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92148178|NCT02979522|Vinblastine|vinblastine|mesh-list
92148179|NCT02979522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92148180|NCT02979522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148181|NCT02979522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92148182|NCT02979522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92148183|NCT02979522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148184|NCT02979522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148185|NCT02979522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92148186|NCT02979522|Alkylating Agents|alkylating agents|mesh-ancestor
92148187|NCT02979522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148188|NCT02979522|Immunotoxins|immunotoxins|mesh-ancestor
92148189|NCT02979522|Immunoconjugates|immunoconjugates|mesh-ancestor
92148190|NCT02979522|Immunologic Factors|immunologic factors|mesh-ancestor
92148191|NCT02979522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148192|NCT02979522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92148193|NCT02979522|Tubulin Modulators|tubulin modulators|mesh-ancestor
92148194|NCT02979522|Antimitotic Agents|antimitotic agents|mesh-ancestor
92148195|NCT02979522|Mitosis Modulators|mitosis modulators|mesh-ancestor
92148196|NCT01420679|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92148197|NCT01420679|Aminopterin|aminopterin|mesh-list
92148198|NCT01420679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92148199|NCT01420679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148200|NCT01420679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148201|NCT01420679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148202|NCT00851409|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92148203|NCT00851409|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92148204|NCT00851409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148205|NCT00851409|Immunologic Factors|immunologic factors|mesh-ancestor
92148206|NCT00851409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148207|NCT04401007|Lidocaine|lidocaine|mesh-list
92148208|NCT04401007|Anesthetics, Local|anesthetics, local|mesh-ancestor
92148209|NCT04401007|Anesthetics|anesthetics|mesh-ancestor
92148210|NCT04401007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148211|NCT04401007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148212|NCT04401007|Sensory System Agents|sensory system agents|mesh-ancestor
92148213|NCT04401007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148214|NCT04401007|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92148215|NCT04401007|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92148216|NCT04401007|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92148217|NCT04401007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148218|NCT04401007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148219|NCT01496846|Lidocaine|lidocaine|mesh-list
92148220|NCT01496846|Carticaine|carticaine|mesh-list
92148221|NCT01496846|Anesthetics, Local|anesthetics, local|mesh-ancestor
92148222|NCT01496846|Anesthetics|anesthetics|mesh-ancestor
92148223|NCT01496846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148224|NCT01496846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148225|NCT01496846|Sensory System Agents|sensory system agents|mesh-ancestor
92148226|NCT01496846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148227|NCT01496846|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92148228|NCT01496846|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92148229|NCT01496846|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92148230|NCT01496846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148231|NCT01496846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148232|NCT00964002|Efavirenz|efavirenz|mesh-list
92148233|NCT00964002|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92148234|NCT00964002|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92148235|NCT00964002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148236|NCT00964002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148237|NCT00964002|Antiviral Agents|antiviral agents|mesh-ancestor
92148238|NCT00964002|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148239|NCT00964002|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92148620|NCT00827073|Anesthetics, Local|anesthetics, local|mesh-ancestor
92148240|NCT00964002|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92148241|NCT00964002|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92148242|NCT00964002|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92148243|NCT00964002|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92148244|NCT00964002|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92148245|NCT00818337|Aspirin|aspirin|mesh-list
92148246|NCT00818337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92148247|NCT00818337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92148248|NCT00818337|Analgesics|analgesics|mesh-ancestor
92148249|NCT00818337|Sensory System Agents|sensory system agents|mesh-ancestor
92148250|NCT00818337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148251|NCT00818337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148252|NCT00818337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148253|NCT00818337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148254|NCT00818337|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92148255|NCT00818337|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92148256|NCT00818337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148257|NCT00818337|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92148258|NCT00818337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92148259|NCT00818337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148260|NCT00818337|Antipyretics|antipyretics|mesh-ancestor
92148261|NCT02577120|Decanoic acid|decanoic acid|mesh-list
92148262|NCT02577120|Petrolatum|petrolatum|mesh-list
92148263|NCT02577120|Emollients|emollients|mesh-ancestor
92148264|NCT02577120|Dermatologic Agents|dermatologic agents|mesh-ancestor
92148265|NCT02577120|Antifungal Agents|antifungal agents|mesh-ancestor
92148266|NCT02577120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148268|NCT01399697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92148269|NCT01399697|Abortifacient Agents|abortifacient agents|mesh-ancestor
92148270|NCT01399697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92148271|NCT01399697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148272|NCT01399697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92148273|NCT01399697|Antimetabolites|antimetabolites|mesh-ancestor
92148274|NCT01399697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148275|NCT01399697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148276|NCT01399697|Dermatologic Agents|dermatologic agents|mesh-ancestor
92148277|NCT01399697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148278|NCT01399697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92148279|NCT01399697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148280|NCT01399697|Immunologic Factors|immunologic factors|mesh-ancestor
92148281|NCT01399697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148282|NCT01399697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92148283|NCT00853671|Adenosine|adenosine|mesh-list
92148284|NCT00853671|Analgesics|analgesics|mesh-ancestor
92148285|NCT00853671|Sensory System Agents|sensory system agents|mesh-ancestor
92148286|NCT00853671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148287|NCT00853671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148288|NCT00853671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92148289|NCT00853671|Vasodilator Agents|vasodilator agents|mesh-ancestor
92148290|NCT00853671|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92148291|NCT00853671|Purinergic Agonists|purinergic agonists|mesh-ancestor
92148292|NCT00853671|Purinergic Agents|purinergic agents|mesh-ancestor
92148293|NCT00853671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148294|NCT00853671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148295|NCT00818805|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92148296|NCT00818805|Tranilast|tranilast|mesh-list
92148297|NCT00818805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92148298|NCT00818805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92148299|NCT00818805|Analgesics|analgesics|mesh-ancestor
92148300|NCT00818805|Sensory System Agents|sensory system agents|mesh-ancestor
92148301|NCT00818805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148302|NCT00818805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148303|NCT00818805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148304|NCT00818805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148305|NCT00818805|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92148306|NCT00818805|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92148307|NCT00818805|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92148308|NCT00818805|Histamine Antagonists|histamine antagonists|mesh-ancestor
92148309|NCT00818805|Histamine Agents|histamine agents|mesh-ancestor
92148310|NCT00818805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148311|NCT00818805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148312|NCT00818805|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92148313|NCT00818805|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148314|NCT00818805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92148315|NCT00818805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92148316|NCT00854061|Prednisone|prednisone|mesh-list
92148317|NCT00854061|Prednisolone acetate|prednisolone acetate|mesh-list
92148318|NCT00854061|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92148319|NCT00854061|Methylprednisolone|methylprednisolone|mesh-list
92148320|NCT00854061|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92148321|NCT00854061|Prednisolone|prednisolone|mesh-list
92148322|NCT00854061|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92148323|NCT00854061|Prednisolone phosphate|prednisolone phosphate|mesh-list
92148324|NCT00854061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148325|NCT00854061|Glucocorticoids|glucocorticoids|mesh-ancestor
92148326|NCT00854061|Hormones|hormones|mesh-ancestor
92148327|NCT00854061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148328|NCT00854061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148329|NCT00854061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92148330|NCT00854061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148331|NCT00854061|Antiemetics|antiemetics|mesh-ancestor
92148332|NCT00854061|Autonomic Agents|autonomic agents|mesh-ancestor
92148333|NCT00854061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148334|NCT00854061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92148335|NCT00854061|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92148336|NCT00854061|Protective Agents|protective agents|mesh-ancestor
92148337|NCT01473602|Vitamin D|vitamin d|mesh-list
92148338|NCT01473602|Teriparatide|teriparatide|mesh-list
92148339|NCT01473602|Calcium|calcium|mesh-list
92148340|NCT01473602|Vitamins|vitamins|mesh-ancestor
92148341|NCT01473602|Micronutrients|micronutrients|mesh-ancestor
92148342|NCT01473602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148343|NCT01473602|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92148344|NCT01473602|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92148345|NCT03336073|Dexamethasone|dexamethasone|mesh-list
92148346|NCT03336073|Cyclophosphamide|cyclophosphamide|mesh-list
92148347|NCT03336073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148348|NCT03336073|Immunologic Factors|immunologic factors|mesh-ancestor
92148349|NCT03336073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148350|NCT03336073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148351|NCT03336073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92148352|NCT03336073|Alkylating Agents|alkylating agents|mesh-ancestor
92148353|NCT03336073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148354|NCT03336073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148355|NCT03336073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92148356|NCT03336073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148357|NCT03336073|Antiemetics|antiemetics|mesh-ancestor
92148358|NCT03336073|Autonomic Agents|autonomic agents|mesh-ancestor
92148359|NCT03336073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148360|NCT03336073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92148361|NCT03336073|Glucocorticoids|glucocorticoids|mesh-ancestor
92148363|NCT03336073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148364|NCT03336073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92148365|NCT05334433|Anesthetics|anesthetics|mesh-list
92148366|NCT05334433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148367|NCT05334433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148368|NCT01496612|Buspirone|buspirone|mesh-list
92148369|NCT01496612|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92148370|NCT01496612|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92148371|NCT01496612|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148372|NCT01496612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148373|NCT01496612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92148374|NCT01496612|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92148375|NCT01496612|Serotonin Agents|serotonin agents|mesh-ancestor
92148376|NCT01496612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148377|NCT01496612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148378|NCT00790218|Adenosine|adenosine|mesh-list
92148379|NCT00790218|Analgesics|analgesics|mesh-ancestor
92148380|NCT00790218|Sensory System Agents|sensory system agents|mesh-ancestor
92148381|NCT00790218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148382|NCT00790218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148383|NCT00790218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92148384|NCT00790218|Vasodilator Agents|vasodilator agents|mesh-ancestor
92148385|NCT00790218|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92148386|NCT00790218|Purinergic Agonists|purinergic agonists|mesh-ancestor
92148387|NCT00790218|Purinergic Agents|purinergic agents|mesh-ancestor
92148388|NCT00790218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148389|NCT00790218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148391|NCT03300427|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92148392|NCT03300427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92148393|NCT03300427|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92148394|NCT03300427|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92148395|NCT03300427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148396|NCT00818961|Cyclophosphamide|cyclophosphamide|mesh-list
92148397|NCT00818961|Busulfan|busulfan|mesh-list
92148398|NCT00818961|Rituximab|rituximab|mesh-list
92148399|NCT00818961|Methotrexate|methotrexate|mesh-list
92148400|NCT00818961|Fludarabine|fludarabine|mesh-list
92148401|NCT00818961|Fludarabine phosphate|fludarabine phosphate|mesh-list
92148402|NCT00818961|Alemtuzumab|alemtuzumab|mesh-list
92148403|NCT00818961|Tacrolimus|tacrolimus|mesh-list
92148404|NCT00818961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148405|NCT00818961|Immunologic Factors|immunologic factors|mesh-ancestor
92148406|NCT00818961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148407|NCT00818961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148408|NCT00818961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92148409|NCT00818961|Alkylating Agents|alkylating agents|mesh-ancestor
92148410|NCT00818961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148411|NCT00818961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148412|NCT00818961|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92148413|NCT00818961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148414|NCT00818961|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92148415|NCT00818961|Abortifacient Agents|abortifacient agents|mesh-ancestor
92148416|NCT00818961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92148417|NCT00818961|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92148418|NCT00818961|Antimetabolites|antimetabolites|mesh-ancestor
92148419|NCT00818961|Dermatologic Agents|dermatologic agents|mesh-ancestor
92148420|NCT00818961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148421|NCT00818961|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92148422|NCT00818961|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92148423|NCT00818961|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92148424|NCT05431218|Cholecalciferol|cholecalciferol|mesh-list
92148425|NCT05431218|Vitamin D|vitamin d|mesh-list
92148426|NCT05431218|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92148427|NCT05431218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148428|NCT05431218|Vitamins|vitamins|mesh-ancestor
92148429|NCT05431218|Micronutrients|micronutrients|mesh-ancestor
92148430|NCT05431218|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92148431|NCT05431062|Bupivacaine|bupivacaine|mesh-list
92148432|NCT05431062|Anesthetics, Local|anesthetics, local|mesh-ancestor
92148433|NCT05431062|Anesthetics|anesthetics|mesh-ancestor
92148434|NCT05431062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148435|NCT05431062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148436|NCT05431062|Sensory System Agents|sensory system agents|mesh-ancestor
92148437|NCT05431062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148438|NCT00819507|Fluocinonide|fluocinonide|mesh-list
92148439|NCT00819507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148440|NCT00819507|Glucocorticoids|glucocorticoids|mesh-ancestor
92148441|NCT00819507|Hormones|hormones|mesh-ancestor
92148442|NCT00819507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148443|NCT00819507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148444|NCT00819507|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92148445|NCT03696121|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92148446|NCT03696121|Hemostatics|hemostatics|mesh-ancestor
92148447|NCT03696121|Coagulants|coagulants|mesh-ancestor
92148448|NCT03696121|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92148449|NCT03696121|Natriuretic Agents|natriuretic agents|mesh-ancestor
92148450|NCT03696121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148451|NCT01995669|Lenalidomide|lenalidomide|mesh-list
92148452|NCT01995669|Obinutuzumab|obinutuzumab|mesh-list
92148453|NCT01995669|Immunologic Factors|immunologic factors|mesh-ancestor
92148454|NCT01995669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148455|NCT01995669|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92148456|NCT01995669|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92148457|NCT01995669|Growth Substances|growth substances|mesh-ancestor
92148458|NCT01995669|Growth Inhibitors|growth inhibitors|mesh-ancestor
92148459|NCT01995669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148460|NCT01995669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148461|NCT03298945|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92148462|NCT03298945|Laxatives|laxatives|mesh-ancestor
92148463|NCT03298945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92148464|NCT01457924|Ofatumumab|ofatumumab|mesh-list
92148465|NCT01457924|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92148466|NCT01457924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148468|NCT01457924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148469|NCT05237115|Amoxicillin|amoxicillin|mesh-list
92148470|NCT05237115|Clarithromycin|clarithromycin|mesh-list
92148471|NCT05237115|Esomeprazole|esomeprazole|mesh-list
92148472|NCT05237115|Bismuth|bismuth|mesh-list
92148473|NCT05237115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148474|NCT05237115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148475|NCT05237115|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92148476|NCT05237115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92148477|NCT05237115|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92148478|NCT05237115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148479|NCT05237115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148480|NCT05237115|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92148481|NCT05237115|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92148482|NCT05237115|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92148483|NCT05237115|Antacids|antacids|mesh-ancestor
92148484|NCT04040621|Ceftazidime|ceftazidime|mesh-list
92148485|NCT04040621|Avibactam|avibactam|mesh-list
92148486|NCT04040621|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92148487|NCT04040621|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148488|NCT04040621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148489|NCT04040621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92148490|NCT04040621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148491|NCT04040621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148492|NCT00856791|ON 01910|on 01910|mesh-list
92148493|NCT00856791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148494|NCT00856791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92148495|NCT00856791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148496|NCT00856791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148497|NCT00857493|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92148498|NCT00857493|Antiviral Agents|antiviral agents|mesh-ancestor
92148499|NCT00857493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148500|NCT05236569|Tranexamic Acid|tranexamic acid|mesh-list
92148501|NCT05236569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92148502|NCT05236569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92148503|NCT05236569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148504|NCT05236569|Hemostatics|hemostatics|mesh-ancestor
92148505|NCT05236569|Coagulants|coagulants|mesh-ancestor
92148506|NCT00857727|Dexmedetomidine|dexmedetomidine|mesh-list
92148507|NCT00857727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92148508|NCT00857727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148509|NCT00857727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148510|NCT00857727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92148511|NCT00857727|Analgesics|analgesics|mesh-ancestor
92148512|NCT00857727|Sensory System Agents|sensory system agents|mesh-ancestor
92148513|NCT00857727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148514|NCT00857727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92148515|NCT00857727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92148516|NCT00857727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148517|NCT00857727|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148518|NCT00857727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148519|NCT00857727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148520|NCT00857961|Testosterone|testosterone|mesh-list
92148521|NCT00857961|Androgens|androgens|mesh-ancestor
92148522|NCT00857961|Hormones|hormones|mesh-ancestor
92148523|NCT00857961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148524|NCT00857961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148525|NCT03839433|Ciclesonide|ciclesonide|mesh-list
92148526|NCT03839433|Glucocorticoids|glucocorticoids|mesh-ancestor
92148527|NCT03839433|Hormones|hormones|mesh-ancestor
92148528|NCT03839433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148529|NCT03839433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148530|NCT03839433|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92148531|NCT05033041|Metoclopramide|metoclopramide|mesh-list
92148532|NCT05033041|Antiemetics|antiemetics|mesh-ancestor
92148533|NCT05033041|Autonomic Agents|autonomic agents|mesh-ancestor
92148534|NCT05033041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148535|NCT05033041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148536|NCT05033041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92148537|NCT05033041|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92148538|NCT05033041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92148539|NCT05033041|Dopamine Agents|dopamine agents|mesh-ancestor
92148540|NCT05033041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148541|NCT05033041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148542|NCT00823797|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92148543|NCT00823797|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92148544|NCT00823797|Alkylating Agents|alkylating agents|mesh-ancestor
92148545|NCT00823797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148546|NCT00823797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148547|NCT00824733|Trastuzumab|trastuzumab|mesh-list
92148548|NCT00824733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148549|NCT00824733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148550|NCT02150499|Albuterol|albuterol|mesh-list
92148551|NCT02150499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92148552|NCT02150499|Autonomic Agents|autonomic agents|mesh-ancestor
92148553|NCT02150499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148554|NCT02150499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148556|NCT02150499|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148557|NCT02150499|Tocolytic Agents|tocolytic agents|mesh-ancestor
92148558|NCT02150499|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92148559|NCT02150499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92148560|NCT02150499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92148561|NCT02150499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148562|NCT02150499|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148563|NCT02150499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148564|NCT02150499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148565|NCT03287947|Nintedanib|nintedanib|mesh-list
92148566|NCT03287947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148567|NCT03287947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92148568|NCT03287947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148569|NCT03287947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148570|NCT05685667|Hyaluronic Acid|hyaluronic acid|mesh-list
92148571|NCT05685667|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92148572|NCT05685667|Immunologic Factors|immunologic factors|mesh-ancestor
92148573|NCT05685667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148574|NCT05685667|Viscosupplements|viscosupplements|mesh-ancestor
92148575|NCT05685667|Protective Agents|protective agents|mesh-ancestor
92148576|NCT00859131|Thymoglobulin|thymoglobulin|mesh-list
92148577|NCT00859131|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92148578|NCT00859131|Daclizumab|daclizumab|mesh-list
92148579|NCT00859131|Immunologic Factors|immunologic factors|mesh-ancestor
92148580|NCT00859131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148581|NCT00859131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148582|NCT00859833|Adenosine|adenosine|mesh-list
92148583|NCT00859833|Regadenoson|regadenoson|mesh-list
92148584|NCT00859833|Analgesics|analgesics|mesh-ancestor
92148585|NCT00859833|Sensory System Agents|sensory system agents|mesh-ancestor
92148586|NCT00859833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148587|NCT00859833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148588|NCT00859833|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92148589|NCT00859833|Vasodilator Agents|vasodilator agents|mesh-ancestor
92148590|NCT00859833|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92148591|NCT00859833|Purinergic Agonists|purinergic agonists|mesh-ancestor
92148592|NCT00859833|Purinergic Agents|purinergic agents|mesh-ancestor
92148593|NCT00859833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148594|NCT00859833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148595|NCT00859833|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92148597|NCT02154477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92148598|NCT02154477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148599|NCT00860379|Selenium|selenium|mesh-list
92148600|NCT00860379|Antioxidants|antioxidants|mesh-ancestor
92148601|NCT00860379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148602|NCT00860379|Protective Agents|protective agents|mesh-ancestor
92148603|NCT00860379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148604|NCT00860379|Trace Elements|trace elements|mesh-ancestor
92148605|NCT00860379|Micronutrients|micronutrients|mesh-ancestor
92148606|NCT00860457|Rituximab|rituximab|mesh-list
92148607|NCT00860457|Fludarabine|fludarabine|mesh-list
92148608|NCT00860457|Lenalidomide|lenalidomide|mesh-list
92148609|NCT00860457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148610|NCT00860457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148611|NCT00860457|Immunologic Factors|immunologic factors|mesh-ancestor
92148612|NCT00860457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148613|NCT00860457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148614|NCT00860457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92148615|NCT00860457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92148616|NCT00860457|Growth Substances|growth substances|mesh-ancestor
92148617|NCT00860457|Growth Inhibitors|growth inhibitors|mesh-ancestor
92148618|NCT00827073|Lidocaine|lidocaine|mesh-list
92148619|NCT00827073|Tetracaine|tetracaine|mesh-list
92148622|NCT00827073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148623|NCT00827073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148624|NCT00827073|Sensory System Agents|sensory system agents|mesh-ancestor
92148625|NCT00827073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148626|NCT00827073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92148627|NCT00827073|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92148628|NCT00827073|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92148629|NCT00827073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148630|NCT00827073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148632|NCT00860847|Coenzyme Q10|coenzyme q10|mesh-list
92148633|NCT00860847|Micronutrients|micronutrients|mesh-ancestor
92148634|NCT00860847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148635|NCT00860847|Vitamins|vitamins|mesh-ancestor
92148636|NCT04347733|Triamcinolone|triamcinolone|mesh-list
92148637|NCT04347733|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92148638|NCT04347733|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92148639|NCT04347733|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92148640|NCT04347733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148641|NCT04347733|Glucocorticoids|glucocorticoids|mesh-ancestor
92148642|NCT04347733|Hormones|hormones|mesh-ancestor
92148643|NCT04347733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148644|NCT04347733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148645|NCT04347733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148646|NCT04347733|Immunologic Factors|immunologic factors|mesh-ancestor
92148647|NCT04347733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148648|NCT04347733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148649|NCT02155101|Ritonavir|ritonavir|mesh-list
92148650|NCT02155101|Lopinavir|lopinavir|mesh-list
92148651|NCT02155101|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92148652|NCT02155101|Darunavir|darunavir|mesh-list
92148653|NCT02155101|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92148654|NCT02155101|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92148655|NCT02155101|Protease Inhibitors|protease inhibitors|mesh-ancestor
92148656|NCT02155101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148657|NCT02155101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148658|NCT02155101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92148659|NCT02155101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92148660|NCT02155101|Antiviral Agents|antiviral agents|mesh-ancestor
92148661|NCT02155101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148662|NCT02155101|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92148663|NCT02155101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92148665|NCT02155257|Modafinil|modafinil|mesh-list
92148666|NCT02155257|Analgesics|analgesics|mesh-ancestor
92148667|NCT02155257|Sensory System Agents|sensory system agents|mesh-ancestor
92148668|NCT02155257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148669|NCT02155257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148670|NCT02155257|Anticonvulsants|anticonvulsants|mesh-ancestor
92148671|NCT02155257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92148672|NCT02155257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92148673|NCT02155257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148674|NCT02155257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92148675|NCT02155257|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92148676|NCT02155257|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92148677|NCT02155257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148678|NCT02155257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148679|NCT02155257|Antimanic Agents|antimanic agents|mesh-ancestor
92148680|NCT02155257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92148681|NCT02155257|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92148682|NCT02155257|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92148683|NCT02155257|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92148685|NCT03243019|Temsirolimus|temsirolimus|mesh-list
92148686|NCT03243019|MTOR Inhibitors|mtor inhibitors|mesh-list
92148687|NCT03243019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148688|NCT03243019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148689|NCT03243019|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92148690|NCT03243019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148691|NCT03243019|Antifungal Agents|antifungal agents|mesh-ancestor
92148692|NCT03243019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148693|NCT03243019|Immunologic Factors|immunologic factors|mesh-ancestor
92148694|NCT03243019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148695|NCT03243019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92148696|NCT03243019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148697|NCT03243019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148698|NCT04382625|Hydroxychloroquine|hydroxychloroquine|mesh-list
92148702|NCT04382625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148703|NCT04382625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148704|NCT04382625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148705|NCT04382625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148706|NCT01673646|Pasireotide|pasireotide|mesh-list
92148707|NCT01673646|Hormones|hormones|mesh-ancestor
92148708|NCT01673646|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148709|NCT01673646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148710|NCT00862563|Topiramate|topiramate|mesh-list
92148711|NCT00862563|Zonisamide|zonisamide|mesh-list
92148712|NCT00862563|Levetiracetam|levetiracetam|mesh-list
92148713|NCT00862563|Anticonvulsants|anticonvulsants|mesh-ancestor
92148714|NCT00862563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92148715|NCT00862563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148716|NCT00862563|Nootropic Agents|nootropic agents|mesh-ancestor
92148717|NCT00862563|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92148718|NCT00862563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92148719|NCT00862563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148720|NCT00862563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92148721|NCT04278937|Azithromycin|azithromycin|mesh-list
92148722|NCT04278937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148723|NCT04278937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148724|NCT02647944|Liraglutide|liraglutide|mesh-list
92148725|NCT02647944|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92148726|NCT02647944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148727|NCT02647944|Incretins|incretins|mesh-ancestor
92148728|NCT02647944|Hormones|hormones|mesh-ancestor
91939590|NCT02273752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148729|NCT02647944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92148731|NCT04278547|Valganciclovir|valganciclovir|mesh-list
92148732|NCT04278547|Antiviral Agents|antiviral agents|mesh-ancestor
92148733|NCT04278547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148734|NCT00863109|Ribavirin|ribavirin|mesh-list
92148735|NCT00863109|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92148736|NCT00863109|Antimetabolites|antimetabolites|mesh-ancestor
92148737|NCT00863109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148738|NCT00863109|Antiviral Agents|antiviral agents|mesh-ancestor
92148739|NCT00863109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148740|NCT03238807|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92148741|NCT03238807|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92148742|NCT03238807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148743|NCT05246371|Dexmedetomidine|dexmedetomidine|mesh-list
92148745|NCT05246371|Desflurane|desflurane|mesh-list
92148746|NCT05246371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92148747|NCT05246371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148748|NCT05246371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148749|NCT05246371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92148750|NCT05246371|Analgesics|analgesics|mesh-ancestor
92148751|NCT05246371|Sensory System Agents|sensory system agents|mesh-ancestor
92148752|NCT05246371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148753|NCT05246371|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92148754|NCT05246371|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92148755|NCT05246371|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148756|NCT05246371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148757|NCT05246371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148758|NCT05246371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148759|NCT05246371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92148760|NCT05246371|Anesthetics, General|anesthetics, general|mesh-ancestor
92148761|NCT05246371|Anesthetics|anesthetics|mesh-ancestor
92148762|NCT05246371|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92148763|NCT00863265|Ezetimibe|ezetimibe|mesh-list
92148764|NCT00863265|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92148765|NCT00863265|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92148766|NCT00863265|Antimetabolites|antimetabolites|mesh-ancestor
92148767|NCT00863265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148768|NCT00863265|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92148769|NCT00831675|Vaccines|vaccines|mesh-list
92148770|NCT00831675|Immunologic Factors|immunologic factors|mesh-ancestor
92148771|NCT00831675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148772|NCT01397825|Rituximab|rituximab|mesh-list
92148774|NCT01397825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148775|NCT01397825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148776|NCT01397825|Immunologic Factors|immunologic factors|mesh-ancestor
92148777|NCT01397825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148778|NCT01397825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148779|NCT01397825|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92148783|NCT01397825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148784|NCT05373186|Insulin Lispro|insulin lispro|mesh-list
92148785|NCT05373186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92148786|NCT05373186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148787|NCT05353764|Ropivacaine|ropivacaine|mesh-list
92148788|NCT05353764|Anesthetics, Local|anesthetics, local|mesh-ancestor
92148789|NCT05353764|Anesthetics|anesthetics|mesh-ancestor
92148790|NCT05353764|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92148791|NCT05353764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148792|NCT05353764|Sensory System Agents|sensory system agents|mesh-ancestor
92148793|NCT05353764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148794|NCT00831987|Vaccines|vaccines|mesh-list
92148795|NCT00831987|Immunologic Factors|immunologic factors|mesh-ancestor
92148796|NCT00831987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148798|NCT05239884|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92148799|NCT05239884|Autonomic Agents|autonomic agents|mesh-ancestor
92148800|NCT05239884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148801|NCT05239884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148802|NCT05239884|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92148803|NCT05239884|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92148804|NCT05239884|Cholinergic Agents|cholinergic agents|mesh-ancestor
92148805|NCT05239884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148806|NCT05239884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148807|NCT03836352|Cyclophosphamide|cyclophosphamide|mesh-list
92148808|NCT03836352|Pembrolizumab|pembrolizumab|mesh-list
92148809|NCT03836352|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148810|NCT03836352|Immunologic Factors|immunologic factors|mesh-ancestor
92148811|NCT03836352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148812|NCT03836352|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92148813|NCT03836352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92148814|NCT03836352|Alkylating Agents|alkylating agents|mesh-ancestor
92148815|NCT03836352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148816|NCT03836352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148817|NCT03836352|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92148818|NCT03836352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148819|NCT03836352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92148820|NCT01397201|Fluticasone|fluticasone|mesh-list
92148821|NCT01397201|Xhance|xhance|mesh-list
92148822|NCT01397201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92148823|NCT01397201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92148824|NCT01397201|Autonomic Agents|autonomic agents|mesh-ancestor
92148825|NCT01397201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148826|NCT01397201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148827|NCT01397201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92148828|NCT01397201|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148829|NCT01397201|Dermatologic Agents|dermatologic agents|mesh-ancestor
92148830|NCT01397201|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92148831|NCT04845919|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92148832|NCT04845919|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92148833|NCT04845919|Dermatologic Agents|dermatologic agents|mesh-ancestor
92148834|NCT00834171|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92148835|NCT00834171|Tobramycin|tobramycin|mesh-list
92148836|NCT00834171|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148837|NCT00834171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148838|NCT00834171|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92148839|NCT02985437|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92148840|NCT02985437|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148841|NCT05205577|Iodine|iodine|mesh-list
92148842|NCT05205577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92148843|NCT05205577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148844|NCT05205577|Trace Elements|trace elements|mesh-ancestor
92148845|NCT05205577|Micronutrients|micronutrients|mesh-ancestor
92148846|NCT05205577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148847|NCT00835185|Leucovorin|leucovorin|mesh-list
92148848|NCT00835185|Folic Acid|folic acid|mesh-list
92148850|NCT00835185|Necitumumab|necitumumab|mesh-list
92148851|NCT00835185|Levoleucovorin|levoleucovorin|mesh-list
92148852|NCT00835185|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92148853|NCT00835185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148854|NCT00835185|Antidotes|antidotes|mesh-ancestor
92148855|NCT00835185|Protective Agents|protective agents|mesh-ancestor
92148856|NCT00835185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148857|NCT00835185|Vitamin B Complex|vitamin b complex|mesh-ancestor
92148858|NCT00835185|Vitamins|vitamins|mesh-ancestor
92148859|NCT00835185|Micronutrients|micronutrients|mesh-ancestor
92148860|NCT00835185|Hematinics|hematinics|mesh-ancestor
92148861|NCT00835185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148862|NCT00835185|Immunologic Factors|immunologic factors|mesh-ancestor
92148867|NCT04399525|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92148868|NCT04399525|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92148869|NCT04399525|Histamine Antagonists|histamine antagonists|mesh-ancestor
92148870|NCT04399525|Histamine Agents|histamine agents|mesh-ancestor
92148871|NCT04399525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148872|NCT04399525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148873|NCT04399525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148874|NCT04399525|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92148875|NCT04399525|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92148876|NCT04399525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92148877|NCT04399525|Antipruritics|antipruritics|mesh-ancestor
92148878|NCT04399525|Dermatologic Agents|dermatologic agents|mesh-ancestor
92148880|NCT00864123|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92148881|NCT00864123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148882|NCT00864123|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92148883|NCT00864123|Antitubercular Agents|antitubercular agents|mesh-ancestor
92148884|NCT00864123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148885|NCT00864123|Antimetabolites|antimetabolites|mesh-ancestor
92148886|NCT00864123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148887|NCT03858465|Phenylephrine|phenylephrine|mesh-list
92148888|NCT03858465|Oxymetazoline|oxymetazoline|mesh-list
92148889|NCT03858465|Ephedrine|ephedrine|mesh-list
92148890|NCT03858465|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92148891|NCT03858465|Mydriatics|mydriatics|mesh-ancestor
92148892|NCT03858465|Autonomic Agents|autonomic agents|mesh-ancestor
92148893|NCT03858465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148894|NCT03858465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148896|NCT03858465|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92148897|NCT03858465|Nasal Decongestants|nasal decongestants|mesh-ancestor
92148898|NCT03858465|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148899|NCT03858465|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92148900|NCT03858465|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92148901|NCT03858465|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148902|NCT03858465|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148903|NCT03858465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148904|NCT03858465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148905|NCT03858465|Protective Agents|protective agents|mesh-ancestor
92148906|NCT03858465|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92148907|NCT00867789|Trimethoprim|trimethoprim|mesh-list
92148908|NCT00867789|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92148909|NCT00867789|Sulfamethoxazole|sulfamethoxazole|mesh-list
92148910|NCT00867789|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92148911|NCT00867789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148912|NCT00867789|Antimalarials|antimalarials|mesh-ancestor
92148913|NCT00867789|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92148914|NCT00867789|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92148915|NCT00867789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92148916|NCT00867789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148917|NCT00867789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148918|NCT00867789|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92148919|NCT00867789|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92148920|NCT00867789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92148921|NCT00867789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148922|NCT01396421|Brexpiprazole|brexpiprazole|mesh-list
92148923|NCT01396421|Serotonin Agents|serotonin agents|mesh-ancestor
92148924|NCT01396421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148925|NCT01396421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148926|NCT01396421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148927|NCT01396421|Dopamine Agonists|dopamine agonists|mesh-ancestor
92148928|NCT01396421|Dopamine Agents|dopamine agents|mesh-ancestor
92148929|NCT04797013|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92148930|NCT04797013|Plasminogen|plasminogen|mesh-list
92148931|NCT04797013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92148932|NCT04797013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92148933|NCT04797013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148934|NCT00838695|Phenylephrine|phenylephrine|mesh-list
92148935|NCT00838695|Oxymetazoline|oxymetazoline|mesh-list
92148936|NCT00838695|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92148937|NCT00838695|Mydriatics|mydriatics|mesh-ancestor
92148938|NCT00838695|Autonomic Agents|autonomic agents|mesh-ancestor
92148939|NCT00838695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92148940|NCT00838695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148941|NCT00838695|Sympathomimetics|sympathomimetics|mesh-ancestor
92148942|NCT00838695|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92148944|NCT00838695|Respiratory System Agents|respiratory system agents|mesh-ancestor
92148945|NCT00838695|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92148946|NCT00838695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92148947|NCT00838695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92148948|NCT00838695|Adrenergic Agents|adrenergic agents|mesh-ancestor
92148949|NCT00838695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92148950|NCT00838695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148951|NCT00838695|Protective Agents|protective agents|mesh-ancestor
92148952|NCT04775173|Sirolimus|sirolimus|mesh-list
92148953|NCT04775173|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148954|NCT04775173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148955|NCT04775173|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92148956|NCT04775173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148957|NCT04775173|Antifungal Agents|antifungal agents|mesh-ancestor
92148958|NCT04775173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92148959|NCT04775173|Immunologic Factors|immunologic factors|mesh-ancestor
92148960|NCT04775173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92148961|NCT01396265|Rifampin|rifampin|mesh-list
92148962|NCT01396265|Afatinib|afatinib|mesh-list
92148963|NCT01396265|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92148964|NCT01396265|Antitubercular Agents|antitubercular agents|mesh-ancestor
92148965|NCT01396265|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92148966|NCT01396265|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92148967|NCT01396265|Leprostatic Agents|leprostatic agents|mesh-ancestor
92148968|NCT01396265|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92148969|NCT01396265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148970|NCT01396265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148971|NCT01396265|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92148972|NCT01396265|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92148973|NCT01396265|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92148974|NCT01396265|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92148975|NCT01396265|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92148976|NCT01396265|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92148977|NCT01396265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148978|NCT01396265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92148979|NCT04760431|Paclitaxel|paclitaxel|mesh-list
92148980|NCT04760431|Docetaxel|docetaxel|mesh-list
92148981|NCT04760431|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92148982|NCT04760431|Trastuzumab|trastuzumab|mesh-list
92148983|NCT04760431|Pertuzumab|pertuzumab|mesh-list
92148985|NCT04760431|Tucatinib|tucatinib|mesh-list
92148986|NCT04760431|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92148987|NCT04760431|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92148988|NCT04760431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92148989|NCT04760431|Tubulin Modulators|tubulin modulators|mesh-ancestor
92148990|NCT04760431|Antimitotic Agents|antimitotic agents|mesh-ancestor
92148991|NCT04760431|Mitosis Modulators|mitosis modulators|mesh-ancestor
92148992|NCT04760431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92148993|NCT04760431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92148994|NCT04760431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92148995|NCT04760431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92148996|NCT00839319|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92148997|NCT00839319|Testosterone|testosterone|mesh-list
92148998|NCT00839319|Acyline|acyline|mesh-list
92148999|NCT00839319|Androgens|androgens|mesh-ancestor
92149000|NCT00839319|Hormones|hormones|mesh-ancestor
92149001|NCT00839319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149002|NCT00839319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149003|NCT00839319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92149004|NCT00839319|Hormone Antagonists|hormone antagonists|mesh-ancestor
92149005|NCT00868959|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92149006|NCT00868959|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92149007|NCT00868959|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92149008|NCT00868959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149009|NCT00868959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149010|NCT00868959|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92149011|NCT00868959|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92149012|NCT00868959|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92149013|NCT00868959|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92149014|NCT00868959|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149015|NCT00868959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149016|NCT00868959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149017|NCT00868959|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92149018|NCT00868959|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92149020|NCT00868959|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92149021|NCT00868959|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92149022|NCT00868959|Dopamine Agents|dopamine agents|mesh-ancestor
92149024|NCT02647866|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149025|NCT02246127|Everolimus|everolimus|mesh-list
92149026|NCT02246127|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92149027|NCT02246127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92149028|NCT02246127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149029|NCT02246127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149030|NCT02246127|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149031|NCT02246127|Immunologic Factors|immunologic factors|mesh-ancestor
92149032|NCT02246127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149033|NCT02246127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149034|NCT04277923|SMOFlipid|smoflipid|mesh-list
92149035|NCT04277923|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92149036|NCT04277923|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92149037|NCT04277923|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92149038|NCT00870363|Efavirenz|efavirenz|mesh-list
92149039|NCT00870363|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92149040|NCT00870363|Raltegravir Potassium|raltegravir potassium|mesh-list
92149041|NCT00870363|Maraviroc|maraviroc|mesh-list
92149042|NCT00870363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92149043|NCT00870363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149044|NCT00870363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149045|NCT00870363|Antiviral Agents|antiviral agents|mesh-ancestor
92149046|NCT00870363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149047|NCT00870363|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92149048|NCT00870363|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92149049|NCT00870363|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92149050|NCT00870363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92149051|NCT00870363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92149052|NCT00870363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92149053|NCT00870363|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92149054|NCT00870363|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92149055|NCT00870363|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92149056|NCT00870363|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92149057|NCT00870363|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92149058|NCT00870363|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92149059|NCT00870363|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92149060|NCT03104634|Bromides|bromides|mesh-list
92149061|NCT03104634|Formoterol Fumarate|formoterol fumarate|mesh-list
92149063|NCT03104634|Autonomic Agents|autonomic agents|mesh-ancestor
92149064|NCT03104634|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149065|NCT03104634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149066|NCT03104634|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92149067|NCT03104634|Respiratory System Agents|respiratory system agents|mesh-ancestor
92149068|NCT03104634|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92149069|NCT03104634|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92149070|NCT03104634|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92149071|NCT03104634|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149072|NCT03104634|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149073|NCT03104634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149074|NCT03104634|Anticonvulsants|anticonvulsants|mesh-ancestor
92149075|NCT00871689|Aldesleukin|aldesleukin|mesh-list
92149076|NCT00871689|Cyclophosphamide|cyclophosphamide|mesh-list
92149077|NCT00871689|Fludarabine|fludarabine|mesh-list
92149078|NCT00871689|Fludarabine phosphate|fludarabine phosphate|mesh-list
92149079|NCT00871689|Interleukin-2|interleukin-2|mesh-list
92149080|NCT00871689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149081|NCT00871689|Immunologic Factors|immunologic factors|mesh-ancestor
92149082|NCT00871689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149083|NCT00871689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149084|NCT00871689|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92149085|NCT00871689|Alkylating Agents|alkylating agents|mesh-ancestor
92149086|NCT00871689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149087|NCT00871689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149088|NCT00871689|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92149089|NCT00871689|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92149090|NCT00871689|Antimetabolites|antimetabolites|mesh-ancestor
92149091|NCT00871689|Antiviral Agents|antiviral agents|mesh-ancestor
92149092|NCT00871689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149093|NCT00871689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149094|NCT00871689|Analgesics|analgesics|mesh-ancestor
92149095|NCT00871689|Sensory System Agents|sensory system agents|mesh-ancestor
92149096|NCT00871689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149098|NCT00871689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92149099|NCT02084797|Vasopressins|vasopressins|mesh-list
92149100|NCT02084797|Arginine Vasopressin|arginine vasopressin|mesh-list
92149101|NCT02084797|Tolvaptan|tolvaptan|mesh-list
92149102|NCT02084797|Hemostatics|hemostatics|mesh-ancestor
92149103|NCT02084797|Coagulants|coagulants|mesh-ancestor
92149104|NCT02084797|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92149105|NCT02084797|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92149106|NCT02084797|Natriuretic Agents|natriuretic agents|mesh-ancestor
92149107|NCT02084797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149108|NCT02084797|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92149109|NCT02084797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149110|NCT00873327|Tazobactam|tazobactam|mesh-list
92149111|NCT00873327|Piperacillin|piperacillin|mesh-list
92149112|NCT00873327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92149113|NCT00873327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92149114|NCT00873327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149115|NCT00873327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92149116|NCT00873327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149117|NCT00873327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149118|NCT04816890|Insulin Lispro|insulin lispro|mesh-list
92149119|NCT04816890|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92149120|NCT04816890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149121|NCT01392677|Dapagliflozin|dapagliflozin|mesh-list
92149122|NCT01392677|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92149123|NCT01392677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149124|NCT01392677|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92149125|NCT01392677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149126|NCT00841971|Fluconazole|fluconazole|mesh-list
92149127|NCT00841971|Anidulafungin|anidulafungin|mesh-list
92149128|NCT00841971|Antifungal Agents|antifungal agents|mesh-ancestor
92149129|NCT00841971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149130|NCT00841971|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92149131|NCT00841971|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92149132|NCT00841971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149133|NCT00841971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149134|NCT00841971|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92149135|NCT00841971|Hormone Antagonists|hormone antagonists|mesh-ancestor
92149136|NCT00841971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149137|NCT00841971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149138|NCT00841971|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92149139|NCT00841971|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92149141|NCT00842751|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92149142|NCT00842751|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92149143|NCT00842751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149144|NCT00842751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149145|NCT00842751|Hormone Antagonists|hormone antagonists|mesh-ancestor
92149146|NCT00842751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149147|NCT00842751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149148|NCT00842751|Urological Agents|urological agents|mesh-ancestor
92149149|NCT03104010|Hormones|hormones|mesh-list
92149150|NCT03104010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149151|NCT03104010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149152|NCT03907969|AZD7648|azd7648|mesh-list
92149153|NCT03907969|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92149154|NCT03907969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149155|NCT03907969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149156|NCT04399213|Histamine|histamine|mesh-list
92149157|NCT04399213|Histamine phosphate|histamine phosphate|mesh-list
92149158|NCT04399213|Histamine Agonists|histamine agonists|mesh-ancestor
92149159|NCT04399213|Histamine Agents|histamine agents|mesh-ancestor
92149160|NCT04399213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149161|NCT04399213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149162|NCT04399213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149163|NCT02154243|Midodrine|midodrine|mesh-list
92149164|NCT02154243|Sympathomimetics|sympathomimetics|mesh-ancestor
92149165|NCT02154243|Autonomic Agents|autonomic agents|mesh-ancestor
92149166|NCT02154243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149167|NCT02154243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149168|NCT02154243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92149169|NCT02154243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92149170|NCT02154243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92149173|NCT02154243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149174|NCT02154243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149175|NCT03995004|Dexamethasone|dexamethasone|mesh-list
92149176|NCT03995004|Melatonin|melatonin|mesh-list
92149177|NCT03995004|Sodium sulfate|sodium sulfate|mesh-list
92149178|NCT03995004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149179|NCT03995004|Antiemetics|antiemetics|mesh-ancestor
92149180|NCT03995004|Autonomic Agents|autonomic agents|mesh-ancestor
92149181|NCT03995004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149182|NCT03995004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149183|NCT03995004|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92149184|NCT03995004|Glucocorticoids|glucocorticoids|mesh-ancestor
92149185|NCT03995004|Hormones|hormones|mesh-ancestor
92149186|NCT03995004|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149187|NCT03995004|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92149188|NCT03995004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149189|NCT03995004|Antioxidants|antioxidants|mesh-ancestor
92149190|NCT03995004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149191|NCT03995004|Protective Agents|protective agents|mesh-ancestor
92149192|NCT03995004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149193|NCT03995004|Cathartics|cathartics|mesh-ancestor
92149194|NCT03216525|Alvimopan|alvimopan|mesh-list
92149195|NCT03216525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92149196|NCT03249181|Dolutegravir|dolutegravir|mesh-list
92149197|NCT03249181|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92149198|NCT03249181|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92149199|NCT03249181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149200|NCT03249181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149201|NCT03249181|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92149202|NCT03249181|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92149203|NCT03249181|Antiviral Agents|antiviral agents|mesh-ancestor
92149204|NCT03249181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149205|NCT03216447|Tacrolimus|tacrolimus|mesh-list
92149206|NCT03216447|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149207|NCT03216447|Immunologic Factors|immunologic factors|mesh-ancestor
92149208|NCT03216447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149209|NCT03216447|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92149210|NCT03216447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149211|NCT03216447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149212|NCT04669938|Immunologic Factors|immunologic factors|mesh-list
92149213|NCT04669938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149214|NCT03957876|Cytarabine|cytarabine|mesh-list
92149215|NCT03957876|Daunorubicin|daunorubicin|mesh-list
92149216|NCT03957876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92149217|NCT03957876|Antimetabolites|antimetabolites|mesh-ancestor
92149218|NCT03957876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149219|NCT03957876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149220|NCT03957876|Antiviral Agents|antiviral agents|mesh-ancestor
92149221|NCT03957876|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149222|NCT03957876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149223|NCT03957876|Immunologic Factors|immunologic factors|mesh-ancestor
92149224|NCT03957876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149225|NCT03957876|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92149226|NCT03957876|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92149227|NCT03957876|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92149228|NCT03957876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149229|NCT03837925|Atorvastatin|atorvastatin|mesh-list
92149230|NCT03837925|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92149231|NCT03837925|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92149232|NCT03837925|Antimetabolites|antimetabolites|mesh-ancestor
92149233|NCT03837925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149234|NCT03837925|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92149235|NCT03837925|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92149236|NCT03837925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149237|NCT04398589|Dexmedetomidine|dexmedetomidine|mesh-list
92149238|NCT04398589|Ropivacaine|ropivacaine|mesh-list
92149239|NCT04398589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92149240|NCT04398589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149241|NCT04398589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149242|NCT04398589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149244|NCT04398589|Sensory System Agents|sensory system agents|mesh-ancestor
92149245|NCT04398589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149246|NCT04398589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92149247|NCT04398589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92149248|NCT04398589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92149250|NCT04398589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149251|NCT04398589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149252|NCT04398589|Anesthetics, Local|anesthetics, local|mesh-ancestor
92149253|NCT04398589|Anesthetics|anesthetics|mesh-ancestor
92149254|NCT00874887|Moxifloxacin|moxifloxacin|mesh-list
92149255|NCT00874887|Gatifloxacin|gatifloxacin|mesh-list
92149256|NCT00874887|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92149257|NCT00874887|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92149258|NCT00874887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92149259|NCT00874887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149260|NCT00874887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92149261|NCT00874887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92149262|NCT00874887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149263|NCT00874887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149264|NCT00874887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149265|NCT03882060|Epoetin Alfa|epoetin alfa|mesh-list
92149266|NCT03882060|Hematinics|hematinics|mesh-ancestor
92149267|NCT01376505|Vaccines|vaccines|mesh-list
92149268|NCT01376505|Immunologic Factors|immunologic factors|mesh-ancestor
92149269|NCT01376505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149270|NCT00875277|Betamethasone|betamethasone|mesh-list
92149271|NCT00875277|Betamethasone Valerate|betamethasone valerate|mesh-list
92149272|NCT00875277|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92149273|NCT00875277|Betamethasone benzoate|betamethasone benzoate|mesh-list
92149274|NCT00875277|Calcipotriene|calcipotriene|mesh-list
92149275|NCT00875277|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92149276|NCT00875277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149277|NCT00875277|Glucocorticoids|glucocorticoids|mesh-ancestor
92149278|NCT00875277|Hormones|hormones|mesh-ancestor
92149279|NCT00875277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149280|NCT00875277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149281|NCT00875277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92149282|NCT00875277|Respiratory System Agents|respiratory system agents|mesh-ancestor
92149283|NCT00875277|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149284|NCT04634539|Paclitaxel|paclitaxel|mesh-list
92149285|NCT04634539|Gemcitabine|gemcitabine|mesh-list
92149286|NCT04634539|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92149287|NCT04634539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149288|NCT04634539|Tubulin Modulators|tubulin modulators|mesh-ancestor
92149289|NCT04634539|Antimitotic Agents|antimitotic agents|mesh-ancestor
92149290|NCT04634539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92149291|NCT04634539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149292|NCT04634539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92149293|NCT04634539|Antimetabolites|antimetabolites|mesh-ancestor
92149294|NCT03750786|Leucovorin|leucovorin|mesh-list
92149295|NCT03750786|Antidotes|antidotes|mesh-ancestor
92149296|NCT03750786|Protective Agents|protective agents|mesh-ancestor
92149297|NCT03750786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149298|NCT03750786|Vitamin B Complex|vitamin b complex|mesh-ancestor
92149299|NCT03750786|Vitamins|vitamins|mesh-ancestor
92149300|NCT03750786|Micronutrients|micronutrients|mesh-ancestor
92149301|NCT04457245|Fluorides|fluorides|mesh-list
92149302|NCT04457245|Cariostatic Agents|cariostatic agents|mesh-ancestor
92149303|NCT04457245|Protective Agents|protective agents|mesh-ancestor
92149304|NCT04457245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149305|NCT01395017|Dasatinib|dasatinib|mesh-list
92149306|NCT01395017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149307|NCT01395017|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92149308|NCT01395017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149309|NCT01395017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149310|NCT03299088|Pembrolizumab|pembrolizumab|mesh-list
92149311|NCT03299088|Trametinib|trametinib|mesh-list
92149312|NCT03299088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149313|NCT03299088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149314|NCT03299088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92149315|NCT03299088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149316|NCT03299088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92149317|NCT03299088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149318|NCT03235986|Poractant alfa|poractant alfa|mesh-list
92149319|NCT03235986|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92149320|NCT03235986|Respiratory System Agents|respiratory system agents|mesh-ancestor
92149321|NCT03657342|Cyclosporine|cyclosporine|mesh-list
92149322|NCT03657342|Cyclosporins|cyclosporins|mesh-list
92149323|NCT03657342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149324|NCT03657342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149325|NCT03657342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149326|NCT03657342|Immunologic Factors|immunologic factors|mesh-ancestor
92149327|NCT03657342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149328|NCT03657342|Antifungal Agents|antifungal agents|mesh-ancestor
92149329|NCT03657342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149330|NCT03657342|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149331|NCT03657342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149332|NCT03657342|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92149333|NCT03600090|Paclitaxel|paclitaxel|mesh-list
92149334|NCT03600090|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92149335|NCT03600090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149336|NCT03600090|Tubulin Modulators|tubulin modulators|mesh-ancestor
92149337|NCT03600090|Antimitotic Agents|antimitotic agents|mesh-ancestor
92149338|NCT03600090|Mitosis Modulators|mitosis modulators|mesh-ancestor
92149339|NCT03600090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149340|NCT02912988|Letrozole|letrozole|mesh-list
92149341|NCT02912988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149342|NCT02912988|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92149343|NCT02912988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92149344|NCT02912988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149345|NCT02912988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149346|NCT02912988|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92149347|NCT02912988|Hormone Antagonists|hormone antagonists|mesh-ancestor
92149348|NCT02912988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149349|NCT02912988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149350|NCT03103074|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92149351|NCT03103074|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92149352|NCT03103074|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92149353|NCT03103074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92149354|NCT03103074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149355|NCT03103074|Cholinergic Agents|cholinergic agents|mesh-ancestor
92149356|NCT03103074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149357|NCT03103074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149358|NCT00876915|Dalteparin|dalteparin|mesh-list
92149359|NCT00876915|Tinzaparin|tinzaparin|mesh-list
92149360|NCT00876915|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92149362|NCT00876915|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92149363|NCT00876915|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92149364|NCT00876915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149365|NCT02854488|Ipilimumab|ipilimumab|mesh-list
92149366|NCT02854488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149367|NCT02854488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149368|NCT02854488|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92149369|NCT02854488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149370|NCT02804022|Morphine|morphine|mesh-list
92149371|NCT02804022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92149372|NCT02804022|Narcotics|narcotics|mesh-ancestor
92149373|NCT02804022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149374|NCT02804022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149375|NCT02804022|Analgesics|analgesics|mesh-ancestor
92149376|NCT02804022|Sensory System Agents|sensory system agents|mesh-ancestor
92149377|NCT02804022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149378|NCT00896181|Carboplatin|carboplatin|mesh-list
92149379|NCT00896181|Docetaxel|docetaxel|mesh-list
92149380|NCT00896181|Fluorouracil|fluorouracil|mesh-list
92149381|NCT00896181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149382|NCT00896181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92149383|NCT00896181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92149384|NCT00896181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92149385|NCT00896181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149386|NCT00896181|Antimetabolites|antimetabolites|mesh-ancestor
92149387|NCT00896181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92149388|NCT00896181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149389|NCT00896181|Immunologic Factors|immunologic factors|mesh-ancestor
92149390|NCT00896181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149391|NCT02647320|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92149392|NCT02647320|Firuglipel|firuglipel|mesh-list
92149393|NCT02647320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92149394|NCT02647320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149395|NCT02647320|Incretins|incretins|mesh-ancestor
92149396|NCT02647320|Hormones|hormones|mesh-ancestor
92149397|NCT02647320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149398|NCT02647320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92149399|NCT02647320|Protease Inhibitors|protease inhibitors|mesh-ancestor
92149400|NCT02647320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149401|NCT02647320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149404|NCT03457896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149405|NCT03457896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149406|NCT04380597|Betamethasone|betamethasone|mesh-list
92149407|NCT04380597|Betamethasone Valerate|betamethasone valerate|mesh-list
92149408|NCT04380597|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92149409|NCT04380597|Betamethasone benzoate|betamethasone benzoate|mesh-list
92149410|NCT04380597|Calcipotriene|calcipotriene|mesh-list
92149411|NCT04380597|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92149412|NCT04380597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149413|NCT04380597|Glucocorticoids|glucocorticoids|mesh-ancestor
92149414|NCT04380597|Hormones|hormones|mesh-ancestor
92149415|NCT04380597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149416|NCT04380597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149417|NCT04380597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92149418|NCT04380597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92149419|NCT04380597|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149420|NCT03214731|Artesunate|artesunate|mesh-list
92149421|NCT03214731|Antimalarials|antimalarials|mesh-ancestor
92149422|NCT03214731|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92149423|NCT03214731|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92149424|NCT03214731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149425|NCT03214731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149426|NCT03214731|Antiviral Agents|antiviral agents|mesh-ancestor
92149427|NCT03214731|Schistosomicides|schistosomicides|mesh-ancestor
92149428|NCT03214731|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92149429|NCT03214731|Anthelmintics|anthelmintics|mesh-ancestor
92149430|NCT04424862|Cyclosporine|cyclosporine|mesh-list
92149432|NCT04424862|Prednisone|prednisone|mesh-list
92149433|NCT04424862|Cyclosporins|cyclosporins|mesh-list
92149434|NCT04424862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149435|NCT04424862|Glucocorticoids|glucocorticoids|mesh-ancestor
92149436|NCT04424862|Hormones|hormones|mesh-ancestor
92149437|NCT04424862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149438|NCT04424862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149439|NCT04424862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92149440|NCT04424862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149441|NCT04424862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149442|NCT04424862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149443|NCT04424862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149444|NCT04424862|Immunologic Factors|immunologic factors|mesh-ancestor
92149445|NCT04424862|Antifungal Agents|antifungal agents|mesh-ancestor
92149446|NCT04424862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149447|NCT04424862|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149448|NCT04424862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149449|NCT04424862|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92149450|NCT04424862|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92149451|NCT04424862|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92149452|NCT04424862|Antitubercular Agents|antitubercular agents|mesh-ancestor
92149453|NCT04424862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92149454|NCT00882687|Lifitegrast|lifitegrast|mesh-list
92149455|NCT00882687|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92149456|NCT00882687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92149457|NCT04313166|Copper|copper|mesh-list
92149458|NCT04313166|Trace Elements|trace elements|mesh-ancestor
92149459|NCT04313166|Micronutrients|micronutrients|mesh-ancestor
92149460|NCT04313166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149461|NCT00883233|Adapalene|adapalene|mesh-list
92149462|NCT00883233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92149463|NCT00883233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149464|NCT00883233|Analgesics|analgesics|mesh-ancestor
92149465|NCT00883233|Sensory System Agents|sensory system agents|mesh-ancestor
92149466|NCT00883233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149467|NCT00883233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149468|NCT00883233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149469|NCT00883233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149470|NCT00883233|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149471|NCT01394939|Irinotecan|irinotecan|mesh-list
92149472|NCT01394939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92149473|NCT01394939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92149474|NCT01394939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149475|NCT01394939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149476|NCT01394939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149477|NCT01394627|Eplerenone|eplerenone|mesh-list
92149478|NCT01394627|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92149479|NCT01394627|Hormone Antagonists|hormone antagonists|mesh-ancestor
92149480|NCT01394627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149481|NCT01394627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149482|NCT01394627|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92149483|NCT01394627|Diuretics|diuretics|mesh-ancestor
92149484|NCT01394627|Natriuretic Agents|natriuretic agents|mesh-ancestor
92149485|NCT01394627|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92149486|NCT02288377|Lanreotide|lanreotide|mesh-list
92149487|NCT02288377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149488|NCT04133532|Metoprolol|metoprolol|mesh-list
92149489|NCT04133532|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92149490|NCT04133532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92149491|NCT04133532|Sympatholytics|sympatholytics|mesh-ancestor
92149492|NCT04133532|Autonomic Agents|autonomic agents|mesh-ancestor
92149493|NCT04133532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149494|NCT04133532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149495|NCT04133532|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92149496|NCT04133532|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92149497|NCT04133532|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92149498|NCT04133532|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149499|NCT04133532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149500|NCT04133532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149501|NCT01391663|Alogliptin|alogliptin|mesh-list
92149502|NCT01391663|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92149503|NCT01391663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149504|NCT01391663|Incretins|incretins|mesh-ancestor
92149505|NCT01391663|Hormones|hormones|mesh-ancestor
92149506|NCT01391663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149507|NCT01391663|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92149508|NCT01391663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92149509|NCT01391663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149510|NCT01391663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149511|NCT03176173|Immunomodulating Agents|immunomodulating agents|mesh-list
92149512|NCT03176173|Immunologic Factors|immunologic factors|mesh-ancestor
92149513|NCT03176173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149514|NCT02220985|Mycophenolic Acid|mycophenolic acid|mesh-list
92149515|NCT02220985|Cyclophosphamide|cyclophosphamide|mesh-list
92149516|NCT02220985|Thiotepa|thiotepa|mesh-list
92149517|NCT02220985|Methotrexate|methotrexate|mesh-list
92149518|NCT02220985|Fludarabine|fludarabine|mesh-list
92149519|NCT02220985|Fludarabine phosphate|fludarabine phosphate|mesh-list
92149520|NCT02220985|Tacrolimus|tacrolimus|mesh-list
92149521|NCT02220985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149522|NCT02220985|Immunologic Factors|immunologic factors|mesh-ancestor
92149523|NCT02220985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149524|NCT02220985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149525|NCT02220985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92149526|NCT02220985|Alkylating Agents|alkylating agents|mesh-ancestor
92149527|NCT02220985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149528|NCT02220985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149529|NCT02220985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92149530|NCT02220985|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92149531|NCT02220985|Abortifacient Agents|abortifacient agents|mesh-ancestor
92149532|NCT02220985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92149533|NCT02220985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92149534|NCT02220985|Antimetabolites|antimetabolites|mesh-ancestor
92149535|NCT02220985|Dermatologic Agents|dermatologic agents|mesh-ancestor
92149536|NCT02220985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149537|NCT02220985|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92149538|NCT02220985|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92149539|NCT02220985|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92149540|NCT02220985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92149541|NCT02220985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92149542|NCT02220985|Antitubercular Agents|antitubercular agents|mesh-ancestor
92149543|NCT02220985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92149544|NCT02220985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149545|NCT05072106|Bosentan|bosentan|mesh-list
92149546|NCT05072106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92149547|NCT05072106|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92149548|NCT05072106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149549|NCT03838497|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92149550|NCT03838497|Immunologic Factors|immunologic factors|mesh-ancestor
92149551|NCT03838497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149552|NCT03358875|Docetaxel|docetaxel|mesh-list
92149553|NCT03358875|Tislelizumab|tislelizumab|mesh-list
92149554|NCT03358875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149555|NCT03358875|Tubulin Modulators|tubulin modulators|mesh-ancestor
92149558|NCT03358875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149559|NCT03358875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149560|NCT05071482|Imatinib Mesylate|imatinib mesylate|mesh-list
92149561|NCT05071482|Flumatinib|flumatinib|mesh-list
92149562|NCT05071482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149563|NCT05071482|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92149564|NCT05071482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149565|NCT05071482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149566|NCT03213249|Gentamicins|gentamicins|mesh-list
92149567|NCT03213249|Cefazolin|cefazolin|mesh-list
92149568|NCT03213249|Bacitracin|bacitracin|mesh-list
92149569|NCT03213249|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92149570|NCT03213249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149571|NCT03213249|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92149573|NCT03213249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149574|NCT03213249|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92149575|NCT03317067|Dexmedetomidine|dexmedetomidine|mesh-list
92149576|NCT03317067|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92149577|NCT03317067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149578|NCT03317067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149579|NCT03317067|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149580|NCT03317067|Analgesics|analgesics|mesh-ancestor
92149581|NCT03317067|Sensory System Agents|sensory system agents|mesh-ancestor
92149582|NCT03317067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149583|NCT03317067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92149584|NCT03317067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92149585|NCT03317067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92149586|NCT03317067|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149587|NCT03317067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149588|NCT03317067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149589|NCT04440007|Abivertinib|abivertinib|mesh-list
92149590|NCT04440007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149591|NCT04440007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149592|NCT04440007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92149593|NCT00888459|Nicotine|nicotine|mesh-list
92149594|NCT00888459|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92149595|NCT00888459|Autonomic Agents|autonomic agents|mesh-ancestor
92149596|NCT00888459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149597|NCT00888459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149598|NCT00888459|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92149599|NCT00888459|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92149600|NCT00888459|Cholinergic Agents|cholinergic agents|mesh-ancestor
92149601|NCT00888459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149602|NCT00888459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149603|NCT05312541|Bupivacaine|bupivacaine|mesh-list
92149604|NCT05312541|Anesthetics, Local|anesthetics, local|mesh-list
92149605|NCT05312541|Anesthetics|anesthetics|mesh-list
92149606|NCT05312541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149607|NCT05312541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149608|NCT05312541|Sensory System Agents|sensory system agents|mesh-ancestor
92149609|NCT05312541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149610|NCT04398823|Polidocanol|polidocanol|mesh-list
92149611|NCT04398823|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92149612|NCT04398823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92149613|NCT04410913|Psilocybin|psilocybin|mesh-list
92149614|NCT04410913|Hallucinogens|hallucinogens|mesh-ancestor
92149615|NCT04410913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149616|NCT04410913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92149617|NCT02013336|Cyclophosphamide|cyclophosphamide|mesh-list
92149618|NCT02013336|Irinotecan|irinotecan|mesh-list
92149619|NCT02013336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149620|NCT02013336|Immunologic Factors|immunologic factors|mesh-ancestor
92149621|NCT02013336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149622|NCT02013336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149623|NCT02013336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92149624|NCT02013336|Alkylating Agents|alkylating agents|mesh-ancestor
92149625|NCT02013336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149626|NCT02013336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149627|NCT02013336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92149628|NCT02013336|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92149629|NCT02013336|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92149630|NCT02013336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149631|NCT04397653|Ezetimibe|ezetimibe|mesh-list
92149632|NCT04397653|Evolocumab|evolocumab|mesh-list
92149633|NCT04397653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92149636|NCT04397653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149637|NCT04397653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92149638|NCT04397653|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92149639|NCT04397653|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92149640|NCT04397653|Protease Inhibitors|protease inhibitors|mesh-ancestor
92149641|NCT04397653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149643|NCT03212781|Dextrans|dextrans|mesh-list
92149644|NCT03212781|Iron-Dextran Complex|iron-dextran complex|mesh-list
92149645|NCT03212781|Anticoagulants|anticoagulants|mesh-ancestor
92149646|NCT03212781|Plasma Substitutes|plasma substitutes|mesh-ancestor
92149647|NCT03212781|Blood Substitutes|blood substitutes|mesh-ancestor
92149649|NCT03212781|Micronutrients|micronutrients|mesh-ancestor
92149650|NCT03212781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149651|NCT03212781|Hematinics|hematinics|mesh-ancestor
92149652|NCT03212937|Carboplatin|carboplatin|mesh-list
92149653|NCT03212937|Etoposide|etoposide|mesh-list
92149654|NCT03212937|Ifosfamide|ifosfamide|mesh-list
92149655|NCT03212937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149656|NCT03212937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92149657|NCT03212937|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92149658|NCT03212937|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92149659|NCT03212937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149660|NCT03212937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149661|NCT03212937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92149662|NCT03212937|Alkylating Agents|alkylating agents|mesh-ancestor
92149663|NCT04397497|Mavrilimumab|mavrilimumab|mesh-list
92149664|NCT04397497|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149665|NCT04412538|Vaccines|vaccines|mesh-list
92149666|NCT04412538|Immunologic Factors|immunologic factors|mesh-ancestor
92149667|NCT04412538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149668|NCT04397341|Docetaxel|docetaxel|mesh-list
92149669|NCT04397341|Fluorouracil|fluorouracil|mesh-list
92149670|NCT04397341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149671|NCT04397341|Tubulin Modulators|tubulin modulators|mesh-ancestor
92149672|NCT04397341|Antimitotic Agents|antimitotic agents|mesh-ancestor
92149673|NCT04397341|Mitosis Modulators|mitosis modulators|mesh-ancestor
92149674|NCT04397341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149675|NCT04397341|Antimetabolites|antimetabolites|mesh-ancestor
92149676|NCT04397341|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92149677|NCT04397341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149678|NCT04397341|Immunologic Factors|immunologic factors|mesh-ancestor
92149679|NCT04397341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149680|NCT03940326|Levetiracetam|levetiracetam|mesh-list
92149681|NCT03940326|Valproic Acid|valproic acid|mesh-list
92149682|NCT03940326|Anticonvulsants|anticonvulsants|mesh-ancestor
92149683|NCT03940326|Nootropic Agents|nootropic agents|mesh-ancestor
92149684|NCT03940326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149685|NCT03940326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149686|NCT03940326|GABA Agents|gaba agents|mesh-ancestor
92149687|NCT03940326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149688|NCT03940326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149689|NCT03940326|Antimanic Agents|antimanic agents|mesh-ancestor
92149690|NCT03940326|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92149691|NCT03940326|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149692|NCT03940326|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92149693|NCT04347889|Hydroxychloroquine|hydroxychloroquine|mesh-list
92149694|NCT04347889|Antimalarials|antimalarials|mesh-ancestor
92149695|NCT04347889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92149696|NCT04347889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92149697|NCT04347889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149698|NCT04347889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149699|NCT04347889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149700|NCT04347889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149701|NCT01473524|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92149702|NCT01473524|Cathartics|cathartics|mesh-ancestor
92149703|NCT01473524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92149704|NCT01390649|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92149705|NCT01390649|Immunologic Factors|immunologic factors|mesh-ancestor
92149706|NCT01390649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149707|NCT03696355|GDC-0084|gdc-0084|mesh-list
92149708|NCT03696355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149709|NCT03696355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149710|NCT03882996|Atorvastatin|atorvastatin|mesh-list
92149711|NCT03882996|Ezetimibe|ezetimibe|mesh-list
92149712|NCT03882996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92149713|NCT03882996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92149714|NCT03882996|Antimetabolites|antimetabolites|mesh-ancestor
92149715|NCT03882996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149716|NCT03882996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92149717|NCT03882996|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92149718|NCT03882996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149719|NCT04383691|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92149720|NCT04383691|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92149721|NCT04383691|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92149722|NCT04383691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149723|NCT04383691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149724|NCT04383691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92149725|NCT04383691|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92149726|NCT04383691|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92149727|NCT04383691|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92149728|NCT04383691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149729|NCT04383691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149730|NCT04383691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149731|NCT04383691|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92149732|NCT04383691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92149733|NCT04383691|Serotonin Agents|serotonin agents|mesh-ancestor
92149734|NCT04383691|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92149735|NCT04383691|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92149736|NCT04383691|Dopamine Agents|dopamine agents|mesh-ancestor
92149737|NCT05070468|Dexamethasone|dexamethasone|mesh-list
92149738|NCT05070468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149739|NCT05070468|Antiemetics|antiemetics|mesh-ancestor
92149740|NCT05070468|Autonomic Agents|autonomic agents|mesh-ancestor
92149741|NCT05070468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149742|NCT05070468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149743|NCT05070468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92149744|NCT05070468|Glucocorticoids|glucocorticoids|mesh-ancestor
92149746|NCT05070468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92149747|NCT05070468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92149748|NCT05070468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149749|NCT01390181|Losartan|losartan|mesh-list
92149750|NCT01390181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92149751|NCT01390181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92149752|NCT01390181|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92149753|NCT01390181|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92149754|NCT01390181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149755|NCT02641080|Aspirin|aspirin|mesh-list
92149756|NCT02641080|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92149757|NCT02641080|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149758|NCT02641080|Analgesics|analgesics|mesh-ancestor
92149759|NCT02641080|Sensory System Agents|sensory system agents|mesh-ancestor
92149760|NCT02641080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149761|NCT02641080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149762|NCT02641080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92149763|NCT02641080|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92149764|NCT02641080|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92149765|NCT02641080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92149766|NCT02641080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149767|NCT02641080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92149768|NCT02641080|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92149769|NCT02641080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149770|NCT02641080|Antipyretics|antipyretics|mesh-ancestor
92149771|NCT03101280|Atezolizumab|atezolizumab|mesh-list
92149772|NCT03101280|Rucaparib|rucaparib|mesh-list
92149773|NCT03101280|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92149774|NCT03101280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149775|NCT03101280|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149776|NCT03101280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149777|NCT03101280|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92149778|NCT03101280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149779|NCT04015739|Bevacizumab|bevacizumab|mesh-list
92149780|NCT04015739|Durvalumab|durvalumab|mesh-list
92149781|NCT04015739|Olaparib|olaparib|mesh-list
92149782|NCT04015739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149783|NCT04015739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149784|NCT04015739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92149785|NCT04015739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92149786|NCT04015739|Growth Substances|growth substances|mesh-ancestor
92149787|NCT04015739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149788|NCT04015739|Growth Inhibitors|growth inhibitors|mesh-ancestor
92149863|NCT01389323|Interferon-alpha|interferon-alpha|mesh-list
92149789|NCT04015739|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92149790|NCT04015739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149791|NCT04015739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149792|NCT03867318|Atorvastatin|atorvastatin|mesh-list
92149793|NCT03867318|Ezetimibe|ezetimibe|mesh-list
92149794|NCT03867318|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92149795|NCT03867318|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92149796|NCT03867318|Antimetabolites|antimetabolites|mesh-ancestor
92149797|NCT03867318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149798|NCT03867318|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92149799|NCT03867318|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92149800|NCT03867318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149801|NCT01876771|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92149802|NCT01876771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149803|NCT01876771|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92149804|NCT05360615|Empagliflozin|empagliflozin|mesh-list
92149805|NCT05360615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92149806|NCT05360615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149807|NCT05360615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92149808|NCT05360615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149809|NCT04381377|Bromides|bromides|mesh-list
92149810|NCT04381377|Anticonvulsants|anticonvulsants|mesh-ancestor
92149812|NCT01457846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92149813|NCT01457846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149814|NCT01457846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92149815|NCT01457846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92149816|NCT01457846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92149817|NCT01457846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149818|NCT04032119|Epinephrine|epinephrine|mesh-list
92149819|NCT04032119|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92149820|NCT04032119|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92149821|NCT04032119|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149822|NCT04032119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149823|NCT04032119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149824|NCT04032119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149825|NCT04032119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92149826|NCT04032119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92149827|NCT04032119|Autonomic Agents|autonomic agents|mesh-ancestor
92149828|NCT04032119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149829|NCT04032119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92149830|NCT04032119|Respiratory System Agents|respiratory system agents|mesh-ancestor
92149831|NCT04032119|Mydriatics|mydriatics|mesh-ancestor
92149832|NCT04032119|Sympathomimetics|sympathomimetics|mesh-ancestor
92149833|NCT04032119|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92149834|NCT03211455|Lidocaine|lidocaine|mesh-list
92149835|NCT03211455|Anesthetics, Local|anesthetics, local|mesh-ancestor
92149836|NCT03211455|Anesthetics|anesthetics|mesh-ancestor
92149837|NCT03211455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149838|NCT03211455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149839|NCT03211455|Sensory System Agents|sensory system agents|mesh-ancestor
92149840|NCT03211455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149841|NCT03211455|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92149842|NCT03211455|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92149843|NCT03211455|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92149844|NCT03211455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92149845|NCT03211455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149846|NCT04375033|Buprenorphine|buprenorphine|mesh-list
92149847|NCT04375033|Naloxone|naloxone|mesh-list
92149848|NCT04375033|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92149849|NCT04375033|Narcotics|narcotics|mesh-ancestor
92149850|NCT04375033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149851|NCT04375033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149852|NCT04375033|Analgesics|analgesics|mesh-ancestor
92149853|NCT04375033|Sensory System Agents|sensory system agents|mesh-ancestor
92149854|NCT04375033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149855|NCT04375033|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92149856|NCT03172819|Pembrolizumab|pembrolizumab|mesh-list
92149857|NCT03172819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149858|NCT03172819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149859|NCT03172819|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92149860|NCT03172819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149861|NCT01389323|Interferons|interferons|mesh-list
92149862|NCT01389323|Ribavirin|ribavirin|mesh-list
92149866|NCT01389323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149867|NCT01389323|Antiviral Agents|antiviral agents|mesh-ancestor
92149868|NCT01389323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149869|NCT01389323|Antimetabolites|antimetabolites|mesh-ancestor
92149870|NCT01389323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149871|NCT01389323|Immunologic Factors|immunologic factors|mesh-ancestor
92149872|NCT01389323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149874|NCT05310591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92149875|NCT05310591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149876|NCT05310591|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92149877|NCT05310591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149878|NCT05314569|Fentanyl|fentanyl|mesh-list
92149879|NCT05314569|Midazolam|midazolam|mesh-list
92149880|NCT05314569|Dexmedetomidine|dexmedetomidine|mesh-list
92149881|NCT05314569|Ketamine|ketamine|mesh-list
92149882|NCT05314569|Isoflurane|isoflurane|mesh-list
92149883|NCT05314569|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92149884|NCT05314569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149885|NCT05314569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149886|NCT05314569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149887|NCT05314569|Analgesics|analgesics|mesh-ancestor
92149888|NCT05314569|Sensory System Agents|sensory system agents|mesh-ancestor
92149889|NCT05314569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149890|NCT05314569|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92149891|NCT05314569|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92149892|NCT05314569|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92149893|NCT05314569|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149894|NCT05314569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92149895|NCT05314569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149896|NCT05314569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92149897|NCT05314569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92149898|NCT05314569|Anesthetics, General|anesthetics, general|mesh-ancestor
92149899|NCT05314569|Anesthetics|anesthetics|mesh-ancestor
92149900|NCT05314569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92149901|NCT05314569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92149902|NCT05314569|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92149903|NCT05314569|Narcotics|narcotics|mesh-ancestor
92149904|NCT05314569|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92149905|NCT05314569|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92149906|NCT05314569|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92149907|NCT05314569|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92149908|NCT05314569|GABA Modulators|gaba modulators|mesh-ancestor
92149909|NCT05314569|GABA Agents|gaba agents|mesh-ancestor
92149910|NCT05314569|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92149911|NCT01494818|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92149912|NCT01494818|Contact Lens Solutions|contact lens solutions|mesh-list
92149913|NCT01494818|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92149914|NCT01494818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92149915|NCT01494818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149916|NCT01494818|Disinfectants|disinfectants|mesh-ancestor
92149917|NCT03167905|Fentanyl|fentanyl|mesh-list
92149918|NCT03167905|Meperidine|meperidine|mesh-list
92149919|NCT03167905|Remifentanil|remifentanil|mesh-list
92149920|NCT03167905|Nitrous Oxide|nitrous oxide|mesh-list
92149921|NCT03167905|Ropivacaine|ropivacaine|mesh-list
92149922|NCT03167905|Entonox|entonox|mesh-list
92149923|NCT03167905|Anesthetics, Local|anesthetics, local|mesh-ancestor
92149924|NCT03167905|Anesthetics|anesthetics|mesh-ancestor
92149925|NCT03167905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92149926|NCT03167905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149927|NCT03167905|Sensory System Agents|sensory system agents|mesh-ancestor
92149928|NCT03167905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92149929|NCT03167905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92149930|NCT03167905|Narcotics|narcotics|mesh-ancestor
92149931|NCT03167905|Analgesics|analgesics|mesh-ancestor
92149932|NCT03167905|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92149933|NCT03167905|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92149934|NCT03167905|Anesthetics, General|anesthetics, general|mesh-ancestor
92149935|NCT03167905|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92149936|NCT03167905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92149937|NCT03167905|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92149938|NCT04030169|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92149939|NCT04030169|Hallucinogens|hallucinogens|mesh-ancestor
92149940|NCT04030169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149941|NCT04030169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92149942|NCT04030169|Serotonin Agents|serotonin agents|mesh-ancestor
92149943|NCT04030169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150098|NCT01456130|Protease Inhibitors|protease inhibitors|mesh-ancestor
92149944|NCT04030169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149945|NCT04030169|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92149946|NCT04030169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92149947|NCT04030169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92149948|NCT04030169|Adrenergic Agents|adrenergic agents|mesh-ancestor
92149949|NCT02638389|Sirolimus|sirolimus|mesh-list
92149950|NCT02638389|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92149951|NCT02638389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149952|NCT02638389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92149953|NCT02638389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149954|NCT02638389|Antifungal Agents|antifungal agents|mesh-ancestor
92149955|NCT02638389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149956|NCT02638389|Immunologic Factors|immunologic factors|mesh-ancestor
92149957|NCT02638389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149958|NCT01494584|Ezogabine|ezogabine|mesh-list
92149959|NCT01494584|Anticonvulsants|anticonvulsants|mesh-ancestor
92149960|NCT01494584|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92149961|NCT01494584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149962|NCT03211143|Esomeprazole|esomeprazole|mesh-list
92149963|NCT03211143|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92149964|NCT03211143|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92149965|NCT03211143|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92149966|NCT03211143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149967|NCT03211143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149968|NCT01388543|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92149969|NCT01388543|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92149970|NCT01388543|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92149971|NCT01388543|Protease Inhibitors|protease inhibitors|mesh-ancestor
92149972|NCT01388543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149973|NCT01388543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149974|NCT01388543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92149975|NCT01388543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92149976|NCT01388543|Antiviral Agents|antiviral agents|mesh-ancestor
92149977|NCT01388543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92149978|NCT00882895|Mycophenolic Acid|mycophenolic acid|mesh-list
92149979|NCT00882895|Methylprednisolone|methylprednisolone|mesh-list
92149980|NCT00882895|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92149981|NCT00882895|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92149983|NCT00882895|Prednisolone acetate|prednisolone acetate|mesh-list
92149984|NCT00882895|Tacrolimus|tacrolimus|mesh-list
92149985|NCT00882895|Thymoglobulin|thymoglobulin|mesh-list
92149986|NCT00882895|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92149987|NCT00882895|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92149988|NCT00882895|Prednisolone phosphate|prednisolone phosphate|mesh-list
92149989|NCT00882895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92149990|NCT00882895|Immunologic Factors|immunologic factors|mesh-ancestor
92149991|NCT00882895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92149992|NCT00882895|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92149993|NCT00882895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92149994|NCT00882895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92149995|NCT00882895|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92149996|NCT00882895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92149997|NCT00882895|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92149998|NCT00882895|Antitubercular Agents|antitubercular agents|mesh-ancestor
92149999|NCT00882895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92150000|NCT00882895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150001|NCT00882895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150002|NCT00882895|Antiemetics|antiemetics|mesh-ancestor
92150003|NCT00882895|Autonomic Agents|autonomic agents|mesh-ancestor
92150004|NCT00882895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150005|NCT00882895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150006|NCT00882895|Glucocorticoids|glucocorticoids|mesh-ancestor
92150007|NCT00882895|Hormones|hormones|mesh-ancestor
92150008|NCT00882895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150009|NCT00882895|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92150010|NCT00882895|Protective Agents|protective agents|mesh-ancestor
92150011|NCT00882895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92150012|NCT00900237|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92150013|NCT00900237|Oxcarbazepine|oxcarbazepine|mesh-list
92150014|NCT00900237|Anticonvulsants|anticonvulsants|mesh-ancestor
92150015|NCT00900237|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92150016|NCT00900237|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92150017|NCT00900237|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150018|NCT00900237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150019|NCT00900237|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92150020|NCT00900237|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92150021|NCT00893997|Vaccines|vaccines|mesh-list
92150022|NCT00893997|Immunologic Factors|immunologic factors|mesh-ancestor
92150023|NCT00893997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150024|NCT00512317|Ganaxolone|ganaxolone|mesh-list
92150025|NCT00512317|Neurosteroids|neurosteroids|mesh-ancestor
92150026|NCT00512317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150027|NCT00512317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150028|NCT00512317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150029|NCT00512317|GABA Modulators|gaba modulators|mesh-ancestor
92150030|NCT00512317|GABA Agents|gaba agents|mesh-ancestor
92150032|NCT01494506|Fluorouracil|fluorouracil|mesh-list
92150033|NCT01494506|Antimetabolites|antimetabolites|mesh-ancestor
92150034|NCT01494506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150035|NCT01494506|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92150036|NCT01494506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150037|NCT01494506|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150038|NCT01494506|Immunologic Factors|immunologic factors|mesh-ancestor
92150039|NCT01494506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150041|NCT01494506|Protective Agents|protective agents|mesh-ancestor
92150042|NCT01494506|Vitamin B Complex|vitamin b complex|mesh-ancestor
92150043|NCT01494506|Vitamins|vitamins|mesh-ancestor
92150044|NCT01494506|Micronutrients|micronutrients|mesh-ancestor
92150045|NCT03024905|Misoprostol|misoprostol|mesh-list
92150046|NCT03024905|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92150047|NCT03024905|Abortifacient Agents|abortifacient agents|mesh-ancestor
92150048|NCT03024905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92150049|NCT03024905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150050|NCT03024905|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92150051|NCT03024905|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150052|NCT03024905|Oxytocics|oxytocics|mesh-ancestor
92150053|NCT02643420|Cyclophosphamide|cyclophosphamide|mesh-list
92150054|NCT02643420|Docetaxel|docetaxel|mesh-list
92150055|NCT02643420|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150056|NCT02643420|Immunologic Factors|immunologic factors|mesh-ancestor
92150057|NCT02643420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150058|NCT02643420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150059|NCT02643420|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92150060|NCT02643420|Alkylating Agents|alkylating agents|mesh-ancestor
92150061|NCT02643420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150062|NCT02643420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150063|NCT02643420|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92150064|NCT02643420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92150065|NCT02643420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92150066|NCT02643420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92150067|NCT01830465|Rituximab|rituximab|mesh-list
92150068|NCT01830465|Bortezomib|bortezomib|mesh-list
92150069|NCT01830465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150070|NCT01830465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150071|NCT01830465|Immunologic Factors|immunologic factors|mesh-ancestor
92150072|NCT01830465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150073|NCT01830465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150074|NCT00894465|Midazolam|midazolam|mesh-list
92150075|NCT00894465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92150076|NCT00894465|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92150077|NCT00894465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150078|NCT00894465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150079|NCT00894465|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92150080|NCT00894465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92150081|NCT00894465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150082|NCT00894465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92150083|NCT00894465|Anesthetics, General|anesthetics, general|mesh-ancestor
92150084|NCT00894465|Anesthetics|anesthetics|mesh-ancestor
92150085|NCT00894465|GABA Modulators|gaba modulators|mesh-ancestor
92150086|NCT00894465|GABA Agents|gaba agents|mesh-ancestor
92150087|NCT00894465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150088|NCT00894465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150089|NCT01456130|Alogliptin|alogliptin|mesh-list
92150090|NCT01456130|Insulin, Short-Acting|insulin, short-acting|mesh-list
92150091|NCT01456130|Secretagogues|secretagogues|mesh-list
92150092|NCT01456130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92150093|NCT01456130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150094|NCT01456130|Incretins|incretins|mesh-ancestor
92150095|NCT01456130|Hormones|hormones|mesh-ancestor
92150096|NCT01456130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150097|NCT01456130|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92150100|NCT01456130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150101|NCT03479671|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92150102|NCT03479671|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92150103|NCT03479671|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92150104|NCT03479671|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92150105|NCT03219645|Aspirin|aspirin|mesh-list
92150106|NCT03219645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92150107|NCT03219645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150108|NCT03219645|Analgesics|analgesics|mesh-ancestor
92150109|NCT03219645|Sensory System Agents|sensory system agents|mesh-ancestor
92150110|NCT03219645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150111|NCT03219645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150112|NCT03219645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150113|NCT03219645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150114|NCT03219645|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92150115|NCT03219645|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92150116|NCT03219645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150117|NCT03219645|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92150118|NCT03219645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92150119|NCT03219645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150120|NCT03219645|Antipyretics|antipyretics|mesh-ancestor
92150121|NCT04435314|Nitazoxanide|nitazoxanide|mesh-list
92150122|NCT04435314|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92150123|NCT04435314|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150124|NCT03102450|Benzalkonium Compounds|benzalkonium compounds|mesh-list
92150125|NCT03102450|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92150126|NCT03102450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150127|NCT01387607|Pregabalin|pregabalin|mesh-list
92150128|NCT01387607|Analgesics|analgesics|mesh-ancestor
92150129|NCT01387607|Sensory System Agents|sensory system agents|mesh-ancestor
92150130|NCT01387607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150131|NCT01387607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150132|NCT01387607|Anticonvulsants|anticonvulsants|mesh-ancestor
92150133|NCT01387607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92150134|NCT01387607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150135|NCT01387607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150136|NCT01387607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92150137|NCT01387607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92150138|NCT01387607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92150139|NCT01387607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150140|NCT01387607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150141|NCT05069454|Vaccines|vaccines|mesh-list
92150142|NCT05069454|Immunologic Factors|immunologic factors|mesh-ancestor
92150143|NCT05069454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150144|NCT05069688|Rifampin|rifampin|mesh-list
92150145|NCT05069688|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92150146|NCT05069688|Antitubercular Agents|antitubercular agents|mesh-ancestor
92150147|NCT05069688|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92150148|NCT05069688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150149|NCT05069688|Leprostatic Agents|leprostatic agents|mesh-ancestor
92150150|NCT05069688|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92150151|NCT05069688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150152|NCT05069688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150153|NCT05069688|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92150154|NCT05069688|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92150155|NCT05069688|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92150156|NCT05069688|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92150157|NCT05069688|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92150158|NCT05069688|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92150159|NCT01830777|Cytarabine|cytarabine|mesh-list
92150160|NCT01830777|Etoposide|etoposide|mesh-list
92150161|NCT01830777|Mitoxantrone|mitoxantrone|mesh-list
92150162|NCT01830777|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92150163|NCT01830777|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92150164|NCT01830777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150165|NCT01830777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92150166|NCT01830777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92150167|NCT01830777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150168|NCT01830777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150169|NCT01830777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92150170|NCT01830777|Antimetabolites|antimetabolites|mesh-ancestor
92150171|NCT01830777|Antiviral Agents|antiviral agents|mesh-ancestor
92150172|NCT01830777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150173|NCT01830777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150174|NCT01830777|Immunologic Factors|immunologic factors|mesh-ancestor
92150175|NCT01830777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150176|NCT01830777|Analgesics|analgesics|mesh-ancestor
92150177|NCT01830777|Sensory System Agents|sensory system agents|mesh-ancestor
92150178|NCT01830777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150179|NCT01830777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150180|NCT01830777|Immunotoxins|immunotoxins|mesh-ancestor
92150181|NCT01830777|Immunoconjugates|immunoconjugates|mesh-ancestor
92150182|NCT04479306|Osimertinib|osimertinib|mesh-list
92150183|NCT04479306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150184|NCT04479306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92150185|NCT04479306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150186|NCT04479306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150201|NCT03451045|Lenabasum|lenabasum|mesh-list
92150202|NCT03451045|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92150203|NCT03451045|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92150204|NCT03451045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150205|NCT03451045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150206|NCT03451045|Hormones|hormones|mesh-ancestor
92150207|NCT03451045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150208|NCT03451045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150209|NCT03451045|Hallucinogens|hallucinogens|mesh-ancestor
91939624|NCT05170256|Trastuzumab|trastuzumab|mesh-list
92150210|NCT03451045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150211|NCT03451045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150212|NCT03451045|Analgesics|analgesics|mesh-ancestor
92150213|NCT03451045|Sensory System Agents|sensory system agents|mesh-ancestor
92150214|NCT03451045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150216|NCT01831011|Cinepazide|cinepazide|mesh-list
92150217|NCT01831011|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
92150218|NCT01831011|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92150219|NCT01831011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150220|NCT01831011|Analgesics|analgesics|mesh-ancestor
92150221|NCT01831011|Sensory System Agents|sensory system agents|mesh-ancestor
92150222|NCT01831011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150223|NCT01831011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150224|NCT01831011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150225|NCT01831011|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150226|NCT01831011|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92150227|NCT01831011|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92150228|NCT01831011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150229|NCT01831011|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92150230|NCT01831011|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92150231|NCT01831011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150232|NCT01831011|Antipyretics|antipyretics|mesh-ancestor
92150233|NCT01831011|Vasodilator Agents|vasodilator agents|mesh-ancestor
92150234|NCT01831011|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92150235|NCT01831011|Immunologic Factors|immunologic factors|mesh-ancestor
92150236|NCT03218709|Vitamins|vitamins|mesh-list
92150237|NCT03218709|Micronutrients|micronutrients|mesh-ancestor
92150238|NCT03218709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150239|NCT03218553|Dexamethasone|dexamethasone|mesh-list
92150240|NCT03218553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150241|NCT03218553|Antiemetics|antiemetics|mesh-ancestor
92150242|NCT03218553|Autonomic Agents|autonomic agents|mesh-ancestor
92150243|NCT03218553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150244|NCT03218553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150245|NCT03218553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150246|NCT03218553|Glucocorticoids|glucocorticoids|mesh-ancestor
92150247|NCT03218553|Hormones|hormones|mesh-ancestor
92150248|NCT03218553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150249|NCT03218553|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92150250|NCT03218553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150251|NCT03430843|Paclitaxel|paclitaxel|mesh-list
92150252|NCT03430843|Docetaxel|docetaxel|mesh-list
92150253|NCT03430843|Irinotecan|irinotecan|mesh-list
92150254|NCT03430843|Tislelizumab|tislelizumab|mesh-list
92150255|NCT03430843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92150256|NCT03430843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150257|NCT03430843|Tubulin Modulators|tubulin modulators|mesh-ancestor
92150258|NCT03430843|Antimitotic Agents|antimitotic agents|mesh-ancestor
92150259|NCT03430843|Mitosis Modulators|mitosis modulators|mesh-ancestor
92150260|NCT03430843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150261|NCT03430843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92150262|NCT03430843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92150263|NCT03430843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150264|NCT03430843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150265|NCT01386125|Mometasone Furoate|mometasone furoate|mesh-list
92150266|NCT01386125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150267|NCT01386125|Dermatologic Agents|dermatologic agents|mesh-ancestor
92150268|NCT01386125|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92150269|NCT01831323|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92150270|NCT01831323|Rifaximin|rifaximin|mesh-list
92150271|NCT01831323|Mesalamine|mesalamine|mesh-list
92150272|NCT01831323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92150273|NCT01831323|Psyllium|psyllium|mesh-list
92150274|NCT01831323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150275|NCT01831323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150276|NCT01831323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92150277|NCT01831323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150278|NCT01831323|Analgesics|analgesics|mesh-ancestor
92150279|NCT01831323|Sensory System Agents|sensory system agents|mesh-ancestor
92150280|NCT01831323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150281|NCT01831323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150282|NCT01831323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150283|NCT01831323|Cathartics|cathartics|mesh-ancestor
92150284|NCT03221400|Leucovorin|leucovorin|mesh-list
92150285|NCT03221400|Folic Acid|folic acid|mesh-list
92150286|NCT03221400|Fluorouracil|fluorouracil|mesh-list
92150287|NCT03221400|Niraparib|niraparib|mesh-list
92150288|NCT03221400|Levoleucovorin|levoleucovorin|mesh-list
92150289|NCT03221400|Antimetabolites|antimetabolites|mesh-ancestor
92150290|NCT03221400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150291|NCT03221400|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92150292|NCT03221400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150293|NCT03221400|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150294|NCT03221400|Immunologic Factors|immunologic factors|mesh-ancestor
92150295|NCT03221400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150296|NCT03221400|Antidotes|antidotes|mesh-ancestor
92150297|NCT03221400|Protective Agents|protective agents|mesh-ancestor
92150298|NCT03221400|Vitamin B Complex|vitamin b complex|mesh-ancestor
92150299|NCT03221400|Vitamins|vitamins|mesh-ancestor
92150300|NCT03221400|Micronutrients|micronutrients|mesh-ancestor
92150301|NCT03221400|Hematinics|hematinics|mesh-ancestor
92150302|NCT03221400|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92150303|NCT03221400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150304|NCT01384877|Lidocaine|lidocaine|mesh-list
92150305|NCT01384877|Anesthetics, Local|anesthetics, local|mesh-ancestor
92150306|NCT01384877|Anesthetics|anesthetics|mesh-ancestor
92150307|NCT01384877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150308|NCT01384877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150309|NCT01384877|Sensory System Agents|sensory system agents|mesh-ancestor
92150310|NCT01384877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150311|NCT01384877|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92150312|NCT01384877|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92150313|NCT01384877|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92150314|NCT01384877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150315|NCT01384877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150316|NCT00114517|Hormones|hormones|mesh-list
92150317|NCT00114517|Estradiol|estradiol|mesh-list
92150318|NCT00114517|Estrogens|estrogens|mesh-list
92150319|NCT00114517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150320|NCT00114517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150321|NCT01831479|Olmesartan|olmesartan|mesh-list
92150322|NCT01831479|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92150323|NCT01831479|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92150324|NCT01831479|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92150325|NCT01831479|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92150326|NCT01831479|Antimetabolites|antimetabolites|mesh-ancestor
92150327|NCT01831479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150328|NCT01831479|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92150329|NCT01831479|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92150330|NCT01831479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150331|NCT01831479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92150332|NCT01831479|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92150333|NCT01831479|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92150334|NCT03099720|Ropivacaine|ropivacaine|mesh-list
92150335|NCT03099720|Anesthetics, Local|anesthetics, local|mesh-ancestor
92150336|NCT03099720|Anesthetics|anesthetics|mesh-ancestor
92150337|NCT03099720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150338|NCT03099720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150339|NCT03099720|Sensory System Agents|sensory system agents|mesh-ancestor
92150340|NCT03099720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150341|NCT03025295|Dexmedetomidine|dexmedetomidine|mesh-list
92150342|NCT03025295|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92150343|NCT03025295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150344|NCT03025295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150345|NCT03025295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150346|NCT03025295|Analgesics|analgesics|mesh-ancestor
92150347|NCT03025295|Sensory System Agents|sensory system agents|mesh-ancestor
92150348|NCT03025295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150349|NCT03025295|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92150350|NCT03025295|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92150351|NCT03025295|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92150352|NCT03025295|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150353|NCT03025295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150354|NCT03025295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150355|NCT01471574|Interferons|interferons|mesh-list
92150356|NCT01471574|Ribavirin|ribavirin|mesh-list
92150357|NCT01471574|Interferon-alpha|interferon-alpha|mesh-list
92150358|NCT01471574|Interferon alpha-2|interferon alpha-2|mesh-list
92150359|NCT01471574|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92150360|NCT01471574|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150361|NCT01471574|Antiviral Agents|antiviral agents|mesh-ancestor
92150362|NCT01471574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150363|NCT01471574|Antimetabolites|antimetabolites|mesh-ancestor
92150364|NCT01471574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150365|NCT01471574|Immunologic Factors|immunologic factors|mesh-ancestor
92150366|NCT01471574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150367|NCT01383707|Leucovorin|leucovorin|mesh-list
92150368|NCT01383707|Bevacizumab|bevacizumab|mesh-list
92150369|NCT01383707|Fluorouracil|fluorouracil|mesh-list
92150370|NCT01383707|Oxaliplatin|oxaliplatin|mesh-list
92150371|NCT01383707|Levoleucovorin|levoleucovorin|mesh-list
92150372|NCT01383707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150373|NCT01383707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150374|NCT01383707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92150375|NCT01383707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92150376|NCT01383707|Growth Substances|growth substances|mesh-ancestor
92150377|NCT01383707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150378|NCT01383707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92150379|NCT01383707|Antimetabolites|antimetabolites|mesh-ancestor
92150380|NCT01383707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150381|NCT01383707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92150382|NCT01383707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150383|NCT01383707|Immunologic Factors|immunologic factors|mesh-ancestor
92150384|NCT01383707|Antidotes|antidotes|mesh-ancestor
92150385|NCT01383707|Protective Agents|protective agents|mesh-ancestor
92150386|NCT01383707|Vitamin B Complex|vitamin b complex|mesh-ancestor
92150387|NCT01383707|Vitamins|vitamins|mesh-ancestor
92150388|NCT01383707|Micronutrients|micronutrients|mesh-ancestor
92150389|NCT01839357|Rivaroxaban|rivaroxaban|mesh-list
92150390|NCT01839357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92150391|NCT01839357|Antithrombins|antithrombins|mesh-ancestor
92150392|NCT01839357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92150393|NCT01839357|Protease Inhibitors|protease inhibitors|mesh-ancestor
92150394|NCT01839357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150395|NCT01839357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150396|NCT01839357|Anticoagulants|anticoagulants|mesh-ancestor
92150397|NCT03306901|Fluorouracil|fluorouracil|mesh-list
92150398|NCT03306901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150399|NCT03306901|Antimetabolites|antimetabolites|mesh-ancestor
92150400|NCT03306901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150401|NCT03306901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92150402|NCT03306901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150403|NCT03306901|Immunologic Factors|immunologic factors|mesh-ancestor
92150404|NCT03306901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150405|NCT01455428|Pregabalin|pregabalin|mesh-list
92150406|NCT01455428|Analgesics|analgesics|mesh-ancestor
92150407|NCT01455428|Sensory System Agents|sensory system agents|mesh-ancestor
92150408|NCT01455428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150409|NCT01455428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150410|NCT01455428|Anticonvulsants|anticonvulsants|mesh-ancestor
92150411|NCT01455428|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92150412|NCT01455428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150413|NCT01455428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150414|NCT01455428|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92150417|NCT01455428|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150418|NCT01455428|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150419|NCT01831947|Ranibizumab|ranibizumab|mesh-list
92150420|NCT01831947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92150421|NCT01831947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92150422|NCT01831947|Growth Substances|growth substances|mesh-ancestor
92150423|NCT01831947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150424|NCT01831947|Growth Inhibitors|growth inhibitors|mesh-ancestor
92150425|NCT01831947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150426|NCT01383161|Curcumin|curcumin|mesh-list
92150427|NCT01383161|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92150428|NCT01383161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150429|NCT01383161|Analgesics|analgesics|mesh-ancestor
92150430|NCT01383161|Sensory System Agents|sensory system agents|mesh-ancestor
92150431|NCT01383161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150432|NCT01383161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150433|NCT01383161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150434|NCT01383161|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150435|NCT01383161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150437|NCT01383161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150438|NCT00894699|Sufentanil|sufentanil|mesh-list
92150439|NCT00894699|Triazolam|triazolam|mesh-list
92150440|NCT00894699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92150441|NCT00894699|Narcotics|narcotics|mesh-ancestor
92150442|NCT00894699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150443|NCT00894699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150444|NCT00894699|Analgesics|analgesics|mesh-ancestor
92150445|NCT00894699|Sensory System Agents|sensory system agents|mesh-ancestor
92150446|NCT00894699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150447|NCT00894699|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92150448|NCT00894699|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92150449|NCT00894699|Anesthetics, General|anesthetics, general|mesh-ancestor
92150450|NCT00894699|Anesthetics|anesthetics|mesh-ancestor
92150451|NCT00894699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92150452|NCT00894699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92150453|NCT00894699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150454|NCT00894699|GABA Modulators|gaba modulators|mesh-ancestor
92150455|NCT00894699|GABA Agents|gaba agents|mesh-ancestor
92150456|NCT00894699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150457|NCT00894699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150458|NCT03087019|Pembrolizumab|pembrolizumab|mesh-list
92150459|NCT03087019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150460|NCT03087019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150461|NCT03087019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92150462|NCT03087019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150463|NCT01382225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92150464|NCT01382225|Hyaluronic Acid|hyaluronic acid|mesh-list
92150465|NCT01382225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92150466|NCT01382225|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92150467|NCT01382225|Immunologic Factors|immunologic factors|mesh-ancestor
92150468|NCT01382225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150469|NCT01382225|Viscosupplements|viscosupplements|mesh-ancestor
92150470|NCT01382225|Protective Agents|protective agents|mesh-ancestor
92150472|NCT01381679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92150473|NCT01381679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92150474|NCT01381679|Antimetabolites|antimetabolites|mesh-ancestor
92150475|NCT01381679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150476|NCT01381679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92150477|NCT01832415|Bevacizumab|bevacizumab|mesh-list
92150478|NCT01832415|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150479|NCT01832415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150480|NCT01832415|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92150481|NCT01832415|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92150482|NCT01832415|Growth Substances|growth substances|mesh-ancestor
92150483|NCT01832415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150484|NCT01832415|Growth Inhibitors|growth inhibitors|mesh-ancestor
92150485|NCT01455194|Ciclesonide|ciclesonide|mesh-list
92150486|NCT01455194|Glucocorticoids|glucocorticoids|mesh-ancestor
92150487|NCT01455194|Hormones|hormones|mesh-ancestor
92150488|NCT01455194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150489|NCT01455194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150490|NCT01455194|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92150491|NCT03216759|Dexmedetomidine|dexmedetomidine|mesh-list
92150492|NCT03216759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92150493|NCT03216759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150494|NCT03216759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150495|NCT03216759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150496|NCT03216759|Analgesics|analgesics|mesh-ancestor
92150497|NCT03216759|Sensory System Agents|sensory system agents|mesh-ancestor
92150498|NCT03216759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150499|NCT03216759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92150500|NCT03216759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92150501|NCT03216759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92150502|NCT03216759|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150503|NCT03216759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150504|NCT03216759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150505|NCT03799445|Nivolumab|nivolumab|mesh-list
92150506|NCT03799445|Ipilimumab|ipilimumab|mesh-list
92150507|NCT03799445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150508|NCT03799445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150509|NCT03799445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92150510|NCT03799445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150511|NCT01832571|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92150512|NCT01832571|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92150513|NCT01832571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92150514|NCT01832571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150515|NCT01832571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150516|NCT01832571|Antiviral Agents|antiviral agents|mesh-ancestor
92150517|NCT01832571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150518|NCT01832571|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92150519|NCT01832571|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92150520|NCT03216915|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92150521|NCT03216915|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92150522|NCT03216915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150523|NCT03216915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150524|NCT03216915|Immunologic Factors|immunologic factors|mesh-ancestor
92150525|NCT03216915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150526|NCT04007393|Topiramate|topiramate|mesh-list
92150527|NCT04007393|Phentermine|phentermine|mesh-list
92150528|NCT04007393|Anticonvulsants|anticonvulsants|mesh-ancestor
92150529|NCT04007393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92150530|NCT04007393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150531|NCT04007393|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92150532|NCT04007393|Appetite Depressants|appetite depressants|mesh-ancestor
92150533|NCT04007393|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92150534|NCT04007393|Sympathomimetics|sympathomimetics|mesh-ancestor
92150535|NCT04007393|Autonomic Agents|autonomic agents|mesh-ancestor
92150536|NCT04007393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150537|NCT04007393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150538|NCT04007393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150539|NCT04007393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150540|NCT05368805|Dabigatran|dabigatran|mesh-list
92150541|NCT05368805|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92150542|NCT05368805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92150543|NCT05368805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92150544|NCT05368805|Antimetabolites|antimetabolites|mesh-ancestor
92150545|NCT05368805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150546|NCT05368805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92150547|NCT05368805|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92150548|NCT05368805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150549|NCT05368805|Antithrombins|antithrombins|mesh-ancestor
92150550|NCT05368805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92150551|NCT05368805|Protease Inhibitors|protease inhibitors|mesh-ancestor
92150552|NCT05368805|Anticoagulants|anticoagulants|mesh-ancestor
92150553|NCT03304717|Tenofovir|tenofovir|mesh-list
92150554|NCT03304717|Emtricitabine|emtricitabine|mesh-list
92150555|NCT03304717|Antiviral Agents|antiviral agents|mesh-ancestor
92150556|NCT03304717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150557|NCT03304717|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92150558|NCT03304717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92150559|NCT03304717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150560|NCT03304717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150561|NCT03304717|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92150562|NCT03304717|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92150564|NCT01839981|Antioxidants|antioxidants|mesh-ancestor
92150565|NCT01839981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150566|NCT01839981|Protective Agents|protective agents|mesh-ancestor
92150643|NCT01720095|Vitamin B Complex|vitamin b complex|mesh-ancestor
92150567|NCT01839981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150568|NCT01839981|Vitamin B Complex|vitamin b complex|mesh-ancestor
92150569|NCT01839981|Vitamins|vitamins|mesh-ancestor
92150570|NCT01839981|Micronutrients|micronutrients|mesh-ancestor
92150571|NCT03081156|Glycopyrrolate|glycopyrrolate|mesh-list
92150572|NCT03081156|Formoterol Fumarate|formoterol fumarate|mesh-list
92150573|NCT03081156|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92150574|NCT03081156|Autonomic Agents|autonomic agents|mesh-ancestor
92150575|NCT03081156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150576|NCT03081156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150577|NCT03081156|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92150578|NCT03081156|Respiratory System Agents|respiratory system agents|mesh-ancestor
92150579|NCT03081156|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92150580|NCT03081156|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92150581|NCT03081156|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92150582|NCT03081156|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150583|NCT03081156|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150584|NCT03081156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150585|NCT03081156|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92150586|NCT03081156|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92150587|NCT03081156|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92150588|NCT03081156|Cholinergic Agents|cholinergic agents|mesh-ancestor
92150589|NCT01494350|Gentamicins|gentamicins|mesh-list
92150590|NCT01494350|Paromomycin|paromomycin|mesh-list
92150591|NCT01494350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92150592|NCT01494350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150593|NCT01494350|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92150594|NCT01494350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150595|NCT01494350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150596|NCT01494350|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92150597|NCT01494350|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92150598|NCT02135484|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92150599|NCT02135484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150600|NCT03258385|Vitamin B 12|vitamin b 12|mesh-list
92150601|NCT03258385|Hydroxocobalamin|hydroxocobalamin|mesh-list
92150602|NCT03258385|Vitamins|vitamins|mesh-ancestor
92150603|NCT03258385|Micronutrients|micronutrients|mesh-ancestor
92150604|NCT03258385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150605|NCT03258385|Vitamin B Complex|vitamin b complex|mesh-ancestor
92150606|NCT03258385|Hematinics|hematinics|mesh-ancestor
92150607|NCT03024515|Analgesics, Opioid|analgesics, opioid|mesh-list
92150608|NCT03024515|Narcotics|narcotics|mesh-ancestor
92150609|NCT03024515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150610|NCT03024515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150611|NCT03024515|Analgesics|analgesics|mesh-ancestor
92150612|NCT03024515|Sensory System Agents|sensory system agents|mesh-ancestor
92150613|NCT03024515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150614|NCT01834911|Tetrabenazine|tetrabenazine|mesh-list
92150615|NCT01834911|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92150616|NCT01834911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92150617|NCT01834911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150618|NCT01834911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150619|NCT01834911|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150620|NCT01834911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150621|NCT01834911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150622|NCT04287829|Pembrolizumab|pembrolizumab|mesh-list
92150623|NCT04287829|Lenvatinib|lenvatinib|mesh-list
92150624|NCT04287829|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150625|NCT04287829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150626|NCT04287829|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92150627|NCT04287829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150628|NCT04287829|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92150629|NCT04287829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150630|NCT03083821|Entecavir|entecavir|mesh-list
92150631|NCT03083821|Antiviral Agents|antiviral agents|mesh-ancestor
92150632|NCT03083821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150633|NCT05367869|Methylene Blue|methylene blue|mesh-list
92150634|NCT05367869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150635|NCT05367869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150636|NCT01720095|Niacin|niacin|mesh-list
92150637|NCT01720095|Nicotinic Acids|nicotinic acids|mesh-list
92150638|NCT01720095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92150639|NCT01720095|Antimetabolites|antimetabolites|mesh-ancestor
92150640|NCT01720095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150641|NCT01720095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92150642|NCT01720095|Vasodilator Agents|vasodilator agents|mesh-ancestor
92150646|NCT01720095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150647|NCT05366777|Acetaminophen|acetaminophen|mesh-list
92150648|NCT05366777|Ibuprofen|ibuprofen|mesh-list
92150649|NCT05366777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150650|NCT05366777|Analgesics|analgesics|mesh-ancestor
92150651|NCT05366777|Sensory System Agents|sensory system agents|mesh-ancestor
92150652|NCT05366777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150653|NCT05366777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150654|NCT05366777|Antipyretics|antipyretics|mesh-ancestor
92150655|NCT05366777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92150657|NCT05366777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92150658|NCT05366777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92150659|NCT05366777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150660|NCT05366777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150661|NCT03836157|Bevacizumab|bevacizumab|mesh-list
92150662|NCT03836157|Maytansine|maytansine|mesh-list
92150663|NCT03836157|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92150664|NCT03836157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150665|NCT03836157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150666|NCT03836157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92150667|NCT03836157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92150668|NCT03836157|Growth Substances|growth substances|mesh-ancestor
92150669|NCT03836157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150670|NCT03836157|Growth Inhibitors|growth inhibitors|mesh-ancestor
92150671|NCT03836157|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92150672|NCT03836157|Tubulin Modulators|tubulin modulators|mesh-ancestor
92150673|NCT03836157|Antimitotic Agents|antimitotic agents|mesh-ancestor
92150674|NCT03836157|Mitosis Modulators|mitosis modulators|mesh-ancestor
92150675|NCT03836157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150676|NCT03836157|Immunoconjugates|immunoconjugates|mesh-ancestor
92150677|NCT03836157|Immunologic Factors|immunologic factors|mesh-ancestor
92150678|NCT03080545|Calcitriol|calcitriol|mesh-list
92150679|NCT03080545|Betamethasone|betamethasone|mesh-list
92150680|NCT03080545|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92150681|NCT03080545|Calcipotriene|calcipotriene|mesh-list
92150682|NCT03080545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150683|NCT03080545|Glucocorticoids|glucocorticoids|mesh-ancestor
92150684|NCT03080545|Hormones|hormones|mesh-ancestor
92150685|NCT03080545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150686|NCT03080545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150687|NCT03080545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92150688|NCT03080545|Respiratory System Agents|respiratory system agents|mesh-ancestor
92150689|NCT03080545|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92150690|NCT03080545|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92150691|NCT03080545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150692|NCT03080545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150693|NCT03080545|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92150694|NCT03080545|Vitamins|vitamins|mesh-ancestor
92150695|NCT03080545|Micronutrients|micronutrients|mesh-ancestor
92150696|NCT03080545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92150697|NCT03080545|Dermatologic Agents|dermatologic agents|mesh-ancestor
92150698|NCT03101124|Tranexamic Acid|tranexamic acid|mesh-list
92150699|NCT03101124|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92150700|NCT03101124|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92150701|NCT03101124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150702|NCT03101124|Hemostatics|hemostatics|mesh-ancestor
92150703|NCT03101124|Coagulants|coagulants|mesh-ancestor
92150704|NCT02985203|Vinorelbine|vinorelbine|mesh-list
92150705|NCT02985203|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92150706|NCT02985203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150707|NCT02985203|Tubulin Modulators|tubulin modulators|mesh-ancestor
92150708|NCT02985203|Antimitotic Agents|antimitotic agents|mesh-ancestor
92150709|NCT02985203|Mitosis Modulators|mitosis modulators|mesh-ancestor
92150710|NCT02985203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150711|NCT04283617|Insulin|insulin|mesh-list
92150712|NCT04283617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92150713|NCT04283617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150714|NCT05247619|Paclitaxel|paclitaxel|mesh-list
92150715|NCT05247619|Bevacizumab|bevacizumab|mesh-list
92150716|NCT05247619|Carboplatin|carboplatin|mesh-list
92150717|NCT05247619|Tislelizumab|tislelizumab|mesh-list
92150718|NCT05247619|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92150719|NCT05247619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150720|NCT05247619|Tubulin Modulators|tubulin modulators|mesh-ancestor
92150721|NCT05247619|Antimitotic Agents|antimitotic agents|mesh-ancestor
92150722|NCT05247619|Mitosis Modulators|mitosis modulators|mesh-ancestor
92150723|NCT05247619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150724|NCT05247619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150725|NCT05247619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92150726|NCT05247619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92150727|NCT05247619|Growth Substances|growth substances|mesh-ancestor
92150728|NCT05247619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150729|NCT05247619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92150730|NCT04018937|Fludarabine|fludarabine|mesh-list
92150731|NCT04018937|Melphalan|melphalan|mesh-list
92150732|NCT04018937|Alemtuzumab|alemtuzumab|mesh-list
92150733|NCT04018937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150734|NCT04018937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150735|NCT04018937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150736|NCT04018937|Immunologic Factors|immunologic factors|mesh-ancestor
92150737|NCT04018937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150738|NCT04018937|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92150739|NCT04018937|Alkylating Agents|alkylating agents|mesh-ancestor
92150740|NCT04018937|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92150741|NCT04018937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150742|NCT00805584|Desloratadine|desloratadine|mesh-list
92150743|NCT00805584|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92150744|NCT00805584|Cholinergic Agents|cholinergic agents|mesh-ancestor
92150745|NCT00805584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150746|NCT00805584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150747|NCT00805584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150748|NCT00805584|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92150749|NCT00805584|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92150750|NCT00805584|Histamine Antagonists|histamine antagonists|mesh-ancestor
92150751|NCT00805584|Histamine Agents|histamine agents|mesh-ancestor
92150752|NCT01833351|Vitamins|vitamins|mesh-list
92150753|NCT01833351|Ascorbic Acid|ascorbic acid|mesh-list
92150754|NCT01833351|Micronutrients|micronutrients|mesh-ancestor
92150755|NCT01833351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150756|NCT01833351|Antioxidants|antioxidants|mesh-ancestor
92150757|NCT01833351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150758|NCT01833351|Protective Agents|protective agents|mesh-ancestor
92150759|NCT03187405|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92150760|NCT03187405|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92150761|NCT03187405|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92150762|NCT03187405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150763|NCT05066958|Antiviral Agents|antiviral agents|mesh-list
92150764|NCT05066958|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150765|NCT03049189|Everolimus|everolimus|mesh-list
92150766|NCT03049189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92150767|NCT03049189|Edotreotide|edotreotide|mesh-list
92150768|NCT03049189|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
92150769|NCT03049189|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92150770|NCT03049189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92150771|NCT03049189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150772|NCT03049189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150773|NCT03049189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92150774|NCT03049189|Immunologic Factors|immunologic factors|mesh-ancestor
92150775|NCT03049189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150776|NCT03049189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150777|NCT03049189|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92150778|NCT00218543|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92150779|NCT00218543|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92150780|NCT00218543|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92150781|NCT00218543|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150782|NCT00218543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150783|NCT00218543|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150784|NCT00218543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150785|NCT00218543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150786|NCT00795522|Desloratadine|desloratadine|mesh-list
92150787|NCT00795522|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92150789|NCT00795522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150790|NCT00795522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150791|NCT00795522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150792|NCT00795522|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92150793|NCT00795522|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92150794|NCT00795522|Histamine Antagonists|histamine antagonists|mesh-ancestor
92150796|NCT00910845|Botulinum Toxins|botulinum toxins|mesh-list
92151484|NCT01835691|Vitamins|vitamins|mesh-list
92150797|NCT00910845|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92150798|NCT00910845|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92150799|NCT00910845|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92150800|NCT00910845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150801|NCT00910845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150802|NCT00910845|Cholinergic Agents|cholinergic agents|mesh-ancestor
92150803|NCT00910845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150804|NCT00910845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150805|NCT00910845|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92150806|NCT00910845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150807|NCT05243251|Olanzapine|olanzapine|mesh-list
92150808|NCT05243251|Antiemetics|antiemetics|mesh-ancestor
92150809|NCT05243251|Autonomic Agents|autonomic agents|mesh-ancestor
92150810|NCT05243251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150811|NCT05243251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150812|NCT05243251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150813|NCT05243251|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92150814|NCT05243251|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92150815|NCT05243251|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150816|NCT05243251|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150817|NCT05243251|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92150818|NCT05243251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92150819|NCT05243251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150820|NCT05243251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150821|NCT05243251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150822|NCT05243251|Serotonin Agents|serotonin agents|mesh-ancestor
92150823|NCT05242705|Cystatins|cystatins|mesh-list
92150824|NCT05242705|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92150825|NCT05242705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92150826|NCT05242705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150827|NCT05242705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150828|NCT00216671|Risperidone|risperidone|mesh-list
92150829|NCT00216671|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92150830|NCT00216671|Serotonin Agents|serotonin agents|mesh-ancestor
92150831|NCT00216671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150832|NCT00216671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150833|NCT00216671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150834|NCT00216671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92150835|NCT00216671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92150836|NCT00216671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150837|NCT00216671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92150838|NCT00216671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92150839|NCT00216671|Dopamine Agents|dopamine agents|mesh-ancestor
92150840|NCT00783354|Loratadine|loratadine|mesh-list
92150841|NCT00783354|Desloratadine|desloratadine|mesh-list
92150842|NCT00783354|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92150843|NCT00783354|Cholinergic Agents|cholinergic agents|mesh-ancestor
92150844|NCT00783354|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150845|NCT00783354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150846|NCT00783354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150847|NCT00783354|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92150848|NCT00783354|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92150849|NCT00783354|Histamine Antagonists|histamine antagonists|mesh-ancestor
92150850|NCT00783354|Histamine Agents|histamine agents|mesh-ancestor
92150851|NCT00783354|Antipruritics|antipruritics|mesh-ancestor
92150852|NCT00783354|Dermatologic Agents|dermatologic agents|mesh-ancestor
92150853|NCT00783354|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92150854|NCT01833663|Solifenacin Succinate|solifenacin succinate|mesh-list
92150855|NCT01833663|Estrogens|estrogens|mesh-list
92150856|NCT01833663|Hormones|hormones|mesh-ancestor
92150857|NCT01833663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150858|NCT01833663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150859|NCT01833663|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92150860|NCT01833663|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92150861|NCT01833663|Cholinergic Agents|cholinergic agents|mesh-ancestor
92150862|NCT01833663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150863|NCT01833663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150864|NCT01833663|Urological Agents|urological agents|mesh-ancestor
92150866|NCT01720875|Bortezomib|bortezomib|mesh-list
92150867|NCT01720875|Vorinostat|vorinostat|mesh-list
92150868|NCT01720875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150869|NCT01720875|Antiemetics|antiemetics|mesh-ancestor
92150870|NCT01720875|Autonomic Agents|autonomic agents|mesh-ancestor
92150871|NCT01720875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150872|NCT01720875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150873|NCT01720875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150874|NCT01720875|Glucocorticoids|glucocorticoids|mesh-ancestor
92150875|NCT01720875|Hormones|hormones|mesh-ancestor
92150876|NCT01720875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150877|NCT01720875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92150878|NCT01720875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150879|NCT01720875|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92150880|NCT01720875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150881|NCT01720875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150882|NCT04277143|Daptomycin|daptomycin|mesh-list
92150883|NCT04277143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92150884|NCT04277143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150885|NCT00750750|Mometasone Furoate|mometasone furoate|mesh-list
92150886|NCT00750750|Amoxicillin|amoxicillin|mesh-list
92150887|NCT00750750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92150888|NCT00750750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150889|NCT00750750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150890|NCT00750750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92150891|NCT00750750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92150892|NCT05066802|Folfirinox|folfirinox|mesh-list
92150893|NCT05066802|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150894|NCT04379739|Apatinib|apatinib|mesh-list
92150895|NCT04379739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150896|NCT04379739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92150897|NCT04379739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150898|NCT04379739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150899|NCT05066568|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92150900|NCT05066568|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150901|NCT05066568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150902|NCT05248633|Dexamethasone|dexamethasone|mesh-list
92150903|NCT05248633|Lenalidomide|lenalidomide|mesh-list
92150905|NCT05248633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92150906|NCT05248633|Antiemetics|antiemetics|mesh-ancestor
92150907|NCT05248633|Autonomic Agents|autonomic agents|mesh-ancestor
92150908|NCT05248633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150909|NCT05248633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150910|NCT05248633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92150911|NCT05248633|Glucocorticoids|glucocorticoids|mesh-ancestor
92150912|NCT05248633|Hormones|hormones|mesh-ancestor
92150913|NCT05248633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92150914|NCT05248633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92150915|NCT05248633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150916|NCT05248633|Immunologic Factors|immunologic factors|mesh-ancestor
92150917|NCT05248633|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92150918|NCT05248633|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92150919|NCT05248633|Growth Substances|growth substances|mesh-ancestor
92150920|NCT05248633|Growth Inhibitors|growth inhibitors|mesh-ancestor
92150921|NCT00216203|Pemetrexed|pemetrexed|mesh-list
92150922|NCT00216203|Cetuximab|cetuximab|mesh-list
92150923|NCT00216203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150924|NCT00216203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150925|NCT00216203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150926|NCT00216203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92150927|NCT00216203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92150928|NCT00216203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92150929|NCT01727271|Interferons|interferons|mesh-list
92150930|NCT01727271|Tenofovir|tenofovir|mesh-list
92150931|NCT01727271|Interferon-alpha|interferon-alpha|mesh-list
92150932|NCT01727271|Interferon alpha-2|interferon alpha-2|mesh-list
92150933|NCT01727271|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92150934|NCT01727271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92150935|NCT01727271|Antiviral Agents|antiviral agents|mesh-ancestor
92150936|NCT01727271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92150937|NCT01727271|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92150938|NCT01727271|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92150939|NCT01727271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150940|NCT01727271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150941|NCT01727271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92150942|NCT01727271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92150943|NCT01727271|Immunologic Factors|immunologic factors|mesh-ancestor
92150944|NCT01727271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150946|NCT00653796|Ezetimibe|ezetimibe|mesh-list
92150947|NCT00653796|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92150948|NCT00653796|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92150949|NCT00653796|Antimetabolites|antimetabolites|mesh-ancestor
91939634|NCT05386979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150950|NCT00653796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150951|NCT00653796|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92150952|NCT00653796|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92150953|NCT00653796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150954|NCT01833819|Lidocaine|lidocaine|mesh-list
92150955|NCT01833819|Dexmedetomidine|dexmedetomidine|mesh-list
92150956|NCT01833819|Remifentanil|remifentanil|mesh-list
92150957|NCT01833819|Anesthetics, Local|anesthetics, local|mesh-ancestor
92150958|NCT01833819|Anesthetics|anesthetics|mesh-ancestor
92150959|NCT01833819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150960|NCT01833819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150961|NCT01833819|Sensory System Agents|sensory system agents|mesh-ancestor
92150962|NCT01833819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150963|NCT01833819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92150964|NCT01833819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92150965|NCT01833819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92150966|NCT01833819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92150967|NCT01833819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150968|NCT01833819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92150969|NCT01833819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92150970|NCT01833819|Analgesics|analgesics|mesh-ancestor
92150971|NCT01833819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92150972|NCT01833819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92150973|NCT01833819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92150974|NCT01833819|Adrenergic Agents|adrenergic agents|mesh-ancestor
92150975|NCT01833819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92150976|NCT01833819|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92150977|NCT01833819|Narcotics|narcotics|mesh-ancestor
92150978|NCT05244109|Antibodies|antibodies|mesh-list
92150979|NCT05244109|Immunoglobulins|immunoglobulins|mesh-list
92150980|NCT05244109|Immunologic Factors|immunologic factors|mesh-ancestor
92150981|NCT05244109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150982|NCT00651144|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92150983|NCT00651144|Ezetimibe|ezetimibe|mesh-list
92150984|NCT00651144|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92150985|NCT00651144|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92150986|NCT00651144|Antimetabolites|antimetabolites|mesh-ancestor
92150987|NCT00651144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92150988|NCT00651144|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92150989|NCT00651144|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92150990|NCT00651144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92150991|NCT01721031|Tramadol|tramadol|mesh-list
92150992|NCT01721031|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92150993|NCT01721031|Narcotics|narcotics|mesh-ancestor
92150994|NCT01721031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92150995|NCT01721031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92150996|NCT01721031|Analgesics|analgesics|mesh-ancestor
92150997|NCT01721031|Sensory System Agents|sensory system agents|mesh-ancestor
92150998|NCT01721031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92150999|NCT03218683|Venetoclax|venetoclax|mesh-list
92151000|NCT03218683|AZD5991|azd5991|mesh-list
92151001|NCT03218683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151002|NCT03182491|Anaphylatoxins|anaphylatoxins|mesh-list
92151003|NCT03182491|Immunologic Factors|immunologic factors|mesh-ancestor
92151004|NCT03182491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151005|NCT04378647|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92151006|NCT04378647|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92151007|NCT04378647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92151008|NCT04378647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151009|NCT04378647|Immunotoxins|immunotoxins|mesh-ancestor
92151010|NCT04378647|Immunoconjugates|immunoconjugates|mesh-ancestor
92151011|NCT04378647|Immunologic Factors|immunologic factors|mesh-ancestor
92151012|NCT04378647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151013|NCT00370890|Gemcitabine|gemcitabine|mesh-list
92151014|NCT00370890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151015|NCT00370890|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92151016|NCT00370890|Antimetabolites|antimetabolites|mesh-ancestor
92151017|NCT00370890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151018|NCT02669953|Aflibercept|aflibercept|mesh-list
92151019|NCT02669953|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92151020|NCT02669953|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92151021|NCT02669953|Growth Substances|growth substances|mesh-ancestor
92151022|NCT02669953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151023|NCT02669953|Growth Inhibitors|growth inhibitors|mesh-ancestor
92151024|NCT02669953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151025|NCT03216967|Everolimus|everolimus|mesh-list
92151026|NCT03216967|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92151027|NCT03216967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92151028|NCT03216967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151029|NCT03216967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151030|NCT03216967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151031|NCT03216967|Immunologic Factors|immunologic factors|mesh-ancestor
92151032|NCT03216967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151033|NCT03216967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151034|NCT01721655|Spironolactone|spironolactone|mesh-list
92151035|NCT01721655|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92151036|NCT01721655|Hormone Antagonists|hormone antagonists|mesh-ancestor
92151037|NCT01721655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151038|NCT01721655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151039|NCT01721655|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92151040|NCT01721655|Diuretics|diuretics|mesh-ancestor
92151041|NCT01721655|Natriuretic Agents|natriuretic agents|mesh-ancestor
92151042|NCT00904995|Voriconazole|voriconazole|mesh-list
92151043|NCT00904995|Antifungal Agents|antifungal agents|mesh-ancestor
92151044|NCT00904995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151045|NCT00904995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92151046|NCT00904995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151047|NCT00904995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151048|NCT00904995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151049|NCT00904995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92151050|NCT00904995|Hormone Antagonists|hormone antagonists|mesh-ancestor
92151051|NCT00904995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151052|NCT00904995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151053|NCT00904995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92151054|NCT05249725|Irsogladine|irsogladine|mesh-list
92151055|NCT05249725|Hydrotalcite|hydrotalcite|mesh-list
92151056|NCT05249725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151057|NCT05249725|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92151058|NCT05249725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151059|NCT05249725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151060|NCT05249725|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92151061|NCT05249725|Protective Agents|protective agents|mesh-ancestor
92151062|NCT05249725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151063|NCT05249725|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92151064|NCT05249725|Antacids|antacids|mesh-ancestor
92151065|NCT01834209|Prednisone|prednisone|mesh-list
92151066|NCT01834209|Prednisolone|prednisolone|mesh-list
92151067|NCT01834209|Abiraterone Acetate|abiraterone acetate|mesh-list
92151068|NCT01834209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151069|NCT01834209|Glucocorticoids|glucocorticoids|mesh-ancestor
92151070|NCT01834209|Hormones|hormones|mesh-ancestor
92151071|NCT01834209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151072|NCT01834209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151073|NCT01834209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92151074|NCT01834209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151075|NCT01834209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92151076|NCT01834209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151077|NCT01834209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151078|NCT01834209|Hormone Antagonists|hormone antagonists|mesh-ancestor
92151079|NCT01834209|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151080|NCT05241535|Moxifloxacin|moxifloxacin|mesh-list
92151081|NCT05241535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92151082|NCT05241535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151083|NCT05241535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92151084|NCT05241535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92151085|NCT05241535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151086|NCT05241535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151087|NCT05241535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151088|NCT02488135|Hemostatics|hemostatics|mesh-list
92151089|NCT02488135|Coagulants|coagulants|mesh-ancestor
92151090|NCT01727973|Doxycycline|doxycycline|mesh-list
92151091|NCT01727973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92151092|NCT01727973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151093|NCT01727973|Antimalarials|antimalarials|mesh-ancestor
92151094|NCT01727973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92151095|NCT01727973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92151096|NCT03100734|Etanercept|etanercept|mesh-list
92151097|NCT03100734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92151098|NCT03100734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151099|NCT03100734|Analgesics|analgesics|mesh-ancestor
92151100|NCT03100734|Sensory System Agents|sensory system agents|mesh-ancestor
92151101|NCT03100734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151102|NCT03100734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151103|NCT03100734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151104|NCT03100734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151105|NCT03100734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151106|NCT03100734|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151107|NCT03100734|Immunologic Factors|immunologic factors|mesh-ancestor
92151108|NCT05243706|Loratadine|loratadine|mesh-list
92151109|NCT05243706|Antipruritics|antipruritics|mesh-ancestor
92151110|NCT05243706|Dermatologic Agents|dermatologic agents|mesh-ancestor
92151111|NCT05243706|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92151112|NCT05243706|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92151113|NCT05243706|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92151114|NCT05243706|Histamine Antagonists|histamine antagonists|mesh-ancestor
92151115|NCT05243706|Histamine Agents|histamine agents|mesh-ancestor
92151116|NCT05243706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151117|NCT05243706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151118|NCT05243706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151119|NCT01728051|Melphalan|melphalan|mesh-list
92151120|NCT01728051|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92151121|NCT01728051|Alkylating Agents|alkylating agents|mesh-ancestor
92151122|NCT01728051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151123|NCT01728051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151124|NCT01728051|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92151125|NCT01728051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151126|NCT01728051|Immunologic Factors|immunologic factors|mesh-ancestor
92151127|NCT01728051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151128|NCT01722201|Risperidone|risperidone|mesh-list
92151129|NCT01722201|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92151130|NCT01722201|Serotonin Agents|serotonin agents|mesh-ancestor
92151131|NCT01722201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151132|NCT01722201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151133|NCT01722201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151134|NCT01722201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92151135|NCT01722201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92151136|NCT01722201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151137|NCT01722201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92151138|NCT01722201|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92151139|NCT01722201|Dopamine Agents|dopamine agents|mesh-ancestor
92151140|NCT01722513|Alprostadil|alprostadil|mesh-list
92151141|NCT01722513|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92151142|NCT01722513|Vasodilator Agents|vasodilator agents|mesh-ancestor
92151143|NCT01722513|Urological Agents|urological agents|mesh-ancestor
92151144|NCT03179995|Octreotide|octreotide|mesh-list
92151145|NCT03179995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151146|NCT03179995|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92151147|NCT03179995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151148|NCT01728441|Paclitaxel|paclitaxel|mesh-list
92151149|NCT01728441|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92151150|NCT01728441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92151151|NCT01728441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151152|NCT01728441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151153|NCT01728441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151154|NCT01728441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151155|NCT01728441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151156|NCT03099408|Metronidazole|metronidazole|mesh-list
92151157|NCT03099408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151158|NCT03099408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92151159|NCT03099408|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92151160|NCT03099408|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92151161|NCT04984200|Mydriatics|mydriatics|mesh-list
92151162|NCT04984200|Autonomic Agents|autonomic agents|mesh-ancestor
92151163|NCT04984200|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151164|NCT04984200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151165|NCT00912873|Ropivacaine|ropivacaine|mesh-list
92151166|NCT00912873|Anesthetics, Local|anesthetics, local|mesh-ancestor
92151167|NCT00912873|Anesthetics|anesthetics|mesh-ancestor
92151168|NCT00912873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151169|NCT00912873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151170|NCT00912873|Sensory System Agents|sensory system agents|mesh-ancestor
92151171|NCT00912873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151172|NCT01494038|Isoniazid|isoniazid|mesh-list
91939635|NCT02367352|Paclitaxel|paclitaxel|mesh-list
92151173|NCT01494038|Antitubercular Agents|antitubercular agents|mesh-ancestor
92151174|NCT01494038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92151175|NCT01494038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151176|NCT01494038|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92151177|NCT01494038|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92151178|NCT01494038|Antimetabolites|antimetabolites|mesh-ancestor
92151179|NCT01494038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151180|NCT01494038|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92151181|NCT05059782|Coal Tar|coal tar|mesh-list
92151182|NCT05059782|Keratolytic Agents|keratolytic agents|mesh-ancestor
92151183|NCT05059782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92151184|NCT05242081|Sufentanil|sufentanil|mesh-list
92151185|NCT05242081|Ketamine|ketamine|mesh-list
92151186|NCT05242081|Esketamine|esketamine|mesh-list
92151187|NCT05242081|Analgesics|analgesics|mesh-ancestor
92151188|NCT05242081|Sensory System Agents|sensory system agents|mesh-ancestor
92151189|NCT05242081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151190|NCT05242081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151191|NCT05242081|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92151192|NCT05242081|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92151193|NCT05242081|Anesthetics, General|anesthetics, general|mesh-ancestor
92151194|NCT05242081|Anesthetics|anesthetics|mesh-ancestor
92151195|NCT05242081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151196|NCT05242081|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92151197|NCT05242081|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92151198|NCT05242081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151199|NCT05242081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151200|NCT05242081|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92151201|NCT05242081|Narcotics|narcotics|mesh-ancestor
92151202|NCT05242081|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92151203|NCT05242081|Antidepressive Agents|antidepressive agents|mesh-ancestor
92151204|NCT05242081|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92151205|NCT03149029|Pembrolizumab|pembrolizumab|mesh-list
92151206|NCT03149029|Trametinib|trametinib|mesh-list
92151207|NCT03149029|Dabrafenib|dabrafenib|mesh-list
92151208|NCT03149029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92151209|NCT03149029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151210|NCT03149029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92151211|NCT03149029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151212|NCT03149029|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92151213|NCT03149029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151214|NCT04412304|Dalteparin|dalteparin|mesh-list
92151215|NCT04412304|Tinzaparin|tinzaparin|mesh-list
92151216|NCT04412304|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92151217|NCT04412304|Anticoagulants|anticoagulants|mesh-ancestor
92151218|NCT04412304|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92151219|NCT04412304|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92151220|NCT04412304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151221|NCT00915603|Paclitaxel|paclitaxel|mesh-list
92151222|NCT00915603|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92151223|NCT00915603|Bevacizumab|bevacizumab|mesh-list
92151224|NCT00915603|Everolimus|everolimus|mesh-list
92151225|NCT00915603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92151226|NCT00915603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151227|NCT00915603|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151228|NCT00915603|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151229|NCT00915603|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151230|NCT00915603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151231|NCT00915603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92151232|NCT00915603|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92151233|NCT00915603|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92151234|NCT00915603|Growth Substances|growth substances|mesh-ancestor
92151235|NCT00915603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151236|NCT00915603|Growth Inhibitors|growth inhibitors|mesh-ancestor
92151237|NCT00915603|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92151238|NCT00915603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92151239|NCT00915603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151241|NCT00915603|Immunologic Factors|immunologic factors|mesh-ancestor
92151242|NCT01929265|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92151243|NCT01929265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92151244|NCT01929265|Alkylating Agents|alkylating agents|mesh-ancestor
92151245|NCT01929265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151246|NCT01929265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151248|NCT01929421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92151249|NCT01929421|Antimetabolites|antimetabolites|mesh-ancestor
92151485|NCT01835691|Micronutrients|micronutrients|mesh-ancestor
92151250|NCT01929421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151251|NCT01929421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151252|NCT04474002|Picosulfate sodium|picosulfate sodium|mesh-list
92151253|NCT04474002|Cathartics|cathartics|mesh-ancestor
92151254|NCT04474002|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151255|NCT01929577|Peficitinib|peficitinib|mesh-list
92151256|NCT01929577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151257|NCT01929577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151258|NCT01929577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151259|NCT01929577|Immunologic Factors|immunologic factors|mesh-ancestor
92151260|NCT01929577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151261|NCT03142321|Vedolizumab|vedolizumab|mesh-list
92151262|NCT03142321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151263|NCT01929655|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92151264|NCT01929655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151265|NCT03836703|Iron|iron|mesh-list
92151266|NCT03836703|Trace Elements|trace elements|mesh-ancestor
92151267|NCT03836703|Micronutrients|micronutrients|mesh-ancestor
92151268|NCT03836703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151269|NCT02398825|Ponatinib|ponatinib|mesh-list
92151270|NCT02398825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151271|NCT02398825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92151272|NCT02398825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151273|NCT02398825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151274|NCT01723059|Amoxicillin|amoxicillin|mesh-list
92151275|NCT01723059|Metronidazole|metronidazole|mesh-list
92151276|NCT01723059|Clarithromycin|clarithromycin|mesh-list
92151277|NCT01723059|Omeprazole|omeprazole|mesh-list
92151278|NCT01723059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92151279|NCT01723059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151280|NCT01723059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92151281|NCT01723059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92151282|NCT01723059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92151283|NCT01723059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151284|NCT01723059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92151285|NCT01723059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151286|NCT01723059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151287|NCT01723059|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92151288|NCT01723059|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92151289|NCT01723059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151290|NCT04379271|Calcium|calcium|mesh-list
92151291|NCT04379271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92151292|NCT04379271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151293|NCT01728909|Oxytocin|oxytocin|mesh-list
92151294|NCT01728909|Oxytocics|oxytocics|mesh-ancestor
92151295|NCT01728909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92151296|NCT01728909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151297|NCT01922713|Vitamin A|vitamin a|mesh-list
92151298|NCT01922713|Beta Carotene|beta carotene|mesh-list
92151299|NCT01922713|Retinol palmitate|retinol palmitate|mesh-list
92151300|NCT01922713|Vitamins|vitamins|mesh-ancestor
92151301|NCT01922713|Micronutrients|micronutrients|mesh-ancestor
92151302|NCT01922713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151303|NCT01922713|Antioxidants|antioxidants|mesh-ancestor
92151304|NCT01922713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151305|NCT01922713|Protective Agents|protective agents|mesh-ancestor
92151306|NCT01922713|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92151307|NCT01922713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151308|NCT01922713|Provitamins|provitamins|mesh-ancestor
92151309|NCT05061732|Amoxicillin|amoxicillin|mesh-list
92151310|NCT05061732|Metronidazole|metronidazole|mesh-list
92151311|NCT05061732|Clarithromycin|clarithromycin|mesh-list
92151312|NCT05061732|Doxycycline|doxycycline|mesh-list
92151313|NCT05061732|Levofloxacin|levofloxacin|mesh-list
92151314|NCT05061732|Tetracycline|tetracycline|mesh-list
92151315|NCT05061732|Potassium Citrate|potassium citrate|mesh-list
92151317|NCT05061732|Bismuth|bismuth|mesh-list
92151318|NCT05061732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151320|NCT05061732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151321|NCT05061732|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92151322|NCT05061732|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92151323|NCT05061732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92151324|NCT05061732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151325|NCT05061732|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92151326|NCT05061732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151327|NCT05061732|Antimalarials|antimalarials|mesh-ancestor
92151328|NCT05061732|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92151329|NCT05061732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92151330|NCT05061732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92151331|NCT05061732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151332|NCT05061732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92151333|NCT05061732|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92151334|NCT05061732|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151335|NCT05061732|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92151337|NCT05061732|Diuretics|diuretics|mesh-ancestor
92151338|NCT05061732|Natriuretic Agents|natriuretic agents|mesh-ancestor
92151339|NCT05061732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151340|NCT05061732|Expectorants|expectorants|mesh-ancestor
92151341|NCT05061732|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151342|NCT02391571|Naltrexone|naltrexone|mesh-list
92151343|NCT02391571|Oxycodone|oxycodone|mesh-list
92151344|NCT02391571|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92151345|NCT02391571|Narcotics|narcotics|mesh-ancestor
92151346|NCT02391571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151347|NCT02391571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151348|NCT02391571|Analgesics|analgesics|mesh-ancestor
92151349|NCT02391571|Sensory System Agents|sensory system agents|mesh-ancestor
92151350|NCT02391571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151351|NCT02391571|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92151352|NCT02391571|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92151353|NCT01728987|Cholecalciferol|cholecalciferol|mesh-list
92151354|NCT01728987|Vitamin D|vitamin d|mesh-list
92151355|NCT01728987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92151356|NCT01728987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151357|NCT01728987|Vitamins|vitamins|mesh-ancestor
92151358|NCT01728987|Micronutrients|micronutrients|mesh-ancestor
92151359|NCT01728987|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92151360|NCT01834989|Mitogens|mitogens|mesh-list
92151361|NCT01834989|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151362|NCT01834989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151363|NCT01835067|Ranibizumab|ranibizumab|mesh-list
92151364|NCT01835067|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92151365|NCT01835067|Plasminogen|plasminogen|mesh-list
92151366|NCT01835067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92151367|NCT01835067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92151368|NCT01835067|Growth Substances|growth substances|mesh-ancestor
92151369|NCT01835067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151370|NCT01835067|Growth Inhibitors|growth inhibitors|mesh-ancestor
92151371|NCT01835067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151372|NCT01835067|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92151373|NCT01835067|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92151374|NCT01835067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151375|NCT03100422|Armin|armin|mesh-list
92151376|NCT03100422|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92151377|NCT03100422|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151378|NCT03100422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151379|NCT03100422|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151380|NCT03100422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151381|NCT03100422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151382|NCT00639769|Cisplatin|cisplatin|mesh-list
92151383|NCT00639769|Irinotecan|irinotecan|mesh-list
92151384|NCT00639769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151385|NCT00639769|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92151386|NCT00639769|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92151387|NCT00639769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151388|NCT00639769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151389|NCT01723371|Carvedilol|carvedilol|mesh-list
92151390|NCT01723371|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92151391|NCT01723371|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92151392|NCT01723371|Adrenergic Agents|adrenergic agents|mesh-ancestor
92151393|NCT01723371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151394|NCT01723371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151395|NCT01723371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151396|NCT01723371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92151397|NCT01723371|Antioxidants|antioxidants|mesh-ancestor
92151398|NCT01723371|Protective Agents|protective agents|mesh-ancestor
92151399|NCT01723371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92151400|NCT01723371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92151401|NCT01723371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92151402|NCT01723371|Vasodilator Agents|vasodilator agents|mesh-ancestor
92151403|NCT01723371|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92151404|NCT01723371|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92151405|NCT00639457|Pioglitazone|pioglitazone|mesh-list
92151406|NCT00639457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92151407|NCT00639457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151408|NCT05057286|Botulinum Toxins|botulinum toxins|mesh-list
92151409|NCT05057286|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92151410|NCT05057286|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92151411|NCT05057286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92151412|NCT05057286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151413|NCT05057286|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151414|NCT05057286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151415|NCT05057286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151416|NCT05057286|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92151417|NCT05057286|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151418|NCT01723527|Buprenorphine|buprenorphine|mesh-list
92151419|NCT01723527|Methadone|methadone|mesh-list
92151420|NCT01723527|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92151421|NCT01723527|Narcotics|narcotics|mesh-ancestor
92151422|NCT01723527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151423|NCT01723527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151424|NCT01723527|Analgesics|analgesics|mesh-ancestor
92151425|NCT01723527|Sensory System Agents|sensory system agents|mesh-ancestor
92151426|NCT01723527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151427|NCT01723527|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92151428|NCT01723527|Antitussive Agents|antitussive agents|mesh-ancestor
92151429|NCT01723527|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151430|NCT00639223|Pravastatin|pravastatin|mesh-list
92151431|NCT00639223|Red yeast rice|red yeast rice|mesh-list
92151432|NCT00639223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92151433|NCT00639223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92151434|NCT00639223|Antimetabolites|antimetabolites|mesh-ancestor
92151435|NCT00639223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151436|NCT00639223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92151437|NCT00639223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92151438|NCT00639223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151439|NCT01723683|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92151440|NCT01723683|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151441|NCT03519984|Cytarabine|cytarabine|mesh-list
92151442|NCT03519984|Vincristine|vincristine|mesh-list
92151443|NCT03519984|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92151444|NCT03519984|Antimetabolites|antimetabolites|mesh-ancestor
92151445|NCT03519984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151446|NCT03519984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151447|NCT03519984|Antiviral Agents|antiviral agents|mesh-ancestor
92151448|NCT03519984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151449|NCT03519984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151450|NCT03519984|Immunologic Factors|immunologic factors|mesh-ancestor
92151451|NCT03519984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151452|NCT03519984|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92151453|NCT03519984|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151454|NCT03519984|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151455|NCT03519984|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151456|NCT05056896|Aspirin|aspirin|mesh-list
92151457|NCT05056896|Salicylic Acid|salicylic acid|mesh-list
92151458|NCT05056896|Salicylates|salicylates|mesh-list
92151459|NCT05056896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92151460|NCT05056896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151461|NCT05056896|Analgesics|analgesics|mesh-ancestor
92151462|NCT05056896|Sensory System Agents|sensory system agents|mesh-ancestor
92151463|NCT05056896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151464|NCT05056896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151465|NCT05056896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151466|NCT05056896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151467|NCT05056896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92151468|NCT05056896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92151469|NCT05056896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151470|NCT05056896|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92151471|NCT05056896|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92151472|NCT05056896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151473|NCT05056896|Antipyretics|antipyretics|mesh-ancestor
92151474|NCT05056896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151475|NCT05056896|Antifungal Agents|antifungal agents|mesh-ancestor
92151476|NCT05056896|Keratolytic Agents|keratolytic agents|mesh-ancestor
92151477|NCT05056896|Dermatologic Agents|dermatologic agents|mesh-ancestor
92151478|NCT00638989|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92151479|NCT00638989|Immunologic Factors|immunologic factors|mesh-ancestor
92151480|NCT00638989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151482|NCT01835691|Ergocalciferols|ergocalciferols|mesh-list
92151483|NCT01835691|Cholecalciferol|cholecalciferol|mesh-list
92151486|NCT01835691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151487|NCT01835691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92151488|NCT01835691|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92151489|NCT01729767|Acyclovir|acyclovir|mesh-list
92151490|NCT01729767|Antiviral Agents|antiviral agents|mesh-ancestor
92151491|NCT01729767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151492|NCT00913263|Flutamide|flutamide|mesh-list
92151493|NCT00913263|Hydroxyflutamide|hydroxyflutamide|mesh-list
92151494|NCT00913263|Androgen Antagonists|androgen antagonists|mesh-ancestor
92151495|NCT00913263|Hormone Antagonists|hormone antagonists|mesh-ancestor
92151496|NCT00913263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151497|NCT00913263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151498|NCT00913263|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92151499|NCT00913263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151500|NCT04377867|Abatacept|abatacept|mesh-list
92151501|NCT04377867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92151502|NCT04377867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151503|NCT04377867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92151504|NCT04377867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151505|NCT04377867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92151506|NCT04377867|Immunologic Factors|immunologic factors|mesh-ancestor
92151507|NCT04377867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151508|NCT04377867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151509|NCT00637273|Pioglitazone|pioglitazone|mesh-list
92151510|NCT00637273|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92151511|NCT00637273|Exenatide|exenatide|mesh-list
92151512|NCT00637273|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92151513|NCT00637273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151514|NCT00637273|Incretins|incretins|mesh-ancestor
92151515|NCT00637273|Hormones|hormones|mesh-ancestor
92151516|NCT00637273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151517|NCT00637273|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92151518|NCT00637273|Protease Inhibitors|protease inhibitors|mesh-ancestor
92151519|NCT00637273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151520|NCT00637273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151521|NCT00637273|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92151522|NCT01923259|Donepezil|donepezil|mesh-list
92151523|NCT01923259|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92151524|NCT01923259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151525|NCT01923259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151526|NCT01923259|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151527|NCT01923259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151528|NCT01923259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151529|NCT01923259|Nootropic Agents|nootropic agents|mesh-ancestor
92151530|NCT01923337|Irinotecan|irinotecan|mesh-list
92151531|NCT01923337|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92151532|NCT01923337|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92151533|NCT01923337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151534|NCT01923337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151535|NCT01923337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151536|NCT03098160|Ipilimumab|ipilimumab|mesh-list
92151537|NCT03098160|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92151538|NCT03098160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151539|NCT03098160|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92151540|NCT03098160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151541|NCT01720563|Leucovorin|leucovorin|mesh-list
92151543|NCT01720563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151544|NCT01720563|Antidotes|antidotes|mesh-ancestor
92151545|NCT01720563|Protective Agents|protective agents|mesh-ancestor
92151546|NCT01720563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151547|NCT01720563|Vitamin B Complex|vitamin b complex|mesh-ancestor
92151549|NCT01720563|Micronutrients|micronutrients|mesh-ancestor
92151550|NCT01720563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92151551|NCT01720563|Antimetabolites|antimetabolites|mesh-ancestor
92151552|NCT01720563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151553|NCT01724385|Bevacizumab|bevacizumab|mesh-list
92151554|NCT01724385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92151555|NCT01724385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151556|NCT01724385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92151557|NCT01724385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92151558|NCT01724385|Growth Substances|growth substances|mesh-ancestor
92151559|NCT01724385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151560|NCT01724385|Growth Inhibitors|growth inhibitors|mesh-ancestor
92151561|NCT04377789|Quercetin|quercetin|mesh-list
92151563|NCT04377789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151564|NCT04377789|Protective Agents|protective agents|mesh-ancestor
92151565|NCT04377789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151567|NCT00988117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92151568|NCT00988117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151569|NCT00988117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151570|NCT00988117|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151571|NCT00988117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151572|NCT00988117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151573|NCT00988117|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92151574|NCT00988117|Protective Agents|protective agents|mesh-ancestor
92151575|NCT01728753|Favipiravir|favipiravir|mesh-list
92151576|NCT01728753|Antiviral Agents|antiviral agents|mesh-ancestor
92151577|NCT01728753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151578|NCT01724619|Dihydrotestosterone|dihydrotestosterone|mesh-list
92151579|NCT01724619|Androgens|androgens|mesh-ancestor
92151580|NCT01724619|Hormones|hormones|mesh-ancestor
92151581|NCT01724619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151582|NCT01724619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151583|NCT05045508|Varenicline|varenicline|mesh-list
92151584|NCT05045508|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92151585|NCT05045508|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92151586|NCT05045508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151587|NCT05045508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151588|NCT05045508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151589|NCT05045508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151590|NCT00637195|Vaccines|vaccines|mesh-list
92151591|NCT00637195|Immunologic Factors|immunologic factors|mesh-ancestor
92151592|NCT00637195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151593|NCT05045274|Aspirin|aspirin|mesh-list
92151594|NCT05045274|Dapagliflozin|dapagliflozin|mesh-list
92151595|NCT05045274|Angiotensin II|angiotensin ii|mesh-list
92151596|NCT05045274|Giapreza|giapreza|mesh-list
92151597|NCT05045274|Clopidogrel|clopidogrel|mesh-list
92151598|NCT05045274|Ticagrelor|ticagrelor|mesh-list
92151599|NCT05045274|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92151600|NCT05045274|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92151601|NCT05045274|Angiotensinogen|angiotensinogen|mesh-list
92151602|NCT05045274|Diuretics|diuretics|mesh-list
92151603|NCT05045274|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92151604|NCT05045274|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92151605|NCT05045274|Mineralocorticoids|mineralocorticoids|mesh-list
92151606|NCT05045274|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92151607|NCT05045274|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92151608|NCT05045274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92151609|NCT05045274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151610|NCT05045274|Analgesics|analgesics|mesh-ancestor
92151611|NCT05045274|Sensory System Agents|sensory system agents|mesh-ancestor
92151612|NCT05045274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151613|NCT05045274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151614|NCT05045274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151615|NCT05045274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151616|NCT05045274|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92151617|NCT05045274|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92151618|NCT05045274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151619|NCT05045274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92151620|NCT05045274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92151622|NCT05045274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92151623|NCT05045274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92151624|NCT05045274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92151625|NCT05045274|Purinergic Agents|purinergic agents|mesh-ancestor
92151626|NCT05045274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151627|NCT05045274|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92151628|NCT05045274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92151629|NCT05045274|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92151630|NCT05045274|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92151631|NCT05045274|Antimetabolites|antimetabolites|mesh-ancestor
92151632|NCT05045274|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92151633|NCT05045274|Natriuretic Agents|natriuretic agents|mesh-ancestor
92151634|NCT05045274|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92151635|NCT05045274|Adrenergic Agents|adrenergic agents|mesh-ancestor
92151636|NCT05045274|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92151637|NCT05045274|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92151638|NCT05045274|Protease Inhibitors|protease inhibitors|mesh-ancestor
92151639|NCT05045274|Hormones|hormones|mesh-ancestor
92151640|NCT05045274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151641|NCT05045274|Hormone Antagonists|hormone antagonists|mesh-ancestor
92151642|NCT05045274|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92151643|NCT01721733|Ubiquinone|ubiquinone|mesh-list
92151644|NCT01721733|Micronutrients|micronutrients|mesh-ancestor
92151645|NCT01721733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151646|NCT01720485|Prednisolone|prednisolone|mesh-list
92151647|NCT01720485|Betamethasone|betamethasone|mesh-list
92151648|NCT01720485|Desloratadine|desloratadine|mesh-list
92151649|NCT01720485|Dexchlorpheniramine|dexchlorpheniramine|mesh-list
92151650|NCT01720485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151651|NCT01720485|Glucocorticoids|glucocorticoids|mesh-ancestor
92151652|NCT01720485|Hormones|hormones|mesh-ancestor
92151653|NCT01720485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151654|NCT01720485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151655|NCT01720485|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92151656|NCT01720485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151657|NCT01720485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92151658|NCT01720485|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151659|NCT01720485|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92151660|NCT01720485|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151661|NCT01720485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151662|NCT01720485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151663|NCT01720485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92151664|NCT01720485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92151665|NCT01720485|Histamine Antagonists|histamine antagonists|mesh-ancestor
92151666|NCT01720485|Histamine Agents|histamine agents|mesh-ancestor
92151667|NCT01726725|Desflurane|desflurane|mesh-list
92151668|NCT01726725|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92151669|NCT01726725|Anesthetics, General|anesthetics, general|mesh-ancestor
92151670|NCT01726725|Anesthetics|anesthetics|mesh-ancestor
92151671|NCT01726725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151672|NCT01726725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151673|NCT05044728|Paclitaxel|paclitaxel|mesh-list
92151674|NCT05044728|Carboplatin|carboplatin|mesh-list
92151675|NCT05044728|Antibodies|antibodies|mesh-list
92151676|NCT05044728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92151677|NCT05044728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151678|NCT05044728|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151679|NCT05044728|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151680|NCT05044728|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151681|NCT05044728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151682|NCT05044728|Immunologic Factors|immunologic factors|mesh-ancestor
92151683|NCT05044728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151684|NCT05054478|Daratumumab|daratumumab|mesh-list
92151685|NCT05054478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151686|NCT01041807|Losartan|losartan|mesh-list
92151687|NCT01041807|Amlodipine|amlodipine|mesh-list
92151688|NCT01041807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92151689|NCT01041807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92151690|NCT01041807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92151691|NCT01041807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151692|NCT01041807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92151693|NCT01041807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151694|NCT01041807|Vasodilator Agents|vasodilator agents|mesh-ancestor
92151695|NCT01041807|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92151696|NCT01041807|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92151697|NCT01041807|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92151698|NCT01724931|Aminopterin|aminopterin|mesh-list
92151699|NCT01724931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92151700|NCT01724931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151701|NCT01724931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151703|NCT00635089|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92151704|NCT00635089|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151705|NCT01725009|Levetiracetam|levetiracetam|mesh-list
92151706|NCT01725009|Anticonvulsants|anticonvulsants|mesh-ancestor
92151707|NCT01725009|Nootropic Agents|nootropic agents|mesh-ancestor
92151708|NCT01725087|Tapentadol|tapentadol|mesh-list
92151709|NCT01725087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92151710|NCT01725087|Narcotics|narcotics|mesh-ancestor
92151711|NCT01725087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151712|NCT01725087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151713|NCT01725087|Analgesics|analgesics|mesh-ancestor
92151714|NCT01725087|Sensory System Agents|sensory system agents|mesh-ancestor
92151715|NCT01725087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151716|NCT01725087|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92151717|NCT01725087|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92151718|NCT01725087|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92151719|NCT01725087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151720|NCT01725087|Adrenergic Agents|adrenergic agents|mesh-ancestor
92151721|NCT01725087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151722|NCT04151082|Prednisone|prednisone|mesh-list
92151723|NCT04151082|Methylprednisolone|methylprednisolone|mesh-list
92151724|NCT04151082|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92151725|NCT04151082|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92151726|NCT04151082|Prednisolone|prednisolone|mesh-list
92151727|NCT04151082|Prednisolone acetate|prednisolone acetate|mesh-list
92151728|NCT04151082|Cortisone|cortisone|mesh-list
92151729|NCT04151082|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92151730|NCT04151082|Prednisolone phosphate|prednisolone phosphate|mesh-list
92151731|NCT04151082|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151732|NCT04151082|Glucocorticoids|glucocorticoids|mesh-ancestor
92151733|NCT04151082|Hormones|hormones|mesh-ancestor
92151734|NCT04151082|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151735|NCT04151082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151736|NCT04151082|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92151737|NCT04151082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151738|NCT04151082|Antiemetics|antiemetics|mesh-ancestor
92151739|NCT04151082|Autonomic Agents|autonomic agents|mesh-ancestor
92151740|NCT04151082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151741|NCT04151082|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151742|NCT04151082|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92151743|NCT04151082|Protective Agents|protective agents|mesh-ancestor
92151744|NCT00634543|Acetaminophen|acetaminophen|mesh-list
92151745|NCT00634543|Gabapentin|gabapentin|mesh-list
92151746|NCT00634543|Tramadol|tramadol|mesh-list
92151747|NCT00634543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151748|NCT00634543|Analgesics|analgesics|mesh-ancestor
92151749|NCT00634543|Sensory System Agents|sensory system agents|mesh-ancestor
92151750|NCT00634543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151751|NCT00634543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151752|NCT00634543|Antipyretics|antipyretics|mesh-ancestor
92151753|NCT00634543|Anticonvulsants|anticonvulsants|mesh-ancestor
92151754|NCT00634543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92151755|NCT00634543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92151756|NCT00634543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151757|NCT00634543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92151758|NCT00634543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92151759|NCT00634543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92151760|NCT00634543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151761|NCT00634543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151762|NCT00634543|Antimanic Agents|antimanic agents|mesh-ancestor
92151763|NCT00634543|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92151764|NCT00634543|Narcotics|narcotics|mesh-ancestor
92151765|NCT05054322|Fluticasone|fluticasone|mesh-list
92151766|NCT05054322|Xhance|xhance|mesh-list
92151767|NCT05054322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151768|NCT05054322|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92151769|NCT05054322|Autonomic Agents|autonomic agents|mesh-ancestor
92151770|NCT05054322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151771|NCT05054322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151773|NCT05054322|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151774|NCT05054322|Dermatologic Agents|dermatologic agents|mesh-ancestor
92151775|NCT05054322|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92151776|NCT00985465|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92151777|NCT00985465|Immunologic Factors|immunologic factors|mesh-ancestor
92151778|NCT00985465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151779|NCT03097380|Tiotropium Bromide|tiotropium bromide|mesh-list
92151780|NCT03097380|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92151781|NCT03097380|Autonomic Agents|autonomic agents|mesh-ancestor
92151782|NCT03097380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151783|NCT03097380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151784|NCT03097380|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92151785|NCT03097380|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151786|NCT03097380|Parasympatholytics|parasympatholytics|mesh-ancestor
92151787|NCT03097380|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92151788|NCT03097380|Cholinergic Agents|cholinergic agents|mesh-ancestor
92151789|NCT03097380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151790|NCT03097380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151791|NCT04759729|Vitamin D|vitamin d|mesh-list
92151792|NCT04759729|Ergocalciferols|ergocalciferols|mesh-list
92151796|NCT04759729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151797|NCT04759729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92151798|NCT04759729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92151799|NCT05053386|Epirubicin|epirubicin|mesh-list
92151800|NCT05053386|Idarubicin|idarubicin|mesh-list
92151801|NCT05053386|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92151802|NCT05053386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151803|NCT05053386|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92151804|NCT05053386|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92151805|NCT05053386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151806|NCT05053386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151807|NCT01725243|Carbetocin|carbetocin|mesh-list
92151808|NCT01725243|Oxytocics|oxytocics|mesh-ancestor
92151809|NCT01725243|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92151810|NCT01725243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151811|NCT01725477|Methylene Blue|methylene blue|mesh-list
92151812|NCT01725477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151813|NCT01725477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151814|NCT03096990|Apremilast|apremilast|mesh-list
92151815|NCT03096990|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92151816|NCT03096990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151817|NCT03096990|Analgesics|analgesics|mesh-ancestor
92151818|NCT03096990|Sensory System Agents|sensory system agents|mesh-ancestor
92151819|NCT03096990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151820|NCT03096990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151821|NCT03096990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151822|NCT03096990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151823|NCT03096990|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92151824|NCT03096990|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92151825|NCT03096990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151826|NCT03096990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151827|NCT01725555|Podophyllotoxin|podophyllotoxin|mesh-list
92151828|NCT01725555|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92151829|NCT01725555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151830|NCT01725555|Keratolytic Agents|keratolytic agents|mesh-ancestor
92151831|NCT01725555|Dermatologic Agents|dermatologic agents|mesh-ancestor
92151832|NCT01725555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151833|NCT01725555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151834|NCT01725555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151835|NCT01725555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151836|NCT01048671|Raltegravir Potassium|raltegravir potassium|mesh-list
92151837|NCT01048671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92151838|NCT01048671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92151839|NCT01048671|Antiviral Agents|antiviral agents|mesh-ancestor
92151840|NCT01048671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151841|NCT01048671|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92151842|NCT01048671|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92151844|NCT01048671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151845|NCT03836781|Chlorhexidine|chlorhexidine|mesh-list
92151846|NCT03836781|Ketorolac|ketorolac|mesh-list
92151847|NCT03836781|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92151848|NCT03836781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151849|NCT03836781|Disinfectants|disinfectants|mesh-ancestor
92151850|NCT03836781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92151851|NCT03836781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151852|NCT03836781|Analgesics|analgesics|mesh-ancestor
92151853|NCT03836781|Sensory System Agents|sensory system agents|mesh-ancestor
92151854|NCT03836781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151855|NCT03836781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151856|NCT03836781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151857|NCT03836781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151858|NCT03836781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92151859|NCT03836781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151860|NCT03836781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151861|NCT01360866|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92151862|NCT01360866|Fluoxetine|fluoxetine|mesh-list
92151864|NCT01360866|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92151865|NCT01360866|Sertraline|sertraline|mesh-list
92151866|NCT01360866|Escitalopram|escitalopram|mesh-list
92151867|NCT01360866|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92151868|NCT01360866|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92151869|NCT01360866|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92151870|NCT01360866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151871|NCT01360866|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151873|NCT01360866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151874|NCT01360866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151875|NCT01360866|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92151876|NCT01360866|Antidepressive Agents|antidepressive agents|mesh-ancestor
92151877|NCT01360866|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92151878|NCT01360866|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92151879|NCT01360866|Analgesics|analgesics|mesh-ancestor
92151880|NCT01360866|Sensory System Agents|sensory system agents|mesh-ancestor
92151881|NCT01360866|Dopamine Agents|dopamine agents|mesh-ancestor
92151882|NCT01360866|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92151883|NCT01360866|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151884|NCT01360866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151885|NCT00984061|Clarithromycin|clarithromycin|mesh-list
92151886|NCT00984061|Colchicine|colchicine|mesh-list
92151887|NCT00984061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92151888|NCT00984061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151889|NCT00984061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92151890|NCT00984061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151891|NCT00984061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151892|NCT00984061|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92151893|NCT00984061|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151894|NCT00984061|Gout Suppressants|gout suppressants|mesh-ancestor
92151895|NCT00984061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151896|NCT00984061|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151897|NCT00984061|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151898|NCT00984061|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151899|NCT00984061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151900|NCT01046643|Estradiol|estradiol|mesh-list
92151901|NCT01046643|Progesterone|progesterone|mesh-list
92151902|NCT01046643|Estrogens|estrogens|mesh-ancestor
92151903|NCT01046643|Hormones|hormones|mesh-ancestor
92151904|NCT01046643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151905|NCT01046643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151906|NCT01046643|Progestins|progestins|mesh-ancestor
92151907|NCT03096756|Avasopasem manganese|avasopasem manganese|mesh-list
92151908|NCT03096756|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92151909|NCT03096756|Antioxidants|antioxidants|mesh-ancestor
92151910|NCT03096756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151911|NCT03096756|Protective Agents|protective agents|mesh-ancestor
92151912|NCT03096756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151913|NCT00983905|Colchicine|colchicine|mesh-list
92151914|NCT00983905|Theophylline|theophylline|mesh-list
92151915|NCT00983905|Gout Suppressants|gout suppressants|mesh-ancestor
92151916|NCT00983905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151917|NCT00983905|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151918|NCT00983905|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151919|NCT00983905|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151920|NCT00983905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151921|NCT00983905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151922|NCT00983905|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92151923|NCT00983905|Autonomic Agents|autonomic agents|mesh-ancestor
92151924|NCT00983905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151925|NCT00983905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151926|NCT00983905|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92151927|NCT00983905|Respiratory System Agents|respiratory system agents|mesh-ancestor
92151928|NCT00983905|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92151929|NCT00983905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151930|NCT00983905|Vasodilator Agents|vasodilator agents|mesh-ancestor
92151931|NCT00983905|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92151932|NCT00983905|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92151933|NCT00983905|Purinergic Agents|purinergic agents|mesh-ancestor
92151934|NCT00983905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151936|NCT01046565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92151937|NCT01046565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92151938|NCT01046565|Analgesics|analgesics|mesh-ancestor
92151939|NCT01046565|Sensory System Agents|sensory system agents|mesh-ancestor
92151940|NCT01046565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151941|NCT01046565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151942|NCT01046565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92151943|NCT01046565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151944|NCT01046565|Dermatologic Agents|dermatologic agents|mesh-ancestor
92151945|NCT01046253|Lansoprazole|lansoprazole|mesh-list
92151946|NCT01046253|Dexlansoprazole|dexlansoprazole|mesh-list
92151947|NCT01046253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92151948|NCT01046253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92151949|NCT01046253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92151950|NCT01046253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151951|NCT01046253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151952|NCT05050656|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92151953|NCT05050656|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92151954|NCT05050656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92151955|NCT05050656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92151956|NCT05050656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151957|NCT05050656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92151958|NCT05050656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151959|NCT05050656|Analgesics|analgesics|mesh-ancestor
92151960|NCT05050656|Sensory System Agents|sensory system agents|mesh-ancestor
92151961|NCT05050656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151962|NCT05050656|Antidepressive Agents|antidepressive agents|mesh-ancestor
92151963|NCT05050656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92151964|NCT05050656|Dopamine Agents|dopamine agents|mesh-ancestor
92151965|NCT00983515|Ritonavir|ritonavir|mesh-list
92151966|NCT00983515|Colchicine|colchicine|mesh-list
92151967|NCT00983515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92151968|NCT00983515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92151969|NCT00983515|Protease Inhibitors|protease inhibitors|mesh-ancestor
92151970|NCT00983515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92151971|NCT00983515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92151972|NCT00983515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92151973|NCT00983515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92151974|NCT00983515|Antiviral Agents|antiviral agents|mesh-ancestor
92151975|NCT00983515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92151976|NCT00983515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92151977|NCT00983515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92151978|NCT00983515|Gout Suppressants|gout suppressants|mesh-ancestor
92151979|NCT00983515|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92151980|NCT00983515|Tubulin Modulators|tubulin modulators|mesh-ancestor
92151981|NCT00983515|Antimitotic Agents|antimitotic agents|mesh-ancestor
92151982|NCT00983515|Mitosis Modulators|mitosis modulators|mesh-ancestor
92151983|NCT00983515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92151984|NCT05033574|Hormones|hormones|mesh-list
92151985|NCT05033574|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92151986|NCT05033574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151987|NCT04471818|Ketamine|ketamine|mesh-list
92151988|NCT04471818|Analgesics|analgesics|mesh-ancestor
92151989|NCT04471818|Sensory System Agents|sensory system agents|mesh-ancestor
92151990|NCT04471818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92151991|NCT04471818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92151993|NCT04471818|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92151994|NCT04471818|Anesthetics, General|anesthetics, general|mesh-ancestor
92151995|NCT04471818|Anesthetics|anesthetics|mesh-ancestor
92151996|NCT04471818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92151997|NCT04471818|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92151998|NCT04471818|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92151999|NCT04471818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152000|NCT04471818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152001|NCT05050188|Lansoprazole|lansoprazole|mesh-list
92152002|NCT05050188|Dexlansoprazole|dexlansoprazole|mesh-list
92152003|NCT05050188|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92152004|NCT05050188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92152005|NCT05050188|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92152006|NCT05050188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152007|NCT05050188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152008|NCT04434378|Tamsulosin|tamsulosin|mesh-list
92152009|NCT04434378|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92152011|NCT04434378|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92152012|NCT04434378|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152013|NCT04434378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152014|NCT04434378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152015|NCT04434378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152016|NCT04434378|Urological Agents|urological agents|mesh-ancestor
92152017|NCT00981799|Cyclophosphamide|cyclophosphamide|mesh-list
92152018|NCT00981799|Methotrexate|methotrexate|mesh-list
92152019|NCT00981799|Etoposide|etoposide|mesh-list
92152020|NCT00981799|Lenograstim|lenograstim|mesh-list
92152021|NCT00981799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152022|NCT00981799|Immunologic Factors|immunologic factors|mesh-ancestor
92152023|NCT00981799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152024|NCT00981799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152025|NCT00981799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92152026|NCT00981799|Alkylating Agents|alkylating agents|mesh-ancestor
92152027|NCT00981799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152028|NCT00981799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152029|NCT00981799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92152030|NCT00981799|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92152031|NCT00981799|Abortifacient Agents|abortifacient agents|mesh-ancestor
92152032|NCT00981799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92152033|NCT00981799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92152034|NCT00981799|Antimetabolites|antimetabolites|mesh-ancestor
92152035|NCT00981799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92152036|NCT00981799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152037|NCT00981799|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92152038|NCT00981799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92152039|NCT00981799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92152040|NCT00981799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92152041|NCT00981799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92152042|NCT00981799|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92152043|NCT05033106|Bevacizumab|bevacizumab|mesh-list
92152044|NCT05033106|Ranibizumab|ranibizumab|mesh-list
92152045|NCT05033106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152046|NCT05033106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152047|NCT05033106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92152048|NCT05033106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92152049|NCT05033106|Growth Substances|growth substances|mesh-ancestor
92152050|NCT05033106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152051|NCT05033106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92152052|NCT03095040|Everolimus|everolimus|mesh-list
92152053|NCT03095040|Vorolanib|vorolanib|mesh-list
92152054|NCT03095040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92152055|NCT03095040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92152056|NCT03095040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152057|NCT03095040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152058|NCT03095040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152059|NCT03095040|Immunologic Factors|immunologic factors|mesh-ancestor
92152060|NCT03095040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152061|NCT03095040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152062|NCT03099499|TIC10 compound|tic10 compound|mesh-list
92152063|NCT03099499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152064|NCT03096522|Phenytoin|phenytoin|mesh-list
92152065|NCT03096522|Anticonvulsants|anticonvulsants|mesh-ancestor
92152066|NCT03096522|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92152067|NCT03096522|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92152068|NCT03096522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92152069|NCT03096522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152070|NCT03096522|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92152071|NCT03096522|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92152073|NCT01045161|Anticonvulsants|anticonvulsants|mesh-ancestor
92152074|NCT05032248|Tacrolimus|tacrolimus|mesh-list
92152075|NCT05032248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152076|NCT05032248|Immunologic Factors|immunologic factors|mesh-ancestor
92152077|NCT05032248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152078|NCT05032248|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92152079|NCT05032248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152080|NCT05032248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152081|NCT00633217|Fluticasone|fluticasone|mesh-list
92152082|NCT00633217|Xhance|xhance|mesh-list
92152083|NCT00633217|Norflurane|norflurane|mesh-list
92152084|NCT00633217|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92152085|NCT00633217|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92152086|NCT00633217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152087|NCT00633217|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92152088|NCT00633217|Autonomic Agents|autonomic agents|mesh-ancestor
92152089|NCT00633217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152090|NCT00633217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152091|NCT00633217|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92152092|NCT00633217|Respiratory System Agents|respiratory system agents|mesh-ancestor
92152093|NCT00633217|Dermatologic Agents|dermatologic agents|mesh-ancestor
92152094|NCT00633217|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92152095|NCT00633217|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92152096|NCT00633217|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92152097|NCT00633217|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92152098|NCT00633217|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152099|NCT00633217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152100|NCT00633217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152101|NCT00633217|Glucocorticoids|glucocorticoids|mesh-ancestor
92152103|NCT00633217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152104|NCT00633217|Sympathomimetics|sympathomimetics|mesh-ancestor
92152105|NCT00633217|Anesthetics|anesthetics|mesh-ancestor
92152106|NCT00633217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152107|NCT01673490|Tamsulosin|tamsulosin|mesh-list
92152108|NCT01673490|Dutasteride|dutasteride|mesh-list
92152109|NCT01673490|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92152110|NCT01673490|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92152111|NCT01673490|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92152112|NCT01673490|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152113|NCT01673490|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152114|NCT01673490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152115|NCT01673490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152116|NCT01673490|Urological Agents|urological agents|mesh-ancestor
92152117|NCT01673490|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92152118|NCT01673490|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92152119|NCT01673490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152120|NCT01673490|Hormone Antagonists|hormone antagonists|mesh-ancestor
92152121|NCT01673490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152122|NCT00633061|Enoxaparin|enoxaparin|mesh-list
92152123|NCT00633061|Anticoagulants|anticoagulants|mesh-ancestor
92152124|NCT00633061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92152125|NCT00633061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92152126|NCT00633061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152127|NCT00632827|Leucovorin|leucovorin|mesh-list
92152128|NCT00632827|Cytarabine|cytarabine|mesh-list
92152129|NCT00632827|Cyclophosphamide|cyclophosphamide|mesh-list
92152130|NCT00632827|Carmustine|carmustine|mesh-list
92152131|NCT00632827|Gemcitabine|gemcitabine|mesh-list
92152132|NCT00632827|Doxorubicin|doxorubicin|mesh-list
92152133|NCT00632827|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92152134|NCT00632827|Methotrexate|methotrexate|mesh-list
92152135|NCT00632827|Etoposide|etoposide|mesh-list
92152136|NCT00632827|Vincristine|vincristine|mesh-list
92152137|NCT00632827|Vinorelbine|vinorelbine|mesh-list
92152138|NCT00632827|Denileukin diftitox|denileukin diftitox|mesh-list
92152139|NCT00632827|Lenograstim|lenograstim|mesh-list
92152140|NCT00632827|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152141|NCT00632827|Immunologic Factors|immunologic factors|mesh-ancestor
92152142|NCT00632827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152143|NCT00632827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152144|NCT00632827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92152145|NCT00632827|Alkylating Agents|alkylating agents|mesh-ancestor
92152146|NCT00632827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152147|NCT00632827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152148|NCT00632827|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92152149|NCT00632827|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92152150|NCT00632827|Antimetabolites|antimetabolites|mesh-ancestor
92152151|NCT00632827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92152152|NCT00632827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92152153|NCT00632827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92152154|NCT00632827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152155|NCT00632827|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92152156|NCT00632827|Abortifacient Agents|abortifacient agents|mesh-ancestor
92152157|NCT00632827|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92152158|NCT00632827|Dermatologic Agents|dermatologic agents|mesh-ancestor
92152159|NCT00632827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92152160|NCT00632827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92152161|NCT00632827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92152162|NCT00632827|Antiviral Agents|antiviral agents|mesh-ancestor
92152163|NCT00632827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152164|NCT00632827|Antidotes|antidotes|mesh-ancestor
92152165|NCT00632827|Protective Agents|protective agents|mesh-ancestor
92152166|NCT00632827|Vitamin B Complex|vitamin b complex|mesh-ancestor
92152167|NCT00632827|Vitamins|vitamins|mesh-ancestor
92152168|NCT00632827|Micronutrients|micronutrients|mesh-ancestor
92152169|NCT00632827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92152170|NCT00632827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92152171|NCT00632827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92152172|NCT00632827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92152173|NCT00214019|Fluticasone|fluticasone|mesh-list
92152174|NCT00214019|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92152175|NCT00214019|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92152176|NCT00214019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152177|NCT00214019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92152178|NCT00214019|Autonomic Agents|autonomic agents|mesh-ancestor
92152179|NCT00214019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152180|NCT00214019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152181|NCT00214019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92152182|NCT00214019|Respiratory System Agents|respiratory system agents|mesh-ancestor
92152183|NCT00214019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92152184|NCT00214019|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92152185|NCT00214019|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92152186|NCT00214019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92152187|NCT00214019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92152188|NCT00214019|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152189|NCT00214019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152190|NCT00214019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152191|NCT00214019|Glucocorticoids|glucocorticoids|mesh-ancestor
92152192|NCT00214019|Hormones|hormones|mesh-ancestor
92152193|NCT00214019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152194|NCT00214019|Sympathomimetics|sympathomimetics|mesh-ancestor
92152195|NCT03097848|Sorafenib|sorafenib|mesh-list
92152196|NCT03097848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152197|NCT03097848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92152198|NCT03097848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152199|NCT03097848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152200|NCT05047848|Fulvestrant|fulvestrant|mesh-list
92152201|NCT05047848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92152202|NCT05047848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152203|NCT05047848|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92152204|NCT05047848|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92152205|NCT05047848|Hormone Antagonists|hormone antagonists|mesh-ancestor
92152206|NCT05047848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152207|NCT05047848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152208|NCT00210119|Imatinib Mesylate|imatinib mesylate|mesh-list
92152209|NCT00210119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152210|NCT00210119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92152211|NCT00210119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152212|NCT00210119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152213|NCT01044459|Bromides|bromides|mesh-list
92152214|NCT01044459|Anticonvulsants|anticonvulsants|mesh-ancestor
92152215|NCT01837329|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92152216|NCT01837329|Chelating Agents|chelating agents|mesh-ancestor
92152217|NCT01837329|Sequestering Agents|sequestering agents|mesh-ancestor
92152218|NCT01837329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152219|NCT01837329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152220|NCT01837329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92152221|NCT01837329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92152222|NCT01837329|Growth Substances|growth substances|mesh-ancestor
92152223|NCT01837329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152224|NCT01837329|Growth Inhibitors|growth inhibitors|mesh-ancestor
92152225|NCT01837329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152226|NCT03993353|Pembrolizumab|pembrolizumab|mesh-list
92152227|NCT03993353|Tadalafil|tadalafil|mesh-list
92152228|NCT03993353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152229|NCT03993353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152230|NCT03993353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92152231|NCT03993353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152232|NCT03993353|Vasodilator Agents|vasodilator agents|mesh-ancestor
92152233|NCT03993353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92152234|NCT03993353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92152235|NCT03993353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152236|NCT03993353|Urological Agents|urological agents|mesh-ancestor
92152238|NCT05040906|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152239|NCT05040906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152240|NCT05040906|Immunologic Factors|immunologic factors|mesh-ancestor
92152241|NCT05040906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152242|NCT05040906|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152243|NCT01044303|Mycophenolic Acid|mycophenolic acid|mesh-list
92152244|NCT01044303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92152245|NCT01044303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152246|NCT01044303|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92152247|NCT01044303|Antitubercular Agents|antitubercular agents|mesh-ancestor
92152248|NCT01044303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92152249|NCT01044303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152250|NCT01044303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152251|NCT01044303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152252|NCT05040828|Montelukast|montelukast|mesh-list
92152253|NCT05040828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92152254|NCT05040828|Respiratory System Agents|respiratory system agents|mesh-ancestor
92152255|NCT05040828|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92152256|NCT05040828|Hormone Antagonists|hormone antagonists|mesh-ancestor
92152257|NCT05040828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152258|NCT05040828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152259|NCT05040828|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92152260|NCT05040828|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92152261|NCT05040828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152262|NCT00983437|Modafinil|modafinil|mesh-list
92152263|NCT00983437|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92152264|NCT00983437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152265|NCT00983437|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92152266|NCT00983437|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92152267|NCT00983437|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92152268|NCT00983437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152269|NCT05031234|Morphine|morphine|mesh-list
92152270|NCT05031234|Anesthetics|anesthetics|mesh-list
92152271|NCT05031234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152272|NCT05031234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152273|NCT05031234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92152274|NCT05031234|Narcotics|narcotics|mesh-ancestor
92152275|NCT05031234|Analgesics|analgesics|mesh-ancestor
92152276|NCT05031234|Sensory System Agents|sensory system agents|mesh-ancestor
92152277|NCT05031234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152278|NCT03599609|Simvastatin|simvastatin|mesh-list
92152279|NCT03599609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92152280|NCT03599609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92152281|NCT03599609|Antimetabolites|antimetabolites|mesh-ancestor
92152282|NCT03599609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152283|NCT03599609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92152284|NCT03599609|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92152285|NCT03599609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152286|NCT05040594|Lidocaine|lidocaine|mesh-list
92152287|NCT05040594|Anesthetics, Local|anesthetics, local|mesh-ancestor
92152288|NCT05040594|Anesthetics|anesthetics|mesh-ancestor
92152289|NCT05040594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152290|NCT05040594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152291|NCT05040594|Sensory System Agents|sensory system agents|mesh-ancestor
92152292|NCT05040594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152293|NCT05040594|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92152294|NCT05040594|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92152295|NCT05040594|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92152296|NCT05040594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92152297|NCT05040594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152298|NCT01042977|Dapagliflozin|dapagliflozin|mesh-list
92152299|NCT01042977|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92152300|NCT01042977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152301|NCT01042977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92152302|NCT01042977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152304|NCT03598673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92152305|NCT03598673|Vasodilator Agents|vasodilator agents|mesh-ancestor
92152306|NCT03598673|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92152307|NCT03598673|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92152308|NCT03598673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92152309|NCT03598673|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152310|NCT03598673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152311|NCT03598673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152312|NCT03598673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152313|NCT05039580|Dexamethasone|dexamethasone|mesh-list
92152314|NCT05039580|Antibodies|antibodies|mesh-list
92152315|NCT05039580|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92152316|NCT05039580|Immunologic Factors|immunologic factors|mesh-ancestor
92152317|NCT05039580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152318|NCT05039580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152319|NCT05039580|Antiemetics|antiemetics|mesh-ancestor
92152320|NCT05039580|Autonomic Agents|autonomic agents|mesh-ancestor
92152321|NCT05039580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152322|NCT05039580|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92152323|NCT05039580|Glucocorticoids|glucocorticoids|mesh-ancestor
92152325|NCT05039580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152326|NCT05039580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92152327|NCT05039580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152328|NCT05025228|Acetaminophen|acetaminophen|mesh-list
92152329|NCT05025228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92152330|NCT05025228|Analgesics|analgesics|mesh-ancestor
92152331|NCT05025228|Sensory System Agents|sensory system agents|mesh-ancestor
92152332|NCT05025228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152333|NCT05025228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152334|NCT05025228|Antipyretics|antipyretics|mesh-ancestor
92152335|NCT05025072|Hydroxyurea|hydroxyurea|mesh-list
92152336|NCT05025072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152337|NCT05025072|Antisickling Agents|antisickling agents|mesh-ancestor
92152338|NCT05025072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152339|NCT05025072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152340|NCT05025072|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92152341|NCT05024604|Progesterone|progesterone|mesh-list
92152342|NCT05024604|Progestins|progestins|mesh-ancestor
92152343|NCT05024604|Hormones|hormones|mesh-ancestor
92152344|NCT05024604|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152345|NCT05024604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152346|NCT03597893|Oxytocin|oxytocin|mesh-list
92152347|NCT03597893|Oxytocics|oxytocics|mesh-ancestor
92152348|NCT03597893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92152349|NCT03597893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152350|NCT01041573|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92152351|NCT01041573|Immunologic Factors|immunologic factors|mesh-ancestor
92152352|NCT01041573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152353|NCT05024448|Prednisone|prednisone|mesh-list
92152354|NCT05024448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152355|NCT05024448|Glucocorticoids|glucocorticoids|mesh-ancestor
92152356|NCT05024448|Hormones|hormones|mesh-ancestor
92152357|NCT05024448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152358|NCT05024448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152359|NCT05024448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92152360|NCT05024448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152361|NCT03596957|Tolvaptan|tolvaptan|mesh-list
92152362|NCT03596957|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92152363|NCT03596957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152364|NCT03596957|Natriuretic Agents|natriuretic agents|mesh-ancestor
92152365|NCT03596957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152366|NCT03408015|Lifitegrast|lifitegrast|mesh-list
92152367|NCT03408015|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92152368|NCT03408015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92152369|NCT01041495|Cyclobenzaprine|cyclobenzaprine|mesh-list
92152370|NCT01041495|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92152371|NCT01041495|Antidepressive Agents|antidepressive agents|mesh-ancestor
92152372|NCT01041495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92152373|NCT01041495|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92152374|NCT01041495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152375|NCT01041495|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92152376|NCT01041495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152377|NCT01041495|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92152378|NCT01041495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152379|NCT03407937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92152380|NCT03407937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152381|NCT03407937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152382|NCT03596099|Acetic Acid|acetic acid|mesh-list
92152383|NCT03596099|Retinol acetate|retinol acetate|mesh-list
92152384|NCT03596099|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92152385|NCT03596099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152386|NCT03596099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92152387|NCT03596099|Immunologic Factors|immunologic factors|mesh-ancestor
92152388|NCT03596099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152389|NCT03596099|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92152390|NCT03596099|Protective Agents|protective agents|mesh-ancestor
92152391|NCT03596099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152392|NCT01041417|Molgramostim|molgramostim|mesh-list
92152393|NCT01041417|Sargramostim|sargramostim|mesh-list
92152394|NCT01041417|Immunologic Factors|immunologic factors|mesh-ancestor
92152395|NCT01041417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152396|NCT01041417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152397|NCT03595397|Magnesium Sulfate|magnesium sulfate|mesh-list
92152398|NCT03595397|Fentanyl|fentanyl|mesh-list
92152399|NCT03595397|Bupivacaine|bupivacaine|mesh-list
92152402|NCT03595397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152403|NCT03595397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152404|NCT03595397|Sensory System Agents|sensory system agents|mesh-ancestor
92152405|NCT03595397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152406|NCT03595397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92152407|NCT03595397|Narcotics|narcotics|mesh-ancestor
92152408|NCT03595397|Analgesics|analgesics|mesh-ancestor
92152409|NCT03595397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92152410|NCT03595397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92152411|NCT03595397|Anesthetics, General|anesthetics, general|mesh-ancestor
92152412|NCT03595397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92152413|NCT03595397|Anticonvulsants|anticonvulsants|mesh-ancestor
92152414|NCT03595397|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92152415|NCT03595397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92152416|NCT03595397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152417|NCT03595397|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92152418|NCT03595397|Tocolytic Agents|tocolytic agents|mesh-ancestor
92152419|NCT03595397|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92152420|NCT03595319|Sevoflurane|sevoflurane|mesh-list
92152421|NCT03595319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92152422|NCT03595319|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92152423|NCT03595319|Anesthetics, General|anesthetics, general|mesh-ancestor
92152424|NCT03595319|Anesthetics|anesthetics|mesh-ancestor
92152425|NCT03595319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152426|NCT03595319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152428|NCT01040871|Cyclophosphamide|cyclophosphamide|mesh-list
92152429|NCT01040871|Rituximab|rituximab|mesh-list
92152430|NCT01040871|Doxorubicin|doxorubicin|mesh-list
92152431|NCT01040871|Vincristine|vincristine|mesh-list
92152432|NCT01040871|Bortezomib|bortezomib|mesh-list
92152433|NCT01040871|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152434|NCT01040871|Immunologic Factors|immunologic factors|mesh-ancestor
92152435|NCT01040871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152436|NCT01040871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152437|NCT01040871|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92152438|NCT01040871|Alkylating Agents|alkylating agents|mesh-ancestor
92152439|NCT01040871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152440|NCT01040871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152441|NCT01040871|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92152442|NCT01040871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152443|NCT01040871|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92152444|NCT01040871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92152445|NCT01040871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92152446|NCT01040871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152447|NCT01040871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152448|NCT01040871|Glucocorticoids|glucocorticoids|mesh-ancestor
92152449|NCT01040871|Hormones|hormones|mesh-ancestor
92152450|NCT01040871|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152451|NCT01040871|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92152452|NCT01040871|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92152453|NCT01040871|Tubulin Modulators|tubulin modulators|mesh-ancestor
92152454|NCT01040871|Antimitotic Agents|antimitotic agents|mesh-ancestor
92152455|NCT01040871|Mitosis Modulators|mitosis modulators|mesh-ancestor
92152456|NCT01040169|Calcium Carbonate|calcium carbonate|mesh-list
92152457|NCT01040169|Calcium|calcium|mesh-list
92152458|NCT01040169|Fluorides|fluorides|mesh-list
92152459|NCT01040169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92152460|NCT01040169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152461|NCT01040169|Cariostatic Agents|cariostatic agents|mesh-ancestor
92152462|NCT01040169|Protective Agents|protective agents|mesh-ancestor
92152463|NCT01040169|Antacids|antacids|mesh-ancestor
92152464|NCT01040169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152465|NCT01040169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92152466|NCT01044381|Luliconazole|luliconazole|mesh-list
92152467|NCT01044381|Antifungal Agents|antifungal agents|mesh-ancestor
92152468|NCT01044381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152469|NCT03594461|Aflibercept|aflibercept|mesh-list
92152470|NCT03594461|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92152471|NCT03594461|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92152472|NCT03594461|Growth Substances|growth substances|mesh-ancestor
92152473|NCT03594461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152474|NCT03594461|Growth Inhibitors|growth inhibitors|mesh-ancestor
92152475|NCT03594461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152476|NCT03407703|Grazoprevir|grazoprevir|mesh-list
92152477|NCT03407703|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92152479|NCT03407703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152480|NCT03594149|Levofloxacin|levofloxacin|mesh-list
92152481|NCT03594149|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92152482|NCT03594149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152483|NCT03594149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92152484|NCT03594149|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92152485|NCT03594149|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92152486|NCT03594149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152487|NCT03594149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152488|NCT03594149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152489|NCT03594149|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92152490|NCT03594149|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92152491|NCT00916539|Calpastatin|calpastatin|mesh-list
92152492|NCT00916539|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92152493|NCT00916539|Protease Inhibitors|protease inhibitors|mesh-ancestor
92152494|NCT00916539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152495|NCT00916539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152496|NCT03593447|Ribavirin|ribavirin|mesh-list
92152497|NCT03593447|Yimitasvir|yimitasvir|mesh-list
92152498|NCT03593447|Antimetabolites|antimetabolites|mesh-ancestor
92152499|NCT03593447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152500|NCT03593447|Antiviral Agents|antiviral agents|mesh-ancestor
92152501|NCT03593447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152502|NCT03593291|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92152503|NCT03593291|Dalteparin|dalteparin|mesh-list
92152504|NCT03593291|Anticoagulants|anticoagulants|mesh-ancestor
92152505|NCT03593291|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92152506|NCT03593291|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92152507|NCT03593291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152508|NCT03593135|Metformin|metformin|mesh-list
92152509|NCT03593135|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92152510|NCT03593135|Acetic Acid|acetic acid|mesh-list
92152511|NCT03593135|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92152512|NCT03593135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152513|NCT03593135|Incretins|incretins|mesh-ancestor
92152514|NCT03593135|Hormones|hormones|mesh-ancestor
92152515|NCT03593135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152516|NCT03593135|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92152517|NCT03593135|Protease Inhibitors|protease inhibitors|mesh-ancestor
92152518|NCT03593135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152519|NCT03593135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152520|NCT03593135|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92152521|NCT03593135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152522|NCT03592901|Anesthetics|anesthetics|mesh-list
92152523|NCT03592901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152524|NCT03592901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152525|NCT03830385|Carboplatin|carboplatin|mesh-list
92152526|NCT03830385|Bleomycin|bleomycin|mesh-list
92152527|NCT03830385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152528|NCT03830385|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92152529|NCT03592823|Hydroxychloroquine|hydroxychloroquine|mesh-list
92152530|NCT03592823|Antimalarials|antimalarials|mesh-ancestor
92152531|NCT03592823|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92152532|NCT03592823|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92152533|NCT03592823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152534|NCT03592823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152535|NCT03592823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152536|NCT03592823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152537|NCT03592667|Dapagliflozin|dapagliflozin|mesh-list
92152538|NCT03592667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92152539|NCT03592667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152540|NCT03592667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92152541|NCT03592667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152543|NCT03406689|Lubricant Eye Drops|lubricant eye drops|mesh-list
92152544|NCT03406689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92152545|NCT03406689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92152546|NCT03406689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92152547|NCT03406689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92152548|NCT03406689|Analgesics|analgesics|mesh-ancestor
92152549|NCT03406689|Sensory System Agents|sensory system agents|mesh-ancestor
92152550|NCT03406689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152551|NCT03406689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152552|NCT03406689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152553|NCT03406689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152554|NCT03591575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92152555|NCT03591575|Deferiprone|deferiprone|mesh-list
92152556|NCT03591575|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92152557|NCT03591575|Chelating Agents|chelating agents|mesh-ancestor
92152558|NCT03591575|Sequestering Agents|sequestering agents|mesh-ancestor
92152559|NCT03591575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152560|NCT03406533|Fentanyl|fentanyl|mesh-list
92152561|NCT03406533|Midazolam|midazolam|mesh-list
92152562|NCT03406533|Dexmedetomidine|dexmedetomidine|mesh-list
92152563|NCT03406533|Remifentanil|remifentanil|mesh-list
92152564|NCT03406533|Propofol|propofol|mesh-list
92152565|NCT03406533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92152566|NCT03406533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152567|NCT03406533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152568|NCT03406533|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92152569|NCT03406533|Analgesics|analgesics|mesh-ancestor
92152570|NCT03406533|Sensory System Agents|sensory system agents|mesh-ancestor
92152571|NCT03406533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152572|NCT03406533|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92152573|NCT03406533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92152574|NCT03406533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92152575|NCT03406533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152576|NCT03406533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152577|NCT03406533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152578|NCT03406533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92152579|NCT03406533|Anesthetics, General|anesthetics, general|mesh-ancestor
92152580|NCT03406533|Anesthetics|anesthetics|mesh-ancestor
92152581|NCT03406533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92152582|NCT03406533|Narcotics|narcotics|mesh-ancestor
92152583|NCT03406533|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92152584|NCT03406533|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92152585|NCT03406533|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92152586|NCT03406533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92152587|NCT03406533|GABA Modulators|gaba modulators|mesh-ancestor
92152588|NCT03406533|GABA Agents|gaba agents|mesh-ancestor
92152589|NCT03591341|Melatonin|melatonin|mesh-list
92152590|NCT03591341|Antioxidants|antioxidants|mesh-ancestor
92152591|NCT03591341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152592|NCT03591341|Protective Agents|protective agents|mesh-ancestor
92152593|NCT03591341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152594|NCT03591341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152595|NCT04377399|Vitamin D|vitamin d|mesh-list
92152596|NCT04377399|Vitamins|vitamins|mesh-ancestor
92152597|NCT04377399|Micronutrients|micronutrients|mesh-ancestor
92152598|NCT04377399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152599|NCT04377399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92152600|NCT03400995|Ziresovir|ziresovir|mesh-list
92152601|NCT03400995|Antiviral Agents|antiviral agents|mesh-ancestor
92152602|NCT03400995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152603|NCT03590873|Vasopressins|vasopressins|mesh-list
92152604|NCT03590873|Arginine Vasopressin|arginine vasopressin|mesh-list
92152605|NCT03590873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152606|NCT03590873|Hemostatics|hemostatics|mesh-ancestor
92152607|NCT03590873|Coagulants|coagulants|mesh-ancestor
92152608|NCT03590873|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92152609|NCT03590873|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92152610|NCT03590873|Natriuretic Agents|natriuretic agents|mesh-ancestor
92152611|NCT02155335|Golimumab|golimumab|mesh-list
92152612|NCT02155335|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92152613|NCT02155335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92152614|NCT02155335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152615|NCT02155335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152616|NCT02155335|Immunologic Factors|immunologic factors|mesh-ancestor
92152617|NCT02155335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152618|NCT05024526|Edaravone|edaravone|mesh-list
92152619|NCT05024526|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92152620|NCT05024526|Antioxidants|antioxidants|mesh-ancestor
92152621|NCT05024526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152622|NCT05024526|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92152623|NCT05024526|Protective Agents|protective agents|mesh-ancestor
92152624|NCT05024526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152625|NCT03597035|Spironolactone|spironolactone|mesh-list
92152626|NCT03597035|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92152627|NCT03597035|Hormone Antagonists|hormone antagonists|mesh-ancestor
92152628|NCT03597035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152629|NCT03597035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152630|NCT03597035|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92152631|NCT03597035|Diuretics|diuretics|mesh-ancestor
92152635|NCT03400683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152636|NCT03400683|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92152637|NCT03400683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92152638|NCT03400683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152639|NCT03400683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152640|NCT03400683|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92152641|NCT03400683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92152642|NCT03400683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152643|NCT03400683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152644|NCT03400683|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92152645|NCT03400683|Abortifacient Agents|abortifacient agents|mesh-ancestor
92152646|NCT03400683|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92152647|NCT03400683|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92152648|NCT03400683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92152649|NCT03400683|Oxytocics|oxytocics|mesh-ancestor
92152650|NCT05037240|Quercetin|quercetin|mesh-list
92152652|NCT05037240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152653|NCT05037240|Protective Agents|protective agents|mesh-ancestor
92152654|NCT05037240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152655|NCT05037006|Anesthetics|anesthetics|mesh-list
92152656|NCT05037006|Sevoflurane|sevoflurane|mesh-list
92152657|NCT05037006|Neostigmine|neostigmine|mesh-list
92152658|NCT05037006|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152659|NCT05037006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152660|NCT05037006|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92152661|NCT05037006|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92152662|NCT05037006|Anesthetics, General|anesthetics, general|mesh-ancestor
92152663|NCT05037006|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92152664|NCT05037006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152665|NCT05037006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152666|NCT05037006|Cholinergic Agents|cholinergic agents|mesh-ancestor
92152667|NCT05037006|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152668|NCT05037006|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92152669|NCT05037006|Autonomic Agents|autonomic agents|mesh-ancestor
92152670|NCT05037006|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152671|NCT03093090|Furosemide|furosemide|mesh-list
92152672|NCT03093090|Diuretics|diuretics|mesh-ancestor
92152673|NCT03093090|Natriuretic Agents|natriuretic agents|mesh-ancestor
92152674|NCT03093090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152675|NCT03093090|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92152676|NCT03093090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92152677|NCT03093090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152678|NCT03093168|Cyclophosphamide|cyclophosphamide|mesh-list
92152679|NCT03093168|Fludarabine|fludarabine|mesh-list
92152680|NCT03093168|Idecabtagene vicleucel|idecabtagene vicleucel|mesh-list
92152681|NCT03093168|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152682|NCT03093168|Immunologic Factors|immunologic factors|mesh-ancestor
92152683|NCT03093168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152684|NCT03093168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152685|NCT03093168|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92152686|NCT03093168|Alkylating Agents|alkylating agents|mesh-ancestor
92152687|NCT03093168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152688|NCT03093168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152689|NCT03093168|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92152690|NCT03093168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152691|NCT04377321|Colchicine|colchicine|mesh-list
92152692|NCT04377321|Gout Suppressants|gout suppressants|mesh-ancestor
92152693|NCT04377321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152694|NCT04377321|Tubulin Modulators|tubulin modulators|mesh-ancestor
92152695|NCT04377321|Antimitotic Agents|antimitotic agents|mesh-ancestor
92152696|NCT04377321|Mitosis Modulators|mitosis modulators|mesh-ancestor
92152697|NCT04377321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152698|NCT04377321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152699|NCT05018364|Epoetin Alfa|epoetin alfa|mesh-list
92152700|NCT05018364|Hematinics|hematinics|mesh-ancestor
92152701|NCT03593213|Cariprazine|cariprazine|mesh-list
92152702|NCT03593213|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92152703|NCT03593213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92152704|NCT03593213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152705|NCT03593213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152706|NCT03593213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92152707|NCT05023824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
92152708|NCT05023824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92152709|NCT05023824|Adrenergic Agents|adrenergic agents|mesh-ancestor
92152710|NCT05023824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152711|NCT05023824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152712|NCT05023824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152713|NCT03595163|Folic Acid|folic acid|mesh-list
92152714|NCT03595163|Vitamin B Complex|vitamin b complex|mesh-list
92152715|NCT03595163|Propofol|propofol|mesh-list
92152716|NCT03595163|Sevoflurane|sevoflurane|mesh-list
92152717|NCT03595163|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92152718|NCT03595163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152719|NCT03595163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152720|NCT03595163|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92152721|NCT03595163|Anesthetics, General|anesthetics, general|mesh-ancestor
92152722|NCT03595163|Anesthetics|anesthetics|mesh-ancestor
92152723|NCT03595163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92152724|NCT03595163|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92152725|NCT03595163|Hematinics|hematinics|mesh-ancestor
92152726|NCT03595163|Vitamins|vitamins|mesh-ancestor
92152727|NCT03595163|Micronutrients|micronutrients|mesh-ancestor
92152728|NCT03404115|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92152729|NCT03404115|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92152730|NCT04199819|Entecavir|entecavir|mesh-list
92152731|NCT04199819|Antiviral Agents|antiviral agents|mesh-ancestor
92152732|NCT04199819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152733|NCT00918723|Cyclophosphamide|cyclophosphamide|mesh-list
92152734|NCT00918723|Rituximab|rituximab|mesh-list
92152735|NCT00918723|Fludarabine|fludarabine|mesh-list
92152736|NCT00918723|Fludarabine phosphate|fludarabine phosphate|mesh-list
92152737|NCT00918723|Vorinostat|vorinostat|mesh-list
92152738|NCT00918723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152739|NCT00918723|Immunologic Factors|immunologic factors|mesh-ancestor
92152740|NCT00918723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152741|NCT00918723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152742|NCT00918723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92152743|NCT00918723|Alkylating Agents|alkylating agents|mesh-ancestor
92152744|NCT00918723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152745|NCT00918723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152746|NCT00918723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92152747|NCT00918723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152748|NCT00918723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92152749|NCT00918723|Antimetabolites|antimetabolites|mesh-ancestor
92152750|NCT00918723|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92152751|NCT00918723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152753|NCT04192331|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92152754|NCT04192331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92152755|NCT04192331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152756|NCT04192331|Tubulin Modulators|tubulin modulators|mesh-ancestor
92152757|NCT04192331|Antimitotic Agents|antimitotic agents|mesh-ancestor
92152758|NCT04192331|Mitosis Modulators|mitosis modulators|mesh-ancestor
92152759|NCT04192331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152761|NCT00919035|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92152762|NCT00919035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92152763|NCT00919035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152764|NCT00919035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152765|NCT00919035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152766|NCT00919035|Immunologic Factors|immunologic factors|mesh-ancestor
92152767|NCT00919035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152768|NCT00919035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152769|NCT03969953|Rivaroxaban|rivaroxaban|mesh-list
92152770|NCT03969953|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92152771|NCT03969953|Antithrombins|antithrombins|mesh-ancestor
92152772|NCT03969953|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92152773|NCT03969953|Protease Inhibitors|protease inhibitors|mesh-ancestor
92152774|NCT03969953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152775|NCT03969953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152776|NCT03969953|Anticoagulants|anticoagulants|mesh-ancestor
92152777|NCT04374981|Celecoxib|celecoxib|mesh-list
92152778|NCT04374981|Montelukast|montelukast|mesh-list
92152779|NCT04374981|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92152780|NCT04374981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92152781|NCT04374981|Analgesics|analgesics|mesh-ancestor
92152782|NCT04374981|Sensory System Agents|sensory system agents|mesh-ancestor
92152783|NCT04374981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152784|NCT04374981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152785|NCT04374981|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152786|NCT04374981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152787|NCT04374981|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92152788|NCT04374981|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92152789|NCT04374981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152790|NCT04374981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152791|NCT04374981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92152792|NCT04374981|Respiratory System Agents|respiratory system agents|mesh-ancestor
92152793|NCT04374981|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92152794|NCT04374981|Hormone Antagonists|hormone antagonists|mesh-ancestor
92152795|NCT04374981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152796|NCT04374981|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92152797|NCT04374981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92152798|NCT03092544|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92152800|NCT03092544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92152801|NCT03092544|Immunologic Factors|immunologic factors|mesh-ancestor
92152802|NCT03092544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152803|NCT03090516|Donepezil|donepezil|mesh-list
92152804|NCT03090516|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92152805|NCT03090516|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152806|NCT03090516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152807|NCT03090516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92152808|NCT03090516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152809|NCT03090516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152810|NCT03090516|Nootropic Agents|nootropic agents|mesh-ancestor
92152811|NCT04198571|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92152812|NCT04198571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92152813|NCT04198571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152814|NCT03092310|Pancrelipase|pancrelipase|mesh-list
92152815|NCT03092310|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92152816|NCT03405207|Vitamin D|vitamin d|mesh-list
92152817|NCT03405207|Cholecalciferol|cholecalciferol|mesh-list
92152818|NCT03405207|Vitamins|vitamins|mesh-ancestor
92152819|NCT03405207|Micronutrients|micronutrients|mesh-ancestor
92152820|NCT03405207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152821|NCT03405207|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92152822|NCT03405207|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92152823|NCT04197323|Alprostadil|alprostadil|mesh-list
92152824|NCT04197323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92152825|NCT04197323|Vasodilator Agents|vasodilator agents|mesh-ancestor
92152826|NCT04197323|Urological Agents|urological agents|mesh-ancestor
92152827|NCT04196855|Teriparatide|teriparatide|mesh-list
92152828|NCT04196855|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92152829|NCT04196855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152830|NCT04196855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92152832|NCT04196621|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92152833|NCT04196621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92152834|NCT04196309|Heparin|heparin|mesh-list
92152835|NCT04196309|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92152836|NCT04196309|Tinzaparin|tinzaparin|mesh-list
92152837|NCT04196309|Dalteparin|dalteparin|mesh-list
92152838|NCT04196309|Anticoagulants|anticoagulants|mesh-ancestor
92152839|NCT04196309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92152840|NCT04196309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92152841|NCT04196309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152842|NCT03090048|Vitamin A|vitamin a|mesh-list
92152843|NCT03090048|Azithromycin|azithromycin|mesh-list
92152844|NCT03090048|Retinol palmitate|retinol palmitate|mesh-list
92152845|NCT03090048|Vitamins|vitamins|mesh-ancestor
92152846|NCT03090048|Micronutrients|micronutrients|mesh-ancestor
92152847|NCT03090048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152848|NCT03090048|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92152849|NCT03090048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152850|NCT03090048|Antioxidants|antioxidants|mesh-ancestor
92152851|NCT03090048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152852|NCT03090048|Protective Agents|protective agents|mesh-ancestor
92152853|NCT03090048|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92152854|NCT03090048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152855|NCT04195997|Heparin|heparin|mesh-list
92152856|NCT04195997|Bivalirudin|bivalirudin|mesh-list
92152857|NCT04195997|Anticoagulants|anticoagulants|mesh-ancestor
92152858|NCT04195997|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92152859|NCT04195997|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92152860|NCT04195997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152861|NCT04195997|Antithrombins|antithrombins|mesh-ancestor
92152862|NCT04195997|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92152863|NCT04195997|Protease Inhibitors|protease inhibitors|mesh-ancestor
92152864|NCT04195997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92152865|NCT05023122|Vitamin D|vitamin d|mesh-list
92152866|NCT05023122|Cholecalciferol|cholecalciferol|mesh-list
92152870|NCT05023122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152871|NCT05023122|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92152872|NCT05023122|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92152873|NCT04195373|Flucytosine|flucytosine|mesh-list
92152874|NCT04195373|Antifungal Agents|antifungal agents|mesh-ancestor
92152875|NCT04195373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152876|NCT04195373|Antimetabolites|antimetabolites|mesh-ancestor
92152877|NCT04195373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152879|NCT04194827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92152880|NCT04194827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92152881|NCT04194827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92152882|NCT04194905|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92152883|NCT04194905|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92152884|NCT04194905|Levonorgestrel|levonorgestrel|mesh-list
92152885|NCT04194905|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92152886|NCT04194905|Estradiol|estradiol|mesh-list
92152887|NCT04194905|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92152888|NCT04194905|Estrogens|estrogens|mesh-ancestor
92152889|NCT04194905|Hormones|hormones|mesh-ancestor
92152890|NCT04194905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152891|NCT04194905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152892|NCT04194905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92152893|NCT04194905|Contraceptive Agents|contraceptive agents|mesh-ancestor
92152894|NCT04194905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92152895|NCT04194905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92152896|NCT04194905|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92152897|NCT04194905|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92152898|NCT04194905|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92152899|NCT05017428|Niacinamide|niacinamide|mesh-list
92152900|NCT05017428|Niacin|niacin|mesh-list
92152901|NCT05017428|Nicotinic Acids|nicotinic acids|mesh-list
92152902|NCT05017428|Vitamin B Complex|vitamin b complex|mesh-ancestor
92152903|NCT05017428|Vitamins|vitamins|mesh-ancestor
92152904|NCT05017428|Micronutrients|micronutrients|mesh-ancestor
92152905|NCT05017428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152906|NCT05017428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92152907|NCT05017428|Antimetabolites|antimetabolites|mesh-ancestor
92152908|NCT05017428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152909|NCT05017428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92152911|NCT04196231|Insulin|insulin|mesh-list
92152912|NCT04196231|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92152913|NCT04196231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92152914|NCT04196231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152915|NCT00013611|Aldesleukin|aldesleukin|mesh-list
92152916|NCT00013611|Interleukin-2|interleukin-2|mesh-list
92152917|NCT00013611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152918|NCT00013611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92152919|NCT00013611|Analgesics|analgesics|mesh-ancestor
92152920|NCT00013611|Sensory System Agents|sensory system agents|mesh-ancestor
92152921|NCT00013611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152922|NCT00013611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152923|NCT00013611|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92152924|NCT00013611|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92152925|NCT00013611|Antiviral Agents|antiviral agents|mesh-ancestor
92152926|NCT00013611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152927|NCT04194515|Metformin|metformin|mesh-list
92152928|NCT04194515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92152929|NCT04194515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152930|NCT03094182|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92152931|NCT03094182|Hematinics|hematinics|mesh-ancestor
92152932|NCT05017116|Entecavir|entecavir|mesh-list
92152933|NCT05017116|Antiviral Agents|antiviral agents|mesh-ancestor
92152934|NCT05017116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92152935|NCT05022030|Cetuximab|cetuximab|mesh-list
92152936|NCT05022030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152937|NCT05022030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152938|NCT04192643|Tranexamic Acid|tranexamic acid|mesh-list
92152939|NCT04192643|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92152940|NCT04192643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92152941|NCT04192643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152942|NCT04192643|Hemostatics|hemostatics|mesh-ancestor
92152943|NCT04192643|Coagulants|coagulants|mesh-ancestor
92152944|NCT03753659|Pembrolizumab|pembrolizumab|mesh-list
92152945|NCT03753659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92152946|NCT03753659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152947|NCT03753659|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92152948|NCT03753659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152951|NCT00010257|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92152952|NCT00010257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152954|NCT00010257|Antimitotic Agents|antimitotic agents|mesh-ancestor
92152955|NCT00010257|Mitosis Modulators|mitosis modulators|mesh-ancestor
92152956|NCT00010257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152957|NCT05022186|Cannabidiol|cannabidiol|mesh-list
92152958|NCT05022186|Tramiprosate|tramiprosate|mesh-list
92152959|NCT05022186|Anticonvulsants|anticonvulsants|mesh-ancestor
92152960|NCT05022186|GABA Agonists|gaba agonists|mesh-ancestor
92152961|NCT05022186|GABA Agents|gaba agents|mesh-ancestor
92152962|NCT05022186|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92152963|NCT05022186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152964|NCT05022186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152965|NCT02240043|Hormones|hormones|mesh-list
92152966|NCT02240043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92152967|NCT02240043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152968|NCT03404037|Endostatins|endostatins|mesh-list
92152969|NCT03404037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92152970|NCT03404037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92152971|NCT03404037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92152972|NCT03404037|Growth Substances|growth substances|mesh-ancestor
92152973|NCT03404037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152974|NCT03404037|Growth Inhibitors|growth inhibitors|mesh-ancestor
92152976|NCT02240199|Pregabalin|pregabalin|mesh-list
92152977|NCT02240199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92152978|NCT02240199|Anesthetics|anesthetics|mesh-ancestor
92152979|NCT02240199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92152980|NCT02240199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92152981|NCT02240199|Sensory System Agents|sensory system agents|mesh-ancestor
92152982|NCT02240199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92152983|NCT02240199|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92152984|NCT02240199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92152985|NCT02240199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92152986|NCT02240199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92152987|NCT02240199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92152988|NCT02240199|Analgesics|analgesics|mesh-ancestor
92152989|NCT02240199|Anticonvulsants|anticonvulsants|mesh-ancestor
92152990|NCT02240199|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92152991|NCT02240199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92152992|NCT02240199|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92152993|NCT02240199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92152994|NCT02240199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92152995|NCT04190927|Estradiol|estradiol|mesh-list
92152996|NCT04190927|Progesterone|progesterone|mesh-list
92152997|NCT04190927|Estrogens|estrogens|mesh-ancestor
92152998|NCT04190927|Hormones|hormones|mesh-ancestor
92152999|NCT04190927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153000|NCT04190927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153001|NCT04190927|Progestins|progestins|mesh-ancestor
92153002|NCT00919191|Adapalene|adapalene|mesh-list
92153003|NCT00919191|Tretinoin|tretinoin|mesh-list
92153004|NCT00919191|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92153005|NCT00919191|Dermatologic Agents|dermatologic agents|mesh-ancestor
92153006|NCT00919191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92153007|NCT00919191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92153008|NCT00919191|Analgesics|analgesics|mesh-ancestor
92153009|NCT00919191|Sensory System Agents|sensory system agents|mesh-ancestor
92153010|NCT00919191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153011|NCT00919191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153012|NCT00919191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153013|NCT00919191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153014|NCT00919191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153015|NCT00919191|Keratolytic Agents|keratolytic agents|mesh-ancestor
92153016|NCT03962465|Cytarabine|cytarabine|mesh-list
92153017|NCT03962465|Prednisone|prednisone|mesh-list
92153018|NCT03962465|Methotrexate|methotrexate|mesh-list
92153019|NCT03962465|Vincristine|vincristine|mesh-list
92153020|NCT03962465|Daunorubicin|daunorubicin|mesh-list
92153021|NCT03962465|Pegaspargase|pegaspargase|mesh-list
92153022|NCT03962465|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92153023|NCT03962465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153024|NCT03962465|Glucocorticoids|glucocorticoids|mesh-ancestor
92153025|NCT03962465|Hormones|hormones|mesh-ancestor
92153026|NCT03962465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153027|NCT03962465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153028|NCT03962465|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92153030|NCT03962465|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92153031|NCT03962465|Abortifacient Agents|abortifacient agents|mesh-ancestor
92153032|NCT03962465|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92153033|NCT03962465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92153034|NCT03962465|Antimetabolites|antimetabolites|mesh-ancestor
92153035|NCT03962465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153036|NCT03962465|Dermatologic Agents|dermatologic agents|mesh-ancestor
92153037|NCT03962465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153038|NCT03962465|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92153039|NCT03962465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92153040|NCT03962465|Immunologic Factors|immunologic factors|mesh-ancestor
92153041|NCT03962465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153042|NCT03962465|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92153043|NCT03962465|Antiviral Agents|antiviral agents|mesh-ancestor
92153044|NCT03962465|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153045|NCT03962465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92153047|NCT03962465|Antimitotic Agents|antimitotic agents|mesh-ancestor
92153048|NCT03962465|Mitosis Modulators|mitosis modulators|mesh-ancestor
92153049|NCT03962465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92153050|NCT03962465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92153051|NCT03962465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92153052|NCT03962465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153053|NCT03962465|Immunotoxins|immunotoxins|mesh-ancestor
92153054|NCT03962465|Immunoconjugates|immunoconjugates|mesh-ancestor
92153055|NCT05021406|Carvedilol|carvedilol|mesh-list
92153056|NCT05021406|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92153057|NCT05021406|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92153058|NCT05021406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153059|NCT05021406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153060|NCT05021406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153061|NCT05021406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153062|NCT05021406|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153063|NCT05021406|Antioxidants|antioxidants|mesh-ancestor
92153064|NCT05021406|Protective Agents|protective agents|mesh-ancestor
92153065|NCT05021406|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92153066|NCT05021406|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92153067|NCT05021406|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92153068|NCT05021406|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153069|NCT05021406|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92153070|NCT05021406|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92153071|NCT04766177|Bumetanide|bumetanide|mesh-list
92153072|NCT04766177|Diuretics|diuretics|mesh-ancestor
92153073|NCT04766177|Natriuretic Agents|natriuretic agents|mesh-ancestor
92153074|NCT04766177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153075|NCT04766177|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92153076|NCT04766177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92153077|NCT04766177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153078|NCT04466280|Hydroxychloroquine|hydroxychloroquine|mesh-list
92153079|NCT04466280|Antimalarials|antimalarials|mesh-ancestor
92153080|NCT04466280|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153081|NCT04466280|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153082|NCT04466280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153083|NCT04466280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153084|NCT04466280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153085|NCT04466280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153086|NCT05016180|Ropivacaine|ropivacaine|mesh-list
92153087|NCT05016180|Anesthetics, Local|anesthetics, local|mesh-ancestor
92153088|NCT05016180|Anesthetics|anesthetics|mesh-ancestor
92153089|NCT05016180|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153090|NCT05016180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153091|NCT05016180|Sensory System Agents|sensory system agents|mesh-ancestor
92153092|NCT05016180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153093|NCT03023501|Gabapentin|gabapentin|mesh-list
92153094|NCT03023501|Analgesics|analgesics|mesh-ancestor
92153095|NCT03023501|Sensory System Agents|sensory system agents|mesh-ancestor
92153096|NCT03023501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153097|NCT03023501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153098|NCT03023501|Anticonvulsants|anticonvulsants|mesh-ancestor
92153099|NCT03023501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92153100|NCT03023501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92153101|NCT03023501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153102|NCT03023501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92153103|NCT03023501|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92153104|NCT03023501|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92153105|NCT03023501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153106|NCT03023501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153107|NCT03023501|Antimanic Agents|antimanic agents|mesh-ancestor
92153108|NCT05015322|Methylprednisolone|methylprednisolone|mesh-list
92153109|NCT05015322|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92153110|NCT05015322|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92153111|NCT05015322|Prednisolone|prednisolone|mesh-list
92153112|NCT05015322|Prednisolone acetate|prednisolone acetate|mesh-list
92153113|NCT05015322|Bupivacaine|bupivacaine|mesh-list
92153114|NCT05015322|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92153115|NCT05015322|Prednisolone phosphate|prednisolone phosphate|mesh-list
92153116|NCT05015322|Anesthetics, Local|anesthetics, local|mesh-ancestor
92153117|NCT05015322|Anesthetics|anesthetics|mesh-ancestor
92153118|NCT05015322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153119|NCT05015322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153120|NCT05015322|Sensory System Agents|sensory system agents|mesh-ancestor
92153121|NCT05015322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153122|NCT05015322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153123|NCT05015322|Antiemetics|antiemetics|mesh-ancestor
92153124|NCT05015322|Autonomic Agents|autonomic agents|mesh-ancestor
92153125|NCT05015322|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92153126|NCT05015322|Glucocorticoids|glucocorticoids|mesh-ancestor
92153127|NCT05015322|Hormones|hormones|mesh-ancestor
92153128|NCT05015322|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153129|NCT05015322|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92153130|NCT05015322|Protective Agents|protective agents|mesh-ancestor
92153131|NCT05015322|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92153132|NCT05015322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153133|NCT05021250|Ethiodized Oil|ethiodized oil|mesh-list
92153134|NCT05021250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153135|NCT00919503|Cyclosporine|cyclosporine|mesh-list
92153136|NCT00919503|Mycophenolic Acid|mycophenolic acid|mesh-list
92153137|NCT00919503|Methotrexate|methotrexate|mesh-list
92153138|NCT00919503|Fludarabine phosphate|fludarabine phosphate|mesh-list
92153139|NCT00919503|Fludarabine|fludarabine|mesh-list
92153140|NCT00919503|Treosulfan|treosulfan|mesh-list
92153141|NCT00919503|Busulfan|busulfan|mesh-list
92153142|NCT00919503|Tacrolimus|tacrolimus|mesh-list
92153143|NCT00919503|Cyclosporins|cyclosporins|mesh-list
92153144|NCT00919503|Thymoglobulin|thymoglobulin|mesh-list
92153145|NCT00919503|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92153146|NCT00919503|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92153147|NCT00919503|Abortifacient Agents|abortifacient agents|mesh-ancestor
92153148|NCT00919503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92153149|NCT00919503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153150|NCT00919503|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92153151|NCT00919503|Antimetabolites|antimetabolites|mesh-ancestor
92153152|NCT00919503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153153|NCT00919503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153154|NCT00919503|Dermatologic Agents|dermatologic agents|mesh-ancestor
92153155|NCT00919503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153156|NCT00919503|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92153157|NCT00919503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92153158|NCT00919503|Immunologic Factors|immunologic factors|mesh-ancestor
92153159|NCT00919503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153160|NCT00919503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92153161|NCT00919503|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92153162|NCT00919503|Antifungal Agents|antifungal agents|mesh-ancestor
92153163|NCT00919503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153164|NCT00919503|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92153165|NCT00919503|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92153166|NCT00919503|Antitubercular Agents|antitubercular agents|mesh-ancestor
92153167|NCT00919503|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153168|NCT00919503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92153169|NCT00919503|Alkylating Agents|alkylating agents|mesh-ancestor
92153170|NCT00919503|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92153171|NCT05020704|Empagliflozin|empagliflozin|mesh-list
92153172|NCT05020704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92153173|NCT05020704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153174|NCT05020704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92153175|NCT05020704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153176|NCT02979665|Ranibizumab|ranibizumab|mesh-list
92153177|NCT02979665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92153178|NCT02979665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92153179|NCT02979665|Growth Substances|growth substances|mesh-ancestor
92153180|NCT02979665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153182|NCT02979665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153183|NCT03092076|Ticagrelor|ticagrelor|mesh-list
92153184|NCT03092076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92153185|NCT03092076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92153186|NCT03092076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92153187|NCT03092076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92153188|NCT03092076|Purinergic Agents|purinergic agents|mesh-ancestor
92153189|NCT03092076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153190|NCT03092076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153191|NCT03092076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153192|NCT04193501|Melatonin|melatonin|mesh-list
92153193|NCT04193501|Antioxidants|antioxidants|mesh-ancestor
92153194|NCT04193501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153195|NCT04193501|Protective Agents|protective agents|mesh-ancestor
92153196|NCT04193501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153197|NCT04193501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153199|NCT04374279|Androgen Antagonists|androgen antagonists|mesh-ancestor
92153200|NCT04374279|Hormone Antagonists|hormone antagonists|mesh-ancestor
92153201|NCT04374279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153202|NCT04374279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153203|NCT04374279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153204|NCT03957551|Pembrolizumab|pembrolizumab|mesh-list
92153205|NCT03957551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153206|NCT03957551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153207|NCT03957551|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92153208|NCT03957551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153209|NCT02240433|Sorafenib|sorafenib|mesh-list
92153210|NCT02240433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153211|NCT02240433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92153212|NCT02240433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153213|NCT02240433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153214|NCT03403647|Vitamin D|vitamin d|mesh-list
92153215|NCT03403647|Vitamins|vitamins|mesh-ancestor
92153216|NCT03403647|Micronutrients|micronutrients|mesh-ancestor
92153217|NCT03403647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153218|NCT03403647|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92153219|NCT05014464|Crizotinib|crizotinib|mesh-list
92153220|NCT05014464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153221|NCT05014464|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92153222|NCT05014464|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153223|NCT05014464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153224|NCT03403101|Oxaliplatin|oxaliplatin|mesh-list
92153225|NCT03403101|Irinotecan|irinotecan|mesh-list
92153226|NCT03403101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153227|NCT03403101|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92153228|NCT03403101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92153229|NCT03403101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153230|NCT03403101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153231|NCT00211757|Valproic Acid|valproic acid|mesh-list
92153232|NCT00211757|Anticonvulsants|anticonvulsants|mesh-ancestor
92153233|NCT00211757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153234|NCT00211757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153235|NCT00211757|GABA Agents|gaba agents|mesh-ancestor
92153236|NCT00211757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153237|NCT00211757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153238|NCT00211757|Antimanic Agents|antimanic agents|mesh-ancestor
92153239|NCT00211757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92153240|NCT00211757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153241|NCT00211757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92153242|NCT04373967|Metformin|metformin|mesh-list
92153243|NCT04373967|Liraglutide|liraglutide|mesh-list
92153244|NCT04373967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92153245|NCT04373967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153246|NCT04373967|Incretins|incretins|mesh-ancestor
92153247|NCT04373967|Hormones|hormones|mesh-ancestor
92153248|NCT04373967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153249|NCT04026191|Hyaluronic Acid|hyaluronic acid|mesh-list
92153250|NCT04026191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92153251|NCT04026191|Immunologic Factors|immunologic factors|mesh-ancestor
92153252|NCT04026191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153253|NCT04026191|Viscosupplements|viscosupplements|mesh-ancestor
92153254|NCT04026191|Protective Agents|protective agents|mesh-ancestor
92153255|NCT04022057|Ropivacaine|ropivacaine|mesh-list
92153256|NCT04022057|Anesthetics, Local|anesthetics, local|mesh-ancestor
92153257|NCT04022057|Anesthetics|anesthetics|mesh-ancestor
92153258|NCT04022057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153259|NCT04022057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153260|NCT04022057|Sensory System Agents|sensory system agents|mesh-ancestor
92153261|NCT04022057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153262|NCT00921843|Methadone|methadone|mesh-list
92153263|NCT00921843|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92153264|NCT00921843|Narcotics|narcotics|mesh-ancestor
92153265|NCT00921843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153266|NCT00921843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153267|NCT00921843|Analgesics|analgesics|mesh-ancestor
92153268|NCT00921843|Sensory System Agents|sensory system agents|mesh-ancestor
92153269|NCT00921843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153270|NCT00921843|Antitussive Agents|antitussive agents|mesh-ancestor
92153271|NCT00921843|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153272|NCT04020653|Ferrous citrate|ferrous citrate|mesh-list
92153273|NCT04020653|Lumefantrine|lumefantrine|mesh-list
92153274|NCT04020653|Artemether|artemether|mesh-list
92153275|NCT04020653|Artemisinins|artemisinins|mesh-list
92153276|NCT04020653|Artemisinin|artemisinin|mesh-list
92153277|NCT04020653|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92153278|NCT04020653|Citric Acid|citric acid|mesh-list
92153279|NCT04020653|Sodium Citrate|sodium citrate|mesh-list
92153280|NCT04020653|Anticoagulants|anticoagulants|mesh-ancestor
92153281|NCT04020653|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92153282|NCT04020653|Chelating Agents|chelating agents|mesh-ancestor
92153283|NCT04020653|Sequestering Agents|sequestering agents|mesh-ancestor
92153284|NCT04020653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153285|NCT04020653|Antimalarials|antimalarials|mesh-ancestor
92153286|NCT04020653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153287|NCT04020653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153288|NCT04020653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153289|NCT04020653|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92153290|NCT04020653|Dermatologic Agents|dermatologic agents|mesh-ancestor
92153291|NCT04020653|Trace Elements|trace elements|mesh-ancestor
92153292|NCT04020653|Micronutrients|micronutrients|mesh-ancestor
92153293|NCT04020653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153295|NCT05008458|Hemostatics|hemostatics|mesh-ancestor
92153296|NCT05008458|Coagulants|coagulants|mesh-ancestor
92153297|NCT05008458|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92153298|NCT05008458|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92153299|NCT05008458|Natriuretic Agents|natriuretic agents|mesh-ancestor
92153300|NCT05008458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153301|NCT02080637|Ambrisentan|ambrisentan|mesh-list
92153302|NCT02080637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153303|NCT05019690|Paclitaxel|paclitaxel|mesh-list
92153304|NCT05019690|Apatinib|apatinib|mesh-list
92153305|NCT05019690|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92153306|NCT05019690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92153307|NCT05019690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153308|NCT05019690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92153309|NCT05019690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92153310|NCT05019690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92153311|NCT05019690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153312|NCT05019690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92153313|NCT05019690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153314|NCT04029467|Dexmedetomidine|dexmedetomidine|mesh-list
92153315|NCT04029467|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92153316|NCT04029467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153317|NCT04029467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153318|NCT04029467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92153319|NCT04029467|Analgesics|analgesics|mesh-ancestor
92153320|NCT04029467|Sensory System Agents|sensory system agents|mesh-ancestor
92153321|NCT04029467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153322|NCT04029467|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92153323|NCT04029467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92153324|NCT04029467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92153325|NCT04029467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153326|NCT04029467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153327|NCT04029467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153328|NCT03402321|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92153329|NCT03402321|Hemostatics|hemostatics|mesh-ancestor
92153330|NCT03402321|Coagulants|coagulants|mesh-ancestor
92153331|NCT03402165|Sofosbuvir|sofosbuvir|mesh-list
92153332|NCT03402165|Ledipasvir|ledipasvir|mesh-list
92153333|NCT03402165|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92153334|NCT03402165|Antiviral Agents|antiviral agents|mesh-ancestor
92153335|NCT03402165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153336|NCT03402087|Leucovorin|leucovorin|mesh-list
92153339|NCT03402087|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92153340|NCT03402087|Abortifacient Agents|abortifacient agents|mesh-ancestor
92153341|NCT03402087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92153342|NCT03402087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153343|NCT03402087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92153344|NCT03402087|Antimetabolites|antimetabolites|mesh-ancestor
92153345|NCT03402087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153346|NCT03402087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153347|NCT03402087|Dermatologic Agents|dermatologic agents|mesh-ancestor
92153348|NCT03402087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153351|NCT03402087|Immunologic Factors|immunologic factors|mesh-ancestor
92153352|NCT03402087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153353|NCT03402087|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92153354|NCT03402087|Antidotes|antidotes|mesh-ancestor
92153355|NCT03402087|Protective Agents|protective agents|mesh-ancestor
92153356|NCT03402087|Vitamin B Complex|vitamin b complex|mesh-ancestor
92153358|NCT03402087|Micronutrients|micronutrients|mesh-ancestor
92153359|NCT03402087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92153360|NCT04020263|Simendan|simendan|mesh-list
92153361|NCT04020263|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92153362|NCT04020263|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153363|NCT04020263|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92153364|NCT04020263|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92153365|NCT04020263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153366|NCT04020263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153367|NCT04020263|Protective Agents|protective agents|mesh-ancestor
92153368|NCT04020263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153369|NCT05013060|Butyric Acid|butyric acid|mesh-list
92153370|NCT05013060|Histamine Antagonists|histamine antagonists|mesh-ancestor
92153371|NCT05013060|Histamine Agents|histamine agents|mesh-ancestor
92153372|NCT05013060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153373|NCT05013060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153374|NCT05013060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153375|NCT05008068|Simvastatin|simvastatin|mesh-list
92153376|NCT05008068|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92153377|NCT05008068|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92153378|NCT05008068|Antimetabolites|antimetabolites|mesh-ancestor
92153379|NCT05008068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153380|NCT05008068|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92153381|NCT05008068|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92153382|NCT05008068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153383|NCT00925119|Atenolol|atenolol|mesh-list
92153384|NCT00925119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92153385|NCT00925119|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153386|NCT00925119|Sympatholytics|sympatholytics|mesh-ancestor
92153387|NCT00925119|Autonomic Agents|autonomic agents|mesh-ancestor
92153388|NCT00925119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153389|NCT00925119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153390|NCT00925119|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92153391|NCT00925119|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92153392|NCT00925119|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92153393|NCT00925119|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153394|NCT00925119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153395|NCT00925119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153396|NCT04020809|Atezolizumab|atezolizumab|mesh-list
92153397|NCT04020809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92153398|NCT04020809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153399|NCT04020809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153400|NCT04020809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153401|NCT04027751|Tropisetron|tropisetron|mesh-list
92153402|NCT04027751|Antiemetics|antiemetics|mesh-ancestor
92153403|NCT04027751|Autonomic Agents|autonomic agents|mesh-ancestor
92153404|NCT04027751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153405|NCT04027751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153406|NCT04027751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92153407|NCT04027751|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92153408|NCT04027751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92153409|NCT04027751|Serotonin Agents|serotonin agents|mesh-ancestor
92153410|NCT04027751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153411|NCT04027751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153413|NCT05018988|Ergocalciferols|ergocalciferols|mesh-list
92153414|NCT05018988|Cholecalciferol|cholecalciferol|mesh-list
92153415|NCT05018988|Vitamins|vitamins|mesh-list
92153416|NCT05018988|Micronutrients|micronutrients|mesh-ancestor
92153417|NCT05018988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153418|NCT05018988|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92153419|NCT05018988|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92153435|NCT02241759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153437|NCT04434144|Azithromycin|azithromycin|mesh-list
92153438|NCT04434144|Doxycycline|doxycycline|mesh-list
92153439|NCT04434144|Hydroxychloroquine|hydroxychloroquine|mesh-list
92153440|NCT04434144|Ivermectin|ivermectin|mesh-list
92153441|NCT04434144|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153442|NCT04434144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153443|NCT04434144|Antimalarials|antimalarials|mesh-ancestor
92153444|NCT04434144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153445|NCT04434144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153446|NCT04434144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153447|NCT04434144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153448|NCT04434144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153449|NCT04957914|Insulin Glargine|insulin glargine|mesh-list
92153450|NCT04957914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92153451|NCT04957914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153452|NCT04027283|Erythritol|erythritol|mesh-list
92153453|NCT04027283|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153454|NCT04028141|Ketamine|ketamine|mesh-list
92153455|NCT04028141|Propofol|propofol|mesh-list
92153456|NCT04028141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92153457|NCT04028141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153458|NCT04028141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153459|NCT04028141|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92153460|NCT04028141|Anesthetics, General|anesthetics, general|mesh-ancestor
92153461|NCT04028141|Anesthetics|anesthetics|mesh-ancestor
92153462|NCT04028141|Analgesics|analgesics|mesh-ancestor
92153463|NCT04028141|Sensory System Agents|sensory system agents|mesh-ancestor
92153464|NCT04028141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153465|NCT04028141|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92153466|NCT04028141|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92153467|NCT04028141|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92153468|NCT04028141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153469|NCT04028141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153470|NCT03401541|Vitamin D|vitamin d|mesh-list
92153471|NCT03401541|Calcifediol|calcifediol|mesh-list
92153472|NCT03401541|Ergocalciferols|ergocalciferols|mesh-list
92153473|NCT03401541|Vitamins|vitamins|mesh-ancestor
92153474|NCT03401541|Micronutrients|micronutrients|mesh-ancestor
92153475|NCT03401541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153476|NCT03401541|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92153477|NCT03401541|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92153478|NCT03953261|Curcumin|curcumin|mesh-list
92153479|NCT03953261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92153480|NCT03953261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92153481|NCT03953261|Analgesics|analgesics|mesh-ancestor
92153482|NCT03953261|Sensory System Agents|sensory system agents|mesh-ancestor
92153483|NCT03953261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153484|NCT03953261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153485|NCT03953261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153486|NCT03953261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153487|NCT03953261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153488|NCT03953261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153489|NCT03953261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153490|NCT02242149|Diacerein|diacerein|mesh-list
92153491|NCT02242149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153492|NCT03022565|Vorinostat|vorinostat|mesh-list
92153493|NCT03022565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153495|NCT03022565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153496|NCT03022565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153497|NCT03079050|Dexlansoprazole|dexlansoprazole|mesh-list
92153498|NCT03079050|Lansoprazole|lansoprazole|mesh-list
92153500|NCT03079050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92153501|NCT03079050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92153502|NCT03079050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153503|NCT03079050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153504|NCT03834129|Dexmedetomidine|dexmedetomidine|mesh-list
92153505|NCT03834129|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92153506|NCT03834129|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153507|NCT03834129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153508|NCT03834129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92153509|NCT03834129|Analgesics|analgesics|mesh-ancestor
92153510|NCT03834129|Sensory System Agents|sensory system agents|mesh-ancestor
92153511|NCT03834129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153512|NCT03834129|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92153513|NCT03834129|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92153514|NCT03834129|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92153515|NCT03834129|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153516|NCT03834129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153517|NCT03834129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153518|NCT05001204|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
92153519|NCT05001204|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92153520|NCT05001204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153521|NCT03022409|Olaparib|olaparib|mesh-list
92153522|NCT03022409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92153523|NCT03022409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153524|NCT03022409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153525|NCT03022409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153526|NCT03833895|Phenylephrine|phenylephrine|mesh-list
92153527|NCT03833895|Oxymetazoline|oxymetazoline|mesh-list
92153528|NCT03833895|Norepinephrine|norepinephrine|mesh-list
92153529|NCT03833895|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92153530|NCT03833895|Mydriatics|mydriatics|mesh-ancestor
92153531|NCT03833895|Autonomic Agents|autonomic agents|mesh-ancestor
92153532|NCT03833895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153533|NCT03833895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153534|NCT03833895|Sympathomimetics|sympathomimetics|mesh-ancestor
92153535|NCT03833895|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92153536|NCT03833895|Nasal Decongestants|nasal decongestants|mesh-ancestor
92153537|NCT03833895|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153538|NCT03833895|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92153539|NCT03833895|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92153540|NCT03833895|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92153541|NCT03833895|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153542|NCT03833895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153543|NCT03833895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153544|NCT03833895|Protective Agents|protective agents|mesh-ancestor
92153545|NCT02242227|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92153546|NCT02242227|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92153547|NCT02242227|Autonomic Agents|autonomic agents|mesh-ancestor
92153548|NCT02242227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153549|NCT02242227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153550|NCT02242227|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92153551|NCT02242227|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153552|NCT02242227|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92153553|NCT02242227|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92153554|NCT02242227|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92153555|NCT02242227|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153556|NCT02242227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153557|NCT02242227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153559|NCT05000892|Carboplatin|carboplatin|mesh-list
92153560|NCT05000892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92153561|NCT05000892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153562|NCT05000892|Tubulin Modulators|tubulin modulators|mesh-ancestor
92153563|NCT05000892|Antimitotic Agents|antimitotic agents|mesh-ancestor
92153564|NCT05000892|Mitosis Modulators|mitosis modulators|mesh-ancestor
92153565|NCT05000892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153567|NCT04372407|Antifungal Agents|antifungal agents|mesh-ancestor
92153568|NCT04372407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153569|NCT04372407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92153570|NCT04372407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92153571|NCT04372407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153572|NCT04372407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153573|NCT04372407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92153575|NCT04372407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153576|NCT04372407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153577|NCT04372407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92153578|NCT02242383|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92153580|NCT02242383|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153581|NCT02242383|Diuretics|diuretics|mesh-ancestor
92153582|NCT02242383|Natriuretic Agents|natriuretic agents|mesh-ancestor
92153583|NCT02242383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153584|NCT02242383|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92153585|NCT02242383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92154043|NCT00927849|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153586|NCT02242383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153587|NCT02242383|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92153588|NCT02242383|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92153589|NCT04366089|Azithromycin|azithromycin|mesh-list
92153590|NCT04366089|Hydroxychloroquine|hydroxychloroquine|mesh-list
92153591|NCT04366089|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153592|NCT04366089|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153593|NCT04366089|Antimalarials|antimalarials|mesh-ancestor
92153594|NCT04366089|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153595|NCT04366089|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153596|NCT04366089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153597|NCT04366089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153598|NCT04366089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153599|NCT03079830|Pirinitramide|pirinitramide|mesh-list
92153600|NCT03079830|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92153601|NCT03079830|Narcotics|narcotics|mesh-ancestor
92153602|NCT03079830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153603|NCT03079830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153604|NCT03079830|Analgesics|analgesics|mesh-ancestor
92153605|NCT03079830|Sensory System Agents|sensory system agents|mesh-ancestor
92153606|NCT03079830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153607|NCT02242695|Clotrimazole|clotrimazole|mesh-list
92153608|NCT02242695|Dequalinium|dequalinium|mesh-list
92153609|NCT02242695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92153610|NCT02242695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153611|NCT02242695|Antifungal Agents|antifungal agents|mesh-ancestor
92153612|NCT02242695|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92153613|NCT02242695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92153614|NCT02242695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153615|NCT02242695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153616|NCT02242695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92153617|NCT02242695|Hormone Antagonists|hormone antagonists|mesh-ancestor
92153618|NCT02242695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153619|NCT02242695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153620|NCT04999800|Pembrolizumab|pembrolizumab|mesh-list
92153621|NCT04999800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153622|NCT04999800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153623|NCT04999800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92153624|NCT04999800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153625|NCT02242851|Telmisartan|telmisartan|mesh-list
92153626|NCT02242851|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153627|NCT02242851|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92153628|NCT02242851|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92153629|NCT02242851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153630|NCT04999878|Dexamethasone|dexamethasone|mesh-list
92153631|NCT04999878|Gemcitabine|gemcitabine|mesh-list
92153632|NCT04999878|Etoposide|etoposide|mesh-list
92153633|NCT04999878|Cisplatin|cisplatin|mesh-list
92153634|NCT04999878|Pegaspargase|pegaspargase|mesh-list
92153635|NCT04999878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153636|NCT04999878|Antiemetics|antiemetics|mesh-ancestor
92153637|NCT04999878|Autonomic Agents|autonomic agents|mesh-ancestor
92153638|NCT04999878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153639|NCT04999878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153640|NCT04999878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92153641|NCT04999878|Glucocorticoids|glucocorticoids|mesh-ancestor
92153642|NCT04999878|Hormones|hormones|mesh-ancestor
92153643|NCT04999878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153644|NCT04999878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92153645|NCT04999878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153646|NCT04999878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92153647|NCT04999878|Antimetabolites|antimetabolites|mesh-ancestor
92153648|NCT04999878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153649|NCT04999878|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92153650|NCT04999878|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92153651|NCT04999878|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92153652|NCT04999878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153653|NCT02242929|Imiquimod|imiquimod|mesh-list
92153654|NCT02242929|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92153655|NCT02242929|Immunologic Factors|immunologic factors|mesh-ancestor
92153656|NCT02242929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153657|NCT02242929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153658|NCT02242929|Interferon Inducers|interferon inducers|mesh-ancestor
92153659|NCT04457856|Plonmarlimab|plonmarlimab|mesh-list
92153660|NCT04457856|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153661|NCT04457856|Antiviral Agents|antiviral agents|mesh-ancestor
92153662|NCT04457856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153663|NCT05006898|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92153664|NCT05006898|Oxymetazoline|oxymetazoline|mesh-list
92153665|NCT05006898|Pilocarpine|pilocarpine|mesh-list
92153666|NCT05006898|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153667|NCT05006898|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92153668|NCT05006898|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92153669|NCT05006898|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92153670|NCT05006898|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153671|NCT05006898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153672|NCT05006898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153673|NCT05006898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153674|NCT05006898|Sympathomimetics|sympathomimetics|mesh-ancestor
92153675|NCT05006898|Autonomic Agents|autonomic agents|mesh-ancestor
92153676|NCT05006898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153677|NCT05006898|Nasal Decongestants|nasal decongestants|mesh-ancestor
92153678|NCT05006898|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92153679|NCT05006898|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153680|NCT05006898|Miotics|miotics|mesh-ancestor
92153681|NCT05006898|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92153682|NCT05006898|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92153683|NCT05006898|Cholinergic Agents|cholinergic agents|mesh-ancestor
92153684|NCT02243241|Moxifloxacin|moxifloxacin|mesh-list
92153685|NCT02243241|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92153686|NCT02243241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153687|NCT02243241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153688|NCT02243241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92153690|NCT02243241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153691|NCT02243241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153692|NCT02243241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153693|NCT02243241|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92153694|NCT02243241|Contraceptive Agents|contraceptive agents|mesh-ancestor
92153695|NCT02243241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92153696|NCT02243241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153697|NCT02243241|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92153698|NCT02243241|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92153699|NCT02243241|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92153700|NCT04365309|Aspirin|aspirin|mesh-list
92153701|NCT04365309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92153702|NCT04365309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92153703|NCT04365309|Analgesics|analgesics|mesh-ancestor
92153704|NCT04365309|Sensory System Agents|sensory system agents|mesh-ancestor
92153705|NCT04365309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153706|NCT04365309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153707|NCT04365309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153708|NCT04365309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153709|NCT04365309|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92153710|NCT04365309|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92153711|NCT04365309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153712|NCT04365309|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92153713|NCT04365309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92153714|NCT04365309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153717|NCT02243553|Ritonavir|ritonavir|mesh-list
92153718|NCT02243553|Tipranavir|tipranavir|mesh-list
92153719|NCT02243553|Digoxin|digoxin|mesh-list
92153720|NCT02243553|Midazolam|midazolam|mesh-list
92153721|NCT02243553|Dextromethorphan|dextromethorphan|mesh-list
92153722|NCT02243553|Caffeine|caffeine|mesh-list
92153723|NCT02243553|Omeprazole|omeprazole|mesh-list
92153724|NCT02243553|Warfarin|warfarin|mesh-list
92153725|NCT02243553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92153726|NCT02243553|Vitamins|vitamins|mesh-ancestor
92153727|NCT02243553|Micronutrients|micronutrients|mesh-ancestor
92153728|NCT02243553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153729|NCT02243553|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92153730|NCT02243553|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92153731|NCT02243553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153732|NCT02243553|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92153733|NCT02243553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92153734|NCT02243553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92153735|NCT02243553|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92153736|NCT02243553|Anesthetics, General|anesthetics, general|mesh-ancestor
92153737|NCT02243553|Anesthetics|anesthetics|mesh-ancestor
92153738|NCT02243553|GABA Modulators|gaba modulators|mesh-ancestor
92153739|NCT02243553|GABA Agents|gaba agents|mesh-ancestor
92153740|NCT02243553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153741|NCT02243553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153742|NCT02243553|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92153743|NCT02243553|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92153744|NCT02243553|Protease Inhibitors|protease inhibitors|mesh-ancestor
92153745|NCT02243553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153746|NCT02243553|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92153747|NCT02243553|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92153748|NCT02243553|Antiviral Agents|antiviral agents|mesh-ancestor
92153749|NCT02243553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153750|NCT02243553|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92153751|NCT02243553|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92153752|NCT02243553|Anticoagulants|anticoagulants|mesh-ancestor
92153753|NCT02243553|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92153754|NCT02243553|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92153755|NCT02243553|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92153756|NCT02243553|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92153757|NCT02243553|Purinergic Agents|purinergic agents|mesh-ancestor
92153758|NCT02243553|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92153759|NCT02243553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92153760|NCT02243553|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92153761|NCT02243553|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92153762|NCT02243553|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92153763|NCT02243553|Protective Agents|protective agents|mesh-ancestor
92153764|NCT02243553|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92153765|NCT02243553|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92153766|NCT02243553|Hemostatics|hemostatics|mesh-ancestor
92153767|NCT02243553|Coagulants|coagulants|mesh-ancestor
92153768|NCT02243553|Antitussive Agents|antitussive agents|mesh-ancestor
92153769|NCT02243553|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153770|NCT02243553|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92153771|NCT02243553|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92153772|NCT00922233|Levonorgestrel|levonorgestrel|mesh-list
92153773|NCT00922233|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92153774|NCT00922233|Contraceptive Agents|contraceptive agents|mesh-ancestor
92153775|NCT00922233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92153776|NCT00922233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153777|NCT00922233|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92153778|NCT00922233|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92153779|NCT00922233|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92153780|NCT05006664|Prednisone|prednisone|mesh-list
92153781|NCT05006664|Cyclophosphamide|cyclophosphamide|mesh-list
92153782|NCT05006664|Doxorubicin|doxorubicin|mesh-list
92153783|NCT05006664|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92153784|NCT05006664|Etoposide|etoposide|mesh-list
92153785|NCT05006664|Etoposide phosphate|etoposide phosphate|mesh-list
92153786|NCT05006664|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92153787|NCT05006664|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92153788|NCT05006664|Immunologic Factors|immunologic factors|mesh-ancestor
92153789|NCT05006664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153790|NCT05006664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153791|NCT05006664|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92153792|NCT05006664|Alkylating Agents|alkylating agents|mesh-ancestor
92153793|NCT05006664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153794|NCT05006664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153795|NCT05006664|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92153796|NCT05006664|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92153798|NCT05006664|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92153799|NCT05006664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153800|NCT05006664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92153801|NCT05006664|Glucocorticoids|glucocorticoids|mesh-ancestor
92153803|NCT05006664|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153804|NCT05006664|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92153805|NCT05006664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92153806|NCT05006664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153807|NCT05006664|Immunotoxins|immunotoxins|mesh-ancestor
92153808|NCT05006664|Immunoconjugates|immunoconjugates|mesh-ancestor
92153809|NCT04346901|Methimazole|methimazole|mesh-list
92153810|NCT04346901|Antithyroid Agents|antithyroid agents|mesh-ancestor
92153811|NCT04346901|Hormone Antagonists|hormone antagonists|mesh-ancestor
92153812|NCT04346901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92153813|NCT04346901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153814|NCT02244021|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92153815|NCT02244021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153816|NCT02244021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153817|NCT02244021|Immunotoxins|immunotoxins|mesh-ancestor
92153818|NCT02244021|Immunoconjugates|immunoconjugates|mesh-ancestor
92153819|NCT02244021|Immunologic Factors|immunologic factors|mesh-ancestor
92153820|NCT02244021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153821|NCT04364451|Asparaginase|asparaginase|mesh-list
92153822|NCT04364451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153823|NCT02245269|Ritonavir|ritonavir|mesh-list
92153824|NCT02245269|Tipranavir|tipranavir|mesh-list
92153825|NCT02245269|Atorvastatin|atorvastatin|mesh-list
92153826|NCT02245269|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92153827|NCT02245269|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92153828|NCT02245269|Antimetabolites|antimetabolites|mesh-ancestor
92153829|NCT02245269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153830|NCT02245269|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92153831|NCT02245269|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92153832|NCT02245269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153833|NCT02245269|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92153834|NCT02245269|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92153835|NCT02245269|Protease Inhibitors|protease inhibitors|mesh-ancestor
92153836|NCT02245269|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92153837|NCT02245269|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92153838|NCT02245269|Antiviral Agents|antiviral agents|mesh-ancestor
92153839|NCT02245269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153840|NCT02245269|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92153841|NCT02245269|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92153842|NCT04364139|Metoprolol|metoprolol|mesh-list
92153843|NCT04364139|Amlodipine|amlodipine|mesh-list
92153844|NCT04364139|Ramipril|ramipril|mesh-list
92153845|NCT04364139|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92153846|NCT04364139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92153847|NCT04364139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92153848|NCT04364139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153849|NCT04364139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92153850|NCT04364139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153851|NCT04364139|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153852|NCT04364139|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92153853|NCT04364139|Sympatholytics|sympatholytics|mesh-ancestor
92153854|NCT04364139|Autonomic Agents|autonomic agents|mesh-ancestor
92153855|NCT04364139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153856|NCT04364139|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92153857|NCT04364139|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92153858|NCT04364139|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92153859|NCT04364139|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153860|NCT04364139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153861|NCT04364139|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92153862|NCT04364139|Protease Inhibitors|protease inhibitors|mesh-ancestor
92153863|NCT04364139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153864|NCT02244255|Tamsulosin|tamsulosin|mesh-list
92153865|NCT02244255|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92153866|NCT02244255|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92153867|NCT02244255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92153868|NCT02244255|Adrenergic Agents|adrenergic agents|mesh-ancestor
92153869|NCT02244255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153870|NCT02244255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153871|NCT02244255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153872|NCT02244255|Urological Agents|urological agents|mesh-ancestor
92153873|NCT04363827|Hydroxychloroquine|hydroxychloroquine|mesh-list
92153874|NCT04363827|Antimalarials|antimalarials|mesh-ancestor
92153875|NCT04363827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153876|NCT04363827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153877|NCT04363827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153878|NCT04363827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153879|NCT04363827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153880|NCT04363827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153881|NCT00923949|Pioglitazone|pioglitazone|mesh-list
92153882|NCT00923949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92153883|NCT00923949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153884|NCT04376541|Fentanyl|fentanyl|mesh-list
92153885|NCT04376541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92153886|NCT04376541|Narcotics|narcotics|mesh-ancestor
92153887|NCT04376541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153888|NCT04376541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153889|NCT04376541|Analgesics|analgesics|mesh-ancestor
92153890|NCT04376541|Sensory System Agents|sensory system agents|mesh-ancestor
92154044|NCT04149587|Brodalumab|brodalumab|mesh-list
92153891|NCT04376541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153892|NCT04376541|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92153893|NCT04376541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92153894|NCT04376541|Anesthetics, General|anesthetics, general|mesh-ancestor
92153895|NCT04376541|Anesthetics|anesthetics|mesh-ancestor
92153896|NCT04376307|Anesthetics|anesthetics|mesh-list
92153897|NCT04376307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153898|NCT04376307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153899|NCT02244489|Capecitabine|capecitabine|mesh-list
92153900|NCT02244489|Oxaliplatin|oxaliplatin|mesh-list
92153901|NCT02244489|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92153902|NCT02244489|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92153903|NCT02244489|Antimetabolites|antimetabolites|mesh-ancestor
92153904|NCT02244489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153905|NCT02244489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153906|NCT02244489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92153907|NCT02244489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153908|NCT02244567|Metformin|metformin|mesh-list
92153909|NCT02244567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153910|NCT02244567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92153911|NCT04376073|Niraparib|niraparib|mesh-list
92153912|NCT04376073|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92153913|NCT04376073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153914|NCT04376073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153915|NCT04376073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153916|NCT04999176|Enoxaparin|enoxaparin|mesh-list
92153917|NCT04999176|Rivaroxaban|rivaroxaban|mesh-list
92153918|NCT04999176|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92153919|NCT04999176|Antithrombins|antithrombins|mesh-ancestor
92153920|NCT04999176|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92153921|NCT04999176|Protease Inhibitors|protease inhibitors|mesh-ancestor
92153922|NCT04999176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153923|NCT04999176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153924|NCT04999176|Anticoagulants|anticoagulants|mesh-ancestor
92153925|NCT04999176|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92153926|NCT04999176|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92153927|NCT04363203|Azithromycin|azithromycin|mesh-list
92153928|NCT04363203|Hydroxychloroquine|hydroxychloroquine|mesh-list
92153929|NCT04363203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153930|NCT04363203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153932|NCT04363203|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153933|NCT04363203|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153934|NCT04363203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153935|NCT04363203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153936|NCT04363203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153937|NCT04363359|Vaccines|vaccines|mesh-list
92153938|NCT04363359|Immunologic Factors|immunologic factors|mesh-ancestor
92153939|NCT04363359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153940|NCT02244879|Resveratrol|resveratrol|mesh-list
92153941|NCT02244879|Antioxidants|antioxidants|mesh-ancestor
92153942|NCT02244879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153943|NCT02244879|Protective Agents|protective agents|mesh-ancestor
92153944|NCT02244879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153945|NCT02244879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153946|NCT02244879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92153947|NCT04362735|Vedolizumab|vedolizumab|mesh-list
92153948|NCT04362735|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92153949|NCT04375995|Nitric Oxide|nitric oxide|mesh-list
92153950|NCT04375995|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92153951|NCT04375995|Autonomic Agents|autonomic agents|mesh-ancestor
92153952|NCT04375995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153953|NCT04375995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153954|NCT04375995|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92153955|NCT04375995|Respiratory System Agents|respiratory system agents|mesh-ancestor
92153956|NCT04375995|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92153957|NCT04375995|Antioxidants|antioxidants|mesh-ancestor
92153958|NCT04375995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153959|NCT04375995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92153960|NCT04375995|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92153961|NCT04375995|Vasodilator Agents|vasodilator agents|mesh-ancestor
92153962|NCT04375995|Gasotransmitters|gasotransmitters|mesh-ancestor
92153963|NCT04375995|Protective Agents|protective agents|mesh-ancestor
92153964|NCT04365231|Azithromycin|azithromycin|mesh-list
92153965|NCT04365231|Hydroxychloroquine|hydroxychloroquine|mesh-list
92153966|NCT04365231|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153967|NCT04365231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153968|NCT04365231|Antimalarials|antimalarials|mesh-ancestor
92153969|NCT04365231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92153970|NCT04365231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92153971|NCT04365231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92153972|NCT04365231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153973|NCT04365231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92153974|NCT04993014|Trastuzumab|trastuzumab|mesh-list
92153975|NCT04993014|Pertuzumab|pertuzumab|mesh-list
92153976|NCT04993014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92153977|NCT04993014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92153978|NCT05005494|Magnesium Sulfate|magnesium sulfate|mesh-list
92153979|NCT05005494|Analgesics|analgesics|mesh-ancestor
92153980|NCT05005494|Sensory System Agents|sensory system agents|mesh-ancestor
92153981|NCT05005494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92153982|NCT05005494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92153983|NCT05005494|Anesthetics|anesthetics|mesh-ancestor
92153984|NCT05005494|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153985|NCT05005494|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92153986|NCT05005494|Anticonvulsants|anticonvulsants|mesh-ancestor
92153987|NCT05005494|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92153988|NCT05005494|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92153989|NCT05005494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92153990|NCT05005494|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92153991|NCT05005494|Tocolytic Agents|tocolytic agents|mesh-ancestor
92153992|NCT05005494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92153993|NCT04025567|Vancomycin|vancomycin|mesh-list
92153994|NCT04025567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92153995|NCT04025567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92153996|NCT03074994|Anesthetics|anesthetics|mesh-list
92153997|NCT03074994|Anesthetics, Local|anesthetics, local|mesh-list
92153998|NCT03074994|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92153999|NCT03074994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154000|NCT03074994|Sensory System Agents|sensory system agents|mesh-ancestor
92154001|NCT03074994|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154002|NCT04025177|Indomethacin|indomethacin|mesh-list
92154003|NCT04025177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92154004|NCT04025177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92154006|NCT04025177|Sensory System Agents|sensory system agents|mesh-ancestor
92154007|NCT04025177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154008|NCT04025177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154009|NCT04025177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92154010|NCT04025177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92154011|NCT04025177|Gout Suppressants|gout suppressants|mesh-ancestor
92154012|NCT04025177|Tocolytic Agents|tocolytic agents|mesh-ancestor
92154013|NCT04025177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92154014|NCT04025177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92154015|NCT04025177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154016|NCT04025177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154017|NCT04358055|Hyaluronic Acid|hyaluronic acid|mesh-list
92154018|NCT04358055|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92154019|NCT04358055|Immunologic Factors|immunologic factors|mesh-ancestor
92154020|NCT04358055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154021|NCT04358055|Viscosupplements|viscosupplements|mesh-ancestor
92154022|NCT04358055|Protective Agents|protective agents|mesh-ancestor
92154023|NCT04147325|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92154024|NCT04147325|Antiviral Agents|antiviral agents|mesh-ancestor
92154025|NCT04147325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154026|NCT02985281|Ribavirin|ribavirin|mesh-list
92154027|NCT02985281|Sofosbuvir|sofosbuvir|mesh-list
92154028|NCT02985281|Antimetabolites|antimetabolites|mesh-ancestor
92154029|NCT02985281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154030|NCT02985281|Antiviral Agents|antiviral agents|mesh-ancestor
92154031|NCT02985281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154032|NCT00927849|Nitroglycerin|nitroglycerin|mesh-list
92154033|NCT00927849|Botulinum Toxins|botulinum toxins|mesh-list
92154034|NCT00927849|Glycerol|glycerol|mesh-list
92154035|NCT00927849|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92154036|NCT00927849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92154037|NCT00927849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154038|NCT00927849|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154039|NCT00927849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154040|NCT00927849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154041|NCT00927849|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92154042|NCT00927849|Protective Agents|protective agents|mesh-ancestor
92154048|NCT02985125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92154049|NCT02985125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154050|NCT02985125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154051|NCT02985125|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92154052|NCT02985125|Immunologic Factors|immunologic factors|mesh-ancestor
92154053|NCT02985125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154054|NCT02985125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154055|NCT04912596|Albuterol|albuterol|mesh-list
92154056|NCT04912596|Procaterol|procaterol|mesh-list
92154057|NCT04912596|Methacholine Chloride|methacholine chloride|mesh-list
92154058|NCT04912596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92154059|NCT04912596|Autonomic Agents|autonomic agents|mesh-ancestor
92154060|NCT04912596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154061|NCT04912596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154062|NCT04912596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92154063|NCT04912596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92154064|NCT04912596|Tocolytic Agents|tocolytic agents|mesh-ancestor
92154065|NCT04912596|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92154066|NCT04912596|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92154067|NCT04912596|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92154068|NCT04912596|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92154069|NCT04912596|Adrenergic Agents|adrenergic agents|mesh-ancestor
92154070|NCT04912596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154071|NCT04912596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154073|NCT04912596|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92154074|NCT04912596|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92154075|NCT04912596|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92154076|NCT04912596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92154077|NCT04912596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92154078|NCT04912596|Sympathomimetics|sympathomimetics|mesh-ancestor
92154079|NCT00936741|Mifepristone|mifepristone|mesh-list
92154080|NCT00936741|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92154081|NCT00936741|Abortifacient Agents|abortifacient agents|mesh-ancestor
92154082|NCT00936741|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91939680|NCT02270242|Sensory System Agents|sensory system agents|mesh-ancestor
92154083|NCT00936741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154084|NCT00936741|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92154085|NCT00936741|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92154086|NCT00936741|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92154087|NCT00936741|Contraceptive Agents|contraceptive agents|mesh-ancestor
92154088|NCT00936741|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92154089|NCT00936741|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92154090|NCT00936741|Hormone Antagonists|hormone antagonists|mesh-ancestor
92154091|NCT00936741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92154092|NCT00936741|Luteolytic Agents|luteolytic agents|mesh-ancestor
92154093|NCT00936741|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92154094|NCT00936741|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92154097|NCT04024865|Autonomic Agents|autonomic agents|mesh-ancestor
92154098|NCT04024865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154099|NCT04024865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154100|NCT04024865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92154101|NCT04024865|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92154102|NCT04024865|Dopamine Agents|dopamine agents|mesh-ancestor
92154103|NCT04024865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92154104|NCT04024865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154105|NCT04024241|Cytarabine|cytarabine|mesh-list
92154106|NCT04024241|Mitoxantrone|mitoxantrone|mesh-list
92154107|NCT04024241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92154108|NCT04024241|Antimetabolites|antimetabolites|mesh-ancestor
92154109|NCT04024241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154110|NCT04024241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154111|NCT04024241|Antiviral Agents|antiviral agents|mesh-ancestor
92154112|NCT04024241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154113|NCT04024241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92154114|NCT04024241|Immunologic Factors|immunologic factors|mesh-ancestor
92154115|NCT04024241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154116|NCT04024241|Analgesics|analgesics|mesh-ancestor
92154117|NCT04024241|Sensory System Agents|sensory system agents|mesh-ancestor
92154118|NCT04024241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154119|NCT04024241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92154120|NCT04024241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92154121|NCT04024241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92154122|NCT04024163|Benzonidazole|benzonidazole|mesh-list
92154123|NCT04024163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92154125|NCT04024163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154126|NCT04024163|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92154127|NCT04024163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92154128|NCT04024163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92154129|NCT04024163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92154130|NCT04996290|Ropivacaine|ropivacaine|mesh-list
92154131|NCT04996290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92154132|NCT04996290|Anesthetics|anesthetics|mesh-ancestor
92154133|NCT04996290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154134|NCT04996290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154135|NCT04996290|Sensory System Agents|sensory system agents|mesh-ancestor
92154136|NCT04996290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154137|NCT04023617|Docetaxel|docetaxel|mesh-list
92154138|NCT04023617|Nivolumab|nivolumab|mesh-list
92154139|NCT04023617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154140|NCT04023617|Tubulin Modulators|tubulin modulators|mesh-ancestor
92154141|NCT04023617|Antimitotic Agents|antimitotic agents|mesh-ancestor
92154142|NCT04023617|Mitosis Modulators|mitosis modulators|mesh-ancestor
92154143|NCT04023617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92154144|NCT04023617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92154146|NCT04023149|Aldesleukin|aldesleukin|mesh-list
92154147|NCT04023149|Interleukin-2|interleukin-2|mesh-list
92154148|NCT04023149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154149|NCT04023149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92154150|NCT04023149|Analgesics|analgesics|mesh-ancestor
92154151|NCT04023149|Sensory System Agents|sensory system agents|mesh-ancestor
92154152|NCT04023149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92154153|NCT04023149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154154|NCT04023149|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92154155|NCT04023149|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92154156|NCT04023149|Antiviral Agents|antiviral agents|mesh-ancestor
92154158|NCT04023305|Sevoflurane|sevoflurane|mesh-list
92154159|NCT04023305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92154160|NCT04023305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92154161|NCT04023305|Anesthetics, General|anesthetics, general|mesh-ancestor
92154162|NCT04023305|Anesthetics|anesthetics|mesh-ancestor
92154163|NCT04023305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92154164|NCT04023305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92154165|NCT04149275|Nivolumab|nivolumab|mesh-list
92154166|NCT04149275|Ipilimumab|ipilimumab|mesh-list
92154167|NCT04149275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92154168|NCT04149275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92154169|NCT04149275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92154170|NCT04149275|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92405140|NCT01434862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405141|NCT01434888|Timolol|timolol|mesh-list
92405142|NCT01434888|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92405143|NCT01434888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92405144|NCT01434888|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92405145|NCT01434888|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405146|NCT01434888|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405147|NCT01434888|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405148|NCT01434888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405149|NCT01434888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405150|NCT01434888|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92405151|NCT01434888|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92405152|NCT01434901|Bethanechol|bethanechol|mesh-list
92405153|NCT01434901|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92405154|NCT01434901|Autonomic Agents|autonomic agents|mesh-ancestor
92405155|NCT01434901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405156|NCT01434901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405157|NCT01434901|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92405158|NCT01434901|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92405159|NCT01434901|Cholinergic Agents|cholinergic agents|mesh-ancestor
92405160|NCT01434901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405161|NCT01434901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405162|NCT01434914|Octenidine|octenidine|mesh-list
92405163|NCT01434914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405164|NCT01434914|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92405165|NCT01435083|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92405166|NCT01435083|Hemostatics|hemostatics|mesh-ancestor
92405167|NCT01435083|Coagulants|coagulants|mesh-ancestor
92405168|NCT01435083|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92405169|NCT01435083|Natriuretic Agents|natriuretic agents|mesh-ancestor
92405170|NCT01435083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405171|NCT01435161|Telmisartan|telmisartan|mesh-list
92405172|NCT01435161|Antihypertensive Agents|antihypertensive agents|mesh-list
92405173|NCT01435161|Nifedipine|nifedipine|mesh-list
92405174|NCT01435161|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92405175|NCT01435161|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92405176|NCT01435161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405177|NCT01435161|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92405178|NCT01435161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405179|NCT01435161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92405180|NCT01435161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405181|NCT01435161|Vasodilator Agents|vasodilator agents|mesh-ancestor
92405182|NCT01435161|Tocolytic Agents|tocolytic agents|mesh-ancestor
92405183|NCT01435161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92405184|NCT01435200|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92405185|NCT01435200|Hematinics|hematinics|mesh-ancestor
92405186|NCT01435213|Insulin|insulin|mesh-list
92405187|NCT01435213|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92405188|NCT01435213|Ketamine|ketamine|mesh-list
92405189|NCT01435213|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92405190|NCT01435213|Atipamezole|atipamezole|mesh-list
92405191|NCT01435213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405192|NCT01435213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405193|NCT01435213|Analgesics|analgesics|mesh-ancestor
92405194|NCT01435213|Sensory System Agents|sensory system agents|mesh-ancestor
92405195|NCT01435213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405196|NCT01435213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92405197|NCT01435213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92405198|NCT01435213|Anesthetics, General|anesthetics, general|mesh-ancestor
92405199|NCT01435213|Anesthetics|anesthetics|mesh-ancestor
92405200|NCT01435213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405201|NCT01435213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92405202|NCT01435213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92405203|NCT01435213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405204|NCT01435213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405205|NCT01435213|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92405206|NCT01435213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92405207|NCT01435213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405208|NCT01435213|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405209|NCT01435213|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92405210|NCT01435213|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92405211|NCT01435213|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405212|NCT01435252|Cetuximab|cetuximab|mesh-list
92405213|NCT01435252|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405214|NCT01435252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405215|NCT01435291|Tacrolimus|tacrolimus|mesh-list
92405216|NCT01435291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405217|NCT01435291|Immunologic Factors|immunologic factors|mesh-ancestor
92405218|NCT01435291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405219|NCT01435291|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92405220|NCT01435291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405221|NCT01435291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405222|NCT01435343|Cytarabine|cytarabine|mesh-list
92405223|NCT01435343|Plerixafor|plerixafor|mesh-list
92405224|NCT01435343|Fludarabine|fludarabine|mesh-list
92405225|NCT01435343|Idarubicin|idarubicin|mesh-list
92405226|NCT01435343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405227|NCT01435343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405228|NCT01435343|Antimetabolites|antimetabolites|mesh-ancestor
92405229|NCT01435343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405230|NCT01435343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405231|NCT01435343|Immunologic Factors|immunologic factors|mesh-ancestor
92405232|NCT01435343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405233|NCT01435343|Antiviral Agents|antiviral agents|mesh-ancestor
92405234|NCT01435343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405235|NCT01435343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92405236|NCT01435343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92405237|NCT01435343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92405238|NCT01435343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405239|NCT01435343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92405240|NCT01435343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92405241|NCT01435395|Bevacizumab|bevacizumab|mesh-list
92405242|NCT01435395|Temozolomide|temozolomide|mesh-list
92405243|NCT01435395|Bortezomib|bortezomib|mesh-list
92405244|NCT01435395|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405245|NCT01435395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405246|NCT01435395|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92405247|NCT01435395|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92405248|NCT01435395|Growth Substances|growth substances|mesh-ancestor
92405249|NCT01435395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405250|NCT01435395|Growth Inhibitors|growth inhibitors|mesh-ancestor
92405251|NCT01435395|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92405252|NCT01435395|Alkylating Agents|alkylating agents|mesh-ancestor
92405253|NCT01435395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405254|NCT01435486|Caffeine|caffeine|mesh-list
92405255|NCT01435486|Caffeine citrate|caffeine citrate|mesh-list
92405256|NCT01435486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405257|NCT01435486|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92405258|NCT01435486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405259|NCT01435486|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92405260|NCT01435486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405261|NCT01435486|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92405262|NCT01435486|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92405263|NCT01435486|Purinergic Agents|purinergic agents|mesh-ancestor
92405264|NCT01435486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405265|NCT01435499|Cyclophosphamide|cyclophosphamide|mesh-list
92405266|NCT01435499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405267|NCT01435499|Immunologic Factors|immunologic factors|mesh-ancestor
92405268|NCT01435499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405269|NCT01435499|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405270|NCT01435499|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92405271|NCT01435499|Alkylating Agents|alkylating agents|mesh-ancestor
92405272|NCT01435499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405273|NCT01435499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405274|NCT01435499|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92405276|NCT01435707|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92405277|NCT01435707|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92405278|NCT01435707|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92405279|NCT01435707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405280|NCT01435707|Glucocorticoids|glucocorticoids|mesh-ancestor
92405281|NCT01435707|Hormones|hormones|mesh-ancestor
92405282|NCT01435707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405283|NCT01435707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405284|NCT01435707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405285|NCT01435707|Immunologic Factors|immunologic factors|mesh-ancestor
92405286|NCT01435707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095980|NCT04614311|Glucocorticoids|glucocorticoids|mesh-ancestor
92405287|NCT01435707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405289|NCT01435837|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92405290|NCT01435837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405291|NCT01435837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92405292|NCT01435837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405293|NCT01435837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405294|NCT01435837|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92405295|NCT01435837|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92405296|NCT01435837|Purinergic Agents|purinergic agents|mesh-ancestor
92405297|NCT01435837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405298|NCT01435915|Ropinirole|ropinirole|mesh-list
92405299|NCT01435915|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92405300|NCT01435915|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92405301|NCT01435915|Dopamine Agonists|dopamine agonists|mesh-ancestor
92405302|NCT01435915|Dopamine Agents|dopamine agents|mesh-ancestor
92405303|NCT01435915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405304|NCT01435915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405305|NCT01435915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405306|NCT01435941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92405307|NCT01435941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92405308|NCT01435941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92405309|NCT01435941|Analgesics|analgesics|mesh-ancestor
92405310|NCT01435941|Sensory System Agents|sensory system agents|mesh-ancestor
92405311|NCT01435941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405312|NCT01435941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405313|NCT01435941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405314|NCT01435954|Doxazosin|doxazosin|mesh-list
92405315|NCT01435954|Tamsulosin|tamsulosin|mesh-list
92405316|NCT01435954|Finasteride|finasteride|mesh-list
92405317|NCT01435954|Silodosin|silodosin|mesh-list
92405318|NCT01435954|Terazosin|terazosin|mesh-list
92405319|NCT01435954|Alfuzosin|alfuzosin|mesh-list
92405320|NCT01435954|Dutasteride|dutasteride|mesh-list
92405396|NCT01436539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405321|NCT01435954|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92405322|NCT01435954|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92405323|NCT01435954|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405324|NCT01435954|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405325|NCT01435954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405326|NCT01435954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405327|NCT01435954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405328|NCT01435954|Urological Agents|urological agents|mesh-ancestor
92405329|NCT01435954|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92405330|NCT01435954|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92405331|NCT01435954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405332|NCT01435954|Hormone Antagonists|hormone antagonists|mesh-ancestor
92405333|NCT01435954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405334|NCT01435954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92405335|NCT01435980|Exenatide|exenatide|mesh-list
92405336|NCT01435980|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405337|NCT01435980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405338|NCT01435980|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92405339|NCT01435980|Incretins|incretins|mesh-ancestor
92405340|NCT01435980|Hormones|hormones|mesh-ancestor
92405341|NCT01435980|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405343|NCT01436123|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92405344|NCT01436123|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92405345|NCT01436123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405346|NCT01436123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405347|NCT01436123|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405348|NCT01436123|Immunologic Factors|immunologic factors|mesh-ancestor
92405349|NCT01436123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405350|NCT01436123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405352|NCT01436188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92405353|NCT01436188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92405354|NCT01436188|Analgesics|analgesics|mesh-ancestor
92405355|NCT01436188|Sensory System Agents|sensory system agents|mesh-ancestor
92405356|NCT01436188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405357|NCT01436188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405358|NCT01436188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405359|NCT01436188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405360|NCT01436188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92405361|NCT01436188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405362|NCT01436188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405363|NCT01436422|Vaccines|vaccines|mesh-list
92405364|NCT01436422|Immunologic Factors|immunologic factors|mesh-ancestor
92405365|NCT01436422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405366|NCT01435902|Fluticasone|fluticasone|mesh-list
92405367|NCT01435902|Xhance|xhance|mesh-list
92405368|NCT01435902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405369|NCT01435902|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92405370|NCT01435902|Autonomic Agents|autonomic agents|mesh-ancestor
92405371|NCT01435902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405372|NCT01435902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405373|NCT01435902|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92405374|NCT01435902|Respiratory System Agents|respiratory system agents|mesh-ancestor
92405375|NCT01435902|Dermatologic Agents|dermatologic agents|mesh-ancestor
92405376|NCT01435902|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92405377|NCT01436474|Varenicline|varenicline|mesh-list
92405378|NCT01436474|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92405379|NCT01436474|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92405380|NCT01436474|Cholinergic Agents|cholinergic agents|mesh-ancestor
92405381|NCT01436474|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405382|NCT01436474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405383|NCT01436474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405384|NCT01436513|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92405385|NCT01436513|Estrogens|estrogens|mesh-ancestor
92405386|NCT01436513|Hormones|hormones|mesh-ancestor
92405387|NCT01436513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405388|NCT01436513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405389|NCT01436539|Adefovir|adefovir|mesh-list
92405390|NCT01436539|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92405391|NCT01436539|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92405392|NCT01436539|Antiviral Agents|antiviral agents|mesh-ancestor
92405393|NCT01436539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405394|NCT01436539|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92405395|NCT01436539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92405397|NCT01436539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405398|NCT01436539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92405399|NCT01436539|Antimetabolites|antimetabolites|mesh-ancestor
92405400|NCT01436539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92405401|NCT01436578|Posaconazole|posaconazole|mesh-list
92405402|NCT01436578|Antifungal Agents|antifungal agents|mesh-ancestor
92405403|NCT01436578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405404|NCT01436578|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92405405|NCT01436578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92405406|NCT01436578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92405407|NCT01436578|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92405408|NCT01436578|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92405409|NCT01436578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405410|NCT01436578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405411|NCT01436578|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92405412|NCT01436578|Hormone Antagonists|hormone antagonists|mesh-ancestor
92405413|NCT01436578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405414|NCT01436578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405415|NCT01436825|Factor VIII|factor viii|mesh-list
92405416|NCT01436825|Coagulants|coagulants|mesh-ancestor
92405417|NCT01436838|Interferons|interferons|mesh-list
92405418|NCT01436838|Interferon-beta|interferon-beta|mesh-list
92405419|NCT01436838|Interferon beta-1b|interferon beta-1b|mesh-list
92405420|NCT01436838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405421|NCT01436838|Antiviral Agents|antiviral agents|mesh-ancestor
92405422|NCT01436838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405423|NCT01436838|Immunologic Factors|immunologic factors|mesh-ancestor
92405424|NCT01436838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405425|NCT01436838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92405426|NCT01436916|Cholecalciferol|cholecalciferol|mesh-list
92405427|NCT01436916|Vitamin D|vitamin d|mesh-list
92405428|NCT01436916|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92405429|NCT01436916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405430|NCT01436916|Vitamins|vitamins|mesh-ancestor
92405431|NCT01436916|Micronutrients|micronutrients|mesh-ancestor
92405432|NCT01436916|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92405433|NCT01436929|Silymarin|silymarin|mesh-list
92405434|NCT01436929|Antioxidants|antioxidants|mesh-ancestor
92405435|NCT01436929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405436|NCT01436929|Protective Agents|protective agents|mesh-ancestor
92405437|NCT01436929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405438|NCT01436994|Propylthiouracil|propylthiouracil|mesh-list
92405439|NCT01436994|Carbimazole|carbimazole|mesh-list
92405440|NCT01436994|Antimetabolites|antimetabolites|mesh-ancestor
92405441|NCT01436994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405442|NCT01436994|Antithyroid Agents|antithyroid agents|mesh-ancestor
92405443|NCT01436994|Hormone Antagonists|hormone antagonists|mesh-ancestor
92405444|NCT01436994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405445|NCT01436994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405446|NCT01437007|TKM-080301|tkm-080301|mesh-list
92405447|NCT01437007|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92405448|NCT01437007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405449|NCT01437007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405450|NCT01437020|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92405451|NCT01437020|Antifungal Agents|antifungal agents|mesh-ancestor
92405452|NCT01437020|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405453|NCT01437020|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92405454|NCT01437020|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92405455|NCT01437046|Doxazosin|doxazosin|mesh-list
92405456|NCT01437046|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92405457|NCT01437046|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92405458|NCT01437046|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92405459|NCT01437046|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405460|NCT01437046|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405461|NCT01437046|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405462|NCT01437046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405463|NCT01437046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405464|NCT01437189|Sertraline|sertraline|mesh-list
92405465|NCT01437189|Antidepressive Agents|antidepressive agents|mesh-ancestor
92405466|NCT01437189|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92405467|NCT01437189|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92405468|NCT01437189|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92405469|NCT01437189|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405470|NCT01437189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405471|NCT01437189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405472|NCT01437189|Serotonin Agents|serotonin agents|mesh-ancestor
92405473|NCT01437189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405474|NCT01437228|Povidone-Iodine|povidone-iodine|mesh-list
92405475|NCT01437228|Povidone|povidone|mesh-list
92405476|NCT01437228|Plasma Substitutes|plasma substitutes|mesh-ancestor
92405477|NCT01437228|Blood Substitutes|blood substitutes|mesh-ancestor
92405478|NCT01437228|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92405479|NCT01437228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405480|NCT01437293|Carbidopa|carbidopa|mesh-list
92405481|NCT01437293|Entacapone|entacapone|mesh-list
92405482|NCT01437293|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92405483|NCT01437293|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92405484|NCT01437293|Dopamine Agents|dopamine agents|mesh-ancestor
92405485|NCT01437293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405486|NCT01437293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405487|NCT01437293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405488|NCT01437293|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92405489|NCT01437293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405490|NCT01437293|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92405491|NCT01437306|Lofexidine|lofexidine|mesh-list
92405492|NCT01437306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92405493|NCT01437306|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92405494|NCT01437306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405495|NCT01437306|Sensory System Agents|sensory system agents|mesh-ancestor
92405496|NCT01437306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405497|NCT01437306|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92405498|NCT01437306|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92405499|NCT01437306|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92405500|NCT01437306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405501|NCT01437306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405502|NCT01437306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405503|NCT01437371|Ramipril|ramipril|mesh-list
92405504|NCT01437371|Enalapril|enalapril|mesh-list
92405505|NCT01437371|Lisinopril|lisinopril|mesh-list
92405506|NCT01437371|Captopril|captopril|mesh-list
92405507|NCT01437371|Trandolapril|trandolapril|mesh-list
92405508|NCT01437371|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92405509|NCT01437371|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92405510|NCT01437371|Protease Inhibitors|protease inhibitors|mesh-ancestor
92405511|NCT01437371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405512|NCT01437371|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92405513|NCT01437371|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92405514|NCT01437371|Protective Agents|protective agents|mesh-ancestor
92405515|NCT01437371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405516|NCT01437462|Propofol|propofol|mesh-list
92405517|NCT01437462|Sevoflurane|sevoflurane|mesh-list
92405518|NCT01437462|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92405519|NCT01437462|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405520|NCT01437462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405521|NCT01437462|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92405522|NCT01437462|Anesthetics, General|anesthetics, general|mesh-ancestor
92405523|NCT01437462|Anesthetics|anesthetics|mesh-ancestor
92405524|NCT01437462|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92405525|NCT01437462|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92405526|NCT01437566|Fulvestrant|fulvestrant|mesh-list
92405527|NCT01437566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92405528|NCT01437566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405529|NCT01437566|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92405530|NCT01437566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92405531|NCT01437566|Hormone Antagonists|hormone antagonists|mesh-ancestor
92405532|NCT01437566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405533|NCT01437566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405534|NCT01437579|Botulinum Toxins|botulinum toxins|mesh-list
92405535|NCT01437579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92405536|NCT01437579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405537|NCT01437579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405538|NCT01437579|Cholinergic Agents|cholinergic agents|mesh-ancestor
92405539|NCT01437579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405540|NCT01437579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405541|NCT01437592|Insulin|insulin|mesh-list
92405542|NCT01437592|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405543|NCT01437592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405544|NCT01437618|Bevacizumab|bevacizumab|mesh-list
92405545|NCT01437618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405546|NCT01437618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405547|NCT01437618|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92405548|NCT01437618|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92405549|NCT01437618|Growth Substances|growth substances|mesh-ancestor
92405550|NCT01437618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405551|NCT01437618|Growth Inhibitors|growth inhibitors|mesh-ancestor
92405552|NCT01437644|Botulinum Toxins|botulinum toxins|mesh-list
92405553|NCT01437644|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92405554|NCT01437644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405555|NCT01437644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405556|NCT01437644|Cholinergic Agents|cholinergic agents|mesh-ancestor
92405557|NCT01437644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405558|NCT01437644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405559|NCT01437670|Solifenacin Succinate|solifenacin succinate|mesh-list
92405560|NCT01437670|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92405561|NCT01437670|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92405562|NCT01437670|Cholinergic Agents|cholinergic agents|mesh-ancestor
92405563|NCT01437670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405564|NCT01437670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405565|NCT01437670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405566|NCT01437670|Urological Agents|urological agents|mesh-ancestor
92405567|NCT01437696|Vitamin D|vitamin d|mesh-list
92405568|NCT01437696|Ergocalciferols|ergocalciferols|mesh-list
92405569|NCT01437696|Cholecalciferol|cholecalciferol|mesh-list
92405570|NCT01437696|Vitamins|vitamins|mesh-list
92405571|NCT01437696|Micronutrients|micronutrients|mesh-ancestor
92405572|NCT01437696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405573|NCT01437696|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92405574|NCT01437696|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92405575|NCT01437748|Bromides|bromides|mesh-list
92405576|NCT01437748|Tiotropium Bromide|tiotropium bromide|mesh-list
92405577|NCT01437748|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92405578|NCT01437748|Autonomic Agents|autonomic agents|mesh-ancestor
92405579|NCT01437748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405580|NCT01437748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405581|NCT01437748|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92405582|NCT01437748|Respiratory System Agents|respiratory system agents|mesh-ancestor
92405583|NCT01437748|Parasympatholytics|parasympatholytics|mesh-ancestor
92405584|NCT01437748|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92405585|NCT01437748|Cholinergic Agents|cholinergic agents|mesh-ancestor
92405586|NCT01437748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405587|NCT01437748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405588|NCT01437748|Anticonvulsants|anticonvulsants|mesh-ancestor
92405589|NCT01437800|Metformin|metformin|mesh-list
92405590|NCT01437800|Glimepiride|glimepiride|mesh-list
92405591|NCT01437800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405592|NCT01437800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405593|NCT01437800|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92405594|NCT01437800|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405595|NCT01437800|Immunologic Factors|immunologic factors|mesh-ancestor
92405596|NCT01437813|Metformin|metformin|mesh-list
92405597|NCT01437813|Glimepiride|glimepiride|mesh-list
92405598|NCT01437813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405599|NCT01437813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405600|NCT01437813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92405601|NCT01437813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405602|NCT01437813|Immunologic Factors|immunologic factors|mesh-ancestor
92405603|NCT01437826|Selenium|selenium|mesh-list
92405604|NCT01437826|Antioxidants|antioxidants|mesh-list
92405605|NCT01437826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405606|NCT01437826|Protective Agents|protective agents|mesh-ancestor
92405607|NCT01437826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405608|NCT01437826|Trace Elements|trace elements|mesh-ancestor
92405609|NCT01437826|Micronutrients|micronutrients|mesh-ancestor
92405610|NCT01437839|Apixaban|apixaban|mesh-list
92405611|NCT01437839|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92405612|NCT01437839|Antithrombins|antithrombins|mesh-ancestor
92405613|NCT01437839|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92405614|NCT01437839|Protease Inhibitors|protease inhibitors|mesh-ancestor
92405615|NCT01437839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405616|NCT01437839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405617|NCT01437839|Anticoagulants|anticoagulants|mesh-ancestor
92405618|NCT01437982|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92405619|NCT01437982|Prednisolone|prednisolone|mesh-list
92405620|NCT01437982|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92405621|NCT01437982|Methylprednisolone|methylprednisolone|mesh-list
92405923|NCT04787848|Methylnaltrexone|methylnaltrexone|mesh-list
92405622|NCT01437982|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92405623|NCT01437982|Prednisolone acetate|prednisolone acetate|mesh-list
92405624|NCT01437982|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92405625|NCT01437982|Prednisolone phosphate|prednisolone phosphate|mesh-list
92405626|NCT01437982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405627|NCT01437982|Glucocorticoids|glucocorticoids|mesh-ancestor
92405628|NCT01437982|Hormones|hormones|mesh-ancestor
92405629|NCT01437982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405630|NCT01437982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405631|NCT01437982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92405632|NCT01437982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405633|NCT01437982|Antiemetics|antiemetics|mesh-ancestor
92405634|NCT01437982|Autonomic Agents|autonomic agents|mesh-ancestor
92405635|NCT01437982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405636|NCT01437982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92405637|NCT01437982|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92405638|NCT01437982|Protective Agents|protective agents|mesh-ancestor
92405639|NCT01437982|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92405640|NCT01438021|Methotrexate|methotrexate|mesh-list
92405641|NCT01438021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92405642|NCT01438021|Abortifacient Agents|abortifacient agents|mesh-ancestor
92405643|NCT01438021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92405644|NCT01438021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405645|NCT01438021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405646|NCT01438021|Antimetabolites|antimetabolites|mesh-ancestor
92405647|NCT01438021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405648|NCT01438021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405649|NCT01438021|Dermatologic Agents|dermatologic agents|mesh-ancestor
92405650|NCT01438021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405651|NCT01438021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92405652|NCT01438021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405653|NCT01438021|Immunologic Factors|immunologic factors|mesh-ancestor
92405654|NCT01438021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405655|NCT01438021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92405656|NCT01438086|Mecasermin|mecasermin|mesh-list
92405657|NCT01438086|Growth Substances|growth substances|mesh-ancestor
92405658|NCT01438086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405659|NCT01438112|Interferons|interferons|mesh-list
92405660|NCT01438112|Gemcitabine|gemcitabine|mesh-list
92405661|NCT01438112|Mitomycins|mitomycins|mesh-list
92405662|NCT01438112|Mitomycin|mitomycin|mesh-list
92405663|NCT01438112|Valrubicin|valrubicin|mesh-list
92405664|NCT01438112|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405665|NCT01438112|Antimetabolites|antimetabolites|mesh-ancestor
92405666|NCT01438112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405667|NCT01438112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405668|NCT01438112|Antiviral Agents|antiviral agents|mesh-ancestor
92405669|NCT01438112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405670|NCT01438112|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92405671|NCT01438112|Alkylating Agents|alkylating agents|mesh-ancestor
92405672|NCT01438112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92405673|NCT01438112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405674|NCT01438112|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92405675|NCT01438112|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92405676|NCT01438190|Metformin|metformin|mesh-list
92405677|NCT01438190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405678|NCT01438190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405679|NCT01438320|Quercetin|quercetin|mesh-list
92405680|NCT01438320|Antioxidants|antioxidants|mesh-ancestor
92405681|NCT01438320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405682|NCT01438320|Protective Agents|protective agents|mesh-ancestor
92405683|NCT01438320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405684|NCT05578859|Sotorasib|sotorasib|mesh-list
92405685|NCT05578859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92405686|NCT05578859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405687|NCT05578859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405688|NCT05578859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405689|NCT05554393|Cytarabine|cytarabine|mesh-list
92405690|NCT05554393|Azacitidine|azacitidine|mesh-list
92405691|NCT05554393|Daunorubicin|daunorubicin|mesh-list
92405692|NCT05554393|Venetoclax|venetoclax|mesh-list
92405693|NCT05554393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405694|NCT05554393|Antimetabolites|antimetabolites|mesh-ancestor
92405695|NCT05554393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405696|NCT05554393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405697|NCT05554393|Antiviral Agents|antiviral agents|mesh-ancestor
92405698|NCT05554393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405699|NCT05554393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405700|NCT05554393|Immunologic Factors|immunologic factors|mesh-ancestor
92405701|NCT05554393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405702|NCT05554393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405703|NCT05554393|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92405704|NCT05554393|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92405705|NCT05554393|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92405706|NCT05525013|Simvastatin|simvastatin|mesh-list
92405707|NCT05525013|Calcium|calcium|mesh-list
92405708|NCT05525013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92405709|NCT05525013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405710|NCT05525013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92405711|NCT05525013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92405712|NCT05525013|Antimetabolites|antimetabolites|mesh-ancestor
92405713|NCT05525013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405714|NCT05525013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92405715|NCT05525013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92405716|NCT05525013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405718|NCT05465174|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405719|NCT05465174|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405720|NCT05465174|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92405721|NCT05465174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405722|NCT05418088|Cyclophosphamide|cyclophosphamide|mesh-list
92405723|NCT05418088|Fludarabine|fludarabine|mesh-list
92405724|NCT05418088|Fludarabine phosphate|fludarabine phosphate|mesh-list
92405725|NCT05418088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405726|NCT05418088|Immunologic Factors|immunologic factors|mesh-ancestor
92405727|NCT05418088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405728|NCT05418088|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405729|NCT05418088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92405730|NCT05418088|Alkylating Agents|alkylating agents|mesh-ancestor
92405731|NCT05418088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405732|NCT05418088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405733|NCT05418088|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92405734|NCT05418088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92405735|NCT05418088|Antimetabolites|antimetabolites|mesh-ancestor
92405737|NCT05387525|Tirbanibulin|tirbanibulin|mesh-list
92405738|NCT05387525|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92405739|NCT05387525|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92405740|NCT05387525|Analgesics|analgesics|mesh-ancestor
92405741|NCT05387525|Sensory System Agents|sensory system agents|mesh-ancestor
92405742|NCT05387525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405743|NCT05387525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405744|NCT05387525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405745|NCT05387525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405746|NCT05387525|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92405747|NCT05387525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405748|NCT05387525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405749|NCT05382312|Bedaquiline|bedaquiline|mesh-list
92405750|NCT05382312|GSK656|gsk656|mesh-list
92405751|NCT05382312|Antitubercular Agents|antitubercular agents|mesh-ancestor
92405752|NCT05382312|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92405753|NCT05382312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405754|NCT05371275|Palbociclib|palbociclib|mesh-list
92405755|NCT05371275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405756|NCT05371275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92405757|NCT05371275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405758|NCT05371275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405759|NCT05370794|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92405760|NCT05370794|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92405761|NCT05370794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405762|NCT05343507|Ketamine|ketamine|mesh-list
92405763|NCT05343507|Analgesics|analgesics|mesh-ancestor
92405764|NCT05343507|Sensory System Agents|sensory system agents|mesh-ancestor
92405765|NCT05343507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405766|NCT05343507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405767|NCT05343507|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92405768|NCT05343507|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92405769|NCT05343507|Anesthetics, General|anesthetics, general|mesh-ancestor
92405770|NCT05343507|Anesthetics|anesthetics|mesh-ancestor
92405771|NCT05343507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405772|NCT05343507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92405773|NCT05343507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92405774|NCT05343507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405775|NCT05343507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405776|NCT05213832|Isoflurane|isoflurane|mesh-list
92405777|NCT05213832|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92405778|NCT05213832|Anesthetics, General|anesthetics, general|mesh-ancestor
92405779|NCT05213832|Anesthetics|anesthetics|mesh-ancestor
91939695|NCT02270242|Purinergic Agents|purinergic agents|mesh-ancestor
92405780|NCT05213832|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405781|NCT05213832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405783|NCT05164159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92405784|NCT05164159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405785|NCT05164159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405786|NCT05164159|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92405787|NCT05164159|Anesthetics, General|anesthetics, general|mesh-ancestor
92405788|NCT05164159|Anesthetics|anesthetics|mesh-ancestor
92405789|NCT05164146|Propofol|propofol|mesh-list
92405790|NCT05164146|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92405791|NCT05164146|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405792|NCT05164146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405793|NCT05164146|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92405794|NCT05164146|Anesthetics, General|anesthetics, general|mesh-ancestor
92405795|NCT05164146|Anesthetics|anesthetics|mesh-ancestor
92405796|NCT05153070|Cyclosporine|cyclosporine|mesh-list
92405797|NCT05153070|Cyclosporins|cyclosporins|mesh-list
92405798|NCT05153070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405799|NCT05153070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405800|NCT05153070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405801|NCT05153070|Immunologic Factors|immunologic factors|mesh-ancestor
92405802|NCT05153070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405803|NCT05153070|Antifungal Agents|antifungal agents|mesh-ancestor
92405804|NCT05153070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92405805|NCT05153070|Dermatologic Agents|dermatologic agents|mesh-ancestor
92405806|NCT05153070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405807|NCT05153070|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92405808|NCT05111431|Dexmedetomidine|dexmedetomidine|mesh-list
92405809|NCT05111431|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92405810|NCT05111431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405811|NCT05111431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405813|NCT05111431|Analgesics|analgesics|mesh-ancestor
92405814|NCT05111431|Sensory System Agents|sensory system agents|mesh-ancestor
92405815|NCT05111431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405816|NCT05111431|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92405817|NCT05111431|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92405818|NCT05111431|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92405819|NCT05111431|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405820|NCT05111431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405821|NCT05111431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405822|NCT04965298|Lansoprazole|lansoprazole|mesh-list
92405823|NCT04965298|Dexlansoprazole|dexlansoprazole|mesh-list
92405824|NCT04965298|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92405825|NCT04965298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92405826|NCT04965298|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92405827|NCT04965298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405828|NCT04965298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405829|NCT04956939|Levodopa|levodopa|mesh-list
92405830|NCT04956939|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92405831|NCT04956939|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92405832|NCT04956939|Dopamine Agents|dopamine agents|mesh-ancestor
92405833|NCT04956939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405834|NCT04956939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405835|NCT04956939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405836|NCT04955470|Midazolam|midazolam|mesh-list
92405837|NCT04955470|Ketamine|ketamine|mesh-list
92405838|NCT04955470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92405839|NCT04955470|Analgesics|analgesics|mesh-ancestor
92405840|NCT04955470|Sensory System Agents|sensory system agents|mesh-ancestor
92405841|NCT04955470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405842|NCT04955470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405843|NCT04955470|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92405844|NCT04955470|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92405845|NCT04955470|Anesthetics, General|anesthetics, general|mesh-ancestor
92405846|NCT04955470|Anesthetics|anesthetics|mesh-ancestor
92405847|NCT04955470|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405848|NCT04955470|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92405849|NCT04955470|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92405850|NCT04955470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405851|NCT04955470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405852|NCT04955470|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92405853|NCT04955470|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92405854|NCT04955470|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92405855|NCT04955470|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92405856|NCT04955470|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92405857|NCT04955470|GABA Modulators|gaba modulators|mesh-ancestor
92405858|NCT04955470|GABA Agents|gaba agents|mesh-ancestor
92405859|NCT04938557|Insulin|insulin|mesh-list
92405860|NCT04938557|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92405861|NCT04938557|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92405862|NCT04938557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405864|NCT04922567|Cyclophosphamide|cyclophosphamide|mesh-list
92405865|NCT04922567|Doxorubicin|doxorubicin|mesh-list
92405866|NCT04922567|Vincristine|vincristine|mesh-list
92405867|NCT04922567|Lenalidomide|lenalidomide|mesh-list
92405868|NCT04922567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405869|NCT04922567|Immunologic Factors|immunologic factors|mesh-ancestor
92405870|NCT04922567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405871|NCT04922567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405872|NCT04922567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92405873|NCT04922567|Alkylating Agents|alkylating agents|mesh-ancestor
92405874|NCT04922567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405875|NCT04922567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405876|NCT04922567|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92405877|NCT04922567|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92405878|NCT04922567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92405879|NCT04922567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92405880|NCT04922567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405881|NCT04922567|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405882|NCT04922567|Glucocorticoids|glucocorticoids|mesh-ancestor
92096574|NCT01064362|Anticoagulants|anticoagulants|mesh-ancestor
92405883|NCT04922567|Hormones|hormones|mesh-ancestor
92405884|NCT04922567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405885|NCT04922567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92405886|NCT04922567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92405887|NCT04922567|Tubulin Modulators|tubulin modulators|mesh-ancestor
92405888|NCT04922567|Antimitotic Agents|antimitotic agents|mesh-ancestor
92405889|NCT04922567|Mitosis Modulators|mitosis modulators|mesh-ancestor
92405890|NCT04922567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92405891|NCT04922567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92405892|NCT04922567|Growth Substances|growth substances|mesh-ancestor
92405893|NCT04922567|Growth Inhibitors|growth inhibitors|mesh-ancestor
92405894|NCT04906278|Oxytocin|oxytocin|mesh-list
92405895|NCT04906278|Oxytocics|oxytocics|mesh-ancestor
92405896|NCT04906278|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92405897|NCT04906278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405898|NCT04850222|Fluoxetine|fluoxetine|mesh-list
92405899|NCT04850222|Calcium|calcium|mesh-list
92405900|NCT04850222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92405901|NCT04850222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405902|NCT04850222|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92405903|NCT04850222|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92405904|NCT04850222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405905|NCT04850222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405906|NCT04850222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405907|NCT04850222|Serotonin Agents|serotonin agents|mesh-ancestor
92405908|NCT04850222|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92405909|NCT04850222|Antidepressive Agents|antidepressive agents|mesh-ancestor
92405910|NCT04850222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92405911|NCT04850222|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92405912|NCT04850222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92405913|NCT04850222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405914|NCT04800692|Verapamil|verapamil|mesh-list
92405915|NCT04800692|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92405916|NCT04800692|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92405917|NCT04800692|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92405918|NCT04800692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405919|NCT04800692|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92405920|NCT04800692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405921|NCT04800692|Vasodilator Agents|vasodilator agents|mesh-ancestor
92405922|NCT04787848|Bromides|bromides|mesh-list
92405926|NCT04787848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405927|NCT04787848|Sensory System Agents|sensory system agents|mesh-ancestor
92405928|NCT04787848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405929|NCT04660799|Diphenhydramine|diphenhydramine|mesh-list
92405930|NCT04660799|Promethazine|promethazine|mesh-list
92405931|NCT04660799|Prednisone|prednisone|mesh-list
92405932|NCT04660799|Cyclophosphamide|cyclophosphamide|mesh-list
92405933|NCT04660799|Rituximab|rituximab|mesh-list
92405934|NCT04660799|Doxorubicin|doxorubicin|mesh-list
92405935|NCT04660799|Vincristine|vincristine|mesh-list
92405936|NCT04660799|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92405937|NCT04660799|Histamine Antagonists|histamine antagonists|mesh-list
92405938|NCT04660799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92405939|NCT04660799|Immunologic Factors|immunologic factors|mesh-ancestor
92405940|NCT04660799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405941|NCT04660799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92405942|NCT04660799|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92405943|NCT04660799|Alkylating Agents|alkylating agents|mesh-ancestor
92405944|NCT04660799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405945|NCT04660799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92405946|NCT04660799|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92405947|NCT04660799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92405948|NCT04660799|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92405949|NCT04660799|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92405950|NCT04660799|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92405951|NCT04660799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92405952|NCT04660799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92405953|NCT04660799|Glucocorticoids|glucocorticoids|mesh-ancestor
92405954|NCT04660799|Hormones|hormones|mesh-ancestor
92405955|NCT04660799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92405956|NCT04660799|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92405957|NCT04660799|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92405958|NCT04660799|Tubulin Modulators|tubulin modulators|mesh-ancestor
92405959|NCT04660799|Antimitotic Agents|antimitotic agents|mesh-ancestor
92405960|NCT04660799|Mitosis Modulators|mitosis modulators|mesh-ancestor
92405961|NCT04660799|Sensory System Agents|sensory system agents|mesh-ancestor
92405962|NCT04660799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405963|NCT04660799|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92405964|NCT04660799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92405965|NCT04660799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92405966|NCT04660799|Anesthetics, Local|anesthetics, local|mesh-ancestor
92405967|NCT04660799|Anesthetics|anesthetics|mesh-ancestor
92405968|NCT04660799|Antiemetics|antiemetics|mesh-ancestor
92405969|NCT04660799|Autonomic Agents|autonomic agents|mesh-ancestor
92405970|NCT04660799|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92405971|NCT04660799|Histamine Agents|histamine agents|mesh-ancestor
92405972|NCT04660799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405973|NCT04660799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92405974|NCT04660799|Antipruritics|antipruritics|mesh-ancestor
92405975|NCT04660799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92405976|NCT04636632|Fosaprepitant|fosaprepitant|mesh-list
92405977|NCT04636632|Aprepitant|aprepitant|mesh-list
92405978|NCT04636632|Antiemetics|antiemetics|mesh-ancestor
92405979|NCT04636632|Autonomic Agents|autonomic agents|mesh-ancestor
92405980|NCT04636632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92405981|NCT04636632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405982|NCT04636632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92405983|NCT04636632|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92405984|NCT04636632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405985|NCT04636632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405987|NCT04597372|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92405988|NCT04597372|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92405989|NCT04597372|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92405990|NCT04597372|Adrenergic Agents|adrenergic agents|mesh-ancestor
92405991|NCT04597372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92405992|NCT04597372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92405993|NCT04597372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92405994|NCT04597372|Urological Agents|urological agents|mesh-ancestor
92405995|NCT04585542|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92405996|NCT04585542|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
92405997|NCT04585542|Laxatives|laxatives|mesh-ancestor
92405998|NCT04585542|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92405999|NCT04585542|Chelating Agents|chelating agents|mesh-ancestor
92406000|NCT04585542|Sequestering Agents|sequestering agents|mesh-ancestor
92406001|NCT04585542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406004|NCT04545060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406005|NCT04502602|Niraparib|niraparib|mesh-list
92406006|NCT04502602|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92406007|NCT04502602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406008|NCT04502602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406009|NCT04502602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406010|NCT04375202|Colchicine|colchicine|mesh-list
92406011|NCT04375202|Gout Suppressants|gout suppressants|mesh-ancestor
92406012|NCT04375202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406013|NCT04375202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92406014|NCT04375202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92406015|NCT04375202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406016|NCT04375202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406017|NCT04375202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406018|NCT04345744|Chlorhexidine|chlorhexidine|mesh-list
92406019|NCT04345744|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92406020|NCT04345744|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92406021|NCT04345744|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406022|NCT04345744|Disinfectants|disinfectants|mesh-ancestor
92406023|NCT04345744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92406025|NCT04332393|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406026|NCT04332393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406027|NCT04329572|Azithromycin|azithromycin|mesh-list
92406028|NCT04329572|Hydroxychloroquine|hydroxychloroquine|mesh-list
92406029|NCT04329572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92406030|NCT04329572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406031|NCT04329572|Antimalarials|antimalarials|mesh-ancestor
92406032|NCT04329572|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92406033|NCT04329572|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92406034|NCT04329572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406035|NCT04329572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406036|NCT04329572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406037|NCT04322552|Apatinib|apatinib|mesh-list
92406038|NCT04322552|Digoxin|digoxin|mesh-list
92406039|NCT04322552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406040|NCT04322552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406041|NCT04322552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406042|NCT04322552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406043|NCT04322552|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92406044|NCT04322552|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92406045|NCT04322552|Protective Agents|protective agents|mesh-ancestor
92406046|NCT04322552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406047|NCT04322305|Pregabalin|pregabalin|mesh-list
92406048|NCT04322305|Analgesics|analgesics|mesh-ancestor
92406049|NCT04322305|Sensory System Agents|sensory system agents|mesh-ancestor
92406050|NCT04322305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406051|NCT04322305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406052|NCT04322305|Anticonvulsants|anticonvulsants|mesh-ancestor
92406053|NCT04322305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92406054|NCT04322305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92406055|NCT04322305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406056|NCT04322305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92406057|NCT04322305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92406058|NCT04322305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92406059|NCT04322305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406060|NCT04322305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92406061|NCT04234061|Tisagenlecleucel|tisagenlecleucel|mesh-list
92406062|NCT04234061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406063|NCT04234061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406064|NCT04189848|Dulaglutide|dulaglutide|mesh-list
92406065|NCT04189848|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406066|NCT04189848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406067|NCT04156334|Anesthetics|anesthetics|mesh-list
92406068|NCT04156334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406069|NCT04156334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406070|NCT04078906|SMOFlipid|smoflipid|mesh-list
92406071|NCT04078906|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92406072|NCT04078906|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92406073|NCT04078906|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92406074|NCT03980171|Lenalidomide|lenalidomide|mesh-list
92406075|NCT03980171|Venetoclax|venetoclax|mesh-list
92406076|NCT03980171|Obinutuzumab|obinutuzumab|mesh-list
92406077|NCT03980171|Immunologic Factors|immunologic factors|mesh-ancestor
92406078|NCT03980171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406079|NCT03980171|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92406080|NCT03980171|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92406083|NCT03980171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406084|NCT03980171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406086|NCT03979365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92406087|NCT03979365|Immunologic Factors|immunologic factors|mesh-ancestor
92406088|NCT03979365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406089|NCT03979365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92406090|NCT03979365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406091|NCT03979365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406092|NCT03860077|Nicotine|nicotine|mesh-list
92406093|NCT03860077|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92406094|NCT03860077|Autonomic Agents|autonomic agents|mesh-ancestor
92406095|NCT03860077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406096|NCT03860077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406097|NCT03860077|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92406098|NCT03860077|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92406099|NCT03860077|Cholinergic Agents|cholinergic agents|mesh-ancestor
92406100|NCT03860077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406101|NCT03860077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406102|NCT03671746|Ketorolac|ketorolac|mesh-list
92406103|NCT03671746|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92406104|NCT03671746|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92406105|NCT03671746|Analgesics|analgesics|mesh-ancestor
92406106|NCT03671746|Sensory System Agents|sensory system agents|mesh-ancestor
92406107|NCT03671746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406108|NCT03671746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406109|NCT03671746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406110|NCT03671746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406111|NCT03671746|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92406112|NCT03671746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406113|NCT03671746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406114|NCT03558724|Bevacizumab|bevacizumab|mesh-list
92406115|NCT03558724|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406116|NCT03558724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406117|NCT03558724|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92406118|NCT03558724|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92406119|NCT03558724|Growth Substances|growth substances|mesh-ancestor
92406120|NCT03558724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406121|NCT03558724|Growth Inhibitors|growth inhibitors|mesh-ancestor
92406122|NCT03512496|Caffeine|caffeine|mesh-list
92406123|NCT03512496|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92406124|NCT03512496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406125|NCT03512496|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92406126|NCT03512496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406127|NCT03512496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406128|NCT03512496|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92406129|NCT03512496|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92406130|NCT03512496|Purinergic Agents|purinergic agents|mesh-ancestor
92406131|NCT03512496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406132|NCT03416127|Metformin|metformin|mesh-list
92406133|NCT03416127|Propolis|propolis|mesh-list
92406134|NCT03416127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406135|NCT03416127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406136|NCT03416127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406137|NCT03293069|Deferiprone|deferiprone|mesh-list
92406138|NCT03293069|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92406139|NCT03293069|Chelating Agents|chelating agents|mesh-ancestor
92406140|NCT03293069|Sequestering Agents|sequestering agents|mesh-ancestor
92406141|NCT03293069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406142|NCT03255018|Pembrolizumab|pembrolizumab|mesh-list
92406143|NCT03255018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406144|NCT03255018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406145|NCT03255018|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92406146|NCT03255018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406147|NCT03250975|Azithromycin|azithromycin|mesh-list
92406148|NCT03250975|Budesonide|budesonide|mesh-list
92406149|NCT03250975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406150|NCT03250975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92406151|NCT03250975|Autonomic Agents|autonomic agents|mesh-ancestor
92406152|NCT03250975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406153|NCT03250975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406154|NCT03250975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92406155|NCT03250975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92406156|NCT03250975|Glucocorticoids|glucocorticoids|mesh-ancestor
92406157|NCT03250975|Hormones|hormones|mesh-ancestor
92406158|NCT03250975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406159|NCT03250975|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92406160|NCT03250975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406161|NCT03232346|Buprenorphine|buprenorphine|mesh-list
92406162|NCT03232346|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92406163|NCT03232346|Narcotics|narcotics|mesh-ancestor
92406164|NCT03232346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406165|NCT03232346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406166|NCT03232346|Analgesics|analgesics|mesh-ancestor
92406167|NCT03232346|Sensory System Agents|sensory system agents|mesh-ancestor
92406168|NCT03232346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406169|NCT03232346|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92406170|NCT03227731|Tenofovir|tenofovir|mesh-list
92406171|NCT03227731|Emtricitabine|emtricitabine|mesh-list
92406172|NCT03227731|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92406173|NCT03227731|Antiviral Agents|antiviral agents|mesh-ancestor
92406174|NCT03227731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406175|NCT03227731|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92406176|NCT03227731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92406177|NCT03227731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406178|NCT03227731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406179|NCT03227731|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92406180|NCT03227731|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92406181|NCT03200015|Metformin|metformin|mesh-list
92406182|NCT03200015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406183|NCT03200015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096871|NCT03186027|Vitamins|vitamins|mesh-ancestor
92406184|NCT03193281|Imatinib Mesylate|imatinib mesylate|mesh-list
92406185|NCT03193281|Dasatinib|dasatinib|mesh-list
92406186|NCT03193281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406187|NCT03193281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406188|NCT03193281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406189|NCT03193281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406190|NCT03149640|Amikacin|amikacin|mesh-list
92406191|NCT03149640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92406192|NCT03149640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406193|NCT03098355|Interleukin-2|interleukin-2|mesh-list
92406194|NCT03098355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406195|NCT03098355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92406196|NCT03098355|Analgesics|analgesics|mesh-ancestor
92406197|NCT03098355|Sensory System Agents|sensory system agents|mesh-ancestor
92406198|NCT03098355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406199|NCT03098355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406200|NCT02986334|Naproxen|naproxen|mesh-list
92406201|NCT02986334|Omeprazole|omeprazole|mesh-list
92406202|NCT02986334|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92406203|NCT02986334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406204|NCT02986334|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92406205|NCT02986334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406206|NCT02986334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406207|NCT02986334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92406208|NCT02986334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92406209|NCT02986334|Analgesics|analgesics|mesh-ancestor
92406210|NCT02986334|Sensory System Agents|sensory system agents|mesh-ancestor
92406211|NCT02986334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406212|NCT02986334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406213|NCT02986334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406214|NCT02986334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406215|NCT02986334|Gout Suppressants|gout suppressants|mesh-ancestor
92406216|NCT02986334|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92406217|NCT02668289|Anesthetics|anesthetics|mesh-list
92406218|NCT02668289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406219|NCT02668289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406220|NCT02655315|Deferiprone|deferiprone|mesh-list
91939701|NCT04869124|Dapagliflozin|dapagliflozin|mesh-list
92406221|NCT02655315|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92406222|NCT02655315|Chelating Agents|chelating agents|mesh-ancestor
92406223|NCT02655315|Sequestering Agents|sequestering agents|mesh-ancestor
92406224|NCT02655315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406225|NCT02572843|Durvalumab|durvalumab|mesh-list
92406226|NCT02572843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406227|NCT02572843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406228|NCT02436733|Pemetrexed|pemetrexed|mesh-list
92406229|NCT02436733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406230|NCT02436733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406306|NCT01781468|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92406231|NCT02436733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406232|NCT02436733|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92406233|NCT02436733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92406234|NCT02426502|Cyclosporine|cyclosporine|mesh-list
92406235|NCT02426502|Mycophenolic Acid|mycophenolic acid|mesh-list
92406236|NCT02426502|Prednisone|prednisone|mesh-list
92406237|NCT02426502|Azathioprine|azathioprine|mesh-list
92406238|NCT02426502|Antihypertensive Agents|antihypertensive agents|mesh-list
92406239|NCT02426502|Cyclosporins|cyclosporins|mesh-list
92406240|NCT02426502|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406241|NCT02426502|Glucocorticoids|glucocorticoids|mesh-ancestor
92406242|NCT02426502|Hormones|hormones|mesh-ancestor
92406243|NCT02426502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406244|NCT02426502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406245|NCT02426502|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92406246|NCT02426502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406247|NCT02426502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406248|NCT02426502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406249|NCT02426502|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92406250|NCT02426502|Immunologic Factors|immunologic factors|mesh-ancestor
92406251|NCT02426502|Antifungal Agents|antifungal agents|mesh-ancestor
92406252|NCT02426502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406253|NCT02426502|Dermatologic Agents|dermatologic agents|mesh-ancestor
92406254|NCT02426502|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406255|NCT02426502|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92406256|NCT02426502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92406257|NCT02426502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92406258|NCT02426502|Antitubercular Agents|antitubercular agents|mesh-ancestor
92096950|NCT02870829|Vitamins|vitamins|mesh-ancestor
92406259|NCT02426502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92406260|NCT02426502|Antimetabolites|antimetabolites|mesh-ancestor
92406261|NCT02426502|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92406262|NCT02275156|Evolocumab|evolocumab|mesh-list
92406263|NCT02275156|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92406264|NCT02275156|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92406265|NCT02275156|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92406266|NCT02275156|Antimetabolites|antimetabolites|mesh-ancestor
92406267|NCT02275156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406268|NCT02275156|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92406269|NCT02275156|Protease Inhibitors|protease inhibitors|mesh-ancestor
92406270|NCT02275156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406271|NCT02275156|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92406272|NCT02124902|Carboplatin|carboplatin|mesh-list
92406273|NCT02124902|Docetaxel|docetaxel|mesh-list
92406274|NCT02124902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406275|NCT02124902|Tubulin Modulators|tubulin modulators|mesh-ancestor
92406276|NCT02124902|Antimitotic Agents|antimitotic agents|mesh-ancestor
92406277|NCT02124902|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406278|NCT02124902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406279|NCT02067182|Dabigatran|dabigatran|mesh-list
92406280|NCT02067182|Antithrombins|antithrombins|mesh-ancestor
92406281|NCT02067182|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92406282|NCT02067182|Protease Inhibitors|protease inhibitors|mesh-ancestor
92406283|NCT02067182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406284|NCT02067182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406285|NCT02067182|Anticoagulants|anticoagulants|mesh-ancestor
92406286|NCT01877837|Fludarabine|fludarabine|mesh-list
92406287|NCT01877837|Fludarabine phosphate|fludarabine phosphate|mesh-list
92406288|NCT01877837|Melphalan|melphalan|mesh-list
92406289|NCT01877837|Alemtuzumab|alemtuzumab|mesh-list
92406290|NCT01877837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406291|NCT01877837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92406292|NCT01877837|Antimetabolites|antimetabolites|mesh-ancestor
92406293|NCT01877837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406294|NCT01877837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92406295|NCT01877837|Immunologic Factors|immunologic factors|mesh-ancestor
92406296|NCT01877837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406297|NCT01877837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92406298|NCT01877837|Alkylating Agents|alkylating agents|mesh-ancestor
92406299|NCT01877837|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92406300|NCT01877837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406301|NCT01781468|Modafinil|modafinil|mesh-list
92406302|NCT01781468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92406303|NCT01781468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406304|NCT01781468|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92406305|NCT01781468|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92406307|NCT01781468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406308|NCT01624142|Evolocumab|evolocumab|mesh-list
92406309|NCT01624142|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92406310|NCT01624142|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92406311|NCT01624142|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92406312|NCT01624142|Antimetabolites|antimetabolites|mesh-ancestor
92406313|NCT01624142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406314|NCT01624142|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92406315|NCT01624142|Protease Inhibitors|protease inhibitors|mesh-ancestor
92406316|NCT01624142|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406317|NCT01624142|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92406318|NCT01375764|Ezetimibe|ezetimibe|mesh-list
92406319|NCT01375764|Evolocumab|evolocumab|mesh-list
92406320|NCT01375764|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92406321|NCT01375764|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92406322|NCT01375764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92406323|NCT01375764|Antimetabolites|antimetabolites|mesh-ancestor
92406324|NCT01375764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406325|NCT01375764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92406326|NCT01375764|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92406327|NCT01375764|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92406328|NCT01375764|Protease Inhibitors|protease inhibitors|mesh-ancestor
92406329|NCT01375764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406330|NCT01375764|Immunologic Factors|immunologic factors|mesh-ancestor
92406331|NCT01375764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406332|NCT00523341|Denosumab|denosumab|mesh-list
92406333|NCT00523341|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92406334|NCT00523341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406335|NCT00364013|Panitumumab|panitumumab|mesh-list
92406336|NCT00364013|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406337|NCT00364013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406338|NCT00345839|Cinacalcet|cinacalcet|mesh-list
92406339|NCT00345839|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92406340|NCT00345839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406341|NCT00345839|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92406342|NCT00345839|Hormone Antagonists|hormone antagonists|mesh-ancestor
92406343|NCT00345839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406344|NCT00330759|Zoledronic Acid|zoledronic acid|mesh-list
92406345|NCT00330759|Denosumab|denosumab|mesh-list
92406346|NCT00330759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92406347|NCT00330759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406349|NCT00113763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406350|NCT00113763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406351|NCT01438359|Furosemide|furosemide|mesh-list
92406352|NCT01438359|Diuretics|diuretics|mesh-ancestor
92406353|NCT01438359|Natriuretic Agents|natriuretic agents|mesh-ancestor
92406354|NCT01438359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406355|NCT01438359|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92406356|NCT01438359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92406357|NCT01438359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406358|NCT01438372|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92406359|NCT01438372|Hematinics|hematinics|mesh-ancestor
92406360|NCT01438515|Chlorhexidine|chlorhexidine|mesh-list
92406361|NCT01438515|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92406362|NCT01438515|Doxycycline|doxycycline|mesh-list
92406363|NCT01438515|Rifampin|rifampin|mesh-list
92406364|NCT01438515|Mupirocin|mupirocin|mesh-list
92406365|NCT01438515|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92406366|NCT01438515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406367|NCT01438515|Disinfectants|disinfectants|mesh-ancestor
92406369|NCT01438515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92406370|NCT01438515|Antimalarials|antimalarials|mesh-ancestor
92406371|NCT01438515|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92406372|NCT01438515|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92406373|NCT01438515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92406374|NCT01438515|Antitubercular Agents|antitubercular agents|mesh-ancestor
92406375|NCT01438515|Leprostatic Agents|leprostatic agents|mesh-ancestor
92406376|NCT01438515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92406377|NCT01438515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406378|NCT01438515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406379|NCT01438515|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92406380|NCT01438515|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92406381|NCT01438515|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92406382|NCT01438515|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92406383|NCT01438515|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92406384|NCT01438515|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92406385|NCT01438515|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92406386|NCT01438554|Trametinib|trametinib|mesh-list
92406387|NCT01438554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406388|NCT01438554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406389|NCT01438554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406390|NCT01438554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406392|NCT01438567|Naloxone|naloxone|mesh-list
92406393|NCT01438567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92406394|NCT01438567|Narcotics|narcotics|mesh-ancestor
92406395|NCT01438567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406396|NCT01438567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406397|NCT01438567|Analgesics|analgesics|mesh-ancestor
92406398|NCT01438567|Sensory System Agents|sensory system agents|mesh-ancestor
92406399|NCT01438567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406400|NCT01438567|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92406401|NCT01438580|Aspirin|aspirin|mesh-list
92406402|NCT01438580|Warfarin|warfarin|mesh-list
92406403|NCT01438580|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92406404|NCT01438580|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92406405|NCT01438580|Analgesics|analgesics|mesh-ancestor
92406406|NCT01438580|Sensory System Agents|sensory system agents|mesh-ancestor
92406407|NCT01438580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406408|NCT01438580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406409|NCT01438580|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406410|NCT01438580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406411|NCT01438580|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92406412|NCT01438580|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92406413|NCT01438580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406414|NCT01438580|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92406415|NCT01438580|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92406416|NCT01438580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406417|NCT01438580|Antipyretics|antipyretics|mesh-ancestor
92406418|NCT01438580|Anticoagulants|anticoagulants|mesh-ancestor
92406419|NCT01438632|Insulin|insulin|mesh-list
92406420|NCT01438632|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406421|NCT01438632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406422|NCT01438723|Metformin|metformin|mesh-list
92406423|NCT01438723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406424|NCT01438723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406425|NCT01438736|Etonogestrel|etonogestrel|mesh-list
92406426|NCT01438736|Desogestrel|desogestrel|mesh-list
92406427|NCT01438736|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92406428|NCT01438736|Contraceptive Agents|contraceptive agents|mesh-ancestor
92406429|NCT01438736|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92406430|NCT01438736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406431|NCT01438736|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92406432|NCT01438736|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92406433|NCT01438736|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92406434|NCT01438736|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92406435|NCT01438736|Progestins|progestins|mesh-ancestor
92406436|NCT01438736|Hormones|hormones|mesh-ancestor
92406437|NCT01438736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406438|NCT01438749|Diazepam|diazepam|mesh-list
92406439|NCT01438749|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92406440|NCT01438749|Anticonvulsants|anticonvulsants|mesh-ancestor
92406441|NCT01438749|Antiemetics|antiemetics|mesh-ancestor
92406442|NCT01438749|Autonomic Agents|autonomic agents|mesh-ancestor
92406443|NCT01438749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406444|NCT01438749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406445|NCT01438749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406446|NCT01438749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92406447|NCT01438749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406448|NCT01438749|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92406449|NCT01438749|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92406450|NCT01438749|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92406451|NCT01438749|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92406452|NCT01438749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92406453|NCT01438749|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92406454|NCT01438749|Anesthetics, General|anesthetics, general|mesh-ancestor
92406455|NCT01438749|Anesthetics|anesthetics|mesh-ancestor
92406456|NCT01438749|GABA Modulators|gaba modulators|mesh-ancestor
92406457|NCT01438749|GABA Agents|gaba agents|mesh-ancestor
92406458|NCT01438749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406459|NCT01438749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406460|NCT01438866|Fluorides|fluorides|mesh-list
92406461|NCT01438866|Sodium Fluoride|sodium fluoride|mesh-list
92406465|NCT01438866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406466|NCT01438944|Nicotine|nicotine|mesh-list
92406467|NCT01438944|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92406468|NCT01438944|Autonomic Agents|autonomic agents|mesh-ancestor
92406469|NCT01438944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406470|NCT01438944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406471|NCT01438944|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92406472|NCT01438944|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92406473|NCT01438944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92406474|NCT01438944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406475|NCT01438944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406476|NCT01439100|Oxycodone|oxycodone|mesh-list
92406477|NCT01439100|Naloxone|naloxone|mesh-list
92406478|NCT01439100|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92406479|NCT01439100|Narcotics|narcotics|mesh-ancestor
92406480|NCT01439100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406481|NCT01439100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406482|NCT01439100|Analgesics|analgesics|mesh-ancestor
92406483|NCT01439100|Sensory System Agents|sensory system agents|mesh-ancestor
92406484|NCT01439100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406485|NCT01439100|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92406486|NCT01439152|Maytansine|maytansine|mesh-list
92406487|NCT01439152|Anetumab ravtansine|anetumab ravtansine|mesh-list
92406489|NCT01439152|Immunologic Factors|immunologic factors|mesh-ancestor
92406490|NCT01439152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406491|NCT01439152|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92406492|NCT01439152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406493|NCT01439152|Tubulin Modulators|tubulin modulators|mesh-ancestor
92406494|NCT01439152|Antimitotic Agents|antimitotic agents|mesh-ancestor
92406495|NCT01439152|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406496|NCT01439152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406497|NCT01439178|Bevacizumab|bevacizumab|mesh-list
92406498|NCT01439178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406499|NCT01439178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406500|NCT01439178|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92406501|NCT01439178|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92406502|NCT01439178|Growth Substances|growth substances|mesh-ancestor
92406503|NCT01439178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406504|NCT01439178|Growth Inhibitors|growth inhibitors|mesh-ancestor
92406505|NCT01439191|Vinorelbine|vinorelbine|mesh-list
92406506|NCT01439191|Antibodies|antibodies|mesh-list
92406507|NCT01439191|Immunologic Factors|immunologic factors|mesh-ancestor
92406508|NCT01439191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406509|NCT01439191|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92406510|NCT01439191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406511|NCT01439191|Tubulin Modulators|tubulin modulators|mesh-ancestor
92406512|NCT01439191|Antimitotic Agents|antimitotic agents|mesh-ancestor
92406513|NCT01439191|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406514|NCT01439191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406515|NCT01439230|Donepezil|donepezil|mesh-list
92406516|NCT01439230|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92406517|NCT01439230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406518|NCT01439230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406519|NCT01439230|Cholinergic Agents|cholinergic agents|mesh-ancestor
92406520|NCT01439230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406521|NCT01439230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406523|NCT01439243|Donepezil|donepezil|mesh-list
92406524|NCT01439243|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92406525|NCT01439243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406526|NCT01439243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406527|NCT01439243|Cholinergic Agents|cholinergic agents|mesh-ancestor
92406528|NCT01439243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406529|NCT01439243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406530|NCT01439243|Nootropic Agents|nootropic agents|mesh-ancestor
92406531|NCT01439399|Lidocaine|lidocaine|mesh-list
92406532|NCT01439399|Ketamine|ketamine|mesh-list
92406533|NCT01439399|Anesthetics, Local|anesthetics, local|mesh-ancestor
92406534|NCT01439399|Anesthetics|anesthetics|mesh-ancestor
92406535|NCT01439399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406536|NCT01439399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406537|NCT01439399|Sensory System Agents|sensory system agents|mesh-ancestor
92406538|NCT01439399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406539|NCT01439399|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92406540|NCT01439399|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92406541|NCT01439399|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92406542|NCT01439399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92406543|NCT01439399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406544|NCT01439399|Analgesics|analgesics|mesh-ancestor
92406545|NCT01439399|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92406546|NCT01439399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92406547|NCT01439399|Anesthetics, General|anesthetics, general|mesh-ancestor
92406548|NCT01439399|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92406549|NCT01439399|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92406550|NCT01439399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406551|NCT01439438|Topiramate|topiramate|mesh-list
92406552|NCT01439438|Anticonvulsants|anticonvulsants|mesh-ancestor
92406553|NCT01439438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406554|NCT01439438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406555|NCT01439542|Hormones|hormones|mesh-list
92406556|NCT01439542|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92406557|NCT01439542|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406558|NCT01439542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406559|NCT01439750|Rituximab|rituximab|mesh-list
92406560|NCT01439750|Bortezomib|bortezomib|mesh-list
92406561|NCT01439750|Cladribine|cladribine|mesh-list
92406562|NCT01439750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406563|NCT01439750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406564|NCT01439750|Immunologic Factors|immunologic factors|mesh-ancestor
92406565|NCT01439750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406567|NCT01439750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92406569|NCT01439984|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92406570|NCT01439984|Antidepressive Agents|antidepressive agents|mesh-ancestor
92406571|NCT01439984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92406572|NCT01439984|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92406573|NCT01439984|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92406574|NCT01439984|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92406575|NCT01439984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406576|NCT01439984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406577|NCT01439984|Serotonin Agents|serotonin agents|mesh-ancestor
92406578|NCT01439984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406579|NCT01440062|Vitamin D|vitamin d|mesh-list
92406580|NCT01440062|Ergocalciferols|ergocalciferols|mesh-list
92406581|NCT01440062|Cholecalciferol|cholecalciferol|mesh-list
92406582|NCT01440062|Vitamins|vitamins|mesh-list
92406583|NCT01440062|Micronutrients|micronutrients|mesh-ancestor
92406584|NCT01440062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406585|NCT01440062|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92406586|NCT01440062|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92406587|NCT01440088|Doxorubicin|doxorubicin|mesh-list
92406588|NCT01440088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92406589|NCT01440088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92406590|NCT01440088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406591|NCT01440088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92406592|NCT01440088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92406593|NCT01440088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406594|NCT01440088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406595|NCT01440114|Fentanyl|fentanyl|mesh-list
92406596|NCT01440114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92406597|NCT01440114|Narcotics|narcotics|mesh-ancestor
92406598|NCT01440114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406599|NCT01440114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406600|NCT01440114|Analgesics|analgesics|mesh-ancestor
92406601|NCT01440114|Sensory System Agents|sensory system agents|mesh-ancestor
92406602|NCT01440114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406603|NCT01440114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92406604|NCT01440114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92406605|NCT01440114|Anesthetics, General|anesthetics, general|mesh-ancestor
92406606|NCT01440114|Anesthetics|anesthetics|mesh-ancestor
92406607|NCT01440127|Metformin|metformin|mesh-list
92406608|NCT01440127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406609|NCT01440127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406610|NCT01440140|Insulin|insulin|mesh-list
92406611|NCT01440140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406612|NCT01440140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406613|NCT01440270|Cetuximab|cetuximab|mesh-list
92406614|NCT01440270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406615|NCT01440270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406616|NCT01440309|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92406617|NCT01440309|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92406618|NCT01440309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406620|NCT01440335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92406621|NCT01440335|Autonomic Agents|autonomic agents|mesh-ancestor
92406622|NCT01440335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406623|NCT01440335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406624|NCT01440335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92406625|NCT01440335|Respiratory System Agents|respiratory system agents|mesh-ancestor
92406626|NCT01440335|Sympathomimetics|sympathomimetics|mesh-ancestor
92406627|NCT01440335|Tocolytic Agents|tocolytic agents|mesh-ancestor
92406628|NCT01440335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92406629|NCT01440335|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92406630|NCT01440335|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92406631|NCT01440335|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92406632|NCT01440335|Adrenergic Agents|adrenergic agents|mesh-ancestor
92406633|NCT01440335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406634|NCT01440335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406635|NCT01440361|Belimumab|belimumab|mesh-list
92406636|NCT01440361|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92406637|NCT01440361|Immunologic Factors|immunologic factors|mesh-ancestor
92406638|NCT01440361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406640|NCT01440400|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406641|NCT01440400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406642|NCT01440439|Insulin|insulin|mesh-list
92406643|NCT01440439|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92406644|NCT01440439|Insulin Glargine|insulin glargine|mesh-list
92406645|NCT01440439|Insulin Detemir|insulin detemir|mesh-list
92406646|NCT01440439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406647|NCT01440439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406648|NCT01440582|Dexamethasone|dexamethasone|mesh-list
92406649|NCT01440582|Lenalidomide|lenalidomide|mesh-list
92406650|NCT01440582|Bortezomib|bortezomib|mesh-list
92406651|NCT01440582|Panobinostat|panobinostat|mesh-list
92406652|NCT01440582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406653|NCT01440582|Antiemetics|antiemetics|mesh-ancestor
92406654|NCT01440582|Autonomic Agents|autonomic agents|mesh-ancestor
92406655|NCT01440582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406656|NCT01440582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406657|NCT01440582|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406658|NCT01440582|Glucocorticoids|glucocorticoids|mesh-ancestor
92406659|NCT01440582|Hormones|hormones|mesh-ancestor
92406660|NCT01440582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406661|NCT01440582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92406662|NCT01440582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406663|NCT01440582|Immunologic Factors|immunologic factors|mesh-ancestor
92406664|NCT01440582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92406665|NCT01440582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92406666|NCT01440582|Growth Substances|growth substances|mesh-ancestor
91939706|NCT05648266|Analgesics|analgesics|mesh-list
92406667|NCT01440582|Growth Inhibitors|growth inhibitors|mesh-ancestor
92406668|NCT01440582|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92406669|NCT01440582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406670|NCT01440582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406671|NCT01440608|Albendazole|albendazole|mesh-list
92406672|NCT01440608|Anthelmintics|anthelmintics|mesh-ancestor
92406673|NCT01440608|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92406674|NCT01440608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406675|NCT01440608|Anticestodal Agents|anticestodal agents|mesh-ancestor
92406676|NCT01440608|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92406677|NCT01440608|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92406678|NCT01440608|Tubulin Modulators|tubulin modulators|mesh-ancestor
92406679|NCT01440608|Antimitotic Agents|antimitotic agents|mesh-ancestor
92406680|NCT01440608|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406681|NCT01440608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406682|NCT01440608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406683|NCT01440621|Pyridoxine|pyridoxine|mesh-list
92406684|NCT01440621|Modafinil|modafinil|mesh-list
92406685|NCT01440621|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92406686|NCT01440621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406687|NCT01440621|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92406688|NCT01440621|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92406689|NCT01440621|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92406690|NCT01440621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406691|NCT01440621|Vitamin B Complex|vitamin b complex|mesh-ancestor
92406692|NCT01440621|Vitamins|vitamins|mesh-ancestor
92406693|NCT01440621|Micronutrients|micronutrients|mesh-ancestor
92406694|NCT01440673|Aprepitant|aprepitant|mesh-list
92406695|NCT01440673|Antiemetics|antiemetics|mesh-ancestor
92406696|NCT01440673|Autonomic Agents|autonomic agents|mesh-ancestor
92406697|NCT01440673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406698|NCT01440673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406699|NCT01440673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406700|NCT01440673|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92406701|NCT01440673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406702|NCT01440673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406703|NCT01440725|Mitogens|mitogens|mesh-list
92406704|NCT01440725|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406705|NCT01440725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406706|NCT01440751|Mitomycins|mitomycins|mesh-list
92406708|NCT01440751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92406709|NCT01440751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406710|NCT01440751|Alkylating Agents|alkylating agents|mesh-ancestor
92406711|NCT01440751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406712|NCT01440751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92406713|NCT01440751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406715|NCT01440790|Ascorbic Acid|ascorbic acid|mesh-list
92406716|NCT01440790|Micronutrients|micronutrients|mesh-ancestor
92406717|NCT01440790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406718|NCT01440790|Antioxidants|antioxidants|mesh-ancestor
92406719|NCT01440790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406720|NCT01440790|Protective Agents|protective agents|mesh-ancestor
92406721|NCT01440829|N-Methylaspartate|n-methylaspartate|mesh-list
92406722|NCT01440829|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92406723|NCT01440829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92406724|NCT01440829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406725|NCT01440829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406726|NCT01440829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406727|NCT01440842|Insulin|insulin|mesh-list
92406728|NCT01440842|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92406729|NCT01440842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406730|NCT01440842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406731|NCT01440933|Magnesium Sulfate|magnesium sulfate|mesh-list
92406732|NCT01440933|Analgesics|analgesics|mesh-ancestor
92406733|NCT01440933|Sensory System Agents|sensory system agents|mesh-ancestor
92406734|NCT01440933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406735|NCT01440933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406736|NCT01440933|Anesthetics|anesthetics|mesh-ancestor
92406737|NCT01440933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406738|NCT01440933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92406739|NCT01440933|Anticonvulsants|anticonvulsants|mesh-ancestor
92406740|NCT01440933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92406741|NCT01440933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92406742|NCT01440933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406743|NCT01440933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92406744|NCT01440933|Tocolytic Agents|tocolytic agents|mesh-ancestor
92406745|NCT01440933|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92406746|NCT01440985|Nicotine|nicotine|mesh-list
92406747|NCT01440985|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92406748|NCT01440985|Autonomic Agents|autonomic agents|mesh-ancestor
92406749|NCT01440985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406750|NCT01440985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406751|NCT01440985|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92406752|NCT01440985|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92406753|NCT01440985|Cholinergic Agents|cholinergic agents|mesh-ancestor
92406754|NCT01440985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406755|NCT01440985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406756|NCT01440998|Paclitaxel|paclitaxel|mesh-list
92406757|NCT01440998|Carboplatin|carboplatin|mesh-list
92406758|NCT01440998|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92406759|NCT01440998|Dasatinib|dasatinib|mesh-list
92406760|NCT01440998|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92406761|NCT01440998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406762|NCT01440998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92406763|NCT01440998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92406764|NCT01440998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92406765|NCT01440998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406766|NCT01440998|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406767|NCT01440998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406768|NCT01441128|Crizotinib|crizotinib|mesh-list
92406769|NCT01441128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406770|NCT01441128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406771|NCT01441128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407236|NCT01443416|Vaccines|vaccines|mesh-list
92406772|NCT01441128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406774|NCT01441193|Immunologic Factors|immunologic factors|mesh-ancestor
92406775|NCT01441193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406776|NCT01441206|Rifampin|rifampin|mesh-list
92406777|NCT01441206|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92406778|NCT01441206|Antitubercular Agents|antitubercular agents|mesh-ancestor
92406779|NCT01441206|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92406780|NCT01441206|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406781|NCT01441206|Leprostatic Agents|leprostatic agents|mesh-ancestor
92406782|NCT01441206|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92406783|NCT01441206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406784|NCT01441206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406785|NCT01441206|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92406786|NCT01441206|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92406787|NCT01441206|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92406788|NCT01441206|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92406789|NCT01441206|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92406790|NCT01441206|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92406791|NCT01441232|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92406792|NCT01441232|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92406793|NCT01441232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406794|NCT01441232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406796|NCT01441232|Hormones|hormones|mesh-ancestor
92406797|NCT01441232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406798|NCT01441232|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92406799|NCT01441232|Protease Inhibitors|protease inhibitors|mesh-ancestor
92406800|NCT01441232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406801|NCT01441232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406802|NCT01441232|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92406803|NCT01441284|Pramipexole|pramipexole|mesh-list
92406804|NCT01441284|Antioxidants|antioxidants|mesh-ancestor
92406805|NCT01441284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406806|NCT01441284|Protective Agents|protective agents|mesh-ancestor
92406807|NCT01441284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406809|NCT01441284|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92406810|NCT01441284|Dopamine Agonists|dopamine agonists|mesh-ancestor
92406811|NCT01441284|Dopamine Agents|dopamine agents|mesh-ancestor
92406812|NCT01441284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406813|NCT01441297|Nintedanib|nintedanib|mesh-list
92406814|NCT01441297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406815|NCT01441297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406816|NCT01441297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406817|NCT01441297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406818|NCT01441388|Bevacizumab|bevacizumab|mesh-list
92406819|NCT01441388|Sunitinib|sunitinib|mesh-list
92406820|NCT01441388|Sorafenib|sorafenib|mesh-list
92406821|NCT01441388|Axitinib|axitinib|mesh-list
92406822|NCT01441388|Crizotinib|crizotinib|mesh-list
92406823|NCT01441388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92406824|NCT01441388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406825|NCT01441388|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92406826|NCT01441388|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92406827|NCT01441388|Growth Substances|growth substances|mesh-ancestor
92406828|NCT01441388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406829|NCT01441388|Growth Inhibitors|growth inhibitors|mesh-ancestor
92406830|NCT01441388|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92406831|NCT01441388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406832|NCT01441388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406833|NCT01441427|Lenograstim|lenograstim|mesh-list
92406834|NCT01441427|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92406835|NCT01441427|Immunologic Factors|immunologic factors|mesh-ancestor
92406836|NCT01441427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406837|NCT01441505|Midazolam|midazolam|mesh-list
92406838|NCT01441505|Ketamine|ketamine|mesh-list
92406839|NCT01441505|Analgesics|analgesics|mesh-ancestor
92406840|NCT01441505|Sensory System Agents|sensory system agents|mesh-ancestor
92406841|NCT01441505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406842|NCT01441505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406843|NCT01441505|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92406844|NCT01441505|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92406845|NCT01441505|Anesthetics, General|anesthetics, general|mesh-ancestor
92406846|NCT01441505|Anesthetics|anesthetics|mesh-ancestor
92406847|NCT01441505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406848|NCT01441505|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92406849|NCT01441505|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92406851|NCT01441505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406852|NCT01441505|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92406853|NCT01441505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92406854|NCT01441505|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92406855|NCT01441505|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92406856|NCT01441505|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92406857|NCT01441505|GABA Modulators|gaba modulators|mesh-ancestor
92406858|NCT01441505|GABA Agents|gaba agents|mesh-ancestor
92406859|NCT01441531|Gabapentin|gabapentin|mesh-list
92097555|NCT01135186|Verapamil|verapamil|mesh-list
92406860|NCT01441531|Analgesics|analgesics|mesh-ancestor
92406861|NCT01441531|Sensory System Agents|sensory system agents|mesh-ancestor
92406862|NCT01441531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406863|NCT01441531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406864|NCT01441531|Anticonvulsants|anticonvulsants|mesh-ancestor
92406865|NCT01441531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92406866|NCT01441531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92406867|NCT01441531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406868|NCT01441531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92406869|NCT01441531|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92406870|NCT01441531|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92406871|NCT01441531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406872|NCT01441531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406873|NCT01441531|Antimanic Agents|antimanic agents|mesh-ancestor
92406874|NCT01441557|Amifampridine|amifampridine|mesh-list
92406875|NCT01441557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92406876|NCT01441557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406877|NCT01441557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406878|NCT01441557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92406879|NCT01441557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92406880|NCT01441557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406882|NCT01441700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92406883|NCT01441700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406885|NCT01441804|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92406886|NCT01441804|Interferon-alpha|interferon-alpha|mesh-list
92406887|NCT01441804|Antimetabolites|antimetabolites|mesh-ancestor
92406888|NCT01441804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406889|NCT01441804|Antiviral Agents|antiviral agents|mesh-ancestor
92406890|NCT01441804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406891|NCT01441804|Immunologic Factors|immunologic factors|mesh-ancestor
92406892|NCT01441804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406893|NCT01441869|Metformin|metformin|mesh-list
92406894|NCT01441869|Saxagliptin|saxagliptin|mesh-list
92406895|NCT01441869|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92406896|NCT01441869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406897|NCT01441869|Incretins|incretins|mesh-ancestor
92406898|NCT01441869|Hormones|hormones|mesh-ancestor
92406899|NCT01441869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406900|NCT01441869|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92406901|NCT01441869|Protease Inhibitors|protease inhibitors|mesh-ancestor
92406902|NCT01441869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406903|NCT01441869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406904|NCT01441908|Pravastatin|pravastatin|mesh-list
92406905|NCT01441908|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92406906|NCT01441908|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92406907|NCT01441908|Antimetabolites|antimetabolites|mesh-ancestor
92406908|NCT01441908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406909|NCT01441908|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92406910|NCT01441908|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92406911|NCT01441908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406912|NCT01441934|Sildenafil Citrate|sildenafil citrate|mesh-list
92406913|NCT01441934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406914|NCT01441934|Vasodilator Agents|vasodilator agents|mesh-ancestor
92406915|NCT01441934|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92406916|NCT01441934|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92406917|NCT01441934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406918|NCT01441934|Urological Agents|urological agents|mesh-ancestor
92406919|NCT01441986|Amantadine|amantadine|mesh-list
92406920|NCT01441986|Dextromethorphan|dextromethorphan|mesh-list
92406921|NCT01441986|Antitussive Agents|antitussive agents|mesh-ancestor
92407312|NCT01444001|Vaccines|vaccines|mesh-list
92406922|NCT01441986|Respiratory System Agents|respiratory system agents|mesh-ancestor
92406923|NCT01441986|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92406924|NCT01441986|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92406925|NCT01441986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92406926|NCT01441986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406927|NCT01441986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406928|NCT01441986|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92406929|NCT01441986|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92406930|NCT01441986|Antiviral Agents|antiviral agents|mesh-ancestor
92406931|NCT01441986|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936717|NCT01590719|Vitamins|vitamins|mesh-ancestor
92406932|NCT01441986|Dopamine Agents|dopamine agents|mesh-ancestor
92406933|NCT01441986|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92406935|NCT01441986|Sensory System Agents|sensory system agents|mesh-ancestor
92406936|NCT01441986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406937|NCT01442025|Infliximab|infliximab|mesh-list
92406938|NCT01442025|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92406939|NCT01442025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406940|NCT01442025|Dermatologic Agents|dermatologic agents|mesh-ancestor
92406941|NCT01442025|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406942|NCT01442025|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406943|NCT01442168|Atovaquone|atovaquone|mesh-list
92406944|NCT01442168|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406945|NCT01442168|Antimalarials|antimalarials|mesh-ancestor
92406946|NCT01442168|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92406947|NCT01442168|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92406948|NCT01442168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406949|NCT01442168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406950|NCT01442272|Calcifediol|calcifediol|mesh-list
92406951|NCT01442272|Vitamins|vitamins|mesh-ancestor
92406952|NCT01442272|Micronutrients|micronutrients|mesh-ancestor
92406953|NCT01442272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406954|NCT01442272|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92406955|NCT01442311|Interferons|interferons|mesh-list
92406956|NCT01442311|Ribavirin|ribavirin|mesh-list
92406958|NCT01442311|Interferon alpha-2|interferon alpha-2|mesh-list
92406959|NCT01442311|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92406960|NCT01442311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406961|NCT01442311|Antiviral Agents|antiviral agents|mesh-ancestor
92406962|NCT01442311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92406963|NCT01442311|Antimetabolites|antimetabolites|mesh-ancestor
92406964|NCT01442311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406965|NCT01442311|Immunologic Factors|immunologic factors|mesh-ancestor
92406966|NCT01442311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406967|NCT01442428|Dexamethasone|dexamethasone|mesh-list
92406968|NCT01442428|Naproxen|naproxen|mesh-list
92406969|NCT01442428|Atorvastatin|atorvastatin|mesh-list
92406970|NCT01442428|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92406971|NCT01442428|Antiemetics|antiemetics|mesh-ancestor
92406972|NCT01442428|Autonomic Agents|autonomic agents|mesh-ancestor
92406973|NCT01442428|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92406974|NCT01442428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92406975|NCT01442428|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92406976|NCT01442428|Glucocorticoids|glucocorticoids|mesh-ancestor
92406977|NCT01442428|Hormones|hormones|mesh-ancestor
92406978|NCT01442428|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92406979|NCT01442428|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92406980|NCT01442428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92406981|NCT01442428|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92406982|NCT01442428|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92406983|NCT01442428|Antimetabolites|antimetabolites|mesh-ancestor
92406984|NCT01442428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92406985|NCT01442428|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92406986|NCT01442428|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92406987|NCT01442428|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92406988|NCT01442428|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92406989|NCT01442428|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92406990|NCT01442428|Analgesics|analgesics|mesh-ancestor
92406991|NCT01442428|Sensory System Agents|sensory system agents|mesh-ancestor
92406992|NCT01442428|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92406993|NCT01442428|Gout Suppressants|gout suppressants|mesh-ancestor
92406994|NCT01442428|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92406995|NCT01442519|Mitomycins|mitomycins|mesh-list
92406996|NCT01442519|Mitomycin|mitomycin|mesh-list
92406997|NCT01442519|BCG Vaccine|bcg vaccine|mesh-list
92406998|NCT01442519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92406999|NCT01442519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407001|NCT01442519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407002|NCT01442519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407003|NCT01442519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407004|NCT01442519|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92407005|NCT01442519|Immunologic Factors|immunologic factors|mesh-ancestor
92407006|NCT01442519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407007|NCT01442532|Midazolam|midazolam|mesh-list
92407008|NCT01442532|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92407009|NCT01442532|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92407010|NCT01442532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407011|NCT01442532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407012|NCT01442532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92407013|NCT01442532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92407014|NCT01442532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92407015|NCT01442532|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92407016|NCT01442532|Anesthetics, General|anesthetics, general|mesh-ancestor
92407017|NCT01442532|Anesthetics|anesthetics|mesh-ancestor
92407018|NCT01442532|GABA Modulators|gaba modulators|mesh-ancestor
92407019|NCT01442532|GABA Agents|gaba agents|mesh-ancestor
92407020|NCT01442532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407021|NCT01442532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407022|NCT01442558|Bupivacaine|bupivacaine|mesh-list
92407023|NCT01442558|Anesthetics, Local|anesthetics, local|mesh-ancestor
92407024|NCT01442558|Anesthetics|anesthetics|mesh-ancestor
92407025|NCT01442558|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407026|NCT01442558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407027|NCT01442558|Sensory System Agents|sensory system agents|mesh-ancestor
92407028|NCT01442558|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407029|NCT01442571|Hyaluronic Acid|hyaluronic acid|mesh-list
92407030|NCT01442571|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92407031|NCT01442571|Immunologic Factors|immunologic factors|mesh-ancestor
92407032|NCT01442571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407033|NCT01442571|Viscosupplements|viscosupplements|mesh-ancestor
92407034|NCT01442571|Protective Agents|protective agents|mesh-ancestor
92407036|NCT01442610|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92407037|NCT01442610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407038|NCT01442610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407039|NCT01442610|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92407040|NCT01442610|Protective Agents|protective agents|mesh-ancestor
92407041|NCT01442610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407042|NCT01442662|Gemcitabine|gemcitabine|mesh-list
92407043|NCT01442662|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92407044|NCT01442662|Antimetabolites|antimetabolites|mesh-ancestor
92407045|NCT01442662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407046|NCT01442662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407047|NCT01442701|Triclosan|triclosan|mesh-list
92407048|NCT01442701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92407049|NCT01442701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407050|NCT01442701|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92407051|NCT01442701|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407052|NCT01442701|Antimetabolites|antimetabolites|mesh-ancestor
92407053|NCT01442701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407054|NCT01442701|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407055|NCT01442727|Selenium|selenium|mesh-list
92407056|NCT01442727|Selenious Acid|selenious acid|mesh-list
92407057|NCT01442727|Sodium Selenite|sodium selenite|mesh-list
92407058|NCT01442727|Antioxidants|antioxidants|mesh-ancestor
92407059|NCT01442727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407060|NCT01442727|Protective Agents|protective agents|mesh-ancestor
92407061|NCT01442727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407062|NCT01442727|Trace Elements|trace elements|mesh-ancestor
92407063|NCT01442727|Micronutrients|micronutrients|mesh-ancestor
92407064|NCT01442766|Donepezil|donepezil|mesh-list
92407065|NCT01442766|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92407066|NCT01442766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407067|NCT01442766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407068|NCT01442766|Cholinergic Agents|cholinergic agents|mesh-ancestor
92407069|NCT01442766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407070|NCT01442766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407071|NCT01442766|Nootropic Agents|nootropic agents|mesh-ancestor
92407072|NCT01442818|Hydromorphone|hydromorphone|mesh-list
92407073|NCT01442818|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92407074|NCT01442818|Narcotics|narcotics|mesh-ancestor
92407075|NCT01442818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407076|NCT01442818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407078|NCT01442818|Sensory System Agents|sensory system agents|mesh-ancestor
92407079|NCT01442818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407080|NCT01442870|Metformin|metformin|mesh-list
92407081|NCT01442870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407082|NCT01442870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407083|NCT01442909|Docetaxel|docetaxel|mesh-list
92407084|NCT01442909|Pemetrexed|pemetrexed|mesh-list
92097771|NCT01184014|Insulin|insulin|mesh-list
92407085|NCT01442909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407086|NCT01442909|Tubulin Modulators|tubulin modulators|mesh-ancestor
92407087|NCT01442909|Antimitotic Agents|antimitotic agents|mesh-ancestor
92407088|NCT01442909|Mitosis Modulators|mitosis modulators|mesh-ancestor
92407089|NCT01442909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407090|NCT01442909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407091|NCT01442909|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92407092|NCT01442909|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407093|NCT01442935|Leucovorin|leucovorin|mesh-list
92407094|NCT01442935|Folic Acid|folic acid|mesh-list
92407095|NCT01442935|Bevacizumab|bevacizumab|mesh-list
92407096|NCT01442935|Cetuximab|cetuximab|mesh-list
92407097|NCT01442935|Oxaliplatin|oxaliplatin|mesh-list
92407098|NCT01442935|Irinotecan|irinotecan|mesh-list
92407099|NCT01442935|Fluorouracil|fluorouracil|mesh-list
92407100|NCT01442935|Levoleucovorin|levoleucovorin|mesh-list
92407101|NCT01442935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407102|NCT01442935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407103|NCT01442935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92407104|NCT01442935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92407105|NCT01442935|Growth Substances|growth substances|mesh-ancestor
92407106|NCT01442935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407108|NCT01442935|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92407109|NCT01442935|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92407110|NCT01442935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407111|NCT01442935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407112|NCT01442935|Antidotes|antidotes|mesh-ancestor
92407113|NCT01442935|Protective Agents|protective agents|mesh-ancestor
92407114|NCT01442935|Vitamin B Complex|vitamin b complex|mesh-ancestor
92407115|NCT01442935|Vitamins|vitamins|mesh-ancestor
92407116|NCT01442935|Micronutrients|micronutrients|mesh-ancestor
92407117|NCT01442935|Hematinics|hematinics|mesh-ancestor
92407118|NCT01442935|Antimetabolites|antimetabolites|mesh-ancestor
92407119|NCT01442935|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92407120|NCT01442935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407121|NCT01442935|Immunologic Factors|immunologic factors|mesh-ancestor
92407122|NCT01442974|Paclitaxel|paclitaxel|mesh-list
92407123|NCT01442974|Gemcitabine|gemcitabine|mesh-list
92407124|NCT01442974|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92407125|NCT01442974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407126|NCT01442974|Tubulin Modulators|tubulin modulators|mesh-ancestor
92407127|NCT01442974|Antimitotic Agents|antimitotic agents|mesh-ancestor
92407128|NCT01442974|Mitosis Modulators|mitosis modulators|mesh-ancestor
92407129|NCT01442974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407130|NCT01442974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92407131|NCT01442974|Antimetabolites|antimetabolites|mesh-ancestor
92407132|NCT01442987|Irbesartan|irbesartan|mesh-list
92407133|NCT01442987|Atorvastatin|atorvastatin|mesh-list
92407134|NCT01442987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407135|NCT01442987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407136|NCT01442987|Antimetabolites|antimetabolites|mesh-ancestor
92407137|NCT01442987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407138|NCT01442987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407139|NCT01442987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92407140|NCT01442987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407141|NCT01442987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407142|NCT01442987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92407143|NCT01442987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92407144|NCT01443065|Leucovorin|leucovorin|mesh-list
92407145|NCT01443065|Folic Acid|folic acid|mesh-list
92407146|NCT01443065|Oxaliplatin|oxaliplatin|mesh-list
92407147|NCT01443065|Panitumumab|panitumumab|mesh-list
92407148|NCT01443065|Fluorouracil|fluorouracil|mesh-list
92407149|NCT01443065|Rilotumumab|rilotumumab|mesh-list
92407150|NCT01443065|Levoleucovorin|levoleucovorin|mesh-list
92407151|NCT01443065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407152|NCT01443065|Antidotes|antidotes|mesh-ancestor
92407153|NCT01443065|Protective Agents|protective agents|mesh-ancestor
92407154|NCT01443065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407157|NCT01443065|Micronutrients|micronutrients|mesh-ancestor
92407158|NCT01443065|Hematinics|hematinics|mesh-ancestor
92097846|NCT02189122|Antipyretics|antipyretics|mesh-ancestor
92407159|NCT01443065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407160|NCT01443065|Antimetabolites|antimetabolites|mesh-ancestor
92407161|NCT01443065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407162|NCT01443065|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92407164|NCT01443065|Immunologic Factors|immunologic factors|mesh-ancestor
92407165|NCT01443104|Sirolimus|sirolimus|mesh-list
92407166|NCT01443104|Everolimus|everolimus|mesh-list
92407167|NCT01443104|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92407168|NCT01443104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92407169|NCT01443104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407170|NCT01443104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407171|NCT01443104|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407172|NCT01443104|Immunologic Factors|immunologic factors|mesh-ancestor
92407173|NCT01443104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407174|NCT01443104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407175|NCT01443104|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92407176|NCT01443104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407177|NCT01443104|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92407178|NCT01443104|Antifungal Agents|antifungal agents|mesh-ancestor
92407179|NCT01443117|Vaccines|vaccines|mesh-list
92407180|NCT01443117|Immunologic Factors|immunologic factors|mesh-ancestor
92407181|NCT01443117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407182|NCT01443169|Pregabalin|pregabalin|mesh-list
92407183|NCT01443169|Analgesics|analgesics|mesh-ancestor
92407184|NCT01443169|Sensory System Agents|sensory system agents|mesh-ancestor
92407185|NCT01443169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407186|NCT01443169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407187|NCT01443169|Anticonvulsants|anticonvulsants|mesh-ancestor
92407188|NCT01443169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92407189|NCT01443169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407190|NCT01443169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407191|NCT01443169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92407192|NCT01443169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92407193|NCT01443169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92407194|NCT01443169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407195|NCT01443169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92407197|NCT01443195|Trace Elements|trace elements|mesh-ancestor
92407198|NCT01443195|Micronutrients|micronutrients|mesh-ancestor
92407199|NCT01443195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407200|NCT01443208|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92407201|NCT01443208|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92407202|NCT01443208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92407203|NCT01443208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407204|NCT01443208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407205|NCT01443208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407206|NCT01443208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407207|NCT01443208|Antidepressive Agents|antidepressive agents|mesh-ancestor
92407208|NCT01443208|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92407209|NCT01443221|Metformin|metformin|mesh-list
92407210|NCT01443221|Mitiglinide|mitiglinide|mesh-list
92407211|NCT01443221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407212|NCT01443221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407213|NCT01443247|gamma-Globulins|gamma-globulins|mesh-list
92407214|NCT01443247|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92407215|NCT01443247|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92407216|NCT01443247|Immunologic Factors|immunologic factors|mesh-ancestor
92407217|NCT01443247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407218|NCT01443325|Lidocaine|lidocaine|mesh-list
92407219|NCT01443325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92407220|NCT01443325|Anesthetics|anesthetics|mesh-ancestor
92407221|NCT01443325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407222|NCT01443325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407223|NCT01443325|Sensory System Agents|sensory system agents|mesh-ancestor
92407224|NCT01443325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407225|NCT01443325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407226|NCT01443325|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92407227|NCT01443325|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92407228|NCT01443325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407229|NCT01443325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407231|NCT01443338|Keratolytic Agents|keratolytic agents|mesh-ancestor
92407232|NCT01443338|Dermatologic Agents|dermatologic agents|mesh-ancestor
92407234|NCT01443377|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407235|NCT01443377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407237|NCT01443416|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92407238|NCT01443416|Immunologic Factors|immunologic factors|mesh-ancestor
92407239|NCT01443416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407240|NCT01443429|Beraprost|beraprost|mesh-list
92407241|NCT01443429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92407242|NCT01443429|Vasodilator Agents|vasodilator agents|mesh-ancestor
92407243|NCT01443520|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92407244|NCT01443520|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92407245|NCT01443520|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92407246|NCT01443520|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92407247|NCT01443520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407248|NCT01443520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407249|NCT01443520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407250|NCT01443520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407251|NCT01443520|Analgesics|analgesics|mesh-ancestor
92407252|NCT01443520|Sensory System Agents|sensory system agents|mesh-ancestor
92407253|NCT01443520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407254|NCT01443520|Antidepressive Agents|antidepressive agents|mesh-ancestor
92407255|NCT01443520|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92407256|NCT01443520|Dopamine Agents|dopamine agents|mesh-ancestor
92407257|NCT01443520|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92407258|NCT01443572|Anesthetics|anesthetics|mesh-list
92407259|NCT01443572|Sevoflurane|sevoflurane|mesh-list
92407260|NCT01443572|Desflurane|desflurane|mesh-list
92407261|NCT01443572|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407262|NCT01443572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407263|NCT01443572|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92407264|NCT01443572|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92407265|NCT01443572|Anesthetics, General|anesthetics, general|mesh-ancestor
92407266|NCT01443624|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92407267|NCT01443624|Hematinics|hematinics|mesh-ancestor
92407268|NCT01443650|Alirocumab|alirocumab|mesh-list
92407269|NCT01443650|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92407270|NCT01443650|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407271|NCT01443650|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407272|NCT01443650|Antimetabolites|antimetabolites|mesh-ancestor
92407273|NCT01443650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407274|NCT01443650|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92407275|NCT01443650|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407276|NCT01443650|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407277|NCT01443650|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407278|NCT01443676|Bevacizumab|bevacizumab|mesh-list
92407279|NCT01443676|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407280|NCT01443676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407281|NCT01443676|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92407282|NCT01443676|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92407283|NCT01443676|Growth Substances|growth substances|mesh-ancestor
92407284|NCT01443676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407285|NCT01443676|Growth Inhibitors|growth inhibitors|mesh-ancestor
92407286|NCT01443741|Insulin|insulin|mesh-list
92407287|NCT01443741|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92407288|NCT01443741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407289|NCT01443741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407290|NCT01443780|Selenium|selenium|mesh-list
92407291|NCT01443780|Antioxidants|antioxidants|mesh-ancestor
92407292|NCT01443780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407293|NCT01443780|Protective Agents|protective agents|mesh-ancestor
92407294|NCT01443780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407295|NCT01443780|Trace Elements|trace elements|mesh-ancestor
92407296|NCT01443780|Micronutrients|micronutrients|mesh-ancestor
92407297|NCT01443806|Oseltamivir|oseltamivir|mesh-list
92407298|NCT01443806|Antiviral Agents|antiviral agents|mesh-ancestor
92407299|NCT01443806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407300|NCT01443806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407301|NCT01443806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407302|NCT01443897|Vitamin D|vitamin d|mesh-list
92407303|NCT01443897|Ergocalciferols|ergocalciferols|mesh-list
92407304|NCT01443897|Cholecalciferol|cholecalciferol|mesh-list
92407305|NCT01443897|Vitamins|vitamins|mesh-list
92407306|NCT01443897|Micronutrients|micronutrients|mesh-ancestor
92407307|NCT01443897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407308|NCT01443897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92407309|NCT01443897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92407310|NCT01443988|Travoprost|travoprost|mesh-list
92407311|NCT01443988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92097991|NCT03467178|Paclitaxel|paclitaxel|mesh-list
92407313|NCT01444001|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92407314|NCT01444001|Immunologic Factors|immunologic factors|mesh-ancestor
92407315|NCT01444001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407316|NCT01444118|Cyclophosphamide|cyclophosphamide|mesh-list
92407317|NCT01444118|Vaccines|vaccines|mesh-list
92407318|NCT01444118|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92407319|NCT01444118|Immunologic Factors|immunologic factors|mesh-ancestor
92407320|NCT01444118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407321|NCT01444118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407322|NCT01444118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407323|NCT01444118|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92407324|NCT01444118|Alkylating Agents|alkylating agents|mesh-ancestor
92407325|NCT01444118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407326|NCT01444118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407327|NCT01444118|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92407328|NCT01444118|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92407329|NCT01444131|Nicotine|nicotine|mesh-list
92407330|NCT01444131|Varenicline|varenicline|mesh-list
92407331|NCT01444131|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92407332|NCT01444131|Autonomic Agents|autonomic agents|mesh-ancestor
92407333|NCT01444131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407334|NCT01444131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407335|NCT01444131|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92407336|NCT01444131|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92407337|NCT01444131|Cholinergic Agents|cholinergic agents|mesh-ancestor
92407338|NCT01444131|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407339|NCT01444131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407340|NCT01444196|Desloratadine|desloratadine|mesh-list
92407341|NCT01444196|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92407342|NCT01444196|Cholinergic Agents|cholinergic agents|mesh-ancestor
92407343|NCT01444196|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407344|NCT01444196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407345|NCT01444196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407346|NCT01444196|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92407347|NCT01444196|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92407348|NCT01444196|Histamine Antagonists|histamine antagonists|mesh-ancestor
92407349|NCT01444196|Histamine Agents|histamine agents|mesh-ancestor
92407351|NCT01444248|Glimepiride|glimepiride|mesh-list
92407352|NCT01444248|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407353|NCT01444248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407354|NCT01444248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407355|NCT01444248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407356|NCT01444248|Immunologic Factors|immunologic factors|mesh-ancestor
92407357|NCT01444339|Vaccines|vaccines|mesh-list
92407358|NCT01444339|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92407359|NCT01444339|Immunologic Factors|immunologic factors|mesh-ancestor
92407360|NCT01444339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407361|NCT01444352|Vaccines|vaccines|mesh-list
92407362|NCT01444352|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92407363|NCT01444352|Immunologic Factors|immunologic factors|mesh-ancestor
92407364|NCT01444352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407365|NCT01444469|Azithromycin|azithromycin|mesh-list
92407366|NCT01444469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92407367|NCT01444469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407368|NCT01444521|Irinotecan|irinotecan|mesh-list
92407369|NCT01444521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407370|NCT01444521|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92407371|NCT01444521|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92407372|NCT01444521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407373|NCT01444521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407374|NCT01444547|Paclitaxel|paclitaxel|mesh-list
92407375|NCT01444547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92407376|NCT01444547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92407377|NCT01444547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407378|NCT01444547|Tubulin Modulators|tubulin modulators|mesh-ancestor
92407379|NCT01444547|Antimitotic Agents|antimitotic agents|mesh-ancestor
92407380|NCT01444547|Mitosis Modulators|mitosis modulators|mesh-ancestor
92407381|NCT01444547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407382|NCT01444586|Rivaroxaban|rivaroxaban|mesh-list
92407383|NCT01444586|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92407384|NCT01444586|Antithrombins|antithrombins|mesh-ancestor
92407385|NCT01444586|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92407386|NCT01444586|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098070|NCT03129594|Glucagon|glucagon|mesh-list
92407387|NCT01444586|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407388|NCT01444586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407389|NCT01444586|Anticoagulants|anticoagulants|mesh-ancestor
92407390|NCT01444612|Heparin|heparin|mesh-list
92407391|NCT01444612|Calcium heparin|calcium heparin|mesh-list
92407392|NCT01444612|Enoxaparin|enoxaparin|mesh-list
92407393|NCT01444612|Dalteparin|dalteparin|mesh-list
92407394|NCT01444612|Tinzaparin|tinzaparin|mesh-list
92407395|NCT01444612|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92407396|NCT01444612|PENTA|penta|mesh-list
92407397|NCT01444612|Fondaparinux|fondaparinux|mesh-list
92407398|NCT01444612|Anticoagulants|anticoagulants|mesh-ancestor
92407399|NCT01444612|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92407400|NCT01444612|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92407401|NCT01444612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407402|NCT01444612|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92407403|NCT01444612|Antithrombins|antithrombins|mesh-ancestor
91939717|NCT04993352|Mitogens|mitogens|mesh-list
92407404|NCT01444612|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92407405|NCT01444612|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407406|NCT01444612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407408|NCT01444677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407409|NCT01444677|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92407410|NCT01444677|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407411|NCT01444677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407412|NCT01444677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407413|NCT01444677|Antiviral Agents|antiviral agents|mesh-ancestor
92407414|NCT01444703|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92407415|NCT01444807|Sorafenib|sorafenib|mesh-list
92407416|NCT01444807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407417|NCT01444807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92407418|NCT01444807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407419|NCT01444807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407420|NCT01444833|Candesartan|candesartan|mesh-list
92407421|NCT01444833|Candesartan cilexetil|candesartan cilexetil|mesh-list
92407422|NCT01444833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407423|NCT01444833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92407424|NCT01444833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92407425|NCT01444833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407426|NCT01444846|Ebselen|ebselen|mesh-list
92407427|NCT01444846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92407428|NCT01444846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92407429|NCT01444846|Analgesics|analgesics|mesh-ancestor
92407430|NCT01444846|Sensory System Agents|sensory system agents|mesh-ancestor
92407431|NCT01444846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407432|NCT01444846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407433|NCT01444846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92407434|NCT01444846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407435|NCT01444846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92407436|NCT01444846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92407437|NCT01444846|Antioxidants|antioxidants|mesh-ancestor
92407438|NCT01444846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407439|NCT01444846|Protective Agents|protective agents|mesh-ancestor
92407440|NCT01444846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92407441|NCT01444846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407442|NCT01444846|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92407443|NCT01444885|Amlodipine|amlodipine|mesh-list
92407444|NCT01444885|Nitroglycerin|nitroglycerin|mesh-list
92407445|NCT01444885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407446|NCT01444885|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92407447|NCT01444885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407448|NCT01444885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407449|NCT01444885|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92407450|NCT01444885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407451|NCT01444885|Vasodilator Agents|vasodilator agents|mesh-ancestor
92407452|NCT01444976|Midazolam|midazolam|mesh-list
92407453|NCT01444976|Anesthetics|anesthetics|mesh-ancestor
92407454|NCT01444976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407455|NCT01444976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407456|NCT01444976|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92407457|NCT01444976|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92407458|NCT01444976|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92407459|NCT01444976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92407460|NCT01444976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92407461|NCT01444976|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92407462|NCT01444976|Anesthetics, General|anesthetics, general|mesh-ancestor
92407463|NCT01444976|GABA Modulators|gaba modulators|mesh-ancestor
92407465|NCT01444976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407466|NCT01444976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407467|NCT01445106|Nelfinavir|nelfinavir|mesh-list
92407468|NCT01445106|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92407469|NCT01445106|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92407470|NCT01445106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407471|NCT01445106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407472|NCT01445106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407473|NCT01445106|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92407474|NCT01445106|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92407475|NCT01445106|Antiviral Agents|antiviral agents|mesh-ancestor
92407476|NCT01445106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407477|NCT01445119|Carboplatin|carboplatin|mesh-list
92407478|NCT01445119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407479|NCT01445210|Ropivacaine|ropivacaine|mesh-list
92407480|NCT01445210|Anesthetics, Local|anesthetics, local|mesh-ancestor
92407481|NCT01445210|Anesthetics|anesthetics|mesh-ancestor
92407482|NCT01445210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407483|NCT01445210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407484|NCT01445210|Sensory System Agents|sensory system agents|mesh-ancestor
92407485|NCT01445210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407486|NCT01445223|Ritonavir|ritonavir|mesh-list
92407487|NCT01445223|Lopinavir|lopinavir|mesh-list
92407488|NCT01445223|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92407489|NCT01445223|Efavirenz|efavirenz|mesh-list
92407490|NCT01445223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92407491|NCT01445223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92407492|NCT01445223|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407493|NCT01445223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407494|NCT01445223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407495|NCT01445223|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92407496|NCT01445223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92407497|NCT01445223|Antiviral Agents|antiviral agents|mesh-ancestor
92407498|NCT01445223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407499|NCT01445223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92407500|NCT01445223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92407501|NCT01445223|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92407502|NCT01445223|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407503|NCT01445223|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92407504|NCT01445223|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92407505|NCT01445223|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92407506|NCT01445223|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92407507|NCT01445223|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92407508|NCT01445236|Cyclosporine|cyclosporine|mesh-list
92407509|NCT01445236|Tacrolimus|tacrolimus|mesh-list
92407510|NCT01445236|Cyclosporins|cyclosporins|mesh-list
92407511|NCT01445236|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407512|NCT01445236|Immunologic Factors|immunologic factors|mesh-ancestor
92407513|NCT01445236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407514|NCT01445236|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92407515|NCT01445236|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407516|NCT01445236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407517|NCT01445236|Antifungal Agents|antifungal agents|mesh-ancestor
92407518|NCT01445236|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407519|NCT01445236|Dermatologic Agents|dermatologic agents|mesh-ancestor
92407520|NCT01445236|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407521|NCT01445262|Levocetirizine|levocetirizine|mesh-list
92407522|NCT01445262|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92407523|NCT01445262|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92407524|NCT01445262|Histamine Antagonists|histamine antagonists|mesh-ancestor
92407525|NCT01445262|Histamine Agents|histamine agents|mesh-ancestor
92407526|NCT01445262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407527|NCT01445262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407528|NCT01445262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407529|NCT01445340|Romidepsin|romidepsin|mesh-list
92407530|NCT01445340|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92407531|NCT01445340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407532|NCT01445340|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92407533|NCT01445340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407534|NCT01445340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407535|NCT01445379|Ipilimumab|ipilimumab|mesh-list
92407536|NCT01445379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407537|NCT01445379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407538|NCT01445379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92407539|NCT01445379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407540|NCT01445392|Pemetrexed|pemetrexed|mesh-list
92407541|NCT01445392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92407542|NCT01445392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407543|NCT01445392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407544|NCT01445392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407545|NCT01445392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92407546|NCT01445392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407547|NCT01445392|Immunologic Factors|immunologic factors|mesh-ancestor
92407548|NCT01445392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407549|NCT01445405|Cetuximab|cetuximab|mesh-list
92407550|NCT01445405|Bortezomib|bortezomib|mesh-list
92407551|NCT01445405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407552|NCT01445405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407553|NCT01445418|Carboplatin|carboplatin|mesh-list
92407554|NCT01445418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407555|NCT01445431|Mineral Oil|mineral oil|mesh-list
92407556|NCT01445431|Emollients|emollients|mesh-ancestor
92407557|NCT01445431|Dermatologic Agents|dermatologic agents|mesh-ancestor
92407558|NCT01445522|Cyclophosphamide|cyclophosphamide|mesh-list
92407559|NCT01445522|Veliparib|veliparib|mesh-list
92407560|NCT01445522|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407561|NCT01445522|Immunologic Factors|immunologic factors|mesh-ancestor
92407562|NCT01445522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407563|NCT01445522|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407564|NCT01445522|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92407565|NCT01445522|Alkylating Agents|alkylating agents|mesh-ancestor
92407566|NCT01445522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407567|NCT01445522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407568|NCT01445522|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92407569|NCT01445522|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92407570|NCT01445522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407571|NCT01445561|Interleukin-2|interleukin-2|mesh-list
92407572|NCT01445561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407573|NCT01445561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92407574|NCT01445561|Analgesics|analgesics|mesh-ancestor
92407575|NCT01445561|Sensory System Agents|sensory system agents|mesh-ancestor
92407576|NCT01445561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407577|NCT01445561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407578|NCT01445587|Bortezomib|bortezomib|mesh-list
92407579|NCT01445587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407580|NCT01445600|Retapamulin|retapamulin|mesh-list
92407581|NCT01445600|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92407582|NCT01445600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407583|NCT01445639|Dexmedetomidine|dexmedetomidine|mesh-list
92407584|NCT01445639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92407585|NCT01445639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407586|NCT01445639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407587|NCT01445639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92407588|NCT01445639|Analgesics|analgesics|mesh-ancestor
92407589|NCT01445639|Sensory System Agents|sensory system agents|mesh-ancestor
92407590|NCT01445639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407591|NCT01445639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92407592|NCT01445639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92407593|NCT01445639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92407594|NCT01445639|Adrenergic Agents|adrenergic agents|mesh-ancestor
92407595|NCT01445639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407596|NCT01445639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407597|NCT01445691|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92407598|NCT01445691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92407599|NCT01445691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92407601|NCT01445743|Immunologic Factors|immunologic factors|mesh-ancestor
92407602|NCT01445743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407603|NCT01445756|Lidocaine|lidocaine|mesh-list
92407604|NCT01445756|Anesthetics, Local|anesthetics, local|mesh-ancestor
92407605|NCT01445756|Anesthetics|anesthetics|mesh-ancestor
92407606|NCT01445756|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407607|NCT01445756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407608|NCT01445756|Sensory System Agents|sensory system agents|mesh-ancestor
92407609|NCT01445756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407610|NCT01445756|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407611|NCT01445756|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92407612|NCT01445756|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92407613|NCT01445756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407689|NCT01446211|Protective Agents|protective agents|mesh-ancestor
92407614|NCT01445756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407616|NCT01445860|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407617|NCT01445860|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407618|NCT01445860|Antimetabolites|antimetabolites|mesh-ancestor
92407619|NCT01445860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407620|NCT01445860|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407621|NCT01445860|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92407622|NCT01445860|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407623|NCT01445938|Lumefantrine|lumefantrine|mesh-list
92407624|NCT01445938|Antimalarials|antimalarials|mesh-ancestor
92407625|NCT01445938|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92407626|NCT01445938|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92407627|NCT01445938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407628|NCT01445964|Atenolol|atenolol|mesh-list
92407629|NCT01445964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407630|NCT01445964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407631|NCT01445964|Sympatholytics|sympatholytics|mesh-ancestor
92407632|NCT01445964|Autonomic Agents|autonomic agents|mesh-ancestor
92407633|NCT01445964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407634|NCT01445964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407635|NCT01445964|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92407636|NCT01445964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92407637|NCT01445964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92407638|NCT01445964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92407639|NCT01445964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407640|NCT01445964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407641|NCT01446094|Regadenoson|regadenoson|mesh-list
92407642|NCT01446094|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92407643|NCT01446094|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92407644|NCT01446094|Purinergic Agonists|purinergic agonists|mesh-ancestor
92407645|NCT01446094|Purinergic Agents|purinergic agents|mesh-ancestor
92407646|NCT01446094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407647|NCT01446094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407648|NCT01446094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407649|NCT01446107|Fluorides|fluorides|mesh-list
92407650|NCT01446107|Fluorides, Topical|fluorides, topical|mesh-list
92407651|NCT01446107|Cariostatic Agents|cariostatic agents|mesh-ancestor
92407652|NCT01446107|Protective Agents|protective agents|mesh-ancestor
92407653|NCT01446107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407654|NCT01446120|Insulin|insulin|mesh-list
92407655|NCT01446120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92407656|NCT01446120|Insulin, Isophane|insulin, isophane|mesh-list
92407657|NCT01446120|Isophane Insulin, Human|isophane insulin, human|mesh-list
92407658|NCT01446120|Isophane insulin, beef|isophane insulin, beef|mesh-list
92407659|NCT01446120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407660|NCT01446120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407661|NCT01446211|Gusperimus|gusperimus|mesh-list
92407662|NCT01446211|Cyclophosphamide|cyclophosphamide|mesh-list
92407663|NCT01446211|Methotrexate|methotrexate|mesh-list
92407664|NCT01446211|Azathioprine|azathioprine|mesh-list
92407665|NCT01446211|Glucocorticoids|glucocorticoids|mesh-list
92407666|NCT01446211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407667|NCT01446211|Immunologic Factors|immunologic factors|mesh-ancestor
92407668|NCT01446211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407669|NCT01446211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407670|NCT01446211|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92407671|NCT01446211|Alkylating Agents|alkylating agents|mesh-ancestor
92407672|NCT01446211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407673|NCT01446211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407674|NCT01446211|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92407675|NCT01446211|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92407676|NCT01446211|Abortifacient Agents|abortifacient agents|mesh-ancestor
92407677|NCT01446211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92407678|NCT01446211|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92407679|NCT01446211|Antimetabolites|antimetabolites|mesh-ancestor
92407680|NCT01446211|Dermatologic Agents|dermatologic agents|mesh-ancestor
92407681|NCT01446211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407682|NCT01446211|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92407683|NCT01446211|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407684|NCT01446211|Hormones|hormones|mesh-ancestor
92407685|NCT01446211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92407686|NCT01446211|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92098386|NCT04453332|Hormones|hormones|mesh-list
92407687|NCT01446211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407688|NCT01446211|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92407692|NCT01446276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407693|NCT01446276|Protective Agents|protective agents|mesh-ancestor
92407694|NCT01446276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407695|NCT01446276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407696|NCT01446276|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92407698|NCT01446328|Aripiprazole|aripiprazole|mesh-list
92407699|NCT01446328|Amisulpride|amisulpride|mesh-list
92407700|NCT01446328|Antiemetics|antiemetics|mesh-ancestor
92407701|NCT01446328|Autonomic Agents|autonomic agents|mesh-ancestor
92407702|NCT01446328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407703|NCT01446328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407704|NCT01446328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92407705|NCT01446328|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92407706|NCT01446328|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92407707|NCT01446328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407708|NCT01446328|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92407709|NCT01446328|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92407710|NCT01446328|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92407711|NCT01446328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92407712|NCT01446328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407713|NCT01446328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407714|NCT01446328|Serotonin Agents|serotonin agents|mesh-ancestor
92407715|NCT01446328|Antidepressive Agents|antidepressive agents|mesh-ancestor
92407716|NCT01446328|Dopamine Agonists|dopamine agonists|mesh-ancestor
92407717|NCT01446328|Dopamine Agents|dopamine agents|mesh-ancestor
92407718|NCT01446328|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92407719|NCT01446328|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92407720|NCT01446328|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92407721|NCT01446328|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92407722|NCT01446328|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92407723|NCT01446328|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92407724|NCT01446328|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92407725|NCT01446445|Valganciclovir|valganciclovir|mesh-list
92407726|NCT01446445|Ganciclovir|ganciclovir|mesh-list
92407727|NCT01446445|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92407728|NCT01446445|Antiviral Agents|antiviral agents|mesh-ancestor
92407729|NCT01446445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407730|NCT01446445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92407731|NCT01446445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407732|NCT01446445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407734|NCT01446458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407735|NCT01446484|Cyclosporine|cyclosporine|mesh-list
92407736|NCT01446484|Sirolimus|sirolimus|mesh-list
92407737|NCT01446484|Mycophenolic Acid|mycophenolic acid|mesh-list
92407738|NCT01446484|Everolimus|everolimus|mesh-list
92407739|NCT01446484|Alemtuzumab|alemtuzumab|mesh-list
92407740|NCT01446484|Tacrolimus|tacrolimus|mesh-list
92407741|NCT01446484|Cyclosporins|cyclosporins|mesh-list
92407742|NCT01446484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407743|NCT01446484|Immunologic Factors|immunologic factors|mesh-ancestor
92407744|NCT01446484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407745|NCT01446484|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92407746|NCT01446484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407747|NCT01446484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407748|NCT01446484|Antifungal Agents|antifungal agents|mesh-ancestor
92407749|NCT01446484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407750|NCT01446484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92407751|NCT01446484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407752|NCT01446484|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92407753|NCT01446484|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92407754|NCT01446484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407755|NCT01446484|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92407756|NCT01446484|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92407757|NCT01446484|Antitubercular Agents|antitubercular agents|mesh-ancestor
92407758|NCT01446484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92407759|NCT01446484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407760|NCT01446497|Timolol|timolol|mesh-list
92407761|NCT01446497|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91936718|NCT01590719|Micronutrients|micronutrients|mesh-ancestor
92407762|NCT01446497|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92407763|NCT01446497|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92407764|NCT01446497|Adrenergic Agents|adrenergic agents|mesh-ancestor
92407765|NCT01446497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407766|NCT01446497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407767|NCT01446497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407768|NCT01446497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407769|NCT01446497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407770|NCT01446497|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92407771|NCT01446497|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92407772|NCT01446497|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92407774|NCT01446523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92407775|NCT01446562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92407776|NCT01446562|Immunologic Factors|immunologic factors|mesh-ancestor
92407777|NCT01446562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407778|NCT01446679|Atorvastatin|atorvastatin|mesh-list
92407779|NCT01446679|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407780|NCT01446679|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407781|NCT01446679|Antimetabolites|antimetabolites|mesh-ancestor
92407782|NCT01446679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407783|NCT01446679|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407784|NCT01446679|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92407785|NCT01446679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407786|NCT01446731|Docetaxel|docetaxel|mesh-list
92407787|NCT01446731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407788|NCT01446731|Tubulin Modulators|tubulin modulators|mesh-ancestor
92407789|NCT01446731|Antimitotic Agents|antimitotic agents|mesh-ancestor
92407790|NCT01446731|Mitosis Modulators|mitosis modulators|mesh-ancestor
92407791|NCT01446731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407792|NCT01446783|Mecasermin|mecasermin|mesh-list
92407793|NCT01446783|Growth Substances|growth substances|mesh-ancestor
92407794|NCT01446783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407795|NCT01446900|Rituximab|rituximab|mesh-list
92407796|NCT01446900|Cladribine|cladribine|mesh-list
92407797|NCT01446900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407798|NCT01446900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407799|NCT01446900|Immunologic Factors|immunologic factors|mesh-ancestor
92407800|NCT01446900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407801|NCT01446900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407802|NCT01446900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92407803|NCT01446926|Vaccines|vaccines|mesh-list
92407804|NCT01446926|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92407805|NCT01446926|Immunologic Factors|immunologic factors|mesh-ancestor
92407806|NCT01446926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407808|NCT01446952|Tocopherols|tocopherols|mesh-list
92407809|NCT01446952|Tocotrienols|tocotrienols|mesh-list
92407810|NCT01446952|Vitamins|vitamins|mesh-ancestor
92407811|NCT01446952|Micronutrients|micronutrients|mesh-ancestor
92407812|NCT01446952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407813|NCT01446952|Antioxidants|antioxidants|mesh-ancestor
92407814|NCT01446952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407815|NCT01446952|Protective Agents|protective agents|mesh-ancestor
92407816|NCT01446978|Vaccines|vaccines|mesh-list
92407817|NCT01446978|Immunologic Factors|immunologic factors|mesh-ancestor
92407818|NCT01446978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407819|NCT01447043|Ranibizumab|ranibizumab|mesh-list
92407820|NCT01447043|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92407821|NCT01447043|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92407822|NCT01447043|Growth Substances|growth substances|mesh-ancestor
92407823|NCT01447043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407824|NCT01447043|Growth Inhibitors|growth inhibitors|mesh-ancestor
92407825|NCT01447043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407826|NCT01447069|Albuterol|albuterol|mesh-list
92407827|NCT01447069|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92407828|NCT01447069|Autonomic Agents|autonomic agents|mesh-ancestor
92407829|NCT01447069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407830|NCT01447069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407831|NCT01447069|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92407832|NCT01447069|Respiratory System Agents|respiratory system agents|mesh-ancestor
92407834|NCT01447069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92407835|NCT01447069|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92407836|NCT01447069|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91936719|NCT01590719|Hematinics|hematinics|mesh-ancestor
92407837|NCT01447069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92407838|NCT01447069|Adrenergic Agents|adrenergic agents|mesh-ancestor
92407839|NCT01447069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407840|NCT01447069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407842|NCT01447095|Tezosentan|tezosentan|mesh-list
92407843|NCT01447095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407844|NCT01447095|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92407845|NCT01447095|Vasodilator Agents|vasodilator agents|mesh-ancestor
92407846|NCT01447160|Cortisone|cortisone|mesh-list
92407847|NCT01447160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92407848|NCT01447173|Vitamin D|vitamin d|mesh-list
92407849|NCT01447173|Vitamins|vitamins|mesh-ancestor
92407850|NCT01447173|Micronutrients|micronutrients|mesh-ancestor
92407851|NCT01447173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407852|NCT01447173|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92407853|NCT01447212|Hydromorphone|hydromorphone|mesh-list
92407854|NCT01447212|Heroin|heroin|mesh-list
92407855|NCT01447212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92407856|NCT01447212|Narcotics|narcotics|mesh-ancestor
92407857|NCT01447212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407858|NCT01447212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407859|NCT01447212|Analgesics|analgesics|mesh-ancestor
92407860|NCT01447212|Sensory System Agents|sensory system agents|mesh-ancestor
92407861|NCT01447212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92407862|NCT01447355|Vitamin D|vitamin d|mesh-list
92407863|NCT01447355|Cholecalciferol|cholecalciferol|mesh-list
92407864|NCT01447355|Vitamins|vitamins|mesh-ancestor
92407865|NCT01447355|Micronutrients|micronutrients|mesh-ancestor
92407866|NCT01447355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407867|NCT01447355|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92407868|NCT01447355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92407869|NCT01447368|Cinacalcet|cinacalcet|mesh-list
92407870|NCT01447368|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92407871|NCT01447368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407872|NCT01447368|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92407873|NCT01447368|Hormone Antagonists|hormone antagonists|mesh-ancestor
92407874|NCT01447368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92407875|NCT01447394|Interferons|interferons|mesh-list
92407876|NCT01447394|Ribavirin|ribavirin|mesh-list
92407877|NCT01447394|Interferon-alpha|interferon-alpha|mesh-list
92407878|NCT01447394|Interferon alpha-2|interferon alpha-2|mesh-list
92407879|NCT01447394|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92407880|NCT01447394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407881|NCT01447394|Antiviral Agents|antiviral agents|mesh-ancestor
92407883|NCT01447394|Antimetabolites|antimetabolites|mesh-ancestor
92407884|NCT01447394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407885|NCT01447394|Immunologic Factors|immunologic factors|mesh-ancestor
92407886|NCT01447394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407887|NCT01447485|Valsartan|valsartan|mesh-list
92407888|NCT01447485|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407889|NCT01447485|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92407890|NCT01447485|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92407891|NCT01447485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407892|NCT01447550|Bosentan|bosentan|mesh-list
92407893|NCT01447550|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407894|NCT01447550|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92407895|NCT01447550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407896|NCT01447563|Clopidogrel|clopidogrel|mesh-list
92407897|NCT01447563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92407898|NCT01447563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92407899|NCT01447563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92407900|NCT01447563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92407901|NCT01447563|Purinergic Agents|purinergic agents|mesh-ancestor
92407902|NCT01447563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92407903|NCT01447563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407904|NCT01447563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407905|NCT01447589|Nelfinavir|nelfinavir|mesh-list
92407906|NCT01447589|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92407907|NCT01447589|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92407908|NCT01447589|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407909|NCT01447589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407910|NCT01447589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407911|NCT01447589|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92407912|NCT01447589|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92407914|NCT01447589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92407915|NCT01447654|Losartan|losartan|mesh-list
92407916|NCT01447654|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407917|NCT01447654|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407918|NCT01447654|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92407919|NCT01447654|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92407920|NCT01447654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407921|NCT01447797|Irbesartan|irbesartan|mesh-list
92407922|NCT01447797|Atorvastatin|atorvastatin|mesh-list
92407923|NCT01447797|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407926|NCT01447797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407927|NCT01447797|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407928|NCT01447797|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92407929|NCT01447797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407930|NCT01447797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92407931|NCT01447797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92407932|NCT01447797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92407933|NCT01447862|Ibutilide|ibutilide|mesh-list
92407934|NCT01447862|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92407935|NCT01447875|Propofol|propofol|mesh-list
92407936|NCT01447875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92407937|NCT01447875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92407938|NCT01447875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407939|NCT01447875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92407940|NCT01447875|Anesthetics, General|anesthetics, general|mesh-ancestor
92407941|NCT01447875|Anesthetics|anesthetics|mesh-ancestor
92407942|NCT01447979|Pancrelipase|pancrelipase|mesh-list
92407943|NCT01447979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92407944|NCT01448018|Ranibizumab|ranibizumab|mesh-list
92407945|NCT01448018|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92407946|NCT01448018|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92407947|NCT01448018|Growth Substances|growth substances|mesh-ancestor
92407948|NCT01448018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407949|NCT01448018|Growth Inhibitors|growth inhibitors|mesh-ancestor
92407950|NCT01448018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407951|NCT01448031|Esomeprazole|esomeprazole|mesh-list
92407952|NCT01448031|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92407953|NCT01448031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92407954|NCT01448031|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92407955|NCT01448031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407956|NCT01448031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407957|NCT01448070|Insulin|insulin|mesh-list
92407958|NCT01448070|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92407959|NCT01448070|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92407960|NCT01448070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407961|NCT01448096|Rituximab|rituximab|mesh-list
92407962|NCT01448096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92407963|NCT01448096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92407964|NCT01448096|Immunologic Factors|immunologic factors|mesh-ancestor
92407965|NCT01448096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407966|NCT01448096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92407967|NCT01448109|Hydrocortisone|hydrocortisone|mesh-list
92407968|NCT01448109|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92407969|NCT01448109|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92407970|NCT01448174|Atorvastatin|atorvastatin|mesh-list
92407971|NCT01448174|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407972|NCT01448174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407973|NCT01448174|Antimetabolites|antimetabolites|mesh-ancestor
92407974|NCT01448174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407975|NCT01448174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407976|NCT01448174|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92407977|NCT01448174|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92407978|NCT01448239|Alirocumab|alirocumab|mesh-list
92407979|NCT01448239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92407980|NCT01448239|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92407981|NCT01448239|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92407982|NCT01448239|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92407983|NCT01448239|Antimetabolites|antimetabolites|mesh-ancestor
92407984|NCT01448239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92407985|NCT01448239|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92407986|NCT01448239|Protease Inhibitors|protease inhibitors|mesh-ancestor
92407988|NCT01448239|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92407989|NCT01448239|Immunologic Factors|immunologic factors|mesh-ancestor
92407990|NCT01448239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92407991|NCT01448291|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92407992|NCT01448291|Etonogestrel|etonogestrel|mesh-list
92407994|NCT01448291|Contraceptive Agents|contraceptive agents|mesh-list
92407995|NCT01448291|Estradiol|estradiol|mesh-list
92407996|NCT01448291|Estrogens|estrogens|mesh-ancestor
92407997|NCT01448291|Hormones|hormones|mesh-ancestor
92407998|NCT01448291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92407999|NCT01448291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408000|NCT01448291|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92408001|NCT01448291|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92408002|NCT01448291|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92408003|NCT01448291|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92408004|NCT01448291|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92408005|NCT01448304|Alirocumab|alirocumab|mesh-list
92408006|NCT01448304|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92408007|NCT01448304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92408008|NCT01448304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92408009|NCT01448304|Antimetabolites|antimetabolites|mesh-ancestor
92408010|NCT01448304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408011|NCT01448304|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92408012|NCT01448304|Protease Inhibitors|protease inhibitors|mesh-ancestor
92408013|NCT01448304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408014|NCT01448304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92408015|NCT01448317|Alirocumab|alirocumab|mesh-list
92408016|NCT01448317|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92408017|NCT01448317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92408018|NCT01448317|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92408019|NCT01448317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92408020|NCT01448317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92408021|NCT01448317|Antimetabolites|antimetabolites|mesh-ancestor
92408022|NCT01448317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408023|NCT01448317|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92408024|NCT01448317|Protease Inhibitors|protease inhibitors|mesh-ancestor
92408025|NCT01448317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408026|NCT01448317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92408027|NCT01448317|Immunologic Factors|immunologic factors|mesh-ancestor
92408028|NCT01448317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408029|NCT01448330|Aspirin|aspirin|mesh-list
92408030|NCT01448330|Clopidogrel|clopidogrel|mesh-list
92408031|NCT01448330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408032|NCT01448330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408033|NCT01448330|Analgesics|analgesics|mesh-ancestor
92408034|NCT01448330|Sensory System Agents|sensory system agents|mesh-ancestor
92408035|NCT01448330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408036|NCT01448330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408037|NCT01448330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408038|NCT01448330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408039|NCT01448330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408040|NCT01448330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408041|NCT01448330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408042|NCT01448330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408043|NCT01448330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408044|NCT01448330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408045|NCT01448330|Antipyretics|antipyretics|mesh-ancestor
92408046|NCT01448330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92408047|NCT01448330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92408048|NCT01448330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92408049|NCT01448330|Purinergic Agents|purinergic agents|mesh-ancestor
92408050|NCT01448330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408051|NCT01448395|Avibactam|avibactam|mesh-list
92408052|NCT01448395|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92408053|NCT01448395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408054|NCT01448395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408055|NCT01448395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408056|NCT01448395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408057|NCT01448434|Plasma-lyte 148|plasma-lyte 148|mesh-list
92408058|NCT01448434|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92408059|NCT01448434|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92408060|NCT01448499|Clozapine|clozapine|mesh-list
92408061|NCT01448499|Amisulpride|amisulpride|mesh-list
91936720|NCT01536041|Montelukast|montelukast|mesh-list
92408062|NCT01448499|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92408063|NCT01448499|Serotonin Agents|serotonin agents|mesh-ancestor
92408064|NCT01448499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408065|NCT01448499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408066|NCT01448499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408067|NCT01448499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92408068|NCT01448499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92408069|NCT01448499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408070|NCT01448499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92408071|NCT01448499|GABA Antagonists|gaba antagonists|mesh-ancestor
92408072|NCT01448499|GABA Agents|gaba agents|mesh-ancestor
92408073|NCT01448499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92408075|NCT01448499|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92408076|NCT01448499|Antidepressive Agents|antidepressive agents|mesh-ancestor
92408077|NCT01448642|Atorvastatin|atorvastatin|mesh-list
92408078|NCT01448642|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92408081|NCT01448642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408082|NCT01448642|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92408083|NCT01448642|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92408084|NCT01448642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408085|NCT01448720|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92408086|NCT01448720|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92408087|NCT01448720|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92408088|NCT01448720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408089|NCT01448720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408090|NCT01448720|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92408091|NCT01448720|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92408092|NCT01448720|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92408093|NCT01448720|Serotonin Agents|serotonin agents|mesh-ancestor
92408094|NCT01448720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408095|NCT01448720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408096|NCT01448720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92408098|NCT01448720|Dopamine Agents|dopamine agents|mesh-ancestor
92408099|NCT01448733|Clindamycin|clindamycin|mesh-list
92408100|NCT01448733|Clindamycin palmitate|clindamycin palmitate|mesh-list
92408101|NCT01448733|Clindamycin phosphate|clindamycin phosphate|mesh-list
92408102|NCT01448733|Tretinoin|tretinoin|mesh-list
92408103|NCT01448733|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92408104|NCT01448733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408105|NCT01448733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408106|NCT01448733|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92408107|NCT01448733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408108|NCT01448733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408109|NCT01448733|Dermatologic Agents|dermatologic agents|mesh-ancestor
92408110|NCT01448733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408111|NCT01448733|Keratolytic Agents|keratolytic agents|mesh-ancestor
92408112|NCT01448746|Heparin|heparin|mesh-list
92408113|NCT01448746|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92408114|NCT01448746|Tinzaparin|tinzaparin|mesh-list
92408115|NCT01448746|Dalteparin|dalteparin|mesh-list
92408116|NCT01448746|Anticoagulants|anticoagulants|mesh-ancestor
92408117|NCT01448746|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408118|NCT01448746|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408119|NCT01448746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408120|NCT01448772|Dronabinol|dronabinol|mesh-list
92408121|NCT01448772|Hallucinogens|hallucinogens|mesh-ancestor
92408122|NCT01448772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408123|NCT01448772|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92408124|NCT01448772|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408125|NCT01448772|Analgesics|analgesics|mesh-ancestor
92408126|NCT01448772|Sensory System Agents|sensory system agents|mesh-ancestor
92408127|NCT01448772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408128|NCT01448772|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92408129|NCT01448772|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92408130|NCT01448772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408131|NCT01448772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408132|NCT01448772|Hormones|hormones|mesh-ancestor
92408133|NCT01448772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408134|NCT01448798|Thrombin|thrombin|mesh-list
92408135|NCT01448798|Hemostatics|hemostatics|mesh-list
92408136|NCT01448798|Coagulants|coagulants|mesh-ancestor
92408137|NCT01448837|Timolol|timolol|mesh-list
92408138|NCT01448837|Bimatoprost|bimatoprost|mesh-list
92408140|NCT01448837|Cloprostenol|cloprostenol|mesh-list
92408141|NCT01448837|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92408142|NCT01448837|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92408143|NCT01448837|Adrenergic Agents|adrenergic agents|mesh-ancestor
92408144|NCT01448837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408145|NCT01448837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408146|NCT01448837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408147|NCT01448837|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92408148|NCT01448837|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92408149|NCT01448837|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92408150|NCT01448837|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92408151|NCT01448837|Luteolytic Agents|luteolytic agents|mesh-ancestor
92408152|NCT01448837|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92408153|NCT01448837|Contraceptive Agents|contraceptive agents|mesh-ancestor
92408154|NCT01448837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92408155|NCT01448837|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92408156|NCT01448993|Azithromycin|azithromycin|mesh-list
92408157|NCT01448993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408158|NCT01448993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408159|NCT01449045|Lumefantrine|lumefantrine|mesh-list
92408160|NCT01449045|Artemether|artemether|mesh-list
92408161|NCT01449045|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92408162|NCT01449045|Antimalarials|antimalarials|mesh-ancestor
92408163|NCT01449045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92408164|NCT01449045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92408165|NCT01449045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408166|NCT01449110|Resveratrol|resveratrol|mesh-list
92408167|NCT01449110|Antioxidants|antioxidants|mesh-ancestor
92408168|NCT01449110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408169|NCT01449110|Protective Agents|protective agents|mesh-ancestor
92408170|NCT01449110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408171|NCT01449110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408172|NCT01449110|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408173|NCT01449123|Mannitol|mannitol|mesh-list
92408174|NCT01449123|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92408175|NCT01449123|Diuretics|diuretics|mesh-ancestor
92408176|NCT01449123|Natriuretic Agents|natriuretic agents|mesh-ancestor
92408177|NCT01449123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408178|NCT01449136|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92408179|NCT01449136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408180|NCT01449188|Moxifloxacin|moxifloxacin|mesh-list
92408181|NCT01449188|Ondansetron|ondansetron|mesh-list
92408182|NCT01449188|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408183|NCT01449188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408184|NCT01449188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92408185|NCT01449188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92408186|NCT01449188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408187|NCT01449188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408188|NCT01449188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408189|NCT01449188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408190|NCT01449188|Antiemetics|antiemetics|mesh-ancestor
92408191|NCT01449188|Autonomic Agents|autonomic agents|mesh-ancestor
92408192|NCT01449188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408193|NCT01449188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92408194|NCT01449188|Antipruritics|antipruritics|mesh-ancestor
92408195|NCT01449188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92408196|NCT01449188|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92408197|NCT01449188|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92408198|NCT01449188|Serotonin Agents|serotonin agents|mesh-ancestor
92408199|NCT01449188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408200|NCT01449253|Bosentan|bosentan|mesh-list
92408201|NCT01449253|Sildenafil Citrate|sildenafil citrate|mesh-list
92408202|NCT01449253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92408203|NCT01449253|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92408204|NCT01449253|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92408205|NCT01449253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408206|NCT01449253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408207|NCT01449253|Urological Agents|urological agents|mesh-ancestor
92408208|NCT01449253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92408209|NCT01449253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92408210|NCT01449344|Cytarabine|cytarabine|mesh-list
92408211|NCT01449344|Dexamethasone|dexamethasone|mesh-list
92408212|NCT01449344|Dexamethasone acetate|dexamethasone acetate|mesh-list
92408213|NCT01449344|Rituximab|rituximab|mesh-list
92408214|NCT01449344|Bortezomib|bortezomib|mesh-list
92408215|NCT01449344|BB 1101|bb 1101|mesh-list
92408216|NCT01449344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408217|NCT01449344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408218|NCT01449344|Immunologic Factors|immunologic factors|mesh-ancestor
92408219|NCT01449344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408220|NCT01449344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408221|NCT01449344|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408222|NCT01449344|Antiemetics|antiemetics|mesh-ancestor
92408223|NCT01449344|Autonomic Agents|autonomic agents|mesh-ancestor
91939729|NCT04992026|Glucocorticoids|glucocorticoids|mesh-ancestor
92408224|NCT01449344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408225|NCT01449344|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92408226|NCT01449344|Glucocorticoids|glucocorticoids|mesh-ancestor
92408227|NCT01449344|Hormones|hormones|mesh-ancestor
92408228|NCT01449344|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408229|NCT01449344|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92408230|NCT01449344|Protease Inhibitors|protease inhibitors|mesh-ancestor
92408231|NCT01449344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408232|NCT01449344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408233|NCT01449344|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92408236|NCT01449344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408237|NCT01449344|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408238|NCT01449357|Zalutumumab|zalutumumab|mesh-list
92408239|NCT01449357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408240|NCT01449357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408241|NCT01449435|Methacholine Chloride|methacholine chloride|mesh-list
92408242|NCT01449435|Miotics|miotics|mesh-ancestor
92408243|NCT01449435|Autonomic Agents|autonomic agents|mesh-ancestor
92408244|NCT01449435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408245|NCT01449435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408246|NCT01449435|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92408247|NCT01449435|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92408248|NCT01449435|Respiratory System Agents|respiratory system agents|mesh-ancestor
92408249|NCT01449435|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92408250|NCT01449435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92408251|NCT01449435|Cholinergic Agents|cholinergic agents|mesh-ancestor
92408252|NCT01449435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408253|NCT01449435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408254|NCT01449448|Triamcinolone|triamcinolone|mesh-list
92408255|NCT01449448|Ketorolac|ketorolac|mesh-list
92408256|NCT01449448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408257|NCT01449448|Glucocorticoids|glucocorticoids|mesh-ancestor
92408258|NCT01449448|Hormones|hormones|mesh-ancestor
92408259|NCT01449448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408260|NCT01449448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408261|NCT01449448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408262|NCT01449448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408263|NCT01449448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408264|NCT01449448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408265|NCT01449448|Analgesics|analgesics|mesh-ancestor
92408266|NCT01449448|Sensory System Agents|sensory system agents|mesh-ancestor
92408267|NCT01449448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408268|NCT01449448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408269|NCT01449448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408270|NCT01447992|Pancrelipase|pancrelipase|mesh-list
92408271|NCT01447992|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92408272|NCT01449552|Tranexamic Acid|tranexamic acid|mesh-list
92408273|NCT01449552|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92408274|NCT01449552|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408275|NCT01449552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408276|NCT01449552|Hemostatics|hemostatics|mesh-ancestor
92408277|NCT01449552|Coagulants|coagulants|mesh-ancestor
92408278|NCT01449565|Naltrexone|naltrexone|mesh-list
92408279|NCT01449565|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92408280|NCT01449565|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92408281|NCT01449565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408282|NCT01449565|Sensory System Agents|sensory system agents|mesh-ancestor
92408283|NCT01449565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408284|NCT01449578|Pramipexole|pramipexole|mesh-list
92408285|NCT01449578|Antioxidants|antioxidants|mesh-ancestor
92408286|NCT01449578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408287|NCT01449578|Protective Agents|protective agents|mesh-ancestor
92408288|NCT01449578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408289|NCT01449578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92408290|NCT01449578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92408291|NCT01449578|Dopamine Agonists|dopamine agonists|mesh-ancestor
92408293|NCT01449578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408294|NCT01449617|Aspirin|aspirin|mesh-list
92408295|NCT01449617|Clopidogrel|clopidogrel|mesh-list
92408296|NCT01449617|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408297|NCT01449617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408298|NCT01449617|Analgesics|analgesics|mesh-ancestor
92408299|NCT01449617|Sensory System Agents|sensory system agents|mesh-ancestor
92408300|NCT01449617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408301|NCT01449617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408302|NCT01449617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408303|NCT01449617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408304|NCT01449617|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408305|NCT01449617|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408306|NCT01449617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408307|NCT01449617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408308|NCT01449617|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408309|NCT01449617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408310|NCT01449617|Antipyretics|antipyretics|mesh-ancestor
92408311|NCT01449617|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92408312|NCT01449617|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92408313|NCT01449617|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92408314|NCT01449617|Purinergic Agents|purinergic agents|mesh-ancestor
92408315|NCT01449617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408316|NCT01449799|Fluticasone|fluticasone|mesh-list
92408318|NCT01449799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408319|NCT01449799|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92408320|NCT01449799|Autonomic Agents|autonomic agents|mesh-ancestor
92408321|NCT01449799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408322|NCT01449799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408323|NCT01449799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92408324|NCT01449799|Respiratory System Agents|respiratory system agents|mesh-ancestor
92408325|NCT01449799|Dermatologic Agents|dermatologic agents|mesh-ancestor
92408326|NCT01449799|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92408327|NCT01449825|Bevacizumab|bevacizumab|mesh-list
92408328|NCT01449825|Sunitinib|sunitinib|mesh-list
92408329|NCT01449825|Sorafenib|sorafenib|mesh-list
92408330|NCT01449825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408331|NCT01449825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408332|NCT01449825|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92408333|NCT01449825|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92408334|NCT01449825|Growth Substances|growth substances|mesh-ancestor
92408335|NCT01449825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408336|NCT01449825|Growth Inhibitors|growth inhibitors|mesh-ancestor
92408337|NCT01449825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92408338|NCT01449825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408339|NCT01449825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408340|NCT01449877|Trimethoprim|trimethoprim|mesh-list
92408341|NCT01449877|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92408342|NCT01449877|Sulfamethoxazole|sulfamethoxazole|mesh-list
92408343|NCT01449877|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92408344|NCT01449877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408345|NCT01449877|Antimalarials|antimalarials|mesh-ancestor
92408346|NCT01449877|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92408347|NCT01449877|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92408348|NCT01449877|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92408349|NCT01449877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408350|NCT01449877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408351|NCT01449877|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92408352|NCT01449877|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92408353|NCT01449877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92408354|NCT01449877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408355|NCT01450163|Oxaliplatin|oxaliplatin|mesh-list
92408356|NCT01450163|Pregabalin|pregabalin|mesh-list
92408357|NCT01450163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408358|NCT01450163|Analgesics|analgesics|mesh-ancestor
92408359|NCT01450163|Sensory System Agents|sensory system agents|mesh-ancestor
92408360|NCT01450163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408361|NCT01450163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408362|NCT01450163|Anticonvulsants|anticonvulsants|mesh-ancestor
92408363|NCT01450163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92408364|NCT01450163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92099042|NCT01161862|Glucagon|glucagon|mesh-list
92408365|NCT01450163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408366|NCT01450163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92408367|NCT01450163|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92408368|NCT01450163|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92408369|NCT01450163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408370|NCT01450163|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92408371|NCT01450267|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92408372|NCT01450995|Sumatriptan|sumatriptan|mesh-list
92408373|NCT01450995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92408374|NCT01450995|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92408375|NCT01450995|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92408376|NCT01450995|Serotonin Agents|serotonin agents|mesh-ancestor
92408377|NCT01450995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408378|NCT01450995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408379|NCT01450995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408380|NCT01451320|Plasminogen|plasminogen|mesh-list
92408381|NCT01451320|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92408382|NCT01451320|Streptokinase|streptokinase|mesh-list
92408383|NCT01451320|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408384|NCT01451320|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408385|NCT01451320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408400|NCT01451853|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408401|NCT01451853|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408402|NCT01451853|Analgesics|analgesics|mesh-ancestor
92408403|NCT01451853|Sensory System Agents|sensory system agents|mesh-ancestor
92408404|NCT01451853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408405|NCT01451853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408406|NCT01451853|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408407|NCT01451853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408408|NCT01451853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92408409|NCT01451853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92408410|NCT01451853|Antioxidants|antioxidants|mesh-ancestor
92408411|NCT01451853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408412|NCT01451853|Protective Agents|protective agents|mesh-ancestor
92408413|NCT01451853|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408414|NCT01451853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408415|NCT01451853|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92408416|NCT01452243|Vitamin D|vitamin d|mesh-list
92408417|NCT01452243|Calcium|calcium|mesh-list
92408418|NCT01452243|Vitamins|vitamins|mesh-ancestor
92408419|NCT01452243|Micronutrients|micronutrients|mesh-ancestor
92408420|NCT01452243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408421|NCT01452243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92408422|NCT01452243|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92408423|NCT01452256|Propofol|propofol|mesh-list
92408424|NCT01452256|Desflurane|desflurane|mesh-list
92408425|NCT01452256|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92408426|NCT01452256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408427|NCT01452256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408428|NCT01452256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92408429|NCT01452256|Anesthetics, General|anesthetics, general|mesh-ancestor
92408430|NCT01452256|Anesthetics|anesthetics|mesh-ancestor
92408431|NCT01452256|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92408432|NCT01452373|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92408433|NCT01452373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92408434|NCT01452373|Immunologic Factors|immunologic factors|mesh-ancestor
92408435|NCT01452373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408436|NCT01452607|Ebselen|ebselen|mesh-list
92408437|NCT01452607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408438|NCT01452607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408439|NCT01452607|Analgesics|analgesics|mesh-ancestor
92408440|NCT01452607|Sensory System Agents|sensory system agents|mesh-ancestor
92408441|NCT01452607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408442|NCT01452607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408443|NCT01452607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408444|NCT01452607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408445|NCT01452607|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92408446|NCT01452607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92408448|NCT01452607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408449|NCT01452607|Protective Agents|protective agents|mesh-ancestor
92408450|NCT01452607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408451|NCT01452607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408452|NCT01452607|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92408453|NCT01453062|Ofatumumab|ofatumumab|mesh-list
92408454|NCT01453062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408455|NCT01453283|Trabectedin|trabectedin|mesh-list
92408456|NCT01453283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92408457|NCT01453283|Alkylating Agents|alkylating agents|mesh-ancestor
92408458|NCT01453283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408459|NCT01453283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408460|NCT01454700|Insulin|insulin|mesh-list
92408461|NCT01454700|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92408462|NCT01454700|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92408463|NCT01454700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408465|NCT01454869|Anticoagulants|anticoagulants|mesh-ancestor
92408466|NCT01454869|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408467|NCT01454869|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408468|NCT01454869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408469|NCT05964387|Lidocaine|lidocaine|mesh-list
92408470|NCT05964387|Epinephrine|epinephrine|mesh-list
92408471|NCT05964387|Anesthetics, Local|anesthetics, local|mesh-ancestor
92408472|NCT05964387|Anesthetics|anesthetics|mesh-ancestor
92408473|NCT05964387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408474|NCT05964387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408475|NCT05964387|Sensory System Agents|sensory system agents|mesh-ancestor
92408476|NCT05964387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408477|NCT05964387|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92408478|NCT05964387|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92408479|NCT05964387|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92408480|NCT05964387|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92408481|NCT05964387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408482|NCT05964387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92408483|NCT05964387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92408484|NCT05964387|Adrenergic Agents|adrenergic agents|mesh-ancestor
92408485|NCT05964387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408486|NCT05964387|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92408487|NCT05964387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92408488|NCT05964387|Autonomic Agents|autonomic agents|mesh-ancestor
92408489|NCT05964387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92408490|NCT05964387|Respiratory System Agents|respiratory system agents|mesh-ancestor
92408491|NCT05964387|Mydriatics|mydriatics|mesh-ancestor
92408492|NCT05964387|Sympathomimetics|sympathomimetics|mesh-ancestor
92408493|NCT05964387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92408494|NCT05964361|Vaccines|vaccines|mesh-list
92408495|NCT05964361|Immunologic Factors|immunologic factors|mesh-ancestor
92408496|NCT05964361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408497|NCT05964335|Nalbuphine|nalbuphine|mesh-list
92408498|NCT05964335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92408499|NCT05964335|Narcotics|narcotics|mesh-ancestor
92408500|NCT05964335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408501|NCT05964335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408502|NCT05964335|Analgesics|analgesics|mesh-ancestor
92408503|NCT05964335|Sensory System Agents|sensory system agents|mesh-ancestor
92408504|NCT05964335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408505|NCT05964257|Botulinum Toxins|botulinum toxins|mesh-list
92408506|NCT05964257|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92408507|NCT05964257|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92408508|NCT05964257|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92408509|NCT05964257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92408510|NCT05964257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408511|NCT05964257|Cholinergic Agents|cholinergic agents|mesh-ancestor
92408512|NCT05964257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408513|NCT05964257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408514|NCT05964257|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92408515|NCT05964257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408516|NCT05964140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92408517|NCT05964140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408519|NCT05964114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408520|NCT05964114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408521|NCT05964101|Paclitaxel|paclitaxel|mesh-list
92408522|NCT05964101|Carboplatin|carboplatin|mesh-list
92408523|NCT05964101|Nivolumab|nivolumab|mesh-list
92408524|NCT05964101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92408525|NCT05964101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408526|NCT05964101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92408527|NCT05964101|Antimitotic Agents|antimitotic agents|mesh-ancestor
92408528|NCT05964101|Mitosis Modulators|mitosis modulators|mesh-ancestor
92408529|NCT05964101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408530|NCT05964101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408531|NCT05964101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92408532|NCT05963984|Fulvestrant|fulvestrant|mesh-list
92408533|NCT05963984|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92408534|NCT05963984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408535|NCT05963984|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92408536|NCT05963984|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92408537|NCT05963984|Hormone Antagonists|hormone antagonists|mesh-ancestor
92408538|NCT05963984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408539|NCT05963984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408540|NCT05963711|Chlorhexidine|chlorhexidine|mesh-list
92408541|NCT05963711|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92408542|NCT05963711|Clindamycin|clindamycin|mesh-list
92408543|NCT05963711|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92408544|NCT05963711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408545|NCT05963711|Disinfectants|disinfectants|mesh-ancestor
92408546|NCT05963711|Dermatologic Agents|dermatologic agents|mesh-ancestor
92408547|NCT05963711|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408548|NCT05963711|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92408549|NCT05963711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408550|NCT05963711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408551|NCT05963347|Prednisone|prednisone|mesh-list
92408552|NCT05963347|Cyclophosphamide|cyclophosphamide|mesh-list
92408553|NCT05963347|Doxorubicin|doxorubicin|mesh-list
92408555|NCT05963347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408556|NCT05963347|Immunologic Factors|immunologic factors|mesh-ancestor
92408557|NCT05963347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408558|NCT05963347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408559|NCT05963347|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92408560|NCT05963347|Alkylating Agents|alkylating agents|mesh-ancestor
92408561|NCT05963347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408562|NCT05963347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408563|NCT05963347|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92408564|NCT05963347|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92408565|NCT05963347|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92408566|NCT05963347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92408567|NCT05963347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408568|NCT05963347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408569|NCT05963347|Glucocorticoids|glucocorticoids|mesh-ancestor
92408570|NCT05963347|Hormones|hormones|mesh-ancestor
92408571|NCT05963347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408572|NCT05963347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92408573|NCT05963347|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92408574|NCT05963347|Tubulin Modulators|tubulin modulators|mesh-ancestor
92408575|NCT05963347|Antimitotic Agents|antimitotic agents|mesh-ancestor
92408576|NCT05963347|Mitosis Modulators|mitosis modulators|mesh-ancestor
92408577|NCT05963334|Paclitaxel|paclitaxel|mesh-list
92408578|NCT05963334|Carboplatin|carboplatin|mesh-list
92408579|NCT05963334|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92408580|NCT05963334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408581|NCT05963334|Tubulin Modulators|tubulin modulators|mesh-ancestor
92408582|NCT05963334|Antimitotic Agents|antimitotic agents|mesh-ancestor
92408583|NCT05963334|Mitosis Modulators|mitosis modulators|mesh-ancestor
92408584|NCT05963334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408585|NCT05963217|Cyclophosphamide|cyclophosphamide|mesh-list
92408586|NCT05963217|Fludarabine|fludarabine|mesh-list
92408587|NCT05963217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408588|NCT05963217|Immunologic Factors|immunologic factors|mesh-ancestor
92408589|NCT05963217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408590|NCT05963217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408591|NCT05963217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92408592|NCT05963217|Alkylating Agents|alkylating agents|mesh-ancestor
92408593|NCT05963217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408594|NCT05963217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408595|NCT05963217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92408596|NCT05963204|Mannitol|mannitol|mesh-list
92408597|NCT05963204|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91936721|NCT01536041|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91936722|NCT01536041|Respiratory System Agents|respiratory system agents|mesh-ancestor
91936723|NCT01536041|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91936724|NCT01536041|Hormone Antagonists|hormone antagonists|mesh-ancestor
91936725|NCT01536041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936726|NCT01536041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936727|NCT01536041|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91936728|NCT01536041|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91936729|NCT01536041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936730|NCT01534403|Epratuzumab|epratuzumab|mesh-list
91936731|NCT01534403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936732|NCT01534403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936733|NCT01522469|Crenolanib|crenolanib|mesh-list
91936734|NCT01522469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936735|NCT02264015|Moxifloxacin|moxifloxacin|mesh-list
91936736|NCT02264015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936737|NCT02264015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936738|NCT02264015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91936739|NCT02264015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91936740|NCT02264015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936741|NCT02264015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936742|NCT02264015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936743|NCT02264093|Propranolol|propranolol|mesh-list
91936744|NCT02264093|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91936745|NCT02264093|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91936746|NCT02264093|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936747|NCT02264093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936748|NCT02264093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936749|NCT02264093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936750|NCT02264093|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91936751|NCT02264093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91936752|NCT02264093|Vasodilator Agents|vasodilator agents|mesh-ancestor
91936753|NCT01516541|Dalcetrapib|dalcetrapib|mesh-list
91936754|NCT01516541|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91936755|NCT01516541|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91936756|NCT01516541|Antimetabolites|antimetabolites|mesh-ancestor
91936757|NCT01516541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936758|NCT01516541|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91936759|NCT01516307|Cyclophosphamide|cyclophosphamide|mesh-list
91936760|NCT01516307|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936761|NCT01516307|Immunologic Factors|immunologic factors|mesh-ancestor
91936762|NCT01516307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936763|NCT01516307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936764|NCT01516307|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91936765|NCT01516307|Alkylating Agents|alkylating agents|mesh-ancestor
91936766|NCT01516307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936767|NCT01516307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936768|NCT01516307|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91936769|NCT01516073|Fluticasone|fluticasone|mesh-list
91936770|NCT01516073|Xhance|xhance|mesh-list
91936771|NCT01516073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936772|NCT01516073|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91936773|NCT01516073|Autonomic Agents|autonomic agents|mesh-ancestor
91936774|NCT01516073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936775|NCT01516073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936776|NCT01516073|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91936777|NCT01516073|Respiratory System Agents|respiratory system agents|mesh-ancestor
91936778|NCT01516073|Dermatologic Agents|dermatologic agents|mesh-ancestor
91936779|NCT01516073|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91936780|NCT01495247|Paclitaxel|paclitaxel|mesh-list
91936781|NCT01495247|Dactolisib|dactolisib|mesh-list
91936782|NCT01495247|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91936783|NCT01495247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936784|NCT01495247|Tubulin Modulators|tubulin modulators|mesh-ancestor
92408598|NCT05963204|Diuretics|diuretics|mesh-ancestor
91936785|NCT01495247|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939735|NCT04992026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408599|NCT05963204|Natriuretic Agents|natriuretic agents|mesh-ancestor
92408600|NCT05963204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408602|NCT05963139|Bupivacaine|bupivacaine|mesh-list
92081527|NCT01920061|Docetaxel|docetaxel|mesh-list
92408603|NCT05963139|Anesthetics, Local|anesthetics, local|mesh-ancestor
92081528|NCT01920061|Gedatolisib|gedatolisib|mesh-list
92408605|NCT05963139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939755|NCT05042102|Nootropic Agents|nootropic agents|mesh-ancestor
92408606|NCT05963139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081529|NCT01920061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936786|NCT01495247|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081530|NCT01920061|Tubulin Modulators|tubulin modulators|mesh-ancestor
92081531|NCT01920061|Antimitotic Agents|antimitotic agents|mesh-ancestor
92408607|NCT05963139|Sensory System Agents|sensory system agents|mesh-ancestor
91939769|NCT04209218|Antiemetics|antiemetics|mesh-ancestor
92081573|NCT01426113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408608|NCT05963139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408609|NCT05963139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92408610|NCT05963139|Narcotics|narcotics|mesh-ancestor
92408611|NCT05963139|Analgesics|analgesics|mesh-ancestor
92408613|NCT05963087|Tislelizumab|tislelizumab|mesh-list
91939781|NCT04218968|Adrenergic Agents|adrenergic agents|mesh-ancestor
92408614|NCT05963087|Dabrafenib|dabrafenib|mesh-list
92081532|NCT01920061|Mitosis Modulators|mitosis modulators|mesh-ancestor
92408615|NCT05963087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408616|NCT05963087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408617|NCT05963087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92408619|NCT05963087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939807|NCT05026736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92408621|NCT05963074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408622|NCT05963048|Rituximab|rituximab|mesh-list
91936787|NCT01495247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939814|NCT02268058|Acetaminophen|acetaminophen|mesh-list
91936788|NCT01495013|Glimepiride|glimepiride|mesh-list
92408623|NCT05963048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936789|NCT01495013|Atorvastatin|atorvastatin|mesh-list
92074224|NCT00071890|Antiviral Agents|antiviral agents|mesh-ancestor
91939830|NCT02267746|Dermatologic Agents|dermatologic agents|mesh-ancestor
92408624|NCT05963048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408625|NCT05963048|Immunologic Factors|immunologic factors|mesh-ancestor
91939840|NCT04970108|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92408626|NCT05963048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095874|NCT01001806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095875|NCT01001806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408627|NCT05963048|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936790|NCT01495013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92408628|NCT05963022|Tirzepatide|tirzepatide|mesh-list
91939855|NCT04205552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936791|NCT01495013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92408629|NCT05963022|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936792|NCT01495013|Antimetabolites|antimetabolites|mesh-ancestor
91939866|NCT04215848|Autonomic Agents|autonomic agents|mesh-ancestor
92408630|NCT05963022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408631|NCT05963022|Incretins|incretins|mesh-ancestor
92408632|NCT05963022|Hormones|hormones|mesh-ancestor
91939885|NCT04215146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92095876|NCT01001806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91939891|NCT04214678|beta-Endorphin|beta-endorphin|mesh-list
91939897|NCT05010200|Poly ICLC|poly iclc|mesh-list
92095877|NCT01001806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939898|NCT05010200|Interferon Inducers|interferon inducers|mesh-ancestor
92074225|NCT00071890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939935|NCT04212416|Leflunomide|leflunomide|mesh-list
91939939|NCT04212416|Immunologic Factors|immunologic factors|mesh-ancestor
91939949|NCT04947254|Androgens|androgens|mesh-list
91945324|NCT00002207|Didanosine|didanosine|mesh-list
92074227|NCT01475253|Anesthetics, Local|anesthetics, local|mesh-ancestor
91939969|NCT04954664|Dimenhydrinate|dimenhydrinate|mesh-list
92408633|NCT05963022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408634|NCT05962970|Ropivacaine|ropivacaine|mesh-list
92408635|NCT05962970|Anesthetics, Local|anesthetics, local|mesh-ancestor
91939980|NCT04946864|Palbociclib|palbociclib|mesh-list
91939981|NCT04946864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095885|NCT04021264|Sensory System Agents|sensory system agents|mesh-ancestor
92074229|NCT01475253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408637|NCT05962970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408638|NCT05962970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408639|NCT05962970|Sensory System Agents|sensory system agents|mesh-ancestor
92408640|NCT05962970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408641|NCT05962957|Pentoxifylline|pentoxifylline|mesh-list
92408642|NCT05962957|Levodopa|levodopa|mesh-list
91940007|NCT05003570|Anesthetics|anesthetics|mesh-ancestor
91940011|NCT02483078|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92408643|NCT05962957|Carbidopa|carbidopa|mesh-list
91940018|NCT02452190|Reslizumab|reslizumab|mesh-list
92408644|NCT05962957|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92074230|NCT01475253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408645|NCT05962957|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91940027|NCT02514122|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92408646|NCT05962957|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91940034|NCT02514122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408648|NCT05962957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408649|NCT05962957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940059|NCT04462003|Antithrombins|antithrombins|mesh-ancestor
92408650|NCT05962957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940065|NCT03344341|Dapagliflozin|dapagliflozin|mesh-list
92074231|NCT01475253|Sensory System Agents|sensory system agents|mesh-ancestor
91940074|NCT03260881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940082|NCT03238495|Trastuzumab|trastuzumab|mesh-list
92408651|NCT05962957|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92095886|NCT04021264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095887|NCT04021264|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92408652|NCT05962957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408653|NCT05962957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91940109|NCT01869361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408654|NCT05962957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408655|NCT05962957|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92408656|NCT05962957|Protective Agents|protective agents|mesh-ancestor
91940119|NCT01578967|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92095888|NCT04021264|Narcotics|narcotics|mesh-ancestor
91940126|NCT01186003|Insulin Detemir|insulin detemir|mesh-list
91940129|NCT02322853|Tamoxifen|tamoxifen|mesh-list
92408657|NCT05962957|Vasodilator Agents|vasodilator agents|mesh-ancestor
92408658|NCT05962957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92095889|NCT04021264|Analgesics|analgesics|mesh-ancestor
92074232|NCT01475253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408660|NCT05962957|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92408661|NCT05962957|Immunologic Factors|immunologic factors|mesh-ancestor
92408662|NCT05962957|Dopamine Agonists|dopamine agonists|mesh-ancestor
92408663|NCT05962775|Ethanol|ethanol|mesh-list
92074233|NCT01475253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92095890|NCT04021264|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92408664|NCT05962775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92408665|NCT05962775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940175|NCT03488485|Sofosbuvir|sofosbuvir|mesh-list
92408666|NCT05962775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940182|NCT00821249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408667|NCT05962775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408668|NCT05962671|Analgesics, Opioid|analgesics, opioid|mesh-list
92408669|NCT05962671|Anesthetics|anesthetics|mesh-list
92408670|NCT05962671|Sevoflurane|sevoflurane|mesh-list
91932424|NCT04972123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940211|NCT04472585|Ivermectin|ivermectin|mesh-list
91940219|NCT03496519|Immunologic Factors|immunologic factors|mesh-ancestor
91940224|NCT00813605|Conatumumab|conatumumab|mesh-list
91940228|NCT00724841|Obatoclax|obatoclax|mesh-list
92095891|NCT04021264|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92095892|NCT04021264|Anesthetics, General|anesthetics, general|mesh-ancestor
92095893|NCT03233139|Paclitaxel|paclitaxel|mesh-list
91932425|NCT04972123|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92408671|NCT05962671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408672|NCT05962671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408673|NCT05962671|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92095894|NCT03233139|Gemcitabine|gemcitabine|mesh-list
91940245|NCT00805805|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92095895|NCT03233139|Pemetrexed|pemetrexed|mesh-list
92408674|NCT05962671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92408675|NCT05962671|Anesthetics, General|anesthetics, general|mesh-ancestor
92408676|NCT05962671|Narcotics|narcotics|mesh-ancestor
92408679|NCT05962671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408680|NCT05962632|Fluorides|fluorides|mesh-list
92408681|NCT05962632|Cariostatic Agents|cariostatic agents|mesh-ancestor
92408682|NCT05962632|Protective Agents|protective agents|mesh-ancestor
92408683|NCT05962632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408684|NCT05962619|Hyaluronic Acid|hyaluronic acid|mesh-list
92408685|NCT05962619|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92408686|NCT05962619|Immunologic Factors|immunologic factors|mesh-ancestor
92408687|NCT05962619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408688|NCT05962619|Viscosupplements|viscosupplements|mesh-ancestor
92408689|NCT05962619|Protective Agents|protective agents|mesh-ancestor
92408690|NCT05962502|Irinotecan|irinotecan|mesh-list
92408691|NCT05962502|Cetuximab|cetuximab|mesh-list
92408692|NCT05962502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92408693|NCT05962502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92408694|NCT05962502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408695|NCT05962502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408696|NCT05962502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408697|NCT05962502|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408698|NCT05962424|Ketamine|ketamine|mesh-list
92408699|NCT05962424|Analgesics|analgesics|mesh-ancestor
92408700|NCT05962424|Sensory System Agents|sensory system agents|mesh-ancestor
92408701|NCT05962424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408702|NCT05962424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408703|NCT05962424|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92408704|NCT05962424|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92408705|NCT05962424|Anesthetics, General|anesthetics, general|mesh-ancestor
92408706|NCT05962424|Anesthetics|anesthetics|mesh-ancestor
92408707|NCT05962424|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408708|NCT05962424|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92408709|NCT05962424|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92408710|NCT05962424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408711|NCT05962424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408712|NCT05962320|Analgesics, Opioid|analgesics, opioid|mesh-list
92408713|NCT05962320|Narcotics|narcotics|mesh-ancestor
92408714|NCT05962320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408715|NCT05962320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408716|NCT05962320|Analgesics|analgesics|mesh-ancestor
92408717|NCT05962320|Sensory System Agents|sensory system agents|mesh-ancestor
92408718|NCT05962320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408719|NCT05962255|Furosemide|furosemide|mesh-list
92408720|NCT05962255|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92408721|NCT05962255|Diuretics|diuretics|mesh-ancestor
92408722|NCT05962255|Natriuretic Agents|natriuretic agents|mesh-ancestor
92408723|NCT05962255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408724|NCT05962255|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92408725|NCT05962255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92408726|NCT05962255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408727|NCT05962229|Nicotine|nicotine|mesh-list
92408728|NCT05962229|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92408729|NCT05962229|Autonomic Agents|autonomic agents|mesh-ancestor
92408730|NCT05962229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408731|NCT05962229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408732|NCT05962229|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92408733|NCT05962229|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92408734|NCT05962229|Cholinergic Agents|cholinergic agents|mesh-ancestor
92408735|NCT05962229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408736|NCT05962229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408737|NCT05962216|Brexpiprazole|brexpiprazole|mesh-list
92408738|NCT05962216|Serotonin Agents|serotonin agents|mesh-ancestor
92408739|NCT05962216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408740|NCT05962216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408741|NCT05962216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408742|NCT05962216|Dopamine Agonists|dopamine agonists|mesh-ancestor
92408743|NCT05962216|Dopamine Agents|dopamine agents|mesh-ancestor
92408745|NCT05962151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92408746|NCT05962151|Narcotics|narcotics|mesh-ancestor
92408747|NCT05962151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408748|NCT05962151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408749|NCT05962151|Analgesics|analgesics|mesh-ancestor
92408750|NCT05962151|Sensory System Agents|sensory system agents|mesh-ancestor
92408751|NCT05962151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408752|NCT05962034|Aspirin|aspirin|mesh-list
92408753|NCT05962034|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408754|NCT05962034|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408755|NCT05962034|Analgesics|analgesics|mesh-ancestor
92408756|NCT05962034|Sensory System Agents|sensory system agents|mesh-ancestor
92408757|NCT05962034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408758|NCT05962034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408759|NCT05962034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408760|NCT05962034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408761|NCT05962034|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408762|NCT05962034|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408763|NCT05962034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408764|NCT05962034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408765|NCT05962034|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408766|NCT05962034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408767|NCT05962034|Antipyretics|antipyretics|mesh-ancestor
92408768|NCT05961761|Pembrolizumab|pembrolizumab|mesh-list
92408769|NCT05961761|Propranolol|propranolol|mesh-list
92408770|NCT05961761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408771|NCT05961761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408772|NCT05961761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92408773|NCT05961761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408774|NCT05961761|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92408775|NCT05961761|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92408776|NCT05961761|Adrenergic Agents|adrenergic agents|mesh-ancestor
92408777|NCT05961761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408778|NCT05961761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408779|NCT05961761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92408780|NCT05961761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92408781|NCT05961761|Vasodilator Agents|vasodilator agents|mesh-ancestor
92408782|NCT05961709|Cemiplimab|cemiplimab|mesh-list
92408783|NCT05961709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92408784|NCT05961709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408785|NCT05961644|Cladribine|cladribine|mesh-list
92408786|NCT05961644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408787|NCT05961644|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408788|NCT05961644|Immunologic Factors|immunologic factors|mesh-ancestor
92408789|NCT05961644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408790|NCT05961527|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92408791|NCT05961527|Hallucinogens|hallucinogens|mesh-ancestor
92408792|NCT05961527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408793|NCT05961527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92408794|NCT05961527|Serotonin Agents|serotonin agents|mesh-ancestor
92408795|NCT05961527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408796|NCT05961527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408797|NCT05961527|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92408798|NCT05961527|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92408799|NCT05961527|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92408801|NCT05961501|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92408802|NCT05961488|Calcium|calcium|mesh-list
92408803|NCT05961488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92408804|NCT05961488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408805|NCT05961202|Hydroxychloroquine|hydroxychloroquine|mesh-list
92408806|NCT05961202|Prednisolone|prednisolone|mesh-list
92408807|NCT05961202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408808|NCT05961202|Glucocorticoids|glucocorticoids|mesh-ancestor
92408809|NCT05961202|Hormones|hormones|mesh-ancestor
92408810|NCT05961202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408811|NCT05961202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408812|NCT05961202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92408813|NCT05961202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408814|NCT05961202|Antimalarials|antimalarials|mesh-ancestor
92408815|NCT05961202|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92408816|NCT05961202|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92408817|NCT05961202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408818|NCT05961202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408819|NCT05961202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408820|NCT05961202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408821|NCT05961189|Azithromycin|azithromycin|mesh-list
92408822|NCT05961189|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92408823|NCT05961189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408824|NCT05961124|Niraparib|niraparib|mesh-list
92408825|NCT05961124|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92408826|NCT05961124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408827|NCT05961124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408828|NCT05961124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408829|NCT05961059|Detox adjuvant|detox adjuvant|mesh-list
92408830|NCT05961059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92408831|NCT05961059|Immunologic Factors|immunologic factors|mesh-ancestor
92408832|NCT05961059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408833|NCT05961007|Aflibercept|aflibercept|mesh-list
92408834|NCT05961007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92408835|NCT05961007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92408836|NCT05961007|Growth Substances|growth substances|mesh-ancestor
92408837|NCT05961007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408838|NCT05961007|Growth Inhibitors|growth inhibitors|mesh-ancestor
92408839|NCT05961007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408840|NCT05960955|Docetaxel|docetaxel|mesh-list
92408841|NCT05960955|Fluorouracil|fluorouracil|mesh-list
92408842|NCT05960955|Oxaliplatin|oxaliplatin|mesh-list
92408843|NCT05960955|Tegafur|tegafur|mesh-list
92408844|NCT05960955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408845|NCT05960955|Tubulin Modulators|tubulin modulators|mesh-ancestor
92408846|NCT05960955|Antimitotic Agents|antimitotic agents|mesh-ancestor
92408847|NCT05960955|Mitosis Modulators|mitosis modulators|mesh-ancestor
92408848|NCT05960955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408849|NCT05960955|Antimetabolites|antimetabolites|mesh-ancestor
92408850|NCT05960955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92408851|NCT05960955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408852|NCT05960955|Immunologic Factors|immunologic factors|mesh-ancestor
92408853|NCT05960955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408854|NCT05960942|Sufentanil|sufentanil|mesh-list
92408855|NCT05960942|Propofol|propofol|mesh-list
92408856|NCT05960942|Esketamine|esketamine|mesh-list
92408857|NCT05960942|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92408858|NCT05960942|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92408859|NCT05960942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408860|NCT05960942|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92408861|NCT05960942|Anesthetics, General|anesthetics, general|mesh-ancestor
92408863|NCT05960942|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92408864|NCT05960942|Narcotics|narcotics|mesh-ancestor
92408865|NCT05960942|Analgesics|analgesics|mesh-ancestor
92408866|NCT05960942|Sensory System Agents|sensory system agents|mesh-ancestor
92408867|NCT05960942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408868|NCT05960942|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92408869|NCT05960942|Antidepressive Agents|antidepressive agents|mesh-ancestor
92408870|NCT05960942|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92408871|NCT05960929|Calfactant|calfactant|mesh-list
92408872|NCT05960929|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92408873|NCT05960929|Respiratory System Agents|respiratory system agents|mesh-ancestor
92408874|NCT05960864|Celecoxib|celecoxib|mesh-list
92408875|NCT05960864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408876|NCT05960864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408877|NCT05960864|Analgesics|analgesics|mesh-ancestor
92408878|NCT05960864|Sensory System Agents|sensory system agents|mesh-ancestor
92408879|NCT05960864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408880|NCT05960864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408881|NCT05960864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408882|NCT05960864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408883|NCT05960864|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92408884|NCT05960864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408885|NCT05960864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408886|NCT05960864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408887|NCT05960773|Decitabine|decitabine|mesh-list
92408888|NCT05960773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92408889|NCT05960773|Antimetabolites|antimetabolites|mesh-ancestor
92408890|NCT05960773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408891|NCT05960773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408892|NCT05960773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408893|NCT05960721|Aspirin|aspirin|mesh-list
92408894|NCT05960721|Rivaroxaban|rivaroxaban|mesh-list
92408895|NCT05960721|Clopidogrel|clopidogrel|mesh-list
92408896|NCT05960721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408897|NCT05960721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408898|NCT05960721|Analgesics|analgesics|mesh-ancestor
92408899|NCT05960721|Sensory System Agents|sensory system agents|mesh-ancestor
92408900|NCT05960721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408901|NCT05960721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408902|NCT05960721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408903|NCT05960721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408904|NCT05960721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408905|NCT05960721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408906|NCT05960721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408907|NCT05960721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408908|NCT05960721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92408909|NCT05960721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408910|NCT05960721|Antipyretics|antipyretics|mesh-ancestor
92408911|NCT05960721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92408912|NCT05960721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92408913|NCT05960721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92408914|NCT05960721|Purinergic Agents|purinergic agents|mesh-ancestor
92408915|NCT05960721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92408916|NCT05960721|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92408917|NCT05960721|Antithrombins|antithrombins|mesh-ancestor
92408918|NCT05960721|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92408919|NCT05960721|Protease Inhibitors|protease inhibitors|mesh-ancestor
92408920|NCT05960721|Anticoagulants|anticoagulants|mesh-ancestor
92408921|NCT05960708|Omalizumab|omalizumab|mesh-list
92408922|NCT05960708|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92408923|NCT05960708|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92408924|NCT05960708|Respiratory System Agents|respiratory system agents|mesh-ancestor
92408925|NCT05960656|Empagliflozin|empagliflozin|mesh-list
92408926|NCT05960656|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92408927|NCT05960656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408928|NCT05960656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92408929|NCT05960656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408930|NCT05960617|Empagliflozin|empagliflozin|mesh-list
91940269|NCT04750759|Niclosamide|niclosamide|mesh-list
92408931|NCT05960617|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92408932|NCT05960617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408933|NCT05960617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92408934|NCT05960617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408936|NCT05960578|Immunoglobulins|immunoglobulins|mesh-list
92408937|NCT05960578|Immunoglobulin G|immunoglobulin g|mesh-list
92408938|NCT05960578|Immunologic Factors|immunologic factors|mesh-ancestor
92408939|NCT05960578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408940|NCT05960578|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92408941|NCT05960578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408942|NCT05960578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408944|NCT05959720|Prednisone|prednisone|mesh-list
92408945|NCT05959720|Cyclophosphamide|cyclophosphamide|mesh-list
92408946|NCT05959720|Doxorubicin|doxorubicin|mesh-list
92408947|NCT05959720|Methotrexate|methotrexate|mesh-list
92408948|NCT05959720|Daunorubicin|daunorubicin|mesh-list
92408949|NCT05959720|Asparaginase|asparaginase|mesh-list
92408950|NCT05959720|Mercaptopurine|mercaptopurine|mesh-list
92408951|NCT05959720|Pegaspargase|pegaspargase|mesh-list
92408952|NCT05959720|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92408953|NCT05959720|Immunologic Factors|immunologic factors|mesh-ancestor
92408954|NCT05959720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408955|NCT05959720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408956|NCT05959720|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92408957|NCT05959720|Alkylating Agents|alkylating agents|mesh-ancestor
92408958|NCT05959720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408959|NCT05959720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92408960|NCT05959720|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92408961|NCT05959720|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92408962|NCT05959720|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92408963|NCT05959720|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92408964|NCT05959720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92408965|NCT05959720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408966|NCT05959720|Glucocorticoids|glucocorticoids|mesh-ancestor
92408967|NCT05959720|Hormones|hormones|mesh-ancestor
92408968|NCT05959720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92408969|NCT05959720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92408970|NCT05959720|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92408971|NCT05959720|Abortifacient Agents|abortifacient agents|mesh-ancestor
92408972|NCT05959720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92408973|NCT05959720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92408974|NCT05959720|Antimetabolites|antimetabolites|mesh-ancestor
92408975|NCT05959720|Dermatologic Agents|dermatologic agents|mesh-ancestor
92408976|NCT05959720|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92408977|NCT05959720|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92408978|NCT05959720|Antiviral Agents|antiviral agents|mesh-ancestor
92408979|NCT05959720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92408980|NCT05957926|Hyaluronic Acid|hyaluronic acid|mesh-list
92408981|NCT05957926|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92408982|NCT05957926|Immunologic Factors|immunologic factors|mesh-ancestor
92408983|NCT05957926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408984|NCT05957926|Viscosupplements|viscosupplements|mesh-ancestor
92408985|NCT05957926|Protective Agents|protective agents|mesh-ancestor
92408986|NCT05955365|Aspirin|aspirin|mesh-list
92408987|NCT05955365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92408988|NCT05955365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92408989|NCT05955365|Analgesics|analgesics|mesh-ancestor
92408990|NCT05955365|Sensory System Agents|sensory system agents|mesh-ancestor
92408991|NCT05955365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92408992|NCT05955365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92408993|NCT05955365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92408994|NCT05955365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92408995|NCT05955365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92408996|NCT05955365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92408997|NCT05955365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92408998|NCT05955365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92408999|NCT05955365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92409000|NCT05955365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409001|NCT05955365|Antipyretics|antipyretics|mesh-ancestor
92409002|NCT05954442|Everolimus|everolimus|mesh-list
92409003|NCT05954442|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92409004|NCT05954442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409006|NCT05954442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409007|NCT05954442|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409008|NCT05954442|Immunologic Factors|immunologic factors|mesh-ancestor
92409009|NCT05954442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409010|NCT05954442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409011|NCT05953766|Ropivacaine|ropivacaine|mesh-list
92409012|NCT05953766|Anesthetics, Local|anesthetics, local|mesh-ancestor
92409013|NCT05953766|Anesthetics|anesthetics|mesh-ancestor
92409014|NCT05953766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409015|NCT05953766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409016|NCT05953766|Sensory System Agents|sensory system agents|mesh-ancestor
92409017|NCT05953766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409018|NCT05938075|Vaccines|vaccines|mesh-list
92409019|NCT05938075|Immunologic Factors|immunologic factors|mesh-ancestor
92409020|NCT05938075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409021|NCT05933577|Pembrolizumab|pembrolizumab|mesh-list
92409022|NCT05933577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409023|NCT05933577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409024|NCT05933577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409025|NCT05933577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409026|NCT05930197|Bismuth|bismuth|mesh-list
92409027|NCT05930197|Bismuth subsalicylate|bismuth subsalicylate|mesh-list
92409028|NCT05930197|Antacids|antacids|mesh-ancestor
92409029|NCT05930197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409030|NCT05930197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409035|NCT05928611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409036|NCT05928611|Antiemetics|antiemetics|mesh-ancestor
92409037|NCT05928611|Autonomic Agents|autonomic agents|mesh-ancestor
92409038|NCT05928611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409039|NCT05928611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409040|NCT05928611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409041|NCT05928611|Glucocorticoids|glucocorticoids|mesh-ancestor
92409042|NCT05928611|Hormones|hormones|mesh-ancestor
92409043|NCT05928611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409044|NCT05928611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409045|NCT05928611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409046|NCT05928611|Protease Inhibitors|protease inhibitors|mesh-ancestor
92409047|NCT05928611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409048|NCT05928611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409049|NCT05918055|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92409050|NCT05918055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409051|NCT05918055|Antimetabolites|antimetabolites|mesh-ancestor
92409052|NCT05918055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409053|NCT05918055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409054|NCT05917912|Amitriptyline|amitriptyline|mesh-list
92409055|NCT05917912|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92409056|NCT05917912|Antidepressive Agents|antidepressive agents|mesh-ancestor
92409057|NCT05917912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409058|NCT05917912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92409059|NCT05917912|Analgesics|analgesics|mesh-ancestor
92409060|NCT05917912|Sensory System Agents|sensory system agents|mesh-ancestor
92409061|NCT05917912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409062|NCT05917912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409063|NCT05917912|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92409064|NCT05917912|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92409065|NCT05917912|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92409066|NCT05917912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409067|NCT05917912|Adrenergic Agents|adrenergic agents|mesh-ancestor
92409068|NCT05917912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409069|NCT05915728|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92409070|NCT05915728|Chelating Agents|chelating agents|mesh-ancestor
92409071|NCT05915728|Sequestering Agents|sequestering agents|mesh-ancestor
92409072|NCT05915728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409073|NCT05915702|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92409075|NCT05915702|Sequestering Agents|sequestering agents|mesh-ancestor
92409076|NCT05915702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409077|NCT05911295|Carboplatin|carboplatin|mesh-list
92409078|NCT05911295|Gemcitabine|gemcitabine|mesh-list
92409079|NCT05911295|Pembrolizumab|pembrolizumab|mesh-list
92409080|NCT05911295|Disitamab vedotin|disitamab vedotin|mesh-list
92409081|NCT05911295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409082|NCT05911295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409083|NCT05911295|Antimetabolites|antimetabolites|mesh-ancestor
92409084|NCT05911295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409085|NCT05911295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409086|NCT05911295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409087|NCT05911295|Immunoconjugates|immunoconjugates|mesh-ancestor
92409088|NCT05911295|Immunologic Factors|immunologic factors|mesh-ancestor
92409089|NCT05911295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409090|NCT05909904|Tislelizumab|tislelizumab|mesh-list
92409091|NCT05909904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409092|NCT05909904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409093|NCT05909397|Letrozole|letrozole|mesh-list
92409094|NCT05909397|Palbociclib|palbociclib|mesh-list
92409095|NCT05909397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409096|NCT05909397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92409097|NCT05909397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92409098|NCT05909397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409099|NCT05909397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409100|NCT05909397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92409101|NCT05909397|Hormone Antagonists|hormone antagonists|mesh-ancestor
92409102|NCT05909397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409103|NCT05909397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409104|NCT05909397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409105|NCT05907759|Daratumumab|daratumumab|mesh-list
92409106|NCT05907759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409111|NCT05907746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409112|NCT05907746|Immunologic Factors|immunologic factors|mesh-ancestor
92409113|NCT05907746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409114|NCT05907746|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409115|NCT05907746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92409116|NCT05907746|Alkylating Agents|alkylating agents|mesh-ancestor
92409117|NCT05907746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409118|NCT05907746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409119|NCT05907746|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92409120|NCT05907746|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92409121|NCT05907746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409122|NCT05907746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92409123|NCT05907746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92409124|NCT05907746|Antitubercular Agents|antitubercular agents|mesh-ancestor
92409125|NCT05907746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92409126|NCT05907746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409127|NCT05907304|Trametinib|trametinib|mesh-list
92409128|NCT05907304|Naporafenib|naporafenib|mesh-list
92409129|NCT05907304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409130|NCT05907304|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409131|NCT05907304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409132|NCT05907304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409133|NCT05904496|Tislelizumab|tislelizumab|mesh-list
92409134|NCT05904496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409135|NCT05904496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409136|NCT05899816|KHK4083|khk4083|mesh-list
92409137|NCT05899816|Dermatologic Agents|dermatologic agents|mesh-ancestor
92409138|NCT05898828|Nivolumab|nivolumab|mesh-list
92409139|NCT05898828|Entinostat|entinostat|mesh-list
92409140|NCT05898828|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92409141|NCT05898828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409142|NCT05898828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409143|NCT05898828|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409144|NCT05898828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940274|NCT04750759|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92409145|NCT05898828|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92409146|NCT05898828|Immunologic Factors|immunologic factors|mesh-ancestor
92409147|NCT05898828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409148|NCT05898828|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92409149|NCT05898828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409150|NCT05896228|Acetaminophen|acetaminophen|mesh-list
92409151|NCT05896228|Diphenhydramine|diphenhydramine|mesh-list
92409152|NCT05896228|Promethazine|promethazine|mesh-list
92409153|NCT05896228|Dexamethasone|dexamethasone|mesh-list
92409154|NCT05896228|Daratumumab|daratumumab|mesh-list
92409155|NCT05896228|Montelukast|montelukast|mesh-list
92409156|NCT05896228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409157|NCT05896228|Antiemetics|antiemetics|mesh-ancestor
92409158|NCT05896228|Autonomic Agents|autonomic agents|mesh-ancestor
92409159|NCT05896228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409160|NCT05896228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409161|NCT05896228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409162|NCT05896228|Glucocorticoids|glucocorticoids|mesh-ancestor
92409163|NCT05896228|Hormones|hormones|mesh-ancestor
92409164|NCT05896228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409165|NCT05896228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409166|NCT05896228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409167|NCT05896228|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92409168|NCT05896228|Analgesics|analgesics|mesh-ancestor
92409169|NCT05896228|Sensory System Agents|sensory system agents|mesh-ancestor
92409170|NCT05896228|Antipyretics|antipyretics|mesh-ancestor
92409171|NCT05896228|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92409172|NCT05896228|Respiratory System Agents|respiratory system agents|mesh-ancestor
92409173|NCT05896228|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92409174|NCT05896228|Hormone Antagonists|hormone antagonists|mesh-ancestor
92409175|NCT05896228|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92409176|NCT05896228|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92409177|NCT05896228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409178|NCT05896228|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92409179|NCT05896228|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92409180|NCT05896228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409181|NCT05896228|Anesthetics, Local|anesthetics, local|mesh-ancestor
92409182|NCT05896228|Anesthetics|anesthetics|mesh-ancestor
92409183|NCT05896228|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92409184|NCT05896228|Histamine Antagonists|histamine antagonists|mesh-ancestor
92409185|NCT05896228|Histamine Agents|histamine agents|mesh-ancestor
92409186|NCT05896228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409187|NCT05896228|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92409188|NCT05896228|Antipruritics|antipruritics|mesh-ancestor
92409189|NCT05896228|Dermatologic Agents|dermatologic agents|mesh-ancestor
92409192|NCT05894239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409193|NCT05894239|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92409194|NCT05894239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409195|NCT05894239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409196|NCT05889182|Upadacitinib|upadacitinib|mesh-list
92409197|NCT05889182|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92409198|NCT05889182|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409199|NCT05889182|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409200|NCT05889182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409201|NCT05889182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409202|NCT05888389|Anesthetics|anesthetics|mesh-list
92409203|NCT05888389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92409204|NCT05888389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409205|NCT05888389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409206|NCT05887726|Prednisone|prednisone|mesh-list
92409207|NCT05887726|Cyclophosphamide|cyclophosphamide|mesh-list
92409208|NCT05887726|Rituximab|rituximab|mesh-list
92409209|NCT05887726|Vincristine|vincristine|mesh-list
92409210|NCT05887726|Epirubicin|epirubicin|mesh-list
92409211|NCT05887726|Zanubrutinib|zanubrutinib|mesh-list
92409212|NCT05887726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409213|NCT05887726|Immunologic Factors|immunologic factors|mesh-ancestor
92409214|NCT05887726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409215|NCT05887726|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409216|NCT05887726|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92409217|NCT05887726|Alkylating Agents|alkylating agents|mesh-ancestor
92409218|NCT05887726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409220|NCT05887726|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92409221|NCT05887726|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409222|NCT05887726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409223|NCT05887726|Glucocorticoids|glucocorticoids|mesh-ancestor
92409224|NCT05887726|Hormones|hormones|mesh-ancestor
92409225|NCT05887726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409226|NCT05887726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409227|NCT05887726|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409228|NCT05887726|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409229|NCT05887726|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409230|NCT05887726|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409231|NCT05887726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92409232|NCT05887726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92409233|NCT05887726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92409234|NCT05887726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409235|NCT05887726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409236|NCT05879484|Pembrolizumab|pembrolizumab|mesh-list
92409237|NCT05879484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409238|NCT05879484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409239|NCT05879484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409240|NCT05879484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409241|NCT05878405|Anti-Infective Agents|anti-infective agents|mesh-list
92409242|NCT05878405|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92409243|NCT05878405|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92409244|NCT05878405|Analgesics|analgesics|mesh-list
92409245|NCT05878405|Methylene Blue|methylene blue|mesh-list
92409246|NCT05878405|Sensory System Agents|sensory system agents|mesh-ancestor
92409247|NCT05878405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409248|NCT05878405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409249|NCT05878405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409250|NCT05878405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409251|NCT05878184|Cyclophosphamide|cyclophosphamide|mesh-list
92409252|NCT05878184|Fludarabine|fludarabine|mesh-list
92409253|NCT05878184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409254|NCT05878184|Immunologic Factors|immunologic factors|mesh-ancestor
92409255|NCT05878184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409256|NCT05878184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409257|NCT05878184|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92409258|NCT05878184|Alkylating Agents|alkylating agents|mesh-ancestor
92409259|NCT05878184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409260|NCT05878184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409261|NCT05878184|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92409262|NCT05867550|Rifaximin|rifaximin|mesh-list
92409263|NCT05867550|Amitriptyline|amitriptyline|mesh-list
92409268|NCT05867550|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92409269|NCT05867550|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409270|NCT05867550|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409271|NCT05867550|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92409272|NCT05867550|Antidepressive Agents|antidepressive agents|mesh-ancestor
92409273|NCT05867550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409274|NCT05867550|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92409275|NCT05867550|Analgesics|analgesics|mesh-ancestor
92409276|NCT05867550|Sensory System Agents|sensory system agents|mesh-ancestor
92409277|NCT05867550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409278|NCT05867550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409279|NCT05867550|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92409280|NCT05867550|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92409281|NCT05867550|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92409282|NCT05867550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409283|NCT05867550|Adrenergic Agents|adrenergic agents|mesh-ancestor
92409284|NCT05867550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409285|NCT05867550|Cathartics|cathartics|mesh-ancestor
92409286|NCT05867550|Antidiarrheals|antidiarrheals|mesh-ancestor
92409287|NCT05867550|Anticonvulsants|anticonvulsants|mesh-ancestor
92409288|NCT05867550|Parasympatholytics|parasympatholytics|mesh-ancestor
92409289|NCT05867550|Autonomic Agents|autonomic agents|mesh-ancestor
92409290|NCT05864846|Cannabidiol|cannabidiol|mesh-list
92409291|NCT05864846|Anticonvulsants|anticonvulsants|mesh-ancestor
92409292|NCT05856695|Paclitaxel|paclitaxel|mesh-list
92409293|NCT05856695|Carboplatin|carboplatin|mesh-list
92409294|NCT05856695|Durvalumab|durvalumab|mesh-list
92409295|NCT05856695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409296|NCT05856695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409297|NCT05856695|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409298|NCT05856695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409299|NCT05856695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409300|NCT05856695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409301|NCT05856695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409302|NCT05854251|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92409303|NCT05854251|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409304|NCT05849753|Pancrelipase|pancrelipase|mesh-list
92409305|NCT05849753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409306|NCT05849480|Capecitabine|capecitabine|mesh-list
92409307|NCT05849480|Oxaliplatin|oxaliplatin|mesh-list
92409308|NCT05849480|Pembrolizumab|pembrolizumab|mesh-list
92409309|NCT05849480|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409310|NCT05849480|Antimetabolites|antimetabolites|mesh-ancestor
92409311|NCT05849480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409312|NCT05849480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409313|NCT05849480|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409314|NCT05849480|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409315|NCT05848947|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
92409316|NCT05848947|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92409317|NCT05848947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409318|NCT05842044|Acetaminophen|acetaminophen|mesh-list
92409319|NCT05842044|Ibuprofen|ibuprofen|mesh-list
92409320|NCT05842044|Ketorolac|ketorolac|mesh-list
92409321|NCT05842044|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92409322|NCT05842044|Oxycodone|oxycodone|mesh-list
92409323|NCT05842044|Hydromorphone|hydromorphone|mesh-list
92409324|NCT05842044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92409325|NCT05842044|Analgesics|analgesics|mesh-ancestor
92409326|NCT05842044|Sensory System Agents|sensory system agents|mesh-ancestor
92409327|NCT05842044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409328|NCT05842044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409330|NCT05842044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92409331|NCT05842044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409332|NCT05842044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409333|NCT05842044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92409334|NCT05842044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409335|NCT05842044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409336|NCT05842044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92409337|NCT05842044|Narcotics|narcotics|mesh-ancestor
92409338|NCT05842044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409339|NCT05841420|Paclitaxel|paclitaxel|mesh-list
92409340|NCT05841420|Gemcitabine|gemcitabine|mesh-list
92409341|NCT05841420|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409342|NCT05841420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409343|NCT05841420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409344|NCT05841420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409346|NCT05841420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409347|NCT05841420|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409348|NCT05841420|Antimetabolites|antimetabolites|mesh-ancestor
92409349|NCT05835284|Silicon|silicon|mesh-list
92409350|NCT05835284|Trace Elements|trace elements|mesh-ancestor
92409351|NCT05835284|Micronutrients|micronutrients|mesh-ancestor
92409352|NCT05835284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409353|NCT05818852|Moxifloxacin|moxifloxacin|mesh-list
92409354|NCT05818852|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92409355|NCT05818852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92409356|NCT05818852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409357|NCT05818852|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92409358|NCT05818852|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92409359|NCT05818852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409360|NCT05818852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409361|NCT05818852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409362|NCT05818852|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92409363|NCT05818852|Contraceptive Agents|contraceptive agents|mesh-ancestor
92409364|NCT05818852|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92409365|NCT05818852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409366|NCT05818852|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92409367|NCT05818852|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92409368|NCT05818852|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92409370|NCT05814627|Upadacitinib|upadacitinib|mesh-list
92409371|NCT05814627|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92409372|NCT05814627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409373|NCT05814627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409374|NCT05814627|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92409375|NCT05814627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409376|NCT05814627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409377|NCT05814627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409378|NCT05814146|Dialysis Solutions|dialysis solutions|mesh-list
92409379|NCT05814146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92409380|NCT05801315|Glycine|glycine|mesh-list
92409381|NCT05801315|Glycine Agents|glycine agents|mesh-ancestor
92409382|NCT05801315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409383|NCT05801315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409384|NCT05801315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409386|NCT05800275|Trastuzumab|trastuzumab|mesh-list
92409387|NCT05800275|Tucatinib|tucatinib|mesh-list
92409388|NCT05800275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409389|NCT05800275|Antimetabolites|antimetabolites|mesh-ancestor
92409390|NCT05800275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409391|NCT05800275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409392|NCT05800275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409393|NCT05800275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409394|NCT05800275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409395|NCT05798403|Solifenacin Succinate|solifenacin succinate|mesh-list
92409396|NCT05798403|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92409397|NCT05798403|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92409398|NCT05798403|Cholinergic Agents|cholinergic agents|mesh-ancestor
92409399|NCT05798403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409400|NCT05798403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409401|NCT05798403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409402|NCT05798403|Urological Agents|urological agents|mesh-ancestor
92409403|NCT05797246|Bevacizumab|bevacizumab|mesh-list
92409404|NCT05797246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409405|NCT05797246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409406|NCT05797246|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92409407|NCT05797246|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92409408|NCT05797246|Growth Substances|growth substances|mesh-ancestor
92409409|NCT05797246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409411|NCT05797233|Cyclophosphamide|cyclophosphamide|mesh-list
92409412|NCT05797233|Fludarabine|fludarabine|mesh-list
92409413|NCT05797233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409414|NCT05797233|Immunologic Factors|immunologic factors|mesh-ancestor
92409415|NCT05797233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409416|NCT05797233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409417|NCT05797233|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92409418|NCT05797233|Alkylating Agents|alkylating agents|mesh-ancestor
92409419|NCT05797233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409420|NCT05797233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409421|NCT05797233|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92409423|NCT05796388|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92409424|NCT05796388|Enzyme Activators|enzyme activators|mesh-ancestor
92409425|NCT05796388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409426|NCT05796388|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409427|NCT05796089|Carboplatin|carboplatin|mesh-list
92409428|NCT05796089|Etoposide|etoposide|mesh-list
92409429|NCT05796089|Etoposide phosphate|etoposide phosphate|mesh-list
92409430|NCT05796089|Durvalumab|durvalumab|mesh-list
92409431|NCT05796089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409432|NCT05796089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409433|NCT05796089|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92409434|NCT05796089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92409435|NCT05796089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409436|NCT05796089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409437|NCT05796089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409438|NCT05795153|Remibrutinib|remibrutinib|mesh-list
92409439|NCT05795153|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409440|NCT05795153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409441|NCT05795153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409442|NCT05783596|Obinutuzumab|obinutuzumab|mesh-list
92409443|NCT05783596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409444|NCT05783596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409445|NCT05777603|Vancomycin|vancomycin|mesh-list
92409446|NCT05777603|Aztreonam|aztreonam|mesh-list
92409447|NCT05777603|Pembrolizumab|pembrolizumab|mesh-list
92409448|NCT05777603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409449|NCT05777603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409450|NCT05777603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409451|NCT05777603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409452|NCT05777603|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92409453|NCT05777603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409454|NCT05774639|Omalizumab|omalizumab|mesh-list
92409455|NCT05774639|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92409456|NCT05774639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92409457|NCT05774639|Respiratory System Agents|respiratory system agents|mesh-ancestor
92409458|NCT05772429|Cannabidiol|cannabidiol|mesh-list
92409459|NCT05772429|Anticonvulsants|anticonvulsants|mesh-ancestor
92409460|NCT05743270|Paclitaxel|paclitaxel|mesh-list
92409461|NCT05743270|Carboplatin|carboplatin|mesh-list
92409462|NCT05743270|Nivolumab|nivolumab|mesh-list
92409463|NCT05743270|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409464|NCT05743270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409465|NCT05743270|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409466|NCT05743270|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409467|NCT05743270|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409468|NCT05743270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409469|NCT05743270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409470|NCT05743270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409471|NCT05740566|Topotecan|topotecan|mesh-list
92409472|NCT05740566|Amrubicin|amrubicin|mesh-list
92409473|NCT05740566|AMG 757|amg 757|mesh-list
92409474|NCT05740566|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92409475|NCT05740566|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92409476|NCT05740566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409477|NCT05740566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409478|NCT05740566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409479|NCT05739942|Temozolomide|temozolomide|mesh-list
92409480|NCT05739942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92409481|NCT05739942|Alkylating Agents|alkylating agents|mesh-ancestor
92409482|NCT05739942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409484|NCT05734625|Methylprednisolone|methylprednisolone|mesh-list
92409485|NCT05734625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92409486|NCT05734625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92409487|NCT05734625|Prednisolone|prednisolone|mesh-list
92409488|NCT05734625|Prednisolone acetate|prednisolone acetate|mesh-list
92409489|NCT05734625|Bupivacaine|bupivacaine|mesh-list
92409490|NCT05734625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92409491|NCT05734625|Prednisolone phosphate|prednisolone phosphate|mesh-list
92409492|NCT05734625|Anesthetics, Local|anesthetics, local|mesh-ancestor
92409493|NCT05734625|Anesthetics|anesthetics|mesh-ancestor
92409494|NCT05734625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409495|NCT05734625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409496|NCT05734625|Sensory System Agents|sensory system agents|mesh-ancestor
92409497|NCT05734625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409498|NCT05734625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409500|NCT05734625|Autonomic Agents|autonomic agents|mesh-ancestor
92409501|NCT05734625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409502|NCT05734625|Glucocorticoids|glucocorticoids|mesh-ancestor
92409503|NCT05734625|Hormones|hormones|mesh-ancestor
92409504|NCT05734625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409505|NCT05734625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92409506|NCT05734625|Protective Agents|protective agents|mesh-ancestor
92409507|NCT05734625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409508|NCT05734625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409509|NCT05733611|Bevacizumab|bevacizumab|mesh-list
92409510|NCT05733611|Atezolizumab|atezolizumab|mesh-list
91940281|NCT04750759|Antinematodal Agents|antinematodal agents|mesh-ancestor
92409511|NCT05733611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409512|NCT05733611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409513|NCT05733611|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92409514|NCT05733611|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92409515|NCT05733611|Growth Substances|growth substances|mesh-ancestor
92409516|NCT05733611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409517|NCT05733611|Growth Inhibitors|growth inhibitors|mesh-ancestor
92409518|NCT05733611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409519|NCT05733611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409520|NCT05724134|Insulin|insulin|mesh-list
92409521|NCT05724134|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92409522|NCT05724134|Octreotide|octreotide|mesh-list
92409523|NCT05724134|Glucagon|glucagon|mesh-list
92409524|NCT05724134|Hormones|hormones|mesh-list
92409525|NCT05724134|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92409526|NCT05724134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409527|NCT05724134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409528|NCT05724134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409529|NCT05724134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409530|NCT05724134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409531|NCT05713799|Thioctic Acid|thioctic acid|mesh-list
92409532|NCT05713799|Mirabegron|mirabegron|mesh-list
92409533|NCT05713799|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92409534|NCT05713799|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92409535|NCT05713799|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92409536|NCT05713799|Adrenergic Agents|adrenergic agents|mesh-ancestor
92409537|NCT05713799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409538|NCT05713799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409539|NCT05713799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409540|NCT05713799|Urological Agents|urological agents|mesh-ancestor
92409541|NCT05713799|Antioxidants|antioxidants|mesh-ancestor
92409542|NCT05713799|Protective Agents|protective agents|mesh-ancestor
92409543|NCT05713799|Vitamin B Complex|vitamin b complex|mesh-ancestor
92409544|NCT05713799|Vitamins|vitamins|mesh-ancestor
92409545|NCT05713799|Micronutrients|micronutrients|mesh-ancestor
92409546|NCT05712356|Paclitaxel|paclitaxel|mesh-list
92409547|NCT05712356|Docetaxel|docetaxel|mesh-list
92409548|NCT05712356|Gemcitabine|gemcitabine|mesh-list
92409549|NCT05712356|Durvalumab|durvalumab|mesh-list
92409550|NCT05712356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409551|NCT05712356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409552|NCT05712356|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409553|NCT05712356|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409554|NCT05712356|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409555|NCT05712356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409556|NCT05712356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409557|NCT05712356|Antimetabolites|antimetabolites|mesh-ancestor
92409558|NCT05712356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409559|NCT05712096|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92409560|NCT05712096|Antiviral Agents|antiviral agents|mesh-ancestor
92409561|NCT05712096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409562|NCT05711940|Psilocybin|psilocybin|mesh-list
92409563|NCT05711940|Hallucinogens|hallucinogens|mesh-ancestor
92409564|NCT05711940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409565|NCT05711940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409566|NCT05707377|Zanubrutinib|zanubrutinib|mesh-list
92409567|NCT05707377|Tacrolimus|tacrolimus|mesh-list
92409568|NCT05707377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409569|NCT05707377|Immunologic Factors|immunologic factors|mesh-ancestor
92409570|NCT05707377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409571|NCT05707377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92409572|NCT05707377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409573|NCT05707377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409574|NCT05707377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409575|NCT05707377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409576|NCT05686044|Phenserine|phenserine|mesh-list
92409577|NCT05686044|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92409578|NCT05686044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409579|NCT05686044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409580|NCT05686044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92409581|NCT05686044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409582|NCT05686044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409583|NCT05684055|Antihypertensive Agents|antihypertensive agents|mesh-list
92409584|NCT05683223|Sertraline|sertraline|mesh-list
92409585|NCT05683223|Antidepressive Agents|antidepressive agents|mesh-ancestor
92409586|NCT05683223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409587|NCT05683223|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92409588|NCT05683223|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92409589|NCT05683223|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92409590|NCT05683223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409591|NCT05683223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409592|NCT05683223|Serotonin Agents|serotonin agents|mesh-ancestor
92409593|NCT05683223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409594|NCT05678959|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
92409595|NCT05678959|Immunologic Factors|immunologic factors|mesh-ancestor
92409596|NCT05678959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409597|NCT05671510|Docetaxel|docetaxel|mesh-list
92409598|NCT05671510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409599|NCT05671510|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409600|NCT05671510|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409601|NCT05671510|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409602|NCT05671510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409603|NCT05671172|Bupivacaine|bupivacaine|mesh-list
92409604|NCT05671172|Anesthetics, Local|anesthetics, local|mesh-ancestor
92409605|NCT05671172|Anesthetics|anesthetics|mesh-ancestor
92409606|NCT05671172|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409607|NCT05671172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409608|NCT05671172|Sensory System Agents|sensory system agents|mesh-ancestor
92409609|NCT05671172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409611|NCT05669482|Gemcitabine|gemcitabine|mesh-list
92409612|NCT05669482|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409613|NCT05669482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409614|NCT05669482|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409615|NCT05669482|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409616|NCT05669482|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409617|NCT05669482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409618|NCT05669482|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92409619|NCT05669482|Antimetabolites|antimetabolites|mesh-ancestor
92409620|NCT05665088|Dexmedetomidine|dexmedetomidine|mesh-list
92409621|NCT05665088|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92409622|NCT05665088|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409623|NCT05665088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409624|NCT05665088|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92409625|NCT05665088|Analgesics|analgesics|mesh-ancestor
92409626|NCT05665088|Sensory System Agents|sensory system agents|mesh-ancestor
92409627|NCT05665088|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409628|NCT05665088|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92409629|NCT05665088|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92409630|NCT05665088|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92409631|NCT05665088|Adrenergic Agents|adrenergic agents|mesh-ancestor
92409632|NCT05665088|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409633|NCT05665088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409634|NCT05662306|Aripiprazole|aripiprazole|mesh-list
92409635|NCT05662306|Aripiprazole lauroxil|aripiprazole lauroxil|mesh-list
92409636|NCT05662306|Antidepressive Agents|antidepressive agents|mesh-ancestor
92409637|NCT05662306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409638|NCT05662306|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92409639|NCT05662306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92409640|NCT05662306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409641|NCT05662306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409642|NCT05662306|Dopamine Agonists|dopamine agonists|mesh-ancestor
92409643|NCT05662306|Dopamine Agents|dopamine agents|mesh-ancestor
92409644|NCT05662306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409645|NCT05662306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409646|NCT05662306|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92409647|NCT05662306|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92409648|NCT05662306|Serotonin Agents|serotonin agents|mesh-ancestor
92409649|NCT05662306|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92409725|NCT05652478|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92409650|NCT05662306|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92409651|NCT05662306|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92409652|NCT05662306|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92409653|NCT05660967|Lenalidomide|lenalidomide|mesh-list
92409654|NCT05660967|Immunologic Factors|immunologic factors|mesh-ancestor
92409655|NCT05660967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409656|NCT05660967|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91940285|NCT03382925|Lidocaine|lidocaine|mesh-list
92409657|NCT05660967|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92409658|NCT05660967|Growth Substances|growth substances|mesh-ancestor
92409659|NCT05660967|Growth Inhibitors|growth inhibitors|mesh-ancestor
92409660|NCT05660967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409661|NCT05658484|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92409662|NCT05658484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92409663|NCT05658484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409664|NCT05658484|Immunologic Factors|immunologic factors|mesh-ancestor
92409665|NCT05658484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409666|NCT05658003|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92409667|NCT05658003|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92409668|NCT05658003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409669|NCT05653401|Diclofenac|diclofenac|mesh-list
92409670|NCT05653401|Lidocaine|lidocaine|mesh-list
92409671|NCT05653401|Magnesium Sulfate|magnesium sulfate|mesh-list
92409672|NCT05653401|Anesthetics, Local|anesthetics, local|mesh-ancestor
92409673|NCT05653401|Anesthetics|anesthetics|mesh-ancestor
92409674|NCT05653401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409675|NCT05653401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409676|NCT05653401|Sensory System Agents|sensory system agents|mesh-ancestor
92409677|NCT05653401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409678|NCT05653401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92409679|NCT05653401|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92409680|NCT05653401|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92409681|NCT05653401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92409682|NCT05653401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409683|NCT05653401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92409684|NCT05653401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92409686|NCT05653401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409687|NCT05653401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409688|NCT05653401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92409689|NCT05653401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409690|NCT05653401|Anticonvulsants|anticonvulsants|mesh-ancestor
92409691|NCT05653401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92409692|NCT05653401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92409694|NCT05653401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92409695|NCT05653193|Interferons|interferons|mesh-list
92409696|NCT05653193|Interferon-gamma|interferon-gamma|mesh-list
92409697|NCT05653193|Clotrimazole|clotrimazole|mesh-list
92409698|NCT05653193|Miconazole|miconazole|mesh-list
92409699|NCT05653193|Antifungal Agents|antifungal agents|mesh-list
92409700|NCT05653193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409701|NCT05653193|Antiviral Agents|antiviral agents|mesh-ancestor
92409702|NCT05653193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409703|NCT05653193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92409704|NCT05653193|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92409705|NCT05653193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92409706|NCT05653193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409707|NCT05653193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409708|NCT05653193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92409709|NCT05653193|Hormone Antagonists|hormone antagonists|mesh-ancestor
92409710|NCT05653193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409711|NCT05653193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409712|NCT05653193|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92409713|NCT05653193|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92409714|NCT05652478|Tenofovir|tenofovir|mesh-list
92409715|NCT05652478|Dolutegravir|dolutegravir|mesh-list
92409716|NCT05652478|Antiviral Agents|antiviral agents|mesh-ancestor
92409717|NCT05652478|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409718|NCT05652478|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92409719|NCT05652478|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92409720|NCT05652478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409721|NCT05652478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409722|NCT05652478|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92409723|NCT05652478|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92409724|NCT05652478|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92409728|NCT05642195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92409729|NCT05642195|Immunologic Factors|immunologic factors|mesh-ancestor
92409730|NCT05642195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409731|NCT05622708|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92409732|NCT05622708|Immunologic Factors|immunologic factors|mesh-ancestor
92409733|NCT05622708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409734|NCT05620901|Prednisolone acetate|prednisolone acetate|mesh-list
92409735|NCT05620901|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92409736|NCT05620901|Methylprednisolone|methylprednisolone|mesh-list
92409737|NCT05620901|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92409739|NCT05620901|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92409740|NCT05620901|Prednisolone phosphate|prednisolone phosphate|mesh-list
92409741|NCT05620901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409742|NCT05620901|Antiemetics|antiemetics|mesh-ancestor
92409743|NCT05620901|Autonomic Agents|autonomic agents|mesh-ancestor
92409744|NCT05620901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409745|NCT05620901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409746|NCT05620901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409747|NCT05620901|Glucocorticoids|glucocorticoids|mesh-ancestor
92409748|NCT05620901|Hormones|hormones|mesh-ancestor
92409749|NCT05620901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409750|NCT05620901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409751|NCT05620901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409752|NCT05620901|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92409753|NCT05620901|Protective Agents|protective agents|mesh-ancestor
92409754|NCT05618353|Colchicine|colchicine|mesh-list
92409755|NCT05618353|Gout Suppressants|gout suppressants|mesh-ancestor
92409756|NCT05618353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409757|NCT05618353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409758|NCT05618353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409759|NCT05618353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409760|NCT05618353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409761|NCT05618353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409762|NCT05618314|Probenecid|probenecid|mesh-list
92409763|NCT05618314|Uricosuric Agents|uricosuric agents|mesh-ancestor
92409764|NCT05618314|Gout Suppressants|gout suppressants|mesh-ancestor
92409765|NCT05618314|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409766|NCT05617677|Deucravacitinib|deucravacitinib|mesh-list
92409767|NCT05617677|Dermatologic Agents|dermatologic agents|mesh-ancestor
92409768|NCT05617677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409769|NCT05617677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409770|NCT05617677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409771|NCT05615220|Ecopipam|ecopipam|mesh-list
92409772|NCT05615220|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92409773|NCT05615220|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92409774|NCT05615220|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409775|NCT05615220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409776|NCT05615220|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409777|NCT05615220|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92409778|NCT05615220|Dopamine Agents|dopamine agents|mesh-ancestor
92409779|NCT05615220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409780|NCT05615220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409781|NCT05613088|Paclitaxel|paclitaxel|mesh-list
92409782|NCT05613088|Doxorubicin|doxorubicin|mesh-list
92409783|NCT05613088|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92409784|NCT05613088|Topotecan|topotecan|mesh-list
92409785|NCT05613088|Farletuzumab|farletuzumab|mesh-list
92409786|NCT05613088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409787|NCT05613088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409788|NCT05613088|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409789|NCT05613088|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409790|NCT05613088|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409791|NCT05613088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409792|NCT05613088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92409793|NCT05613088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92409794|NCT05613088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92409795|NCT05613088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409796|NCT05613088|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92409797|NCT05609578|Carboplatin|carboplatin|mesh-list
92409798|NCT05609578|Pembrolizumab|pembrolizumab|mesh-list
92409799|NCT05609578|Pemetrexed|pemetrexed|mesh-list
92409800|NCT05609578|Adagrasib|adagrasib|mesh-list
92409801|NCT05609578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409802|NCT05609578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409803|NCT05609578|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409804|NCT05609578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409806|NCT05609578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92409807|NCT05609578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92409808|NCT05603754|Lorecivivint|lorecivivint|mesh-list
92409809|NCT05603754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409810|NCT05603104|Lamotrigine|lamotrigine|mesh-list
92409811|NCT05603104|Ketamine|ketamine|mesh-list
92409812|NCT05603104|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92409813|NCT05603104|Valproic Acid|valproic acid|mesh-list
92409814|NCT05603104|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92409815|NCT05603104|Clozapine|clozapine|mesh-list
92409816|NCT05603104|Antipsychotic Agents|antipsychotic agents|mesh-list
92409817|NCT05603104|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92409818|NCT05603104|Sertraline|sertraline|mesh-list
92409819|NCT05603104|Antidepressive Agents|antidepressive agents|mesh-list
92409820|NCT05603104|Esketamine|esketamine|mesh-list
92409821|NCT05603104|Escitalopram|escitalopram|mesh-list
92409822|NCT05603104|Analgesics|analgesics|mesh-ancestor
92409823|NCT05603104|Sensory System Agents|sensory system agents|mesh-ancestor
92409824|NCT05603104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409825|NCT05603104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409826|NCT05603104|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92409827|NCT05603104|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92409828|NCT05603104|Anesthetics, General|anesthetics, general|mesh-ancestor
92409829|NCT05603104|Anesthetics|anesthetics|mesh-ancestor
92409830|NCT05603104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409831|NCT05603104|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92409832|NCT05603104|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92409833|NCT05603104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409834|NCT05603104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409835|NCT05603104|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92409836|NCT05603104|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92409837|NCT05603104|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92409838|NCT05603104|Serotonin Agents|serotonin agents|mesh-ancestor
92409839|NCT05603104|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92409840|NCT05603104|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92409841|NCT05603104|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92409842|NCT05603104|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92409843|NCT05603104|Dopamine Agents|dopamine agents|mesh-ancestor
92409844|NCT05603104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409845|NCT05603104|Antimanic Agents|antimanic agents|mesh-ancestor
92409846|NCT05603104|Anticonvulsants|anticonvulsants|mesh-ancestor
92409847|NCT05603104|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92409848|NCT05603104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92409849|NCT05603104|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92409851|NCT05603104|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92409852|NCT05603104|GABA Antagonists|gaba antagonists|mesh-ancestor
92409853|NCT05601973|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
92409854|NCT05601973|Lazertinib|lazertinib|mesh-list
92409855|NCT05601973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409856|NCT05601973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409857|NCT05601973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409858|NCT05601973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409859|NCT05601973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409861|NCT05601882|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92409862|NCT05601882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92409863|NCT05601882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409864|NCT05601882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409865|NCT05601882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409866|NCT05593055|Eplerenone|eplerenone|mesh-list
92409867|NCT05593055|Chlorthalidone|chlorthalidone|mesh-list
92409868|NCT05593055|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92409869|NCT05593055|Hormone Antagonists|hormone antagonists|mesh-ancestor
92409870|NCT05593055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409871|NCT05593055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409872|NCT05593055|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92409873|NCT05593055|Diuretics|diuretics|mesh-ancestor
92409874|NCT05593055|Natriuretic Agents|natriuretic agents|mesh-ancestor
92409875|NCT05593055|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92409876|NCT05593055|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92409877|NCT05593055|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92409878|NCT05593055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409879|NCT05586789|Tryptophan|tryptophan|mesh-list
92409880|NCT05586789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92409881|NCT05586789|Antidepressive Agents|antidepressive agents|mesh-ancestor
92409884|NCT05582694|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92409885|NCT05582694|Antiviral Agents|antiviral agents|mesh-ancestor
92409886|NCT05582694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92409887|NCT05580562|TIC10 compound|tic10 compound|mesh-list
92409888|NCT05580562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409889|NCT05578976|Prednisone|prednisone|mesh-list
92409890|NCT05578976|Cyclophosphamide|cyclophosphamide|mesh-list
92409891|NCT05578976|Rituximab|rituximab|mesh-list
92409892|NCT05578976|Doxorubicin|doxorubicin|mesh-list
92409893|NCT05578976|Vincristine|vincristine|mesh-list
92409894|NCT05578976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92409895|NCT05578976|Immunologic Factors|immunologic factors|mesh-ancestor
92409896|NCT05578976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409897|NCT05578976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92409898|NCT05578976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92409899|NCT05578976|Alkylating Agents|alkylating agents|mesh-ancestor
92409900|NCT05578976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409901|NCT05578976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409902|NCT05578976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92409903|NCT05578976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409904|NCT05578976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92409905|NCT05578976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92409906|NCT05578976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92409907|NCT05578976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409908|NCT05578976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409909|NCT05578976|Glucocorticoids|glucocorticoids|mesh-ancestor
92409910|NCT05578976|Hormones|hormones|mesh-ancestor
92409911|NCT05578976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409912|NCT05578976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409913|NCT05578976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92409914|NCT05578976|Tubulin Modulators|tubulin modulators|mesh-ancestor
92409915|NCT05578976|Antimitotic Agents|antimitotic agents|mesh-ancestor
92409916|NCT05578976|Mitosis Modulators|mitosis modulators|mesh-ancestor
92409917|NCT05578092|Adagrasib|adagrasib|mesh-list
92409918|NCT05578092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409920|NCT05577702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409921|NCT05577702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409922|NCT05568888|Thrombin|thrombin|mesh-list
92409923|NCT05568888|Hemostatics|hemostatics|mesh-ancestor
92409924|NCT05568888|Coagulants|coagulants|mesh-ancestor
92409925|NCT05568550|Pembrolizumab|pembrolizumab|mesh-list
92409926|NCT05568550|Olaparib|olaparib|mesh-list
92409927|NCT05568550|Androgens|androgens|mesh-list
92409928|NCT05568550|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92409929|NCT05568550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409930|NCT05568550|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92409931|NCT05568550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409932|NCT05568550|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92409933|NCT05568550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409934|NCT05568550|Hormones|hormones|mesh-ancestor
92409935|NCT05568550|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409936|NCT05568550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409937|NCT05558956|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92409938|NCT05558956|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92409939|NCT05558956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409940|NCT05552976|Dexamethasone|dexamethasone|mesh-list
92409941|NCT05552976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92409942|NCT05552976|Antiemetics|antiemetics|mesh-ancestor
92409943|NCT05552976|Autonomic Agents|autonomic agents|mesh-ancestor
92409944|NCT05552976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409945|NCT05552976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409946|NCT05552976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92409947|NCT05552976|Glucocorticoids|glucocorticoids|mesh-ancestor
92409948|NCT05552976|Hormones|hormones|mesh-ancestor
92409949|NCT05552976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92409950|NCT05552976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92409951|NCT05552976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92409953|NCT05547542|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92409954|NCT05547542|Narcotics|narcotics|mesh-ancestor
92409955|NCT05547542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409956|NCT05547542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409957|NCT05547542|Analgesics|analgesics|mesh-ancestor
92409958|NCT05547542|Sensory System Agents|sensory system agents|mesh-ancestor
92409959|NCT05547542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409960|NCT05546554|Suvorexant|suvorexant|mesh-list
92409961|NCT05546554|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92409962|NCT05546554|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92409963|NCT05546554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409964|NCT05546554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409965|NCT05546554|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92409966|NCT05546554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409967|NCT05546554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409968|NCT05542849|Acarbose|acarbose|mesh-list
92409969|NCT05542849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92409970|NCT05542849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92409971|NCT05542849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409972|NCT05542849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92409973|NCT05542849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409974|NCT05540574|Zolpidem|zolpidem|mesh-list
92409975|NCT05540574|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92409976|NCT05540574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92409977|NCT05540574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409978|NCT05540574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409979|NCT05540574|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92409980|NCT05540574|GABA Agonists|gaba agonists|mesh-ancestor
92409981|NCT05540574|GABA Agents|gaba agents|mesh-ancestor
92409982|NCT05540574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409983|NCT05540574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409984|NCT05538910|Nicotine|nicotine|mesh-list
92409985|NCT05538910|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92409986|NCT05538910|Autonomic Agents|autonomic agents|mesh-ancestor
92409987|NCT05538910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92409988|NCT05538910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409989|NCT05538910|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92409990|NCT05538910|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92409991|NCT05538910|Cholinergic Agents|cholinergic agents|mesh-ancestor
92409992|NCT05538910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92409993|NCT05538910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92409994|NCT05537883|Bupivacaine|bupivacaine|mesh-list
92409995|NCT05537883|Anesthetics, Local|anesthetics, local|mesh-ancestor
92409996|NCT05537883|Anesthetics|anesthetics|mesh-ancestor
92409997|NCT05537883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92409998|NCT05537883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92409999|NCT05537883|Sensory System Agents|sensory system agents|mesh-ancestor
92410000|NCT05537883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410001|NCT05537766|Cyclophosphamide|cyclophosphamide|mesh-list
92410002|NCT05537766|Fludarabine|fludarabine|mesh-list
92410003|NCT05537766|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92410004|NCT05537766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410005|NCT05537766|Immunologic Factors|immunologic factors|mesh-ancestor
92410006|NCT05537766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410008|NCT05537766|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92410009|NCT05537766|Alkylating Agents|alkylating agents|mesh-ancestor
92410010|NCT05537766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410011|NCT05537766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410012|NCT05537766|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92410013|NCT05537766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410014|NCT05523934|Capsaicin|capsaicin|mesh-list
92410015|NCT05523934|Antipruritics|antipruritics|mesh-ancestor
92410016|NCT05523934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410017|NCT05523934|Sensory System Agents|sensory system agents|mesh-ancestor
92410018|NCT05523934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410019|NCT05523934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410020|NCT05519085|Dexamethasone|dexamethasone|mesh-list
92410021|NCT05519085|Bortezomib|bortezomib|mesh-list
92410023|NCT05519085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410024|NCT05519085|Antiemetics|antiemetics|mesh-ancestor
92410025|NCT05519085|Autonomic Agents|autonomic agents|mesh-ancestor
92410026|NCT05519085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410027|NCT05519085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410028|NCT05519085|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410029|NCT05519085|Glucocorticoids|glucocorticoids|mesh-ancestor
92410030|NCT05519085|Hormones|hormones|mesh-ancestor
92410031|NCT05519085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410032|NCT05519085|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410033|NCT05519085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410034|NCT05519085|Immunologic Factors|immunologic factors|mesh-ancestor
92410035|NCT05519085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410036|NCT05519085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410037|NCT05519085|Growth Substances|growth substances|mesh-ancestor
92410041|NCT05508100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410042|NCT05508100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410043|NCT05508100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410044|NCT05508100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410045|NCT05507580|Upadacitinib|upadacitinib|mesh-list
92410046|NCT05507580|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92410047|NCT05507580|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92410048|NCT05507580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410049|NCT05507580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410050|NCT05507580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92410051|NCT05501678|Diphenhydramine|diphenhydramine|mesh-list
92410052|NCT05501678|Promethazine|promethazine|mesh-list
92410053|NCT05501678|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92410054|NCT05501678|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92410055|NCT05501678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92410056|NCT05501678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410057|NCT05501678|Anesthetics, Local|anesthetics, local|mesh-ancestor
92410058|NCT05501678|Anesthetics|anesthetics|mesh-ancestor
92410059|NCT05501678|Sensory System Agents|sensory system agents|mesh-ancestor
92410060|NCT05501678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410061|NCT05501678|Antiemetics|antiemetics|mesh-ancestor
92410062|NCT05501678|Autonomic Agents|autonomic agents|mesh-ancestor
92410063|NCT05501678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410064|NCT05501678|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92410065|NCT05501678|Histamine Antagonists|histamine antagonists|mesh-ancestor
92410066|NCT05501678|Histamine Agents|histamine agents|mesh-ancestor
92410067|NCT05501678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410068|NCT05501678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410069|NCT05501678|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92410070|NCT05501678|Antipruritics|antipruritics|mesh-ancestor
92410071|NCT05501678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410073|NCT05498233|Doxylamine|doxylamine|mesh-list
92410074|NCT05498233|Vitamin B Complex|vitamin b complex|mesh-ancestor
92410075|NCT05498233|Vitamins|vitamins|mesh-ancestor
92410076|NCT05498233|Micronutrients|micronutrients|mesh-ancestor
92410077|NCT05498233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410078|NCT05498233|Antiemetics|antiemetics|mesh-ancestor
92410079|NCT05498233|Autonomic Agents|autonomic agents|mesh-ancestor
92410080|NCT05498233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410082|NCT05498233|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92410083|NCT05498233|Histamine Antagonists|histamine antagonists|mesh-ancestor
92410084|NCT05498233|Histamine Agents|histamine agents|mesh-ancestor
92410085|NCT05498233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410086|NCT05498233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410087|NCT05469737|Azacitidine|azacitidine|mesh-list
92410088|NCT05469737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92410089|NCT05469737|Antimetabolites|antimetabolites|mesh-ancestor
92410090|NCT05469737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410091|NCT05469737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410092|NCT05469737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410093|NCT05465317|Empagliflozin|empagliflozin|mesh-list
92410094|NCT05465317|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92410095|NCT05465317|Glucagon|glucagon|mesh-list
92410096|NCT05465317|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92410097|NCT05465317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410098|NCT05465317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410099|NCT05465317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410100|NCT05465317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410101|NCT05465317|Hormones|hormones|mesh-ancestor
92410102|NCT05465317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410103|NCT05465317|Incretins|incretins|mesh-ancestor
92410104|NCT05459571|Dexamethasone|dexamethasone|mesh-list
92410105|NCT05459571|Cyclophosphamide|cyclophosphamide|mesh-list
92410106|NCT05459571|Fludarabine|fludarabine|mesh-list
92410107|NCT05459571|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92410108|NCT05459571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410109|NCT05459571|Immunologic Factors|immunologic factors|mesh-ancestor
92410110|NCT05459571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410111|NCT05459571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92410112|NCT05459571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92410113|NCT05459571|Alkylating Agents|alkylating agents|mesh-ancestor
92410114|NCT05459571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410115|NCT05459571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410116|NCT05459571|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92410117|NCT05459571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410120|NCT05459571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410121|NCT05459571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410122|NCT05459571|Glucocorticoids|glucocorticoids|mesh-ancestor
92410123|NCT05459571|Hormones|hormones|mesh-ancestor
92410124|NCT05459571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410125|NCT05459571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410126|NCT05459571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410127|NCT05450562|Atezolizumab|atezolizumab|mesh-list
92410128|NCT05450562|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410129|NCT05450562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410130|NCT05450562|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410131|NCT05450562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410132|NCT05434000|Hydroxyurea|hydroxyurea|mesh-list
92410133|NCT05434000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410134|NCT05434000|Antisickling Agents|antisickling agents|mesh-ancestor
92410135|NCT05434000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410136|NCT05434000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940328|NCT00796289|Sequestering Agents|sequestering agents|mesh-ancestor
92410137|NCT05434000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92410138|NCT05433480|Fulvestrant|fulvestrant|mesh-list
92410139|NCT05433480|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410140|NCT05433480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410141|NCT05433480|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92410142|NCT05433480|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92410143|NCT05433480|Hormone Antagonists|hormone antagonists|mesh-ancestor
92410144|NCT05433480|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410145|NCT05433480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410146|NCT05430438|Dialysis Solutions|dialysis solutions|mesh-list
92410147|NCT05430438|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92410148|NCT05428215|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92410150|NCT05428215|Estradiol|estradiol|mesh-list
92410151|NCT05428215|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92410152|NCT05428215|Estrogens|estrogens|mesh-ancestor
92410153|NCT05428215|Hormones|hormones|mesh-ancestor
92410154|NCT05428215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410155|NCT05428215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410156|NCT05428215|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92410157|NCT05428215|Contraceptive Agents|contraceptive agents|mesh-ancestor
92410158|NCT05428215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92410159|NCT05428215|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92410160|NCT05417646|Empagliflozin|empagliflozin|mesh-list
92410161|NCT05417646|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92410162|NCT05417646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410163|NCT05417646|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410164|NCT05417646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410165|NCT05412173|Molnupiravir|molnupiravir|mesh-list
92410166|NCT05412173|Antiviral Agents|antiviral agents|mesh-ancestor
92410167|NCT05412173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410168|NCT05409066|Rituximab|rituximab|mesh-list
92410169|NCT05409066|Lenalidomide|lenalidomide|mesh-list
92410170|NCT05409066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410171|NCT05409066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410172|NCT05409066|Immunologic Factors|immunologic factors|mesh-ancestor
92410173|NCT05409066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410174|NCT05409066|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92410175|NCT05409066|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410176|NCT05409066|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410177|NCT05409066|Growth Substances|growth substances|mesh-ancestor
92410178|NCT05409066|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410179|NCT05396859|Decitabine|decitabine|mesh-list
92410180|NCT05396859|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92410181|NCT05396859|Entrectinib|entrectinib|mesh-list
92410182|NCT05396859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92410183|NCT05396859|Antimetabolites|antimetabolites|mesh-ancestor
92410184|NCT05396859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410185|NCT05396859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410186|NCT05396859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410187|NCT05396859|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92410188|NCT05390892|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92410189|NCT05390892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410190|NCT05390892|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410191|NCT05390892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410194|NCT05383456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410195|NCT05380453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92410196|NCT05380453|Immunologic Factors|immunologic factors|mesh-ancestor
92410197|NCT05380453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410198|NCT05378113|Lidocaine|lidocaine|mesh-list
92410199|NCT05378113|Ondansetron|ondansetron|mesh-list
92410200|NCT05378113|Anesthetics, Local|anesthetics, local|mesh-ancestor
92410201|NCT05378113|Anesthetics|anesthetics|mesh-ancestor
92410202|NCT05378113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92410203|NCT05378113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410204|NCT05378113|Sensory System Agents|sensory system agents|mesh-ancestor
92410205|NCT05378113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410206|NCT05378113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92410207|NCT05378113|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92410208|NCT05378113|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92410209|NCT05378113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92410210|NCT05378113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410211|NCT05378113|Antiemetics|antiemetics|mesh-ancestor
92410212|NCT05378113|Autonomic Agents|autonomic agents|mesh-ancestor
92410213|NCT05378113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410214|NCT05378113|Antipruritics|antipruritics|mesh-ancestor
92410215|NCT05378113|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410216|NCT05378113|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92410217|NCT05378113|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92410218|NCT05378113|Serotonin Agents|serotonin agents|mesh-ancestor
92410219|NCT05378113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410220|NCT05375825|LMB-100|lmb-100|mesh-list
92410221|NCT05375825|Immunoconjugates|immunoconjugates|mesh-ancestor
92410222|NCT05375825|Immunologic Factors|immunologic factors|mesh-ancestor
92410223|NCT05375825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410224|NCT05374538|Sotorasib|sotorasib|mesh-list
92410225|NCT05374538|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410226|NCT05374538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410227|NCT05374538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410228|NCT05374538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410229|NCT05351801|Dronabinol|dronabinol|mesh-list
92410230|NCT05351801|Nabiximols|nabiximols|mesh-list
92410231|NCT05351801|Hallucinogens|hallucinogens|mesh-ancestor
92410232|NCT05351801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410233|NCT05351801|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92410234|NCT05351801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92410235|NCT05351801|Analgesics|analgesics|mesh-ancestor
92410236|NCT05351801|Sensory System Agents|sensory system agents|mesh-ancestor
92410237|NCT05351801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410238|NCT05351801|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92410239|NCT05351801|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92410240|NCT05351801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410241|NCT05351801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410242|NCT05351801|Hormones|hormones|mesh-ancestor
92410243|NCT05351801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410244|NCT05335941|Pemetrexed|pemetrexed|mesh-list
92410245|NCT05335941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410246|NCT05335941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410247|NCT05335941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410248|NCT05335941|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92410249|NCT05335941|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92410250|NCT05330429|Leucovorin|leucovorin|mesh-list
92410251|NCT05330429|Bevacizumab|bevacizumab|mesh-list
92410252|NCT05330429|Magrolimab|magrolimab|mesh-list
92410253|NCT05330429|Fluorouracil|fluorouracil|mesh-list
92410254|NCT05330429|Irinotecan|irinotecan|mesh-list
92410255|NCT05330429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410256|NCT05330429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410257|NCT05330429|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410258|NCT05330429|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410259|NCT05330429|Growth Substances|growth substances|mesh-ancestor
92410260|NCT05330429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410261|NCT05330429|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410262|NCT05330429|Antimetabolites|antimetabolites|mesh-ancestor
92410263|NCT05330429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410264|NCT05330429|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92410265|NCT05330429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410266|NCT05330429|Immunologic Factors|immunologic factors|mesh-ancestor
92410267|NCT05330429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92410268|NCT05330429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92410278|NCT05328908|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410279|NCT05328908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410280|NCT05328908|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410281|NCT05328908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410282|NCT05328908|Antimetabolites|antimetabolites|mesh-ancestor
92410284|NCT05328908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410285|NCT05315713|Atezolizumab|atezolizumab|mesh-list
92410286|NCT05315713|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410287|NCT05315713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410288|NCT05315713|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410289|NCT05315713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410290|NCT05314374|Bile Acids and Salts|bile acids and salts|mesh-list
92410291|NCT05314374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410292|NCT05306340|Tamoxifen|tamoxifen|mesh-list
92410293|NCT05306340|Dexamethasone|dexamethasone|mesh-list
92410294|NCT05306340|Fulvestrant|fulvestrant|mesh-list
92410295|NCT05306340|Everolimus|everolimus|mesh-list
92410296|NCT05306340|Exemestane|exemestane|mesh-list
92410297|NCT05306340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410298|NCT05306340|Antiemetics|antiemetics|mesh-ancestor
92410299|NCT05306340|Autonomic Agents|autonomic agents|mesh-ancestor
92410300|NCT05306340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410301|NCT05306340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410302|NCT05306340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410303|NCT05306340|Glucocorticoids|glucocorticoids|mesh-ancestor
92410304|NCT05306340|Hormones|hormones|mesh-ancestor
92410305|NCT05306340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410306|NCT05306340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410307|NCT05306340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410308|NCT05306340|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92410309|NCT05306340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92410310|NCT05306340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410311|NCT05306340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410312|NCT05306340|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410313|NCT05306340|Immunologic Factors|immunologic factors|mesh-ancestor
92410314|NCT05306340|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92410315|NCT05306340|Hormone Antagonists|hormone antagonists|mesh-ancestor
92410316|NCT05306340|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92410317|NCT05306340|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92410318|NCT05306340|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92410319|NCT05306340|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92410320|NCT05306340|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92410321|NCT05306340|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92410322|NCT05300048|Paclitaxel|paclitaxel|mesh-list
92410323|NCT05300048|Serabelisib|serabelisib|mesh-list
92410324|NCT05300048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92410325|NCT05300048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410326|NCT05300048|Tubulin Modulators|tubulin modulators|mesh-ancestor
92410327|NCT05300048|Antimitotic Agents|antimitotic agents|mesh-ancestor
92410328|NCT05300048|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410329|NCT05300048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410330|NCT05300048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410331|NCT05298592|Paclitaxel|paclitaxel|mesh-list
92410332|NCT05298592|Carboplatin|carboplatin|mesh-list
92410333|NCT05298592|Nivolumab|nivolumab|mesh-list
92410334|NCT05298592|Pemetrexed|pemetrexed|mesh-list
92410335|NCT05298592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92410336|NCT05298592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410337|NCT05298592|Tubulin Modulators|tubulin modulators|mesh-ancestor
92410338|NCT05298592|Antimitotic Agents|antimitotic agents|mesh-ancestor
92410339|NCT05298592|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410340|NCT05298592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410341|NCT05298592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410342|NCT05298592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410343|NCT05298592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410344|NCT05298592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92410345|NCT05298592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92410346|NCT05289323|Neostigmine|neostigmine|mesh-list
92410347|NCT05289323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92410348|NCT05289323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410349|NCT05289323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410350|NCT05289323|Cholinergic Agents|cholinergic agents|mesh-ancestor
92410351|NCT05289323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410352|NCT05289323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410353|NCT05289323|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92410355|NCT05289323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410356|NCT05286827|Olaparib|olaparib|mesh-list
92410357|NCT05286827|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92410358|NCT05286827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410359|NCT05286827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410360|NCT05286827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410362|NCT05282121|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92410363|NCT05282121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410364|NCT05282121|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410365|NCT05282121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410366|NCT05275738|Niacinamide|niacinamide|mesh-list
92410368|NCT05275738|Nicotinic Acids|nicotinic acids|mesh-list
92410369|NCT05275738|Vitamin B Complex|vitamin b complex|mesh-ancestor
92410370|NCT05275738|Vitamins|vitamins|mesh-ancestor
92410371|NCT05275738|Micronutrients|micronutrients|mesh-ancestor
92410372|NCT05275738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410373|NCT05275738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92410374|NCT05275738|Antimetabolites|antimetabolites|mesh-ancestor
92410375|NCT05275738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410376|NCT05275738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92410377|NCT05275738|Vasodilator Agents|vasodilator agents|mesh-ancestor
92410378|NCT05271552|Dexmedetomidine|dexmedetomidine|mesh-list
92410379|NCT05271552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92410380|NCT05271552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92410381|NCT05271552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410382|NCT05271552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92410383|NCT05271552|Analgesics|analgesics|mesh-ancestor
92410384|NCT05271552|Sensory System Agents|sensory system agents|mesh-ancestor
92410385|NCT05271552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410386|NCT05271552|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92410387|NCT05271552|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92410388|NCT05271552|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92410389|NCT05271552|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410390|NCT05271552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410391|NCT05271552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410393|NCT05269849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92410394|NCT05269849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410395|NCT05269849|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92410396|NCT05269849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410397|NCT05269849|Antifungal Agents|antifungal agents|mesh-ancestor
92410398|NCT05269849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410399|NCT05269849|Immunologic Factors|immunologic factors|mesh-ancestor
92410400|NCT05269849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410401|NCT05267470|Paclitaxel|paclitaxel|mesh-list
92410402|NCT05267470|Docetaxel|docetaxel|mesh-list
92410403|NCT05267470|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92410404|NCT05267470|Carboplatin|carboplatin|mesh-list
92410405|NCT05267470|Pembrolizumab|pembrolizumab|mesh-list
92410406|NCT05267470|Bemarituzumab|bemarituzumab|mesh-list
92410407|NCT05267470|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92410408|NCT05267470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410409|NCT05267470|Tubulin Modulators|tubulin modulators|mesh-ancestor
92410410|NCT05267470|Antimitotic Agents|antimitotic agents|mesh-ancestor
92410411|NCT05267470|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410412|NCT05267470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410413|NCT05267470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410414|NCT05267470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410415|NCT05264168|Rivaroxaban|rivaroxaban|mesh-list
92410416|NCT05264168|Apixaban|apixaban|mesh-list
92410417|NCT05264168|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92410418|NCT05264168|Antithrombins|antithrombins|mesh-ancestor
92410419|NCT05264168|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92410420|NCT05264168|Protease Inhibitors|protease inhibitors|mesh-ancestor
92410421|NCT05264168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410422|NCT05264168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410423|NCT05264168|Anticoagulants|anticoagulants|mesh-ancestor
92410424|NCT05259839|Dexamethasone|dexamethasone|mesh-list
92410425|NCT05259839|Lenalidomide|lenalidomide|mesh-list
92410426|NCT05259839|Daratumumab|daratumumab|mesh-list
92410427|NCT05259839|Pomalidomide|pomalidomide|mesh-list
92410428|NCT05259839|Nirogacestat|nirogacestat|mesh-list
92410429|NCT05259839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410430|NCT05259839|Antiemetics|antiemetics|mesh-ancestor
92410431|NCT05259839|Autonomic Agents|autonomic agents|mesh-ancestor
92410432|NCT05259839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410433|NCT05259839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410434|NCT05259839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410435|NCT05259839|Glucocorticoids|glucocorticoids|mesh-ancestor
92410437|NCT05259839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410438|NCT05259839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410439|NCT05259839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410440|NCT05259839|Immunologic Factors|immunologic factors|mesh-ancestor
92410441|NCT05259839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410442|NCT05259839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410443|NCT05259839|Growth Substances|growth substances|mesh-ancestor
92410444|NCT05259839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410445|NCT05259839|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92410446|NCT05259839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410447|NCT05259839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410448|NCT05257408|Paclitaxel|paclitaxel|mesh-list
92410449|NCT05257408|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92410450|NCT05257408|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92410451|NCT05257408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410452|NCT05257408|Tubulin Modulators|tubulin modulators|mesh-ancestor
92410453|NCT05257408|Antimitotic Agents|antimitotic agents|mesh-ancestor
92410454|NCT05257408|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410455|NCT05257408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410456|NCT05256797|Rivaroxaban|rivaroxaban|mesh-list
92410457|NCT05256797|Apixaban|apixaban|mesh-list
92410458|NCT05256797|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92410459|NCT05256797|Antithrombins|antithrombins|mesh-ancestor
92410460|NCT05256797|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92410461|NCT05256797|Protease Inhibitors|protease inhibitors|mesh-ancestor
92410462|NCT05256797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410463|NCT05256797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410464|NCT05256797|Anticoagulants|anticoagulants|mesh-ancestor
92410465|NCT05220722|Pembrolizumab|pembrolizumab|mesh-list
92410466|NCT05220722|Nivolumab|nivolumab|mesh-list
92410467|NCT05220722|Ipilimumab|ipilimumab|mesh-list
92410468|NCT05220722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410469|NCT05220722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410470|NCT05220722|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410471|NCT05220722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410472|NCT05213650|Methamphetamine|methamphetamine|mesh-list
92410473|NCT05213650|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92410474|NCT05213650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410475|NCT05213650|Sympathomimetics|sympathomimetics|mesh-ancestor
92410476|NCT05213650|Autonomic Agents|autonomic agents|mesh-ancestor
92410477|NCT05213650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410478|NCT05213650|Dopamine Agents|dopamine agents|mesh-ancestor
92410479|NCT05213650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410480|NCT05213650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410481|NCT05213650|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410482|NCT05213650|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92410483|NCT05213650|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92410484|NCT05213650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92410485|NCT05213650|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92410486|NCT05203510|Treprostinil|treprostinil|mesh-list
92410487|NCT05203510|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92410488|NCT05201547|Paclitaxel|paclitaxel|mesh-list
92410489|NCT05201547|Carboplatin|carboplatin|mesh-list
92410490|NCT05201547|Dostarlimab|dostarlimab|mesh-list
92410491|NCT05201547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92410492|NCT05201547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410493|NCT05201547|Tubulin Modulators|tubulin modulators|mesh-ancestor
92410494|NCT05201547|Antimitotic Agents|antimitotic agents|mesh-ancestor
92410495|NCT05201547|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410496|NCT05201547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410497|NCT05179512|Fluticasone|fluticasone|mesh-list
92410498|NCT05179512|Tiotropium Bromide|tiotropium bromide|mesh-list
92410499|NCT05179512|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92410500|NCT05179512|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92410501|NCT05179512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410502|NCT05179512|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92410503|NCT05179512|Autonomic Agents|autonomic agents|mesh-ancestor
92410504|NCT05179512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410505|NCT05179512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410506|NCT05179512|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92410507|NCT05179512|Respiratory System Agents|respiratory system agents|mesh-ancestor
92410508|NCT05179512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410511|NCT05179512|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92410512|NCT05179512|Cholinergic Agents|cholinergic agents|mesh-ancestor
92410513|NCT05179512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410514|NCT05179512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410515|NCT05179512|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92410516|NCT05179512|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92410517|NCT05179512|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92410518|NCT05179512|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410520|NCT05179512|Hormones|hormones|mesh-ancestor
92410521|NCT05179512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410522|NCT05179512|Sympathomimetics|sympathomimetics|mesh-ancestor
92410523|NCT05164081|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92410524|NCT05164081|Clindamycin|clindamycin|mesh-list
92410525|NCT05164081|Clindamycin palmitate|clindamycin palmitate|mesh-list
92410526|NCT05164081|Clindamycin phosphate|clindamycin phosphate|mesh-list
92410527|NCT05164081|Gentamicins|gentamicins|mesh-list
92410528|NCT05164081|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92410529|NCT05164081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410530|NCT05164081|Antitubercular Agents|antitubercular agents|mesh-ancestor
92410531|NCT05164081|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92410532|NCT05164081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410533|NCT05164081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410534|NCT05162976|Nivolumab|nivolumab|mesh-list
92410535|NCT05162976|Azacitidine|azacitidine|mesh-list
92410536|NCT05162976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410537|NCT05162976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410538|NCT05162976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410539|NCT05162976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410540|NCT05162976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92410541|NCT05162976|Antimetabolites|antimetabolites|mesh-ancestor
92410542|NCT05162976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410543|NCT05162183|Liraglutide|liraglutide|mesh-list
92410544|NCT05162183|Glimepiride|glimepiride|mesh-list
92410545|NCT05162183|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410546|NCT05162183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410547|NCT05162183|Incretins|incretins|mesh-ancestor
92410548|NCT05162183|Hormones|hormones|mesh-ancestor
92410549|NCT05162183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410550|NCT05162183|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92410551|NCT05162183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410552|NCT05162183|Immunologic Factors|immunologic factors|mesh-ancestor
92410553|NCT05153395|Insulin|insulin|mesh-list
92410554|NCT05153395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92410555|NCT05153395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410556|NCT05153395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410557|NCT05130268|Dronedarone|dronedarone|mesh-list
92410558|NCT05130268|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92410559|NCT05128162|Psilocybin|psilocybin|mesh-list
92410560|NCT05128162|Hallucinogens|hallucinogens|mesh-ancestor
92410561|NCT05128162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410562|NCT05128162|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92410563|NCT05113745|Reboxetine|reboxetine|mesh-list
92410564|NCT05113745|Antidepressive Agents|antidepressive agents|mesh-ancestor
92410565|NCT05113745|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92410566|NCT05113745|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92410567|NCT05113745|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92410568|NCT05113745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92410569|NCT05113745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410570|NCT05113745|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410571|NCT05113745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410572|NCT05113745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410573|NCT05112965|Atezolizumab|atezolizumab|mesh-list
92410574|NCT05112965|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410575|NCT05112965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410576|NCT05112965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410577|NCT05112965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410578|NCT05100862|Rituximab|rituximab|mesh-list
92410579|NCT05100862|Obinutuzumab|obinutuzumab|mesh-list
92410580|NCT05100862|Lenalidomide|lenalidomide|mesh-list
92410582|NCT05100862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410583|NCT05100862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410584|NCT05100862|Immunologic Factors|immunologic factors|mesh-ancestor
92410585|NCT05100862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410586|NCT05100862|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92410587|NCT05100862|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410588|NCT05100862|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410589|NCT05100862|Growth Substances|growth substances|mesh-ancestor
92410590|NCT05100862|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410591|NCT05100862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92410592|NCT05100862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410593|NCT05100862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410594|NCT05099198|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92410596|NCT05099198|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410597|NCT05099198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410598|NCT05099198|Incretins|incretins|mesh-ancestor
92410599|NCT05099198|Hormones|hormones|mesh-ancestor
92410600|NCT05099198|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410601|NCT05099198|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92410602|NCT05099198|Protease Inhibitors|protease inhibitors|mesh-ancestor
92410603|NCT05099198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410604|NCT05099198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410605|NCT05099198|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92410606|NCT05099198|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410607|NCT05099198|Immunologic Factors|immunologic factors|mesh-ancestor
92410608|NCT05088798|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92410609|NCT05088798|Dopamine Agents|dopamine agents|mesh-ancestor
92410610|NCT05088798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410611|NCT05088798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410612|NCT05088798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410613|NCT05087992|Bevacizumab|bevacizumab|mesh-list
92410614|NCT05087992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410615|NCT05087992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410616|NCT05087992|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410617|NCT05087992|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410618|NCT05087992|Growth Substances|growth substances|mesh-ancestor
92410619|NCT05087992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410620|NCT05087992|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410621|NCT05086081|Ticagrelor|ticagrelor|mesh-list
92410622|NCT05086081|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92410623|NCT05086081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92410624|NCT05086081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92410625|NCT05086081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92410626|NCT05086081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92410627|NCT05086081|Purinergic Agents|purinergic agents|mesh-ancestor
92410628|NCT05086081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410629|NCT05086081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410630|NCT05086081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410631|NCT05083949|Metformin|metformin|mesh-list
92410632|NCT05083949|Empagliflozin|empagliflozin|mesh-list
92410633|NCT05083949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410634|NCT05083949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410635|NCT05083949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92410636|NCT05083949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410637|NCT05083455|Enoxaparin|enoxaparin|mesh-list
92410638|NCT05083455|Rivaroxaban|rivaroxaban|mesh-list
92410639|NCT05083455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92410640|NCT05083455|Antithrombins|antithrombins|mesh-ancestor
92410641|NCT05083455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92410642|NCT05083455|Protease Inhibitors|protease inhibitors|mesh-ancestor
92410643|NCT05083455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410644|NCT05083455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410645|NCT05083455|Anticoagulants|anticoagulants|mesh-ancestor
92410646|NCT05083455|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92410647|NCT05083455|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92410648|NCT05083429|Tiotropium Bromide|tiotropium bromide|mesh-list
92410649|NCT05083429|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92410650|NCT05083429|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92410651|NCT05083429|Autonomic Agents|autonomic agents|mesh-ancestor
92410652|NCT05083429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940333|NCT00796289|Hormone Antagonists|hormone antagonists|mesh-ancestor
92410653|NCT05083429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410654|NCT05083429|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92410655|NCT05083429|Respiratory System Agents|respiratory system agents|mesh-ancestor
92410656|NCT05083429|Parasympatholytics|parasympatholytics|mesh-ancestor
92410657|NCT05083429|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92410658|NCT05083429|Cholinergic Agents|cholinergic agents|mesh-ancestor
92410659|NCT05083429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410660|NCT05083429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410661|NCT05083429|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92410662|NCT05083429|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92410663|NCT05083429|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92410664|NCT05083429|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410665|NCT05078879|Empagliflozin|empagliflozin|mesh-list
92410666|NCT05078879|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92410667|NCT05078879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410668|NCT05078879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410669|NCT05078879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410670|NCT05075980|Cisplatin|cisplatin|mesh-list
92410671|NCT05075980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410672|NCT05073237|Bazedoxifene|bazedoxifene|mesh-list
92410673|NCT05073237|Estrogens|estrogens|mesh-list
92410674|NCT05073237|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92410675|NCT05073237|Hormones|hormones|mesh-ancestor
92410676|NCT05073237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410677|NCT05073237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410678|NCT05073237|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92410679|NCT05073237|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92410680|NCT05073237|Hormone Antagonists|hormone antagonists|mesh-ancestor
92410681|NCT05073237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92410682|NCT05067634|Cenobamate|cenobamate|mesh-list
92410683|NCT05067634|Anticonvulsants|anticonvulsants|mesh-ancestor
92410684|NCT05063201|Cariprazine|cariprazine|mesh-list
92410685|NCT05063201|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92410686|NCT05063201|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92410687|NCT05063201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92410688|NCT05063201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410689|NCT05063201|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92410690|NCT05062304|Fluticasone|fluticasone|mesh-list
92410692|NCT05062304|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410693|NCT05062304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92410694|NCT05062304|Autonomic Agents|autonomic agents|mesh-ancestor
92410695|NCT05062304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410696|NCT05062304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410697|NCT05062304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92410698|NCT05062304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92410699|NCT05062304|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410700|NCT05062304|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92410701|NCT05052801|Bemarituzumab|bemarituzumab|mesh-list
92410702|NCT05052801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410703|NCT05052801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410704|NCT05042440|Factor VIII|factor viii|mesh-list
92410705|NCT05042440|BAX 855|bax 855|mesh-list
92410706|NCT05042440|Coagulants|coagulants|mesh-ancestor
92410707|NCT05029466|Psilocybin|psilocybin|mesh-list
92410708|NCT05029466|Hallucinogens|hallucinogens|mesh-ancestor
92410709|NCT05029466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410710|NCT05029466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92410711|NCT05018481|Hyaluronic Acid|hyaluronic acid|mesh-list
92410712|NCT05018481|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92410713|NCT05018481|Immunologic Factors|immunologic factors|mesh-ancestor
92410714|NCT05018481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410715|NCT05018481|Viscosupplements|viscosupplements|mesh-ancestor
92410716|NCT05018481|Protective Agents|protective agents|mesh-ancestor
92410717|NCT05004259|Daratumumab|daratumumab|mesh-list
92410718|NCT05004259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410719|NCT05002569|Nivolumab|nivolumab|mesh-list
92410720|NCT05002569|Relatlimab|relatlimab|mesh-list
92410721|NCT05002569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410722|NCT05002569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410723|NCT05002569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410724|NCT05002569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410725|NCT05001750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92410726|NCT05001750|Doxycycline|doxycycline|mesh-list
92410727|NCT05001750|Nafcillin|nafcillin|mesh-list
92410728|NCT05001750|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92410729|NCT05001750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410730|NCT05001750|Antitubercular Agents|antitubercular agents|mesh-ancestor
92410731|NCT05001750|Antimalarials|antimalarials|mesh-ancestor
92410732|NCT05001750|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92410733|NCT05001750|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92410734|NCT04997811|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92410736|NCT04997811|Bezafibrate|bezafibrate|mesh-list
92410737|NCT04997811|Medroxyprogesterone|medroxyprogesterone|mesh-list
92410738|NCT04997811|Danazol|danazol|mesh-list
92410739|NCT04997811|Anticonvulsants|anticonvulsants|mesh-ancestor
92410740|NCT04997811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410741|NCT04997811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410742|NCT04997811|GABA Agents|gaba agents|mesh-ancestor
92410743|NCT04997811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410744|NCT04997811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410745|NCT04997811|Antimanic Agents|antimanic agents|mesh-ancestor
92410746|NCT04997811|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92410747|NCT04997811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92410748|NCT04997811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92410749|NCT04997811|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92410750|NCT04997811|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92410751|NCT04997811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92410752|NCT04997811|Contraceptive Agents|contraceptive agents|mesh-ancestor
92410753|NCT04997811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92410754|NCT04997811|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92410755|NCT04997811|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92410756|NCT04997811|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92410757|NCT04997811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410758|NCT04997811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410759|NCT04997811|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92410760|NCT04997811|Hormone Antagonists|hormone antagonists|mesh-ancestor
92410761|NCT04997811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410762|NCT04997811|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92410763|NCT04997811|Antimetabolites|antimetabolites|mesh-ancestor
92410764|NCT04997811|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92410765|NCT04995484|Belzutifan|belzutifan|mesh-list
92410766|NCT04995484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410767|NCT04994522|Belzutifan|belzutifan|mesh-list
92410768|NCT04994522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410769|NCT04994509|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92410770|NCT04994509|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92410771|NCT04994509|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92410772|NCT04994509|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92410773|NCT04994509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410774|NCT04994509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410775|NCT04994509|Antiviral Agents|antiviral agents|mesh-ancestor
92410776|NCT04994509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410777|NCT04994509|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92410778|NCT04994509|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92410779|NCT04979884|Cyclosporine|cyclosporine|mesh-list
92410780|NCT04979884|Interleukin-2|interleukin-2|mesh-list
92410781|NCT04979884|Cyclosporins|cyclosporins|mesh-list
92410782|NCT04979884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410783|NCT04979884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410784|NCT04979884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92410785|NCT04979884|Immunologic Factors|immunologic factors|mesh-ancestor
92410786|NCT04979884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410787|NCT04979884|Antifungal Agents|antifungal agents|mesh-ancestor
92410788|NCT04979884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410789|NCT04979884|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410790|NCT04979884|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92410791|NCT04979884|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92410792|NCT04979884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410793|NCT04979884|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92410794|NCT04979884|Analgesics|analgesics|mesh-ancestor
92410795|NCT04979884|Sensory System Agents|sensory system agents|mesh-ancestor
92410796|NCT04979884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410797|NCT04975997|Dexamethasone|dexamethasone|mesh-list
92410798|NCT04975997|Bortezomib|bortezomib|mesh-list
92410799|NCT04975997|Daratumumab|daratumumab|mesh-list
92410800|NCT04975997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410801|NCT04975997|Antiemetics|antiemetics|mesh-ancestor
92410802|NCT04975997|Autonomic Agents|autonomic agents|mesh-ancestor
92410803|NCT04975997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410804|NCT04975997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410805|NCT04975997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92410806|NCT04975997|Glucocorticoids|glucocorticoids|mesh-ancestor
92410807|NCT04975997|Hormones|hormones|mesh-ancestor
92410808|NCT04975997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410809|NCT04975997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410810|NCT04975997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410812|NCT04971304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92410813|NCT04971304|Immunologic Factors|immunologic factors|mesh-ancestor
92410814|NCT04971304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410815|NCT04968366|Temozolomide|temozolomide|mesh-list
92410816|NCT04968366|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92410817|NCT04968366|Alkylating Agents|alkylating agents|mesh-ancestor
92410818|NCT04968366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410819|NCT04968366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410820|NCT04951206|Clobetasol|clobetasol|mesh-list
92410821|NCT04951206|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410822|NCT04951206|Glucocorticoids|glucocorticoids|mesh-ancestor
92410823|NCT04951206|Hormones|hormones|mesh-ancestor
92410824|NCT04951206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410825|NCT04951206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410826|NCT04951115|Carboplatin|carboplatin|mesh-list
92410828|NCT04951115|Durvalumab|durvalumab|mesh-list
92410829|NCT04951115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410830|NCT04951115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92410831|NCT04951115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92410832|NCT04951115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92410833|NCT04951115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410834|NCT04951115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410835|NCT04951115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410836|NCT04949503|Nimotuzumab|nimotuzumab|mesh-list
92410837|NCT04949503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410838|NCT04949503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410839|NCT04945213|Biperiden|biperiden|mesh-list
92410840|NCT04945213|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92410841|NCT04945213|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92410842|NCT04945213|Parasympatholytics|parasympatholytics|mesh-ancestor
92410843|NCT04945213|Autonomic Agents|autonomic agents|mesh-ancestor
92410844|NCT04945213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410845|NCT04945213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410846|NCT04945213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92410847|NCT04945213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92410848|NCT04945213|Cholinergic Agents|cholinergic agents|mesh-ancestor
92410849|NCT04945213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410850|NCT04945213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410851|NCT04938466|Hormones|hormones|mesh-list
92410852|NCT04938466|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410853|NCT04938466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410854|NCT04934514|Gemcitabine|gemcitabine|mesh-list
92410855|NCT04934514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410856|NCT04934514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92410857|NCT04934514|Antimetabolites|antimetabolites|mesh-ancestor
92410858|NCT04934514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410859|NCT04932980|Aflibercept|aflibercept|mesh-list
92410860|NCT04932980|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410861|NCT04932980|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410862|NCT04932980|Growth Substances|growth substances|mesh-ancestor
92410863|NCT04932980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410864|NCT04932980|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410865|NCT04932980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410866|NCT04930094|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92410867|NCT04930094|Immunologic Factors|immunologic factors|mesh-ancestor
92410868|NCT04930094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410869|NCT04928846|Docetaxel|docetaxel|mesh-list
92410870|NCT04928846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410871|NCT04928846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92410872|NCT04928846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92410873|NCT04928846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92410874|NCT04928846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410875|NCT04927390|Mycophenolic Acid|mycophenolic acid|mesh-list
92410876|NCT04927390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92410877|NCT04927390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410878|NCT04927390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92410879|NCT04927390|Antitubercular Agents|antitubercular agents|mesh-ancestor
92410880|NCT04927390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92410881|NCT04927390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410882|NCT04927390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410883|NCT04927390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410884|NCT04925284|Bevacizumab|bevacizumab|mesh-list
92410886|NCT04925284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92410887|NCT04925284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410888|NCT04925284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92410889|NCT04925284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92410890|NCT04925284|Growth Substances|growth substances|mesh-ancestor
92410891|NCT04925284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410892|NCT04925284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92410893|NCT04925284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92410894|NCT04925284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410895|NCT04915729|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92410896|NCT04915729|Tenecteplase|tenecteplase|mesh-list
92410897|NCT04915729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92410898|NCT04915729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92410899|NCT04915729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410900|NCT04915183|Atorvastatin|atorvastatin|mesh-list
92410901|NCT04915183|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92410902|NCT04915183|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92410903|NCT04915183|Antimetabolites|antimetabolites|mesh-ancestor
92410904|NCT04915183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410905|NCT04915183|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92410906|NCT04915183|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92410907|NCT04915183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410908|NCT04910711|Dolutegravir|dolutegravir|mesh-list
92410909|NCT04910711|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92410910|NCT04910711|Levonorgestrel|levonorgestrel|mesh-list
92410911|NCT04910711|Medroxyprogesterone|medroxyprogesterone|mesh-list
92410912|NCT04910711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92410913|NCT04910711|Contraceptive Agents|contraceptive agents|mesh-ancestor
92410914|NCT04910711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92410915|NCT04910711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410916|NCT04910711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92410917|NCT04910711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92410918|NCT04910711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92410919|NCT04910711|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92410920|NCT04910711|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92410921|NCT04910711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410922|NCT04910711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410923|NCT04910711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92410924|NCT04910711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92410925|NCT04910711|Antiviral Agents|antiviral agents|mesh-ancestor
92410926|NCT04910711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92410927|NCT04910711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92410928|NCT04910711|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92410929|NCT04910711|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410930|NCT04910711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410931|NCT04909333|Exenatide|exenatide|mesh-list
92410932|NCT04909333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92410933|NCT04909333|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92410934|NCT04909333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410935|NCT04909333|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92410936|NCT04909333|Incretins|incretins|mesh-ancestor
92410937|NCT04909333|Hormones|hormones|mesh-ancestor
92410938|NCT04909333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410939|NCT04906395|Tamoxifen|tamoxifen|mesh-list
92410940|NCT04906395|Letrozole|letrozole|mesh-list
92410941|NCT04906395|Anastrozole|anastrozole|mesh-list
92410942|NCT04906395|Exemestane|exemestane|mesh-list
92410943|NCT04906395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410944|NCT04906395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92410945|NCT04906395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92410946|NCT04906395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92410947|NCT04906395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410948|NCT04906395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92410949|NCT04906395|Hormone Antagonists|hormone antagonists|mesh-ancestor
92410950|NCT04906395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410951|NCT04906395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410952|NCT04906395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410953|NCT04906395|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92410954|NCT04906395|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92410955|NCT04906395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92410956|NCT04897958|Leuprolide|leuprolide|mesh-list
92410957|NCT04897958|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92410958|NCT04897958|Fertility Agents|fertility agents|mesh-ancestor
92410959|NCT04897958|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92410960|NCT04897958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410961|NCT04897958|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92410962|NCT04897958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92410963|NCT04892758|Mometasone Furoate|mometasone furoate|mesh-list
92410964|NCT04892758|Formoterol Fumarate|formoterol fumarate|mesh-list
92410965|NCT04892758|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92410966|NCT04892758|Autonomic Agents|autonomic agents|mesh-ancestor
92410967|NCT04892758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410968|NCT04892758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410969|NCT04892758|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92410970|NCT04892758|Respiratory System Agents|respiratory system agents|mesh-ancestor
92410971|NCT04892758|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92410972|NCT04892758|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92410973|NCT04892758|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92410974|NCT04892758|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410975|NCT04892758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410976|NCT04892758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410977|NCT04892758|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410978|NCT04892758|Dermatologic Agents|dermatologic agents|mesh-ancestor
92410979|NCT04892758|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92410980|NCT04892732|Budesonide|budesonide|mesh-list
92410981|NCT04892732|Formoterol Fumarate|formoterol fumarate|mesh-list
92410982|NCT04892732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92410983|NCT04892732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92410984|NCT04892732|Autonomic Agents|autonomic agents|mesh-ancestor
92410985|NCT04892732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92410986|NCT04892732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92410987|NCT04892732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92410988|NCT04892732|Respiratory System Agents|respiratory system agents|mesh-ancestor
92410989|NCT04892732|Glucocorticoids|glucocorticoids|mesh-ancestor
92410990|NCT04892732|Hormones|hormones|mesh-ancestor
92410991|NCT04892732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92410992|NCT04892732|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92410993|NCT04892732|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92410994|NCT04892732|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92410995|NCT04892732|Adrenergic Agents|adrenergic agents|mesh-ancestor
92410996|NCT04892732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92410997|NCT04892732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92410998|NCT04890093|Vincristine|vincristine|mesh-list
92410999|NCT04890093|Temozolomide|temozolomide|mesh-list
92411000|NCT04890093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411001|NCT04890093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411002|NCT04890093|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411003|NCT04890093|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411004|NCT04890093|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411005|NCT04890093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411006|NCT04890093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411007|NCT04890093|Alkylating Agents|alkylating agents|mesh-ancestor
92411008|NCT04884763|Erenumab|erenumab|mesh-list
92411009|NCT04884763|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92411010|NCT04884763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411011|NCT04884763|Analgesics|analgesics|mesh-ancestor
92411012|NCT04884763|Sensory System Agents|sensory system agents|mesh-ancestor
92411013|NCT04884763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411014|NCT04884763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411015|NCT04879420|Teriparatide|teriparatide|mesh-list
92411016|NCT04879420|Risedronic Acid|risedronic acid|mesh-list
92411017|NCT04879420|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92411018|NCT04879420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411019|NCT04879420|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92411020|NCT04879420|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92411021|NCT04879420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92411022|NCT04879420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411023|NCT04858009|Paclitaxel|paclitaxel|mesh-list
92411024|NCT04858009|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92411025|NCT04858009|Cisplatin|cisplatin|mesh-list
92411026|NCT04858009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411027|NCT04858009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411028|NCT04858009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411029|NCT04858009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411030|NCT04858009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411031|NCT04858009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411032|NCT04849910|Gemtuzumab|gemtuzumab|mesh-list
92411033|NCT04849910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411034|NCT04849910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411035|NCT04849910|Immunotoxins|immunotoxins|mesh-ancestor
92411036|NCT04849910|Immunoconjugates|immunoconjugates|mesh-ancestor
92411037|NCT04849910|Immunologic Factors|immunologic factors|mesh-ancestor
92411038|NCT04849910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411039|NCT04848519|Pembrolizumab|pembrolizumab|mesh-list
92411040|NCT04848519|Nivolumab|nivolumab|mesh-list
92411041|NCT04848519|Avelumab|avelumab|mesh-list
92411042|NCT04848519|Propranolol|propranolol|mesh-list
92411043|NCT04848519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411044|NCT04848519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411045|NCT04848519|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411046|NCT04848519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411047|NCT04848519|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92411048|NCT04848519|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92411049|NCT04848519|Adrenergic Agents|adrenergic agents|mesh-ancestor
92411050|NCT04848519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411051|NCT04848519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411052|NCT04848519|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92411053|NCT04848519|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92411054|NCT04848519|Vasodilator Agents|vasodilator agents|mesh-ancestor
92411055|NCT04822337|Dexamethasone|dexamethasone|mesh-list
92411056|NCT04822337|Lenalidomide|lenalidomide|mesh-list
92411057|NCT04822337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92411058|NCT04822337|Antiemetics|antiemetics|mesh-ancestor
92411059|NCT04822337|Autonomic Agents|autonomic agents|mesh-ancestor
92411060|NCT04822337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411061|NCT04822337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411062|NCT04822337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92411063|NCT04822337|Glucocorticoids|glucocorticoids|mesh-ancestor
92411064|NCT04822337|Hormones|hormones|mesh-ancestor
92411065|NCT04822337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411066|NCT04822337|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92411067|NCT04822337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411068|NCT04822337|Immunologic Factors|immunologic factors|mesh-ancestor
92411069|NCT04822337|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411070|NCT04822337|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411071|NCT04822337|Growth Substances|growth substances|mesh-ancestor
92411072|NCT04822337|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411073|NCT04808323|Capecitabine|capecitabine|mesh-list
92411074|NCT04808323|Oxaliplatin|oxaliplatin|mesh-list
92411075|NCT04808323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411076|NCT04808323|Antimetabolites|antimetabolites|mesh-ancestor
92411077|NCT04808323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411078|NCT04808323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411079|NCT04793529|Cholecalciferol|cholecalciferol|mesh-list
92411080|NCT04793529|Vitamin D|vitamin d|mesh-list
92411081|NCT04793529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92411082|NCT04793529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411083|NCT04793529|Vitamins|vitamins|mesh-ancestor
92411084|NCT04793529|Micronutrients|micronutrients|mesh-ancestor
92411085|NCT04793529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92411086|NCT04787289|Bevacizumab|bevacizumab|mesh-list
92411087|NCT04787289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411088|NCT04787289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411089|NCT04787289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411090|NCT04787289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411091|NCT04787289|Growth Substances|growth substances|mesh-ancestor
92411092|NCT04787289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411093|NCT04787289|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411094|NCT04771130|Posaconazole|posaconazole|mesh-list
92411095|NCT04771130|Azacitidine|azacitidine|mesh-list
92411096|NCT04771130|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411097|NCT04771130|Antimetabolites|antimetabolites|mesh-ancestor
92411098|NCT04771130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411099|NCT04771130|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411100|NCT04771130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411101|NCT04771130|Antifungal Agents|antifungal agents|mesh-ancestor
92411102|NCT04771130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411103|NCT04771130|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92411104|NCT04771130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92411105|NCT04771130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92411106|NCT04771130|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92411107|NCT04771130|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92411108|NCT04771130|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92411109|NCT04771130|Hormone Antagonists|hormone antagonists|mesh-ancestor
92411110|NCT04771130|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411111|NCT04771130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411113|NCT04749641|Immunologic Factors|immunologic factors|mesh-ancestor
92411117|NCT04745299|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92411118|NCT04745299|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92411119|NCT04745299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411120|NCT04745299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411121|NCT04745299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411122|NCT04745299|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92411123|NCT04745299|Protective Agents|protective agents|mesh-ancestor
92411125|NCT04742777|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92411126|NCT04742777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411127|NCT04742777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92411128|NCT04742777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411129|NCT04742777|Antifungal Agents|antifungal agents|mesh-ancestor
92411130|NCT04742777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411131|NCT04742777|Immunologic Factors|immunologic factors|mesh-ancestor
92411132|NCT04742777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411133|NCT04730258|Azacitidine|azacitidine|mesh-list
92411134|NCT04730258|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411135|NCT04730258|Antimetabolites|antimetabolites|mesh-ancestor
92411136|NCT04730258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411137|NCT04730258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411138|NCT04730258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411139|NCT04725201|Heparin|heparin|mesh-list
92411140|NCT04725201|Calcium heparin|calcium heparin|mesh-list
92411141|NCT04725201|Anticoagulants|anticoagulants|mesh-ancestor
92411142|NCT04725201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92411143|NCT04725201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92411144|NCT04725201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411145|NCT04720157|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92411146|NCT04720157|177Lu-PSMA-617|177lu-psma-617|mesh-list
92411147|NCT04720157|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92411148|NCT04720157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411149|NCT04705727|Budesonide|budesonide|mesh-list
92411150|NCT04705727|Terbutaline|terbutaline|mesh-list
92411151|NCT04705727|Formoterol Fumarate|formoterol fumarate|mesh-list
92411152|NCT04705727|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92411153|NCT04705727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92411154|NCT04705727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92411155|NCT04705727|Autonomic Agents|autonomic agents|mesh-ancestor
92411156|NCT04705727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411157|NCT04705727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411158|NCT04705727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92411159|NCT04705727|Respiratory System Agents|respiratory system agents|mesh-ancestor
92411160|NCT04705727|Glucocorticoids|glucocorticoids|mesh-ancestor
92411161|NCT04705727|Hormones|hormones|mesh-ancestor
92411162|NCT04705727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411163|NCT04705727|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92411164|NCT04705727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92411165|NCT04705727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92411166|NCT04705727|Adrenergic Agents|adrenergic agents|mesh-ancestor
92411167|NCT04705727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411168|NCT04705727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411169|NCT04705727|Sympathomimetics|sympathomimetics|mesh-ancestor
92411170|NCT04705727|Tocolytic Agents|tocolytic agents|mesh-ancestor
92411171|NCT04705727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92411172|NCT04704934|Paclitaxel|paclitaxel|mesh-list
92411173|NCT04704934|Trastuzumab|trastuzumab|mesh-list
92411174|NCT04704934|Ramucirumab|ramucirumab|mesh-list
92411175|NCT04704934|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92411176|NCT04704934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411177|NCT04704934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411178|NCT04704934|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411179|NCT04704934|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411180|NCT04704934|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411181|NCT04704934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411182|NCT04704934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411183|NCT04704934|Immunoconjugates|immunoconjugates|mesh-ancestor
92411184|NCT04704934|Immunologic Factors|immunologic factors|mesh-ancestor
92411185|NCT04704934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411186|NCT04695340|Psyllium|psyllium|mesh-list
92411187|NCT04695340|Cathartics|cathartics|mesh-ancestor
92411188|NCT04695340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92411189|NCT04674683|Nivolumab|nivolumab|mesh-list
92411190|NCT04674683|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411191|NCT04674683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411192|NCT04674683|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411193|NCT04674683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411195|NCT04666740|Olaparib|olaparib|mesh-list
92411196|NCT04666740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411197|NCT04666740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411198|NCT04666740|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411199|NCT04666740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411200|NCT04666740|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92411201|NCT04666740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411202|NCT04662944|Ranibizumab|ranibizumab|mesh-list
92411203|NCT04662944|Aflibercept|aflibercept|mesh-list
92411204|NCT04662944|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411205|NCT04662944|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411206|NCT04662944|Growth Substances|growth substances|mesh-ancestor
92411207|NCT04662944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411208|NCT04662944|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411209|NCT04662944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411210|NCT04661007|Lenalidomide|lenalidomide|mesh-list
92411211|NCT04661007|Immunologic Factors|immunologic factors|mesh-ancestor
92411212|NCT04661007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411213|NCT04661007|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411214|NCT04661007|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411215|NCT04661007|Growth Substances|growth substances|mesh-ancestor
92411216|NCT04661007|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411217|NCT04661007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411218|NCT04644237|Trastuzumab|trastuzumab|mesh-list
92411219|NCT04644237|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92411220|NCT04644237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411221|NCT04644237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411222|NCT04644237|Immunoconjugates|immunoconjugates|mesh-ancestor
92411223|NCT04644237|Immunologic Factors|immunologic factors|mesh-ancestor
92411224|NCT04644237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411225|NCT04635826|Adderall|adderall|mesh-list
92411226|NCT04635826|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92411227|NCT04635826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411228|NCT04629781|Docetaxel|docetaxel|mesh-list
92411229|NCT04629781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411230|NCT04629781|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411231|NCT04629781|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411232|NCT04629781|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411233|NCT04629781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411234|NCT04624945|Thromboplastin|thromboplastin|mesh-list
92411235|NCT04624945|Hemostatics|hemostatics|mesh-ancestor
92411236|NCT04624945|Coagulants|coagulants|mesh-ancestor
92411237|NCT04623216|Azacitidine|azacitidine|mesh-list
92411238|NCT04623216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411239|NCT04623216|Antimetabolites|antimetabolites|mesh-ancestor
92411240|NCT04623216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411241|NCT04623216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411242|NCT04623216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411243|NCT04610866|Mitapivat|mitapivat|mesh-list
92411244|NCT04610866|Enzyme Activators|enzyme activators|mesh-ancestor
92411245|NCT04610866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411246|NCT04608474|Evolocumab|evolocumab|mesh-list
92411247|NCT04608474|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92411249|NCT04608474|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92411250|NCT04608474|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92411251|NCT04608474|Antimetabolites|antimetabolites|mesh-ancestor
91932426|NCT04972123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92411252|NCT04608474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411253|NCT04608474|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92411254|NCT04608474|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411255|NCT04608474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411256|NCT04608474|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92411257|NCT04600414|Analgesics, Opioid|analgesics, opioid|mesh-list
92411258|NCT04600414|Narcotics|narcotics|mesh-ancestor
92411259|NCT04600414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411260|NCT04600414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411261|NCT04600414|Analgesics|analgesics|mesh-ancestor
92411262|NCT04600414|Sensory System Agents|sensory system agents|mesh-ancestor
92411263|NCT04600414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411264|NCT04593043|Warfarin|warfarin|mesh-list
92411265|NCT04593043|Dabigatran|dabigatran|mesh-list
92411266|NCT04593043|Anticoagulants|anticoagulants|mesh-ancestor
92411267|NCT04593043|Antithrombins|antithrombins|mesh-ancestor
92411268|NCT04593043|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92411269|NCT04593043|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411271|NCT04593043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411272|NCT04593030|Warfarin|warfarin|mesh-list
92411273|NCT04593030|Apixaban|apixaban|mesh-list
92411274|NCT04593030|Anticoagulants|anticoagulants|mesh-ancestor
92411275|NCT04593030|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92411276|NCT04593030|Antithrombins|antithrombins|mesh-ancestor
92411277|NCT04593030|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92411278|NCT04593030|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411279|NCT04593030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411280|NCT04593030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411281|NCT04589663|Mometasone Furoate|mometasone furoate|mesh-list
92411282|NCT04589663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92411283|NCT04589663|Dermatologic Agents|dermatologic agents|mesh-ancestor
92411284|NCT04589663|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92411285|NCT04588311|Epoetin Alfa|epoetin alfa|mesh-list
92411286|NCT04588311|Hematinics|hematinics|mesh-ancestor
92411287|NCT04567303|Ranibizumab|ranibizumab|mesh-list
92411288|NCT04567303|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411289|NCT04567303|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411290|NCT04567303|Growth Substances|growth substances|mesh-ancestor
92411291|NCT04567303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411292|NCT04567303|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411293|NCT04567303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411294|NCT04545736|Metformin|metformin|mesh-list
92411295|NCT04545736|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411296|NCT04545736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411297|NCT04532229|Nimotuzumab|nimotuzumab|mesh-list
92411298|NCT04532229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411299|NCT04532229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411300|NCT04521478|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92411301|NCT04521478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92411302|NCT04521478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92411303|NCT04521478|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92411304|NCT04521478|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92411305|NCT04521478|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411306|NCT04521478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411307|NCT04518410|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92411308|NCT04518410|Bamlanivimab|bamlanivimab|mesh-list
92411309|NCT04518410|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92411310|NCT04518410|Gabexate|gabexate|mesh-list
92411311|NCT04518410|Immunoglobulins|immunoglobulins|mesh-list
92411312|NCT04518410|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92411313|NCT04518410|Antibodies|antibodies|mesh-list
92411314|NCT04518410|Camostat|camostat|mesh-list
92411316|NCT04518410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411317|NCT04518410|Antiviral Agents|antiviral agents|mesh-ancestor
92411318|NCT04518410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411319|NCT04518410|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411320|NCT04518410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411321|NCT04518410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411322|NCT04518410|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92411323|NCT04518410|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92411324|NCT04518410|Anticoagulants|anticoagulants|mesh-ancestor
92411325|NCT04507204|Methylphenidate|methylphenidate|mesh-list
92411326|NCT04507204|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92411327|NCT04507204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411328|NCT04507204|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92411329|NCT04507204|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92411330|NCT04507204|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92411331|NCT04507204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411332|NCT04507204|Dopamine Agents|dopamine agents|mesh-ancestor
92411333|NCT04507204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411334|NCT04491136|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92411335|NCT04491136|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92411336|NCT04491136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411337|NCT04486391|Tislelizumab|tislelizumab|mesh-list
92411338|NCT04486391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411339|NCT04486391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411340|NCT04468061|Pembrolizumab|pembrolizumab|mesh-list
92411341|NCT04468061|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92411342|NCT04468061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411343|NCT04468061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411344|NCT04468061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411345|NCT04468061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411348|NCT04468061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411349|NCT04435834|Propofol|propofol|mesh-list
92411350|NCT04435834|Sevoflurane|sevoflurane|mesh-list
92411351|NCT04435834|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92411352|NCT04435834|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411353|NCT04435834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411354|NCT04435834|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92411355|NCT04435834|Anesthetics, General|anesthetics, general|mesh-ancestor
92411356|NCT04435834|Anesthetics|anesthetics|mesh-ancestor
92411357|NCT04435834|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92411358|NCT04435834|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92411359|NCT04392622|Cisplatin|cisplatin|mesh-list
92411360|NCT04392622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411361|NCT04388839|Dactinomycin|dactinomycin|mesh-list
92411362|NCT04388839|Cyclophosphamide|cyclophosphamide|mesh-list
92411363|NCT04388839|Vincristine|vincristine|mesh-list
92411364|NCT04388839|Vinorelbine|vinorelbine|mesh-list
92411365|NCT04388839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411366|NCT04388839|Immunologic Factors|immunologic factors|mesh-ancestor
92411367|NCT04388839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411368|NCT04388839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411369|NCT04388839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411370|NCT04388839|Alkylating Agents|alkylating agents|mesh-ancestor
92411371|NCT04388839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411372|NCT04388839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411373|NCT04388839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92411374|NCT04388839|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411375|NCT04388839|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411376|NCT04388839|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411377|NCT04388839|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411378|NCT04388839|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92411379|NCT04388839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411380|NCT04388839|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92411381|NCT04388839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92411382|NCT04388839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411383|NCT04388839|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92411384|NCT04384484|Rituximab|rituximab|mesh-list
92411385|NCT04384484|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92411386|NCT04384484|Gemcitabine|gemcitabine|mesh-list
92411387|NCT04384484|Oxaliplatin|oxaliplatin|mesh-list
92411388|NCT04384484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411389|NCT04384484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411390|NCT04384484|Immunologic Factors|immunologic factors|mesh-ancestor
92411391|NCT04384484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411392|NCT04384484|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411393|NCT04384484|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411394|NCT04384484|Antimetabolites|antimetabolites|mesh-ancestor
92411395|NCT04384484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411397|NCT04370795|Busulfan|busulfan|mesh-list
92411398|NCT04370795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92411399|NCT04370795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411400|NCT04370795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92411401|NCT04370795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411402|NCT04370795|Antifungal Agents|antifungal agents|mesh-ancestor
92411403|NCT04370795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411404|NCT04370795|Immunologic Factors|immunologic factors|mesh-ancestor
92411405|NCT04370795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411406|NCT04370795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411407|NCT04370795|Alkylating Agents|alkylating agents|mesh-ancestor
92411408|NCT04370795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411409|NCT04370795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92411410|NCT04345341|Bupivacaine|bupivacaine|mesh-list
92411411|NCT04345341|Anesthetics, Local|anesthetics, local|mesh-ancestor
92411412|NCT04345341|Anesthetics|anesthetics|mesh-ancestor
92411413|NCT04345341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411414|NCT04345341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411415|NCT04345341|Sensory System Agents|sensory system agents|mesh-ancestor
92411416|NCT04345341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411417|NCT04339751|Vorinostat|vorinostat|mesh-list
92411418|NCT04339751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411419|NCT04339751|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92411420|NCT04339751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411421|NCT04339751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411422|NCT04336241|Nivolumab|nivolumab|mesh-list
92411423|NCT04336241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411424|NCT04336241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411425|NCT04336241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411426|NCT04336241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411427|NCT04332744|Talazoparib|talazoparib|mesh-list
92411428|NCT04332744|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92411429|NCT04332744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411430|NCT04332744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411431|NCT04332744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411432|NCT04331002|Triamcinolone|triamcinolone|mesh-list
92411433|NCT04331002|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92411434|NCT04331002|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92411435|NCT04331002|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92411436|NCT04331002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92411437|NCT04331002|Glucocorticoids|glucocorticoids|mesh-ancestor
92411438|NCT04331002|Hormones|hormones|mesh-ancestor
92411439|NCT04331002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411440|NCT04331002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411441|NCT04331002|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411442|NCT04331002|Immunologic Factors|immunologic factors|mesh-ancestor
92411443|NCT04331002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411444|NCT04331002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411445|NCT04291820|Anesthetics|anesthetics|mesh-list
92411446|NCT04291820|Sevoflurane|sevoflurane|mesh-list
92411447|NCT04291820|Desflurane|desflurane|mesh-list
92411448|NCT04291820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411449|NCT04291820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411450|NCT04291820|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92411451|NCT04291820|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92411452|NCT04291820|Anesthetics, General|anesthetics, general|mesh-ancestor
92411453|NCT04279847|INCB057643|incb057643|mesh-list
92411454|NCT04279847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411455|NCT04279054|Morphine|morphine|mesh-list
92411456|NCT04279054|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92411457|NCT04279054|Narcotics|narcotics|mesh-ancestor
92411458|NCT04279054|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411459|NCT04279054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411461|NCT04279054|Sensory System Agents|sensory system agents|mesh-ancestor
92411462|NCT04279054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411463|NCT04277637|Obinutuzumab|obinutuzumab|mesh-list
92411464|NCT04277637|Zanubrutinib|zanubrutinib|mesh-list
92411465|NCT04277637|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411466|NCT04277637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411467|NCT04277637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92411468|NCT04277637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411469|NCT04277637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411470|NCT04263051|Nivolumab|nivolumab|mesh-list
92411471|NCT04263051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411472|NCT04263051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411473|NCT04263051|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411474|NCT04263051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411475|NCT04237935|Clopidogrel|clopidogrel|mesh-list
92411476|NCT04237935|Ticagrelor|ticagrelor|mesh-list
91932427|NCT04972123|Purinergic Agents|purinergic agents|mesh-ancestor
92411477|NCT04237935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92411478|NCT04237935|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92411479|NCT04237935|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92411480|NCT04237935|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92411481|NCT04237935|Purinergic Agents|purinergic agents|mesh-ancestor
92411482|NCT04237935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411483|NCT04237935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411484|NCT04237935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411485|NCT04237922|Clopidogrel|clopidogrel|mesh-list
92411486|NCT04237922|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92411487|NCT04237922|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92411488|NCT04237922|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92411489|NCT04237922|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92411490|NCT04237922|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92411491|NCT04237922|Purinergic Agents|purinergic agents|mesh-ancestor
92411492|NCT04237922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411493|NCT04237922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411494|NCT04237922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411495|NCT04233021|Osimertinib|osimertinib|mesh-list
92411496|NCT04233021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411497|NCT04233021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92411498|NCT04233021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411499|NCT04233021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411500|NCT04229004|Paclitaxel|paclitaxel|mesh-list
92411501|NCT04229004|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92411502|NCT04229004|Gemcitabine|gemcitabine|mesh-list
92411503|NCT04229004|Spartalizumab|spartalizumab|mesh-list
92411504|NCT04229004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411505|NCT04229004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411506|NCT04229004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411507|NCT04229004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411508|NCT04229004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411509|NCT04229004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411510|NCT04229004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411511|NCT04229004|Antimetabolites|antimetabolites|mesh-ancestor
92411512|NCT04229004|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411513|NCT04229004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411514|NCT04228289|Oxytocin|oxytocin|mesh-list
92411515|NCT04228289|Oxytocics|oxytocics|mesh-ancestor
92411516|NCT04228289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92411517|NCT04228289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411518|NCT04227821|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92411519|NCT04221542|Docetaxel|docetaxel|mesh-list
92411520|NCT04221542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411521|NCT04221542|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411522|NCT04221542|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411523|NCT04221542|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411524|NCT04221542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411525|NCT04215536|Empagliflozin|empagliflozin|mesh-list
92411526|NCT04215536|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92411527|NCT04215536|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92411528|NCT04215536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411529|NCT04215536|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411530|NCT04215536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411531|NCT04215536|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411532|NCT04215536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411533|NCT04215523|Dapagliflozin|dapagliflozin|mesh-list
92411534|NCT04215523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92411535|NCT04215523|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92411536|NCT04215523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411537|NCT04215523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411538|NCT04215523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411539|NCT04215523|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411540|NCT04215523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411541|NCT04169347|Leucovorin|leucovorin|mesh-list
92411542|NCT04169347|Oxaliplatin|oxaliplatin|mesh-list
92411543|NCT04169347|Irinotecan|irinotecan|mesh-list
92411544|NCT04169347|Panitumumab|panitumumab|mesh-list
92411545|NCT04169347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411546|NCT04169347|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92411547|NCT04169347|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92411548|NCT04169347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411549|NCT04169347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411550|NCT04169347|Antidotes|antidotes|mesh-ancestor
92411551|NCT04169347|Protective Agents|protective agents|mesh-ancestor
92411552|NCT04169347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411553|NCT04169347|Vitamin B Complex|vitamin b complex|mesh-ancestor
92411554|NCT04169347|Vitamins|vitamins|mesh-ancestor
92411555|NCT04169347|Micronutrients|micronutrients|mesh-ancestor
92411556|NCT04169347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411557|NCT04164199|Capecitabine|capecitabine|mesh-list
92411558|NCT04164199|Pemetrexed|pemetrexed|mesh-list
92411559|NCT04164199|Temozolomide|temozolomide|mesh-list
92411560|NCT04164199|Tislelizumab|tislelizumab|mesh-list
92411561|NCT04164199|Pamiparib|pamiparib|mesh-list
92411562|NCT04164199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411563|NCT04164199|Antimetabolites|antimetabolites|mesh-ancestor
92411564|NCT04164199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411565|NCT04164199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411566|NCT04164199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411567|NCT04164199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92411568|NCT04164199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92411569|NCT04164199|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411570|NCT04164199|Alkylating Agents|alkylating agents|mesh-ancestor
92411571|NCT04164199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411572|NCT04164199|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92411573|NCT04161885|Azacitidine|azacitidine|mesh-list
92411574|NCT04161885|Venetoclax|venetoclax|mesh-list
92411575|NCT04161885|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411576|NCT04161885|Antimetabolites|antimetabolites|mesh-ancestor
92411577|NCT04161885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411578|NCT04161885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411579|NCT04161885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411580|NCT04155424|Eculizumab|eculizumab|mesh-list
92411581|NCT04155424|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92411582|NCT04155424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411583|NCT04155424|Immunologic Factors|immunologic factors|mesh-ancestor
92411584|NCT04155424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411585|NCT04150939|Immunomodulating Agents|immunomodulating agents|mesh-list
92411586|NCT04150939|Immunologic Factors|immunologic factors|mesh-list
92411587|NCT04150939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411588|NCT04140305|Ozanimod|ozanimod|mesh-list
92411589|NCT04140305|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92411590|NCT04140305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411591|NCT04140305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411592|NCT04140305|Immunologic Factors|immunologic factors|mesh-ancestor
92411593|NCT04140305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411594|NCT04135937|Bupropion|bupropion|mesh-list
92411595|NCT04135937|Nicotine|nicotine|mesh-list
92411596|NCT04135937|Varenicline|varenicline|mesh-list
92411597|NCT04135937|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92411598|NCT04135937|Autonomic Agents|autonomic agents|mesh-ancestor
92411599|NCT04135937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411600|NCT04135937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411601|NCT04135937|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92411602|NCT04135937|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92411603|NCT04135937|Cholinergic Agents|cholinergic agents|mesh-ancestor
92411604|NCT04135937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92411605|NCT04135937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411606|NCT04135937|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92411607|NCT04135937|Antidepressive Agents|antidepressive agents|mesh-ancestor
92411608|NCT04135937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92411609|NCT04135937|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92411610|NCT04135937|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92411611|NCT04135937|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92411612|NCT04135937|Dopamine Agents|dopamine agents|mesh-ancestor
92411613|NCT04135937|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92411614|NCT04135937|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92411616|NCT04126070|Docetaxel|docetaxel|mesh-list
92411617|NCT04126070|Nivolumab|nivolumab|mesh-list
92411618|NCT04126070|Leuprolide|leuprolide|mesh-list
92411619|NCT04126070|Goserelin|goserelin|mesh-list
92411620|NCT04126070|Androgens|androgens|mesh-list
92411621|NCT04126070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411622|NCT04126070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411623|NCT04126070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411625|NCT04126070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411626|NCT04126070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411627|NCT04126070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411628|NCT04126070|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92411629|NCT04126070|Fertility Agents|fertility agents|mesh-ancestor
92411630|NCT04126070|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92411631|NCT04126070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411632|NCT04126070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92411633|NCT04126070|Hormones|hormones|mesh-ancestor
92411634|NCT04126070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411635|NCT04120987|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92411636|NCT04120987|Lifitegrast|lifitegrast|mesh-list
92411637|NCT04120987|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92411638|NCT04102436|Aldesleukin|aldesleukin|mesh-list
92411639|NCT04102436|Cyclophosphamide|cyclophosphamide|mesh-list
92411640|NCT04102436|Fludarabine|fludarabine|mesh-list
92411641|NCT04102436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411642|NCT04102436|Immunologic Factors|immunologic factors|mesh-ancestor
92411643|NCT04102436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411644|NCT04102436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411645|NCT04102436|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411646|NCT04102436|Alkylating Agents|alkylating agents|mesh-ancestor
92411647|NCT04102436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411648|NCT04102436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411649|NCT04102436|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92411650|NCT04102436|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92411651|NCT04102436|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92411652|NCT04102436|Antiviral Agents|antiviral agents|mesh-ancestor
92411653|NCT04102436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411654|NCT04047862|Paclitaxel|paclitaxel|mesh-list
92411655|NCT04047862|Etoposide|etoposide|mesh-list
92411656|NCT04047862|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92411657|NCT04047862|Carboplatin|carboplatin|mesh-list
92411658|NCT04047862|Fluorouracil|fluorouracil|mesh-list
92411659|NCT04047862|Capecitabine|capecitabine|mesh-list
92411660|NCT04047862|Oxaliplatin|oxaliplatin|mesh-list
92411661|NCT04047862|Pemetrexed|pemetrexed|mesh-list
92411662|NCT04047862|Tislelizumab|tislelizumab|mesh-list
92411663|NCT04047862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411664|NCT04047862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411665|NCT04047862|Tubulin Modulators|tubulin modulators|mesh-ancestor
92411666|NCT04047862|Antimitotic Agents|antimitotic agents|mesh-ancestor
92411667|NCT04047862|Mitosis Modulators|mitosis modulators|mesh-ancestor
92411668|NCT04047862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411669|NCT04047862|Antimetabolites|antimetabolites|mesh-ancestor
92411670|NCT04047862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411671|NCT04047862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411672|NCT04047862|Immunologic Factors|immunologic factors|mesh-ancestor
92411673|NCT04047862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411674|NCT04047862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92411675|NCT04047862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92411676|NCT04047862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411677|NCT04047862|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92411678|NCT04047862|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92411679|NCT04047862|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411680|NCT04028765|Misoprostol|misoprostol|mesh-list
92411681|NCT04028765|Oxytocin|oxytocin|mesh-list
92411682|NCT04028765|Oxytocics|oxytocics|mesh-ancestor
92411683|NCT04028765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92411684|NCT04028765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411685|NCT04028765|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92411686|NCT04028765|Abortifacient Agents|abortifacient agents|mesh-ancestor
92411687|NCT04028765|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92411688|NCT04028765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92411689|NCT04019093|Ethanol|ethanol|mesh-list
92411690|NCT04019093|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92411691|NCT04019093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411692|NCT04019093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411693|NCT04019093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411694|NCT04003636|Cisplatin|cisplatin|mesh-list
92411695|NCT04003636|Gemcitabine|gemcitabine|mesh-list
92411696|NCT04003636|Pembrolizumab|pembrolizumab|mesh-list
92411697|NCT04003636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411698|NCT04003636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411699|NCT04003636|Antimetabolites|antimetabolites|mesh-ancestor
92411700|NCT04003636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411701|NCT04003636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411702|NCT04003636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411703|NCT04002297|Rituximab|rituximab|mesh-list
92411704|NCT04002297|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92411705|NCT04002297|Zanubrutinib|zanubrutinib|mesh-list
92411706|NCT04002297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411707|NCT04002297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411708|NCT04002297|Immunologic Factors|immunologic factors|mesh-ancestor
92411709|NCT04002297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411710|NCT04002297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411711|NCT04002297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411712|NCT04002297|Alkylating Agents|alkylating agents|mesh-ancestor
92411713|NCT04002297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411714|NCT04002297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92411715|NCT04002297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411716|NCT03978598|Etonogestrel|etonogestrel|mesh-list
92411717|NCT03978598|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92411718|NCT03978598|Contraceptive Agents|contraceptive agents|mesh-ancestor
92411719|NCT03978598|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92411720|NCT03978598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411721|NCT03978598|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92411722|NCT03975231|Trametinib|trametinib|mesh-list
92411723|NCT03975231|Dabrafenib|dabrafenib|mesh-list
92411724|NCT03975231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411725|NCT03975231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92411727|NCT03975231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411728|NCT03972488|Octreotide|octreotide|mesh-list
92411729|NCT03972488|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92411730|NCT03972488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92411731|NCT03972488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92411732|NCT03972488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411733|NCT03972488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92411734|NCT03972488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411735|NCT03971253|Peficitinib|peficitinib|mesh-list
92411736|NCT03971253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411737|NCT03971253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411738|NCT03971253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411739|NCT03971253|Immunologic Factors|immunologic factors|mesh-ancestor
92411740|NCT03971253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411741|NCT03949855|Rituximab|rituximab|mesh-list
92411742|NCT03949855|Belimumab|belimumab|mesh-list
92411743|NCT03949855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411744|NCT03949855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411745|NCT03949855|Immunologic Factors|immunologic factors|mesh-ancestor
92411746|NCT03949855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411747|NCT03949855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411748|NCT03949855|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411749|NCT03944772|Carboplatin|carboplatin|mesh-list
92411750|NCT03944772|Etoposide|etoposide|mesh-list
92411751|NCT03944772|Pemetrexed|pemetrexed|mesh-list
92411752|NCT03944772|Durvalumab|durvalumab|mesh-list
92411753|NCT03944772|Gefitinib|gefitinib|mesh-list
92411754|NCT03944772|Osimertinib|osimertinib|mesh-list
92411755|NCT03944772|Necitumumab|necitumumab|mesh-list
92411756|NCT03944772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411757|NCT03944772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92411758|NCT03944772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92411759|NCT03944772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92411760|NCT03944772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411761|NCT03944772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411762|NCT03944772|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92411763|NCT03944772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92411764|NCT03944772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411765|NCT03944772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92411766|NCT03943537|Insulin|insulin|mesh-list
92411767|NCT03943537|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411768|NCT03943537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411769|NCT03937830|Bevacizumab|bevacizumab|mesh-list
92411770|NCT03937830|Durvalumab|durvalumab|mesh-list
92411771|NCT03937830|Doxorubicin|doxorubicin|mesh-list
92411772|NCT03937830|Tremelimumab|tremelimumab|mesh-list
92411773|NCT03937830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411774|NCT03937830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411775|NCT03937830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411776|NCT03937830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411777|NCT03937830|Growth Substances|growth substances|mesh-ancestor
92411778|NCT03937830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411779|NCT03937830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411780|NCT03937830|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92411781|NCT03937830|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92411782|NCT03937830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92411783|NCT03937830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411784|NCT03937830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411785|NCT03936062|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92411786|NCT03936062|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411787|NCT03936062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411788|NCT03936062|Incretins|incretins|mesh-ancestor
92411789|NCT03936062|Hormones|hormones|mesh-ancestor
92411790|NCT03936062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411791|NCT03936062|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92411792|NCT03936062|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411793|NCT03936062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411794|NCT03936062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411795|NCT03936049|Liraglutide|liraglutide|mesh-list
92411796|NCT03936049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92411797|NCT03936049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411798|NCT03936049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411799|NCT03936049|Incretins|incretins|mesh-ancestor
92411800|NCT03936049|Hormones|hormones|mesh-ancestor
92411801|NCT03936049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411804|NCT03936049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411805|NCT03936036|Linagliptin|linagliptin|mesh-list
92411806|NCT03936036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411807|NCT03936036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411808|NCT03936036|Incretins|incretins|mesh-ancestor
92411809|NCT03936036|Hormones|hormones|mesh-ancestor
92411810|NCT03936036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411811|NCT03936036|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92411812|NCT03936036|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411813|NCT03936036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411814|NCT03936036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411815|NCT03936010|Canagliflozin|canagliflozin|mesh-list
92411816|NCT03936010|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92411817|NCT03936010|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92411818|NCT03936010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411819|NCT03936010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411820|NCT03936010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411821|NCT03936010|Protease Inhibitors|protease inhibitors|mesh-ancestor
92411822|NCT03936010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411823|NCT03934372|Ponatinib|ponatinib|mesh-list
92411824|NCT03934372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411825|NCT03934372|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92411826|NCT03934372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411827|NCT03934372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411828|NCT03919448|Bevacizumab|bevacizumab|mesh-list
92411829|NCT03919448|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411830|NCT03919448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411831|NCT03919448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92411832|NCT03919448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92411833|NCT03919448|Growth Substances|growth substances|mesh-ancestor
92411834|NCT03919448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411835|NCT03919448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92411836|NCT03900637|Letrozole|letrozole|mesh-list
92411837|NCT03900637|Leuprolide|leuprolide|mesh-list
92411838|NCT03900637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411839|NCT03900637|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92411840|NCT03900637|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92411841|NCT03900637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411842|NCT03900637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411843|NCT03900637|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92411844|NCT03900637|Hormone Antagonists|hormone antagonists|mesh-ancestor
92411845|NCT03900637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411846|NCT03900637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411848|NCT03900637|Fertility Agents|fertility agents|mesh-ancestor
92411849|NCT03900637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92411850|NCT03900637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92411851|NCT03893045|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92411852|NCT03893045|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92411853|NCT03893045|Hematinics|hematinics|mesh-ancestor
92411854|NCT03893045|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92411855|NCT03893045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92411856|NCT03877354|Anesthetics|anesthetics|mesh-list
92411857|NCT03877354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411858|NCT03877354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411859|NCT03876262|Ivermectin|ivermectin|mesh-list
92411860|NCT03876262|Moxidectin|moxidectin|mesh-list
92411861|NCT03876262|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92411862|NCT03876262|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92411863|NCT03876262|Anthelmintics|anthelmintics|mesh-ancestor
92411864|NCT03876262|Antinematodal Agents|antinematodal agents|mesh-ancestor
92411865|NCT03867344|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92411866|NCT03867344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411867|NCT03836040|Erenumab|erenumab|mesh-list
92411868|NCT03836040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92411869|NCT03836040|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92411870|NCT03836040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411871|NCT03836040|Analgesics|analgesics|mesh-ancestor
92411872|NCT03836040|Sensory System Agents|sensory system agents|mesh-ancestor
92411873|NCT03836040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411874|NCT03836040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411875|NCT03836040|Immunologic Factors|immunologic factors|mesh-ancestor
92411876|NCT03821272|Vaccines|vaccines|mesh-list
92411877|NCT03821272|Immunologic Factors|immunologic factors|mesh-ancestor
92412027|NCT03611881|Autonomic Agents|autonomic agents|mesh-ancestor
92411878|NCT03821272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411879|NCT03818737|Methylprednisolone|methylprednisolone|mesh-list
92411880|NCT03818737|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92411881|NCT03818737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92411882|NCT03818737|Antiemetics|antiemetics|mesh-ancestor
92411883|NCT03818737|Autonomic Agents|autonomic agents|mesh-ancestor
92411884|NCT03818737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411885|NCT03818737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411886|NCT03818737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92411887|NCT03818737|Glucocorticoids|glucocorticoids|mesh-ancestor
92411888|NCT03818737|Hormones|hormones|mesh-ancestor
92411889|NCT03818737|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411890|NCT03818737|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92411891|NCT03818737|Protective Agents|protective agents|mesh-ancestor
92411892|NCT03777982|Prednisone|prednisone|mesh-list
92411893|NCT03777982|Abiraterone Acetate|abiraterone acetate|mesh-list
92411894|NCT03777982|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92411895|NCT03777982|Glucocorticoids|glucocorticoids|mesh-ancestor
92411896|NCT03777982|Hormones|hormones|mesh-ancestor
92411897|NCT03777982|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92411898|NCT03777982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411899|NCT03777982|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92411900|NCT03777982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411901|NCT03777982|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92411902|NCT03777982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411903|NCT03777982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411904|NCT03777982|Hormone Antagonists|hormone antagonists|mesh-ancestor
92411905|NCT03777982|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92411906|NCT03770416|Nivolumab|nivolumab|mesh-list
92411907|NCT03770416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411908|NCT03770416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411909|NCT03770416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411910|NCT03770416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411911|NCT03769025|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92411912|NCT03769025|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92411913|NCT03769025|Narcotics|narcotics|mesh-ancestor
92411914|NCT03769025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92411915|NCT03769025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411916|NCT03769025|Analgesics|analgesics|mesh-ancestor
92411917|NCT03769025|Sensory System Agents|sensory system agents|mesh-ancestor
92411918|NCT03769025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411919|NCT03769025|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92411920|NCT03768063|Atezolizumab|atezolizumab|mesh-list
92411921|NCT03768063|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411922|NCT03768063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411923|NCT03768063|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411924|NCT03768063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411925|NCT03762473|Tacrolimus|tacrolimus|mesh-list
92411926|NCT03762473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411927|NCT03762473|Immunologic Factors|immunologic factors|mesh-ancestor
92411928|NCT03762473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411929|NCT03762473|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92411930|NCT03762473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92411931|NCT03762473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411932|NCT03761056|Cyclophosphamide|cyclophosphamide|mesh-list
92411933|NCT03761056|Fludarabine|fludarabine|mesh-list
92411934|NCT03761056|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92411935|NCT03761056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411936|NCT03761056|Immunologic Factors|immunologic factors|mesh-ancestor
92411937|NCT03761056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411938|NCT03761056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411939|NCT03761056|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92411940|NCT03761056|Alkylating Agents|alkylating agents|mesh-ancestor
92411941|NCT03761056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411942|NCT03761056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411943|NCT03761056|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92411944|NCT03761056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411945|NCT03759366|Eculizumab|eculizumab|mesh-list
92411946|NCT03759366|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92411947|NCT03759366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411948|NCT03759366|Immunologic Factors|immunologic factors|mesh-ancestor
92411949|NCT03759366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411950|NCT03736889|Tislelizumab|tislelizumab|mesh-list
92411951|NCT03736889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411952|NCT03736889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411953|NCT03733067|Abatacept|abatacept|mesh-list
92411954|NCT03733067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92411955|NCT03733067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411956|NCT03733067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411957|NCT03733067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411958|NCT03733067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92411959|NCT03733067|Immunologic Factors|immunologic factors|mesh-ancestor
92411960|NCT03733067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411961|NCT03733067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92411962|NCT03710343|Metformin|metformin|mesh-list
92411963|NCT03710343|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411964|NCT03710343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411965|NCT03677596|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
91940349|NCT04460521|Antioxidants|antioxidants|mesh-ancestor
92411966|NCT03677596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92411967|NCT03677596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411968|NCT03677596|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92411969|NCT03677596|Immunotoxins|immunotoxins|mesh-ancestor
92411970|NCT03677596|Immunoconjugates|immunoconjugates|mesh-ancestor
92411971|NCT03677596|Immunologic Factors|immunologic factors|mesh-ancestor
92411972|NCT03677596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411973|NCT03667846|Topiramate|topiramate|mesh-list
92411974|NCT03667846|Anticonvulsants|anticonvulsants|mesh-ancestor
92411975|NCT03667846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92411976|NCT03667846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411977|NCT03656536|Gemcitabine|gemcitabine|mesh-list
92411978|NCT03656536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92411979|NCT03656536|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92411980|NCT03656536|Antimetabolites|antimetabolites|mesh-ancestor
92411981|NCT03656536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92411982|NCT03648021|Acetaminophen|acetaminophen|mesh-list
92411983|NCT03648021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92411984|NCT03648021|Analgesics|analgesics|mesh-ancestor
92411985|NCT03648021|Sensory System Agents|sensory system agents|mesh-ancestor
92411986|NCT03648021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411987|NCT03648021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411988|NCT03648021|Antipyretics|antipyretics|mesh-ancestor
92411989|NCT03613792|Fentanyl|fentanyl|mesh-list
92411990|NCT03613792|Midazolam|midazolam|mesh-list
92411991|NCT03613792|Ketamine|ketamine|mesh-list
92411992|NCT03613792|Remifentanil|remifentanil|mesh-list
92411993|NCT03613792|Analgesics|analgesics|mesh-ancestor
92411994|NCT03613792|Sensory System Agents|sensory system agents|mesh-ancestor
92411995|NCT03613792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92411996|NCT03613792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92411997|NCT03613792|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92411998|NCT03613792|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92411999|NCT03613792|Anesthetics, General|anesthetics, general|mesh-ancestor
92412000|NCT03613792|Anesthetics|anesthetics|mesh-ancestor
92412001|NCT03613792|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92412002|NCT03613792|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92412003|NCT03613792|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92412004|NCT03613792|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92412005|NCT03613792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412006|NCT03613792|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92412007|NCT03613792|Narcotics|narcotics|mesh-ancestor
92412008|NCT03613792|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92412009|NCT03613792|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92412010|NCT03613792|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92412011|NCT03613792|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92412012|NCT03613792|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92412013|NCT03613792|GABA Modulators|gaba modulators|mesh-ancestor
92412014|NCT03613792|GABA Agents|gaba agents|mesh-ancestor
92412015|NCT03612960|Nicotine|nicotine|mesh-list
92412016|NCT03612960|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92412017|NCT03612960|Autonomic Agents|autonomic agents|mesh-ancestor
92412018|NCT03612960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412019|NCT03612960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412020|NCT03612960|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92412021|NCT03612960|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92412022|NCT03612960|Cholinergic Agents|cholinergic agents|mesh-ancestor
92412023|NCT03612960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92412024|NCT03612960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412025|NCT03611881|Nicotine|nicotine|mesh-list
92412026|NCT03611881|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92412028|NCT03611881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412029|NCT03611881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412030|NCT03611881|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92412031|NCT03611881|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92412032|NCT03611881|Cholinergic Agents|cholinergic agents|mesh-ancestor
92412033|NCT03611881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92412034|NCT03611881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412035|NCT03605927|Sirolimus|sirolimus|mesh-list
92412036|NCT03605927|Tacrolimus|tacrolimus|mesh-list
92412037|NCT03605927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412038|NCT03605927|Immunologic Factors|immunologic factors|mesh-ancestor
92412039|NCT03605927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412040|NCT03605927|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92412041|NCT03605927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412042|NCT03605927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412044|NCT03605927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412045|NCT03605927|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412046|NCT03605927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412047|NCT03605927|Antifungal Agents|antifungal agents|mesh-ancestor
92412048|NCT03595917|Prednisone|prednisone|mesh-list
92412049|NCT03595917|Dasatinib|dasatinib|mesh-list
92412050|NCT03595917|Blinatumomab|blinatumomab|mesh-list
92412051|NCT03595917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412052|NCT03595917|Glucocorticoids|glucocorticoids|mesh-ancestor
92412053|NCT03595917|Hormones|hormones|mesh-ancestor
92412054|NCT03595917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412055|NCT03595917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412056|NCT03595917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412057|NCT03595917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412058|NCT03595917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412059|NCT03595917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412060|NCT03595917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412061|NCT03594110|Empagliflozin|empagliflozin|mesh-list
92412062|NCT03594110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92412063|NCT03594110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412064|NCT03594110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92412065|NCT03594110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412066|NCT03591510|Cytarabine|cytarabine|mesh-list
92412067|NCT03591510|Fludarabine|fludarabine|mesh-list
92412068|NCT03591510|Etoposide|etoposide|mesh-list
92412069|NCT03591510|Daunorubicin|daunorubicin|mesh-list
92412070|NCT03591510|Mitoxantrone|mitoxantrone|mesh-list
92412071|NCT03591510|Idarubicin|idarubicin|mesh-list
92412072|NCT03591510|Midostaurin|midostaurin|mesh-list
92412073|NCT03591510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412074|NCT03591510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412075|NCT03591510|Antimetabolites|antimetabolites|mesh-ancestor
92412076|NCT03591510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412077|NCT03591510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412078|NCT03591510|Immunologic Factors|immunologic factors|mesh-ancestor
92412079|NCT03591510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412080|NCT03591510|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412081|NCT03591510|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412082|NCT03591510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412083|NCT03591510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412084|NCT03591510|Antiviral Agents|antiviral agents|mesh-ancestor
92412085|NCT03591510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412086|NCT03591510|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412087|NCT03591510|Analgesics|analgesics|mesh-ancestor
92412088|NCT03591510|Sensory System Agents|sensory system agents|mesh-ancestor
92412089|NCT03591510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412090|NCT03591510|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412091|NCT03584516|Prednisone|prednisone|mesh-list
92412092|NCT03584516|Methylprednisolone|methylprednisolone|mesh-list
92412093|NCT03584516|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92412094|NCT03584516|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92412095|NCT03584516|Prednisolone|prednisolone|mesh-list
92412096|NCT03584516|Prednisolone acetate|prednisolone acetate|mesh-list
92412097|NCT03584516|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92412098|NCT03584516|Prednisolone phosphate|prednisolone phosphate|mesh-list
92412099|NCT03584516|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412100|NCT03584516|Glucocorticoids|glucocorticoids|mesh-ancestor
92412101|NCT03584516|Hormones|hormones|mesh-ancestor
92412102|NCT03584516|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412103|NCT03584516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412334|NCT03193190|Gemcitabine|gemcitabine|mesh-list
92412104|NCT03584516|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412105|NCT03584516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412106|NCT03584516|Antiemetics|antiemetics|mesh-ancestor
92412107|NCT03584516|Autonomic Agents|autonomic agents|mesh-ancestor
92412108|NCT03584516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412109|NCT03584516|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92412110|NCT03584516|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92412111|NCT03584516|Protective Agents|protective agents|mesh-ancestor
92412112|NCT03575598|Nivolumab|nivolumab|mesh-list
92412113|NCT03575598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412114|NCT03575598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412115|NCT03575598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412116|NCT03575598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412117|NCT03531645|Fulvestrant|fulvestrant|mesh-list
92412118|NCT03531645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412119|NCT03531645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412120|NCT03531645|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92412121|NCT03531645|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92412122|NCT03531645|Hormone Antagonists|hormone antagonists|mesh-ancestor
92412123|NCT03531645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412124|NCT03531645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412125|NCT03493685|Irbesartan|irbesartan|mesh-list
92412126|NCT03493685|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92412127|NCT03493685|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92412128|NCT03493685|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92412129|NCT03493685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412130|NCT03462459|Vancomycin|vancomycin|mesh-list
92412131|NCT03462459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92412132|NCT03462459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412133|NCT03450343|Azacitidine|azacitidine|mesh-list
92412134|NCT03450343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412135|NCT03450343|Antimetabolites|antimetabolites|mesh-ancestor
92412136|NCT03450343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412137|NCT03450343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412138|NCT03450343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412139|NCT03440567|Rituximab|rituximab|mesh-list
92412140|NCT03440567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92412142|NCT03440567|Carboplatin|carboplatin|mesh-list
92412143|NCT03440567|Etoposide|etoposide|mesh-list
92412144|NCT03440567|Ifosfamide|ifosfamide|mesh-list
92412145|NCT03440567|Isophosphamide mustard|isophosphamide mustard|mesh-list
92412146|NCT03440567|Etoposide phosphate|etoposide phosphate|mesh-list
92412147|NCT03440567|Antibodies|antibodies|mesh-list
92412148|NCT03440567|Immunoglobulins|immunoglobulins|mesh-list
92412149|NCT03440567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92412150|NCT03440567|Immunoglobulin G|immunoglobulin g|mesh-list
92412151|NCT03440567|Immunologic Factors|immunologic factors|mesh-ancestor
92412152|NCT03440567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412153|NCT03440567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412154|NCT03440567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412155|NCT03440567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412156|NCT03440567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412157|NCT03440567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412158|NCT03440567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412159|NCT03440567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412160|NCT03440567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412161|NCT03440567|Alkylating Agents|alkylating agents|mesh-ancestor
92412162|NCT03425643|Gemcitabine|gemcitabine|mesh-list
92412163|NCT03425643|Pembrolizumab|pembrolizumab|mesh-list
92412164|NCT03425643|Pemetrexed|pemetrexed|mesh-list
92412165|NCT03425643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412166|NCT03425643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412167|NCT03425643|Antimetabolites|antimetabolites|mesh-ancestor
92412168|NCT03425643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412169|NCT03425643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412170|NCT03425643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412171|NCT03425643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412172|NCT03425643|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92412173|NCT03425643|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412174|NCT03423667|Acetylcysteine|acetylcysteine|mesh-list
92412175|NCT03423667|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92412176|NCT03423667|Antiviral Agents|antiviral agents|mesh-ancestor
92412177|NCT03423667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412178|NCT03423667|Expectorants|expectorants|mesh-ancestor
92412179|NCT03423667|Respiratory System Agents|respiratory system agents|mesh-ancestor
92412180|NCT03423667|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92412181|NCT03423667|Antioxidants|antioxidants|mesh-ancestor
92412182|NCT03423667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412183|NCT03423667|Protective Agents|protective agents|mesh-ancestor
92412184|NCT03423667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412185|NCT03423667|Antidotes|antidotes|mesh-ancestor
92412186|NCT03419897|Tislelizumab|tislelizumab|mesh-list
92412187|NCT03419897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412188|NCT03419897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412189|NCT03406897|Vitamin D|vitamin d|mesh-list
92412190|NCT03406897|Cholecalciferol|cholecalciferol|mesh-list
92412191|NCT03406897|Vitamins|vitamins|mesh-ancestor
92412192|NCT03406897|Micronutrients|micronutrients|mesh-ancestor
92412193|NCT03406897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412194|NCT03406897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92412195|NCT03406897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92412196|NCT03377049|Acetazolamide|acetazolamide|mesh-list
92412197|NCT03377049|Anticonvulsants|anticonvulsants|mesh-ancestor
92412198|NCT03377049|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92412199|NCT03377049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412200|NCT03377049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412201|NCT03377049|Diuretics|diuretics|mesh-ancestor
92412202|NCT03377049|Natriuretic Agents|natriuretic agents|mesh-ancestor
92412203|NCT03377049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412205|NCT03369223|Ipilimumab|ipilimumab|mesh-list
92412206|NCT03369223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412207|NCT03369223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412208|NCT03369223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412209|NCT03369223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412210|NCT03355976|Nivolumab|nivolumab|mesh-list
92412211|NCT03355976|Ipilimumab|ipilimumab|mesh-list
92412212|NCT03355976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412213|NCT03355976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412214|NCT03355976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412215|NCT03355976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412216|NCT03349450|Cyclophosphamide|cyclophosphamide|mesh-list
92412217|NCT03349450|Pembrolizumab|pembrolizumab|mesh-list
92412218|NCT03349450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412219|NCT03349450|Immunologic Factors|immunologic factors|mesh-ancestor
92412220|NCT03349450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412221|NCT03349450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412222|NCT03349450|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412223|NCT03349450|Alkylating Agents|alkylating agents|mesh-ancestor
92412224|NCT03349450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412225|NCT03349450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412226|NCT03349450|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92412227|NCT03349450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412228|NCT03349450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412229|NCT03341078|Ibudilast|ibudilast|mesh-list
92412230|NCT03341078|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92412231|NCT03341078|Autonomic Agents|autonomic agents|mesh-ancestor
92412232|NCT03341078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412233|NCT03341078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412234|NCT03341078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92412235|NCT03341078|Respiratory System Agents|respiratory system agents|mesh-ancestor
92412236|NCT03341078|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92412237|NCT03341078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412238|NCT03341078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412239|NCT03341078|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92412240|NCT03341078|Vasodilator Agents|vasodilator agents|mesh-ancestor
92412241|NCT03335488|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92412242|NCT03335488|Glycerol|glycerol|mesh-list
92412243|NCT03335488|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92412244|NCT03335488|Protective Agents|protective agents|mesh-ancestor
92412245|NCT03335488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412246|NCT03335488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412247|NCT03323437|Risperidone|risperidone|mesh-list
92412248|NCT03323437|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92412249|NCT03323437|Serotonin Agents|serotonin agents|mesh-ancestor
92412250|NCT03323437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92412251|NCT03323437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412252|NCT03323437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412253|NCT03323437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92412254|NCT03323437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92412255|NCT03323437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92412256|NCT03323437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92412257|NCT03323437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92412258|NCT03323437|Dopamine Agents|dopamine agents|mesh-ancestor
92412259|NCT03263572|Cytarabine|cytarabine|mesh-list
92412260|NCT03263572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92412261|NCT03263572|Methotrexate|methotrexate|mesh-list
91940354|NCT00698789|Metformin|metformin|mesh-list
92412262|NCT03263572|Blinatumomab|blinatumomab|mesh-list
92412263|NCT03263572|Ponatinib|ponatinib|mesh-list
92412264|NCT03263572|Antibodies|antibodies|mesh-list
92412265|NCT03263572|Immunoglobulins|immunoglobulins|mesh-list
92412266|NCT03263572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92412267|NCT03263572|Muromonab-CD3|muromonab-cd3|mesh-list
92412268|NCT03263572|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92412269|NCT03263572|Immunologic Factors|immunologic factors|mesh-ancestor
92412270|NCT03263572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412271|NCT03263572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412272|NCT03263572|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92412273|NCT03263572|Abortifacient Agents|abortifacient agents|mesh-ancestor
92412274|NCT03263572|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92412275|NCT03263572|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412276|NCT03263572|Antimetabolites|antimetabolites|mesh-ancestor
92412277|NCT03263572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412278|NCT03263572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92412279|NCT03263572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412280|NCT03263572|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92412281|NCT03263572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412282|NCT03263572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412283|NCT03263572|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412284|NCT03263572|Antiviral Agents|antiviral agents|mesh-ancestor
92412285|NCT03263572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412286|NCT03263572|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412287|NCT03244072|Moxifloxacin|moxifloxacin|mesh-list
92412288|NCT03244072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92412289|NCT03244072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412290|NCT03244072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412291|NCT03244072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412292|NCT03244072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412293|NCT03244072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412294|NCT03244072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412295|NCT03243058|Aldesleukin|aldesleukin|mesh-list
92412296|NCT03243058|Interleukin-2|interleukin-2|mesh-list
92412297|NCT03243058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412298|NCT03243058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92412299|NCT03243058|Analgesics|analgesics|mesh-ancestor
92412300|NCT03243058|Sensory System Agents|sensory system agents|mesh-ancestor
92412301|NCT03243058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412302|NCT03243058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412303|NCT03243058|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92412304|NCT03243058|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92412305|NCT03243058|Antiviral Agents|antiviral agents|mesh-ancestor
92412306|NCT03243058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412307|NCT03237689|Hydrocortisone|hydrocortisone|mesh-list
92412308|NCT03237689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412309|NCT03215277|Certolizumab Pegol|certolizumab pegol|mesh-list
92412310|NCT03215277|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92412311|NCT03215277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412312|NCT03215277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412313|NCT03215277|Immunologic Factors|immunologic factors|mesh-ancestor
92412314|NCT03215277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412315|NCT03215277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412316|NCT03214510|Fentanyl|fentanyl|mesh-list
92412317|NCT03214510|Hydromorphone|hydromorphone|mesh-list
92412318|NCT03214510|Bupivacaine|bupivacaine|mesh-list
92412319|NCT03214510|Anesthetics, Local|anesthetics, local|mesh-ancestor
92412320|NCT03214510|Anesthetics|anesthetics|mesh-ancestor
92412321|NCT03214510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92412322|NCT03214510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412323|NCT03214510|Sensory System Agents|sensory system agents|mesh-ancestor
92412324|NCT03214510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412325|NCT03214510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92412326|NCT03214510|Narcotics|narcotics|mesh-ancestor
92412327|NCT03214510|Analgesics|analgesics|mesh-ancestor
92412328|NCT03214510|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92412329|NCT03214510|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92412330|NCT03214510|Anesthetics, General|anesthetics, general|mesh-ancestor
92412332|NCT03193190|Paclitaxel|paclitaxel|mesh-list
92412333|NCT03193190|Bevacizumab|bevacizumab|mesh-list
92412338|NCT03193190|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412339|NCT03193190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412340|NCT03193190|Tubulin Modulators|tubulin modulators|mesh-ancestor
92412341|NCT03193190|Antimitotic Agents|antimitotic agents|mesh-ancestor
92412342|NCT03193190|Mitosis Modulators|mitosis modulators|mesh-ancestor
92412343|NCT03193190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412344|NCT03193190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412345|NCT03193190|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92412346|NCT03193190|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92412347|NCT03193190|Growth Substances|growth substances|mesh-ancestor
92412348|NCT03193190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412349|NCT03193190|Growth Inhibitors|growth inhibitors|mesh-ancestor
92412350|NCT03193190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412351|NCT03193190|Antimetabolites|antimetabolites|mesh-ancestor
92412352|NCT03193190|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412353|NCT03193190|Immunologic Factors|immunologic factors|mesh-ancestor
92412354|NCT03193190|Antidotes|antidotes|mesh-ancestor
92412355|NCT03193190|Protective Agents|protective agents|mesh-ancestor
92412356|NCT03193190|Vitamin B Complex|vitamin b complex|mesh-ancestor
92412357|NCT03193190|Vitamins|vitamins|mesh-ancestor
92412358|NCT03193190|Micronutrients|micronutrients|mesh-ancestor
92412359|NCT03193190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412360|NCT03182907|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92412361|NCT03182907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412362|NCT03170960|Atezolizumab|atezolizumab|mesh-list
92412363|NCT03170960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412364|NCT03170960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412365|NCT03170960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412366|NCT03170960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412367|NCT03037385|Pralsetinib|pralsetinib|mesh-list
92412368|NCT03037385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412369|NCT03016338|Niraparib|niraparib|mesh-list
92412370|NCT03016338|Dostarlimab|dostarlimab|mesh-list
92412371|NCT03016338|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92412372|NCT03016338|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412373|NCT03016338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412374|NCT03016338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412375|NCT02966756|Venetoclax|venetoclax|mesh-list
92412376|NCT02966756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412377|NCT02922192|Antirheumatic Agents|antirheumatic agents|mesh-list
92412378|NCT02921191|Lenograstim|lenograstim|mesh-list
92412379|NCT02921191|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92412380|NCT02921191|Immunologic Factors|immunologic factors|mesh-ancestor
92412381|NCT02921191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412382|NCT02911701|Acetaminophen|acetaminophen|mesh-list
92412383|NCT02911701|Ibuprofen|ibuprofen|mesh-list
92412384|NCT02911701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92412385|NCT02911701|Analgesics|analgesics|mesh-ancestor
92412386|NCT02911701|Sensory System Agents|sensory system agents|mesh-ancestor
92412387|NCT02911701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412388|NCT02911701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412389|NCT02911701|Antipyretics|antipyretics|mesh-ancestor
92412390|NCT02911701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92412391|NCT02911701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412392|NCT02911701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412393|NCT02911701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92412394|NCT02911701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412395|NCT02911701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412397|NCT02903368|Leuprolide|leuprolide|mesh-list
92412398|NCT02903368|Abiraterone Acetate|abiraterone acetate|mesh-list
92412399|NCT02903368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412400|NCT02903368|Glucocorticoids|glucocorticoids|mesh-ancestor
92412401|NCT02903368|Hormones|hormones|mesh-ancestor
92412402|NCT02903368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412403|NCT02903368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412404|NCT02903368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412405|NCT02903368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412406|NCT02903368|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92412407|NCT02903368|Fertility Agents|fertility agents|mesh-ancestor
92412408|NCT02903368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92412409|NCT02903368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92412410|NCT02903368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412411|NCT02903368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412412|NCT02903368|Hormone Antagonists|hormone antagonists|mesh-ancestor
92412413|NCT02903368|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92412416|NCT02899052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412417|NCT02899052|Antiemetics|antiemetics|mesh-ancestor
92412418|NCT02899052|Autonomic Agents|autonomic agents|mesh-ancestor
92412419|NCT02899052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412420|NCT02899052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412421|NCT02899052|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92412422|NCT02899052|Glucocorticoids|glucocorticoids|mesh-ancestor
92412423|NCT02899052|Hormones|hormones|mesh-ancestor
92412424|NCT02899052|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412425|NCT02899052|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412426|NCT02899052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412427|NCT02874742|Dexamethasone|dexamethasone|mesh-list
92412428|NCT02874742|Lenalidomide|lenalidomide|mesh-list
92412429|NCT02874742|Bortezomib|bortezomib|mesh-list
92412430|NCT02874742|Daratumumab|daratumumab|mesh-list
92412431|NCT02874742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412432|NCT02874742|Antiemetics|antiemetics|mesh-ancestor
92412433|NCT02874742|Autonomic Agents|autonomic agents|mesh-ancestor
92412434|NCT02874742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412435|NCT02874742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412436|NCT02874742|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92412437|NCT02874742|Glucocorticoids|glucocorticoids|mesh-ancestor
92412438|NCT02874742|Hormones|hormones|mesh-ancestor
92412439|NCT02874742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412440|NCT02874742|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412441|NCT02874742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412442|NCT02874742|Immunologic Factors|immunologic factors|mesh-ancestor
92412443|NCT02874742|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92412444|NCT02874742|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92412445|NCT02874742|Growth Substances|growth substances|mesh-ancestor
92412446|NCT02874742|Growth Inhibitors|growth inhibitors|mesh-ancestor
92412447|NCT02757859|Pancrelipase|pancrelipase|mesh-list
92412449|NCT02757859|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92412450|NCT02749292|Rituximab|rituximab|mesh-list
92412451|NCT02749292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412452|NCT02749292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412453|NCT02749292|Immunologic Factors|immunologic factors|mesh-ancestor
92412454|NCT02749292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412455|NCT02749292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412457|NCT02715609|Temozolomide|temozolomide|mesh-list
92412458|NCT02715609|Disulfiram|disulfiram|mesh-list
92412459|NCT02715609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412460|NCT02715609|Alkylating Agents|alkylating agents|mesh-ancestor
92412461|NCT02715609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412462|NCT02715609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412463|NCT02715609|Trace Elements|trace elements|mesh-ancestor
92412464|NCT02715609|Micronutrients|micronutrients|mesh-ancestor
92412465|NCT02715609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412466|NCT02715609|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92412467|NCT02715609|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92412468|NCT02715609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412469|NCT02714881|Certolizumab Pegol|certolizumab pegol|mesh-list
92412470|NCT02714881|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92412471|NCT02714881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412472|NCT02714881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412473|NCT02714881|Immunologic Factors|immunologic factors|mesh-ancestor
92412474|NCT02714881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412475|NCT02714881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412476|NCT02707042|Amoxicillin|amoxicillin|mesh-list
92412477|NCT02707042|Azithromycin|azithromycin|mesh-list
92412478|NCT02707042|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92412479|NCT02707042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412480|NCT02598661|Imetelstat|imetelstat|mesh-list
92412481|NCT02598661|Motesanib diphosphate|motesanib diphosphate|mesh-list
92412482|NCT02598661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412483|NCT02598661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412484|NCT02598661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412485|NCT02586831|Exenatide|exenatide|mesh-list
92412486|NCT02586831|Aldesleukin|aldesleukin|mesh-list
92412487|NCT02586831|Adalimumab|adalimumab|mesh-list
92412488|NCT02586831|Interleukin-2|interleukin-2|mesh-list
92412489|NCT02586831|Thymoglobulin|thymoglobulin|mesh-list
92412490|NCT02586831|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92412491|NCT02586831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92412492|NCT02586831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412493|NCT02586831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412494|NCT02586831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412495|NCT02586831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92412497|NCT02586831|Sensory System Agents|sensory system agents|mesh-ancestor
92412498|NCT02586831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412499|NCT02586831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412500|NCT02586831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92412501|NCT02586831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92412502|NCT02586831|Antiviral Agents|antiviral agents|mesh-ancestor
92412503|NCT02586831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412504|NCT02586831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92412505|NCT02586831|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92412506|NCT02586831|Incretins|incretins|mesh-ancestor
92412507|NCT02586831|Hormones|hormones|mesh-ancestor
92412508|NCT02586831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412509|NCT02586831|Immunologic Factors|immunologic factors|mesh-ancestor
92412510|NCT02586831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412511|NCT02576990|Pembrolizumab|pembrolizumab|mesh-list
92412512|NCT02576990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412513|NCT02576990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412514|NCT02576990|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412515|NCT02576990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412516|NCT02511106|Osimertinib|osimertinib|mesh-list
92412517|NCT02511106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412518|NCT02511106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412519|NCT02511106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412520|NCT02511106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412521|NCT02494882|Dexamethasone|dexamethasone|mesh-list
92412522|NCT02494882|Dasatinib|dasatinib|mesh-list
92412523|NCT02494882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412524|NCT02494882|Antiemetics|antiemetics|mesh-ancestor
92412525|NCT02494882|Autonomic Agents|autonomic agents|mesh-ancestor
92412526|NCT02494882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412527|NCT02494882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412528|NCT02494882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92412529|NCT02494882|Glucocorticoids|glucocorticoids|mesh-ancestor
92412530|NCT02494882|Hormones|hormones|mesh-ancestor
92412531|NCT02494882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412532|NCT02494882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412533|NCT02494882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412534|NCT02494882|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412535|NCT02494882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412536|NCT02494882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412537|NCT02481830|Nivolumab|nivolumab|mesh-list
92412538|NCT02481830|Topotecan|topotecan|mesh-list
92412539|NCT02481830|Amrubicin|amrubicin|mesh-list
92412540|NCT02481830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412541|NCT02481830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412542|NCT02481830|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412543|NCT02481830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412544|NCT02481830|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92412545|NCT02481830|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412546|NCT02481830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412547|NCT02425943|Mannitol|mannitol|mesh-list
92412548|NCT02425943|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92412549|NCT02425943|Diuretics|diuretics|mesh-ancestor
92412550|NCT02425943|Natriuretic Agents|natriuretic agents|mesh-ancestor
92412551|NCT02425943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412552|NCT02419495|Calcium, Dietary|calcium, dietary|mesh-list
92412553|NCT02419495|Leucovorin|leucovorin|mesh-list
92412554|NCT02419495|Folic Acid|folic acid|mesh-list
92412555|NCT02419495|Paclitaxel|paclitaxel|mesh-list
92412556|NCT02419495|Camptothecin|camptothecin|mesh-list
92412557|NCT02419495|Cyclophosphamide|cyclophosphamide|mesh-list
92412558|NCT02419495|Carboplatin|carboplatin|mesh-list
92412559|NCT02419495|Doxorubicin|doxorubicin|mesh-list
92412560|NCT02419495|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92412561|NCT02419495|Pembrolizumab|pembrolizumab|mesh-list
92412562|NCT02419495|Fluorouracil|fluorouracil|mesh-list
92412563|NCT02419495|Capecitabine|capecitabine|mesh-list
92412564|NCT02419495|Oxaliplatin|oxaliplatin|mesh-list
92412565|NCT02419495|Nivolumab|nivolumab|mesh-list
92412566|NCT02419495|Irinotecan|irinotecan|mesh-list
92412567|NCT02419495|Pemetrexed|pemetrexed|mesh-list
92412568|NCT02419495|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92412570|NCT02419495|Daunorubicin|daunorubicin|mesh-list
92412571|NCT02419495|Topotecan|topotecan|mesh-list
92412572|NCT02419495|Olaparib|olaparib|mesh-list
92412573|NCT02419495|Calcium|calcium|mesh-list
92412574|NCT02419495|Levoleucovorin|levoleucovorin|mesh-list
92412575|NCT02419495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412576|NCT02419495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412577|NCT02419495|Tubulin Modulators|tubulin modulators|mesh-ancestor
92412580|NCT02419495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412581|NCT02419495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412582|NCT02419495|Immunologic Factors|immunologic factors|mesh-ancestor
92412583|NCT02419495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412584|NCT02419495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412585|NCT02419495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412586|NCT02419495|Alkylating Agents|alkylating agents|mesh-ancestor
92412587|NCT02419495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92412588|NCT02419495|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412589|NCT02419495|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412590|NCT02419495|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412591|NCT02419495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412592|NCT02419495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412593|NCT02419495|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412594|NCT02419495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92412595|NCT02419495|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92412596|NCT02419495|Antimetabolites|antimetabolites|mesh-ancestor
92412597|NCT02419495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412598|NCT02419495|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92412599|NCT02419495|Antidotes|antidotes|mesh-ancestor
92412600|NCT02419495|Protective Agents|protective agents|mesh-ancestor
92412601|NCT02419495|Vitamin B Complex|vitamin b complex|mesh-ancestor
92412602|NCT02419495|Vitamins|vitamins|mesh-ancestor
92412603|NCT02419495|Micronutrients|micronutrients|mesh-ancestor
92412604|NCT02419495|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92412605|NCT02419495|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412606|NCT02419495|Hematinics|hematinics|mesh-ancestor
92412607|NCT02419495|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92412608|NCT02416674|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92412609|NCT02416674|Immunologic Factors|immunologic factors|mesh-ancestor
92412610|NCT02416674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412611|NCT02362997|Pembrolizumab|pembrolizumab|mesh-list
92412612|NCT02362997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412613|NCT02362997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412614|NCT02362997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412615|NCT02362997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412616|NCT02356159|Rituximab|rituximab|mesh-list
92412617|NCT02356159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412618|NCT02356159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412619|NCT02356159|Immunologic Factors|immunologic factors|mesh-ancestor
92412620|NCT02356159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412621|NCT02356159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412622|NCT02276443|Immunomodulating Agents|immunomodulating agents|mesh-list
92412623|NCT02276443|Immunologic Factors|immunologic factors|mesh-ancestor
92412624|NCT02276443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412625|NCT02220426|Xenon|xenon|mesh-list
92412626|NCT02220426|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92412627|NCT02220426|Anesthetics, General|anesthetics, general|mesh-ancestor
92412628|NCT02220426|Anesthetics|anesthetics|mesh-ancestor
92412629|NCT02220426|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92412630|NCT02220426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412631|NCT02135042|Paclitaxel|paclitaxel|mesh-list
92412632|NCT02135042|Cisplatin|cisplatin|mesh-list
92412633|NCT02135042|Gemcitabine|gemcitabine|mesh-list
92412634|NCT02135042|Fluorouracil|fluorouracil|mesh-list
92412635|NCT02135042|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92412636|NCT02135042|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412637|NCT02135042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412638|NCT02135042|Tubulin Modulators|tubulin modulators|mesh-ancestor
92412639|NCT02135042|Antimitotic Agents|antimitotic agents|mesh-ancestor
92412640|NCT02135042|Mitosis Modulators|mitosis modulators|mesh-ancestor
92412641|NCT02135042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412642|NCT02135042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412643|NCT02135042|Antimetabolites|antimetabolites|mesh-ancestor
92412644|NCT02135042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412645|NCT02135042|Immunologic Factors|immunologic factors|mesh-ancestor
92412646|NCT02135042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412648|NCT02123121|Antioxidants|antioxidants|mesh-ancestor
92412649|NCT02123121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412650|NCT02123121|Protective Agents|protective agents|mesh-ancestor
92412651|NCT02123121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412652|NCT02123121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412653|NCT02123121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92412654|NCT02031419|Rituximab|rituximab|mesh-list
92412655|NCT02031419|Spebrutinib|spebrutinib|mesh-list
92412656|NCT02031419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412657|NCT02031419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412658|NCT02031419|Immunologic Factors|immunologic factors|mesh-ancestor
92412659|NCT02031419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412660|NCT02031419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412661|NCT02031419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412662|NCT02031419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412663|NCT02031419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412664|NCT02009579|Nintedanib|nintedanib|mesh-list
92412665|NCT02009579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412666|NCT02009579|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412667|NCT02009579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412668|NCT02009579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412669|NCT01959698|Rituximab|rituximab|mesh-list
92412670|NCT01959698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92412671|NCT01959698|Carboplatin|carboplatin|mesh-list
92412672|NCT01959698|Etoposide|etoposide|mesh-list
92412673|NCT01959698|Etoposide phosphate|etoposide phosphate|mesh-list
92412674|NCT01959698|Ifosfamide|ifosfamide|mesh-list
92412675|NCT01959698|Isophosphamide mustard|isophosphamide mustard|mesh-list
92412676|NCT01959698|Podophyllotoxin|podophyllotoxin|mesh-list
92412677|NCT01959698|Antibodies|antibodies|mesh-list
92412678|NCT01959698|Immunoglobulins|immunoglobulins|mesh-list
92412679|NCT01959698|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92412680|NCT01959698|Immunologic Factors|immunologic factors|mesh-ancestor
92412681|NCT01959698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412682|NCT01959698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412683|NCT01959698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412684|NCT01959698|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412685|NCT01959698|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412686|NCT01959698|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412687|NCT01959698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412688|NCT01959698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412689|NCT01959698|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412690|NCT01959698|Alkylating Agents|alkylating agents|mesh-ancestor
92412691|NCT01959698|Keratolytic Agents|keratolytic agents|mesh-ancestor
92412692|NCT01959698|Dermatologic Agents|dermatologic agents|mesh-ancestor
92412693|NCT01959698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92412694|NCT01959698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92412695|NCT01959698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92412696|NCT01910402|Ritonavir|ritonavir|mesh-list
92412697|NCT01910402|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92412698|NCT01910402|Tenofovir|tenofovir|mesh-list
92412699|NCT01910402|Lamivudine|lamivudine|mesh-list
92412700|NCT01910402|Emtricitabine|emtricitabine|mesh-list
92412701|NCT01910402|Dolutegravir|dolutegravir|mesh-list
92412702|NCT01910402|Abacavir|abacavir|mesh-list
92412703|NCT01910402|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92412704|NCT01910402|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92412705|NCT01910402|Protease Inhibitors|protease inhibitors|mesh-ancestor
92412706|NCT01910402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412707|NCT01910402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412708|NCT01910402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92412709|NCT01910402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92412710|NCT01910402|Antiviral Agents|antiviral agents|mesh-ancestor
92412711|NCT01910402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412712|NCT01910402|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92412713|NCT01910402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92412714|NCT01910402|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92412715|NCT01910402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412716|NCT01910402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92412717|NCT01910402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92412719|NCT01772420|Immunologic Factors|immunologic factors|mesh-ancestor
92412720|NCT01772420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412721|NCT01772420|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92412722|NCT01772420|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92412723|NCT01772420|Growth Substances|growth substances|mesh-ancestor
92412724|NCT01772420|Growth Inhibitors|growth inhibitors|mesh-ancestor
92412725|NCT01772420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412726|NCT01757535|Azacitidine|azacitidine|mesh-list
92412727|NCT01757535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412728|NCT01757535|Antimetabolites|antimetabolites|mesh-ancestor
92412729|NCT01757535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412730|NCT01757535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412731|NCT01757535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412732|NCT01734512|Everolimus|everolimus|mesh-list
92412733|NCT01734512|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92412734|NCT01734512|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412735|NCT01734512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412736|NCT01734512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412737|NCT01734512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412738|NCT01734512|Immunologic Factors|immunologic factors|mesh-ancestor
92412739|NCT01734512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412740|NCT01734512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412741|NCT01728363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92412742|NCT01728363|Rifampin|rifampin|mesh-list
92412743|NCT01728363|Clindamycin|clindamycin|mesh-list
92412744|NCT01728363|Clavulanic Acid|clavulanic acid|mesh-list
92412745|NCT01728363|Ticarcillin|ticarcillin|mesh-list
92412746|NCT01728363|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
92412747|NCT01728363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412748|NCT01728363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92412749|NCT01728363|Antitubercular Agents|antitubercular agents|mesh-ancestor
92412750|NCT01728363|Leprostatic Agents|leprostatic agents|mesh-ancestor
92412751|NCT01728363|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412752|NCT01728363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412753|NCT01728363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412754|NCT01728363|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92412755|NCT01728363|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92412756|NCT01728363|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92412757|NCT01728363|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92412758|NCT01728363|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92412759|NCT01728363|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92412760|NCT01728363|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92412761|NCT01728363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92412763|NCT01614197|Hydrocortisone|hydrocortisone|mesh-list
92412764|NCT01614197|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92412765|NCT01614197|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92412766|NCT01614197|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92412767|NCT01614197|Cyclophosphamide|cyclophosphamide|mesh-list
92412768|NCT01614197|Methotrexate|methotrexate|mesh-list
92412769|NCT01614197|Etoposide|etoposide|mesh-list
92412770|NCT01614197|Temsirolimus|temsirolimus|mesh-list
92412771|NCT01614197|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412772|NCT01614197|Immunologic Factors|immunologic factors|mesh-ancestor
92412773|NCT01614197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412774|NCT01614197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412775|NCT01614197|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412776|NCT01614197|Alkylating Agents|alkylating agents|mesh-ancestor
92412777|NCT01614197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412778|NCT01614197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412779|NCT01614197|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92412780|NCT01614197|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92412781|NCT01614197|Abortifacient Agents|abortifacient agents|mesh-ancestor
92412782|NCT01614197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92412783|NCT01614197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412784|NCT01614197|Antimetabolites|antimetabolites|mesh-ancestor
92412785|NCT01614197|Dermatologic Agents|dermatologic agents|mesh-ancestor
92412786|NCT01614197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412787|NCT01614197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92412788|NCT01614197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412789|NCT01614197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412790|NCT01614197|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412792|NCT01614197|Antiviral Agents|antiviral agents|mesh-ancestor
92412793|NCT01614197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412794|NCT01614197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412795|NCT01614197|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92412796|NCT01614197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412797|NCT01422148|Minocycline|minocycline|mesh-list
92412799|NCT01422148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92412800|NCT01422148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412801|NCT01422148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92412802|NCT01422148|Vasodilator Agents|vasodilator agents|mesh-ancestor
92412803|NCT01422148|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92412804|NCT01422148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92412805|NCT01422148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412806|NCT01422148|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92412807|NCT01422148|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92412808|NCT01422148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92412809|NCT01422148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412810|NCT01422148|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92412811|NCT01422148|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92412812|NCT01422148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92412813|NCT01419561|Zidovudine|zidovudine|mesh-list
92412814|NCT01419561|Rituximab|rituximab|mesh-list
92412815|NCT01419561|Doxorubicin|doxorubicin|mesh-list
92412816|NCT01419561|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92412817|NCT01419561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412818|NCT01419561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412819|NCT01419561|Immunologic Factors|immunologic factors|mesh-ancestor
92412820|NCT01419561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412821|NCT01419561|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412822|NCT01419561|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412823|NCT01419561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412824|NCT01419561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412825|NCT01419561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412826|NCT01419561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412827|NCT01419561|Antimetabolites|antimetabolites|mesh-ancestor
92412828|NCT01419561|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92412829|NCT01419561|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412830|NCT01419561|Antiviral Agents|antiviral agents|mesh-ancestor
92412831|NCT01419561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412832|NCT01419561|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92412833|NCT01419561|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92412834|NCT01341964|Aspirin|aspirin|mesh-list
92412835|NCT01341964|Clopidogrel|clopidogrel|mesh-list
92412836|NCT01341964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92412837|NCT01341964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92412838|NCT01341964|Analgesics|analgesics|mesh-ancestor
92412839|NCT01341964|Sensory System Agents|sensory system agents|mesh-ancestor
92412840|NCT01341964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412841|NCT01341964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412842|NCT01341964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412843|NCT01341964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412844|NCT01341964|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92412845|NCT01341964|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92412846|NCT01341964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412847|NCT01341964|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92412848|NCT01341964|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92412849|NCT01341964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412850|NCT01341964|Antipyretics|antipyretics|mesh-ancestor
92412851|NCT01341964|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92412852|NCT01341964|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92412853|NCT01341964|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92412854|NCT01341964|Purinergic Agents|purinergic agents|mesh-ancestor
92412855|NCT01341964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92412856|NCT01267812|Rituximab|rituximab|mesh-list
92412857|NCT01267812|Bortezomib|bortezomib|mesh-list
92412858|NCT01267812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412859|NCT01267812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412860|NCT01267812|Immunologic Factors|immunologic factors|mesh-ancestor
92412861|NCT01267812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412862|NCT01267812|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412864|NCT01236521|Sensory System Agents|sensory system agents|mesh-ancestor
92412865|NCT01236521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92412866|NCT01236521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412867|NCT01101438|Metformin|metformin|mesh-list
92412868|NCT01101438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92412869|NCT01101438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412870|NCT01042379|Metformin|metformin|mesh-list
92412871|NCT01042379|Paclitaxel|paclitaxel|mesh-list
92412872|NCT01042379|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92412873|NCT01042379|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92412874|NCT01042379|Carboplatin|carboplatin|mesh-list
92412875|NCT01042379|Doxorubicin|doxorubicin|mesh-list
92412876|NCT01042379|Pembrolizumab|pembrolizumab|mesh-list
92412877|NCT01042379|Trastuzumab|trastuzumab|mesh-list
92412878|NCT01042379|Irinotecan|irinotecan|mesh-list
92412879|NCT01042379|Durvalumab|durvalumab|mesh-list
92412880|NCT01042379|Letrozole|letrozole|mesh-list
92412881|NCT01042379|Olaparib|olaparib|mesh-list
92412882|NCT01042379|Pertuzumab|pertuzumab|mesh-list
92412883|NCT01042379|Veliparib|veliparib|mesh-list
92412884|NCT01042379|Cemiplimab|cemiplimab|mesh-list
92412885|NCT01042379|Talazoparib|talazoparib|mesh-list
92412886|NCT01042379|Dostarlimab|dostarlimab|mesh-list
92412887|NCT01042379|Trebananib|trebananib|mesh-list
92412888|NCT01042379|Tucatinib|tucatinib|mesh-list
92412889|NCT01042379|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92412890|NCT01042379|SGN-LIV1A|sgn-liv1a|mesh-list
92412891|NCT01042379|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412892|NCT01042379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412893|NCT01042379|Tubulin Modulators|tubulin modulators|mesh-ancestor
92412894|NCT01042379|Antimitotic Agents|antimitotic agents|mesh-ancestor
92412895|NCT01042379|Mitosis Modulators|mitosis modulators|mesh-ancestor
92412896|NCT01042379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412897|NCT01042379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92412898|NCT01042379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412899|NCT01042379|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412900|NCT01042379|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412901|NCT01042379|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412902|NCT01042379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412903|NCT01042379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412904|NCT01042379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92412905|NCT01042379|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92412906|NCT01042379|Immunologic Factors|immunologic factors|mesh-ancestor
92412907|NCT01042379|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92412908|NCT01042379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92412909|NCT01042379|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92412910|NCT01042379|Hormone Antagonists|hormone antagonists|mesh-ancestor
92412911|NCT01042379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412912|NCT01042379|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92412913|NCT01042379|Immunotoxins|immunotoxins|mesh-ancestor
92412914|NCT01042379|Immunoconjugates|immunoconjugates|mesh-ancestor
92412915|NCT01042379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92412916|NCT01042379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92412917|NCT01042379|Growth Substances|growth substances|mesh-ancestor
92412918|NCT01042379|Growth Inhibitors|growth inhibitors|mesh-ancestor
92412919|NCT01042379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92412920|NCT00670358|Prednisone|prednisone|mesh-list
92412921|NCT00670358|Cyclophosphamide|cyclophosphamide|mesh-list
92412922|NCT00670358|Rituximab|rituximab|mesh-list
92412923|NCT00670358|Doxorubicin|doxorubicin|mesh-list
92412924|NCT00670358|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92412925|NCT00670358|Vincristine|vincristine|mesh-list
92412926|NCT00670358|Lenalidomide|lenalidomide|mesh-list
92412927|NCT00670358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412928|NCT00670358|Immunologic Factors|immunologic factors|mesh-ancestor
92412929|NCT00670358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412930|NCT00670358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412931|NCT00670358|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412932|NCT00670358|Alkylating Agents|alkylating agents|mesh-ancestor
92412933|NCT00670358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412934|NCT00670358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412935|NCT00670358|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92412936|NCT00670358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92412937|NCT00670358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412938|NCT00670358|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412939|NCT00670358|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412940|NCT00670358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412941|NCT00670358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92412942|NCT00670358|Glucocorticoids|glucocorticoids|mesh-ancestor
92412943|NCT00670358|Hormones|hormones|mesh-ancestor
92412944|NCT00670358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92412945|NCT00670358|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92412946|NCT00670358|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412947|NCT00670358|Tubulin Modulators|tubulin modulators|mesh-ancestor
92412948|NCT00670358|Antimitotic Agents|antimitotic agents|mesh-ancestor
92412949|NCT00670358|Mitosis Modulators|mitosis modulators|mesh-ancestor
92412950|NCT00670358|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92412951|NCT00670358|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92412952|NCT00670358|Growth Substances|growth substances|mesh-ancestor
92412953|NCT00670358|Growth Inhibitors|growth inhibitors|mesh-ancestor
92412954|NCT00544115|Cyclosporine|cyclosporine|mesh-list
92412955|NCT00544115|Sirolimus|sirolimus|mesh-list
92412956|NCT00544115|Mycophenolic Acid|mycophenolic acid|mesh-list
92412957|NCT00544115|Cyclophosphamide|cyclophosphamide|mesh-list
92412958|NCT00544115|Melphalan|melphalan|mesh-list
92412959|NCT00544115|Busulfan|busulfan|mesh-list
92412960|NCT00544115|Methotrexate|methotrexate|mesh-list
92412961|NCT00544115|Fludarabine|fludarabine|mesh-list
92412962|NCT00544115|Fludarabine phosphate|fludarabine phosphate|mesh-list
92412963|NCT00544115|Etoposide|etoposide|mesh-list
92412964|NCT00544115|Tacrolimus|tacrolimus|mesh-list
92412965|NCT00544115|Cyclosporins|cyclosporins|mesh-list
92412966|NCT00544115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92412967|NCT00544115|Immunologic Factors|immunologic factors|mesh-ancestor
92412968|NCT00544115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92412969|NCT00544115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92412970|NCT00544115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92412971|NCT00544115|Alkylating Agents|alkylating agents|mesh-ancestor
92412972|NCT00544115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92412973|NCT00544115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92412974|NCT00544115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92412975|NCT00544115|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92412976|NCT00544115|Abortifacient Agents|abortifacient agents|mesh-ancestor
92412977|NCT00544115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92412978|NCT00544115|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92412979|NCT00544115|Antimetabolites|antimetabolites|mesh-ancestor
92412980|NCT00544115|Dermatologic Agents|dermatologic agents|mesh-ancestor
92412981|NCT00544115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92412982|NCT00544115|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92412983|NCT00544115|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92412984|NCT00544115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92412985|NCT00544115|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92412986|NCT00544115|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92412987|NCT00544115|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92412988|NCT00544115|Antifungal Agents|antifungal agents|mesh-ancestor
92412989|NCT00544115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92412990|NCT00544115|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92412991|NCT00544115|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92412992|NCT00544115|Antitubercular Agents|antitubercular agents|mesh-ancestor
92412993|NCT00544115|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936793|NCT01495013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936794|NCT01495013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91936795|NCT01495013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91936796|NCT01495013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936797|NCT01495013|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91936798|NCT01495013|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936799|NCT01495013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936800|NCT01495013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936801|NCT01495013|Immunologic Factors|immunologic factors|mesh-ancestor
91936802|NCT02264171|Ketoconazole|ketoconazole|mesh-list
91936804|NCT02264171|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91936805|NCT02264171|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91936806|NCT02264171|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91936807|NCT02264171|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936808|NCT02264171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095896|NCT03233139|Ipilimumab|ipilimumab|mesh-list
91940382|NCT03495739|Anticoagulants|anticoagulants|mesh-ancestor
92095898|NCT03233139|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92081533|NCT01920061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932428|NCT04972123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940417|NCT02011321|Clevidipine|clevidipine|mesh-list
92081534|NCT01920061|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081535|NCT01920061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932429|NCT04972123|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91940452|NCT03484507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940454|NCT03484507|Plasma Substitutes|plasma substitutes|mesh-ancestor
92081537|NCT01426347|Ergocalciferols|ergocalciferols|mesh-list
91940462|NCT02744183|Benzocaine|benzocaine|mesh-list
91932430|NCT04972123|Mydriatics|mydriatics|mesh-ancestor
91932431|NCT04972123|Autonomic Agents|autonomic agents|mesh-ancestor
91940471|NCT03484195|Irinotecan|irinotecan|mesh-list
92081539|NCT01426347|Micronutrients|micronutrients|mesh-ancestor
91940501|NCT02323399|Phenylephrine|phenylephrine|mesh-list
91940538|NCT00873275|Leucovorin|leucovorin|mesh-list
91940938|NCT00728351|Vildagliptin|vildagliptin|mesh-list
91932432|NCT04972123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932433|NCT04972123|Sympathomimetics|sympathomimetics|mesh-ancestor
91941000|NCT02357368|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91941014|NCT04873570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932434|NCT04972123|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91932435|NCT04972123|Nasal Decongestants|nasal decongestants|mesh-ancestor
91941046|NCT03486925|Oxytocin|oxytocin|mesh-list
91941047|NCT03486925|Oxytocics|oxytocics|mesh-ancestor
91941079|NCT02356588|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91941099|NCT02355028|Growth Substances|growth substances|mesh-ancestor
91941110|NCT05647330|Antimetabolites|antimetabolites|mesh-ancestor
91941120|NCT01643668|Busulfan|busulfan|mesh-list
92081540|NCT01426347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941162|NCT04179019|Amlodipine|amlodipine|mesh-list
91941176|NCT02260492|Autonomic Agents|autonomic agents|mesh-ancestor
91941192|NCT02260492|Sympathomimetics|sympathomimetics|mesh-ancestor
91932436|NCT04972123|Respiratory System Agents|respiratory system agents|mesh-ancestor
91941234|NCT02523859|Propofol|propofol|mesh-list
92095899|NCT03233139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932437|NCT04972123|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91941275|NCT02259088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941279|NCT02259010|Antifungal Agents|antifungal agents|mesh-ancestor
91932438|NCT04972123|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92081542|NCT01426347|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92081543|NCT04612309|Immunomodulating Agents|immunomodulating agents|mesh-list
92081544|NCT04612309|Immunologic Factors|immunologic factors|mesh-ancestor
92081545|NCT04612309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081547|NCT04415983|Clarithromycin|clarithromycin|mesh-list
92081548|NCT04415983|Nitazoxanide|nitazoxanide|mesh-list
92081549|NCT04415983|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92081550|NCT04415983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081551|NCT04415983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92081552|NCT04415983|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92081553|NCT04415983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92081554|NCT04415983|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91932439|NCT04972123|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91941295|NCT05153785|Anesthetics|anesthetics|mesh-ancestor
92074234|NCT01475253|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91932441|NCT04972123|Protective Agents|protective agents|mesh-ancestor
91932442|NCT04972123|Antipruritics|antipruritics|mesh-ancestor
91941328|NCT00609323|Sensory System Agents|sensory system agents|mesh-ancestor
92095900|NCT03233139|Tubulin Modulators|tubulin modulators|mesh-ancestor
91932443|NCT04972123|Dermatologic Agents|dermatologic agents|mesh-ancestor
91941357|NCT04473053|Nafamostat|nafamostat|mesh-list
92095901|NCT03233139|Antimitotic Agents|antimitotic agents|mesh-ancestor
91941384|NCT02281721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932444|NCT04972123|Sensory System Agents|sensory system agents|mesh-ancestor
92074235|NCT01475253|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91932447|NCT02322892|Micronutrients|micronutrients|mesh-ancestor
92095902|NCT03233139|Mitosis Modulators|mitosis modulators|mesh-ancestor
91941400|NCT01642732|Androgen Antagonists|androgen antagonists|mesh-ancestor
91941418|NCT02283515|Antimetabolites|antimetabolites|mesh-ancestor
91932448|NCT02322892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932449|NCT02322892|Vitamin B Complex|vitamin b complex|mesh-ancestor
91941436|NCT02190721|Lenograstim|lenograstim|mesh-list
91932450|NCT03274375|Rituximab|rituximab|mesh-list
91941438|NCT02190721|Immunologic Factors|immunologic factors|mesh-ancestor
91941476|NCT03480997|Bromides|bromides|mesh-list
92074236|NCT01475253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941481|NCT03480997|Autonomic Agents|autonomic agents|mesh-ancestor
91941491|NCT03480997|Adrenergic Agents|adrenergic agents|mesh-ancestor
91941492|NCT03480997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941498|NCT02348008|Pembrolizumab|pembrolizumab|mesh-list
91941502|NCT02348008|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91941514|NCT04468087|Protease Inhibitors|protease inhibitors|mesh-ancestor
91941515|NCT04468087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941537|NCT05944887|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941541|NCT05944887|Sensory System Agents|sensory system agents|mesh-ancestor
91941592|NCT05944341|Sensory System Agents|sensory system agents|mesh-ancestor
91941596|NCT05944341|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91941608|NCT05944341|Mydriatics|mydriatics|mesh-ancestor
91941645|NCT05943821|Allopurinol|allopurinol|mesh-list
91932451|NCT03274375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941687|NCT05943535|Treprostinil|treprostinil|mesh-list
91941690|NCT05943470|Dialysis Solutions|dialysis solutions|mesh-list
91932452|NCT03274375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941731|NCT05943158|Folic Acid|folic acid|mesh-list
91941732|NCT05943158|Vitamin B Complex|vitamin b complex|mesh-list
91941768|NCT05939622|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91941773|NCT05939193|Furosemide|furosemide|mesh-list
91941777|NCT05939193|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91941778|NCT05939193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941779|NCT05939193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941780|NCT05938387|Vaccines|vaccines|mesh-list
91941781|NCT05938387|Immunologic Factors|immunologic factors|mesh-ancestor
91932453|NCT03274375|Immunologic Factors|immunologic factors|mesh-ancestor
91941881|NCT05813327|Ifosfamide|ifosfamide|mesh-list
91941886|NCT05813327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941900|NCT05797506|Sulforaphane|sulforaphane|mesh-list
91941908|NCT05784753|8-chloro-cyclic adenosine monophosphate|8-chloro-cyclic adenosine monophosphate|mesh-list
91941909|NCT05784753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941911|NCT05784753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941922|NCT05768360|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91941930|NCT05768360|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91941932|NCT05756972|Carboplatin|carboplatin|mesh-list
91932454|NCT03274375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941948|NCT05737693|Anesthetics|anesthetics|mesh-ancestor
91932455|NCT03274375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941956|NCT05737693|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91932456|NCT02739997|Metronidazole|metronidazole|mesh-list
91942100|NCT05600426|Immunologic Factors|immunologic factors|mesh-ancestor
91932457|NCT02739997|Tazobactam|tazobactam|mesh-list
91942134|NCT05569954|Immunologic Factors|immunologic factors|mesh-ancestor
91942139|NCT05567094|Dexamethasone|dexamethasone|mesh-list
91942141|NCT05567094|Antiemetics|antiemetics|mesh-ancestor
91942143|NCT05567094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932458|NCT02739997|Ceftolozane|ceftolozane|mesh-list
91942167|NCT05537220|Acetylcysteine|acetylcysteine|mesh-list
91942218|NCT05401227|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91942251|NCT05364424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942260|NCT05362058|Insulin|insulin|mesh-list
91932459|NCT02739997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942279|NCT05350774|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91942280|NCT05350774|Antibodies|antibodies|mesh-list
91942298|NCT05334329|Cyclophosphamide|cyclophosphamide|mesh-list
91942367|NCT05255653|Contraceptive Agents|contraceptive agents|mesh-ancestor
91932460|NCT02739997|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91942416|NCT05120349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942447|NCT05103358|Antifungal Agents|antifungal agents|mesh-ancestor
91942448|NCT05103358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942449|NCT05103358|Immunologic Factors|immunologic factors|mesh-ancestor
91942450|NCT05103358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942467|NCT05076175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932462|NCT02739997|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91942470|NCT05072314|Lidocaine|lidocaine|mesh-list
91942512|NCT05006079|Morphine|morphine|mesh-list
91932463|NCT02739997|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91942580|NCT04959175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942615|NCT04895137|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942621|NCT04852224|Leuprolide|leuprolide|mesh-list
91942649|NCT04744545|Curcumin|curcumin|mesh-list
91942664|NCT04740905|Aflibercept|aflibercept|mesh-list
91942678|NCT04667117|Ofatumumab|ofatumumab|mesh-list
91942704|NCT04650893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942738|NCT04510194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91911918|NCT02145091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91911919|NCT02145091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91911920|NCT02145091|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91911921|NCT03352934|Avelumab|avelumab|mesh-list
91911922|NCT03352934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91911923|NCT03352934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91911924|NCT04871828|Leukotriene Antagonists|leukotriene antagonists|mesh-list
91911925|NCT04871828|Hormone Antagonists|hormone antagonists|mesh-ancestor
91911926|NCT04871828|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91911927|NCT04871828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91911928|NCT04871828|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91911929|NCT04871828|Respiratory System Agents|respiratory system agents|mesh-ancestor
91911930|NCT04881110|Liraglutide|liraglutide|mesh-list
91911931|NCT04881110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91911932|NCT04881110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91911933|NCT04881110|Incretins|incretins|mesh-ancestor
91911934|NCT04881110|Hormones|hormones|mesh-ancestor
91911935|NCT04881110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91911936|NCT02152423|Enoxaparin|enoxaparin|mesh-list
91911937|NCT02152423|Anticoagulants|anticoagulants|mesh-ancestor
91911938|NCT02152423|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91911939|NCT02152423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91911940|NCT02152423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91911941|NCT02145559|Metformin|metformin|mesh-list
91911942|NCT02145559|Sirolimus|sirolimus|mesh-list
91911943|NCT02145559|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91911944|NCT02145559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91911945|NCT02145559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91911946|NCT02145559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91911947|NCT02145559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91911948|NCT02145559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91911949|NCT02145559|Antifungal Agents|antifungal agents|mesh-ancestor
91911950|NCT02145559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91911951|NCT02145559|Immunologic Factors|immunologic factors|mesh-ancestor
91911952|NCT02145637|Afatinib|afatinib|mesh-list
91911953|NCT02145637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91911954|NCT02145637|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91911955|NCT02145637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91911956|NCT02145637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91911960|NCT03154580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91911961|NCT03154580|Expectorants|expectorants|mesh-ancestor
91911962|NCT03154580|Respiratory System Agents|respiratory system agents|mesh-ancestor
91911963|NCT03154580|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91911964|NCT03154580|Antioxidants|antioxidants|mesh-ancestor
91911965|NCT03154580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91911966|NCT03154580|Protective Agents|protective agents|mesh-ancestor
91911967|NCT03154580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91911968|NCT03154580|Antidotes|antidotes|mesh-ancestor
91911969|NCT02145715|Thalidomide|thalidomide|mesh-list
91911970|NCT02145715|Dexamethasone|dexamethasone|mesh-list
91911971|NCT02145715|Bortezomib|bortezomib|mesh-list
91911972|NCT02145715|Panobinostat|panobinostat|mesh-list
91911973|NCT02145715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91911975|NCT02145715|Autonomic Agents|autonomic agents|mesh-ancestor
91911976|NCT02145715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91911977|NCT02145715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91911978|NCT02145715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91911979|NCT02145715|Glucocorticoids|glucocorticoids|mesh-ancestor
91911980|NCT02145715|Hormones|hormones|mesh-ancestor
91942896|NCT04141995|Calcium|calcium|mesh-list
91911981|NCT02145715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91911982|NCT02145715|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91911983|NCT02145715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91911984|NCT02145715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91911986|NCT02145715|Leprostatic Agents|leprostatic agents|mesh-ancestor
91911987|NCT02145715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91911988|NCT02145715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91911989|NCT02145715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91911990|NCT02145715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91911991|NCT02145715|Growth Substances|growth substances|mesh-ancestor
91911992|NCT02145715|Growth Inhibitors|growth inhibitors|mesh-ancestor
91911993|NCT02145715|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91911994|NCT02145715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91911995|NCT02145715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91911997|NCT04871750|Chelating Agents|chelating agents|mesh-ancestor
91911998|NCT04871750|Sequestering Agents|sequestering agents|mesh-ancestor
91911999|NCT04871750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912000|NCT02152579|Isosorbide|isosorbide|mesh-list
91912001|NCT02152579|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
91912002|NCT02152579|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91912003|NCT02152579|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91912004|NCT02152579|Diuretics|diuretics|mesh-ancestor
91912005|NCT02152579|Natriuretic Agents|natriuretic agents|mesh-ancestor
91912006|NCT02152579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912007|NCT02152579|Vasodilator Agents|vasodilator agents|mesh-ancestor
91912008|NCT02152579|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91912009|NCT02152579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912010|NCT02155777|Norinyl|norinyl|mesh-list
91912011|NCT02155777|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91912012|NCT02155777|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91912013|NCT02155777|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91912014|NCT02155777|Contraceptive Agents|contraceptive agents|mesh-ancestor
91912015|NCT02155777|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91912016|NCT02155777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912017|NCT02155777|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91912018|NCT02155777|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91912020|NCT02145949|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91912021|NCT02145949|Antidepressive Agents|antidepressive agents|mesh-ancestor
91912022|NCT02145949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91912023|NCT00806390|Metoprolol|metoprolol|mesh-list
91912024|NCT00806390|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91912025|NCT00806390|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912026|NCT00806390|Sympatholytics|sympatholytics|mesh-ancestor
91912027|NCT00806390|Autonomic Agents|autonomic agents|mesh-ancestor
91912028|NCT00806390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912029|NCT00806390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912030|NCT00806390|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91912031|NCT00806390|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91912032|NCT00806390|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91912033|NCT00806390|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912034|NCT00806390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912035|NCT00806390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912036|NCT00566618|Zoledronic Acid|zoledronic acid|mesh-list
91912037|NCT00566618|Dasatinib|dasatinib|mesh-list
91912038|NCT00566618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912039|NCT00566618|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91912040|NCT00566618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912041|NCT00566618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912042|NCT00566618|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91912043|NCT00566618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912044|NCT02769481|Glimepiride|glimepiride|mesh-list
91912045|NCT02769481|Bexagliflozin|bexagliflozin|mesh-list
91912046|NCT02769481|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91912047|NCT02769481|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91912048|NCT02769481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912049|NCT02769481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912050|NCT02769481|Immunologic Factors|immunologic factors|mesh-ancestor
91912051|NCT04877210|Insulin|insulin|mesh-list
91912052|NCT04877210|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91912053|NCT04877210|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91912054|NCT04877210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912055|NCT02152969|Amlodipine|amlodipine|mesh-list
91912056|NCT02152969|Telmisartan|telmisartan|mesh-list
91912057|NCT02152969|Chlorthalidone|chlorthalidone|mesh-list
91912058|NCT02152969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912059|NCT02152969|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91912060|NCT02152969|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91912061|NCT02152969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912062|NCT02152969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91912063|NCT02152969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912064|NCT02152969|Vasodilator Agents|vasodilator agents|mesh-ancestor
91912065|NCT02152969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91912066|NCT02152969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91912067|NCT02152969|Diuretics|diuretics|mesh-ancestor
91912068|NCT02152969|Natriuretic Agents|natriuretic agents|mesh-ancestor
91912069|NCT02152969|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91912070|NCT04879004|Ropivacaine|ropivacaine|mesh-list
91912071|NCT04879004|Anesthetics, Local|anesthetics, local|mesh-ancestor
91912072|NCT04879004|Anesthetics|anesthetics|mesh-ancestor
91912073|NCT04879004|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912074|NCT04879004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912075|NCT04879004|Sensory System Agents|sensory system agents|mesh-ancestor
91912076|NCT04879004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912077|NCT02153125|Eplerenone|eplerenone|mesh-list
91912078|NCT02153125|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91912079|NCT02153125|Hormone Antagonists|hormone antagonists|mesh-ancestor
91912080|NCT02153125|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912081|NCT02153125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912082|NCT02153125|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91912083|NCT02153125|Diuretics|diuretics|mesh-ancestor
91912084|NCT02153125|Natriuretic Agents|natriuretic agents|mesh-ancestor
91912085|NCT02153125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912086|NCT04878926|Midazolam|midazolam|mesh-list
91912087|NCT04878926|Propofol|propofol|mesh-list
91912088|NCT04878926|Anesthetics|anesthetics|mesh-list
91912089|NCT04878926|Anesthetics, Local|anesthetics, local|mesh-list
91912090|NCT04878926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91912091|NCT04878926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912092|NCT04878926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912093|NCT04878926|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91912094|NCT04878926|Anesthetics, General|anesthetics, general|mesh-ancestor
91912095|NCT04878926|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91912096|NCT04878926|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91912097|NCT04878926|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91912098|NCT04878926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91912099|NCT04878926|GABA Modulators|gaba modulators|mesh-ancestor
91912100|NCT04878926|GABA Agents|gaba agents|mesh-ancestor
91912101|NCT04878926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912102|NCT04878926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912103|NCT04878926|Sensory System Agents|sensory system agents|mesh-ancestor
91912104|NCT04878926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912105|NCT04862767|Aldesleukin|aldesleukin|mesh-list
91912106|NCT04862767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912107|NCT04862767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91912108|NCT04862767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91912109|NCT04862767|Antiviral Agents|antiviral agents|mesh-ancestor
91912110|NCT04862767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912111|NCT02146261|Quetmolimab|quetmolimab|mesh-list
91912112|NCT02146261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912113|NCT02153281|Phenelzine|phenelzine|mesh-list
91912114|NCT02153281|Antidepressive Agents|antidepressive agents|mesh-ancestor
91912115|NCT02153281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91912116|NCT02153281|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91912117|NCT02153281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912118|NCT02153281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912119|NCT03542851|Pentylenetetrazole|pentylenetetrazole|mesh-list
91912120|NCT03542851|Convulsants|convulsants|mesh-ancestor
91912121|NCT03542851|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91912122|NCT03542851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912123|NCT03542851|GABA Antagonists|gaba antagonists|mesh-ancestor
91912124|NCT03542851|GABA Agents|gaba agents|mesh-ancestor
91912125|NCT03542851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912126|NCT03542851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912128|NCT02769247|Lidocaine|lidocaine|mesh-list
91912129|NCT02769247|Anesthetics, Local|anesthetics, local|mesh-ancestor
91912130|NCT02769247|Anesthetics|anesthetics|mesh-ancestor
91912131|NCT02769247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912132|NCT02769247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912133|NCT02769247|Sensory System Agents|sensory system agents|mesh-ancestor
91912134|NCT02769247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912135|NCT02769247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91912136|NCT02769247|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91912137|NCT02769247|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91912138|NCT02769247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91912139|NCT02769247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912140|NCT02769247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91912141|NCT02769247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91912142|NCT02769247|Analgesics|analgesics|mesh-ancestor
91912143|NCT02769247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912144|NCT02769247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912145|NCT02769247|Gout Suppressants|gout suppressants|mesh-ancestor
91912146|NCT02769247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91912147|NCT02769247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912149|NCT02153437|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91912150|NCT02153437|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91912151|NCT02153437|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912152|NCT02153437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912153|NCT02153437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912154|NCT02153437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912155|NCT02153437|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91912156|NCT02153437|Sympatholytics|sympatholytics|mesh-ancestor
91912157|NCT02153437|Autonomic Agents|autonomic agents|mesh-ancestor
91912158|NCT02153437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912159|NCT02146651|Insulin|insulin|mesh-list
91912160|NCT02146651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91912161|NCT02146651|Insulin Lispro|insulin lispro|mesh-list
91912162|NCT02146651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91912163|NCT02146651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912164|NCT03542149|Tocopherols|tocopherols|mesh-list
91912165|NCT03542149|Vitamin E|vitamin e|mesh-list
91912166|NCT03542149|Tocotrienols|tocotrienols|mesh-list
91912168|NCT03542149|Piperaquine|piperaquine|mesh-list
91912169|NCT03542149|Antimalarials|antimalarials|mesh-ancestor
91912170|NCT03542149|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91912171|NCT03542149|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91912172|NCT03542149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912173|NCT03542149|Antioxidants|antioxidants|mesh-ancestor
91912174|NCT03542149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912175|NCT03542149|Protective Agents|protective agents|mesh-ancestor
91912176|NCT03542149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912177|NCT03542149|Vitamins|vitamins|mesh-ancestor
91912178|NCT03542149|Micronutrients|micronutrients|mesh-ancestor
91912179|NCT02153593|Tranexamic Acid|tranexamic acid|mesh-list
91912180|NCT02153593|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91912181|NCT02153593|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91912182|NCT02153593|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91912183|NCT02153593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912184|NCT02153593|Hemostatics|hemostatics|mesh-ancestor
91912185|NCT02153593|Coagulants|coagulants|mesh-ancestor
91912186|NCT02154217|Timolol|timolol|mesh-list
91912187|NCT02154217|Bimatoprost|bimatoprost|mesh-list
91912188|NCT02154217|Latanoprost|latanoprost|mesh-list
91912189|NCT02154217|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91912190|NCT02154217|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91912191|NCT02154217|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912192|NCT02154217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912193|NCT02154217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912194|NCT02154217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912195|NCT02154217|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91912196|NCT02154217|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912197|NCT02154217|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91912198|NCT02154217|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91912199|NCT02147041|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
91912200|NCT02147041|Antioxidants|antioxidants|mesh-ancestor
91912201|NCT02147041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912202|NCT02147041|Protective Agents|protective agents|mesh-ancestor
91912203|NCT02147041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912204|NCT02147041|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
91912205|NCT02147041|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91912206|NCT02147041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912207|NCT02147041|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91912208|NCT02767765|Epoetin Alfa|epoetin alfa|mesh-list
91912209|NCT02767765|Hematinics|hematinics|mesh-ancestor
91912210|NCT00103207|Cetuximab|cetuximab|mesh-list
91912211|NCT00103207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91912212|NCT00103207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912213|NCT02254915|BCG Vaccine|bcg vaccine|mesh-list
91912214|NCT02254915|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91912215|NCT02254915|Immunologic Factors|immunologic factors|mesh-ancestor
91912216|NCT02254915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912217|NCT02157181|Rituximab|rituximab|mesh-list
91912218|NCT02157181|Cladribine|cladribine|mesh-list
91912219|NCT02157181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91912220|NCT02157181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912221|NCT02157181|Immunologic Factors|immunologic factors|mesh-ancestor
91912222|NCT02157181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912223|NCT02157181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912224|NCT02157181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912225|NCT02159287|Heparin|heparin|mesh-list
91912226|NCT02159287|Calcium heparin|calcium heparin|mesh-list
91912227|NCT02159287|Enoxaparin|enoxaparin|mesh-list
91912228|NCT02159287|Enoxaparin sodium|enoxaparin sodium|mesh-list
91912229|NCT02159287|Anticoagulants|anticoagulants|mesh-ancestor
91912230|NCT02159287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91912231|NCT02159287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91912232|NCT02159287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912233|NCT05005273|Nivolumab|nivolumab|mesh-list
91912234|NCT05005273|Ipilimumab|ipilimumab|mesh-list
91912235|NCT05005273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91912236|NCT05005273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912237|NCT05005273|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91912238|NCT05005273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912239|NCT02157337|Atorvastatin|atorvastatin|mesh-list
91912240|NCT02157337|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91912241|NCT02157337|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91912243|NCT02157337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912244|NCT02157337|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91912245|NCT02157337|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91912246|NCT02157337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912247|NCT02159599|Ritonavir|ritonavir|mesh-list
91912248|NCT02159599|Darunavir|darunavir|mesh-list
91912249|NCT02159599|Tenofovir|tenofovir|mesh-list
91912250|NCT02159599|Lamivudine|lamivudine|mesh-list
91912251|NCT02159599|Emtricitabine|emtricitabine|mesh-list
91912252|NCT02159599|Abacavir|abacavir|mesh-list
91912253|NCT02159599|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91912254|NCT02159599|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91912255|NCT02159599|Protease Inhibitors|protease inhibitors|mesh-ancestor
91912256|NCT02159599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912257|NCT02159599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912258|NCT02159599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91912259|NCT02159599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91912260|NCT02159599|Antiviral Agents|antiviral agents|mesh-ancestor
91912261|NCT02159599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912262|NCT02159599|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91912263|NCT02159599|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91912264|NCT02159599|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91912265|NCT02159599|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91912266|NCT03541681|Anesthetics|anesthetics|mesh-list
91912267|NCT03541681|Glucocorticoids|glucocorticoids|mesh-list
91912268|NCT03541681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912269|NCT03541681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912270|NCT03541681|Hormones|hormones|mesh-ancestor
91912271|NCT03541681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912272|NCT02157415|Polihexanide|polihexanide|mesh-list
91912273|NCT02157415|Disinfectants|disinfectants|mesh-ancestor
91912274|NCT02157415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912275|NCT02157571|Levofloxacin|levofloxacin|mesh-list
91912276|NCT02157571|Ofloxacin|ofloxacin|mesh-list
91912277|NCT02157571|Prulifloxacin|prulifloxacin|mesh-list
91912278|NCT02157571|Fluoroquinolones|fluoroquinolones|mesh-list
91912279|NCT02157571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91912280|NCT02157571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912281|NCT02157571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91912282|NCT02157571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91912283|NCT02157571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91912284|NCT02157571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912285|NCT02157571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912286|NCT02157571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912287|NCT02157571|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91912288|NCT02157571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91912289|NCT02157571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91912290|NCT01369355|Ustekinumab|ustekinumab|mesh-list
91912291|NCT01369355|Dermatologic Agents|dermatologic agents|mesh-ancestor
91912292|NCT03541993|Resveratrol|resveratrol|mesh-list
91912293|NCT03541993|Antioxidants|antioxidants|mesh-ancestor
91912294|NCT03541993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912295|NCT03541993|Protective Agents|protective agents|mesh-ancestor
91912296|NCT03541993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912297|NCT03541993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912298|NCT03541993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91912299|NCT02157649|Phenylpropanolamine|phenylpropanolamine|mesh-list
91912300|NCT02157649|Codeine|codeine|mesh-list
91912301|NCT02157649|Guaifenesin|guaifenesin|mesh-list
91912302|NCT02157649|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
91912303|NCT02157649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91912304|NCT02157649|Narcotics|narcotics|mesh-ancestor
91912305|NCT02157649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912306|NCT02157649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912307|NCT02157649|Analgesics|analgesics|mesh-ancestor
91912308|NCT02157649|Sensory System Agents|sensory system agents|mesh-ancestor
91912309|NCT02157649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912310|NCT02157649|Antitussive Agents|antitussive agents|mesh-ancestor
91912311|NCT02157649|Respiratory System Agents|respiratory system agents|mesh-ancestor
91912312|NCT02157649|Expectorants|expectorants|mesh-ancestor
91912313|NCT02157649|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91912314|NCT02157649|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91912315|NCT02157649|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912316|NCT02157649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912317|NCT02157649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912319|NCT02157649|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91912320|NCT02157649|Sympathomimetics|sympathomimetics|mesh-ancestor
91912321|NCT02157649|Autonomic Agents|autonomic agents|mesh-ancestor
91912322|NCT02157649|Nasal Decongestants|nasal decongestants|mesh-ancestor
91912323|NCT02157649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91912324|NCT02159911|Misoprostol|misoprostol|mesh-list
91912325|NCT02159911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91912326|NCT02159911|Abortifacient Agents|abortifacient agents|mesh-ancestor
91912327|NCT02159911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91912328|NCT02159911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912329|NCT02159911|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91912330|NCT02159911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91912331|NCT02159911|Oxytocics|oxytocics|mesh-ancestor
91912332|NCT03542617|Dexamethasone|dexamethasone|mesh-list
91912333|NCT03542617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912334|NCT03542617|Antiemetics|antiemetics|mesh-ancestor
91912335|NCT03542617|Autonomic Agents|autonomic agents|mesh-ancestor
91912336|NCT03542617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912337|NCT03542617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912338|NCT03542617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91912339|NCT03542617|Glucocorticoids|glucocorticoids|mesh-ancestor
91912340|NCT03542617|Hormones|hormones|mesh-ancestor
91912341|NCT03542617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912342|NCT03542617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942909|NCT04141995|Antidotes|antidotes|mesh-ancestor
91912343|NCT03542617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912344|NCT04878770|Cyclosporine|cyclosporine|mesh-list
91912345|NCT04878770|Cyclosporins|cyclosporins|mesh-list
91912346|NCT04878770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912347|NCT04878770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912348|NCT04878770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912349|NCT04878770|Immunologic Factors|immunologic factors|mesh-ancestor
91912350|NCT04878770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912351|NCT04878770|Antifungal Agents|antifungal agents|mesh-ancestor
91912352|NCT04878770|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912353|NCT04878770|Dermatologic Agents|dermatologic agents|mesh-ancestor
91912354|NCT04878770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912355|NCT04878770|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91912358|NCT02086019|Heparin|heparin|mesh-list
91912359|NCT02086019|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91912360|NCT02086019|Tinzaparin|tinzaparin|mesh-list
91912361|NCT02086019|Dalteparin|dalteparin|mesh-list
91912362|NCT02086019|Clopidogrel|clopidogrel|mesh-list
91912363|NCT02086019|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91912364|NCT02086019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912365|NCT02086019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912366|NCT02086019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91912367|NCT02086019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91912368|NCT02086019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912369|NCT02086019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91912370|NCT02086019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912371|NCT02086019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91912372|NCT02086019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91912373|NCT02086019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91912374|NCT02086019|Purinergic Agents|purinergic agents|mesh-ancestor
91912375|NCT02086019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912376|NCT02086019|Anticoagulants|anticoagulants|mesh-ancestor
91912377|NCT02086019|Protease Inhibitors|protease inhibitors|mesh-ancestor
91912378|NCT02086019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912379|NCT02086019|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91912380|NCT02086019|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91912381|NCT02086019|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912383|NCT02086019|Autonomic Agents|autonomic agents|mesh-ancestor
91912384|NCT02086019|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91912385|NCT02086097|Ibuprofen|ibuprofen|mesh-list
91912386|NCT02086097|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91912387|NCT02086097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91912388|NCT02086097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91912389|NCT02086097|Analgesics|analgesics|mesh-ancestor
91912390|NCT02086097|Sensory System Agents|sensory system agents|mesh-ancestor
91912391|NCT02086097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912392|NCT02086097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912393|NCT02086097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912394|NCT02086097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912395|NCT02086097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91912396|NCT02086097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912397|NCT02086097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912399|NCT02307682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91912400|NCT02307682|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91912401|NCT02307682|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91912402|NCT02307682|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91912403|NCT02307682|Growth Substances|growth substances|mesh-ancestor
91912404|NCT02307682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912405|NCT02307682|Growth Inhibitors|growth inhibitors|mesh-ancestor
91912406|NCT02307682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912407|NCT02088515|Docetaxel|docetaxel|mesh-list
91912408|NCT02088515|Nedaplatin|nedaplatin|mesh-list
91912409|NCT02088515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912410|NCT02088515|Tubulin Modulators|tubulin modulators|mesh-ancestor
91912411|NCT02088515|Antimitotic Agents|antimitotic agents|mesh-ancestor
91912412|NCT02088515|Mitosis Modulators|mitosis modulators|mesh-ancestor
91912413|NCT02088515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912414|NCT02086253|BQ 788|bq 788|mesh-list
91912415|NCT02086253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912416|NCT02086253|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91912417|NCT02086253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912418|NCT02086253|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
91912419|NCT04870502|Clomiphene|clomiphene|mesh-list
91912420|NCT04870502|Enclomiphene|enclomiphene|mesh-list
91912421|NCT04870502|Zuclomiphene|zuclomiphene|mesh-list
91912422|NCT04870502|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91912423|NCT04870502|Hormone Antagonists|hormone antagonists|mesh-ancestor
91912424|NCT04870502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912425|NCT04870502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912426|NCT04870502|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91912427|NCT04870502|Fertility Agents|fertility agents|mesh-ancestor
91912428|NCT04870502|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91912429|NCT04870502|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91912430|NCT04870502|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91912433|NCT02088671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91912434|NCT02088671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912435|NCT02088671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912436|NCT02088671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91912437|NCT02088671|Anesthetics, General|anesthetics, general|mesh-ancestor
91912438|NCT02088671|Anesthetics|anesthetics|mesh-ancestor
91912439|NCT02088671|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91912440|NCT04870190|Osimertinib|osimertinib|mesh-list
91912441|NCT04870190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912442|NCT04870190|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91912443|NCT04870190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912444|NCT04870190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912445|NCT03049046|Caffeic acid|caffeic acid|mesh-list
91912446|NCT03049046|Antioxidants|antioxidants|mesh-ancestor
91912447|NCT03049046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912448|NCT03049046|Protective Agents|protective agents|mesh-ancestor
91912449|NCT03049046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912450|NCT04385966|Levobupivacaine|levobupivacaine|mesh-list
91912451|NCT04385966|Anesthetics, Local|anesthetics, local|mesh-ancestor
91912452|NCT04385966|Anesthetics|anesthetics|mesh-ancestor
91912453|NCT04385966|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912454|NCT04385966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912455|NCT04385966|Sensory System Agents|sensory system agents|mesh-ancestor
91912456|NCT04385966|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912457|NCT03046082|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91912458|NCT03046082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912459|NCT03048110|Itraconazole|itraconazole|mesh-list
91912460|NCT03048110|Rifampin|rifampin|mesh-list
91912461|NCT03048110|Antifungal Agents|antifungal agents|mesh-ancestor
91912462|NCT03048110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912463|NCT03048110|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91912464|NCT03048110|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91912465|NCT03048110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912466|NCT03048110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912467|NCT03048110|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91912468|NCT03048110|Hormone Antagonists|hormone antagonists|mesh-ancestor
91912469|NCT03048110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912470|NCT03048110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912471|NCT03048110|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91912472|NCT03048110|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91912473|NCT03048110|Antitubercular Agents|antitubercular agents|mesh-ancestor
91912474|NCT03048110|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91912475|NCT03048110|Leprostatic Agents|leprostatic agents|mesh-ancestor
91912476|NCT03048110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91912477|NCT03048110|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91912478|NCT03048110|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91912479|NCT03048110|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91912480|NCT03048110|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91912481|NCT03048110|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91912482|NCT03048110|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91912483|NCT05256758|Fenofibrate|fenofibrate|mesh-list
91912484|NCT05256758|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91912485|NCT05256758|Antimetabolites|antimetabolites|mesh-ancestor
91912486|NCT05256758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912487|NCT05256758|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91912488|NCT02791763|Glycine|glycine|mesh-list
91912489|NCT02791763|Glycine Agents|glycine agents|mesh-ancestor
91912490|NCT02791763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912491|NCT02791763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912492|NCT02791763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912493|NCT02086409|Calcium, Dietary|calcium, dietary|mesh-list
91912494|NCT02086409|Vitamin D|vitamin d|mesh-list
91912495|NCT02086409|Ergocalciferols|ergocalciferols|mesh-list
91912496|NCT02086409|Cholecalciferol|cholecalciferol|mesh-list
91912497|NCT02086409|Vitamins|vitamins|mesh-list
91912498|NCT02086409|Calcium|calcium|mesh-list
91912499|NCT02086409|Micronutrients|micronutrients|mesh-ancestor
91912500|NCT02086409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912501|NCT02086409|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91912502|NCT02086409|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91912503|NCT02613572|Thioctic Acid|thioctic acid|mesh-list
91912504|NCT02613572|Antioxidants|antioxidants|mesh-ancestor
91912505|NCT02613572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912506|NCT02613572|Protective Agents|protective agents|mesh-ancestor
91912507|NCT02613572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912508|NCT02613572|Vitamin B Complex|vitamin b complex|mesh-ancestor
91912509|NCT02613572|Vitamins|vitamins|mesh-ancestor
91912510|NCT02613572|Micronutrients|micronutrients|mesh-ancestor
91912511|NCT02088983|Choline|choline|mesh-list
91912512|NCT02088983|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
91912513|NCT02088983|Lipotropic Agents|lipotropic agents|mesh-ancestor
91912514|NCT02088983|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91912515|NCT02088983|Antimetabolites|antimetabolites|mesh-ancestor
91912516|NCT02088983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912517|NCT02088983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91912518|NCT02088983|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91912519|NCT02088983|Nootropic Agents|nootropic agents|mesh-ancestor
91912520|NCT02089061|Atorvastatin|atorvastatin|mesh-list
91912521|NCT02089061|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91912522|NCT02089061|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91912523|NCT02089061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91912524|NCT02089061|Antimetabolites|antimetabolites|mesh-ancestor
91912525|NCT02089061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912526|NCT02089061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91912527|NCT02089061|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91912528|NCT02089061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912529|NCT02082665|Dabrafenib|dabrafenib|mesh-list
91912530|NCT02082665|Midazolam|midazolam|mesh-list
91912531|NCT02082665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91912532|NCT02082665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91912533|NCT02082665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91912534|NCT02082665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912535|NCT02082665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912536|NCT02082665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91912537|NCT02082665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91912538|NCT02082665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91912539|NCT02082665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91912540|NCT02082665|Anesthetics, General|anesthetics, general|mesh-ancestor
91912541|NCT02082665|Anesthetics|anesthetics|mesh-ancestor
91912542|NCT02082665|GABA Modulators|gaba modulators|mesh-ancestor
91912543|NCT02082665|GABA Agents|gaba agents|mesh-ancestor
91912544|NCT02082665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912545|NCT02082665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912546|NCT02082665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91912547|NCT02082665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91912548|NCT02082665|Antimetabolites|antimetabolites|mesh-ancestor
91912549|NCT02082665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91912550|NCT02082665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91912551|NCT02082665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912552|NCT02082665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912553|NCT02082665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91912554|NCT03047954|Broncho-Vaxom|broncho-vaxom|mesh-list
91912555|NCT03047954|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91912556|NCT03047954|Immunologic Factors|immunologic factors|mesh-ancestor
91912557|NCT03047954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912558|NCT03558971|Hydrocortisone|hydrocortisone|mesh-list
91912559|NCT03558971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912560|NCT02341456|Paclitaxel|paclitaxel|mesh-list
91912561|NCT02341456|Carboplatin|carboplatin|mesh-list
91912562|NCT02341456|Adavosertib|adavosertib|mesh-list
91912563|NCT02341456|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91912564|NCT02341456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912565|NCT02341456|Tubulin Modulators|tubulin modulators|mesh-ancestor
91912566|NCT02341456|Antimitotic Agents|antimitotic agents|mesh-ancestor
91912567|NCT02341456|Mitosis Modulators|mitosis modulators|mesh-ancestor
91912568|NCT02341456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912569|NCT02341456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912570|NCT02083055|Nitroglycerin|nitroglycerin|mesh-list
91912571|NCT02083055|Dexmedetomidine|dexmedetomidine|mesh-list
91912572|NCT02083055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91912573|NCT02083055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912574|NCT02083055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912575|NCT02083055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91912577|NCT02083055|Sensory System Agents|sensory system agents|mesh-ancestor
91912578|NCT02083055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912579|NCT02083055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91912580|NCT02083055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91912581|NCT02083055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91912582|NCT02083055|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912583|NCT02083055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912584|NCT02083055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912585|NCT02083055|Vasodilator Agents|vasodilator agents|mesh-ancestor
91912586|NCT02089295|Oxycodone|oxycodone|mesh-list
91912587|NCT02089295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91912588|NCT02089295|Narcotics|narcotics|mesh-ancestor
91912589|NCT02089295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912590|NCT02089295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912591|NCT02089295|Analgesics|analgesics|mesh-ancestor
91912592|NCT02089295|Sensory System Agents|sensory system agents|mesh-ancestor
91912593|NCT02089295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912594|NCT02370784|Atorvastatin|atorvastatin|mesh-list
91912595|NCT02370784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91912596|NCT02370784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91912597|NCT02370784|Antimetabolites|antimetabolites|mesh-ancestor
91912598|NCT02370784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912599|NCT02370784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91912600|NCT02370784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91912601|NCT02370784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912602|NCT02083211|Nimotuzumab|nimotuzumab|mesh-list
91912603|NCT02083211|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91912604|NCT02083211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912605|NCT01595438|Ciprofloxacin|ciprofloxacin|mesh-list
91912606|NCT01595438|Ceftazidime|ceftazidime|mesh-list
91912607|NCT01595438|Avibactam|avibactam|mesh-list
91912608|NCT01595438|Doripenem|doripenem|mesh-list
91912609|NCT01595438|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91912610|NCT01595438|Trimethoprim|trimethoprim|mesh-list
91912611|NCT01595438|Sulfamethoxazole|sulfamethoxazole|mesh-list
91912612|NCT01595438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91912613|NCT01595438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912614|NCT01595438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91912615|NCT01595438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91912616|NCT01595438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912617|NCT01595438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912618|NCT01595438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912619|NCT01595438|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91912620|NCT01595438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91912621|NCT01595438|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91912622|NCT01595438|Antimalarials|antimalarials|mesh-ancestor
91912623|NCT01595438|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91912624|NCT01595438|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91912625|NCT01595438|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91912626|NCT01595438|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91912627|NCT01595438|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91912628|NCT01595438|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91912629|NCT02089451|Insulin Aspart|insulin aspart|mesh-list
91912630|NCT02089451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91912631|NCT02089451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912632|NCT02340520|Theophylline|theophylline|mesh-list
91912633|NCT02340520|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91912634|NCT02340520|Autonomic Agents|autonomic agents|mesh-ancestor
91912635|NCT02340520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912636|NCT02340520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912637|NCT02340520|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91912638|NCT02340520|Respiratory System Agents|respiratory system agents|mesh-ancestor
91912639|NCT02340520|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91912640|NCT02340520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912641|NCT02340520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912642|NCT02340520|Vasodilator Agents|vasodilator agents|mesh-ancestor
91912643|NCT02340520|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91912644|NCT02340520|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91912645|NCT02340520|Purinergic Agents|purinergic agents|mesh-ancestor
91912646|NCT02340520|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912647|NCT02087579|Olanzapine|olanzapine|mesh-list
91912648|NCT02087579|Risperidone|risperidone|mesh-list
91912649|NCT02087579|Aripiprazole|aripiprazole|mesh-list
91912650|NCT02087579|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91912651|NCT02087579|Paliperidone Palmitate|paliperidone palmitate|mesh-list
91912652|NCT02087579|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91912653|NCT02087579|Serotonin Agents|serotonin agents|mesh-ancestor
91912654|NCT02087579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912655|NCT02087579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912656|NCT02087579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912657|NCT02087579|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91912658|NCT02087579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91912659|NCT02087579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912660|NCT02087579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91912661|NCT02087579|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91912662|NCT02087579|Dopamine Agents|dopamine agents|mesh-ancestor
91912663|NCT02087579|Antiemetics|antiemetics|mesh-ancestor
91912664|NCT02087579|Autonomic Agents|autonomic agents|mesh-ancestor
91912665|NCT02087579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912666|NCT02087579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91912667|NCT02087579|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91912668|NCT02087579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91912669|NCT02087579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91912670|NCT02087579|Antidepressive Agents|antidepressive agents|mesh-ancestor
91912671|NCT02087579|Dopamine Agonists|dopamine agonists|mesh-ancestor
91912672|NCT02087579|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91912673|NCT02087579|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91912674|NCT02087579|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91912675|NCT02087579|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91912676|NCT02339584|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91912677|NCT02339584|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91912678|NCT02339584|Brinzolamide|brinzolamide|mesh-list
91912679|NCT02339584|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91912680|NCT02339584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912681|NCT02339584|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91912682|NCT02339584|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91912683|NCT02339584|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91912684|NCT02339584|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912685|NCT02339584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912686|NCT02339584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912687|NCT02339584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912688|NCT02339584|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91912689|NCT02339584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912690|NCT02339506|Cosyntropin|cosyntropin|mesh-list
91912692|NCT02339506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912693|NCT02339506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912694|NCT02087813|Methylprednisolone|methylprednisolone|mesh-list
91912695|NCT02087813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91912696|NCT02087813|Protease Inhibitors|protease inhibitors|mesh-list
91912697|NCT02087813|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
91912698|NCT02087813|Protein C Inhibitor|protein c inhibitor|mesh-list
91912699|NCT02087813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912700|NCT02087813|Antiemetics|antiemetics|mesh-ancestor
91912701|NCT02087813|Autonomic Agents|autonomic agents|mesh-ancestor
91912702|NCT02087813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912703|NCT02087813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912705|NCT02087813|Glucocorticoids|glucocorticoids|mesh-ancestor
91912706|NCT02087813|Hormones|hormones|mesh-ancestor
91912707|NCT02087813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912708|NCT02087813|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91912709|NCT02087813|Protective Agents|protective agents|mesh-ancestor
91912710|NCT02087813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91912711|NCT02087813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912712|NCT02087813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912713|NCT02087813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912714|NCT02087813|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91912715|NCT02087813|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91912716|NCT02089529|Ibuprofen|ibuprofen|mesh-list
91912717|NCT02089529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91912718|NCT02089529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91912719|NCT02089529|Analgesics|analgesics|mesh-ancestor
91912720|NCT02089529|Sensory System Agents|sensory system agents|mesh-ancestor
91912721|NCT02089529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912722|NCT02089529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912723|NCT02089529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912724|NCT02089529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912725|NCT02089529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91912726|NCT02089529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912727|NCT02089529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912729|NCT02090933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91912730|NCT02090933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91912732|NCT02090933|Sensory System Agents|sensory system agents|mesh-ancestor
91912733|NCT02090933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912734|NCT02090933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912735|NCT02090933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912736|NCT02090933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912737|NCT02090933|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91912738|NCT02090933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91912739|NCT02090933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912740|NCT02090933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912741|NCT03046238|Dexmedetomidine|dexmedetomidine|mesh-list
91912742|NCT03046238|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91912743|NCT03046238|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912744|NCT03046238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912745|NCT03046238|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91912746|NCT03046238|Analgesics|analgesics|mesh-ancestor
91912747|NCT03046238|Sensory System Agents|sensory system agents|mesh-ancestor
91912748|NCT03046238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912749|NCT03046238|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91912750|NCT03046238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91912751|NCT03046238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91912752|NCT03046238|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912753|NCT03046238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912754|NCT03046238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912755|NCT02089763|BCT-100|bct-100|mesh-list
91912756|NCT02089763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912757|NCT04884802|Phenylephrine|phenylephrine|mesh-list
91912758|NCT04884802|Norepinephrine|norepinephrine|mesh-list
91912759|NCT04884802|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91912760|NCT04884802|Propofol|propofol|mesh-list
91912761|NCT04884802|Etomidate|etomidate|mesh-list
91912762|NCT04884802|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91912763|NCT04884802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912764|NCT04884802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912765|NCT04884802|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91912766|NCT04884802|Anesthetics, General|anesthetics, general|mesh-ancestor
91912767|NCT04884802|Anesthetics|anesthetics|mesh-ancestor
91912768|NCT04884802|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91912769|NCT04884802|Mydriatics|mydriatics|mesh-ancestor
91912770|NCT04884802|Autonomic Agents|autonomic agents|mesh-ancestor
91912771|NCT04884802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912772|NCT04884802|Sympathomimetics|sympathomimetics|mesh-ancestor
91912773|NCT04884802|Nasal Decongestants|nasal decongestants|mesh-ancestor
91912774|NCT04884802|Respiratory System Agents|respiratory system agents|mesh-ancestor
91912775|NCT04884802|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91912776|NCT04884802|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91912777|NCT04884802|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91912778|NCT04884802|Adrenergic Agents|adrenergic agents|mesh-ancestor
91912779|NCT04884802|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912780|NCT04884802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912781|NCT04884802|Protective Agents|protective agents|mesh-ancestor
91912782|NCT02089841|Lumefantrine|lumefantrine|mesh-list
91912783|NCT02089841|Artemether|artemether|mesh-list
91912784|NCT02089841|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91912785|NCT02089841|Antimalarials|antimalarials|mesh-ancestor
91912786|NCT02089841|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91912787|NCT02089841|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91912788|NCT02089841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912789|NCT03045770|Leucovorin|leucovorin|mesh-list
91912790|NCT03045770|Paclitaxel|paclitaxel|mesh-list
91912791|NCT03045770|Fluorouracil|fluorouracil|mesh-list
91912792|NCT03045770|Oxaliplatin|oxaliplatin|mesh-list
91912793|NCT03045770|Irinotecan|irinotecan|mesh-list
91912794|NCT03045770|Calcium|calcium|mesh-list
91912795|NCT03045770|Levoleucovorin|levoleucovorin|mesh-list
91912796|NCT03045770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91912797|NCT03045770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912798|NCT03045770|Tubulin Modulators|tubulin modulators|mesh-ancestor
91912799|NCT03045770|Antimitotic Agents|antimitotic agents|mesh-ancestor
91912800|NCT03045770|Mitosis Modulators|mitosis modulators|mesh-ancestor
91912801|NCT03045770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912802|NCT03045770|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91912803|NCT03045770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912804|NCT03045770|Antimetabolites|antimetabolites|mesh-ancestor
91912805|NCT03045770|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91912806|NCT03045770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912807|NCT03045770|Immunologic Factors|immunologic factors|mesh-ancestor
91912808|NCT03045770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91912809|NCT03045770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91912810|NCT03045770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912811|NCT03045770|Antidotes|antidotes|mesh-ancestor
91912812|NCT03045770|Protective Agents|protective agents|mesh-ancestor
91912813|NCT03045770|Vitamin B Complex|vitamin b complex|mesh-ancestor
91912815|NCT03045770|Micronutrients|micronutrients|mesh-ancestor
91912816|NCT02260505|Imatinib Mesylate|imatinib mesylate|mesh-list
91912817|NCT02260505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912818|NCT02260505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91912819|NCT02260505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912820|NCT02260505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912821|NCT02095847|Proflavine|proflavine|mesh-list
91912822|NCT02095847|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91912823|NCT02095847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912824|NCT02091401|Magnesium Sulfate|magnesium sulfate|mesh-list
91912825|NCT02091401|Analgesics|analgesics|mesh-ancestor
91912826|NCT02091401|Sensory System Agents|sensory system agents|mesh-ancestor
91912827|NCT02091401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912828|NCT02091401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912829|NCT02091401|Anesthetics|anesthetics|mesh-ancestor
91912830|NCT02091401|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91912831|NCT02091401|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91912832|NCT02091401|Anticonvulsants|anticonvulsants|mesh-ancestor
91912833|NCT02091401|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91912834|NCT02091401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91912835|NCT02091401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912836|NCT02091401|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91912837|NCT02091401|Tocolytic Agents|tocolytic agents|mesh-ancestor
91912838|NCT02091401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91912839|NCT01594970|Bimatoprost|bimatoprost|mesh-list
91912840|NCT01594970|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912841|NCT04869176|Caffeine|caffeine|mesh-list
91912842|NCT04869176|Caffeine citrate|caffeine citrate|mesh-list
91912843|NCT04869176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912844|NCT04869176|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91912845|NCT04869176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912846|NCT04869176|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91912847|NCT04869176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912848|NCT04869176|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91942931|NCT04127578|Immunologic Factors|immunologic factors|mesh-ancestor
91912849|NCT04869176|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91912850|NCT04869176|Purinergic Agents|purinergic agents|mesh-ancestor
91912851|NCT04869176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912852|NCT03557255|Simendan|simendan|mesh-list
91912853|NCT03557255|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91912854|NCT03557255|Vasodilator Agents|vasodilator agents|mesh-ancestor
91912855|NCT03557255|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91912856|NCT03557255|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91912857|NCT03557255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912858|NCT03557255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912859|NCT03557255|Protective Agents|protective agents|mesh-ancestor
91912860|NCT03557255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912861|NCT04868552|Naloxone|naloxone|mesh-list
91912862|NCT04868552|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91912863|NCT04868552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912864|NCT04868552|Sensory System Agents|sensory system agents|mesh-ancestor
91912865|NCT04868552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912866|NCT02090153|Leucovorin|leucovorin|mesh-list
91912867|NCT02090153|Tegafur|tegafur|mesh-list
91912868|NCT02090153|Antidotes|antidotes|mesh-ancestor
91912869|NCT02090153|Protective Agents|protective agents|mesh-ancestor
91912870|NCT02090153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912871|NCT02090153|Vitamin B Complex|vitamin b complex|mesh-ancestor
91912872|NCT02090153|Vitamins|vitamins|mesh-ancestor
91912873|NCT02090153|Micronutrients|micronutrients|mesh-ancestor
91912874|NCT02090153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91912876|NCT02090153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912877|NCT02090153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912879|NCT00358163|Vatalanib|vatalanib|mesh-list
91912880|NCT00358163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91912881|NCT00358163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912885|NCT00358163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912886|NCT00358163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91912887|NCT00358163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912888|NCT02096315|Murepavadin|murepavadin|mesh-list
91912889|NCT02096315|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91912890|NCT02096315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912891|NCT02337946|Calcium, Dietary|calcium, dietary|mesh-list
91912892|NCT02337946|Leucovorin|leucovorin|mesh-list
91912893|NCT02337946|Oxaliplatin|oxaliplatin|mesh-list
91912894|NCT02337946|Fluorouracil|fluorouracil|mesh-list
91912895|NCT02337946|Panitumumab|panitumumab|mesh-list
91912896|NCT02337946|Calcium|calcium|mesh-list
91912897|NCT02337946|Levoleucovorin|levoleucovorin|mesh-list
91912898|NCT02337946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91912899|NCT02337946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912900|NCT02337946|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91912901|NCT02337946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912902|NCT02337946|Antimetabolites|antimetabolites|mesh-ancestor
91912903|NCT02337946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912904|NCT02337946|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91912905|NCT02337946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912906|NCT02337946|Immunologic Factors|immunologic factors|mesh-ancestor
91912907|NCT02337946|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91912909|NCT02337946|Protective Agents|protective agents|mesh-ancestor
91912910|NCT02337946|Vitamin B Complex|vitamin b complex|mesh-ancestor
91912911|NCT02337946|Vitamins|vitamins|mesh-ancestor
91912912|NCT02337946|Micronutrients|micronutrients|mesh-ancestor
91912913|NCT04865510|Heparin|heparin|mesh-list
91912914|NCT04865510|Anticoagulants|anticoagulants|mesh-ancestor
91912915|NCT04865510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912916|NCT04865510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91912917|NCT04865510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91912918|NCT02090309|Hydrocortisone|hydrocortisone|mesh-list
91912919|NCT02090309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91912920|NCT03047096|Hyaluronic Acid|hyaluronic acid|mesh-list
91912921|NCT03047096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91912922|NCT03047096|Immunologic Factors|immunologic factors|mesh-ancestor
91912923|NCT03047096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912924|NCT03047096|Viscosupplements|viscosupplements|mesh-ancestor
91912925|NCT03047096|Protective Agents|protective agents|mesh-ancestor
91912926|NCT02090543|Rivaroxaban|rivaroxaban|mesh-list
91912927|NCT02090543|Phenprocoumon|phenprocoumon|mesh-list
91912928|NCT02090543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91912930|NCT02090543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91912931|NCT02090543|Protease Inhibitors|protease inhibitors|mesh-ancestor
91912932|NCT02090543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912933|NCT02090543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912934|NCT02090543|Anticoagulants|anticoagulants|mesh-ancestor
91912935|NCT02093195|Bosentan|bosentan|mesh-list
91912936|NCT02093195|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
91912937|NCT02093195|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91912938|NCT02093195|Respiratory System Agents|respiratory system agents|mesh-ancestor
91912939|NCT02093195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91912940|NCT02093195|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91912941|NCT02093195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912942|NCT02096939|Antihypertensive Agents|antihypertensive agents|mesh-list
91912943|NCT03555617|Itraconazole|itraconazole|mesh-list
91912944|NCT03555617|Antifungal Agents|antifungal agents|mesh-ancestor
91912945|NCT03555617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912946|NCT03555617|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91912947|NCT03555617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91912948|NCT03555617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912949|NCT03555617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912950|NCT03555617|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91912951|NCT03555617|Hormone Antagonists|hormone antagonists|mesh-ancestor
91912952|NCT03555617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91912953|NCT03555617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912954|NCT03555617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91912955|NCT02098889|Scopolamine|scopolamine|mesh-list
91912956|NCT02098889|Bromides|bromides|mesh-list
91912957|NCT02098889|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
91912958|NCT02098889|Anticonvulsants|anticonvulsants|mesh-ancestor
91912959|NCT02098889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91912960|NCT02098889|Antiemetics|antiemetics|mesh-ancestor
91912961|NCT02098889|Autonomic Agents|autonomic agents|mesh-ancestor
91913115|NCT02094287|Dermatologic Agents|dermatologic agents|mesh-ancestor
91912962|NCT02098889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91912963|NCT02098889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912964|NCT02098889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91912965|NCT02098889|Mydriatics|mydriatics|mesh-ancestor
91912966|NCT02098889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91912967|NCT02098889|Cholinergic Agents|cholinergic agents|mesh-ancestor
91912968|NCT02098889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91912969|NCT02098889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912970|NCT02098889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91912971|NCT02098889|Parasympatholytics|parasympatholytics|mesh-ancestor
91912972|NCT01369199|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91912973|NCT01369199|Entecavir|entecavir|mesh-list
91912974|NCT01369199|Antiviral Agents|antiviral agents|mesh-ancestor
91912975|NCT01369199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91912976|NCT02097173|Methotrexate|methotrexate|mesh-list
91912977|NCT02097173|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91912978|NCT02097173|Abortifacient Agents|abortifacient agents|mesh-ancestor
91912979|NCT02097173|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91912980|NCT02097173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91912981|NCT02097173|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91912982|NCT02097173|Antimetabolites|antimetabolites|mesh-ancestor
91912983|NCT02097173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91912984|NCT02097173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91912985|NCT02097173|Dermatologic Agents|dermatologic agents|mesh-ancestor
91912986|NCT02097173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91912987|NCT02097173|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91912988|NCT02097173|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91912989|NCT02097173|Immunologic Factors|immunologic factors|mesh-ancestor
91912990|NCT02097173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91912991|NCT02097173|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91912993|NCT02097329|Rabeprazole|rabeprazole|mesh-list
91912994|NCT02097329|Famotidine|famotidine|mesh-list
91912995|NCT02097329|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
91912996|NCT02097329|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
91912997|NCT02097329|Aluminum Hydroxide|aluminum hydroxide|mesh-list
91912998|NCT02097329|Magnesium Hydroxide|magnesium hydroxide|mesh-list
91912999|NCT02097329|Antacids|antacids|mesh-list
91913000|NCT02097329|TEMPO|tempo|mesh-list
91913001|NCT02097329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913002|NCT02097329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913003|NCT02097329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913004|NCT02097329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913005|NCT02097329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913006|NCT02097329|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91913007|NCT02097329|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91913008|NCT02097329|Histamine Antagonists|histamine antagonists|mesh-ancestor
91913009|NCT02097329|Histamine Agents|histamine agents|mesh-ancestor
91913010|NCT02097329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913011|NCT02097329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913012|NCT02097329|Antioxidants|antioxidants|mesh-ancestor
91913013|NCT02097329|Protective Agents|protective agents|mesh-ancestor
91913014|NCT02097329|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91913015|NCT02097329|Immunologic Factors|immunologic factors|mesh-ancestor
91913016|NCT02093585|Tenofovir|tenofovir|mesh-list
91913017|NCT02093585|Abacavir|abacavir|mesh-list
91913018|NCT02093585|Antiviral Agents|antiviral agents|mesh-ancestor
91913019|NCT02093585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913020|NCT02093585|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91913021|NCT02093585|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91913022|NCT02093585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913023|NCT02093585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913024|NCT02093585|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91913025|NCT02093585|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91913028|NCT02099357|Micronutrients|micronutrients|mesh-ancestor
91913029|NCT02099357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913030|NCT02099357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91913031|NCT02093741|Factor VIII|factor viii|mesh-list
91913032|NCT02093741|Coagulants|coagulants|mesh-ancestor
91913033|NCT02097407|Dexmedetomidine|dexmedetomidine|mesh-list
91913034|NCT02097407|Propofol|propofol|mesh-list
91913035|NCT02097407|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91913036|NCT02097407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913037|NCT02097407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913038|NCT02097407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913039|NCT02097407|Analgesics|analgesics|mesh-ancestor
91913040|NCT02097407|Sensory System Agents|sensory system agents|mesh-ancestor
91913041|NCT02097407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913042|NCT02097407|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91913043|NCT02097407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91913044|NCT02097407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91913045|NCT02097407|Adrenergic Agents|adrenergic agents|mesh-ancestor
91913046|NCT02097407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913047|NCT02097407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913048|NCT02097407|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91913049|NCT02097407|Anesthetics, General|anesthetics, general|mesh-ancestor
91913050|NCT02097407|Anesthetics|anesthetics|mesh-ancestor
91913051|NCT02250599|Paclitaxel|paclitaxel|mesh-list
91913052|NCT02250599|Bevacizumab|bevacizumab|mesh-list
91913053|NCT02250599|Carboplatin|carboplatin|mesh-list
91913054|NCT02250599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91913055|NCT02250599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913056|NCT02250599|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913057|NCT02250599|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913058|NCT02250599|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913059|NCT02250599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913060|NCT02250599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913061|NCT02250599|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91913062|NCT02250599|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91913063|NCT02250599|Growth Substances|growth substances|mesh-ancestor
91913064|NCT02250599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913065|NCT02250599|Growth Inhibitors|growth inhibitors|mesh-ancestor
91913066|NCT02094053|Donepezil|donepezil|mesh-list
91913067|NCT02094053|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91913068|NCT02094053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913069|NCT02094053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913070|NCT02094053|Cholinergic Agents|cholinergic agents|mesh-ancestor
91913071|NCT02094053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913072|NCT02094053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913073|NCT02094053|Nootropic Agents|nootropic agents|mesh-ancestor
91913074|NCT03555929|Dexamethasone|dexamethasone|mesh-list
91913075|NCT03555929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913076|NCT03555929|Antiemetics|antiemetics|mesh-ancestor
91913077|NCT03555929|Autonomic Agents|autonomic agents|mesh-ancestor
91913078|NCT03555929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913079|NCT03555929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913080|NCT03555929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913081|NCT03555929|Glucocorticoids|glucocorticoids|mesh-ancestor
91913082|NCT03555929|Hormones|hormones|mesh-ancestor
91913083|NCT03555929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913084|NCT03555929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91913085|NCT03555929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913086|NCT02099981|Pimagedine|pimagedine|mesh-list
91913087|NCT02099981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913088|NCT02099981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913089|NCT02250209|Capecitabine|capecitabine|mesh-list
91913090|NCT02250209|Oxaliplatin|oxaliplatin|mesh-list
91913091|NCT02250209|Trastuzumab|trastuzumab|mesh-list
91913092|NCT02250209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91913093|NCT02250209|Antimetabolites|antimetabolites|mesh-ancestor
91913094|NCT02250209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913095|NCT02250209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913096|NCT02250209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913097|NCT02097953|Rifampin|rifampin|mesh-list
91913098|NCT02097953|Daptomycin|daptomycin|mesh-list
91913099|NCT02097953|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91913100|NCT02097953|Antitubercular Agents|antitubercular agents|mesh-ancestor
91913101|NCT02097953|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91913102|NCT02097953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913103|NCT02097953|Leprostatic Agents|leprostatic agents|mesh-ancestor
91913104|NCT02097953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91913105|NCT02097953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913106|NCT02097953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913107|NCT02097953|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91913108|NCT02097953|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91913109|NCT02097953|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91913110|NCT02097953|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91913111|NCT02097953|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91913112|NCT02097953|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91913113|NCT02094287|Dimethindene|dimethindene|mesh-list
91913114|NCT02094287|Antipruritics|antipruritics|mesh-ancestor
91913116|NCT02094287|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91913117|NCT02094287|Histamine Antagonists|histamine antagonists|mesh-ancestor
91913118|NCT02094287|Histamine Agents|histamine agents|mesh-ancestor
91913119|NCT02094287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913120|NCT02094287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913121|NCT02094287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913122|NCT02094287|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91913123|NCT02100293|Magnesium Sulfate|magnesium sulfate|mesh-list
91913124|NCT02100293|Analgesics|analgesics|mesh-ancestor
91913125|NCT02100293|Sensory System Agents|sensory system agents|mesh-ancestor
91913126|NCT02100293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913127|NCT02100293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913128|NCT02100293|Anesthetics|anesthetics|mesh-ancestor
91913129|NCT02100293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913130|NCT02100293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91913131|NCT02100293|Anticonvulsants|anticonvulsants|mesh-ancestor
91913132|NCT02100293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91913133|NCT02100293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91913134|NCT02100293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913135|NCT02100293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91913136|NCT02100293|Tocolytic Agents|tocolytic agents|mesh-ancestor
91913137|NCT02100293|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91913138|NCT02094599|Dronabinol|dronabinol|mesh-list
91913139|NCT02094599|Hallucinogens|hallucinogens|mesh-ancestor
91913140|NCT02094599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913141|NCT02094599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913142|NCT02094599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913143|NCT02094599|Analgesics|analgesics|mesh-ancestor
91913144|NCT02094599|Sensory System Agents|sensory system agents|mesh-ancestor
91913145|NCT02094599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913146|NCT02094599|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91913147|NCT02094599|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91913148|NCT02094599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942934|NCT04127578|Antiemetics|antiemetics|mesh-ancestor
91913149|NCT02094599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913150|NCT02094599|Hormones|hormones|mesh-ancestor
91913151|NCT02094599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913152|NCT02094833|Vaccines|vaccines|mesh-list
91913153|NCT02094833|Immunologic Factors|immunologic factors|mesh-ancestor
91913154|NCT02094833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913155|NCT02100605|Nasal Decongestants|nasal decongestants|mesh-list
91913156|NCT02100605|Pseudoephedrine|pseudoephedrine|mesh-list
91913157|NCT02100605|Ephedrine|ephedrine|mesh-list
91913158|NCT02100605|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91913159|NCT02100605|Respiratory System Agents|respiratory system agents|mesh-ancestor
91913160|NCT02100605|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91913161|NCT02100605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913162|NCT02100605|Sympathomimetics|sympathomimetics|mesh-ancestor
91913163|NCT02100605|Autonomic Agents|autonomic agents|mesh-ancestor
91913164|NCT02100605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913165|NCT02100605|Adrenergic Agents|adrenergic agents|mesh-ancestor
91913166|NCT02100605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913167|NCT02100605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913168|NCT02100605|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91913169|NCT02100605|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91913170|NCT02100761|Voriconazole|voriconazole|mesh-list
91913171|NCT02100761|Antifungal Agents|antifungal agents|mesh-ancestor
91913172|NCT02100761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913173|NCT02100761|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91913174|NCT02100761|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91913175|NCT02100761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913176|NCT02100761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913177|NCT02100761|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91913178|NCT02100761|Hormone Antagonists|hormone antagonists|mesh-ancestor
91913179|NCT02100761|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913180|NCT02100761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913181|NCT02100761|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91913182|NCT02100917|Trastuzumab|trastuzumab|mesh-list
91913183|NCT02100917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913184|NCT02100917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913185|NCT02098421|Oxytocin|oxytocin|mesh-list
91913186|NCT02098421|Oxytocics|oxytocics|mesh-ancestor
91913187|NCT02098421|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91913188|NCT02098421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913189|NCT02098499|Diphenhydramine|diphenhydramine|mesh-list
91913190|NCT02098499|Promethazine|promethazine|mesh-list
91913191|NCT02098499|Haloperidol|haloperidol|mesh-list
91913192|NCT02098499|Metoclopramide|metoclopramide|mesh-list
91913193|NCT02098499|Haloperidol decanoate|haloperidol decanoate|mesh-list
91913194|NCT02098499|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91913195|NCT02098499|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91913196|NCT02098499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913197|NCT02098499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913198|NCT02098499|Anesthetics, Local|anesthetics, local|mesh-ancestor
91913199|NCT02098499|Anesthetics|anesthetics|mesh-ancestor
91913200|NCT02098499|Sensory System Agents|sensory system agents|mesh-ancestor
91913201|NCT02098499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913202|NCT02098499|Antiemetics|antiemetics|mesh-ancestor
91913203|NCT02098499|Autonomic Agents|autonomic agents|mesh-ancestor
91913204|NCT02098499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913205|NCT02098499|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91913206|NCT02098499|Histamine Antagonists|histamine antagonists|mesh-ancestor
91913207|NCT02098499|Histamine Agents|histamine agents|mesh-ancestor
91913208|NCT02098499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913209|NCT02098499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913210|NCT02098499|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91913211|NCT02098499|Antipruritics|antipruritics|mesh-ancestor
91913212|NCT02098499|Dermatologic Agents|dermatologic agents|mesh-ancestor
91913213|NCT02098499|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91913214|NCT02098499|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91913215|NCT02098499|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913216|NCT02098499|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91913217|NCT02098499|Dopamine Agents|dopamine agents|mesh-ancestor
91913218|NCT02098499|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91913219|NCT02098499|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91913220|NCT02097017|Lidocaine|lidocaine|mesh-list
91913221|NCT02097017|Anesthetics, Local|anesthetics, local|mesh-ancestor
91913222|NCT02097017|Anesthetics|anesthetics|mesh-ancestor
91913223|NCT02097017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913224|NCT02097017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913225|NCT02097017|Sensory System Agents|sensory system agents|mesh-ancestor
91913226|NCT02097017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913227|NCT02097017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91913228|NCT02097017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91913229|NCT02097017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91913230|NCT02097017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91913231|NCT02097017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913232|NCT03555383|Hemostatics|hemostatics|mesh-list
91913233|NCT03555383|Coagulants|coagulants|mesh-ancestor
91913234|NCT02101151|Vitamin D|vitamin d|mesh-list
91913235|NCT02101151|Cholecalciferol|cholecalciferol|mesh-list
91913236|NCT02101151|Vitamins|vitamins|mesh-ancestor
91913237|NCT02101151|Micronutrients|micronutrients|mesh-ancestor
91913238|NCT02101151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913239|NCT02101151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91913240|NCT02101151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91913241|NCT02101229|Insulin|insulin|mesh-list
91913242|NCT02101229|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91913243|NCT02101229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91913244|NCT02101229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913245|NCT02102555|Acetaminophen|acetaminophen|mesh-list
91913246|NCT02102555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913247|NCT02102555|Analgesics|analgesics|mesh-ancestor
91913248|NCT02102555|Sensory System Agents|sensory system agents|mesh-ancestor
91913249|NCT02102555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913250|NCT02102555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913251|NCT02102555|Antipyretics|antipyretics|mesh-ancestor
91913252|NCT02102633|Dabigatran|dabigatran|mesh-list
91913253|NCT02102633|Antithrombins|antithrombins|mesh-ancestor
91913254|NCT02102633|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91913255|NCT02102633|Protease Inhibitors|protease inhibitors|mesh-ancestor
91913256|NCT02102633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913257|NCT02102633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913258|NCT02102633|Anticoagulants|anticoagulants|mesh-ancestor
91913259|NCT02102711|Vitamin A|vitamin a|mesh-list
91913260|NCT02102711|Vitamins|vitamins|mesh-ancestor
91913261|NCT02102711|Micronutrients|micronutrients|mesh-ancestor
91913262|NCT02102711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913263|NCT02106767|Rifampin|rifampin|mesh-list
91913264|NCT02106767|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91913265|NCT02106767|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91913268|NCT02106767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913269|NCT02106767|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913270|NCT02106767|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91913271|NCT02106767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913272|NCT02106767|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91913273|NCT02106767|Antitubercular Agents|antitubercular agents|mesh-ancestor
91913274|NCT02106767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91913275|NCT02106767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913276|NCT02106767|Leprostatic Agents|leprostatic agents|mesh-ancestor
91913277|NCT02106767|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91913278|NCT02106767|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91913279|NCT02106767|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91913280|NCT02106767|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91913281|NCT02106767|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91913282|NCT02106767|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91913283|NCT02106767|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91913285|NCT02103023|Vaccines|vaccines|mesh-list
91913286|NCT02103023|Immunologic Factors|immunologic factors|mesh-ancestor
91913287|NCT02103023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913288|NCT02103023|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91913289|NCT02103023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913290|NCT02103023|Interferon Inducers|interferon inducers|mesh-ancestor
91913291|NCT02101931|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91913292|NCT02101931|Levulinic acid|levulinic acid|mesh-list
91913293|NCT02101931|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91913294|NCT02101931|Dermatologic Agents|dermatologic agents|mesh-ancestor
91913295|NCT02101931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913296|NCT02101931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913298|NCT02106845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91913299|NCT02106845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91913300|NCT02106845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91913301|NCT02106845|Antimetabolites|antimetabolites|mesh-ancestor
91913302|NCT02106845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913303|NCT02106845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913304|NCT02106845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91913305|NCT02106845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913306|NCT02106845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91913307|NCT02106845|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91913308|NCT02106845|Protective Agents|protective agents|mesh-ancestor
91913309|NCT02106845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913310|NCT03554447|Pentoxifylline|pentoxifylline|mesh-list
91913311|NCT03554447|Dexetimide|dexetimide|mesh-list
91913312|NCT03554447|Citalopram|citalopram|mesh-list
91913313|NCT03554447|Escitalopram|escitalopram|mesh-list
91913314|NCT03554447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91913315|NCT03554447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91913316|NCT03554447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91913317|NCT03554447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913318|NCT03554447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913319|NCT03554447|Serotonin Agents|serotonin agents|mesh-ancestor
91913320|NCT03554447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913321|NCT03554447|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91913322|NCT03554447|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91913323|NCT03554447|Parasympatholytics|parasympatholytics|mesh-ancestor
91913324|NCT03554447|Autonomic Agents|autonomic agents|mesh-ancestor
91913325|NCT03554447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913326|NCT03554447|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91913327|NCT03554447|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91913328|NCT03554447|Cholinergic Agents|cholinergic agents|mesh-ancestor
91913329|NCT03554447|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91913330|NCT03554447|Antidepressive Agents|antidepressive agents|mesh-ancestor
91913331|NCT03554447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913332|NCT03554447|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91913333|NCT03554447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913334|NCT03554447|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91913335|NCT03554447|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91913336|NCT03554447|Protective Agents|protective agents|mesh-ancestor
91913337|NCT03554447|Vasodilator Agents|vasodilator agents|mesh-ancestor
91913338|NCT03554447|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91913340|NCT02103335|Dexamethasone|dexamethasone|mesh-list
91913341|NCT02103335|Pomalidomide|pomalidomide|mesh-list
91913342|NCT02103335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913343|NCT02103335|Antiemetics|antiemetics|mesh-ancestor
91913344|NCT02103335|Autonomic Agents|autonomic agents|mesh-ancestor
91913345|NCT02103335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913346|NCT02103335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913347|NCT02103335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913348|NCT02103335|Glucocorticoids|glucocorticoids|mesh-ancestor
91913349|NCT02103335|Hormones|hormones|mesh-ancestor
91913350|NCT02103335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913351|NCT02103335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91913352|NCT02103335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913353|NCT02103335|Immunologic Factors|immunologic factors|mesh-ancestor
91913354|NCT02103335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91913355|NCT02103335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91913356|NCT02103335|Growth Substances|growth substances|mesh-ancestor
91913357|NCT02103335|Growth Inhibitors|growth inhibitors|mesh-ancestor
91913358|NCT02610140|Vinorelbine|vinorelbine|mesh-list
91913359|NCT02610140|Maytansine|maytansine|mesh-list
91913360|NCT02610140|Anetumab ravtansine|anetumab ravtansine|mesh-list
91913361|NCT02610140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91913362|NCT02610140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913363|NCT02610140|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913364|NCT02610140|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913365|NCT02610140|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913366|NCT02610140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913367|NCT02610140|Immunoconjugates|immunoconjugates|mesh-ancestor
91913368|NCT02610140|Immunologic Factors|immunologic factors|mesh-ancestor
91913369|NCT02610140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913371|NCT02102321|Anthelmintics|anthelmintics|mesh-ancestor
91913372|NCT02102321|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91913373|NCT02102321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913374|NCT02102321|Anticestodal Agents|anticestodal agents|mesh-ancestor
91913375|NCT02102321|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91913376|NCT02102321|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91913377|NCT02102321|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913378|NCT02102321|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913379|NCT02102321|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913380|NCT02102321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913381|NCT02102321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913382|NCT02103569|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91913383|NCT02103569|Norethindrone|norethindrone|mesh-list
91913384|NCT02103569|Norethindrone Acetate|norethindrone acetate|mesh-list
91913385|NCT02103569|Estradiol|estradiol|mesh-list
91913386|NCT02103569|Asunaprevir|asunaprevir|mesh-list
91913387|NCT02103569|Estrogens|estrogens|mesh-ancestor
91913388|NCT02103569|Hormones|hormones|mesh-ancestor
91913389|NCT02103569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913390|NCT02103569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913391|NCT02103569|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91913392|NCT02103569|Contraceptive Agents|contraceptive agents|mesh-ancestor
91913393|NCT02103569|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91913394|NCT02103569|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91913395|NCT02103569|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91913396|NCT02103569|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91913397|NCT02103569|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91913398|NCT02103569|Protease Inhibitors|protease inhibitors|mesh-ancestor
91913399|NCT02103569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913400|NCT02103569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913401|NCT02103647|Pregabalin|pregabalin|mesh-list
91913402|NCT02103647|Analgesics|analgesics|mesh-ancestor
91913403|NCT02103647|Sensory System Agents|sensory system agents|mesh-ancestor
91913404|NCT02103647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913405|NCT02103647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913406|NCT02103647|Anticonvulsants|anticonvulsants|mesh-ancestor
91913407|NCT02103647|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91913408|NCT02103647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91913409|NCT02103647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913410|NCT02103647|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91913411|NCT02103647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91913412|NCT02103647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91913413|NCT02103647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913414|NCT02103647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913415|NCT02109965|Midazolam|midazolam|mesh-list
91913416|NCT02109965|Dexmedetomidine|dexmedetomidine|mesh-list
91913417|NCT02109965|Propofol|propofol|mesh-list
91913418|NCT02109965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91913419|NCT02109965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913420|NCT02109965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913421|NCT02109965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913422|NCT02109965|Analgesics|analgesics|mesh-ancestor
91913423|NCT02109965|Sensory System Agents|sensory system agents|mesh-ancestor
91913424|NCT02109965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913425|NCT02109965|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91913426|NCT02109965|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91913427|NCT02109965|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91913428|NCT02109965|Adrenergic Agents|adrenergic agents|mesh-ancestor
91913429|NCT02109965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913430|NCT02109965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913431|NCT02109965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91913432|NCT02109965|Anesthetics, General|anesthetics, general|mesh-ancestor
91913433|NCT02109965|Anesthetics|anesthetics|mesh-ancestor
91913434|NCT02109965|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91913435|NCT02109965|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91913436|NCT02109965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91913437|NCT02109965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913438|NCT02109965|GABA Modulators|gaba modulators|mesh-ancestor
91913439|NCT02109965|GABA Agents|gaba agents|mesh-ancestor
91913440|NCT02789657|Paclitaxel|paclitaxel|mesh-list
91913441|NCT02789657|Carboplatin|carboplatin|mesh-list
91913442|NCT02789657|Trastuzumab|trastuzumab|mesh-list
91913443|NCT02789657|Pertuzumab|pertuzumab|mesh-list
91913444|NCT02789657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91913445|NCT02789657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913446|NCT02789657|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913447|NCT02789657|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913448|NCT02789657|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913449|NCT02789657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913450|NCT02789657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913451|NCT03555071|Vaccines|vaccines|mesh-list
91913452|NCT03555071|Immunologic Factors|immunologic factors|mesh-ancestor
91913453|NCT03555071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913454|NCT02609984|Atezolizumab|atezolizumab|mesh-list
91913455|NCT02609984|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91913456|NCT02609984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913457|NCT02609984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913458|NCT02609984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913459|NCT02107079|Melatonin|melatonin|mesh-list
91913460|NCT02107079|Antioxidants|antioxidants|mesh-ancestor
91913461|NCT02107079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913462|NCT02107079|Protective Agents|protective agents|mesh-ancestor
91913463|NCT02107079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913464|NCT02107079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913465|NCT02107235|ON 01910|on 01910|mesh-list
91913466|NCT02107235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913467|NCT02107235|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913468|NCT02107235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913469|NCT02107235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913470|NCT02103725|Pimecrolimus|pimecrolimus|mesh-list
91913471|NCT02103725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91913472|NCT02103725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913473|NCT02103725|Analgesics|analgesics|mesh-ancestor
91913474|NCT02103725|Sensory System Agents|sensory system agents|mesh-ancestor
91913475|NCT02103725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913476|NCT02103725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913477|NCT02103725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913478|NCT02103725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913479|NCT02103725|Dermatologic Agents|dermatologic agents|mesh-ancestor
91913480|NCT02103725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91913481|NCT02103725|Immunologic Factors|immunologic factors|mesh-ancestor
91913482|NCT02103725|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91913483|NCT02103725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913484|NCT02103725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913485|NCT03042260|Trimethoprim|trimethoprim|mesh-list
91913486|NCT03042260|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91913487|NCT03042260|Sulfamethoxazole|sulfamethoxazole|mesh-list
91913488|NCT03042260|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91913489|NCT03042260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913490|NCT03042260|Antimalarials|antimalarials|mesh-ancestor
91913491|NCT03042260|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91913492|NCT03042260|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91913493|NCT03042260|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91913494|NCT03042260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913495|NCT03042260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913496|NCT03042260|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91913497|NCT03042260|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91913498|NCT03042260|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91913499|NCT03042260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91913500|NCT02110355|Trametinib|trametinib|mesh-list
91913501|NCT02110355|Dabrafenib|dabrafenib|mesh-list
91913502|NCT02110355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913503|NCT02110355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913504|NCT02110355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913505|NCT02110355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913506|NCT02107391|Leuprolide|leuprolide|mesh-list
91913507|NCT02107391|Goserelin|goserelin|mesh-list
91913508|NCT02107391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91913509|NCT02107391|Fertility Agents|fertility agents|mesh-ancestor
91913510|NCT02107391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91913511|NCT02107391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913512|NCT02107391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91913513|NCT02107391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913515|NCT02103881|Haloperidol|haloperidol|mesh-list
91913516|NCT02103881|Haloperidol decanoate|haloperidol decanoate|mesh-list
91913517|NCT02103881|Analgesics|analgesics|mesh-ancestor
91913518|NCT02103881|Sensory System Agents|sensory system agents|mesh-ancestor
91913519|NCT02103881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913520|NCT02103881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913521|NCT02103881|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91913522|NCT02103881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91913523|NCT02103881|Anesthetics, General|anesthetics, general|mesh-ancestor
91913524|NCT02103881|Anesthetics|anesthetics|mesh-ancestor
91913525|NCT02103881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913526|NCT02103881|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91913527|NCT02103881|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91913528|NCT02103881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913529|NCT02103881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913530|NCT02103881|Antiemetics|antiemetics|mesh-ancestor
91913531|NCT02103881|Autonomic Agents|autonomic agents|mesh-ancestor
91913532|NCT02103881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913533|NCT02103881|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91913534|NCT02103881|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91913535|NCT02103881|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913536|NCT02103881|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91913537|NCT02103881|Dopamine Agents|dopamine agents|mesh-ancestor
91913538|NCT02103881|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91913540|NCT03554915|Ketamine|ketamine|mesh-list
91913541|NCT03554915|Analgesics|analgesics|mesh-ancestor
91913542|NCT03554915|Sensory System Agents|sensory system agents|mesh-ancestor
91913543|NCT03554915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913544|NCT03554915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913545|NCT03554915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91913546|NCT03554915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91913547|NCT03554915|Anesthetics, General|anesthetics, general|mesh-ancestor
91913549|NCT03554915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913550|NCT03554915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91913551|NCT03554915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91913552|NCT03554915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913553|NCT03554915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913554|NCT03554915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91913555|NCT03554915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91913556|NCT03554915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91913557|NCT03554915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91913558|NCT03554915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91913559|NCT03554915|GABA Modulators|gaba modulators|mesh-ancestor
91913560|NCT03554915|GABA Agents|gaba agents|mesh-ancestor
91913561|NCT03044522|Analgesics, Opioid|analgesics, opioid|mesh-list
91913562|NCT03044522|Narcotics|narcotics|mesh-ancestor
91913563|NCT03044522|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913564|NCT03044522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913565|NCT03044522|Analgesics|analgesics|mesh-ancestor
91913566|NCT03044522|Sensory System Agents|sensory system agents|mesh-ancestor
91913567|NCT03044522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913568|NCT03044366|Anesthetics|anesthetics|mesh-list
91913569|NCT03044366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913570|NCT03044366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913571|NCT02250833|Amlodipine|amlodipine|mesh-list
91913572|NCT02250833|Telmisartan|telmisartan|mesh-list
91913573|NCT02250833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91913574|NCT02250833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91913575|NCT02250833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91913576|NCT02250833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913577|NCT02250833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91913578|NCT02250833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913579|NCT02250833|Vasodilator Agents|vasodilator agents|mesh-ancestor
91913580|NCT02250833|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91913581|NCT02250833|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91913582|NCT02110745|Propofol|propofol|mesh-list
91913583|NCT02110745|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91913584|NCT02110745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913585|NCT02110745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913586|NCT02110745|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91913587|NCT02110745|Anesthetics, General|anesthetics, general|mesh-ancestor
91913588|NCT02110745|Anesthetics|anesthetics|mesh-ancestor
91913589|NCT04857320|Insulin|insulin|mesh-list
91913590|NCT04857320|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91913591|NCT04857320|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91913592|NCT04857320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913593|NCT03041948|Acetaminophen|acetaminophen|mesh-list
91913594|NCT03041948|Dexamethasone|dexamethasone|mesh-list
91913595|NCT03041948|Ketorolac|ketorolac|mesh-list
91913596|NCT03041948|Morphine|morphine|mesh-list
91913597|NCT03041948|Remifentanil|remifentanil|mesh-list
91913598|NCT03041948|Ondansetron|ondansetron|mesh-list
91913599|NCT03041948|Propofol|propofol|mesh-list
91913600|NCT03041948|Sevoflurane|sevoflurane|mesh-list
91913601|NCT03041948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913602|NCT03041948|Antiemetics|antiemetics|mesh-ancestor
91913603|NCT03041948|Autonomic Agents|autonomic agents|mesh-ancestor
91913604|NCT03041948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913605|NCT03041948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913606|NCT03041948|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913607|NCT03041948|Glucocorticoids|glucocorticoids|mesh-ancestor
91913608|NCT03041948|Hormones|hormones|mesh-ancestor
91913609|NCT03041948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913610|NCT03041948|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91913611|NCT03041948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913612|NCT03041948|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91913613|NCT03041948|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913614|NCT03041948|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91913615|NCT03041948|Anesthetics, General|anesthetics, general|mesh-ancestor
91913616|NCT03041948|Anesthetics|anesthetics|mesh-ancestor
91913617|NCT03041948|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91913618|NCT03041948|Narcotics|narcotics|mesh-ancestor
91913619|NCT03041948|Analgesics|analgesics|mesh-ancestor
91913620|NCT03041948|Sensory System Agents|sensory system agents|mesh-ancestor
91913621|NCT03041948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913622|NCT03041948|Antipyretics|antipyretics|mesh-ancestor
91913623|NCT03041948|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91913624|NCT03041948|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91913625|NCT03041948|Antipruritics|antipruritics|mesh-ancestor
91913626|NCT03041948|Dermatologic Agents|dermatologic agents|mesh-ancestor
91913627|NCT03041948|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91913628|NCT03041948|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91913629|NCT03041948|Serotonin Agents|serotonin agents|mesh-ancestor
91913630|NCT03041948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913631|NCT03041948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913632|NCT03041948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91913633|NCT03041948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913634|NCT03041948|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91913635|NCT03041948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913636|NCT02104193|Simvastatin|simvastatin|mesh-list
91913637|NCT02104193|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91913638|NCT02104193|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91913639|NCT02104193|Antimetabolites|antimetabolites|mesh-ancestor
91913640|NCT02104193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913641|NCT02104193|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913642|NCT02104193|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91913643|NCT02104193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913645|NCT03042182|Immunologic Factors|immunologic factors|mesh-ancestor
91913646|NCT03042182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913647|NCT02104661|Oxcarbazepine|oxcarbazepine|mesh-list
91913648|NCT02104661|Anticonvulsants|anticonvulsants|mesh-ancestor
91913649|NCT02104661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91913650|NCT02104661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91913651|NCT02104661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91913652|NCT02104661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913653|NCT02104661|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91913654|NCT02104661|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91913655|NCT02611778|Ranibizumab|ranibizumab|mesh-list
91913656|NCT02611778|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91913657|NCT02611778|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91913658|NCT02611778|Growth Substances|growth substances|mesh-ancestor
91913659|NCT02611778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913660|NCT02611778|Growth Inhibitors|growth inhibitors|mesh-ancestor
91913661|NCT02611778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913662|NCT04867226|Colchicine|colchicine|mesh-list
91913663|NCT04867226|Gout Suppressants|gout suppressants|mesh-ancestor
91913664|NCT04867226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913665|NCT04867226|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913666|NCT04867226|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913667|NCT04867226|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913668|NCT04867226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913669|NCT04867226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913671|NCT04856852|Temozolomide|temozolomide|mesh-list
91913672|NCT04856852|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91913673|NCT04856852|Alkylating Agents|alkylating agents|mesh-ancestor
91913674|NCT04856852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913675|NCT04856852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913676|NCT04856852|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91913677|NCT04856852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913678|NCT04856852|Trace Elements|trace elements|mesh-ancestor
91913679|NCT04856852|Micronutrients|micronutrients|mesh-ancestor
91913680|NCT04856852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913681|NCT02711553|Gemcitabine|gemcitabine|mesh-list
91913682|NCT02711553|Ramucirumab|ramucirumab|mesh-list
91913683|NCT02711553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913684|NCT02711553|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91913685|NCT02711553|Antimetabolites|antimetabolites|mesh-ancestor
91913686|NCT02711553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913687|NCT01453179|Diclofenac|diclofenac|mesh-list
91913688|NCT01453179|Imiquimod|imiquimod|mesh-list
91913689|NCT01453179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91913690|NCT01453179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913691|NCT01453179|Analgesics|analgesics|mesh-ancestor
91913692|NCT01453179|Sensory System Agents|sensory system agents|mesh-ancestor
91913693|NCT01453179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913694|NCT01453179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913695|NCT01453179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913696|NCT01453179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913697|NCT01453179|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91913698|NCT01453179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913699|NCT01453179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913700|NCT01453179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91913701|NCT01453179|Immunologic Factors|immunologic factors|mesh-ancestor
91913702|NCT01453179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913703|NCT01453179|Interferon Inducers|interferon inducers|mesh-ancestor
91913705|NCT03192033|Coagulants|coagulants|mesh-ancestor
91913706|NCT03188445|Ascorbic Acid|ascorbic acid|mesh-list
91913707|NCT03188445|Ferrous fumarate|ferrous fumarate|mesh-list
91913708|NCT03188445|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
91913709|NCT03188445|Antioxidants|antioxidants|mesh-ancestor
91913710|NCT03188445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913711|NCT03188445|Protective Agents|protective agents|mesh-ancestor
91913712|NCT03188445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913713|NCT03188445|Vitamins|vitamins|mesh-ancestor
91913714|NCT03188445|Micronutrients|micronutrients|mesh-ancestor
91913715|NCT03188445|Trace Elements|trace elements|mesh-ancestor
91913716|NCT03188445|Hematinics|hematinics|mesh-ancestor
91913717|NCT04483635|Vitamin D|vitamin d|mesh-list
91913718|NCT04483635|Cholecalciferol|cholecalciferol|mesh-list
91913719|NCT04483635|Vitamins|vitamins|mesh-ancestor
91913720|NCT04483635|Micronutrients|micronutrients|mesh-ancestor
91913721|NCT04483635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913722|NCT04483635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91913723|NCT04483635|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91913724|NCT04865900|Antibodies|antibodies|mesh-list
91913725|NCT04865900|Immunologic Factors|immunologic factors|mesh-ancestor
91913726|NCT04865900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913727|NCT03191721|Triclosan|triclosan|mesh-list
91913728|NCT03191721|Anti-Infective Agents|anti-infective agents|mesh-list
91913729|NCT03191721|Fluorides|fluorides|mesh-list
91913730|NCT03191721|Cariostatic Agents|cariostatic agents|mesh-ancestor
91913732|NCT03191721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913733|NCT03191721|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91913734|NCT03191721|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91913735|NCT03191721|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91913736|NCT03191721|Antimetabolites|antimetabolites|mesh-ancestor
91913737|NCT03191721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913738|NCT03191721|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913739|NCT04864496|Acetylcysteine|acetylcysteine|mesh-list
91913740|NCT04864496|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91913741|NCT04864496|Antiviral Agents|antiviral agents|mesh-ancestor
91913742|NCT04864496|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913743|NCT04864496|Expectorants|expectorants|mesh-ancestor
91913744|NCT04864496|Respiratory System Agents|respiratory system agents|mesh-ancestor
91913745|NCT04864496|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91913746|NCT04864496|Antioxidants|antioxidants|mesh-ancestor
91913747|NCT04864496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913748|NCT04864496|Protective Agents|protective agents|mesh-ancestor
91913749|NCT04864496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913750|NCT04864496|Antidotes|antidotes|mesh-ancestor
91913751|NCT03188289|Chitosan|chitosan|mesh-list
91913752|NCT03188289|Hyaluronic Acid|hyaluronic acid|mesh-list
91913753|NCT03188289|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91913754|NCT03188289|Immunologic Factors|immunologic factors|mesh-ancestor
91913755|NCT03188289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913756|NCT03188289|Viscosupplements|viscosupplements|mesh-ancestor
91913757|NCT03188289|Protective Agents|protective agents|mesh-ancestor
91913758|NCT03188289|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91913759|NCT03188289|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91913760|NCT03188289|Antimetabolites|antimetabolites|mesh-ancestor
91913761|NCT03188289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913762|NCT03188289|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913763|NCT03188289|Chelating Agents|chelating agents|mesh-ancestor
91913764|NCT03188289|Sequestering Agents|sequestering agents|mesh-ancestor
91913765|NCT03188289|Hemostatics|hemostatics|mesh-ancestor
91913766|NCT03188289|Coagulants|coagulants|mesh-ancestor
91913767|NCT03044912|Mirabegron|mirabegron|mesh-list
91913768|NCT03044912|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91913769|NCT03044912|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91913770|NCT03044912|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91913771|NCT03044912|Adrenergic Agents|adrenergic agents|mesh-ancestor
91913772|NCT03044912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91913773|NCT03044912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913774|NCT03044912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913775|NCT03044912|Urological Agents|urological agents|mesh-ancestor
91913776|NCT03041012|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91913778|NCT03041012|Antibodies, Blocking|antibodies, blocking|mesh-list
91913779|NCT03041012|Antiviral Agents|antiviral agents|mesh-ancestor
91913780|NCT03041012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913781|NCT03041012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91913782|NCT03041012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913783|NCT03041012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91913784|NCT03041012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913785|NCT03041012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913786|NCT03041012|Immunologic Factors|immunologic factors|mesh-ancestor
91913787|NCT03041012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913788|NCT03187899|Ropivacaine|ropivacaine|mesh-list
91913789|NCT03187899|Anesthetics, Local|anesthetics, local|mesh-ancestor
91913790|NCT03187899|Anesthetics|anesthetics|mesh-ancestor
91913791|NCT03187899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913792|NCT03187899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913793|NCT03187899|Sensory System Agents|sensory system agents|mesh-ancestor
91913794|NCT03187899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913795|NCT01648582|Metformin|metformin|mesh-list
91913796|NCT01648582|Insulin Glargine|insulin glargine|mesh-list
91913797|NCT01648582|Dulaglutide|dulaglutide|mesh-list
91913798|NCT01648582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91913799|NCT01648582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913800|NCT02440347|Anesthetics|anesthetics|mesh-list
91913801|NCT02440347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91913802|NCT02440347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913803|NCT03043820|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
91913804|NCT03043820|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91913805|NCT03043820|Hormone Antagonists|hormone antagonists|mesh-ancestor
91913806|NCT03043820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913807|NCT03043820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913808|NCT03043820|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91913809|NCT03043820|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91913810|NCT03043820|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91913811|NCT03191097|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
91913812|NCT03191097|Antiviral Agents|antiviral agents|mesh-ancestor
91913813|NCT03191097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913814|NCT04854668|Bevacizumab|bevacizumab|mesh-list
91913815|NCT04854668|Capecitabine|capecitabine|mesh-list
91913816|NCT04854668|Oxaliplatin|oxaliplatin|mesh-list
91942950|NCT04068597|Autonomic Agents|autonomic agents|mesh-ancestor
91913817|NCT04854668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913818|NCT04854668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913819|NCT04854668|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91913820|NCT04854668|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91913821|NCT04854668|Growth Substances|growth substances|mesh-ancestor
91913822|NCT04854668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913823|NCT04854668|Growth Inhibitors|growth inhibitors|mesh-ancestor
91913824|NCT04854668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91913825|NCT04854668|Antimetabolites|antimetabolites|mesh-ancestor
91913826|NCT04854668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913827|NCT03189069|Warfarin|warfarin|mesh-list
91913828|NCT03189069|Rivaroxaban|rivaroxaban|mesh-list
91913829|NCT03189069|Dabigatran|dabigatran|mesh-list
91913830|NCT03189069|Apixaban|apixaban|mesh-list
91913831|NCT03189069|Anticoagulants|anticoagulants|mesh-ancestor
91913832|NCT03189069|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91913833|NCT03189069|Antithrombins|antithrombins|mesh-ancestor
91913834|NCT03189069|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91913835|NCT03189069|Protease Inhibitors|protease inhibitors|mesh-ancestor
91913836|NCT03189069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913837|NCT03189069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913838|NCT03040934|Sirolimus|sirolimus|mesh-list
91913839|NCT03040934|Everolimus|everolimus|mesh-list
91913840|NCT03040934|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91913841|NCT03040934|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913842|NCT03040934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913843|NCT03040934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913844|NCT03040934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91913845|NCT03040934|Immunologic Factors|immunologic factors|mesh-ancestor
91913846|NCT03040934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913847|NCT03040934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913848|NCT03040934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91913849|NCT03040934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913850|NCT03040934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91913851|NCT03040934|Antifungal Agents|antifungal agents|mesh-ancestor
91913852|NCT04861142|Denosumab|denosumab|mesh-list
91913853|NCT04861142|Alendronate|alendronate|mesh-list
91913854|NCT04861142|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91913855|NCT04861142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913856|NCT03117855|Capecitabine|capecitabine|mesh-list
91913857|NCT03117855|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91913858|NCT03117855|Antimetabolites|antimetabolites|mesh-ancestor
91913859|NCT03117855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913860|NCT03117855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913862|NCT02607800|Velpatasvir|velpatasvir|mesh-list
91913863|NCT02607800|Antiviral Agents|antiviral agents|mesh-ancestor
91913864|NCT02607800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913865|NCT02304484|Evolocumab|evolocumab|mesh-list
91913866|NCT02304484|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91913867|NCT02304484|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91913868|NCT02304484|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91913869|NCT02304484|Antimetabolites|antimetabolites|mesh-ancestor
91913870|NCT02304484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913871|NCT02304484|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91913872|NCT02304484|Protease Inhibitors|protease inhibitors|mesh-ancestor
91913873|NCT02304484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913874|NCT02304484|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913875|NCT02434029|Budesonide|budesonide|mesh-list
91913876|NCT02434029|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913877|NCT02434029|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91913878|NCT02434029|Autonomic Agents|autonomic agents|mesh-ancestor
91913879|NCT02434029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913880|NCT02434029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913881|NCT02434029|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91913882|NCT02434029|Respiratory System Agents|respiratory system agents|mesh-ancestor
91913883|NCT02434029|Glucocorticoids|glucocorticoids|mesh-ancestor
91913884|NCT02434029|Hormones|hormones|mesh-ancestor
91913885|NCT02434029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91913886|NCT02708355|Esomeprazole|esomeprazole|mesh-list
91913887|NCT02708355|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91913888|NCT02708355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91913889|NCT02708355|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91913890|NCT02708355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913891|NCT02708355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913893|NCT04854044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913894|NCT02708277|Contraceptive Agents|contraceptive agents|mesh-list
91913895|NCT02708277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91913896|NCT02708277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913897|NCT02337478|Vincristine|vincristine|mesh-list
91913898|NCT02337478|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91913899|NCT02337478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913900|NCT02337478|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913901|NCT02337478|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913902|NCT02337478|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913903|NCT02337478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913904|NCT02434653|Chrysarobin|chrysarobin|mesh-list
91913905|NCT02434653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91913906|NCT02434653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91913907|NCT02434653|Analgesics|analgesics|mesh-ancestor
91913908|NCT02434653|Sensory System Agents|sensory system agents|mesh-ancestor
91913909|NCT02434653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913910|NCT02434653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913911|NCT02434653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913912|NCT02434653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913913|NCT03043196|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91913914|NCT03043196|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91913915|NCT03043196|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91913916|NCT03043196|Antimetabolites|antimetabolites|mesh-ancestor
91913917|NCT03043196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913918|NCT03043196|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91913919|NCT03043196|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91913920|NCT03043196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913921|NCT03188835|Glycerol|glycerol|mesh-list
91913922|NCT03188835|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91913923|NCT03188835|Protective Agents|protective agents|mesh-ancestor
91913924|NCT03188835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913925|NCT04847024|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91913926|NCT04847024|Parecoxib|parecoxib|mesh-list
91913927|NCT04847024|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91913929|NCT04847024|Analgesics|analgesics|mesh-ancestor
91913930|NCT04847024|Sensory System Agents|sensory system agents|mesh-ancestor
91913931|NCT04847024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91913932|NCT04847024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913933|NCT04847024|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91913934|NCT04847024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913935|NCT04847024|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91913936|NCT04847024|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91913937|NCT04847024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913938|NCT04847024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913939|NCT04860674|Carboplatin|carboplatin|mesh-list
91913940|NCT04860674|Etoposide|etoposide|mesh-list
91913941|NCT04860674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91913942|NCT04860674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913943|NCT04860674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91913944|NCT04860674|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91913945|NCT04860674|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91913946|NCT04860674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913947|NCT04860674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913948|NCT04860674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913949|NCT04853342|Aflutinib|aflutinib|mesh-list
91913950|NCT04853342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913951|NCT04853342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913952|NCT04853342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913953|NCT04853030|Insulin Aspart|insulin aspart|mesh-list
91913954|NCT04853030|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91913955|NCT04853030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913956|NCT02430363|Pembrolizumab|pembrolizumab|mesh-list
91913957|NCT02430363|Ipatasertib|ipatasertib|mesh-list
91913958|NCT02430363|Dactolisib|dactolisib|mesh-list
91913959|NCT02430363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91913960|NCT02430363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942954|NCT04068597|Glucocorticoids|glucocorticoids|mesh-ancestor
91913961|NCT02430363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91913962|NCT02430363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913963|NCT02430363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91913964|NCT02430363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913965|NCT02429973|Sirolimus|sirolimus|mesh-list
91913966|NCT02429973|Gemcitabine|gemcitabine|mesh-list
91913967|NCT02429973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91913968|NCT02429973|Antimetabolites|antimetabolites|mesh-ancestor
91913969|NCT02429973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913970|NCT02429973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913971|NCT02429973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91913972|NCT02429973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913973|NCT02429973|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91913974|NCT02429973|Antifungal Agents|antifungal agents|mesh-ancestor
91913975|NCT02429973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91913976|NCT02429973|Immunologic Factors|immunologic factors|mesh-ancestor
91913977|NCT02429973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91913978|NCT04860284|Hydroxychloroquine|hydroxychloroquine|mesh-list
91913979|NCT04860284|Antimalarials|antimalarials|mesh-ancestor
91913980|NCT04860284|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91913981|NCT04860284|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91913982|NCT04860284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91913983|NCT04860284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91913984|NCT04860284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913985|NCT04860284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91913986|NCT04846634|Paclitaxel|paclitaxel|mesh-list
91913987|NCT04846634|Docetaxel|docetaxel|mesh-list
91913988|NCT04846634|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91913989|NCT04846634|Cisplatin|cisplatin|mesh-list
91913990|NCT04846634|Carboplatin|carboplatin|mesh-list
91913991|NCT04846634|Gemcitabine|gemcitabine|mesh-list
91913992|NCT04846634|Pemetrexed|pemetrexed|mesh-list
91913993|NCT04846634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91913994|NCT04846634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91913995|NCT04846634|Tubulin Modulators|tubulin modulators|mesh-ancestor
91913996|NCT04846634|Antimitotic Agents|antimitotic agents|mesh-ancestor
91913997|NCT04846634|Mitosis Modulators|mitosis modulators|mesh-ancestor
91913998|NCT04846634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91913999|NCT04846634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91914000|NCT04846634|Antimetabolites|antimetabolites|mesh-ancestor
91914001|NCT04846634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914002|NCT04846634|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91914003|NCT04846634|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91914004|NCT02433717|Paliperidone Palmitate|paliperidone palmitate|mesh-list
91914005|NCT02433717|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91914006|NCT02433717|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91914007|NCT02433717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914008|NCT02433717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914009|NCT02433717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914010|NCT02433717|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91914011|NCT02433717|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91914012|NCT02433717|Serotonin Agents|serotonin agents|mesh-ancestor
91914013|NCT02433717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914014|NCT02433717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914015|NCT02433717|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91914016|NCT02433717|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91914017|NCT02433717|Dopamine Agents|dopamine agents|mesh-ancestor
91914018|NCT02429817|Edetic Acid|edetic acid|mesh-list
91914019|NCT02429817|Pentetic Acid|pentetic acid|mesh-list
91914020|NCT02429817|Antidotes|antidotes|mesh-ancestor
91914022|NCT02429817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914023|NCT02429817|Chelating Agents|chelating agents|mesh-ancestor
91914024|NCT02429817|Sequestering Agents|sequestering agents|mesh-ancestor
91914025|NCT02429817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914026|NCT02429817|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91914027|NCT02429817|Anticoagulants|anticoagulants|mesh-ancestor
91914028|NCT02429817|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91914029|NCT04851860|Immunomodulating Agents|immunomodulating agents|mesh-list
91914030|NCT04851860|Immunologic Factors|immunologic factors|mesh-ancestor
91914031|NCT04851860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914032|NCT04851548|Hyaluronic Acid|hyaluronic acid|mesh-list
91914033|NCT04851548|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91914034|NCT04851548|Immunologic Factors|immunologic factors|mesh-ancestor
91914035|NCT04851548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914040|NCT02706951|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91914041|NCT02706951|Abortifacient Agents|abortifacient agents|mesh-ancestor
91914042|NCT02706951|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91914043|NCT02706951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914044|NCT02706951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91914045|NCT02706951|Antimetabolites|antimetabolites|mesh-ancestor
91914046|NCT02706951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914047|NCT02706951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914048|NCT02706951|Dermatologic Agents|dermatologic agents|mesh-ancestor
91914049|NCT02706951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914050|NCT02706951|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91914051|NCT02706951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914052|NCT02706951|Immunologic Factors|immunologic factors|mesh-ancestor
91914053|NCT02706951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914054|NCT02706951|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91914055|NCT02706951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91914056|NCT02706951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91914057|NCT04851626|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
91914058|NCT04851626|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914059|NCT04851626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914060|NCT04851392|Dronabinol|dronabinol|mesh-list
91914061|NCT04851392|Cannabidiol|cannabidiol|mesh-list
91914062|NCT04851392|Anticonvulsants|anticonvulsants|mesh-ancestor
91914063|NCT04851392|Hallucinogens|hallucinogens|mesh-ancestor
91914064|NCT04851392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914065|NCT04851392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914066|NCT04851392|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914067|NCT04851392|Analgesics|analgesics|mesh-ancestor
91914068|NCT04851392|Sensory System Agents|sensory system agents|mesh-ancestor
91914069|NCT04851392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914070|NCT04851392|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91914071|NCT04851392|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91914072|NCT04851392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914073|NCT04851392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914074|NCT04851392|Hormones|hormones|mesh-ancestor
91914075|NCT04851392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914077|NCT02429193|Abiraterone Acetate|abiraterone acetate|mesh-list
91914078|NCT02429193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914079|NCT02429193|Glucocorticoids|glucocorticoids|mesh-ancestor
91914080|NCT02429193|Hormones|hormones|mesh-ancestor
91914081|NCT02429193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914082|NCT02429193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914083|NCT02429193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914084|NCT02429193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914085|NCT02429193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91914086|NCT02429193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914087|NCT02429193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914088|NCT02429193|Hormone Antagonists|hormone antagonists|mesh-ancestor
91914089|NCT02429193|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91914090|NCT04859738|Lidocaine|lidocaine|mesh-list
91914091|NCT04859738|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914092|NCT04859738|Anesthetics|anesthetics|mesh-ancestor
91914093|NCT04859738|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914094|NCT04859738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914095|NCT04859738|Sensory System Agents|sensory system agents|mesh-ancestor
91914096|NCT04859738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914097|NCT04859738|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91914098|NCT04859738|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91914099|NCT04859738|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91914100|NCT04859738|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914101|NCT04859738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914102|NCT02429271|Clopidogrel|clopidogrel|mesh-list
91914103|NCT02429271|Ticagrelor|ticagrelor|mesh-list
91914104|NCT02429271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91914105|NCT02429271|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91914106|NCT02429271|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91914107|NCT02429271|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91914108|NCT02429271|Purinergic Agents|purinergic agents|mesh-ancestor
91914109|NCT02429271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914110|NCT02429271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914111|NCT02429271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914112|NCT02429505|Miltefosine|miltefosine|mesh-list
91914114|NCT02429505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914115|NCT02429505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914116|NCT02429505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91914117|NCT02429505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91914118|NCT04851002|Mitogens|mitogens|mesh-list
91914119|NCT04851002|Mitosis Modulators|mitosis modulators|mesh-ancestor
91914120|NCT04851002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914121|NCT04844996|Ezetimibe|ezetimibe|mesh-list
91914122|NCT04844996|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91914123|NCT04844996|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91914124|NCT04844996|Antimetabolites|antimetabolites|mesh-ancestor
91914125|NCT04844996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914126|NCT04844996|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91914127|NCT02425137|Gemcitabine|gemcitabine|mesh-list
91914128|NCT02425137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91914129|NCT02425137|Antimetabolites|antimetabolites|mesh-ancestor
91914130|NCT02425137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914131|NCT02425137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914132|NCT04841018|Dexamethasone|dexamethasone|mesh-list
91914133|NCT04841018|Dexamethasone acetate|dexamethasone acetate|mesh-list
91914134|NCT04841018|BB 1101|bb 1101|mesh-list
91914135|NCT04841018|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914136|NCT04841018|Antiemetics|antiemetics|mesh-ancestor
91914137|NCT04841018|Autonomic Agents|autonomic agents|mesh-ancestor
91914138|NCT04841018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914139|NCT04841018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914140|NCT04841018|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914141|NCT04841018|Glucocorticoids|glucocorticoids|mesh-ancestor
91914142|NCT04841018|Hormones|hormones|mesh-ancestor
91914143|NCT04841018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914144|NCT04841018|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914145|NCT04841018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914146|NCT04841018|Protease Inhibitors|protease inhibitors|mesh-ancestor
91914147|NCT04841018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914148|NCT04841018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914149|NCT03182595|Acetaminophen|acetaminophen|mesh-list
91914150|NCT03182595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914151|NCT03182595|Analgesics|analgesics|mesh-ancestor
91914152|NCT03182595|Sensory System Agents|sensory system agents|mesh-ancestor
91914153|NCT03182595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914154|NCT03182595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914155|NCT03182595|Antipyretics|antipyretics|mesh-ancestor
91914156|NCT02428959|Amyl Nitrite|amyl nitrite|mesh-list
91914157|NCT02428959|Vasodilator Agents|vasodilator agents|mesh-ancestor
91914159|NCT02429037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914160|NCT04833608|Carbon Fiber|carbon fiber|mesh-list
91914161|NCT04833608|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91914162|NCT04833608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914163|NCT02428881|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91914164|NCT02428881|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91914165|NCT02428881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91914166|NCT02428881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914167|NCT02428881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914168|NCT02428881|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91914169|NCT02428881|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914170|NCT02428881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914171|NCT02428881|Cholinergic Agents|cholinergic agents|mesh-ancestor
91914172|NCT02428881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914173|NCT04833218|Propranolol|propranolol|mesh-list
91914174|NCT04833218|Clonidine|clonidine|mesh-list
91914175|NCT04833218|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91914176|NCT04833218|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91914177|NCT04833218|Adrenergic Agents|adrenergic agents|mesh-ancestor
91914178|NCT04833218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914179|NCT04833218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914180|NCT04833218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914181|NCT04833218|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91914182|NCT04833218|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91914183|NCT04833218|Vasodilator Agents|vasodilator agents|mesh-ancestor
91914184|NCT04833218|Analgesics|analgesics|mesh-ancestor
91914185|NCT04833218|Sensory System Agents|sensory system agents|mesh-ancestor
91914186|NCT04833218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914187|NCT04833218|Sympatholytics|sympatholytics|mesh-ancestor
91914188|NCT04833218|Autonomic Agents|autonomic agents|mesh-ancestor
91914189|NCT04833218|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91914190|NCT04833218|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91914191|NCT04833218|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91914192|NCT04833374|Prednisone|prednisone|mesh-list
91914193|NCT04833374|Methylprednisolone|methylprednisolone|mesh-list
91914194|NCT04833374|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91914195|NCT04833374|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91914196|NCT04833374|Prednisolone|prednisolone|mesh-list
91914197|NCT04833374|Prednisolone acetate|prednisolone acetate|mesh-list
91914198|NCT04833374|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91914199|NCT04833374|Prednisolone phosphate|prednisolone phosphate|mesh-list
91914200|NCT04833374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914201|NCT04833374|Glucocorticoids|glucocorticoids|mesh-ancestor
91914202|NCT04833374|Hormones|hormones|mesh-ancestor
91914203|NCT04833374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914204|NCT04833374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914205|NCT04833374|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914206|NCT04833374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914207|NCT04833374|Antiemetics|antiemetics|mesh-ancestor
91914208|NCT04833374|Autonomic Agents|autonomic agents|mesh-ancestor
91914209|NCT04833374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914210|NCT04833374|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914211|NCT04833374|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91914212|NCT04833374|Protective Agents|protective agents|mesh-ancestor
91914213|NCT02707965|Topiramate|topiramate|mesh-list
91914214|NCT02707965|Lamotrigine|lamotrigine|mesh-list
91914215|NCT02707965|Zonisamide|zonisamide|mesh-list
91914216|NCT02707965|Carbamazepine|carbamazepine|mesh-list
91914217|NCT02707965|Phenytoin|phenytoin|mesh-list
91914218|NCT02707965|Oxcarbazepine|oxcarbazepine|mesh-list
91914219|NCT02707965|Levetiracetam|levetiracetam|mesh-list
91914220|NCT02707965|Valproic Acid|valproic acid|mesh-list
91914221|NCT02707965|Anticonvulsants|anticonvulsants|mesh-ancestor
91914222|NCT02707965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91914223|NCT02707965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914224|NCT02707965|Nootropic Agents|nootropic agents|mesh-ancestor
91914225|NCT02707965|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91914226|NCT02707965|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914227|NCT02707965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914228|NCT02707965|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91914229|NCT02707965|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91914230|NCT02707965|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91914231|NCT02707965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914232|NCT02707965|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914233|NCT02707965|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91914234|NCT02707965|Antimanic Agents|antimanic agents|mesh-ancestor
91914235|NCT02707965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914236|NCT02707965|Analgesics|analgesics|mesh-ancestor
91914237|NCT02707965|Sensory System Agents|sensory system agents|mesh-ancestor
91914238|NCT02707965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914239|NCT02707965|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91914240|NCT02707965|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91914241|NCT02707965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914242|NCT02707965|GABA Agents|gaba agents|mesh-ancestor
91914243|NCT02707965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914244|NCT02707965|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91914245|NCT02707965|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91914246|NCT04839536|Sevoflurane|sevoflurane|mesh-list
91914247|NCT04839536|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91914248|NCT04839536|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91914249|NCT04839536|Anesthetics, General|anesthetics, general|mesh-ancestor
91914250|NCT04839536|Anesthetics|anesthetics|mesh-ancestor
91914251|NCT04839536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914252|NCT04839536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914254|NCT02428257|Bupivacaine|bupivacaine|mesh-list
91914255|NCT02428257|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914256|NCT02428257|Anesthetics|anesthetics|mesh-ancestor
91914257|NCT02428257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914258|NCT02428257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914259|NCT02428257|Sensory System Agents|sensory system agents|mesh-ancestor
91914260|NCT02428257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914261|NCT02428257|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91914262|NCT02428257|Sympathomimetics|sympathomimetics|mesh-ancestor
91914263|NCT02428257|Autonomic Agents|autonomic agents|mesh-ancestor
91914264|NCT02428257|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91914265|NCT02428257|Adrenergic Agents|adrenergic agents|mesh-ancestor
91914266|NCT02428257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914344|NCT02433795|Immunologic Factors|immunologic factors|mesh-ancestor
91914267|NCT02428257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914268|NCT04839224|Phenylephrine|phenylephrine|mesh-list
91914269|NCT04839224|Oxymetazoline|oxymetazoline|mesh-list
91914270|NCT04839224|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91914271|NCT04839224|Mydriatics|mydriatics|mesh-ancestor
91914272|NCT04839224|Autonomic Agents|autonomic agents|mesh-ancestor
91914273|NCT04839224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914274|NCT04839224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914275|NCT04839224|Sympathomimetics|sympathomimetics|mesh-ancestor
91914276|NCT04839224|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91914277|NCT04839224|Nasal Decongestants|nasal decongestants|mesh-ancestor
91914278|NCT04839224|Respiratory System Agents|respiratory system agents|mesh-ancestor
91914279|NCT04839224|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91914280|NCT04839224|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91914281|NCT04839224|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91914282|NCT04839224|Adrenergic Agents|adrenergic agents|mesh-ancestor
91914283|NCT04839224|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914284|NCT04839224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914285|NCT04839224|Protective Agents|protective agents|mesh-ancestor
91914287|NCT03036644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91914288|NCT03036644|Autonomic Agents|autonomic agents|mesh-ancestor
91914289|NCT03036644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914290|NCT03036644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914291|NCT03036644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91914292|NCT03036644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91914293|NCT03036644|Cholinergic Agents|cholinergic agents|mesh-ancestor
91914294|NCT03036644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914295|NCT03036644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914296|NCT02424201|Ascorbic Acid|ascorbic acid|mesh-list
91914297|NCT02424201|Misoprostol|misoprostol|mesh-list
91914298|NCT02424201|Vitamins|vitamins|mesh-ancestor
91914299|NCT02424201|Micronutrients|micronutrients|mesh-ancestor
91914300|NCT02424201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914301|NCT02424201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91914302|NCT02424201|Abortifacient Agents|abortifacient agents|mesh-ancestor
91914303|NCT02424201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91914304|NCT02424201|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91914305|NCT02424201|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914306|NCT02424201|Oxytocics|oxytocics|mesh-ancestor
91914307|NCT02424201|Antioxidants|antioxidants|mesh-ancestor
91914308|NCT02424201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914309|NCT02424201|Protective Agents|protective agents|mesh-ancestor
91914310|NCT02432781|Insulin|insulin|mesh-list
91914311|NCT02432781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91914312|NCT02432781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914313|NCT01667900|Dulaglutide|dulaglutide|mesh-list
91914314|NCT01667900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91914315|NCT01667900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914316|NCT04843280|Coal Tar|coal tar|mesh-list
91914317|NCT04843280|Keratolytic Agents|keratolytic agents|mesh-ancestor
91914318|NCT04843280|Dermatologic Agents|dermatologic agents|mesh-ancestor
91914319|NCT04833296|Ropivacaine|ropivacaine|mesh-list
91914320|NCT04833296|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914321|NCT04833296|Anesthetics|anesthetics|mesh-ancestor
91914322|NCT04833296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914323|NCT04833296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914324|NCT04833296|Sensory System Agents|sensory system agents|mesh-ancestor
91914325|NCT04833296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914326|NCT04832906|Ulipristal acetate|ulipristal acetate|mesh-list
91914327|NCT04832906|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91914328|NCT04832906|Contraceptive Agents|contraceptive agents|mesh-ancestor
91914329|NCT04832906|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91914330|NCT04832906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914331|NCT04832906|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91914332|NCT00702273|Progesterone|progesterone|mesh-list
91914333|NCT00702273|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91914334|NCT00702273|Ganirelix|ganirelix|mesh-list
91914335|NCT00702273|Progestins|progestins|mesh-ancestor
91914336|NCT00702273|Hormones|hormones|mesh-ancestor
91914337|NCT00702273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914338|NCT00702273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914339|NCT00702273|Hormone Antagonists|hormone antagonists|mesh-ancestor
91914340|NCT02433795|Rituximab|rituximab|mesh-list
91914341|NCT02433795|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91914342|NCT02433795|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91914343|NCT02433795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914345|NCT02433795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914346|NCT02433795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914347|NCT02433795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91914348|NCT02433795|Alkylating Agents|alkylating agents|mesh-ancestor
91914349|NCT02433795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914350|NCT03038516|Cholecalciferol|cholecalciferol|mesh-list
91914352|NCT03038516|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91914353|NCT03038516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914354|NCT03038516|Vitamins|vitamins|mesh-ancestor
91914355|NCT03038516|Micronutrients|micronutrients|mesh-ancestor
91914356|NCT03038516|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91914357|NCT02424435|Methylprednisolone|methylprednisolone|mesh-list
91914358|NCT02424435|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91914359|NCT02424435|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91914360|NCT02424435|Prednisolone|prednisolone|mesh-list
91914361|NCT02424435|Prednisolone acetate|prednisolone acetate|mesh-list
91914362|NCT02424435|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91914363|NCT02424435|Prednisolone phosphate|prednisolone phosphate|mesh-list
91914364|NCT02424435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914365|NCT02424435|Antiemetics|antiemetics|mesh-ancestor
91914366|NCT02424435|Autonomic Agents|autonomic agents|mesh-ancestor
91914367|NCT02424435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914368|NCT02424435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914369|NCT02424435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914370|NCT02424435|Glucocorticoids|glucocorticoids|mesh-ancestor
91914371|NCT02424435|Hormones|hormones|mesh-ancestor
91914372|NCT02424435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914373|NCT02424435|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91914374|NCT02424435|Protective Agents|protective agents|mesh-ancestor
91914375|NCT02424435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914376|NCT02424435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914379|NCT04842968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914380|NCT04832204|Apatinib|apatinib|mesh-list
91914381|NCT04832204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914382|NCT04832204|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91914383|NCT04832204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914384|NCT04832204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914385|NCT03038282|Chromium|chromium|mesh-list
91914386|NCT03038282|Chromous chloride|chromous chloride|mesh-list
91914387|NCT03038282|Trace Elements|trace elements|mesh-ancestor
91914388|NCT03038282|Micronutrients|micronutrients|mesh-ancestor
91914389|NCT03038282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914390|NCT03038282|Antioxidants|antioxidants|mesh-ancestor
91914391|NCT03038282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914392|NCT03038282|Protective Agents|protective agents|mesh-ancestor
91914393|NCT02424045|Dexamethasone|dexamethasone|mesh-list
91914394|NCT02424045|Carboplatin|carboplatin|mesh-list
91914395|NCT02424045|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91914396|NCT02424045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914397|NCT02424045|Antiemetics|antiemetics|mesh-ancestor
91914398|NCT02424045|Autonomic Agents|autonomic agents|mesh-ancestor
91914399|NCT02424045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914400|NCT02424045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914401|NCT02424045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914402|NCT02424045|Glucocorticoids|glucocorticoids|mesh-ancestor
91914403|NCT02424045|Hormones|hormones|mesh-ancestor
91914404|NCT02424045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914405|NCT02424045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914406|NCT02424045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914407|NCT02424045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91914408|NCT02424045|Alkylating Agents|alkylating agents|mesh-ancestor
91914409|NCT02424045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914410|NCT03037970|Becaplermin|becaplermin|mesh-list
91914411|NCT03037970|Anticoagulants|anticoagulants|mesh-ancestor
91914412|NCT03037970|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-ancestor
91914413|NCT03037970|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91914414|NCT03037970|Growth Substances|growth substances|mesh-ancestor
91914415|NCT03037970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914416|NCT04841720|Metformin|metformin|mesh-list
91914417|NCT04841720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91914418|NCT04841720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914419|NCT05117931|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
91914420|NCT05117931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91914421|NCT05117931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914422|NCT03039842|Valproic Acid|valproic acid|mesh-list
91914426|NCT03039842|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91914427|NCT03039842|Dopamine Agents|dopamine agents|mesh-ancestor
91914428|NCT03039842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914429|NCT03039842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914430|NCT03039842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914431|NCT03039842|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91914432|NCT03039842|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91914433|NCT03039842|Antitussive Agents|antitussive agents|mesh-ancestor
91914434|NCT03039842|Respiratory System Agents|respiratory system agents|mesh-ancestor
91914435|NCT03039842|Anticonvulsants|anticonvulsants|mesh-ancestor
91914436|NCT03039842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914437|NCT03039842|GABA Agents|gaba agents|mesh-ancestor
91914438|NCT03039842|Antimanic Agents|antimanic agents|mesh-ancestor
91914439|NCT03039842|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91914440|NCT03039842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914441|NCT03039842|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914442|NCT03181815|Cytarabine|cytarabine|mesh-list
91914443|NCT03181815|Cladribine|cladribine|mesh-list
91914444|NCT03181815|Aclarubicin|aclarubicin|mesh-list
91914445|NCT03181815|Aclacinomycins|aclacinomycins|mesh-list
91914446|NCT03181815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91914447|NCT03181815|Antimetabolites|antimetabolites|mesh-ancestor
91914448|NCT03181815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914449|NCT03181815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914450|NCT03181815|Antiviral Agents|antiviral agents|mesh-ancestor
91914451|NCT03181815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914452|NCT03181815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914453|NCT03181815|Immunologic Factors|immunologic factors|mesh-ancestor
91914454|NCT03181815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914455|NCT03181815|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91914456|NCT03181815|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91914457|NCT03181815|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91914458|NCT03181815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914459|NCT03181815|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91914460|NCT03038048|Ranibizumab|ranibizumab|mesh-list
91914461|NCT03038048|Aflibercept|aflibercept|mesh-list
91914462|NCT03038048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91914463|NCT03038048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91914464|NCT03038048|Growth Substances|growth substances|mesh-ancestor
91914465|NCT03038048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914466|NCT03038048|Growth Inhibitors|growth inhibitors|mesh-ancestor
91914467|NCT03038048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914469|NCT03185871|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91914470|NCT03185871|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914471|NCT03185871|Analgesics|analgesics|mesh-ancestor
91914472|NCT03185871|Sensory System Agents|sensory system agents|mesh-ancestor
91914473|NCT03185871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914474|NCT03185871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914475|NCT03185871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942968|NCT04064294|Levodopa|levodopa|mesh-list
91914476|NCT03185871|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914477|NCT03185871|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91914478|NCT03185871|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91914479|NCT03185871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914480|NCT03185871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914481|NCT03181113|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91914482|NCT03181113|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91914483|NCT03181113|Antiviral Agents|antiviral agents|mesh-ancestor
91914484|NCT03181113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914486|NCT03180957|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91914487|NCT03180957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914488|NCT03180957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914489|NCT02427165|Albuterol|albuterol|mesh-list
91914490|NCT02427165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91914491|NCT02427165|Autonomic Agents|autonomic agents|mesh-ancestor
91914492|NCT02427165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914493|NCT02427165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914494|NCT02427165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91914495|NCT02427165|Respiratory System Agents|respiratory system agents|mesh-ancestor
91914496|NCT02427165|Tocolytic Agents|tocolytic agents|mesh-ancestor
91914497|NCT02427165|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91914498|NCT02427165|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91914499|NCT02427165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91914500|NCT02427165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91914501|NCT02427165|Adrenergic Agents|adrenergic agents|mesh-ancestor
91914502|NCT02427165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914503|NCT02427165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914504|NCT03037736|Bevacizumab|bevacizumab|mesh-list
91914505|NCT03037736|Fluorouracil|fluorouracil|mesh-list
91914506|NCT03037736|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91914507|NCT03037736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914508|NCT03037736|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91914509|NCT03037736|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91914510|NCT03037736|Growth Substances|growth substances|mesh-ancestor
91914511|NCT03037736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914512|NCT03037736|Growth Inhibitors|growth inhibitors|mesh-ancestor
91914513|NCT03037736|Antimetabolites|antimetabolites|mesh-ancestor
91914514|NCT03037736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914515|NCT03037736|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91914516|NCT03037736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914517|NCT03037736|Immunologic Factors|immunologic factors|mesh-ancestor
91914518|NCT04838132|Ropivacaine|ropivacaine|mesh-list
91914519|NCT04838132|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914520|NCT04838132|Anesthetics|anesthetics|mesh-ancestor
91914521|NCT04838132|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914522|NCT04838132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914523|NCT04838132|Sensory System Agents|sensory system agents|mesh-ancestor
91914524|NCT04838132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914525|NCT03037892|Fentanyl|fentanyl|mesh-list
91914526|NCT03037892|Midazolam|midazolam|mesh-list
91914527|NCT03037892|Remifentanil|remifentanil|mesh-list
91914528|NCT03037892|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91914529|NCT03037892|Narcotics|narcotics|mesh-ancestor
91914530|NCT03037892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914531|NCT03037892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914532|NCT03037892|Analgesics|analgesics|mesh-ancestor
91914533|NCT03037892|Sensory System Agents|sensory system agents|mesh-ancestor
91914534|NCT03037892|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914535|NCT03037892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91914536|NCT03037892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91914537|NCT03037892|Anesthetics, General|anesthetics, general|mesh-ancestor
91914538|NCT03037892|Anesthetics|anesthetics|mesh-ancestor
91914539|NCT03037892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91914540|NCT03037892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91914541|NCT03037892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91914542|NCT03037892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914543|NCT03037892|GABA Modulators|gaba modulators|mesh-ancestor
91914544|NCT03037892|GABA Agents|gaba agents|mesh-ancestor
91914545|NCT03037892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914546|NCT03037892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914547|NCT03183843|Warfarin|warfarin|mesh-list
91914548|NCT03183843|Dabigatran|dabigatran|mesh-list
91914549|NCT03183843|Anticoagulants|anticoagulants|mesh-ancestor
91914551|NCT03183843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91914552|NCT03183843|Protease Inhibitors|protease inhibitors|mesh-ancestor
91914553|NCT03183843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914554|NCT03183843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914555|NCT03180879|Ibuprofen|ibuprofen|mesh-list
91914556|NCT03180879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91914557|NCT03180879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914558|NCT03180879|Analgesics|analgesics|mesh-ancestor
91914559|NCT03180879|Sensory System Agents|sensory system agents|mesh-ancestor
91914560|NCT03180879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914561|NCT03180879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914562|NCT03180879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914563|NCT03180879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914564|NCT03180879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91914565|NCT03180879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914566|NCT03180879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914567|NCT03180723|Cyclosporine|cyclosporine|mesh-list
91914568|NCT03180723|Rituximab|rituximab|mesh-list
91914569|NCT03180723|Cyclosporins|cyclosporins|mesh-list
91914570|NCT03180723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91914571|NCT03180723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914572|NCT03180723|Immunologic Factors|immunologic factors|mesh-ancestor
91914573|NCT03180723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914574|NCT03180723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914575|NCT03180723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914576|NCT03180723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914577|NCT03180723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914578|NCT03180723|Antifungal Agents|antifungal agents|mesh-ancestor
91914579|NCT03180723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914581|NCT03180723|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91914582|NCT04841096|Metformin|metformin|mesh-list
91914583|NCT04841096|Glimepiride|glimepiride|mesh-list
91914584|NCT04841096|Vildagliptin|vildagliptin|mesh-list
91914585|NCT04841096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91914586|NCT04841096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914587|NCT04841096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91914588|NCT04841096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914589|NCT04841096|Immunologic Factors|immunologic factors|mesh-ancestor
91914590|NCT04841096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91914591|NCT04841096|Protease Inhibitors|protease inhibitors|mesh-ancestor
91914592|NCT04841096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914593|NCT04841096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914594|NCT02427243|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91914595|NCT02427243|Immunologic Factors|immunologic factors|mesh-ancestor
91914596|NCT02427243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914597|NCT02426697|Fentanyl|fentanyl|mesh-list
91914598|NCT02426697|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91914599|NCT02426697|Narcotics|narcotics|mesh-ancestor
91914600|NCT02426697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914601|NCT02426697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914603|NCT02426697|Sensory System Agents|sensory system agents|mesh-ancestor
91914604|NCT02426697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914606|NCT02426697|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91914607|NCT02426697|Anesthetics, General|anesthetics, general|mesh-ancestor
91914608|NCT02426697|Anesthetics|anesthetics|mesh-ancestor
91914609|NCT03039608|Prednisone|prednisone|mesh-list
91914610|NCT03039608|Triamcinolone|triamcinolone|mesh-list
91914611|NCT03039608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914612|NCT03039608|Glucocorticoids|glucocorticoids|mesh-ancestor
91914613|NCT03039608|Hormones|hormones|mesh-ancestor
91914614|NCT03039608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914615|NCT03039608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914616|NCT03039608|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914617|NCT03039608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914618|NCT02423811|Fursultiamin|fursultiamin|mesh-list
91914619|NCT02423811|Vitamin B Complex|vitamin b complex|mesh-ancestor
91914620|NCT02423811|Vitamins|vitamins|mesh-ancestor
91914621|NCT02423811|Micronutrients|micronutrients|mesh-ancestor
91914622|NCT02423811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914623|NCT04837664|Nystatin|nystatin|mesh-list
91914624|NCT04837664|Curcumin|curcumin|mesh-list
91914625|NCT04837664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91914626|NCT04837664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914627|NCT04837664|Analgesics|analgesics|mesh-ancestor
91914628|NCT04837664|Sensory System Agents|sensory system agents|mesh-ancestor
91914629|NCT04837664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914630|NCT04837664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914631|NCT04837664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914632|NCT04837664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914633|NCT04837664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914634|NCT04837664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914635|NCT04837664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914636|NCT04837664|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91914637|NCT04837664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914638|NCT04837664|Antifungal Agents|antifungal agents|mesh-ancestor
91914639|NCT04837664|Ionophores|ionophores|mesh-ancestor
91914640|NCT04837664|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914641|NCT01331837|Etanercept|etanercept|mesh-list
91914642|NCT01331837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91914643|NCT01331837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914644|NCT01331837|Analgesics|analgesics|mesh-ancestor
91914645|NCT01331837|Sensory System Agents|sensory system agents|mesh-ancestor
91914646|NCT01331837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914647|NCT01331837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914648|NCT01331837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914649|NCT01331837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914650|NCT01331837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914651|NCT01331837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914652|NCT01331837|Immunologic Factors|immunologic factors|mesh-ancestor
91914653|NCT02706483|Plecanatide|plecanatide|mesh-list
91914654|NCT02706483|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91914655|NCT02706483|Enzyme Activators|enzyme activators|mesh-ancestor
91914656|NCT02706483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914657|NCT02706483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914658|NCT03183375|Hydroxyurea|hydroxyurea|mesh-list
91914659|NCT03183375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914662|NCT03183375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914663|NCT03183375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91914664|NCT03183297|Fexofenadine|fexofenadine|mesh-list
91914665|NCT03183297|Naproxen|naproxen|mesh-list
91914666|NCT03183297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91914667|NCT03183297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91914668|NCT03183297|Analgesics|analgesics|mesh-ancestor
91914669|NCT03183297|Sensory System Agents|sensory system agents|mesh-ancestor
91914670|NCT03183297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914671|NCT03183297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914672|NCT03183297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914673|NCT03183297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914674|NCT03183297|Gout Suppressants|gout suppressants|mesh-ancestor
91914675|NCT03183297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91914676|NCT03183297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914677|NCT03183297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914678|NCT03183297|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91914679|NCT03183297|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91914680|NCT03183297|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91914681|NCT03183297|Histamine Antagonists|histamine antagonists|mesh-ancestor
91914682|NCT03183297|Histamine Agents|histamine agents|mesh-ancestor
91914683|NCT03183297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914684|NCT02426619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91914685|NCT02426619|Fluorides|fluorides|mesh-list
91914686|NCT02426619|Sodium Fluoride|sodium fluoride|mesh-list
91914687|NCT02426619|Fluorides, Topical|fluorides, topical|mesh-list
91914688|NCT02426619|Cariostatic Agents|cariostatic agents|mesh-ancestor
91914689|NCT02426619|Protective Agents|protective agents|mesh-ancestor
91914690|NCT02426619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914691|NCT02108483|Dapsone|dapsone|mesh-list
91914692|NCT02108483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914693|NCT02108483|Antimalarials|antimalarials|mesh-ancestor
91914694|NCT02108483|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91914695|NCT02108483|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91914696|NCT02108483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91914697|NCT02108483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914698|NCT02108483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914699|NCT02108483|Leprostatic Agents|leprostatic agents|mesh-ancestor
91914700|NCT02108483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91914701|NCT01648348|Bevacizumab|bevacizumab|mesh-list
91914702|NCT01648348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91914703|NCT01648348|Endothelial Growth Factors|endothelial growth factors|mesh-list
91914705|NCT01648348|Immunoglobulins|immunoglobulins|mesh-list
91914706|NCT01648348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91914707|NCT01648348|Immunoglobulin G|immunoglobulin g|mesh-list
91914708|NCT01648348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914709|NCT01648348|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91914710|NCT01648348|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91914711|NCT01648348|Growth Substances|growth substances|mesh-ancestor
91914712|NCT01648348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914713|NCT01648348|Growth Inhibitors|growth inhibitors|mesh-ancestor
91914714|NCT01648348|Immunologic Factors|immunologic factors|mesh-ancestor
91914715|NCT03180255|Dexamethasone|dexamethasone|mesh-list
91914716|NCT03180255|Sodium Citrate|sodium citrate|mesh-list
91914717|NCT03180255|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91914718|NCT03180255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914719|NCT03180255|Antiemetics|antiemetics|mesh-ancestor
91914720|NCT03180255|Autonomic Agents|autonomic agents|mesh-ancestor
91914721|NCT03180255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914722|NCT03180255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914723|NCT03180255|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914724|NCT03180255|Glucocorticoids|glucocorticoids|mesh-ancestor
91914725|NCT03180255|Hormones|hormones|mesh-ancestor
91914726|NCT03180255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914727|NCT03180255|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914728|NCT03180255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914729|NCT03180255|Anticoagulants|anticoagulants|mesh-ancestor
91914730|NCT02431221|Perhexiline|perhexiline|mesh-list
91914731|NCT02431221|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91914732|NCT02431221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914733|NCT02431221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914734|NCT02431221|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91914735|NCT02431221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914736|NCT02431221|Vasodilator Agents|vasodilator agents|mesh-ancestor
91914737|NCT02108639|Asunaprevir|asunaprevir|mesh-list
91914740|NCT02108639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914741|NCT03180099|Bupivacaine|bupivacaine|mesh-list
91914742|NCT03180099|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914743|NCT03180099|Anesthetics|anesthetics|mesh-ancestor
91914744|NCT03180099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914745|NCT03180099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914746|NCT03180099|Sensory System Agents|sensory system agents|mesh-ancestor
91914747|NCT03180099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914748|NCT04770272|Paclitaxel|paclitaxel|mesh-list
91914749|NCT04770272|Cyclophosphamide|cyclophosphamide|mesh-list
91914750|NCT04770272|Carboplatin|carboplatin|mesh-list
91914751|NCT04770272|Atezolizumab|atezolizumab|mesh-list
91914752|NCT04770272|Epirubicin|epirubicin|mesh-list
91914753|NCT04770272|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91914754|NCT04770272|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91914756|NCT04770272|Tubulin Modulators|tubulin modulators|mesh-ancestor
91914757|NCT04770272|Antimitotic Agents|antimitotic agents|mesh-ancestor
91914758|NCT04770272|Mitosis Modulators|mitosis modulators|mesh-ancestor
91914759|NCT04770272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914760|NCT04770272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914761|NCT04770272|Immunologic Factors|immunologic factors|mesh-ancestor
91914762|NCT04770272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914763|NCT04770272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914764|NCT04770272|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91914765|NCT04770272|Alkylating Agents|alkylating agents|mesh-ancestor
91914766|NCT04770272|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91914767|NCT04770272|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91914768|NCT04770272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91914769|NCT04770272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91914770|NCT04770272|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91914771|NCT04770272|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91914772|NCT04770272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914773|NCT02251145|Ritonavir|ritonavir|mesh-list
91914774|NCT02251145|Tenofovir|tenofovir|mesh-list
91914775|NCT02251145|Tipranavir|tipranavir|mesh-list
91914776|NCT02251145|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91914777|NCT02251145|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91914778|NCT02251145|Protease Inhibitors|protease inhibitors|mesh-ancestor
91914779|NCT02251145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914780|NCT02251145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914781|NCT02251145|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91914782|NCT02251145|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91914783|NCT02251145|Antiviral Agents|antiviral agents|mesh-ancestor
91914784|NCT02251145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914785|NCT02251145|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91914786|NCT02251145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91914787|NCT02251145|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91914788|NCT02251145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91914789|NCT04792424|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91914790|NCT04792424|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91914791|NCT04792424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914792|NCT00709371|Zonisamide|zonisamide|mesh-list
91914793|NCT00709371|Bupropion|bupropion|mesh-list
91914794|NCT00709371|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91914795|NCT00709371|Antidepressive Agents|antidepressive agents|mesh-ancestor
91914796|NCT00709371|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914797|NCT00709371|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91914798|NCT00709371|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91914799|NCT00709371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914800|NCT00709371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914801|NCT00709371|Dopamine Agents|dopamine agents|mesh-ancestor
91914802|NCT00709371|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914803|NCT00709371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914804|NCT00709371|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91914805|NCT00709371|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91914807|NCT00709371|Anticonvulsants|anticonvulsants|mesh-ancestor
91914808|NCT00709371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91914809|NCT00709371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91914810|NCT02426463|Oxycodone|oxycodone|mesh-list
91914811|NCT02426463|Propofol|propofol|mesh-list
91914812|NCT02426463|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91914813|NCT02426463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914814|NCT02426463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914815|NCT02426463|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91914821|NCT02426463|Sensory System Agents|sensory system agents|mesh-ancestor
91914822|NCT02426463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914823|NCT02426229|Dabigatran|dabigatran|mesh-list
91914824|NCT02426229|Antithrombins|antithrombins|mesh-ancestor
91914825|NCT02426229|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91914826|NCT02426229|Protease Inhibitors|protease inhibitors|mesh-ancestor
91914827|NCT02426229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914828|NCT02426229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914830|NCT01648270|Buprenorphine|buprenorphine|mesh-list
91914831|NCT01648270|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91914832|NCT01648270|Narcotics|narcotics|mesh-ancestor
91914833|NCT01648270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914834|NCT01648270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914835|NCT01648270|Analgesics|analgesics|mesh-ancestor
91914836|NCT01648270|Sensory System Agents|sensory system agents|mesh-ancestor
91914837|NCT01648270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914838|NCT01648270|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91914839|NCT02108795|Remifentanil|remifentanil|mesh-list
91914840|NCT02108795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91914841|NCT02108795|Narcotics|narcotics|mesh-ancestor
91914842|NCT02108795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914843|NCT02108795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914844|NCT02108795|Analgesics|analgesics|mesh-ancestor
91914845|NCT02108795|Sensory System Agents|sensory system agents|mesh-ancestor
91914846|NCT02108795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914847|NCT02431143|Miltefosine|miltefosine|mesh-list
91914848|NCT02431143|Antifungal Agents|antifungal agents|mesh-ancestor
91914849|NCT02431143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914850|NCT02431143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914851|NCT02431143|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91914852|NCT02431143|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91914853|NCT02302846|Ixazomib|ixazomib|mesh-list
91914854|NCT02302846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914855|NCT02302846|Protease Inhibitors|protease inhibitors|mesh-ancestor
91914856|NCT02302846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914857|NCT02302846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914858|NCT02431065|Ropivacaine|ropivacaine|mesh-list
91914859|NCT02431065|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914860|NCT02431065|Anesthetics|anesthetics|mesh-ancestor
91914861|NCT02431065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914862|NCT02431065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914863|NCT02431065|Sensory System Agents|sensory system agents|mesh-ancestor
91914864|NCT02431065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914865|NCT04836806|Cetirizine|cetirizine|mesh-list
91914866|NCT04836806|Famotidine|famotidine|mesh-list
91914867|NCT04836806|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91914868|NCT04836806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914869|NCT04836806|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91914870|NCT04836806|Histamine Antagonists|histamine antagonists|mesh-ancestor
91914871|NCT04836806|Histamine Agents|histamine agents|mesh-ancestor
91914872|NCT04836806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914873|NCT04836806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914874|NCT04836806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914875|NCT04836806|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91914876|NCT04836806|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91914877|NCT04836806|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91914879|NCT04836728|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91914880|NCT04836728|Carboplatin|carboplatin|mesh-list
91914881|NCT04836728|Pemetrexed|pemetrexed|mesh-list
91914882|NCT04836728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91914883|NCT04836728|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91914884|NCT04836728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914885|NCT04836728|Tubulin Modulators|tubulin modulators|mesh-ancestor
91914886|NCT04836728|Antimitotic Agents|antimitotic agents|mesh-ancestor
91914887|NCT04836728|Mitosis Modulators|mitosis modulators|mesh-ancestor
91914888|NCT04836728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914889|NCT04836728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914890|NCT04836728|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91914891|NCT04836728|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91914892|NCT04836728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91914893|NCT02109185|Mometasone Furoate|mometasone furoate|mesh-list
91914894|NCT02109185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914895|NCT02109185|Dermatologic Agents|dermatologic agents|mesh-ancestor
91914896|NCT02109185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91914897|NCT02430909|Certolizumab Pegol|certolizumab pegol|mesh-list
91914898|NCT02430909|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91914899|NCT02430909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914900|NCT02430909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914901|NCT02430909|Immunologic Factors|immunologic factors|mesh-ancestor
91914902|NCT02430909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914903|NCT02430909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914904|NCT02105675|Docetaxel|docetaxel|mesh-list
91914905|NCT02105675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914906|NCT02105675|Tubulin Modulators|tubulin modulators|mesh-ancestor
91914907|NCT02105675|Antimitotic Agents|antimitotic agents|mesh-ancestor
91914908|NCT02105675|Mitosis Modulators|mitosis modulators|mesh-ancestor
91914909|NCT02105675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914910|NCT02336230|Remestemcel-l|remestemcel-l|mesh-list
91914911|NCT02336230|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914912|NCT02336230|Antiviral Agents|antiviral agents|mesh-ancestor
91914913|NCT02336230|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914914|NCT04835948|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91914915|NCT04835948|Immunologic Factors|immunologic factors|mesh-ancestor
91914916|NCT04835948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914917|NCT04835948|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91914918|NCT04824404|Buprenorphine|buprenorphine|mesh-list
91914919|NCT04824404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91914920|NCT04824404|Narcotics|narcotics|mesh-ancestor
91914921|NCT04824404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914922|NCT04824404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914923|NCT04824404|Analgesics|analgesics|mesh-ancestor
91914924|NCT04824404|Sensory System Agents|sensory system agents|mesh-ancestor
91914925|NCT04824404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914926|NCT04824404|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91914927|NCT02109341|Paclitaxel|paclitaxel|mesh-list
91914928|NCT02109341|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91914929|NCT02109341|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91914930|NCT02109341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914931|NCT02109341|Tubulin Modulators|tubulin modulators|mesh-ancestor
91914932|NCT02109341|Antimitotic Agents|antimitotic agents|mesh-ancestor
91914933|NCT02109341|Mitosis Modulators|mitosis modulators|mesh-ancestor
91914934|NCT02109341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914935|NCT02336074|Raltegravir Potassium|raltegravir potassium|mesh-list
91914936|NCT02336074|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91914937|NCT02336074|Vorinostat|vorinostat|mesh-list
91914938|NCT02336074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914939|NCT02336074|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91914940|NCT02336074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91914941|NCT02336074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914942|NCT02336074|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91914943|NCT02336074|Antiviral Agents|antiviral agents|mesh-ancestor
91914944|NCT02336074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91914945|NCT02336074|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91914946|NCT02336074|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91914947|NCT04367168|Colchicine|colchicine|mesh-list
91914948|NCT04367168|Gout Suppressants|gout suppressants|mesh-ancestor
91914949|NCT04367168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91914950|NCT04367168|Tubulin Modulators|tubulin modulators|mesh-ancestor
91914951|NCT04367168|Antimitotic Agents|antimitotic agents|mesh-ancestor
91914952|NCT04367168|Mitosis Modulators|mitosis modulators|mesh-ancestor
91914953|NCT04367168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914954|NCT04367168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914955|NCT02113943|Citalopram|citalopram|mesh-list
91914956|NCT02113943|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91914957|NCT02113943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91914958|NCT02113943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914959|NCT02113943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914960|NCT02113943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91914961|NCT02113943|Serotonin Agents|serotonin agents|mesh-ancestor
91914962|NCT02113943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914963|NCT02113943|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91914964|NCT02113943|Antidepressive Agents|antidepressive agents|mesh-ancestor
91914965|NCT02113943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91914966|NCT02114021|Betamethasone|betamethasone|mesh-list
91914967|NCT02114021|Lidocaine|lidocaine|mesh-list
91914968|NCT02114021|Anesthetics, Local|anesthetics, local|mesh-ancestor
91914969|NCT02114021|Anesthetics|anesthetics|mesh-ancestor
91914970|NCT02114021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91914971|NCT02114021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914972|NCT02114021|Sensory System Agents|sensory system agents|mesh-ancestor
91914973|NCT02114021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91914974|NCT02114021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91914975|NCT02114021|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91914976|NCT02114021|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91914977|NCT02114021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91914978|NCT02114021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91914979|NCT02114021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914980|NCT02114021|Glucocorticoids|glucocorticoids|mesh-ancestor
91914981|NCT02114021|Hormones|hormones|mesh-ancestor
91914982|NCT02114021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914983|NCT02114021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91914984|NCT02114021|Respiratory System Agents|respiratory system agents|mesh-ancestor
91914985|NCT04826822|Dexamethasone|dexamethasone|mesh-list
91914986|NCT04826822|Spironolactone|spironolactone|mesh-list
91914987|NCT04826822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91914988|NCT04826822|Antiemetics|antiemetics|mesh-ancestor
91914989|NCT04826822|Autonomic Agents|autonomic agents|mesh-ancestor
91914990|NCT04826822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942979|NCT04029688|Topotecan|topotecan|mesh-list
91914991|NCT04826822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91914992|NCT04826822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91914994|NCT04826822|Hormones|hormones|mesh-ancestor
91914995|NCT04826822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91914996|NCT04826822|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91914997|NCT04826822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91914998|NCT04826822|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91914999|NCT04826822|Hormone Antagonists|hormone antagonists|mesh-ancestor
91915000|NCT04826822|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91915001|NCT04826822|Diuretics|diuretics|mesh-ancestor
91915002|NCT04826822|Natriuretic Agents|natriuretic agents|mesh-ancestor
91915003|NCT02251457|Ranolazine|ranolazine|mesh-list
91915004|NCT02251457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91915005|NCT02251457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915006|NCT02251457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915007|NCT02112305|Magnesium Sulfate|magnesium sulfate|mesh-list
91915008|NCT02112305|Analgesics|analgesics|mesh-ancestor
91915009|NCT02112305|Sensory System Agents|sensory system agents|mesh-ancestor
91915010|NCT02112305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915011|NCT02112305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915013|NCT02112305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915014|NCT02112305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91915015|NCT02112305|Anticonvulsants|anticonvulsants|mesh-ancestor
91915016|NCT02112305|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91915017|NCT02112305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915018|NCT02112305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915019|NCT02112305|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91915020|NCT02112305|Tocolytic Agents|tocolytic agents|mesh-ancestor
91915021|NCT02112305|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915022|NCT02114099|Atorvastatin|atorvastatin|mesh-list
91915023|NCT02114099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91915024|NCT02114099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915025|NCT02114099|Antimetabolites|antimetabolites|mesh-ancestor
91915026|NCT02114099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915027|NCT02114099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915028|NCT02114099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91915029|NCT02114099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915030|NCT02251223|Ritonavir|ritonavir|mesh-list
91915031|NCT02251223|Tipranavir|tipranavir|mesh-list
91915032|NCT02251223|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91915033|NCT02251223|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91915034|NCT02251223|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915035|NCT02251223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915036|NCT02251223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915038|NCT02251223|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91915039|NCT02251223|Antiviral Agents|antiviral agents|mesh-ancestor
91915040|NCT02251223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915041|NCT02251223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91915042|NCT02251223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91915043|NCT02114333|Vaccines|vaccines|mesh-list
91915044|NCT02114333|Immunologic Factors|immunologic factors|mesh-ancestor
91915045|NCT02114333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915046|NCT02114489|Ibandronic Acid|ibandronic acid|mesh-list
91915047|NCT02114489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91915048|NCT02114489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915049|NCT02114645|Leuprolide|leuprolide|mesh-list
91915050|NCT02114645|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91915051|NCT02114645|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91915052|NCT02114645|Estradiol|estradiol|mesh-list
91915053|NCT02114645|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91915054|NCT02114645|Progesterone|progesterone|mesh-list
91915055|NCT02114645|Estrogens|estrogens|mesh-ancestor
91915056|NCT02114645|Hormones|hormones|mesh-ancestor
91915057|NCT02114645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915058|NCT02114645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915059|NCT02114645|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91915060|NCT02114645|Contraceptive Agents|contraceptive agents|mesh-ancestor
91942985|NCT04029688|Alkylating Agents|alkylating agents|mesh-ancestor
91915061|NCT02114645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915062|NCT02114645|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91915063|NCT02114645|Progestins|progestins|mesh-ancestor
91915064|NCT02114645|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91915065|NCT02114645|Fertility Agents|fertility agents|mesh-ancestor
91915066|NCT02114645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91915067|NCT02114645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915068|NCT02112695|Diprenorphine|diprenorphine|mesh-list
91915069|NCT02112695|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91915070|NCT02112695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915071|NCT02112695|Sensory System Agents|sensory system agents|mesh-ancestor
91915072|NCT02112695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915073|NCT04826900|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
91915074|NCT04826900|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91915075|NCT04826900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915076|NCT04826900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915077|NCT04826900|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91915078|NCT04826900|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915079|NCT04826900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915080|NCT04826900|Cholinergic Agents|cholinergic agents|mesh-ancestor
91915081|NCT04826900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915082|NCT04361162|Nivolumab|nivolumab|mesh-list
91915083|NCT04361162|Ipilimumab|ipilimumab|mesh-list
91915084|NCT04361162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915085|NCT04361162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915086|NCT04361162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91915087|NCT04361162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915088|NCT04823390|Fentanyl|fentanyl|mesh-list
91915089|NCT04823390|Midazolam|midazolam|mesh-list
91915090|NCT04823390|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91915091|NCT04823390|Narcotics|narcotics|mesh-ancestor
91915092|NCT04823390|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915093|NCT04823390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915094|NCT04823390|Analgesics|analgesics|mesh-ancestor
91915095|NCT04823390|Sensory System Agents|sensory system agents|mesh-ancestor
91915096|NCT04823390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915097|NCT04823390|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91915098|NCT04823390|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91915099|NCT04823390|Anesthetics, General|anesthetics, general|mesh-ancestor
91915100|NCT04823390|Anesthetics|anesthetics|mesh-ancestor
91915101|NCT04823390|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91915102|NCT04823390|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91915103|NCT04823390|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91915104|NCT04823390|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91915105|NCT04823390|GABA Modulators|gaba modulators|mesh-ancestor
91915106|NCT04823390|GABA Agents|gaba agents|mesh-ancestor
91915107|NCT04823390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915108|NCT04823390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915110|NCT05618912|Emollients|emollients|mesh-ancestor
91915111|NCT05618912|Dermatologic Agents|dermatologic agents|mesh-ancestor
91915112|NCT04826510|Lithium Carbonate|lithium carbonate|mesh-list
91915113|NCT04826510|Perospirone|perospirone|mesh-list
91915114|NCT04826510|Antidepressive Agents|antidepressive agents|mesh-ancestor
91915115|NCT04826510|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91915116|NCT04826510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915117|NCT04826510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915118|NCT04826510|Antimanic Agents|antimanic agents|mesh-ancestor
91915119|NCT04826510|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91915120|NCT04826510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915121|NCT04826510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915122|NCT04826510|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91915123|NCT03036800|Liraglutide|liraglutide|mesh-list
91915124|NCT03036800|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91915125|NCT03036800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915128|NCT03036800|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915129|NCT02301988|Paclitaxel|paclitaxel|mesh-list
91915130|NCT02301988|Ipatasertib|ipatasertib|mesh-list
91915131|NCT02301988|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91915132|NCT02301988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915133|NCT02301988|Tubulin Modulators|tubulin modulators|mesh-ancestor
91915134|NCT02301988|Antimitotic Agents|antimitotic agents|mesh-ancestor
91915135|NCT02301988|Mitosis Modulators|mitosis modulators|mesh-ancestor
91915136|NCT02301988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915137|NCT02301988|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91915138|NCT02301988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915139|NCT04326920|Sargramostim|sargramostim|mesh-list
91915140|NCT04326920|Immunologic Factors|immunologic factors|mesh-ancestor
91915141|NCT04326920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915143|NCT02112929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91915144|NCT02112929|Anesthetics, General|anesthetics, general|mesh-ancestor
91915145|NCT02112929|Anesthetics|anesthetics|mesh-ancestor
91915146|NCT02112929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915147|NCT02112929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915148|NCT02119091|Moxifloxacin|moxifloxacin|mesh-list
91915149|NCT02119091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915150|NCT02119091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915151|NCT02119091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91915152|NCT02119091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91915153|NCT02119091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915154|NCT02119091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915155|NCT02119091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915156|NCT02115035|Vemurafenib|vemurafenib|mesh-list
91915157|NCT02115035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915158|NCT02115035|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91915159|NCT02115035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915160|NCT02115035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915161|NCT02113319|Dasatinib|dasatinib|mesh-list
91915162|NCT02113319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915163|NCT02113319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91915164|NCT02113319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915165|NCT02113319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915166|NCT02113397|Tobramycin|tobramycin|mesh-list
91915167|NCT02113397|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915168|NCT02113397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915169|NCT04822064|Dexmedetomidine|dexmedetomidine|mesh-list
91915170|NCT04822064|Ketamine|ketamine|mesh-list
91915171|NCT04822064|Chloral Hydrate|chloral hydrate|mesh-list
91915172|NCT04822064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91915173|NCT04822064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915174|NCT04822064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915175|NCT04822064|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915176|NCT04822064|Analgesics|analgesics|mesh-ancestor
91915177|NCT04822064|Sensory System Agents|sensory system agents|mesh-ancestor
91915178|NCT04822064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915179|NCT04822064|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91915180|NCT04822064|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91915181|NCT04822064|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91915182|NCT04822064|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915183|NCT04822064|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915184|NCT04822064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915185|NCT04822064|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91915186|NCT04822064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91915187|NCT04822064|Anesthetics, General|anesthetics, general|mesh-ancestor
91915188|NCT04822064|Anesthetics|anesthetics|mesh-ancestor
91915189|NCT04822064|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91915190|NCT04822064|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91915191|NCT03553433|Apremilast|apremilast|mesh-list
91915192|NCT03553433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91915193|NCT03553433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915194|NCT03553433|Analgesics|analgesics|mesh-ancestor
91915195|NCT03553433|Sensory System Agents|sensory system agents|mesh-ancestor
91915196|NCT03553433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915197|NCT03553433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915198|NCT03553433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91915199|NCT03553433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915200|NCT03553433|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91915201|NCT03553433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91915202|NCT03553433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915203|NCT03553433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915205|NCT02604212|Entecavir|entecavir|mesh-list
91915206|NCT02604212|Histamine Antagonists|histamine antagonists|mesh-list
91915207|NCT02604212|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
91915208|NCT02604212|Antiviral Agents|antiviral agents|mesh-ancestor
91915209|NCT02604212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915210|NCT02604212|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91915211|NCT02604212|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91915212|NCT02604212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915213|NCT02604212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915214|NCT02604212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91915215|NCT02604212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91915216|NCT02604212|Histamine Agents|histamine agents|mesh-ancestor
91915217|NCT02604212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915218|NCT02604212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915221|NCT02115659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915222|NCT02115659|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91915223|NCT02115659|Contraceptive Agents|contraceptive agents|mesh-ancestor
91915224|NCT02115659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915225|NCT02115659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915226|NCT02115659|Immunologic Factors|immunologic factors|mesh-ancestor
91915227|NCT02115659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91915228|NCT02115659|Alkylating Agents|alkylating agents|mesh-ancestor
91915229|NCT02115659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915230|NCT02115659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915231|NCT02113631|Interferons|interferons|mesh-list
91915232|NCT02113631|Ribavirin|ribavirin|mesh-list
91915233|NCT02113631|Interferon-alpha|interferon-alpha|mesh-list
91915234|NCT02113631|Interferon alpha-2|interferon alpha-2|mesh-list
91915235|NCT02113631|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91915236|NCT02113631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915237|NCT02113631|Antiviral Agents|antiviral agents|mesh-ancestor
91915238|NCT02113631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915239|NCT02113631|Antimetabolites|antimetabolites|mesh-ancestor
91915240|NCT02113631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915241|NCT02113631|Immunologic Factors|immunologic factors|mesh-ancestor
91915242|NCT02113631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915243|NCT02123069|Nitroprusside|nitroprusside|mesh-list
91915244|NCT02123069|Phenylephrine|phenylephrine|mesh-list
91915245|NCT02123069|Oxymetazoline|oxymetazoline|mesh-list
91915246|NCT02123069|Norepinephrine|norepinephrine|mesh-list
91915247|NCT02123069|Acetylcholine|acetylcholine|mesh-list
91915248|NCT02123069|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91915249|NCT02123069|Mydriatics|mydriatics|mesh-ancestor
91915250|NCT02123069|Autonomic Agents|autonomic agents|mesh-ancestor
91915251|NCT02123069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915252|NCT02123069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915253|NCT02123069|Sympathomimetics|sympathomimetics|mesh-ancestor
91915254|NCT02123069|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91915255|NCT02123069|Nasal Decongestants|nasal decongestants|mesh-ancestor
91915256|NCT02123069|Respiratory System Agents|respiratory system agents|mesh-ancestor
91915257|NCT02123069|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91915258|NCT02123069|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91915259|NCT02123069|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91915260|NCT02123069|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915261|NCT02123069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915262|NCT02123069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915263|NCT02123069|Protective Agents|protective agents|mesh-ancestor
91915264|NCT02123069|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91915265|NCT02123069|Vasodilator Agents|vasodilator agents|mesh-ancestor
91915266|NCT02123069|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91915267|NCT02123069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91915268|NCT02123069|Cholinergic Agents|cholinergic agents|mesh-ancestor
91915269|NCT04428632|Berotralstat|berotralstat|mesh-list
91915270|NCT04428632|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91915271|NCT04428632|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915272|NCT04428632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915273|NCT04428632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915274|NCT05618210|Anesthetics|anesthetics|mesh-list
91915275|NCT05618210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915276|NCT05618210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915277|NCT04807634|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
91915278|NCT04807634|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
91915279|NCT04807634|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91915280|NCT04807634|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91915282|NCT02789111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91915283|NCT04807166|Paclitaxel|paclitaxel|mesh-list
91915284|NCT04807166|Carboplatin|carboplatin|mesh-list
91915285|NCT04807166|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91915286|NCT04807166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915287|NCT04807166|Tubulin Modulators|tubulin modulators|mesh-ancestor
91915288|NCT04807166|Antimitotic Agents|antimitotic agents|mesh-ancestor
91915289|NCT04807166|Mitosis Modulators|mitosis modulators|mesh-ancestor
91915290|NCT04807166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915291|NCT02251925|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91915292|NCT02251925|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91915293|NCT02251925|Estradiol|estradiol|mesh-list
91915294|NCT02251925|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91915295|NCT02251925|Estrogens|estrogens|mesh-ancestor
91915296|NCT02251925|Hormones|hormones|mesh-ancestor
91915297|NCT02251925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915298|NCT02251925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915299|NCT02251925|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91915300|NCT02251925|Contraceptive Agents|contraceptive agents|mesh-ancestor
91915301|NCT02251925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915302|NCT02251925|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91915303|NCT03552653|Vitamin D|vitamin d|mesh-list
91915304|NCT03552653|Ergocalciferols|ergocalciferols|mesh-list
91915305|NCT03552653|Cholecalciferol|cholecalciferol|mesh-list
91915306|NCT03552653|Vitamins|vitamins|mesh-list
91915307|NCT03552653|Micronutrients|micronutrients|mesh-ancestor
91915308|NCT03552653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915309|NCT03552653|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91915310|NCT03552653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91915311|NCT01359644|Ribavirin|ribavirin|mesh-list
91915312|NCT01359644|Sofosbuvir|sofosbuvir|mesh-list
91915313|NCT01359644|Antimetabolites|antimetabolites|mesh-ancestor
91915314|NCT01359644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915315|NCT01359644|Antiviral Agents|antiviral agents|mesh-ancestor
91915316|NCT01359644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915317|NCT04821206|Antirheumatic Agents|antirheumatic agents|mesh-list
91915318|NCT04821206|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
91915319|NCT04821206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91915320|NCT04821206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915321|NCT04821206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915322|NCT04806230|Mirtazapine|mirtazapine|mesh-list
91915323|NCT04806230|Citalopram|citalopram|mesh-list
91915324|NCT04806230|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91915325|NCT04806230|Sertraline|sertraline|mesh-list
91915326|NCT04806230|Escitalopram|escitalopram|mesh-list
91915327|NCT04806230|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91915328|NCT04806230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91915329|NCT04806230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915330|NCT04806230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915331|NCT04806230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915332|NCT04806230|Serotonin Agents|serotonin agents|mesh-ancestor
91915333|NCT04806230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915334|NCT04806230|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91915335|NCT04806230|Antidepressive Agents|antidepressive agents|mesh-ancestor
91915336|NCT04806230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91915337|NCT04806230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91915338|NCT04806230|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91915339|NCT04806230|Histamine Antagonists|histamine antagonists|mesh-ancestor
91915340|NCT04806230|Histamine Agents|histamine agents|mesh-ancestor
91915341|NCT04806230|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91915342|NCT04806230|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91915343|NCT04806230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915344|NCT04806230|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91915345|NCT04806230|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91915346|NCT04806230|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91915347|NCT04806230|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915348|NCT04806230|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91915349|NCT04806230|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91915350|NCT04806230|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91915352|NCT02603120|Emtricitabine|emtricitabine|mesh-list
91915353|NCT02603120|Lamivudine|lamivudine|mesh-list
91915354|NCT02603120|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
91915355|NCT02603120|Antiviral Agents|antiviral agents|mesh-ancestor
91915356|NCT02603120|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915584|NCT01368497|Antiviral Agents|antiviral agents|mesh-ancestor
91915357|NCT02603120|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91915358|NCT02603120|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91915359|NCT02603120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915360|NCT02603120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915361|NCT02603120|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91915362|NCT02603120|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91915363|NCT04815200|Copper|copper|mesh-list
91915364|NCT04815200|Nickel|nickel|mesh-list
91915365|NCT04815200|Trace Elements|trace elements|mesh-ancestor
91915366|NCT04815200|Micronutrients|micronutrients|mesh-ancestor
91915367|NCT04815200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915368|NCT04426994|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91915369|NCT04426994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915370|NCT04426994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915371|NCT04814030|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91915372|NCT04814030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915373|NCT04814030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915374|NCT04814030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915375|NCT04412252|Tofacitinib|tofacitinib|mesh-list
91915376|NCT04412252|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91915377|NCT04412252|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91915378|NCT04412252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915379|NCT04412252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915380|NCT04813952|Sevoflurane|sevoflurane|mesh-list
91915381|NCT04813952|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91915382|NCT04813952|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91915383|NCT04813952|Anesthetics, General|anesthetics, general|mesh-ancestor
91915384|NCT04813952|Anesthetics|anesthetics|mesh-ancestor
91915385|NCT04813952|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915386|NCT04813952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915387|NCT04813874|Nitrous Oxide|nitrous oxide|mesh-list
91915388|NCT04813874|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91915389|NCT04813874|Anesthetics, General|anesthetics, general|mesh-ancestor
91915390|NCT04813874|Anesthetics|anesthetics|mesh-ancestor
91915391|NCT04813874|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915392|NCT04813874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915393|NCT04813874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915394|NCT04813874|Analgesics|analgesics|mesh-ancestor
91915395|NCT04813874|Sensory System Agents|sensory system agents|mesh-ancestor
91915396|NCT04813874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915397|NCT04803500|Simvastatin|simvastatin|mesh-list
91915398|NCT04803500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91915399|NCT04803500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915400|NCT04803500|Antimetabolites|antimetabolites|mesh-ancestor
91915401|NCT04803500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915402|NCT04803500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915403|NCT04803500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91915404|NCT04803500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915405|NCT01331681|Aflibercept|aflibercept|mesh-list
91915406|NCT01331681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91915407|NCT01331681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91915408|NCT01331681|Growth Substances|growth substances|mesh-ancestor
91915409|NCT01331681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915410|NCT01331681|Growth Inhibitors|growth inhibitors|mesh-ancestor
91915411|NCT01331681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915412|NCT02120339|Carvedilol|carvedilol|mesh-list
91915413|NCT02120339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91915414|NCT02120339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91915415|NCT02120339|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915416|NCT02120339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915417|NCT02120339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915418|NCT02120339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915419|NCT02120339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91915420|NCT02120339|Antioxidants|antioxidants|mesh-ancestor
91915421|NCT02120339|Protective Agents|protective agents|mesh-ancestor
91915422|NCT02120339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91915423|NCT02120339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915424|NCT02120339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91915425|NCT02120339|Vasodilator Agents|vasodilator agents|mesh-ancestor
91915426|NCT02120339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91915427|NCT02120339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91942991|NCT04029688|Antiviral Agents|antiviral agents|mesh-ancestor
91915429|NCT02123381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915430|NCT02123381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915432|NCT02123615|Antibodies|antibodies|mesh-list
91915433|NCT02123615|gamma-Globulins|gamma-globulins|mesh-list
91915434|NCT02123615|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91915435|NCT02123615|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91915436|NCT02123615|Immunoglobulin G|immunoglobulin g|mesh-list
91915437|NCT02123615|Immunologic Factors|immunologic factors|mesh-ancestor
91915438|NCT02123615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915439|NCT02120651|Hemostatics|hemostatics|mesh-list
91915440|NCT02120651|Coagulants|coagulants|mesh-ancestor
91915441|NCT02117219|Azacitidine|azacitidine|mesh-list
91915442|NCT02117219|Durvalumab|durvalumab|mesh-list
91915443|NCT02117219|Tremelimumab|tremelimumab|mesh-list
91915444|NCT02117219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91915445|NCT02117219|Antimetabolites|antimetabolites|mesh-ancestor
91915446|NCT02117219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915447|NCT02117219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915448|NCT02117219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915449|NCT02117219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915450|NCT02117453|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91915451|NCT02117453|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91915452|NCT02117453|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915453|NCT02117453|Antimetabolites|antimetabolites|mesh-ancestor
91915454|NCT02117453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915455|NCT02117453|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915456|NCT02117453|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91915457|NCT02117453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915458|NCT02124005|Bupivacaine|bupivacaine|mesh-list
91915459|NCT02124005|Anesthetics, Local|anesthetics, local|mesh-ancestor
91915460|NCT02124005|Anesthetics|anesthetics|mesh-ancestor
91915461|NCT02124005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915462|NCT02124005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915463|NCT02124005|Sensory System Agents|sensory system agents|mesh-ancestor
91915464|NCT02124005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915465|NCT03551873|Plecanatide|plecanatide|mesh-list
91915466|NCT03551873|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91915467|NCT03551873|Enzyme Activators|enzyme activators|mesh-ancestor
91915468|NCT03551873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915469|NCT03551873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91915470|NCT02117765|Ustekinumab|ustekinumab|mesh-list
91915471|NCT02117765|Dermatologic Agents|dermatologic agents|mesh-ancestor
91915472|NCT02121119|Lidocaine|lidocaine|mesh-list
91915473|NCT02121119|Bupivacaine|bupivacaine|mesh-list
91915474|NCT02121119|Anesthetics, Local|anesthetics, local|mesh-ancestor
91915475|NCT02121119|Anesthetics|anesthetics|mesh-ancestor
91915476|NCT02121119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915477|NCT02121119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915478|NCT02121119|Sensory System Agents|sensory system agents|mesh-ancestor
91915479|NCT02121119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915480|NCT02121119|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91915481|NCT02121119|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91915482|NCT02121119|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91915483|NCT02121119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915484|NCT02121119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915485|NCT02121197|Dexamethasone|dexamethasone|mesh-list
91915486|NCT02121197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91915487|NCT02121197|Antiemetics|antiemetics|mesh-ancestor
91915488|NCT02121197|Autonomic Agents|autonomic agents|mesh-ancestor
91915489|NCT02121197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915490|NCT02121197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915491|NCT02121197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91915492|NCT02121197|Glucocorticoids|glucocorticoids|mesh-ancestor
91915494|NCT02121197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915495|NCT02121197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91915496|NCT02121197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915497|NCT02124317|Paclitaxel|paclitaxel|mesh-list
91915498|NCT02124317|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91915500|NCT02124317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915501|NCT02124317|Tubulin Modulators|tubulin modulators|mesh-ancestor
91915502|NCT02124317|Antimitotic Agents|antimitotic agents|mesh-ancestor
91915503|NCT02124317|Mitosis Modulators|mitosis modulators|mesh-ancestor
91915504|NCT02124317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915505|NCT02117843|Arsenic Trioxide|arsenic trioxide|mesh-list
91915506|NCT02117843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915507|NCT02121353|Ranibizumab|ranibizumab|mesh-list
91915508|NCT02121353|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91915509|NCT02121353|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91915510|NCT02121353|Growth Substances|growth substances|mesh-ancestor
91915511|NCT02121353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915512|NCT02121353|Growth Inhibitors|growth inhibitors|mesh-ancestor
91915513|NCT02121353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915514|NCT05617430|Leucovorin|leucovorin|mesh-list
91915515|NCT05617430|Bevacizumab|bevacizumab|mesh-list
91915516|NCT05617430|Fluorouracil|fluorouracil|mesh-list
91915517|NCT05617430|Oxaliplatin|oxaliplatin|mesh-list
91915518|NCT05617430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915519|NCT05617430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915520|NCT05617430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91915521|NCT05617430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91915522|NCT05617430|Growth Substances|growth substances|mesh-ancestor
91915523|NCT05617430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915524|NCT05617430|Growth Inhibitors|growth inhibitors|mesh-ancestor
91915525|NCT05617430|Antimetabolites|antimetabolites|mesh-ancestor
91915526|NCT05617430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915527|NCT05617430|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91915528|NCT05617430|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915529|NCT05617430|Immunologic Factors|immunologic factors|mesh-ancestor
91915530|NCT05617430|Antidotes|antidotes|mesh-ancestor
91915531|NCT05617430|Protective Agents|protective agents|mesh-ancestor
91915532|NCT05617430|Vitamin B Complex|vitamin b complex|mesh-ancestor
91915533|NCT05617430|Vitamins|vitamins|mesh-ancestor
91915534|NCT05617430|Micronutrients|micronutrients|mesh-ancestor
91915535|NCT02251691|Tacrolimus|tacrolimus|mesh-list
91915536|NCT02251691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915537|NCT02251691|Immunologic Factors|immunologic factors|mesh-ancestor
91915538|NCT02251691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915539|NCT02251691|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91915540|NCT02251691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915541|NCT02251691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915542|NCT02595398|Triamcinolone|triamcinolone|mesh-list
91915543|NCT02595398|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91915544|NCT02595398|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91915545|NCT02595398|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91915546|NCT02595398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91915547|NCT02595398|Glucocorticoids|glucocorticoids|mesh-ancestor
91915548|NCT02595398|Hormones|hormones|mesh-ancestor
91915549|NCT02595398|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915550|NCT02595398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915551|NCT02595398|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915552|NCT02595398|Immunologic Factors|immunologic factors|mesh-ancestor
91915553|NCT02595398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915554|NCT02595398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915555|NCT02251769|Ritonavir|ritonavir|mesh-list
91915556|NCT02251769|Tipranavir|tipranavir|mesh-list
91915557|NCT02251769|Clarithromycin|clarithromycin|mesh-list
91915558|NCT02251769|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91915559|NCT02251769|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91915560|NCT02251769|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915561|NCT02251769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915562|NCT02251769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915563|NCT02251769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91915564|NCT02251769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91915565|NCT02251769|Antiviral Agents|antiviral agents|mesh-ancestor
91915566|NCT02251769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915567|NCT02251769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91915568|NCT02251769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91915569|NCT02251769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915570|NCT02251769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91915571|NCT02118311|Cyclophosphamide|cyclophosphamide|mesh-list
91915572|NCT02118311|Fludarabine|fludarabine|mesh-list
91915573|NCT02118311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915575|NCT02118311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915576|NCT02118311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915577|NCT02118311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91915578|NCT02118311|Alkylating Agents|alkylating agents|mesh-ancestor
91942995|NCT04029688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915579|NCT02118311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915580|NCT02118311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915581|NCT02118311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91915582|NCT01368497|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91915583|NCT01368497|Entecavir|entecavir|mesh-list
91915585|NCT01368497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915586|NCT04812860|Tramadol|tramadol|mesh-list
91915587|NCT04812860|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91915588|NCT04812860|Narcotics|narcotics|mesh-ancestor
91915589|NCT04812860|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915590|NCT04812860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915591|NCT04812860|Analgesics|analgesics|mesh-ancestor
91915592|NCT04812860|Sensory System Agents|sensory system agents|mesh-ancestor
91915593|NCT04812860|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915594|NCT03551561|Chlorhexidine|chlorhexidine|mesh-list
91915595|NCT03551561|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91915596|NCT03551561|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91915597|NCT03551561|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915598|NCT03551561|Disinfectants|disinfectants|mesh-ancestor
91915599|NCT03551561|Dermatologic Agents|dermatologic agents|mesh-ancestor
91915600|NCT04427540|Oxytocin|oxytocin|mesh-list
91915601|NCT04427540|Oxytocics|oxytocics|mesh-ancestor
91915602|NCT04427540|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915603|NCT04427540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915604|NCT04801940|Apixaban|apixaban|mesh-list
91915605|NCT04801940|Atorvastatin|atorvastatin|mesh-list
91915606|NCT04801940|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91915607|NCT04801940|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915608|NCT04801940|Antimetabolites|antimetabolites|mesh-ancestor
91915609|NCT04801940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915610|NCT04801940|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915611|NCT04801940|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91915612|NCT04801940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915613|NCT04801940|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91915614|NCT04801940|Antithrombins|antithrombins|mesh-ancestor
91915615|NCT04801940|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91915616|NCT04801940|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915617|NCT04801940|Anticoagulants|anticoagulants|mesh-ancestor
91915618|NCT02251847|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91915619|NCT02251847|Ezetimibe|ezetimibe|mesh-list
91915620|NCT02251847|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91915621|NCT02251847|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915622|NCT02251847|Antimetabolites|antimetabolites|mesh-ancestor
91915623|NCT02251847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915624|NCT02251847|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915625|NCT02251847|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91915626|NCT02251847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915627|NCT02127047|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91915628|NCT02127047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91915629|NCT02127047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915630|NCT02127047|Incretins|incretins|mesh-ancestor
91915631|NCT02127047|Hormones|hormones|mesh-ancestor
91915632|NCT02127047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915633|NCT02127047|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91915634|NCT02127047|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915635|NCT02127047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915636|NCT02127047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915637|NCT02122055|Fentanyl|fentanyl|mesh-list
91915638|NCT02122055|Midazolam|midazolam|mesh-list
91915639|NCT02122055|Dexmedetomidine|dexmedetomidine|mesh-list
91915640|NCT02122055|Propofol|propofol|mesh-list
91915641|NCT02122055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91915642|NCT02122055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915643|NCT02122055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915644|NCT02122055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915645|NCT02122055|Analgesics|analgesics|mesh-ancestor
91915646|NCT02122055|Sensory System Agents|sensory system agents|mesh-ancestor
91915647|NCT02122055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915648|NCT02122055|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91915649|NCT02122055|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91915650|NCT02122055|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91915651|NCT02122055|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915652|NCT02122055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915653|NCT02122055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915655|NCT02122055|Anesthetics, General|anesthetics, general|mesh-ancestor
91915656|NCT02122055|Anesthetics|anesthetics|mesh-ancestor
91915657|NCT02122055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91915658|NCT02122055|Narcotics|narcotics|mesh-ancestor
91915659|NCT02122055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91915660|NCT02122055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91915661|NCT02122055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91915662|NCT02122055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91915666|NCT02125409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91915667|NCT02125409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915668|NCT02125409|Analgesics|analgesics|mesh-ancestor
91915669|NCT02125409|Sensory System Agents|sensory system agents|mesh-ancestor
91915670|NCT02125409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915671|NCT02125409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915672|NCT02125409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91915673|NCT02125409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915674|NCT02125409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91915675|NCT02125409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91915676|NCT02125409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915677|NCT02125409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91915678|NCT02125409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91915679|NCT02125409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915680|NCT02125409|Antipyretics|antipyretics|mesh-ancestor
91915681|NCT04816838|Osimertinib|osimertinib|mesh-list
91915682|NCT04816838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915683|NCT04816838|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91915684|NCT04816838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915685|NCT04816838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915686|NCT02788175|Vedolizumab|vedolizumab|mesh-list
91915687|NCT02788175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91915688|NCT03551171|Niraparib|niraparib|mesh-list
91915689|NCT03551171|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91915690|NCT03551171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915691|NCT03551171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915692|NCT03551171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915693|NCT02787083|Mirabegron|mirabegron|mesh-list
91915694|NCT02787083|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91915695|NCT02787083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91915696|NCT02787083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91915697|NCT02787083|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915698|NCT02787083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915699|NCT02787083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915700|NCT02787083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915701|NCT02787083|Urological Agents|urological agents|mesh-ancestor
91915702|NCT02122211|Betaine|betaine|mesh-list
91915703|NCT02122211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91915704|NCT02122211|Lipotropic Agents|lipotropic agents|mesh-ancestor
91915705|NCT02122211|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915706|NCT02122211|Antimetabolites|antimetabolites|mesh-ancestor
91915707|NCT02122211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915708|NCT02122211|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915709|NCT02125565|Lidocaine|lidocaine|mesh-list
91915710|NCT02125565|Anesthetics, Local|anesthetics, local|mesh-ancestor
91915711|NCT02125565|Anesthetics|anesthetics|mesh-ancestor
91915712|NCT02125565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915713|NCT02125565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915714|NCT02125565|Sensory System Agents|sensory system agents|mesh-ancestor
91915715|NCT02125565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915716|NCT02125565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91915717|NCT02125565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91915718|NCT02125565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91915719|NCT02125565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91915720|NCT02125565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915721|NCT02125643|Caffeine|caffeine|mesh-list
91915722|NCT02125643|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91915723|NCT02125643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915724|NCT02125643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91915725|NCT02125643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942998|NCT04009044|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91915726|NCT02125643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915727|NCT02125643|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91915728|NCT02125643|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91915729|NCT02125643|Purinergic Agents|purinergic agents|mesh-ancestor
91915730|NCT02125643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915731|NCT02127437|Lanreotide|lanreotide|mesh-list
91915732|NCT02127437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915733|NCT02122601|Hyaluronic Acid|hyaluronic acid|mesh-list
91915734|NCT02122601|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91915735|NCT02122601|Immunologic Factors|immunologic factors|mesh-ancestor
91915736|NCT02122601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915737|NCT02122601|Viscosupplements|viscosupplements|mesh-ancestor
91915740|NCT02127593|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91915741|NCT02127593|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91915742|NCT02127593|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91915743|NCT02127593|Norgestimate|norgestimate|mesh-list
91915744|NCT02127593|Norgestrel|norgestrel|mesh-list
91915745|NCT02127593|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91915746|NCT02127593|Estradiol|estradiol|mesh-list
91915747|NCT02127593|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91915748|NCT02127593|Estrogens|estrogens|mesh-ancestor
91915749|NCT02127593|Hormones|hormones|mesh-ancestor
91915750|NCT02127593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915751|NCT02127593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915752|NCT02127593|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91915753|NCT02127593|Contraceptive Agents|contraceptive agents|mesh-ancestor
91915754|NCT02127593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915755|NCT02127593|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91915756|NCT02127593|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91915757|NCT02127593|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91915758|NCT02127593|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91915759|NCT02127593|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915760|NCT02127593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915761|NCT02127593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91915762|NCT02127593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91915763|NCT02127593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915764|NCT02127593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915765|NCT02127593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915766|NCT02127593|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91915767|NCT02122679|Tranexamic Acid|tranexamic acid|mesh-list
91915768|NCT02122679|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91915769|NCT02122679|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91915770|NCT02122679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915771|NCT02122679|Hemostatics|hemostatics|mesh-ancestor
91915772|NCT02122679|Coagulants|coagulants|mesh-ancestor
91915773|NCT04810754|Daratumumab|daratumumab|mesh-list
91915774|NCT04810754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915775|NCT02127749|Metronidazole|metronidazole|mesh-list
91915776|NCT02127749|Vancomycin|vancomycin|mesh-list
91915777|NCT02127749|Ciprofloxacin|ciprofloxacin|mesh-list
91915778|NCT02127749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915779|NCT02127749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915780|NCT02127749|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91915781|NCT02127749|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91915782|NCT02127749|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91915783|NCT02127749|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91915784|NCT02127749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915785|NCT02127749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915786|NCT02127749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915787|NCT02127749|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91915788|NCT02127749|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91915790|NCT04797338|Progesterone|progesterone|mesh-list
91915791|NCT04797338|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
91915792|NCT04797338|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
91915793|NCT04797338|Estradiol|estradiol|mesh-list
91915794|NCT04797338|Progestins|progestins|mesh-ancestor
91915795|NCT04797338|Hormones|hormones|mesh-ancestor
91915796|NCT04797338|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915798|NCT04797338|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91915799|NCT04797338|Hormone Antagonists|hormone antagonists|mesh-ancestor
91915800|NCT04797338|Estrogens|estrogens|mesh-ancestor
91915801|NCT04797338|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91915802|NCT04797338|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91915803|NCT04797338|Fertility Agents|fertility agents|mesh-ancestor
91915804|NCT05272865|Dronabinol|dronabinol|mesh-list
91915805|NCT05272865|Hallucinogens|hallucinogens|mesh-ancestor
91915806|NCT05272865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915807|NCT05272865|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91915808|NCT05272865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915809|NCT05272865|Analgesics|analgesics|mesh-ancestor
91915810|NCT05272865|Sensory System Agents|sensory system agents|mesh-ancestor
91915811|NCT05272865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915812|NCT05272865|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91915813|NCT05272865|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91915814|NCT05272865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915815|NCT05272865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915816|NCT05272865|Hormones|hormones|mesh-ancestor
91915969|NCT02128841|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91915817|NCT05272865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915818|NCT02787863|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91915819|NCT02787863|Immunologic Factors|immunologic factors|mesh-ancestor
91915820|NCT02787863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915821|NCT04809818|Aspirin|aspirin|mesh-list
91915822|NCT04809818|Dabigatran|dabigatran|mesh-list
91915823|NCT04809818|Apixaban|apixaban|mesh-list
91915824|NCT04809818|Clopidogrel|clopidogrel|mesh-list
91915825|NCT04809818|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91915826|NCT04809818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915827|NCT04809818|Analgesics|analgesics|mesh-ancestor
91915828|NCT04809818|Sensory System Agents|sensory system agents|mesh-ancestor
91915829|NCT04809818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915830|NCT04809818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915831|NCT04809818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91915832|NCT04809818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915833|NCT04809818|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91915834|NCT04809818|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91915835|NCT04809818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915836|NCT04809818|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91915837|NCT04809818|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91915838|NCT04809818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915839|NCT04809818|Antipyretics|antipyretics|mesh-ancestor
91915840|NCT04809818|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91915841|NCT04809818|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91915842|NCT04809818|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91915843|NCT04809818|Purinergic Agents|purinergic agents|mesh-ancestor
91915844|NCT04809818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915845|NCT04809818|Antithrombins|antithrombins|mesh-ancestor
91915846|NCT04809818|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91915847|NCT04809818|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915848|NCT04809818|Anticoagulants|anticoagulants|mesh-ancestor
91915849|NCT04809818|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91915850|NCT04796402|Bamlanivimab|bamlanivimab|mesh-list
91915851|NCT04796402|Antiviral Agents|antiviral agents|mesh-ancestor
91915852|NCT04796402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915853|NCT04809584|Motexafin gadolinium|motexafin gadolinium|mesh-list
91915854|NCT04809584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915855|NCT04809584|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91915856|NCT04809584|Dermatologic Agents|dermatologic agents|mesh-ancestor
91915857|NCT02126267|Chlorhexidine|chlorhexidine|mesh-list
91915858|NCT02126267|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91915859|NCT02126267|Azithromycin|azithromycin|mesh-list
91915860|NCT02126267|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91915861|NCT02126267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915862|NCT02126267|Disinfectants|disinfectants|mesh-ancestor
91915863|NCT02126267|Dermatologic Agents|dermatologic agents|mesh-ancestor
91915864|NCT02126267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915865|NCT02128061|Rituximab|rituximab|mesh-list
91915866|NCT02128061|Lenalidomide|lenalidomide|mesh-list
91915867|NCT02128061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915868|NCT02128061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915869|NCT02128061|Immunologic Factors|immunologic factors|mesh-ancestor
91915870|NCT02128061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915871|NCT02128061|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915872|NCT02128061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91915873|NCT02128061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91915874|NCT02128061|Growth Substances|growth substances|mesh-ancestor
91915875|NCT02128061|Growth Inhibitors|growth inhibitors|mesh-ancestor
91915876|NCT02596958|Bevacizumab|bevacizumab|mesh-list
91915877|NCT02596958|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91915878|NCT02596958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915879|NCT02596958|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91915880|NCT02596958|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91915881|NCT02596958|Growth Substances|growth substances|mesh-ancestor
91915882|NCT02596958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915883|NCT02596958|Growth Inhibitors|growth inhibitors|mesh-ancestor
91915884|NCT02126579|Poly ICLC|poly iclc|mesh-list
91915885|NCT02126579|Interferon Inducers|interferon inducers|mesh-ancestor
91915886|NCT02126579|Immunologic Factors|immunologic factors|mesh-ancestor
91915887|NCT02126579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915888|NCT04808648|Itraconazole|itraconazole|mesh-list
91915889|NCT04808648|Rifampin|rifampin|mesh-list
91915890|NCT04808648|Antifungal Agents|antifungal agents|mesh-ancestor
91915891|NCT04808648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91915892|NCT04808648|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91915970|NCT02128841|Antithrombins|antithrombins|mesh-ancestor
91915893|NCT04808648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91915894|NCT04808648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915895|NCT04808648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915896|NCT04808648|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91915897|NCT04808648|Hormone Antagonists|hormone antagonists|mesh-ancestor
91915898|NCT04808648|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915899|NCT04808648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915900|NCT04808648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91915901|NCT04808648|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91915902|NCT04808648|Antitubercular Agents|antitubercular agents|mesh-ancestor
91915903|NCT04808648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91915904|NCT04808648|Leprostatic Agents|leprostatic agents|mesh-ancestor
91915905|NCT04808648|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91915906|NCT04808648|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91915907|NCT04808648|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91915908|NCT04808648|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91915909|NCT04808648|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91915910|NCT04808648|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91915911|NCT04808648|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91915912|NCT02126657|Glycolic acid|glycolic acid|mesh-list
91915913|NCT02126657|Keratolytic Agents|keratolytic agents|mesh-ancestor
91915914|NCT02126657|Dermatologic Agents|dermatologic agents|mesh-ancestor
91915915|NCT02128451|Fentanyl|fentanyl|mesh-list
91915916|NCT02128451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91915917|NCT02128451|Narcotics|narcotics|mesh-ancestor
91915918|NCT02128451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91915919|NCT02128451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915920|NCT02128451|Analgesics|analgesics|mesh-ancestor
91915921|NCT02128451|Sensory System Agents|sensory system agents|mesh-ancestor
91915922|NCT02128451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915923|NCT02128451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91915924|NCT02128451|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91915925|NCT02128451|Anesthetics, General|anesthetics, general|mesh-ancestor
91915926|NCT02128451|Anesthetics|anesthetics|mesh-ancestor
91915927|NCT04785716|Niraparib|niraparib|mesh-list
91915928|NCT04785716|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91915929|NCT04785716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915930|NCT04785716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915931|NCT04785716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915933|NCT01367249|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91915934|NCT01367249|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91915935|NCT01367249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91915936|NCT01367249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91915937|NCT01367249|Analgesics|analgesics|mesh-ancestor
91915938|NCT01367249|Sensory System Agents|sensory system agents|mesh-ancestor
91915939|NCT01367249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915940|NCT01367249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915941|NCT01367249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91915942|NCT01367249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915943|NCT02128685|Dydrogesterone|dydrogesterone|mesh-list
91915944|NCT02128685|Progestins|progestins|mesh-ancestor
91915946|NCT02128685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91915947|NCT02128685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915948|NCT02252627|Phenylephrine|phenylephrine|mesh-list
91915949|NCT02252627|Oxymetazoline|oxymetazoline|mesh-list
91915951|NCT02252627|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91915952|NCT02252627|Mydriatics|mydriatics|mesh-ancestor
91915953|NCT02252627|Autonomic Agents|autonomic agents|mesh-ancestor
91915954|NCT02252627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91915955|NCT02252627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915956|NCT02252627|Sympathomimetics|sympathomimetics|mesh-ancestor
91915957|NCT02252627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91915958|NCT02252627|Nasal Decongestants|nasal decongestants|mesh-ancestor
91915959|NCT02252627|Respiratory System Agents|respiratory system agents|mesh-ancestor
91915960|NCT02252627|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91915961|NCT02252627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91915962|NCT02252627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91915963|NCT02252627|Adrenergic Agents|adrenergic agents|mesh-ancestor
91915964|NCT02252627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91915965|NCT02252627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915966|NCT02252627|Protective Agents|protective agents|mesh-ancestor
91915967|NCT02252627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91915968|NCT02128841|Rivaroxaban|rivaroxaban|mesh-list
91915971|NCT02128841|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91915972|NCT02128841|Protease Inhibitors|protease inhibitors|mesh-ancestor
91915973|NCT02128841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915974|NCT02128841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915975|NCT02128841|Anticoagulants|anticoagulants|mesh-ancestor
91915976|NCT03550859|Telmisartan|telmisartan|mesh-list
91915977|NCT03550859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91915978|NCT03550859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91915979|NCT03550859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91915980|NCT03550859|Antimetabolites|antimetabolites|mesh-ancestor
91915981|NCT03550859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915982|NCT03550859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91915983|NCT03550859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91915984|NCT03550859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91915985|NCT03550859|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91915986|NCT03550859|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91915987|NCT03550859|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91915989|NCT03550781|Cyclophosphamide|cyclophosphamide|mesh-list
91915990|NCT03550781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91915991|NCT03550781|Immunologic Factors|immunologic factors|mesh-ancestor
91915992|NCT03550781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91915993|NCT03550781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91915994|NCT03550781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91915995|NCT03550781|Alkylating Agents|alkylating agents|mesh-ancestor
91915996|NCT03550781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91915997|NCT03550781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91915998|NCT03550781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91915999|NCT03550781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916000|NCT03550781|Glucocorticoids|glucocorticoids|mesh-ancestor
91916002|NCT03550781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916003|NCT03550781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916004|NCT02260661|Fulvestrant|fulvestrant|mesh-list
91916005|NCT02260661|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916006|NCT02260661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916007|NCT02260661|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91916008|NCT02260661|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91916009|NCT02260661|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916010|NCT02260661|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916011|NCT02260661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916012|NCT02136329|Sildenafil Citrate|sildenafil citrate|mesh-list
91916013|NCT02136329|Vasodilator Agents|vasodilator agents|mesh-ancestor
91916014|NCT02136329|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91916015|NCT02136329|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91916016|NCT02136329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916017|NCT02136329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916018|NCT02136329|Urological Agents|urological agents|mesh-ancestor
91916019|NCT02129231|Magnesium Oxide|magnesium oxide|mesh-list
91916021|NCT02129231|Simvastatin|simvastatin|mesh-list
91916022|NCT02129231|Ezetimibe|ezetimibe|mesh-list
91916023|NCT02129231|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
91916024|NCT02129231|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91916025|NCT02129231|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91916026|NCT02129231|Antimetabolites|antimetabolites|mesh-ancestor
91916027|NCT02129231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916028|NCT02129231|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91916029|NCT02129231|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91916030|NCT02129231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916031|NCT02129231|Antacids|antacids|mesh-ancestor
91916032|NCT02129231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916033|NCT02136641|Fentanyl|fentanyl|mesh-list
91916034|NCT02136641|Midazolam|midazolam|mesh-list
91916035|NCT02136641|Ketamine|ketamine|mesh-list
91916036|NCT02136641|Analgesics|analgesics|mesh-ancestor
91916037|NCT02136641|Sensory System Agents|sensory system agents|mesh-ancestor
91916038|NCT02136641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916039|NCT02136641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916040|NCT02136641|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91916041|NCT02136641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91916042|NCT02136641|Anesthetics, General|anesthetics, general|mesh-ancestor
91916043|NCT02136641|Anesthetics|anesthetics|mesh-ancestor
91916044|NCT02136641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916045|NCT02136641|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91916046|NCT02136641|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91916047|NCT02136641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916048|NCT02136641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916049|NCT02136641|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91916050|NCT02136641|Narcotics|narcotics|mesh-ancestor
91916051|NCT02136641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91916052|NCT02136641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91916053|NCT02136641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91916054|NCT02136641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91916055|NCT02136641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91916056|NCT02136641|GABA Modulators|gaba modulators|mesh-ancestor
91916057|NCT02136641|GABA Agents|gaba agents|mesh-ancestor
91916058|NCT03549689|Tenofovir|tenofovir|mesh-list
91916059|NCT03549689|Lamivudine|lamivudine|mesh-list
91916060|NCT03549689|Dolutegravir|dolutegravir|mesh-list
91916061|NCT03549689|Antiviral Agents|antiviral agents|mesh-ancestor
91916062|NCT03549689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916063|NCT03549689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91916064|NCT03549689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91916065|NCT03549689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916066|NCT03549689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916067|NCT03549689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91916068|NCT03549689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91916070|NCT03549689|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91916071|NCT02129621|Spironolactone|spironolactone|mesh-list
91916072|NCT02129621|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91916073|NCT02129621|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916074|NCT02129621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916075|NCT02129621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916076|NCT02129621|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91916077|NCT02129621|Diuretics|diuretics|mesh-ancestor
91916078|NCT02129621|Natriuretic Agents|natriuretic agents|mesh-ancestor
91916079|NCT02129699|Denosumab|denosumab|mesh-list
91916080|NCT02129699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91916081|NCT02129699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916082|NCT03549923|Esmolol|esmolol|mesh-list
91916083|NCT03549923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91916084|NCT03549923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91916085|NCT03549923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91916086|NCT03549923|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916087|NCT03549923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916088|NCT03549923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916089|NCT03549923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916090|NCT02136875|Fluticasone|fluticasone|mesh-list
91916091|NCT02136875|Xhance|xhance|mesh-list
91916092|NCT02136875|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91916093|NCT02136875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916094|NCT02136875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91916096|NCT02136875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916097|NCT02136875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916098|NCT02136875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916099|NCT02136875|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916100|NCT02136875|Dermatologic Agents|dermatologic agents|mesh-ancestor
91916101|NCT02136875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91916102|NCT02136875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91916103|NCT02136875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91916104|NCT02136875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91916105|NCT02136875|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916106|NCT02136875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916107|NCT02136875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916109|NCT02129933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916110|NCT02129933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916111|NCT02129933|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91916112|NCT02129933|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91916113|NCT02129933|Growth Substances|growth substances|mesh-ancestor
91916114|NCT02129933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916115|NCT02129933|Growth Inhibitors|growth inhibitors|mesh-ancestor
91916116|NCT02132897|Carbamazepine|carbamazepine|mesh-list
91916117|NCT02132897|Anticonvulsants|anticonvulsants|mesh-ancestor
91916118|NCT02132897|Antimanic Agents|antimanic agents|mesh-ancestor
91916119|NCT02132897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91916120|NCT02132897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916121|NCT02132897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916122|NCT02132897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91916123|NCT02132897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916124|NCT02132897|Analgesics|analgesics|mesh-ancestor
91916125|NCT02132897|Sensory System Agents|sensory system agents|mesh-ancestor
91916126|NCT02132897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916127|NCT02132897|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91916128|NCT02132897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916129|NCT02132897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916130|NCT02132897|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91916131|NCT02132897|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91916132|NCT02133053|Beclomethasone|beclomethasone|mesh-list
91916133|NCT02133053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916134|NCT02133053|Glucocorticoids|glucocorticoids|mesh-ancestor
91916135|NCT02133053|Hormones|hormones|mesh-ancestor
91916136|NCT02133053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916137|NCT02133053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916138|NCT02133053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916139|NCT02133053|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916140|NCT02137109|Natalizumab|natalizumab|mesh-list
91916141|NCT02137109|Immunologic Factors|immunologic factors|mesh-ancestor
91916142|NCT02137109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916143|NCT02130167|Atropine|atropine|mesh-list
91916144|NCT02130167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91916145|NCT02130167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91916146|NCT02130167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91916147|NCT02130167|Autonomic Agents|autonomic agents|mesh-ancestor
91916148|NCT02130167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916149|NCT02130167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916150|NCT02130167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916151|NCT02130167|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916152|NCT02130167|Mydriatics|mydriatics|mesh-ancestor
91916153|NCT02130167|Parasympatholytics|parasympatholytics|mesh-ancestor
91916154|NCT02130167|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91916155|NCT02130167|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91916156|NCT02130167|Cholinergic Agents|cholinergic agents|mesh-ancestor
91916157|NCT02130167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916158|NCT02130167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916159|NCT02130323|Imiquimod|imiquimod|mesh-list
91916160|NCT02130323|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91916161|NCT02130323|Immunologic Factors|immunologic factors|mesh-ancestor
91916162|NCT02130323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916163|NCT02130323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916164|NCT02130323|Interferon Inducers|interferon inducers|mesh-ancestor
91916165|NCT03549611|Acetaminophen|acetaminophen|mesh-list
91916166|NCT03549611|Celecoxib|celecoxib|mesh-list
91916167|NCT03549611|Oxycodone|oxycodone|mesh-list
91916168|NCT03549611|Gabapentin|gabapentin|mesh-list
91916169|NCT03549611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916170|NCT03549611|Analgesics|analgesics|mesh-ancestor
91916171|NCT03549611|Sensory System Agents|sensory system agents|mesh-ancestor
91916172|NCT03549611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916173|NCT03549611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916174|NCT03549611|Antipyretics|antipyretics|mesh-ancestor
91916175|NCT03549611|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91916176|NCT03549611|Narcotics|narcotics|mesh-ancestor
91916177|NCT03549611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916178|NCT03549611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91916179|NCT03549611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916180|NCT03549611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916181|NCT03549611|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91916182|NCT03549611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91916183|NCT03549611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916184|NCT03549611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916185|NCT03549611|Anticonvulsants|anticonvulsants|mesh-ancestor
91916186|NCT03549611|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91916187|NCT03549611|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91916188|NCT03549611|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91916189|NCT03549611|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91916190|NCT03549611|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91916191|NCT03549611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916192|NCT03549611|Antimanic Agents|antimanic agents|mesh-ancestor
91916193|NCT02133287|Sirolimus|sirolimus|mesh-list
91916194|NCT02133287|Arsenic Trioxide|arsenic trioxide|mesh-list
91916195|NCT02133287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91916196|NCT02133287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916197|NCT02133287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91916198|NCT02133287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916199|NCT02133287|Antifungal Agents|antifungal agents|mesh-ancestor
91916200|NCT02133287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91916202|NCT02133287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916203|NCT02137265|Clomiphene|clomiphene|mesh-list
91916204|NCT02137265|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91916205|NCT02137265|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916206|NCT02137265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916207|NCT02137265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916208|NCT02137265|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91916209|NCT02137265|Fertility Agents|fertility agents|mesh-ancestor
91916210|NCT02137265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91916211|NCT02137265|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91916212|NCT02137265|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91916213|NCT02592434|Tofacitinib|tofacitinib|mesh-list
91916214|NCT02592434|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91916215|NCT02592434|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91916216|NCT02592434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916217|NCT02592434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916218|NCT02130713|Fluoroquinolones|fluoroquinolones|mesh-list
91916219|NCT02130713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91916220|NCT02130713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916221|NCT02130713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91916222|NCT02130713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916223|NCT02130713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916224|NCT02137421|Resveratrol|resveratrol|mesh-list
91916225|NCT02137421|Antioxidants|antioxidants|mesh-ancestor
91916226|NCT02137421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916227|NCT02137421|Protective Agents|protective agents|mesh-ancestor
91916228|NCT02137421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916229|NCT02137421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916230|NCT02137421|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91916231|NCT02133677|Temozolomide|temozolomide|mesh-list
91916232|NCT02133677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91916233|NCT02133677|Alkylating Agents|alkylating agents|mesh-ancestor
91916234|NCT02133677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916235|NCT02133677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916236|NCT02137733|Carvedilol|carvedilol|mesh-list
91916237|NCT02137733|Bisoprolol|bisoprolol|mesh-list
91943007|NCT03928210|Digoxin|digoxin|mesh-list
91916238|NCT02137733|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91916239|NCT02137733|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91916240|NCT02137733|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916241|NCT02137733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916242|NCT02137733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916243|NCT02137733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916244|NCT02137733|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91916245|NCT02137733|Antioxidants|antioxidants|mesh-ancestor
91916246|NCT02137733|Protective Agents|protective agents|mesh-ancestor
91916247|NCT02137733|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91916248|NCT02137733|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916249|NCT02137733|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91916250|NCT02137733|Vasodilator Agents|vasodilator agents|mesh-ancestor
91916251|NCT02137733|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91916252|NCT02137733|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91916253|NCT02137733|Sympatholytics|sympatholytics|mesh-ancestor
91916254|NCT02137733|Autonomic Agents|autonomic agents|mesh-ancestor
91916255|NCT02137733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916256|NCT02137733|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91916258|NCT02133755|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91916259|NCT02133755|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91916260|NCT02133755|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916261|NCT02133755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916262|NCT02133755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916263|NCT02133755|Dopamine Agonists|dopamine agonists|mesh-ancestor
91916264|NCT02133755|Dopamine Agents|dopamine agents|mesh-ancestor
91916265|NCT02133755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916266|NCT02133755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916268|NCT02130869|Aldesleukin|aldesleukin|mesh-list
91916269|NCT02130869|Carboplatin|carboplatin|mesh-list
91916270|NCT02130869|Etoposide|etoposide|mesh-list
91916271|NCT02130869|Etoposide phosphate|etoposide phosphate|mesh-list
91916272|NCT02130869|Melphalan|melphalan|mesh-list
91916273|NCT02130869|Busulfan|busulfan|mesh-list
91916275|NCT02130869|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91916276|NCT02130869|Mechlorethamine|mechlorethamine|mesh-list
91916277|NCT02130869|Sargramostim|sargramostim|mesh-list
91916278|NCT02130869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916279|NCT02130869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91916280|NCT02130869|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91916281|NCT02130869|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91916282|NCT02130869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916283|NCT02130869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916284|NCT02130869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91916285|NCT02130869|Antimetabolites|antimetabolites|mesh-ancestor
91916286|NCT02130869|Antiviral Agents|antiviral agents|mesh-ancestor
91916287|NCT02130869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916288|NCT02130869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91916289|NCT02130869|Immunologic Factors|immunologic factors|mesh-ancestor
91916290|NCT02130869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916291|NCT02130869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91916292|NCT02130869|Alkylating Agents|alkylating agents|mesh-ancestor
91916293|NCT02130869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91916294|NCT02130869|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916295|NCT02130869|Analgesics|analgesics|mesh-ancestor
91916296|NCT02130869|Sensory System Agents|sensory system agents|mesh-ancestor
91916297|NCT02130869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916298|NCT02130869|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91916299|NCT02130869|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91916300|NCT02133911|Ranolazine|ranolazine|mesh-list
91916301|NCT02133911|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91916302|NCT02133911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916303|NCT02133911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916304|NCT02133989|Ticlopidine|ticlopidine|mesh-list
91916305|NCT02133989|Clopidogrel|clopidogrel|mesh-list
91916306|NCT02133989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91916307|NCT02133989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91916308|NCT02133989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91916309|NCT02133989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91916310|NCT02133989|Purinergic Agents|purinergic agents|mesh-ancestor
91916311|NCT02133989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916312|NCT02133989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916313|NCT02133989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916314|NCT02133989|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91916315|NCT02133989|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91916316|NCT02133989|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91916317|NCT02133989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91916318|NCT02133989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916319|NCT02138045|Liraglutide|liraglutide|mesh-list
91916320|NCT02138045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91916321|NCT02138045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916323|NCT02138045|Hormones|hormones|mesh-ancestor
91916324|NCT02138045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916325|NCT02134067|Paclitaxel|paclitaxel|mesh-list
91916326|NCT02134067|TAS-119|tas-119|mesh-list
91916327|NCT02134067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91916328|NCT02134067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916329|NCT02134067|Tubulin Modulators|tubulin modulators|mesh-ancestor
91916330|NCT02134067|Antimitotic Agents|antimitotic agents|mesh-ancestor
91916331|NCT02134067|Mitosis Modulators|mitosis modulators|mesh-ancestor
91916332|NCT02134067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916333|NCT02134067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91916334|NCT02134067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916335|NCT04091126|Dexamethasone|dexamethasone|mesh-list
91916336|NCT04091126|Lenalidomide|lenalidomide|mesh-list
91916337|NCT04091126|Bortezomib|bortezomib|mesh-list
91916338|NCT04091126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916339|NCT04091126|Antiemetics|antiemetics|mesh-ancestor
91916340|NCT04091126|Autonomic Agents|autonomic agents|mesh-ancestor
91916341|NCT04091126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916342|NCT04091126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916343|NCT04091126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916344|NCT04091126|Glucocorticoids|glucocorticoids|mesh-ancestor
91916345|NCT04091126|Hormones|hormones|mesh-ancestor
91916346|NCT04091126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916347|NCT04091126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916348|NCT04091126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916349|NCT04091126|Immunologic Factors|immunologic factors|mesh-ancestor
91916350|NCT04091126|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91916351|NCT04091126|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91916352|NCT04091126|Growth Substances|growth substances|mesh-ancestor
91916359|NCT03962114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916360|NCT03962114|Vitamin B Complex|vitamin b complex|mesh-ancestor
91916361|NCT03962114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91916362|NCT03962114|Antimetabolites|antimetabolites|mesh-ancestor
91916363|NCT03962114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916364|NCT03962114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91916365|NCT03962114|Vasodilator Agents|vasodilator agents|mesh-ancestor
91916366|NCT04346186|Immunoglobulin G|immunoglobulin g|mesh-list
91916367|NCT04346186|Immunoglobulin M|immunoglobulin m|mesh-list
91916368|NCT04346186|Immunologic Factors|immunologic factors|mesh-ancestor
91916369|NCT04346186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916370|NCT05472896|Epirubicin|epirubicin|mesh-list
91916371|NCT05472896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91916372|NCT05472896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916373|NCT05472896|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91916374|NCT05472896|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91916375|NCT05472896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916376|NCT05472896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916377|NCT02138357|Buprenorphine|buprenorphine|mesh-list
91916378|NCT02138357|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91916379|NCT02138357|Narcotics|narcotics|mesh-ancestor
91916380|NCT02138357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916381|NCT02138357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916382|NCT02138357|Analgesics|analgesics|mesh-ancestor
91916383|NCT02138357|Sensory System Agents|sensory system agents|mesh-ancestor
91916384|NCT02138357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916385|NCT02138357|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91916386|NCT03596918|Vincristine|vincristine|mesh-list
91916387|NCT03596918|Bleomycin|bleomycin|mesh-list
91916388|NCT03596918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91916389|NCT03596918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916390|NCT03596918|Tubulin Modulators|tubulin modulators|mesh-ancestor
91916391|NCT03596918|Antimitotic Agents|antimitotic agents|mesh-ancestor
91916392|NCT03596918|Mitosis Modulators|mitosis modulators|mesh-ancestor
91916393|NCT03596918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916394|NCT03596918|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91916395|NCT03535298|Interferons|interferons|mesh-list
91916396|NCT03535298|Interferon-beta|interferon-beta|mesh-list
91916397|NCT03535298|Teriflunomide|teriflunomide|mesh-list
91916398|NCT03535298|Alemtuzumab|alemtuzumab|mesh-list
91916399|NCT03535298|Ofatumumab|ofatumumab|mesh-list
91916400|NCT03535298|Cladribine|cladribine|mesh-list
91916401|NCT03535298|Glatiramer Acetate|glatiramer acetate|mesh-list
91916402|NCT03535298|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91916403|NCT03535298|Ocrelizumab|ocrelizumab|mesh-list
91916404|NCT03535298|Natalizumab|natalizumab|mesh-list
91916405|NCT03535298|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91916406|NCT03535298|(T,G)-A-L|(t,g)-a-l|mesh-list
91916407|NCT03535298|Ozanimod|ozanimod|mesh-list
91916408|NCT03535298|Ponesimod|ponesimod|mesh-list
91916409|NCT03535298|Siponimod|siponimod|mesh-list
91916410|NCT03535298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916411|NCT03535298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916412|NCT03535298|Immunologic Factors|immunologic factors|mesh-ancestor
91916413|NCT03535298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916414|NCT03535298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916415|NCT03535298|Antiviral Agents|antiviral agents|mesh-ancestor
91916416|NCT03535298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916417|NCT03535298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91916418|NCT03535298|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91916419|NCT03535298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916420|NCT03535298|Dermatologic Agents|dermatologic agents|mesh-ancestor
91916421|NCT03535298|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91916422|NCT03535298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91916423|NCT03535298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916424|NCT03535298|Analgesics|analgesics|mesh-ancestor
91916425|NCT03535298|Sensory System Agents|sensory system agents|mesh-ancestor
91916426|NCT03535298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916427|NCT03535298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916428|NCT02134379|Clotrimazole|clotrimazole|mesh-list
91916429|NCT02134379|Miconazole|miconazole|mesh-list
91916430|NCT02134379|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91916431|NCT02134379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916432|NCT02134379|Antifungal Agents|antifungal agents|mesh-ancestor
91916433|NCT02134379|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91916434|NCT02134379|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91916435|NCT02134379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916661|NCT05474924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916436|NCT02134379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916437|NCT02134379|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91916438|NCT02134379|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916439|NCT02134379|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916440|NCT02134379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916441|NCT02134379|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91916442|NCT02134379|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91916443|NCT02134457|Ranibizumab|ranibizumab|mesh-list
91916444|NCT02134457|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91916445|NCT02134457|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91916446|NCT02134457|Growth Substances|growth substances|mesh-ancestor
91916447|NCT02134457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916448|NCT02134457|Growth Inhibitors|growth inhibitors|mesh-ancestor
91916449|NCT02134457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916450|NCT04090190|Solifenacin Succinate|solifenacin succinate|mesh-list
91916451|NCT04090190|Tolterodine Tartrate|tolterodine tartrate|mesh-list
91916452|NCT04090190|Fesoterodine|fesoterodine|mesh-list
91916453|NCT04090190|Oxybutynin|oxybutynin|mesh-list
91916454|NCT04090190|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91916455|NCT04090190|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91916456|NCT04090190|Cholinergic Agents|cholinergic agents|mesh-ancestor
91916457|NCT04090190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916458|NCT04090190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916459|NCT04090190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916460|NCT04090190|Urological Agents|urological agents|mesh-ancestor
91916461|NCT04090190|Parasympatholytics|parasympatholytics|mesh-ancestor
91916462|NCT04090190|Autonomic Agents|autonomic agents|mesh-ancestor
91916463|NCT04090190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916464|NCT04792034|Cocaine|cocaine|mesh-list
91916465|NCT04792034|Anesthetics, Local|anesthetics, local|mesh-ancestor
91916466|NCT04792034|Anesthetics|anesthetics|mesh-ancestor
91916467|NCT04792034|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916468|NCT04792034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916469|NCT04792034|Sensory System Agents|sensory system agents|mesh-ancestor
91916470|NCT04792034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916472|NCT04792034|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91916473|NCT04792034|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91916474|NCT04792034|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916475|NCT04792034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916476|NCT04792034|Dopamine Agents|dopamine agents|mesh-ancestor
91916477|NCT04792034|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916478|NCT02253095|Micronutrients|micronutrients|mesh-list
91916479|NCT02253095|Trace Elements|trace elements|mesh-list
91916480|NCT02253095|Albendazole|albendazole|mesh-list
91916481|NCT02253095|Anthelmintics|anthelmintics|mesh-ancestor
91916482|NCT02253095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91916483|NCT02253095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916484|NCT02253095|Anticestodal Agents|anticestodal agents|mesh-ancestor
91916485|NCT02253095|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91916486|NCT02253095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91916487|NCT02253095|Tubulin Modulators|tubulin modulators|mesh-ancestor
91916488|NCT02253095|Antimitotic Agents|antimitotic agents|mesh-ancestor
91916489|NCT02253095|Mitosis Modulators|mitosis modulators|mesh-ancestor
91916490|NCT02253095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916491|NCT02253095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916492|NCT02253095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916493|NCT04791332|Aticaprant|aticaprant|mesh-list
91916494|NCT04791332|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91916495|NCT04791332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916496|NCT04791332|Sensory System Agents|sensory system agents|mesh-ancestor
91916497|NCT04791332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916498|NCT05461820|Methimazole|methimazole|mesh-list
91916499|NCT05461820|Antithyroid Agents|antithyroid agents|mesh-ancestor
91916500|NCT05461820|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916501|NCT05461820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916502|NCT05461820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916503|NCT04791020|Lidocaine|lidocaine|mesh-list
91916504|NCT04791020|Anesthetics, Local|anesthetics, local|mesh-ancestor
91916505|NCT04791020|Anesthetics|anesthetics|mesh-ancestor
91916506|NCT04791020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916507|NCT04791020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916508|NCT04791020|Sensory System Agents|sensory system agents|mesh-ancestor
91916509|NCT04791020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916510|NCT04791020|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91916511|NCT04791020|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91916512|NCT04791020|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91916513|NCT04791020|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916514|NCT04791020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916515|NCT02531906|Oxycodone|oxycodone|mesh-list
91916516|NCT02531906|Methadone|methadone|mesh-list
91916517|NCT02531906|Gabapentin|gabapentin|mesh-list
91916518|NCT02531906|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91916519|NCT02531906|Narcotics|narcotics|mesh-ancestor
91916520|NCT02531906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916521|NCT02531906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916522|NCT02531906|Analgesics|analgesics|mesh-ancestor
91916523|NCT02531906|Sensory System Agents|sensory system agents|mesh-ancestor
91916524|NCT02531906|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916525|NCT02531906|Anticonvulsants|anticonvulsants|mesh-ancestor
91916526|NCT02531906|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91916527|NCT02531906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91916528|NCT02531906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91916529|NCT02531906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91916530|NCT02531906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91916531|NCT02531906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916532|NCT02531906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916533|NCT02531906|Antimanic Agents|antimanic agents|mesh-ancestor
91916534|NCT02531906|Antitussive Agents|antitussive agents|mesh-ancestor
91943014|NCT03915769|Ozanimod|ozanimod|mesh-list
91916535|NCT02531906|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916536|NCT02783729|Zolpidem|zolpidem|mesh-list
91916537|NCT02783729|Lemborexant|lemborexant|mesh-list
91916538|NCT02783729|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91916539|NCT02783729|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91916540|NCT02783729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916541|NCT02783729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916542|NCT02783729|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91916544|NCT02783729|GABA Agents|gaba agents|mesh-ancestor
91916545|NCT02783729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916546|NCT02783729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916547|NCT02783729|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
91916548|NCT02227940|Paclitaxel|paclitaxel|mesh-list
91916549|NCT02227940|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91916550|NCT02227940|Cisplatin|cisplatin|mesh-list
91916551|NCT02227940|Gemcitabine|gemcitabine|mesh-list
91916552|NCT02227940|Ceritinib|ceritinib|mesh-list
91916553|NCT02227940|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91916554|NCT02227940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916555|NCT02227940|Tubulin Modulators|tubulin modulators|mesh-ancestor
91916556|NCT02227940|Antimitotic Agents|antimitotic agents|mesh-ancestor
91916557|NCT02227940|Mitosis Modulators|mitosis modulators|mesh-ancestor
91916558|NCT02227940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916559|NCT02227940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91916560|NCT02227940|Antimetabolites|antimetabolites|mesh-ancestor
91916561|NCT02227940|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91916562|NCT02227940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916563|NCT02072486|Sorafenib|sorafenib|mesh-list
91916564|NCT02072486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916565|NCT02072486|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91916566|NCT02072486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916567|NCT02072486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916568|NCT00988364|Simvastatin|simvastatin|mesh-list
91916569|NCT00988364|Ezetimibe|ezetimibe|mesh-list
91916570|NCT00988364|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
91916571|NCT00988364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91916572|NCT00988364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91916573|NCT00988364|Antimetabolites|antimetabolites|mesh-ancestor
91916574|NCT00988364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916575|NCT00988364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91916576|NCT00988364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91916577|NCT00988364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916578|NCT05578001|Pilocarpine|pilocarpine|mesh-list
91916579|NCT05578001|Miotics|miotics|mesh-ancestor
91916580|NCT05578001|Autonomic Agents|autonomic agents|mesh-ancestor
91916581|NCT05578001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916582|NCT05578001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916583|NCT05578001|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91916584|NCT05578001|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91916585|NCT05578001|Cholinergic Agents|cholinergic agents|mesh-ancestor
91916586|NCT05578001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916587|NCT05578001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916588|NCT05577923|Trastuzumab|trastuzumab|mesh-list
91916589|NCT05577923|Fulvestrant|fulvestrant|mesh-list
91916590|NCT05577923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916591|NCT05577923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916592|NCT05577923|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916593|NCT05577923|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91916594|NCT05577923|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91916595|NCT05577923|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916596|NCT05577923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916597|NCT05577923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916598|NCT04790708|Octreotide|octreotide|mesh-list
91916599|NCT04790708|Edotreotide|edotreotide|mesh-list
91916600|NCT04790708|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
91916601|NCT04790708|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91916602|NCT04790708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916603|NCT04790708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916604|NCT04790708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916605|NCT04790708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916606|NCT05615012|Metformin|metformin|mesh-list
91916607|NCT05615012|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91916608|NCT05615012|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91916609|NCT05615012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916610|NCT05615012|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91916611|NCT05615012|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91916612|NCT05615012|Antimetabolites|antimetabolites|mesh-ancestor
91916613|NCT05615012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916614|NCT05615012|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91916615|NCT05615012|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91916616|NCT05615012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916617|NCT05614934|Clarithromycin|clarithromycin|mesh-list
91916618|NCT05614934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91916619|NCT05614934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916620|NCT05614934|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91916621|NCT05614934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916622|NCT05614934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916623|NCT05614934|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91916624|NCT05614934|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91916625|NCT02135393|Folic Acid|folic acid|mesh-list
91916626|NCT02135393|Hematinics|hematinics|mesh-ancestor
91916627|NCT02135393|Vitamin B Complex|vitamin b complex|mesh-ancestor
91916628|NCT02135393|Vitamins|vitamins|mesh-ancestor
91916629|NCT02135393|Micronutrients|micronutrients|mesh-ancestor
91916630|NCT02135393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916632|NCT02139761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91916633|NCT02139761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91916634|NCT02139761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91916635|NCT02139761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916636|NCT02139761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916637|NCT02139761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91916638|NCT02139761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916639|NCT02139761|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91916640|NCT02139761|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91916641|NCT02139761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916642|NCT02139761|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91916643|NCT02139761|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91916644|NCT02139761|Dopamine Agents|dopamine agents|mesh-ancestor
91916645|NCT02139761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916646|NCT02139761|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916647|NCT02139761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916648|NCT02139761|Analgesics|analgesics|mesh-ancestor
91916649|NCT02139761|Sensory System Agents|sensory system agents|mesh-ancestor
91916650|NCT02139761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916651|NCT05614778|Zoledronic Acid|zoledronic acid|mesh-list
91916652|NCT05614778|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91916653|NCT05614778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916654|NCT05474924|Prednisolone|prednisolone|mesh-list
91916655|NCT05474924|Budesonide|budesonide|mesh-list
91916656|NCT05474924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916657|NCT05474924|Glucocorticoids|glucocorticoids|mesh-ancestor
91916658|NCT05474924|Hormones|hormones|mesh-ancestor
91916659|NCT05474924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916660|NCT05474924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916662|NCT05474924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916663|NCT05474924|Autonomic Agents|autonomic agents|mesh-ancestor
91916664|NCT05474924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916665|NCT05474924|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91916666|NCT05474924|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916667|NCT05474924|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916668|NCT02135627|Epinephrine|epinephrine|mesh-list
91916669|NCT02135627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91916670|NCT02135627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91916671|NCT02135627|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916672|NCT02135627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916673|NCT02135627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916674|NCT02135627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916675|NCT02135627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91916676|NCT02135627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91916677|NCT02135627|Autonomic Agents|autonomic agents|mesh-ancestor
91916678|NCT02135627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916679|NCT02135627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916680|NCT02135627|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916682|NCT02135627|Sympathomimetics|sympathomimetics|mesh-ancestor
91916683|NCT02135627|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91916684|NCT05614622|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91916685|NCT05614622|Cyclopentolate|cyclopentolate|mesh-list
91916686|NCT05614622|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91916687|NCT05614622|Mydriatics|mydriatics|mesh-ancestor
91916688|NCT05614622|Autonomic Agents|autonomic agents|mesh-ancestor
91916689|NCT05614622|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916690|NCT05614622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916691|NCT05614622|Parasympatholytics|parasympatholytics|mesh-ancestor
91916692|NCT05614622|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91916693|NCT05614622|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91916694|NCT05614622|Cholinergic Agents|cholinergic agents|mesh-ancestor
91916695|NCT05614622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916696|NCT05614622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916697|NCT03548129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91916698|NCT03548129|Fosfomycin|fosfomycin|mesh-list
91916699|NCT03548129|Anti-Infective Agents|anti-infective agents|mesh-list
91916700|NCT02140073|Domperidone|domperidone|mesh-list
91916701|NCT02140073|Omeprazole|omeprazole|mesh-list
91916702|NCT02140073|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91916703|NCT02140073|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916704|NCT02140073|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91916705|NCT02140073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916706|NCT02140073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916707|NCT02140073|Antiemetics|antiemetics|mesh-ancestor
91916708|NCT02140073|Autonomic Agents|autonomic agents|mesh-ancestor
91916709|NCT02140073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916710|NCT02140073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916711|NCT02140073|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91916712|NCT02140073|Dopamine Agents|dopamine agents|mesh-ancestor
91916713|NCT02140073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916714|NCT05474690|Cyclophosphamide|cyclophosphamide|mesh-list
91916715|NCT05474690|Carboplatin|carboplatin|mesh-list
91916716|NCT05474690|Docetaxel|docetaxel|mesh-list
91916717|NCT05474690|Trastuzumab|trastuzumab|mesh-list
91916718|NCT05474690|Epirubicin|epirubicin|mesh-list
91916719|NCT05474690|Pertuzumab|pertuzumab|mesh-list
91916720|NCT05474690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91916721|NCT05474690|Immunologic Factors|immunologic factors|mesh-ancestor
91916722|NCT05474690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916723|NCT05474690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916724|NCT05474690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91916725|NCT05474690|Alkylating Agents|alkylating agents|mesh-ancestor
91916726|NCT05474690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916727|NCT05474690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916728|NCT05474690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91916729|NCT05474690|Tubulin Modulators|tubulin modulators|mesh-ancestor
91916730|NCT05474690|Antimitotic Agents|antimitotic agents|mesh-ancestor
91916731|NCT05474690|Mitosis Modulators|mitosis modulators|mesh-ancestor
91916732|NCT05474690|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916733|NCT05474690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91916734|NCT05474690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91916735|NCT05474690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91916736|NCT05474690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916737|NCT05575973|Rituximab|rituximab|mesh-list
91916738|NCT05575973|Lenalidomide|lenalidomide|mesh-list
91916739|NCT05575973|Mitoxantrone|mitoxantrone|mesh-list
91916896|NCT05575271|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916740|NCT05575973|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916741|NCT05575973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916742|NCT05575973|Immunologic Factors|immunologic factors|mesh-ancestor
91916743|NCT05575973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916744|NCT05575973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916745|NCT05575973|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91916746|NCT05575973|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91916747|NCT05575973|Growth Substances|growth substances|mesh-ancestor
91916748|NCT05575973|Growth Inhibitors|growth inhibitors|mesh-ancestor
91916749|NCT05575973|Analgesics|analgesics|mesh-ancestor
91916750|NCT05575973|Sensory System Agents|sensory system agents|mesh-ancestor
91916751|NCT05575973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916752|NCT05575973|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91916753|NCT05575973|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91916754|NCT05575973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916755|NCT05575973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916756|NCT03547895|Vitamin K|vitamin k|mesh-list
91916757|NCT03547895|Vitamin K 1|vitamin k 1|mesh-list
91916758|NCT03547895|Ribavirin|ribavirin|mesh-list
91916759|NCT03547895|Sofosbuvir|sofosbuvir|mesh-list
91916760|NCT03547895|Furosemide|furosemide|mesh-list
91916761|NCT03547895|Spironolactone|spironolactone|mesh-list
91916762|NCT03547895|Silymarin|silymarin|mesh-list
91916763|NCT03547895|Vitamins|vitamins|mesh-ancestor
91916764|NCT03547895|Micronutrients|micronutrients|mesh-ancestor
91916765|NCT03547895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916766|NCT03547895|Antimetabolites|antimetabolites|mesh-ancestor
91916767|NCT03547895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916768|NCT03547895|Antiviral Agents|antiviral agents|mesh-ancestor
91916769|NCT03547895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916770|NCT03547895|Diuretics|diuretics|mesh-ancestor
91916771|NCT03547895|Natriuretic Agents|natriuretic agents|mesh-ancestor
91916772|NCT03547895|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91916773|NCT03547895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916774|NCT03547895|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91916775|NCT03547895|Hormone Antagonists|hormone antagonists|mesh-ancestor
91916776|NCT03547895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916777|NCT03547895|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91916778|NCT03547895|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91916779|NCT03547895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91916780|NCT03547895|Hemostatics|hemostatics|mesh-ancestor
91916781|NCT03547895|Coagulants|coagulants|mesh-ancestor
91916782|NCT03547895|Antioxidants|antioxidants|mesh-ancestor
91916783|NCT03547895|Protective Agents|protective agents|mesh-ancestor
91916785|NCT01359254|Fludarabine phosphate|fludarabine phosphate|mesh-list
91916786|NCT01359254|Melphalan|melphalan|mesh-list
91916787|NCT01359254|Busulfan|busulfan|mesh-list
91916788|NCT01359254|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91916789|NCT01359254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916790|NCT01359254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91916791|NCT01359254|Antimetabolites|antimetabolites|mesh-ancestor
91916792|NCT01359254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916793|NCT01359254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91916794|NCT01359254|Immunologic Factors|immunologic factors|mesh-ancestor
91916795|NCT01359254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916796|NCT01359254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91916797|NCT01359254|Alkylating Agents|alkylating agents|mesh-ancestor
91916798|NCT01359254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91916799|NCT05575739|Antioxidants|antioxidants|mesh-list
91916800|NCT05575739|Superoxide Dismutase|superoxide dismutase|mesh-list
91916801|NCT05575739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916802|NCT05575739|Protective Agents|protective agents|mesh-ancestor
91916803|NCT05575739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916804|NCT05575739|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91916805|NCT05035862|Interferons|interferons|mesh-list
91916806|NCT05035862|Interferon-gamma|interferon-gamma|mesh-list
91916807|NCT05035862|Prednisone|prednisone|mesh-list
91916808|NCT05035862|Albuterol|albuterol|mesh-list
91916809|NCT05035862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916810|NCT05035862|Glucocorticoids|glucocorticoids|mesh-ancestor
91916811|NCT05035862|Hormones|hormones|mesh-ancestor
91916812|NCT05035862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916813|NCT05035862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916814|NCT05035862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916815|NCT05035862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916816|NCT05035862|Antiviral Agents|antiviral agents|mesh-ancestor
91916817|NCT05035862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916818|NCT05035862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91916819|NCT05035862|Autonomic Agents|autonomic agents|mesh-ancestor
91916820|NCT05035862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916821|NCT05035862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916822|NCT05035862|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916823|NCT05035862|Tocolytic Agents|tocolytic agents|mesh-ancestor
91916824|NCT05035862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91916825|NCT05035862|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91916826|NCT05035862|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91916827|NCT05035862|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91916828|NCT05035862|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916829|NCT05035862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916830|NCT05035862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916831|NCT03549221|Ketorolac|ketorolac|mesh-list
91916832|NCT03549221|Epinephrine|epinephrine|mesh-list
91916833|NCT03549221|Levobupivacaine|levobupivacaine|mesh-list
91916834|NCT03549221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91916835|NCT03549221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91916836|NCT03549221|Adrenergic Agents|adrenergic agents|mesh-ancestor
91916837|NCT03549221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916838|NCT03549221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916839|NCT03549221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916840|NCT03549221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91916841|NCT03549221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91916842|NCT03549221|Autonomic Agents|autonomic agents|mesh-ancestor
91916843|NCT03549221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916844|NCT03549221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91916845|NCT03549221|Respiratory System Agents|respiratory system agents|mesh-ancestor
91916846|NCT03549221|Mydriatics|mydriatics|mesh-ancestor
91916848|NCT03549221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91916849|NCT03549221|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91916850|NCT03549221|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916851|NCT03549221|Analgesics|analgesics|mesh-ancestor
91916852|NCT03549221|Sensory System Agents|sensory system agents|mesh-ancestor
91916853|NCT03549221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916854|NCT03549221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916855|NCT03549221|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91916856|NCT03549221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916857|NCT03549221|Anesthetics, Local|anesthetics, local|mesh-ancestor
91916858|NCT03549221|Anesthetics|anesthetics|mesh-ancestor
91916859|NCT03549221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916861|NCT05013632|Remdesivir|remdesivir|mesh-list
91916862|NCT05013632|Sotrovimab|sotrovimab|mesh-list
91916863|NCT05013632|Molnupiravir|molnupiravir|mesh-list
91916864|NCT05013632|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
91916865|NCT05013632|Antibodies|antibodies|mesh-list
91916866|NCT05013632|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91916867|NCT05013632|Immunologic Factors|immunologic factors|mesh-ancestor
91916868|NCT05013632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916869|NCT05013632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916870|NCT05013632|Antimetabolites|antimetabolites|mesh-ancestor
91916871|NCT05013632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916872|NCT05614544|Propofol|propofol|mesh-list
91916873|NCT05614544|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91916874|NCT05614544|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91916875|NCT05614544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916876|NCT05614544|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91916877|NCT05614544|Anesthetics, General|anesthetics, general|mesh-ancestor
91916878|NCT05614544|Anesthetics|anesthetics|mesh-ancestor
91916879|NCT05185505|Bevacizumab|bevacizumab|mesh-list
91916880|NCT05185505|Atezolizumab|atezolizumab|mesh-list
91916881|NCT05185505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916882|NCT05185505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916883|NCT05185505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91916884|NCT05185505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91916885|NCT05185505|Growth Substances|growth substances|mesh-ancestor
91916886|NCT05185505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916887|NCT05185505|Growth Inhibitors|growth inhibitors|mesh-ancestor
91916888|NCT05185505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91916889|NCT05185505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916890|NCT01667432|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91916891|NCT01667432|Antiviral Agents|antiviral agents|mesh-ancestor
91916892|NCT01667432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916893|NCT05575271|Norepinephrine|norepinephrine|mesh-list
91916894|NCT05575271|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91916895|NCT05575271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91916897|NCT05575271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916898|NCT05575271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916899|NCT05575271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916900|NCT05575271|Sympathomimetics|sympathomimetics|mesh-ancestor
91916901|NCT05575271|Autonomic Agents|autonomic agents|mesh-ancestor
91916902|NCT05575271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916903|NCT05575271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91916904|NCT04750460|Teriparatide|teriparatide|mesh-list
91943020|NCT03908736|Picolinic acid|picolinic acid|mesh-list
91916905|NCT04750460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91916906|NCT04750460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916907|NCT04750460|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91916908|NCT05575037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91916909|NCT05575037|Immunologic Factors|immunologic factors|mesh-ancestor
91916910|NCT05575037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916911|NCT05574881|Trastuzumab|trastuzumab|mesh-list
91916912|NCT05574881|Pertuzumab|pertuzumab|mesh-list
91916913|NCT05574881|Fulvestrant|fulvestrant|mesh-list
91916914|NCT05574881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91916915|NCT05574881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91916916|NCT05574881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91916917|NCT05574881|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91916918|NCT05574881|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91916919|NCT05574881|Hormone Antagonists|hormone antagonists|mesh-ancestor
92074237|NCT01475253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916920|NCT05574881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91916921|NCT05574881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916922|NCT05612984|Aspirin|aspirin|mesh-list
91916923|NCT05612984|Folic Acid|folic acid|mesh-list
91916924|NCT05612984|Micronutrients|micronutrients|mesh-list
91916925|NCT05612984|Trace Elements|trace elements|mesh-list
91916926|NCT05612984|Calcium|calcium|mesh-list
91916927|NCT05612984|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91916928|NCT05612984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916929|NCT05612984|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91916930|NCT05612984|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91916931|NCT05612984|Analgesics|analgesics|mesh-ancestor
91916932|NCT05612984|Sensory System Agents|sensory system agents|mesh-ancestor
91916933|NCT05612984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916934|NCT05612984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91916935|NCT05612984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91916936|NCT05612984|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91916937|NCT05612984|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91916938|NCT05612984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916939|NCT05612984|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91916940|NCT05612984|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91916941|NCT05612984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916942|NCT05612984|Antipyretics|antipyretics|mesh-ancestor
91916943|NCT05612984|Hematinics|hematinics|mesh-ancestor
91916944|NCT05612984|Vitamin B Complex|vitamin b complex|mesh-ancestor
91916945|NCT05612984|Vitamins|vitamins|mesh-ancestor
91916946|NCT04787510|Heparin|heparin|mesh-list
91916947|NCT04787510|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91916948|NCT04787510|Tinzaparin|tinzaparin|mesh-list
91916949|NCT04787510|Dalteparin|dalteparin|mesh-list
91916950|NCT04787510|Anticoagulants|anticoagulants|mesh-ancestor
91916951|NCT04787510|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91916952|NCT04787510|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91916953|NCT04787510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916954|NCT05424263|Calcium, Dietary|calcium, dietary|mesh-list
91916955|NCT05424263|Calcium Carbonate|calcium carbonate|mesh-list
91916956|NCT05424263|Calcium|calcium|mesh-list
91916957|NCT05424263|Calcium acetate|calcium acetate|mesh-list
91916958|NCT05424263|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91916959|NCT05424263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916960|NCT05424263|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91916961|NCT05424263|Antacids|antacids|mesh-ancestor
91916962|NCT05424263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916963|NCT05424263|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916964|NCT05424263|Chelating Agents|chelating agents|mesh-ancestor
91916965|NCT05424263|Sequestering Agents|sequestering agents|mesh-ancestor
91916966|NCT04787276|Rifaximin|rifaximin|mesh-list
91916967|NCT04787276|Lactulose|lactulose|mesh-list
91916968|NCT04787276|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91916969|NCT04787276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91916970|NCT04787276|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91916972|NCT01564979|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91916973|NCT01564979|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91916974|NCT01564979|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91916975|NCT01564979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91916976|NCT01564979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916977|NCT01564979|Cholinergic Agents|cholinergic agents|mesh-ancestor
91916978|NCT01564979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91916979|NCT01564979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916980|NCT01564979|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91916981|NCT01564979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91916982|NCT05613140|Valsartan|valsartan|mesh-list
91916983|NCT05613140|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91916984|NCT05613140|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91916985|NCT05613140|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91916986|NCT05613140|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91916987|NCT05613140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916988|NCT03547505|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
91916989|NCT03547505|Vasodilator Agents|vasodilator agents|mesh-ancestor
91916990|NCT03547505|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
91916991|NCT03547505|Protective Agents|protective agents|mesh-ancestor
91916992|NCT03547505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91916994|NCT05279183|Vasodilator Agents|vasodilator agents|mesh-ancestor
91916995|NCT04462952|Adavosertib|adavosertib|mesh-list
91916996|NCT04462952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91916997|NCT04462952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91916998|NCT04429022|Acetaminophen|acetaminophen|mesh-list
91916999|NCT04429022|Celecoxib|celecoxib|mesh-list
91917000|NCT04429022|Ketorolac|ketorolac|mesh-list
91917001|NCT04429022|Oxycodone|oxycodone|mesh-list
91917002|NCT04429022|Gabapentin|gabapentin|mesh-list
91917003|NCT04429022|Hydromorphone|hydromorphone|mesh-list
91917004|NCT04429022|Ropivacaine|ropivacaine|mesh-list
91917005|NCT04429022|Anesthetics, Local|anesthetics, local|mesh-list
91917006|NCT04429022|Anesthetics|anesthetics|mesh-list
91917007|NCT04429022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917008|NCT04429022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917009|NCT04429022|Sensory System Agents|sensory system agents|mesh-ancestor
91917010|NCT04429022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917011|NCT04429022|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917012|NCT04429022|Analgesics|analgesics|mesh-ancestor
91917013|NCT04429022|Antipyretics|antipyretics|mesh-ancestor
91917014|NCT04429022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91917015|NCT04429022|Narcotics|narcotics|mesh-ancestor
91917016|NCT04429022|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917017|NCT04429022|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917018|NCT04429022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917019|NCT04429022|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91917020|NCT04429022|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91917021|NCT04429022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917022|NCT04429022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917023|NCT04429022|Anticonvulsants|anticonvulsants|mesh-ancestor
91917024|NCT04429022|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91917025|NCT04429022|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91917026|NCT04429022|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917027|NCT04429022|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91917028|NCT04429022|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91917029|NCT04429022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917030|NCT04429022|Antimanic Agents|antimanic agents|mesh-ancestor
91917031|NCT02253485|Telbivudine|telbivudine|mesh-list
91917032|NCT02253485|Antiviral Agents|antiviral agents|mesh-ancestor
91917033|NCT02253485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917034|NCT02253485|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91917035|NCT02253485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917036|NCT02253485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917037|NCT05612516|Hydrogen Peroxide|hydrogen peroxide|mesh-list
91917038|NCT05612516|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91917039|NCT05612516|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917040|NCT02589626|Empagliflozin|empagliflozin|mesh-list
91917041|NCT02589626|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91917042|NCT02589626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917043|NCT02589626|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91917044|NCT02589626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917045|NCT04976036|Nintedanib|nintedanib|mesh-list
91917046|NCT04976036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917047|NCT04976036|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91917049|NCT04976036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917050|NCT05557604|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91917051|NCT05557604|Luteolytic Agents|luteolytic agents|mesh-ancestor
91917052|NCT05557604|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91917054|NCT05557604|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917055|NCT05557604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917056|NCT05557604|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91917057|NCT05557604|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91917058|NCT05557604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917059|NCT05556122|Betamethasone|betamethasone|mesh-list
91917060|NCT05556122|Ropivacaine|ropivacaine|mesh-list
91917061|NCT05556122|Anesthetics, Local|anesthetics, local|mesh-ancestor
91917062|NCT05556122|Anesthetics|anesthetics|mesh-ancestor
91917063|NCT05556122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917064|NCT05556122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917065|NCT05556122|Sensory System Agents|sensory system agents|mesh-ancestor
91917066|NCT05556122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917067|NCT05556122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917068|NCT05556122|Glucocorticoids|glucocorticoids|mesh-ancestor
91917069|NCT05556122|Hormones|hormones|mesh-ancestor
91917070|NCT05556122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917071|NCT05556122|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91917072|NCT05556122|Respiratory System Agents|respiratory system agents|mesh-ancestor
91917074|NCT05611268|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91917075|NCT05611268|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917076|NCT05611268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917077|NCT05611268|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91917078|NCT05611268|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91917079|NCT05611268|Protective Agents|protective agents|mesh-ancestor
91917080|NCT05611268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917081|NCT05611268|Vasodilator Agents|vasodilator agents|mesh-ancestor
91917082|NCT05611268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91917083|NCT05611268|Antioxidants|antioxidants|mesh-ancestor
91917084|NCT05549570|Metformin|metformin|mesh-list
91917085|NCT05549570|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91917086|NCT05549570|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91917087|NCT05549570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917088|NCT05549570|Incretins|incretins|mesh-ancestor
91917089|NCT05549570|Hormones|hormones|mesh-ancestor
91917090|NCT05549570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917091|NCT05549570|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91917092|NCT05549570|Protease Inhibitors|protease inhibitors|mesh-ancestor
91917093|NCT05549570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917094|NCT05549570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917095|NCT05549492|Buprenorphine|buprenorphine|mesh-list
91917096|NCT05549492|Ropivacaine|ropivacaine|mesh-list
91917097|NCT05549492|Anesthetics, Local|anesthetics, local|mesh-ancestor
91917098|NCT05549492|Anesthetics|anesthetics|mesh-ancestor
91917099|NCT05549492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917100|NCT05549492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917101|NCT05549492|Sensory System Agents|sensory system agents|mesh-ancestor
91917102|NCT05549492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917103|NCT05549492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91917104|NCT05549492|Narcotics|narcotics|mesh-ancestor
91917105|NCT05549492|Analgesics|analgesics|mesh-ancestor
91917106|NCT05549492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91917107|NCT04331132|Tolvaptan|tolvaptan|mesh-list
91917108|NCT04331132|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91917109|NCT04331132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917110|NCT04331132|Natriuretic Agents|natriuretic agents|mesh-ancestor
91917111|NCT04331132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917112|NCT05549336|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91917113|NCT05549336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917114|NCT05549336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917115|NCT05549336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917116|NCT04759274|Diuretics|diuretics|mesh-list
91917117|NCT04759274|Natriuretic Agents|natriuretic agents|mesh-ancestor
91917118|NCT04759274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917119|NCT05549024|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91917120|NCT05549024|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91917121|NCT05549024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917122|NCT01666730|Leucovorin|leucovorin|mesh-list
91917123|NCT01666730|Metformin|metformin|mesh-list
91917124|NCT01666730|Fluorouracil|fluorouracil|mesh-list
91917129|NCT01666730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917130|NCT01666730|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91917131|NCT01666730|Antimetabolites|antimetabolites|mesh-ancestor
91917132|NCT01666730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917133|NCT01666730|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91917134|NCT01666730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917135|NCT01666730|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917136|NCT01666730|Immunologic Factors|immunologic factors|mesh-ancestor
91917137|NCT01666730|Antidotes|antidotes|mesh-ancestor
91917138|NCT01666730|Protective Agents|protective agents|mesh-ancestor
91917139|NCT01666730|Vitamin B Complex|vitamin b complex|mesh-ancestor
91917140|NCT01666730|Vitamins|vitamins|mesh-ancestor
91917141|NCT01666730|Micronutrients|micronutrients|mesh-ancestor
91917142|NCT05554094|Psilocybin|psilocybin|mesh-list
91917143|NCT05554094|Hallucinogens|hallucinogens|mesh-ancestor
91917144|NCT05554094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917145|NCT05554094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917146|NCT04434560|Nivolumab|nivolumab|mesh-list
91917147|NCT04434560|Ipilimumab|ipilimumab|mesh-list
91917148|NCT04434560|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917149|NCT04434560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917150|NCT04434560|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91917151|NCT04434560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917152|NCT05700656|Capecitabine|capecitabine|mesh-list
91917153|NCT05700656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91917154|NCT05700656|Antimetabolites|antimetabolites|mesh-ancestor
91917155|NCT05700656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917156|NCT05700656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917157|NCT00103285|Calcium, Dietary|calcium, dietary|mesh-list
91917158|NCT00103285|Leucovorin|leucovorin|mesh-list
91917159|NCT00103285|Folic Acid|folic acid|mesh-list
91917160|NCT00103285|Cytarabine|cytarabine|mesh-list
91917161|NCT00103285|Dexamethasone|dexamethasone|mesh-list
91917163|NCT00103285|Cyclophosphamide|cyclophosphamide|mesh-list
91917164|NCT00103285|Doxorubicin|doxorubicin|mesh-list
91917165|NCT00103285|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91917166|NCT00103285|Methotrexate|methotrexate|mesh-list
91917167|NCT00103285|Vincristine|vincristine|mesh-list
91917168|NCT00103285|Asparaginase|asparaginase|mesh-list
91917169|NCT00103285|Mercaptopurine|mercaptopurine|mesh-list
91917170|NCT00103285|Pegaspargase|pegaspargase|mesh-list
91917171|NCT00103285|Thioguanine|thioguanine|mesh-list
91917172|NCT00103285|BB 1101|bb 1101|mesh-list
91917173|NCT00103285|Calcium|calcium|mesh-list
91917174|NCT00103285|2-Aminopurine|2-aminopurine|mesh-list
91917175|NCT00103285|Levoleucovorin|levoleucovorin|mesh-list
91917176|NCT00103285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917177|NCT00103285|Immunologic Factors|immunologic factors|mesh-ancestor
91917178|NCT00103285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917179|NCT00103285|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917180|NCT00103285|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91917181|NCT00103285|Alkylating Agents|alkylating agents|mesh-ancestor
91917182|NCT00103285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917183|NCT00103285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917184|NCT00103285|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91917185|NCT00103285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917186|NCT00103285|Antiemetics|antiemetics|mesh-ancestor
91917187|NCT00103285|Autonomic Agents|autonomic agents|mesh-ancestor
91917188|NCT00103285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917189|NCT00103285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917190|NCT00103285|Glucocorticoids|glucocorticoids|mesh-ancestor
91917191|NCT00103285|Hormones|hormones|mesh-ancestor
91917192|NCT00103285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917193|NCT00103285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91917194|NCT00103285|Protease Inhibitors|protease inhibitors|mesh-ancestor
91917195|NCT00103285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917196|NCT00103285|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91917197|NCT00103285|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91917198|NCT00103285|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91917199|NCT00103285|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91917200|NCT00103285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91917201|NCT00103285|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91917202|NCT00103285|Abortifacient Agents|abortifacient agents|mesh-ancestor
91917203|NCT00103285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917204|NCT00103285|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91917205|NCT00103285|Antimetabolites|antimetabolites|mesh-ancestor
91917206|NCT00103285|Dermatologic Agents|dermatologic agents|mesh-ancestor
91917207|NCT00103285|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91917208|NCT00103285|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91917209|NCT00103285|Antiviral Agents|antiviral agents|mesh-ancestor
91917210|NCT00103285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917211|NCT00103285|Antidotes|antidotes|mesh-ancestor
91917212|NCT00103285|Protective Agents|protective agents|mesh-ancestor
91917213|NCT00103285|Vitamin B Complex|vitamin b complex|mesh-ancestor
91917214|NCT00103285|Vitamins|vitamins|mesh-ancestor
91917215|NCT00103285|Micronutrients|micronutrients|mesh-ancestor
91917216|NCT00103285|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917217|NCT00103285|Tubulin Modulators|tubulin modulators|mesh-ancestor
91917218|NCT00103285|Antimitotic Agents|antimitotic agents|mesh-ancestor
91917219|NCT00103285|Mitosis Modulators|mitosis modulators|mesh-ancestor
91917220|NCT00103285|Hematinics|hematinics|mesh-ancestor
91917221|NCT03541915|Magnesium Sulfate|magnesium sulfate|mesh-list
91917222|NCT03541915|Analgesics|analgesics|mesh-ancestor
91917223|NCT03541915|Sensory System Agents|sensory system agents|mesh-ancestor
91917224|NCT03541915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917225|NCT03541915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917226|NCT03541915|Anesthetics|anesthetics|mesh-ancestor
91917227|NCT03541915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917228|NCT03541915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91917229|NCT03541915|Anticonvulsants|anticonvulsants|mesh-ancestor
91917230|NCT03541915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91917231|NCT03541915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917232|NCT03541915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917233|NCT03541915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91917234|NCT03541915|Tocolytic Agents|tocolytic agents|mesh-ancestor
91917235|NCT03541915|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917237|NCT03541837|Anesthetics, Local|anesthetics, local|mesh-ancestor
91917238|NCT03541837|Anesthetics|anesthetics|mesh-ancestor
91917239|NCT03541837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917240|NCT03541837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917241|NCT03541837|Sensory System Agents|sensory system agents|mesh-ancestor
91917242|NCT03541837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917244|NCT02158117|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91917245|NCT02158117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917246|NCT02158117|Sensory System Agents|sensory system agents|mesh-ancestor
91917247|NCT02158117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917248|NCT03541603|Simendan|simendan|mesh-list
91917249|NCT03541603|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91917250|NCT03541603|Vasodilator Agents|vasodilator agents|mesh-ancestor
91917251|NCT03541603|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91917252|NCT03541603|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91917253|NCT03541603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917254|NCT03541603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917255|NCT03541603|Protective Agents|protective agents|mesh-ancestor
91917256|NCT03541603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917257|NCT02160223|Neostigmine|neostigmine|mesh-list
91917258|NCT02160223|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91917259|NCT02160223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917260|NCT02160223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917261|NCT02160223|Cholinergic Agents|cholinergic agents|mesh-ancestor
91917262|NCT02160223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917263|NCT02160223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917264|NCT02160223|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91917265|NCT02160223|Autonomic Agents|autonomic agents|mesh-ancestor
91917266|NCT02160223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917267|NCT04802837|Vancomycin|vancomycin|mesh-list
91917268|NCT04802837|Ridinilazole|ridinilazole|mesh-list
91917269|NCT04802837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91917270|NCT04802837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917280|NCT02160301|Acetaminophen|acetaminophen|mesh-list
91917281|NCT02160301|Dexamethasone|dexamethasone|mesh-list
91917282|NCT02160301|Celecoxib|celecoxib|mesh-list
91917283|NCT02160301|Oxycodone|oxycodone|mesh-list
91917284|NCT02160301|Gabapentin|gabapentin|mesh-list
91917285|NCT02160301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917286|NCT02160301|Antiemetics|antiemetics|mesh-ancestor
91917287|NCT02160301|Autonomic Agents|autonomic agents|mesh-ancestor
91917288|NCT02160301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917289|NCT02160301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917290|NCT02160301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917291|NCT02160301|Glucocorticoids|glucocorticoids|mesh-ancestor
91917292|NCT02160301|Hormones|hormones|mesh-ancestor
91917293|NCT02160301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917294|NCT02160301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91917295|NCT02160301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917296|NCT02160301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917297|NCT02160301|Analgesics|analgesics|mesh-ancestor
91917298|NCT02160301|Sensory System Agents|sensory system agents|mesh-ancestor
91917299|NCT02160301|Antipyretics|antipyretics|mesh-ancestor
91917301|NCT02160301|Narcotics|narcotics|mesh-ancestor
91917302|NCT02160301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917303|NCT02160301|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917304|NCT02160301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917305|NCT02160301|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91917306|NCT02160301|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91917307|NCT02160301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917308|NCT02160301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917309|NCT02160301|Anticonvulsants|anticonvulsants|mesh-ancestor
91917310|NCT02160301|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91917311|NCT02160301|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91917312|NCT02160301|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917313|NCT02160301|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91917314|NCT02160301|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91917315|NCT02160301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917316|NCT02160301|Antimanic Agents|antimanic agents|mesh-ancestor
91917317|NCT03541759|Hydromorphone|hydromorphone|mesh-list
91917318|NCT03541759|Pirinitramide|pirinitramide|mesh-list
91917319|NCT03541759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91917320|NCT03541759|Narcotics|narcotics|mesh-ancestor
91917321|NCT03541759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917322|NCT03541759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917323|NCT03541759|Analgesics|analgesics|mesh-ancestor
91917324|NCT03541759|Sensory System Agents|sensory system agents|mesh-ancestor
91917325|NCT03541759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917326|NCT05206955|Tadalafil|tadalafil|mesh-list
91917327|NCT05206955|Vasodilator Agents|vasodilator agents|mesh-ancestor
91917328|NCT05206955|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91917329|NCT05206955|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91917330|NCT05206955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917331|NCT05206955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917332|NCT05206955|Urological Agents|urological agents|mesh-ancestor
91917333|NCT01666652|Aluminum Hydroxide|aluminum hydroxide|mesh-list
91917334|NCT01666652|Aluminum sulfate|aluminum sulfate|mesh-list
91917335|NCT01666652|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91917336|NCT01666652|Immunologic Factors|immunologic factors|mesh-ancestor
91917337|NCT01666652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917338|NCT01666652|Antacids|antacids|mesh-ancestor
91917339|NCT01666652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917340|NCT01666652|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917341|NCT05174585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91917342|NCT05174585|Pembrolizumab|pembrolizumab|mesh-list
91917343|NCT05174585|Antibodies|antibodies|mesh-list
91917344|NCT05174585|Immunoglobulins|immunoglobulins|mesh-list
91917345|NCT05174585|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91917346|NCT05174585|Immunologic Factors|immunologic factors|mesh-ancestor
91917347|NCT05174585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917348|NCT05174585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917349|NCT05174585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91917350|NCT05174585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917351|NCT04428086|Metformin|metformin|mesh-list
91917352|NCT04428086|Apatinib|apatinib|mesh-list
91917353|NCT04428086|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91917354|NCT04428086|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91917355|NCT04428086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917356|NCT04428086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91917357|NCT04428086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91917358|NCT04428086|Antimetabolites|antimetabolites|mesh-ancestor
91943030|NCT03867201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917359|NCT04428086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917360|NCT04428086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91917361|NCT04428086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91917362|NCT04428086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917363|NCT04428086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917364|NCT04428086|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91917365|NCT05125055|Paclitaxel|paclitaxel|mesh-list
91917366|NCT05125055|Docetaxel|docetaxel|mesh-list
91917367|NCT05125055|Fluorouracil|fluorouracil|mesh-list
91917368|NCT05125055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917369|NCT05125055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917370|NCT05125055|Tubulin Modulators|tubulin modulators|mesh-ancestor
91917373|NCT05125055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917374|NCT05125055|Antimetabolites|antimetabolites|mesh-ancestor
91917375|NCT05125055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91917376|NCT05125055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917377|NCT05125055|Immunologic Factors|immunologic factors|mesh-ancestor
91917378|NCT05125055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917379|NCT04355858|Paclitaxel|paclitaxel|mesh-list
91917380|NCT04355858|Capecitabine|capecitabine|mesh-list
91917381|NCT04355858|Everolimus|everolimus|mesh-list
91917382|NCT04355858|Fluzoparib|fluzoparib|mesh-list
91917383|NCT04355858|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917384|NCT04355858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917385|NCT04355858|Tubulin Modulators|tubulin modulators|mesh-ancestor
91917386|NCT04355858|Antimitotic Agents|antimitotic agents|mesh-ancestor
91917387|NCT04355858|Mitosis Modulators|mitosis modulators|mesh-ancestor
91917388|NCT04355858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917389|NCT04355858|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91917390|NCT04355858|Antimetabolites|antimetabolites|mesh-ancestor
91917391|NCT04355858|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91917392|NCT04355858|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91917393|NCT04355858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917394|NCT04355858|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917395|NCT04355858|Immunologic Factors|immunologic factors|mesh-ancestor
91917396|NCT04355858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917397|NCT04355858|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91917398|NCT05610956|Empagliflozin|empagliflozin|mesh-list
91917399|NCT05610956|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91917400|NCT05610956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917401|NCT05610956|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91917402|NCT05610956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917403|NCT00109733|Hormones|hormones|mesh-list
91917404|NCT00109733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917405|NCT00109733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917406|NCT05699876|Gabapentin|gabapentin|mesh-list
91917407|NCT05699876|Melatonin|melatonin|mesh-list
91917408|NCT05699876|Analgesics|analgesics|mesh-ancestor
91917409|NCT05699876|Sensory System Agents|sensory system agents|mesh-ancestor
91917410|NCT05699876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917411|NCT05699876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917412|NCT05699876|Anticonvulsants|anticonvulsants|mesh-ancestor
91917413|NCT05699876|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91917414|NCT05699876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91917415|NCT05699876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917416|NCT05699876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917417|NCT05699876|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91917418|NCT05699876|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91917419|NCT05699876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917420|NCT05699876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917421|NCT05699876|Antimanic Agents|antimanic agents|mesh-ancestor
91917422|NCT05699876|Antioxidants|antioxidants|mesh-ancestor
91917423|NCT05699876|Protective Agents|protective agents|mesh-ancestor
91917424|NCT05610878|Curcumin|curcumin|mesh-list
91917425|NCT05610878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917426|NCT05610878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917427|NCT05610878|Analgesics|analgesics|mesh-ancestor
91917428|NCT05610878|Sensory System Agents|sensory system agents|mesh-ancestor
91917429|NCT05610878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917430|NCT05610878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917431|NCT05610878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917432|NCT05610878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917433|NCT05610878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917434|NCT05610878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917435|NCT05610878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917436|NCT02706405|Cyclophosphamide|cyclophosphamide|mesh-list
91917437|NCT02706405|Fludarabine|fludarabine|mesh-list
91917438|NCT02706405|Durvalumab|durvalumab|mesh-list
91917439|NCT02706405|Immunoglobulins|immunoglobulins|mesh-list
91917440|NCT02706405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91917441|NCT02706405|Immunoglobulin G|immunoglobulin g|mesh-list
91917442|NCT02706405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917443|NCT02706405|Immunologic Factors|immunologic factors|mesh-ancestor
91917444|NCT02706405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917445|NCT02706405|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917446|NCT02706405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91917447|NCT02706405|Alkylating Agents|alkylating agents|mesh-ancestor
91917448|NCT02706405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917449|NCT02706405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917450|NCT02706405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91917451|NCT02706405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917453|NCT02254031|Bivatuzumab mertansine|bivatuzumab mertansine|mesh-list
91917454|NCT02254031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917455|NCT02254031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917456|NCT02254031|Tubulin Modulators|tubulin modulators|mesh-ancestor
91917457|NCT02254031|Antimitotic Agents|antimitotic agents|mesh-ancestor
91917458|NCT02254031|Mitosis Modulators|mitosis modulators|mesh-ancestor
91917459|NCT02254031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917460|NCT02254031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917461|NCT02254031|Immunotoxins|immunotoxins|mesh-ancestor
91917462|NCT02254031|Immunoconjugates|immunoconjugates|mesh-ancestor
91917463|NCT02254031|Immunologic Factors|immunologic factors|mesh-ancestor
91917464|NCT02254031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917465|NCT03545711|Irinotecan|irinotecan|mesh-list
91917466|NCT03545711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91917467|NCT03545711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91917468|NCT03545711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917469|NCT03545711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917470|NCT03545711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917471|NCT03546959|Botulinum Toxins|botulinum toxins|mesh-list
91917472|NCT03546959|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91917473|NCT03546959|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917474|NCT03546959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917475|NCT03546959|Cholinergic Agents|cholinergic agents|mesh-ancestor
91917476|NCT03546959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917477|NCT03546959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917478|NCT03998813|Ropivacaine|ropivacaine|mesh-list
91917479|NCT03998813|Anesthetics, Local|anesthetics, local|mesh-ancestor
91917480|NCT03998813|Anesthetics|anesthetics|mesh-ancestor
91917481|NCT03998813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917482|NCT03998813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917483|NCT03998813|Sensory System Agents|sensory system agents|mesh-ancestor
91917484|NCT03998813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917485|NCT01569659|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
91917486|NCT01569659|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91917487|NCT01569659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91917488|NCT01569659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917489|NCT01569659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917490|NCT01569659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917491|NCT01569659|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91917492|NCT01569659|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91917493|NCT01569659|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91917494|NCT01569659|Adrenergic Agents|adrenergic agents|mesh-ancestor
91917495|NCT01569659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917496|NCT01569659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917497|NCT01569659|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91917498|NCT01569659|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91917499|NCT01569659|Serotonin Agents|serotonin agents|mesh-ancestor
91917500|NCT01569659|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91917501|NCT01569659|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91917502|NCT01569659|Dopamine Agents|dopamine agents|mesh-ancestor
91917503|NCT02253953|Ritonavir|ritonavir|mesh-list
91917504|NCT02253953|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91917505|NCT02253953|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91917506|NCT02253953|Protease Inhibitors|protease inhibitors|mesh-ancestor
91917507|NCT02253953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917508|NCT02253953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917509|NCT02253953|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91917510|NCT02253953|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91917511|NCT02253953|Antiviral Agents|antiviral agents|mesh-ancestor
91917512|NCT02253953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917513|NCT02253953|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92074238|NCT00072514|Dexamethasone|dexamethasone|mesh-list
91917514|NCT02253953|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91917515|NCT03546803|Protective Agents|protective agents|mesh-list
91917516|NCT03546803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917517|NCT02422953|Micronutrients|micronutrients|mesh-list
91917518|NCT02422953|Trace Elements|trace elements|mesh-list
91917519|NCT02422953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917520|NCT04053140|Penicillins|penicillins|mesh-list
91917522|NCT04053140|Penicillin G Benzathine|penicillin g benzathine|mesh-list
91917523|NCT04053140|Penicillin G Procaine|penicillin g procaine|mesh-list
91917524|NCT04053140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91917525|NCT04053140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917526|NCT03713879|Indomethacin|indomethacin|mesh-list
91917527|NCT03713879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917528|NCT03713879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917529|NCT03713879|Analgesics|analgesics|mesh-ancestor
91917530|NCT03713879|Sensory System Agents|sensory system agents|mesh-ancestor
91917531|NCT03713879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917532|NCT03713879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917533|NCT03713879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917534|NCT03713879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917535|NCT03713879|Gout Suppressants|gout suppressants|mesh-ancestor
91917536|NCT03713879|Tocolytic Agents|tocolytic agents|mesh-ancestor
91917537|NCT03713879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917538|NCT03713879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91917539|NCT03713879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917540|NCT03713879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917542|NCT03107169|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91917543|NCT03107169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917544|NCT05552300|Antihypertensive Agents|antihypertensive agents|mesh-list
91917545|NCT05064059|Pembrolizumab|pembrolizumab|mesh-list
91917546|NCT05064059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917547|NCT05064059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917548|NCT05064059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91917549|NCT05064059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917550|NCT02425605|Sorafenib|sorafenib|mesh-list
91917551|NCT02425605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917552|NCT02425605|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91917553|NCT02425605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917554|NCT02425605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917555|NCT02422563|Paclitaxel|paclitaxel|mesh-list
91917556|NCT02422563|Carboplatin|carboplatin|mesh-list
91917557|NCT02422563|Ifosfamide|ifosfamide|mesh-list
91917558|NCT02422563|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917559|NCT02422563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917560|NCT02422563|Tubulin Modulators|tubulin modulators|mesh-ancestor
91917561|NCT02422563|Antimitotic Agents|antimitotic agents|mesh-ancestor
91917562|NCT02422563|Mitosis Modulators|mitosis modulators|mesh-ancestor
91917563|NCT02422563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917564|NCT02422563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91917565|NCT02422563|Alkylating Agents|alkylating agents|mesh-ancestor
91917566|NCT03185403|Sufentanil|sufentanil|mesh-list
91917567|NCT03185403|Ropivacaine|ropivacaine|mesh-list
91917568|NCT03185403|Anesthetics, Local|anesthetics, local|mesh-ancestor
91917569|NCT03185403|Anesthetics|anesthetics|mesh-ancestor
91917570|NCT03185403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917571|NCT03185403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917572|NCT03185403|Sensory System Agents|sensory system agents|mesh-ancestor
91917573|NCT03185403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917574|NCT03185403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91917575|NCT03185403|Narcotics|narcotics|mesh-ancestor
91917576|NCT03185403|Analgesics|analgesics|mesh-ancestor
91917577|NCT03185403|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91917578|NCT03185403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91917579|NCT03185403|Anesthetics, General|anesthetics, general|mesh-ancestor
91917580|NCT04329806|Amlodipine|amlodipine|mesh-list
91917581|NCT04329806|Moxonidine|moxonidine|mesh-list
91917582|NCT04329806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91917583|NCT04329806|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91917584|NCT04329806|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917585|NCT04329806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917586|NCT04329806|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91917587|NCT04329806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917589|NCT03635021|Bevacizumab|bevacizumab|mesh-list
91917590|NCT03635021|Panitumumab|panitumumab|mesh-list
91917591|NCT03635021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917592|NCT03635021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917593|NCT03635021|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91917594|NCT03635021|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91917595|NCT03635021|Growth Substances|growth substances|mesh-ancestor
91917596|NCT03635021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917597|NCT03635021|Growth Inhibitors|growth inhibitors|mesh-ancestor
91917598|NCT02422485|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
91917599|NCT02422485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917600|NCT02422485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917601|NCT02422485|Analgesics|analgesics|mesh-ancestor
91917602|NCT02422485|Sensory System Agents|sensory system agents|mesh-ancestor
91917603|NCT02422485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917604|NCT02422485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917605|NCT02422485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917606|NCT02422485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917607|NCT05551910|Remifentanil|remifentanil|mesh-list
91917608|NCT05551910|Propofol|propofol|mesh-list
91917609|NCT05551910|Esketamine|esketamine|mesh-list
91917610|NCT05551910|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91917611|NCT05551910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917612|NCT05551910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917613|NCT05551910|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91917614|NCT05551910|Anesthetics, General|anesthetics, general|mesh-ancestor
91917615|NCT05551910|Anesthetics|anesthetics|mesh-ancestor
91917616|NCT05551910|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91917617|NCT05551910|Narcotics|narcotics|mesh-ancestor
91917618|NCT05551910|Analgesics|analgesics|mesh-ancestor
91917619|NCT05551910|Sensory System Agents|sensory system agents|mesh-ancestor
91917620|NCT05551910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917621|NCT05551910|Antidepressive Agents|antidepressive agents|mesh-ancestor
91917622|NCT05551910|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917623|NCT05699720|Magnesium Sulfate|magnesium sulfate|mesh-list
91917624|NCT05699720|Analgesics|analgesics|mesh-ancestor
91917625|NCT05699720|Sensory System Agents|sensory system agents|mesh-ancestor
91917626|NCT05699720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917627|NCT05699720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917628|NCT05699720|Anesthetics|anesthetics|mesh-ancestor
91917629|NCT05699720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917630|NCT05699720|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91917631|NCT05699720|Anticonvulsants|anticonvulsants|mesh-ancestor
91917632|NCT05699720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91917633|NCT05699720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917634|NCT05699720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917635|NCT05699720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91917636|NCT05699720|Tocolytic Agents|tocolytic agents|mesh-ancestor
91917637|NCT05699720|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917638|NCT05546762|Povidone-Iodine|povidone-iodine|mesh-list
91917639|NCT05546762|Povidone|povidone|mesh-list
91917640|NCT05546762|Plasma Substitutes|plasma substitutes|mesh-ancestor
91917641|NCT05546762|Blood Substitutes|blood substitutes|mesh-ancestor
91917642|NCT05546762|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91917643|NCT05546762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917644|NCT03863288|Oxytocin|oxytocin|mesh-list
91917645|NCT03863288|Oxytocics|oxytocics|mesh-ancestor
91917646|NCT03863288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917647|NCT03863288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917648|NCT03535883|Anticoagulants|anticoagulants|mesh-list
91917649|NCT03535883|Coagulants|coagulants|mesh-list
91917650|NCT05551598|Mitoxantrone|mitoxantrone|mesh-list
91917651|NCT05551598|Analgesics|analgesics|mesh-ancestor
91917652|NCT05551598|Sensory System Agents|sensory system agents|mesh-ancestor
91917653|NCT05551598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917654|NCT05551598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917655|NCT05551598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917656|NCT05551598|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91917657|NCT05551598|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91917658|NCT05551598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917659|NCT05551598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917660|NCT03810794|Donepezil|donepezil|mesh-list
91917661|NCT03810794|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91917662|NCT03810794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917663|NCT03810794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917664|NCT03810794|Cholinergic Agents|cholinergic agents|mesh-ancestor
91917665|NCT03810794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917666|NCT03810794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917667|NCT03810794|Nootropic Agents|nootropic agents|mesh-ancestor
91917668|NCT03185793|Benzbromarone|benzbromarone|mesh-list
91917669|NCT03185793|Uricosuric Agents|uricosuric agents|mesh-ancestor
91917670|NCT03185793|Gout Suppressants|gout suppressants|mesh-ancestor
91917671|NCT03185793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917672|NCT03660488|Penicillins|penicillins|mesh-list
91917674|NCT03660488|Penicillin G|penicillin g|mesh-list
91917675|NCT03660488|Penicillin G Benzathine|penicillin g benzathine|mesh-list
91917676|NCT03660488|Penicillin G Procaine|penicillin g procaine|mesh-list
91917677|NCT03660488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91917678|NCT03660488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917679|NCT02422017|Timolol|timolol|mesh-list
91917680|NCT02422017|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91917681|NCT02422017|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91917682|NCT02422017|Adrenergic Agents|adrenergic agents|mesh-ancestor
91917683|NCT02422017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917684|NCT02422017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917685|NCT02422017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917686|NCT02422017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91917687|NCT02422017|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91917688|NCT02761915|Cyclophosphamide|cyclophosphamide|mesh-list
91917689|NCT02761915|Fludarabine|fludarabine|mesh-list
91917690|NCT02761915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917691|NCT02761915|Immunologic Factors|immunologic factors|mesh-ancestor
91917692|NCT02761915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917693|NCT02761915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917694|NCT02761915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91917695|NCT02761915|Alkylating Agents|alkylating agents|mesh-ancestor
91917696|NCT02761915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917697|NCT02761915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917698|NCT02761915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91917699|NCT03464084|Melatonin|melatonin|mesh-list
91917700|NCT03464084|Antioxidants|antioxidants|mesh-ancestor
91917701|NCT03464084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917702|NCT03464084|Protective Agents|protective agents|mesh-ancestor
91917703|NCT03464084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917704|NCT03464084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917705|NCT05551208|Bevacizumab|bevacizumab|mesh-list
91917706|NCT05551208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917707|NCT05551208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917708|NCT05551208|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91917709|NCT05551208|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91917710|NCT05551208|Growth Substances|growth substances|mesh-ancestor
91917711|NCT05551208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917712|NCT05551208|Growth Inhibitors|growth inhibitors|mesh-ancestor
91917713|NCT02764333|Durvalumab|durvalumab|mesh-list
91917714|NCT02764333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917715|NCT02764333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917716|NCT02161159|Botulinum Toxins|botulinum toxins|mesh-list
91917717|NCT02161159|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91917718|NCT02161159|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91917719|NCT02161159|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91917720|NCT02161159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917721|NCT02161159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917722|NCT02161159|Cholinergic Agents|cholinergic agents|mesh-ancestor
91917723|NCT02161159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917724|NCT02161159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917725|NCT02161159|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91917726|NCT02161159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917727|NCT02160925|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
91917728|NCT02160925|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91917729|NCT02160925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917730|NCT02161237|Tacrolimus|tacrolimus|mesh-list
91917731|NCT02161237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917732|NCT02161237|Immunologic Factors|immunologic factors|mesh-ancestor
91917733|NCT02161237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917734|NCT02161237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91917735|NCT02161237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917736|NCT02161237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917737|NCT03173066|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91917739|NCT03173066|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91917740|NCT03173066|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91917741|NCT05546060|Dexamethasone|dexamethasone|mesh-list
91917742|NCT05546060|Etoposide|etoposide|mesh-list
91917743|NCT05546060|Venetoclax|venetoclax|mesh-list
91917744|NCT05546060|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917745|NCT05546060|Antiemetics|antiemetics|mesh-ancestor
91917746|NCT05546060|Autonomic Agents|autonomic agents|mesh-ancestor
91917747|NCT05546060|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917748|NCT05546060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917749|NCT05546060|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917750|NCT05546060|Glucocorticoids|glucocorticoids|mesh-ancestor
91917752|NCT05546060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917753|NCT05546060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91917754|NCT05546060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917755|NCT05546060|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917756|NCT05546060|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91917757|NCT05546060|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91917758|NCT05546060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917759|NCT05546060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917760|NCT02416869|Dexamethasone|dexamethasone|mesh-list
91917761|NCT02416869|Dexamethasone acetate|dexamethasone acetate|mesh-list
91917762|NCT02416869|BB 1101|bb 1101|mesh-list
91917763|NCT02416869|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917764|NCT02416869|Antiemetics|antiemetics|mesh-ancestor
91917765|NCT02416869|Autonomic Agents|autonomic agents|mesh-ancestor
91917766|NCT02416869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917767|NCT02416869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917768|NCT02416869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917769|NCT02416869|Glucocorticoids|glucocorticoids|mesh-ancestor
91917771|NCT02416869|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917772|NCT02416869|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91917773|NCT02416869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917774|NCT02416869|Protease Inhibitors|protease inhibitors|mesh-ancestor
91917775|NCT02416869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917776|NCT02416869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917777|NCT02588612|Cyclophosphamide|cyclophosphamide|mesh-list
91917778|NCT02588612|Fludarabine|fludarabine|mesh-list
91917779|NCT02588612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91917780|NCT02588612|Immunologic Factors|immunologic factors|mesh-ancestor
91917781|NCT02588612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917782|NCT02588612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917783|NCT02588612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91917784|NCT02588612|Alkylating Agents|alkylating agents|mesh-ancestor
91917785|NCT02588612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917786|NCT02588612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917787|NCT02588612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91917788|NCT02161939|Sofosbuvir|sofosbuvir|mesh-list
91917789|NCT02161939|Antiviral Agents|antiviral agents|mesh-ancestor
91917790|NCT02161939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917791|NCT03540979|Letrozole|letrozole|mesh-list
91917792|NCT03540979|Progesterone|progesterone|mesh-list
91917793|NCT03540979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917794|NCT03540979|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91917795|NCT03540979|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91917796|NCT03540979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917797|NCT03540979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917798|NCT03540979|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91917799|NCT03540979|Hormone Antagonists|hormone antagonists|mesh-ancestor
91917800|NCT03540979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917801|NCT03540979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917802|NCT03540979|Progestins|progestins|mesh-ancestor
91917803|NCT03540979|Hormones|hormones|mesh-ancestor
91917804|NCT02946788|Minocycline|minocycline|mesh-list
91917805|NCT02946788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91917806|NCT02946788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917807|NCT02159131|Cabotegravir|cabotegravir|mesh-list
91917808|NCT02159131|Levonorgestrel|levonorgestrel|mesh-list
91917809|NCT02159131|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91917810|NCT02159131|Contraceptive Agents|contraceptive agents|mesh-ancestor
91917811|NCT02159131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91917812|NCT02159131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917813|NCT02159131|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91917814|NCT02159131|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91917815|NCT02159131|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91917816|NCT02159131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91917817|NCT02159131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91917818|NCT02159131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917819|NCT02159131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917820|NCT02159131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91917821|NCT02159131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91917822|NCT02159131|Antiviral Agents|antiviral agents|mesh-ancestor
91917823|NCT02159131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917824|NCT05550506|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91917825|NCT05550506|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91917826|NCT05550506|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91917827|NCT05550506|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917828|NCT05550506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917829|NCT05550506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917830|NCT05550506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917831|NCT05550506|Analgesics|analgesics|mesh-ancestor
91917832|NCT05550506|Sensory System Agents|sensory system agents|mesh-ancestor
91917833|NCT05550506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917834|NCT05550506|Antidepressive Agents|antidepressive agents|mesh-ancestor
91917835|NCT05550506|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917836|NCT05550506|Dopamine Agents|dopamine agents|mesh-ancestor
91917838|NCT03174795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91917839|NCT03174795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917840|NCT02163655|Furosemide|furosemide|mesh-list
91917841|NCT02163655|Diuretics|diuretics|mesh-ancestor
91917842|NCT02163655|Natriuretic Agents|natriuretic agents|mesh-ancestor
91917843|NCT02163655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917844|NCT02163655|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91917845|NCT02163655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917846|NCT02163655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917847|NCT02410083|Aspirin|aspirin|mesh-list
91917848|NCT02410083|Clopidogrel|clopidogrel|mesh-list
91917849|NCT02410083|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917850|NCT02410083|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917851|NCT02410083|Analgesics|analgesics|mesh-ancestor
91917852|NCT02410083|Sensory System Agents|sensory system agents|mesh-ancestor
91917853|NCT02410083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917854|NCT02410083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917855|NCT02410083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917856|NCT02410083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917857|NCT02410083|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91917858|NCT02410083|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91917859|NCT02410083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917860|NCT02410083|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91917861|NCT02410083|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91917862|NCT02410083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917863|NCT02410083|Antipyretics|antipyretics|mesh-ancestor
91917864|NCT02410083|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91917865|NCT02410083|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91917866|NCT02410083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91917867|NCT02410083|Purinergic Agents|purinergic agents|mesh-ancestor
91917868|NCT02410083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917869|NCT02416245|Micronutrients|micronutrients|mesh-list
91917870|NCT02416245|Trace Elements|trace elements|mesh-list
91917871|NCT02416245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917872|NCT02416167|Dotinurad|dotinurad|mesh-list
91917873|NCT02416167|Uricosuric Agents|uricosuric agents|mesh-ancestor
91917874|NCT02416167|Gout Suppressants|gout suppressants|mesh-ancestor
91917875|NCT02416167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917876|NCT01463072|Paclitaxel|paclitaxel|mesh-list
91917877|NCT01463072|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91917878|NCT01463072|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91917879|NCT01463072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917880|NCT01463072|Tubulin Modulators|tubulin modulators|mesh-ancestor
91917881|NCT01463072|Antimitotic Agents|antimitotic agents|mesh-ancestor
91917882|NCT01463072|Mitosis Modulators|mitosis modulators|mesh-ancestor
91917883|NCT01463072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917884|NCT02166853|Midazolam|midazolam|mesh-list
91917885|NCT02166853|Sevoflurane|sevoflurane|mesh-list
91917886|NCT02166853|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91917887|NCT02166853|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91917888|NCT02166853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91917889|NCT02166853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917890|NCT02166853|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91917891|NCT02166853|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91917892|NCT02166853|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91917893|NCT02166853|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91917894|NCT02166853|Anesthetics, General|anesthetics, general|mesh-ancestor
91917896|NCT02166853|GABA Modulators|gaba modulators|mesh-ancestor
91917897|NCT02166853|GABA Agents|gaba agents|mesh-ancestor
91917898|NCT02166853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917899|NCT02166853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917900|NCT02166853|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91917901|NCT02166853|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91917902|NCT02162251|Donepezil|donepezil|mesh-list
91917903|NCT02162251|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91917904|NCT02162251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917905|NCT02162251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917906|NCT02162251|Cholinergic Agents|cholinergic agents|mesh-ancestor
91917907|NCT02162251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91917908|NCT02162251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917909|NCT02162251|Nootropic Agents|nootropic agents|mesh-ancestor
91917910|NCT02164045|Fostemsavir|fostemsavir|mesh-list
91917911|NCT02164045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91917912|NCT02164045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91917913|NCT02164045|Antiviral Agents|antiviral agents|mesh-ancestor
91917914|NCT02164045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91917915|NCT02164045|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91917916|NCT02164045|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91917917|NCT02164045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917918|NCT02410005|Calcitriol|calcitriol|mesh-list
91917919|NCT02410005|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
91917920|NCT02410005|Losartan|losartan|mesh-list
91917921|NCT02410005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91917922|NCT02410005|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91917923|NCT02410005|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91917924|NCT02410005|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91917925|NCT02410005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917926|NCT02410005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91917927|NCT02410005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917928|NCT02410005|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
91917929|NCT02410005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91917930|NCT02410005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91917931|NCT02410005|Vitamins|vitamins|mesh-ancestor
91917932|NCT02410005|Micronutrients|micronutrients|mesh-ancestor
91917933|NCT02410005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91917934|NCT05543330|Cisplatin|cisplatin|mesh-list
91917935|NCT05543330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917936|NCT03174561|Choline|choline|mesh-list
91917937|NCT03174561|Silymarin|silymarin|mesh-list
91917938|NCT03174561|Lipotropic Agents|lipotropic agents|mesh-ancestor
91917939|NCT03174561|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91917940|NCT03174561|Antimetabolites|antimetabolites|mesh-ancestor
91917941|NCT03174561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917942|NCT03174561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917943|NCT03174561|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91917944|NCT03174561|Nootropic Agents|nootropic agents|mesh-ancestor
91917945|NCT03174561|Antioxidants|antioxidants|mesh-ancestor
91917946|NCT03174561|Protective Agents|protective agents|mesh-ancestor
91917947|NCT03174561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917949|NCT05545592|Hormones|hormones|mesh-ancestor
91917950|NCT05545592|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91917951|NCT05545592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917952|NCT05545436|Capecitabine|capecitabine|mesh-list
91917953|NCT05545436|Oxaliplatin|oxaliplatin|mesh-list
91917954|NCT05545436|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91917955|NCT05545436|Antimetabolites|antimetabolites|mesh-ancestor
91917956|NCT05545436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917957|NCT05545436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917958|NCT02167165|Digoxin|digoxin|mesh-list
91917959|NCT02167165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91917960|NCT02167165|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91917961|NCT02167165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917962|NCT02167165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917963|NCT02167165|Protective Agents|protective agents|mesh-ancestor
91917964|NCT02167165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917965|NCT05545124|Tislelizumab|tislelizumab|mesh-list
91917966|NCT05545124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91917967|NCT05545124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917968|NCT02409849|Octreotide|octreotide|mesh-list
91917969|NCT02409849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91917970|NCT02409849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91917971|NCT02409849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91917972|NCT00664040|Aspirin|aspirin|mesh-list
91917973|NCT00664040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91917974|NCT00664040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91917975|NCT00664040|Analgesics|analgesics|mesh-ancestor
91917976|NCT00664040|Sensory System Agents|sensory system agents|mesh-ancestor
91917977|NCT00664040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91917978|NCT00664040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917979|NCT00664040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917980|NCT00664040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91917982|NCT00664040|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91917983|NCT00664040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91917984|NCT00664040|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91917985|NCT00664040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91917986|NCT00664040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91917987|NCT00664040|Antipyretics|antipyretics|mesh-ancestor
91917988|NCT02162407|Insulin|insulin|mesh-list
91917989|NCT02162407|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91917990|NCT02162407|Insulin Detemir|insulin detemir|mesh-list
91917991|NCT02162407|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91917992|NCT02162407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91917993|NCT02162485|Fluticasone|fluticasone|mesh-list
91917995|NCT02162485|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91917996|NCT02162485|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91917997|NCT02162485|Charcoal|charcoal|mesh-list
91917998|NCT02162485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91917999|NCT02162485|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91918000|NCT02162485|Autonomic Agents|autonomic agents|mesh-ancestor
91918001|NCT02162485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918002|NCT02162485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918003|NCT02162485|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91918004|NCT02162485|Respiratory System Agents|respiratory system agents|mesh-ancestor
91918005|NCT02162485|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918006|NCT02162485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91918007|NCT02162485|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91918008|NCT02162485|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91918009|NCT02162485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91918010|NCT02162485|Adrenergic Agents|adrenergic agents|mesh-ancestor
91918011|NCT02162485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918012|NCT02162485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918013|NCT02162485|Glucocorticoids|glucocorticoids|mesh-ancestor
91918014|NCT02162485|Hormones|hormones|mesh-ancestor
91918015|NCT02162485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918016|NCT02162485|Sympathomimetics|sympathomimetics|mesh-ancestor
91918017|NCT02162485|Antidotes|antidotes|mesh-ancestor
91918018|NCT02162485|Protective Agents|protective agents|mesh-ancestor
91918019|NCT02415777|Riboflavin|riboflavin|mesh-list
91918020|NCT02415777|Thiamine|thiamine|mesh-list
91918021|NCT02415777|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91918022|NCT02415777|Vitamin B Complex|vitamin b complex|mesh-ancestor
91918023|NCT02415777|Vitamins|vitamins|mesh-ancestor
91918024|NCT02415777|Micronutrients|micronutrients|mesh-ancestor
91918025|NCT02415777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918026|NCT02415777|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91918027|NCT02415777|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918028|NCT02415777|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91918029|NCT02415777|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91918030|NCT05544968|Antibodies|antibodies|mesh-list
91918031|NCT05544968|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91918032|NCT05544968|Immunologic Factors|immunologic factors|mesh-ancestor
91918033|NCT05544968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918034|NCT03178539|Diclofenac|diclofenac|mesh-list
91918035|NCT03178539|Ketorolac|ketorolac|mesh-list
91918036|NCT03178539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918037|NCT03178539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918038|NCT03178539|Analgesics|analgesics|mesh-ancestor
91918039|NCT03178539|Sensory System Agents|sensory system agents|mesh-ancestor
91918040|NCT03178539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918041|NCT03178539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918042|NCT03178539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918043|NCT03178539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918044|NCT03178539|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918045|NCT03178539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918046|NCT03178539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918047|NCT03174483|Fluticasone|fluticasone|mesh-list
91918048|NCT03174483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918049|NCT03174483|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91918050|NCT03174483|Autonomic Agents|autonomic agents|mesh-ancestor
91918051|NCT03174483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918052|NCT03174483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918053|NCT03174483|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91918054|NCT03174483|Respiratory System Agents|respiratory system agents|mesh-ancestor
91918055|NCT03174483|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918056|NCT03174483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91918057|NCT05699174|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91918058|NCT05699174|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91918059|NCT05699174|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918060|NCT05699174|Antitubercular Agents|antitubercular agents|mesh-ancestor
91918061|NCT04320914|Ibuprofen|ibuprofen|mesh-list
91918062|NCT04320914|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918063|NCT04320914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918064|NCT04320914|Analgesics|analgesics|mesh-ancestor
91918065|NCT04320914|Sensory System Agents|sensory system agents|mesh-ancestor
91918067|NCT04320914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918068|NCT04320914|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918069|NCT04320914|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918070|NCT04320914|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918071|NCT04320914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918072|NCT04320914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918073|NCT05544812|Cetuximab|cetuximab|mesh-list
91918074|NCT05544812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91918075|NCT05544812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918076|NCT02415699|Leucovorin|leucovorin|mesh-list
91918077|NCT02415699|Fluorouracil|fluorouracil|mesh-list
91918078|NCT02415699|Oxaliplatin|oxaliplatin|mesh-list
91918079|NCT02415699|Antimetabolites|antimetabolites|mesh-ancestor
91918080|NCT02415699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918081|NCT02415699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91918082|NCT02415699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918083|NCT02415699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918084|NCT02415699|Immunologic Factors|immunologic factors|mesh-ancestor
91918085|NCT02415699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918086|NCT02415699|Antidotes|antidotes|mesh-ancestor
91918087|NCT02415699|Protective Agents|protective agents|mesh-ancestor
91918088|NCT02415699|Vitamin B Complex|vitamin b complex|mesh-ancestor
91918089|NCT02415699|Vitamins|vitamins|mesh-ancestor
91918090|NCT02415699|Micronutrients|micronutrients|mesh-ancestor
91918091|NCT05544656|Tolperisone|tolperisone|mesh-list
91918092|NCT05544656|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91918093|NCT05544656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918094|NCT05544656|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91918095|NCT05544656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918097|NCT02409537|Antioxidants|antioxidants|mesh-ancestor
91918098|NCT02409537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918099|NCT02409537|Protective Agents|protective agents|mesh-ancestor
91918100|NCT02409537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918101|NCT02409537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918102|NCT02409537|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91918103|NCT03177993|Ivermectin|ivermectin|mesh-list
91918104|NCT03177993|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91918105|NCT03177993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918106|NCT04425590|Aspirin|aspirin|mesh-list
91918107|NCT04425590|Atorvastatin|atorvastatin|mesh-list
91918108|NCT04425590|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918109|NCT04425590|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918110|NCT04425590|Analgesics|analgesics|mesh-ancestor
91918111|NCT04425590|Sensory System Agents|sensory system agents|mesh-ancestor
91918112|NCT04425590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918113|NCT04425590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918114|NCT04425590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918115|NCT04425590|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918116|NCT04425590|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91918117|NCT04425590|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91918118|NCT04425590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918119|NCT04425590|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91918120|NCT04425590|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918121|NCT04425590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918122|NCT04425590|Antipyretics|antipyretics|mesh-ancestor
91918123|NCT04425590|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91918124|NCT04425590|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91918126|NCT04425590|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91918127|NCT04425590|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91918128|NCT00707889|Leucovorin|leucovorin|mesh-list
91918129|NCT00707889|Folic Acid|folic acid|mesh-list
91918130|NCT00707889|Bevacizumab|bevacizumab|mesh-list
91918131|NCT00707889|Fluorouracil|fluorouracil|mesh-list
91918132|NCT00707889|Oxaliplatin|oxaliplatin|mesh-list
91918133|NCT00707889|Levoleucovorin|levoleucovorin|mesh-list
91918134|NCT00707889|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91918135|NCT00707889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918136|NCT00707889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91918137|NCT00707889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91918138|NCT00707889|Growth Substances|growth substances|mesh-ancestor
91918293|NCT02408289|Procyanidin|procyanidin|mesh-list
91918139|NCT00707889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918140|NCT00707889|Growth Inhibitors|growth inhibitors|mesh-ancestor
91918141|NCT00707889|Antimetabolites|antimetabolites|mesh-ancestor
91918142|NCT00707889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918143|NCT00707889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91918144|NCT00707889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918145|NCT00707889|Immunologic Factors|immunologic factors|mesh-ancestor
91918146|NCT00707889|Antidotes|antidotes|mesh-ancestor
91918147|NCT00707889|Protective Agents|protective agents|mesh-ancestor
91918148|NCT00707889|Vitamin B Complex|vitamin b complex|mesh-ancestor
91918149|NCT00707889|Vitamins|vitamins|mesh-ancestor
91918150|NCT00707889|Micronutrients|micronutrients|mesh-ancestor
91918151|NCT00707889|Hematinics|hematinics|mesh-ancestor
91918152|NCT00109031|Cyclophosphamide|cyclophosphamide|mesh-list
91918153|NCT00109031|Etoposide|etoposide|mesh-list
91918154|NCT00109031|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918155|NCT00109031|Immunologic Factors|immunologic factors|mesh-ancestor
91918156|NCT00109031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918157|NCT00109031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918158|NCT00109031|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91918159|NCT00109031|Alkylating Agents|alkylating agents|mesh-ancestor
91918160|NCT00109031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918161|NCT00109031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918162|NCT00109031|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91918163|NCT00109031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91918164|NCT00109031|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91918165|NCT00109031|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91918166|NCT00109031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918167|NCT02419443|Gabapentin|gabapentin|mesh-list
91918168|NCT02419443|Analgesics|analgesics|mesh-ancestor
91918169|NCT02419443|Sensory System Agents|sensory system agents|mesh-ancestor
91918170|NCT02419443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943049|NCT03699319|Leucovorin|leucovorin|mesh-list
91918171|NCT02419443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918172|NCT02419443|Anticonvulsants|anticonvulsants|mesh-ancestor
91918173|NCT02419443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91918174|NCT02419443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91918175|NCT02419443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918176|NCT02419443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91918177|NCT02419443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91918178|NCT02419443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91918179|NCT02419443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918180|NCT02419443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918181|NCT02419443|Antimanic Agents|antimanic agents|mesh-ancestor
91918183|NCT02409147|Prednisone|prednisone|mesh-list
91918184|NCT02409147|Thymoglobulin|thymoglobulin|mesh-list
91918185|NCT02409147|Basiliximab|basiliximab|mesh-list
91918186|NCT02409147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918187|NCT02409147|Glucocorticoids|glucocorticoids|mesh-ancestor
91918188|NCT02409147|Hormones|hormones|mesh-ancestor
91918189|NCT02409147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918190|NCT02409147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918191|NCT02409147|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91918192|NCT02409147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918193|NCT02409147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918194|NCT02409147|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918195|NCT02409147|Immunologic Factors|immunologic factors|mesh-ancestor
91918196|NCT02409147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91918197|NCT02409147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918198|NCT02409147|Antifungal Agents|antifungal agents|mesh-ancestor
91918199|NCT02409147|Ionophores|ionophores|mesh-ancestor
91918200|NCT02409147|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918201|NCT05017103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91918202|NCT05017103|Antibodies|antibodies|mesh-list
91918203|NCT05017103|Immunoglobulins|immunoglobulins|mesh-list
91918204|NCT05017103|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91918205|NCT05017103|Immunologic Factors|immunologic factors|mesh-ancestor
91918206|NCT05017103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918207|NCT05017103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918208|NCT02414919|Levonorgestrel|levonorgestrel|mesh-list
91918209|NCT02414919|Etonogestrel|etonogestrel|mesh-list
91918210|NCT02414919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91918211|NCT02414919|Contraceptive Agents|contraceptive agents|mesh-ancestor
91918212|NCT02414919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918213|NCT02414919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918214|NCT02414919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91918215|NCT02414919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91918216|NCT02414919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91918217|NCT05005559|Myeloma Proteins|myeloma proteins|mesh-list
91918218|NCT05005559|Paraproteins|paraproteins|mesh-list
91918219|NCT05005559|Immunologic Factors|immunologic factors|mesh-ancestor
91918220|NCT05005559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918221|NCT05543954|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91918222|NCT05543954|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91918223|NCT05543954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918224|NCT02408679|Vitamin D|vitamin d|mesh-list
91918225|NCT02408679|Vitamins|vitamins|mesh-ancestor
91918226|NCT02408679|Micronutrients|micronutrients|mesh-ancestor
91918227|NCT02408679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918228|NCT02408679|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91918229|NCT04486781|Pembrolizumab|pembrolizumab|mesh-list
91918230|NCT04486781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91918231|NCT04486781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918232|NCT04486781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91918233|NCT04486781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918234|NCT05089565|Interferons|interferons|mesh-list
91918235|NCT05089565|Interferon-gamma|interferon-gamma|mesh-list
91918236|NCT05089565|Antibodies|antibodies|mesh-list
91918237|NCT05089565|Immunoglobulin G|immunoglobulin g|mesh-list
91918238|NCT05089565|Immunologic Factors|immunologic factors|mesh-ancestor
91918239|NCT05089565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918240|NCT05089565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918241|NCT05089565|Antiviral Agents|antiviral agents|mesh-ancestor
91918242|NCT05089565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918243|NCT03174171|Everolimus|everolimus|mesh-list
91918244|NCT03174171|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91918245|NCT03174171|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91918246|NCT03174171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918247|NCT03174171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918248|NCT03174171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918249|NCT03174171|Immunologic Factors|immunologic factors|mesh-ancestor
91918250|NCT03174171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918251|NCT03174171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918253|NCT02414529|Ergocalciferols|ergocalciferols|mesh-list
91918254|NCT02414529|Cholecalciferol|cholecalciferol|mesh-list
91918255|NCT02414529|Vitamins|vitamins|mesh-list
91918256|NCT02414529|Micronutrients|micronutrients|mesh-ancestor
91918257|NCT02414529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918258|NCT02414529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91918259|NCT02414529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91918260|NCT02418273|Denosumab|denosumab|mesh-list
91918261|NCT02418273|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91918262|NCT02418273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918263|NCT02414685|Paclitaxel|paclitaxel|mesh-list
91918264|NCT02414685|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91918265|NCT02414685|Cisplatin|cisplatin|mesh-list
91918266|NCT02414685|Ifosfamide|ifosfamide|mesh-list
91918267|NCT02414685|Isophosphamide mustard|isophosphamide mustard|mesh-list
91918268|NCT02414685|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91918269|NCT02414685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918270|NCT02414685|Tubulin Modulators|tubulin modulators|mesh-ancestor
91918271|NCT02414685|Antimitotic Agents|antimitotic agents|mesh-ancestor
91918272|NCT02414685|Mitosis Modulators|mitosis modulators|mesh-ancestor
91918273|NCT02414685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918274|NCT02414685|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91918275|NCT02414685|Alkylating Agents|alkylating agents|mesh-ancestor
91918276|NCT04425824|Rituximab|rituximab|mesh-list
91918277|NCT04425824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91918279|NCT04425824|Immunologic Factors|immunologic factors|mesh-ancestor
91918280|NCT04425824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918281|NCT04425824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918282|NCT02414451|Propranolol|propranolol|mesh-list
91918283|NCT02414451|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91918284|NCT02414451|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91918285|NCT02414451|Adrenergic Agents|adrenergic agents|mesh-ancestor
91918286|NCT02414451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918287|NCT02414451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918288|NCT02414451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918289|NCT02414451|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91918290|NCT02414451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91918291|NCT02414451|Vasodilator Agents|vasodilator agents|mesh-ancestor
91918292|NCT02408289|Proanthocyanidin|proanthocyanidin|mesh-list
91918295|NCT02408289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918296|NCT02408289|Protective Agents|protective agents|mesh-ancestor
91918297|NCT02408289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918298|NCT02408289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91918299|NCT02408289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91918300|NCT02408289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918301|NCT02417883|Furosemide|furosemide|mesh-list
91918302|NCT02417883|Diuretics|diuretics|mesh-ancestor
91918303|NCT02417883|Natriuretic Agents|natriuretic agents|mesh-ancestor
91918304|NCT02417883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918305|NCT02417883|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91918306|NCT02417883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918307|NCT02417883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918309|NCT01664624|Alogliptin|alogliptin|mesh-list
91918310|NCT01664624|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91918311|NCT01664624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918312|NCT01664624|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91918313|NCT01664624|Incretins|incretins|mesh-ancestor
91918314|NCT01664624|Hormones|hormones|mesh-ancestor
91918315|NCT01664624|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918316|NCT01664624|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91918317|NCT01664624|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918318|NCT01664624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918319|NCT01664624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918320|NCT03173781|Droxidopa|droxidopa|mesh-list
91918321|NCT03173781|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91918322|NCT03173781|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91918323|NCT05540834|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91918324|NCT05540834|Plasminogen|plasminogen|mesh-list
91918325|NCT05540834|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91918326|NCT05540834|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91918327|NCT05540834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918328|NCT05696132|Povidone-Iodine|povidone-iodine|mesh-list
91918329|NCT05696132|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91918330|NCT05696132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918332|NCT02407899|Cholecalciferol|cholecalciferol|mesh-list
91918333|NCT02407899|Insulin|insulin|mesh-list
91918334|NCT02407899|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91918335|NCT02407899|Metformin|metformin|mesh-list
91918336|NCT02407899|Saxagliptin|saxagliptin|mesh-list
91918337|NCT02407899|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
91918338|NCT02407899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91918339|NCT02407899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918340|NCT02407899|Vitamins|vitamins|mesh-ancestor
91918341|NCT02407899|Micronutrients|micronutrients|mesh-ancestor
91918342|NCT02407899|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91918343|NCT02407899|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91918344|NCT02407899|Incretins|incretins|mesh-ancestor
91918345|NCT02407899|Hormones|hormones|mesh-ancestor
91918346|NCT02407899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918347|NCT02407899|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918348|NCT02407899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918349|NCT02407899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918350|NCT02417493|Epinephrine|epinephrine|mesh-list
91918351|NCT02417493|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91918352|NCT02417493|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91918353|NCT02417493|Adrenergic Agents|adrenergic agents|mesh-ancestor
91918354|NCT02417493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918355|NCT02417493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918356|NCT02417493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918357|NCT02417493|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91918358|NCT02417493|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91918359|NCT02417493|Autonomic Agents|autonomic agents|mesh-ancestor
91918360|NCT02417493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918361|NCT02417493|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91918362|NCT02417493|Respiratory System Agents|respiratory system agents|mesh-ancestor
91918363|NCT02417493|Mydriatics|mydriatics|mesh-ancestor
91918364|NCT02417493|Sympathomimetics|sympathomimetics|mesh-ancestor
91918365|NCT02417493|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91918366|NCT05540600|Digoxin|digoxin|mesh-list
91918367|NCT05540600|Bisoprolol|bisoprolol|mesh-list
91918368|NCT05540600|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91918369|NCT05540600|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91918371|NCT05540600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918372|NCT05540600|Protective Agents|protective agents|mesh-ancestor
91918373|NCT05540600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918374|NCT05540600|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91918375|NCT05540600|Sympatholytics|sympatholytics|mesh-ancestor
91918376|NCT05540600|Autonomic Agents|autonomic agents|mesh-ancestor
91918377|NCT05540600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918378|NCT05540600|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91918379|NCT05540600|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91918380|NCT05540600|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91918381|NCT05540600|Adrenergic Agents|adrenergic agents|mesh-ancestor
91918382|NCT05540600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918383|NCT02417649|Broncho-Vaxom|broncho-vaxom|mesh-list
91918384|NCT02417649|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91918385|NCT02417649|Immunologic Factors|immunologic factors|mesh-ancestor
91918386|NCT02417649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918387|NCT03265574|Enalapril|enalapril|mesh-list
91918388|NCT03265574|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91918389|NCT03265574|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918390|NCT03265574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918391|NCT03265574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918392|NCT03265574|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91918393|NCT03177837|Acetazolamide|acetazolamide|mesh-list
91918394|NCT03177837|Anticonvulsants|anticonvulsants|mesh-ancestor
91918395|NCT03177837|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91918396|NCT03177837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918397|NCT03177837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918398|NCT03177837|Diuretics|diuretics|mesh-ancestor
91918399|NCT03177837|Natriuretic Agents|natriuretic agents|mesh-ancestor
91918400|NCT03177837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918401|NCT02414373|Bupivacaine|bupivacaine|mesh-list
91918402|NCT02414373|Ropivacaine|ropivacaine|mesh-list
91918403|NCT02414373|Anesthetics, Local|anesthetics, local|mesh-ancestor
91918404|NCT02414373|Anesthetics|anesthetics|mesh-ancestor
91918405|NCT02414373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918406|NCT02414373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918407|NCT02414373|Sensory System Agents|sensory system agents|mesh-ancestor
91918408|NCT02414373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918409|NCT04320290|Antiviral Agents|antiviral agents|mesh-list
91918410|NCT04320290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918411|NCT03173235|Vitamin D|vitamin d|mesh-list
91918412|NCT03173235|Vitamins|vitamins|mesh-ancestor
91918413|NCT03173235|Micronutrients|micronutrients|mesh-ancestor
91918414|NCT03173235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918415|NCT03173235|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91918416|NCT05697692|Heparin|heparin|mesh-list
91918417|NCT05697692|Calcium heparin|calcium heparin|mesh-list
91918418|NCT05697692|Anticoagulants|anticoagulants|mesh-ancestor
91918419|NCT05697692|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91918420|NCT05697692|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91918421|NCT05697692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918422|NCT02761057|Sunitinib|sunitinib|mesh-list
91918423|NCT02761057|Crizotinib|crizotinib|mesh-list
91918424|NCT02761057|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91918425|NCT02761057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918426|NCT02761057|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91918427|NCT02761057|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91918428|NCT02761057|Growth Substances|growth substances|mesh-ancestor
91918429|NCT02761057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918430|NCT02761057|Growth Inhibitors|growth inhibitors|mesh-ancestor
91918431|NCT02761057|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91918432|NCT02761057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918433|NCT02761057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918434|NCT02407821|Escitalopram|escitalopram|mesh-list
91918435|NCT02407821|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91918436|NCT02407821|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91918437|NCT02407821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918438|NCT02407821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918439|NCT02407821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918440|NCT02407821|Serotonin Agents|serotonin agents|mesh-ancestor
91918441|NCT02407821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918442|NCT02164357|Fibrinolytic Agents|fibrinolytic agents|mesh-list
91918443|NCT02164357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91918444|NCT02164357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918445|NCT02417337|Acetaminophen|acetaminophen|mesh-list
91918447|NCT02417337|Diclofenac|diclofenac|mesh-list
91918448|NCT02417337|Mefenamic Acid|mefenamic acid|mesh-list
91918449|NCT02417337|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918450|NCT02417337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918451|NCT02417337|Analgesics|analgesics|mesh-ancestor
91918452|NCT02417337|Sensory System Agents|sensory system agents|mesh-ancestor
91918453|NCT02417337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918454|NCT02417337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918455|NCT02417337|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918456|NCT02417337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918457|NCT02417337|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918458|NCT02417337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918459|NCT02417337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918460|NCT02417337|Antipyretics|antipyretics|mesh-ancestor
91918461|NCT02167321|Leucovorin|leucovorin|mesh-list
91918462|NCT02167321|Fluorouracil|fluorouracil|mesh-list
91918463|NCT02167321|Oxaliplatin|oxaliplatin|mesh-list
91918464|NCT02167321|Antimetabolites|antimetabolites|mesh-ancestor
91918465|NCT02167321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918466|NCT02167321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91918467|NCT02167321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918468|NCT02167321|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918469|NCT02167321|Immunologic Factors|immunologic factors|mesh-ancestor
91918470|NCT02167321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918471|NCT02167321|Antidotes|antidotes|mesh-ancestor
91918472|NCT02167321|Protective Agents|protective agents|mesh-ancestor
91918473|NCT02167321|Vitamin B Complex|vitamin b complex|mesh-ancestor
91918475|NCT02167321|Micronutrients|micronutrients|mesh-ancestor
91918477|NCT02162797|Trace Elements|trace elements|mesh-ancestor
91918478|NCT02162797|Micronutrients|micronutrients|mesh-ancestor
91918479|NCT02162797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918480|NCT02162875|Praziquantel|praziquantel|mesh-list
91918481|NCT02162875|Anthelmintics|anthelmintics|mesh-ancestor
91918482|NCT02162875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91918483|NCT02162875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918484|NCT02167633|Pantoprazole|pantoprazole|mesh-list
91918485|NCT02167633|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91918486|NCT02167633|Glucocorticoids|glucocorticoids|mesh-list
91918487|NCT02167633|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91918488|NCT02167633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91918489|NCT02167633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918490|NCT02167633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918491|NCT02167633|Hormones|hormones|mesh-ancestor
91918492|NCT02167633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918493|NCT02167633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918494|NCT02413281|Buprenorphine|buprenorphine|mesh-list
91918495|NCT02413281|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91918496|NCT02413281|Narcotics|narcotics|mesh-ancestor
91918497|NCT02413281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918498|NCT02413281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918499|NCT02413281|Analgesics|analgesics|mesh-ancestor
91918500|NCT02413281|Sensory System Agents|sensory system agents|mesh-ancestor
91918501|NCT02413281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918502|NCT02413281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91918503|NCT02170909|Dabigatran|dabigatran|mesh-list
91918504|NCT02170909|Antithrombins|antithrombins|mesh-ancestor
91918505|NCT02170909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91918506|NCT02170909|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918507|NCT02170909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918508|NCT02170909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918509|NCT02170909|Anticoagulants|anticoagulants|mesh-ancestor
91918511|NCT02164825|Ropivacaine|ropivacaine|mesh-list
91918512|NCT02164825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91918513|NCT02164825|Narcotics|narcotics|mesh-ancestor
91918514|NCT02164825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918515|NCT02164825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918516|NCT02164825|Analgesics|analgesics|mesh-ancestor
91918517|NCT02164825|Sensory System Agents|sensory system agents|mesh-ancestor
91918518|NCT02164825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918519|NCT02164825|Anesthetics, Local|anesthetics, local|mesh-ancestor
91918520|NCT02164825|Anesthetics|anesthetics|mesh-ancestor
91918521|NCT02170987|Moxifloxacin|moxifloxacin|mesh-list
91918522|NCT02170987|Dabigatran|dabigatran|mesh-list
91918523|NCT02170987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91918524|NCT02170987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918525|NCT02170987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91918526|NCT02170987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91918527|NCT02170987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918528|NCT02170987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918529|NCT02170987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918530|NCT02170987|Antithrombins|antithrombins|mesh-ancestor
91918531|NCT02170987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91918532|NCT02170987|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918533|NCT02170987|Anticoagulants|anticoagulants|mesh-ancestor
91918534|NCT03176121|Oxycodone|oxycodone|mesh-list
91918535|NCT03176121|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91918536|NCT03176121|Narcotics|narcotics|mesh-ancestor
91918537|NCT03176121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918538|NCT03176121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918539|NCT03176121|Analgesics|analgesics|mesh-ancestor
91918540|NCT03176121|Sensory System Agents|sensory system agents|mesh-ancestor
91918541|NCT03176121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918542|NCT02261155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
91918543|NCT02261155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074239|NCT00072514|Rituximab|rituximab|mesh-list
91918544|NCT02261155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918546|NCT02171143|Immunoconjugates|immunoconjugates|mesh-ancestor
91918547|NCT02171143|Immunologic Factors|immunologic factors|mesh-ancestor
91918548|NCT02171143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918549|NCT03176199|Oxycodone|oxycodone|mesh-list
91918550|NCT03176199|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91918551|NCT03176199|Narcotics|narcotics|mesh-ancestor
91918552|NCT03176199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918553|NCT03176199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918554|NCT03176199|Analgesics|analgesics|mesh-ancestor
91918555|NCT03176199|Sensory System Agents|sensory system agents|mesh-ancestor
91918556|NCT03176199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918557|NCT05697614|Lamotrigine|lamotrigine|mesh-list
91918558|NCT05697614|Carbamazepine|carbamazepine|mesh-list
91918559|NCT05697614|Phenytoin|phenytoin|mesh-list
91918560|NCT05697614|Oxcarbazepine|oxcarbazepine|mesh-list
91918561|NCT05697614|Valproic Acid|valproic acid|mesh-list
91918562|NCT05697614|Clobazam|clobazam|mesh-list
91918563|NCT05697614|Anticonvulsants|anticonvulsants|mesh-ancestor
91918564|NCT05697614|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91918565|NCT05697614|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918566|NCT05697614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918567|NCT05697614|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91918568|NCT05697614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918569|NCT05697614|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91918570|NCT05697614|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91918571|NCT05697614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918572|NCT05697614|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91918573|NCT05697614|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91918574|NCT05697614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918575|NCT05697614|GABA Agents|gaba agents|mesh-ancestor
91918576|NCT05697614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918577|NCT05697614|Antimanic Agents|antimanic agents|mesh-ancestor
91918578|NCT05697614|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918579|NCT05697614|Analgesics|analgesics|mesh-ancestor
91918580|NCT05697614|Sensory System Agents|sensory system agents|mesh-ancestor
91918581|NCT05697614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918582|NCT05697614|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91918583|NCT05697614|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91918584|NCT05697614|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91918585|NCT05697614|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91918586|NCT05697614|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91918587|NCT05697614|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91918588|NCT05697614|GABA Agonists|gaba agonists|mesh-ancestor
91918589|NCT02171221|DFP-11207|dfp-11207|mesh-list
91918590|NCT02171221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91918591|NCT02171221|Antimetabolites|antimetabolites|mesh-ancestor
91918592|NCT02171221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918593|NCT02171221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918594|NCT02413515|Nifedipine|nifedipine|mesh-list
91918595|NCT02413515|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91918596|NCT02413515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918597|NCT02413515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918598|NCT02413515|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91918599|NCT02413515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918600|NCT02413515|Vasodilator Agents|vasodilator agents|mesh-ancestor
91918601|NCT02413515|Tocolytic Agents|tocolytic agents|mesh-ancestor
91918602|NCT02413515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918603|NCT03194906|Memantine|memantine|mesh-list
91918604|NCT03194906|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91918605|NCT03194906|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91918606|NCT03194906|Dopamine Agents|dopamine agents|mesh-ancestor
91918607|NCT03194906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918608|NCT03194906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918609|NCT03194906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918610|NCT03194906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91918611|NCT03194906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91918612|NCT03171987|Flurbiprofen|flurbiprofen|mesh-list
91918614|NCT03171987|Anesthetics, Local|anesthetics, local|mesh-ancestor
91918615|NCT03171987|Anesthetics|anesthetics|mesh-ancestor
91918616|NCT03171987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918617|NCT03171987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918618|NCT03171987|Sensory System Agents|sensory system agents|mesh-ancestor
91918619|NCT03171987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918620|NCT03171987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91918621|NCT03171987|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91918622|NCT03171987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91918623|NCT03171987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918624|NCT03171987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918625|NCT03171987|Analgesics|analgesics|mesh-ancestor
91918626|NCT03171987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918627|NCT03171987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918628|NCT03171987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918629|NCT03171987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918630|NCT03171987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918631|NCT03171987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918632|NCT05540288|Nalmefene|nalmefene|mesh-list
91918633|NCT05540288|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91918634|NCT05540288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918635|NCT05540288|Sensory System Agents|sensory system agents|mesh-ancestor
91918636|NCT05540288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918637|NCT03172065|Dexmedetomidine|dexmedetomidine|mesh-list
91918638|NCT03172065|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91918639|NCT03172065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918640|NCT03172065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918641|NCT03172065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918642|NCT03172065|Analgesics|analgesics|mesh-ancestor
91918643|NCT03172065|Sensory System Agents|sensory system agents|mesh-ancestor
91918644|NCT03172065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918645|NCT03172065|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91918646|NCT03172065|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91918647|NCT03172065|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91918648|NCT03172065|Adrenergic Agents|adrenergic agents|mesh-ancestor
91918649|NCT03172065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918650|NCT03172065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918651|NCT02171299|Ropivacaine|ropivacaine|mesh-list
91918652|NCT02171299|Anesthetics, Local|anesthetics, local|mesh-list
91918653|NCT02171299|Anesthetics|anesthetics|mesh-list
91918654|NCT02171299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918656|NCT02171299|Sensory System Agents|sensory system agents|mesh-ancestor
91918657|NCT02171299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918658|NCT03171831|Mycophenolic Acid|mycophenolic acid|mesh-list
91918659|NCT03171831|Cyclophosphamide|cyclophosphamide|mesh-list
91918660|NCT03171831|Busulfan|busulfan|mesh-list
91918661|NCT03171831|Methotrexate|methotrexate|mesh-list
91918662|NCT03171831|Fludarabine|fludarabine|mesh-list
91918663|NCT03171831|Tacrolimus|tacrolimus|mesh-list
91918664|NCT03171831|Thymoglobulin|thymoglobulin|mesh-list
91918665|NCT03171831|Basiliximab|basiliximab|mesh-list
91918666|NCT03171831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918667|NCT03171831|Immunologic Factors|immunologic factors|mesh-ancestor
91918668|NCT03171831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918669|NCT03171831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918670|NCT03171831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91918671|NCT03171831|Alkylating Agents|alkylating agents|mesh-ancestor
91918672|NCT03171831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918673|NCT03171831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918674|NCT03171831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92074240|NCT00072514|Carboplatin|carboplatin|mesh-list
91918675|NCT03171831|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91918676|NCT03171831|Abortifacient Agents|abortifacient agents|mesh-ancestor
91918677|NCT03171831|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918678|NCT03171831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91918680|NCT03171831|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918682|NCT03171831|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91918683|NCT03171831|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91918684|NCT03171831|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91918685|NCT03171831|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91918686|NCT03171831|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91918687|NCT03171831|Antitubercular Agents|antitubercular agents|mesh-ancestor
91918688|NCT03171831|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91918689|NCT03171831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918691|NCT02171455|Antithrombins|antithrombins|mesh-ancestor
91918692|NCT02171455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91918694|NCT02171455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918695|NCT02171455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918696|NCT02171455|Anticoagulants|anticoagulants|mesh-ancestor
91918697|NCT02171533|Verapamil|verapamil|mesh-list
91918698|NCT02171533|Dabigatran|dabigatran|mesh-list
91918699|NCT02171533|Antithrombins|antithrombins|mesh-ancestor
91918700|NCT02171533|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91918701|NCT02171533|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918702|NCT02171533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918703|NCT02171533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918704|NCT02171533|Anticoagulants|anticoagulants|mesh-ancestor
91918705|NCT02171533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91918706|NCT02171533|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91918707|NCT02171533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91918708|NCT02171533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91918709|NCT02171533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918710|NCT02171533|Vasodilator Agents|vasodilator agents|mesh-ancestor
91918711|NCT04482543|Methotrexate|methotrexate|mesh-list
91918712|NCT04482543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91918713|NCT04482543|Abortifacient Agents|abortifacient agents|mesh-ancestor
91918714|NCT04482543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918715|NCT04482543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918716|NCT04482543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91918717|NCT04482543|Antimetabolites|antimetabolites|mesh-ancestor
91918718|NCT04482543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918719|NCT04482543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918720|NCT04482543|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918721|NCT04482543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918722|NCT04482543|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91918723|NCT04482543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918724|NCT04482543|Immunologic Factors|immunologic factors|mesh-ancestor
91918725|NCT04482543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918726|NCT04482543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91918727|NCT04728230|Carboplatin|carboplatin|mesh-list
91918728|NCT04728230|Etoposide|etoposide|mesh-list
91918729|NCT04728230|Etoposide phosphate|etoposide phosphate|mesh-list
91918731|NCT04728230|Olaparib|olaparib|mesh-list
91918732|NCT04728230|Podophyllotoxin|podophyllotoxin|mesh-list
91918733|NCT04728230|Immunoglobulins|immunoglobulins|mesh-list
91918734|NCT04728230|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91918735|NCT04728230|Immunoglobulin G|immunoglobulin g|mesh-list
91918736|NCT04728230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918737|NCT04728230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91918738|NCT04728230|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91918739|NCT04728230|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91918740|NCT04728230|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918741|NCT04728230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918742|NCT04728230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91918743|NCT04728230|Immunologic Factors|immunologic factors|mesh-ancestor
91918744|NCT04728230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918745|NCT04728230|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91918746|NCT04728230|Keratolytic Agents|keratolytic agents|mesh-ancestor
91918747|NCT04728230|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918748|NCT04728230|Tubulin Modulators|tubulin modulators|mesh-ancestor
91918749|NCT04728230|Antimitotic Agents|antimitotic agents|mesh-ancestor
91918750|NCT04728230|Mitosis Modulators|mitosis modulators|mesh-ancestor
91918751|NCT02406183|Ipilimumab|ipilimumab|mesh-list
91918752|NCT02406183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91918753|NCT02406183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918754|NCT02406183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91918755|NCT02406183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918756|NCT04723472|Cefuroxime|cefuroxime|mesh-list
91918757|NCT04723472|Cefuroxime axetil|cefuroxime axetil|mesh-list
91918758|NCT04723472|Bismuth|bismuth|mesh-list
91918759|NCT04723472|Antacids|antacids|mesh-ancestor
91918760|NCT04723472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918761|NCT04723472|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91918762|NCT04723472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91918763|NCT04723472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918764|NCT02412813|Cobalt|cobalt|mesh-list
91918765|NCT02412813|Trace Elements|trace elements|mesh-ancestor
91918766|NCT02412813|Micronutrients|micronutrients|mesh-ancestor
91918767|NCT02412813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918768|NCT03116295|Opicapone|opicapone|mesh-list
91918769|NCT03116295|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
91918770|NCT03116295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918771|NCT03116295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918772|NCT03116295|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91918773|NCT03116295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91918774|NCT02405715|Oxytocin|oxytocin|mesh-list
91918775|NCT02405715|Oxytocics|oxytocics|mesh-ancestor
91918776|NCT02405715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918777|NCT02405715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918778|NCT02412423|Cyclophosphamide|cyclophosphamide|mesh-list
91918779|NCT02412423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918780|NCT02412423|Immunologic Factors|immunologic factors|mesh-ancestor
91918781|NCT02412423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918782|NCT02412423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918783|NCT02412423|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91918784|NCT02412423|Alkylating Agents|alkylating agents|mesh-ancestor
91918785|NCT02412423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918786|NCT02412423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918787|NCT02412423|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91918788|NCT02412345|Alprostadil|alprostadil|mesh-list
91918789|NCT02412345|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91918790|NCT02412345|Vasodilator Agents|vasodilator agents|mesh-ancestor
91918791|NCT02412345|Urological Agents|urological agents|mesh-ancestor
91918792|NCT05679050|Folfirinox|folfirinox|mesh-list
91918793|NCT05679050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918794|NCT02412267|Carboplatin|carboplatin|mesh-list
91918795|NCT02412267|Etoposide|etoposide|mesh-list
91918796|NCT02412267|Ifosfamide|ifosfamide|mesh-list
91918797|NCT02412267|Ofatumumab|ofatumumab|mesh-list
91918798|NCT02412267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918799|NCT02412267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91918800|NCT02412267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91918801|NCT02412267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91918802|NCT02412267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918803|NCT02412267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918804|NCT02412267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91918805|NCT02412267|Alkylating Agents|alkylating agents|mesh-ancestor
91918806|NCT03172455|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
91918807|NCT03172455|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91918808|NCT03172455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91918809|NCT03172455|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918810|NCT03172455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918811|NCT03172455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918812|NCT03171597|Vasodilator Agents|vasodilator agents|mesh-list
91918813|NCT03171597|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91918814|NCT03171597|Lipid Regulating Agents|lipid regulating agents|mesh-list
91918815|NCT05698394|Esketamine|esketamine|mesh-list
91918816|NCT05698394|Antidepressive Agents|antidepressive agents|mesh-ancestor
91918818|NCT05539118|Interferons|interferons|mesh-list
91918819|NCT05539118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918820|NCT05539118|Antiviral Agents|antiviral agents|mesh-ancestor
91918821|NCT05539118|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918822|NCT02405793|Meloxicam|meloxicam|mesh-list
91918823|NCT02405793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918824|NCT02405793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918826|NCT02405793|Sensory System Agents|sensory system agents|mesh-ancestor
91918827|NCT02405793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918828|NCT02405793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918829|NCT02405793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918830|NCT02405793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918831|NCT02405793|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91918832|NCT02405793|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918833|NCT02405793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918834|NCT02405793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918835|NCT05695664|Ibuprofen|ibuprofen|mesh-list
91918836|NCT05695664|Ketorolac|ketorolac|mesh-list
91918837|NCT05695664|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918838|NCT05695664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918839|NCT05695664|Analgesics|analgesics|mesh-ancestor
91918840|NCT05695664|Sensory System Agents|sensory system agents|mesh-ancestor
91918841|NCT05695664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918842|NCT05695664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918843|NCT05695664|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918844|NCT05695664|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918845|NCT05695664|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918846|NCT05695664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918847|NCT05695664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918848|NCT02412189|Norepinephrine|norepinephrine|mesh-list
91918849|NCT02412189|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91918850|NCT02412189|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91918851|NCT02412189|Adrenergic Agents|adrenergic agents|mesh-ancestor
91918852|NCT02412189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91918853|NCT02412189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918854|NCT02412189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918855|NCT02412189|Sympathomimetics|sympathomimetics|mesh-ancestor
91918856|NCT02412189|Autonomic Agents|autonomic agents|mesh-ancestor
91918857|NCT02412189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918858|NCT02412189|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91918859|NCT02411955|Nicotinic Acids|nicotinic acids|mesh-list
91918861|NCT02411955|Dermatologic Agents|dermatologic agents|mesh-ancestor
91918862|NCT02411955|Keratolytic Agents|keratolytic agents|mesh-ancestor
91918863|NCT02411955|Vitamin B Complex|vitamin b complex|mesh-ancestor
91918864|NCT02411955|Vitamins|vitamins|mesh-ancestor
91918865|NCT02411955|Micronutrients|micronutrients|mesh-ancestor
91918866|NCT02411955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918867|NCT03172533|Dienogest|dienogest|mesh-list
91918868|NCT03172533|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91918869|NCT03172533|Estradiol|estradiol|mesh-list
91918870|NCT03172533|Estrogens|estrogens|mesh-ancestor
91918871|NCT03172533|Hormones|hormones|mesh-ancestor
91918872|NCT03172533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918873|NCT03172533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918874|NCT03172533|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91918875|NCT03172533|Contraceptive Agents|contraceptive agents|mesh-ancestor
91918876|NCT03172533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918877|NCT03172533|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91918878|NCT03172533|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91918879|NCT03172533|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91918880|NCT03172533|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91918881|NCT03172533|Hormone Antagonists|hormone antagonists|mesh-ancestor
91918882|NCT03172533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91918883|NCT03172533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918884|NCT02412033|Misoprostol|misoprostol|mesh-list
91918885|NCT02412033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91918886|NCT02412033|Abortifacient Agents|abortifacient agents|mesh-ancestor
91918887|NCT02412033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918888|NCT02412033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918889|NCT02412033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91918890|NCT02412033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91918891|NCT02412033|Oxytocics|oxytocics|mesh-ancestor
91918892|NCT02401971|Thalidomide|thalidomide|mesh-list
91918893|NCT02401971|Irinotecan|irinotecan|mesh-list
91918894|NCT02401971|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91918895|NCT02401971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91918896|NCT02401971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918897|NCT02401971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918898|NCT02401971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918899|NCT02401971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91918900|NCT02401971|Immunologic Factors|immunologic factors|mesh-ancestor
91918901|NCT02401971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918902|NCT02401971|Leprostatic Agents|leprostatic agents|mesh-ancestor
91918903|NCT02401971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91918904|NCT02401971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918905|NCT02401971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91918906|NCT02401971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91918907|NCT02401971|Growth Substances|growth substances|mesh-ancestor
91918908|NCT02401971|Growth Inhibitors|growth inhibitors|mesh-ancestor
91918909|NCT00701883|Atorvastatin|atorvastatin|mesh-list
91918910|NCT00701883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91918912|NCT00701883|Antimetabolites|antimetabolites|mesh-ancestor
91918913|NCT00701883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918914|NCT00701883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91918992|NCT04480827|Cholic Acids|cholic acids|mesh-list
91918915|NCT00701883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91918916|NCT00701883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918917|NCT05678738|Antioxidants|antioxidants|mesh-list
91918918|NCT05678738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918919|NCT05678738|Protective Agents|protective agents|mesh-ancestor
91918920|NCT05678738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918922|NCT03175653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91918923|NCT03175653|Narcotics|narcotics|mesh-ancestor
91918924|NCT03175653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91918925|NCT03175653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918926|NCT03175653|Analgesics|analgesics|mesh-ancestor
91918927|NCT03175653|Sensory System Agents|sensory system agents|mesh-ancestor
91918928|NCT03175653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918929|NCT02401737|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91918930|NCT02401737|Antiviral Agents|antiviral agents|mesh-ancestor
91918931|NCT02401737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91918932|NCT03175341|Ascorbic Acid|ascorbic acid|mesh-list
91918933|NCT03175341|Vitamins|vitamins|mesh-ancestor
91918934|NCT03175341|Micronutrients|micronutrients|mesh-ancestor
91918935|NCT03175341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918936|NCT03175341|Antioxidants|antioxidants|mesh-ancestor
91918937|NCT03175341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918938|NCT03175341|Protective Agents|protective agents|mesh-ancestor
91918939|NCT05538026|Mesalamine|mesalamine|mesh-list
91918940|NCT05538026|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918941|NCT05538026|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918942|NCT05538026|Analgesics|analgesics|mesh-ancestor
91918943|NCT05538026|Sensory System Agents|sensory system agents|mesh-ancestor
91918944|NCT05538026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918945|NCT05538026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918946|NCT05538026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918947|NCT05538026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918948|NCT02401425|Letrozole|letrozole|mesh-list
91918949|NCT02401425|Misoprostol|misoprostol|mesh-list
91918950|NCT02401425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91918951|NCT02401425|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91918952|NCT02401425|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91918954|NCT02401425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918955|NCT02401425|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91918956|NCT02401425|Hormone Antagonists|hormone antagonists|mesh-ancestor
91918957|NCT02401425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91918958|NCT02401425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918959|NCT02401425|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91918960|NCT02401425|Abortifacient Agents|abortifacient agents|mesh-ancestor
91918961|NCT02401425|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91918962|NCT02401425|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91918963|NCT02401425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91918964|NCT02401425|Oxytocics|oxytocics|mesh-ancestor
91918965|NCT05537948|Pitavastatin|pitavastatin|mesh-list
91918966|NCT05537948|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
91918967|NCT05537948|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91918968|NCT05537948|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91918969|NCT05537948|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91918970|NCT05537948|Antimetabolites|antimetabolites|mesh-ancestor
91918971|NCT05537948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918972|NCT05537948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918973|NCT05537948|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91918974|NCT05537948|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91918975|NCT05537948|Protease Inhibitors|protease inhibitors|mesh-ancestor
91918977|NCT02401269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91918978|NCT02401269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91918979|NCT02401269|Analgesics|analgesics|mesh-ancestor
91918980|NCT02401269|Sensory System Agents|sensory system agents|mesh-ancestor
91918981|NCT02401269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91918982|NCT02401269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91918983|NCT02401269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91918984|NCT02401269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91918985|NCT02401269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91918986|NCT02401269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91918987|NCT02401269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91918988|NCT02401269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91918989|NCT02401269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91918990|NCT02401269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918991|NCT02401269|Antipyretics|antipyretics|mesh-ancestor
91918993|NCT04480827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91918994|NCT02582684|Lamivudine|lamivudine|mesh-list
91918995|NCT02582684|Dolutegravir|dolutegravir|mesh-list
91918996|NCT02582684|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91918997|NCT02582684|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91918998|NCT02582684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91918999|NCT02582684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919000|NCT02582684|Antiviral Agents|antiviral agents|mesh-ancestor
91919001|NCT02582684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919002|NCT02582684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91919003|NCT02582684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91919004|NCT02582684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91919005|NCT02582684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91919006|NCT02411877|Clotrimazole|clotrimazole|mesh-list
91919007|NCT02411877|Miconazole|miconazole|mesh-list
91919008|NCT02411877|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91919009|NCT02411877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919010|NCT02411877|Antifungal Agents|antifungal agents|mesh-ancestor
91919011|NCT02411877|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91919012|NCT02411877|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919013|NCT02411877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919014|NCT02411877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919015|NCT02411877|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91919016|NCT02411877|Hormone Antagonists|hormone antagonists|mesh-ancestor
91919017|NCT02411877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919018|NCT02411877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919019|NCT02411877|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91919020|NCT02411877|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919022|NCT03169569|Coagulants|coagulants|mesh-ancestor
91919023|NCT02585960|Factor VIII|factor viii|mesh-list
91919024|NCT02585960|BAX 855|bax 855|mesh-list
91919025|NCT02585960|Coagulants|coagulants|mesh-ancestor
91919027|NCT03169413|Analgesics|analgesics|mesh-ancestor
91919028|NCT03169413|Sensory System Agents|sensory system agents|mesh-ancestor
91919029|NCT03169413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919030|NCT03169413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919031|NCT03169413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91919032|NCT03169413|Vasodilator Agents|vasodilator agents|mesh-ancestor
91919033|NCT03169413|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91919034|NCT03169413|Purinergic Agonists|purinergic agonists|mesh-ancestor
91919035|NCT03169413|Purinergic Agents|purinergic agents|mesh-ancestor
91919036|NCT03169413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919037|NCT03169413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919038|NCT03169335|Paclitaxel|paclitaxel|mesh-list
91919039|NCT03169335|Bevacizumab|bevacizumab|mesh-list
91919040|NCT03169335|Carboplatin|carboplatin|mesh-list
91919041|NCT03169335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91919042|NCT03169335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919043|NCT03169335|Tubulin Modulators|tubulin modulators|mesh-ancestor
91919044|NCT03169335|Antimitotic Agents|antimitotic agents|mesh-ancestor
91919045|NCT03169335|Mitosis Modulators|mitosis modulators|mesh-ancestor
91919046|NCT03169335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919047|NCT03169335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91919048|NCT03169335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91919049|NCT03169335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91919050|NCT03169335|Growth Substances|growth substances|mesh-ancestor
91919051|NCT03169335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919052|NCT03169335|Growth Inhibitors|growth inhibitors|mesh-ancestor
91919053|NCT03106623|Solifenacin Succinate|solifenacin succinate|mesh-list
91919054|NCT03106623|Mirabegron|mirabegron|mesh-list
91919055|NCT03106623|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91919056|NCT03106623|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91919057|NCT03106623|Cholinergic Agents|cholinergic agents|mesh-ancestor
91919058|NCT03106623|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919059|NCT03106623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919060|NCT03106623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919061|NCT03106623|Urological Agents|urological agents|mesh-ancestor
91919062|NCT03106623|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91919063|NCT03106623|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91919064|NCT03106623|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91919065|NCT03106623|Adrenergic Agents|adrenergic agents|mesh-ancestor
91919066|NCT02411175|Ethanol|ethanol|mesh-list
91919067|NCT02411175|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91919068|NCT02411175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919069|NCT02411175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919070|NCT02411175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919071|NCT05537558|Antidepressive Agents|antidepressive agents|mesh-list
91919072|NCT05537558|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91919074|NCT02411331|Enoxaparin|enoxaparin|mesh-list
91919075|NCT02411331|Anticoagulants|anticoagulants|mesh-ancestor
91919076|NCT02411331|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91919077|NCT02411331|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91919078|NCT02411331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919079|NCT02411331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91919080|NCT02411331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919081|NCT02411331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919082|NCT02411331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919083|NCT00100789|Paclitaxel|paclitaxel|mesh-list
91919084|NCT00100789|Gemcitabine|gemcitabine|mesh-list
92074241|NCT00072514|Gemcitabine|gemcitabine|mesh-list
91919085|NCT00100789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91919086|NCT00100789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919087|NCT00100789|Tubulin Modulators|tubulin modulators|mesh-ancestor
91919088|NCT00100789|Antimitotic Agents|antimitotic agents|mesh-ancestor
91919089|NCT00100789|Mitosis Modulators|mitosis modulators|mesh-ancestor
91919090|NCT00100789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919091|NCT00100789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91919092|NCT00100789|Antimetabolites|antimetabolites|mesh-ancestor
91919093|NCT02410863|Trametinib|trametinib|mesh-list
91919094|NCT02410863|Dabrafenib|dabrafenib|mesh-list
91919095|NCT02410863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919096|NCT02410863|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91919097|NCT02410863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919098|NCT02410863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919099|NCT05678192|Hormones|hormones|mesh-list
91919100|NCT05678192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919101|NCT05678192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919102|NCT00708123|Listerine|listerine|mesh-list
91919103|NCT00708123|Fluorides|fluorides|mesh-list
91919104|NCT00708123|Sodium Fluoride|sodium fluoride|mesh-list
91919105|NCT00708123|Cariostatic Agents|cariostatic agents|mesh-ancestor
91919106|NCT00708123|Protective Agents|protective agents|mesh-ancestor
91919107|NCT00708123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919108|NCT00708123|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91919109|NCT00708123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919110|NCT05678036|Analgesics, Opioid|analgesics, opioid|mesh-list
91919111|NCT05678036|Narcotics|narcotics|mesh-ancestor
91919112|NCT05678036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919113|NCT05678036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919114|NCT05678036|Analgesics|analgesics|mesh-ancestor
91919115|NCT05678036|Sensory System Agents|sensory system agents|mesh-ancestor
91919116|NCT05678036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919117|NCT05537090|Midazolam|midazolam|mesh-list
91919118|NCT05537090|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91919119|NCT05537090|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91919120|NCT05537090|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919121|NCT05537090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919122|NCT05537090|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91919123|NCT05537090|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91919124|NCT05537090|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91919125|NCT05537090|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919126|NCT05537090|Anesthetics, General|anesthetics, general|mesh-ancestor
91919127|NCT05537090|Anesthetics|anesthetics|mesh-ancestor
91919128|NCT05537090|GABA Modulators|gaba modulators|mesh-ancestor
91919129|NCT05537090|GABA Agents|gaba agents|mesh-ancestor
91919130|NCT05537090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919131|NCT05537090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919132|NCT02400879|Sufentanil|sufentanil|mesh-list
91919133|NCT02400879|Remifentanil|remifentanil|mesh-list
91919134|NCT02400879|Sevoflurane|sevoflurane|mesh-list
91919135|NCT02400879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91919136|NCT02400879|Narcotics|narcotics|mesh-ancestor
91919137|NCT02400879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919138|NCT02400879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919139|NCT02400879|Analgesics|analgesics|mesh-ancestor
91919140|NCT02400879|Sensory System Agents|sensory system agents|mesh-ancestor
91919141|NCT02400879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919142|NCT02400879|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91919143|NCT02400879|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91919144|NCT02400879|Anesthetics, General|anesthetics, general|mesh-ancestor
91919145|NCT02400879|Anesthetics|anesthetics|mesh-ancestor
91919146|NCT02400879|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91919147|NCT02400879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919149|NCT04133480|Anticonvulsants|anticonvulsants|mesh-ancestor
91919150|NCT02400645|Ketorolac|ketorolac|mesh-list
91919151|NCT02400645|Bupivacaine|bupivacaine|mesh-list
91919152|NCT02400645|Anesthetics, Local|anesthetics, local|mesh-ancestor
91919153|NCT02400645|Anesthetics|anesthetics|mesh-ancestor
91919154|NCT02400645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919155|NCT02400645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919156|NCT02400645|Sensory System Agents|sensory system agents|mesh-ancestor
91919157|NCT02400645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919158|NCT02400645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91919159|NCT02400645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919160|NCT02400645|Analgesics|analgesics|mesh-ancestor
91919161|NCT02400645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91919162|NCT02400645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919163|NCT02400645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91919164|NCT02400645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919165|NCT02400645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919166|NCT02165215|Etrolizumab|etrolizumab|mesh-list
91919167|NCT02165215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919168|NCT02165215|Immunologic Factors|immunologic factors|mesh-ancestor
91919169|NCT02165215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919170|NCT02400801|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91919171|NCT02400801|Dienogest|dienogest|mesh-list
91919172|NCT02400801|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91919173|NCT02400801|Luteolytic Agents|luteolytic agents|mesh-ancestor
91919174|NCT02400801|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91919175|NCT02400801|Contraceptive Agents|contraceptive agents|mesh-ancestor
91919176|NCT02400801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91919177|NCT02400801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919178|NCT02400801|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91919179|NCT02400801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91919180|NCT02400801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919181|NCT02400801|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91919182|NCT02400801|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91919183|NCT02400801|Estrogens|estrogens|mesh-ancestor
91919184|NCT02400801|Hormones|hormones|mesh-ancestor
91919185|NCT02400801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919186|NCT02400801|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91919187|NCT02400801|Hormone Antagonists|hormone antagonists|mesh-ancestor
91919188|NCT02168569|Artesunate|artesunate|mesh-list
91919189|NCT02168569|Lumefantrine|lumefantrine|mesh-list
91919190|NCT02168569|Artemether|artemether|mesh-list
91919191|NCT02168569|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91919192|NCT02168569|Amodiaquine|amodiaquine|mesh-list
91919193|NCT02168569|Antimalarials|antimalarials|mesh-ancestor
91919194|NCT02168569|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91919195|NCT02168569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91919196|NCT02168569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919197|NCT02168569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919198|NCT02168569|Antiviral Agents|antiviral agents|mesh-ancestor
91919199|NCT02168569|Schistosomicides|schistosomicides|mesh-ancestor
91919200|NCT02168569|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91919201|NCT02168569|Anthelmintics|anthelmintics|mesh-ancestor
91919202|NCT02400255|Crenolanib|crenolanib|mesh-list
91919203|NCT02400255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919204|NCT02171689|Afatinib|afatinib|mesh-list
91919205|NCT02171689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919206|NCT02171689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91919207|NCT02171689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919208|NCT02171689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919209|NCT02171767|Afatinib|afatinib|mesh-list
91919210|NCT02171767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919211|NCT02171767|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91919212|NCT02171767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919213|NCT02171767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919214|NCT02400021|Progesterone|progesterone|mesh-list
91919215|NCT02400021|Progestins|progestins|mesh-ancestor
91919216|NCT02400021|Hormones|hormones|mesh-ancestor
91919217|NCT02400021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919218|NCT02400021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919219|NCT02165449|Ketamine|ketamine|mesh-list
91919220|NCT02165449|Analgesics|analgesics|mesh-ancestor
91919221|NCT02165449|Sensory System Agents|sensory system agents|mesh-ancestor
91919222|NCT02165449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919223|NCT02165449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919224|NCT02165449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91919225|NCT02165449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919228|NCT02165449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919229|NCT02165449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91919230|NCT02165449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91919231|NCT02165449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919232|NCT02165449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919233|NCT02172001|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
91919234|NCT02172001|Hematinics|hematinics|mesh-ancestor
91919235|NCT05535998|Chlorotrianisene|chlorotrianisene|mesh-list
91919236|NCT05535998|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91919237|NCT05535998|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91919238|NCT05535998|Estrogens|estrogens|mesh-ancestor
91919239|NCT05535998|Hormones|hormones|mesh-ancestor
91919240|NCT05535998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919241|NCT05535998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919242|NCT05535998|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91919243|NCT05535998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919244|NCT05535998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919245|NCT05535998|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91919246|NCT03540199|Antibodies|antibodies|mesh-list
91919247|NCT03540199|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91919248|NCT03540199|Immunologic Factors|immunologic factors|mesh-ancestor
91919249|NCT03540199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919250|NCT02165917|Hyaluronic Acid|hyaluronic acid|mesh-list
91919251|NCT02165917|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91919252|NCT02165917|Immunologic Factors|immunologic factors|mesh-ancestor
91919253|NCT02165917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919254|NCT02165917|Viscosupplements|viscosupplements|mesh-ancestor
91919255|NCT02165917|Protective Agents|protective agents|mesh-ancestor
91919256|NCT02168881|Misoprostol|misoprostol|mesh-list
91919257|NCT02168881|Dinoprostone|dinoprostone|mesh-list
91919258|NCT02168881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91919259|NCT02168881|Abortifacient Agents|abortifacient agents|mesh-ancestor
91919260|NCT02168881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91919261|NCT02168881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919262|NCT02168881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91919263|NCT02168881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919264|NCT02168881|Oxytocics|oxytocics|mesh-ancestor
91919265|NCT02168959|Bupivacaine|bupivacaine|mesh-list
91919266|NCT02168959|Anesthetics, Local|anesthetics, local|mesh-ancestor
91919267|NCT02168959|Anesthetics|anesthetics|mesh-ancestor
91919268|NCT02168959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919269|NCT02168959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919270|NCT02168959|Sensory System Agents|sensory system agents|mesh-ancestor
91919271|NCT02168959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919272|NCT05696678|Morphine|morphine|mesh-list
91919273|NCT05696678|Ropivacaine|ropivacaine|mesh-list
91919274|NCT05696678|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91919275|NCT05696678|Narcotics|narcotics|mesh-ancestor
91919276|NCT05696678|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919277|NCT05696678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919278|NCT05696678|Analgesics|analgesics|mesh-ancestor
91919279|NCT05696678|Sensory System Agents|sensory system agents|mesh-ancestor
91919280|NCT05696678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919281|NCT05696678|Anesthetics, Local|anesthetics, local|mesh-ancestor
91919282|NCT05696678|Anesthetics|anesthetics|mesh-ancestor
91919283|NCT05450822|Lamotrigine|lamotrigine|mesh-list
91919284|NCT05450822|Levetiracetam|levetiracetam|mesh-list
91919285|NCT05450822|Anticonvulsants|anticonvulsants|mesh-list
91919286|NCT05450822|Nootropic Agents|nootropic agents|mesh-ancestor
91919287|NCT05450822|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91919288|NCT05450822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91919289|NCT05450822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919290|NCT05450822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91919291|NCT05450822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919292|NCT05450822|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91919293|NCT05450822|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91919294|NCT05450822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919295|NCT05450822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91919296|NCT05450822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91919297|NCT02172157|Olodaterol|olodaterol|mesh-list
91919298|NCT02172157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91919299|NCT02172157|Autonomic Agents|autonomic agents|mesh-ancestor
91919300|NCT02172157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919301|NCT02172157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919302|NCT02172157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91919303|NCT02172157|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919304|NCT02172235|Pioglitazone|pioglitazone|mesh-list
91919305|NCT02172235|Empagliflozin|empagliflozin|mesh-list
91919306|NCT02172235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919307|NCT02172235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919308|NCT02172235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91919309|NCT02172235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919310|NCT02166229|Valproic Acid|valproic acid|mesh-list
91919311|NCT02166229|Anticonvulsants|anticonvulsants|mesh-ancestor
91919312|NCT02166229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919313|NCT02166229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919314|NCT02166229|GABA Agents|gaba agents|mesh-ancestor
91919315|NCT02166229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919316|NCT02166229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919317|NCT02166229|Antimanic Agents|antimanic agents|mesh-ancestor
91919318|NCT02166229|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91919319|NCT02166229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919320|NCT02166229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91919321|NCT05297864|Niraparib|niraparib|mesh-list
91919322|NCT05297864|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91919323|NCT05297864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919324|NCT05297864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919325|NCT05297864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919326|NCT02757625|Dexmedetomidine|dexmedetomidine|mesh-list
91919327|NCT02757625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91919328|NCT02757625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919329|NCT02757625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919330|NCT02757625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919332|NCT02757625|Sensory System Agents|sensory system agents|mesh-ancestor
91919333|NCT02757625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919334|NCT02757625|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91919335|NCT02757625|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91919336|NCT02757625|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91919337|NCT02757625|Adrenergic Agents|adrenergic agents|mesh-ancestor
91919338|NCT02757625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919339|NCT02757625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919340|NCT05691920|Fentanyl|fentanyl|mesh-list
91919341|NCT05691920|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91919342|NCT05691920|Narcotics|narcotics|mesh-ancestor
91919343|NCT05691920|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919344|NCT05691920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919345|NCT05691920|Analgesics|analgesics|mesh-ancestor
91919346|NCT05691920|Sensory System Agents|sensory system agents|mesh-ancestor
91919347|NCT05691920|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919348|NCT05691920|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91919349|NCT05691920|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919350|NCT05691920|Anesthetics, General|anesthetics, general|mesh-ancestor
91919352|NCT05696366|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
91919353|NCT05696366|Volagidemab|volagidemab|mesh-list
91919354|NCT05696366|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91919355|NCT05696366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919356|NCT05696366|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919357|NCT05696366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919358|NCT02169583|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91919360|NCT05613842|Bombesin|bombesin|mesh-list
91919361|NCT05613842|Trace Elements|trace elements|mesh-ancestor
91919362|NCT05613842|Micronutrients|micronutrients|mesh-ancestor
91919363|NCT05613842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919364|NCT05613842|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919365|NCT05613842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919366|NCT02172391|Tiotropium Bromide|tiotropium bromide|mesh-list
91919367|NCT02172391|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91919368|NCT02172391|Autonomic Agents|autonomic agents|mesh-ancestor
91919369|NCT02172391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919370|NCT02172391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919371|NCT02172391|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91919372|NCT02172391|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919373|NCT02172391|Parasympatholytics|parasympatholytics|mesh-ancestor
91919374|NCT02172391|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91919375|NCT02172391|Cholinergic Agents|cholinergic agents|mesh-ancestor
91919376|NCT02172391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919377|NCT02172391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919378|NCT00109681|Iloprost|iloprost|mesh-list
91919379|NCT00109681|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91919380|NCT00109681|Vasodilator Agents|vasodilator agents|mesh-ancestor
91919381|NCT02172469|Bromides|bromides|mesh-list
91919382|NCT02172469|Tiotropium Bromide|tiotropium bromide|mesh-list
91919383|NCT02172469|Ipratropium|ipratropium|mesh-list
91919384|NCT02172469|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91919385|NCT02172469|Autonomic Agents|autonomic agents|mesh-ancestor
91919386|NCT02172469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919387|NCT02172469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919388|NCT02172469|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91919389|NCT02172469|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919390|NCT02172469|Parasympatholytics|parasympatholytics|mesh-ancestor
91919391|NCT02172469|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91919392|NCT02172469|Cholinergic Agents|cholinergic agents|mesh-ancestor
91919393|NCT02172469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919394|NCT02172469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919395|NCT02172469|Anticonvulsants|anticonvulsants|mesh-ancestor
91919396|NCT02172547|Tiotropium Bromide|tiotropium bromide|mesh-list
91919397|NCT02172547|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91919398|NCT02172547|Autonomic Agents|autonomic agents|mesh-ancestor
91919399|NCT02172547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919400|NCT02172547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919401|NCT02172547|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91919402|NCT02172547|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919403|NCT02172547|Parasympatholytics|parasympatholytics|mesh-ancestor
91919404|NCT02172547|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91919405|NCT02172547|Cholinergic Agents|cholinergic agents|mesh-ancestor
91919406|NCT02172547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919407|NCT02172547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919408|NCT02174887|Paclitaxel|paclitaxel|mesh-list
91919409|NCT02174887|Gemcitabine|gemcitabine|mesh-list
91919410|NCT02174887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91919411|NCT02174887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919412|NCT02174887|Tubulin Modulators|tubulin modulators|mesh-ancestor
91919413|NCT02174887|Antimitotic Agents|antimitotic agents|mesh-ancestor
91919414|NCT02174887|Mitosis Modulators|mitosis modulators|mesh-ancestor
91919415|NCT02174887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919416|NCT02174887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91919417|NCT02174887|Antimetabolites|antimetabolites|mesh-ancestor
91919418|NCT04373564|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
91919419|NCT04373564|Chelating Agents|chelating agents|mesh-ancestor
91919420|NCT04373564|Sequestering Agents|sequestering agents|mesh-ancestor
91919421|NCT04373564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919422|NCT05142319|Vaccines|vaccines|mesh-list
91919423|NCT05142319|Immunologic Factors|immunologic factors|mesh-ancestor
91919424|NCT05142319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919425|NCT02169973|JNJ-42165279|jnj-42165279|mesh-list
91919426|NCT02169973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919427|NCT02169973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919428|NCT04298528|Dronabinol|dronabinol|mesh-list
91919429|NCT04298528|Hallucinogens|hallucinogens|mesh-ancestor
91919430|NCT04298528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919431|NCT04298528|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91919432|NCT04298528|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919433|NCT04298528|Analgesics|analgesics|mesh-ancestor
91919434|NCT04298528|Sensory System Agents|sensory system agents|mesh-ancestor
91919435|NCT04298528|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919436|NCT04298528|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91919437|NCT04298528|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91919438|NCT04298528|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919439|NCT04298528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919440|NCT04298528|Hormones|hormones|mesh-ancestor
91919441|NCT04298528|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919442|NCT00100711|Motexafin gadolinium|motexafin gadolinium|mesh-list
91919443|NCT00100711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919444|NCT00100711|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91919445|NCT00100711|Dermatologic Agents|dermatologic agents|mesh-ancestor
91919447|NCT02581202|Lopinavir|lopinavir|mesh-list
91919448|NCT02581202|Lamivudine|lamivudine|mesh-list
91919449|NCT02581202|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91919450|NCT02581202|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91919453|NCT02581202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919454|NCT02581202|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91919455|NCT02581202|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91919456|NCT02581202|Antiviral Agents|antiviral agents|mesh-ancestor
91919457|NCT02581202|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919458|NCT02581202|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919459|NCT02581202|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919460|NCT02581202|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91919461|NCT02581202|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91919462|NCT02758171|Empagliflozin|empagliflozin|mesh-list
91919463|NCT02758171|Linagliptin|linagliptin|mesh-list
91919464|NCT02758171|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91919465|NCT02758171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919466|NCT02758171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919467|NCT02758171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919468|NCT02758171|Incretins|incretins|mesh-ancestor
91919469|NCT02758171|Hormones|hormones|mesh-ancestor
91919470|NCT02758171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919471|NCT02758171|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91919472|NCT02758171|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919473|NCT02758171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919474|NCT00101101|Aldesleukin|aldesleukin|mesh-list
91919475|NCT00101101|Dexamethasone|dexamethasone|mesh-list
91919476|NCT00101101|Prednisone|prednisone|mesh-list
91919477|NCT00101101|Cyclophosphamide|cyclophosphamide|mesh-list
91919478|NCT00101101|Doxorubicin|doxorubicin|mesh-list
91919479|NCT00101101|Vincristine|vincristine|mesh-list
91919480|NCT00101101|Interleukin-2|interleukin-2|mesh-list
91919481|NCT00101101|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91919482|NCT00101101|Immunologic Factors|immunologic factors|mesh-ancestor
91919483|NCT00101101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919484|NCT00101101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919485|NCT00101101|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91919486|NCT00101101|Alkylating Agents|alkylating agents|mesh-ancestor
91919487|NCT00101101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919488|NCT00101101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919489|NCT00101101|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91919490|NCT00101101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91919491|NCT00101101|Antiemetics|antiemetics|mesh-ancestor
91919492|NCT00101101|Autonomic Agents|autonomic agents|mesh-ancestor
91919493|NCT00101101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919494|NCT00101101|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919495|NCT00101101|Glucocorticoids|glucocorticoids|mesh-ancestor
91919496|NCT00101101|Hormones|hormones|mesh-ancestor
91919497|NCT00101101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919498|NCT00101101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91919499|NCT00101101|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91919500|NCT00101101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91919501|NCT00101101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91919502|NCT00101101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919503|NCT00101101|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91919504|NCT00101101|Tubulin Modulators|tubulin modulators|mesh-ancestor
91919505|NCT00101101|Antimitotic Agents|antimitotic agents|mesh-ancestor
91919506|NCT00101101|Mitosis Modulators|mitosis modulators|mesh-ancestor
91919507|NCT00101101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919508|NCT00101101|Analgesics|analgesics|mesh-ancestor
91919509|NCT00101101|Sensory System Agents|sensory system agents|mesh-ancestor
91919510|NCT00101101|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91919511|NCT00101101|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91919512|NCT00101101|Antiviral Agents|antiviral agents|mesh-ancestor
91919513|NCT00101101|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919514|NCT02172781|Tiotropium Bromide|tiotropium bromide|mesh-list
91919515|NCT02172781|Ipratropium|ipratropium|mesh-list
91919516|NCT02172781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91919517|NCT02172781|Autonomic Agents|autonomic agents|mesh-ancestor
91919518|NCT02172781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919519|NCT02172781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919520|NCT02172781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91919521|NCT02172781|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919522|NCT02172781|Parasympatholytics|parasympatholytics|mesh-ancestor
91919523|NCT02172781|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91919524|NCT02172781|Cholinergic Agents|cholinergic agents|mesh-ancestor
91919525|NCT02172781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919526|NCT02172781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919527|NCT02173093|Aldesleukin|aldesleukin|mesh-list
91919529|NCT02173093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919530|NCT02173093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919531|NCT02173093|Analgesics|analgesics|mesh-ancestor
91919532|NCT02173093|Sensory System Agents|sensory system agents|mesh-ancestor
91919533|NCT02173093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919534|NCT02173093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919535|NCT02173093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91919536|NCT02173093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91919537|NCT02173093|Antiviral Agents|antiviral agents|mesh-ancestor
91919538|NCT02173093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919539|NCT01465100|Liver Extracts|liver extracts|mesh-list
91919540|NCT01465100|Hematinics|hematinics|mesh-ancestor
91919541|NCT05142085|Mineral Oil|mineral oil|mesh-list
91919542|NCT05142085|Emollients|emollients|mesh-ancestor
91919543|NCT05142085|Dermatologic Agents|dermatologic agents|mesh-ancestor
91919544|NCT00103831|Taxane|taxane|mesh-list
91919545|NCT00103831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919546|NCT03538483|Bupivacaine|bupivacaine|mesh-list
91919547|NCT03538483|Anesthetics, Local|anesthetics, local|mesh-ancestor
91919548|NCT03538483|Anesthetics|anesthetics|mesh-ancestor
91919549|NCT03538483|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919550|NCT03538483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919551|NCT03538483|Sensory System Agents|sensory system agents|mesh-ancestor
91919552|NCT03538483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919554|NCT05033054|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91919555|NCT05033054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919556|NCT05033054|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919557|NCT05033054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919558|NCT02175355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91919559|NCT02175355|Telmisartan|telmisartan|mesh-list
91919560|NCT02175355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91919561|NCT02175355|Diuretics|diuretics|mesh-ancestor
91919562|NCT02175355|Natriuretic Agents|natriuretic agents|mesh-ancestor
91919563|NCT02175355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919564|NCT02175355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91919565|NCT02175355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91919566|NCT02175355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919567|NCT02175355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91919568|NCT02175355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91919570|NCT03538327|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91919571|NCT03538327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919572|NCT03538327|Protective Agents|protective agents|mesh-ancestor
91919573|NCT03538327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919574|NCT02170597|Dabigatran|dabigatran|mesh-list
91919575|NCT02170597|Antithrombins|antithrombins|mesh-ancestor
91919576|NCT02170597|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91919577|NCT02170597|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919578|NCT02170597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919579|NCT02170597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919580|NCT02170597|Anticoagulants|anticoagulants|mesh-ancestor
91919581|NCT02170675|Ketoconazole|ketoconazole|mesh-list
91919582|NCT02170675|Dabigatran|dabigatran|mesh-list
91919583|NCT02170675|Antithrombins|antithrombins|mesh-ancestor
91919584|NCT02170675|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91919585|NCT02170675|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919586|NCT02170675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919587|NCT02170675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919588|NCT02170675|Anticoagulants|anticoagulants|mesh-ancestor
91919589|NCT02170675|Antifungal Agents|antifungal agents|mesh-ancestor
91919590|NCT02170675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919591|NCT02170675|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91919592|NCT02170675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919593|NCT02170675|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91919594|NCT02170675|Hormone Antagonists|hormone antagonists|mesh-ancestor
91919595|NCT02170675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919596|NCT02170675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919597|NCT02170675|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919598|NCT02175433|AGS67E|ags67e|mesh-list
91919599|NCT02175433|Immunoconjugates|immunoconjugates|mesh-ancestor
91919600|NCT02175433|Immunologic Factors|immunologic factors|mesh-ancestor
91919601|NCT02175433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919602|NCT04154150|Ketamine|ketamine|mesh-list
91919603|NCT04154150|Analgesics|analgesics|mesh-ancestor
91919604|NCT04154150|Sensory System Agents|sensory system agents|mesh-ancestor
91919605|NCT04154150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919606|NCT04154150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919607|NCT04154150|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91919608|NCT04154150|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919609|NCT04154150|Anesthetics, General|anesthetics, general|mesh-ancestor
91919610|NCT04154150|Anesthetics|anesthetics|mesh-ancestor
91919611|NCT04154150|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919612|NCT04154150|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91919613|NCT04154150|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91919614|NCT04154150|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919615|NCT04154150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919616|NCT00521846|Cimetidine|cimetidine|mesh-list
91919617|NCT00521846|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91919618|NCT00521846|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919619|NCT00521846|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91919620|NCT00521846|Histamine Antagonists|histamine antagonists|mesh-ancestor
91919621|NCT00521846|Histamine Agents|histamine agents|mesh-ancestor
91919622|NCT00521846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919623|NCT00521846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919624|NCT00521846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919625|NCT00521846|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91919626|NCT00521846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919627|NCT00521846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919629|NCT02170831|Antithrombins|antithrombins|mesh-ancestor
91919630|NCT02170831|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91919631|NCT02170831|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919632|NCT02170831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919633|NCT02170831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919634|NCT02170831|Anticoagulants|anticoagulants|mesh-ancestor
91919635|NCT02175589|Colchicine|colchicine|mesh-list
91919636|NCT02175589|Gout Suppressants|gout suppressants|mesh-ancestor
91919637|NCT02175589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919638|NCT02175589|Tubulin Modulators|tubulin modulators|mesh-ancestor
91919639|NCT02175589|Antimitotic Agents|antimitotic agents|mesh-ancestor
91919640|NCT02175589|Mitosis Modulators|mitosis modulators|mesh-ancestor
91919641|NCT02175589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919642|NCT02175589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919643|NCT05438186|Liraglutide|liraglutide|mesh-list
91919644|NCT05438186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919645|NCT05438186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919646|NCT05438186|Incretins|incretins|mesh-ancestor
91919647|NCT05438186|Hormones|hormones|mesh-ancestor
91919648|NCT05438186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919649|NCT02178397|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91919650|NCT02178397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919651|NCT02178397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91919652|NCT02178397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919653|NCT02178397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919654|NCT02173639|Metformin|metformin|mesh-list
91919655|NCT02173639|Linagliptin|linagliptin|mesh-list
91919656|NCT02173639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919657|NCT02173639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919658|NCT02173639|Incretins|incretins|mesh-ancestor
91919659|NCT02173639|Hormones|hormones|mesh-ancestor
91919660|NCT02173639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919661|NCT02173639|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91919662|NCT02173639|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919663|NCT02173639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919664|NCT02173639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919665|NCT02173717|Rifampin|rifampin|mesh-list
91919666|NCT02173717|Dabigatran|dabigatran|mesh-list
91919667|NCT02173717|Antithrombins|antithrombins|mesh-ancestor
91919668|NCT02173717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91919669|NCT02173717|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919670|NCT02173717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919671|NCT02173717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919672|NCT02173717|Anticoagulants|anticoagulants|mesh-ancestor
91919673|NCT02173717|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91919674|NCT02173717|Antitubercular Agents|antitubercular agents|mesh-ancestor
91919675|NCT02173717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919676|NCT02173717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919677|NCT02173717|Leprostatic Agents|leprostatic agents|mesh-ancestor
91919678|NCT02173717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91919679|NCT02173717|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91919988|NCT02578706|Analgesics|analgesics|mesh-ancestor
91919680|NCT02173717|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91919681|NCT02173717|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91919682|NCT02173717|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91919683|NCT02173717|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91919684|NCT02173717|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91919685|NCT04067648|Sufentanil|sufentanil|mesh-list
91919686|NCT04067648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91919687|NCT04067648|Narcotics|narcotics|mesh-ancestor
91919688|NCT04067648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919689|NCT04067648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919690|NCT04067648|Analgesics|analgesics|mesh-ancestor
91919691|NCT04067648|Sensory System Agents|sensory system agents|mesh-ancestor
91919692|NCT04067648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919693|NCT04067648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91919694|NCT04067648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919695|NCT04067648|Anesthetics, General|anesthetics, general|mesh-ancestor
91919696|NCT04067648|Anesthetics|anesthetics|mesh-ancestor
91919697|NCT02173795|Fenoterol|fenoterol|mesh-list
91919698|NCT02173795|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
91919699|NCT02173795|Ipratropium|ipratropium|mesh-list
91919700|NCT02173795|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91919701|NCT02173795|Autonomic Agents|autonomic agents|mesh-ancestor
91919702|NCT02173795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919703|NCT02173795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919704|NCT02173795|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91919705|NCT02173795|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919706|NCT02173795|Sympathomimetics|sympathomimetics|mesh-ancestor
91919707|NCT02173795|Tocolytic Agents|tocolytic agents|mesh-ancestor
91919708|NCT02173795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91919709|NCT02173795|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91919710|NCT02173795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91919711|NCT02173795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91919712|NCT02173795|Adrenergic Agents|adrenergic agents|mesh-ancestor
91919713|NCT02173795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919714|NCT02173795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919715|NCT02173795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91919716|NCT02173795|Cholinergic Agents|cholinergic agents|mesh-ancestor
91919717|NCT02175901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91919718|NCT02175901|Amoxicillin|amoxicillin|mesh-list
91919719|NCT02175901|Metronidazole|metronidazole|mesh-list
91919720|NCT02175901|Clarithromycin|clarithromycin|mesh-list
91919721|NCT02175901|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91919722|NCT02175901|Potassium Citrate|potassium citrate|mesh-list
91919723|NCT02175901|Lansoprazole|lansoprazole|mesh-list
91919724|NCT02175901|Bismuth|bismuth|mesh-list
91919725|NCT02175901|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91919726|NCT02175901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919727|NCT02175901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919728|NCT02175901|Antitubercular Agents|antitubercular agents|mesh-ancestor
91919729|NCT02175901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91919730|NCT02175901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91919731|NCT02175901|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91919732|NCT02175901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919733|NCT02175901|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919734|NCT02175901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919735|NCT02175901|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91919736|NCT02175901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919738|NCT02175901|Diuretics|diuretics|mesh-ancestor
91919739|NCT02175901|Natriuretic Agents|natriuretic agents|mesh-ancestor
91919740|NCT02175901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919741|NCT02175901|Expectorants|expectorants|mesh-ancestor
91919742|NCT02175901|Respiratory System Agents|respiratory system agents|mesh-ancestor
91919743|NCT05534750|Linezolid|linezolid|mesh-list
91919744|NCT05534750|Tedizolid|tedizolid|mesh-list
91919745|NCT05534750|Tedizolid phosphate|tedizolid phosphate|mesh-list
91919746|NCT05534750|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919747|NCT05534750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919748|NCT05534750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91919749|NCT05534750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919750|NCT05534750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919751|NCT02173873|Aflibercept|aflibercept|mesh-list
91919752|NCT02173873|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91919753|NCT02173873|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91919754|NCT02173873|Growth Substances|growth substances|mesh-ancestor
91919755|NCT02173873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919756|NCT02173873|Growth Inhibitors|growth inhibitors|mesh-ancestor
91919757|NCT02173873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919758|NCT02176057|Azithromycin|azithromycin|mesh-list
91919759|NCT02176057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919760|NCT02176057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919761|NCT02173951|Deferiprone|deferiprone|mesh-list
91919762|NCT02173951|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91919763|NCT02173951|Chelating Agents|chelating agents|mesh-ancestor
91919764|NCT02173951|Sequestering Agents|sequestering agents|mesh-ancestor
91919765|NCT02173951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919766|NCT02176135|Auranofin|auranofin|mesh-list
91919767|NCT02176135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919768|NCT02176213|Dexamethasone|dexamethasone|mesh-list
91919769|NCT02176213|Cyclophosphamide|cyclophosphamide|mesh-list
91919770|NCT02176213|Pomalidomide|pomalidomide|mesh-list
91919771|NCT02176213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91919772|NCT02176213|Immunologic Factors|immunologic factors|mesh-ancestor
91919773|NCT02176213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919774|NCT02176213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919775|NCT02176213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91919776|NCT02176213|Alkylating Agents|alkylating agents|mesh-ancestor
91919777|NCT02176213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919778|NCT02176213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919779|NCT02176213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91919780|NCT02176213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91919781|NCT02176213|Antiemetics|antiemetics|mesh-ancestor
91919782|NCT02176213|Autonomic Agents|autonomic agents|mesh-ancestor
91919783|NCT02176213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919784|NCT02176213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919785|NCT02176213|Glucocorticoids|glucocorticoids|mesh-ancestor
91919787|NCT02176213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919788|NCT02176213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91919789|NCT02176213|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91919790|NCT02176213|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91919791|NCT02176213|Growth Substances|growth substances|mesh-ancestor
91919792|NCT02176213|Growth Inhibitors|growth inhibitors|mesh-ancestor
91919793|NCT03537547|Antipsychotic Agents|antipsychotic agents|mesh-list
91919794|NCT03537547|Antidepressive Agents|antidepressive agents|mesh-list
91919795|NCT03537547|Psychotropic Drugs|psychotropic drugs|mesh-list
91919796|NCT03537547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91919797|NCT03537547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919798|NCT03537547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919799|NCT04305002|Exenatide|exenatide|mesh-list
91919800|NCT04305002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91919801|NCT04305002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919802|NCT04305002|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91919804|NCT04305002|Hormones|hormones|mesh-ancestor
91919805|NCT04305002|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91919806|NCT02253797|Ritonavir|ritonavir|mesh-list
91919807|NCT02253797|Tipranavir|tipranavir|mesh-list
91919808|NCT02253797|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91919809|NCT02253797|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91919810|NCT02253797|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919811|NCT02253797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919812|NCT02253797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919813|NCT02253797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91919814|NCT02253797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91919815|NCT02253797|Antiviral Agents|antiviral agents|mesh-ancestor
91919816|NCT02253797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919817|NCT02253797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919818|NCT02253797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919819|NCT04620746|Penicillins|penicillins|mesh-list
91919820|NCT04620746|Penicillin G|penicillin g|mesh-list
91919821|NCT04620746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919822|NCT04620746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919823|NCT02253875|Ritonavir|ritonavir|mesh-list
91919824|NCT02253875|Tipranavir|tipranavir|mesh-list
91919825|NCT02253875|Omeprazole|omeprazole|mesh-list
91919826|NCT02253875|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91919827|NCT02253875|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91919828|NCT02253875|Protease Inhibitors|protease inhibitors|mesh-ancestor
91919829|NCT02253875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919830|NCT02253875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919831|NCT02253875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91919832|NCT02253875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91919833|NCT02253875|Antiviral Agents|antiviral agents|mesh-ancestor
91919834|NCT02253875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920140|NCT02174263|Immunoglobulin G|immunoglobulin g|mesh-list
91919835|NCT02253875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919836|NCT02253875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919837|NCT02253875|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91919838|NCT02253875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91919839|NCT02253875|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91919840|NCT05534672|Sirolimus|sirolimus|mesh-list
91919841|NCT05534672|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919842|NCT05534672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919843|NCT05534672|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91919844|NCT05534672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919845|NCT05534672|Antifungal Agents|antifungal agents|mesh-ancestor
91919846|NCT05534672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91919847|NCT05534672|Immunologic Factors|immunologic factors|mesh-ancestor
91919848|NCT05534672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919849|NCT03819140|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
91919850|NCT03819140|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91919851|NCT03819140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919852|NCT04597268|Midazolam|midazolam|mesh-list
91919853|NCT04597268|Dexmedetomidine|dexmedetomidine|mesh-list
91919854|NCT04597268|Ketamine|ketamine|mesh-list
91919855|NCT04597268|Propofol|propofol|mesh-list
91919856|NCT04597268|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91919857|NCT04597268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919858|NCT04597268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919859|NCT04597268|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919860|NCT04597268|Analgesics|analgesics|mesh-ancestor
91919861|NCT04597268|Sensory System Agents|sensory system agents|mesh-ancestor
91919862|NCT04597268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919863|NCT04597268|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91919864|NCT04597268|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91919865|NCT04597268|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91919866|NCT04597268|Adrenergic Agents|adrenergic agents|mesh-ancestor
91919867|NCT04597268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91919868|NCT04597268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919869|NCT04597268|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919870|NCT04597268|Anesthetics, General|anesthetics, general|mesh-ancestor
91919871|NCT04597268|Anesthetics|anesthetics|mesh-ancestor
91919872|NCT04597268|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91919873|NCT04597268|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91919874|NCT04597268|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91919875|NCT04597268|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91919876|NCT04597268|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91919877|NCT04597268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91919878|NCT04597268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91919879|NCT04597268|GABA Modulators|gaba modulators|mesh-ancestor
91919880|NCT04597268|GABA Agents|gaba agents|mesh-ancestor
91919881|NCT04976543|Nadroparin|nadroparin|mesh-list
91919882|NCT04976543|Warfarin|warfarin|mesh-list
91919883|NCT04976543|Calcium|calcium|mesh-list
91919884|NCT04976543|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91919885|NCT04976543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919886|NCT04976543|Anticoagulants|anticoagulants|mesh-ancestor
91919887|NCT04976543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91919888|NCT04976543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91919889|NCT04976543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919890|NCT04310930|Azithromycin|azithromycin|mesh-list
91919891|NCT04310930|Moxifloxacin|moxifloxacin|mesh-list
91919892|NCT04310930|Clarithromycin|clarithromycin|mesh-list
91919893|NCT04310930|Doxycycline|doxycycline|mesh-list
91919894|NCT04310930|Linezolid|linezolid|mesh-list
91919895|NCT04310930|Imipenem|imipenem|mesh-list
91919896|NCT04310930|Amikacin|amikacin|mesh-list
91919897|NCT04310930|Ethambutol|ethambutol|mesh-list
91919898|NCT04310930|Rifabutin|rifabutin|mesh-list
91919899|NCT04310930|Tigecycline|tigecycline|mesh-list
91919900|NCT04310930|Bedaquiline|bedaquiline|mesh-list
91919901|NCT04310930|Clofazimine|clofazimine|mesh-list
91919902|NCT04310930|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91919903|NCT04310930|Cefoxitin|cefoxitin|mesh-list
91919904|NCT04310930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919905|NCT04310930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919906|NCT04310930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91919907|NCT04310930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91919908|NCT04310930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919909|NCT04310930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919910|NCT04310930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919911|NCT04310930|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91920141|NCT02174263|Immunologic Factors|immunologic factors|mesh-ancestor
91919912|NCT04310930|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91919913|NCT04310930|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91919914|NCT04310930|Antimalarials|antimalarials|mesh-ancestor
91919915|NCT04310930|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91919916|NCT04310930|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91919917|NCT04310930|Antitubercular Agents|antitubercular agents|mesh-ancestor
91919918|NCT04310930|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91919919|NCT04310930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91919920|NCT04310930|Leprostatic Agents|leprostatic agents|mesh-ancestor
91919921|NCT04310930|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91919922|NCT05533892|Lenvatinib|lenvatinib|mesh-list
91919923|NCT05533892|Tislelizumab|tislelizumab|mesh-list
91919924|NCT05533892|Cell Wall Skeleton|cell wall skeleton|mesh-list
91919925|NCT05533892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919926|NCT05533892|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91919927|NCT05533892|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919928|NCT05533892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919929|NCT05533892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91919930|NCT05533892|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91919931|NCT05533892|Immunologic Factors|immunologic factors|mesh-ancestor
91919932|NCT05533892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919933|NCT02924441|Lidocaine|lidocaine|mesh-list
91919934|NCT02924441|Anesthetics, Local|anesthetics, local|mesh-ancestor
91919935|NCT02924441|Anesthetics|anesthetics|mesh-ancestor
91919936|NCT02924441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919937|NCT02924441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919938|NCT02924441|Sensory System Agents|sensory system agents|mesh-ancestor
91919939|NCT02924441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919940|NCT02924441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91919941|NCT02924441|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91919942|NCT02924441|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91919943|NCT02924441|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91919944|NCT02924441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919945|NCT00109967|Sirolimus|sirolimus|mesh-list
91919946|NCT00109967|Rituximab|rituximab|mesh-list
91919947|NCT00109967|Temsirolimus|temsirolimus|mesh-list
91919948|NCT00109967|MTOR Inhibitors|mtor inhibitors|mesh-list
91919949|NCT00109967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91919950|NCT00109967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91919951|NCT00109967|Immunologic Factors|immunologic factors|mesh-ancestor
91919952|NCT00109967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919953|NCT00109967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919954|NCT00109967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91919955|NCT00109967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919956|NCT00109967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919957|NCT00109967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91919958|NCT00109967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91919959|NCT00109967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91919960|NCT00109967|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91919961|NCT00109967|Antifungal Agents|antifungal agents|mesh-ancestor
91919962|NCT02579096|Allopurinol|allopurinol|mesh-list
91919963|NCT02579096|Febuxostat|febuxostat|mesh-list
91919964|NCT02579096|Antimetabolites|antimetabolites|mesh-ancestor
91919965|NCT02579096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919966|NCT02579096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91919967|NCT02579096|Gout Suppressants|gout suppressants|mesh-ancestor
91919968|NCT02579096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919969|NCT02579096|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91919970|NCT02579096|Antioxidants|antioxidants|mesh-ancestor
91919971|NCT02579096|Protective Agents|protective agents|mesh-ancestor
91919972|NCT02579096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919973|NCT02578862|Propofol|propofol|mesh-list
91919974|NCT02578862|Sevoflurane|sevoflurane|mesh-list
91919975|NCT02578862|Isoflurane|isoflurane|mesh-list
91919976|NCT02578862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91919977|NCT02578862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91919978|NCT02578862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919979|NCT02578862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91919980|NCT02578862|Anesthetics, General|anesthetics, general|mesh-ancestor
91919981|NCT02578862|Anesthetics|anesthetics|mesh-ancestor
91919982|NCT02578862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91919983|NCT02578862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91919984|NCT02578706|Aspirin|aspirin|mesh-list
91919985|NCT02578706|Clopidogrel|clopidogrel|mesh-list
91919986|NCT02578706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91919987|NCT02578706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91919989|NCT02578706|Sensory System Agents|sensory system agents|mesh-ancestor
91919990|NCT02578706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91919991|NCT02578706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91919992|NCT02578706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91919993|NCT02578706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91919994|NCT02578706|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91919995|NCT02578706|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91919996|NCT02578706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91919997|NCT02578706|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91919998|NCT02578706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91919999|NCT02578706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920000|NCT02578706|Antipyretics|antipyretics|mesh-ancestor
91920001|NCT02578706|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91920002|NCT02578706|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91920003|NCT02578706|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91920004|NCT02578706|Purinergic Agents|purinergic agents|mesh-ancestor
91920005|NCT02578706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920006|NCT03455504|Venetoclax|venetoclax|mesh-list
91920007|NCT03455504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920008|NCT00108953|Doxorubicin|doxorubicin|mesh-list
91920009|NCT00108953|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91920010|NCT00108953|Sorafenib|sorafenib|mesh-list
91920011|NCT00108953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91920012|NCT00108953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920013|NCT00108953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91920014|NCT00108953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91920015|NCT00108953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920016|NCT00108953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920017|NCT00108953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920018|NCT04464980|Naltrexone|naltrexone|mesh-list
91920019|NCT04464980|Buprenorphine|buprenorphine|mesh-list
91920020|NCT04464980|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91920021|NCT04464980|Narcotics|narcotics|mesh-ancestor
91920022|NCT04464980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920023|NCT04464980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920024|NCT04464980|Analgesics|analgesics|mesh-ancestor
91920025|NCT04464980|Sensory System Agents|sensory system agents|mesh-ancestor
91920026|NCT04464980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920027|NCT04464980|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91920028|NCT04464980|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91920029|NCT02741531|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91920031|NCT02578316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920032|NCT02578316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920033|NCT02578316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920034|NCT02578316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920035|NCT05532878|Apixaban|apixaban|mesh-list
91920036|NCT05532878|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91920037|NCT05532878|Antithrombins|antithrombins|mesh-ancestor
91920038|NCT05532878|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91920039|NCT05532878|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920040|NCT05532878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920041|NCT05532878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920042|NCT05532878|Anticoagulants|anticoagulants|mesh-ancestor
91920043|NCT02576678|Apremilast|apremilast|mesh-list
91920044|NCT02576678|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920045|NCT02576678|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920046|NCT02576678|Analgesics|analgesics|mesh-ancestor
91920047|NCT02576678|Sensory System Agents|sensory system agents|mesh-ancestor
91920048|NCT02576678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920049|NCT02576678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920050|NCT02576678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920051|NCT02576678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920052|NCT02576678|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91920053|NCT02576678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91920054|NCT02576678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920055|NCT02576678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920056|NCT05532332|Fluoxetine|fluoxetine|mesh-list
91920057|NCT05532332|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91920058|NCT05532332|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91920059|NCT05532332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91920060|NCT05532332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920061|NCT05532332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920062|NCT05532332|Serotonin Agents|serotonin agents|mesh-ancestor
91920063|NCT05532332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920064|NCT05532332|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91920065|NCT05532332|Antidepressive Agents|antidepressive agents|mesh-ancestor
91920066|NCT05532332|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91920067|NCT05532332|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91920068|NCT05532332|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91920069|NCT05532332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920070|NCT05532254|Aripiprazole|aripiprazole|mesh-list
91920071|NCT05532254|Antidepressive Agents|antidepressive agents|mesh-ancestor
91920073|NCT05532254|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91920074|NCT05532254|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91920075|NCT05532254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920076|NCT05532254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920077|NCT05532254|Dopamine Agonists|dopamine agonists|mesh-ancestor
91920078|NCT05532254|Dopamine Agents|dopamine agents|mesh-ancestor
91920079|NCT05532254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920080|NCT05532254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920081|NCT05532254|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91920082|NCT05532254|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91920083|NCT05532254|Serotonin Agents|serotonin agents|mesh-ancestor
91920084|NCT05532254|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91920085|NCT05532254|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91920086|NCT05532254|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91920087|NCT05532254|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91920088|NCT05471648|Pertuzumab|pertuzumab|mesh-list
91920089|NCT05471648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920090|NCT05471648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920091|NCT00108745|Paclitaxel|paclitaxel|mesh-list
91920092|NCT00108745|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91920093|NCT00108745|Paclitaxel poliglumex|paclitaxel poliglumex|mesh-list
91920094|NCT00108745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91920095|NCT00108745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920096|NCT00108745|Tubulin Modulators|tubulin modulators|mesh-ancestor
91920097|NCT00108745|Antimitotic Agents|antimitotic agents|mesh-ancestor
91920098|NCT00108745|Mitosis Modulators|mitosis modulators|mesh-ancestor
91920099|NCT00108745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920101|NCT05532020|Choline|choline|mesh-list
91920102|NCT05532020|Lipotropic Agents|lipotropic agents|mesh-ancestor
91920103|NCT05532020|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91920104|NCT05532020|Antimetabolites|antimetabolites|mesh-ancestor
91920105|NCT05532020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920106|NCT05532020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91920107|NCT05532020|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91920108|NCT05532020|Nootropic Agents|nootropic agents|mesh-ancestor
91920109|NCT05532020|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91920110|NCT05532020|Vasodilator Agents|vasodilator agents|mesh-ancestor
91920111|NCT02098343|Carboplatin|carboplatin|mesh-list
91920112|NCT02098343|Doxorubicin|doxorubicin|mesh-list
91920113|NCT02098343|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91920114|NCT02098343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920115|NCT02098343|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91920116|NCT02098343|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91920117|NCT02098343|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91920118|NCT02098343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920119|NCT02098343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920120|NCT02176369|Vinorelbine|vinorelbine|mesh-list
91920121|NCT02176369|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91920122|NCT02176369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920123|NCT02176369|Tubulin Modulators|tubulin modulators|mesh-ancestor
91920124|NCT02176369|Antimitotic Agents|antimitotic agents|mesh-ancestor
91920125|NCT02176369|Mitosis Modulators|mitosis modulators|mesh-ancestor
91920126|NCT02176369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920127|NCT02716805|Melphalan|melphalan|mesh-list
91920128|NCT02716805|Durvalumab|durvalumab|mesh-list
91920129|NCT02716805|Tremelimumab|tremelimumab|mesh-list
91920130|NCT02716805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91920131|NCT02716805|Alkylating Agents|alkylating agents|mesh-ancestor
91920132|NCT02716805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920133|NCT02716805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920134|NCT02716805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91920135|NCT02716805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91920136|NCT02716805|Immunologic Factors|immunologic factors|mesh-ancestor
91920137|NCT02716805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920138|NCT02716805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920139|NCT02174263|Immunoglobulins|immunoglobulins|mesh-list
91920142|NCT02174263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920144|NCT04152473|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91920145|NCT04152473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91920146|NCT04099355|Dronabinol|dronabinol|mesh-list
91920147|NCT04099355|Hallucinogens|hallucinogens|mesh-ancestor
91920148|NCT04099355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920149|NCT04099355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91920150|NCT04099355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920151|NCT04099355|Analgesics|analgesics|mesh-ancestor
91920152|NCT04099355|Sensory System Agents|sensory system agents|mesh-ancestor
91920153|NCT04099355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920154|NCT04099355|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91920155|NCT04099355|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91920156|NCT04099355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920157|NCT04099355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920159|NCT04099355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920160|NCT02581982|Paclitaxel|paclitaxel|mesh-list
91920161|NCT02581982|Pembrolizumab|pembrolizumab|mesh-list
91920162|NCT02581982|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91920163|NCT02581982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91920164|NCT02581982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920165|NCT02581982|Tubulin Modulators|tubulin modulators|mesh-ancestor
91920166|NCT02581982|Antimitotic Agents|antimitotic agents|mesh-ancestor
91920167|NCT02581982|Mitosis Modulators|mitosis modulators|mesh-ancestor
91920168|NCT02581982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920169|NCT02581982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920170|NCT02581982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91920172|NCT03751397|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
91920173|NCT03751397|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920174|NCT03751397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920175|NCT03751397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920176|NCT02176681|Vildagliptin|vildagliptin|mesh-list
91920177|NCT02176681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920178|NCT02176681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920179|NCT02176681|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91920180|NCT02176681|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920181|NCT02176681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920182|NCT02176681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920183|NCT02179099|Botulinum Toxins|botulinum toxins|mesh-list
91920184|NCT02179099|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91920185|NCT02179099|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91920186|NCT02179099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91920187|NCT02179099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920188|NCT02179099|Cholinergic Agents|cholinergic agents|mesh-ancestor
91920189|NCT02179099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920190|NCT02179099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920191|NCT02179099|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91920192|NCT02179099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920193|NCT02254577|Progesterone|progesterone|mesh-list
91920194|NCT02254577|Progestins|progestins|mesh-ancestor
91920195|NCT02254577|Hormones|hormones|mesh-ancestor
91920196|NCT02254577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920197|NCT02254577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920198|NCT02176759|Citric Acid|citric acid|mesh-list
91920199|NCT02176759|Sodium Citrate|sodium citrate|mesh-list
91920200|NCT02176759|Anticoagulants|anticoagulants|mesh-ancestor
91920201|NCT02176759|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91920202|NCT02176759|Chelating Agents|chelating agents|mesh-ancestor
91920203|NCT02176759|Sequestering Agents|sequestering agents|mesh-ancestor
91920204|NCT02176759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920210|NCT03538171|Exemestane|exemestane|mesh-list
91920211|NCT03538171|Entinostat|entinostat|mesh-list
91920212|NCT03538171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920213|NCT03538171|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91920214|NCT03538171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91920215|NCT03538171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920216|NCT03538171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920217|NCT03538171|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91920218|NCT03538171|Hormone Antagonists|hormone antagonists|mesh-ancestor
91920219|NCT03538171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920220|NCT03538171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920221|NCT03538171|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91920223|NCT05312216|Lenvatinib|lenvatinib|mesh-list
91920224|NCT05312216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920225|NCT05312216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920226|NCT05312216|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920227|NCT05312216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920228|NCT05312216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920229|NCT02256319|Dexmedetomidine|dexmedetomidine|mesh-list
91920230|NCT02256319|Propofol|propofol|mesh-list
91920231|NCT02256319|Imidazole|imidazole|mesh-list
91920232|NCT02256319|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91920233|NCT02256319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920234|NCT02256319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920235|NCT02256319|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920236|NCT02256319|Analgesics|analgesics|mesh-ancestor
91920237|NCT02256319|Sensory System Agents|sensory system agents|mesh-ancestor
91920238|NCT02256319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920239|NCT02256319|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91920240|NCT02256319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91920241|NCT02256319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91920242|NCT02256319|Adrenergic Agents|adrenergic agents|mesh-ancestor
91920243|NCT02256319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920244|NCT02256319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920245|NCT02256319|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91920246|NCT02256319|Anesthetics, General|anesthetics, general|mesh-ancestor
91920247|NCT02256319|Anesthetics|anesthetics|mesh-ancestor
91920248|NCT02256319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920249|NCT04510285|Pembrolizumab|pembrolizumab|mesh-list
91920250|NCT04510285|Trastuzumab|trastuzumab|mesh-list
91920251|NCT04510285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920252|NCT04510285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920253|NCT04510285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91920254|NCT04510285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920255|NCT05450432|Ketamine|ketamine|mesh-list
91920256|NCT05450432|Esketamine|esketamine|mesh-list
91920257|NCT05450432|Analgesics|analgesics|mesh-ancestor
91920258|NCT05450432|Sensory System Agents|sensory system agents|mesh-ancestor
91920259|NCT05450432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920260|NCT05450432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920261|NCT05450432|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91920262|NCT05450432|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91920263|NCT05450432|Anesthetics, General|anesthetics, general|mesh-ancestor
91920264|NCT05450432|Anesthetics|anesthetics|mesh-ancestor
91920265|NCT05450432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920266|NCT05450432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91920267|NCT05450432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91920268|NCT05450432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920269|NCT05450432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920270|NCT05450432|Antidepressive Agents|antidepressive agents|mesh-ancestor
91920271|NCT05450432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91920272|NCT02179255|Hormones|hormones|mesh-list
91920273|NCT02179255|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91920274|NCT02179255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920275|NCT02179255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920276|NCT02182063|Nintedanib|nintedanib|mesh-list
91920277|NCT02182063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920278|NCT02182063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920279|NCT02182063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920280|NCT02182063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920281|NCT02182141|Nintedanib|nintedanib|mesh-list
91920282|NCT02182141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920283|NCT02182141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920284|NCT02182141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920285|NCT02182141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920286|NCT02182219|Nintedanib|nintedanib|mesh-list
91920287|NCT02182219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920288|NCT02182219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920289|NCT02182219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920290|NCT02182219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920291|NCT05303480|Mechlorethamine|mechlorethamine|mesh-list
91920292|NCT05303480|Alkylating Agents|alkylating agents|mesh-ancestor
91920293|NCT05303480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920294|NCT05303480|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91920295|NCT05303480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920296|NCT02182375|Raltegravir Potassium|raltegravir potassium|mesh-list
91920298|NCT02182375|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91920299|NCT02182375|Antiviral Agents|antiviral agents|mesh-ancestor
91920300|NCT02182375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920301|NCT02182375|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91920302|NCT02182375|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91920303|NCT02182375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920304|NCT02182375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920306|NCT02179567|Docetaxel|docetaxel|mesh-list
91920307|NCT02179567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920308|NCT02179567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920309|NCT02179567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91920310|NCT02179567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91920311|NCT02179567|Growth Substances|growth substances|mesh-ancestor
91920312|NCT02179567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920313|NCT02179567|Growth Inhibitors|growth inhibitors|mesh-ancestor
91920314|NCT02179567|Tubulin Modulators|tubulin modulators|mesh-ancestor
91920315|NCT02179567|Antimitotic Agents|antimitotic agents|mesh-ancestor
91920316|NCT02179567|Mitosis Modulators|mitosis modulators|mesh-ancestor
91920317|NCT02179567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920318|NCT02182453|Empagliflozin|empagliflozin|mesh-list
91920319|NCT02182453|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91920320|NCT02182453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920321|NCT02182453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920322|NCT02182453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920323|NCT02182531|Pseudoephedrine|pseudoephedrine|mesh-list
91920325|NCT02182531|Epinastine|epinastine|mesh-list
91920326|NCT02182531|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91920327|NCT02182531|Autonomic Agents|autonomic agents|mesh-ancestor
91920328|NCT02182531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920329|NCT02182531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920330|NCT02182531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91920331|NCT02182531|Respiratory System Agents|respiratory system agents|mesh-ancestor
91920332|NCT02182531|Nasal Decongestants|nasal decongestants|mesh-ancestor
91920333|NCT02182531|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91920334|NCT02182531|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91920335|NCT02182531|Sympathomimetics|sympathomimetics|mesh-ancestor
91920336|NCT02182531|Adrenergic Agents|adrenergic agents|mesh-ancestor
91920337|NCT02182531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920338|NCT02182531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920339|NCT02182531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91920340|NCT02182531|Histamine Antagonists|histamine antagonists|mesh-ancestor
91920341|NCT02182531|Histamine Agents|histamine agents|mesh-ancestor
91920342|NCT01990352|Doxorubicin|doxorubicin|mesh-list
91920343|NCT01990352|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91920344|NCT01990352|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91920345|NCT01990352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920346|NCT01990352|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91920347|NCT01990352|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91920348|NCT01990352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920349|NCT01990352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920350|NCT02177305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91920351|NCT02177305|Tiotropium Bromide|tiotropium bromide|mesh-list
91920352|NCT02177305|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91920353|NCT02177305|Autonomic Agents|autonomic agents|mesh-ancestor
91920354|NCT02177305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920355|NCT02177305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920356|NCT02177305|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91920357|NCT02177305|Respiratory System Agents|respiratory system agents|mesh-ancestor
91920358|NCT02177305|Parasympatholytics|parasympatholytics|mesh-ancestor
91920359|NCT02177305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91920360|NCT02177305|Cholinergic Agents|cholinergic agents|mesh-ancestor
91920361|NCT02177305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920362|NCT02177305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920364|NCT02182765|Abacavir|abacavir|mesh-list
91920365|NCT02182765|Amprenavir|amprenavir|mesh-list
91920366|NCT02182765|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91920367|NCT02182765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91920368|NCT02182765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920369|NCT02182765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920370|NCT02182765|Antiviral Agents|antiviral agents|mesh-ancestor
91920371|NCT02182765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920372|NCT02182765|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91920373|NCT02182765|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91920374|NCT02182765|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91920375|NCT02182765|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91920376|NCT02182765|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91920377|NCT02182765|Antitubercular Agents|antitubercular agents|mesh-ancestor
91920378|NCT02182765|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91920379|NCT02182765|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91920380|NCT02182765|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91920381|NCT02182765|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920383|NCT02179645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920384|NCT02179645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920385|NCT02179645|Analgesics|analgesics|mesh-ancestor
91920386|NCT02179645|Sensory System Agents|sensory system agents|mesh-ancestor
91920387|NCT02179645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920388|NCT02179645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920389|NCT02179645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920390|NCT02179645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920391|NCT02179645|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91920392|NCT02179645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91920394|NCT02179645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920395|NCT03537157|Rifaximin|rifaximin|mesh-list
91920396|NCT03537157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91920397|NCT03537157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920398|NCT03537157|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91920399|NCT01606202|Nabiximols|nabiximols|mesh-list
91920400|NCT01606202|Analgesics|analgesics|mesh-ancestor
91920401|NCT01606202|Sensory System Agents|sensory system agents|mesh-ancestor
91920402|NCT01606202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920403|NCT01606202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920404|NCT05529290|Acetaminophen|acetaminophen|mesh-list
91920405|NCT05529290|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91920406|NCT05529290|Ketoprofen|ketoprofen|mesh-list
91920407|NCT05529290|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920408|NCT05529290|Analgesics|analgesics|mesh-ancestor
91920409|NCT05529290|Sensory System Agents|sensory system agents|mesh-ancestor
91920410|NCT05529290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920411|NCT05529290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920412|NCT05529290|Antipyretics|antipyretics|mesh-ancestor
91920413|NCT05529290|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920414|NCT05529290|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920415|NCT05529290|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920416|NCT05529290|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91920417|NCT05529290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920418|NCT05529290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920419|NCT03536611|Warfarin|warfarin|mesh-list
91920420|NCT03536611|Dabigatran|dabigatran|mesh-list
91920421|NCT03536611|Anticoagulants|anticoagulants|mesh-ancestor
91920422|NCT03536611|Antithrombins|antithrombins|mesh-ancestor
91920423|NCT03536611|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91920424|NCT03536611|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920425|NCT03536611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920426|NCT03536611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920427|NCT02630459|Erenumab|erenumab|mesh-list
91920428|NCT02630459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91920429|NCT02630459|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91920430|NCT02630459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920431|NCT02630459|Analgesics|analgesics|mesh-ancestor
91920432|NCT02630459|Sensory System Agents|sensory system agents|mesh-ancestor
91920433|NCT02630459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920434|NCT02630459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920435|NCT02630459|Immunologic Factors|immunologic factors|mesh-ancestor
91920436|NCT02183077|Meloxicam|meloxicam|mesh-list
91920437|NCT02183077|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920438|NCT02183077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920439|NCT02183077|Analgesics|analgesics|mesh-ancestor
91920440|NCT02183077|Sensory System Agents|sensory system agents|mesh-ancestor
91920441|NCT02183077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920442|NCT02183077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920443|NCT02183077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920444|NCT02183077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920445|NCT02183077|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91920446|NCT02183077|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91920447|NCT02183077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920448|NCT02183077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920449|NCT02183155|Indomethacin|indomethacin|mesh-list
91920450|NCT02183155|Meloxicam|meloxicam|mesh-list
91920526|NCT02177539|Phenylephrine|phenylephrine|mesh-list
91920451|NCT02183155|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920452|NCT02183155|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920453|NCT02183155|Analgesics|analgesics|mesh-ancestor
91920454|NCT02183155|Sensory System Agents|sensory system agents|mesh-ancestor
91920455|NCT02183155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920456|NCT02183155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920457|NCT02183155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920458|NCT02183155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920459|NCT02183155|Gout Suppressants|gout suppressants|mesh-ancestor
91920460|NCT02183155|Tocolytic Agents|tocolytic agents|mesh-ancestor
91920461|NCT02183155|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91920462|NCT02183155|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91920463|NCT02183155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920464|NCT02183155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920465|NCT02183155|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91920467|NCT02177461|Clonidine|clonidine|mesh-list
91920468|NCT02177461|Enalapril|enalapril|mesh-list
91920469|NCT02177461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91920470|NCT02177461|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91920471|NCT02177461|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91920472|NCT02177461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920473|NCT02177461|Analgesics|analgesics|mesh-ancestor
91920474|NCT02177461|Sensory System Agents|sensory system agents|mesh-ancestor
91920475|NCT02177461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920476|NCT02177461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920477|NCT02177461|Sympatholytics|sympatholytics|mesh-ancestor
91920478|NCT02177461|Autonomic Agents|autonomic agents|mesh-ancestor
91920479|NCT02177461|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91920480|NCT02177461|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91920481|NCT02177461|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91920482|NCT02177461|Adrenergic Agents|adrenergic agents|mesh-ancestor
91920483|NCT02177461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920484|NCT02177461|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91920485|NCT02177461|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920486|NCT02177461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920487|NCT03545243|Pantoprazole|pantoprazole|mesh-list
91920488|NCT03545243|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91920489|NCT03545243|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91920490|NCT03545243|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91920491|NCT03545243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920492|NCT03545243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920493|NCT02183311|Linagliptin|linagliptin|mesh-list
91920494|NCT02183311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920495|NCT02183311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920496|NCT02183311|Incretins|incretins|mesh-ancestor
91920497|NCT02183311|Hormones|hormones|mesh-ancestor
91920498|NCT02183311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920499|NCT02183311|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91920500|NCT02183311|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920501|NCT02183311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920502|NCT02183311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920503|NCT05518526|Annamycin|annamycin|mesh-list
91920504|NCT05518526|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91920505|NCT05518526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920506|NCT01464593|Doxorubicin|doxorubicin|mesh-list
91920507|NCT01464593|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91920508|NCT01464593|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91920509|NCT01464593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920510|NCT01464593|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91920511|NCT01464593|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91920512|NCT01464593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920513|NCT01464593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920514|NCT02183389|Linagliptin|linagliptin|mesh-list
91920515|NCT02183389|Warfarin|warfarin|mesh-list
91920516|NCT02183389|Anticoagulants|anticoagulants|mesh-ancestor
91920517|NCT02183389|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920518|NCT02183389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920519|NCT02183389|Incretins|incretins|mesh-ancestor
91920520|NCT02183389|Hormones|hormones|mesh-ancestor
91920521|NCT02183389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920522|NCT02183389|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91920523|NCT02183389|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920524|NCT02183389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920525|NCT02183389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920533|NCT02177539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920534|NCT02177539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920535|NCT02177539|Sympathomimetics|sympathomimetics|mesh-ancestor
91920536|NCT02177539|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91920537|NCT02177539|Nasal Decongestants|nasal decongestants|mesh-ancestor
91920538|NCT02177539|Respiratory System Agents|respiratory system agents|mesh-ancestor
91920539|NCT02177539|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91920540|NCT02177539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91920541|NCT02177539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91920542|NCT02177539|Adrenergic Agents|adrenergic agents|mesh-ancestor
91920543|NCT02177539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920544|NCT02177539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920545|NCT02177539|Protective Agents|protective agents|mesh-ancestor
91920546|NCT02177539|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91920547|NCT02177539|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91920548|NCT02177539|Cholinergic Agents|cholinergic agents|mesh-ancestor
91920549|NCT02177539|Parasympatholytics|parasympatholytics|mesh-ancestor
91920551|NCT04141904|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91920552|NCT04141904|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91920553|NCT04141904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920554|NCT04141904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920556|NCT05523986|Vitamins|vitamins|mesh-ancestor
91920557|NCT05523986|Micronutrients|micronutrients|mesh-ancestor
91920558|NCT05523986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920559|NCT05523986|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91920560|NCT01361711|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91920561|NCT01361711|Alemtuzumab|alemtuzumab|mesh-list
91920562|NCT01361711|Ofatumumab|ofatumumab|mesh-list
91920563|NCT01361711|Antibodies|antibodies|mesh-list
91920564|NCT01361711|Immunoglobulins|immunoglobulins|mesh-list
91920565|NCT01361711|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91920566|NCT01361711|Immunologic Factors|immunologic factors|mesh-ancestor
91920567|NCT01361711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920568|NCT01361711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920569|NCT05517746|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91920570|NCT05527340|Dexamethasone|dexamethasone|mesh-list
91920571|NCT05527340|Daratumumab|daratumumab|mesh-list
91920572|NCT05527340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920573|NCT05527340|Antiemetics|antiemetics|mesh-ancestor
91920574|NCT05527340|Autonomic Agents|autonomic agents|mesh-ancestor
91920575|NCT05527340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920576|NCT05527340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920577|NCT05527340|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91920578|NCT05527340|Glucocorticoids|glucocorticoids|mesh-ancestor
91920579|NCT05527340|Hormones|hormones|mesh-ancestor
91920580|NCT05527340|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920581|NCT05527340|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91920582|NCT05527340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920583|NCT05527106|Ascorbic Acid|ascorbic acid|mesh-list
91920584|NCT05527106|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
91920585|NCT05527106|Vitamins|vitamins|mesh-ancestor
91920586|NCT05527106|Micronutrients|micronutrients|mesh-ancestor
91920587|NCT05527106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920588|NCT05527106|Antioxidants|antioxidants|mesh-ancestor
91920589|NCT05527106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920590|NCT05527106|Protective Agents|protective agents|mesh-ancestor
91920591|NCT05527106|Nootropic Agents|nootropic agents|mesh-ancestor
91920593|NCT05526794|Sensory System Agents|sensory system agents|mesh-ancestor
91920594|NCT05526794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920595|NCT05526794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920596|NCT05522894|Paclitaxel|paclitaxel|mesh-list
91920597|NCT05522894|Cisplatin|cisplatin|mesh-list
91920598|NCT05522894|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91920599|NCT05522894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920600|NCT05522894|Tubulin Modulators|tubulin modulators|mesh-ancestor
91920601|NCT05522894|Antimitotic Agents|antimitotic agents|mesh-ancestor
91920602|NCT05522894|Mitosis Modulators|mitosis modulators|mesh-ancestor
91920603|NCT05522894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920604|NCT05522816|Tirbanibulin|tirbanibulin|mesh-list
91920605|NCT05522816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920606|NCT05522816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920607|NCT02573870|Fluticasone|fluticasone|mesh-list
91920608|NCT02573870|Xhance|xhance|mesh-list
91920609|NCT02573870|Albuterol|albuterol|mesh-list
91920610|NCT02573870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920611|NCT02573870|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91920613|NCT02573870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920614|NCT02573870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920615|NCT02573870|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91920616|NCT02573870|Respiratory System Agents|respiratory system agents|mesh-ancestor
91920617|NCT02573870|Dermatologic Agents|dermatologic agents|mesh-ancestor
91920618|NCT02573870|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91920619|NCT02573870|Tocolytic Agents|tocolytic agents|mesh-ancestor
91920620|NCT02573870|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91920621|NCT02573870|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91920622|NCT02573870|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91920623|NCT02573870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91920624|NCT02573870|Adrenergic Agents|adrenergic agents|mesh-ancestor
91920625|NCT02573870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920626|NCT02573870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920627|NCT05149898|Cannabidiol|cannabidiol|mesh-list
91920628|NCT05149898|Anticonvulsants|anticonvulsants|mesh-ancestor
91920629|NCT05148026|Heparin|heparin|mesh-list
91920630|NCT05148026|Calcium heparin|calcium heparin|mesh-list
91920631|NCT05148026|Dialysis Solutions|dialysis solutions|mesh-list
91920632|NCT05148026|Anticoagulants|anticoagulants|mesh-ancestor
91920633|NCT05148026|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91920634|NCT05148026|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91920635|NCT05148026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920636|NCT05148026|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91920637|NCT05522270|Mitogens|mitogens|mesh-list
91920638|NCT05522270|Mitosis Modulators|mitosis modulators|mesh-ancestor
91920639|NCT05522270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920640|NCT05522192|Venetoclax|venetoclax|mesh-list
91920641|NCT05522192|Mitoxantrone|mitoxantrone|mesh-list
91920642|NCT05522192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920643|NCT05522192|Analgesics|analgesics|mesh-ancestor
91920644|NCT05522192|Sensory System Agents|sensory system agents|mesh-ancestor
91920645|NCT05522192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920646|NCT05522192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920647|NCT05522192|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91920648|NCT05522192|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91920649|NCT05522192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920650|NCT05522192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920651|NCT05522036|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
91920652|NCT05522036|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91920653|NCT05522036|Dermatologic Agents|dermatologic agents|mesh-ancestor
91920654|NCT05515874|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91920655|NCT05515874|Hematinics|hematinics|mesh-ancestor
91920656|NCT05515874|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91920657|NCT05515874|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91920658|NCT05525234|Thalidomide|thalidomide|mesh-list
91920659|NCT05525234|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91920660|NCT05525234|Immunologic Factors|immunologic factors|mesh-ancestor
91920661|NCT05525234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920662|NCT05525234|Leprostatic Agents|leprostatic agents|mesh-ancestor
91920663|NCT05525234|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91920664|NCT05525234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920665|NCT05525234|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91920666|NCT05525234|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91920667|NCT05525234|Growth Substances|growth substances|mesh-ancestor
91920668|NCT05525234|Growth Inhibitors|growth inhibitors|mesh-ancestor
91920669|NCT05525234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920670|NCT02574260|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
91920671|NCT02574260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920672|NCT02574260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920673|NCT04300790|Metformin|metformin|mesh-list
91920674|NCT04300790|Letrozole|letrozole|mesh-list
91920675|NCT04300790|Fulvestrant|fulvestrant|mesh-list
91920676|NCT04300790|Exemestane|exemestane|mesh-list
91920677|NCT04300790|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920678|NCT04300790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920679|NCT04300790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920680|NCT04300790|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91920681|NCT04300790|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91920682|NCT04300790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920683|NCT04300790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920684|NCT04300790|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91920685|NCT04300790|Hormone Antagonists|hormone antagonists|mesh-ancestor
91920686|NCT04300790|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920687|NCT04300790|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91920763|NCT02183467|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920688|NCT04300790|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91920689|NCT04295330|Lidocaine|lidocaine|mesh-list
91920690|NCT04295330|Anesthetics, Local|anesthetics, local|mesh-ancestor
91920691|NCT04295330|Anesthetics|anesthetics|mesh-ancestor
91920692|NCT04295330|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920693|NCT04295330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920694|NCT04295330|Sensory System Agents|sensory system agents|mesh-ancestor
91920695|NCT04295330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920696|NCT04295330|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91920697|NCT04295330|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91920698|NCT04295330|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91920699|NCT04295330|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91920700|NCT04295330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920701|NCT05525156|Aspirin|aspirin|mesh-list
91920702|NCT05525156|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920703|NCT05525156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920704|NCT05525156|Analgesics|analgesics|mesh-ancestor
91920705|NCT05525156|Sensory System Agents|sensory system agents|mesh-ancestor
91920706|NCT05525156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920707|NCT05525156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920708|NCT05525156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920709|NCT05525156|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920710|NCT05525156|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91920711|NCT05525156|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91920712|NCT05525156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920713|NCT05525156|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91920714|NCT05525156|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91920715|NCT05525156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920716|NCT05525156|Antipyretics|antipyretics|mesh-ancestor
91920717|NCT05512364|Tamoxifen|tamoxifen|mesh-list
91920718|NCT05512364|Letrozole|letrozole|mesh-list
91920719|NCT05512364|Anastrozole|anastrozole|mesh-list
91920720|NCT05512364|Exemestane|exemestane|mesh-list
91920721|NCT05512364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920722|NCT05512364|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91920723|NCT05512364|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91920724|NCT05512364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920725|NCT05512364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920726|NCT05512364|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91920727|NCT05512364|Hormone Antagonists|hormone antagonists|mesh-ancestor
91920728|NCT05512364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920729|NCT05512364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920730|NCT05512364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91920731|NCT05512364|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91920732|NCT05512364|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91920733|NCT05512364|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91920734|NCT05512130|Empagliflozin|empagliflozin|mesh-list
91920735|NCT05512130|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91920736|NCT05512130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920737|NCT05512130|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920738|NCT05512130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920741|NCT02180425|Isotretinoin|isotretinoin|mesh-list
91920742|NCT02180425|Dermatologic Agents|dermatologic agents|mesh-ancestor
91920743|NCT02180425|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920744|NCT02180425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920745|NCT02180425|Analgesics|analgesics|mesh-ancestor
91920746|NCT02180425|Sensory System Agents|sensory system agents|mesh-ancestor
91920747|NCT02180425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920748|NCT02180425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920749|NCT02180425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920750|NCT02180425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920751|NCT02180425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920752|NCT02180425|Keratolytic Agents|keratolytic agents|mesh-ancestor
91920753|NCT02183467|Linagliptin|linagliptin|mesh-list
91920754|NCT02183467|Moxifloxacin|moxifloxacin|mesh-list
91920755|NCT02183467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91920756|NCT02183467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920757|NCT02183467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91920758|NCT02183467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91920759|NCT02183467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920760|NCT02183467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920761|NCT02183467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920762|NCT02183467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920766|NCT02183467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920767|NCT02183467|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91920768|NCT02183467|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920769|NCT02180503|Linagliptin|linagliptin|mesh-list
91920770|NCT02180503|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920771|NCT02180503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920772|NCT02180503|Incretins|incretins|mesh-ancestor
91920773|NCT02180503|Hormones|hormones|mesh-ancestor
91920774|NCT02180503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920775|NCT02180503|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91920776|NCT02180503|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920777|NCT02180503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920778|NCT02180503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920779|NCT02177851|Iron|iron|mesh-list
91920780|NCT02177851|Trace Elements|trace elements|mesh-ancestor
91920781|NCT02177851|Micronutrients|micronutrients|mesh-ancestor
91920782|NCT02177851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920783|NCT05075876|Granisetron|granisetron|mesh-list
91920784|NCT05075876|Antiemetics|antiemetics|mesh-ancestor
91920785|NCT05075876|Autonomic Agents|autonomic agents|mesh-ancestor
91920786|NCT05075876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920787|NCT05075876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920788|NCT05075876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91920789|NCT05075876|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91920790|NCT05075876|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91920791|NCT05075876|Serotonin Agents|serotonin agents|mesh-ancestor
91920792|NCT05075876|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920793|NCT05075876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920794|NCT02180737|Dexmedetomidine|dexmedetomidine|mesh-list
91920795|NCT02180737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91920796|NCT02180737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920797|NCT02180737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920798|NCT02180737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920799|NCT02180737|Analgesics|analgesics|mesh-ancestor
91920800|NCT02180737|Sensory System Agents|sensory system agents|mesh-ancestor
91920801|NCT02180737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920802|NCT02180737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91920803|NCT02180737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91920804|NCT02180737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91920805|NCT02180737|Adrenergic Agents|adrenergic agents|mesh-ancestor
91920806|NCT02180737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920807|NCT02180737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920808|NCT05520944|Chlorpheniramine|chlorpheniramine|mesh-list
91920809|NCT05520944|Antipruritics|antipruritics|mesh-ancestor
91920810|NCT05520944|Dermatologic Agents|dermatologic agents|mesh-ancestor
91920811|NCT05520944|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91920812|NCT05520944|Histamine Antagonists|histamine antagonists|mesh-ancestor
91920814|NCT05520944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920815|NCT05520944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920816|NCT05520944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920817|NCT05520944|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91920818|NCT02183623|Linagliptin|linagliptin|mesh-list
91920819|NCT02183623|Simvastatin|simvastatin|mesh-list
91920820|NCT02183623|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91920821|NCT02183623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91920822|NCT02183623|Antimetabolites|antimetabolites|mesh-ancestor
91920823|NCT02183623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920824|NCT02183623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91920825|NCT02183623|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91920826|NCT02183623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920827|NCT02183623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920828|NCT02183623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920829|NCT02183623|Incretins|incretins|mesh-ancestor
91920831|NCT02183623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920832|NCT02183623|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91920833|NCT02183623|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920834|NCT02183701|Losartan|losartan|mesh-list
91920835|NCT02183701|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91920836|NCT02183701|Telmisartan|telmisartan|mesh-list
91920837|NCT02183701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91920838|NCT02183701|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91920839|NCT02183701|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91920840|NCT02183701|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91920841|NCT02183701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920842|NCT02183701|Diuretics|diuretics|mesh-ancestor
91920843|NCT02183701|Natriuretic Agents|natriuretic agents|mesh-ancestor
91920844|NCT02183701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920845|NCT02183701|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91920846|NCT02183701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91920847|NCT02183779|Fluconazole|fluconazole|mesh-list
91920848|NCT02183779|Antifungal Agents|antifungal agents|mesh-ancestor
91920849|NCT02183779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920850|NCT02183779|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91920851|NCT02183779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91920852|NCT02183779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920853|NCT02183779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920854|NCT02183779|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91920855|NCT02183779|Hormone Antagonists|hormone antagonists|mesh-ancestor
91920856|NCT02183779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920857|NCT02183779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920858|NCT02183779|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91920859|NCT02183779|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91920860|NCT02184091|Nevirapine|nevirapine|mesh-list
91920861|NCT02184091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91920862|NCT02184091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91920863|NCT02184091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920864|NCT02184091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920865|NCT02184091|Antiviral Agents|antiviral agents|mesh-ancestor
91920866|NCT02184091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920867|NCT02184091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91920868|NCT02184091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91920869|NCT02184091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91920870|NCT02184091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91920871|NCT02184247|Theophylline|theophylline|mesh-list
91920872|NCT02184247|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91920873|NCT02184247|Autonomic Agents|autonomic agents|mesh-ancestor
91920874|NCT02184247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920875|NCT02184247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920876|NCT02184247|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91920877|NCT02184247|Respiratory System Agents|respiratory system agents|mesh-ancestor
91920878|NCT02184247|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91920879|NCT02184247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920880|NCT02184247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920882|NCT02184247|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91920884|NCT02184247|Purinergic Agents|purinergic agents|mesh-ancestor
91920885|NCT02184247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91920886|NCT04292756|Triamcinolone|triamcinolone|mesh-list
91920887|NCT04292756|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91920888|NCT04292756|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91920889|NCT04292756|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91920890|NCT04292756|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920891|NCT04292756|Glucocorticoids|glucocorticoids|mesh-ancestor
91920892|NCT04292756|Hormones|hormones|mesh-ancestor
91920893|NCT04292756|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91920894|NCT04292756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920895|NCT04292756|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91920896|NCT04292756|Immunologic Factors|immunologic factors|mesh-ancestor
91920897|NCT04292756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920898|NCT04292756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920899|NCT05074706|Antibodies|antibodies|mesh-list
91920900|NCT05074706|Immunoglobulin G|immunoglobulin g|mesh-list
91920901|NCT05074706|Immunologic Factors|immunologic factors|mesh-ancestor
91920902|NCT05074706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920903|NCT02181205|Bupivacaine|bupivacaine|mesh-list
91920904|NCT02181205|Anesthetics, Local|anesthetics, local|mesh-ancestor
91920905|NCT02181205|Anesthetics|anesthetics|mesh-ancestor
91920906|NCT02181205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920907|NCT02181205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920908|NCT02181205|Sensory System Agents|sensory system agents|mesh-ancestor
91920909|NCT02181205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920910|NCT02184559|Ropivacaine|ropivacaine|mesh-list
91920911|NCT02184559|Anesthetics, Local|anesthetics, local|mesh-ancestor
91920912|NCT02184559|Anesthetics|anesthetics|mesh-ancestor
91920913|NCT02184559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91920914|NCT02184559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920915|NCT02184559|Sensory System Agents|sensory system agents|mesh-ancestor
91920916|NCT02184559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920918|NCT02185651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920919|NCT02185651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920920|NCT02185651|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91920921|NCT02185651|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91920922|NCT02185651|Antiviral Agents|antiviral agents|mesh-ancestor
91920923|NCT02185651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920924|NCT02185651|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91920925|NCT02185651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920926|NCT02185651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920927|NCT02181361|Aspirin|aspirin|mesh-list
91920928|NCT02181361|Hirudins|hirudins|mesh-list
91920929|NCT02181361|Warfarin|warfarin|mesh-list
91920930|NCT02181361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91920931|NCT02181361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91920932|NCT02181361|Analgesics|analgesics|mesh-ancestor
91920933|NCT02181361|Sensory System Agents|sensory system agents|mesh-ancestor
91920934|NCT02181361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91920935|NCT02181361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920936|NCT02181361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91920937|NCT02181361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920938|NCT02181361|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91920939|NCT02181361|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91920940|NCT02181361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920941|NCT02181361|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91920942|NCT02181361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91920943|NCT02181361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920944|NCT02181361|Antipyretics|antipyretics|mesh-ancestor
91920945|NCT02181361|Anticoagulants|anticoagulants|mesh-ancestor
91920946|NCT02181361|Antithrombins|antithrombins|mesh-ancestor
91920947|NCT02181361|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91920948|NCT02181361|Protease Inhibitors|protease inhibitors|mesh-ancestor
91920949|NCT05060276|Immunoconjugates|immunoconjugates|mesh-list
91920950|NCT05060276|Immunologic Factors|immunologic factors|mesh-ancestor
91920951|NCT05060276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920952|NCT02184637|Lumefantrine|lumefantrine|mesh-list
91920953|NCT02184637|Artemether|artemether|mesh-list
91920954|NCT02184637|Piperaquine|piperaquine|mesh-list
91920955|NCT02184637|Artenimol|artenimol|mesh-list
91920956|NCT02184637|Tafenoquine|tafenoquine|mesh-list
91920957|NCT02184637|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91920958|NCT02184637|Antimalarials|antimalarials|mesh-ancestor
91920959|NCT02184637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91920961|NCT02184637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91920963|NCT04870424|Gout Suppressants|gout suppressants|mesh-ancestor
91920964|NCT04870424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91920965|NCT04870424|Tubulin Modulators|tubulin modulators|mesh-ancestor
91920966|NCT04870424|Antimitotic Agents|antimitotic agents|mesh-ancestor
91920967|NCT04870424|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074242|NCT00072514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91920968|NCT04870424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920969|NCT04870424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91920971|NCT03536845|Cholecalciferol|cholecalciferol|mesh-list
91920972|NCT03536845|Vitamins|vitamins|mesh-ancestor
91920973|NCT03536845|Micronutrients|micronutrients|mesh-ancestor
91920974|NCT03536845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920975|NCT03536845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91920976|NCT03536845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91920977|NCT02256709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91920978|NCT02181985|Heparin|heparin|mesh-list
91920979|NCT02181985|Enoxaparin|enoxaparin|mesh-list
91920980|NCT02181985|Tenecteplase|tenecteplase|mesh-list
91920981|NCT02181985|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91920982|NCT02181985|Abciximab|abciximab|mesh-list
91920983|NCT02181985|Anticoagulants|anticoagulants|mesh-ancestor
91920984|NCT02181985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91920985|NCT02181985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91920986|NCT02181985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920987|NCT02181985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91920989|NCT05514080|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91920990|NCT05514080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91920991|NCT02185963|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91920992|NCT02185963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91920993|NCT02185963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91920994|NCT02185963|Antimetabolites|antimetabolites|mesh-ancestor
91920995|NCT02185963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91920996|NCT02185963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91920997|NCT02185963|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91920998|NCT02185963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91920999|NCT02186119|Ranibizumab|ranibizumab|mesh-list
91921000|NCT02186119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91921001|NCT02186119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91921002|NCT02186119|Growth Substances|growth substances|mesh-ancestor
91921003|NCT02186119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921004|NCT02186119|Growth Inhibitors|growth inhibitors|mesh-ancestor
91921005|NCT02186119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921006|NCT02185261|Interferons|interferons|mesh-list
91921007|NCT02185261|Interferon-alpha|interferon-alpha|mesh-list
91921008|NCT02185261|Interferon alpha-2|interferon alpha-2|mesh-list
91921009|NCT02185261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921010|NCT02185261|Antiviral Agents|antiviral agents|mesh-ancestor
91921011|NCT02185261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921012|NCT02185261|Immunologic Factors|immunologic factors|mesh-ancestor
91921013|NCT02185261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921014|NCT02573012|Prednisone|prednisone|mesh-list
91921015|NCT02573012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921016|NCT02573012|Glucocorticoids|glucocorticoids|mesh-ancestor
91921017|NCT02573012|Hormones|hormones|mesh-ancestor
91921018|NCT02573012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921019|NCT02573012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921020|NCT02573012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91921021|NCT02573012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921022|NCT04128176|Omalizumab|omalizumab|mesh-list
91921023|NCT04128176|Rituximab|rituximab|mesh-list
91921024|NCT04128176|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921025|NCT04128176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921026|NCT04128176|Immunologic Factors|immunologic factors|mesh-ancestor
91921027|NCT04128176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921028|NCT04128176|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921029|NCT04128176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91921030|NCT04128176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91921031|NCT04128176|Respiratory System Agents|respiratory system agents|mesh-ancestor
91921032|NCT02186275|Vitamin D|vitamin d|mesh-list
91921033|NCT02186275|Ergocalciferols|ergocalciferols|mesh-list
91921034|NCT02186275|Cholecalciferol|cholecalciferol|mesh-list
91921035|NCT02186275|Vitamins|vitamins|mesh-list
91921037|NCT02186275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921038|NCT02186275|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91921039|NCT02186275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91921041|NCT05117281|Anesthetics, Local|anesthetics, local|mesh-ancestor
91921042|NCT05117281|Anesthetics|anesthetics|mesh-ancestor
91921043|NCT05117281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921044|NCT05117281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921045|NCT05117281|Sensory System Agents|sensory system agents|mesh-ancestor
91921046|NCT05117281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921047|NCT05519072|Ciprofloxacin|ciprofloxacin|mesh-list
91921048|NCT05519072|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
91921049|NCT05519072|Cephalexin|cephalexin|mesh-list
91921050|NCT05519072|Fosfomycin|fosfomycin|mesh-list
91921051|NCT05519072|Nitrofurantoin|nitrofurantoin|mesh-list
91921052|NCT05519072|Trimethoprim|trimethoprim|mesh-list
91921053|NCT05519072|Sulfamethoxazole|sulfamethoxazole|mesh-list
91921054|NCT05519072|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921055|NCT05519072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921056|NCT05519072|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91921057|NCT05519072|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91921058|NCT05519072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921059|NCT05519072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921060|NCT05519072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921061|NCT05519072|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91921062|NCT05519072|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91921063|NCT05519072|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91921064|NCT05519072|Antimalarials|antimalarials|mesh-ancestor
91921065|NCT05519072|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91921066|NCT05519072|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91921067|NCT05519072|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91921068|NCT05519072|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91921069|NCT05519072|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91921070|NCT05519072|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91921071|NCT04411706|Capecitabine|capecitabine|mesh-list
91921072|NCT04411706|Apatinib|apatinib|mesh-list
91921073|NCT04411706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921075|NCT04411706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921076|NCT04411706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921077|NCT04411706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91921078|NCT04411706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921079|NCT05518994|Bevacizumab|bevacizumab|mesh-list
91921080|NCT05518994|Tislelizumab|tislelizumab|mesh-list
91921081|NCT05518994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921082|NCT05518994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921083|NCT05518994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91921084|NCT05518994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91921085|NCT05518994|Growth Substances|growth substances|mesh-ancestor
91921086|NCT05518994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921087|NCT05518994|Growth Inhibitors|growth inhibitors|mesh-ancestor
91921088|NCT02256943|Amitriptyline|amitriptyline|mesh-list
91921089|NCT02256943|Tolterodine Tartrate|tolterodine tartrate|mesh-list
91921090|NCT02256943|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91921091|NCT02256943|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91921092|NCT02256943|Cholinergic Agents|cholinergic agents|mesh-ancestor
91921093|NCT02256943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921094|NCT02256943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921095|NCT02256943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921096|NCT02256943|Urological Agents|urological agents|mesh-ancestor
91921097|NCT02256943|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91921098|NCT02256943|Antidepressive Agents|antidepressive agents|mesh-ancestor
91921099|NCT02256943|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921100|NCT02256943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921101|NCT02256943|Analgesics|analgesics|mesh-ancestor
91921102|NCT02256943|Sensory System Agents|sensory system agents|mesh-ancestor
91921103|NCT02256943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921104|NCT02256943|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91921105|NCT02256943|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91921106|NCT02256943|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921107|NCT02256943|Adrenergic Agents|adrenergic agents|mesh-ancestor
91921108|NCT05059951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91921109|NCT05059951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921110|NCT05059951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921111|NCT05059951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921112|NCT02186899|Anesthetics|anesthetics|mesh-list
91921113|NCT02186899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921114|NCT02186899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921115|NCT05510024|Immunomodulating Agents|immunomodulating agents|mesh-list
91921116|NCT05510024|Immunologic Factors|immunologic factors|mesh-ancestor
91921117|NCT05510024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921118|NCT02752633|Allopurinol|allopurinol|mesh-list
91921120|NCT02752633|Antimetabolites|antimetabolites|mesh-ancestor
91921121|NCT02752633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921122|NCT02752633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921123|NCT02752633|Gout Suppressants|gout suppressants|mesh-ancestor
91921124|NCT02752633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921125|NCT02752633|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91921126|NCT02752633|Antioxidants|antioxidants|mesh-ancestor
91921127|NCT02752633|Protective Agents|protective agents|mesh-ancestor
91921128|NCT02752633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921129|NCT02191189|Nevirapine|nevirapine|mesh-list
91921130|NCT02191189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91921131|NCT02191189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91921132|NCT02191189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921133|NCT02191189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921134|NCT02191189|Antiviral Agents|antiviral agents|mesh-ancestor
91921135|NCT02191189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921136|NCT02191189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921137|NCT02191189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91921138|NCT02191189|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91921139|NCT02191189|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91921140|NCT05512520|Capecitabine|capecitabine|mesh-list
91921141|NCT05512520|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921142|NCT05512520|Antimetabolites|antimetabolites|mesh-ancestor
91921143|NCT05512520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921144|NCT05512520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921145|NCT02187133|Rituximab|rituximab|mesh-list
91921146|NCT02187133|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91921147|NCT02187133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921148|NCT02187133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921150|NCT02187133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921151|NCT02187133|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921152|NCT02187133|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91921153|NCT02187133|Alkylating Agents|alkylating agents|mesh-ancestor
91921154|NCT02187133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921155|NCT04411862|Choline|choline|mesh-list
91921156|NCT04411862|Lipotropic Agents|lipotropic agents|mesh-ancestor
91921157|NCT04411862|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91921158|NCT04411862|Antimetabolites|antimetabolites|mesh-ancestor
91921159|NCT04411862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921160|NCT04411862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921161|NCT04411862|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91921162|NCT04411862|Nootropic Agents|nootropic agents|mesh-ancestor
91921163|NCT02187211|Minocycline|minocycline|mesh-list
91921164|NCT02187211|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921165|NCT02187211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921166|NCT04766996|Aspirin|aspirin|mesh-list
91921167|NCT04766996|Acetaminophen|acetaminophen|mesh-list
91921168|NCT04766996|Prednisone|prednisone|mesh-list
91921169|NCT04766996|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
91921170|NCT04766996|Meloxicam|meloxicam|mesh-list
91921171|NCT04766996|Diclofenac|diclofenac|mesh-list
91921172|NCT04766996|Lidocaine|lidocaine|mesh-list
91921173|NCT04766996|Pregabalin|pregabalin|mesh-list
91921174|NCT04766996|Tramadol|tramadol|mesh-list
91921175|NCT04766996|Bupivacaine|bupivacaine|mesh-list
91921176|NCT04766996|Propofol|propofol|mesh-list
91921177|NCT04766996|Omeprazole|omeprazole|mesh-list
91921178|NCT04766996|Tranexamic Acid|tranexamic acid|mesh-list
91921180|NCT04766996|Anesthetics|anesthetics|mesh-ancestor
91921181|NCT04766996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921182|NCT04766996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921183|NCT04766996|Sensory System Agents|sensory system agents|mesh-ancestor
91921184|NCT04766996|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921185|NCT04766996|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91921186|NCT04766996|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91921187|NCT04766996|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91921189|NCT04766996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921190|NCT04766996|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921191|NCT04766996|Glucocorticoids|glucocorticoids|mesh-ancestor
91921192|NCT04766996|Hormones|hormones|mesh-ancestor
91921193|NCT04766996|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921194|NCT04766996|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91921195|NCT04766996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921196|NCT04766996|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91921197|NCT04766996|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91921198|NCT04766996|Anesthetics, General|anesthetics, general|mesh-ancestor
91921199|NCT04766996|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921200|NCT04766996|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921201|NCT04766996|Analgesics|analgesics|mesh-ancestor
91921202|NCT04766996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921203|NCT04766996|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91921204|NCT04766996|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91921205|NCT04766996|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91921206|NCT04766996|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921207|NCT04766996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921208|NCT04766996|Antipyretics|antipyretics|mesh-ancestor
91921209|NCT04766996|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921210|NCT04766996|Anticonvulsants|anticonvulsants|mesh-ancestor
91921211|NCT04766996|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91921212|NCT04766996|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91921214|NCT04766996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91921215|NCT04766996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921216|NCT04766996|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91921217|NCT04766996|Hemostatics|hemostatics|mesh-ancestor
91921218|NCT04766996|Coagulants|coagulants|mesh-ancestor
91921219|NCT04766996|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91921220|NCT04766996|Narcotics|narcotics|mesh-ancestor
91921221|NCT04766996|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91921222|NCT04766996|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91921223|NCT04766996|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91921225|NCT02191423|Oxytocics|oxytocics|mesh-ancestor
91921226|NCT02191423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91921227|NCT02191423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921228|NCT05509946|Celecoxib|celecoxib|mesh-list
91921229|NCT05509946|Pregabalin|pregabalin|mesh-list
91921230|NCT05509946|Analgesics|analgesics|mesh-ancestor
91921231|NCT05509946|Sensory System Agents|sensory system agents|mesh-ancestor
91921232|NCT05509946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921233|NCT05509946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921234|NCT05509946|Anticonvulsants|anticonvulsants|mesh-ancestor
91921235|NCT05509946|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91921236|NCT05509946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921237|NCT05509946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921238|NCT05509946|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91921239|NCT05509946|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91921240|NCT05509946|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91921241|NCT05509946|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921242|NCT05509946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921243|NCT05509946|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921244|NCT05509946|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921245|NCT05509946|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921246|NCT05509946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921247|NCT05509946|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91921248|NCT05509946|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921249|NCT05509946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921250|NCT04304209|Capecitabine|capecitabine|mesh-list
91921251|NCT04304209|Oxaliplatin|oxaliplatin|mesh-list
91921252|NCT04304209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921253|NCT04304209|Antimetabolites|antimetabolites|mesh-ancestor
91921254|NCT04304209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921255|NCT04304209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921256|NCT02187367|Cyclophosphamide|cyclophosphamide|mesh-list
91921257|NCT02187367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921258|NCT02187367|Immunologic Factors|immunologic factors|mesh-ancestor
91921259|NCT02187367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921260|NCT02187367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921261|NCT02187367|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91921262|NCT02187367|Alkylating Agents|alkylating agents|mesh-ancestor
91921263|NCT02187367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921264|NCT02187367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921265|NCT02187367|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91921267|NCT02187445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921268|NCT02187445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91921269|NCT02187445|Autonomic Agents|autonomic agents|mesh-ancestor
91921270|NCT02187445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921271|NCT02187445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921272|NCT02187445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91921273|NCT02187445|Respiratory System Agents|respiratory system agents|mesh-ancestor
91921274|NCT02187445|Glucocorticoids|glucocorticoids|mesh-ancestor
91921275|NCT02187445|Hormones|hormones|mesh-ancestor
91921276|NCT02187445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921277|NCT02187523|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91921278|NCT02187523|Telmisartan|telmisartan|mesh-list
91921279|NCT02187523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91921280|NCT02187523|Diuretics|diuretics|mesh-ancestor
91921281|NCT02187523|Natriuretic Agents|natriuretic agents|mesh-ancestor
91921282|NCT02187523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921283|NCT02187523|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91921284|NCT02187523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921285|NCT02187523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921286|NCT02187523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91921287|NCT02187523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91921288|NCT02187679|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91921289|NCT02187679|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91921290|NCT02187679|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91921291|NCT02187679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921292|NCT02187679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921293|NCT02187679|Cholinergic Agents|cholinergic agents|mesh-ancestor
91921294|NCT02187679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921295|NCT02187679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921296|NCT02187679|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91921297|NCT02187679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921298|NCT05507606|Bevacizumab|bevacizumab|mesh-list
91921299|NCT05507606|Carboplatin|carboplatin|mesh-list
91921301|NCT05507606|Osimertinib|osimertinib|mesh-list
91921302|NCT05507606|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921303|NCT05507606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921304|NCT05507606|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91921305|NCT05507606|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91921306|NCT05507606|Growth Substances|growth substances|mesh-ancestor
91921307|NCT05507606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921308|NCT05507606|Growth Inhibitors|growth inhibitors|mesh-ancestor
91921309|NCT05507606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921310|NCT05507606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921311|NCT05507606|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91921312|NCT05507606|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91921313|NCT05507606|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91921315|NCT02191657|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91921316|NCT02191657|Chelating Agents|chelating agents|mesh-ancestor
91921317|NCT02191657|Sequestering Agents|sequestering agents|mesh-ancestor
91921318|NCT02191657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921319|NCT02191891|Afatinib|afatinib|mesh-list
91921320|NCT02191891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921321|NCT02191891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91921322|NCT02191891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074243|NCT00072514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921323|NCT02191891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921324|NCT05507372|Pimozide|pimozide|mesh-list
91921325|NCT05507372|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91921326|NCT05507372|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91921327|NCT05507372|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921328|NCT05507372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921329|NCT05507372|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921330|NCT05507372|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91921331|NCT05507372|Dopamine Agents|dopamine agents|mesh-ancestor
91921332|NCT05507372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921333|NCT05507372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921334|NCT05507372|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91921335|NCT02192203|Diclofenac|diclofenac|mesh-list
91921336|NCT02192203|Menthol|menthol|mesh-list
91921337|NCT02192203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921338|NCT02192203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921339|NCT02192203|Analgesics|analgesics|mesh-ancestor
91921340|NCT02192203|Sensory System Agents|sensory system agents|mesh-ancestor
91921341|NCT02192203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921342|NCT02192203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921343|NCT02192203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921344|NCT02192203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921345|NCT02192203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921346|NCT02192203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921347|NCT02192203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921348|NCT02192203|Antipruritics|antipruritics|mesh-ancestor
91921349|NCT02192203|Dermatologic Agents|dermatologic agents|mesh-ancestor
91921350|NCT02257021|Ritonavir|ritonavir|mesh-list
91921351|NCT02257021|Tipranavir|tipranavir|mesh-list
91921352|NCT02257021|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91921353|NCT02257021|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91921354|NCT02257021|Protease Inhibitors|protease inhibitors|mesh-ancestor
91921355|NCT02257021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921356|NCT02257021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921357|NCT02257021|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921358|NCT02257021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91921359|NCT02257021|Antiviral Agents|antiviral agents|mesh-ancestor
91921360|NCT02257021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921361|NCT02257021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91921362|NCT02257021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91921363|NCT03536065|Analgesics, Opioid|analgesics, opioid|mesh-list
91921364|NCT03536065|Narcotics|narcotics|mesh-ancestor
91921365|NCT03536065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921366|NCT03536065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921367|NCT03536065|Analgesics|analgesics|mesh-ancestor
91921368|NCT03536065|Sensory System Agents|sensory system agents|mesh-ancestor
91921369|NCT03536065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921370|NCT02192827|Dexamethasone|dexamethasone|mesh-list
91921371|NCT02192827|Dexamethasone acetate|dexamethasone acetate|mesh-list
91921372|NCT02192827|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91921373|NCT02192827|BB 1101|bb 1101|mesh-list
91921374|NCT02192827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921375|NCT02192827|Antiemetics|antiemetics|mesh-ancestor
91921376|NCT02192827|Autonomic Agents|autonomic agents|mesh-ancestor
91921377|NCT02192827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921378|NCT02192827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921379|NCT02192827|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921380|NCT02192827|Glucocorticoids|glucocorticoids|mesh-ancestor
91921381|NCT02192827|Hormones|hormones|mesh-ancestor
91921382|NCT02192827|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921383|NCT02192827|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91921384|NCT02192827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921385|NCT02192827|Protease Inhibitors|protease inhibitors|mesh-ancestor
91921386|NCT02192827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921387|NCT02192827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921388|NCT02188225|Fluoxetine|fluoxetine|mesh-list
91921389|NCT02188225|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91921390|NCT02188225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91921391|NCT02188225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921392|NCT02188225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921393|NCT02188225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921395|NCT02188225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921396|NCT02188225|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91921397|NCT02188225|Antidepressive Agents|antidepressive agents|mesh-ancestor
91921398|NCT02188225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921399|NCT02188225|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91921400|NCT02188225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91921401|NCT02188225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921402|NCT04535089|Lidocaine|lidocaine|mesh-list
91921403|NCT04535089|Dexmedetomidine|dexmedetomidine|mesh-list
91921404|NCT04535089|Anesthetics, Local|anesthetics, local|mesh-ancestor
91921405|NCT04535089|Anesthetics|anesthetics|mesh-ancestor
91921406|NCT04535089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921407|NCT04535089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921408|NCT04535089|Sensory System Agents|sensory system agents|mesh-ancestor
91921409|NCT04535089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921410|NCT04535089|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91921411|NCT04535089|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91921412|NCT04535089|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91921413|NCT04535089|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921414|NCT04535089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921415|NCT04535089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91921416|NCT04535089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921417|NCT04535089|Analgesics|analgesics|mesh-ancestor
91921418|NCT04535089|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91921419|NCT04535089|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91921420|NCT04535089|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91921421|NCT04535089|Adrenergic Agents|adrenergic agents|mesh-ancestor
91921422|NCT04535089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921423|NCT02188537|Nelfinavir|nelfinavir|mesh-list
91921424|NCT02188537|Dexamethasone|dexamethasone|mesh-list
91921425|NCT02188537|Bortezomib|bortezomib|mesh-list
91921426|NCT02188537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921427|NCT02188537|Antiemetics|antiemetics|mesh-ancestor
91921428|NCT02188537|Autonomic Agents|autonomic agents|mesh-ancestor
91921429|NCT02188537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921430|NCT02188537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921431|NCT02188537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921432|NCT02188537|Glucocorticoids|glucocorticoids|mesh-ancestor
91921433|NCT02188537|Hormones|hormones|mesh-ancestor
91921434|NCT02188537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921435|NCT02188537|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91921436|NCT02188537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921437|NCT02188537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91921438|NCT02188537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91921439|NCT02188537|Protease Inhibitors|protease inhibitors|mesh-ancestor
91921440|NCT02188537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921441|NCT02188537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921442|NCT02188537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921443|NCT02188537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91921444|NCT02188537|Antiviral Agents|antiviral agents|mesh-ancestor
91921445|NCT02188537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921447|NCT03535051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921448|NCT03535051|Immunologic Factors|immunologic factors|mesh-ancestor
91921449|NCT03535051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921450|NCT03535051|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91921451|NCT03535051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921452|NCT03535051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921453|NCT02188615|Vinorelbine|vinorelbine|mesh-list
91921454|NCT02188615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921455|NCT02188615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91921459|NCT02188615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921460|NCT02188771|Hyaluronic Acid|hyaluronic acid|mesh-list
91921461|NCT02188771|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91921462|NCT02188771|Immunologic Factors|immunologic factors|mesh-ancestor
91921463|NCT02188771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921464|NCT02188771|Viscosupplements|viscosupplements|mesh-ancestor
91921465|NCT02188771|Protective Agents|protective agents|mesh-ancestor
91921466|NCT02194075|Fluvoxamine|fluvoxamine|mesh-list
91921467|NCT02194075|Methylphenidate|methylphenidate|mesh-list
91921468|NCT02194075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91921469|NCT02194075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921470|NCT02194075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91921471|NCT02194075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91921472|NCT02194075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921473|NCT02194075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921474|NCT02194075|Dopamine Agents|dopamine agents|mesh-ancestor
91921475|NCT02194075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921476|NCT02194075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91921477|NCT02194075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91921478|NCT02194075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921479|NCT02194075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921480|NCT02194075|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91921481|NCT02194075|Serotonin Agents|serotonin agents|mesh-ancestor
91921482|NCT02194075|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91921483|NCT02194075|Antidepressive Agents|antidepressive agents|mesh-ancestor
91921484|NCT02194075|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91921485|NCT02194075|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91921486|NCT02194075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921487|NCT02194075|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91921488|NCT02193217|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91921489|NCT02193217|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91921490|NCT02193217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921491|NCT02193217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921492|NCT02193217|Immunologic Factors|immunologic factors|mesh-ancestor
91921493|NCT02193217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921494|NCT03534973|Caffeine|caffeine|mesh-list
91921495|NCT03534973|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91921496|NCT03534973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921497|NCT03534973|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91921498|NCT03534973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921499|NCT03534973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921500|NCT03534973|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91921501|NCT03534973|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91921502|NCT03534973|Purinergic Agents|purinergic agents|mesh-ancestor
91921503|NCT03534973|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921504|NCT03534895|Midazolam|midazolam|mesh-list
91921506|NCT03534895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921507|NCT03534895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921508|NCT03534895|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91921509|NCT03534895|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91921510|NCT03534895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91921511|NCT03534895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91921512|NCT03534895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91921513|NCT03534895|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91921514|NCT03534895|Anesthetics, General|anesthetics, general|mesh-ancestor
91921515|NCT03534895|GABA Modulators|gaba modulators|mesh-ancestor
91921516|NCT03534895|GABA Agents|gaba agents|mesh-ancestor
91921517|NCT03534895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921518|NCT03534895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921519|NCT03535753|Decitabine|decitabine|mesh-list
91921520|NCT03535753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921521|NCT03535753|Antimetabolites|antimetabolites|mesh-ancestor
91921522|NCT03535753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921523|NCT03535753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921524|NCT03535753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921525|NCT02189395|Insulin|insulin|mesh-list
91921526|NCT02189395|Insulin Lispro|insulin lispro|mesh-list
91921527|NCT02189395|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91921528|NCT02189395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91921529|NCT02189395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921530|NCT03535519|Methotrexate|methotrexate|mesh-list
91921531|NCT03535519|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91921533|NCT03535519|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91921534|NCT03535519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921535|NCT03535519|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921536|NCT03535519|Antimetabolites|antimetabolites|mesh-ancestor
91921537|NCT03535519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921538|NCT03535519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921539|NCT03535519|Dermatologic Agents|dermatologic agents|mesh-ancestor
91921540|NCT03535519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921541|NCT03535519|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91921542|NCT03535519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921543|NCT03535519|Immunologic Factors|immunologic factors|mesh-ancestor
91921544|NCT03535519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921545|NCT03535519|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91921546|NCT02194153|Tenecteplase|tenecteplase|mesh-list
91921547|NCT02194153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91921548|NCT02194153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91921549|NCT02194153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921550|NCT02194231|Trabectedin|trabectedin|mesh-list
91921551|NCT02194231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91921552|NCT02194231|Alkylating Agents|alkylating agents|mesh-ancestor
91921553|NCT02194231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921554|NCT02194231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921555|NCT04292054|Cefazolin|cefazolin|mesh-list
91921556|NCT04292054|Tazobactam|tazobactam|mesh-list
91921557|NCT04292054|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921558|NCT04292054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921559|NCT04292054|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91921560|NCT04292054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921561|NCT04292054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921562|NCT04291508|Acetaminophen|acetaminophen|mesh-list
91921563|NCT04291508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921564|NCT04291508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921565|NCT04291508|Analgesics|analgesics|mesh-ancestor
91921566|NCT04291508|Sensory System Agents|sensory system agents|mesh-ancestor
91921567|NCT04291508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921568|NCT04291508|Antipyretics|antipyretics|mesh-ancestor
91921569|NCT02933671|Ropivacaine|ropivacaine|mesh-list
91921570|NCT02933671|Anesthetics, Local|anesthetics, local|mesh-ancestor
91921571|NCT02933671|Anesthetics|anesthetics|mesh-ancestor
91921572|NCT02933671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921573|NCT02933671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921574|NCT02933671|Sensory System Agents|sensory system agents|mesh-ancestor
91921575|NCT02933671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921577|NCT05509478|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91921578|NCT05509478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921579|NCT05509478|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91921580|NCT05509478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921581|NCT05509478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921582|NCT05509478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921584|NCT02194309|Telmisartan|telmisartan|mesh-list
91921585|NCT02194309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91921586|NCT02194309|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91921587|NCT02194309|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91921588|NCT02194309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921589|NCT02194309|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91921590|NCT02194309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921591|NCT02194309|Vasodilator Agents|vasodilator agents|mesh-ancestor
91921592|NCT02194309|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91921593|NCT02194309|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91921594|NCT04392505|Durvalumab|durvalumab|mesh-list
91921595|NCT04392505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921596|NCT04392505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921597|NCT05502458|Propofol|propofol|mesh-list
91921598|NCT05502458|Desflurane|desflurane|mesh-list
91921599|NCT05502458|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91921600|NCT05502458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921601|NCT05502458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921602|NCT05502458|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91921603|NCT05502458|Anesthetics, General|anesthetics, general|mesh-ancestor
91921604|NCT05502458|Anesthetics|anesthetics|mesh-ancestor
91921605|NCT05502458|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91921606|NCT03534037|Febuxostat|febuxostat|mesh-list
91921607|NCT03534037|Benzbromarone|benzbromarone|mesh-list
91921608|NCT03534037|Gout Suppressants|gout suppressants|mesh-ancestor
91921613|NCT03533959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91921614|NCT03533959|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91921615|NCT03533959|Antimetabolites|antimetabolites|mesh-ancestor
91921616|NCT03533959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921617|NCT03533959|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91921618|NCT03533959|Protease Inhibitors|protease inhibitors|mesh-ancestor
91921619|NCT03533959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921620|NCT03533959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91921621|NCT05502380|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91921622|NCT05502380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921623|NCT02567708|Nemiralisib|nemiralisib|mesh-list
91921624|NCT02567708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91921625|NCT02567708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921626|NCT02567708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921627|NCT05509244|Acetaminophen|acetaminophen|mesh-list
91921628|NCT05509244|Ibuprofen|ibuprofen|mesh-list
91921629|NCT05509244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921630|NCT05509244|Analgesics|analgesics|mesh-ancestor
91921631|NCT05509244|Sensory System Agents|sensory system agents|mesh-ancestor
91921632|NCT05509244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921633|NCT05509244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921634|NCT05509244|Antipyretics|antipyretics|mesh-ancestor
91921635|NCT05509244|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921636|NCT05509244|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921637|NCT05509244|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921638|NCT05509244|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921639|NCT05509244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921640|NCT05509244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921642|NCT05502068|Vitamins|vitamins|mesh-ancestor
91921643|NCT05502068|Micronutrients|micronutrients|mesh-ancestor
91921644|NCT05502068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921645|NCT05502068|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91921646|NCT02194777|Olcegepant|olcegepant|mesh-list
91921647|NCT02194777|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91921648|NCT02194777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921649|NCT02194777|Analgesics|analgesics|mesh-ancestor
91921650|NCT02194777|Sensory System Agents|sensory system agents|mesh-ancestor
91921651|NCT02194777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921652|NCT02194777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921653|NCT02030977|Resveratrol|resveratrol|mesh-list
91921654|NCT02030977|Antioxidants|antioxidants|mesh-ancestor
91921655|NCT02030977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921656|NCT02030977|Protective Agents|protective agents|mesh-ancestor
91921657|NCT02030977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921658|NCT02030977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921659|NCT02030977|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91921660|NCT02194855|Rocuronium|rocuronium|mesh-list
91921661|NCT02194855|Cisatracurium|cisatracurium|mesh-list
91921662|NCT02194855|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91921663|NCT02194855|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91921664|NCT02194855|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91921665|NCT02194855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921666|NCT02194855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921667|NCT03534661|Teduglutide|teduglutide|mesh-list
91921668|NCT03534661|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
91921669|NCT03534661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921670|NCT03534661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921671|NCT03534661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921672|NCT03534661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91921673|NCT03534661|Protective Agents|protective agents|mesh-ancestor
91921674|NCT03534661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921675|NCT02562716|Paclitaxel|paclitaxel|mesh-list
91921676|NCT02562716|Camptothecin|camptothecin|mesh-list
91921677|NCT02562716|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91921678|NCT02562716|Gemcitabine|gemcitabine|mesh-list
91921679|NCT02562716|Fluorouracil|fluorouracil|mesh-list
91921680|NCT02562716|Oxaliplatin|oxaliplatin|mesh-list
91921681|NCT02562716|Irinotecan|irinotecan|mesh-list
91921682|NCT02562716|Pancrelipase|pancrelipase|mesh-list
91921683|NCT02562716|Pancreatin|pancreatin|mesh-list
91921684|NCT02562716|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91921685|NCT02562716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921686|NCT02562716|Tubulin Modulators|tubulin modulators|mesh-ancestor
91921687|NCT02562716|Antimitotic Agents|antimitotic agents|mesh-ancestor
91921688|NCT02562716|Mitosis Modulators|mitosis modulators|mesh-ancestor
91921767|NCT03534505|Anesthetics, Local|anesthetics, local|mesh-ancestor
91921689|NCT02562716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921690|NCT02562716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921691|NCT02562716|Antimetabolites|antimetabolites|mesh-ancestor
91921692|NCT02562716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921693|NCT02562716|Immunologic Factors|immunologic factors|mesh-ancestor
91921694|NCT02562716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921695|NCT02562716|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91921696|NCT02562716|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91921697|NCT02562716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921698|NCT02562716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921699|NCT02031211|Etanercept|etanercept|mesh-list
91921700|NCT02031211|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921701|NCT02031211|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921702|NCT02031211|Analgesics|analgesics|mesh-ancestor
91921703|NCT02031211|Sensory System Agents|sensory system agents|mesh-ancestor
91921704|NCT02031211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921705|NCT02031211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921706|NCT02031211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921707|NCT02031211|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921708|NCT02031211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921709|NCT02031211|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921710|NCT02031211|Immunologic Factors|immunologic factors|mesh-ancestor
91921712|NCT02195089|Immunologic Factors|immunologic factors|mesh-ancestor
91921713|NCT02195089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921714|NCT02031289|Folic Acid|folic acid|mesh-list
91921715|NCT02031289|Vitamin B 12|vitamin b 12|mesh-list
91921716|NCT02031289|Hydroxocobalamin|hydroxocobalamin|mesh-list
91921717|NCT02031289|Epoetin Alfa|epoetin alfa|mesh-list
91921718|NCT02031289|Vitamins|vitamins|mesh-ancestor
91921719|NCT02031289|Micronutrients|micronutrients|mesh-ancestor
91921720|NCT02031289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921721|NCT02031289|Hematinics|hematinics|mesh-ancestor
91921722|NCT02031289|Vitamin B Complex|vitamin b complex|mesh-ancestor
91921723|NCT02197741|Opiate Alkaloids|opiate alkaloids|mesh-list
91921724|NCT02197741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91921725|NCT02197741|Narcotics|narcotics|mesh-ancestor
91921726|NCT02197741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921727|NCT02197741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921728|NCT02197741|Analgesics|analgesics|mesh-ancestor
91921729|NCT02197741|Sensory System Agents|sensory system agents|mesh-ancestor
91921730|NCT02197741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921731|NCT02196493|Azithromycin|azithromycin|mesh-list
91921732|NCT02196493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921733|NCT02196493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921734|NCT05506592|Dermatologic Agents|dermatologic agents|mesh-list
91921735|NCT03533803|Indomethacin|indomethacin|mesh-list
91921736|NCT03533803|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921737|NCT03533803|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921738|NCT03533803|Analgesics|analgesics|mesh-ancestor
91921739|NCT03533803|Sensory System Agents|sensory system agents|mesh-ancestor
91921740|NCT03533803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921741|NCT03533803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921742|NCT03533803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921743|NCT03533803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921744|NCT03533803|Gout Suppressants|gout suppressants|mesh-ancestor
91921745|NCT03533803|Tocolytic Agents|tocolytic agents|mesh-ancestor
91921746|NCT03533803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91921747|NCT03533803|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921748|NCT03533803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921749|NCT03533803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921750|NCT02198209|Liraglutide|liraglutide|mesh-list
91921751|NCT02198209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91921752|NCT02198209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921753|NCT02198209|Incretins|incretins|mesh-ancestor
91921754|NCT02198209|Hormones|hormones|mesh-ancestor
91921755|NCT02198209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921756|NCT02031055|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91921757|NCT02195557|Hylan|hylan|mesh-list
91921758|NCT02195557|Viscosupplements|viscosupplements|mesh-ancestor
91921759|NCT02195557|Protective Agents|protective agents|mesh-ancestor
91921760|NCT02195557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921761|NCT02195635|Octreotide|octreotide|mesh-list
91921762|NCT02195635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921763|NCT02195635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91921764|NCT02195635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921765|NCT03534505|Ketorolac|ketorolac|mesh-list
91921766|NCT03534505|Bupivacaine|bupivacaine|mesh-list
91921769|NCT03534505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921770|NCT03534505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921771|NCT03534505|Sensory System Agents|sensory system agents|mesh-ancestor
91921772|NCT03534505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921773|NCT03534505|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921774|NCT03534505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921775|NCT03534505|Analgesics|analgesics|mesh-ancestor
91921776|NCT03534505|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921777|NCT03534505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921778|NCT03534505|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921779|NCT03534505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921780|NCT03534505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921781|NCT02195791|Pioglitazone|pioglitazone|mesh-list
91921782|NCT02195791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91921783|NCT02195791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921784|NCT02196805|Probucol|probucol|mesh-list
91921785|NCT02196805|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91921786|NCT02196805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91921788|NCT02196805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921789|NCT02196805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91921790|NCT02196805|Antioxidants|antioxidants|mesh-ancestor
91921791|NCT02196805|Protective Agents|protective agents|mesh-ancestor
91921792|NCT02196805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921793|NCT02198443|Ritonavir|ritonavir|mesh-list
91921794|NCT02198443|Lopinavir|lopinavir|mesh-list
91921795|NCT02198443|Tenofovir|tenofovir|mesh-list
91921796|NCT02198443|Emtricitabine|emtricitabine|mesh-list
91921797|NCT02198443|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91921798|NCT02198443|Cobicistat|cobicistat|mesh-list
91921799|NCT02198443|Elvitegravir|elvitegravir|mesh-list
91921800|NCT02198443|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91921801|NCT02198443|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91921802|NCT02198443|Protease Inhibitors|protease inhibitors|mesh-ancestor
91921803|NCT02198443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921804|NCT02198443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921805|NCT02198443|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921806|NCT02198443|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91921807|NCT02198443|Antiviral Agents|antiviral agents|mesh-ancestor
91921808|NCT02198443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921809|NCT02198443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91921810|NCT02198443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91921811|NCT02198443|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91921812|NCT02198443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91921813|NCT02198443|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91921814|NCT03533179|Glucagon|glucagon|mesh-list
91921815|NCT03533179|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91921816|NCT03533179|Esmolol|esmolol|mesh-list
91921817|NCT03533179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921818|NCT03533179|Hormones|hormones|mesh-ancestor
91921819|NCT03533179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921820|NCT03533179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921821|NCT03533179|Incretins|incretins|mesh-ancestor
91921822|NCT03533179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91921823|NCT03533179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91921824|NCT03533179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91921825|NCT03533179|Adrenergic Agents|adrenergic agents|mesh-ancestor
91921826|NCT03533179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921827|NCT03533179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921828|NCT02201407|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91921829|NCT02201407|Antiviral Agents|antiviral agents|mesh-ancestor
91921830|NCT02201407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921831|NCT05261971|Etodolac|etodolac|mesh-list
92074244|NCT00072514|Immunologic Factors|immunologic factors|mesh-ancestor
91921832|NCT05261971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91921833|NCT05261971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91921834|NCT05261971|Analgesics|analgesics|mesh-ancestor
91921835|NCT05261971|Sensory System Agents|sensory system agents|mesh-ancestor
91921836|NCT05261971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921837|NCT05261971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921838|NCT05261971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921839|NCT05261971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921840|NCT05261971|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91921841|NCT05261971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91921842|NCT05261971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921843|NCT05261971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921844|NCT02201563|Minocycline|minocycline|mesh-list
91921845|NCT02201563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921846|NCT02201563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921847|NCT02206477|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
91921848|NCT02206477|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91921849|NCT02206477|Protective Agents|protective agents|mesh-ancestor
91921850|NCT02206477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921851|NCT02206477|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91921852|NCT02206477|Antioxidants|antioxidants|mesh-ancestor
91921853|NCT02206477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921854|NCT02201641|Calcium|calcium|mesh-list
91921855|NCT02201641|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91921856|NCT02201641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921857|NCT02206555|Tenofovir|tenofovir|mesh-list
91921858|NCT02206555|Emtricitabine|emtricitabine|mesh-list
91921859|NCT02206555|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91921861|NCT02206555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921862|NCT02206555|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91921863|NCT02206555|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91921864|NCT02206555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921865|NCT02206555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921866|NCT02206555|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921867|NCT02206555|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91921868|NCT02206711|BMS-955176|bms-955176|mesh-list
91921869|NCT02206711|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91921870|NCT02206711|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91921871|NCT02206711|Antiviral Agents|antiviral agents|mesh-ancestor
91921872|NCT02206711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921873|NCT02202187|Gepotidacin|gepotidacin|mesh-list
91921874|NCT02202187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91921875|NCT02202187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921876|NCT02202187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921877|NCT02202187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921878|NCT02206789|Cyclosporine|cyclosporine|mesh-list
91921879|NCT02206789|Prednisolone|prednisolone|mesh-list
91921880|NCT02206789|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91921881|NCT02206789|Methylprednisolone|methylprednisolone|mesh-list
91921882|NCT02206789|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91921883|NCT02206789|Prednisolone acetate|prednisolone acetate|mesh-list
91921884|NCT02206789|Cyclosporins|cyclosporins|mesh-list
91921885|NCT02206789|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91921886|NCT02206789|Prednisolone phosphate|prednisolone phosphate|mesh-list
91921887|NCT02206789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91921888|NCT02206789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921889|NCT02206789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921890|NCT02206789|Immunologic Factors|immunologic factors|mesh-ancestor
91921891|NCT02206789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921892|NCT02206789|Antifungal Agents|antifungal agents|mesh-ancestor
91921893|NCT02206789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921894|NCT02206789|Dermatologic Agents|dermatologic agents|mesh-ancestor
91921895|NCT02206789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921896|NCT02206789|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91921897|NCT02206789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921898|NCT02206789|Glucocorticoids|glucocorticoids|mesh-ancestor
91921899|NCT02206789|Hormones|hormones|mesh-ancestor
91921900|NCT02206789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921901|NCT02206789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91921902|NCT02206789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921903|NCT02206789|Antiemetics|antiemetics|mesh-ancestor
91921904|NCT02206789|Autonomic Agents|autonomic agents|mesh-ancestor
91921905|NCT02206789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921906|NCT02206789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921908|NCT02206789|Protective Agents|protective agents|mesh-ancestor
91921909|NCT03892369|Ethanol|ethanol|mesh-list
91921910|NCT03892369|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91921911|NCT03892369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921912|NCT03892369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91921913|NCT03892369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921914|NCT02206867|Adalimumab|adalimumab|mesh-list
91921915|NCT02206867|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91921916|NCT02206867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91921917|NCT02206867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91921918|NCT02751931|Mirabegron|mirabegron|mesh-list
91921919|NCT02751931|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91921920|NCT02751931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91921921|NCT02751931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91921922|NCT02751931|Adrenergic Agents|adrenergic agents|mesh-ancestor
91921923|NCT02751931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91921924|NCT02751931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921925|NCT02751931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921926|NCT02751931|Urological Agents|urological agents|mesh-ancestor
91921927|NCT05261581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91921928|NCT05261581|Analgesics|analgesics|mesh-list
91921929|NCT05261581|Sensory System Agents|sensory system agents|mesh-ancestor
91921930|NCT05261581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91921931|NCT05261581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921932|NCT02199223|Panitumumab|panitumumab|mesh-list
91921933|NCT02199223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91921934|NCT02199223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921936|NCT02207335|Gemcitabine|gemcitabine|mesh-list
91921937|NCT02207335|Capecitabine|capecitabine|mesh-list
91921938|NCT02207335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921939|NCT02207335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91921940|NCT02207335|Antimetabolites|antimetabolites|mesh-ancestor
91921941|NCT02207335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921942|NCT02561078|Insulin|insulin|mesh-list
91921943|NCT02561078|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91921944|NCT02561078|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91921945|NCT02561078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921946|NCT02202889|Calcium|calcium|mesh-list
91921947|NCT02202889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91921948|NCT02202889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921949|NCT04058197|Deferoxamine|deferoxamine|mesh-list
91921950|NCT04058197|Siderophores|siderophores|mesh-ancestor
91921951|NCT04058197|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91921952|NCT04058197|Chelating Agents|chelating agents|mesh-ancestor
91921953|NCT04058197|Sequestering Agents|sequestering agents|mesh-ancestor
91921954|NCT04058197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921955|NCT02202967|Misoprostol|misoprostol|mesh-list
91921956|NCT02202967|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91921957|NCT02202967|Abortifacient Agents|abortifacient agents|mesh-ancestor
91921958|NCT02202967|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91921959|NCT02202967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921960|NCT02202967|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91921961|NCT02202967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91921962|NCT02202967|Oxytocics|oxytocics|mesh-ancestor
91921963|NCT03532867|Tin Fluorides|tin fluorides|mesh-list
91921964|NCT03532867|Cariostatic Agents|cariostatic agents|mesh-ancestor
91921965|NCT03532867|Protective Agents|protective agents|mesh-ancestor
91921966|NCT03532867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921967|NCT02207959|Proflavine|proflavine|mesh-list
91921968|NCT02207959|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91921969|NCT02207959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921970|NCT02567552|Progesterone|progesterone|mesh-list
91921971|NCT02567552|Progestins|progestins|mesh-ancestor
91921972|NCT02567552|Hormones|hormones|mesh-ancestor
91921973|NCT02567552|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91921974|NCT02567552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921975|NCT02208427|Isoniazid|isoniazid|mesh-list
91921976|NCT02208427|Rifapentine|rifapentine|mesh-list
91921977|NCT02208427|Antitubercular Agents|antitubercular agents|mesh-ancestor
91921978|NCT02208427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921979|NCT02208427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921980|NCT02208427|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91921981|NCT02208427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91921982|NCT02208427|Antimetabolites|antimetabolites|mesh-ancestor
91921983|NCT02208427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91921984|NCT02208427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91921985|NCT02208427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91921986|NCT02208427|Leprostatic Agents|leprostatic agents|mesh-ancestor
91921987|NCT05508620|Sirolimus|sirolimus|mesh-list
91921988|NCT05508620|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91921989|NCT05508620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91921990|NCT05508620|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91921991|NCT05508620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921992|NCT05508620|Antifungal Agents|antifungal agents|mesh-ancestor
91921993|NCT05508620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91921994|NCT05508620|Immunologic Factors|immunologic factors|mesh-ancestor
91921995|NCT05508620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91921996|NCT03803605|Vorinostat|vorinostat|mesh-list
91921997|NCT03803605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91921998|NCT03803605|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91921999|NCT03803605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922000|NCT03803605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922001|NCT02208505|Dexmedetomidine|dexmedetomidine|mesh-list
91922002|NCT02208505|Remifentanil|remifentanil|mesh-list
91922003|NCT02208505|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922004|NCT02208505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922005|NCT02208505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922006|NCT02208505|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922007|NCT02208505|Analgesics|analgesics|mesh-ancestor
91922008|NCT02208505|Sensory System Agents|sensory system agents|mesh-ancestor
91922009|NCT02208505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922010|NCT02208505|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91922011|NCT02208505|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91922012|NCT02208505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91922013|NCT02208505|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922014|NCT02208505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922015|NCT02208505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922016|NCT02208505|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91922017|NCT02208505|Narcotics|narcotics|mesh-ancestor
91922018|NCT02208583|Prednisone|prednisone|mesh-list
91922019|NCT02208583|Cisplatin|cisplatin|mesh-list
91922020|NCT02208583|Docetaxel|docetaxel|mesh-list
91922021|NCT02208583|Etoposide|etoposide|mesh-list
91922022|NCT02208583|Etoposide phosphate|etoposide phosphate|mesh-list
91922023|NCT02208583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922024|NCT02208583|Tubulin Modulators|tubulin modulators|mesh-ancestor
91922025|NCT02208583|Antimitotic Agents|antimitotic agents|mesh-ancestor
91922026|NCT02208583|Mitosis Modulators|mitosis modulators|mesh-ancestor
91922027|NCT02208583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922028|NCT02208583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922029|NCT02208583|Glucocorticoids|glucocorticoids|mesh-ancestor
91922030|NCT02208583|Hormones|hormones|mesh-ancestor
91922031|NCT02208583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922032|NCT02208583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922033|NCT02208583|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91922034|NCT02208583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91922035|NCT02208583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91922036|NCT02208583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91922037|NCT02208583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922038|NCT05501288|Pholcodine|pholcodine|mesh-list
91922039|NCT05501288|Analgesics|analgesics|mesh-ancestor
91922040|NCT05501288|Sensory System Agents|sensory system agents|mesh-ancestor
91943169|NCT03323463|Carboplatin|carboplatin|mesh-list
91922041|NCT05501288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922042|NCT05501288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922043|NCT05501288|Antitussive Agents|antitussive agents|mesh-ancestor
91922044|NCT05501288|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922045|NCT04738292|Fulvestrant|fulvestrant|mesh-list
91922046|NCT04738292|Onapristone|onapristone|mesh-list
91922047|NCT04738292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91922048|NCT04738292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922049|NCT04738292|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91922050|NCT04738292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91922051|NCT04738292|Hormone Antagonists|hormone antagonists|mesh-ancestor
91922052|NCT04738292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922053|NCT04738292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922054|NCT04738292|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91922055|NCT04738292|Fertility Agents|fertility agents|mesh-ancestor
91922056|NCT04738292|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91922057|NCT02199379|Lenvatinib|lenvatinib|mesh-list
91922058|NCT02199379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922059|NCT02199379|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91922060|NCT02199379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922061|NCT02199379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922062|NCT03532711|Leucovorin|leucovorin|mesh-list
91922063|NCT03532711|Fluorouracil|fluorouracil|mesh-list
91922064|NCT03532711|Capecitabine|capecitabine|mesh-list
91922065|NCT03532711|Oxaliplatin|oxaliplatin|mesh-list
91922066|NCT03532711|Irinotecan|irinotecan|mesh-list
91922067|NCT03532711|Levoleucovorin|levoleucovorin|mesh-list
91922068|NCT03532711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922069|NCT03532711|Antimetabolites|antimetabolites|mesh-ancestor
91922070|NCT03532711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922071|NCT03532711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91922072|NCT03532711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922073|NCT03532711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91922074|NCT03532711|Immunologic Factors|immunologic factors|mesh-ancestor
91922075|NCT03532711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91922076|NCT03532711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91922077|NCT03532711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922078|NCT03532711|Antidotes|antidotes|mesh-ancestor
91922079|NCT03532711|Protective Agents|protective agents|mesh-ancestor
91922080|NCT03532711|Vitamin B Complex|vitamin b complex|mesh-ancestor
91922081|NCT03532711|Vitamins|vitamins|mesh-ancestor
91922082|NCT03532711|Micronutrients|micronutrients|mesh-ancestor
91922083|NCT04714112|Dexamethasone|dexamethasone|mesh-list
91922084|NCT04714112|Dexamethasone acetate|dexamethasone acetate|mesh-list
91922085|NCT04714112|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91922086|NCT04714112|BB 1101|bb 1101|mesh-list
91922087|NCT04714112|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922088|NCT04714112|Antiemetics|antiemetics|mesh-ancestor
91922089|NCT04714112|Autonomic Agents|autonomic agents|mesh-ancestor
91922090|NCT04714112|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922091|NCT04714112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922092|NCT04714112|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922093|NCT04714112|Glucocorticoids|glucocorticoids|mesh-ancestor
91922094|NCT04714112|Hormones|hormones|mesh-ancestor
91922095|NCT04714112|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922096|NCT04714112|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91922097|NCT04714112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922098|NCT04714112|Protease Inhibitors|protease inhibitors|mesh-ancestor
91922099|NCT04714112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922100|NCT04714112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922101|NCT02199613|Darunavir|darunavir|mesh-list
91922102|NCT02199613|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91922103|NCT02199613|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91922104|NCT02199613|Protease Inhibitors|protease inhibitors|mesh-ancestor
91922105|NCT02199613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922106|NCT02199613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922107|NCT02199613|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91922108|NCT02199613|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91922109|NCT02199613|Antiviral Agents|antiviral agents|mesh-ancestor
91922110|NCT02199613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922112|NCT02209441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922113|NCT02209441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91922114|NCT02209441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943174|NCT03323463|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91922115|NCT02209441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922116|NCT02199925|gamma-Globulins|gamma-globulins|mesh-list
91922117|NCT02199925|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91922118|NCT02199925|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91922119|NCT02199925|Immunologic Factors|immunologic factors|mesh-ancestor
91922120|NCT02199925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922121|NCT03338647|Doxorubicin|doxorubicin|mesh-list
91922122|NCT03338647|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91922123|NCT03338647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922124|NCT03338647|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91922125|NCT03338647|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91922126|NCT03338647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922127|NCT03338647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922128|NCT05500742|Selenium|selenium|mesh-list
91922129|NCT05500742|Ubiquinone|ubiquinone|mesh-list
91922130|NCT05500742|Coenzyme Q10|coenzyme q10|mesh-list
91922131|NCT05500742|Resveratrol|resveratrol|mesh-list
91922132|NCT05500742|Antioxidants|antioxidants|mesh-ancestor
91922133|NCT05500742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922134|NCT05500742|Protective Agents|protective agents|mesh-ancestor
91922135|NCT05500742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922136|NCT05500742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922137|NCT05500742|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91922138|NCT05500742|Trace Elements|trace elements|mesh-ancestor
91922139|NCT05500742|Micronutrients|micronutrients|mesh-ancestor
91922140|NCT05500742|Vitamins|vitamins|mesh-ancestor
91922141|NCT03533335|Chlorhexidine|chlorhexidine|mesh-list
91922142|NCT03533335|Chlorine dioxide|chlorine dioxide|mesh-list
91922143|NCT03533335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91922144|NCT03533335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922145|NCT03533335|Disinfectants|disinfectants|mesh-ancestor
91922146|NCT03533335|Dental Disinfectants|dental disinfectants|mesh-ancestor
91922147|NCT02200159|Dexmedetomidine|dexmedetomidine|mesh-list
91922148|NCT02200159|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922223|NCT02209909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91922149|NCT02200159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922150|NCT02200159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922151|NCT02200159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922152|NCT02200159|Analgesics|analgesics|mesh-ancestor
91922153|NCT02200159|Sensory System Agents|sensory system agents|mesh-ancestor
91922154|NCT02200159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922155|NCT02200159|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91922156|NCT02200159|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91922157|NCT02200159|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91922158|NCT02200159|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922159|NCT02200159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922160|NCT02200159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922161|NCT02204527|Vitamin D|vitamin d|mesh-list
91922162|NCT02204527|Ergocalciferols|ergocalciferols|mesh-list
91922163|NCT02204527|Cholecalciferol|cholecalciferol|mesh-list
91922164|NCT02204527|Vitamins|vitamins|mesh-list
91922165|NCT02204527|Micronutrients|micronutrients|mesh-ancestor
91922166|NCT02204527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922167|NCT02204527|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91922168|NCT02204527|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922169|NCT02200237|Aluminum phosphate|aluminum phosphate|mesh-list
91922170|NCT02200237|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91922171|NCT02200237|Immunologic Factors|immunologic factors|mesh-ancestor
91922172|NCT02200237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922173|NCT02200237|Antacids|antacids|mesh-ancestor
91922174|NCT02200237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922175|NCT02200237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922176|NCT02209831|Pantoprazole|pantoprazole|mesh-list
91922177|NCT02209831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91922178|NCT02209831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922179|NCT02209831|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91922180|NCT02209831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074245|NCT00072514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922181|NCT02209831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922182|NCT01663532|Aripiprazole|aripiprazole|mesh-list
91922183|NCT01663532|Antidepressive Agents|antidepressive agents|mesh-ancestor
91922184|NCT01663532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91922185|NCT01663532|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91922186|NCT01663532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91922187|NCT01663532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922188|NCT01663532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922189|NCT01663532|Dopamine Agonists|dopamine agonists|mesh-ancestor
91922190|NCT01663532|Dopamine Agents|dopamine agents|mesh-ancestor
91922191|NCT01663532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922192|NCT01663532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922193|NCT01663532|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91922194|NCT01663532|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91922195|NCT01663532|Serotonin Agents|serotonin agents|mesh-ancestor
91922196|NCT01663532|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91922197|NCT01663532|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91922198|NCT01663532|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91922199|NCT01663532|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91922200|NCT02200315|Anti-Infective Agents|anti-infective agents|mesh-list
91922201|NCT02200315|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91922202|NCT02204683|Aflibercept|aflibercept|mesh-list
91922203|NCT02204683|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91922204|NCT02204683|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91922205|NCT02204683|Growth Substances|growth substances|mesh-ancestor
91922206|NCT02204683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922207|NCT02204683|Growth Inhibitors|growth inhibitors|mesh-ancestor
91922208|NCT02204683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922209|NCT02204839|Insulin|insulin|mesh-list
91922210|NCT02204839|Insulin Glargine|insulin glargine|mesh-list
91922211|NCT02204839|Insulin Detemir|insulin detemir|mesh-list
91922212|NCT02204839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91922213|NCT02204839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922214|NCT02209909|Aspirin|aspirin|mesh-list
91922215|NCT02209909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91922216|NCT02209909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922217|NCT02209909|Analgesics|analgesics|mesh-ancestor
91922218|NCT02209909|Sensory System Agents|sensory system agents|mesh-ancestor
91922219|NCT02209909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922220|NCT02209909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922221|NCT02209909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922222|NCT02209909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91922224|NCT02209909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91922225|NCT02209909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922226|NCT02209909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91922227|NCT02209909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91922228|NCT02209909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922229|NCT02209909|Antipyretics|antipyretics|mesh-ancestor
91922230|NCT02209987|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91922231|NCT02209987|Immunologic Factors|immunologic factors|mesh-ancestor
91922232|NCT02209987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922233|NCT02205151|Amlodipine|amlodipine|mesh-list
91922234|NCT02205151|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91922235|NCT02205151|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91922236|NCT02205151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91922237|NCT02205151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922238|NCT02205151|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922239|NCT02205151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922240|NCT02205151|Vasodilator Agents|vasodilator agents|mesh-ancestor
91922241|NCT05262985|Durvalumab|durvalumab|mesh-list
91922242|NCT05262985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91922243|NCT05262985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922244|NCT05504720|Pembrolizumab|pembrolizumab|mesh-list
91922245|NCT05504720|Trastuzumab|trastuzumab|mesh-list
91922246|NCT05504720|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91922247|NCT05504720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922248|NCT05504720|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91922249|NCT05504720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922250|NCT04476992|Nitric Oxide|nitric oxide|mesh-list
91922251|NCT04476992|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91922252|NCT04476992|Autonomic Agents|autonomic agents|mesh-ancestor
91922253|NCT04476992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922254|NCT04476992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922255|NCT04476992|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91922256|NCT04476992|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922257|NCT04476992|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91922258|NCT04476992|Antioxidants|antioxidants|mesh-ancestor
91922259|NCT04476992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922260|NCT04476992|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922261|NCT04476992|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91922262|NCT04476992|Vasodilator Agents|vasodilator agents|mesh-ancestor
91922263|NCT04476992|Gasotransmitters|gasotransmitters|mesh-ancestor
91922264|NCT04476992|Protective Agents|protective agents|mesh-ancestor
91922265|NCT02220673|Butylated Hydroxytoluene|butylated hydroxytoluene|mesh-list
91922266|NCT02220673|Antioxidants|antioxidants|mesh-ancestor
91922267|NCT02220673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922268|NCT02220673|Protective Agents|protective agents|mesh-ancestor
91922269|NCT02220673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922270|NCT05499572|Minocycline|minocycline|mesh-list
91922271|NCT05499572|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91922272|NCT05499572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922273|NCT02220751|Doxycycline|doxycycline|mesh-list
91922274|NCT02220751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91922275|NCT02220751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922276|NCT02220751|Antimalarials|antimalarials|mesh-ancestor
91922277|NCT02220751|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91922278|NCT02220751|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91922279|NCT02205541|Eculizumab|eculizumab|mesh-list
91922280|NCT02205541|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91922281|NCT02205541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91922282|NCT02205541|Immunologic Factors|immunologic factors|mesh-ancestor
91922283|NCT02205541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922284|NCT02205619|Glycine|glycine|mesh-list
91922285|NCT02205619|Glycine Agents|glycine agents|mesh-ancestor
91922286|NCT02205619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922287|NCT02205619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922288|NCT02205619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922289|NCT05504330|Aspirin|aspirin|mesh-list
91922290|NCT05504330|Clopidogrel|clopidogrel|mesh-list
91922291|NCT05504330|Atorvastatin|atorvastatin|mesh-list
91922292|NCT05504330|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91922293|NCT05504330|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922294|NCT05504330|Analgesics|analgesics|mesh-ancestor
91922295|NCT05504330|Sensory System Agents|sensory system agents|mesh-ancestor
91922296|NCT05504330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922297|NCT05504330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922298|NCT05504330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922299|NCT05504330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91922300|NCT05504330|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91922301|NCT05504330|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91922302|NCT05504330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922303|NCT05504330|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91922304|NCT05504330|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91922305|NCT05504330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922306|NCT05504330|Antipyretics|antipyretics|mesh-ancestor
91922307|NCT05504330|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91922308|NCT05504330|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91922309|NCT05504330|Antimetabolites|antimetabolites|mesh-ancestor
91922310|NCT05504330|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91922311|NCT05504330|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91922312|NCT05504330|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91922313|NCT05504330|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91922314|NCT05504330|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91922315|NCT05504330|Purinergic Agents|purinergic agents|mesh-ancestor
91922316|NCT05504330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922318|NCT02220829|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91922319|NCT02220829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91922320|NCT02220829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91922321|NCT02220829|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922322|NCT02220829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922323|NCT02220829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922324|NCT02220829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922325|NCT02220829|Urological Agents|urological agents|mesh-ancestor
91922326|NCT02525939|Dalcetrapib|dalcetrapib|mesh-list
91922327|NCT02525939|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91922328|NCT02525939|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91922329|NCT02525939|Antimetabolites|antimetabolites|mesh-ancestor
91922330|NCT02525939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922331|NCT02525939|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91922332|NCT02215213|Vitamin D|vitamin d|mesh-list
91922333|NCT02215213|Ergocalciferols|ergocalciferols|mesh-list
91922334|NCT02215213|Cholecalciferol|cholecalciferol|mesh-list
91922335|NCT02215213|Vitamins|vitamins|mesh-list
91922336|NCT02215213|Micronutrients|micronutrients|mesh-ancestor
91922337|NCT02215213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922338|NCT02215213|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91922339|NCT02215213|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922340|NCT04419272|Methylphenidate|methylphenidate|mesh-list
91922341|NCT04419272|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91922342|NCT04419272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922343|NCT04419272|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91922344|NCT04419272|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91922345|NCT04419272|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91922346|NCT04419272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922347|NCT04419272|Dopamine Agents|dopamine agents|mesh-ancestor
91922348|NCT04419272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922349|NCT02205775|Atorvastatin|atorvastatin|mesh-list
91922350|NCT02205775|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91922351|NCT02205775|Ezetimibe|ezetimibe|mesh-list
91922352|NCT02205775|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91922353|NCT02205775|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91922354|NCT02205775|Antimetabolites|antimetabolites|mesh-ancestor
91922355|NCT02205775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922356|NCT02205775|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91922357|NCT02205775|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91922358|NCT02205775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922359|NCT02217787|PF-06372865|pf-06372865|mesh-list
91922360|NCT02217787|GABA Modulators|gaba modulators|mesh-ancestor
91922361|NCT02217787|GABA Agents|gaba agents|mesh-ancestor
91922362|NCT02217787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922363|NCT02217787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922364|NCT02217787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922365|NCT02205931|Topiramate|topiramate|mesh-list
91922366|NCT02205931|Lamotrigine|lamotrigine|mesh-list
91922367|NCT02205931|Zonisamide|zonisamide|mesh-list
91922368|NCT02205931|Carbamazepine|carbamazepine|mesh-list
91922369|NCT02205931|Phenytoin|phenytoin|mesh-list
91922370|NCT02205931|Rufinamide|rufinamide|mesh-list
91922371|NCT02205931|Levetiracetam|levetiracetam|mesh-list
91922372|NCT02205931|Valproic Acid|valproic acid|mesh-list
91922373|NCT02205931|Clonazepam|clonazepam|mesh-list
91922374|NCT02205931|Vigabatrin|vigabatrin|mesh-list
91922381|NCT02205931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922382|NCT02205931|Nootropic Agents|nootropic agents|mesh-ancestor
91922383|NCT02205931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91922384|NCT02205931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91922385|NCT02205931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922386|NCT02205931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922387|NCT02205931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91922388|NCT02205931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91922389|NCT02205931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922390|NCT02205931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91922396|NCT02205931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922397|NCT02205931|Analgesics|analgesics|mesh-ancestor
91922398|NCT02205931|Sensory System Agents|sensory system agents|mesh-ancestor
91922399|NCT02205931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922400|NCT02205931|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91922401|NCT02205931|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91922402|NCT02205931|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91922403|NCT02205931|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91922404|NCT02205931|GABA Modulators|gaba modulators|mesh-ancestor
91922405|NCT02205931|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91922406|NCT02205931|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91922407|NCT02205931|GABA Agonists|gaba agonists|mesh-ancestor
91922408|NCT02205931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922409|NCT02221063|Thiamine|thiamine|mesh-list
91922410|NCT02221063|Vitamin B Complex|vitamin b complex|mesh-ancestor
91922411|NCT02221063|Vitamins|vitamins|mesh-ancestor
91922412|NCT02221063|Micronutrients|micronutrients|mesh-ancestor
91922413|NCT02221063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922415|NCT02220049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922416|NCT01351805|Vitamin D|vitamin d|mesh-list
91922417|NCT01351805|Ergocalciferols|ergocalciferols|mesh-list
91922418|NCT01351805|Cholecalciferol|cholecalciferol|mesh-list
91922419|NCT01351805|Vitamins|vitamins|mesh-list
91922420|NCT01351805|Micronutrients|micronutrients|mesh-ancestor
91922421|NCT01351805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922422|NCT01351805|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91922423|NCT01351805|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922424|NCT02206165|Amlodipine|amlodipine|mesh-list
91922425|NCT02206165|Candesartan|candesartan|mesh-list
91922426|NCT02206165|Candesartan cilexetil|candesartan cilexetil|mesh-list
91922427|NCT02206165|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91922428|NCT02206165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91922429|NCT02206165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91922430|NCT02206165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922431|NCT02206165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922432|NCT02206165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922433|NCT02206165|Vasodilator Agents|vasodilator agents|mesh-ancestor
91922434|NCT02206165|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91922435|NCT02206165|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91922436|NCT04356950|Thrombin|thrombin|mesh-list
91922437|NCT04356950|Hemostatics|hemostatics|mesh-ancestor
91922438|NCT04356950|Coagulants|coagulants|mesh-ancestor
91922444|NCT02254187|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91922445|NCT02254187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91922446|NCT02254187|Autonomic Agents|autonomic agents|mesh-ancestor
91922447|NCT02254187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922448|NCT02254187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922449|NCT02254187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91922450|NCT02254187|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922451|NCT02254187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91922452|NCT02254187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91922453|NCT02254187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91922454|NCT02254187|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922455|NCT02254187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922456|NCT02254187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922457|NCT05563610|Amoxicillin|amoxicillin|mesh-list
91922458|NCT05563610|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91922459|NCT05563610|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922460|NCT05503706|Selenium|selenium|mesh-list
91922461|NCT05503706|Salicylic Acid|salicylic acid|mesh-list
91922462|NCT05503706|Salicylates|salicylates|mesh-list
91922463|NCT05503706|Selenium disulfide|selenium disulfide|mesh-list
91922464|NCT05503706|Antioxidants|antioxidants|mesh-ancestor
91922465|NCT05503706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922466|NCT05503706|Protective Agents|protective agents|mesh-ancestor
91922467|NCT05503706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922469|NCT05503706|Micronutrients|micronutrients|mesh-ancestor
91922470|NCT05503706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922471|NCT05503706|Antifungal Agents|antifungal agents|mesh-ancestor
91922472|NCT05503706|Keratolytic Agents|keratolytic agents|mesh-ancestor
91922473|NCT05503706|Dermatologic Agents|dermatologic agents|mesh-ancestor
91922474|NCT05503706|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91922475|NCT05503706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922476|NCT05503706|Analgesics|analgesics|mesh-ancestor
91922477|NCT05503706|Sensory System Agents|sensory system agents|mesh-ancestor
91922478|NCT05503706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922479|NCT05503706|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922480|NCT05503706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91922481|NCT05503706|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91922482|NCT05503706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922483|NCT02174861|Erenumab|erenumab|mesh-list
91922484|NCT02174861|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91922485|NCT02174861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922486|NCT02174861|Analgesics|analgesics|mesh-ancestor
91922487|NCT02174861|Sensory System Agents|sensory system agents|mesh-ancestor
91922488|NCT02174861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922489|NCT02174861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922490|NCT02221375|Ciclesonide|ciclesonide|mesh-list
91922491|NCT02221375|Glucocorticoids|glucocorticoids|mesh-ancestor
91922492|NCT02221375|Hormones|hormones|mesh-ancestor
91922493|NCT02221375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922494|NCT02221375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922495|NCT02221375|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91922496|NCT02399709|Simvastatin|simvastatin|mesh-list
91922497|NCT02399709|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91922498|NCT02399709|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91922499|NCT02399709|Antimetabolites|antimetabolites|mesh-ancestor
91922500|NCT02399709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922501|NCT02399709|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91922502|NCT02399709|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91922503|NCT02399709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922504|NCT02220361|Dexmedetomidine|dexmedetomidine|mesh-list
91922505|NCT02220361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922506|NCT02220361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922507|NCT02220361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922508|NCT02220361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922509|NCT02220361|Analgesics|analgesics|mesh-ancestor
91922510|NCT02220361|Sensory System Agents|sensory system agents|mesh-ancestor
91922511|NCT02220361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922512|NCT02220361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91922513|NCT02220361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91922514|NCT02220361|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91922515|NCT02220361|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922516|NCT02220361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922517|NCT02220361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922518|NCT05175001|Betamethasone|betamethasone|mesh-list
91922519|NCT05175001|Betamethasone dipropionate, betamethasone sodium phosphate drug combination|betamethasone dipropionate, betamethasone sodium phosphate drug combination|mesh-list
91922520|NCT05175001|Ropivacaine|ropivacaine|mesh-list
91922521|NCT05175001|Anesthetics, Local|anesthetics, local|mesh-ancestor
91922522|NCT05175001|Anesthetics|anesthetics|mesh-ancestor
91922523|NCT05175001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922524|NCT05175001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922525|NCT05175001|Sensory System Agents|sensory system agents|mesh-ancestor
91922526|NCT05175001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922527|NCT05175001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922528|NCT05175001|Glucocorticoids|glucocorticoids|mesh-ancestor
91922529|NCT05175001|Hormones|hormones|mesh-ancestor
91922530|NCT05175001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922531|NCT05175001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91922532|NCT05175001|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922533|NCT00140855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91922534|NCT00140855|Ipilimumab|ipilimumab|mesh-list
91922535|NCT00140855|Antibodies|antibodies|mesh-list
91922536|NCT00140855|Immunoglobulins|immunoglobulins|mesh-list
91922537|NCT00140855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91922538|NCT00140855|Immunologic Factors|immunologic factors|mesh-ancestor
91922539|NCT00140855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922540|NCT00140855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922541|NCT00140855|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91922542|NCT00140855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922543|NCT02399397|Fentanyl|fentanyl|mesh-list
91922544|NCT02399397|Midazolam|midazolam|mesh-list
91922545|NCT02399397|Anesthetics|anesthetics|mesh-list
91922546|NCT02399397|Propofol|propofol|mesh-list
91922547|NCT02399397|Rocuronium|rocuronium|mesh-list
91922548|NCT02399397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922549|NCT02399397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922550|NCT02399397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922551|NCT02399397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91922552|NCT02399397|Anesthetics, General|anesthetics, general|mesh-ancestor
91922553|NCT02399397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91922554|NCT02399397|Narcotics|narcotics|mesh-ancestor
91922555|NCT02399397|Analgesics|analgesics|mesh-ancestor
91922556|NCT02399397|Sensory System Agents|sensory system agents|mesh-ancestor
91922557|NCT02399397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943190|NCT03287908|Glucocorticoids|glucocorticoids|mesh-ancestor
91922558|NCT02399397|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91922559|NCT02399397|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91922560|NCT02399397|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91922561|NCT02399397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91922562|NCT02399397|GABA Modulators|gaba modulators|mesh-ancestor
91922564|NCT02399397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922565|NCT02399397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922566|NCT02399397|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91922567|NCT02399397|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91922568|NCT02399397|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91922569|NCT02221453|Triamcinolone|triamcinolone|mesh-list
91922570|NCT02221453|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91922571|NCT02221453|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91922572|NCT02221453|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91922573|NCT02221453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922574|NCT02221453|Glucocorticoids|glucocorticoids|mesh-ancestor
91922575|NCT02221453|Hormones|hormones|mesh-ancestor
91922576|NCT02221453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922577|NCT02221453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922578|NCT02221453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91922579|NCT02221453|Immunologic Factors|immunologic factors|mesh-ancestor
91922580|NCT02221453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922581|NCT02221453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922582|NCT03106545|Bupivacaine|bupivacaine|mesh-list
91922583|NCT03106545|Anesthetics, Local|anesthetics, local|mesh-ancestor
91922584|NCT03106545|Anesthetics|anesthetics|mesh-ancestor
91922585|NCT03106545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922586|NCT03106545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922587|NCT03106545|Sensory System Agents|sensory system agents|mesh-ancestor
91922588|NCT03106545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922589|NCT02221531|Carbetocin|carbetocin|mesh-list
91922590|NCT02221531|Oxytocin|oxytocin|mesh-list
91922591|NCT02221531|Oxytocics|oxytocics|mesh-ancestor
91922592|NCT02221531|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91922593|NCT02221531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922594|NCT02231125|Losartan|losartan|mesh-list
91922595|NCT02231125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91922596|NCT02231125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91922597|NCT02231125|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91922598|NCT02231125|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91922599|NCT02231125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922600|NCT02396433|Carboplatin|carboplatin|mesh-list
91922601|NCT02396433|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
91922602|NCT02396433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922603|NCT02396433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922604|NCT02396433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922605|NCT02231203|Tocopherols|tocopherols|mesh-list
91922606|NCT02231203|Antioxidants|antioxidants|mesh-list
91922607|NCT02231203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922608|NCT02231203|Protective Agents|protective agents|mesh-ancestor
91922609|NCT02231203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922610|NCT02231203|Vitamins|vitamins|mesh-ancestor
91922611|NCT02231203|Micronutrients|micronutrients|mesh-ancestor
91922612|NCT02231281|Ritonavir|ritonavir|mesh-list
91922613|NCT02231281|Lopinavir|lopinavir|mesh-list
91922614|NCT02231281|Tenofovir|tenofovir|mesh-list
91922615|NCT02231281|Lamivudine|lamivudine|mesh-list
91922616|NCT02231281|Zidovudine|zidovudine|mesh-list
91922617|NCT02231281|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91922618|NCT02231281|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91922620|NCT02231281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922621|NCT02231281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922622|NCT02231281|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91922623|NCT02231281|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91922624|NCT02231281|Antiviral Agents|antiviral agents|mesh-ancestor
91922625|NCT02231281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922626|NCT02231281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91922627|NCT02231281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91922628|NCT02231281|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91922629|NCT02231281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91922630|NCT02231281|Antimetabolites|antimetabolites|mesh-ancestor
91922631|NCT02231359|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
91943191|NCT03287908|Hormones|hormones|mesh-ancestor
91922633|NCT02231359|Autonomic Agents|autonomic agents|mesh-ancestor
91922634|NCT02231359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922635|NCT02231359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922636|NCT02231359|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91922637|NCT02231359|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922638|NCT02780687|Afatinib|afatinib|mesh-list
91922639|NCT02780687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922640|NCT02780687|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91922641|NCT02780687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922642|NCT02780687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922643|NCT02231437|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
91922644|NCT02231437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91922646|NCT02231437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922647|NCT02231437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922648|NCT02231437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91922649|NCT02231437|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922650|NCT02147873|Azacitidine|azacitidine|mesh-list
91922651|NCT02147873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91922652|NCT02147873|Antimetabolites|antimetabolites|mesh-ancestor
91922653|NCT02147873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922654|NCT02147873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922655|NCT02147873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922656|NCT02398929|Bisoprolol|bisoprolol|mesh-list
91922657|NCT02398929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91922658|NCT02398929|Sympatholytics|sympatholytics|mesh-ancestor
91922659|NCT02398929|Autonomic Agents|autonomic agents|mesh-ancestor
91922660|NCT02398929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922661|NCT02398929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922662|NCT02398929|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91922663|NCT02398929|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91922664|NCT02398929|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91922665|NCT02398929|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922666|NCT02398929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922667|NCT02398929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922668|NCT02221765|Pancreatic Polypeptide|pancreatic polypeptide|mesh-list
91922669|NCT02221765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922670|NCT02221765|Hormones|hormones|mesh-ancestor
91922671|NCT02221765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922672|NCT02221765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922673|NCT05069129|Vaccines|vaccines|mesh-list
91922674|NCT05069129|Immunologic Factors|immunologic factors|mesh-ancestor
91922675|NCT05069129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922676|NCT02147951|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
91922677|NCT02147951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91922678|NCT02147951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922679|NCT03544073|Leuprolide|leuprolide|mesh-list
91922680|NCT03544073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91922681|NCT03544073|Fertility Agents|fertility agents|mesh-ancestor
91922682|NCT03544073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91922683|NCT03544073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922684|NCT03544073|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91922685|NCT03544073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922686|NCT02398383|Hypoglycemic Agents|hypoglycemic agents|mesh-list
91922687|NCT02398383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922688|NCT03168087|Plasma-lyte 148|plasma-lyte 148|mesh-list
91922689|NCT03168087|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91922690|NCT03168087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91922691|NCT02781311|Finasteride|finasteride|mesh-list
91922692|NCT02781311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91922693|NCT02781311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91922694|NCT02781311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922695|NCT02781311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922696|NCT02781311|Hormone Antagonists|hormone antagonists|mesh-ancestor
91922697|NCT02781311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922698|NCT02781311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922699|NCT02781311|Urological Agents|urological agents|mesh-ancestor
91922700|NCT02144441|Insulin Glargine|insulin glargine|mesh-list
91922701|NCT02144441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91922702|NCT02144441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922703|NCT02225977|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91922704|NCT02225977|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91922705|NCT02225977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922706|NCT02225977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91922707|NCT02225977|Immunologic Factors|immunologic factors|mesh-ancestor
91922708|NCT02225977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922709|NCT02141009|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91922710|NCT02141009|Immunologic Factors|immunologic factors|mesh-ancestor
91922711|NCT02141009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922713|NCT02221999|Letrozole|letrozole|mesh-list
91922714|NCT02221999|Hormones|hormones|mesh-list
91922715|NCT02221999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91922716|NCT02221999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922717|NCT02221999|Tubulin Modulators|tubulin modulators|mesh-ancestor
91922718|NCT02221999|Antimitotic Agents|antimitotic agents|mesh-ancestor
91922719|NCT02221999|Mitosis Modulators|mitosis modulators|mesh-ancestor
91922720|NCT02221999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922721|NCT02221999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922722|NCT02221999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922723|NCT02221999|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91922724|NCT02221999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91922725|NCT02221999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922726|NCT02221999|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91922727|NCT02221999|Hormone Antagonists|hormone antagonists|mesh-ancestor
91922728|NCT02564198|Ramucirumab|ramucirumab|mesh-list
91922729|NCT02564198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922730|NCT02398539|Silver Nitrate|silver nitrate|mesh-list
91922731|NCT02398539|Triamcinolone|triamcinolone|mesh-list
91922732|NCT02398539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922733|NCT02398539|Glucocorticoids|glucocorticoids|mesh-ancestor
91922734|NCT02398539|Hormones|hormones|mesh-ancestor
91922735|NCT02398539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91922736|NCT02398539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922737|NCT02398539|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91922738|NCT02398539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922739|NCT02144753|Psyllium|psyllium|mesh-list
91922740|NCT02144753|Calcium polycarbophil|calcium polycarbophil|mesh-list
91922741|NCT02144753|Cathartics|cathartics|mesh-ancestor
91922742|NCT02144753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922743|NCT02144753|Antidiarrheals|antidiarrheals|mesh-ancestor
91922744|NCT02231905|Pramipexole|pramipexole|mesh-list
91922745|NCT02231905|Antioxidants|antioxidants|mesh-ancestor
91922746|NCT02231905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922747|NCT02231905|Protective Agents|protective agents|mesh-ancestor
91922748|NCT02231905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922749|NCT02231905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91922750|NCT02231905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91922751|NCT02231905|Dopamine Agonists|dopamine agonists|mesh-ancestor
91922752|NCT02231905|Dopamine Agents|dopamine agents|mesh-ancestor
91922753|NCT02231905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922754|NCT02141087|Pirfenidone|pirfenidone|mesh-list
91922755|NCT02141087|Analgesics|analgesics|mesh-ancestor
91922756|NCT02141087|Sensory System Agents|sensory system agents|mesh-ancestor
91922757|NCT02141087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922758|NCT02141087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922759|NCT02141087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91922760|NCT02141087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922761|NCT02141087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922762|NCT02141087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91922763|NCT02141087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922764|NCT02698293|Vitamin D|vitamin d|mesh-list
91922765|NCT02698293|Ergocalciferols|ergocalciferols|mesh-list
91922766|NCT02698293|Cholecalciferol|cholecalciferol|mesh-list
91922767|NCT02698293|Vitamins|vitamins|mesh-list
91922768|NCT02698293|Micronutrients|micronutrients|mesh-ancestor
91922769|NCT02698293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922770|NCT02698293|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91922771|NCT02698293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91922772|NCT02226289|Bevacizumab|bevacizumab|mesh-list
91922773|NCT02226289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91922774|NCT02226289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922775|NCT02226289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91922776|NCT02226289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91922777|NCT02226289|Growth Substances|growth substances|mesh-ancestor
91922778|NCT02226289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922779|NCT02226289|Growth Inhibitors|growth inhibitors|mesh-ancestor
91922780|NCT04480593|Propolis|propolis|mesh-list
91922781|NCT04480593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922782|NCT05079217|Vaccines|vaccines|mesh-list
91922783|NCT05079217|Immunologic Factors|immunologic factors|mesh-ancestor
91922784|NCT05079217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922785|NCT02141321|Alprostadil|alprostadil|mesh-list
91922786|NCT02141321|Misoprostol|misoprostol|mesh-list
91922787|NCT02141321|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91922788|NCT02141321|Abortifacient Agents|abortifacient agents|mesh-ancestor
91922789|NCT02141321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91922790|NCT02141321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922791|NCT02141321|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91922792|NCT02141321|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922793|NCT02141321|Oxytocics|oxytocics|mesh-ancestor
91922794|NCT02141321|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91922795|NCT02141321|Vasodilator Agents|vasodilator agents|mesh-ancestor
91922796|NCT02141321|Urological Agents|urological agents|mesh-ancestor
91922797|NCT03965078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91922798|NCT03965078|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91922799|NCT03965078|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91922800|NCT02141477|Decitabine|decitabine|mesh-list
91922801|NCT02141477|Homoharringtonine|homoharringtonine|mesh-list
91922802|NCT02141477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91922803|NCT02141477|Antimetabolites|antimetabolites|mesh-ancestor
91922804|NCT02141477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922805|NCT02141477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922806|NCT02141477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922807|NCT02141477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91922808|NCT02141477|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91922809|NCT02232139|Midazolam|midazolam|mesh-list
91922810|NCT02232139|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91922811|NCT02232139|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922812|NCT02232139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922813|NCT02232139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922814|NCT02232139|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91922815|NCT02232139|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91922816|NCT02232139|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91922817|NCT02232139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91922818|NCT02232139|Anesthetics, General|anesthetics, general|mesh-ancestor
91922819|NCT02232139|Anesthetics|anesthetics|mesh-ancestor
91922820|NCT02232139|GABA Modulators|gaba modulators|mesh-ancestor
91922821|NCT02232139|GABA Agents|gaba agents|mesh-ancestor
91922822|NCT02232139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922823|NCT02232139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922824|NCT04288778|Metformin|metformin|mesh-list
91922825|NCT04288778|Canagliflozin|canagliflozin|mesh-list
91922826|NCT04288778|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91922827|NCT04288778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922828|NCT04288778|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91922829|NCT04288778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922830|NCT02226601|Aprepitant|aprepitant|mesh-list
91922831|NCT02226601|Antiemetics|antiemetics|mesh-ancestor
91922832|NCT02226601|Autonomic Agents|autonomic agents|mesh-ancestor
91922833|NCT02226601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922834|NCT02226601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922835|NCT02226601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91922836|NCT02226601|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91922837|NCT02226601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922838|NCT02226601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922839|NCT02397603|Dexmedetomidine|dexmedetomidine|mesh-list
91922840|NCT02397603|Bupivacaine|bupivacaine|mesh-list
91922841|NCT02397603|Anesthetics, Local|anesthetics, local|mesh-ancestor
91922842|NCT02397603|Anesthetics|anesthetics|mesh-ancestor
91922843|NCT02397603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922844|NCT02397603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922845|NCT02397603|Sensory System Agents|sensory system agents|mesh-ancestor
91922846|NCT02397603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922847|NCT02397603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91922848|NCT02397603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922849|NCT02397603|Analgesics|analgesics|mesh-ancestor
91922850|NCT02397603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91922851|NCT02397603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91922852|NCT02397603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91922853|NCT02397603|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922854|NCT02397603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922855|NCT02397603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922857|NCT02145065|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91922858|NCT02145065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922859|NCT02145065|Tubulin Modulators|tubulin modulators|mesh-ancestor
91922860|NCT02145065|Antimitotic Agents|antimitotic agents|mesh-ancestor
91922861|NCT02145065|Mitosis Modulators|mitosis modulators|mesh-ancestor
91922862|NCT02145065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922863|NCT02226757|Paclitaxel|paclitaxel|mesh-list
91922864|NCT02226757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91922865|NCT02226757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922866|NCT02226757|Tubulin Modulators|tubulin modulators|mesh-ancestor
91922867|NCT02226757|Antimitotic Agents|antimitotic agents|mesh-ancestor
91922868|NCT02226757|Mitosis Modulators|mitosis modulators|mesh-ancestor
91922869|NCT02226757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922870|NCT04616924|Clarithromycin|clarithromycin|mesh-list
91922871|NCT04616924|Rifabutin|rifabutin|mesh-list
91922872|NCT04616924|Clofazimine|clofazimine|mesh-list
91922873|NCT04616924|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91922874|NCT04616924|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922875|NCT04616924|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91922876|NCT04616924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922877|NCT04616924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922878|NCT04616924|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91922879|NCT04616924|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91922880|NCT04616924|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91922881|NCT04616924|Antitubercular Agents|antitubercular agents|mesh-ancestor
91922882|NCT04616924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922883|NCT04616924|Leprostatic Agents|leprostatic agents|mesh-ancestor
91922884|NCT02226913|Lidocaine|lidocaine|mesh-list
91922885|NCT02226913|Epinephrine|epinephrine|mesh-list
91922886|NCT02226913|Anesthetics, Local|anesthetics, local|mesh-ancestor
91922887|NCT02226913|Anesthetics|anesthetics|mesh-ancestor
91922888|NCT02226913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922889|NCT02226913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922890|NCT02226913|Sensory System Agents|sensory system agents|mesh-ancestor
91922891|NCT02226913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922892|NCT02226913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91922893|NCT02226913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91922894|NCT02226913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91922895|NCT02226913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91922896|NCT02226913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922897|NCT02226913|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91922898|NCT02226913|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91922899|NCT02226913|Adrenergic Agents|adrenergic agents|mesh-ancestor
91922900|NCT02226913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922901|NCT02226913|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91922902|NCT02226913|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91922903|NCT02226913|Autonomic Agents|autonomic agents|mesh-ancestor
91922904|NCT02226913|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91922905|NCT02226913|Respiratory System Agents|respiratory system agents|mesh-ancestor
91922906|NCT02226913|Mydriatics|mydriatics|mesh-ancestor
91922907|NCT02226913|Sympathomimetics|sympathomimetics|mesh-ancestor
91922908|NCT02226913|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91922909|NCT05491616|Nivolumab|nivolumab|mesh-list
91922910|NCT05491616|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91922911|NCT05491616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922912|NCT05491616|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91922913|NCT05491616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922914|NCT02254655|Antirheumatic Agents|antirheumatic agents|mesh-list
91922915|NCT02254655|Puerarin|puerarin|mesh-list
91922916|NCT02254655|Vasodilator Agents|vasodilator agents|mesh-ancestor
91922917|NCT02226991|Ritonavir|ritonavir|mesh-list
91922918|NCT02226991|Tipranavir|tipranavir|mesh-list
91922919|NCT02226991|Efavirenz|efavirenz|mesh-list
91922920|NCT02226991|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91922921|NCT02226991|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91922922|NCT02226991|Protease Inhibitors|protease inhibitors|mesh-ancestor
91922923|NCT02226991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922924|NCT02226991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922925|NCT02226991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91922926|NCT02226991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91922927|NCT02226991|Antiviral Agents|antiviral agents|mesh-ancestor
91922928|NCT02226991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91922929|NCT02226991|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91922930|NCT02226991|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91922931|NCT02226991|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91922932|NCT02226991|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91922933|NCT02226991|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91922934|NCT02226991|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91922935|NCT02226991|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91922936|NCT02226991|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91922937|NCT02226991|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91922938|NCT05042791|Capecitabine|capecitabine|mesh-list
91922939|NCT05042791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91922940|NCT05042791|Antimetabolites|antimetabolites|mesh-ancestor
91922941|NCT05042791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922942|NCT05042791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922943|NCT00705783|Aripiprazole|aripiprazole|mesh-list
91922944|NCT00705783|Antidepressive Agents|antidepressive agents|mesh-ancestor
91922945|NCT00705783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91922946|NCT00705783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91922947|NCT00705783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91922948|NCT00705783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91922949|NCT00705783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922950|NCT00705783|Dopamine Agonists|dopamine agonists|mesh-ancestor
91922951|NCT00705783|Dopamine Agents|dopamine agents|mesh-ancestor
91922952|NCT00705783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922953|NCT00705783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922954|NCT00705783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91922955|NCT00705783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91922956|NCT00705783|Serotonin Agents|serotonin agents|mesh-ancestor
91922957|NCT00705783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91922958|NCT00705783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91922959|NCT00705783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91922960|NCT00705783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91922961|NCT02145611|Vildagliptin|vildagliptin|mesh-list
91922962|NCT02145611|Glyburide|glyburide|mesh-list
91922963|NCT02145611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91922964|NCT02145611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922965|NCT02145611|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91922966|NCT02145611|Protease Inhibitors|protease inhibitors|mesh-ancestor
91922967|NCT02145611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922968|NCT02145611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922969|NCT02222623|Isophane Insulin, Human|isophane insulin, human|mesh-list
91922970|NCT02222623|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91922971|NCT02222623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922972|NCT03543683|Aspirin|aspirin|mesh-list
91922973|NCT03543683|Osimertinib|osimertinib|mesh-list
92074246|NCT00072514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91922974|NCT03543683|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91922975|NCT03543683|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91922976|NCT03543683|Analgesics|analgesics|mesh-ancestor
91922977|NCT03543683|Sensory System Agents|sensory system agents|mesh-ancestor
91922978|NCT03543683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91922979|NCT03543683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91922980|NCT03543683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91922981|NCT03543683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91922982|NCT03543683|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91922983|NCT03543683|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91922984|NCT03543683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922985|NCT03543683|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91922986|NCT03543683|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91922987|NCT03543683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91922988|NCT03543683|Antipyretics|antipyretics|mesh-ancestor
91922989|NCT03543683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91922990|NCT03543683|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91922992|NCT02145689|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91922993|NCT02145689|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91922994|NCT02145689|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91922995|NCT02145689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91922996|NCT02145689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91922997|NCT02145689|Cholinergic Agents|cholinergic agents|mesh-ancestor
91922998|NCT02145689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91922999|NCT02145689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923000|NCT02145689|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91923001|NCT02145689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923002|NCT02396979|Methadone|methadone|mesh-list
91923003|NCT02396979|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91923004|NCT02396979|Narcotics|narcotics|mesh-ancestor
91923005|NCT02396979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923006|NCT02396979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923007|NCT02396979|Analgesics|analgesics|mesh-ancestor
91923008|NCT02396979|Sensory System Agents|sensory system agents|mesh-ancestor
91923009|NCT02396979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923010|NCT02396979|Antitussive Agents|antitussive agents|mesh-ancestor
91923011|NCT02396979|Respiratory System Agents|respiratory system agents|mesh-ancestor
91923012|NCT02145767|Progesterone|progesterone|mesh-list
91923013|NCT02145767|Progestins|progestins|mesh-ancestor
91923014|NCT02145767|Hormones|hormones|mesh-ancestor
91923015|NCT02145767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923016|NCT02145767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923017|NCT02031523|Analgesics|analgesics|mesh-list
91923018|NCT02031523|Sensory System Agents|sensory system agents|mesh-ancestor
91923019|NCT02031523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923020|NCT02031523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923021|NCT02397213|Cyclosporine|cyclosporine|mesh-list
91923022|NCT02397213|Cyclosporins|cyclosporins|mesh-list
91923023|NCT02397213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923024|NCT02397213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923025|NCT02397213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923026|NCT02397213|Immunologic Factors|immunologic factors|mesh-ancestor
91923027|NCT02397213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923028|NCT02397213|Antifungal Agents|antifungal agents|mesh-ancestor
91923029|NCT02397213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923030|NCT02397213|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923031|NCT02397213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923032|NCT02397213|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91923033|NCT04480281|Lidocaine|lidocaine|mesh-list
91923034|NCT04480281|Anesthetics, Local|anesthetics, local|mesh-ancestor
91923035|NCT04480281|Anesthetics|anesthetics|mesh-ancestor
91923036|NCT04480281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923037|NCT04480281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923038|NCT04480281|Sensory System Agents|sensory system agents|mesh-ancestor
91923039|NCT04480281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923040|NCT04480281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91923041|NCT04480281|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91923042|NCT04480281|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91923043|NCT04480281|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923044|NCT04480281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923045|NCT03544775|Anesthetics|anesthetics|mesh-list
91923046|NCT03544775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923047|NCT03544775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923048|NCT02258815|Dinutuximab|dinutuximab|mesh-list
91923049|NCT02258815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923051|NCT02149433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923052|NCT02149433|Glucocorticoids|glucocorticoids|mesh-ancestor
91923053|NCT02149433|Hormones|hormones|mesh-ancestor
91923054|NCT02149433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923055|NCT02149433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923056|NCT02149433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91923057|NCT02149433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923058|NCT02228005|Sertraline|sertraline|mesh-list
91923059|NCT02228005|Antidepressive Agents|antidepressive agents|mesh-ancestor
91923060|NCT02228005|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91923061|NCT02228005|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91923062|NCT02228005|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91923063|NCT02228005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923064|NCT02228005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923066|NCT02228005|Serotonin Agents|serotonin agents|mesh-ancestor
91923067|NCT02228005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923068|NCT02228083|Lidocaine|lidocaine|mesh-list
91923069|NCT02228083|Epinephrine|epinephrine|mesh-list
91923070|NCT02228083|Anesthetics, Local|anesthetics, local|mesh-ancestor
91923071|NCT02228083|Anesthetics|anesthetics|mesh-ancestor
91923072|NCT02228083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923073|NCT02228083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923074|NCT02228083|Sensory System Agents|sensory system agents|mesh-ancestor
91923075|NCT02228083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923076|NCT02228083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91923077|NCT02228083|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91923078|NCT02228083|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91923079|NCT02228083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923080|NCT02228083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923081|NCT02228083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91923082|NCT02228083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91923083|NCT02228083|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923084|NCT02228083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923085|NCT02228083|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91923086|NCT02228083|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91923087|NCT02228083|Autonomic Agents|autonomic agents|mesh-ancestor
91923088|NCT02228083|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91923089|NCT02228083|Respiratory System Agents|respiratory system agents|mesh-ancestor
91923090|NCT02228083|Mydriatics|mydriatics|mesh-ancestor
91923091|NCT02228083|Sympathomimetics|sympathomimetics|mesh-ancestor
91923092|NCT02228083|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91923093|NCT02394483|Olorofim|olorofim|mesh-list
91923094|NCT02394483|Antifungal Agents|antifungal agents|mesh-ancestor
91923095|NCT02394483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923096|NCT02142335|Rituximab|rituximab|mesh-list
91923097|NCT02142335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91923098|NCT02142335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923099|NCT02142335|Immunologic Factors|immunologic factors|mesh-ancestor
91923100|NCT02142335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923101|NCT02142335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923102|NCT02228239|Mirtazapine|mirtazapine|mesh-list
91923103|NCT02228239|Esketamine|esketamine|mesh-list
91923104|NCT02228239|Antidepressive Agents|antidepressive agents|mesh-ancestor
91923105|NCT02228239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91923106|NCT02228239|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91923107|NCT02228239|Histamine Antagonists|histamine antagonists|mesh-ancestor
91923108|NCT02228239|Histamine Agents|histamine agents|mesh-ancestor
91923109|NCT02228239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923110|NCT02228239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923111|NCT02228239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923112|NCT02228239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91923113|NCT02228239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91923114|NCT02228239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923115|NCT02228239|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91923116|NCT02228239|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91923117|NCT02228239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91923118|NCT02228239|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923119|NCT02228239|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91923120|NCT02228239|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91923122|NCT02228239|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91923124|NCT03167385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923125|NCT03167385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91923126|NCT03167385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923127|NCT03167385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923128|NCT02142569|Tocotrienols|tocotrienols|mesh-list
91923129|NCT02142569|Vitamin E|vitamin e|mesh-list
91923130|NCT02142569|Tocopherols|tocopherols|mesh-list
91923131|NCT02142569|Red yeast rice|red yeast rice|mesh-list
91923132|NCT02142569|Antioxidants|antioxidants|mesh-ancestor
91923133|NCT02142569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923134|NCT02142569|Protective Agents|protective agents|mesh-ancestor
91923135|NCT02142569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923137|NCT02142569|Micronutrients|micronutrients|mesh-ancestor
91923138|NCT02142569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91923139|NCT02142569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91923140|NCT02142569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91923141|NCT02142569|Antimetabolites|antimetabolites|mesh-ancestor
91923142|NCT02142569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923143|NCT02142569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91923144|NCT02228473|Atropine|atropine|mesh-list
91923146|NCT02228473|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91923147|NCT02228473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91923148|NCT02228473|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91923149|NCT02228473|Autonomic Agents|autonomic agents|mesh-ancestor
91923150|NCT02228473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923151|NCT02228473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923152|NCT02228473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91923153|NCT02228473|Respiratory System Agents|respiratory system agents|mesh-ancestor
91923154|NCT02228473|Mydriatics|mydriatics|mesh-ancestor
91923155|NCT02228473|Parasympatholytics|parasympatholytics|mesh-ancestor
91923156|NCT02228473|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91923157|NCT02228473|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91923158|NCT02228473|Cholinergic Agents|cholinergic agents|mesh-ancestor
91923159|NCT02228473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923160|NCT02228473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923162|NCT02394093|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91923163|NCT02394093|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91923164|NCT02394093|Analgesics|analgesics|mesh-ancestor
91923165|NCT02394093|Sensory System Agents|sensory system agents|mesh-ancestor
91923166|NCT02394093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923167|NCT02394093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923168|NCT02394093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923169|NCT02394093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923170|NCT02394093|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91923171|NCT02394093|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91923172|NCT02394093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923173|NCT02394093|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91923174|NCT02394093|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91923175|NCT02394093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923176|NCT02394093|Antipyretics|antipyretics|mesh-ancestor
91923177|NCT02146391|Enclomiphene|enclomiphene|mesh-list
91923178|NCT02146391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91923179|NCT02146391|Hormone Antagonists|hormone antagonists|mesh-ancestor
91923180|NCT02146391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923181|NCT02146391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923182|NCT02146391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91923183|NCT02146391|Fertility Agents|fertility agents|mesh-ancestor
91923184|NCT02146391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91923185|NCT02146391|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91923186|NCT02146391|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91923187|NCT04225273|Lidocaine|lidocaine|mesh-list
91923188|NCT04225273|Anesthetics, Local|anesthetics, local|mesh-ancestor
91923189|NCT04225273|Anesthetics|anesthetics|mesh-ancestor
91923190|NCT04225273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923191|NCT04225273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923192|NCT04225273|Sensory System Agents|sensory system agents|mesh-ancestor
91923193|NCT04225273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923194|NCT04225273|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91923195|NCT04225273|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91923196|NCT04225273|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91923197|NCT04225273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923198|NCT04225273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923200|NCT02146547|Paliperidone Palmitate|paliperidone palmitate|mesh-list
91923201|NCT02146547|Antidepressive Agents|antidepressive agents|mesh-ancestor
91923202|NCT02146547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91923203|NCT02146547|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91923204|NCT02146547|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91923205|NCT02146547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923206|NCT02146547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923207|NCT02146547|Dopamine Agonists|dopamine agonists|mesh-ancestor
91923208|NCT02146547|Dopamine Agents|dopamine agents|mesh-ancestor
91923209|NCT02146547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923210|NCT02146547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923211|NCT02146547|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91923212|NCT02146547|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91923213|NCT02146547|Serotonin Agents|serotonin agents|mesh-ancestor
91923214|NCT02146547|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91923215|NCT02146547|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91923216|NCT02146547|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91923217|NCT02146547|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91923218|NCT02394015|Doxorubicin|doxorubicin|mesh-list
91923219|NCT02394015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91923220|NCT02394015|Trabectedin|trabectedin|mesh-list
91923221|NCT02394015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91923222|NCT02394015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923223|NCT02394015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91923224|NCT02394015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91923225|NCT02394015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923226|NCT02394015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923227|NCT02394015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91923228|NCT02394015|Alkylating Agents|alkylating agents|mesh-ancestor
91923229|NCT02142881|Antihypertensive Agents|antihypertensive agents|mesh-list
91923230|NCT02146703|Gemcitabine|gemcitabine|mesh-list
91923231|NCT02146703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91923232|NCT02146703|Antimetabolites|antimetabolites|mesh-ancestor
91923233|NCT02146703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923234|NCT02146703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923235|NCT02228863|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91923236|NCT02228863|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91923237|NCT02228863|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91923238|NCT02228863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923239|NCT02228863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923240|NCT02228863|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91923241|NCT02228863|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923242|NCT02228863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923243|NCT02228863|Cholinergic Agents|cholinergic agents|mesh-ancestor
91923244|NCT02228863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923245|NCT02782169|Pregabalin|pregabalin|mesh-list
91923246|NCT02782169|Analgesics|analgesics|mesh-ancestor
91923247|NCT02782169|Sensory System Agents|sensory system agents|mesh-ancestor
91923248|NCT02782169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923249|NCT02782169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923250|NCT02782169|Anticonvulsants|anticonvulsants|mesh-ancestor
91923251|NCT02782169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91923252|NCT02782169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923253|NCT02782169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923254|NCT02782169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91923255|NCT02782169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91923256|NCT02782169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91923257|NCT02782169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923258|NCT02782169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91923259|NCT04163185|Meloxicam|meloxicam|mesh-list
91923260|NCT04163185|Rizatriptan|rizatriptan|mesh-list
91923261|NCT04163185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91923262|NCT04163185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91923263|NCT04163185|Analgesics|analgesics|mesh-ancestor
91923264|NCT04163185|Sensory System Agents|sensory system agents|mesh-ancestor
91923265|NCT04163185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923266|NCT04163185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923267|NCT04163185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923268|NCT04163185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923269|NCT04163185|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91923270|NCT04163185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91923271|NCT04163185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923272|NCT04163185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923273|NCT04163185|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91923274|NCT04163185|Serotonin Agents|serotonin agents|mesh-ancestor
91923275|NCT04163185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923276|NCT02149901|Pseudoephedrine|pseudoephedrine|mesh-list
91923277|NCT02149901|Ephedrine|ephedrine|mesh-list
91923278|NCT02149901|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91923279|NCT02149901|Autonomic Agents|autonomic agents|mesh-ancestor
91923280|NCT02149901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923282|NCT02149901|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91923283|NCT02149901|Respiratory System Agents|respiratory system agents|mesh-ancestor
91923284|NCT02149901|Nasal Decongestants|nasal decongestants|mesh-ancestor
91923285|NCT02149901|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91923286|NCT02149901|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91923287|NCT02149901|Sympathomimetics|sympathomimetics|mesh-ancestor
91923288|NCT02149901|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923289|NCT02149901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923290|NCT02149901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923291|NCT04440267|Dexamethasone|dexamethasone|mesh-list
91923292|NCT04440267|Prednisone|prednisone|mesh-list
91923293|NCT04440267|Cyclophosphamide|cyclophosphamide|mesh-list
91923294|NCT04440267|Methotrexate|methotrexate|mesh-list
91923295|NCT04440267|Vincristine|vincristine|mesh-list
91923299|NCT04440267|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91923300|NCT04440267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923301|NCT04440267|Immunologic Factors|immunologic factors|mesh-ancestor
91923302|NCT04440267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923304|NCT04440267|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91923305|NCT04440267|Alkylating Agents|alkylating agents|mesh-ancestor
91923306|NCT04440267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923307|NCT04440267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923308|NCT04440267|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91923309|NCT04440267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923310|NCT04440267|Antiemetics|antiemetics|mesh-ancestor
91923311|NCT04440267|Autonomic Agents|autonomic agents|mesh-ancestor
91923312|NCT04440267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923313|NCT04440267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923314|NCT04440267|Glucocorticoids|glucocorticoids|mesh-ancestor
91923315|NCT04440267|Hormones|hormones|mesh-ancestor
91923316|NCT04440267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923317|NCT04440267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91923318|NCT04440267|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91923319|NCT04440267|Abortifacient Agents|abortifacient agents|mesh-ancestor
91923320|NCT04440267|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91923321|NCT04440267|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91923322|NCT04440267|Antimetabolites|antimetabolites|mesh-ancestor
91923323|NCT04440267|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923324|NCT04440267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923325|NCT04440267|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91923326|NCT04440267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91923327|NCT04440267|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91923328|NCT04440267|Tubulin Modulators|tubulin modulators|mesh-ancestor
91923329|NCT04440267|Antimitotic Agents|antimitotic agents|mesh-ancestor
91923330|NCT04440267|Mitosis Modulators|mitosis modulators|mesh-ancestor
91923331|NCT04440267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91923332|NCT04440267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91923333|NCT04440267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91923334|NCT04440267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91923335|NCT02043847|Melphalan|melphalan|mesh-list
91923336|NCT02043847|Lenograstim|lenograstim|mesh-list
91923337|NCT02043847|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91923338|NCT02043847|Immunologic Factors|immunologic factors|mesh-ancestor
91923339|NCT02043847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923340|NCT02043847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91923341|NCT02043847|Alkylating Agents|alkylating agents|mesh-ancestor
91923342|NCT02043847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923343|NCT02043847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923344|NCT02043847|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91923345|NCT02043847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923346|NCT02146937|Bicalutamide|bicalutamide|mesh-list
91923347|NCT02146937|Finasteride|finasteride|mesh-list
91923348|NCT02146937|Androgen Antagonists|androgen antagonists|mesh-ancestor
91923349|NCT02146937|Hormone Antagonists|hormone antagonists|mesh-ancestor
91923350|NCT02146937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923351|NCT02146937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923352|NCT02146937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923353|NCT02146937|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91923354|NCT02146937|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91923355|NCT02146937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923356|NCT02146937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923357|NCT02146937|Urological Agents|urological agents|mesh-ancestor
91923358|NCT02147015|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91923360|NCT02147015|Glucocorticoids|glucocorticoids|mesh-list
91923361|NCT02147015|Cholinergic Agents|cholinergic agents|mesh-list
91923362|NCT02147015|Muscarinic Antagonists|muscarinic antagonists|mesh-list
91923363|NCT02147015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923364|NCT02147015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923365|NCT02147015|Antiemetics|antiemetics|mesh-ancestor
91923366|NCT02147015|Autonomic Agents|autonomic agents|mesh-ancestor
91923367|NCT02147015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923368|NCT02147015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923369|NCT02147015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923370|NCT02147015|Hormones|hormones|mesh-ancestor
91923371|NCT02147015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923372|NCT02147015|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91923373|NCT02147015|Protective Agents|protective agents|mesh-ancestor
91923374|NCT02147015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923375|NCT02147015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923376|NCT02147015|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91923378|NCT02229175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91923379|NCT02229175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923380|NCT02229175|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91923381|NCT02229175|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91923382|NCT02229175|Growth Substances|growth substances|mesh-ancestor
91923383|NCT02229175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923384|NCT02229175|Growth Inhibitors|growth inhibitors|mesh-ancestor
91923385|NCT05744739|Azacitidine|azacitidine|mesh-list
91923386|NCT05744739|Venetoclax|venetoclax|mesh-list
91923387|NCT05744739|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91923388|NCT05744739|Antimetabolites|antimetabolites|mesh-ancestor
91923389|NCT05744739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923390|NCT05744739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923391|NCT05744739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923392|NCT04947007|Bupivacaine|bupivacaine|mesh-list
91923393|NCT04947007|Anesthetics, Local|anesthetics, local|mesh-ancestor
91923394|NCT04947007|Anesthetics|anesthetics|mesh-ancestor
91923395|NCT04947007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923396|NCT04947007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923397|NCT04947007|Sensory System Agents|sensory system agents|mesh-ancestor
91923398|NCT04947007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923399|NCT04104685|Minocycline|minocycline|mesh-list
91923400|NCT04104685|Adapalene|adapalene|mesh-list
91923401|NCT04104685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91923402|NCT04104685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923403|NCT04104685|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91923404|NCT04104685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91923405|NCT04104685|Analgesics|analgesics|mesh-ancestor
91923406|NCT04104685|Sensory System Agents|sensory system agents|mesh-ancestor
91923407|NCT04104685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923408|NCT04104685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923409|NCT04104685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923410|NCT04104685|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923411|NCT04104685|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923412|NCT02147249|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91923413|NCT02147249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923414|NCT02392845|Docetaxel|docetaxel|mesh-list
91923415|NCT02392845|Epirubicin|epirubicin|mesh-list
91923416|NCT02392845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923417|NCT02392845|Tubulin Modulators|tubulin modulators|mesh-ancestor
91923418|NCT02392845|Antimitotic Agents|antimitotic agents|mesh-ancestor
91923419|NCT02392845|Mitosis Modulators|mitosis modulators|mesh-ancestor
91923420|NCT02392845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923421|NCT02392845|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91923422|NCT02392845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91923423|NCT02392845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91923424|NCT02392845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923425|NCT04093765|Antimalarials|antimalarials|mesh-list
91923426|NCT04093765|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91923427|NCT04093765|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91923429|NCT03166605|Simethicone|simethicone|mesh-list
91923430|NCT03166605|Antifoaming Agents|antifoaming agents|mesh-ancestor
91923431|NCT03166605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923432|NCT03166605|Emollients|emollients|mesh-ancestor
91923433|NCT03166605|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923434|NCT03699956|Carboplatin|carboplatin|mesh-list
91923436|NCT03699956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923437|NCT03699956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91923438|NCT03699956|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91923439|NCT03699956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91923440|NCT03699956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923441|NCT03699956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923442|NCT03166527|Immunoglobulins|immunoglobulins|mesh-list
91923443|NCT03166527|Antibodies|antibodies|mesh-list
91923444|NCT03166527|gamma-Globulins|gamma-globulins|mesh-list
91923445|NCT03166527|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91923446|NCT03166527|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91923447|NCT03166527|Immunologic Factors|immunologic factors|mesh-ancestor
91923448|NCT03166527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923449|NCT02695719|Lubiprostone|lubiprostone|mesh-list
91923450|NCT02695719|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91923451|NCT02695719|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923531|NCT02229955|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91923452|NCT02695719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923454|NCT05498012|Anticonvulsants|anticonvulsants|mesh-ancestor
91923455|NCT02150291|Folic Acid|folic acid|mesh-list
91923456|NCT02150291|Vitamin B Complex|vitamin b complex|mesh-list
91923457|NCT02150291|Hematinics|hematinics|mesh-ancestor
91923458|NCT02150291|Vitamins|vitamins|mesh-ancestor
91923459|NCT02150291|Micronutrients|micronutrients|mesh-ancestor
91923460|NCT02150291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923461|NCT04907071|Coal Tar|coal tar|mesh-list
91923462|NCT04907071|Keratolytic Agents|keratolytic agents|mesh-ancestor
91923463|NCT04907071|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923464|NCT02155517|Propofol|propofol|mesh-list
91923465|NCT02155517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91923466|NCT02155517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923467|NCT02155517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923468|NCT02155517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91923469|NCT02155517|Anesthetics, General|anesthetics, general|mesh-ancestor
91923470|NCT02155517|Anesthetics|anesthetics|mesh-ancestor
91923471|NCT05497934|Glycerol|glycerol|mesh-list
91923472|NCT05497934|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91923473|NCT05497934|Protective Agents|protective agents|mesh-ancestor
91923474|NCT05497934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923475|NCT02229721|Oxytocin|oxytocin|mesh-list
91923476|NCT02229721|Oxytocics|oxytocics|mesh-ancestor
91923477|NCT02229721|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91923478|NCT02229721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923479|NCT05497700|Norepinephrine|norepinephrine|mesh-list
91923480|NCT05497700|Ephedrine|ephedrine|mesh-list
91923481|NCT05497700|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91923482|NCT05497700|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91923483|NCT05497700|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923484|NCT05497700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923485|NCT05497700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923486|NCT05497700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923487|NCT05497700|Sympathomimetics|sympathomimetics|mesh-ancestor
91923488|NCT05497700|Autonomic Agents|autonomic agents|mesh-ancestor
91923489|NCT05497700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923490|NCT05497700|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91923491|NCT05497700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91923492|NCT03106389|Misoprostol|misoprostol|mesh-list
91923493|NCT03106389|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91923494|NCT03106389|Abortifacient Agents|abortifacient agents|mesh-ancestor
91923495|NCT03106389|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91923496|NCT03106389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923497|NCT03106389|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91923498|NCT03106389|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923500|NCT03106311|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91923501|NCT03106311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91923502|NCT03106311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923503|NCT02255045|Diclofenac|diclofenac|mesh-list
91923505|NCT02255045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91923506|NCT02255045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91923507|NCT02255045|Analgesics|analgesics|mesh-ancestor
91923508|NCT02255045|Sensory System Agents|sensory system agents|mesh-ancestor
91923509|NCT02255045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923510|NCT02255045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923511|NCT02255045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923512|NCT02255045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923513|NCT02255045|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91923514|NCT02255045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923515|NCT02255045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923516|NCT02255045|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91923517|NCT02229799|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91923518|NCT02229799|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91923519|NCT02229799|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91923520|NCT02229799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923521|NCT02150447|Lansoprazole|lansoprazole|mesh-list
91923522|NCT02150447|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91923523|NCT02150447|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91923524|NCT02150447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923525|NCT02150447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923526|NCT02150447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923527|NCT02254889|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91923528|NCT02254889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923529|NCT02254889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923530|NCT02229955|Cyclosporine|cyclosporine|mesh-list
91923534|NCT02229955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923535|NCT02229955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923536|NCT02229955|Immunologic Factors|immunologic factors|mesh-ancestor
91923537|NCT02229955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923538|NCT02229955|Antifungal Agents|antifungal agents|mesh-ancestor
91923539|NCT02229955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923540|NCT02229955|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923541|NCT02229955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923542|NCT02229955|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91923543|NCT02229955|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91923545|NCT02230033|Gemfibrozil|gemfibrozil|mesh-list
91923546|NCT02230033|Antifungal Agents|antifungal agents|mesh-ancestor
91923547|NCT02230033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923548|NCT02230033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91923549|NCT02230033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91923551|NCT02230033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923552|NCT02230033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91923553|NCT02230033|Hormone Antagonists|hormone antagonists|mesh-ancestor
91923554|NCT02230033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923555|NCT02230033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923556|NCT02230033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91923557|NCT02230033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91923558|NCT02230033|Antimetabolites|antimetabolites|mesh-ancestor
91923559|NCT02230033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91923560|NCT02230033|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91923561|NCT05740371|Argatroban|argatroban|mesh-list
91923562|NCT05740371|Antithrombins|antithrombins|mesh-ancestor
91923563|NCT05740371|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91923564|NCT05740371|Protease Inhibitors|protease inhibitors|mesh-ancestor
91923565|NCT05740371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923566|NCT05740371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923567|NCT05740371|Anticoagulants|anticoagulants|mesh-ancestor
91923568|NCT05740371|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91923569|NCT02223949|Alprostadil|alprostadil|mesh-list
91923570|NCT02223949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91923571|NCT02223949|Vasodilator Agents|vasodilator agents|mesh-ancestor
91923572|NCT02223949|Urological Agents|urological agents|mesh-ancestor
91923573|NCT02691507|Decanoic acid|decanoic acid|mesh-list
91923574|NCT02691507|Antifungal Agents|antifungal agents|mesh-ancestor
91923575|NCT02691507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923576|NCT02259361|4-Aminopyridine|4-aminopyridine|mesh-list
91923577|NCT02259361|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91923578|NCT02259361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923579|NCT02259361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923580|NCT02151695|Aflibercept|aflibercept|mesh-list
91923581|NCT02151695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91923582|NCT02151695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91923583|NCT02151695|Growth Substances|growth substances|mesh-ancestor
91923584|NCT02151695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923585|NCT02151695|Growth Inhibitors|growth inhibitors|mesh-ancestor
91923586|NCT02151695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923587|NCT02151929|Everolimus|everolimus|mesh-list
91923588|NCT02151929|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91923589|NCT02151929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91923590|NCT02151929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923591|NCT02151929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923592|NCT02151929|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923593|NCT02151929|Immunologic Factors|immunologic factors|mesh-ancestor
91923594|NCT02151929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923595|NCT02151929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923596|NCT03542357|Calcitonin|calcitonin|mesh-list
91923597|NCT03542357|Salmon calcitonin|salmon calcitonin|mesh-list
91923598|NCT03542357|Sumatriptan|sumatriptan|mesh-list
91923599|NCT03542357|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
91923600|NCT03542357|Katacalcin|katacalcin|mesh-list
91923601|NCT03542357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91923602|NCT03542357|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91923603|NCT03542357|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91923604|NCT03542357|Serotonin Agents|serotonin agents|mesh-ancestor
91923605|NCT03542357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923606|NCT03542357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923607|NCT03542357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923608|NCT03542357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91923609|NCT03542357|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91923610|NCT03542357|Vasodilator Agents|vasodilator agents|mesh-ancestor
91923611|NCT04811001|Osimertinib|osimertinib|mesh-list
91923612|NCT04811001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923613|NCT04811001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91923614|NCT04811001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923615|NCT04811001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923617|NCT02150993|Lopinavir|lopinavir|mesh-list
91923618|NCT02150993|Tenofovir|tenofovir|mesh-list
91923619|NCT02150993|Lamivudine|lamivudine|mesh-list
91923620|NCT02150993|Emtricitabine|emtricitabine|mesh-list
91923621|NCT02150993|Zidovudine|zidovudine|mesh-list
91923622|NCT02150993|Raltegravir Potassium|raltegravir potassium|mesh-list
91923623|NCT02150993|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
91923624|NCT02150993|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91923625|NCT02150993|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91923626|NCT02150993|Protease Inhibitors|protease inhibitors|mesh-ancestor
91923627|NCT02150993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923628|NCT02150993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923629|NCT02150993|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91923630|NCT02150993|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91923631|NCT02150993|Antiviral Agents|antiviral agents|mesh-ancestor
91923632|NCT02150993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923633|NCT02150993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91923634|NCT02150993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91923635|NCT02150993|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91923636|NCT02150993|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91923637|NCT02150993|Antimetabolites|antimetabolites|mesh-ancestor
91923638|NCT02150993|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91923639|NCT02150993|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91923640|NCT02690727|Tenalisib|tenalisib|mesh-list
91923641|NCT02690727|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
91923642|NCT02690727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923643|NCT02690727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923644|NCT02224105|Prednisolone|prednisolone|mesh-list
91923646|NCT02224105|Methylprednisolone|methylprednisolone|mesh-list
91923647|NCT02224105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91923648|NCT02224105|Prednisolone acetate|prednisolone acetate|mesh-list
91923649|NCT02224105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91923650|NCT02224105|Prednisolone phosphate|prednisolone phosphate|mesh-list
91923651|NCT02224105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923652|NCT02224105|Glucocorticoids|glucocorticoids|mesh-ancestor
91923654|NCT02224105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923655|NCT02224105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923656|NCT02224105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91923657|NCT02224105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923658|NCT02224105|Antiemetics|antiemetics|mesh-ancestor
91923659|NCT02224105|Autonomic Agents|autonomic agents|mesh-ancestor
91923660|NCT02224105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923661|NCT02224105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923662|NCT02224105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91923663|NCT02224105|Protective Agents|protective agents|mesh-ancestor
91923664|NCT02156375|Ustekinumab|ustekinumab|mesh-list
91923665|NCT02156375|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923666|NCT04057131|Icatibant|icatibant|mesh-list
91923667|NCT04057131|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91923668|NCT04057131|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91923669|NCT04057131|Analgesics|analgesics|mesh-ancestor
91923670|NCT04057131|Sensory System Agents|sensory system agents|mesh-ancestor
91923671|NCT04057131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923672|NCT04057131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923673|NCT04057131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923674|NCT04057131|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923675|NCT04057131|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
91923676|NCT04057131|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
91923677|NCT04057131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923678|NCT04057131|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91923679|NCT04057131|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923680|NCT04057131|Immunologic Factors|immunologic factors|mesh-ancestor
91923681|NCT03542279|Glucocorticoids|glucocorticoids|mesh-list
91923682|NCT03542279|Hormones|hormones|mesh-ancestor
91923683|NCT03542279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923684|NCT03542279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923685|NCT02230735|Epinephrine|epinephrine|mesh-list
91923686|NCT02230735|Racepinephrine|racepinephrine|mesh-list
91923688|NCT02230735|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91923689|NCT02230735|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91923690|NCT02230735|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923691|NCT02230735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923692|NCT02230735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923693|NCT02230735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923694|NCT02230735|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91923695|NCT02230735|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91923697|NCT02230735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923698|NCT02230735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91923699|NCT02230735|Respiratory System Agents|respiratory system agents|mesh-ancestor
91923700|NCT02230735|Mydriatics|mydriatics|mesh-ancestor
91923701|NCT02230735|Sympathomimetics|sympathomimetics|mesh-ancestor
91923702|NCT02230735|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91923704|NCT02258581|Vesatolimod|vesatolimod|mesh-list
91923705|NCT02258581|Antiviral Agents|antiviral agents|mesh-ancestor
91923706|NCT02258581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923707|NCT02258581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91923708|NCT02258581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91923709|NCT02258581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923710|NCT02258581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923711|NCT02258581|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91923712|NCT02258581|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91923713|NCT03165825|Dexamethasone|dexamethasone|mesh-list
91923714|NCT03165825|Betamethasone|betamethasone|mesh-list
91923715|NCT03165825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923716|NCT03165825|Antiemetics|antiemetics|mesh-ancestor
91923717|NCT03165825|Autonomic Agents|autonomic agents|mesh-ancestor
91923718|NCT03165825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923719|NCT03165825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923720|NCT03165825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923721|NCT03165825|Glucocorticoids|glucocorticoids|mesh-ancestor
91923722|NCT03165825|Hormones|hormones|mesh-ancestor
91923723|NCT03165825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923724|NCT03165825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91923725|NCT03165825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923726|NCT03165825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91923727|NCT03165825|Respiratory System Agents|respiratory system agents|mesh-ancestor
91923728|NCT03167853|Antibodies|antibodies|mesh-list
91923729|NCT03167853|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91923730|NCT03167853|Immunologic Factors|immunologic factors|mesh-ancestor
91923731|NCT03167853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923732|NCT05746143|Zolpidem|zolpidem|mesh-list
91923733|NCT05746143|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91923734|NCT05746143|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91923735|NCT05746143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923736|NCT05746143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923737|NCT05746143|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91923738|NCT05746143|GABA Agonists|gaba agonists|mesh-ancestor
91923739|NCT05746143|GABA Agents|gaba agents|mesh-ancestor
91923740|NCT05746143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923741|NCT05746143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923742|NCT03165591|Vaccines|vaccines|mesh-list
91923743|NCT03165591|Immunologic Factors|immunologic factors|mesh-ancestor
91923744|NCT03165591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923745|NCT03114813|Carvedilol|carvedilol|mesh-list
91923746|NCT03114813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91923747|NCT03114813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91923748|NCT03114813|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923749|NCT03114813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923750|NCT03114813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923751|NCT03114813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923752|NCT03114813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91923753|NCT03114813|Antioxidants|antioxidants|mesh-ancestor
91923754|NCT03114813|Protective Agents|protective agents|mesh-ancestor
91923755|NCT03114813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91923756|NCT03114813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923757|NCT03114813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91923758|NCT03114813|Vasodilator Agents|vasodilator agents|mesh-ancestor
91923759|NCT03114813|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91923760|NCT03114813|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91923761|NCT01358864|Interferons|interferons|mesh-list
91923762|NCT01358864|Ribavirin|ribavirin|mesh-list
91923763|NCT01358864|Interferon-alpha|interferon-alpha|mesh-list
91923764|NCT01358864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923766|NCT01358864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923767|NCT01358864|Antimetabolites|antimetabolites|mesh-ancestor
91923768|NCT01358864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923769|NCT01358864|Immunologic Factors|immunologic factors|mesh-ancestor
91923770|NCT01358864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923771|NCT02750761|Tedizolid phosphate|tedizolid phosphate|mesh-list
91923772|NCT02750761|Tedizolid|tedizolid|mesh-list
91923773|NCT02750761|Oxazolidinones|oxazolidinones|mesh-list
91923774|NCT02750761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91923775|NCT02750761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923776|NCT02750761|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91923777|NCT02750761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923778|NCT02750761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923779|NCT05746065|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91923780|NCT05746065|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91923781|NCT05746065|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91923782|NCT05746065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923783|NCT05746065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923784|NCT05746065|Antiviral Agents|antiviral agents|mesh-ancestor
91923785|NCT05746065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923786|NCT05746065|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91923787|NCT05746065|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91923788|NCT02814019|Idebenone|idebenone|mesh-list
91923789|NCT02814019|Antioxidants|antioxidants|mesh-ancestor
91923790|NCT02814019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923791|NCT02814019|Protective Agents|protective agents|mesh-ancestor
91923792|NCT02814019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923793|NCT03364244|Sildenafil Citrate|sildenafil citrate|mesh-list
91923794|NCT03364244|Vasodilator Agents|vasodilator agents|mesh-ancestor
91923795|NCT03364244|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91923796|NCT03364244|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91923797|NCT03364244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923798|NCT03364244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923799|NCT03364244|Urological Agents|urological agents|mesh-ancestor
91923800|NCT03165123|Azithromycin|azithromycin|mesh-list
91923801|NCT03165123|Dexamethasone|dexamethasone|mesh-list
91923802|NCT03165123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923803|NCT03165123|Antiemetics|antiemetics|mesh-ancestor
91923804|NCT03165123|Autonomic Agents|autonomic agents|mesh-ancestor
91923805|NCT03165123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923806|NCT03165123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923807|NCT03165123|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923808|NCT03165123|Glucocorticoids|glucocorticoids|mesh-ancestor
91923809|NCT03165123|Hormones|hormones|mesh-ancestor
91923810|NCT03165123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923811|NCT03165123|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91923812|NCT03165123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923813|NCT03165123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91923814|NCT03165123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923815|NCT01131169|Vidarabine|vidarabine|mesh-list
91923816|NCT01131169|Fludarabine|fludarabine|mesh-list
91923817|NCT01131169|Fludarabine phosphate|fludarabine phosphate|mesh-list
91923818|NCT01131169|Melphalan|melphalan|mesh-list
91923819|NCT01131169|Busulfan|busulfan|mesh-list
91923820|NCT01131169|Lenograstim|lenograstim|mesh-list
91923821|NCT01131169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923822|NCT01131169|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91923823|NCT01131169|Antimetabolites|antimetabolites|mesh-ancestor
91923824|NCT01131169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923825|NCT01131169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923826|NCT01131169|Immunologic Factors|immunologic factors|mesh-ancestor
91923827|NCT01131169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923828|NCT01131169|Antiviral Agents|antiviral agents|mesh-ancestor
91923829|NCT01131169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923830|NCT01131169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91923831|NCT01131169|Alkylating Agents|alkylating agents|mesh-ancestor
91923832|NCT01131169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91923833|NCT01131169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91923834|NCT02688933|Insulin|insulin|mesh-list
91923835|NCT02688933|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91923836|NCT02688933|Insulin Glargine|insulin glargine|mesh-list
91923837|NCT02688933|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91923838|NCT02688933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923839|NCT04372628|Ritonavir|ritonavir|mesh-list
91923840|NCT04372628|Lopinavir|lopinavir|mesh-list
91923841|NCT04372628|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91923842|NCT04372628|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91923843|NCT04372628|Protease Inhibitors|protease inhibitors|mesh-ancestor
91923844|NCT04372628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923845|NCT04372628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923846|NCT04372628|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91923847|NCT04372628|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91923848|NCT04372628|Antiviral Agents|antiviral agents|mesh-ancestor
91923849|NCT04372628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91923850|NCT04372628|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91923851|NCT04372628|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91923853|NCT03626545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923854|NCT03626545|Tubulin Modulators|tubulin modulators|mesh-ancestor
91923855|NCT03626545|Antimitotic Agents|antimitotic agents|mesh-ancestor
91923856|NCT03626545|Mitosis Modulators|mitosis modulators|mesh-ancestor
91923857|NCT03626545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923858|NCT04230980|Gabapentin|gabapentin|mesh-list
91923859|NCT04230980|Analgesics|analgesics|mesh-ancestor
91923860|NCT04230980|Sensory System Agents|sensory system agents|mesh-ancestor
91923861|NCT04230980|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923862|NCT04230980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923863|NCT04230980|Anticonvulsants|anticonvulsants|mesh-ancestor
91923864|NCT04230980|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91923865|NCT04230980|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91923866|NCT04230980|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923867|NCT04230980|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91923868|NCT04230980|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91923869|NCT04230980|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91923870|NCT04230980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923871|NCT04230980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923872|NCT04230980|Antimanic Agents|antimanic agents|mesh-ancestor
91923873|NCT00882505|Vitamin D|vitamin d|mesh-list
91923874|NCT00882505|Vitamins|vitamins|mesh-ancestor
91923875|NCT00882505|Micronutrients|micronutrients|mesh-ancestor
91923876|NCT00882505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923877|NCT00882505|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91923878|NCT04480359|Meloxicam|meloxicam|mesh-list
91923879|NCT04480359|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91923880|NCT04480359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91923881|NCT04480359|Analgesics|analgesics|mesh-ancestor
91923882|NCT04480359|Sensory System Agents|sensory system agents|mesh-ancestor
91923883|NCT04480359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923884|NCT04480359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923885|NCT04480359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91923886|NCT04480359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923887|NCT04480359|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91923888|NCT04480359|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91923889|NCT04480359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923890|NCT04480359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923891|NCT03724825|Testosterone|testosterone|mesh-list
91923892|NCT03724825|Androgens|androgens|mesh-ancestor
91923893|NCT03724825|Hormones|hormones|mesh-ancestor
91923894|NCT03724825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91923895|NCT03724825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923896|NCT04227704|Ketamine|ketamine|mesh-list
91923897|NCT04227704|Analgesics|analgesics|mesh-ancestor
91923898|NCT04227704|Sensory System Agents|sensory system agents|mesh-ancestor
91923899|NCT04227704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923900|NCT04227704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923901|NCT04227704|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91923902|NCT04227704|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91923903|NCT04227704|Anesthetics, General|anesthetics, general|mesh-ancestor
91923904|NCT04227704|Anesthetics|anesthetics|mesh-ancestor
91923905|NCT04227704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91923906|NCT04227704|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91923907|NCT04227704|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91923908|NCT04227704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923909|NCT04227704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923910|NCT03720613|Naloxegol|naloxegol|mesh-list
91923911|NCT03720613|Lubiprostone|lubiprostone|mesh-list
91923912|NCT03720613|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91923913|NCT03720613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923914|NCT03720613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923915|NCT03720613|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91924372|NCT02558894|Tremelimumab|tremelimumab|mesh-list
91923916|NCT03720613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923917|NCT03720613|Sensory System Agents|sensory system agents|mesh-ancestor
91923918|NCT03720613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923919|NCT02709512|Cisplatin|cisplatin|mesh-list
91923920|NCT02709512|Pemetrexed|pemetrexed|mesh-list
91923921|NCT02709512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923922|NCT02709512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923923|NCT02709512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923924|NCT02709512|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91923925|NCT02709512|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91923926|NCT03699475|Cyclophosphamide|cyclophosphamide|mesh-list
91923927|NCT03699475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91923928|NCT03699475|Immunologic Factors|immunologic factors|mesh-ancestor
91923929|NCT03699475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923930|NCT03699475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91923931|NCT03699475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91923932|NCT03699475|Alkylating Agents|alkylating agents|mesh-ancestor
91923933|NCT03699475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923934|NCT03699475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923935|NCT03699475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91923936|NCT03659929|Amphetamine|amphetamine|mesh-list
91923937|NCT03659929|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91923938|NCT03659929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923939|NCT03659929|Sympathomimetics|sympathomimetics|mesh-ancestor
91923940|NCT03659929|Autonomic Agents|autonomic agents|mesh-ancestor
91923941|NCT03659929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91923943|NCT03659929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91923944|NCT03659929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923945|NCT03659929|Adrenergic Agents|adrenergic agents|mesh-ancestor
91923946|NCT03659929|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91923947|NCT03659929|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91923948|NCT03659929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923949|NCT03659929|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91923950|NCT02811679|Blinatumomab|blinatumomab|mesh-list
91923951|NCT02811679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923952|NCT03448081|Calcipotriene|calcipotriene|mesh-list
91923953|NCT03448081|Dermatologic Agents|dermatologic agents|mesh-ancestor
91923954|NCT02232607|Lacidipine|lacidipine|mesh-list
91923955|NCT02232607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91923956|NCT02232607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91923957|NCT02232607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91923958|NCT02232607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923959|NCT02232607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91923960|NCT02232607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91923961|NCT02232685|Choline|choline|mesh-list
91923962|NCT02232685|Lipotropic Agents|lipotropic agents|mesh-ancestor
91923963|NCT02232685|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91923964|NCT02232685|Antimetabolites|antimetabolites|mesh-ancestor
91923965|NCT02232685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923966|NCT02232685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91923967|NCT02232685|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91923968|NCT02232685|Nootropic Agents|nootropic agents|mesh-ancestor
91923969|NCT02232763|Losartan|losartan|mesh-list
91923970|NCT02232763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91923971|NCT02232763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91923972|NCT02232763|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91923973|NCT02232763|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91923974|NCT02232763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923975|NCT04294784|Paclitaxel|paclitaxel|mesh-list
91923976|NCT04294784|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91923977|NCT04294784|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91923978|NCT04294784|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91923979|NCT04294784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91923980|NCT04294784|Tubulin Modulators|tubulin modulators|mesh-ancestor
91923981|NCT04294784|Antimitotic Agents|antimitotic agents|mesh-ancestor
91923982|NCT04294784|Mitosis Modulators|mitosis modulators|mesh-ancestor
91923983|NCT04294784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923984|NCT04294784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91923985|NCT02262559|Telmisartan|telmisartan|mesh-list
91923986|NCT02262559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91923987|NCT02262559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91923988|NCT02262559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91923989|NCT02262559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91923990|NCT05491460|Rivaroxaban|rivaroxaban|mesh-list
91923991|NCT05491460|Apixaban|apixaban|mesh-list
91923992|NCT05491460|Edoxaban|edoxaban|mesh-list
91923993|NCT05491460|Dabigatran|dabigatran|mesh-list
91923994|NCT05491460|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91923996|NCT05491460|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91923997|NCT05491460|Protease Inhibitors|protease inhibitors|mesh-ancestor
91923998|NCT05491460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91923999|NCT05491460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924000|NCT05491460|Anticoagulants|anticoagulants|mesh-ancestor
91924001|NCT03311269|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
91924002|NCT03311269|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
91924003|NCT03311269|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91924004|NCT02762929|Bupivacaine|bupivacaine|mesh-list
91924005|NCT02762929|Anesthetics, Local|anesthetics, local|mesh-ancestor
91924006|NCT02762929|Anesthetics|anesthetics|mesh-ancestor
91924007|NCT02762929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924008|NCT02762929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924009|NCT02762929|Sensory System Agents|sensory system agents|mesh-ancestor
91924010|NCT02762929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924012|NCT02262637|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
91924013|NCT02262637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91924014|NCT02262637|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91924015|NCT02262637|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91924016|NCT02262637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924017|NCT02262637|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91924018|NCT02262637|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924019|NCT02262637|Diuretics|diuretics|mesh-ancestor
91924020|NCT02262637|Natriuretic Agents|natriuretic agents|mesh-ancestor
91924021|NCT02262637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924022|NCT03301051|Vaccines|vaccines|mesh-list
91924023|NCT03301051|Immunologic Factors|immunologic factors|mesh-ancestor
91924024|NCT03301051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924025|NCT02606305|Bevacizumab|bevacizumab|mesh-list
91924026|NCT02606305|Pembrolizumab|pembrolizumab|mesh-list
91924027|NCT02606305|Carboplatin|carboplatin|mesh-list
91924028|NCT02606305|Doxorubicin|doxorubicin|mesh-list
91924029|NCT02606305|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91924030|NCT02606305|Maytansine|maytansine|mesh-list
91924031|NCT02606305|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
91924032|NCT02606305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924033|NCT02606305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924034|NCT02606305|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91924035|NCT02606305|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91924036|NCT02606305|Growth Substances|growth substances|mesh-ancestor
91924037|NCT02606305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924038|NCT02606305|Growth Inhibitors|growth inhibitors|mesh-ancestor
91924039|NCT02606305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91924040|NCT02606305|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924041|NCT02606305|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924042|NCT02606305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924043|NCT02606305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924044|NCT02606305|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924045|NCT02606305|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924046|NCT02606305|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924047|NCT02606305|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924048|NCT02606305|Mitosis Modulators|mitosis modulators|mesh-ancestor
91924049|NCT02606305|Immunoconjugates|immunoconjugates|mesh-ancestor
91924050|NCT02606305|Immunologic Factors|immunologic factors|mesh-ancestor
91924051|NCT01662986|Bromides|bromides|mesh-list
91924052|NCT01662986|Tiotropium Bromide|tiotropium bromide|mesh-list
91924053|NCT01662986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91924054|NCT01662986|Autonomic Agents|autonomic agents|mesh-ancestor
91924055|NCT01662986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924056|NCT01662986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924057|NCT01662986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91924058|NCT01662986|Respiratory System Agents|respiratory system agents|mesh-ancestor
91924059|NCT01662986|Parasympatholytics|parasympatholytics|mesh-ancestor
91924060|NCT01662986|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91924061|NCT01662986|Cholinergic Agents|cholinergic agents|mesh-ancestor
91924062|NCT01662986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924063|NCT01662986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924064|NCT01662986|Anticonvulsants|anticonvulsants|mesh-ancestor
91924065|NCT05497232|Pancrelipase|pancrelipase|mesh-list
91924066|NCT05497232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924067|NCT00054158|Thalidomide|thalidomide|mesh-list
91924068|NCT00054158|Dexamethasone|dexamethasone|mesh-list
91924069|NCT00054158|Doxorubicin|doxorubicin|mesh-list
91924070|NCT00054158|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91924071|NCT00054158|Vincristine|vincristine|mesh-list
91924072|NCT00054158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924073|NCT00054158|Antiemetics|antiemetics|mesh-ancestor
91924074|NCT00054158|Autonomic Agents|autonomic agents|mesh-ancestor
91924075|NCT00054158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924076|NCT00054158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924077|NCT00054158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924078|NCT00054158|Glucocorticoids|glucocorticoids|mesh-ancestor
91924079|NCT00054158|Hormones|hormones|mesh-ancestor
91924080|NCT00054158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924081|NCT00054158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91924082|NCT00054158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924083|NCT00054158|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91924084|NCT00054158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924085|NCT00054158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924086|NCT00054158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924087|NCT00054158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924088|NCT00054158|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924089|NCT00054158|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924090|NCT00054158|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924091|NCT00054158|Mitosis Modulators|mitosis modulators|mesh-ancestor
91924092|NCT00054158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924093|NCT00054158|Immunologic Factors|immunologic factors|mesh-ancestor
91924094|NCT00054158|Leprostatic Agents|leprostatic agents|mesh-ancestor
91924095|NCT00054158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924096|NCT00054158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924097|NCT00054158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91924098|NCT00054158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91924099|NCT00054158|Growth Substances|growth substances|mesh-ancestor
91924100|NCT00054158|Growth Inhibitors|growth inhibitors|mesh-ancestor
91924101|NCT01337167|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91924102|NCT01337167|Immunologic Factors|immunologic factors|mesh-ancestor
91924103|NCT01337167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924104|NCT05496764|Dexamethasone|dexamethasone|mesh-list
91924105|NCT05496764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924106|NCT05496764|Antiemetics|antiemetics|mesh-ancestor
91924107|NCT05496764|Autonomic Agents|autonomic agents|mesh-ancestor
91924108|NCT05496764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924109|NCT05496764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924110|NCT05496764|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924111|NCT05496764|Glucocorticoids|glucocorticoids|mesh-ancestor
91924112|NCT05496764|Hormones|hormones|mesh-ancestor
91924113|NCT05496764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924114|NCT05496764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91924115|NCT05496764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924116|NCT05496530|Triamcinolone|triamcinolone|mesh-list
91924117|NCT05496530|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91924118|NCT05496530|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91924119|NCT05496530|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91924120|NCT05496530|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924121|NCT05496530|Glucocorticoids|glucocorticoids|mesh-ancestor
91924122|NCT05496530|Hormones|hormones|mesh-ancestor
91924123|NCT05496530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924124|NCT05496530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924125|NCT05496530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924126|NCT05496530|Immunologic Factors|immunologic factors|mesh-ancestor
91924127|NCT05496530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924128|NCT05496530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924130|NCT02744833|Enoxaparin sodium|enoxaparin sodium|mesh-list
91924131|NCT02744833|Anticoagulants|anticoagulants|mesh-ancestor
91924132|NCT02744833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91924133|NCT02744833|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91924134|NCT02744833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924135|NCT02234869|Interferons|interferons|mesh-list
91924136|NCT02234869|Interferon-beta|interferon-beta|mesh-list
91924137|NCT02234869|Interferon beta-1a|interferon beta-1a|mesh-list
91924138|NCT02234869|Interferon beta-1b|interferon beta-1b|mesh-list
91924139|NCT02234869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924140|NCT02234869|Antiviral Agents|antiviral agents|mesh-ancestor
91924141|NCT02234869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924142|NCT02234869|Immunologic Factors|immunologic factors|mesh-ancestor
91924143|NCT02234869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924144|NCT02234869|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91924145|NCT05499026|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
91924146|NCT05499026|Cathartics|cathartics|mesh-ancestor
91924147|NCT05499026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924148|NCT05498714|Lactulose|lactulose|mesh-list
91924149|NCT05498714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924150|NCT05490836|Interferon-alpha|interferon-alpha|mesh-list
91924151|NCT05490836|Interferon alpha-2|interferon alpha-2|mesh-list
91924152|NCT05490836|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
91924153|NCT05490836|Antiviral Agents|antiviral agents|mesh-ancestor
91924154|NCT05490836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924155|NCT05490836|Immunologic Factors|immunologic factors|mesh-ancestor
91924156|NCT05490836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924157|NCT05490836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924158|NCT01338025|Lamivudine|lamivudine|mesh-list
91924159|NCT01338025|Emtricitabine|emtricitabine|mesh-list
91924160|NCT01338025|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91924161|NCT01338025|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91924162|NCT01338025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924163|NCT01338025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924164|NCT01338025|Antiviral Agents|antiviral agents|mesh-ancestor
91924165|NCT01338025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924166|NCT01338025|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91924167|NCT01338025|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91924168|NCT05498636|Prednisone|prednisone|mesh-list
91924169|NCT05498636|Etoposide|etoposide|mesh-list
91924170|NCT05498636|Lenalidomide|lenalidomide|mesh-list
91924171|NCT05498636|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924172|NCT05498636|Glucocorticoids|glucocorticoids|mesh-ancestor
91924173|NCT05498636|Hormones|hormones|mesh-ancestor
91924174|NCT05498636|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924175|NCT05498636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924176|NCT05498636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91924177|NCT05498636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924178|NCT05498636|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924179|NCT05498636|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924180|NCT05498636|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924181|NCT05498636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924182|NCT05498636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924183|NCT05498636|Immunologic Factors|immunologic factors|mesh-ancestor
91924184|NCT05498636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91924185|NCT05498636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91924186|NCT05498636|Growth Substances|growth substances|mesh-ancestor
91924187|NCT05498636|Growth Inhibitors|growth inhibitors|mesh-ancestor
91924188|NCT02262715|Oseltamivir|oseltamivir|mesh-list
91924189|NCT02262715|Antiviral Agents|antiviral agents|mesh-ancestor
91924190|NCT02262715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924191|NCT02262715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924192|NCT02262715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924193|NCT03137407|Botulinum Toxins|botulinum toxins|mesh-list
91924194|NCT03137407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91924195|NCT03137407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91924196|NCT03137407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91924197|NCT03137407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924198|NCT03137407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924199|NCT03137407|Cholinergic Agents|cholinergic agents|mesh-ancestor
91924200|NCT03137407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924201|NCT03137407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924202|NCT03137407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91924203|NCT03137407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924204|NCT02588677|Riluzole|riluzole|mesh-list
91924205|NCT02588677|Anticonvulsants|anticonvulsants|mesh-ancestor
91924206|NCT02588677|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91924207|NCT02588677|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91924208|NCT02588677|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924209|NCT02588677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924210|NCT02588677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924211|NCT02588677|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91924212|NCT02588677|Protective Agents|protective agents|mesh-ancestor
91924213|NCT04424420|Acetaminophen|acetaminophen|mesh-list
91924214|NCT04424420|Ibuprofen|ibuprofen|mesh-list
91924215|NCT04424420|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91924216|NCT04424420|Analgesics|analgesics|mesh-ancestor
91924217|NCT04424420|Sensory System Agents|sensory system agents|mesh-ancestor
91924218|NCT04424420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924219|NCT04424420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924220|NCT04424420|Antipyretics|antipyretics|mesh-ancestor
91924221|NCT04424420|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91924222|NCT04424420|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924223|NCT04424420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924224|NCT04424420|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91924225|NCT04424420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924226|NCT04424420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924227|NCT05495750|Bupivacaine|bupivacaine|mesh-list
91924228|NCT05495750|Anesthetics, Local|anesthetics, local|mesh-ancestor
91924229|NCT05495750|Anesthetics|anesthetics|mesh-ancestor
91924230|NCT05495750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924231|NCT05495750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924232|NCT05495750|Sensory System Agents|sensory system agents|mesh-ancestor
91924233|NCT05495750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924234|NCT02233075|Interferons|interferons|mesh-list
91924235|NCT02233075|Interferon-alpha|interferon-alpha|mesh-list
91924236|NCT02233075|Interferon alpha-2|interferon alpha-2|mesh-list
91924237|NCT02233075|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91924238|NCT02233075|REP 2139|rep 2139|mesh-list
91924239|NCT02233075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924240|NCT02233075|Antiviral Agents|antiviral agents|mesh-ancestor
91924241|NCT02233075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924242|NCT02233075|Immunologic Factors|immunologic factors|mesh-ancestor
91924243|NCT02233075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924245|NCT04300244|Ipilimumab|ipilimumab|mesh-list
91924246|NCT04300244|Sargramostim|sargramostim|mesh-list
91924247|NCT04300244|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924248|NCT04300244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924249|NCT04300244|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924250|NCT04300244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924251|NCT04300244|Immunologic Factors|immunologic factors|mesh-ancestor
91924252|NCT04300244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924253|NCT02578771|Methylene Blue|methylene blue|mesh-list
91924254|NCT02578771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924255|NCT02578771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924256|NCT02259595|Acetylcysteine|acetylcysteine|mesh-list
91924257|NCT02259595|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91924258|NCT02259595|Disufenton sodium|disufenton sodium|mesh-list
91924259|NCT02259595|Antiviral Agents|antiviral agents|mesh-ancestor
91924260|NCT02259595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924261|NCT02259595|Expectorants|expectorants|mesh-ancestor
91924262|NCT02259595|Respiratory System Agents|respiratory system agents|mesh-ancestor
91924263|NCT02259595|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91924264|NCT02259595|Antioxidants|antioxidants|mesh-ancestor
91924265|NCT02259595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924266|NCT02259595|Protective Agents|protective agents|mesh-ancestor
91924267|NCT02259595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924268|NCT02259595|Antidotes|antidotes|mesh-ancestor
91924269|NCT02804035|Furosemide|furosemide|mesh-list
91924270|NCT02804035|Diuretics|diuretics|mesh-ancestor
91924271|NCT02804035|Natriuretic Agents|natriuretic agents|mesh-ancestor
91924272|NCT02804035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924273|NCT02804035|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91924274|NCT02804035|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924275|NCT02804035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924276|NCT02262793|Telmisartan|telmisartan|mesh-list
91924277|NCT02262793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91924278|NCT02262793|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91924279|NCT02262793|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91924280|NCT02262793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924281|NCT02559206|Linaclotide|linaclotide|mesh-list
91924282|NCT02559206|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91924283|NCT02559206|Enzyme Activators|enzyme activators|mesh-ancestor
91924284|NCT02559206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924285|NCT02559206|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924287|NCT05485766|Carboplatin|carboplatin|mesh-list
91924288|NCT05485766|Pembrolizumab|pembrolizumab|mesh-list
91924289|NCT05485766|Olaparib|olaparib|mesh-list
91924290|NCT05485766|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924291|NCT05485766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924292|NCT05485766|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924293|NCT05485766|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924294|NCT05485766|Mitosis Modulators|mitosis modulators|mesh-ancestor
91924295|NCT05485766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924296|NCT05485766|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924297|NCT05485766|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924298|NCT05485766|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91924299|NCT05485766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924300|NCT04402723|Cytarabine|cytarabine|mesh-list
91924301|NCT04402723|Daunorubicin|daunorubicin|mesh-list
91924302|NCT04402723|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924303|NCT04402723|Antimetabolites|antimetabolites|mesh-ancestor
91924304|NCT04402723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924305|NCT04402723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924306|NCT04402723|Antiviral Agents|antiviral agents|mesh-ancestor
91924307|NCT04402723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924308|NCT04402723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924309|NCT04402723|Immunologic Factors|immunologic factors|mesh-ancestor
91924310|NCT04402723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924311|NCT04402723|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91924312|NCT04402723|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924313|NCT04402723|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924314|NCT04402723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924315|NCT02235337|Riboflavin|riboflavin|mesh-list
91924316|NCT02235337|Vitamins|vitamins|mesh-ancestor
91924317|NCT02235337|Micronutrients|micronutrients|mesh-ancestor
91924318|NCT02235337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924319|NCT02235337|Vitamin B Complex|vitamin b complex|mesh-ancestor
91924320|NCT02235337|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91924321|NCT02235337|Dermatologic Agents|dermatologic agents|mesh-ancestor
91924322|NCT02233231|Varenicline|varenicline|mesh-list
91924323|NCT02233231|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91924324|NCT02233231|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91924325|NCT02233231|Cholinergic Agents|cholinergic agents|mesh-ancestor
91924326|NCT02233231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924327|NCT02233231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924328|NCT02233231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924329|NCT02263027|Vaccines|vaccines|mesh-list
91924330|NCT02263027|Immunologic Factors|immunologic factors|mesh-ancestor
91924331|NCT02263027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924332|NCT02263105|Temozolomide|temozolomide|mesh-list
91924333|NCT02263105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91924334|NCT02263105|Alkylating Agents|alkylating agents|mesh-ancestor
91924335|NCT02263105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924336|NCT02263105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924337|NCT05485064|Fentanyl|fentanyl|mesh-list
91924338|NCT05485064|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91924339|NCT05485064|Narcotics|narcotics|mesh-ancestor
91924340|NCT05485064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924341|NCT05485064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924342|NCT05485064|Analgesics|analgesics|mesh-ancestor
91924343|NCT05485064|Sensory System Agents|sensory system agents|mesh-ancestor
91924344|NCT05485064|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924345|NCT05485064|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91924346|NCT05485064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91924347|NCT05485064|Anesthetics, General|anesthetics, general|mesh-ancestor
91924348|NCT05485064|Anesthetics|anesthetics|mesh-ancestor
91924349|NCT05626153|Anesthetics|anesthetics|mesh-list
91924350|NCT05626153|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924351|NCT05626153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924353|NCT02553343|Immunologic Factors|immunologic factors|mesh-ancestor
91924354|NCT02553343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924355|NCT02235415|Lacidipine|lacidipine|mesh-list
91924356|NCT02235415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91924357|NCT02235415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91924358|NCT02235415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924359|NCT02235415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924360|NCT02235415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91924361|NCT02235415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924362|NCT03995017|Nivolumab|nivolumab|mesh-list
91924363|NCT03995017|Ramucirumab|ramucirumab|mesh-list
91924364|NCT03995017|Rucaparib|rucaparib|mesh-list
91924365|NCT03995017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924366|NCT03995017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924367|NCT03995017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924368|NCT03995017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924369|NCT03995017|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91924370|NCT03995017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924371|NCT02558894|Durvalumab|durvalumab|mesh-list
91924374|NCT02558894|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943239|NCT03004287|Melphalan|melphalan|mesh-list
91924375|NCT02558894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924377|NCT02558894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924378|NCT02233387|Imidazole|imidazole|mesh-list
91924379|NCT02233387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924380|NCT02233387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924381|NCT02510599|Solithromycin|solithromycin|mesh-list
91924382|NCT02510599|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924383|NCT02510599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924384|NCT02235805|Magnesium citrate|magnesium citrate|mesh-list
91924385|NCT02235805|Cathartics|cathartics|mesh-ancestor
91924386|NCT02235805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924387|NCT04227769|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91924388|NCT04227769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924389|NCT02688387|Ambrisentan|ambrisentan|mesh-list
91924390|NCT02688387|Tadalafil|tadalafil|mesh-list
91924391|NCT02688387|Vasodilator Agents|vasodilator agents|mesh-ancestor
91924392|NCT02688387|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91924393|NCT02688387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91924395|NCT02688387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924396|NCT02688387|Urological Agents|urological agents|mesh-ancestor
91924397|NCT02688387|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91924398|NCT05489900|Dexmedetomidine|dexmedetomidine|mesh-list
91924399|NCT05489900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91924400|NCT05489900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924401|NCT05489900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924402|NCT05489900|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91924403|NCT05489900|Analgesics|analgesics|mesh-ancestor
91924404|NCT05489900|Sensory System Agents|sensory system agents|mesh-ancestor
91924405|NCT05489900|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924406|NCT05489900|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91924407|NCT05489900|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91924408|NCT05489900|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91924409|NCT05489900|Adrenergic Agents|adrenergic agents|mesh-ancestor
91924410|NCT05489900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924411|NCT05489900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924418|NCT05489666|Vitamin D|vitamin d|mesh-list
91924419|NCT05489666|Cholecalciferol|cholecalciferol|mesh-list
91924420|NCT05489666|Vitamins|vitamins|mesh-ancestor
91924421|NCT05489666|Micronutrients|micronutrients|mesh-ancestor
91924422|NCT05489666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924423|NCT05489666|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91924424|NCT05489666|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91924426|NCT05484284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924427|NCT05483894|Atorvastatin|atorvastatin|mesh-list
91924428|NCT05483894|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91924429|NCT05483894|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91924430|NCT05483894|Antimetabolites|antimetabolites|mesh-ancestor
91924431|NCT05483894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924432|NCT05483894|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91924433|NCT05483894|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91924434|NCT05483894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924435|NCT01621243|Paclitaxel|paclitaxel|mesh-list
91924436|NCT01621243|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91924437|NCT01621243|Gemcitabine|gemcitabine|mesh-list
91924438|NCT01621243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924439|NCT01621243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924440|NCT01621243|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924441|NCT01621243|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924442|NCT01621243|Mitosis Modulators|mitosis modulators|mesh-ancestor
91924443|NCT01621243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924444|NCT01621243|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924445|NCT01621243|Antimetabolites|antimetabolites|mesh-ancestor
91924446|NCT04076761|Trifluridine|trifluridine|mesh-list
91924447|NCT04076761|Antimetabolites|antimetabolites|mesh-ancestor
91924448|NCT04076761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924449|NCT04076761|Antiviral Agents|antiviral agents|mesh-ancestor
91924450|NCT04076761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924451|NCT04046887|Paclitaxel|paclitaxel|mesh-list
91924452|NCT04046887|Gemcitabine|gemcitabine|mesh-list
91924453|NCT04046887|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943243|NCT03004287|Bortezomib|bortezomib|mesh-list
91924454|NCT04046887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924455|NCT04046887|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924458|NCT04046887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924459|NCT04046887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924461|NCT02235961|Liraglutide|liraglutide|mesh-list
91924462|NCT02235961|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91924463|NCT02235961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924464|NCT02235961|Incretins|incretins|mesh-ancestor
91924465|NCT02235961|Hormones|hormones|mesh-ancestor
91924466|NCT02235961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924468|NCT01610245|Nitazoxanide|nitazoxanide|mesh-list
91924469|NCT01610245|Antiviral Agents|antiviral agents|mesh-ancestor
91924470|NCT01610245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924471|NCT01610245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924472|NCT01610245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924473|NCT01610245|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91924474|NCT04138628|Atezolizumab|atezolizumab|mesh-list
91924475|NCT04138628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924476|NCT04138628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924477|NCT04138628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924478|NCT04138628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924479|NCT02741791|Bupropion|bupropion|mesh-list
91924480|NCT02741791|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91924481|NCT02741791|Antidepressive Agents|antidepressive agents|mesh-ancestor
91924482|NCT02741791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924483|NCT02741791|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91924484|NCT02741791|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91924485|NCT02741791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924486|NCT02741791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924488|NCT02741791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924489|NCT02741791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924490|NCT02741791|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91924491|NCT02741791|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91924492|NCT02741791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924493|NCT04275518|Cytarabine|cytarabine|mesh-list
91924494|NCT04275518|Azacitidine|azacitidine|mesh-list
91924495|NCT04275518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924496|NCT04275518|Antimetabolites|antimetabolites|mesh-ancestor
91924497|NCT04275518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924498|NCT04275518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924499|NCT04275518|Antiviral Agents|antiviral agents|mesh-ancestor
91924500|NCT04275518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924501|NCT04275518|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924502|NCT04275518|Immunologic Factors|immunologic factors|mesh-ancestor
91924503|NCT04275518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924504|NCT04275518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924505|NCT02263495|Paclitaxel|paclitaxel|mesh-list
91924506|NCT02263495|Gemcitabine|gemcitabine|mesh-list
91924507|NCT02263495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924508|NCT02263495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924509|NCT02263495|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924510|NCT02263495|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924511|NCT02263495|Mitosis Modulators|mitosis modulators|mesh-ancestor
91924512|NCT02263495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924513|NCT02263495|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924514|NCT02263495|Antimetabolites|antimetabolites|mesh-ancestor
91924515|NCT02687451|Oxymorphone|oxymorphone|mesh-list
91924516|NCT02687451|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91924517|NCT02687451|Narcotics|narcotics|mesh-ancestor
91924518|NCT02687451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924519|NCT02687451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924520|NCT02687451|Analgesics|analgesics|mesh-ancestor
91924521|NCT02687451|Sensory System Agents|sensory system agents|mesh-ancestor
91924522|NCT02687451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924523|NCT02687451|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91924524|NCT02557646|Ribavirin|ribavirin|mesh-list
91924525|NCT02557646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91924526|NCT02557646|Antimetabolites|antimetabolites|mesh-ancestor
91924527|NCT02557646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924528|NCT02557646|Antiviral Agents|antiviral agents|mesh-ancestor
91924529|NCT02557646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924531|NCT03859687|Vitamin A|vitamin a|mesh-list
91924532|NCT03859687|Retinol palmitate|retinol palmitate|mesh-list
91924533|NCT03859687|Micronutrients|micronutrients|mesh-ancestor
91924534|NCT03859687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924535|NCT03859687|Antioxidants|antioxidants|mesh-ancestor
91924536|NCT03859687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924537|NCT03859687|Protective Agents|protective agents|mesh-ancestor
91924538|NCT03859687|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91924539|NCT03859687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924540|NCT02679573|Moxifloxacin|moxifloxacin|mesh-list
91924542|NCT02679573|Delafloxacin|delafloxacin|mesh-list
91924543|NCT02679573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924544|NCT02679573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924545|NCT02679573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924546|NCT02679573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924547|NCT02679573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924548|NCT02679573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924549|NCT02679573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924550|NCT02679573|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91924551|NCT05493332|Leucovorin|leucovorin|mesh-list
91924552|NCT05493332|Fluorouracil|fluorouracil|mesh-list
91924553|NCT05493332|Oxaliplatin|oxaliplatin|mesh-list
91924554|NCT05493332|Antimetabolites|antimetabolites|mesh-ancestor
91924555|NCT05493332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924556|NCT05493332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924557|NCT05493332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924558|NCT05493332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924559|NCT05493332|Immunologic Factors|immunologic factors|mesh-ancestor
91924560|NCT05493332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924561|NCT05493332|Antidotes|antidotes|mesh-ancestor
91924562|NCT05493332|Protective Agents|protective agents|mesh-ancestor
91924563|NCT05493332|Vitamin B Complex|vitamin b complex|mesh-ancestor
91924565|NCT05493332|Micronutrients|micronutrients|mesh-ancestor
91924566|NCT01591447|Solithromycin|solithromycin|mesh-list
91924567|NCT01591447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924568|NCT01591447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924569|NCT01578655|Prednisone|prednisone|mesh-list
91924570|NCT01578655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924571|NCT01578655|Glucocorticoids|glucocorticoids|mesh-ancestor
91924572|NCT01578655|Hormones|hormones|mesh-ancestor
91924573|NCT01578655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924574|NCT01578655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924575|NCT01578655|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91924576|NCT01578655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924577|NCT05361447|Diazepam|diazepam|mesh-list
91924578|NCT05361447|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91924579|NCT05361447|Anticonvulsants|anticonvulsants|mesh-ancestor
91924580|NCT05361447|Antiemetics|antiemetics|mesh-ancestor
91924581|NCT05361447|Autonomic Agents|autonomic agents|mesh-ancestor
91924582|NCT05361447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924583|NCT05361447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924584|NCT05361447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924585|NCT05361447|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91924586|NCT05361447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924587|NCT05361447|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91924588|NCT05361447|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91924589|NCT05361447|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91924590|NCT05361447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91924591|NCT05361447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924592|NCT05361447|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91924593|NCT05361447|Anesthetics, General|anesthetics, general|mesh-ancestor
91924594|NCT05361447|Anesthetics|anesthetics|mesh-ancestor
91924595|NCT05361447|GABA Modulators|gaba modulators|mesh-ancestor
91924596|NCT05361447|GABA Agents|gaba agents|mesh-ancestor
91924597|NCT05361447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924598|NCT05361447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924599|NCT01577173|Cetuximab|cetuximab|mesh-list
91924600|NCT01577173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924601|NCT01577173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924602|NCT01573351|Interferons|interferons|mesh-list
91924603|NCT01573351|Ribavirin|ribavirin|mesh-list
91924604|NCT01573351|Interferon-alpha|interferon-alpha|mesh-list
91924605|NCT01573351|Interferon alpha-2|interferon alpha-2|mesh-list
91924606|NCT01573351|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91924607|NCT01573351|Asunaprevir|asunaprevir|mesh-list
91924608|NCT01573351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924609|NCT01573351|Antiviral Agents|antiviral agents|mesh-ancestor
91924610|NCT01573351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924611|NCT01573351|Antimetabolites|antimetabolites|mesh-ancestor
91924612|NCT01573351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924613|NCT01573351|Immunologic Factors|immunologic factors|mesh-ancestor
91924614|NCT01573351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924618|NCT02685033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924619|NCT02685033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924620|NCT05579223|Hydromorphone|hydromorphone|mesh-list
91924621|NCT05579223|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91924622|NCT05579223|Narcotics|narcotics|mesh-ancestor
91924623|NCT05579223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924624|NCT05579223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924625|NCT05579223|Analgesics|analgesics|mesh-ancestor
91924626|NCT05579223|Sensory System Agents|sensory system agents|mesh-ancestor
91924627|NCT05579223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924628|NCT00258427|Methylprednisolone|methylprednisolone|mesh-list
91924629|NCT00258427|Cyclophosphamide|cyclophosphamide|mesh-list
91924630|NCT00258427|Busulfan|busulfan|mesh-list
91924631|NCT00258427|Fludarabine|fludarabine|mesh-list
91924632|NCT00258427|Fludarabine phosphate|fludarabine phosphate|mesh-list
91924633|NCT00258427|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91924634|NCT00258427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924635|NCT00258427|Immunologic Factors|immunologic factors|mesh-ancestor
91924636|NCT00258427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924637|NCT00258427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924638|NCT00258427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91924639|NCT00258427|Alkylating Agents|alkylating agents|mesh-ancestor
91924640|NCT00258427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924641|NCT00258427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924642|NCT00258427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91924643|NCT00258427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924644|NCT00258427|Antimetabolites|antimetabolites|mesh-ancestor
91924645|NCT00258427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924646|NCT00258427|Antiemetics|antiemetics|mesh-ancestor
91924647|NCT00258427|Autonomic Agents|autonomic agents|mesh-ancestor
91924648|NCT00258427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924649|NCT00258427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924650|NCT00258427|Glucocorticoids|glucocorticoids|mesh-ancestor
91924651|NCT00258427|Hormones|hormones|mesh-ancestor
91924652|NCT00258427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924653|NCT00258427|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91924654|NCT00258427|Protective Agents|protective agents|mesh-ancestor
91924655|NCT01531699|Povidone-Iodine|povidone-iodine|mesh-list
91924656|NCT01531699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91924657|NCT01531699|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91924658|NCT01531699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924659|NCT02233621|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91924660|NCT02233621|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91924661|NCT02233621|Estradiol|estradiol|mesh-list
91924662|NCT02233621|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91924663|NCT02233621|Estrogens|estrogens|mesh-ancestor
91924664|NCT02233621|Hormones|hormones|mesh-ancestor
91924665|NCT02233621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924666|NCT02233621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924667|NCT02233621|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91924668|NCT02233621|Contraceptive Agents|contraceptive agents|mesh-ancestor
91924669|NCT02233621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91924670|NCT02233621|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91924671|NCT02557100|Adalimumab|adalimumab|mesh-list
91924672|NCT02557100|Methotrexate|methotrexate|mesh-list
91924673|NCT02557100|Abatacept|abatacept|mesh-list
91924674|NCT02557100|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91924675|NCT02557100|Abortifacient Agents|abortifacient agents|mesh-ancestor
91924676|NCT02557100|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91924677|NCT02557100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924678|NCT02557100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91924679|NCT02557100|Antimetabolites|antimetabolites|mesh-ancestor
91924680|NCT02557100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924681|NCT02557100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924682|NCT02557100|Dermatologic Agents|dermatologic agents|mesh-ancestor
91924683|NCT02557100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924684|NCT02557100|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91924685|NCT02557100|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924686|NCT02557100|Immunologic Factors|immunologic factors|mesh-ancestor
91924687|NCT02557100|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924688|NCT02557100|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91924689|NCT02557100|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91924690|NCT02557100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924691|NCT02557100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924692|NCT02557100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924847|NCT05105035|Meropenem|meropenem|mesh-list
91924695|NCT02233777|Sensory System Agents|sensory system agents|mesh-ancestor
91924696|NCT02233777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924697|NCT02233777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924698|NCT02233777|Anticonvulsants|anticonvulsants|mesh-ancestor
91924699|NCT02233777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91924700|NCT02233777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924701|NCT02233777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924702|NCT02233777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91924703|NCT02233777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91924704|NCT02233777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91924705|NCT02233777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924706|NCT02233777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924707|NCT02634853|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91924708|NCT02634853|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91924710|NCT01520545|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91924711|NCT01520545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924712|NCT01520545|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91924713|NCT01520545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924714|NCT01520545|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91924715|NCT01520545|GABA Agonists|gaba agonists|mesh-ancestor
91924716|NCT01520545|GABA Agents|gaba agents|mesh-ancestor
91924717|NCT01520545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924718|NCT01520545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924720|NCT05488106|Vitamin B Complex|vitamin b complex|mesh-ancestor
91924721|NCT05488106|Vitamins|vitamins|mesh-ancestor
91924722|NCT05488106|Micronutrients|micronutrients|mesh-ancestor
91924723|NCT05488106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924724|NCT05488106|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91924725|NCT05488106|Dermatologic Agents|dermatologic agents|mesh-ancestor
91924726|NCT05492318|Clarithromycin|clarithromycin|mesh-list
91924727|NCT05492318|Midazolam|midazolam|mesh-list
91924728|NCT05492318|Dabigatran|dabigatran|mesh-list
91924729|NCT05492318|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
91924730|NCT05492318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91924731|NCT05492318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91924732|NCT05492318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924733|NCT05492318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924734|NCT05492318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91924735|NCT05492318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91924736|NCT05492318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924737|NCT05492318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91924738|NCT05492318|Anesthetics, General|anesthetics, general|mesh-ancestor
91924739|NCT05492318|Anesthetics|anesthetics|mesh-ancestor
91924740|NCT05492318|GABA Modulators|gaba modulators|mesh-ancestor
91924741|NCT05492318|GABA Agents|gaba agents|mesh-ancestor
91924742|NCT05492318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924743|NCT05492318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924744|NCT05492318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924745|NCT05492318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924746|NCT05492318|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91924747|NCT05492318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924748|NCT05492318|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91924749|NCT05492318|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91924750|NCT05492318|Antithrombins|antithrombins|mesh-ancestor
91924751|NCT05492318|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91924752|NCT05492318|Protease Inhibitors|protease inhibitors|mesh-ancestor
91924753|NCT05492318|Anticoagulants|anticoagulants|mesh-ancestor
91924754|NCT05492318|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91924755|NCT01337635|Vitamin D|vitamin d|mesh-list
91924756|NCT01337635|Vitamins|vitamins|mesh-ancestor
91924757|NCT01337635|Micronutrients|micronutrients|mesh-ancestor
91924758|NCT01337635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924759|NCT01337635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91924760|NCT02264041|Itraconazole|itraconazole|mesh-list
91924761|NCT02264041|Antifungal Agents|antifungal agents|mesh-ancestor
91924762|NCT02264041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924763|NCT02264041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91924764|NCT02264041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91924765|NCT02264041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924766|NCT02264041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924767|NCT02264041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91924768|NCT02264041|Hormone Antagonists|hormone antagonists|mesh-ancestor
91924769|NCT02264041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924770|NCT02264041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924771|NCT02264041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91924772|NCT02261779|Tretinoin|tretinoin|mesh-list
91924773|NCT02261779|Tranylcypromine|tranylcypromine|mesh-list
91924774|NCT02261779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924775|NCT02261779|Keratolytic Agents|keratolytic agents|mesh-ancestor
91924776|NCT02261779|Dermatologic Agents|dermatologic agents|mesh-ancestor
91924777|NCT02261779|Antidepressive Agents|antidepressive agents|mesh-ancestor
91924778|NCT02261779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924779|NCT02261779|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91924780|NCT02261779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924781|NCT02261779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924782|NCT02261779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91924783|NCT02261779|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91924784|NCT02261779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924785|NCT02261779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924786|NCT05157685|Azithromycin|azithromycin|mesh-list
91924787|NCT05157685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924788|NCT05157685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924790|NCT02556632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91924791|NCT02556632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91924792|NCT02556632|Analgesics|analgesics|mesh-ancestor
91924793|NCT02556632|Sensory System Agents|sensory system agents|mesh-ancestor
91924794|NCT02556632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924795|NCT02556632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924796|NCT02556632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924797|NCT02556632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924798|NCT02556632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924799|NCT02556632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924800|NCT02556632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924801|NCT05491928|Tempol|tempol|mesh-list
91924802|NCT05491928|Antioxidants|antioxidants|mesh-ancestor
91924803|NCT05491928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924804|NCT05491928|Protective Agents|protective agents|mesh-ancestor
91924805|NCT05491928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924806|NCT05491928|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91924807|NCT05491928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924808|NCT05491928|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91924809|NCT05491928|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91924810|NCT01515007|Ciprofloxacin|ciprofloxacin|mesh-list
91924811|NCT01515007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924812|NCT01515007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924813|NCT01515007|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924814|NCT01515007|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924815|NCT01515007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924816|NCT01515007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924817|NCT01515007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924818|NCT01515007|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91924819|NCT01515007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91924820|NCT02262169|Omeprazole|omeprazole|mesh-list
91924821|NCT02262169|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91924822|NCT02262169|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924823|NCT02262169|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91924824|NCT02262169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924825|NCT02262169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924827|NCT05491694|Cyclophosphamide|cyclophosphamide|mesh-list
91924828|NCT05491694|Carboplatin|carboplatin|mesh-list
91924829|NCT05491694|Epirubicin|epirubicin|mesh-list
91924830|NCT05491694|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91924831|NCT05491694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924832|NCT05491694|Tubulin Modulators|tubulin modulators|mesh-ancestor
91924833|NCT05491694|Antimitotic Agents|antimitotic agents|mesh-ancestor
91924834|NCT05491694|Mitosis Modulators|mitosis modulators|mesh-ancestor
91924835|NCT05491694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924836|NCT05491694|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91924837|NCT05491694|Immunologic Factors|immunologic factors|mesh-ancestor
91924838|NCT05491694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924839|NCT05491694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924840|NCT05491694|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91924841|NCT05491694|Alkylating Agents|alkylating agents|mesh-ancestor
91924842|NCT05491694|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91924843|NCT05491694|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91924844|NCT05491694|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924845|NCT05491694|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924846|NCT05491694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924849|NCT05105035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924850|NCT05105035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924851|NCT01501513|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
91924852|NCT01501513|Laxatives|laxatives|mesh-ancestor
91924853|NCT01501513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924854|NCT05480072|Palmidrol|palmidrol|mesh-list
91924855|NCT05480072|Analgesics|analgesics|mesh-ancestor
91924856|NCT05480072|Sensory System Agents|sensory system agents|mesh-ancestor
91924857|NCT05480072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924858|NCT05480072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924859|NCT05480072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91924860|NCT05480072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91924861|NCT05480072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924862|NCT05480072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924863|NCT05480072|Antiviral Agents|antiviral agents|mesh-ancestor
91924864|NCT05480072|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924865|NCT05480072|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91924866|NCT05480072|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91924867|NCT05480072|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924868|NCT05480072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924869|NCT05480072|Hormones|hormones|mesh-ancestor
91924870|NCT05480072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924871|NCT01499563|Risperidone|risperidone|mesh-list
91924872|NCT01499563|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91924873|NCT01499563|Serotonin Agents|serotonin agents|mesh-ancestor
91924874|NCT01499563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924875|NCT01499563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924876|NCT01499563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924877|NCT01499563|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91924878|NCT01499563|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91924879|NCT01499563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91924880|NCT01499563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924881|NCT01499563|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91924882|NCT01499563|Dopamine Agents|dopamine agents|mesh-ancestor
91924883|NCT03922880|Nivolumab|nivolumab|mesh-list
91924884|NCT03922880|Ipilimumab|ipilimumab|mesh-list
91924885|NCT03922880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924886|NCT03922880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924887|NCT03922880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91924888|NCT03922880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924889|NCT02264119|Pantoprazole|pantoprazole|mesh-list
91924890|NCT02264119|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91924891|NCT02264119|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91924892|NCT02264119|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91924893|NCT02264119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924894|NCT02264119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924895|NCT02262481|Dydrogesterone|dydrogesterone|mesh-list
91924896|NCT02262481|Progestins|progestins|mesh-ancestor
91924897|NCT02262481|Hormones|hormones|mesh-ancestor
91924898|NCT02262481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91924899|NCT02262481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924901|NCT01435369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91924902|NCT01435369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924903|NCT01257607|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91924904|NCT01257607|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91924905|NCT01252693|Goserelin|goserelin|mesh-list
91924906|NCT01252693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91924907|NCT01252693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924908|NCT01486849|Riluzole|riluzole|mesh-list
91924909|NCT01486849|Anticonvulsants|anticonvulsants|mesh-ancestor
91924910|NCT01486849|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91924911|NCT01486849|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91924912|NCT01486849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924913|NCT01486849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924914|NCT01486849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924915|NCT01486849|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91924916|NCT01486849|Protective Agents|protective agents|mesh-ancestor
91924918|NCT01484119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91924919|NCT01484119|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91924920|NCT01484119|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91924921|NCT01484119|Histamine Antagonists|histamine antagonists|mesh-ancestor
91924922|NCT01484119|Histamine Agents|histamine agents|mesh-ancestor
91924923|NCT01484119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925074|NCT02264743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91924924|NCT01484119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924925|NCT01484119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924926|NCT01482403|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91924927|NCT01482403|Interferon-alpha|interferon-alpha|mesh-list
91924928|NCT01482403|Ribavirin|ribavirin|mesh-list
91924929|NCT01482403|Antiviral Agents|antiviral agents|mesh-ancestor
91924930|NCT01482403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924931|NCT01482403|Immunologic Factors|immunologic factors|mesh-ancestor
91924932|NCT01482403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924933|NCT01482403|Antimetabolites|antimetabolites|mesh-ancestor
91924934|NCT01482403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924935|NCT01481077|Latanoprost|latanoprost|mesh-list
91924936|NCT01481077|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91924937|NCT01481077|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91924938|NCT02268409|Luspatercept|luspatercept|mesh-list
91924939|NCT02268409|Hematinics|hematinics|mesh-ancestor
91924940|NCT02268487|Sertraline|sertraline|mesh-list
91924941|NCT02268487|Antidepressive Agents|antidepressive agents|mesh-ancestor
91924942|NCT02268487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91924943|NCT02268487|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91924944|NCT02268487|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91924945|NCT02268487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91924946|NCT02268487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924947|NCT02268487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924948|NCT02268487|Serotonin Agents|serotonin agents|mesh-ancestor
91924949|NCT02268487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924950|NCT02265289|Clopidogrel|clopidogrel|mesh-list
91924951|NCT02265289|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91924952|NCT02265289|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91924953|NCT02265289|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91924954|NCT02265289|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91924955|NCT02265289|Purinergic Agents|purinergic agents|mesh-ancestor
91924956|NCT02265289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91924957|NCT02265289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924958|NCT02265289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924959|NCT02265445|beta-Lactams|beta-lactams|mesh-list
91924960|NCT02265445|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91924961|NCT02265445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91924962|NCT04476121|Aspirin|aspirin|mesh-list
91924963|NCT04476121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91924964|NCT04476121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91924965|NCT04476121|Analgesics|analgesics|mesh-ancestor
91924966|NCT04476121|Sensory System Agents|sensory system agents|mesh-ancestor
91924967|NCT04476121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924968|NCT04476121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924969|NCT04476121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91924970|NCT04476121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924971|NCT04476121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91924972|NCT04476121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91924973|NCT04476121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924974|NCT04476121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91924975|NCT04476121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91924976|NCT04476121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924977|NCT04476121|Antipyretics|antipyretics|mesh-ancestor
91924978|NCT01234519|Doxorubicin|doxorubicin|mesh-list
91924979|NCT01234519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91924980|NCT01234519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91924981|NCT01234519|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91924982|NCT01234519|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91924983|NCT01234519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91924984|NCT01234519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924986|NCT01474135|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91924987|NCT02268565|Aspirin|aspirin|mesh-list
91924988|NCT02268565|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
91924989|NCT02268565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91924990|NCT02268565|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91924991|NCT02268565|Analgesics|analgesics|mesh-ancestor
91924992|NCT02268565|Sensory System Agents|sensory system agents|mesh-ancestor
91924993|NCT02268565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91924994|NCT02268565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91924995|NCT02268565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91924996|NCT02268565|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91924997|NCT02268565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91925075|NCT02264743|Contraceptive Agents|contraceptive agents|mesh-ancestor
91924998|NCT02268565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91924999|NCT02268565|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91925000|NCT02268565|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91925001|NCT02268565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925002|NCT02268565|Antipyretics|antipyretics|mesh-ancestor
91925004|NCT05479448|Hormones|hormones|mesh-list
91925005|NCT05479448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925006|NCT05479448|Glucocorticoids|glucocorticoids|mesh-ancestor
91925007|NCT05479448|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925008|NCT05479448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925009|NCT05479448|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925010|NCT05479448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925011|NCT02264587|Domperidone|domperidone|mesh-list
91925012|NCT02264587|Mosapride|mosapride|mesh-list
91925013|NCT02264587|Antiemetics|antiemetics|mesh-ancestor
91925014|NCT02264587|Autonomic Agents|autonomic agents|mesh-ancestor
91925015|NCT02264587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925016|NCT02264587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925017|NCT02264587|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925018|NCT02264587|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91925019|NCT02264587|Dopamine Agents|dopamine agents|mesh-ancestor
91925020|NCT02264587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925021|NCT02264587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925022|NCT02264587|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91925023|NCT02264587|Serotonin Agents|serotonin agents|mesh-ancestor
91925024|NCT05475080|Anticoagulants|anticoagulants|mesh-list
91925025|NCT05475080|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91925026|NCT02264665|Everolimus|everolimus|mesh-list
91925027|NCT02264665|Sunitinib|sunitinib|mesh-list
91925028|NCT02264665|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91925029|NCT02264665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925030|NCT02264665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925031|NCT02264665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925032|NCT02264665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925033|NCT02264665|Immunologic Factors|immunologic factors|mesh-ancestor
91925034|NCT02264665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925035|NCT02264665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925036|NCT02264665|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91925037|NCT02264665|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91925038|NCT02264665|Growth Substances|growth substances|mesh-ancestor
91925039|NCT02264665|Growth Inhibitors|growth inhibitors|mesh-ancestor
91925040|NCT02683941|Lanreotide|lanreotide|mesh-list
91925041|NCT02683941|Somatostatin|somatostatin|mesh-list
91925042|NCT02683941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925043|NCT02683941|Hormones|hormones|mesh-ancestor
91925044|NCT02683941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925045|NCT02683941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925046|NCT01225393|Adalimumab|adalimumab|mesh-list
91925047|NCT01225393|Methotrexate|methotrexate|mesh-list
91925048|NCT01225393|Leflunomide|leflunomide|mesh-list
91925049|NCT01225393|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91925050|NCT01225393|Abortifacient Agents|abortifacient agents|mesh-ancestor
91925051|NCT01225393|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925052|NCT01225393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925053|NCT01225393|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91925054|NCT01225393|Antimetabolites|antimetabolites|mesh-ancestor
91925055|NCT01225393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925056|NCT01225393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925057|NCT01225393|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925058|NCT01225393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925059|NCT01225393|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91925060|NCT01225393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925061|NCT01225393|Immunologic Factors|immunologic factors|mesh-ancestor
91925062|NCT01225393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925063|NCT01225393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91925064|NCT01225393|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91925065|NCT01225393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925066|NCT02264743|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91925067|NCT02264743|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91925068|NCT02264743|Estradiol|estradiol|mesh-list
91925069|NCT02264743|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91925070|NCT02264743|Estrogens|estrogens|mesh-ancestor
91925071|NCT02264743|Hormones|hormones|mesh-ancestor
91925072|NCT02264743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925073|NCT02264743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925076|NCT02264743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925077|NCT02264743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91925078|NCT01220947|Ritonavir|ritonavir|mesh-list
91925079|NCT01220947|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91925080|NCT01220947|Lactams|lactams|mesh-list
91925081|NCT01220947|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91925082|NCT01220947|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91925083|NCT01220947|Protease Inhibitors|protease inhibitors|mesh-ancestor
91925084|NCT01220947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925085|NCT01220947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925086|NCT01220947|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91925087|NCT01220947|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91925088|NCT01220947|Antiviral Agents|antiviral agents|mesh-ancestor
91925089|NCT01220947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925090|NCT01220947|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91925091|NCT01220947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91925092|NCT01220947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925093|NCT03953833|Antibodies|antibodies|mesh-list
91925094|NCT03953833|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91925095|NCT03953833|Immunologic Factors|immunologic factors|mesh-ancestor
91925096|NCT03953833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925097|NCT01393639|Prednisone|prednisone|mesh-list
91925098|NCT01393639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925099|NCT01393639|Glucocorticoids|glucocorticoids|mesh-ancestor
91925101|NCT01393639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925102|NCT01393639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925103|NCT01393639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925104|NCT01393639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925105|NCT01379209|Mycophenolic Acid|mycophenolic acid|mesh-list
91925106|NCT01379209|Sirolimus|sirolimus|mesh-list
91925107|NCT01379209|Methotrexate|methotrexate|mesh-list
91925108|NCT01379209|KRN 7000|krn 7000|mesh-list
91925109|NCT01379209|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
91925110|NCT01379209|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91925111|NCT01379209|Abortifacient Agents|abortifacient agents|mesh-ancestor
91925112|NCT01379209|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925113|NCT01379209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925114|NCT01379209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91925115|NCT01379209|Antimetabolites|antimetabolites|mesh-ancestor
91925116|NCT01379209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925117|NCT01379209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925118|NCT01379209|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925119|NCT01379209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925120|NCT01379209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91925121|NCT01379209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925122|NCT01379209|Immunologic Factors|immunologic factors|mesh-ancestor
91925123|NCT01379209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925124|NCT01379209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91925125|NCT01379209|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91925126|NCT01379209|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91925127|NCT01379209|Antitubercular Agents|antitubercular agents|mesh-ancestor
91925128|NCT01379209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925129|NCT01379209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925130|NCT01379209|Antifungal Agents|antifungal agents|mesh-ancestor
91925131|NCT01379209|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91925132|NCT01204099|Docetaxel|docetaxel|mesh-list
91925133|NCT01204099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925134|NCT01204099|Tubulin Modulators|tubulin modulators|mesh-ancestor
91925135|NCT01204099|Antimitotic Agents|antimitotic agents|mesh-ancestor
91925136|NCT01204099|Mitosis Modulators|mitosis modulators|mesh-ancestor
91925137|NCT01204099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925139|NCT02853500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91925140|NCT02853500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925141|NCT02853500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91925142|NCT02853500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91925143|NCT02853500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925144|NCT02853500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925145|NCT01188187|Dexamethasone|dexamethasone|mesh-list
91925147|NCT01188187|Docetaxel|docetaxel|mesh-list
91925148|NCT01188187|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925149|NCT01188187|Antiemetics|antiemetics|mesh-ancestor
91925150|NCT01188187|Autonomic Agents|autonomic agents|mesh-ancestor
91925151|NCT01188187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925152|NCT01188187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925153|NCT01188187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925154|NCT01188187|Glucocorticoids|glucocorticoids|mesh-ancestor
91925156|NCT01188187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925157|NCT01188187|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925158|NCT01188187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925159|NCT01188187|Tubulin Modulators|tubulin modulators|mesh-ancestor
91925160|NCT01188187|Antimitotic Agents|antimitotic agents|mesh-ancestor
91925161|NCT01188187|Mitosis Modulators|mitosis modulators|mesh-ancestor
91925162|NCT01188187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925163|NCT05478356|Atropine|atropine|mesh-list
91925164|NCT05478356|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91925165|NCT05478356|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91925166|NCT05478356|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91925167|NCT05478356|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91925168|NCT05478356|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91925169|NCT05478356|Autonomic Agents|autonomic agents|mesh-ancestor
91925170|NCT05478356|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925171|NCT05478356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925172|NCT05478356|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91925173|NCT05478356|Respiratory System Agents|respiratory system agents|mesh-ancestor
91925174|NCT05478356|Mydriatics|mydriatics|mesh-ancestor
91925175|NCT05478356|Parasympatholytics|parasympatholytics|mesh-ancestor
91925176|NCT05478356|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91925177|NCT05478356|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91925178|NCT05478356|Cholinergic Agents|cholinergic agents|mesh-ancestor
91925179|NCT05478356|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925180|NCT05478356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925181|NCT01186861|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91925182|NCT01186861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925183|NCT01186861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925184|NCT01186861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925185|NCT01186861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925186|NCT01175785|Cyclosporine|cyclosporine|mesh-list
91925187|NCT01175785|Mycophenolic Acid|mycophenolic acid|mesh-list
91925188|NCT01175785|Cyclophosphamide|cyclophosphamide|mesh-list
91925189|NCT01175785|Fludarabine|fludarabine|mesh-list
91925190|NCT01175785|Fludarabine phosphate|fludarabine phosphate|mesh-list
91925192|NCT01175785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925193|NCT01175785|Immunologic Factors|immunologic factors|mesh-ancestor
91925194|NCT01175785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925195|NCT01175785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925196|NCT01175785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91925197|NCT01175785|Alkylating Agents|alkylating agents|mesh-ancestor
91925198|NCT01175785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925199|NCT01175785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925200|NCT01175785|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91925201|NCT01175785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91925202|NCT01175785|Antimetabolites|antimetabolites|mesh-ancestor
91925203|NCT01175785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925204|NCT01175785|Antifungal Agents|antifungal agents|mesh-ancestor
91925205|NCT01175785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925206|NCT01175785|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925207|NCT01175785|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91925208|NCT01175785|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91925209|NCT01175785|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91925210|NCT01175785|Antitubercular Agents|antitubercular agents|mesh-ancestor
91925211|NCT01175785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925213|NCT05478044|Vitamins|vitamins|mesh-ancestor
91925214|NCT05478044|Micronutrients|micronutrients|mesh-ancestor
91925215|NCT05478044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925216|NCT05478044|Antioxidants|antioxidants|mesh-ancestor
91925217|NCT05478044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925218|NCT05478044|Protective Agents|protective agents|mesh-ancestor
91925219|NCT05472506|Nivolumab|nivolumab|mesh-list
91925220|NCT05472506|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925221|NCT05472506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925222|NCT05472506|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91925223|NCT05472506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925224|NCT01445899|Ranibizumab|ranibizumab|mesh-list
91925225|NCT01445899|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91925226|NCT01445899|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91925227|NCT01445899|Growth Substances|growth substances|mesh-ancestor
91925228|NCT01445899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925229|NCT01445899|Growth Inhibitors|growth inhibitors|mesh-ancestor
91925230|NCT01445899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925231|NCT03649724|Leuprolide|leuprolide|mesh-list
91925232|NCT03649724|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91925233|NCT03649724|Fertility Agents|fertility agents|mesh-ancestor
91925234|NCT03649724|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925235|NCT03649724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925236|NCT03649724|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925237|NCT03649724|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925238|NCT01358695|Botulinum Toxins|botulinum toxins|mesh-list
91925239|NCT01358695|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91925240|NCT01358695|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91925241|NCT01358695|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91925242|NCT01358695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925243|NCT01358695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925244|NCT01358695|Cholinergic Agents|cholinergic agents|mesh-ancestor
91925245|NCT01358695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925246|NCT01358695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925247|NCT01358695|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91925248|NCT01358695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925249|NCT02266303|Insulin|insulin|mesh-list
91925250|NCT02266303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91925251|NCT02266303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925252|NCT02551874|Metformin|metformin|mesh-list
91925253|NCT02551874|Insulin Glargine|insulin glargine|mesh-list
91925254|NCT02551874|Dapagliflozin|dapagliflozin|mesh-list
91925255|NCT02551874|Saxagliptin|saxagliptin|mesh-list
91925256|NCT02551874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91925257|NCT02551874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925258|NCT02551874|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91925259|NCT02551874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925260|NCT02551874|Incretins|incretins|mesh-ancestor
91925261|NCT02551874|Hormones|hormones|mesh-ancestor
91925262|NCT02551874|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925263|NCT02551874|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91925264|NCT02551874|Protease Inhibitors|protease inhibitors|mesh-ancestor
91925265|NCT02551874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925266|NCT03646604|Upadacitinib|upadacitinib|mesh-list
91925267|NCT03646604|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91925268|NCT03646604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925269|NCT03646604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925270|NCT03646604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925271|NCT03646604|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925272|NCT01354717|Fluorouracil|fluorouracil|mesh-list
91925273|NCT01354717|Antimetabolites|antimetabolites|mesh-ancestor
91925274|NCT01354717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925275|NCT01354717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91925276|NCT01354717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925277|NCT01354717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925278|NCT01354717|Immunologic Factors|immunologic factors|mesh-ancestor
91925279|NCT01354717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925280|NCT01072981|Gemcitabine|gemcitabine|mesh-list
91925281|NCT01072981|Fluorouracil|fluorouracil|mesh-list
91925282|NCT01072981|Pancrelipase|pancrelipase|mesh-list
91925283|NCT01072981|Immunologic Factors|immunologic factors|mesh-list
91925284|NCT01072981|Immunomodulating Agents|immunomodulating agents|mesh-list
91925285|NCT01072981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91925286|NCT01072981|Antimetabolites|antimetabolites|mesh-ancestor
91925287|NCT01072981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925288|NCT01072981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925289|NCT01072981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925290|NCT01072981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925291|NCT01072981|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925292|NCT03347708|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91925293|NCT03347708|Hyaluronic Acid|hyaluronic acid|mesh-list
91925294|NCT03347708|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91925295|NCT03347708|Immunologic Factors|immunologic factors|mesh-ancestor
91925296|NCT03347708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925297|NCT03347708|Viscosupplements|viscosupplements|mesh-ancestor
91925298|NCT03347708|Protective Agents|protective agents|mesh-ancestor
91925299|NCT01159249|Vildagliptin|vildagliptin|mesh-list
91925300|NCT01159249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91925301|NCT01159249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925302|NCT01159249|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91925303|NCT01159249|Protease Inhibitors|protease inhibitors|mesh-ancestor
91925304|NCT01159249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925305|NCT01159249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925309|NCT01156753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925310|NCT01156753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925311|NCT01156753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925312|NCT01345045|Pregabalin|pregabalin|mesh-list
91925313|NCT01345045|Analgesics|analgesics|mesh-ancestor
91925314|NCT01345045|Sensory System Agents|sensory system agents|mesh-ancestor
91925315|NCT01345045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925316|NCT01345045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925317|NCT01345045|Anticonvulsants|anticonvulsants|mesh-ancestor
91925318|NCT01345045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91925319|NCT01345045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925320|NCT01345045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925321|NCT01345045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91925322|NCT01345045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91925324|NCT01345045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925325|NCT01345045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91925326|NCT01344187|Riboflavin|riboflavin|mesh-list
91925327|NCT01344187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91925328|NCT01344187|Vitamin B Complex|vitamin b complex|mesh-ancestor
91925329|NCT01344187|Vitamins|vitamins|mesh-ancestor
91925330|NCT01344187|Micronutrients|micronutrients|mesh-ancestor
91925331|NCT01344187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925332|NCT01344187|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91925333|NCT01344187|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925334|NCT01338883|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91925335|NCT01338883|Efavirenz|efavirenz|mesh-list
91925336|NCT01338883|Cenicriviroc|cenicriviroc|mesh-list
91925337|NCT01338883|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91925338|NCT01338883|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91925339|NCT01338883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925340|NCT01338883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925341|NCT01338883|Antiviral Agents|antiviral agents|mesh-ancestor
91925342|NCT01338883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925343|NCT01338883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91925344|NCT01338883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91925345|NCT01338883|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91925346|NCT01338883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91925347|NCT01338883|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91925348|NCT01338883|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91925349|NCT01338883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91925350|NCT01338883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91925351|NCT01338883|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91925353|NCT05625919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925354|NCT05625919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925355|NCT05625919|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91925356|NCT05625919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925357|NCT05625919|Antifungal Agents|antifungal agents|mesh-ancestor
91925358|NCT05625919|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925359|NCT05625919|Immunologic Factors|immunologic factors|mesh-ancestor
91925360|NCT05625919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925361|NCT02682927|Fenfluramine|fenfluramine|mesh-list
91925362|NCT02682927|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91925363|NCT02682927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91925364|NCT02682927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925365|NCT02682927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925366|NCT02682927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925367|NCT02682927|Serotonin Agents|serotonin agents|mesh-ancestor
91925368|NCT02682927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925369|NCT02266537|Doxazosin|doxazosin|mesh-list
91925370|NCT02266537|Tamsulosin|tamsulosin|mesh-list
91925371|NCT02266537|Alfuzosin|alfuzosin|mesh-list
91925372|NCT02266537|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91925373|NCT02266537|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91925374|NCT02266537|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91925375|NCT02266537|Adrenergic Agents|adrenergic agents|mesh-ancestor
91925376|NCT02266537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925377|NCT02266537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925378|NCT02266537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925379|NCT02266537|Urological Agents|urological agents|mesh-ancestor
91925380|NCT02266537|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91925381|NCT02269735|Insulin|insulin|mesh-list
91925382|NCT02269735|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91925383|NCT02269735|Insulin Aspart|insulin aspart|mesh-list
91925386|NCT02269735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925387|NCT05625373|Vancomycin|vancomycin|mesh-list
91925388|NCT05625373|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925389|NCT05625373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925390|NCT01038739|Mesalamine|mesalamine|mesh-list
91925391|NCT01038739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91925392|NCT01038739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91925393|NCT01038739|Analgesics|analgesics|mesh-ancestor
91925394|NCT01038739|Sensory System Agents|sensory system agents|mesh-ancestor
91925395|NCT01038739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925396|NCT01038739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925397|NCT01038739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925398|NCT01038739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925399|NCT01336465|Etrolizumab|etrolizumab|mesh-list
91925400|NCT01336465|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925401|NCT01336465|Immunologic Factors|immunologic factors|mesh-ancestor
91925402|NCT01336465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925403|NCT03315026|Siltuximab|siltuximab|mesh-list
91925404|NCT03315026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925405|NCT02769065|Donepezil|donepezil|mesh-list
91925406|NCT02769065|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91925407|NCT02769065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925408|NCT02769065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925409|NCT02769065|Cholinergic Agents|cholinergic agents|mesh-ancestor
91925410|NCT02769065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925411|NCT02769065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925412|NCT02769065|Nootropic Agents|nootropic agents|mesh-ancestor
91925413|NCT02540954|Aflibercept|aflibercept|mesh-list
91925414|NCT02540954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91925415|NCT02540954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91925416|NCT02540954|Growth Substances|growth substances|mesh-ancestor
91925417|NCT02540954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925418|NCT02540954|Growth Inhibitors|growth inhibitors|mesh-ancestor
91925419|NCT02540954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925420|NCT05265975|Rituximab|rituximab|mesh-list
91925421|NCT05265975|Lenalidomide|lenalidomide|mesh-list
91925422|NCT05265975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925423|NCT05265975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925424|NCT05265975|Immunologic Factors|immunologic factors|mesh-ancestor
91925425|NCT05265975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925426|NCT05265975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925427|NCT05265975|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91925428|NCT05265975|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91925429|NCT05265975|Growth Substances|growth substances|mesh-ancestor
91925430|NCT05265975|Growth Inhibitors|growth inhibitors|mesh-ancestor
91925432|NCT02151305|Propofol|propofol|mesh-list
91925433|NCT02151305|Sevoflurane|sevoflurane|mesh-list
91925434|NCT02151305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91925435|NCT02151305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925436|NCT02151305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925437|NCT02151305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91925438|NCT02151305|Anesthetics, General|anesthetics, general|mesh-ancestor
91925439|NCT02151305|Anesthetics|anesthetics|mesh-ancestor
91925440|NCT02151305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91925441|NCT02151305|Narcotics|narcotics|mesh-ancestor
91925442|NCT02151305|Analgesics|analgesics|mesh-ancestor
91925443|NCT02151305|Sensory System Agents|sensory system agents|mesh-ancestor
91925444|NCT02151305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925445|NCT02151305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91925446|NCT02151305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91925447|NCT03164421|Acetylcysteine|acetylcysteine|mesh-list
91925448|NCT03164421|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91925449|NCT03164421|Antiviral Agents|antiviral agents|mesh-ancestor
91925450|NCT03164421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925451|NCT03164421|Expectorants|expectorants|mesh-ancestor
91925452|NCT03164421|Respiratory System Agents|respiratory system agents|mesh-ancestor
91925453|NCT03164421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91925454|NCT03164421|Antioxidants|antioxidants|mesh-ancestor
91925455|NCT03164421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925456|NCT03164421|Protective Agents|protective agents|mesh-ancestor
91925457|NCT03164421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925458|NCT03164421|Antidotes|antidotes|mesh-ancestor
91925459|NCT05476952|Rocuronium|rocuronium|mesh-list
91925460|NCT05476952|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91925461|NCT05476952|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91925462|NCT05476952|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91925463|NCT05476952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925464|NCT05476952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925465|NCT05228613|Vaccines|vaccines|mesh-list
91925466|NCT05228613|Immunologic Factors|immunologic factors|mesh-ancestor
91925467|NCT05228613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925468|NCT02658812|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
91925469|NCT02658812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925470|NCT02658812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925471|NCT02628704|Dexamethasone|dexamethasone|mesh-list
91925472|NCT02628704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925473|NCT02628704|Antiemetics|antiemetics|mesh-ancestor
91925474|NCT02628704|Autonomic Agents|autonomic agents|mesh-ancestor
91925475|NCT02628704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925476|NCT02628704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925477|NCT02628704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925478|NCT02628704|Glucocorticoids|glucocorticoids|mesh-ancestor
91925479|NCT02628704|Hormones|hormones|mesh-ancestor
91925480|NCT02628704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925481|NCT02628704|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925482|NCT02628704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925483|NCT02152475|Curcumin|curcumin|mesh-list
91925484|NCT02152475|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91925485|NCT02152475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91925486|NCT02152475|Analgesics|analgesics|mesh-ancestor
91925487|NCT02152475|Sensory System Agents|sensory system agents|mesh-ancestor
91925488|NCT02152475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925489|NCT02152475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925490|NCT02152475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925491|NCT02152475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925492|NCT02152475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925493|NCT02152475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925494|NCT02152475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925495|NCT02152553|Hydrocortisone|hydrocortisone|mesh-list
91925496|NCT02152553|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91925497|NCT02152553|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925498|NCT03161457|Rituximab|rituximab|mesh-list
91925499|NCT03161457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925500|NCT03161457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925501|NCT03161457|Immunologic Factors|immunologic factors|mesh-ancestor
91925502|NCT03161457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925503|NCT03161457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925504|NCT02576912|Dronabinol|dronabinol|mesh-list
91925505|NCT02576912|Hallucinogens|hallucinogens|mesh-ancestor
91925506|NCT02576912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925507|NCT02576912|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91925508|NCT02576912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91925509|NCT02576912|Analgesics|analgesics|mesh-ancestor
91925510|NCT02576912|Sensory System Agents|sensory system agents|mesh-ancestor
91925511|NCT02576912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925512|NCT02576912|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91925513|NCT02576912|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91925514|NCT02576912|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925515|NCT02576912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925516|NCT02576912|Hormones|hormones|mesh-ancestor
91925517|NCT02576912|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925518|NCT02159573|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91925519|NCT02159573|Natalizumab|natalizumab|mesh-list
91925520|NCT02159573|Immunologic Factors|immunologic factors|mesh-ancestor
91925521|NCT02159573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925522|NCT02159573|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925523|NCT02159573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925524|NCT02152709|Vaccines|vaccines|mesh-list
91925525|NCT02152709|Immunologic Factors|immunologic factors|mesh-ancestor
91925526|NCT02152709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925527|NCT03164109|Moxifloxacin|moxifloxacin|mesh-list
91925528|NCT03164109|Avasopasem manganese|avasopasem manganese|mesh-list
91925529|NCT03164109|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925530|NCT03164109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925531|NCT03164109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91925532|NCT03164109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91925533|NCT03164109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925534|NCT03164109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925535|NCT03164109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925536|NCT03164109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925537|NCT03164109|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91925538|NCT03164109|Antioxidants|antioxidants|mesh-ancestor
91925541|NCT02152787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91925542|NCT02152787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925543|NCT02152787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925544|NCT02152787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91925545|NCT02152787|Anesthetics, General|anesthetics, general|mesh-ancestor
91925546|NCT02152787|Anesthetics|anesthetics|mesh-ancestor
91925547|NCT00154375|Imatinib Mesylate|imatinib mesylate|mesh-list
91925548|NCT00154375|Hydroxyurea|hydroxyurea|mesh-list
91925549|NCT00154375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925550|NCT00154375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925551|NCT00154375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925552|NCT00154375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925553|NCT00154375|Antisickling Agents|antisickling agents|mesh-ancestor
91925554|NCT00154375|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91925555|NCT02765399|Liraglutide|liraglutide|mesh-list
91925556|NCT02765399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91925557|NCT02765399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925558|NCT02765399|Incretins|incretins|mesh-ancestor
91925559|NCT02765399|Hormones|hormones|mesh-ancestor
91925560|NCT02765399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925561|NCT03970304|Vaccines|vaccines|mesh-list
91925562|NCT03970304|Immunologic Factors|immunologic factors|mesh-ancestor
91925563|NCT03970304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925564|NCT01037179|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
91925565|NCT01037179|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91925566|NCT01037179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91925567|NCT01037179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91925568|NCT01037179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91925569|NCT01037179|Analgesics|analgesics|mesh-ancestor
91925570|NCT01037179|Sensory System Agents|sensory system agents|mesh-ancestor
91925571|NCT01037179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925572|NCT01037179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925573|NCT01037179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925574|NCT01037179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925575|NCT01037179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91925576|NCT01037179|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91925577|NCT01037179|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91925578|NCT01037179|Histamine Antagonists|histamine antagonists|mesh-ancestor
91925579|NCT01037179|Histamine Agents|histamine agents|mesh-ancestor
91925580|NCT01037179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925581|NCT01037179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925583|NCT02269969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925584|NCT02269969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925585|NCT03555578|Leuprolide|leuprolide|mesh-list
91925586|NCT03555578|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91925587|NCT03555578|Fertility Agents|fertility agents|mesh-ancestor
91925588|NCT03555578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925589|NCT03555578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925590|NCT03555578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925591|NCT03555578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925592|NCT03232424|Temozolomide|temozolomide|mesh-list
91925593|NCT03232424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91925594|NCT03232424|Alkylating Agents|alkylating agents|mesh-ancestor
91925595|NCT03232424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925596|NCT03232424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925597|NCT02484404|Durvalumab|durvalumab|mesh-list
91925598|NCT02484404|Olaparib|olaparib|mesh-list
91925599|NCT02484404|Cediranib|cediranib|mesh-list
91925600|NCT02484404|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925601|NCT02484404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925602|NCT02484404|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91925603|NCT02484404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925604|NCT02484404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925605|NCT02484404|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925606|NCT03163407|Norepinephrine|norepinephrine|mesh-list
91925607|NCT03163407|Ephedrine|ephedrine|mesh-list
91925608|NCT03163407|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91925609|NCT03163407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91925610|NCT03163407|Adrenergic Agents|adrenergic agents|mesh-ancestor
91925611|NCT03163407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925612|NCT03163407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925613|NCT03163407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925614|NCT03163407|Sympathomimetics|sympathomimetics|mesh-ancestor
91925615|NCT03163407|Autonomic Agents|autonomic agents|mesh-ancestor
91925616|NCT03163407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925617|NCT03163407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91925618|NCT03163407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91925619|NCT02547974|Vaccines|vaccines|mesh-list
91925620|NCT02547974|Immunologic Factors|immunologic factors|mesh-ancestor
91925621|NCT02547974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925622|NCT00154297|Everolimus|everolimus|mesh-list
91925623|NCT00154297|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91925624|NCT00154297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925625|NCT00154297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925626|NCT00154297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925627|NCT00154297|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925628|NCT00154297|Immunologic Factors|immunologic factors|mesh-ancestor
91925629|NCT00154297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925630|NCT00154297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925631|NCT02270281|Dexmedetomidine|dexmedetomidine|mesh-list
91925632|NCT02270281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91925633|NCT02270281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925634|NCT02270281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925635|NCT02270281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91925636|NCT02270281|Analgesics|analgesics|mesh-ancestor
91925637|NCT02270281|Sensory System Agents|sensory system agents|mesh-ancestor
91925638|NCT02270281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925639|NCT02270281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91925640|NCT02270281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91925641|NCT02270281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91925642|NCT02270281|Adrenergic Agents|adrenergic agents|mesh-ancestor
91925643|NCT02270281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925644|NCT02270281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925645|NCT01033123|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
91925647|NCT01033123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925648|NCT01033123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925649|NCT01033123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925650|NCT03163173|Avasopasem manganese|avasopasem manganese|mesh-list
91925651|NCT03163173|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91925652|NCT03163173|Antioxidants|antioxidants|mesh-ancestor
91925653|NCT03163173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925654|NCT03163173|Protective Agents|protective agents|mesh-ancestor
91925655|NCT03163173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925656|NCT01323205|Antipsychotic Agents|antipsychotic agents|mesh-list
91925657|NCT01323205|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91925658|NCT01323205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925659|NCT01323205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925660|NCT01323205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91925661|NCT03162861|Anesthetics|anesthetics|mesh-list
91925663|NCT03162861|Sevoflurane|sevoflurane|mesh-list
91925664|NCT03162861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925665|NCT03162861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925666|NCT03162861|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91925667|NCT03162861|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91925668|NCT03162861|Anesthetics, General|anesthetics, general|mesh-ancestor
91925669|NCT03162861|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91925670|NCT03162861|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91925672|NCT04506554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925673|NCT04506554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925674|NCT04506554|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91925675|NCT04506554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925676|NCT02765165|Lomustine|lomustine|mesh-list
91925677|NCT02765165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91925678|NCT02765165|Alkylating Agents|alkylating agents|mesh-ancestor
91925679|NCT02765165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925680|NCT02765165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925681|NCT02156843|Pyridoxamine|pyridoxamine|mesh-list
91925682|NCT02156843|Vitamin B Complex|vitamin b complex|mesh-ancestor
91925683|NCT02156843|Vitamins|vitamins|mesh-ancestor
91925684|NCT02156843|Micronutrients|micronutrients|mesh-ancestor
91925685|NCT02156843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925686|NCT02675907|Meloxicam|meloxicam|mesh-list
91925687|NCT02675907|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91925688|NCT02675907|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91925689|NCT02675907|Analgesics|analgesics|mesh-ancestor
91925690|NCT02675907|Sensory System Agents|sensory system agents|mesh-ancestor
91925691|NCT02675907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925692|NCT02675907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925693|NCT02675907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925694|NCT02675907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91925695|NCT02675907|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91925696|NCT02675907|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91925697|NCT02675907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925698|NCT02675907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925699|NCT02152865|Lupeol|lupeol|mesh-list
91925700|NCT02152865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91925701|NCT02152943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91925702|NCT02152943|Trastuzumab|trastuzumab|mesh-list
91925703|NCT02152943|Everolimus|everolimus|mesh-list
91925704|NCT02152943|Letrozole|letrozole|mesh-list
91925705|NCT02152943|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
91925706|NCT02152943|Antibodies|antibodies|mesh-list
91925707|NCT02152943|Immunoglobulins|immunoglobulins|mesh-list
91925708|NCT02152943|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91925709|NCT02152943|Immunologic Factors|immunologic factors|mesh-ancestor
91925710|NCT02152943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925711|NCT02152943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925712|NCT02152943|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91925713|NCT02152943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925714|NCT02152943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925715|NCT02152943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925716|NCT02152943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925717|NCT02152943|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91925718|NCT02152943|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91925719|NCT02152943|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91925720|NCT02152943|Hormone Antagonists|hormone antagonists|mesh-ancestor
91925721|NCT02152943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91925723|NCT02156999|Ibandronic Acid|ibandronic acid|mesh-list
91925724|NCT02156999|Vitamins|vitamins|mesh-ancestor
91925725|NCT02156999|Micronutrients|micronutrients|mesh-ancestor
91925726|NCT02156999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925727|NCT02156999|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91925728|NCT05014581|Norepinephrine|norepinephrine|mesh-list
91925729|NCT05014581|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91925730|NCT05014581|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91925731|NCT05014581|Adrenergic Agents|adrenergic agents|mesh-ancestor
91925732|NCT05014581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925733|NCT05014581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925734|NCT05014581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925736|NCT05014581|Autonomic Agents|autonomic agents|mesh-ancestor
91925737|NCT05014581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925738|NCT05014581|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91925739|NCT02159651|Tacrolimus|tacrolimus|mesh-list
91925740|NCT02159651|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91925741|NCT02159651|Immunologic Factors|immunologic factors|mesh-ancestor
91925742|NCT02159651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925743|NCT02159651|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91925744|NCT02159651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925745|NCT02159651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925746|NCT02774681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91925747|NCT02774681|Trastuzumab|trastuzumab|mesh-list
91925748|NCT02774681|Palbociclib|palbociclib|mesh-list
91925749|NCT02774681|Antibodies|antibodies|mesh-list
91925750|NCT02774681|Immunoglobulins|immunoglobulins|mesh-list
91925751|NCT02774681|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91925752|NCT02774681|Immunologic Factors|immunologic factors|mesh-ancestor
91925753|NCT02774681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925754|NCT02774681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925755|NCT02774681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91925756|NCT02774681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925757|NCT02774681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925758|NCT02157311|Tenofovir|tenofovir|mesh-list
91925759|NCT02157311|Lamivudine|lamivudine|mesh-list
91925760|NCT02157311|Emtricitabine|emtricitabine|mesh-list
91925761|NCT02157311|Efavirenz|efavirenz|mesh-list
91925762|NCT02157311|Lopinavir|lopinavir|mesh-list
91925763|NCT02157311|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91925764|NCT02157311|Darunavir|darunavir|mesh-list
91925765|NCT02157311|Abacavir|abacavir|mesh-list
91925766|NCT02157311|Rilpivirine|rilpivirine|mesh-list
91925767|NCT02157311|Etravirine|etravirine|mesh-list
91925768|NCT02157311|Antiviral Agents|antiviral agents|mesh-ancestor
91925769|NCT02157311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925770|NCT02157311|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91925771|NCT02157311|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91925773|NCT02157311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925774|NCT02157311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91925775|NCT02157311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91925776|NCT02157311|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91943269|NCT03004287|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91925777|NCT02157311|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91925778|NCT02157311|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91925779|NCT02157311|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91925780|NCT02157311|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91925781|NCT02157311|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91925782|NCT02157311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91925783|NCT02157311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91925784|NCT02157311|Protease Inhibitors|protease inhibitors|mesh-ancestor
91925785|NCT02157311|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91925786|NCT04784039|Fibrin fragment D|fibrin fragment d|mesh-list
91925787|NCT04784039|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91925788|NCT04784039|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91925789|NCT04784039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925790|NCT04784039|Hemostatics|hemostatics|mesh-ancestor
91925791|NCT04784039|Coagulants|coagulants|mesh-ancestor
91925792|NCT02157467|Moxifloxacin|moxifloxacin|mesh-list
91925794|NCT02157467|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91925795|NCT02157467|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925796|NCT02157467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925797|NCT02157467|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91925798|NCT02157467|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91925799|NCT02157467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925800|NCT02157467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925801|NCT02157467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925802|NCT02157467|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91925803|NCT02157467|Contraceptive Agents|contraceptive agents|mesh-ancestor
91925804|NCT02157467|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925805|NCT02157467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925806|NCT02157467|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91925807|NCT02157467|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91925808|NCT02157467|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91925809|NCT02157467|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91925810|NCT02157467|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91925811|NCT02157467|Antiviral Agents|antiviral agents|mesh-ancestor
91925812|NCT01374087|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91925813|NCT01374087|Luteolytic Agents|luteolytic agents|mesh-ancestor
91925814|NCT01374087|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91925815|NCT01374087|Contraceptive Agents|contraceptive agents|mesh-ancestor
91925816|NCT01374087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925817|NCT01374087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925818|NCT01374087|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91925819|NCT01374087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91925820|NCT01374087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925821|NCT00152971|Enoxaparin|enoxaparin|mesh-list
91925822|NCT00152971|Dabigatran|dabigatran|mesh-list
91925823|NCT00152971|Anticoagulants|anticoagulants|mesh-ancestor
91925824|NCT00152971|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91925825|NCT00152971|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91925826|NCT00152971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925827|NCT00152971|Antithrombins|antithrombins|mesh-ancestor
91925828|NCT00152971|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91925829|NCT00152971|Protease Inhibitors|protease inhibitors|mesh-ancestor
91925830|NCT00152971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925831|NCT02538614|Idelalisib|idelalisib|mesh-list
91925832|NCT02538614|BI 836826|bi 836826|mesh-list
91925833|NCT02538614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925834|NCT02538614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925835|NCT02538614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925836|NCT02538614|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91925837|NCT03504644|Vincristine|vincristine|mesh-list
91925838|NCT03504644|Venetoclax|venetoclax|mesh-list
91925839|NCT03504644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91925840|NCT03504644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925841|NCT03504644|Tubulin Modulators|tubulin modulators|mesh-ancestor
91925842|NCT03504644|Antimitotic Agents|antimitotic agents|mesh-ancestor
91925843|NCT03504644|Mitosis Modulators|mitosis modulators|mesh-ancestor
91925844|NCT03504644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925845|NCT04620135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91925851|NCT02160275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925852|NCT02160275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925853|NCT03126968|Epinephrine|epinephrine|mesh-list
91925854|NCT03126968|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91925855|NCT03126968|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91925856|NCT03126968|Adrenergic Agents|adrenergic agents|mesh-ancestor
91925857|NCT03126968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925858|NCT03126968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925859|NCT03126968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925860|NCT03126968|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91925861|NCT03126968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91925862|NCT03126968|Autonomic Agents|autonomic agents|mesh-ancestor
91925863|NCT03126968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925864|NCT03126968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91925865|NCT03126968|Respiratory System Agents|respiratory system agents|mesh-ancestor
91925866|NCT03126968|Mydriatics|mydriatics|mesh-ancestor
91925867|NCT03126968|Sympathomimetics|sympathomimetics|mesh-ancestor
91925868|NCT03126968|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91925870|NCT02266849|Antidiarrheals|antidiarrheals|mesh-list
91925871|NCT02266849|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91925872|NCT01309945|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91925873|NCT01309945|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91925874|NCT01309945|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91925875|NCT01309945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925876|NCT01309945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925877|NCT01309945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925878|NCT01309945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925879|NCT01309945|Analgesics|analgesics|mesh-ancestor
91925880|NCT01309945|Sensory System Agents|sensory system agents|mesh-ancestor
91925881|NCT01309945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925882|NCT01309945|Antidepressive Agents|antidepressive agents|mesh-ancestor
91925883|NCT01309945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91925884|NCT01309945|Dopamine Agents|dopamine agents|mesh-ancestor
91925885|NCT02153567|Escitalopram|escitalopram|mesh-list
91925886|NCT02153567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91925887|NCT02153567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91925888|NCT02153567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925889|NCT02153567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925890|NCT02153567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91925891|NCT02153567|Serotonin Agents|serotonin agents|mesh-ancestor
91925892|NCT02153567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925894|NCT02441660|Antipruritics|antipruritics|mesh-ancestor
91925895|NCT02441660|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925896|NCT02441660|Sensory System Agents|sensory system agents|mesh-ancestor
91925897|NCT02441660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925898|NCT02441660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925900|NCT01303783|Candesartan cilexetil|candesartan cilexetil|mesh-list
91925901|NCT01303783|Nifedipine|nifedipine|mesh-list
91925902|NCT01303783|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91925903|NCT01303783|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91925904|NCT01303783|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91925905|NCT01303783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925906|NCT01303783|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91925907|NCT01303783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925908|NCT01303783|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91925909|NCT01303783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925910|NCT01303783|Vasodilator Agents|vasodilator agents|mesh-ancestor
91925911|NCT01303783|Tocolytic Agents|tocolytic agents|mesh-ancestor
91925912|NCT01303783|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925913|NCT02160587|Chlorhexidine|chlorhexidine|mesh-list
91925914|NCT02160587|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91925915|NCT02160587|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91925916|NCT02160587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925917|NCT02160587|Disinfectants|disinfectants|mesh-ancestor
91925918|NCT02160587|Dermatologic Agents|dermatologic agents|mesh-ancestor
91925919|NCT02153879|Niacin|niacin|mesh-list
91925920|NCT02153879|Fenofibrate|fenofibrate|mesh-list
91925921|NCT02153879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91925923|NCT02153879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925924|NCT02153879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91925926|NCT02153879|Vitamin B Complex|vitamin b complex|mesh-ancestor
91925928|NCT02153879|Micronutrients|micronutrients|mesh-ancestor
91925929|NCT02153879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925931|NCT01373931|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91925932|NCT01373931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91925933|NCT01373931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91925934|NCT01373931|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91925935|NCT01373931|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91925936|NCT01373931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925937|NCT01373931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925938|NCT01373931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925939|NCT01373931|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91925940|NCT01373931|Contraceptive Agents|contraceptive agents|mesh-ancestor
91925941|NCT01373931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925942|NCT01373931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925943|NCT01373931|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91925944|NCT01373931|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91925945|NCT01373931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91925946|NCT02160743|Metformin|metformin|mesh-list
91925947|NCT02160743|Atorvastatin|atorvastatin|mesh-list
91925948|NCT02160743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91925949|NCT02160743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925950|NCT02160743|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91925951|NCT02160743|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91925952|NCT02160743|Antimetabolites|antimetabolites|mesh-ancestor
91925953|NCT02160743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925954|NCT02160743|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91925955|NCT02160743|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91925956|NCT02160743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91925957|NCT02158013|Diltiazem|diltiazem|mesh-list
91925958|NCT02158013|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91925959|NCT02158013|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91925960|NCT02158013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91925961|NCT02158013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925962|NCT02158013|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91925963|NCT02158013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925964|NCT02158013|Vasodilator Agents|vasodilator agents|mesh-ancestor
91925965|NCT01023295|Fosbretabulin|fosbretabulin|mesh-list
91925966|NCT01023295|Combretastatin|combretastatin|mesh-list
91925967|NCT01023295|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91925968|NCT01023295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91925969|NCT01023295|Tubulin Modulators|tubulin modulators|mesh-ancestor
91925970|NCT01023295|Antimitotic Agents|antimitotic agents|mesh-ancestor
91925971|NCT01023295|Mitosis Modulators|mitosis modulators|mesh-ancestor
91925972|NCT01023295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91925973|NCT05468138|Antibodies|antibodies|mesh-list
91925974|NCT05468138|Immunologic Factors|immunologic factors|mesh-ancestor
91925975|NCT05468138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925976|NCT01140217|Norethindrone|norethindrone|mesh-list
91925977|NCT01140217|Norethindrone Acetate|norethindrone acetate|mesh-list
91925978|NCT01140217|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91925979|NCT01140217|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91925980|NCT01140217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91925981|NCT01140217|Contraceptive Agents|contraceptive agents|mesh-ancestor
91925982|NCT01140217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91925983|NCT01140217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925984|NCT01140217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91925985|NCT01140217|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91925986|NCT01297543|Lenograstim|lenograstim|mesh-list
91925987|NCT01297543|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91925988|NCT01297543|Immunologic Factors|immunologic factors|mesh-ancestor
91925989|NCT01297543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925990|NCT03541265|Bupivacaine|bupivacaine|mesh-list
91925991|NCT03541265|Anesthetics, Local|anesthetics, local|mesh-ancestor
91925992|NCT03541265|Anesthetics|anesthetics|mesh-ancestor
91925993|NCT03541265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91925994|NCT03541265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91925996|NCT03541265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91925997|NCT02547038|Amoxicillin|amoxicillin|mesh-list
91925998|NCT02547038|Metronidazole|metronidazole|mesh-list
91925999|NCT02547038|Clarithromycin|clarithromycin|mesh-list
91926000|NCT02547038|Tetracycline|tetracycline|mesh-list
91926001|NCT02547038|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
91926002|NCT02547038|Pantoprazole|pantoprazole|mesh-list
91926003|NCT02547038|Bismuth|bismuth|mesh-list
91926004|NCT02547038|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926005|NCT02547038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926008|NCT02547038|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91926009|NCT02547038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926010|NCT02547038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926011|NCT02547038|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91926012|NCT02547038|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91926013|NCT02547038|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91926014|NCT02547038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926015|NCT02547038|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91926016|NCT02547038|Antacids|antacids|mesh-ancestor
91926017|NCT02161055|Insulin|insulin|mesh-list
91926018|NCT02161055|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91926019|NCT02161055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91926020|NCT02161055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926021|NCT02764697|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91926022|NCT02764697|Hormones|hormones|mesh-ancestor
91926023|NCT02764697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926024|NCT02764697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926025|NCT02266927|Fluticasone|fluticasone|mesh-list
91926026|NCT02266927|Xhance|xhance|mesh-list
91926027|NCT02266927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926028|NCT02266927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91926029|NCT02266927|Autonomic Agents|autonomic agents|mesh-ancestor
91926030|NCT02266927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926031|NCT02266927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926032|NCT02266927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91926033|NCT02266927|Respiratory System Agents|respiratory system agents|mesh-ancestor
91926034|NCT02266927|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926035|NCT02266927|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91926036|NCT02158481|Carotenoids|carotenoids|mesh-list
91926037|NCT02158481|Antioxidants|antioxidants|mesh-ancestor
91926038|NCT02158481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926039|NCT02158481|Protective Agents|protective agents|mesh-ancestor
91926040|NCT02158481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926041|NCT05445362|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91926042|NCT05445362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926043|NCT01020565|Entecavir|entecavir|mesh-list
91926044|NCT01020565|Antiviral Agents|antiviral agents|mesh-ancestor
91926045|NCT01020565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926046|NCT01020097|Fluorides|fluorides|mesh-list
91926047|NCT01020097|Cariostatic Agents|cariostatic agents|mesh-ancestor
91926048|NCT01020097|Protective Agents|protective agents|mesh-ancestor
91926049|NCT01020097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926050|NCT02154269|Lenograstim|lenograstim|mesh-list
91926051|NCT02154269|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91926052|NCT02154269|Immunologic Factors|immunologic factors|mesh-ancestor
91926053|NCT02154269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926054|NCT04914741|Prednisolone|prednisolone|mesh-list
91926055|NCT04914741|Cyclophosphamide|cyclophosphamide|mesh-list
91926056|NCT04914741|Rituximab|rituximab|mesh-list
91926057|NCT04914741|Doxorubicin|doxorubicin|mesh-list
91926058|NCT04914741|Vincristine|vincristine|mesh-list
91926059|NCT04914741|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
91926060|NCT04914741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91926061|NCT04914741|Immunologic Factors|immunologic factors|mesh-ancestor
91926062|NCT04914741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926063|NCT04914741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926064|NCT04914741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91926065|NCT04914741|Alkylating Agents|alkylating agents|mesh-ancestor
91926066|NCT04914741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926067|NCT04914741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926068|NCT04914741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91926069|NCT04914741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926070|NCT04914741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91926071|NCT04914741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91926072|NCT04914741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926073|NCT04914741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926074|NCT04914741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91926075|NCT04914741|Tubulin Modulators|tubulin modulators|mesh-ancestor
91926076|NCT04914741|Antimitotic Agents|antimitotic agents|mesh-ancestor
91926077|NCT04914741|Mitosis Modulators|mitosis modulators|mesh-ancestor
91926078|NCT04914741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926079|NCT04914741|Glucocorticoids|glucocorticoids|mesh-ancestor
91926080|NCT04914741|Hormones|hormones|mesh-ancestor
91926081|NCT04914741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926082|NCT04914741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926083|NCT04914741|Immunoconjugates|immunoconjugates|mesh-ancestor
91926086|NCT03738683|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91926087|NCT03738683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926088|NCT03738683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926089|NCT03738683|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91926090|NCT03738683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926091|NCT03738683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926092|NCT04475887|Iron|iron|mesh-list
91926093|NCT04475887|Trace Elements|trace elements|mesh-ancestor
91926094|NCT04475887|Micronutrients|micronutrients|mesh-ancestor
91926095|NCT04475887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926096|NCT02267239|Chlorhexidine|chlorhexidine|mesh-list
91926097|NCT02267239|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91926098|NCT02267239|Listerine|listerine|mesh-list
91926099|NCT02267239|Hexetidine|hexetidine|mesh-list
91926100|NCT02267239|Menthol|menthol|mesh-list
91926101|NCT02267239|Sodium Fluoride|sodium fluoride|mesh-list
91926102|NCT02267239|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91926103|NCT02267239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926104|NCT02267239|Disinfectants|disinfectants|mesh-ancestor
91926105|NCT02267239|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926106|NCT02267239|Cariostatic Agents|cariostatic agents|mesh-ancestor
91926107|NCT02267239|Protective Agents|protective agents|mesh-ancestor
91926108|NCT02267239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926109|NCT02267239|Antipruritics|antipruritics|mesh-ancestor
91926110|NCT02267239|Antifungal Agents|antifungal agents|mesh-ancestor
91926111|NCT02766023|Metronidazole|metronidazole|mesh-list
91926112|NCT02766023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926113|NCT02766023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926114|NCT02766023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91926115|NCT02766023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91926116|NCT05466500|Dexamethasone|dexamethasone|mesh-list
91926117|NCT05466500|Dexamethasone acetate|dexamethasone acetate|mesh-list
91926118|NCT05466500|Bupivacaine|bupivacaine|mesh-list
91926119|NCT05466500|BB 1101|bb 1101|mesh-list
91926120|NCT05466500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926121|NCT05466500|Antiemetics|antiemetics|mesh-ancestor
91926122|NCT05466500|Autonomic Agents|autonomic agents|mesh-ancestor
91926123|NCT05466500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926124|NCT05466500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926125|NCT05466500|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926126|NCT05466500|Glucocorticoids|glucocorticoids|mesh-ancestor
91926127|NCT05466500|Hormones|hormones|mesh-ancestor
91926128|NCT05466500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926129|NCT05466500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926130|NCT05466500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926131|NCT05466500|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926132|NCT05466500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926133|NCT05466500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926134|NCT05466500|Anesthetics, Local|anesthetics, local|mesh-ancestor
91926135|NCT05466500|Anesthetics|anesthetics|mesh-ancestor
91926136|NCT05466500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926137|NCT05466500|Sensory System Agents|sensory system agents|mesh-ancestor
91926138|NCT04475107|Artesunate|artesunate|mesh-list
91926139|NCT04475107|Pyronaridine|pyronaridine|mesh-list
91926140|NCT04475107|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
91926141|NCT04475107|Antimalarials|antimalarials|mesh-ancestor
91926142|NCT04475107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91926143|NCT04475107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91926144|NCT04475107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926145|NCT04475107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926147|NCT04475107|Schistosomicides|schistosomicides|mesh-ancestor
91926148|NCT04475107|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91926149|NCT04475107|Anthelmintics|anthelmintics|mesh-ancestor
91926150|NCT02254967|Vancomycin|vancomycin|mesh-list
91926152|NCT02254967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926153|NCT02254967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926154|NCT05444036|Ketamine|ketamine|mesh-list
91926155|NCT05444036|Analgesics|analgesics|mesh-ancestor
91926156|NCT05444036|Sensory System Agents|sensory system agents|mesh-ancestor
91926157|NCT05444036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926158|NCT05444036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926159|NCT05444036|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91926160|NCT05444036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91926161|NCT05444036|Anesthetics, General|anesthetics, general|mesh-ancestor
91926162|NCT05444036|Anesthetics|anesthetics|mesh-ancestor
91926163|NCT05444036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926164|NCT05444036|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91926165|NCT05444036|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91926166|NCT05444036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926167|NCT05444036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926168|NCT03923959|Tranexamic Acid|tranexamic acid|mesh-list
91926169|NCT03923959|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91926170|NCT03923959|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91926171|NCT03923959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926172|NCT03923959|Hemostatics|hemostatics|mesh-ancestor
91926173|NCT03923959|Coagulants|coagulants|mesh-ancestor
91926174|NCT02161367|Simethicone|simethicone|mesh-list
91926175|NCT02161367|Antifoaming Agents|antifoaming agents|mesh-ancestor
91926176|NCT02161367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926177|NCT02161367|Emollients|emollients|mesh-ancestor
91926178|NCT02161367|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926179|NCT03542825|Iron|iron|mesh-list
91926180|NCT03542825|Lactoferrin|lactoferrin|mesh-list
91926181|NCT03542825|Iron Chelating Agents|iron chelating agents|mesh-list
91926182|NCT03542825|Trace Elements|trace elements|mesh-ancestor
91926183|NCT03542825|Micronutrients|micronutrients|mesh-ancestor
91926184|NCT03542825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926185|NCT03542825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926187|NCT03542825|Sequestering Agents|sequestering agents|mesh-ancestor
91926188|NCT03542825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926189|NCT01001923|Fasinumab|fasinumab|mesh-list
91926190|NCT01001923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926191|NCT01001923|Analgesics|analgesics|mesh-ancestor
91926192|NCT01001923|Sensory System Agents|sensory system agents|mesh-ancestor
91926193|NCT01001923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926194|NCT01001923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926195|NCT02154503|Minoxidil|minoxidil|mesh-list
91926196|NCT02154503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91926197|NCT02154503|Vasodilator Agents|vasodilator agents|mesh-ancestor
91926198|NCT02536976|Mirabegron|mirabegron|mesh-list
91926199|NCT02536976|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91926200|NCT02536976|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91926201|NCT02536976|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91926202|NCT02536976|Adrenergic Agents|adrenergic agents|mesh-ancestor
91926203|NCT02536976|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926204|NCT02536976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926205|NCT02536976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926206|NCT02536976|Urological Agents|urological agents|mesh-ancestor
91926207|NCT04310397|Trametinib|trametinib|mesh-list
91926208|NCT04310397|Dabrafenib|dabrafenib|mesh-list
91926209|NCT04310397|Spartalizumab|spartalizumab|mesh-list
91926210|NCT04310397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926211|NCT04310397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91926212|NCT04310397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926213|NCT04310397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926214|NCT04310397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91926215|NCT04310397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926216|NCT05526703|Antihypertensive Agents|antihypertensive agents|mesh-list
91926217|NCT00992563|Ranibizumab|ranibizumab|mesh-list
91926218|NCT00992563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91926219|NCT00992563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91926220|NCT00992563|Growth Substances|growth substances|mesh-ancestor
91926221|NCT00992563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926222|NCT00992563|Growth Inhibitors|growth inhibitors|mesh-ancestor
91926223|NCT00992563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926224|NCT02267707|Paclitaxel|paclitaxel|mesh-list
91926225|NCT02267707|Gemcitabine|gemcitabine|mesh-list
91926226|NCT02267707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91926227|NCT02267707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926228|NCT02267707|Tubulin Modulators|tubulin modulators|mesh-ancestor
91926229|NCT02267707|Antimitotic Agents|antimitotic agents|mesh-ancestor
91926230|NCT02267707|Mitosis Modulators|mitosis modulators|mesh-ancestor
91926231|NCT02267707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926232|NCT02267707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926233|NCT02267707|Antimetabolites|antimetabolites|mesh-ancestor
91926234|NCT01373229|Plerixafor|plerixafor|mesh-list
91926235|NCT01373229|Rituximab|rituximab|mesh-list
91926236|NCT01373229|Lenalidomide|lenalidomide|mesh-list
91926237|NCT01373229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926238|NCT01373229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926239|NCT01373229|Immunologic Factors|immunologic factors|mesh-ancestor
91926240|NCT01373229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926241|NCT01373229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926242|NCT01373229|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91926319|NCT02535416|Promethazine|promethazine|mesh-list
91926243|NCT01373229|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91926244|NCT01373229|Growth Substances|growth substances|mesh-ancestor
91926245|NCT01373229|Growth Inhibitors|growth inhibitors|mesh-ancestor
91926246|NCT01373229|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91926247|NCT01373229|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91926248|NCT01373229|Antiviral Agents|antiviral agents|mesh-ancestor
91926249|NCT01373229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926250|NCT02671461|Aspirin|aspirin|mesh-list
91926251|NCT02671461|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91926252|NCT02671461|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926253|NCT02671461|Analgesics|analgesics|mesh-ancestor
91926254|NCT02671461|Sensory System Agents|sensory system agents|mesh-ancestor
91926255|NCT02671461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926256|NCT02671461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926257|NCT02671461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926258|NCT02671461|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926259|NCT02671461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91926260|NCT02671461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91926261|NCT02671461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926262|NCT02671461|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91926263|NCT02671461|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91926264|NCT02671461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926265|NCT02671461|Antipyretics|antipyretics|mesh-ancestor
91926266|NCT05467033|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
91926267|NCT05467033|Hemostatics|hemostatics|mesh-ancestor
91926268|NCT05467033|Coagulants|coagulants|mesh-ancestor
91926269|NCT05467033|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
91926270|NCT05467033|Natriuretic Agents|natriuretic agents|mesh-ancestor
91926271|NCT05467033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926272|NCT04196283|Paclitaxel|paclitaxel|mesh-list
91926273|NCT04196283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91926274|NCT04196283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926275|NCT04196283|Tubulin Modulators|tubulin modulators|mesh-ancestor
91926276|NCT04196283|Antimitotic Agents|antimitotic agents|mesh-ancestor
91926277|NCT04196283|Mitosis Modulators|mitosis modulators|mesh-ancestor
91926278|NCT04196283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926279|NCT02268019|Epinephrine|epinephrine|mesh-list
91926280|NCT02268019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91926281|NCT02268019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91926282|NCT02268019|Adrenergic Agents|adrenergic agents|mesh-ancestor
91926283|NCT02268019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926284|NCT02268019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926285|NCT02268019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926286|NCT02268019|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91926287|NCT02268019|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91926288|NCT02268019|Autonomic Agents|autonomic agents|mesh-ancestor
91926289|NCT02268019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926290|NCT02268019|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91926291|NCT02268019|Respiratory System Agents|respiratory system agents|mesh-ancestor
91926292|NCT02268019|Mydriatics|mydriatics|mesh-ancestor
91926293|NCT02268019|Sympathomimetics|sympathomimetics|mesh-ancestor
91926294|NCT02268019|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91926295|NCT03114111|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91926296|NCT03114111|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91926297|NCT03114111|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926298|NCT01110889|Agomelatine|agomelatine|mesh-list
91926299|NCT01110889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91926300|NCT01110889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926301|NCT01110889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926303|NCT01106989|Tetracaine|tetracaine|mesh-list
91926304|NCT01106989|Anesthetics, Local|anesthetics, local|mesh-ancestor
91926305|NCT01106989|Anesthetics|anesthetics|mesh-ancestor
91926306|NCT01106989|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926307|NCT01106989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926308|NCT01106989|Sensory System Agents|sensory system agents|mesh-ancestor
91926309|NCT01106989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926310|NCT01106989|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91926311|NCT01106989|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91926312|NCT01106989|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91926313|NCT01106989|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926314|NCT01106989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926315|NCT00975091|Entecavir|entecavir|mesh-list
91926316|NCT00975091|Antiviral Agents|antiviral agents|mesh-ancestor
91926317|NCT00975091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926318|NCT02535416|Diphenhydramine|diphenhydramine|mesh-list
91926321|NCT02535416|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91926322|NCT02535416|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91926323|NCT02535416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926324|NCT02535416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926325|NCT02535416|Anesthetics, Local|anesthetics, local|mesh-ancestor
91926326|NCT02535416|Anesthetics|anesthetics|mesh-ancestor
91926327|NCT02535416|Sensory System Agents|sensory system agents|mesh-ancestor
91926328|NCT02535416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926329|NCT02535416|Antiemetics|antiemetics|mesh-ancestor
91926330|NCT02535416|Autonomic Agents|autonomic agents|mesh-ancestor
91926331|NCT02535416|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926332|NCT02535416|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91926333|NCT02535416|Histamine Antagonists|histamine antagonists|mesh-ancestor
91926334|NCT02535416|Histamine Agents|histamine agents|mesh-ancestor
91926335|NCT02535416|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926336|NCT02535416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926337|NCT02535416|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91926339|NCT02535416|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926340|NCT02535416|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91926341|NCT00911443|Interferons|interferons|mesh-list
91926342|NCT00911443|Interferon-alpha|interferon-alpha|mesh-list
91926343|NCT00911443|Interferon alpha-2|interferon alpha-2|mesh-list
91926344|NCT00911443|Dacarbazine|dacarbazine|mesh-list
91926345|NCT00911443|Thymalfasin|thymalfasin|mesh-list
91926346|NCT00911443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926347|NCT00911443|Antiviral Agents|antiviral agents|mesh-ancestor
91926348|NCT00911443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926349|NCT00911443|Immunologic Factors|immunologic factors|mesh-ancestor
91926350|NCT00911443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926351|NCT00911443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91926352|NCT00911443|Alkylating Agents|alkylating agents|mesh-ancestor
91926353|NCT00911443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926354|NCT00911443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91926355|NCT03949478|Ibuprofen|ibuprofen|mesh-list
91926356|NCT03949478|Nifedipine|nifedipine|mesh-list
91926357|NCT03949478|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91926358|NCT03949478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926359|NCT03949478|Analgesics|analgesics|mesh-ancestor
91926360|NCT03949478|Sensory System Agents|sensory system agents|mesh-ancestor
91926361|NCT03949478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926362|NCT03949478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926363|NCT03949478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926364|NCT03949478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926365|NCT03949478|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91926366|NCT03949478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926367|NCT03949478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926368|NCT03949478|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91926369|NCT03949478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926370|NCT03949478|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91926371|NCT03949478|Vasodilator Agents|vasodilator agents|mesh-ancestor
91926372|NCT03949478|Tocolytic Agents|tocolytic agents|mesh-ancestor
91926373|NCT03949478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91926374|NCT00909649|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91926375|NCT00909649|Hemostatics|hemostatics|mesh-ancestor
91926376|NCT00909649|Coagulants|coagulants|mesh-ancestor
91926377|NCT00971035|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91926378|NCT00971035|Immunologic Factors|immunologic factors|mesh-ancestor
91926379|NCT00971035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926380|NCT04787965|Opicapone|opicapone|mesh-list
91926381|NCT04787965|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
91926382|NCT04787965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926383|NCT04787965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926384|NCT04787965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91926385|NCT04787965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91926386|NCT02670915|Insulin|insulin|mesh-list
91926387|NCT02670915|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91926388|NCT02670915|Insulin Aspart|insulin aspart|mesh-list
91926389|NCT02670915|Insulin, Long-Acting|insulin, long-acting|mesh-list
91926390|NCT02670915|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
91926391|NCT02670915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91926392|NCT02670915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926393|NCT02545868|Vaccines|vaccines|mesh-list
91926394|NCT02545868|Immunologic Factors|immunologic factors|mesh-ancestor
91926395|NCT02545868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926396|NCT00821977|Vildagliptin|vildagliptin|mesh-list
91926397|NCT00821977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91926398|NCT00821977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926399|NCT00821977|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91926400|NCT00821977|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926401|NCT00821977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926402|NCT00821977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926403|NCT04474327|Montelukast|montelukast|mesh-list
91926404|NCT04474327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91926405|NCT04474327|Respiratory System Agents|respiratory system agents|mesh-ancestor
91926406|NCT04474327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91926407|NCT04474327|Hormone Antagonists|hormone antagonists|mesh-ancestor
91926408|NCT04474327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926409|NCT04474327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926410|NCT04474327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91926411|NCT04474327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91926412|NCT04474327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926413|NCT04745949|Prednisone|prednisone|mesh-list
91926414|NCT04745949|Cortisone|cortisone|mesh-list
91926415|NCT04745949|Cyclophosphamide|cyclophosphamide|mesh-list
91926416|NCT04745949|Rituximab|rituximab|mesh-list
91926417|NCT04745949|Doxorubicin|doxorubicin|mesh-list
91926418|NCT04745949|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91926419|NCT04745949|Nivolumab|nivolumab|mesh-list
91926420|NCT04745949|Daunorubicin|daunorubicin|mesh-list
91926421|NCT04745949|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91926422|NCT04745949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91926423|NCT04745949|Antibodies|antibodies|mesh-list
91926424|NCT04745949|Immunoglobulins|immunoglobulins|mesh-list
91926425|NCT04745949|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91926426|NCT04745949|Immunoconjugates|immunoconjugates|mesh-list
91926427|NCT04745949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91926428|NCT04745949|Immunologic Factors|immunologic factors|mesh-ancestor
91926429|NCT04745949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926430|NCT04745949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926431|NCT04745949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91926432|NCT04745949|Alkylating Agents|alkylating agents|mesh-ancestor
91926433|NCT04745949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926434|NCT04745949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926435|NCT04745949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91926436|NCT04745949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91926437|NCT04745949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91926438|NCT04745949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926439|NCT04745949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926440|NCT04745949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926441|NCT04745949|Glucocorticoids|glucocorticoids|mesh-ancestor
91926442|NCT04745949|Hormones|hormones|mesh-ancestor
91926443|NCT04745949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926444|NCT04745949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926445|NCT04745949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91926446|NCT04745949|Immunotoxins|immunotoxins|mesh-ancestor
91926447|NCT00961675|Ciprofloxacin|ciprofloxacin|mesh-list
91926448|NCT00961675|Povidone-Iodine|povidone-iodine|mesh-list
91926449|NCT00961675|Dexamethasone|dexamethasone|mesh-list
91926450|NCT00961675|Dexamethasone acetate|dexamethasone acetate|mesh-list
91926451|NCT00961675|Povidone|povidone|mesh-list
91926452|NCT00961675|BB 1101|bb 1101|mesh-list
91926453|NCT00961675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926454|NCT00961675|Antiemetics|antiemetics|mesh-ancestor
91926455|NCT00961675|Autonomic Agents|autonomic agents|mesh-ancestor
91926456|NCT00961675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926457|NCT00961675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926458|NCT00961675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926459|NCT00961675|Glucocorticoids|glucocorticoids|mesh-ancestor
91926460|NCT00961675|Hormones|hormones|mesh-ancestor
91926461|NCT00961675|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926462|NCT00961675|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926463|NCT00961675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926464|NCT00961675|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926465|NCT00961675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926466|NCT00961675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926467|NCT00961675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926468|NCT00961675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926469|NCT00961675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91926470|NCT00961675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926471|NCT00961675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91926472|NCT00961675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91926475|NCT00961675|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91926476|NCT00819169|Conatumumab|conatumumab|mesh-list
91926477|NCT00819169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926478|NCT00819169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926479|NCT02161679|Carboplatin|carboplatin|mesh-list
91926480|NCT02161679|Camptothecin|camptothecin|mesh-list
91926481|NCT02161679|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
91926482|NCT02161679|Immunoconjugates|immunoconjugates|mesh-list
91926483|NCT02161679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926484|NCT02161679|Immunologic Factors|immunologic factors|mesh-ancestor
91926485|NCT02161679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926486|NCT02161679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91926487|NCT02161679|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91926488|NCT02161679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926489|NCT02161679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926490|NCT02161679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926492|NCT04729725|Antibodies|antibodies|mesh-list
91926493|NCT04729725|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91926494|NCT04729725|Immunologic Factors|immunologic factors|mesh-ancestor
91926495|NCT04729725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926496|NCT04729725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926497|NCT04729725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926498|NCT04262492|Rivaroxaban|rivaroxaban|mesh-list
91926499|NCT04262492|Apixaban|apixaban|mesh-list
91926500|NCT04262492|Edoxaban|edoxaban|mesh-list
91926501|NCT04262492|Dabigatran|dabigatran|mesh-list
91926502|NCT04262492|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91926503|NCT04262492|Antithrombins|antithrombins|mesh-ancestor
91926504|NCT04262492|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91926505|NCT04262492|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926506|NCT04262492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926507|NCT04262492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926508|NCT04262492|Anticoagulants|anticoagulants|mesh-ancestor
91926509|NCT00955981|Lesinurad|lesinurad|mesh-list
91926510|NCT00955981|Gout Suppressants|gout suppressants|mesh-ancestor
91926511|NCT00955981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926512|NCT00955981|Uricosuric Agents|uricosuric agents|mesh-ancestor
91926513|NCT03541031|Micronutrients|micronutrients|mesh-list
91926514|NCT03541031|Trace Elements|trace elements|mesh-list
91926515|NCT03541031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926516|NCT05454709|Glucagon|glucagon|mesh-list
91926517|NCT05454709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926519|NCT05454709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926520|NCT05454709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926521|NCT02154737|Gemcitabine|gemcitabine|mesh-list
91926522|NCT02154737|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91926523|NCT02154737|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926524|NCT02154737|Antimetabolites|antimetabolites|mesh-ancestor
91926525|NCT02154737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926526|NCT02154737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926527|NCT02154737|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91926528|NCT02154737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926529|NCT00813163|Irinotecan|irinotecan|mesh-list
91926530|NCT00813163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91926531|NCT00813163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926533|NCT00813163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926534|NCT00813163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926535|NCT04030455|Cisplatin|cisplatin|mesh-list
91926536|NCT04030455|Carboplatin|carboplatin|mesh-list
91926537|NCT04030455|Docetaxel|docetaxel|mesh-list
91926538|NCT04030455|Pembrolizumab|pembrolizumab|mesh-list
91926539|NCT04030455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926540|NCT04030455|Tubulin Modulators|tubulin modulators|mesh-ancestor
91926541|NCT04030455|Antimitotic Agents|antimitotic agents|mesh-ancestor
91926542|NCT04030455|Mitosis Modulators|mitosis modulators|mesh-ancestor
91926543|NCT04030455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926544|NCT04030455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926545|NCT04030455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91926546|NCT05440916|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91926547|NCT05440916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926548|NCT05440916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926549|NCT05440916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926550|NCT00901693|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91926551|NCT00901693|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91926552|NCT04474093|Lithium Carbonate|lithium carbonate|mesh-list
91926553|NCT04474093|Antidepressive Agents|antidepressive agents|mesh-ancestor
91926556|NCT04474093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926557|NCT04474093|Antimanic Agents|antimanic agents|mesh-ancestor
91926558|NCT04474093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91926559|NCT04474093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926560|NCT04474093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926561|NCT02159027|Maraviroc|maraviroc|mesh-list
91926562|NCT02159027|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91926563|NCT02159027|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91926564|NCT02159027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926566|NCT02159027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91926567|NCT02159027|Antiviral Agents|antiviral agents|mesh-ancestor
91926568|NCT02159027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926569|NCT02159027|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91926570|NCT02161991|Aprepitant|aprepitant|mesh-list
91926571|NCT02161991|Antiemetics|antiemetics|mesh-ancestor
91926572|NCT02161991|Autonomic Agents|autonomic agents|mesh-ancestor
91926573|NCT02161991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926574|NCT02161991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926575|NCT02161991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926576|NCT02161991|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91926577|NCT02161991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926578|NCT02161991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926579|NCT00948961|Poly I-C|poly i-c|mesh-list
91926580|NCT00948961|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91926581|NCT00948961|Poly ICLC|poly iclc|mesh-list
91926582|NCT00948961|Interferon Inducers|interferon inducers|mesh-ancestor
91926583|NCT00948961|Immunologic Factors|immunologic factors|mesh-ancestor
91926584|NCT00948961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926585|NCT00948961|Laxatives|laxatives|mesh-ancestor
91926586|NCT00948961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926587|NCT00948961|Antiviral Agents|antiviral agents|mesh-ancestor
91926588|NCT00948961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926589|NCT02159105|Chrysarobin|chrysarobin|mesh-list
91926590|NCT02159105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91926591|NCT02159105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926592|NCT02159105|Analgesics|analgesics|mesh-ancestor
91926593|NCT02159105|Sensory System Agents|sensory system agents|mesh-ancestor
91926594|NCT02159105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926595|NCT02159105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926596|NCT02159105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926597|NCT02159105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926598|NCT00890305|Pidilizumab|pidilizumab|mesh-list
91926599|NCT00890305|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926600|NCT00890305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926601|NCT01661972|Capecitabine|capecitabine|mesh-list
91926602|NCT01661972|Aflibercept|aflibercept|mesh-list
91926603|NCT01661972|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926604|NCT01661972|Antimetabolites|antimetabolites|mesh-ancestor
91926605|NCT01661972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926606|NCT01661972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926607|NCT01661972|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91926608|NCT01661972|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91926609|NCT01661972|Growth Substances|growth substances|mesh-ancestor
91926610|NCT01661972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926611|NCT01661972|Growth Inhibitors|growth inhibitors|mesh-ancestor
91926612|NCT02155049|Bimatoprost|bimatoprost|mesh-list
91926613|NCT02155049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91926614|NCT03540953|Mitomycins|mitomycins|mesh-list
91926615|NCT03540953|Mitomycin|mitomycin|mesh-list
91926616|NCT03540953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91926617|NCT03540953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926618|NCT03540953|Alkylating Agents|alkylating agents|mesh-ancestor
91926619|NCT03540953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926620|NCT03540953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91926621|NCT03540953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926622|NCT00888355|Losartan|losartan|mesh-list
91926623|NCT00888355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91926624|NCT00888355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91926625|NCT00888355|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91926626|NCT00888355|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91926627|NCT00888355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926628|NCT00794677|Ezetimibe|ezetimibe|mesh-list
91926629|NCT00794677|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91926630|NCT00794677|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91926631|NCT00794677|Antimetabolites|antimetabolites|mesh-ancestor
91926632|NCT00794677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926633|NCT00794677|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91926634|NCT00792727|Ketoprofen|ketoprofen|mesh-list
91926635|NCT00792727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91926636|NCT00792727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926638|NCT00792727|Sensory System Agents|sensory system agents|mesh-ancestor
91926639|NCT00792727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926640|NCT00792727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926641|NCT00792727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926642|NCT00792727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926643|NCT00792727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91926644|NCT00792727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926645|NCT00792727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926646|NCT00945763|Ibuprofen|ibuprofen|mesh-list
91926647|NCT00945763|Meloxicam|meloxicam|mesh-list
91926648|NCT00945763|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91926649|NCT00945763|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91926650|NCT00945763|Analgesics|analgesics|mesh-ancestor
91926651|NCT00945763|Sensory System Agents|sensory system agents|mesh-ancestor
91926652|NCT00945763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926653|NCT00945763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926654|NCT00945763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926655|NCT00945763|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926656|NCT00945763|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91926657|NCT00945763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926658|NCT00945763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926659|NCT00945763|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91926660|NCT02770391|Leuprolide|leuprolide|mesh-list
91926661|NCT02770391|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91926662|NCT02770391|Fertility Agents|fertility agents|mesh-ancestor
91926663|NCT02770391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91943289|NCT02885974|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91926664|NCT02770391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926665|NCT02770391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926666|NCT02770391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926667|NCT02155205|Moxifloxacin|moxifloxacin|mesh-list
91926668|NCT02155205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926669|NCT02155205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926670|NCT02155205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91926671|NCT02155205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926672|NCT02155205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926673|NCT02155205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926674|NCT02155205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926675|NCT00938587|Prednisone|prednisone|mesh-list
91926676|NCT00938587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926677|NCT00938587|Glucocorticoids|glucocorticoids|mesh-ancestor
91926678|NCT00938587|Hormones|hormones|mesh-ancestor
91926679|NCT00938587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926680|NCT00938587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926681|NCT00938587|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926682|NCT00938587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926683|NCT02162303|Colchicine|colchicine|mesh-list
91926684|NCT02162303|Gout Suppressants|gout suppressants|mesh-ancestor
91926685|NCT02162303|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926686|NCT02162303|Tubulin Modulators|tubulin modulators|mesh-ancestor
91926687|NCT02162303|Antimitotic Agents|antimitotic agents|mesh-ancestor
91926688|NCT02162303|Mitosis Modulators|mitosis modulators|mesh-ancestor
91926689|NCT02162303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926690|NCT02162303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926691|NCT05430308|Chlorhexidine|chlorhexidine|mesh-list
91926692|NCT05430308|Povidone-Iodine|povidone-iodine|mesh-list
91926693|NCT05430308|Povidone|povidone|mesh-list
91926694|NCT05430308|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91926695|NCT05430308|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926696|NCT05430308|Disinfectants|disinfectants|mesh-ancestor
91926697|NCT05430308|Plasma Substitutes|plasma substitutes|mesh-ancestor
91926698|NCT05430308|Blood Substitutes|blood substitutes|mesh-ancestor
91926699|NCT00877903|Remestemcel-l|remestemcel-l|mesh-list
91926700|NCT00877903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926701|NCT00877903|Antiviral Agents|antiviral agents|mesh-ancestor
91926702|NCT00877903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926703|NCT04707703|Isavuconazole|isavuconazole|mesh-list
91926704|NCT04707703|Antifungal Agents|antifungal agents|mesh-ancestor
91926705|NCT04707703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926706|NCT04681105|Acetaminophen|acetaminophen|mesh-list
91926707|NCT04681105|Diphenhydramine|diphenhydramine|mesh-list
91926734|NCT04681105|Sensory System Agents|sensory system agents|mesh-ancestor
91926735|NCT04681105|Antipyretics|antipyretics|mesh-ancestor
91926736|NCT04681105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91926737|NCT04681105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926738|NCT04681105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91926739|NCT04681105|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91926740|NCT04681105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91926741|NCT04681105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926742|NCT04681105|Anesthetics, Local|anesthetics, local|mesh-ancestor
91926743|NCT04681105|Anesthetics|anesthetics|mesh-ancestor
91926744|NCT04681105|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91926745|NCT04681105|Histamine Antagonists|histamine antagonists|mesh-ancestor
91926746|NCT04681105|Histamine Agents|histamine agents|mesh-ancestor
91926747|NCT04681105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926748|NCT04681105|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91926749|NCT04681105|Antipruritics|antipruritics|mesh-ancestor
91926750|NCT04681105|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926751|NCT04681105|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91926752|NCT04681105|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91926753|NCT00936871|Moxifloxacin|moxifloxacin|mesh-list
91926754|NCT00936871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91926755|NCT00936871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91926756|NCT00936871|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91926757|NCT00936871|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926758|NCT00936871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926759|NCT00936871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926760|NCT00936871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926761|NCT00934921|Ondansetron|ondansetron|mesh-list
91926762|NCT00934921|Antiemetics|antiemetics|mesh-ancestor
91926763|NCT00934921|Autonomic Agents|autonomic agents|mesh-ancestor
91926764|NCT00934921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91926765|NCT00934921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926766|NCT00934921|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91926767|NCT00934921|Antipruritics|antipruritics|mesh-ancestor
91926768|NCT00934921|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926769|NCT00934921|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91926770|NCT00934921|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91926771|NCT00934921|Serotonin Agents|serotonin agents|mesh-ancestor
91926772|NCT00934921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926773|NCT00934921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926774|NCT05429450|Triamcinolone|triamcinolone|mesh-list
91926775|NCT05429450|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91926776|NCT05429450|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91926777|NCT05429450|Methotrexate|methotrexate|mesh-list
91926778|NCT05429450|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91926779|NCT05429450|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91926780|NCT05429450|Abortifacient Agents|abortifacient agents|mesh-ancestor
91926781|NCT05429450|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91926782|NCT05429450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926783|NCT05429450|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926784|NCT05429450|Antimetabolites|antimetabolites|mesh-ancestor
91926785|NCT05429450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926786|NCT05429450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926787|NCT05429450|Dermatologic Agents|dermatologic agents|mesh-ancestor
91926788|NCT05429450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926789|NCT05429450|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91926790|NCT05429450|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91926791|NCT05429450|Immunologic Factors|immunologic factors|mesh-ancestor
91926792|NCT05429450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91926793|NCT05429450|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91926794|NCT05429450|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926795|NCT05429450|Glucocorticoids|glucocorticoids|mesh-ancestor
91926797|NCT05429450|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926798|NCT00103259|Irinotecan|irinotecan|mesh-list
91926799|NCT00103259|Bortezomib|bortezomib|mesh-list
91926800|NCT00103259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91926801|NCT00103259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91926802|NCT00103259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926803|NCT00103259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926804|NCT00103259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926805|NCT02162381|Methylphenidate|methylphenidate|mesh-list
91926806|NCT02162381|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91926807|NCT02162381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926808|NCT02162381|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91926885|NCT02162693|Protective Agents|protective agents|mesh-ancestor
91926809|NCT02162381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91926810|NCT02162381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926811|NCT02162381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926812|NCT02162381|Dopamine Agents|dopamine agents|mesh-ancestor
91926813|NCT02162381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926814|NCT00782431|Vaccines|vaccines|mesh-list
91926816|NCT00782431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926818|NCT02155439|Fluorouracil|fluorouracil|mesh-list
91926819|NCT02155439|Antimetabolites|antimetabolites|mesh-ancestor
91926820|NCT02155439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926821|NCT02155439|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91926822|NCT02155439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926823|NCT02155439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91926824|NCT02155439|Immunologic Factors|immunologic factors|mesh-ancestor
91926825|NCT02155439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926826|NCT02155439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926827|NCT02155439|Glucocorticoids|glucocorticoids|mesh-ancestor
91926828|NCT02155439|Hormones|hormones|mesh-ancestor
91926829|NCT02155439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926830|NCT04627285|Lacosamide|lacosamide|mesh-list
91926831|NCT04627285|Anticonvulsants|anticonvulsants|mesh-ancestor
91926832|NCT04627285|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91926833|NCT04627285|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91926834|NCT04627285|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926835|NCT04627285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926836|NCT02544152|Lubiprostone|lubiprostone|mesh-list
91926837|NCT02544152|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91926838|NCT02544152|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926839|NCT02544152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926840|NCT02162537|Bevacizumab|bevacizumab|mesh-list
91926842|NCT02162537|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926843|NCT02162537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926844|NCT02162537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91926845|NCT02162537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91926846|NCT02162537|Growth Substances|growth substances|mesh-ancestor
91926847|NCT02162537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926848|NCT02162537|Growth Inhibitors|growth inhibitors|mesh-ancestor
91926849|NCT02162537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926850|NCT02162537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926851|NCT02162537|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91926852|NCT02162537|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91926853|NCT04597411|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91926854|NCT04597411|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91926855|NCT04597411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926856|NCT02534324|Antihypertensive Agents|antihypertensive agents|mesh-list
91926857|NCT00864175|Docetaxel|docetaxel|mesh-list
91926858|NCT00864175|Trastuzumab|trastuzumab|mesh-list
91926859|NCT00864175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926860|NCT00864175|Tubulin Modulators|tubulin modulators|mesh-ancestor
91926861|NCT00864175|Antimitotic Agents|antimitotic agents|mesh-ancestor
91926862|NCT00864175|Mitosis Modulators|mitosis modulators|mesh-ancestor
91926863|NCT00864175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926864|NCT00864175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91926865|NCT02166593|Atorvastatin|atorvastatin|mesh-list
91926866|NCT02166593|Pravastatin|pravastatin|mesh-list
91926867|NCT02166593|Fenofibrate|fenofibrate|mesh-list
91926868|NCT02166593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91926869|NCT02166593|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91926870|NCT02166593|Antimetabolites|antimetabolites|mesh-ancestor
91926871|NCT02166593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926872|NCT02166593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91926873|NCT02166593|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91926874|NCT02166593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926875|NCT00858871|Sorafenib|sorafenib|mesh-list
91926876|NCT00858871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926877|NCT00858871|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91926878|NCT00858871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926879|NCT00858871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926880|NCT02162693|Hyaluronic Acid|hyaluronic acid|mesh-list
91926881|NCT02162693|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91926882|NCT02162693|Immunologic Factors|immunologic factors|mesh-ancestor
91926883|NCT02162693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926884|NCT02162693|Viscosupplements|viscosupplements|mesh-ancestor
91926916|NCT02255591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926917|NCT02255591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926918|NCT02255591|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91926919|NCT02255591|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91926920|NCT02255591|Adrenergic Agents|adrenergic agents|mesh-ancestor
91926921|NCT02255591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91926922|NCT02255591|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91926923|NCT02255591|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91926924|NCT02255591|Autonomic Agents|autonomic agents|mesh-ancestor
91926925|NCT02255591|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91926926|NCT02255591|Respiratory System Agents|respiratory system agents|mesh-ancestor
91926927|NCT02255591|Mydriatics|mydriatics|mesh-ancestor
91926928|NCT02255591|Sympathomimetics|sympathomimetics|mesh-ancestor
91926929|NCT02255591|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91926930|NCT00913393|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91926931|NCT00913393|Immunologic Factors|immunologic factors|mesh-ancestor
91926932|NCT00913393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926934|NCT02167061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91926935|NCT02167061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926936|NCT03715465|Melatonin|melatonin|mesh-list
91926937|NCT03715465|Antioxidants|antioxidants|mesh-ancestor
91926938|NCT03715465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926939|NCT03715465|Protective Agents|protective agents|mesh-ancestor
91926940|NCT03715465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926941|NCT03715465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926942|NCT04706741|Prednisone|prednisone|mesh-list
91926943|NCT04706741|Prednisolone|prednisolone|mesh-list
91926944|NCT04706741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91926945|NCT04706741|Glucocorticoids|glucocorticoids|mesh-ancestor
91926946|NCT04706741|Hormones|hormones|mesh-ancestor
91926947|NCT04706741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91926948|NCT04706741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926949|NCT04706741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91926950|NCT04706741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926951|NCT02171039|Dabigatran|dabigatran|mesh-list
91926952|NCT02171039|Atorvastatin|atorvastatin|mesh-list
91926953|NCT02171039|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91926954|NCT02171039|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91926955|NCT02171039|Antimetabolites|antimetabolites|mesh-ancestor
91926956|NCT02171039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926957|NCT02171039|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91926958|NCT02171039|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91926959|NCT02171039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926960|NCT02171039|Antithrombins|antithrombins|mesh-ancestor
91926961|NCT02171039|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91926962|NCT02171039|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926963|NCT02171039|Anticoagulants|anticoagulants|mesh-ancestor
91926964|NCT00840073|Trandolapril|trandolapril|mesh-list
91926965|NCT00840073|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91926966|NCT00840073|Protease Inhibitors|protease inhibitors|mesh-ancestor
91926967|NCT00840073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926968|NCT00840073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926969|NCT00840073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91926970|NCT02261207|Axitinib|axitinib|mesh-list
91926971|NCT02261207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91926972|NCT02261207|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91926973|NCT02261207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91926974|NCT02261207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926975|NCT00838279|Lamotrigine|lamotrigine|mesh-list
91926976|NCT00838279|Anticonvulsants|anticonvulsants|mesh-ancestor
91926977|NCT00838279|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91926978|NCT00838279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91926979|NCT00838279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91926980|NCT00838279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91926981|NCT00838279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926982|NCT00838279|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91926983|NCT00838279|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91926984|NCT00838279|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91926985|NCT00838279|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91926986|NCT00838279|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91926988|NCT02163707|Hallucinogens|hallucinogens|mesh-ancestor
91926989|NCT02163707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91926990|NCT02163707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91926991|NCT00769795|Goserelin|goserelin|mesh-list
91927008|NCT03134677|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91927009|NCT03134677|Anesthetics, General|anesthetics, general|mesh-ancestor
91927010|NCT00722917|Pioglitazone|pioglitazone|mesh-list
91927011|NCT00722917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927012|NCT00722917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927013|NCT02164097|Heparin|heparin|mesh-list
91927014|NCT02164097|Anticoagulants|anticoagulants|mesh-ancestor
91927015|NCT02164097|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91927016|NCT02164097|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91927017|NCT02164097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927019|NCT00717457|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91927020|NCT00717457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927021|NCT00717457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927022|NCT00717457|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91927023|NCT00717457|Incretins|incretins|mesh-ancestor
91927024|NCT00717457|Hormones|hormones|mesh-ancestor
91927025|NCT00717457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927026|NCT02171507|Diclofenac|diclofenac|mesh-list
91927027|NCT02171507|Dabigatran|dabigatran|mesh-list
91927028|NCT02171507|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91927029|NCT02171507|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91927030|NCT02171507|Analgesics|analgesics|mesh-ancestor
91927031|NCT02171507|Sensory System Agents|sensory system agents|mesh-ancestor
91927032|NCT02171507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927033|NCT02171507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927034|NCT02171507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927035|NCT02171507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927036|NCT02171507|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91927037|NCT02171507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927038|NCT02171507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927039|NCT02171507|Antithrombins|antithrombins|mesh-ancestor
91927040|NCT02171507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91927041|NCT02171507|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927042|NCT02171507|Anticoagulants|anticoagulants|mesh-ancestor
91927043|NCT03539159|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91927044|NCT03539159|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91927046|NCT00758953|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91927047|NCT00758953|Hormone Antagonists|hormone antagonists|mesh-ancestor
91927048|NCT00758953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927049|NCT00758953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927050|NCT02167685|Brincidofovir|brincidofovir|mesh-list
91927051|NCT02167685|Antiviral Agents|antiviral agents|mesh-ancestor
91927052|NCT02167685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927053|NCT00758563|Triclosan|triclosan|mesh-list
91927054|NCT00758563|Fluorides|fluorides|mesh-list
91927055|NCT00758563|Cariostatic Agents|cariostatic agents|mesh-ancestor
91927056|NCT00758563|Protective Agents|protective agents|mesh-ancestor
91927057|NCT00758563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927058|NCT00758563|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91927059|NCT00758563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927060|NCT00758563|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91927061|NCT00758563|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91927062|NCT00758563|Antimetabolites|antimetabolites|mesh-ancestor
91927063|NCT00758563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927064|NCT00758563|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91927065|NCT02171585|Clarithromycin|clarithromycin|mesh-list
91927066|NCT02171585|Dabigatran|dabigatran|mesh-list
91927067|NCT02171585|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927068|NCT02171585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927069|NCT02171585|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91927070|NCT02171585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927071|NCT02171585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927072|NCT02171585|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91927073|NCT02171585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91927074|NCT02171585|Antithrombins|antithrombins|mesh-ancestor
91927075|NCT02171585|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91927076|NCT02171585|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927077|NCT02171585|Anticoagulants|anticoagulants|mesh-ancestor
91927078|NCT03134443|Andrographolide|andrographolide|mesh-list
91927079|NCT03134443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927080|NCT03134443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91927081|NCT03134443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91927082|NCT03134443|Analgesics|analgesics|mesh-ancestor
91927083|NCT03134443|Sensory System Agents|sensory system agents|mesh-ancestor
91927084|NCT03134443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927085|NCT03134443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927086|NCT03134443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927087|NCT03134443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91927088|NCT03134443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91927089|NCT03134443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927090|NCT03134443|Antiviral Agents|antiviral agents|mesh-ancestor
91927091|NCT03134443|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91927092|NCT02171663|Afatinib|afatinib|mesh-list
91927093|NCT02171663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927094|NCT02171663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91927095|NCT02171663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927096|NCT02171663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927097|NCT02171741|Docetaxel|docetaxel|mesh-list
91927098|NCT02171741|Afatinib|afatinib|mesh-list
91927099|NCT02171741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927100|NCT02171741|Tubulin Modulators|tubulin modulators|mesh-ancestor
91927101|NCT02171741|Antimitotic Agents|antimitotic agents|mesh-ancestor
91927102|NCT02171741|Mitosis Modulators|mitosis modulators|mesh-ancestor
91927103|NCT02171741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927104|NCT02171741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91927105|NCT02171741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927106|NCT00835705|Amoxicillin|amoxicillin|mesh-list
91927107|NCT00835705|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
91927109|NCT00835705|Clavulanic Acid|clavulanic acid|mesh-list
91927110|NCT00835705|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927111|NCT00835705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927112|NCT00835705|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91927113|NCT00835705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927114|NCT00835705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927115|NCT02938520|Rilpivirine|rilpivirine|mesh-list
91927116|NCT02938520|Cabotegravir|cabotegravir|mesh-list
91927117|NCT02938520|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91927118|NCT02938520|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91927119|NCT02938520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927120|NCT02938520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927121|NCT02938520|Antiviral Agents|antiviral agents|mesh-ancestor
91927122|NCT02938520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927123|NCT02938520|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91927124|NCT02938520|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91927125|NCT02938520|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91927126|NCT02938520|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91927127|NCT00713401|Esmolol|esmolol|mesh-list
91927128|NCT00713401|Tecadenoson|tecadenoson|mesh-list
91927129|NCT00713401|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91927130|NCT00713401|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91927131|NCT00713401|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91927132|NCT00713401|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927133|NCT00713401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927134|NCT00713401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927135|NCT00713401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927136|NCT00713401|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91927137|NCT00713401|Purinergic Agonists|purinergic agonists|mesh-ancestor
91927138|NCT00713401|Purinergic Agents|purinergic agents|mesh-ancestor
91927139|NCT02171975|Anesthetics|anesthetics|mesh-list
91927140|NCT02171975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927141|NCT02171975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927143|NCT00835549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927144|NCT00835549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927145|NCT02164253|Deferiprone|deferiprone|mesh-list
91927146|NCT02164253|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91927147|NCT02164253|Chelating Agents|chelating agents|mesh-ancestor
91927148|NCT02164253|Sequestering Agents|sequestering agents|mesh-ancestor
91927149|NCT02164253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927150|NCT00755287|Metformin|metformin|mesh-list
91927151|NCT00755287|Insulin Glargine|insulin glargine|mesh-list
91927152|NCT00755287|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91927153|NCT00755287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927154|NCT00755287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927155|NCT00755287|Incretins|incretins|mesh-ancestor
91927156|NCT00755287|Hormones|hormones|mesh-ancestor
91927157|NCT00755287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927158|NCT02168075|Mannitol|mannitol|mesh-list
91927159|NCT02168075|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91927160|NCT02168075|Diuretics|diuretics|mesh-ancestor
91927161|NCT02168075|Natriuretic Agents|natriuretic agents|mesh-ancestor
91927241|NCT04265534|Carboplatin|carboplatin|mesh-list
91927162|NCT02168075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927163|NCT00712699|Adderall|adderall|mesh-list
91927164|NCT00712699|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91927165|NCT00712699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927166|NCT03945825|Vaccines|vaccines|mesh-list
91927167|NCT03945825|Immunologic Factors|immunologic factors|mesh-ancestor
91927168|NCT03945825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927169|NCT03819517|Resveratrol|resveratrol|mesh-list
91927170|NCT03819517|Antioxidants|antioxidants|mesh-ancestor
91927171|NCT03819517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927172|NCT03819517|Protective Agents|protective agents|mesh-ancestor
91927173|NCT03819517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927174|NCT03819517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927175|NCT03819517|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91927176|NCT02759315|Uprifosbuvir|uprifosbuvir|mesh-list
91927177|NCT02759315|Ruzasvir|ruzasvir|mesh-list
91927178|NCT02759315|Antiviral Agents|antiviral agents|mesh-ancestor
91927179|NCT02759315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927180|NCT00697099|Enoxaparin|enoxaparin|mesh-list
91927181|NCT00697099|Semuloparin|semuloparin|mesh-list
91927182|NCT00697099|Enoxaparin sodium|enoxaparin sodium|mesh-list
91927183|NCT00697099|Anticoagulants|anticoagulants|mesh-ancestor
91927184|NCT00697099|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91927185|NCT00697099|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91927186|NCT00697099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927187|NCT02172131|Olodaterol|olodaterol|mesh-list
91927188|NCT02172131|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927189|NCT02172131|Autonomic Agents|autonomic agents|mesh-ancestor
91927190|NCT02172131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927191|NCT02172131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927192|NCT02172131|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927193|NCT02172131|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927194|NCT05435768|Denosumab|denosumab|mesh-list
91927195|NCT05435768|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91927196|NCT05435768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927197|NCT00835081|Cefadroxil|cefadroxil|mesh-list
91927198|NCT00835081|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927199|NCT00835081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927200|NCT02543918|Ixekizumab|ixekizumab|mesh-list
91927201|NCT02543918|Vaccines|vaccines|mesh-list
91927202|NCT02543918|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91927203|NCT02543918|Immunologic Factors|immunologic factors|mesh-ancestor
91927204|NCT02543918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927205|NCT02543918|Dermatologic Agents|dermatologic agents|mesh-ancestor
91927207|NCT03539003|Propofol|propofol|mesh-list
91927208|NCT03539003|Sevoflurane|sevoflurane|mesh-list
91927209|NCT03539003|Desflurane|desflurane|mesh-list
91927210|NCT03539003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91927211|NCT03539003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927212|NCT03539003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927213|NCT03539003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91927214|NCT03539003|Anesthetics, General|anesthetics, general|mesh-ancestor
91927215|NCT03539003|Anesthetics|anesthetics|mesh-ancestor
91927216|NCT03539003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91927217|NCT03539003|Narcotics|narcotics|mesh-ancestor
91927218|NCT03539003|Analgesics|analgesics|mesh-ancestor
91927219|NCT03539003|Sensory System Agents|sensory system agents|mesh-ancestor
91927220|NCT03539003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927221|NCT03539003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91927222|NCT03539003|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91927223|NCT00751231|Clopidogrel|clopidogrel|mesh-list
91927224|NCT00751231|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91927225|NCT00751231|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91927226|NCT00751231|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91927227|NCT00751231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91927228|NCT00751231|Purinergic Agents|purinergic agents|mesh-ancestor
91927229|NCT00751231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927230|NCT00751231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927231|NCT00751231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927232|NCT02164565|Tranexamic Acid|tranexamic acid|mesh-list
91927233|NCT02164565|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91927234|NCT02164565|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91927235|NCT02164565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927236|NCT02164565|Hemostatics|hemostatics|mesh-ancestor
91927237|NCT02164565|Coagulants|coagulants|mesh-ancestor
91927238|NCT04265534|Folic Acid|folic acid|mesh-list
91927239|NCT04265534|Vitamin B 12|vitamin b 12|mesh-list
91927240|NCT04265534|Dexamethasone|dexamethasone|mesh-list
91927246|NCT04265534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927247|NCT04265534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927248|NCT04265534|Antiemetics|antiemetics|mesh-ancestor
91927249|NCT04265534|Autonomic Agents|autonomic agents|mesh-ancestor
91927250|NCT04265534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927251|NCT04265534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927252|NCT04265534|Glucocorticoids|glucocorticoids|mesh-ancestor
91927253|NCT04265534|Hormones|hormones|mesh-ancestor
91927254|NCT04265534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927255|NCT04265534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943307|NCT02611960|Antimetabolites|antimetabolites|mesh-ancestor
91927256|NCT04265534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927257|NCT04265534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91927258|NCT04265534|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91927259|NCT04265534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927260|NCT04265534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927261|NCT04265534|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91927262|NCT04265534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91927263|NCT04265534|Hematinics|hematinics|mesh-ancestor
91927264|NCT04265534|Vitamin B Complex|vitamin b complex|mesh-ancestor
91927265|NCT00750295|Ferric Compounds|ferric compounds|mesh-list
91927266|NCT00750295|Hematinics|hematinics|mesh-ancestor
91927267|NCT02172209|Empagliflozin|empagliflozin|mesh-list
91927268|NCT02172209|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91927269|NCT02172209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927270|NCT02172209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927271|NCT02172209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927272|NCT02168543|Alendronate|alendronate|mesh-list
91927273|NCT02168543|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91927274|NCT02168543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927275|NCT01372995|Vitamin D|vitamin d|mesh-list
91927276|NCT01372995|Ergocalciferols|ergocalciferols|mesh-list
91927277|NCT01372995|Cholecalciferol|cholecalciferol|mesh-list
91927278|NCT01372995|Vitamins|vitamins|mesh-list
91927280|NCT01372995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927281|NCT01372995|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91927282|NCT01372995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91927283|NCT04239859|Cyclosporine|cyclosporine|mesh-list
91927284|NCT04239859|Methotrexate|methotrexate|mesh-list
91927285|NCT04239859|Acitretin|acitretin|mesh-list
91927286|NCT04239859|Cyclosporins|cyclosporins|mesh-list
91927287|NCT04239859|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91927288|NCT04239859|Abortifacient Agents|abortifacient agents|mesh-ancestor
91927289|NCT04239859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91927290|NCT04239859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927291|NCT04239859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91927292|NCT04239859|Antimetabolites|antimetabolites|mesh-ancestor
91927293|NCT04239859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927294|NCT04239859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927295|NCT04239859|Dermatologic Agents|dermatologic agents|mesh-ancestor
91927296|NCT04239859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927297|NCT04239859|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91927298|NCT04239859|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91927299|NCT04239859|Immunologic Factors|immunologic factors|mesh-ancestor
91927300|NCT04239859|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927301|NCT04239859|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91927302|NCT04239859|Antifungal Agents|antifungal agents|mesh-ancestor
91927303|NCT04239859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927304|NCT04239859|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91927305|NCT04239859|Keratolytic Agents|keratolytic agents|mesh-ancestor
91927306|NCT02938923|Testosterone|testosterone|mesh-list
91927307|NCT02938923|Androgens|androgens|mesh-ancestor
91927308|NCT02938923|Hormones|hormones|mesh-ancestor
91927309|NCT02938923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927310|NCT02938923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927311|NCT02757521|Nitrous Oxide|nitrous oxide|mesh-list
91927312|NCT02757521|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91927313|NCT02757521|Anesthetics, General|anesthetics, general|mesh-ancestor
91927314|NCT02757521|Anesthetics|anesthetics|mesh-ancestor
91927315|NCT02757521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927316|NCT02757521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927317|NCT02757521|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91927318|NCT02757521|Analgesics|analgesics|mesh-ancestor
91927319|NCT02757521|Sensory System Agents|sensory system agents|mesh-ancestor
91927320|NCT02757521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927323|NCT00744367|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91927324|NCT00744367|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927325|NCT00744367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927326|NCT00744367|Incretins|incretins|mesh-ancestor
91927327|NCT00744367|Hormones|hormones|mesh-ancestor
91927328|NCT00744367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927329|NCT02172287|Tiotropium Bromide|tiotropium bromide|mesh-list
91927330|NCT02172287|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91927331|NCT02172287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927332|NCT02172287|Autonomic Agents|autonomic agents|mesh-ancestor
91927333|NCT02172287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927334|NCT02172287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927335|NCT02172287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927336|NCT02172287|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927337|NCT02172287|Parasympatholytics|parasympatholytics|mesh-ancestor
91927338|NCT02172287|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91927339|NCT02172287|Cholinergic Agents|cholinergic agents|mesh-ancestor
91927340|NCT02172287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927341|NCT02172287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927342|NCT02172287|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91927343|NCT02172287|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91927344|NCT02172287|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91927345|NCT02172287|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927346|NCT02261129|Telmisartan|telmisartan|mesh-list
91927347|NCT02261129|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91927348|NCT02261129|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91927349|NCT02261129|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91927350|NCT02261129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927351|NCT00694135|Dexamethasone|dexamethasone|mesh-list
91927352|NCT00694135|Dexamethasone acetate|dexamethasone acetate|mesh-list
91927353|NCT00694135|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91927354|NCT00694135|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91927355|NCT00694135|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91927357|NCT00694135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927358|NCT00694135|Antiemetics|antiemetics|mesh-ancestor
91927359|NCT00694135|Autonomic Agents|autonomic agents|mesh-ancestor
91927360|NCT00694135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927361|NCT00694135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927362|NCT00694135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927363|NCT00694135|Glucocorticoids|glucocorticoids|mesh-ancestor
91927364|NCT00694135|Hormones|hormones|mesh-ancestor
91927365|NCT00694135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927366|NCT00694135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91927367|NCT00694135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927368|NCT00694135|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927369|NCT00694135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927370|NCT00694135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927371|NCT03540095|Bupivacaine|bupivacaine|mesh-list
91927372|NCT03540095|Anesthetics, Local|anesthetics, local|mesh-ancestor
91927373|NCT03540095|Anesthetics|anesthetics|mesh-ancestor
91927374|NCT03540095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927375|NCT03540095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927376|NCT03540095|Sensory System Agents|sensory system agents|mesh-ancestor
91927377|NCT03540095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927378|NCT03071185|Dexmedetomidine|dexmedetomidine|mesh-list
91927379|NCT03071185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91927380|NCT03071185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927381|NCT03071185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927382|NCT03071185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91927383|NCT03071185|Analgesics|analgesics|mesh-ancestor
91927384|NCT03071185|Sensory System Agents|sensory system agents|mesh-ancestor
91927385|NCT03071185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927386|NCT03071185|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91927387|NCT03071185|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91927388|NCT03071185|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91927389|NCT03071185|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927390|NCT03071185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927391|NCT03071185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927392|NCT00741715|Atorvastatin|atorvastatin|mesh-list
91927393|NCT00741715|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91927394|NCT00741715|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91927395|NCT00741715|Antimetabolites|antimetabolites|mesh-ancestor
91927396|NCT00741715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927397|NCT00741715|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91927398|NCT00741715|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91927399|NCT00741715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927401|NCT02169167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927402|NCT02169167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91927403|NCT02172443|Tiotropium Bromide|tiotropium bromide|mesh-list
91927404|NCT02172443|Ipratropium|ipratropium|mesh-list
91927405|NCT02172443|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927406|NCT02172443|Autonomic Agents|autonomic agents|mesh-ancestor
91927407|NCT02172443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927408|NCT02172443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927409|NCT02172443|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927410|NCT02172443|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927411|NCT02172443|Parasympatholytics|parasympatholytics|mesh-ancestor
91927412|NCT02172443|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91927413|NCT02172443|Cholinergic Agents|cholinergic agents|mesh-ancestor
91927414|NCT02172443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927415|NCT02172443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927416|NCT00834613|Metformin|metformin|mesh-list
91927417|NCT00834613|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927418|NCT00834613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927419|NCT02172521|Bromides|bromides|mesh-list
91927420|NCT02172521|Tiotropium Bromide|tiotropium bromide|mesh-list
91927421|NCT02172521|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927422|NCT02172521|Autonomic Agents|autonomic agents|mesh-ancestor
91927423|NCT02172521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927424|NCT02172521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927425|NCT02172521|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927426|NCT02172521|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927427|NCT02172521|Parasympatholytics|parasympatholytics|mesh-ancestor
91927428|NCT02172521|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91927429|NCT02172521|Cholinergic Agents|cholinergic agents|mesh-ancestor
91927430|NCT02172521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927431|NCT02172521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927432|NCT02172521|Anticonvulsants|anticonvulsants|mesh-ancestor
91927433|NCT00834535|Cefdinir|cefdinir|mesh-list
91927434|NCT00834535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927435|NCT00834535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927436|NCT00691717|Hydrocortisone|hydrocortisone|mesh-list
91927437|NCT00691717|Anecortave|anecortave|mesh-list
91927438|NCT00691717|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91927439|NCT00691717|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91927440|NCT00691717|Growth Substances|growth substances|mesh-ancestor
91927441|NCT00691717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927442|NCT00691717|Growth Inhibitors|growth inhibitors|mesh-ancestor
91927443|NCT00691717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927444|NCT00691717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927445|NCT00834067|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91927446|NCT00834067|Moexipril|moexipril|mesh-list
91927447|NCT00834067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91927448|NCT00834067|Diuretics|diuretics|mesh-ancestor
91927449|NCT00834067|Natriuretic Agents|natriuretic agents|mesh-ancestor
91927450|NCT00834067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927451|NCT00834067|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91927452|NCT00834067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91927453|NCT00834067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927454|NCT00834067|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91927455|NCT00834067|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927456|NCT00834067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927457|NCT00682981|Carboplatin|carboplatin|mesh-list
91927458|NCT00682981|Etoposide|etoposide|mesh-list
91927459|NCT00682981|Obatoclax|obatoclax|mesh-list
91927460|NCT00682981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927461|NCT00682981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91927462|NCT00682981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91927463|NCT00682981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91927464|NCT00682981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927465|NCT00682981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927466|NCT00833521|Zolpidem|zolpidem|mesh-list
91927467|NCT00833521|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91927468|NCT00833521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91927469|NCT00833521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927470|NCT00833521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927471|NCT00833521|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91927472|NCT00833521|GABA Agonists|gaba agonists|mesh-ancestor
91927475|NCT00833521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927476|NCT00832507|Cicletanine|cicletanine|mesh-list
91927477|NCT00832507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91927478|NCT00832507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91927479|NCT00832507|Diuretics|diuretics|mesh-ancestor
91927480|NCT00832507|Natriuretic Agents|natriuretic agents|mesh-ancestor
91927481|NCT00832507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927482|NCT04862143|Fulvestrant|fulvestrant|mesh-list
91927483|NCT04862143|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91927484|NCT04862143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927485|NCT04862143|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91927486|NCT04862143|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91927487|NCT04862143|Hormone Antagonists|hormone antagonists|mesh-ancestor
91927488|NCT04862143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927489|NCT04862143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927490|NCT02721459|Vemurafenib|vemurafenib|mesh-list
91927491|NCT02721459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927492|NCT02721459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91927493|NCT02721459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927494|NCT02721459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927495|NCT02802943|Imiquimod|imiquimod|mesh-list
91927496|NCT02802943|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91927497|NCT02802943|Immunologic Factors|immunologic factors|mesh-ancestor
91927498|NCT02802943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927499|NCT02802943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927500|NCT02802943|Interferon Inducers|interferon inducers|mesh-ancestor
91927501|NCT02165033|Budesonide|budesonide|mesh-list
91927502|NCT02165033|Procaterol|procaterol|mesh-list
91927503|NCT02165033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927504|NCT02165033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927505|NCT02165033|Autonomic Agents|autonomic agents|mesh-ancestor
91927506|NCT02165033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927507|NCT02165033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927508|NCT02165033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927509|NCT02165033|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927510|NCT02165033|Glucocorticoids|glucocorticoids|mesh-ancestor
91927511|NCT02165033|Hormones|hormones|mesh-ancestor
91927512|NCT02165033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927513|NCT02165033|Sympathomimetics|sympathomimetics|mesh-ancestor
91927514|NCT02165033|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91927515|NCT02165033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91927516|NCT02165033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91927517|NCT02165033|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927518|NCT02165033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927519|NCT02165033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927520|NCT00734461|Naltrexone|naltrexone|mesh-list
91927521|NCT00734461|Oxycodone|oxycodone|mesh-list
91927522|NCT00734461|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91927523|NCT00734461|Narcotics|narcotics|mesh-ancestor
91927524|NCT00734461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927525|NCT00734461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927526|NCT00734461|Analgesics|analgesics|mesh-ancestor
91927527|NCT00734461|Sensory System Agents|sensory system agents|mesh-ancestor
91927528|NCT00734461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927529|NCT00734461|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91927530|NCT00734461|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91927531|NCT02169713|Tamsulosin|tamsulosin|mesh-list
91927532|NCT02169713|Solifenacin Succinate|solifenacin succinate|mesh-list
91927533|NCT02169713|Mirabegron|mirabegron|mesh-list
91927534|NCT02169713|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91927535|NCT02169713|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91927536|NCT02169713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91927537|NCT02169713|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927538|NCT02169713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927539|NCT02169713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927540|NCT02169713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927541|NCT02169713|Urological Agents|urological agents|mesh-ancestor
91927542|NCT02169713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91927543|NCT02169713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91927544|NCT02169713|Cholinergic Agents|cholinergic agents|mesh-ancestor
91927545|NCT02169713|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91927546|NCT02169713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91927547|NCT02169713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91927548|NCT03980041|Nivolumab|nivolumab|mesh-list
91927549|NCT03980041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91927550|NCT03980041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927551|NCT03980041|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91927552|NCT03980041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927553|NCT02756819|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
91927554|NCT02756819|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91927555|NCT02756819|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91927556|NCT02756819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927557|NCT00829309|Pravastatin|pravastatin|mesh-list
91927558|NCT00829309|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91927559|NCT00829309|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91927560|NCT00829309|Antimetabolites|antimetabolites|mesh-ancestor
91927561|NCT00829309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927562|NCT00829309|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91927563|NCT00829309|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91927564|NCT00829309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927565|NCT02165189|Ribavirin|ribavirin|mesh-list
91927566|NCT02165189|Sofosbuvir|sofosbuvir|mesh-list
91927567|NCT02165189|Simeprevir|simeprevir|mesh-list
91927568|NCT02165189|Antimetabolites|antimetabolites|mesh-ancestor
91927569|NCT02165189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927570|NCT02165189|Antiviral Agents|antiviral agents|mesh-ancestor
91927571|NCT02165189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927572|NCT02165189|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927573|NCT02165189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927574|NCT00725881|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
91927575|NCT00725881|Antioxidants|antioxidants|mesh-ancestor
91927576|NCT00725881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927577|NCT00725881|Protective Agents|protective agents|mesh-ancestor
91927578|NCT00725881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927579|NCT00725881|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91927580|NCT00725881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927581|NCT02292225|Obinutuzumab|obinutuzumab|mesh-list
91927582|NCT02292225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91927583|NCT02292225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927584|NCT00677053|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|mesh-list
91927585|NCT00677053|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91927586|NCT00677053|Antithrombins|antithrombins|mesh-ancestor
91927587|NCT00677053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91927588|NCT00677053|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927589|NCT00677053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927590|NCT00677053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927591|NCT00677053|Anticoagulants|anticoagulants|mesh-ancestor
91927592|NCT01950403|Linaclotide|linaclotide|mesh-list
91927593|NCT01950403|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91927594|NCT01950403|Enzyme Activators|enzyme activators|mesh-ancestor
91927595|NCT01950403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927596|NCT01950403|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927597|NCT03607539|Pemetrexed|pemetrexed|mesh-list
91927598|NCT03607539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927599|NCT03607539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927600|NCT03607539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927601|NCT03607539|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91927602|NCT03607539|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91927603|NCT00629941|Azithromycin|azithromycin|mesh-list
91927604|NCT00629941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927605|NCT00629941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927606|NCT02404779|Cisatracurium|cisatracurium|mesh-list
91927607|NCT02404779|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91927608|NCT02404779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91927609|NCT02404779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927610|NCT02404779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927611|NCT00629551|Paroxetine|paroxetine|mesh-list
91927612|NCT00629551|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91927613|NCT00629551|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91927614|NCT00629551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91927615|NCT00629551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927617|NCT00629551|Serotonin Agents|serotonin agents|mesh-ancestor
91927618|NCT00629551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927619|NCT00629551|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91927620|NCT00629551|Antidepressive Agents|antidepressive agents|mesh-ancestor
91927621|NCT00629551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91927622|NCT00629551|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91927623|NCT00629551|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91927624|NCT00629551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927625|NCT00625651|Bevacizumab|bevacizumab|mesh-list
91927626|NCT00625651|Conatumumab|conatumumab|mesh-list
91927627|NCT00625651|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91927628|NCT00625651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927629|NCT00625651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91927630|NCT00625651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91927631|NCT00625651|Growth Substances|growth substances|mesh-ancestor
91927632|NCT00625651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927633|NCT00625651|Growth Inhibitors|growth inhibitors|mesh-ancestor
91927634|NCT00672997|Timolol|timolol|mesh-list
91927635|NCT00672997|Travoprost|travoprost|mesh-list
91927636|NCT00672997|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91927637|NCT00672997|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91927638|NCT00672997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91927639|NCT00672997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91927640|NCT00672997|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927641|NCT00672997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927642|NCT00672997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927643|NCT00672997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927644|NCT00672997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91927645|NCT00672997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91927646|NCT02130453|Regadenoson|regadenoson|mesh-list
91927647|NCT02130453|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
91927648|NCT02130453|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91927649|NCT02130453|Purinergic Agonists|purinergic agonists|mesh-ancestor
91927650|NCT02130453|Purinergic Agents|purinergic agents|mesh-ancestor
91927651|NCT02130453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927652|NCT02130453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927653|NCT02130453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927655|NCT02669043|Analgesics|analgesics|mesh-ancestor
91927656|NCT02669043|Sensory System Agents|sensory system agents|mesh-ancestor
91927657|NCT02669043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927658|NCT02669043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927659|NCT02669043|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91927660|NCT02669043|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91927661|NCT02669043|Anesthetics, General|anesthetics, general|mesh-ancestor
91927662|NCT02669043|Anesthetics|anesthetics|mesh-ancestor
91927663|NCT02669043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927664|NCT02669043|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91927665|NCT02669043|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91927666|NCT02669043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927667|NCT02669043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927668|NCT02760407|Adalimumab|adalimumab|mesh-list
91927669|NCT02760407|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91927670|NCT02760407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927671|NCT02760407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927672|NCT02281045|Citric Acid|citric acid|mesh-list
91927673|NCT02281045|Sodium Citrate|sodium citrate|mesh-list
91927674|NCT02281045|Anticoagulants|anticoagulants|mesh-ancestor
91927675|NCT02281045|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91927676|NCT02281045|Chelating Agents|chelating agents|mesh-ancestor
91927677|NCT02281045|Sequestering Agents|sequestering agents|mesh-ancestor
91927678|NCT02281045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927679|NCT04472689|Lidocaine|lidocaine|mesh-list
91927680|NCT04472689|Anesthetics, Local|anesthetics, local|mesh-ancestor
91927681|NCT04472689|Anesthetics|anesthetics|mesh-ancestor
91927682|NCT04472689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927683|NCT04472689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943323|NCT02358850|Acetaminophen|acetaminophen|mesh-list
91927684|NCT04472689|Sensory System Agents|sensory system agents|mesh-ancestor
91927685|NCT04472689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927686|NCT04472689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91927687|NCT04472689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91927688|NCT04472689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91927689|NCT04472689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91927690|NCT04472689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927691|NCT02405013|Ribavirin|ribavirin|mesh-list
91927692|NCT02405013|Sofosbuvir|sofosbuvir|mesh-list
91927693|NCT02405013|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91927694|NCT02405013|Ledipasvir|ledipasvir|mesh-list
91927695|NCT02405013|Antimetabolites|antimetabolites|mesh-ancestor
91927696|NCT02405013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927697|NCT02405013|Antiviral Agents|antiviral agents|mesh-ancestor
91927698|NCT02405013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927699|NCT02173145|Azithromycin|azithromycin|mesh-list
91927700|NCT02173145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927701|NCT02173145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927702|NCT00670033|Travoprost|travoprost|mesh-list
91927703|NCT00670033|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91927704|NCT00670033|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91927705|NCT00670033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91927706|NCT02283775|Dexamethasone|dexamethasone|mesh-list
91927707|NCT02283775|Pomalidomide|pomalidomide|mesh-list
91927708|NCT02283775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927709|NCT02283775|Antiemetics|antiemetics|mesh-ancestor
91927710|NCT02283775|Autonomic Agents|autonomic agents|mesh-ancestor
91927711|NCT02283775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927712|NCT02283775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927713|NCT02283775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927714|NCT02283775|Glucocorticoids|glucocorticoids|mesh-ancestor
91927715|NCT02283775|Hormones|hormones|mesh-ancestor
91927716|NCT02283775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927717|NCT02283775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91927718|NCT02283775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927719|NCT02283775|Immunologic Factors|immunologic factors|mesh-ancestor
91927720|NCT02283775|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91927721|NCT02283775|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91927722|NCT02283775|Growth Substances|growth substances|mesh-ancestor
91927723|NCT02283775|Growth Inhibitors|growth inhibitors|mesh-ancestor
91927724|NCT04479891|Itraconazole|itraconazole|mesh-list
91927725|NCT04479891|Antifungal Agents|antifungal agents|mesh-ancestor
91927726|NCT04479891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927727|NCT04479891|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91927728|NCT04479891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91927729|NCT04479891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927730|NCT04479891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927731|NCT04479891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91927732|NCT04479891|Hormone Antagonists|hormone antagonists|mesh-ancestor
91927733|NCT04479891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927734|NCT04479891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927735|NCT04479891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91927737|NCT02281201|Hemostatics|hemostatics|mesh-ancestor
91927738|NCT02281201|Coagulants|coagulants|mesh-ancestor
91927739|NCT02281279|Rituximab|rituximab|mesh-list
91927740|NCT02281279|Lenalidomide|lenalidomide|mesh-list
91927741|NCT02281279|Romidepsin|romidepsin|mesh-list
91927742|NCT02281279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91927743|NCT02281279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927744|NCT02281279|Immunologic Factors|immunologic factors|mesh-ancestor
91927745|NCT02281279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927746|NCT02281279|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927747|NCT02281279|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91927748|NCT02281279|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91927749|NCT02281279|Growth Substances|growth substances|mesh-ancestor
91927750|NCT02281279|Growth Inhibitors|growth inhibitors|mesh-ancestor
91927751|NCT02281279|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91927752|NCT02281279|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91927753|NCT02281279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927754|NCT02281279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927755|NCT02173457|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91927756|NCT02173457|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91927757|NCT02173457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927758|NCT02173457|Incretins|incretins|mesh-ancestor
91927760|NCT02173457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91927761|NCT02173457|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91927762|NCT02173457|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927763|NCT02173457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927764|NCT02173457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927765|NCT00805129|Everolimus|everolimus|mesh-list
91927766|NCT00805129|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91927767|NCT00805129|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91927768|NCT00805129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927769|NCT00805129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927770|NCT00805129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91927771|NCT00805129|Immunologic Factors|immunologic factors|mesh-ancestor
91927772|NCT00805129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927773|NCT00805129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927774|NCT02165813|Nitazoxanide|nitazoxanide|mesh-list
91927775|NCT02165813|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91927776|NCT02165813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927777|NCT00501709|Abatacept|abatacept|mesh-list
91927778|NCT00501709|Immunosuppressive Agents|immunosuppressive agents|mesh-list
91927779|NCT00501709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91927780|NCT00501709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927781|NCT00501709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91927782|NCT00501709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927783|NCT00501709|Immunologic Factors|immunologic factors|mesh-ancestor
91927784|NCT00501709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927785|NCT00501709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927786|NCT02273635|Andrographolide|andrographolide|mesh-list
91927787|NCT02273635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91927788|NCT02273635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91927789|NCT02273635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91927790|NCT02273635|Analgesics|analgesics|mesh-ancestor
91927791|NCT02273635|Sensory System Agents|sensory system agents|mesh-ancestor
91927792|NCT02273635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927793|NCT02273635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927794|NCT02273635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91927795|NCT02273635|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91927796|NCT02273635|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91927797|NCT02273635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927798|NCT02273635|Antiviral Agents|antiviral agents|mesh-ancestor
91927799|NCT02273635|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91927800|NCT02170415|Pregabalin|pregabalin|mesh-list
91927801|NCT02170415|Anesthetics|anesthetics|mesh-list
91927802|NCT02170415|Anesthetics, Local|anesthetics, local|mesh-list
91927803|NCT02170415|Analgesics|analgesics|mesh-ancestor
91927804|NCT02170415|Sensory System Agents|sensory system agents|mesh-ancestor
91927805|NCT02170415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927806|NCT02170415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927807|NCT02170415|Anticonvulsants|anticonvulsants|mesh-ancestor
91927808|NCT02170415|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91927809|NCT02170415|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91927810|NCT02170415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927811|NCT02170415|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91927812|NCT02170415|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91927813|NCT02170415|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91927814|NCT02170415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91927815|NCT02170415|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91927816|NCT00622063|Beta-lapachone|beta-lapachone|mesh-list
91927817|NCT00622063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927818|NCT00622063|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91927819|NCT00622063|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91927820|NCT00622063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927821|NCT00622063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927822|NCT00622063|Antiviral Agents|antiviral agents|mesh-ancestor
91927823|NCT02173691|Tiotropium Bromide|tiotropium bromide|mesh-list
91927824|NCT02173691|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91927825|NCT02173691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927826|NCT02173691|Autonomic Agents|autonomic agents|mesh-ancestor
91927827|NCT02173691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927828|NCT02173691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943325|NCT02358850|Oxycodone|oxycodone|mesh-list
91927829|NCT02173691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927830|NCT02173691|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927831|NCT02173691|Parasympatholytics|parasympatholytics|mesh-ancestor
91927832|NCT02173691|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91927833|NCT02173691|Cholinergic Agents|cholinergic agents|mesh-ancestor
91927834|NCT02173691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927835|NCT02173691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927836|NCT02173691|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91927837|NCT02173691|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91927838|NCT02173691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91927839|NCT02173691|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927841|NCT02274259|Aflibercept|aflibercept|mesh-list
91927842|NCT02274259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91927843|NCT02274259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91927844|NCT02274259|Growth Substances|growth substances|mesh-ancestor
91927845|NCT02274259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927847|NCT02274259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927848|NCT05571111|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91927849|NCT05571111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91927850|NCT05571111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927851|NCT02404623|Vitamin D|vitamin d|mesh-list
91927853|NCT02404623|Micronutrients|micronutrients|mesh-ancestor
91927854|NCT02404623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927855|NCT02404623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91927856|NCT02170571|Dabigatran|dabigatran|mesh-list
91927857|NCT02170571|Antithrombins|antithrombins|mesh-ancestor
91927858|NCT02170571|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91927859|NCT02170571|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927860|NCT02170571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927861|NCT02170571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927862|NCT02170571|Anticoagulants|anticoagulants|mesh-ancestor
91927863|NCT04481841|Vitamins|vitamins|mesh-list
91927864|NCT04481841|Vitamin E|vitamin e|mesh-list
91927865|NCT04481841|Riboflavin|riboflavin|mesh-list
91927866|NCT04481841|Micronutrients|micronutrients|mesh-ancestor
91927867|NCT04481841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927868|NCT04481841|Vitamin B Complex|vitamin b complex|mesh-ancestor
91927869|NCT04481841|Antioxidants|antioxidants|mesh-ancestor
91927870|NCT04481841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927871|NCT04481841|Protective Agents|protective agents|mesh-ancestor
91927872|NCT04481841|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91927873|NCT04481841|Dermatologic Agents|dermatologic agents|mesh-ancestor
91927874|NCT02388477|Doxycycline|doxycycline|mesh-list
91927875|NCT02388477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91927876|NCT02388477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927877|NCT02388477|Antimalarials|antimalarials|mesh-ancestor
91927878|NCT02388477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91927879|NCT02388477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91927880|NCT02166359|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91927882|NCT02166359|Dialysis Solutions|dialysis solutions|mesh-ancestor
91927883|NCT00488839|Baclofen|baclofen|mesh-list
91927884|NCT00488839|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91927885|NCT00488839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927886|NCT00488839|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91927887|NCT00488839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927888|NCT00488839|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91927889|NCT00488839|GABA Agonists|gaba agonists|mesh-ancestor
91927890|NCT00488839|GABA Agents|gaba agents|mesh-ancestor
91927891|NCT00488839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927892|NCT00488839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927893|NCT02255747|Lactulose|lactulose|mesh-list
91927894|NCT02255747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927895|NCT01654731|Bezafibrate|bezafibrate|mesh-list
91927896|NCT01654731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91927897|NCT01654731|Antimetabolites|antimetabolites|mesh-ancestor
91927898|NCT01654731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927899|NCT01654731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91927900|NCT00485563|Folic Acid|folic acid|mesh-list
91927901|NCT00485563|Vitamin B Complex|vitamin b complex|mesh-list
91927902|NCT00485563|Interferons|interferons|mesh-list
91927903|NCT00485563|Interferon-alpha|interferon-alpha|mesh-list
91927904|NCT00485563|Interleukin-2|interleukin-2|mesh-list
91927905|NCT00485563|Keyhole-limpet hemocyanin|keyhole-limpet hemocyanin|mesh-list
91927906|NCT00485563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91927907|NCT00485563|Antiviral Agents|antiviral agents|mesh-ancestor
91927908|NCT00485563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927909|NCT00485563|Immunologic Factors|immunologic factors|mesh-ancestor
91927910|NCT00485563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927911|NCT00485563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91927912|NCT00485563|Analgesics|analgesics|mesh-ancestor
91927913|NCT00485563|Sensory System Agents|sensory system agents|mesh-ancestor
91927914|NCT00485563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927916|NCT00485563|Vitamins|vitamins|mesh-ancestor
91927917|NCT00485563|Micronutrients|micronutrients|mesh-ancestor
91927918|NCT00485563|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91927919|NCT02170805|Pantoprazole|pantoprazole|mesh-list
91927920|NCT02170805|Dabigatran|dabigatran|mesh-list
91927921|NCT02170805|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91927922|NCT02170805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927923|NCT02170805|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91927924|NCT02170805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927925|NCT02170805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927926|NCT02170805|Antithrombins|antithrombins|mesh-ancestor
91927927|NCT02170805|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91927928|NCT02170805|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927932|NCT00606697|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91927933|NCT00606697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927934|NCT00606697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927935|NCT00606697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927936|NCT00606697|Antiemetics|antiemetics|mesh-ancestor
91927937|NCT00606697|Autonomic Agents|autonomic agents|mesh-ancestor
91927938|NCT00606697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927939|NCT00606697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91927940|NCT02404077|Clonidine|clonidine|mesh-list
91927941|NCT02404077|Analgesics|analgesics|mesh-ancestor
91927942|NCT02404077|Sensory System Agents|sensory system agents|mesh-ancestor
91927943|NCT02404077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927944|NCT02404077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927945|NCT02404077|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91927946|NCT02404077|Sympatholytics|sympatholytics|mesh-ancestor
91927947|NCT02404077|Autonomic Agents|autonomic agents|mesh-ancestor
91927948|NCT02404077|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91927949|NCT02404077|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91927950|NCT02404077|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91927951|NCT02404077|Adrenergic Agents|adrenergic agents|mesh-ancestor
91927952|NCT02404077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927953|NCT02404077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927954|NCT02174939|Cilostazol|cilostazol|mesh-list
91927955|NCT02174939|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91927956|NCT02174939|Autonomic Agents|autonomic agents|mesh-ancestor
91927957|NCT02174939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91927958|NCT02174939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927959|NCT02174939|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91927960|NCT02174939|Respiratory System Agents|respiratory system agents|mesh-ancestor
91927961|NCT02174939|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91927962|NCT02174939|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91927963|NCT02174939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927964|NCT02174939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91927965|NCT02174939|Vasodilator Agents|vasodilator agents|mesh-ancestor
91927966|NCT02174939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91927967|NCT02174939|Protective Agents|protective agents|mesh-ancestor
91927968|NCT02174939|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91927969|NCT02174939|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91927970|NCT02174939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927971|NCT02404233|Darunavir|darunavir|mesh-list
91927972|NCT02404233|Cobicistat|cobicistat|mesh-list
91927973|NCT02404233|Rilpivirine|rilpivirine|mesh-list
91927974|NCT02404233|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
91927975|NCT02404233|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91927976|NCT02404233|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91927977|NCT02404233|Protease Inhibitors|protease inhibitors|mesh-ancestor
91927978|NCT02404233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91927979|NCT02404233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927980|NCT02404233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91927981|NCT02404233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91927982|NCT02404233|Antiviral Agents|antiviral agents|mesh-ancestor
91927983|NCT02404233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91927984|NCT02404233|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91927985|NCT02404233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91927986|NCT02404233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91927987|NCT02404233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91927988|NCT00603577|Xaliproden|xaliproden|mesh-list
91927989|NCT00603577|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91927990|NCT00603577|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91927991|NCT00603577|Serotonin Agents|serotonin agents|mesh-ancestor
91927992|NCT00603577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91927993|NCT00603577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91927994|NCT00603577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91927995|NCT02178293|Ketoprofen|ketoprofen|mesh-list
91927996|NCT02178293|Ketoprofen lysine|ketoprofen lysine|mesh-list
91927997|NCT02178293|Benzydamine|benzydamine|mesh-list
91927998|NCT02178293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91927999|NCT02178293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928000|NCT02178293|Analgesics|analgesics|mesh-ancestor
91928001|NCT02178293|Sensory System Agents|sensory system agents|mesh-ancestor
91928002|NCT02178293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928003|NCT02178293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928004|NCT02178293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928005|NCT02178293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928006|NCT02178293|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928007|NCT02178293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928008|NCT02178293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928009|NCT03170895|Sorafenib|sorafenib|mesh-list
91928010|NCT03170895|Homoharringtonine|homoharringtonine|mesh-list
91928011|NCT03170895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928012|NCT03170895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91928013|NCT03170895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928014|NCT03170895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928015|NCT03170895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91928016|NCT03170895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91928017|NCT02277847|Cytarabine|cytarabine|mesh-list
91928018|NCT02277847|Idarubicin|idarubicin|mesh-list
91928019|NCT02277847|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91928020|NCT02277847|Antimetabolites|antimetabolites|mesh-ancestor
91928021|NCT02277847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928022|NCT02277847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928023|NCT02277847|Antiviral Agents|antiviral agents|mesh-ancestor
91928024|NCT02277847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928025|NCT02277847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928026|NCT02277847|Immunologic Factors|immunologic factors|mesh-ancestor
91928027|NCT02277847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928028|NCT02277847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91928029|NCT02277847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91928030|NCT02277847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91928031|NCT02277847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928032|NCT01457781|Nitric Oxide|nitric oxide|mesh-list
91928033|NCT01457781|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91928034|NCT01457781|Autonomic Agents|autonomic agents|mesh-ancestor
91928035|NCT01457781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928036|NCT01457781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928037|NCT01457781|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91928038|NCT01457781|Respiratory System Agents|respiratory system agents|mesh-ancestor
91928039|NCT01457781|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91928040|NCT01457781|Antioxidants|antioxidants|mesh-ancestor
91928041|NCT01457781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928042|NCT01457781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928043|NCT01457781|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91928044|NCT01457781|Vasodilator Agents|vasodilator agents|mesh-ancestor
91928045|NCT01457781|Gasotransmitters|gasotransmitters|mesh-ancestor
91928046|NCT01457781|Protective Agents|protective agents|mesh-ancestor
91928047|NCT00468403|Mycophenolic Acid|mycophenolic acid|mesh-list
91928048|NCT00468403|Abatacept|abatacept|mesh-list
91928049|NCT00468403|Tacrolimus|tacrolimus|mesh-list
91928050|NCT00468403|Basiliximab|basiliximab|mesh-list
91928051|NCT00468403|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928052|NCT00468403|Immunologic Factors|immunologic factors|mesh-ancestor
91928053|NCT00468403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928054|NCT00468403|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91943329|NCT02358850|Analgesics|analgesics|mesh-ancestor
91928055|NCT00468403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928056|NCT00468403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928057|NCT00468403|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91928058|NCT00468403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928059|NCT00468403|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91928060|NCT00468403|Antitubercular Agents|antitubercular agents|mesh-ancestor
91928061|NCT00468403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91928062|NCT00468403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928063|NCT00468403|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91928064|NCT00468403|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91928065|NCT00468403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928066|NCT02175017|Nivolumab|nivolumab|mesh-list
91928067|NCT02175017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91928068|NCT02175017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928069|NCT02175017|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91928070|NCT02175017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928071|NCT02178449|Dexamethasone|dexamethasone|mesh-list
91928072|NCT02178449|Dexamethasone acetate|dexamethasone acetate|mesh-list
91928073|NCT02178449|Ropivacaine|ropivacaine|mesh-list
91928074|NCT02178449|BB 1101|bb 1101|mesh-list
91928075|NCT02178449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928076|NCT02178449|Antiemetics|antiemetics|mesh-ancestor
91928077|NCT02178449|Autonomic Agents|autonomic agents|mesh-ancestor
91928078|NCT02178449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928079|NCT02178449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928080|NCT02178449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91928081|NCT02178449|Glucocorticoids|glucocorticoids|mesh-ancestor
91928082|NCT02178449|Hormones|hormones|mesh-ancestor
91928083|NCT02178449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928084|NCT02178449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91928085|NCT02178449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928086|NCT02178449|Anesthetics, Local|anesthetics, local|mesh-ancestor
91928087|NCT02178449|Anesthetics|anesthetics|mesh-ancestor
91928088|NCT02178449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928089|NCT02178449|Sensory System Agents|sensory system agents|mesh-ancestor
91928090|NCT02178449|Protease Inhibitors|protease inhibitors|mesh-ancestor
91928091|NCT02178449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928092|NCT02178449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928093|NCT02387931|Vitamin D|vitamin d|mesh-list
91928094|NCT02387931|Ergocalciferols|ergocalciferols|mesh-list
91928095|NCT02387931|Cholecalciferol|cholecalciferol|mesh-list
91928096|NCT02387931|Vitamins|vitamins|mesh-list
91928097|NCT02387931|Micronutrients|micronutrients|mesh-ancestor
91928098|NCT02387931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928099|NCT02387931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91928100|NCT02387931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91928101|NCT02281669|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
91928102|NCT02281669|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91928103|NCT02281669|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91928104|NCT02281669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928105|NCT02281669|Schistosomicides|schistosomicides|mesh-ancestor
91928106|NCT02281669|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91928107|NCT02281669|Anthelmintics|anthelmintics|mesh-ancestor
91928108|NCT02178683|Mycophenolic Acid|mycophenolic acid|mesh-list
91928109|NCT02178683|Tacrolimus|tacrolimus|mesh-list
91928110|NCT02178683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928111|NCT02178683|Immunologic Factors|immunologic factors|mesh-ancestor
91928112|NCT02178683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928113|NCT02178683|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91928114|NCT02178683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928115|NCT02178683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928116|NCT02178683|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91928117|NCT02178683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928118|NCT02178683|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91928119|NCT02178683|Antitubercular Agents|antitubercular agents|mesh-ancestor
91928120|NCT02178683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91928121|NCT02178683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928122|NCT03170739|Dopamine|dopamine|mesh-list
91928123|NCT03170739|Dexmedetomidine|dexmedetomidine|mesh-list
91928124|NCT03170739|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91928125|NCT03170739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928126|NCT03170739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928127|NCT03170739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928128|NCT03170739|Analgesics|analgesics|mesh-ancestor
91928129|NCT03170739|Sensory System Agents|sensory system agents|mesh-ancestor
91928130|NCT03170739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928131|NCT03170739|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91928132|NCT03170739|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91928133|NCT03170739|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91928134|NCT03170739|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928135|NCT03170739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928136|NCT03170739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928137|NCT03170739|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91928138|NCT03170739|Sympathomimetics|sympathomimetics|mesh-ancestor
91928139|NCT03170739|Autonomic Agents|autonomic agents|mesh-ancestor
91928141|NCT03170739|Protective Agents|protective agents|mesh-ancestor
91928143|NCT05309421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91928144|NCT05309421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928145|NCT05309421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91928146|NCT05309421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928147|NCT00459745|Fenofibrate|fenofibrate|mesh-list
91928148|NCT00459745|Pravastatin|pravastatin|mesh-list
91928149|NCT00459745|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91928150|NCT00459745|Antimetabolites|antimetabolites|mesh-ancestor
91928151|NCT00459745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928152|NCT00459745|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91928153|NCT00459745|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91928154|NCT00459745|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91928155|NCT00459745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928156|NCT02178761|Chromium|chromium|mesh-list
91928159|NCT02178761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91928160|NCT02178761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928161|NCT02178761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928162|NCT02178761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928163|NCT02178761|Immunologic Factors|immunologic factors|mesh-ancestor
91928164|NCT02178761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928165|NCT02178761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928166|NCT02178761|Trace Elements|trace elements|mesh-ancestor
91928167|NCT02178761|Micronutrients|micronutrients|mesh-ancestor
91928168|NCT02742181|Alvimopan|alvimopan|mesh-list
91928169|NCT02742181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91928170|NCT02175407|Itraconazole|itraconazole|mesh-list
91928171|NCT02175407|Antifungal Agents|antifungal agents|mesh-ancestor
91928172|NCT02175407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928173|NCT02175407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91928174|NCT02175407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91928175|NCT02175407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928176|NCT02175407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928177|NCT02175407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91928178|NCT02175407|Hormone Antagonists|hormone antagonists|mesh-ancestor
91928179|NCT02175407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928180|NCT02175407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928181|NCT02175407|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91928182|NCT02182193|Nintedanib|nintedanib|mesh-list
91928183|NCT02182193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928184|NCT02182193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91928185|NCT02182193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928186|NCT02182193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928187|NCT02175485|Fexofenadine|fexofenadine|mesh-list
91928188|NCT02175485|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91928189|NCT02175485|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91928190|NCT02175485|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91928191|NCT02175485|Histamine Antagonists|histamine antagonists|mesh-ancestor
91928192|NCT02175485|Histamine Agents|histamine agents|mesh-ancestor
91928193|NCT02175485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928194|NCT02175485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928195|NCT02175485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928196|NCT04575779|Cyclosporine|cyclosporine|mesh-list
91928197|NCT04575779|Cyclosporins|cyclosporins|mesh-list
91928198|NCT04575779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928199|NCT04575779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943333|NCT02358850|Antipyretics|antipyretics|mesh-ancestor
91928200|NCT04575779|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928201|NCT04575779|Immunologic Factors|immunologic factors|mesh-ancestor
91928202|NCT04575779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928203|NCT04575779|Antifungal Agents|antifungal agents|mesh-ancestor
91928204|NCT04575779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928205|NCT04575779|Dermatologic Agents|dermatologic agents|mesh-ancestor
91928206|NCT04575779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928207|NCT04575779|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91928208|NCT02741713|Lidocaine|lidocaine|mesh-list
91928209|NCT02741713|Clonidine|clonidine|mesh-list
91928210|NCT02741713|Epinephrine|epinephrine|mesh-list
91928211|NCT02741713|Racepinephrine|racepinephrine|mesh-list
91928212|NCT02741713|Bupivacaine|bupivacaine|mesh-list
91928213|NCT02741713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91928214|NCT02741713|Epinephryl borate|epinephryl borate|mesh-list
91928215|NCT02741713|Anesthetics, Local|anesthetics, local|mesh-ancestor
91928217|NCT02741713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928218|NCT02741713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928219|NCT02741713|Sensory System Agents|sensory system agents|mesh-ancestor
91928220|NCT02741713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928221|NCT02741713|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91928222|NCT02741713|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91928223|NCT02741713|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91928224|NCT02741713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928225|NCT02741713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928226|NCT02741713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91928227|NCT02741713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91928228|NCT02741713|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928229|NCT02741713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928230|NCT02741713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91928231|NCT02741713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91928232|NCT02741713|Autonomic Agents|autonomic agents|mesh-ancestor
91928233|NCT02741713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91928234|NCT02741713|Respiratory System Agents|respiratory system agents|mesh-ancestor
91928235|NCT02741713|Mydriatics|mydriatics|mesh-ancestor
91928236|NCT02741713|Sympathomimetics|sympathomimetics|mesh-ancestor
91928237|NCT02741713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91928238|NCT02741713|Analgesics|analgesics|mesh-ancestor
91928239|NCT02741713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928240|NCT02741713|Sympatholytics|sympatholytics|mesh-ancestor
91928241|NCT02741713|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91928242|NCT00459277|Fentanyl|fentanyl|mesh-list
91928243|NCT00459277|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91928244|NCT00459277|Narcotics|narcotics|mesh-ancestor
91928245|NCT00459277|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928246|NCT00459277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928247|NCT00459277|Analgesics|analgesics|mesh-ancestor
91928248|NCT00459277|Sensory System Agents|sensory system agents|mesh-ancestor
91928249|NCT00459277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928250|NCT00459277|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91928251|NCT00459277|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91928252|NCT00459277|Anesthetics, General|anesthetics, general|mesh-ancestor
91928253|NCT00459277|Anesthetics|anesthetics|mesh-ancestor
91928254|NCT00602329|Leucovorin|leucovorin|mesh-list
91928255|NCT00602329|Bevacizumab|bevacizumab|mesh-list
91928256|NCT00602329|Fluorouracil|fluorouracil|mesh-list
91928257|NCT00602329|Oxaliplatin|oxaliplatin|mesh-list
91928258|NCT00602329|Calcium|calcium|mesh-list
91928259|NCT00602329|Levoleucovorin|levoleucovorin|mesh-list
91928260|NCT00602329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91928261|NCT00602329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928262|NCT00602329|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91928263|NCT00602329|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91928264|NCT00602329|Growth Substances|growth substances|mesh-ancestor
91928265|NCT00602329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928266|NCT00602329|Growth Inhibitors|growth inhibitors|mesh-ancestor
91928267|NCT00602329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91928268|NCT00602329|Antimetabolites|antimetabolites|mesh-ancestor
91928269|NCT00602329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928270|NCT00602329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91928271|NCT00602329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928272|NCT00602329|Immunologic Factors|immunologic factors|mesh-ancestor
91928273|NCT00602329|Antidotes|antidotes|mesh-ancestor
91928274|NCT00602329|Protective Agents|protective agents|mesh-ancestor
91928275|NCT00602329|Vitamin B Complex|vitamin b complex|mesh-ancestor
91928276|NCT00602329|Vitamins|vitamins|mesh-ancestor
91928277|NCT00602329|Micronutrients|micronutrients|mesh-ancestor
91928278|NCT02182505|Fenoterol|fenoterol|mesh-list
91928279|NCT02182505|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
91928280|NCT02182505|Ipratropium|ipratropium|mesh-list
91928281|NCT02182505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91928282|NCT02182505|Autonomic Agents|autonomic agents|mesh-ancestor
91928283|NCT02182505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928284|NCT02182505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928285|NCT02182505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91928286|NCT02182505|Respiratory System Agents|respiratory system agents|mesh-ancestor
91928287|NCT02182505|Sympathomimetics|sympathomimetics|mesh-ancestor
91928288|NCT02182505|Tocolytic Agents|tocolytic agents|mesh-ancestor
91928289|NCT02182505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91928290|NCT02182505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91928291|NCT02182505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91928292|NCT02182505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91928293|NCT02182505|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928294|NCT02182505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928295|NCT02182505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928296|NCT02182505|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91928297|NCT02182505|Cholinergic Agents|cholinergic agents|mesh-ancestor
91928298|NCT02387619|Amlodipine|amlodipine|mesh-list
91928299|NCT02387619|Telmisartan|telmisartan|mesh-list
91928300|NCT02387619|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
91928301|NCT02387619|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91928302|NCT02387619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928303|NCT02387619|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91928304|NCT02387619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928305|NCT02387619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928306|NCT02387619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91928307|NCT02387619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928308|NCT02387619|Vasodilator Agents|vasodilator agents|mesh-ancestor
91928309|NCT02387619|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91928312|NCT02387619|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91928313|NCT02387619|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91928314|NCT02387619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928315|NCT02387619|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91928316|NCT02387619|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91928317|NCT03537443|Vitamin D|vitamin d|mesh-list
91928318|NCT03537443|Cholecalciferol|cholecalciferol|mesh-list
91928319|NCT03537443|Vitamins|vitamins|mesh-ancestor
91928320|NCT03537443|Micronutrients|micronutrients|mesh-ancestor
91928321|NCT03537443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928322|NCT03537443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91928323|NCT03537443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91928324|NCT00595699|Escitalopram|escitalopram|mesh-list
91928325|NCT00595699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91928326|NCT00595699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91928327|NCT00595699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928328|NCT00595699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928329|NCT00595699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928330|NCT00595699|Serotonin Agents|serotonin agents|mesh-ancestor
91928331|NCT00595699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928332|NCT02256215|Vitamin D|vitamin d|mesh-list
91928333|NCT02256215|Vitamins|vitamins|mesh-ancestor
91928334|NCT02256215|Micronutrients|micronutrients|mesh-ancestor
91928335|NCT02256215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928336|NCT02256215|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91928337|NCT02182583|Oxitropium|oxitropium|mesh-list
91928338|NCT02182583|Parasympatholytics|parasympatholytics|mesh-ancestor
91928339|NCT02182583|Autonomic Agents|autonomic agents|mesh-ancestor
91928340|NCT02182583|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928341|NCT02182583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928342|NCT03133975|Vitamin D|vitamin d|mesh-list
91928343|NCT03133975|Cholecalciferol|cholecalciferol|mesh-list
91928344|NCT03133975|Vitamins|vitamins|mesh-ancestor
91928345|NCT03133975|Micronutrients|micronutrients|mesh-ancestor
91928346|NCT03133975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928347|NCT03133975|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91928348|NCT03133975|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91928349|NCT02282137|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91928350|NCT02282137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91928351|NCT02282137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928352|NCT02182661|Oxitropium|oxitropium|mesh-list
91928353|NCT02182661|Parasympatholytics|parasympatholytics|mesh-ancestor
91928354|NCT02182661|Autonomic Agents|autonomic agents|mesh-ancestor
91928355|NCT02182661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928356|NCT02182661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928357|NCT02663271|Bevacizumab|bevacizumab|mesh-list
91928358|NCT02663271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91928359|NCT02663271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928360|NCT02663271|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91928361|NCT02663271|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91928362|NCT02663271|Growth Substances|growth substances|mesh-ancestor
91928363|NCT02663271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928364|NCT02663271|Growth Inhibitors|growth inhibitors|mesh-ancestor
91928365|NCT00659191|Cabotegravir|cabotegravir|mesh-list
91928366|NCT00659191|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91928367|NCT00659191|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91928368|NCT00659191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928369|NCT00659191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928370|NCT00659191|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91928371|NCT00659191|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91928372|NCT00659191|Antiviral Agents|antiviral agents|mesh-ancestor
91928373|NCT00659191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928375|NCT02182739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928376|NCT02182739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928377|NCT02182739|Analgesics|analgesics|mesh-ancestor
91928378|NCT02182739|Sensory System Agents|sensory system agents|mesh-ancestor
91928379|NCT02182739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928380|NCT02182739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928381|NCT02182739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928382|NCT02182739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928383|NCT02182739|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91928384|NCT02182739|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928385|NCT02182739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928386|NCT02182739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928387|NCT00583609|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
91928388|NCT00583609|Laxatives|laxatives|mesh-ancestor
91928389|NCT00583609|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91928390|NCT03170115|Aspirin|aspirin|mesh-list
91928391|NCT03170115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928392|NCT03170115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928393|NCT03170115|Analgesics|analgesics|mesh-ancestor
91928394|NCT03170115|Sensory System Agents|sensory system agents|mesh-ancestor
91928395|NCT03170115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928396|NCT03170115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928397|NCT03170115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928398|NCT03170115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928399|NCT03170115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91928400|NCT03170115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91928401|NCT03170115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928402|NCT03170115|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91928403|NCT03170115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928404|NCT03170115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928406|NCT03169959|Metformin|metformin|mesh-list
91928407|NCT03169959|Dapagliflozin|dapagliflozin|mesh-list
91928408|NCT03169959|Saxagliptin|saxagliptin|mesh-list
91928409|NCT03169959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928410|NCT03169959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928411|NCT03169959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91928412|NCT03169959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928413|NCT03169959|Incretins|incretins|mesh-ancestor
91928414|NCT03169959|Hormones|hormones|mesh-ancestor
91928415|NCT03169959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928416|NCT03169959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91928417|NCT03169959|Protease Inhibitors|protease inhibitors|mesh-ancestor
91928418|NCT03169959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928419|NCT02176187|Fenoterol|fenoterol|mesh-list
91928420|NCT02176187|Fenoterol, ipratropium drug combination|fenoterol, ipratropium drug combination|mesh-list
91928421|NCT02176187|Ipratropium|ipratropium|mesh-list
91928422|NCT02176187|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91928423|NCT02176187|Autonomic Agents|autonomic agents|mesh-ancestor
91928424|NCT02176187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928425|NCT02176187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928426|NCT02176187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91928427|NCT02176187|Respiratory System Agents|respiratory system agents|mesh-ancestor
91928428|NCT02176187|Sympathomimetics|sympathomimetics|mesh-ancestor
91928429|NCT02176187|Tocolytic Agents|tocolytic agents|mesh-ancestor
91928430|NCT02176187|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91928431|NCT02176187|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91928432|NCT02176187|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91928433|NCT02176187|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91928434|NCT02176187|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928435|NCT02176187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928436|NCT02176187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928437|NCT02176187|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91928438|NCT02176187|Cholinergic Agents|cholinergic agents|mesh-ancestor
91928439|NCT02176499|Telmisartan|telmisartan|mesh-list
91928440|NCT02176499|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928441|NCT02176499|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91928442|NCT02176499|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91928443|NCT02176499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928444|NCT02176733|Cyclosporine|cyclosporine|mesh-list
91928445|NCT02176733|Cyclosporins|cyclosporins|mesh-list
91928446|NCT02176733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928447|NCT02176733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928448|NCT02176733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928449|NCT02176733|Immunologic Factors|immunologic factors|mesh-ancestor
91928450|NCT02176733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928451|NCT02176733|Antifungal Agents|antifungal agents|mesh-ancestor
91928452|NCT02176733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928453|NCT02176733|Dermatologic Agents|dermatologic agents|mesh-ancestor
91928454|NCT02176733|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928455|NCT02176733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91928456|NCT03536741|Anesthetics|anesthetics|mesh-list
91928457|NCT03536741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
91928458|NCT03536741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928459|NCT03536741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928460|NCT03536741|Anesthetics, General|anesthetics, general|mesh-ancestor
91928461|NCT02403687|Topiramate|topiramate|mesh-list
91928480|NCT02403687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928481|NCT02403687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928482|NCT02403687|Sensory System Agents|sensory system agents|mesh-ancestor
91928483|NCT02403687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928484|NCT02403687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91928485|NCT02403687|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91928486|NCT02403687|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91928487|NCT02403687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928488|NCT02403687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928489|NCT02403687|Analgesics|analgesics|mesh-ancestor
91928490|NCT02403687|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91928491|NCT02403687|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91928492|NCT02403687|Anesthetics, General|anesthetics, general|mesh-ancestor
91928493|NCT02403687|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91928494|NCT02403687|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91928495|NCT02403687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928496|NCT02403687|Anticonvulsants|anticonvulsants|mesh-ancestor
91928497|NCT02403687|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91928498|NCT02403687|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91928499|NCT02403687|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91928500|NCT02403687|Antimanic Agents|antimanic agents|mesh-ancestor
91928501|NCT02403687|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928503|NCT02403687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928504|NCT02403687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928505|NCT02403687|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928506|NCT02403687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928507|NCT02403687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928508|NCT02403687|Antipruritics|antipruritics|mesh-ancestor
91928509|NCT02403687|Dermatologic Agents|dermatologic agents|mesh-ancestor
91928510|NCT02403687|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91928511|NCT02403687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91928512|NCT02403687|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91928513|NCT02403687|GABA Agonists|gaba agonists|mesh-ancestor
91928514|NCT02403687|GABA Agents|gaba agents|mesh-ancestor
91928515|NCT02403687|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91928516|NCT02403687|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91928517|NCT02403687|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91928518|NCT02403687|Serotonin Agents|serotonin agents|mesh-ancestor
91928519|NCT02403687|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91928520|NCT02403687|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91928521|NCT02403687|Antidepressive Agents|antidepressive agents|mesh-ancestor
91928522|NCT02403687|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91928523|NCT02403687|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91928524|NCT02403687|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928525|NCT02403687|Parasympatholytics|parasympatholytics|mesh-ancestor
91928526|NCT02403687|Autonomic Agents|autonomic agents|mesh-ancestor
91928527|NCT02403687|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91928528|NCT02403687|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91928529|NCT02403687|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91928530|NCT02403687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928531|NCT02403687|Sympatholytics|sympatholytics|mesh-ancestor
91928533|NCT02742649|Bimatoprost|bimatoprost|mesh-list
91928534|NCT02742649|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91928535|NCT02742649|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91928536|NCT02742649|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928537|NCT02742649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928538|NCT02742649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928539|NCT02742649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928540|NCT02742649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91928541|NCT02742649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928542|NCT02183051|Ibuprofen|ibuprofen|mesh-list
91928543|NCT02183051|Meloxicam|meloxicam|mesh-list
91928544|NCT02183051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928545|NCT02183051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928546|NCT02183051|Analgesics|analgesics|mesh-ancestor
91928547|NCT02183051|Sensory System Agents|sensory system agents|mesh-ancestor
91928548|NCT02183051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928549|NCT02183051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928550|NCT02183051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928551|NCT02183051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928552|NCT02183051|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928553|NCT02183051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928554|NCT02183051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928555|NCT02183051|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91928558|NCT03169725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928559|NCT02403531|Docetaxel|docetaxel|mesh-list
91928560|NCT02403531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928561|NCT02403531|Tubulin Modulators|tubulin modulators|mesh-ancestor
91928562|NCT02403531|Antimitotic Agents|antimitotic agents|mesh-ancestor
91928563|NCT02403531|Mitosis Modulators|mitosis modulators|mesh-ancestor
91928564|NCT02403531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928565|NCT02183129|Diclofenac|diclofenac|mesh-list
91928566|NCT02183129|Meloxicam|meloxicam|mesh-list
91928567|NCT02183129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928568|NCT02183129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928569|NCT02183129|Analgesics|analgesics|mesh-ancestor
91928570|NCT02183129|Sensory System Agents|sensory system agents|mesh-ancestor
91928571|NCT02183129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928572|NCT02183129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928573|NCT02183129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928574|NCT02183129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928575|NCT02183129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928576|NCT02183129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928577|NCT02183129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928578|NCT02183129|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91928579|NCT02279953|Vortioxetine|vortioxetine|mesh-list
91928580|NCT02279953|Antidepressive Agents|antidepressive agents|mesh-ancestor
91928581|NCT02279953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91928582|NCT02279953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91928583|NCT02279953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91928584|NCT02279953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928585|NCT02279953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928586|NCT02279953|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91928587|NCT02279953|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91928588|NCT02279953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928589|NCT02279953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928590|NCT02279953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928591|NCT02279953|Serotonin Agents|serotonin agents|mesh-ancestor
91928592|NCT02279953|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91928593|NCT02279953|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91928594|NCT02279953|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91928595|NCT02279953|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91928596|NCT00578773|Moxifloxacin|moxifloxacin|mesh-list
91928597|NCT00578773|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91928598|NCT00578773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91928599|NCT00578773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928600|NCT00578773|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91928601|NCT00578773|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91928602|NCT00578773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928603|NCT00578773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928604|NCT00578773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928605|NCT02387307|Interferons|interferons|mesh-list
91928606|NCT02387307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928607|NCT02387307|Antiviral Agents|antiviral agents|mesh-ancestor
91928608|NCT02387307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928609|NCT02183363|Linagliptin|linagliptin|mesh-list
91928610|NCT02183363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928611|NCT02183363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928612|NCT02183363|Incretins|incretins|mesh-ancestor
91928613|NCT02183363|Hormones|hormones|mesh-ancestor
91928614|NCT02183363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928615|NCT02183363|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91928616|NCT02183363|Protease Inhibitors|protease inhibitors|mesh-ancestor
91928617|NCT02183363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928618|NCT02183363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928619|NCT02183441|Linagliptin|linagliptin|mesh-list
91928620|NCT02183441|Ritonavir|ritonavir|mesh-list
91928621|NCT02183441|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91928622|NCT02183441|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91928623|NCT02183441|Protease Inhibitors|protease inhibitors|mesh-ancestor
91928624|NCT02183441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928625|NCT02183441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928626|NCT02183441|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91928627|NCT02183441|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91928628|NCT02183441|Antiviral Agents|antiviral agents|mesh-ancestor
91928629|NCT02183441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928630|NCT02183441|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91928631|NCT02183441|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91928632|NCT02183441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928633|NCT02183441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928635|NCT02183441|Hormones|hormones|mesh-ancestor
91928636|NCT02183441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928637|NCT02183441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91928638|NCT02403219|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91928639|NCT02403219|Botulinum Toxins|botulinum toxins|mesh-list
91928640|NCT02403219|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91928641|NCT02403219|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91928642|NCT02403219|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91928643|NCT02403219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928644|NCT02403219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928645|NCT02403219|Cholinergic Agents|cholinergic agents|mesh-ancestor
91928646|NCT02403219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928647|NCT02403219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928648|NCT02403219|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91928649|NCT02403219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928650|NCT03537287|Progesterone|progesterone|mesh-list
91928651|NCT03537287|Dydrogesterone|dydrogesterone|mesh-list
91928652|NCT03537287|Progestins|progestins|mesh-ancestor
91928653|NCT03537287|Hormones|hormones|mesh-ancestor
91928654|NCT03537287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928655|NCT03537287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928656|NCT02280031|Aspirin|aspirin|mesh-list
91928657|NCT02280031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928658|NCT02280031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928659|NCT02280031|Analgesics|analgesics|mesh-ancestor
91928660|NCT02280031|Sensory System Agents|sensory system agents|mesh-ancestor
91928661|NCT02280031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928662|NCT02280031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928663|NCT02280031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928664|NCT02280031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928665|NCT02280031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91928666|NCT02280031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91928667|NCT02280031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928668|NCT02280031|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91928669|NCT02280031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928670|NCT02280031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928671|NCT02280031|Antipyretics|antipyretics|mesh-ancestor
91928672|NCT00449605|Metformin|metformin|mesh-list
91928673|NCT00449605|Glimepiride|glimepiride|mesh-list
91928674|NCT00449605|Rimonabant|rimonabant|mesh-list
91928675|NCT00449605|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928676|NCT00449605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928677|NCT00449605|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91928678|NCT00449605|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928679|NCT00449605|Immunologic Factors|immunologic factors|mesh-ancestor
91928680|NCT00449605|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91928681|NCT00449605|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
91928682|NCT00449605|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91928683|NCT00449605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928684|NCT00449605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928685|NCT00449605|Hormones|hormones|mesh-ancestor
91928686|NCT00449605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928687|NCT02774239|Immunoglobulins|immunoglobulins|mesh-list
91928688|NCT02774239|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91928689|NCT02774239|Antibodies|antibodies|mesh-list
91928690|NCT02774239|Immunoglobulin G|immunoglobulin g|mesh-list
91928691|NCT02774239|Immunologic Factors|immunologic factors|mesh-ancestor
91928692|NCT02774239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928693|NCT02280109|Tenofovir|tenofovir|mesh-list
91928694|NCT02280109|Antiviral Agents|antiviral agents|mesh-ancestor
91928695|NCT02280109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928696|NCT02280109|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91928697|NCT02280109|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91928698|NCT02280109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928699|NCT02280109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928700|NCT02280109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91928701|NCT02280109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91928703|NCT00576667|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91928704|NCT00576667|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
91928705|NCT00576667|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91928706|NCT00576667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928707|NCT00576667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928708|NCT00576667|Hormones|hormones|mesh-ancestor
91928709|NCT00576667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928710|NCT00576667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928711|NCT02403063|Neostigmine|neostigmine|mesh-list
91928712|NCT02403063|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91928713|NCT02403063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928714|NCT02403063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928715|NCT02403063|Cholinergic Agents|cholinergic agents|mesh-ancestor
91928716|NCT02403063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928717|NCT02403063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928718|NCT02403063|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91928719|NCT02403063|Autonomic Agents|autonomic agents|mesh-ancestor
91928720|NCT02403063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928721|NCT02177357|Pramipexole|pramipexole|mesh-list
91928722|NCT02177357|Antioxidants|antioxidants|mesh-ancestor
91928723|NCT02177357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928724|NCT02177357|Protective Agents|protective agents|mesh-ancestor
91928725|NCT02177357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928726|NCT02177357|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91928727|NCT02177357|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91928728|NCT02177357|Dopamine Agonists|dopamine agonists|mesh-ancestor
91928729|NCT02177357|Dopamine Agents|dopamine agents|mesh-ancestor
91928730|NCT02177357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928731|NCT02386449|Mannitol|mannitol|mesh-list
91928732|NCT02386449|Bisacodyl|bisacodyl|mesh-list
91928733|NCT02386449|Picosulfate sodium|picosulfate sodium|mesh-list
91928734|NCT02386449|Magnesium Oxide|magnesium oxide|mesh-list
91928735|NCT02386449|Citric Acid|citric acid|mesh-list
91928736|NCT02386449|Sodium Citrate|sodium citrate|mesh-list
91928737|NCT02386449|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91928738|NCT02386449|Diuretics|diuretics|mesh-ancestor
91928739|NCT02386449|Natriuretic Agents|natriuretic agents|mesh-ancestor
91928740|NCT02386449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928741|NCT02386449|Cathartics|cathartics|mesh-ancestor
91928742|NCT02386449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91928743|NCT02386449|Laxatives|laxatives|mesh-ancestor
91928744|NCT02386449|Anticoagulants|anticoagulants|mesh-ancestor
91928745|NCT02386449|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91928746|NCT02386449|Chelating Agents|chelating agents|mesh-ancestor
91928747|NCT02386449|Sequestering Agents|sequestering agents|mesh-ancestor
91928748|NCT02386449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928749|NCT02386449|Antacids|antacids|mesh-ancestor
91928750|NCT00656539|Azithromycin|azithromycin|mesh-list
91928751|NCT00656539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91928752|NCT00656539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928753|NCT02179775|Propranolol|propranolol|mesh-list
91928754|NCT02179775|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91928755|NCT02179775|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91928756|NCT02179775|Adrenergic Agents|adrenergic agents|mesh-ancestor
91928757|NCT02179775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928758|NCT02179775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928759|NCT02179775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928760|NCT02179775|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91928761|NCT02179775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928762|NCT02179775|Vasodilator Agents|vasodilator agents|mesh-ancestor
91928763|NCT02177435|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91928764|NCT02177435|Telmisartan|telmisartan|mesh-list
91928765|NCT02177435|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
91928766|NCT02177435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928767|NCT02177435|Diuretics|diuretics|mesh-ancestor
91928768|NCT02177435|Natriuretic Agents|natriuretic agents|mesh-ancestor
91928769|NCT02177435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928770|NCT02177435|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91928771|NCT02177435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928772|NCT02177435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928773|NCT02177435|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91928774|NCT02177435|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91928775|NCT02280265|Factor VIII|factor viii|mesh-list
91928776|NCT02280265|Coagulants|coagulants|mesh-ancestor
91928777|NCT02179931|Flupenthixol|flupenthixol|mesh-list
91928778|NCT02179931|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
91928779|NCT02179931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91928780|NCT02179931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91928781|NCT02179931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928782|NCT02179931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928787|NCT02179931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928788|NCT02184065|Meloxicam|meloxicam|mesh-list
91928789|NCT02184065|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928790|NCT02184065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928791|NCT02184065|Analgesics|analgesics|mesh-ancestor
91928792|NCT02184065|Sensory System Agents|sensory system agents|mesh-ancestor
91928793|NCT02184065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928794|NCT02184065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928795|NCT02184065|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928796|NCT02184065|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928797|NCT02184065|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91928798|NCT02184065|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928799|NCT02184065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928800|NCT02184065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928801|NCT00564421|Epinastine|epinastine|mesh-list
91928802|NCT00564421|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91928803|NCT00564421|Histamine Antagonists|histamine antagonists|mesh-ancestor
91928804|NCT00564421|Histamine Agents|histamine agents|mesh-ancestor
91928805|NCT00564421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928806|NCT00564421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928807|NCT00564421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928808|NCT02665689|Ranibizumab|ranibizumab|mesh-list
91928809|NCT02665689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91928810|NCT02665689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91928811|NCT02665689|Growth Substances|growth substances|mesh-ancestor
91928812|NCT02665689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928813|NCT02665689|Growth Inhibitors|growth inhibitors|mesh-ancestor
91928814|NCT02665689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928815|NCT02386293|Irbesartan|irbesartan|mesh-list
91928816|NCT02386293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91928817|NCT02386293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91928818|NCT02386293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91928819|NCT02386293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928820|NCT00563563|Naltrexone|naltrexone|mesh-list
91928821|NCT00563563|Bupropion|bupropion|mesh-list
91928822|NCT00563563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91928823|NCT00563563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91928824|NCT00563563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928825|NCT00563563|Sensory System Agents|sensory system agents|mesh-ancestor
91928826|NCT00563563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928827|NCT00563563|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91928828|NCT00563563|Antidepressive Agents|antidepressive agents|mesh-ancestor
91928829|NCT00563563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91928830|NCT00563563|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91928831|NCT00563563|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91928832|NCT00563563|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91928833|NCT00563563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928834|NCT00563563|Dopamine Agents|dopamine agents|mesh-ancestor
91928835|NCT00563563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928836|NCT00563563|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91928837|NCT00563563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91928838|NCT00563563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928839|NCT05149365|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91928840|NCT05149365|Cyclosporine|cyclosporine|mesh-list
91928841|NCT05149365|Methotrexate|methotrexate|mesh-list
91928842|NCT05149365|Cyclosporins|cyclosporins|mesh-list
91928843|NCT05149365|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91928844|NCT05149365|Abortifacient Agents|abortifacient agents|mesh-ancestor
91928845|NCT05149365|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91928846|NCT05149365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928847|NCT05149365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91928848|NCT05149365|Antimetabolites|antimetabolites|mesh-ancestor
91928849|NCT05149365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928850|NCT05149365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928851|NCT05149365|Dermatologic Agents|dermatologic agents|mesh-ancestor
91928852|NCT05149365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928853|NCT05149365|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91928854|NCT05149365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928855|NCT05149365|Immunologic Factors|immunologic factors|mesh-ancestor
91928856|NCT05149365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928857|NCT05149365|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91928858|NCT05149365|Antifungal Agents|antifungal agents|mesh-ancestor
91928859|NCT05149365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928860|NCT05149365|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91928861|NCT05149365|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91928862|NCT05149365|Incretins|incretins|mesh-ancestor
91928864|NCT05149365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928865|NCT05149365|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91928866|NCT05149365|Protease Inhibitors|protease inhibitors|mesh-ancestor
91928867|NCT02180087|Ketoprofen|ketoprofen|mesh-list
91928868|NCT02180087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91928869|NCT02180087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91928870|NCT02180087|Analgesics|analgesics|mesh-ancestor
91928871|NCT02180087|Sensory System Agents|sensory system agents|mesh-ancestor
91928872|NCT02180087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928873|NCT02180087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928874|NCT02180087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928875|NCT02180087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91928876|NCT02180087|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91928877|NCT02180087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928878|NCT02180087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928879|NCT02184299|Nevirapine|nevirapine|mesh-list
91928880|NCT02184299|Prednisone|prednisone|mesh-list
91928881|NCT02184299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928882|NCT02184299|Glucocorticoids|glucocorticoids|mesh-ancestor
91928883|NCT02184299|Hormones|hormones|mesh-ancestor
91928884|NCT02184299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928885|NCT02184299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928886|NCT02184299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91928887|NCT02184299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928888|NCT02184299|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91928889|NCT02184299|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91928890|NCT02184299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928891|NCT02184299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928892|NCT02184299|Antiviral Agents|antiviral agents|mesh-ancestor
91928893|NCT02184299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928894|NCT02184299|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91928895|NCT02184299|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91928896|NCT02184299|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91928897|NCT02184299|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91928898|NCT00549679|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|6-((3-((dimethylamino)carbonyl)phenyl)sulfonyl)-8-methyl-4-((3-methyloxyphenyl)amino)-3-quinolinecarboxamide|mesh-list
91928899|NCT00549679|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91928900|NCT00549679|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91928901|NCT00549679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928902|NCT00549679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928903|NCT02282371|Cetuximab|cetuximab|mesh-list
91928904|NCT02282371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91928905|NCT02282371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928906|NCT02402595|Itraconazole|itraconazole|mesh-list
91928907|NCT02402595|Antifungal Agents|antifungal agents|mesh-ancestor
91928908|NCT02402595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928909|NCT02402595|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91928910|NCT02402595|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91928911|NCT02402595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928912|NCT02402595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928913|NCT02402595|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91928914|NCT02402595|Hormone Antagonists|hormone antagonists|mesh-ancestor
91928915|NCT02402595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928916|NCT02402595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928917|NCT02402595|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91928918|NCT02180321|Tranexamic Acid|tranexamic acid|mesh-list
91928919|NCT02180321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91928920|NCT02180321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91928921|NCT02180321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928922|NCT02180321|Hemostatics|hemostatics|mesh-ancestor
91928923|NCT02180321|Coagulants|coagulants|mesh-ancestor
91928924|NCT00547651|Topotecan|topotecan|mesh-list
91928925|NCT00547651|Amrubicin|amrubicin|mesh-list
91928926|NCT00547651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91928927|NCT00547651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91928928|NCT00547651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928929|NCT00547651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928930|NCT00547651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928931|NCT00546793|Veltuzumab|veltuzumab|mesh-list
91928932|NCT00546793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928933|NCT02402283|Metronidazole|metronidazole|mesh-list
91928934|NCT02402283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91928935|NCT02402283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91928936|NCT02402283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91928937|NCT02402283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91928938|NCT02184533|Selenious Acid|selenious acid|mesh-list
91928939|NCT02184533|Sodium Selenite|sodium selenite|mesh-list
91928940|NCT02184533|Trace Elements|trace elements|mesh-ancestor
91928941|NCT02184533|Micronutrients|micronutrients|mesh-ancestor
91928942|NCT02184533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928943|NCT02386059|Dexamethasone|dexamethasone|mesh-list
91928944|NCT02386059|Dexamethasone acetate|dexamethasone acetate|mesh-list
91928945|NCT02386059|Ondansetron|ondansetron|mesh-list
91928946|NCT02386059|BB 1101|bb 1101|mesh-list
91928947|NCT02386059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91928948|NCT02386059|Antiemetics|antiemetics|mesh-ancestor
91928949|NCT02386059|Autonomic Agents|autonomic agents|mesh-ancestor
91928950|NCT02386059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928951|NCT02386059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928952|NCT02386059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91928953|NCT02386059|Glucocorticoids|glucocorticoids|mesh-ancestor
91928954|NCT02386059|Hormones|hormones|mesh-ancestor
91928955|NCT02386059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91928956|NCT02386059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91928957|NCT02386059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91928958|NCT02386059|Protease Inhibitors|protease inhibitors|mesh-ancestor
91928959|NCT02386059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928960|NCT02386059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928961|NCT02386059|Antipruritics|antipruritics|mesh-ancestor
91928962|NCT02386059|Dermatologic Agents|dermatologic agents|mesh-ancestor
91928963|NCT02386059|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91928964|NCT02386059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91928965|NCT02386059|Serotonin Agents|serotonin agents|mesh-ancestor
91928966|NCT02386059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91928967|NCT00443287|Cilostazol|cilostazol|mesh-list
91928968|NCT00443287|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-N-(4-(morpholine-4-sulfonyl)phenyl)benzamide|5-chloro-2-(5-chlorothiophene-2-sulfonylamino)-n-(4-(morpholine-4-sulfonyl)phenyl)benzamide|mesh-list
91928969|NCT00443287|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91928970|NCT00443287|Autonomic Agents|autonomic agents|mesh-ancestor
91928971|NCT00443287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91928972|NCT00443287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928973|NCT00443287|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91928974|NCT00443287|Respiratory System Agents|respiratory system agents|mesh-ancestor
91928975|NCT00443287|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91928976|NCT00443287|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91928977|NCT00443287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928978|NCT00443287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91928979|NCT00443287|Vasodilator Agents|vasodilator agents|mesh-ancestor
91928980|NCT00443287|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91928981|NCT00443287|Protective Agents|protective agents|mesh-ancestor
91928982|NCT00443287|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91928983|NCT00443287|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91928984|NCT00443287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928985|NCT00443287|Enzyme Activators|enzyme activators|mesh-ancestor
91928986|NCT00442039|Lithium Carbonate|lithium carbonate|mesh-list
91928987|NCT00442039|Antidepressive Agents|antidepressive agents|mesh-ancestor
91928988|NCT00442039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91928989|NCT00442039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91928990|NCT00442039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91928991|NCT00442039|Antimanic Agents|antimanic agents|mesh-ancestor
91928992|NCT00442039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91928993|NCT00442039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91928994|NCT00442039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91928995|NCT02390739|Aldesleukin|aldesleukin|mesh-list
91928996|NCT02390739|Cyclophosphamide|cyclophosphamide|mesh-list
91928997|NCT02390739|Fludarabine|fludarabine|mesh-list
91928998|NCT02390739|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91928999|NCT02390739|Immunologic Factors|immunologic factors|mesh-ancestor
91929000|NCT02390739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929001|NCT02390739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91929002|NCT02390739|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91929003|NCT02390739|Alkylating Agents|alkylating agents|mesh-ancestor
91929004|NCT02390739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929005|NCT02390739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929006|NCT02390739|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91929008|NCT02390739|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929009|NCT02390739|Antiviral Agents|antiviral agents|mesh-ancestor
91929010|NCT02390739|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929011|NCT02385825|Vaccines|vaccines|mesh-list
91929012|NCT02385825|Immunologic Factors|immunologic factors|mesh-ancestor
91929013|NCT02385825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929014|NCT02177825|Imatinib Mesylate|imatinib mesylate|mesh-list
91929015|NCT02177825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929016|NCT02177825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929017|NCT02177825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929018|NCT02177825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929019|NCT02390817|Neostigmine|neostigmine|mesh-list
91929020|NCT02390817|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91929021|NCT02390817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929022|NCT02390817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929023|NCT02390817|Cholinergic Agents|cholinergic agents|mesh-ancestor
91929024|NCT02390817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929025|NCT02390817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929026|NCT02390817|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91929027|NCT02390817|Autonomic Agents|autonomic agents|mesh-ancestor
91929028|NCT02390817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929029|NCT00537043|Carvedilol|carvedilol|mesh-list
91929030|NCT00537043|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91929031|NCT00537043|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91929032|NCT00537043|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929033|NCT00537043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929034|NCT00537043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929035|NCT00537043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929036|NCT00537043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91929037|NCT00537043|Antioxidants|antioxidants|mesh-ancestor
91929038|NCT00537043|Protective Agents|protective agents|mesh-ancestor
91929039|NCT00537043|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91929040|NCT00537043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929041|NCT00537043|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91929042|NCT00537043|Vasodilator Agents|vasodilator agents|mesh-ancestor
91929043|NCT00537043|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91929044|NCT00537043|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91929045|NCT00387907|Trastuzumab|trastuzumab|mesh-list
91929046|NCT00387907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91929047|NCT00387907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929048|NCT02180789|Tamsulosin|tamsulosin|mesh-list
91929049|NCT02180789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91929050|NCT02180789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91929051|NCT02180789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91929052|NCT02180789|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929053|NCT02180789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929054|NCT02180789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929055|NCT02180789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929056|NCT02180789|Urological Agents|urological agents|mesh-ancestor
91929057|NCT02282683|Prednisone|prednisone|mesh-list
91929058|NCT02282683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929059|NCT02282683|Glucocorticoids|glucocorticoids|mesh-ancestor
91929060|NCT02282683|Hormones|hormones|mesh-ancestor
91929061|NCT02282683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929062|NCT02282683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929063|NCT02282683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929064|NCT02282683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943358|NCT01784159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932465|NCT02739997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929065|NCT02183909|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91929066|NCT02183909|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91929067|NCT02183909|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929068|NCT02183909|Antiviral Agents|antiviral agents|mesh-ancestor
91929069|NCT02183909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929070|NCT00375193|Amrubicin|amrubicin|mesh-list
91929071|NCT00375193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929072|NCT00151411|Metformin|metformin|mesh-list
91929073|NCT00151411|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929074|NCT00151411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929075|NCT04471441|Mycophenolic Acid|mycophenolic acid|mesh-list
91929076|NCT04471441|Everolimus|everolimus|mesh-list
91929077|NCT04471441|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91929078|NCT04471441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929080|NCT04471441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929081|NCT04471441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91929082|NCT04471441|Immunologic Factors|immunologic factors|mesh-ancestor
91929083|NCT04471441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929084|NCT04471441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929085|NCT04471441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91929086|NCT04471441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91929087|NCT04471441|Antitubercular Agents|antitubercular agents|mesh-ancestor
91929088|NCT04471441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91929089|NCT04471441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929090|NCT02662569|Atorvastatin|atorvastatin|mesh-list
91929091|NCT02662569|Evolocumab|evolocumab|mesh-list
91929092|NCT02662569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91929093|NCT02662569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91929094|NCT02662569|Antimetabolites|antimetabolites|mesh-ancestor
91929095|NCT02662569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929096|NCT02662569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91929097|NCT02662569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91929098|NCT02662569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929099|NCT02662569|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91929100|NCT02662569|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91929101|NCT02662569|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929102|NCT02178137|Zinc Sulfate|zinc sulfate|mesh-list
91929103|NCT02178137|Astringents|astringents|mesh-ancestor
91929104|NCT02178137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929105|NCT02178137|Dermatologic Agents|dermatologic agents|mesh-ancestor
91929106|NCT02181023|Glycopyrrolate|glycopyrrolate|mesh-list
91929107|NCT02181023|Bromides|bromides|mesh-list
91929108|NCT02181023|Anticonvulsants|anticonvulsants|mesh-ancestor
91929109|NCT02181023|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91929110|NCT02181023|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91929111|NCT02181023|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91929112|NCT02181023|Cholinergic Agents|cholinergic agents|mesh-ancestor
91929113|NCT02181023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929114|NCT02181023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929115|NCT02181023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929116|NCT02286973|Tranexamic Acid|tranexamic acid|mesh-list
91929117|NCT02286973|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91929118|NCT02286973|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91929119|NCT02286973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929120|NCT02286973|Hemostatics|hemostatics|mesh-ancestor
91929121|NCT02286973|Coagulants|coagulants|mesh-ancestor
91929122|NCT02181101|Zoledronic Acid|zoledronic acid|mesh-list
91929123|NCT02181101|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91929124|NCT02181101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929125|NCT02287129|Paclitaxel|paclitaxel|mesh-list
91929126|NCT02287129|Carboplatin|carboplatin|mesh-list
91929127|NCT02287129|Capecitabine|capecitabine|mesh-list
91929128|NCT02287129|Oxaliplatin|oxaliplatin|mesh-list
91929129|NCT02287129|Epirubicin|epirubicin|mesh-list
91929130|NCT02287129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91929131|NCT02287129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929132|NCT02287129|Tubulin Modulators|tubulin modulators|mesh-ancestor
91929133|NCT02287129|Antimitotic Agents|antimitotic agents|mesh-ancestor
91929134|NCT02287129|Mitosis Modulators|mitosis modulators|mesh-ancestor
91929135|NCT02287129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929136|NCT02287129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91929137|NCT02287129|Antimetabolites|antimetabolites|mesh-ancestor
91929138|NCT02287129|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91929139|NCT02287129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91929140|NCT02287129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91929142|NCT02256683|Dabigatran|dabigatran|mesh-list
91929143|NCT02256683|Phenprocoumon|phenprocoumon|mesh-list
91929144|NCT02256683|Antithrombins|antithrombins|mesh-ancestor
91929145|NCT02256683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91929146|NCT02256683|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929147|NCT02256683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929148|NCT02256683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929149|NCT02256683|Anticoagulants|anticoagulants|mesh-ancestor
91929150|NCT00411385|Interferons|interferons|mesh-list
91929151|NCT00411385|Ribavirin|ribavirin|mesh-list
91929152|NCT00411385|Interferon-alpha|interferon-alpha|mesh-list
91929153|NCT00411385|Interferon alpha-2|interferon alpha-2|mesh-list
91929154|NCT00411385|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91929155|NCT00411385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929156|NCT00411385|Antiviral Agents|antiviral agents|mesh-ancestor
91929157|NCT00411385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929159|NCT00411385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929160|NCT00411385|Immunologic Factors|immunologic factors|mesh-ancestor
91929161|NCT00411385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929162|NCT02385513|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91929163|NCT02385513|Immunologic Factors|immunologic factors|mesh-ancestor
91929164|NCT02385513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929165|NCT02185547|Sertraline|sertraline|mesh-list
91929166|NCT02185547|Antidepressive Agents|antidepressive agents|mesh-ancestor
91929167|NCT02185547|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91929168|NCT02185547|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91929169|NCT02185547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91929170|NCT02185547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929171|NCT02185547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929172|NCT02185547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929173|NCT02185547|Serotonin Agents|serotonin agents|mesh-ancestor
91929174|NCT02185547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929175|NCT02030483|Dexamethasone|dexamethasone|mesh-list
91929176|NCT02030483|Lenalidomide|lenalidomide|mesh-list
91929177|NCT02030483|Palbociclib|palbociclib|mesh-list
91929178|NCT02030483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929179|NCT02030483|Antiemetics|antiemetics|mesh-ancestor
91929180|NCT02030483|Autonomic Agents|autonomic agents|mesh-ancestor
91929181|NCT02030483|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929182|NCT02030483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929183|NCT02030483|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91929184|NCT02030483|Glucocorticoids|glucocorticoids|mesh-ancestor
91929185|NCT02030483|Hormones|hormones|mesh-ancestor
91929186|NCT02030483|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929187|NCT02030483|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929188|NCT02030483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929189|NCT02030483|Immunologic Factors|immunologic factors|mesh-ancestor
91929190|NCT02030483|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91929191|NCT02030483|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91929192|NCT02030483|Growth Substances|growth substances|mesh-ancestor
91929193|NCT02030483|Growth Inhibitors|growth inhibitors|mesh-ancestor
91929194|NCT02030483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929195|NCT02030483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929196|NCT02030483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929197|NCT00528697|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91929198|NCT00528697|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91929199|NCT00528697|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91929200|NCT00528697|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929201|NCT00528697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929202|NCT00528697|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929203|NCT00528697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929204|NCT00528697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929205|NCT02385435|Dexmedetomidine|dexmedetomidine|mesh-list
91929206|NCT02385435|Bupivacaine|bupivacaine|mesh-list
91929207|NCT02385435|Anesthetics, Local|anesthetics, local|mesh-ancestor
91929208|NCT02385435|Anesthetics|anesthetics|mesh-ancestor
91929209|NCT02385435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929210|NCT02385435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929211|NCT02385435|Sensory System Agents|sensory system agents|mesh-ancestor
91929212|NCT02385435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929213|NCT02385435|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91929214|NCT02385435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91929215|NCT02385435|Analgesics|analgesics|mesh-ancestor
91932466|NCT04467931|Losartan|losartan|mesh-list
91929216|NCT02385435|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91929217|NCT02385435|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91929218|NCT02385435|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91929219|NCT02385435|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929220|NCT02385435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929221|NCT02385435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929223|NCT02753075|Cariostatic Agents|cariostatic agents|mesh-ancestor
91929224|NCT02753075|Protective Agents|protective agents|mesh-ancestor
91929225|NCT02753075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929226|NCT03133897|Dexamethasone|dexamethasone|mesh-list
91929227|NCT03133897|Prednisone|prednisone|mesh-list
91929228|NCT03133897|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929229|NCT03133897|Antiemetics|antiemetics|mesh-ancestor
91929230|NCT03133897|Autonomic Agents|autonomic agents|mesh-ancestor
91929231|NCT03133897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929308|NCT02181335|Hormones|hormones|mesh-ancestor
91929232|NCT03133897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929233|NCT03133897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91929234|NCT03133897|Glucocorticoids|glucocorticoids|mesh-ancestor
91929235|NCT03133897|Hormones|hormones|mesh-ancestor
91929236|NCT03133897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929237|NCT03133897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929238|NCT03133897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929239|NCT05443425|Cholestyramine Resin|cholestyramine resin|mesh-list
91929240|NCT05443425|Leflunomide|leflunomide|mesh-list
91929241|NCT05443425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929242|NCT05443425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929243|NCT05443425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91929244|NCT05443425|Immunologic Factors|immunologic factors|mesh-ancestor
91929245|NCT05443425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929246|NCT05443425|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91929247|NCT05443425|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91929248|NCT05443425|Antimetabolites|antimetabolites|mesh-ancestor
91929249|NCT05443425|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91929250|NCT02190149|Factor VIII|factor viii|mesh-list
91929251|NCT02190149|Coagulants|coagulants|mesh-ancestor
91929252|NCT00366145|Remestemcel-l|remestemcel-l|mesh-list
91929253|NCT00366145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929254|NCT00366145|Antiviral Agents|antiviral agents|mesh-ancestor
91929255|NCT00366145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929256|NCT02185859|Lidocaine|lidocaine|mesh-list
91929257|NCT02185859|Magnesium Sulfate|magnesium sulfate|mesh-list
91929258|NCT02185859|Anesthetics, Local|anesthetics, local|mesh-ancestor
91929259|NCT02185859|Anesthetics|anesthetics|mesh-ancestor
91929260|NCT02185859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929261|NCT02185859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929262|NCT02185859|Sensory System Agents|sensory system agents|mesh-ancestor
91929263|NCT02185859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929264|NCT02185859|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91929265|NCT02185859|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91929266|NCT02185859|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91929267|NCT02185859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929268|NCT02185859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929269|NCT02185859|Analgesics|analgesics|mesh-ancestor
91929270|NCT02185859|Anticonvulsants|anticonvulsants|mesh-ancestor
91929271|NCT02185859|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91929272|NCT02185859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91929273|NCT02185859|Tocolytic Agents|tocolytic agents|mesh-ancestor
91929274|NCT02185859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91929275|NCT02332720|Ribavirin|ribavirin|mesh-list
91929276|NCT02332720|Grazoprevir|grazoprevir|mesh-list
91929277|NCT02332720|Uprifosbuvir|uprifosbuvir|mesh-list
91929279|NCT02332720|Antimetabolites|antimetabolites|mesh-ancestor
91929280|NCT02332720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929281|NCT02332720|Antiviral Agents|antiviral agents|mesh-ancestor
91929282|NCT02332720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929283|NCT05089175|Aspirin|aspirin|mesh-list
91929284|NCT05089175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91929285|NCT05089175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91929286|NCT05089175|Analgesics|analgesics|mesh-ancestor
91929287|NCT05089175|Sensory System Agents|sensory system agents|mesh-ancestor
91943362|NCT01784159|Antipyretics|antipyretics|mesh-ancestor
91929288|NCT05089175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929289|NCT05089175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929290|NCT05089175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929291|NCT05089175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91929292|NCT05089175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91929293|NCT05089175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91929294|NCT05089175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929295|NCT05089175|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91929296|NCT05089175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91929297|NCT05089175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929298|NCT05089175|Antipyretics|antipyretics|mesh-ancestor
91929299|NCT02181335|Budesonide|budesonide|mesh-list
91929300|NCT02181335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929301|NCT02181335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91929302|NCT02181335|Autonomic Agents|autonomic agents|mesh-ancestor
91929303|NCT02181335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929304|NCT02181335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929305|NCT02181335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91929306|NCT02181335|Respiratory System Agents|respiratory system agents|mesh-ancestor
91929307|NCT02181335|Glucocorticoids|glucocorticoids|mesh-ancestor
91929309|NCT02181335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929310|NCT00517153|Miglustat|miglustat|mesh-list
91929311|NCT00517153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929312|NCT00517153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929313|NCT00517153|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91929314|NCT00517153|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929315|NCT00517153|Antiviral Agents|antiviral agents|mesh-ancestor
91929316|NCT00517153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929317|NCT00517153|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91929318|NCT00517153|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929319|NCT00517153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929320|NCT02285101|BCT-100|bct-100|mesh-list
91929321|NCT02285101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929322|NCT00359437|Satavaptan|satavaptan|mesh-list
91929323|NCT00359437|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91929324|NCT00359437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929325|NCT00359437|Natriuretic Agents|natriuretic agents|mesh-ancestor
91929326|NCT00359437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929327|NCT05064449|Itraconazole|itraconazole|mesh-list
91929328|NCT05064449|Mefenamic Acid|mefenamic acid|mesh-list
91929329|NCT05064449|Antifungal Agents|antifungal agents|mesh-ancestor
91929330|NCT05064449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929331|NCT05064449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91929332|NCT05064449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91929333|NCT05064449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929334|NCT05064449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929335|NCT05064449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91929336|NCT05064449|Hormone Antagonists|hormone antagonists|mesh-ancestor
91929337|NCT05064449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929338|NCT05064449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929339|NCT05064449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91929340|NCT05064449|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91929341|NCT05064449|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91929342|NCT05064449|Analgesics|analgesics|mesh-ancestor
91929343|NCT05064449|Sensory System Agents|sensory system agents|mesh-ancestor
91929344|NCT05064449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929345|NCT05064449|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929346|NCT05064449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91929347|NCT05064449|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91929348|NCT00401011|Dexamethasone|dexamethasone|mesh-list
91929349|NCT00401011|Bortezomib|bortezomib|mesh-list
91929350|NCT00401011|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929351|NCT00401011|Antiemetics|antiemetics|mesh-ancestor
91929352|NCT00401011|Autonomic Agents|autonomic agents|mesh-ancestor
91929353|NCT00401011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929354|NCT00401011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929355|NCT00401011|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91929356|NCT00401011|Glucocorticoids|glucocorticoids|mesh-ancestor
91929357|NCT00401011|Hormones|hormones|mesh-ancestor
91943364|NCT01749969|Lenalidomide|lenalidomide|mesh-list
91943366|NCT01749969|Antiemetics|antiemetics|mesh-ancestor
91929358|NCT00401011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929359|NCT00401011|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929360|NCT00401011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929361|NCT01645930|Dexamethasone|dexamethasone|mesh-list
91929362|NCT01645930|Lenalidomide|lenalidomide|mesh-list
91929363|NCT01645930|Ixazomib|ixazomib|mesh-list
91929364|NCT01645930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929365|NCT01645930|Antiemetics|antiemetics|mesh-ancestor
91929366|NCT01645930|Autonomic Agents|autonomic agents|mesh-ancestor
91929367|NCT01645930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929368|NCT01645930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929369|NCT01645930|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91929370|NCT01645930|Glucocorticoids|glucocorticoids|mesh-ancestor
91929371|NCT01645930|Hormones|hormones|mesh-ancestor
91929372|NCT01645930|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929373|NCT01645930|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929374|NCT01645930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929375|NCT01645930|Immunologic Factors|immunologic factors|mesh-ancestor
91929376|NCT01645930|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91929377|NCT01645930|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91929378|NCT01645930|Growth Substances|growth substances|mesh-ancestor
91929379|NCT01645930|Growth Inhibitors|growth inhibitors|mesh-ancestor
91929380|NCT01645930|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929382|NCT01645930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929383|NCT02190695|Carboplatin|carboplatin|mesh-list
91929385|NCT02190695|Arsenic Trioxide|arsenic trioxide|mesh-list
91929386|NCT02190695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929387|NCT02190695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91929388|NCT02190695|Antimetabolites|antimetabolites|mesh-ancestor
91929389|NCT02190695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929390|NCT02190695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929391|NCT00514267|Prednisone|prednisone|mesh-list
91929392|NCT00514267|Docetaxel|docetaxel|mesh-list
91929393|NCT00514267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929394|NCT00514267|Tubulin Modulators|tubulin modulators|mesh-ancestor
91929395|NCT00514267|Antimitotic Agents|antimitotic agents|mesh-ancestor
91929396|NCT00514267|Mitosis Modulators|mitosis modulators|mesh-ancestor
91929397|NCT00514267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929398|NCT00514267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929399|NCT00514267|Glucocorticoids|glucocorticoids|mesh-ancestor
91929400|NCT00514267|Hormones|hormones|mesh-ancestor
91929401|NCT00514267|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929402|NCT00514267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929403|NCT00514267|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929404|NCT04199104|Pembrolizumab|pembrolizumab|mesh-list
91929405|NCT04199104|Lenvatinib|lenvatinib|mesh-list
91929406|NCT04199104|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91929407|NCT04199104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929408|NCT04199104|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91929409|NCT04199104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929410|NCT04199104|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929411|NCT04199104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929412|NCT02384967|Darunavir|darunavir|mesh-list
91929413|NCT02384967|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91929414|NCT02384967|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91929415|NCT02384967|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929416|NCT02384967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929417|NCT02384967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929418|NCT02384967|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91929419|NCT02384967|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929420|NCT02384967|Antiviral Agents|antiviral agents|mesh-ancestor
91929421|NCT02384967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929422|NCT02186249|Nivolumab|nivolumab|mesh-list
91929423|NCT02186249|Ipilimumab|ipilimumab|mesh-list
91929424|NCT02186249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91929425|NCT02186249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929426|NCT02186249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91929427|NCT02186249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929428|NCT00511459|Paclitaxel|paclitaxel|mesh-list
91929429|NCT00511459|Bevacizumab|bevacizumab|mesh-list
91929430|NCT00511459|Trebananib|trebananib|mesh-list
91929431|NCT00511459|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91929432|NCT00511459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929433|NCT00511459|Tubulin Modulators|tubulin modulators|mesh-ancestor
91929434|NCT00511459|Antimitotic Agents|antimitotic agents|mesh-ancestor
91929435|NCT00511459|Mitosis Modulators|mitosis modulators|mesh-ancestor
91929436|NCT00511459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929437|NCT00511459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91929438|NCT00511459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91932467|NCT04467931|Timolol|timolol|mesh-list
91929439|NCT00511459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91929440|NCT00511459|Growth Substances|growth substances|mesh-ancestor
91929441|NCT00511459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929442|NCT00511459|Growth Inhibitors|growth inhibitors|mesh-ancestor
91929443|NCT02384889|Eflornithine|eflornithine|mesh-list
91929444|NCT02384889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929445|NCT02384889|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91929446|NCT02384889|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91929447|NCT02384889|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91929448|NCT02384889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929449|NCT02384889|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
91929450|NCT02384889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929451|NCT02384889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929452|NCT02299336|Aflibercept|aflibercept|mesh-list
91929453|NCT02299336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91929454|NCT02299336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91929455|NCT02299336|Growth Substances|growth substances|mesh-ancestor
91929456|NCT02299336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929458|NCT02299336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929459|NCT02384655|Fenugreek seed meal|fenugreek seed meal|mesh-list
91929460|NCT02384655|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929461|NCT02384655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929462|NCT02186483|Metformin|metformin|mesh-list
91929463|NCT02186483|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91929464|NCT02186483|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929465|NCT02186483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929466|NCT02186483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91929467|NCT02186483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91929468|NCT02186483|Antimetabolites|antimetabolites|mesh-ancestor
91929469|NCT02186483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929470|NCT02186483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91929471|NCT02186483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91929472|NCT02186483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929473|NCT02256605|Vitamin D|vitamin d|mesh-list
91929474|NCT02256605|Cholecalciferol|cholecalciferol|mesh-list
91929475|NCT02256605|Vitamins|vitamins|mesh-ancestor
91929476|NCT02256605|Micronutrients|micronutrients|mesh-ancestor
91929477|NCT02256605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929478|NCT02256605|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91929479|NCT02256605|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91929480|NCT00393991|Fluticasone|fluticasone|mesh-list
91929481|NCT00393991|Xhance|xhance|mesh-list
91929482|NCT00393991|Formoterol Fumarate|formoterol fumarate|mesh-list
91929483|NCT00393991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929484|NCT00393991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91929485|NCT00393991|Autonomic Agents|autonomic agents|mesh-ancestor
91929486|NCT00393991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929487|NCT00393991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929488|NCT00393991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91929489|NCT00393991|Respiratory System Agents|respiratory system agents|mesh-ancestor
91929490|NCT00393991|Dermatologic Agents|dermatologic agents|mesh-ancestor
91929491|NCT00393991|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91929492|NCT00393991|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91929493|NCT00393991|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91929494|NCT00393991|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91929495|NCT00393991|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929496|NCT00393991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929497|NCT00393991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929498|NCT02664441|Exenatide|exenatide|mesh-list
91929499|NCT02664441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929500|NCT02664441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943372|NCT01749969|Hormones|hormones|mesh-ancestor
91929501|NCT02664441|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91929502|NCT02664441|Incretins|incretins|mesh-ancestor
91929503|NCT02664441|Hormones|hormones|mesh-ancestor
91929504|NCT02664441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929505|NCT02191007|Calcitriol|calcitriol|mesh-list
91929506|NCT02191007|Betamethasone|betamethasone|mesh-list
91929507|NCT02191007|Betamethasone Valerate|betamethasone valerate|mesh-list
91929508|NCT02191007|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91929509|NCT02191007|Betamethasone benzoate|betamethasone benzoate|mesh-list
91929510|NCT02191007|Calcipotriene|calcipotriene|mesh-list
91929511|NCT02191007|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91929512|NCT02191007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929513|NCT02191007|Glucocorticoids|glucocorticoids|mesh-ancestor
91929514|NCT02191007|Hormones|hormones|mesh-ancestor
91929515|NCT02191007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929516|NCT02191007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929517|NCT02191007|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91929518|NCT02191007|Respiratory System Agents|respiratory system agents|mesh-ancestor
91929519|NCT02191007|Dermatologic Agents|dermatologic agents|mesh-ancestor
91929520|NCT02191007|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91929521|NCT02191007|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
91929522|NCT02191007|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929523|NCT02191007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929524|NCT02191007|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91929526|NCT02191007|Micronutrients|micronutrients|mesh-ancestor
91929527|NCT02191007|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91929528|NCT02298946|Cyclophosphamide|cyclophosphamide|mesh-list
91929529|NCT02298946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91929530|NCT02298946|Immunologic Factors|immunologic factors|mesh-ancestor
91929531|NCT02298946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929532|NCT02298946|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91929533|NCT02298946|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91929534|NCT02298946|Alkylating Agents|alkylating agents|mesh-ancestor
91929535|NCT02298946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929536|NCT02298946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929537|NCT02298946|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91929538|NCT04470115|Anesthetics|anesthetics|mesh-list
91929539|NCT04470115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929540|NCT04470115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929541|NCT02384343|Dexmedetomidine|dexmedetomidine|mesh-list
91929542|NCT02384343|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91929543|NCT02384343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929544|NCT02384343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929545|NCT02384343|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91929546|NCT02384343|Analgesics|analgesics|mesh-ancestor
91929547|NCT02384343|Sensory System Agents|sensory system agents|mesh-ancestor
91929548|NCT02384343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929549|NCT02384343|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91929550|NCT02384343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91929551|NCT02384343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91929552|NCT02384343|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929553|NCT02384343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929554|NCT02384343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929555|NCT05033639|Melatonin|melatonin|mesh-list
91929556|NCT05033639|Antioxidants|antioxidants|mesh-ancestor
91929557|NCT05033639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929558|NCT05033639|Protective Agents|protective agents|mesh-ancestor
91929559|NCT05033639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929560|NCT05033639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929561|NCT02328040|Insulin|insulin|mesh-list
91929562|NCT02328040|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91929563|NCT02328040|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91929564|NCT02328040|Insulin Aspart|insulin aspart|mesh-list
91929565|NCT02328040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929566|NCT02328040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929567|NCT02328040|Incretins|incretins|mesh-ancestor
91929568|NCT02328040|Hormones|hormones|mesh-ancestor
91929569|NCT02328040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929570|NCT02328040|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91929571|NCT02328040|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929572|NCT02328040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929573|NCT02328040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929574|NCT00355849|Insulin|insulin|mesh-list
91929576|NCT00355849|Insulin Glargine|insulin glargine|mesh-list
91929577|NCT00355849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929578|NCT00355849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929579|NCT02384499|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91929580|NCT02384499|Hemostatics|hemostatics|mesh-ancestor
91929581|NCT02384499|Coagulants|coagulants|mesh-ancestor
91929582|NCT02186951|Amoxicillin|amoxicillin|mesh-list
91929583|NCT02186951|Clavulanic Acids|clavulanic acids|mesh-list
91929584|NCT02186951|Clavulanic Acid|clavulanic acid|mesh-list
91929585|NCT02186951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91929586|NCT02186951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929587|NCT02186951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929588|NCT02186951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929589|NCT02186951|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91929590|NCT02285413|Cisplatin|cisplatin|mesh-list
91929591|NCT02285413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929592|NCT02381379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91929593|NCT02381379|Antiviral Agents|antiviral agents|mesh-ancestor
91929594|NCT02381379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929595|NCT02187107|Darunavir|darunavir|mesh-list
91929596|NCT02187107|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91929597|NCT02187107|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91929598|NCT02187107|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929599|NCT02187107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929600|NCT02187107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929601|NCT02187107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91929602|NCT02187107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929603|NCT02187107|Antiviral Agents|antiviral agents|mesh-ancestor
91929604|NCT02187107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929605|NCT02285491|Bupivacaine|bupivacaine|mesh-list
91929606|NCT02285491|Anesthetics, Local|anesthetics, local|mesh-ancestor
91929607|NCT02285491|Anesthetics|anesthetics|mesh-ancestor
91929608|NCT02285491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930064|NCT02194049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929609|NCT02285491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929610|NCT02285491|Sensory System Agents|sensory system agents|mesh-ancestor
91929611|NCT02285491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929612|NCT02298868|Baclofen|baclofen|mesh-list
91929613|NCT02298868|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91929614|NCT02298868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929615|NCT02298868|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91929616|NCT02298868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929617|NCT02298868|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91929618|NCT02298868|GABA Agonists|gaba agonists|mesh-ancestor
91929619|NCT02298868|GABA Agents|gaba agents|mesh-ancestor
91929620|NCT02298868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929621|NCT02298868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929623|NCT02389179|Cholecalciferol|cholecalciferol|mesh-list
91929624|NCT02389179|Vitamins|vitamins|mesh-ancestor
91929625|NCT02389179|Micronutrients|micronutrients|mesh-ancestor
91929626|NCT02389179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929627|NCT02389179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91929628|NCT02389179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91929629|NCT02285647|Rolapitant|rolapitant|mesh-list
91929630|NCT02285647|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91929631|NCT02285647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929632|NCT02285647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929633|NCT02285647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929634|NCT02187419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
91929635|NCT02187419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929636|NCT02187419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929637|NCT02187497|Telmisartan|telmisartan|mesh-list
91929638|NCT02187497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91929639|NCT02187497|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91929640|NCT02187497|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91929641|NCT02187497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929642|NCT04195750|Everolimus|everolimus|mesh-list
91929643|NCT04195750|Belzutifan|belzutifan|mesh-list
91929644|NCT04195750|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91929645|NCT04195750|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929646|NCT04195750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929647|NCT04195750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929648|NCT04195750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91929649|NCT04195750|Immunologic Factors|immunologic factors|mesh-ancestor
91929650|NCT04195750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929651|NCT04195750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929653|NCT00099853|Vildagliptin|vildagliptin|mesh-list
91929654|NCT00099853|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929655|NCT00099853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929656|NCT00099853|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91929657|NCT00099853|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929658|NCT00099853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929659|NCT00099853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929660|NCT02381145|Resveratrol|resveratrol|mesh-list
91929661|NCT02381145|Antioxidants|antioxidants|mesh-ancestor
91929662|NCT02381145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929663|NCT02381145|Protective Agents|protective agents|mesh-ancestor
91929664|NCT02381145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929665|NCT02381145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929666|NCT02381145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91929667|NCT00097357|Enoxaparin|enoxaparin|mesh-list
91929668|NCT00097357|Warfarin|warfarin|mesh-list
91929669|NCT00097357|Enoxaparin sodium|enoxaparin sodium|mesh-list
91929670|NCT00097357|Apixaban|apixaban|mesh-list
91929671|NCT00097357|Anticoagulants|anticoagulants|mesh-ancestor
91929672|NCT00097357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91929673|NCT00097357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91929674|NCT00097357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929675|NCT00097357|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91929676|NCT00097357|Antithrombins|antithrombins|mesh-ancestor
91929677|NCT00097357|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91929678|NCT00097357|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929679|NCT00097357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929680|NCT02296840|Acetaminophen|acetaminophen|mesh-list
91929681|NCT02296840|Ibuprofen|ibuprofen|mesh-list
91929682|NCT02296840|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
91929683|NCT02296840|Hydrocodone|hydrocodone|mesh-list
91929684|NCT02296840|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91929685|NCT02296840|Analgesics|analgesics|mesh-ancestor
91929686|NCT02296840|Sensory System Agents|sensory system agents|mesh-ancestor
91929687|NCT02296840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929688|NCT02296840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929689|NCT02296840|Antipyretics|antipyretics|mesh-ancestor
91929690|NCT02296840|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91929691|NCT02296840|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929692|NCT02296840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91929693|NCT02296840|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91929695|NCT02296840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929696|NCT02296840|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91929697|NCT02296840|Narcotics|narcotics|mesh-ancestor
91929698|NCT02296840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929699|NCT02296840|Antitussive Agents|antitussive agents|mesh-ancestor
91929700|NCT02296840|Respiratory System Agents|respiratory system agents|mesh-ancestor
91929701|NCT02191319|Nevirapine|nevirapine|mesh-list
91929702|NCT02191319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91929703|NCT02191319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91929704|NCT02191319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929705|NCT02191319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929706|NCT02191319|Antiviral Agents|antiviral agents|mesh-ancestor
91929707|NCT02191319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929708|NCT02191319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91929709|NCT02191319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929710|NCT02191319|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91929711|NCT02191319|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91929712|NCT02191475|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91929713|NCT02191475|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91929714|NCT02191475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929715|NCT02191475|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91929716|NCT02191475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929717|NCT02191475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929718|NCT02191709|Dextromethorphan|dextromethorphan|mesh-list
91929719|NCT02191709|Antitussive Agents|antitussive agents|mesh-ancestor
91929720|NCT02191709|Respiratory System Agents|respiratory system agents|mesh-ancestor
91929721|NCT02191709|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91929722|NCT02191709|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91929723|NCT02191709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929724|NCT02191709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929725|NCT02191709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929726|NCT00326287|Ceftriaxone|ceftriaxone|mesh-list
91929727|NCT00326287|Linezolid|linezolid|mesh-list
91929728|NCT00326287|Ceftobiprole|ceftobiprole|mesh-list
91929729|NCT00326287|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
91929730|NCT00326287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91929731|NCT00326287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929732|NCT00326287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91929733|NCT00326287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929734|NCT00326287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929735|NCT02191943|Fluorides|fluorides|mesh-list
91929736|NCT02191943|Fluorides, Topical|fluorides, topical|mesh-list
91929737|NCT02191943|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
91929738|NCT02191943|Cariostatic Agents|cariostatic agents|mesh-ancestor
91929739|NCT02191943|Protective Agents|protective agents|mesh-ancestor
91929740|NCT02191943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929741|NCT02663895|Treprostinil|treprostinil|mesh-list
91929742|NCT02663895|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91929743|NCT00320203|Hydrocortisone|hydrocortisone|mesh-list
91929744|NCT00320203|Anecortave|anecortave|mesh-list
91929745|NCT00320203|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91929746|NCT00320203|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91929747|NCT00320203|Growth Substances|growth substances|mesh-ancestor
91929748|NCT00320203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929749|NCT00320203|Growth Inhibitors|growth inhibitors|mesh-ancestor
91929750|NCT00320203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929751|NCT00320203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929753|NCT00071461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91929754|NCT00071461|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91929755|NCT00071461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929756|NCT00069745|Prednisone|prednisone|mesh-list
91929757|NCT00069745|Satraplatin|satraplatin|mesh-list
91929758|NCT00069745|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929759|NCT00069745|Glucocorticoids|glucocorticoids|mesh-ancestor
91929760|NCT00069745|Hormones|hormones|mesh-ancestor
91929838|NCT00317395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929761|NCT00069745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929762|NCT00069745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929763|NCT00069745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91929764|NCT00069745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929765|NCT02192411|Lidocaine|lidocaine|mesh-list
91929766|NCT02192411|Anesthetics, Local|anesthetics, local|mesh-ancestor
91929767|NCT02192411|Anesthetics|anesthetics|mesh-ancestor
91929768|NCT02192411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929769|NCT02192411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929770|NCT02192411|Sensory System Agents|sensory system agents|mesh-ancestor
91929771|NCT02192411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929772|NCT02192411|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91929773|NCT02192411|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91929774|NCT02192411|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91929775|NCT02192411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929776|NCT02192411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929777|NCT02193893|Coal Tar|coal tar|mesh-list
91929778|NCT02193893|Keratolytic Agents|keratolytic agents|mesh-ancestor
91929779|NCT02193893|Dermatologic Agents|dermatologic agents|mesh-ancestor
91929780|NCT02384187|Gabapentin|gabapentin|mesh-list
91929781|NCT02384187|Analgesics|analgesics|mesh-ancestor
91929782|NCT02384187|Sensory System Agents|sensory system agents|mesh-ancestor
91929783|NCT02384187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929784|NCT02384187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929785|NCT02384187|Anticonvulsants|anticonvulsants|mesh-ancestor
91929786|NCT02384187|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91929787|NCT02384187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91929788|NCT02384187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929789|NCT02384187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91929790|NCT02384187|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91929791|NCT02384187|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91929792|NCT02384187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929793|NCT02384187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929794|NCT02384187|Antimanic Agents|antimanic agents|mesh-ancestor
91929795|NCT02192723|Olanzapine|olanzapine|mesh-list
91929796|NCT02192723|Risperidone|risperidone|mesh-list
91929797|NCT02192723|Aripiprazole|aripiprazole|mesh-list
91929798|NCT02192723|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91929800|NCT02192723|Antipsychotic Agents|antipsychotic agents|mesh-list
91929801|NCT02192723|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91929802|NCT02192723|Serotonin Agents|serotonin agents|mesh-ancestor
91929803|NCT02192723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929804|NCT02192723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929805|NCT02192723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929806|NCT02192723|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91929807|NCT02192723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91929808|NCT02192723|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91929809|NCT02192723|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91929810|NCT02192723|Dopamine Agents|dopamine agents|mesh-ancestor
91929811|NCT02192723|Antiemetics|antiemetics|mesh-ancestor
91929812|NCT02192723|Autonomic Agents|autonomic agents|mesh-ancestor
91929813|NCT02192723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929814|NCT02192723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91929815|NCT02192723|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91929816|NCT02192723|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91929817|NCT02192723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929818|NCT02192723|Antidepressive Agents|antidepressive agents|mesh-ancestor
91929819|NCT02192723|Dopamine Agonists|dopamine agonists|mesh-ancestor
91929820|NCT02192723|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91929821|NCT02192723|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91929822|NCT02192723|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91929825|NCT00319969|Amrubicin|amrubicin|mesh-list
91929826|NCT00319969|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91929827|NCT00319969|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91929828|NCT00319969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929829|NCT00319969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929830|NCT00319969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929831|NCT00317395|Heparin|heparin|mesh-list
91929832|NCT00317395|Calcium heparin|calcium heparin|mesh-list
91929833|NCT00317395|Otamixaban|otamixaban|mesh-list
91929834|NCT00317395|Eptifibatide|eptifibatide|mesh-list
91929835|NCT00317395|Anticoagulants|anticoagulants|mesh-ancestor
91929836|NCT00317395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91929837|NCT00317395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91929839|NCT00317395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91929840|NCT00317395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91929841|NCT00317395|Antithrombins|antithrombins|mesh-ancestor
91929842|NCT00317395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91929843|NCT00317395|Protease Inhibitors|protease inhibitors|mesh-ancestor
91929844|NCT00317395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929846|NCT02383563|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929847|NCT02383563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929848|NCT03535961|Etoposide|etoposide|mesh-list
91929849|NCT03535961|Apatinib|apatinib|mesh-list
91929850|NCT03535961|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91929851|NCT03535961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929852|NCT03535961|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91929853|NCT03535961|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91929854|NCT03535961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929855|NCT03535961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929856|NCT03535961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929857|NCT02380755|Clomiphene|clomiphene|mesh-list
91929858|NCT02380755|Enclomiphene|enclomiphene|mesh-list
91929859|NCT02380755|Zuclomiphene|zuclomiphene|mesh-list
91929860|NCT02380755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91929861|NCT02380755|Hormone Antagonists|hormone antagonists|mesh-ancestor
91929862|NCT02380755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929863|NCT02380755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929864|NCT02380755|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91929865|NCT02380755|Fertility Agents|fertility agents|mesh-ancestor
91929866|NCT02380755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91929867|NCT02380755|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91929868|NCT02380755|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91929869|NCT02188277|Botulinum Toxins|botulinum toxins|mesh-list
91929870|NCT02188277|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91929871|NCT02188277|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91929872|NCT02188277|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
91929873|NCT02188277|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91929874|NCT02188277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91929875|NCT02188277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929876|NCT02188277|Cholinergic Agents|cholinergic agents|mesh-ancestor
91929877|NCT02188277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929878|NCT02188277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929879|NCT02188277|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91929880|NCT02188277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929881|NCT02380521|Exenatide|exenatide|mesh-list
91929882|NCT02380521|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91929883|NCT02380521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929884|NCT02380521|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91929885|NCT02380521|Incretins|incretins|mesh-ancestor
91929886|NCT02380521|Hormones|hormones|mesh-ancestor
91929887|NCT02380521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929888|NCT00315757|Bortezomib|bortezomib|mesh-list
91929889|NCT00315757|Mapatumumab|mapatumumab|mesh-list
91929890|NCT00315757|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91929891|NCT00315757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929892|NCT00315757|Immunologic Factors|immunologic factors|mesh-ancestor
91929893|NCT00315757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929894|NCT02377401|Zanamivir|zanamivir|mesh-list
91929895|NCT02377401|Antiviral Agents|antiviral agents|mesh-ancestor
91929896|NCT02377401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929897|NCT02377401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929898|NCT02377401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929899|NCT00312091|Lamivudine|lamivudine|mesh-list
91929900|NCT00312091|Nevirapine|nevirapine|mesh-list
91929901|NCT00312091|Stavudine|stavudine|mesh-list
91929902|NCT00312091|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91929903|NCT00312091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91929904|NCT00312091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929905|NCT00312091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929906|NCT00312091|Antiviral Agents|antiviral agents|mesh-ancestor
91929907|NCT00312091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91929908|NCT00312091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91929909|NCT00312091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91929910|NCT00312091|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91929911|NCT00312091|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91929912|NCT00312091|Antimetabolites|antimetabolites|mesh-ancestor
91929913|NCT00389779|Guanfacine|guanfacine|mesh-list
91929914|NCT00389779|Darusentan|darusentan|mesh-list
91929915|NCT00389779|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91929916|NCT00389779|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91929917|NCT00389779|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91929918|NCT00389779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91929919|NCT00389779|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929920|NCT00389779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929921|NCT00389779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929922|NCT00389779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929923|NCT00389779|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91929924|NCT00389155|Gemcitabine|gemcitabine|mesh-list
91929925|NCT00389155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91929926|NCT00389155|Antimetabolites|antimetabolites|mesh-ancestor
91929927|NCT00389155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929928|NCT00389155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929929|NCT02188511|Nicotine|nicotine|mesh-list
91929930|NCT02188511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91929931|NCT02188511|Autonomic Agents|autonomic agents|mesh-ancestor
91929932|NCT02188511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929933|NCT02188511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929934|NCT02188511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91929935|NCT02188511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91929936|NCT02188511|Cholinergic Agents|cholinergic agents|mesh-ancestor
91929937|NCT02188511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929938|NCT02188511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929939|NCT02380131|Capecitabine|capecitabine|mesh-list
91929940|NCT02380131|Oxaliplatin|oxaliplatin|mesh-list
91929941|NCT02380131|Trastuzumab|trastuzumab|mesh-list
91929942|NCT02380131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91929943|NCT02380131|Antimetabolites|antimetabolites|mesh-ancestor
91929944|NCT02380131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929945|NCT02380131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929946|NCT02380131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91929947|NCT03535103|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91929948|NCT03535103|Hormones|hormones|mesh-ancestor
91929949|NCT03535103|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91929950|NCT03535103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929951|NCT04360941|Palbociclib|palbociclib|mesh-list
91929952|NCT04360941|Avelumab|avelumab|mesh-list
91929953|NCT04360941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929954|NCT04360941|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929955|NCT04360941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929956|NCT04360941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929957|NCT04360941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91929958|NCT04551365|Chitosan|chitosan|mesh-list
91929959|NCT04551365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91929960|NCT04551365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91929961|NCT04551365|Antimetabolites|antimetabolites|mesh-ancestor
91929962|NCT04551365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929963|NCT04551365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91929964|NCT04551365|Chelating Agents|chelating agents|mesh-ancestor
91929965|NCT04551365|Sequestering Agents|sequestering agents|mesh-ancestor
91929966|NCT04551365|Hemostatics|hemostatics|mesh-ancestor
91929967|NCT04551365|Coagulants|coagulants|mesh-ancestor
91929969|NCT00028639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929970|NCT02371941|Cromolyn Sodium|cromolyn sodium|mesh-list
91929971|NCT02371941|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
91929972|NCT02371941|Immunologic Factors|immunologic factors|mesh-ancestor
91929973|NCT02371941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929974|NCT02371941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91929975|NCT02371941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91929976|NCT02371941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91929977|NCT02371941|Respiratory System Agents|respiratory system agents|mesh-ancestor
91929978|NCT00298987|Dasatinib|dasatinib|mesh-list
91929979|NCT00298987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91929980|NCT00298987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91929981|NCT00298987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91929982|NCT00298987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929983|NCT02380053|Celiprolol|celiprolol|mesh-list
91929984|NCT02380053|Bisoprolol|bisoprolol|mesh-list
91929985|NCT02380053|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91929986|NCT02380053|Sympatholytics|sympatholytics|mesh-ancestor
91929987|NCT02380053|Autonomic Agents|autonomic agents|mesh-ancestor
91929988|NCT02380053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91929989|NCT02380053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91929990|NCT02380053|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91929991|NCT02380053|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91929992|NCT02380053|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91929993|NCT02380053|Adrenergic Agents|adrenergic agents|mesh-ancestor
91929994|NCT02380053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91929995|NCT02380053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91929996|NCT02380053|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91929997|NCT02380053|Sympathomimetics|sympathomimetics|mesh-ancestor
91929998|NCT02380053|Vasodilator Agents|vasodilator agents|mesh-ancestor
91929999|NCT03725761|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
91930000|NCT03725761|Immunoconjugates|immunoconjugates|mesh-ancestor
91930001|NCT03725761|Immunologic Factors|immunologic factors|mesh-ancestor
91930002|NCT03725761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930003|NCT02371707|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
91930004|NCT02371707|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91930005|NCT02371707|Serotonin Agents|serotonin agents|mesh-ancestor
91930006|NCT02371707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930007|NCT02371707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930008|NCT02371707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930009|NCT02193971|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91930010|NCT02193971|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91930011|NCT00004915|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
91930012|NCT00004915|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91930013|NCT00004915|Hormone Antagonists|hormone antagonists|mesh-ancestor
91930014|NCT00004915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930015|NCT00004915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930016|NCT00004915|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91930017|NCT00004915|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91930018|NCT00004915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91930020|NCT03535415|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930021|NCT03535415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930022|NCT02030717|Clonidine|clonidine|mesh-list
91930023|NCT02030717|Anesthetics|anesthetics|mesh-list
91930024|NCT02030717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930025|NCT02030717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930026|NCT02030717|Analgesics|analgesics|mesh-ancestor
91930027|NCT02030717|Sensory System Agents|sensory system agents|mesh-ancestor
91930028|NCT02030717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930029|NCT02030717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91930030|NCT02030717|Sympatholytics|sympatholytics|mesh-ancestor
91930031|NCT02030717|Autonomic Agents|autonomic agents|mesh-ancestor
91930032|NCT02030717|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91930033|NCT02030717|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91930034|NCT02030717|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91930035|NCT02030717|Adrenergic Agents|adrenergic agents|mesh-ancestor
91930036|NCT02030717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930037|NCT02030717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930038|NCT02371473|Acetazolamide|acetazolamide|mesh-list
91930039|NCT02371473|Anticonvulsants|anticonvulsants|mesh-ancestor
91930040|NCT02371473|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91930041|NCT02371473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930042|NCT02371473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930043|NCT02371473|Diuretics|diuretics|mesh-ancestor
91930044|NCT02371473|Natriuretic Agents|natriuretic agents|mesh-ancestor
91930045|NCT02371473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930046|NCT04301661|Tenofovir|tenofovir|mesh-list
91930047|NCT04301661|Lamivudine|lamivudine|mesh-list
91930048|NCT04301661|Emtricitabine|emtricitabine|mesh-list
91930049|NCT04301661|Abacavir|abacavir|mesh-list
91930050|NCT04301661|Antiviral Agents|antiviral agents|mesh-ancestor
91930051|NCT04301661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930052|NCT04301661|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91930053|NCT04301661|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930054|NCT04301661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930055|NCT04301661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930056|NCT04301661|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930057|NCT04301661|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930058|NCT02194049|Etoposide|etoposide|mesh-list
91930059|NCT02194049|Etoposide phosphate|etoposide phosphate|mesh-list
91930060|NCT02194049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930061|NCT02194049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930062|NCT02194049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91930063|NCT02194049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91930065|NCT02194049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930066|NCT02379663|Enoxaparin|enoxaparin|mesh-list
91930067|NCT02379663|Rivaroxaban|rivaroxaban|mesh-list
91930068|NCT02379663|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91930069|NCT02379663|Antithrombins|antithrombins|mesh-ancestor
91930070|NCT02379663|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91930071|NCT02379663|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930072|NCT02379663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930073|NCT02379663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930074|NCT02379663|Anticoagulants|anticoagulants|mesh-ancestor
91930075|NCT02379663|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91930076|NCT02379663|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91930077|NCT02030639|ON 01910|on 01910|mesh-list
91930078|NCT02030639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930079|NCT02030639|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91930080|NCT02030639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930081|NCT02030639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930082|NCT00004897|Leucovorin|leucovorin|mesh-list
91930083|NCT00004897|Interferons|interferons|mesh-list
91930084|NCT00004897|Interferon-alpha|interferon-alpha|mesh-list
91930085|NCT00004897|Fluorouracil|fluorouracil|mesh-list
91930086|NCT00004897|Hydroxyurea|hydroxyurea|mesh-list
91930087|NCT00004897|Calcium|calcium|mesh-list
91930088|NCT00004897|Levoleucovorin|levoleucovorin|mesh-list
91930089|NCT00004897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930090|NCT00004897|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91930091|NCT00004897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930092|NCT00004897|Antimetabolites|antimetabolites|mesh-ancestor
91930093|NCT00004897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930094|NCT00004897|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91930095|NCT00004897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930096|NCT00004897|Immunologic Factors|immunologic factors|mesh-ancestor
91930097|NCT00004897|Antiviral Agents|antiviral agents|mesh-ancestor
91930098|NCT00004897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930099|NCT00004897|Antidotes|antidotes|mesh-ancestor
91930100|NCT00004897|Protective Agents|protective agents|mesh-ancestor
91930101|NCT00004897|Vitamin B Complex|vitamin b complex|mesh-ancestor
91930102|NCT00004897|Vitamins|vitamins|mesh-ancestor
91930103|NCT00004897|Micronutrients|micronutrients|mesh-ancestor
91930104|NCT00004897|Antisickling Agents|antisickling agents|mesh-ancestor
91930105|NCT00004897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930106|NCT00004897|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930107|NCT00004231|Leucovorin|leucovorin|mesh-list
91930108|NCT00004231|Interferons|interferons|mesh-list
91930109|NCT00004231|Cytarabine|cytarabine|mesh-list
91930110|NCT00004231|Interferon-alpha|interferon-alpha|mesh-list
91930111|NCT00004231|Aldesleukin|aldesleukin|mesh-list
91930112|NCT00004231|Prednisone|prednisone|mesh-list
91930113|NCT00004231|Cyclophosphamide|cyclophosphamide|mesh-list
91930114|NCT00004231|Busulfan|busulfan|mesh-list
91930115|NCT00004231|Doxorubicin|doxorubicin|mesh-list
91930116|NCT00004231|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91930117|NCT00004231|Methotrexate|methotrexate|mesh-list
91930118|NCT00004231|Vincristine|vincristine|mesh-list
91930119|NCT00004231|Teniposide|teniposide|mesh-list
91930120|NCT00004231|Levoleucovorin|levoleucovorin|mesh-list
91930121|NCT00004231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930122|NCT00004231|Immunologic Factors|immunologic factors|mesh-ancestor
91930123|NCT00004231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930124|NCT00004231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930125|NCT00004231|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91930126|NCT00004231|Alkylating Agents|alkylating agents|mesh-ancestor
91930127|NCT00004231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930128|NCT00004231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930129|NCT00004231|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91930130|NCT00004231|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91930131|NCT00004231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91930132|NCT00004231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91930133|NCT00004231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930134|NCT00004231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930135|NCT00004231|Glucocorticoids|glucocorticoids|mesh-ancestor
91930136|NCT00004231|Hormones|hormones|mesh-ancestor
91930137|NCT00004231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930138|NCT00004231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91930139|NCT00004231|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91930141|NCT00004231|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91930142|NCT00004231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91930143|NCT00004231|Antimetabolites|antimetabolites|mesh-ancestor
91930144|NCT00004231|Dermatologic Agents|dermatologic agents|mesh-ancestor
91930145|NCT00004231|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91930146|NCT00004231|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930147|NCT00004231|Antiviral Agents|antiviral agents|mesh-ancestor
91930148|NCT00004231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930149|NCT00004231|Antidotes|antidotes|mesh-ancestor
91930150|NCT00004231|Protective Agents|protective agents|mesh-ancestor
91930151|NCT00004231|Vitamin B Complex|vitamin b complex|mesh-ancestor
91930153|NCT00004231|Micronutrients|micronutrients|mesh-ancestor
91930154|NCT00004231|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930155|NCT00004231|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930156|NCT00004231|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930157|NCT00004231|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930158|NCT00004231|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930159|NCT00004231|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930160|NCT04681131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91930161|NCT04681131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930162|NCT04681131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91930163|NCT04681131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930164|NCT00004171|Cyclophosphamide|cyclophosphamide|mesh-list
91930165|NCT00004171|Busulfan|busulfan|mesh-list
91930166|NCT00004171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930167|NCT00004171|Immunologic Factors|immunologic factors|mesh-ancestor
91930168|NCT00004171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930169|NCT00004171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930170|NCT00004171|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91930171|NCT00004171|Alkylating Agents|alkylating agents|mesh-ancestor
91930172|NCT00004171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930173|NCT00004171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930174|NCT00004171|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91930176|NCT00004165|Immunologic Factors|immunologic factors|mesh-ancestor
91930177|NCT00004165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930178|NCT00004165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91930179|NCT00004165|Alkylating Agents|alkylating agents|mesh-ancestor
91930180|NCT00004165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930181|NCT00004165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930182|NCT00004165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91930183|NCT00004165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930184|NCT00004093|Paclitaxel|paclitaxel|mesh-list
91930185|NCT00004093|Vinorelbine|vinorelbine|mesh-list
91930186|NCT00004093|Carboplatin|carboplatin|mesh-list
91930187|NCT00004093|Gemcitabine|gemcitabine|mesh-list
91930188|NCT00004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930189|NCT00004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930190|NCT00004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930191|NCT00004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930192|NCT00004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930193|NCT00004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930194|NCT00004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91930195|NCT00004093|Antimetabolites|antimetabolites|mesh-ancestor
91930196|NCT02193269|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91930197|NCT02193269|Minocycline|minocycline|mesh-list
91930198|NCT02193269|Tetracycline|tetracycline|mesh-list
91930199|NCT02193269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930200|NCT02193269|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91930201|NCT02193269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930202|NCT02193269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930203|NCT00002479|Tretinoin|tretinoin|mesh-list
91930204|NCT00002479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930205|NCT00002479|Keratolytic Agents|keratolytic agents|mesh-ancestor
91930206|NCT00002479|Dermatologic Agents|dermatologic agents|mesh-ancestor
91930207|NCT00002371|Lamivudine|lamivudine|mesh-list
91930208|NCT00002371|Zidovudine|zidovudine|mesh-list
91930209|NCT00002371|Stavudine|stavudine|mesh-list
91930210|NCT00002371|Indinavir|indinavir|mesh-list
91930211|NCT00002371|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91930212|NCT00002371|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930213|NCT00002371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930214|NCT00002371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930215|NCT00002371|Antiviral Agents|antiviral agents|mesh-ancestor
91930216|NCT00002371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930217|NCT00002371|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930218|NCT00002371|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930219|NCT00002371|Antimetabolites|antimetabolites|mesh-ancestor
91930220|NCT00002371|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91930221|NCT00002371|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91930222|NCT00002371|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930224|NCT02189681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930225|NCT02189681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930226|NCT05715385|Bromfenac|bromfenac|mesh-list
91930227|NCT05715385|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91930228|NCT05715385|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91930229|NCT05715385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91930230|NCT05715385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930231|NCT05715385|Analgesics|analgesics|mesh-ancestor
91930232|NCT05715385|Sensory System Agents|sensory system agents|mesh-ancestor
91930233|NCT05715385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930234|NCT05715385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930235|NCT05715385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930236|NCT05715385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930237|NCT04182633|Vancomycin|vancomycin|mesh-list
91930238|NCT04182633|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
91930239|NCT04182633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91930240|NCT04182633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930241|NCT04182633|Laxatives|laxatives|mesh-ancestor
91930242|NCT04182633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91930243|NCT02194283|Ambroxol|ambroxol|mesh-list
91930244|NCT02194283|Expectorants|expectorants|mesh-ancestor
91930245|NCT02194283|Respiratory System Agents|respiratory system agents|mesh-ancestor
91930246|NCT00263341|Contraceptive Agents|contraceptive agents|mesh-list
91930247|NCT00263341|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91930248|NCT00263341|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91930249|NCT00263341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930250|NCT00263341|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91930251|NCT00263341|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91930252|NCT00263341|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91930253|NCT00263341|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91930254|NCT00263341|Estrogens|estrogens|mesh-ancestor
91930255|NCT00263341|Hormones|hormones|mesh-ancestor
91930256|NCT00263341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930257|NCT03534869|Analgesics|analgesics|mesh-list
91930258|NCT03534869|Sensory System Agents|sensory system agents|mesh-ancestor
91930259|NCT03534869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930260|NCT03534869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930261|NCT02370849|Nimotuzumab|nimotuzumab|mesh-list
91930262|NCT02370849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930263|NCT02370849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91930264|NCT02378649|Sildenafil Citrate|sildenafil citrate|mesh-list
91930265|NCT02378649|Vasodilator Agents|vasodilator agents|mesh-ancestor
91930266|NCT02378649|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91930267|NCT02378649|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91930268|NCT02378649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930269|NCT02378649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930270|NCT02378649|Urological Agents|urological agents|mesh-ancestor
91930271|NCT02197169|Interferons|interferons|mesh-list
91930272|NCT02197169|Interferon-gamma|interferon-gamma|mesh-list
91930273|NCT02197169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930274|NCT02197169|Antiviral Agents|antiviral agents|mesh-ancestor
91930275|NCT02197169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930276|NCT02376309|Nandrolone|nandrolone|mesh-list
91930278|NCT02376309|Hormones|hormones|mesh-ancestor
91930279|NCT02376309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930280|NCT02376309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930281|NCT02376309|Anabolic Agents|anabolic agents|mesh-ancestor
91930282|NCT00232141|Pregabalin|pregabalin|mesh-list
91930283|NCT00232141|Analgesics|analgesics|mesh-ancestor
91930284|NCT00232141|Sensory System Agents|sensory system agents|mesh-ancestor
91930285|NCT00232141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930286|NCT00232141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930287|NCT00232141|Anticonvulsants|anticonvulsants|mesh-ancestor
91930288|NCT00232141|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91930289|NCT00232141|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91930290|NCT00232141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930291|NCT00232141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91930292|NCT00232141|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91930293|NCT00232141|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91930294|NCT00232141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930295|NCT00232141|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91930296|NCT02378415|Ketamine|ketamine|mesh-list
91930297|NCT02378415|Analgesics|analgesics|mesh-ancestor
91930298|NCT02378415|Sensory System Agents|sensory system agents|mesh-ancestor
91930299|NCT02378415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930374|NCT02288923|Acetaminophen|acetaminophen|mesh-list
91930300|NCT02378415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930301|NCT02378415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91930302|NCT02378415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91930303|NCT02378415|Anesthetics, General|anesthetics, general|mesh-ancestor
91930304|NCT02378415|Anesthetics|anesthetics|mesh-ancestor
91930305|NCT02378415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930306|NCT02378415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91930307|NCT02378415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91930308|NCT02378415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930309|NCT02378415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930310|NCT02197403|Dexmedetomidine|dexmedetomidine|mesh-list
91930311|NCT02197403|Propofol|propofol|mesh-list
91930312|NCT02197403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91930313|NCT02197403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930314|NCT02197403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930315|NCT02197403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930316|NCT02197403|Analgesics|analgesics|mesh-ancestor
91930317|NCT02197403|Sensory System Agents|sensory system agents|mesh-ancestor
91930318|NCT02197403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930319|NCT02197403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91930320|NCT02197403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91930321|NCT02197403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91930322|NCT02197403|Adrenergic Agents|adrenergic agents|mesh-ancestor
91930323|NCT02197403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930324|NCT02197403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930325|NCT02197403|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91930326|NCT02197403|Anesthetics, General|anesthetics, general|mesh-ancestor
91930327|NCT02197403|Anesthetics|anesthetics|mesh-ancestor
91930328|NCT02370069|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91930329|NCT02370069|Immunologic Factors|immunologic factors|mesh-ancestor
91930330|NCT02370069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930331|NCT03534713|Paclitaxel|paclitaxel|mesh-list
91930332|NCT03534713|Carboplatin|carboplatin|mesh-list
91930333|NCT03534713|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930334|NCT03534713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930335|NCT03534713|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930336|NCT03534713|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930337|NCT03534713|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930338|NCT03534713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930339|NCT02376075|Linagliptin|linagliptin|mesh-list
91930340|NCT02376075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91930341|NCT02376075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930342|NCT02376075|Incretins|incretins|mesh-ancestor
91930343|NCT02376075|Hormones|hormones|mesh-ancestor
91930344|NCT02376075|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930345|NCT02376075|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91930346|NCT02376075|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930347|NCT02376075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930348|NCT02376075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930349|NCT02197637|Vinorelbine|vinorelbine|mesh-list
91930350|NCT02197637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930351|NCT02197637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930352|NCT02197637|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930353|NCT02197637|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930354|NCT02197637|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930355|NCT02197637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930356|NCT04469413|Acetaminophen|acetaminophen|mesh-list
91930357|NCT04469413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930358|NCT04469413|Analgesics|analgesics|mesh-ancestor
91930359|NCT04469413|Sensory System Agents|sensory system agents|mesh-ancestor
91930360|NCT04469413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930361|NCT04469413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930362|NCT04469413|Antipyretics|antipyretics|mesh-ancestor
91930363|NCT03532087|Denosumab|denosumab|mesh-list
91930364|NCT03532087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91930365|NCT03532087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930366|NCT02369523|Bupivacaine|bupivacaine|mesh-list
91930367|NCT02369523|Ropivacaine|ropivacaine|mesh-list
91930368|NCT02369523|Anesthetics, Local|anesthetics, local|mesh-ancestor
91930369|NCT02369523|Anesthetics|anesthetics|mesh-ancestor
91930370|NCT02369523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930371|NCT02369523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930372|NCT02369523|Sensory System Agents|sensory system agents|mesh-ancestor
91930373|NCT02369523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930380|NCT02288923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930381|NCT02288923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930382|NCT02288923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91930383|NCT02288923|Narcotics|narcotics|mesh-ancestor
91930384|NCT02288923|Analgesics|analgesics|mesh-ancestor
91930385|NCT02288923|Sensory System Agents|sensory system agents|mesh-ancestor
91930386|NCT02288923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930387|NCT02288923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91930388|NCT02288923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930389|NCT02288923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930390|NCT02288923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930391|NCT02288923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91930392|NCT02288923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930393|NCT02288923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930395|NCT02288923|Autonomic Agents|autonomic agents|mesh-ancestor
91930396|NCT02288923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91930397|NCT02195375|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91930398|NCT02195375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91930399|NCT02195375|Autonomic Agents|autonomic agents|mesh-ancestor
91930400|NCT02195375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930401|NCT02195375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930402|NCT02195375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91930403|NCT02195375|Respiratory System Agents|respiratory system agents|mesh-ancestor
91930404|NCT02195375|Glucocorticoids|glucocorticoids|mesh-ancestor
91930405|NCT02195375|Hormones|hormones|mesh-ancestor
91930406|NCT02195375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930407|NCT02195375|Sympathomimetics|sympathomimetics|mesh-ancestor
91930408|NCT03531931|Apatinib|apatinib|mesh-list
91930409|NCT03531931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930410|NCT03531931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91930411|NCT03531931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930412|NCT03531931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930413|NCT03601455|Durvalumab|durvalumab|mesh-list
91930414|NCT03601455|Ipilimumab|ipilimumab|mesh-list
91930415|NCT03601455|Tremelimumab|tremelimumab|mesh-list
91930416|NCT03601455|Immunoglobulins|immunoglobulins|mesh-list
91930417|NCT03601455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91930418|NCT03601455|Immunoglobulin G|immunoglobulin g|mesh-list
91930419|NCT03601455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91930420|NCT03601455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930421|NCT03601455|Immunologic Factors|immunologic factors|mesh-ancestor
91930422|NCT03601455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930423|NCT03601455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91930424|NCT03601455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930425|NCT03531697|Loteprednol Etabonate|loteprednol etabonate|mesh-list
91930426|NCT03531697|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91930427|NCT02369133|Acetaminophen|acetaminophen|mesh-list
91930428|NCT02369133|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930429|NCT02369133|Analgesics|analgesics|mesh-ancestor
91930430|NCT02369133|Sensory System Agents|sensory system agents|mesh-ancestor
91930431|NCT02369133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930432|NCT02369133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930433|NCT02369133|Antipyretics|antipyretics|mesh-ancestor
91930434|NCT02377635|Selenious Acid|selenious acid|mesh-list
91930435|NCT02377635|Sodium Selenite|sodium selenite|mesh-list
91930436|NCT02377635|Trace Elements|trace elements|mesh-ancestor
91930437|NCT02377635|Micronutrients|micronutrients|mesh-ancestor
91930438|NCT02377635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930439|NCT03534479|Immunoglobulins|immunoglobulins|mesh-list
91930440|NCT03534479|Immunologic Factors|immunologic factors|mesh-ancestor
91930441|NCT03534479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930443|NCT02198027|Anesthetics, Local|anesthetics, local|mesh-ancestor
91930444|NCT02198027|Anesthetics|anesthetics|mesh-ancestor
91930445|NCT02198027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930446|NCT02198027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930447|NCT02198027|Sensory System Agents|sensory system agents|mesh-ancestor
91930448|NCT02198027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930449|NCT02257463|Theophylline|theophylline|mesh-list
91930450|NCT02257463|Bronchodilator Agents|bronchodilator agents|mesh-list
91930451|NCT02257463|Autonomic Agents|autonomic agents|mesh-ancestor
91930452|NCT02257463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930453|NCT02257463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930454|NCT02257463|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91930455|NCT02257463|Respiratory System Agents|respiratory system agents|mesh-ancestor
91930456|NCT02257463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930457|NCT02257463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930458|NCT02257463|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91930459|NCT02257463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930461|NCT02257463|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91930462|NCT02257463|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91930463|NCT02257463|Purinergic Agents|purinergic agents|mesh-ancestor
91930464|NCT02198261|Minoxidil|minoxidil|mesh-list
91930465|NCT02198261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91930466|NCT02198261|Vasodilator Agents|vasodilator agents|mesh-ancestor
91930467|NCT03533699|Propranolol|propranolol|mesh-list
91930468|NCT03533699|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91930469|NCT03533699|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91930470|NCT03533699|Adrenergic Agents|adrenergic agents|mesh-ancestor
91930471|NCT03533699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930472|NCT03533699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930473|NCT03533699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930474|NCT03533699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91930475|NCT03533699|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91930476|NCT03533699|Vasodilator Agents|vasodilator agents|mesh-ancestor
91930477|NCT00135421|Escitalopram|escitalopram|mesh-list
91930478|NCT00135421|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91930479|NCT00135421|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91930480|NCT00135421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91930481|NCT00135421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930482|NCT00135421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930483|NCT00135421|Serotonin Agents|serotonin agents|mesh-ancestor
91930484|NCT00135421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930485|NCT02200991|Insulin Glargine|insulin glargine|mesh-list
91930486|NCT02200991|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91930487|NCT02200991|Lixisenatide|lixisenatide|mesh-list
91930488|NCT02200991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91930489|NCT02200991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930490|NCT02200991|Incretins|incretins|mesh-ancestor
91930491|NCT02200991|Hormones|hormones|mesh-ancestor
91930492|NCT02200991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930493|NCT02200991|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91930494|NCT02200991|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930495|NCT02200991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930496|NCT02200991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930497|NCT01979367|Analgesics|analgesics|mesh-list
91930498|NCT01979367|Sensory System Agents|sensory system agents|mesh-ancestor
91930499|NCT01979367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930500|NCT01979367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930501|NCT02368743|Mesalamine|mesalamine|mesh-list
91930502|NCT02368743|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91930503|NCT02368743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930504|NCT02368743|Analgesics|analgesics|mesh-ancestor
91930505|NCT02368743|Sensory System Agents|sensory system agents|mesh-ancestor
91930506|NCT02368743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930507|NCT02368743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930508|NCT02368743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930509|NCT02368743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930510|NCT00135343|Ritonavir|ritonavir|mesh-list
91930511|NCT00135343|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91930512|NCT00135343|Efavirenz|efavirenz|mesh-list
91930513|NCT00135343|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91930514|NCT00135343|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91930515|NCT00135343|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930516|NCT00135343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930517|NCT00135343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930518|NCT00135343|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930519|NCT00135343|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930520|NCT00135343|Antiviral Agents|antiviral agents|mesh-ancestor
91930521|NCT00135343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930522|NCT00135343|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91930523|NCT00135343|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91930524|NCT00135343|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91930525|NCT00135343|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930526|NCT00135343|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91930527|NCT00135343|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91930528|NCT00135343|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91930529|NCT00135343|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91930687|NCT03529201|Anesthetics, General|anesthetics, general|mesh-ancestor
91930530|NCT00135343|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91930531|NCT02201225|Micronutrients|micronutrients|mesh-list
91930532|NCT02201225|Trace Elements|trace elements|mesh-list
91930533|NCT02201225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930535|NCT02365155|Vitamins|vitamins|mesh-ancestor
91930536|NCT02365155|Micronutrients|micronutrients|mesh-ancestor
91930537|NCT02365155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930538|NCT02365155|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91930539|NCT05724745|Albuterol|albuterol|mesh-list
91930540|NCT05724745|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91930541|NCT05724745|Autonomic Agents|autonomic agents|mesh-ancestor
91930542|NCT05724745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930543|NCT05724745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930544|NCT05724745|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91930545|NCT05724745|Respiratory System Agents|respiratory system agents|mesh-ancestor
91930546|NCT05724745|Tocolytic Agents|tocolytic agents|mesh-ancestor
91930547|NCT05724745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91930548|NCT05724745|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91930549|NCT05724745|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91930550|NCT05724745|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91930551|NCT05724745|Adrenergic Agents|adrenergic agents|mesh-ancestor
91930552|NCT05724745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930553|NCT05724745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930554|NCT02198339|Olcegepant|olcegepant|mesh-list
91930555|NCT02198339|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91930556|NCT02198339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930557|NCT02198339|Analgesics|analgesics|mesh-ancestor
91930558|NCT02198339|Sensory System Agents|sensory system agents|mesh-ancestor
91930559|NCT02198339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930560|NCT02198339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930561|NCT02198807|Piperaquine|piperaquine|mesh-list
91930562|NCT02198807|Fosmidomycin|fosmidomycin|mesh-list
91930563|NCT02198807|Antimalarials|antimalarials|mesh-ancestor
91930564|NCT02198807|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91930565|NCT02198807|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91930566|NCT02198807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930567|NCT02198807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91930568|NCT02198417|Metformin|metformin|mesh-list
91930569|NCT02198417|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91930570|NCT02198417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930571|NCT02201459|Interferons|interferons|mesh-list
91930572|NCT02201459|Interferon-alpha|interferon-alpha|mesh-list
91930573|NCT02201459|Interferon alpha-2|interferon alpha-2|mesh-list
91930574|NCT02201459|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91930575|NCT02201459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930576|NCT02201459|Antiviral Agents|antiviral agents|mesh-ancestor
91930577|NCT02201459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930578|NCT02201459|Immunologic Factors|immunologic factors|mesh-ancestor
91930579|NCT02201459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930581|NCT05724589|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930582|NCT05724589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930583|NCT02198495|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
91930584|NCT02198495|Hematinics|hematinics|mesh-ancestor
91930585|NCT02201849|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91930586|NCT02201849|Dermatologic Agents|dermatologic agents|mesh-ancestor
91930587|NCT02201849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930588|NCT02201849|Immunologic Factors|immunologic factors|mesh-ancestor
91930589|NCT02201849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930590|NCT02375217|Glycopyrrolate|glycopyrrolate|mesh-list
91930591|NCT02375217|Neostigmine|neostigmine|mesh-list
91930592|NCT02375217|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91930593|NCT02375217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930594|NCT02375217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930595|NCT02375217|Cholinergic Agents|cholinergic agents|mesh-ancestor
91930596|NCT02375217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930597|NCT02375217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930598|NCT02375217|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91930599|NCT02375217|Autonomic Agents|autonomic agents|mesh-ancestor
91930600|NCT02375217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930601|NCT02375217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91930602|NCT02375217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91930603|NCT02375217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91930604|NCT02206295|Selexipag|selexipag|mesh-list
91930605|NCT02206295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91930606|NCT02375139|Metformin|metformin|mesh-list
91930607|NCT02375139|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91930688|NCT03529201|Anesthetics|anesthetics|mesh-ancestor
91930608|NCT02375139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930609|NCT02202005|Nevirapine|nevirapine|mesh-list
91930610|NCT02202005|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91930611|NCT02202005|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930612|NCT02202005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930613|NCT02202005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930614|NCT02202005|Antiviral Agents|antiviral agents|mesh-ancestor
91930615|NCT02202005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930616|NCT02202005|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930617|NCT02202005|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930618|NCT02202005|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91930619|NCT02202005|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91930620|NCT02741245|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91930621|NCT02741245|Ezetimibe|ezetimibe|mesh-list
91930622|NCT02741245|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91930623|NCT02741245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91930624|NCT02741245|Antimetabolites|antimetabolites|mesh-ancestor
91930625|NCT02741245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930626|NCT02741245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91930627|NCT02741245|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91930628|NCT02741245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930629|NCT02202239|Fentanyl|fentanyl|mesh-list
91930630|NCT02202239|Midazolam|midazolam|mesh-list
91930631|NCT02202239|Remifentanil|remifentanil|mesh-list
91930632|NCT02202239|Propofol|propofol|mesh-list
91930633|NCT02202239|Etomidate|etomidate|mesh-list
91930634|NCT02202239|Sevoflurane|sevoflurane|mesh-list
91930635|NCT02202239|Cisatracurium|cisatracurium|mesh-list
91930636|NCT02202239|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91930637|NCT02202239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930638|NCT02202239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930639|NCT02202239|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91930640|NCT02202239|Anesthetics, General|anesthetics, general|mesh-ancestor
91930641|NCT02202239|Anesthetics|anesthetics|mesh-ancestor
91930642|NCT02202239|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91930643|NCT02202239|Narcotics|narcotics|mesh-ancestor
91930644|NCT02202239|Analgesics|analgesics|mesh-ancestor
91930645|NCT02202239|Sensory System Agents|sensory system agents|mesh-ancestor
91930646|NCT02202239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930647|NCT02202239|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91930648|NCT02202239|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91930649|NCT02202239|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91930650|NCT02202239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91930651|NCT02202239|GABA Modulators|gaba modulators|mesh-ancestor
91930652|NCT02202239|GABA Agents|gaba agents|mesh-ancestor
91930653|NCT02202239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930654|NCT02202239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930655|NCT02202239|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91930656|NCT02202239|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91930657|NCT02202239|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91930658|NCT02202239|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91930659|NCT02368197|Paclitaxel|paclitaxel|mesh-list
91930660|NCT02368197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930661|NCT02368197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930662|NCT02368197|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930663|NCT02368197|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930665|NCT02368197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930666|NCT02364765|Remifentanil|remifentanil|mesh-list
91930667|NCT02364765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91930668|NCT02364765|Narcotics|narcotics|mesh-ancestor
91930669|NCT02364765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930670|NCT02364765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930671|NCT02364765|Analgesics|analgesics|mesh-ancestor
91930672|NCT02364765|Sensory System Agents|sensory system agents|mesh-ancestor
91930673|NCT02364765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930674|NCT03529201|Fentanyl|fentanyl|mesh-list
91930675|NCT03529201|Oxycodone|oxycodone|mesh-list
91930676|NCT03529201|Sevoflurane|sevoflurane|mesh-list
91930677|NCT03529201|Rocuronium|rocuronium|mesh-list
91930678|NCT03529201|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91930679|NCT03529201|Narcotics|narcotics|mesh-ancestor
91930680|NCT03529201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930681|NCT03529201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930682|NCT03529201|Analgesics|analgesics|mesh-ancestor
91930683|NCT03529201|Sensory System Agents|sensory system agents|mesh-ancestor
91930684|NCT03529201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930685|NCT03529201|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91930686|NCT03529201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91930689|NCT03529201|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91930690|NCT03529201|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91930691|NCT03529201|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91930692|NCT03529201|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91930693|NCT03529201|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91930694|NCT04547049|Cytarabine|cytarabine|mesh-list
91930695|NCT04547049|Cyclosporine|cyclosporine|mesh-list
91930696|NCT04547049|Mycophenolic Acid|mycophenolic acid|mesh-list
91930697|NCT04547049|Cyclophosphamide|cyclophosphamide|mesh-list
91930698|NCT04547049|Busulfan|busulfan|mesh-list
91930699|NCT04547049|Cyclosporins|cyclosporins|mesh-list
91930700|NCT04547049|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91930701|NCT04547049|Thymoglobulin|thymoglobulin|mesh-list
91930702|NCT04547049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930703|NCT04547049|Immunologic Factors|immunologic factors|mesh-ancestor
91930704|NCT04547049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930705|NCT04547049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930706|NCT04547049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91930707|NCT04547049|Alkylating Agents|alkylating agents|mesh-ancestor
91930708|NCT04547049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930709|NCT04547049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930710|NCT04547049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91930711|NCT04547049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91930712|NCT04547049|Antimetabolites|antimetabolites|mesh-ancestor
91930713|NCT04547049|Antiviral Agents|antiviral agents|mesh-ancestor
91930714|NCT04547049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930715|NCT04547049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930716|NCT04547049|Antifungal Agents|antifungal agents|mesh-ancestor
91930717|NCT04547049|Dermatologic Agents|dermatologic agents|mesh-ancestor
91930718|NCT04547049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91930719|NCT04547049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91930720|NCT04547049|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91930721|NCT04547049|Antitubercular Agents|antitubercular agents|mesh-ancestor
91930722|NCT04547049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91930723|NCT05647291|Methylprednisolone|methylprednisolone|mesh-list
91930724|NCT05647291|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930725|NCT05647291|Antiemetics|antiemetics|mesh-ancestor
91930726|NCT05647291|Autonomic Agents|autonomic agents|mesh-ancestor
91930727|NCT05647291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930728|NCT05647291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930729|NCT05647291|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91930731|NCT05647291|Hormones|hormones|mesh-ancestor
91930732|NCT05647291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930733|NCT05647291|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91930734|NCT05647291|Protective Agents|protective agents|mesh-ancestor
91930735|NCT03105765|Ketamine|ketamine|mesh-list
91930736|NCT03105765|Analgesics|analgesics|mesh-ancestor
91930737|NCT03105765|Sensory System Agents|sensory system agents|mesh-ancestor
91930738|NCT03105765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930739|NCT03105765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930740|NCT03105765|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91930742|NCT03105765|Anesthetics, General|anesthetics, general|mesh-ancestor
91930743|NCT03105765|Anesthetics|anesthetics|mesh-ancestor
91930744|NCT03105765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930745|NCT03105765|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91930746|NCT03105765|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91930747|NCT03105765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930748|NCT03105765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930749|NCT02202473|Lamivudine|lamivudine|mesh-list
91930750|NCT02202473|Oxymatrine|oxymatrine|mesh-list
91930751|NCT02202473|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91930752|NCT02202473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930753|NCT02202473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943401|NCT01275677|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91930754|NCT02202473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930755|NCT02202473|Antiviral Agents|antiviral agents|mesh-ancestor
91930756|NCT02202473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930757|NCT02202473|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930758|NCT02202473|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930759|NCT02202473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91930760|NCT02364531|Abiraterone Acetate|abiraterone acetate|mesh-list
91930761|NCT02364531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930762|NCT02364531|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91930763|NCT02364531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930764|NCT02364531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930766|NCT02364531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930767|NCT02364531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930768|NCT02364531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91930769|NCT02206763|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91930770|NCT02206763|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
91930771|NCT02206763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930772|NCT02206763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91930773|NCT02206763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930774|NCT02206763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930775|NCT02202707|Gabapentin|gabapentin|mesh-list
91930776|NCT02202707|Analgesics|analgesics|mesh-ancestor
91930777|NCT02202707|Sensory System Agents|sensory system agents|mesh-ancestor
91930778|NCT02202707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930779|NCT02202707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930780|NCT02202707|Anticonvulsants|anticonvulsants|mesh-ancestor
91930781|NCT02202707|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91930782|NCT02202707|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91930783|NCT02202707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930784|NCT02202707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91930785|NCT02202707|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91930786|NCT02202707|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91930787|NCT02202707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930788|NCT02202707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930789|NCT02202707|Antimanic Agents|antimanic agents|mesh-ancestor
91930790|NCT02367807|Tenofovir|tenofovir|mesh-list
91930791|NCT02367807|Emtricitabine|emtricitabine|mesh-list
91930792|NCT02367807|Antiviral Agents|antiviral agents|mesh-ancestor
91930793|NCT02367807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930794|NCT02367807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91930795|NCT02367807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91930796|NCT02367807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930797|NCT02367807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930798|NCT02367807|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930799|NCT02367807|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930800|NCT02364609|Pembrolizumab|pembrolizumab|mesh-list
91930801|NCT02364609|Afatinib|afatinib|mesh-list
91930802|NCT02364609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91930803|NCT02364609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930804|NCT02364609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91930805|NCT02364609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930806|NCT02364609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91930807|NCT02364609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930808|NCT02364453|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
91930809|NCT02364453|Growth Substances|growth substances|mesh-ancestor
91930810|NCT02364453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930811|NCT02364453|Vasodilator Agents|vasodilator agents|mesh-ancestor
91930812|NCT02364453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91930813|NCT02364453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930814|NCT02258009|Ranibizumab|ranibizumab|mesh-list
91930815|NCT02258009|Aflibercept|aflibercept|mesh-list
91930816|NCT02258009|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91930817|NCT02258009|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91930818|NCT02258009|Growth Substances|growth substances|mesh-ancestor
91930819|NCT02258009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930820|NCT02258009|Growth Inhibitors|growth inhibitors|mesh-ancestor
91930821|NCT02258009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930822|NCT02203097|Propofol|propofol|mesh-list
91930823|NCT02203097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91930824|NCT02203097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930825|NCT02203097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930826|NCT02203097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91930827|NCT02203097|Anesthetics, General|anesthetics, general|mesh-ancestor
91930828|NCT02203097|Anesthetics|anesthetics|mesh-ancestor
91930829|NCT04439487|Anesthetics|anesthetics|mesh-list
91930830|NCT04439487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930831|NCT04439487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930832|NCT03528967|Aspirin|aspirin|mesh-list
91930833|NCT03528967|Enoxaparin|enoxaparin|mesh-list
91930834|NCT03528967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91930835|NCT03528967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930836|NCT03528967|Analgesics|analgesics|mesh-ancestor
91930837|NCT03528967|Sensory System Agents|sensory system agents|mesh-ancestor
91930838|NCT03528967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930839|NCT03528967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930840|NCT03528967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930841|NCT03528967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930842|NCT03528967|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91930843|NCT03528967|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91930844|NCT03528967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930845|NCT03528967|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91930846|NCT03528967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91930847|NCT03528967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930848|NCT03528967|Antipyretics|antipyretics|mesh-ancestor
91930849|NCT03528967|Anticoagulants|anticoagulants|mesh-ancestor
91930850|NCT02363985|Vitamin A|vitamin a|mesh-list
91930851|NCT02363985|Vitamins|vitamins|mesh-ancestor
91930852|NCT02363985|Micronutrients|micronutrients|mesh-ancestor
91930853|NCT02363985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930854|NCT05723731|Laxatives|laxatives|mesh-list
91930855|NCT05723731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91930856|NCT02363829|Nelfinavir|nelfinavir|mesh-list
91930857|NCT02363829|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91930858|NCT02363829|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91930859|NCT02363829|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930860|NCT02363829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930861|NCT02363829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930862|NCT02363829|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930863|NCT02363829|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930864|NCT02363829|Antiviral Agents|antiviral agents|mesh-ancestor
91930865|NCT02363829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930866|NCT03113019|Immunomodulating Agents|immunomodulating agents|mesh-list
91930867|NCT03113019|Immunologic Factors|immunologic factors|mesh-ancestor
91930868|NCT03113019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930869|NCT02363751|Bevacizumab|bevacizumab|mesh-list
91930870|NCT02363751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91930871|NCT02363751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930872|NCT02363751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91930873|NCT02363751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91930874|NCT02363751|Growth Substances|growth substances|mesh-ancestor
91930875|NCT02363751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930876|NCT02363751|Growth Inhibitors|growth inhibitors|mesh-ancestor
91930877|NCT03240861|Aldesleukin|aldesleukin|mesh-list
91930878|NCT03240861|Plerixafor|plerixafor|mesh-list
91930879|NCT03240861|Fludarabine|fludarabine|mesh-list
91930880|NCT03240861|Busulfan|busulfan|mesh-list
91930881|NCT03240861|Interleukin-2|interleukin-2|mesh-list
91930882|NCT03240861|Lenograstim|lenograstim|mesh-list
91930883|NCT03240861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930884|NCT03240861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930885|NCT03240861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91930886|NCT03240861|Immunologic Factors|immunologic factors|mesh-ancestor
91930887|NCT03240861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930888|NCT03240861|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91930889|NCT03240861|Alkylating Agents|alkylating agents|mesh-ancestor
91930890|NCT03240861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91930891|NCT03240861|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91930892|NCT03240861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930893|NCT03240861|Analgesics|analgesics|mesh-ancestor
91930894|NCT03240861|Sensory System Agents|sensory system agents|mesh-ancestor
91930895|NCT03240861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930896|NCT03240861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91930897|NCT03240861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91930898|NCT03240861|Antiviral Agents|antiviral agents|mesh-ancestor
91930899|NCT03240861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930900|NCT03527251|Ipilimumab|ipilimumab|mesh-list
91930901|NCT03527251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91930902|NCT03527251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930903|NCT03527251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91930904|NCT03527251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930905|NCT02363517|Sofosbuvir|sofosbuvir|mesh-list
91930906|NCT02363517|Antiviral Agents|antiviral agents|mesh-ancestor
91930907|NCT02363517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930908|NCT04467463|Levobupivacaine|levobupivacaine|mesh-list
91930909|NCT04467463|Anesthetics, Local|anesthetics, local|mesh-ancestor
91930910|NCT04467463|Anesthetics|anesthetics|mesh-ancestor
91930911|NCT04467463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930912|NCT04467463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930913|NCT04467463|Sensory System Agents|sensory system agents|mesh-ancestor
91930914|NCT04467463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930916|NCT02363361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930917|NCT02363361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91930918|NCT02363361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930919|NCT02363361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930920|NCT04594915|Edoxaban|edoxaban|mesh-list
91930921|NCT04594915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91930922|NCT04594915|Antithrombins|antithrombins|mesh-ancestor
91930923|NCT04594915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91930924|NCT04594915|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930925|NCT04594915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930926|NCT04594915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930927|NCT04594915|Anticoagulants|anticoagulants|mesh-ancestor
91930928|NCT04546633|Lumefantrine|lumefantrine|mesh-list
91930929|NCT04546633|Antimalarials|antimalarials|mesh-ancestor
91930930|NCT04546633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91930931|NCT04546633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91930932|NCT04546633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91930933|NCT02367027|Rivaroxaban|rivaroxaban|mesh-list
91930934|NCT02367027|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91930935|NCT02367027|Antithrombins|antithrombins|mesh-ancestor
91930936|NCT02367027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91930937|NCT02367027|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930938|NCT02367027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930939|NCT02367027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930940|NCT02367027|Anticoagulants|anticoagulants|mesh-ancestor
91930941|NCT02366949|Paclitaxel|paclitaxel|mesh-list
91930942|NCT02366949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91930943|NCT02366949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930944|NCT02366949|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930945|NCT02366949|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930946|NCT02366949|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930947|NCT02366949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930948|NCT03532919|Cystatins|cystatins|mesh-list
91930949|NCT03532919|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
91930950|NCT03532919|Protease Inhibitors|protease inhibitors|mesh-ancestor
91930951|NCT03532919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91930952|NCT03532919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930953|NCT05503225|Colchicine|colchicine|mesh-list
91930954|NCT05503225|Gout Suppressants|gout suppressants|mesh-ancestor
91930955|NCT05503225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930956|NCT05503225|Tubulin Modulators|tubulin modulators|mesh-ancestor
91930957|NCT05503225|Antimitotic Agents|antimitotic agents|mesh-ancestor
91930958|NCT05503225|Mitosis Modulators|mitosis modulators|mesh-ancestor
91930959|NCT05503225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91930960|NCT05503225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930961|NCT02203175|Fentanyl|fentanyl|mesh-list
91930962|NCT02203175|Propofol|propofol|mesh-list
91930963|NCT02203175|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91930964|NCT02203175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91930965|NCT02203175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930966|NCT02203175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91930967|NCT02203175|Anesthetics, General|anesthetics, general|mesh-ancestor
91930968|NCT02203175|Anesthetics|anesthetics|mesh-ancestor
91930969|NCT02203175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91930970|NCT02203175|Narcotics|narcotics|mesh-ancestor
91930971|NCT02203175|Analgesics|analgesics|mesh-ancestor
91930972|NCT02203175|Sensory System Agents|sensory system agents|mesh-ancestor
91930973|NCT02203175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930974|NCT02203175|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91930975|NCT05791799|Etonogestrel|etonogestrel|mesh-list
91930976|NCT05791799|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91930977|NCT05791799|Contraceptive Agents|contraceptive agents|mesh-ancestor
91930978|NCT05791799|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91930979|NCT05791799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930980|NCT05791799|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91930981|NCT05791721|Dexamethasone|dexamethasone|mesh-list
91930982|NCT05791721|Etoricoxib|etoricoxib|mesh-list
91930983|NCT05791721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91930984|NCT05791721|Antiemetics|antiemetics|mesh-ancestor
91930985|NCT05791721|Autonomic Agents|autonomic agents|mesh-ancestor
91930986|NCT05791721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91930987|NCT05791721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91930988|NCT05791721|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91930989|NCT05791721|Glucocorticoids|glucocorticoids|mesh-ancestor
91930990|NCT05791721|Hormones|hormones|mesh-ancestor
91930991|NCT05791721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91930992|NCT05791721|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91930993|NCT05791721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91930994|NCT05791721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91930995|NCT05791721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91930996|NCT05791721|Analgesics|analgesics|mesh-ancestor
91930997|NCT05791721|Sensory System Agents|sensory system agents|mesh-ancestor
91930998|NCT05791721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91930999|NCT05791721|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91931000|NCT05791721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91931001|NCT05791721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931002|NCT05791721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931003|NCT05791669|Listerine|listerine|mesh-list
91931004|NCT05791669|Fluorides|fluorides|mesh-list
91931005|NCT05791669|Sodium Fluoride|sodium fluoride|mesh-list
91931006|NCT05791669|Fluorides, Topical|fluorides, topical|mesh-list
91931007|NCT05791669|Cariostatic Agents|cariostatic agents|mesh-ancestor
91931008|NCT05791669|Protective Agents|protective agents|mesh-ancestor
91931009|NCT05791669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931010|NCT05791669|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91931011|NCT05791669|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931012|NCT05791487|Budesonide|budesonide|mesh-list
91931013|NCT05791487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931014|NCT05791487|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91931015|NCT05791487|Autonomic Agents|autonomic agents|mesh-ancestor
91931016|NCT05791487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931017|NCT05791487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931018|NCT05791487|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91931019|NCT05791487|Respiratory System Agents|respiratory system agents|mesh-ancestor
91931021|NCT05791487|Hormones|hormones|mesh-ancestor
91931022|NCT05791487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931023|NCT05791409|Venetoclax|venetoclax|mesh-list
91931024|NCT05791409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931025|NCT05791331|Pulmonary Surfactants|pulmonary surfactants|mesh-list
91931026|NCT05791331|Respiratory System Agents|respiratory system agents|mesh-ancestor
91931027|NCT05791136|Immunomodulating Agents|immunomodulating agents|mesh-list
91931028|NCT05791136|Immunologic Factors|immunologic factors|mesh-ancestor
91931029|NCT05791136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931030|NCT05791058|Anesthetics|anesthetics|mesh-list
91931031|NCT05791058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931032|NCT05791058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931033|NCT05790941|Minoxidil|minoxidil|mesh-list
91931034|NCT05790941|Latanoprost|latanoprost|mesh-list
91931035|NCT05790941|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91931036|NCT05790941|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91931037|NCT05790941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91931039|NCT05790902|Tamsulosin|tamsulosin|mesh-list
91931040|NCT05790902|Silodosin|silodosin|mesh-list
91931041|NCT05790902|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91931042|NCT05790902|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91931043|NCT05790902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91931044|NCT05790902|Adrenergic Agents|adrenergic agents|mesh-ancestor
91931045|NCT05790902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931046|NCT05790902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931047|NCT05790902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931049|NCT05790720|Propofol|propofol|mesh-list
91931050|NCT05790720|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91931051|NCT05790720|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931052|NCT05790720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931053|NCT05790720|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91931054|NCT05790720|Anesthetics, General|anesthetics, general|mesh-ancestor
91931055|NCT05790720|Anesthetics|anesthetics|mesh-ancestor
91931056|NCT05790629|Calcium, Dietary|calcium, dietary|mesh-list
91931057|NCT05790629|Calcium|calcium|mesh-list
91931058|NCT05790629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91931059|NCT05790629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931060|NCT05790629|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931061|NCT05790603|Hemostatics|hemostatics|mesh-list
91931062|NCT05790603|Coagulants|coagulants|mesh-ancestor
91931063|NCT05790525|Bismuth|bismuth|mesh-list
91931064|NCT05790525|Antacids|antacids|mesh-ancestor
91931065|NCT05790525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931066|NCT05790525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931067|NCT05790447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91931068|NCT05790447|Thymalfasin|thymalfasin|mesh-list
91931069|NCT05790447|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91931070|NCT05790447|Immunologic Factors|immunologic factors|mesh-ancestor
91931071|NCT05790447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931072|NCT05790447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931073|NCT05790447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931074|NCT05790447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931075|NCT05790330|Methotrexate|methotrexate|mesh-list
91931076|NCT05790330|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91931077|NCT05790330|Abortifacient Agents|abortifacient agents|mesh-ancestor
91931078|NCT05790330|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91931079|NCT05790330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931080|NCT05790330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931081|NCT05790330|Antimetabolites|antimetabolites|mesh-ancestor
91931082|NCT05790330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931083|NCT05790330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931084|NCT05790330|Dermatologic Agents|dermatologic agents|mesh-ancestor
91931085|NCT05790330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931086|NCT05790330|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91931087|NCT05790330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931088|NCT05790330|Immunologic Factors|immunologic factors|mesh-ancestor
91931089|NCT05790330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931090|NCT05790330|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91931091|NCT05790239|Amphetamine|amphetamine|mesh-list
91931092|NCT05790239|Dextroamphetamine|dextroamphetamine|mesh-list
91931093|NCT05790239|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
91931094|NCT05790239|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91931095|NCT05790239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931096|NCT05790239|Sympathomimetics|sympathomimetics|mesh-ancestor
91931097|NCT05790239|Autonomic Agents|autonomic agents|mesh-ancestor
91931098|NCT05790239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931099|NCT05790239|Dopamine Agents|dopamine agents|mesh-ancestor
91931100|NCT05790239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931101|NCT05790239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931102|NCT05790239|Adrenergic Agents|adrenergic agents|mesh-ancestor
91931103|NCT05790239|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91931104|NCT05790239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91931105|NCT05790239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91931106|NCT05790239|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91931107|NCT05790239|Hallucinogens|hallucinogens|mesh-ancestor
91931108|NCT05790239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91931109|NCT05790239|Serotonin Agents|serotonin agents|mesh-ancestor
91931110|NCT05786716|Trastuzumab|trastuzumab|mesh-list
91931112|NCT05786716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931113|NCT05786716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931115|NCT05786599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91931116|NCT05786599|Narcotics|narcotics|mesh-ancestor
91931117|NCT05786599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943412|NCT01275677|Immunologic Factors|immunologic factors|mesh-ancestor
91931118|NCT05786599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931119|NCT05786599|Analgesics|analgesics|mesh-ancestor
91931120|NCT05786599|Sensory System Agents|sensory system agents|mesh-ancestor
91931121|NCT05786599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931122|NCT05786599|Antitussive Agents|antitussive agents|mesh-ancestor
91931123|NCT05786599|Respiratory System Agents|respiratory system agents|mesh-ancestor
91931124|NCT05768178|Vemurafenib|vemurafenib|mesh-list
91931125|NCT05768178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931126|NCT05768178|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91931127|NCT05768178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931128|NCT05768178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931129|NCT05746481|Carboplatin|carboplatin|mesh-list
91931130|NCT05746481|Pemetrexed|pemetrexed|mesh-list
91931131|NCT05746481|Atezolizumab|atezolizumab|mesh-list
91931132|NCT05746481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931133|NCT05746481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931134|NCT05746481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931135|NCT05746481|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91931136|NCT05746481|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91931137|NCT05746481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931138|NCT05746481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931139|NCT05704725|Aflibercept|aflibercept|mesh-list
91931140|NCT05704725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91931141|NCT05704725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91931142|NCT05704725|Growth Substances|growth substances|mesh-ancestor
91931143|NCT05704725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931144|NCT05704725|Growth Inhibitors|growth inhibitors|mesh-ancestor
91931145|NCT05704725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931146|NCT05683444|Octreotide|octreotide|mesh-list
91931147|NCT05683444|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931148|NCT05683444|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931149|NCT05683444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931150|NCT05669274|Caseins|caseins|mesh-list
91931151|NCT05669274|Chelating Agents|chelating agents|mesh-ancestor
91931152|NCT05669274|Sequestering Agents|sequestering agents|mesh-ancestor
91931153|NCT05669274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931154|NCT05667090|Vitamin D|vitamin d|mesh-list
91931155|NCT05667090|Vitamins|vitamins|mesh-ancestor
91931156|NCT05667090|Micronutrients|micronutrients|mesh-ancestor
91931157|NCT05667090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931158|NCT05667090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931159|NCT05647343|Ciclopirox|ciclopirox|mesh-list
91931160|NCT05647343|Antifungal Agents|antifungal agents|mesh-ancestor
91931161|NCT05647343|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931162|NCT05644561|Ravulizumab|ravulizumab|mesh-list
91931163|NCT05644561|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91931164|NCT05644561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931165|NCT05644561|Immunologic Factors|immunologic factors|mesh-ancestor
91931166|NCT05644561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931168|NCT05553392|Emollients|emollients|mesh-ancestor
91931169|NCT05553392|Dermatologic Agents|dermatologic agents|mesh-ancestor
91931170|NCT05530421|Dexamethasone|dexamethasone|mesh-list
91931171|NCT05530421|Venetoclax|venetoclax|mesh-list
91931172|NCT05530421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931173|NCT05530421|Antiemetics|antiemetics|mesh-ancestor
91931174|NCT05530421|Autonomic Agents|autonomic agents|mesh-ancestor
91931175|NCT05530421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931176|NCT05530421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931177|NCT05530421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931178|NCT05530421|Glucocorticoids|glucocorticoids|mesh-ancestor
91931179|NCT05530421|Hormones|hormones|mesh-ancestor
91931180|NCT05530421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931181|NCT05530421|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931182|NCT05530421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931183|NCT05523596|Benzonidazole|benzonidazole|mesh-list
91931184|NCT05523596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931185|NCT05523596|Immunologic Factors|immunologic factors|mesh-ancestor
91931186|NCT05523596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931187|NCT05523596|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91931188|NCT05523596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91931189|NCT05523596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91931190|NCT05523596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931191|NCT05518734|Itraconazole|itraconazole|mesh-list
91931193|NCT05518734|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91931194|NCT05518734|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91931195|NCT05518734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931196|NCT05518734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931197|NCT05518734|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91931198|NCT05518734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91931199|NCT05518734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91931200|NCT05518734|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91931201|NCT05518734|Anesthetics, General|anesthetics, general|mesh-ancestor
91931202|NCT05518734|Anesthetics|anesthetics|mesh-ancestor
91931203|NCT05518734|GABA Modulators|gaba modulators|mesh-ancestor
91931204|NCT05518734|GABA Agents|gaba agents|mesh-ancestor
91931205|NCT05518734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931206|NCT05518734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931207|NCT05518734|Antifungal Agents|antifungal agents|mesh-ancestor
91931208|NCT05518734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931209|NCT05518734|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91931210|NCT05518734|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91931211|NCT05518734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931212|NCT05518734|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91931213|NCT05518734|Hormone Antagonists|hormone antagonists|mesh-ancestor
91931214|NCT05518734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931215|NCT05518734|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91931216|NCT05513365|Goserelin|goserelin|mesh-list
91931217|NCT05513365|Bicalutamide|bicalutamide|mesh-list
91931218|NCT05513365|Dutasteride|dutasteride|mesh-list
91931219|NCT05513365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931220|NCT05513365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931221|NCT05513365|Androgen Antagonists|androgen antagonists|mesh-ancestor
91931222|NCT05513365|Hormone Antagonists|hormone antagonists|mesh-ancestor
91931223|NCT05513365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931224|NCT05513365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931225|NCT05513365|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91931226|NCT05513365|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91931227|NCT05513365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931228|NCT05513365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931229|NCT05442749|Niraparib|niraparib|mesh-list
91931230|NCT05442749|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91931231|NCT05442749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931232|NCT05442749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931233|NCT05442749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931234|NCT05361655|Palbociclib|palbociclib|mesh-list
91931235|NCT05361655|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91931236|NCT05361655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931237|NCT05361655|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91931238|NCT05361655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931239|NCT05361655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931240|NCT05361655|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91931241|NCT05361655|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91931242|NCT05361655|Hormone Antagonists|hormone antagonists|mesh-ancestor
91931243|NCT05361655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931244|NCT05361655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931245|NCT05355740|Chlorhexidine|chlorhexidine|mesh-list
91931246|NCT05355740|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91931247|NCT05355740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931248|NCT05355740|Disinfectants|disinfectants|mesh-ancestor
91931249|NCT05320887|Nicotine|nicotine|mesh-list
91931250|NCT05320887|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91931251|NCT05320887|Autonomic Agents|autonomic agents|mesh-ancestor
91931252|NCT05320887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931253|NCT05320887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931254|NCT05320887|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91931255|NCT05320887|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91931256|NCT05320887|Cholinergic Agents|cholinergic agents|mesh-ancestor
91931257|NCT05320887|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931258|NCT05320887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931259|NCT05316831|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91931260|NCT05316831|Immunologic Factors|immunologic factors|mesh-ancestor
91931264|NCT05308056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931265|NCT05276284|Atezolizumab|atezolizumab|mesh-list
91931266|NCT05276284|Mercaptopurine|mercaptopurine|mesh-list
91931267|NCT05276284|Thioguanine|thioguanine|mesh-list
91931268|NCT05276284|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931269|NCT05276284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931270|NCT05276284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931271|NCT05276284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931272|NCT05276284|Antimetabolites|antimetabolites|mesh-ancestor
91931273|NCT05276284|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931274|NCT05276284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931275|NCT05276284|Immunologic Factors|immunologic factors|mesh-ancestor
91931276|NCT05276284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931277|NCT05276284|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91931278|NCT05276284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931280|NCT05237960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91931281|NCT05237960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931282|NCT05179356|Dapagliflozin|dapagliflozin|mesh-list
91931283|NCT05179356|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91931284|NCT05179356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931285|NCT05179356|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91931286|NCT05179356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931287|NCT05144698|Sirolimus|sirolimus|mesh-list
91931288|NCT05144698|Temsirolimus|temsirolimus|mesh-list
91931289|NCT05144698|MTOR Inhibitors|mtor inhibitors|mesh-list
91931290|NCT05144698|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931291|NCT05144698|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931292|NCT05144698|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931293|NCT05144698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931294|NCT05144698|Antifungal Agents|antifungal agents|mesh-ancestor
91931295|NCT05144698|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931296|NCT05144698|Immunologic Factors|immunologic factors|mesh-ancestor
91931297|NCT05144698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931298|NCT05144698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91931299|NCT05144698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931300|NCT05144698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931301|NCT05122182|Propagermanium|propagermanium|mesh-list
91931304|NCT05122182|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91931305|NCT05122182|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91931306|NCT05122182|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91931307|NCT05122182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931308|NCT05122182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931309|NCT05122182|Interferon Inducers|interferon inducers|mesh-ancestor
91931310|NCT05122182|Immunologic Factors|immunologic factors|mesh-ancestor
91931311|NCT05122182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931312|NCT05065801|Folfirinox|folfirinox|mesh-list
91931313|NCT05065801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931314|NCT05045066|Vitamin D|vitamin d|mesh-list
91931315|NCT05045066|Cholecalciferol|cholecalciferol|mesh-list
91931316|NCT05045066|Vitamins|vitamins|mesh-ancestor
91931317|NCT05045066|Micronutrients|micronutrients|mesh-ancestor
91931318|NCT05045066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931319|NCT05045066|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931320|NCT05045066|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91931325|NCT04979442|Trabectedin|trabectedin|mesh-list
91931326|NCT04979442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91931327|NCT04979442|Alkylating Agents|alkylating agents|mesh-ancestor
91931328|NCT04979442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931329|NCT04979442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931330|NCT04969133|Levobupivacaine|levobupivacaine|mesh-list
91931331|NCT04969133|Anesthetics, Local|anesthetics, local|mesh-ancestor
91931332|NCT04969133|Anesthetics|anesthetics|mesh-ancestor
91931333|NCT04969133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931334|NCT04969133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931335|NCT04969133|Sensory System Agents|sensory system agents|mesh-ancestor
91931336|NCT04969133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931338|NCT04910061|Niacin|niacin|mesh-list
91931339|NCT04910061|Nicotinic Acids|nicotinic acids|mesh-list
91931340|NCT04910061|Vitamin B Complex|vitamin b complex|mesh-ancestor
91931341|NCT04910061|Vitamins|vitamins|mesh-ancestor
91931342|NCT04910061|Micronutrients|micronutrients|mesh-ancestor
91931343|NCT04910061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931344|NCT04910061|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91931345|NCT04910061|Antimetabolites|antimetabolites|mesh-ancestor
91943417|NCT01275677|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91931346|NCT04910061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931347|NCT04910061|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91931348|NCT04910061|Vasodilator Agents|vasodilator agents|mesh-ancestor
91931350|NCT04892264|Dexamethasone acetate|dexamethasone acetate|mesh-list
91931351|NCT04892264|Lenalidomide|lenalidomide|mesh-list
91931352|NCT04892264|Daratumumab|daratumumab|mesh-list
91931353|NCT04892264|Ichthammol|ichthammol|mesh-list
91931354|NCT04892264|BB 1101|bb 1101|mesh-list
91931355|NCT04892264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931356|NCT04892264|Antiemetics|antiemetics|mesh-ancestor
91931357|NCT04892264|Autonomic Agents|autonomic agents|mesh-ancestor
91931358|NCT04892264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931359|NCT04892264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931360|NCT04892264|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931361|NCT04892264|Glucocorticoids|glucocorticoids|mesh-ancestor
91931362|NCT04892264|Hormones|hormones|mesh-ancestor
91931363|NCT04892264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931364|NCT04892264|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931365|NCT04892264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931366|NCT04892264|Protease Inhibitors|protease inhibitors|mesh-ancestor
91931367|NCT04892264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931368|NCT04892264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931369|NCT04892264|Immunologic Factors|immunologic factors|mesh-ancestor
91931370|NCT04892264|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91931371|NCT04892264|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91931372|NCT04892264|Growth Substances|growth substances|mesh-ancestor
91931373|NCT04892264|Growth Inhibitors|growth inhibitors|mesh-ancestor
91931374|NCT04892264|Dermatologic Agents|dermatologic agents|mesh-ancestor
91931375|NCT04887467|Apomorphine|apomorphine|mesh-list
91931376|NCT04887467|Emetics|emetics|mesh-ancestor
91931377|NCT04887467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931378|NCT04887467|Autonomic Agents|autonomic agents|mesh-ancestor
91931379|NCT04887467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931380|NCT04887467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931381|NCT04887467|Dopamine Agonists|dopamine agonists|mesh-ancestor
91931382|NCT04887467|Dopamine Agents|dopamine agents|mesh-ancestor
91931383|NCT04887467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931384|NCT04887467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931387|NCT04868409|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91931388|NCT04868409|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91931389|NCT04868409|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91931390|NCT04868409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931391|NCT04868409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931392|NCT04868409|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
91931394|NCT04861064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931395|NCT04861064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931396|NCT04861064|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931397|NCT04861064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931398|NCT04861064|Antifungal Agents|antifungal agents|mesh-ancestor
91931399|NCT04861064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931400|NCT04861064|Immunologic Factors|immunologic factors|mesh-ancestor
91931401|NCT04861064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931402|NCT04846335|Doxycycline|doxycycline|mesh-list
91931403|NCT04846335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931404|NCT04846335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931405|NCT04846335|Antimalarials|antimalarials|mesh-ancestor
91931406|NCT04846335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91931407|NCT04846335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91931408|NCT04817241|Cytarabine|cytarabine|mesh-list
91931409|NCT04817241|Decitabine|decitabine|mesh-list
91931410|NCT04817241|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
91931411|NCT04817241|Daunorubicin|daunorubicin|mesh-list
91931412|NCT04817241|Venetoclax|venetoclax|mesh-list
91931413|NCT04817241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931414|NCT04817241|Antimetabolites|antimetabolites|mesh-ancestor
91931415|NCT04817241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931416|NCT04817241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931417|NCT04817241|Antiviral Agents|antiviral agents|mesh-ancestor
91931418|NCT04817241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931419|NCT04817241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931420|NCT04817241|Immunologic Factors|immunologic factors|mesh-ancestor
91931421|NCT04817241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931422|NCT04817241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931423|NCT04817241|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91931424|NCT04817241|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91931425|NCT04817241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931427|NCT04796220|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931428|NCT04796220|Antimetabolites|antimetabolites|mesh-ancestor
91931429|NCT04796220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931430|NCT04796220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931431|NCT04777045|Diltiazem|diltiazem|mesh-list
91931432|NCT04777045|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91931433|NCT04777045|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91931434|NCT04777045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91931435|NCT04777045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931436|NCT04777045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91931437|NCT04777045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931438|NCT04777045|Vasodilator Agents|vasodilator agents|mesh-ancestor
91931439|NCT04632238|Metronidazole|metronidazole|mesh-list
91931440|NCT04632238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931441|NCT04632238|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931442|NCT04632238|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91931443|NCT04632238|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91931444|NCT04597190|Norepinephrine|norepinephrine|mesh-list
91931445|NCT04597190|Serotonin|serotonin|mesh-list
91931446|NCT04597190|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
91931447|NCT04597190|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91931448|NCT04597190|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91931449|NCT04597190|Adrenergic Agents|adrenergic agents|mesh-ancestor
91931450|NCT04597190|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931451|NCT04597190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931452|NCT04597190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931453|NCT04597190|Sympathomimetics|sympathomimetics|mesh-ancestor
91931454|NCT04597190|Autonomic Agents|autonomic agents|mesh-ancestor
91931455|NCT04597190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931456|NCT04597190|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91931457|NCT04597190|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91931458|NCT04597190|Serotonin Agents|serotonin agents|mesh-ancestor
91931459|NCT04597190|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91931460|NCT04597190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91931461|NCT04577638|Nivolumab|nivolumab|mesh-list
91931462|NCT04577638|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931463|NCT04577638|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931464|NCT04577638|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931465|NCT04577638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931466|NCT04517799|Cannabidiol|cannabidiol|mesh-list
91931467|NCT04517799|Anticonvulsants|anticonvulsants|mesh-ancestor
91931468|NCT04495296|Paclitaxel|paclitaxel|mesh-list
91931469|NCT04495296|Gemcitabine|gemcitabine|mesh-list
91931470|NCT04495296|Capecitabine|capecitabine|mesh-list
91931471|NCT04495296|Oxaliplatin|oxaliplatin|mesh-list
91931472|NCT04495296|Nivolumab|nivolumab|mesh-list
91931473|NCT04495296|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91931474|NCT04495296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931475|NCT04495296|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931476|NCT04495296|Antimitotic Agents|antimitotic agents|mesh-ancestor
91931477|NCT04495296|Mitosis Modulators|mitosis modulators|mesh-ancestor
91931478|NCT04495296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931479|NCT04495296|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931480|NCT04495296|Antimetabolites|antimetabolites|mesh-ancestor
91931481|NCT04495296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931482|NCT04495296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931483|NCT04404062|Antibodies|antibodies|mesh-list
91931484|NCT04404062|Immunoglobulins|immunoglobulins|mesh-list
91931485|NCT04404062|Immunologic Factors|immunologic factors|mesh-ancestor
91931486|NCT04404062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931487|NCT04352777|Fulvestrant|fulvestrant|mesh-list
91931489|NCT04352777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931490|NCT04352777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931491|NCT04352777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91931492|NCT04352777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91931493|NCT04352777|Hormone Antagonists|hormone antagonists|mesh-ancestor
91931494|NCT04352777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931495|NCT04352777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931496|NCT04352777|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91931497|NCT04352777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931498|NCT04352777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931500|NCT04276363|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91931501|NCT04276363|Autonomic Agents|autonomic agents|mesh-ancestor
91931502|NCT04276363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931503|NCT04276363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931504|NCT04276363|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91931505|NCT04276363|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91931506|NCT04276363|Cholinergic Agents|cholinergic agents|mesh-ancestor
91931507|NCT04276363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931508|NCT04276363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931509|NCT04260854|Bupivacaine|bupivacaine|mesh-list
91931510|NCT04260854|Anesthetics, Local|anesthetics, local|mesh-ancestor
91931511|NCT04260854|Anesthetics|anesthetics|mesh-ancestor
91931512|NCT04260854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931513|NCT04260854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931514|NCT04260854|Sensory System Agents|sensory system agents|mesh-ancestor
91931515|NCT04260854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931516|NCT04147546|Artenimol|artenimol|mesh-list
91931517|NCT04147546|Antimalarials|antimalarials|mesh-ancestor
91931518|NCT04147546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91931519|NCT04147546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91931520|NCT04147546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931521|NCT04141579|Evolocumab|evolocumab|mesh-list
91931522|NCT04141579|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91931523|NCT04141579|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91931524|NCT04141579|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91931525|NCT04141579|Antimetabolites|antimetabolites|mesh-ancestor
91931526|NCT04141579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931527|NCT04141579|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91931528|NCT04141579|Protease Inhibitors|protease inhibitors|mesh-ancestor
91931529|NCT04141579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931530|NCT04141579|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91931532|NCT04095689|Pembrolizumab|pembrolizumab|mesh-list
91931533|NCT04095689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931534|NCT04095689|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931535|NCT04095689|Antimitotic Agents|antimitotic agents|mesh-ancestor
91931536|NCT04095689|Mitosis Modulators|mitosis modulators|mesh-ancestor
91931537|NCT04095689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931538|NCT04095689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931539|NCT04095689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931540|NCT04059484|Tamoxifen|tamoxifen|mesh-list
91931541|NCT04059484|Letrozole|letrozole|mesh-list
91931545|NCT04059484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931546|NCT04059484|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91931547|NCT04059484|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91931548|NCT04059484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931549|NCT04059484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931550|NCT04059484|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91931551|NCT04059484|Hormone Antagonists|hormone antagonists|mesh-ancestor
91931552|NCT04059484|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931553|NCT04059484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931554|NCT04059484|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931555|NCT04059484|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91931556|NCT04059484|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91931557|NCT04059484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931558|NCT04059484|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91931559|NCT04038502|Carboplatin|carboplatin|mesh-list
91931560|NCT04038502|Olaparib|olaparib|mesh-list
91931561|NCT04038502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931562|NCT04038502|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91931563|NCT04038502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931564|NCT04038502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931565|NCT03977493|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
91931566|NCT03977493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91931567|NCT03977493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931568|NCT03977493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931569|NCT03977493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91931570|NCT03977493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91931571|NCT03977493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931572|NCT03977493|Cholinergic Agents|cholinergic agents|mesh-ancestor
91931573|NCT03977493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931574|NCT03867175|Pembrolizumab|pembrolizumab|mesh-list
91931575|NCT03867175|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931576|NCT03867175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931577|NCT03867175|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931578|NCT03867175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931579|NCT03852433|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91931580|NCT03852433|Antiviral Agents|antiviral agents|mesh-ancestor
91931581|NCT03852433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931582|NCT03849469|Pembrolizumab|pembrolizumab|mesh-list
91931583|NCT03849469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931584|NCT03849469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931585|NCT03849469|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931586|NCT03849469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931587|NCT03816397|Adalimumab|adalimumab|mesh-list
91931588|NCT03816397|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91931589|NCT03816397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931590|NCT03816397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931591|NCT03805607|Ketorolac|ketorolac|mesh-list
91931592|NCT03805607|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
91931593|NCT03805607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91931594|NCT03805607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91931595|NCT03805607|Analgesics|analgesics|mesh-ancestor
91931596|NCT03805607|Sensory System Agents|sensory system agents|mesh-ancestor
91931597|NCT03805607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931598|NCT03805607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931599|NCT03805607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931600|NCT03805607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931601|NCT03805607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91931602|NCT03805607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931603|NCT03805607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931604|NCT03678545|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91931605|NCT03678545|Immunologic Factors|immunologic factors|mesh-ancestor
91931606|NCT03678545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931607|NCT03671018|Rituximab|rituximab|mesh-list
91931608|NCT03671018|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
91931609|NCT03671018|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931610|NCT03671018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931611|NCT03671018|Immunologic Factors|immunologic factors|mesh-ancestor
91931612|NCT03671018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931613|NCT03671018|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931614|NCT03671018|Immunoconjugates|immunoconjugates|mesh-ancestor
91931615|NCT03514368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91931812|NCT02195895|Calcium|calcium|mesh-list
91931616|NCT03514368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931617|NCT03514368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931618|NCT03514368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931619|NCT03496766|Tipifarnib|tipifarnib|mesh-list
91931620|NCT03496766|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931621|NCT03467789|Vitamin D|vitamin d|mesh-list
91931622|NCT03467789|Ergocalciferols|ergocalciferols|mesh-list
91931623|NCT03467789|Cholecalciferol|cholecalciferol|mesh-list
91931624|NCT03467789|Vitamins|vitamins|mesh-list
91931625|NCT03467789|Micronutrients|micronutrients|mesh-ancestor
91931626|NCT03467789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931627|NCT03467789|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931628|NCT03467789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91931629|NCT03406715|Nivolumab|nivolumab|mesh-list
91931630|NCT03406715|Ipilimumab|ipilimumab|mesh-list
91931631|NCT03406715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931632|NCT03406715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931633|NCT03406715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931634|NCT03406715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931636|NCT03363763|Temsirolimus|temsirolimus|mesh-list
91931637|NCT03363763|MTOR Inhibitors|mtor inhibitors|mesh-list
91943424|NCT01203020|Busulfan|busulfan|mesh-list
91931638|NCT03363763|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931639|NCT03363763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931640|NCT03363763|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91932468|NCT04467931|Propranolol|propranolol|mesh-list
91932470|NCT04467931|Atenolol|atenolol|mesh-list
91932471|NCT04467931|Verapamil|verapamil|mesh-list
91932472|NCT04467931|Felodipine|felodipine|mesh-list
91932473|NCT04467931|Nadolol|nadolol|mesh-list
91932474|NCT04467931|Acebutolol|acebutolol|mesh-list
91932475|NCT04467931|Amlodipine|amlodipine|mesh-list
91932476|NCT04467931|Valsartan|valsartan|mesh-list
91932477|NCT04467931|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91932478|NCT04467931|Telmisartan|telmisartan|mesh-list
91932479|NCT04467931|Clonidine|clonidine|mesh-list
91932480|NCT04467931|Carvedilol|carvedilol|mesh-list
91932481|NCT04467931|Candesartan|candesartan|mesh-list
91932482|NCT04467931|Candesartan cilexetil|candesartan cilexetil|mesh-list
91932483|NCT04467931|Ramipril|ramipril|mesh-list
91932484|NCT04467931|Olmesartan|olmesartan|mesh-list
91932485|NCT04467931|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91932486|NCT04467931|Enalapril|enalapril|mesh-list
91932487|NCT04467931|Enalaprilat|enalaprilat|mesh-list
91932488|NCT04467931|Lisinopril|lisinopril|mesh-list
91932489|NCT04467931|Irbesartan|irbesartan|mesh-list
91932490|NCT04467931|Eplerenone|eplerenone|mesh-list
91932491|NCT04467931|Nebivolol|nebivolol|mesh-list
91932492|NCT04467931|Chlorthalidone|chlorthalidone|mesh-list
91932493|NCT04467931|Bisoprolol|bisoprolol|mesh-list
91932494|NCT04467931|Perindopril|perindopril|mesh-list
91932495|NCT04467931|Diltiazem|diltiazem|mesh-list
91932496|NCT04467931|Minoxidil|minoxidil|mesh-list
91932497|NCT04467931|Guanfacine|guanfacine|mesh-list
91932498|NCT04467931|Prazosin|prazosin|mesh-list
91932499|NCT04467931|Doxazosin|doxazosin|mesh-list
91932500|NCT04467931|Benazepril|benazepril|mesh-list
91932501|NCT04467931|Labetalol|labetalol|mesh-list
91932502|NCT04467931|Captopril|captopril|mesh-list
91932503|NCT04467931|Hydralazine|hydralazine|mesh-list
91932504|NCT04467931|Indapamide|indapamide|mesh-list
91932505|NCT04467931|Nicardipine|nicardipine|mesh-list
91932506|NCT04467931|Quinapril|quinapril|mesh-list
91932507|NCT04467931|Metolazone|metolazone|mesh-list
91932508|NCT04467931|Trandolapril|trandolapril|mesh-list
91932509|NCT04467931|Torsemide|torsemide|mesh-list
91932510|NCT04467931|Methyldopa|methyldopa|mesh-list
91932511|NCT04467931|Fosinopril|fosinopril|mesh-list
91932513|NCT04467931|Eprosartan|eprosartan|mesh-list
91932514|NCT04467931|Pindolol|pindolol|mesh-list
91932515|NCT04467931|Moexipril|moexipril|mesh-list
91932516|NCT04467931|Betaxolol|betaxolol|mesh-list
91932517|NCT04467931|Chlorothiazide|chlorothiazide|mesh-list
91932518|NCT04467931|Bendroflumethiazide|bendroflumethiazide|mesh-list
91932519|NCT04467931|Reserpine|reserpine|mesh-list
91932520|NCT04467931|Guanabenz|guanabenz|mesh-list
91932521|NCT04467931|Nisoldipine|nisoldipine|mesh-list
91932522|NCT04467931|Penbutolol|penbutolol|mesh-list
91932523|NCT04467931|Nifedipine|nifedipine|mesh-list
91932524|NCT04467931|Amiloride|amiloride|mesh-list
91932525|NCT04467931|Triamterene|triamterene|mesh-list
91932526|NCT04467931|Furosemide|furosemide|mesh-list
91932527|NCT04467931|Spironolactone|spironolactone|mesh-list
91932528|NCT04467931|Bumetanide|bumetanide|mesh-list
91932529|NCT04467931|Ethacrynic Acid|ethacrynic acid|mesh-list
91932530|NCT04467931|Terazosin|terazosin|mesh-list
91932531|NCT04467931|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
91932532|NCT04467931|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91932533|NCT04467931|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91932534|NCT04467931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91932535|NCT04467931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91932536|NCT04467931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932537|NCT04467931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91932538|NCT04467931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932539|NCT04467931|Vasodilator Agents|vasodilator agents|mesh-ancestor
91932540|NCT04467931|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91932541|NCT04467931|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91932542|NCT04467931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91932543|NCT04467931|Diuretics|diuretics|mesh-ancestor
91932544|NCT04467931|Natriuretic Agents|natriuretic agents|mesh-ancestor
91932545|NCT04467931|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91932546|NCT04467931|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91932547|NCT04467931|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91932548|NCT04467931|Adrenergic Agents|adrenergic agents|mesh-ancestor
91932549|NCT04467931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932550|NCT04467931|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91932551|NCT04467931|Sympatholytics|sympatholytics|mesh-ancestor
91932552|NCT04467931|Autonomic Agents|autonomic agents|mesh-ancestor
91932553|NCT04467931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932554|NCT04467931|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91932555|NCT04467931|Analgesics|analgesics|mesh-ancestor
91932556|NCT04467931|Sensory System Agents|sensory system agents|mesh-ancestor
91931641|NCT03363763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931642|NCT03363763|Antifungal Agents|antifungal agents|mesh-ancestor
91931643|NCT03363763|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931644|NCT03363763|Immunologic Factors|immunologic factors|mesh-ancestor
91931645|NCT03363763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931646|NCT03363763|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91931647|NCT03363763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931648|NCT03363763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931649|NCT03224507|Dexamethasone|dexamethasone|mesh-list
91931650|NCT03224507|Dexamethasone acetate|dexamethasone acetate|mesh-list
91931651|NCT03224507|Lenalidomide|lenalidomide|mesh-list
91931652|NCT03224507|Daratumumab|daratumumab|mesh-list
91931653|NCT03224507|BB 1101|bb 1101|mesh-list
91931654|NCT03224507|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91931655|NCT03224507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931656|NCT03224507|Antiemetics|antiemetics|mesh-ancestor
91931657|NCT03224507|Autonomic Agents|autonomic agents|mesh-ancestor
91931658|NCT03224507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931659|NCT03224507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931660|NCT03224507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931661|NCT03224507|Glucocorticoids|glucocorticoids|mesh-ancestor
91931662|NCT03224507|Hormones|hormones|mesh-ancestor
91931663|NCT03224507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931664|NCT03224507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931665|NCT03224507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931666|NCT03224507|Protease Inhibitors|protease inhibitors|mesh-ancestor
91931667|NCT03224507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932557|NCT04467931|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91932558|NCT04467931|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91932559|NCT04467931|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91932560|NCT04467931|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91932561|NCT04467931|Hormone Antagonists|hormone antagonists|mesh-ancestor
91932562|NCT04467931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91932563|NCT04467931|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91932565|NCT04467931|Protective Agents|protective agents|mesh-ancestor
91932566|NCT04467931|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91932567|NCT04467931|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91932568|NCT04467931|Protease Inhibitors|protease inhibitors|mesh-ancestor
91932569|NCT04467931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932570|NCT04467931|Tocolytic Agents|tocolytic agents|mesh-ancestor
91932571|NCT04467931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91932572|NCT04467931|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91932573|NCT04467931|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91932574|NCT04467931|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91932575|NCT04467931|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
91932576|NCT04467931|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91932577|NCT04467931|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
91932578|NCT04467931|Sympathomimetics|sympathomimetics|mesh-ancestor
91932579|NCT04467931|Urological Agents|urological agents|mesh-ancestor
91931668|NCT03224507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931669|NCT03224507|Immunologic Factors|immunologic factors|mesh-ancestor
91931670|NCT03224507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91931671|NCT03224507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91931672|NCT03224507|Growth Substances|growth substances|mesh-ancestor
91931673|NCT03224507|Growth Inhibitors|growth inhibitors|mesh-ancestor
91931674|NCT03182751|Tranexamic Acid|tranexamic acid|mesh-list
91931675|NCT03182751|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91931676|NCT03182751|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91931677|NCT03182751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931678|NCT03182751|Hemostatics|hemostatics|mesh-ancestor
91931679|NCT03182751|Coagulants|coagulants|mesh-ancestor
91931680|NCT03105245|Thiopental|thiopental|mesh-list
91931681|NCT03105245|Anesthetics|anesthetics|mesh-list
91931682|NCT03105245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931683|NCT03105245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931684|NCT03105245|Anticonvulsants|anticonvulsants|mesh-ancestor
91931685|NCT03105245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91931686|NCT03105245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91931687|NCT03105245|Anesthetics, General|anesthetics, general|mesh-ancestor
91931688|NCT03105245|GABA Modulators|gaba modulators|mesh-ancestor
91931689|NCT03105245|GABA Agents|gaba agents|mesh-ancestor
91931690|NCT03105245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931691|NCT03105245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931692|NCT03057106|Durvalumab|durvalumab|mesh-list
91931693|NCT03057106|Tremelimumab|tremelimumab|mesh-list
91931694|NCT03057106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931695|NCT03057106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931696|NCT03020199|Betamethasone|betamethasone|mesh-list
91931697|NCT03020199|Calcipotriene|calcipotriene|mesh-list
91931698|NCT03020199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91931699|NCT03020199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931700|NCT03020199|Glucocorticoids|glucocorticoids|mesh-ancestor
91931701|NCT03020199|Hormones|hormones|mesh-ancestor
91931702|NCT03020199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931703|NCT03020199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931704|NCT03020199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91931705|NCT03020199|Respiratory System Agents|respiratory system agents|mesh-ancestor
91931706|NCT03020199|Immunologic Factors|immunologic factors|mesh-ancestor
91931707|NCT03020199|Dermatologic Agents|dermatologic agents|mesh-ancestor
91931709|NCT03019588|Pembrolizumab|pembrolizumab|mesh-list
91931710|NCT03019588|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91931711|NCT03019588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931712|NCT03019588|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931713|NCT03019588|Antimitotic Agents|antimitotic agents|mesh-ancestor
91931714|NCT03019588|Mitosis Modulators|mitosis modulators|mesh-ancestor
91931715|NCT03019588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931716|NCT03019588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931717|NCT03019588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91931719|NCT02959944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931720|NCT02959944|Glucocorticoids|glucocorticoids|mesh-ancestor
91931721|NCT02959944|Hormones|hormones|mesh-ancestor
91932580|NCT04467931|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
91932581|NCT04467931|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91932582|NCT04467931|Serotonin Agents|serotonin agents|mesh-ancestor
91932583|NCT04467931|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91932584|NCT04467931|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91932585|NCT04467931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932586|NCT04467931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91932587|NCT04467931|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91932588|NCT04467931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91932589|NCT03705559|Analgesics, Opioid|analgesics, opioid|mesh-list
91932590|NCT03705559|Narcotics|narcotics|mesh-ancestor
91932591|NCT03705559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932592|NCT03705559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932593|NCT03705559|Analgesics|analgesics|mesh-ancestor
91932594|NCT03705559|Sensory System Agents|sensory system agents|mesh-ancestor
91932595|NCT03705559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932596|NCT03522649|Leucovorin|leucovorin|mesh-list
91932597|NCT03522649|Fluorouracil|fluorouracil|mesh-list
91932598|NCT03522649|Irinotecan|irinotecan|mesh-list
91932599|NCT03522649|Antimetabolites|antimetabolites|mesh-ancestor
91932600|NCT03522649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932601|NCT03522649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91932602|NCT03522649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932603|NCT03522649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932604|NCT03522649|Immunologic Factors|immunologic factors|mesh-ancestor
91932605|NCT03522649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932606|NCT03522649|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91932607|NCT03522649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932608|NCT03522649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932609|NCT03522649|Antidotes|antidotes|mesh-ancestor
91932610|NCT03522649|Protective Agents|protective agents|mesh-ancestor
91932611|NCT03522649|Vitamin B Complex|vitamin b complex|mesh-ancestor
91932612|NCT03522649|Vitamins|vitamins|mesh-ancestor
91932613|NCT03522649|Micronutrients|micronutrients|mesh-ancestor
91932614|NCT02366481|Vitamins|vitamins|mesh-list
91932615|NCT02366481|Vitamin K|vitamin k|mesh-list
91932616|NCT02366481|Vitamin K 2|vitamin k 2|mesh-list
91932617|NCT02366481|Menaquinone 7|menaquinone 7|mesh-list
91932618|NCT02366481|Micronutrients|micronutrients|mesh-ancestor
91932619|NCT02366481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932620|NCT02366481|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91932621|NCT02366481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91932622|NCT02366481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932623|NCT02366481|Hemostatics|hemostatics|mesh-ancestor
91932624|NCT02366481|Coagulants|coagulants|mesh-ancestor
91932625|NCT02366247|Adefovir|adefovir|mesh-list
91932626|NCT02366247|Thymalfasin|thymalfasin|mesh-list
91932628|NCT02366247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932629|NCT02366247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91932630|NCT02366247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91932631|NCT02366247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932632|NCT02366247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932633|NCT02366247|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91932634|NCT02366247|Immunologic Factors|immunologic factors|mesh-ancestor
91932635|NCT02366247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932636|NCT02373735|Mannitol|mannitol|mesh-list
91932637|NCT02373735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91932638|NCT02373735|Diuretics|diuretics|mesh-ancestor
91932639|NCT02373735|Natriuretic Agents|natriuretic agents|mesh-ancestor
91932640|NCT02373735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932642|NCT03526315|Cariostatic Agents|cariostatic agents|mesh-ancestor
91932643|NCT03526315|Protective Agents|protective agents|mesh-ancestor
91932644|NCT03526315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932645|NCT03112551|Magnesium Sulfate|magnesium sulfate|mesh-list
91932646|NCT03112551|Analgesics|analgesics|mesh-ancestor
91932647|NCT03112551|Sensory System Agents|sensory system agents|mesh-ancestor
91932648|NCT03112551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932649|NCT03112551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932650|NCT03112551|Anesthetics|anesthetics|mesh-ancestor
91932651|NCT03112551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932652|NCT03112551|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91932653|NCT03112551|Anticonvulsants|anticonvulsants|mesh-ancestor
91932654|NCT03112551|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91932655|NCT03112551|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91932656|NCT03112551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932657|NCT03112551|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91932658|NCT03112551|Tocolytic Agents|tocolytic agents|mesh-ancestor
91932659|NCT03112551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91932660|NCT05373433|Ritonavir|ritonavir|mesh-list
91932661|NCT05373433|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91932662|NCT05373433|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91932663|NCT05373433|Protease Inhibitors|protease inhibitors|mesh-ancestor
91932664|NCT05373433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932665|NCT05373433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932666|NCT05373433|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91932667|NCT05373433|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91932668|NCT05373433|Antiviral Agents|antiviral agents|mesh-ancestor
91932669|NCT05373433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932670|NCT05373433|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91931722|NCT02959944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931723|NCT02959944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931724|NCT02959944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931725|NCT02959944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931726|NCT02823002|Lidocaine|lidocaine|mesh-list
91931727|NCT02823002|Anesthetics, Local|anesthetics, local|mesh-ancestor
91931728|NCT02823002|Anesthetics|anesthetics|mesh-ancestor
91931729|NCT02823002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931730|NCT02823002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931731|NCT02823002|Sensory System Agents|sensory system agents|mesh-ancestor
91931732|NCT02823002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931733|NCT02823002|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91931734|NCT02823002|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91931735|NCT02823002|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91931736|NCT02823002|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91931737|NCT02823002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931738|NCT02806687|Gemcitabine|gemcitabine|mesh-list
91931739|NCT02806687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931740|NCT02806687|Antimetabolites|antimetabolites|mesh-ancestor
91931741|NCT02806687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931742|NCT02806687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931743|NCT02581137|Metformin|metformin|mesh-list
91931744|NCT02581137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91931745|NCT02581137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931746|NCT02559180|Aflibercept|aflibercept|mesh-list
91931747|NCT02559180|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91931748|NCT02559180|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91931749|NCT02559180|Growth Substances|growth substances|mesh-ancestor
91931750|NCT02559180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931751|NCT02559180|Growth Inhibitors|growth inhibitors|mesh-ancestor
91931752|NCT02559180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931753|NCT02539966|Sirolimus|sirolimus|mesh-list
91931754|NCT02539966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931755|NCT02539966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931756|NCT02539966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931757|NCT02539966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931758|NCT02539966|Antifungal Agents|antifungal agents|mesh-ancestor
91931759|NCT02539966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931760|NCT02539966|Immunologic Factors|immunologic factors|mesh-ancestor
91931761|NCT02539966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931762|NCT02525029|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91931763|NCT02525029|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91931764|NCT02525029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931765|NCT02455557|Temozolomide|temozolomide|mesh-list
91931766|NCT02455557|Sargramostim|sargramostim|mesh-list
91931767|NCT02455557|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
91931768|NCT02455557|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91931769|NCT02455557|Alkylating Agents|alkylating agents|mesh-ancestor
91931770|NCT02455557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931771|NCT02455557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931772|NCT02455557|Immunologic Factors|immunologic factors|mesh-ancestor
91931773|NCT02455557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931774|NCT02455557|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91931775|NCT02401139|Ketamine|ketamine|mesh-list
91931776|NCT02401139|Analgesics|analgesics|mesh-ancestor
91931777|NCT02401139|Sensory System Agents|sensory system agents|mesh-ancestor
91931778|NCT02401139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931779|NCT02401139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931780|NCT02401139|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91931781|NCT02401139|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91931782|NCT02401139|Anesthetics, General|anesthetics, general|mesh-ancestor
91931783|NCT02401139|Anesthetics|anesthetics|mesh-ancestor
91931784|NCT02401139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91931785|NCT02401139|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91931786|NCT02401139|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91931787|NCT02401139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91931788|NCT02401139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931789|NCT02390635|Deoxyglucose|deoxyglucose|mesh-list
91931790|NCT02390635|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91931791|NCT02390635|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91931792|NCT02390635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931793|NCT02390635|Antimetabolites|antimetabolites|mesh-ancestor
91931794|NCT02390635|Antiviral Agents|antiviral agents|mesh-ancestor
91931795|NCT02390635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931796|NCT02367846|Contraceptive Agents|contraceptive agents|mesh-list
91931797|NCT02367846|NuvaRing|nuvaring|mesh-list
91931798|NCT02367846|Contraceptives, Oral|contraceptives, oral|mesh-list
91931799|NCT02367846|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
91931800|NCT02367846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91931801|NCT02367846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931802|NCT02367846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91931803|NCT02367846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91931804|NCT02195895|Calcium, Dietary|calcium, dietary|mesh-list
91931805|NCT02195895|Vitamin D|vitamin d|mesh-list
91931807|NCT02195895|Cholecalciferol|cholecalciferol|mesh-list
91931808|NCT02195895|Alendronate|alendronate|mesh-list
91931809|NCT02195895|Vitamins|vitamins|mesh-list
91931810|NCT02195895|Calcium Carbonate|calcium carbonate|mesh-list
91931811|NCT02195895|Antacids|antacids|mesh-list
91931814|NCT02195895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931815|NCT02195895|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91931816|NCT02195895|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91931817|NCT02195895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931818|NCT02195895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931819|NCT01970722|Paclitaxel|paclitaxel|mesh-list
91931820|NCT01970722|Cisplatin|cisplatin|mesh-list
91931821|NCT01970722|Carboplatin|carboplatin|mesh-list
91931822|NCT01970722|Gemcitabine|gemcitabine|mesh-list
91931823|NCT01970722|Doxorubicin|doxorubicin|mesh-list
91931824|NCT01970722|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91931825|NCT01970722|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91931826|NCT01970722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91931827|NCT01970722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931828|NCT01970722|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931829|NCT01970722|Antimitotic Agents|antimitotic agents|mesh-ancestor
91931830|NCT01970722|Mitosis Modulators|mitosis modulators|mesh-ancestor
91931831|NCT01970722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931832|NCT01970722|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931833|NCT01970722|Antimetabolites|antimetabolites|mesh-ancestor
91931834|NCT01970722|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931835|NCT01970722|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91931836|NCT01970722|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91931837|NCT01970722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931838|NCT01953900|Cyclophosphamide|cyclophosphamide|mesh-list
91931839|NCT01953900|Fludarabine|fludarabine|mesh-list
91931840|NCT01953900|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931841|NCT01953900|Immunologic Factors|immunologic factors|mesh-ancestor
91931842|NCT01953900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931843|NCT01953900|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931844|NCT01953900|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91931845|NCT01953900|Alkylating Agents|alkylating agents|mesh-ancestor
91931846|NCT01953900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931847|NCT01953900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931848|NCT01953900|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91931849|NCT01913951|Azacitidine|azacitidine|mesh-list
91931850|NCT01913951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931851|NCT01913951|Antimetabolites|antimetabolites|mesh-ancestor
91931852|NCT01913951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931853|NCT01913951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931854|NCT01913951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931855|NCT01867320|Raltegravir Potassium|raltegravir potassium|mesh-list
91931856|NCT01867320|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91931857|NCT01867320|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91931858|NCT01867320|Antiviral Agents|antiviral agents|mesh-ancestor
91931859|NCT01867320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931860|NCT01867320|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91931861|NCT01867320|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91931862|NCT01867320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931863|NCT01867320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931864|NCT01709136|Sirolimus|sirolimus|mesh-list
91931865|NCT01709136|Temsirolimus|temsirolimus|mesh-list
91931866|NCT01709136|MTOR Inhibitors|mtor inhibitors|mesh-list
91931867|NCT01709136|Tacrolimus|tacrolimus|mesh-list
91931868|NCT01709136|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931869|NCT01709136|Immunologic Factors|immunologic factors|mesh-ancestor
91931870|NCT01709136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931871|NCT01709136|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91931872|NCT01709136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931873|NCT01709136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931874|NCT01709136|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91931875|NCT01709136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931876|NCT01709136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931877|NCT01709136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931878|NCT01709136|Antifungal Agents|antifungal agents|mesh-ancestor
91931879|NCT01709136|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91931880|NCT01570868|Ponatinib|ponatinib|mesh-list
91931881|NCT01570868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931882|NCT01570868|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91931883|NCT01570868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931884|NCT01570868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931885|NCT01565499|Paclitaxel|paclitaxel|mesh-list
91931886|NCT01565499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91931887|NCT01565499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931888|NCT01565499|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931891|NCT01565499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931892|NCT01371630|Cytarabine|cytarabine|mesh-list
91931893|NCT01371630|Dexamethasone|dexamethasone|mesh-list
91931894|NCT01371630|Prednisone|prednisone|mesh-list
91931895|NCT01371630|Cyclophosphamide|cyclophosphamide|mesh-list
91931896|NCT01371630|Rituximab|rituximab|mesh-list
91931897|NCT01371630|Methotrexate|methotrexate|mesh-list
91931898|NCT01371630|Vincristine|vincristine|mesh-list
91931899|NCT01371630|Mercaptopurine|mercaptopurine|mesh-list
91931900|NCT01371630|Blinatumomab|blinatumomab|mesh-list
91931901|NCT01371630|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
91931902|NCT01371630|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931903|NCT01371630|Immunologic Factors|immunologic factors|mesh-ancestor
91931904|NCT01371630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931905|NCT01371630|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931906|NCT01371630|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91931907|NCT01371630|Alkylating Agents|alkylating agents|mesh-ancestor
91931908|NCT01371630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931909|NCT01371630|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931910|NCT01371630|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91931911|NCT01371630|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931912|NCT01371630|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931913|NCT01371630|Antiemetics|antiemetics|mesh-ancestor
91931914|NCT01371630|Autonomic Agents|autonomic agents|mesh-ancestor
91931915|NCT01371630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931916|NCT01371630|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931917|NCT01371630|Glucocorticoids|glucocorticoids|mesh-ancestor
91931918|NCT01371630|Hormones|hormones|mesh-ancestor
91931919|NCT01371630|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931920|NCT01371630|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931921|NCT01371630|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91931922|NCT01371630|Abortifacient Agents|abortifacient agents|mesh-ancestor
91931923|NCT01371630|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91931924|NCT01371630|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931926|NCT01371630|Dermatologic Agents|dermatologic agents|mesh-ancestor
91931927|NCT01371630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931928|NCT01371630|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91931929|NCT01371630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91931930|NCT01371630|Antiviral Agents|antiviral agents|mesh-ancestor
91931931|NCT01371630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91931932|NCT01371630|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91931933|NCT01371630|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931934|NCT01371630|Antimitotic Agents|antimitotic agents|mesh-ancestor
91931935|NCT01371630|Mitosis Modulators|mitosis modulators|mesh-ancestor
91931936|NCT01371630|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931938|NCT01371630|Immunoconjugates|immunoconjugates|mesh-ancestor
91931939|NCT01036087|Paclitaxel|paclitaxel|mesh-list
91931940|NCT01036087|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91931941|NCT01036087|Cyclophosphamide|cyclophosphamide|mesh-list
91931942|NCT01036087|Carboplatin|carboplatin|mesh-list
91931943|NCT01036087|Fluorouracil|fluorouracil|mesh-list
91931945|NCT01036087|Panitumumab|panitumumab|mesh-list
91931946|NCT01036087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91931947|NCT01036087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931948|NCT01036087|Tubulin Modulators|tubulin modulators|mesh-ancestor
91931949|NCT01036087|Antimitotic Agents|antimitotic agents|mesh-ancestor
91931950|NCT01036087|Mitosis Modulators|mitosis modulators|mesh-ancestor
91931951|NCT01036087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931952|NCT01036087|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91931953|NCT01036087|Immunologic Factors|immunologic factors|mesh-ancestor
91931954|NCT01036087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931955|NCT01036087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931956|NCT01036087|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91931957|NCT01036087|Alkylating Agents|alkylating agents|mesh-ancestor
91931958|NCT01036087|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91931959|NCT01036087|Antimetabolites|antimetabolites|mesh-ancestor
91931960|NCT01036087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91931961|NCT01036087|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91931962|NCT01036087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91931963|NCT01036087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91931964|NCT01036087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931965|NCT01036087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931967|NCT00783367|Dexamethasone acetate|dexamethasone acetate|mesh-list
91931968|NCT00783367|Rituximab|rituximab|mesh-list
91931969|NCT00783367|Lenalidomide|lenalidomide|mesh-list
91931970|NCT00783367|BB 1101|bb 1101|mesh-list
91931971|NCT00783367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91931972|NCT00783367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91931973|NCT00783367|Immunologic Factors|immunologic factors|mesh-ancestor
91931974|NCT00783367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931975|NCT00783367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91931976|NCT00783367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91931977|NCT00783367|Antiemetics|antiemetics|mesh-ancestor
91931978|NCT00783367|Autonomic Agents|autonomic agents|mesh-ancestor
91931979|NCT00783367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91931980|NCT00783367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91931981|NCT00783367|Glucocorticoids|glucocorticoids|mesh-ancestor
91931982|NCT00783367|Hormones|hormones|mesh-ancestor
91931983|NCT00783367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91931984|NCT00783367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91931985|NCT00783367|Protease Inhibitors|protease inhibitors|mesh-ancestor
91931986|NCT00783367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91931987|NCT00783367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91931988|NCT00783367|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91931989|NCT00783367|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91931990|NCT00783367|Growth Substances|growth substances|mesh-ancestor
91931991|NCT00783367|Growth Inhibitors|growth inhibitors|mesh-ancestor
91931992|NCT00572156|Mecasermin|mecasermin|mesh-list
91931993|NCT00572156|Growth Substances|growth substances|mesh-ancestor
91931994|NCT00572156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91931995|NCT00447772|Botulinum Toxins|botulinum toxins|mesh-list
91943447|NCT00644228|Glucocorticoids|glucocorticoids|mesh-ancestor
91931996|NCT00447772|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91931997|NCT00447772|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91931998|NCT00447772|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91931999|NCT00447772|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91932000|NCT00447772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932001|NCT00447772|Cholinergic Agents|cholinergic agents|mesh-ancestor
91932002|NCT00447772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932003|NCT00447772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932004|NCT00447772|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91932005|NCT00447772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932006|NCT00255216|Policosanol|policosanol|mesh-list
91932007|NCT00255216|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91932008|NCT00255216|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91932009|NCT00255216|Antimetabolites|antimetabolites|mesh-ancestor
91932010|NCT00255216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932011|NCT00255216|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91932012|NCT00255216|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91932013|NCT00079066|Cetuximab|cetuximab|mesh-list
91932014|NCT00079066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932015|NCT00079066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932017|NCT03525223|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91932018|NCT02257697|Mizoribine|mizoribine|mesh-list
91932019|NCT02257697|Cyclophosphamide|cyclophosphamide|mesh-list
91932020|NCT02257697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932021|NCT02257697|Immunologic Factors|immunologic factors|mesh-ancestor
91932022|NCT02257697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932023|NCT02257697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932024|NCT02257697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91932025|NCT02257697|Alkylating Agents|alkylating agents|mesh-ancestor
91932026|NCT02257697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932027|NCT02257697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932028|NCT02257697|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91932029|NCT02257697|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91932030|NCT02257697|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932031|NCT02257697|Analgesics|analgesics|mesh-ancestor
91932032|NCT02257697|Sensory System Agents|sensory system agents|mesh-ancestor
91932033|NCT02257697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932034|NCT02257697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932035|NCT02257697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932036|NCT02257697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932037|NCT02257697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91932038|NCT02257697|Antimalarials|antimalarials|mesh-ancestor
91932039|NCT02257697|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91932040|NCT02257697|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91932041|NCT02257697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932042|NCT04468711|Vitamin D|vitamin d|mesh-list
91932043|NCT04468711|Hydrocortisone|hydrocortisone|mesh-list
91932044|NCT04468711|Vitamins|vitamins|mesh-ancestor
91932045|NCT04468711|Micronutrients|micronutrients|mesh-ancestor
91932046|NCT04468711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932047|NCT04468711|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91932048|NCT04468711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932049|NCT02207387|Rasagiline|rasagiline|mesh-list
91932050|NCT02207387|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91932051|NCT02207387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932052|NCT02207387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932053|NCT02207387|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91932054|NCT02207387|Protective Agents|protective agents|mesh-ancestor
91932055|NCT02207387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932056|NCT03528421|Cyclophosphamide|cyclophosphamide|mesh-list
91932057|NCT03528421|Fludarabine|fludarabine|mesh-list
91932058|NCT03528421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932059|NCT03528421|Immunologic Factors|immunologic factors|mesh-ancestor
91932060|NCT03528421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932061|NCT03528421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932062|NCT03528421|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91932063|NCT03528421|Alkylating Agents|alkylating agents|mesh-ancestor
91932064|NCT03528421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932065|NCT03528421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932066|NCT03528421|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91932067|NCT02374047|Atorvastatin|atorvastatin|mesh-list
91932068|NCT02374047|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91932069|NCT02374047|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91932070|NCT02374047|Antimetabolites|antimetabolites|mesh-ancestor
91932071|NCT02374047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932072|NCT02374047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91932073|NCT02374047|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91932074|NCT02374047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932075|NCT02203253|Thalidomide|thalidomide|mesh-list
91932076|NCT02203253|Dexamethasone|dexamethasone|mesh-list
91932077|NCT02203253|Palonosetron|palonosetron|mesh-list
91932078|NCT02203253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932079|NCT02203253|Antiemetics|antiemetics|mesh-ancestor
91932080|NCT02203253|Autonomic Agents|autonomic agents|mesh-ancestor
91932081|NCT02203253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932082|NCT02203253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932083|NCT02203253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932084|NCT02203253|Glucocorticoids|glucocorticoids|mesh-ancestor
91932085|NCT02203253|Hormones|hormones|mesh-ancestor
91932671|NCT05373433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91932672|NCT02363127|Progesterone|progesterone|mesh-list
91932673|NCT02363127|Progestins|progestins|mesh-ancestor
91932674|NCT02363127|Hormones|hormones|mesh-ancestor
91932675|NCT02363127|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91932676|NCT02363127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932677|NCT03526159|Gentamicins|gentamicins|mesh-list
91932678|NCT03526159|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932679|NCT03526159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932680|NCT03526159|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91932681|NCT03526159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932682|NCT03526159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932683|NCT03523741|Clozapine|clozapine|mesh-list
91932684|NCT03523741|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91932685|NCT03523741|Serotonin Agents|serotonin agents|mesh-ancestor
91932686|NCT03523741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932687|NCT03523741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932688|NCT03523741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932689|NCT03523741|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91932690|NCT03523741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91932691|NCT03523741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932692|NCT03523741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91932693|NCT03523741|GABA Antagonists|gaba antagonists|mesh-ancestor
91932694|NCT03523741|GABA Agents|gaba agents|mesh-ancestor
91932695|NCT02362581|Factor VIII|factor viii|mesh-list
91932696|NCT02362581|Coagulants|coagulants|mesh-ancestor
91932698|NCT03525925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932699|NCT03525925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932700|NCT03525925|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91932701|NCT03525925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932702|NCT02373579|Methotrexate|methotrexate|mesh-list
91932703|NCT02373579|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91932704|NCT02373579|Abortifacient Agents|abortifacient agents|mesh-ancestor
91932705|NCT02373579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91932706|NCT02373579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932707|NCT02373579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91932709|NCT02373579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932710|NCT02373579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932711|NCT02373579|Dermatologic Agents|dermatologic agents|mesh-ancestor
91932712|NCT02373579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932713|NCT02373579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91932714|NCT02373579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932715|NCT02373579|Immunologic Factors|immunologic factors|mesh-ancestor
91932716|NCT02373579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932717|NCT02373579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91932718|NCT02365857|Dexmedetomidine|dexmedetomidine|mesh-list
91932719|NCT02365857|Bupivacaine|bupivacaine|mesh-list
91932720|NCT02365857|Anesthetics, Local|anesthetics, local|mesh-ancestor
91932721|NCT02365857|Anesthetics|anesthetics|mesh-ancestor
91932722|NCT02365857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932723|NCT02365857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932724|NCT02365857|Sensory System Agents|sensory system agents|mesh-ancestor
91932725|NCT02365857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932726|NCT02365857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91932727|NCT02365857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932728|NCT02365857|Analgesics|analgesics|mesh-ancestor
91932729|NCT02365857|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91932730|NCT02365857|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91932731|NCT02365857|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91932732|NCT02365857|Adrenergic Agents|adrenergic agents|mesh-ancestor
91932733|NCT02365857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932734|NCT02365857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932735|NCT02365935|Paclitaxel|paclitaxel|mesh-list
91932737|NCT02365935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91932738|NCT02365935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932739|NCT02365935|Tubulin Modulators|tubulin modulators|mesh-ancestor
91932740|NCT02365935|Antimitotic Agents|antimitotic agents|mesh-ancestor
91932741|NCT02365935|Mitosis Modulators|mitosis modulators|mesh-ancestor
91932742|NCT02365935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932743|NCT02365623|Bedaquiline|bedaquiline|mesh-list
91932744|NCT02365623|Diarylquinolines|diarylquinolines|mesh-list
91932745|NCT02365623|Antitubercular Agents|antitubercular agents|mesh-ancestor
91932746|NCT02365623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932747|NCT02365623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932748|NCT03112707|Aspirin|aspirin|mesh-list
91932749|NCT03112707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91932750|NCT03112707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932751|NCT03112707|Analgesics|analgesics|mesh-ancestor
91932752|NCT03112707|Sensory System Agents|sensory system agents|mesh-ancestor
91932753|NCT03112707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932754|NCT03112707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932755|NCT03112707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932756|NCT03112707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932757|NCT03112707|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91932758|NCT03112707|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91932759|NCT03112707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932086|NCT02203253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91932087|NCT02203253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91932088|NCT02203253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932089|NCT02203253|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932090|NCT02203253|Immunologic Factors|immunologic factors|mesh-ancestor
91932091|NCT02203253|Leprostatic Agents|leprostatic agents|mesh-ancestor
91932092|NCT02203253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932093|NCT02203253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932094|NCT02203253|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91932095|NCT02203253|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91932096|NCT02203253|Growth Substances|growth substances|mesh-ancestor
91932097|NCT02203253|Growth Inhibitors|growth inhibitors|mesh-ancestor
91932098|NCT02203253|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91932099|NCT02203253|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91932101|NCT02203253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932102|NCT02203253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932103|NCT02207699|Moxifloxacin|moxifloxacin|mesh-list
91932104|NCT02207699|Benzonatate|benzonatate|mesh-list
91932105|NCT02207699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932106|NCT02207699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932107|NCT02207699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91932108|NCT02207699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932109|NCT02207699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932187|NCT03532763|Tocovid|tocovid|mesh-list
91932110|NCT02207699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932111|NCT02207699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932112|NCT02207699|Antitussive Agents|antitussive agents|mesh-ancestor
91932113|NCT02207699|Respiratory System Agents|respiratory system agents|mesh-ancestor
91932114|NCT01838187|Vorinostat|vorinostat|mesh-list
91932115|NCT01838187|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
91932116|NCT01838187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932117|NCT01838187|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91932118|NCT01838187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932119|NCT01838187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932120|NCT01838187|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91932122|NCT02296138|Olodaterol|olodaterol|mesh-list
91932123|NCT02296138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91932124|NCT02296138|Autonomic Agents|autonomic agents|mesh-ancestor
91932125|NCT02296138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932126|NCT02296138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932127|NCT02296138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91932128|NCT02296138|Respiratory System Agents|respiratory system agents|mesh-ancestor
91932129|NCT02296138|Parasympatholytics|parasympatholytics|mesh-ancestor
91932130|NCT02296138|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91932131|NCT02296138|Cholinergic Agents|cholinergic agents|mesh-ancestor
91932132|NCT02296138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932133|NCT02296138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932134|NCT01306942|Paclitaxel|paclitaxel|mesh-list
91932135|NCT01306942|Trastuzumab|trastuzumab|mesh-list
91932136|NCT01306942|Dasatinib|dasatinib|mesh-list
91932137|NCT01306942|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91932138|NCT01306942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932139|NCT01306942|Tubulin Modulators|tubulin modulators|mesh-ancestor
91932140|NCT01306942|Antimitotic Agents|antimitotic agents|mesh-ancestor
91932141|NCT01306942|Mitosis Modulators|mitosis modulators|mesh-ancestor
91932142|NCT01306942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932143|NCT01306942|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932144|NCT01306942|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91932145|NCT01306942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932146|NCT02207855|Chloroprocaine|chloroprocaine|mesh-list
91932147|NCT02207855|Anesthetics, Local|anesthetics, local|mesh-ancestor
91932148|NCT02207855|Anesthetics|anesthetics|mesh-ancestor
91932149|NCT02207855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932150|NCT02207855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932151|NCT02207855|Sensory System Agents|sensory system agents|mesh-ancestor
91932152|NCT02207855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932153|NCT01345851|Paclitaxel|paclitaxel|mesh-list
91932154|NCT01345851|Carboplatin|carboplatin|mesh-list
91932155|NCT01345851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91932156|NCT01345851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932157|NCT01345851|Tubulin Modulators|tubulin modulators|mesh-ancestor
91932158|NCT01345851|Antimitotic Agents|antimitotic agents|mesh-ancestor
91932159|NCT01345851|Mitosis Modulators|mitosis modulators|mesh-ancestor
91932160|NCT01345851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932162|NCT03532841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91932163|NCT03532841|Narcotics|narcotics|mesh-ancestor
91932164|NCT03532841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932165|NCT03532841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932166|NCT03532841|Analgesics|analgesics|mesh-ancestor
91932167|NCT03532841|Sensory System Agents|sensory system agents|mesh-ancestor
91932168|NCT03532841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932169|NCT02199431|Itraconazole|itraconazole|mesh-list
91932170|NCT02199431|Antifungal Agents|antifungal agents|mesh-ancestor
91932171|NCT02199431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932172|NCT02199431|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91932173|NCT02199431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91932174|NCT02199431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932175|NCT02199431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932176|NCT02199431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91932177|NCT02199431|Hormone Antagonists|hormone antagonists|mesh-ancestor
91932178|NCT02199431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91932179|NCT02199431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932180|NCT02199431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91932181|NCT02203799|Immunomodulating Agents|immunomodulating agents|mesh-list
91932182|NCT02203799|Immunologic Factors|immunologic factors|mesh-list
91932183|NCT02203799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932184|NCT03532763|Tocotrienols|tocotrienols|mesh-list
91932186|NCT03532763|Tocopherols|tocopherols|mesh-list
91932189|NCT03532763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932190|NCT03532763|Protective Agents|protective agents|mesh-ancestor
91932191|NCT03532763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932192|NCT03532763|Vitamins|vitamins|mesh-ancestor
91932193|NCT03532763|Micronutrients|micronutrients|mesh-ancestor
91932194|NCT02208245|Ropivacaine|ropivacaine|mesh-list
91932195|NCT02208245|Anesthetics, Local|anesthetics, local|mesh-ancestor
91932196|NCT02208245|Anesthetics|anesthetics|mesh-ancestor
91932197|NCT02208245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932198|NCT02208245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932199|NCT02208245|Sensory System Agents|sensory system agents|mesh-ancestor
91932200|NCT02208245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932201|NCT03514901|Pembrolizumab|pembrolizumab|mesh-list
91932202|NCT03514901|Nivolumab|nivolumab|mesh-list
91932203|NCT03514901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932204|NCT03514901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932205|NCT03514901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91932206|NCT03514901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932207|NCT04441021|Penicillins|penicillins|mesh-list
91943459|NCT00644228|Growth Inhibitors|growth inhibitors|mesh-ancestor
91932209|NCT04441021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932210|NCT03533387|Ibudilast|ibudilast|mesh-list
91932211|NCT03533387|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91932212|NCT03533387|Autonomic Agents|autonomic agents|mesh-ancestor
91932213|NCT03533387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932214|NCT03533387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932215|NCT03533387|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91932216|NCT03533387|Respiratory System Agents|respiratory system agents|mesh-ancestor
91932217|NCT03533387|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91932218|NCT03533387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932219|NCT03533387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932220|NCT03533387|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91932221|NCT03533387|Vasodilator Agents|vasodilator agents|mesh-ancestor
91932222|NCT02324842|Liraglutide|liraglutide|mesh-list
91932223|NCT02324842|Canagliflozin|canagliflozin|mesh-list
91932224|NCT02324842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91932225|NCT02324842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932226|NCT02324842|Incretins|incretins|mesh-ancestor
91932227|NCT02324842|Hormones|hormones|mesh-ancestor
91932228|NCT02324842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91932760|NCT03112707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91932761|NCT03112707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91932762|NCT03112707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932763|NCT03112707|Antipyretics|antipyretics|mesh-ancestor
91932765|NCT05262413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932766|NCT05262413|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91932767|NCT05262413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932768|NCT05262413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932769|NCT02209649|Telmisartan|telmisartan|mesh-list
91932770|NCT02209649|Lacidipine|lacidipine|mesh-list
91932771|NCT02209649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91932772|NCT02209649|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91932773|NCT02209649|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91932774|NCT02209649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932775|NCT02209649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91932776|NCT02209649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91932777|NCT02209649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91932778|NCT02209649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932781|NCT02361567|Tramadol|tramadol|mesh-list
91932782|NCT02361567|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91932783|NCT02361567|Narcotics|narcotics|mesh-ancestor
91932784|NCT02361567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932785|NCT02361567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932786|NCT02361567|Analgesics|analgesics|mesh-ancestor
91932787|NCT02361567|Sensory System Agents|sensory system agents|mesh-ancestor
91932788|NCT02361567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932789|NCT02361567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932790|NCT02361567|Antipyretics|antipyretics|mesh-ancestor
91932791|NCT03112785|Cimetidine|cimetidine|mesh-list
91932792|NCT03112785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91932793|NCT03112785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932794|NCT03112785|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91932795|NCT03112785|Histamine Antagonists|histamine antagonists|mesh-ancestor
91932796|NCT03112785|Histamine Agents|histamine agents|mesh-ancestor
91932797|NCT03112785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932798|NCT03112785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932799|NCT03112785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932800|NCT03112785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91932801|NCT03112785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91932802|NCT03112785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932803|NCT02361879|Leuprolide|leuprolide|mesh-list
91932804|NCT02361879|Ulipristal acetate|ulipristal acetate|mesh-list
91932229|NCT02324842|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91932230|NCT02324842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932231|NCT02295280|Diphenhydramine|diphenhydramine|mesh-list
91932232|NCT02295280|Promethazine|promethazine|mesh-list
91932233|NCT02295280|Codeine|codeine|mesh-list
91932234|NCT02295280|Metoclopramide|metoclopramide|mesh-list
91932235|NCT02295280|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91932236|NCT02295280|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91932237|NCT02295280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932238|NCT02295280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932239|NCT02295280|Anesthetics, Local|anesthetics, local|mesh-ancestor
91932241|NCT02295280|Sensory System Agents|sensory system agents|mesh-ancestor
91932242|NCT02295280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932244|NCT02295280|Autonomic Agents|autonomic agents|mesh-ancestor
91932245|NCT02295280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932246|NCT02295280|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91932247|NCT02295280|Histamine Antagonists|histamine antagonists|mesh-ancestor
91932248|NCT02295280|Histamine Agents|histamine agents|mesh-ancestor
91932249|NCT02295280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932250|NCT02295280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932251|NCT02295280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91932252|NCT02295280|Antipruritics|antipruritics|mesh-ancestor
91932253|NCT02295280|Dermatologic Agents|dermatologic agents|mesh-ancestor
91932254|NCT02295280|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91932255|NCT02295280|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91932256|NCT02295280|Dopamine Agents|dopamine agents|mesh-ancestor
91932257|NCT02295280|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91932258|NCT02295280|Narcotics|narcotics|mesh-ancestor
91932259|NCT02295280|Analgesics|analgesics|mesh-ancestor
91932260|NCT02295280|Antitussive Agents|antitussive agents|mesh-ancestor
91932261|NCT02295280|Respiratory System Agents|respiratory system agents|mesh-ancestor
91932262|NCT05263505|Methotrexate|methotrexate|mesh-list
91932263|NCT05263505|Azathioprine|azathioprine|mesh-list
91932264|NCT05263505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91932265|NCT05263505|Abortifacient Agents|abortifacient agents|mesh-ancestor
91932266|NCT05263505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91932267|NCT05263505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932268|NCT05263505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91932269|NCT05263505|Antimetabolites|antimetabolites|mesh-ancestor
91932270|NCT05263505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932271|NCT05263505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932272|NCT05263505|Dermatologic Agents|dermatologic agents|mesh-ancestor
91932273|NCT05263505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932274|NCT05263505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91932275|NCT05263505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932276|NCT05263505|Immunologic Factors|immunologic factors|mesh-ancestor
91932277|NCT05263505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932278|NCT05263505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91932279|NCT02204501|Midazolam|midazolam|mesh-list
91932280|NCT02204501|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91932281|NCT02204501|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91932282|NCT02204501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932283|NCT02204501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932284|NCT02204501|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91932285|NCT02204501|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91932286|NCT02204501|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91932287|NCT02204501|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91932288|NCT02204501|Anesthetics, General|anesthetics, general|mesh-ancestor
91932289|NCT02204501|Anesthetics|anesthetics|mesh-ancestor
91932290|NCT02204501|GABA Modulators|gaba modulators|mesh-ancestor
91932291|NCT02204501|GABA Agents|gaba agents|mesh-ancestor
91932292|NCT02204501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932293|NCT02204501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932294|NCT02294734|Nemiralisib|nemiralisib|mesh-list
91932295|NCT02294734|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91932296|NCT02294734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932297|NCT02294734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932298|NCT03533231|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91932302|NCT03533231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932303|NCT03533231|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91932304|NCT03533231|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91932305|NCT03533231|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91932306|NCT03533231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932307|NCT03533231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932308|NCT03533231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932309|NCT03533231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932310|NCT03533231|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91932311|NCT03533231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91932312|NCT02200757|Topotecan|topotecan|mesh-list
91932313|NCT02200757|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91932314|NCT02200757|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932315|NCT02200757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932316|NCT02200757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932317|NCT02200757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932318|NCT05374057|Ibuprofen|ibuprofen|mesh-list
91932319|NCT05374057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91932320|NCT05374057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932321|NCT05374057|Analgesics|analgesics|mesh-ancestor
91932322|NCT05374057|Sensory System Agents|sensory system agents|mesh-ancestor
91932323|NCT05374057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932324|NCT05374057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932325|NCT05374057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932326|NCT05374057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932327|NCT05374057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91932328|NCT05374057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932329|NCT05374057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932330|NCT02208791|Sirolimus|sirolimus|mesh-list
91932331|NCT02208791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932332|NCT02208791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932333|NCT02208791|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91932334|NCT02208791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932335|NCT02208791|Antifungal Agents|antifungal agents|mesh-ancestor
91932336|NCT02208791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932337|NCT02208791|Immunologic Factors|immunologic factors|mesh-ancestor
91932338|NCT02208791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932339|NCT05223101|Telmisartan|telmisartan|mesh-list
91932340|NCT05223101|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91932341|NCT05223101|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91932342|NCT05223101|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91932343|NCT05223101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932805|NCT02361879|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91932806|NCT02361879|Fertility Agents|fertility agents|mesh-ancestor
91932807|NCT02361879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91932808|NCT02361879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932809|NCT02361879|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91932810|NCT02361879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932811|NCT02361879|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91932812|NCT02361879|Contraceptive Agents|contraceptive agents|mesh-ancestor
91932813|NCT02361879|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91932814|NCT05262335|Paclitaxel|paclitaxel|mesh-list
91932815|NCT05262335|Docetaxel|docetaxel|mesh-list
91932816|NCT05262335|Capecitabine|capecitabine|mesh-list
91932817|NCT05262335|Oxaliplatin|oxaliplatin|mesh-list
91932818|NCT05262335|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91932819|NCT05262335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932820|NCT05262335|Tubulin Modulators|tubulin modulators|mesh-ancestor
91932821|NCT05262335|Antimitotic Agents|antimitotic agents|mesh-ancestor
91932822|NCT05262335|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074247|NCT00072514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932823|NCT05262335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932824|NCT05262335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91932825|NCT05262335|Antimetabolites|antimetabolites|mesh-ancestor
91932827|NCT02361645|Indomethacin|indomethacin|mesh-list
91932828|NCT02361645|Nepafenac|nepafenac|mesh-list
91932829|NCT02361645|Bromfenac|bromfenac|mesh-list
91932830|NCT02361645|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91932831|NCT02361645|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91932832|NCT02361645|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932833|NCT02361645|Analgesics|analgesics|mesh-ancestor
91932834|NCT02361645|Sensory System Agents|sensory system agents|mesh-ancestor
91932835|NCT02361645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932836|NCT02361645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932837|NCT02361645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91932838|NCT02361645|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932839|NCT02361645|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91932840|NCT02361645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932841|NCT02361645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932842|NCT02361645|Gout Suppressants|gout suppressants|mesh-ancestor
91932843|NCT02361645|Tocolytic Agents|tocolytic agents|mesh-ancestor
91932844|NCT02361645|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91932845|NCT02361645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91932847|NCT03522181|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91932848|NCT03522181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91932849|NCT03522181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932850|NCT02373033|Folic Acid|folic acid|mesh-list
91932851|NCT02373033|Vitamin B Complex|vitamin b complex|mesh-list
91932853|NCT02373033|Vitamins|vitamins|mesh-ancestor
91932855|NCT02373033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932856|NCT05186129|Clopidogrel|clopidogrel|mesh-list
91932857|NCT05186129|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91932858|NCT05186129|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91932859|NCT05186129|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91932860|NCT05186129|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91932861|NCT05186129|Purinergic Agents|purinergic agents|mesh-ancestor
91932862|NCT05186129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932863|NCT05186129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932864|NCT05186129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932865|NCT02361723|Pamiparib|pamiparib|mesh-list
91932866|NCT02361723|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91932867|NCT02361723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932868|NCT02361723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932869|NCT02361723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932870|NCT03596281|Bevacizumab|bevacizumab|mesh-list
91932871|NCT03596281|Pembrolizumab|pembrolizumab|mesh-list
91932872|NCT03596281|Doxorubicin|doxorubicin|mesh-list
91932873|NCT03596281|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91932874|NCT03596281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932875|NCT03596281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932876|NCT03596281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91932877|NCT03596281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91932878|NCT03596281|Growth Substances|growth substances|mesh-ancestor
91932879|NCT03596281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932880|NCT03596281|Growth Inhibitors|growth inhibitors|mesh-ancestor
91932881|NCT03596281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91932882|NCT03596281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91932883|NCT03596281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932884|NCT03596281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932885|NCT03596281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932886|NCT03596281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91932888|NCT05172167|Immunologic Factors|immunologic factors|mesh-ancestor
91932889|NCT05172167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932890|NCT02359149|Endothelial Growth Factors|endothelial growth factors|mesh-list
91932891|NCT02359149|Growth Substances|growth substances|mesh-ancestor
91932892|NCT02359149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932893|NCT02221583|Mycophenolic Acid|mycophenolic acid|mesh-list
91932894|NCT02221583|Tacrolimus|tacrolimus|mesh-list
91932895|NCT02221583|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932896|NCT02221583|Immunologic Factors|immunologic factors|mesh-ancestor
91932897|NCT02221583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932898|NCT02221583|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91932899|NCT02221583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932900|NCT02221583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932901|NCT02221583|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91932902|NCT02221583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932903|NCT02221583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91932904|NCT02221583|Antitubercular Agents|antitubercular agents|mesh-ancestor
91932905|NCT02221583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932906|NCT02221583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932344|NCT05438953|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91932345|NCT05438953|Antiviral Agents|antiviral agents|mesh-ancestor
91932346|NCT05438953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932347|NCT02852057|Timolol|timolol|mesh-list
91932348|NCT02852057|Dorzolamide|dorzolamide|mesh-list
91932349|NCT02852057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932350|NCT02852057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932351|NCT02852057|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91932352|NCT02852057|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91932353|NCT02852057|Adrenergic Agents|adrenergic agents|mesh-ancestor
91932354|NCT02852057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932355|NCT02852057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932356|NCT02852057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91932357|NCT02852057|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91932358|NCT02852057|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91932359|NCT04020445|Insulin|insulin|mesh-list
91932360|NCT04020445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91932361|NCT04020445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932362|NCT03524833|Amoxicillin|amoxicillin|mesh-list
91932363|NCT03524833|Metronidazole|metronidazole|mesh-list
91932364|NCT03524833|Lansoprazole|lansoprazole|mesh-list
91932365|NCT03524833|Dexlansoprazole|dexlansoprazole|mesh-list
91932366|NCT03524833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932367|NCT03524833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932368|NCT03524833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91932369|NCT03524833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91932370|NCT03524833|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91932371|NCT03524833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932372|NCT03524833|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91932373|NCT03524833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932908|NCT03514069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91932909|NCT03514069|Alkylating Agents|alkylating agents|mesh-ancestor
91932374|NCT03524833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932376|NCT02220647|Linagliptin|linagliptin|mesh-list
91932377|NCT02220647|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91932378|NCT02220647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932380|NCT02220647|Hormones|hormones|mesh-ancestor
91932381|NCT02220647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91932382|NCT02220647|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91932383|NCT02220647|Protease Inhibitors|protease inhibitors|mesh-ancestor
91932384|NCT02220647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932385|NCT02220647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932386|NCT05426395|Vitamins|vitamins|mesh-list
91932387|NCT05426395|Hydroxocobalamin|hydroxocobalamin|mesh-list
91932388|NCT05426395|Vitamin B 12|vitamin b 12|mesh-list
91932389|NCT05426395|Vitamin B Complex|vitamin b complex|mesh-list
91932390|NCT05426395|Micronutrients|micronutrients|mesh-ancestor
91932391|NCT05426395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932392|NCT05426395|Hematinics|hematinics|mesh-ancestor
91932393|NCT03544567|Paclitaxel|paclitaxel|mesh-list
91932394|NCT03544567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91932395|NCT03544567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932396|NCT03544567|Tubulin Modulators|tubulin modulators|mesh-ancestor
91932397|NCT03544567|Antimitotic Agents|antimitotic agents|mesh-ancestor
91932398|NCT03544567|Mitosis Modulators|mitosis modulators|mesh-ancestor
91932399|NCT03544567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932400|NCT02209025|Theobromine|theobromine|mesh-list
91932401|NCT02209025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91932402|NCT02209025|Autonomic Agents|autonomic agents|mesh-ancestor
91932403|NCT02209025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932404|NCT02209025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932405|NCT02209025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91932406|NCT02209025|Respiratory System Agents|respiratory system agents|mesh-ancestor
91932407|NCT02209025|Vasodilator Agents|vasodilator agents|mesh-ancestor
91932409|NCT02220803|Anticonvulsants|anticonvulsants|mesh-ancestor
91932910|NCT03514069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932911|NCT03514069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932912|NCT03500731|Rituximab|rituximab|mesh-list
91932913|NCT03500731|Alemtuzumab|alemtuzumab|mesh-list
91932914|NCT03500731|Fludarabine|fludarabine|mesh-list
91932915|NCT03500731|Thiotepa|thiotepa|mesh-list
91932916|NCT03500731|Hydroxyurea|hydroxyurea|mesh-list
91932917|NCT03500731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91932918|NCT03500731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932919|NCT03500731|Immunologic Factors|immunologic factors|mesh-ancestor
91932920|NCT03500731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932921|NCT03500731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91932922|NCT03500731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932923|NCT03500731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91932924|NCT03500731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91932926|NCT03500731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91932927|NCT03500731|Antisickling Agents|antisickling agents|mesh-ancestor
91932928|NCT03500731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932929|NCT03500731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91932930|NCT02751359|Cannabidiol|cannabidiol|mesh-list
91932931|NCT02751359|Anticonvulsants|anticonvulsants|mesh-ancestor
91932932|NCT02358993|Ciprofloxacin|ciprofloxacin|mesh-list
91932933|NCT02358993|Methenamine hippurate|methenamine hippurate|mesh-list
91932934|NCT02358993|Methenamine mandelate|methenamine mandelate|mesh-list
91932935|NCT02358993|Methenamine|methenamine|mesh-list
91932936|NCT02358993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91932937|NCT02358993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91932938|NCT02358993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91932939|NCT02358993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91932940|NCT02358993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932941|NCT02358993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932942|NCT02358993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932943|NCT02358993|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91932944|NCT02358993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91932945|NCT02358993|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91932947|NCT04059445|Calcium|calcium|mesh-list
91932948|NCT04059445|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91932949|NCT04059445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932950|NCT04059445|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91932951|NCT03395197|Talazoparib|talazoparib|mesh-list
91932952|NCT03395197|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91932953|NCT03395197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932954|NCT03395197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932955|NCT03395197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91932959|NCT05092841|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91932960|NCT05092841|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91932961|NCT05092841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932962|NCT05092841|Sensory System Agents|sensory system agents|mesh-ancestor
91932963|NCT05092841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932964|NCT05092841|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91932965|NCT05092841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91932966|NCT05092841|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91932968|NCT05092841|GABA Agents|gaba agents|mesh-ancestor
91932969|NCT05092841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91932970|NCT05092841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932972|NCT05092841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932973|NCT02224937|Melatonin|melatonin|mesh-list
91932975|NCT02224937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932976|NCT02224937|Protective Agents|protective agents|mesh-ancestor
91932977|NCT02224937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932978|NCT02224937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932979|NCT02290327|Pantoprazole|pantoprazole|mesh-list
91932980|NCT02290327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91932981|NCT02290327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91932982|NCT02290327|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91932983|NCT02290327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91932984|NCT02290327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932985|NCT02372955|Dapagliflozin|dapagliflozin|mesh-list
91932986|NCT02372955|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91932987|NCT02372955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91932988|NCT02372955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91932989|NCT02372955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932990|NCT02358057|Dexmedetomidine|dexmedetomidine|mesh-list
91932991|NCT02358057|Alfentanil|alfentanil|mesh-list
91932992|NCT02358057|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91932993|NCT02358057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91932994|NCT02358057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91932995|NCT02358057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91932996|NCT02358057|Analgesics|analgesics|mesh-ancestor
91932997|NCT02358057|Sensory System Agents|sensory system agents|mesh-ancestor
91932998|NCT02358057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91932999|NCT02358057|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91933000|NCT02358057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91933001|NCT02358057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91933002|NCT02358057|Adrenergic Agents|adrenergic agents|mesh-ancestor
91933003|NCT02358057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933004|NCT02358057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933005|NCT02358057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91933006|NCT02358057|Narcotics|narcotics|mesh-ancestor
91933007|NCT02358057|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91933008|NCT02358057|Anesthetics, General|anesthetics, general|mesh-ancestor
91933012|NCT02225093|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91933013|NCT02225093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933014|NCT02225093|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91933015|NCT02225093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933016|NCT02225093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933017|NCT02225093|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91933018|NCT02225093|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91933019|NCT02225093|Purinergic Agents|purinergic agents|mesh-ancestor
91933020|NCT02225093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933021|NCT02225093|Antitussive Agents|antitussive agents|mesh-ancestor
91933022|NCT02225093|Respiratory System Agents|respiratory system agents|mesh-ancestor
91933023|NCT02225093|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91933024|NCT02225093|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91933025|NCT02212535|Plerixafor|plerixafor|mesh-list
91933027|NCT02212535|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91933028|NCT02212535|Antiviral Agents|antiviral agents|mesh-ancestor
91933029|NCT02212535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933030|NCT02372487|Sildenafil Citrate|sildenafil citrate|mesh-list
91933031|NCT02372487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933032|NCT02372487|Vasodilator Agents|vasodilator agents|mesh-ancestor
91933033|NCT02372487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91933034|NCT02372487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91933035|NCT02372487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933036|NCT02372487|Urological Agents|urological agents|mesh-ancestor
91933039|NCT02361177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91933040|NCT02361177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933041|NCT05055713|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91933042|NCT05055713|Somatostatin|somatostatin|mesh-list
91933043|NCT05055713|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91933044|NCT05055713|Adrenergic Agents|adrenergic agents|mesh-ancestor
91933045|NCT05055713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933046|NCT05055713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933047|NCT05055713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933048|NCT05055713|Hormones|hormones|mesh-ancestor
91933049|NCT05055713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933050|NCT02360709|Sirolimus|sirolimus|mesh-list
91933051|NCT02360709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91933052|NCT02360709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933053|NCT02360709|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91933054|NCT02360709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933055|NCT02360709|Antifungal Agents|antifungal agents|mesh-ancestor
91933056|NCT02360709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91933057|NCT02360709|Immunologic Factors|immunologic factors|mesh-ancestor
91933058|NCT02360709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933059|NCT04624113|Pembrolizumab|pembrolizumab|mesh-list
91933060|NCT04624113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91933061|NCT04624113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933062|NCT04624113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91933063|NCT04624113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933064|NCT05030519|Trastuzumab|trastuzumab|mesh-list
91933065|NCT05030519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91933066|NCT05030519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933068|NCT02357277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933069|NCT02357277|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91933070|NCT02357277|Autonomic Agents|autonomic agents|mesh-ancestor
91933071|NCT02357277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933072|NCT02357277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933073|NCT02357277|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91933074|NCT02357277|Respiratory System Agents|respiratory system agents|mesh-ancestor
91933075|NCT02357277|Glucocorticoids|glucocorticoids|mesh-ancestor
91933076|NCT02357277|Hormones|hormones|mesh-ancestor
91933077|NCT02357277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933078|NCT02222441|Pioglitazone|pioglitazone|mesh-list
91933079|NCT02222441|Palbociclib|palbociclib|mesh-list
91933080|NCT02222441|Modafinil|modafinil|mesh-list
91933081|NCT02222441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91933082|NCT02222441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933083|NCT02222441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933084|NCT02222441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91933085|NCT02222441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933086|NCT02222441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933087|NCT02222441|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91933162|NCT02220023|Nitric Oxide|nitric oxide|mesh-list
91933088|NCT02222441|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
91933089|NCT02222441|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91933090|NCT02222441|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91933091|NCT02290717|Fluticasone|fluticasone|mesh-list
91933092|NCT02290717|Xhance|xhance|mesh-list
91933093|NCT02290717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933094|NCT02290717|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91933095|NCT02290717|Autonomic Agents|autonomic agents|mesh-ancestor
91933096|NCT02290717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933097|NCT02290717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933098|NCT02290717|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91933099|NCT02290717|Respiratory System Agents|respiratory system agents|mesh-ancestor
91933100|NCT02290717|Dermatologic Agents|dermatologic agents|mesh-ancestor
91933101|NCT02290717|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91933102|NCT02225795|Cyclophosphamide|cyclophosphamide|mesh-list
91933103|NCT02225795|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91933104|NCT02225795|Thymoglobulin|thymoglobulin|mesh-list
91933105|NCT02225795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91933106|NCT02225795|Immunologic Factors|immunologic factors|mesh-ancestor
91933107|NCT02225795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933108|NCT02225795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91933109|NCT02225795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91933110|NCT02225795|Alkylating Agents|alkylating agents|mesh-ancestor
91933111|NCT02225795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933112|NCT02225795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933113|NCT02225795|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91933114|NCT02360007|Buprenorphine|buprenorphine|mesh-list
91933115|NCT02360007|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91933116|NCT02360007|Narcotics|narcotics|mesh-ancestor
91933117|NCT02360007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933118|NCT02360007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933120|NCT02360007|Sensory System Agents|sensory system agents|mesh-ancestor
91933121|NCT02360007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933122|NCT02360007|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91933123|NCT02294305|Vortioxetine|vortioxetine|mesh-list
91933124|NCT02294305|Antidepressive Agents|antidepressive agents|mesh-ancestor
91933125|NCT02294305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933126|NCT02294305|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91933127|NCT02294305|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91933128|NCT02294305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933129|NCT02294305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933130|NCT02294305|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91933131|NCT02294305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91933132|NCT02294305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933133|NCT02294305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933134|NCT02294305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933135|NCT02294305|Serotonin Agents|serotonin agents|mesh-ancestor
91933136|NCT02294305|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91933137|NCT02294305|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91933138|NCT02294305|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91933139|NCT02294305|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91933140|NCT01672255|Fluoxetine|fluoxetine|mesh-list
91933141|NCT01672255|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91933142|NCT01672255|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91933143|NCT01672255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933144|NCT01672255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933145|NCT01672255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933146|NCT01672255|Serotonin Agents|serotonin agents|mesh-ancestor
91933147|NCT01672255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933148|NCT01672255|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91933149|NCT01672255|Antidepressive Agents|antidepressive agents|mesh-ancestor
91933150|NCT01672255|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933151|NCT01672255|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91933152|NCT01672255|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91933153|NCT01672255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933154|NCT02222519|Bromides|bromides|mesh-list
91933155|NCT02222519|Rocuronium|rocuronium|mesh-list
91933156|NCT02222519|Anticonvulsants|anticonvulsants|mesh-ancestor
91933157|NCT02222519|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91933158|NCT02222519|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91933159|NCT02222519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91933160|NCT02222519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933161|NCT02222519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933163|NCT02220023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91933164|NCT02220023|Autonomic Agents|autonomic agents|mesh-ancestor
91933165|NCT02220023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933166|NCT02220023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933167|NCT02220023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91933168|NCT02220023|Respiratory System Agents|respiratory system agents|mesh-ancestor
91933169|NCT02220023|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91933170|NCT02220023|Antioxidants|antioxidants|mesh-ancestor
91933171|NCT02220023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933172|NCT02220023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933173|NCT02220023|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91933174|NCT02220023|Vasodilator Agents|vasodilator agents|mesh-ancestor
91933175|NCT02220023|Gasotransmitters|gasotransmitters|mesh-ancestor
91933176|NCT02220023|Protective Agents|protective agents|mesh-ancestor
91933177|NCT02356965|Ketamine|ketamine|mesh-list
91933178|NCT02356965|Analgesics|analgesics|mesh-ancestor
91933179|NCT02356965|Sensory System Agents|sensory system agents|mesh-ancestor
91933180|NCT02356965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933181|NCT02356965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933182|NCT02356965|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91933183|NCT02356965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91933184|NCT02356965|Anesthetics, General|anesthetics, general|mesh-ancestor
91933185|NCT02356965|Anesthetics|anesthetics|mesh-ancestor
91933186|NCT02356965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933187|NCT02356965|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91933188|NCT02356965|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91933189|NCT02356965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933190|NCT02356965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933191|NCT02359695|Hormones|hormones|mesh-list
91933192|NCT02359695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933193|NCT02359695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933194|NCT02294539|Losartan|losartan|mesh-list
91933195|NCT02294539|Amlodipine|amlodipine|mesh-list
91933196|NCT02294539|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91933197|NCT02294539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91933198|NCT02294539|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91933199|NCT02294539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933200|NCT02294539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933201|NCT02294539|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91933202|NCT02294539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933203|NCT02294539|Vasodilator Agents|vasodilator agents|mesh-ancestor
91933204|NCT02294539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91933205|NCT02294539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91933206|NCT02294539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91933207|NCT02294539|Diuretics|diuretics|mesh-ancestor
91933208|NCT02294539|Natriuretic Agents|natriuretic agents|mesh-ancestor
91933209|NCT02294539|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91933210|NCT02359617|Insulin|insulin|mesh-list
91933211|NCT02359617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91933212|NCT02359617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933213|NCT03154125|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
91933214|NCT03154125|Medroxyprogesterone|medroxyprogesterone|mesh-list
91933215|NCT03154125|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91933216|NCT03154125|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91933217|NCT03154125|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91933218|NCT03154125|Contraceptive Agents|contraceptive agents|mesh-ancestor
91933219|NCT03154125|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91933220|NCT03154125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933221|NCT03154125|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91933222|NCT03154125|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91933223|NCT03154125|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91933224|NCT03154125|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91933225|NCT03154125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933227|NCT02294617|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91933228|NCT02294617|Autonomic Agents|autonomic agents|mesh-ancestor
91933229|NCT02294617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933230|NCT02294617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933231|NCT02294617|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91933232|NCT02294617|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91933233|NCT02294617|Cholinergic Agents|cholinergic agents|mesh-ancestor
91933234|NCT02294617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933235|NCT02294617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933236|NCT02291341|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91933237|NCT02291341|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91933238|NCT02291341|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91943495|NCT00501826|Protease Inhibitors|protease inhibitors|mesh-ancestor
91933239|NCT02291341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933240|NCT02291341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933241|NCT02291341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933242|NCT02291341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933243|NCT02291341|Analgesics|analgesics|mesh-ancestor
91933244|NCT02291341|Sensory System Agents|sensory system agents|mesh-ancestor
91933245|NCT02291341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933246|NCT02291341|Antidepressive Agents|antidepressive agents|mesh-ancestor
91933247|NCT02291341|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933248|NCT02291341|Dopamine Agents|dopamine agents|mesh-ancestor
91933249|NCT02352987|Salicylic Acid|salicylic acid|mesh-list
91933250|NCT02352987|Salicylates|salicylates|mesh-list
91933251|NCT02352987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933252|NCT02352987|Antifungal Agents|antifungal agents|mesh-ancestor
91933253|NCT02352987|Keratolytic Agents|keratolytic agents|mesh-ancestor
91933254|NCT02352987|Dermatologic Agents|dermatologic agents|mesh-ancestor
91933255|NCT02352987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91933256|NCT02352987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91933257|NCT02352987|Analgesics|analgesics|mesh-ancestor
91933258|NCT02352987|Sensory System Agents|sensory system agents|mesh-ancestor
91933259|NCT02352987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933260|NCT02352987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933261|NCT02352987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933262|NCT02352987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91933263|NCT02352987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91933264|NCT02352987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933265|NCT02352987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933266|NCT02226341|Mycophenolic Acid|mycophenolic acid|mesh-list
91933267|NCT02226341|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91933268|NCT02226341|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91933269|NCT02226341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933270|NCT02226341|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91933271|NCT02226341|Antitubercular Agents|antitubercular agents|mesh-ancestor
91933272|NCT02226341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91933273|NCT02226341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933274|NCT02226341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933275|NCT02226341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933277|NCT02226341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933278|NCT02226341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933279|NCT02222987|Clopidogrel|clopidogrel|mesh-list
91933280|NCT02222987|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91933281|NCT02222987|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91933282|NCT02222987|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91933283|NCT02222987|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91933284|NCT02222987|Purinergic Agents|purinergic agents|mesh-ancestor
91933285|NCT02222987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933286|NCT02222987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933287|NCT02222987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933288|NCT03521245|Trastuzumab|trastuzumab|mesh-list
91933289|NCT03521245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91933290|NCT03521245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933291|NCT02481245|Bezafibrate|bezafibrate|mesh-list
91933292|NCT02481245|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91933293|NCT02481245|Antimetabolites|antimetabolites|mesh-ancestor
91933294|NCT02481245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933295|NCT02481245|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91933296|NCT02352597|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91933297|NCT02352597|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91933298|NCT02352597|Clomiphene|clomiphene|mesh-list
91933299|NCT02352597|Enclomiphene|enclomiphene|mesh-list
91933300|NCT02352597|Zuclomiphene|zuclomiphene|mesh-list
91933301|NCT02352597|Estradiol|estradiol|mesh-list
91933302|NCT02352597|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91933303|NCT02352597|Phytoestrogens|phytoestrogens|mesh-list
91933304|NCT02352597|Estrogens|estrogens|mesh-ancestor
91933306|NCT02352597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933307|NCT02352597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933308|NCT02352597|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91933309|NCT02352597|Contraceptive Agents|contraceptive agents|mesh-ancestor
91933310|NCT02352597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91933311|NCT02352597|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91933312|NCT02352597|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91933313|NCT02352597|Hormone Antagonists|hormone antagonists|mesh-ancestor
91933314|NCT02352597|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91933315|NCT02352597|Fertility Agents|fertility agents|mesh-ancestor
91933316|NCT02352597|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91933317|NCT02352597|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91933318|NCT02352597|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91933319|NCT03521167|Acetaminophen|acetaminophen|mesh-list
91933320|NCT03521167|Lidocaine|lidocaine|mesh-list
91933321|NCT03521167|Dexmedetomidine|dexmedetomidine|mesh-list
91933322|NCT03521167|Ketamine|ketamine|mesh-list
91933323|NCT03521167|Gabapentin|gabapentin|mesh-list
91933324|NCT03521167|Anesthetics, Local|anesthetics, local|mesh-ancestor
91933325|NCT03521167|Anesthetics|anesthetics|mesh-ancestor
91933326|NCT03521167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933327|NCT03521167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933328|NCT03521167|Sensory System Agents|sensory system agents|mesh-ancestor
91933329|NCT03521167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933330|NCT03521167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91933331|NCT03521167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91933332|NCT03521167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91933333|NCT03521167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933334|NCT03521167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933335|NCT03521167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91933336|NCT03521167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91933337|NCT03521167|Analgesics|analgesics|mesh-ancestor
91933338|NCT03521167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91933339|NCT03521167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91933340|NCT03521167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91933341|NCT03521167|Adrenergic Agents|adrenergic agents|mesh-ancestor
91933342|NCT03521167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933343|NCT03521167|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91933344|NCT03521167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91933345|NCT03521167|Anesthetics, General|anesthetics, general|mesh-ancestor
91933346|NCT03521167|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91933347|NCT03521167|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91933348|NCT03521167|Anticonvulsants|anticonvulsants|mesh-ancestor
91933349|NCT03521167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91933350|NCT03521167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91933351|NCT03521167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933352|NCT03521167|Antimanic Agents|antimanic agents|mesh-ancestor
91933353|NCT03521167|Antipyretics|antipyretics|mesh-ancestor
91933354|NCT02352519|Anesthetics|anesthetics|mesh-list
91933355|NCT02352519|Anesthetics, Local|anesthetics, local|mesh-list
91933356|NCT02352519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933357|NCT02352519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933358|NCT02352519|Sensory System Agents|sensory system agents|mesh-ancestor
91933359|NCT02352519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933360|NCT02356419|Epoetin Alfa|epoetin alfa|mesh-list
91933361|NCT02356419|Hematinics|hematinics|mesh-ancestor
91933362|NCT02220335|Digoxin|digoxin|mesh-list
91933363|NCT02220335|Diuretics|diuretics|mesh-list
91933364|NCT02220335|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91933365|NCT02220335|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
91933366|NCT02220335|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91933367|NCT02220335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91933368|NCT02220335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933369|NCT02220335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933370|NCT02220335|Protective Agents|protective agents|mesh-ancestor
91933371|NCT02220335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933372|NCT02220335|Natriuretic Agents|natriuretic agents|mesh-ancestor
91933373|NCT02220335|Protease Inhibitors|protease inhibitors|mesh-ancestor
91933374|NCT02220335|Hormone Antagonists|hormone antagonists|mesh-ancestor
91933375|NCT02220335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933376|NCT02220335|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91933377|NCT02291731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91933378|NCT02291731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91933379|NCT02223299|Tryptophan|tryptophan|mesh-list
91933380|NCT02223299|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91933381|NCT02223299|Antidepressive Agents|antidepressive agents|mesh-ancestor
91933382|NCT02223299|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933383|NCT02356341|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91933384|NCT02356341|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91933385|NCT02223377|Morphine|morphine|mesh-list
91933389|NCT02223377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933390|NCT02223377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933391|NCT02223377|Analgesics|analgesics|mesh-ancestor
91933392|NCT02223377|Sensory System Agents|sensory system agents|mesh-ancestor
91933393|NCT02223377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933394|NCT02291887|Ranibizumab|ranibizumab|mesh-list
91933395|NCT02291887|Aflibercept|aflibercept|mesh-list
91933396|NCT02291887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91933397|NCT02291887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91933398|NCT02291887|Growth Substances|growth substances|mesh-ancestor
91933399|NCT02291887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933400|NCT02291887|Growth Inhibitors|growth inhibitors|mesh-ancestor
91933401|NCT02291887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933402|NCT02352285|Tolvaptan|tolvaptan|mesh-list
91933403|NCT02352285|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91933404|NCT02352285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933405|NCT02352285|Natriuretic Agents|natriuretic agents|mesh-ancestor
91933406|NCT02352285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933407|NCT03521713|Epoetin Alfa|epoetin alfa|mesh-list
91933408|NCT03521713|Hematinics|hematinics|mesh-ancestor
91933409|NCT02223533|Morphine|morphine|mesh-list
91933410|NCT02223533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91933411|NCT02223533|Narcotics|narcotics|mesh-ancestor
91933412|NCT02223533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933413|NCT02223533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933414|NCT02223533|Analgesics|analgesics|mesh-ancestor
91933415|NCT02223533|Sensory System Agents|sensory system agents|mesh-ancestor
91933416|NCT02223533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933417|NCT02231021|Pioglitazone|pioglitazone|mesh-list
91933418|NCT02231021|Alogliptin|alogliptin|mesh-list
91933419|NCT02231021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91933420|NCT02231021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933421|NCT02231021|Incretins|incretins|mesh-ancestor
91933422|NCT02231021|Hormones|hormones|mesh-ancestor
91933423|NCT02231021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933424|NCT02231021|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91933425|NCT02231021|Protease Inhibitors|protease inhibitors|mesh-ancestor
91933426|NCT02231021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933427|NCT02231021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933428|NCT04465123|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91933429|NCT04465123|Spironolactone|spironolactone|mesh-list
91933430|NCT04465123|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91933431|NCT04465123|Diuretics|diuretics|mesh-ancestor
91933432|NCT04465123|Natriuretic Agents|natriuretic agents|mesh-ancestor
91933433|NCT04465123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933434|NCT04465123|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91933435|NCT04465123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933436|NCT04465123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933437|NCT04465123|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91933438|NCT04465123|Hormone Antagonists|hormone antagonists|mesh-ancestor
91933439|NCT04465123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933440|NCT04465123|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91933441|NCT02401347|Talazoparib|talazoparib|mesh-list
91933442|NCT02401347|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91933443|NCT02401347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933444|NCT02401347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933445|NCT02401347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933448|NCT02231255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933449|NCT02231255|Protective Agents|protective agents|mesh-ancestor
91933450|NCT02231255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933451|NCT02231255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91933452|NCT02231255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91933453|NCT02231255|Dopamine Agonists|dopamine agonists|mesh-ancestor
91933454|NCT02231255|Dopamine Agents|dopamine agents|mesh-ancestor
91933455|NCT02231255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933456|NCT02352051|Methylphenidate|methylphenidate|mesh-list
91933457|NCT02352051|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91933458|NCT02352051|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91933459|NCT02352051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933460|NCT02352051|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91933461|NCT02352051|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91933462|NCT02352051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933772|NCT02231957|Immunologic Factors|immunologic factors|mesh-ancestor
91933463|NCT02352051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933464|NCT02352051|Dopamine Agents|dopamine agents|mesh-ancestor
91933465|NCT02352051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933466|NCT02352051|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91933467|NCT02352051|Adrenergic Agents|adrenergic agents|mesh-ancestor
91933468|NCT02227277|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91933469|NCT02227277|Interferon alpha-2|interferon alpha-2|mesh-list
91933470|NCT02227277|Antiviral Agents|antiviral agents|mesh-ancestor
91933471|NCT02227277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933472|NCT02227277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933473|NCT03147183|Thymoglobulin|thymoglobulin|mesh-list
91933474|NCT03147183|Immunologic Factors|immunologic factors|mesh-ancestor
91933475|NCT03147183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933476|NCT03147183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91933478|NCT02292121|Lactitol|lactitol|mesh-list
91933479|NCT02292121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91933480|NCT02292121|Diuretics|diuretics|mesh-ancestor
91933481|NCT02292121|Natriuretic Agents|natriuretic agents|mesh-ancestor
91933482|NCT02292121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933483|NCT02292121|Cathartics|cathartics|mesh-ancestor
91933484|NCT02292121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933485|NCT02223611|Cisplatin|cisplatin|mesh-list
91933486|NCT02223611|Vinorelbine|vinorelbine|mesh-list
91933487|NCT02223611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933488|NCT02223611|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91933489|NCT02223611|Tubulin Modulators|tubulin modulators|mesh-ancestor
91933490|NCT02223611|Antimitotic Agents|antimitotic agents|mesh-ancestor
91933491|NCT02223611|Mitosis Modulators|mitosis modulators|mesh-ancestor
91933492|NCT02223611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933493|NCT02231333|Pentoxifylline|pentoxifylline|mesh-list
91933494|NCT02231333|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91933495|NCT02231333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933496|NCT02231333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933497|NCT02231333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91933498|NCT02231333|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91933500|NCT02231333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933501|NCT02231333|Vasodilator Agents|vasodilator agents|mesh-ancestor
91933502|NCT02231333|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91933503|NCT02231333|Antioxidants|antioxidants|mesh-ancestor
91933504|NCT02227433|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91933505|NCT02227433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91933506|NCT02227433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933507|NCT02227433|Immunotoxins|immunotoxins|mesh-ancestor
91933508|NCT02227433|Immunoconjugates|immunoconjugates|mesh-ancestor
91933509|NCT02227433|Immunologic Factors|immunologic factors|mesh-ancestor
91933510|NCT02227433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933511|NCT02351973|Amiloride|amiloride|mesh-list
91933512|NCT02351973|Diuretics|diuretics|mesh-ancestor
91933513|NCT02351973|Natriuretic Agents|natriuretic agents|mesh-ancestor
91933514|NCT02351973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933515|NCT02351973|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
91933517|NCT02351973|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933518|NCT02351973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933519|NCT02351973|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
91933520|NCT02351973|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91933521|NCT04831619|Deoxyglucose|deoxyglucose|mesh-list
91933522|NCT04831619|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91933523|NCT04831619|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91933524|NCT04831619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933526|NCT04831619|Antiviral Agents|antiviral agents|mesh-ancestor
91933527|NCT04831619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933529|NCT03520543|Yohimbine|yohimbine|mesh-list
91933530|NCT03520543|Analgesics|analgesics|mesh-ancestor
91933531|NCT03520543|Sensory System Agents|sensory system agents|mesh-ancestor
91933532|NCT03520543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933533|NCT03520543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933534|NCT03520543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91933535|NCT03520543|Sympatholytics|sympatholytics|mesh-ancestor
91933536|NCT03520543|Autonomic Agents|autonomic agents|mesh-ancestor
91933537|NCT03520543|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91933538|NCT03520543|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91933539|NCT03520543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91933540|NCT03520543|Adrenergic Agents|adrenergic agents|mesh-ancestor
91933541|NCT03520543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933542|NCT03520543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933544|NCT03520543|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91933545|NCT03520543|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91933546|NCT03520543|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91933547|NCT03520543|Urological Agents|urological agents|mesh-ancestor
91933548|NCT02355639|Betamethasone|betamethasone|mesh-list
91933549|NCT02355639|Betamethasone Valerate|betamethasone valerate|mesh-list
91933550|NCT02355639|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91933551|NCT02355639|Betamethasone benzoate|betamethasone benzoate|mesh-list
91933552|NCT02355639|Clobetasol|clobetasol|mesh-list
91933553|NCT02355639|Petrolatum|petrolatum|mesh-list
91933554|NCT02355639|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91933555|NCT02355639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933556|NCT02355639|Glucocorticoids|glucocorticoids|mesh-ancestor
91933557|NCT02355639|Hormones|hormones|mesh-ancestor
91933558|NCT02355639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933559|NCT02355639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933560|NCT02355639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91933561|NCT02355639|Respiratory System Agents|respiratory system agents|mesh-ancestor
91933562|NCT02355639|Emollients|emollients|mesh-ancestor
91933563|NCT02355639|Dermatologic Agents|dermatologic agents|mesh-ancestor
91933564|NCT02351895|Copper|copper|mesh-list
91933565|NCT02351895|Trace Elements|trace elements|mesh-ancestor
91933566|NCT02351895|Micronutrients|micronutrients|mesh-ancestor
91933567|NCT02351895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933568|NCT00503035|Celecoxib|celecoxib|mesh-list
91933569|NCT00503035|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91933570|NCT00503035|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91933571|NCT00503035|Analgesics|analgesics|mesh-ancestor
91933572|NCT00503035|Sensory System Agents|sensory system agents|mesh-ancestor
91933573|NCT00503035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933574|NCT00503035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933575|NCT00503035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933576|NCT00503035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91933577|NCT00503035|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91933578|NCT00503035|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91933579|NCT00503035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933580|NCT00503035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933581|NCT02227745|Dorzolamide|dorzolamide|mesh-list
91933582|NCT02227745|Hyaluronic Acid|hyaluronic acid|mesh-list
91933583|NCT02227745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91933584|NCT02227745|Immunologic Factors|immunologic factors|mesh-ancestor
91933585|NCT02227745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933586|NCT02227745|Viscosupplements|viscosupplements|mesh-ancestor
91933587|NCT02227745|Protective Agents|protective agents|mesh-ancestor
91933588|NCT02227745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91933589|NCT02227745|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91933590|NCT02227745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933591|NCT02227745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933592|NCT03517033|Nebivolol|nebivolol|mesh-list
91933593|NCT03517033|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91933594|NCT03517033|Vasodilator Agents|vasodilator agents|mesh-ancestor
91933595|NCT03517033|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91933596|NCT03517033|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91933597|NCT03517033|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91933598|NCT03517033|Adrenergic Agents|adrenergic agents|mesh-ancestor
91933599|NCT03517033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933600|NCT03517033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933601|NCT03517033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933602|NCT03516955|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91933603|NCT03516955|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91933604|NCT03516955|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91933606|NCT03516955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933607|NCT03516955|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91933608|NCT03516955|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91933609|NCT03516955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933610|NCT02259179|Naltrexone|naltrexone|mesh-list
91933611|NCT02259179|Bupropion|bupropion|mesh-list
91933612|NCT02259179|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91933613|NCT02259179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91933614|NCT02259179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933615|NCT02259179|Sensory System Agents|sensory system agents|mesh-ancestor
91933616|NCT02259179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933617|NCT02259179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91933618|NCT02259179|Antidepressive Agents|antidepressive agents|mesh-ancestor
91933619|NCT02259179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933620|NCT02259179|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91933621|NCT02259179|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91933622|NCT02259179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933623|NCT02259179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933624|NCT02259179|Dopamine Agents|dopamine agents|mesh-ancestor
91933625|NCT02259179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933626|NCT02259179|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91933627|NCT02259179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91943548|NCT02256982|Cisplatin|cisplatin|mesh-list
91933628|NCT02259179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933630|NCT02355093|Anesthetics, Local|anesthetics, local|mesh-ancestor
91933631|NCT02355093|Anesthetics|anesthetics|mesh-ancestor
91933632|NCT02355093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933633|NCT02355093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933634|NCT02355093|Sensory System Agents|sensory system agents|mesh-ancestor
91933635|NCT02355093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933636|NCT02227823|Bromides|bromides|mesh-list
91933637|NCT02227823|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
91933638|NCT02227823|Anticonvulsants|anticonvulsants|mesh-ancestor
91933639|NCT02227823|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91933640|NCT02227823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933641|NCT02227823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933642|NCT02227823|Cholinergic Agents|cholinergic agents|mesh-ancestor
91933643|NCT02227823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933644|NCT02227823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933645|NCT02295475|Warfarin|warfarin|mesh-list
91933646|NCT02295475|Apixaban|apixaban|mesh-list
91933647|NCT02295475|Anticoagulants|anticoagulants|mesh-ancestor
91933648|NCT02295475|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91933649|NCT02295475|Antithrombins|antithrombins|mesh-ancestor
91933650|NCT02295475|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91933651|NCT02295475|Protease Inhibitors|protease inhibitors|mesh-ancestor
91933652|NCT02295475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933653|NCT02295475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933654|NCT02227901|Temozolomide|temozolomide|mesh-list
91933655|NCT02227901|Tipifarnib|tipifarnib|mesh-list
91933656|NCT02227901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91933657|NCT02227901|Alkylating Agents|alkylating agents|mesh-ancestor
91933658|NCT02227901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933659|NCT02227901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933660|NCT03146793|Sodium thiosulfate|sodium thiosulfate|mesh-list
91933661|NCT03146793|Antidotes|antidotes|mesh-ancestor
91933662|NCT03146793|Protective Agents|protective agents|mesh-ancestor
91933663|NCT03146793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933664|NCT03146793|Antioxidants|antioxidants|mesh-ancestor
91933665|NCT03146793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933666|NCT03146793|Antitubercular Agents|antitubercular agents|mesh-ancestor
91933667|NCT03146793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91933668|NCT03146793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933669|NCT03146793|Chelating Agents|chelating agents|mesh-ancestor
91933670|NCT03146793|Sequestering Agents|sequestering agents|mesh-ancestor
91933672|NCT03133195|Teriparatide|teriparatide|mesh-list
91933674|NCT03133195|Parathyroid Hormone|parathyroid hormone|mesh-list
91933675|NCT03133195|Vitamins|vitamins|mesh-ancestor
91933676|NCT03133195|Micronutrients|micronutrients|mesh-ancestor
91933677|NCT03133195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933678|NCT03133195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91933679|NCT03133195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91933680|NCT03159741|Glucagon|glucagon|mesh-list
91933681|NCT03159741|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91933682|NCT03159741|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933683|NCT03159741|Hormones|hormones|mesh-ancestor
91933684|NCT03159741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933685|NCT03159741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933686|NCT03159741|Incretins|incretins|mesh-ancestor
91933687|NCT02292277|Ticagrelor|ticagrelor|mesh-list
91933688|NCT02292277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91933689|NCT02292277|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91933690|NCT02292277|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91933691|NCT02292277|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91933692|NCT02292277|Purinergic Agents|purinergic agents|mesh-ancestor
91933693|NCT02292277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933694|NCT02292277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933695|NCT02292277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933696|NCT02228135|Dexamethasone|dexamethasone|mesh-list
91933697|NCT02228135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933698|NCT02228135|Antiemetics|antiemetics|mesh-ancestor
91933699|NCT02228135|Autonomic Agents|autonomic agents|mesh-ancestor
91933700|NCT02228135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933701|NCT02228135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933702|NCT02228135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933703|NCT02228135|Glucocorticoids|glucocorticoids|mesh-ancestor
91933704|NCT02228135|Hormones|hormones|mesh-ancestor
91933705|NCT02228135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933706|NCT02228135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91933707|NCT02228135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933708|NCT03152877|Bupivacaine|bupivacaine|mesh-list
91933709|NCT03152877|Anesthetics, Local|anesthetics, local|mesh-ancestor
91933710|NCT03152877|Anesthetics|anesthetics|mesh-ancestor
91933711|NCT03152877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933712|NCT03152877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933713|NCT03152877|Sensory System Agents|sensory system agents|mesh-ancestor
91933714|NCT03152877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933715|NCT02295709|Dexamethasone|dexamethasone|mesh-list
91933716|NCT02295709|Dexamethasone acetate|dexamethasone acetate|mesh-list
91933717|NCT02295709|BB 1101|bb 1101|mesh-list
91933718|NCT02295709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933719|NCT02295709|Antiemetics|antiemetics|mesh-ancestor
91933720|NCT02295709|Autonomic Agents|autonomic agents|mesh-ancestor
91933721|NCT02295709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933722|NCT02295709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933723|NCT02295709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933724|NCT02295709|Glucocorticoids|glucocorticoids|mesh-ancestor
91933725|NCT02295709|Hormones|hormones|mesh-ancestor
91933726|NCT02295709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933727|NCT02295709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91933728|NCT02295709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933729|NCT02295709|Protease Inhibitors|protease inhibitors|mesh-ancestor
91933730|NCT02295709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933731|NCT02295709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933732|NCT02354937|Cabotegravir|cabotegravir|mesh-list
91933733|NCT02354937|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91933734|NCT02354937|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91933735|NCT02354937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933736|NCT02354937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933737|NCT02354937|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91933738|NCT02354937|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91933739|NCT02354937|Antiviral Agents|antiviral agents|mesh-ancestor
91933740|NCT02354937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933741|NCT02295787|Ketamine|ketamine|mesh-list
91933742|NCT02295787|Analgesics|analgesics|mesh-ancestor
91933743|NCT02295787|Sensory System Agents|sensory system agents|mesh-ancestor
91933744|NCT02295787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933745|NCT02295787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933746|NCT02295787|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91933747|NCT02295787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91933748|NCT02295787|Anesthetics, General|anesthetics, general|mesh-ancestor
91933749|NCT02295787|Anesthetics|anesthetics|mesh-ancestor
91933750|NCT02295787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933751|NCT02295787|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91933752|NCT02295787|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91933753|NCT02295787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933754|NCT02295787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933755|NCT04464967|Trastuzumab|trastuzumab|mesh-list
91933756|NCT04464967|Cetuximab|cetuximab|mesh-list
91933757|NCT04464967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91933758|NCT04464967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933759|NCT02228369|Osimertinib|osimertinib|mesh-list
91933760|NCT02228369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933761|NCT02228369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91933762|NCT02228369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933763|NCT02228369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933764|NCT03146871|Azacitidine|azacitidine|mesh-list
91933765|NCT03146871|Decitabine|decitabine|mesh-list
91933766|NCT03146871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91933767|NCT03146871|Antimetabolites|antimetabolites|mesh-ancestor
91933768|NCT03146871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933769|NCT03146871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933770|NCT03146871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933771|NCT02231957|Vaccines|vaccines|mesh-list
91933773|NCT02231957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933774|NCT02354547|Cyclophosphamide|cyclophosphamide|mesh-list
91933775|NCT02354547|Topotecan|topotecan|mesh-list
91933776|NCT02354547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91933777|NCT02354547|Immunologic Factors|immunologic factors|mesh-ancestor
91933778|NCT02354547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933779|NCT02354547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91933780|NCT02354547|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91933781|NCT02354547|Alkylating Agents|alkylating agents|mesh-ancestor
91933782|NCT02354547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933783|NCT02354547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933784|NCT02354547|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91933785|NCT02354547|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91933786|NCT02354547|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91933787|NCT02354547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933788|NCT02232035|Diazepam|diazepam|mesh-list
91933789|NCT02232035|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91933790|NCT02232035|Anticonvulsants|anticonvulsants|mesh-ancestor
91933791|NCT02232035|Antiemetics|antiemetics|mesh-ancestor
91933792|NCT02232035|Autonomic Agents|autonomic agents|mesh-ancestor
91933793|NCT02232035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933794|NCT02232035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933795|NCT02232035|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933796|NCT02232035|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91933797|NCT02232035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933798|NCT02232035|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91933799|NCT02232035|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91933800|NCT02232035|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91933801|NCT02232035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91933802|NCT02232035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91933803|NCT02232035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91933804|NCT02232035|Anesthetics, General|anesthetics, general|mesh-ancestor
91933805|NCT02232035|Anesthetics|anesthetics|mesh-ancestor
91933806|NCT02232035|GABA Modulators|gaba modulators|mesh-ancestor
91933807|NCT02232035|GABA Agents|gaba agents|mesh-ancestor
91933808|NCT02232035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933809|NCT02232035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933810|NCT02296021|Amoxicillin|amoxicillin|mesh-list
91933811|NCT02296021|Clarithromycin|clarithromycin|mesh-list
91933812|NCT02296021|Esomeprazole|esomeprazole|mesh-list
91933814|NCT02296021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91933815|NCT02296021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933816|NCT02296021|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91933817|NCT02296021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933818|NCT02296021|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91933819|NCT02296021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933820|NCT02296021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933821|NCT02296021|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91933822|NCT02296021|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91933823|NCT02296021|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91933824|NCT02296021|Antacids|antacids|mesh-ancestor
91933825|NCT02289391|Anesthetics|anesthetics|mesh-list
91933826|NCT02289391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933827|NCT02289391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933828|NCT02354313|Lenalidomide|lenalidomide|mesh-list
91933829|NCT02354313|Immunologic Factors|immunologic factors|mesh-ancestor
91933830|NCT02354313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933831|NCT02354313|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91933832|NCT02354313|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91933833|NCT02354313|Growth Substances|growth substances|mesh-ancestor
91933834|NCT02354313|Growth Inhibitors|growth inhibitors|mesh-ancestor
91933835|NCT02354313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933836|NCT02292667|Acetaminophen|acetaminophen|mesh-list
91933837|NCT02292667|Morphine|morphine|mesh-list
91933838|NCT02292667|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91933839|NCT02292667|Narcotics|narcotics|mesh-ancestor
91933840|NCT02292667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933841|NCT02292667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933842|NCT02292667|Analgesics|analgesics|mesh-ancestor
91933843|NCT02292667|Sensory System Agents|sensory system agents|mesh-ancestor
91933844|NCT02292667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933845|NCT02292667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91933846|NCT02292667|Antipyretics|antipyretics|mesh-ancestor
91933847|NCT02232269|Felodipine|felodipine|mesh-list
91933848|NCT02232269|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91933849|NCT02232269|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91943560|NCT03480607|Antiemetics|antiemetics|mesh-ancestor
91933850|NCT02232269|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91933851|NCT02232269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91933852|NCT02232269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933853|NCT02232269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91933854|NCT02232269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933855|NCT02232269|Vasodilator Agents|vasodilator agents|mesh-ancestor
91933856|NCT04486313|Nitazoxanide|nitazoxanide|mesh-list
91933857|NCT04486313|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91933858|NCT04486313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91933859|NCT02354001|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
91933860|NCT02354001|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91933861|NCT02354001|Hormone Antagonists|hormone antagonists|mesh-ancestor
91933862|NCT02354001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933863|NCT02354001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933864|NCT02354001|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91933865|NCT02354001|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91933866|NCT02354001|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91933867|NCT02347839|Gefitinib|gefitinib|mesh-list
91933868|NCT02347839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933869|NCT02347839|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91933870|NCT02347839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933871|NCT02347839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933872|NCT02289547|Capecitabine|capecitabine|mesh-list
91933873|NCT02289547|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91933874|NCT02289547|Antimetabolites|antimetabolites|mesh-ancestor
91933875|NCT02289547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933876|NCT02289547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933877|NCT02351427|Bortezomib|bortezomib|mesh-list
91933878|NCT02351427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933879|NCT02232971|Glucagon|glucagon|mesh-list
91933880|NCT02232971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933881|NCT02232971|Hormones|hormones|mesh-ancestor
91933882|NCT02232971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933883|NCT02232971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933884|NCT02296333|Ondansetron|ondansetron|mesh-list
91933885|NCT02296333|Antiemetics|antiemetics|mesh-ancestor
91933886|NCT02296333|Autonomic Agents|autonomic agents|mesh-ancestor
91933887|NCT02296333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933888|NCT02296333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933889|NCT02296333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91933890|NCT02296333|Antipruritics|antipruritics|mesh-ancestor
91933891|NCT02296333|Dermatologic Agents|dermatologic agents|mesh-ancestor
91933892|NCT02296333|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91933893|NCT02296333|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91933894|NCT02296333|Serotonin Agents|serotonin agents|mesh-ancestor
91933895|NCT02296333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933896|NCT02296333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933897|NCT03149913|Paclitaxel|paclitaxel|mesh-list
91933898|NCT03149913|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91933899|NCT03149913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933900|NCT03149913|Tubulin Modulators|tubulin modulators|mesh-ancestor
91933901|NCT03149913|Antimitotic Agents|antimitotic agents|mesh-ancestor
91933902|NCT03149913|Mitosis Modulators|mitosis modulators|mesh-ancestor
91933903|NCT03149913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933904|NCT02289703|Rivaroxaban|rivaroxaban|mesh-list
91933906|NCT02289703|Antithrombins|antithrombins|mesh-ancestor
91933907|NCT02289703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91933908|NCT02289703|Protease Inhibitors|protease inhibitors|mesh-ancestor
91933909|NCT02289703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933910|NCT02289703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933912|NCT02232347|Sufentanil|sufentanil|mesh-list
91933913|NCT02232347|Ketamine|ketamine|mesh-list
91933914|NCT02232347|Analgesics|analgesics|mesh-ancestor
91933915|NCT02232347|Sensory System Agents|sensory system agents|mesh-ancestor
91933916|NCT02232347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933917|NCT02232347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933918|NCT02232347|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91933919|NCT02232347|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91933920|NCT02232347|Anesthetics, General|anesthetics, general|mesh-ancestor
91933922|NCT02232347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933923|NCT02232347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91933924|NCT02232347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91933925|NCT02232347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933926|NCT02232347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933927|NCT02232347|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91933928|NCT02232347|Narcotics|narcotics|mesh-ancestor
91933929|NCT02232347|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91933930|NCT03542669|Doxorubicin|doxorubicin|mesh-list
91933931|NCT03542669|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91933932|NCT03542669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933933|NCT03542669|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91933934|NCT03542669|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91933935|NCT03542669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933936|NCT03542669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933937|NCT03146481|Aceclofenac|aceclofenac|mesh-list
91933938|NCT03146481|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91933939|NCT03146481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91933940|NCT03146481|Analgesics|analgesics|mesh-ancestor
91933941|NCT03146481|Sensory System Agents|sensory system agents|mesh-ancestor
91933942|NCT03146481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933943|NCT03146481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933944|NCT03146481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933945|NCT03146481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91933946|NCT03541655|Celecoxib|celecoxib|mesh-list
91933947|NCT03541655|Bupivacaine|bupivacaine|mesh-list
91933948|NCT03541655|Anesthetics, Local|anesthetics, local|mesh-ancestor
91933949|NCT03541655|Anesthetics|anesthetics|mesh-ancestor
91933950|NCT03541655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91933951|NCT03541655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933952|NCT03541655|Sensory System Agents|sensory system agents|mesh-ancestor
91933953|NCT03541655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91933954|NCT03541655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91933955|NCT03541655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91933956|NCT03541655|Analgesics|analgesics|mesh-ancestor
91933957|NCT03541655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91933958|NCT03541655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91933959|NCT03541655|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91933960|NCT03541655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91933961|NCT03541655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933962|NCT03541655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933963|NCT02296411|Glycopyrrolate|glycopyrrolate|mesh-list
91933964|NCT02296411|Bromides|bromides|mesh-list
91933965|NCT02296411|Anticonvulsants|anticonvulsants|mesh-ancestor
91933966|NCT02296411|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91933967|NCT02296411|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91933968|NCT02296411|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91933969|NCT02296411|Cholinergic Agents|cholinergic agents|mesh-ancestor
91933970|NCT02296411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91933971|NCT02296411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933972|NCT02296411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933973|NCT04581473|Paclitaxel|paclitaxel|mesh-list
91933974|NCT04581473|Irinotecan|irinotecan|mesh-list
91933975|NCT04581473|Apatinib|apatinib|mesh-list
91933976|NCT04581473|Antibodies|antibodies|mesh-list
91933977|NCT04581473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91933978|NCT04581473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91933979|NCT04581473|Tubulin Modulators|tubulin modulators|mesh-ancestor
91933980|NCT04581473|Antimitotic Agents|antimitotic agents|mesh-ancestor
91933981|NCT04581473|Mitosis Modulators|mitosis modulators|mesh-ancestor
91933982|NCT04581473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91933983|NCT04581473|Immunologic Factors|immunologic factors|mesh-ancestor
91933984|NCT04581473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933985|NCT04581473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91933986|NCT04581473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91933987|NCT04581473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91933988|NCT04581473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91933989|NCT02229617|Methyltestosterone|methyltestosterone|mesh-list
91933991|NCT02229617|Testosterone undecanoate|testosterone undecanoate|mesh-list
91933992|NCT02229617|Testosterone enanthate|testosterone enanthate|mesh-list
91933993|NCT02229617|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
91933995|NCT02229617|Hormones|hormones|mesh-ancestor
91933996|NCT02229617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91933997|NCT02229617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91933998|NCT02229617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91933999|NCT02229617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934000|NCT02229617|Anabolic Agents|anabolic agents|mesh-ancestor
91934001|NCT02347059|Dopamine|dopamine|mesh-list
91934002|NCT02347059|Levodopa|levodopa|mesh-list
91934003|NCT02347059|Pramipexole|pramipexole|mesh-list
91934006|NCT02347059|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91934008|NCT02347059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934009|NCT02347059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934010|NCT02347059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934011|NCT02347059|Antioxidants|antioxidants|mesh-ancestor
91934012|NCT02347059|Protective Agents|protective agents|mesh-ancestor
91934013|NCT02347059|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91934014|NCT02347059|Sympathomimetics|sympathomimetics|mesh-ancestor
91934015|NCT02347059|Autonomic Agents|autonomic agents|mesh-ancestor
91934016|NCT02347059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934017|NCT02353611|Hydrogen Peroxide|hydrogen peroxide|mesh-list
91934018|NCT02353611|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91934019|NCT02353611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934020|NCT02296567|Bevacizumab|bevacizumab|mesh-list
91934021|NCT02296567|Ranibizumab|ranibizumab|mesh-list
91934022|NCT02296567|Aflibercept|aflibercept|mesh-list
91934023|NCT02296567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934024|NCT02296567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934025|NCT02296567|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91934026|NCT02296567|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91934027|NCT02296567|Growth Substances|growth substances|mesh-ancestor
91934028|NCT02296567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934029|NCT02296567|Growth Inhibitors|growth inhibitors|mesh-ancestor
91934030|NCT02296723|Valganciclovir|valganciclovir|mesh-list
91934031|NCT02296723|Antiviral Agents|antiviral agents|mesh-ancestor
91934032|NCT02296723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934033|NCT02289937|Ropivacaine|ropivacaine|mesh-list
91934034|NCT02289937|Anesthetics, Local|anesthetics, local|mesh-ancestor
91934035|NCT02289937|Anesthetics|anesthetics|mesh-ancestor
91934036|NCT02289937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934037|NCT02289937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934038|NCT02289937|Sensory System Agents|sensory system agents|mesh-ancestor
91934039|NCT02289937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934041|NCT03446807|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91934042|NCT03446807|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91934043|NCT03519061|Budesonide|budesonide|mesh-list
91934044|NCT03519061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934045|NCT03519061|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91934046|NCT03519061|Autonomic Agents|autonomic agents|mesh-ancestor
91934047|NCT03519061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934048|NCT03519061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934049|NCT03519061|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91934050|NCT03519061|Respiratory System Agents|respiratory system agents|mesh-ancestor
91934051|NCT03519061|Glucocorticoids|glucocorticoids|mesh-ancestor
91934052|NCT03519061|Hormones|hormones|mesh-ancestor
91934053|NCT03519061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934055|NCT02229773|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91934056|NCT02229773|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91934057|NCT02229773|Antimetabolites|antimetabolites|mesh-ancestor
91934058|NCT02229773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934059|NCT02229773|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91934060|NCT02229773|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91934061|NCT02229773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934062|NCT02293291|Lithium Carbonate|lithium carbonate|mesh-list
91934063|NCT02293291|Antidepressive Agents|antidepressive agents|mesh-ancestor
91934064|NCT02293291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91934065|NCT02293291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934066|NCT02293291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934067|NCT02293291|Antimanic Agents|antimanic agents|mesh-ancestor
91934068|NCT02293291|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91934069|NCT02293291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934070|NCT02293291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934072|NCT03515707|Podophyllotoxin|podophyllotoxin|mesh-list
91934073|NCT03515707|Etoposide phosphate|etoposide phosphate|mesh-list
91934074|NCT03515707|Busulfan|busulfan|mesh-list
91934075|NCT03515707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91934076|NCT03515707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934077|NCT03515707|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91934078|NCT03515707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91934079|NCT03515707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934080|NCT03515707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934081|NCT03515707|Alkylating Agents|alkylating agents|mesh-ancestor
91934082|NCT03515707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934083|NCT03515707|Immunologic Factors|immunologic factors|mesh-ancestor
91934084|NCT03515707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934085|NCT03515707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91934086|NCT03515707|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91934087|NCT03515707|Keratolytic Agents|keratolytic agents|mesh-ancestor
91934088|NCT03515707|Dermatologic Agents|dermatologic agents|mesh-ancestor
91934089|NCT03515707|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934090|NCT03515707|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934091|NCT03515707|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934093|NCT02298205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934094|NCT02298205|Glucocorticoids|glucocorticoids|mesh-ancestor
91934096|NCT02298205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934097|NCT02298205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934098|NCT02298205|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91934099|NCT02298205|Respiratory System Agents|respiratory system agents|mesh-ancestor
91934100|NCT03514771|Valacyclovir|valacyclovir|mesh-list
91934101|NCT03514771|Isotretinoin|isotretinoin|mesh-list
91934102|NCT03514771|Antiviral Agents|antiviral agents|mesh-ancestor
91934103|NCT03514771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934105|NCT02298283|Prednisone|prednisone|mesh-list
91934106|NCT02298283|Cyclophosphamide|cyclophosphamide|mesh-list
91934107|NCT02298283|Doxorubicin|doxorubicin|mesh-list
91934108|NCT02298283|Etoposide|etoposide|mesh-list
91934109|NCT02298283|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91934110|NCT02298283|Vincristine|vincristine|mesh-list
91934111|NCT02298283|Bleomycin|bleomycin|mesh-list
91934112|NCT02298283|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91934113|NCT02298283|Procarbazine|procarbazine|mesh-list
91934114|NCT02298283|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934115|NCT02298283|Immunologic Factors|immunologic factors|mesh-ancestor
91934116|NCT02298283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934117|NCT02298283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934118|NCT02298283|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91934119|NCT02298283|Alkylating Agents|alkylating agents|mesh-ancestor
91934120|NCT02298283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934121|NCT02298283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934122|NCT02298283|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91934123|NCT02298283|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91934124|NCT02298283|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91934125|NCT02298283|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91934126|NCT02298283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934127|NCT02298283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934128|NCT02298283|Glucocorticoids|glucocorticoids|mesh-ancestor
91934129|NCT02298283|Hormones|hormones|mesh-ancestor
91934130|NCT02298283|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934131|NCT02298283|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91934132|NCT02298283|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91934133|NCT02298283|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934134|NCT02298283|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934135|NCT02298283|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934136|NCT02298283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934137|NCT02298283|Immunotoxins|immunotoxins|mesh-ancestor
91934138|NCT02298283|Immunoconjugates|immunoconjugates|mesh-ancestor
91934139|NCT02346357|Ropivacaine|ropivacaine|mesh-list
91934140|NCT02346357|Anesthetics, Local|anesthetics, local|mesh-ancestor
91934141|NCT02346357|Anesthetics|anesthetics|mesh-ancestor
91934142|NCT02346357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934143|NCT02346357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934144|NCT02346357|Sensory System Agents|sensory system agents|mesh-ancestor
91934145|NCT02346357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934146|NCT03146247|Apremilast|apremilast|mesh-list
91934147|NCT03146247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91934148|NCT03146247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934149|NCT03146247|Analgesics|analgesics|mesh-ancestor
91934150|NCT03146247|Sensory System Agents|sensory system agents|mesh-ancestor
91934151|NCT03146247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934152|NCT03146247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934153|NCT03146247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934155|NCT03146247|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91934157|NCT03146247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934158|NCT03146247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934161|NCT03263273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934162|NCT03146325|Metronidazole|metronidazole|mesh-list
91934163|NCT03146325|Tetracycline|tetracycline|mesh-list
91934164|NCT03146325|Omeprazole|omeprazole|mesh-list
91934165|NCT03146325|Bismuth|bismuth|mesh-list
91934166|NCT03146325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934167|NCT03146325|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934168|NCT03146325|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91934169|NCT03146325|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91934170|NCT03146325|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91934171|NCT03146325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91934172|NCT03146325|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91934173|NCT03146325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934174|NCT03146325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934176|NCT03146325|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91934178|NCT02233049|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91934179|NCT02233049|Dasatinib|dasatinib|mesh-list
91934180|NCT02233049|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91934181|NCT02233049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91934182|NCT02233049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934183|NCT02233049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934184|NCT02233049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934185|NCT02233049|Immunologic Factors|immunologic factors|mesh-ancestor
91934186|NCT02233049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934187|NCT02233049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934188|NCT02350725|Furosemide|furosemide|mesh-list
91934189|NCT02350725|Diuretics|diuretics|mesh-ancestor
91934190|NCT02350725|Natriuretic Agents|natriuretic agents|mesh-ancestor
91934191|NCT02350725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934192|NCT02350725|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91934193|NCT02350725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934194|NCT02350725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934195|NCT02350959|Atorvastatin|atorvastatin|mesh-list
91934196|NCT02350959|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91934198|NCT02350959|Antimetabolites|antimetabolites|mesh-ancestor
91934199|NCT02350959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934200|NCT02350959|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91934201|NCT02350959|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91934202|NCT02350959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934203|NCT02350335|Nicotine|nicotine|mesh-list
91934204|NCT02350335|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91934205|NCT02350335|Autonomic Agents|autonomic agents|mesh-ancestor
91934207|NCT02350335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934208|NCT02350335|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91934209|NCT02350335|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91934210|NCT02350335|Cholinergic Agents|cholinergic agents|mesh-ancestor
91934211|NCT02350335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934212|NCT02350335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934213|NCT02293447|Lidocaine|lidocaine|mesh-list
91934214|NCT02293447|Anesthetics, Local|anesthetics, local|mesh-list
91934215|NCT02293447|Anesthetics|anesthetics|mesh-list
91934216|NCT02293447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934217|NCT02293447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934218|NCT02293447|Sensory System Agents|sensory system agents|mesh-ancestor
91934219|NCT02293447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934220|NCT02293447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91934221|NCT02293447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91934222|NCT02293447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91934223|NCT02293447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934224|NCT02293447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934225|NCT04464811|Furosemide|furosemide|mesh-list
91934226|NCT04464811|Diuretics|diuretics|mesh-ancestor
91934227|NCT04464811|Natriuretic Agents|natriuretic agents|mesh-ancestor
91934228|NCT04464811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934229|NCT04464811|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91934230|NCT04464811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934231|NCT04464811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934233|NCT02293525|Oxycodone|oxycodone|mesh-list
91934235|NCT02293525|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91934236|NCT02293525|Narcotics|narcotics|mesh-ancestor
91934237|NCT02293525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934238|NCT02293525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934239|NCT02293525|Analgesics|analgesics|mesh-ancestor
91934240|NCT02293525|Sensory System Agents|sensory system agents|mesh-ancestor
91934241|NCT02293525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934243|NCT02293525|Anesthetics|anesthetics|mesh-ancestor
91934245|NCT02298595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934246|NCT02298595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934247|NCT02345343|Apixaban|apixaban|mesh-list
91934248|NCT02345343|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91934249|NCT02345343|Antithrombins|antithrombins|mesh-ancestor
91934250|NCT02345343|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91934251|NCT02345343|Protease Inhibitors|protease inhibitors|mesh-ancestor
91934252|NCT02345343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934253|NCT02345343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934254|NCT02345343|Anticoagulants|anticoagulants|mesh-ancestor
91934256|NCT03949673|Diclofenac|diclofenac|mesh-list
91934257|NCT03949673|Naproxen|naproxen|mesh-list
91934258|NCT03949673|Fasinumab|fasinumab|mesh-list
91934259|NCT03949673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91934260|NCT03949673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934261|NCT03949673|Analgesics|analgesics|mesh-ancestor
91934262|NCT03949673|Sensory System Agents|sensory system agents|mesh-ancestor
91934263|NCT03949673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934264|NCT03949673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934265|NCT03949673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934266|NCT03949673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934267|NCT03949673|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91934268|NCT03949673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91934270|NCT03949673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934272|NCT02350179|Tranexamic Acid|tranexamic acid|mesh-list
91934273|NCT02350179|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91934274|NCT02350179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91934275|NCT02350179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934278|NCT02233205|Gemcitabine|gemcitabine|mesh-list
91934279|NCT02233205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934281|NCT02233205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934282|NCT02233205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934283|NCT02843633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91934284|NCT02293681|Infliximab|infliximab|mesh-list
91934285|NCT02293681|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91934286|NCT02293681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934287|NCT02293681|Dermatologic Agents|dermatologic agents|mesh-ancestor
91934288|NCT02293681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91934289|NCT02293681|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934290|NCT02259491|Calcium|calcium|mesh-list
91934291|NCT02259491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91934292|NCT02259491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934293|NCT05255523|Capecitabine|capecitabine|mesh-list
91934294|NCT05255523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934295|NCT05255523|Antimetabolites|antimetabolites|mesh-ancestor
92074248|NCT00072514|Antiemetics|antiemetics|mesh-ancestor
91934296|NCT05255523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934297|NCT05255523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934298|NCT03149679|Cyclophosphamide|cyclophosphamide|mesh-list
91934299|NCT03149679|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934300|NCT03149679|Immunologic Factors|immunologic factors|mesh-ancestor
91934301|NCT03149679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934302|NCT03149679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934303|NCT03149679|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91934304|NCT03149679|Alkylating Agents|alkylating agents|mesh-ancestor
91934305|NCT03149679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934306|NCT03149679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934307|NCT03149679|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91934308|NCT02298985|Curcumin|curcumin|mesh-list
91934309|NCT02298985|Antipsychotic Agents|antipsychotic agents|mesh-list
91934310|NCT02298985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91934311|NCT02298985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934313|NCT02298985|Sensory System Agents|sensory system agents|mesh-ancestor
91934314|NCT02298985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934315|NCT02298985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934316|NCT02298985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934317|NCT02298985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934318|NCT02298985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934319|NCT02298985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934320|NCT02298985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934322|NCT02298985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934323|NCT02298985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91934325|NCT03149445|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91934326|NCT03149445|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91934327|NCT03149445|Sympatholytics|sympatholytics|mesh-ancestor
91934328|NCT03149445|Autonomic Agents|autonomic agents|mesh-ancestor
91934329|NCT03149445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934330|NCT03149445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934331|NCT03149445|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91934332|NCT03149445|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91934333|NCT03149445|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91934334|NCT03149445|Adrenergic Agents|adrenergic agents|mesh-ancestor
91934335|NCT03149445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934336|NCT03149445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934338|NCT02345187|Trace Elements|trace elements|mesh-list
91934339|NCT02345187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934340|NCT02299063|Dexmedetomidine|dexmedetomidine|mesh-list
91934341|NCT02299063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91934342|NCT02299063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934343|NCT02299063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934344|NCT02299063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934345|NCT02299063|Analgesics|analgesics|mesh-ancestor
91934346|NCT02299063|Sensory System Agents|sensory system agents|mesh-ancestor
91934347|NCT02299063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934348|NCT02299063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91934349|NCT02299063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91934350|NCT02299063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91934351|NCT02299063|Adrenergic Agents|adrenergic agents|mesh-ancestor
91934352|NCT02299063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934353|NCT02299063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934354|NCT03149289|Antiviral Agents|antiviral agents|mesh-list
91934355|NCT03149289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934356|NCT05624801|Vitamin D|vitamin d|mesh-list
91934358|NCT05624801|Micronutrients|micronutrients|mesh-ancestor
91934359|NCT05624801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934360|NCT05624801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91934361|NCT05255211|Propofol|propofol|mesh-list
91934362|NCT05255211|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91934363|NCT05255211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934364|NCT05255211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934366|NCT05255211|Anesthetics, General|anesthetics, general|mesh-ancestor
91934367|NCT05255211|Anesthetics|anesthetics|mesh-ancestor
91934368|NCT03514381|Doxorubicin|doxorubicin|mesh-list
91934370|NCT03514381|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91934371|NCT03514381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934372|NCT03514381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91934373|NCT03514381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91934374|NCT03514381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934375|NCT03514381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934376|NCT03514381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91934377|NCT03514381|Alkylating Agents|alkylating agents|mesh-ancestor
91934379|NCT02343393|Isosorbide|isosorbide|mesh-list
91934380|NCT02343393|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
91934381|NCT02343393|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91934384|NCT02343393|Natriuretic Agents|natriuretic agents|mesh-ancestor
91934385|NCT02343393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934387|NCT02343393|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91934388|NCT02343393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934389|NCT02343393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91934390|NCT03896009|Meloxicam|meloxicam|mesh-list
91934391|NCT03896009|Rizatriptan|rizatriptan|mesh-list
91934392|NCT03896009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91934393|NCT03896009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934395|NCT03896009|Sensory System Agents|sensory system agents|mesh-ancestor
91934396|NCT03896009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934397|NCT03896009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934398|NCT03896009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934399|NCT03896009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934400|NCT03896009|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91934401|NCT03896009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91934402|NCT03896009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934403|NCT03896009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934404|NCT03896009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91934405|NCT03896009|Serotonin Agents|serotonin agents|mesh-ancestor
91934408|NCT02344875|Uricosuric Agents|uricosuric agents|mesh-ancestor
91934409|NCT02344875|Gout Suppressants|gout suppressants|mesh-ancestor
91934410|NCT02344875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934411|NCT03145623|Grazoprevir|grazoprevir|mesh-list
91934412|NCT03145623|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91934413|NCT03145623|Antiviral Agents|antiviral agents|mesh-ancestor
91934414|NCT03145623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934415|NCT02294071|Acetaminophen|acetaminophen|mesh-list
91934416|NCT02294071|Ibuprofen|ibuprofen|mesh-list
91934417|NCT02294071|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934419|NCT02294071|Sensory System Agents|sensory system agents|mesh-ancestor
91934420|NCT02294071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934421|NCT02294071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934422|NCT02294071|Antipyretics|antipyretics|mesh-ancestor
91934423|NCT02294071|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91934424|NCT02294071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934425|NCT02294071|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934426|NCT02294071|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91934427|NCT02294071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934428|NCT02294071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934429|NCT02233439|Galactogogues|galactogogues|mesh-list
91934430|NCT02233439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934431|NCT02350023|Betamethasone|betamethasone|mesh-list
91934432|NCT02350023|Latanoprost|latanoprost|mesh-list
91934433|NCT02350023|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91934434|NCT02350023|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91934435|NCT02350023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934436|NCT02350023|Glucocorticoids|glucocorticoids|mesh-ancestor
91934437|NCT02350023|Hormones|hormones|mesh-ancestor
91936809|NCT02264171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934438|NCT02350023|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934439|NCT02350023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934440|NCT02350023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91934441|NCT02350023|Respiratory System Agents|respiratory system agents|mesh-ancestor
91934442|NCT02342925|Metformin|metformin|mesh-list
91934443|NCT02342925|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91934444|NCT02342925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934445|NCT03879863|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91934446|NCT03879863|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91934448|NCT02344641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91934449|NCT02344641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934450|NCT02344641|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91934451|NCT02344641|Incretins|incretins|mesh-ancestor
91934452|NCT02344641|Hormones|hormones|mesh-ancestor
91934453|NCT02344641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934454|NCT03798743|Docetaxel|docetaxel|mesh-list
91934455|NCT03798743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934456|NCT03798743|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934457|NCT03798743|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934458|NCT03798743|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934459|NCT03798743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934460|NCT04083183|Mycophenolic Acid|mycophenolic acid|mesh-list
91934461|NCT04083183|Sirolimus|sirolimus|mesh-list
91934462|NCT04083183|Vidarabine|vidarabine|mesh-list
91934463|NCT04083183|Cyclophosphamide|cyclophosphamide|mesh-list
91934464|NCT04083183|Fludarabine|fludarabine|mesh-list
91934465|NCT04083183|Fludarabine phosphate|fludarabine phosphate|mesh-list
91934466|NCT04083183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91934467|NCT04083183|Thymoglobulin|thymoglobulin|mesh-list
91934468|NCT04083183|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91934469|NCT04083183|Antibodies|antibodies|mesh-list
91934470|NCT04083183|Immunoglobulins|immunoglobulins|mesh-list
91934471|NCT04083183|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91934472|NCT04083183|gamma-Globulins|gamma-globulins|mesh-list
91934473|NCT04083183|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91934475|NCT04083183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934476|NCT04083183|Immunologic Factors|immunologic factors|mesh-ancestor
91934477|NCT04083183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934478|NCT04083183|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934479|NCT04083183|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91934480|NCT04083183|Alkylating Agents|alkylating agents|mesh-ancestor
91934481|NCT04083183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934482|NCT04083183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934483|NCT04083183|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91934484|NCT04083183|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934485|NCT04083183|Antimetabolites|antimetabolites|mesh-ancestor
91934486|NCT04083183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91934487|NCT04083183|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91934488|NCT04083183|Antitubercular Agents|antitubercular agents|mesh-ancestor
91934489|NCT04083183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934490|NCT04083183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934491|NCT04083183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934492|NCT04083183|Antifungal Agents|antifungal agents|mesh-ancestor
91934493|NCT04083183|Antiviral Agents|antiviral agents|mesh-ancestor
91934494|NCT02342769|Dolutegravir|dolutegravir|mesh-list
91934496|NCT02342769|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91934497|NCT02342769|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91934498|NCT02342769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934499|NCT02342769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934500|NCT02342769|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91934501|NCT02342769|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91934502|NCT02342769|Antiviral Agents|antiviral agents|mesh-ancestor
91934503|NCT02342769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934504|NCT02342769|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91934505|NCT02342769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91934506|NCT03766295|Gemcitabine|gemcitabine|mesh-list
91934507|NCT03766295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934508|NCT03766295|Antimetabolites|antimetabolites|mesh-ancestor
91934509|NCT03766295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934510|NCT03766295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934511|NCT03761225|Prednisone|prednisone|mesh-list
91934512|NCT03761225|Docetaxel|docetaxel|mesh-list
91934513|NCT03761225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934514|NCT03761225|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934515|NCT03761225|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934516|NCT03761225|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934517|NCT03761225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934518|NCT03761225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934519|NCT03761225|Glucocorticoids|glucocorticoids|mesh-ancestor
91934520|NCT03761225|Hormones|hormones|mesh-ancestor
91934521|NCT03761225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934522|NCT03761225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934523|NCT03761225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91934524|NCT02349945|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91934525|NCT02349945|Hormones|hormones|mesh-ancestor
91934526|NCT02349945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934527|NCT02349945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934528|NCT02302495|Prednisone|prednisone|mesh-list
91934529|NCT02302495|Melphalan|melphalan|mesh-list
91934530|NCT02302495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934531|NCT02302495|Glucocorticoids|glucocorticoids|mesh-ancestor
91934532|NCT02302495|Hormones|hormones|mesh-ancestor
91936810|NCT02264171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936811|NCT02264171|Urological Agents|urological agents|mesh-ancestor
91936812|NCT02264171|Antifungal Agents|antifungal agents|mesh-ancestor
91934533|NCT02302495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934534|NCT02302495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074249|NCT00072514|Autonomic Agents|autonomic agents|mesh-ancestor
91934536|NCT02302495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934538|NCT02302495|Alkylating Agents|alkylating agents|mesh-ancestor
91934539|NCT02302495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934540|NCT02302495|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91934541|NCT02302495|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91934543|NCT02813447|Sertraline|sertraline|mesh-list
91934544|NCT02813447|Antidepressive Agents|antidepressive agents|mesh-ancestor
91934545|NCT02813447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91934546|NCT02813447|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91934547|NCT02813447|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91934548|NCT02813447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934549|NCT02813447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934550|NCT02813447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934551|NCT02813447|Serotonin Agents|serotonin agents|mesh-ancestor
91934552|NCT02813447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934554|NCT02342145|Mycophenolic Acid|mycophenolic acid|mesh-list
91934555|NCT02342145|Methotrexate|methotrexate|mesh-list
91934556|NCT02342145|Cyclosporins|cyclosporins|mesh-list
91934557|NCT02342145|Basiliximab|basiliximab|mesh-list
91934558|NCT02342145|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91934559|NCT02342145|Abortifacient Agents|abortifacient agents|mesh-ancestor
91934560|NCT02342145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91934561|NCT02342145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934562|NCT02342145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934563|NCT02342145|Antimetabolites|antimetabolites|mesh-ancestor
91936813|NCT02264171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934564|NCT02342145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934565|NCT02342145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934566|NCT02342145|Dermatologic Agents|dermatologic agents|mesh-ancestor
91934567|NCT02342145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934568|NCT02342145|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91934570|NCT02342145|Immunologic Factors|immunologic factors|mesh-ancestor
91934571|NCT02342145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934572|NCT02342145|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91934573|NCT02342145|Antifungal Agents|antifungal agents|mesh-ancestor
91934574|NCT02342145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934575|NCT02342145|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91934576|NCT02342145|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91934577|NCT02342145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91934578|NCT02342145|Antitubercular Agents|antitubercular agents|mesh-ancestor
91934579|NCT02342145|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934580|NCT02349399|Cyproterone Acetate|cyproterone acetate|mesh-list
91934581|NCT02349399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91934582|NCT02349399|Cyproterone|cyproterone|mesh-list
91936814|NCT02264171|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91936815|NCT02264171|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91936816|NCT02264171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936817|NCT02264171|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91934583|NCT02349399|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
91934584|NCT02349399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91934585|NCT02349399|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91936818|NCT02264171|Hormone Antagonists|hormone antagonists|mesh-ancestor
91934586|NCT02349399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91934587|NCT02349399|Contraceptive Agents|contraceptive agents|mesh-ancestor
91934588|NCT02349399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91934589|NCT02349399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934590|NCT02349399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91934591|NCT02349399|Estrogens|estrogens|mesh-ancestor
91934593|NCT02349399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934594|NCT02349399|Androgen Antagonists|androgen antagonists|mesh-ancestor
91934595|NCT02349399|Hormone Antagonists|hormone antagonists|mesh-ancestor
91934596|NCT02349399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934597|NCT02349399|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91934598|NCT02306473|Mannitol|mannitol|mesh-list
91934599|NCT02306473|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91934600|NCT02306473|Diuretics|diuretics|mesh-ancestor
91934601|NCT02306473|Natriuretic Agents|natriuretic agents|mesh-ancestor
91934602|NCT02306473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934603|NCT03737123|Carboplatin|carboplatin|mesh-list
91934604|NCT03737123|Gemcitabine|gemcitabine|mesh-list
91934605|NCT03737123|Docetaxel|docetaxel|mesh-list
91934606|NCT03737123|Atezolizumab|atezolizumab|mesh-list
91934607|NCT03737123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934608|NCT03737123|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934609|NCT03737123|Antimetabolites|antimetabolites|mesh-ancestor
91934610|NCT03737123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934611|NCT03737123|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934612|NCT03737123|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934613|NCT03737123|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934615|NCT03737123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934616|NCT03709121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91934617|NCT03709121|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91934618|NCT02344095|Paclitaxel|paclitaxel|mesh-list
91934619|NCT02344095|Cisplatin|cisplatin|mesh-list
91934620|NCT02344095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91934622|NCT02344095|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934623|NCT02344095|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934624|NCT02344095|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934625|NCT02344095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934626|NCT00157339|Insulin|insulin|mesh-list
91934627|NCT00157339|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91934628|NCT00157339|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91934629|NCT00157339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934630|NCT02342067|Pioglitazone|pioglitazone|mesh-list
91934631|NCT02342067|Cenicriviroc|cenicriviroc|mesh-list
91934632|NCT02342067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91934633|NCT02342067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934634|NCT02342067|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91934635|NCT02342067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934636|NCT02342067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91934637|NCT02342067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91934638|NCT02342067|Antiviral Agents|antiviral agents|mesh-ancestor
91934639|NCT02342067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934640|NCT02344017|Prednisone|prednisone|mesh-list
91934641|NCT02344017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934643|NCT02344017|Hormones|hormones|mesh-ancestor
91934644|NCT02344017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91934645|NCT02344017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934646|NCT02344017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91934647|NCT02344017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934648|NCT02343861|Emollients|emollients|mesh-list
91934649|NCT02343861|Dermatologic Agents|dermatologic agents|mesh-ancestor
91934650|NCT03676751|Azithromycin|azithromycin|mesh-list
91934651|NCT03676751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934652|NCT03676751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934653|NCT02302729|Micronutrients|micronutrients|mesh-list
91934654|NCT02302729|Trace Elements|trace elements|mesh-list
91934655|NCT02302729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934656|NCT03513601|Rituximab|rituximab|mesh-list
91934657|NCT03513601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934658|NCT03513601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934659|NCT03513601|Immunologic Factors|immunologic factors|mesh-ancestor
91934660|NCT03513601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934661|NCT03513601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934664|NCT03647111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91934665|NCT03647111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934666|NCT03647111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934667|NCT03507829|Insulin|insulin|mesh-list
91934668|NCT03507829|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91934669|NCT03507829|Insulin Lispro|insulin lispro|mesh-list
91934670|NCT03507829|Isophane Insulin, Human|isophane insulin, human|mesh-list
91934671|NCT03507829|Insulin, Isophane|insulin, isophane|mesh-list
91934672|NCT03507829|Isophane insulin, beef|isophane insulin, beef|mesh-list
91934673|NCT03507829|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91934674|NCT03507829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934676|NCT02232581|Dideoxynucleosides|dideoxynucleosides|mesh-list
91934677|NCT02232581|Antiviral Agents|antiviral agents|mesh-ancestor
91934678|NCT02232581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934679|NCT02232581|Antimetabolites|antimetabolites|mesh-ancestor
91934680|NCT02232581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934681|NCT02232581|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91934682|NCT02232581|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91934683|NCT02232581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934684|NCT02341833|Sevoflurane|sevoflurane|mesh-list
91934685|NCT02341833|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91934686|NCT02341833|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91934687|NCT02341833|Anesthetics, General|anesthetics, general|mesh-ancestor
91934688|NCT02341833|Anesthetics|anesthetics|mesh-ancestor
91934689|NCT02341833|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934690|NCT02341833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934691|NCT02337231|Borage oil|borage oil|mesh-list
91934692|NCT02337231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934693|NCT03507751|Meropenem|meropenem|mesh-list
91934694|NCT03507751|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934695|NCT03507751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934696|NCT02306629|Epratuzumab|epratuzumab|mesh-list
91934697|NCT02306629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934698|NCT02306629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934699|NCT03510793|Anesthetics|anesthetics|mesh-list
91934700|NCT03510793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934701|NCT03510793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934702|NCT05230797|Zinc|zinc|mesh-list
91934703|NCT05230797|Propolis|propolis|mesh-list
91934704|NCT05230797|Eugenol|eugenol|mesh-list
91934705|NCT05230797|Zinc Oxide|zinc oxide|mesh-list
91934706|NCT05230797|Trace Elements|trace elements|mesh-ancestor
91934707|NCT05230797|Micronutrients|micronutrients|mesh-ancestor
91934708|NCT05230797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934709|NCT05230797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934710|NCT05230797|Dermatologic Agents|dermatologic agents|mesh-ancestor
91934711|NCT05230797|Sunscreening Agents|sunscreening agents|mesh-ancestor
91934712|NCT05230797|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91934713|NCT05230797|Protective Agents|protective agents|mesh-ancestor
91934714|NCT02341365|Vitamin D|vitamin d|mesh-list
91934716|NCT02341365|Micronutrients|micronutrients|mesh-ancestor
91934717|NCT02341365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934718|NCT02341365|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91934719|NCT02299687|Omeprazole|omeprazole|mesh-list
91934720|NCT02299687|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91934721|NCT02299687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91934722|NCT02299687|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91934723|NCT02299687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934724|NCT02299687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934725|NCT02349243|Entacapone|entacapone|mesh-list
91934726|NCT02349243|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91934727|NCT02349243|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91934728|NCT02349243|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
91934730|NCT02349243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934732|NCT02341209|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934733|NCT02341209|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934735|NCT02341209|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91934736|NCT02341209|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91934737|NCT02349165|Riboflavin|riboflavin|mesh-list
91934738|NCT02349165|Vitamin B Complex|vitamin b complex|mesh-ancestor
91934740|NCT02349165|Micronutrients|micronutrients|mesh-ancestor
91934741|NCT02349165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934742|NCT02349165|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91934743|NCT02349165|Dermatologic Agents|dermatologic agents|mesh-ancestor
91934744|NCT03112005|Mydriatics|mydriatics|mesh-list
91934745|NCT03112005|Autonomic Agents|autonomic agents|mesh-ancestor
91934746|NCT03112005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934747|NCT03112005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934748|NCT02306785|Mesalamine|mesalamine|mesh-list
91934749|NCT02306785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91934750|NCT02306785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934752|NCT02306785|Sensory System Agents|sensory system agents|mesh-ancestor
91934753|NCT02306785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934754|NCT02306785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934756|NCT02306785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91934757|NCT02299765|Carboplatin|carboplatin|mesh-list
91934758|NCT02299765|Gemcitabine|gemcitabine|mesh-list
91934759|NCT02299765|Gefitinib|gefitinib|mesh-list
91934760|NCT02299765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934762|NCT02299765|Antimetabolites|antimetabolites|mesh-ancestor
91934763|NCT02299765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934764|NCT02299765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91934766|NCT04771923|Epinephrine|epinephrine|mesh-list
91934767|NCT04771923|Racepinephrine|racepinephrine|mesh-list
91934768|NCT04771923|Tranexamic Acid|tranexamic acid|mesh-list
91934769|NCT04771923|Epinephryl borate|epinephryl borate|mesh-list
91934770|NCT04771923|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91934771|NCT04771923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91934772|NCT04771923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934774|NCT04771923|Coagulants|coagulants|mesh-ancestor
91934775|NCT04771923|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91934776|NCT04771923|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91934777|NCT04771923|Adrenergic Agents|adrenergic agents|mesh-ancestor
91934778|NCT04771923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934779|NCT04771923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934780|NCT04771923|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91934781|NCT04771923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91934783|NCT04771923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934784|NCT04771923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91934785|NCT04771923|Respiratory System Agents|respiratory system agents|mesh-ancestor
91934786|NCT04771923|Mydriatics|mydriatics|mesh-ancestor
91934787|NCT04771923|Sympathomimetics|sympathomimetics|mesh-ancestor
91934789|NCT04718415|Paclitaxel|paclitaxel|mesh-list
91934790|NCT04718415|Carboplatin|carboplatin|mesh-list
91934791|NCT04718415|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91934792|NCT04718415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934793|NCT04718415|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934794|NCT04718415|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934795|NCT04718415|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934796|NCT04718415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934797|NCT04598321|Talazoparib|talazoparib|mesh-list
91934798|NCT04598321|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91934799|NCT04598321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934800|NCT04598321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934801|NCT04598321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934802|NCT05254899|Gemcitabine|gemcitabine|mesh-list
91934803|NCT05254899|Oxaliplatin|oxaliplatin|mesh-list
91934804|NCT05254899|Tislelizumab|tislelizumab|mesh-list
91934805|NCT05254899|Pegaspargase|pegaspargase|mesh-list
91934806|NCT05254899|Antibodies|antibodies|mesh-list
91934807|NCT05254899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91934808|NCT05254899|Immunologic Factors|immunologic factors|mesh-ancestor
91934809|NCT05254899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934810|NCT05254899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91934811|NCT05254899|Antimetabolites|antimetabolites|mesh-ancestor
91934812|NCT05254899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934813|NCT05254899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934814|NCT05254899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91934815|NCT03148509|Risperidone|risperidone|mesh-list
91934816|NCT03148509|Aripiprazole|aripiprazole|mesh-list
91934817|NCT03148509|Bupropion|bupropion|mesh-list
91934818|NCT03148509|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91934819|NCT03148509|Serotonin Agents|serotonin agents|mesh-ancestor
91934820|NCT03148509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934821|NCT03148509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934822|NCT03148509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934823|NCT03148509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91934824|NCT03148509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91934825|NCT03148509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934826|NCT03148509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91934827|NCT03148509|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91934828|NCT03148509|Dopamine Agents|dopamine agents|mesh-ancestor
91934829|NCT03148509|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91934830|NCT03148509|Antidepressive Agents|antidepressive agents|mesh-ancestor
91934831|NCT03148509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91934832|NCT03148509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91934833|NCT03148509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934834|NCT03148509|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91934835|NCT03148509|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91934836|NCT03148509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934837|NCT03148509|Dopamine Agonists|dopamine agonists|mesh-ancestor
91934838|NCT03148509|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91934839|NCT03148509|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91934840|NCT03148509|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91934841|NCT03148509|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91934842|NCT05254665|Docetaxel|docetaxel|mesh-list
91934843|NCT05254665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934844|NCT05254665|Tubulin Modulators|tubulin modulators|mesh-ancestor
91934845|NCT05254665|Antimitotic Agents|antimitotic agents|mesh-ancestor
91934846|NCT05254665|Mitosis Modulators|mitosis modulators|mesh-ancestor
91934847|NCT05254665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934848|NCT03513055|Insulin|insulin|mesh-list
91934849|NCT03513055|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91934850|NCT03513055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934851|NCT03510325|Olanzapine|olanzapine|mesh-list
91934852|NCT03510325|Risperidone|risperidone|mesh-list
91934853|NCT03510325|Aripiprazole|aripiprazole|mesh-list
91934854|NCT03510325|Paliperidone Palmitate|paliperidone palmitate|mesh-list
91934855|NCT03510325|Amisulpride|amisulpride|mesh-list
91934856|NCT03510325|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91934857|NCT03510325|Serotonin Agents|serotonin agents|mesh-ancestor
91934858|NCT03510325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934859|NCT03510325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934860|NCT03510325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934861|NCT03510325|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91934862|NCT03510325|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91934863|NCT03510325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934864|NCT03510325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91934865|NCT03510325|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91934866|NCT03510325|Dopamine Agents|dopamine agents|mesh-ancestor
91934867|NCT03510325|Antiemetics|antiemetics|mesh-ancestor
91934868|NCT03510325|Autonomic Agents|autonomic agents|mesh-ancestor
91934869|NCT03510325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934870|NCT03510325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91934871|NCT03510325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91934872|NCT03510325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91934873|NCT03510325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91934874|NCT03510325|Antidepressive Agents|antidepressive agents|mesh-ancestor
91934875|NCT03510325|Dopamine Agonists|dopamine agonists|mesh-ancestor
91934876|NCT03510325|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91934877|NCT03510325|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91934878|NCT03510325|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91934879|NCT03510325|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91934880|NCT03510325|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91934882|NCT03507127|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91934883|NCT03507127|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91934884|NCT03507127|Cholinergic Agents|cholinergic agents|mesh-ancestor
91934886|NCT03507127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934887|NCT03507127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934888|NCT03512821|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91934889|NCT03512821|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91934890|NCT03512821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91934891|NCT02336529|Bupivacaine|bupivacaine|mesh-list
91934892|NCT02336529|Anesthetics, Local|anesthetics, local|mesh-ancestor
91934893|NCT02336529|Anesthetics|anesthetics|mesh-ancestor
91934894|NCT02336529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934895|NCT02336529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934896|NCT02336529|Sensory System Agents|sensory system agents|mesh-ancestor
91934897|NCT02336529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934898|NCT02307487|Mitomycins|mitomycins|mesh-list
91934899|NCT02307487|Mitomycin|mitomycin|mesh-list
91934900|NCT02307487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91934901|NCT02307487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934902|NCT02307487|Alkylating Agents|alkylating agents|mesh-ancestor
91934903|NCT02307487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934904|NCT02307487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91934905|NCT02307487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934907|NCT02307565|Sympathomimetics|sympathomimetics|mesh-ancestor
91934908|NCT02307565|Autonomic Agents|autonomic agents|mesh-ancestor
91934909|NCT02307565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934910|NCT02307565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934911|NCT02307565|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91934912|NCT02307565|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91934913|NCT02307565|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91934914|NCT02307565|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91934915|NCT02307565|Adrenergic Agents|adrenergic agents|mesh-ancestor
91934916|NCT02307565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934917|NCT02307565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934918|NCT03510013|Anesthetics|anesthetics|mesh-list
91934919|NCT03510013|Sevoflurane|sevoflurane|mesh-list
91934920|NCT03510013|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
91934921|NCT03510013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934922|NCT03510013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934923|NCT03510013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91934924|NCT03510013|Anesthetics, General|anesthetics, general|mesh-ancestor
91934925|NCT02307721|Remifentanil|remifentanil|mesh-list
91934927|NCT02307721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91934928|NCT02307721|Narcotics|narcotics|mesh-ancestor
91934929|NCT02307721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91934930|NCT02307721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934931|NCT02307721|Analgesics|analgesics|mesh-ancestor
91934932|NCT02307721|Sensory System Agents|sensory system agents|mesh-ancestor
91934933|NCT02307721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934934|NCT02307721|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91934935|NCT03506815|Rivaroxaban|rivaroxaban|mesh-list
91934936|NCT03506815|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91934937|NCT03506815|Antithrombins|antithrombins|mesh-ancestor
91934939|NCT03506815|Protease Inhibitors|protease inhibitors|mesh-ancestor
91934940|NCT03506815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934941|NCT03506815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934942|NCT03506815|Anticoagulants|anticoagulants|mesh-ancestor
91934943|NCT05227677|Hypoglycemic Agents|hypoglycemic agents|mesh-list
91934944|NCT05227677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934945|NCT02348463|Clindamycin|clindamycin|mesh-list
91934946|NCT02348463|Clindamycin palmitate|clindamycin palmitate|mesh-list
91934947|NCT02348463|Clindamycin phosphate|clindamycin phosphate|mesh-list
91934948|NCT02348463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91934949|NCT02348463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934950|NCT02348463|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91934951|NCT02348463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934952|NCT02348463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934953|NCT02340273|Oxymetazoline|oxymetazoline|mesh-list
91934954|NCT02340273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91934955|NCT02340273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91934957|NCT02340273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91934958|NCT02340273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934959|NCT02340273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934960|NCT02340273|Sympathomimetics|sympathomimetics|mesh-ancestor
91934961|NCT02340273|Autonomic Agents|autonomic agents|mesh-ancestor
91934962|NCT02340273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934963|NCT02340273|Nasal Decongestants|nasal decongestants|mesh-ancestor
91934964|NCT02340273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91934965|NCT02340273|Respiratory System Agents|respiratory system agents|mesh-ancestor
91934966|NCT02300623|Lamivudine|lamivudine|mesh-list
91934967|NCT02300623|Stavudine|stavudine|mesh-list
91934971|NCT02300623|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91934972|NCT02300623|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91934973|NCT02300623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91934974|NCT02300623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91934975|NCT02300623|Antiviral Agents|antiviral agents|mesh-ancestor
91934976|NCT02300623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91934977|NCT02300623|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91934978|NCT02300623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91934979|NCT02300623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91934980|NCT02300623|Analgesics|analgesics|mesh-ancestor
91934981|NCT02300623|Sensory System Agents|sensory system agents|mesh-ancestor
91934982|NCT02300623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934984|NCT02300623|Antimetabolites|antimetabolites|mesh-ancestor
91934985|NCT02300623|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91934986|NCT02300623|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91934988|NCT04463953|Dexamethasone|dexamethasone|mesh-list
91934989|NCT04463953|Ixazomib|ixazomib|mesh-list
91934990|NCT04463953|Zanubrutinib|zanubrutinib|mesh-list
91934991|NCT04463953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91934992|NCT04463953|Antiemetics|antiemetics|mesh-ancestor
91934993|NCT04463953|Autonomic Agents|autonomic agents|mesh-ancestor
91934994|NCT04463953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91934995|NCT04463953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91934996|NCT04463953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91934997|NCT04463953|Glucocorticoids|glucocorticoids|mesh-ancestor
91934999|NCT04463953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935000|NCT04463953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935001|NCT04463953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935002|NCT04463953|Protease Inhibitors|protease inhibitors|mesh-ancestor
91935003|NCT04463953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935004|NCT04463953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935005|NCT04463953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935006|NCT02307955|Fluorophosphate|fluorophosphate|mesh-list
91935007|NCT02307955|Cariostatic Agents|cariostatic agents|mesh-ancestor
91935008|NCT02307955|Protective Agents|protective agents|mesh-ancestor
91935009|NCT02307955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935010|NCT03147963|Docetaxel|docetaxel|mesh-list
91935011|NCT03147963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935012|NCT03147963|Tubulin Modulators|tubulin modulators|mesh-ancestor
91935013|NCT03147963|Antimitotic Agents|antimitotic agents|mesh-ancestor
91935014|NCT03147963|Mitosis Modulators|mitosis modulators|mesh-ancestor
91935015|NCT03147963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935017|NCT02348307|Uricosuric Agents|uricosuric agents|mesh-ancestor
91935018|NCT02348307|Gout Suppressants|gout suppressants|mesh-ancestor
91935019|NCT02348307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935020|NCT02340117|Paclitaxel|paclitaxel|mesh-list
91935021|NCT02340117|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91935022|NCT02340117|Gemcitabine|gemcitabine|mesh-list
91935023|NCT02340117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91935024|NCT02340117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935025|NCT02340117|Tubulin Modulators|tubulin modulators|mesh-ancestor
91935026|NCT02340117|Antimitotic Agents|antimitotic agents|mesh-ancestor
91935028|NCT02340117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935029|NCT02340117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91935031|NCT02300701|Omalizumab|omalizumab|mesh-list
91935032|NCT02300701|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91935033|NCT02300701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91935034|NCT02300701|Respiratory System Agents|respiratory system agents|mesh-ancestor
91935035|NCT02336139|Sofosbuvir|sofosbuvir|mesh-list
91935036|NCT02336139|Velpatasvir|velpatasvir|mesh-list
91935037|NCT02336139|Antiviral Agents|antiviral agents|mesh-ancestor
91935038|NCT02336139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936819|NCT02264171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936820|NCT02264171|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91936821|NCT01481051|Latanoprost|latanoprost|mesh-list
91936822|NCT01481051|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91935039|NCT02340195|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
91935040|NCT02340195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91935041|NCT02340195|Serotonin Agents|serotonin agents|mesh-ancestor
91935042|NCT02340195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935043|NCT02340195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935044|NCT02340195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935045|NCT02300935|Paclitaxel|paclitaxel|mesh-list
91935046|NCT02300935|Trametinib|trametinib|mesh-list
91935047|NCT02300935|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91935048|NCT02300935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935049|NCT02300935|Tubulin Modulators|tubulin modulators|mesh-ancestor
91935050|NCT02300935|Antimitotic Agents|antimitotic agents|mesh-ancestor
91935051|NCT02300935|Mitosis Modulators|mitosis modulators|mesh-ancestor
91935052|NCT02300935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935053|NCT02300935|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935055|NCT02339805|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91935056|NCT02339805|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91935057|NCT02339805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935058|NCT02301091|Mitomycins|mitomycins|mesh-list
91935059|NCT02301091|Mitomycin|mitomycin|mesh-list
91935060|NCT02301091|Pirarubicin|pirarubicin|mesh-list
91935061|NCT02301091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91935062|NCT02301091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935063|NCT02301091|Alkylating Agents|alkylating agents|mesh-ancestor
91935064|NCT02301091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935065|NCT02301091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91935066|NCT02301091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935067|NCT02335593|Zinc Sulfate|zinc sulfate|mesh-list
91935068|NCT02335593|Epoetin Alfa|epoetin alfa|mesh-list
91935069|NCT02335593|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91935070|NCT02335593|Hematinics|hematinics|mesh-ancestor
91935071|NCT02335593|Astringents|astringents|mesh-ancestor
91935072|NCT02335593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935073|NCT02335593|Dermatologic Agents|dermatologic agents|mesh-ancestor
91935074|NCT02308891|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91935075|NCT02308969|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
91935076|NCT02308969|Hallucinogens|hallucinogens|mesh-ancestor
91935077|NCT02308969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935078|NCT02308969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91935079|NCT02308969|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91935080|NCT02308969|Serotonin Agents|serotonin agents|mesh-ancestor
91935091|NCT02335281|Mesalamine|mesalamine|mesh-list
91935092|NCT02335281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935093|NCT02335281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91935094|NCT02335281|Analgesics|analgesics|mesh-ancestor
91935095|NCT02335281|Sensory System Agents|sensory system agents|mesh-ancestor
91935096|NCT02335281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935097|NCT02335281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935098|NCT02335281|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935099|NCT02335281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935100|NCT02309437|Oxycodone|oxycodone|mesh-list
91935101|NCT02309437|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91935102|NCT02309437|Narcotics|narcotics|mesh-ancestor
91935103|NCT02309437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935104|NCT02309437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935105|NCT02309437|Analgesics|analgesics|mesh-ancestor
91935106|NCT02309437|Sensory System Agents|sensory system agents|mesh-ancestor
91935107|NCT02309437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935108|NCT02335359|Tranexamic Acid|tranexamic acid|mesh-list
91935109|NCT02335359|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91935110|NCT02335359|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91936823|NCT01481051|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91936825|NCT01480583|Trastuzumab|trastuzumab|mesh-list
91936826|NCT01480583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935111|NCT02335359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935112|NCT02335359|Hemostatics|hemostatics|mesh-ancestor
91935113|NCT02335359|Coagulants|coagulants|mesh-ancestor
91935114|NCT03511261|Curcumin|curcumin|mesh-list
91935115|NCT03511261|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935116|NCT03511261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91935117|NCT03511261|Analgesics|analgesics|mesh-ancestor
91935118|NCT03511261|Sensory System Agents|sensory system agents|mesh-ancestor
91935119|NCT03511261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935120|NCT03511261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935121|NCT03511261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935122|NCT03511261|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935123|NCT03511261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935124|NCT03511261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935125|NCT03511261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935127|NCT03509701|Immunologic Factors|immunologic factors|mesh-ancestor
91935128|NCT03509701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935129|NCT03511183|Bevacizumab|bevacizumab|mesh-list
91935130|NCT03511183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935131|NCT03511183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935132|NCT03511183|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91935133|NCT03511183|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91935134|NCT03511183|Growth Substances|growth substances|mesh-ancestor
91935135|NCT03511183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935136|NCT03511183|Growth Inhibitors|growth inhibitors|mesh-ancestor
91935137|NCT02303587|Methylprednisolone|methylprednisolone|mesh-list
91935138|NCT02303587|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91935160|NCT03916419|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91935161|NCT03916419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935162|NCT03916419|Tubulin Modulators|tubulin modulators|mesh-ancestor
91935163|NCT03916419|Antimitotic Agents|antimitotic agents|mesh-ancestor
91935164|NCT03916419|Mitosis Modulators|mitosis modulators|mesh-ancestor
91935165|NCT03916419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935166|NCT03916419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935167|NCT02301481|Oxaliplatin|oxaliplatin|mesh-list
91935168|NCT02301481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935169|NCT03107871|Valganciclovir|valganciclovir|mesh-list
91935170|NCT03107871|Antiviral Agents|antiviral agents|mesh-ancestor
91935171|NCT03107871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935172|NCT03064113|Ipratropium|ipratropium|mesh-list
91935173|NCT03064113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91935174|NCT03064113|Autonomic Agents|autonomic agents|mesh-ancestor
91935175|NCT03064113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935176|NCT03064113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935177|NCT03064113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91935178|NCT03064113|Respiratory System Agents|respiratory system agents|mesh-ancestor
91935179|NCT03064113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91935180|NCT03064113|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935181|NCT03064113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935182|NCT03064113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935184|NCT02301715|Oxytocics|oxytocics|mesh-ancestor
91943648|NCT00561743|Doxorubicin|doxorubicin|mesh-list
91935185|NCT02301715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935186|NCT02301715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935188|NCT03509545|Furosemide|furosemide|mesh-list
91935193|NCT03509545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935194|NCT03509545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935195|NCT03509545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91935196|NCT02301949|Thalidomide|thalidomide|mesh-list
91935197|NCT02301949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91935198|NCT02301949|Immunologic Factors|immunologic factors|mesh-ancestor
91935199|NCT02301949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935200|NCT02301949|Leprostatic Agents|leprostatic agents|mesh-ancestor
91935201|NCT02301949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91935202|NCT02301949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935203|NCT02301949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91935204|NCT02301949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91935205|NCT02301949|Growth Substances|growth substances|mesh-ancestor
91935206|NCT02301949|Growth Inhibitors|growth inhibitors|mesh-ancestor
91935207|NCT02301949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935208|NCT02335203|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
91935209|NCT02335203|Medroxyprogesterone|medroxyprogesterone|mesh-list
91935210|NCT02335203|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91935211|NCT02335203|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91935212|NCT02335203|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91935213|NCT02335203|Contraceptive Agents|contraceptive agents|mesh-ancestor
91935214|NCT02335203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935215|NCT02335203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935216|NCT02335203|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91935217|NCT02335203|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91935218|NCT02335203|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91935219|NCT02335203|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935220|NCT02335203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935221|NCT02303899|Gemcitabine|gemcitabine|mesh-list
91935222|NCT02303899|Imatinib Mesylate|imatinib mesylate|mesh-list
91935223|NCT02303899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936829|NCT01480583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935225|NCT02303899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935226|NCT02303899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935227|NCT02303899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935228|NCT02303899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935229|NCT02338635|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91935230|NCT02338635|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91935231|NCT02338635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935233|NCT03510871|Ipilimumab|ipilimumab|mesh-list
91935234|NCT03510871|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935235|NCT03510871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935236|NCT03510871|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91935237|NCT03510871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935238|NCT02331771|Donepezil|donepezil|mesh-list
91935239|NCT02331771|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91935240|NCT02331771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935241|NCT02331771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935243|NCT02331771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935244|NCT02331771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935245|NCT02331771|Nootropic Agents|nootropic agents|mesh-ancestor
91935246|NCT02334501|Lansoprazole|lansoprazole|mesh-list
91935247|NCT02334501|Dexlansoprazole|dexlansoprazole|mesh-list
91935248|NCT02334501|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91935249|NCT02334501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935250|NCT02334501|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91935251|NCT02334501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935255|NCT02331927|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91935256|NCT02331927|Growth Substances|growth substances|mesh-ancestor
91935257|NCT02331927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935258|NCT02331927|Growth Inhibitors|growth inhibitors|mesh-ancestor
91935259|NCT02331927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935260|NCT02322190|Methoxsalen|methoxsalen|mesh-list
91935261|NCT02322190|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91935262|NCT02322190|Dermatologic Agents|dermatologic agents|mesh-ancestor
91935263|NCT02304055|Oxytocin|oxytocin|mesh-list
91935264|NCT02304055|Carbetocin|carbetocin|mesh-list
91935265|NCT02304055|Oxytocics|oxytocics|mesh-ancestor
91935266|NCT02304055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935267|NCT02304055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935269|NCT05012865|Axitinib|axitinib|mesh-list
91935270|NCT05012865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935271|NCT05012865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935272|NCT05012865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935274|NCT05012865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935275|NCT03505489|Mannitol|mannitol|mesh-list
91935276|NCT03505489|Methacholine Chloride|methacholine chloride|mesh-list
91935277|NCT03505489|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91935278|NCT03505489|Diuretics|diuretics|mesh-ancestor
91935279|NCT03505489|Natriuretic Agents|natriuretic agents|mesh-ancestor
91935280|NCT03505489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935281|NCT03505489|Miotics|miotics|mesh-ancestor
91935282|NCT03505489|Autonomic Agents|autonomic agents|mesh-ancestor
91935283|NCT03505489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935284|NCT03505489|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91935285|NCT03505489|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
91935286|NCT03505489|Respiratory System Agents|respiratory system agents|mesh-ancestor
91935287|NCT03505489|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91935288|NCT03505489|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91935289|NCT03505489|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935290|NCT03505489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935291|NCT03505489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935292|NCT02310373|Nicotine|nicotine|mesh-list
91935293|NCT02310373|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91935294|NCT02310373|Autonomic Agents|autonomic agents|mesh-ancestor
91935295|NCT02310373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935296|NCT02310373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935297|NCT02310373|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91935298|NCT02310373|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91935299|NCT02310373|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935300|NCT02310373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935301|NCT02310373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935302|NCT02338323|Febuxostat|febuxostat|mesh-list
91935303|NCT02338323|Benzbromarone|benzbromarone|mesh-list
91935304|NCT02338323|Gout Suppressants|gout suppressants|mesh-ancestor
91935305|NCT02338323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935306|NCT02338323|Uricosuric Agents|uricosuric agents|mesh-ancestor
91935307|NCT02321800|Imipenem|imipenem|mesh-list
91935308|NCT02321800|Cilastatin|cilastatin|mesh-list
91935309|NCT02321800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91935310|NCT02321800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935311|NCT02321800|Protease Inhibitors|protease inhibitors|mesh-ancestor
91935312|NCT02321800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935313|NCT02321800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935314|NCT02310295|Triamcinolone|triamcinolone|mesh-list
91935315|NCT02310295|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91935316|NCT02310295|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91935317|NCT02310295|Bevacizumab|bevacizumab|mesh-list
91935318|NCT02310295|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91935319|NCT02310295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935320|NCT02310295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935321|NCT02310295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91935330|NCT02310295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91935331|NCT02310295|Immunologic Factors|immunologic factors|mesh-ancestor
91935332|NCT02310295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935333|NCT02310295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935334|NCT02338089|Oxytocin|oxytocin|mesh-list
91935335|NCT02338089|Oxytocics|oxytocics|mesh-ancestor
91935336|NCT02338089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935337|NCT02338089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935338|NCT02338245|Capecitabine|capecitabine|mesh-list
91935339|NCT02338245|Lapatinib|lapatinib|mesh-list
91935340|NCT02338245|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91935341|NCT02338245|Antimetabolites|antimetabolites|mesh-ancestor
91935342|NCT02338245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935343|NCT02338245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935344|NCT02338245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935345|NCT02338245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935346|NCT02332005|Choline|choline|mesh-list
91935347|NCT02332005|Lipotropic Agents|lipotropic agents|mesh-ancestor
91935348|NCT02332005|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91935349|NCT02332005|Antimetabolites|antimetabolites|mesh-ancestor
91935350|NCT02332005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943695|NCT02523547|Entecavir|entecavir|mesh-list
91935351|NCT02332005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935352|NCT02332005|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91935353|NCT02332005|Nootropic Agents|nootropic agents|mesh-ancestor
91935354|NCT02304211|Insulin|insulin|mesh-list
91935355|NCT02304211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91935356|NCT02304211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935358|NCT02311777|Ketamine|ketamine|mesh-list
91935359|NCT02311777|Analgesics|analgesics|mesh-ancestor
91935360|NCT02311777|Sensory System Agents|sensory system agents|mesh-ancestor
91935361|NCT02311777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935362|NCT02311777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935363|NCT02311777|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91935364|NCT02311777|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91935365|NCT02311777|Anesthetics, General|anesthetics, general|mesh-ancestor
91935366|NCT02311777|Anesthetics|anesthetics|mesh-ancestor
91935367|NCT02311777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935368|NCT02311777|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91935369|NCT02311777|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91935370|NCT02311777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935371|NCT02311777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935372|NCT02311777|Anticonvulsants|anticonvulsants|mesh-ancestor
91935373|NCT02311777|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91935374|NCT02311777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935375|NCT02311777|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91935376|NCT02311777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91935377|NCT02311777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91935378|NCT02311777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91935379|NCT03504865|Bupivacaine|bupivacaine|mesh-list
91935380|NCT03504865|Anesthetics, Local|anesthetics, local|mesh-ancestor
91935388|NCT02304289|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91935389|NCT02304289|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91935390|NCT02304289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935391|NCT02304289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935392|NCT02304289|Antiviral Agents|antiviral agents|mesh-ancestor
91935393|NCT02304289|Schistosomicides|schistosomicides|mesh-ancestor
91935394|NCT02304289|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91935395|NCT02304289|Anthelmintics|anthelmintics|mesh-ancestor
91935396|NCT02292784|Atosiban|atosiban|mesh-list
91935397|NCT02292784|Hormone Antagonists|hormone antagonists|mesh-ancestor
91935398|NCT02292784|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935399|NCT02292784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935400|NCT02292784|Tocolytic Agents|tocolytic agents|mesh-ancestor
91935401|NCT02292784|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935402|NCT02338011|Gefitinib|gefitinib|mesh-list
91935403|NCT02338011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935404|NCT02338011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935405|NCT02338011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935406|NCT02338011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935407|NCT02337855|Aluminum Hydroxide|aluminum hydroxide|mesh-list
91935408|NCT02337855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91935409|NCT02337855|Immunologic Factors|immunologic factors|mesh-ancestor
91935410|NCT02337855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935411|NCT02337855|Antacids|antacids|mesh-ancestor
91935412|NCT02337855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935413|NCT02337855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935415|NCT02320396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91935416|NCT02320396|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935417|NCT02320396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935418|NCT02320396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935419|NCT02320396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935420|NCT02320396|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91935421|NCT02320396|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91935422|NCT02320396|Histamine Antagonists|histamine antagonists|mesh-ancestor
91935423|NCT02320396|Histamine Agents|histamine agents|mesh-ancestor
91935424|NCT02312089|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91935425|NCT02312089|Luteolytic Agents|luteolytic agents|mesh-ancestor
91935426|NCT02312089|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91935427|NCT02312089|Contraceptive Agents|contraceptive agents|mesh-ancestor
91935428|NCT02312089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935429|NCT02312089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935430|NCT02312089|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91935431|NCT02312089|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935432|NCT02312089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935433|NCT02310997|Cyclophosphamide|cyclophosphamide|mesh-list
91935435|NCT02310997|Busulfan|busulfan|mesh-list
91935437|NCT02310997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91935438|NCT02310997|Immunologic Factors|immunologic factors|mesh-ancestor
91935439|NCT02310997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935440|NCT02310997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935441|NCT02310997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91935442|NCT02310997|Alkylating Agents|alkylating agents|mesh-ancestor
91935443|NCT02310997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935445|NCT02310997|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91935446|NCT03505411|Melatonin|melatonin|mesh-list
91935447|NCT03505411|Antioxidants|antioxidants|mesh-ancestor
91935448|NCT03505411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935449|NCT03505411|Protective Agents|protective agents|mesh-ancestor
91935450|NCT03505411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935451|NCT03505411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935452|NCT02292238|Benphothiamine|benphothiamine|mesh-list
91935453|NCT02292238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91935454|NCT02292238|Immunologic Factors|immunologic factors|mesh-ancestor
91935455|NCT02292238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935456|NCT02292238|Chelating Agents|chelating agents|mesh-ancestor
91935457|NCT02292238|Sequestering Agents|sequestering agents|mesh-ancestor
91935458|NCT02292238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935460|NCT02631447|Ipilimumab|ipilimumab|mesh-list
91935461|NCT02631447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935462|NCT02631447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935463|NCT02631447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91935464|NCT02631447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935465|NCT03867123|Temozolomide|temozolomide|mesh-list
91935466|NCT03867123|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91935467|NCT03867123|Alkylating Agents|alkylating agents|mesh-ancestor
91935468|NCT03867123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935469|NCT03867123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935470|NCT03504475|Paroxetine|paroxetine|mesh-list
91935471|NCT03504475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91935472|NCT03504475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91935473|NCT03504475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935474|NCT03504475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935475|NCT03504475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935476|NCT03504475|Serotonin Agents|serotonin agents|mesh-ancestor
91935477|NCT03504475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935478|NCT03504475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91935479|NCT03504475|Antidepressive Agents|antidepressive agents|mesh-ancestor
91935480|NCT03504475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91935481|NCT03504475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91935482|NCT03504475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91935483|NCT03504475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935484|NCT02327247|Felodipine|felodipine|mesh-list
91935485|NCT02327247|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91935486|NCT02327247|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91935487|NCT02327247|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91935488|NCT02327247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935489|NCT02327247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935490|NCT02327247|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91935491|NCT02327247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935492|NCT02327247|Vasodilator Agents|vasodilator agents|mesh-ancestor
91935493|NCT03505255|Neostigmine|neostigmine|mesh-list
91935494|NCT03505255|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91935495|NCT03505255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935496|NCT03505255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935497|NCT03505255|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935498|NCT03505255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935499|NCT03505255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935501|NCT03505255|Autonomic Agents|autonomic agents|mesh-ancestor
91935502|NCT03505255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935503|NCT02333799|Linezolid|linezolid|mesh-list
91935504|NCT02333799|Bedaquiline|bedaquiline|mesh-list
91935505|NCT02333799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91935506|NCT02333799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935507|NCT02333799|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91935508|NCT02333799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935509|NCT02333799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935510|NCT02333799|Antitubercular Agents|antitubercular agents|mesh-ancestor
91935512|NCT02311231|Calcium heparin|calcium heparin|mesh-list
91935513|NCT02311231|Bivalirudin|bivalirudin|mesh-list
91935514|NCT02311231|Anticoagulants|anticoagulants|mesh-ancestor
91935515|NCT02311231|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91935516|NCT02311231|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91935517|NCT02311231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935518|NCT02311231|Antithrombins|antithrombins|mesh-ancestor
91935519|NCT02311231|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91935520|NCT02311231|Protease Inhibitors|protease inhibitors|mesh-ancestor
91935521|NCT02311231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935522|NCT03508999|Metronidazole|metronidazole|mesh-list
91935523|NCT03508999|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935524|NCT03508999|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91935525|NCT03508999|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91935526|NCT03508999|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91935527|NCT03105375|Omeprazole|omeprazole|mesh-list
91935528|NCT03105375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91935529|NCT03105375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935530|NCT03105375|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91935531|NCT03105375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935532|NCT03105375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935533|NCT02304445|Chlorotrianisene|chlorotrianisene|mesh-list
91935534|NCT02304445|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91935535|NCT02304445|Estrogens|estrogens|mesh-ancestor
91935536|NCT02304445|Hormones|hormones|mesh-ancestor
91935537|NCT02304445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935538|NCT02304445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935539|NCT02304445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935540|NCT02304445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935541|NCT02316301|Misoprostol|misoprostol|mesh-list
91935542|NCT02316301|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91935543|NCT02316301|Abortifacient Agents|abortifacient agents|mesh-ancestor
91935544|NCT02316301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935545|NCT02316301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935546|NCT02316301|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91935547|NCT02316301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935548|NCT02316301|Oxytocics|oxytocics|mesh-ancestor
91935550|NCT02327091|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
91935551|NCT02327091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91935552|NCT02327091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935553|NCT02327091|Vitamins|vitamins|mesh-ancestor
91935554|NCT02327091|Micronutrients|micronutrients|mesh-ancestor
91935555|NCT02316535|Capecitabine|capecitabine|mesh-list
91935556|NCT02316535|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91935557|NCT02316535|Antimetabolites|antimetabolites|mesh-ancestor
91935558|NCT02316535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935559|NCT02316535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935560|NCT02333253|Cetrorelix|cetrorelix|mesh-list
91935561|NCT02333253|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91935562|NCT02333253|Fertility Agents|fertility agents|mesh-ancestor
91935563|NCT02333253|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935564|NCT02333253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935565|NCT02333253|Hormone Antagonists|hormone antagonists|mesh-ancestor
91935566|NCT02333253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935567|NCT02039661|Lidocaine|lidocaine|mesh-list
91935568|NCT02039661|Anesthetics, Local|anesthetics, local|mesh-ancestor
91935569|NCT02039661|Anesthetics|anesthetics|mesh-ancestor
91935570|NCT02039661|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935571|NCT02039661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935572|NCT02039661|Sensory System Agents|sensory system agents|mesh-ancestor
91935573|NCT02039661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935574|NCT02039661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91935575|NCT02039661|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91935576|NCT02039661|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91935577|NCT02039661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935578|NCT02039661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935579|NCT02326779|Aspirin|aspirin|mesh-list
91935580|NCT02326779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935581|NCT02326779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91935583|NCT02326779|Sensory System Agents|sensory system agents|mesh-ancestor
91935584|NCT02326779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935585|NCT02326779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935586|NCT02326779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935587|NCT02326779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935588|NCT02326779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91935589|NCT02326779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91935590|NCT02326779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935591|NCT02326779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91935592|NCT02326779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91935593|NCT02326779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935594|NCT02326779|Antipyretics|antipyretics|mesh-ancestor
91935595|NCT02331303|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
91935596|NCT02331303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935597|NCT02312635|Cycloserine|cycloserine|mesh-list
91935598|NCT02312635|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91935599|NCT02312635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935600|NCT02312635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91935601|NCT02312635|Antitubercular Agents|antitubercular agents|mesh-ancestor
91935602|NCT02312635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91935603|NCT02312635|Antimetabolites|antimetabolites|mesh-ancestor
91935604|NCT02312635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935605|NCT03144453|Atropine|atropine|mesh-list
91935606|NCT03144453|Neostigmine|neostigmine|mesh-list
91935607|NCT03144453|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91935608|NCT03144453|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91935609|NCT03144453|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91935610|NCT03144453|Autonomic Agents|autonomic agents|mesh-ancestor
91935611|NCT03144453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935612|NCT03144453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935613|NCT03144453|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91935614|NCT03144453|Respiratory System Agents|respiratory system agents|mesh-ancestor
91935615|NCT03144453|Mydriatics|mydriatics|mesh-ancestor
91935616|NCT03144453|Parasympatholytics|parasympatholytics|mesh-ancestor
91935617|NCT03144453|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91935618|NCT03144453|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91935619|NCT03144453|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935620|NCT03144453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935621|NCT03144453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935622|NCT03144453|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91935623|NCT03144453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935624|NCT03144453|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91935625|NCT02317159|Imatinib Mesylate|imatinib mesylate|mesh-list
91935626|NCT02317159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935627|NCT02317159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91935628|NCT02317159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935629|NCT02317159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935630|NCT02332941|Rituximab|rituximab|mesh-list
91935631|NCT02332941|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935632|NCT02332941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935633|NCT02332941|Immunologic Factors|immunologic factors|mesh-ancestor
91935634|NCT02332941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935635|NCT02332941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935636|NCT03503227|Aspirin|aspirin|mesh-list
91935637|NCT03503227|Salicylic Acid|salicylic acid|mesh-list
91935638|NCT03503227|Prednisolone|prednisolone|mesh-list
91935639|NCT03503227|Salicylates|salicylates|mesh-list
91935640|NCT03503227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935641|NCT03503227|Glucocorticoids|glucocorticoids|mesh-ancestor
91935642|NCT03503227|Hormones|hormones|mesh-ancestor
91935643|NCT03503227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935644|NCT03503227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935645|NCT03503227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935646|NCT03503227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935647|NCT03503227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935648|NCT03503227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935649|NCT03503227|Antifungal Agents|antifungal agents|mesh-ancestor
91935650|NCT03503227|Keratolytic Agents|keratolytic agents|mesh-ancestor
91935651|NCT03503227|Dermatologic Agents|dermatologic agents|mesh-ancestor
91935652|NCT03503227|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935653|NCT03503227|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91935654|NCT03503227|Analgesics|analgesics|mesh-ancestor
91935655|NCT03503227|Sensory System Agents|sensory system agents|mesh-ancestor
91935656|NCT03503227|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935657|NCT03503227|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91935658|NCT03503227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935659|NCT03503227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935660|NCT03503227|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91935661|NCT03503227|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91935662|NCT03503227|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91935663|NCT03503227|Antipyretics|antipyretics|mesh-ancestor
91935664|NCT02305069|Pioglitazone|pioglitazone|mesh-list
91935665|NCT02305069|Octreotide|octreotide|mesh-list
91935666|NCT02305069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91935667|NCT02305069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935668|NCT02305069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935669|NCT02305069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935670|NCT02305069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935671|NCT02317237|Anesthetics|anesthetics|mesh-list
91935672|NCT02317237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935673|NCT02317237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935674|NCT02332473|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91935675|NCT02332473|Molgramostim|molgramostim|mesh-list
91935676|NCT02332473|Sargramostim|sargramostim|mesh-list
91935677|NCT02332473|Antiviral Agents|antiviral agents|mesh-ancestor
91935678|NCT02332473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935679|NCT02332473|Immunologic Factors|immunologic factors|mesh-ancestor
91935680|NCT02332473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935681|NCT02332473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935682|NCT03501433|Niacinamide|niacinamide|mesh-list
91935683|NCT03501433|Niacin|niacin|mesh-list
91935684|NCT03501433|Nicotinic Acids|nicotinic acids|mesh-list
91935685|NCT03501433|Vitamin B Complex|vitamin b complex|mesh-ancestor
91935686|NCT03501433|Vitamins|vitamins|mesh-ancestor
91935687|NCT03501433|Micronutrients|micronutrients|mesh-ancestor
91935688|NCT03501433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935689|NCT03501433|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91935690|NCT03501433|Antimetabolites|antimetabolites|mesh-ancestor
91935691|NCT03501433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935692|NCT03501433|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91935693|NCT03501433|Vasodilator Agents|vasodilator agents|mesh-ancestor
91935694|NCT02383251|Paclitaxel|paclitaxel|mesh-list
91935695|NCT02383251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91935696|NCT02383251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935697|NCT02383251|Tubulin Modulators|tubulin modulators|mesh-ancestor
91935698|NCT02383251|Antimitotic Agents|antimitotic agents|mesh-ancestor
91935699|NCT02383251|Mitosis Modulators|mitosis modulators|mesh-ancestor
91935700|NCT02383251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935702|NCT02313103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91935703|NCT02313103|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91935704|NCT02313103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935705|NCT02313103|Sensory System Agents|sensory system agents|mesh-ancestor
91935706|NCT02313103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935707|NCT02313103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91935708|NCT02313103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91935709|NCT02313103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91935710|NCT02313103|Adrenergic Agents|adrenergic agents|mesh-ancestor
91935711|NCT02313103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935793|NCT02330757|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91935712|NCT02313103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935713|NCT01959633|Interferons|interferons|mesh-list
91935714|NCT01959633|Vemurafenib|vemurafenib|mesh-list
91935715|NCT01959633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935716|NCT01959633|Antiviral Agents|antiviral agents|mesh-ancestor
91935717|NCT01959633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935719|NCT01959633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935720|NCT01959633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935721|NCT02326623|Anesthetics|anesthetics|mesh-list
91935722|NCT02326623|Anesthetics, Local|anesthetics, local|mesh-list
91935723|NCT02326623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935724|NCT02326623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935725|NCT02326623|Sensory System Agents|sensory system agents|mesh-ancestor
91935726|NCT02326623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935727|NCT02317471|Oxaliplatin|oxaliplatin|mesh-list
91935728|NCT02317471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935729|NCT02332629|Methylprednisolone|methylprednisolone|mesh-list
91935730|NCT02332629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91935731|NCT02332629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91935732|NCT02332629|Prednisolone|prednisolone|mesh-list
91935733|NCT02332629|Prednisolone acetate|prednisolone acetate|mesh-list
91935734|NCT02332629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91935735|NCT02332629|Prednisolone phosphate|prednisolone phosphate|mesh-list
91935736|NCT02332629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935737|NCT02332629|Antiemetics|antiemetics|mesh-ancestor
91935738|NCT02332629|Autonomic Agents|autonomic agents|mesh-ancestor
91935739|NCT02332629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935740|NCT02332629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935741|NCT02332629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935742|NCT02332629|Glucocorticoids|glucocorticoids|mesh-ancestor
91935743|NCT02332629|Hormones|hormones|mesh-ancestor
91935744|NCT02332629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935745|NCT02332629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91935746|NCT02332629|Protective Agents|protective agents|mesh-ancestor
91935747|NCT02332629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935748|NCT02332629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935749|NCT02313337|Fentanyl|fentanyl|mesh-list
91935750|NCT02313337|Midazolam|midazolam|mesh-list
91935751|NCT02313337|Anesthetics|anesthetics|mesh-list
91935752|NCT02313337|Propofol|propofol|mesh-list
91935753|NCT02313337|Atracurium|atracurium|mesh-list
91935754|NCT02313337|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935755|NCT02313337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935756|NCT02313337|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91935757|NCT02313337|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91935758|NCT02313337|Anesthetics, General|anesthetics, general|mesh-ancestor
91935759|NCT02313337|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91935760|NCT02313337|Narcotics|narcotics|mesh-ancestor
91935761|NCT02313337|Analgesics|analgesics|mesh-ancestor
91935762|NCT02313337|Sensory System Agents|sensory system agents|mesh-ancestor
91935763|NCT02313337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935764|NCT02313337|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91935765|NCT02313337|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91935766|NCT02313337|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91935767|NCT02313337|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91935768|NCT02313337|GABA Modulators|gaba modulators|mesh-ancestor
91935769|NCT02313337|GABA Agents|gaba agents|mesh-ancestor
91935770|NCT02313337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935771|NCT02313337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935772|NCT02313337|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91935773|NCT02313337|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91935774|NCT02313337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91935775|NCT02313337|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
91935776|NCT02313337|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91935777|NCT02313337|Cholinergic Agents|cholinergic agents|mesh-ancestor
91935778|NCT02330757|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91935779|NCT02330757|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91935781|NCT02330757|Enclomiphene|enclomiphene|mesh-list
91935782|NCT02330757|Zuclomiphene|zuclomiphene|mesh-list
91935784|NCT02330757|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91935785|NCT02330757|Estrogens|estrogens|mesh-ancestor
91935786|NCT02330757|Hormones|hormones|mesh-ancestor
91935787|NCT02330757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935788|NCT02330757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935789|NCT02330757|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91935791|NCT02330757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91935792|NCT02330757|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91935794|NCT02330757|Hormone Antagonists|hormone antagonists|mesh-ancestor
91935795|NCT02330757|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91935796|NCT02330757|Fertility Agents|fertility agents|mesh-ancestor
91935797|NCT02330757|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91935798|NCT02330757|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91935799|NCT03502993|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91935800|NCT03502993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935801|NCT02305615|Bevacizumab|bevacizumab|mesh-list
91935802|NCT02305615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935803|NCT02305615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935804|NCT02305615|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91935805|NCT02305615|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91935807|NCT02305615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935808|NCT02305615|Growth Inhibitors|growth inhibitors|mesh-ancestor
91935809|NCT02305693|Letrozole|letrozole|mesh-list
91935810|NCT02305693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935811|NCT02305693|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91935812|NCT02305693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91935813|NCT02305693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935814|NCT02305693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935815|NCT02305693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91935816|NCT02305693|Hormone Antagonists|hormone antagonists|mesh-ancestor
91935817|NCT02305693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935818|NCT02305693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935819|NCT02317861|Febuxostat|febuxostat|mesh-list
91935820|NCT02317861|Verinurad|verinurad|mesh-list
91935821|NCT02317861|Benzbromarone|benzbromarone|mesh-list
91935822|NCT02317861|Gout Suppressants|gout suppressants|mesh-ancestor
91935823|NCT02317861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935824|NCT02317861|Uricosuric Agents|uricosuric agents|mesh-ancestor
91935825|NCT02318017|Methylphenidate|methylphenidate|mesh-list
91935826|NCT02318017|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91935827|NCT02318017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935828|NCT02318017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91935829|NCT02318017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91935830|NCT02318017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935831|NCT02318017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935832|NCT02318017|Dopamine Agents|dopamine agents|mesh-ancestor
91935833|NCT02318017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935834|NCT02313727|Pamidronate|pamidronate|mesh-list
91935835|NCT02313727|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91935836|NCT02313727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935837|NCT02313805|Insulin|insulin|mesh-list
91935838|NCT02313805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91935839|NCT02313805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935840|NCT03132493|Nivolumab|nivolumab|mesh-list
91935841|NCT03132493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91935842|NCT03132493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935843|NCT03132493|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91935844|NCT03132493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935845|NCT02313883|Taurolidine|taurolidine|mesh-list
91935846|NCT02313883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935847|NCT02313883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91935848|NCT02313883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935849|NCT03500653|Curcumin|curcumin|mesh-list
91935850|NCT03500653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935851|NCT03500653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91935852|NCT03500653|Analgesics|analgesics|mesh-ancestor
91935853|NCT03500653|Sensory System Agents|sensory system agents|mesh-ancestor
91935854|NCT03500653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935855|NCT03500653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935856|NCT03500653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935857|NCT03500653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935858|NCT03500653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935860|NCT03500653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935861|NCT02305927|Vitamin D|vitamin d|mesh-list
91935862|NCT02305927|Cholecalciferol|cholecalciferol|mesh-list
91935864|NCT02305927|Micronutrients|micronutrients|mesh-ancestor
91935865|NCT02305927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935866|NCT02305927|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91935867|NCT02305927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91935869|NCT02440009|Glucocorticoids|glucocorticoids|mesh-list
91935870|NCT02440009|Antifungal Agents|antifungal agents|mesh-ancestor
91935871|NCT02440009|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935872|NCT02440009|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91935873|NCT02440009|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91935874|NCT02440009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935875|NCT02440009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935876|NCT02440009|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91935877|NCT02440009|Hormone Antagonists|hormone antagonists|mesh-ancestor
91935878|NCT02440009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935879|NCT02440009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935880|NCT02440009|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91935881|NCT02440009|Hormones|hormones|mesh-ancestor
91935882|NCT02318563|Cannabidiol|cannabidiol|mesh-list
91935883|NCT02318563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91935884|NCT02318563|Anticonvulsants|anticonvulsants|mesh-ancestor
91935885|NCT02314195|Serotonin|serotonin|mesh-list
91935886|NCT02314195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
91935887|NCT02314195|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91935888|NCT02314195|Serotonin Agents|serotonin agents|mesh-ancestor
91935889|NCT02314195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935890|NCT02314195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935891|NCT02314195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935892|NCT02314195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91935893|NCT02314195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91935894|NCT02314273|Oprelvekin|oprelvekin|mesh-list
91935895|NCT02314273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935896|NCT02314351|Fentanyl|fentanyl|mesh-list
91935897|NCT02314351|Metoclopramide|metoclopramide|mesh-list
91935898|NCT02314351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91935899|NCT02314351|Narcotics|narcotics|mesh-ancestor
91935900|NCT02314351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935901|NCT02314351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935902|NCT02314351|Analgesics|analgesics|mesh-ancestor
91935903|NCT02314351|Sensory System Agents|sensory system agents|mesh-ancestor
91935904|NCT02314351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935905|NCT02314351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91935906|NCT02314351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91935907|NCT02314351|Anesthetics, General|anesthetics, general|mesh-ancestor
91935908|NCT02314351|Anesthetics|anesthetics|mesh-ancestor
91935909|NCT02314351|Antiemetics|antiemetics|mesh-ancestor
91935910|NCT02314351|Autonomic Agents|autonomic agents|mesh-ancestor
91935911|NCT02314351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935912|NCT02314351|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91935913|NCT02314351|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91935914|NCT02314351|Dopamine Agents|dopamine agents|mesh-ancestor
91935915|NCT02314351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935916|NCT02314351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935917|NCT04463875|Coenzyme Q10|coenzyme q10|mesh-list
91935918|NCT04463875|Riboflavin|riboflavin|mesh-list
91935919|NCT04463875|Ubiquinone|ubiquinone|mesh-list
91935920|NCT04463875|Andrographolide|andrographolide|mesh-list
91935921|NCT04463875|Vitamins|vitamins|mesh-ancestor
91935923|NCT04463875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935924|NCT04463875|Vitamin B Complex|vitamin b complex|mesh-ancestor
91935925|NCT04463875|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91935926|NCT04463875|Dermatologic Agents|dermatologic agents|mesh-ancestor
91935927|NCT04463875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935928|NCT04463875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91935929|NCT04463875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91935930|NCT04463875|Analgesics|analgesics|mesh-ancestor
91935931|NCT04463875|Sensory System Agents|sensory system agents|mesh-ancestor
91935932|NCT04463875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935933|NCT04463875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91935934|NCT04463875|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91935935|NCT04463875|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91935936|NCT04463875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91935937|NCT04463875|Antiviral Agents|antiviral agents|mesh-ancestor
91935938|NCT04463875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91935939|NCT03500029|Antidepressive Agents|antidepressive agents|mesh-list
91935940|NCT03500029|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91935941|NCT04462939|Micronutrients|micronutrients|mesh-list
91935942|NCT04462939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935943|NCT02306239|Terlipressin|terlipressin|mesh-list
91935944|NCT02306239|Norepinephrine|norepinephrine|mesh-list
91935945|NCT02306239|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91935946|NCT02306239|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91935947|NCT02306239|Adrenergic Agents|adrenergic agents|mesh-ancestor
91935948|NCT02306239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91935949|NCT02306239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935950|NCT02306239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935951|NCT02306239|Sympathomimetics|sympathomimetics|mesh-ancestor
91935952|NCT02306239|Autonomic Agents|autonomic agents|mesh-ancestor
91935953|NCT02306239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935954|NCT02306239|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91935955|NCT02306239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91935957|NCT02319187|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91935958|NCT02319187|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91935959|NCT02319187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91935960|NCT02319187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935961|NCT02319187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935964|NCT02319265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91935965|NCT02319265|Protective Agents|protective agents|mesh-ancestor
91935966|NCT02319265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935967|NCT02319265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91935968|NCT02319343|Methylprednisolone|methylprednisolone|mesh-list
91935969|NCT02319343|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91935970|NCT02319343|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91935971|NCT02319343|Prednisolone|prednisolone|mesh-list
91935972|NCT02319343|Prednisolone acetate|prednisolone acetate|mesh-list
91935973|NCT02319343|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91935974|NCT02319343|Prednisolone phosphate|prednisolone phosphate|mesh-list
91935975|NCT02319343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91935976|NCT02319343|Antiemetics|antiemetics|mesh-ancestor
91935977|NCT02319343|Autonomic Agents|autonomic agents|mesh-ancestor
91935978|NCT02319343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91935979|NCT02319343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935980|NCT02319343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91935981|NCT02319343|Glucocorticoids|glucocorticoids|mesh-ancestor
91935983|NCT02319343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91935984|NCT02319343|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91935985|NCT02319343|Protective Agents|protective agents|mesh-ancestor
91935986|NCT02319343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91935987|NCT02319343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91935989|NCT02319499|Iron|iron|mesh-list
91935990|NCT02319499|Zinc|zinc|mesh-list
91935991|NCT02319499|Vitamins|vitamins|mesh-ancestor
91935992|NCT02319499|Micronutrients|micronutrients|mesh-ancestor
91935993|NCT02319499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91935994|NCT02319499|Trace Elements|trace elements|mesh-ancestor
91935995|NCT03499639|Ritonavir|ritonavir|mesh-list
91935996|NCT03499639|Ribavirin|ribavirin|mesh-list
91935997|NCT03499639|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91935998|NCT03499639|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91935999|NCT03499639|Protease Inhibitors|protease inhibitors|mesh-ancestor
91936000|NCT03499639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936001|NCT03499639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936002|NCT03499639|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91936003|NCT03499639|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91936004|NCT03499639|Antiviral Agents|antiviral agents|mesh-ancestor
91936005|NCT03499639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936006|NCT03499639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91936007|NCT03499639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91936008|NCT03499639|Antimetabolites|antimetabolites|mesh-ancestor
91936010|NCT03502135|Oxymetazoline|oxymetazoline|mesh-list
91936011|NCT03502135|Tetracaine|tetracaine|mesh-list
91936012|NCT03502135|Anesthetics, Local|anesthetics, local|mesh-ancestor
91936013|NCT03502135|Anesthetics|anesthetics|mesh-ancestor
91936014|NCT03502135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936015|NCT03502135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936016|NCT03502135|Sensory System Agents|sensory system agents|mesh-ancestor
91936017|NCT03502135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936018|NCT03502135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91936019|NCT03502135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91936020|NCT03502135|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936021|NCT03502135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936022|NCT03502135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936024|NCT03502135|Autonomic Agents|autonomic agents|mesh-ancestor
91936025|NCT03502135|Nasal Decongestants|nasal decongestants|mesh-ancestor
91936026|NCT03502135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91936027|NCT03502135|Respiratory System Agents|respiratory system agents|mesh-ancestor
91936028|NCT03502135|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91936029|NCT03502135|Mydriatics|mydriatics|mesh-ancestor
91936030|NCT03502135|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91936031|NCT03502135|Protective Agents|protective agents|mesh-ancestor
91936032|NCT02315287|Pioglitazone|pioglitazone|mesh-list
91936033|NCT02315287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936034|NCT02315287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936035|NCT02319577|Vinorelbine|vinorelbine|mesh-list
91936036|NCT02319577|Gefitinib|gefitinib|mesh-list
91936037|NCT02319577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91936038|NCT02319577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936039|NCT02319577|Tubulin Modulators|tubulin modulators|mesh-ancestor
91936040|NCT02319577|Antimitotic Agents|antimitotic agents|mesh-ancestor
91936041|NCT02319577|Mitosis Modulators|mitosis modulators|mesh-ancestor
91936042|NCT02319577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936043|NCT02319577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936044|NCT02319577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936045|NCT03501901|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91936046|NCT03501901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936048|NCT03132259|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936049|NCT03132259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936050|NCT03132259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936051|NCT03132259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936052|NCT03132259|Analgesics|analgesics|mesh-ancestor
91936053|NCT03132259|Sensory System Agents|sensory system agents|mesh-ancestor
91936054|NCT03132259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936055|NCT03132259|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91936056|NCT03132259|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91936057|NCT03132259|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91936058|NCT03132259|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936059|NCT03132259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936060|NCT03132259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936061|NCT03499171|Citalopram|citalopram|mesh-list
91936062|NCT03499171|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91936063|NCT03499171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91936064|NCT03499171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91936065|NCT03499171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936066|NCT03499171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936067|NCT03499171|Serotonin Agents|serotonin agents|mesh-ancestor
91936068|NCT03499171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936069|NCT03499171|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91936070|NCT03499171|Antidepressive Agents|antidepressive agents|mesh-ancestor
91936071|NCT03499171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91936073|NCT02447419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936074|NCT02447419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936075|NCT02447419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943778|NCT02282891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936076|NCT02447419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936077|NCT02319889|Paclitaxel|paclitaxel|mesh-list
91936078|NCT02319889|Carboplatin|carboplatin|mesh-list
91936079|NCT02319889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91936080|NCT02319889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91936081|NCT02319889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936082|NCT02319889|Tubulin Modulators|tubulin modulators|mesh-ancestor
91936083|NCT02319889|Antimitotic Agents|antimitotic agents|mesh-ancestor
91936084|NCT02319889|Mitosis Modulators|mitosis modulators|mesh-ancestor
91936085|NCT02319889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936086|NCT02324413|Clonidine|clonidine|mesh-list
91936087|NCT02324413|Analgesics|analgesics|mesh-ancestor
91936088|NCT02324413|Sensory System Agents|sensory system agents|mesh-ancestor
91936089|NCT02324413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936090|NCT02324413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936091|NCT02324413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91936092|NCT02324413|Sympatholytics|sympatholytics|mesh-ancestor
91936093|NCT02324413|Autonomic Agents|autonomic agents|mesh-ancestor
91936094|NCT02324413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91936095|NCT02324413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91936096|NCT02324413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91936097|NCT02324413|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936098|NCT02324413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936099|NCT02324413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936100|NCT03498703|Azathioprine|azathioprine|mesh-list
91936101|NCT03498703|Antimetabolites|antimetabolites|mesh-ancestor
91936102|NCT03498703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936103|NCT03498703|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936104|NCT03498703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936106|NCT03498703|Immunologic Factors|immunologic factors|mesh-ancestor
91936107|NCT03498703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936108|NCT03498703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936109|NCT02324491|CKD732|ckd732|mesh-list
91936110|NCT02324491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91936111|NCT02324491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91936112|NCT02324491|Growth Substances|growth substances|mesh-ancestor
91936113|NCT02324491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936114|NCT02324491|Growth Inhibitors|growth inhibitors|mesh-ancestor
91936115|NCT02324491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936116|NCT03494257|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91936117|NCT03494257|Brinzolamide|brinzolamide|mesh-list
91936118|NCT03494257|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91936119|NCT03494257|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91936120|NCT03494257|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91936121|NCT03494257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91936122|NCT03494257|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936123|NCT03494257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936124|NCT03494257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936125|NCT03494257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936126|NCT03494257|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91936127|NCT03494257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936129|NCT03132181|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91936130|NCT03132181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936131|NCT03132181|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936132|NCT03132181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936134|NCT02320045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936135|NCT02320045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936136|NCT02320045|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91936137|NCT02320045|Incretins|incretins|mesh-ancestor
91936138|NCT02320045|Hormones|hormones|mesh-ancestor
91936139|NCT02320045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936140|NCT02320357|Clopidogrel|clopidogrel|mesh-list
91936141|NCT02320357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91936142|NCT02320357|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91936143|NCT02320357|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91936144|NCT02320357|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91936145|NCT02320357|Purinergic Agents|purinergic agents|mesh-ancestor
91936146|NCT02320357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936147|NCT02320357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936148|NCT02320357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936150|NCT03498235|Sevoflurane|sevoflurane|mesh-list
91936151|NCT03498235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936152|NCT03498235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936153|NCT03498235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936154|NCT03498235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91936156|NCT03498235|Anesthetics|anesthetics|mesh-ancestor
91936157|NCT03498235|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91936158|NCT03498235|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91936159|NCT03491761|Hyaluronic Acid|hyaluronic acid|mesh-list
91936160|NCT03491761|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91936161|NCT03491761|Immunologic Factors|immunologic factors|mesh-ancestor
91936162|NCT03491761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936163|NCT03491761|Viscosupplements|viscosupplements|mesh-ancestor
91936164|NCT03491761|Protective Agents|protective agents|mesh-ancestor
91936165|NCT03132103|Vitamin D|vitamin d|mesh-list
91936166|NCT03132103|Ergocalciferols|ergocalciferols|mesh-list
91936167|NCT03132103|Cholecalciferol|cholecalciferol|mesh-list
91936168|NCT03132103|Vitamins|vitamins|mesh-list
91936169|NCT03132103|Micronutrients|micronutrients|mesh-ancestor
91936170|NCT03132103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936171|NCT03132103|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91936172|NCT03132103|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91936173|NCT04635943|Ivermectin|ivermectin|mesh-list
91936174|NCT04635943|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91936175|NCT04635943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936176|NCT04461925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91936177|NCT04461925|Azithromycin|azithromycin|mesh-list
91936178|NCT04461925|Ceftriaxone|ceftriaxone|mesh-list
91936179|NCT04461925|Dexamethasone|dexamethasone|mesh-list
91936180|NCT04461925|Enoxaparin|enoxaparin|mesh-list
91936181|NCT04461925|Anticoagulants|anticoagulants|mesh-list
91936182|NCT04461925|Hormones|hormones|mesh-list
91936183|NCT04461925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936184|NCT04461925|Antiemetics|antiemetics|mesh-ancestor
91936185|NCT04461925|Autonomic Agents|autonomic agents|mesh-ancestor
91936186|NCT04461925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936187|NCT04461925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936188|NCT04461925|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936189|NCT04461925|Glucocorticoids|glucocorticoids|mesh-ancestor
92081556|NCT04415983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081557|NCT04415983|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92081558|NCT04415983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92081559|NCT01426269|Metronidazole|metronidazole|mesh-list
91936190|NCT04461925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936191|NCT04461925|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91936192|NCT04461925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936193|NCT04461925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936194|NCT04461925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936197|NCT02325583|Midazolam|midazolam|mesh-list
91936198|NCT02325583|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91936199|NCT02325583|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936200|NCT02325583|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936201|NCT02325583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936203|NCT02325583|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91936204|NCT02325583|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91936205|NCT02325583|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91936206|NCT02325583|Anesthetics, General|anesthetics, general|mesh-ancestor
91936207|NCT02325583|Anesthetics|anesthetics|mesh-ancestor
91936208|NCT02325583|GABA Modulators|gaba modulators|mesh-ancestor
91936209|NCT02325583|GABA Agents|gaba agents|mesh-ancestor
91936210|NCT02325583|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936211|NCT02325583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936213|NCT02321293|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91936214|NCT02321293|Gefitinib|gefitinib|mesh-list
91936215|NCT02321293|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91936216|NCT02321293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936217|NCT02321293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936218|NCT02321293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936219|NCT02321293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936220|NCT02321293|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91936221|NCT02321293|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936222|NCT02321293|Analgesics|analgesics|mesh-ancestor
91936223|NCT02321293|Sensory System Agents|sensory system agents|mesh-ancestor
91936224|NCT02321293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936225|NCT02321293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936226|NCT02321293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936227|NCT02321293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936229|NCT02321371|Lactulose|lactulose|mesh-list
91936230|NCT02321371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936231|NCT02321371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936232|NCT02321371|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936233|NCT04002037|Dexamethasone|dexamethasone|mesh-list
91936234|NCT04002037|Triamcinolone|triamcinolone|mesh-list
91936235|NCT04002037|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91936237|NCT04002037|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91936238|NCT04002037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936239|NCT04002037|Antiemetics|antiemetics|mesh-ancestor
91936240|NCT04002037|Autonomic Agents|autonomic agents|mesh-ancestor
91936241|NCT04002037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936242|NCT04002037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936244|NCT04002037|Glucocorticoids|glucocorticoids|mesh-ancestor
91936245|NCT04002037|Hormones|hormones|mesh-ancestor
91936246|NCT04002037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936247|NCT04002037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91936248|NCT04002037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936249|NCT04002037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936250|NCT04002037|Immunologic Factors|immunologic factors|mesh-ancestor
91936251|NCT04002037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936252|NCT04002037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936253|NCT03491371|Apatinib|apatinib|mesh-list
91936254|NCT03491371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936255|NCT03491371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936256|NCT03491371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936257|NCT03491371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936258|NCT03546829|Vancomycin|vancomycin|mesh-list
91936259|NCT03546829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936260|NCT03546829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936261|NCT03284047|Botulinum Toxins|botulinum toxins|mesh-list
91936262|NCT03284047|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91936263|NCT03284047|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91936264|NCT03284047|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91936265|NCT03284047|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91943784|NCT00464633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936266|NCT03284047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936268|NCT03284047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936269|NCT03284047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936270|NCT03284047|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91936271|NCT03284047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936273|NCT03493087|Vitamins|vitamins|mesh-ancestor
91936274|NCT03493087|Micronutrients|micronutrients|mesh-ancestor
91936275|NCT03493087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936276|NCT03493087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91936277|NCT03493087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92081561|NCT01426269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936278|NCT03493087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936279|NCT03493087|Hemostatics|hemostatics|mesh-ancestor
91936282|NCT03136627|Tivozanib|tivozanib|mesh-list
91936283|NCT03136627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936284|NCT03136627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936285|NCT03136627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91936286|NCT03136627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936287|NCT03136627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936288|NCT03136627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936289|NCT02922985|Acetaminophen|acetaminophen|mesh-list
91936290|NCT02922985|Ketorolac|ketorolac|mesh-list
91936291|NCT02922985|Bupivacaine|bupivacaine|mesh-list
91936292|NCT02922985|Anesthetics, Local|anesthetics, local|mesh-ancestor
91936293|NCT02922985|Anesthetics|anesthetics|mesh-ancestor
91936294|NCT02922985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936295|NCT02922985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936296|NCT02922985|Sensory System Agents|sensory system agents|mesh-ancestor
91936297|NCT02922985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936298|NCT02922985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91936299|NCT02922985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936300|NCT02922985|Analgesics|analgesics|mesh-ancestor
91936301|NCT02922985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936302|NCT02922985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936303|NCT02922985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91936304|NCT02922985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936305|NCT02922985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936306|NCT02922985|Antipyretics|antipyretics|mesh-ancestor
91936308|NCT04881955|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91936309|NCT04881955|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91936310|NCT04881955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936311|NCT04881955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936313|NCT04881955|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91936314|NCT04881955|Dopamine Agents|dopamine agents|mesh-ancestor
91936315|NCT04881955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936316|NCT04881955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936317|NCT02234843|Rivaroxaban|rivaroxaban|mesh-list
91936318|NCT02234843|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91936319|NCT02234843|Antithrombins|antithrombins|mesh-ancestor
91936320|NCT02234843|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91936321|NCT02234843|Protease Inhibitors|protease inhibitors|mesh-ancestor
91936322|NCT02234843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936323|NCT02234843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936324|NCT02234843|Anticoagulants|anticoagulants|mesh-ancestor
91936325|NCT03492931|Ticagrelor|ticagrelor|mesh-list
91936326|NCT03492931|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91936327|NCT03492931|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91943791|NCT00464555|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91936328|NCT03492931|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91936329|NCT03492931|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91936330|NCT03492931|Purinergic Agents|purinergic agents|mesh-ancestor
91936331|NCT03492931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936332|NCT03492931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936333|NCT03492931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936334|NCT02234921|Cyclophosphamide|cyclophosphamide|mesh-list
91936335|NCT02234921|Imiquimod|imiquimod|mesh-list
91936336|NCT02234921|Vaccines|vaccines|mesh-list
91936337|NCT02234921|Immunologic Factors|immunologic factors|mesh-ancestor
91936338|NCT02234921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936339|NCT02234921|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936340|NCT02234921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936341|NCT02234921|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91936342|NCT02234921|Alkylating Agents|alkylating agents|mesh-ancestor
91936343|NCT02234921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936344|NCT02234921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936346|NCT02234921|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91936347|NCT02234921|Interferon Inducers|interferon inducers|mesh-ancestor
91936348|NCT02321761|Amantadine|amantadine|mesh-list
91936349|NCT02321761|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91936350|NCT02321761|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91936351|NCT02321761|Antiviral Agents|antiviral agents|mesh-ancestor
91936352|NCT02321761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936353|NCT02321761|Dopamine Agents|dopamine agents|mesh-ancestor
91936354|NCT02321761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936355|NCT02321761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936356|NCT02321761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936357|NCT02321761|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936358|NCT02321761|Analgesics|analgesics|mesh-ancestor
91936359|NCT02321761|Sensory System Agents|sensory system agents|mesh-ancestor
91936360|NCT02321761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936361|NCT04674241|Dexmedetomidine|dexmedetomidine|mesh-list
91936362|NCT04674241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936363|NCT04674241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936364|NCT04674241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936365|NCT04674241|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936366|NCT04674241|Analgesics|analgesics|mesh-ancestor
91936367|NCT04674241|Sensory System Agents|sensory system agents|mesh-ancestor
91936368|NCT04674241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936369|NCT04674241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91936370|NCT04674241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91936371|NCT04674241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91936372|NCT04674241|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936373|NCT04674241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936374|NCT04674241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936375|NCT02259647|Sorafenib|sorafenib|mesh-list
91936376|NCT02259647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936377|NCT02259647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936378|NCT02259647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936379|NCT02259647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936381|NCT02321839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91936382|NCT02321839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91936384|NCT02321839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936385|NCT02321839|Growth Inhibitors|growth inhibitors|mesh-ancestor
91936386|NCT02321839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936387|NCT03490279|Lactoferrin|lactoferrin|mesh-list
91936388|NCT03490279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936389|NCT02750345|Nitisinone|nitisinone|mesh-list
91936390|NCT02750345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936391|NCT02750345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936392|NCT01329263|Menthol|menthol|mesh-list
91936393|NCT01329263|Antipruritics|antipruritics|mesh-ancestor
91936394|NCT01329263|Dermatologic Agents|dermatologic agents|mesh-ancestor
91936395|NCT03490123|Azithromycin|azithromycin|mesh-list
91936396|NCT03490123|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936397|NCT03490123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936398|NCT02235233|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
91936399|NCT02235233|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91936400|NCT02235233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936401|NCT02182687|Doxorubicin|doxorubicin|mesh-list
91936402|NCT02182687|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91936403|NCT02182687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936404|NCT02182687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936405|NCT02182687|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91936406|NCT02182687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91936407|NCT02182687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936408|NCT02182687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936409|NCT02235389|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91936410|NCT02235389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91936411|NCT02235389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92081562|NCT01426269|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92081563|NCT01426269|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91936412|NCT02235389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936413|NCT03489889|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91936414|NCT03489889|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91936415|NCT03489889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936416|NCT01388491|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91936417|NCT01388491|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91936418|NCT01388491|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91936419|NCT01388491|Desogestrel|desogestrel|mesh-list
91936420|NCT01388491|Estradiol|estradiol|mesh-list
91936421|NCT01388491|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91936422|NCT01388491|Estrogens|estrogens|mesh-ancestor
91936423|NCT01388491|Hormones|hormones|mesh-ancestor
91936424|NCT01388491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081564|NCT01426269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92081565|NCT01426269|Antimalarials|antimalarials|mesh-ancestor
92081566|NCT01426113|Timolol|timolol|mesh-list
92081567|NCT01426113|Bimatoprost|bimatoprost|mesh-list
91936426|NCT01388491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91936427|NCT01388491|Contraceptive Agents|contraceptive agents|mesh-ancestor
91936428|NCT01388491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91936429|NCT01388491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91936430|NCT01388491|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91936431|NCT01388491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91936432|NCT01388491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91936433|NCT01388491|Progestins|progestins|mesh-ancestor
91936434|NCT02236169|Bromides|bromides|mesh-list
91936435|NCT02236169|Norflurane|norflurane|mesh-list
91936436|NCT02236169|Ipratropium|ipratropium|mesh-list
91936437|NCT02236169|Anticonvulsants|anticonvulsants|mesh-ancestor
91936438|NCT02236169|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91936439|NCT02236169|Autonomic Agents|autonomic agents|mesh-ancestor
91936440|NCT02236169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936441|NCT02236169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936442|NCT02236169|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91936443|NCT02236169|Respiratory System Agents|respiratory system agents|mesh-ancestor
91936444|NCT02236169|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91936445|NCT02236169|Cholinergic Agents|cholinergic agents|mesh-ancestor
91936446|NCT02236169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936447|NCT02236169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936448|NCT02236169|Anesthetics|anesthetics|mesh-ancestor
91936449|NCT02236169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936450|NCT02749799|Betamethasone|betamethasone|mesh-list
91936451|NCT02749799|Betamethasone Valerate|betamethasone valerate|mesh-list
91936452|NCT02749799|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91936453|NCT02749799|Betamethasone benzoate|betamethasone benzoate|mesh-list
91936454|NCT02749799|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91936455|NCT02749799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936457|NCT02749799|Hormones|hormones|mesh-ancestor
91936458|NCT02749799|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936459|NCT02749799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936460|NCT02749799|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91936461|NCT02749799|Respiratory System Agents|respiratory system agents|mesh-ancestor
91936463|NCT03492541|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91936464|NCT03492385|Ticagrelor|ticagrelor|mesh-list
91936465|NCT03492385|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91936466|NCT03492385|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91936467|NCT03492385|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91936468|NCT03492385|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91936469|NCT03492385|Purinergic Agents|purinergic agents|mesh-ancestor
91936470|NCT03492385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936471|NCT03492385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936472|NCT03492385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936474|NCT03736265|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91936476|NCT03736265|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936477|NCT03736265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936478|NCT03736265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936481|NCT03736265|Antioxidants|antioxidants|mesh-ancestor
91936482|NCT03736265|Protective Agents|protective agents|mesh-ancestor
91936483|NCT03736265|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91936484|NCT03736265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91936485|NCT03736265|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91936487|NCT03736265|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91936488|NCT03736265|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91936489|NCT04939363|Venetoclax|venetoclax|mesh-list
91936490|NCT04939363|Obinutuzumab|obinutuzumab|mesh-list
91936491|NCT04939363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936492|NCT04939363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936493|NCT02236403|Metronidazole|metronidazole|mesh-list
91936494|NCT02236403|Ivermectin|ivermectin|mesh-list
91936495|NCT02236403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936496|NCT02236403|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936497|NCT02236403|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91936498|NCT02236403|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91936499|NCT02236481|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91936500|NCT02236481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936502|NCT03491527|Pemetrexed|pemetrexed|mesh-list
91936504|NCT03491527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081568|NCT01426113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91936505|NCT03491527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936506|NCT03491527|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92081569|NCT01426113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91936507|NCT03491527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91936508|NCT03491527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936509|NCT03491527|Antifungal Agents|antifungal agents|mesh-ancestor
91936510|NCT03491527|Keratolytic Agents|keratolytic agents|mesh-ancestor
91936511|NCT03491527|Dermatologic Agents|dermatologic agents|mesh-ancestor
91936512|NCT02934529|Leucovorin|leucovorin|mesh-list
91936513|NCT02934529|Folic Acid|folic acid|mesh-list
91936514|NCT02934529|Bevacizumab|bevacizumab|mesh-list
91936515|NCT02934529|Cetuximab|cetuximab|mesh-list
91936516|NCT02934529|Fluorouracil|fluorouracil|mesh-list
91936517|NCT02934529|Capecitabine|capecitabine|mesh-list
91936518|NCT02934529|Irinotecan|irinotecan|mesh-list
91936519|NCT02934529|Levoleucovorin|levoleucovorin|mesh-list
91936520|NCT02934529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936521|NCT02934529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936522|NCT02934529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91936523|NCT02934529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91936524|NCT02934529|Growth Substances|growth substances|mesh-ancestor
91936525|NCT02934529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936526|NCT02934529|Growth Inhibitors|growth inhibitors|mesh-ancestor
91936527|NCT02934529|Antimetabolites|antimetabolites|mesh-ancestor
91936528|NCT02934529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936529|NCT02934529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936530|NCT02934529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936531|NCT02934529|Immunologic Factors|immunologic factors|mesh-ancestor
91936532|NCT02934529|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91936533|NCT02934529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91936534|NCT02934529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936535|NCT02934529|Antidotes|antidotes|mesh-ancestor
91936536|NCT02934529|Protective Agents|protective agents|mesh-ancestor
91936537|NCT02934529|Vitamin B Complex|vitamin b complex|mesh-ancestor
91936538|NCT02934529|Vitamins|vitamins|mesh-ancestor
91936539|NCT02934529|Micronutrients|micronutrients|mesh-ancestor
91936540|NCT02934529|Hematinics|hematinics|mesh-ancestor
91936541|NCT02638805|Metformin|metformin|mesh-list
91936542|NCT02638805|Liraglutide|liraglutide|mesh-list
91936543|NCT02638805|Exenatide|exenatide|mesh-list
91936544|NCT02638805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936545|NCT02638805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936546|NCT02638805|Incretins|incretins|mesh-ancestor
91936548|NCT02638805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936549|NCT02638805|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91936550|NCT02261675|Dexmedetomidine|dexmedetomidine|mesh-list
91936551|NCT02261675|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936552|NCT02261675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936553|NCT02261675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936554|NCT02261675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936555|NCT02261675|Analgesics|analgesics|mesh-ancestor
91936556|NCT02261675|Sensory System Agents|sensory system agents|mesh-ancestor
91936557|NCT02261675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936558|NCT02261675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91936559|NCT02261675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91936561|NCT02261675|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936562|NCT02261675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936563|NCT02261675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936564|NCT02262143|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91936565|NCT02262143|Fenofibrate|fenofibrate|mesh-list
91936566|NCT02262143|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91936567|NCT02262143|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91936568|NCT02262143|Antimetabolites|antimetabolites|mesh-ancestor
92081570|NCT01426113|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91936569|NCT02262143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936570|NCT02262143|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91936868|NCT02264795|Lidocaine|lidocaine|mesh-list
91936571|NCT02262143|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91936572|NCT02262143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936573|NCT02620553|Insulin|insulin|mesh-list
91936574|NCT02620553|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91936575|NCT02620553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936576|NCT02620553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936577|NCT04588727|Aspirin|aspirin|mesh-list
91936578|NCT04588727|Ticagrelor|ticagrelor|mesh-list
91936579|NCT04588727|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91936580|NCT04588727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936581|NCT04588727|Analgesics|analgesics|mesh-ancestor
91936582|NCT04588727|Sensory System Agents|sensory system agents|mesh-ancestor
91936583|NCT04588727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936584|NCT04588727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936585|NCT04588727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936586|NCT04588727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936587|NCT04588727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91936588|NCT04588727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91943801|NCT00464555|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936589|NCT04588727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936590|NCT04588727|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91936591|NCT04588727|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91936592|NCT04588727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936593|NCT04588727|Antipyretics|antipyretics|mesh-ancestor
91936594|NCT04588727|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91936595|NCT04588727|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91936596|NCT04588727|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91936598|NCT04588727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936599|NCT02262299|Pirfenidone|pirfenidone|mesh-list
91936600|NCT02262299|Analgesics|analgesics|mesh-ancestor
91936601|NCT02262299|Sensory System Agents|sensory system agents|mesh-ancestor
91936602|NCT02262299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936603|NCT02262299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936604|NCT02262299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91936605|NCT02262299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936606|NCT02262299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936608|NCT02262299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936609|NCT02608697|Atorvastatin|atorvastatin|mesh-list
91936610|NCT02608697|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91936611|NCT02608697|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91936612|NCT02608697|Antimetabolites|antimetabolites|mesh-ancestor
91936613|NCT02608697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936614|NCT02608697|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91936615|NCT02608697|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91936616|NCT02608697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936617|NCT02262455|Doxorubicin|doxorubicin|mesh-list
91936618|NCT02262455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91936619|NCT02262455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936620|NCT02262455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936621|NCT02262455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91936622|NCT02262455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91936623|NCT02262455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936624|NCT02262455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936627|NCT02262533|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91936628|NCT02262533|Antithrombins|antithrombins|mesh-ancestor
91936630|NCT02262533|Protease Inhibitors|protease inhibitors|mesh-ancestor
91936632|NCT02262533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936633|NCT02262533|Anticoagulants|anticoagulants|mesh-ancestor
91936634|NCT02262533|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91936635|NCT02262533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91936636|NCT02262533|Sympatholytics|sympatholytics|mesh-ancestor
91936637|NCT02262533|Autonomic Agents|autonomic agents|mesh-ancestor
91936638|NCT02262533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936639|NCT02262533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936640|NCT02262533|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91936641|NCT02262533|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91936642|NCT02262533|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91936643|NCT02262533|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936644|NCT02262533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936645|NCT02262611|Telmisartan|telmisartan|mesh-list
91936646|NCT02262611|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
91936647|NCT02262611|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91936649|NCT02262611|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91936650|NCT02262611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936651|NCT02262611|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91936652|NCT02262611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91936653|NCT02262611|Diuretics|diuretics|mesh-ancestor
91936654|NCT02262611|Natriuretic Agents|natriuretic agents|mesh-ancestor
91936655|NCT02262611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936657|NCT02262767|Antiemetics|antiemetics|mesh-ancestor
91936658|NCT02262767|Autonomic Agents|autonomic agents|mesh-ancestor
91936659|NCT02262767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936660|NCT02262767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936661|NCT02262767|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936662|NCT02589275|Cyclobenzaprine|cyclobenzaprine|mesh-list
91936663|NCT02589275|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91936664|NCT02589275|Antidepressive Agents|antidepressive agents|mesh-ancestor
91936666|NCT02589275|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91936667|NCT02589275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936668|NCT02589275|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91936670|NCT02589275|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91936671|NCT02589275|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081571|NCT01426113|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92081572|NCT01426113|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936672|NCT02543567|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91936673|NCT02543567|Antiviral Agents|antiviral agents|mesh-ancestor
91936674|NCT02543567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936675|NCT02515175|Vaccines|vaccines|mesh-list
91936676|NCT02515175|Immunologic Factors|immunologic factors|mesh-ancestor
91936677|NCT02515175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936678|NCT02513303|Sirolimus|sirolimus|mesh-list
91936679|NCT02513303|Temsirolimus|temsirolimus|mesh-list
91936680|NCT02513303|MTOR Inhibitors|mtor inhibitors|mesh-list
91936681|NCT02513303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91936682|NCT02513303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936683|NCT02513303|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91936684|NCT02513303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936685|NCT02513303|Antifungal Agents|antifungal agents|mesh-ancestor
91936686|NCT02513303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936687|NCT02513303|Immunologic Factors|immunologic factors|mesh-ancestor
91936688|NCT02513303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936689|NCT02513303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936690|NCT02513303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936691|NCT02513303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936692|NCT01616303|Paclitaxel|paclitaxel|mesh-list
91936693|NCT01616303|Carboplatin|carboplatin|mesh-list
91936694|NCT01616303|Oregovomab|oregovomab|mesh-list
91936695|NCT01616303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91936696|NCT01616303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936697|NCT01616303|Tubulin Modulators|tubulin modulators|mesh-ancestor
91936698|NCT01616303|Antimitotic Agents|antimitotic agents|mesh-ancestor
91936699|NCT01616303|Mitosis Modulators|mitosis modulators|mesh-ancestor
91936700|NCT01616303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936701|NCT01616303|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936703|NCT01590719|Folic Acid|folic acid|mesh-list
91936705|NCT01590719|Oxaliplatin|oxaliplatin|mesh-list
91936706|NCT01590719|Levoleucovorin|levoleucovorin|mesh-list
91936707|NCT01590719|Antimetabolites|antimetabolites|mesh-ancestor
91936708|NCT01590719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936709|NCT01590719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936710|NCT01590719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936711|NCT01590719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936712|NCT01590719|Immunologic Factors|immunologic factors|mesh-ancestor
91936713|NCT01590719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936714|NCT01590719|Antidotes|antidotes|mesh-ancestor
91936716|NCT01590719|Vitamin B Complex|vitamin b complex|mesh-ancestor
92081574|NCT01426113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081575|NCT01426113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081576|NCT01426113|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081578|NCT01393899|Tofacitinib|tofacitinib|mesh-list
92081579|NCT01393899|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92081580|NCT01393899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081582|NCT01393899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081583|NCT02078193|Abatacept|abatacept|mesh-list
92081584|NCT02078193|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92081585|NCT02078193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936869|NCT02264795|Anesthetics, Local|anesthetics, local|mesh-ancestor
92081586|NCT02078193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92081587|NCT02078193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081588|NCT02078193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081589|NCT02078193|Immunologic Factors|immunologic factors|mesh-ancestor
92081590|NCT02078193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081591|NCT02078193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081592|NCT01405911|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92081593|NCT01405911|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92081594|NCT01405911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081595|NCT01405911|Incretins|incretins|mesh-ancestor
91945267|NCT03529643|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945268|NCT03529643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081597|NCT01405911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081598|NCT01405911|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92081599|NCT01405911|Protease Inhibitors|protease inhibitors|mesh-ancestor
92081600|NCT01405911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081601|NCT01405911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081602|NCT01425801|Albuterol|albuterol|mesh-list
92081603|NCT01425801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92081604|NCT01425801|Autonomic Agents|autonomic agents|mesh-ancestor
92081605|NCT01425801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081606|NCT01425801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081607|NCT01425801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92081608|NCT01425801|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081609|NCT01425801|Tocolytic Agents|tocolytic agents|mesh-ancestor
92081610|NCT01425801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92081611|NCT01425801|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92081612|NCT01425801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92081613|NCT01425801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92081614|NCT01425801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92081615|NCT01425801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081616|NCT01425801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081617|NCT02335125|Psychotropic Drugs|psychotropic drugs|mesh-list
92081618|NCT02076243|Paclitaxel|paclitaxel|mesh-list
92081619|NCT02076243|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92081620|NCT02076243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081621|NCT02076243|Tubulin Modulators|tubulin modulators|mesh-ancestor
91936830|NCT01470131|Dexamethasone|dexamethasone|mesh-list
91936831|NCT01470131|Bortezomib|bortezomib|mesh-list
91936832|NCT01470131|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91936834|NCT01470131|Autonomic Agents|autonomic agents|mesh-ancestor
91936835|NCT01470131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936836|NCT01470131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936837|NCT01470131|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936838|NCT01470131|Glucocorticoids|glucocorticoids|mesh-ancestor
91936839|NCT01470131|Hormones|hormones|mesh-ancestor
91936840|NCT01470131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91936841|NCT01470131|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91936842|NCT01470131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936843|NCT02264561|Caffeine|caffeine|mesh-list
91936844|NCT02264561|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91936845|NCT02264561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936846|NCT02264561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91936847|NCT02264561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936848|NCT02264561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936849|NCT02264561|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91936850|NCT02264561|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91936851|NCT02264561|Purinergic Agents|purinergic agents|mesh-ancestor
91936852|NCT02264561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936853|NCT01464437|Metformin|metformin|mesh-list
91936854|NCT01464437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91936855|NCT01464437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936856|NCT01461317|Etrolizumab|etrolizumab|mesh-list
91936857|NCT01461317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936858|NCT01461317|Immunologic Factors|immunologic factors|mesh-ancestor
91936859|NCT01461317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936860|NCT01449071|Epratuzumab|epratuzumab|mesh-list
91936861|NCT01449071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936862|NCT01449071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936863|NCT01445795|Ribavirin|ribavirin|mesh-list
91936864|NCT01445795|Antimetabolites|antimetabolites|mesh-ancestor
91936865|NCT01445795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936866|NCT01445795|Antiviral Agents|antiviral agents|mesh-ancestor
91936867|NCT01445795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936870|NCT02264795|Anesthetics|anesthetics|mesh-ancestor
91936871|NCT02264795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936872|NCT02264795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936873|NCT02264795|Sensory System Agents|sensory system agents|mesh-ancestor
91936874|NCT02264795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936875|NCT02264795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91945269|NCT03529643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91936876|NCT02264795|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91936877|NCT02264795|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91936878|NCT02264795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945270|NCT03529643|Analgesics|analgesics|mesh-ancestor
91945271|NCT03529643|Sensory System Agents|sensory system agents|mesh-ancestor
91945272|NCT03529643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936879|NCT02264795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936881|NCT02264873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936882|NCT02264873|Antimetabolites|antimetabolites|mesh-ancestor
91936883|NCT02264873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936884|NCT02264873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936885|NCT02264873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936886|NCT00156533|Zolpidem|zolpidem|mesh-list
91936887|NCT00156533|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91936888|NCT00156533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91936889|NCT00156533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936890|NCT00156533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936891|NCT00156533|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91936892|NCT00156533|GABA Agonists|gaba agonists|mesh-ancestor
91936894|NCT00156533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936895|NCT00156533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936896|NCT01410695|Methotrexate|methotrexate|mesh-list
91936897|NCT01410695|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91936898|NCT01410695|Abortifacient Agents|abortifacient agents|mesh-ancestor
91936899|NCT01410695|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91936900|NCT01410695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936901|NCT01410695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936902|NCT01410695|Antimetabolites|antimetabolites|mesh-ancestor
91943812|NCT00464243|Volinanserin|volinanserin|mesh-list
91936903|NCT01410695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936904|NCT01410695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936906|NCT01410695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936907|NCT01410695|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91936908|NCT01410695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91936909|NCT01410695|Immunologic Factors|immunologic factors|mesh-ancestor
91936910|NCT01410695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936911|NCT01410695|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91936912|NCT01660022|Piperaquine|piperaquine|mesh-list
91936913|NCT01660022|Artefenomel|artefenomel|mesh-list
91936914|NCT01660022|Antimalarials|antimalarials|mesh-ancestor
91936915|NCT01660022|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91936916|NCT01660022|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91936917|NCT01660022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936918|NCT02265575|Hyaluronic Acid|hyaluronic acid|mesh-list
91936919|NCT02265575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91936920|NCT02265575|Immunologic Factors|immunologic factors|mesh-ancestor
91936921|NCT02265575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936922|NCT02265575|Viscosupplements|viscosupplements|mesh-ancestor
91936923|NCT02265575|Protective Agents|protective agents|mesh-ancestor
91936924|NCT02265731|Rituximab|rituximab|mesh-list
91936925|NCT02265731|Venetoclax|venetoclax|mesh-list
91936926|NCT02265731|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91936927|NCT02265731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936928|NCT02265731|Immunologic Factors|immunologic factors|mesh-ancestor
91936929|NCT02265731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936930|NCT02265731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91936931|NCT02265809|Aldesleukin|aldesleukin|mesh-list
91936932|NCT02265809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936933|NCT02265809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91936934|NCT02265809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91936935|NCT02265809|Antiviral Agents|antiviral agents|mesh-ancestor
91936936|NCT02265809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936937|NCT01372475|Hyaluronic Acid|hyaluronic acid|mesh-list
91936938|NCT01372475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91936939|NCT01372475|Immunologic Factors|immunologic factors|mesh-ancestor
91936940|NCT01372475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936941|NCT01372475|Viscosupplements|viscosupplements|mesh-ancestor
91936943|NCT00156065|Haloperidol|haloperidol|mesh-list
91936944|NCT00156065|Haloperidol decanoate|haloperidol decanoate|mesh-list
91936947|NCT00156065|Autonomic Agents|autonomic agents|mesh-ancestor
91936948|NCT00156065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936949|NCT00156065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936950|NCT00156065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91936951|NCT00156065|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91936952|NCT00156065|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91936953|NCT00156065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91936955|NCT00156065|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91936956|NCT00156065|Dopamine Agents|dopamine agents|mesh-ancestor
91936957|NCT00156065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91936958|NCT00156065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936959|NCT00156065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91936960|NCT04476173|Morphine|morphine|mesh-list
91936962|NCT04476173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91936963|NCT04476173|Narcotics|narcotics|mesh-ancestor
91936964|NCT04476173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943813|NCT00464243|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91936965|NCT04476173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936967|NCT04476173|Sensory System Agents|sensory system agents|mesh-ancestor
91936968|NCT04476173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91936969|NCT04476173|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91936970|NCT04476173|Anesthetics, General|anesthetics, general|mesh-ancestor
91936971|NCT04476173|Anesthetics|anesthetics|mesh-ancestor
91936972|NCT01554956|Plasminogen|plasminogen|mesh-list
91936973|NCT01554956|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91936974|NCT01554956|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91945273|NCT03529643|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91936975|NCT01554956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936977|NCT01360853|ON 01910|on 01910|mesh-list
91936978|NCT01360853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91936979|NCT01360853|Antimetabolites|antimetabolites|mesh-ancestor
91936980|NCT01360853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91936981|NCT01360853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91936982|NCT01360853|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91936983|NCT01360853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91936984|NCT01355393|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
91936985|NCT01355393|Sargramostim|sargramostim|mesh-list
91936986|NCT01355393|Immunologic Factors|immunologic factors|mesh-ancestor
91936987|NCT01355393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91936988|NCT01355393|Antiviral Agents|antiviral agents|mesh-ancestor
91936989|NCT01355393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91936990|NCT02266355|Omalizumab|omalizumab|mesh-list
91936991|NCT02266355|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91936992|NCT02266355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91936993|NCT02266355|Respiratory System Agents|respiratory system agents|mesh-ancestor
91936994|NCT02266511|Tamsulosin|tamsulosin|mesh-list
91945274|NCT03529643|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91945275|NCT03529643|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91936995|NCT02266511|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91936996|NCT02266511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91936997|NCT02266511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91936998|NCT02266511|Adrenergic Agents|adrenergic agents|mesh-ancestor
91936999|NCT02266511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937000|NCT02266511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937001|NCT02266511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937003|NCT02266589|Hydrocortisone|hydrocortisone|mesh-list
91937004|NCT02266589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937006|NCT01330979|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91945276|NCT03529643|Adrenergic Agents|adrenergic agents|mesh-ancestor
91937007|NCT01311713|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
91937008|NCT01311713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945277|NCT03529643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937009|NCT01311713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937010|NCT01311713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937011|NCT01298687|Travoprost|travoprost|mesh-list
91937012|NCT01298687|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91937013|NCT01298687|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91937014|NCT01298687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91937015|NCT02267057|Acetaminophen|acetaminophen|mesh-list
91937017|NCT02267057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937018|NCT02267057|Analgesics|analgesics|mesh-ancestor
91937019|NCT02267057|Sensory System Agents|sensory system agents|mesh-ancestor
91937020|NCT02267057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937021|NCT02267057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937022|NCT02267057|Antipyretics|antipyretics|mesh-ancestor
91937023|NCT02267057|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91937024|NCT02267057|Narcotics|narcotics|mesh-ancestor
91937025|NCT02267057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937026|NCT02267057|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91937027|NCT05260541|Pramoxine|pramoxine|mesh-list
91937028|NCT05260541|Anesthetics, Local|anesthetics, local|mesh-ancestor
91937029|NCT05260541|Anesthetics|anesthetics|mesh-ancestor
91937030|NCT05260541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937031|NCT05260541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937032|NCT05260541|Sensory System Agents|sensory system agents|mesh-ancestor
91937033|NCT05260541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937035|NCT01262261|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91937036|NCT01262261|Narcotics|narcotics|mesh-ancestor
91937037|NCT01262261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937038|NCT01262261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937040|NCT01262261|Sensory System Agents|sensory system agents|mesh-ancestor
91937041|NCT01262261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937042|NCT01262261|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91937043|NCT02267681|Fentanyl|fentanyl|mesh-list
91937044|NCT02267681|Alfentanil|alfentanil|mesh-list
91937045|NCT02267681|Propofol|propofol|mesh-list
91937046|NCT02267681|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91937047|NCT02267681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937048|NCT02267681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937049|NCT02267681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91937050|NCT02267681|Anesthetics, General|anesthetics, general|mesh-ancestor
91937052|NCT02267681|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91937053|NCT02267681|Narcotics|narcotics|mesh-ancestor
91937054|NCT02267681|Analgesics|analgesics|mesh-ancestor
91937055|NCT02267681|Sensory System Agents|sensory system agents|mesh-ancestor
91937056|NCT02267681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937057|NCT02267681|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91937058|NCT05177939|Methylprednisolone|methylprednisolone|mesh-list
91937059|NCT05177939|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91937060|NCT05177939|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91937061|NCT05177939|Prednisolone|prednisolone|mesh-list
91937062|NCT05177939|Prednisolone acetate|prednisolone acetate|mesh-list
91937064|NCT05177939|Prednisolone phosphate|prednisolone phosphate|mesh-list
91937065|NCT05177939|Immunoglobulins|immunoglobulins|mesh-list
91937066|NCT05177939|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91937067|NCT05177939|gamma-Globulins|gamma-globulins|mesh-list
91937068|NCT05177939|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91937069|NCT05177939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937070|NCT05177939|Antiemetics|antiemetics|mesh-ancestor
91937071|NCT05177939|Autonomic Agents|autonomic agents|mesh-ancestor
91937072|NCT05177939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937073|NCT05177939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937074|NCT05177939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937075|NCT05177939|Glucocorticoids|glucocorticoids|mesh-ancestor
91937077|NCT05177939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937078|NCT05177939|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91937079|NCT05177939|Protective Agents|protective agents|mesh-ancestor
91937080|NCT05177939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91937081|NCT05177939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937082|NCT05177939|Immunologic Factors|immunologic factors|mesh-ancestor
91937083|NCT05174507|Empagliflozin|empagliflozin|mesh-list
91937084|NCT05174507|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91937085|NCT05174507|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91937086|NCT05174507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937087|NCT05174507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91937088|NCT05174507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937090|NCT01480154|Hydroxychloroquine|hydroxychloroquine|mesh-list
91937093|NCT01480154|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91937094|NCT01480154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937096|NCT01480154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937097|NCT01480154|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937098|NCT02267915|Rituximab|rituximab|mesh-list
91937099|NCT02267915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937100|NCT02267915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937101|NCT02267915|Immunologic Factors|immunologic factors|mesh-ancestor
91937102|NCT02267915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937103|NCT02267915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937104|NCT02268071|Antihypertensive Agents|antihypertensive agents|mesh-list
91937106|NCT02268149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937107|NCT02268149|Glucocorticoids|glucocorticoids|mesh-ancestor
91937108|NCT02268149|Hormones|hormones|mesh-ancestor
91945278|NCT03529643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937109|NCT02268149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937110|NCT02268149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937111|NCT02268149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91937112|NCT02268149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937114|NCT01258907|Immunologic Factors|immunologic factors|mesh-ancestor
91937115|NCT01258907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937116|NCT01255709|Epinephrine|epinephrine|mesh-list
91937117|NCT01255709|Racepinephrine|racepinephrine|mesh-list
91937118|NCT01255709|Epinephryl borate|epinephryl borate|mesh-list
91937119|NCT01255709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91937120|NCT01255709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91937121|NCT01255709|Adrenergic Agents|adrenergic agents|mesh-ancestor
91937122|NCT01255709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937123|NCT01255709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937124|NCT01255709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937125|NCT01255709|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91937126|NCT01255709|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91937127|NCT01255709|Autonomic Agents|autonomic agents|mesh-ancestor
91937129|NCT01255709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91937130|NCT01255709|Respiratory System Agents|respiratory system agents|mesh-ancestor
91937131|NCT01255709|Mydriatics|mydriatics|mesh-ancestor
91937132|NCT01255709|Sympathomimetics|sympathomimetics|mesh-ancestor
91937133|NCT01255709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91937134|NCT02233907|Oxitropium|oxitropium|mesh-list
91937135|NCT02233907|Parasympatholytics|parasympatholytics|mesh-ancestor
91937136|NCT02233907|Autonomic Agents|autonomic agents|mesh-ancestor
91937137|NCT02233907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937138|NCT02233907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937139|NCT01253603|Fluticasone|fluticasone|mesh-list
91937141|NCT01253603|Indoleacetic Acids|indoleacetic acids|mesh-list
91937142|NCT01253603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937143|NCT01253603|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91937144|NCT01253603|Autonomic Agents|autonomic agents|mesh-ancestor
91937145|NCT01253603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937146|NCT01253603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937147|NCT01253603|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91943824|NCT03336541|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91937148|NCT01253603|Respiratory System Agents|respiratory system agents|mesh-ancestor
91937149|NCT01253603|Dermatologic Agents|dermatologic agents|mesh-ancestor
91937150|NCT01253603|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91937151|NCT01253603|Plant Growth Regulators|plant growth regulators|mesh-ancestor
91937152|NCT01253603|Growth Substances|growth substances|mesh-ancestor
91937153|NCT02268305|Dimethyl sulfone|dimethyl sulfone|mesh-list
91937154|NCT02268305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937155|NCT02268383|Luspatercept|luspatercept|mesh-list
91937156|NCT02268383|Hematinics|hematinics|mesh-ancestor
91937158|NCT01329419|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
91937159|NCT01329419|Antiviral Agents|antiviral agents|mesh-ancestor
91937160|NCT01329419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937161|NCT01329419|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91937162|NCT01329419|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91937163|NCT01329419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937164|NCT01329419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937165|NCT01235039|Insulin|insulin|mesh-list
91937167|NCT01235039|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91937168|NCT01235039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91937169|NCT01235039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937170|NCT01234025|Prednisone|prednisone|mesh-list
91937171|NCT01234025|Docetaxel|docetaxel|mesh-list
91937172|NCT01234025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937173|NCT01234025|Tubulin Modulators|tubulin modulators|mesh-ancestor
91937174|NCT01234025|Antimitotic Agents|antimitotic agents|mesh-ancestor
91937175|NCT01234025|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074250|NCT00072514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937176|NCT01234025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937177|NCT01234025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937178|NCT01234025|Glucocorticoids|glucocorticoids|mesh-ancestor
91945280|NCT03529331|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
91945281|NCT03529331|Morphine|morphine|mesh-list
91945282|NCT03529331|Oxycodone|oxycodone|mesh-list
91945283|NCT03529331|Hydrocodone|hydrocodone|mesh-list
91945285|NCT03529331|Narcotics|narcotics|mesh-ancestor
91945286|NCT03529331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945287|NCT03529331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937180|NCT01234025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937181|NCT01234025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937182|NCT01234025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91937183|NCT01221077|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91937184|NCT01221077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937185|NCT01221077|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937186|NCT01221077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945288|NCT03529331|Analgesics|analgesics|mesh-ancestor
91937187|NCT01221077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937188|NCT01207115|Naproxen|naproxen|mesh-list
91937189|NCT01207115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937190|NCT01207115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937192|NCT01207115|Sensory System Agents|sensory system agents|mesh-ancestor
91937193|NCT01207115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937194|NCT01207115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937195|NCT01207115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937196|NCT01207115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937198|NCT01207115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91937199|NCT01207115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937200|NCT01207115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937201|NCT01186991|Paclitaxel|paclitaxel|mesh-list
91937202|NCT01186991|Bevacizumab|bevacizumab|mesh-list
91937203|NCT01186991|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91937204|NCT01186991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91937206|NCT01186991|Tubulin Modulators|tubulin modulators|mesh-ancestor
91937208|NCT01186991|Mitosis Modulators|mitosis modulators|mesh-ancestor
91937209|NCT01186991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937210|NCT01186991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937212|NCT01186991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91937213|NCT01186991|Growth Substances|growth substances|mesh-ancestor
91937214|NCT01186991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937215|NCT01186991|Growth Inhibitors|growth inhibitors|mesh-ancestor
91937216|NCT01186991|Immunologic Factors|immunologic factors|mesh-ancestor
91937217|NCT02268773|Aspirin|aspirin|mesh-list
91937218|NCT02268773|Dipyridamole|dipyridamole|mesh-list
91937219|NCT02268773|Aspirin, Dipyridamole Drug Combination|aspirin, dipyridamole drug combination|mesh-list
91937220|NCT02268773|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937221|NCT02268773|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937222|NCT02268773|Analgesics|analgesics|mesh-ancestor
91937223|NCT02268773|Sensory System Agents|sensory system agents|mesh-ancestor
91937224|NCT02268773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937225|NCT02268773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937226|NCT02268773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937228|NCT02268773|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91937229|NCT02268773|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91937230|NCT02268773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937231|NCT02268773|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91937232|NCT02268773|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91937233|NCT02268773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937234|NCT02268773|Antipyretics|antipyretics|mesh-ancestor
91937235|NCT02268773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91937236|NCT02268773|Vasodilator Agents|vasodilator agents|mesh-ancestor
91937238|NCT01183949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937239|NCT01092065|Levodopa|levodopa|mesh-list
91937241|NCT01092065|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91937242|NCT01092065|Dopamine Agents|dopamine agents|mesh-ancestor
91937243|NCT01092065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937244|NCT01092065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937245|NCT01092065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937247|NCT05626829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937248|NCT05626829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937249|NCT05626829|Analgesics|analgesics|mesh-ancestor
91937250|NCT05626829|Sensory System Agents|sensory system agents|mesh-ancestor
91937251|NCT05626829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937252|NCT05626829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937253|NCT05626829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937254|NCT05626829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937255|NCT05626829|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91937256|NCT05626829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91937257|NCT05626829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937258|NCT05626829|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91937422|NCT01004081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91937259|NCT05626829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91937260|NCT05626829|Histamine Antagonists|histamine antagonists|mesh-ancestor
91937261|NCT05626829|Histamine Agents|histamine agents|mesh-ancestor
91937262|NCT05626829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937263|NCT05626829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91937264|NCT05626829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91937265|NCT01173497|Irinotecan|irinotecan|mesh-list
91937267|NCT01173497|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91937268|NCT01173497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937269|NCT01173497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937270|NCT01173497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937271|NCT01173497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937272|NCT01173497|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91937273|NCT01171313|Carbidopa|carbidopa|mesh-list
91937274|NCT01171313|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
91937275|NCT01171313|Levodopa|levodopa|mesh-list
91937276|NCT01171313|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91937277|NCT01171313|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91937278|NCT01171313|Dopamine Agents|dopamine agents|mesh-ancestor
91937279|NCT01171313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937280|NCT01171313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937281|NCT01171313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937282|NCT01171313|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
91937283|NCT01171313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937284|NCT01171313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91937285|NCT01171313|Immunologic Factors|immunologic factors|mesh-ancestor
91937286|NCT01171313|Dopamine Agonists|dopamine agonists|mesh-ancestor
91937287|NCT02269319|Linezolid|linezolid|mesh-list
91937288|NCT02269319|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937289|NCT02269319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937290|NCT02269319|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91937291|NCT02269319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937292|NCT02269319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937293|NCT01071239|Cyclophosphamide|cyclophosphamide|mesh-list
91937294|NCT01071239|Busulfan|busulfan|mesh-list
91937295|NCT01071239|Fludarabine|fludarabine|mesh-list
91937296|NCT01071239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937297|NCT01071239|Immunologic Factors|immunologic factors|mesh-ancestor
91937298|NCT01071239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937299|NCT01071239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937300|NCT01071239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91937302|NCT01071239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937303|NCT01071239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937304|NCT01071239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91937305|NCT01156415|Agomelatine|agomelatine|mesh-list
91937306|NCT01156415|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91937307|NCT01156415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937308|NCT01156415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937309|NCT01057667|Ribavirin|ribavirin|mesh-list
91937310|NCT01057667|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91937311|NCT01057667|Antimetabolites|antimetabolites|mesh-ancestor
91937312|NCT01057667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937313|NCT01057667|Antiviral Agents|antiviral agents|mesh-ancestor
91937314|NCT01057667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937315|NCT01027013|Rebamipide|rebamipide|mesh-list
91937316|NCT01027013|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91937317|NCT01027013|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91937318|NCT01027013|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91937319|NCT01027013|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937320|NCT01027013|Antioxidants|antioxidants|mesh-ancestor
91937321|NCT01027013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937322|NCT01027013|Protective Agents|protective agents|mesh-ancestor
91937324|NCT01027013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937325|NCT04197076|Immunomodulating Agents|immunomodulating agents|mesh-list
91937327|NCT04197076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937330|NCT01138163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937331|NCT01138163|Tubulin Modulators|tubulin modulators|mesh-ancestor
91937332|NCT01138163|Antimitotic Agents|antimitotic agents|mesh-ancestor
91937333|NCT01138163|Mitosis Modulators|mitosis modulators|mesh-ancestor
91937334|NCT01138163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937335|NCT01138163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937337|NCT01022801|Antiviral Agents|antiviral agents|mesh-ancestor
91937338|NCT01022801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937340|NCT05628467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91937342|NCT05628389|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91937344|NCT05628389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937345|NCT05628389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937347|NCT05628389|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91937348|NCT05628389|Cholinergic Agents|cholinergic agents|mesh-ancestor
91937349|NCT05628389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937350|NCT05628389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937352|NCT01128335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937353|NCT01128335|Immunologic Factors|immunologic factors|mesh-ancestor
91937354|NCT01128335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937355|NCT01128335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91937356|NCT01128335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937357|NCT01128335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937358|NCT01012895|Interferons|interferons|mesh-list
91937359|NCT01012895|Ribavirin|ribavirin|mesh-list
91937360|NCT01012895|Interferon-alpha|interferon-alpha|mesh-list
91937361|NCT01012895|Interferon alpha-2|interferon alpha-2|mesh-list
91937362|NCT01012895|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91937363|NCT01012895|Asunaprevir|asunaprevir|mesh-list
91937364|NCT01012895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937365|NCT01012895|Antiviral Agents|antiviral agents|mesh-ancestor
91937366|NCT01012895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937367|NCT01012895|Antimetabolites|antimetabolites|mesh-ancestor
91937368|NCT01012895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937369|NCT01012895|Immunologic Factors|immunologic factors|mesh-ancestor
91937370|NCT01012895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937371|NCT01012895|Protease Inhibitors|protease inhibitors|mesh-ancestor
91937372|NCT01012895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937374|NCT01009775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937375|NCT01009775|Tubulin Modulators|tubulin modulators|mesh-ancestor
91937376|NCT01009775|Antimitotic Agents|antimitotic agents|mesh-ancestor
91937377|NCT01009775|Mitosis Modulators|mitosis modulators|mesh-ancestor
91937378|NCT01009775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937380|NCT02319148|Verapamil|verapamil|mesh-list
91937381|NCT02319148|Diltiazem|diltiazem|mesh-list
91937382|NCT02319148|Antifungal Agents|antifungal agents|mesh-ancestor
91937383|NCT02319148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937384|NCT02319148|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91937385|NCT02319148|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91937386|NCT02319148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937387|NCT02319148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937388|NCT02319148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91937389|NCT02319148|Hormone Antagonists|hormone antagonists|mesh-ancestor
91945289|NCT03529331|Sensory System Agents|sensory system agents|mesh-ancestor
91937390|NCT02319148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937391|NCT02319148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937392|NCT02319148|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91937393|NCT02319148|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91937394|NCT02319148|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91937395|NCT02319148|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91937396|NCT02319148|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91937397|NCT02319148|Vasodilator Agents|vasodilator agents|mesh-ancestor
91937398|NCT02319148|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91937399|NCT02526212|Buprenorphine|buprenorphine|mesh-list
91937400|NCT02526212|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91937402|NCT02526212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937403|NCT02526212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937404|NCT02526212|Analgesics|analgesics|mesh-ancestor
91937405|NCT02526212|Sensory System Agents|sensory system agents|mesh-ancestor
91937406|NCT02526212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937407|NCT02526212|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91937409|NCT05627843|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937410|NCT05627843|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937411|NCT05627843|Analgesics|analgesics|mesh-ancestor
91937412|NCT05627843|Sensory System Agents|sensory system agents|mesh-ancestor
91937413|NCT05627843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937414|NCT05627843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937415|NCT05627843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937416|NCT05627843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937417|NCT05627843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937418|NCT05627843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937419|NCT05627843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937420|NCT01004081|Exemestane|exemestane|mesh-list
91937421|NCT01004081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937423|NCT01004081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91937425|NCT01004081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937426|NCT01004081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91937427|NCT01004081|Hormone Antagonists|hormone antagonists|mesh-ancestor
91937428|NCT01004081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937429|NCT01004081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937431|NCT05401916|Ibuprofen|ibuprofen|mesh-list
91937432|NCT05401916|Tramadol|tramadol|mesh-list
91937433|NCT05401916|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937434|NCT05401916|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937435|NCT05401916|Analgesics|analgesics|mesh-ancestor
91937436|NCT05401916|Sensory System Agents|sensory system agents|mesh-ancestor
91937437|NCT05401916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937438|NCT05401916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937439|NCT05401916|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937441|NCT05401916|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91937442|NCT05401916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937443|NCT05401916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937444|NCT05401916|Antipyretics|antipyretics|mesh-ancestor
91937445|NCT05401916|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91937446|NCT05401916|Narcotics|narcotics|mesh-ancestor
91937447|NCT05401916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937448|NCT01113593|Formoterol Fumarate|formoterol fumarate|mesh-list
91937449|NCT01113593|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91937450|NCT01113593|Autonomic Agents|autonomic agents|mesh-ancestor
91937451|NCT01113593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937452|NCT01113593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937453|NCT01113593|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91937454|NCT01113593|Respiratory System Agents|respiratory system agents|mesh-ancestor
91937455|NCT01113593|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91943837|NCT00525941|GABA Agents|gaba agents|mesh-ancestor
91937456|NCT01113593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91937457|NCT01113593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91937458|NCT01113593|Adrenergic Agents|adrenergic agents|mesh-ancestor
91937459|NCT01113593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937460|NCT01113593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937461|NCT04137224|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91937462|NCT04137224|Immunologic Factors|immunologic factors|mesh-ancestor
91937463|NCT04137224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937464|NCT05401214|Prednisone|prednisone|mesh-list
91937465|NCT05401214|Prednisolone|prednisolone|mesh-list
91937466|NCT05401214|Abiraterone Acetate|abiraterone acetate|mesh-list
91937467|NCT05401214|Niraparib|niraparib|mesh-list
91937468|NCT05401214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937469|NCT05401214|Glucocorticoids|glucocorticoids|mesh-ancestor
91937470|NCT05401214|Hormones|hormones|mesh-ancestor
91937471|NCT05401214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937472|NCT05401214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937473|NCT05401214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91937474|NCT05401214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937475|NCT05401214|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91937476|NCT05401214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937477|NCT05401214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937478|NCT05401214|Hormone Antagonists|hormone antagonists|mesh-ancestor
91937479|NCT05401214|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91937480|NCT05401214|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91937481|NCT02532374|Nicotine|nicotine|mesh-list
91937482|NCT02532374|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91937483|NCT02532374|Autonomic Agents|autonomic agents|mesh-ancestor
91937484|NCT02532374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937485|NCT02532374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937487|NCT02532374|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91937488|NCT02532374|Cholinergic Agents|cholinergic agents|mesh-ancestor
91937489|NCT02532374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937490|NCT02532374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937492|NCT05398874|Diclofenac|diclofenac|mesh-list
91937493|NCT05398874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937494|NCT05398874|Analgesics|analgesics|mesh-ancestor
91937495|NCT05398874|Sensory System Agents|sensory system agents|mesh-ancestor
91937496|NCT05398874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937497|NCT05398874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937498|NCT05398874|Antipyretics|antipyretics|mesh-ancestor
91937499|NCT05398874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937500|NCT05398874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937501|NCT05398874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937502|NCT05398874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91937503|NCT05398874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937504|NCT05398874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937505|NCT01281176|Paclitaxel|paclitaxel|mesh-list
91937506|NCT01281176|Carboplatin|carboplatin|mesh-list
91937507|NCT01281176|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91937508|NCT01281176|Vorinostat|vorinostat|mesh-list
91937509|NCT01281176|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91937510|NCT01281176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937511|NCT01281176|Tubulin Modulators|tubulin modulators|mesh-ancestor
91937513|NCT01281176|Mitosis Modulators|mitosis modulators|mesh-ancestor
91937514|NCT01281176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937515|NCT01281176|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91937516|NCT01281176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937517|NCT02525744|Insulin Lispro|insulin lispro|mesh-list
91937518|NCT02525744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91937519|NCT02525744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937520|NCT05360732|Folfirinox|folfirinox|mesh-list
91937521|NCT05360732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937522|NCT00152477|Paclitaxel|paclitaxel|mesh-list
91937523|NCT00152477|Carboplatin|carboplatin|mesh-list
91937524|NCT00152477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91937525|NCT00152477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937526|NCT00152477|Tubulin Modulators|tubulin modulators|mesh-ancestor
91937527|NCT00152477|Antimitotic Agents|antimitotic agents|mesh-ancestor
91937528|NCT00152477|Mitosis Modulators|mitosis modulators|mesh-ancestor
91937529|NCT00152477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937531|NCT01111955|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91937532|NCT01111955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945290|NCT03529331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937534|NCT01106807|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
91937536|NCT01106807|Dermatologic Agents|dermatologic agents|mesh-ancestor
91937537|NCT01106807|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91937538|NCT01106807|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937539|NCT01106807|Analgesics|analgesics|mesh-ancestor
91937540|NCT01106807|Sensory System Agents|sensory system agents|mesh-ancestor
91937541|NCT01106807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937542|NCT01106807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937543|NCT01106807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937544|NCT01106807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937545|NCT05533229|Fentanyl|fentanyl|mesh-list
91937546|NCT05533229|Morphine|morphine|mesh-list
91937547|NCT05533229|Bupivacaine|bupivacaine|mesh-list
91937548|NCT05533229|Anesthetics, Local|anesthetics, local|mesh-ancestor
91937550|NCT05533229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937551|NCT05533229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937552|NCT05533229|Sensory System Agents|sensory system agents|mesh-ancestor
91937553|NCT05533229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937554|NCT05533229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91937556|NCT05533229|Analgesics|analgesics|mesh-ancestor
91937557|NCT05533229|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91937558|NCT05533229|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91937559|NCT05533229|Anesthetics, General|anesthetics, general|mesh-ancestor
91937560|NCT00153179|Acipimox|acipimox|mesh-list
91937561|NCT00153179|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91937562|NCT00153179|Antimetabolites|antimetabolites|mesh-ancestor
91937563|NCT00153179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937564|NCT00153179|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91937565|NCT02743949|Esomeprazole|esomeprazole|mesh-list
91937566|NCT02743949|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91937567|NCT02743949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937568|NCT02743949|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91937569|NCT02743949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937570|NCT02743949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937571|NCT02531438|Moxifloxacin|moxifloxacin|mesh-list
91937572|NCT02531438|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937573|NCT02531438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937574|NCT02531438|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91937575|NCT02531438|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937576|NCT02531438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937577|NCT02531438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937578|NCT02531438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937579|NCT02289898|Gemcitabine|gemcitabine|mesh-list
91938049|NCT05382104|Maribavir|maribavir|mesh-list
91937580|NCT02289898|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91937581|NCT02289898|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937582|NCT02289898|Antimetabolites|antimetabolites|mesh-ancestor
91937583|NCT02289898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937584|NCT02289898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937586|NCT01659554|Doxorubicin|doxorubicin|mesh-list
91937587|NCT01659554|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91937588|NCT01659554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937589|NCT01659554|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91937590|NCT01659554|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91937591|NCT01659554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937592|NCT01659554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937593|NCT01659554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937594|NCT05355350|Meropenem|meropenem|mesh-list
91937596|NCT05355350|Piperacillin|piperacillin|mesh-list
91937597|NCT05355350|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91937598|NCT05355350|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937599|NCT05355350|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937600|NCT05355350|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91937601|NCT05355350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937602|NCT05355350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937603|NCT01054196|Lenalidomide|lenalidomide|mesh-list
91937605|NCT01054196|Immunologic Factors|immunologic factors|mesh-ancestor
91937606|NCT01054196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937607|NCT01054196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91937608|NCT01054196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91937609|NCT01054196|Growth Substances|growth substances|mesh-ancestor
91937610|NCT01054196|Growth Inhibitors|growth inhibitors|mesh-ancestor
91937611|NCT01054196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937612|NCT01054196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91937613|NCT01054196|Alkylating Agents|alkylating agents|mesh-ancestor
92074251|NCT00072514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937614|NCT01054196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937615|NCT01054196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91937616|NCT01054196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937617|NCT01659320|Minocycline|minocycline|mesh-list
91937618|NCT01659320|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937619|NCT01659320|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937621|NCT05414084|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91937622|NCT05414084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937623|NCT05414084|Disinfectants|disinfectants|mesh-ancestor
91937625|NCT05414084|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91937626|NCT01660334|Voriconazole|voriconazole|mesh-list
91937627|NCT01660334|Antifungal Agents|antifungal agents|mesh-ancestor
91937628|NCT01660334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937629|NCT01660334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91937630|NCT01660334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91937631|NCT01660334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945291|NCT03529331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91937632|NCT01660334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937634|NCT01660334|Hormone Antagonists|hormone antagonists|mesh-ancestor
91937635|NCT01660334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937636|NCT01660334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945292|NCT03529331|Antipyretics|antipyretics|mesh-ancestor
91937637|NCT01660334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91937639|NCT01660256|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91937640|NCT01660256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937641|NCT01660256|Antioxidants|antioxidants|mesh-ancestor
91937642|NCT01660256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937644|NCT01660256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937645|NCT01660256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945293|NCT03529331|Antitussive Agents|antitussive agents|mesh-ancestor
91937646|NCT04968938|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
91937648|NCT04968938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937649|NCT04968938|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91937651|NCT04968938|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937652|NCT04968938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937653|NCT04968938|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91937654|NCT04968938|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91937655|NCT04968938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91937656|NCT04968938|Adrenergic Agents|adrenergic agents|mesh-ancestor
91937657|NCT05412758|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
91937658|NCT05412758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937659|NCT02330367|Abivertinib|abivertinib|mesh-list
91937660|NCT02330367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937661|NCT02330367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937662|NCT02330367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937663|NCT02318602|Cannabidiol|cannabidiol|mesh-list
91937664|NCT02318602|Anticonvulsants|anticonvulsants|mesh-ancestor
91937665|NCT05077215|Pembrolizumab|pembrolizumab|mesh-list
91937666|NCT05077215|Lenvatinib|lenvatinib|mesh-list
91937667|NCT05077215|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937668|NCT05077215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937669|NCT05077215|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91937670|NCT05077215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937671|NCT05077215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937672|NCT05077215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937673|NCT02330679|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
91937674|NCT02330679|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91937675|NCT02330679|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91937676|NCT02330679|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945294|NCT03529331|Respiratory System Agents|respiratory system agents|mesh-ancestor
92074252|NCT00072514|Glucocorticoids|glucocorticoids|mesh-ancestor
91937677|NCT02330679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937678|NCT02330679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937679|NCT02330679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937680|NCT02330679|Antidepressive Agents|antidepressive agents|mesh-ancestor
91937681|NCT02330679|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91937682|NCT05559008|Azacitidine|azacitidine|mesh-list
91937683|NCT05559008|Apatinib|apatinib|mesh-list
91937684|NCT05559008|Dasatinib|dasatinib|mesh-list
91937685|NCT05559008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937686|NCT05559008|Antimetabolites|antimetabolites|mesh-ancestor
91937687|NCT05559008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937688|NCT05559008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937690|NCT05559008|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937691|NCT02318368|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91937692|NCT02318368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937693|NCT02318368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937694|NCT02318368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937695|NCT02318368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937696|NCT05053425|Cytarabine|cytarabine|mesh-list
91937697|NCT05053425|Azacitidine|azacitidine|mesh-list
91937698|NCT05053425|Venetoclax|venetoclax|mesh-list
91937699|NCT05053425|Idarubicin|idarubicin|mesh-list
91937700|NCT05053425|Cladribine|cladribine|mesh-list
91937701|NCT05053425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937702|NCT05053425|Antimetabolites|antimetabolites|mesh-ancestor
91937703|NCT05053425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937704|NCT05053425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937705|NCT05053425|Antiviral Agents|antiviral agents|mesh-ancestor
91937706|NCT05053425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937707|NCT05053425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937708|NCT05053425|Immunologic Factors|immunologic factors|mesh-ancestor
91937709|NCT05053425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937710|NCT05053425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937711|NCT05053425|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91937712|NCT05053425|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91937713|NCT05053425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937714|NCT02317510|Anesthetics|anesthetics|mesh-list
91937715|NCT02317510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91937716|NCT02317510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937717|NCT05350124|Vitamins|vitamins|mesh-list
91937718|NCT05350124|Ascorbic Acid|ascorbic acid|mesh-list
91937719|NCT05350124|Vitamin E|vitamin e|mesh-list
91937720|NCT05350124|Tocopherols|tocopherols|mesh-list
91937721|NCT05350124|Micronutrients|micronutrients|mesh-ancestor
91937722|NCT05350124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937723|NCT05350124|Antioxidants|antioxidants|mesh-ancestor
91937724|NCT05350124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937725|NCT05350124|Protective Agents|protective agents|mesh-ancestor
91937726|NCT04925427|Naloxone|naloxone|mesh-list
91937727|NCT04925427|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91937728|NCT04925427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937729|NCT04925427|Sensory System Agents|sensory system agents|mesh-ancestor
91937730|NCT04925427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937731|NCT00494234|Olaparib|olaparib|mesh-list
91938050|NCT05382104|Antiviral Agents|antiviral agents|mesh-ancestor
91937732|NCT00494234|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
91937733|NCT00494234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081622|NCT02076243|Antimitotic Agents|antimitotic agents|mesh-ancestor
91937734|NCT00494234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937735|NCT00494234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937736|NCT05556746|Rifampin|rifampin|mesh-list
91937737|NCT05556746|Clofazimine|clofazimine|mesh-list
91937738|NCT05556746|Isoniazid|isoniazid|mesh-list
91937739|NCT05556746|Pyrazinamide|pyrazinamide|mesh-list
91937740|NCT05556746|Ethambutol|ethambutol|mesh-list
91937741|NCT05556746|Bedaquiline|bedaquiline|mesh-list
91937742|NCT05556746|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91937743|NCT05556746|Antitubercular Agents|antitubercular agents|mesh-ancestor
91937744|NCT05556746|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937745|NCT05556746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937746|NCT05556746|Leprostatic Agents|leprostatic agents|mesh-ancestor
91937747|NCT05556746|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91937749|NCT05556746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937750|NCT05556746|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91937751|NCT05556746|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91937752|NCT05556746|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91937753|NCT05556746|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91937754|NCT05556746|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91937755|NCT05556746|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91937756|NCT05556746|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91937757|NCT05556746|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91937758|NCT05556746|Antimetabolites|antimetabolites|mesh-ancestor
91937759|NCT05556746|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91937760|NCT05556746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937762|NCT05554406|Azacitidine|azacitidine|mesh-list
91937763|NCT05554406|Daunorubicin|daunorubicin|mesh-list
91937764|NCT05554406|Venetoclax|venetoclax|mesh-list
91937765|NCT05554406|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937766|NCT05554406|Antimetabolites|antimetabolites|mesh-ancestor
91937767|NCT05554406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943851|NCT02738203|Anesthetics|anesthetics|mesh-ancestor
91937768|NCT05554406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937769|NCT05554406|Antiviral Agents|antiviral agents|mesh-ancestor
91937770|NCT05554406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937771|NCT05554406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937773|NCT05554406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937774|NCT05554406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937775|NCT05554406|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91937776|NCT05554406|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91937777|NCT05554406|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937778|NCT04803591|Tranexamic Acid|tranexamic acid|mesh-list
91937779|NCT04803591|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91937780|NCT04803591|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91937781|NCT04803591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937782|NCT04803591|Hemostatics|hemostatics|mesh-ancestor
91937784|NCT05536856|Fluorouracil|fluorouracil|mesh-list
91937785|NCT05536856|Antimetabolites|antimetabolites|mesh-ancestor
91937786|NCT05536856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937787|NCT05536856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937788|NCT05536856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937789|NCT05536856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937790|NCT05536856|Immunologic Factors|immunologic factors|mesh-ancestor
91937792|NCT04735263|Atorvastatin|atorvastatin|mesh-list
91937793|NCT04735263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91937794|NCT04735263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91937795|NCT04735263|Antimetabolites|antimetabolites|mesh-ancestor
91937796|NCT04735263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937797|NCT04735263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91937798|NCT04735263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91937799|NCT04735263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937801|NCT00493298|Immunologic Factors|immunologic factors|mesh-ancestor
91937802|NCT00493298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937803|NCT02329197|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91937804|NCT02329197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91937805|NCT02329197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937806|NCT04662723|Dapagliflozin|dapagliflozin|mesh-list
91937807|NCT04662723|Empagliflozin|empagliflozin|mesh-list
92081623|NCT02076243|Mitosis Modulators|mitosis modulators|mesh-ancestor
91937809|NCT04662723|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91937810|NCT04662723|Methylprednisolone|methylprednisolone|mesh-list
91937811|NCT04662723|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91937812|NCT04662723|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91937813|NCT04662723|Prednisolone|prednisolone|mesh-list
91937814|NCT04662723|Prednisolone acetate|prednisolone acetate|mesh-list
91937815|NCT04662723|Losartan|losartan|mesh-list
91937816|NCT04662723|Ramipril|ramipril|mesh-list
91937817|NCT04662723|Lisinopril|lisinopril|mesh-list
91937818|NCT04662723|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91937819|NCT04662723|Prednisolone phosphate|prednisolone phosphate|mesh-list
91937820|NCT04662723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937821|NCT04662723|Antiemetics|antiemetics|mesh-ancestor
91937822|NCT04662723|Autonomic Agents|autonomic agents|mesh-ancestor
91937823|NCT04662723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937824|NCT04662723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937825|NCT04662723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937826|NCT04662723|Glucocorticoids|glucocorticoids|mesh-ancestor
91937827|NCT04662723|Hormones|hormones|mesh-ancestor
91937828|NCT04662723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937829|NCT04662723|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91937830|NCT04662723|Protective Agents|protective agents|mesh-ancestor
91937831|NCT04662723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91937832|NCT04662723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937833|NCT04662723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937834|NCT04662723|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91937835|NCT04662723|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91937836|NCT04662723|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91937837|NCT04662723|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91937838|NCT04662723|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91937839|NCT04662723|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91937842|NCT04662723|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91937843|NCT05307926|Lenvatinib|lenvatinib|mesh-list
91937844|NCT05307926|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91937845|NCT05307926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937846|NCT05307926|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937847|NCT05307926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937848|NCT05307926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074253|NCT00072514|Hormones|hormones|mesh-ancestor
91937849|NCT05307926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937850|NCT04026945|Lidocaine|lidocaine|mesh-list
91937851|NCT04026945|Anesthetics, Local|anesthetics, local|mesh-ancestor
91937852|NCT04026945|Anesthetics|anesthetics|mesh-ancestor
91937854|NCT04026945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937855|NCT04026945|Sensory System Agents|sensory system agents|mesh-ancestor
91937856|NCT04026945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937857|NCT04026945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91937858|NCT04026945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91937859|NCT04026945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91937860|NCT04026945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91937861|NCT04026945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937862|NCT02328729|Epinephrine|epinephrine|mesh-list
91937863|NCT02328729|Racepinephrine|racepinephrine|mesh-list
91937864|NCT02328729|Epinephryl borate|epinephryl borate|mesh-list
91937865|NCT02328729|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91937866|NCT02328729|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91937867|NCT02328729|Adrenergic Agents|adrenergic agents|mesh-ancestor
91937868|NCT02328729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937869|NCT02328729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937870|NCT02328729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937871|NCT02328729|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91937872|NCT02328729|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91937873|NCT02328729|Autonomic Agents|autonomic agents|mesh-ancestor
91937874|NCT02328729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937875|NCT02328729|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91937876|NCT02328729|Respiratory System Agents|respiratory system agents|mesh-ancestor
91937878|NCT02328729|Sympathomimetics|sympathomimetics|mesh-ancestor
91937879|NCT02328729|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91937880|NCT02328963|Mycophenolic Acid|mycophenolic acid|mesh-list
91937881|NCT02328963|Everolimus|everolimus|mesh-list
91937882|NCT02328963|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91937883|NCT02328963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91937884|NCT02328963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937885|NCT02328963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937886|NCT02328963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937887|NCT02328963|Immunologic Factors|immunologic factors|mesh-ancestor
91937888|NCT02328963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937889|NCT02328963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937890|NCT02328963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91937891|NCT02328963|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91937892|NCT02328963|Antitubercular Agents|antitubercular agents|mesh-ancestor
91937893|NCT02328963|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937894|NCT02328963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937895|NCT03353259|Tranexamic Acid|tranexamic acid|mesh-list
91937896|NCT03353259|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91937897|NCT03353259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91937898|NCT03353259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937899|NCT03353259|Hemostatics|hemostatics|mesh-ancestor
91937900|NCT03353259|Coagulants|coagulants|mesh-ancestor
91937901|NCT02328651|Ribavirin|ribavirin|mesh-list
91937902|NCT02328651|Antimetabolites|antimetabolites|mesh-ancestor
91937903|NCT02328651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937904|NCT02328651|Antiviral Agents|antiviral agents|mesh-ancestor
91937905|NCT02328651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937906|NCT02289352|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91937907|NCT02289352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91937908|NCT02289352|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91937909|NCT02289352|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91937910|NCT02289352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91937912|NCT02289352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91937913|NCT02289352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937914|NCT02289352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937915|NCT05337566|Azithromycin|azithromycin|mesh-list
91937917|NCT05337566|Cefuroxime axetil|cefuroxime axetil|mesh-list
91937918|NCT05337566|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91937919|NCT05337566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91937920|NCT02328495|Misoprostol|misoprostol|mesh-list
91937921|NCT02328495|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91937922|NCT02328495|Abortifacient Agents|abortifacient agents|mesh-ancestor
91937923|NCT02328495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91937924|NCT02328495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937925|NCT02328495|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91937926|NCT02328495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937930|NCT04886986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937932|NCT02287402|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91937933|NCT02287402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937934|NCT02287402|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91937935|NCT02287402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937936|NCT02287402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937937|NCT02913495|Progesterone|progesterone|mesh-list
91937939|NCT02913495|Hormones|hormones|mesh-ancestor
91937940|NCT02913495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937942|NCT03111069|Doxorubicin|doxorubicin|mesh-list
91937943|NCT03111069|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91937944|NCT03111069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91937945|NCT03111069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937946|NCT03111069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91937947|NCT03111069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937948|NCT03111069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937949|NCT03111069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937950|NCT03110757|Aluminum Hydroxide|aluminum hydroxide|mesh-list
91937951|NCT03110757|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91937952|NCT03110757|Immunologic Factors|immunologic factors|mesh-ancestor
91937953|NCT03110757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937954|NCT03110757|Antacids|antacids|mesh-ancestor
91937955|NCT03110757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937956|NCT03110757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937957|NCT05303792|Cytarabine|cytarabine|mesh-list
91937958|NCT05303792|Dexamethasone|dexamethasone|mesh-list
91937959|NCT05303792|Prednisone|prednisone|mesh-list
91937960|NCT05303792|Methylprednisolone|methylprednisolone|mesh-list
91937962|NCT05303792|Rituximab|rituximab|mesh-list
91937963|NCT05303792|Doxorubicin|doxorubicin|mesh-list
91937964|NCT05303792|Methotrexate|methotrexate|mesh-list
91937966|NCT05303792|Mercaptopurine|mercaptopurine|mesh-list
91937967|NCT05303792|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
91937968|NCT05303792|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91937969|NCT05303792|Immunologic Factors|immunologic factors|mesh-ancestor
91937970|NCT05303792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91937971|NCT05303792|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937972|NCT05303792|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91937973|NCT05303792|Alkylating Agents|alkylating agents|mesh-ancestor
91937974|NCT05303792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91937975|NCT05303792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91937976|NCT05303792|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91937977|NCT05303792|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91937978|NCT05303792|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937979|NCT05303792|Antiemetics|antiemetics|mesh-ancestor
91937980|NCT05303792|Autonomic Agents|autonomic agents|mesh-ancestor
91937981|NCT05303792|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91937982|NCT05303792|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91937983|NCT05303792|Glucocorticoids|glucocorticoids|mesh-ancestor
91945295|NCT03529331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91945296|NCT03529331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91937985|NCT05303792|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91937986|NCT05303792|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91937987|NCT05303792|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91937988|NCT05303792|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91937989|NCT05303792|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91937990|NCT05303792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91937991|NCT05303792|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91937992|NCT05303792|Abortifacient Agents|abortifacient agents|mesh-ancestor
91937993|NCT05303792|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91937994|NCT05303792|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91937995|NCT05303792|Antimetabolites|antimetabolites|mesh-ancestor
91937996|NCT05303792|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945297|NCT03529331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91937997|NCT05303792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91937998|NCT05303792|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91937999|NCT05303792|Antiviral Agents|antiviral agents|mesh-ancestor
91938000|NCT05303792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945298|NCT03529253|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91938001|NCT05303792|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91938003|NCT05303792|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938004|NCT05303792|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938005|NCT05303792|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91938006|NCT05303792|Protective Agents|protective agents|mesh-ancestor
91938007|NCT05303792|Immunotoxins|immunotoxins|mesh-ancestor
91938008|NCT05303792|Immunoconjugates|immunoconjugates|mesh-ancestor
91938009|NCT05080569|Progesterone|progesterone|mesh-list
91938010|NCT05080569|Progestins|progestins|mesh-ancestor
91938011|NCT05080569|Hormones|hormones|mesh-ancestor
91938012|NCT05080569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938013|NCT05080569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938014|NCT03145467|Acetaminophen|acetaminophen|mesh-list
91938015|NCT03145467|Zolmitriptan|zolmitriptan|mesh-list
91938016|NCT03145467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938017|NCT03145467|Analgesics|analgesics|mesh-ancestor
91938018|NCT03145467|Sensory System Agents|sensory system agents|mesh-ancestor
91938019|NCT03145467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938020|NCT03145467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938022|NCT03145467|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91938023|NCT03145467|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91938024|NCT03145467|Serotonin Agents|serotonin agents|mesh-ancestor
91938026|NCT03145467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938028|NCT05302856|Testosterone|testosterone|mesh-list
91938030|NCT05302856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938031|NCT05302856|Androgens|androgens|mesh-ancestor
91938032|NCT05302856|Hormones|hormones|mesh-ancestor
91945301|NCT03529253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945302|NCT03529253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938033|NCT05302856|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938034|NCT02328183|Polymyxins|polymyxins|mesh-list
91938035|NCT02328183|Polymyxin B|polymyxin b|mesh-list
91938036|NCT02328183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938037|NCT02328183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938039|NCT05610488|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938040|NCT05610488|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938041|NCT05610488|Growth Substances|growth substances|mesh-ancestor
91938042|NCT05610488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938043|NCT05610488|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938044|NCT05610488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938045|NCT01646398|Vaccines|vaccines|mesh-list
91938046|NCT01646398|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91938047|NCT01646398|Immunologic Factors|immunologic factors|mesh-ancestor
91938048|NCT01646398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938051|NCT05382104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938053|NCT01646320|Dapagliflozin|dapagliflozin|mesh-list
91938054|NCT01646320|Saxagliptin|saxagliptin|mesh-list
91938056|NCT01646320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938057|NCT01646320|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91945303|NCT03529253|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91945304|NCT03529253|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91938058|NCT01646320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938059|NCT01646320|Incretins|incretins|mesh-ancestor
91938060|NCT01646320|Hormones|hormones|mesh-ancestor
91945305|NCT03529253|Antimetabolites|antimetabolites|mesh-ancestor
91938061|NCT01646320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938062|NCT01646320|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91938063|NCT01646320|Protease Inhibitors|protease inhibitors|mesh-ancestor
91938064|NCT01646320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938065|NCT03141645|Ondansetron|ondansetron|mesh-list
91938067|NCT03141645|Autonomic Agents|autonomic agents|mesh-ancestor
91938068|NCT03141645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938069|NCT03141645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938070|NCT03141645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938071|NCT03141645|Antipruritics|antipruritics|mesh-ancestor
91938072|NCT03141645|Dermatologic Agents|dermatologic agents|mesh-ancestor
91938073|NCT03141645|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91938074|NCT03141645|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91938075|NCT03141645|Serotonin Agents|serotonin agents|mesh-ancestor
91938076|NCT03141645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938077|NCT03141645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938079|NCT05327426|Immunologic Factors|immunologic factors|mesh-ancestor
91938080|NCT05327426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938081|NCT05327270|Nivolumab|nivolumab|mesh-list
91938082|NCT05327270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938083|NCT05327270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938084|NCT05327270|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91938085|NCT05327270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938086|NCT05297396|Analgesics, Opioid|analgesics, opioid|mesh-list
91938088|NCT05297396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938089|NCT05297396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938090|NCT05297396|Analgesics|analgesics|mesh-ancestor
91938091|NCT05297396|Sensory System Agents|sensory system agents|mesh-ancestor
91938092|NCT05297396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938093|NCT01658150|Isradipine|isradipine|mesh-list
91938094|NCT01658150|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91938095|NCT01658150|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91938096|NCT01658150|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938097|NCT01658150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938098|NCT01658150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91938099|NCT01658150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938100|NCT01658150|Vasodilator Agents|vasodilator agents|mesh-ancestor
91938101|NCT02285998|Vaccines|vaccines|mesh-list
91938102|NCT02285998|Immunologic Factors|immunologic factors|mesh-ancestor
91938103|NCT02285998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938104|NCT02285920|Spironolactone|spironolactone|mesh-list
91938105|NCT02285920|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91938106|NCT02285920|Hormone Antagonists|hormone antagonists|mesh-ancestor
91945306|NCT03529253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938107|NCT02285920|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938108|NCT02285920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938109|NCT02285920|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91938110|NCT02285920|Diuretics|diuretics|mesh-ancestor
91938111|NCT02285920|Natriuretic Agents|natriuretic agents|mesh-ancestor
91938112|NCT05292872|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
91938113|NCT05292872|Cathartics|cathartics|mesh-ancestor
91938114|NCT05292872|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938115|NCT02035137|Irinotecan|irinotecan|mesh-list
91938116|NCT02035137|Vincristine|vincristine|mesh-list
91938118|NCT02035137|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
91938119|NCT02035137|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91938120|NCT02035137|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91938121|NCT02035137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938122|NCT02035137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938123|NCT02035137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938124|NCT02035137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91938126|NCT02035137|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938127|NCT02035137|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938128|NCT02035137|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91938129|NCT02035137|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91938130|NCT05321810|Warfarin|warfarin|mesh-list
91938131|NCT05321810|Apixaban|apixaban|mesh-list
91938132|NCT05321810|Anticoagulants|anticoagulants|mesh-ancestor
91938133|NCT05321810|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91938134|NCT05321810|Antithrombins|antithrombins|mesh-ancestor
91938135|NCT05321810|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91938136|NCT05321810|Protease Inhibitors|protease inhibitors|mesh-ancestor
91938137|NCT05321810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945307|NCT03529253|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91938138|NCT05321810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938139|NCT05264870|Norepinephrine|norepinephrine|mesh-list
91938140|NCT05264870|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91938141|NCT05264870|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91938142|NCT05264870|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938144|NCT05264870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938145|NCT05264870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938146|NCT05264870|Sympathomimetics|sympathomimetics|mesh-ancestor
91938148|NCT05264870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938149|NCT05264870|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91938151|NCT04249232|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91938152|NCT04249232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938153|NCT05079087|Midazolam|midazolam|mesh-list
91938154|NCT05079087|Ketamine|ketamine|mesh-list
91938155|NCT05079087|Analgesics|analgesics|mesh-ancestor
91938156|NCT05079087|Sensory System Agents|sensory system agents|mesh-ancestor
91938157|NCT05079087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938158|NCT05079087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938159|NCT05079087|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91938160|NCT05079087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91938162|NCT05079087|Anesthetics|anesthetics|mesh-ancestor
91938163|NCT05079087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938164|NCT05079087|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91938165|NCT05079087|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91938166|NCT05079087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938167|NCT05079087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938168|NCT05079087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91938169|NCT05079087|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938170|NCT05079087|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91938172|NCT05079087|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91938173|NCT05079087|GABA Modulators|gaba modulators|mesh-ancestor
91938174|NCT05079087|GABA Agents|gaba agents|mesh-ancestor
91938176|NCT02522780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91938177|NCT02522780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938179|NCT02522780|Sensory System Agents|sensory system agents|mesh-ancestor
91938180|NCT02522780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938181|NCT02522780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938182|NCT02522780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938183|NCT02522780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938185|NCT03618225|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91938186|NCT03618225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91938187|NCT03618225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938188|NCT03618225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938189|NCT03618225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938190|NCT03618225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938191|NCT03618225|Analgesics|analgesics|mesh-ancestor
91938192|NCT03618225|Sensory System Agents|sensory system agents|mesh-ancestor
91938193|NCT03618225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938194|NCT03618225|Antidepressive Agents|antidepressive agents|mesh-ancestor
91938195|NCT03618225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91938196|NCT03618225|Dopamine Agents|dopamine agents|mesh-ancestor
91938198|NCT03566199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938199|NCT03566199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91938201|NCT03566199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938203|NCT03561831|Sevoflurane|sevoflurane|mesh-list
91938204|NCT03561831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938205|NCT03561831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938206|NCT03561831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938207|NCT03561831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91938208|NCT03561831|Anesthetics, General|anesthetics, general|mesh-ancestor
91938209|NCT03561831|Anesthetics|anesthetics|mesh-ancestor
91938210|NCT03561831|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91938211|NCT03561831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91938212|NCT05289830|Escitalopram|escitalopram|mesh-list
91938213|NCT05289830|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91938214|NCT05289830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91938215|NCT05289830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938216|NCT05289830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938217|NCT05289830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938218|NCT05289830|Serotonin Agents|serotonin agents|mesh-ancestor
91938219|NCT05289830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938220|NCT03144843|Apatinib|apatinib|mesh-list
91938221|NCT03144843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938222|NCT03144843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91938223|NCT03144843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938224|NCT03144843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938225|NCT05288348|Sufentanil|sufentanil|mesh-list
91938227|NCT05288348|Narcotics|narcotics|mesh-ancestor
91938228|NCT05288348|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938229|NCT05288348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938230|NCT05288348|Analgesics|analgesics|mesh-ancestor
91938231|NCT05288348|Sensory System Agents|sensory system agents|mesh-ancestor
91938232|NCT05288348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938233|NCT05288348|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91938234|NCT05288348|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91938235|NCT05288348|Anesthetics, General|anesthetics, general|mesh-ancestor
91938236|NCT05288348|Anesthetics|anesthetics|mesh-ancestor
91938237|NCT03111615|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91938238|NCT03111615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91938239|NCT03111615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938240|NCT03111615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938241|NCT03111615|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91938242|NCT03111615|Hormone Antagonists|hormone antagonists|mesh-ancestor
91938243|NCT03111615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938244|NCT03111615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938245|NCT05259800|Peppermint oil|peppermint oil|mesh-list
91938246|NCT05259800|Mineral Oil|mineral oil|mesh-list
91938247|NCT05259800|Antiemetics|antiemetics|mesh-ancestor
91938248|NCT05259800|Autonomic Agents|autonomic agents|mesh-ancestor
91938249|NCT05259800|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938250|NCT05259800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938251|NCT05259800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938252|NCT05259800|Parasympatholytics|parasympatholytics|mesh-ancestor
91938253|NCT05259800|Emollients|emollients|mesh-ancestor
91938256|NCT03199755|Artemether|artemether|mesh-list
91938257|NCT03199755|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91938258|NCT03199755|Antimalarials|antimalarials|mesh-ancestor
91938259|NCT03199755|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91938260|NCT03199755|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91938261|NCT03199755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938262|NCT05318066|Norepinephrine|norepinephrine|mesh-list
91938263|NCT05318066|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91938264|NCT05318066|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91938265|NCT05318066|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938266|NCT05318066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938267|NCT05318066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938268|NCT05318066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938269|NCT05318066|Sympathomimetics|sympathomimetics|mesh-ancestor
91938270|NCT05318066|Autonomic Agents|autonomic agents|mesh-ancestor
91938271|NCT05318066|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938272|NCT05318066|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91938274|NCT02327793|Nitroglycerin|nitroglycerin|mesh-list
91938275|NCT02327793|Vasodilator Agents|vasodilator agents|mesh-ancestor
91938276|NCT02327793|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91938277|NCT02327793|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91938278|NCT02327793|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938279|NCT02327793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938280|NCT02327793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938281|NCT02327793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938282|NCT02327793|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91938283|NCT02327793|Sympathomimetics|sympathomimetics|mesh-ancestor
91938284|NCT02327793|Autonomic Agents|autonomic agents|mesh-ancestor
91938285|NCT02327793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938286|NCT02327793|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91938287|NCT02327793|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91938288|NCT02327715|Emtricitabine|emtricitabine|mesh-list
91938289|NCT02327715|Antiviral Agents|antiviral agents|mesh-ancestor
91938290|NCT02327715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938291|NCT02327715|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91938292|NCT02327715|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91938293|NCT02327715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938294|NCT02327715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938296|NCT02327715|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91938297|NCT02951013|Chrysarobin|chrysarobin|mesh-list
91938298|NCT02951013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91938299|NCT02951013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938300|NCT02951013|Analgesics|analgesics|mesh-ancestor
91938302|NCT02951013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938303|NCT02951013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938304|NCT02951013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938305|NCT02951013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938306|NCT05080803|Bevacizumab|bevacizumab|mesh-list
91938307|NCT05080803|Ranibizumab|ranibizumab|mesh-list
91938308|NCT05080803|Aflibercept|aflibercept|mesh-list
91938309|NCT05080803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938310|NCT05080803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938311|NCT05080803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938312|NCT05080803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938313|NCT05080803|Growth Substances|growth substances|mesh-ancestor
91938314|NCT05080803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938315|NCT05080803|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938317|NCT02285062|Cyclophosphamide|cyclophosphamide|mesh-list
91938318|NCT02285062|Rituximab|rituximab|mesh-list
91938319|NCT02285062|Doxorubicin|doxorubicin|mesh-list
91938320|NCT02285062|Vincristine|vincristine|mesh-list
91938321|NCT02285062|Lenalidomide|lenalidomide|mesh-list
91938322|NCT02285062|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938323|NCT02285062|Immunologic Factors|immunologic factors|mesh-ancestor
91938324|NCT02285062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938325|NCT02285062|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938326|NCT02285062|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91938327|NCT02285062|Alkylating Agents|alkylating agents|mesh-ancestor
91938328|NCT02285062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938330|NCT02285062|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91938331|NCT02285062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938332|NCT02285062|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91938333|NCT02285062|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91938334|NCT02285062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91938335|NCT02285062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938336|NCT02285062|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938337|NCT02285062|Glucocorticoids|glucocorticoids|mesh-ancestor
91938338|NCT02285062|Hormones|hormones|mesh-ancestor
91938339|NCT02285062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938340|NCT02285062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91938341|NCT02285062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91938342|NCT02285062|Tubulin Modulators|tubulin modulators|mesh-ancestor
91938343|NCT02285062|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938344|NCT02285062|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938345|NCT02285062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938346|NCT02285062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938347|NCT02285062|Growth Substances|growth substances|mesh-ancestor
91938348|NCT02285062|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938349|NCT02431767|Interleukin-12|interleukin-12|mesh-list
91938350|NCT02431767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91938351|NCT02431767|Immunologic Factors|immunologic factors|mesh-ancestor
91938352|NCT02431767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938353|NCT02431767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938354|NCT02431767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938355|NCT02431767|Growth Substances|growth substances|mesh-ancestor
91938356|NCT02431767|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938357|NCT02431767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938358|NCT05313620|Adalimumab|adalimumab|mesh-list
91938359|NCT05313620|Infliximab|infliximab|mesh-list
91938360|NCT05313620|Golimumab|golimumab|mesh-list
91938361|NCT05313620|Tofacitinib|tofacitinib|mesh-list
91938362|NCT05313620|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91938363|NCT05313620|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938364|NCT05313620|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938365|NCT05313620|Dermatologic Agents|dermatologic agents|mesh-ancestor
91938366|NCT05313620|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938367|NCT05313620|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91938368|NCT05313620|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91938369|NCT05313620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938370|NCT05313620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938371|NCT05313620|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938372|NCT05313620|Immunologic Factors|immunologic factors|mesh-ancestor
91938373|NCT05313620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938374|NCT04571697|Methotrexate|methotrexate|mesh-list
91938375|NCT04571697|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91938376|NCT04571697|Abortifacient Agents|abortifacient agents|mesh-ancestor
91938377|NCT04571697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91938378|NCT04571697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938379|NCT04571697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91938380|NCT04571697|Antimetabolites|antimetabolites|mesh-ancestor
91938381|NCT04571697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938382|NCT04571697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938383|NCT04571697|Dermatologic Agents|dermatologic agents|mesh-ancestor
91938384|NCT04571697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938385|NCT04571697|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91938386|NCT04571697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938387|NCT04571697|Immunologic Factors|immunologic factors|mesh-ancestor
91938388|NCT04571697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938389|NCT04571697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91938390|NCT05482334|Molgramostim|molgramostim|mesh-list
91938391|NCT05482334|Sargramostim|sargramostim|mesh-list
91938392|NCT05482334|Immunologic Factors|immunologic factors|mesh-ancestor
91938393|NCT05482334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938394|NCT05482334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938395|NCT05253794|Colchicine|colchicine|mesh-list
91938396|NCT05253794|Gout Suppressants|gout suppressants|mesh-ancestor
91938397|NCT05253794|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938398|NCT05253794|Tubulin Modulators|tubulin modulators|mesh-ancestor
91938399|NCT05253794|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938400|NCT05253794|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938401|NCT05253794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938403|NCT03140943|Thalidomide|thalidomide|mesh-list
91938404|NCT03140943|Dexamethasone|dexamethasone|mesh-list
91938405|NCT03140943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938406|NCT03140943|Antiemetics|antiemetics|mesh-ancestor
91938407|NCT03140943|Autonomic Agents|autonomic agents|mesh-ancestor
91938408|NCT03140943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938409|NCT03140943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938410|NCT03140943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938411|NCT03140943|Glucocorticoids|glucocorticoids|mesh-ancestor
91938412|NCT03140943|Hormones|hormones|mesh-ancestor
91938413|NCT03140943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938414|NCT03140943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91938415|NCT03140943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938416|NCT03140943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938417|NCT03140943|Immunologic Factors|immunologic factors|mesh-ancestor
91938418|NCT03140943|Leprostatic Agents|leprostatic agents|mesh-ancestor
91938419|NCT03140943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938420|NCT03140943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938421|NCT03140943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938422|NCT03140943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938423|NCT03140943|Growth Substances|growth substances|mesh-ancestor
91938424|NCT03140943|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938425|NCT02038257|Petrolatum|petrolatum|mesh-list
91938426|NCT02038257|Emollients|emollients|mesh-ancestor
91938427|NCT02038257|Dermatologic Agents|dermatologic agents|mesh-ancestor
91938429|NCT05311436|Folic Acid|folic acid|mesh-list
91938430|NCT05311436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938431|NCT05311436|Trace Elements|trace elements|mesh-ancestor
91938432|NCT05311436|Micronutrients|micronutrients|mesh-ancestor
91938433|NCT05311436|Hematinics|hematinics|mesh-ancestor
91938434|NCT05311436|Vitamin B Complex|vitamin b complex|mesh-ancestor
91938435|NCT05311436|Vitamins|vitamins|mesh-ancestor
91938436|NCT05199753|Antibodies|antibodies|mesh-list
91938437|NCT05199753|Immunologic Factors|immunologic factors|mesh-ancestor
91938438|NCT05199753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938439|NCT01352741|Pregabalin|pregabalin|mesh-list
91938441|NCT01352741|Analgesics|analgesics|mesh-ancestor
91938442|NCT01352741|Sensory System Agents|sensory system agents|mesh-ancestor
91938443|NCT01352741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938444|NCT01352741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938445|NCT01352741|Anticonvulsants|anticonvulsants|mesh-ancestor
91938446|NCT01352741|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91938447|NCT01352741|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938448|NCT01352741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938449|NCT01352741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91938450|NCT01352741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91938451|NCT01352741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91938452|NCT01352741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938454|NCT01352741|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91938456|NCT01352741|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91938457|NCT01352741|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91938458|NCT01352741|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938459|NCT01352741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938460|NCT04422392|Paclitaxel|paclitaxel|mesh-list
91938461|NCT04422392|Carboplatin|carboplatin|mesh-list
91938462|NCT04422392|Pemetrexed|pemetrexed|mesh-list
91938463|NCT04422392|Antibodies|antibodies|mesh-list
91938464|NCT04422392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91938465|NCT04422392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938466|NCT04422392|Tubulin Modulators|tubulin modulators|mesh-ancestor
91938467|NCT04422392|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938468|NCT04422392|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938469|NCT04422392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938470|NCT04422392|Immunologic Factors|immunologic factors|mesh-ancestor
91938471|NCT04422392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938472|NCT04422392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938473|NCT04422392|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91938474|NCT04422392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91938475|NCT03973593|Contraceptive Agents|contraceptive agents|mesh-list
91938476|NCT03973593|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91938477|NCT03973593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938479|NCT00911963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91938480|NCT00911963|Antimetabolites|antimetabolites|mesh-ancestor
91938481|NCT00911963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938482|NCT00911963|Antiviral Agents|antiviral agents|mesh-ancestor
91938483|NCT00911963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938485|NCT01657292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938486|NCT01657292|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91945308|NCT03529253|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91938488|NCT04167033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938489|NCT04167033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938491|NCT00907907|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91938492|NCT00907907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938493|NCT00907907|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91938494|NCT00907907|Antitubercular Agents|antitubercular agents|mesh-ancestor
91938495|NCT00907907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938496|NCT00907907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938497|NCT00907907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938498|NCT00907907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938499|NCT03140553|Cyclophosphamide|cyclophosphamide|mesh-list
91938500|NCT03140553|Carboplatin|carboplatin|mesh-list
91938502|NCT03140553|Trastuzumab|trastuzumab|mesh-list
91938503|NCT03140553|Epirubicin|epirubicin|mesh-list
91938504|NCT03140553|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938505|NCT03140553|Immunologic Factors|immunologic factors|mesh-ancestor
91938506|NCT03140553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938507|NCT03140553|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938508|NCT03140553|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91938509|NCT03140553|Alkylating Agents|alkylating agents|mesh-ancestor
91938510|NCT03140553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938511|NCT03140553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938512|NCT03140553|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91938513|NCT03140553|Tubulin Modulators|tubulin modulators|mesh-ancestor
91938514|NCT03140553|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938515|NCT03140553|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938516|NCT03140553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938517|NCT03140553|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91938518|NCT03140553|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91938519|NCT03140553|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91938520|NCT03140553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938521|NCT05279456|Myeloma Proteins|myeloma proteins|mesh-list
91938522|NCT05279456|Paraproteins|paraproteins|mesh-list
91938523|NCT05279456|Immunologic Factors|immunologic factors|mesh-ancestor
91938524|NCT05279456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938525|NCT00905567|Topiramate|topiramate|mesh-list
91938526|NCT00905567|Anticonvulsants|anticonvulsants|mesh-ancestor
91938527|NCT00905567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91938528|NCT00905567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938529|NCT05277896|Ketamine|ketamine|mesh-list
91938530|NCT05277896|Etomidate|etomidate|mesh-list
91938531|NCT05277896|Analgesics|analgesics|mesh-ancestor
91938532|NCT05277896|Sensory System Agents|sensory system agents|mesh-ancestor
91938533|NCT05277896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938534|NCT05277896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938535|NCT05277896|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91938536|NCT05277896|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91938537|NCT05277896|Anesthetics, General|anesthetics, general|mesh-ancestor
91938539|NCT05277896|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938540|NCT05277896|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91938541|NCT05277896|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91938542|NCT05277896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938543|NCT05277896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938544|NCT05277896|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938545|NCT02282020|Olaparib|olaparib|mesh-list
91938546|NCT02282020|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91938547|NCT02282020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938548|NCT02282020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938549|NCT02282020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938551|NCT05249972|Betamethasone|betamethasone|mesh-list
91938552|NCT05249972|Betamethasone Valerate|betamethasone valerate|mesh-list
91938553|NCT05249972|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91938555|NCT05249972|Calcipotriene|calcipotriene|mesh-list
91938556|NCT05249972|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91938557|NCT05249972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938558|NCT05249972|Glucocorticoids|glucocorticoids|mesh-ancestor
91938560|NCT05249972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938561|NCT05249972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938562|NCT05249972|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91938563|NCT05249972|Respiratory System Agents|respiratory system agents|mesh-ancestor
91938564|NCT05249972|Dermatologic Agents|dermatologic agents|mesh-ancestor
91938565|NCT05249972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91938566|NCT05249972|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
91938567|NCT05249972|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945309|NCT03529253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938568|NCT05249972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938569|NCT05249972|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91938571|NCT05249972|Micronutrients|micronutrients|mesh-ancestor
91938572|NCT05249972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91938574|NCT00904943|Anticonvulsants|anticonvulsants|mesh-ancestor
91938575|NCT00904943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91938576|NCT00904943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938578|NCT00902291|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91938579|NCT00902291|Antimetabolites|antimetabolites|mesh-ancestor
91938580|NCT00902291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938581|NCT00902291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938582|NCT05217680|Bevacizumab|bevacizumab|mesh-list
91938583|NCT05217680|Ranibizumab|ranibizumab|mesh-list
91938584|NCT05217680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938585|NCT05217680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938586|NCT05217680|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91945310|NCT03529253|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91938587|NCT05217680|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938588|NCT05217680|Growth Substances|growth substances|mesh-ancestor
91938589|NCT05217680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938590|NCT05217680|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938591|NCT02281552|Tofacitinib|tofacitinib|mesh-list
91938592|NCT02281552|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91938593|NCT02281552|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91938594|NCT02281552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945311|NCT03529253|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91938595|NCT02281552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938597|NCT03832647|Salicylates|salicylates|mesh-list
91938598|NCT03832647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938599|NCT03832647|Antifungal Agents|antifungal agents|mesh-ancestor
91938600|NCT03832647|Keratolytic Agents|keratolytic agents|mesh-ancestor
91938601|NCT03832647|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945312|NCT03529253|Protease Inhibitors|protease inhibitors|mesh-ancestor
91938602|NCT03832647|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91938603|NCT03832647|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938606|NCT03832647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945313|NCT03529175|Paclitaxel|paclitaxel|mesh-list
91945314|NCT03529175|Gemcitabine|gemcitabine|mesh-list
91938607|NCT03832647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938608|NCT03832647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91938609|NCT03832647|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938610|NCT03832647|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91938611|NCT03832647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938612|NCT03832647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938613|NCT00901979|Metformin|metformin|mesh-list
91938615|NCT00901979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91938616|NCT00901979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938618|NCT00901979|Hormones|hormones|mesh-ancestor
91945315|NCT03529175|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91938619|NCT00901979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938620|NCT00901979|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91938621|NCT00901979|Protease Inhibitors|protease inhibitors|mesh-ancestor
91938622|NCT00901979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938623|NCT00901979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938624|NCT03778671|Fentanyl|fentanyl|mesh-list
91938625|NCT03778671|Dexmedetomidine|dexmedetomidine|mesh-list
91938626|NCT03778671|Levobupivacaine|levobupivacaine|mesh-list
91938627|NCT03778671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938628|NCT03778671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938629|NCT03778671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938630|NCT03778671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938631|NCT03778671|Analgesics|analgesics|mesh-ancestor
91938633|NCT03778671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938634|NCT03778671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91938635|NCT03778671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91938636|NCT03778671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91938637|NCT03778671|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938638|NCT03778671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938639|NCT03778671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938640|NCT03778671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91938641|NCT03778671|Narcotics|narcotics|mesh-ancestor
91938642|NCT03778671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91938643|NCT03778671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91938644|NCT03778671|Anesthetics, General|anesthetics, general|mesh-ancestor
91938645|NCT03778671|Anesthetics|anesthetics|mesh-ancestor
91938646|NCT03778671|Anesthetics, Local|anesthetics, local|mesh-ancestor
91938647|NCT00978497|Ribavirin|ribavirin|mesh-list
91938648|NCT00978497|Antimetabolites|antimetabolites|mesh-ancestor
91938649|NCT00978497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938650|NCT00978497|Antiviral Agents|antiviral agents|mesh-ancestor
91938651|NCT00978497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938652|NCT03692715|Ciprofloxacin|ciprofloxacin|mesh-list
91938653|NCT03692715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938654|NCT03692715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938655|NCT03692715|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91938656|NCT03692715|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91938657|NCT03692715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938658|NCT03692715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938660|NCT03692715|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91938661|NCT03692715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91938663|NCT03558789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938664|NCT00890591|Amlodipine|amlodipine|mesh-list
91938665|NCT00890591|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91938667|NCT00890591|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91938668|NCT00890591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91938670|NCT00890591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938671|NCT00890591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938672|NCT00890591|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91938673|NCT00890591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938674|NCT00890591|Vasodilator Agents|vasodilator agents|mesh-ancestor
91938675|NCT00890591|Diuretics|diuretics|mesh-ancestor
91938676|NCT00890591|Natriuretic Agents|natriuretic agents|mesh-ancestor
91938677|NCT00890591|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91938678|NCT00890591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91938679|NCT00890591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91938680|NCT05248334|Ranibizumab|ranibizumab|mesh-list
91938681|NCT05248334|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938682|NCT05248334|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938683|NCT05248334|Growth Substances|growth substances|mesh-ancestor
91938684|NCT05248334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938685|NCT05248334|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938686|NCT05248334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938688|NCT03140787|Anesthetics, Local|anesthetics, local|mesh-ancestor
91938690|NCT03140787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938692|NCT03140787|Sensory System Agents|sensory system agents|mesh-ancestor
91938693|NCT03140787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938694|NCT03140787|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91938695|NCT03140787|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91938697|NCT03140787|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945316|NCT03529175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91938698|NCT03140787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938699|NCT00889967|Ciprofloxacin|ciprofloxacin|mesh-list
91938700|NCT00889967|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938701|NCT00889967|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938702|NCT00889967|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91938703|NCT00889967|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91938704|NCT00889967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938705|NCT00889967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938707|NCT00889967|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91938708|NCT00889967|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91938710|NCT03317223|Clarithromycin|clarithromycin|mesh-list
91938711|NCT03317223|Lansoprazole|lansoprazole|mesh-list
91938712|NCT03317223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938713|NCT03317223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938714|NCT03317223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91938715|NCT03317223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938716|NCT03317223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938717|NCT03317223|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91938718|NCT03317223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91938719|NCT03317223|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91938720|NCT03317223|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938721|NCT03317223|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91938723|NCT02284906|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91938724|NCT02284906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938725|NCT02566863|Dexmedetomidine|dexmedetomidine|mesh-list
91938726|NCT02566863|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91938727|NCT02566863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938728|NCT02566863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938729|NCT02566863|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938730|NCT02566863|Analgesics|analgesics|mesh-ancestor
91938731|NCT02566863|Sensory System Agents|sensory system agents|mesh-ancestor
91938732|NCT02566863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938733|NCT02566863|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91938734|NCT02566863|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91938735|NCT02566863|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91938736|NCT02566863|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938737|NCT02566863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938738|NCT02566863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938739|NCT05137847|Denileukin diftitox|denileukin diftitox|mesh-list
91938740|NCT05137847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938741|NCT00968825|Botulinum Toxins|botulinum toxins|mesh-list
91938742|NCT00968825|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91938743|NCT00968825|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91938744|NCT00968825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91938745|NCT00968825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938746|NCT00968825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938747|NCT00968825|Cholinergic Agents|cholinergic agents|mesh-ancestor
91938748|NCT00968825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938749|NCT00968825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938750|NCT00968825|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91938751|NCT00968825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938752|NCT04474457|Favipiravir|favipiravir|mesh-list
91938753|NCT04474457|Antiviral Agents|antiviral agents|mesh-ancestor
91938754|NCT04474457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938755|NCT03139383|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91938756|NCT00880217|Methylphenidate|methylphenidate|mesh-list
91938757|NCT00880217|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91938758|NCT00880217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91938759|NCT00880217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938760|NCT00880217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91938761|NCT00880217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91938762|NCT00880217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938763|NCT00880217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938764|NCT00880217|Dopamine Agents|dopamine agents|mesh-ancestor
91938765|NCT00880217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938766|NCT00880217|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91938767|NCT00880217|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938768|NCT01657760|Citalopram|citalopram|mesh-list
91938769|NCT01657760|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91938770|NCT01657760|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91938771|NCT01657760|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91938772|NCT01657760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938773|NCT01657760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938774|NCT01657760|Serotonin Agents|serotonin agents|mesh-ancestor
91938775|NCT01657760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938776|NCT01657760|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91938777|NCT01657760|Antidepressive Agents|antidepressive agents|mesh-ancestor
91938778|NCT01657760|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91938781|NCT00966953|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91938782|NCT00966953|Fluorides|fluorides|mesh-list
91938783|NCT00966953|Cariostatic Agents|cariostatic agents|mesh-ancestor
91938784|NCT00966953|Protective Agents|protective agents|mesh-ancestor
91938785|NCT00966953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938786|NCT00966953|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91938787|NCT00966953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938788|NCT00966953|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91938789|NCT00966953|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91938790|NCT00966953|Antimetabolites|antimetabolites|mesh-ancestor
91938791|NCT00966953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938792|NCT00966953|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91938793|NCT00966953|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91938794|NCT00966953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91938795|NCT00966953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938796|NCT00966953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938797|NCT00966953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938798|NCT00966953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91938799|NCT00966953|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91938800|NCT00966953|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91938801|NCT00966953|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91938802|NCT00966953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91938804|NCT05247320|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91938805|NCT05247320|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91938806|NCT05247320|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938807|NCT05247320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938808|NCT05247320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938809|NCT05247320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938810|NCT05247320|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91938812|NCT05247320|Autonomic Agents|autonomic agents|mesh-ancestor
91938813|NCT05247320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938815|NCT05084079|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91938816|NCT05084079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91938817|NCT05084079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938818|NCT05084001|Listerine|listerine|mesh-list
91938819|NCT05084001|Fluorides|fluorides|mesh-list
91938820|NCT05084001|Sodium Fluoride|sodium fluoride|mesh-list
91938821|NCT05084001|Fluorides, Topical|fluorides, topical|mesh-list
91938822|NCT05084001|Cariostatic Agents|cariostatic agents|mesh-ancestor
91938823|NCT05084001|Protective Agents|protective agents|mesh-ancestor
91938824|NCT05084001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938825|NCT05084001|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91938826|NCT05084001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938827|NCT05245916|Rituximab|rituximab|mesh-list
91938828|NCT05245916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938829|NCT05245916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938830|NCT05245916|Immunologic Factors|immunologic factors|mesh-ancestor
91938831|NCT05245916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938832|NCT05245916|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938833|NCT00875459|Insulin|insulin|mesh-list
91938834|NCT00875459|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91938835|NCT00875459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91938836|NCT00875459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938837|NCT03837353|Docetaxel|docetaxel|mesh-list
91938838|NCT03837353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938839|NCT03837353|Tubulin Modulators|tubulin modulators|mesh-ancestor
91938840|NCT03837353|Antimitotic Agents|antimitotic agents|mesh-ancestor
91938841|NCT03837353|Mitosis Modulators|mitosis modulators|mesh-ancestor
91938842|NCT03837353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938843|NCT03140709|Oxytocin|oxytocin|mesh-list
91938844|NCT03140709|Oxytocics|oxytocics|mesh-ancestor
91938845|NCT03140709|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91938846|NCT03140709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938847|NCT02283658|Everolimus|everolimus|mesh-list
91938848|NCT02283658|Letrozole|letrozole|mesh-list
91938849|NCT02283658|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91938850|NCT02283658|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91938851|NCT02283658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938852|NCT02283658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938853|NCT02283658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938854|NCT02283658|Immunologic Factors|immunologic factors|mesh-ancestor
91938855|NCT02283658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938856|NCT02283658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938857|NCT02283658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91938858|NCT02283658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91938859|NCT02283658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91938860|NCT02283658|Hormone Antagonists|hormone antagonists|mesh-ancestor
91938861|NCT02283658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91938862|NCT00872885|Morphine|morphine|mesh-list
91938863|NCT00872885|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91938864|NCT00872885|Narcotics|narcotics|mesh-ancestor
91938865|NCT00872885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91938866|NCT00872885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938867|NCT00872885|Analgesics|analgesics|mesh-ancestor
91938868|NCT00872885|Sensory System Agents|sensory system agents|mesh-ancestor
91938869|NCT00872885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938871|NCT00871481|Cyclophosphamide|cyclophosphamide|mesh-list
91938872|NCT00871481|Ipilimumab|ipilimumab|mesh-list
91938873|NCT00871481|Interleukin-2|interleukin-2|mesh-list
91938874|NCT00871481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91938875|NCT00871481|Antibodies|antibodies|mesh-list
91938876|NCT00871481|Immunoglobulins|immunoglobulins|mesh-list
91938877|NCT00871481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91938878|NCT00871481|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91938879|NCT00871481|Immunologic Factors|immunologic factors|mesh-ancestor
91938880|NCT00871481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938882|NCT00871481|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91938883|NCT00871481|Alkylating Agents|alkylating agents|mesh-ancestor
91938884|NCT00871481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938885|NCT00871481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938886|NCT00871481|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91938887|NCT00871481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91938888|NCT00871481|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91938889|NCT00871481|Analgesics|analgesics|mesh-ancestor
91938890|NCT00871481|Sensory System Agents|sensory system agents|mesh-ancestor
91938891|NCT00871481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91938892|NCT00871481|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91938893|NCT00871481|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91938894|NCT00871481|Antiviral Agents|antiviral agents|mesh-ancestor
91938895|NCT00871481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938896|NCT05456165|Ipilimumab|ipilimumab|mesh-list
91938897|NCT05456165|Atezolizumab|atezolizumab|mesh-list
91938898|NCT05456165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938899|NCT05456165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938900|NCT05456165|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91938901|NCT05456165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938902|NCT05083689|Bevacizumab|bevacizumab|mesh-list
91938903|NCT05083689|Timolol|timolol|mesh-list
91938904|NCT05083689|Dorzolamide|dorzolamide|mesh-list
91938906|NCT05083689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91938907|NCT05083689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938908|NCT05083689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91938909|NCT05083689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91938910|NCT05083689|Growth Substances|growth substances|mesh-ancestor
91938911|NCT05083689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938912|NCT05083689|Growth Inhibitors|growth inhibitors|mesh-ancestor
91938913|NCT05083689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91938914|NCT05083689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91938915|NCT05083689|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938916|NCT05083689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945317|NCT03529175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938917|NCT05083689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938918|NCT05083689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91938919|NCT05083689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91938920|NCT05083689|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91938921|NCT05083689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91938922|NCT05083689|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91938923|NCT05083689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938924|NCT05165966|Vaccines|vaccines|mesh-list
91938925|NCT05165966|Immunologic Factors|immunologic factors|mesh-ancestor
91938926|NCT05165966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938927|NCT05165732|Vaccines|vaccines|mesh-list
91938928|NCT05165732|Immunologic Factors|immunologic factors|mesh-ancestor
91938929|NCT05165732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938930|NCT04477083|Hydroxychloroquine|hydroxychloroquine|mesh-list
91938931|NCT04477083|Antimalarials|antimalarials|mesh-ancestor
91938932|NCT04477083|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91938933|NCT04477083|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91938934|NCT04477083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938935|NCT04477083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938936|NCT04477083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938937|NCT04477083|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938938|NCT03138759|Probenecid|probenecid|mesh-list
91938939|NCT03138759|Uricosuric Agents|uricosuric agents|mesh-ancestor
91938940|NCT03138759|Gout Suppressants|gout suppressants|mesh-ancestor
91938941|NCT03138759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91938943|NCT03079921|Phentolamine|phentolamine|mesh-list
91938944|NCT03079921|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91938945|NCT03079921|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91938946|NCT03079921|Adrenergic Agents|adrenergic agents|mesh-ancestor
91938947|NCT03079921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91938948|NCT03079921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938949|NCT03079921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938950|NCT03079921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91938951|NCT03079921|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91938952|NCT03079921|Vasodilator Agents|vasodilator agents|mesh-ancestor
91938955|NCT04473989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91938957|NCT04473989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91938959|NCT05209490|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91938960|NCT05209490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938961|NCT05209490|Trace Elements|trace elements|mesh-ancestor
91938962|NCT05209490|Micronutrients|micronutrients|mesh-ancestor
91938963|NCT05209490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91938984|NCT04473911|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91938985|NCT04473911|Alkylating Agents|alkylating agents|mesh-ancestor
91938986|NCT04473911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91938987|NCT04473911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91938988|NCT04473911|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91938989|NCT04473911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91938990|NCT04473911|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91938991|NCT04473911|Antitubercular Agents|antitubercular agents|mesh-ancestor
91938992|NCT04473911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91938993|NCT04473911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91938994|NCT04473911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91938995|NCT04473911|Antifungal Agents|antifungal agents|mesh-ancestor
91938996|NCT05162222|Itraconazole|itraconazole|mesh-list
91938997|NCT05162222|Diltiazem|diltiazem|mesh-list
91938998|NCT05162222|Antifungal Agents|antifungal agents|mesh-ancestor
91938999|NCT05162222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939000|NCT05162222|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91939001|NCT05162222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91939002|NCT05162222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939003|NCT05162222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939004|NCT05162222|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91939005|NCT05162222|Hormone Antagonists|hormone antagonists|mesh-ancestor
91939006|NCT05162222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939007|NCT05162222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939008|NCT05162222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91939009|NCT05162222|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939010|NCT05162222|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91939011|NCT05162222|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939012|NCT05162222|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939013|NCT05162222|Vasodilator Agents|vasodilator agents|mesh-ancestor
91939014|NCT05088057|Cyclophosphamide|cyclophosphamide|mesh-list
91939016|NCT05088057|Doxorubicin|doxorubicin|mesh-list
91939018|NCT05088057|Immunologic Factors|immunologic factors|mesh-ancestor
91939019|NCT05088057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939020|NCT05088057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939021|NCT05088057|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91939022|NCT05088057|Alkylating Agents|alkylating agents|mesh-ancestor
91939023|NCT05088057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939024|NCT05088057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939025|NCT05088057|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91939026|NCT05088057|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939027|NCT05088057|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939028|NCT05088057|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943899|NCT02283203|Antipyretics|antipyretics|mesh-ancestor
91939030|NCT05088057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91945318|NCT03529175|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939031|NCT05088057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91939032|NCT05088057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939033|NCT03132025|Capecitabine|capecitabine|mesh-list
91939034|NCT03132025|Apatinib|apatinib|mesh-list
91939035|NCT03132025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91939036|NCT03132025|Antimetabolites|antimetabolites|mesh-ancestor
91939037|NCT03132025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939038|NCT03132025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939039|NCT03132025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939040|NCT03132025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939041|NCT00857285|Losartan|losartan|mesh-list
91939042|NCT00857285|Olmesartan|olmesartan|mesh-list
91939043|NCT00857285|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91939044|NCT00857285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91939045|NCT00857285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939046|NCT00857285|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91939047|NCT00857285|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91939048|NCT00857285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939050|NCT04461379|BCG Vaccine|bcg vaccine|mesh-list
91939051|NCT04461379|Immunologic Factors|immunologic factors|mesh-ancestor
91939052|NCT04461379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939053|NCT04461379|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91939054|NCT00854945|ON 01910|on 01910|mesh-list
91939055|NCT00854945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939056|NCT00854945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939057|NCT00854945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939058|NCT00854945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939059|NCT04876534|Methylprednisolone|methylprednisolone|mesh-list
91939060|NCT04876534|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91939061|NCT04876534|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91939062|NCT04876534|Prednisolone|prednisolone|mesh-list
91939063|NCT04876534|Prednisolone acetate|prednisolone acetate|mesh-list
91939064|NCT04876534|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91939065|NCT04876534|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91939066|NCT04876534|Prednisolone phosphate|prednisolone phosphate|mesh-list
91939067|NCT04876534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939068|NCT04876534|Antiemetics|antiemetics|mesh-ancestor
91939069|NCT04876534|Autonomic Agents|autonomic agents|mesh-ancestor
91939070|NCT04876534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939071|NCT04876534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939072|NCT04876534|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91939073|NCT04876534|Glucocorticoids|glucocorticoids|mesh-ancestor
91939075|NCT04876534|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939076|NCT04876534|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91939077|NCT04876534|Protective Agents|protective agents|mesh-ancestor
91939078|NCT04876534|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91939079|NCT04876534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939080|NCT05082753|Ivermectin|ivermectin|mesh-list
91939081|NCT05082753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91939082|NCT05082753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939083|NCT02443831|Cyclophosphamide|cyclophosphamide|mesh-list
91939085|NCT02443831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91939086|NCT02443831|Immunologic Factors|immunologic factors|mesh-ancestor
91939087|NCT02443831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939088|NCT02443831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939089|NCT02443831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91939090|NCT02443831|Alkylating Agents|alkylating agents|mesh-ancestor
91939091|NCT02443831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939092|NCT02443831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939093|NCT02443831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91939094|NCT00851045|Leucovorin|leucovorin|mesh-list
91939095|NCT00851045|Bevacizumab|bevacizumab|mesh-list
91939096|NCT00851045|Fluorouracil|fluorouracil|mesh-list
91939097|NCT00851045|Irinotecan|irinotecan|mesh-list
91939098|NCT00851045|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91939100|NCT00851045|Levoleucovorin|levoleucovorin|mesh-list
91939101|NCT00851045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939102|NCT00851045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939103|NCT00851045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91939104|NCT00851045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91939105|NCT00851045|Growth Substances|growth substances|mesh-ancestor
91939106|NCT00851045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939107|NCT00851045|Growth Inhibitors|growth inhibitors|mesh-ancestor
91939108|NCT00851045|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945319|NCT03529175|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939110|NCT00851045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939111|NCT00851045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91939112|NCT00851045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91939113|NCT00851045|Immunologic Factors|immunologic factors|mesh-ancestor
91939114|NCT00851045|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91939115|NCT00851045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91939116|NCT00851045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939117|NCT00851045|Antidotes|antidotes|mesh-ancestor
91939118|NCT00851045|Protective Agents|protective agents|mesh-ancestor
91939119|NCT00851045|Vitamin B Complex|vitamin b complex|mesh-ancestor
91939120|NCT00851045|Vitamins|vitamins|mesh-ancestor
91939121|NCT00851045|Micronutrients|micronutrients|mesh-ancestor
91939122|NCT00850577|Paclitaxel|paclitaxel|mesh-list
91939124|NCT00850577|Carboplatin|carboplatin|mesh-list
91939125|NCT00850577|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91939126|NCT00850577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939127|NCT00850577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939128|NCT00850577|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939129|NCT00850577|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939130|NCT00850577|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939131|NCT00850577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939132|NCT00850577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939133|NCT00850577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91939134|NCT00850577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91939135|NCT00850577|Growth Substances|growth substances|mesh-ancestor
91939136|NCT00850577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939137|NCT00850577|Growth Inhibitors|growth inhibitors|mesh-ancestor
91939138|NCT00838981|Methadone|methadone|mesh-list
91939139|NCT00838981|Modafinil|modafinil|mesh-list
91939140|NCT00838981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91939141|NCT00838981|Narcotics|narcotics|mesh-ancestor
91939142|NCT00838981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939143|NCT00838981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939144|NCT00838981|Analgesics|analgesics|mesh-ancestor
91939145|NCT00838981|Sensory System Agents|sensory system agents|mesh-ancestor
91939146|NCT00838981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939147|NCT00838981|Antitussive Agents|antitussive agents|mesh-ancestor
91939148|NCT00838981|Respiratory System Agents|respiratory system agents|mesh-ancestor
91939149|NCT00838981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91939150|NCT00838981|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
91939151|NCT00838981|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91939152|NCT00838981|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91939153|NCT00838981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939154|NCT00849797|Oxcarbazepine|oxcarbazepine|mesh-list
91939155|NCT00849797|Anticonvulsants|anticonvulsants|mesh-ancestor
91939156|NCT00849797|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91939157|NCT00849797|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91939158|NCT00849797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939159|NCT00849797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939160|NCT00849797|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91939161|NCT00849797|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91939163|NCT05082441|Anesthetics, Local|anesthetics, local|mesh-ancestor
91939164|NCT05082441|Anesthetics|anesthetics|mesh-ancestor
91939165|NCT05082441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939166|NCT05082441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939167|NCT05082441|Sensory System Agents|sensory system agents|mesh-ancestor
91939168|NCT05082441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939169|NCT00950885|Melatonin|melatonin|mesh-list
91939170|NCT00950885|Antioxidants|antioxidants|mesh-ancestor
91939171|NCT00950885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939172|NCT00950885|Protective Agents|protective agents|mesh-ancestor
91939173|NCT00950885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939174|NCT00950885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939175|NCT00849485|Levetiracetam|levetiracetam|mesh-list
91939176|NCT00849485|Anticonvulsants|anticonvulsants|mesh-ancestor
91939177|NCT00849485|Nootropic Agents|nootropic agents|mesh-ancestor
91939178|NCT03140397|8-prenylnaringenin|8-prenylnaringenin|mesh-list
91939179|NCT03140397|Phytoestrogens|phytoestrogens|mesh-ancestor
91939180|NCT03140397|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91939181|NCT03140397|Estrogens|estrogens|mesh-ancestor
91939182|NCT03140397|Hormones|hormones|mesh-ancestor
91939183|NCT03140397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939184|NCT03140397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939185|NCT05047445|Vaccines|vaccines|mesh-list
91939186|NCT05047445|Immunologic Factors|immunologic factors|mesh-ancestor
91939187|NCT05047445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939188|NCT05235542|Paclitaxel|paclitaxel|mesh-list
91939189|NCT05235542|Docetaxel|docetaxel|mesh-list
91939190|NCT05235542|Capecitabine|capecitabine|mesh-list
91939191|NCT05235542|Oxaliplatin|oxaliplatin|mesh-list
91939193|NCT05235542|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939194|NCT05235542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939195|NCT05235542|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939196|NCT05235542|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939197|NCT05235542|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939198|NCT05235542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939199|NCT05235542|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91939200|NCT05235542|Antimetabolites|antimetabolites|mesh-ancestor
91939201|NCT05235542|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91939202|NCT05235542|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91939203|NCT05235542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939204|NCT00840281|Cefprozil|cefprozil|mesh-list
91939205|NCT00840281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91939206|NCT00840281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939207|NCT00840203|Mesalamine|mesalamine|mesh-list
91939208|NCT00840203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91939209|NCT00840203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91939210|NCT00840203|Analgesics|analgesics|mesh-ancestor
91939211|NCT00840203|Sensory System Agents|sensory system agents|mesh-ancestor
91939212|NCT00840203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939213|NCT00840203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939214|NCT00840203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939215|NCT00840203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939216|NCT00838799|Pregabalin|pregabalin|mesh-list
91939218|NCT00838799|Sensory System Agents|sensory system agents|mesh-ancestor
91939219|NCT00838799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939220|NCT00838799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939221|NCT00838799|Anticonvulsants|anticonvulsants|mesh-ancestor
91939222|NCT00838799|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91939223|NCT00838799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939224|NCT00838799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939225|NCT00838799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939226|NCT00838799|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91939227|NCT00838799|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91939228|NCT00838799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939229|NCT00838799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91939230|NCT05025735|Dapagliflozin|dapagliflozin|mesh-list
91939231|NCT05025735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91939232|NCT05025735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939233|NCT05025735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939234|NCT05025735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939236|NCT00836069|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91939237|NCT00836069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91939238|NCT00836069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939239|NCT00836069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939240|NCT00836069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939241|NCT00836069|Serotonin Agents|serotonin agents|mesh-ancestor
91939242|NCT00836069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939243|NCT00836069|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91939244|NCT00836069|Antidepressive Agents|antidepressive agents|mesh-ancestor
91939245|NCT00836069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91939246|NCT00836069|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91939247|NCT00836069|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91939248|NCT00836069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939250|NCT03134729|Anesthetics, Local|anesthetics, local|mesh-ancestor
91939251|NCT03134729|Anesthetics|anesthetics|mesh-ancestor
91939252|NCT03134729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939253|NCT03134729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939254|NCT03134729|Sensory System Agents|sensory system agents|mesh-ancestor
91939255|NCT03134729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939257|NCT03134651|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91939258|NCT03134651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939259|NCT03134651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939260|NCT03134651|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91939261|NCT03134651|Anesthetics, General|anesthetics, general|mesh-ancestor
91939262|NCT03134651|Anesthetics|anesthetics|mesh-ancestor
91939264|NCT05202860|Immunologic Factors|immunologic factors|mesh-ancestor
91939265|NCT05202860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939266|NCT05202782|Zanubrutinib|zanubrutinib|mesh-list
91939267|NCT05202782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939268|NCT05202782|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939269|NCT05202782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939270|NCT05202782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939272|NCT05202080|Narcotics|narcotics|mesh-ancestor
91939273|NCT05202080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939274|NCT05202080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939276|NCT05202080|Sensory System Agents|sensory system agents|mesh-ancestor
91939277|NCT05202080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939278|NCT00935987|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
91939279|NCT00935987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939280|NCT00935987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939281|NCT00935987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939283|NCT05155124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939284|NCT05155124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939285|NCT00927641|Ketoprofen|ketoprofen|mesh-list
91939286|NCT00927641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91939287|NCT00927641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91939289|NCT00927641|Sensory System Agents|sensory system agents|mesh-ancestor
91939290|NCT00927641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939291|NCT00927641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939293|NCT00927641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943914|NCT02452034|Posaconazole|posaconazole|mesh-list
91939294|NCT00927641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91939295|NCT00927641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939296|NCT00927641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939298|NCT05200364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939299|NCT05200364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939300|NCT05200364|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91939301|NCT05200364|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91939302|NCT05200364|Growth Substances|growth substances|mesh-ancestor
91939303|NCT05200364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939304|NCT05200364|Growth Inhibitors|growth inhibitors|mesh-ancestor
91939306|NCT00835991|Glyburide|glyburide|mesh-list
91939307|NCT00835991|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939308|NCT00835991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939310|NCT05200052|Gout Suppressants|gout suppressants|mesh-ancestor
91939311|NCT05200052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939312|NCT05200052|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939313|NCT05200052|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939314|NCT05200052|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939315|NCT05200052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939316|NCT05200052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939317|NCT00925535|Rifabutin|rifabutin|mesh-list
91939318|NCT00925535|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91939319|NCT00925535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939320|NCT00925535|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91939321|NCT00925535|Antitubercular Agents|antitubercular agents|mesh-ancestor
91939322|NCT02276872|Treprostinil|treprostinil|mesh-list
91939323|NCT02276872|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939325|NCT00835367|Benazepril|benazepril|mesh-list
91939326|NCT00835367|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939327|NCT00835367|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91939328|NCT00835367|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939329|NCT00835367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939330|NCT00835367|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939331|NCT00835367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939332|NCT00835367|Vasodilator Agents|vasodilator agents|mesh-ancestor
91939500|NCT02274766|Amantadine|amantadine|mesh-list
91939333|NCT00835367|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91939334|NCT00835367|Protease Inhibitors|protease inhibitors|mesh-ancestor
91939335|NCT00835367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939337|NCT02276560|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91939338|NCT02276560|Cisplatin|cisplatin|mesh-list
91939339|NCT02276560|Gemcitabine|gemcitabine|mesh-list
91939342|NCT02276560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939343|NCT02276560|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939344|NCT02276560|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939345|NCT02276560|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939346|NCT02276560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939347|NCT02276560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91939348|NCT02276560|Antimetabolites|antimetabolites|mesh-ancestor
91939349|NCT02276560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939350|NCT02276560|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91939351|NCT02276560|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91939352|NCT02276482|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91939353|NCT02276482|Metronidazole|metronidazole|mesh-list
91939354|NCT02276482|Vancomycin|vancomycin|mesh-list
91939355|NCT02276482|Clindamycin|clindamycin|mesh-list
91939356|NCT02276482|Cefazolin|cefazolin|mesh-list
91939357|NCT02276482|Linezolid|linezolid|mesh-list
91939358|NCT02276482|Cephalexin|cephalexin|mesh-list
91939359|NCT02276482|Aztreonam|aztreonam|mesh-list
91939360|NCT02276482|Tedizolid|tedizolid|mesh-list
91939361|NCT02276482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939362|NCT02276482|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91939363|NCT02276482|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91939364|NCT02276482|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91939365|NCT02276482|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939366|NCT02276482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939368|NCT00924833|Nebivolol|nebivolol|mesh-list
91939369|NCT00924833|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91939370|NCT00924833|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91939371|NCT00924833|Adrenergic Agents|adrenergic agents|mesh-ancestor
91939372|NCT00924833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939373|NCT00924833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939375|NCT00924833|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939376|NCT00924833|Antioxidants|antioxidants|mesh-ancestor
91939377|NCT00924833|Protective Agents|protective agents|mesh-ancestor
91939378|NCT00924833|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91939379|NCT00924833|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939380|NCT00924833|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939382|NCT00924833|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91939383|NCT00924833|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91939384|NCT00924833|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91939385|NCT00924833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91939386|NCT00924833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91939387|NCT05142254|Hydroxyurea|hydroxyurea|mesh-list
91939388|NCT05142254|Tadalafil|tadalafil|mesh-list
91939389|NCT05142254|Vasodilator Agents|vasodilator agents|mesh-ancestor
91939390|NCT05142254|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91939391|NCT05142254|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91939392|NCT05142254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939393|NCT05142254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939394|NCT05142254|Urological Agents|urological agents|mesh-ancestor
91939395|NCT05142254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939397|NCT05142254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91939398|NCT00835211|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
91939399|NCT00835211|Hemostatics|hemostatics|mesh-ancestor
91939400|NCT00835211|Coagulants|coagulants|mesh-ancestor
91939401|NCT00835211|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
91939402|NCT00835211|Natriuretic Agents|natriuretic agents|mesh-ancestor
91939403|NCT00835211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939405|NCT00834977|Benazepril|benazepril|mesh-list
91939406|NCT00834977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939407|NCT00834977|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91939408|NCT00834977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939409|NCT00834977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939410|NCT00834977|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939411|NCT00834977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939412|NCT00834977|Vasodilator Agents|vasodilator agents|mesh-ancestor
91939413|NCT00834977|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91939414|NCT00834977|Protease Inhibitors|protease inhibitors|mesh-ancestor
91939415|NCT00834977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939416|NCT05227664|Paclitaxel|paclitaxel|mesh-list
91939417|NCT05227664|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91939418|NCT05227664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939419|NCT05227664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939421|NCT05227664|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939422|NCT05227664|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939423|NCT05227664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939426|NCT00834743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939427|NCT00834587|Metformin|metformin|mesh-list
91939428|NCT00834587|Glipizide|glipizide|mesh-list
91939429|NCT00834587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939431|NCT00834431|Famciclovir|famciclovir|mesh-list
91939432|NCT00834431|Antiviral Agents|antiviral agents|mesh-ancestor
91939433|NCT00834431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939434|NCT00834431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91939435|NCT00834431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939436|NCT00834431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939438|NCT04875767|Keratolytic Agents|keratolytic agents|mesh-ancestor
91939439|NCT04875767|Dermatologic Agents|dermatologic agents|mesh-ancestor
91939440|NCT05191940|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91939441|NCT05191940|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91939442|NCT05191940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939443|NCT00834275|Cefadroxil|cefadroxil|mesh-list
91939444|NCT00834275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91939445|NCT00834275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939446|NCT05191472|Pembrolizumab|pembrolizumab|mesh-list
91939447|NCT05191472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939448|NCT05191472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939449|NCT05191472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91939450|NCT05191472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939451|NCT00834197|Mirtazapine|mirtazapine|mesh-list
91939452|NCT00834197|Antidepressive Agents|antidepressive agents|mesh-ancestor
91939453|NCT00834197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91939455|NCT00834197|Histamine Antagonists|histamine antagonists|mesh-ancestor
91939456|NCT00834197|Histamine Agents|histamine agents|mesh-ancestor
91939457|NCT00834197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939458|NCT00834197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939459|NCT00834197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939460|NCT00834197|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91939461|NCT00834197|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91939462|NCT00834197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939463|NCT00834197|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91939464|NCT00834197|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91939465|NCT00834197|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91939466|NCT00834197|Adrenergic Agents|adrenergic agents|mesh-ancestor
91939467|NCT00834197|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91939468|NCT00834197|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91939469|NCT00834197|Serotonin Agents|serotonin agents|mesh-ancestor
91939470|NCT00834197|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91939471|NCT00833495|Prednisolone|prednisolone|mesh-list
91939472|NCT00833495|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91939473|NCT00833495|Methylprednisolone|methylprednisolone|mesh-list
91939474|NCT00833495|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91939475|NCT00833495|Prednisolone acetate|prednisolone acetate|mesh-list
91939477|NCT00833495|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91939478|NCT00833495|Prednisolone phosphate|prednisolone phosphate|mesh-list
91939479|NCT00833495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939480|NCT00833495|Glucocorticoids|glucocorticoids|mesh-ancestor
91939481|NCT00833495|Hormones|hormones|mesh-ancestor
91939482|NCT00833495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939483|NCT00833495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943928|NCT02283359|Irinotecan|irinotecan|mesh-list
91939484|NCT00833495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91939487|NCT00833495|Autonomic Agents|autonomic agents|mesh-ancestor
91939488|NCT00833495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939489|NCT00833495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91939490|NCT00833495|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91939491|NCT00833495|Protective Agents|protective agents|mesh-ancestor
91939493|NCT00830219|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91939494|NCT00830219|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91939495|NCT00830219|Dopamine Agonists|dopamine agonists|mesh-ancestor
91939496|NCT00830219|Dopamine Agents|dopamine agents|mesh-ancestor
91939497|NCT00830219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939498|NCT00830219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939499|NCT00830219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939501|NCT02274766|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91939502|NCT02274766|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91939503|NCT02274766|Antiviral Agents|antiviral agents|mesh-ancestor
91939504|NCT02274766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939505|NCT02274766|Dopamine Agents|dopamine agents|mesh-ancestor
91939506|NCT02274766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939507|NCT02274766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939508|NCT02274766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939510|NCT02274766|Analgesics|analgesics|mesh-ancestor
91939511|NCT02274766|Sensory System Agents|sensory system agents|mesh-ancestor
91939512|NCT02274766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939513|NCT05134922|Gedatolisib|gedatolisib|mesh-list
91939514|NCT05134922|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939515|NCT05134922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939516|NCT05134922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939517|NCT04757363|Oxaliplatin|oxaliplatin|mesh-list
91939518|NCT04757363|Nivolumab|nivolumab|mesh-list
91939519|NCT04757363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939520|NCT04757363|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939521|NCT04757363|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91939522|NCT04757363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939523|NCT00829673|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
91939524|NCT00829673|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91939525|NCT00829673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939526|NCT00829673|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91939527|NCT00829673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91939528|NCT00829673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939529|NCT00829673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939530|NCT00829673|Dopamine Agents|dopamine agents|mesh-ancestor
91939531|NCT00829673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939532|NCT05221658|Cisplatin|cisplatin|mesh-list
91939533|NCT05221658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939534|NCT05132114|Lugol's solution|lugol's solution|mesh-list
91939535|NCT05132114|Hemostatics|hemostatics|mesh-ancestor
91939536|NCT05132114|Coagulants|coagulants|mesh-ancestor
91939537|NCT02370238|Paclitaxel|paclitaxel|mesh-list
91939538|NCT02370238|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939539|NCT02370238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939541|NCT02370238|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939542|NCT02370238|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939543|NCT02370238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939544|NCT05109104|Sunscreening Agents|sunscreening agents|mesh-list
91939545|NCT05109104|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91939546|NCT05109104|Protective Agents|protective agents|mesh-ancestor
91939547|NCT05109104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939548|NCT05109104|Dermatologic Agents|dermatologic agents|mesh-ancestor
91939550|NCT05108870|Carboplatin|carboplatin|mesh-list
91939551|NCT05108870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939552|NCT05108870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939553|NCT05108870|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939554|NCT05108870|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939555|NCT05108870|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939556|NCT05108870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939557|NCT05126342|Niraparib|niraparib|mesh-list
91939558|NCT05126342|Dostarlimab|dostarlimab|mesh-list
91939559|NCT05126342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91939560|NCT05126342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939561|NCT05126342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939562|NCT05126342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939563|NCT05126108|Parathyroid Hormone|parathyroid hormone|mesh-list
91939564|NCT05126108|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939565|NCT05126108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939566|NCT05473910|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
91939567|NCT05473910|Antioxidants|antioxidants|mesh-ancestor
91939568|NCT05473910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939569|NCT05473910|Protective Agents|protective agents|mesh-ancestor
91939570|NCT05473910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939571|NCT05473910|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91939572|NCT05473910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939573|NCT05180708|Sirolimus|sirolimus|mesh-list
91939574|NCT05180708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91939575|NCT05180708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939576|NCT05180708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91939577|NCT05180708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939578|NCT05180708|Antifungal Agents|antifungal agents|mesh-ancestor
91939579|NCT05180708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91939580|NCT05180708|Immunologic Factors|immunologic factors|mesh-ancestor
91939581|NCT05180708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939583|NCT02273752|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91939584|NCT02273752|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939585|NCT02273752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939586|NCT02273752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939587|NCT02273752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91939588|NCT02273752|Immunologic Factors|immunologic factors|mesh-ancestor
91939589|NCT02273752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939591|NCT05102552|Huperzine A|huperzine a|mesh-list
91939592|NCT05102552|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91939593|NCT05102552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939594|NCT05102552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939595|NCT05102552|Cholinergic Agents|cholinergic agents|mesh-ancestor
91939596|NCT05102552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939597|NCT05102552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939598|NCT05102552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91939599|NCT05102552|Protective Agents|protective agents|mesh-ancestor
91939600|NCT05096390|Pembrolizumab|pembrolizumab|mesh-list
91939601|NCT05096390|Axitinib|axitinib|mesh-list
91939602|NCT05096390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939603|NCT05096390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939604|NCT05096390|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91939605|NCT05096390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939606|NCT05096390|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939607|NCT05096390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939608|NCT02273050|Metformin|metformin|mesh-list
91939609|NCT02273050|Saxagliptin|saxagliptin|mesh-list
91939610|NCT02273050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939611|NCT02273050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939612|NCT02273050|Incretins|incretins|mesh-ancestor
91939613|NCT02273050|Hormones|hormones|mesh-ancestor
91939614|NCT02273050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939615|NCT02273050|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91939616|NCT02273050|Protease Inhibitors|protease inhibitors|mesh-ancestor
91939617|NCT02273050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939618|NCT02273050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939619|NCT02272816|Carboplatin|carboplatin|mesh-list
91939620|NCT02272816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939621|NCT04869436|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91939622|NCT04869436|Immunologic Factors|immunologic factors|mesh-ancestor
91939623|NCT04869436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939625|NCT05170256|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939626|NCT05170256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939627|NCT05386979|Analgesics, Opioid|analgesics, opioid|mesh-list
91939628|NCT05386979|Anesthetics|anesthetics|mesh-list
91939629|NCT05386979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939630|NCT05386979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939631|NCT05386979|Narcotics|narcotics|mesh-ancestor
91939632|NCT05386979|Analgesics|analgesics|mesh-ancestor
91939633|NCT05386979|Sensory System Agents|sensory system agents|mesh-ancestor
91939636|NCT02367352|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939637|NCT02367352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939638|NCT02367352|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939639|NCT02367352|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939640|NCT02367352|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939641|NCT02367352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939642|NCT02270944|Vaccines|vaccines|mesh-list
91939643|NCT02270944|Immunologic Factors|immunologic factors|mesh-ancestor
91939644|NCT02270944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939645|NCT05648734|Pirfenidone|pirfenidone|mesh-list
91939646|NCT05648734|Colchicine|colchicine|mesh-list
91939647|NCT05648734|Gout Suppressants|gout suppressants|mesh-ancestor
91939648|NCT05648734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939649|NCT05648734|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939650|NCT05648734|Antimitotic Agents|antimitotic agents|mesh-ancestor
91939651|NCT05648734|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939652|NCT05648734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939653|NCT05648734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939654|NCT05648734|Analgesics|analgesics|mesh-ancestor
91939655|NCT05648734|Sensory System Agents|sensory system agents|mesh-ancestor
91939656|NCT05648734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939657|NCT05648734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939658|NCT05648734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91939659|NCT05648734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91939660|NCT05648734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939661|NCT02365558|Omeprazole|omeprazole|mesh-list
91939662|NCT02365558|Evacetrapib|evacetrapib|mesh-list
91939663|NCT02365558|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91939664|NCT02365558|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91939665|NCT02365558|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91939666|NCT02365558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939667|NCT02365558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939668|NCT02365558|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91939669|NCT02365558|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91939670|NCT02365558|Antimetabolites|antimetabolites|mesh-ancestor
91939671|NCT02365558|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91939672|NCT05050214|Obinutuzumab|obinutuzumab|mesh-list
91939673|NCT05050214|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939674|NCT05050214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939675|NCT02270242|Aspirin|aspirin|mesh-list
91939676|NCT02270242|Ticagrelor|ticagrelor|mesh-list
91939677|NCT02270242|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91939678|NCT02270242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91939679|NCT02270242|Analgesics|analgesics|mesh-ancestor
91939681|NCT02270242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939682|NCT02270242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939683|NCT02270242|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939684|NCT02270242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939685|NCT02270242|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91939686|NCT02270242|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91939687|NCT02270242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939688|NCT02270242|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91939689|NCT02270242|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91939690|NCT02270242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939691|NCT02270242|Antipyretics|antipyretics|mesh-ancestor
91939692|NCT02270242|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91939693|NCT02270242|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91939694|NCT02270242|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91939696|NCT02270242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939697|NCT04875364|Eszopiclone|eszopiclone|mesh-list
91939698|NCT04875364|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91939699|NCT04875364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91939700|NCT04875364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939702|NCT04869124|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91939703|NCT04869124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939704|NCT04869124|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939705|NCT04869124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939707|NCT05648266|Sensory System Agents|sensory system agents|mesh-ancestor
91939708|NCT05648266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939709|NCT05648266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939710|NCT05047094|Pembrolizumab|pembrolizumab|mesh-list
91939711|NCT05047094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939712|NCT05047094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939713|NCT05047094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91939714|NCT05047094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939715|NCT04993352|Antibodies|antibodies|mesh-list
91939716|NCT04993352|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91939718|NCT04993352|Endothelial Growth Factors|endothelial growth factors|mesh-list
91939719|NCT04993352|Immunologic Factors|immunologic factors|mesh-ancestor
91939720|NCT04993352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939721|NCT04993352|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939722|NCT04993352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939723|NCT04993352|Growth Substances|growth substances|mesh-ancestor
91939724|NCT04992026|Prednisone|prednisone|mesh-list
91939725|NCT04992026|Abiraterone Acetate|abiraterone acetate|mesh-list
91939726|NCT04992026|Hormones|hormones|mesh-list
91939727|NCT04992026|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
91939728|NCT04992026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939730|NCT04992026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939731|NCT04992026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939732|NCT04992026|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91939733|NCT04992026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939734|NCT04992026|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91939736|NCT04992026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939737|NCT04992026|Hormone Antagonists|hormone antagonists|mesh-ancestor
91939738|NCT04992026|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91939739|NCT04991402|Dolutegravir|dolutegravir|mesh-list
91939740|NCT04991402|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91939741|NCT04991402|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91939742|NCT04991402|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91939743|NCT04991402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939744|NCT04991402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939745|NCT04991402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91939746|NCT04991402|Antiviral Agents|antiviral agents|mesh-ancestor
91939747|NCT04991402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939748|NCT05042102|Donepezil|donepezil|mesh-list
91939749|NCT05042102|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91939750|NCT05042102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939751|NCT05042102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939753|NCT05042102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939754|NCT05042102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939756|NCT05074940|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
91939757|NCT05074940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939758|NCT05074940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939760|NCT05036798|Tislelizumab|tislelizumab|mesh-list
91939761|NCT05036798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939762|NCT05036798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939763|NCT05036798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939764|NCT05036798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939765|NCT05036798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939766|NCT04209218|Dexamethasone|dexamethasone|mesh-list
91939767|NCT04209218|Glucocorticoids|glucocorticoids|mesh-list
91939768|NCT04209218|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939770|NCT04209218|Autonomic Agents|autonomic agents|mesh-ancestor
91939771|NCT04209218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939772|NCT04209218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939773|NCT04209218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91939774|NCT04209218|Hormones|hormones|mesh-ancestor
91939775|NCT04209218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939776|NCT04209218|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91939777|NCT04209218|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939778|NCT04218968|Carvedilol|carvedilol|mesh-list
91939779|NCT04218968|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91939780|NCT04218968|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91939782|NCT04218968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939783|NCT04218968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939784|NCT04218968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939785|NCT04218968|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939786|NCT04218968|Antioxidants|antioxidants|mesh-ancestor
91939787|NCT04218968|Protective Agents|protective agents|mesh-ancestor
91939788|NCT04218968|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91939789|NCT04218968|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91939790|NCT04218968|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91939791|NCT04218968|Vasodilator Agents|vasodilator agents|mesh-ancestor
91939792|NCT04218968|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91939793|NCT04218968|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91939794|NCT02268214|Dapagliflozin|dapagliflozin|mesh-list
91939795|NCT02268214|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91939796|NCT02268214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939797|NCT02268214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939798|NCT02268214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939799|NCT04421300|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91939800|NCT04421300|Hyaluronic Acid|hyaluronic acid|mesh-list
91939801|NCT04421300|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91939802|NCT04421300|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91939803|NCT04421300|Immunologic Factors|immunologic factors|mesh-ancestor
91939804|NCT04421300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939805|NCT04421300|Viscosupplements|viscosupplements|mesh-ancestor
91939806|NCT04421300|Protective Agents|protective agents|mesh-ancestor
91939808|NCT05026736|Antibodies|antibodies|mesh-list
91939809|NCT05026736|Immunoglobulins|immunoglobulins|mesh-list
91939810|NCT05026736|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91939811|NCT05026736|Immunologic Factors|immunologic factors|mesh-ancestor
91939812|NCT05026736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939813|NCT05026736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939815|NCT02268058|Ibuprofen|ibuprofen|mesh-list
91939816|NCT02268058|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91939817|NCT02268058|Analgesics|analgesics|mesh-ancestor
91939818|NCT02268058|Sensory System Agents|sensory system agents|mesh-ancestor
91939819|NCT02268058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939820|NCT02268058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939821|NCT02268058|Antipyretics|antipyretics|mesh-ancestor
91939822|NCT02268058|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91939823|NCT02268058|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939824|NCT02268058|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91939825|NCT02268058|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91939826|NCT02268058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939827|NCT02268058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939828|NCT02267746|Nicotinic Acids|nicotinic acids|mesh-list
91939831|NCT02267746|Keratolytic Agents|keratolytic agents|mesh-ancestor
91939832|NCT02267746|Vitamin B Complex|vitamin b complex|mesh-ancestor
91939833|NCT02267746|Vitamins|vitamins|mesh-ancestor
91939834|NCT02267746|Micronutrients|micronutrients|mesh-ancestor
91939835|NCT02267746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939838|NCT04970108|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91939839|NCT04970108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939841|NCT04970108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939842|NCT04970108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91939843|NCT04970108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91939844|NCT04970108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91939845|NCT04421534|Lactoferrin|lactoferrin|mesh-list
91939846|NCT04421534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939847|NCT05059028|Oxytocin|oxytocin|mesh-list
91939848|NCT05059028|Oxytocics|oxytocics|mesh-ancestor
91939849|NCT05059028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91939850|NCT05059028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939851|NCT04205552|Nivolumab|nivolumab|mesh-list
91939852|NCT04205552|Relatlimab|relatlimab|mesh-list
91939853|NCT04205552|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91943948|NCT00508625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91939854|NCT04205552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939856|NCT04205552|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91939857|NCT04205552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939858|NCT02517866|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
91939859|NCT02517866|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91939860|NCT02517866|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91939861|NCT02517866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939863|NCT04215848|Formoterol Fumarate|formoterol fumarate|mesh-list
91939864|NCT04215848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939865|NCT04215848|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91939867|NCT04215848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939868|NCT04215848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939869|NCT04215848|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91939870|NCT04215848|Respiratory System Agents|respiratory system agents|mesh-ancestor
91939871|NCT04215848|Glucocorticoids|glucocorticoids|mesh-ancestor
91939872|NCT04215848|Hormones|hormones|mesh-ancestor
91939873|NCT04215848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939874|NCT04215848|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91939875|NCT04215848|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91939876|NCT04215848|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91939877|NCT04215848|Adrenergic Agents|adrenergic agents|mesh-ancestor
91939878|NCT04215848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939879|NCT04215848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939880|NCT04215146|Paclitaxel|paclitaxel|mesh-list
91939881|NCT04215146|Avelumab|avelumab|mesh-list
91939882|NCT04215146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91939883|NCT04215146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939884|NCT04215146|Tubulin Modulators|tubulin modulators|mesh-ancestor
91939886|NCT04215146|Mitosis Modulators|mitosis modulators|mesh-ancestor
91939887|NCT04215146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939888|NCT04215146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91939889|NCT04214678|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91939890|NCT04214678|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
91939892|NCT04214678|Hormones|hormones|mesh-ancestor
91939893|NCT04214678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939894|NCT04214678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939895|NCT04214678|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939896|NCT04214678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939899|NCT05010200|Immunologic Factors|immunologic factors|mesh-ancestor
91939900|NCT05010200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939901|NCT04959266|Itraconazole|itraconazole|mesh-list
91939903|NCT04959266|Omeprazole|omeprazole|mesh-list
91939904|NCT04959266|Adavosertib|adavosertib|mesh-list
91939905|NCT04959266|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91939906|NCT04959266|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91939907|NCT04959266|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91939908|NCT04959266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939909|NCT04959266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939910|NCT04959266|Antifungal Agents|antifungal agents|mesh-ancestor
91939911|NCT04959266|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91939912|NCT04959266|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91939913|NCT04959266|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91939914|NCT04959266|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91939915|NCT04959266|Hormone Antagonists|hormone antagonists|mesh-ancestor
91939916|NCT04959266|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939917|NCT04959266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939918|NCT04959266|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91939919|NCT04959266|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91939920|NCT04959266|Antitubercular Agents|antitubercular agents|mesh-ancestor
91939921|NCT04959266|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91939922|NCT04959266|Leprostatic Agents|leprostatic agents|mesh-ancestor
91939923|NCT04959266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91939924|NCT04959266|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91939925|NCT04959266|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91939926|NCT04959266|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91939927|NCT04959266|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91939928|NCT04959266|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91939929|NCT04959266|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91939930|NCT05008484|Vitamin D|vitamin d|mesh-list
91939931|NCT05008484|Vitamins|vitamins|mesh-ancestor
91939932|NCT05008484|Micronutrients|micronutrients|mesh-ancestor
91939933|NCT05008484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939934|NCT05008484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91939936|NCT04212416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939937|NCT04212416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939938|NCT04212416|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91939940|NCT04212416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939941|NCT04947254|Ascorbic Acid|ascorbic acid|mesh-list
91939942|NCT04947254|Prednisone|prednisone|mesh-list
91939943|NCT04947254|Cortisone|cortisone|mesh-list
91939944|NCT04947254|Methyltestosterone|methyltestosterone|mesh-list
91939945|NCT04947254|Abiraterone Acetate|abiraterone acetate|mesh-list
91939947|NCT04947254|Hormones|hormones|mesh-list
91939948|NCT04947254|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
91939950|NCT04947254|Androgen Antagonists|androgen antagonists|mesh-list
91939951|NCT04947254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91939952|NCT04947254|Glucocorticoids|glucocorticoids|mesh-ancestor
91945321|NCT03529175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945322|NCT03529175|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91945323|NCT03529175|Antimetabolites|antimetabolites|mesh-ancestor
91939953|NCT04947254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91939954|NCT04947254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939955|NCT04947254|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91939956|NCT04947254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939957|NCT04947254|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91939958|NCT04947254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945325|NCT00002207|Stavudine|stavudine|mesh-list
91939959|NCT04947254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939960|NCT04947254|Hormone Antagonists|hormone antagonists|mesh-ancestor
91939961|NCT04947254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91945326|NCT00002207|Antimetabolites|antimetabolites|mesh-ancestor
91939962|NCT04947254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91939963|NCT04947254|Antioxidants|antioxidants|mesh-ancestor
91939964|NCT04947254|Protective Agents|protective agents|mesh-ancestor
91939966|NCT04947254|Micronutrients|micronutrients|mesh-ancestor
91939967|NCT04947254|Estrogens|estrogens|mesh-ancestor
91939968|NCT04947254|Anabolic Agents|anabolic agents|mesh-ancestor
91939970|NCT04954664|Antiemetics|antiemetics|mesh-ancestor
91939971|NCT04954664|Autonomic Agents|autonomic agents|mesh-ancestor
91939972|NCT04954664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91939973|NCT04954664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943955|NCT02284529|Antimetabolites|antimetabolites|mesh-ancestor
91939975|NCT04954664|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91939976|NCT04954664|Histamine Antagonists|histamine antagonists|mesh-ancestor
91939978|NCT04954664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91939979|NCT04954664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939982|NCT04946864|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91939983|NCT04946864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91939984|NCT04946864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939985|NCT04945148|Metformin|metformin|mesh-list
91939986|NCT04945148|Temozolomide|temozolomide|mesh-list
91939987|NCT04945148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91939988|NCT04945148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91939989|NCT04945148|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91939990|NCT04945148|Alkylating Agents|alkylating agents|mesh-ancestor
91939991|NCT04945148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91939992|NCT04945148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91939993|NCT02516306|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91939994|NCT02516306|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91939995|NCT05003570|Fentanyl|fentanyl|mesh-list
91939996|NCT05003570|Remifentanil|remifentanil|mesh-list
91939997|NCT05003570|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91939998|NCT05003570|Narcotics|narcotics|mesh-ancestor
91939999|NCT05003570|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940000|NCT05003570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940001|NCT05003570|Analgesics|analgesics|mesh-ancestor
91940002|NCT05003570|Sensory System Agents|sensory system agents|mesh-ancestor
91940003|NCT05003570|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940004|NCT05003570|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91940005|NCT05003570|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91940006|NCT05003570|Anesthetics, General|anesthetics, general|mesh-ancestor
91940008|NCT04999592|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91940009|NCT04999592|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940010|NCT02483078|Leronlimab|leronlimab|mesh-list
91940012|NCT02483078|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91940013|NCT02483078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940015|NCT02483078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91940016|NCT02483078|Antiviral Agents|antiviral agents|mesh-ancestor
91940017|NCT02483078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940019|NCT02452190|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91940020|NCT02452190|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940021|NCT02514122|Ketamine|ketamine|mesh-list
91940022|NCT02514122|Analgesics|analgesics|mesh-ancestor
91940023|NCT02514122|Sensory System Agents|sensory system agents|mesh-ancestor
91940024|NCT02514122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940025|NCT02514122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940026|NCT02514122|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91940028|NCT02514122|Anesthetics, General|anesthetics, general|mesh-ancestor
91940029|NCT02514122|Anesthetics|anesthetics|mesh-ancestor
91940030|NCT02514122|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940031|NCT02514122|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91940032|NCT02514122|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91940033|NCT02514122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940036|NCT00730639|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940037|NCT00730639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940038|NCT00730639|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940039|NCT00730639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940040|NCT03964207|Tiotropium Bromide|tiotropium bromide|mesh-list
91940041|NCT03964207|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91940042|NCT03964207|Autonomic Agents|autonomic agents|mesh-ancestor
91940043|NCT03964207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940044|NCT03964207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940045|NCT03964207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91940046|NCT03964207|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940047|NCT03964207|Parasympatholytics|parasympatholytics|mesh-ancestor
91940048|NCT03964207|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91940049|NCT03964207|Cholinergic Agents|cholinergic agents|mesh-ancestor
91940050|NCT03964207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940051|NCT03964207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940053|NCT04462003|Apixaban|apixaban|mesh-list
91940054|NCT04462003|Anticoagulants|anticoagulants|mesh-ancestor
91940055|NCT04462003|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91940056|NCT04462003|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91940057|NCT04462003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940058|NCT04462003|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91940060|NCT04462003|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91940061|NCT04462003|Protease Inhibitors|protease inhibitors|mesh-ancestor
91940062|NCT04462003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940063|NCT03489265|Eluxadoline|eluxadoline|mesh-list
91940064|NCT03489265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940066|NCT03344341|Acarbose|acarbose|mesh-list
91940067|NCT03344341|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91940068|NCT03344341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940069|NCT03344341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940070|NCT03344341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940071|NCT03344341|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91940072|NCT03344341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940073|NCT03260881|Liraglutide|liraglutide|mesh-list
91940075|NCT03260881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940076|NCT03260881|Incretins|incretins|mesh-ancestor
91940077|NCT03260881|Hormones|hormones|mesh-ancestor
91940078|NCT03260881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940079|NCT03238495|Metformin|metformin|mesh-list
91940080|NCT03238495|Carboplatin|carboplatin|mesh-list
91940081|NCT03238495|Docetaxel|docetaxel|mesh-list
91940083|NCT03238495|Pertuzumab|pertuzumab|mesh-list
91940084|NCT03238495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940085|NCT03238495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940086|NCT03238495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940087|NCT03238495|Tubulin Modulators|tubulin modulators|mesh-ancestor
91940088|NCT03238495|Antimitotic Agents|antimitotic agents|mesh-ancestor
91940089|NCT03238495|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940090|NCT03238495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940091|NCT03238495|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940092|NCT02536339|Trastuzumab|trastuzumab|mesh-list
91940093|NCT02536339|Pertuzumab|pertuzumab|mesh-list
91940094|NCT02536339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940095|NCT02536339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940096|NCT01869361|Indomethacin|indomethacin|mesh-list
91940097|NCT01869361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91940098|NCT01869361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940099|NCT01869361|Analgesics|analgesics|mesh-ancestor
91940100|NCT01869361|Sensory System Agents|sensory system agents|mesh-ancestor
91940101|NCT01869361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940102|NCT01869361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940103|NCT01869361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940104|NCT01869361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940105|NCT01869361|Gout Suppressants|gout suppressants|mesh-ancestor
91940106|NCT01869361|Tocolytic Agents|tocolytic agents|mesh-ancestor
91940107|NCT01869361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91940108|NCT01869361|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91940110|NCT01869361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940112|NCT02322619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91940113|NCT02322619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940114|NCT02322619|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91940115|NCT02322619|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91940116|NCT02322619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940117|NCT02322619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940118|NCT02322619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940120|NCT01578967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940121|NCT01578967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940122|NCT01578967|Immunotoxins|immunotoxins|mesh-ancestor
91940123|NCT01578967|Immunoconjugates|immunoconjugates|mesh-ancestor
91940124|NCT01578967|Immunologic Factors|immunologic factors|mesh-ancestor
91940125|NCT01578967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940127|NCT01186003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940128|NCT01186003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940130|NCT02322853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91940131|NCT02322853|Hormone Antagonists|hormone antagonists|mesh-ancestor
91940132|NCT02322853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940133|NCT02322853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940134|NCT02322853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91940135|NCT02322853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940136|NCT02322853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91940137|NCT02322853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91940138|NCT02322853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91940139|NCT03488719|Metoprolol|metoprolol|mesh-list
91940140|NCT03488719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91940141|NCT03488719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91940142|NCT03488719|Sympatholytics|sympatholytics|mesh-ancestor
91940143|NCT03488719|Autonomic Agents|autonomic agents|mesh-ancestor
91940144|NCT03488719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940145|NCT03488719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940146|NCT03488719|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91940147|NCT03488719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91940148|NCT03488719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91940149|NCT03488719|Adrenergic Agents|adrenergic agents|mesh-ancestor
91940150|NCT03488719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940151|NCT03488719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940153|NCT03496831|Infliximab|infliximab|mesh-list
91940154|NCT03496831|Golimumab|golimumab|mesh-list
91940155|NCT03496831|Etanercept|etanercept|mesh-list
91940157|NCT03496831|Ustekinumab|ustekinumab|mesh-list
91940158|NCT03496831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940159|NCT03496831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940161|NCT03496831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940162|NCT03496831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940163|NCT03496831|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91940164|NCT03496831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940165|NCT03496831|Dermatologic Agents|dermatologic agents|mesh-ancestor
91940166|NCT03496831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940167|NCT03496831|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91940168|NCT03496831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940169|NCT03496831|Analgesics|analgesics|mesh-ancestor
91940170|NCT03496831|Sensory System Agents|sensory system agents|mesh-ancestor
91940171|NCT03496831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940172|NCT03496831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940173|NCT03496831|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940174|NCT03496831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940176|NCT03488485|Antiviral Agents|antiviral agents|mesh-list
91940177|NCT03488485|Ledipasvir|ledipasvir|mesh-list
91940178|NCT03488485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940179|NCT00821249|Dexamethasone|dexamethasone|mesh-list
91940180|NCT00821249|Filanesib|filanesib|mesh-list
91940181|NCT00821249|Lenograstim|lenograstim|mesh-list
91940183|NCT00821249|Antiemetics|antiemetics|mesh-ancestor
91940184|NCT00821249|Autonomic Agents|autonomic agents|mesh-ancestor
91940185|NCT00821249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940186|NCT00821249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940187|NCT00821249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940188|NCT00821249|Glucocorticoids|glucocorticoids|mesh-ancestor
91940189|NCT00821249|Hormones|hormones|mesh-ancestor
91940190|NCT00821249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940191|NCT00821249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91940192|NCT00821249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940193|NCT00821249|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91940194|NCT00821249|Immunologic Factors|immunologic factors|mesh-ancestor
91940195|NCT00821249|Antimitotic Agents|antimitotic agents|mesh-ancestor
91940196|NCT00821249|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940197|NCT00821249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940198|NCT03752723|Cyclophosphamide|cyclophosphamide|mesh-list
91940200|NCT03752723|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940201|NCT03752723|Immunologic Factors|immunologic factors|mesh-ancestor
91940202|NCT03752723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940203|NCT03752723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940204|NCT03752723|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91940205|NCT03752723|Alkylating Agents|alkylating agents|mesh-ancestor
91940206|NCT03752723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940207|NCT03752723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940208|NCT03752723|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91940209|NCT03752723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940210|NCT03752723|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940212|NCT04472585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91940213|NCT04472585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940214|NCT03496519|Durvalumab|durvalumab|mesh-list
91940216|NCT03496519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91940217|NCT03496519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943963|NCT02284529|Protective Agents|protective agents|mesh-ancestor
91940218|NCT03496519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940220|NCT03496519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940221|NCT03496519|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91940222|NCT03496519|Alkylating Agents|alkylating agents|mesh-ancestor
91940223|NCT03496519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940225|NCT00813605|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940226|NCT00813605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940227|NCT00724841|Temozolomide|temozolomide|mesh-list
91940229|NCT00724841|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91940230|NCT00724841|Alkylating Agents|alkylating agents|mesh-ancestor
91940231|NCT00724841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940232|NCT00724841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940233|NCT00724841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940234|NCT03131791|Botulinum Toxins|botulinum toxins|mesh-list
91940235|NCT03131791|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91940236|NCT03131791|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91940237|NCT03131791|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91940238|NCT03131791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940239|NCT03131791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940240|NCT03131791|Cholinergic Agents|cholinergic agents|mesh-ancestor
91940241|NCT03131791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940242|NCT03131791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940243|NCT03131791|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91940244|NCT03131791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940246|NCT00805805|Chelating Agents|chelating agents|mesh-ancestor
91940247|NCT00805805|Sequestering Agents|sequestering agents|mesh-ancestor
91940248|NCT00805805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940249|NCT00805805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940250|NCT00805805|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91940251|NCT00805805|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91940252|NCT00805805|Growth Substances|growth substances|mesh-ancestor
91940253|NCT00805805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940254|NCT00805805|Growth Inhibitors|growth inhibitors|mesh-ancestor
91940255|NCT00805805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940256|NCT03488173|Lansoprazole|lansoprazole|mesh-list
91940257|NCT03488173|Dexlansoprazole|dexlansoprazole|mesh-list
91940258|NCT03488173|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91940259|NCT03488173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940260|NCT03488173|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91940261|NCT03488173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940262|NCT03488173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940264|NCT03420521|Ipilimumab|ipilimumab|mesh-list
91940265|NCT03420521|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940266|NCT03420521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940267|NCT03420521|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940268|NCT03420521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940270|NCT04750759|Camostat|camostat|mesh-list
91940272|NCT04750759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940273|NCT04750759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940275|NCT04750759|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91940276|NCT04750759|Anticestodal Agents|anticestodal agents|mesh-ancestor
91940277|NCT04750759|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91940278|NCT04750759|Anthelmintics|anthelmintics|mesh-ancestor
91940279|NCT04750759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91940280|NCT04750759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940282|NCT03382925|Triamcinolone|triamcinolone|mesh-list
91940283|NCT03382925|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91940284|NCT03382925|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91940286|NCT03382925|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91940287|NCT03382925|Anesthetics, Local|anesthetics, local|mesh-ancestor
91940288|NCT03382925|Anesthetics|anesthetics|mesh-ancestor
91940289|NCT03382925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940290|NCT03382925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940291|NCT03382925|Sensory System Agents|sensory system agents|mesh-ancestor
91940292|NCT03382925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940293|NCT03382925|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91940294|NCT03382925|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91940295|NCT03382925|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91940296|NCT03382925|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940297|NCT03382925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940298|NCT03382925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940299|NCT03382925|Glucocorticoids|glucocorticoids|mesh-ancestor
91940300|NCT03382925|Hormones|hormones|mesh-ancestor
91940301|NCT03382925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940302|NCT03382925|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940303|NCT03382925|Immunologic Factors|immunologic factors|mesh-ancestor
91940304|NCT03382925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940305|NCT03487939|Fluorouracil|fluorouracil|mesh-list
91940306|NCT03487939|Oxaliplatin|oxaliplatin|mesh-list
91940307|NCT03487939|Irinotecan|irinotecan|mesh-list
91940308|NCT03487939|Antimetabolites|antimetabolites|mesh-ancestor
91940309|NCT03487939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940310|NCT03487939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91940311|NCT03487939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940312|NCT03487939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940313|NCT03487939|Immunologic Factors|immunologic factors|mesh-ancestor
91940314|NCT03487939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940315|NCT03487939|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91940316|NCT03487939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91940317|NCT03487939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940318|NCT00796289|Citric Acid|citric acid|mesh-list
91940319|NCT00796289|Sodium Citrate|sodium citrate|mesh-list
91940320|NCT00796289|Clomiphene|clomiphene|mesh-list
91940321|NCT00796289|Enclomiphene|enclomiphene|mesh-list
91940322|NCT00796289|Zuclomiphene|zuclomiphene|mesh-list
91940323|NCT00796289|Hormones|hormones|mesh-list
91940324|NCT00796289|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
91940325|NCT00796289|Anticoagulants|anticoagulants|mesh-ancestor
91940326|NCT00796289|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91940327|NCT00796289|Chelating Agents|chelating agents|mesh-ancestor
91940329|NCT00796289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945327|NCT00002207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940330|NCT00796289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940331|NCT00796289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940332|NCT00796289|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91940334|NCT00796289|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91940335|NCT00796289|Fertility Agents|fertility agents|mesh-ancestor
91940336|NCT00796289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91940337|NCT00796289|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91940338|NCT00796289|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91940339|NCT04460443|Sofosbuvir|sofosbuvir|mesh-list
91940340|NCT04460443|Antiviral Agents|antiviral agents|mesh-ancestor
91940341|NCT04460443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940342|NCT04460521|Acetylcysteine|acetylcysteine|mesh-list
91940343|NCT04460521|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91940344|NCT04460521|Antiviral Agents|antiviral agents|mesh-ancestor
91940345|NCT04460521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940346|NCT04460521|Expectorants|expectorants|mesh-ancestor
91940347|NCT04460521|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940348|NCT04460521|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91940350|NCT04460521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940351|NCT04460521|Protective Agents|protective agents|mesh-ancestor
91940352|NCT04460521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940353|NCT04460521|Antidotes|antidotes|mesh-ancestor
91940355|NCT00698789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940356|NCT00698789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940357|NCT03487783|Aripiprazole|aripiprazole|mesh-list
91940358|NCT03487783|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91940359|NCT03487783|Antidepressive Agents|antidepressive agents|mesh-ancestor
91940360|NCT03487783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91940361|NCT03487783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91940362|NCT03487783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91940363|NCT03487783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940364|NCT03487783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940365|NCT03487783|Dopamine Agonists|dopamine agonists|mesh-ancestor
91940366|NCT03487783|Dopamine Agents|dopamine agents|mesh-ancestor
91940367|NCT03487783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940368|NCT03487783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940369|NCT03487783|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91940370|NCT03487783|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91940371|NCT03487783|Serotonin Agents|serotonin agents|mesh-ancestor
91940372|NCT03487783|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91940373|NCT03487783|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91940374|NCT03487783|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91940375|NCT03487783|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91940377|NCT03495739|Antithrombins|antithrombins|mesh-ancestor
91940378|NCT03495739|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91940379|NCT03495739|Protease Inhibitors|protease inhibitors|mesh-ancestor
91940380|NCT03495739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940381|NCT03495739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940383|NCT03298061|Prednisolone|prednisolone|mesh-list
91940384|NCT03298061|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940385|NCT03298061|Glucocorticoids|glucocorticoids|mesh-ancestor
91940386|NCT03298061|Hormones|hormones|mesh-ancestor
91940465|NCT02744183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940387|NCT03298061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940388|NCT03298061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940389|NCT03298061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91940390|NCT03298061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940391|NCT04071613|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91940392|NCT04071613|Plasminogen|plasminogen|mesh-list
91940393|NCT04071613|Tenecteplase|tenecteplase|mesh-list
91940394|NCT04071613|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91940395|NCT04071613|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91940396|NCT04071613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940397|NCT00678119|Sunitinib|sunitinib|mesh-list
91940398|NCT00678119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940399|NCT00678119|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91940400|NCT00678119|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91940401|NCT00678119|Growth Substances|growth substances|mesh-ancestor
91940402|NCT00678119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940403|NCT00678119|Growth Inhibitors|growth inhibitors|mesh-ancestor
91940404|NCT00678119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91940405|NCT00678119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940406|NCT00678119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940408|NCT02812667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940409|NCT02812667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940410|NCT02812667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940411|NCT02812667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940413|NCT02799095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940414|NCT02799095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940415|NCT02799095|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940416|NCT02799095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940418|NCT02011321|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91940419|NCT02011321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940420|NCT02011321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945328|NCT00002207|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91940421|NCT02011321|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91940422|NCT02011321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940424|NCT01352585|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91940425|NCT01352585|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91940426|NCT01352585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940427|NCT01352585|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91940428|NCT03484507|Chlorhexidine|chlorhexidine|mesh-list
91940429|NCT03484507|Povidone-Iodine|povidone-iodine|mesh-list
91940430|NCT03484507|Prednisolone|prednisolone|mesh-list
91940431|NCT03484507|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91940432|NCT03484507|Methylprednisolone|methylprednisolone|mesh-list
91940433|NCT03484507|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91940434|NCT03484507|Prednisolone acetate|prednisolone acetate|mesh-list
91940436|NCT03484507|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91940437|NCT03484507|Prednisolone phosphate|prednisolone phosphate|mesh-list
91940438|NCT03484507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940439|NCT03484507|Glucocorticoids|glucocorticoids|mesh-ancestor
91940440|NCT03484507|Hormones|hormones|mesh-ancestor
91940441|NCT03484507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940442|NCT03484507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940443|NCT03484507|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91940444|NCT03484507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940445|NCT03484507|Antiemetics|antiemetics|mesh-ancestor
91940446|NCT03484507|Autonomic Agents|autonomic agents|mesh-ancestor
91940447|NCT03484507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940448|NCT03484507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940449|NCT03484507|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91940450|NCT03484507|Protective Agents|protective agents|mesh-ancestor
91940451|NCT03484507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91940453|NCT03484507|Disinfectants|disinfectants|mesh-ancestor
91940455|NCT03484507|Blood Substitutes|blood substitutes|mesh-ancestor
91940456|NCT02773355|Liraglutide|liraglutide|mesh-list
91940457|NCT02773355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940458|NCT02773355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940459|NCT02773355|Incretins|incretins|mesh-ancestor
91940460|NCT02773355|Hormones|hormones|mesh-ancestor
91945329|NCT00002207|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91940461|NCT02773355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940463|NCT02744183|Anesthetics, Local|anesthetics, local|mesh-ancestor
91940464|NCT02744183|Anesthetics|anesthetics|mesh-ancestor
91943976|NCT04470479|Pilocarpine|pilocarpine|mesh-list
91940466|NCT02744183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940467|NCT02744183|Sensory System Agents|sensory system agents|mesh-ancestor
91940468|NCT02744183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940470|NCT03484195|Oxaliplatin|oxaliplatin|mesh-list
91940472|NCT03484195|Antimetabolites|antimetabolites|mesh-ancestor
91945330|NCT00002207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940473|NCT03484195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945331|NCT00002207|Antiviral Agents|antiviral agents|mesh-ancestor
91940474|NCT03484195|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91940475|NCT03484195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940476|NCT03484195|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940477|NCT03484195|Immunologic Factors|immunologic factors|mesh-ancestor
91940478|NCT03484195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940479|NCT03484195|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91940480|NCT03484195|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91940481|NCT03484195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940482|NCT02713607|Doxycycline|doxycycline|mesh-list
91940483|NCT02713607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91940484|NCT02713607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940485|NCT02713607|Antimalarials|antimalarials|mesh-ancestor
91940486|NCT02713607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91940487|NCT02713607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91940488|NCT04526821|Lactoferrin|lactoferrin|mesh-list
91940489|NCT04526821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940490|NCT02681549|Bevacizumab|bevacizumab|mesh-list
91940491|NCT02681549|Pembrolizumab|pembrolizumab|mesh-list
91940492|NCT02681549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940493|NCT02681549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940494|NCT02681549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91940495|NCT02681549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91940496|NCT02681549|Growth Substances|growth substances|mesh-ancestor
91940497|NCT02681549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940498|NCT02681549|Growth Inhibitors|growth inhibitors|mesh-ancestor
91940499|NCT02681549|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940500|NCT02681549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940502|NCT02323399|Oxymetazoline|oxymetazoline|mesh-list
91940503|NCT02323399|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91940504|NCT02323399|Mydriatics|mydriatics|mesh-ancestor
91940505|NCT02323399|Autonomic Agents|autonomic agents|mesh-ancestor
91940506|NCT02323399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940507|NCT02323399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940508|NCT02323399|Sympathomimetics|sympathomimetics|mesh-ancestor
91940509|NCT02323399|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91940510|NCT02323399|Nasal Decongestants|nasal decongestants|mesh-ancestor
91940511|NCT02323399|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940512|NCT02323399|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91940513|NCT02323399|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91940514|NCT02323399|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91940515|NCT02323399|Adrenergic Agents|adrenergic agents|mesh-ancestor
91940516|NCT02323399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940517|NCT02323399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940518|NCT02323399|Protective Agents|protective agents|mesh-ancestor
91940519|NCT01352507|Sildenafil Citrate|sildenafil citrate|mesh-list
91940521|NCT01352507|Vasodilator Agents|vasodilator agents|mesh-ancestor
91940522|NCT01352507|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91940523|NCT01352507|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91940524|NCT01352507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940525|NCT01352507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940526|NCT01352507|Urological Agents|urological agents|mesh-ancestor
91940527|NCT04460963|Adrenomedullin|adrenomedullin|mesh-list
91940528|NCT04460963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91940529|NCT04460963|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91940530|NCT04460963|Autonomic Agents|autonomic agents|mesh-ancestor
91940531|NCT04460963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940532|NCT04460963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940533|NCT04460963|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91940534|NCT04460963|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940535|NCT04460963|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91940536|NCT04460963|Vasodilator Agents|vasodilator agents|mesh-ancestor
91940537|NCT04460963|Protective Agents|protective agents|mesh-ancestor
91940540|NCT00873275|Fluorouracil|fluorouracil|mesh-list
91940541|NCT00873275|Oxaliplatin|oxaliplatin|mesh-list
91940542|NCT00873275|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91940543|NCT00873275|Calcium|calcium|mesh-list
91940544|NCT00873275|Levoleucovorin|levoleucovorin|mesh-list
91940545|NCT00873275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940546|NCT00873275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940547|NCT00873275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91940548|NCT00873275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91940549|NCT00873275|Growth Substances|growth substances|mesh-ancestor
91940550|NCT00873275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940551|NCT00873275|Growth Inhibitors|growth inhibitors|mesh-ancestor
91940552|NCT00873275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91940553|NCT00873275|Antimetabolites|antimetabolites|mesh-ancestor
91940554|NCT00873275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940555|NCT00873275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91940556|NCT00873275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940557|NCT00873275|Immunologic Factors|immunologic factors|mesh-ancestor
91940558|NCT00873275|Antidotes|antidotes|mesh-ancestor
91940559|NCT00873275|Protective Agents|protective agents|mesh-ancestor
91940560|NCT00873275|Vitamin B Complex|vitamin b complex|mesh-ancestor
91940561|NCT00873275|Vitamins|vitamins|mesh-ancestor
91940562|NCT00873275|Micronutrients|micronutrients|mesh-ancestor
91940563|NCT00873275|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91940564|NCT00873275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940565|NCT04403243|Colchicine|colchicine|mesh-list
91940566|NCT04403243|Gout Suppressants|gout suppressants|mesh-ancestor
91940567|NCT04403243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940568|NCT04403243|Tubulin Modulators|tubulin modulators|mesh-ancestor
91940569|NCT04403243|Antimitotic Agents|antimitotic agents|mesh-ancestor
91940570|NCT04403243|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940571|NCT04403243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940572|NCT04403243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940573|NCT05648032|Triamcinolone|triamcinolone|mesh-list
91940574|NCT05648032|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91940575|NCT05648032|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91940576|NCT05648032|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91940577|NCT05648032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940578|NCT05648032|Glucocorticoids|glucocorticoids|mesh-ancestor
91940580|NCT05648032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940581|NCT05648032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940582|NCT05648032|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940583|NCT05648032|Immunologic Factors|immunologic factors|mesh-ancestor
91940584|NCT05648032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940585|NCT05648032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940586|NCT00774761|Fluticasone|fluticasone|mesh-list
91940588|NCT00774761|Formoterol Fumarate|formoterol fumarate|mesh-list
91940589|NCT00774761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940590|NCT00774761|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91940591|NCT00774761|Autonomic Agents|autonomic agents|mesh-ancestor
91940592|NCT00774761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940593|NCT00774761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940594|NCT00774761|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91940595|NCT00774761|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940596|NCT00774761|Dermatologic Agents|dermatologic agents|mesh-ancestor
91940597|NCT00774761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91940598|NCT00774761|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91940599|NCT00774761|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91940600|NCT00774761|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91940601|NCT00774761|Adrenergic Agents|adrenergic agents|mesh-ancestor
91940602|NCT00774761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940603|NCT00774761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940604|NCT00772343|Vaccines|vaccines|mesh-list
91940605|NCT00772343|Immunologic Factors|immunologic factors|mesh-ancestor
91940606|NCT00772343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940607|NCT05647954|Pembrolizumab|pembrolizumab|mesh-list
91940608|NCT05647954|Temozolomide|temozolomide|mesh-list
91940609|NCT05647954|Chlorotrianisene|chlorotrianisene|mesh-list
91940610|NCT05647954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940611|NCT05647954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940612|NCT05647954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940613|NCT05647954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940614|NCT05647954|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91940615|NCT05647954|Alkylating Agents|alkylating agents|mesh-ancestor
91940616|NCT05647954|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91940617|NCT05647954|Estrogens|estrogens|mesh-ancestor
91940618|NCT05647954|Hormones|hormones|mesh-ancestor
91940619|NCT05647954|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940620|NCT05647954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940621|NCT05647954|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91940622|NCT00770081|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91940623|NCT00770081|Vildagliptin|vildagliptin|mesh-list
91940624|NCT00770081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940625|NCT00770081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940626|NCT00770081|Incretins|incretins|mesh-ancestor
91940627|NCT00770081|Hormones|hormones|mesh-ancestor
91940628|NCT00770081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940629|NCT00770081|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91940630|NCT00770081|Protease Inhibitors|protease inhibitors|mesh-ancestor
91940631|NCT00770081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940632|NCT00770081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940633|NCT02360098|Anesthetics|anesthetics|mesh-list
91940634|NCT02360098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940635|NCT02360098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940637|NCT02273609|Warfarin|warfarin|mesh-list
91940638|NCT02273609|Acenocoumarol|acenocoumarol|mesh-list
91940639|NCT02273609|Vitamins|vitamins|mesh-ancestor
91940640|NCT02273609|Micronutrients|micronutrients|mesh-ancestor
91940641|NCT02273609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940642|NCT02273609|Anticoagulants|anticoagulants|mesh-ancestor
91940643|NCT02273609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91940644|NCT02273609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91940645|NCT02273609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940646|NCT02273609|Hemostatics|hemostatics|mesh-ancestor
91940647|NCT02273609|Coagulants|coagulants|mesh-ancestor
91940648|NCT02273843|Vitamin D|vitamin d|mesh-list
91940649|NCT02273843|Ergocalciferols|ergocalciferols|mesh-list
91940650|NCT02273843|Cholecalciferol|cholecalciferol|mesh-list
91940651|NCT02273843|Vitamins|vitamins|mesh-list
91940652|NCT02273843|Micronutrients|micronutrients|mesh-ancestor
91940653|NCT02273843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940654|NCT02273843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91940655|NCT02273843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91940656|NCT00666497|Azacitidine|azacitidine|mesh-list
91940657|NCT00666497|Mocetinostat|mocetinostat|mesh-list
91940658|NCT00666497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91940659|NCT00666497|Antimetabolites|antimetabolites|mesh-ancestor
91940660|NCT00666497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940661|NCT00666497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940662|NCT00666497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940663|NCT00666497|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91940664|NCT02274077|Bupivacaine|bupivacaine|mesh-list
91940665|NCT02274077|Anesthetics, Local|anesthetics, local|mesh-ancestor
91940666|NCT02274077|Anesthetics|anesthetics|mesh-ancestor
91940667|NCT02274077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940668|NCT02274077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940669|NCT02274077|Sensory System Agents|sensory system agents|mesh-ancestor
91940670|NCT02274077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940671|NCT00765323|Octreotide|octreotide|mesh-list
91940672|NCT00765323|Somatostatin|somatostatin|mesh-list
91940673|NCT00765323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940674|NCT00765323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91940675|NCT00765323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940676|NCT00765323|Hormones|hormones|mesh-ancestor
91940677|NCT00765323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940678|NCT00765323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940679|NCT02276495|Ketorolac|ketorolac|mesh-list
91940680|NCT02276495|Clonidine|clonidine|mesh-list
91940681|NCT02276495|Epinephrine|epinephrine|mesh-list
91940682|NCT02276495|Ropivacaine|ropivacaine|mesh-list
91940683|NCT02276495|Anesthetics, Local|anesthetics, local|mesh-ancestor
91940684|NCT02276495|Anesthetics|anesthetics|mesh-ancestor
91940685|NCT02276495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940686|NCT02276495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940687|NCT02276495|Sensory System Agents|sensory system agents|mesh-ancestor
91940688|NCT02276495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940689|NCT02276495|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91940690|NCT02276495|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91940691|NCT02276495|Adrenergic Agents|adrenergic agents|mesh-ancestor
91940692|NCT02276495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940693|NCT02276495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940694|NCT02276495|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91940695|NCT02276495|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91940696|NCT02276495|Autonomic Agents|autonomic agents|mesh-ancestor
91940697|NCT02276495|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91940698|NCT02276495|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940699|NCT02276495|Mydriatics|mydriatics|mesh-ancestor
91940700|NCT02276495|Sympathomimetics|sympathomimetics|mesh-ancestor
91940701|NCT02276495|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91940702|NCT02276495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91940703|NCT02276495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940704|NCT02276495|Analgesics|analgesics|mesh-ancestor
91940705|NCT02276495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940706|NCT02276495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940707|NCT02276495|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91940708|NCT02276495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940709|NCT02276495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91940710|NCT02276495|Sympatholytics|sympatholytics|mesh-ancestor
91940711|NCT02276495|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91940713|NCT02277587|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
91940714|NCT02277587|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
91940715|NCT02277587|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91940716|NCT02277587|Cortisone|cortisone|mesh-list
91940717|NCT02277587|Glucocorticoids|glucocorticoids|mesh-list
91940718|NCT02277587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940719|NCT02277587|Hormones|hormones|mesh-ancestor
91940720|NCT02277587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940721|NCT02277587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940722|NCT00663767|Celecoxib|celecoxib|mesh-list
91940723|NCT00663767|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-list
91940724|NCT00663767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91940725|NCT00663767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940726|NCT00663767|Analgesics|analgesics|mesh-ancestor
91940727|NCT00663767|Sensory System Agents|sensory system agents|mesh-ancestor
91940728|NCT00663767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940729|NCT00663767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940730|NCT00663767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940731|NCT00663767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940732|NCT00663767|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91940733|NCT00663767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940734|NCT00663767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940735|NCT00662597|Paclitaxel|paclitaxel|mesh-list
91940736|NCT00662597|Carboplatin|carboplatin|mesh-list
91940737|NCT00662597|Vadimezan|vadimezan|mesh-list
91940738|NCT00662597|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91940739|NCT00662597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940740|NCT00662597|Tubulin Modulators|tubulin modulators|mesh-ancestor
91940741|NCT00662597|Antimitotic Agents|antimitotic agents|mesh-ancestor
91940742|NCT00662597|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940743|NCT00662597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940744|NCT02266888|Rituximab|rituximab|mesh-list
91940745|NCT02266888|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940746|NCT02266888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940747|NCT02266888|Immunologic Factors|immunologic factors|mesh-ancestor
91940748|NCT02266888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940749|NCT02266888|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940750|NCT01641952|Rituximab|rituximab|mesh-list
91940751|NCT01641952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940752|NCT01641952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940753|NCT01641952|Immunologic Factors|immunologic factors|mesh-ancestor
91940754|NCT01641952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940755|NCT01641952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940756|NCT00660881|Epratuzumab|epratuzumab|mesh-list
91940757|NCT00660881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940758|NCT00660881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940759|NCT02359552|Rasagiline|rasagiline|mesh-list
91940760|NCT02359552|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91940761|NCT02359552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940762|NCT02359552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940763|NCT02359552|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91940764|NCT02359552|Protective Agents|protective agents|mesh-ancestor
91940765|NCT02359552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940766|NCT02279537|Aflibercept|aflibercept|mesh-list
91940767|NCT02279537|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91940768|NCT02279537|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91940769|NCT02279537|Growth Substances|growth substances|mesh-ancestor
91940770|NCT02279537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940771|NCT02279537|Growth Inhibitors|growth inhibitors|mesh-ancestor
91940772|NCT02279537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940773|NCT02280083|Botulinum Toxins|botulinum toxins|mesh-list
91940774|NCT02280083|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91940775|NCT02280083|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91940776|NCT02280083|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91940777|NCT02280083|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940778|NCT02280083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940779|NCT02280083|Cholinergic Agents|cholinergic agents|mesh-ancestor
91940780|NCT02280083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940781|NCT02280083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940782|NCT02280083|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91940783|NCT02280083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940784|NCT00752297|Botulinum Toxins|botulinum toxins|mesh-list
91940785|NCT00752297|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91940786|NCT00752297|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91940787|NCT00752297|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91940788|NCT00752297|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940789|NCT00752297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940790|NCT00752297|Cholinergic Agents|cholinergic agents|mesh-ancestor
91940791|NCT00752297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940792|NCT00752297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940793|NCT00752297|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91940794|NCT00752297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940796|NCT00656357|Anesthetics, Local|anesthetics, local|mesh-ancestor
91940797|NCT00656357|Anesthetics|anesthetics|mesh-ancestor
91940798|NCT00656357|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940799|NCT00656357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940800|NCT00656357|Sensory System Agents|sensory system agents|mesh-ancestor
91940801|NCT00656357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940802|NCT00656357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91940803|NCT00656357|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91940804|NCT00656357|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91940805|NCT00656357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940806|NCT00656357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940807|NCT00656357|Dopamine Agents|dopamine agents|mesh-ancestor
91940808|NCT00656357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940809|NCT02280629|Mesalamine|mesalamine|mesh-list
91940810|NCT02280629|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91940811|NCT02280629|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940812|NCT02280629|Analgesics|analgesics|mesh-ancestor
91940813|NCT02280629|Sensory System Agents|sensory system agents|mesh-ancestor
91940814|NCT02280629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940815|NCT02280629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940816|NCT02280629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940817|NCT02280629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940818|NCT03134573|Interferons|interferons|mesh-list
91940819|NCT03134573|Interferon-beta|interferon-beta|mesh-list
91940820|NCT03134573|Interferon beta-1b|interferon beta-1b|mesh-list
91940821|NCT03134573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940822|NCT03134573|Antiviral Agents|antiviral agents|mesh-ancestor
91940823|NCT03134573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940824|NCT03134573|Immunologic Factors|immunologic factors|mesh-ancestor
91940825|NCT03134573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940826|NCT03134573|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91940827|NCT00743795|Ribavirin|ribavirin|mesh-list
91940828|NCT00743795|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91940829|NCT00743795|Antimetabolites|antimetabolites|mesh-ancestor
91940830|NCT00743795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940831|NCT00743795|Antiviral Agents|antiviral agents|mesh-ancestor
91940832|NCT00743795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940833|NCT04232033|Mitogens|mitogens|mesh-list
91940834|NCT04232033|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940835|NCT04232033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940836|NCT03134417|Vitamin D|vitamin d|mesh-list
91940837|NCT03134417|Ergocalciferols|ergocalciferols|mesh-list
91940838|NCT03134417|Cholecalciferol|cholecalciferol|mesh-list
91940839|NCT03134417|Vitamins|vitamins|mesh-list
91940840|NCT03134417|Micronutrients|micronutrients|mesh-ancestor
91940841|NCT03134417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940842|NCT03134417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91940843|NCT03134417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91940844|NCT00649025|Fluticasone|fluticasone|mesh-list
91940845|NCT00649025|Xhance|xhance|mesh-list
91940846|NCT00649025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940847|NCT00649025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91940848|NCT00649025|Autonomic Agents|autonomic agents|mesh-ancestor
91940849|NCT00649025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940850|NCT00649025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940851|NCT00649025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91940852|NCT00649025|Respiratory System Agents|respiratory system agents|mesh-ancestor
91940853|NCT00649025|Dermatologic Agents|dermatologic agents|mesh-ancestor
91940854|NCT00649025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91940855|NCT00647231|Ketoprofen|ketoprofen|mesh-list
91940856|NCT00647231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91940857|NCT00647231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940858|NCT00647231|Analgesics|analgesics|mesh-ancestor
91940859|NCT00647231|Sensory System Agents|sensory system agents|mesh-ancestor
91940860|NCT00647231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940861|NCT00647231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940862|NCT00647231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91940863|NCT00647231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940864|NCT00647231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91940865|NCT00647231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940866|NCT00647231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940867|NCT00739349|Cyclosporine|cyclosporine|mesh-list
91940868|NCT00739349|Cyclosporins|cyclosporins|mesh-list
91940869|NCT00739349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940870|NCT00739349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940871|NCT00739349|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91940872|NCT00739349|Immunologic Factors|immunologic factors|mesh-ancestor
91940873|NCT00739349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940874|NCT00739349|Antifungal Agents|antifungal agents|mesh-ancestor
91940875|NCT00739349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91940876|NCT00739349|Dermatologic Agents|dermatologic agents|mesh-ancestor
91940877|NCT00739349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91940878|NCT00739349|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91940879|NCT00152009|Guanfacine|guanfacine|mesh-list
91940880|NCT00152009|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91940881|NCT00152009|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91940882|NCT00152009|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91940883|NCT00152009|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91940884|NCT00152009|Adrenergic Agents|adrenergic agents|mesh-ancestor
91940885|NCT00152009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940886|NCT00152009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940887|NCT00152009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940888|NCT02280785|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91940889|NCT02280785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940890|NCT02280785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940891|NCT02280785|Immunotoxins|immunotoxins|mesh-ancestor
91940892|NCT02280785|Immunoconjugates|immunoconjugates|mesh-ancestor
91940893|NCT02280785|Immunologic Factors|immunologic factors|mesh-ancestor
91940894|NCT02280785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940895|NCT04158635|Paclitaxel|paclitaxel|mesh-list
91943989|NCT00382811|Carboplatin|carboplatin|mesh-list
91940896|NCT04158635|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91940897|NCT04158635|Gemcitabine|gemcitabine|mesh-list
91940898|NCT04158635|Bosentan|bosentan|mesh-list
91940899|NCT04158635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91940900|NCT04158635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940901|NCT04158635|Tubulin Modulators|tubulin modulators|mesh-ancestor
91940902|NCT04158635|Antimitotic Agents|antimitotic agents|mesh-ancestor
91940903|NCT04158635|Mitosis Modulators|mitosis modulators|mesh-ancestor
91940904|NCT04158635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940905|NCT04158635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91940906|NCT04158635|Antimetabolites|antimetabolites|mesh-ancestor
91940907|NCT04158635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91940908|NCT04158635|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91940909|NCT00734435|Zonisamide|zonisamide|mesh-list
91940910|NCT00734435|Olanzapine|olanzapine|mesh-list
91940911|NCT00734435|Antiemetics|antiemetics|mesh-ancestor
91940912|NCT00734435|Autonomic Agents|autonomic agents|mesh-ancestor
91940913|NCT00734435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940914|NCT00734435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940915|NCT00734435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91940916|NCT00734435|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91940917|NCT00734435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91940918|NCT00734435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940919|NCT00734435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91940920|NCT00734435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91940921|NCT00734435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91940922|NCT00734435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940923|NCT00734435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940924|NCT00734435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940925|NCT00734435|Serotonin Agents|serotonin agents|mesh-ancestor
91940926|NCT00734435|Anticonvulsants|anticonvulsants|mesh-ancestor
91940927|NCT00734435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91940928|NCT00734435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91940929|NCT04040231|Nivolumab|nivolumab|mesh-list
91940930|NCT04040231|Sargramostim|sargramostim|mesh-list
91940931|NCT04040231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91940932|NCT04040231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91940933|NCT04040231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91940934|NCT04040231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940935|NCT04040231|Immunologic Factors|immunologic factors|mesh-ancestor
91940936|NCT04040231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940939|NCT00728351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940940|NCT00728351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940941|NCT00728351|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91940942|NCT00728351|Protease Inhibitors|protease inhibitors|mesh-ancestor
91940943|NCT00728351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940944|NCT00728351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940945|NCT00616811|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91940946|NCT00616811|Vildagliptin|vildagliptin|mesh-list
91940947|NCT00616811|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91940948|NCT00616811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940949|NCT00616811|Incretins|incretins|mesh-ancestor
91940950|NCT00616811|Hormones|hormones|mesh-ancestor
91940951|NCT00616811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940952|NCT00616811|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91940953|NCT00616811|Protease Inhibitors|protease inhibitors|mesh-ancestor
91940954|NCT00616811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91940955|NCT00616811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940956|NCT00615251|Progesterone|progesterone|mesh-list
91940957|NCT00615251|Progestins|progestins|mesh-ancestor
91940959|NCT00615251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91940960|NCT00615251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940961|NCT02265796|Ranolazine|ranolazine|mesh-list
91940962|NCT02265796|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91940963|NCT02265796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91940964|NCT02265796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940966|NCT05647642|Dexmedetomidine|dexmedetomidine|mesh-list
91940967|NCT05647642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91940968|NCT05647642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91940969|NCT05647642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940970|NCT05647642|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91940972|NCT05647642|Sensory System Agents|sensory system agents|mesh-ancestor
91940973|NCT05647642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91940974|NCT05647642|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91940975|NCT05647642|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91940976|NCT05647642|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91940977|NCT05647642|Adrenergic Agents|adrenergic agents|mesh-ancestor
91940978|NCT05647642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91940979|NCT05647642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91940980|NCT05647642|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91940981|NCT05647642|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91940982|NCT05647642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91940983|NCT05647642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91940984|NCT05647642|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91940985|NCT05647642|Anesthetics, General|anesthetics, general|mesh-ancestor
91940987|NCT05647642|GABA Modulators|gaba modulators|mesh-ancestor
91940988|NCT05647642|GABA Agents|gaba agents|mesh-ancestor
91940989|NCT02357368|Copper|copper|mesh-list
91940990|NCT02357368|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
91940991|NCT02357368|Levonorgestrel|levonorgestrel|mesh-list
91940992|NCT02357368|Medroxyprogesterone|medroxyprogesterone|mesh-list
91940993|NCT02357368|Etonogestrel|etonogestrel|mesh-list
91940994|NCT02357368|Contraceptive Agents|contraceptive agents|mesh-list
91940995|NCT02357368|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91940996|NCT02357368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91940997|NCT02357368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91940998|NCT02357368|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91940999|NCT02357368|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91941001|NCT02357368|Trace Elements|trace elements|mesh-ancestor
91941002|NCT02357368|Micronutrients|micronutrients|mesh-ancestor
91941003|NCT02357368|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91941322|NCT00609323|Lidocaine|lidocaine|mesh-list
91941004|NCT02357368|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91941005|NCT02357368|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941006|NCT02357368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941008|NCT04873570|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91941009|NCT04873570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941010|NCT04873570|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91941011|NCT04873570|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91941012|NCT04873570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941013|NCT04873570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941015|NCT05647408|Dexamethasone|dexamethasone|mesh-list
91941016|NCT05647408|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941017|NCT05647408|Antiemetics|antiemetics|mesh-ancestor
91941018|NCT05647408|Autonomic Agents|autonomic agents|mesh-ancestor
91941019|NCT05647408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941020|NCT05647408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941021|NCT05647408|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91941022|NCT05647408|Glucocorticoids|glucocorticoids|mesh-ancestor
91941023|NCT05647408|Hormones|hormones|mesh-ancestor
91941024|NCT05647408|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941025|NCT05647408|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941026|NCT05647408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941028|NCT03483415|Bupivacaine|bupivacaine|mesh-list
91941029|NCT03483415|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941030|NCT03483415|Anesthetics|anesthetics|mesh-ancestor
91941031|NCT03483415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941032|NCT03483415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941033|NCT03483415|Sensory System Agents|sensory system agents|mesh-ancestor
91941034|NCT03483415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941035|NCT03483415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91941036|NCT03483415|Narcotics|narcotics|mesh-ancestor
91941037|NCT03483415|Analgesics|analgesics|mesh-ancestor
91941038|NCT03487003|Bromides|bromides|mesh-list
91941039|NCT03487003|Rocuronium|rocuronium|mesh-list
91941040|NCT03487003|Anticonvulsants|anticonvulsants|mesh-ancestor
91941041|NCT03487003|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91941042|NCT03487003|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91941043|NCT03487003|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91941044|NCT03487003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941045|NCT03487003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941048|NCT03486925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91941049|NCT03486925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941050|NCT02262754|Naproxen|naproxen|mesh-list
91941051|NCT02262754|PF-06372865|pf-06372865|mesh-list
91941052|NCT02262754|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91941053|NCT02262754|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91941054|NCT02262754|Analgesics|analgesics|mesh-ancestor
91941055|NCT02262754|Sensory System Agents|sensory system agents|mesh-ancestor
91941056|NCT02262754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941057|NCT02262754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941058|NCT02262754|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941059|NCT02262754|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941060|NCT02262754|Gout Suppressants|gout suppressants|mesh-ancestor
91941061|NCT02262754|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91941062|NCT02262754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941063|NCT02262754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941064|NCT02262754|GABA Modulators|gaba modulators|mesh-ancestor
91941065|NCT02262754|GABA Agents|gaba agents|mesh-ancestor
91941066|NCT02262754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941068|NCT03483181|Rivaroxaban|rivaroxaban|mesh-list
91941069|NCT03483181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91941070|NCT03483181|Antithrombins|antithrombins|mesh-ancestor
91941071|NCT03483181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91941072|NCT03483181|Protease Inhibitors|protease inhibitors|mesh-ancestor
91941073|NCT03483181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941074|NCT03483181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941075|NCT03483181|Anticoagulants|anticoagulants|mesh-ancestor
91941076|NCT03483181|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91941077|NCT03483181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91941078|NCT02356588|Sufentanil|sufentanil|mesh-list
91941081|NCT02356588|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941082|NCT02356588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941083|NCT02356588|Analgesics|analgesics|mesh-ancestor
91941084|NCT02356588|Sensory System Agents|sensory system agents|mesh-ancestor
91941085|NCT02356588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941086|NCT02356588|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91941323|NCT00609323|Tetracaine|tetracaine|mesh-list
91941087|NCT02356588|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91941088|NCT02356588|Anesthetics, General|anesthetics, general|mesh-ancestor
91941090|NCT04445389|Vaccines|vaccines|mesh-list
91941091|NCT04445389|Immunologic Factors|immunologic factors|mesh-ancestor
91941092|NCT04445389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941093|NCT02355028|Ranibizumab|ranibizumab|mesh-list
91941094|NCT02355028|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91941095|NCT02355028|Acrizanib|acrizanib|mesh-list
91941096|NCT02355028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91941097|NCT02355028|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91941098|NCT02355028|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91941100|NCT02355028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941101|NCT02355028|Growth Inhibitors|growth inhibitors|mesh-ancestor
91941102|NCT02355028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941103|NCT02355028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91941104|NCT02355028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945332|NCT00002207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941105|NCT02355028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941106|NCT05647330|Hydroxychloroquine|hydroxychloroquine|mesh-list
91941107|NCT05647330|Chloroquine|chloroquine|mesh-list
91941108|NCT05647330|Gemcitabine|gemcitabine|mesh-list
91945333|NCT00002207|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91941109|NCT05647330|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91941111|NCT05647330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941112|NCT05647330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941113|NCT05647330|Antimalarials|antimalarials|mesh-ancestor
91941114|NCT05647330|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91941115|NCT05647330|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91941116|NCT05647330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941118|NCT05647330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941121|NCT01643668|Clofarabine|clofarabine|mesh-list
91941122|NCT01643668|Alkylating Agents|alkylating agents|mesh-ancestor
91941123|NCT01643668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941124|NCT01643668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91941125|NCT01643668|Immunologic Factors|immunologic factors|mesh-ancestor
91941126|NCT01643668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941127|NCT01643668|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91941128|NCT01643668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941129|NCT01643668|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91941130|NCT01643668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91941131|NCT01643668|Antimetabolites|antimetabolites|mesh-ancestor
91941132|NCT02260882|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91941133|NCT02260882|Immunologic Factors|immunologic factors|mesh-ancestor
91941134|NCT02260882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941135|NCT00112411|Bronchodilator Agents|bronchodilator agents|mesh-list
91941136|NCT00112411|Autonomic Agents|autonomic agents|mesh-ancestor
91941137|NCT00112411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941138|NCT00112411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941139|NCT00112411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91941140|NCT00112411|Respiratory System Agents|respiratory system agents|mesh-ancestor
91941141|NCT02260804|Rituximab|rituximab|mesh-list
91941142|NCT02260804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941143|NCT02260804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941144|NCT02260804|Immunologic Factors|immunologic factors|mesh-ancestor
91941145|NCT02260804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941146|NCT02260804|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941147|NCT03486457|Tofacitinib|tofacitinib|mesh-list
91941148|NCT03486457|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91941149|NCT03486457|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91941150|NCT03486457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941151|NCT03486457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941152|NCT02260648|Atorvastatin|atorvastatin|mesh-list
91941153|NCT02260648|Ezetimibe|ezetimibe|mesh-list
91941154|NCT02260648|Evacetrapib|evacetrapib|mesh-list
91941155|NCT02260648|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91941156|NCT02260648|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91941157|NCT02260648|Antimetabolites|antimetabolites|mesh-ancestor
91941158|NCT02260648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941159|NCT02260648|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91945334|NCT00002207|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91941160|NCT02260648|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91941161|NCT02260648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941163|NCT04179019|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91941164|NCT04179019|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91941165|NCT04179019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941166|NCT04179019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941167|NCT04179019|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91941168|NCT04179019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941169|NCT04179019|Vasodilator Agents|vasodilator agents|mesh-ancestor
91941170|NCT02260492|Fluticasone|fluticasone|mesh-list
91941172|NCT02260492|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91945336|NCT03529097|Diclofenac|diclofenac|mesh-list
91941173|NCT02260492|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91941174|NCT02260492|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941175|NCT02260492|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91941177|NCT02260492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941179|NCT02260492|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91941180|NCT02260492|Respiratory System Agents|respiratory system agents|mesh-ancestor
91941181|NCT02260492|Dermatologic Agents|dermatologic agents|mesh-ancestor
91941182|NCT02260492|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91941183|NCT02260492|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91941184|NCT02260492|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91941185|NCT02260492|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91941186|NCT02260492|Adrenergic Agents|adrenergic agents|mesh-ancestor
91941187|NCT02260492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941188|NCT02260492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941189|NCT02260492|Glucocorticoids|glucocorticoids|mesh-ancestor
91941190|NCT02260492|Hormones|hormones|mesh-ancestor
91945338|NCT03529097|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91941191|NCT02260492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941193|NCT03966625|Autoantibodies|autoantibodies|mesh-list
91941194|NCT03966625|Immunologic Factors|immunologic factors|mesh-ancestor
91945339|NCT03529097|Narcotics|narcotics|mesh-ancestor
91941195|NCT03966625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941196|NCT02260258|Rocuronium|rocuronium|mesh-list
91941197|NCT02260258|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91941198|NCT02260258|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91941199|NCT02260258|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91941200|NCT02260258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941201|NCT02260258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941203|NCT05151679|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
91941204|NCT05151679|Iron Chelating Agents|iron chelating agents|mesh-list
91941205|NCT05151679|Trace Elements|trace elements|mesh-ancestor
91941206|NCT05151679|Micronutrients|micronutrients|mesh-ancestor
91941207|NCT05151679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941208|NCT05151679|Hematinics|hematinics|mesh-ancestor
91941209|NCT05151679|Chelating Agents|chelating agents|mesh-ancestor
91941210|NCT05151679|Sequestering Agents|sequestering agents|mesh-ancestor
91941211|NCT05151679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941212|NCT02324257|Obinutuzumab|obinutuzumab|mesh-list
91941213|NCT02324257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941214|NCT02324257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941215|NCT02353468|Dexamethasone|dexamethasone|mesh-list
91941216|NCT02353468|Lenalidomide|lenalidomide|mesh-list
91941217|NCT02353468|Bortezomib|bortezomib|mesh-list
91941218|NCT02353468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941219|NCT02353468|Antiemetics|antiemetics|mesh-ancestor
91941220|NCT02353468|Autonomic Agents|autonomic agents|mesh-ancestor
91941221|NCT02353468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941222|NCT02353468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941223|NCT02353468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91941224|NCT02353468|Glucocorticoids|glucocorticoids|mesh-ancestor
91941225|NCT02353468|Hormones|hormones|mesh-ancestor
91941226|NCT02353468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941227|NCT02353468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941228|NCT02353468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941229|NCT02353468|Immunologic Factors|immunologic factors|mesh-ancestor
91941230|NCT02353468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91941231|NCT02353468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91941232|NCT02353468|Growth Substances|growth substances|mesh-ancestor
91941233|NCT02353468|Growth Inhibitors|growth inhibitors|mesh-ancestor
91941235|NCT02523859|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91941236|NCT02523859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941237|NCT02523859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941238|NCT02523859|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91941239|NCT02523859|Anesthetics, General|anesthetics, general|mesh-ancestor
91941240|NCT02523859|Anesthetics|anesthetics|mesh-ancestor
91941242|NCT04459663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941243|NCT04459663|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91941244|NCT04459663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941245|NCT04459663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941246|NCT05150899|Fexofenadine|fexofenadine|mesh-list
91941247|NCT05150899|Tamsulosin|tamsulosin|mesh-list
91941248|NCT05150899|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91941249|NCT05150899|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91941250|NCT05150899|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91941251|NCT05150899|Adrenergic Agents|adrenergic agents|mesh-ancestor
91941252|NCT05150899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941253|NCT05150899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941254|NCT05150899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941255|NCT05150899|Urological Agents|urological agents|mesh-ancestor
91941256|NCT05150899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91941257|NCT05150899|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91941258|NCT05150899|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91941259|NCT05150899|Histamine Antagonists|histamine antagonists|mesh-ancestor
91941260|NCT05150899|Histamine Agents|histamine agents|mesh-ancestor
91941261|NCT01530997|Cisplatin|cisplatin|mesh-list
91941262|NCT01530997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941263|NCT00593905|Bosentan|bosentan|mesh-list
91941264|NCT00593905|Ambrisentan|ambrisentan|mesh-list
91941265|NCT00593905|Sitaxsentan|sitaxsentan|mesh-list
91941266|NCT00593905|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91941267|NCT00593905|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91941268|NCT00593905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941269|NCT02259088|Ranibizumab|ranibizumab|mesh-list
91941270|NCT02259088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91941271|NCT02259088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91941272|NCT02259088|Growth Substances|growth substances|mesh-ancestor
91941273|NCT02259088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941274|NCT02259088|Growth Inhibitors|growth inhibitors|mesh-ancestor
91941276|NCT02830477|Factor VIII|factor viii|mesh-list
91941277|NCT02830477|Coagulants|coagulants|mesh-ancestor
91941278|NCT02259010|Itraconazole|itraconazole|mesh-list
91941280|NCT02259010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941281|NCT02259010|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91941282|NCT02259010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91941283|NCT02259010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941284|NCT02259010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941285|NCT02259010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91941286|NCT02259010|Hormone Antagonists|hormone antagonists|mesh-ancestor
91941287|NCT02259010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941288|NCT02259010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941289|NCT02259010|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91941290|NCT02021773|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91941291|NCT02021773|Immunologic Factors|immunologic factors|mesh-ancestor
91941292|NCT02021773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941293|NCT05153785|Lidocaine|lidocaine|mesh-list
91941294|NCT05153785|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941296|NCT05153785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941297|NCT05153785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941298|NCT05153785|Sensory System Agents|sensory system agents|mesh-ancestor
91941299|NCT05153785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941300|NCT05153785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91941301|NCT05153785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91941302|NCT05153785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91941303|NCT05153785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941304|NCT05153785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941305|NCT00151775|Olmesartan|olmesartan|mesh-list
91941306|NCT00151775|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91941307|NCT00151775|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91941308|NCT00151775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91941310|NCT00151775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941311|NCT02258464|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
91941312|NCT02258464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941313|NCT03476941|Clindamycin|clindamycin|mesh-list
91941314|NCT03476941|Clindamycin palmitate|clindamycin palmitate|mesh-list
91941315|NCT03476941|Clindamycin phosphate|clindamycin phosphate|mesh-list
91941316|NCT03476941|Gentamicins|gentamicins|mesh-list
91941317|NCT03476941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91941318|NCT03476941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941319|NCT03476941|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91941320|NCT03476941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941321|NCT03476941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941324|NCT00609323|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941325|NCT00609323|Anesthetics|anesthetics|mesh-ancestor
91941326|NCT00609323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941327|NCT00609323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941329|NCT00609323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941330|NCT00609323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91941331|NCT00609323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91941332|NCT00609323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91941333|NCT00609323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941334|NCT00609323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941335|NCT02682901|Bromocriptine|bromocriptine|mesh-list
91941336|NCT02682901|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91941337|NCT02682901|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91941338|NCT02682901|Hormone Antagonists|hormone antagonists|mesh-ancestor
91941339|NCT02682901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941340|NCT02682901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941341|NCT02682901|Dopamine Agonists|dopamine agonists|mesh-ancestor
91941342|NCT02682901|Dopamine Agents|dopamine agents|mesh-ancestor
91941343|NCT02682901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941344|NCT02682901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941345|NCT02258074|Niacinamide|niacinamide|mesh-list
91941347|NCT02258074|Nicotinic Acids|nicotinic acids|mesh-list
91941348|NCT02258074|Vitamin B Complex|vitamin b complex|mesh-ancestor
91941349|NCT02258074|Vitamins|vitamins|mesh-ancestor
91941350|NCT02258074|Micronutrients|micronutrients|mesh-ancestor
91941351|NCT02258074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941352|NCT02258074|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91941353|NCT02258074|Antimetabolites|antimetabolites|mesh-ancestor
91941354|NCT02258074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941355|NCT02258074|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91941356|NCT02258074|Vasodilator Agents|vasodilator agents|mesh-ancestor
91941358|NCT04473053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91941359|NCT04473053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91941360|NCT04473053|Analgesics|analgesics|mesh-ancestor
91941361|NCT04473053|Sensory System Agents|sensory system agents|mesh-ancestor
91941362|NCT04473053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941363|NCT04473053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941364|NCT04473053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941365|NCT04473053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941366|NCT04473053|Anticoagulants|anticoagulants|mesh-ancestor
91941367|NCT04473053|Protease Inhibitors|protease inhibitors|mesh-ancestor
91944015|NCT00440531|Vaccines|vaccines|mesh-list
91941369|NCT04473053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941370|NCT04473053|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91941371|NCT04473053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91941372|NCT04473053|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91941373|NCT04473053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91941374|NCT04473053|Immunologic Factors|immunologic factors|mesh-ancestor
91941375|NCT02281643|Doxycycline|doxycycline|mesh-list
91941376|NCT02281643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91941377|NCT02281643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941378|NCT02281643|Antimalarials|antimalarials|mesh-ancestor
91941379|NCT02281643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91941380|NCT02281643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91941381|NCT02281721|Calcium Carbonate|calcium carbonate|mesh-list
91941382|NCT02281721|Antacids|antacids|mesh-ancestor
91941383|NCT02281721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941385|NCT01642732|Everolimus|everolimus|mesh-list
91941386|NCT01642732|Leuprolide|leuprolide|mesh-list
91941387|NCT01642732|Bicalutamide|bicalutamide|mesh-list
91941388|NCT01642732|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91941389|NCT01642732|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91941390|NCT01642732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945340|NCT03529097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941391|NCT01642732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941392|NCT01642732|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91941393|NCT01642732|Immunologic Factors|immunologic factors|mesh-ancestor
91941394|NCT01642732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941395|NCT01642732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941396|NCT01642732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91941397|NCT01642732|Fertility Agents|fertility agents|mesh-ancestor
91941398|NCT01642732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91941399|NCT01642732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941401|NCT01642732|Hormone Antagonists|hormone antagonists|mesh-ancestor
91941978|NCT05668091|Protease Inhibitors|protease inhibitors|mesh-ancestor
91941402|NCT01642732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941403|NCT02281799|Mercaptopurine|mercaptopurine|mesh-list
91941404|NCT02281799|Azathioprine|azathioprine|mesh-list
91941405|NCT02281799|Antimetabolites|antimetabolites|mesh-ancestor
91941406|NCT02281799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941407|NCT02281799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91941408|NCT02281799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941409|NCT02281799|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91941410|NCT02281799|Immunologic Factors|immunologic factors|mesh-ancestor
91941411|NCT02281799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941412|NCT02281799|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91941413|NCT02281799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941414|NCT02281799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941415|NCT02283515|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91941416|NCT02283515|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91941417|NCT02283515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91941419|NCT02283515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941420|NCT02283515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91941421|NCT02283515|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91941422|NCT02283515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941423|NCT00589823|Fentanyl|fentanyl|mesh-list
91941424|NCT00589823|Morphine|morphine|mesh-list
91941425|NCT00589823|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91941426|NCT00589823|Narcotics|narcotics|mesh-ancestor
91941427|NCT00589823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941428|NCT00589823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941429|NCT00589823|Analgesics|analgesics|mesh-ancestor
91941430|NCT00589823|Sensory System Agents|sensory system agents|mesh-ancestor
91941431|NCT00589823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941432|NCT00589823|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91941433|NCT00589823|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91941434|NCT00589823|Anesthetics, General|anesthetics, general|mesh-ancestor
91941435|NCT00589823|Anesthetics|anesthetics|mesh-ancestor
91941437|NCT02190721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91941439|NCT02190721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941441|NCT00581477|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91941442|NCT00581477|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91941443|NCT03134339|Nicotine|nicotine|mesh-list
91941444|NCT03134339|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91941445|NCT03134339|Autonomic Agents|autonomic agents|mesh-ancestor
91941446|NCT03134339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941447|NCT03134339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941448|NCT03134339|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91941449|NCT03134339|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91941450|NCT03134339|Cholinergic Agents|cholinergic agents|mesh-ancestor
91941451|NCT03134339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941452|NCT03134339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941454|NCT02282267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941455|NCT02282267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91941456|NCT02282267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941457|NCT02282267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941458|NCT02283905|Voriconazole|voriconazole|mesh-list
91941459|NCT02283905|Amphotericin B|amphotericin b|mesh-list
91941460|NCT02283905|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91941461|NCT02283905|Antifungal Agents|antifungal agents|mesh-ancestor
91941462|NCT02283905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941463|NCT02283905|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91941464|NCT02283905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91941465|NCT02283905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941466|NCT02283905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941467|NCT02283905|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91941468|NCT02283905|Hormone Antagonists|hormone antagonists|mesh-ancestor
91941469|NCT02283905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941470|NCT02283905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941471|NCT02283905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91941472|NCT02283905|Amebicides|amebicides|mesh-ancestor
91941473|NCT02283905|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91941474|NCT02283905|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91941475|NCT02283905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91941477|NCT03480997|Albuterol|albuterol|mesh-list
91941478|NCT03480997|Ipratropium|ipratropium|mesh-list
91941479|NCT03480997|Anticonvulsants|anticonvulsants|mesh-ancestor
91941480|NCT03480997|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91941482|NCT03480997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941483|NCT03480997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941484|NCT03480997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91941485|NCT03480997|Respiratory System Agents|respiratory system agents|mesh-ancestor
91941487|NCT03480997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91941488|NCT03480997|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91941489|NCT03480997|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91941490|NCT03480997|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91941493|NCT03480997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941494|NCT03480997|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91941495|NCT03480997|Cholinergic Agents|cholinergic agents|mesh-ancestor
91941496|NCT04660747|Anticoagulants|anticoagulants|mesh-list
91941497|NCT02348008|Bevacizumab|bevacizumab|mesh-list
91941499|NCT02348008|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941500|NCT02348008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941501|NCT02348008|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91941503|NCT02348008|Growth Substances|growth substances|mesh-ancestor
91941504|NCT02348008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941505|NCT02348008|Growth Inhibitors|growth inhibitors|mesh-ancestor
91941506|NCT02348008|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91941507|NCT02348008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941508|NCT00569387|Vaccines|vaccines|mesh-list
91941509|NCT00569387|Immunologic Factors|immunologic factors|mesh-ancestor
91941510|NCT00569387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941511|NCT04468087|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91941512|NCT04468087|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91941513|NCT04468087|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91941516|NCT04468087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941517|NCT04468087|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91941518|NCT04468087|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91941519|NCT04468087|Antiviral Agents|antiviral agents|mesh-ancestor
91941520|NCT04468087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941521|NCT05944926|Fluoxetine|fluoxetine|mesh-list
91941522|NCT05944926|Antidepressive Agents|antidepressive agents|mesh-list
91941523|NCT05944926|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91941524|NCT05944926|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91941525|NCT05944926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941526|NCT05944926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941527|NCT05944926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941528|NCT05944926|Serotonin Agents|serotonin agents|mesh-ancestor
91941529|NCT05944926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941530|NCT05944926|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91941531|NCT05944926|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91941532|NCT05944926|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91941533|NCT05944926|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91941534|NCT05944926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941535|NCT05944887|Lidocaine|lidocaine|mesh-list
91941536|NCT05944887|Propofol|propofol|mesh-list
91941538|NCT05944887|Anesthetics|anesthetics|mesh-ancestor
91941539|NCT05944887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941540|NCT05944887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941542|NCT05944887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941543|NCT05944887|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91945341|NCT03529097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941544|NCT05944887|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91941545|NCT05944887|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91941546|NCT05944887|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941547|NCT05944887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941548|NCT05944887|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91941549|NCT05944887|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91941550|NCT05944887|Anesthetics, General|anesthetics, general|mesh-ancestor
91941551|NCT05944783|Dasatinib|dasatinib|mesh-list
91941552|NCT05944783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941553|NCT05944783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91941554|NCT05944783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941555|NCT05944783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941556|NCT05944458|Acetylcysteine|acetylcysteine|mesh-list
91941557|NCT05944458|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91941558|NCT05944458|Antiviral Agents|antiviral agents|mesh-ancestor
91941559|NCT05944458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941560|NCT05944458|Expectorants|expectorants|mesh-ancestor
91941561|NCT05944458|Respiratory System Agents|respiratory system agents|mesh-ancestor
91941562|NCT05944458|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91941563|NCT05944458|Antioxidants|antioxidants|mesh-ancestor
91941564|NCT05944458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941565|NCT05944458|Protective Agents|protective agents|mesh-ancestor
91941566|NCT05944458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941567|NCT05944458|Antidotes|antidotes|mesh-ancestor
91941568|NCT05944393|Ropivacaine|ropivacaine|mesh-list
91941569|NCT05944393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91941570|NCT05944393|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941571|NCT05944393|Anesthetics|anesthetics|mesh-ancestor
91941572|NCT05944393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941573|NCT05944393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941574|NCT05944393|Sensory System Agents|sensory system agents|mesh-ancestor
91941575|NCT05944393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941577|NCT05944380|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941578|NCT05944380|Anesthetics|anesthetics|mesh-ancestor
91945342|NCT03529097|Analgesics|analgesics|mesh-ancestor
91941579|NCT05944380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941580|NCT05944380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941581|NCT05944380|Sensory System Agents|sensory system agents|mesh-ancestor
91941582|NCT05944380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941584|NCT05944341|Epinephrine|epinephrine|mesh-list
91941585|NCT05944341|Racepinephrine|racepinephrine|mesh-list
91941586|NCT05944341|Carticaine|carticaine|mesh-list
91941587|NCT05944341|Epinephryl borate|epinephryl borate|mesh-list
91941588|NCT05944341|Anesthetics, Local|anesthetics, local|mesh-ancestor
91941589|NCT05944341|Anesthetics|anesthetics|mesh-ancestor
91941590|NCT05944341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941591|NCT05944341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941593|NCT05944341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941594|NCT05944341|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91941595|NCT05944341|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91941597|NCT05944341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941598|NCT05944341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941599|NCT05944341|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91941600|NCT05944341|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91941601|NCT05944341|Adrenergic Agents|adrenergic agents|mesh-ancestor
91941602|NCT05944341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941603|NCT05944341|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91941604|NCT05944341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91941605|NCT05944341|Autonomic Agents|autonomic agents|mesh-ancestor
91941606|NCT05944341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91941607|NCT05944341|Respiratory System Agents|respiratory system agents|mesh-ancestor
91941609|NCT05944341|Sympathomimetics|sympathomimetics|mesh-ancestor
91941610|NCT05944341|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91941611|NCT05944237|Atezolizumab|atezolizumab|mesh-list
91941612|NCT05944237|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945343|NCT03529097|Sensory System Agents|sensory system agents|mesh-ancestor
91941613|NCT05944237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941614|NCT05944237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941615|NCT05944237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941617|NCT05944146|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91941618|NCT05944146|Sympathomimetics|sympathomimetics|mesh-ancestor
91941619|NCT05944146|Autonomic Agents|autonomic agents|mesh-ancestor
91941620|NCT05944146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941621|NCT05944146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941622|NCT05944146|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91941623|NCT05944146|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91941624|NCT05944146|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91941625|NCT05944146|Adrenergic Agents|adrenergic agents|mesh-ancestor
91941626|NCT05944146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941627|NCT05944146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941628|NCT05944146|Protective Agents|protective agents|mesh-ancestor
91941629|NCT05944016|Dapagliflozin|dapagliflozin|mesh-list
91944030|NCT00437021|Antiviral Agents|antiviral agents|mesh-ancestor
91941630|NCT05944016|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91941631|NCT05944016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941632|NCT05944016|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91941633|NCT05944016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941635|NCT05943990|Fludarabine|fludarabine|mesh-list
91941636|NCT05943990|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91941637|NCT05943990|Immunologic Factors|immunologic factors|mesh-ancestor
91941638|NCT05943990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941639|NCT05943990|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941640|NCT05943990|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91941641|NCT05943990|Alkylating Agents|alkylating agents|mesh-ancestor
91941642|NCT05943990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941643|NCT05943990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941644|NCT05943990|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91941646|NCT05943821|Antimetabolites|antimetabolites|mesh-ancestor
91941647|NCT05943821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941648|NCT05943821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941649|NCT05943821|Gout Suppressants|gout suppressants|mesh-ancestor
91941650|NCT05943821|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941651|NCT05943821|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91941652|NCT05943821|Antioxidants|antioxidants|mesh-ancestor
91941653|NCT05943821|Protective Agents|protective agents|mesh-ancestor
91941654|NCT05943821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941655|NCT05943795|Docetaxel|docetaxel|mesh-list
91941656|NCT05943795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941657|NCT05943795|Tubulin Modulators|tubulin modulators|mesh-ancestor
91941658|NCT05943795|Antimitotic Agents|antimitotic agents|mesh-ancestor
91941659|NCT05943795|Mitosis Modulators|mitosis modulators|mesh-ancestor
91941660|NCT05943795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941661|NCT05943691|Dexamethasone|dexamethasone|mesh-list
91941662|NCT05943691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941663|NCT05943691|Antiemetics|antiemetics|mesh-ancestor
91941664|NCT05943691|Autonomic Agents|autonomic agents|mesh-ancestor
91941665|NCT05943691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941666|NCT05943691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941667|NCT05943691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91941668|NCT05943691|Glucocorticoids|glucocorticoids|mesh-ancestor
91941669|NCT05943691|Hormones|hormones|mesh-ancestor
91941670|NCT05943691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941671|NCT05943691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941672|NCT05943691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941673|NCT05943613|Clonidine|clonidine|mesh-list
91941674|NCT05943613|Analgesics|analgesics|mesh-ancestor
91941675|NCT05943613|Sensory System Agents|sensory system agents|mesh-ancestor
91941676|NCT05943613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941677|NCT05943613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941678|NCT05943613|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91941679|NCT05943613|Sympatholytics|sympatholytics|mesh-ancestor
91941680|NCT05943613|Autonomic Agents|autonomic agents|mesh-ancestor
91941681|NCT05943613|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91941682|NCT05943613|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91941683|NCT05943613|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91941684|NCT05943613|Adrenergic Agents|adrenergic agents|mesh-ancestor
91941685|NCT05943613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941686|NCT05943613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941688|NCT05943535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91941691|NCT05943470|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91941692|NCT05943457|Vitamin K|vitamin k|mesh-list
91941693|NCT05943457|Vitamin K 2|vitamin k 2|mesh-list
91941694|NCT05943457|Menaquinone 7|menaquinone 7|mesh-list
91941695|NCT05943457|Vitamins|vitamins|mesh-ancestor
91941696|NCT05943457|Micronutrients|micronutrients|mesh-ancestor
91941697|NCT05943457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941698|NCT05943457|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91941699|NCT05943457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91945344|NCT03529097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941700|NCT05943457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941701|NCT05943457|Hemostatics|hemostatics|mesh-ancestor
91941702|NCT05943457|Coagulants|coagulants|mesh-ancestor
91941703|NCT05943379|Gemcitabine|gemcitabine|mesh-list
91941704|NCT05943379|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91941705|NCT05943379|Antimetabolites|antimetabolites|mesh-ancestor
91941706|NCT05943379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941707|NCT05943379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941708|NCT05943353|Pentoxifylline|pentoxifylline|mesh-list
91941709|NCT05943353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91941710|NCT05943353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941711|NCT05943353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941712|NCT05943353|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91941713|NCT05943353|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91941714|NCT05943353|Protective Agents|protective agents|mesh-ancestor
91941715|NCT05943353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941716|NCT05943353|Vasodilator Agents|vasodilator agents|mesh-ancestor
91941717|NCT05943353|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91941719|NCT05943223|Metronidazole|metronidazole|mesh-list
91941720|NCT05943223|Ceftriaxone|ceftriaxone|mesh-list
91941722|NCT05943223|Piperacillin|piperacillin|mesh-list
91941723|NCT05943223|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91941724|NCT05943223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941725|NCT05943223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91941726|NCT05943223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91941727|NCT05943223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91941728|NCT05943223|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91941729|NCT05943223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941730|NCT05943223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941733|NCT05943158|Inositol|inositol|mesh-list
91941734|NCT05943158|Hematinics|hematinics|mesh-ancestor
91941735|NCT05943158|Vitamins|vitamins|mesh-ancestor
91941736|NCT05943158|Micronutrients|micronutrients|mesh-ancestor
91941737|NCT05943158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941738|NCT05943106|Durvalumab|durvalumab|mesh-list
91941739|NCT05943106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941740|NCT05943106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941741|NCT05941949|Vitamins|vitamins|mesh-list
91941742|NCT05941949|Vitamin E|vitamin e|mesh-list
91941743|NCT05941949|Tocopherols|tocopherols|mesh-list
91941744|NCT05941949|Tocotrienols|tocotrienols|mesh-list
91941745|NCT05941949|alpha-Tocopherol|alpha-tocopherol|mesh-list
91941746|NCT05941949|Micronutrients|micronutrients|mesh-ancestor
91941747|NCT05941949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941748|NCT05941949|Antioxidants|antioxidants|mesh-ancestor
91944049|NCT02287181|Propofol|propofol|mesh-list
91941749|NCT05941949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941750|NCT05941949|Protective Agents|protective agents|mesh-ancestor
91941751|NCT05939674|Flumazenil|flumazenil|mesh-list
91941752|NCT05939674|Antidotes|antidotes|mesh-ancestor
91941753|NCT05939674|Protective Agents|protective agents|mesh-ancestor
91941754|NCT05939674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941755|NCT05939674|GABA Modulators|gaba modulators|mesh-ancestor
91941756|NCT05939674|GABA Agents|gaba agents|mesh-ancestor
91941757|NCT05939674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941758|NCT05939674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941759|NCT05939635|Morphine|morphine|mesh-list
91941760|NCT05939635|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91941761|NCT05939635|Narcotics|narcotics|mesh-ancestor
91941762|NCT05939635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941763|NCT05939635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941764|NCT05939635|Analgesics|analgesics|mesh-ancestor
91941765|NCT05939635|Sensory System Agents|sensory system agents|mesh-ancestor
91941766|NCT05939635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941767|NCT05939622|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
91941769|NCT05939622|Immunologic Factors|immunologic factors|mesh-ancestor
91941770|NCT05939622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941771|NCT05939544|Milk fat globule|milk fat globule|mesh-list
91941772|NCT05939544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941774|NCT05939193|Diuretics|diuretics|mesh-ancestor
91941775|NCT05939193|Natriuretic Agents|natriuretic agents|mesh-ancestor
91941776|NCT05939193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941782|NCT05938387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941783|NCT05920213|Lactulose|lactulose|mesh-list
91941784|NCT05920213|N-Methylaspartate|n-methylaspartate|mesh-list
91941785|NCT05920213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91941786|NCT05920213|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
91941787|NCT05920213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91941788|NCT05920213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941789|NCT05920213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941790|NCT05920213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941804|NCT05901714|Midazolam|midazolam|mesh-list
91941805|NCT05901714|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91941806|NCT05901714|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91941807|NCT05901714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941808|NCT05901714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941809|NCT05901714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91941810|NCT05901714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91941811|NCT05901714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91941812|NCT05901714|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91941813|NCT05901714|Anesthetics, General|anesthetics, general|mesh-ancestor
91941814|NCT05901714|Anesthetics|anesthetics|mesh-ancestor
91941815|NCT05901714|GABA Modulators|gaba modulators|mesh-ancestor
91941816|NCT05901714|GABA Agents|gaba agents|mesh-ancestor
91941817|NCT05901714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941818|NCT05901714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941819|NCT05901714|Anticonvulsants|anticonvulsants|mesh-ancestor
91941820|NCT05901714|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91941821|NCT05901714|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91941822|NCT05901714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941823|NCT05901714|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91941824|NCT05901714|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91941825|NCT05898399|Olaparib|olaparib|mesh-list
91941826|NCT05898399|Talazoparib|talazoparib|mesh-list
91941827|NCT05898399|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91941828|NCT05898399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941829|NCT05898399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941830|NCT05898399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941831|NCT05893862|Moxifloxacin|moxifloxacin|mesh-list
91941832|NCT05893862|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91941833|NCT05893862|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941834|NCT05893862|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91941835|NCT05893862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91941836|NCT05893862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941837|NCT05893862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941838|NCT05893862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941840|NCT05866627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91941841|NCT05866627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91941842|NCT05866627|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91941843|NCT05866627|Histamine Antagonists|histamine antagonists|mesh-ancestor
91941844|NCT05866627|Histamine Agents|histamine agents|mesh-ancestor
91941845|NCT05866627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941846|NCT05866627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941847|NCT05866627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941848|NCT05856331|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
91941849|NCT05856331|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91941850|NCT05856331|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91941851|NCT05856331|Protease Inhibitors|protease inhibitors|mesh-ancestor
91941852|NCT05856331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941853|NCT05856331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941854|NCT05838391|Fluorouracil|fluorouracil|mesh-list
91941855|NCT05838391|Capecitabine|capecitabine|mesh-list
91941856|NCT05838391|Mitomycins|mitomycins|mesh-list
91941857|NCT05838391|Mitomycin|mitomycin|mesh-list
91941859|NCT05838391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941860|NCT05838391|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91941861|NCT05838391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941862|NCT05838391|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91941863|NCT05838391|Immunologic Factors|immunologic factors|mesh-ancestor
91941864|NCT05838391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941865|NCT05838391|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91941866|NCT05838391|Alkylating Agents|alkylating agents|mesh-ancestor
91941867|NCT05838391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91941868|NCT05838391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941870|NCT05837455|Taxane|taxane|mesh-list
91941871|NCT05837455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91941872|NCT05837455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941873|NCT05837455|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91941874|NCT05837455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91941875|NCT05837455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941876|NCT05837455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941877|NCT05837455|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91941878|NCT05837455|Hormone Antagonists|hormone antagonists|mesh-ancestor
91945345|NCT03529097|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91941879|NCT05837455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91941880|NCT05837455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941882|NCT05813327|Mesna|mesna|mesh-list
91941883|NCT05813327|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91941884|NCT05813327|Alkylating Agents|alkylating agents|mesh-ancestor
91941885|NCT05813327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941887|NCT05813327|Protective Agents|protective agents|mesh-ancestor
91941888|NCT05813327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941889|NCT05803421|Insulin Glargine|insulin glargine|mesh-list
91941890|NCT05803421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91941891|NCT05803421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941892|NCT05799144|Pembrolizumab|pembrolizumab|mesh-list
91941893|NCT05799144|Vaccines|vaccines|mesh-list
91941894|NCT05799144|Immunologic Factors|immunologic factors|mesh-ancestor
91941895|NCT05799144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941896|NCT05799144|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941897|NCT05799144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941898|NCT05799144|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91941899|NCT05799144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941901|NCT05797506|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91941902|NCT05797506|Protective Agents|protective agents|mesh-ancestor
91941903|NCT05797506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941904|NCT05797506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941905|NCT05794230|Vaccines|vaccines|mesh-list
91941906|NCT05794230|Immunologic Factors|immunologic factors|mesh-ancestor
91941907|NCT05794230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945346|NCT03529097|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91941910|NCT05784753|Immunologic Factors|immunologic factors|mesh-ancestor
91941912|NCT05768360|Metformin|metformin|mesh-list
91941913|NCT05768360|Digoxin|digoxin|mesh-list
91941914|NCT05768360|Furosemide|furosemide|mesh-list
91941915|NCT05768360|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91941916|NCT05768360|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91941917|NCT05768360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941918|NCT05768360|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91941919|NCT05768360|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91941920|NCT05768360|Antimetabolites|antimetabolites|mesh-ancestor
91941921|NCT05768360|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941923|NCT05768360|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91941924|NCT05768360|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941925|NCT05768360|Diuretics|diuretics|mesh-ancestor
91941926|NCT05768360|Natriuretic Agents|natriuretic agents|mesh-ancestor
91941927|NCT05768360|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91941928|NCT05768360|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91941929|NCT05768360|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91941931|NCT05768360|Protective Agents|protective agents|mesh-ancestor
91941933|NCT05756972|Pemetrexed|pemetrexed|mesh-list
91941934|NCT05756972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941935|NCT05756972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941936|NCT05756972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941937|NCT05756972|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91941938|NCT05756972|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91941939|NCT05737693|Midazolam|midazolam|mesh-list
91941941|NCT05737693|Analgesics|analgesics|mesh-ancestor
91941942|NCT05737693|Sensory System Agents|sensory system agents|mesh-ancestor
91941943|NCT05737693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91941944|NCT05737693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941945|NCT05737693|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91941946|NCT05737693|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91941947|NCT05737693|Anesthetics, General|anesthetics, general|mesh-ancestor
91941949|NCT05737693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941950|NCT05737693|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91941951|NCT05737693|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91941952|NCT05737693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941953|NCT05737693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941954|NCT05737693|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91941955|NCT05737693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91941957|NCT05737693|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91941958|NCT05737693|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91941959|NCT05737693|GABA Modulators|gaba modulators|mesh-ancestor
91941960|NCT05737693|GABA Agents|gaba agents|mesh-ancestor
91941961|NCT05708950|Pembrolizumab|pembrolizumab|mesh-list
91941962|NCT05708950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91941963|NCT05708950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91941964|NCT05708950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945347|NCT03529097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91941965|NCT05708950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941966|NCT05689827|3-(2,2,2-trimethylhydrazine)propionate|3-(2,2,2-trimethylhydrazine)propionate|mesh-list
91941967|NCT05689827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91941968|NCT05689827|Immunologic Factors|immunologic factors|mesh-ancestor
91945348|NCT03529097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91941969|NCT05689827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941970|NCT05682443|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
91941971|NCT05682443|Chelating Agents|chelating agents|mesh-ancestor
91941972|NCT05682443|Sequestering Agents|sequestering agents|mesh-ancestor
91941973|NCT05682443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941974|NCT05668091|Ritonavir|ritonavir|mesh-list
91941975|NCT05668091|Nirmatrelvir|nirmatrelvir|mesh-list
91941976|NCT05668091|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91941977|NCT05668091|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91941979|NCT05668091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91941980|NCT05668091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941981|NCT05668091|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91941982|NCT05668091|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91941983|NCT05668091|Antiviral Agents|antiviral agents|mesh-ancestor
91941984|NCT05668091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91941985|NCT05668091|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91941986|NCT05668091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91941987|NCT05656534|Suvorexant|suvorexant|mesh-list
91941988|NCT05656534|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91941989|NCT05656534|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91941990|NCT05656534|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91941991|NCT05656534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941992|NCT05656534|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
91941993|NCT05656534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91941994|NCT05656534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91941995|NCT05653050|Insulin|insulin|mesh-list
91941996|NCT05653050|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91941997|NCT05653050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91941998|NCT05651607|Cannabidiol|cannabidiol|mesh-list
91941999|NCT05651607|Anticonvulsants|anticonvulsants|mesh-ancestor
91942000|NCT05650736|Abrocitinib|abrocitinib|mesh-list
91942001|NCT05650736|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91942002|NCT05650736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942003|NCT05650736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942005|NCT05648006|Capecitabine|capecitabine|mesh-list
91942006|NCT05648006|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942007|NCT05648006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942008|NCT05648006|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942009|NCT05648006|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942010|NCT05648006|Growth Substances|growth substances|mesh-ancestor
91942011|NCT05648006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942012|NCT05648006|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942013|NCT05648006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942014|NCT05648006|Antimetabolites|antimetabolites|mesh-ancestor
91942015|NCT05648006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942016|NCT05644626|Tislelizumab|tislelizumab|mesh-list
91942017|NCT05644626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942018|NCT05644626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942019|NCT05627232|Diphenhydramine|diphenhydramine|mesh-list
91942021|NCT05627232|Cytarabine|cytarabine|mesh-list
91942022|NCT05627232|Daunorubicin|daunorubicin|mesh-list
91942023|NCT05627232|Palbociclib|palbociclib|mesh-list
91942024|NCT05627232|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942025|NCT05627232|Antimetabolites|antimetabolites|mesh-ancestor
91942026|NCT05627232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942027|NCT05627232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942028|NCT05627232|Antiviral Agents|antiviral agents|mesh-ancestor
91942029|NCT05627232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942030|NCT05627232|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942031|NCT05627232|Immunologic Factors|immunologic factors|mesh-ancestor
91942032|NCT05627232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942033|NCT05627232|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91942034|NCT05627232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91942035|NCT05627232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91942036|NCT05627232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942037|NCT05627232|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91942038|NCT05627232|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91942039|NCT05627232|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91942040|NCT05627232|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942041|NCT05627232|Anesthetics, Local|anesthetics, local|mesh-ancestor
91942042|NCT05627232|Anesthetics|anesthetics|mesh-ancestor
91942043|NCT05627232|Sensory System Agents|sensory system agents|mesh-ancestor
91942044|NCT05627232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942045|NCT05627232|Antiemetics|antiemetics|mesh-ancestor
91942046|NCT05627232|Autonomic Agents|autonomic agents|mesh-ancestor
91942047|NCT05627232|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91942048|NCT05627232|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91942049|NCT05627232|Histamine Antagonists|histamine antagonists|mesh-ancestor
91942050|NCT05627232|Histamine Agents|histamine agents|mesh-ancestor
91942051|NCT05627232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942052|NCT05627232|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91942053|NCT05627232|Antipruritics|antipruritics|mesh-ancestor
91942054|NCT05627232|Dermatologic Agents|dermatologic agents|mesh-ancestor
91942055|NCT05626322|Lenalidomide|lenalidomide|mesh-list
91942056|NCT05626322|Immunologic Factors|immunologic factors|mesh-ancestor
91942057|NCT05626322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942058|NCT05626322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942059|NCT05626322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942060|NCT05626322|Growth Substances|growth substances|mesh-ancestor
91942061|NCT05626322|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942062|NCT05626322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942063|NCT05625412|Docetaxel|docetaxel|mesh-list
91942064|NCT05625412|Capecitabine|capecitabine|mesh-list
91942065|NCT05625412|Nivolumab|nivolumab|mesh-list
91942066|NCT05625412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942067|NCT05625412|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942068|NCT05625412|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942069|NCT05625412|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942070|NCT05625412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942071|NCT05625412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942072|NCT05625412|Antimetabolites|antimetabolites|mesh-ancestor
91942073|NCT05625412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942074|NCT05625412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942075|NCT05624528|Tolcapone|tolcapone|mesh-list
91942076|NCT05624528|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91942077|NCT05624528|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91942078|NCT05624528|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
91942079|NCT05624528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942080|NCT05624528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942081|NCT05602818|Alprazolam|alprazolam|mesh-list
91942082|NCT05602818|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91942083|NCT05602818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942084|NCT05602818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942085|NCT05602818|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91942086|NCT05602818|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91942087|NCT05602818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91942089|NCT05602818|GABA Agents|gaba agents|mesh-ancestor
91942090|NCT05602818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942091|NCT05602818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942092|NCT05600426|Cyclosporine|cyclosporine|mesh-list
91942093|NCT05600426|Cyclophosphamide|cyclophosphamide|mesh-list
91942094|NCT05600426|Methotrexate|methotrexate|mesh-list
91942095|NCT05600426|Fludarabine|fludarabine|mesh-list
91942096|NCT05600426|Cyclosporins|cyclosporins|mesh-list
91942097|NCT05600426|Thymoglobulin|thymoglobulin|mesh-list
91942098|NCT05600426|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91942099|NCT05600426|Immunosuppressive Agents|immunosuppressive agents|mesh-list
91942101|NCT05600426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942102|NCT05600426|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942103|NCT05600426|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942104|NCT05600426|Alkylating Agents|alkylating agents|mesh-ancestor
91945349|NCT03529097|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91945350|NCT03529097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942105|NCT05600426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942106|NCT05600426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942107|NCT05600426|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91942108|NCT05600426|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91942109|NCT05600426|Abortifacient Agents|abortifacient agents|mesh-ancestor
91942110|NCT05600426|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91942111|NCT05600426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942112|NCT05600426|Antimetabolites|antimetabolites|mesh-ancestor
91942113|NCT05600426|Dermatologic Agents|dermatologic agents|mesh-ancestor
91942114|NCT05600426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942115|NCT05600426|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91942116|NCT05600426|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91942117|NCT05600426|Antifungal Agents|antifungal agents|mesh-ancestor
91942118|NCT05600426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942119|NCT05600426|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91942120|NCT05592379|Psilocybin|psilocybin|mesh-list
91942121|NCT05592379|Hallucinogens|hallucinogens|mesh-ancestor
91942122|NCT05592379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942123|NCT05592379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91942124|NCT05590793|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91942125|NCT05590793|Luteolytic Agents|luteolytic agents|mesh-ancestor
91942126|NCT05590793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91942127|NCT05590793|Contraceptive Agents|contraceptive agents|mesh-ancestor
91942128|NCT05590793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91942129|NCT05590793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942130|NCT05590793|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91942540|NCT04975308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942131|NCT05590793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942132|NCT05590793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942133|NCT05569954|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91942135|NCT05569954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942136|NCT05568407|Avelumab|avelumab|mesh-list
91942137|NCT05568407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942138|NCT05568407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942140|NCT05567094|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942142|NCT05567094|Autonomic Agents|autonomic agents|mesh-ancestor
91942144|NCT05567094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942145|NCT05567094|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91942146|NCT05567094|Glucocorticoids|glucocorticoids|mesh-ancestor
91942147|NCT05567094|Hormones|hormones|mesh-ancestor
91942148|NCT05567094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942149|NCT05567094|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942150|NCT05567094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942151|NCT05550246|Oxybutynin|oxybutynin|mesh-list
91942152|NCT05550246|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91942153|NCT05550246|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91942154|NCT05550246|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91942155|NCT05550246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91942156|NCT05550246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942157|NCT05550246|Adrenergic Agents|adrenergic agents|mesh-ancestor
91942158|NCT05550246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942159|NCT05550246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942160|NCT05550246|Parasympatholytics|parasympatholytics|mesh-ancestor
91942161|NCT05550246|Autonomic Agents|autonomic agents|mesh-ancestor
91942162|NCT05550246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942163|NCT05550246|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91942164|NCT05550246|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91942165|NCT05550246|Cholinergic Agents|cholinergic agents|mesh-ancestor
91942166|NCT05550246|Urological Agents|urological agents|mesh-ancestor
91942168|NCT05537220|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91942170|NCT05537220|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942171|NCT05537220|Expectorants|expectorants|mesh-ancestor
91942172|NCT05537220|Respiratory System Agents|respiratory system agents|mesh-ancestor
91942173|NCT05537220|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91942174|NCT05537220|Antioxidants|antioxidants|mesh-ancestor
91942175|NCT05537220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942176|NCT05537220|Protective Agents|protective agents|mesh-ancestor
91942177|NCT05537220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942178|NCT05537220|Antidotes|antidotes|mesh-ancestor
91942179|NCT05536804|Tirzepatide|tirzepatide|mesh-list
91942180|NCT05536804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942181|NCT05536804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942182|NCT05536804|Incretins|incretins|mesh-ancestor
91942183|NCT05536804|Hormones|hormones|mesh-ancestor
91942184|NCT05536804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942185|NCT05514535|Insulin Glargine|insulin glargine|mesh-list
91942186|NCT05514535|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942187|NCT05514535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942188|NCT05463744|Insulin|insulin|mesh-list
91942189|NCT05463744|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91942190|NCT05463744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942191|NCT05463744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942192|NCT05446129|Pembrolizumab|pembrolizumab|mesh-list
91942193|NCT05446129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942194|NCT05446129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942195|NCT05446129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942196|NCT05446129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942197|NCT05430399|Docetaxel|docetaxel|mesh-list
91942198|NCT05430399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942199|NCT05430399|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942200|NCT05430399|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942201|NCT05430399|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942202|NCT05430399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942203|NCT05403476|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91942204|NCT05403476|Hormones|hormones|mesh-ancestor
91942205|NCT05403476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942206|NCT05403476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942207|NCT05401227|Ketamine|ketamine|mesh-list
91942208|NCT05401227|Analgesics|analgesics|mesh-ancestor
91942209|NCT05401227|Sensory System Agents|sensory system agents|mesh-ancestor
91942210|NCT05401227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942211|NCT05401227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942212|NCT05401227|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91942213|NCT05401227|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91944104|NCT00364247|Tapentadol|tapentadol|mesh-list
91942214|NCT05401227|Anesthetics, General|anesthetics, general|mesh-ancestor
91942215|NCT05401227|Anesthetics|anesthetics|mesh-ancestor
91942216|NCT05401227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942217|NCT05401227|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91942219|NCT05401227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942220|NCT05401227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942221|NCT05399329|Palbociclib|palbociclib|mesh-list
91942222|NCT05399329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942223|NCT05399329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91942224|NCT05399329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942225|NCT05399329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942226|NCT05386888|Paclitaxel|paclitaxel|mesh-list
91942227|NCT05386888|Carboplatin|carboplatin|mesh-list
91942228|NCT05386888|Pemetrexed|pemetrexed|mesh-list
91942229|NCT05386888|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942230|NCT05386888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942231|NCT05386888|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942232|NCT05386888|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942233|NCT05386888|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942234|NCT05386888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942235|NCT05386888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942236|NCT05386888|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91942237|NCT05386888|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91942239|NCT05374291|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91942240|NCT05374291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942241|NCT05374291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942242|NCT05374291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942243|NCT05364424|Rituximab|rituximab|mesh-list
91942244|NCT05364424|Obinutuzumab|obinutuzumab|mesh-list
91942246|NCT05364424|Etoposide|etoposide|mesh-list
91942247|NCT05364424|Ifosfamide|ifosfamide|mesh-list
91942248|NCT05364424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942249|NCT05364424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942250|NCT05364424|Immunologic Factors|immunologic factors|mesh-ancestor
91942252|NCT05364424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942253|NCT05364424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942254|NCT05364424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91942255|NCT05364424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91942256|NCT05364424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942257|NCT05364424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942258|NCT05364424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942259|NCT05364424|Alkylating Agents|alkylating agents|mesh-ancestor
91942261|NCT05362058|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91942262|NCT05362058|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942263|NCT05362058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942264|NCT05354674|Bevacizumab|bevacizumab|mesh-list
91942265|NCT05354674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942266|NCT05354674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942267|NCT05354674|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942268|NCT05354674|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942269|NCT05354674|Growth Substances|growth substances|mesh-ancestor
91942270|NCT05354674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942271|NCT05354674|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942272|NCT05352672|Pembrolizumab|pembrolizumab|mesh-list
91942273|NCT05352672|Cemiplimab|cemiplimab|mesh-list
91942274|NCT05352672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942275|NCT05352672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942276|NCT05352672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942277|NCT05352672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942278|NCT05350774|Immunoglobulins|immunoglobulins|mesh-list
91942281|NCT05350774|gamma-Globulins|gamma-globulins|mesh-list
91942282|NCT05350774|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91942283|NCT05350774|Immunologic Factors|immunologic factors|mesh-ancestor
91942284|NCT05350774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942285|NCT05344469|Interferons|interferons|mesh-list
91942286|NCT05344469|Interferon-beta|interferon-beta|mesh-list
91942287|NCT05344469|Ofatumumab|ofatumumab|mesh-list
91942288|NCT05344469|Glatiramer Acetate|glatiramer acetate|mesh-list
91942289|NCT05344469|(T,G)-A-L|(t,g)-a-l|mesh-list
91942290|NCT05344469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942291|NCT05344469|Antiviral Agents|antiviral agents|mesh-ancestor
91942292|NCT05344469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942293|NCT05344469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91942294|NCT05344469|Immunologic Factors|immunologic factors|mesh-ancestor
91942295|NCT05344469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942296|NCT05344469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942297|NCT05344469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942299|NCT05334329|Fludarabine|fludarabine|mesh-list
91942300|NCT05334329|Atezolizumab|atezolizumab|mesh-list
91942301|NCT05334329|Antineoplastic Agents|antineoplastic agents|mesh-list
91942302|NCT05334329|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91942303|NCT05334329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942304|NCT05334329|Immunologic Factors|immunologic factors|mesh-ancestor
91942305|NCT05334329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942306|NCT05334329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942307|NCT05334329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942308|NCT05334329|Alkylating Agents|alkylating agents|mesh-ancestor
91942309|NCT05334329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942310|NCT05334329|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91942311|NCT05334329|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942312|NCT05334329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942313|NCT05293041|Arginine Vasopressin|arginine vasopressin|mesh-list
91942315|NCT05293041|Coagulants|coagulants|mesh-ancestor
91942316|NCT05293041|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91942317|NCT05293041|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
91942318|NCT05293041|Natriuretic Agents|natriuretic agents|mesh-ancestor
91942319|NCT05293041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942320|NCT05288166|Prednisone|prednisone|mesh-list
91942321|NCT05288166|Prednisolone|prednisolone|mesh-list
91942322|NCT05288166|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942323|NCT05288166|Glucocorticoids|glucocorticoids|mesh-ancestor
91942324|NCT05288166|Hormones|hormones|mesh-ancestor
91942325|NCT05288166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942326|NCT05288166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942327|NCT05288166|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942328|NCT05288166|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942329|NCT05279417|Methotrexate|methotrexate|mesh-list
91942330|NCT05279417|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91942331|NCT05279417|Abortifacient Agents|abortifacient agents|mesh-ancestor
91942332|NCT05279417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91942333|NCT05279417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942334|NCT05279417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942335|NCT05279417|Antimetabolites|antimetabolites|mesh-ancestor
91942336|NCT05279417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942337|NCT05279417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942338|NCT05279417|Dermatologic Agents|dermatologic agents|mesh-ancestor
91942339|NCT05279417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942340|NCT05279417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91942341|NCT05279417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942342|NCT05279417|Immunologic Factors|immunologic factors|mesh-ancestor
91942343|NCT05279417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942344|NCT05279417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91942345|NCT05269355|Dacarbazine|dacarbazine|mesh-list
91942346|NCT05269355|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942347|NCT05269355|Alkylating Agents|alkylating agents|mesh-ancestor
91942348|NCT05269355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942349|NCT05269355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942350|NCT05255653|Cisplatin|cisplatin|mesh-list
91942351|NCT05255653|Carboplatin|carboplatin|mesh-list
91942352|NCT05255653|Durvalumab|durvalumab|mesh-list
91942353|NCT05255653|Olaparib|olaparib|mesh-list
91942354|NCT05255653|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
91942356|NCT05255653|Megestrol Acetate|megestrol acetate|mesh-list
91942357|NCT05255653|Medroxyprogesterone|medroxyprogesterone|mesh-list
91942358|NCT05255653|Progestins|progestins|mesh-list
91942359|NCT05255653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942360|NCT05255653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942361|NCT05255653|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942362|NCT05255653|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91942363|NCT05255653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942364|NCT05255653|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91942365|NCT05255653|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91942366|NCT05255653|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91942368|NCT05255653|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91942369|NCT05255653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942623|NCT04852224|Androgens|androgens|mesh-list
91942370|NCT05255653|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91942371|NCT05255653|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91942372|NCT05255653|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91942373|NCT05255653|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942374|NCT05255653|Appetite Stimulants|appetite stimulants|mesh-ancestor
91942375|NCT05255653|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91942376|NCT05255653|Hormones|hormones|mesh-ancestor
91942377|NCT05255653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942378|NCT05249426|Cetuximab|cetuximab|mesh-list
91942379|NCT05249426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942381|NCT05239182|Gemcitabine|gemcitabine|mesh-list
91942382|NCT05239182|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91942383|NCT05239182|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942384|NCT05239182|Antimetabolites|antimetabolites|mesh-ancestor
91942385|NCT05239182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942386|NCT05239182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942387|NCT05236894|Nicotine|nicotine|mesh-list
91942388|NCT05236894|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91942389|NCT05236894|Autonomic Agents|autonomic agents|mesh-ancestor
91942390|NCT05236894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942391|NCT05236894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942392|NCT05236894|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91942393|NCT05236894|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91942394|NCT05236894|Cholinergic Agents|cholinergic agents|mesh-ancestor
91942395|NCT05236894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942396|NCT05236894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942397|NCT05169567|Fulvestrant|fulvestrant|mesh-list
91942398|NCT05169567|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942399|NCT05169567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942400|NCT05169567|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91942401|NCT05169567|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91942402|NCT05169567|Hormone Antagonists|hormone antagonists|mesh-ancestor
91942403|NCT05169567|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942404|NCT05169567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942405|NCT05153226|Cyclophosphamide|cyclophosphamide|mesh-list
91942406|NCT05153226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942407|NCT05153226|Immunologic Factors|immunologic factors|mesh-ancestor
91942408|NCT05153226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942409|NCT05153226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942410|NCT05153226|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942411|NCT05153226|Alkylating Agents|alkylating agents|mesh-ancestor
91942412|NCT05153226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942413|NCT05153226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942414|NCT05153226|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91942415|NCT05120349|Osimertinib|osimertinib|mesh-list
91942417|NCT05120349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91942418|NCT05120349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942419|NCT05120349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942420|NCT05109052|Bevacizumab|bevacizumab|mesh-list
91942421|NCT05109052|Atezolizumab|atezolizumab|mesh-list
91942422|NCT05109052|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942423|NCT05109052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942424|NCT05109052|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942425|NCT05109052|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942426|NCT05109052|Growth Substances|growth substances|mesh-ancestor
91942427|NCT05109052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942428|NCT05109052|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942429|NCT05109052|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942430|NCT05109052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942431|NCT05104866|Gemcitabine|gemcitabine|mesh-list
91942432|NCT05104866|Capecitabine|capecitabine|mesh-list
91942433|NCT05104866|Vinorelbine|vinorelbine|mesh-list
91942434|NCT05104866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942435|NCT05104866|Antimetabolites|antimetabolites|mesh-ancestor
91942436|NCT05104866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942437|NCT05104866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942438|NCT05104866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942439|NCT05104866|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942440|NCT05104866|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942441|NCT05104866|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942442|NCT05103358|Sirolimus|sirolimus|mesh-list
91942443|NCT05103358|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91942444|NCT05103358|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942445|NCT05103358|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91942446|NCT05103358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942464|NCT05076175|Ozanimod|ozanimod|mesh-list
91942465|NCT05076175|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91942466|NCT05076175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942468|NCT05076175|Immunologic Factors|immunologic factors|mesh-ancestor
91942469|NCT05076175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942471|NCT05072314|Anesthetics, Local|anesthetics, local|mesh-ancestor
91942472|NCT05072314|Anesthetics|anesthetics|mesh-ancestor
91942473|NCT05072314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942474|NCT05072314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942475|NCT05072314|Sensory System Agents|sensory system agents|mesh-ancestor
91942476|NCT05072314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942477|NCT05072314|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91942478|NCT05072314|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91942479|NCT05072314|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91942480|NCT05072314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91942481|NCT05072314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942482|NCT05060315|Treprostinil|treprostinil|mesh-list
91942483|NCT05060315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91942484|NCT05037929|Astegolimab|astegolimab|mesh-list
91942485|NCT05037929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91942486|NCT05037929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942487|NCT05037929|Antiviral Agents|antiviral agents|mesh-ancestor
91942488|NCT05037929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942489|NCT05032157|Remibrutinib|remibrutinib|mesh-list
91942490|NCT05032157|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91942491|NCT05032157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942492|NCT05032157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942494|NCT05024773|Hyaluronic Acid|hyaluronic acid|mesh-list
91942495|NCT05024773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942496|NCT05024773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942497|NCT05024773|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942498|NCT05024773|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942499|NCT05024773|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942500|NCT05024773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942501|NCT05024773|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91942502|NCT05024773|Immunologic Factors|immunologic factors|mesh-ancestor
91942503|NCT05024773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942504|NCT05024773|Viscosupplements|viscosupplements|mesh-ancestor
91942505|NCT05024773|Protective Agents|protective agents|mesh-ancestor
91942506|NCT05019027|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91942507|NCT05019027|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91942508|NCT05019027|Adrenergic Agents|adrenergic agents|mesh-ancestor
91942509|NCT05019027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942510|NCT05019027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942511|NCT05019027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942513|NCT05006079|Alprazolam|alprazolam|mesh-list
91942514|NCT05006079|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91942515|NCT05006079|Narcotics|narcotics|mesh-ancestor
91942516|NCT05006079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942517|NCT05006079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942518|NCT05006079|Analgesics|analgesics|mesh-ancestor
91942519|NCT05006079|Sensory System Agents|sensory system agents|mesh-ancestor
91942520|NCT05006079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942521|NCT05006079|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91942522|NCT05006079|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91942523|NCT05006079|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91942524|NCT05006079|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91942525|NCT05006079|GABA Modulators|gaba modulators|mesh-ancestor
91942526|NCT05006079|GABA Agents|gaba agents|mesh-ancestor
91942527|NCT05006079|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942528|NCT05006079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942529|NCT04975308|Fulvestrant|fulvestrant|mesh-list
91942531|NCT04975308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942532|NCT04975308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942533|NCT04975308|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91942534|NCT04975308|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91942535|NCT04975308|Hormone Antagonists|hormone antagonists|mesh-ancestor
91942536|NCT04975308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942537|NCT04975308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942538|NCT04975308|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91942539|NCT04975308|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91942541|NCT04975308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942542|NCT04962022|Ritonavir|ritonavir|mesh-list
91942543|NCT04962022|Itraconazole|itraconazole|mesh-list
91942544|NCT04962022|Nirmatrelvir|nirmatrelvir|mesh-list
91942546|NCT04962022|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91942547|NCT04962022|Protease Inhibitors|protease inhibitors|mesh-ancestor
91942548|NCT04962022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942549|NCT04962022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942550|NCT04962022|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91942551|NCT04962022|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91942552|NCT04962022|Antiviral Agents|antiviral agents|mesh-ancestor
91942553|NCT04962022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942554|NCT04962022|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91942555|NCT04962022|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91942556|NCT04962022|Antifungal Agents|antifungal agents|mesh-ancestor
91942557|NCT04962022|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91942558|NCT04962022|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91942559|NCT04962022|Hormone Antagonists|hormone antagonists|mesh-ancestor
91942560|NCT04962022|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942561|NCT04962022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942562|NCT04959175|Mycophenolic Acid|mycophenolic acid|mesh-list
91942564|NCT04959175|Cyclophosphamide|cyclophosphamide|mesh-list
91942565|NCT04959175|Fludarabine|fludarabine|mesh-list
91942566|NCT04959175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942567|NCT04959175|Immunologic Factors|immunologic factors|mesh-ancestor
91942568|NCT04959175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942569|NCT04959175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942570|NCT04959175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942571|NCT04959175|Alkylating Agents|alkylating agents|mesh-ancestor
91942572|NCT04959175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942573|NCT04959175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942574|NCT04959175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91942575|NCT04959175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91942576|NCT04959175|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91942577|NCT04959175|Antitubercular Agents|antitubercular agents|mesh-ancestor
91942578|NCT04959175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91942579|NCT04959175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942581|NCT04959175|Antifungal Agents|antifungal agents|mesh-ancestor
91942583|NCT04929808|Dermatologic Agents|dermatologic agents|mesh-ancestor
91942584|NCT04910386|Cisplatin|cisplatin|mesh-list
91942585|NCT04910386|Gemcitabine|gemcitabine|mesh-list
91942586|NCT04910386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942587|NCT04910386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942588|NCT04910386|Antimetabolites|antimetabolites|mesh-ancestor
91942589|NCT04910386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942590|NCT04903223|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91942591|NCT04903223|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91942592|NCT04903223|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91942594|NCT04903223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942595|NCT04903223|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91942596|NCT04903223|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91942597|NCT04903223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942598|NCT04895748|Everolimus|everolimus|mesh-list
91942599|NCT04895748|Spartalizumab|spartalizumab|mesh-list
91942601|NCT04895748|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91942602|NCT04895748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942603|NCT04895748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942604|NCT04895748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942605|NCT04895748|Immunologic Factors|immunologic factors|mesh-ancestor
91942606|NCT04895748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942607|NCT04895748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942608|NCT04895748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942609|NCT04895748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942610|NCT04895137|Bevacizumab|bevacizumab|mesh-list
91942611|NCT04895137|Antibodies|antibodies|mesh-list
91942612|NCT04895137|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91942613|NCT04895137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942614|NCT04895137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942616|NCT04895137|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942617|NCT04895137|Growth Substances|growth substances|mesh-ancestor
91942618|NCT04895137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942619|NCT04895137|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942620|NCT04895137|Immunologic Factors|immunologic factors|mesh-ancestor
91942622|NCT04852224|Goserelin|goserelin|mesh-list
91942624|NCT04852224|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91942625|NCT04852224|Fertility Agents|fertility agents|mesh-ancestor
91942626|NCT04852224|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91942627|NCT04852224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942628|NCT04852224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942629|NCT04852224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942630|NCT04852224|Hormones|hormones|mesh-ancestor
91942631|NCT04852224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942633|NCT04827953|Gemcitabine|gemcitabine|mesh-list
91942634|NCT04827953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942635|NCT04827953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942636|NCT04827953|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942637|NCT04827953|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942638|NCT04827953|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942639|NCT04827953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942640|NCT04827953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942641|NCT04827953|Antimetabolites|antimetabolites|mesh-ancestor
91942642|NCT04752774|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91942643|NCT04752774|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91942644|NCT04752774|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91942645|NCT04752774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942646|NCT04752774|Cholinergic Agents|cholinergic agents|mesh-ancestor
91942647|NCT04752774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942648|NCT04752774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942650|NCT04744545|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91942651|NCT04744545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91942652|NCT04744545|Analgesics|analgesics|mesh-ancestor
91942653|NCT04744545|Sensory System Agents|sensory system agents|mesh-ancestor
91942654|NCT04744545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942655|NCT04744545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942656|NCT04744545|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942657|NCT04744545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942658|NCT04744545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942659|NCT04744545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942660|NCT04744545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942661|NCT04742751|Metformin|metformin|mesh-list
91942662|NCT04742751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942663|NCT04742751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942665|NCT04740905|Faricimab|faricimab|mesh-list
91942666|NCT04740905|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942667|NCT04740905|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942668|NCT04740905|Growth Substances|growth substances|mesh-ancestor
91942669|NCT04740905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942670|NCT04740905|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942671|NCT04740905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942672|NCT04667949|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91942673|NCT04667949|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91942674|NCT04667949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942675|NCT04667949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942676|NCT04667949|Immunologic Factors|immunologic factors|mesh-ancestor
91942677|NCT04667949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942679|NCT04667117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942680|NCT04657991|Pembrolizumab|pembrolizumab|mesh-list
91942681|NCT04657991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942682|NCT04657991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942683|NCT04657991|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942684|NCT04657991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942685|NCT04650893|Dexamethasone|dexamethasone|mesh-list
91942686|NCT04650893|Ketorolac|ketorolac|mesh-list
91942687|NCT04650893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942688|NCT04650893|Antiemetics|antiemetics|mesh-ancestor
91942689|NCT04650893|Autonomic Agents|autonomic agents|mesh-ancestor
91942690|NCT04650893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942691|NCT04650893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942692|NCT04650893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91942693|NCT04650893|Glucocorticoids|glucocorticoids|mesh-ancestor
91942694|NCT04650893|Hormones|hormones|mesh-ancestor
91942695|NCT04650893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942696|NCT04650893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942697|NCT04650893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942698|NCT04650893|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91944204|NCT02256436|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91944205|NCT00343109|Sargramostim|sargramostim|mesh-list
91942699|NCT04650893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91942700|NCT04650893|Analgesics|analgesics|mesh-ancestor
91942701|NCT04650893|Sensory System Agents|sensory system agents|mesh-ancestor
91942702|NCT04650893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942703|NCT04650893|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91942705|NCT04650893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942706|NCT04632927|Ustekinumab|ustekinumab|mesh-list
91942707|NCT04632927|Dermatologic Agents|dermatologic agents|mesh-ancestor
91942708|NCT04617522|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
91942709|NCT04617522|Immunoconjugates|immunoconjugates|mesh-ancestor
91942710|NCT04617522|Immunologic Factors|immunologic factors|mesh-ancestor
91942711|NCT04617522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942713|NCT04594551|Immunoglobulins|immunoglobulins|mesh-list
91942714|NCT04594551|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91942715|NCT04594551|Antibodies|antibodies|mesh-list
91942716|NCT04594551|Immunologic Factors|immunologic factors|mesh-ancestor
91942717|NCT04594551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942718|NCT04548349|Benzoyl Peroxide|benzoyl peroxide|mesh-list
91942719|NCT04548349|Dermatologic Agents|dermatologic agents|mesh-ancestor
91942721|NCT04544449|Immunologic Factors|immunologic factors|mesh-ancestor
91942722|NCT04544449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942723|NCT04510194|Metformin|metformin|mesh-list
91942724|NCT04510194|Ivermectin|ivermectin|mesh-list
91942725|NCT04510194|Fluvoxamine|fluvoxamine|mesh-list
91942726|NCT04510194|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942727|NCT04510194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942728|NCT04510194|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91942729|NCT04510194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942730|NCT04510194|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91942731|NCT04510194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91942732|NCT04510194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942733|NCT04510194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91942734|NCT04510194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91942735|NCT04510194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91942736|NCT04510194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91942737|NCT04510194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942739|NCT04510194|Serotonin Agents|serotonin agents|mesh-ancestor
91942740|NCT04510194|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91942741|NCT04510194|Antidepressive Agents|antidepressive agents|mesh-ancestor
91942742|NCT04510194|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91942743|NCT04510194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91942744|NCT04510194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942745|NCT04510194|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91942746|NCT04502966|Immunomodulating Agents|immunomodulating agents|mesh-list
91942747|NCT04502966|Immunologic Factors|immunologic factors|mesh-list
91942748|NCT04502966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91942749|NCT04502966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942750|NCT04482803|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91942751|NCT04482803|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
91942754|NCT04482803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942755|NCT04482803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942756|NCT04482803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942757|NCT04482803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942758|NCT04462328|Durvalumab|durvalumab|mesh-list
91942759|NCT04462328|Acalabrutinib|acalabrutinib|mesh-list
91942760|NCT04462328|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942761|NCT04462328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942762|NCT04419519|Venetoclax|venetoclax|mesh-list
91942763|NCT04419519|Antibodies|antibodies|mesh-list
91942764|NCT04419519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91942765|NCT04419519|Immunologic Factors|immunologic factors|mesh-ancestor
91942766|NCT04419519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942767|NCT04419519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942768|NCT04414475|Dexamethasone|dexamethasone|mesh-list
91942769|NCT04414475|Bortezomib|bortezomib|mesh-list
91942770|NCT04414475|Pomalidomide|pomalidomide|mesh-list
91942771|NCT04414475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942772|NCT04414475|Antiemetics|antiemetics|mesh-ancestor
91942773|NCT04414475|Autonomic Agents|autonomic agents|mesh-ancestor
91942774|NCT04414475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942775|NCT04414475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942776|NCT04414475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91942778|NCT04414475|Hormones|hormones|mesh-ancestor
91942779|NCT04414475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942780|NCT04414475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942781|NCT04414475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942782|NCT04414475|Immunologic Factors|immunologic factors|mesh-ancestor
91942783|NCT04414475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942784|NCT04414475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942785|NCT04414475|Growth Substances|growth substances|mesh-ancestor
91942787|NCT04406272|Bevacizumab|bevacizumab|mesh-list
91942788|NCT04406272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942789|NCT04406272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942790|NCT04406272|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942791|NCT04406272|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942792|NCT04406272|Growth Substances|growth substances|mesh-ancestor
91942793|NCT04406272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942794|NCT04406272|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942795|NCT04398706|Vaccines|vaccines|mesh-list
91944219|NCT00405743|Cytarabine|cytarabine|mesh-list
91944220|NCT00405743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944221|NCT00405743|Antimetabolites|antimetabolites|mesh-ancestor
91944222|NCT00405743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944223|NCT00405743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944224|NCT00405743|Antiviral Agents|antiviral agents|mesh-ancestor
91944225|NCT00405743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944226|NCT00405743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942796|NCT04398706|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91942797|NCT04398706|Immunologic Factors|immunologic factors|mesh-ancestor
91942798|NCT04398706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942799|NCT04396535|Docetaxel|docetaxel|mesh-list
91942800|NCT04396535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942801|NCT04396535|Tubulin Modulators|tubulin modulators|mesh-ancestor
91942802|NCT04396535|Antimitotic Agents|antimitotic agents|mesh-ancestor
91942803|NCT04396535|Mitosis Modulators|mitosis modulators|mesh-ancestor
91942804|NCT04396535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942805|NCT04390009|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
91942806|NCT04390009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942820|NCT04357366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942822|NCT04335461|Anesthetics, Local|anesthetics, local|mesh-list
91942823|NCT04335461|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91942824|NCT04335461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942825|NCT04335461|Sensory System Agents|sensory system agents|mesh-ancestor
91942826|NCT04335461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942828|NCT04332211|Ephedrine|ephedrine|mesh-list
91942829|NCT04332211|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91942830|NCT04332211|Autonomic Agents|autonomic agents|mesh-ancestor
91942831|NCT04332211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942832|NCT04332211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942833|NCT04332211|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91942834|NCT04332211|Respiratory System Agents|respiratory system agents|mesh-ancestor
91942835|NCT04332211|Nasal Decongestants|nasal decongestants|mesh-ancestor
91942836|NCT04332211|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91942837|NCT04332211|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91942838|NCT04332211|Sympathomimetics|sympathomimetics|mesh-ancestor
91942839|NCT04332211|Adrenergic Agents|adrenergic agents|mesh-ancestor
91942840|NCT04332211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942841|NCT04332211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942842|NCT04319198|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
91942843|NCT04319198|Immunoconjugates|immunoconjugates|mesh-ancestor
91942844|NCT04319198|Immunologic Factors|immunologic factors|mesh-ancestor
91942845|NCT04319198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942846|NCT04300192|Vaccines|vaccines|mesh-list
91942847|NCT04300192|Immunologic Factors|immunologic factors|mesh-ancestor
91942848|NCT04300192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942850|NCT04278898|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91942851|NCT04278898|Antiviral Agents|antiviral agents|mesh-ancestor
91942852|NCT04278898|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942853|NCT04278898|Expectorants|expectorants|mesh-ancestor
91942854|NCT04278898|Respiratory System Agents|respiratory system agents|mesh-ancestor
91942855|NCT04278898|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91942856|NCT04278898|Antioxidants|antioxidants|mesh-ancestor
91942857|NCT04278898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942858|NCT04278898|Protective Agents|protective agents|mesh-ancestor
91942859|NCT04278898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942860|NCT04278898|Antidotes|antidotes|mesh-ancestor
91942861|NCT04256421|Carboplatin|carboplatin|mesh-list
91942863|NCT04256421|Atezolizumab|atezolizumab|mesh-list
91942864|NCT04256421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942865|NCT04256421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942866|NCT04256421|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91942867|NCT04256421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91942869|NCT04256421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942870|NCT04256421|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91942871|NCT04256421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91942872|NCT04255433|Dulaglutide|dulaglutide|mesh-list
91942873|NCT04255433|Tirzepatide|tirzepatide|mesh-list
91942874|NCT04255433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942875|NCT04255433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942876|NCT04255433|Incretins|incretins|mesh-ancestor
91942877|NCT04255433|Hormones|hormones|mesh-ancestor
91942878|NCT04255433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942879|NCT04188665|Lectins|lectins|mesh-list
91942880|NCT04188665|Agglutinins|agglutinins|mesh-ancestor
91942881|NCT04188665|Immunologic Factors|immunologic factors|mesh-ancestor
91942882|NCT04188665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942883|NCT04188665|Coagulants|coagulants|mesh-ancestor
91942884|NCT04166773|Tirzepatide|tirzepatide|mesh-list
91942885|NCT04166773|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91942886|NCT04166773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942888|NCT04166773|Hormones|hormones|mesh-ancestor
91942889|NCT04166773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942891|NCT04141995|Fluorouracil|fluorouracil|mesh-list
91942893|NCT04141995|Irinotecan|irinotecan|mesh-list
91942894|NCT04141995|Camptothecin|camptothecin|mesh-list
91942895|NCT04141995|Digoxin|digoxin|mesh-list
91942897|NCT04141995|Levoleucovorin|levoleucovorin|mesh-list
91942898|NCT04141995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91942899|NCT04141995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942900|NCT04141995|Antimetabolites|antimetabolites|mesh-ancestor
91942901|NCT04141995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942902|NCT04141995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942903|NCT04141995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942904|NCT04141995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942905|NCT04141995|Immunologic Factors|immunologic factors|mesh-ancestor
91942906|NCT04141995|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91942907|NCT04141995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91942908|NCT04141995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942910|NCT04141995|Protective Agents|protective agents|mesh-ancestor
91942911|NCT04141995|Vitamin B Complex|vitamin b complex|mesh-ancestor
91942912|NCT04141995|Vitamins|vitamins|mesh-ancestor
91942913|NCT04141995|Micronutrients|micronutrients|mesh-ancestor
91942914|NCT04141995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91942915|NCT04141995|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91942916|NCT04141995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91942917|NCT04127578|Sirolimus|sirolimus|mesh-list
91942918|NCT04127578|Methylprednisolone|methylprednisolone|mesh-list
91942919|NCT04127578|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91942920|NCT04127578|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91942921|NCT04127578|Prednisolone|prednisolone|mesh-list
91942922|NCT04127578|Prednisolone acetate|prednisolone acetate|mesh-list
91942923|NCT04127578|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91942924|NCT04127578|Prednisolone phosphate|prednisolone phosphate|mesh-list
91942925|NCT04127578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91942926|NCT04127578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942927|NCT04127578|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91942928|NCT04127578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942929|NCT04127578|Antifungal Agents|antifungal agents|mesh-ancestor
91942930|NCT04127578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942932|NCT04127578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942933|NCT04127578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942935|NCT04127578|Autonomic Agents|autonomic agents|mesh-ancestor
91942936|NCT04127578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942937|NCT04127578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91942938|NCT04127578|Glucocorticoids|glucocorticoids|mesh-ancestor
91942939|NCT04127578|Hormones|hormones|mesh-ancestor
91942940|NCT04127578|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942941|NCT04127578|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91942942|NCT04127578|Protective Agents|protective agents|mesh-ancestor
91942943|NCT04127578|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942944|NCT04068597|Dexamethasone|dexamethasone|mesh-list
91942945|NCT04068597|Azacitidine|azacitidine|mesh-list
91942946|NCT04068597|Venetoclax|venetoclax|mesh-list
91942947|NCT04068597|Pomalidomide|pomalidomide|mesh-list
91942948|NCT04068597|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91942949|NCT04068597|Antiemetics|antiemetics|mesh-ancestor
91942951|NCT04068597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91942952|NCT04068597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942953|NCT04068597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91942955|NCT04068597|Hormones|hormones|mesh-ancestor
91942956|NCT04068597|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91942957|NCT04068597|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91942958|NCT04068597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942959|NCT04068597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942960|NCT04068597|Antimetabolites|antimetabolites|mesh-ancestor
91942961|NCT04068597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942962|NCT04068597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91942963|NCT04068597|Immunologic Factors|immunologic factors|mesh-ancestor
91942964|NCT04068597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91942965|NCT04068597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91942966|NCT04068597|Growth Substances|growth substances|mesh-ancestor
91942967|NCT04068597|Growth Inhibitors|growth inhibitors|mesh-ancestor
91942969|NCT04064294|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91942970|NCT04064294|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91942971|NCT04064294|Dopamine Agents|dopamine agents|mesh-ancestor
91942972|NCT04064294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91942973|NCT04064294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942974|NCT04064294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942975|NCT04029688|Cytarabine|cytarabine|mesh-list
91942976|NCT04029688|Cyclophosphamide|cyclophosphamide|mesh-list
91942977|NCT04029688|Fludarabine|fludarabine|mesh-list
91942980|NCT04029688|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91942981|NCT04029688|Immunologic Factors|immunologic factors|mesh-ancestor
91942982|NCT04029688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91942983|NCT04029688|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91942984|NCT04029688|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91942986|NCT04029688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91942987|NCT04029688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91942988|NCT04029688|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91942989|NCT04029688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91942990|NCT04029688|Antimetabolites|antimetabolites|mesh-ancestor
91942992|NCT04029688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91942993|NCT04029688|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91942994|NCT04029688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91942996|NCT04009044|Tamoxifen|tamoxifen|mesh-list
91942997|NCT04009044|Afimoxifene|afimoxifene|mesh-list
91942999|NCT04009044|Hormone Antagonists|hormone antagonists|mesh-ancestor
91943000|NCT04009044|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943001|NCT04009044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943002|NCT04009044|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943003|NCT04009044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943004|NCT04009044|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91943005|NCT04009044|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91943006|NCT04009044|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91943008|NCT03928210|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91943009|NCT03928210|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91943010|NCT03928210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943011|NCT03928210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943012|NCT03928210|Protective Agents|protective agents|mesh-ancestor
91943013|NCT03928210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943015|NCT03915769|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91943016|NCT03915769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943017|NCT03915769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943018|NCT03915769|Immunologic Factors|immunologic factors|mesh-ancestor
91943019|NCT03915769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943021|NCT03908736|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91943022|NCT03908736|Chelating Agents|chelating agents|mesh-ancestor
91943023|NCT03908736|Sequestering Agents|sequestering agents|mesh-ancestor
91943024|NCT03908736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943025|NCT03867201|Erenumab|erenumab|mesh-list
91943026|NCT03867201|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91943027|NCT03867201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943028|NCT03867201|Analgesics|analgesics|mesh-ancestor
91943029|NCT03867201|Sensory System Agents|sensory system agents|mesh-ancestor
91943031|NCT03867201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943032|NCT03827798|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91943033|NCT03827798|Immunologic Factors|immunologic factors|mesh-ancestor
91943034|NCT03827798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943035|NCT03805932|Rituximab|rituximab|mesh-list
91943036|NCT03805932|Immunotoxin HA22|immunotoxin ha22|mesh-list
91943037|NCT03805932|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943038|NCT03805932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943039|NCT03805932|Immunologic Factors|immunologic factors|mesh-ancestor
91943040|NCT03805932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943041|NCT03805932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943042|NCT03805932|Immunotoxins|immunotoxins|mesh-ancestor
91943043|NCT03805932|Immunoconjugates|immunoconjugates|mesh-ancestor
91943044|NCT03790670|Sargramostim|sargramostim|mesh-list
91943045|NCT03790670|Immunologic Factors|immunologic factors|mesh-ancestor
91943046|NCT03790670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943047|NCT03720990|Cholic Acids|cholic acids|mesh-list
91943048|NCT03720990|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943050|NCT03699319|Folic Acid|folic acid|mesh-list
91943051|NCT03699319|Oxaliplatin|oxaliplatin|mesh-list
91943052|NCT03699319|Irinotecan|irinotecan|mesh-list
91943053|NCT03699319|Levoleucovorin|levoleucovorin|mesh-list
91943054|NCT03699319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943055|NCT03699319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943056|NCT03699319|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91943057|NCT03699319|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943058|NCT03699319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943059|NCT03699319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943060|NCT03699319|Antidotes|antidotes|mesh-ancestor
91943061|NCT03699319|Protective Agents|protective agents|mesh-ancestor
91943062|NCT03699319|Vitamin B Complex|vitamin b complex|mesh-ancestor
91943063|NCT03699319|Vitamins|vitamins|mesh-ancestor
91943064|NCT03699319|Micronutrients|micronutrients|mesh-ancestor
91943065|NCT03699319|Hematinics|hematinics|mesh-ancestor
91943066|NCT03677141|Prednisone|prednisone|mesh-list
91943067|NCT03677141|Cyclophosphamide|cyclophosphamide|mesh-list
91943068|NCT03677141|Doxorubicin|doxorubicin|mesh-list
91943069|NCT03677141|Vincristine|vincristine|mesh-list
91943070|NCT03677141|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
91943071|NCT03677141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943072|NCT03677141|Immunologic Factors|immunologic factors|mesh-ancestor
91943073|NCT03677141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943074|NCT03677141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943075|NCT03677141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91943076|NCT03677141|Alkylating Agents|alkylating agents|mesh-ancestor
91943077|NCT03677141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943078|NCT03677141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943079|NCT03677141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91943080|NCT03677141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91943081|NCT03677141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91943082|NCT03677141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943083|NCT03677141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943084|NCT03677141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943085|NCT03677141|Glucocorticoids|glucocorticoids|mesh-ancestor
91943087|NCT03677141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943088|NCT03677141|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943089|NCT03677141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943090|NCT03677141|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943091|NCT03677141|Antimitotic Agents|antimitotic agents|mesh-ancestor
91943092|NCT03677141|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943093|NCT03677141|Immunoconjugates|immunoconjugates|mesh-ancestor
91943094|NCT03651271|Nivolumab|nivolumab|mesh-list
91943095|NCT03651271|Ipilimumab|ipilimumab|mesh-list
91943096|NCT03651271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943097|NCT03651271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943098|NCT03651271|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943099|NCT03651271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943100|NCT03635892|Nivolumab|nivolumab|mesh-list
91943101|NCT03635892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943102|NCT03635892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943103|NCT03635892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943104|NCT03635892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943105|NCT03594435|Ibudilast|ibudilast|mesh-list
91943106|NCT03594435|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91943107|NCT03594435|Autonomic Agents|autonomic agents|mesh-ancestor
91943108|NCT03594435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943109|NCT03594435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943110|NCT03594435|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91943111|NCT03594435|Respiratory System Agents|respiratory system agents|mesh-ancestor
91943112|NCT03594435|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91943113|NCT03594435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943114|NCT03594435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943115|NCT03594435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91943116|NCT03594435|Vasodilator Agents|vasodilator agents|mesh-ancestor
91943117|NCT03568656|Atezolizumab|atezolizumab|mesh-list
91943118|NCT03568656|Olaparib|olaparib|mesh-list
91943119|NCT03568656|Abiraterone Acetate|abiraterone acetate|mesh-list
91943120|NCT03568656|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943121|NCT03568656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943122|NCT03568656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943123|NCT03568656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943124|NCT03568656|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91943125|NCT03568656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943126|NCT03568656|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91943127|NCT03568656|Hormone Antagonists|hormone antagonists|mesh-ancestor
91943128|NCT03568656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943129|NCT03568656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943130|NCT03568656|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91943131|NCT03563729|Pembrolizumab|pembrolizumab|mesh-list
91943132|NCT03563729|Nivolumab|nivolumab|mesh-list
91943133|NCT03563729|Ipilimumab|ipilimumab|mesh-list
91943134|NCT03563729|Trametinib|trametinib|mesh-list
91943135|NCT03563729|Dabrafenib|dabrafenib|mesh-list
91943136|NCT03563729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943137|NCT03563729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943138|NCT03563729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943139|NCT03563729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943140|NCT03563729|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943141|NCT03563729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943142|NCT03539822|Durvalumab|durvalumab|mesh-list
91943143|NCT03539822|Tremelimumab|tremelimumab|mesh-list
91943144|NCT03539822|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91943145|NCT03539822|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91943146|NCT03539822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943147|NCT03539822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943148|NCT03539822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943149|NCT03539822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943150|NCT03539822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943151|NCT03533283|Atezolizumab|atezolizumab|mesh-list
91943152|NCT03533283|Obinutuzumab|obinutuzumab|mesh-list
91943153|NCT03533283|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
91943154|NCT03533283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943155|NCT03533283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943156|NCT03533283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943157|NCT03533283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943159|NCT03533283|Immunologic Factors|immunologic factors|mesh-ancestor
91943160|NCT03533283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943161|NCT03448042|Trastuzumab|trastuzumab|mesh-list
91943162|NCT03448042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943163|NCT03448042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943164|NCT03325101|Pembrolizumab|pembrolizumab|mesh-list
91943165|NCT03325101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943166|NCT03325101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943167|NCT03325101|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943168|NCT03325101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943170|NCT03323463|Fluorouracil|fluorouracil|mesh-list
91943171|NCT03323463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943172|NCT03323463|Antimetabolites|antimetabolites|mesh-ancestor
91943173|NCT03323463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943175|NCT03323463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943176|NCT03323463|Immunologic Factors|immunologic factors|mesh-ancestor
91943177|NCT03323463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943178|NCT03291028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91943179|NCT03291028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943180|NCT03291028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943181|NCT03291028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943182|NCT03287908|Dexamethasone|dexamethasone|mesh-list
91943183|NCT03287908|Pomalidomide|pomalidomide|mesh-list
91943184|NCT03287908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943185|NCT03287908|Antiemetics|antiemetics|mesh-ancestor
91943186|NCT03287908|Autonomic Agents|autonomic agents|mesh-ancestor
91943187|NCT03287908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943436|NCT00644228|Dexamethasone acetate|dexamethasone acetate|mesh-list
91943188|NCT03287908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943189|NCT03287908|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943192|NCT03287908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943193|NCT03287908|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943194|NCT03287908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943195|NCT03287908|Immunologic Factors|immunologic factors|mesh-ancestor
91943196|NCT03287908|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91943197|NCT03287908|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91943198|NCT03287908|Growth Substances|growth substances|mesh-ancestor
91943199|NCT03287908|Growth Inhibitors|growth inhibitors|mesh-ancestor
91943200|NCT03257163|Pembrolizumab|pembrolizumab|mesh-list
91943201|NCT03257163|Capecitabine|capecitabine|mesh-list
91943202|NCT03257163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943203|NCT03257163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943204|NCT03257163|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943205|NCT03257163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943206|NCT03257163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943208|NCT03194893|Crizotinib|crizotinib|mesh-list
91943209|NCT03194893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943210|NCT03194893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943211|NCT03194893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943212|NCT03194893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943213|NCT03091192|Sunitinib|sunitinib|mesh-list
91943214|NCT03091192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943215|NCT03091192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91943216|NCT03091192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91943217|NCT03091192|Growth Substances|growth substances|mesh-ancestor
91943218|NCT03091192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943219|NCT03091192|Growth Inhibitors|growth inhibitors|mesh-ancestor
91943220|NCT03091192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943221|NCT03091192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943222|NCT03091192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943223|NCT03049462|Mirabegron|mirabegron|mesh-list
91943224|NCT03049462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943225|NCT03049462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943226|NCT03049462|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91943227|NCT03049462|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91943228|NCT03049462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91943229|NCT03049462|Adrenergic Agents|adrenergic agents|mesh-ancestor
91943230|NCT03049462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943231|NCT03049462|Urological Agents|urological agents|mesh-ancestor
91943233|NCT03027388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943234|NCT03027388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943235|NCT03027388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943236|NCT03004287|Thalidomide|thalidomide|mesh-list
91943237|NCT03004287|Dexamethasone|dexamethasone|mesh-list
91943238|NCT03004287|Cyclophosphamide|cyclophosphamide|mesh-list
91943240|NCT03004287|Doxorubicin|doxorubicin|mesh-list
91943241|NCT03004287|Etoposide|etoposide|mesh-list
91943242|NCT03004287|Lenalidomide|lenalidomide|mesh-list
91943244|NCT03004287|Daratumumab|daratumumab|mesh-list
91943245|NCT03004287|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943246|NCT03004287|Immunologic Factors|immunologic factors|mesh-ancestor
91943247|NCT03004287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943248|NCT03004287|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943249|NCT03004287|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91943250|NCT03004287|Alkylating Agents|alkylating agents|mesh-ancestor
91943251|NCT03004287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943252|NCT03004287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943253|NCT03004287|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91943254|NCT03004287|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943255|NCT03004287|Antiemetics|antiemetics|mesh-ancestor
91943256|NCT03004287|Autonomic Agents|autonomic agents|mesh-ancestor
91943257|NCT03004287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943258|NCT03004287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943259|NCT03004287|Glucocorticoids|glucocorticoids|mesh-ancestor
91943261|NCT03004287|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943262|NCT03004287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943263|NCT03004287|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91943264|NCT03004287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91943265|NCT03004287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943266|NCT03004287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943267|NCT03004287|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943268|NCT03004287|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91943270|NCT03004287|Growth Substances|growth substances|mesh-ancestor
91943271|NCT03004287|Growth Inhibitors|growth inhibitors|mesh-ancestor
91943272|NCT03004287|Leprostatic Agents|leprostatic agents|mesh-ancestor
91943273|NCT03004287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91943274|NCT03004287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943275|NCT02885974|Celecoxib|celecoxib|mesh-list
91943276|NCT02885974|Gemcitabine|gemcitabine|mesh-list
91943277|NCT02885974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943278|NCT02885974|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943279|NCT02885974|Antimetabolites|antimetabolites|mesh-ancestor
91943280|NCT02885974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943281|NCT02885974|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91943282|NCT02885974|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943284|NCT02885974|Sensory System Agents|sensory system agents|mesh-ancestor
91943285|NCT02885974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943286|NCT02885974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943287|NCT02885974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943288|NCT02885974|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943290|NCT02885974|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91943291|NCT02885974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943292|NCT02861300|Capecitabine|capecitabine|mesh-list
91943293|NCT02861300|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943294|NCT02861300|Antimetabolites|antimetabolites|mesh-ancestor
91943295|NCT02861300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943296|NCT02861300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943298|NCT02838420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943299|NCT02838420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943300|NCT02838420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943301|NCT02838420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943302|NCT02611960|Gemcitabine|gemcitabine|mesh-list
91943303|NCT02611960|Capecitabine|capecitabine|mesh-list
91943304|NCT02611960|Docetaxel|docetaxel|mesh-list
91943305|NCT02611960|Pembrolizumab|pembrolizumab|mesh-list
91943306|NCT02611960|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943308|NCT02611960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943309|NCT02611960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943310|NCT02611960|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943311|NCT02611960|Antimitotic Agents|antimitotic agents|mesh-ancestor
91943312|NCT02611960|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943313|NCT02611960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943314|NCT02611960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943315|NCT02603146|Hydroxychloroquine|hydroxychloroquine|mesh-list
91943316|NCT02603146|Antimalarials|antimalarials|mesh-ancestor
91943317|NCT02603146|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91943318|NCT02603146|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91943319|NCT02603146|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943320|NCT02603146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943321|NCT02603146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943322|NCT02603146|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943324|NCT02358850|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
91943327|NCT02358850|Hydrocodone|hydrocodone|mesh-list
91943328|NCT02358850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943330|NCT02358850|Sensory System Agents|sensory system agents|mesh-ancestor
91943331|NCT02358850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943332|NCT02358850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943334|NCT02358850|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91943335|NCT02358850|Narcotics|narcotics|mesh-ancestor
91943336|NCT02358850|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943337|NCT02358850|Antitussive Agents|antitussive agents|mesh-ancestor
91943338|NCT02358850|Respiratory System Agents|respiratory system agents|mesh-ancestor
91943339|NCT02358850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91943340|NCT02358850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943341|NCT02358850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943342|NCT01909453|Vemurafenib|vemurafenib|mesh-list
91943343|NCT01909453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943344|NCT01909453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943345|NCT01909453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943346|NCT01909453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943347|NCT01784159|Aspirin|aspirin|mesh-list
91943348|NCT01784159|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91943349|NCT01784159|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943350|NCT01784159|Analgesics|analgesics|mesh-ancestor
91943351|NCT01784159|Sensory System Agents|sensory system agents|mesh-ancestor
91943352|NCT01784159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943353|NCT01784159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943354|NCT01784159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943355|NCT01784159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943356|NCT01784159|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91943357|NCT01784159|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91943359|NCT01784159|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91943360|NCT01784159|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91943361|NCT01784159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943363|NCT01749969|Dexamethasone|dexamethasone|mesh-list
91943365|NCT01749969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943367|NCT01749969|Autonomic Agents|autonomic agents|mesh-ancestor
91943368|NCT01749969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943369|NCT01749969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943370|NCT01749969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943371|NCT01749969|Glucocorticoids|glucocorticoids|mesh-ancestor
91943373|NCT01749969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943374|NCT01749969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943375|NCT01749969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943376|NCT01749969|Immunologic Factors|immunologic factors|mesh-ancestor
91943377|NCT01749969|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91943378|NCT01749969|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91943379|NCT01749969|Growth Substances|growth substances|mesh-ancestor
91943380|NCT01749969|Growth Inhibitors|growth inhibitors|mesh-ancestor
91943381|NCT01458327|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
91943382|NCT01458327|Hallucinogens|hallucinogens|mesh-ancestor
91943383|NCT01458327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943384|NCT01458327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91943385|NCT01458327|Serotonin Agents|serotonin agents|mesh-ancestor
91943386|NCT01458327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943387|NCT01458327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943388|NCT01458327|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91943389|NCT01458327|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91943390|NCT01458327|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91943391|NCT01458327|Adrenergic Agents|adrenergic agents|mesh-ancestor
91943392|NCT01275677|Paclitaxel|paclitaxel|mesh-list
91943393|NCT01275677|Docetaxel|docetaxel|mesh-list
91943394|NCT01275677|Cyclophosphamide|cyclophosphamide|mesh-list
91943395|NCT01275677|Doxorubicin|doxorubicin|mesh-list
91943396|NCT01275677|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91943397|NCT01275677|Trastuzumab|trastuzumab|mesh-list
91943398|NCT01275677|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91943399|NCT01275677|Daunorubicin|daunorubicin|mesh-list
91943400|NCT01275677|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
91943402|NCT01275677|Antibodies|antibodies|mesh-list
91943403|NCT01275677|Immunoglobulins|immunoglobulins|mesh-list
91943404|NCT01275677|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91943405|NCT01275677|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943406|NCT01275677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943407|NCT01275677|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943408|NCT01275677|Antimitotic Agents|antimitotic agents|mesh-ancestor
91943409|NCT01275677|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943410|NCT01275677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943411|NCT01275677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943413|NCT01275677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943414|NCT01275677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943415|NCT01275677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91943416|NCT01275677|Alkylating Agents|alkylating agents|mesh-ancestor
91943418|NCT01275677|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91943419|NCT01275677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91943420|NCT01275677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943421|NCT01275677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943422|NCT01203020|Fludarabine|fludarabine|mesh-list
91943423|NCT01203020|Fludarabine phosphate|fludarabine phosphate|mesh-list
91943425|NCT01203020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943426|NCT01203020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943427|NCT01203020|Antimetabolites|antimetabolites|mesh-ancestor
91943428|NCT01203020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943429|NCT01203020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943430|NCT01203020|Immunologic Factors|immunologic factors|mesh-ancestor
91943431|NCT01203020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943432|NCT01203020|Alkylating Agents|alkylating agents|mesh-ancestor
91943433|NCT01203020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91943434|NCT01203020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91943435|NCT00644228|Dexamethasone|dexamethasone|mesh-list
91943437|NCT00644228|Lenalidomide|lenalidomide|mesh-list
91943438|NCT00644228|Bortezomib|bortezomib|mesh-list
91943439|NCT00644228|Ichthammol|ichthammol|mesh-list
91943440|NCT00644228|BB 1101|bb 1101|mesh-list
91943441|NCT00644228|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943442|NCT00644228|Antiemetics|antiemetics|mesh-ancestor
91943443|NCT00644228|Autonomic Agents|autonomic agents|mesh-ancestor
91943444|NCT00644228|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943445|NCT00644228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943446|NCT00644228|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943448|NCT00644228|Hormones|hormones|mesh-ancestor
91943449|NCT00644228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943450|NCT00644228|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943451|NCT00644228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943452|NCT00644228|Protease Inhibitors|protease inhibitors|mesh-ancestor
91943453|NCT00644228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943454|NCT00644228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943455|NCT00644228|Immunologic Factors|immunologic factors|mesh-ancestor
91943456|NCT00644228|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91943457|NCT00644228|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91943458|NCT00644228|Growth Substances|growth substances|mesh-ancestor
91943460|NCT00644228|Dermatologic Agents|dermatologic agents|mesh-ancestor
91943461|NCT00501826|Cytarabine|cytarabine|mesh-list
91943462|NCT00501826|6-methoxypurine arabinoside|6-methoxypurine arabinoside|mesh-list
91943463|NCT00501826|Dexamethasone|dexamethasone|mesh-list
91943464|NCT00501826|Dexamethasone acetate|dexamethasone acetate|mesh-list
91943465|NCT00501826|Prednisone|prednisone|mesh-list
91943466|NCT00501826|Cortisone|cortisone|mesh-list
91943467|NCT00501826|Cyclophosphamide|cyclophosphamide|mesh-list
91943468|NCT00501826|Doxorubicin|doxorubicin|mesh-list
91943469|NCT00501826|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91943470|NCT00501826|Methotrexate|methotrexate|mesh-list
91943471|NCT00501826|Vincristine|vincristine|mesh-list
91943473|NCT00501826|Asparaginase|asparaginase|mesh-list
91943474|NCT00501826|Mercaptopurine|mercaptopurine|mesh-list
91943475|NCT00501826|Pegaspargase|pegaspargase|mesh-list
91943476|NCT00501826|BB 1101|bb 1101|mesh-list
91943477|NCT00501826|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943478|NCT00501826|Immunologic Factors|immunologic factors|mesh-ancestor
91943479|NCT00501826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943480|NCT00501826|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943481|NCT00501826|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91943482|NCT00501826|Alkylating Agents|alkylating agents|mesh-ancestor
91943483|NCT00501826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943484|NCT00501826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943485|NCT00501826|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91943486|NCT00501826|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943487|NCT00501826|Antiemetics|antiemetics|mesh-ancestor
91943488|NCT00501826|Autonomic Agents|autonomic agents|mesh-ancestor
91943489|NCT00501826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943490|NCT00501826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943491|NCT00501826|Glucocorticoids|glucocorticoids|mesh-ancestor
91943492|NCT00501826|Hormones|hormones|mesh-ancestor
91943493|NCT00501826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943494|NCT00501826|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943496|NCT00501826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943497|NCT00501826|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91943498|NCT00501826|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91943499|NCT00501826|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943500|NCT00501826|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91943501|NCT00501826|Abortifacient Agents|abortifacient agents|mesh-ancestor
91943502|NCT00501826|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91943503|NCT00501826|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943504|NCT00501826|Antimetabolites|antimetabolites|mesh-ancestor
91943505|NCT00501826|Dermatologic Agents|dermatologic agents|mesh-ancestor
91943506|NCT00501826|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91943507|NCT00501826|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91943508|NCT00501826|Antiviral Agents|antiviral agents|mesh-ancestor
91943509|NCT00501826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943510|NCT00501826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943511|NCT00501826|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943512|NCT00501826|Antimitotic Agents|antimitotic agents|mesh-ancestor
91943513|NCT00501826|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943514|NCT00006256|Paclitaxel|paclitaxel|mesh-list
91943515|NCT00006256|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943516|NCT00006256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943517|NCT00006256|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943518|NCT00006256|Antimitotic Agents|antimitotic agents|mesh-ancestor
91943519|NCT00006256|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943520|NCT00006256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943521|NCT00495131|Interferons|interferons|mesh-list
91943522|NCT00495131|Ribavirin|ribavirin|mesh-list
91943523|NCT00495131|Interferon-alpha|interferon-alpha|mesh-list
91943524|NCT00495131|Interferon alpha-2|interferon alpha-2|mesh-list
91943525|NCT00495131|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91943526|NCT00495131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943527|NCT00495131|Antiviral Agents|antiviral agents|mesh-ancestor
91943528|NCT00495131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943529|NCT00495131|Antimetabolites|antimetabolites|mesh-ancestor
91943530|NCT00495131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943531|NCT00495131|Immunologic Factors|immunologic factors|mesh-ancestor
91943532|NCT00495131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943533|NCT02257372|Albuterol|albuterol|mesh-list
91943534|NCT02257372|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91943535|NCT02257372|Autonomic Agents|autonomic agents|mesh-ancestor
91943536|NCT02257372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943537|NCT02257372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943538|NCT02257372|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91943539|NCT02257372|Respiratory System Agents|respiratory system agents|mesh-ancestor
91943541|NCT02257372|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91943542|NCT02257372|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91943543|NCT02257372|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91943544|NCT02257372|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91943545|NCT02257372|Adrenergic Agents|adrenergic agents|mesh-ancestor
91943546|NCT02257372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943547|NCT02257372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943550|NCT02256982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943551|NCT02256982|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943552|NCT02256982|Antimetabolites|antimetabolites|mesh-ancestor
91943553|NCT02256982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943554|NCT04860154|Hematoporphyrins|hematoporphyrins|mesh-list
91943555|NCT04860154|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91943556|NCT04860154|Dermatologic Agents|dermatologic agents|mesh-ancestor
91943557|NCT03480607|Dexamethasone|dexamethasone|mesh-list
91943558|NCT03480607|Dexmedetomidine|dexmedetomidine|mesh-list
91943559|NCT03480607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943561|NCT03480607|Autonomic Agents|autonomic agents|mesh-ancestor
91943562|NCT03480607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943563|NCT03480607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943564|NCT03480607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943565|NCT03480607|Glucocorticoids|glucocorticoids|mesh-ancestor
91943566|NCT03480607|Hormones|hormones|mesh-ancestor
91943567|NCT03480607|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943568|NCT03480607|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943569|NCT03480607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943570|NCT03480607|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91943571|NCT03480607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943572|NCT03480607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943573|NCT03480607|Analgesics|analgesics|mesh-ancestor
91943574|NCT03480607|Sensory System Agents|sensory system agents|mesh-ancestor
91943575|NCT03480607|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91943576|NCT03480607|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91943577|NCT03480607|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91943578|NCT03480607|Adrenergic Agents|adrenergic agents|mesh-ancestor
91943579|NCT03480607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943580|NCT03480607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943581|NCT00489203|Beclomethasone|beclomethasone|mesh-list
91943582|NCT00489203|Methotrexate|methotrexate|mesh-list
91943583|NCT00489203|Tacrolimus|tacrolimus|mesh-list
91943584|NCT00489203|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91943585|NCT00489203|Abortifacient Agents|abortifacient agents|mesh-ancestor
91943586|NCT00489203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91943587|NCT00489203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943588|NCT00489203|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943589|NCT00489203|Antimetabolites|antimetabolites|mesh-ancestor
91943590|NCT00489203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943591|NCT00489203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943592|NCT00489203|Dermatologic Agents|dermatologic agents|mesh-ancestor
91943593|NCT00489203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943594|NCT00489203|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91943595|NCT00489203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943596|NCT00489203|Immunologic Factors|immunologic factors|mesh-ancestor
91943597|NCT00489203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943598|NCT00489203|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91943599|NCT00489203|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91943600|NCT00489203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943601|NCT00489203|Glucocorticoids|glucocorticoids|mesh-ancestor
91943602|NCT00489203|Hormones|hormones|mesh-ancestor
91943603|NCT00489203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943604|NCT00489203|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91943605|NCT00489203|Respiratory System Agents|respiratory system agents|mesh-ancestor
91943606|NCT05646394|Aspirin|aspirin|mesh-list
91943607|NCT05646394|Vitamins|vitamins|mesh-list
91943608|NCT05646394|Vitamin K|vitamin k|mesh-list
91943609|NCT05646394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91943610|NCT05646394|Micronutrients|micronutrients|mesh-ancestor
91943611|NCT05646394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943612|NCT05646394|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91943613|NCT05646394|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943614|NCT05646394|Analgesics|analgesics|mesh-ancestor
91943615|NCT05646394|Sensory System Agents|sensory system agents|mesh-ancestor
91943616|NCT05646394|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943617|NCT05646394|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943618|NCT05646394|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943619|NCT05646394|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91943620|NCT05646394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91943621|NCT05646394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943622|NCT05646394|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91943623|NCT05646394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943624|NCT05646394|Antipyretics|antipyretics|mesh-ancestor
91943625|NCT05646394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91943626|NCT05646394|Hemostatics|hemostatics|mesh-ancestor
91943627|NCT05646394|Coagulants|coagulants|mesh-ancestor
91943629|NCT00563459|Levetiracetam|levetiracetam|mesh-list
91943630|NCT00563459|Anticonvulsants|anticonvulsants|mesh-ancestor
91943631|NCT00563459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91943632|NCT00563459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943633|NCT00563459|Nootropic Agents|nootropic agents|mesh-ancestor
91943634|NCT04947631|Tadalafil|tadalafil|mesh-list
91943635|NCT04947631|Dutasteride|dutasteride|mesh-list
91943636|NCT04947631|Vasodilator Agents|vasodilator agents|mesh-ancestor
91943637|NCT04947631|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91943638|NCT04947631|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91943639|NCT04947631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943640|NCT04947631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943641|NCT04947631|Urological Agents|urological agents|mesh-ancestor
91943642|NCT04947631|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91943643|NCT04947631|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91943644|NCT04947631|Hormone Antagonists|hormone antagonists|mesh-ancestor
91943645|NCT04947631|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943646|NCT04947631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943647|NCT00561743|Dexamethasone|dexamethasone|mesh-list
91943649|NCT00561743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91943651|NCT00561743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943652|NCT00561743|Antiemetics|antiemetics|mesh-ancestor
91943653|NCT00561743|Autonomic Agents|autonomic agents|mesh-ancestor
91943654|NCT00561743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943655|NCT00561743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943656|NCT00561743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91943657|NCT00561743|Glucocorticoids|glucocorticoids|mesh-ancestor
91943658|NCT00561743|Hormones|hormones|mesh-ancestor
91943659|NCT00561743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943660|NCT00561743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91943661|NCT00561743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943662|NCT00561743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91943663|NCT00561743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91943664|NCT00561743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943665|NCT00561743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943666|NCT00561743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943667|NCT00488267|Ketoprofen|ketoprofen|mesh-list
91943668|NCT00488267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91943669|NCT00488267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943670|NCT00488267|Analgesics|analgesics|mesh-ancestor
91943671|NCT00488267|Sensory System Agents|sensory system agents|mesh-ancestor
91943672|NCT00488267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943673|NCT00488267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943674|NCT00488267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943675|NCT00488267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943676|NCT00488267|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91943677|NCT00488267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943678|NCT00488267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943679|NCT00560183|Morphine|morphine|mesh-list
91943680|NCT00560183|Oxycodone|oxycodone|mesh-list
91943681|NCT00560183|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91943682|NCT00560183|Narcotics|narcotics|mesh-ancestor
91943683|NCT00560183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943684|NCT00560183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943685|NCT00560183|Analgesics|analgesics|mesh-ancestor
91943686|NCT00560183|Sensory System Agents|sensory system agents|mesh-ancestor
91943687|NCT00560183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943688|NCT02736721|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91943689|NCT02736721|Antiviral Agents|antiviral agents|mesh-ancestor
91943690|NCT02736721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943691|NCT00542633|Insulin|insulin|mesh-list
91943692|NCT00542633|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91943693|NCT00542633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91943694|NCT00542633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943696|NCT02523547|Antiviral Agents|antiviral agents|mesh-ancestor
91943697|NCT02523547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943698|NCT00483977|Oxycodone|oxycodone|mesh-list
91943699|NCT00483977|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91943700|NCT00483977|Narcotics|narcotics|mesh-ancestor
91943701|NCT00483977|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943702|NCT00483977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943703|NCT00483977|Analgesics|analgesics|mesh-ancestor
91943704|NCT00483977|Sensory System Agents|sensory system agents|mesh-ancestor
91943705|NCT00483977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943706|NCT00481325|Escitalopram|escitalopram|mesh-list
91943707|NCT00481325|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91943708|NCT00481325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91943709|NCT00481325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91943710|NCT00481325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943711|NCT00481325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943712|NCT00481325|Serotonin Agents|serotonin agents|mesh-ancestor
91943713|NCT00481325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943714|NCT02523703|N-Methylaspartate|n-methylaspartate|mesh-list
91943715|NCT02523703|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
91943716|NCT02523703|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91943717|NCT02523703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943718|NCT02523703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943719|NCT02523703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943720|NCT03480295|Hyaluronic Acid|hyaluronic acid|mesh-list
91943721|NCT03480295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91943722|NCT03480295|Immunologic Factors|immunologic factors|mesh-ancestor
91943723|NCT03480295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943724|NCT03480295|Viscosupplements|viscosupplements|mesh-ancestor
91943725|NCT03480295|Protective Agents|protective agents|mesh-ancestor
91943726|NCT03472963|Darunavir|darunavir|mesh-list
91943727|NCT03472963|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91943728|NCT03472963|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91943729|NCT03472963|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91943730|NCT03472963|Protease Inhibitors|protease inhibitors|mesh-ancestor
91943731|NCT03472963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943732|NCT03472963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943733|NCT03472963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91943734|NCT03472963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91943735|NCT03472963|Antiviral Agents|antiviral agents|mesh-ancestor
91943736|NCT03472963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943737|NCT02282657|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
91943738|NCT02282657|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91943739|NCT02282657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943740|NCT02282657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943741|NCT00465959|Trospium chloride|trospium chloride|mesh-list
91943742|NCT00465959|Parasympatholytics|parasympatholytics|mesh-ancestor
91943743|NCT00465959|Autonomic Agents|autonomic agents|mesh-ancestor
91943744|NCT00465959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943745|NCT00465959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943746|NCT00465959|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91943747|NCT00465959|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91943748|NCT00465959|Cholinergic Agents|cholinergic agents|mesh-ancestor
91943749|NCT00465959|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943750|NCT00465959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943751|NCT00465959|Urological Agents|urological agents|mesh-ancestor
91943752|NCT00465803|Timolol|timolol|mesh-list
91943753|NCT00465803|Travoprost|travoprost|mesh-list
91943754|NCT00465803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91943755|NCT00465803|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91943756|NCT00465803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943757|NCT00465803|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91943758|NCT00465803|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91943759|NCT00465803|Adrenergic Agents|adrenergic agents|mesh-ancestor
91943760|NCT00465803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943761|NCT00465803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943762|NCT00465803|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91943763|NCT00465803|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91943764|NCT02282891|Ketamine|ketamine|mesh-list
91943765|NCT02282891|Propofol|propofol|mesh-list
91943766|NCT02282891|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91943767|NCT02282891|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943768|NCT02282891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943769|NCT02282891|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91943770|NCT02282891|Anesthetics, General|anesthetics, general|mesh-ancestor
91943771|NCT02282891|Anesthetics|anesthetics|mesh-ancestor
91943772|NCT02282891|Analgesics|analgesics|mesh-ancestor
91943773|NCT02282891|Sensory System Agents|sensory system agents|mesh-ancestor
91943774|NCT02282891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943775|NCT02282891|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91943776|NCT02282891|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91943777|NCT02282891|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91943779|NCT02282891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943780|NCT00464633|Alvocidib|alvocidib|mesh-list
91943781|NCT00464633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943782|NCT00464633|Growth Inhibitors|growth inhibitors|mesh-ancestor
91943783|NCT00464633|Growth Substances|growth substances|mesh-ancestor
91943785|NCT00464633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943787|NCT00464633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943788|NCT00464555|Sirolimus|sirolimus|mesh-list
91943789|NCT00464555|Lisofylline|lisofylline|mesh-list
91943790|NCT00464555|Tacrolimus|tacrolimus|mesh-list
91943792|NCT00464555|Basiliximab|basiliximab|mesh-list
91943793|NCT00464555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943794|NCT00464555|Immunologic Factors|immunologic factors|mesh-ancestor
91943795|NCT00464555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943796|NCT00464555|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91943797|NCT00464555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943798|NCT00464555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943799|NCT00464555|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91943800|NCT00464555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943802|NCT00464555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943803|NCT00464555|Antifungal Agents|antifungal agents|mesh-ancestor
91943804|NCT00464555|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91943805|NCT00464555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91943806|NCT00464555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943807|NCT00464555|Analgesics|analgesics|mesh-ancestor
91943808|NCT00464555|Sensory System Agents|sensory system agents|mesh-ancestor
91943809|NCT00464555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943810|NCT00464555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91943811|NCT00464555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943814|NCT00464243|Serotonin Agents|serotonin agents|mesh-ancestor
91943815|NCT00464243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943816|NCT00464243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943817|NCT00464243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943819|NCT03336541|Analgesics|analgesics|mesh-ancestor
91943820|NCT03336541|Sensory System Agents|sensory system agents|mesh-ancestor
91943821|NCT03336541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943822|NCT03336541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943823|NCT03336541|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91943825|NCT03336541|Anesthetics, General|anesthetics, general|mesh-ancestor
91943826|NCT03336541|Anesthetics|anesthetics|mesh-ancestor
91943827|NCT03336541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943828|NCT03336541|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91943829|NCT03336541|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91943830|NCT03336541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943831|NCT03336541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943832|NCT00525941|Indiplon|indiplon|mesh-list
91943833|NCT00525941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91943834|NCT00525941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943835|NCT00525941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943836|NCT00525941|GABA Modulators|gaba modulators|mesh-ancestor
91943838|NCT00525941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943839|NCT00525941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943840|NCT03476083|Tenofovir|tenofovir|mesh-list
91943841|NCT03476083|Antiviral Agents|antiviral agents|mesh-ancestor
91943842|NCT03476083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943843|NCT03476083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91943844|NCT03476083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91943845|NCT03476083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943846|NCT03476083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943847|NCT03476083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91943848|NCT03476083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91943849|NCT02738203|Lidocaine|lidocaine|mesh-list
91943850|NCT02738203|Anesthetics, Local|anesthetics, local|mesh-ancestor
91943852|NCT02738203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943853|NCT02738203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943854|NCT02738203|Sensory System Agents|sensory system agents|mesh-ancestor
91943855|NCT02738203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943856|NCT02738203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91943857|NCT02738203|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91943858|NCT02738203|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91943859|NCT02738203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91943860|NCT02738203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943861|NCT00457457|Tamsulosin|tamsulosin|mesh-list
91943862|NCT00457457|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91943863|NCT00457457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91943864|NCT00457457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91943865|NCT00457457|Adrenergic Agents|adrenergic agents|mesh-ancestor
91943866|NCT00457457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943867|NCT00457457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943868|NCT00457457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943869|NCT00457457|Urological Agents|urological agents|mesh-ancestor
91943870|NCT00517439|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91943871|NCT00517439|Interferon-alpha|interferon-alpha|mesh-list
91943872|NCT00517439|Antiviral Agents|antiviral agents|mesh-ancestor
91943873|NCT00517439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943874|NCT00517439|Immunologic Factors|immunologic factors|mesh-ancestor
91943875|NCT00517439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943876|NCT03472651|Flupenthixol|flupenthixol|mesh-list
91943877|NCT03472651|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
91943878|NCT03472651|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91943879|NCT03472651|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91943880|NCT03472651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91943881|NCT03472651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943882|NCT03472651|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91943883|NCT03472651|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91943884|NCT03472651|Dopamine Agents|dopamine agents|mesh-ancestor
91943885|NCT03472651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943886|NCT03472651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943887|NCT00517049|Rituximab|rituximab|mesh-list
91943888|NCT00517049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943889|NCT00517049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943890|NCT00517049|Immunologic Factors|immunologic factors|mesh-ancestor
91943891|NCT00517049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943892|NCT00517049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91943893|NCT02283203|Acetaminophen|acetaminophen|mesh-list
91943894|NCT02283203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91943895|NCT02283203|Analgesics|analgesics|mesh-ancestor
91943896|NCT02283203|Sensory System Agents|sensory system agents|mesh-ancestor
91943897|NCT02283203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943898|NCT02283203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943900|NCT02536183|Doxorubicin|doxorubicin|mesh-list
91943901|NCT02536183|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91943902|NCT02536183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91943903|NCT02536183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943904|NCT02536183|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91943905|NCT02536183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943906|NCT02536183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943907|NCT02536183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943908|NCT02523313|Nivolumab|nivolumab|mesh-list
91943909|NCT02523313|Ipilimumab|ipilimumab|mesh-list
91943910|NCT02523313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943911|NCT02523313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943912|NCT02523313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91943913|NCT02523313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943915|NCT02452034|Antifungal Agents|antifungal agents|mesh-ancestor
91943916|NCT02452034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943917|NCT02452034|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91943918|NCT02452034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91943919|NCT02452034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91943920|NCT02452034|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91943921|NCT02452034|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91943922|NCT02452034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943923|NCT02452034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943924|NCT02452034|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91943925|NCT02452034|Hormone Antagonists|hormone antagonists|mesh-ancestor
91943926|NCT02452034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91943927|NCT02452034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943929|NCT02283359|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91943930|NCT02283359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91943931|NCT02283359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943932|NCT02283359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943933|NCT02283359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943934|NCT00511043|Vatalanib|vatalanib|mesh-list
91943935|NCT00511043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91943936|NCT00511043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943937|NCT00511043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943938|NCT00508625|Paclitaxel|paclitaxel|mesh-list
91943939|NCT00508625|Bevacizumab|bevacizumab|mesh-list
91943940|NCT00508625|Carboplatin|carboplatin|mesh-list
91943941|NCT00508625|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91943942|NCT00508625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943943|NCT00508625|Tubulin Modulators|tubulin modulators|mesh-ancestor
91943944|NCT00508625|Antimitotic Agents|antimitotic agents|mesh-ancestor
91943945|NCT00508625|Mitosis Modulators|mitosis modulators|mesh-ancestor
91943946|NCT00508625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943947|NCT00508625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943949|NCT00508625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91943950|NCT00508625|Growth Substances|growth substances|mesh-ancestor
91943951|NCT00508625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943953|NCT02284529|Leucovorin|leucovorin|mesh-list
91943954|NCT02284529|Fluorouracil|fluorouracil|mesh-list
91943956|NCT02284529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943957|NCT02284529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91943958|NCT02284529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943959|NCT02284529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91943960|NCT02284529|Immunologic Factors|immunologic factors|mesh-ancestor
91943961|NCT02284529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943962|NCT02284529|Antidotes|antidotes|mesh-ancestor
91943964|NCT02284529|Vitamin B Complex|vitamin b complex|mesh-ancestor
91943965|NCT02284529|Vitamins|vitamins|mesh-ancestor
91943966|NCT02284529|Micronutrients|micronutrients|mesh-ancestor
91943967|NCT02482298|Ticagrelor|ticagrelor|mesh-list
91943968|NCT02482298|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91943969|NCT02482298|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91943970|NCT02482298|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91943971|NCT02482298|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91943972|NCT02482298|Purinergic Agents|purinergic agents|mesh-ancestor
91943973|NCT02482298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943974|NCT02482298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943975|NCT02482298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943977|NCT04470479|Miotics|miotics|mesh-ancestor
91943978|NCT04470479|Autonomic Agents|autonomic agents|mesh-ancestor
91943979|NCT04470479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91943980|NCT04470479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91943981|NCT04470479|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91943982|NCT04470479|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91943983|NCT04470479|Cholinergic Agents|cholinergic agents|mesh-ancestor
91943984|NCT04470479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91943985|NCT04470479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943986|NCT00383513|Epratuzumab|epratuzumab|mesh-list
91943987|NCT00383513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91943988|NCT00383513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943990|NCT00382811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91943992|NCT02286635|Rifampin|rifampin|mesh-list
91943993|NCT02286635|Deflazacort|deflazacort|mesh-list
91943994|NCT02286635|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91943995|NCT02286635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91943996|NCT02286635|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91943997|NCT02286635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91943998|NCT02286635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91943999|NCT02286635|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91944000|NCT02286635|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91944001|NCT02286635|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91944002|NCT02286635|Antitubercular Agents|antitubercular agents|mesh-ancestor
91944003|NCT02286635|Leprostatic Agents|leprostatic agents|mesh-ancestor
91944004|NCT02286635|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944005|NCT02286635|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91944006|NCT02286635|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91944007|NCT02286635|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91944008|NCT02286635|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91944009|NCT02286635|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91944010|NCT02286635|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91944011|NCT02286635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944012|NCT02286635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91944013|NCT02286635|Immunologic Factors|immunologic factors|mesh-ancestor
91944014|NCT02286635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944016|NCT00440531|Immunologic Factors|immunologic factors|mesh-ancestor
91944017|NCT00440531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944019|NCT00380159|Emtricitabine|emtricitabine|mesh-list
91944020|NCT00380159|Dexelvucitabine|dexelvucitabine|mesh-list
91944021|NCT00380159|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91944022|NCT00380159|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944023|NCT00380159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944024|NCT00380159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944026|NCT00380159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944027|NCT00380159|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91944028|NCT00380159|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91945351|NCT03529097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944029|NCT00437021|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91944031|NCT00437021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944033|NCT00375791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944034|NCT00375791|Antiemetics|antiemetics|mesh-ancestor
91944035|NCT00375791|Autonomic Agents|autonomic agents|mesh-ancestor
91944036|NCT00375791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944037|NCT00375791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944038|NCT00375791|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91944039|NCT00375791|Glucocorticoids|glucocorticoids|mesh-ancestor
91944040|NCT00375791|Hormones|hormones|mesh-ancestor
91944041|NCT00375791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944042|NCT00375791|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91944043|NCT00375791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944044|NCT00431873|Mocetinostat|mocetinostat|mesh-list
91944045|NCT00431873|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91944046|NCT00431873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944047|NCT00431873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944048|NCT02287181|Remifentanil|remifentanil|mesh-list
91944050|NCT02287181|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91944051|NCT02287181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944052|NCT02287181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944053|NCT02287181|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91944054|NCT02287181|Anesthetics, General|anesthetics, general|mesh-ancestor
91944055|NCT02287181|Anesthetics|anesthetics|mesh-ancestor
91944056|NCT02287181|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91944057|NCT02287181|Narcotics|narcotics|mesh-ancestor
91944058|NCT02287181|Analgesics|analgesics|mesh-ancestor
91944059|NCT02287181|Sensory System Agents|sensory system agents|mesh-ancestor
91944060|NCT02287181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944061|NCT02287259|Olanzapine|olanzapine|mesh-list
91944062|NCT02287259|Antiemetics|antiemetics|mesh-ancestor
91944063|NCT02287259|Autonomic Agents|autonomic agents|mesh-ancestor
91944064|NCT02287259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944065|NCT02287259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944066|NCT02287259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91944067|NCT02287259|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91944068|NCT02287259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91944069|NCT02287259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944070|NCT02287259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91944071|NCT02287259|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91944072|NCT02287259|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91945352|NCT03529097|Antipyretics|antipyretics|mesh-ancestor
91944073|NCT02287259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944074|NCT02287259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944075|NCT02287259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944076|NCT02287259|Serotonin Agents|serotonin agents|mesh-ancestor
91944077|NCT00429923|Fluprednisolone|fluprednisolone|mesh-list
91944078|NCT00429923|Difluprednate|difluprednate|mesh-list
91944079|NCT00429923|Glucocorticoids|glucocorticoids|mesh-ancestor
91944080|NCT00429923|Hormones|hormones|mesh-ancestor
91944081|NCT00429923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944082|NCT00429923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944083|NCT00429923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944084|NCT04470557|Fibrin fragment D|fibrin fragment d|mesh-list
91944085|NCT04470557|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91944086|NCT04470557|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91944087|NCT04470557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944088|NCT04470557|Hemostatics|hemostatics|mesh-ancestor
91944089|NCT04470557|Coagulants|coagulants|mesh-ancestor
91944090|NCT00372437|Gemcitabine|gemcitabine|mesh-list
91944091|NCT00372437|Mocetinostat|mocetinostat|mesh-list
91944092|NCT00372437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944093|NCT00372437|Antimetabolites|antimetabolites|mesh-ancestor
91944094|NCT00372437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944095|NCT00372437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944096|NCT00372437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91944097|NCT00372437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944098|NCT00369473|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91944099|NCT00369473|Immunologic Factors|immunologic factors|mesh-ancestor
91944100|NCT00369473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944101|NCT04470791|Antivenins|antivenins|mesh-list
91944102|NCT04470791|Immunologic Factors|immunologic factors|mesh-ancestor
91944103|NCT04470791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944105|NCT00364247|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91944106|NCT00364247|Narcotics|narcotics|mesh-ancestor
91944107|NCT00364247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944108|NCT00364247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944109|NCT00364247|Analgesics|analgesics|mesh-ancestor
91944110|NCT00364247|Sensory System Agents|sensory system agents|mesh-ancestor
91944111|NCT00364247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944112|NCT00364247|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91944113|NCT00364247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91944114|NCT00364247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944115|NCT00364247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944116|NCT00364247|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944117|NCT00364247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944118|NCT00424697|Lorazepam|lorazepam|mesh-list
91944119|NCT00424697|Anticonvulsants|anticonvulsants|mesh-ancestor
91944120|NCT00424697|Antiemetics|antiemetics|mesh-ancestor
91944121|NCT00424697|Autonomic Agents|autonomic agents|mesh-ancestor
91944122|NCT00424697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944123|NCT00424697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944124|NCT00424697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91944125|NCT00424697|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91944126|NCT00424697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944127|NCT00424697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91944128|NCT00424697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91944129|NCT00424697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91944130|NCT00424697|GABA Modulators|gaba modulators|mesh-ancestor
91944131|NCT00424697|GABA Agents|gaba agents|mesh-ancestor
91944132|NCT00424697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944133|NCT00424697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944134|NCT00360035|Obatoclax|obatoclax|mesh-list
91944135|NCT00360035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944136|NCT00360035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944137|NCT00356681|Niacinamide|niacinamide|mesh-list
91944138|NCT00356681|Paclitaxel|paclitaxel|mesh-list
91944139|NCT00356681|Bevacizumab|bevacizumab|mesh-list
91944140|NCT00356681|Motesanib diphosphate|motesanib diphosphate|mesh-list
91944141|NCT00356681|Imetelstat|imetelstat|mesh-list
91944142|NCT00356681|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91944143|NCT00356681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944144|NCT00356681|Tubulin Modulators|tubulin modulators|mesh-ancestor
91944145|NCT00356681|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944146|NCT00356681|Mitosis Modulators|mitosis modulators|mesh-ancestor
91944147|NCT00356681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944148|NCT00356681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91944149|NCT00356681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91944150|NCT00356681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91944151|NCT00356681|Growth Substances|growth substances|mesh-ancestor
91944152|NCT00356681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944153|NCT00356681|Growth Inhibitors|growth inhibitors|mesh-ancestor
91944154|NCT00356681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91944155|NCT00356681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944156|NCT00356681|Vitamin B Complex|vitamin b complex|mesh-ancestor
91944157|NCT00356681|Vitamins|vitamins|mesh-ancestor
91944158|NCT00356681|Micronutrients|micronutrients|mesh-ancestor
91944159|NCT00417209|Fluorouracil|fluorouracil|mesh-list
91944160|NCT00417209|Capecitabine|capecitabine|mesh-list
91944161|NCT00417209|Antimetabolites|antimetabolites|mesh-ancestor
91944162|NCT00417209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944163|NCT00417209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944164|NCT00417209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944165|NCT00417209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91944166|NCT00417209|Immunologic Factors|immunologic factors|mesh-ancestor
91944167|NCT00417209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944168|NCT04470401|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91944169|NCT04470401|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91944170|NCT04470401|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91944171|NCT04470401|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944172|NCT04470401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944173|NCT04470401|Cholinergic Agents|cholinergic agents|mesh-ancestor
91944174|NCT04470401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944175|NCT04470401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944176|NCT04470401|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91944177|NCT04470401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944178|NCT00355355|Talaporfin|talaporfin|mesh-list
91944179|NCT00355355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944180|NCT00355355|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91944181|NCT00355355|Dermatologic Agents|dermatologic agents|mesh-ancestor
91944182|NCT00407303|Bortezomib|bortezomib|mesh-list
91944183|NCT00407303|Obatoclax|obatoclax|mesh-list
91944184|NCT00407303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944185|NCT00407303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944186|NCT00407303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944187|NCT00344045|Acetaminophen|acetaminophen|mesh-list
91944188|NCT00344045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91944189|NCT00344045|Analgesics|analgesics|mesh-ancestor
91944190|NCT00344045|Sensory System Agents|sensory system agents|mesh-ancestor
91944191|NCT00344045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944192|NCT00344045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944193|NCT00344045|Antipyretics|antipyretics|mesh-ancestor
91944194|NCT02256436|Paclitaxel|paclitaxel|mesh-list
91944195|NCT02256436|Docetaxel|docetaxel|mesh-list
91944196|NCT02256436|Pembrolizumab|pembrolizumab|mesh-list
91944197|NCT02256436|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91944198|NCT02256436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944199|NCT02256436|Tubulin Modulators|tubulin modulators|mesh-ancestor
91944200|NCT02256436|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944201|NCT02256436|Mitosis Modulators|mitosis modulators|mesh-ancestor
91944202|NCT02256436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944203|NCT02256436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91945353|NCT03531749|Ascorbic Acid|ascorbic acid|mesh-list
91944207|NCT00343109|Immunologic Factors|immunologic factors|mesh-ancestor
91944208|NCT00343109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945354|NCT03531749|Antioxidants|antioxidants|mesh-ancestor
91944227|NCT00405743|Immunologic Factors|immunologic factors|mesh-ancestor
91944228|NCT00405743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944229|NCT00403169|Lenalidomide|lenalidomide|mesh-list
91944230|NCT00403169|Immunologic Factors|immunologic factors|mesh-ancestor
91944231|NCT00403169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944232|NCT00403169|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91944233|NCT00403169|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91944234|NCT00403169|Growth Substances|growth substances|mesh-ancestor
91944235|NCT00403169|Growth Inhibitors|growth inhibitors|mesh-ancestor
91944236|NCT00403169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944237|NCT00332657|Hydrocortisone|hydrocortisone|mesh-list
91944238|NCT00332657|Anecortave|anecortave|mesh-list
91944239|NCT00332657|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91944240|NCT00332657|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91944241|NCT00332657|Growth Substances|growth substances|mesh-ancestor
91944242|NCT00332657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944243|NCT00332657|Growth Inhibitors|growth inhibitors|mesh-ancestor
91944244|NCT00332657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944245|NCT00332657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944246|NCT00330473|Insulin|insulin|mesh-list
91944247|NCT00330473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91944248|NCT00330473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91944249|NCT00330473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944250|NCT00327743|Capecitabine|capecitabine|mesh-list
91944251|NCT00327743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944252|NCT00327743|Antimetabolites|antimetabolites|mesh-ancestor
91944253|NCT00327743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944254|NCT00327743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944255|NCT02285075|Temocillin|temocillin|mesh-list
91944256|NCT02285075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944257|NCT02285075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944258|NCT00321815|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91944259|NCT00321815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944260|NCT00321815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91944261|NCT00321815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944262|NCT00321815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944263|NCT00398879|Capecitabine|capecitabine|mesh-list
91944264|NCT00398879|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944265|NCT00398879|Antimetabolites|antimetabolites|mesh-ancestor
91944266|NCT00398879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944267|NCT00398879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944268|NCT00309179|Cetuximab|cetuximab|mesh-list
91944269|NCT00309179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91944270|NCT00309179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944271|NCT00394199|Fluticasone|fluticasone|mesh-list
91944273|NCT00394199|Formoterol Fumarate|formoterol fumarate|mesh-list
91944274|NCT00394199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944275|NCT00394199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91944276|NCT00394199|Autonomic Agents|autonomic agents|mesh-ancestor
91944277|NCT00394199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944278|NCT00394199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944279|NCT00394199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91944280|NCT00394199|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944281|NCT00394199|Dermatologic Agents|dermatologic agents|mesh-ancestor
91944282|NCT00394199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91944283|NCT00394199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91944284|NCT00394199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91944285|NCT00394199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91944286|NCT00394199|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944287|NCT00394199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944288|NCT00394199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944289|NCT00394121|Fluticasone|fluticasone|mesh-list
91944290|NCT00394121|Xhance|xhance|mesh-list
91944291|NCT00394121|Formoterol Fumarate|formoterol fumarate|mesh-list
91944292|NCT00394121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944293|NCT00394121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91944294|NCT00394121|Autonomic Agents|autonomic agents|mesh-ancestor
91944295|NCT00394121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944296|NCT00394121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944297|NCT00394121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91944298|NCT00394121|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944299|NCT00394121|Dermatologic Agents|dermatologic agents|mesh-ancestor
91944300|NCT00394121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91944301|NCT00394121|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91944302|NCT00394121|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91944303|NCT00394121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91944304|NCT00394121|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944305|NCT00394121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944306|NCT00394121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944307|NCT02480114|Acetaminophen|acetaminophen|mesh-list
91944308|NCT02480114|Ibuprofen|ibuprofen|mesh-list
91944309|NCT02480114|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
91944310|NCT02480114|Fentanyl|fentanyl|mesh-list
91944311|NCT02480114|Oxycodone|oxycodone|mesh-list
91944312|NCT02480114|Hydrocodone|hydrocodone|mesh-list
91944313|NCT02480114|Gabapentin|gabapentin|mesh-list
91944314|NCT02480114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91944315|NCT02480114|Narcotics|narcotics|mesh-ancestor
91944316|NCT02480114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944317|NCT02480114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944318|NCT02480114|Analgesics|analgesics|mesh-ancestor
91944319|NCT02480114|Sensory System Agents|sensory system agents|mesh-ancestor
91944320|NCT02480114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944321|NCT02480114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91944322|NCT02480114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91944323|NCT02480114|Anesthetics, General|anesthetics, general|mesh-ancestor
91944324|NCT02480114|Anesthetics|anesthetics|mesh-ancestor
91944326|NCT02480114|Antipyretics|antipyretics|mesh-ancestor
91944327|NCT02480114|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91944328|NCT02480114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944329|NCT02480114|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944330|NCT02480114|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91944331|NCT02480114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944332|NCT02480114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944333|NCT02480114|Anticonvulsants|anticonvulsants|mesh-ancestor
91944334|NCT02480114|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91944335|NCT02480114|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91944336|NCT02480114|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91944337|NCT02480114|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91944338|NCT02480114|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91944339|NCT02480114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944340|NCT02480114|Antimanic Agents|antimanic agents|mesh-ancestor
91944341|NCT02480114|Antitussive Agents|antitussive agents|mesh-ancestor
91944342|NCT02480114|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944343|NCT00299507|Hydrocortisone|hydrocortisone|mesh-list
91944344|NCT00299507|Anecortave|anecortave|mesh-list
91944345|NCT00299507|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91944346|NCT00299507|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91944347|NCT00299507|Growth Substances|growth substances|mesh-ancestor
91944348|NCT00299507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944349|NCT00299507|Growth Inhibitors|growth inhibitors|mesh-ancestor
91944350|NCT00299507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944351|NCT00299507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944352|NCT02285309|Enoximone|enoximone|mesh-list
91944353|NCT02285309|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91944354|NCT02285309|Vasodilator Agents|vasodilator agents|mesh-ancestor
91944355|NCT02285309|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91944356|NCT02285309|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91944357|NCT02285309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944358|NCT02285309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944359|NCT02285309|Protective Agents|protective agents|mesh-ancestor
91944360|NCT02285309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944361|NCT02479880|Tenofovir|tenofovir|mesh-list
91944362|NCT02479880|Antiviral Agents|antiviral agents|mesh-ancestor
91944363|NCT02479880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944364|NCT02479880|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91944365|NCT02479880|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944366|NCT02479880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945808|NCT04837924|Narcotics|narcotics|mesh-ancestor
91945809|NCT04837924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945810|NCT04837924|Anesthetics, Local|anesthetics, local|mesh-ancestor
91945811|NCT04837924|Anesthetics|anesthetics|mesh-ancestor
91945812|NCT05406466|Lenvatinib|lenvatinib|mesh-list
91945813|NCT05406466|Tislelizumab|tislelizumab|mesh-list
91945814|NCT05406466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945815|NCT05406466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91945816|NCT05406466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945817|NCT05406466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945818|NCT05406466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91945819|NCT05152420|Rivaroxaban|rivaroxaban|mesh-list
91945820|NCT05152420|Apixaban|apixaban|mesh-list
91945821|NCT05152420|Edoxaban|edoxaban|mesh-list
91945822|NCT05152420|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91945823|NCT05152420|Antithrombins|antithrombins|mesh-ancestor
91945824|NCT05152420|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91945825|NCT05152420|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945826|NCT05152420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945827|NCT05152420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945828|NCT05152420|Anticoagulants|anticoagulants|mesh-ancestor
91945829|NCT01601470|Sildenafil Citrate|sildenafil citrate|mesh-list
91946321|NCT04791514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91946322|NCT04810546|Lactoferrin|lactoferrin|mesh-list
91946323|NCT04810546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946324|NCT04596826|Dronabinol|dronabinol|mesh-list
91946325|NCT04596826|Hallucinogens|hallucinogens|mesh-ancestor
91946654|NCT04551261|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91946655|NCT04534257|Sirolimus|sirolimus|mesh-list
91946656|NCT04534257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946657|NCT04534257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946658|NCT04534257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91946659|NCT04534257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944367|NCT02479880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944368|NCT02479880|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91946660|NCT04534257|Antifungal Agents|antifungal agents|mesh-ancestor
91946661|NCT04534257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946662|NCT04534257|Immunologic Factors|immunologic factors|mesh-ancestor
91946663|NCT04534257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946665|NCT03522935|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946666|NCT03522935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946667|NCT03522935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946668|NCT03138681|Phosphocreatine|phosphocreatine|mesh-list
91946669|NCT03138681|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91946670|NCT03138681|Protective Agents|protective agents|mesh-ancestor
91946671|NCT03138681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946672|NCT05392257|Rituximab|rituximab|mesh-list
91946673|NCT05392257|Lenalidomide|lenalidomide|mesh-list
91946674|NCT05392257|Zanubrutinib|zanubrutinib|mesh-list
91946675|NCT05392257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946676|NCT05392257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946677|NCT05392257|Immunologic Factors|immunologic factors|mesh-ancestor
91946678|NCT05392257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946679|NCT05392257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946680|NCT05392257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91946681|NCT05392257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91946682|NCT05392257|Growth Substances|growth substances|mesh-ancestor
91946683|NCT05392257|Growth Inhibitors|growth inhibitors|mesh-ancestor
91946684|NCT05392257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946685|NCT05392257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946686|NCT05392257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946687|NCT02240680|Linagliptin|linagliptin|mesh-list
91946688|NCT02240680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91946689|NCT02240680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946702|NCT05391867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946704|NCT03110679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91946705|NCT03110679|Immunologic Factors|immunologic factors|mesh-ancestor
91946706|NCT03110679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946707|NCT03110679|Viscosupplements|viscosupplements|mesh-ancestor
91946708|NCT03110679|Protective Agents|protective agents|mesh-ancestor
91946709|NCT05391789|Urinastatin|urinastatin|mesh-list
91946710|NCT05391789|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91946711|NCT05391789|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91946712|NCT05391789|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946713|NCT05391789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946714|NCT05391789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946715|NCT04699071|Pembrolizumab|pembrolizumab|mesh-list
91946716|NCT04699071|Lenvatinib|lenvatinib|mesh-list
91946717|NCT04699071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946718|NCT04699071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946719|NCT04699071|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91946720|NCT04699071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946721|NCT04699071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946722|NCT04699071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946723|NCT03139851|Cyclophosphamide|cyclophosphamide|mesh-list
91946724|NCT03139851|Pembrolizumab|pembrolizumab|mesh-list
91946725|NCT03139851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946726|NCT03139851|Immunologic Factors|immunologic factors|mesh-ancestor
91946727|NCT03139851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946728|NCT03139851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946729|NCT03139851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91946730|NCT03139851|Alkylating Agents|alkylating agents|mesh-ancestor
91946731|NCT03139851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946732|NCT03139851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946733|NCT03139851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91946734|NCT03139851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946735|NCT03139851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91946737|NCT03967288|Chloroprocaine|chloroprocaine|mesh-list
91946739|NCT03967288|Anesthetics, Local|anesthetics, local|mesh-ancestor
91946740|NCT03967288|Anesthetics|anesthetics|mesh-ancestor
91947068|NCT02296073|Dexmedetomidine|dexmedetomidine|mesh-list
91946741|NCT03967288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944369|NCT02479880|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91944370|NCT00297401|Ruboxistaurin|ruboxistaurin|mesh-list
91944371|NCT00297401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944372|NCT00297401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946742|NCT03967288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946743|NCT03967288|Sensory System Agents|sensory system agents|mesh-ancestor
91946744|NCT03967288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946745|NCT04167111|Vitamin D|vitamin d|mesh-list
91946746|NCT04167111|Cholecalciferol|cholecalciferol|mesh-list
91946747|NCT04167111|Vitamins|vitamins|mesh-ancestor
91946748|NCT04167111|Micronutrients|micronutrients|mesh-ancestor
91946749|NCT04167111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946750|NCT04167111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91946751|NCT04167111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91946775|NCT03899961|Carbetocin|carbetocin|mesh-list
91946776|NCT03899961|Oxytocics|oxytocics|mesh-ancestor
91946777|NCT03899961|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91946778|NCT03899961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946779|NCT02462486|Ranibizumab|ranibizumab|mesh-list
91946780|NCT02462486|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91946781|NCT02462486|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91946782|NCT02462486|Growth Substances|growth substances|mesh-ancestor
91946783|NCT02462486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946784|NCT02462486|Growth Inhibitors|growth inhibitors|mesh-ancestor
91946785|NCT02462486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946786|NCT03521219|Apatinib|apatinib|mesh-list
91946787|NCT03521219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946788|NCT03521219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946789|NCT03521219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946790|NCT03521219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946791|NCT05318157|Emedastine|emedastine|mesh-list
91946792|NCT05318157|Budesonide|budesonide|mesh-list
91946793|NCT05318157|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91946794|NCT05318157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91946795|NCT05318157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946796|NCT05318157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946797|NCT05318157|Autonomic Agents|autonomic agents|mesh-ancestor
91946798|NCT05318157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946799|NCT05318157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946800|NCT05318157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946801|NCT05318157|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946802|NCT05318157|Glucocorticoids|glucocorticoids|mesh-ancestor
91946803|NCT05318157|Hormones|hormones|mesh-ancestor
91946804|NCT05318157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946805|NCT05318157|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91946806|NCT05318157|Histamine Antagonists|histamine antagonists|mesh-ancestor
91946818|NCT02294279|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946820|NCT02294357|Dexamethasone acetate|dexamethasone acetate|mesh-list
91946821|NCT02294357|Prednisone|prednisone|mesh-list
91946822|NCT02294357|Methylprednisolone|methylprednisolone|mesh-list
91946823|NCT02294357|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91946824|NCT02294357|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91946825|NCT02294357|Prednisolone|prednisolone|mesh-list
91946826|NCT02294357|Prednisolone acetate|prednisolone acetate|mesh-list
91946827|NCT02294357|Lenalidomide|lenalidomide|mesh-list
91946828|NCT02294357|Pomalidomide|pomalidomide|mesh-list
91946829|NCT02294357|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91946830|NCT02294357|Prednisolone phosphate|prednisolone phosphate|mesh-list
91946831|NCT02294357|BB 1101|bb 1101|mesh-list
91946832|NCT02294357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946833|NCT02294357|Antiemetics|antiemetics|mesh-ancestor
91946834|NCT02294357|Autonomic Agents|autonomic agents|mesh-ancestor
91946835|NCT02294357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946836|NCT02294357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946837|NCT02294357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946838|NCT02294357|Glucocorticoids|glucocorticoids|mesh-ancestor
91946839|NCT02294357|Hormones|hormones|mesh-ancestor
91946840|NCT02294357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946841|NCT02294357|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91946842|NCT02294357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946843|NCT02294357|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946844|NCT02294357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944374|NCT00297089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946845|NCT02294357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946846|NCT02294357|Immunologic Factors|immunologic factors|mesh-ancestor
91946847|NCT02294357|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91946848|NCT02294357|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91946849|NCT02294357|Growth Substances|growth substances|mesh-ancestor
91946850|NCT02294357|Growth Inhibitors|growth inhibitors|mesh-ancestor
91946851|NCT02294357|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91946852|NCT02294357|Protective Agents|protective agents|mesh-ancestor
91946853|NCT03880539|Vancomycin|vancomycin|mesh-list
91946854|NCT03880539|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946855|NCT03880539|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946856|NCT03518021|Naloxone|naloxone|mesh-list
91946857|NCT03518021|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91946858|NCT03518021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946859|NCT03518021|Sensory System Agents|sensory system agents|mesh-ancestor
91946860|NCT03518021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946861|NCT02495948|Hydrogen Peroxide|hydrogen peroxide|mesh-list
91946862|NCT02495948|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91946863|NCT02495948|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91946864|NCT02495948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946865|NCT02294591|Acetylcysteine|acetylcysteine|mesh-list
91946866|NCT02294591|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91946867|NCT02294591|Antiviral Agents|antiviral agents|mesh-ancestor
91946868|NCT02294591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946869|NCT02294591|Expectorants|expectorants|mesh-ancestor
91946870|NCT02294591|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946871|NCT02294591|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91946872|NCT02294591|Antioxidants|antioxidants|mesh-ancestor
91946900|NCT03520985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946901|NCT03520985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91946902|NCT03520985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946903|NCT03520985|Immunologic Factors|immunologic factors|mesh-ancestor
91946904|NCT03520985|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91946905|NCT03520985|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91946906|NCT03520985|Growth Substances|growth substances|mesh-ancestor
91946907|NCT03520985|Growth Inhibitors|growth inhibitors|mesh-ancestor
91946908|NCT03517943|Loratadine|loratadine|mesh-list
91946909|NCT03517943|Pseudoephedrine|pseudoephedrine|mesh-list
91946910|NCT03517943|Ephedrine|ephedrine|mesh-list
91946911|NCT03517943|Antipruritics|antipruritics|mesh-ancestor
91946912|NCT03517943|Dermatologic Agents|dermatologic agents|mesh-ancestor
91946913|NCT03517943|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91946914|NCT03517943|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91946915|NCT03517943|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91946916|NCT03517943|Histamine Antagonists|histamine antagonists|mesh-ancestor
91946917|NCT03517943|Histamine Agents|histamine agents|mesh-ancestor
91946918|NCT03517943|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946919|NCT03517943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946920|NCT03517943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946921|NCT03517943|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946938|NCT03136341|Cholinergic Agents|cholinergic agents|mesh-ancestor
91946939|NCT03136341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946940|NCT03136341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946941|NCT03136341|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91946942|NCT03136341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946944|NCT04465175|Analgesics|analgesics|mesh-ancestor
91946945|NCT04465175|Sensory System Agents|sensory system agents|mesh-ancestor
91946946|NCT04465175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946947|NCT04465175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946948|NCT04465175|Anesthetics|anesthetics|mesh-ancestor
91946949|NCT04465175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946950|NCT04465175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91946951|NCT04465175|Anticonvulsants|anticonvulsants|mesh-ancestor
91946952|NCT04465175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91946953|NCT04465175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946954|NCT04465175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946955|NCT04465175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91946956|NCT04465175|Tocolytic Agents|tocolytic agents|mesh-ancestor
91946957|NCT04465175|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91944375|NCT00297089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944376|NCT00297089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946958|NCT03158883|Avelumab|avelumab|mesh-list
91946959|NCT03158883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946960|NCT03158883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946962|NCT03138447|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91946963|NCT03138447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946964|NCT03109977|Pertuzumab|pertuzumab|mesh-list
91946965|NCT03109977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946966|NCT03109977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946967|NCT03520595|Diclofenac|diclofenac|mesh-list
91946968|NCT03520595|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91946969|NCT03520595|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91946970|NCT03520595|Analgesics|analgesics|mesh-ancestor
91946971|NCT03520595|Sensory System Agents|sensory system agents|mesh-ancestor
91946972|NCT03520595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946973|NCT03520595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946974|NCT03520595|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946975|NCT03520595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946976|NCT03520595|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91946977|NCT03520595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946978|NCT03520595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946995|NCT04543227|Analgesics, Opioid|analgesics, opioid|mesh-list
91946996|NCT04543227|Narcotics|narcotics|mesh-ancestor
91946997|NCT04543227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946998|NCT04543227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946999|NCT04543227|Analgesics|analgesics|mesh-ancestor
91947000|NCT04543227|Sensory System Agents|sensory system agents|mesh-ancestor
91947001|NCT04543227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947002|NCT04542993|Zinc|zinc|mesh-list
91947003|NCT04542993|Resveratrol|resveratrol|mesh-list
91947004|NCT04542993|Picolinic acid|picolinic acid|mesh-list
91947005|NCT04542993|Trace Elements|trace elements|mesh-ancestor
91947006|NCT04542993|Micronutrients|micronutrients|mesh-ancestor
91947007|NCT04542993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947008|NCT04542993|Antioxidants|antioxidants|mesh-ancestor
91947009|NCT04542993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947010|NCT04542993|Protective Agents|protective agents|mesh-ancestor
91947011|NCT04542993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947012|NCT04542993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91947013|NCT04542993|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91947014|NCT04542993|Chelating Agents|chelating agents|mesh-ancestor
91947015|NCT04542993|Sequestering Agents|sequestering agents|mesh-ancestor
91947016|NCT03520361|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91947017|NCT02292173|Sorafenib|sorafenib|mesh-list
91947018|NCT02292173|Trametinib|trametinib|mesh-list
91947019|NCT02292173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947020|NCT02292173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947021|NCT02292173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947022|NCT02292173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947023|NCT03517319|Botulinum Toxins|botulinum toxins|mesh-list
91947024|NCT03517319|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91947025|NCT03517319|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91947026|NCT03517319|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91947027|NCT03517319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947028|NCT03517319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947029|NCT03517319|Cholinergic Agents|cholinergic agents|mesh-ancestor
91947030|NCT03517319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947031|NCT03517319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947032|NCT03517319|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91947033|NCT03517319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947034|NCT03520049|Oseltamivir|oseltamivir|mesh-list
91947035|NCT03520049|Antiviral Agents|antiviral agents|mesh-ancestor
91947050|NCT03516773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947051|NCT02461160|Midazolam|midazolam|mesh-list
91947052|NCT02461160|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91947053|NCT02461160|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91947054|NCT02461160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947055|NCT02461160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947056|NCT02461160|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91947057|NCT02461160|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91947058|NCT02461160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91947059|NCT02461160|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91944377|NCT00297089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91944378|NCT00297089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944379|NCT00286793|Gossypol acetic acid|gossypol acetic acid|mesh-list
91944380|NCT00286793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91947060|NCT02461160|Anesthetics, General|anesthetics, general|mesh-ancestor
91947062|NCT02461160|GABA Modulators|gaba modulators|mesh-ancestor
91947063|NCT02461160|GABA Agents|gaba agents|mesh-ancestor
91947064|NCT02461160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947065|NCT02461160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947066|NCT02296073|Fentanyl|fentanyl|mesh-list
91947067|NCT02296073|Midazolam|midazolam|mesh-list
91947069|NCT02296073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91947070|NCT02296073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947071|NCT02296073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947072|NCT02296073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947073|NCT02296073|Analgesics|analgesics|mesh-ancestor
91947074|NCT02296073|Sensory System Agents|sensory system agents|mesh-ancestor
91947075|NCT02296073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947076|NCT02296073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91947077|NCT02296073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91947078|NCT02296073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91947079|NCT02296073|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947080|NCT02296073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947081|NCT02296073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947082|NCT02296073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91947083|NCT02296073|Narcotics|narcotics|mesh-ancestor
91947084|NCT02296073|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91947085|NCT02296073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91947086|NCT02296073|Anesthetics, General|anesthetics, general|mesh-ancestor
91947087|NCT02296073|Anesthetics|anesthetics|mesh-ancestor
91947088|NCT02296073|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91947089|NCT02296073|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91947090|NCT02296073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91947091|NCT02296073|GABA Modulators|gaba modulators|mesh-ancestor
91947092|NCT02296073|GABA Agents|gaba agents|mesh-ancestor
91947093|NCT03132779|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
91947094|NCT03132779|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91947121|NCT02495168|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91947122|NCT02495168|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91947123|NCT02495168|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947124|NCT02495168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947125|NCT02495168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947126|NCT04934072|Denosumab|denosumab|mesh-list
91947127|NCT04934072|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947128|NCT04934072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947129|NCT03518489|Lappaconitine|lappaconitine|mesh-list
91947130|NCT03518489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91947131|NCT03518489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91947132|NCT03518489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947133|NCT03518489|Analgesics|analgesics|mesh-ancestor
91947134|NCT03518489|Sensory System Agents|sensory system agents|mesh-ancestor
91947135|NCT03518489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947136|NCT03518489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947137|NCT04933526|Dasatinib|dasatinib|mesh-list
91947138|NCT04933526|Flumatinib|flumatinib|mesh-list
91947139|NCT04933526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947140|NCT04933526|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947141|NCT04933526|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947142|NCT04933526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947168|NCT03514667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947169|NCT03514667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947170|NCT03514667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947171|NCT04465097|Exemestane|exemestane|mesh-list
91947172|NCT04465097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947173|NCT04465097|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91947174|NCT04465097|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91947175|NCT04465097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947176|NCT04465097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944382|NCT00286793|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91944383|NCT00286793|Contraceptive Agents|contraceptive agents|mesh-ancestor
91944384|NCT00286793|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91947177|NCT04465097|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91947178|NCT04465097|Hormone Antagonists|hormone antagonists|mesh-ancestor
91947179|NCT04465097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947180|NCT04465097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947181|NCT02493764|Linezolid|linezolid|mesh-list
91947182|NCT02493764|Tazobactam|tazobactam|mesh-list
91947184|NCT02493764|Imipenem|imipenem|mesh-list
91947185|NCT02493764|Relebactam|relebactam|mesh-list
91947186|NCT02493764|Cilastatin|cilastatin|mesh-list
91947187|NCT02493764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91947188|NCT02493764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947189|NCT02493764|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91947190|NCT02493764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947191|NCT02493764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947192|NCT02493764|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91947213|NCT02460380|Micronutrients|micronutrients|mesh-ancestor
91947214|NCT02460380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947215|NCT02460380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947216|NCT02460380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947217|NCT02299115|Prednisolone|prednisolone|mesh-list
91947218|NCT02299115|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91947219|NCT02299115|Methylprednisolone|methylprednisolone|mesh-list
91947220|NCT02299115|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91947221|NCT02299115|Prednisolone acetate|prednisolone acetate|mesh-list
91947222|NCT02299115|Vigabatrin|vigabatrin|mesh-list
91947223|NCT02299115|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91947224|NCT02299115|Prednisolone phosphate|prednisolone phosphate|mesh-list
91947225|NCT02299115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947226|NCT02299115|Glucocorticoids|glucocorticoids|mesh-ancestor
91947227|NCT02299115|Hormones|hormones|mesh-ancestor
91947228|NCT02299115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947229|NCT02299115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947230|NCT02299115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91947231|NCT02299115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947232|NCT02299115|Antiemetics|antiemetics|mesh-ancestor
91947233|NCT02299115|Autonomic Agents|autonomic agents|mesh-ancestor
91947234|NCT02299115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947235|NCT02299115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947236|NCT02299115|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91947237|NCT02299115|Protective Agents|protective agents|mesh-ancestor
91947238|NCT02299115|Anticonvulsants|anticonvulsants|mesh-ancestor
91947239|NCT02299115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947240|NCT02299115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947241|NCT02299115|GABA Agents|gaba agents|mesh-ancestor
91947242|NCT02299115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947243|NCT03515213|Fenofibrate|fenofibrate|mesh-list
91947244|NCT03515213|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91947245|NCT03515213|Antimetabolites|antimetabolites|mesh-ancestor
91947246|NCT03515213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947247|NCT03515213|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91947248|NCT02297945|Metyrapone|metyrapone|mesh-list
91947249|NCT02297945|Antimetabolites|antimetabolites|mesh-ancestor
91947250|NCT02297945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947251|NCT02297945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947283|NCT02491892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91947284|NCT02491892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947285|NCT03476811|Analgesics|analgesics|mesh-list
91947286|NCT03476811|Bupivacaine|bupivacaine|mesh-list
91947287|NCT03476811|Anesthetics, Local|anesthetics, local|mesh-ancestor
91947288|NCT03476811|Anesthetics|anesthetics|mesh-ancestor
91947289|NCT03476811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947290|NCT03476811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947291|NCT03476811|Sensory System Agents|sensory system agents|mesh-ancestor
91947292|NCT03476811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947293|NCT02834403|Aspirin|aspirin|mesh-list
91947294|NCT02834403|Docetaxel|docetaxel|mesh-list
91944386|NCT00286793|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
91944387|NCT00286793|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
91944388|NCT00286793|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91944389|NCT02285699|Fluvoxamine|fluvoxamine|mesh-list
91947295|NCT02834403|Amlodipine|amlodipine|mesh-list
91947316|NCT02834403|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91947317|NCT02834403|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91947318|NCT02834403|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947319|NCT02834403|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947321|NCT02299271|Ropivacaine|ropivacaine|mesh-list
91947322|NCT02299271|Anesthetics, Local|anesthetics, local|mesh-ancestor
91947323|NCT02299271|Anesthetics|anesthetics|mesh-ancestor
91947324|NCT02299271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947325|NCT02299271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947326|NCT02299271|Sensory System Agents|sensory system agents|mesh-ancestor
91947327|NCT02299271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947328|NCT02302469|Lenalidomide|lenalidomide|mesh-list
91947329|NCT02302469|Immunologic Factors|immunologic factors|mesh-ancestor
91947330|NCT02302469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947331|NCT02302469|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91947332|NCT02302469|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91947333|NCT02302469|Growth Substances|growth substances|mesh-ancestor
91947334|NCT02302469|Growth Inhibitors|growth inhibitors|mesh-ancestor
91947335|NCT02302469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947338|NCT02302547|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91947339|NCT02302547|Darunavir|darunavir|mesh-list
91947340|NCT02302547|Indinavir|indinavir|mesh-list
91947341|NCT02302547|Saquinavir|saquinavir|mesh-list
91947342|NCT02302547|Fosamprenavir|fosamprenavir|mesh-list
91947343|NCT02302547|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
91947344|NCT02302547|Tenofovir|tenofovir|mesh-list
91947345|NCT02302547|Emtricitabine|emtricitabine|mesh-list
91947346|NCT02302547|Raltegravir Potassium|raltegravir potassium|mesh-list
91947347|NCT02302547|Nevirapine|nevirapine|mesh-list
91947348|NCT02302547|Dolutegravir|dolutegravir|mesh-list
91947349|NCT02302547|Maraviroc|maraviroc|mesh-list
91947350|NCT02302547|Cobicistat|cobicistat|mesh-list
91947351|NCT02302547|Rilpivirine|rilpivirine|mesh-list
91947352|NCT02302547|Tipranavir|tipranavir|mesh-list
91947370|NCT02302547|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91947371|NCT02302547|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91947372|NCT02302547|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91947373|NCT02302547|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91947374|NCT02302547|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91947375|NCT02302547|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91947376|NCT02302547|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91947377|NCT02302547|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91947378|NCT02302547|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91947379|NCT01190787|Prednisone|prednisone|mesh-list
91947380|NCT01190787|Cyclophosphamide|cyclophosphamide|mesh-list
91947381|NCT01190787|Melphalan|melphalan|mesh-list
91947382|NCT01190787|Bortezomib|bortezomib|mesh-list
91947383|NCT01190787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91947384|NCT01190787|Immunologic Factors|immunologic factors|mesh-ancestor
91947385|NCT01190787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947386|NCT01190787|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947387|NCT01190787|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91947388|NCT01190787|Alkylating Agents|alkylating agents|mesh-ancestor
91947389|NCT01190787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947390|NCT01190787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947391|NCT01190787|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91947392|NCT01190787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947393|NCT01190787|Glucocorticoids|glucocorticoids|mesh-ancestor
91947394|NCT01190787|Hormones|hormones|mesh-ancestor
91947395|NCT01190787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947396|NCT01190787|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91947397|NCT03515369|Liver Extracts|liver extracts|mesh-list
91947398|NCT03515369|Hematinics|hematinics|mesh-ancestor
91947399|NCT02634411|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91947400|NCT02634411|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91947401|NCT02634411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944391|NCT02285699|Fluoxetine|fluoxetine|mesh-list
91944392|NCT02285699|Paroxetine|paroxetine|mesh-list
91944393|NCT02285699|Sertraline|sertraline|mesh-list
91944394|NCT02285699|Escitalopram|escitalopram|mesh-list
91947402|NCT02634411|Antitubercular Agents|antitubercular agents|mesh-ancestor
91947403|NCT03513575|Chlorhexidine|chlorhexidine|mesh-list
91947418|NCT02299817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947419|NCT02299817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947420|NCT01679613|Ketoconazole|ketoconazole|mesh-list
91947421|NCT01679613|Nintedanib|nintedanib|mesh-list
91947422|NCT01679613|Antifungal Agents|antifungal agents|mesh-ancestor
91947423|NCT01679613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947424|NCT01679613|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91947425|NCT01679613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91947426|NCT01679613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947427|NCT01679613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947428|NCT01679613|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91947429|NCT01679613|Hormone Antagonists|hormone antagonists|mesh-ancestor
91947430|NCT01679613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947431|NCT01679613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947432|NCT01679613|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91947433|NCT01679613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947434|NCT01679613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947435|NCT02489630|Ketamine|ketamine|mesh-list
91947436|NCT02489630|Analgesics|analgesics|mesh-list
91947437|NCT02489630|Sensory System Agents|sensory system agents|mesh-ancestor
91947438|NCT02489630|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947439|NCT02489630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947440|NCT02489630|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91947441|NCT02489630|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91947442|NCT02489630|Anesthetics, General|anesthetics, general|mesh-ancestor
91947443|NCT02489630|Anesthetics|anesthetics|mesh-ancestor
91947444|NCT02489630|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947445|NCT02489630|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91947446|NCT02489630|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91947447|NCT02489630|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947448|NCT02489630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947449|NCT05089539|Valsartan|valsartan|mesh-list
91947450|NCT05089539|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91947451|NCT05089539|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91947452|NCT05089539|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91947453|NCT05089539|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91947454|NCT05089539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947455|NCT05089383|Progesterone|progesterone|mesh-list
91947456|NCT05089383|Progestins|progestins|mesh-ancestor
91947457|NCT05089383|Hormones|hormones|mesh-ancestor
91947458|NCT05089383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947459|NCT05089383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947460|NCT03510533|Autoantibodies|autoantibodies|mesh-list
91947461|NCT03510533|alpha-MSH|alpha-msh|mesh-list
91947485|NCT01678911|Gabapentin|gabapentin|mesh-list
91947486|NCT01678911|Analgesics|analgesics|mesh-ancestor
91947487|NCT01678911|Sensory System Agents|sensory system agents|mesh-ancestor
91947488|NCT01678911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947489|NCT01678911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947490|NCT01678911|Anticonvulsants|anticonvulsants|mesh-ancestor
91947491|NCT01678911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91947492|NCT01678911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91947493|NCT01678911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947494|NCT01678911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91944395|NCT02285699|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91944396|NCT02285699|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91944397|NCT02285699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947495|NCT01678911|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91947496|NCT01678911|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91947497|NCT01678911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947498|NCT01678911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947499|NCT01678911|Antimanic Agents|antimanic agents|mesh-ancestor
91947500|NCT03132701|Magnesium Sulfate|magnesium sulfate|mesh-list
91947501|NCT03132701|Analgesics|analgesics|mesh-ancestor
91947502|NCT03132701|Sensory System Agents|sensory system agents|mesh-ancestor
91947503|NCT03132701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947504|NCT03132701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947505|NCT03132701|Anesthetics|anesthetics|mesh-ancestor
91947506|NCT03132701|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947507|NCT03132701|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91947508|NCT03132701|Anticonvulsants|anticonvulsants|mesh-ancestor
91947509|NCT03132701|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91947528|NCT02322099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947529|NCT02322099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91947530|NCT02322099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91947531|NCT02322099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947532|NCT02322099|Antacids|antacids|mesh-ancestor
91947533|NCT02322099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947534|NCT02322099|Vitamins|vitamins|mesh-ancestor
91947535|NCT02322099|Micronutrients|micronutrients|mesh-ancestor
91947536|NCT02487446|Glycopyrrolate|glycopyrrolate|mesh-list
91947537|NCT02487446|Bromides|bromides|mesh-list
91947538|NCT02487446|Anticonvulsants|anticonvulsants|mesh-ancestor
91947539|NCT02487446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947540|NCT02487446|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91947541|NCT02487446|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91947542|NCT02487446|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91947543|NCT02487446|Cholinergic Agents|cholinergic agents|mesh-ancestor
91947544|NCT02487446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947545|NCT02487446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947546|NCT05081349|Hydroxyurea|hydroxyurea|mesh-list
91947547|NCT05081349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947548|NCT05081349|Antisickling Agents|antisickling agents|mesh-ancestor
91947549|NCT05081349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947550|NCT05081349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947551|NCT05081349|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91947552|NCT04464005|Magnesium Sulfate|magnesium sulfate|mesh-list
91947553|NCT04464005|Analgesics|analgesics|mesh-ancestor
91947554|NCT04464005|Sensory System Agents|sensory system agents|mesh-ancestor
91947555|NCT04464005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947774|NCT03508817|Mydriatics|mydriatics|mesh-ancestor
91947556|NCT04464005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947557|NCT04464005|Anesthetics|anesthetics|mesh-ancestor
91947558|NCT04464005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947559|NCT04464005|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91947560|NCT04464005|Anticonvulsants|anticonvulsants|mesh-ancestor
91947561|NCT04464005|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91947562|NCT04464005|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947563|NCT04464005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947564|NCT04464005|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947566|NCT04464005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91947568|NCT02303327|Hormones|hormones|mesh-ancestor
91947569|NCT02303327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947570|NCT02303327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947571|NCT03510221|Antioxidants|antioxidants|mesh-list
91947572|NCT03510221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947573|NCT03510221|Protective Agents|protective agents|mesh-ancestor
91947574|NCT03510221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947575|NCT03509831|Irsogladine|irsogladine|mesh-list
91947576|NCT03509831|Nizatidine|nizatidine|mesh-list
91947577|NCT03509831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947578|NCT03509831|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91944398|NCT02285699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944400|NCT02285699|Serotonin Agents|serotonin agents|mesh-ancestor
91947579|NCT03509831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947580|NCT03509831|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91947581|NCT03509831|Histamine Antagonists|histamine antagonists|mesh-ancestor
91947582|NCT03509831|Histamine Agents|histamine agents|mesh-ancestor
91947583|NCT03509831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947584|NCT03509831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947585|NCT03509831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947586|NCT03509831|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91947587|NCT03509831|Protective Agents|protective agents|mesh-ancestor
91947588|NCT03509831|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91947589|NCT02303483|Niacinamide|niacinamide|mesh-list
91947590|NCT02303483|Niacin|niacin|mesh-list
91947591|NCT02303483|Nicotinic Acids|nicotinic acids|mesh-list
91947592|NCT02303483|Vitamin B Complex|vitamin b complex|mesh-ancestor
91947593|NCT02303483|Vitamins|vitamins|mesh-ancestor
91947594|NCT02303483|Micronutrients|micronutrients|mesh-ancestor
91947595|NCT02303483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947596|NCT02303483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91947597|NCT02303483|Antimetabolites|antimetabolites|mesh-ancestor
91947598|NCT02303483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947599|NCT02303483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91947600|NCT02303483|Vasodilator Agents|vasodilator agents|mesh-ancestor
91947601|NCT05378061|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
91947602|NCT05378061|Growth Substances|growth substances|mesh-ancestor
91947603|NCT05378061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947604|NCT05378061|Vasodilator Agents|vasodilator agents|mesh-ancestor
91947605|NCT05378061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947606|NCT05378061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947607|NCT02303639|Amiodarone|amiodarone|mesh-list
91947608|NCT02303639|Sotalol|sotalol|mesh-list
91947609|NCT02303639|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
91947610|NCT02303639|Vasodilator Agents|vasodilator agents|mesh-ancestor
91947611|NCT02303639|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91947612|NCT02303639|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947613|NCT02303639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947614|NCT02303639|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91947615|NCT02303639|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91947616|NCT02303639|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91947617|NCT02303639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947618|NCT02303639|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91947619|NCT02303639|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91947620|NCT02303639|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91947621|NCT02303639|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91947622|NCT02303639|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91947623|NCT02303639|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947624|NCT02303639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947625|NCT02303639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947626|NCT02303639|Sympatholytics|sympatholytics|mesh-ancestor
91947627|NCT02303639|Autonomic Agents|autonomic agents|mesh-ancestor
91947775|NCT03508817|Parasympatholytics|parasympatholytics|mesh-ancestor
91947628|NCT02303639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947629|NCT02303873|Alendronate|alendronate|mesh-list
91947630|NCT02303873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947631|NCT02303873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947632|NCT04757493|Prucalopride|prucalopride|mesh-list
91947633|NCT04757493|Laxatives|laxatives|mesh-ancestor
91947634|NCT04757493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947635|NCT04757493|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
91947636|NCT04757493|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91947637|NCT04757493|Serotonin Agents|serotonin agents|mesh-ancestor
91947661|NCT04406415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947663|NCT04406415|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91947664|NCT04406415|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91947665|NCT04406415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91947666|NCT04406415|Immunologic Factors|immunologic factors|mesh-ancestor
91947667|NCT02304107|Letrozole|letrozole|mesh-list
91947668|NCT02304107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947669|NCT02304107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91947670|NCT02304107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91947671|NCT02304107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947672|NCT02304107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947673|NCT02304107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91947674|NCT02304107|Hormone Antagonists|hormone antagonists|mesh-ancestor
91947675|NCT02304107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947676|NCT02304107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947677|NCT03509285|Cenobamate|cenobamate|mesh-list
91947678|NCT03509285|Alprazolam|alprazolam|mesh-list
91947679|NCT03509285|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91947680|NCT03509285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947681|NCT03509285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947682|NCT03509285|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91947683|NCT03509285|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91947684|NCT03509285|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91947685|NCT03509285|GABA Modulators|gaba modulators|mesh-ancestor
91947686|NCT03509285|GABA Agents|gaba agents|mesh-ancestor
91947734|NCT03135795|Narcotics|narcotics|mesh-ancestor
91947735|NCT03135795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91947736|NCT03135795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91947737|NCT03135795|Anticonvulsants|anticonvulsants|mesh-ancestor
91947738|NCT03135795|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91947739|NCT03135795|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91947740|NCT03135795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91947741|NCT03135795|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91947742|NCT03135795|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91947743|NCT03135795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91947744|NCT03135795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947745|NCT03135795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947746|NCT03135795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947747|NCT03135795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947748|NCT04958967|Aflutinib|aflutinib|mesh-list
91947749|NCT04958967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947750|NCT04958967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947751|NCT04958967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947752|NCT03469531|Cisplatin|cisplatin|mesh-list
91947753|NCT03469531|Nimotuzumab|nimotuzumab|mesh-list
91947754|NCT03469531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947755|NCT03469531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91947756|NCT03309007|Metformin|metformin|mesh-list
91947757|NCT03309007|Calcium Carbonate|calcium carbonate|mesh-list
91947758|NCT03309007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91947759|NCT03309007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947760|NCT03309007|Antacids|antacids|mesh-ancestor
91947761|NCT03309007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947762|NCT03309007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947763|NCT03508817|Atropine|atropine|mesh-list
91947764|NCT03508817|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91947765|NCT03508817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91947766|NCT03508817|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91947767|NCT03508817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91947768|NCT03508817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91947769|NCT03508817|Autonomic Agents|autonomic agents|mesh-ancestor
91947770|NCT03508817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947771|NCT03508817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947772|NCT03508817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91947773|NCT03508817|Respiratory System Agents|respiratory system agents|mesh-ancestor
91947776|NCT03508817|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91947777|NCT03508817|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91947778|NCT03508817|Cholinergic Agents|cholinergic agents|mesh-ancestor
91947779|NCT03508817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947813|NCT05158699|Ketorolac|ketorolac|mesh-list
91947814|NCT05158699|Bromfenac|bromfenac|mesh-list
91947815|NCT05158699|Phenylephrine|phenylephrine|mesh-list
91947816|NCT05158699|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91947817|NCT05158699|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91947818|NCT05158699|BB 1101|bb 1101|mesh-list
91947819|NCT05158699|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91947820|NCT05158699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947821|NCT05158699|Antiemetics|antiemetics|mesh-ancestor
91947836|NCT05158699|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947837|NCT05158699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947839|NCT05158699|Sensory System Agents|sensory system agents|mesh-ancestor
91947840|NCT05158699|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947841|NCT05158699|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91947842|NCT05158699|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91947843|NCT05158699|Mydriatics|mydriatics|mesh-ancestor
91947844|NCT05158699|Sympathomimetics|sympathomimetics|mesh-ancestor
91947845|NCT05158699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91947846|NCT05158699|Nasal Decongestants|nasal decongestants|mesh-ancestor
91947847|NCT05158699|Respiratory System Agents|respiratory system agents|mesh-ancestor
91947848|NCT05158699|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91947849|NCT05158699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91947850|NCT05158699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91947851|NCT05158699|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947853|NCT05158699|Protective Agents|protective agents|mesh-ancestor
91947854|NCT04464629|Prednisolone|prednisolone|mesh-list
91947855|NCT04464629|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91947856|NCT04464629|Methylprednisolone|methylprednisolone|mesh-list
91947857|NCT04464629|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91947858|NCT04464629|Prednisolone acetate|prednisolone acetate|mesh-list
91947859|NCT04464629|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91947860|NCT04464629|Prednisolone phosphate|prednisolone phosphate|mesh-list
91947861|NCT04464629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947862|NCT04464629|Glucocorticoids|glucocorticoids|mesh-ancestor
91947863|NCT04464629|Hormones|hormones|mesh-ancestor
91947864|NCT04464629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947865|NCT04464629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947866|NCT04464629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91947867|NCT04464629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947868|NCT04464629|Antiemetics|antiemetics|mesh-ancestor
91947869|NCT04464629|Autonomic Agents|autonomic agents|mesh-ancestor
91947870|NCT04464629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947871|NCT04464629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947872|NCT04464629|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91947873|NCT04464629|Protective Agents|protective agents|mesh-ancestor
91947874|NCT02304887|Denosumab|denosumab|mesh-list
91947875|NCT02304887|Teriparatide|teriparatide|mesh-list
91947876|NCT02304887|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947877|NCT02304887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947878|NCT02304887|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947879|NCT03474133|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91947880|NCT03474133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91947881|NCT03474133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947882|NCT03474133|Immunotoxins|immunotoxins|mesh-ancestor
91947896|NCT03512171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947898|NCT03512171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91947899|NCT03512171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91947900|NCT03512171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947901|NCT03512171|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91947902|NCT03512171|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91947903|NCT03512171|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91947904|NCT03739099|Pancrelipase|pancrelipase|mesh-list
91947905|NCT03739099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947906|NCT02305199|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91947907|NCT03469375|Folfirinox|folfirinox|mesh-list
91947908|NCT03469375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947909|NCT01603407|Prednisone|prednisone|mesh-list
91947910|NCT01603407|Deflazacort|deflazacort|mesh-list
91947911|NCT01603407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947912|NCT01603407|Glucocorticoids|glucocorticoids|mesh-ancestor
91947913|NCT01603407|Hormones|hormones|mesh-ancestor
91947914|NCT01603407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947915|NCT01603407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947916|NCT01603407|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91947917|NCT01603407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947918|NCT01603407|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91947919|NCT01603407|Immunologic Factors|immunologic factors|mesh-ancestor
91947920|NCT02305355|Atorvastatin|atorvastatin|mesh-list
91947921|NCT02305355|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91947922|NCT02305355|Simvastatin|simvastatin|mesh-list
91947923|NCT02305355|Pravastatin|pravastatin|mesh-list
91947924|NCT02305355|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91947925|NCT02305355|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91947926|NCT02305355|Antimetabolites|antimetabolites|mesh-ancestor
91947927|NCT02305355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944401|NCT02285699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944402|NCT02285699|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91944403|NCT02285699|Antidepressive Agents|antidepressive agents|mesh-ancestor
91947928|NCT02305355|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91947929|NCT02305355|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91947930|NCT02305355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947932|NCT03511703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947933|NCT03511703|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947934|NCT03511703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947935|NCT03511703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947936|NCT05157295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91947937|NCT05157295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91947938|NCT05157295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91947939|NCT05157295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947940|NCT05157295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947941|NCT05157295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91947942|NCT05157295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090403|NCT04382014|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947978|NCT02305823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947979|NCT02305823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947980|NCT02305823|Dopamine Agonists|dopamine agonists|mesh-ancestor
91947981|NCT02305823|Dopamine Agents|dopamine agents|mesh-ancestor
91947982|NCT02305823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947983|NCT02305823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947984|NCT02305823|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91947985|NCT02305823|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91947986|NCT02305823|Serotonin Agents|serotonin agents|mesh-ancestor
91947987|NCT02305823|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91947988|NCT02305823|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91947989|NCT02305823|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91947990|NCT02305823|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91947991|NCT05376189|Vitamin D|vitamin d|mesh-list
91947992|NCT05376189|Ergocalciferols|ergocalciferols|mesh-list
91947993|NCT05376189|Cholecalciferol|cholecalciferol|mesh-list
91947994|NCT05376189|Vitamins|vitamins|mesh-list
91947995|NCT05376189|Micronutrients|micronutrients|mesh-ancestor
91947996|NCT05376189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947997|NCT05376189|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947998|NCT05376189|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947999|NCT02235298|Metformin|metformin|mesh-list
91948000|NCT02235298|Dapagliflozin|dapagliflozin|mesh-list
91948001|NCT02235298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948002|NCT02235298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948003|NCT02235298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91948004|NCT02235298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948006|NCT02305901|Bupropion|bupropion|mesh-list
91948007|NCT02305901|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91948008|NCT02305901|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948009|NCT02305901|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948010|NCT02305901|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91948011|NCT02305901|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91948064|NCT02305979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948065|NCT02305979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948066|NCT02305979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948067|NCT04539951|Memantine|memantine|mesh-list
91948068|NCT04539951|Aripiprazole|aripiprazole|mesh-list
91948069|NCT04539951|Fluvoxamine|fluvoxamine|mesh-list
91948070|NCT04539951|Sertraline|sertraline|mesh-list
91948071|NCT04539951|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91948072|NCT04539951|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948073|NCT04539951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948074|NCT04539951|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91948075|NCT04539951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91948076|NCT04539951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948077|NCT04539951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948078|NCT04539951|Dopamine Agonists|dopamine agonists|mesh-ancestor
91948079|NCT04539951|Dopamine Agents|dopamine agents|mesh-ancestor
91944404|NCT02285699|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91944405|NCT02285699|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91944406|NCT02285699|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91944407|NCT02285699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948080|NCT04539951|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948081|NCT04539951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948082|NCT04539951|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91948083|NCT04539951|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91948084|NCT04539951|Serotonin Agents|serotonin agents|mesh-ancestor
91948085|NCT04539951|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91948086|NCT04539951|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91948087|NCT04539951|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91948088|NCT04539951|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91948089|NCT04539951|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91948090|NCT04539951|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91948091|NCT04539951|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948092|NCT04539951|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91948093|NCT04539951|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91948094|NCT04539951|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91948111|NCT02234362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91948112|NCT02234362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91948113|NCT02234362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948114|NCT02234362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948115|NCT02234362|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91948116|NCT02234362|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91948117|NCT02234362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948118|NCT02234362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948119|NCT02234362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948120|NCT02234362|Serotonin Agents|serotonin agents|mesh-ancestor
91948121|NCT02234362|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91948122|NCT02234362|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91948123|NCT02234362|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91948124|NCT02234362|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91948125|NCT05091177|Acetylcholine|acetylcholine|mesh-list
91948127|NCT05091177|Neostigmine|neostigmine|mesh-list
91948128|NCT05091177|Immunologic Factors|immunologic factors|mesh-ancestor
91948129|NCT05091177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948130|NCT05091177|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91948131|NCT05091177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948132|NCT05091177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948133|NCT05091177|Cholinergic Agents|cholinergic agents|mesh-ancestor
91948134|NCT05091177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948135|NCT05091177|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91948136|NCT05091177|Autonomic Agents|autonomic agents|mesh-ancestor
91948137|NCT05091177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948138|NCT05091177|Vasodilator Agents|vasodilator agents|mesh-ancestor
91948139|NCT05091177|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91948140|NCT05091099|Zoledronic Acid|zoledronic acid|mesh-list
91948141|NCT05091099|Alendronate|alendronate|mesh-list
91948142|NCT05091099|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91948143|NCT05091099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948144|NCT05197426|Azacitidine|azacitidine|mesh-list
91948145|NCT05197426|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91948146|NCT05197426|Antimetabolites|antimetabolites|mesh-ancestor
91948147|NCT05197426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948148|NCT05197426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948160|NCT02232880|Immunologic Factors|immunologic factors|mesh-ancestor
91948161|NCT02232880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948162|NCT02232880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91948164|NCT02896855|Trastuzumab|trastuzumab|mesh-list
91948165|NCT02896855|Pertuzumab|pertuzumab|mesh-list
91948166|NCT02896855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948167|NCT02896855|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948168|NCT02896855|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948169|NCT02896855|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948170|NCT02896855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948171|NCT02896855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91944408|NCT02285699|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91944409|NCT02285699|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91944410|NCT02285699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948173|NCT02311439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948174|NCT02311517|Ropivacaine|ropivacaine|mesh-list
91948175|NCT02311517|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948176|NCT02311517|Anesthetics|anesthetics|mesh-ancestor
91948177|NCT02311517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948178|NCT02311517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948179|NCT02311517|Sensory System Agents|sensory system agents|mesh-ancestor
91948180|NCT02311517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948181|NCT02232802|Enoxaparin|enoxaparin|mesh-list
91948182|NCT02232802|Enoxaparin sodium|enoxaparin sodium|mesh-list
91948183|NCT02232802|Anticoagulants|anticoagulants|mesh-ancestor
91948184|NCT02232802|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91948185|NCT02232802|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91948186|NCT02232802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948187|NCT04463459|Vitamins|vitamins|mesh-list
91948188|NCT04463459|Vitamin E|vitamin e|mesh-list
91948189|NCT04463459|Micronutrients|micronutrients|mesh-ancestor
91948190|NCT04463459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948191|NCT04463459|Antioxidants|antioxidants|mesh-ancestor
91948192|NCT04463459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948193|NCT04463459|Protective Agents|protective agents|mesh-ancestor
91948194|NCT02434328|Aflibercept|aflibercept|mesh-list
91948195|NCT02434328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91948196|NCT02434328|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91948197|NCT02434328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91948198|NCT02434328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91948199|NCT02434328|Growth Substances|growth substances|mesh-ancestor
91948200|NCT02434328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948201|NCT02434328|Growth Inhibitors|growth inhibitors|mesh-ancestor
91948202|NCT02434328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948203|NCT04785274|Chrysarobin|chrysarobin|mesh-list
91948204|NCT04785274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91948205|NCT04785274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91948206|NCT04785274|Analgesics|analgesics|mesh-ancestor
91948207|NCT04785274|Sensory System Agents|sensory system agents|mesh-ancestor
91948208|NCT04785274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948209|NCT04785274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948210|NCT04785274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948211|NCT04785274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91948212|NCT04778176|Levodopa|levodopa|mesh-list
91948243|NCT05077683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948245|NCT03132233|Calcium|calcium|mesh-list
91948246|NCT03132233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91948247|NCT03132233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948248|NCT02307227|Paclitaxel|paclitaxel|mesh-list
91948249|NCT02307227|Docetaxel|docetaxel|mesh-list
91948250|NCT02307227|Trastuzumab|trastuzumab|mesh-list
91948251|NCT02307227|Epirubicin|epirubicin|mesh-list
91948252|NCT02307227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91948253|NCT02307227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948254|NCT02307227|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948255|NCT02307227|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948256|NCT02307227|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948257|NCT02307227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948271|NCT02307305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91948272|NCT02307305|Analgesics|analgesics|mesh-ancestor
91948273|NCT02307305|Sensory System Agents|sensory system agents|mesh-ancestor
91948274|NCT02307305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948275|NCT02307305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948276|NCT02307305|Antipyretics|antipyretics|mesh-ancestor
91948277|NCT02307305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91948278|NCT02307305|Narcotics|narcotics|mesh-ancestor
91948279|NCT02307305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948280|NCT02307305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91948281|NCT02307305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948282|NCT02307305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91948283|NCT02307305|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91944411|NCT02285699|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91944412|NCT02285699|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91944414|NCT02288429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948284|NCT02307305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91948285|NCT02307305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948286|NCT02307305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948287|NCT02307305|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91948288|NCT02307305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948289|NCT02307305|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91948290|NCT02307305|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91948291|NCT02307305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91948292|NCT02307305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948293|NCT02307305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948294|NCT02307305|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948295|NCT02307305|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948296|NCT02307305|Dopamine Agents|dopamine agents|mesh-ancestor
91948297|NCT02307305|Gout Suppressants|gout suppressants|mesh-ancestor
91948298|NCT02307305|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91948299|NCT02660229|Morphine|morphine|mesh-list
91948300|NCT02660229|Oxycodone|oxycodone|mesh-list
91948301|NCT02660229|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91948302|NCT02660229|Narcotics|narcotics|mesh-ancestor
91948303|NCT02660229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948304|NCT02660229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948305|NCT02660229|Analgesics|analgesics|mesh-ancestor
91948306|NCT02660229|Sensory System Agents|sensory system agents|mesh-ancestor
91948307|NCT02660229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948308|NCT02307383|Lactitol|lactitol|mesh-list
91948309|NCT02307383|Cathartics|cathartics|mesh-ancestor
91948310|NCT02307383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948311|NCT02232178|Bupivacaine|bupivacaine|mesh-list
91948312|NCT02232178|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948313|NCT02232178|Anesthetics|anesthetics|mesh-ancestor
91948314|NCT02232178|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948315|NCT02232178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948316|NCT02232178|Sensory System Agents|sensory system agents|mesh-ancestor
91948317|NCT02232178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948318|NCT04457323|Metoprolol|metoprolol|mesh-list
91948319|NCT04457323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91948320|NCT04457323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91948321|NCT04457323|Sympatholytics|sympatholytics|mesh-ancestor
91948322|NCT04457323|Autonomic Agents|autonomic agents|mesh-ancestor
91948323|NCT04457323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948342|NCT04448431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948343|NCT04448431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948345|NCT04448431|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91948346|NCT04448431|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91948347|NCT04448431|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91948348|NCT04448431|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91948349|NCT04448431|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91948350|NCT05713149|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91948351|NCT05713149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948352|NCT02307695|Saxagliptin|saxagliptin|mesh-list
91948353|NCT02307695|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
91948354|NCT02307695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948355|NCT02307695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948356|NCT02307695|Incretins|incretins|mesh-ancestor
91948357|NCT02307695|Hormones|hormones|mesh-ancestor
91948358|NCT02307695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948359|NCT02307695|Protease Inhibitors|protease inhibitors|mesh-ancestor
91948360|NCT02307695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948361|NCT02307695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948362|NCT05161975|Vitamin K|vitamin k|mesh-list
91948363|NCT05161975|Vitamin K 2|vitamin k 2|mesh-list
91948364|NCT05161975|Vitamins|vitamins|mesh-ancestor
91948365|NCT05161975|Micronutrients|micronutrients|mesh-ancestor
91948366|NCT05161975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948367|NCT05161975|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91944415|NCT02288429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944416|NCT03133637|Ceftriaxone|ceftriaxone|mesh-list
91944417|NCT03133637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944418|NCT03133637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944419|NCT00265655|Satraplatin|satraplatin|mesh-list
91944420|NCT00265655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944421|NCT00254891|Paclitaxel|paclitaxel|mesh-list
91944422|NCT00254891|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91944423|NCT00254891|Carboplatin|carboplatin|mesh-list
91944424|NCT00254891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91944425|NCT00254891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944426|NCT00254891|Tubulin Modulators|tubulin modulators|mesh-ancestor
91944427|NCT00254891|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944428|NCT00254891|Mitosis Modulators|mitosis modulators|mesh-ancestor
91944429|NCT00254891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944430|NCT02479412|Albuterol|albuterol|mesh-list
91944431|NCT02479412|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91948368|NCT05161975|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91948369|NCT05161975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948370|NCT05161975|Hemostatics|hemostatics|mesh-ancestor
91948371|NCT05161975|Coagulants|coagulants|mesh-ancestor
91948372|NCT03504527|Budesonide|budesonide|mesh-list
91948373|NCT03504527|Bromides|bromides|mesh-list
91948374|NCT03504527|Tiotropium Bromide|tiotropium bromide|mesh-list
91948375|NCT03504527|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948376|NCT03504527|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91948396|NCT01678131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948397|NCT01678131|Antiviral Agents|antiviral agents|mesh-ancestor
91948398|NCT01678131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948399|NCT01678131|Hematinics|hematinics|mesh-ancestor
91948400|NCT01678131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948401|NCT04579783|Triamcinolone|triamcinolone|mesh-list
91948402|NCT04579783|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91948403|NCT04579783|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91948404|NCT04579783|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91948405|NCT04579783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948406|NCT04579783|Glucocorticoids|glucocorticoids|mesh-ancestor
91948408|NCT04579783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948409|NCT04579783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948410|NCT04579783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91948411|NCT04579783|Immunologic Factors|immunologic factors|mesh-ancestor
91948412|NCT04579783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948413|NCT04579783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948414|NCT02231164|Docetaxel|docetaxel|mesh-list
91948415|NCT02231164|Nintedanib|nintedanib|mesh-list
91948416|NCT02231164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948417|NCT02231164|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948418|NCT02231164|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948419|NCT02231164|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948420|NCT02231164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948421|NCT02231164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91948422|NCT02231164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948423|NCT03506789|Dexamethasone|dexamethasone|mesh-list
91948424|NCT03506789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948425|NCT03506789|Antiemetics|antiemetics|mesh-ancestor
91948426|NCT03506789|Autonomic Agents|autonomic agents|mesh-ancestor
91948427|NCT03506789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948428|NCT03506789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948429|NCT03506789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91944432|NCT02479412|Autonomic Agents|autonomic agents|mesh-ancestor
91944433|NCT02479412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944434|NCT02479412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948430|NCT03506789|Glucocorticoids|glucocorticoids|mesh-ancestor
91948431|NCT03506789|Hormones|hormones|mesh-ancestor
91948432|NCT03506789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948454|NCT03473431|Anesthetics|anesthetics|mesh-ancestor
91948455|NCT03473431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948456|NCT03473431|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91948457|NCT03473431|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91948458|NCT03473431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948459|NCT03473431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948460|NCT02378805|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91948461|NCT02378805|Ramipril|ramipril|mesh-list
91948462|NCT02378805|Spironolactone|spironolactone|mesh-list
91948463|NCT02378805|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91948464|NCT02378805|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91948465|NCT02378805|Hormone Antagonists|hormone antagonists|mesh-ancestor
91948466|NCT02378805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948467|NCT02378805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948468|NCT02378805|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91948469|NCT02378805|Diuretics|diuretics|mesh-ancestor
91948470|NCT02378805|Natriuretic Agents|natriuretic agents|mesh-ancestor
91948471|NCT02378805|Protease Inhibitors|protease inhibitors|mesh-ancestor
91948472|NCT02378805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948473|NCT02378805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948474|NCT02378805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91948475|NCT02378805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948476|NCT05094375|Misoprostol|misoprostol|mesh-list
91948477|NCT05094375|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91948478|NCT05094375|Abortifacient Agents|abortifacient agents|mesh-ancestor
91948479|NCT05094375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91948480|NCT05094375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948481|NCT05094375|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91948482|NCT05094375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948483|NCT05094375|Oxytocics|oxytocics|mesh-ancestor
91948484|NCT04345861|Azithromycin|azithromycin|mesh-list
91948485|NCT04345861|Hydroxychloroquine|hydroxychloroquine|mesh-list
91948511|NCT02308319|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91948512|NCT02308319|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91948514|NCT02308319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948515|NCT02308319|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91948516|NCT02308319|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91948517|NCT02312375|Amlodipine|amlodipine|mesh-list
91948518|NCT02312375|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91948519|NCT02312375|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91948520|NCT02312375|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948521|NCT02312375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948522|NCT02312375|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91948523|NCT02312375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948524|NCT02312375|Vasodilator Agents|vasodilator agents|mesh-ancestor
91948525|NCT05062174|Mifepristone|mifepristone|mesh-list
91948526|NCT05062174|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91948527|NCT05062174|Abortifacient Agents|abortifacient agents|mesh-ancestor
91948528|NCT05062174|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91948529|NCT05062174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948530|NCT05062174|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91948531|NCT05062174|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91948532|NCT05062174|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91948533|NCT05062174|Contraceptive Agents|contraceptive agents|mesh-ancestor
91948534|NCT05062174|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91948551|NCT05095467|Antimetabolites|antimetabolites|mesh-ancestor
91948552|NCT02312531|Immunoglobulins|immunoglobulins|mesh-list
91948553|NCT02312531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91948554|NCT02312531|Antibodies|antibodies|mesh-list
91948555|NCT02312531|Immunologic Factors|immunologic factors|mesh-ancestor
91948556|NCT02312531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948557|NCT04234477|Metoprolol|metoprolol|mesh-list
91948558|NCT04234477|Verapamil|verapamil|mesh-list
91944435|NCT02479412|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91944436|NCT02479412|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944437|NCT02479412|Tocolytic Agents|tocolytic agents|mesh-ancestor
91944438|NCT02479412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91944439|NCT02479412|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91948560|NCT04234477|Calcium Channel Blockers|calcium channel blockers|mesh-list
91948561|NCT04234477|Calcium|calcium|mesh-list
91948562|NCT04234477|Esmolol|esmolol|mesh-list
91948563|NCT04234477|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91948564|NCT04234477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91948565|NCT04234477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948566|NCT04234477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91948567|NCT04234477|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91948568|NCT04234477|Sympatholytics|sympatholytics|mesh-ancestor
91948569|NCT04234477|Autonomic Agents|autonomic agents|mesh-ancestor
91948570|NCT04234477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948571|NCT04234477|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91948572|NCT04234477|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91948573|NCT04234477|Adrenergic Agents|adrenergic agents|mesh-ancestor
91948574|NCT04234477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948575|NCT04234477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948576|NCT04234477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948577|NCT04234477|Vasodilator Agents|vasodilator agents|mesh-ancestor
91948578|NCT02449031|Tobramycin|tobramycin|mesh-list
91948579|NCT02449031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948580|NCT02449031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948581|NCT01680861|Mycophenolic Acid|mycophenolic acid|mesh-list
91948582|NCT01680861|Methylprednisolone|methylprednisolone|mesh-list
91948583|NCT01680861|Everolimus|everolimus|mesh-list
91948584|NCT01680861|Tacrolimus|tacrolimus|mesh-list
91948585|NCT01680861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91948586|NCT01680861|Immunologic Factors|immunologic factors|mesh-ancestor
91948587|NCT01680861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948588|NCT01680861|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91948589|NCT01680861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948590|NCT01680861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948591|NCT01680861|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91948592|NCT01680861|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91948593|NCT01680861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948614|NCT02229214|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91948615|NCT02229214|Appetite Depressants|appetite depressants|mesh-ancestor
91948616|NCT02229214|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91948617|NCT02229214|Sympathomimetics|sympathomimetics|mesh-ancestor
91948618|NCT02229214|Autonomic Agents|autonomic agents|mesh-ancestor
91948619|NCT02229214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948620|NCT02229214|Adrenergic Agents|adrenergic agents|mesh-ancestor
91948621|NCT02229214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948622|NCT02229214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948623|NCT02308553|Paclitaxel|paclitaxel|mesh-list
91948624|NCT02308553|Nintedanib|nintedanib|mesh-list
91948625|NCT02308553|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91948626|NCT02308553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948627|NCT02308553|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948628|NCT02308553|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948629|NCT02308553|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948630|NCT02308553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948631|NCT02308553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91948632|NCT02308553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948633|NCT05093907|Capecitabine|capecitabine|mesh-list
91948634|NCT05093907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91948635|NCT05093907|Antimetabolites|antimetabolites|mesh-ancestor
91948636|NCT05093907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948637|NCT05093907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948638|NCT02228980|Vaccines|vaccines|mesh-list
91948639|NCT02228980|Immunologic Factors|immunologic factors|mesh-ancestor
91948640|NCT02228980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948641|NCT03783091|Hydroxocobalamin|hydroxocobalamin|mesh-list
91948642|NCT03783091|Vitamin B 12|vitamin b 12|mesh-list
91948643|NCT03783091|Hematinics|hematinics|mesh-ancestor
91948644|NCT03783091|Vitamin B Complex|vitamin b complex|mesh-ancestor
91944440|NCT02479412|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91944441|NCT02479412|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91944442|NCT02479412|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944443|NCT02479412|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944444|NCT02479412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944446|NCT00254579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944447|NCT00252005|Apixaban|apixaban|mesh-list
91948646|NCT03783091|Micronutrients|micronutrients|mesh-ancestor
91948647|NCT03783091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948648|NCT05057481|Mycophenolic Acid|mycophenolic acid|mesh-list
91948649|NCT05057481|Rituximab|rituximab|mesh-list
91948650|NCT05057481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948651|NCT05057481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948652|NCT05057481|Immunologic Factors|immunologic factors|mesh-ancestor
91948663|NCT02312609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948664|NCT02312609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948665|NCT03506399|Levonorgestrel|levonorgestrel|mesh-list
91948666|NCT03506399|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91948667|NCT03506399|Contraceptive Agents|contraceptive agents|mesh-list
91948668|NCT03506399|Contraceptives, Oral|contraceptives, oral|mesh-list
91948670|NCT03506399|Estrogens|estrogens|mesh-ancestor
91948671|NCT03506399|Hormones|hormones|mesh-ancestor
91948672|NCT03506399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948673|NCT03506399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948674|NCT03506399|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91948675|NCT03506399|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91948676|NCT03506399|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91948677|NCT03506399|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91948678|NCT03506399|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91948679|NCT02228590|Apomorphine|apomorphine|mesh-list
91948680|NCT02228590|Emetics|emetics|mesh-ancestor
91948681|NCT02228590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948682|NCT02228590|Autonomic Agents|autonomic agents|mesh-ancestor
91948683|NCT02228590|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948684|NCT02228590|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948685|NCT02228590|Dopamine Agonists|dopamine agonists|mesh-ancestor
91948686|NCT02228590|Dopamine Agents|dopamine agents|mesh-ancestor
91948687|NCT02228590|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948688|NCT02228590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948689|NCT03503201|Chromium|chromium|mesh-list
91948690|NCT03503201|Trace Elements|trace elements|mesh-ancestor
91948691|NCT03503201|Micronutrients|micronutrients|mesh-ancestor
91948692|NCT03503201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948693|NCT05095077|Tadalafil|tadalafil|mesh-list
91948694|NCT05095077|Vasodilator Agents|vasodilator agents|mesh-ancestor
91948695|NCT05095077|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91948696|NCT05095077|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91948697|NCT05095077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948698|NCT05095077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948699|NCT05095077|Urological Agents|urological agents|mesh-ancestor
91948700|NCT02309177|Paclitaxel|paclitaxel|mesh-list
91948701|NCT02309177|Carboplatin|carboplatin|mesh-list
91948702|NCT02309177|Gemcitabine|gemcitabine|mesh-list
91948703|NCT02309177|Nivolumab|nivolumab|mesh-list
91948704|NCT02309177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91948705|NCT02309177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948706|NCT02309177|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948707|NCT02309177|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948708|NCT02309177|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948709|NCT02309177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948710|NCT02309177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91948711|NCT02309177|Antimetabolites|antimetabolites|mesh-ancestor
91948712|NCT02309177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948713|NCT02309177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91948714|NCT02227108|Immunotoxin HA22|immunotoxin ha22|mesh-list
91948715|NCT02227108|Immunotoxins|immunotoxins|mesh-ancestor
91948716|NCT02227108|Immunoconjugates|immunoconjugates|mesh-ancestor
91944448|NCT00252005|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91944449|NCT00252005|Antithrombins|antithrombins|mesh-ancestor
91944450|NCT00252005|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91944451|NCT00252005|Protease Inhibitors|protease inhibitors|mesh-ancestor
91944452|NCT00252005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944453|NCT00252005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944454|NCT00252005|Anticoagulants|anticoagulants|mesh-ancestor
91944455|NCT02288507|Sorafenib|sorafenib|mesh-list
91944456|NCT02288507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944457|NCT02288507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91944458|NCT02288507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944459|NCT02288507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944460|NCT00231257|Sirolimus|sirolimus|mesh-list
91944461|NCT00231257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944462|NCT00231257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944463|NCT00231257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91944464|NCT00231257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944465|NCT00231257|Antifungal Agents|antifungal agents|mesh-ancestor
91944466|NCT00231257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91948717|NCT02227108|Immunologic Factors|immunologic factors|mesh-ancestor
91948735|NCT03423355|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91948736|NCT03423355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948738|NCT03423355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948739|NCT03423355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91948740|NCT03423355|Diuretics|diuretics|mesh-ancestor
91948741|NCT03423355|Natriuretic Agents|natriuretic agents|mesh-ancestor
91948742|NCT03423355|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91948743|NCT03423355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948744|NCT02226562|Listerine|listerine|mesh-list
91948745|NCT02226562|Fluorides|fluorides|mesh-list
91948746|NCT02226562|Sodium Fluoride|sodium fluoride|mesh-list
91948747|NCT02226562|Cariostatic Agents|cariostatic agents|mesh-ancestor
91948748|NCT02226562|Protective Agents|protective agents|mesh-ancestor
91948749|NCT02226562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948750|NCT02226562|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91948751|NCT02226562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948752|NCT04430985|Leucovorin|leucovorin|mesh-list
91948753|NCT04430985|Fluorouracil|fluorouracil|mesh-list
91948754|NCT04430985|Oxaliplatin|oxaliplatin|mesh-list
91948755|NCT04430985|Nivolumab|nivolumab|mesh-list
91948756|NCT04430985|Ipilimumab|ipilimumab|mesh-list
91948757|NCT04430985|Antimetabolites|antimetabolites|mesh-ancestor
91948758|NCT04430985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948759|NCT04430985|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91948760|NCT04430985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948761|NCT04430985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91948762|NCT04430985|Immunologic Factors|immunologic factors|mesh-ancestor
91948763|NCT04430985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948764|NCT04430985|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948765|NCT04430985|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91948766|NCT04430985|Antidotes|antidotes|mesh-ancestor
91948767|NCT04430985|Protective Agents|protective agents|mesh-ancestor
91948768|NCT04430985|Vitamin B Complex|vitamin b complex|mesh-ancestor
91948769|NCT04430985|Vitamins|vitamins|mesh-ancestor
91948770|NCT04430985|Micronutrients|micronutrients|mesh-ancestor
91948771|NCT03365635|Ribavirin|ribavirin|mesh-list
91948772|NCT03365635|Grazoprevir|grazoprevir|mesh-list
91944467|NCT00231257|Immunologic Factors|immunologic factors|mesh-ancestor
91944468|NCT00231257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944469|NCT00224003|Ferric gluconate|ferric gluconate|mesh-list
91944470|NCT00224003|Hematinics|hematinics|mesh-ancestor
91944471|NCT00216593|Galantamine|galantamine|mesh-list
91944472|NCT00216593|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91944473|NCT00216593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944474|NCT00216593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944475|NCT00216593|Cholinergic Agents|cholinergic agents|mesh-ancestor
91944476|NCT00216593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944477|NCT00216593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944478|NCT00216593|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91948773|NCT03365635|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91948774|NCT03365635|Antimetabolites|antimetabolites|mesh-ancestor
91948791|NCT04456777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948792|NCT04456777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948793|NCT04456777|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91948794|NCT04456777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91948795|NCT04456777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948796|NCT04456777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948798|NCT04456777|Serotonin Agents|serotonin agents|mesh-ancestor
91948799|NCT04456777|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91948800|NCT04456777|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91948801|NCT04456777|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91948802|NCT04456777|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91948803|NCT02874430|Metformin|metformin|mesh-list
91948804|NCT02874430|Doxycycline|doxycycline|mesh-list
91948805|NCT02874430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948806|NCT02874430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948807|NCT02874430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948808|NCT02874430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948809|NCT02874430|Antimalarials|antimalarials|mesh-ancestor
91948810|NCT02874430|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91948811|NCT02874430|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91948812|NCT05160727|Irinotecan|irinotecan|mesh-list
91948813|NCT05160727|Tislelizumab|tislelizumab|mesh-list
91948814|NCT05160727|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91948815|NCT05160727|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91948816|NCT05160727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948817|NCT05160727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948818|NCT05160727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948819|NCT05160727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948820|NCT03506009|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91948821|NCT03506009|Argatroban|argatroban|mesh-list
91948822|NCT03506009|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91948823|NCT03506009|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91948824|NCT03506009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948825|NCT03506009|Antithrombins|antithrombins|mesh-ancestor
91948826|NCT03506009|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91948827|NCT03506009|Protease Inhibitors|protease inhibitors|mesh-ancestor
91948828|NCT03506009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948829|NCT03506009|Anticoagulants|anticoagulants|mesh-ancestor
91948847|NCT02309879|Lidocaine|lidocaine|mesh-list
91948848|NCT02309879|Magnesium Sulfate|magnesium sulfate|mesh-list
91948849|NCT02309879|Remifentanil|remifentanil|mesh-list
91948850|NCT02309879|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948851|NCT02309879|Anesthetics|anesthetics|mesh-ancestor
91948852|NCT02309879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948853|NCT02309879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948854|NCT02309879|Sensory System Agents|sensory system agents|mesh-ancestor
91944479|NCT00216593|Autonomic Agents|autonomic agents|mesh-ancestor
91944480|NCT00216593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944481|NCT00216593|Nootropic Agents|nootropic agents|mesh-ancestor
91944483|NCT00389675|Darusentan|darusentan|mesh-list
91944484|NCT00389675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91944485|NCT00389675|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91948855|NCT02309879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948856|NCT02309879|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91948857|NCT02309879|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91948858|NCT02309879|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91948859|NCT02309879|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948860|NCT02309879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948861|NCT02309879|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91948862|NCT02309879|Narcotics|narcotics|mesh-ancestor
91948863|NCT02309879|Analgesics|analgesics|mesh-ancestor
91948864|NCT02309879|Anticonvulsants|anticonvulsants|mesh-ancestor
91948865|NCT02309879|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91948866|NCT02309879|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91948867|NCT02309879|Tocolytic Agents|tocolytic agents|mesh-ancestor
91948868|NCT02309879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91948869|NCT02476786|Tamoxifen|tamoxifen|mesh-list
91948870|NCT02476786|Fulvestrant|fulvestrant|mesh-list
91948871|NCT02476786|Anastrozole|anastrozole|mesh-list
91948872|NCT02476786|Goserelin|goserelin|mesh-list
91948873|NCT02476786|Exemestane|exemestane|mesh-list
91948874|NCT02476786|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91948875|NCT02476786|Hormone Antagonists|hormone antagonists|mesh-ancestor
91948876|NCT02476786|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948877|NCT02476786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948878|NCT02476786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91948879|NCT02476786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948880|NCT02476786|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91948881|NCT02476786|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91948882|NCT02476786|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91948883|NCT02476786|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91948884|NCT02476786|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91948885|NCT02476786|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91948886|NCT02476786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948887|NCT02476786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948904|NCT04658173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948905|NCT04658173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91948906|NCT04658173|Anesthetics, General|anesthetics, general|mesh-ancestor
91948907|NCT04658173|Anesthetics|anesthetics|mesh-ancestor
91948908|NCT04658173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91948909|NCT04658173|Narcotics|narcotics|mesh-ancestor
91948910|NCT04658173|Analgesics|analgesics|mesh-ancestor
91948911|NCT04658173|Sensory System Agents|sensory system agents|mesh-ancestor
91948912|NCT04658173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948913|NCT02399410|Bevacizumab|bevacizumab|mesh-list
91948914|NCT02399410|Oxaliplatin|oxaliplatin|mesh-list
91948915|NCT02399410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948916|NCT02399410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948917|NCT02399410|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91948918|NCT02399410|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91948919|NCT02399410|Growth Substances|growth substances|mesh-ancestor
91948920|NCT02399410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948921|NCT02399410|Growth Inhibitors|growth inhibitors|mesh-ancestor
91948922|NCT03636165|Methylprednisolone|methylprednisolone|mesh-list
91948923|NCT03636165|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91948924|NCT03636165|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91948925|NCT03636165|Prednisolone|prednisolone|mesh-list
91948926|NCT03636165|Prednisolone acetate|prednisolone acetate|mesh-list
91948927|NCT03636165|Ropivacaine|ropivacaine|mesh-list
91948928|NCT03636165|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91948929|NCT03636165|Prednisolone phosphate|prednisolone phosphate|mesh-list
91948930|NCT03636165|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948931|NCT03636165|Anesthetics|anesthetics|mesh-ancestor
91948932|NCT03636165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944486|NCT00389675|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91944487|NCT00389675|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91944488|NCT00389675|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944489|NCT00389675|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944490|NCT00389675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948933|NCT03636165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948934|NCT03636165|Sensory System Agents|sensory system agents|mesh-ancestor
91948935|NCT03636165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948936|NCT03636165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948938|NCT03636165|Autonomic Agents|autonomic agents|mesh-ancestor
91948939|NCT03636165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948940|NCT03636165|Glucocorticoids|glucocorticoids|mesh-ancestor
91948941|NCT03636165|Hormones|hormones|mesh-ancestor
91948942|NCT03636165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948943|NCT03636165|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91948944|NCT03636165|Protective Agents|protective agents|mesh-ancestor
91948945|NCT03636165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91948946|NCT03636165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948947|NCT02310347|Dronabinol|dronabinol|mesh-list
91948965|NCT03502889|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948966|NCT03502889|Anesthetics|anesthetics|mesh-ancestor
91948967|NCT03502889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948968|NCT03502889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948969|NCT03502889|Sensory System Agents|sensory system agents|mesh-ancestor
91948970|NCT03502889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948971|NCT05098353|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91948972|NCT05098353|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948973|NCT05098353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948974|NCT05098353|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91948975|NCT05098353|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91948976|NCT05098353|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948977|NCT05098353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948978|NCT05098119|Paclitaxel|paclitaxel|mesh-list
91948979|NCT05098119|Carboplatin|carboplatin|mesh-list
91948980|NCT05098119|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91948981|NCT05098119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948982|NCT05098119|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948983|NCT05098119|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948984|NCT05098119|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948985|NCT05098119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948987|NCT02738879|Insulin Glargine|insulin glargine|mesh-list
91948988|NCT02738879|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91948989|NCT02738879|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948990|NCT02738879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948991|NCT02738879|Incretins|incretins|mesh-ancestor
91948992|NCT02738879|Hormones|hormones|mesh-ancestor
91948993|NCT02738879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948994|NCT02738879|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91948995|NCT02738879|Protease Inhibitors|protease inhibitors|mesh-ancestor
91948996|NCT02738879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948997|NCT02738879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948999|NCT03253913|Resveratrol|resveratrol|mesh-list
91949000|NCT03253913|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91949001|NCT03253913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949002|NCT03253913|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91949003|NCT03253913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949004|NCT03253913|Antifungal Agents|antifungal agents|mesh-ancestor
91949020|NCT03237819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91949021|NCT03237819|Anticonvulsants|anticonvulsants|mesh-ancestor
91949022|NCT03237819|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91949023|NCT03237819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949024|NCT03237819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949025|NCT03237819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949026|NCT03237819|Tocolytic Agents|tocolytic agents|mesh-ancestor
91949027|NCT03237819|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91949029|NCT03468907|Telbivudine|telbivudine|mesh-list
91949030|NCT03468907|Antiviral Agents|antiviral agents|mesh-ancestor
91944491|NCT00389675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944492|NCT00389675|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91944493|NCT02288741|Dexamethasone|dexamethasone|mesh-list
91944494|NCT02288741|Dexamethasone acetate|dexamethasone acetate|mesh-list
91944495|NCT02288741|Melphalan|melphalan|mesh-list
91944496|NCT02288741|BB 1101|bb 1101|mesh-list
91949031|NCT03468907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949032|NCT03468907|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91949033|NCT03468907|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91949034|NCT03468907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949035|NCT03468907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949036|NCT03468907|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91949037|NCT03468907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91949038|NCT05089851|Sunscreening Agents|sunscreening agents|mesh-list
91949039|NCT05089851|Botulinum Toxins|botulinum toxins|mesh-list
91949040|NCT05089851|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91949041|NCT05089851|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91949042|NCT05089851|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91949043|NCT05089851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949044|NCT05089851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949045|NCT05089851|Cholinergic Agents|cholinergic agents|mesh-ancestor
91949046|NCT05089851|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949047|NCT05089851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949048|NCT05089851|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91949049|NCT05089851|Protective Agents|protective agents|mesh-ancestor
91949050|NCT05089851|Dermatologic Agents|dermatologic agents|mesh-ancestor
91949051|NCT05089851|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91949052|NCT05089851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949053|NCT04657809|Insulin|insulin|mesh-list
91949054|NCT04657809|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91949055|NCT04657809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949057|NCT05350917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949058|NCT05350917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949059|NCT02311205|Sorafenib|sorafenib|mesh-list
91949060|NCT02311205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949061|NCT02311205|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949062|NCT02311205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949082|NCT05390749|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91949084|NCT05390749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91949085|NCT05390749|Growth Substances|growth substances|mesh-ancestor
91949086|NCT05390749|Growth Inhibitors|growth inhibitors|mesh-ancestor
91949087|NCT02813655|Cosyntropin|cosyntropin|mesh-list
91949088|NCT02813655|Hormones|hormones|mesh-ancestor
91949089|NCT02813655|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949090|NCT02813655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949091|NCT03468829|Gontivimab|gontivimab|mesh-list
91949092|NCT03468829|Antiviral Agents|antiviral agents|mesh-ancestor
91949093|NCT03468829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949094|NCT04912791|Anesthetics|anesthetics|mesh-list
91949095|NCT04912791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949096|NCT04912791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949097|NCT02316197|Peposertib|peposertib|mesh-list
91949098|NCT02316197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949099|NCT02316197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949100|NCT02316197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949101|NCT02314013|Metronidazole|metronidazole|mesh-list
91949102|NCT02314013|Cephalosporins|cephalosporins|mesh-list
91949103|NCT02314013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949104|NCT02314013|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91949105|NCT02314013|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91949106|NCT02314013|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91949107|NCT01677195|Calcium Carbonate|calcium carbonate|mesh-list
91949108|NCT01677195|Antacids|antacids|mesh-ancestor
91949109|NCT01677195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949110|NCT01677195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949111|NCT05331807|Vitamin D|vitamin d|mesh-list
91949112|NCT05331807|Ergocalciferols|ergocalciferols|mesh-list
91949113|NCT05331807|Cholecalciferol|cholecalciferol|mesh-list
91949114|NCT05331807|Vitamins|vitamins|mesh-list
91949115|NCT05331807|Micronutrients|micronutrients|mesh-ancestor
91944497|NCT02288741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944499|NCT02288741|Autonomic Agents|autonomic agents|mesh-ancestor
91944500|NCT02288741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944501|NCT02288741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949116|NCT05331807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949117|NCT05331807|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91949134|NCT02314481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949135|NCT02314481|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949136|NCT02314481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949137|NCT02314481|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91949138|NCT02314481|Tubulin Modulators|tubulin modulators|mesh-ancestor
91949139|NCT02314481|Antimitotic Agents|antimitotic agents|mesh-ancestor
91949140|NCT02314481|Mitosis Modulators|mitosis modulators|mesh-ancestor
91949141|NCT02314481|Immunotoxins|immunotoxins|mesh-ancestor
91949142|NCT02314481|Immunoconjugates|immunoconjugates|mesh-ancestor
91949143|NCT02314481|Immunologic Factors|immunologic factors|mesh-ancestor
91949144|NCT02314481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949145|NCT03502421|Ketamine|ketamine|mesh-list
91949146|NCT03502421|Analgesics|analgesics|mesh-ancestor
91949147|NCT03502421|Sensory System Agents|sensory system agents|mesh-ancestor
91949148|NCT03502421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949149|NCT03502421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949150|NCT03502421|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91949151|NCT03502421|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91949152|NCT03502421|Anesthetics, General|anesthetics, general|mesh-ancestor
91949153|NCT03502421|Anesthetics|anesthetics|mesh-ancestor
91949154|NCT03502421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949155|NCT03502421|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91949156|NCT03502421|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91949157|NCT03502421|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949158|NCT03502421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949159|NCT03502343|Paclitaxel|paclitaxel|mesh-list
91949160|NCT03502343|Gemcitabine|gemcitabine|mesh-list
91949161|NCT03502343|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91949162|NCT03502343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949163|NCT03502343|Tubulin Modulators|tubulin modulators|mesh-ancestor
91949164|NCT03502343|Antimitotic Agents|antimitotic agents|mesh-ancestor
91949165|NCT03502343|Mitosis Modulators|mitosis modulators|mesh-ancestor
91949166|NCT03502343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949167|NCT03502343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91949168|NCT03502343|Antimetabolites|antimetabolites|mesh-ancestor
91949169|NCT05390515|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91949170|NCT05390515|Immunologic Factors|immunologic factors|mesh-ancestor
91949171|NCT05390515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949172|NCT04345887|Spironolactone|spironolactone|mesh-list
91949173|NCT04345887|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91949174|NCT04345887|Hormone Antagonists|hormone antagonists|mesh-ancestor
92090404|NCT04382014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949235|NCT03501251|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91949236|NCT03501251|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91949237|NCT03501251|Tubulin Modulators|tubulin modulators|mesh-ancestor
91949238|NCT03501251|Antimitotic Agents|antimitotic agents|mesh-ancestor
91949239|NCT03501251|Mitosis Modulators|mitosis modulators|mesh-ancestor
91949240|NCT03501251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949241|NCT03501251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949242|NCT03501251|Antinematodal Agents|antinematodal agents|mesh-ancestor
91949243|NCT05163691|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
91949244|NCT05163691|Hallucinogens|hallucinogens|mesh-ancestor
91949245|NCT05163691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949246|NCT05163691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91949247|NCT05163691|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91949248|NCT05163691|Serotonin Agents|serotonin agents|mesh-ancestor
91949249|NCT05163691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949250|NCT05163691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949251|NCT05163691|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91949252|NCT05390203|Testosterone|testosterone|mesh-list
91944503|NCT02288741|Glucocorticoids|glucocorticoids|mesh-ancestor
91944504|NCT02288741|Hormones|hormones|mesh-ancestor
91949253|NCT05390203|Androgens|androgens|mesh-ancestor
91949254|NCT05390203|Hormones|hormones|mesh-ancestor
91949255|NCT05390203|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949256|NCT05390203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949258|NCT01634152|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91949259|NCT01634152|Autonomic Agents|autonomic agents|mesh-ancestor
91949260|NCT01634152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949261|NCT01634152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949262|NCT01634152|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91949263|NCT01634152|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949264|NCT01634152|Parasympatholytics|parasympatholytics|mesh-ancestor
91949265|NCT01634152|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91949266|NCT01634152|Cholinergic Agents|cholinergic agents|mesh-ancestor
91949267|NCT01634152|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949268|NCT01634152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949269|NCT02315495|Saxagliptin|saxagliptin|mesh-list
91949270|NCT02315495|Acarbose|acarbose|mesh-list
91949271|NCT02315495|Incretins|incretins|mesh-ancestor
91949272|NCT02315495|Hormones|hormones|mesh-ancestor
91949273|NCT02315495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949274|NCT02315495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949275|NCT02315495|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91949276|NCT02315495|Protease Inhibitors|protease inhibitors|mesh-ancestor
91949277|NCT02315495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949278|NCT02315495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949279|NCT02315495|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91949280|NCT02315495|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91949281|NCT02317601|Methylprednisolone|methylprednisolone|mesh-list
91949282|NCT02317601|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91949283|NCT02317601|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91949285|NCT02317601|Prednisolone acetate|prednisolone acetate|mesh-list
91949286|NCT02317601|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91949287|NCT02317601|Prednisolone phosphate|prednisolone phosphate|mesh-list
91949288|NCT02317601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949289|NCT02317601|Antiemetics|antiemetics|mesh-ancestor
91949290|NCT02317601|Autonomic Agents|autonomic agents|mesh-ancestor
91949291|NCT02317601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949292|NCT02317601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949293|NCT02317601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949294|NCT02317601|Glucocorticoids|glucocorticoids|mesh-ancestor
91949295|NCT02317601|Hormones|hormones|mesh-ancestor
91949296|NCT02317601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949297|NCT02317601|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91949298|NCT02317601|Protective Agents|protective agents|mesh-ancestor
91949299|NCT02317601|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91949300|NCT02317601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949301|NCT05101785|Lidocaine|lidocaine|mesh-list
91949302|NCT05101785|Epinephrine|epinephrine|mesh-list
91949303|NCT05101785|Racepinephrine|racepinephrine|mesh-list
91949304|NCT05101785|Carticaine|carticaine|mesh-list
91949305|NCT05101785|Epinephryl borate|epinephryl borate|mesh-list
91949306|NCT05101785|Anesthetics, Local|anesthetics, local|mesh-ancestor
91949307|NCT05101785|Anesthetics|anesthetics|mesh-ancestor
91949308|NCT05101785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949309|NCT05101785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949310|NCT05101785|Sensory System Agents|sensory system agents|mesh-ancestor
91949311|NCT05101785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949312|NCT05101785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91949313|NCT05101785|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91949314|NCT05101785|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91949315|NCT05101785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949316|NCT05101785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949317|NCT05101785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91949318|NCT05101785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91949319|NCT05101785|Adrenergic Agents|adrenergic agents|mesh-ancestor
91949320|NCT05101785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949321|NCT05101785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91949322|NCT05101785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91949323|NCT05101785|Autonomic Agents|autonomic agents|mesh-ancestor
91944505|NCT02288741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944506|NCT02288741|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91944507|NCT02288741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944508|NCT02288741|Protease Inhibitors|protease inhibitors|mesh-ancestor
91949324|NCT05101785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91949325|NCT05101785|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949326|NCT05101785|Mydriatics|mydriatics|mesh-ancestor
91949327|NCT05101785|Sympathomimetics|sympathomimetics|mesh-ancestor
91949328|NCT05101785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91949329|NCT02315573|Lidocaine|lidocaine|mesh-list
91949330|NCT02315573|Epinephrine|epinephrine|mesh-list
91949331|NCT02315573|Racepinephrine|racepinephrine|mesh-list
91949332|NCT02315573|Bupivacaine|bupivacaine|mesh-list
91949343|NCT02315573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949344|NCT02315573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949345|NCT02315573|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91949346|NCT02315573|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91949347|NCT02315573|Adrenergic Agents|adrenergic agents|mesh-ancestor
91949348|NCT02315573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949349|NCT02315573|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91949350|NCT02315573|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91949351|NCT02315573|Autonomic Agents|autonomic agents|mesh-ancestor
91949352|NCT02315573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91949353|NCT02315573|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949354|NCT02315573|Mydriatics|mydriatics|mesh-ancestor
91949355|NCT02315573|Sympathomimetics|sympathomimetics|mesh-ancestor
91949356|NCT02315573|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91949357|NCT02724241|Nicotine|nicotine|mesh-list
91949358|NCT02724241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91949359|NCT02724241|Autonomic Agents|autonomic agents|mesh-ancestor
91949360|NCT02724241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949361|NCT02724241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949362|NCT02724241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91949363|NCT02724241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91949364|NCT02724241|Cholinergic Agents|cholinergic agents|mesh-ancestor
91949365|NCT02724241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949366|NCT02724241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949367|NCT02315651|Ubiquinone|ubiquinone|mesh-list
91949368|NCT02315651|Coenzyme Q10|coenzyme q10|mesh-list
91949369|NCT02315651|Micronutrients|micronutrients|mesh-ancestor
91949370|NCT02315651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949371|NCT02315651|Vitamins|vitamins|mesh-ancestor
91949372|NCT05366725|Avelumab|avelumab|mesh-list
91949373|NCT05366725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949374|NCT05366725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949375|NCT04437693|Hydroxychloroquine|hydroxychloroquine|mesh-list
91949376|NCT04437693|Antimalarials|antimalarials|mesh-ancestor
91949377|NCT04437693|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91949378|NCT04437693|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91949379|NCT04437693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949380|NCT04437693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949381|NCT04437693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949382|NCT04437693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949383|NCT02317679|Bosentan|bosentan|mesh-list
91949384|NCT02317679|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91949385|NCT02317679|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91949386|NCT02317679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949387|NCT03475381|Ivacaftor|ivacaftor|mesh-list
91949388|NCT03475381|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91949389|NCT03475381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949390|NCT03475381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949391|NCT04462757|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91949392|NCT04462757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949393|NCT04535505|Erythromycin|erythromycin|mesh-list
91949394|NCT04535505|Erythromycin Estolate|erythromycin estolate|mesh-list
91949395|NCT04535505|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
91949396|NCT04535505|Erythromycin stearate|erythromycin stearate|mesh-list
91949401|NCT04535505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949402|NCT04535505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949403|NCT03500783|Nitric Oxide|nitric oxide|mesh-list
91949404|NCT03500783|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91944509|NCT02288741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949405|NCT03500783|Autonomic Agents|autonomic agents|mesh-ancestor
91949406|NCT03500783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949407|NCT03500783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949408|NCT03500783|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91949409|NCT03500783|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949410|NCT03500783|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91949411|NCT03500783|Antioxidants|antioxidants|mesh-ancestor
91949412|NCT03500783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949413|NCT03500783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949414|NCT03500783|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91949415|NCT03500783|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949416|NCT03500783|Gasotransmitters|gasotransmitters|mesh-ancestor
91949417|NCT03500783|Protective Agents|protective agents|mesh-ancestor
91949418|NCT03353233|Ropivacaine|ropivacaine|mesh-list
91949419|NCT03353233|Anesthetics, Local|anesthetics, local|mesh-ancestor
91949420|NCT03353233|Anesthetics|anesthetics|mesh-ancestor
91949421|NCT03353233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949422|NCT03353233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949423|NCT03353233|Sensory System Agents|sensory system agents|mesh-ancestor
91949424|NCT03353233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949425|NCT02320877|Methaqualone|methaqualone|mesh-list
91949426|NCT02320877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91949427|NCT02320877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949428|NCT02320877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949429|NCT01322971|Metronidazole|metronidazole|mesh-list
91949430|NCT01322971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949431|NCT01322971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91949432|NCT01322971|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91949433|NCT01322971|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91949435|NCT04454281|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91949436|NCT04454281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949437|NCT04454281|Sensory System Agents|sensory system agents|mesh-ancestor
91949438|NCT04454281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949439|NCT02318225|Misoprostol|misoprostol|mesh-list
91949440|NCT02318225|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91949441|NCT02318225|Abortifacient Agents|abortifacient agents|mesh-ancestor
91949442|NCT02318225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91949443|NCT02318225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949444|NCT02318225|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91949445|NCT02318225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949446|NCT02318225|Oxytocics|oxytocics|mesh-ancestor
91949447|NCT01378429|Ciclesonide|ciclesonide|mesh-list
91949448|NCT01378429|Glucocorticoids|glucocorticoids|mesh-ancestor
91949449|NCT01378429|Hormones|hormones|mesh-ancestor
91949527|NCT03109691|Anesthetics|anesthetics|mesh-ancestor
91949450|NCT01378429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949451|NCT01378429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949452|NCT01378429|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91949453|NCT01599754|Axitinib|axitinib|mesh-list
91949454|NCT01599754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949455|NCT01599754|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949456|NCT01599754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949457|NCT01599754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949458|NCT02321267|Ranibizumab|ranibizumab|mesh-list
91949459|NCT02321267|Aflibercept|aflibercept|mesh-list
91949460|NCT02321267|Verteporfin|verteporfin|mesh-list
91949461|NCT02321267|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91949462|NCT02321267|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91949463|NCT02321267|Growth Substances|growth substances|mesh-ancestor
91949464|NCT02321267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949465|NCT02321267|Growth Inhibitors|growth inhibitors|mesh-ancestor
91949466|NCT02321267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949467|NCT02321267|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91949468|NCT02321267|Dermatologic Agents|dermatologic agents|mesh-ancestor
91949474|NCT04642261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949475|NCT04642261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91949476|NCT04642261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949477|NCT02318771|Pembrolizumab|pembrolizumab|mesh-list
91949478|NCT02318771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949479|NCT02318771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949480|NCT02318771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91944510|NCT02288741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944511|NCT02288741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91949481|NCT02318771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949482|NCT04936399|Nivolumab|nivolumab|mesh-list
91949483|NCT04936399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949484|NCT04936399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949485|NCT04936399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91949486|NCT04936399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949487|NCT02319161|Calcium Channel Blockers|calcium channel blockers|mesh-list
91949488|NCT02319161|Calcium|calcium|mesh-list
91949489|NCT02319161|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91949490|NCT02319161|Esmolol|esmolol|mesh-list
91949491|NCT02319161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949492|NCT02319161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949493|NCT02319161|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91949494|NCT02319161|Adrenergic Agents|adrenergic agents|mesh-ancestor
91949495|NCT02319161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949496|NCT02319161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949497|NCT02319161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949498|NCT02319161|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91949499|NCT02321579|Vitamin B 6|vitamin b 6|mesh-list
91949500|NCT02321579|Pyridoxal|pyridoxal|mesh-list
91949501|NCT02321579|Pyridoxine|pyridoxine|mesh-list
91949502|NCT02321579|Vitamins|vitamins|mesh-ancestor
91949503|NCT02321579|Micronutrients|micronutrients|mesh-ancestor
91949504|NCT02321579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949505|NCT02321579|Vitamin B Complex|vitamin b complex|mesh-ancestor
91949506|NCT01584934|Sodium Oxybate|sodium oxybate|mesh-list
91949507|NCT01584934|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91949508|NCT01584934|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91949509|NCT01584934|Anesthetics, General|anesthetics, general|mesh-ancestor
91949510|NCT01584934|Anesthetics|anesthetics|mesh-ancestor
91949511|NCT01584934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949512|NCT01584934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949513|NCT03109691|Dexamethasone|dexamethasone|mesh-list
91949514|NCT03109691|Bupivacaine|bupivacaine|mesh-list
91949515|NCT03109691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949516|NCT03109691|Antiemetics|antiemetics|mesh-ancestor
91949517|NCT03109691|Autonomic Agents|autonomic agents|mesh-ancestor
91949518|NCT03109691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949519|NCT03109691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949520|NCT03109691|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949521|NCT03109691|Glucocorticoids|glucocorticoids|mesh-ancestor
91949522|NCT03109691|Hormones|hormones|mesh-ancestor
91949523|NCT03109691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949524|NCT03109691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91949525|NCT03109691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949526|NCT03109691|Anesthetics, Local|anesthetics, local|mesh-ancestor
91949528|NCT03109691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949529|NCT03109691|Sensory System Agents|sensory system agents|mesh-ancestor
91949530|NCT03497351|Nicardipine|nicardipine|mesh-list
91949531|NCT03497351|Urapidil|urapidil|mesh-list
91949532|NCT03497351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91949533|NCT03497351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91949534|NCT03497351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949535|NCT03497351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949536|NCT03497351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949537|NCT03497351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949538|NCT03497351|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949540|NCT03497351|Serotonin Agents|serotonin agents|mesh-ancestor
91949541|NCT03497351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949542|NCT03497351|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91949543|NCT03497351|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91949544|NCT03497351|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91949545|NCT03497351|Adrenergic Agents|adrenergic agents|mesh-ancestor
91949546|NCT02223364|Bupivacaine|bupivacaine|mesh-list
91949547|NCT02223364|Ropivacaine|ropivacaine|mesh-list
91949548|NCT02223364|Anesthetics, Local|anesthetics, local|mesh-ancestor
91949549|NCT02223364|Anesthetics|anesthetics|mesh-ancestor
91949550|NCT02223364|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944512|NCT02288741|Alkylating Agents|alkylating agents|mesh-ancestor
91944513|NCT02288741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91944514|NCT02288741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91949551|NCT02223364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949552|NCT02223364|Sensory System Agents|sensory system agents|mesh-ancestor
91949553|NCT02223364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949554|NCT01378975|Vemurafenib|vemurafenib|mesh-list
91949555|NCT01378975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949556|NCT01378975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949557|NCT01378975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949558|NCT01378975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949559|NCT02222896|Chlorhexidine|chlorhexidine|mesh-list
91949560|NCT02222896|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91949561|NCT02222896|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91949562|NCT02222896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949563|NCT02222896|Disinfectants|disinfectants|mesh-ancestor
91949564|NCT02222896|Dermatologic Agents|dermatologic agents|mesh-ancestor
91949565|NCT03499457|Amoxicillin|amoxicillin|mesh-list
91949566|NCT03499457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91949567|NCT03499457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949568|NCT03499379|Levonorgestrel|levonorgestrel|mesh-list
91949569|NCT03499379|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91949570|NCT03499379|Contraceptive Agents|contraceptive agents|mesh-ancestor
91949571|NCT03499379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91949572|NCT03499379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949573|NCT03499379|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91949574|NCT03499379|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91949575|NCT03499379|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91949577|NCT02322203|Niacinamide|niacinamide|mesh-list
91949578|NCT02322203|Nicotinic Acids|nicotinic acids|mesh-list
91949579|NCT02322203|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91949580|NCT02322203|Antimetabolites|antimetabolites|mesh-ancestor
91949581|NCT02322203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949582|NCT02322203|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91949583|NCT02322203|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949584|NCT02322203|Vitamin B Complex|vitamin b complex|mesh-ancestor
91949585|NCT02322203|Vitamins|vitamins|mesh-ancestor
91949586|NCT02322203|Micronutrients|micronutrients|mesh-ancestor
91949587|NCT02322203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949588|NCT04638751|Immunomodulating Agents|immunomodulating agents|mesh-list
91949589|NCT04638751|Immunologic Factors|immunologic factors|mesh-ancestor
91949590|NCT04638751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949591|NCT02319629|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91949592|NCT02319629|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91949593|NCT02319629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949594|NCT04691362|Tranexamic Acid|tranexamic acid|mesh-list
91949595|NCT04691362|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91949596|NCT04691362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91949597|NCT04691362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949598|NCT04691362|Hemostatics|hemostatics|mesh-ancestor
91949599|NCT04691362|Coagulants|coagulants|mesh-ancestor
91949600|NCT03499223|Ranibizumab|ranibizumab|mesh-list
91949601|NCT03499223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91949602|NCT03499223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91949603|NCT03499223|Growth Substances|growth substances|mesh-ancestor
91949604|NCT03499223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949605|NCT03499223|Growth Inhibitors|growth inhibitors|mesh-ancestor
91949606|NCT03499223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949608|NCT02319707|Oxytocics|oxytocics|mesh-ancestor
91949609|NCT02319707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91949610|NCT02319707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949611|NCT05398861|Bevacizumab|bevacizumab|mesh-list
91949612|NCT05398861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949613|NCT05398861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949614|NCT05398861|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91949635|NCT05398393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949636|NCT05398393|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91949637|NCT05398393|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91949638|NCT05398393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949639|NCT05398393|Antiviral Agents|antiviral agents|mesh-ancestor
91949640|NCT05398393|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944515|NCT02288741|Immunologic Factors|immunologic factors|mesh-ancestor
91944516|NCT02450552|Ezogabine|ezogabine|mesh-list
91944517|NCT02450552|Anticonvulsants|anticonvulsants|mesh-ancestor
91944518|NCT02450552|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944519|NCT02450552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944520|NCT02508428|Methyclothiazide|methyclothiazide|mesh-list
91949641|NCT05398393|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91949642|NCT05398393|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91949643|NCT05398393|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91949644|NCT05398393|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91949645|NCT05398393|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91949646|NCT05398393|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91949647|NCT05398393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949648|NCT05398393|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949649|NCT05398393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949650|NCT05398393|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949651|NCT01356628|Palbociclib|palbociclib|mesh-list
91949652|NCT01356628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949653|NCT01356628|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949654|NCT01356628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949655|NCT01356628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949656|NCT02319941|Clopidogrel|clopidogrel|mesh-list
91949658|NCT02319941|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91949659|NCT02319941|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91949660|NCT02319941|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91949661|NCT02319941|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91949662|NCT02319941|Purinergic Agents|purinergic agents|mesh-ancestor
91949663|NCT02319941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949664|NCT02319941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949665|NCT02319941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949666|NCT05164627|Magnesium Sulfate|magnesium sulfate|mesh-list
91949667|NCT05164627|Dexmedetomidine|dexmedetomidine|mesh-list
91949668|NCT05164627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91949684|NCT05164627|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91949685|NCT05164627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949686|NCT05164627|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949687|NCT05164627|Tocolytic Agents|tocolytic agents|mesh-ancestor
91949688|NCT05164627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91949690|NCT02322671|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91949691|NCT02322671|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949692|NCT02322671|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91949693|NCT02322671|Hormone Antagonists|hormone antagonists|mesh-ancestor
91949694|NCT02322671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949695|NCT02322671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949696|NCT02322671|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91949697|NCT02322671|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91949698|NCT02322671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949699|NCT05096143|Valsartan|valsartan|mesh-list
91949700|NCT05096143|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91949701|NCT05096143|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91949702|NCT05096143|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91949703|NCT05096143|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91949704|NCT05096143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949705|NCT03494387|Ascorbic Acid|ascorbic acid|mesh-list
91949706|NCT03494387|Acetylcysteine|acetylcysteine|mesh-list
91949707|NCT03494387|Antioxidants|antioxidants|mesh-list
91949708|NCT03494387|Antiviral Agents|antiviral agents|mesh-ancestor
91949709|NCT03494387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949710|NCT03494387|Expectorants|expectorants|mesh-ancestor
91949711|NCT03494387|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949712|NCT03494387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91949713|NCT03494387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949714|NCT03494387|Protective Agents|protective agents|mesh-ancestor
91944522|NCT02508428|Natriuretic Agents|natriuretic agents|mesh-ancestor
91949715|NCT03494387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949716|NCT03494387|Vitamins|vitamins|mesh-ancestor
91949717|NCT03494387|Micronutrients|micronutrients|mesh-ancestor
91949718|NCT03496649|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91949719|NCT03496649|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91949720|NCT03496649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949721|NCT03496649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949722|NCT03496649|Cholinergic Agents|cholinergic agents|mesh-ancestor
91949723|NCT03496649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949744|NCT03821545|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91949745|NCT03821545|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91949746|NCT03821545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949748|NCT02324933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91949749|NCT02324933|Narcotics|narcotics|mesh-ancestor
91949750|NCT02324933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949751|NCT02324933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949752|NCT02324933|Analgesics|analgesics|mesh-ancestor
91949753|NCT02324933|Sensory System Agents|sensory system agents|mesh-ancestor
91949754|NCT02324933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949755|NCT02324933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91949756|NCT02324933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91949757|NCT02324933|Anesthetics, General|anesthetics, general|mesh-ancestor
91949758|NCT02324933|Anesthetics|anesthetics|mesh-ancestor
91949759|NCT01378117|Insulin Glargine|insulin glargine|mesh-list
91949760|NCT01378117|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91949761|NCT01378117|Insulin Lispro|insulin lispro|mesh-list
91949762|NCT01378117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91949763|NCT01378117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949764|NCT01378117|Incretins|incretins|mesh-ancestor
91949765|NCT01378117|Hormones|hormones|mesh-ancestor
91949766|NCT01378117|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949767|NCT01378117|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91949768|NCT01378117|Protease Inhibitors|protease inhibitors|mesh-ancestor
91949769|NCT01378117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949770|NCT01378117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949771|NCT02323139|Azacitidine|azacitidine|mesh-list
91949772|NCT02323139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91949773|NCT02323139|Antimetabolites|antimetabolites|mesh-ancestor
92090405|NCT04382014|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949790|NCT02325479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949791|NCT05236231|Tadalafil|tadalafil|mesh-list
91949792|NCT05236231|Macitentan|macitentan|mesh-list
91949793|NCT05236231|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949794|NCT05236231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91949795|NCT05236231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91949796|NCT05236231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949797|NCT05236231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949798|NCT05236231|Urological Agents|urological agents|mesh-ancestor
91949799|NCT05236231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
91949800|NCT05236231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91949801|NCT05236231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
91949802|NCT02325557|Pembrolizumab|pembrolizumab|mesh-list
91949803|NCT02325557|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949804|NCT02325557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949805|NCT02325557|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91949806|NCT02325557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949807|NCT03495323|Prexasertib|prexasertib|mesh-list
91949808|NCT03495323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91949809|NCT03495323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949810|NCT03495323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949811|NCT02323451|Chitosan|chitosan|mesh-list
91949812|NCT02323451|Hyaluronic Acid|hyaluronic acid|mesh-list
91949813|NCT02323451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91949814|NCT02323451|Immunologic Factors|immunologic factors|mesh-ancestor
91949815|NCT02323451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944523|NCT02508428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949816|NCT02323451|Viscosupplements|viscosupplements|mesh-ancestor
91949817|NCT02323451|Protective Agents|protective agents|mesh-ancestor
91949818|NCT02323451|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91949819|NCT02323451|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91949820|NCT02323451|Antimetabolites|antimetabolites|mesh-ancestor
91949821|NCT02323451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949822|NCT02323451|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91949823|NCT02323451|Chelating Agents|chelating agents|mesh-ancestor
91949824|NCT02323451|Sequestering Agents|sequestering agents|mesh-ancestor
91949825|NCT02323451|Hemostatics|hemostatics|mesh-ancestor
91949826|NCT02323451|Coagulants|coagulants|mesh-ancestor
91949827|NCT02323529|Nitisinone|nitisinone|mesh-list
91949849|NCT03493841|Protective Agents|protective agents|mesh-ancestor
91949850|NCT03493841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949851|NCT03493841|Vitamin B Complex|vitamin b complex|mesh-ancestor
91949853|NCT03493841|Micronutrients|micronutrients|mesh-ancestor
91949854|NCT05118737|Colchicine|colchicine|mesh-list
91949855|NCT05118737|Gout Suppressants|gout suppressants|mesh-ancestor
91949856|NCT05118737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949857|NCT05118737|Tubulin Modulators|tubulin modulators|mesh-ancestor
91949858|NCT05118737|Antimitotic Agents|antimitotic agents|mesh-ancestor
91949859|NCT05118737|Mitosis Modulators|mitosis modulators|mesh-ancestor
91949860|NCT05118737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949861|NCT05118737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949862|NCT04987931|Talazoparib|talazoparib|mesh-list
91949863|NCT04987931|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91949864|NCT04987931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949865|NCT04987931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949866|NCT04987931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949867|NCT03492827|Chlorhexidine|chlorhexidine|mesh-list
91949868|NCT03492827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91949869|NCT03492827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91949870|NCT03492827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949883|NCT03491579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949885|NCT04600895|Antiviral Agents|antiviral agents|mesh-ancestor
91949886|NCT04600895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949887|NCT03492593|Beta Carotene|beta carotene|mesh-list
91949888|NCT03492593|Lycopene|lycopene|mesh-list
91949889|NCT03492593|Carotenoids|carotenoids|mesh-list
91949890|NCT03492593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949891|NCT03492593|Antioxidants|antioxidants|mesh-ancestor
91949892|NCT03492593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949893|NCT03492593|Protective Agents|protective agents|mesh-ancestor
91949894|NCT03492593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949895|NCT03492593|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91949896|NCT03492593|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91949897|NCT03492593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949898|NCT03492593|Provitamins|provitamins|mesh-ancestor
91949899|NCT03492593|Vitamins|vitamins|mesh-ancestor
91949900|NCT03492593|Micronutrients|micronutrients|mesh-ancestor
91949901|NCT04461353|Hydroxychloroquine|hydroxychloroquine|mesh-list
91949902|NCT04461353|Antimalarials|antimalarials|mesh-ancestor
91949903|NCT04461353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91949904|NCT04461353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91949905|NCT04461353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949906|NCT04461353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949907|NCT04461353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949908|NCT04461353|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949909|NCT04034459|Leucovorin|leucovorin|mesh-list
91949910|NCT04034459|Folic Acid|folic acid|mesh-list
91949911|NCT04034459|Bevacizumab|bevacizumab|mesh-list
91949912|NCT04034459|Cetuximab|cetuximab|mesh-list
91949913|NCT04034459|Oxaliplatin|oxaliplatin|mesh-list
91949914|NCT04034459|Irinotecan|irinotecan|mesh-list
91944524|NCT02508428|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91944525|NCT02508428|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944526|NCT02508428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949915|NCT04034459|Levoleucovorin|levoleucovorin|mesh-list
91949916|NCT04034459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949917|NCT04034459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949918|NCT04034459|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91949919|NCT04034459|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91949920|NCT04034459|Growth Substances|growth substances|mesh-ancestor
91949921|NCT04034459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949922|NCT04034459|Growth Inhibitors|growth inhibitors|mesh-ancestor
91949923|NCT04034459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91949924|NCT04034459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91949925|NCT04034459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949926|NCT04034459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949927|NCT04034459|Antidotes|antidotes|mesh-ancestor
91949928|NCT04034459|Protective Agents|protective agents|mesh-ancestor
91949929|NCT04034459|Vitamin B Complex|vitamin b complex|mesh-ancestor
91949930|NCT04034459|Vitamins|vitamins|mesh-ancestor
91949931|NCT04034459|Micronutrients|micronutrients|mesh-ancestor
91949932|NCT04034459|Hematinics|hematinics|mesh-ancestor
91949933|NCT03914885|Fludarabine|fludarabine|mesh-list
91949934|NCT03914885|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91949935|NCT03914885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949936|NCT03914885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949954|NCT03757013|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91949955|NCT03757013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91949956|NCT03757013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949957|NCT03757013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949958|NCT02736409|Budesonide|budesonide|mesh-list
91949959|NCT02736409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949960|NCT02736409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91949961|NCT02736409|Autonomic Agents|autonomic agents|mesh-ancestor
91949962|NCT02736409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949963|NCT02736409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949964|NCT02736409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91949965|NCT02736409|Respiratory System Agents|respiratory system agents|mesh-ancestor
91949966|NCT02736409|Glucocorticoids|glucocorticoids|mesh-ancestor
91949967|NCT02736409|Hormones|hormones|mesh-ancestor
91949968|NCT02736409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949969|NCT05396677|Acetaminophen|acetaminophen|mesh-list
91949970|NCT05396677|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91949971|NCT05396677|Analgesics|analgesics|mesh-ancestor
91949972|NCT05396677|Sensory System Agents|sensory system agents|mesh-ancestor
91949973|NCT05396677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949974|NCT05396677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949975|NCT05396677|Antipyretics|antipyretics|mesh-ancestor
91949976|NCT05131867|Nimodipine|nimodipine|mesh-list
91949977|NCT05131867|Milrinone|milrinone|mesh-list
91949978|NCT05131867|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91949979|NCT05131867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91949980|NCT05131867|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949981|NCT05131867|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91949982|NCT05131867|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91949983|NCT05131867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949984|NCT05131867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949985|NCT05131867|Protective Agents|protective agents|mesh-ancestor
91949986|NCT05131867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949987|NCT05131867|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91949988|NCT05131867|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91949989|NCT05131867|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949990|NCT05131867|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949991|NCT02837783|Linaclotide|linaclotide|mesh-list
91949992|NCT02837783|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91950007|NCT05007145|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91950008|NCT05007145|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91950009|NCT05007145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91944528|NCT02448446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91944529|NCT02448446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91950010|NCT05007145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950011|NCT05007145|Tubulin Modulators|tubulin modulators|mesh-ancestor
91950012|NCT05007145|Antimitotic Agents|antimitotic agents|mesh-ancestor
91950013|NCT05007145|Mitosis Modulators|mitosis modulators|mesh-ancestor
91950014|NCT05007145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950015|NCT05007145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91950016|NCT04952857|Vitamin D|vitamin d|mesh-list
91950017|NCT04952857|Cholecalciferol|cholecalciferol|mesh-list
91950018|NCT04952857|Vitamins|vitamins|mesh-ancestor
91950019|NCT04952857|Micronutrients|micronutrients|mesh-ancestor
91950020|NCT04952857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950021|NCT04952857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91950022|NCT04952857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91950023|NCT02220712|Aripiprazole|aripiprazole|mesh-list
91950024|NCT02220712|Antidepressive Agents|antidepressive agents|mesh-ancestor
91950025|NCT02220712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950026|NCT02220712|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91950027|NCT02220712|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91950028|NCT02220712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950029|NCT02220712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950030|NCT02220712|Dopamine Agonists|dopamine agonists|mesh-ancestor
91950031|NCT02220712|Dopamine Agents|dopamine agents|mesh-ancestor
91950032|NCT02220712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950033|NCT02220712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950034|NCT02220712|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91950035|NCT02220712|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91950036|NCT02220712|Serotonin Agents|serotonin agents|mesh-ancestor
91950037|NCT02220712|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91950038|NCT02220712|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91950039|NCT02220712|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91950040|NCT02220712|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91950041|NCT04923295|Dapagliflozin|dapagliflozin|mesh-list
91950042|NCT04923295|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91950043|NCT04923295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950044|NCT04923295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950045|NCT04923295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950046|NCT05396209|Dimenhydrinate|dimenhydrinate|mesh-list
91950047|NCT05396209|Antiemetics|antiemetics|mesh-ancestor
91950048|NCT05396209|Autonomic Agents|autonomic agents|mesh-ancestor
92090406|NCT04382014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950067|NCT00846430|Temozolomide|temozolomide|mesh-list
91950068|NCT00846430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950069|NCT00846430|Antiviral Agents|antiviral agents|mesh-ancestor
91950070|NCT00846430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950071|NCT00846430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91950072|NCT00846430|Tubulin Modulators|tubulin modulators|mesh-ancestor
91950073|NCT00846430|Antimitotic Agents|antimitotic agents|mesh-ancestor
91950074|NCT00846430|Mitosis Modulators|mitosis modulators|mesh-ancestor
91950075|NCT00846430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950076|NCT00846430|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91950077|NCT00846430|Alkylating Agents|alkylating agents|mesh-ancestor
91950078|NCT00846430|Immunologic Factors|immunologic factors|mesh-ancestor
91950079|NCT00846430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950080|NCT00846430|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91950081|NCT00846430|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91950082|NCT00846430|Analgesics|analgesics|mesh-ancestor
91950083|NCT00846430|Sensory System Agents|sensory system agents|mesh-ancestor
91950084|NCT00846430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950085|NCT00846430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950086|NCT00846430|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950087|NCT00846430|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91950088|NCT00846430|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91950089|NCT00846430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950090|NCT05439577|Heparinoids|heparinoids|mesh-list
91950091|NCT05439577|Glucocorticoids|glucocorticoids|mesh-list
91950092|NCT05439577|Hormones|hormones|mesh-ancestor
91950093|NCT05439577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944531|NCT02448446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944532|NCT02448446|Growth Inhibitors|growth inhibitors|mesh-ancestor
91944533|NCT02448446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950094|NCT05439577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950095|NCT05439577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950096|NCT05439577|Anticoagulants|anticoagulants|mesh-ancestor
91950097|NCT05385523|Dexamethasone|dexamethasone|mesh-list
91950098|NCT05385523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950099|NCT05385523|Antiemetics|antiemetics|mesh-ancestor
91950100|NCT05385523|Autonomic Agents|autonomic agents|mesh-ancestor
91950101|NCT05385523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950102|NCT05385523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950103|NCT05385523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950104|NCT05385523|Glucocorticoids|glucocorticoids|mesh-ancestor
91950105|NCT05385523|Hormones|hormones|mesh-ancestor
91950125|NCT02217982|Antidiarrheals|antidiarrheals|mesh-list
91950126|NCT02217982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950127|NCT02217982|Antifoaming Agents|antifoaming agents|mesh-ancestor
91950128|NCT02217982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950129|NCT02217982|Emollients|emollients|mesh-ancestor
91950130|NCT02217982|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950131|NCT02207608|Hyaluronic Acid|hyaluronic acid|mesh-list
91950132|NCT02207608|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91950133|NCT02207608|Immunologic Factors|immunologic factors|mesh-ancestor
91950134|NCT02207608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950135|NCT02207608|Viscosupplements|viscosupplements|mesh-ancestor
91950136|NCT02207608|Protective Agents|protective agents|mesh-ancestor
91950137|NCT03530995|Itraconazole|itraconazole|mesh-list
91950138|NCT03530995|Rifampin|rifampin|mesh-list
91950139|NCT03530995|Omeprazole|omeprazole|mesh-list
91950140|NCT03530995|Rabeprazole|rabeprazole|mesh-list
91950141|NCT03530995|Belumosudil|belumosudil|mesh-list
91950142|NCT03530995|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91950143|NCT03530995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950144|NCT03530995|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91950145|NCT03530995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950146|NCT03530995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950147|NCT03530995|Antifungal Agents|antifungal agents|mesh-ancestor
91950148|NCT03530995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950149|NCT03530995|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91950150|NCT03530995|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91950151|NCT03530995|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91950152|NCT03530995|Hormone Antagonists|hormone antagonists|mesh-ancestor
91950153|NCT03530995|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950154|NCT03530995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950155|NCT03530995|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91950156|NCT03530995|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91950157|NCT03530995|Antitubercular Agents|antitubercular agents|mesh-ancestor
91950158|NCT03530995|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91950159|NCT03530995|Leprostatic Agents|leprostatic agents|mesh-ancestor
91950160|NCT03530995|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91950161|NCT03530995|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91950172|NCT04740307|Pembrolizumab|pembrolizumab|mesh-list
91950173|NCT04740307|Lenvatinib|lenvatinib|mesh-list
91950174|NCT04740307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91950175|NCT04740307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950176|NCT04740307|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91950177|NCT04740307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950178|NCT04740307|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950179|NCT04740307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950180|NCT02207530|Durvalumab|durvalumab|mesh-list
91950181|NCT02207530|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91950182|NCT02207530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950183|NCT05359315|Interferons|interferons|mesh-list
91950184|NCT05359315|Interferon-gamma|interferon-gamma|mesh-list
91950185|NCT05359315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950186|NCT05359315|Antiviral Agents|antiviral agents|mesh-ancestor
91950187|NCT05359315|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950189|NCT02616055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950190|NCT02616055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950191|NCT02616055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950192|NCT02616055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944534|NCT02478398|Mometasone Furoate|mometasone furoate|mesh-list
91944536|NCT02478398|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
91944537|NCT02478398|Epinephrine|epinephrine|mesh-list
91944538|NCT02478398|Albuterol|albuterol|mesh-list
91950193|NCT02207374|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
91950194|NCT02207374|Protease Inhibitors|protease inhibitors|mesh-ancestor
91950195|NCT02207374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950196|NCT02207374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950197|NCT02207374|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950198|NCT02207374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950199|NCT02786537|Ritonavir|ritonavir|mesh-list
91950200|NCT02786537|Ribavirin|ribavirin|mesh-list
91950201|NCT02786537|Sofosbuvir|sofosbuvir|mesh-list
91950202|NCT02786537|Grazoprevir|grazoprevir|mesh-list
91950203|NCT02786537|Ledipasvir|ledipasvir|mesh-list
91950204|NCT02786537|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91950205|NCT02786537|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91950206|NCT02786537|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91950207|NCT02786537|Protease Inhibitors|protease inhibitors|mesh-ancestor
91950208|NCT02786537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950209|NCT02786537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950210|NCT02786537|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91950211|NCT02786537|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91950212|NCT02786537|Antiviral Agents|antiviral agents|mesh-ancestor
91950213|NCT02786537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950214|NCT02786537|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91950215|NCT02786537|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91950216|NCT02786537|Antimetabolites|antimetabolites|mesh-ancestor
91950217|NCT03307759|Pembrolizumab|pembrolizumab|mesh-list
91950218|NCT03307759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91950219|NCT03307759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950220|NCT03307759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91950221|NCT03307759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950222|NCT03466645|Vancomycin|vancomycin|mesh-list
91950223|NCT03466645|Cefazolin|cefazolin|mesh-list
91950224|NCT03466645|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91950225|NCT03466645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950226|NCT04461665|Vitamin D|vitamin d|mesh-list
91950227|NCT04461665|Ergocalciferols|ergocalciferols|mesh-list
91950249|NCT03490487|Prednisolone|prednisolone|mesh-list
91950250|NCT03490487|Carbamazepine|carbamazepine|mesh-list
91950251|NCT03490487|Oxcarbazepine|oxcarbazepine|mesh-list
91950252|NCT03490487|Levetiracetam|levetiracetam|mesh-list
91950253|NCT03490487|Valproic Acid|valproic acid|mesh-list
91950254|NCT03490487|Anticonvulsants|anticonvulsants|mesh-list
91950255|NCT03490487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950256|NCT03490487|Glucocorticoids|glucocorticoids|mesh-ancestor
91950257|NCT03490487|Hormones|hormones|mesh-ancestor
91950258|NCT03490487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950259|NCT03490487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950260|NCT03490487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91950261|NCT03490487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950262|NCT03490487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950263|NCT03490487|Nootropic Agents|nootropic agents|mesh-ancestor
91950264|NCT03490487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950265|NCT03490487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950266|NCT03490487|GABA Agents|gaba agents|mesh-ancestor
91950267|NCT03490487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950268|NCT03490487|Antimanic Agents|antimanic agents|mesh-ancestor
91950269|NCT03490487|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91950270|NCT03490487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950271|NCT03490487|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950272|NCT03490487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91950273|NCT03490487|Analgesics|analgesics|mesh-ancestor
91950274|NCT03490487|Sensory System Agents|sensory system agents|mesh-ancestor
91950275|NCT03490487|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91950276|NCT03490487|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950277|NCT03490487|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91950278|NCT03490487|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91950279|NCT03490487|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91950280|NCT05271331|Anesthetics|anesthetics|mesh-list
91944539|NCT02478398|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91944540|NCT02478398|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91944541|NCT02478398|Adrenergic Agents|adrenergic agents|mesh-ancestor
91950302|NCT03130153|Salicylic Acid|salicylic acid|mesh-list
91950303|NCT03130153|Salicylates|salicylates|mesh-list
91950304|NCT03130153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91950305|NCT03130153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91950306|NCT03130153|Analgesics|analgesics|mesh-ancestor
91950307|NCT03130153|Sensory System Agents|sensory system agents|mesh-ancestor
91950308|NCT03130153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950309|NCT03130153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950310|NCT03130153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950311|NCT03130153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950312|NCT03130153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91950313|NCT03130153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91950314|NCT03130153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950315|NCT03130153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91950316|NCT03130153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91950317|NCT03130153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950318|NCT03130153|Antipyretics|antipyretics|mesh-ancestor
91950319|NCT03130153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950320|NCT03130153|Antifungal Agents|antifungal agents|mesh-ancestor
91950321|NCT03130153|Keratolytic Agents|keratolytic agents|mesh-ancestor
91950322|NCT03130153|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950323|NCT03466333|Enalapril|enalapril|mesh-list
91950324|NCT03466333|Enalaprilat|enalaprilat|mesh-list
91950325|NCT03466333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950326|NCT03466333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950327|NCT03466333|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91950328|NCT03466333|Protease Inhibitors|protease inhibitors|mesh-ancestor
91950329|NCT03466333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91950330|NCT05382715|Ozanimod|ozanimod|mesh-list
91950331|NCT05382715|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91950614|NCT02799641|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91950332|NCT05382715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950333|NCT05382715|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91950334|NCT05382715|Immunologic Factors|immunologic factors|mesh-ancestor
91950335|NCT05382715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950349|NCT03492047|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91950350|NCT03492047|Antioxidants|antioxidants|mesh-ancestor
91950351|NCT03492047|Protective Agents|protective agents|mesh-ancestor
91950352|NCT03492047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950353|NCT03492047|Antidotes|antidotes|mesh-ancestor
91950354|NCT02251990|Grazoprevir|grazoprevir|mesh-list
91950355|NCT02251990|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91950356|NCT02251990|Antiviral Agents|antiviral agents|mesh-ancestor
91950357|NCT02251990|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950358|NCT03490097|Sofosbuvir|sofosbuvir|mesh-list
91950359|NCT03490097|Simvastatin|simvastatin|mesh-list
91950360|NCT03490097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91950361|NCT03490097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91950362|NCT03490097|Antimetabolites|antimetabolites|mesh-ancestor
91950363|NCT03490097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950364|NCT03490097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91950365|NCT03490097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91950366|NCT03490097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950367|NCT03490097|Antiviral Agents|antiviral agents|mesh-ancestor
91950368|NCT03490097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950369|NCT04453735|Atorvastatin|atorvastatin|mesh-list
91950370|NCT04453735|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91950371|NCT04453735|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91950372|NCT04453735|Antimetabolites|antimetabolites|mesh-ancestor
91950373|NCT04453735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950374|NCT04453735|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91950375|NCT04453735|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91950376|NCT04453735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950377|NCT03490019|Metformin|metformin|mesh-list
91950378|NCT03490019|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950379|NCT03490019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950380|NCT03491969|Thioctic Acid|thioctic acid|mesh-list
91950381|NCT03491969|Antioxidants|antioxidants|mesh-ancestor
91950382|NCT03491969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944543|NCT02478398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944544|NCT02478398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944545|NCT02478398|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91950383|NCT03491969|Protective Agents|protective agents|mesh-ancestor
91950384|NCT03491969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950385|NCT03491969|Vitamin B Complex|vitamin b complex|mesh-ancestor
91950386|NCT03491969|Vitamins|vitamins|mesh-ancestor
91950387|NCT03491969|Micronutrients|micronutrients|mesh-ancestor
91950388|NCT05349409|Fluzoparib|fluzoparib|mesh-list
91950389|NCT05349409|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91950390|NCT05349409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950391|NCT05349409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950392|NCT05349409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950393|NCT02251912|Oxytocin|oxytocin|mesh-list
91950394|NCT02251912|Oxytocics|oxytocics|mesh-ancestor
91950395|NCT02251912|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91950396|NCT02251912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950397|NCT01976273|Glycolic acid|glycolic acid|mesh-list
91950398|NCT01976273|Keratolytic Agents|keratolytic agents|mesh-ancestor
91950409|NCT04112407|Benzoyl Peroxide|benzoyl peroxide|mesh-list
91950410|NCT04112407|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950411|NCT02205814|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
91950412|NCT02205814|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
91950413|NCT02205814|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
91950414|NCT02205814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950415|NCT02205814|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91950416|NCT02205814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91950417|NCT02205814|Immunologic Factors|immunologic factors|mesh-ancestor
91950418|NCT02205814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950419|NCT02662985|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91950420|NCT02662985|Immunologic Factors|immunologic factors|mesh-ancestor
91950421|NCT02662985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950422|NCT04080271|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91950423|NCT04080271|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91950424|NCT04080271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950425|NCT03489005|Moxifloxacin|moxifloxacin|mesh-list
91950426|NCT03489005|Zamicastat|zamicastat|mesh-list
91950427|NCT03489005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91950428|NCT03489005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950429|NCT03489005|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91950430|NCT03489005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91950431|NCT03489005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950432|NCT03489005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950433|NCT03489005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950434|NCT02215252|Pregabalin|pregabalin|mesh-list
91950435|NCT02215252|Analgesics|analgesics|mesh-ancestor
91950436|NCT02215252|Sensory System Agents|sensory system agents|mesh-ancestor
91950437|NCT02215252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950438|NCT02215252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950439|NCT02215252|Anticonvulsants|anticonvulsants|mesh-ancestor
91950440|NCT02215252|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91950441|NCT02215252|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950442|NCT02215252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950443|NCT02215252|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91950444|NCT02215252|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91950445|NCT02215252|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91950446|NCT02215252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950447|NCT02215252|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950448|NCT04894721|Ivermectin|ivermectin|mesh-list
91950449|NCT04894721|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91950450|NCT04894721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950451|NCT02204410|Methylphenidate|methylphenidate|mesh-list
91950452|NCT02204410|Amphetamine|amphetamine|mesh-list
91950453|NCT02204410|Adderall|adderall|mesh-list
91950454|NCT02204410|Dextroamphetamine|dextroamphetamine|mesh-list
91944546|NCT02478398|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91944548|NCT02478398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944550|NCT02478398|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944551|NCT02478398|Mydriatics|mydriatics|mesh-ancestor
91944552|NCT02478398|Sympathomimetics|sympathomimetics|mesh-ancestor
91944553|NCT02478398|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91944554|NCT02478398|Tocolytic Agents|tocolytic agents|mesh-ancestor
91950455|NCT02204410|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91950456|NCT02204410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950457|NCT02204410|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91950458|NCT02204410|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91950459|NCT02204410|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950467|NCT02204410|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91950468|NCT03465397|Immunosuppressive Agents|immunosuppressive agents|mesh-list
91950469|NCT03465397|Immunologic Factors|immunologic factors|mesh-ancestor
91950470|NCT03465397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950472|NCT03461575|Cyclosporins|cyclosporins|mesh-list
91950473|NCT03461575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950474|NCT03461575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950475|NCT03461575|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91950476|NCT03461575|Immunologic Factors|immunologic factors|mesh-ancestor
91950477|NCT03461575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950478|NCT03461575|Antifungal Agents|antifungal agents|mesh-ancestor
91950479|NCT03461575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950480|NCT03461575|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950481|NCT03461575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950482|NCT03461575|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91950483|NCT03131843|Ethanol|ethanol|mesh-list
91950484|NCT03131843|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91950485|NCT03131843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950486|NCT03131843|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950487|NCT03131843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950488|NCT02213380|Anesthetics|anesthetics|mesh-list
91950489|NCT02213380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950490|NCT02213380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950491|NCT03488147|Esomeprazole|esomeprazole|mesh-list
91950492|NCT03488147|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91950493|NCT03488147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950494|NCT03488147|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91950495|NCT03488147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950496|NCT03488147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950497|NCT03797261|Venetoclax|venetoclax|mesh-list
91950498|NCT03797261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950499|NCT02202850|Etanercept|etanercept|mesh-list
91950500|NCT02202850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91950501|NCT02202850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91950502|NCT02202850|Analgesics|analgesics|mesh-ancestor
91950503|NCT02202850|Sensory System Agents|sensory system agents|mesh-ancestor
91950504|NCT02202850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950505|NCT02202850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950506|NCT02202850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950507|NCT02202850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950508|NCT02202850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950509|NCT02202850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91950510|NCT02202850|Immunologic Factors|immunologic factors|mesh-ancestor
91950511|NCT03489395|Edoxaban|edoxaban|mesh-list
91950512|NCT03489395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91950513|NCT03489395|Antithrombins|antithrombins|mesh-ancestor
91950514|NCT03489395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91950515|NCT03489395|Protease Inhibitors|protease inhibitors|mesh-ancestor
91950516|NCT03489395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950517|NCT03489395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950518|NCT03489395|Anticoagulants|anticoagulants|mesh-ancestor
91950519|NCT03489317|Metformin|metformin|mesh-list
91950520|NCT03489317|Amlodipine|amlodipine|mesh-list
91944555|NCT02478398|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91944556|NCT02478398|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91944557|NCT02478398|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950521|NCT03489317|Simvastatin|simvastatin|mesh-list
91950522|NCT03489317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950523|NCT03489317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950524|NCT03489317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91950525|NCT03489317|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91950526|NCT03489317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950550|NCT03489239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950551|NCT03489239|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91950552|NCT03489239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91950553|NCT03489239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950554|NCT03489239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950555|NCT03489239|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91950556|NCT03489239|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91950557|NCT03489161|Buprenorphine|buprenorphine|mesh-list
91950558|NCT03489161|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91950559|NCT03489161|Narcotics|narcotics|mesh-ancestor
91950560|NCT03489161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950561|NCT03489161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950562|NCT03489161|Analgesics|analgesics|mesh-ancestor
91950563|NCT03489161|Sensory System Agents|sensory system agents|mesh-ancestor
91950564|NCT03489161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950565|NCT03489161|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91950566|NCT04804709|Panobinostat|panobinostat|mesh-list
91950567|NCT04804709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950568|NCT04804709|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91950569|NCT04804709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950570|NCT04804709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950571|NCT04690673|Acetaminophen|acetaminophen|mesh-list
91950572|NCT04690673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91950573|NCT04690673|Analgesics|analgesics|mesh-ancestor
91950574|NCT04690673|Sensory System Agents|sensory system agents|mesh-ancestor
91950575|NCT04690673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950576|NCT04690673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950577|NCT04690673|Antipyretics|antipyretics|mesh-ancestor
91950578|NCT03104075|Vaccines|vaccines|mesh-list
91950598|NCT02799641|Sensory System Agents|sensory system agents|mesh-ancestor
91950599|NCT02799641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950600|NCT02799641|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91950601|NCT02799641|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91950602|NCT02799641|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91950603|NCT02799641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950604|NCT02799641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950605|NCT02799641|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91950606|NCT02799641|Anticonvulsants|anticonvulsants|mesh-ancestor
91950607|NCT02799641|Antiemetics|antiemetics|mesh-ancestor
91950608|NCT02799641|Autonomic Agents|autonomic agents|mesh-ancestor
91950609|NCT02799641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950610|NCT02799641|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91950611|NCT02799641|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91950612|NCT02799641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91950613|NCT02799641|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91950615|NCT02799641|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950616|NCT02799641|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91950617|NCT02799641|Anesthetics, General|anesthetics, general|mesh-ancestor
91950618|NCT02799641|GABA Modulators|gaba modulators|mesh-ancestor
91950619|NCT02799641|GABA Agents|gaba agents|mesh-ancestor
91950620|NCT02799641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950621|NCT04388501|Atorvastatin|atorvastatin|mesh-list
91950622|NCT04388501|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91950623|NCT04388501|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91950624|NCT04388501|Antimetabolites|antimetabolites|mesh-ancestor
91950625|NCT04388501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950626|NCT04388501|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91950627|NCT04388501|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91950628|NCT04388501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950629|NCT02249182|Ribavirin|ribavirin|mesh-list
91950630|NCT02249182|Sofosbuvir|sofosbuvir|mesh-list
91944558|NCT02478398|Dermatologic Agents|dermatologic agents|mesh-ancestor
91944559|NCT02478398|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91950631|NCT02249182|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91950632|NCT02249182|Ledipasvir|ledipasvir|mesh-list
91950633|NCT02249182|Antimetabolites|antimetabolites|mesh-ancestor
91950634|NCT02249182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950657|NCT03487211|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950658|NCT03487211|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91950659|NCT03487211|Analgesics|analgesics|mesh-ancestor
91950660|NCT03487211|Sensory System Agents|sensory system agents|mesh-ancestor
91950661|NCT03487211|Dopamine Agents|dopamine agents|mesh-ancestor
91950662|NCT03487133|Dexamethasone|dexamethasone|mesh-list
91950664|NCT03487133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950665|NCT03487133|Antiemetics|antiemetics|mesh-ancestor
91950667|NCT03487133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950668|NCT03487133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950669|NCT03487133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950670|NCT03487133|Glucocorticoids|glucocorticoids|mesh-ancestor
91950671|NCT03487133|Hormones|hormones|mesh-ancestor
91950672|NCT03487133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950673|NCT03487133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91950674|NCT03487133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950675|NCT02248480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91950676|NCT02248480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91950677|NCT02248480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91950678|NCT02248480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950679|NCT02248480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950680|NCT02248480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950681|NCT02248480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950682|NCT02248480|Analgesics|analgesics|mesh-ancestor
91950683|NCT02248480|Sensory System Agents|sensory system agents|mesh-ancestor
91950690|NCT01653158|Tubulin Modulators|tubulin modulators|mesh-ancestor
91950691|NCT01653158|Antimitotic Agents|antimitotic agents|mesh-ancestor
91950692|NCT01653158|Mitosis Modulators|mitosis modulators|mesh-ancestor
91950693|NCT01653158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950694|NCT00701207|Nicotine|nicotine|mesh-list
91950695|NCT00701207|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91950696|NCT00701207|Autonomic Agents|autonomic agents|mesh-ancestor
91950697|NCT00701207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950698|NCT00701207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950699|NCT00701207|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91950700|NCT00701207|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91950701|NCT00701207|Cholinergic Agents|cholinergic agents|mesh-ancestor
91950702|NCT00701207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950703|NCT00701207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950704|NCT02247466|Rocuronium|rocuronium|mesh-list
91950705|NCT02247466|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91950706|NCT02247466|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91950707|NCT02247466|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91950708|NCT02247466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950709|NCT02247466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950710|NCT03417479|Gabapentin|gabapentin|mesh-list
91950711|NCT03417479|Analgesics|analgesics|mesh-ancestor
91950712|NCT03417479|Sensory System Agents|sensory system agents|mesh-ancestor
91950713|NCT03417479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950714|NCT03417479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950715|NCT03417479|Anticonvulsants|anticonvulsants|mesh-ancestor
91950716|NCT03417479|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91950717|NCT03417479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91950718|NCT03417479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950719|NCT03417479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950720|NCT03417479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91950721|NCT03417479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91950722|NCT03417479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950723|NCT03417479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950724|NCT03417479|Antimanic Agents|antimanic agents|mesh-ancestor
91950725|NCT03317795|Tranexamic Acid|tranexamic acid|mesh-list
91950726|NCT03317795|Levonorgestrel|levonorgestrel|mesh-list
91950727|NCT03317795|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91950728|NCT03317795|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91944560|NCT02478398|Antipruritics|antipruritics|mesh-ancestor
91944561|NCT02478398|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91944562|NCT02478398|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91950729|NCT03317795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950731|NCT03317795|Coagulants|coagulants|mesh-ancestor
91950732|NCT03317795|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91950733|NCT03317795|Contraceptive Agents|contraceptive agents|mesh-ancestor
91950734|NCT03317795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91950735|NCT03317795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950736|NCT03317795|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91950737|NCT03317795|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91950738|NCT03317795|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91950739|NCT02202616|Glycopyrrolate|glycopyrrolate|mesh-list
91950740|NCT02202616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950741|NCT02202616|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91950742|NCT02202616|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91950743|NCT02202616|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91950744|NCT02202616|Cholinergic Agents|cholinergic agents|mesh-ancestor
91950745|NCT02202616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950746|NCT02202616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950747|NCT03876119|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91950748|NCT03876119|Plasminogen|plasminogen|mesh-list
91950749|NCT03876119|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91950750|NCT03876119|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91950751|NCT03876119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950752|NCT02455076|Exenatide|exenatide|mesh-list
91950786|NCT02246998|Antiviral Agents|antiviral agents|mesh-ancestor
91950803|NCT00805961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91950804|NCT00805961|Growth Substances|growth substances|mesh-ancestor
91950805|NCT00805961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950806|NCT00805961|Growth Inhibitors|growth inhibitors|mesh-ancestor
91950807|NCT00805961|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91950808|NCT00805961|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950809|NCT00805961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950810|NCT00805961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950811|NCT00805961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91950812|NCT00805961|Immunologic Factors|immunologic factors|mesh-ancestor
91950813|NCT00805961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91950814|NCT00805961|Alkylating Agents|alkylating agents|mesh-ancestor
91950815|NCT02454608|Verapamil|verapamil|mesh-list
91950816|NCT02454608|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91950817|NCT02454608|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91950818|NCT02454608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950819|NCT02454608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950820|NCT02454608|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91950821|NCT02454608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950822|NCT02454608|Vasodilator Agents|vasodilator agents|mesh-ancestor
91950823|NCT05152355|Budesonide|budesonide|mesh-list
91950824|NCT05152355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91950825|NCT05152355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91950826|NCT05152355|Autonomic Agents|autonomic agents|mesh-ancestor
91950827|NCT05152355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950828|NCT05152355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950829|NCT05152355|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91950830|NCT05152355|Respiratory System Agents|respiratory system agents|mesh-ancestor
91950832|NCT05152355|Hormones|hormones|mesh-ancestor
91950833|NCT05152355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950834|NCT02246764|Timolol|timolol|mesh-list
91950835|NCT02246764|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91950836|NCT02246764|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91950941|NCT05152667|Contraceptive Agents|contraceptive agents|mesh-ancestor
91950837|NCT02246764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950838|NCT02246764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91950839|NCT02246764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91950840|NCT02246764|Adrenergic Agents|adrenergic agents|mesh-ancestor
91950841|NCT02246764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950842|NCT02246764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950843|NCT02246764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91950844|NCT02246764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91944563|NCT02478398|Histamine Antagonists|histamine antagonists|mesh-ancestor
91944564|NCT02478398|Histamine Agents|histamine agents|mesh-ancestor
91944565|NCT02478398|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91950859|NCT02431676|Metformin|metformin|mesh-list
91950860|NCT02431676|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950861|NCT02431676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950862|NCT03483545|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91950863|NCT03483545|Hormones|hormones|mesh-ancestor
91950864|NCT03483545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950865|NCT03483545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950866|NCT03483389|Ethanol|ethanol|mesh-list
91950867|NCT03483389|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91950868|NCT03483389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950869|NCT03483389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950870|NCT03483389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950871|NCT03486119|Nivolumab|nivolumab|mesh-list
91950872|NCT03486119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91950873|NCT03486119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950874|NCT03486119|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91950875|NCT03486119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950876|NCT02523833|Albuterol|albuterol|mesh-list
91950877|NCT02523833|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91950878|NCT02523833|Autonomic Agents|autonomic agents|mesh-ancestor
91950879|NCT02523833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950880|NCT02523833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950881|NCT02523833|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91950882|NCT02523833|Respiratory System Agents|respiratory system agents|mesh-ancestor
91950883|NCT02523833|Tocolytic Agents|tocolytic agents|mesh-ancestor
91950884|NCT02523833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91950885|NCT02523833|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91950886|NCT02523833|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91950887|NCT02523833|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91950888|NCT02523833|Adrenergic Agents|adrenergic agents|mesh-ancestor
91950889|NCT02523833|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950890|NCT02523833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950891|NCT04349579|Rifamycins|rifamycins|mesh-list
91950892|NCT04349579|Rifamycin SV|rifamycin sv|mesh-list
91950893|NCT04349579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91950894|NCT04349579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950895|NCT04349579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950896|NCT04234529|Caffeine|caffeine|mesh-list
91950897|NCT04234529|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91950898|NCT04234529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950899|NCT04234529|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91950900|NCT04234529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950901|NCT04234529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950902|NCT04234529|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91950903|NCT04234529|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91950905|NCT04234529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950906|NCT01652690|Denosumab|denosumab|mesh-list
91950925|NCT02201524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950927|NCT05153603|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91950928|NCT05153603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950929|NCT05153603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950930|NCT05153603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950931|NCT02137252|Naltrexone|naltrexone|mesh-list
91950932|NCT02137252|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91950933|NCT02137252|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91950934|NCT02137252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950935|NCT02137252|Sensory System Agents|sensory system agents|mesh-ancestor
91950936|NCT02137252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950937|NCT05152667|Dienogest|dienogest|mesh-list
91950938|NCT05152667|Levonorgestrel|levonorgestrel|mesh-list
91950939|NCT05152667|Progestins|progestins|mesh-list
91950940|NCT05152667|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91950942|NCT05152667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91950943|NCT05152667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950944|NCT05152667|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91944566|NCT02478398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91944567|NCT02478398|Analgesics|analgesics|mesh-ancestor
91944568|NCT02478398|Sensory System Agents|sensory system agents|mesh-ancestor
91950945|NCT05152667|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91950946|NCT05152667|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91950947|NCT05152667|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91950948|NCT05152667|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91950949|NCT05152667|Hormone Antagonists|hormone antagonists|mesh-ancestor
91950950|NCT05152667|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950951|NCT05152667|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91950952|NCT05152667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950954|NCT05152511|Pentoxifylline|pentoxifylline|mesh-list
91950955|NCT05152511|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91950956|NCT05152511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950957|NCT05152511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950958|NCT05152511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91950959|NCT05152511|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91950969|NCT02568449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950970|NCT02568449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950972|NCT02738333|Antiviral Agents|antiviral agents|mesh-ancestor
91950973|NCT02738333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950974|NCT04884893|Nitrous Oxide|nitrous oxide|mesh-list
91950975|NCT04884893|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91950976|NCT04884893|Anesthetics, General|anesthetics, general|mesh-ancestor
91950977|NCT04884893|Anesthetics|anesthetics|mesh-ancestor
91950978|NCT04884893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950979|NCT04884893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950980|NCT04884893|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91950981|NCT04884893|Analgesics|analgesics|mesh-ancestor
91950982|NCT04884893|Sensory System Agents|sensory system agents|mesh-ancestor
91950983|NCT04884893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950984|NCT03479879|Misoprostol|misoprostol|mesh-list
91950985|NCT03479879|Estradiol|estradiol|mesh-list
91950986|NCT03479879|Estrogens|estrogens|mesh-ancestor
91950987|NCT03479879|Hormones|hormones|mesh-ancestor
91950988|NCT03479879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950989|NCT03479879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950990|NCT03479879|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91950991|NCT03479879|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91950992|NCT03479879|Abortifacient Agents|abortifacient agents|mesh-ancestor
91950993|NCT03479879|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91950994|NCT03479879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950995|NCT03479879|Oxytocics|oxytocics|mesh-ancestor
91950996|NCT03479411|Itraconazole|itraconazole|mesh-list
91950997|NCT03479411|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
91950998|NCT03479411|Antifungal Agents|antifungal agents|mesh-ancestor
91950999|NCT03479411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951000|NCT03479411|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91951001|NCT03479411|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91951002|NCT03479411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951003|NCT03479411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951004|NCT03479411|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91951005|NCT03479411|Hormone Antagonists|hormone antagonists|mesh-ancestor
91951006|NCT03479411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951007|NCT03479411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951008|NCT03479411|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91951009|NCT03131375|Dexmedetomidine|dexmedetomidine|mesh-list
91951010|NCT03131375|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91951011|NCT03131375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951012|NCT03131375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951013|NCT03131375|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91951014|NCT03131375|Analgesics|analgesics|mesh-ancestor
91951015|NCT03131375|Sensory System Agents|sensory system agents|mesh-ancestor
91951016|NCT03131375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951017|NCT03131375|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91951018|NCT03131375|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91951019|NCT03131375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91951020|NCT03131375|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944569|NCT02478398|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951125|NCT02523131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91944571|NCT02478164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944572|NCT02478164|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91951021|NCT03131375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951022|NCT03131375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951023|NCT03475589|Apatinib|apatinib|mesh-list
91951024|NCT03475589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951042|NCT03478475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951044|NCT03478475|Micronutrients|micronutrients|mesh-ancestor
91951045|NCT03478475|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91951046|NCT03475121|Topotecan|topotecan|mesh-list
91951047|NCT03475121|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91951048|NCT03475121|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91951049|NCT03475121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951050|NCT03475121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951051|NCT03475121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951052|NCT03131063|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91951053|NCT03131063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951054|NCT02523755|Ropivacaine|ropivacaine|mesh-list
91951055|NCT02523755|Anesthetics, Local|anesthetics, local|mesh-ancestor
91951056|NCT02523755|Anesthetics|anesthetics|mesh-ancestor
91951057|NCT02523755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951058|NCT02523755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951059|NCT02523755|Sensory System Agents|sensory system agents|mesh-ancestor
91951060|NCT02523755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951061|NCT02168842|Isradipine|isradipine|mesh-list
91951062|NCT02168842|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91951063|NCT02168842|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91951064|NCT02168842|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951065|NCT02168842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951066|NCT02168842|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91951067|NCT02168842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951068|NCT02168842|Vasodilator Agents|vasodilator agents|mesh-ancestor
91951069|NCT03347123|Nivolumab|nivolumab|mesh-list
91951070|NCT03347123|Ipilimumab|ipilimumab|mesh-list
91951071|NCT03347123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951072|NCT03347123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951073|NCT03347123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91951074|NCT03347123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951075|NCT03131141|Lefamulin|lefamulin|mesh-list
91951076|NCT03131141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91951077|NCT03131141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951078|NCT05258045|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91951079|NCT05258045|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91951095|NCT03474263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951096|NCT03477461|Terlipressin|terlipressin|mesh-list
91951097|NCT03477461|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91951098|NCT03477461|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91951099|NCT02553161|Escitalopram|escitalopram|mesh-list
91951100|NCT02553161|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91951101|NCT02553161|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91951102|NCT02553161|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951103|NCT02553161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951104|NCT02553161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951105|NCT02553161|Serotonin Agents|serotonin agents|mesh-ancestor
91951106|NCT02553161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951107|NCT03473093|Pregabalin|pregabalin|mesh-list
91951108|NCT03473093|Morphine|morphine|mesh-list
91951109|NCT03473093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91951110|NCT03473093|Narcotics|narcotics|mesh-ancestor
91951111|NCT03473093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951112|NCT03473093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951113|NCT03473093|Analgesics|analgesics|mesh-ancestor
91951114|NCT03473093|Sensory System Agents|sensory system agents|mesh-ancestor
91951115|NCT03473093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951116|NCT03473093|Anticonvulsants|anticonvulsants|mesh-ancestor
91951117|NCT03473093|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91951118|NCT03473093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944573|NCT02478164|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951119|NCT03473093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951120|NCT03473093|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91951121|NCT03473093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91951122|NCT03473093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91951123|NCT03473093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91951124|NCT02523131|Insulin|insulin|mesh-list
91951126|NCT02523131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951127|NCT04339049|Lidocaine|lidocaine|mesh-list
91951128|NCT04339049|Misoprostol|misoprostol|mesh-list
91951129|NCT04339049|Anesthetics, Local|anesthetics, local|mesh-ancestor
91951130|NCT04339049|Anesthetics|anesthetics|mesh-ancestor
91951131|NCT04339049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951132|NCT04339049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951133|NCT04339049|Sensory System Agents|sensory system agents|mesh-ancestor
91951134|NCT04339049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951135|NCT04339049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91951136|NCT04339049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91951137|NCT04339049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91951154|NCT02133352|Ranolazine|ranolazine|mesh-list
91951155|NCT02133352|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91951156|NCT02133352|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951157|NCT02133352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951158|NCT04418128|Nafamostat|nafamostat|mesh-list
91951159|NCT04418128|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91951160|NCT04418128|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91951161|NCT04418128|Analgesics|analgesics|mesh-ancestor
91951162|NCT04418128|Sensory System Agents|sensory system agents|mesh-ancestor
91951163|NCT04418128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951164|NCT04418128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951165|NCT04418128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951166|NCT04418128|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951167|NCT04418128|Anticoagulants|anticoagulants|mesh-ancestor
91951168|NCT04418128|Protease Inhibitors|protease inhibitors|mesh-ancestor
91951169|NCT04418128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951170|NCT04418128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951171|NCT04418128|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91951172|NCT04418128|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91951173|NCT04418128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91951174|NCT04418128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91951175|NCT04418128|Immunologic Factors|immunologic factors|mesh-ancestor
91951176|NCT02555657|Gemcitabine|gemcitabine|mesh-list
91951177|NCT02555657|Capecitabine|capecitabine|mesh-list
91951178|NCT02555657|Pembrolizumab|pembrolizumab|mesh-list
91951179|NCT02555657|Vinorelbine|vinorelbine|mesh-list
91951180|NCT02555657|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91951181|NCT02555657|Antimetabolites|antimetabolites|mesh-ancestor
91951182|NCT02555657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951183|NCT02555657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951184|NCT02555657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951185|NCT02555657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91951186|NCT02555657|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91951187|NCT02555657|Tubulin Modulators|tubulin modulators|mesh-ancestor
91951188|NCT02555657|Antimitotic Agents|antimitotic agents|mesh-ancestor
91951189|NCT02555657|Mitosis Modulators|mitosis modulators|mesh-ancestor
91951190|NCT02195518|Tenofovir|tenofovir|mesh-list
91951191|NCT02195518|Antiviral Agents|antiviral agents|mesh-ancestor
91951192|NCT02195518|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951193|NCT02195518|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91951194|NCT02195518|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91951195|NCT02195518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951220|NCT03471455|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91951221|NCT03471455|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91951222|NCT03471455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951223|NCT03471455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951224|NCT03471455|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91951225|NCT03471455|Hormone Antagonists|hormone antagonists|mesh-ancestor
91951226|NCT03471455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951227|NCT03471455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944574|NCT02478164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944575|NCT02476994|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
91944576|NCT02476994|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91951228|NCT03471455|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91951229|NCT03471455|Dermatologic Agents|dermatologic agents|mesh-ancestor
91951231|NCT02824679|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
91951232|NCT02824679|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91951233|NCT02824679|Antiemetics|antiemetics|mesh-ancestor
91951234|NCT02824679|Autonomic Agents|autonomic agents|mesh-ancestor
91951235|NCT02824679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951504|NCT02492867|Tubulin Modulators|tubulin modulators|mesh-ancestor
91951236|NCT02824679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951237|NCT02824679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951238|NCT02824679|Mydriatics|mydriatics|mesh-ancestor
91951239|NCT02824679|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91951240|NCT02824679|Cholinergic Agents|cholinergic agents|mesh-ancestor
91951241|NCT02824679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951242|NCT02824679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951243|NCT02824679|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91951244|NCT02824679|Parasympatholytics|parasympatholytics|mesh-ancestor
91951245|NCT03202667|Empagliflozin|empagliflozin|mesh-list
91951246|NCT03202667|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91951247|NCT03202667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951271|NCT04457609|Oseltamivir|oseltamivir|mesh-list
91951272|NCT04457609|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91951273|NCT04457609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951274|NCT04457609|Antiviral Agents|antiviral agents|mesh-ancestor
91951275|NCT04457609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951276|NCT04457609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951277|NCT05157269|Nitazoxanide|nitazoxanide|mesh-list
91951278|NCT05157269|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91951279|NCT05157269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951280|NCT04457765|Povidone-Iodine|povidone-iodine|mesh-list
91951281|NCT04457765|Povidone|povidone|mesh-list
91951282|NCT04457765|Plasma Substitutes|plasma substitutes|mesh-ancestor
91951283|NCT04457765|Blood Substitutes|blood substitutes|mesh-ancestor
91951284|NCT04457765|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91951285|NCT04457765|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951286|NCT03795233|Vancomycin|vancomycin|mesh-list
91951287|NCT03795233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91951288|NCT03795233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951290|NCT03645863|Trace Elements|trace elements|mesh-ancestor
91951291|NCT03645863|Micronutrients|micronutrients|mesh-ancestor
91951292|NCT03645863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951293|NCT03564119|Benzoyl Peroxide|benzoyl peroxide|mesh-list
91951294|NCT03564119|Dermatologic Agents|dermatologic agents|mesh-ancestor
91951295|NCT04503707|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91951296|NCT04503707|Hormones|hormones|mesh-ancestor
91951297|NCT04503707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951298|NCT04503707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951299|NCT03470597|Iodine|iodine|mesh-list
91951336|NCT04206761|Cholinergic Agents|cholinergic agents|mesh-ancestor
91951337|NCT04206761|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951338|NCT04206761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951339|NCT04206761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951340|NCT03181529|Psilocybin|psilocybin|mesh-list
91951361|NCT03470363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951362|NCT03470363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951363|NCT03470363|Sensory System Agents|sensory system agents|mesh-ancestor
91951364|NCT03470363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951365|NCT03470363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91951366|NCT03470363|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91951367|NCT03470363|Anesthetics, General|anesthetics, general|mesh-ancestor
91951368|NCT03470363|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91951369|NCT03470363|Narcotics|narcotics|mesh-ancestor
91951370|NCT03470363|Analgesics|analgesics|mesh-ancestor
91951371|NCT03470363|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91951372|NCT03470363|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91951373|NCT03469895|Idelalisib|idelalisib|mesh-list
91951374|NCT03469895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951375|NCT03469895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944577|NCT02476994|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91944578|NCT02476994|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91944579|NCT02318329|Bemarituzumab|bemarituzumab|mesh-list
91951376|NCT03469895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951377|NCT05160623|Povidone-Iodine|povidone-iodine|mesh-list
91951378|NCT05160623|Povidone|povidone|mesh-list
91951379|NCT05160623|Plasma Substitutes|plasma substitutes|mesh-ancestor
91951380|NCT05160623|Blood Substitutes|blood substitutes|mesh-ancestor
91951381|NCT05160623|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91951382|NCT05160623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951383|NCT04713137|Erythritol|erythritol|mesh-list
91951384|NCT04713137|Vasodilator Agents|vasodilator agents|mesh-ancestor
91951385|NCT04456985|Folic Acid|folic acid|mesh-list
91951386|NCT04456985|Vitamin B 12|vitamin b 12|mesh-list
91951387|NCT04456985|Hydroxocobalamin|hydroxocobalamin|mesh-list
91951388|NCT04456985|Vitamins|vitamins|mesh-ancestor
91951389|NCT04456985|Micronutrients|micronutrients|mesh-ancestor
91951505|NCT02492867|Antimitotic Agents|antimitotic agents|mesh-ancestor
91951390|NCT04456985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951391|NCT04456985|Hematinics|hematinics|mesh-ancestor
91951392|NCT04456985|Vitamin B Complex|vitamin b complex|mesh-ancestor
91951393|NCT03469583|Entecavir|entecavir|mesh-list
91951394|NCT03469583|Antiviral Agents|antiviral agents|mesh-ancestor
91951395|NCT03469583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951396|NCT05096039|Valsartan|valsartan|mesh-list
91951397|NCT05096039|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91951398|NCT05096039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91951413|NCT03469271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951414|NCT03469271|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91951415|NCT03469271|Vitamins|vitamins|mesh-ancestor
91951416|NCT03469271|Micronutrients|micronutrients|mesh-ancestor
91951417|NCT03469271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91951418|NCT03361865|Pembrolizumab|pembrolizumab|mesh-list
91951419|NCT03361865|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951420|NCT03361865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951421|NCT03361865|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91951422|NCT03361865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951423|NCT02982083|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
91951424|NCT02982083|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91951425|NCT02982083|Hormone Antagonists|hormone antagonists|mesh-ancestor
91951426|NCT02982083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951427|NCT02982083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951428|NCT02982083|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91951429|NCT02982083|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91951430|NCT02982083|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91951432|NCT02421341|Analgesics, Opioid|analgesics, opioid|mesh-list
91951433|NCT02421341|Analgesics|analgesics|mesh-list
91951434|NCT02421341|Narcotics|narcotics|mesh-ancestor
91951435|NCT02421341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951436|NCT02421341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951437|NCT02421341|Sensory System Agents|sensory system agents|mesh-ancestor
91951438|NCT02421341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951439|NCT02421341|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91951440|NCT02421341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91951441|NCT02421341|Anesthetics, General|anesthetics, general|mesh-ancestor
91951442|NCT02421341|Anesthetics|anesthetics|mesh-ancestor
91951443|NCT02149121|Rituximab|rituximab|mesh-list
91951444|NCT02149121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951445|NCT02149121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951446|NCT02149121|Immunologic Factors|immunologic factors|mesh-ancestor
91951447|NCT02149121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951448|NCT02149121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951449|NCT05162417|Tolonium Chloride|tolonium chloride|mesh-list
91951477|NCT03166085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944580|NCT02318329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91944581|NCT02318329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944582|NCT05259319|Atezolizumab|atezolizumab|mesh-list
91951478|NCT03166085|Tubulin Modulators|tubulin modulators|mesh-ancestor
91951479|NCT03166085|Antimitotic Agents|antimitotic agents|mesh-ancestor
91951480|NCT03166085|Mitosis Modulators|mitosis modulators|mesh-ancestor
91951481|NCT03166085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951482|NCT05390255|Mometasone Furoate|mometasone furoate|mesh-list
91951483|NCT05390255|Omalizumab|omalizumab|mesh-list
91951484|NCT05390255|Hormones|hormones|mesh-list
91951485|NCT05390255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951486|NCT05390255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951487|NCT05390255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951488|NCT05390255|Dermatologic Agents|dermatologic agents|mesh-ancestor
91951489|NCT05390255|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91951490|NCT05390255|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91951491|NCT05390255|Respiratory System Agents|respiratory system agents|mesh-ancestor
91951492|NCT04456829|Resveratrol|resveratrol|mesh-list
91951493|NCT04456829|Antioxidants|antioxidants|mesh-ancestor
91951494|NCT04456829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951495|NCT04456829|Protective Agents|protective agents|mesh-ancestor
91951496|NCT04456829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951497|NCT04456829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951498|NCT04456829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91951499|NCT02492867|Paclitaxel|paclitaxel|mesh-list
91951500|NCT02492867|Carboplatin|carboplatin|mesh-list
91951501|NCT02492867|Durvalumab|durvalumab|mesh-list
91951502|NCT02492867|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91951503|NCT02492867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951506|NCT02492867|Mitosis Modulators|mitosis modulators|mesh-ancestor
92090407|NCT04382014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951522|NCT05389943|Micronutrients|micronutrients|mesh-ancestor
91951523|NCT05389943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951524|NCT05389943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91951525|NCT05389943|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91951526|NCT04575961|Pembrolizumab|pembrolizumab|mesh-list
91951527|NCT04575961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951528|NCT04575961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951529|NCT04575961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91951530|NCT04575961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951531|NCT02522975|Epoetin Alfa|epoetin alfa|mesh-list
91951532|NCT02522975|Hematinics|hematinics|mesh-ancestor
91951533|NCT04508803|Trastuzumab|trastuzumab|mesh-list
91951534|NCT04508803|Niraparib|niraparib|mesh-list
91951535|NCT04508803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951536|NCT04508803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951537|NCT04508803|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91951538|NCT04508803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951539|NCT04508803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951540|NCT04492033|Paclitaxel|paclitaxel|mesh-list
91951541|NCT04492033|Irinotecan|irinotecan|mesh-list
91951542|NCT04492033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91951543|NCT04492033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951544|NCT04492033|Tubulin Modulators|tubulin modulators|mesh-ancestor
91951545|NCT04492033|Antimitotic Agents|antimitotic agents|mesh-ancestor
91951546|NCT04492033|Mitosis Modulators|mitosis modulators|mesh-ancestor
91951547|NCT04492033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951548|NCT04492033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91951549|NCT04492033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91951550|NCT04492033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951551|NCT03461185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
91951552|NCT03461185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91951553|NCT03461185|Growth Substances|growth substances|mesh-ancestor
91951554|NCT03461185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951555|NCT03461185|Growth Inhibitors|growth inhibitors|mesh-ancestor
91951556|NCT03461185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951557|NCT04453423|Carboplatin|carboplatin|mesh-list
91951558|NCT04453423|Pemetrexed|pemetrexed|mesh-list
91951559|NCT04453423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951560|NCT04453423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944583|NCT05259319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91944584|NCT05259319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951561|NCT04453423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951562|NCT04453423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91951563|NCT04453423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91951564|NCT04453189|Lansoprazole|lansoprazole|mesh-list
91951565|NCT04453189|Dexlansoprazole|dexlansoprazole|mesh-list
91951577|NCT03465085|Heparin|heparin|mesh-list
91951578|NCT03465085|Calcium heparin|calcium heparin|mesh-list
91951579|NCT03465085|Streptokinase|streptokinase|mesh-list
91951580|NCT03465085|Anticoagulants|anticoagulants|mesh-ancestor
91951581|NCT03465085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91951582|NCT03465085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91951583|NCT03465085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951584|NCT03465007|Hydrocortisone|hydrocortisone|mesh-list
91951585|NCT03465007|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951586|NCT05030155|Cyclophosphamide|cyclophosphamide|mesh-list
91951587|NCT05030155|Azathioprine|azathioprine|mesh-list
91951588|NCT05030155|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91951589|NCT05030155|Immunologic Factors|immunologic factors|mesh-ancestor
91951590|NCT05030155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951591|NCT05030155|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951592|NCT05030155|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91951593|NCT05030155|Alkylating Agents|alkylating agents|mesh-ancestor
91951594|NCT05030155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951595|NCT05030155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951596|NCT05030155|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91951597|NCT05030155|Antimetabolites|antimetabolites|mesh-ancestor
91951598|NCT05030155|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91951599|NCT04453111|Hyaluronic Acid|hyaluronic acid|mesh-list
91951600|NCT04453111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91951601|NCT04453111|Immunologic Factors|immunologic factors|mesh-ancestor
91951602|NCT04453111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951603|NCT04453111|Viscosupplements|viscosupplements|mesh-ancestor
91951604|NCT04453111|Protective Agents|protective agents|mesh-ancestor
91951605|NCT03468595|Listerine|listerine|mesh-list
91951606|NCT03468595|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91951607|NCT03468595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951608|NCT04453345|Thalidomide|thalidomide|mesh-list
91951609|NCT04453345|Prednisone|prednisone|mesh-list
91951610|NCT04453345|Methotrexate|methotrexate|mesh-list
91951611|NCT04453345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951612|NCT04453345|Glucocorticoids|glucocorticoids|mesh-ancestor
91951613|NCT04453345|Hormones|hormones|mesh-ancestor
91951614|NCT04453345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951615|NCT04453345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951616|NCT04453345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91951617|NCT04453345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951618|NCT04453345|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91951619|NCT04453345|Abortifacient Agents|abortifacient agents|mesh-ancestor
91951620|NCT04453345|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91951621|NCT04453345|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91951622|NCT04453345|Antimetabolites|antimetabolites|mesh-ancestor
91951623|NCT04453345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951624|NCT04453345|Dermatologic Agents|dermatologic agents|mesh-ancestor
91951625|NCT04453345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951626|NCT04453345|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91951627|NCT04453345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91951628|NCT04453345|Immunologic Factors|immunologic factors|mesh-ancestor
91951644|NCT03464539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951645|NCT03464539|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91951646|NCT03464539|Chelating Agents|chelating agents|mesh-ancestor
91951647|NCT03464539|Sequestering Agents|sequestering agents|mesh-ancestor
91951648|NCT03464539|Hemostatics|hemostatics|mesh-ancestor
91951649|NCT03464539|Coagulants|coagulants|mesh-ancestor
91951651|NCT03460405|Immunologic Factors|immunologic factors|mesh-ancestor
91951652|NCT03460405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951653|NCT05166005|Vitamin D|vitamin d|mesh-list
91951654|NCT05166005|Vitamins|vitamins|mesh-ancestor
91951655|NCT05166005|Micronutrients|micronutrients|mesh-ancestor
91951656|NCT05166005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951657|NCT05166005|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91951658|NCT03464305|Aspirin|aspirin|mesh-list
91944585|NCT05259319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91944586|NCT05259319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944587|NCT05259007|Amoxicillin|amoxicillin|mesh-list
91944588|NCT05259007|Clarithromycin|clarithromycin|mesh-list
91944590|NCT05259007|Lansoprazole|lansoprazole|mesh-list
91951659|NCT03464305|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91951660|NCT03464305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91951661|NCT03464305|Analgesics|analgesics|mesh-ancestor
91951662|NCT03464305|Sensory System Agents|sensory system agents|mesh-ancestor
91951663|NCT03464305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951664|NCT03464305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951665|NCT03464305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951666|NCT03464305|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951667|NCT03464305|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91951668|NCT03464305|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91951669|NCT03464305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951670|NCT03464305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91951671|NCT03464305|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91951672|NCT03464305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951673|NCT03464305|Antipyretics|antipyretics|mesh-ancestor
91951674|NCT05165615|Insulin|insulin|mesh-list
91951675|NCT05165615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91951676|NCT05165615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951677|NCT03468439|Phenol|phenol|mesh-list
91951678|NCT03468439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91951679|NCT03468439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951680|NCT03468439|Disinfectants|disinfectants|mesh-ancestor
91951681|NCT03468439|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
91951682|NCT03468439|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91951683|NCT05165303|Lidocaine|lidocaine|mesh-list
91951684|NCT05165303|Propofol|propofol|mesh-list
91951685|NCT05165303|Anesthetics, Local|anesthetics, local|mesh-ancestor
91951686|NCT05165303|Anesthetics|anesthetics|mesh-ancestor
91951687|NCT05165303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951688|NCT05165303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951689|NCT05165303|Sensory System Agents|sensory system agents|mesh-ancestor
91951690|NCT05165303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951691|NCT05165303|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91951704|NCT03376763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951705|NCT03376763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951706|NCT03376763|Dopamine Agonists|dopamine agonists|mesh-ancestor
91951707|NCT03376763|Dopamine Agents|dopamine agents|mesh-ancestor
91951708|NCT03376763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951709|NCT03376763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951710|NCT03376763|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91951711|NCT03376763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91951712|NCT03376763|Serotonin Agents|serotonin agents|mesh-ancestor
91951713|NCT03376763|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91951714|NCT03376763|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91951715|NCT03376763|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91951716|NCT03376763|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91951717|NCT05153135|Palbociclib|palbociclib|mesh-list
91951718|NCT05153135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951719|NCT05153135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91951720|NCT05153135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951721|NCT05153135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951722|NCT02616185|Tremelimumab|tremelimumab|mesh-list
91951723|NCT02616185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951724|NCT04857307|Alprazolam|alprazolam|mesh-list
91951725|NCT04857307|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91951726|NCT04857307|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951727|NCT04857307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951728|NCT04857307|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91951729|NCT04857307|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91951730|NCT04857307|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91951731|NCT04857307|GABA Modulators|gaba modulators|mesh-ancestor
91951732|NCT04857307|GABA Agents|gaba agents|mesh-ancestor
91951733|NCT04857307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944591|NCT05259007|Dexlansoprazole|dexlansoprazole|mesh-list
91944592|NCT05259007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944593|NCT05259007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944594|NCT05259007|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91951734|NCT04857307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951735|NCT03467893|Antacids|antacids|mesh-list
91951736|NCT03467893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951737|NCT03467893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951738|NCT05170711|Antihypertensive Agents|antihypertensive agents|mesh-list
91951739|NCT05170711|Anesthetics|anesthetics|mesh-list
91951740|NCT05170711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951741|NCT05170711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951742|NCT03454945|Doxycycline|doxycycline|mesh-list
91951743|NCT03454945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91951744|NCT03454945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951745|NCT03454945|Antimalarials|antimalarials|mesh-ancestor
91951746|NCT03454945|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91951747|NCT03454945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91951748|NCT01857115|Dexamethasone|dexamethasone|mesh-list
91951749|NCT01857115|Cyclophosphamide|cyclophosphamide|mesh-list
91951750|NCT01857115|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91951751|NCT01857115|Immunologic Factors|immunologic factors|mesh-ancestor
91951752|NCT01857115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951763|NCT01857115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951765|NCT01857115|Hormones|hormones|mesh-ancestor
91951766|NCT01857115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951767|NCT01857115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91951768|NCT03453541|Ketorolac|ketorolac|mesh-list
91951769|NCT03453541|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
91951770|NCT03453541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91951771|NCT03453541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91951772|NCT03453541|Analgesics|analgesics|mesh-ancestor
91951773|NCT03453541|Sensory System Agents|sensory system agents|mesh-ancestor
91951774|NCT03453541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951775|NCT03453541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951776|NCT03453541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951777|NCT03453541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951778|NCT03453541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91951779|NCT03453541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951780|NCT03453541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951781|NCT00893789|Modafinil|modafinil|mesh-list
91951782|NCT00893789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91951783|NCT00893789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951784|NCT00893789|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
91951785|NCT00893789|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91951786|NCT00893789|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91951787|NCT00893789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951788|NCT03449251|Verapamil|verapamil|mesh-list
91951789|NCT03449251|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
91951790|NCT03449251|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91951791|NCT03449251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91951792|NCT03449251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951793|NCT03449251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951794|NCT03449251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91951795|NCT03449251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951796|NCT03449251|Vasodilator Agents|vasodilator agents|mesh-ancestor
91951797|NCT03449251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951799|NCT05322499|Docetaxel|docetaxel|mesh-list
91951800|NCT05322499|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91951801|NCT05322499|Irinotecan|irinotecan|mesh-list
91951802|NCT05322499|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91951803|NCT05322499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951804|NCT05322499|Tubulin Modulators|tubulin modulators|mesh-ancestor
91951805|NCT05322499|Antimitotic Agents|antimitotic agents|mesh-ancestor
91951806|NCT05322499|Mitosis Modulators|mitosis modulators|mesh-ancestor
91951807|NCT05322499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951808|NCT05322499|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91951809|NCT05322499|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91951810|NCT05322499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951811|NCT03449173|Sunitinib|sunitinib|mesh-list
91944595|NCT05259007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944596|NCT05259007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944597|NCT05259007|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91944598|NCT05259007|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91951812|NCT03449173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951813|NCT03449173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91951814|NCT03449173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91951815|NCT03449173|Growth Substances|growth substances|mesh-ancestor
91951832|NCT04760041|GABA Modulators|gaba modulators|mesh-ancestor
91951833|NCT04760041|GABA Agents|gaba agents|mesh-ancestor
91951834|NCT04760041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951835|NCT04760041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951837|NCT04754035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951838|NCT05322265|Epinephrine|epinephrine|mesh-list
91951839|NCT05322265|Racepinephrine|racepinephrine|mesh-list
91951840|NCT05322265|Epinephryl borate|epinephryl borate|mesh-list
91951841|NCT05322265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91951842|NCT05322265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91951843|NCT05322265|Adrenergic Agents|adrenergic agents|mesh-ancestor
91951844|NCT05322265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951845|NCT05322265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951846|NCT05322265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951847|NCT05322265|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91951848|NCT05322265|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91951849|NCT05322265|Autonomic Agents|autonomic agents|mesh-ancestor
91951850|NCT05322265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951851|NCT05322265|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91951852|NCT05322265|Respiratory System Agents|respiratory system agents|mesh-ancestor
91951853|NCT05322265|Mydriatics|mydriatics|mesh-ancestor
91951854|NCT05322265|Sympathomimetics|sympathomimetics|mesh-ancestor
91951855|NCT05322265|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91951857|NCT02164864|Warfarin|warfarin|mesh-list
91951858|NCT02164864|Dabigatran|dabigatran|mesh-list
91951859|NCT02164864|Clopidogrel|clopidogrel|mesh-list
91951860|NCT02164864|Ticagrelor|ticagrelor|mesh-list
91951861|NCT02164864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91951862|NCT02164864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91951863|NCT02164864|Analgesics|analgesics|mesh-ancestor
91951864|NCT02164864|Sensory System Agents|sensory system agents|mesh-ancestor
91951865|NCT02164864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951866|NCT02164864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951867|NCT02164864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951868|NCT02164864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951869|NCT02164864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91951870|NCT02164864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91951871|NCT02164864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951872|NCT02164864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91951873|NCT02164864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91951874|NCT02164864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951875|NCT02164864|Antipyretics|antipyretics|mesh-ancestor
91951923|NCT02419807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951925|NCT05386589|Antiviral Agents|antiviral agents|mesh-ancestor
91951926|NCT05386589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951927|NCT01998529|Cisplatin|cisplatin|mesh-list
91951928|NCT01998529|Amifostine|amifostine|mesh-list
91951929|NCT01998529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951930|NCT01998529|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91951931|NCT01998529|Protective Agents|protective agents|mesh-ancestor
91951932|NCT01998529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951933|NCT03448705|Vaccines|vaccines|mesh-list
91951934|NCT03448705|Immunologic Factors|immunologic factors|mesh-ancestor
91951935|NCT03448705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951936|NCT04637425|Broncho-Vaxom|broncho-vaxom|mesh-list
91951937|NCT04637425|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91951938|NCT04637425|Immunologic Factors|immunologic factors|mesh-ancestor
91951939|NCT04637425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951940|NCT03448549|Capecitabine|capecitabine|mesh-list
91951941|NCT03448549|Tegafur|tegafur|mesh-list
91951942|NCT03448549|Oxaliplatin|oxaliplatin|mesh-list
91951943|NCT03448549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944600|NCT05259007|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951944|NCT03448549|Antimetabolites|antimetabolites|mesh-ancestor
91951945|NCT03448549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951946|NCT03448549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951947|NCT03679091|Clopidogrel|clopidogrel|mesh-list
91951948|NCT03679091|Ticagrelor|ticagrelor|mesh-list
91951949|NCT03679091|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91951950|NCT03679091|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91951951|NCT03679091|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91951952|NCT03679091|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91951953|NCT03679091|Purinergic Agents|purinergic agents|mesh-ancestor
91951954|NCT03679091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951955|NCT03679091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951956|NCT03679091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951957|NCT01628926|Ropinirole|ropinirole|mesh-list
91951958|NCT01628926|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91951959|NCT01628926|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91951960|NCT01628926|Dopamine Agonists|dopamine agonists|mesh-ancestor
91951961|NCT01628926|Dopamine Agents|dopamine agents|mesh-ancestor
91951962|NCT01628926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951963|NCT01628926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951964|NCT01628926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951965|NCT05313659|Ketamine|ketamine|mesh-list
91951966|NCT05313659|Analgesics|analgesics|mesh-ancestor
91951967|NCT05313659|Sensory System Agents|sensory system agents|mesh-ancestor
91951968|NCT05313659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951969|NCT05313659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951970|NCT05313659|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91951997|NCT03436199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951998|NCT03436199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91951999|NCT03436199|Analgesics|analgesics|mesh-ancestor
91952000|NCT03436199|Sensory System Agents|sensory system agents|mesh-ancestor
91952001|NCT03436199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952002|NCT02131324|Clobetasol|clobetasol|mesh-list
91952003|NCT02131324|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952004|NCT02131324|Glucocorticoids|glucocorticoids|mesh-ancestor
91952005|NCT02131324|Hormones|hormones|mesh-ancestor
91952006|NCT02131324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952007|NCT02131324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952008|NCT04749394|Apatinib|apatinib|mesh-list
91952009|NCT04749394|Antibodies|antibodies|mesh-list
91952010|NCT04749394|Immunoglobulins|immunoglobulins|mesh-list
91952011|NCT04749394|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91952012|NCT04749394|Immunologic Factors|immunologic factors|mesh-ancestor
91952013|NCT04749394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952014|NCT04749394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952015|NCT04749394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952016|NCT04749394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952017|NCT04749394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952018|NCT02193880|Cyclophosphamide|cyclophosphamide|mesh-list
91952036|NCT05321329|Capecitabine|capecitabine|mesh-list
91952037|NCT05321329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91952038|NCT05321329|Antimetabolites|antimetabolites|mesh-ancestor
91952039|NCT05321329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952040|NCT05321329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952041|NCT02521831|Bupivacaine|bupivacaine|mesh-list
91952042|NCT02521831|Anesthetics|anesthetics|mesh-list
91952043|NCT02521831|Isoflurane|isoflurane|mesh-list
91952044|NCT02521831|Anesthetics, Local|anesthetics, local|mesh-ancestor
91952045|NCT02521831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952046|NCT02521831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952047|NCT02521831|Sensory System Agents|sensory system agents|mesh-ancestor
91952048|NCT02521831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952049|NCT02521831|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91952050|NCT02521831|Anesthetics, General|anesthetics, general|mesh-ancestor
91952051|NCT01425541|Progesterone|progesterone|mesh-list
91952052|NCT01425541|Estradiol|estradiol|mesh-list
91952053|NCT01425541|Estrogens|estrogens|mesh-list
91952054|NCT01425541|Progestins|progestins|mesh-ancestor
91952055|NCT01425541|Hormones|hormones|mesh-ancestor
91952056|NCT01425541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952057|NCT01425541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944601|NCT05259007|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91944602|NCT02255656|Alemtuzumab|alemtuzumab|mesh-list
91944603|NCT02255656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952058|NCT03447925|Salicylic Acid|salicylic acid|mesh-list
91952059|NCT03447925|Salicylates|salicylates|mesh-list
91952061|NCT03447925|Emollients|emollients|mesh-ancestor
91952062|NCT03447925|Dermatologic Agents|dermatologic agents|mesh-ancestor
91952063|NCT03447925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91952065|NCT03447925|Analgesics|analgesics|mesh-ancestor
91952066|NCT03447925|Sensory System Agents|sensory system agents|mesh-ancestor
91952067|NCT03447925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952068|NCT03447925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952069|NCT03447925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952070|NCT03447925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952071|NCT03447925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91952072|NCT03447925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952073|NCT03447925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952074|NCT03447925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952075|NCT03447925|Antifungal Agents|antifungal agents|mesh-ancestor
91952076|NCT03447925|Keratolytic Agents|keratolytic agents|mesh-ancestor
91952100|NCT04928183|Vasodilator Agents|vasodilator agents|mesh-ancestor
91952101|NCT04928183|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91952102|NCT04311073|Tranexamic Acid|tranexamic acid|mesh-list
91952103|NCT04311073|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91952104|NCT04311073|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91952105|NCT04311073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952107|NCT04311073|Coagulants|coagulants|mesh-ancestor
91952108|NCT03447691|Remifentanil|remifentanil|mesh-list
91952109|NCT03447691|Anesthetics|anesthetics|mesh-list
91952110|NCT03447691|Propofol|propofol|mesh-list
91952111|NCT03447691|Desflurane|desflurane|mesh-list
91952112|NCT03447691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952113|NCT03447691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952114|NCT03447691|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91952115|NCT03447691|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91952116|NCT03447691|Anesthetics, General|anesthetics, general|mesh-ancestor
91952117|NCT03447691|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91952118|NCT03447691|Narcotics|narcotics|mesh-ancestor
91952119|NCT03447691|Analgesics|analgesics|mesh-ancestor
91952120|NCT03447691|Sensory System Agents|sensory system agents|mesh-ancestor
91952121|NCT03447691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952122|NCT03447691|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91952123|NCT04923659|Nimodipine|nimodipine|mesh-list
91952124|NCT04923659|Carbamazepine|carbamazepine|mesh-list
91952125|NCT04923659|Lorazepam|lorazepam|mesh-list
91952126|NCT04923659|Dextromethorphan|dextromethorphan|mesh-list
91952127|NCT04923659|Antitussive Agents|antitussive agents|mesh-ancestor
91952128|NCT04923659|Respiratory System Agents|respiratory system agents|mesh-ancestor
91952129|NCT04923659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91952130|NCT04923659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91952131|NCT04923659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952163|NCT05398679|Clindamycin|clindamycin|mesh-list
91952164|NCT05398679|Clindamycin palmitate|clindamycin palmitate|mesh-list
91952165|NCT05398679|Clindamycin phosphate|clindamycin phosphate|mesh-list
91952166|NCT05398679|Rifampin|rifampin|mesh-list
91952167|NCT05398679|Linezolid|linezolid|mesh-list
91952168|NCT05398679|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91952169|NCT05398679|Tedizolid|tedizolid|mesh-list
91952170|NCT05398679|Fusidic Acid|fusidic acid|mesh-list
91952171|NCT05398679|Dicloxacillin|dicloxacillin|mesh-list
91952172|NCT05398679|Cefaclor|cefaclor|mesh-list
91952173|NCT05398679|Trimethoprim|trimethoprim|mesh-list
91952174|NCT05398679|Sulfamethoxazole|sulfamethoxazole|mesh-list
91952175|NCT05398679|Oxazolidinones|oxazolidinones|mesh-list
91952176|NCT05398679|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91952177|NCT05398679|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952193|NCT05398679|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91952194|NCT05398679|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91952195|NCT05398679|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91952196|NCT05398679|Antitubercular Agents|antitubercular agents|mesh-ancestor
91952197|NCT05398679|Leprostatic Agents|leprostatic agents|mesh-ancestor
91952198|NCT05398679|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944604|NCT02255656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944605|NCT00380653|Sapacitabine|sapacitabine|mesh-list
91944606|NCT00380653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944607|NCT03472339|Diclofenac|diclofenac|mesh-list
91944608|NCT03472339|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91952199|NCT05398679|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91952200|NCT05398679|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91952201|NCT05398679|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91952202|NCT05398679|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91952203|NCT05398679|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91952204|NCT05398679|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91952206|NCT05398679|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91952207|NCT05398679|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91952208|NCT05398679|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91952209|NCT05398679|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91952210|NCT05398679|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91952211|NCT04817501|Edetic Acid|edetic acid|mesh-list
91952212|NCT04817501|Anticoagulants|anticoagulants|mesh-ancestor
91952213|NCT04817501|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91952214|NCT04817501|Chelating Agents|chelating agents|mesh-ancestor
91952215|NCT04817501|Sequestering Agents|sequestering agents|mesh-ancestor
91952216|NCT04817501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952217|NCT05398055|Azithromycin|azithromycin|mesh-list
91952218|NCT05398055|Doxycycline|doxycycline|mesh-list
91952219|NCT05398055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952220|NCT05398055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952221|NCT05398055|Antimalarials|antimalarials|mesh-ancestor
91952222|NCT05398055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91952223|NCT05398055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91952224|NCT01378325|Phenylephrine|phenylephrine|mesh-list
91952225|NCT01378325|Oxymetazoline|oxymetazoline|mesh-list
91952226|NCT01378325|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91952227|NCT01378325|Mydriatics|mydriatics|mesh-ancestor
91952228|NCT01378325|Autonomic Agents|autonomic agents|mesh-ancestor
91952229|NCT01378325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952230|NCT01378325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952231|NCT01378325|Sympathomimetics|sympathomimetics|mesh-ancestor
91952232|NCT01378325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91952233|NCT01378325|Nasal Decongestants|nasal decongestants|mesh-ancestor
91952282|NCT05174845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952284|NCT05174845|Micronutrients|micronutrients|mesh-ancestor
91952285|NCT04155203|Calcium, Dietary|calcium, dietary|mesh-list
91952286|NCT04155203|Mupirocin|mupirocin|mesh-list
91952287|NCT04155203|Calcium|calcium|mesh-list
91952288|NCT04155203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91952289|NCT04155203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952290|NCT04155203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91952291|NCT04155203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952292|NCT04155203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952293|NCT04155203|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91952294|NCT04155203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952295|NCT04155203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952296|NCT04238143|Complement Factor H|complement factor h|mesh-list
91952297|NCT04238143|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91952298|NCT04238143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952299|NCT04238143|Immunologic Factors|immunologic factors|mesh-ancestor
91952300|NCT04238143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952301|NCT04073615|Trifluridine|trifluridine|mesh-list
91952302|NCT04073615|Apatinib|apatinib|mesh-list
91952303|NCT04073615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952304|NCT04073615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952305|NCT04073615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952306|NCT04073615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952307|NCT04073615|Antimetabolites|antimetabolites|mesh-ancestor
91952308|NCT04073615|Antiviral Agents|antiviral agents|mesh-ancestor
91952462|NCT03466775|Angiotensinogen|angiotensinogen|mesh-list
91952309|NCT04073615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952310|NCT03057613|Pembrolizumab|pembrolizumab|mesh-list
91952311|NCT03057613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952312|NCT03057613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952313|NCT03057613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91944609|NCT03472339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91952314|NCT03057613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952315|NCT03446911|Pembrolizumab|pembrolizumab|mesh-list
91952316|NCT03446911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952317|NCT03446911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952318|NCT03446911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91952319|NCT03446911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952320|NCT03446599|Hydroxocobalamin|hydroxocobalamin|mesh-list
91952321|NCT03446599|Vitamin B 12|vitamin b 12|mesh-list
91952322|NCT03446599|Methylene Blue|methylene blue|mesh-list
91952323|NCT03446599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952324|NCT03446599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952350|NCT03443869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952351|NCT03443869|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91952353|NCT03443869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952354|NCT03443869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952355|NCT03130517|Immunoglobulins|immunoglobulins|mesh-list
91952356|NCT03130517|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91952358|NCT03130517|gamma-Globulins|gamma-globulins|mesh-list
91952359|NCT03130517|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91952360|NCT03130517|Immunologic Factors|immunologic factors|mesh-ancestor
91952361|NCT03130517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952362|NCT03445897|Miltefosine|miltefosine|mesh-list
91952363|NCT03445897|Pentamidine|pentamidine|mesh-list
91952364|NCT03445897|Antifungal Agents|antifungal agents|mesh-ancestor
91952365|NCT03445897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952366|NCT03445897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952367|NCT03445897|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91952368|NCT03445897|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91952369|NCT03445897|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91952370|NCT03237611|Dexamethasone|dexamethasone|mesh-list
91952371|NCT03237611|Ondansetron|ondansetron|mesh-list
91952372|NCT03237611|Aprepitant|aprepitant|mesh-list
91952373|NCT03237611|Fosaprepitant|fosaprepitant|mesh-list
91952374|NCT03237611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952375|NCT03237611|Antiemetics|antiemetics|mesh-ancestor
91952376|NCT03237611|Autonomic Agents|autonomic agents|mesh-ancestor
91952377|NCT03237611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952398|NCT01961063|Alkylating Agents|alkylating agents|mesh-ancestor
91952399|NCT01961063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952400|NCT01961063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952401|NCT01961063|Immunologic Factors|immunologic factors|mesh-ancestor
91952402|NCT01961063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952403|NCT01961063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91952404|NCT01961063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952405|NCT01961063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91952406|NCT02951377|Dexamethasone|dexamethasone|mesh-list
91952407|NCT02951377|Lidocaine|lidocaine|mesh-list
91952408|NCT02951377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952409|NCT02951377|Antiemetics|antiemetics|mesh-ancestor
91952410|NCT02951377|Autonomic Agents|autonomic agents|mesh-ancestor
91952411|NCT02951377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952412|NCT02951377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952413|NCT02951377|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91952414|NCT02951377|Glucocorticoids|glucocorticoids|mesh-ancestor
91952415|NCT02951377|Hormones|hormones|mesh-ancestor
91952416|NCT02951377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952417|NCT02951377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91952418|NCT02951377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952419|NCT02951377|Anesthetics, Local|anesthetics, local|mesh-ancestor
91952420|NCT02951377|Anesthetics|anesthetics|mesh-ancestor
91952421|NCT02951377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952422|NCT02951377|Sensory System Agents|sensory system agents|mesh-ancestor
91952423|NCT02951377|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91952424|NCT02951377|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91952425|NCT02951377|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91952426|NCT02951377|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91952427|NCT02951377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952428|NCT05082259|Pembrolizumab|pembrolizumab|mesh-list
91952429|NCT05082259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952463|NCT03466775|Immunologic Factors|immunologic factors|mesh-ancestor
91952464|NCT03466775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952465|NCT03466775|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91952466|NCT03466775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91952467|NCT03466775|Protease Inhibitors|protease inhibitors|mesh-ancestor
91952468|NCT03466775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952469|NCT03466775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952470|NCT02611817|Vedolizumab|vedolizumab|mesh-list
91952471|NCT02611817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91952482|NCT05430893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952484|NCT02557139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952485|NCT02557139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952486|NCT02557139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952487|NCT01677741|Dabrafenib|dabrafenib|mesh-list
91952488|NCT01677741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952489|NCT01677741|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952490|NCT01677741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952491|NCT01677741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952492|NCT02457221|Prednisone|prednisone|mesh-list
91952493|NCT02457221|Cyclophosphamide|cyclophosphamide|mesh-list
91952494|NCT02457221|Tacrolimus|tacrolimus|mesh-list
91952495|NCT02457221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952496|NCT02457221|Immunologic Factors|immunologic factors|mesh-ancestor
91952497|NCT02457221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952498|NCT02457221|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952499|NCT02457221|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91952500|NCT02457221|Alkylating Agents|alkylating agents|mesh-ancestor
91952501|NCT02457221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952502|NCT02457221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952503|NCT02457221|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91952504|NCT02457221|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952505|NCT02457221|Glucocorticoids|glucocorticoids|mesh-ancestor
91952506|NCT02457221|Hormones|hormones|mesh-ancestor
91952507|NCT02457221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952508|NCT02457221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91952509|NCT02457221|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91952510|NCT02457221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952511|NCT05263895|Ritonavir|ritonavir|mesh-list
91952512|NCT05263895|Nirmatrelvir|nirmatrelvir|mesh-list
91952513|NCT05263895|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91952514|NCT05263895|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91952515|NCT05263895|Protease Inhibitors|protease inhibitors|mesh-ancestor
91952516|NCT05263895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952517|NCT05263895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952518|NCT05263895|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91952519|NCT05263895|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91952520|NCT05263895|Antiviral Agents|antiviral agents|mesh-ancestor
91952521|NCT05263895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952522|NCT05263895|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91952523|NCT05263895|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91952525|NCT01709981|Gout Suppressants|gout suppressants|mesh-ancestor
91952526|NCT01709981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952527|NCT01709981|Tubulin Modulators|tubulin modulators|mesh-ancestor
91952528|NCT01709981|Antimitotic Agents|antimitotic agents|mesh-ancestor
91952529|NCT01709981|Mitosis Modulators|mitosis modulators|mesh-ancestor
91952530|NCT01709981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952531|NCT01709981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952532|NCT03268083|Vaccines|vaccines|mesh-list
91952548|NCT05101005|Sirolimus|sirolimus|mesh-list
91952549|NCT05101005|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952550|NCT05101005|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952551|NCT05101005|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91952552|NCT05101005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952553|NCT05101005|Antifungal Agents|antifungal agents|mesh-ancestor
91952554|NCT05101005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952555|NCT05101005|Immunologic Factors|immunologic factors|mesh-ancestor
91952556|NCT05101005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952557|NCT03130205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91952558|NCT03130205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91952559|NCT03130205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952560|NCT05015387|Proanthocyanidin|proanthocyanidin|mesh-list
91952561|NCT05015387|Procyanidin|procyanidin|mesh-list
91952562|NCT05015387|Antioxidants|antioxidants|mesh-ancestor
91952563|NCT05015387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944611|NCT03472339|Sensory System Agents|sensory system agents|mesh-ancestor
91944612|NCT03472339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944613|NCT03472339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952564|NCT05015387|Protective Agents|protective agents|mesh-ancestor
91952565|NCT05015387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952566|NCT05015387|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91952567|NCT05015387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91952568|NCT05015387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952569|NCT00003857|Tamoxifen|tamoxifen|mesh-list
91952570|NCT00003857|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91952571|NCT00003857|Hormone Antagonists|hormone antagonists|mesh-ancestor
91952572|NCT00003857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952573|NCT00003857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952574|NCT00003857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91952575|NCT00003857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952576|NCT00003857|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91952577|NCT00003857|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91952578|NCT00003857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91952579|NCT03464435|Loteprednol Etabonate|loteprednol etabonate|mesh-list
91952580|NCT03464435|Tobramycin|tobramycin|mesh-list
91952581|NCT03464435|Tacrolimus|tacrolimus|mesh-list
91952582|NCT03464435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952583|NCT03464435|Immunologic Factors|immunologic factors|mesh-ancestor
91952584|NCT03464435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952585|NCT03464435|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91952586|NCT03464435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952587|NCT03464435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952588|NCT03464435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952589|NCT03464435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952617|NCT03468023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952618|NCT03468023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952619|NCT04830215|Brexpiprazole|brexpiprazole|mesh-list
91952620|NCT04830215|Serotonin Agents|serotonin agents|mesh-ancestor
91952621|NCT04830215|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952622|NCT04830215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952623|NCT04830215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952624|NCT04830215|Dopamine Agonists|dopamine agonists|mesh-ancestor
91952625|NCT04830215|Dopamine Agents|dopamine agents|mesh-ancestor
91952626|NCT05100303|Cytarabine|cytarabine|mesh-list
91952627|NCT05100303|Mitoxantrone|mitoxantrone|mesh-list
91952628|NCT05100303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91952629|NCT05100303|Antimetabolites|antimetabolites|mesh-ancestor
91952630|NCT05100303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952631|NCT05100303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952632|NCT05100303|Antiviral Agents|antiviral agents|mesh-ancestor
91952633|NCT05100303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952634|NCT05100303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952635|NCT05100303|Immunologic Factors|immunologic factors|mesh-ancestor
91952636|NCT05100303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952637|NCT05100303|Analgesics|analgesics|mesh-ancestor
91952652|NCT05096715|Growth Substances|growth substances|mesh-ancestor
91952653|NCT05096715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952654|NCT05096715|Growth Inhibitors|growth inhibitors|mesh-ancestor
91952655|NCT05096715|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91952656|NCT05096715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952658|NCT04984889|Anticoagulants|anticoagulants|mesh-ancestor
91952659|NCT04984889|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91952660|NCT04984889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91952661|NCT04984889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952663|NCT05099601|Antioxidants|antioxidants|mesh-ancestor
91952664|NCT05099601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952665|NCT05099601|Protective Agents|protective agents|mesh-ancestor
91952666|NCT05099601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952667|NCT03736629|Azithromycin|azithromycin|mesh-list
91952668|NCT03736629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952669|NCT03736629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944614|NCT03472339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944615|NCT03472339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944616|NCT03472339|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91952670|NCT03461783|Charcoal|charcoal|mesh-list
91952671|NCT03461783|Antidotes|antidotes|mesh-ancestor
91952672|NCT03461783|Protective Agents|protective agents|mesh-ancestor
91952673|NCT03461783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952674|NCT01677507|Timolol|timolol|mesh-list
91952675|NCT01677507|Latanoprost|latanoprost|mesh-list
91952676|NCT01677507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91952677|NCT01677507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91952678|NCT01677507|Adrenergic Agents|adrenergic agents|mesh-ancestor
91952679|NCT01677507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952680|NCT01677507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952681|NCT01677507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952682|NCT01677507|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91952683|NCT01677507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91952684|NCT01677507|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91952686|NCT04796363|Anesthetics|anesthetics|mesh-list
91952698|NCT03522753|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952699|NCT03522753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952701|NCT05103813|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91952702|NCT05103813|Vasodilator Agents|vasodilator agents|mesh-ancestor
91952703|NCT03461627|Fluticasone|fluticasone|mesh-list
91952704|NCT03461627|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91952705|NCT03461627|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91952706|NCT03461627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952707|NCT03461627|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91952708|NCT03461627|Autonomic Agents|autonomic agents|mesh-ancestor
91952709|NCT03461627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952710|NCT03461627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952711|NCT03461627|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91952712|NCT03461627|Respiratory System Agents|respiratory system agents|mesh-ancestor
91952713|NCT03461627|Dermatologic Agents|dermatologic agents|mesh-ancestor
91952714|NCT03461627|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91952715|NCT03461627|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91952716|NCT03461627|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91952717|NCT03461627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91952718|NCT03461627|Adrenergic Agents|adrenergic agents|mesh-ancestor
91952719|NCT03461627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952720|NCT03461627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952721|NCT03461627|Glucocorticoids|glucocorticoids|mesh-ancestor
91952722|NCT03461627|Hormones|hormones|mesh-ancestor
91952723|NCT03461627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952724|NCT03461627|Sympathomimetics|sympathomimetics|mesh-ancestor
91952725|NCT04452929|Calcitonin|calcitonin|mesh-list
91952726|NCT04452929|Salmon calcitonin|salmon calcitonin|mesh-list
91952727|NCT04452929|Cilostazol|cilostazol|mesh-list
91952728|NCT04452929|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
91952729|NCT04452929|Erenumab|erenumab|mesh-list
91952730|NCT04452929|Katacalcin|katacalcin|mesh-list
91952731|NCT04452929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91952732|NCT04452929|Autonomic Agents|autonomic agents|mesh-ancestor
91952733|NCT04452929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952734|NCT04452929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952735|NCT04452929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91952736|NCT04452929|Respiratory System Agents|respiratory system agents|mesh-ancestor
91952737|NCT04452929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91944617|NCT03472339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944618|NCT03472339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944619|NCT03472261|Botulinum Toxins|botulinum toxins|mesh-list
91944620|NCT03472261|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91944621|NCT03472261|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91952738|NCT04452929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91952739|NCT04452929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952740|NCT04452929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91952741|NCT04452929|Vasodilator Agents|vasodilator agents|mesh-ancestor
91952742|NCT04452929|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91952743|NCT04452929|Protective Agents|protective agents|mesh-ancestor
91952744|NCT04452929|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91952745|NCT04452929|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91952746|NCT04452929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952761|NCT05103501|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952762|NCT05103501|Immunologic Factors|immunologic factors|mesh-ancestor
91952763|NCT05103501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952764|NCT02522117|Atorvastatin|atorvastatin|mesh-list
91952765|NCT02522117|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91952766|NCT02522117|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91952767|NCT02522117|Antimetabolites|antimetabolites|mesh-ancestor
91952768|NCT02522117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952769|NCT02522117|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91952770|NCT02522117|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91952771|NCT02522117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952772|NCT05087199|Fibrin fragment D|fibrin fragment d|mesh-list
91952773|NCT05087199|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91952774|NCT05087199|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91952775|NCT05087199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952776|NCT05087199|Hemostatics|hemostatics|mesh-ancestor
91952777|NCT05087199|Coagulants|coagulants|mesh-ancestor
91952778|NCT04628429|Erenumab|erenumab|mesh-list
91952779|NCT04628429|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91952780|NCT04628429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952781|NCT04628429|Analgesics|analgesics|mesh-ancestor
91952782|NCT04628429|Sensory System Agents|sensory system agents|mesh-ancestor
91952783|NCT04628429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952784|NCT04628429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952785|NCT03461081|Amlodipine|amlodipine|mesh-list
91952786|NCT03461081|Telmisartan|telmisartan|mesh-list
91952787|NCT03461081|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
91952788|NCT03461081|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
91952789|NCT03461081|Atorvastatin|atorvastatin|mesh-list
91952790|NCT03461081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91952791|NCT03461081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91952792|NCT03461081|Antimetabolites|antimetabolites|mesh-ancestor
91952793|NCT03461081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952794|NCT03461081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91952795|NCT03461081|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91952796|NCT03461081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952797|NCT03461081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91952798|NCT03461081|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91952799|NCT03461081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91952800|NCT03461081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91952801|NCT03461081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952802|NCT03461081|Vasodilator Agents|vasodilator agents|mesh-ancestor
91952803|NCT03461081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91952820|NCT05107791|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91952821|NCT05107791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91952823|NCT04430699|Pembrolizumab|pembrolizumab|mesh-list
91952824|NCT04430699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952825|NCT04430699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952826|NCT04430699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91952827|NCT04430699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952828|NCT05111769|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
91952829|NCT05111769|Natriuretic Agents|natriuretic agents|mesh-ancestor
91944622|NCT03472261|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91944623|NCT03472261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944624|NCT03472261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952830|NCT05111769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952832|NCT04358003|Keratolytic Agents|keratolytic agents|mesh-ancestor
91952833|NCT04358003|Dermatologic Agents|dermatologic agents|mesh-ancestor
91952834|NCT04519905|Paclitaxel|paclitaxel|mesh-list
91952835|NCT04519905|Carboplatin|carboplatin|mesh-list
91952836|NCT04519905|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91952837|NCT04519905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952838|NCT04519905|Tubulin Modulators|tubulin modulators|mesh-ancestor
91952839|NCT04519905|Antimitotic Agents|antimitotic agents|mesh-ancestor
91952840|NCT04519905|Mitosis Modulators|mitosis modulators|mesh-ancestor
91952841|NCT04519905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952842|NCT04423341|Cannabidiol|cannabidiol|mesh-list
91952843|NCT04423341|Anticonvulsants|anticonvulsants|mesh-ancestor
91952844|NCT03378479|Posaconazole|posaconazole|mesh-list
91952845|NCT03378479|Antifungal Agents|antifungal agents|mesh-ancestor
91952846|NCT03378479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952847|NCT03378479|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91952848|NCT03378479|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91952849|NCT03378479|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91952850|NCT03378479|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91952851|NCT03378479|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91952852|NCT03378479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952853|NCT03378479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952854|NCT03378479|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91952855|NCT03378479|Hormone Antagonists|hormone antagonists|mesh-ancestor
91952856|NCT03378479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952857|NCT03378479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952858|NCT03460145|Propofol|propofol|mesh-list
91952859|NCT03460145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91952860|NCT03460145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952877|NCT05115123|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91952878|NCT05115123|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91952879|NCT05115123|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91952880|NCT05115123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91952881|NCT05115123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952882|NCT05115123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952883|NCT05115123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952884|NCT05115123|Analgesics|analgesics|mesh-ancestor
91952885|NCT05115123|Sensory System Agents|sensory system agents|mesh-ancestor
91952886|NCT05115123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952887|NCT05115123|Antidepressive Agents|antidepressive agents|mesh-ancestor
91952888|NCT05115123|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91952889|NCT05115123|Dopamine Agents|dopamine agents|mesh-ancestor
91952890|NCT04636671|Dexamethasone|dexamethasone|mesh-list
91952891|NCT04636671|Methylprednisolone|methylprednisolone|mesh-list
91952892|NCT04636671|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91952893|NCT04636671|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91952894|NCT04636671|Prednisolone|prednisolone|mesh-list
91952895|NCT04636671|Prednisolone acetate|prednisolone acetate|mesh-list
91952896|NCT04636671|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91952897|NCT04636671|Prednisolone phosphate|prednisolone phosphate|mesh-list
91952898|NCT04636671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952899|NCT04636671|Antiemetics|antiemetics|mesh-ancestor
91952900|NCT04636671|Autonomic Agents|autonomic agents|mesh-ancestor
91952901|NCT04636671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952902|NCT04636671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952903|NCT04636671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91952904|NCT04636671|Glucocorticoids|glucocorticoids|mesh-ancestor
91952905|NCT04636671|Hormones|hormones|mesh-ancestor
91952906|NCT04636671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952907|NCT04636671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91952908|NCT04636671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952909|NCT04636671|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91944625|NCT03472261|Cholinergic Agents|cholinergic agents|mesh-ancestor
91944626|NCT03472261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944627|NCT03472261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944628|NCT03472261|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91944629|NCT03472261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944631|NCT03951025|Antioxidants|antioxidants|mesh-ancestor
91952910|NCT04636671|Protective Agents|protective agents|mesh-ancestor
91952911|NCT03459599|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91952912|NCT03459599|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
91952913|NCT03459599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952914|NCT03459599|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91952915|NCT03459599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952916|NCT03459599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952917|NCT03645603|Dexmedetomidine|dexmedetomidine|mesh-list
91952936|NCT04019873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952937|NCT04019873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952938|NCT04019873|Antiviral Agents|antiviral agents|mesh-ancestor
91952939|NCT04019873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952940|NCT04019873|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91952941|NCT04019873|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91952942|NCT04019873|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91952943|NCT04019873|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91952944|NCT04771689|Buprenorphine|buprenorphine|mesh-list
91952945|NCT04771689|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
91952947|NCT04771689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91952948|NCT04771689|Narcotics|narcotics|mesh-ancestor
91952949|NCT04771689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952950|NCT04771689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952951|NCT04771689|Analgesics|analgesics|mesh-ancestor
91952952|NCT04771689|Sensory System Agents|sensory system agents|mesh-ancestor
91952953|NCT04771689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952954|NCT04771689|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91952955|NCT04674345|Sorafenib|sorafenib|mesh-list
91952956|NCT04674345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952957|NCT04674345|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952958|NCT04674345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952959|NCT04674345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953058|NCT03449537|Chelating Agents|chelating agents|mesh-ancestor
91952960|NCT04165239|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
91952961|NCT04165239|Antioxidants|antioxidants|mesh-ancestor
91952962|NCT04165239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952963|NCT04165239|Protective Agents|protective agents|mesh-ancestor
91952964|NCT04165239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952965|NCT03756311|Paclitaxel|paclitaxel|mesh-list
91952966|NCT03756311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91952967|NCT03756311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91952968|NCT03756311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952969|NCT03756311|Tubulin Modulators|tubulin modulators|mesh-ancestor
91952970|NCT03756311|Antimitotic Agents|antimitotic agents|mesh-ancestor
91952971|NCT03756311|Mitosis Modulators|mitosis modulators|mesh-ancestor
91952972|NCT03756311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952988|NCT03129347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952989|NCT03129347|Sensory System Agents|sensory system agents|mesh-ancestor
91952990|NCT03129347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952992|NCT02262923|Antiemetics|antiemetics|mesh-ancestor
91952993|NCT02262923|Autonomic Agents|autonomic agents|mesh-ancestor
91952994|NCT02262923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952995|NCT02262923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952996|NCT02262923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91952997|NCT02262923|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91952998|NCT02262923|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91952999|NCT02262923|Dopamine Agents|dopamine agents|mesh-ancestor
91953000|NCT02262923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953001|NCT02262923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953002|NCT02194595|Insulin|insulin|mesh-list
91953003|NCT02194595|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91953004|NCT02194595|Insulin Glargine|insulin glargine|mesh-list
91953005|NCT02194595|Exenatide|exenatide|mesh-list
91944632|NCT03951025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944633|NCT03951025|Protective Agents|protective agents|mesh-ancestor
91944634|NCT03951025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944635|NCT03951025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944636|NCT02255500|Bupivacaine|bupivacaine|mesh-list
91953006|NCT02194595|Insulin Lispro|insulin lispro|mesh-list
91953007|NCT02194595|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91953008|NCT02194595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953009|NCT02194595|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91953010|NCT02194595|Incretins|incretins|mesh-ancestor
91953011|NCT02194595|Hormones|hormones|mesh-ancestor
91953012|NCT02194595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953013|NCT02656329|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
91953014|NCT02656329|Lugol's solution|lugol's solution|mesh-list
91953015|NCT02656329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953016|NCT02656329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953017|NCT02656329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953018|NCT02656329|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91953019|NCT02656329|Hemostatics|hemostatics|mesh-ancestor
91953020|NCT02656329|Coagulants|coagulants|mesh-ancestor
91953021|NCT02712905|Nivolumab|nivolumab|mesh-list
91953022|NCT02712905|Azacitidine|azacitidine|mesh-list
91953023|NCT02712905|Tretinoin|tretinoin|mesh-list
91953024|NCT02712905|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953025|NCT02712905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953026|NCT02712905|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953027|NCT02712905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953028|NCT02712905|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91953029|NCT02712905|Antimetabolites|antimetabolites|mesh-ancestor
91953030|NCT02712905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953031|NCT02712905|Keratolytic Agents|keratolytic agents|mesh-ancestor
91953032|NCT02712905|Dermatologic Agents|dermatologic agents|mesh-ancestor
91953033|NCT01166633|Atorvastatin|atorvastatin|mesh-list
91953034|NCT01166633|Pitavastatin|pitavastatin|mesh-list
91953035|NCT01166633|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91953048|NCT05320757|Olaparib|olaparib|mesh-list
91953049|NCT05320757|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91953050|NCT05320757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953051|NCT05320757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953052|NCT05320757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953053|NCT03449693|Magnesium Oxide|magnesium oxide|mesh-list
91953054|NCT03449693|Antacids|antacids|mesh-ancestor
91953055|NCT03449693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953056|NCT03449693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91953057|NCT03449537|Caseins|caseins|mesh-list
91953059|NCT03449537|Sequestering Agents|sequestering agents|mesh-ancestor
91953060|NCT03449537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953061|NCT02237183|Iloprost|iloprost|mesh-list
91953062|NCT02237183|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91953063|NCT02237183|Vasodilator Agents|vasodilator agents|mesh-ancestor
91953064|NCT03371979|Pembrolizumab|pembrolizumab|mesh-list
91953065|NCT03371979|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953066|NCT03371979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953067|NCT03371979|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953068|NCT03371979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953069|NCT05104437|Vaccines|vaccines|mesh-list
91953070|NCT05104437|Immunologic Factors|immunologic factors|mesh-ancestor
91953071|NCT05104437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953072|NCT03179943|Atezolizumab|atezolizumab|mesh-list
91953073|NCT03179943|Guadecitabine|guadecitabine|mesh-list
91953074|NCT03179943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953075|NCT03179943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953076|NCT03179943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953077|NCT03179943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953078|NCT04528173|Ketorolac|ketorolac|mesh-list
91953079|NCT04528173|Fentanyl|fentanyl|mesh-list
91953080|NCT04528173|Dexmedetomidine|dexmedetomidine|mesh-list
91953081|NCT04528173|Morphine|morphine|mesh-list
91953082|NCT04528173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91944637|NCT02255500|Anesthetics, Local|anesthetics, local|mesh-ancestor
91944638|NCT02255500|Anesthetics|anesthetics|mesh-ancestor
91944639|NCT02255500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953083|NCT04528173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953084|NCT04528173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953085|NCT04528173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953086|NCT04528173|Analgesics|analgesics|mesh-ancestor
91953087|NCT04528173|Sensory System Agents|sensory system agents|mesh-ancestor
91953088|NCT04528173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953089|NCT04528173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91953090|NCT04528173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91953091|NCT04528173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953092|NCT04528173|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953093|NCT04528173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953094|NCT04528173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953095|NCT04528173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91953096|NCT04528173|Narcotics|narcotics|mesh-ancestor
91953097|NCT04528173|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91953098|NCT04528173|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91953143|NCT05283161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953144|NCT05283161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953145|NCT05283161|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953146|NCT05283161|Analgesics|analgesics|mesh-ancestor
91953147|NCT05283161|Sensory System Agents|sensory system agents|mesh-ancestor
91953148|NCT05283161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953149|NCT05283161|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91953150|NCT05283161|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91953151|NCT05283161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953152|NCT05283161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953153|NCT05283161|Hormones|hormones|mesh-ancestor
91953154|NCT05283161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953155|NCT03691311|Denosumab|denosumab|mesh-list
91953156|NCT03691311|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91953157|NCT03691311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953158|NCT03448835|Docetaxel|docetaxel|mesh-list
91953159|NCT03448835|Capecitabine|capecitabine|mesh-list
91953160|NCT03448835|Oxaliplatin|oxaliplatin|mesh-list
91953161|NCT03448835|Atezolizumab|atezolizumab|mesh-list
91953162|NCT03448835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953163|NCT03448835|Tubulin Modulators|tubulin modulators|mesh-ancestor
91953164|NCT03448835|Antimitotic Agents|antimitotic agents|mesh-ancestor
91953165|NCT03448835|Mitosis Modulators|mitosis modulators|mesh-ancestor
91953166|NCT03448835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953167|NCT03448835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91953168|NCT03448835|Antimetabolites|antimetabolites|mesh-ancestor
91953169|NCT03448835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953170|NCT03448835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953171|NCT03690453|Ivermectin|ivermectin|mesh-list
91953172|NCT03690453|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91953173|NCT03690453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953174|NCT05211635|Vitamin D|vitamin d|mesh-list
91953175|NCT05211635|Vitamins|vitamins|mesh-ancestor
91953176|NCT05211635|Micronutrients|micronutrients|mesh-ancestor
91953177|NCT05211635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953178|NCT05211635|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91953180|NCT05184335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91953195|NCT01301807|Panobinostat|panobinostat|mesh-list
91953196|NCT01301807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953197|NCT01301807|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91953198|NCT01301807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953199|NCT01301807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953200|NCT04962893|Vaccines|vaccines|mesh-list
91953201|NCT04962893|Immunologic Factors|immunologic factors|mesh-ancestor
91953202|NCT04962893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953203|NCT03443141|Vitamin E|vitamin e|mesh-list
91953204|NCT03443141|Vitamins|vitamins|mesh-ancestor
91953205|NCT03443141|Micronutrients|micronutrients|mesh-ancestor
91953206|NCT03443141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953207|NCT03443141|Antioxidants|antioxidants|mesh-ancestor
91953208|NCT03443141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953209|NCT03443141|Protective Agents|protective agents|mesh-ancestor
91953210|NCT04937543|Beclomethasone|beclomethasone|mesh-list
91944640|NCT02255500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944641|NCT02255500|Sensory System Agents|sensory system agents|mesh-ancestor
91944642|NCT02255500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944643|NCT03475693|Acetaminophen|acetaminophen|mesh-list
91953211|NCT04937543|Glycopyrrolate|glycopyrrolate|mesh-list
91953212|NCT04937543|Formoterol Fumarate|formoterol fumarate|mesh-list
91953213|NCT04937543|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91953214|NCT04937543|Autonomic Agents|autonomic agents|mesh-ancestor
91953215|NCT04937543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953216|NCT04937543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953217|NCT04937543|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91953218|NCT04937543|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953219|NCT04937543|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91953220|NCT04937543|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91953221|NCT04937543|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953222|NCT04937543|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953223|NCT04937543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953224|NCT04937543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953225|NCT04937543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953226|NCT04937543|Glucocorticoids|glucocorticoids|mesh-ancestor
91953227|NCT04937543|Hormones|hormones|mesh-ancestor
91953228|NCT04937543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953229|NCT04937543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91953230|NCT04937543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91953231|NCT04937543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91953232|NCT04937543|Cholinergic Agents|cholinergic agents|mesh-ancestor
91953233|NCT03442907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91953234|NCT04923737|Dexmedetomidine|dexmedetomidine|mesh-list
91953235|NCT04923737|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91953236|NCT04923737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953237|NCT04923737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953238|NCT04923737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953239|NCT04923737|Analgesics|analgesics|mesh-ancestor
91953240|NCT04923737|Sensory System Agents|sensory system agents|mesh-ancestor
91953256|NCT04921943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91953257|NCT04921943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953258|NCT04921943|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91953259|NCT04921943|Antitubercular Agents|antitubercular agents|mesh-ancestor
91953260|NCT04921943|Leprostatic Agents|leprostatic agents|mesh-ancestor
91953261|NCT04921943|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91953262|NCT04921943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953263|NCT04921943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953264|NCT04921943|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91953265|NCT04921943|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91953266|NCT04921943|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91953267|NCT04921943|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91953268|NCT04921943|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91953269|NCT04921943|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91953270|NCT02419508|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91953271|NCT02419508|Bimatoprost|bimatoprost|mesh-list
91953272|NCT02419508|Travoprost|travoprost|mesh-list
91953273|NCT02419508|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91953274|NCT02419508|Latanoprost|latanoprost|mesh-list
91953275|NCT02419508|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91953276|NCT02419508|Brinzolamide|brinzolamide|mesh-list
91953277|NCT02419508|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91953278|NCT02419508|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91953279|NCT02419508|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91953280|NCT02419508|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953281|NCT02419508|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953282|NCT02419508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953283|NCT02419508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953284|NCT02419508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953285|NCT02419508|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91953286|NCT02419508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953287|NCT03442283|Vitamins|vitamins|mesh-list
91953288|NCT03442283|Micronutrients|micronutrients|mesh-ancestor
91953289|NCT03442283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953290|NCT03441815|Histamine|histamine|mesh-list
91944644|NCT03475693|Ondansetron|ondansetron|mesh-list
91944645|NCT03475693|Magnesium Oxide|magnesium oxide|mesh-list
91944646|NCT03475693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91944647|NCT03475693|Analgesics|analgesics|mesh-ancestor
91944648|NCT03475693|Sensory System Agents|sensory system agents|mesh-ancestor
91953291|NCT03441815|Glutarimide|glutarimide|mesh-list
91953292|NCT03441815|Histamine Agonists|histamine agonists|mesh-ancestor
91953293|NCT03441815|Histamine Agents|histamine agents|mesh-ancestor
91953294|NCT03441815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953295|NCT03441815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953296|NCT03441815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953297|NCT03441815|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91953313|NCT02387762|Antimetabolites|antimetabolites|mesh-ancestor
91953314|NCT02387762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953315|NCT02387762|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953316|NCT02387762|Dermatologic Agents|dermatologic agents|mesh-ancestor
91953317|NCT02387762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953318|NCT02387762|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91953319|NCT02387762|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91953320|NCT02387762|Immunologic Factors|immunologic factors|mesh-ancestor
91953321|NCT02387762|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953322|NCT02387762|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91953323|NCT02418182|Acetaminophen|acetaminophen|mesh-list
91953324|NCT02418182|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953325|NCT02418182|Analgesics|analgesics|mesh-ancestor
91953326|NCT02418182|Sensory System Agents|sensory system agents|mesh-ancestor
91953327|NCT02418182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953328|NCT02418182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953329|NCT02418182|Antipyretics|antipyretics|mesh-ancestor
91953330|NCT02387372|Tazobactam|tazobactam|mesh-list
91953331|NCT02387372|Ceftolozane|ceftolozane|mesh-list
91953332|NCT02387372|Cephalosporins|cephalosporins|mesh-list
91953333|NCT02387372|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
91953334|NCT02387372|Penicillanic Acid|penicillanic acid|mesh-list
91953335|NCT02387372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91953336|NCT02387372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953337|NCT02387372|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91953338|NCT02387372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953339|NCT02387372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953340|NCT02387372|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91953341|NCT03446495|Trabectedin|trabectedin|mesh-list
91953342|NCT03446495|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91953343|NCT03446495|Alkylating Agents|alkylating agents|mesh-ancestor
91953344|NCT03446495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953345|NCT03446495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953346|NCT03441035|Anesthetics|anesthetics|mesh-list
91953347|NCT03441035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953348|NCT03441035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953349|NCT05105633|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91953350|NCT05105633|Tenecteplase|tenecteplase|mesh-list
91953351|NCT05105633|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91953352|NCT05105633|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91953353|NCT05105633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953354|NCT04807673|Paclitaxel|paclitaxel|mesh-list
91953355|NCT04807673|Pembrolizumab|pembrolizumab|mesh-list
91953356|NCT04807673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91953366|NCT02656173|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91953367|NCT02656173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91953368|NCT02656173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91953369|NCT02656173|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953370|NCT02656173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953371|NCT02656173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953372|NCT02656173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953373|NCT02656173|Urological Agents|urological agents|mesh-ancestor
91953374|NCT02656173|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91953375|NCT02656173|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91953376|NCT02656173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953377|NCT03440333|Pulmonary Surfactants|pulmonary surfactants|mesh-list
91953378|NCT03440333|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953379|NCT04418895|Leucovorin|leucovorin|mesh-list
91953380|NCT04418895|Fluorouracil|fluorouracil|mesh-list
91953381|NCT04418895|Capecitabine|capecitabine|mesh-list
91953382|NCT04418895|Oxaliplatin|oxaliplatin|mesh-list
91953383|NCT04418895|Levoleucovorin|levoleucovorin|mesh-list
91953384|NCT04418895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953385|NCT04418895|Antimetabolites|antimetabolites|mesh-ancestor
91953386|NCT04418895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953387|NCT04418895|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91953388|NCT04418895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953389|NCT04418895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91953390|NCT04418895|Immunologic Factors|immunologic factors|mesh-ancestor
91953391|NCT04418895|Antidotes|antidotes|mesh-ancestor
91953392|NCT04418895|Protective Agents|protective agents|mesh-ancestor
91953393|NCT04418895|Vitamin B Complex|vitamin b complex|mesh-ancestor
91953394|NCT04418895|Vitamins|vitamins|mesh-ancestor
91953395|NCT04418895|Micronutrients|micronutrients|mesh-ancestor
91953396|NCT04715633|Apatinib|apatinib|mesh-list
91953397|NCT04715633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91953398|NCT04715633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953399|NCT04715633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91953400|NCT04715633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953401|NCT04715633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953402|NCT04715633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953403|NCT03439943|Lixisenatide|lixisenatide|mesh-list
91953404|NCT03439943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91953405|NCT03439943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953406|NCT03439787|Epinephrine|epinephrine|mesh-list
91953407|NCT03439787|Bupivacaine|bupivacaine|mesh-list
91953408|NCT03439787|Anesthetics, Local|anesthetics, local|mesh-ancestor
91953409|NCT03439787|Anesthetics|anesthetics|mesh-ancestor
91953410|NCT03439787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953411|NCT03439787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953412|NCT03439787|Sensory System Agents|sensory system agents|mesh-ancestor
91953413|NCT03439787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953414|NCT03439787|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91953415|NCT03439787|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953416|NCT03439787|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953417|NCT03439787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953418|NCT03439787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953419|NCT03439787|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91953420|NCT03439787|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91953421|NCT03439787|Autonomic Agents|autonomic agents|mesh-ancestor
91953422|NCT03439787|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91953442|NCT04451447|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91953443|NCT04516941|Colchicine|colchicine|mesh-list
91953444|NCT04516941|Edoxaban|edoxaban|mesh-list
91953445|NCT04516941|Gout Suppressants|gout suppressants|mesh-ancestor
91953446|NCT04516941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953447|NCT04516941|Tubulin Modulators|tubulin modulators|mesh-ancestor
91953448|NCT04516941|Antimitotic Agents|antimitotic agents|mesh-ancestor
91953449|NCT04516941|Mitosis Modulators|mitosis modulators|mesh-ancestor
91953450|NCT04516941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953451|NCT04516941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953452|NCT04516941|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91953453|NCT04516941|Antithrombins|antithrombins|mesh-ancestor
91953454|NCT04516941|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91953455|NCT04516941|Protease Inhibitors|protease inhibitors|mesh-ancestor
91953456|NCT04516941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953457|NCT04516941|Anticoagulants|anticoagulants|mesh-ancestor
91953458|NCT03444467|Glucagon|glucagon|mesh-list
91953459|NCT03444467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91953460|NCT03444467|Hormones|hormones|mesh-ancestor
91953461|NCT03444467|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953462|NCT03444467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953463|NCT02657343|Trastuzumab|trastuzumab|mesh-list
91953464|NCT02657343|Fulvestrant|fulvestrant|mesh-list
91953465|NCT02657343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953466|NCT02657343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953467|NCT02657343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91953468|NCT02657343|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91953469|NCT02657343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91953470|NCT02657343|Hormone Antagonists|hormone antagonists|mesh-ancestor
91953471|NCT02657343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944650|NCT03475693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944651|NCT03475693|Antipyretics|antipyretics|mesh-ancestor
91944652|NCT03475693|Antiemetics|antiemetics|mesh-ancestor
91953472|NCT02657343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953473|NCT03445169|Belzutifan|belzutifan|mesh-list
91953474|NCT03445169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953475|NCT04542837|Lenvatinib|lenvatinib|mesh-list
91953476|NCT04542837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953477|NCT04542837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91953478|NCT04542837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953496|NCT03890133|Anticonvulsants|anticonvulsants|mesh-ancestor
91953497|NCT03890133|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91953498|NCT03890133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91953499|NCT03890133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953500|NCT03890133|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91953501|NCT03890133|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91953502|NCT03890133|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91953503|NCT03890133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953504|NCT03890133|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953505|NCT03871647|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91953506|NCT03871647|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91953507|NCT03871647|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953508|NCT03871647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953509|NCT03871647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953510|NCT03871647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953511|NCT03443921|Paclitaxel|paclitaxel|mesh-list
91953512|NCT03443921|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91953513|NCT03443921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953514|NCT03443921|Tubulin Modulators|tubulin modulators|mesh-ancestor
91953515|NCT03443921|Antimitotic Agents|antimitotic agents|mesh-ancestor
91953516|NCT03443921|Mitosis Modulators|mitosis modulators|mesh-ancestor
91953517|NCT03443921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953518|NCT03443843|Fluticasone|fluticasone|mesh-list
91953519|NCT03443843|Xhance|xhance|mesh-list
91953520|NCT03443843|Loratadine|loratadine|mesh-list
91953521|NCT03443843|Pseudoephedrine|pseudoephedrine|mesh-list
91953522|NCT03443843|Ephedrine|ephedrine|mesh-list
91953523|NCT03443843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953524|NCT03443843|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91953525|NCT03443843|Autonomic Agents|autonomic agents|mesh-ancestor
91953526|NCT03443843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953527|NCT03443843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953528|NCT03443843|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91953529|NCT03443843|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953530|NCT03443843|Dermatologic Agents|dermatologic agents|mesh-ancestor
91953531|NCT03443843|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91953532|NCT03443843|Antipruritics|antipruritics|mesh-ancestor
91953533|NCT03443843|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91953534|NCT03443843|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91953535|NCT03443843|Histamine Antagonists|histamine antagonists|mesh-ancestor
91953549|NCT03438227|Hematinics|hematinics|mesh-ancestor
91953550|NCT03433235|Edoxaban|edoxaban|mesh-list
91953551|NCT03433235|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91953552|NCT03433235|Antithrombins|antithrombins|mesh-ancestor
91953553|NCT03433235|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91953554|NCT03433235|Protease Inhibitors|protease inhibitors|mesh-ancestor
91953555|NCT03433235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953556|NCT03433235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953557|NCT03433235|Anticoagulants|anticoagulants|mesh-ancestor
91953558|NCT03783351|Clopidogrel|clopidogrel|mesh-list
91953559|NCT03783351|Ticagrelor|ticagrelor|mesh-list
91953560|NCT03783351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91953561|NCT03783351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91953562|NCT03783351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91953563|NCT03783351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91953564|NCT03783351|Purinergic Agents|purinergic agents|mesh-ancestor
91953565|NCT03783351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953566|NCT03783351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953567|NCT03783351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953568|NCT03342417|Nivolumab|nivolumab|mesh-list
91953569|NCT03342417|Ipilimumab|ipilimumab|mesh-list
91953570|NCT03342417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953571|NCT03342417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944653|NCT03475693|Autonomic Agents|autonomic agents|mesh-ancestor
91944654|NCT03475693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91944655|NCT03475693|Antipruritics|antipruritics|mesh-ancestor
91953572|NCT03342417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953573|NCT03342417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953574|NCT03234309|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91953575|NCT03234309|Hematinics|hematinics|mesh-ancestor
91953576|NCT03234309|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91953577|NCT03234309|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91953578|NCT02657031|Diphenhydramine|diphenhydramine|mesh-list
91953579|NCT02657031|Promethazine|promethazine|mesh-list
91953580|NCT02657031|Ketamine|ketamine|mesh-list
91953581|NCT02657031|Ondansetron|ondansetron|mesh-list
91953582|NCT02657031|Prochlorperazine|prochlorperazine|mesh-list
91953583|NCT02657031|Analgesics|analgesics|mesh-ancestor
91953584|NCT02657031|Sensory System Agents|sensory system agents|mesh-ancestor
91953585|NCT02657031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953586|NCT02657031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953587|NCT02657031|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91953588|NCT02657031|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91953589|NCT02657031|Anesthetics, General|anesthetics, general|mesh-ancestor
91953590|NCT02657031|Anesthetics|anesthetics|mesh-ancestor
91953591|NCT02657031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953592|NCT02657031|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91953593|NCT02657031|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91953594|NCT02657031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953595|NCT02657031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953596|NCT02657031|Antiemetics|antiemetics|mesh-ancestor
91953597|NCT02657031|Autonomic Agents|autonomic agents|mesh-ancestor
91953598|NCT02657031|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91953613|NCT02657031|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953614|NCT02657031|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91953615|NCT02657031|Dopamine Agents|dopamine agents|mesh-ancestor
91953616|NCT04944953|Botulinum Toxins|botulinum toxins|mesh-list
91953617|NCT04944953|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91953618|NCT04944953|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91953619|NCT04944953|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91953620|NCT04944953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91953621|NCT04944953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953622|NCT04944953|Cholinergic Agents|cholinergic agents|mesh-ancestor
91953623|NCT04944953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953624|NCT04944953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953625|NCT04944953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91953626|NCT04944953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953627|NCT03433001|Dexamethasone|dexamethasone|mesh-list
91953628|NCT03433001|Lenalidomide|lenalidomide|mesh-list
91953630|NCT03433001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953631|NCT03433001|Antiemetics|antiemetics|mesh-ancestor
91953632|NCT03433001|Autonomic Agents|autonomic agents|mesh-ancestor
91953633|NCT03433001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953634|NCT03433001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953635|NCT03433001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91953636|NCT03433001|Glucocorticoids|glucocorticoids|mesh-ancestor
91953637|NCT03433001|Hormones|hormones|mesh-ancestor
91953638|NCT03433001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953639|NCT03433001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91953640|NCT03433001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953641|NCT03433001|Immunologic Factors|immunologic factors|mesh-ancestor
91953642|NCT03433001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91953643|NCT03433001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91953644|NCT03433001|Growth Substances|growth substances|mesh-ancestor
91953645|NCT03433001|Growth Inhibitors|growth inhibitors|mesh-ancestor
91953646|NCT03433001|Protease Inhibitors|protease inhibitors|mesh-ancestor
91953647|NCT03433001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953648|NCT03433001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953649|NCT03797469|Niacinamide|niacinamide|mesh-list
91953651|NCT03797469|Nicotinic Acids|nicotinic acids|mesh-list
91953652|NCT03797469|Vitamins|vitamins|mesh-ancestor
91953653|NCT03797469|Micronutrients|micronutrients|mesh-ancestor
91953654|NCT03797469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953655|NCT03797469|Vitamin B Complex|vitamin b complex|mesh-ancestor
91953656|NCT03797469|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91953657|NCT03797469|Antimetabolites|antimetabolites|mesh-ancestor
91953658|NCT03797469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953659|NCT03797469|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91953675|NCT02384577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91953676|NCT02384577|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953677|NCT02384577|Glucocorticoids|glucocorticoids|mesh-ancestor
91953678|NCT02384577|Hormones|hormones|mesh-ancestor
91953679|NCT02384577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953680|NCT02384577|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91953681|NCT02384577|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91953682|NCT02384577|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953683|NCT02384577|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953684|NCT02384577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953685|NCT02384577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953686|NCT03437213|Anesthetics|anesthetics|mesh-list
91953687|NCT03437213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953688|NCT03437213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953689|NCT02030457|Beclomethasone|beclomethasone|mesh-list
91953690|NCT02030457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953691|NCT02030457|Glucocorticoids|glucocorticoids|mesh-ancestor
91953692|NCT02030457|Hormones|hormones|mesh-ancestor
91953693|NCT02030457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953694|NCT02030457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953695|NCT02030457|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91953696|NCT02030457|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953698|NCT03432767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91953699|NCT03432767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953700|NCT03432767|Analgesics|analgesics|mesh-ancestor
91953701|NCT03432767|Sensory System Agents|sensory system agents|mesh-ancestor
91953702|NCT03432767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953703|NCT03432767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953704|NCT03432767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953705|NCT03432767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953706|NCT03437057|Aspirin|aspirin|mesh-list
91953707|NCT03437057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91953708|NCT03437057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953709|NCT03437057|Analgesics|analgesics|mesh-ancestor
91953710|NCT03437057|Sensory System Agents|sensory system agents|mesh-ancestor
91953711|NCT03437057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953712|NCT03437057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953713|NCT03437057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953714|NCT03437057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953715|NCT03437057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91953716|NCT03437057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91953717|NCT03437057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953718|NCT03437057|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91953719|NCT03437057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91953738|NCT03432689|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91953739|NCT03432689|Antitubercular Agents|antitubercular agents|mesh-ancestor
91953740|NCT03432689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91953741|NCT03432689|Antimetabolites|antimetabolites|mesh-ancestor
91953742|NCT03432689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953744|NCT02991807|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91953745|NCT02991807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91953746|NCT02991807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953747|NCT02991807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953748|NCT02991807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91953749|NCT02991807|Immunologic Factors|immunologic factors|mesh-ancestor
91953750|NCT02991807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953751|NCT02991807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953752|NCT04380311|Tacrolimus|tacrolimus|mesh-list
91953753|NCT04380311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91953754|NCT04380311|Immunologic Factors|immunologic factors|mesh-ancestor
91953755|NCT04380311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953756|NCT04380311|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91953757|NCT04380311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953758|NCT04380311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953759|NCT05018013|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91944656|NCT03475693|Dermatologic Agents|dermatologic agents|mesh-ancestor
91944657|NCT03475693|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91944658|NCT03475693|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91944659|NCT03475693|Serotonin Agents|serotonin agents|mesh-ancestor
91944660|NCT03475693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944661|NCT03475693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953760|NCT05018013|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91953761|NCT05018013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91953762|NCT05018013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91953763|NCT05018013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953764|NCT05018013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953765|NCT05018013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953766|NCT05018013|Analgesics|analgesics|mesh-ancestor
91953767|NCT05018013|Sensory System Agents|sensory system agents|mesh-ancestor
91953768|NCT05018013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953769|NCT05018013|Antidepressive Agents|antidepressive agents|mesh-ancestor
91953770|NCT05018013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953771|NCT05018013|Dopamine Agents|dopamine agents|mesh-ancestor
91953772|NCT03432221|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
91953773|NCT03432221|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91953774|NCT03432221|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91953775|NCT03432221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91953776|NCT03432221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953788|NCT04360421|Sensory System Agents|sensory system agents|mesh-ancestor
91953789|NCT04360421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953790|NCT02387216|Docetaxel|docetaxel|mesh-list
91953791|NCT02387216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953792|NCT02387216|Tubulin Modulators|tubulin modulators|mesh-ancestor
91953793|NCT02387216|Antimitotic Agents|antimitotic agents|mesh-ancestor
91953794|NCT02387216|Mitosis Modulators|mitosis modulators|mesh-ancestor
91953795|NCT02387216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953796|NCT03431909|Aspirin|aspirin|mesh-list
91953797|NCT03431909|Kallikreins|kallikreins|mesh-list
91953798|NCT03431909|Clopidogrel|clopidogrel|mesh-list
91953799|NCT03431909|Atorvastatin|atorvastatin|mesh-list
91953800|NCT03431909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91953801|NCT03431909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953802|NCT03431909|Analgesics|analgesics|mesh-ancestor
91953803|NCT03431909|Sensory System Agents|sensory system agents|mesh-ancestor
91953804|NCT03431909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953805|NCT03431909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953806|NCT03431909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953807|NCT03431909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953808|NCT03431909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91953809|NCT03431909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91953810|NCT03431909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953811|NCT03431909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91953812|NCT03431909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91953813|NCT03431909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953814|NCT03431909|Antipyretics|antipyretics|mesh-ancestor
91953815|NCT03431909|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91953816|NCT03431909|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91953817|NCT03431909|Antimetabolites|antimetabolites|mesh-ancestor
91953818|NCT03431909|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91953819|NCT03431909|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91953820|NCT03431909|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91953821|NCT03431909|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91953822|NCT03431909|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91953823|NCT03431909|Purinergic Agents|purinergic agents|mesh-ancestor
91953824|NCT03431909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953825|NCT03431909|Coagulants|coagulants|mesh-ancestor
91953826|NCT03431909|Fertility Agents, Male|fertility agents, male|mesh-ancestor
91953827|NCT03431909|Fertility Agents|fertility agents|mesh-ancestor
91953828|NCT03431909|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91953829|NCT03436121|Midazolam|midazolam|mesh-list
91944662|NCT03475693|Antacids|antacids|mesh-ancestor
91944663|NCT05156749|Calpastatin|calpastatin|mesh-list
91953830|NCT03436121|Ketamine|ketamine|mesh-list
91953831|NCT03436121|Analgesics|analgesics|mesh-ancestor
91953832|NCT03436121|Sensory System Agents|sensory system agents|mesh-ancestor
91953833|NCT03436121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953834|NCT03436121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953835|NCT03436121|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91953836|NCT03436121|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91953837|NCT03436121|Anesthetics, General|anesthetics, general|mesh-ancestor
91953838|NCT03436121|Anesthetics|anesthetics|mesh-ancestor
91953839|NCT03436121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953840|NCT03436121|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91953857|NCT02417246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953858|NCT02417246|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91953859|NCT02417246|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91953860|NCT02417246|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91953861|NCT02417246|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953862|NCT02417246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953863|NCT02417246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953865|NCT03431675|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91953866|NCT03431675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953867|NCT03431675|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91953868|NCT03431675|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91953869|NCT03431675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953870|NCT03431675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953871|NCT03431675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953872|NCT03431675|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91953873|NCT03431675|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91953874|NCT02424734|Ampicillin|ampicillin|mesh-list
91953875|NCT02424734|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
91953876|NCT02424734|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91953877|NCT02424734|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953879|NCT03431597|Trace Elements|trace elements|mesh-list
91953880|NCT03431597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953881|NCT02424578|Diclofenac|diclofenac|mesh-list
91953882|NCT02424578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91953883|NCT02424578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953884|NCT02424578|Analgesics|analgesics|mesh-ancestor
91953885|NCT02424578|Sensory System Agents|sensory system agents|mesh-ancestor
91953886|NCT02424578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953887|NCT02424578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953888|NCT02424578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953889|NCT02424578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953890|NCT02424578|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91953891|NCT02424578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953892|NCT02424578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953893|NCT03431285|Ketamine|ketamine|mesh-list
91953894|NCT03431285|Morphine|morphine|mesh-list
91953895|NCT03431285|Analgesics|analgesics|mesh-ancestor
91953896|NCT03431285|Sensory System Agents|sensory system agents|mesh-ancestor
91953897|NCT03431285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953898|NCT03431285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953899|NCT03431285|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91953919|NCT02416934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953921|NCT02416934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953922|NCT02819635|Upadacitinib|upadacitinib|mesh-list
91953923|NCT02819635|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91953924|NCT02819635|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91953925|NCT02819635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953926|NCT02819635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953927|NCT02819635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953928|NCT03874325|Durvalumab|durvalumab|mesh-list
91953929|NCT03874325|Letrozole|letrozole|mesh-list
91953930|NCT03874325|Anastrozole|anastrozole|mesh-list
91953931|NCT03874325|Exemestane|exemestane|mesh-list
91953932|NCT03874325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953933|NCT03874325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953934|NCT03874325|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91953935|NCT03874325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91953936|NCT03874325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944664|NCT05156749|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
91944665|NCT05156749|Protease Inhibitors|protease inhibitors|mesh-ancestor
91944666|NCT05156749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944667|NCT05156749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953937|NCT03874325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953938|NCT03874325|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91953939|NCT03874325|Hormone Antagonists|hormone antagonists|mesh-ancestor
91953940|NCT03874325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953941|NCT03874325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953942|NCT03874325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91953943|NCT02424344|Formoterol Fumarate|formoterol fumarate|mesh-list
91953944|NCT02424344|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91953945|NCT02424344|Autonomic Agents|autonomic agents|mesh-ancestor
91953946|NCT02424344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954086|NCT03428633|Narcotics|narcotics|mesh-ancestor
91953947|NCT02424344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953948|NCT02424344|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91953949|NCT02424344|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953950|NCT02424344|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91953951|NCT02424344|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91953952|NCT02424344|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953953|NCT02424344|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953979|NCT03430817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953980|NCT03430817|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953981|NCT03430817|Analgesics|analgesics|mesh-ancestor
91953982|NCT03430817|Sensory System Agents|sensory system agents|mesh-ancestor
91953983|NCT03430817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953984|NCT03430817|Nootropic Agents|nootropic agents|mesh-ancestor
91953985|NCT02383940|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
91953986|NCT02383940|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91953987|NCT02383940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953988|NCT02383940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91953989|NCT02383940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953990|NCT03799835|Atezolizumab|atezolizumab|mesh-list
91953991|NCT03799835|BCG Vaccine|bcg vaccine|mesh-list
91953992|NCT03799835|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953993|NCT03799835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953994|NCT03799835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953995|NCT03799835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953996|NCT03799835|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91953997|NCT03799835|Immunologic Factors|immunologic factors|mesh-ancestor
91953998|NCT03799835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953999|NCT03430505|Albuterol|albuterol|mesh-list
91954000|NCT03430505|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91954044|NCT03429179|Narcotics|narcotics|mesh-ancestor
91954045|NCT03429179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954046|NCT03429179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954047|NCT03429179|Analgesics|analgesics|mesh-ancestor
91954048|NCT03429179|Sensory System Agents|sensory system agents|mesh-ancestor
91954049|NCT03429179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954050|NCT03429179|Antitussive Agents|antitussive agents|mesh-ancestor
91954051|NCT03429179|Respiratory System Agents|respiratory system agents|mesh-ancestor
91954052|NCT03429179|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91954053|NCT03429101|Trastuzumab|trastuzumab|mesh-list
91954054|NCT03429101|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
91954055|NCT03429101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91954056|NCT03429101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954057|NCT03429101|Tubulin Modulators|tubulin modulators|mesh-ancestor
91954058|NCT03429101|Antimitotic Agents|antimitotic agents|mesh-ancestor
91954059|NCT03429101|Mitosis Modulators|mitosis modulators|mesh-ancestor
91954060|NCT03429101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954061|NCT03429101|Immunotoxins|immunotoxins|mesh-ancestor
91954062|NCT03429101|Immunoconjugates|immunoconjugates|mesh-ancestor
91954063|NCT03429101|Immunologic Factors|immunologic factors|mesh-ancestor
91954064|NCT03429101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954065|NCT04048343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91954066|NCT04048343|Immunologic Factors|immunologic factors|mesh-ancestor
91944669|NCT03475615|Oxaliplatin|oxaliplatin|mesh-list
91944670|NCT03475615|Tegafur|tegafur|mesh-list
91954067|NCT04048343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954068|NCT04016753|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
91954069|NCT04016753|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91954070|NCT04016753|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91954071|NCT04016753|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91954072|NCT04016753|Contraceptive Agents|contraceptive agents|mesh-ancestor
91954073|NCT04016753|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91954074|NCT04016753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954075|NCT04016753|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91954076|NCT04016753|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91954077|NCT04016753|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
91954078|NCT04016753|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91954079|NCT02732639|Interferons|interferons|mesh-list
91954080|NCT02732639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954081|NCT02732639|Antiviral Agents|antiviral agents|mesh-ancestor
91954082|NCT02732639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954084|NCT03428633|Ropivacaine|ropivacaine|mesh-list
91954085|NCT03428633|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954087|NCT03428633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954088|NCT03428633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954089|NCT03428633|Analgesics|analgesics|mesh-ancestor
91954090|NCT03428633|Sensory System Agents|sensory system agents|mesh-ancestor
91954091|NCT03428633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954092|NCT03428633|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954093|NCT03428633|Anesthetics|anesthetics|mesh-ancestor
91954094|NCT02412878|Dexamethasone|dexamethasone|mesh-list
91954095|NCT02412878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954109|NCT03423329|Analgesics|analgesics|mesh-ancestor
91954110|NCT03423329|Sensory System Agents|sensory system agents|mesh-ancestor
91954111|NCT03423329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954112|NCT03423329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954113|NCT03423329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954114|NCT03423329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954115|NCT03423329|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91954116|NCT03423329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954117|NCT03423329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954119|NCT02380742|Prilocaine|prilocaine|mesh-list
91954120|NCT02380742|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
91954121|NCT02380742|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954122|NCT02380742|Anesthetics|anesthetics|mesh-ancestor
91954123|NCT02380742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954124|NCT02380742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954125|NCT02380742|Sensory System Agents|sensory system agents|mesh-ancestor
91954126|NCT02380742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954127|NCT02380742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91954128|NCT02380742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91954129|NCT02380742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91954130|NCT02380742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954131|NCT02380742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954132|NCT02380742|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
91954133|NCT02944019|Edoxaban|edoxaban|mesh-list
91954134|NCT02944019|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91954135|NCT02944019|Antithrombins|antithrombins|mesh-ancestor
91954136|NCT02944019|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91954137|NCT02944019|Protease Inhibitors|protease inhibitors|mesh-ancestor
91954138|NCT02944019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954139|NCT02944019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954140|NCT02944019|Anticoagulants|anticoagulants|mesh-ancestor
91954141|NCT02022059|Lidocaine|lidocaine|mesh-list
91954142|NCT02022059|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954143|NCT02022059|Anesthetics|anesthetics|mesh-ancestor
91954144|NCT02022059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954145|NCT02022059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954146|NCT02022059|Sensory System Agents|sensory system agents|mesh-ancestor
91954147|NCT02022059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954148|NCT02022059|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91954149|NCT02022059|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91944671|NCT03475615|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91944672|NCT03475615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954150|NCT02022059|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91954151|NCT02022059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954152|NCT02022059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954153|NCT02922725|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
91954154|NCT02922725|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91954167|NCT03427385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954168|NCT03427385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954169|NCT03427385|Sensory System Agents|sensory system agents|mesh-ancestor
91954170|NCT03427385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954171|NCT03427229|Vancomycin|vancomycin|mesh-list
91954172|NCT03427229|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954173|NCT03427229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954174|NCT04449185|Amoxicillin|amoxicillin|mesh-list
91954175|NCT04449185|Clarithromycin|clarithromycin|mesh-list
91954176|NCT04449185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954177|NCT04449185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954178|NCT04449185|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91954179|NCT04449185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954180|NCT04449185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954181|NCT04449185|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91954182|NCT04449185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91954183|NCT03426761|Vancomycin|vancomycin|mesh-list
91954184|NCT03426761|Cefazolin|cefazolin|mesh-list
91954185|NCT03426761|Daptomycin|daptomycin|mesh-list
91954186|NCT03426761|Dalbavancin|dalbavancin|mesh-list
91954187|NCT03426761|Nafcillin|nafcillin|mesh-list
91954188|NCT03426761|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954189|NCT03426761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954190|NCT03426527|Dexmedetomidine|dexmedetomidine|mesh-list
91954191|NCT03426527|Levobupivacaine|levobupivacaine|mesh-list
91954192|NCT03426527|Anesthetics|anesthetics|mesh-ancestor
91954193|NCT03426527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954194|NCT03426527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954196|NCT03426527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954197|NCT03426527|Analgesics|analgesics|mesh-ancestor
91954198|NCT03426527|Sensory System Agents|sensory system agents|mesh-ancestor
91954199|NCT03426527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954200|NCT03426527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91954201|NCT03426527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91954202|NCT03426527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91954203|NCT03426527|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954204|NCT03426527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954205|NCT03426527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954206|NCT03426527|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954207|NCT02805257|Mitomycins|mitomycins|mesh-list
91954208|NCT02805257|Mitomycin|mitomycin|mesh-list
91954209|NCT02805257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91954210|NCT02805257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954211|NCT02805257|Alkylating Agents|alkylating agents|mesh-ancestor
91954212|NCT02805257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954213|NCT02805257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91954214|NCT02805257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954215|NCT02636387|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
91954216|NCT02636387|Hemostatics|hemostatics|mesh-ancestor
91954217|NCT02636387|Coagulants|coagulants|mesh-ancestor
91954218|NCT02636387|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
91954219|NCT02636387|Natriuretic Agents|natriuretic agents|mesh-ancestor
91954235|NCT03425669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954236|NCT03425669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954237|NCT03425669|Dopamine Agents|dopamine agents|mesh-ancestor
91954238|NCT03425669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954239|NCT03424889|Xylometazoline|xylometazoline|mesh-list
91954240|NCT03424889|Nasal Decongestants|nasal decongestants|mesh-ancestor
91954241|NCT03424889|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91954242|NCT03424889|Respiratory System Agents|respiratory system agents|mesh-ancestor
91954243|NCT03424733|Acetaminophen|acetaminophen|mesh-list
91954244|NCT03424733|Interferons|interferons|mesh-list
91954245|NCT03424733|Interferon-beta|interferon-beta|mesh-list
91954246|NCT03424733|Interferon beta-1a|interferon beta-1a|mesh-list
91954247|NCT03424733|Prednisone|prednisone|mesh-list
91944673|NCT03475615|Tubulin Modulators|tubulin modulators|mesh-ancestor
91944674|NCT03475615|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944675|NCT03475615|Mitosis Modulators|mitosis modulators|mesh-ancestor
91944676|NCT03475615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954248|NCT03424733|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954249|NCT03424733|Glucocorticoids|glucocorticoids|mesh-ancestor
91954250|NCT03424733|Hormones|hormones|mesh-ancestor
91954251|NCT03424733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954252|NCT03424733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954253|NCT03424733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91954254|NCT03424733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954255|NCT03424733|Antiviral Agents|antiviral agents|mesh-ancestor
91954256|NCT03424733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954257|NCT03424733|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954258|NCT03424733|Analgesics|analgesics|mesh-ancestor
91954259|NCT03424733|Sensory System Agents|sensory system agents|mesh-ancestor
91954260|NCT03424733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954261|NCT03424733|Antipyretics|antipyretics|mesh-ancestor
91954262|NCT03424733|Immunologic Factors|immunologic factors|mesh-ancestor
91954263|NCT03424733|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91954264|NCT03423797|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91954265|NCT03441841|Lidocaine|lidocaine|mesh-list
91954266|NCT03441841|Prilocaine|prilocaine|mesh-list
91954267|NCT03441841|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
91954268|NCT03441841|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954269|NCT03441841|Anesthetics|anesthetics|mesh-ancestor
91954270|NCT03441841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954271|NCT03441841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954272|NCT03441841|Sensory System Agents|sensory system agents|mesh-ancestor
91954483|NCT03436225|Hormones|hormones|mesh-ancestor
91954273|NCT03441841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954274|NCT03441841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91954275|NCT03441841|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91954276|NCT03441841|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91954277|NCT03441841|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954296|NCT02692339|Growth Substances|growth substances|mesh-ancestor
91954297|NCT02692339|Growth Inhibitors|growth inhibitors|mesh-ancestor
91954298|NCT03444025|Goserelin|goserelin|mesh-list
91954299|NCT03444025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91954300|NCT03444025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954301|NCT03438253|Anesthetics|anesthetics|mesh-list
91954302|NCT03438253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954303|NCT03438253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954304|NCT02535325|Cisplatin|cisplatin|mesh-list
91954305|NCT02535325|Pemetrexed|pemetrexed|mesh-list
91954306|NCT02535325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954307|NCT02535325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954308|NCT02535325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954309|NCT02535325|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91954310|NCT02535325|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91954311|NCT03441529|Tazobactam|tazobactam|mesh-list
91954312|NCT03441529|Piperacillin|piperacillin|mesh-list
91954313|NCT03441529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91954314|NCT03441529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954315|NCT03441529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954316|NCT03441529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91954317|NCT03441529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954318|NCT03441529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954319|NCT03441373|Histamine|histamine|mesh-list
91954320|NCT03441373|Histamine phosphate|histamine phosphate|mesh-list
91954321|NCT03441373|Glutarimide|glutarimide|mesh-list
91954322|NCT03441373|Histamine Agonists|histamine agonists|mesh-ancestor
91954323|NCT03441373|Histamine Agents|histamine agents|mesh-ancestor
91954324|NCT03441373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954325|NCT03441373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954326|NCT03441373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954327|NCT03441373|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91954328|NCT03441373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954329|NCT03449797|Hydrocortisone|hydrocortisone|mesh-list
91944677|NCT03475615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944678|NCT03475615|Antimetabolites|antimetabolites|mesh-ancestor
91954330|NCT03449797|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
91954331|NCT03449797|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
91954332|NCT03449797|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91954333|NCT03449797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954352|NCT03437785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954353|NCT03437785|Protective Agents|protective agents|mesh-ancestor
91954354|NCT03437785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954356|NCT03437707|Ibuprofen|ibuprofen|mesh-list
91954357|NCT03437707|Morphine|morphine|mesh-list
91954358|NCT03437707|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954359|NCT03437707|Narcotics|narcotics|mesh-ancestor
91954360|NCT03437707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954361|NCT03437707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954362|NCT03437707|Analgesics|analgesics|mesh-ancestor
91954363|NCT03437707|Sensory System Agents|sensory system agents|mesh-ancestor
91954364|NCT03437707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954365|NCT03437707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954366|NCT03437707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954367|NCT03437707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954368|NCT03437707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954369|NCT03437707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91954370|NCT03437707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954371|NCT03437707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954372|NCT03437707|Antipyretics|antipyretics|mesh-ancestor
91954373|NCT03437629|Calcium|calcium|mesh-list
91954374|NCT03437629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91954375|NCT03437629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954376|NCT03437473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91954377|NCT03437473|Cholinergic Agents|cholinergic agents|mesh-list
91954378|NCT03437473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954379|NCT03437473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954380|NCT03437473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954381|NCT03441217|Scopolamine|scopolamine|mesh-list
91954382|NCT03441217|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
91954383|NCT03441217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91954384|NCT03441217|Antiemetics|antiemetics|mesh-ancestor
91954385|NCT03441217|Autonomic Agents|autonomic agents|mesh-ancestor
91954386|NCT03441217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954387|NCT03441217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954398|NCT03128515|Antisickling Agents|antisickling agents|mesh-ancestor
91954399|NCT03128515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954400|NCT03128515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954401|NCT03128515|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91954403|NCT02521441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91954404|NCT02521441|Immunologic Factors|immunologic factors|mesh-ancestor
91954405|NCT02521441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954406|NCT04451239|Cyclosporine|cyclosporine|mesh-list
91954407|NCT04451239|Cyclosporins|cyclosporins|mesh-list
91954408|NCT04451239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954409|NCT04451239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954410|NCT04451239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91954411|NCT04451239|Immunologic Factors|immunologic factors|mesh-ancestor
91954412|NCT04451239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954413|NCT04451239|Antifungal Agents|antifungal agents|mesh-ancestor
91954414|NCT04451239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954415|NCT04451239|Dermatologic Agents|dermatologic agents|mesh-ancestor
91954416|NCT04451239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954417|NCT04451239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91954418|NCT03440515|Prednisone|prednisone|mesh-list
91954419|NCT03440515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954420|NCT03440515|Glucocorticoids|glucocorticoids|mesh-ancestor
91954421|NCT03440515|Hormones|hormones|mesh-ancestor
91954422|NCT03440515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954423|NCT03440515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954424|NCT03440515|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91954425|NCT03440515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954426|NCT03432793|Itraconazole|itraconazole|mesh-list
91954427|NCT03432793|Fluvoxamine|fluvoxamine|mesh-list
91954428|NCT03432793|Caffeine|caffeine|mesh-list
91954429|NCT03432793|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91944679|NCT03478423|Oxycodone|oxycodone|mesh-list
91944680|NCT03478423|Hydromorphone|hydromorphone|mesh-list
91944681|NCT03478423|Codeine|codeine|mesh-list
91954430|NCT03432793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954431|NCT03432793|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91954432|NCT03432793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954433|NCT03432793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954434|NCT03432793|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91954435|NCT03432793|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91954436|NCT03432793|Purinergic Agents|purinergic agents|mesh-ancestor
91954437|NCT03432793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954438|NCT03432793|Antifungal Agents|antifungal agents|mesh-ancestor
91954439|NCT03432793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954440|NCT03432793|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91954441|NCT03432793|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91954442|NCT03432793|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91954443|NCT03432793|Hormone Antagonists|hormone antagonists|mesh-ancestor
91954444|NCT03432793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954445|NCT03432793|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91954446|NCT03432793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91954447|NCT03432793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91954448|NCT03432793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954449|NCT03432793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91954467|NCT03436303|Progestins|progestins|mesh-ancestor
91954469|NCT03436303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954470|NCT03436303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954471|NCT03436225|Dexamethasone|dexamethasone|mesh-list
91954472|NCT03436225|Dexamethasone acetate|dexamethasone acetate|mesh-list
91954473|NCT03436225|Budesonide|budesonide|mesh-list
91954474|NCT03436225|Albuterol|albuterol|mesh-list
91954475|NCT03436225|BB 1101|bb 1101|mesh-list
91954476|NCT03436225|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954477|NCT03436225|Antiemetics|antiemetics|mesh-ancestor
91954478|NCT03436225|Autonomic Agents|autonomic agents|mesh-ancestor
91954479|NCT03436225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954480|NCT03436225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954481|NCT03436225|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954482|NCT03436225|Glucocorticoids|glucocorticoids|mesh-ancestor
91954484|NCT03436225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954485|NCT03436225|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91954486|NCT03436225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954487|NCT03436225|Protease Inhibitors|protease inhibitors|mesh-ancestor
91954488|NCT03436225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954489|NCT03436225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954490|NCT03436225|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91954491|NCT03436225|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91954492|NCT03436225|Respiratory System Agents|respiratory system agents|mesh-ancestor
91954493|NCT03436225|Tocolytic Agents|tocolytic agents|mesh-ancestor
91954494|NCT03436225|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91954495|NCT03436225|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91954496|NCT03436225|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91954497|NCT03436225|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91954498|NCT03436225|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954499|NCT03436225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954500|NCT03440359|Letrozole|letrozole|mesh-list
91954501|NCT03440359|Progesterone|progesterone|mesh-list
91954502|NCT03440359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954503|NCT03440359|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91954525|NCT04451083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954526|NCT04451083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954527|NCT04451083|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91954528|NCT04451083|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91954529|NCT03435289|Paclitaxel|paclitaxel|mesh-list
91954530|NCT03435289|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91954531|NCT03435289|Gemcitabine|gemcitabine|mesh-list
91954532|NCT03435289|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91954533|NCT03435289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954534|NCT03435289|Tubulin Modulators|tubulin modulators|mesh-ancestor
91954535|NCT03435289|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944682|NCT03478423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954536|NCT03435289|Mitosis Modulators|mitosis modulators|mesh-ancestor
91954537|NCT03435289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954538|NCT03435289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91954539|NCT03435289|Antimetabolites|antimetabolites|mesh-ancestor
91954540|NCT03435133|Ticagrelor|ticagrelor|mesh-list
91954541|NCT03435133|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91954542|NCT03435133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91954543|NCT03435133|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91954544|NCT03435133|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91954545|NCT03435133|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91954546|NCT03435133|Purinergic Agents|purinergic agents|mesh-ancestor
91954547|NCT03435133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954548|NCT03435133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954549|NCT03435133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954550|NCT03431077|Angiotensin II|angiotensin ii|mesh-list
91954551|NCT03431077|Giapreza|giapreza|mesh-list
91954552|NCT03431077|Angiotensinogen|angiotensinogen|mesh-list
91954553|NCT03431077|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91954554|NCT03431077|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91954555|NCT03431077|Protease Inhibitors|protease inhibitors|mesh-ancestor
91954556|NCT03431077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954557|NCT03431077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954591|NCT03434197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954592|NCT03430609|Hormones|hormones|mesh-list
91954593|NCT03430609|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954594|NCT03430609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954595|NCT03438955|Telmisartan|telmisartan|mesh-list
91954596|NCT03438955|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91954630|NCT01559363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954631|NCT01559363|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91954632|NCT01559363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954633|NCT01559363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954635|NCT03569839|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91954636|NCT03569839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954637|NCT03569839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954638|NCT03569839|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91954639|NCT03569839|Anesthetics, General|anesthetics, general|mesh-ancestor
91954640|NCT03569839|Anesthetics|anesthetics|mesh-ancestor
91954641|NCT01504919|Nicotine|nicotine|mesh-list
91954642|NCT01504919|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91954643|NCT01504919|Autonomic Agents|autonomic agents|mesh-ancestor
91954644|NCT01504919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954645|NCT01504919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954646|NCT01504919|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91954647|NCT01504919|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91954648|NCT01504919|Cholinergic Agents|cholinergic agents|mesh-ancestor
91954649|NCT01504919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954668|NCT03428503|Sensory System Agents|sensory system agents|mesh-ancestor
91954669|NCT03428503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954670|NCT03428503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954671|NCT03428503|Antipyretics|antipyretics|mesh-ancestor
91954672|NCT03428503|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954673|NCT03428503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954674|NCT03428503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954675|NCT03428425|Paclitaxel|paclitaxel|mesh-list
91954676|NCT03428425|Apatinib|apatinib|mesh-list
91954677|NCT03428425|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91954678|NCT03428425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954679|NCT03428425|Tubulin Modulators|tubulin modulators|mesh-ancestor
91954680|NCT03428425|Antimitotic Agents|antimitotic agents|mesh-ancestor
91954681|NCT03428425|Mitosis Modulators|mitosis modulators|mesh-ancestor
91954682|NCT03428425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954683|NCT03428425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91954684|NCT03428425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954685|NCT03416777|Tocopherols|tocopherols|mesh-list
91954686|NCT03416777|Vitamin E|vitamin e|mesh-list
91954687|NCT03416777|Tocotrienols|tocotrienols|mesh-list
91954688|NCT03416777|alpha-Tocopherol|alpha-tocopherol|mesh-list
91954689|NCT03416777|Antioxidants|antioxidants|mesh-ancestor
91944683|NCT03478423|Narcotics|narcotics|mesh-ancestor
91944684|NCT03478423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944685|NCT03478423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954690|NCT03416777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954691|NCT03416777|Protective Agents|protective agents|mesh-ancestor
91954692|NCT03416777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954693|NCT03416777|Vitamins|vitamins|mesh-ancestor
91954694|NCT03416777|Micronutrients|micronutrients|mesh-ancestor
91954695|NCT03429439|Antiviral Agents|antiviral agents|mesh-list
91954696|NCT03429439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954698|NCT03422887|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
91954699|NCT03422887|Nalbuphine|nalbuphine|mesh-list
91954700|NCT03422887|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954701|NCT03422887|Narcotics|narcotics|mesh-ancestor
91954702|NCT03422887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954703|NCT03422887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954704|NCT03422887|Analgesics|analgesics|mesh-ancestor
91954705|NCT03422887|Sensory System Agents|sensory system agents|mesh-ancestor
91954706|NCT03422887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954707|NCT03422887|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954708|NCT03422887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954731|NCT03179605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954732|NCT03173053|Chlorhexidine|chlorhexidine|mesh-list
91954733|NCT03173053|Povidone-Iodine|povidone-iodine|mesh-list
91954734|NCT03173053|Clarithromycin|clarithromycin|mesh-list
91954735|NCT03173053|Doxycycline|doxycycline|mesh-list
91954736|NCT03173053|Ciprofloxacin|ciprofloxacin|mesh-list
91954737|NCT03173053|Rifampin|rifampin|mesh-list
91954738|NCT03173053|Clindamycin|clindamycin|mesh-list
91954739|NCT03173053|Trimethoprim|trimethoprim|mesh-list
91954740|NCT03173053|Sulfamethoxazole|sulfamethoxazole|mesh-list
91954741|NCT03173053|Mupirocin|mupirocin|mesh-list
91954742|NCT03173053|Fusidic Acid|fusidic acid|mesh-list
91954743|NCT03173053|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91954744|NCT03173053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91954745|NCT03173053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954746|NCT03173053|Disinfectants|disinfectants|mesh-ancestor
91954748|NCT03173053|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91954749|NCT03173053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954750|NCT03173053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954751|NCT03173053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91954752|NCT03173053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91954753|NCT03173053|Antimalarials|antimalarials|mesh-ancestor
91954754|NCT03173053|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91954755|NCT03173053|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91954756|NCT03173053|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91954757|NCT03173053|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91954758|NCT03173053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954759|NCT03173053|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91954769|NCT03173053|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91954770|NCT03173053|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91954771|NCT03173053|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91954772|NCT03173053|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91954773|NCT03173053|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91954774|NCT03109795|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91954775|NCT03109795|Clonidine|clonidine|mesh-list
91954776|NCT03109795|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91954777|NCT03109795|Diuretics|diuretics|mesh-ancestor
91954778|NCT03109795|Natriuretic Agents|natriuretic agents|mesh-ancestor
91954779|NCT03109795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954780|NCT03109795|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91954781|NCT03109795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954782|NCT03109795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954783|NCT03109795|Analgesics|analgesics|mesh-ancestor
91954784|NCT03109795|Sensory System Agents|sensory system agents|mesh-ancestor
91954785|NCT03109795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954787|NCT03109795|Autonomic Agents|autonomic agents|mesh-ancestor
91954788|NCT03109795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91954789|NCT03109795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91944686|NCT03478423|Analgesics|analgesics|mesh-ancestor
91944687|NCT03478423|Sensory System Agents|sensory system agents|mesh-ancestor
91944688|NCT03478423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944689|NCT03478423|Antitussive Agents|antitussive agents|mesh-ancestor
91954790|NCT03109795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91954791|NCT03109795|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954792|NCT03109795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954793|NCT03429127|Plasma-lyte 148|plasma-lyte 148|mesh-list
91954794|NCT03429127|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91954795|NCT03429127|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91954796|NCT03428191|Dexmedetomidine|dexmedetomidine|mesh-list
91954797|NCT03428191|Remifentanil|remifentanil|mesh-list
91954798|NCT03428191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91954799|NCT03428191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954800|NCT03428191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954801|NCT03428191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954802|NCT03428191|Analgesics|analgesics|mesh-ancestor
91954803|NCT03428191|Sensory System Agents|sensory system agents|mesh-ancestor
91954804|NCT03428191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954805|NCT03428191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91954806|NCT03428191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91954807|NCT03428191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91954808|NCT03428191|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954809|NCT03428191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954810|NCT03428191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954811|NCT03428191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954812|NCT03428191|Narcotics|narcotics|mesh-ancestor
91954813|NCT03422575|Etoricoxib|etoricoxib|mesh-list
91954814|NCT03422575|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954815|NCT03422575|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954816|NCT03422575|Analgesics|analgesics|mesh-ancestor
91954817|NCT03422575|Sensory System Agents|sensory system agents|mesh-ancestor
91954818|NCT03422575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954819|NCT03422575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954820|NCT03422575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954837|NCT03422419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954839|NCT04449289|Ropivacaine|ropivacaine|mesh-list
91954840|NCT04449289|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954841|NCT04449289|Anesthetics|anesthetics|mesh-ancestor
91954842|NCT04449289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954843|NCT04449289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954844|NCT04449289|Sensory System Agents|sensory system agents|mesh-ancestor
91954845|NCT04449289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954846|NCT04449289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91954847|NCT04449289|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91954848|NCT04449289|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91954849|NCT04449289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954850|NCT04449289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954851|NCT03128203|Oxytocin|oxytocin|mesh-list
91954852|NCT03128203|Oxytocics|oxytocics|mesh-ancestor
91954853|NCT03128203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91954854|NCT03128203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954855|NCT03469999|Botulinum Toxins|botulinum toxins|mesh-list
91954856|NCT03469999|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91954857|NCT03469999|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91954858|NCT03469999|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91954859|NCT03469999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954860|NCT03469999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954861|NCT03469999|Cholinergic Agents|cholinergic agents|mesh-ancestor
91954862|NCT03469999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954863|NCT03469999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954864|NCT03469999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91954865|NCT03469999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954866|NCT02935309|Capecitabine|capecitabine|mesh-list
91954867|NCT02935309|Lenvatinib|lenvatinib|mesh-list
91954868|NCT02935309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91954869|NCT02935309|Antimetabolites|antimetabolites|mesh-ancestor
91954870|NCT02935309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954871|NCT02935309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954872|NCT02935309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91954873|NCT02935309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954874|NCT03463993|Tranexamic Acid|tranexamic acid|mesh-list
91954875|NCT03463993|Oxytocin|oxytocin|mesh-list
91954876|NCT03463993|Oxytocics|oxytocics|mesh-ancestor
91954877|NCT03463993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91954893|NCT03417037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954894|NCT02378480|Linezolid|linezolid|mesh-list
91954895|NCT02378480|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954896|NCT02378480|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954897|NCT02378480|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91954898|NCT02378480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954899|NCT02378480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954900|NCT03421717|Chitosan|chitosan|mesh-list
91954901|NCT03421717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91954902|NCT03421717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91954903|NCT03421717|Antimetabolites|antimetabolites|mesh-ancestor
91954904|NCT03421717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954905|NCT03421717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91954906|NCT03421717|Chelating Agents|chelating agents|mesh-ancestor
91954907|NCT03421717|Sequestering Agents|sequestering agents|mesh-ancestor
91954908|NCT03421717|Hemostatics|hemostatics|mesh-ancestor
91954909|NCT03421717|Coagulants|coagulants|mesh-ancestor
91954910|NCT03427801|Hematinics|hematinics|mesh-list
91954911|NCT03416569|Prazosin|prazosin|mesh-list
91954912|NCT03416569|Nicotine|nicotine|mesh-list
91954913|NCT03416569|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91954914|NCT03416569|Autonomic Agents|autonomic agents|mesh-ancestor
91954915|NCT03416569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954916|NCT03416569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954917|NCT03416569|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91954918|NCT03416569|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91954919|NCT03416569|Cholinergic Agents|cholinergic agents|mesh-ancestor
91954920|NCT03416569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954921|NCT03416569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954922|NCT03416569|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91954923|NCT03416569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91954924|NCT03416569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91954925|NCT03416569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91954926|NCT03416569|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954927|NCT01004029|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
91954928|NCT01004029|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
91954929|NCT01004029|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91954930|NCT01004029|Hormone Antagonists|hormone antagonists|mesh-ancestor
91954931|NCT01004029|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954932|NCT01004029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954933|NCT01004029|Progestins|progestins|mesh-ancestor
91954934|NCT01004029|Hormones|hormones|mesh-ancestor
91954935|NCT03416491|Sofosbuvir|sofosbuvir|mesh-list
91954936|NCT03416491|Antiviral Agents|antiviral agents|mesh-ancestor
91954967|NCT02900443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954969|NCT02900443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91954970|NCT02900443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91954971|NCT02900443|Immunologic Factors|immunologic factors|mesh-ancestor
91954972|NCT02900443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954973|NCT02900443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954974|NCT04594213|Botulinum Toxins|botulinum toxins|mesh-list
91954975|NCT04594213|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91954976|NCT04594213|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91954977|NCT04594213|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
91954978|NCT04594213|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91954979|NCT04594213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954980|NCT04594213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954981|NCT04594213|Cholinergic Agents|cholinergic agents|mesh-ancestor
91955011|NCT03415711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91955012|NCT03415711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91955014|NCT03415711|Sensory System Agents|sensory system agents|mesh-ancestor
91955015|NCT03415711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955016|NCT03415711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955017|NCT03415711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955018|NCT03415711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955019|NCT03420313|Buprenorphine|buprenorphine|mesh-list
91955020|NCT03420313|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
91955021|NCT03420313|Naloxone|naloxone|mesh-list
91955022|NCT03420313|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91944690|NCT03478423|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955023|NCT03420313|Narcotics|narcotics|mesh-ancestor
91955024|NCT03420313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955025|NCT03420313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955026|NCT03420313|Analgesics|analgesics|mesh-ancestor
91955043|NCT03415477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955044|NCT02345252|Emtricitabine, Rilpivirine, Tenofovir Drug Combination|emtricitabine, rilpivirine, tenofovir drug combination|mesh-list
91955045|NCT02345252|Antiviral Agents|antiviral agents|mesh-ancestor
91955046|NCT02345252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955047|NCT02345252|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91955048|NCT02345252|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955049|NCT02345252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955050|NCT02345252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955051|NCT02345252|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91955052|NCT02345252|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91955053|NCT03419923|Citric Acid|citric acid|mesh-list
91955054|NCT03419923|Sodium Citrate|sodium citrate|mesh-list
91955055|NCT03419923|Anticoagulants|anticoagulants|mesh-ancestor
91955056|NCT03419923|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91955057|NCT03419923|Chelating Agents|chelating agents|mesh-ancestor
91955058|NCT03419923|Sequestering Agents|sequestering agents|mesh-ancestor
91955059|NCT03419923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955060|NCT03426553|Riboflavin|riboflavin|mesh-list
91955061|NCT03426553|Vitamin B Complex|vitamin b complex|mesh-ancestor
91955062|NCT03426553|Vitamins|vitamins|mesh-ancestor
91955063|NCT03426553|Micronutrients|micronutrients|mesh-ancestor
91955064|NCT03426553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955065|NCT03426553|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91955066|NCT03426553|Dermatologic Agents|dermatologic agents|mesh-ancestor
91955067|NCT03415087|Fentanyl|fentanyl|mesh-list
91955068|NCT03415087|Bupivacaine|bupivacaine|mesh-list
91955069|NCT03415087|Anesthetics, Local|anesthetics, local|mesh-ancestor
91955070|NCT03415087|Anesthetics|anesthetics|mesh-ancestor
91955071|NCT03415087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955072|NCT03415087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955073|NCT03415087|Sensory System Agents|sensory system agents|mesh-ancestor
91955074|NCT03415087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955075|NCT03415087|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91955076|NCT03415087|Narcotics|narcotics|mesh-ancestor
91955077|NCT03415087|Analgesics|analgesics|mesh-ancestor
91955078|NCT03415087|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91955079|NCT03415087|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91955080|NCT03415087|Anesthetics, General|anesthetics, general|mesh-ancestor
91955081|NCT02833753|Oxaliplatin|oxaliplatin|mesh-list
91955082|NCT02833753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955083|NCT03419767|Melatonin|melatonin|mesh-list
91955084|NCT03419767|Antioxidants|antioxidants|mesh-ancestor
91955085|NCT03419767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955086|NCT03419767|Protective Agents|protective agents|mesh-ancestor
91955100|NCT04448821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91955101|NCT04448821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955102|NCT02835157|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91955103|NCT04448977|Ocrelizumab|ocrelizumab|mesh-list
91955104|NCT04448977|Immunologic Factors|immunologic factors|mesh-ancestor
91955105|NCT04448977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955106|NCT03418831|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
91955107|NCT03418831|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91955108|NCT03418831|Hormone Antagonists|hormone antagonists|mesh-ancestor
91955109|NCT03418831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955110|NCT03418831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955111|NCT03418831|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91955112|NCT03418831|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91955113|NCT03418831|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91955114|NCT04448587|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91955115|NCT04448587|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91955116|NCT04448587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955117|NCT04448587|Incretins|incretins|mesh-ancestor
91955118|NCT04448587|Hormones|hormones|mesh-ancestor
91955119|NCT04448587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955120|NCT04448587|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91955121|NCT04448587|Protease Inhibitors|protease inhibitors|mesh-ancestor
91955122|NCT04448587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944691|NCT03478345|Endocrine Disruptors|endocrine disruptors|mesh-list
91944692|NCT03478345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955123|NCT04448587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955124|NCT03426085|Liraglutide|liraglutide|mesh-list
91955125|NCT03426085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91955126|NCT03426085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955127|NCT03426085|Incretins|incretins|mesh-ancestor
91955128|NCT03426085|Hormones|hormones|mesh-ancestor
91955129|NCT03426085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955130|NCT03418597|Anesthetics|anesthetics|mesh-list
91955131|NCT03418597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955132|NCT03418597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955133|NCT03425929|Oxytocin|oxytocin|mesh-list
91955134|NCT03425929|Oxytocics|oxytocics|mesh-ancestor
91955135|NCT03425929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955136|NCT03425929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955137|NCT03127189|Rilpivirine|rilpivirine|mesh-list
91955138|NCT03127189|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91955139|NCT03127189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955140|NCT03127189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955141|NCT03127189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955142|NCT03127189|Antiviral Agents|antiviral agents|mesh-ancestor
91955143|NCT03127189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955144|NCT03127189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91955162|NCT01239797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955163|NCT01239797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955165|NCT01239797|Glucocorticoids|glucocorticoids|mesh-ancestor
91955166|NCT01239797|Hormones|hormones|mesh-ancestor
91955167|NCT01239797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955168|NCT01239797|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91955169|NCT01239797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955170|NCT01239797|Protease Inhibitors|protease inhibitors|mesh-ancestor
91955171|NCT01239797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955172|NCT01239797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955173|NCT01239797|Immunologic Factors|immunologic factors|mesh-ancestor
91955174|NCT01239797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91955175|NCT01239797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91955176|NCT01239797|Growth Substances|growth substances|mesh-ancestor
91955177|NCT01239797|Growth Inhibitors|growth inhibitors|mesh-ancestor
91955178|NCT02639065|Durvalumab|durvalumab|mesh-list
91955179|NCT02639065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91955180|NCT02639065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955185|NCT01092143|Fluticasone|fluticasone|mesh-list
91955186|NCT01092143|Xhance|xhance|mesh-list
91955187|NCT01092143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955188|NCT01092143|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91955189|NCT01092143|Autonomic Agents|autonomic agents|mesh-ancestor
91955190|NCT01092143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955191|NCT01092143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955192|NCT01092143|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91955193|NCT01092143|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955194|NCT01092143|Dermatologic Agents|dermatologic agents|mesh-ancestor
91955195|NCT01092143|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91955196|NCT00950989|Folic Acid|folic acid|mesh-list
91955197|NCT00950989|Methotrexate|methotrexate|mesh-list
91955198|NCT00950989|Brodalumab|brodalumab|mesh-list
91955199|NCT00950989|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91955200|NCT00950989|Abortifacient Agents|abortifacient agents|mesh-ancestor
91955201|NCT00950989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955202|NCT00950989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955203|NCT00950989|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91955204|NCT00950989|Antimetabolites|antimetabolites|mesh-ancestor
91955225|NCT03420911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91955226|NCT03420911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91955227|NCT03420911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91955228|NCT03420911|Anesthetics, General|anesthetics, general|mesh-ancestor
91955230|NCT03420911|GABA Modulators|gaba modulators|mesh-ancestor
91955231|NCT03420911|GABA Agents|gaba agents|mesh-ancestor
91955232|NCT03420911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955233|NCT03420911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955234|NCT03420911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91955235|NCT03420911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91944693|NCT03130933|Amoxicillin|amoxicillin|mesh-list
91944694|NCT03130933|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944695|NCT03130933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944696|NCT05155969|Ketamine|ketamine|mesh-list
91944697|NCT05155969|Esketamine|esketamine|mesh-list
91955236|NCT03420911|Analgesics|analgesics|mesh-ancestor
91955237|NCT03420911|Sensory System Agents|sensory system agents|mesh-ancestor
91955238|NCT03420911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955239|NCT03420911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955240|NCT03420911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955241|NCT03416231|Docetaxel|docetaxel|mesh-list
91955242|NCT03416231|Apatinib|apatinib|mesh-list
91955243|NCT03416231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955244|NCT03416231|Tubulin Modulators|tubulin modulators|mesh-ancestor
91955245|NCT03416231|Antimitotic Agents|antimitotic agents|mesh-ancestor
91955246|NCT03416231|Mitosis Modulators|mitosis modulators|mesh-ancestor
91955247|NCT03416231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955248|NCT03416231|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955249|NCT03416231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955250|NCT03415763|Leucovorin|leucovorin|mesh-list
91955251|NCT03415763|Capecitabine|capecitabine|mesh-list
91955252|NCT03415763|Oxaliplatin|oxaliplatin|mesh-list
91955253|NCT03415763|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91955254|NCT03415763|Antimetabolites|antimetabolites|mesh-ancestor
91955255|NCT03415763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955256|NCT03415763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955257|NCT03415763|Antidotes|antidotes|mesh-ancestor
91955258|NCT03415763|Protective Agents|protective agents|mesh-ancestor
91955259|NCT03415763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955260|NCT03415763|Vitamin B Complex|vitamin b complex|mesh-ancestor
91955280|NCT00006455|Cytarabine|cytarabine|mesh-list
91955281|NCT00006455|Dexamethasone|dexamethasone|mesh-list
91955282|NCT00006455|Hydrocortisone|hydrocortisone|mesh-list
91955283|NCT00006455|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
91955284|NCT00006455|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
91955285|NCT00006455|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91955286|NCT00006455|Cyclophosphamide|cyclophosphamide|mesh-list
91955287|NCT00006455|Ifosfamide|ifosfamide|mesh-list
91955288|NCT00006455|Doxorubicin|doxorubicin|mesh-list
91955289|NCT00006455|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91955290|NCT00006455|Methotrexate|methotrexate|mesh-list
91955291|NCT00006455|Etoposide|etoposide|mesh-list
91955292|NCT00006455|Vinblastine|vinblastine|mesh-list
91955293|NCT00006455|Levoleucovorin|levoleucovorin|mesh-list
91955294|NCT00006455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91955295|NCT00006455|Immunologic Factors|immunologic factors|mesh-ancestor
91955296|NCT00006455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955297|NCT00006455|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955298|NCT00006455|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91955299|NCT00006455|Alkylating Agents|alkylating agents|mesh-ancestor
91955300|NCT00006455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955301|NCT00006455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955302|NCT00006455|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91955303|NCT00006455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955304|NCT00006455|Antiemetics|antiemetics|mesh-ancestor
91955305|NCT00006455|Autonomic Agents|autonomic agents|mesh-ancestor
91955306|NCT00006455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955307|NCT00006455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955308|NCT00006455|Glucocorticoids|glucocorticoids|mesh-ancestor
91955309|NCT00006455|Hormones|hormones|mesh-ancestor
91955310|NCT00006455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955311|NCT00006455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91955312|NCT00006455|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91955313|NCT00006455|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91955314|NCT00006455|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91955315|NCT00006455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955316|NCT00006455|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91955317|NCT00006455|Abortifacient Agents|abortifacient agents|mesh-ancestor
91955342|NCT02537197|Sensory System Agents|sensory system agents|mesh-ancestor
91955343|NCT02537197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955344|NCT03127345|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
91955345|NCT03127345|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91955346|NCT03127345|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91944698|NCT05155969|Analgesics|analgesics|mesh-ancestor
91944699|NCT05155969|Sensory System Agents|sensory system agents|mesh-ancestor
91955347|NCT03127345|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91955348|NCT03413371|Acetaminophen|acetaminophen|mesh-list
91955349|NCT03413371|Lidocaine|lidocaine|mesh-list
91955350|NCT03413371|Bupivacaine|bupivacaine|mesh-list
91955351|NCT03413371|Ropivacaine|ropivacaine|mesh-list
91955352|NCT03413371|Anesthetics, Local|anesthetics, local|mesh-ancestor
91955353|NCT03413371|Anesthetics|anesthetics|mesh-ancestor
91955354|NCT03413371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955355|NCT03413371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955356|NCT03413371|Sensory System Agents|sensory system agents|mesh-ancestor
91955357|NCT03413371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955358|NCT03413371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91955359|NCT03413371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91955360|NCT03413371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91955361|NCT03413371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91955362|NCT03413371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955363|NCT03413371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91955365|NCT03413371|Antipyretics|antipyretics|mesh-ancestor
91955366|NCT05116995|Rivaroxaban|rivaroxaban|mesh-list
91955367|NCT05116995|Ticagrelor|ticagrelor|mesh-list
91955368|NCT05116995|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91955379|NCT05116995|Protease Inhibitors|protease inhibitors|mesh-ancestor
91955380|NCT05116995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955381|NCT05116995|Anticoagulants|anticoagulants|mesh-ancestor
91955382|NCT02344004|Amikacin|amikacin|mesh-list
91955383|NCT02344004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91955384|NCT02344004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955385|NCT03677115|Dexmedetomidine|dexmedetomidine|mesh-list
91955386|NCT03677115|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91955387|NCT03677115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955388|NCT03677115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955389|NCT03677115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91955390|NCT03677115|Analgesics|analgesics|mesh-ancestor
91955391|NCT03677115|Sensory System Agents|sensory system agents|mesh-ancestor
91955392|NCT03677115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955393|NCT03677115|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91955394|NCT03677115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91955396|NCT03677115|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955397|NCT03677115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955398|NCT03677115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955399|NCT05116371|Levonorgestrel|levonorgestrel|mesh-list
91955400|NCT05116371|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91955401|NCT05116371|Contraceptive Agents|contraceptive agents|mesh-list
91955402|NCT05116371|Contraceptives, Oral|contraceptives, oral|mesh-list
91955403|NCT05116371|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
91955404|NCT05116371|Estradiol|estradiol|mesh-list
91955405|NCT05116371|Estrogens|estrogens|mesh-ancestor
91955406|NCT05116371|Hormones|hormones|mesh-ancestor
91955407|NCT05116371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955408|NCT05116371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955409|NCT05116371|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91955410|NCT05116371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955411|NCT05116371|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91955412|NCT05116371|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91955413|NCT05116371|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91955414|NCT01328093|Aripiprazole|aripiprazole|mesh-list
91955415|NCT01328093|Antidepressive Agents|antidepressive agents|mesh-ancestor
91955416|NCT01328093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91955417|NCT01328093|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91955418|NCT01328093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91955419|NCT01328093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955420|NCT01328093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955421|NCT01328093|Dopamine Agonists|dopamine agonists|mesh-ancestor
91955422|NCT01328093|Dopamine Agents|dopamine agents|mesh-ancestor
91955423|NCT01328093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955424|NCT01328093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955425|NCT01328093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91955426|NCT01328093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91944700|NCT05155969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955427|NCT01328093|Serotonin Agents|serotonin agents|mesh-ancestor
91955428|NCT01328093|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91955429|NCT01328093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91955430|NCT01328093|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91955442|NCT03417427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955443|NCT03417427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955444|NCT03425617|Tiotropium Bromide|tiotropium bromide|mesh-list
91955446|NCT03425617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91955447|NCT03425617|Autonomic Agents|autonomic agents|mesh-ancestor
91955448|NCT03425617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955449|NCT03425617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955450|NCT03425617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91955451|NCT03425617|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955452|NCT03425617|Parasympatholytics|parasympatholytics|mesh-ancestor
91955453|NCT03425617|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91955454|NCT03425617|Cholinergic Agents|cholinergic agents|mesh-ancestor
91955455|NCT03425617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955456|NCT03425617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955457|NCT03419429|Simvastatin|simvastatin|mesh-list
91955458|NCT03419429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91955459|NCT03419429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91955460|NCT03419429|Antimetabolites|antimetabolites|mesh-ancestor
91955461|NCT03419429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955462|NCT03419429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91955463|NCT03419429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91955464|NCT03419429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955465|NCT02654145|Omalizumab|omalizumab|mesh-list
91955466|NCT02654145|Albuterol|albuterol|mesh-list
91955467|NCT02654145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91955468|NCT02654145|Autonomic Agents|autonomic agents|mesh-ancestor
91955469|NCT02654145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955470|NCT02654145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955471|NCT02654145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91955472|NCT02654145|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955473|NCT02654145|Tocolytic Agents|tocolytic agents|mesh-ancestor
91955474|NCT02654145|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955475|NCT02654145|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91955476|NCT02654145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91955477|NCT02654145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91955478|NCT02654145|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955479|NCT02654145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955480|NCT02654145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955481|NCT02654145|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91955482|NCT05122455|Edoxaban|edoxaban|mesh-list
91955483|NCT05122455|Clopidogrel|clopidogrel|mesh-list
91955484|NCT05122455|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91955485|NCT05122455|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91955486|NCT05122455|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91955487|NCT05122455|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91955488|NCT05122455|Purinergic Agents|purinergic agents|mesh-ancestor
91955489|NCT05122455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955490|NCT05122455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955491|NCT05122455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955492|NCT05122455|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91955507|NCT03413059|Analgesics|analgesics|mesh-ancestor
91955508|NCT03413059|Sensory System Agents|sensory system agents|mesh-ancestor
91955509|NCT03413059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955510|NCT03413059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955511|NCT03413059|Glucocorticoids|glucocorticoids|mesh-ancestor
91955512|NCT03413059|Hormones|hormones|mesh-ancestor
91955513|NCT03413059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955514|NCT03413059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91955515|NCT03413059|Immunologic Factors|immunologic factors|mesh-ancestor
91955516|NCT03413059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955517|NCT03413059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955518|NCT05122377|Goserelin|goserelin|mesh-list
91955519|NCT05122377|Leuprolide|leuprolide|mesh-list
91955520|NCT05122377|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91955521|NCT05122377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955522|NCT05122377|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91955523|NCT05122377|Fertility Agents|fertility agents|mesh-ancestor
91944701|NCT05155969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944702|NCT05155969|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91955524|NCT05122377|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955525|NCT05122377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955526|NCT03425461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91955527|NCT03425461|Nivolumab|nivolumab|mesh-list
91955528|NCT03425461|Ipilimumab|ipilimumab|mesh-list
91955529|NCT03425461|Antibodies|antibodies|mesh-list
91955530|NCT03425461|Immunoglobulins|immunoglobulins|mesh-list
91955531|NCT03425461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91955532|NCT03425461|Immunologic Factors|immunologic factors|mesh-ancestor
91955533|NCT03425461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955534|NCT03425461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955535|NCT03425461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91955536|NCT03425461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955537|NCT04753437|Amoxicillin|amoxicillin|mesh-list
91955538|NCT04753437|Clarithromycin|clarithromycin|mesh-list
91955539|NCT04753437|Potassium Citrate|potassium citrate|mesh-list
91955540|NCT04753437|Esomeprazole|esomeprazole|mesh-list
91955541|NCT04753437|Bismuth|bismuth|mesh-list
91955542|NCT04753437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955543|NCT04753437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91955544|NCT04753437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955545|NCT04753437|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91955546|NCT04753437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955547|NCT04753437|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91955548|NCT04753437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955549|NCT04753437|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91955550|NCT04753437|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91955551|NCT04753437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91955552|NCT04753437|Antacids|antacids|mesh-ancestor
91955553|NCT04753437|Diuretics|diuretics|mesh-ancestor
91955554|NCT04753437|Natriuretic Agents|natriuretic agents|mesh-ancestor
91955555|NCT04753437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955556|NCT04753437|Expectorants|expectorants|mesh-ancestor
91955588|NCT04564365|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91955589|NCT04564365|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91955590|NCT04564365|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955591|NCT04564365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955592|NCT04564365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955593|NCT04564365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955594|NCT03412513|Mirabegron|mirabegron|mesh-list
91955595|NCT03412513|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91955609|NCT04370379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955610|NCT03413891|Tranexamic Acid|tranexamic acid|mesh-list
91955611|NCT03413891|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91955612|NCT03413891|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91955613|NCT03413891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955615|NCT03413891|Coagulants|coagulants|mesh-ancestor
91955616|NCT03317613|Capsaicin|capsaicin|mesh-list
91955617|NCT03317613|Antipruritics|antipruritics|mesh-ancestor
91955618|NCT03317613|Dermatologic Agents|dermatologic agents|mesh-ancestor
91955619|NCT03317613|Sensory System Agents|sensory system agents|mesh-ancestor
91955620|NCT03317613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955621|NCT03317613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955622|NCT03126877|Mitomycins|mitomycins|mesh-list
91955623|NCT03126877|Mitomycin|mitomycin|mesh-list
91955624|NCT03126877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91955625|NCT03126877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955626|NCT03126877|Alkylating Agents|alkylating agents|mesh-ancestor
91955627|NCT03126877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955628|NCT03126877|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955629|NCT03126877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955630|NCT04260477|Rifampin|rifampin|mesh-list
91955631|NCT04260477|Isoniazid|isoniazid|mesh-list
91955632|NCT04260477|Pyrazinamide|pyrazinamide|mesh-list
91955633|NCT04260477|Ethambutol|ethambutol|mesh-list
91955634|NCT04260477|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91955635|NCT04260477|Antitubercular Agents|antitubercular agents|mesh-ancestor
91955636|NCT04260477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91955637|NCT04260477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955638|NCT04260477|Leprostatic Agents|leprostatic agents|mesh-ancestor
91955639|NCT04260477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955641|NCT04260477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955642|NCT04260477|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91955643|NCT04260477|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91955644|NCT04260477|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91955645|NCT04260477|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91955646|NCT04260477|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91955647|NCT04260477|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91955648|NCT04260477|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91955649|NCT04260477|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91955650|NCT04260477|Antimetabolites|antimetabolites|mesh-ancestor
91955651|NCT04260477|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91955652|NCT02343458|Glycopyrrolate|glycopyrrolate|mesh-list
91955653|NCT02343458|Formoterol Fumarate|formoterol fumarate|mesh-list
91955654|NCT02343458|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91955655|NCT02343458|Autonomic Agents|autonomic agents|mesh-ancestor
91955656|NCT02343458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955675|NCT03413579|Nimotuzumab|nimotuzumab|mesh-list
91955676|NCT03413579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91955677|NCT03413579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955678|NCT04814745|Morphine|morphine|mesh-list
91955679|NCT04814745|Tramadol|tramadol|mesh-list
91955680|NCT04814745|Ropivacaine|ropivacaine|mesh-list
91955681|NCT04814745|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91955682|NCT04814745|Narcotics|narcotics|mesh-ancestor
91955683|NCT04814745|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955684|NCT04814745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955685|NCT04814745|Analgesics|analgesics|mesh-ancestor
91955686|NCT04814745|Sensory System Agents|sensory system agents|mesh-ancestor
91955687|NCT04814745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955688|NCT04814745|Anesthetics, Local|anesthetics, local|mesh-ancestor
91955689|NCT04814745|Anesthetics|anesthetics|mesh-ancestor
91955690|NCT04640571|Metformin|metformin|mesh-list
91955691|NCT04640571|Valacyclovir|valacyclovir|mesh-list
91955692|NCT04640571|Enalaprilat|enalaprilat|mesh-list
91955693|NCT04640571|Enalapril|enalapril|mesh-list
91955694|NCT04640571|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
91955695|NCT04640571|Pravastatin|pravastatin|mesh-list
91955696|NCT04640571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91955697|NCT04640571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955698|NCT04640571|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91955699|NCT04640571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91955700|NCT04640571|Antimetabolites|antimetabolites|mesh-ancestor
91955701|NCT04640571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955702|NCT04640571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91955703|NCT04640571|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91955704|NCT04640571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955705|NCT04640571|Antiviral Agents|antiviral agents|mesh-ancestor
91955706|NCT04640571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955707|NCT04640571|Cathartics|cathartics|mesh-ancestor
91955708|NCT04640571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955709|NCT04640571|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91955710|NCT04640571|Protease Inhibitors|protease inhibitors|mesh-ancestor
91955711|NCT04640571|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91955712|NCT04431141|Empagliflozin|empagliflozin|mesh-list
91955713|NCT04431141|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91955714|NCT04431141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955730|NCT01976169|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
91955731|NCT01976169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955732|NCT01976169|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955733|NCT01976169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955734|NCT01976169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955735|NCT01976169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91955737|NCT01976169|Immunoconjugates|immunoconjugates|mesh-ancestor
91955738|NCT01976169|Immunologic Factors|immunologic factors|mesh-ancestor
91955739|NCT01976169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955740|NCT01976169|Tubulin Modulators|tubulin modulators|mesh-ancestor
91955741|NCT01976169|Antimitotic Agents|antimitotic agents|mesh-ancestor
91955742|NCT01976169|Mitosis Modulators|mitosis modulators|mesh-ancestor
91955743|NCT00148629|Mebendazole|mebendazole|mesh-list
91955744|NCT00148629|Piperazine|piperazine|mesh-list
91955745|NCT00148629|Piperazine citrate|piperazine citrate|mesh-list
91955746|NCT00148629|DMP 777|dmp 777|mesh-list
91955747|NCT00148629|Antinematodal Agents|antinematodal agents|mesh-ancestor
91944703|NCT05155969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91944704|NCT05155969|Anesthetics, General|anesthetics, general|mesh-ancestor
91944705|NCT05155969|Anesthetics|anesthetics|mesh-ancestor
91955748|NCT00148629|Anthelmintics|anthelmintics|mesh-ancestor
91955749|NCT00148629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91955750|NCT00148629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955751|NCT00148629|Tubulin Modulators|tubulin modulators|mesh-ancestor
91955752|NCT00148629|Antimitotic Agents|antimitotic agents|mesh-ancestor
91955753|NCT00148629|Mitosis Modulators|mitosis modulators|mesh-ancestor
91955754|NCT00148629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955755|NCT00148629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955756|NCT00148629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955757|NCT04448015|Analgesics, Opioid|analgesics, opioid|mesh-list
91955758|NCT04448015|Narcotics|narcotics|mesh-ancestor
91955759|NCT04448015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955760|NCT04448015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955761|NCT04448015|Analgesics|analgesics|mesh-ancestor
91955762|NCT04448015|Sensory System Agents|sensory system agents|mesh-ancestor
91955763|NCT04448015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955764|NCT01328041|Dolutegravir|dolutegravir|mesh-list
91955765|NCT01328041|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91955766|NCT01328041|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91955767|NCT01328041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955768|NCT01328041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955769|NCT01328041|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91955770|NCT01328041|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91955771|NCT01328041|Antiviral Agents|antiviral agents|mesh-ancestor
91955772|NCT01328041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955787|NCT03411967|Tubulin Modulators|tubulin modulators|mesh-ancestor
91955788|NCT03411967|Antimitotic Agents|antimitotic agents|mesh-ancestor
91955789|NCT03411967|Mitosis Modulators|mitosis modulators|mesh-ancestor
91955790|NCT03411967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955791|NCT03411967|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955792|NCT03411967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955794|NCT05228925|Vitamins|vitamins|mesh-ancestor
91955795|NCT05228925|Micronutrients|micronutrients|mesh-ancestor
91955796|NCT05228925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955797|NCT05228925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91955799|NCT03412409|Cyclophosphamide|cyclophosphamide|mesh-list
91955800|NCT03412409|Busulfan|busulfan|mesh-list
91955801|NCT03412409|Semustine|semustine|mesh-list
91955802|NCT03412409|Fludarabine|fludarabine|mesh-list
91955803|NCT03412409|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91955804|NCT03412409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91955805|NCT03412409|Immunologic Factors|immunologic factors|mesh-ancestor
91955806|NCT03412409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955807|NCT03412409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955808|NCT03412409|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91955809|NCT03412409|Alkylating Agents|alkylating agents|mesh-ancestor
91955810|NCT03412409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955811|NCT03412409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955812|NCT03412409|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91955813|NCT03412409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91955814|NCT03412409|Antimetabolites|antimetabolites|mesh-ancestor
91955815|NCT03412409|Antiviral Agents|antiviral agents|mesh-ancestor
91955816|NCT03412409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955817|NCT02410772|Moxifloxacin|moxifloxacin|mesh-list
91955818|NCT02410772|Rifapentine|rifapentine|mesh-list
91955820|NCT02410772|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91955821|NCT02410772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955822|NCT02410772|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91955823|NCT02410772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91955824|NCT02410772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955825|NCT02410772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955826|NCT02410772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955827|NCT02410772|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91955828|NCT02410772|Antitubercular Agents|antitubercular agents|mesh-ancestor
91955829|NCT02410772|Leprostatic Agents|leprostatic agents|mesh-ancestor
91955830|NCT02410772|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955831|NCT02410772|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91955832|NCT02410772|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91955833|NCT02410772|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91955834|NCT02410772|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91955835|NCT02410772|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91955853|NCT03417947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91955854|NCT03417947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91955856|NCT03905811|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91955857|NCT03905811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91955858|NCT03905811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91955859|NCT03905811|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955860|NCT03905811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955861|NCT03905811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955862|NCT03905811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955863|NCT03905811|Urological Agents|urological agents|mesh-ancestor
91955864|NCT01648790|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91955865|NCT01648790|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91955866|NCT05171309|Apatinib|apatinib|mesh-list
91955867|NCT05171309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955868|NCT05171309|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955869|NCT05171309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955870|NCT05171309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955871|NCT03409237|Mannitol|mannitol|mesh-list
91955872|NCT03409237|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91955873|NCT03409237|Diuretics|diuretics|mesh-ancestor
91955874|NCT03409237|Natriuretic Agents|natriuretic agents|mesh-ancestor
91955875|NCT03409237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955876|NCT03408847|Beclomethasone|beclomethasone|mesh-list
91955877|NCT03408847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955878|NCT03408847|Glucocorticoids|glucocorticoids|mesh-ancestor
91955879|NCT03408847|Hormones|hormones|mesh-ancestor
91955880|NCT03408847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91955881|NCT03408847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955882|NCT03408847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91955883|NCT03408847|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955884|NCT03424291|Apatinib|apatinib|mesh-list
91955885|NCT03424291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955886|NCT03424291|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955887|NCT03424291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955888|NCT03424291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955889|NCT04412889|Immunomodulating Agents|immunomodulating agents|mesh-list
91955890|NCT04412889|Immunologic Factors|immunologic factors|mesh-ancestor
91955891|NCT04412889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955892|NCT03407521|Isosorbide|isosorbide|mesh-list
91955894|NCT03407521|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91955895|NCT03407521|Misoprostol|misoprostol|mesh-list
91955914|NCT03424135|Analgesics|analgesics|mesh-ancestor
91955915|NCT03424135|Sensory System Agents|sensory system agents|mesh-ancestor
91955916|NCT03424135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955917|NCT03424135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955918|NCT03424135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955919|NCT03424135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955920|NCT03424135|Gout Suppressants|gout suppressants|mesh-ancestor
91955921|NCT03424135|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91955922|NCT03424135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955923|NCT03424135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955924|NCT03424135|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91955925|NCT03424135|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91955926|NCT03424135|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955927|NCT03424135|Anesthetics, Local|anesthetics, local|mesh-ancestor
91955928|NCT03424135|Anesthetics|anesthetics|mesh-ancestor
91955929|NCT03424135|Antiemetics|antiemetics|mesh-ancestor
91955930|NCT03424135|Autonomic Agents|autonomic agents|mesh-ancestor
91955931|NCT03424135|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955932|NCT03424135|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91955933|NCT03424135|Histamine Antagonists|histamine antagonists|mesh-ancestor
91955934|NCT03424135|Histamine Agents|histamine agents|mesh-ancestor
91955935|NCT03424135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955936|NCT03424135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91955937|NCT03424135|Antipruritics|antipruritics|mesh-ancestor
91955938|NCT03424135|Dermatologic Agents|dermatologic agents|mesh-ancestor
91955939|NCT03411941|Aflibercept|aflibercept|mesh-list
91955940|NCT03411941|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91955941|NCT03411941|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91955942|NCT03411941|Growth Substances|growth substances|mesh-ancestor
91944706|NCT05155969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955943|NCT03411941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955944|NCT03411941|Growth Inhibitors|growth inhibitors|mesh-ancestor
91955945|NCT03411941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955946|NCT05170555|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91955947|NCT05170555|177Lu-EB-PSMA-617|177lu-eb-psma-617|mesh-list
91955948|NCT05170555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91955949|NCT05170555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955950|NCT03406819|Nitroprusside|nitroprusside|mesh-list
91955952|NCT03406819|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91955953|NCT03406819|Vasodilator Agents|vasodilator agents|mesh-ancestor
91955963|NCT03411551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955964|NCT05170061|Valsartan|valsartan|mesh-list
91955965|NCT05170061|Nebivolol|nebivolol|mesh-list
91955966|NCT05170061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91955967|NCT05170061|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91955968|NCT05170061|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91955969|NCT05170061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955970|NCT05170061|Vasodilator Agents|vasodilator agents|mesh-ancestor
91955971|NCT05170061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91955972|NCT05170061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91955973|NCT05170061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91955974|NCT05170061|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955975|NCT05170061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955976|NCT05170061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955977|NCT04235205|Cholestyramine Resin|cholestyramine resin|mesh-list
91955978|NCT04235205|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91955979|NCT04235205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91955980|NCT04235205|Antimetabolites|antimetabolites|mesh-ancestor
91955981|NCT04235205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955982|NCT04235205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91955983|NCT02520635|Temozolomide|temozolomide|mesh-list
91955984|NCT02520635|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91955985|NCT02520635|Alkylating Agents|alkylating agents|mesh-ancestor
91955986|NCT02520635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955987|NCT02520635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955988|NCT03404947|Ethanol|ethanol|mesh-list
91955989|NCT03404947|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91955990|NCT03404947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955991|NCT03404947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955992|NCT03404947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955994|NCT03411473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91955995|NCT03411473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955996|NCT03411473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91955997|NCT03411473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955998|NCT03423823|Ranibizumab|ranibizumab|mesh-list
91955999|NCT03423823|Aflibercept|aflibercept|mesh-list
91956000|NCT03423823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956001|NCT03423823|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91956002|NCT03423823|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91956003|NCT03423823|Growth Substances|growth substances|mesh-ancestor
91956004|NCT03423823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956005|NCT03423823|Growth Inhibitors|growth inhibitors|mesh-ancestor
91956006|NCT03411161|Paclitaxel|paclitaxel|mesh-list
91956007|NCT03411161|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91956008|NCT03411161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91956009|NCT03411161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956010|NCT03411161|Tubulin Modulators|tubulin modulators|mesh-ancestor
91956011|NCT03411161|Antimitotic Agents|antimitotic agents|mesh-ancestor
91956012|NCT03411161|Mitosis Modulators|mitosis modulators|mesh-ancestor
91956013|NCT03411161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956014|NCT04737603|Buprenorphine|buprenorphine|mesh-list
91956015|NCT04737603|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
91956016|NCT04737603|Naloxone|naloxone|mesh-list
91956017|NCT04737603|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91956018|NCT04737603|Narcotics|narcotics|mesh-ancestor
91956028|NCT05168137|Tubulin Modulators|tubulin modulators|mesh-ancestor
91956029|NCT05168137|Antimitotic Agents|antimitotic agents|mesh-ancestor
91956030|NCT05168137|Mitosis Modulators|mitosis modulators|mesh-ancestor
91956031|NCT05168137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944707|NCT05155969|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91944708|NCT05155969|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91944709|NCT05155969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956032|NCT05168137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956033|NCT03410771|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91956034|NCT03410771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956036|NCT05168059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91956037|NCT05168059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91956038|NCT05168059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956039|NCT05168059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91956040|NCT05168059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956041|NCT02375295|Ciprofloxacin|ciprofloxacin|mesh-list
91956042|NCT02375295|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91956044|NCT02375295|Trimethoprim|trimethoprim|mesh-list
91956045|NCT02375295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91956046|NCT02375295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956047|NCT02375295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91956048|NCT02375295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91956049|NCT02375295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956050|NCT02375295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956051|NCT02375295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956052|NCT02375295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91956053|NCT02375295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91956054|NCT02375295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91956055|NCT02375295|Antimalarials|antimalarials|mesh-ancestor
91956056|NCT02375295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91956057|NCT02375295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91956058|NCT02375295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91956059|NCT02375295|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91956060|NCT02375295|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91956061|NCT03394105|Docetaxel|docetaxel|mesh-list
91956062|NCT03394105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956063|NCT03394105|Tubulin Modulators|tubulin modulators|mesh-ancestor
91956064|NCT03394105|Antimitotic Agents|antimitotic agents|mesh-ancestor
91956065|NCT03394105|Mitosis Modulators|mitosis modulators|mesh-ancestor
91956066|NCT03394105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956067|NCT03393949|Methylprednisolone|methylprednisolone|mesh-list
91956068|NCT03393949|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91956069|NCT03393949|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91956070|NCT03393949|Prednisolone|prednisolone|mesh-list
91956071|NCT03393949|Prednisolone acetate|prednisolone acetate|mesh-list
91956072|NCT03393949|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91956073|NCT03393949|Prednisolone phosphate|prednisolone phosphate|mesh-list
91956074|NCT03393949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956075|NCT03393949|Antiemetics|antiemetics|mesh-ancestor
91956076|NCT03393949|Autonomic Agents|autonomic agents|mesh-ancestor
91956077|NCT03393949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956078|NCT03393949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956079|NCT03393949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91956080|NCT03393949|Glucocorticoids|glucocorticoids|mesh-ancestor
91956081|NCT03393949|Hormones|hormones|mesh-ancestor
91956082|NCT03393949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956083|NCT03393949|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91956109|NCT04435743|Growth Inhibitors|growth inhibitors|mesh-ancestor
91956110|NCT04435743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956111|NCT03393715|Perindopril|perindopril|mesh-list
91956112|NCT03393715|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91956113|NCT03393715|Protease Inhibitors|protease inhibitors|mesh-ancestor
91956114|NCT03393715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956115|NCT03393715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956116|NCT03393715|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91956117|NCT03397537|Letrozole|letrozole|mesh-list
91956118|NCT03397537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956119|NCT03397537|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91956120|NCT03397537|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91956121|NCT03397537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944710|NCT05155969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944711|NCT05155969|Antidepressive Agents|antidepressive agents|mesh-ancestor
91956122|NCT03397537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956123|NCT03397537|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91956124|NCT03397537|Hormone Antagonists|hormone antagonists|mesh-ancestor
91956125|NCT03397537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956126|NCT03397537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956127|NCT03612921|Amantadine|amantadine|mesh-list
91956128|NCT03612921|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91956129|NCT03612921|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91956130|NCT03612921|Antiviral Agents|antiviral agents|mesh-ancestor
91956131|NCT03612921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956145|NCT01936857|Buprenorphine|buprenorphine|mesh-list
91956146|NCT01936857|Methadone|methadone|mesh-list
91956147|NCT01936857|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
91956148|NCT01936857|Naloxone|naloxone|mesh-list
91956149|NCT01936857|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91956150|NCT01936857|Narcotics|narcotics|mesh-ancestor
91956151|NCT01936857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956152|NCT01936857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956153|NCT01936857|Analgesics|analgesics|mesh-ancestor
91956154|NCT01936857|Sensory System Agents|sensory system agents|mesh-ancestor
91956155|NCT01936857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956156|NCT01936857|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91956157|NCT01936857|Antitussive Agents|antitussive agents|mesh-ancestor
91956158|NCT01936857|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956159|NCT03393403|Dexmedetomidine|dexmedetomidine|mesh-list
91956160|NCT03393403|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956161|NCT03393403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956162|NCT03393403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956163|NCT03393403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956164|NCT03393403|Analgesics|analgesics|mesh-ancestor
91956165|NCT03393403|Sensory System Agents|sensory system agents|mesh-ancestor
91956166|NCT03393403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956167|NCT03393403|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91956168|NCT03393403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91956169|NCT03393403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91956170|NCT03393403|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956171|NCT03393403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956172|NCT03393403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956173|NCT03399955|Amphotericin B|amphotericin b|mesh-list
91956174|NCT03399955|Paromomycin|paromomycin|mesh-list
91956175|NCT03399955|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91956176|NCT03399955|Miltefosine|miltefosine|mesh-list
91956177|NCT03399955|Amebicides|amebicides|mesh-ancestor
91956178|NCT03399955|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91956179|NCT03399955|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91956180|NCT03399955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956181|NCT03399955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91956182|NCT03399955|Antifungal Agents|antifungal agents|mesh-ancestor
91956183|NCT03399955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956184|NCT03397199|Apatinib|apatinib|mesh-list
91956185|NCT03397199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956186|NCT03397199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91956187|NCT03397199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956188|NCT03397199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956189|NCT05188053|Ketorolac|ketorolac|mesh-list
91956190|NCT05188053|Epinephrine|epinephrine|mesh-list
91956191|NCT05188053|Ropivacaine|ropivacaine|mesh-list
91956192|NCT05188053|Anesthetics, Local|anesthetics, local|mesh-ancestor
91956193|NCT05188053|Anesthetics|anesthetics|mesh-ancestor
91956194|NCT05188053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956209|NCT05188053|Sympathomimetics|sympathomimetics|mesh-ancestor
91956210|NCT05188053|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91956211|NCT05188053|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91956212|NCT05188053|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956214|NCT05188053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956215|NCT05188053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956216|NCT05188053|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91956217|NCT05188053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956219|NCT03393325|Vasodilator Agents|vasodilator agents|mesh-ancestor
91956220|NCT03393325|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91944712|NCT05155969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91944714|NCT05112913|Immunologic Factors|immunologic factors|mesh-ancestor
91956221|NCT03393325|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91956222|NCT03393325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956223|NCT03393325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956224|NCT03393325|Urological Agents|urological agents|mesh-ancestor
91956225|NCT03399643|Atezolizumab|atezolizumab|mesh-list
91956226|NCT03399643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91956227|NCT03399643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956228|NCT03399643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956229|NCT03399643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956230|NCT03393247|Infliximab|infliximab|mesh-list
91956231|NCT03393247|Azathioprine|azathioprine|mesh-list
91956232|NCT03393247|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91956233|NCT03393247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956234|NCT03393247|Dermatologic Agents|dermatologic agents|mesh-ancestor
91956235|NCT03393247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91956236|NCT03393247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956237|NCT03393247|Antimetabolites|antimetabolites|mesh-ancestor
91956238|NCT03393247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956239|NCT03393247|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91956240|NCT03393247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956241|NCT03393247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91956242|NCT03393247|Immunologic Factors|immunologic factors|mesh-ancestor
91956243|NCT03393247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956244|NCT03407027|Triamcinolone|triamcinolone|mesh-list
91956245|NCT03407027|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91956246|NCT03407027|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91956247|NCT03407027|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91956248|NCT03407027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956249|NCT03407027|Glucocorticoids|glucocorticoids|mesh-ancestor
91956251|NCT03407027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956252|NCT03407027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956253|NCT03407027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91956281|NCT05161429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956282|NCT03984045|Lidocaine|lidocaine|mesh-list
91956283|NCT03984045|Prochlorperazine|prochlorperazine|mesh-list
91956284|NCT03984045|Anesthetics, Local|anesthetics, local|mesh-ancestor
91956285|NCT03984045|Anesthetics|anesthetics|mesh-ancestor
91956286|NCT03984045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956287|NCT03984045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956288|NCT03984045|Sensory System Agents|sensory system agents|mesh-ancestor
91956289|NCT03984045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956290|NCT03984045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91956291|NCT03984045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91956292|NCT03984045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91956293|NCT03984045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91956294|NCT03984045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956295|NCT03984045|Antiemetics|antiemetics|mesh-ancestor
91956296|NCT03984045|Autonomic Agents|autonomic agents|mesh-ancestor
91956297|NCT03984045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91956298|NCT03984045|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91956299|NCT03984045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956300|NCT03984045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956301|NCT03984045|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91956302|NCT03984045|Dopamine Agents|dopamine agents|mesh-ancestor
91956320|NCT03397069|Anesthetics|anesthetics|mesh-ancestor
91956321|NCT03397069|GABA Modulators|gaba modulators|mesh-ancestor
91956322|NCT03397069|GABA Agents|gaba agents|mesh-ancestor
91956323|NCT03397069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956324|NCT03397069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956325|NCT03396497|Pembrolizumab|pembrolizumab|mesh-list
91956326|NCT03396497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956327|NCT03396497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956328|NCT03396497|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91956329|NCT03396497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956331|NCT03399019|Dexmedetomidine|dexmedetomidine|mesh-list
91956332|NCT03399019|Propofol|propofol|mesh-list
91944715|NCT05112913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956333|NCT03399019|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956334|NCT03399019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956335|NCT03399019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956336|NCT03399019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956337|NCT03399019|Analgesics|analgesics|mesh-ancestor
91956338|NCT03399019|Sensory System Agents|sensory system agents|mesh-ancestor
91956339|NCT03399019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956340|NCT03399019|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91956341|NCT03399019|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91956342|NCT03399019|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91956343|NCT03399019|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956344|NCT03399019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956345|NCT03399019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956346|NCT03399019|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956347|NCT03399019|Anesthetics, General|anesthetics, general|mesh-ancestor
91956348|NCT03399019|Anesthetics|anesthetics|mesh-ancestor
91956349|NCT03399019|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91956350|NCT03399019|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91956351|NCT03399019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956352|NCT03399019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956353|NCT03399019|GABA Modulators|gaba modulators|mesh-ancestor
91956354|NCT03399019|GABA Agents|gaba agents|mesh-ancestor
91956355|NCT04452383|Ketamine|ketamine|mesh-list
91956356|NCT04452383|Propofol|propofol|mesh-list
91956357|NCT04452383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956358|NCT04452383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956359|NCT04452383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956370|NCT04452383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956372|NCT02520479|Asparaginase|asparaginase|mesh-list
91956373|NCT02520479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956374|NCT02520947|Desflurane|desflurane|mesh-list
91956375|NCT02520947|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91956377|NCT02520947|Anesthetics|anesthetics|mesh-ancestor
91956378|NCT02520947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956379|NCT02520947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956380|NCT03398941|Octreotide|octreotide|mesh-list
91956381|NCT03398941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91956382|NCT03398941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91956383|NCT03398941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956384|NCT03396601|Ketamine|ketamine|mesh-list
91956385|NCT03396601|Analgesics|analgesics|mesh-ancestor
91956386|NCT03396601|Sensory System Agents|sensory system agents|mesh-ancestor
91956387|NCT03396601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956388|NCT03396601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956389|NCT03396601|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91956390|NCT03396601|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956391|NCT03396601|Anesthetics, General|anesthetics, general|mesh-ancestor
91956392|NCT03396601|Anesthetics|anesthetics|mesh-ancestor
91956393|NCT03396601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956394|NCT03396601|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91956395|NCT03396601|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91956396|NCT03396601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956397|NCT03396601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956398|NCT03392623|Niacinamide|niacinamide|mesh-list
91956399|NCT03392623|Niacin|niacin|mesh-list
91956400|NCT03392623|Nicotinic Acids|nicotinic acids|mesh-list
91956401|NCT03392623|Tretinoin|tretinoin|mesh-list
91956402|NCT03392623|Sunscreening Agents|sunscreening agents|mesh-list
91956403|NCT03392623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956404|NCT03392623|Keratolytic Agents|keratolytic agents|mesh-ancestor
91956405|NCT03392623|Dermatologic Agents|dermatologic agents|mesh-ancestor
91956406|NCT03392623|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91956407|NCT03392623|Protective Agents|protective agents|mesh-ancestor
91956408|NCT03392623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956409|NCT03392623|Vitamin B Complex|vitamin b complex|mesh-ancestor
91956410|NCT03392623|Vitamins|vitamins|mesh-ancestor
91956411|NCT03392623|Micronutrients|micronutrients|mesh-ancestor
91956412|NCT03392623|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91956413|NCT03392623|Antimetabolites|antimetabolites|mesh-ancestor
91956414|NCT03392623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956415|NCT03392623|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91944717|NCT03475459|Antioxidants|antioxidants|mesh-ancestor
91944718|NCT03475459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944719|NCT03475459|Protective Agents|protective agents|mesh-ancestor
91956416|NCT03392623|Vasodilator Agents|vasodilator agents|mesh-ancestor
91956417|NCT03396107|Dexamethasone|dexamethasone|mesh-list
91956418|NCT03396107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956419|NCT03396107|Antiemetics|antiemetics|mesh-ancestor
91956420|NCT03396107|Autonomic Agents|autonomic agents|mesh-ancestor
91956421|NCT03396107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956422|NCT03396107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956423|NCT03396107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91956424|NCT03396107|Glucocorticoids|glucocorticoids|mesh-ancestor
91956445|NCT03398785|Sympathomimetics|sympathomimetics|mesh-ancestor
91956446|NCT03398785|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91956447|NCT03392545|Adjuvants, Immunologic|adjuvants, immunologic|mesh-list
91956448|NCT03392545|Immunologic Factors|immunologic factors|mesh-ancestor
91956449|NCT03392545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956450|NCT03126695|Ticagrelor|ticagrelor|mesh-list
91956451|NCT03126695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91956452|NCT03126695|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91956453|NCT03126695|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91956454|NCT03126695|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91956455|NCT03126695|Purinergic Agents|purinergic agents|mesh-ancestor
91956456|NCT03126695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956457|NCT03126695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956458|NCT03126695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956459|NCT04647643|Paclitaxel|paclitaxel|mesh-list
91956460|NCT04647643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91956461|NCT04647643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956462|NCT04647643|Tubulin Modulators|tubulin modulators|mesh-ancestor
91956463|NCT04647643|Antimitotic Agents|antimitotic agents|mesh-ancestor
91956464|NCT04647643|Mitosis Modulators|mitosis modulators|mesh-ancestor
91956465|NCT04647643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956466|NCT04167761|Ertugliflozin|ertugliflozin|mesh-list
91956467|NCT04167761|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91956468|NCT04167761|Glipizide|glipizide|mesh-list
91956469|NCT04167761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956470|NCT04167761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91956471|NCT04167761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956472|NCT03401177|Naproxen|naproxen|mesh-list
91956473|NCT03401177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91956474|NCT03401177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956475|NCT03401177|Analgesics|analgesics|mesh-ancestor
91956476|NCT03401177|Sensory System Agents|sensory system agents|mesh-ancestor
91956486|NCT04446715|Meperidine|meperidine|mesh-list
91956487|NCT04446715|Bupivacaine|bupivacaine|mesh-list
91956488|NCT04446715|Anesthetics, Local|anesthetics, local|mesh-ancestor
91956489|NCT04446715|Anesthetics|anesthetics|mesh-ancestor
91956490|NCT04446715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956491|NCT04446715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956492|NCT04446715|Sensory System Agents|sensory system agents|mesh-ancestor
91956493|NCT04446715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956494|NCT04446715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91956495|NCT04446715|Narcotics|narcotics|mesh-ancestor
91956496|NCT04446715|Analgesics|analgesics|mesh-ancestor
91956497|NCT04446715|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91956498|NCT04446715|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956499|NCT04446715|Anesthetics, General|anesthetics, general|mesh-ancestor
91956500|NCT03398473|Epoetin Alfa|epoetin alfa|mesh-list
91956501|NCT03398473|Hematinics|hematinics|mesh-ancestor
91956502|NCT03395951|Diuretics|diuretics|mesh-list
91956503|NCT03395951|Natriuretic Agents|natriuretic agents|mesh-ancestor
91956504|NCT03395951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956505|NCT04535791|Vitamin D|vitamin d|mesh-list
91956506|NCT04535791|Cholecalciferol|cholecalciferol|mesh-list
91956507|NCT04535791|Vitamins|vitamins|mesh-ancestor
91956508|NCT04535791|Micronutrients|micronutrients|mesh-ancestor
91956509|NCT04535791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956510|NCT04535791|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91956511|NCT04535791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91956512|NCT03395873|Decitabine|decitabine|mesh-list
91956513|NCT03395873|Avelumab|avelumab|mesh-list
91956514|NCT03395873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944720|NCT03475459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944721|NCT03475459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944722|NCT03478111|Infliximab|infliximab|mesh-list
91944723|NCT03478111|Methotrexate|methotrexate|mesh-list
91944724|NCT03478111|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91944725|NCT03478111|Abortifacient Agents|abortifacient agents|mesh-ancestor
91944726|NCT03478111|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91944727|NCT03478111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956515|NCT03395873|Antimetabolites|antimetabolites|mesh-ancestor
91956516|NCT03395873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956517|NCT03395873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956518|NCT03395873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956519|NCT03395873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956520|NCT04447625|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91956521|NCT04447625|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91956522|NCT04447625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956523|NCT04447625|Antitubercular Agents|antitubercular agents|mesh-ancestor
91956524|NCT03396523|Losartan|losartan|mesh-list
91956525|NCT03396523|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91956526|NCT03396523|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91956527|NCT03396523|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91956528|NCT03396523|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91956529|NCT03396523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956530|NCT03126097|Drospirenone|drospirenone|mesh-list
91956531|NCT03126097|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91956532|NCT03126097|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
91956533|NCT03126097|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91956534|NCT03126097|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91956535|NCT03126097|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91956536|NCT03126097|Contraceptive Agents|contraceptive agents|mesh-ancestor
91956537|NCT03126097|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91956538|NCT03126097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956539|NCT03126097|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91956540|NCT03126097|Estrogens|estrogens|mesh-ancestor
91956541|NCT03126097|Hormones|hormones|mesh-ancestor
91956542|NCT03126097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956553|NCT03398083|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956554|NCT03398083|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956556|NCT03398083|GABA Agents|gaba agents|mesh-ancestor
91956557|NCT03398083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956558|NCT03398083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956559|NCT03392311|Calcipotriene|calcipotriene|mesh-list
91956560|NCT03392311|Dermatologic Agents|dermatologic agents|mesh-ancestor
91956561|NCT03126721|Midazolam|midazolam|mesh-list
91956562|NCT03126721|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91956563|NCT03126721|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956564|NCT03126721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956565|NCT03126721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956566|NCT03126721|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91956567|NCT03126721|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956568|NCT03126721|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956569|NCT03126721|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956570|NCT03126721|Anesthetics, General|anesthetics, general|mesh-ancestor
91956571|NCT03126721|Anesthetics|anesthetics|mesh-ancestor
91956572|NCT03126721|GABA Modulators|gaba modulators|mesh-ancestor
91956573|NCT03126721|GABA Agents|gaba agents|mesh-ancestor
91956574|NCT03126721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956575|NCT03126721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956576|NCT04928521|Bupivacaine|bupivacaine|mesh-list
91956577|NCT04928521|Anesthetics, Local|anesthetics, local|mesh-ancestor
91956578|NCT04928521|Anesthetics|anesthetics|mesh-ancestor
91956579|NCT04928521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956580|NCT04928521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956581|NCT04928521|Sensory System Agents|sensory system agents|mesh-ancestor
91956582|NCT04928521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956583|NCT02823847|Carbon Monoxide|carbon monoxide|mesh-list
91944728|NCT03478111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91944730|NCT03478111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956584|NCT02823847|Antimetabolites|antimetabolites|mesh-ancestor
91956585|NCT02823847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956586|NCT02823847|Gasotransmitters|gasotransmitters|mesh-ancestor
91956587|NCT02823847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956588|NCT02823847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956589|NCT03391843|Cetuximab|cetuximab|mesh-list
91956590|NCT03391843|Oxaliplatin|oxaliplatin|mesh-list
91956591|NCT03391843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956592|NCT03391843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956593|NCT03389659|Vitamin D|vitamin d|mesh-list
91956594|NCT03389659|Cholecalciferol|cholecalciferol|mesh-list
91956595|NCT03389659|Vitamins|vitamins|mesh-ancestor
91956596|NCT03389659|Micronutrients|micronutrients|mesh-ancestor
91956597|NCT03389659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956598|NCT03389659|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91956599|NCT03389659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91956600|NCT04446637|Albuterol|albuterol|mesh-list
91956601|NCT04446637|Ipratropium|ipratropium|mesh-list
91956602|NCT04446637|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91956603|NCT04446637|Autonomic Agents|autonomic agents|mesh-ancestor
91956604|NCT04446637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956605|NCT04446637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956606|NCT04446637|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91956607|NCT04446637|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956608|NCT04446637|Tocolytic Agents|tocolytic agents|mesh-ancestor
91956627|NCT03395977|Gout Suppressants|gout suppressants|mesh-ancestor
91956628|NCT03395977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956629|NCT02678143|Mycophenolic Acid|mycophenolic acid|mesh-list
91956630|NCT02678143|Sirolimus|sirolimus|mesh-list
91956631|NCT02678143|Cyclophosphamide|cyclophosphamide|mesh-list
91956632|NCT02678143|Fludarabine|fludarabine|mesh-list
91956633|NCT02678143|Alemtuzumab|alemtuzumab|mesh-list
91956634|NCT02678143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91956635|NCT02678143|Immunologic Factors|immunologic factors|mesh-ancestor
91956636|NCT02678143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956637|NCT02678143|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956638|NCT02678143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91956639|NCT02678143|Alkylating Agents|alkylating agents|mesh-ancestor
91956640|NCT02678143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956641|NCT02678143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956642|NCT02678143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91956643|NCT02678143|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91956644|NCT02678143|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91956645|NCT02678143|Antitubercular Agents|antitubercular agents|mesh-ancestor
91956646|NCT02678143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91956647|NCT02678143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956648|NCT02678143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956649|NCT02678143|Antifungal Agents|antifungal agents|mesh-ancestor
91956650|NCT02678143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956652|NCT03395093|Midazolam|midazolam|mesh-list
91956653|NCT03395093|Propofol|propofol|mesh-list
91956654|NCT03395093|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956907|NCT03388853|Antitussive Agents|antitussive agents|mesh-ancestor
91956655|NCT03395093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956656|NCT03395093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956657|NCT03395093|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956658|NCT03395093|Anesthetics, General|anesthetics, general|mesh-ancestor
91956659|NCT03395093|Anesthetics|anesthetics|mesh-ancestor
91956660|NCT03395093|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91956661|NCT03395093|Narcotics|narcotics|mesh-ancestor
91956662|NCT03395093|Analgesics|analgesics|mesh-ancestor
91956663|NCT03395093|Sensory System Agents|sensory system agents|mesh-ancestor
91956664|NCT03395093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956665|NCT03395093|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91956666|NCT03395093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91956696|NCT03398993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956697|NCT03398993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956699|NCT03398993|Fertility Agents|fertility agents|mesh-ancestor
91944731|NCT03478111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944732|NCT03478111|Dermatologic Agents|dermatologic agents|mesh-ancestor
91956700|NCT03398993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91956701|NCT03398993|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91956702|NCT03398993|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91956703|NCT04249297|Dydrogesterone|dydrogesterone|mesh-list
91956704|NCT04249297|Progestins|progestins|mesh-ancestor
91956705|NCT04249297|Hormones|hormones|mesh-ancestor
91956706|NCT04249297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956707|NCT04249297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956708|NCT03391609|Dexmedetomidine|dexmedetomidine|mesh-list
91956709|NCT03391609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956710|NCT03391609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956711|NCT03391609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956727|NCT03398837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956728|NCT03398837|Hormones|hormones|mesh-ancestor
91956729|NCT03398837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956730|NCT03398837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956731|NCT03398837|Hallucinogens|hallucinogens|mesh-ancestor
91956732|NCT03398837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956733|NCT03398837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956734|NCT03398837|Analgesics|analgesics|mesh-ancestor
91956735|NCT03398837|Sensory System Agents|sensory system agents|mesh-ancestor
91956736|NCT03398837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956737|NCT03398759|Butorphanol|butorphanol|mesh-list
91956738|NCT03398759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91956739|NCT03398759|Narcotics|narcotics|mesh-ancestor
91956740|NCT03398759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956741|NCT03398759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956743|NCT03398759|Sensory System Agents|sensory system agents|mesh-ancestor
91956744|NCT03398759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956745|NCT03398759|Antitussive Agents|antitussive agents|mesh-ancestor
91956746|NCT03398759|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956747|NCT03398759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91956748|NCT03391219|Bevacizumab|bevacizumab|mesh-list
91956749|NCT03391219|Fasudil|fasudil|mesh-list
91956750|NCT03391219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956751|NCT03391219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956752|NCT03391219|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91956753|NCT03391219|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91956754|NCT03391219|Growth Substances|growth substances|mesh-ancestor
91956755|NCT03391219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956756|NCT03391219|Growth Inhibitors|growth inhibitors|mesh-ancestor
91956757|NCT03391219|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91956758|NCT03391219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91956759|NCT03391219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956760|NCT03391219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91956761|NCT03391219|Vasodilator Agents|vasodilator agents|mesh-ancestor
91956762|NCT03391219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91956763|NCT03391219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956764|NCT04446923|Propranolol|propranolol|mesh-list
91956765|NCT04446923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91956766|NCT04446923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91956767|NCT04446923|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956802|NCT03394001|Anesthetics|anesthetics|mesh-ancestor
91956803|NCT03394001|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956804|NCT03394001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956805|NCT03394001|Sensory System Agents|sensory system agents|mesh-ancestor
91956806|NCT03394001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956807|NCT03394001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91956808|NCT03394001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91956809|NCT03394001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91956810|NCT03394001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91956828|NCT03389321|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
91956830|NCT03389321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956831|NCT03389321|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
91956832|NCT03389321|Enzyme Activators|enzyme activators|mesh-ancestor
91956833|NCT03393377|Valsartan|valsartan|mesh-list
91956834|NCT03393377|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91944733|NCT03478111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944734|NCT03478111|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91944735|NCT03478111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91956835|NCT03393377|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91956836|NCT03393377|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91956837|NCT03393377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956838|NCT02421263|Psilocybin|psilocybin|mesh-list
91956839|NCT02421263|Hallucinogens|hallucinogens|mesh-ancestor
91956840|NCT02421263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956841|NCT02421263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956842|NCT01889303|Docetaxel|docetaxel|mesh-list
91956843|NCT01889303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956844|NCT01889303|Tubulin Modulators|tubulin modulators|mesh-ancestor
91956845|NCT01889303|Antimitotic Agents|antimitotic agents|mesh-ancestor
91956846|NCT01889303|Mitosis Modulators|mitosis modulators|mesh-ancestor
91956847|NCT01889303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956848|NCT00783263|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91956849|NCT00783263|Ezetimibe|ezetimibe|mesh-list
91956850|NCT00783263|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91956851|NCT00783263|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91956852|NCT00783263|Antimetabolites|antimetabolites|mesh-ancestor
91956853|NCT00783263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956854|NCT00783263|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91956855|NCT00783263|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91956856|NCT00783263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956857|NCT00664937|Montelukast|montelukast|mesh-list
91956858|NCT00664937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91956859|NCT00664937|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956860|NCT00664937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91956861|NCT00664937|Hormone Antagonists|hormone antagonists|mesh-ancestor
91956862|NCT00664937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956863|NCT00664937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956864|NCT00664937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91956865|NCT00664937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91956880|NCT00540839|Hormone Antagonists|hormone antagonists|mesh-ancestor
91956881|NCT00540839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956882|NCT00540839|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91956883|NCT00540839|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91956884|NCT00540839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956885|NCT03389087|Etoposide|etoposide|mesh-list
91956886|NCT03389087|Apatinib|apatinib|mesh-list
91956887|NCT03389087|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91956888|NCT03389087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956889|NCT03389087|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91956890|NCT03389087|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91956891|NCT03389087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956892|NCT03389087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956893|NCT03389087|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91956894|NCT03388853|Acetylcysteine|acetylcysteine|mesh-list
91956895|NCT03388853|Doxofylline|doxofylline|mesh-list
91956896|NCT03388853|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91956897|NCT03388853|Antiviral Agents|antiviral agents|mesh-ancestor
91956898|NCT03388853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956899|NCT03388853|Expectorants|expectorants|mesh-ancestor
91956900|NCT03388853|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956901|NCT03388853|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91956902|NCT03388853|Antioxidants|antioxidants|mesh-ancestor
91956903|NCT03388853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956904|NCT03388853|Protective Agents|protective agents|mesh-ancestor
91956905|NCT03388853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956906|NCT03388853|Antidotes|antidotes|mesh-ancestor
91956908|NCT03388853|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91956909|NCT03388853|Autonomic Agents|autonomic agents|mesh-ancestor
91956910|NCT03388853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956911|NCT03388853|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91956912|NCT03388853|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91956913|NCT03388853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956914|NCT00380705|Montelukast|montelukast|mesh-list
91956915|NCT00380705|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91944736|NCT03478111|Immunologic Factors|immunologic factors|mesh-ancestor
91944737|NCT03478111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944738|NCT03478111|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944739|NCT03478111|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91956916|NCT00380705|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956917|NCT00380705|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91956918|NCT00380705|Hormone Antagonists|hormone antagonists|mesh-ancestor
91956919|NCT00380705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956920|NCT00380705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956921|NCT00380705|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91956922|NCT00380705|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91956923|NCT00380705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956942|NCT03388957|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956943|NCT03388957|Anesthetics, General|anesthetics, general|mesh-ancestor
91956944|NCT03388957|Anesthetics|anesthetics|mesh-ancestor
91956945|NCT03388957|GABA Modulators|gaba modulators|mesh-ancestor
91956946|NCT03388957|GABA Agents|gaba agents|mesh-ancestor
91956947|NCT03388957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956948|NCT03388957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956949|NCT03388957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91956950|NCT03388957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91956951|NCT03388957|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956952|NCT03388957|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91956953|NCT03388957|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91956954|NCT03388957|Vasodilator Agents|vasodilator agents|mesh-ancestor
91956955|NCT03395665|Estradiol|estradiol|mesh-list
91956956|NCT03395665|Progesterone|progesterone|mesh-list
91956957|NCT03395665|Estrogens|estrogens|mesh-ancestor
91956958|NCT03395665|Hormones|hormones|mesh-ancestor
91956959|NCT03395665|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956960|NCT03395665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956961|NCT03395665|Progestins|progestins|mesh-ancestor
91956962|NCT00535405|Atorvastatin|atorvastatin|mesh-list
91956963|NCT00535405|Simvastatin|simvastatin|mesh-list
91956964|NCT00535405|Ezetimibe|ezetimibe|mesh-list
91956965|NCT00535405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91956966|NCT00535405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91956967|NCT00535405|Antimetabolites|antimetabolites|mesh-ancestor
91956968|NCT00535405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956969|NCT00535405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91956970|NCT00535405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91956971|NCT00535405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956972|NCT03390595|Carboplatin|carboplatin|mesh-list
91956973|NCT03390595|Gemcitabine|gemcitabine|mesh-list
91956974|NCT03390595|Avelumab|avelumab|mesh-list
91956975|NCT03390595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956976|NCT03390595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91956977|NCT03390595|Antimetabolites|antimetabolites|mesh-ancestor
91956978|NCT03390595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956979|NCT03390595|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956980|NCT00271817|Niacin|niacin|mesh-list
91956981|NCT00271817|Niacinamide|niacinamide|mesh-list
91956982|NCT00271817|Nicotinic Acids|nicotinic acids|mesh-list
91956983|NCT00271817|Simvastatin|simvastatin|mesh-list
91956984|NCT00271817|Ezetimibe|ezetimibe|mesh-list
91957002|NCT03388541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91957003|NCT03388541|Analgesics|analgesics|mesh-ancestor
91957004|NCT03388541|Sensory System Agents|sensory system agents|mesh-ancestor
91957005|NCT03388541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957006|NCT03388541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91957007|NCT03388541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91957008|NCT03388541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91957009|NCT03388541|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957010|NCT03388541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957011|NCT03388541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957012|NCT00092989|Montelukast|montelukast|mesh-list
91957013|NCT00092989|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91957014|NCT00092989|Respiratory System Agents|respiratory system agents|mesh-ancestor
91957015|NCT00092989|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91944740|NCT03478111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944741|NCT03478111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957016|NCT00092989|Hormone Antagonists|hormone antagonists|mesh-ancestor
91957017|NCT00092989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957018|NCT00092989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957019|NCT00092989|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91957020|NCT00092989|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91957021|NCT00092989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957022|NCT03388463|Omeprazole|omeprazole|mesh-list
91957023|NCT03388463|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91957024|NCT03388463|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957025|NCT03388463|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91957026|NCT03388463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957027|NCT03388463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957028|NCT03858049|Dydrogesterone|dydrogesterone|mesh-list
91957029|NCT03858049|Progestins|progestins|mesh-ancestor
91957030|NCT03858049|Hormones|hormones|mesh-ancestor
91957031|NCT03858049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957032|NCT03858049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957033|NCT03388151|Midazolam|midazolam|mesh-list
91957034|NCT03388151|Propofol|propofol|mesh-list
91957035|NCT03388151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91957036|NCT03388151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957037|NCT03388151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957038|NCT03388151|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91957039|NCT03388151|Anesthetics, General|anesthetics, general|mesh-ancestor
91957060|NCT04501211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957061|NCT04501211|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91957062|NCT04501211|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91957063|NCT04501211|Serotonin Agents|serotonin agents|mesh-ancestor
91957064|NCT04501211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957065|NCT04501211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957066|NCT03126071|Bevacizumab|bevacizumab|mesh-list
91957067|NCT03126071|Oxaliplatin|oxaliplatin|mesh-list
91957068|NCT03126071|Irinotecan|irinotecan|mesh-list
91957069|NCT03126071|Raltitrexed|raltitrexed|mesh-list
91957070|NCT03126071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957071|NCT03126071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957072|NCT03126071|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91957073|NCT03126071|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91957074|NCT03126071|Growth Substances|growth substances|mesh-ancestor
91957075|NCT03126071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957076|NCT03126071|Growth Inhibitors|growth inhibitors|mesh-ancestor
91957077|NCT03126071|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91957078|NCT03126071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91957079|NCT03126071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957080|NCT03126071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957081|NCT03126071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91957082|NCT03126071|Antimetabolites|antimetabolites|mesh-ancestor
91957083|NCT03126071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91957084|NCT03392051|Clopidogrel|clopidogrel|mesh-list
91957085|NCT03392051|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957086|NCT03392051|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91957087|NCT03392051|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91957088|NCT03392051|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91957089|NCT03392051|Purinergic Agents|purinergic agents|mesh-ancestor
91957090|NCT03392051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957091|NCT03392051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957093|NCT04446533|Chlorhexidine|chlorhexidine|mesh-list
91957094|NCT04446533|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91957107|NCT03386591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91957108|NCT03386591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957109|NCT03386591|Sensory System Agents|sensory system agents|mesh-ancestor
91957110|NCT03386591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957111|NCT03386279|Moxifloxacin|moxifloxacin|mesh-list
91957112|NCT03386279|Abrocitinib|abrocitinib|mesh-list
91957113|NCT03386279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957114|NCT03386279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957115|NCT03386279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91944743|NCT03478033|Rifabutin|rifabutin|mesh-list
91944744|NCT03478033|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91944745|NCT03478033|Antitubercular Agents|antitubercular agents|mesh-ancestor
91944746|NCT03478033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957116|NCT03386279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91957117|NCT03386279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957118|NCT03386279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957119|NCT03386279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957120|NCT03386279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957121|NCT03386201|Methylene Blue|methylene blue|mesh-list
91957122|NCT03386201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957123|NCT03386201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957124|NCT03268811|Teduglutide|teduglutide|mesh-list
91957125|NCT03268811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957126|NCT03268811|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91957127|NCT03268811|Protective Agents|protective agents|mesh-ancestor
91957128|NCT03268811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957129|NCT03385967|Dexmedetomidine|dexmedetomidine|mesh-list
91957130|NCT03385967|Ropivacaine|ropivacaine|mesh-list
91957131|NCT03385967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91957132|NCT03385967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957133|NCT03385967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957134|NCT03385967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91957135|NCT03385967|Analgesics|analgesics|mesh-ancestor
91957136|NCT03385967|Sensory System Agents|sensory system agents|mesh-ancestor
91957137|NCT03385967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957138|NCT03385967|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91957139|NCT03385967|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91957140|NCT03385967|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91957141|NCT03385967|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957142|NCT03385967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957143|NCT03385967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957144|NCT03385967|Anesthetics, Local|anesthetics, local|mesh-ancestor
91957145|NCT03385967|Anesthetics|anesthetics|mesh-ancestor
91957146|NCT02732015|Dexamethasone|dexamethasone|mesh-list
91957147|NCT02732015|Dexamethasone acetate|dexamethasone acetate|mesh-list
91957148|NCT02732015|Doxorubicin|doxorubicin|mesh-list
91957149|NCT02732015|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91957150|NCT02732015|Vincristine|vincristine|mesh-list
91957151|NCT02732015|Daunorubicin|daunorubicin|mesh-list
91957152|NCT02732015|Ifosfamide|ifosfamide|mesh-list
91957153|NCT02732015|Isophosphamide mustard|isophosphamide mustard|mesh-list
91957154|NCT02732015|Ondansetron|ondansetron|mesh-list
91957155|NCT02732015|Fosaprepitant|fosaprepitant|mesh-list
91957156|NCT02732015|Aprepitant|aprepitant|mesh-list
91957157|NCT02732015|BB 1101|bb 1101|mesh-list
91957158|NCT02732015|Rolapitant|rolapitant|mesh-list
91957159|NCT02732015|Mesna|mesna|mesh-list
91957160|NCT02732015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91957161|NCT02732015|Antiemetics|antiemetics|mesh-ancestor
91957176|NCT02732015|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91957177|NCT02732015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91957178|NCT02732015|Tubulin Modulators|tubulin modulators|mesh-ancestor
91957179|NCT02732015|Antimitotic Agents|antimitotic agents|mesh-ancestor
91957182|NCT02732015|Dermatologic Agents|dermatologic agents|mesh-ancestor
91957183|NCT02732015|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91957184|NCT02732015|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91957185|NCT02732015|Serotonin Agents|serotonin agents|mesh-ancestor
91957186|NCT02732015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957187|NCT02732015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91957188|NCT02732015|Alkylating Agents|alkylating agents|mesh-ancestor
91957189|NCT02732015|Protective Agents|protective agents|mesh-ancestor
91957190|NCT02732015|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91957191|NCT02520245|Cemiplimab|cemiplimab|mesh-list
91957192|NCT02520245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957193|NCT02520245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957194|NCT03537833|Pemetrexed|pemetrexed|mesh-list
91957195|NCT03537833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957196|NCT03537833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957197|NCT03537833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957198|NCT03537833|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91944747|NCT03478033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944748|NCT03478033|Leprostatic Agents|leprostatic agents|mesh-ancestor
91944749|NCT03478033|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944750|NCT03478033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957199|NCT03537833|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91957200|NCT03439085|Durvalumab|durvalumab|mesh-list
91957201|NCT03439085|Interleukin-12|interleukin-12|mesh-list
91957202|NCT03439085|Vaccines|vaccines|mesh-list
91957203|NCT03439085|Immunoglobulins|immunoglobulins|mesh-list
91957204|NCT03439085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91957205|NCT03439085|Immunoglobulin G|immunoglobulin g|mesh-list
91957206|NCT03439085|Immunologic Factors|immunologic factors|mesh-ancestor
91957207|NCT03439085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957208|NCT03439085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957209|NCT03439085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957210|NCT03439085|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91957211|NCT03439085|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91957212|NCT03439085|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91957213|NCT03439085|Growth Substances|growth substances|mesh-ancestor
91957214|NCT03439085|Growth Inhibitors|growth inhibitors|mesh-ancestor
91957215|NCT01964807|Nicotine|nicotine|mesh-list
91957216|NCT01964807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91957217|NCT01964807|Autonomic Agents|autonomic agents|mesh-ancestor
91957218|NCT01964807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957219|NCT01964807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957238|NCT04446065|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
91957239|NCT04446065|Antioxidants|antioxidants|mesh-ancestor
91957240|NCT04446065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957241|NCT04446065|Protective Agents|protective agents|mesh-ancestor
91957242|NCT04446065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957244|NCT04446065|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91957245|NCT04446065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957246|NCT04446065|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91957247|NCT00225095|Hyaluronic Acid|hyaluronic acid|mesh-list
91957248|NCT00225095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91957249|NCT00225095|Immunologic Factors|immunologic factors|mesh-ancestor
91957250|NCT00225095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957251|NCT00225095|Viscosupplements|viscosupplements|mesh-ancestor
91957252|NCT00225095|Protective Agents|protective agents|mesh-ancestor
91957253|NCT02732119|Everolimus|everolimus|mesh-list
91957254|NCT02732119|Exemestane|exemestane|mesh-list
91957255|NCT02732119|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91957256|NCT02732119|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957257|NCT02732119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957258|NCT02732119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957259|NCT02732119|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91957260|NCT02732119|Immunologic Factors|immunologic factors|mesh-ancestor
91957261|NCT02732119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957262|NCT02732119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957263|NCT02732119|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91957264|NCT02732119|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91957265|NCT02732119|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91957266|NCT02732119|Hormone Antagonists|hormone antagonists|mesh-ancestor
91957267|NCT02732119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957269|NCT04448717|Immunologic Factors|immunologic factors|mesh-ancestor
91957270|NCT04448717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957271|NCT05174195|Desogestrel|desogestrel|mesh-list
91957272|NCT05174195|Etonogestrel|etonogestrel|mesh-list
91957273|NCT05174195|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91957274|NCT05174195|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91957275|NCT05174195|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91957276|NCT05174195|Contraceptive Agents|contraceptive agents|mesh-ancestor
91957288|NCT05238727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957289|NCT05238727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957291|NCT05238727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957292|NCT03754153|Atropine|atropine|mesh-list
91957293|NCT03754153|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91957294|NCT03754153|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91957295|NCT03754153|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91957296|NCT03754153|Autonomic Agents|autonomic agents|mesh-ancestor
91957297|NCT03754153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957298|NCT03754153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957299|NCT03754153|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91957300|NCT03754153|Respiratory System Agents|respiratory system agents|mesh-ancestor
91957302|NCT03754153|Parasympatholytics|parasympatholytics|mesh-ancestor
91957303|NCT03754153|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91957304|NCT03754153|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91957305|NCT03754153|Cholinergic Agents|cholinergic agents|mesh-ancestor
91957306|NCT03754153|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957307|NCT03754153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957308|NCT03380039|Cyclophosphamide|cyclophosphamide|mesh-list
91957309|NCT03380039|Fludarabine|fludarabine|mesh-list
91957310|NCT03380039|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91957311|NCT03380039|Immunologic Factors|immunologic factors|mesh-ancestor
91957312|NCT03380039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957313|NCT03380039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91957314|NCT03380039|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91957315|NCT03380039|Alkylating Agents|alkylating agents|mesh-ancestor
91957316|NCT03380039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957317|NCT03380039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957318|NCT03380039|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91957319|NCT03125213|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91957320|NCT03125213|Antiviral Agents|antiviral agents|mesh-ancestor
91957321|NCT03125213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957322|NCT02520817|Vitamins|vitamins|mesh-list
91957323|NCT02520817|Vitamin E|vitamin e|mesh-list
91957324|NCT02520817|Vitamin A|vitamin a|mesh-list
91957325|NCT02520817|Lactulose|lactulose|mesh-list
91957326|NCT02520817|Micronutrients|micronutrients|mesh-ancestor
91957327|NCT02520817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957328|NCT02520817|Antioxidants|antioxidants|mesh-ancestor
91957329|NCT02520817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957330|NCT02520817|Protective Agents|protective agents|mesh-ancestor
91957331|NCT02520817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957333|NCT03387943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957334|NCT03384095|Hyaluronic Acid|hyaluronic acid|mesh-list
91957335|NCT03384095|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91957336|NCT03384095|Immunologic Factors|immunologic factors|mesh-ancestor
91957337|NCT03384095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957338|NCT03384095|Viscosupplements|viscosupplements|mesh-ancestor
91957339|NCT03384095|Protective Agents|protective agents|mesh-ancestor
91957340|NCT03379181|Propranolol|propranolol|mesh-list
91957354|NCT03383939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957355|NCT03383939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957356|NCT03379103|Propofol|propofol|mesh-list
91957357|NCT03379103|Sevoflurane|sevoflurane|mesh-list
91957358|NCT03379103|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91957359|NCT03379103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957360|NCT03379103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957361|NCT03379103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91957362|NCT03379103|Anesthetics, General|anesthetics, general|mesh-ancestor
91957363|NCT03379103|Anesthetics|anesthetics|mesh-ancestor
91957364|NCT03379103|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957366|NCT03387631|Lumefantrine|lumefantrine|mesh-list
91957367|NCT03387631|Artemether|artemether|mesh-list
91957368|NCT03387631|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91957369|NCT03387631|Antimalarials|antimalarials|mesh-ancestor
91957370|NCT03387631|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91957371|NCT03387631|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91957372|NCT03387631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957373|NCT03383393|Adenosine|adenosine|mesh-list
91957374|NCT03383393|Eptifibatide|eptifibatide|mesh-list
91957375|NCT03383393|Analgesics|analgesics|mesh-ancestor
91957376|NCT03383393|Sensory System Agents|sensory system agents|mesh-ancestor
91957377|NCT03383393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957378|NCT03383393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957379|NCT03383393|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91957380|NCT03383393|Vasodilator Agents|vasodilator agents|mesh-ancestor
91957381|NCT03383393|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91957382|NCT03383393|Purinergic Agonists|purinergic agonists|mesh-ancestor
91957383|NCT03383393|Purinergic Agents|purinergic agents|mesh-ancestor
91944751|NCT03478033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944752|NCT03478033|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91944753|NCT03478033|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91944754|NCT03478033|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91957384|NCT03383393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957385|NCT03383393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957386|NCT03383393|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957388|NCT03394807|Anesthetics, Local|anesthetics, local|mesh-ancestor
91957389|NCT03394807|Anesthetics|anesthetics|mesh-ancestor
91957390|NCT03394807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957391|NCT03394807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957392|NCT03394807|Sensory System Agents|sensory system agents|mesh-ancestor
91957393|NCT03394807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957395|NCT03383315|Metoclopramide|metoclopramide|mesh-list
91957396|NCT03383315|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91957397|NCT03383315|Narcotics|narcotics|mesh-ancestor
91957398|NCT03383315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957399|NCT03383315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957400|NCT03383315|Analgesics|analgesics|mesh-ancestor
91957401|NCT03383315|Sensory System Agents|sensory system agents|mesh-ancestor
91957402|NCT03383315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957403|NCT03383315|Antiemetics|antiemetics|mesh-ancestor
91957421|NCT03252925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957422|NCT03252925|Protective Agents|protective agents|mesh-ancestor
91957423|NCT03252925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957424|NCT03252925|Antidotes|antidotes|mesh-ancestor
91957425|NCT03383237|Apatinib|apatinib|mesh-list
91957426|NCT03383237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957427|NCT03383237|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957428|NCT03383237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957429|NCT03383237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957430|NCT03387241|Fluticasone|fluticasone|mesh-list
91957432|NCT03387241|Formoterol Fumarate|formoterol fumarate|mesh-list
91957433|NCT03387241|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91957434|NCT03387241|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91957435|NCT03387241|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91957436|NCT03387241|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91957437|NCT03387241|Autonomic Agents|autonomic agents|mesh-ancestor
91957438|NCT03387241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957439|NCT03387241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957440|NCT03387241|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91957441|NCT03387241|Respiratory System Agents|respiratory system agents|mesh-ancestor
91957442|NCT03387241|Dermatologic Agents|dermatologic agents|mesh-ancestor
91957443|NCT03387241|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91957444|NCT03387241|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91957445|NCT03387241|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91957446|NCT03387241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91957447|NCT03387241|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957448|NCT03387241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957449|NCT03387241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957450|NCT03387241|Glucocorticoids|glucocorticoids|mesh-ancestor
91957451|NCT03387241|Hormones|hormones|mesh-ancestor
91957452|NCT03387241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957453|NCT03387241|Sympathomimetics|sympathomimetics|mesh-ancestor
91957454|NCT03378791|Ferrous fumarate|ferrous fumarate|mesh-list
91957455|NCT03378791|Trace Elements|trace elements|mesh-ancestor
91957456|NCT03378791|Micronutrients|micronutrients|mesh-ancestor
91957457|NCT03378791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957458|NCT03383003|Amoxicillin|amoxicillin|mesh-list
91957459|NCT03383003|Metronidazole|metronidazole|mesh-list
91957460|NCT03383003|Clarithromycin|clarithromycin|mesh-list
91957461|NCT03383003|Esomeprazole|esomeprazole|mesh-list
91957462|NCT03383003|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957463|NCT03383003|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957480|NCT03378713|Hormones|hormones|mesh-ancestor
91944755|NCT03478033|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91944756|NCT03478033|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91957481|NCT03378713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957482|NCT03378713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957483|NCT03378713|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91957484|NCT03378713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957485|NCT03378713|Anabolic Agents|anabolic agents|mesh-ancestor
91957486|NCT03378401|Octenidine|octenidine|mesh-list
91957487|NCT03378401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957488|NCT03378401|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91957489|NCT03378323|Anesthetics|anesthetics|mesh-list
91957490|NCT03378323|Anesthetics, Local|anesthetics, local|mesh-list
91957491|NCT03378323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957492|NCT03378323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957493|NCT03378323|Sensory System Agents|sensory system agents|mesh-ancestor
91957494|NCT03378323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957495|NCT01327885|Dacarbazine|dacarbazine|mesh-list
91957496|NCT01327885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91957497|NCT01327885|Alkylating Agents|alkylating agents|mesh-ancestor
91957498|NCT01327885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957499|NCT01327885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957500|NCT03381833|Hepcidins|hepcidins|mesh-list
91957501|NCT03381833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957502|NCT02976337|Naloxone|naloxone|mesh-list
91957503|NCT02976337|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91957504|NCT02976337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957505|NCT02976337|Sensory System Agents|sensory system agents|mesh-ancestor
91957506|NCT02976337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957507|NCT03377465|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
91957508|NCT03377465|N,N-dimethylarginine|n,n-dimethylarginine|mesh-list
91957509|NCT03377465|Natriuretic Agents|natriuretic agents|mesh-ancestor
91957510|NCT03377465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957511|NCT03377465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957512|NCT03377465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957513|NCT03381755|Ticagrelor|ticagrelor|mesh-list
91957514|NCT03381755|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957515|NCT03381755|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91957516|NCT03381755|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91957517|NCT03381755|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91957518|NCT03381755|Purinergic Agents|purinergic agents|mesh-ancestor
91957519|NCT03381755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957520|NCT03381755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957537|NCT05237791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957538|NCT05237791|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91957540|NCT05237791|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91957541|NCT05237791|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91957542|NCT05237791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957543|NCT05237791|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91957544|NCT05237791|Tocolytic Agents|tocolytic agents|mesh-ancestor
91957545|NCT05237791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91957546|NCT03381599|Lenograstim|lenograstim|mesh-list
91957547|NCT03381599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91957548|NCT03381599|Immunologic Factors|immunologic factors|mesh-ancestor
91957549|NCT03381599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957550|NCT03394573|Aflibercept|aflibercept|mesh-list
91957551|NCT03394573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91957552|NCT03394573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91957553|NCT03394573|Growth Substances|growth substances|mesh-ancestor
91957554|NCT03394573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957555|NCT03394573|Growth Inhibitors|growth inhibitors|mesh-ancestor
91957556|NCT03394573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957557|NCT03381053|Imatinib Mesylate|imatinib mesylate|mesh-list
91957558|NCT03381053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957559|NCT03381053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957560|NCT03381053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957561|NCT03381053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957562|NCT03380975|Montelukast|montelukast|mesh-list
91957563|NCT03380975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91957564|NCT03380975|Respiratory System Agents|respiratory system agents|mesh-ancestor
91957565|NCT03380975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91944757|NCT03478033|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91944759|NCT03477955|Trace Elements|trace elements|mesh-ancestor
91944760|NCT03477955|Micronutrients|micronutrients|mesh-ancestor
91944761|NCT03477955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944762|NCT05189197|Zanubrutinib|zanubrutinib|mesh-list
91944763|NCT05189197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944764|NCT05189197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91944765|NCT05189197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944766|NCT05189197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944767|NCT05084599|Metaraminol|metaraminol|mesh-list
91944768|NCT05084599|Sympathomimetics|sympathomimetics|mesh-ancestor
91944769|NCT05084599|Autonomic Agents|autonomic agents|mesh-ancestor
91944770|NCT05084599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944771|NCT05084599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944772|NCT05084599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91944773|NCT05084599|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91944774|NCT05084599|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91944776|NCT05084599|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944777|NCT05084599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944778|NCT05084599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957566|NCT03380975|Hormone Antagonists|hormone antagonists|mesh-ancestor
91957567|NCT03380975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957568|NCT03380975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957569|NCT03380975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91957570|NCT03380975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91957571|NCT03380975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957572|NCT03460015|Propofol|propofol|mesh-list
91957573|NCT03460015|Sevoflurane|sevoflurane|mesh-list
91957574|NCT03460015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91957593|NCT03375515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957595|NCT03375515|Sensory System Agents|sensory system agents|mesh-ancestor
91957596|NCT03375515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957597|NCT03099863|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
91957598|NCT03099863|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91957599|NCT03099863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957600|NCT03099863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957601|NCT03374501|PAZ320|paz320|mesh-list
91957602|NCT03374501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91957603|NCT03374501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957604|NCT03374345|Juzentaihoto|juzentaihoto|mesh-list
91957605|NCT03374345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957606|NCT03374345|Mitogens|mitogens|mesh-ancestor
91957607|NCT03374345|Mitosis Modulators|mitosis modulators|mesh-ancestor
91957608|NCT03374345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957609|NCT03373955|Pembrolizumab|pembrolizumab|mesh-list
91957610|NCT03373955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957611|NCT03373955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957612|NCT03373955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91957613|NCT03373955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944779|NCT02505542|Certolizumab Pegol|certolizumab pegol|mesh-list
91944780|NCT02505542|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91944781|NCT02505542|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944782|NCT02505542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91957614|NCT02814695|Ascorbic Acid|ascorbic acid|mesh-list
91957615|NCT02814695|Antioxidants|antioxidants|mesh-ancestor
91957616|NCT02814695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957617|NCT02814695|Protective Agents|protective agents|mesh-ancestor
91957618|NCT02814695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957619|NCT02814695|Vitamins|vitamins|mesh-ancestor
91957620|NCT02814695|Micronutrients|micronutrients|mesh-ancestor
91957621|NCT03386305|Tacrolimus|tacrolimus|mesh-list
91957622|NCT03386305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91957623|NCT03386305|Immunologic Factors|immunologic factors|mesh-ancestor
91957624|NCT03386305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957625|NCT03386305|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91957626|NCT03386305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957627|NCT03386305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957628|NCT03386227|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91957643|NCT05237323|Immunologic Factors|immunologic factors|mesh-ancestor
91957644|NCT05237323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957645|NCT05237323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91957646|NCT02520505|Citric Acid|citric acid|mesh-list
91957647|NCT02520505|Sodium Citrate|sodium citrate|mesh-list
91957648|NCT02520505|Clomiphene|clomiphene|mesh-list
91957649|NCT02520505|Enclomiphene|enclomiphene|mesh-list
91957650|NCT02520505|Zuclomiphene|zuclomiphene|mesh-list
91957651|NCT02520505|Anticoagulants|anticoagulants|mesh-ancestor
91957652|NCT02520505|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91957653|NCT02520505|Chelating Agents|chelating agents|mesh-ancestor
91957654|NCT02520505|Sequestering Agents|sequestering agents|mesh-ancestor
91957655|NCT02520505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957656|NCT02520505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91957657|NCT02520505|Hormone Antagonists|hormone antagonists|mesh-ancestor
91957658|NCT02520505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957659|NCT02520505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957660|NCT02520505|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91957661|NCT02520505|Fertility Agents|fertility agents|mesh-ancestor
91957662|NCT02520505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91957663|NCT02520505|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91957664|NCT02520505|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91957665|NCT03380689|Bevacizumab|bevacizumab|mesh-list
91957666|NCT03380689|Irinotecan|irinotecan|mesh-list
91957667|NCT03380689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957668|NCT03380689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957669|NCT03380689|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91957670|NCT03380689|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91957671|NCT03380689|Growth Substances|growth substances|mesh-ancestor
91957672|NCT03380689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957673|NCT03380689|Growth Inhibitors|growth inhibitors|mesh-ancestor
91957674|NCT03380689|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91957675|NCT03380689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91957676|NCT03380689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957677|NCT03380689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957678|NCT03380533|Buprenorphine|buprenorphine|mesh-list
91957679|NCT03380533|Tramadol|tramadol|mesh-list
91957680|NCT03380533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91957681|NCT03380533|Narcotics|narcotics|mesh-ancestor
91957682|NCT03380533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957683|NCT03380533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957684|NCT03380533|Analgesics|analgesics|mesh-ancestor
91957685|NCT03380533|Sensory System Agents|sensory system agents|mesh-ancestor
91957686|NCT03380533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957687|NCT03380533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91957688|NCT03386149|Loxoprofen|loxoprofen|mesh-list
91957689|NCT03386149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91957702|NCT03231085|Ferrous fumarate|ferrous fumarate|mesh-list
91957703|NCT03231085|Trace Elements|trace elements|mesh-ancestor
91957704|NCT03231085|Micronutrients|micronutrients|mesh-ancestor
91957705|NCT03231085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957706|NCT03385135|Allopurinol|allopurinol|mesh-list
91944783|NCT02505542|Immunologic Factors|immunologic factors|mesh-ancestor
91944784|NCT02505542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944785|NCT02505542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944786|NCT00701623|Heparin|heparin|mesh-list
91944787|NCT00701623|Calcium heparin|calcium heparin|mesh-list
91944788|NCT00701623|Anticoagulants|anticoagulants|mesh-ancestor
91944789|NCT00701623|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91944790|NCT00701623|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91944791|NCT00701623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944792|NCT04456153|Atovaquone|atovaquone|mesh-list
91944793|NCT04456153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944794|NCT04456153|Antimalarials|antimalarials|mesh-ancestor
91944795|NCT04456153|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91944796|NCT04456153|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91944797|NCT04456153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944798|NCT04456153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944799|NCT04403971|Chlorhexidine|chlorhexidine|mesh-list
91944800|NCT04403971|Listerine|listerine|mesh-list
91944801|NCT04403971|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91944802|NCT04403971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944803|NCT04403971|Disinfectants|disinfectants|mesh-ancestor
91944804|NCT02447432|Vaccines|vaccines|mesh-list
91944805|NCT02447432|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91944806|NCT02447432|Immunologic Factors|immunologic factors|mesh-ancestor
91944807|NCT02447432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944808|NCT02446886|Hormones|hormones|mesh-list
91944809|NCT02446886|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91944810|NCT02446886|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
91944811|NCT02446886|beta-Endorphin|beta-endorphin|mesh-list
91944812|NCT02446886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944813|NCT02446886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944814|NCT02446886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91944815|NCT02446886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944816|NCT04351243|Gimsilumab|gimsilumab|mesh-list
91944817|NCT04351243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91957707|NCT03385135|Antimetabolites|antimetabolites|mesh-ancestor
91957708|NCT03385135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957709|NCT03385135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957710|NCT03385135|Gout Suppressants|gout suppressants|mesh-ancestor
91957711|NCT03385135|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944818|NCT04351243|Antiviral Agents|antiviral agents|mesh-ancestor
91944819|NCT04351243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944820|NCT05008003|Vitamin D|vitamin d|mesh-list
91957712|NCT03385135|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91957713|NCT03385135|Antioxidants|antioxidants|mesh-ancestor
91957714|NCT03385135|Protective Agents|protective agents|mesh-ancestor
91957715|NCT03385135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957716|NCT00462943|Homoharringtonine|homoharringtonine|mesh-list
91957717|NCT00462943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91957718|NCT00462943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957719|NCT00462943|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91957720|NCT00462943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957721|NCT00462943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957722|NCT04436965|Cisplatin|cisplatin|mesh-list
91957723|NCT04436965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957725|NCT04420741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957726|NCT04420741|Vasodilator Agents|vasodilator agents|mesh-ancestor
91957727|NCT04409041|Naltrexone|naltrexone|mesh-list
91957728|NCT04409041|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91957729|NCT04409041|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91957730|NCT04409041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957731|NCT04409041|Sensory System Agents|sensory system agents|mesh-ancestor
91957732|NCT04409041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957733|NCT03090997|Vitamins|vitamins|mesh-list
91957734|NCT03090997|Ascorbic Acid|ascorbic acid|mesh-list
91957735|NCT03090997|Resveratrol|resveratrol|mesh-list
91957736|NCT03090997|Micronutrients|micronutrients|mesh-ancestor
91957737|NCT03090997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957738|NCT03090997|Antioxidants|antioxidants|mesh-ancestor
91957739|NCT03090997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957740|NCT03090997|Protective Agents|protective agents|mesh-ancestor
91957741|NCT03090997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957742|NCT03090997|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957743|NCT04446091|Irinotecan|irinotecan|mesh-list
91957744|NCT04446091|Apatinib|apatinib|mesh-list
91957745|NCT04446091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
91957746|NCT04446091|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91957747|NCT04446091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91957748|NCT04446091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957749|NCT04446091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957750|NCT04446091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957751|NCT04446091|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957752|NCT04446091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91957771|NCT03385057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91957773|NCT03385057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91957774|NCT03385057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91957775|NCT03385057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957776|NCT03385057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957778|NCT02051309|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91957779|NCT02051309|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91957780|NCT02051309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91957781|NCT02051309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91957782|NCT02051309|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957783|NCT02051309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957784|NCT02051309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957785|NCT02051309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957786|NCT00372073|Roscovitine|roscovitine|mesh-list
91957787|NCT00372073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957788|NCT00372073|Antiviral Agents|antiviral agents|mesh-ancestor
91957789|NCT00372073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957790|NCT00372073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957791|NCT00372073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957792|NCT00372073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957793|NCT03373409|Albuterol|albuterol|mesh-list
91957794|NCT03373409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91957795|NCT03373409|Autonomic Agents|autonomic agents|mesh-ancestor
91957796|NCT03373409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957797|NCT03373409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957798|NCT03373409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91957799|NCT03373409|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944822|NCT05008003|Vitamins|vitamins|mesh-ancestor
91957800|NCT03373409|Tocolytic Agents|tocolytic agents|mesh-ancestor
91957801|NCT03373409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91957802|NCT03373409|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91957803|NCT03373409|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91957804|NCT03373409|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91957805|NCT03373409|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957806|NCT03373409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957807|NCT03373409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957808|NCT03379987|Morphine|morphine|mesh-list
91957830|NCT03379441|Pembrolizumab|pembrolizumab|mesh-list
91957831|NCT03379441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91957832|NCT03379441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957833|NCT03379441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91957834|NCT03379441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957835|NCT03384511|Apatinib|apatinib|mesh-list
91957836|NCT03384511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957837|NCT03384511|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957838|NCT03384511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957839|NCT03384511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957840|NCT03385525|Valproic Acid|valproic acid|mesh-list
91957841|NCT03385525|Anticonvulsants|anticonvulsants|mesh-ancestor
91957842|NCT03385525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957843|NCT03385525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957844|NCT03385525|GABA Agents|gaba agents|mesh-ancestor
91957845|NCT03385525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957846|NCT03385525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957847|NCT03385525|Antimanic Agents|antimanic agents|mesh-ancestor
91957848|NCT03385525|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91957849|NCT03385525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957850|NCT03385525|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91957851|NCT05172739|Analgesics, Opioid|analgesics, opioid|mesh-list
91957852|NCT05172739|Anesthetics|anesthetics|mesh-list
91957853|NCT05172739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957854|NCT05172739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957855|NCT05172739|Narcotics|narcotics|mesh-ancestor
91957856|NCT05172739|Analgesics|analgesics|mesh-ancestor
91957857|NCT05172739|Sensory System Agents|sensory system agents|mesh-ancestor
91957858|NCT05172739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957859|NCT03375463|Tirzepatide|tirzepatide|mesh-list
91957860|NCT03375463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91957861|NCT03375463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957862|NCT03375463|Incretins|incretins|mesh-ancestor
91957864|NCT03375463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957882|NCT03384121|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91957883|NCT03384121|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91957884|NCT03384121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91957885|NCT03378661|Benzonidazole|benzonidazole|mesh-list
91957886|NCT03378661|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91957887|NCT03378661|Immunologic Factors|immunologic factors|mesh-ancestor
91957888|NCT03378661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957889|NCT03378661|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91957890|NCT03378661|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91957891|NCT03378661|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91957892|NCT03378661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957893|NCT03378427|Doxycycline|doxycycline|mesh-list
91957894|NCT03378427|Ciprofloxacin|ciprofloxacin|mesh-list
91957895|NCT03378427|Levofloxacin|levofloxacin|mesh-list
91957897|NCT03378427|Minocycline|minocycline|mesh-list
91957898|NCT03378427|Rifampin|rifampin|mesh-list
91957899|NCT03378427|Clindamycin|clindamycin|mesh-list
91957900|NCT03378427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91957901|NCT03378427|Tedizolid|tedizolid|mesh-list
91957902|NCT03378427|Teicoplanin|teicoplanin|mesh-list
91957903|NCT03378427|Fusidic Acid|fusidic acid|mesh-list
91957904|NCT03378427|Tedizolid phosphate|tedizolid phosphate|mesh-list
91957905|NCT03378427|Trimethoprim|trimethoprim|mesh-list
91957906|NCT03378427|Sulfamethoxazole|sulfamethoxazole|mesh-list
91957907|NCT03378427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957908|NCT03378427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957909|NCT03378427|Antimalarials|antimalarials|mesh-ancestor
91957910|NCT03378427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91944823|NCT05008003|Micronutrients|micronutrients|mesh-ancestor
91944824|NCT05008003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944825|NCT05008003|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91957911|NCT03378427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91957912|NCT03378427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91957913|NCT03378427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91957914|NCT03378427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957915|NCT03378427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957916|NCT03378427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957917|NCT03378427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91957918|NCT03378427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91957919|NCT03378427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91957920|NCT03378427|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91957921|NCT03378427|Antitubercular Agents|antitubercular agents|mesh-ancestor
91957932|NCT03378427|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91957933|NCT03378427|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91957936|NCT05172115|Plasminogen|plasminogen|mesh-list
91957937|NCT05172115|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91957938|NCT05172115|Tinzaparin|tinzaparin|mesh-list
91957939|NCT05172115|Dalteparin|dalteparin|mesh-list
91957940|NCT05172115|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91957941|NCT05172115|Anticoagulants|anticoagulants|mesh-ancestor
91957942|NCT05172115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91957943|NCT05172115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91957944|NCT05172115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957945|NCT03383185|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
91957946|NCT03383185|Contraceptive Agents|contraceptive agents|mesh-list
91957947|NCT03383185|Medroxyprogesterone|medroxyprogesterone|mesh-list
91957948|NCT03383185|Contraceptives, Oral|contraceptives, oral|mesh-list
91957949|NCT03383185|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
91957950|NCT03383185|Progestins|progestins|mesh-list
91957951|NCT03383185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91957952|NCT03383185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957953|NCT03383185|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91957954|NCT03383185|Hormones|hormones|mesh-ancestor
91957955|NCT03383185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957956|NCT03383185|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91957957|NCT03383185|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91957958|NCT03383185|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91957959|NCT03383185|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91957960|NCT03383185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91957961|NCT03383185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957962|NCT03377725|Decitabine|decitabine|mesh-list
91957963|NCT03377725|Arsenic Trioxide|arsenic trioxide|mesh-list
91957964|NCT03377725|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91957965|NCT03377725|Antimetabolites|antimetabolites|mesh-ancestor
91957966|NCT03377725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957967|NCT03377725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957968|NCT03377725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957969|NCT03374293|Antibodies|antibodies|mesh-list
91957970|NCT03374293|Immunologic Factors|immunologic factors|mesh-ancestor
91957971|NCT03374293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957972|NCT02730871|Timolol|timolol|mesh-list
91957973|NCT02730871|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91957974|NCT02730871|Travoprost|travoprost|mesh-list
91957975|NCT02730871|Brinzolamide|brinzolamide|mesh-list
91957976|NCT02730871|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91957977|NCT02730871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91957978|NCT02730871|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957979|NCT02730871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957980|NCT02730871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957981|NCT02730871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957982|NCT02730871|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91957983|NCT02730871|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91957984|NCT02730871|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91958003|NCT03377257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958004|NCT03377257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91958005|NCT03377257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958006|NCT03373903|Everolimus|everolimus|mesh-list
91958007|NCT03373903|Dactolisib|dactolisib|mesh-list
91944826|NCT05008003|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91944827|NCT03475225|Cholecalciferol|cholecalciferol|mesh-list
91958008|NCT03373903|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91958009|NCT03373903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91958010|NCT03373903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958011|NCT03373903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958012|NCT03373903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958013|NCT03373903|Immunologic Factors|immunologic factors|mesh-ancestor
91958014|NCT03373903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958015|NCT03373903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958016|NCT04445857|Calcitonin|calcitonin|mesh-list
91958017|NCT04445857|Salmon calcitonin|salmon calcitonin|mesh-list
91958018|NCT04445857|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
91958019|NCT04445857|Katacalcin|katacalcin|mesh-list
91958020|NCT04445857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91958021|NCT04445857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958022|NCT04445857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91958023|NCT04445857|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958024|NCT03373825|Fentanyl|fentanyl|mesh-list
91958025|NCT03373825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91958026|NCT03373825|Narcotics|narcotics|mesh-ancestor
91958027|NCT03373825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958028|NCT03373825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958029|NCT03373825|Analgesics|analgesics|mesh-ancestor
91958030|NCT03373825|Sensory System Agents|sensory system agents|mesh-ancestor
91958031|NCT03373825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958032|NCT03373825|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91958033|NCT03373825|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958034|NCT03373825|Anesthetics, General|anesthetics, general|mesh-ancestor
91958036|NCT04445779|Ubiquinone|ubiquinone|mesh-list
91958037|NCT04445779|Coenzyme Q10|coenzyme q10|mesh-list
91958038|NCT04445779|Micronutrients|micronutrients|mesh-ancestor
91958039|NCT04445779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958040|NCT04445779|Vitamins|vitamins|mesh-ancestor
91958041|NCT03377101|Fulvestrant|fulvestrant|mesh-list
91958056|NCT03373669|Vaccines|vaccines|mesh-list
91958057|NCT03373669|Immunologic Factors|immunologic factors|mesh-ancestor
91958058|NCT03373669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958059|NCT03382717|Amorolfine|amorolfine|mesh-list
91958060|NCT03382717|Antifungal Agents|antifungal agents|mesh-ancestor
91958061|NCT03382717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958062|NCT03125473|Vaccines|vaccines|mesh-list
91958063|NCT03125473|Immunologic Factors|immunologic factors|mesh-ancestor
91958064|NCT03125473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958065|NCT03376789|MYL-1501D|myl-1501d|mesh-list
91958066|NCT03376789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958067|NCT03376789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958068|NCT03376555|Nitroglycerin|nitroglycerin|mesh-list
91958069|NCT03376555|Acetylcholine|acetylcholine|mesh-list
91958070|NCT03376555|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958071|NCT03376555|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91958072|NCT03376555|Cholinergic Agents|cholinergic agents|mesh-ancestor
91958073|NCT03376555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958074|NCT03376555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958075|NCT03376555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958076|NCT03376243|Emollients|emollients|mesh-list
91958077|NCT03376243|Dermatologic Agents|dermatologic agents|mesh-ancestor
91958078|NCT03700411|Morphine|morphine|mesh-list
91958079|NCT03700411|Pirinitramide|pirinitramide|mesh-list
91958080|NCT03700411|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91958081|NCT03700411|Narcotics|narcotics|mesh-ancestor
91958082|NCT03700411|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958083|NCT03700411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958084|NCT03700411|Analgesics|analgesics|mesh-ancestor
91958085|NCT03700411|Sensory System Agents|sensory system agents|mesh-ancestor
91958086|NCT03700411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958087|NCT03691051|Capecitabine|capecitabine|mesh-list
91958088|NCT03691051|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91958089|NCT03691051|Antimetabolites|antimetabolites|mesh-ancestor
91958090|NCT03691051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958091|NCT03691051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958092|NCT03381859|Grazoprevir|grazoprevir|mesh-list
91958093|NCT03381859|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91958094|NCT03381859|Antiviral Agents|antiviral agents|mesh-ancestor
91958095|NCT03381859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958096|NCT03381781|Cytarabine|cytarabine|mesh-list
91958097|NCT03381781|Decitabine|decitabine|mesh-list
91958098|NCT03381781|Arsenic Trioxide|arsenic trioxide|mesh-list
91958099|NCT03381781|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91958100|NCT03381781|Antimetabolites|antimetabolites|mesh-ancestor
91958101|NCT03381781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958102|NCT03381781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958103|NCT03381781|Antiviral Agents|antiviral agents|mesh-ancestor
91958115|NCT03381703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958116|NCT03372265|Ropivacaine|ropivacaine|mesh-list
91958117|NCT03372265|Anesthetics, Local|anesthetics, local|mesh-ancestor
91958118|NCT03372265|Anesthetics|anesthetics|mesh-ancestor
91958119|NCT03372265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958120|NCT03372265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958121|NCT03372265|Sensory System Agents|sensory system agents|mesh-ancestor
91958122|NCT03372265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958123|NCT03372109|Calcium|calcium|mesh-list
91958124|NCT03372109|Turmeric extract|turmeric extract|mesh-list
91958125|NCT03372109|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91958126|NCT03372109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958127|NCT03372109|Antioxidants|antioxidants|mesh-ancestor
91958128|NCT03372109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958129|NCT03372109|Protective Agents|protective agents|mesh-ancestor
91958130|NCT03371953|Atracurium|atracurium|mesh-list
91958131|NCT03371953|Vecuronium Bromide|vecuronium bromide|mesh-list
91958132|NCT03371953|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91958133|NCT03371953|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91958134|NCT03371953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91958135|NCT03371953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958136|NCT03371953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958137|NCT03371953|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
91958138|NCT03371953|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91958139|NCT03371953|Cholinergic Agents|cholinergic agents|mesh-ancestor
91958140|NCT03371953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958141|NCT03371953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958142|NCT03371797|Amlodipine|amlodipine|mesh-list
91958143|NCT03371797|Valsartan|valsartan|mesh-list
91958144|NCT03371797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91958145|NCT03371797|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91958146|NCT03371797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958147|NCT03371797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958148|NCT03371797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91958149|NCT03371797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958150|NCT03371797|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958151|NCT03371797|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91958152|NCT03371797|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91958153|NCT02520115|Dexamethasone|dexamethasone|mesh-list
91958154|NCT02520115|Dexamethasone acetate|dexamethasone acetate|mesh-list
91958155|NCT02520115|Valproic Acid|valproic acid|mesh-list
91958156|NCT02520115|Ichthammol|ichthammol|mesh-list
91958157|NCT02520115|BB 1101|bb 1101|mesh-list
91958158|NCT02520115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91958159|NCT02520115|Antiemetics|antiemetics|mesh-ancestor
91958160|NCT02520115|Autonomic Agents|autonomic agents|mesh-ancestor
91958161|NCT02520115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958162|NCT02520115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958163|NCT02520115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958164|NCT02520115|Glucocorticoids|glucocorticoids|mesh-ancestor
91958165|NCT02520115|Hormones|hormones|mesh-ancestor
92090432|NCT04416035|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91958184|NCT04527133|Hemostatics|hemostatics|mesh-ancestor
91958185|NCT04527133|Coagulants|coagulants|mesh-ancestor
91958186|NCT04527133|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91958187|NCT04527133|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91958188|NCT04527133|Protease Inhibitors|protease inhibitors|mesh-ancestor
91958189|NCT04527133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958190|NCT04527133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958191|NCT03371563|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91958192|NCT03371563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958193|NCT03369925|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
91958194|NCT03369925|Nootropic Agents|nootropic agents|mesh-ancestor
91958195|NCT03369847|Budesonide|budesonide|mesh-list
91958196|NCT03369847|Beclomethasone|beclomethasone|mesh-list
91944829|NCT03475225|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91944830|NCT03475225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944831|NCT03475225|Vitamins|vitamins|mesh-ancestor
91944832|NCT03475225|Micronutrients|micronutrients|mesh-ancestor
91958197|NCT03369847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91958198|NCT03369847|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91958199|NCT03369847|Autonomic Agents|autonomic agents|mesh-ancestor
91958200|NCT03369847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958201|NCT03369847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958202|NCT03369847|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91958203|NCT03369847|Respiratory System Agents|respiratory system agents|mesh-ancestor
91958204|NCT03369847|Glucocorticoids|glucocorticoids|mesh-ancestor
91958205|NCT03369847|Hormones|hormones|mesh-ancestor
91958206|NCT03369847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958207|NCT04526353|Oxybutynin|oxybutynin|mesh-list
91958208|NCT04526353|Parasympatholytics|parasympatholytics|mesh-ancestor
91958209|NCT04526353|Autonomic Agents|autonomic agents|mesh-ancestor
91958210|NCT04526353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958211|NCT04526353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958212|NCT04526353|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91958213|NCT04526353|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91958214|NCT04526353|Cholinergic Agents|cholinergic agents|mesh-ancestor
91958215|NCT04526353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958216|NCT04526353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958217|NCT04526353|Urological Agents|urological agents|mesh-ancestor
91958218|NCT03371173|Ferric maltol|ferric maltol|mesh-list
91958219|NCT03371173|Hematinics|hematinics|mesh-ancestor
91958220|NCT03371095|Infliximab|infliximab|mesh-list
91958221|NCT03371095|Cyclophosphamide|cyclophosphamide|mesh-list
91958233|NCT03371095|Dermatologic Agents|dermatologic agents|mesh-ancestor
91958234|NCT03371095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958235|NCT03363451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91958236|NCT03363451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958238|NCT03363295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91958239|NCT03363295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958240|NCT03363295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91958241|NCT03363295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91958242|NCT03363295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958243|NCT03363295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958244|NCT03363295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958245|NCT03370861|Immunomodulating Agents|immunomodulating agents|mesh-list
91958246|NCT03370861|Immunologic Factors|immunologic factors|mesh-ancestor
91958247|NCT03370861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958248|NCT03370705|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
91958249|NCT03370705|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
91958250|NCT03370705|Captopril|captopril|mesh-list
91958251|NCT03370705|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91958252|NCT03370705|Atorvastatin|atorvastatin|mesh-list
91958253|NCT03370705|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91958254|NCT03370705|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91958255|NCT03370705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91958256|NCT03370705|Antimetabolites|antimetabolites|mesh-ancestor
91958257|NCT03370705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958258|NCT03370705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91958259|NCT03370705|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91958260|NCT03370705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958261|NCT03370705|Protease Inhibitors|protease inhibitors|mesh-ancestor
91958262|NCT03370705|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91958263|NCT03370705|Anticoagulants|anticoagulants|mesh-ancestor
91958264|NCT03370705|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91958265|NCT03370705|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91958266|NCT03370705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958267|NCT03370705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958268|NCT03370705|Analgesics|analgesics|mesh-ancestor
91958269|NCT03370705|Sensory System Agents|sensory system agents|mesh-ancestor
91958270|NCT03370705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958271|NCT03370705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91958272|NCT03370705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91958273|NCT03370705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944833|NCT03475225|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91944835|NCT03448939|Dermatologic Agents|dermatologic agents|mesh-ancestor
91944836|NCT02504294|Epoetin Alfa|epoetin alfa|mesh-list
91944837|NCT02504294|Hematinics|hematinics|mesh-ancestor
91958274|NCT03370705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958275|NCT03370705|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91958276|NCT03369379|Cholecalciferol|cholecalciferol|mesh-list
91958277|NCT03369379|Vitamins|vitamins|mesh-ancestor
91958278|NCT03369379|Micronutrients|micronutrients|mesh-ancestor
91958279|NCT03369379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958280|NCT03369379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91958281|NCT03369379|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91958282|NCT03362905|Lidocaine|lidocaine|mesh-list
91958283|NCT03362905|Anesthetics, Local|anesthetics, local|mesh-ancestor
91958297|NCT03370159|Tubulin Modulators|tubulin modulators|mesh-ancestor
91958298|NCT03370159|Antimitotic Agents|antimitotic agents|mesh-ancestor
91958299|NCT03370159|Mitosis Modulators|mitosis modulators|mesh-ancestor
91958300|NCT03370159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958301|NCT03370159|Antioxidants|antioxidants|mesh-ancestor
91958302|NCT03370159|Protective Agents|protective agents|mesh-ancestor
91958303|NCT03370159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958304|NCT03370159|Vitamin B Complex|vitamin b complex|mesh-ancestor
91958306|NCT03370159|Micronutrients|micronutrients|mesh-ancestor
91958307|NCT04522297|Octreotide|octreotide|mesh-list
91958308|NCT04522297|Epinephrine|epinephrine|mesh-list
91958309|NCT04522297|Midodrine|midodrine|mesh-list
91958310|NCT04522297|Norepinephrine|norepinephrine|mesh-list
91958311|NCT04522297|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91958312|NCT04522297|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91958313|NCT04522297|Adrenergic Agents|adrenergic agents|mesh-ancestor
91958314|NCT04522297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958315|NCT04522297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958316|NCT04522297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958317|NCT04522297|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91958318|NCT04522297|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91958319|NCT04522297|Autonomic Agents|autonomic agents|mesh-ancestor
91958320|NCT04522297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958321|NCT04522297|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91958322|NCT04522297|Respiratory System Agents|respiratory system agents|mesh-ancestor
91958323|NCT04522297|Mydriatics|mydriatics|mesh-ancestor
91958324|NCT04522297|Sympathomimetics|sympathomimetics|mesh-ancestor
91958325|NCT04522297|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91958326|NCT04522297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958327|NCT04522297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91958328|NCT04522297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958329|NCT04522297|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91958330|NCT03369067|Insulin|insulin|mesh-list
91958331|NCT03369067|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91958332|NCT03369067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958333|NCT03369067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958334|NCT03368989|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
91958335|NCT03368989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958336|NCT04525729|Rituximab|rituximab|mesh-list
91958337|NCT04525729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91958338|NCT04525729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958339|NCT04525729|Immunologic Factors|immunologic factors|mesh-ancestor
91958340|NCT04525729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958341|NCT04525729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958342|NCT04525495|Dopamine|dopamine|mesh-list
91958343|NCT04525495|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91958344|NCT04525495|Sympathomimetics|sympathomimetics|mesh-ancestor
91958345|NCT04525495|Autonomic Agents|autonomic agents|mesh-ancestor
91958353|NCT03362359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958354|NCT03362359|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91958356|NCT03362281|Clarithromycin|clarithromycin|mesh-list
91958357|NCT03362281|Omeprazole|omeprazole|mesh-list
91958358|NCT03362281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91958359|NCT03362281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958360|NCT03362281|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91958361|NCT03362281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958362|NCT03362281|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91958363|NCT03362281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944838|NCT02446418|Fluticasone|fluticasone|mesh-list
91944839|NCT02446418|Xhance|xhance|mesh-list
91958364|NCT03362281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958365|NCT03362281|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91958366|NCT03362281|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91958367|NCT03362281|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91958368|NCT02518789|Fentanyl|fentanyl|mesh-list
91958369|NCT02518789|Midazolam|midazolam|mesh-list
91958370|NCT02518789|Dexmedetomidine|dexmedetomidine|mesh-list
91958371|NCT02518789|Remifentanil|remifentanil|mesh-list
91958372|NCT02518789|Propofol|propofol|mesh-list
91958373|NCT02518789|Etomidate|etomidate|mesh-list
91958374|NCT02518789|Atracurium|atracurium|mesh-list
91958375|NCT02518789|Rocuronium|rocuronium|mesh-list
91958376|NCT02518789|Cisatracurium|cisatracurium|mesh-list
91958377|NCT02518789|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91958378|NCT02518789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958379|NCT02518789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958380|NCT02518789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91958381|NCT02518789|Analgesics|analgesics|mesh-ancestor
91958382|NCT02518789|Sensory System Agents|sensory system agents|mesh-ancestor
91958383|NCT02518789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958384|NCT02518789|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91958385|NCT02518789|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91958386|NCT02518789|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91958387|NCT02518789|Adrenergic Agents|adrenergic agents|mesh-ancestor
91958388|NCT02518789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958389|NCT02518789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958390|NCT02518789|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958391|NCT02518789|Anesthetics, General|anesthetics, general|mesh-ancestor
91958392|NCT02518789|Anesthetics|anesthetics|mesh-ancestor
91958393|NCT02518789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91958394|NCT02518789|Narcotics|narcotics|mesh-ancestor
91958395|NCT02518789|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91958396|NCT02518789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91958397|NCT02518789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91958398|NCT02518789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91958399|NCT02518789|GABA Modulators|gaba modulators|mesh-ancestor
91958400|NCT02518789|GABA Agents|gaba agents|mesh-ancestor
91958401|NCT02518789|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91958402|NCT02518789|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91958403|NCT02518789|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91958404|NCT02518789|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
91958405|NCT02518789|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91958406|NCT02518789|Cholinergic Agents|cholinergic agents|mesh-ancestor
91958407|NCT03357757|Avelumab|avelumab|mesh-list
91958408|NCT03357757|Valproic Acid|valproic acid|mesh-list
91958409|NCT03357757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91958410|NCT03357757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958412|NCT03357757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958413|NCT03357757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958429|NCT02929485|Dopamine Agents|dopamine agents|mesh-ancestor
91958430|NCT02929485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958431|NCT02929485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958432|NCT02929485|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
91958433|NCT02929485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958434|NCT04523623|Ibuprofen|ibuprofen|mesh-list
91958435|NCT04523623|Oxycodone|oxycodone|mesh-list
91958436|NCT04523623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91958437|NCT04523623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91958438|NCT04523623|Analgesics|analgesics|mesh-ancestor
91958439|NCT04523623|Sensory System Agents|sensory system agents|mesh-ancestor
91958440|NCT04523623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958441|NCT04523623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958442|NCT04523623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91958443|NCT04523623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958444|NCT04523623|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91958445|NCT04523623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958446|NCT04523623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958447|NCT04523623|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91958448|NCT04523623|Narcotics|narcotics|mesh-ancestor
91958449|NCT04523623|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958450|NCT03357289|Immunomodulating Agents|immunomodulating agents|mesh-list
91944841|NCT02446418|Formoterol Fumarate|formoterol fumarate|mesh-list
91944842|NCT02446418|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91958451|NCT03357289|Immunologic Factors|immunologic factors|mesh-ancestor
91958452|NCT03357289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958453|NCT03368131|Capecitabine|capecitabine|mesh-list
91958454|NCT03368131|Oxaliplatin|oxaliplatin|mesh-list
91958455|NCT03368131|Trastuzumab|trastuzumab|mesh-list
91958456|NCT03368131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91958457|NCT03368131|Antimetabolites|antimetabolites|mesh-ancestor
91958458|NCT03368131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958459|NCT03368131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958460|NCT03368131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91958461|NCT04521751|Acarbose|acarbose|mesh-list
91958462|NCT04521751|Orlistat|orlistat|mesh-list
91958463|NCT04521751|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91958464|NCT04521751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958465|NCT04521751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958466|NCT04521751|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958467|NCT04521751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958468|NCT04521751|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91958469|NCT04521751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91958470|NCT04521517|Imidacloprid|imidacloprid|mesh-list
91958471|NCT04521517|Cholinergic Agents|cholinergic agents|mesh-ancestor
92090433|NCT04416035|Growth Substances|growth substances|mesh-ancestor
91958485|NCT03370627|Immunologic Factors|immunologic factors|mesh-ancestor
91958486|NCT03370627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958487|NCT03367663|Prednisone|prednisone|mesh-list
91958488|NCT03367663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91958489|NCT03367663|Glucocorticoids|glucocorticoids|mesh-ancestor
91958490|NCT03367663|Hormones|hormones|mesh-ancestor
91958491|NCT03367663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958492|NCT03367663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958493|NCT03367663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91958494|NCT03367663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958495|NCT03123289|Gallium citrate|gallium citrate|mesh-list
91958496|NCT03123289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958497|NCT03123289|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91958498|NCT04521049|Saxagliptin|saxagliptin|mesh-list
91958499|NCT04521049|Incretins|incretins|mesh-ancestor
91958500|NCT04521049|Hormones|hormones|mesh-ancestor
91958501|NCT04521049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958502|NCT04521049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958503|NCT04521049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91958504|NCT04521049|Protease Inhibitors|protease inhibitors|mesh-ancestor
91958505|NCT04521049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958506|NCT04521049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958507|NCT04521049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958509|NCT02267343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91958510|NCT02267343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958511|NCT02267343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91958512|NCT02267343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958513|NCT03123445|Gemcitabine|gemcitabine|mesh-list
91958514|NCT03123445|Endostar protein|endostar protein|mesh-list
91958515|NCT03123445|Endostatins|endostatins|mesh-list
91958516|NCT03123445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958517|NCT03123445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91958518|NCT03123445|Antimetabolites|antimetabolites|mesh-ancestor
91958727|NCT03366571|Antiviral Agents|antiviral agents|mesh-ancestor
91958519|NCT03123445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958520|NCT03123445|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91958521|NCT03123445|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91958522|NCT03123445|Growth Substances|growth substances|mesh-ancestor
91958523|NCT03123445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958524|NCT03123445|Growth Inhibitors|growth inhibitors|mesh-ancestor
91958525|NCT03357133|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91958526|NCT03357133|Tirofiban|tirofiban|mesh-list
91958527|NCT03357133|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91958528|NCT03357133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91958529|NCT03357133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958530|NCT03357133|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91958531|NCT03357055|Ketamine|ketamine|mesh-list
91958549|NCT03367585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958550|NCT03367585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91958551|NCT03367585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91958553|NCT03360955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958554|NCT03360955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958555|NCT00584025|Levetiracetam|levetiracetam|mesh-list
91958556|NCT00584025|Anticonvulsants|anticonvulsants|mesh-ancestor
91958557|NCT00584025|Nootropic Agents|nootropic agents|mesh-ancestor
91958558|NCT01735461|Calcium Carbonate|calcium carbonate|mesh-list
91958559|NCT01735461|Calcium|calcium|mesh-list
91958560|NCT01735461|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91958561|NCT01735461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958562|NCT01735461|Antacids|antacids|mesh-ancestor
91958563|NCT01735461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958564|NCT01735461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958565|NCT01595841|Sirolimus|sirolimus|mesh-list
91958566|NCT01595841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91958567|NCT01595841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958568|NCT01595841|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91958569|NCT01595841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958570|NCT01595841|Antifungal Agents|antifungal agents|mesh-ancestor
91958571|NCT01595841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958572|NCT01595841|Immunologic Factors|immunologic factors|mesh-ancestor
91958573|NCT01595841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958574|NCT05405049|Lidocaine|lidocaine|mesh-list
91958575|NCT05405049|Fentanyl|fentanyl|mesh-list
91958576|NCT05405049|Morphine|morphine|mesh-list
91958577|NCT05405049|Bupivacaine|bupivacaine|mesh-list
91958578|NCT05405049|Anesthetics, Local|anesthetics, local|mesh-ancestor
91958579|NCT05405049|Anesthetics|anesthetics|mesh-ancestor
91958580|NCT05405049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958581|NCT05405049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958582|NCT05405049|Sensory System Agents|sensory system agents|mesh-ancestor
91958583|NCT05405049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958584|NCT05405049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91958585|NCT05405049|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91958586|NCT05405049|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91958587|NCT05405049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958588|NCT05405049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958589|NCT05405049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91958590|NCT05405049|Narcotics|narcotics|mesh-ancestor
91958610|NCT03356899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958611|NCT03356899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958612|NCT03356899|Sensory System Agents|sensory system agents|mesh-ancestor
91958613|NCT03356899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958614|NCT04523467|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-list
91958616|NCT04523467|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91958617|NCT04523467|Growth Substances|growth substances|mesh-ancestor
91958618|NCT04523467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958619|NCT04523467|Growth Inhibitors|growth inhibitors|mesh-ancestor
91958620|NCT04523467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958621|NCT04523467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91958622|NCT02801097|Irinotecan|irinotecan|mesh-list
91958623|NCT02801097|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91958624|NCT02801097|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91958625|NCT02801097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958626|NCT02801097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958627|NCT02801097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958628|NCT03367195|Omeprazole|omeprazole|mesh-list
91958629|NCT03367195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91958630|NCT03367195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958631|NCT03367195|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91958632|NCT03367195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958633|NCT03367195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958634|NCT05123781|Metformin|metformin|mesh-list
91958635|NCT05123781|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958636|NCT05123781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958637|NCT04523233|Vitamins|vitamins|mesh-list
91958638|NCT04523233|Micronutrients|micronutrients|mesh-ancestor
91958639|NCT04523233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958640|NCT05127369|Fluoxetine|fluoxetine|mesh-list
91958641|NCT05127369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91958642|NCT05127369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91944843|NCT02446418|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944844|NCT02446418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91944845|NCT02446418|Autonomic Agents|autonomic agents|mesh-ancestor
91944846|NCT02446418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958643|NCT05127369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958644|NCT05127369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958645|NCT05127369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958646|NCT05127369|Serotonin Agents|serotonin agents|mesh-ancestor
91958659|NCT03356353|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91958660|NCT03356353|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91958661|NCT03356353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958662|NCT03356353|Urological Agents|urological agents|mesh-ancestor
91958663|NCT04520035|Paclitaxel|paclitaxel|mesh-list
91958664|NCT04520035|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91958665|NCT04520035|Cisplatin|cisplatin|mesh-list
91958666|NCT04520035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91958667|NCT04520035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958668|NCT04520035|Tubulin Modulators|tubulin modulators|mesh-ancestor
91958669|NCT04520035|Antimitotic Agents|antimitotic agents|mesh-ancestor
91958670|NCT04520035|Mitosis Modulators|mitosis modulators|mesh-ancestor
91958671|NCT04520035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958672|NCT04208997|Amiodarone|amiodarone|mesh-list
91958673|NCT04208997|Sotalol|sotalol|mesh-list
91958674|NCT04208997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
91958675|NCT04208997|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958676|NCT04208997|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91958677|NCT04208997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958678|NCT04208997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958679|NCT04208997|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91958680|NCT04208997|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91958681|NCT04208997|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91958682|NCT04208997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958683|NCT04208997|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91958684|NCT04208997|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91958685|NCT04208997|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91958686|NCT04208997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91958687|NCT04208997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91958688|NCT04208997|Adrenergic Agents|adrenergic agents|mesh-ancestor
91958689|NCT04208997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958690|NCT04208997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958691|NCT04208997|Sympatholytics|sympatholytics|mesh-ancestor
91958692|NCT04208997|Autonomic Agents|autonomic agents|mesh-ancestor
91958693|NCT04208997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958694|NCT03355963|Botulinum Toxins|botulinum toxins|mesh-list
91958695|NCT03355963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91958696|NCT03355963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91958697|NCT03355963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91958698|NCT03355963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958699|NCT03355963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958700|NCT03355963|Cholinergic Agents|cholinergic agents|mesh-ancestor
91958701|NCT03355963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958702|NCT03355963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958703|NCT03355963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91958704|NCT03355963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958705|NCT04518475|Rituximab|rituximab|mesh-list
91958706|NCT04518475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91958721|NCT03366883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958722|NCT03366883|Tubulin Modulators|tubulin modulators|mesh-ancestor
91958723|NCT03366883|Antimitotic Agents|antimitotic agents|mesh-ancestor
91958724|NCT03366883|Mitosis Modulators|mitosis modulators|mesh-ancestor
91958725|NCT03366883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958728|NCT03366571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958729|NCT05124951|Carboplatin|carboplatin|mesh-list
91958730|NCT05124951|Etoposide|etoposide|mesh-list
91958731|NCT05124951|Etoposide phosphate|etoposide phosphate|mesh-list
91958732|NCT05124951|Ifosfamide|ifosfamide|mesh-list
91958733|NCT05124951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944847|NCT02446418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944848|NCT02446418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91944849|NCT02446418|Respiratory System Agents|respiratory system agents|mesh-ancestor
91944851|NCT02446418|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91958734|NCT05124951|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91958735|NCT05124951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91958736|NCT05124951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91958737|NCT05124951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958738|NCT05124951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958739|NCT05124951|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91958740|NCT05124951|Alkylating Agents|alkylating agents|mesh-ancestor
91958741|NCT04523077|Antibodies|antibodies|mesh-list
91958742|NCT04523077|Hormones|hormones|mesh-list
91958743|NCT04523077|Immunologic Factors|immunologic factors|mesh-ancestor
91958744|NCT04523077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958745|NCT04523077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958746|NCT05124717|Metformin|metformin|mesh-list
91958747|NCT05124717|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958748|NCT05124717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958749|NCT04139655|Colchicine|colchicine|mesh-list
91958750|NCT04139655|Gout Suppressants|gout suppressants|mesh-ancestor
91958751|NCT04139655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958752|NCT04139655|Tubulin Modulators|tubulin modulators|mesh-ancestor
91958753|NCT04139655|Antimitotic Agents|antimitotic agents|mesh-ancestor
91958754|NCT04139655|Mitosis Modulators|mitosis modulators|mesh-ancestor
91958755|NCT04139655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958756|NCT04139655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958757|NCT03366259|Misoprostol|misoprostol|mesh-list
91958758|NCT03366259|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91958759|NCT03366259|Abortifacient Agents|abortifacient agents|mesh-ancestor
91958760|NCT03366259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91958761|NCT03366259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958762|NCT03366259|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91958763|NCT03366259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958764|NCT03366259|Oxytocics|oxytocics|mesh-ancestor
91958765|NCT03366025|Progesterone|progesterone|mesh-list
91958766|NCT03366025|Progestins|progestins|mesh-ancestor
91958767|NCT03366025|Hormones|hormones|mesh-ancestor
91958768|NCT03366025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958780|NCT03365869|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91958781|NCT03365869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958782|NCT03365869|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91958783|NCT03365869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958784|NCT03365869|Antifungal Agents|antifungal agents|mesh-ancestor
91958785|NCT03365869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958786|NCT03365869|Immunologic Factors|immunologic factors|mesh-ancestor
91958787|NCT03365869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958788|NCT04932213|Tropicamide|tropicamide|mesh-list
91958789|NCT04932213|Mydriatics|mydriatics|mesh-ancestor
91958790|NCT04932213|Autonomic Agents|autonomic agents|mesh-ancestor
91958791|NCT04932213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958792|NCT04932213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958793|NCT04932213|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91958794|NCT04932213|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91958795|NCT04932213|Cholinergic Agents|cholinergic agents|mesh-ancestor
91958796|NCT04932213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958797|NCT04932213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958798|NCT03684213|Ascorbic Acid|ascorbic acid|mesh-list
91958799|NCT03684213|Norepinephrine|norepinephrine|mesh-list
91958800|NCT03684213|NG-Nitroarginine Methyl Ester|ng-nitroarginine methyl ester|mesh-list
91958801|NCT03684213|Antioxidants|antioxidants|mesh-ancestor
91958802|NCT03684213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958803|NCT03684213|Protective Agents|protective agents|mesh-ancestor
91958804|NCT03684213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958805|NCT03684213|Vitamins|vitamins|mesh-ancestor
91958806|NCT03684213|Micronutrients|micronutrients|mesh-ancestor
91958807|NCT03684213|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91958808|NCT03684213|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91958809|NCT03684213|Adrenergic Agents|adrenergic agents|mesh-ancestor
91958810|NCT03684213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958811|NCT03684213|Sympathomimetics|sympathomimetics|mesh-ancestor
91958812|NCT03684213|Autonomic Agents|autonomic agents|mesh-ancestor
91958813|NCT03684213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958814|NCT03684213|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91958815|NCT03684213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958816|NCT03365479|Iloprost|iloprost|mesh-list
91958817|NCT03365479|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91958818|NCT03365479|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958819|NCT03355027|Atorvastatin|atorvastatin|mesh-list
91958820|NCT03355027|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91958821|NCT03355027|Simvastatin|simvastatin|mesh-list
91958822|NCT03355027|Ezetimibe|ezetimibe|mesh-list
91958823|NCT03355027|Alirocumab|alirocumab|mesh-list
91958824|NCT03355027|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91958825|NCT03355027|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91958826|NCT03355027|Antimetabolites|antimetabolites|mesh-ancestor
91958827|NCT03355027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958828|NCT03355027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91958829|NCT03355027|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91958830|NCT03355027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958831|NCT03355027|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91958832|NCT03355027|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91958833|NCT03355027|Protease Inhibitors|protease inhibitors|mesh-ancestor
91958834|NCT03828045|Apremilast|apremilast|mesh-list
91958851|NCT02519413|Dermatologic Agents|dermatologic agents|mesh-ancestor
91958852|NCT02519413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958853|NCT02519413|Immunologic Factors|immunologic factors|mesh-ancestor
91958854|NCT02519413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958855|NCT02519335|Dexrazoxane|dexrazoxane|mesh-list
91958856|NCT02519335|Razoxane|razoxane|mesh-list
91958857|NCT02519335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958858|NCT02519335|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91958859|NCT02519335|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91958860|NCT02519335|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91958861|NCT02519335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958862|NCT02519335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958863|NCT02519335|Protective Agents|protective agents|mesh-ancestor
91958864|NCT02519335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958865|NCT02519335|Antimitotic Agents|antimitotic agents|mesh-ancestor
91958866|NCT02519335|Mitosis Modulators|mitosis modulators|mesh-ancestor
91958868|NCT04509583|Vitamins|vitamins|mesh-ancestor
91958869|NCT04509583|Micronutrients|micronutrients|mesh-ancestor
91958870|NCT04509583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958871|NCT04509583|Antioxidants|antioxidants|mesh-ancestor
91958872|NCT04509583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958873|NCT04509583|Protective Agents|protective agents|mesh-ancestor
91958874|NCT04509661|Bronchodilator Agents|bronchodilator agents|mesh-list
91958875|NCT04509661|Autonomic Agents|autonomic agents|mesh-ancestor
91958876|NCT04509661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958877|NCT04509661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958878|NCT04509661|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91958879|NCT04509661|Respiratory System Agents|respiratory system agents|mesh-ancestor
91958880|NCT03350737|Heparin|heparin|mesh-list
91958881|NCT03350737|Anticoagulants|anticoagulants|mesh-ancestor
91958882|NCT03350737|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91958883|NCT03350737|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91958884|NCT03350737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958885|NCT03350659|Midodrine|midodrine|mesh-list
91958886|NCT03350659|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91958887|NCT03350659|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91958888|NCT03350659|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91958889|NCT03350659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090434|NCT04416035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958911|NCT03350191|Glucagon|glucagon|mesh-list
91958912|NCT03350191|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91958913|NCT03350191|Hormones|hormones|mesh-ancestor
91958914|NCT03350191|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958915|NCT03350191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958916|NCT03350191|Incretins|incretins|mesh-ancestor
91958917|NCT03350191|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958918|NCT03350191|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91958919|NCT02649231|Ketamine|ketamine|mesh-list
91958920|NCT02649231|Analgesics|analgesics|mesh-ancestor
91958921|NCT02649231|Sensory System Agents|sensory system agents|mesh-ancestor
91944853|NCT02446418|Hormones|hormones|mesh-ancestor
91944854|NCT02446418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958922|NCT02649231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958923|NCT02649231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958924|NCT02649231|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91958925|NCT02649231|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958926|NCT02649231|Anesthetics, General|anesthetics, general|mesh-ancestor
91958927|NCT02649231|Anesthetics|anesthetics|mesh-ancestor
91958928|NCT02649231|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958929|NCT02649231|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91958930|NCT02649231|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91958931|NCT02649231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958932|NCT02649231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958933|NCT03364075|Propranolol|propranolol|mesh-list
91958934|NCT03364075|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91958935|NCT03364075|Serotonin|serotonin|mesh-list
91958936|NCT03364075|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91958937|NCT03364075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91958938|NCT03364075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958939|NCT03364075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958940|NCT03364075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958955|NCT03364075|Serotonin Agents|serotonin agents|mesh-ancestor
91958956|NCT03349957|Idarubicin|idarubicin|mesh-list
91958957|NCT03349957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91958958|NCT03349957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958959|NCT03349957|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91958960|NCT03349957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91958961|NCT03349957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958962|NCT03349957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958963|NCT04524169|Thymalfasin|thymalfasin|mesh-list
91958964|NCT04524169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91958965|NCT04524169|Immunologic Factors|immunologic factors|mesh-ancestor
91958966|NCT04524169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958967|NCT03568929|Idelalisib|idelalisib|mesh-list
91958968|NCT03568929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958969|NCT03568929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958970|NCT03568929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958971|NCT04503967|Nivolumab|nivolumab|mesh-list
91958972|NCT04503967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91958973|NCT04503967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958974|NCT04503967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91958975|NCT04503967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958976|NCT04841499|Niacinamide|niacinamide|mesh-list
91958977|NCT04841499|Niacin|niacin|mesh-list
91958978|NCT04841499|Nicotinic Acids|nicotinic acids|mesh-list
91958979|NCT04841499|Vitamin B Complex|vitamin b complex|mesh-ancestor
91958980|NCT04841499|Vitamins|vitamins|mesh-ancestor
91958981|NCT04841499|Micronutrients|micronutrients|mesh-ancestor
91958982|NCT04841499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958983|NCT04841499|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91958984|NCT04841499|Antimetabolites|antimetabolites|mesh-ancestor
91958985|NCT04841499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958986|NCT04841499|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91958987|NCT04841499|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958988|NCT04773405|Lidocaine|lidocaine|mesh-list
91958989|NCT04773405|Epinephrine|epinephrine|mesh-list
91958990|NCT04773405|Levobupivacaine|levobupivacaine|mesh-list
91958991|NCT04773405|Anesthetics, Local|anesthetics, local|mesh-ancestor
91958992|NCT04773405|Anesthetics|anesthetics|mesh-ancestor
91958993|NCT04773405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958994|NCT04773405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958995|NCT04773405|Sensory System Agents|sensory system agents|mesh-ancestor
91958996|NCT04773405|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958997|NCT04773405|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91958998|NCT04773405|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91958999|NCT04773405|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91959000|NCT04773405|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91959001|NCT04773405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944855|NCT02446418|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91944856|NCT02446418|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91944857|NCT02446418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91944858|NCT02446418|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944859|NCT02446418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959020|NCT01376245|Xhance|xhance|mesh-list
91959021|NCT01376245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959022|NCT01376245|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91959023|NCT01376245|Autonomic Agents|autonomic agents|mesh-ancestor
91959024|NCT01376245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959025|NCT01376245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959026|NCT01376245|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91959027|NCT01376245|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959028|NCT01376245|Dermatologic Agents|dermatologic agents|mesh-ancestor
91959029|NCT01376245|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91959030|NCT04754061|Psilocybin|psilocybin|mesh-list
91959031|NCT04754061|Hallucinogens|hallucinogens|mesh-ancestor
91959032|NCT04754061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959033|NCT04754061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959034|NCT03349489|Insulin|insulin|mesh-list
91959035|NCT03349489|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91959036|NCT03349489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959037|NCT03349489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959038|NCT04584567|Doxycycline|doxycycline|mesh-list
91959039|NCT04584567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959040|NCT04584567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959041|NCT04584567|Antimalarials|antimalarials|mesh-ancestor
91959042|NCT04584567|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91959043|NCT04584567|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91959044|NCT03349177|Cyclophosphamide|cyclophosphamide|mesh-list
91959046|NCT03349177|Fluorouracil|fluorouracil|mesh-list
91959047|NCT03349177|Epirubicin|epirubicin|mesh-list
91959048|NCT03349177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91959049|NCT03349177|Immunologic Factors|immunologic factors|mesh-ancestor
91959050|NCT03349177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959051|NCT03349177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959052|NCT03349177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91959053|NCT03349177|Alkylating Agents|alkylating agents|mesh-ancestor
91959054|NCT03349177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959055|NCT03349177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959056|NCT03349177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91959057|NCT03349177|Tubulin Modulators|tubulin modulators|mesh-ancestor
91959058|NCT03349177|Antimitotic Agents|antimitotic agents|mesh-ancestor
91959059|NCT03349177|Mitosis Modulators|mitosis modulators|mesh-ancestor
91959060|NCT03349177|Antimetabolites|antimetabolites|mesh-ancestor
92090435|NCT04416035|Growth Inhibitors|growth inhibitors|mesh-ancestor
91959084|NCT04691505|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91959085|NCT04691505|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91959086|NCT04691505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959087|NCT05400265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91959088|NCT05400265|Antibodies|antibodies|mesh-list
91959089|NCT05400265|Immunoglobulins|immunoglobulins|mesh-list
91959090|NCT05400265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91959091|NCT05400265|Immunologic Factors|immunologic factors|mesh-ancestor
91959092|NCT05400265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959093|NCT05400265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959094|NCT05364619|Bismuth|bismuth|mesh-list
91959095|NCT05364619|Antacids|antacids|mesh-ancestor
91959096|NCT05364619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959097|NCT05364619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959098|NCT03353857|Rifampin|rifampin|mesh-list
91959099|NCT03353857|Dienogest|dienogest|mesh-list
91959100|NCT03353857|Drospirenone|drospirenone|mesh-list
91959101|NCT03353857|Midazolam|midazolam|mesh-list
91959102|NCT03353857|Levonorgestrel|levonorgestrel|mesh-list
91959103|NCT03353857|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91959104|NCT03353857|Norethindrone|norethindrone|mesh-list
91959105|NCT03353857|Norethindrone Acetate|norethindrone acetate|mesh-list
91959106|NCT03353857|Desogestrel|desogestrel|mesh-list
91959107|NCT03353857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91959108|NCT03353857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91959109|NCT03353857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959110|NCT03353857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959111|NCT03353857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91944860|NCT02446418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959112|NCT03353857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91959113|NCT03353857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959137|NCT03353857|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91959138|NCT03353857|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91959139|NCT03353857|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91959140|NCT03353857|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91959141|NCT03353857|Estrogens|estrogens|mesh-ancestor
91959142|NCT03353857|Hormones|hormones|mesh-ancestor
91959143|NCT03353857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959144|NCT03353857|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91959145|NCT03353857|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959146|NCT03353857|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91959147|NCT03353857|Diuretics|diuretics|mesh-ancestor
91959148|NCT03353857|Natriuretic Agents|natriuretic agents|mesh-ancestor
91959149|NCT03353857|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91959150|NCT03353857|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959151|NCT03353857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959153|NCT04499859|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91959154|NCT04499859|Ezetimibe|ezetimibe|mesh-list
91959155|NCT04499859|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91959156|NCT04499859|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91959157|NCT04499859|Antimetabolites|antimetabolites|mesh-ancestor
91959158|NCT04499859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959159|NCT04499859|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91959160|NCT04499859|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91959161|NCT04499859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959174|NCT05306899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959175|NCT05306899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959177|NCT00807651|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91959178|NCT00807651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959179|NCT00807651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959180|NCT00700791|Vitamins|vitamins|mesh-list
91959181|NCT00700791|Vitamin E|vitamin e|mesh-list
91959182|NCT00700791|Tocopherols|tocopherols|mesh-list
91959183|NCT00700791|Tocotrienols|tocotrienols|mesh-list
91959184|NCT00700791|alpha-Tocopherol|alpha-tocopherol|mesh-list
91959185|NCT00700791|Micronutrients|micronutrients|mesh-ancestor
91959186|NCT00700791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959187|NCT00700791|Antioxidants|antioxidants|mesh-ancestor
91959188|NCT00700791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959189|NCT00700791|Protective Agents|protective agents|mesh-ancestor
91959190|NCT05344365|Iloperidone|iloperidone|mesh-list
91959191|NCT05344365|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91959192|NCT05344365|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91959193|NCT05344365|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959194|NCT05344365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959195|NCT05344365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959197|NCT04373733|Antiviral Agents|antiviral agents|mesh-ancestor
91959198|NCT04373733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959199|NCT05403489|Dimercaprol|dimercaprol|mesh-list
91959200|NCT05403489|Chelating Agents|chelating agents|mesh-ancestor
91959201|NCT05403489|Sequestering Agents|sequestering agents|mesh-ancestor
91959202|NCT05403489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959203|NCT04969731|Gemcitabine|gemcitabine|mesh-list
91959204|NCT04969731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959205|NCT04969731|Antimetabolites|antimetabolites|mesh-ancestor
91959206|NCT04969731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959207|NCT04969731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959208|NCT02045901|Dicyclomine, doxylamine, pyridoxine drug combination|dicyclomine, doxylamine, pyridoxine drug combination|mesh-list
91959209|NCT02045901|Antiemetics|antiemetics|mesh-ancestor
91959210|NCT02045901|Autonomic Agents|autonomic agents|mesh-ancestor
91959211|NCT02045901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959212|NCT02045901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959213|NCT02045901|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959214|NCT02045901|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91959215|NCT02045901|Histamine Antagonists|histamine antagonists|mesh-ancestor
91959216|NCT02045901|Histamine Agents|histamine agents|mesh-ancestor
91959217|NCT02045901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959218|NCT02045901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959219|NCT01674621|Abaloparatide|abaloparatide|mesh-list
91944861|NCT04859062|Lidocaine|lidocaine|mesh-list
91944862|NCT04859062|Anesthetics, Local|anesthetics, local|mesh-ancestor
91944863|NCT04859062|Anesthetics|anesthetics|mesh-ancestor
91959220|NCT01674621|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
91959221|NCT01674621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959222|NCT01674621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959223|NCT01674621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91959224|NCT04644705|Niclosamide|niclosamide|mesh-list
91959259|NCT04038489|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91959260|NCT04038489|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91959261|NCT04038489|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91959262|NCT04038489|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91959263|NCT04038489|Antipyretics|antipyretics|mesh-ancestor
91959264|NCT04038489|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91959265|NCT04038489|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959334|NCT05131893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959335|NCT05131893|Antimetabolites|antimetabolites|mesh-ancestor
91959336|NCT05131893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91959337|NCT05131893|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91959338|NCT05131893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91959339|NCT05131893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959340|NCT05131893|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91959341|NCT05131893|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959342|NCT05131893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959350|NCT02889237|Calcium, Dietary|calcium, dietary|mesh-list
91959351|NCT02889237|Vitamin D|vitamin d|mesh-list
91959352|NCT02889237|Ergocalciferols|ergocalciferols|mesh-list
91959353|NCT02889237|Cholecalciferol|cholecalciferol|mesh-list
91959354|NCT02889237|Vitamins|vitamins|mesh-list
91959355|NCT02889237|Calcium|calcium|mesh-list
91959356|NCT02889237|Micronutrients|micronutrients|mesh-ancestor
91959357|NCT02889237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959358|NCT02889237|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91959359|NCT02889237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959360|NCT02689167|Sunitinib|sunitinib|mesh-list
91959361|NCT02689167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959362|NCT02689167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91959364|NCT02689167|Growth Substances|growth substances|mesh-ancestor
91959365|NCT02689167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959366|NCT02689167|Growth Inhibitors|growth inhibitors|mesh-ancestor
91959367|NCT02689167|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91959368|NCT02689167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959369|NCT02689167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959370|NCT02582697|Cisplatin|cisplatin|mesh-list
91959371|NCT02582697|Etoposide|etoposide|mesh-list
91959372|NCT02582697|Etoposide phosphate|etoposide phosphate|mesh-list
91959373|NCT02582697|Bleomycin|bleomycin|mesh-list
91959374|NCT02582697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959375|NCT02582697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91959376|NCT02582697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91959377|NCT02582697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91959378|NCT02582697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959379|NCT02582697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959380|NCT02582697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91959381|NCT01503489|Norepinephrine|norepinephrine|mesh-list
91959382|NCT01503489|Antidepressive Agents|antidepressive agents|mesh-list
91959383|NCT01503489|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-list
91959384|NCT01503489|Serotonin|serotonin|mesh-list
91959385|NCT01503489|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
91959386|NCT01503489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91959387|NCT01503489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91959388|NCT01503489|Adrenergic Agents|adrenergic agents|mesh-ancestor
91959389|NCT01503489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959390|NCT01503489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959391|NCT01503489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959392|NCT01503489|Sympathomimetics|sympathomimetics|mesh-ancestor
91959393|NCT01503489|Autonomic Agents|autonomic agents|mesh-ancestor
91959394|NCT01503489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959395|NCT01503489|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91944864|NCT04859062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944865|NCT04859062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944866|NCT04859062|Sensory System Agents|sensory system agents|mesh-ancestor
91959396|NCT01503489|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959397|NCT01503489|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91959398|NCT01503489|Serotonin Agents|serotonin agents|mesh-ancestor
91959399|NCT01503489|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91959400|NCT01503489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91959401|NCT05059587|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91959402|NCT05059587|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91959403|NCT05059587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959404|NCT05059587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959405|NCT05059587|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91959406|NCT05059587|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91959407|NCT05059587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959440|NCT04244877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959441|NCT04495179|Durvalumab|durvalumab|mesh-list
91959442|NCT04495179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91959443|NCT04495179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959444|NCT05118945|Insulin|insulin|mesh-list
91959445|NCT05118945|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91959446|NCT05118945|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959447|NCT05118945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959448|NCT05305131|Bevacizumab|bevacizumab|mesh-list
91959449|NCT05305131|Pembrolizumab|pembrolizumab|mesh-list
91959450|NCT05305131|Cisplatin|cisplatin|mesh-list
91959451|NCT05305131|Gemcitabine|gemcitabine|mesh-list
91959452|NCT05305131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91959453|NCT05305131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959468|NCT03122665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959469|NCT05099913|Flupenthixol|flupenthixol|mesh-list
91959470|NCT05099913|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91959471|NCT05099913|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91959472|NCT05099913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959473|NCT05099913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959474|NCT05099913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959475|NCT05099913|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91959476|NCT05099913|Dopamine Agents|dopamine agents|mesh-ancestor
91959477|NCT05099913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959478|NCT05099913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959479|NCT03346993|Bupivacaine|bupivacaine|mesh-list
91959480|NCT03346993|Anesthetics, Local|anesthetics, local|mesh-ancestor
91959481|NCT03346993|Anesthetics|anesthetics|mesh-ancestor
91959482|NCT03346993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959483|NCT03346993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959484|NCT03346993|Sensory System Agents|sensory system agents|mesh-ancestor
91959485|NCT03346993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959486|NCT03346837|Itraconazole|itraconazole|mesh-list
91959487|NCT03346837|Rifampin|rifampin|mesh-list
91959488|NCT03346837|Linrodostat|linrodostat|mesh-list
91959489|NCT03346837|Antifungal Agents|antifungal agents|mesh-ancestor
91959490|NCT03346837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959491|NCT03346837|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91959492|NCT03346837|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91959493|NCT03346837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959494|NCT03346837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959495|NCT03346837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91959496|NCT03346837|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959497|NCT03346837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959498|NCT03346837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959499|NCT03346837|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91959500|NCT03346837|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91959501|NCT03346837|Antitubercular Agents|antitubercular agents|mesh-ancestor
91959502|NCT03346837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959503|NCT03346837|Leprostatic Agents|leprostatic agents|mesh-ancestor
91959504|NCT03346837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91959505|NCT03346837|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91959506|NCT03346837|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91959507|NCT03346837|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91944867|NCT04859062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959508|NCT03346837|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91959509|NCT03346837|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91959510|NCT03346837|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91959511|NCT04564521|Nitroglycerin|nitroglycerin|mesh-list
91959533|NCT03122353|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91959534|NCT03122353|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959535|NCT03122353|Dermatologic Agents|dermatologic agents|mesh-ancestor
91959536|NCT03122353|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91959537|NCT03122353|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
91959538|NCT03122353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91959539|NCT03122353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959540|NCT03122353|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91959541|NCT03122353|Vitamins|vitamins|mesh-ancestor
91959542|NCT03122353|Micronutrients|micronutrients|mesh-ancestor
91959543|NCT03122353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959544|NCT05303259|Bevacizumab|bevacizumab|mesh-list
91959545|NCT05303259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91959546|NCT05303259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959547|NCT05303259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91959548|NCT05303259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91959549|NCT05303259|Growth Substances|growth substances|mesh-ancestor
91959550|NCT05303259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959551|NCT05303259|Growth Inhibitors|growth inhibitors|mesh-ancestor
91959552|NCT03121963|Acetaminophen|acetaminophen|mesh-list
91959553|NCT03121963|Celecoxib|celecoxib|mesh-list
91959554|NCT03121963|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
91959555|NCT03121963|Oxycodone|oxycodone|mesh-list
91959556|NCT03121963|Gabapentin|gabapentin|mesh-list
91959557|NCT03121963|Hydrocodone|hydrocodone|mesh-list
91959558|NCT03121963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91959559|NCT03121963|Analgesics|analgesics|mesh-ancestor
91959560|NCT03121963|Sensory System Agents|sensory system agents|mesh-ancestor
91959561|NCT03121963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959562|NCT03121963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959563|NCT03121963|Antipyretics|antipyretics|mesh-ancestor
91959564|NCT03121963|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91959565|NCT03121963|Narcotics|narcotics|mesh-ancestor
91959566|NCT03121963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959577|NCT03121963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959578|NCT03121963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91959579|NCT03121963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91959580|NCT03121963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959581|NCT03121963|Antimanic Agents|antimanic agents|mesh-ancestor
91959582|NCT03121963|Antitussive Agents|antitussive agents|mesh-ancestor
91959583|NCT03121963|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959585|NCT04502251|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91959586|NCT04502251|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91959587|NCT04502251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959588|NCT04502251|Sensory System Agents|sensory system agents|mesh-ancestor
91959589|NCT04502251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959590|NCT02648217|Insulin|insulin|mesh-list
91959591|NCT02648217|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91959592|NCT02648217|Insulin Aspart|insulin aspart|mesh-list
91959593|NCT02648217|Insulin, Long-Acting|insulin, long-acting|mesh-list
91959594|NCT02648217|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
91959595|NCT02648217|Biphasic Insulins|biphasic insulins|mesh-list
91959596|NCT02648217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959597|NCT02648217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959598|NCT03122041|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91959599|NCT03122041|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959600|NCT03122041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959601|NCT03122041|Incretins|incretins|mesh-ancestor
91959602|NCT03122041|Hormones|hormones|mesh-ancestor
91959603|NCT03122041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959604|NCT03122041|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91959605|NCT03122041|Protease Inhibitors|protease inhibitors|mesh-ancestor
91959606|NCT03122041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959607|NCT03122041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959608|NCT04943679|Interferons|interferons|mesh-list
91959609|NCT04943679|Interferon-alpha|interferon-alpha|mesh-list
91944868|NCT04859062|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91944869|NCT04859062|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91944870|NCT04859062|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91959610|NCT04943679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959611|NCT04943679|Antiviral Agents|antiviral agents|mesh-ancestor
91959612|NCT04943679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959613|NCT04943679|Immunologic Factors|immunologic factors|mesh-ancestor
91959614|NCT04943679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959615|NCT04507165|Analgesics, Opioid|analgesics, opioid|mesh-list
91959617|NCT04507165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959618|NCT04507165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959619|NCT04507165|Narcotics|narcotics|mesh-ancestor
91959620|NCT04507165|Analgesics|analgesics|mesh-ancestor
91959621|NCT04507165|Sensory System Agents|sensory system agents|mesh-ancestor
91959622|NCT04507165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959623|NCT04475991|Maraviroc|maraviroc|mesh-list
91959624|NCT04475991|Favipiravir|favipiravir|mesh-list
91959625|NCT04475991|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91959626|NCT04475991|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91959627|NCT04475991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959628|NCT04475991|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91959629|NCT04475991|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91959632|NCT04475991|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91959633|NCT03387475|Deferasirox|deferasirox|mesh-list
91959634|NCT03387475|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91959635|NCT03387475|Chelating Agents|chelating agents|mesh-ancestor
91959636|NCT03387475|Sequestering Agents|sequestering agents|mesh-ancestor
91959637|NCT03387475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959638|NCT04502017|Clopidogrel|clopidogrel|mesh-list
91959639|NCT04502017|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91959800|NCT03347461|Glucocorticoids|glucocorticoids|mesh-ancestor
91959640|NCT04502017|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91959641|NCT04502017|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91959642|NCT04502017|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91959643|NCT04502017|Purinergic Agents|purinergic agents|mesh-ancestor
91959645|NCT04502017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959646|NCT04502017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959647|NCT05302713|Calcium, Dietary|calcium, dietary|mesh-list
91959648|NCT05302713|Calcium Carbonate|calcium carbonate|mesh-list
91959650|NCT05302713|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91959651|NCT05302713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959652|NCT05302713|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959654|NCT05302713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959655|NCT05302713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959656|NCT04921033|Prednisolone|prednisolone|mesh-list
91959657|NCT04921033|Budesonide|budesonide|mesh-list
91959658|NCT04921033|Azathioprine|azathioprine|mesh-list
91959659|NCT04921033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959660|NCT04921033|Glucocorticoids|glucocorticoids|mesh-ancestor
91959661|NCT04921033|Hormones|hormones|mesh-ancestor
91959662|NCT04921033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959663|NCT04921033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959664|NCT04921033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959665|NCT04921033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959666|NCT04921033|Autonomic Agents|autonomic agents|mesh-ancestor
91959667|NCT04921033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959668|NCT04921033|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91959669|NCT04921033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91959670|NCT04921033|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959671|NCT04921033|Antimetabolites|antimetabolites|mesh-ancestor
91959672|NCT04921033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959673|NCT04921033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959674|NCT04921033|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91959675|NCT04921033|Immunologic Factors|immunologic factors|mesh-ancestor
91959676|NCT04921033|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959677|NCT03346681|Acetylcysteine|acetylcysteine|mesh-list
91959678|NCT03346681|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91959680|NCT03346681|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959681|NCT03346681|Expectorants|expectorants|mesh-ancestor
91959682|NCT03346681|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959683|NCT03346681|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91959684|NCT03346681|Antioxidants|antioxidants|mesh-ancestor
91959685|NCT03346681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959686|NCT03346681|Protective Agents|protective agents|mesh-ancestor
91959687|NCT03346681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959688|NCT03346681|Antidotes|antidotes|mesh-ancestor
91959689|NCT04488315|Dexamethasone|dexamethasone|mesh-list
91959690|NCT04488315|Ropivacaine|ropivacaine|mesh-list
91959691|NCT04488315|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959692|NCT04488315|Antiemetics|antiemetics|mesh-ancestor
91959693|NCT04488315|Autonomic Agents|autonomic agents|mesh-ancestor
91959694|NCT04488315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959695|NCT04488315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959696|NCT04488315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959697|NCT04488315|Glucocorticoids|glucocorticoids|mesh-ancestor
91959698|NCT04488315|Hormones|hormones|mesh-ancestor
91959699|NCT04488315|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959700|NCT04488315|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959701|NCT04488315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959702|NCT04488315|Anesthetics, Local|anesthetics, local|mesh-ancestor
91959710|NCT00709735|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959711|NCT00709735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959712|NCT00709735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959713|NCT00709735|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91959714|NCT00709735|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91959716|NCT04505995|Azacitidine|azacitidine|mesh-list
91959717|NCT04505995|Homoharringtonine|homoharringtonine|mesh-list
91959718|NCT04505995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959719|NCT04505995|Antimetabolites|antimetabolites|mesh-ancestor
91959720|NCT04505995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959721|NCT04505995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959722|NCT04505995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959723|NCT04505995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91959724|NCT04505995|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91959726|NCT04486911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959727|NCT04486911|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91959728|NCT04486911|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91959729|NCT04486911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959730|NCT04486911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959731|NCT04486911|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91959732|NCT04486911|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959733|NCT04486911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959734|NCT04486911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959735|NCT05135013|Drospirenone|drospirenone|mesh-list
91959736|NCT05135013|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91959737|NCT05135013|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91959738|NCT05135013|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91959739|NCT05135013|Norethindrone|norethindrone|mesh-list
91959740|NCT05135013|Norethindrone Acetate|norethindrone acetate|mesh-list
91959741|NCT05135013|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
91959742|NCT05135013|Estradiol|estradiol|mesh-list
91959743|NCT05135013|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91959744|NCT05135013|Dydrogesterone|dydrogesterone|mesh-list
91959745|NCT05135013|Estrogens|estrogens|mesh-ancestor
91959746|NCT05135013|Hormones|hormones|mesh-ancestor
91959747|NCT05135013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959748|NCT05135013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959749|NCT05135013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91959750|NCT05135013|Contraceptive Agents|contraceptive agents|mesh-ancestor
91959751|NCT05135013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91959752|NCT05135013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91959753|NCT05135013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91959754|NCT05135013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91959755|NCT05135013|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91959756|NCT05135013|Hormone Antagonists|hormone antagonists|mesh-ancestor
91959757|NCT05135013|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91959758|NCT05135013|Diuretics|diuretics|mesh-ancestor
91959759|NCT05135013|Natriuretic Agents|natriuretic agents|mesh-ancestor
91959760|NCT05135013|Progestins|progestins|mesh-ancestor
91944871|NCT04859062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944872|NCT04859062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944873|NCT04864210|Bupivacaine|bupivacaine|mesh-list
91944874|NCT04864210|Anesthetics, Local|anesthetics, local|mesh-ancestor
91959761|NCT05135013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91959762|NCT04516161|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
91959763|NCT04516161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959764|NCT04505917|Misoprostol|misoprostol|mesh-list
91959765|NCT04505917|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91959766|NCT04505917|Abortifacient Agents|abortifacient agents|mesh-ancestor
91959767|NCT04505917|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91959768|NCT04505917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959772|NCT04505683|Ertapenem|ertapenem|mesh-list
91959773|NCT04505683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959774|NCT04505683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959775|NCT05576155|Compound 21|compound 21|mesh-list
91959776|NCT05576155|Losartan|losartan|mesh-list
91959777|NCT05576155|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91959778|NCT05576155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91959779|NCT05576155|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91959780|NCT05576155|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91959781|NCT05576155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959782|NCT05576155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959783|NCT04501783|Favipiravir|favipiravir|mesh-list
91959784|NCT04501783|Antiviral Agents|antiviral agents|mesh-ancestor
91959785|NCT04501783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959786|NCT03351751|PF-06372865|pf-06372865|mesh-list
91959787|NCT03351751|GABA Modulators|gaba modulators|mesh-ancestor
91959788|NCT03351751|GABA Agents|gaba agents|mesh-ancestor
91959789|NCT03351751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959790|NCT03351751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959791|NCT03351751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959792|NCT03347461|Ciprofloxacin|ciprofloxacin|mesh-list
91959793|NCT03347461|Dexamethasone|dexamethasone|mesh-list
91959794|NCT03347461|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959795|NCT03347461|Antiemetics|antiemetics|mesh-ancestor
91959796|NCT03347461|Autonomic Agents|autonomic agents|mesh-ancestor
91959797|NCT03347461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959798|NCT03347461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959799|NCT03347461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959801|NCT03347461|Hormones|hormones|mesh-ancestor
91959802|NCT03347461|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959803|NCT03347461|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959804|NCT03347461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959805|NCT03347461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959806|NCT03347461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959807|NCT03347461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959808|NCT03347461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959809|NCT03347461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91959810|NCT03347461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91959811|NCT03347461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91959812|NCT03347461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91959813|NCT03351517|Tapentadol|tapentadol|mesh-list
91959814|NCT03351517|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91959815|NCT03351517|Narcotics|narcotics|mesh-ancestor
91959816|NCT03351517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959817|NCT03351517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959818|NCT03351517|Analgesics|analgesics|mesh-ancestor
91959819|NCT03351517|Sensory System Agents|sensory system agents|mesh-ancestor
91959820|NCT03351517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959821|NCT03351517|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91959822|NCT03351517|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91959823|NCT03351517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91959824|NCT03351517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959825|NCT03351517|Adrenergic Agents|adrenergic agents|mesh-ancestor
91959826|NCT03351517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959827|NCT03346525|Penicillins|penicillins|mesh-list
91959828|NCT03346525|Penicillin G|penicillin g|mesh-list
91944875|NCT04864210|Anesthetics|anesthetics|mesh-ancestor
91944876|NCT04864210|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944877|NCT04864210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944878|NCT04864210|Sensory System Agents|sensory system agents|mesh-ancestor
91959829|NCT03346525|Penicillin G Benzathine|penicillin g benzathine|mesh-list
91959830|NCT03346525|Penicillin G Procaine|penicillin g procaine|mesh-list
91959831|NCT03346525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959832|NCT03346525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959834|NCT05060523|Midodrine|midodrine|mesh-list
91959835|NCT05060523|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91959836|NCT05060523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959837|NCT05060523|Natriuretic Agents|natriuretic agents|mesh-ancestor
91959838|NCT05060523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959839|NCT05060523|Sympathomimetics|sympathomimetics|mesh-ancestor
91959852|NCT04502641|Antimitotic Agents|antimitotic agents|mesh-ancestor
91959853|NCT04502641|Mitosis Modulators|mitosis modulators|mesh-ancestor
91959854|NCT04502641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959855|NCT04502641|Antimetabolites|antimetabolites|mesh-ancestor
91959856|NCT04502641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959857|NCT04502641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91959858|NCT04502641|Immunologic Factors|immunologic factors|mesh-ancestor
91959859|NCT04502641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959860|NCT05555797|Betamethasone|betamethasone|mesh-list
91959861|NCT05555797|Betamethasone Valerate|betamethasone valerate|mesh-list
91959862|NCT05555797|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91959863|NCT05555797|Betamethasone benzoate|betamethasone benzoate|mesh-list
91959864|NCT05555797|Tazarotene|tazarotene|mesh-list
91959865|NCT05555797|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91959866|NCT05555797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959867|NCT05555797|Glucocorticoids|glucocorticoids|mesh-ancestor
91959869|NCT05555797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959870|NCT05555797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959871|NCT05555797|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91959872|NCT05555797|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959873|NCT05555797|Dermatologic Agents|dermatologic agents|mesh-ancestor
91959874|NCT05555797|Keratolytic Agents|keratolytic agents|mesh-ancestor
91959875|NCT03955575|Liraglutide|liraglutide|mesh-list
91959876|NCT03955575|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
91959877|NCT03955575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959878|NCT03955575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959879|NCT03955575|Incretins|incretins|mesh-ancestor
91959880|NCT03955575|Hormones|hormones|mesh-ancestor
91959881|NCT03955575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959882|NCT03955575|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91959883|NCT03955575|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91959884|NCT03955575|Antimetabolites|antimetabolites|mesh-ancestor
91959885|NCT03955575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959886|NCT03955575|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91959887|NCT04163419|Tanezumab|tanezumab|mesh-list
91959888|NCT04163419|Analgesics|analgesics|mesh-ancestor
91959889|NCT04163419|Sensory System Agents|sensory system agents|mesh-ancestor
91959890|NCT04163419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959891|NCT04163419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959892|NCT03351205|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91959893|NCT03351205|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91959894|NCT03351205|Estradiol|estradiol|mesh-list
91959895|NCT03351205|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91959896|NCT03351205|Dydrogesterone|dydrogesterone|mesh-list
91959897|NCT03351205|Estrogens|estrogens|mesh-ancestor
91959898|NCT03351205|Hormones|hormones|mesh-ancestor
91959899|NCT03351205|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959900|NCT03351205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959901|NCT03351205|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91959902|NCT03351205|Contraceptive Agents|contraceptive agents|mesh-ancestor
91959903|NCT03351205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91959913|NCT04698057|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91959915|NCT04698057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959916|NCT04698057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944879|NCT04864210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944881|NCT01641640|Ribavirin|ribavirin|mesh-list
91944882|NCT01641640|Antiviral Agents|antiviral agents|mesh-ancestor
91959917|NCT04698057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959918|NCT04698057|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91959919|NCT04698057|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91959920|NCT04698057|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91959921|NCT02449005|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91959922|NCT02449005|Hemostatics|hemostatics|mesh-ancestor
91959923|NCT02449005|Coagulants|coagulants|mesh-ancestor
91959924|NCT04132791|Aspirin|aspirin|mesh-list
91959925|NCT04132791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91959926|NCT04132791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91959927|NCT04132791|Analgesics|analgesics|mesh-ancestor
91959928|NCT04132791|Sensory System Agents|sensory system agents|mesh-ancestor
91959929|NCT04132791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959930|NCT04132791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959931|NCT04132791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959932|NCT04132791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959933|NCT04132791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91959934|NCT04132791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91959935|NCT04132791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959936|NCT04132791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91959937|NCT04132791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91959938|NCT04132791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959939|NCT04132791|Antipyretics|antipyretics|mesh-ancestor
91959940|NCT04065009|Ropivacaine|ropivacaine|mesh-list
91959941|NCT04065009|Anesthetics, Local|anesthetics, local|mesh-ancestor
91959943|NCT04065009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959944|NCT04065009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959945|NCT04065009|Sensory System Agents|sensory system agents|mesh-ancestor
91959946|NCT04065009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959947|NCT04250493|Insulin|insulin|mesh-list
91959948|NCT04250493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959949|NCT04250493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959950|NCT03833479|Dostarlimab|dostarlimab|mesh-list
91959951|NCT03833479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959952|NCT04147221|Imipenem|imipenem|mesh-list
91959953|NCT04147221|Relebactam|relebactam|mesh-list
91959954|NCT04147221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959955|NCT04147221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959956|NCT04147221|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91959957|NCT04147221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959958|NCT04147221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959959|NCT02517619|Dexamethasone|dexamethasone|mesh-list
91959960|NCT02517619|Prednisolone|prednisolone|mesh-list
91959961|NCT02517619|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91959962|NCT02517619|Methylprednisolone|methylprednisolone|mesh-list
91959963|NCT02517619|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91959964|NCT02517619|Prednisolone acetate|prednisolone acetate|mesh-list
91959965|NCT02517619|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91959966|NCT02517619|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91959967|NCT02517619|Prednisolone phosphate|prednisolone phosphate|mesh-list
91959968|NCT02517619|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91959969|NCT02517619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959970|NCT02517619|Antiemetics|antiemetics|mesh-ancestor
91959971|NCT02517619|Autonomic Agents|autonomic agents|mesh-ancestor
91959989|NCT03892395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959990|NCT03892395|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959991|NCT04481451|Ropivacaine|ropivacaine|mesh-list
91959992|NCT04481451|Anesthetics, Local|anesthetics, local|mesh-ancestor
91959993|NCT04481451|Anesthetics|anesthetics|mesh-ancestor
91959994|NCT04481451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959995|NCT04481451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959996|NCT04481451|Sensory System Agents|sensory system agents|mesh-ancestor
91959997|NCT04481451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959998|NCT03376659|Bevacizumab|bevacizumab|mesh-list
91959999|NCT03376659|Durvalumab|durvalumab|mesh-list
91960000|NCT03376659|Capecitabine|capecitabine|mesh-list
91960001|NCT03376659|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91960002|NCT03376659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960003|NCT03376659|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91960004|NCT03376659|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91960005|NCT03376659|Growth Substances|growth substances|mesh-ancestor
91960006|NCT03376659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960007|NCT03376659|Growth Inhibitors|growth inhibitors|mesh-ancestor
91960008|NCT03376659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960009|NCT03376659|Antimetabolites|antimetabolites|mesh-ancestor
91960010|NCT03376659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960011|NCT04102371|Plasma-lyte 148|plasma-lyte 148|mesh-list
91960012|NCT04102371|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91960013|NCT04102371|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91960014|NCT04086147|Tenecteplase|tenecteplase|mesh-list
91960015|NCT04086147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91960016|NCT04086147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91960017|NCT04086147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960018|NCT03161223|Azacitidine|azacitidine|mesh-list
91960019|NCT03161223|Durvalumab|durvalumab|mesh-list
91960020|NCT03161223|Romidepsin|romidepsin|mesh-list
91960021|NCT03161223|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960022|NCT03161223|Antimetabolites|antimetabolites|mesh-ancestor
91960023|NCT03161223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960024|NCT03161223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960025|NCT03161223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960026|NCT03161223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91960027|NCT03161223|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92090436|NCT04381858|Immunoglobulins|immunoglobulins|mesh-list
91960031|NCT03660813|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91960032|NCT03660813|Contraceptive Agents|contraceptive agents|mesh-ancestor
91960033|NCT03660813|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960034|NCT03660813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960035|NCT03660813|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91960036|NCT03660813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91960037|NCT03660813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960038|NCT01285557|Cisplatin|cisplatin|mesh-list
91960039|NCT01285557|Fluorouracil|fluorouracil|mesh-list
91960040|NCT01285557|Tegafur|tegafur|mesh-list
91960042|NCT01285557|Antimetabolites|antimetabolites|mesh-ancestor
91960043|NCT01285557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960044|NCT01285557|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960045|NCT01285557|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91960046|NCT01285557|Immunologic Factors|immunologic factors|mesh-ancestor
91960047|NCT01285557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960048|NCT03083067|Budesonide|budesonide|mesh-list
91960049|NCT03083067|Bromides|bromides|mesh-list
91960050|NCT03083067|Formoterol Fumarate|formoterol fumarate|mesh-list
91960051|NCT03083067|Tiotropium Bromide|tiotropium bromide|mesh-list
91960052|NCT03083067|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960053|NCT03083067|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91960054|NCT03083067|Autonomic Agents|autonomic agents|mesh-ancestor
91960055|NCT03083067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960056|NCT03083067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960057|NCT03083067|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91960058|NCT03083067|Respiratory System Agents|respiratory system agents|mesh-ancestor
91960059|NCT03083067|Glucocorticoids|glucocorticoids|mesh-ancestor
91960060|NCT03083067|Hormones|hormones|mesh-ancestor
91960061|NCT03083067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91960062|NCT03083067|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91960063|NCT03083067|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91960064|NCT03083067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91960065|NCT03083067|Adrenergic Agents|adrenergic agents|mesh-ancestor
91960066|NCT03083067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960067|NCT03083067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960068|NCT03083067|Parasympatholytics|parasympatholytics|mesh-ancestor
91960069|NCT03083067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91960070|NCT03083067|Cholinergic Agents|cholinergic agents|mesh-ancestor
91960071|NCT03083067|Anticonvulsants|anticonvulsants|mesh-ancestor
91960072|NCT03218137|Adenosine|adenosine|mesh-list
91960073|NCT03218137|Verapamil|verapamil|mesh-list
91960074|NCT03218137|Analgesics|analgesics|mesh-ancestor
91960075|NCT03218137|Sensory System Agents|sensory system agents|mesh-ancestor
91960076|NCT03218137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960077|NCT03218137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960078|NCT03218137|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91960079|NCT03218137|Vasodilator Agents|vasodilator agents|mesh-ancestor
91960080|NCT03218137|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91960081|NCT03218137|Purinergic Agonists|purinergic agonists|mesh-ancestor
91960082|NCT03218137|Purinergic Agents|purinergic agents|mesh-ancestor
91960083|NCT03218137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960084|NCT03218137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960085|NCT03218137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91960086|NCT03218137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960087|NCT03218137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91960088|NCT05638399|Zoledronic Acid|zoledronic acid|mesh-list
91960089|NCT05638399|Denosumab|denosumab|mesh-list
91960090|NCT05638399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91960091|NCT05638399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960093|NCT02512471|Anesthetics, Local|anesthetics, local|mesh-ancestor
91960094|NCT02512471|Anesthetics|anesthetics|mesh-ancestor
91960095|NCT02512471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960096|NCT02512471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960097|NCT02512471|Sensory System Agents|sensory system agents|mesh-ancestor
91960098|NCT02512471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960099|NCT02507479|Thiotepa|thiotepa|mesh-list
91960100|NCT02507479|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91960113|NCT02512315|Mitosis Modulators|mitosis modulators|mesh-ancestor
91960114|NCT02512315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960115|NCT02507323|Ticagrelor|ticagrelor|mesh-list
91960116|NCT02507323|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91960117|NCT02507323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91960118|NCT02507323|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91960119|NCT02507323|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91960120|NCT02507323|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91960121|NCT02507323|Purinergic Agents|purinergic agents|mesh-ancestor
91960122|NCT02507323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960123|NCT02507323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960124|NCT02507323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960125|NCT05431413|Phosphocreatine|phosphocreatine|mesh-list
91960126|NCT05431413|Fluoxetine|fluoxetine|mesh-list
91960127|NCT05431413|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91960128|NCT05431413|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91960129|NCT05431413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960130|NCT05431413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960131|NCT05431413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960132|NCT05431413|Serotonin Agents|serotonin agents|mesh-ancestor
91960133|NCT05431413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960134|NCT05431413|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91960135|NCT05431413|Antidepressive Agents|antidepressive agents|mesh-ancestor
91960136|NCT05431413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960137|NCT05431413|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91960138|NCT05431413|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91960139|NCT05431413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960140|NCT05431413|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91960141|NCT05431413|Protective Agents|protective agents|mesh-ancestor
91960142|NCT02507245|Hormones|hormones|mesh-list
91960143|NCT02507245|Growth Hormone-Releasing Hormone|growth hormone-releasing hormone|mesh-list
91960144|NCT02507245|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91960145|NCT02507245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960146|NCT02517307|Heparin|heparin|mesh-list
91960147|NCT02517307|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
91960148|NCT02517307|Glycerol|glycerol|mesh-list
91960149|NCT02517307|Anticoagulants|anticoagulants|mesh-ancestor
91960150|NCT02517307|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91960151|NCT02517307|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91960152|NCT02517307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960153|NCT02517307|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91960154|NCT02517307|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91960155|NCT02517307|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91960156|NCT02517307|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91960157|NCT02517307|Protective Agents|protective agents|mesh-ancestor
91960158|NCT02517307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960159|NCT05431257|Venetoclax|venetoclax|mesh-list
91960160|NCT05431257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960161|NCT05431023|Lactoferrin|lactoferrin|mesh-list
91960164|NCT02507167|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91960165|NCT02507167|Antitubercular Agents|antitubercular agents|mesh-ancestor
91960166|NCT02507167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944884|NCT01641640|Antimetabolites|antimetabolites|mesh-ancestor
91944885|NCT01641640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944887|NCT05650216|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91944888|NCT05650216|Carboplatin|carboplatin|mesh-list
91960167|NCT02507167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960168|NCT02507167|Leprostatic Agents|leprostatic agents|mesh-ancestor
91960169|NCT02507167|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91960170|NCT02507167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960171|NCT02507167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960172|NCT02507167|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91960173|NCT02507167|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91960174|NCT02507167|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91960175|NCT02507167|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91960176|NCT02507167|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91960177|NCT02507167|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91960178|NCT01376167|Chloroquine|chloroquine|mesh-list
91960179|NCT01376167|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
91960180|NCT01376167|Primaquine|primaquine|mesh-list
91960181|NCT01376167|Tafenoquine|tafenoquine|mesh-list
91960182|NCT01376167|Amebicides|amebicides|mesh-ancestor
91960183|NCT01376167|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91960184|NCT01376167|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91960185|NCT01376167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960186|NCT01376167|Antimalarials|antimalarials|mesh-ancestor
91960187|NCT01376167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91960188|NCT01376167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91960189|NCT01376167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91960190|NCT01376167|Analgesics|analgesics|mesh-ancestor
91960191|NCT01376167|Sensory System Agents|sensory system agents|mesh-ancestor
91960192|NCT01376167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960193|NCT01376167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960194|NCT01376167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960196|NCT01376167|Antinematodal Agents|antinematodal agents|mesh-ancestor
91960197|NCT01376167|Anthelmintics|anthelmintics|mesh-ancestor
91960198|NCT02511613|Squalamine|squalamine|mesh-list
91960199|NCT02511613|Ranibizumab|ranibizumab|mesh-list
91960200|NCT02511613|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91960201|NCT02511613|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91960202|NCT02511613|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91960203|NCT02511613|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91960204|NCT02511613|Growth Substances|growth substances|mesh-ancestor
91960205|NCT02511613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960206|NCT02511613|Growth Inhibitors|growth inhibitors|mesh-ancestor
91960207|NCT02511613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960208|NCT02511613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91960209|NCT02511613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960210|NCT02511613|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91960211|NCT02511613|Protective Agents|protective agents|mesh-ancestor
91960212|NCT02506699|Analgesics|analgesics|mesh-list
91960213|NCT02506699|Sensory System Agents|sensory system agents|mesh-ancestor
91960214|NCT02506699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960215|NCT02506699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960216|NCT02506777|Metformin|metformin|mesh-list
91960217|NCT02506777|Cyclophosphamide|cyclophosphamide|mesh-list
91960218|NCT02506777|Doxorubicin|doxorubicin|mesh-list
91960219|NCT02506777|Fluorouracil|fluorouracil|mesh-list
91960220|NCT02506777|Melatonin|melatonin|mesh-list
91960221|NCT02506777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91960222|NCT02506777|Immunologic Factors|immunologic factors|mesh-ancestor
91960223|NCT02506777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960224|NCT02506777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91960225|NCT02506777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91960226|NCT02506777|Alkylating Agents|alkylating agents|mesh-ancestor
91960227|NCT02506777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960228|NCT02506777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960229|NCT02506777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91960230|NCT02506777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91960231|NCT02506777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91960232|NCT02506777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91960233|NCT02506777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91944889|NCT05650216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91944890|NCT05650216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960235|NCT02506777|Antioxidants|antioxidants|mesh-ancestor
91960236|NCT02506777|Protective Agents|protective agents|mesh-ancestor
91960238|NCT02506777|Antimetabolites|antimetabolites|mesh-ancestor
91960239|NCT02506777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960240|NCT02516527|Ipilimumab|ipilimumab|mesh-list
91960241|NCT02516527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91960243|NCT02516527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91960244|NCT02516527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960245|NCT02511847|Afatinib|afatinib|mesh-list
91960246|NCT02511847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960247|NCT02511847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91960248|NCT02511847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960249|NCT02511847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960250|NCT02506855|Ropivacaine|ropivacaine|mesh-list
91960251|NCT02506855|Anesthetics, Local|anesthetics, local|mesh-ancestor
91960252|NCT02506855|Anesthetics|anesthetics|mesh-ancestor
91960253|NCT02506855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960254|NCT02506855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960255|NCT02506855|Sensory System Agents|sensory system agents|mesh-ancestor
91960256|NCT02506855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960257|NCT02511223|Olaparib|olaparib|mesh-list
91960258|NCT02511223|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91960259|NCT02511223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960260|NCT02511223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960261|NCT02511223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960262|NCT02516059|Oxycodone|oxycodone|mesh-list
91960263|NCT02516059|Naloxone|naloxone|mesh-list
91960264|NCT02516059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91960265|NCT02516059|Narcotics|narcotics|mesh-ancestor
91960266|NCT02516059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960267|NCT02516059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960269|NCT02516059|Sensory System Agents|sensory system agents|mesh-ancestor
91960270|NCT02516059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960271|NCT02516059|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91960272|NCT02506231|Leucovorin|leucovorin|mesh-list
91960273|NCT02506231|Folic Acid|folic acid|mesh-list
91960274|NCT02506231|Levoleucovorin|levoleucovorin|mesh-list
91960275|NCT02506231|Antidotes|antidotes|mesh-ancestor
91960276|NCT02506231|Protective Agents|protective agents|mesh-ancestor
91960277|NCT02506231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960278|NCT02506231|Vitamin B Complex|vitamin b complex|mesh-ancestor
91960279|NCT02506231|Vitamins|vitamins|mesh-ancestor
91960280|NCT02506231|Micronutrients|micronutrients|mesh-ancestor
91960281|NCT02506231|Hematinics|hematinics|mesh-ancestor
91960282|NCT02511145|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
91960283|NCT02511145|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91960284|NCT02511145|Dermatologic Agents|dermatologic agents|mesh-ancestor
91960285|NCT02505997|Delafloxacin|delafloxacin|mesh-list
91960286|NCT02505997|Midazolam|midazolam|mesh-list
91960287|NCT02505997|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960288|NCT02505997|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960289|NCT02505997|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960290|NCT02505997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960291|NCT02505997|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91960292|NCT02505997|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91960293|NCT02505997|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960294|NCT02505997|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960295|NCT02505997|Anesthetics, General|anesthetics, general|mesh-ancestor
91960296|NCT02505997|Anesthetics|anesthetics|mesh-ancestor
91960297|NCT02505997|GABA Modulators|gaba modulators|mesh-ancestor
91960298|NCT02505997|GABA Agents|gaba agents|mesh-ancestor
91960299|NCT02505997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960300|NCT02505997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960301|NCT02505997|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960302|NCT02511067|Ranibizumab|ranibizumab|mesh-list
91960303|NCT02511067|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91960304|NCT02511067|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91960305|NCT02511067|Growth Substances|growth substances|mesh-ancestor
91960306|NCT02511067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960307|NCT02511067|Growth Inhibitors|growth inhibitors|mesh-ancestor
91944891|NCT05650216|Tubulin Modulators|tubulin modulators|mesh-ancestor
91944892|NCT05650216|Antimitotic Agents|antimitotic agents|mesh-ancestor
91944893|NCT05650216|Mitosis Modulators|mitosis modulators|mesh-ancestor
91960308|NCT02511067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960310|NCT02505841|Succinylcholine|succinylcholine|mesh-list
91960312|NCT02505841|Anesthetics, Local|anesthetics, local|mesh-ancestor
91960313|NCT02505841|Anesthetics|anesthetics|mesh-ancestor
91960316|NCT02505841|Sensory System Agents|sensory system agents|mesh-ancestor
91960317|NCT02505841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960318|NCT02505841|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
91960319|NCT02505841|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91960320|NCT02505841|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91960321|NCT02505841|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91960322|NCT02505841|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
91960323|NCT02505841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91960324|NCT02505841|Cholinergic Agents|cholinergic agents|mesh-ancestor
91960325|NCT02505841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960326|NCT02505841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960328|NCT03345667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91960329|NCT03345667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91960330|NCT03345667|Growth Substances|growth substances|mesh-ancestor
91960331|NCT03345667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960332|NCT03345667|Growth Inhibitors|growth inhibitors|mesh-ancestor
91960333|NCT03345667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960335|NCT04499989|Antitubercular Agents|antitubercular agents|mesh-ancestor
91960336|NCT04499989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91960337|NCT04499989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960338|NCT04499989|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91960339|NCT04499989|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91960340|NCT04499989|Antimetabolites|antimetabolites|mesh-ancestor
91960341|NCT04499989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960342|NCT04499989|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91960343|NCT04500067|Immunoglobulins|immunoglobulins|mesh-list
91960344|NCT04500067|Immunologic Factors|immunologic factors|mesh-ancestor
91960345|NCT04500067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960346|NCT04497649|Sofosbuvir|sofosbuvir|mesh-list
91960347|NCT04497649|Antiviral Agents|antiviral agents|mesh-ancestor
91960348|NCT04497649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960349|NCT02505451|Dobutamine|dobutamine|mesh-list
91960350|NCT02505451|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91960351|NCT02505451|Sympathomimetics|sympathomimetics|mesh-ancestor
91960352|NCT02505451|Autonomic Agents|autonomic agents|mesh-ancestor
91960353|NCT02505451|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960354|NCT02505451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960355|NCT02505451|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91960356|NCT02505451|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91960357|NCT02505451|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91960358|NCT02505451|Adrenergic Agents|adrenergic agents|mesh-ancestor
91960359|NCT02505451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960360|NCT02505451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960361|NCT02505451|Protective Agents|protective agents|mesh-ancestor
91960362|NCT02505295|Selenium|selenium|mesh-list
91960363|NCT02505295|Antioxidants|antioxidants|mesh-ancestor
91960364|NCT02505295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960365|NCT02505295|Protective Agents|protective agents|mesh-ancestor
91960366|NCT02505295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960367|NCT02505295|Trace Elements|trace elements|mesh-ancestor
91960368|NCT02505295|Micronutrients|micronutrients|mesh-ancestor
91960369|NCT02510911|Caffeine|caffeine|mesh-list
91960370|NCT02510911|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91960371|NCT02510911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960372|NCT02510911|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91960373|NCT02510911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960374|NCT02510911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960375|NCT02510911|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91960376|NCT02510911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91960377|NCT02510911|Purinergic Agents|purinergic agents|mesh-ancestor
91960378|NCT02510911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960379|NCT03121807|Leucovorin|leucovorin|mesh-list
91960380|NCT03121807|Fluorouracil|fluorouracil|mesh-list
91960381|NCT03121807|Oxaliplatin|oxaliplatin|mesh-list
91944894|NCT05650216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944896|NCT04848688|Moxidectin|moxidectin|mesh-list
91944897|NCT04848688|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91960382|NCT03121807|Antimetabolites|antimetabolites|mesh-ancestor
91960383|NCT03121807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960384|NCT03121807|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960385|NCT03121807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960389|NCT03121807|Antidotes|antidotes|mesh-ancestor
91960390|NCT03121807|Protective Agents|protective agents|mesh-ancestor
91960391|NCT03121807|Vitamin B Complex|vitamin b complex|mesh-ancestor
91960393|NCT03121807|Micronutrients|micronutrients|mesh-ancestor
91960394|NCT03343873|Midazolam|midazolam|mesh-list
91960395|NCT03343873|Dexmedetomidine|dexmedetomidine|mesh-list
91960396|NCT03343873|Propofol|propofol|mesh-list
91960397|NCT03343873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960398|NCT03343873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960399|NCT03343873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960400|NCT03343873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91960401|NCT03343873|Analgesics|analgesics|mesh-ancestor
91960402|NCT03343873|Sensory System Agents|sensory system agents|mesh-ancestor
91960403|NCT03343873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960404|NCT03343873|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91960405|NCT03343873|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91960406|NCT03343873|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91960407|NCT03343873|Adrenergic Agents|adrenergic agents|mesh-ancestor
91960408|NCT03343873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960409|NCT03343873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960410|NCT03343873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960411|NCT03343873|Anesthetics, General|anesthetics, general|mesh-ancestor
91960412|NCT03343873|Anesthetics|anesthetics|mesh-ancestor
91960413|NCT03343873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960414|NCT03343873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91960415|NCT03343873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91960416|NCT03343873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960417|NCT03343873|GABA Modulators|gaba modulators|mesh-ancestor
91960418|NCT03343873|GABA Agents|gaba agents|mesh-ancestor
91960419|NCT03343795|Progesterone|progesterone|mesh-list
91960420|NCT03343795|Progestins|progestins|mesh-ancestor
91960421|NCT03343795|Hormones|hormones|mesh-ancestor
91960422|NCT03343795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91960423|NCT03343795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960424|NCT02510287|Lidocaine|lidocaine|mesh-list
91960425|NCT02510287|Fentanyl|fentanyl|mesh-list
91960426|NCT02510287|Bupivacaine|bupivacaine|mesh-list
91960427|NCT02510287|Anesthetics, Local|anesthetics, local|mesh-ancestor
91960428|NCT02510287|Anesthetics|anesthetics|mesh-ancestor
91960429|NCT02510287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960430|NCT02510287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960431|NCT02510287|Sensory System Agents|sensory system agents|mesh-ancestor
91960432|NCT02510287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960433|NCT02510287|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91960434|NCT02510287|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91960435|NCT02510287|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91960436|NCT02510287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960437|NCT02510287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960438|NCT02510287|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91960439|NCT02510287|Narcotics|narcotics|mesh-ancestor
91960440|NCT02510287|Analgesics|analgesics|mesh-ancestor
91960441|NCT02510287|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960442|NCT02510287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960443|NCT02510287|Anesthetics, General|anesthetics, general|mesh-ancestor
91960444|NCT02515435|Apatinib|apatinib|mesh-list
91960445|NCT02515435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960446|NCT02515435|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91960447|NCT02515435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960448|NCT02515435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960449|NCT02515201|Taurolidine|taurolidine|mesh-list
91960450|NCT02515201|Heparin|heparin|mesh-list
91960451|NCT02515201|Calcium heparin|calcium heparin|mesh-list
91960452|NCT02515201|Anticoagulants|anticoagulants|mesh-ancestor
91960453|NCT02515201|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91960454|NCT02515201|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91960455|NCT02515201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960456|NCT02515201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960457|NCT02515201|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91960458|NCT02515201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960459|NCT02504983|Sorafenib|sorafenib|mesh-list
91960469|NCT02504359|Cytarabine|cytarabine|mesh-list
91960471|NCT02504359|Etoposide|etoposide|mesh-list
91960472|NCT02504359|Etoposide phosphate|etoposide phosphate|mesh-list
91960473|NCT02504359|Melphalan|melphalan|mesh-list
91960474|NCT02504359|Mechlorethamine|mechlorethamine|mesh-list
91960475|NCT02504359|Carmustine|carmustine|mesh-list
91960476|NCT02504359|Ixazomib|ixazomib|mesh-list
91960477|NCT02504359|Podophyllotoxin|podophyllotoxin|mesh-list
91960478|NCT02504359|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
91960479|NCT02504359|Tacrolimus|tacrolimus|mesh-list
91960480|NCT02504359|Glycine|glycine|mesh-list
91960481|NCT02504359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91960482|NCT02504359|Abortifacient Agents|abortifacient agents|mesh-ancestor
91960483|NCT02504359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960484|NCT02504359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960485|NCT02504359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960486|NCT02504359|Antimetabolites|antimetabolites|mesh-ancestor
91960487|NCT02504359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960488|NCT02504359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960489|NCT02504359|Dermatologic Agents|dermatologic agents|mesh-ancestor
91960490|NCT02504359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960491|NCT02504359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91960492|NCT02504359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91960493|NCT02504359|Immunologic Factors|immunologic factors|mesh-ancestor
91960494|NCT02504359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91960495|NCT02504359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91960496|NCT02504359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91960497|NCT02504359|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91960498|NCT02504359|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91960499|NCT02504359|Antiviral Agents|antiviral agents|mesh-ancestor
91960500|NCT02504359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960501|NCT02504359|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91960502|NCT02504359|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91960503|NCT02504359|Alkylating Agents|alkylating agents|mesh-ancestor
91960504|NCT02504359|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91960505|NCT02504359|Protease Inhibitors|protease inhibitors|mesh-ancestor
91960506|NCT02504359|Keratolytic Agents|keratolytic agents|mesh-ancestor
91960507|NCT02504359|Tubulin Modulators|tubulin modulators|mesh-ancestor
91960508|NCT02504359|Antimitotic Agents|antimitotic agents|mesh-ancestor
91960509|NCT02504359|Mitosis Modulators|mitosis modulators|mesh-ancestor
91960510|NCT02504359|Glycine Agents|glycine agents|mesh-ancestor
91960511|NCT02504359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960512|NCT02729545|Cyproterone Acetate|cyproterone acetate|mesh-list
91960513|NCT02729545|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91960514|NCT02729545|Cyproterone|cyproterone|mesh-list
91960515|NCT02729545|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91960516|NCT02729545|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91960517|NCT02729545|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91960518|NCT02729545|Contraceptive Agents|contraceptive agents|mesh-ancestor
91960519|NCT02729545|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960520|NCT02729545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960521|NCT02729545|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91960522|NCT02729545|Estrogens|estrogens|mesh-ancestor
91960524|NCT02729545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91960525|NCT02729545|Androgen Antagonists|androgen antagonists|mesh-ancestor
91960526|NCT02729545|Hormone Antagonists|hormone antagonists|mesh-ancestor
91960527|NCT02729545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960542|NCT02509429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960543|NCT02509273|Clonidine|clonidine|mesh-list
91960544|NCT02509273|Midazolam|midazolam|mesh-list
91960545|NCT02509273|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960546|NCT02509273|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960547|NCT02509273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960548|NCT02509273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960549|NCT02509273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91960550|NCT02509273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91960551|NCT02509273|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960552|NCT02509273|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960553|NCT02509273|Anesthetics, General|anesthetics, general|mesh-ancestor
91960554|NCT02509273|Anesthetics|anesthetics|mesh-ancestor
91960555|NCT02509273|GABA Modulators|gaba modulators|mesh-ancestor
91944898|NCT04848688|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944900|NCT04848688|Antinematodal Agents|antinematodal agents|mesh-ancestor
91960556|NCT02509273|GABA Agents|gaba agents|mesh-ancestor
91960557|NCT02509273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960558|NCT02509273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960559|NCT02509273|Analgesics|analgesics|mesh-ancestor
91960560|NCT02509273|Sensory System Agents|sensory system agents|mesh-ancestor
91960561|NCT02509273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960562|NCT02509273|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91960563|NCT02509273|Sympatholytics|sympatholytics|mesh-ancestor
91960564|NCT02509273|Autonomic Agents|autonomic agents|mesh-ancestor
91960565|NCT02509273|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91960566|NCT02509273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91960567|NCT02509273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91960568|NCT02509273|Adrenergic Agents|adrenergic agents|mesh-ancestor
91960569|NCT02514343|Magnesium Sulfate|magnesium sulfate|mesh-list
91960570|NCT02514343|Bupivacaine|bupivacaine|mesh-list
91960571|NCT02514343|Anesthetics, Local|anesthetics, local|mesh-ancestor
91960572|NCT02514343|Anesthetics|anesthetics|mesh-ancestor
91960573|NCT02514343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960574|NCT02514343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960575|NCT02514343|Sensory System Agents|sensory system agents|mesh-ancestor
91960576|NCT02514343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960577|NCT02514343|Analgesics|analgesics|mesh-ancestor
91960578|NCT02514343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91960579|NCT02514343|Anticonvulsants|anticonvulsants|mesh-ancestor
91960580|NCT02514343|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91960581|NCT02514343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960582|NCT02514343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960583|NCT02514343|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91960584|NCT02514343|Tocolytic Agents|tocolytic agents|mesh-ancestor
91960585|NCT02514343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960586|NCT02514421|Paclitaxel|paclitaxel|mesh-list
91960587|NCT02514421|Gemcitabine|gemcitabine|mesh-list
91960588|NCT02514421|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91960589|NCT02514421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960601|NCT04499209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960602|NCT04499209|Anticonvulsants|anticonvulsants|mesh-ancestor
91960603|NCT04499209|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91960604|NCT04499209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960605|NCT04499209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960606|NCT04499209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91960607|NCT04499209|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91960608|NCT04499209|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91960609|NCT04499209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960610|NCT04499209|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960611|NCT04499209|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91960612|NCT04499209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91960613|NCT04499209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960614|NCT04499209|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91960615|NCT04499209|Gout Suppressants|gout suppressants|mesh-ancestor
91960616|NCT04499209|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91960617|NCT04499209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960618|NCT02509351|Misoprostol|misoprostol|mesh-list
91960619|NCT02509351|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91960620|NCT02509351|Abortifacient Agents|abortifacient agents|mesh-ancestor
91960621|NCT02509351|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960623|NCT02509351|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91960624|NCT02509351|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91960625|NCT02509351|Oxytocics|oxytocics|mesh-ancestor
91960626|NCT02509195|Lamivudine|lamivudine|mesh-list
91960627|NCT02509195|Abacavir|abacavir|mesh-list
91960628|NCT02509195|Dolutegravir|dolutegravir|mesh-list
91960629|NCT02509195|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
91960630|NCT02509195|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91960631|NCT02509195|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91960632|NCT02509195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960633|NCT02509195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960634|NCT02509195|Antiviral Agents|antiviral agents|mesh-ancestor
91960635|NCT02509195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960636|NCT02509195|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91944902|NCT05369650|Anesthetics, Local|anesthetics, local|mesh-ancestor
91944903|NCT05369650|Anesthetics|anesthetics|mesh-ancestor
91944904|NCT05369650|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944905|NCT05369650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960637|NCT02509195|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91960638|NCT02509195|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91960639|NCT02509195|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91960640|NCT02508805|Diclofenac|diclofenac|mesh-list
91960641|NCT02508805|Tizanidine|tizanidine|mesh-list
91960642|NCT02508805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91960813|NCT03344029|Immunologic Factors|immunologic factors|mesh-ancestor
91960643|NCT02508805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91960644|NCT02508805|Analgesics|analgesics|mesh-ancestor
91960645|NCT02508805|Sensory System Agents|sensory system agents|mesh-ancestor
91960646|NCT02508805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960647|NCT02508805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960648|NCT02508805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960649|NCT02508805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91960650|NCT02508805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91960651|NCT02508805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960652|NCT02508805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960653|NCT02508805|Anticonvulsants|anticonvulsants|mesh-ancestor
91960667|NCT03121573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960668|NCT03121573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960669|NCT03121573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960670|NCT03121573|Analgesics|analgesics|mesh-ancestor
91960671|NCT03121573|Sensory System Agents|sensory system agents|mesh-ancestor
91960672|NCT03121573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960673|NCT03121573|Antidepressive Agents|antidepressive agents|mesh-ancestor
91960674|NCT03121573|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960675|NCT03121573|Dopamine Agents|dopamine agents|mesh-ancestor
91960676|NCT03121417|Nivolumab|nivolumab|mesh-list
91960677|NCT03121417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91960678|NCT03121417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960679|NCT03121417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91960680|NCT03121417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960681|NCT02503189|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91960682|NCT02503189|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91960683|NCT02502643|Picibanil|picibanil|mesh-list
91960684|NCT02502643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960685|NCT02502565|Uric Acid|uric acid|mesh-list
91960686|NCT02502565|Antioxidants|antioxidants|mesh-ancestor
91960687|NCT02502565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960688|NCT02502565|Protective Agents|protective agents|mesh-ancestor
91960689|NCT02502565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960690|NCT04498897|Acamprosate|acamprosate|mesh-list
91960691|NCT04498897|Vortioxetine|vortioxetine|mesh-list
91960692|NCT04498897|Antidepressive Agents|antidepressive agents|mesh-ancestor
91960693|NCT04498897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960694|NCT04498897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91960695|NCT04498897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91960696|NCT04498897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960697|NCT04498897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960698|NCT04498897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91960699|NCT04498897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91960700|NCT04498897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960701|NCT04498897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960702|NCT04498897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960703|NCT04498897|Serotonin Agents|serotonin agents|mesh-ancestor
91960704|NCT04498897|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91960705|NCT04498897|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91960706|NCT04498897|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91960707|NCT04498897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91960708|NCT04498897|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91960710|NCT02502877|Propofol|propofol|mesh-list
91960711|NCT02502877|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960712|NCT02502877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960713|NCT02502877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944906|NCT05369650|Sensory System Agents|sensory system agents|mesh-ancestor
91960718|NCT02502877|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91960719|NCT02502877|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91960720|NCT02502877|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91960721|NCT02502877|GABA Modulators|gaba modulators|mesh-ancestor
91960722|NCT02502877|GABA Agents|gaba agents|mesh-ancestor
91960723|NCT02502877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960724|NCT02502877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960725|NCT03121339|Vaccines|vaccines|mesh-list
91960726|NCT03121339|Immunologic Factors|immunologic factors|mesh-ancestor
91960727|NCT03121339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960728|NCT03343327|Hydrocortisone|hydrocortisone|mesh-list
91960729|NCT03343327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960730|NCT02502175|Methadone|methadone|mesh-list
91960731|NCT02502175|Opium|opium|mesh-list
91960732|NCT02502175|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91960733|NCT02502175|Narcotics|narcotics|mesh-ancestor
91960734|NCT02502175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960735|NCT02502175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960736|NCT02502175|Analgesics|analgesics|mesh-ancestor
91960737|NCT02502175|Sensory System Agents|sensory system agents|mesh-ancestor
91960738|NCT02502175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960739|NCT02502175|Antitussive Agents|antitussive agents|mesh-ancestor
91960740|NCT02502175|Respiratory System Agents|respiratory system agents|mesh-ancestor
91960741|NCT02502175|Antidiarrheals|antidiarrheals|mesh-ancestor
91960742|NCT02502175|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91960743|NCT02501941|Ketamine|ketamine|mesh-list
91960744|NCT02501941|Analgesics|analgesics|mesh-ancestor
91960745|NCT02501941|Sensory System Agents|sensory system agents|mesh-ancestor
91960746|NCT02501941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960747|NCT02501941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960748|NCT02501941|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91960749|NCT02501941|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960750|NCT02501941|Anesthetics, General|anesthetics, general|mesh-ancestor
91960751|NCT02501941|Anesthetics|anesthetics|mesh-ancestor
91960752|NCT02501941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960753|NCT02501941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91960754|NCT02501941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91960755|NCT02501941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960756|NCT02501941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960757|NCT02500927|Naquotinib|naquotinib|mesh-list
91960758|NCT02500927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960759|NCT02500927|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91960760|NCT02500927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960761|NCT02500927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960762|NCT02501863|Fentanyl|fentanyl|mesh-list
91960763|NCT02501863|Ropivacaine|ropivacaine|mesh-list
91960764|NCT02501863|Anesthetics, Local|anesthetics, local|mesh-ancestor
91960765|NCT02501863|Anesthetics|anesthetics|mesh-ancestor
91960766|NCT02501863|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960767|NCT02501863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960768|NCT02501863|Sensory System Agents|sensory system agents|mesh-ancestor
91960769|NCT02501863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960770|NCT02501863|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91960771|NCT02501863|Narcotics|narcotics|mesh-ancestor
91960772|NCT02501863|Analgesics|analgesics|mesh-ancestor
91960773|NCT02501863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960774|NCT02501863|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960775|NCT02501863|Anesthetics, General|anesthetics, general|mesh-ancestor
91960776|NCT02500459|Topotecan|topotecan|mesh-list
91960777|NCT02500459|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91960778|NCT02500459|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91960779|NCT02500459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960780|NCT02500459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960781|NCT02500459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960782|NCT02500225|Sevoflurane|sevoflurane|mesh-list
91960783|NCT02500225|Etomidate|etomidate|mesh-list
91960784|NCT02500225|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91960785|NCT02500225|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91960786|NCT02500225|Anesthetics, General|anesthetics, general|mesh-ancestor
91960789|NCT02500225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960790|NCT02500225|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960791|NCT02500225|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960793|NCT02507635|Desloratadine|desloratadine|mesh-list
91944907|NCT05369650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960794|NCT02507635|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91960795|NCT02507635|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91960796|NCT02507635|Histamine Antagonists|histamine antagonists|mesh-ancestor
91960797|NCT02507635|Histamine Agents|histamine agents|mesh-ancestor
91960798|NCT02507635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960799|NCT02507635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960800|NCT02507635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960801|NCT02507635|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91960802|NCT02507635|Cholinergic Agents|cholinergic agents|mesh-ancestor
91960803|NCT04495933|Vaccines|vaccines|mesh-list
91960804|NCT04495933|MF59 oil emulsion|mf59 oil emulsion|mesh-list
91960805|NCT04495933|Immunologic Factors|immunologic factors|mesh-ancestor
91960806|NCT04495933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960807|NCT04495933|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91960808|NCT02500069|Caseins|caseins|mesh-list
91960809|NCT02500069|Chelating Agents|chelating agents|mesh-ancestor
91960810|NCT02500069|Sequestering Agents|sequestering agents|mesh-ancestor
91960811|NCT02500069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960812|NCT03344029|Vaccines|vaccines|mesh-list
91960814|NCT03344029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960815|NCT03120637|Methylene Blue|methylene blue|mesh-list
91960816|NCT03120637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960817|NCT03120637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960818|NCT02499757|Nicotine|nicotine|mesh-list
91960819|NCT02499757|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91960820|NCT02499757|Autonomic Agents|autonomic agents|mesh-ancestor
91960821|NCT02499757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960822|NCT02499757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960823|NCT02499757|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91960824|NCT02499757|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91960825|NCT02499757|Cholinergic Agents|cholinergic agents|mesh-ancestor
91960826|NCT02499757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960827|NCT02499757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960828|NCT00706849|Mipomersen|mipomersen|mesh-list
91960829|NCT00706849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91960830|NCT00706849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91960831|NCT00706849|Antimetabolites|antimetabolites|mesh-ancestor
91960832|NCT00706849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960833|NCT00706849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91960834|NCT02499445|Sufentanil|sufentanil|mesh-list
91960835|NCT02499445|Remifentanil|remifentanil|mesh-list
91960836|NCT02499445|Propofol|propofol|mesh-list
91960837|NCT02499445|Sevoflurane|sevoflurane|mesh-list
91960838|NCT02499445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960839|NCT02499445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960840|NCT02499445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960841|NCT02499445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91960842|NCT02499445|Anesthetics, General|anesthetics, general|mesh-ancestor
91960843|NCT02499445|Anesthetics|anesthetics|mesh-ancestor
91960844|NCT02499445|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91960845|NCT02499445|Narcotics|narcotics|mesh-ancestor
91960846|NCT02499445|Analgesics|analgesics|mesh-ancestor
91960847|NCT02499445|Sensory System Agents|sensory system agents|mesh-ancestor
91960848|NCT02499445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960849|NCT02499445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91960850|NCT02499445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91960851|NCT02499445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960852|NCT04443049|Mebendazole|mebendazole|mesh-list
91960853|NCT04443049|Piperazine|piperazine|mesh-list
91960854|NCT04443049|Piperazine citrate|piperazine citrate|mesh-list
91960855|NCT04443049|Lenvatinib|lenvatinib|mesh-list
91960856|NCT04443049|DMP 777|dmp 777|mesh-list
91960857|NCT04443049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960858|NCT04443049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91960859|NCT04443049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960860|NCT04443049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960861|NCT04443049|Antinematodal Agents|antinematodal agents|mesh-ancestor
91960875|NCT03341845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91960876|NCT03341845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960877|NCT03341845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960878|NCT02498977|Cyclosporine|cyclosporine|mesh-list
91960879|NCT02498977|Mycophenolic Acid|mycophenolic acid|mesh-list
91960880|NCT02498977|Azathioprine|azathioprine|mesh-list
91960881|NCT02498977|Tacrolimus|tacrolimus|mesh-list
91960882|NCT02498977|Cyclosporins|cyclosporins|mesh-list
91960883|NCT02498977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91960884|NCT02498977|Immunologic Factors|immunologic factors|mesh-ancestor
91960885|NCT02498977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960886|NCT02498977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91960887|NCT02498977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960888|NCT02498977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960889|NCT02498977|Antifungal Agents|antifungal agents|mesh-ancestor
91960890|NCT02498977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960891|NCT02498977|Dermatologic Agents|dermatologic agents|mesh-ancestor
91960892|NCT02498977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91960893|NCT02498977|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91960894|NCT02498977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960895|NCT02498977|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91960896|NCT02498977|Antitubercular Agents|antitubercular agents|mesh-ancestor
91960897|NCT02498977|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91960898|NCT02498977|Antimetabolites|antimetabolites|mesh-ancestor
91960899|NCT02498977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960900|NCT02494687|Domperidone|domperidone|mesh-list
91960901|NCT02494687|Antiemetics|antiemetics|mesh-ancestor
91960902|NCT02494687|Autonomic Agents|autonomic agents|mesh-ancestor
91960903|NCT02494687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960904|NCT02494687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960905|NCT02494687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91960906|NCT02494687|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91960907|NCT02494687|Dopamine Agents|dopamine agents|mesh-ancestor
91960908|NCT02494687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960909|NCT02494687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074254|NCT00072514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91960910|NCT02494609|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
91960911|NCT02494609|Contraceptive Agents|contraceptive agents|mesh-list
91960912|NCT02494609|Contraceptives, Oral|contraceptives, oral|mesh-list
91960913|NCT02494609|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960914|NCT02494609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960915|NCT02494609|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91960916|NCT02494609|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91960917|NCT02494609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960918|NCT02494609|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91960919|NCT03341767|Clofazimine|clofazimine|mesh-list
91960920|NCT03341767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960921|NCT03341767|Leprostatic Agents|leprostatic agents|mesh-ancestor
91960922|NCT03341767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91960937|NCT03342859|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91960938|NCT03342859|Contraceptive Agents|contraceptive agents|mesh-ancestor
91960939|NCT03342859|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91960940|NCT03342859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960941|NCT03342859|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91960943|NCT02493283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960944|NCT02493283|Antimalarials|antimalarials|mesh-ancestor
91960945|NCT02493283|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91960946|NCT02493283|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91960947|NCT02493283|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91960948|NCT02493283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960949|NCT02493283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960950|NCT02493283|Leprostatic Agents|leprostatic agents|mesh-ancestor
91960951|NCT02493283|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91960953|NCT03335527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91960954|NCT03335527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960955|NCT03335527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960956|NCT03335527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91960957|NCT03335527|Analgesics|analgesics|mesh-ancestor
91960958|NCT03335527|Sensory System Agents|sensory system agents|mesh-ancestor
91960959|NCT03335527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960960|NCT03335527|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91960961|NCT03335527|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91960962|NCT03335527|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91960963|NCT03335527|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944909|NCT05369650|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91960964|NCT03335527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960965|NCT03335527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960966|NCT02493049|Domperidone|domperidone|mesh-list
91960967|NCT02493049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960968|NCT02493049|Antiemetics|antiemetics|mesh-ancestor
91960969|NCT02493049|Autonomic Agents|autonomic agents|mesh-ancestor
91960970|NCT02493049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960971|NCT02493049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960972|NCT02493049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91960973|NCT02493049|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91960974|NCT02493049|Dopamine Agents|dopamine agents|mesh-ancestor
91960975|NCT02493049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960976|NCT03120715|Heparin|heparin|mesh-list
91960977|NCT03120715|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91960978|NCT03120715|Tinzaparin|tinzaparin|mesh-list
91960979|NCT03120715|Dalteparin|dalteparin|mesh-list
91960980|NCT03120715|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91960981|NCT03120715|Progesterone|progesterone|mesh-list
91960982|NCT03120715|Estrogens|estrogens|mesh-list
91960983|NCT03120715|Anticoagulants|anticoagulants|mesh-ancestor
91960992|NCT03120403|Morphine|morphine|mesh-list
91960993|NCT03120403|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91960994|NCT03120403|Narcotics|narcotics|mesh-ancestor
91960995|NCT03120403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960996|NCT03120403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960997|NCT03120403|Analgesics|analgesics|mesh-ancestor
91960998|NCT03120403|Sensory System Agents|sensory system agents|mesh-ancestor
91960999|NCT03120403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961000|NCT03335293|Epinephrine|epinephrine|mesh-list
91961001|NCT03335293|Racepinephrine|racepinephrine|mesh-list
91961002|NCT03335293|Epinephryl borate|epinephryl borate|mesh-list
91961003|NCT03335293|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91961004|NCT03335293|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961005|NCT03335293|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961006|NCT03335293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961007|NCT03335293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961008|NCT03335293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961009|NCT03335293|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91961010|NCT03335293|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91961011|NCT03335293|Autonomic Agents|autonomic agents|mesh-ancestor
91961012|NCT03335293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961013|NCT03335293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91961014|NCT03335293|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961015|NCT03335293|Mydriatics|mydriatics|mesh-ancestor
91961016|NCT03335293|Sympathomimetics|sympathomimetics|mesh-ancestor
91961017|NCT03335293|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91961018|NCT03340753|Mineralocorticoids|mineralocorticoids|mesh-list
91961019|NCT03340753|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
91961020|NCT03340753|Hormones|hormones|mesh-ancestor
91961021|NCT03340753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961022|NCT03340753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961023|NCT03340753|Hormone Antagonists|hormone antagonists|mesh-ancestor
91961024|NCT03340753|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91961025|NCT03340753|Diuretics|diuretics|mesh-ancestor
91961026|NCT03340753|Natriuretic Agents|natriuretic agents|mesh-ancestor
91961027|NCT02494531|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91961028|NCT02494531|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91961029|NCT02494531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961030|NCT03340597|Olorofim|olorofim|mesh-list
91961031|NCT03340597|Antifungal Agents|antifungal agents|mesh-ancestor
91961032|NCT03340597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961033|NCT00707161|Cisplatin|cisplatin|mesh-list
91961034|NCT00707161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961035|NCT03120247|Dexmedetomidine|dexmedetomidine|mesh-list
91961036|NCT03120247|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91961037|NCT03120247|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961038|NCT03120247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961039|NCT03120247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961040|NCT03120247|Analgesics|analgesics|mesh-ancestor
91961041|NCT03120247|Sensory System Agents|sensory system agents|mesh-ancestor
91961042|NCT03120247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961043|NCT03120247|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91961044|NCT03120247|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91944910|NCT05369650|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91944911|NCT05369650|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91961045|NCT03120247|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961046|NCT03120247|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961047|NCT03120247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961048|NCT03120247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961052|NCT03335059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961053|NCT03335059|Alkylating Agents|alkylating agents|mesh-ancestor
91961054|NCT03335059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961055|NCT03335059|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91961056|NCT03335059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961057|NCT03334981|Buprenorphine|buprenorphine|mesh-list
91961058|NCT03334981|Methadone|methadone|mesh-list
91961059|NCT03334981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91961060|NCT03334981|Narcotics|narcotics|mesh-ancestor
91961061|NCT03334981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961062|NCT03334981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961063|NCT03334981|Analgesics|analgesics|mesh-ancestor
91961064|NCT03334981|Sensory System Agents|sensory system agents|mesh-ancestor
91961065|NCT03334981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961066|NCT03334981|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91961067|NCT03334981|Antitussive Agents|antitussive agents|mesh-ancestor
91961068|NCT03334981|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961069|NCT02492503|Paclitaxel|paclitaxel|mesh-list
91961070|NCT02492503|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91961071|NCT02492503|Carboplatin|carboplatin|mesh-list
91961072|NCT02492503|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91961073|NCT02492503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961074|NCT02492503|Tubulin Modulators|tubulin modulators|mesh-ancestor
91961075|NCT02492503|Antimitotic Agents|antimitotic agents|mesh-ancestor
91961076|NCT02492503|Mitosis Modulators|mitosis modulators|mesh-ancestor
91961077|NCT02492503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961078|NCT03334591|Apatinib|apatinib|mesh-list
91961079|NCT03334591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961080|NCT03334591|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961081|NCT03334591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961082|NCT03334591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961083|NCT03334513|Bevacizumab|bevacizumab|mesh-list
91961084|NCT03334513|Ranibizumab|ranibizumab|mesh-list
91961085|NCT03334513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91961086|NCT03334513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961087|NCT03334513|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91961088|NCT03334513|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91961089|NCT03334513|Growth Substances|growth substances|mesh-ancestor
91961090|NCT03334513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961091|NCT03334513|Growth Inhibitors|growth inhibitors|mesh-ancestor
91961092|NCT02130466|Pembrolizumab|pembrolizumab|mesh-list
91961093|NCT02130466|Trametinib|trametinib|mesh-list
91961094|NCT02130466|Dabrafenib|dabrafenib|mesh-list
91961095|NCT02130466|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91961096|NCT02130466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961097|NCT02130466|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91961098|NCT02130466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961099|NCT02130466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961100|NCT02130466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961101|NCT03339427|Vitamin D|vitamin d|mesh-list
91961102|NCT03339427|Vitamins|vitamins|mesh-ancestor
91961103|NCT03339427|Micronutrients|micronutrients|mesh-ancestor
91961104|NCT03339427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961105|NCT03339427|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91961106|NCT03339349|Enoxaparin|enoxaparin|mesh-list
91961107|NCT03339349|Anticoagulants|anticoagulants|mesh-ancestor
91961108|NCT03339349|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91961109|NCT03339349|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91961110|NCT03339349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961111|NCT02496715|Fluticasone|fluticasone|mesh-list
91961113|NCT02496715|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91961114|NCT02496715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961115|NCT02496715|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91961116|NCT02496715|Autonomic Agents|autonomic agents|mesh-ancestor
91961117|NCT02496715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961118|NCT02496715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944912|NCT05369650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944913|NCT05071612|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91961119|NCT02496715|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91961120|NCT02496715|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961121|NCT02496715|Dermatologic Agents|dermatologic agents|mesh-ancestor
91961122|NCT02496715|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91961127|NCT02496715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961128|NCT02496715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961129|NCT02492581|Nalmefene|nalmefene|mesh-list
91961130|NCT02492581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91961131|NCT02492581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961132|NCT02492581|Sensory System Agents|sensory system agents|mesh-ancestor
91961133|NCT02492581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961134|NCT03342079|Nitrous Oxide|nitrous oxide|mesh-list
91961135|NCT03342079|Anesthetics|anesthetics|mesh-list
91961136|NCT03342079|Anesthetics, Local|anesthetics, local|mesh-list
91961137|NCT03342079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961138|NCT03342079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961139|NCT03342079|Sensory System Agents|sensory system agents|mesh-ancestor
91961140|NCT03342079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961141|NCT03342079|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91961142|NCT03342079|Anesthetics, General|anesthetics, general|mesh-ancestor
91961143|NCT03342079|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961144|NCT03342079|Analgesics|analgesics|mesh-ancestor
91961145|NCT04494763|Propranolol|propranolol|mesh-list
91961146|NCT04494763|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91961147|NCT04494763|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91961148|NCT04494763|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961149|NCT04494763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961150|NCT04494763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961151|NCT04494763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961152|NCT04494763|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91961153|NCT04494763|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91961155|NCT02162758|Dexlansoprazole|dexlansoprazole|mesh-list
91961156|NCT02162758|Lansoprazole|lansoprazole|mesh-list
91961157|NCT02162758|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91961158|NCT02162758|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91961159|NCT02162758|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91961160|NCT02162758|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961161|NCT02162758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961162|NCT03333499|Trimetazidine|trimetazidine|mesh-list
91961163|NCT03333499|Vasodilator Agents|vasodilator agents|mesh-ancestor
91961164|NCT04494529|Betamethasone|betamethasone|mesh-list
91961165|NCT04494529|Betamethasone Valerate|betamethasone valerate|mesh-list
91961166|NCT04494529|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91961167|NCT04494529|Betamethasone benzoate|betamethasone benzoate|mesh-list
91961168|NCT04494529|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91961169|NCT04494529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961170|NCT04494529|Glucocorticoids|glucocorticoids|mesh-ancestor
91961171|NCT04494529|Hormones|hormones|mesh-ancestor
91961172|NCT04494529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961173|NCT04494529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961174|NCT04494529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91961175|NCT04494529|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961176|NCT02491879|Ketoprofen|ketoprofen|mesh-list
91961177|NCT02491879|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91961178|NCT02491879|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961179|NCT02491879|Analgesics|analgesics|mesh-ancestor
91961180|NCT02491879|Sensory System Agents|sensory system agents|mesh-ancestor
91961181|NCT02491879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961182|NCT02491879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961183|NCT02491879|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961184|NCT02491879|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961185|NCT02491879|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91961186|NCT02491879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961187|NCT02491879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961188|NCT03332953|Nicotine|nicotine|mesh-list
91961189|NCT03332953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91961190|NCT03332953|Autonomic Agents|autonomic agents|mesh-ancestor
91961191|NCT03332953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91944914|NCT05071612|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91944915|NCT05071612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91961192|NCT03332953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961217|NCT03332719|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91961218|NCT03332719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91961219|NCT03332719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961220|NCT03332719|Analgesics|analgesics|mesh-ancestor
91961221|NCT03332719|Sensory System Agents|sensory system agents|mesh-ancestor
91961222|NCT03332719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961223|NCT03332719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961225|NCT03330769|Antirheumatic Agents|antirheumatic agents|mesh-list
91961226|NCT03330613|Anesthetics|anesthetics|mesh-list
91961227|NCT03330613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961228|NCT03330613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961229|NCT03332329|Entecavir|entecavir|mesh-list
91961230|NCT03332329|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91961231|NCT03332329|Molgramostim|molgramostim|mesh-list
91961232|NCT03332329|Vaccines|vaccines|mesh-list
91961233|NCT03332329|Sargramostim|sargramostim|mesh-list
91961234|NCT03332329|Immunologic Factors|immunologic factors|mesh-ancestor
91961235|NCT03332329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961236|NCT03332329|Antiviral Agents|antiviral agents|mesh-ancestor
91961237|NCT03332329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961238|NCT03332329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961239|NCT03330223|Clopidogrel|clopidogrel|mesh-list
91961240|NCT03330223|Ticagrelor|ticagrelor|mesh-list
91961241|NCT03330223|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91961242|NCT03330223|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91961243|NCT03330223|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91961244|NCT03330223|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91961246|NCT03330223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074255|NCT00072514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961247|NCT03330223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961248|NCT03330223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961249|NCT03331861|Metformin|metformin|mesh-list
91961250|NCT03331861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961251|NCT03331861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961252|NCT03329443|Spironolactone|spironolactone|mesh-list
91961253|NCT03329443|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91961254|NCT03329443|Hormone Antagonists|hormone antagonists|mesh-ancestor
91961255|NCT03329443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961256|NCT03329443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961257|NCT03329443|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91961258|NCT03329443|Diuretics|diuretics|mesh-ancestor
91961259|NCT03329443|Natriuretic Agents|natriuretic agents|mesh-ancestor
91961260|NCT03328975|Dexamethasone|dexamethasone|mesh-list
91961261|NCT03328975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961262|NCT03328975|Antiemetics|antiemetics|mesh-ancestor
91961263|NCT03328975|Autonomic Agents|autonomic agents|mesh-ancestor
91961264|NCT03328975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961265|NCT03328975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961266|NCT03328975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91961267|NCT03328975|Glucocorticoids|glucocorticoids|mesh-ancestor
91961268|NCT03328975|Hormones|hormones|mesh-ancestor
91961269|NCT03328975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961270|NCT03328975|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961271|NCT03328975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961272|NCT05430711|Dinoprostone|dinoprostone|mesh-list
91961273|NCT05430711|Oxytocics|oxytocics|mesh-ancestor
91961274|NCT05430711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961275|NCT05430711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961276|NCT03324685|Levonorgestrel|levonorgestrel|mesh-list
91961277|NCT03324685|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91961278|NCT03324685|Estradiol|estradiol|mesh-list
91961279|NCT03324685|Estrogens|estrogens|mesh-ancestor
91961280|NCT03324685|Hormones|hormones|mesh-ancestor
91961281|NCT03324685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961282|NCT03324685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961283|NCT03324685|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91961284|NCT03324685|Contraceptive Agents|contraceptive agents|mesh-ancestor
91961285|NCT03324685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961286|NCT03324685|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91961287|NCT03324685|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91944916|NCT05071612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91944917|NCT05071612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944918|NCT05071612|Adrenergic Agents|adrenergic agents|mesh-ancestor
91944919|NCT05071612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961288|NCT03324685|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91961289|NCT03324685|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91961290|NCT03324139|Heparin|heparin|mesh-list
91961291|NCT03324139|Calcium heparin|calcium heparin|mesh-list
91961292|NCT03324139|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91961293|NCT03324139|Tinzaparin|tinzaparin|mesh-list
91961294|NCT03324139|Dalteparin|dalteparin|mesh-list
91961295|NCT03324139|Anticoagulants|anticoagulants|mesh-ancestor
91961296|NCT03324139|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91961297|NCT03324139|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91961298|NCT03324139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961299|NCT03324061|Fulvestrant|fulvestrant|mesh-list
91961300|NCT03324061|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961301|NCT03324061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961302|NCT03324061|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91961303|NCT03324061|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91961304|NCT03324061|Hormone Antagonists|hormone antagonists|mesh-ancestor
91961305|NCT03324061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961306|NCT03324061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961307|NCT02488603|Tamoxifen|tamoxifen|mesh-list
91961308|NCT02488603|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91961309|NCT02488603|Hormone Antagonists|hormone antagonists|mesh-ancestor
91961310|NCT02488603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961311|NCT02488603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961312|NCT02488603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961313|NCT02488603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961314|NCT02488603|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91961315|NCT02488603|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91961316|NCT02488603|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91961317|NCT03328117|Imatinib Mesylate|imatinib mesylate|mesh-list
91961320|NCT03328117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961321|NCT03328117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961323|NCT05430087|Cholecalciferol|cholecalciferol|mesh-list
91961324|NCT05430087|Curcumin|curcumin|mesh-list
91961325|NCT05430087|Piperine|piperine|mesh-list
91961326|NCT05430087|Vitamins|vitamins|mesh-ancestor
91961327|NCT05430087|Micronutrients|micronutrients|mesh-ancestor
91961328|NCT05430087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961329|NCT05430087|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91961330|NCT05430087|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91961331|NCT05430087|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91961332|NCT05430087|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961333|NCT05430087|Analgesics|analgesics|mesh-ancestor
91961334|NCT05430087|Sensory System Agents|sensory system agents|mesh-ancestor
91961335|NCT05430087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961336|NCT05430087|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961337|NCT05430087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961338|NCT05430087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961339|NCT05430087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961340|NCT05430087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961341|NCT05430087|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91961343|NCT03327727|Amphotericin B|amphotericin b|mesh-list
91961344|NCT03327727|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91961345|NCT03327727|Isavuconazole|isavuconazole|mesh-list
91961346|NCT03327727|VL-2397|vl-2397|mesh-list
91961347|NCT03327727|Antifungal Agents|antifungal agents|mesh-ancestor
91961348|NCT03327727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961349|NCT03327727|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91961350|NCT03327727|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91961351|NCT03327727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961352|NCT03327727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961353|NCT03327727|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91961354|NCT03327727|Hormone Antagonists|hormone antagonists|mesh-ancestor
91944920|NCT05071612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944921|NCT05069740|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
91944922|NCT05069740|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91944923|NCT05069740|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961355|NCT03327727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961356|NCT03327727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961357|NCT03327727|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91961358|NCT03327727|Amebicides|amebicides|mesh-ancestor
91961359|NCT03327727|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91961360|NCT03327727|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91961361|NCT03327727|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91961362|NCT03323671|Mefenamic Acid|mefenamic acid|mesh-list
91961363|NCT03323671|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91961364|NCT03323671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961365|NCT03323671|Analgesics|analgesics|mesh-ancestor
91961366|NCT03323671|Sensory System Agents|sensory system agents|mesh-ancestor
91961367|NCT03323671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961368|NCT03323671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961369|NCT03323671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961370|NCT03323671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961371|NCT03323671|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91961372|NCT03323671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961373|NCT03323671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961374|NCT03323593|Dexmedetomidine|dexmedetomidine|mesh-list
91961375|NCT03323593|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91961376|NCT03323593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961377|NCT03323593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961378|NCT03323593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961379|NCT03323593|Analgesics|analgesics|mesh-ancestor
91961380|NCT03323593|Sensory System Agents|sensory system agents|mesh-ancestor
91961381|NCT03323593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961382|NCT03323593|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91961383|NCT03323593|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91961384|NCT03323593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961385|NCT03323593|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961386|NCT03323593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961387|NCT03323593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961388|NCT02499003|Obinutuzumab|obinutuzumab|mesh-list
91961392|NCT02499003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91961394|NCT02499003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961395|NCT02499003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961396|NCT04492813|Remifentanil|remifentanil|mesh-list
91961397|NCT04492813|Propofol|propofol|mesh-list
91961398|NCT04492813|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91961399|NCT04492813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961400|NCT04492813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961401|NCT04492813|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91961402|NCT04492813|Anesthetics, General|anesthetics, general|mesh-ancestor
91961403|NCT04492813|Anesthetics|anesthetics|mesh-ancestor
91961404|NCT04492813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91961405|NCT04492813|Narcotics|narcotics|mesh-ancestor
91961406|NCT04492813|Analgesics|analgesics|mesh-ancestor
91961407|NCT04492813|Sensory System Agents|sensory system agents|mesh-ancestor
91961408|NCT04492813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961409|NCT03102801|Insulin|insulin|mesh-list
91961410|NCT03102801|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91961411|NCT03102801|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961412|NCT03102801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961413|NCT02488057|Liraglutide|liraglutide|mesh-list
91961414|NCT02488057|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961415|NCT02488057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961416|NCT02488057|Incretins|incretins|mesh-ancestor
91961417|NCT02488057|Hormones|hormones|mesh-ancestor
91961418|NCT02488057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961419|NCT04039347|Cyclosporine|cyclosporine|mesh-list
91961420|NCT04039347|Cyclosporins|cyclosporins|mesh-list
91961421|NCT04039347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961422|NCT04039347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961423|NCT04039347|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91944924|NCT05069740|Analgesics|analgesics|mesh-ancestor
91944925|NCT05069740|Sensory System Agents|sensory system agents|mesh-ancestor
91944926|NCT05069740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961424|NCT04039347|Immunologic Factors|immunologic factors|mesh-ancestor
91961425|NCT04039347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961426|NCT04039347|Antifungal Agents|antifungal agents|mesh-ancestor
91961427|NCT04039347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961428|NCT04039347|Dermatologic Agents|dermatologic agents|mesh-ancestor
91961429|NCT04039347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961430|NCT04039347|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91961431|NCT05253573|Nicotine|nicotine|mesh-list
91961432|NCT05253573|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91961433|NCT05253573|Autonomic Agents|autonomic agents|mesh-ancestor
91961434|NCT05253573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961435|NCT05253573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961436|NCT05253573|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91961437|NCT05253573|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91961438|NCT05253573|Cholinergic Agents|cholinergic agents|mesh-ancestor
91961439|NCT05253573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961440|NCT05253573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961441|NCT02488291|Sufentanil|sufentanil|mesh-list
91961443|NCT02488291|Ropivacaine|ropivacaine|mesh-list
91961444|NCT02488291|Anesthetics, Local|anesthetics, local|mesh-list
91961445|NCT02488291|Anesthetics|anesthetics|mesh-list
91961446|NCT02488291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961447|NCT02488291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961448|NCT02488291|Sensory System Agents|sensory system agents|mesh-ancestor
91961449|NCT02488291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961450|NCT02488291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91961451|NCT02488291|Narcotics|narcotics|mesh-ancestor
91961452|NCT02488291|Analgesics|analgesics|mesh-ancestor
91961453|NCT02488291|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91961454|NCT02488291|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91961455|NCT02488291|Anesthetics, General|anesthetics, general|mesh-ancestor
91961456|NCT03323047|Acetaminophen|acetaminophen|mesh-list
91961457|NCT03323047|Dexamethasone|dexamethasone|mesh-list
91961458|NCT03323047|Dexamethasone acetate|dexamethasone acetate|mesh-list
91961459|NCT03323047|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91961460|NCT03323047|BB 1101|bb 1101|mesh-list
91961461|NCT03323047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961462|NCT03323047|Antiemetics|antiemetics|mesh-ancestor
91961463|NCT03323047|Autonomic Agents|autonomic agents|mesh-ancestor
91961467|NCT03323047|Glucocorticoids|glucocorticoids|mesh-ancestor
91961468|NCT03323047|Hormones|hormones|mesh-ancestor
91961469|NCT03323047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961470|NCT03323047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961471|NCT03323047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961472|NCT03323047|Protease Inhibitors|protease inhibitors|mesh-ancestor
91961473|NCT03323047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961474|NCT03323047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961475|NCT03323047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961476|NCT03323047|Analgesics|analgesics|mesh-ancestor
91961477|NCT03323047|Sensory System Agents|sensory system agents|mesh-ancestor
91961478|NCT03323047|Antipyretics|antipyretics|mesh-ancestor
91961479|NCT03322969|Paclitaxel|paclitaxel|mesh-list
91961480|NCT03322969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91961481|NCT03322969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961482|NCT03322969|Tubulin Modulators|tubulin modulators|mesh-ancestor
91961483|NCT03322969|Antimitotic Agents|antimitotic agents|mesh-ancestor
91961484|NCT03322969|Mitosis Modulators|mitosis modulators|mesh-ancestor
91961485|NCT03322969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961486|NCT05464303|Antibodies|antibodies|mesh-list
91961487|NCT05464303|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91961488|NCT05464303|gamma-Globulins|gamma-globulins|mesh-list
91961489|NCT05464303|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91961490|NCT05464303|Immunologic Factors|immunologic factors|mesh-ancestor
91961491|NCT05464303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961492|NCT03322735|Cyclophosphamide|cyclophosphamide|mesh-list
91961493|NCT03322735|Fludarabine|fludarabine|mesh-list
91961494|NCT03322735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91961495|NCT03322735|Immunologic Factors|immunologic factors|mesh-ancestor
91961496|NCT03322735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961497|NCT03322735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961498|NCT03322735|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91944927|NCT05069740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944928|NCT05069740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961499|NCT03322735|Alkylating Agents|alkylating agents|mesh-ancestor
91961500|NCT03322735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961501|NCT03322735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961502|NCT03322735|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91961503|NCT02487823|Bicalutamide|bicalutamide|mesh-list
91961504|NCT02487823|Buserelin|buserelin|mesh-list
91961505|NCT02487823|Androgen Antagonists|androgen antagonists|mesh-ancestor
91961506|NCT02487823|Hormone Antagonists|hormone antagonists|mesh-ancestor
91961507|NCT02487823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961508|NCT02487823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961509|NCT02487823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961510|NCT02487823|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91961511|NCT02487823|Fertility Agents|fertility agents|mesh-ancestor
91961512|NCT02487823|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961513|NCT05463913|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91961514|NCT05463913|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91961515|NCT05463913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961516|NCT02487433|Tofacitinib|tofacitinib|mesh-list
91961517|NCT02487433|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91961518|NCT02487433|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961519|NCT02487433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961520|NCT02487433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961521|NCT04493125|Mosapride|mosapride|mesh-list
91961522|NCT04493125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961523|NCT04493125|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91961524|NCT04493125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91961525|NCT04493125|Serotonin Agents|serotonin agents|mesh-ancestor
91961526|NCT04493125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961527|NCT04493125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961528|NCT03318835|Thalidomide|thalidomide|mesh-list
91961529|NCT03318835|Prednisone|prednisone|mesh-list
91961530|NCT03318835|Cyclophosphamide|cyclophosphamide|mesh-list
91961531|NCT03318835|Vincristine|vincristine|mesh-list
91961532|NCT03318835|Rituximab|rituximab|mesh-list
91961534|NCT03318835|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91961535|NCT03318835|Immunologic Factors|immunologic factors|mesh-ancestor
91961549|NCT03318835|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91961550|NCT03318835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961551|NCT03318835|Glucocorticoids|glucocorticoids|mesh-ancestor
91961552|NCT03318835|Hormones|hormones|mesh-ancestor
91961553|NCT03318835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961554|NCT03318835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961555|NCT03318835|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91961556|NCT03318835|Tubulin Modulators|tubulin modulators|mesh-ancestor
91961557|NCT03318835|Antimitotic Agents|antimitotic agents|mesh-ancestor
91961558|NCT03318835|Mitosis Modulators|mitosis modulators|mesh-ancestor
91961559|NCT03318835|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91961560|NCT03318835|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91961561|NCT03318835|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91961562|NCT03318835|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91961563|NCT03318835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961564|NCT03318757|Bupivacaine|bupivacaine|mesh-list
91961565|NCT03318757|Anesthetics, Local|anesthetics, local|mesh-ancestor
91961566|NCT03318757|Anesthetics|anesthetics|mesh-ancestor
91961567|NCT03318757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961568|NCT03318757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961569|NCT03318757|Sensory System Agents|sensory system agents|mesh-ancestor
91961570|NCT03318757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961571|NCT02487355|Magnesium Sulfate|magnesium sulfate|mesh-list
91961572|NCT02487355|Dexmedetomidine|dexmedetomidine|mesh-list
91961573|NCT02487355|Bupivacaine|bupivacaine|mesh-list
91961574|NCT02487355|Anesthetics, Local|anesthetics, local|mesh-ancestor
91961575|NCT02487355|Anesthetics|anesthetics|mesh-ancestor
91961576|NCT02487355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961577|NCT02487355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961578|NCT02487355|Sensory System Agents|sensory system agents|mesh-ancestor
91961579|NCT02487355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961580|NCT02487355|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91961581|NCT02487355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961582|NCT02487355|Analgesics|analgesics|mesh-ancestor
91944929|NCT05069740|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944930|NCT01601626|Pyridoxine|pyridoxine|mesh-list
91944931|NCT01601626|Vitamin B 6|vitamin b 6|mesh-list
91944932|NCT01601626|Ritonavir|ritonavir|mesh-list
91961583|NCT02487355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91961584|NCT02487355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91961585|NCT02487355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961586|NCT02487355|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961587|NCT02487355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961588|NCT02487355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961589|NCT02487355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91961590|NCT02487355|Anticonvulsants|anticonvulsants|mesh-ancestor
91961591|NCT02487355|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91961592|NCT02487355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91961593|NCT02487355|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91961594|NCT02487355|Tocolytic Agents|tocolytic agents|mesh-ancestor
91961595|NCT02487355|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961599|NCT03325465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91961600|NCT03325465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961602|NCT01876953|Dasatinib|dasatinib|mesh-list
91961603|NCT01876953|Idarubicin|idarubicin|mesh-list
91961604|NCT01876953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91961605|NCT01876953|Antimetabolites|antimetabolites|mesh-ancestor
91961606|NCT01876953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961607|NCT01876953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961608|NCT01876953|Antiviral Agents|antiviral agents|mesh-ancestor
91961609|NCT01876953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961610|NCT01876953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91961611|NCT01876953|Immunologic Factors|immunologic factors|mesh-ancestor
91961612|NCT01876953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961613|NCT01876953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961614|NCT01876953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961615|NCT01876953|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91961616|NCT01876953|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91961617|NCT01876953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91961619|NCT03321955|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91961620|NCT03321955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91961621|NCT03321955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961622|NCT03321955|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91961623|NCT03321955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961624|NCT03321955|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91961625|NCT03321955|Protective Agents|protective agents|mesh-ancestor
91961626|NCT03321955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961627|NCT03321955|Analgesics|analgesics|mesh-ancestor
91961628|NCT03321955|Sensory System Agents|sensory system agents|mesh-ancestor
91961629|NCT03321955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961630|NCT04493281|Edaravone|edaravone|mesh-list
91961631|NCT04493281|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91961632|NCT04493281|Antioxidants|antioxidants|mesh-ancestor
91961633|NCT04493281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961634|NCT04493281|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91961635|NCT04493281|Protective Agents|protective agents|mesh-ancestor
91961636|NCT04493281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961637|NCT01764711|Cosyntropin|cosyntropin|mesh-list
91961638|NCT01764711|Hormones|hormones|mesh-ancestor
91961639|NCT01764711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961640|NCT01764711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961641|NCT04493515|Oxytocin|oxytocin|mesh-list
91961642|NCT04493515|Oxytocics|oxytocics|mesh-ancestor
91961643|NCT04493515|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961644|NCT04493515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961645|NCT03318445|Irinotecan|irinotecan|mesh-list
91961646|NCT03318445|Rucaparib|rucaparib|mesh-list
91961647|NCT03318445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91961648|NCT03318445|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91961649|NCT03318445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961650|NCT03318445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961651|NCT03318445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961652|NCT03318445|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91961653|NCT02485015|Apatinib|apatinib|mesh-list
91944933|NCT01601626|Lopinavir|lopinavir|mesh-list
91944934|NCT01601626|Raltegravir Potassium|raltegravir potassium|mesh-list
91944935|NCT01601626|Rifampin|rifampin|mesh-list
91944936|NCT01601626|Isoniazid|isoniazid|mesh-list
91961654|NCT02485015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961655|NCT02485015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961656|NCT02485015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961657|NCT02485015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961658|NCT03316339|Dexmedetomidine|dexmedetomidine|mesh-list
91961659|NCT03316339|Remifentanil|remifentanil|mesh-list
91961660|NCT03316339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91961661|NCT03316339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961662|NCT03316339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961663|NCT03316339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961664|NCT03316339|Analgesics|analgesics|mesh-ancestor
91961665|NCT03316339|Sensory System Agents|sensory system agents|mesh-ancestor
91961670|NCT03316339|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961671|NCT03316339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961672|NCT03316339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961673|NCT03316339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91961675|NCT02490865|RNS60|rns60|mesh-list
91961676|NCT02490865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91961677|NCT02490865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961678|NCT02490865|Analgesics|analgesics|mesh-ancestor
91961679|NCT02490865|Sensory System Agents|sensory system agents|mesh-ancestor
91961680|NCT02490865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961681|NCT02490865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961682|NCT02490865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961683|NCT02490865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961684|NCT02490865|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91961685|NCT03318211|Magnesium Sulfate|magnesium sulfate|mesh-list
91961686|NCT03318211|Analgesics|analgesics|mesh-ancestor
91961687|NCT03318211|Sensory System Agents|sensory system agents|mesh-ancestor
91961688|NCT03318211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961689|NCT03318211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961690|NCT03318211|Anesthetics|anesthetics|mesh-ancestor
91961691|NCT03318211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961692|NCT03318211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91961693|NCT03318211|Anticonvulsants|anticonvulsants|mesh-ancestor
91961694|NCT03318211|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91961695|NCT03318211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91961696|NCT03318211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961697|NCT03318211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91961698|NCT03318211|Tocolytic Agents|tocolytic agents|mesh-ancestor
91961699|NCT03318211|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961700|NCT02483767|Goserelin|goserelin|mesh-list
91961701|NCT02483767|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961702|NCT02483767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961703|NCT02483845|Natalizumab|natalizumab|mesh-list
91961704|NCT02483845|Immunologic Factors|immunologic factors|mesh-ancestor
91961705|NCT02483845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961706|NCT02486341|Insulin|insulin|mesh-list
91961707|NCT02486341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961708|NCT02486341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961709|NCT02484001|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
91961710|NCT02484001|Anticonvulsants|anticonvulsants|mesh-ancestor
91961711|NCT02484001|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91961712|NCT02484001|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91961713|NCT02484001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91961714|NCT02484001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961715|NCT02483923|Ropivacaine|ropivacaine|mesh-list
91961716|NCT02483923|Anesthetics, Local|anesthetics, local|mesh-ancestor
91961717|NCT02483923|Anesthetics|anesthetics|mesh-ancestor
91961718|NCT02483923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961719|NCT02483923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961720|NCT02483923|Sensory System Agents|sensory system agents|mesh-ancestor
91961721|NCT02483923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961722|NCT02483689|Bupivacaine|bupivacaine|mesh-list
91961723|NCT02483689|Anesthetics, Local|anesthetics, local|mesh-list
91961724|NCT02483689|Anesthetics|anesthetics|mesh-list
91961725|NCT02483689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944937|NCT01601626|Pyrazinamide|pyrazinamide|mesh-list
91944939|NCT01601626|Rifabutin|rifabutin|mesh-list
91944940|NCT01601626|Vitamins|vitamins|mesh-ancestor
91961726|NCT02483689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961727|NCT02483689|Sensory System Agents|sensory system agents|mesh-ancestor
91961728|NCT02483689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961729|NCT02490085|Insulin|insulin|mesh-list
91961730|NCT02490085|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91961731|NCT02490085|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961732|NCT02490085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961733|NCT03102021|Epoetin Alfa|epoetin alfa|mesh-list
91961734|NCT03102021|Hematinics|hematinics|mesh-ancestor
91961735|NCT04916691|Ropivacaine|ropivacaine|mesh-list
91961752|NCT05105139|Keratolytic Agents|keratolytic agents|mesh-ancestor
91961753|NCT05105139|Dermatologic Agents|dermatologic agents|mesh-ancestor
91961754|NCT03862833|Zoledronic Acid|zoledronic acid|mesh-list
91961755|NCT03862833|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91961756|NCT03862833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961757|NCT03317275|Fluorides|fluorides|mesh-list
91961758|NCT03317275|Cariostatic Agents|cariostatic agents|mesh-ancestor
91961759|NCT03317275|Protective Agents|protective agents|mesh-ancestor
91961760|NCT03317275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961761|NCT03317197|Vasopressins|vasopressins|mesh-list
91961762|NCT03317197|Arginine Vasopressin|arginine vasopressin|mesh-list
91961763|NCT03317197|Epinephrine|epinephrine|mesh-list
91961764|NCT03317197|Racepinephrine|racepinephrine|mesh-list
91961765|NCT03317197|Epinephryl borate|epinephryl borate|mesh-list
91961766|NCT03317197|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91961767|NCT03317197|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961768|NCT03317197|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961769|NCT03317197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961770|NCT03317197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961771|NCT03317197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961772|NCT03317197|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91961773|NCT03317197|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91961774|NCT03317197|Autonomic Agents|autonomic agents|mesh-ancestor
91961775|NCT03317197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961776|NCT03317197|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91961777|NCT03317197|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961778|NCT03317197|Mydriatics|mydriatics|mesh-ancestor
91961779|NCT03317197|Sympathomimetics|sympathomimetics|mesh-ancestor
91961780|NCT03317197|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91961781|NCT03317197|Hemostatics|hemostatics|mesh-ancestor
91961782|NCT03317197|Coagulants|coagulants|mesh-ancestor
91961783|NCT03317197|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
91961784|NCT03317197|Natriuretic Agents|natriuretic agents|mesh-ancestor
91961785|NCT02483299|Metformin|metformin|mesh-list
91961786|NCT02483299|Liraglutide|liraglutide|mesh-list
91961787|NCT02483299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961788|NCT02483299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961789|NCT02483299|Incretins|incretins|mesh-ancestor
91961790|NCT02483299|Hormones|hormones|mesh-ancestor
91961791|NCT02483299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961792|NCT01597479|Anesthetics|anesthetics|mesh-list
91961793|NCT01597479|Levobupivacaine|levobupivacaine|mesh-list
91961794|NCT01597479|Anesthetics, Local|anesthetics, local|mesh-list
91961795|NCT01597479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961798|NCT01597479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961799|NCT03316963|Neostigmine|neostigmine|mesh-list
91961800|NCT03316963|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91961801|NCT03316963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961802|NCT03316963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961803|NCT03316963|Cholinergic Agents|cholinergic agents|mesh-ancestor
91961804|NCT03316963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961805|NCT03316963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961806|NCT03316963|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91961807|NCT03316963|Autonomic Agents|autonomic agents|mesh-ancestor
91961808|NCT03316963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961809|NCT02489929|Azacitidine|azacitidine|mesh-list
91961810|NCT02489929|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91961811|NCT02489929|Antimetabolites|antimetabolites|mesh-ancestor
91961812|NCT02489929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961813|NCT02489929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944941|NCT01601626|Micronutrients|micronutrients|mesh-ancestor
91944942|NCT01601626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961814|NCT02489929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961815|NCT05154903|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
91961816|NCT05154903|Nootropic Agents|nootropic agents|mesh-ancestor
91961817|NCT02483143|Acetylcysteine|acetylcysteine|mesh-list
91961818|NCT02483143|Antiviral Agents|antiviral agents|mesh-ancestor
91961819|NCT02483143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961820|NCT02483143|Expectorants|expectorants|mesh-ancestor
91961821|NCT02483143|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961822|NCT02483143|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91961823|NCT02483143|Antioxidants|antioxidants|mesh-ancestor
91961824|NCT02483143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961825|NCT02483143|Protective Agents|protective agents|mesh-ancestor
91961826|NCT02483143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961828|NCT02483221|Hydromorphone|hydromorphone|mesh-list
91961829|NCT02483221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91961830|NCT02483221|Narcotics|narcotics|mesh-ancestor
91961831|NCT02483221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961832|NCT02483221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961833|NCT02483221|Analgesics|analgesics|mesh-ancestor
91961834|NCT02483221|Sensory System Agents|sensory system agents|mesh-ancestor
91961835|NCT02483221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961836|NCT02489461|Efavirenz|efavirenz|mesh-list
91961837|NCT02489461|Elsulfavirine|elsulfavirine|mesh-list
91961838|NCT02489461|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91961839|NCT02489461|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91961840|NCT02489461|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91961841|NCT02489461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961842|NCT02489461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961843|NCT02489461|Antiviral Agents|antiviral agents|mesh-ancestor
91961844|NCT02489461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961845|NCT02489461|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91961846|NCT02489461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91961847|NCT02489461|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91961848|NCT02489461|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91961849|NCT02489461|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91961850|NCT02489461|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91961851|NCT02489461|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91961852|NCT05129475|Ritonavir|ritonavir|mesh-list
91961853|NCT05129475|Nirmatrelvir|nirmatrelvir|mesh-list
91961854|NCT05129475|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91961855|NCT05129475|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91961856|NCT05129475|Protease Inhibitors|protease inhibitors|mesh-ancestor
91961857|NCT05129475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961858|NCT05129475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961859|NCT05129475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91961860|NCT05129475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91961861|NCT05129475|Antiviral Agents|antiviral agents|mesh-ancestor
91961862|NCT05129475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961863|NCT05129475|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91961864|NCT05129475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91961865|NCT02485873|Vitamin K|vitamin k|mesh-list
91961866|NCT02485873|Rivaroxaban|rivaroxaban|mesh-list
91961867|NCT02485873|Vitamins|vitamins|mesh-ancestor
91961868|NCT02485873|Micronutrients|micronutrients|mesh-ancestor
91961869|NCT02485873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961888|NCT02488993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91961889|NCT02488993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961890|NCT02488993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91961891|NCT02485327|Insulin|insulin|mesh-list
91961892|NCT02485327|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91961893|NCT02485327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91961894|NCT02485327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961895|NCT02485249|Dexamethasone|dexamethasone|mesh-list
91961896|NCT02485249|Dexamethasone acetate|dexamethasone acetate|mesh-list
91961897|NCT02485249|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91961898|NCT02485249|BB 1101|bb 1101|mesh-list
91961899|NCT02485249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961900|NCT02485249|Antiemetics|antiemetics|mesh-ancestor
91961901|NCT02485249|Autonomic Agents|autonomic agents|mesh-ancestor
91961902|NCT02485249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961903|NCT02485249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944943|NCT01601626|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91944944|NCT01601626|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91944945|NCT01601626|Protease Inhibitors|protease inhibitors|mesh-ancestor
91944946|NCT01601626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961904|NCT02485249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91961905|NCT02485249|Glucocorticoids|glucocorticoids|mesh-ancestor
91961907|NCT02485249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91961908|NCT02485249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91961909|NCT02485249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961910|NCT02485249|Protease Inhibitors|protease inhibitors|mesh-ancestor
91961911|NCT02485249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961912|NCT02485249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961913|NCT03320707|Daratumumab|daratumumab|mesh-list
91961914|NCT03320707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961915|NCT03320629|Apatinib|apatinib|mesh-list
91961916|NCT03320629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961917|NCT03320629|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961918|NCT03320629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961919|NCT03320629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961920|NCT03316417|Immunomodulating Agents|immunomodulating agents|mesh-list
91961921|NCT03316417|Immunologic Factors|immunologic factors|mesh-ancestor
91961922|NCT03316417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961923|NCT02482207|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91961924|NCT02482207|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91961925|NCT02482207|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91961926|NCT02482207|Antimetabolites|antimetabolites|mesh-ancestor
91961927|NCT02482207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961928|NCT02482207|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91961930|NCT02482207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961932|NCT02476981|Midazolam|midazolam|mesh-list
91961933|NCT02476981|Dexmedetomidine|dexmedetomidine|mesh-list
91961934|NCT02476981|Remifentanil|remifentanil|mesh-list
91961935|NCT02476981|Propofol|propofol|mesh-list
91961936|NCT02476981|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91961937|NCT02476981|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961938|NCT02476981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961939|NCT02476981|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91961940|NCT02476981|Analgesics|analgesics|mesh-ancestor
91961941|NCT02476981|Sensory System Agents|sensory system agents|mesh-ancestor
91961942|NCT02476981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961943|NCT02476981|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91961944|NCT02476981|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91961945|NCT02476981|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961946|NCT02476981|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961947|NCT02476981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961948|NCT02476981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961949|NCT02476981|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91961950|NCT02476981|Anesthetics, General|anesthetics, general|mesh-ancestor
91961951|NCT02476981|Anesthetics|anesthetics|mesh-ancestor
91961952|NCT02476981|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91961953|NCT02476981|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91961954|NCT02476981|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91961955|NCT02476981|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91961956|NCT02476981|GABA Modulators|gaba modulators|mesh-ancestor
91961957|NCT02476981|GABA Agents|gaba agents|mesh-ancestor
91961958|NCT02476981|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91961959|NCT02476981|Narcotics|narcotics|mesh-ancestor
91961960|NCT02476981|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91961961|NCT02476981|Sympathomimetics|sympathomimetics|mesh-ancestor
91961962|NCT02476981|Autonomic Agents|autonomic agents|mesh-ancestor
91961963|NCT02476981|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91961964|NCT04248465|Ravulizumab|ravulizumab|mesh-list
91961965|NCT04248465|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91961966|NCT04248465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91961967|NCT04248465|Immunologic Factors|immunologic factors|mesh-ancestor
91961968|NCT04248465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961969|NCT02480335|Bosentan|bosentan|mesh-list
91961970|NCT02480335|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91961971|NCT02480335|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91961972|NCT02480335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944947|NCT01601626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961974|NCT05456269|Decitabine|decitabine|mesh-list
91961975|NCT05456269|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
91961976|NCT05456269|Bisantrene|bisantrene|mesh-list
91961977|NCT05456269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91961978|NCT05456269|Antimetabolites|antimetabolites|mesh-ancestor
91961979|NCT05456269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961980|NCT05456269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961981|NCT05456269|Antiviral Agents|antiviral agents|mesh-ancestor
91961982|NCT05456269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961983|NCT05456269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91961984|NCT05456269|Immunologic Factors|immunologic factors|mesh-ancestor
91961985|NCT05456269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961986|NCT05456269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961987|NCT05456269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91961988|NCT02476825|Fluticasone|fluticasone|mesh-list
91961990|NCT02476825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91961991|NCT02476825|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91961992|NCT02476825|Autonomic Agents|autonomic agents|mesh-ancestor
91961993|NCT02476825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961994|NCT02476825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961995|NCT02476825|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91961996|NCT02476825|Respiratory System Agents|respiratory system agents|mesh-ancestor
91961997|NCT02476825|Dermatologic Agents|dermatologic agents|mesh-ancestor
91961998|NCT02476825|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91961999|NCT05245227|Misoprostol|misoprostol|mesh-list
91962000|NCT05245227|Oxytocin|oxytocin|mesh-list
91962001|NCT05245227|Oxytocics|oxytocics|mesh-ancestor
91962002|NCT05245227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91962003|NCT05245227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962007|NCT05245227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962009|NCT02479867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91962010|NCT02479867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962011|NCT05244837|Paclitaxel|paclitaxel|mesh-list
91962012|NCT05244837|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91962013|NCT05244837|Carboplatin|carboplatin|mesh-list
91962014|NCT05244837|Pemetrexed|pemetrexed|mesh-list
91962015|NCT05244837|Tislelizumab|tislelizumab|mesh-list
91962016|NCT05244837|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91962017|NCT05244837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962018|NCT05244837|Tubulin Modulators|tubulin modulators|mesh-ancestor
91962019|NCT05244837|Antimitotic Agents|antimitotic agents|mesh-ancestor
91962020|NCT05244837|Mitosis Modulators|mitosis modulators|mesh-ancestor
91962021|NCT05244837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962022|NCT05244837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962023|NCT05244837|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91962024|NCT05244837|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91962025|NCT05244837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962027|NCT03103893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91962028|NCT03103893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962029|NCT03103893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91962030|NCT03103893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962031|NCT03103893|Antifungal Agents|antifungal agents|mesh-ancestor
91962032|NCT03103893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962033|NCT03103893|Immunologic Factors|immunologic factors|mesh-ancestor
91962034|NCT03103893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962035|NCT02479789|Lidocaine|lidocaine|mesh-list
91962036|NCT02479789|Anesthetics, Local|anesthetics, local|mesh-ancestor
91962037|NCT02479789|Anesthetics|anesthetics|mesh-ancestor
91962038|NCT02479789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962039|NCT02479789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962040|NCT02479789|Sensory System Agents|sensory system agents|mesh-ancestor
91962041|NCT02479789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962042|NCT02479789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91962043|NCT02479789|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91962044|NCT02479789|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91962045|NCT02479789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962046|NCT02479789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962047|NCT02726113|Vitamin D|vitamin d|mesh-list
91962048|NCT02726113|Cholecalciferol|cholecalciferol|mesh-list
91962049|NCT02726113|Vitamins|vitamins|mesh-ancestor
91944948|NCT01601626|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91944949|NCT01601626|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91944950|NCT01601626|Antiviral Agents|antiviral agents|mesh-ancestor
91962050|NCT02726113|Micronutrients|micronutrients|mesh-ancestor
91962051|NCT02726113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962052|NCT02726113|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91962053|NCT02726113|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91962055|NCT05243355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962056|NCT05243355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91962057|NCT05243355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91962058|NCT05243355|Growth Substances|growth substances|mesh-ancestor
91962059|NCT05243355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962060|NCT05243355|Growth Inhibitors|growth inhibitors|mesh-ancestor
91962061|NCT02479711|Methamphetamine|methamphetamine|mesh-list
91962062|NCT02479711|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91962063|NCT02479711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962064|NCT02479711|Sympathomimetics|sympathomimetics|mesh-ancestor
91962065|NCT02479711|Autonomic Agents|autonomic agents|mesh-ancestor
91962066|NCT02479711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962067|NCT02479711|Dopamine Agents|dopamine agents|mesh-ancestor
91962068|NCT02479711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962069|NCT02479711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962070|NCT02479711|Adrenergic Agents|adrenergic agents|mesh-ancestor
91962071|NCT02479711|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91962072|NCT02479711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91962073|NCT02479711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962074|NCT02479711|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91962087|NCT05196945|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91962088|NCT05196945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91962089|NCT05196945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91962091|NCT05196945|Diuretics|diuretics|mesh-ancestor
91962092|NCT05196945|Natriuretic Agents|natriuretic agents|mesh-ancestor
91962093|NCT05196945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962094|NCT05196945|Expectorants|expectorants|mesh-ancestor
91962095|NCT05196945|Respiratory System Agents|respiratory system agents|mesh-ancestor
91962096|NCT03800979|Tofacitinib|tofacitinib|mesh-list
91962097|NCT03800979|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91962098|NCT03800979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91962099|NCT03800979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962100|NCT03800979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962101|NCT02476123|Nivolumab|nivolumab|mesh-list
91962102|NCT02476123|Mogamulizumab|mogamulizumab|mesh-list
91962103|NCT02476123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962104|NCT02476123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962105|NCT02476123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962106|NCT02476123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962107|NCT02481193|Cisatracurium|cisatracurium|mesh-list
91962108|NCT02481193|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91962109|NCT02481193|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91962110|NCT02481193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962111|NCT02481193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962112|NCT03101709|Cyclophosphamide|cyclophosphamide|mesh-list
91962113|NCT03101709|Fludarabine|fludarabine|mesh-list
91962114|NCT03101709|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962115|NCT03101709|Immunologic Factors|immunologic factors|mesh-ancestor
91962116|NCT03101709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962117|NCT03101709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962118|NCT03101709|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91962119|NCT03101709|Alkylating Agents|alkylating agents|mesh-ancestor
91962120|NCT03101709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962121|NCT03101709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962122|NCT03101709|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91962123|NCT03101319|Vitamin D|vitamin d|mesh-list
91962124|NCT03101319|Cholecalciferol|cholecalciferol|mesh-list
91962125|NCT03101319|Vitamins|vitamins|mesh-ancestor
91962126|NCT03101319|Micronutrients|micronutrients|mesh-ancestor
91962127|NCT03101319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962128|NCT03101319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91962129|NCT03101319|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91944951|NCT01601626|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91944952|NCT01601626|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91944953|NCT01601626|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91944954|NCT01601626|Vitamin B Complex|vitamin b complex|mesh-ancestor
91962130|NCT02479555|Dexamethasone|dexamethasone|mesh-list
91962131|NCT02479555|Dexamethasone acetate|dexamethasone acetate|mesh-list
91962132|NCT02479555|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91962133|NCT02479555|BB 1101|bb 1101|mesh-list
91962134|NCT02479555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962135|NCT02479555|Antiemetics|antiemetics|mesh-ancestor
91962136|NCT02479555|Autonomic Agents|autonomic agents|mesh-ancestor
91962137|NCT02479555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962152|NCT02476045|Levoleucovorin|levoleucovorin|mesh-list
91962153|NCT02476045|Antimetabolites|antimetabolites|mesh-ancestor
91962154|NCT02476045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962155|NCT02476045|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91962156|NCT02476045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962157|NCT02476045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962158|NCT02476045|Immunologic Factors|immunologic factors|mesh-ancestor
91962159|NCT02476045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962160|NCT02476045|Antidotes|antidotes|mesh-ancestor
91962161|NCT02476045|Protective Agents|protective agents|mesh-ancestor
91962162|NCT02476045|Vitamin B Complex|vitamin b complex|mesh-ancestor
91962163|NCT02476045|Vitamins|vitamins|mesh-ancestor
91962164|NCT02476045|Micronutrients|micronutrients|mesh-ancestor
91962165|NCT02476045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962166|NCT02479399|Ipragliflozin|ipragliflozin|mesh-list
91962167|NCT02479399|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91962168|NCT02479399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962169|NCT02479399|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91962170|NCT02479399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962171|NCT03885921|Atorvastatin|atorvastatin|mesh-list
91962172|NCT03885921|Simvastatin|simvastatin|mesh-list
91962173|NCT03885921|Ezetimibe|ezetimibe|mesh-list
91962174|NCT03885921|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91962175|NCT03885921|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91962176|NCT03885921|Antimetabolites|antimetabolites|mesh-ancestor
91962177|NCT03885921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962178|NCT03885921|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91962179|NCT03885921|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91962180|NCT03885921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962181|NCT02480881|Fostemsavir|fostemsavir|mesh-list
91962182|NCT02480881|Contraceptive Agents|contraceptive agents|mesh-list
91962183|NCT02480881|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
91962184|NCT02480881|Contraceptives, Oral|contraceptives, oral|mesh-list
91962185|NCT02480881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91962186|NCT02480881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962187|NCT02480881|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91962188|NCT02480881|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91962189|NCT02480881|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91962190|NCT02480881|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91962191|NCT02480881|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
91962192|NCT02480881|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91962193|NCT02480881|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91962194|NCT02480881|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91962195|NCT02480881|Antiviral Agents|antiviral agents|mesh-ancestor
91962196|NCT02480881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962197|NCT02480881|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91962215|NCT03100071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962216|NCT03100071|Anticoagulants|anticoagulants|mesh-ancestor
91962217|NCT02479165|Oxycodone|oxycodone|mesh-list
91962218|NCT02479165|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91962219|NCT02479165|Narcotics|narcotics|mesh-ancestor
91962220|NCT02479165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962221|NCT02479165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962222|NCT02479165|Analgesics|analgesics|mesh-ancestor
91962223|NCT02479165|Sensory System Agents|sensory system agents|mesh-ancestor
91962224|NCT02479165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962225|NCT05072691|Immunoglobulins|immunoglobulins|mesh-list
91944955|NCT01601626|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91944956|NCT01601626|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91962226|NCT05072691|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91962227|NCT05072691|Antibodies|antibodies|mesh-list
91962228|NCT05072691|Immunologic Factors|immunologic factors|mesh-ancestor
91962229|NCT05072691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962230|NCT05714839|Dexamethasone|dexamethasone|mesh-list
91962231|NCT05714839|Lenalidomide|lenalidomide|mesh-list
91962232|NCT05714839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962233|NCT05714839|Antiemetics|antiemetics|mesh-ancestor
91962234|NCT05714839|Autonomic Agents|autonomic agents|mesh-ancestor
91962235|NCT05714839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962236|NCT05714839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962237|NCT05714839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962238|NCT05714839|Glucocorticoids|glucocorticoids|mesh-ancestor
91962239|NCT05714839|Hormones|hormones|mesh-ancestor
91962240|NCT05714839|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962241|NCT05714839|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91962242|NCT05714839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962243|NCT05714839|Immunologic Factors|immunologic factors|mesh-ancestor
91962244|NCT05714839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91962245|NCT05714839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91962246|NCT05714839|Growth Substances|growth substances|mesh-ancestor
91962247|NCT05714839|Growth Inhibitors|growth inhibitors|mesh-ancestor
91962248|NCT05378425|Pembrolizumab|pembrolizumab|mesh-list
91962249|NCT05378425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962250|NCT05378425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962251|NCT05378425|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962252|NCT05378425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962253|NCT05377255|Naloxone|naloxone|mesh-list
91962254|NCT05377255|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91962255|NCT05377255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962279|NCT02475499|Troglitazone|troglitazone|mesh-list
91962280|NCT02475499|Acetohexamide|acetohexamide|mesh-list
91962281|NCT02475499|Phenformin|phenformin|mesh-list
91962282|NCT02475499|Chlorpropamide|chlorpropamide|mesh-list
91962283|NCT02475499|Buformin|buformin|mesh-list
91962284|NCT02475499|Gliquidone|gliquidone|mesh-list
91962285|NCT02475499|Carbutamide|carbutamide|mesh-list
91962286|NCT02475499|Tolazamide|tolazamide|mesh-list
91962287|NCT02475499|Glibornuride|glibornuride|mesh-list
91962288|NCT02475499|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
91962289|NCT02475499|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
91962290|NCT02475499|Incretins|incretins|mesh-list
91962291|NCT02475499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962292|NCT02475499|Hormones|hormones|mesh-ancestor
91962293|NCT02475499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962294|NCT02475499|Protease Inhibitors|protease inhibitors|mesh-ancestor
91962295|NCT02475499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962296|NCT02475499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962297|NCT02475499|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91962298|NCT02475499|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91962299|NCT02475499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962300|NCT02475499|Immunologic Factors|immunologic factors|mesh-ancestor
91962302|NCT03375645|Narcotics|narcotics|mesh-ancestor
91962303|NCT03375645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962304|NCT03375645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962305|NCT03375645|Analgesics|analgesics|mesh-ancestor
91962306|NCT03375645|Sensory System Agents|sensory system agents|mesh-ancestor
91962307|NCT03375645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962308|NCT03136809|Copper|copper|mesh-list
91962309|NCT03136809|Trace Elements|trace elements|mesh-ancestor
91962310|NCT03136809|Micronutrients|micronutrients|mesh-ancestor
91962311|NCT03136809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962312|NCT02475421|Glucagon|glucagon|mesh-list
91962313|NCT02475421|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962314|NCT02475421|Hormones|hormones|mesh-ancestor
91962315|NCT02475421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962316|NCT02475421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962317|NCT03646617|Nivolumab|nivolumab|mesh-list
91962318|NCT03646617|Ipilimumab|ipilimumab|mesh-list
91962341|NCT03101085|Hormones|hormones|mesh-ancestor
91962342|NCT03101085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91944957|NCT01601626|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91944958|NCT01601626|Antitubercular Agents|antitubercular agents|mesh-ancestor
91944959|NCT01601626|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91944960|NCT01601626|Leprostatic Agents|leprostatic agents|mesh-ancestor
91962343|NCT03101085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962345|NCT05070195|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91962346|NCT05070195|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91962347|NCT05070195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962348|NCT05070195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962349|NCT05070195|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91962350|NCT05070195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962351|NCT05070195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962352|NCT05070195|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91962353|NCT05070195|Anesthetics, General|anesthetics, general|mesh-ancestor
91962354|NCT05070195|Anesthetics|anesthetics|mesh-ancestor
91962355|NCT05070195|GABA Modulators|gaba modulators|mesh-ancestor
91962356|NCT05070195|GABA Agents|gaba agents|mesh-ancestor
91962357|NCT05070195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962358|NCT05070195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962359|NCT02474953|Curcumin|curcumin|mesh-list
91962360|NCT02474953|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91962361|NCT02474953|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91962362|NCT02474953|Analgesics|analgesics|mesh-ancestor
91962363|NCT02474953|Sensory System Agents|sensory system agents|mesh-ancestor
91962364|NCT02474953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962365|NCT02474953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962366|NCT02474953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962367|NCT02474953|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962368|NCT02474953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962369|NCT02474953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962370|NCT02474953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962371|NCT05714371|Pembrolizumab|pembrolizumab|mesh-list
91962372|NCT05714371|Nivolumab|nivolumab|mesh-list
91962373|NCT05714371|Ipilimumab|ipilimumab|mesh-list
91962383|NCT02472613|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91962384|NCT02472613|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91962385|NCT02472613|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962386|NCT02472613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962387|NCT02472613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962389|NCT02472613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962390|NCT02472613|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91962391|NCT02472613|Antidepressive Agents|antidepressive agents|mesh-ancestor
91962392|NCT02472613|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962393|NCT02472613|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91962394|NCT02472613|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91962395|NCT02472613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962396|NCT00783237|Mometasone Furoate|mometasone furoate|mesh-list
91962397|NCT00783237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962398|NCT00783237|Dermatologic Agents|dermatologic agents|mesh-ancestor
91962399|NCT00783237|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91962400|NCT02478229|Sofosbuvir|sofosbuvir|mesh-list
91962401|NCT02478229|Ledipasvir|ledipasvir|mesh-list
91962402|NCT02478229|Antiviral Agents|antiviral agents|mesh-ancestor
91962403|NCT02478229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962404|NCT04879615|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91962405|NCT04879615|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91962406|NCT04879615|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91962407|NCT04879615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962408|NCT05713045|Vitamin K 1|vitamin k 1|mesh-list
91962409|NCT05713045|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91962410|NCT05713045|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91962411|NCT05713045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962412|NCT05713045|Hemostatics|hemostatics|mesh-ancestor
91962413|NCT05713045|Coagulants|coagulants|mesh-ancestor
91962414|NCT05713045|Vitamins|vitamins|mesh-ancestor
91962415|NCT05713045|Micronutrients|micronutrients|mesh-ancestor
91962416|NCT05713045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962417|NCT00653835|Simvastatin|simvastatin|mesh-list
91962418|NCT00653835|Ezetimibe|ezetimibe|mesh-list
91962419|NCT00653835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91962420|NCT00653835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91944961|NCT01601626|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91944962|NCT01601626|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91944963|NCT01601626|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91944964|NCT01601626|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91944965|NCT01601626|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91944966|NCT01601626|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91962421|NCT00653835|Antimetabolites|antimetabolites|mesh-ancestor
91962422|NCT00653835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962423|NCT00653835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91962424|NCT00653835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91962425|NCT00653835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962426|NCT03099759|Vitamin D|vitamin d|mesh-list
91962427|NCT03099759|Cholecalciferol|cholecalciferol|mesh-list
91962428|NCT03099759|Ergocalciferols|ergocalciferols|mesh-list
91962429|NCT03099759|Vitamins|vitamins|mesh-ancestor
91962430|NCT03099759|Micronutrients|micronutrients|mesh-ancestor
91962431|NCT03099759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962432|NCT03099759|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91962433|NCT03099759|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91962434|NCT05244577|Olanzapine|olanzapine|mesh-list
91962435|NCT05244577|Antiemetics|antiemetics|mesh-ancestor
91962436|NCT05244577|Autonomic Agents|autonomic agents|mesh-ancestor
91962437|NCT05244577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962438|NCT05244577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962440|NCT05244577|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91962441|NCT05244577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962442|NCT05244577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962443|NCT05244577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962444|NCT05244577|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91962445|NCT05244577|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91962446|NCT05244577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962447|NCT05244577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962448|NCT05244577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962449|NCT05244577|Serotonin Agents|serotonin agents|mesh-ancestor
91962450|NCT05710237|Risperidone|risperidone|mesh-list
91962451|NCT05710237|Psilocybin|psilocybin|mesh-list
91962452|NCT05710237|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91962453|NCT05710237|Serotonin Agents|serotonin agents|mesh-ancestor
91962454|NCT05710237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962455|NCT05710237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962456|NCT05710237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962457|NCT05710237|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91962458|NCT05710237|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962459|NCT05710237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962460|NCT05710237|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962461|NCT05710237|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91962462|NCT05710237|Dopamine Agents|dopamine agents|mesh-ancestor
91962463|NCT05710237|Hallucinogens|hallucinogens|mesh-ancestor
91962464|NCT05067699|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
91962465|NCT05067699|Calcifediol|calcifediol|mesh-list
91962467|NCT05067699|Micronutrients|micronutrients|mesh-ancestor
91962468|NCT05067699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962469|NCT05067699|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91962470|NCT05067153|Heparin|heparin|mesh-list
91962471|NCT05067153|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91962472|NCT05067153|Tinzaparin|tinzaparin|mesh-list
91962473|NCT05067153|Dalteparin|dalteparin|mesh-list
91962474|NCT05067153|Anticoagulants|anticoagulants|mesh-ancestor
91962475|NCT05067153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91962476|NCT05067153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91962477|NCT05067153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962478|NCT05067309|Letrozole|letrozole|mesh-list
91962479|NCT05067309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962480|NCT05067309|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91944967|NCT01601626|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91944968|NCT01601626|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91962481|NCT05067309|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91962482|NCT05067309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962483|NCT05067309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962484|NCT05067309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91962485|NCT05067309|Hormone Antagonists|hormone antagonists|mesh-ancestor
91962486|NCT05067309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962487|NCT05067309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962488|NCT02474563|Prednisone|prednisone|mesh-list
91962489|NCT02474563|Bortezomib|bortezomib|mesh-list
91962490|NCT02474563|Melphalan|melphalan|mesh-list
91962491|NCT02474563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962492|NCT02474563|Glucocorticoids|glucocorticoids|mesh-ancestor
91962493|NCT02474563|Hormones|hormones|mesh-ancestor
91962494|NCT02474563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962495|NCT02474563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962496|NCT02474563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91962497|NCT02474563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962498|NCT02474563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91962499|NCT02474563|Alkylating Agents|alkylating agents|mesh-ancestor
91962500|NCT02474563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962501|NCT02474563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91962502|NCT02474563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962503|NCT02474563|Immunologic Factors|immunologic factors|mesh-ancestor
91962504|NCT02477995|Vaccines|vaccines|mesh-list
91962505|NCT02477995|Immunologic Factors|immunologic factors|mesh-ancestor
91962506|NCT02477995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962507|NCT03098823|Prednisone|prednisone|mesh-list
91962508|NCT03098823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962509|NCT03098823|Glucocorticoids|glucocorticoids|mesh-ancestor
91962510|NCT03098823|Hormones|hormones|mesh-ancestor
91962511|NCT03098823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962512|NCT03098823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962527|NCT03108937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962528|NCT03108937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962529|NCT03913845|Lidocaine|lidocaine|mesh-list
91962530|NCT03913845|Epinephrine|epinephrine|mesh-list
91962531|NCT03913845|Racepinephrine|racepinephrine|mesh-list
91962532|NCT03913845|Epinephryl borate|epinephryl borate|mesh-list
91962533|NCT03913845|Anesthetics, Local|anesthetics, local|mesh-ancestor
91962534|NCT03913845|Anesthetics|anesthetics|mesh-ancestor
91962535|NCT03913845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962536|NCT03913845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962537|NCT03913845|Sensory System Agents|sensory system agents|mesh-ancestor
91962538|NCT03913845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962539|NCT03913845|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91962540|NCT03913845|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91962541|NCT03913845|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91962542|NCT03913845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962543|NCT03913845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962544|NCT03913845|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91962545|NCT03913845|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91962546|NCT03913845|Adrenergic Agents|adrenergic agents|mesh-ancestor
91962547|NCT03913845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962548|NCT03913845|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91962549|NCT03913845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91962550|NCT03913845|Autonomic Agents|autonomic agents|mesh-ancestor
91962551|NCT03913845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91962552|NCT03913845|Respiratory System Agents|respiratory system agents|mesh-ancestor
91962554|NCT03913845|Sympathomimetics|sympathomimetics|mesh-ancestor
91962555|NCT03913845|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91962556|NCT00705523|Varenicline|varenicline|mesh-list
91962557|NCT00705523|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91962558|NCT00705523|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91962559|NCT00705523|Cholinergic Agents|cholinergic agents|mesh-ancestor
91962560|NCT00705523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962561|NCT00705523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962562|NCT00705523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944969|NCT01601626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91944970|NCT01601626|Antimetabolites|antimetabolites|mesh-ancestor
91944971|NCT01601626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91944972|NCT05428150|Pirfenidone|pirfenidone|mesh-list
91962564|NCT03903939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91962565|NCT03903939|Vasodilator Agents|vasodilator agents|mesh-ancestor
91962566|NCT05065905|Interferons|interferons|mesh-list
91962567|NCT05065905|Interferon-gamma|interferon-gamma|mesh-list
91962568|NCT05065905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962569|NCT05065905|Antiviral Agents|antiviral agents|mesh-ancestor
91962570|NCT05065905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962571|NCT05010681|Lenvatinib|lenvatinib|mesh-list
91962572|NCT05010681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962578|NCT02725411|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91962579|NCT02725411|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91962580|NCT02725411|Analgesics|analgesics|mesh-ancestor
91962581|NCT02725411|Sensory System Agents|sensory system agents|mesh-ancestor
91962582|NCT02725411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962583|NCT02725411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962584|NCT02725411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962585|NCT02725411|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962586|NCT02725411|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91962587|NCT02725411|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91962588|NCT02725411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962589|NCT02725411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962591|NCT05058105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91962592|NCT05058105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962593|NCT05649943|Androgens|androgens|mesh-list
91962594|NCT05649943|Hormones|hormones|mesh-ancestor
91962595|NCT05649943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962596|NCT05649943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962597|NCT05046015|Carbamide Peroxide|carbamide peroxide|mesh-list
91962598|NCT05046015|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91962599|NCT05046015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962600|NCT04652557|4-Aminopyridine|4-aminopyridine|mesh-list
91962601|NCT04652557|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91962602|NCT04652557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962603|NCT04652557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962604|NCT04474353|Temozolomide|temozolomide|mesh-list
91962605|NCT04474353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91962606|NCT04474353|Alkylating Agents|alkylating agents|mesh-ancestor
91962714|NCT02473237|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91962607|NCT04474353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962608|NCT04474353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962609|NCT03099213|Ramipril|ramipril|mesh-list
91962610|NCT03099213|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91962611|NCT03099213|Protease Inhibitors|protease inhibitors|mesh-ancestor
91962612|NCT03099213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962613|NCT03099213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962614|NCT03099213|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91962615|NCT05061147|Azacitidine|azacitidine|mesh-list
91962616|NCT05061147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91962617|NCT05061147|Antimetabolites|antimetabolites|mesh-ancestor
91962618|NCT05061147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962619|NCT05061147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962620|NCT05061147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962621|NCT02127970|Dalbavancin|dalbavancin|mesh-list
91962622|NCT02127970|Teicoplanin|teicoplanin|mesh-list
91962623|NCT02127970|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91962624|NCT02127970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962625|NCT05056389|Oxaliplatin|oxaliplatin|mesh-list
91962626|NCT05056389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962627|NCT02471677|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91962628|NCT02471677|Hormones|hormones|mesh-ancestor
91962629|NCT02471677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962630|NCT02471677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962631|NCT04755634|Hyaluronic Acid|hyaluronic acid|mesh-list
91962632|NCT04755634|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91962633|NCT04755634|Immunologic Factors|immunologic factors|mesh-ancestor
91962634|NCT04755634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944973|NCT05428150|Analgesics|analgesics|mesh-ancestor
91944974|NCT05428150|Sensory System Agents|sensory system agents|mesh-ancestor
91962635|NCT04755634|Viscosupplements|viscosupplements|mesh-ancestor
91962636|NCT04755634|Protective Agents|protective agents|mesh-ancestor
91962637|NCT05395507|Interferons|interferons|mesh-list
91962638|NCT05395507|Interferon-alpha|interferon-alpha|mesh-list
91962639|NCT05395507|Interferon alpha-2|interferon alpha-2|mesh-list
91962640|NCT05395507|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91962641|NCT05395507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962642|NCT05395507|Antiviral Agents|antiviral agents|mesh-ancestor
91962663|NCT02473627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91962664|NCT02473627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962665|NCT02473627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962666|NCT02473627|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91962667|NCT02473627|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962668|NCT02473627|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962669|NCT02473627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91962670|NCT02473627|Anesthetics, General|anesthetics, general|mesh-ancestor
91962671|NCT02473627|Anesthetics|anesthetics|mesh-ancestor
91962672|NCT02473627|GABA Modulators|gaba modulators|mesh-ancestor
91962673|NCT02473627|GABA Agents|gaba agents|mesh-ancestor
91962674|NCT02473627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962675|NCT02473627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962676|NCT02473627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91962677|NCT02473627|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91962678|NCT02473627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962679|NCT02473627|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91962680|NCT02473627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962681|NCT02473627|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91962682|NCT02473627|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91962683|NCT02473627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962684|NCT03095703|Sirolimus|sirolimus|mesh-list
91962685|NCT03095703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91962686|NCT03095703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962687|NCT03095703|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91962688|NCT03095703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962689|NCT03095703|Antifungal Agents|antifungal agents|mesh-ancestor
91962690|NCT03095703|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962691|NCT03095703|Immunologic Factors|immunologic factors|mesh-ancestor
91962692|NCT03095703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962693|NCT05035953|Edaravone|edaravone|mesh-list
91962694|NCT05035953|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91962695|NCT05035953|Antioxidants|antioxidants|mesh-ancestor
91962696|NCT05035953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962697|NCT05035953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91962711|NCT02476903|Viscosupplements|viscosupplements|mesh-ancestor
91962712|NCT02476903|Protective Agents|protective agents|mesh-ancestor
91962713|NCT02473237|Tiotropium Bromide|tiotropium bromide|mesh-list
91962715|NCT02473237|Autonomic Agents|autonomic agents|mesh-ancestor
91962716|NCT02473237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962717|NCT02473237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962718|NCT02473237|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91962719|NCT02473237|Respiratory System Agents|respiratory system agents|mesh-ancestor
91962720|NCT02473237|Parasympatholytics|parasympatholytics|mesh-ancestor
91962721|NCT02473237|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91962722|NCT02473237|Cholinergic Agents|cholinergic agents|mesh-ancestor
91962723|NCT02473237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962724|NCT02473237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962725|NCT03403621|Pentamidine|pentamidine|mesh-list
91962726|NCT03403621|Antifungal Agents|antifungal agents|mesh-ancestor
91962727|NCT03403621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962728|NCT03403621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91962729|NCT03403621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91962730|NCT03403621|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91962731|NCT04220125|Midazolam|midazolam|mesh-list
91962732|NCT04220125|Ketamine|ketamine|mesh-list
91962733|NCT04220125|Analgesics|analgesics|mesh-ancestor
91962734|NCT04220125|Sensory System Agents|sensory system agents|mesh-ancestor
91962735|NCT04220125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962736|NCT04220125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962737|NCT04220125|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91962738|NCT04220125|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91944975|NCT05428150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962739|NCT04220125|Anesthetics, General|anesthetics, general|mesh-ancestor
91962740|NCT04220125|Anesthetics|anesthetics|mesh-ancestor
91962741|NCT04220125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962742|NCT04220125|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91962743|NCT04220125|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91962744|NCT04220125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962745|NCT04220125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962746|NCT04220125|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91962747|NCT04220125|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91962748|NCT04220125|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91962749|NCT04220125|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962750|NCT04220125|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962751|NCT04220125|GABA Modulators|gaba modulators|mesh-ancestor
91962752|NCT04220125|GABA Agents|gaba agents|mesh-ancestor
91962753|NCT02472691|Lenalidomide|lenalidomide|mesh-list
91962754|NCT02472691|Azacitidine|azacitidine|mesh-list
91962755|NCT02472691|Immunologic Factors|immunologic factors|mesh-ancestor
91962756|NCT02472691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962757|NCT02472691|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91962758|NCT02472691|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91962759|NCT02472691|Growth Substances|growth substances|mesh-ancestor
91962760|NCT02472691|Growth Inhibitors|growth inhibitors|mesh-ancestor
91962764|NCT02472691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962765|NCT02472691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962766|NCT02470663|Calcium Carbonate|calcium carbonate|mesh-list
91962767|NCT02470663|Calcium|calcium|mesh-list
91962768|NCT02470663|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91962769|NCT02470663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962770|NCT02470663|Antacids|antacids|mesh-ancestor
91962771|NCT02470663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962772|NCT02470663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962773|NCT00705367|Abatacept|abatacept|mesh-list
91962774|NCT00705367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962775|NCT00705367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962776|NCT00705367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962777|NCT00705367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962778|NCT00705367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962779|NCT00705367|Immunologic Factors|immunologic factors|mesh-ancestor
91962780|NCT00705367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962781|NCT00705367|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962782|NCT03043729|Leucovorin|leucovorin|mesh-list
91962783|NCT03043729|Oxaliplatin|oxaliplatin|mesh-list
91962784|NCT03043729|Aflibercept|aflibercept|mesh-list
91962785|NCT03043729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962786|NCT03043729|Antidotes|antidotes|mesh-ancestor
91962787|NCT03043729|Protective Agents|protective agents|mesh-ancestor
91962788|NCT03043729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962789|NCT03043729|Vitamin B Complex|vitamin b complex|mesh-ancestor
91962790|NCT03043729|Vitamins|vitamins|mesh-ancestor
91962791|NCT03043729|Micronutrients|micronutrients|mesh-ancestor
91962792|NCT03043729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91962793|NCT03043729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91962794|NCT03043729|Growth Substances|growth substances|mesh-ancestor
91962795|NCT03043729|Growth Inhibitors|growth inhibitors|mesh-ancestor
91962796|NCT05306431|Biguanides|biguanides|mesh-list
91962797|NCT05306431|Sodium Hypochlorite|sodium hypochlorite|mesh-list
91962798|NCT05306431|Polihexanide|polihexanide|mesh-list
91962799|NCT05306431|Eusol|eusol|mesh-list
91962800|NCT05306431|Disinfectants|disinfectants|mesh-ancestor
91962801|NCT05306431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962802|NCT05306431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91962803|NCT05306431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962804|NCT03108313|Fluorides|fluorides|mesh-list
91962805|NCT03108313|Cariostatic Agents|cariostatic agents|mesh-ancestor
91962806|NCT03108313|Protective Agents|protective agents|mesh-ancestor
91962807|NCT03108313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962808|NCT03108625|Vortioxetine|vortioxetine|mesh-list
91962809|NCT03108625|Antidepressive Agents|antidepressive agents|mesh-ancestor
91962810|NCT03108625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962811|NCT03108625|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91962812|NCT03108625|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962813|NCT03108625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962814|NCT03108625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944976|NCT05428150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944977|NCT05428150|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91944978|NCT05428150|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91962815|NCT03108625|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91962816|NCT03108625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91962817|NCT03108625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91962818|NCT03108625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962819|NCT03108625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962821|NCT03108625|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91962822|NCT03108625|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91962823|NCT03108625|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91962824|NCT03108625|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91962825|NCT03310567|Pembrolizumab|pembrolizumab|mesh-list
91962826|NCT03310567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962827|NCT03310567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962828|NCT03310567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962829|NCT03310567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962830|NCT03900949|Cytarabine|cytarabine|mesh-list
91962831|NCT03900949|Daunorubicin|daunorubicin|mesh-list
91962832|NCT03900949|Gemtuzumab|gemtuzumab|mesh-list
91962833|NCT03900949|Midostaurin|midostaurin|mesh-list
91962876|NCT02693821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962877|NCT02693821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962878|NCT02693821|Anticonvulsants|anticonvulsants|mesh-ancestor
91962879|NCT02693821|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91962880|NCT02693821|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91962881|NCT02693821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962882|NCT02693821|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91962883|NCT02693821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91962884|NCT02693821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91962885|NCT02693821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91962886|NCT02693821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962887|NCT02693821|Antimanic Agents|antimanic agents|mesh-ancestor
91962888|NCT02470117|Antacids|antacids|mesh-list
91962889|NCT02470117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962890|NCT02470117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962891|NCT03310333|Dinoprostone|dinoprostone|mesh-list
91962892|NCT03310333|Oxytocics|oxytocics|mesh-ancestor
91962893|NCT03310333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91962894|NCT03310333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962895|NCT02299999|Vincristine|vincristine|mesh-list
91962896|NCT02299999|Vinorelbine|vinorelbine|mesh-list
91962897|NCT02299999|Vinblastine|vinblastine|mesh-list
91962898|NCT02299999|Docetaxel|docetaxel|mesh-list
91962899|NCT02299999|Vinca Alkaloids|vinca alkaloids|mesh-list
91962900|NCT02299999|Cyclophosphamide|cyclophosphamide|mesh-list
91962901|NCT02299999|Bevacizumab|bevacizumab|mesh-list
91962902|NCT02299999|Cisplatin|cisplatin|mesh-list
91962903|NCT02299999|Carboplatin|carboplatin|mesh-list
91962904|NCT02299999|Gemcitabine|gemcitabine|mesh-list
91962905|NCT02299999|Doxorubicin|doxorubicin|mesh-list
91962906|NCT02299999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91962907|NCT02299999|Capecitabine|capecitabine|mesh-list
91962908|NCT02299999|Methotrexate|methotrexate|mesh-list
91962909|NCT02299999|Durvalumab|durvalumab|mesh-list
91962910|NCT02299999|Epirubicin|epirubicin|mesh-list
91962911|NCT02299999|Olaparib|olaparib|mesh-list
91962912|NCT02299999|Mitomycins|mitomycins|mesh-list
91962913|NCT02299999|Mitomycin|mitomycin|mesh-list
91962914|NCT02299999|Bicalutamide|bicalutamide|mesh-list
91962916|NCT02299999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91962917|NCT02299999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962918|NCT02299999|Tubulin Modulators|tubulin modulators|mesh-ancestor
91962919|NCT02299999|Antimitotic Agents|antimitotic agents|mesh-ancestor
91962920|NCT02299999|Mitosis Modulators|mitosis modulators|mesh-ancestor
91962921|NCT02299999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962922|NCT02299999|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962923|NCT02299999|Immunologic Factors|immunologic factors|mesh-ancestor
91962924|NCT02299999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962925|NCT02299999|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962926|NCT02299999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91962927|NCT02299999|Alkylating Agents|alkylating agents|mesh-ancestor
91962928|NCT02299999|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91944979|NCT05428150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91944980|NCT05428150|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91944981|NCT05428150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962929|NCT02299999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962930|NCT02299999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91962931|NCT02299999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91962932|NCT02299999|Growth Substances|growth substances|mesh-ancestor
91962933|NCT02299999|Growth Inhibitors|growth inhibitors|mesh-ancestor
91962934|NCT02299999|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91962935|NCT02299999|Antimetabolites|antimetabolites|mesh-ancestor
91962936|NCT02299999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91962937|NCT02299999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91962938|NCT02299999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91962939|NCT02299999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962940|NCT02299999|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91962941|NCT02299999|Abortifacient Agents|abortifacient agents|mesh-ancestor
91962942|NCT02299999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91962943|NCT02299999|Dermatologic Agents|dermatologic agents|mesh-ancestor
91962944|NCT02299999|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91962948|NCT02299999|Hormone Antagonists|hormone antagonists|mesh-ancestor
91962949|NCT02299999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962950|NCT00705289|Infliximab|infliximab|mesh-list
91962951|NCT00705289|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91962952|NCT00705289|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91962953|NCT00705289|Dermatologic Agents|dermatologic agents|mesh-ancestor
91962954|NCT00705289|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962955|NCT00705289|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962956|NCT02263729|Losartan|losartan|mesh-list
91962957|NCT02263729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91962958|NCT02263729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91962959|NCT02263729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91962960|NCT02263729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91962961|NCT02263729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962962|NCT03309865|Vedolizumab|vedolizumab|mesh-list
91962963|NCT03309865|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962964|NCT02038777|Cytarabine|cytarabine|mesh-list
91962965|NCT02038777|Azacitidine|azacitidine|mesh-list
91962966|NCT02038777|Daunorubicin|daunorubicin|mesh-list
91962967|NCT02038777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91962968|NCT02038777|Antimetabolites|antimetabolites|mesh-ancestor
91962969|NCT02038777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962970|NCT02038777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962971|NCT02038777|Antiviral Agents|antiviral agents|mesh-ancestor
91962972|NCT02038777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962973|NCT02038777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962974|NCT02038777|Immunologic Factors|immunologic factors|mesh-ancestor
91962975|NCT02038777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962976|NCT02038777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962977|NCT02038777|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91962978|NCT02038777|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91962979|NCT02038777|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91962980|NCT03744793|Pemetrexed|pemetrexed|mesh-list
91962981|NCT03744793|Avelumab|avelumab|mesh-list
91962982|NCT03744793|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91962983|NCT03744793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962984|NCT03744793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962985|NCT03744793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962986|NCT03744793|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91962987|NCT03744793|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91962988|NCT03744793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962989|NCT03744793|Immunologic Factors|immunologic factors|mesh-ancestor
91962990|NCT03744793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962991|NCT03309709|Progesterone|progesterone|mesh-list
91962992|NCT03309709|Progestins|progestins|mesh-ancestor
91962993|NCT03309709|Hormones|hormones|mesh-ancestor
91962994|NCT03309709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962995|NCT03309709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962996|NCT01720147|Quercetin|quercetin|mesh-list
91944983|NCT02737501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91944984|NCT02737501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91944985|NCT02737501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944986|NCT02737501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962997|NCT01720147|Antioxidants|antioxidants|mesh-ancestor
91962998|NCT01720147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962999|NCT01720147|Protective Agents|protective agents|mesh-ancestor
91963000|NCT01720147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963001|NCT03309319|Rosiglitazone|rosiglitazone|mesh-list
91963002|NCT03309319|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91963003|NCT03309319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963004|NCT03309163|Tramadol|tramadol|mesh-list
91963005|NCT03309163|Hydromorphone|hydromorphone|mesh-list
91963006|NCT03309163|Ropivacaine|ropivacaine|mesh-list
91963007|NCT03309163|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963008|NCT03309163|Anesthetics|anesthetics|mesh-ancestor
91963009|NCT03309163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963010|NCT03309163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963011|NCT03309163|Sensory System Agents|sensory system agents|mesh-ancestor
91963012|NCT03309163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963013|NCT03309163|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91963014|NCT03309163|Narcotics|narcotics|mesh-ancestor
91963015|NCT03309163|Analgesics|analgesics|mesh-ancestor
91963016|NCT03174847|Eplerenone|eplerenone|mesh-list
91963021|NCT03174847|Hormone Antagonists|hormone antagonists|mesh-ancestor
91963022|NCT03174847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963023|NCT03174847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963024|NCT03174847|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91963025|NCT03174847|Diuretics|diuretics|mesh-ancestor
91963026|NCT03174847|Natriuretic Agents|natriuretic agents|mesh-ancestor
91963027|NCT03174847|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91963028|NCT03174847|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
91963029|NCT03174847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91963030|NCT03174847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963031|NCT03174847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963032|NCT03174847|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
91963033|NCT03174847|Hormones|hormones|mesh-ancestor
91963034|NCT03313531|Thrombin|thrombin|mesh-list
91963035|NCT03313531|Hemostatics|hemostatics|mesh-ancestor
91963036|NCT03313531|Coagulants|coagulants|mesh-ancestor
91963037|NCT02468167|Polidocanol|polidocanol|mesh-list
91963038|NCT02468167|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
91963039|NCT02468167|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91963040|NCT03308149|Triamcinolone|triamcinolone|mesh-list
91963041|NCT03308149|Bupivacaine|bupivacaine|mesh-list
91963042|NCT03308149|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963043|NCT03308149|Anesthetics|anesthetics|mesh-ancestor
91963044|NCT03308149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963045|NCT03308149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963046|NCT03308149|Sensory System Agents|sensory system agents|mesh-ancestor
91963047|NCT03308149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963048|NCT03308149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963049|NCT03308149|Glucocorticoids|glucocorticoids|mesh-ancestor
91963050|NCT03308149|Hormones|hormones|mesh-ancestor
91963051|NCT03308149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963052|NCT03303235|Methylergonovine|methylergonovine|mesh-list
91963053|NCT03303235|Oxytocics|oxytocics|mesh-ancestor
91963054|NCT03303235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91963055|NCT03303235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963056|NCT03307993|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
91963057|NCT03307993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91963058|NCT03307993|Serotonin Agents|serotonin agents|mesh-ancestor
91963059|NCT03307993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963060|NCT03307993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963141|NCT03302065|Autonomic Agents|autonomic agents|mesh-ancestor
91963061|NCT03307993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963062|NCT03302845|Omeprazole|omeprazole|mesh-list
91963063|NCT03302845|Famotidine|famotidine|mesh-list
91963064|NCT03302845|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91963065|NCT03302845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963066|NCT03302845|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91963067|NCT03302845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91944988|NCT04848220|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91963068|NCT03302845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963069|NCT03302845|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91963070|NCT03302845|Histamine Antagonists|histamine antagonists|mesh-ancestor
91963071|NCT03302845|Histamine Agents|histamine agents|mesh-ancestor
91963072|NCT03302845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963073|NCT03302845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963074|NCT03302689|Ropivacaine|ropivacaine|mesh-list
91963075|NCT03302689|Levobupivacaine|levobupivacaine|mesh-list
91963076|NCT03302689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91963077|NCT03302689|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963078|NCT03302689|Anesthetics|anesthetics|mesh-ancestor
91963079|NCT03302689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963080|NCT03302689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963081|NCT03302689|Sensory System Agents|sensory system agents|mesh-ancestor
91963082|NCT03302689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963083|NCT03307603|Nivolumab|nivolumab|mesh-list
91963084|NCT03307603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963085|NCT03307603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963086|NCT03307603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91963087|NCT03307603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963091|NCT02468323|Autonomic Agents|autonomic agents|mesh-ancestor
91963092|NCT02468323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963093|NCT02468323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963094|NCT02468323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963095|NCT02468323|Antipruritics|antipruritics|mesh-ancestor
91963096|NCT02468323|Dermatologic Agents|dermatologic agents|mesh-ancestor
91963097|NCT02468323|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91963098|NCT02468323|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91963099|NCT02468323|Serotonin Agents|serotonin agents|mesh-ancestor
91963100|NCT02468323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963101|NCT02468323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963102|NCT02469259|Oxytocin|oxytocin|mesh-list
91963103|NCT02469259|Oxytocics|oxytocics|mesh-ancestor
91963104|NCT02469259|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91963105|NCT02469259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963106|NCT03307213|Sirolimus|sirolimus|mesh-list
91963107|NCT03307213|Umirolimus|umirolimus|mesh-list
91963108|NCT03307213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963109|NCT03307213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963110|NCT03307213|Immunologic Factors|immunologic factors|mesh-ancestor
91963111|NCT03307213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963112|NCT03307213|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91963113|NCT03307213|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963114|NCT03307213|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91963115|NCT03307213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963116|NCT03307213|Antifungal Agents|antifungal agents|mesh-ancestor
91963118|NCT03302299|Vitamin B 6|vitamin b 6|mesh-list
91963119|NCT03302299|Isoniazid|isoniazid|mesh-list
91963120|NCT03302299|Vitamins|vitamins|mesh-ancestor
91963121|NCT03302299|Micronutrients|micronutrients|mesh-ancestor
91963122|NCT03302299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963123|NCT03302299|Vitamin B Complex|vitamin b complex|mesh-ancestor
91963124|NCT03302299|Antitubercular Agents|antitubercular agents|mesh-ancestor
91963125|NCT03302299|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91963126|NCT03302299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963127|NCT03302299|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91963128|NCT03302299|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91963130|NCT03302299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963131|NCT03302299|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91963132|NCT03302221|Ropivacaine|ropivacaine|mesh-list
91963133|NCT03302221|Anesthetics|anesthetics|mesh-ancestor
91963134|NCT03302221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963135|NCT03302221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963136|NCT03302221|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963137|NCT03302221|Sensory System Agents|sensory system agents|mesh-ancestor
91963138|NCT03302221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963139|NCT03302065|Tiotropium Bromide|tiotropium bromide|mesh-list
91963140|NCT03302065|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91963142|NCT03302065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963143|NCT03302065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963144|NCT03302065|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91963145|NCT03302065|Respiratory System Agents|respiratory system agents|mesh-ancestor
91963146|NCT03302065|Parasympatholytics|parasympatholytics|mesh-ancestor
91963147|NCT03302065|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91963148|NCT03302065|Cholinergic Agents|cholinergic agents|mesh-ancestor
91963149|NCT03302065|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963150|NCT03302065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963152|NCT03306745|Hematinics|hematinics|mesh-ancestor
91963153|NCT03306745|Vitamin B Complex|vitamin b complex|mesh-ancestor
91963154|NCT03306745|Vitamins|vitamins|mesh-ancestor
91963155|NCT03306745|Micronutrients|micronutrients|mesh-ancestor
91963156|NCT03306745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963157|NCT03306667|Dotinurad|dotinurad|mesh-list
91963158|NCT03306667|Uricosuric Agents|uricosuric agents|mesh-ancestor
91963159|NCT03306667|Gout Suppressants|gout suppressants|mesh-ancestor
91963160|NCT03306667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963161|NCT03312283|Ranibizumab|ranibizumab|mesh-list
91963162|NCT03312283|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91963163|NCT03312283|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91963175|NCT03301207|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
91963176|NCT03301207|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91963177|NCT03301207|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91963178|NCT03301207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963179|NCT03301207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963180|NCT03301207|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91963181|NCT03301207|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91963182|NCT03301207|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91963183|NCT03301207|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91963184|NCT03301207|Anesthetics, General|anesthetics, general|mesh-ancestor
91963185|NCT03301207|Anesthetics|anesthetics|mesh-ancestor
91963186|NCT03301207|GABA Modulators|gaba modulators|mesh-ancestor
91963187|NCT03301207|GABA Agents|gaba agents|mesh-ancestor
91963188|NCT03301207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963189|NCT03301207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963190|NCT03301207|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91963191|NCT03301207|Antidepressive Agents|antidepressive agents|mesh-ancestor
91963192|NCT03301207|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91963193|NCT03301207|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91963194|NCT03301207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963195|NCT03301207|Dopamine Agents|dopamine agents|mesh-ancestor
91963196|NCT03301207|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91963197|NCT03301207|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91963199|NCT03301207|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91963200|NCT03301207|Contraceptive Agents|contraceptive agents|mesh-ancestor
91963201|NCT03301207|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91963202|NCT03301207|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91963203|NCT03301207|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91963204|NCT03301207|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91963205|NCT03301207|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91963207|NCT03301207|Hormones|hormones|mesh-ancestor
91963208|NCT03301207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963209|NCT03301207|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91963210|NCT03311971|Methamphetamine|methamphetamine|mesh-list
91963211|NCT03311971|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91963212|NCT03311971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963213|NCT03311971|Sympathomimetics|sympathomimetics|mesh-ancestor
91963214|NCT03311971|Autonomic Agents|autonomic agents|mesh-ancestor
91963215|NCT03311971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963216|NCT03311971|Dopamine Agents|dopamine agents|mesh-ancestor
91963217|NCT03311971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963218|NCT03311971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963219|NCT03311971|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963220|NCT03311971|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91963221|NCT03311971|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91963222|NCT03311971|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963223|NCT03311971|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91963224|NCT03311737|Anesthetics|anesthetics|mesh-list
91963225|NCT03311737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91944989|NCT04848220|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91944991|NCT04848220|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963463|NCT05259709|Cemiplimab|cemiplimab|mesh-list
91963226|NCT03311737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963227|NCT02467543|Ethanol|ethanol|mesh-list
91963229|NCT02467543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963230|NCT02467543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963231|NCT02467543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963232|NCT03311581|Propofol|propofol|mesh-list
91963233|NCT03311581|Sevoflurane|sevoflurane|mesh-list
91963234|NCT03311581|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91963235|NCT03311581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963236|NCT03311581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963237|NCT03311581|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91963238|NCT03311581|Anesthetics, General|anesthetics, general|mesh-ancestor
91963239|NCT03311581|Anesthetics|anesthetics|mesh-ancestor
91963240|NCT03311581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91963241|NCT03311581|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91963242|NCT03311425|Dexamethasone|dexamethasone|mesh-list
91963243|NCT03311425|Methylprednisolone|methylprednisolone|mesh-list
91963244|NCT03311425|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91963245|NCT03311425|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91963246|NCT03311425|Prednisolone|prednisolone|mesh-list
91963247|NCT03311425|Prednisolone acetate|prednisolone acetate|mesh-list
91963248|NCT03311425|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91963249|NCT03311425|Prednisolone phosphate|prednisolone phosphate|mesh-list
91963250|NCT03311425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963251|NCT03311425|Antiemetics|antiemetics|mesh-ancestor
91963252|NCT03311425|Autonomic Agents|autonomic agents|mesh-ancestor
91963253|NCT03311425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963254|NCT03311425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963255|NCT03311425|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963256|NCT03311425|Glucocorticoids|glucocorticoids|mesh-ancestor
91963257|NCT03311425|Hormones|hormones|mesh-ancestor
91963258|NCT03311425|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963259|NCT03311425|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91963260|NCT03311425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963261|NCT03311425|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91963262|NCT03311425|Protective Agents|protective agents|mesh-ancestor
91963263|NCT03305263|Hydroxychloroquine|hydroxychloroquine|mesh-list
91963264|NCT03305263|Antimalarials|antimalarials|mesh-ancestor
91963265|NCT03305263|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91963266|NCT03305263|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91963267|NCT03305263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963268|NCT03305263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963269|NCT03305263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963270|NCT03305263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963271|NCT03300115|Abivertinib|abivertinib|mesh-list
91963272|NCT03300115|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91963273|NCT03300115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963274|NCT03300115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963275|NCT02916979|Methotrexate|methotrexate|mesh-list
91963276|NCT02916979|Fludarabine|fludarabine|mesh-list
91963277|NCT02916979|Busulfan|busulfan|mesh-list
91963278|NCT02916979|Thymoglobulin|thymoglobulin|mesh-list
91963279|NCT02916979|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91963280|NCT02916979|Abortifacient Agents|abortifacient agents|mesh-ancestor
91963281|NCT02916979|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91963282|NCT02916979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963283|NCT02916979|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91963284|NCT02916979|Antimetabolites|antimetabolites|mesh-ancestor
91963285|NCT02916979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963286|NCT02916979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963287|NCT02916979|Dermatologic Agents|dermatologic agents|mesh-ancestor
91963288|NCT02916979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963289|NCT02916979|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91963290|NCT02916979|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963291|NCT02916979|Immunologic Factors|immunologic factors|mesh-ancestor
91963292|NCT02916979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963293|NCT02916979|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91963294|NCT02916979|Alkylating Agents|alkylating agents|mesh-ancestor
91963295|NCT02916979|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91963296|NCT02916979|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91944992|NCT04848220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91944993|NCT04848220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91944994|NCT05642182|Vitamin D|vitamin d|mesh-list
91963297|NCT00702949|Pregabalin|pregabalin|mesh-list
91963298|NCT00702949|Analgesics|analgesics|mesh-ancestor
91963299|NCT00702949|Sensory System Agents|sensory system agents|mesh-ancestor
91963300|NCT00702949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963301|NCT00702949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963302|NCT00702949|Anticonvulsants|anticonvulsants|mesh-ancestor
91963309|NCT00702949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963310|NCT00702949|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91963311|NCT04791475|Dexamethasone|dexamethasone|mesh-list
91963312|NCT04791475|Dexmedetomidine|dexmedetomidine|mesh-list
91963313|NCT04791475|Bupivacaine|bupivacaine|mesh-list
91963314|NCT04791475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963315|NCT04791475|Antiemetics|antiemetics|mesh-ancestor
91963316|NCT04791475|Autonomic Agents|autonomic agents|mesh-ancestor
91963317|NCT04791475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963318|NCT04791475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963319|NCT04791475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963320|NCT04791475|Glucocorticoids|glucocorticoids|mesh-ancestor
91963321|NCT04791475|Hormones|hormones|mesh-ancestor
91963322|NCT04791475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963323|NCT04791475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91963324|NCT04791475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963325|NCT04791475|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963326|NCT04791475|Anesthetics|anesthetics|mesh-ancestor
91963327|NCT04791475|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963328|NCT04791475|Sensory System Agents|sensory system agents|mesh-ancestor
91963329|NCT04791475|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91963330|NCT04791475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91963331|NCT04791475|Analgesics|analgesics|mesh-ancestor
91963332|NCT04791475|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91963333|NCT04791475|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91963334|NCT04791475|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91963335|NCT04791475|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963336|NCT04791475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963337|NCT04791475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963338|NCT03299725|Bismuth|bismuth|mesh-list
91963339|NCT03299725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963340|NCT03299725|Antacids|antacids|mesh-ancestor
91963341|NCT03299725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963342|NCT02466997|Tacrolimus|tacrolimus|mesh-list
91963343|NCT02466997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963344|NCT02466997|Immunologic Factors|immunologic factors|mesh-ancestor
91963345|NCT02466997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963346|NCT02466997|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91963347|NCT02466997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963348|NCT02466997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963349|NCT04939909|Botulinum Toxins|botulinum toxins|mesh-list
91963350|NCT04939909|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91963351|NCT04939909|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91963352|NCT04939909|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91963353|NCT04939909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963354|NCT04939909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963355|NCT04939909|Cholinergic Agents|cholinergic agents|mesh-ancestor
91963356|NCT04939909|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963357|NCT04939909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963358|NCT04939909|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91963359|NCT04939909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963360|NCT03299257|Donepezil|donepezil|mesh-list
91963361|NCT03299257|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91963362|NCT03299257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963363|NCT03299257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963364|NCT03299257|Cholinergic Agents|cholinergic agents|mesh-ancestor
91963365|NCT03299257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963366|NCT03299257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963367|NCT03299257|Nootropic Agents|nootropic agents|mesh-ancestor
91963368|NCT02466373|Clonidine|clonidine|mesh-list
91963369|NCT02466373|Analgesics|analgesics|mesh-ancestor
91963373|NCT02466373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91963374|NCT02466373|Sympatholytics|sympatholytics|mesh-ancestor
91963375|NCT02466373|Autonomic Agents|autonomic agents|mesh-ancestor
91963376|NCT02466373|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91963377|NCT02466373|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91963378|NCT02466373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91963379|NCT02466373|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963380|NCT02466373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963381|NCT02466373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963382|NCT05727397|Aflibercept|aflibercept|mesh-list
91963383|NCT05727397|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91963384|NCT05727397|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91963385|NCT05727397|Growth Substances|growth substances|mesh-ancestor
91963386|NCT05727397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963387|NCT05727397|Growth Inhibitors|growth inhibitors|mesh-ancestor
91963388|NCT05727397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963389|NCT02466919|Amoxicillin|amoxicillin|mesh-list
91963390|NCT02466919|Metronidazole|metronidazole|mesh-list
91963391|NCT02466919|Clarithromycin|clarithromycin|mesh-list
91963392|NCT02466919|Levofloxacin|levofloxacin|mesh-list
91963393|NCT02466919|Pantoprazole|pantoprazole|mesh-list
91963394|NCT02466919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91963395|NCT02466919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963396|NCT02466919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91963397|NCT02466919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91963398|NCT02466919|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91963399|NCT02466919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963400|NCT02466919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963401|NCT02466919|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91963402|NCT02466919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91963403|NCT02466919|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91963404|NCT02466919|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91963405|NCT02466919|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91963406|NCT02466919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963407|NCT02466919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91963408|NCT02466919|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91963409|NCT02466919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963410|NCT02466919|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91963412|NCT05727163|Dexamethasone|dexamethasone|mesh-list
91963413|NCT05727163|Anisodamine|anisodamine|mesh-list
91963414|NCT05727163|Bevacizumab|bevacizumab|mesh-list
91963415|NCT05727163|Fluorouracil|fluorouracil|mesh-list
91963416|NCT05727163|Oxaliplatin|oxaliplatin|mesh-list
91963417|NCT05727163|Irinotecan|irinotecan|mesh-list
91963418|NCT05727163|Levoleucovorin|levoleucovorin|mesh-list
91963419|NCT05727163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963420|NCT05727163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963421|NCT05727163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91963422|NCT05727163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91963423|NCT05727163|Growth Substances|growth substances|mesh-ancestor
91963424|NCT05727163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963425|NCT05727163|Growth Inhibitors|growth inhibitors|mesh-ancestor
91963426|NCT05727163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963427|NCT05727163|Antiemetics|antiemetics|mesh-ancestor
91963428|NCT05727163|Autonomic Agents|autonomic agents|mesh-ancestor
91963429|NCT05727163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963430|NCT05727163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963431|NCT05727163|Glucocorticoids|glucocorticoids|mesh-ancestor
91963432|NCT05727163|Hormones|hormones|mesh-ancestor
91963433|NCT05727163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963434|NCT05727163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91963435|NCT05727163|Antimetabolites|antimetabolites|mesh-ancestor
91963436|NCT05727163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963437|NCT05727163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91963438|NCT05727163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963439|NCT05727163|Immunologic Factors|immunologic factors|mesh-ancestor
91963440|NCT05727163|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91963441|NCT05727163|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91963445|NCT05727163|Vitamin B Complex|vitamin b complex|mesh-ancestor
91963447|NCT05727163|Micronutrients|micronutrients|mesh-ancestor
91963448|NCT05727163|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91963449|NCT05727163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91963450|NCT05727163|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963451|NCT05727163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963452|NCT05727163|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91963453|NCT05727163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91944996|NCT05642182|Cholecalciferol|cholecalciferol|mesh-list
91944997|NCT05642182|Vitamins|vitamins|mesh-list
91944998|NCT05642182|Micronutrients|micronutrients|mesh-ancestor
91963454|NCT05727163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91963455|NCT05727163|Analgesics|analgesics|mesh-ancestor
91963456|NCT05727163|Sensory System Agents|sensory system agents|mesh-ancestor
91963457|NCT05727163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963458|NCT05727163|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91963459|NCT05727163|Parasympatholytics|parasympatholytics|mesh-ancestor
91963460|NCT05727163|Vasodilator Agents|vasodilator agents|mesh-ancestor
91963461|NCT05727163|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91963462|NCT05727163|Antioxidants|antioxidants|mesh-ancestor
91963464|NCT05259709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963465|NCT05259709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963466|NCT05302531|Amoxicillin|amoxicillin|mesh-list
91963467|NCT05302531|Levofloxacin|levofloxacin|mesh-list
91963468|NCT05302531|Ofloxacin|ofloxacin|mesh-list
91963469|NCT05302531|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91963470|NCT05302531|Trimethoprim|trimethoprim|mesh-list
91963471|NCT05302531|Sulfamethoxazole|sulfamethoxazole|mesh-list
91963472|NCT05302531|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91963473|NCT05302531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963474|NCT05302531|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91963475|NCT05302531|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91963476|NCT05302531|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91963477|NCT05302531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963478|NCT05302531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963479|NCT05302531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963480|NCT05302531|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91963481|NCT05302531|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91963482|NCT05302531|Antimalarials|antimalarials|mesh-ancestor
91963483|NCT05302531|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91963484|NCT05302531|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91963485|NCT05302531|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91963486|NCT05302531|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91963487|NCT05302531|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91963488|NCT00702403|Imatinib Mesylate|imatinib mesylate|mesh-list
91963489|NCT00702403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963490|NCT00702403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91963491|NCT00702403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963492|NCT00702403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963493|NCT00702325|Budesonide|budesonide|mesh-list
91963494|NCT00702325|Formoterol Fumarate|formoterol fumarate|mesh-list
91963495|NCT00702325|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
91963496|NCT00702325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963497|NCT00702325|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91963498|NCT00702325|Autonomic Agents|autonomic agents|mesh-ancestor
91963499|NCT00702325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963500|NCT00702325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963501|NCT00702325|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91963502|NCT00702325|Respiratory System Agents|respiratory system agents|mesh-ancestor
91963503|NCT00702325|Glucocorticoids|glucocorticoids|mesh-ancestor
91963505|NCT00702325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963506|NCT00702325|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91963507|NCT00702325|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91963508|NCT00702325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91963509|NCT00702325|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963510|NCT00702325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963511|NCT00702325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963512|NCT02719171|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91963513|NCT02719171|Immunologic Factors|immunologic factors|mesh-ancestor
91963515|NCT02464813|Pregabalin|pregabalin|mesh-list
91963516|NCT02464813|Oxycodone|oxycodone|mesh-list
91963517|NCT02464813|Analgesics|analgesics|mesh-ancestor
91963518|NCT02464813|Sensory System Agents|sensory system agents|mesh-ancestor
91963519|NCT02464813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963520|NCT02464813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963521|NCT02464813|Anticonvulsants|anticonvulsants|mesh-ancestor
91944999|NCT05642182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945000|NCT05642182|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91963522|NCT02464813|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91963523|NCT02464813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963524|NCT02464813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963525|NCT02464813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91963526|NCT02464813|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91963527|NCT02464813|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91963528|NCT02464813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963529|NCT02464813|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91963530|NCT02464813|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91963531|NCT02464813|Narcotics|narcotics|mesh-ancestor
91963532|NCT05726929|Capsaicin|capsaicin|mesh-list
91963533|NCT05726929|Antipruritics|antipruritics|mesh-ancestor
91963534|NCT05726929|Dermatologic Agents|dermatologic agents|mesh-ancestor
91963535|NCT05726929|Sensory System Agents|sensory system agents|mesh-ancestor
91963536|NCT05726929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963537|NCT05726929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963538|NCT05122351|Acetaminophen|acetaminophen|mesh-list
91963539|NCT05122351|Bupivacaine|bupivacaine|mesh-list
91963540|NCT05122351|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963541|NCT05122351|Anesthetics|anesthetics|mesh-ancestor
91963542|NCT05122351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963543|NCT05122351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963544|NCT05122351|Sensory System Agents|sensory system agents|mesh-ancestor
91963545|NCT05122351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963546|NCT05122351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91963547|NCT05122351|Analgesics|analgesics|mesh-ancestor
91963548|NCT05122351|Antipyretics|antipyretics|mesh-ancestor
91963549|NCT02464501|Paclitaxel|paclitaxel|mesh-list
91963550|NCT02464501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91963551|NCT02464501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963552|NCT02464501|Tubulin Modulators|tubulin modulators|mesh-ancestor
91963553|NCT02464501|Antimitotic Agents|antimitotic agents|mesh-ancestor
91963554|NCT02464501|Mitosis Modulators|mitosis modulators|mesh-ancestor
91963555|NCT02464501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963556|NCT02465827|Ropivacaine|ropivacaine|mesh-list
91963557|NCT02465827|Anesthetics, Local|anesthetics, local|mesh-ancestor
91963558|NCT02465827|Anesthetics|anesthetics|mesh-ancestor
91963559|NCT02465827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963560|NCT02465827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963561|NCT02465827|Sensory System Agents|sensory system agents|mesh-ancestor
91963562|NCT02465827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963563|NCT04368403|Brodalumab|brodalumab|mesh-list
91963564|NCT04368403|Dermatologic Agents|dermatologic agents|mesh-ancestor
91963566|NCT04298203|Phentermine|phentermine|mesh-list
91963567|NCT04298203|Anticonvulsants|anticonvulsants|mesh-ancestor
91963568|NCT04298203|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91963569|NCT04298203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963570|NCT04298203|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91963571|NCT04298203|Appetite Depressants|appetite depressants|mesh-ancestor
91963572|NCT04298203|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91963573|NCT04298203|Sympathomimetics|sympathomimetics|mesh-ancestor
91963574|NCT04298203|Autonomic Agents|autonomic agents|mesh-ancestor
91963575|NCT04298203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963576|NCT04298203|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963577|NCT04298203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963578|NCT04298203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963579|NCT05679661|Chlorhexidine|chlorhexidine|mesh-list
91963580|NCT05679661|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91963581|NCT05679661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963582|NCT05679661|Disinfectants|disinfectants|mesh-ancestor
91963583|NCT02465983|Cyclophosphamide|cyclophosphamide|mesh-list
91963584|NCT02465983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963585|NCT02465983|Immunologic Factors|immunologic factors|mesh-ancestor
91963586|NCT02465983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963587|NCT02465983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963588|NCT02465983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91963589|NCT02465983|Alkylating Agents|alkylating agents|mesh-ancestor
91963592|NCT02465983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91963594|NCT02465749|Micronutrients|micronutrients|mesh-ancestor
91963595|NCT02465749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963596|NCT00701779|Tamsulosin|tamsulosin|mesh-list
91945001|NCT05642182|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945002|NCT03471559|Cannabidiol|cannabidiol|mesh-list
91945003|NCT03471559|Anticonvulsants|anticonvulsants|mesh-ancestor
91945004|NCT05641480|Donepezil|donepezil|mesh-list
91945005|NCT05641480|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91945006|NCT05641480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963597|NCT00701779|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91963598|NCT00701779|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91963599|NCT00701779|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91963600|NCT00701779|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963601|NCT00701779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963602|NCT00701779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963603|NCT00701779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963604|NCT00701779|Urological Agents|urological agents|mesh-ancestor
91963605|NCT02463643|Rabeprazole|rabeprazole|mesh-list
91963606|NCT02463643|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91963607|NCT02463643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91963608|NCT02463643|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91963609|NCT02463643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963610|NCT02463643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963611|NCT04927975|Upadacitinib|upadacitinib|mesh-list
91963612|NCT04927975|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91963613|NCT04927975|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91963614|NCT04927975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963615|NCT04927975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963616|NCT04927975|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963617|NCT04913467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91963618|NCT04150861|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91963619|NCT04150861|Hormones|hormones|mesh-ancestor
91963620|NCT04150861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963621|NCT04150861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963622|NCT02465359|Immunoglobulins|immunoglobulins|mesh-list
91963623|NCT02465359|Antibodies|antibodies|mesh-list
91963624|NCT02465359|gamma-Globulins|gamma-globulins|mesh-list
91963625|NCT02465359|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91963626|NCT02465359|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91963627|NCT02465359|Immunologic Factors|immunologic factors|mesh-ancestor
91963628|NCT02465359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963629|NCT02463019|Tenofovir|tenofovir|mesh-list
91963630|NCT02463019|Antiviral Agents|antiviral agents|mesh-ancestor
91963631|NCT02463019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963632|NCT02463019|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91963633|NCT02463019|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91963634|NCT02463019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963635|NCT02463019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963636|NCT02463019|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91963637|NCT02463019|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91963639|NCT02462941|Analgesics|analgesics|mesh-ancestor
91963640|NCT02462941|Sensory System Agents|sensory system agents|mesh-ancestor
91963641|NCT02462941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963642|NCT02462941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963643|NCT02462941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91963644|NCT02462941|Vasodilator Agents|vasodilator agents|mesh-ancestor
91963645|NCT02462941|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91963646|NCT02462941|Purinergic Agonists|purinergic agonists|mesh-ancestor
91963647|NCT02462941|Purinergic Agents|purinergic agents|mesh-ancestor
91963648|NCT02462941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963649|NCT02462941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963651|NCT02462707|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
91963652|NCT02462707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963653|NCT02462707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963654|NCT02463175|Plasma-lyte 148|plasma-lyte 148|mesh-list
91963655|NCT02463175|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91963656|NCT02463175|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91963657|NCT04824391|Vaccines|vaccines|mesh-list
91963658|NCT04824391|Immunologic Factors|immunologic factors|mesh-ancestor
91963659|NCT04824391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945007|NCT05641480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945008|NCT05641480|Cholinergic Agents|cholinergic agents|mesh-ancestor
91945009|NCT05641480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963660|NCT03297073|Acetaminophen|acetaminophen|mesh-list
91963661|NCT03297073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91963666|NCT03297073|Antipyretics|antipyretics|mesh-ancestor
91963668|NCT02462317|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91963669|NCT02462317|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91963670|NCT02462317|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91963671|NCT02462317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963672|NCT02462317|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91963673|NCT02462317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963674|NCT02462317|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91963675|NCT02462317|GABA Agonists|gaba agonists|mesh-ancestor
91963676|NCT02462317|GABA Agents|gaba agents|mesh-ancestor
91963677|NCT02462317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963678|NCT02462317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963679|NCT02462317|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91963680|NCT02462317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963681|NCT02462317|Cholinergic Agents|cholinergic agents|mesh-ancestor
91963682|NCT02461069|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91963683|NCT02461069|Dermatologic Agents|dermatologic agents|mesh-ancestor
91963684|NCT02461069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963685|NCT02461069|Immunologic Factors|immunologic factors|mesh-ancestor
91963686|NCT02461069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963687|NCT03332095|Tenofovir|tenofovir|mesh-list
91963688|NCT03332095|Lamivudine|lamivudine|mesh-list
91963689|NCT03332095|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91963690|NCT03332095|Antiviral Agents|antiviral agents|mesh-ancestor
91963691|NCT03332095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963692|NCT03332095|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91963693|NCT03332095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91963694|NCT03332095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963695|NCT03332095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963696|NCT03332095|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91963697|NCT04489381|Nitazoxanide|nitazoxanide|mesh-list
91963698|NCT04489381|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91963699|NCT04489381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963700|NCT04489849|Apixaban|apixaban|mesh-list
91963701|NCT04489849|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91963702|NCT04489849|Antithrombins|antithrombins|mesh-ancestor
91963703|NCT04489849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91963704|NCT04489849|Protease Inhibitors|protease inhibitors|mesh-ancestor
91963705|NCT04489849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963706|NCT04489849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963707|NCT04489849|Anticoagulants|anticoagulants|mesh-ancestor
91963708|NCT04488367|Tranexamic Acid|tranexamic acid|mesh-list
91963709|NCT04488367|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91963710|NCT04488367|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91963711|NCT04488367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963712|NCT04488367|Hemostatics|hemostatics|mesh-ancestor
91963713|NCT04488367|Coagulants|coagulants|mesh-ancestor
91963714|NCT03734653|Testosterone|testosterone|mesh-list
91963715|NCT03734653|Androgens|androgens|mesh-ancestor
91963716|NCT03734653|Hormones|hormones|mesh-ancestor
91963717|NCT03734653|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963718|NCT03734653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963719|NCT04489459|Meropenem|meropenem|mesh-list
91963720|NCT04489459|Colistin|colistin|mesh-list
91963721|NCT04489459|Tigecycline|tigecycline|mesh-list
91963722|NCT04489459|Polymyxins|polymyxins|mesh-list
91963723|NCT04489459|Polymyxin B|polymyxin b|mesh-list
91963724|NCT04489459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91963725|NCT04489459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963726|NCT04489459|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91963727|NCT04489459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963728|NCT04489459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963729|NCT03296137|Aldesleukin|aldesleukin|mesh-list
91963730|NCT03296137|Cyclophosphamide|cyclophosphamide|mesh-list
91963731|NCT03296137|Nivolumab|nivolumab|mesh-list
91963732|NCT03296137|Ipilimumab|ipilimumab|mesh-list
91963733|NCT03296137|Fludarabine phosphate|fludarabine phosphate|mesh-list
91945011|NCT05641480|Nootropic Agents|nootropic agents|mesh-ancestor
91963734|NCT03296137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963735|NCT03296137|Immunologic Factors|immunologic factors|mesh-ancestor
91963738|NCT03296137|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91963739|NCT03296137|Alkylating Agents|alkylating agents|mesh-ancestor
91963740|NCT03296137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963741|NCT03296137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963742|NCT03296137|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91963743|NCT03296137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963744|NCT03296137|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91963745|NCT03296137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91963746|NCT03296137|Antimetabolites|antimetabolites|mesh-ancestor
91963747|NCT03296137|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91963748|NCT03296137|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91963749|NCT03296137|Antiviral Agents|antiviral agents|mesh-ancestor
91963750|NCT03296137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91963751|NCT03295903|Cannabidiol|cannabidiol|mesh-list
91963752|NCT03295903|Anticonvulsants|anticonvulsants|mesh-ancestor
91963753|NCT02460913|Morphine|morphine|mesh-list
91963754|NCT02460913|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91963755|NCT02460913|Narcotics|narcotics|mesh-ancestor
91963756|NCT02460913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963757|NCT02460913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963758|NCT02460913|Analgesics|analgesics|mesh-ancestor
91963759|NCT02460913|Sensory System Agents|sensory system agents|mesh-ancestor
91963760|NCT02460913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963761|NCT02973997|Pembrolizumab|pembrolizumab|mesh-list
91963762|NCT02973997|Lenvatinib|lenvatinib|mesh-list
91963763|NCT02973997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963764|NCT02973997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963765|NCT02973997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91963766|NCT02973997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963767|NCT02973997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91963768|NCT02973997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963769|NCT03295825|Heparin|heparin|mesh-list
91963770|NCT03295825|Anticoagulants|anticoagulants|mesh-ancestor
91963771|NCT03295825|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91963772|NCT03295825|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91963773|NCT03295825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963774|NCT03290365|Hyaluronic Acid|hyaluronic acid|mesh-list
91963775|NCT03290365|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91963776|NCT03290365|Immunologic Factors|immunologic factors|mesh-ancestor
91963777|NCT03290365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963778|NCT03290365|Viscosupplements|viscosupplements|mesh-ancestor
91963779|NCT03290365|Protective Agents|protective agents|mesh-ancestor
91963780|NCT02764489|Thrombin|thrombin|mesh-list
91963781|NCT02764489|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
91963782|NCT02764489|Coagulants|coagulants|mesh-list
91963783|NCT02764489|Hemostatics|hemostatics|mesh-ancestor
91963784|NCT02462161|Insulin|insulin|mesh-list
91963785|NCT02462161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91963786|NCT02462161|Insulin Aspart|insulin aspart|mesh-list
91963787|NCT02462161|Insulin, Long-Acting|insulin, long-acting|mesh-list
91963788|NCT02462161|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
91963789|NCT02462161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91963790|NCT02462161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963791|NCT03289819|Paclitaxel|paclitaxel|mesh-list
91963792|NCT03289819|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91963793|NCT03289819|Cyclophosphamide|cyclophosphamide|mesh-list
91963794|NCT03289819|Pembrolizumab|pembrolizumab|mesh-list
91963795|NCT03289819|Epirubicin|epirubicin|mesh-list
91963796|NCT03289819|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91963797|NCT03289819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963798|NCT03289819|Tubulin Modulators|tubulin modulators|mesh-ancestor
91963799|NCT03289819|Antimitotic Agents|antimitotic agents|mesh-ancestor
91963800|NCT03289819|Mitosis Modulators|mitosis modulators|mesh-ancestor
91963801|NCT03289819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963802|NCT03289819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963804|NCT03289819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963805|NCT03289819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963806|NCT03289819|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91963807|NCT03289819|Alkylating Agents|alkylating agents|mesh-ancestor
91963808|NCT03289819|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91945012|NCT03377803|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91963809|NCT03289819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963813|NCT03289819|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91963814|NCT03289819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963815|NCT02001623|Tisotumab vedotin|tisotumab vedotin|mesh-list
91963816|NCT02001623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963817|NCT02001623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963818|NCT02713867|Nivolumab|nivolumab|mesh-list
91963819|NCT02713867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963820|NCT02713867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963821|NCT02713867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91963822|NCT02713867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963823|NCT03372785|Aspirin|aspirin|mesh-list
91963824|NCT03372785|Metoprolol|metoprolol|mesh-list
91963825|NCT03372785|Clopidogrel|clopidogrel|mesh-list
91963826|NCT03372785|Ticagrelor|ticagrelor|mesh-list
91963827|NCT03372785|Atorvastatin|atorvastatin|mesh-list
91963828|NCT03372785|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91963829|NCT03372785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91963830|NCT03372785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91963831|NCT03372785|Analgesics|analgesics|mesh-ancestor
91963832|NCT03372785|Sensory System Agents|sensory system agents|mesh-ancestor
91963833|NCT03372785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963834|NCT03372785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963835|NCT03372785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91963836|NCT03372785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963837|NCT03372785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91963838|NCT03372785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91963839|NCT03372785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963840|NCT03372785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91963841|NCT03372785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91963842|NCT03372785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963843|NCT03372785|Antipyretics|antipyretics|mesh-ancestor
91963844|NCT03372785|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91963845|NCT03372785|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91963846|NCT03372785|Antimetabolites|antimetabolites|mesh-ancestor
91963847|NCT03372785|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91963848|NCT03372785|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91963849|NCT03372785|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91963850|NCT03372785|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91963851|NCT03372785|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91963852|NCT03372785|Purinergic Agents|purinergic agents|mesh-ancestor
91963853|NCT03372785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963854|NCT03372785|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91963855|NCT03372785|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91963856|NCT03372785|Sympatholytics|sympatholytics|mesh-ancestor
91963857|NCT03372785|Autonomic Agents|autonomic agents|mesh-ancestor
91963858|NCT03372785|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91963859|NCT03372785|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91963860|NCT03372785|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91963861|NCT03372785|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963862|NCT03372473|Loratadine|loratadine|mesh-list
91963863|NCT03372473|Montelukast|montelukast|mesh-list
91963864|NCT03372473|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91963865|NCT03372473|Respiratory System Agents|respiratory system agents|mesh-ancestor
91963866|NCT03372473|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91963867|NCT03372473|Hormone Antagonists|hormone antagonists|mesh-ancestor
91963868|NCT03372473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963869|NCT03372473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963870|NCT03372473|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91963871|NCT03372473|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91963872|NCT03372473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963873|NCT03372473|Antipruritics|antipruritics|mesh-ancestor
91963874|NCT03372473|Dermatologic Agents|dermatologic agents|mesh-ancestor
91963875|NCT03372473|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91963876|NCT03372473|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91963877|NCT03372473|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91963878|NCT03372473|Histamine Antagonists|histamine antagonists|mesh-ancestor
91963879|NCT03372473|Histamine Agents|histamine agents|mesh-ancestor
91963880|NCT03372473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963884|NCT03289429|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91963886|NCT03289429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945013|NCT03377803|Cantharidin|cantharidin|mesh-list
91963887|NCT03289429|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91963888|NCT03289429|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91963889|NCT03289429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963890|NCT03289429|Analgesics|analgesics|mesh-ancestor
91963891|NCT03289429|Sensory System Agents|sensory system agents|mesh-ancestor
91963892|NCT03289429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963893|NCT03289429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963894|NCT03289429|Anesthetics|anesthetics|mesh-ancestor
91963895|NCT03289429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91963896|NCT03289429|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91963897|NCT03289429|Anticonvulsants|anticonvulsants|mesh-ancestor
91963898|NCT03289429|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91963899|NCT03289429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963900|NCT03289429|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91963901|NCT03289429|Tocolytic Agents|tocolytic agents|mesh-ancestor
91963902|NCT03289429|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91963903|NCT03372239|Tryptophan|tryptophan|mesh-list
91963904|NCT03372239|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91963905|NCT03372239|Antidepressive Agents|antidepressive agents|mesh-ancestor
91963906|NCT03372239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91963907|NCT03294967|Vitamin E|vitamin e|mesh-list
91963908|NCT03294967|Caffeine|caffeine|mesh-list
91963909|NCT03294967|Vitamins|vitamins|mesh-ancestor
91963910|NCT03294967|Micronutrients|micronutrients|mesh-ancestor
91963911|NCT03294967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963912|NCT03294967|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91963913|NCT03294967|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91963914|NCT03294967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963915|NCT03294967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963916|NCT03294967|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91963917|NCT03294967|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91963918|NCT03294967|Purinergic Agents|purinergic agents|mesh-ancestor
91963919|NCT03294967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963920|NCT03294967|Antioxidants|antioxidants|mesh-ancestor
91963921|NCT03294967|Protective Agents|protective agents|mesh-ancestor
91963922|NCT03371849|Montelukast|montelukast|mesh-list
91963923|NCT03371849|Levocetirizine|levocetirizine|mesh-list
91963924|NCT03371849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91963925|NCT03371849|Respiratory System Agents|respiratory system agents|mesh-ancestor
91963926|NCT03371849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91963927|NCT03371849|Hormone Antagonists|hormone antagonists|mesh-ancestor
91963928|NCT03371849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91963929|NCT03371849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963930|NCT03371849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91963931|NCT03371849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91963932|NCT03371849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963933|NCT03371849|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91963934|NCT03371849|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91963935|NCT03371849|Histamine Antagonists|histamine antagonists|mesh-ancestor
91963936|NCT03371849|Histamine Agents|histamine agents|mesh-ancestor
91963937|NCT03371849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963938|NCT04307329|Trastuzumab|trastuzumab|mesh-list
91963939|NCT04307329|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91963940|NCT04307329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963941|NCT03371069|Methylphenidate|methylphenidate|mesh-list
91963942|NCT03371069|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91963943|NCT03371069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963944|NCT03371069|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91963945|NCT03371069|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91963946|NCT03371069|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963947|NCT03371069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963948|NCT03371069|Dopamine Agents|dopamine agents|mesh-ancestor
91963949|NCT03371069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963950|NCT03294577|Cyclophosphamide|cyclophosphamide|mesh-list
91963952|NCT03294577|Doxorubicin|doxorubicin|mesh-list
91963953|NCT03294577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91963954|NCT03294577|Immunologic Factors|immunologic factors|mesh-ancestor
91963955|NCT03294577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963956|NCT03294577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963957|NCT03294577|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945014|NCT03377803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945015|NCT03377803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945017|NCT03471325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91945018|NCT03471325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945019|NCT03471325|Sympathomimetics|sympathomimetics|mesh-ancestor
91945020|NCT03471325|Autonomic Agents|autonomic agents|mesh-ancestor
91945021|NCT03471325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945022|NCT03471325|Dopamine Agents|dopamine agents|mesh-ancestor
91945023|NCT03471325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945024|NCT03471325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945025|NCT03471325|Adrenergic Agents|adrenergic agents|mesh-ancestor
91945026|NCT03471325|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91945027|NCT03471325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91945028|NCT03471325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945029|NCT03471325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91945030|NCT04844164|Cholecalciferol|cholecalciferol|mesh-list
91945031|NCT04844164|Vitamin D|vitamin d|mesh-list
91945032|NCT04844164|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945033|NCT04844164|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945034|NCT04844164|Vitamins|vitamins|mesh-ancestor
91945035|NCT04844164|Micronutrients|micronutrients|mesh-ancestor
91945036|NCT04844164|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91945037|NCT05392972|Anesthetics|anesthetics|mesh-list
91945038|NCT05392972|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945039|NCT05392972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945040|NCT03474601|Hormones|hormones|mesh-list
91945041|NCT03474601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945042|NCT03474601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945043|NCT04988308|Adalimumab|adalimumab|mesh-list
91945044|NCT04988308|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91945045|NCT04988308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91945047|NCT04984798|Vitamin E|vitamin e|mesh-list
91963958|NCT03294577|Alkylating Agents|alkylating agents|mesh-ancestor
91963959|NCT03294577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963960|NCT03294577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945049|NCT04984798|alpha-Tocopherol|alpha-tocopherol|mesh-list
91945050|NCT04984798|Vitamins|vitamins|mesh-ancestor
91945051|NCT04984798|Micronutrients|micronutrients|mesh-ancestor
91945052|NCT04984798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945053|NCT04984798|Antioxidants|antioxidants|mesh-ancestor
91945054|NCT04984798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945055|NCT04984798|Protective Agents|protective agents|mesh-ancestor
91945056|NCT02230163|Immunoglobulins|immunoglobulins|mesh-list
91945057|NCT02230163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91945058|NCT02230163|Antibodies|antibodies|mesh-list
91945059|NCT02230163|Immunologic Factors|immunologic factors|mesh-ancestor
91945060|NCT02230163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945061|NCT02230319|Paclitaxel|paclitaxel|mesh-list
91945062|NCT02230319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945063|NCT02230319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945064|NCT02230319|Tubulin Modulators|tubulin modulators|mesh-ancestor
91945065|NCT02230319|Antimitotic Agents|antimitotic agents|mesh-ancestor
91945066|NCT02230319|Mitosis Modulators|mitosis modulators|mesh-ancestor
91945067|NCT02230319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963961|NCT03294577|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91963962|NCT03294577|Tubulin Modulators|tubulin modulators|mesh-ancestor
91963963|NCT03294577|Antimitotic Agents|antimitotic agents|mesh-ancestor
91963964|NCT03294577|Mitosis Modulators|mitosis modulators|mesh-ancestor
91963965|NCT03294577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91963966|NCT03294577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91963967|NCT03294577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91963968|NCT03294577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963969|NCT03370835|Metoprolol|metoprolol|mesh-list
91963970|NCT03370835|Carvedilol|carvedilol|mesh-list
91963971|NCT03370835|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91963972|NCT03370835|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91963973|NCT03370835|Sympatholytics|sympatholytics|mesh-ancestor
91963974|NCT03370835|Autonomic Agents|autonomic agents|mesh-ancestor
91963975|NCT03370835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963976|NCT03370835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963977|NCT03370835|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91963978|NCT03370835|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91963979|NCT03370835|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91963980|NCT03370835|Adrenergic Agents|adrenergic agents|mesh-ancestor
91963981|NCT03370835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91963982|NCT03370835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963983|NCT03370835|Antioxidants|antioxidants|mesh-ancestor
91963984|NCT03370835|Protective Agents|protective agents|mesh-ancestor
91963985|NCT03370835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91963986|NCT03370835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963987|NCT03370835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91963988|NCT03370835|Vasodilator Agents|vasodilator agents|mesh-ancestor
91963989|NCT03370835|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91963990|NCT03370835|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91963991|NCT02460367|Docetaxel|docetaxel|mesh-list
91963992|NCT02460367|Tryptophan|tryptophan|mesh-list
91963993|NCT02460367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963994|NCT02460367|Tubulin Modulators|tubulin modulators|mesh-ancestor
91963995|NCT02460367|Antimitotic Agents|antimitotic agents|mesh-ancestor
91963996|NCT02460367|Mitosis Modulators|mitosis modulators|mesh-ancestor
91945068|NCT00135395|Ritonavir|ritonavir|mesh-list
91945069|NCT00135395|Lopinavir|lopinavir|mesh-list
91945070|NCT00135395|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91945071|NCT00135395|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91945072|NCT00135395|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91945073|NCT00135395|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945074|NCT00135395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945075|NCT00135395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945076|NCT00135395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91945077|NCT00135395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91945078|NCT00135395|Antiviral Agents|antiviral agents|mesh-ancestor
91963997|NCT02460367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963998|NCT02460367|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91963999|NCT02460367|Antidepressive Agents|antidepressive agents|mesh-ancestor
91964000|NCT02460367|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91964001|NCT03370601|Infliximab|infliximab|mesh-list
91964002|NCT03370601|Mercaptopurine|mercaptopurine|mesh-list
91964003|NCT03370601|Azathioprine|azathioprine|mesh-list
91964004|NCT03370601|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91964005|NCT03370601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964006|NCT03370601|Dermatologic Agents|dermatologic agents|mesh-ancestor
91964007|NCT03370601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964008|NCT03370601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91964009|NCT03370601|Antimetabolites|antimetabolites|mesh-ancestor
91964010|NCT03370601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964011|NCT03370601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91964012|NCT03370601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964013|NCT03370601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964014|NCT03370601|Immunologic Factors|immunologic factors|mesh-ancestor
91964015|NCT03370601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964016|NCT03370601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91964017|NCT03370601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964018|NCT03376529|Tazobactam|tazobactam|mesh-list
91964019|NCT03376529|Piperacillin|piperacillin|mesh-list
91964020|NCT03376529|Ceftazidime|ceftazidime|mesh-list
91964021|NCT03376529|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91964022|NCT03376529|Aztreonam|aztreonam|mesh-list
91964023|NCT03376529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91964024|NCT03376529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964027|NCT03376529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964028|NCT04132661|Bisacodyl|bisacodyl|mesh-list
91964029|NCT04132661|Cathartics|cathartics|mesh-ancestor
91964030|NCT04132661|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964031|NCT04132661|Laxatives|laxatives|mesh-ancestor
91964032|NCT03700541|Morphine|morphine|mesh-list
91964033|NCT03700541|Pirinitramide|pirinitramide|mesh-list
91964034|NCT03700541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91964035|NCT03700541|Narcotics|narcotics|mesh-ancestor
91964036|NCT03700541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964037|NCT03700541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964038|NCT03700541|Analgesics|analgesics|mesh-ancestor
91964039|NCT03700541|Sensory System Agents|sensory system agents|mesh-ancestor
91964040|NCT03700541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964041|NCT01854775|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91964042|NCT01854775|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91964043|NCT01854775|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91964044|NCT01854775|Antiviral Agents|antiviral agents|mesh-ancestor
91964045|NCT01854775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964046|NCT02460211|Vitamin D|vitamin d|mesh-list
91964047|NCT02460211|Cholecalciferol|cholecalciferol|mesh-list
91964048|NCT02460211|Vitamins|vitamins|mesh-ancestor
91964049|NCT02460211|Micronutrients|micronutrients|mesh-ancestor
91964050|NCT02460211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964051|NCT02460211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91964052|NCT02460211|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945079|NCT00135395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945080|NCT00135395|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91945081|NCT00135395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91945082|NCT02230553|Lapatinib|lapatinib|mesh-list
91945083|NCT02230553|Trametinib|trametinib|mesh-list
91945084|NCT02230553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945085|NCT02230553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91945086|NCT02230553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945087|NCT02230553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945088|NCT04261049|Triamcinolone|triamcinolone|mesh-list
91945089|NCT04261049|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91945090|NCT04261049|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91945091|NCT04261049|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91945092|NCT04261049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91945093|NCT04261049|Glucocorticoids|glucocorticoids|mesh-ancestor
91945094|NCT04261049|Hormones|hormones|mesh-ancestor
91945095|NCT04261049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945096|NCT04261049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964053|NCT03288259|Anesthetics|anesthetics|mesh-list
91964054|NCT03288259|Anesthetics, Local|anesthetics, local|mesh-list
91964055|NCT03288259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964056|NCT03288259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964057|NCT03288259|Sensory System Agents|sensory system agents|mesh-ancestor
91964058|NCT03288259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964059|NCT01653925|Dutasteride|dutasteride|mesh-list
91964060|NCT01653925|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91964061|NCT01653925|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91964062|NCT01653925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964063|NCT01653925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964064|NCT01653925|Hormone Antagonists|hormone antagonists|mesh-ancestor
91964065|NCT01653925|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964066|NCT01653925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964067|NCT02730455|Natalizumab|natalizumab|mesh-list
91964068|NCT02730455|Immunologic Factors|immunologic factors|mesh-ancestor
91964069|NCT02730455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964070|NCT03376139|Zonisamide|zonisamide|mesh-list
91964071|NCT03376139|Anticonvulsants|anticonvulsants|mesh-ancestor
91964072|NCT03376139|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91964073|NCT03376139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91964074|NCT03376139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964075|NCT03376139|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91964076|NCT03376139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964077|NCT03369119|Montelukast|montelukast|mesh-list
91964078|NCT03369119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91964079|NCT03369119|Respiratory System Agents|respiratory system agents|mesh-ancestor
91964080|NCT03369119|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91964081|NCT03369119|Hormone Antagonists|hormone antagonists|mesh-ancestor
91964082|NCT03369119|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964083|NCT03369119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964084|NCT03369119|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91964085|NCT03369119|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91964086|NCT03369119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964087|NCT03287011|Listerine|listerine|mesh-list
91945097|NCT04261049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945098|NCT04261049|Immunologic Factors|immunologic factors|mesh-ancestor
91945099|NCT04261049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945100|NCT04261049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945101|NCT00057473|Carboplatin|carboplatin|mesh-list
91945102|NCT00057473|Irinotecan|irinotecan|mesh-list
91945103|NCT00057473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945104|NCT00057473|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91945105|NCT00057473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945106|NCT00057473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945107|NCT00057473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945108|NCT00035789|Entecavir|entecavir|mesh-list
91945109|NCT00035789|Antiviral Agents|antiviral agents|mesh-ancestor
91945110|NCT00035789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945111|NCT00035633|Entecavir|entecavir|mesh-list
91945112|NCT00035633|Antiviral Agents|antiviral agents|mesh-ancestor
91945113|NCT00035633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945114|NCT00028301|Ritonavir|ritonavir|mesh-list
91945115|NCT00028301|Lopinavir|lopinavir|mesh-list
91945116|NCT00028301|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91945117|NCT00028301|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91945118|NCT00028301|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91945119|NCT00028301|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945120|NCT00028301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964088|NCT03287011|Sodium Fluoride|sodium fluoride|mesh-list
91964089|NCT03287011|Cariostatic Agents|cariostatic agents|mesh-ancestor
91964090|NCT03287011|Protective Agents|protective agents|mesh-ancestor
91964091|NCT03287011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964092|NCT03287011|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91964093|NCT03287011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964094|NCT03293641|Folic Acid|folic acid|mesh-list
91964096|NCT03293641|Penicillin V|penicillin v|mesh-list
91964100|NCT03293641|Hematinics|hematinics|mesh-ancestor
91964101|NCT03293641|Vitamin B Complex|vitamin b complex|mesh-ancestor
91964102|NCT03293641|Vitamins|vitamins|mesh-ancestor
91964103|NCT03293641|Micronutrients|micronutrients|mesh-ancestor
91964104|NCT03293641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964105|NCT03293641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964106|NCT03293641|Antisickling Agents|antisickling agents|mesh-ancestor
91964107|NCT03293641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964108|NCT03293641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964109|NCT03293641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91964110|NCT03293641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91964111|NCT03293641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964112|NCT03293641|Astringents|astringents|mesh-ancestor
91964113|NCT03293641|Dermatologic Agents|dermatologic agents|mesh-ancestor
91964114|NCT03293641|Antimalarials|antimalarials|mesh-ancestor
91964115|NCT03293641|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91964116|NCT03293641|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91964117|NCT03293641|Antimetabolites|antimetabolites|mesh-ancestor
91964118|NCT02519543|Metformin|metformin|mesh-list
91964119|NCT02519543|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91945121|NCT00028301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945122|NCT00028301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91945123|NCT00028301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91945124|NCT00028301|Antiviral Agents|antiviral agents|mesh-ancestor
91945125|NCT00028301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945126|NCT00028301|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91945127|NCT00028301|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91945128|NCT00028067|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91945129|NCT00028067|Nelfinavir|nelfinavir|mesh-list
91945130|NCT00028067|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91945131|NCT00028067|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91945132|NCT00028067|Protease Inhibitors|protease inhibitors|mesh-ancestor
91964120|NCT02519543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964121|NCT03293407|Iloprost|iloprost|mesh-list
91964122|NCT03293407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91964123|NCT03293407|Vasodilator Agents|vasodilator agents|mesh-ancestor
91964124|NCT02519699|Norepinephrine|norepinephrine|mesh-list
91964125|NCT02519699|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91964126|NCT02519699|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91964127|NCT02519699|Adrenergic Agents|adrenergic agents|mesh-ancestor
91964128|NCT02519699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964129|NCT02519699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964130|NCT02519699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964131|NCT02519699|Sympathomimetics|sympathomimetics|mesh-ancestor
91964132|NCT02519699|Autonomic Agents|autonomic agents|mesh-ancestor
91964133|NCT02519699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964134|NCT02519699|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91964135|NCT00701311|Apremilast|apremilast|mesh-list
91964136|NCT00701311|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91964137|NCT00701311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91964138|NCT00701311|Analgesics|analgesics|mesh-ancestor
91964139|NCT00701311|Sensory System Agents|sensory system agents|mesh-ancestor
91964140|NCT00701311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964141|NCT00701311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964142|NCT00701311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964143|NCT00701311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91964144|NCT00701311|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91964145|NCT00701311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91964146|NCT00701311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964147|NCT00701311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964149|NCT03375671|Ketamine|ketamine|mesh-list
91964150|NCT03375671|Haloperidol|haloperidol|mesh-list
91964151|NCT03375671|Haloperidol decanoate|haloperidol decanoate|mesh-list
91964152|NCT03375671|Analgesics|analgesics|mesh-ancestor
91964153|NCT03375671|Sensory System Agents|sensory system agents|mesh-ancestor
91964154|NCT03375671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964155|NCT03375671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964156|NCT03375671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91964157|NCT03375671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91964158|NCT03375671|Anesthetics, General|anesthetics, general|mesh-ancestor
91964159|NCT03375671|Anesthetics|anesthetics|mesh-ancestor
91964160|NCT03375671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964161|NCT03375671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91964162|NCT03375671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91964163|NCT03375671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964164|NCT03375671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964165|NCT03375671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91964166|NCT03375671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964167|NCT03375671|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91964168|NCT03375671|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91964169|NCT03375671|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91945133|NCT00028067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945134|NCT00028067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945135|NCT00028067|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91945136|NCT00028067|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91945137|NCT00028067|Antiviral Agents|antiviral agents|mesh-ancestor
91945138|NCT00028067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945139|NCT00005795|Arsenic Trioxide|arsenic trioxide|mesh-list
91945140|NCT00005795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945141|NCT00004907|Cyclophosphamide|cyclophosphamide|mesh-list
91945143|NCT00004907|Etoposide|etoposide|mesh-list
91945144|NCT00004907|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945145|NCT00004907|Immunologic Factors|immunologic factors|mesh-ancestor
91945146|NCT00004907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945147|NCT00004907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945148|NCT00004907|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91964170|NCT03375671|GABA Modulators|gaba modulators|mesh-ancestor
91964171|NCT03375671|GABA Agents|gaba agents|mesh-ancestor
91964175|NCT03375671|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91964176|NCT03375671|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91964178|NCT03375671|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91964179|NCT03375593|Acetaminophen|acetaminophen|mesh-list
91964180|NCT03375593|Ibuprofen|ibuprofen|mesh-list
91964181|NCT03375593|Oxycodone|oxycodone|mesh-list
91964182|NCT03375593|Hydrocodone|hydrocodone|mesh-list
91964183|NCT03375593|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91964184|NCT03375593|Analgesics|analgesics|mesh-ancestor
91964185|NCT03375593|Sensory System Agents|sensory system agents|mesh-ancestor
91964186|NCT03375593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964187|NCT03375593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964188|NCT03375593|Antipyretics|antipyretics|mesh-ancestor
91964189|NCT03375593|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91964190|NCT03375593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964191|NCT03375593|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91964192|NCT03375593|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91964193|NCT03375593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964194|NCT03375593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964195|NCT03375593|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91964196|NCT03375593|Narcotics|narcotics|mesh-ancestor
91964197|NCT03375593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964198|NCT03375593|Antitussive Agents|antitussive agents|mesh-ancestor
91964199|NCT03375593|Respiratory System Agents|respiratory system agents|mesh-ancestor
91964200|NCT04525235|Tolbutamide|tolbutamide|mesh-list
91964201|NCT04525235|Rifampin|rifampin|mesh-list
91964202|NCT04525235|Digoxin|digoxin|mesh-list
91964203|NCT04525235|Midazolam|midazolam|mesh-list
91964204|NCT04525235|Dextromethorphan|dextromethorphan|mesh-list
91964205|NCT04525235|Caffeine|caffeine|mesh-list
91964206|NCT04525235|Omeprazole|omeprazole|mesh-list
91964207|NCT04525235|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91964208|NCT04525235|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964209|NCT04525235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964210|NCT04525235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964211|NCT04525235|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91964212|NCT04525235|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91964213|NCT04525235|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91964214|NCT04525235|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91964215|NCT04525235|Anesthetics, General|anesthetics, general|mesh-ancestor
91964216|NCT04525235|Anesthetics|anesthetics|mesh-ancestor
91964217|NCT04525235|GABA Modulators|gaba modulators|mesh-ancestor
91964218|NCT04525235|GABA Agents|gaba agents|mesh-ancestor
91964219|NCT04525235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964220|NCT04525235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945149|NCT00004907|Alkylating Agents|alkylating agents|mesh-ancestor
91945150|NCT00004907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945151|NCT00004907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945152|NCT00004907|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91945153|NCT00004907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945154|NCT00004907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91964221|NCT04525235|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91964222|NCT04525235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91964223|NCT04525235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964224|NCT04525235|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91964225|NCT04525235|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91964226|NCT04525235|Purinergic Agents|purinergic agents|mesh-ancestor
91964227|NCT04525235|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91964228|NCT04525235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964229|NCT04525235|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91964230|NCT04525235|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91964231|NCT04525235|Antitubercular Agents|antitubercular agents|mesh-ancestor
91964232|NCT04525235|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91964233|NCT04525235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964234|NCT04525235|Leprostatic Agents|leprostatic agents|mesh-ancestor
91964235|NCT04525235|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91964236|NCT04525235|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91964237|NCT04525235|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91964238|NCT04525235|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91964239|NCT04525235|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91964240|NCT04525235|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91964241|NCT04525235|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91964242|NCT04525235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91964243|NCT04525235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91964244|NCT04525235|Protective Agents|protective agents|mesh-ancestor
91964249|NCT04525235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964250|NCT03363815|Vitamin K|vitamin k|mesh-list
91964251|NCT03363815|Metformin|metformin|mesh-list
91964252|NCT03363815|Nintedanib|nintedanib|mesh-list
91964253|NCT03363815|Digoxin|digoxin|mesh-list
91964254|NCT03363815|Midazolam|midazolam|mesh-list
91964255|NCT03363815|Omeprazole|omeprazole|mesh-list
91964256|NCT03363815|Warfarin|warfarin|mesh-list
91964257|NCT03363815|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91964258|NCT03363815|Vitamins|vitamins|mesh-ancestor
91964259|NCT03363815|Micronutrients|micronutrients|mesh-ancestor
91964260|NCT03363815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964261|NCT03363815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964262|NCT03363815|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91964263|NCT03363815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964264|NCT03363815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964265|NCT03363815|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91964266|NCT03363815|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91964267|NCT03363815|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91964268|NCT03363815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91964269|NCT03363815|Anesthetics, General|anesthetics, general|mesh-ancestor
91964271|NCT03363815|GABA Modulators|gaba modulators|mesh-ancestor
91964272|NCT03363815|GABA Agents|gaba agents|mesh-ancestor
91964273|NCT03363815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964274|NCT03363815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964275|NCT03363815|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91964276|NCT03363815|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91964277|NCT03363815|Antimetabolites|antimetabolites|mesh-ancestor
91964278|NCT03363815|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91964279|NCT03363815|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91964280|NCT03363815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964281|NCT03363815|Anticoagulants|anticoagulants|mesh-ancestor
91964282|NCT03363815|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91964283|NCT03363815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964284|NCT03363815|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91964285|NCT03363815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91964286|NCT03363815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91964287|NCT03363815|Protective Agents|protective agents|mesh-ancestor
91945156|NCT00004907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945157|NCT04469777|Epoetin Alfa|epoetin alfa|mesh-list
91945158|NCT04469777|Hematinics|hematinics|mesh-ancestor
91945159|NCT00004895|Octreotide|octreotide|mesh-list
91964288|NCT03363815|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91964289|NCT03363815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91964290|NCT03363815|Hemostatics|hemostatics|mesh-ancestor
91964291|NCT03363815|Coagulants|coagulants|mesh-ancestor
91964292|NCT03363815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964293|NCT03363815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91964294|NCT03363659|Copper|copper|mesh-list
91964295|NCT03363659|Temozolomide|temozolomide|mesh-list
91964296|NCT03363659|Disulfiram|disulfiram|mesh-list
91964297|NCT03363659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91964298|NCT03363659|Alkylating Agents|alkylating agents|mesh-ancestor
91964299|NCT03363659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964300|NCT03363659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964301|NCT03363659|Trace Elements|trace elements|mesh-ancestor
91964302|NCT03363659|Micronutrients|micronutrients|mesh-ancestor
91964303|NCT03363659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964304|NCT03363659|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91964305|NCT03363659|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
91964306|NCT03363659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964307|NCT03363425|Lidocaine|lidocaine|mesh-list
91964308|NCT03363425|Dexmedetomidine|dexmedetomidine|mesh-list
91964309|NCT03363425|Anesthetics, Local|anesthetics, local|mesh-ancestor
91964310|NCT03363425|Anesthetics|anesthetics|mesh-ancestor
91964311|NCT03363425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964312|NCT03363425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964313|NCT03363425|Sensory System Agents|sensory system agents|mesh-ancestor
91964314|NCT03363425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964315|NCT03363425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91964316|NCT03363425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91964317|NCT03363425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91964318|NCT03363425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91964320|NCT03363425|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964321|NCT03363425|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91964322|NCT03363425|Analgesics|analgesics|mesh-ancestor
91964323|NCT03363425|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91964324|NCT03363425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91964325|NCT03363425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91964326|NCT03363425|Adrenergic Agents|adrenergic agents|mesh-ancestor
91964327|NCT03363425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964328|NCT02459977|Basiliximab|basiliximab|mesh-list
91964329|NCT02459977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964330|NCT02459977|Immunologic Factors|immunologic factors|mesh-ancestor
91964331|NCT02459977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964332|NCT02519153|Sildenafil Citrate|sildenafil citrate|mesh-list
91964333|NCT02519153|Vasodilator Agents|vasodilator agents|mesh-ancestor
91964334|NCT02519153|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91964335|NCT02519153|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91964336|NCT02519153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964337|NCT02519153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964338|NCT02519153|Urological Agents|urological agents|mesh-ancestor
91964339|NCT04523987|Ciprofloxacin|ciprofloxacin|mesh-list
91964340|NCT04523987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91964341|NCT04523987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964342|NCT04523987|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91964343|NCT04523987|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91964344|NCT04523987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964345|NCT04523987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964346|NCT04523987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964347|NCT04523987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91964348|NCT04523987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91964349|NCT03363191|Fluticasone|fluticasone|mesh-list
91964352|NCT03363191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964353|NCT03363191|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91964354|NCT03363191|Autonomic Agents|autonomic agents|mesh-ancestor
91945160|NCT00004895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945161|NCT00004895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91964355|NCT03363191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964356|NCT03363191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964357|NCT03363191|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91964358|NCT03363191|Respiratory System Agents|respiratory system agents|mesh-ancestor
91964359|NCT03363191|Dermatologic Agents|dermatologic agents|mesh-ancestor
91964360|NCT03363191|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91964361|NCT03363191|Tocolytic Agents|tocolytic agents|mesh-ancestor
91964362|NCT03363191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91964363|NCT03363191|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91964364|NCT03363191|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91964365|NCT03363191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91964366|NCT03363191|Adrenergic Agents|adrenergic agents|mesh-ancestor
91964367|NCT03363191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964368|NCT03363191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964369|NCT03363113|Botulinum Toxins|botulinum toxins|mesh-list
91964370|NCT03363113|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91964371|NCT03363113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91964372|NCT03363113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964373|NCT03363113|Cholinergic Agents|cholinergic agents|mesh-ancestor
91964374|NCT03363113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964375|NCT03363113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964377|NCT03285607|Cyclophosphamide|cyclophosphamide|mesh-list
91964378|NCT03285607|Doxorubicin|doxorubicin|mesh-list
91964379|NCT03285607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91964380|NCT03285607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964381|NCT03285607|Tubulin Modulators|tubulin modulators|mesh-ancestor
91964382|NCT03285607|Antimitotic Agents|antimitotic agents|mesh-ancestor
91964383|NCT03285607|Mitosis Modulators|mitosis modulators|mesh-ancestor
91964384|NCT03285607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964385|NCT03285607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964386|NCT03285607|Immunologic Factors|immunologic factors|mesh-ancestor
91964387|NCT03285607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964388|NCT03285607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91964389|NCT03285607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91964390|NCT03285607|Alkylating Agents|alkylating agents|mesh-ancestor
91964396|NCT03298321|Azacitidine|azacitidine|mesh-list
91964397|NCT03298321|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91964398|NCT03298321|Antimetabolites|antimetabolites|mesh-ancestor
91964399|NCT03298321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964400|NCT03298321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964401|NCT03298321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964403|NCT04527055|Tetracycline|tetracycline|mesh-list
91964404|NCT04527055|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
91964407|NCT04527055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964408|NCT04527055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91964409|NCT04527055|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91964410|NCT04527055|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91964411|NCT04527055|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91964412|NCT04527055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964413|NCT04527055|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91964414|NCT04527055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964415|NCT04527055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964416|NCT04527055|Antacids|antacids|mesh-ancestor
91964417|NCT04527055|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91964418|NCT02518763|Vitamin D|vitamin d|mesh-list
91964419|NCT02518763|Ergocalciferols|ergocalciferols|mesh-list
91964420|NCT02518763|Cholecalciferol|cholecalciferol|mesh-list
91964421|NCT02518763|Vitamins|vitamins|mesh-list
91964422|NCT02518763|Micronutrients|micronutrients|mesh-ancestor
91964423|NCT02518763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964424|NCT02518763|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91964425|NCT02518763|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91964431|NCT03362411|Linrodostat|linrodostat|mesh-list
91964432|NCT03362411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964433|NCT03362411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964434|NCT02460289|Minoxidil|minoxidil|mesh-list
91945162|NCT00004895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945163|NCT00004181|Cyclophosphamide|cyclophosphamide|mesh-list
91945164|NCT00004181|Busulfan|busulfan|mesh-list
91945165|NCT00004181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945166|NCT00004181|Immunologic Factors|immunologic factors|mesh-ancestor
91945167|NCT00004181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945168|NCT00004181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945169|NCT00004181|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945170|NCT00004181|Alkylating Agents|alkylating agents|mesh-ancestor
91945171|NCT00004181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964435|NCT02460289|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91964436|NCT02460289|Vasodilator Agents|vasodilator agents|mesh-ancestor
91964437|NCT03291457|Glucocorticoids|glucocorticoids|mesh-list
91964438|NCT03291457|Hormones|hormones|mesh-ancestor
91964439|NCT03291457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964440|NCT03291457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964441|NCT03361709|Dexamethasone|dexamethasone|mesh-list
91964442|NCT03361709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964443|NCT03361709|Antiemetics|antiemetics|mesh-ancestor
91964444|NCT03361709|Autonomic Agents|autonomic agents|mesh-ancestor
91964445|NCT03361709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964446|NCT03361709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964447|NCT03361709|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964448|NCT03361709|Glucocorticoids|glucocorticoids|mesh-ancestor
91964449|NCT03361709|Hormones|hormones|mesh-ancestor
91964450|NCT03361709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964451|NCT03361709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91964452|NCT03361709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964453|NCT03284749|Copper|copper|mesh-list
91964454|NCT03284749|Trace Elements|trace elements|mesh-ancestor
91964455|NCT03284749|Micronutrients|micronutrients|mesh-ancestor
91964456|NCT03284749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964457|NCT04523675|Acetylcysteine|acetylcysteine|mesh-list
91964458|NCT04523675|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91964459|NCT04523675|Antiviral Agents|antiviral agents|mesh-ancestor
91964460|NCT04523675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964461|NCT04523675|Expectorants|expectorants|mesh-ancestor
91964462|NCT04523675|Respiratory System Agents|respiratory system agents|mesh-ancestor
91964463|NCT04523675|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91964464|NCT04523675|Antioxidants|antioxidants|mesh-ancestor
91964465|NCT04523675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964466|NCT04523675|Protective Agents|protective agents|mesh-ancestor
91964467|NCT04523675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964470|NCT03298009|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91964471|NCT03298009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964472|NCT03298009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964473|NCT03298009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964474|NCT03291145|Spironolactone|spironolactone|mesh-list
91964475|NCT03291145|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
91964476|NCT03291145|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91964477|NCT03291145|Hormone Antagonists|hormone antagonists|mesh-ancestor
91964478|NCT03291145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964479|NCT03291145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964480|NCT03291145|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91964482|NCT03291145|Natriuretic Agents|natriuretic agents|mesh-ancestor
91964483|NCT03291145|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91964484|NCT03291145|Adrenergic Agents|adrenergic agents|mesh-ancestor
91964485|NCT03291145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945176|NCT00004175|Doxorubicin|doxorubicin|mesh-list
91964486|NCT03291145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964487|NCT03297931|Iproplatin|iproplatin|mesh-list
91964488|NCT03297931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964489|NCT03284593|Azacitidine|azacitidine|mesh-list
91964490|NCT03284593|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91964491|NCT03284593|Antimetabolites|antimetabolites|mesh-ancestor
91964492|NCT03284593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964493|NCT03284593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964494|NCT03284593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964495|NCT03361397|Lidocaine|lidocaine|mesh-list
91964496|NCT03361397|Anesthetics, Local|anesthetics, local|mesh-ancestor
91964497|NCT03361397|Anesthetics|anesthetics|mesh-ancestor
91964498|NCT03361397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964499|NCT03361397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964500|NCT03361397|Sensory System Agents|sensory system agents|mesh-ancestor
91964501|NCT03361397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964502|NCT03361397|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91964503|NCT03361397|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91964504|NCT03361397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91964505|NCT03361397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91964506|NCT03361397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964507|NCT03109379|Trospium chloride|trospium chloride|mesh-list
91964508|NCT03109379|Parasympatholytics|parasympatholytics|mesh-ancestor
91964509|NCT03109379|Autonomic Agents|autonomic agents|mesh-ancestor
91964510|NCT03109379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964511|NCT03109379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964512|NCT03109379|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91964513|NCT03109379|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91964514|NCT03109379|Cholinergic Agents|cholinergic agents|mesh-ancestor
91964515|NCT03109379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964516|NCT03109379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964517|NCT03109379|Urological Agents|urological agents|mesh-ancestor
91964518|NCT03361319|Paclitaxel|paclitaxel|mesh-list
91964519|NCT03361319|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91964520|NCT03361319|Nintedanib|nintedanib|mesh-list
91964521|NCT03361319|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91964522|NCT03361319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964523|NCT03361319|Tubulin Modulators|tubulin modulators|mesh-ancestor
91964524|NCT03361319|Antimitotic Agents|antimitotic agents|mesh-ancestor
91964525|NCT03361319|Mitosis Modulators|mitosis modulators|mesh-ancestor
91964526|NCT03361319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964527|NCT03361319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91964528|NCT03361319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964529|NCT04489147|Metformin|metformin|mesh-list
91964530|NCT04489147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964531|NCT04489147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964532|NCT03365999|Tranexamic Acid|tranexamic acid|mesh-list
91964533|NCT03365999|Aminocaproic Acid|aminocaproic acid|mesh-list
91964534|NCT03365999|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91964535|NCT03365999|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91964536|NCT03365999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964537|NCT03365999|Hemostatics|hemostatics|mesh-ancestor
91964538|NCT03365999|Coagulants|coagulants|mesh-ancestor
91964539|NCT02460055|Dexamethasone|dexamethasone|mesh-list
91964545|NCT02460055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964546|NCT02460055|Antiemetics|antiemetics|mesh-ancestor
91964547|NCT02460055|Autonomic Agents|autonomic agents|mesh-ancestor
91964548|NCT02460055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964549|NCT02460055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964550|NCT02460055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964551|NCT02460055|Glucocorticoids|glucocorticoids|mesh-ancestor
92081624|NCT02076243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964553|NCT02460055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964554|NCT02460055|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91964555|NCT02460055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964556|NCT02460055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964557|NCT02460055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964558|NCT02460055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91964559|NCT02460055|Anesthetics, General|anesthetics, general|mesh-ancestor
91964561|NCT02460055|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91964562|NCT02460055|Narcotics|narcotics|mesh-ancestor
91964563|NCT02460055|Analgesics|analgesics|mesh-ancestor
91964564|NCT02460055|Sensory System Agents|sensory system agents|mesh-ancestor
91945174|NCT00004175|Cyclophosphamide|cyclophosphamide|mesh-list
91945175|NCT00004175|Docetaxel|docetaxel|mesh-list
91964565|NCT02460055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91964566|NCT02460055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91964567|NCT02460055|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91964568|NCT02460055|Antipruritics|antipruritics|mesh-ancestor
91964569|NCT02460055|Dermatologic Agents|dermatologic agents|mesh-ancestor
91964570|NCT02460055|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91964571|NCT02460055|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91964572|NCT02460055|Serotonin Agents|serotonin agents|mesh-ancestor
91964573|NCT02460055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964574|NCT02460055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964575|NCT02460055|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91964576|NCT03361163|Bromoacetylalprenololmenthane|bromoacetylalprenololmenthane|mesh-list
91964577|NCT03361163|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91964578|NCT03361163|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91964579|NCT03361163|Adrenergic Agents|adrenergic agents|mesh-ancestor
91964580|NCT03361163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964581|NCT03361163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964582|NCT03361163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964583|NCT03361163|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91964584|NCT03361163|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91964585|NCT03365765|Fluorouracil|fluorouracil|mesh-list
91964586|NCT03365765|Oxaliplatin|oxaliplatin|mesh-list
91964587|NCT03365765|Apatinib|apatinib|mesh-list
91964588|NCT03365765|Antimetabolites|antimetabolites|mesh-ancestor
91964589|NCT03365765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964590|NCT03365765|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91964591|NCT03365765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964592|NCT03365765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964593|NCT03365765|Immunologic Factors|immunologic factors|mesh-ancestor
91964594|NCT03365765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964595|NCT03365765|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91964596|NCT03365765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964597|NCT03297463|Ipilimumab|ipilimumab|mesh-list
91964598|NCT03297463|Interleukin-2|interleukin-2|mesh-list
91964599|NCT03297463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91964600|NCT03297463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964601|NCT03297463|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91964602|NCT03297463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964603|NCT03297463|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91964604|NCT03297463|Analgesics|analgesics|mesh-ancestor
91964605|NCT03297463|Sensory System Agents|sensory system agents|mesh-ancestor
91964606|NCT03297463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964607|NCT03297463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964608|NCT03282643|Heparin|heparin|mesh-list
91964609|NCT03282643|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91964612|NCT03282643|Rivaroxaban|rivaroxaban|mesh-list
91964613|NCT03282643|Anticoagulants|anticoagulants|mesh-ancestor
91964614|NCT03282643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91964615|NCT03282643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91964616|NCT03282643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964617|NCT03282643|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91964618|NCT03282643|Antithrombins|antithrombins|mesh-ancestor
91964619|NCT03282643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91964620|NCT03282643|Protease Inhibitors|protease inhibitors|mesh-ancestor
91964621|NCT03282643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964622|NCT03282487|Hydrocortisone|hydrocortisone|mesh-list
91964623|NCT03282487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964624|NCT02458729|Tranylcypromine|tranylcypromine|mesh-list
91964625|NCT02458729|Rivaroxaban|rivaroxaban|mesh-list
91964626|NCT02458729|Tranexamic Acid|tranexamic acid|mesh-list
91964627|NCT02458729|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91964628|NCT02458729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91964629|NCT02458729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964630|NCT02458729|Hemostatics|hemostatics|mesh-ancestor
91964631|NCT02458729|Coagulants|coagulants|mesh-ancestor
91964632|NCT02458729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91964633|NCT02458729|Antithrombins|antithrombins|mesh-ancestor
91945177|NCT00004175|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91945178|NCT00004175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945179|NCT00004175|Immunologic Factors|immunologic factors|mesh-ancestor
91945180|NCT00004175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945181|NCT00004175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945182|NCT00004175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91964634|NCT02458729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91964635|NCT02458729|Protease Inhibitors|protease inhibitors|mesh-ancestor
91964636|NCT02458729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964637|NCT02458729|Anticoagulants|anticoagulants|mesh-ancestor
91964638|NCT02458729|Antidepressive Agents|antidepressive agents|mesh-ancestor
91964639|NCT02458729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91964640|NCT02458729|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91964641|NCT02458729|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91964642|NCT02458729|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91964643|NCT02458729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964644|NCT02458729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964645|NCT03920527|Itraconazole|itraconazole|mesh-list
91964646|NCT03920527|Antifungal Agents|antifungal agents|mesh-ancestor
91964647|NCT03920527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964648|NCT03920527|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91964649|NCT03920527|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91964650|NCT03920527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964651|NCT03920527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964652|NCT03920527|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91964653|NCT03920527|Hormone Antagonists|hormone antagonists|mesh-ancestor
91964654|NCT03920527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964655|NCT03920527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964656|NCT03920527|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91964657|NCT03536455|Acetazolamide|acetazolamide|mesh-list
91964658|NCT03536455|Anticonvulsants|anticonvulsants|mesh-ancestor
91964659|NCT03536455|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91964660|NCT03536455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964661|NCT03536455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964662|NCT03536455|Diuretics|diuretics|mesh-ancestor
91964663|NCT03536455|Natriuretic Agents|natriuretic agents|mesh-ancestor
91964664|NCT03536455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964666|NCT03529825|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91964667|NCT03529825|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964668|NCT03529825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964669|NCT03281941|Capsaicin|capsaicin|mesh-list
91964670|NCT03281941|Antipruritics|antipruritics|mesh-ancestor
91964671|NCT03281941|Dermatologic Agents|dermatologic agents|mesh-ancestor
91964672|NCT03281941|Sensory System Agents|sensory system agents|mesh-ancestor
91964673|NCT03281941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964674|NCT03281941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964675|NCT02459509|Dexmedetomidine|dexmedetomidine|mesh-list
91964676|NCT02459509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964677|NCT02459509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964678|NCT02459509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964679|NCT02459509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91964680|NCT02459509|Analgesics|analgesics|mesh-ancestor
91964681|NCT02459509|Sensory System Agents|sensory system agents|mesh-ancestor
91964682|NCT02459509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964683|NCT02459509|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91964684|NCT02459509|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91964687|NCT02459509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964688|NCT02459509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964689|NCT03264781|CycloProvera|cycloprovera|mesh-list
91964690|NCT03264781|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91964691|NCT03264781|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91964692|NCT03264781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91964693|NCT03264781|Contraceptive Agents|contraceptive agents|mesh-ancestor
91964694|NCT03264781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91964695|NCT03264781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964696|NCT03264781|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91945183|NCT00004175|Alkylating Agents|alkylating agents|mesh-ancestor
91945184|NCT00004175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945185|NCT00004175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945186|NCT00004175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91945187|NCT00004175|Tubulin Modulators|tubulin modulators|mesh-ancestor
91964697|NCT03264781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91964699|NCT03281863|Antistreptolysin|antistreptolysin|mesh-list
91964700|NCT03281863|Immunologic Factors|immunologic factors|mesh-ancestor
91964701|NCT03281863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964702|NCT03264625|Vitamin D|vitamin d|mesh-list
91964703|NCT03264625|Cholecalciferol|cholecalciferol|mesh-list
91964704|NCT03264625|Vitamins|vitamins|mesh-ancestor
91964705|NCT03264625|Micronutrients|micronutrients|mesh-ancestor
91964706|NCT03264625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964707|NCT03264625|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91964708|NCT03264625|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91964709|NCT03269929|Midazolam|midazolam|mesh-list
91964710|NCT03269929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91964711|NCT03269929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91964712|NCT03269929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964713|NCT03269929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964714|NCT03269929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91964715|NCT03269929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91964716|NCT03269929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91964717|NCT03269929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91964718|NCT03269929|Anesthetics, General|anesthetics, general|mesh-ancestor
91964719|NCT03269929|Anesthetics|anesthetics|mesh-ancestor
91964720|NCT03269929|GABA Modulators|gaba modulators|mesh-ancestor
91964721|NCT03269929|GABA Agents|gaba agents|mesh-ancestor
91964722|NCT03269929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964723|NCT03269929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964724|NCT02730377|Liraglutide|liraglutide|mesh-list
91964726|NCT02730377|Meglitinide|meglitinide|mesh-list
91964727|NCT02730377|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91964728|NCT02730377|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
91964729|NCT02730377|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
91964730|NCT02730377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964731|NCT02730377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964732|NCT02730377|Incretins|incretins|mesh-ancestor
91964733|NCT02730377|Hormones|hormones|mesh-ancestor
91964734|NCT02730377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964735|NCT02730377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964736|NCT02730377|Protease Inhibitors|protease inhibitors|mesh-ancestor
91964737|NCT02730377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964738|NCT03264547|Paclitaxel|paclitaxel|mesh-list
91964739|NCT03264547|Docetaxel|docetaxel|mesh-list
91964740|NCT03264547|Trastuzumab|trastuzumab|mesh-list
91964741|NCT03264547|Pertuzumab|pertuzumab|mesh-list
91964742|NCT03264547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91964743|NCT03264547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964744|NCT03264547|Tubulin Modulators|tubulin modulators|mesh-ancestor
91964745|NCT03264547|Antimitotic Agents|antimitotic agents|mesh-ancestor
91964746|NCT03264547|Mitosis Modulators|mitosis modulators|mesh-ancestor
91964747|NCT03264547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964748|NCT03264547|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91964749|NCT03365141|Triamcinolone|triamcinolone|mesh-list
91964750|NCT03365141|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91964751|NCT03365141|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91964752|NCT03365141|Tacrolimus|tacrolimus|mesh-list
91964753|NCT03365141|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91964754|NCT03365141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964755|NCT03365141|Immunologic Factors|immunologic factors|mesh-ancestor
91964756|NCT03365141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964757|NCT03365141|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91964758|NCT03365141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964760|NCT03365141|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91964761|NCT03365141|Glucocorticoids|glucocorticoids|mesh-ancestor
91964762|NCT03365141|Hormones|hormones|mesh-ancestor
91945188|NCT00004175|Antimitotic Agents|antimitotic agents|mesh-ancestor
91945189|NCT00004175|Mitosis Modulators|mitosis modulators|mesh-ancestor
91964763|NCT03365141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964764|NCT03364985|Dapagliflozin|dapagliflozin|mesh-list
91964765|NCT03364985|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91964766|NCT03364985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964767|NCT03364985|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964768|NCT03364985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964769|NCT03364829|Glycopyrrolate|glycopyrrolate|mesh-list
91964770|NCT03364829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91964771|NCT03364829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91964772|NCT03364829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91964773|NCT03364829|Cholinergic Agents|cholinergic agents|mesh-ancestor
91964774|NCT03364829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964775|NCT03364829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964776|NCT03364829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964777|NCT03359837|Insulin|insulin|mesh-list
91964778|NCT03359837|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91964779|NCT03359837|Metformin|metformin|mesh-list
91964780|NCT03359837|Insulin Glargine|insulin glargine|mesh-list
91964781|NCT03359837|Insulin Aspart|insulin aspart|mesh-list
91964782|NCT03359837|Biphasic Insulins|biphasic insulins|mesh-list
91964783|NCT03359837|Acarbose|acarbose|mesh-list
91964784|NCT03359837|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
91964785|NCT03359837|Insulin glulisine|insulin glulisine|mesh-list
91964786|NCT03359837|Repaglinide|repaglinide|mesh-list
91964787|NCT03359837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964788|NCT03359837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964789|NCT03359837|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91964790|NCT03359837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964791|NCT03359837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964792|NCT03359681|Metformin|metformin|mesh-list
91964793|NCT03359681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91964794|NCT03359681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964795|NCT03359525|Tranexamic Acid|tranexamic acid|mesh-list
91964796|NCT03359525|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91964797|NCT03359525|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91964798|NCT03359525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964799|NCT03359525|Hemostatics|hemostatics|mesh-ancestor
91964800|NCT03359525|Coagulants|coagulants|mesh-ancestor
91964801|NCT03358433|Antidepressive Agents|antidepressive agents|mesh-list
91964802|NCT03358433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91964803|NCT03359291|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91964804|NCT03359291|Macitentan|macitentan|mesh-list
91964805|NCT03359291|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91964806|NCT03359291|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91964807|NCT03359291|Antimetabolites|antimetabolites|mesh-ancestor
91964808|NCT03359291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964809|NCT03359291|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91964810|NCT03359291|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91964811|NCT03359291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964812|NCT03359291|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
91964813|NCT03359291|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91964814|NCT03359291|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
91964815|NCT03358277|Methylphenidate|methylphenidate|mesh-list
91964816|NCT03358277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964817|NCT03358277|Dopamine Agents|dopamine agents|mesh-ancestor
91964818|NCT03358277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964819|NCT03358277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964820|NCT03358277|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91964821|NCT03358277|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91964822|NCT03358277|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91964823|NCT03358277|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91964825|NCT03359057|Vitamin B Complex|vitamin b complex|mesh-list
91964826|NCT03359057|Levonorgestrel|levonorgestrel|mesh-list
91964827|NCT03359057|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91964828|NCT03359057|Estradiol|estradiol|mesh-list
91964829|NCT03359057|Estrogens|estrogens|mesh-ancestor
91964830|NCT03359057|Hormones|hormones|mesh-ancestor
91964842|NCT03359057|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91964844|NCT02714569|Simvastatin|simvastatin|mesh-list
91945190|NCT00004175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91945191|NCT00004175|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91964845|NCT02714569|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91964846|NCT02714569|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91964847|NCT02714569|Antimetabolites|antimetabolites|mesh-ancestor
91964848|NCT02714569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964849|NCT02714569|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91964850|NCT02714569|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91964851|NCT02714569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964852|NCT04522037|Morphine|morphine|mesh-list
91964853|NCT04522037|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91964854|NCT04522037|Narcotics|narcotics|mesh-ancestor
91964855|NCT04522037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964856|NCT04522037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964857|NCT04522037|Analgesics|analgesics|mesh-ancestor
91964858|NCT04522037|Sensory System Agents|sensory system agents|mesh-ancestor
91964859|NCT04522037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964860|NCT03357653|Losartan|losartan|mesh-list
91964861|NCT03357653|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91964862|NCT03357653|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91964863|NCT03357653|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91964864|NCT03357653|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91964865|NCT03357653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964866|NCT04522661|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91964867|NCT04522661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964868|NCT03357575|Hyaluronic Acid|hyaluronic acid|mesh-list
91964869|NCT03357575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91964870|NCT03357575|Immunologic Factors|immunologic factors|mesh-ancestor
91964871|NCT03357575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964872|NCT03357575|Viscosupplements|viscosupplements|mesh-ancestor
91964873|NCT03357575|Protective Agents|protective agents|mesh-ancestor
91964874|NCT03280927|Efinaconazole|efinaconazole|mesh-list
91964875|NCT03280927|Antifungal Agents|antifungal agents|mesh-ancestor
91964876|NCT03280927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964877|NCT03269383|Bupivacaine|bupivacaine|mesh-list
91964878|NCT03269383|Anesthetics, Local|anesthetics, local|mesh-ancestor
91964879|NCT03269383|Anesthetics|anesthetics|mesh-ancestor
91964880|NCT03269383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964881|NCT03269383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964882|NCT03269383|Sensory System Agents|sensory system agents|mesh-ancestor
91964883|NCT03269383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964884|NCT03280849|Chitosan|chitosan|mesh-list
91964885|NCT03280849|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91964886|NCT03280849|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91964887|NCT03280849|Antimetabolites|antimetabolites|mesh-ancestor
91964888|NCT03280849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964889|NCT03280849|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91964890|NCT03280849|Chelating Agents|chelating agents|mesh-ancestor
91964891|NCT03280849|Sequestering Agents|sequestering agents|mesh-ancestor
91964892|NCT03280849|Hemostatics|hemostatics|mesh-ancestor
91964906|NCT04521491|Vitamin B Complex|vitamin b complex|mesh-ancestor
91964907|NCT04521491|Vitamins|vitamins|mesh-ancestor
91964908|NCT04521491|Micronutrients|micronutrients|mesh-ancestor
91964909|NCT04509635|Cetuximab|cetuximab|mesh-list
91964910|NCT04509635|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91964911|NCT04509635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964912|NCT04444817|Tacrolimus|tacrolimus|mesh-list
91964913|NCT04444817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964914|NCT04444817|Immunologic Factors|immunologic factors|mesh-ancestor
91964915|NCT04444817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964916|NCT04444817|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91964917|NCT04444817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964918|NCT04444817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964919|NCT03264079|Itraconazole|itraconazole|mesh-list
91964920|NCT03264079|Antifungal Agents|antifungal agents|mesh-ancestor
91964921|NCT03264079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964922|NCT03264079|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91964923|NCT03264079|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91964924|NCT03264079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964925|NCT03264079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964926|NCT03264079|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91945192|NCT00004175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945193|NCT00004175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964927|NCT03264079|Hormone Antagonists|hormone antagonists|mesh-ancestor
91964928|NCT03264079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964929|NCT03264079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964930|NCT03264079|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91964932|NCT04509323|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91964933|NCT04509323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964934|NCT04509323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964935|NCT04509323|Cholinergic Agents|cholinergic agents|mesh-ancestor
91964936|NCT04509323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91964937|NCT04509323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964938|NCT04509323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91964939|NCT04509323|Protective Agents|protective agents|mesh-ancestor
91964941|NCT04443647|Oxytocics|oxytocics|mesh-ancestor
91964942|NCT04443647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91964943|NCT04443647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964944|NCT04443881|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91964945|NCT04443881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91964946|NCT02458339|Methotrexate|methotrexate|mesh-list
91964947|NCT02458339|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91964948|NCT02458339|Abortifacient Agents|abortifacient agents|mesh-ancestor
91964949|NCT02458339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91964950|NCT02458339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964951|NCT02458339|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91964952|NCT02458339|Antimetabolites|antimetabolites|mesh-ancestor
91964953|NCT02458339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964969|NCT02456935|Esomeprazole|esomeprazole|mesh-list
91964970|NCT02456935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91964971|NCT02456935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964972|NCT02456935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91964973|NCT02456935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964974|NCT02456935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964975|NCT03280147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91964976|NCT03280147|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91964977|NCT03280147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91964978|NCT03280147|Antitubercular Agents|antitubercular agents|mesh-ancestor
91964979|NCT03263689|Morphine|morphine|mesh-list
91964980|NCT03263689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91964981|NCT03263689|Narcotics|narcotics|mesh-ancestor
91964982|NCT03263689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964983|NCT03263689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964984|NCT03263689|Analgesics|analgesics|mesh-ancestor
91964985|NCT03263689|Sensory System Agents|sensory system agents|mesh-ancestor
91964986|NCT03263689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964987|NCT03279679|Ropivacaine|ropivacaine|mesh-list
91964988|NCT03279679|Anesthetics, Local|anesthetics, local|mesh-ancestor
91964989|NCT03279679|Anesthetics|anesthetics|mesh-ancestor
91964990|NCT03279679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964991|NCT03279679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964992|NCT03279679|Sensory System Agents|sensory system agents|mesh-ancestor
91964993|NCT03279679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91964994|NCT02518451|Valsartan|valsartan|mesh-list
91964995|NCT02518451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91964996|NCT02518451|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91964997|NCT02518451|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91964998|NCT02518451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964999|NCT03263299|Aspirin|aspirin|mesh-list
91965000|NCT03263299|Cabergoline|cabergoline|mesh-list
92081625|NCT01392963|Botulinum Toxins|botulinum toxins|mesh-list
91965001|NCT03263299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965002|NCT03263299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965004|NCT03263299|Sensory System Agents|sensory system agents|mesh-ancestor
91965005|NCT03263299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965006|NCT03263299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965007|NCT03263299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965008|NCT03263299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965009|NCT03263299|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91965010|NCT03263299|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91945194|NCT05708573|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91945195|NCT05708573|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91945196|NCT05708573|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91945197|NCT05708573|Antimetabolites|antimetabolites|mesh-ancestor
91965011|NCT03263299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965012|NCT03263299|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91965020|NCT03263299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965022|NCT04444349|Coenzyme Q10|coenzyme q10|mesh-list
91965023|NCT04444349|Micronutrients|micronutrients|mesh-ancestor
91965024|NCT04444349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965025|NCT04444349|Vitamins|vitamins|mesh-ancestor
91965026|NCT03263533|Vorinostat|vorinostat|mesh-list
91965027|NCT03263533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965028|NCT03263533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91965029|NCT03263533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965030|NCT03263533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965031|NCT03123107|Ascorbic Acid|ascorbic acid|mesh-list
91965032|NCT03123107|Vitamins|vitamins|mesh-ancestor
91965033|NCT03123107|Micronutrients|micronutrients|mesh-ancestor
91965034|NCT03123107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965035|NCT03123107|Antioxidants|antioxidants|mesh-ancestor
91965036|NCT03123107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965037|NCT03123107|Protective Agents|protective agents|mesh-ancestor
91965038|NCT04516655|Rituximab|rituximab|mesh-list
91965039|NCT04516655|Methotrexate|methotrexate|mesh-list
91965040|NCT04516655|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91965041|NCT04516655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965042|NCT04516655|Immunologic Factors|immunologic factors|mesh-ancestor
91965043|NCT04516655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965044|NCT04516655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965045|NCT04516655|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91965046|NCT04516655|Abortifacient Agents|abortifacient agents|mesh-ancestor
91965047|NCT04516655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91965048|NCT04516655|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965049|NCT04516655|Antimetabolites|antimetabolites|mesh-ancestor
91965050|NCT04516655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965051|NCT04516655|Dermatologic Agents|dermatologic agents|mesh-ancestor
91965052|NCT04516655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965053|NCT04516655|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91965054|NCT04516655|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91965055|NCT04516655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91965056|NCT02458183|Vaccines|vaccines|mesh-list
91965057|NCT02458183|Immunologic Factors|immunologic factors|mesh-ancestor
91965058|NCT02458183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965059|NCT04444193|Durvalumab|durvalumab|mesh-list
91965060|NCT04444193|Lenvatinib|lenvatinib|mesh-list
91965061|NCT04444193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91965062|NCT04444193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91965063|NCT04444193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965064|NCT04444193|Immunologic Factors|immunologic factors|mesh-ancestor
91965065|NCT04444193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965066|NCT04444193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965067|NCT04444193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965068|NCT04444193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965069|NCT03984955|Mannitol|mannitol|mesh-list
91965070|NCT03984955|Hyaluronic Acid|hyaluronic acid|mesh-list
91965071|NCT03984955|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91965072|NCT03984955|Diuretics|diuretics|mesh-ancestor
91965073|NCT03984955|Natriuretic Agents|natriuretic agents|mesh-ancestor
91965074|NCT03984955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965075|NCT03984955|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91965077|NCT03984955|Viscosupplements|viscosupplements|mesh-ancestor
91965078|NCT03984955|Protective Agents|protective agents|mesh-ancestor
91965079|NCT03946969|Paclitaxel|paclitaxel|mesh-list
91965080|NCT03946969|Cisplatin|cisplatin|mesh-list
91965081|NCT03946969|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91965082|NCT03946969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965083|NCT03946969|Tubulin Modulators|tubulin modulators|mesh-ancestor
91965085|NCT03946969|Mitosis Modulators|mitosis modulators|mesh-ancestor
91965086|NCT03946969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945198|NCT05708573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945199|NCT05708573|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91945200|NCT05708573|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91945201|NCT05708573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945202|NCT00004169|Cyclophosphamide|cyclophosphamide|mesh-list
91945203|NCT00004169|Carboplatin|carboplatin|mesh-list
91945204|NCT00004169|Etoposide|etoposide|mesh-list
91945205|NCT00004169|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945206|NCT00004169|Immunologic Factors|immunologic factors|mesh-ancestor
91945207|NCT00004169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945208|NCT00004169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945209|NCT00004169|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945210|NCT00004169|Alkylating Agents|alkylating agents|mesh-ancestor
91945211|NCT00004169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945212|NCT00004169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945213|NCT00004169|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91945214|NCT00004169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945215|NCT00004169|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91945216|NCT00004169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945217|NCT00004169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945218|NCT00002429|Lamivudine|lamivudine|mesh-list
91965087|NCT03277573|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
91965088|NCT03277573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965089|NCT03277573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965091|NCT03277573|Sensory System Agents|sensory system agents|mesh-ancestor
91965092|NCT03277573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965093|NCT03277573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965094|NCT03277573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965095|NCT03277573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965096|NCT03353909|Hyaluronic Acid|hyaluronic acid|mesh-list
91965097|NCT03353909|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91965098|NCT03353909|Immunologic Factors|immunologic factors|mesh-ancestor
91965099|NCT03353909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965100|NCT03353909|Viscosupplements|viscosupplements|mesh-ancestor
91965101|NCT03353909|Protective Agents|protective agents|mesh-ancestor
91965102|NCT02459353|Dapagliflozin|dapagliflozin|mesh-list
91965103|NCT02459353|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91965104|NCT02459353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965105|NCT02459353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91965501|NCT03348527|Hormone Antagonists|hormone antagonists|mesh-ancestor
91965106|NCT02459353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965107|NCT04508231|Hormones|hormones|mesh-list
91965108|NCT04508231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965110|NCT03263065|Psyllium|psyllium|mesh-list
91965111|NCT03263065|Cathartics|cathartics|mesh-ancestor
91965112|NCT03263065|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965113|NCT02518373|Omeprazole|omeprazole|mesh-list
91965114|NCT02518373|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91965115|NCT02518373|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965116|NCT02518373|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91965117|NCT02518373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945220|NCT00002429|Didanosine|didanosine|mesh-list
91945221|NCT00002429|Stavudine|stavudine|mesh-list
91945222|NCT00002429|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
91945223|NCT00002429|Nelfinavir|nelfinavir|mesh-list
91965118|NCT02518373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965119|NCT03266965|Carbidopa|carbidopa|mesh-list
91965120|NCT03266965|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91965121|NCT03266965|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91965122|NCT03266965|Dopamine Agents|dopamine agents|mesh-ancestor
91965123|NCT03266965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965124|NCT03266965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965125|NCT03266965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965126|NCT03266965|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
91965127|NCT03266965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965128|NCT03266731|Aspirin|aspirin|mesh-list
91965129|NCT03266731|Clopidogrel|clopidogrel|mesh-list
91965130|NCT03266731|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965131|NCT03266731|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965132|NCT03266731|Analgesics|analgesics|mesh-ancestor
91965133|NCT03266731|Sensory System Agents|sensory system agents|mesh-ancestor
91965134|NCT03266731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965135|NCT03266731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965136|NCT03266731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965137|NCT03266731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965138|NCT03266731|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91965139|NCT03266731|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91965140|NCT03266731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965141|NCT03266731|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91965142|NCT03266731|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91965143|NCT03266731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965144|NCT03266731|Antipyretics|antipyretics|mesh-ancestor
91965145|NCT03266731|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91965146|NCT03266731|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91965147|NCT03266731|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91965148|NCT03266731|Purinergic Agents|purinergic agents|mesh-ancestor
91965149|NCT03266731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965150|NCT02458963|Menotropins|menotropins|mesh-list
91965151|NCT02458963|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91965152|NCT02458963|Fertility Agents|fertility agents|mesh-ancestor
91965153|NCT02458963|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91965154|NCT02458963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965155|NCT04507607|Tenofovir|tenofovir|mesh-list
91965158|NCT04507607|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91965159|NCT04507607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91965160|NCT04507607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965161|NCT04507607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965162|NCT04507607|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91965163|NCT04507607|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91965164|NCT03353441|Glycine|glycine|mesh-list
91965165|NCT03353441|Glycine Agents|glycine agents|mesh-ancestor
91965166|NCT03353441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965167|NCT03353441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965168|NCT03353441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965169|NCT03353363|Bupivacaine|bupivacaine|mesh-list
91965170|NCT03353363|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965171|NCT03353363|Anesthetics|anesthetics|mesh-ancestor
91965172|NCT03353363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965173|NCT03353363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965174|NCT03353363|Sensory System Agents|sensory system agents|mesh-ancestor
91965175|NCT03353363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965177|NCT04511195|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965178|NCT04511195|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965179|NCT04511195|Analgesics|analgesics|mesh-ancestor
91965180|NCT04511195|Sensory System Agents|sensory system agents|mesh-ancestor
91965181|NCT04511195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965182|NCT04511195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965183|NCT04511195|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91945224|NCT00002429|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91945225|NCT00002429|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91965184|NCT04511195|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965185|NCT04511195|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91965186|NCT04511195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965187|NCT04511195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965188|NCT04443725|Hydroxychloroquine|hydroxychloroquine|mesh-list
91965189|NCT04443725|Sofosbuvir|sofosbuvir|mesh-list
91965190|NCT04443725|Antimalarials|antimalarials|mesh-ancestor
91965191|NCT04443725|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91965192|NCT04443725|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91965193|NCT04443725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965194|NCT04443725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965195|NCT04443725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965196|NCT04443725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965197|NCT04443725|Antiviral Agents|antiviral agents|mesh-ancestor
91965198|NCT03262363|Curcumin|curcumin|mesh-list
91965199|NCT03262363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965200|NCT03262363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965201|NCT03262363|Analgesics|analgesics|mesh-ancestor
91965202|NCT03262363|Sensory System Agents|sensory system agents|mesh-ancestor
91965203|NCT03262363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965204|NCT03262363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965205|NCT03262363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965206|NCT03262363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965207|NCT03262363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965208|NCT03262363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965209|NCT03262363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965210|NCT04506827|Hyaluronic Acid|hyaluronic acid|mesh-list
91965211|NCT04506827|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91965212|NCT04506827|Immunologic Factors|immunologic factors|mesh-ancestor
91965213|NCT04506827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965214|NCT04506827|Viscosupplements|viscosupplements|mesh-ancestor
91965215|NCT04506827|Protective Agents|protective agents|mesh-ancestor
91965216|NCT03352895|Grape Seed Extract|grape seed extract|mesh-list
91965218|NCT03352895|Antioxidants|antioxidants|mesh-ancestor
91965219|NCT03352895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965220|NCT03352895|Protective Agents|protective agents|mesh-ancestor
91965221|NCT03352895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965222|NCT03352895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965223|NCT03352895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91965224|NCT03352895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91965225|NCT03352895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965226|NCT05074147|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91965227|NCT05074147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965228|NCT03350633|Azathioprine|azathioprine|mesh-list
91965245|NCT03350399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965247|NCT03350321|Hematinics|hematinics|mesh-ancestor
91965248|NCT03352349|Terlipressin|terlipressin|mesh-list
91965249|NCT03352349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91965250|NCT03352349|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91965251|NCT03265171|Plasminogen|plasminogen|mesh-list
91965252|NCT03265171|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91965253|NCT03265171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91965254|NCT03265171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965255|NCT04933669|Imatinib Mesylate|imatinib mesylate|mesh-list
91965256|NCT04933669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965257|NCT04933669|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965258|NCT04933669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074256|NCT00072514|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965259|NCT04933669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965260|NCT04889287|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91965261|NCT04889287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91965262|NCT04889287|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91965263|NCT04889287|Antimetabolites|antimetabolites|mesh-ancestor
91965264|NCT04889287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965265|NCT04889287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91945227|NCT00002429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945228|NCT00002429|Antiviral Agents|antiviral agents|mesh-ancestor
91945229|NCT00002429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945230|NCT00002429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91945231|NCT00002429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91945232|NCT00002429|Antimetabolites|antimetabolites|mesh-ancestor
91945233|NCT00002429|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91945234|NCT00002429|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91965266|NCT04889287|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91965267|NCT04889287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965268|NCT04669561|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91965269|NCT04669561|Lifitegrast|lifitegrast|mesh-list
91965270|NCT04669561|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91965271|NCT02729909|Lubiprostone|lubiprostone|mesh-list
91965272|NCT02729909|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91965273|NCT02729909|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965274|NCT02729909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965275|NCT03352115|Prednisolone|prednisolone|mesh-list
91965276|NCT03352115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965277|NCT03352115|Glucocorticoids|glucocorticoids|mesh-ancestor
91965278|NCT03352115|Hormones|hormones|mesh-ancestor
91965279|NCT03352115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965280|NCT03352115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965281|NCT03352115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91965282|NCT03352115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965283|NCT03252457|Dexamethasone|dexamethasone|mesh-list
91965284|NCT03252457|Hydrocortisone|hydrocortisone|mesh-list
91965285|NCT03252457|Decitabine|decitabine|mesh-list
91965296|NCT03252457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965297|NCT03252457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965298|NCT03252457|Antimetabolites|antimetabolites|mesh-ancestor
91965299|NCT03252457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965300|NCT03252457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965301|NCT03258931|Cytarabine|cytarabine|mesh-list
91965302|NCT03258931|Midostaurin|midostaurin|mesh-list
91965303|NCT03258931|Crenolanib|crenolanib|mesh-list
91965304|NCT03258931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965305|NCT03258931|Antimetabolites|antimetabolites|mesh-ancestor
91965306|NCT03258931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965307|NCT03258931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965308|NCT03258931|Antiviral Agents|antiviral agents|mesh-ancestor
91965309|NCT03258931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965310|NCT03258931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91965311|NCT03258931|Immunologic Factors|immunologic factors|mesh-ancestor
91965312|NCT03258931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965313|NCT03258931|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965314|NCT03258931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965315|NCT04506125|Chrysarobin|chrysarobin|mesh-list
91965316|NCT04506125|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965317|NCT04506125|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965318|NCT04506125|Analgesics|analgesics|mesh-ancestor
91965319|NCT04506125|Sensory System Agents|sensory system agents|mesh-ancestor
91965320|NCT04506125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965321|NCT04506125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965322|NCT04506125|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965323|NCT04506125|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965324|NCT03261349|Sofosbuvir|sofosbuvir|mesh-list
91965325|NCT03261349|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91965326|NCT03261349|Ledipasvir|ledipasvir|mesh-list
91965327|NCT03261349|Antiviral Agents|antiviral agents|mesh-ancestor
91965328|NCT03261349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965329|NCT02455609|Dexmedetomidine|dexmedetomidine|mesh-list
91965330|NCT02455609|Ketamine|ketamine|mesh-list
91965331|NCT02455609|Bupivacaine|bupivacaine|mesh-list
91965332|NCT02455609|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965333|NCT02455609|Anesthetics|anesthetics|mesh-ancestor
91945235|NCT00002429|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945236|NCT00002411|Lamivudine|lamivudine|mesh-list
91945237|NCT00002411|Zidovudine|zidovudine|mesh-list
91965334|NCT02455609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965335|NCT02455609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965336|NCT02455609|Sensory System Agents|sensory system agents|mesh-ancestor
91965337|NCT02455609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965338|NCT02455609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91965339|NCT02455609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965340|NCT02455609|Analgesics|analgesics|mesh-ancestor
91965341|NCT02455609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91965342|NCT02455609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91965343|NCT02455609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91965344|NCT02455609|Adrenergic Agents|adrenergic agents|mesh-ancestor
91965345|NCT02455609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965346|NCT02455609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965347|NCT02455609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91965348|NCT02455609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91965349|NCT02455609|Anesthetics, General|anesthetics, general|mesh-ancestor
91965357|NCT05723627|Anesthetics, General|anesthetics, general|mesh-ancestor
91965358|NCT05723627|Anesthetics|anesthetics|mesh-ancestor
91965359|NCT03349619|Resveratrol|resveratrol|mesh-list
91965360|NCT03349619|Antioxidants|antioxidants|mesh-ancestor
91965361|NCT03349619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965362|NCT03349619|Protective Agents|protective agents|mesh-ancestor
91965363|NCT03349619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965364|NCT03349619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965365|NCT03349619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91965366|NCT04505657|Celecoxib|celecoxib|mesh-list
91965367|NCT04505657|Lidocaine|lidocaine|mesh-list
91965368|NCT04505657|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965369|NCT04505657|Anesthetics|anesthetics|mesh-ancestor
91965370|NCT04505657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965371|NCT04505657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965372|NCT04505657|Sensory System Agents|sensory system agents|mesh-ancestor
91965373|NCT04505657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965374|NCT04505657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91965375|NCT04505657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91965376|NCT04505657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91965377|NCT04505657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965378|NCT04505657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965379|NCT04505657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965380|NCT04505657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965381|NCT04505657|Analgesics|analgesics|mesh-ancestor
91965382|NCT04505657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965383|NCT04505657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965384|NCT04505657|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91965385|NCT04505657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91965386|NCT04505657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965387|NCT03259243|Bupivacaine|bupivacaine|mesh-list
91965388|NCT03259243|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965389|NCT03259243|Anesthetics|anesthetics|mesh-ancestor
91965390|NCT03259243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965391|NCT03259243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965392|NCT03259243|Sensory System Agents|sensory system agents|mesh-ancestor
91965393|NCT03259243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965394|NCT03258697|Levobupivacaine|levobupivacaine|mesh-list
91965395|NCT03258697|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965396|NCT03258697|Anesthetics|anesthetics|mesh-ancestor
91965397|NCT03258697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965398|NCT03258697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965399|NCT03258697|Sensory System Agents|sensory system agents|mesh-ancestor
91965400|NCT03258697|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965401|NCT02456701|Vemurafenib|vemurafenib|mesh-list
91965402|NCT02456701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965403|NCT02456701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965404|NCT02456701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965405|NCT02456701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965406|NCT03252067|Azithromycin|azithromycin|mesh-list
91965407|NCT03252067|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91945239|NCT00002411|Stavudine|stavudine|mesh-list
91945240|NCT00002411|Nelfinavir|nelfinavir|mesh-list
91945241|NCT00002411|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91945242|NCT00002411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91965408|NCT03252067|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91965409|NCT03252067|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965410|NCT03252067|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91965411|NCT03252223|Hormones|hormones|mesh-list
91965412|NCT03252223|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91965413|NCT03252223|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965414|NCT03252223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965415|NCT05513807|Niacinamide|niacinamide|mesh-list
91965416|NCT05513807|Niacin|niacin|mesh-list
91965439|NCT03251521|Botulinum Toxins|botulinum toxins|mesh-list
91965440|NCT03251521|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91965441|NCT03251521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965442|NCT03251521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965443|NCT03251521|Cholinergic Agents|cholinergic agents|mesh-ancestor
91965444|NCT03251521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965445|NCT03251521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965446|NCT03351569|Immunoglobulins|immunoglobulins|mesh-list
91965447|NCT03351569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91965449|NCT03351569|gamma-Globulins|gamma-globulins|mesh-list
91965450|NCT03351569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91965451|NCT03351569|Immunologic Factors|immunologic factors|mesh-ancestor
91965452|NCT03351569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965453|NCT03348917|Chlorhexidine|chlorhexidine|mesh-list
91965454|NCT03348917|Povidone-Iodine|povidone-iodine|mesh-list
91965455|NCT03348917|Povidone|povidone|mesh-list
91965456|NCT03348917|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91965457|NCT03348917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965458|NCT03348917|Disinfectants|disinfectants|mesh-ancestor
91965459|NCT03348917|Plasma Substitutes|plasma substitutes|mesh-ancestor
91965460|NCT03348917|Blood Substitutes|blood substitutes|mesh-ancestor
91965461|NCT03251599|Nitroglycerin|nitroglycerin|mesh-list
91965462|NCT03251599|Vasodilator Agents|vasodilator agents|mesh-ancestor
91965463|NCT03251365|Gemcitabine|gemcitabine|mesh-list
91965464|NCT03251365|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965465|NCT03251365|Antimetabolites|antimetabolites|mesh-ancestor
91965466|NCT03251365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965467|NCT03251365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965468|NCT03251443|Apatinib|apatinib|mesh-list
91965469|NCT03251443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965472|NCT03251443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965473|NCT04502303|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91965474|NCT04502303|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91965475|NCT04502303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965476|NCT05350943|Gemcitabine|gemcitabine|mesh-list
91965477|NCT05350943|Oxaliplatin|oxaliplatin|mesh-list
91965478|NCT05350943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965479|NCT05350943|Antimetabolites|antimetabolites|mesh-ancestor
91965480|NCT05350943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965481|NCT05350943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965482|NCT03261427|Pregabalin|pregabalin|mesh-list
91965483|NCT03261427|Analgesics|analgesics|mesh-ancestor
91965484|NCT03261427|Sensory System Agents|sensory system agents|mesh-ancestor
91965485|NCT03261427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965486|NCT03261427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965487|NCT03261427|Anticonvulsants|anticonvulsants|mesh-ancestor
91965488|NCT03261427|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91965489|NCT03261427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074257|NCT00072514|Antimetabolites|antimetabolites|mesh-ancestor
91965490|NCT03261427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965491|NCT03261427|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91965492|NCT03261427|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91965493|NCT03261427|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91965494|NCT03261427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965495|NCT03261427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91965496|NCT03261115|Anesthetics|anesthetics|mesh-list
91965497|NCT03261115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945243|NCT00002411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945244|NCT00002411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945245|NCT00002411|Antiviral Agents|antiviral agents|mesh-ancestor
91945246|NCT00002411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945247|NCT00002411|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91945248|NCT00002411|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91945249|NCT00002411|Antimetabolites|antimetabolites|mesh-ancestor
91945250|NCT00002411|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91945251|NCT00002411|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91945252|NCT00002411|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945253|NCT03530033|Lidocaine|lidocaine|mesh-list
91945254|NCT03530033|Anesthetics, Local|anesthetics, local|mesh-ancestor
91945255|NCT03530033|Anesthetics|anesthetics|mesh-ancestor
91945256|NCT03530033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945257|NCT03530033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945258|NCT03530033|Sensory System Agents|sensory system agents|mesh-ancestor
91945259|NCT03530033|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945260|NCT03530033|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91945261|NCT03530033|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91945262|NCT03530033|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91945263|NCT03530033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965498|NCT03261115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965499|NCT03348527|Hydroxyflutamide|hydroxyflutamide|mesh-list
91965500|NCT03348527|Androgen Antagonists|androgen antagonists|mesh-ancestor
91965502|NCT03348527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965503|NCT03348527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965504|NCT05320133|Bismuth|bismuth|mesh-list
91965505|NCT05320133|Antacids|antacids|mesh-ancestor
91965506|NCT05320133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965507|NCT05320133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965508|NCT03122561|Acetaminophen|acetaminophen|mesh-list
91965509|NCT03122561|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965510|NCT03122561|Analgesics|analgesics|mesh-ancestor
91965511|NCT03122561|Sensory System Agents|sensory system agents|mesh-ancestor
91965512|NCT03122561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965513|NCT03122561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965514|NCT03122561|Antipyretics|antipyretics|mesh-ancestor
91965515|NCT04503629|Rabeprazole|rabeprazole|mesh-list
91965516|NCT04503629|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91965517|NCT04503629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965518|NCT04503629|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91965519|NCT04503629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965520|NCT04503629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965521|NCT03256981|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91965522|NCT03256981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965523|NCT03256981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965524|NCT03256981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965525|NCT03256903|Methoxyflurane|methoxyflurane|mesh-list
91945264|NCT03530033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945265|NCT03529643|Dexmedetomidine|dexmedetomidine|mesh-list
91945266|NCT03529643|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91965526|NCT03256903|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91965527|NCT03256903|Anesthetics, General|anesthetics, general|mesh-ancestor
91965528|NCT03256903|Anesthetics|anesthetics|mesh-ancestor
91965529|NCT03256903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965530|NCT03256903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965531|NCT03256825|Anti-Infective Agents|anti-infective agents|mesh-list
91965532|NCT03256825|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91965533|NCT03348371|Ethanol|ethanol|mesh-list
91965534|NCT03348371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91965535|NCT03348371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965536|NCT03348371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965537|NCT03348371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965539|NCT05231603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91965540|NCT05231603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965563|NCT03434041|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91965564|NCT03434041|Analgesics|analgesics|mesh-ancestor
91965565|NCT03434041|Sensory System Agents|sensory system agents|mesh-ancestor
91965566|NCT03434041|Dopamine Agents|dopamine agents|mesh-ancestor
91965567|NCT03250741|Rotigotine|rotigotine|mesh-list
91965568|NCT03250741|Dopamine Agonists|dopamine agonists|mesh-ancestor
91965569|NCT03250741|Dopamine Agents|dopamine agents|mesh-ancestor
91965570|NCT03250741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965571|NCT03250741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965572|NCT03250741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965573|NCT03255811|Apatinib|apatinib|mesh-list
91965574|NCT03255811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965575|NCT03255811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965576|NCT03255811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965577|NCT03255811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965578|NCT01842035|Regadenoson|regadenoson|mesh-list
91965579|NCT01842035|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
91965580|NCT01842035|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91965581|NCT01842035|Purinergic Agonists|purinergic agonists|mesh-ancestor
91965582|NCT01842035|Purinergic Agents|purinergic agents|mesh-ancestor
91965583|NCT01842035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965584|NCT01842035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965585|NCT01842035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965586|NCT03348059|Antiviral Agents|antiviral agents|mesh-list
91965587|NCT03348059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965588|NCT05585177|Hormones|hormones|mesh-list
91965589|NCT05585177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965590|NCT05585177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965591|NCT03250039|Abrocitinib|abrocitinib|mesh-list
91965596|NCT02517827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91965597|NCT02517827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965598|NCT02517827|Tubulin Modulators|tubulin modulators|mesh-ancestor
91965599|NCT02517827|Antimitotic Agents|antimitotic agents|mesh-ancestor
91965600|NCT02517827|Mitosis Modulators|mitosis modulators|mesh-ancestor
91965601|NCT02517827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965602|NCT05045183|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91965603|NCT05045183|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
91965604|NCT05045183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965605|NCT03246451|Metformin|metformin|mesh-list
91965606|NCT03246451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91965607|NCT03246451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965608|NCT05013437|Acetaminophen|acetaminophen|mesh-list
91965609|NCT05013437|Diphenhydramine|diphenhydramine|mesh-list
91965610|NCT05013437|Promethazine|promethazine|mesh-list
91965611|NCT05013437|Melphalan|melphalan|mesh-list
91965612|NCT05013437|Prochlorperazine|prochlorperazine|mesh-list
91965613|NCT05013437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965614|NCT05013437|Analgesics|analgesics|mesh-ancestor
91965615|NCT05013437|Sensory System Agents|sensory system agents|mesh-ancestor
91965616|NCT05013437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965617|NCT05013437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965618|NCT05013437|Antipyretics|antipyretics|mesh-ancestor
91965619|NCT05013437|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91965620|NCT05013437|Alkylating Agents|alkylating agents|mesh-ancestor
91945355|NCT03531749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945356|NCT03531749|Protective Agents|protective agents|mesh-ancestor
91945357|NCT03531749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945358|NCT03531749|Vitamins|vitamins|mesh-ancestor
91965621|NCT05013437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965622|NCT05013437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965623|NCT05013437|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91965624|NCT05013437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91965625|NCT05013437|Immunologic Factors|immunologic factors|mesh-ancestor
91965626|NCT05013437|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91965627|NCT05013437|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91965628|NCT05013437|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965629|NCT05013437|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965630|NCT05013437|Anesthetics|anesthetics|mesh-ancestor
91965631|NCT05013437|Antiemetics|antiemetics|mesh-ancestor
91965632|NCT05013437|Autonomic Agents|autonomic agents|mesh-ancestor
91965633|NCT05013437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965634|NCT05013437|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91965635|NCT05013437|Histamine Antagonists|histamine antagonists|mesh-ancestor
91965636|NCT05013437|Histamine Agents|histamine agents|mesh-ancestor
91965637|NCT05013437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965638|NCT05013437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91965639|NCT05013437|Antipruritics|antipruritics|mesh-ancestor
91965640|NCT05013437|Dermatologic Agents|dermatologic agents|mesh-ancestor
91965641|NCT05013437|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91965642|NCT05013437|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91965643|NCT05013437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91965644|NCT05013437|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91965645|NCT05013437|Dopamine Agents|dopamine agents|mesh-ancestor
91965646|NCT03246295|Insulin|insulin|mesh-list
91965647|NCT03246295|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91965648|NCT03246295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965649|NCT03346733|Psyllium|psyllium|mesh-list
91965650|NCT03346733|Cathartics|cathartics|mesh-ancestor
91965651|NCT03346733|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965652|NCT03249337|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91965653|NCT03249337|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91965654|NCT03346187|Atorvastatin|atorvastatin|mesh-list
91965655|NCT03346187|Fenofibrate|fenofibrate|mesh-list
91965656|NCT03346187|Calcium|calcium|mesh-list
91965657|NCT03346187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91965658|NCT03346187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965659|NCT03346187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91965660|NCT03346187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91965661|NCT03346187|Antimetabolites|antimetabolites|mesh-ancestor
91965662|NCT03346187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965663|NCT03346187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92090437|NCT04381858|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91965677|NCT05584631|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91965679|NCT05584631|Immunoglobulin G|immunoglobulin g|mesh-list
91965680|NCT05584631|Immunologic Factors|immunologic factors|mesh-ancestor
91965681|NCT05584631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965682|NCT03249259|Choline|choline|mesh-list
91965683|NCT03249259|Lipotropic Agents|lipotropic agents|mesh-ancestor
91965684|NCT03249259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91965685|NCT03249259|Antimetabolites|antimetabolites|mesh-ancestor
91965686|NCT03249259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965687|NCT03249259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965688|NCT03249259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91965689|NCT03249259|Nootropic Agents|nootropic agents|mesh-ancestor
91965690|NCT04487587|Olaparib|olaparib|mesh-list
91965691|NCT04487587|Cediranib|cediranib|mesh-list
91965692|NCT04487587|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91965693|NCT04487587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965694|NCT04487587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965695|NCT04487587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965696|NCT04487587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965697|NCT04833413|Insulin|insulin|mesh-list
91965698|NCT04833413|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91965699|NCT04833413|Hypoglycemic Agents|hypoglycemic agents|mesh-list
91965700|NCT04833413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965701|NCT02454751|Fentanyl|fentanyl|mesh-list
91965702|NCT02454751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91945359|NCT03531749|Micronutrients|micronutrients|mesh-ancestor
91945360|NCT03528785|Leucovorin|leucovorin|mesh-list
91945361|NCT03528785|Oxaliplatin|oxaliplatin|mesh-list
91945362|NCT03528785|Irinotecan|irinotecan|mesh-list
91945363|NCT03528785|Levoleucovorin|levoleucovorin|mesh-list
91945364|NCT03528785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945365|NCT03528785|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91945366|NCT03528785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945367|NCT03528785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945368|NCT03528785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945369|NCT03528785|Antidotes|antidotes|mesh-ancestor
91945370|NCT03528785|Protective Agents|protective agents|mesh-ancestor
91945371|NCT03528785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945372|NCT03528785|Vitamin B Complex|vitamin b complex|mesh-ancestor
91945373|NCT03528785|Vitamins|vitamins|mesh-ancestor
91945374|NCT03528785|Micronutrients|micronutrients|mesh-ancestor
91945375|NCT03531437|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91945376|NCT03531437|Gestodene|gestodene|mesh-list
91945377|NCT03531437|Estradiol|estradiol|mesh-list
91965703|NCT02454751|Narcotics|narcotics|mesh-ancestor
91965704|NCT02454751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965705|NCT02454751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965706|NCT02454751|Analgesics|analgesics|mesh-ancestor
91965707|NCT02454751|Sensory System Agents|sensory system agents|mesh-ancestor
91965708|NCT02454751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965709|NCT02454751|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91965710|NCT02454751|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91965711|NCT02454751|Anesthetics, General|anesthetics, general|mesh-ancestor
91965712|NCT02454751|Anesthetics|anesthetics|mesh-ancestor
91965713|NCT02455921|Atropine|atropine|mesh-list
91965714|NCT02455921|Neostigmine|neostigmine|mesh-list
91965715|NCT02455921|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91965716|NCT02455921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91965717|NCT02455921|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91965718|NCT02455921|Autonomic Agents|autonomic agents|mesh-ancestor
91965719|NCT02455921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965720|NCT02455921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965721|NCT02455921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91965722|NCT02455921|Respiratory System Agents|respiratory system agents|mesh-ancestor
91965723|NCT02455921|Mydriatics|mydriatics|mesh-ancestor
91965724|NCT02455921|Parasympatholytics|parasympatholytics|mesh-ancestor
91965725|NCT02455921|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91965726|NCT02455921|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91965727|NCT02455921|Cholinergic Agents|cholinergic agents|mesh-ancestor
91965730|NCT02455921|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91965731|NCT02455921|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965732|NCT02455921|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91965734|NCT04786613|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91965735|NCT04786613|Immunologic Factors|immunologic factors|mesh-ancestor
91965736|NCT04786613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965737|NCT04786613|Viscosupplements|viscosupplements|mesh-ancestor
91965738|NCT04786613|Protective Agents|protective agents|mesh-ancestor
91965739|NCT04767191|Lumefantrine|lumefantrine|mesh-list
91965740|NCT04767191|Artemether|artemether|mesh-list
91965741|NCT04767191|Piperaquine|piperaquine|mesh-list
91965742|NCT04767191|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91965743|NCT04767191|Artenimol|artenimol|mesh-list
91965744|NCT04767191|Antimalarials|antimalarials|mesh-ancestor
91965745|NCT04767191|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91965746|NCT04767191|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91965747|NCT04767191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965748|NCT00700999|Paroxetine|paroxetine|mesh-list
91945378|NCT03531437|Estrogens|estrogens|mesh-ancestor
91945379|NCT03531437|Hormones|hormones|mesh-ancestor
91945380|NCT03531437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945381|NCT03531437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945382|NCT03531437|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91945383|NCT03531437|Contraceptive Agents|contraceptive agents|mesh-ancestor
91945384|NCT03531437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91945385|NCT03531437|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91945386|NCT03531437|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91945387|NCT03531437|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91945388|NCT03531437|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91945389|NCT03531437|Progestins|progestins|mesh-ancestor
91945390|NCT03527381|Nitric Oxide|nitric oxide|mesh-list
91945391|NCT03527381|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91945392|NCT03527381|Autonomic Agents|autonomic agents|mesh-ancestor
91945393|NCT03527381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945394|NCT03527381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945395|NCT03527381|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91945396|NCT03527381|Respiratory System Agents|respiratory system agents|mesh-ancestor
91965749|NCT00700999|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91965750|NCT00700999|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91965751|NCT00700999|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965752|NCT00700999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965753|NCT00700999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965754|NCT00700999|Serotonin Agents|serotonin agents|mesh-ancestor
91965755|NCT00700999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965756|NCT00700999|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91965757|NCT00700999|Antidepressive Agents|antidepressive agents|mesh-ancestor
91965758|NCT00700999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91965759|NCT00700999|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91965760|NCT00700999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91965761|NCT00700999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965762|NCT04502771|Antifungal Agents|antifungal agents|mesh-list
91965764|NCT04502771|Miconazole|miconazole|mesh-list
91965765|NCT04502771|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965766|NCT04502771|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91965767|NCT04502771|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91965768|NCT04502771|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91965769|NCT04502771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965770|NCT04502771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965771|NCT04502771|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91965772|NCT04502771|Hormone Antagonists|hormone antagonists|mesh-ancestor
91965773|NCT04502771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965774|NCT04502771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965775|NCT04502771|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91965776|NCT04502771|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91965777|NCT04761887|Ropivacaine|ropivacaine|mesh-list
91965778|NCT04761887|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965779|NCT04761887|Anesthetics|anesthetics|mesh-ancestor
91965780|NCT04761887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945397|NCT03527381|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91945399|NCT03527381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965781|NCT04761887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965782|NCT04761887|Sensory System Agents|sensory system agents|mesh-ancestor
91965783|NCT04761887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965784|NCT03249025|Lidocaine|lidocaine|mesh-list
91965785|NCT03249025|Ketamine|ketamine|mesh-list
91965786|NCT03249025|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965787|NCT03249025|Anesthetics|anesthetics|mesh-ancestor
91965788|NCT03249025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965789|NCT03249025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965790|NCT03249025|Sensory System Agents|sensory system agents|mesh-ancestor
91965791|NCT03249025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965792|NCT03249025|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91965793|NCT03249025|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91965794|NCT03249025|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91965795|NCT03249025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965796|NCT03249025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965797|NCT03249025|Analgesics|analgesics|mesh-ancestor
91965805|NCT03248713|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91965806|NCT03248713|Abortifacient Agents|abortifacient agents|mesh-ancestor
91965807|NCT03248713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91965808|NCT03248713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965809|NCT03248713|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91965810|NCT03248713|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91965811|NCT03248713|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91965812|NCT03248713|Contraceptive Agents|contraceptive agents|mesh-ancestor
91965813|NCT03248713|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91965814|NCT03248713|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91965815|NCT03248713|Hormone Antagonists|hormone antagonists|mesh-ancestor
91965816|NCT03248713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965817|NCT03248713|Luteolytic Agents|luteolytic agents|mesh-ancestor
91965818|NCT03248713|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91965819|NCT03248713|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91965820|NCT03245671|Dexamethasone|dexamethasone|mesh-list
91965821|NCT03245671|Dexamethasone acetate|dexamethasone acetate|mesh-list
91965822|NCT03245671|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91965823|NCT03245671|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91965824|NCT03245671|BB 1101|bb 1101|mesh-list
91965825|NCT03245671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965826|NCT03245671|Antiemetics|antiemetics|mesh-ancestor
91965827|NCT03245671|Autonomic Agents|autonomic agents|mesh-ancestor
91965828|NCT03245671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965829|NCT03245671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965830|NCT03245671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965831|NCT03245671|Glucocorticoids|glucocorticoids|mesh-ancestor
91965832|NCT03245671|Hormones|hormones|mesh-ancestor
91965833|NCT03245671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965834|NCT03245671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91965835|NCT03245671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965836|NCT03245671|Protease Inhibitors|protease inhibitors|mesh-ancestor
91965837|NCT03245671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965838|NCT03245671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965839|NCT03245671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91965840|NCT03245671|Immunologic Factors|immunologic factors|mesh-ancestor
91965841|NCT03254641|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91965842|NCT03254641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91965843|NCT03254641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965844|NCT04627571|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91965845|NCT04627571|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91965846|NCT03245515|Branebrutinib|branebrutinib|mesh-list
91965847|NCT03245515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965848|NCT03245515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965849|NCT03245515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965850|NCT03363503|Fluticasone|fluticasone|mesh-list
91965851|NCT03363503|Xhance|xhance|mesh-list
91965852|NCT03363503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91965853|NCT03363503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965854|NCT03363503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91945400|NCT03527381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945401|NCT03527381|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91945402|NCT03527381|Vasodilator Agents|vasodilator agents|mesh-ancestor
91945403|NCT03527381|Gasotransmitters|gasotransmitters|mesh-ancestor
91945404|NCT03527381|Protective Agents|protective agents|mesh-ancestor
91945405|NCT04441385|Maraviroc|maraviroc|mesh-list
91945406|NCT04441385|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91945407|NCT04441385|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91945408|NCT04441385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945409|NCT04441385|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91945410|NCT04441385|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91965855|NCT03363503|Autonomic Agents|autonomic agents|mesh-ancestor
91965856|NCT03363503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965857|NCT03363503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965858|NCT03363503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91965859|NCT03363503|Respiratory System Agents|respiratory system agents|mesh-ancestor
91965860|NCT03363503|Dermatologic Agents|dermatologic agents|mesh-ancestor
91965861|NCT03363503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91965862|NCT03363503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91965863|NCT03363503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91965864|NCT03363503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91965871|NCT03248791|Bupivacaine|bupivacaine|mesh-list
91965872|NCT03248791|Anesthetics, Local|anesthetics, local|mesh-ancestor
91965873|NCT03248791|Anesthetics|anesthetics|mesh-ancestor
91965874|NCT03248791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965875|NCT03248791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965876|NCT03248791|Sensory System Agents|sensory system agents|mesh-ancestor
91965877|NCT03248791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965878|NCT03248791|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91965879|NCT03248791|Mydriatics|mydriatics|mesh-ancestor
91965880|NCT03248791|Autonomic Agents|autonomic agents|mesh-ancestor
91965881|NCT03248791|Sympathomimetics|sympathomimetics|mesh-ancestor
91965882|NCT03248791|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91965883|NCT03248791|Nasal Decongestants|nasal decongestants|mesh-ancestor
91965884|NCT03248791|Respiratory System Agents|respiratory system agents|mesh-ancestor
91965885|NCT03248791|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91965886|NCT03248791|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91965887|NCT03248791|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91965888|NCT03248791|Adrenergic Agents|adrenergic agents|mesh-ancestor
91965889|NCT03248791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965890|NCT03248791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965891|NCT03248791|Protective Agents|protective agents|mesh-ancestor
91965892|NCT03254173|Mirtazapine|mirtazapine|mesh-list
91965893|NCT03254173|Antidepressive Agents|antidepressive agents|mesh-ancestor
91965894|NCT03254173|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91965895|NCT03254173|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91965896|NCT03254173|Histamine Antagonists|histamine antagonists|mesh-ancestor
91965897|NCT03254173|Histamine Agents|histamine agents|mesh-ancestor
91965898|NCT03254173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965899|NCT03254173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965900|NCT03254173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965901|NCT03254173|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91965902|NCT03254173|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91965903|NCT03254173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965904|NCT03254173|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91965905|NCT03254173|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91965906|NCT03254173|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91965907|NCT03254173|Adrenergic Agents|adrenergic agents|mesh-ancestor
91965908|NCT03254173|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91965909|NCT03254173|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91965910|NCT03254173|Serotonin Agents|serotonin agents|mesh-ancestor
91965911|NCT03254173|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91965912|NCT03248401|Aspirin|aspirin|mesh-list
91965913|NCT03248401|Cilostazol|cilostazol|mesh-list
91965914|NCT03248401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91965915|NCT03248401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91965916|NCT03248401|Analgesics|analgesics|mesh-ancestor
91965917|NCT03248401|Sensory System Agents|sensory system agents|mesh-ancestor
91965918|NCT03248401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965919|NCT03248401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965920|NCT03248401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965921|NCT03248401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965922|NCT03248401|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91965923|NCT03248401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91965924|NCT03248401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965925|NCT03248401|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91965926|NCT03248401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91965927|NCT03248401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965928|NCT03248401|Antipyretics|antipyretics|mesh-ancestor
91965929|NCT03248401|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91965930|NCT03248401|Autonomic Agents|autonomic agents|mesh-ancestor
91965931|NCT03248401|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91965932|NCT03248401|Respiratory System Agents|respiratory system agents|mesh-ancestor
91965937|NCT03248401|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91965938|NCT02516423|Zoledronic Acid|zoledronic acid|mesh-list
91965940|NCT02516423|Lenalidomide|lenalidomide|mesh-list
91965941|NCT02516423|Ixazomib|ixazomib|mesh-list
91965942|NCT02516423|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965943|NCT02516423|Antiemetics|antiemetics|mesh-ancestor
91965944|NCT02516423|Autonomic Agents|autonomic agents|mesh-ancestor
91965945|NCT02516423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965946|NCT02516423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965947|NCT02516423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965948|NCT02516423|Glucocorticoids|glucocorticoids|mesh-ancestor
91965949|NCT02516423|Hormones|hormones|mesh-ancestor
91965950|NCT02516423|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965951|NCT02516423|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91965952|NCT02516423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965953|NCT02516423|Immunologic Factors|immunologic factors|mesh-ancestor
91965954|NCT02516423|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91965955|NCT02516423|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91965956|NCT02516423|Growth Substances|growth substances|mesh-ancestor
91965957|NCT02516423|Growth Inhibitors|growth inhibitors|mesh-ancestor
91965958|NCT02516423|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91965959|NCT02516423|Protease Inhibitors|protease inhibitors|mesh-ancestor
91965960|NCT02516423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965961|NCT02516423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965962|NCT03245281|Diuretics|diuretics|mesh-list
91965963|NCT03245281|Natriuretic Agents|natriuretic agents|mesh-ancestor
91965964|NCT03245281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965966|NCT02515955|Amphetamine|amphetamine|mesh-list
91965967|NCT02515955|Dextroamphetamine|dextroamphetamine|mesh-list
91965968|NCT02515955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91965969|NCT02515955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965970|NCT02515955|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91965971|NCT02515955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965972|NCT02515955|Sympathomimetics|sympathomimetics|mesh-ancestor
91965973|NCT02515955|Autonomic Agents|autonomic agents|mesh-ancestor
91965974|NCT02515955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965975|NCT02515955|Dopamine Agents|dopamine agents|mesh-ancestor
91965976|NCT02515955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965977|NCT02515955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965978|NCT02515955|Adrenergic Agents|adrenergic agents|mesh-ancestor
91965979|NCT02515955|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91965980|NCT02515955|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91965981|NCT02515955|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965982|NCT02515955|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91965983|NCT03345797|Testosterone|testosterone|mesh-list
91965984|NCT03345797|Androgens|androgens|mesh-ancestor
91965985|NCT03345797|Hormones|hormones|mesh-ancestor
91965986|NCT03345797|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965987|NCT03345797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965988|NCT04500743|Leuprolide|leuprolide|mesh-list
91965989|NCT04500743|Dienogest|dienogest|mesh-list
91965990|NCT04500743|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91965991|NCT04500743|Fertility Agents|fertility agents|mesh-ancestor
91965992|NCT04500743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91965993|NCT04500743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965994|NCT04500743|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91965995|NCT04500743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965996|NCT04500743|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91965997|NCT04500743|Contraceptive Agents|contraceptive agents|mesh-ancestor
91965998|NCT04500743|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91965999|NCT04500743|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91966000|NCT04500743|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91966001|NCT04500743|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91966002|NCT04500743|Hormone Antagonists|hormone antagonists|mesh-ancestor
91966004|NCT04501991|Hypoglycemic Agents|hypoglycemic agents|mesh-list
91966005|NCT04501991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966006|NCT03239353|Entecavir|entecavir|mesh-list
91966007|NCT03239353|Antiviral Agents|antiviral agents|mesh-ancestor
91966008|NCT03239353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966009|NCT03347591|polysaccharide-K|polysaccharide-k|mesh-list
91966010|NCT03347591|Hemostatics|hemostatics|mesh-list
91966011|NCT03347591|Coagulants|coagulants|mesh-ancestor
91966012|NCT03347591|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91966013|NCT03347591|Immunologic Factors|immunologic factors|mesh-ancestor
91966014|NCT03347591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966015|NCT03347591|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91966016|NCT03347591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966017|NCT03347591|Antiviral Agents|antiviral agents|mesh-ancestor
91966018|NCT03347591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966019|NCT03347591|Interferon Inducers|interferon inducers|mesh-ancestor
91966020|NCT03347591|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91966021|NCT03347591|Protective Agents|protective agents|mesh-ancestor
91966022|NCT04486651|Irinotecan|irinotecan|mesh-list
91966023|NCT04486651|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91966024|NCT04486651|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91966025|NCT04486651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966026|NCT04486651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966027|NCT04486651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966028|NCT03347513|Glycine|glycine|mesh-list
91966029|NCT03347513|Glycine Agents|glycine agents|mesh-ancestor
91966030|NCT03347513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966031|NCT03347513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966032|NCT03347513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966033|NCT04088591|Ascorbic Acid|ascorbic acid|mesh-list
91966034|NCT04088591|Antioxidants|antioxidants|mesh-ancestor
91966035|NCT04088591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966036|NCT04088591|Protective Agents|protective agents|mesh-ancestor
91966037|NCT04088591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966038|NCT04088591|Vitamins|vitamins|mesh-ancestor
91966039|NCT04088591|Micronutrients|micronutrients|mesh-ancestor
91966040|NCT04501289|Magnesium Sulfate|magnesium sulfate|mesh-list
91966041|NCT04501289|Analgesics|analgesics|mesh-ancestor
91966042|NCT04501289|Sensory System Agents|sensory system agents|mesh-ancestor
91966043|NCT04501289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966044|NCT04501289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966045|NCT04501289|Anesthetics|anesthetics|mesh-ancestor
91966046|NCT04501289|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966047|NCT04501289|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966049|NCT04501289|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91966050|NCT04501289|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91966051|NCT04501289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966052|NCT04501289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966053|NCT04501289|Tocolytic Agents|tocolytic agents|mesh-ancestor
91966054|NCT04501289|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91966055|NCT03244423|Tranexamic Acid|tranexamic acid|mesh-list
91966056|NCT03244423|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91966057|NCT03244423|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91966058|NCT03244423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966059|NCT03244423|Hemostatics|hemostatics|mesh-ancestor
91966060|NCT03244423|Coagulants|coagulants|mesh-ancestor
91966061|NCT03347357|Tacrolimus|tacrolimus|mesh-list
91966062|NCT03347357|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966063|NCT03347357|Immunologic Factors|immunologic factors|mesh-ancestor
91966064|NCT03347357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945413|NCT04441385|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91945415|NCT03531359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91966065|NCT03347357|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91966066|NCT03347357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966067|NCT03347357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966068|NCT02325349|Radiopharmaceuticals|radiopharmaceuticals|mesh-list
91966069|NCT02325349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966070|NCT02515877|Carboplatin|carboplatin|mesh-list
91966071|NCT02515877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966072|NCT03952091|Dexamethasone|dexamethasone|mesh-list
91966073|NCT03952091|Dexamethasone acetate|dexamethasone acetate|mesh-list
91966074|NCT03952091|Lenalidomide|lenalidomide|mesh-list
91966075|NCT03952091|BB 1101|bb 1101|mesh-list
91966076|NCT03952091|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91966077|NCT03952091|Antiemetics|antiemetics|mesh-ancestor
91966095|NCT03246919|Oxytocin|oxytocin|mesh-list
91966096|NCT03246919|Oxytocics|oxytocics|mesh-ancestor
91966097|NCT03246919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91966098|NCT03246919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966099|NCT04502537|Epoetin Alfa|epoetin alfa|mesh-list
91966100|NCT04502537|Hematinics|hematinics|mesh-ancestor
91966101|NCT02453659|Nicotine|nicotine|mesh-list
91966102|NCT02453659|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91966103|NCT02453659|Autonomic Agents|autonomic agents|mesh-ancestor
91966104|NCT02453659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966105|NCT02453659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966106|NCT02453659|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91966107|NCT02453659|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91966108|NCT02453659|Cholinergic Agents|cholinergic agents|mesh-ancestor
91966109|NCT02453659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966110|NCT02453659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966111|NCT02513147|Lopinavir|lopinavir|mesh-list
91966112|NCT02513147|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91966113|NCT02513147|Darunavir|darunavir|mesh-list
91966114|NCT02513147|Fosamprenavir|fosamprenavir|mesh-list
91966115|NCT02513147|Dolutegravir|dolutegravir|mesh-list
91966116|NCT02513147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91966117|NCT02513147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91966118|NCT02513147|Protease Inhibitors|protease inhibitors|mesh-ancestor
91966119|NCT02513147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966120|NCT02513147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966121|NCT02513147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91966122|NCT02513147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91966123|NCT02513147|Antiviral Agents|antiviral agents|mesh-ancestor
91966124|NCT02513147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966125|NCT02513147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91966126|NCT02513147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91966127|NCT02513147|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91966128|NCT02513147|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91966138|NCT03246685|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966139|NCT03246685|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91966140|NCT03246685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966141|NCT02453893|Risperidone|risperidone|mesh-list
91966142|NCT02453893|Iloperidone|iloperidone|mesh-list
91966143|NCT02453893|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91966144|NCT02453893|Serotonin Agents|serotonin agents|mesh-ancestor
91966145|NCT02453893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966146|NCT02453893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966147|NCT02453893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966148|NCT02453893|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91966149|NCT02453893|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91966150|NCT02453893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966151|NCT02453893|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91966152|NCT02453893|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91966153|NCT02453893|Dopamine Agents|dopamine agents|mesh-ancestor
91966155|NCT03664895|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91966156|NCT03664895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966157|NCT02513069|Nicotine|nicotine|mesh-list
91966158|NCT02513069|Carbon Monoxide|carbon monoxide|mesh-list
91966159|NCT02513069|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91966160|NCT02513069|Autonomic Agents|autonomic agents|mesh-ancestor
91966161|NCT02513069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966162|NCT02513069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945416|NCT03531359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91945417|NCT03531359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966163|NCT02513069|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91966164|NCT02513069|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91966165|NCT02513069|Cholinergic Agents|cholinergic agents|mesh-ancestor
91966166|NCT02513069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966167|NCT02513069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966169|NCT02513069|Gasotransmitters|gasotransmitters|mesh-ancestor
91966170|NCT02454205|Moxifloxacin|moxifloxacin|mesh-list
91966171|NCT02454205|Levofloxacin|levofloxacin|mesh-list
91966172|NCT02454205|Isoniazid|isoniazid|mesh-list
91966173|NCT02454205|Linezolid|linezolid|mesh-list
91966174|NCT02454205|Pyrazinamide|pyrazinamide|mesh-list
91966175|NCT02454205|Bedaquiline|bedaquiline|mesh-list
91966176|NCT02454205|Kanamycin|kanamycin|mesh-list
91966177|NCT02454205|Ethionamide|ethionamide|mesh-list
91966178|NCT02454205|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966179|NCT02454205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966180|NCT02454205|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91966181|NCT02454205|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91966182|NCT02454205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966183|NCT02454205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966184|NCT02454205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966185|NCT02454205|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91966186|NCT02454205|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91966187|NCT02454205|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91966188|NCT02454205|Antitubercular Agents|antitubercular agents|mesh-ancestor
91966189|NCT02454205|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91966190|NCT02454205|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91966191|NCT02454205|Antimetabolites|antimetabolites|mesh-ancestor
91966192|NCT02454205|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91966193|NCT02454205|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91966194|NCT03235141|Azithromycin|azithromycin|mesh-list
91966195|NCT03235141|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91966196|NCT03235141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966197|NCT03235141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966198|NCT03235141|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91966199|NCT03234751|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
91966200|NCT03234751|Natriuretic Agents|natriuretic agents|mesh-ancestor
91966201|NCT03234751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966202|NCT03107689|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
91966203|NCT03107689|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91966204|NCT03107689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91966205|NCT03234673|Calcipotriene|calcipotriene|mesh-list
91966206|NCT03234673|Tacrolimus|tacrolimus|mesh-list
91966207|NCT03234673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966208|NCT03234673|Immunologic Factors|immunologic factors|mesh-ancestor
91966209|NCT03234673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966210|NCT03234673|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91966237|NCT03238183|Viscosupplements|viscosupplements|mesh-ancestor
91966238|NCT03238183|Protective Agents|protective agents|mesh-ancestor
91966239|NCT02729051|Albuterol|albuterol|mesh-list
91966240|NCT02729051|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91966241|NCT02729051|Autonomic Agents|autonomic agents|mesh-ancestor
91966242|NCT02729051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966243|NCT02729051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966244|NCT02729051|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91966245|NCT02729051|Respiratory System Agents|respiratory system agents|mesh-ancestor
91966246|NCT02729051|Tocolytic Agents|tocolytic agents|mesh-ancestor
91966247|NCT02729051|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91966248|NCT02729051|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91966249|NCT02729051|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91966250|NCT02729051|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91966251|NCT02729051|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966252|NCT02729051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966253|NCT02729051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966254|NCT03237637|Propranolol|propranolol|mesh-list
91966255|NCT03237637|Atenolol|atenolol|mesh-list
91966256|NCT03237637|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91966257|NCT03237637|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91966261|NCT03237637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966263|NCT03237637|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91966264|NCT03237637|Vasodilator Agents|vasodilator agents|mesh-ancestor
91945418|NCT03531359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945419|NCT03531359|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91945420|NCT03531359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91945421|NCT03531359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91966265|NCT03237637|Sympatholytics|sympatholytics|mesh-ancestor
91966266|NCT03237637|Autonomic Agents|autonomic agents|mesh-ancestor
91966267|NCT03237637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966268|NCT03237637|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91966269|NCT03243331|Gedatolisib|gedatolisib|mesh-list
91966270|NCT03243331|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91966271|NCT03243331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966272|NCT03243331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966273|NCT03237715|Bilirubin|bilirubin|mesh-list
91966274|NCT03237715|Antioxidants|antioxidants|mesh-ancestor
91966275|NCT03237715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966276|NCT03237715|Protective Agents|protective agents|mesh-ancestor
91966277|NCT03237715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966278|NCT02515565|Erythromycin|erythromycin|mesh-list
91966279|NCT02515565|Erythromycin Estolate|erythromycin estolate|mesh-list
91966280|NCT02515565|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
91966281|NCT02515565|Erythromycin stearate|erythromycin stearate|mesh-list
91966282|NCT02515565|Cephalosporins|cephalosporins|mesh-list
91966283|NCT02515565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966284|NCT02515565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966285|NCT02515565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91966286|NCT02515565|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91966287|NCT02515565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966288|NCT02515565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966290|NCT05600075|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91966291|NCT05600075|Glycolic acid|glycolic acid|mesh-list
91966292|NCT05600075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966293|NCT05600075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966294|NCT05600075|Keratolytic Agents|keratolytic agents|mesh-ancestor
91966295|NCT05600075|Dermatologic Agents|dermatologic agents|mesh-ancestor
91966296|NCT02512601|Glucuronyl glucosamine glycan sulfate|glucuronyl glucosamine glycan sulfate|mesh-list
91966297|NCT02512601|Anticoagulants|anticoagulants|mesh-ancestor
91966298|NCT02512601|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91966299|NCT02512601|Antimetabolites|antimetabolites|mesh-ancestor
91966300|NCT02512601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966301|NCT02512601|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91966302|NCT02512601|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91966303|NCT02512601|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91966304|NCT02512601|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966305|NCT02512601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966306|NCT03233815|Propofol|propofol|mesh-list
91966307|NCT03233815|Sevoflurane|sevoflurane|mesh-list
91966308|NCT03233815|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91966309|NCT03233815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966310|NCT03233815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966311|NCT03233815|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91966312|NCT03233815|Anesthetics, General|anesthetics, general|mesh-ancestor
91966313|NCT03233815|Anesthetics|anesthetics|mesh-ancestor
91966388|NCT02514941|Analgesics|analgesics|mesh-ancestor
91966314|NCT03233815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91966315|NCT03233815|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91966316|NCT02507609|Rocuronium|rocuronium|mesh-list
91966317|NCT02507609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966318|NCT02507609|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91966319|NCT02507609|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91966320|NCT02507609|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91966321|NCT02507609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966322|NCT02512523|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91966323|NCT02512523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966324|NCT02512523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966325|NCT02512523|Incretins|incretins|mesh-ancestor
91966326|NCT02512523|Hormones|hormones|mesh-ancestor
91966327|NCT02512523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966328|NCT02512523|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91966331|NCT02512523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966333|NCT03233893|Calcium|calcium|mesh-list
91966334|NCT03233893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945422|NCT03531359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91945423|NCT03531359|Anesthetics, General|anesthetics, general|mesh-ancestor
91945424|NCT03531359|Anesthetics|anesthetics|mesh-ancestor
91945425|NCT03531359|GABA Modulators|gaba modulators|mesh-ancestor
91966335|NCT03233893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966336|NCT03233893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91966337|NCT05597813|Timolol|timolol|mesh-list
91966338|NCT05597813|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91966339|NCT05597813|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91966340|NCT05597813|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966341|NCT05597813|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966342|NCT05597813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966343|NCT05597813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966344|NCT05597813|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966345|NCT05597813|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91966346|NCT03242707|Hyaluronic Acid|hyaluronic acid|mesh-list
91966347|NCT03242707|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91966348|NCT03242707|Immunologic Factors|immunologic factors|mesh-ancestor
91966349|NCT03242707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966350|NCT03242707|Viscosupplements|viscosupplements|mesh-ancestor
91966351|NCT03242707|Protective Agents|protective agents|mesh-ancestor
91966352|NCT03242629|Chloral Hydrate|chloral hydrate|mesh-list
91966353|NCT03242629|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91966354|NCT03242629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966355|NCT03242629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966356|NCT02512055|Atropine|atropine|mesh-list
91966357|NCT02512055|Ketamine|ketamine|mesh-list
91966358|NCT02512055|Analgesics|analgesics|mesh-ancestor
91966359|NCT02512055|Sensory System Agents|sensory system agents|mesh-ancestor
91966360|NCT02512055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966361|NCT02512055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966362|NCT02512055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91966363|NCT02512055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91966364|NCT02512055|Anesthetics, General|anesthetics, general|mesh-ancestor
91966365|NCT02512055|Anesthetics|anesthetics|mesh-ancestor
91966366|NCT02512055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966367|NCT02512055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91966368|NCT02512055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91966369|NCT02512055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966370|NCT02512055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966371|NCT02512055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91966372|NCT02512055|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966373|NCT02512055|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91966374|NCT02512055|Autonomic Agents|autonomic agents|mesh-ancestor
91966375|NCT02512055|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91966376|NCT02512055|Respiratory System Agents|respiratory system agents|mesh-ancestor
91966377|NCT02512055|Mydriatics|mydriatics|mesh-ancestor
91966378|NCT02512055|Parasympatholytics|parasympatholytics|mesh-ancestor
91966379|NCT02512055|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91966380|NCT02512055|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91966381|NCT02512055|Cholinergic Agents|cholinergic agents|mesh-ancestor
91966382|NCT02514941|Acetaminophen|acetaminophen|mesh-list
91966383|NCT02514941|Amoxicillin|amoxicillin|mesh-list
91966384|NCT02514941|Talinolol|talinolol|mesh-list
91966385|NCT02514941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966386|NCT02514941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966387|NCT02514941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966389|NCT02514941|Sensory System Agents|sensory system agents|mesh-ancestor
91966390|NCT02514941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966391|NCT02514941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966392|NCT02514941|Antipyretics|antipyretics|mesh-ancestor
91966393|NCT02514941|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91966394|NCT02514941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91966395|NCT02514941|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966396|NCT02514941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966397|NCT02514941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966398|NCT02514941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966399|NCT02514941|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91966400|NCT02511665|Metformin|metformin|mesh-list
91966401|NCT02511665|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966404|NCT02514629|Methyltestosterone|methyltestosterone|mesh-list
91966405|NCT02514629|Testosterone|testosterone|mesh-list
91945427|NCT03531359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966406|NCT02514629|Testosterone undecanoate|testosterone undecanoate|mesh-list
91966407|NCT02514629|Testosterone enanthate|testosterone enanthate|mesh-list
91966408|NCT02514629|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
91966409|NCT02514629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966410|NCT02514629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966411|NCT02514629|Androgens|androgens|mesh-ancestor
91966412|NCT02514629|Hormones|hormones|mesh-ancestor
91966413|NCT02514629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966414|NCT02514629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91966415|NCT02514629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966416|NCT02514629|Anabolic Agents|anabolic agents|mesh-ancestor
91966417|NCT02511353|Ivermectin|ivermectin|mesh-list
91966418|NCT02511353|Piperaquine|piperaquine|mesh-list
91966419|NCT02511353|Artenimol|artenimol|mesh-list
91966420|NCT02511353|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91966421|NCT02511353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966422|NCT02511353|Antimalarials|antimalarials|mesh-ancestor
91966423|NCT02511353|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91966424|NCT03242317|Mitomycins|mitomycins|mesh-list
91966425|NCT03242317|Mitomycin|mitomycin|mesh-list
91966426|NCT03242317|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91966427|NCT03242317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966428|NCT03242317|Alkylating Agents|alkylating agents|mesh-ancestor
91966429|NCT03242317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966430|NCT03242317|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91966431|NCT03242317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966432|NCT02453503|Triamcinolone|triamcinolone|mesh-list
91966433|NCT02453503|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91966434|NCT02453503|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91966435|NCT02453503|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91966436|NCT02453503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91966437|NCT02453503|Glucocorticoids|glucocorticoids|mesh-ancestor
91966438|NCT02453503|Hormones|hormones|mesh-ancestor
91966439|NCT02453503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966440|NCT02453503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966441|NCT02453503|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966442|NCT02453503|Immunologic Factors|immunologic factors|mesh-ancestor
91966443|NCT02453503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966444|NCT02453503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966445|NCT04499885|Mineral Oil|mineral oil|mesh-list
91966446|NCT04499885|Emollients|emollients|mesh-ancestor
91966447|NCT04499885|Dermatologic Agents|dermatologic agents|mesh-ancestor
91966448|NCT02453425|Norepinephrine|norepinephrine|mesh-list
91966449|NCT02453425|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91966450|NCT02453425|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91966451|NCT02453425|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966452|NCT02453425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966453|NCT02453425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966454|NCT02453425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966455|NCT02453425|Sympathomimetics|sympathomimetics|mesh-ancestor
91966456|NCT02453425|Autonomic Agents|autonomic agents|mesh-ancestor
91966457|NCT02453425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966458|NCT02453425|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91966460|NCT03233035|Analgesics|analgesics|mesh-ancestor
91966461|NCT03233035|Sensory System Agents|sensory system agents|mesh-ancestor
91966462|NCT03233035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966463|NCT03233035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966464|NCT03233035|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91966465|NCT03233035|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91966466|NCT03233035|Anesthetics, General|anesthetics, general|mesh-ancestor
91966467|NCT03233035|Anesthetics|anesthetics|mesh-ancestor
91966468|NCT03233035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966469|NCT03233035|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91966470|NCT03233035|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91966471|NCT03233035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966472|NCT03233035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966473|NCT03242239|Trastuzumab|trastuzumab|mesh-list
91966474|NCT03242239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91966475|NCT03242239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945428|NCT03531359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945429|NCT03531281|Sirolimus|sirolimus|mesh-list
91945430|NCT03531281|Cyclophosphamide|cyclophosphamide|mesh-list
91945431|NCT03531281|Etoposide|etoposide|mesh-list
91945432|NCT03531281|Etoposide phosphate|etoposide phosphate|mesh-list
91945433|NCT03531281|Podophyllotoxin|podophyllotoxin|mesh-list
91945434|NCT03531281|Tacrolimus|tacrolimus|mesh-list
91945435|NCT03531281|Mitogens|mitogens|mesh-list
91945436|NCT03531281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945437|NCT03531281|Immunologic Factors|immunologic factors|mesh-ancestor
91945438|NCT03531281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945439|NCT03531281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945440|NCT03531281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945441|NCT03531281|Alkylating Agents|alkylating agents|mesh-ancestor
91945442|NCT03531281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945443|NCT03531281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945444|NCT03531281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91945445|NCT03531281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945446|NCT03531281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91945447|NCT03531281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945448|NCT03531281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945449|NCT03531281|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91945450|NCT03531281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966488|NCT02513849|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91966489|NCT02513849|Hormone Antagonists|hormone antagonists|mesh-ancestor
91966490|NCT02513849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966491|NCT02513849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966492|NCT02513849|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91966493|NCT02513849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966494|NCT02513849|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91966495|NCT02513849|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91966496|NCT02513849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91966497|NCT02513927|Metoprolol|metoprolol|mesh-list
91966498|NCT02513927|Nifedipine|nifedipine|mesh-list
91966499|NCT02513927|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966500|NCT02513927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91966501|NCT02513927|Sympatholytics|sympatholytics|mesh-ancestor
91966502|NCT02513927|Autonomic Agents|autonomic agents|mesh-ancestor
91966503|NCT02513927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966504|NCT02513927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966505|NCT02513927|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91966506|NCT02513927|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91966507|NCT02513927|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91966508|NCT02513927|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966509|NCT02513927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966510|NCT02513927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966511|NCT02513927|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91966512|NCT02513927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91966513|NCT02513927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966514|NCT02513927|Vasodilator Agents|vasodilator agents|mesh-ancestor
91966515|NCT02513927|Tocolytic Agents|tocolytic agents|mesh-ancestor
91966516|NCT02513927|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91966518|NCT03236623|Antipruritics|antipruritics|mesh-ancestor
91966519|NCT03236623|Dermatologic Agents|dermatologic agents|mesh-ancestor
91966520|NCT03121313|Tegafur|tegafur|mesh-list
91966521|NCT03121313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91966522|NCT03121313|Antimetabolites|antimetabolites|mesh-ancestor
91966523|NCT03121313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966524|NCT03121313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966525|NCT03236233|PC-786|pc-786|mesh-list
91966526|NCT03236233|Antiviral Agents|antiviral agents|mesh-ancestor
91966527|NCT03236233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966528|NCT03236233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966529|NCT03236233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966530|NCT02513693|Rocuronium|rocuronium|mesh-list
91966531|NCT02513693|Neostigmine|neostigmine|mesh-list
91966532|NCT02513693|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91966533|NCT02513693|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91966534|NCT02513693|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91966535|NCT02513693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966536|NCT02513693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966537|NCT02513693|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91966538|NCT02513693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966539|NCT02513693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966542|NCT02513693|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91966543|NCT02513693|Autonomic Agents|autonomic agents|mesh-ancestor
91966544|NCT03121547|Tramadol|tramadol|mesh-list
91966545|NCT03121547|Tapentadol|tapentadol|mesh-list
91966546|NCT03121547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966547|NCT03121547|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91966548|NCT03121547|Narcotics|narcotics|mesh-ancestor
91966549|NCT03121547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966550|NCT03121547|Analgesics|analgesics|mesh-ancestor
91966551|NCT03121547|Sensory System Agents|sensory system agents|mesh-ancestor
91966552|NCT03121547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966553|NCT03121547|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91966554|NCT03121547|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91966555|NCT03121547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91966556|NCT03121547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966557|NCT03121547|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966558|NCT03121547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966559|NCT03241381|Vitamin D|vitamin d|mesh-list
91966560|NCT03241381|Vitamins|vitamins|mesh-ancestor
91966561|NCT03241381|Micronutrients|micronutrients|mesh-ancestor
91966562|NCT03241381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966563|NCT03241381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91966564|NCT03241303|Acarbose|acarbose|mesh-list
91966565|NCT03241303|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91966566|NCT03241303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966567|NCT03241303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966568|NCT03241303|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966569|NCT03241303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966570|NCT02510963|Tenofovir|tenofovir|mesh-list
91966571|NCT02510963|Antiviral Agents|antiviral agents|mesh-ancestor
91966572|NCT02510963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966573|NCT02510963|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91966574|NCT02510963|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91966575|NCT02510963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966576|NCT02510963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966578|NCT02510963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91966579|NCT02513381|Vitamin D|vitamin d|mesh-list
91966580|NCT02513381|Cholecalciferol|cholecalciferol|mesh-list
91966581|NCT02513381|Vitamins|vitamins|mesh-ancestor
91966582|NCT02513381|Micronutrients|micronutrients|mesh-ancestor
91966583|NCT02513381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966584|NCT02513381|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91966585|NCT02513381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966586|NCT03235921|Nitroglycerin|nitroglycerin|mesh-list
91966587|NCT03235921|Vasodilator Agents|vasodilator agents|mesh-ancestor
91966588|NCT03232021|Pregabalin|pregabalin|mesh-list
91966589|NCT03232021|Analgesics|analgesics|mesh-ancestor
91966590|NCT03232021|Sensory System Agents|sensory system agents|mesh-ancestor
91966591|NCT03232021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966592|NCT03232021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945452|NCT03531281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91945453|NCT03531281|Antifungal Agents|antifungal agents|mesh-ancestor
91945454|NCT03531281|Mitosis Modulators|mitosis modulators|mesh-ancestor
91945455|NCT03531281|Keratolytic Agents|keratolytic agents|mesh-ancestor
91966593|NCT03232021|Anticonvulsants|anticonvulsants|mesh-ancestor
91966594|NCT03232021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91966595|NCT03232021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91966596|NCT03232021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966597|NCT03232021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966598|NCT03232021|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91966599|NCT03232021|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91966600|NCT03232021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966601|NCT03232021|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91966603|NCT03235609|Ketamine|ketamine|mesh-list
91966604|NCT03235609|Analgesics|analgesics|mesh-ancestor
91966605|NCT03235609|Sensory System Agents|sensory system agents|mesh-ancestor
91966606|NCT03235609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966607|NCT03235609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966608|NCT03235609|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91966609|NCT03235609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91966610|NCT03235609|Anesthetics, General|anesthetics, general|mesh-ancestor
91966611|NCT03235609|Anesthetics|anesthetics|mesh-ancestor
91966612|NCT03235609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090438|NCT04381858|Antibodies|antibodies|mesh-list
91966616|NCT03235609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966617|NCT03235609|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91966618|NCT03235609|Narcotics|narcotics|mesh-ancestor
91966619|NCT03235609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91966620|NCT02509949|Dexmedetomidine|dexmedetomidine|mesh-list
91966621|NCT02509949|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91966622|NCT02509949|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966623|NCT02509949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966624|NCT02509949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966625|NCT02509949|Analgesics|analgesics|mesh-ancestor
91966626|NCT02509949|Sensory System Agents|sensory system agents|mesh-ancestor
91966627|NCT02509949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966628|NCT02509949|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91966629|NCT02509949|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91966630|NCT02509949|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91966631|NCT02509949|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966632|NCT02509949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966633|NCT02509949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966634|NCT03344705|Cyclophosphamide|cyclophosphamide|mesh-list
91966635|NCT03344705|Fludarabine|fludarabine|mesh-list
91966636|NCT03344705|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966637|NCT03344705|Immunologic Factors|immunologic factors|mesh-ancestor
91966638|NCT03344705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966639|NCT03344705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91966640|NCT03344705|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91966641|NCT03344705|Alkylating Agents|alkylating agents|mesh-ancestor
91966642|NCT03344705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966643|NCT03344705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966644|NCT03344705|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91966646|NCT02501603|Afatinib|afatinib|mesh-list
91966647|NCT02501603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91966648|NCT02501603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966649|NCT02501603|Tubulin Modulators|tubulin modulators|mesh-ancestor
91966650|NCT02501603|Antimitotic Agents|antimitotic agents|mesh-ancestor
91966651|NCT02501603|Mitosis Modulators|mitosis modulators|mesh-ancestor
91966652|NCT02501603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966653|NCT02501603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91966654|NCT02501603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966655|NCT03344627|Meropenem|meropenem|mesh-list
91966656|NCT03344627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966657|NCT03344627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966658|NCT02501213|Furosemide|furosemide|mesh-list
91966659|NCT02501213|Spironolactone|spironolactone|mesh-list
91966660|NCT02501213|Diuretics|diuretics|mesh-ancestor
91966661|NCT02501213|Natriuretic Agents|natriuretic agents|mesh-ancestor
91945456|NCT03531281|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945457|NCT03531281|Tubulin Modulators|tubulin modulators|mesh-ancestor
91945458|NCT03531281|Antimitotic Agents|antimitotic agents|mesh-ancestor
91966662|NCT02501213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966663|NCT02501213|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91966664|NCT02501213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91966665|NCT02501213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966666|NCT02501213|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91966667|NCT02501213|Hormone Antagonists|hormone antagonists|mesh-ancestor
91966668|NCT02501213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966669|NCT02501213|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91966670|NCT02501291|Thalidomide|thalidomide|mesh-list
91966671|NCT02501291|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966672|NCT02501291|Immunologic Factors|immunologic factors|mesh-ancestor
91966673|NCT02501291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966674|NCT02501291|Leprostatic Agents|leprostatic agents|mesh-ancestor
91966675|NCT02501291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966676|NCT02501291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966677|NCT02501291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91966678|NCT02501291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91966679|NCT02501291|Growth Substances|growth substances|mesh-ancestor
91966680|NCT02501291|Growth Inhibitors|growth inhibitors|mesh-ancestor
91966681|NCT02501291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966682|NCT02509559|Propranolol|propranolol|mesh-list
91966684|NCT02509559|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91966685|NCT02509559|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966686|NCT02509559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966687|NCT02509559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966688|NCT02509559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966689|NCT02509559|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966690|NCT02509559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91966691|NCT02509559|Vasodilator Agents|vasodilator agents|mesh-ancestor
91966692|NCT00707993|Alogliptin|alogliptin|mesh-list
91966693|NCT00707993|Glipizide|glipizide|mesh-list
91966694|NCT00707993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966695|NCT00707993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966696|NCT00707993|Incretins|incretins|mesh-ancestor
91966697|NCT00707993|Hormones|hormones|mesh-ancestor
91966698|NCT00707993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966699|NCT00707993|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91966700|NCT00707993|Protease Inhibitors|protease inhibitors|mesh-ancestor
91966701|NCT00707993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966702|NCT00707993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966703|NCT02509091|Amikacin|amikacin|mesh-list
91966704|NCT02509091|Dimercaprol|dimercaprol|mesh-list
91966705|NCT02509091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966706|NCT02509091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966707|NCT02509091|Chelating Agents|chelating agents|mesh-ancestor
91966708|NCT02509091|Sequestering Agents|sequestering agents|mesh-ancestor
91966709|NCT02509091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966710|NCT02508857|Ketorolac|ketorolac|mesh-list
91966711|NCT02508857|Magnesium Sulfate|magnesium sulfate|mesh-list
91966712|NCT02508857|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91966713|NCT02508857|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966714|NCT02508857|Analgesics|analgesics|mesh-ancestor
91966715|NCT02508857|Sensory System Agents|sensory system agents|mesh-ancestor
91966716|NCT02508857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966717|NCT02508857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966718|NCT02508857|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91966719|NCT02508857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91966720|NCT02508857|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91966721|NCT02508857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966722|NCT02508857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966723|NCT02508857|Anesthetics|anesthetics|mesh-ancestor
91966724|NCT02508857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966725|NCT02508857|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966726|NCT02508857|Anticonvulsants|anticonvulsants|mesh-ancestor
91966727|NCT02508857|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91966728|NCT02508857|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945459|NCT04468685|Ondansetron|ondansetron|mesh-list
91945460|NCT04468685|Antiemetics|antiemetics|mesh-ancestor
91966729|NCT02508857|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966730|NCT02508857|Tocolytic Agents|tocolytic agents|mesh-ancestor
91966731|NCT02508857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91966732|NCT02508623|Rifaximin|rifaximin|mesh-list
91966733|NCT02508623|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966734|NCT02508623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966735|NCT02508623|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91966736|NCT02500667|Rifampin|rifampin|mesh-list
91966737|NCT02500667|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91966738|NCT02500667|Antitubercular Agents|antitubercular agents|mesh-ancestor
91966739|NCT02500667|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966740|NCT02500667|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966741|NCT02500667|Leprostatic Agents|leprostatic agents|mesh-ancestor
91966742|NCT02500667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91966743|NCT02500667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966744|NCT02500667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966745|NCT02500667|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91966746|NCT02500667|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91966747|NCT02500667|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91966748|NCT02500667|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91966749|NCT02500667|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91966750|NCT02500667|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91966751|NCT02500511|Vaccines|vaccines|mesh-list
91966752|NCT02500511|Immunologic Factors|immunologic factors|mesh-ancestor
91966753|NCT02500511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966754|NCT03344393|Ketamine|ketamine|mesh-list
91966758|NCT03344393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966759|NCT03344393|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91966761|NCT03344393|Anesthetics, General|anesthetics, general|mesh-ancestor
91966762|NCT03344393|Anesthetics|anesthetics|mesh-ancestor
91966763|NCT03344393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966764|NCT03344393|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91966765|NCT03344393|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91966766|NCT03344393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966767|NCT03344393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966768|NCT04498793|Paclitaxel|paclitaxel|mesh-list
91966769|NCT04498793|Cyclophosphamide|cyclophosphamide|mesh-list
91966770|NCT04498793|Doxorubicin|doxorubicin|mesh-list
91966771|NCT04498793|Epirubicin|epirubicin|mesh-list
91966772|NCT04498793|Tislelizumab|tislelizumab|mesh-list
91966773|NCT04498793|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91966774|NCT04498793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966775|NCT04498793|Tubulin Modulators|tubulin modulators|mesh-ancestor
91966776|NCT04498793|Antimitotic Agents|antimitotic agents|mesh-ancestor
91966777|NCT04498793|Mitosis Modulators|mitosis modulators|mesh-ancestor
91966778|NCT04498793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966779|NCT04498793|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966780|NCT04498793|Immunologic Factors|immunologic factors|mesh-ancestor
91966781|NCT04498793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966783|NCT04498793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91966784|NCT04498793|Alkylating Agents|alkylating agents|mesh-ancestor
91966785|NCT04498793|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91966786|NCT04498793|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91966787|NCT04498793|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91966788|NCT04498793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91966789|NCT04498793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966790|NCT04498793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91966792|NCT04498325|Immunologic Factors|immunologic factors|mesh-ancestor
91966793|NCT04498325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966794|NCT02507843|Vitamin D|vitamin d|mesh-list
91966795|NCT02507843|Cholecalciferol|cholecalciferol|mesh-list
91966796|NCT02507843|Vitamins|vitamins|mesh-ancestor
91966797|NCT02507843|Micronutrients|micronutrients|mesh-ancestor
91966798|NCT02507843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966799|NCT02507843|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91966800|NCT02507843|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966801|NCT02425891|Paclitaxel|paclitaxel|mesh-list
91966802|NCT02425891|Atezolizumab|atezolizumab|mesh-list
91966803|NCT02425891|Antibodies|antibodies|mesh-list
91966804|NCT02425891|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91945461|NCT04468685|Autonomic Agents|autonomic agents|mesh-ancestor
91966805|NCT02425891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91966806|NCT02425891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966807|NCT02425891|Tubulin Modulators|tubulin modulators|mesh-ancestor
91966808|NCT02425891|Antimitotic Agents|antimitotic agents|mesh-ancestor
91966809|NCT02425891|Mitosis Modulators|mitosis modulators|mesh-ancestor
91966810|NCT02425891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966811|NCT02425891|Immunologic Factors|immunologic factors|mesh-ancestor
91966812|NCT02425891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966813|NCT02425891|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91966814|NCT02425891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91966815|NCT02499965|Anesthetics|anesthetics|mesh-list
91966816|NCT02499965|Ethyl Chloride|ethyl chloride|mesh-list
91966817|NCT02499965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966818|NCT02499965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966819|NCT02499965|Anesthetics, Local|anesthetics, local|mesh-ancestor
91966820|NCT02499965|Sensory System Agents|sensory system agents|mesh-ancestor
91966821|NCT02499965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966822|NCT05504057|Amantadine|amantadine|mesh-list
91966823|NCT05504057|Histamine Antagonists|histamine antagonists|mesh-list
91966824|NCT05504057|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
91966825|NCT05504057|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91966826|NCT05504057|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91966830|NCT05504057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966831|NCT05504057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966832|NCT05504057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966833|NCT05504057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966834|NCT05504057|Analgesics|analgesics|mesh-ancestor
91966835|NCT05504057|Sensory System Agents|sensory system agents|mesh-ancestor
91966836|NCT05504057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966837|NCT05504057|Histamine Agents|histamine agents|mesh-ancestor
91966838|NCT03344003|Factor VIII|factor viii|mesh-list
91966840|NCT03235531|Valproic Acid|valproic acid|mesh-list
91966841|NCT03235531|Lorazepam|lorazepam|mesh-list
91966842|NCT03235531|Anticonvulsants|anticonvulsants|mesh-ancestor
91966843|NCT03235531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966844|NCT03235531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966845|NCT03235531|GABA Agents|gaba agents|mesh-ancestor
91966846|NCT03235531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966847|NCT03235531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966848|NCT03235531|Antimanic Agents|antimanic agents|mesh-ancestor
91966849|NCT03235531|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91966850|NCT03235531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966851|NCT03235531|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91966852|NCT03235531|Antiemetics|antiemetics|mesh-ancestor
91966853|NCT03235531|Autonomic Agents|autonomic agents|mesh-ancestor
91966854|NCT03235531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966855|NCT03235531|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91966856|NCT03235531|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91966857|NCT03235531|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91966858|NCT03235531|GABA Modulators|gaba modulators|mesh-ancestor
91966859|NCT02506829|Nicotine|nicotine|mesh-list
91966860|NCT02506829|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91966861|NCT02506829|Autonomic Agents|autonomic agents|mesh-ancestor
91966862|NCT02506829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966863|NCT02506829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966864|NCT02506829|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91966865|NCT02506829|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91966866|NCT02506829|Cholinergic Agents|cholinergic agents|mesh-ancestor
91966867|NCT02506829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966868|NCT02506829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966869|NCT02506439|Vitamin D|vitamin d|mesh-list
91966870|NCT02506439|Ergocalciferols|ergocalciferols|mesh-list
91966871|NCT02506439|Cholecalciferol|cholecalciferol|mesh-list
91966872|NCT02506439|Vitamins|vitamins|mesh-list
91966873|NCT02506439|Micronutrients|micronutrients|mesh-ancestor
91966874|NCT02506439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966875|NCT02506439|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91966876|NCT02506439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91966878|NCT02495519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966879|NCT02495519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91966880|NCT02495519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945462|NCT04468685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966881|NCT02495519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966882|NCT02499341|Ketamine|ketamine|mesh-list
91966883|NCT02499341|Tramadol|tramadol|mesh-list
91966884|NCT02499341|Analgesics|analgesics|mesh-ancestor
91966885|NCT02499341|Sensory System Agents|sensory system agents|mesh-ancestor
91966886|NCT02499341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966887|NCT02499341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966888|NCT02499341|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91966889|NCT02499341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91966890|NCT02499341|Anesthetics, General|anesthetics, general|mesh-ancestor
91966891|NCT02499341|Anesthetics|anesthetics|mesh-ancestor
91966892|NCT02499341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966893|NCT02499341|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91966894|NCT02499341|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91966895|NCT02499341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966896|NCT02499341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966897|NCT02499341|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91966898|NCT02499341|Narcotics|narcotics|mesh-ancestor
91966899|NCT02495285|Polygeline|polygeline|mesh-list
91966900|NCT02495285|Plasma Substitutes|plasma substitutes|mesh-ancestor
91966901|NCT02495285|Blood Substitutes|blood substitutes|mesh-ancestor
91966904|NCT02495363|Anesthetics|anesthetics|mesh-ancestor
91966905|NCT02495363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966906|NCT02495363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966907|NCT02495363|Sensory System Agents|sensory system agents|mesh-ancestor
91966908|NCT02495363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966909|NCT03121079|Interferons|interferons|mesh-list
91966910|NCT03121079|Interferon-alpha|interferon-alpha|mesh-list
91966911|NCT03121079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966912|NCT03121079|Antiviral Agents|antiviral agents|mesh-ancestor
91966913|NCT03121079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966914|NCT03121079|Immunologic Factors|immunologic factors|mesh-ancestor
91966915|NCT03121079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966917|NCT02494973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966919|NCT02494895|Ticagrelor|ticagrelor|mesh-list
91966920|NCT02494895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91966921|NCT02494895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966922|NCT02494895|Analgesics|analgesics|mesh-ancestor
91966923|NCT02494895|Sensory System Agents|sensory system agents|mesh-ancestor
91966924|NCT02494895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966925|NCT02494895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966926|NCT02494895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91966927|NCT02494895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91966928|NCT02494895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91966929|NCT02494895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91966930|NCT02494895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966931|NCT02494895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91966932|NCT02494895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91966933|NCT02494895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966935|NCT02494895|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91966936|NCT02494895|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91966937|NCT02494895|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91966938|NCT02494895|Purinergic Agents|purinergic agents|mesh-ancestor
91966939|NCT02494895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966940|NCT03341741|Tobramycin|tobramycin|mesh-list
91966941|NCT03341741|Colistin|colistin|mesh-list
91966942|NCT03341741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966943|NCT03341741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966944|NCT01597245|Etanercept|etanercept|mesh-list
91966945|NCT01597245|Ixekizumab|ixekizumab|mesh-list
91966946|NCT01597245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91966947|NCT01597245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966948|NCT01597245|Analgesics|analgesics|mesh-ancestor
91966949|NCT01597245|Sensory System Agents|sensory system agents|mesh-ancestor
91966950|NCT01597245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966951|NCT01597245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966952|NCT01597245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91966953|NCT01597245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91966954|NCT01597245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945463|NCT04468685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945464|NCT04468685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945465|NCT04468685|Antipruritics|antipruritics|mesh-ancestor
91966955|NCT01597245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91966956|NCT01597245|Immunologic Factors|immunologic factors|mesh-ancestor
91966957|NCT01597245|Dermatologic Agents|dermatologic agents|mesh-ancestor
91966958|NCT03341429|Liraglutide|liraglutide|mesh-list
91966959|NCT03341429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91966960|NCT03341429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966961|NCT03341429|Incretins|incretins|mesh-ancestor
91966962|NCT03341429|Hormones|hormones|mesh-ancestor
91966963|NCT03341429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966964|NCT04494659|Rifampin|rifampin|mesh-list
91966965|NCT04494659|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91966966|NCT04494659|Antitubercular Agents|antitubercular agents|mesh-ancestor
91966967|NCT04494659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966968|NCT04494659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966969|NCT04494659|Leprostatic Agents|leprostatic agents|mesh-ancestor
91966970|NCT04494659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91966971|NCT04494659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966972|NCT04494659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966973|NCT04494659|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91966974|NCT04494659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91966977|NCT04494659|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91966978|NCT04494659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91966979|NCT03342599|Thioctic Acid|thioctic acid|mesh-list
91966980|NCT03342599|Antioxidants|antioxidants|mesh-ancestor
91966981|NCT03342599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966982|NCT03342599|Protective Agents|protective agents|mesh-ancestor
91966983|NCT03342599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966984|NCT03342599|Vitamin B Complex|vitamin b complex|mesh-ancestor
91966986|NCT03342599|Micronutrients|micronutrients|mesh-ancestor
91966987|NCT03341117|Aspirin|aspirin|mesh-list
91966988|NCT03341117|Magnesium Oxide|magnesium oxide|mesh-list
91966989|NCT03341117|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91966990|NCT03341117|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91966991|NCT03341117|Analgesics|analgesics|mesh-ancestor
91966992|NCT03341117|Sensory System Agents|sensory system agents|mesh-ancestor
91966993|NCT03341117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966994|NCT03341117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966995|NCT03341117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91966996|NCT03341117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91966997|NCT03341117|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91966998|NCT03341117|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91966999|NCT03341117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967000|NCT03341117|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91967001|NCT03341117|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967002|NCT03341117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967004|NCT03341117|Antacids|antacids|mesh-ancestor
91967005|NCT03341117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967006|NCT02498171|Fentanyl|fentanyl|mesh-list
91967007|NCT02498171|Morphine|morphine|mesh-list
91967008|NCT02498171|Bupivacaine|bupivacaine|mesh-list
91967009|NCT02498171|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967010|NCT02498171|Anesthetics|anesthetics|mesh-ancestor
91967011|NCT02498171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967012|NCT02498171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967013|NCT02498171|Sensory System Agents|sensory system agents|mesh-ancestor
91967014|NCT02498171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967015|NCT02498171|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967016|NCT02498171|Narcotics|narcotics|mesh-ancestor
91967017|NCT02498171|Analgesics|analgesics|mesh-ancestor
91967018|NCT02498171|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91967019|NCT02498171|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91967020|NCT02498171|Anesthetics, General|anesthetics, general|mesh-ancestor
91967021|NCT03120533|Treprostinil|treprostinil|mesh-list
91967022|NCT03120533|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91967023|NCT03342443|Memantine|memantine|mesh-list
91967024|NCT03342443|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91967025|NCT03342443|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91967026|NCT03342443|Dopamine Agents|dopamine agents|mesh-ancestor
91945466|NCT04468685|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945467|NCT04468685|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91945468|NCT04468685|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91967027|NCT03342443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967028|NCT03342443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967029|NCT03342443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967030|NCT03342443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91967031|NCT03342443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91967032|NCT05035485|Phenylephrine|phenylephrine|mesh-list
91967033|NCT05035485|Oxymetazoline|oxymetazoline|mesh-list
91967034|NCT05035485|Norepinephrine|norepinephrine|mesh-list
91967035|NCT05035485|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91967036|NCT05035485|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91967037|NCT05035485|Mydriatics|mydriatics|mesh-ancestor
91967038|NCT05035485|Autonomic Agents|autonomic agents|mesh-ancestor
91967039|NCT05035485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967040|NCT05035485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967041|NCT05035485|Sympathomimetics|sympathomimetics|mesh-ancestor
91967042|NCT05035485|Nasal Decongestants|nasal decongestants|mesh-ancestor
91967043|NCT05035485|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967044|NCT05035485|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91967045|NCT05035485|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91967046|NCT05035485|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91967047|NCT05035485|Adrenergic Agents|adrenergic agents|mesh-ancestor
91967048|NCT05035485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967064|NCT02494505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967065|NCT03340493|Tenecteplase|tenecteplase|mesh-list
91967066|NCT03340493|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91967067|NCT03340493|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91967068|NCT03340493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967070|NCT03098199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967071|NCT03098199|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91967072|NCT03098199|Fertility Agents|fertility agents|mesh-ancestor
91967073|NCT03098199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91967074|NCT00707057|Ibuprofen|ibuprofen|mesh-list
91967075|NCT00707057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91967076|NCT00707057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967077|NCT00707057|Analgesics|analgesics|mesh-ancestor
91967078|NCT00707057|Sensory System Agents|sensory system agents|mesh-ancestor
91967079|NCT00707057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967080|NCT00707057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967081|NCT00707057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967082|NCT00707057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967083|NCT00707057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967084|NCT00707057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967085|NCT00707057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967086|NCT02494349|Tamsulosin|tamsulosin|mesh-list
91967087|NCT02494349|Solifenacin Succinate|solifenacin succinate|mesh-list
91967088|NCT02494349|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91967089|NCT02494349|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91967090|NCT02494349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91967091|NCT02494349|Adrenergic Agents|adrenergic agents|mesh-ancestor
91967092|NCT02494349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967093|NCT02494349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967094|NCT02494349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967095|NCT02494349|Urological Agents|urological agents|mesh-ancestor
91967096|NCT02494349|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91967097|NCT02494349|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91967098|NCT02494349|Cholinergic Agents|cholinergic agents|mesh-ancestor
91967099|NCT03095469|Dexmedetomidine|dexmedetomidine|mesh-list
91967100|NCT03095469|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91967101|NCT03095469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967102|NCT03095469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967103|NCT03095469|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967104|NCT03095469|Analgesics|analgesics|mesh-ancestor
91967105|NCT03095469|Sensory System Agents|sensory system agents|mesh-ancestor
91967108|NCT03095469|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91967109|NCT03095469|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91945469|NCT04468685|Serotonin Agents|serotonin agents|mesh-ancestor
91945470|NCT04468685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945471|NCT04468685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945472|NCT03531047|Riboflavin|riboflavin|mesh-list
91967110|NCT03095469|Adrenergic Agents|adrenergic agents|mesh-ancestor
91967111|NCT03095469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967112|NCT03095469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967113|NCT02497547|Oxytocin|oxytocin|mesh-list
91967114|NCT02497547|Oxytocics|oxytocics|mesh-ancestor
91967115|NCT02497547|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91967116|NCT02497547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967117|NCT05043129|Vaccines|vaccines|mesh-list
91967118|NCT05043129|Immunologic Factors|immunologic factors|mesh-ancestor
91967119|NCT05043129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967120|NCT02497313|Metformin|metformin|mesh-list
91967121|NCT02497313|Cholecystokinin|cholecystokinin|mesh-list
91967122|NCT02497313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91967123|NCT02497313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967124|NCT02497313|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91967125|NCT02497313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967126|NCT02497157|Leucovorin|leucovorin|mesh-list
91967127|NCT02497157|Bevacizumab|bevacizumab|mesh-list
91967128|NCT02497157|Fluorouracil|fluorouracil|mesh-list
91967129|NCT02497157|Oxaliplatin|oxaliplatin|mesh-list
91967130|NCT02497157|Irinotecan|irinotecan|mesh-list
91967131|NCT02497157|Calcium|calcium|mesh-list
91967132|NCT02497157|Levoleucovorin|levoleucovorin|mesh-list
91967133|NCT02497157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967134|NCT02497157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967135|NCT02497157|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91967136|NCT02497157|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91967137|NCT02497157|Growth Substances|growth substances|mesh-ancestor
91967138|NCT02497157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967139|NCT02497157|Growth Inhibitors|growth inhibitors|mesh-ancestor
91967140|NCT02497157|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91967141|NCT02497157|Antimetabolites|antimetabolites|mesh-ancestor
91967142|NCT02497157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967143|NCT02497157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91967144|NCT02497157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91967145|NCT02497157|Immunologic Factors|immunologic factors|mesh-ancestor
91967146|NCT02497157|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91967147|NCT02497157|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91967148|NCT02497157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967149|NCT02497157|Antidotes|antidotes|mesh-ancestor
91967150|NCT02497157|Protective Agents|protective agents|mesh-ancestor
91967151|NCT02497157|Vitamin B Complex|vitamin b complex|mesh-ancestor
91967152|NCT02497157|Vitamins|vitamins|mesh-ancestor
91967153|NCT02497157|Micronutrients|micronutrients|mesh-ancestor
91967154|NCT03095235|Riboflavin|riboflavin|mesh-list
91967155|NCT03095235|Vitamins|vitamins|mesh-ancestor
91967156|NCT03095235|Micronutrients|micronutrients|mesh-ancestor
91967157|NCT03095235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967158|NCT03095235|Vitamin B Complex|vitamin b complex|mesh-ancestor
91967159|NCT03095235|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91967160|NCT03095235|Dermatologic Agents|dermatologic agents|mesh-ancestor
91967161|NCT03095079|Endostatins|endostatins|mesh-list
91967162|NCT03095079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91967163|NCT03095079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91967164|NCT03095079|Growth Substances|growth substances|mesh-ancestor
91967165|NCT03095079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967166|NCT03095079|Growth Inhibitors|growth inhibitors|mesh-ancestor
91967167|NCT03095079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967168|NCT03120923|Triamcinolone|triamcinolone|mesh-list
91967169|NCT03120923|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91967170|NCT03120923|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91967171|NCT03120923|Lidocaine|lidocaine|mesh-list
91967172|NCT03120923|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91967173|NCT03120923|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967174|NCT03120923|Anesthetics|anesthetics|mesh-ancestor
91967175|NCT03120923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967176|NCT03120923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967177|NCT03120923|Sensory System Agents|sensory system agents|mesh-ancestor
91967178|NCT03120923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967179|NCT03120923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91945473|NCT03531047|Vitamin B Complex|vitamin b complex|mesh-ancestor
91967180|NCT03120923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91967187|NCT03120923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967189|NCT03120923|Immunologic Factors|immunologic factors|mesh-ancestor
91967190|NCT03120923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967192|NCT02497079|Disinfectants|disinfectants|mesh-ancestor
91967193|NCT02497079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967194|NCT04135677|Rivaroxaban|rivaroxaban|mesh-list
91967195|NCT04135677|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91967196|NCT04135677|Antithrombins|antithrombins|mesh-ancestor
91967197|NCT04135677|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91967198|NCT04135677|Protease Inhibitors|protease inhibitors|mesh-ancestor
91967199|NCT04135677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967200|NCT04135677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967201|NCT04135677|Anticoagulants|anticoagulants|mesh-ancestor
91967203|NCT02639247|Velpatasvir|velpatasvir|mesh-list
91967204|NCT02639247|Antiviral Agents|antiviral agents|mesh-ancestor
91967205|NCT02639247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967206|NCT05033535|Olmesartan|olmesartan|mesh-list
91967207|NCT05033535|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91967208|NCT05033535|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91967209|NCT05033535|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91967210|NCT05033535|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91967211|NCT05033535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967212|NCT05053893|Valsartan|valsartan|mesh-list
91967213|NCT05053893|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91967214|NCT05053893|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91967215|NCT05053893|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91967216|NCT05053893|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91967217|NCT05053893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967218|NCT03096327|Montelukast|montelukast|mesh-list
91967219|NCT03096327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91967220|NCT03096327|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967221|NCT03096327|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91967222|NCT03096327|Hormone Antagonists|hormone antagonists|mesh-ancestor
91967223|NCT03096327|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967224|NCT03096327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967225|NCT03096327|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91967226|NCT03096327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91967227|NCT03096327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967228|NCT03098121|Grazoprevir|grazoprevir|mesh-list
91967229|NCT03098121|Antiviral Agents|antiviral agents|mesh-ancestor
91967230|NCT03098121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967231|NCT03095001|Paclitaxel|paclitaxel|mesh-list
91967232|NCT03095001|Bevacizumab|bevacizumab|mesh-list
91967233|NCT03095001|Carboplatin|carboplatin|mesh-list
91967234|NCT03095001|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91967235|NCT03095001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967236|NCT03095001|Tubulin Modulators|tubulin modulators|mesh-ancestor
91967237|NCT03095001|Antimitotic Agents|antimitotic agents|mesh-ancestor
91967238|NCT03095001|Mitosis Modulators|mitosis modulators|mesh-ancestor
91967239|NCT03095001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967240|NCT03095001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967241|NCT03095001|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91967242|NCT03095001|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91967243|NCT03095001|Growth Substances|growth substances|mesh-ancestor
91967244|NCT03095001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967245|NCT03095001|Growth Inhibitors|growth inhibitors|mesh-ancestor
91967246|NCT05042271|Meropenem|meropenem|mesh-list
91967247|NCT05042271|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967257|NCT02138955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967258|NCT02138955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967259|NCT02138955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967260|NCT02138955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967261|NCT03096405|Methicillin|methicillin|mesh-list
91967262|NCT03096405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967263|NCT03096405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967265|NCT05032287|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91967266|NCT05032287|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91945474|NCT03531047|Vitamins|vitamins|mesh-ancestor
91945475|NCT03531047|Micronutrients|micronutrients|mesh-ancestor
91967267|NCT05032287|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91967268|NCT05032287|Adrenergic Agents|adrenergic agents|mesh-ancestor
91967269|NCT05032287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967270|NCT05032287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967271|NCT05032287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967272|NCT05032287|Urological Agents|urological agents|mesh-ancestor
91967273|NCT02493959|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91967274|NCT02493959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91967275|NCT02493959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967276|NCT02493959|Incretins|incretins|mesh-ancestor
91967277|NCT02493959|Hormones|hormones|mesh-ancestor
91967278|NCT02493959|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967279|NCT02493959|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91967280|NCT02493959|Protease Inhibitors|protease inhibitors|mesh-ancestor
91967281|NCT02493959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967282|NCT02493959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967283|NCT02496377|Epoetin Alfa|epoetin alfa|mesh-list
91967284|NCT02496377|Glycine|glycine|mesh-list
91967285|NCT02496377|Hematinics|hematinics|mesh-ancestor
91967286|NCT02496377|Glycine Agents|glycine agents|mesh-ancestor
91967287|NCT02496377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967288|NCT02496377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967289|NCT02496377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967290|NCT02496455|Tramadol|tramadol|mesh-list
91967291|NCT02496455|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967292|NCT02496455|Narcotics|narcotics|mesh-ancestor
91967293|NCT02496455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967294|NCT02496455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967295|NCT02496455|Analgesics|analgesics|mesh-ancestor
91967296|NCT02496455|Sensory System Agents|sensory system agents|mesh-ancestor
91967297|NCT02496455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967298|NCT02496299|Dexamethasone|dexamethasone|mesh-list
91967299|NCT02496299|Bupivacaine|bupivacaine|mesh-list
91967300|NCT02496299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967301|NCT02496299|Antiemetics|antiemetics|mesh-ancestor
91967302|NCT02496299|Autonomic Agents|autonomic agents|mesh-ancestor
91967303|NCT02496299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967304|NCT02496299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967305|NCT02496299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967306|NCT02496299|Glucocorticoids|glucocorticoids|mesh-ancestor
91967307|NCT02496299|Hormones|hormones|mesh-ancestor
91967308|NCT02496299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967309|NCT02496299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91967310|NCT02496299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967321|NCT04467957|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91967322|NCT04467957|Anesthetics, General|anesthetics, general|mesh-ancestor
91967323|NCT04467957|Anesthetics|anesthetics|mesh-ancestor
91967324|NCT04467957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967325|NCT04467957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967326|NCT02121405|Capecitabine|capecitabine|mesh-list
91967327|NCT02121405|Oxaliplatin|oxaliplatin|mesh-list
91967328|NCT02121405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91967329|NCT02121405|Antimetabolites|antimetabolites|mesh-ancestor
91967330|NCT02121405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967331|NCT02121405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967332|NCT03337841|Pembrolizumab|pembrolizumab|mesh-list
91967333|NCT03337841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967334|NCT03337841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967335|NCT03337841|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91967336|NCT03337841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967337|NCT02493335|Budesonide|budesonide|mesh-list
91967338|NCT02493335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967339|NCT02493335|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91967340|NCT02493335|Autonomic Agents|autonomic agents|mesh-ancestor
91967341|NCT02493335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967342|NCT02493335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967343|NCT02493335|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91967344|NCT02493335|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967345|NCT02493335|Glucocorticoids|glucocorticoids|mesh-ancestor
91967346|NCT02493335|Hormones|hormones|mesh-ancestor
91945476|NCT03531047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945477|NCT03531047|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91945478|NCT03531047|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945479|NCT04440917|Apatinib|apatinib|mesh-list
91967347|NCT02493335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967348|NCT03336593|Vaccines|vaccines|mesh-list
91967349|NCT03336593|Immunologic Factors|immunologic factors|mesh-ancestor
91967350|NCT03336593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967351|NCT03337607|Celecoxib|celecoxib|mesh-list
91967352|NCT03337607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
91967353|NCT03337607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91967354|NCT03337607|Eperisone|eperisone|mesh-list
91967355|NCT03337607|Parasympatholytics|parasympatholytics|mesh-list
91967356|NCT03337607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967357|NCT03337607|Analgesics|analgesics|mesh-ancestor
91967358|NCT03337607|Sensory System Agents|sensory system agents|mesh-ancestor
91967359|NCT03337607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967360|NCT03337607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967361|NCT03337607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967362|NCT03337607|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91967363|NCT03337607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967364|NCT03337607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967365|NCT03337607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967366|NCT03337607|Anticonvulsants|anticonvulsants|mesh-ancestor
91967367|NCT03337607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91967368|NCT03337607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967369|NCT03337607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91967370|NCT03337607|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91967371|NCT03337607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91967372|NCT03337607|Autonomic Agents|autonomic agents|mesh-ancestor
91967373|NCT03337607|Vasodilator Agents|vasodilator agents|mesh-ancestor
91967374|NCT02493179|Serratiopeptidase|serratiopeptidase|mesh-list
91967375|NCT02493179|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91967389|NCT03337373|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91967390|NCT03337373|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91967391|NCT03337373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967392|NCT03337373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967393|NCT03336281|Ustekinumab|ustekinumab|mesh-list
91967394|NCT03336281|Dermatologic Agents|dermatologic agents|mesh-ancestor
91967396|NCT03336125|Vitamins|vitamins|mesh-ancestor
91967397|NCT03336125|Micronutrients|micronutrients|mesh-ancestor
91967398|NCT03336125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967399|NCT03336125|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91967401|NCT05051163|Ceftriaxone|ceftriaxone|mesh-list
91967402|NCT05051163|Ampicillin|ampicillin|mesh-list
91967403|NCT05051163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967404|NCT05051163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967405|NCT05051163|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91967406|NCT05051163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967407|NCT05051163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967408|NCT03331211|Dasatinib|dasatinib|mesh-list
91967409|NCT03331211|Ponatinib|ponatinib|mesh-list
91967410|NCT03331211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967411|NCT03331211|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91967412|NCT03331211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967413|NCT03331211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967415|NCT01929915|Morphine|morphine|mesh-list
91967416|NCT01929915|Bupivacaine|bupivacaine|mesh-list
91967417|NCT01929915|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967418|NCT01929915|Anesthetics|anesthetics|mesh-ancestor
91967419|NCT01929915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967420|NCT01929915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967421|NCT01929915|Sensory System Agents|sensory system agents|mesh-ancestor
91967422|NCT01929915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967423|NCT01929915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967424|NCT01929915|Narcotics|narcotics|mesh-ancestor
91967425|NCT01929915|Analgesics|analgesics|mesh-ancestor
91967426|NCT01929915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91967427|NCT01929915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91945480|NCT04440917|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91945481|NCT04440917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945482|NCT04440917|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91967428|NCT01929915|Anesthetics, General|anesthetics, general|mesh-ancestor
91967429|NCT05464745|Perindopril|perindopril|mesh-list
91967431|NCT05464745|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91967432|NCT05464745|Protease Inhibitors|protease inhibitors|mesh-ancestor
91967433|NCT05464745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967434|NCT05464745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967435|NCT05464745|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91967436|NCT05464745|Diuretics|diuretics|mesh-ancestor
91967437|NCT05464745|Natriuretic Agents|natriuretic agents|mesh-ancestor
91967438|NCT05464745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967439|NCT05464745|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91967440|NCT05464745|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967443|NCT03094533|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91967444|NCT03094533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967445|NCT03094533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967446|NCT03094533|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91967447|NCT03094533|Anesthetics, General|anesthetics, general|mesh-ancestor
91967448|NCT03094533|Anesthetics|anesthetics|mesh-ancestor
91967449|NCT03094533|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91967450|NCT03094533|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91967451|NCT05028231|Immunomodulating Agents|immunomodulating agents|mesh-list
91967452|NCT05028231|Immunologic Factors|immunologic factors|mesh-ancestor
91967453|NCT05028231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967454|NCT03335579|Sufentanil|sufentanil|mesh-list
91967455|NCT03335579|Remifentanil|remifentanil|mesh-list
91967456|NCT03335579|Propofol|propofol|mesh-list
91967457|NCT03335579|Anesthetics|anesthetics|mesh-ancestor
91967458|NCT03335579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967459|NCT03335579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967460|NCT03335579|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91967461|NCT03335579|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91967462|NCT03335579|Anesthetics, General|anesthetics, general|mesh-ancestor
91967463|NCT03335579|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967464|NCT03335579|Narcotics|narcotics|mesh-ancestor
91967465|NCT03335579|Analgesics|analgesics|mesh-ancestor
91967466|NCT03335579|Sensory System Agents|sensory system agents|mesh-ancestor
91967467|NCT03335579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967468|NCT03335579|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91967469|NCT05050071|Calcium, Dietary|calcium, dietary|mesh-list
91967470|NCT05050071|Calcium|calcium|mesh-list
91967471|NCT05050071|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91967472|NCT05050071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967473|NCT05050071|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91967474|NCT03335501|Pancrelipase|pancrelipase|mesh-list
91967475|NCT03335501|Hormones|hormones|mesh-list
91967476|NCT03335501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967477|NCT03335501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967478|NCT03335501|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967479|NCT02492945|Lidocaine|lidocaine|mesh-list
91967480|NCT02492945|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91967481|NCT02492945|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967482|NCT02492945|Anesthetics|anesthetics|mesh-ancestor
91967483|NCT02492945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967484|NCT02492945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967485|NCT02492945|Sensory System Agents|sensory system agents|mesh-ancestor
91967486|NCT02492945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967487|NCT02492945|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91967488|NCT02492945|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91967489|NCT02492945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91967490|NCT02492945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967491|NCT02492945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967492|NCT03335423|Metformin|metformin|mesh-list
91967493|NCT03335423|Codeine|codeine|mesh-list
91967494|NCT03335423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91967495|NCT03335423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967496|NCT03335423|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967497|NCT03335423|Narcotics|narcotics|mesh-ancestor
91967498|NCT03335423|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967499|NCT03335423|Analgesics|analgesics|mesh-ancestor
91967500|NCT03335423|Sensory System Agents|sensory system agents|mesh-ancestor
91967501|NCT03335423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967502|NCT03335423|Antitussive Agents|antitussive agents|mesh-ancestor
91967503|NCT03335423|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967504|NCT05038605|Metronidazole|metronidazole|mesh-list
91967505|NCT05038605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967506|NCT05038605|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967507|NCT05038605|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91967508|NCT05038605|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91967509|NCT03329729|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91967510|NCT03329729|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91967511|NCT03329729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91967512|NCT03329729|Antimetabolites|antimetabolites|mesh-ancestor
91967513|NCT03329729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967535|NCT03095547|Dermatologic Agents|dermatologic agents|mesh-ancestor
91967536|NCT03095547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967537|NCT03095547|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91967538|NCT03095547|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967539|NCT03095547|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91967540|NCT03095547|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91967541|NCT03095547|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91967542|NCT03095547|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91967543|NCT03095547|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91967544|NCT03095547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91967545|NCT03095547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91967546|NCT03095547|Hormone Antagonists|hormone antagonists|mesh-ancestor
91967547|NCT03095547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967548|NCT03329651|Metformin|metformin|mesh-list
91967549|NCT03329651|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91967550|NCT03329651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967551|NCT03334877|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91967552|NCT03334877|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91967553|NCT03334877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967554|NCT04968951|Metronidazole|metronidazole|mesh-list
91967555|NCT04968951|Vancomycin|vancomycin|mesh-list
91967556|NCT04968951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967557|NCT04968951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967558|NCT04968951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91967559|NCT04968951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91967560|NCT05049681|Apatinib|apatinib|mesh-list
91967561|NCT05049681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967562|NCT05049681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91967563|NCT05049681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967564|NCT05049681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967565|NCT03334487|Dexamethasone|dexamethasone|mesh-list
91967566|NCT03334487|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
91967567|NCT03334487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967593|NCT05038059|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91967594|NCT05038059|Immunologic Factors|immunologic factors|mesh-ancestor
91967595|NCT05038059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967596|NCT05038059|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91967597|NCT05038059|Protective Agents|protective agents|mesh-ancestor
91967598|NCT05038059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967599|NCT05038059|Plant Growth Regulators|plant growth regulators|mesh-ancestor
91967600|NCT05038059|Growth Substances|growth substances|mesh-ancestor
91967601|NCT01236547|Paclitaxel|paclitaxel|mesh-list
91967602|NCT01236547|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91967603|NCT01236547|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91967604|NCT01236547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967605|NCT01236547|Tubulin Modulators|tubulin modulators|mesh-ancestor
91967606|NCT01236547|Antimitotic Agents|antimitotic agents|mesh-ancestor
91967607|NCT01236547|Mitosis Modulators|mitosis modulators|mesh-ancestor
91967608|NCT01236547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967609|NCT03329339|Ascorbic Acid|ascorbic acid|mesh-list
91967610|NCT03329339|Antioxidants|antioxidants|mesh-ancestor
91967611|NCT03329339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967612|NCT03329339|Protective Agents|protective agents|mesh-ancestor
91967613|NCT03329339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967614|NCT03329339|Vitamins|vitamins|mesh-ancestor
91967615|NCT03329339|Micronutrients|micronutrients|mesh-ancestor
91967616|NCT03329261|Clopidogrel|clopidogrel|mesh-list
91967617|NCT03329261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91945483|NCT04440917|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945484|NCT04440917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945485|NCT04440917|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967618|NCT03329261|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91967620|NCT03329261|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91967621|NCT03329261|Purinergic Agents|purinergic agents|mesh-ancestor
91967622|NCT03329261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967623|NCT03329261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967624|NCT03329261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967626|NCT03329183|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91967627|NCT03329183|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91967628|NCT03329183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967629|NCT03329183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967630|NCT03329183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967631|NCT05048511|Vitamin D|vitamin d|mesh-list
91967632|NCT05048511|Vitamins|vitamins|mesh-ancestor
91967633|NCT05048511|Micronutrients|micronutrients|mesh-ancestor
91967634|NCT05048511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967635|NCT05048511|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91967636|NCT02167945|Ritonavir|ritonavir|mesh-list
91967637|NCT02167945|Ribavirin|ribavirin|mesh-list
91967638|NCT02167945|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91967639|NCT02167945|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91967640|NCT02167945|Protease Inhibitors|protease inhibitors|mesh-ancestor
91967641|NCT02167945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967642|NCT02167945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967643|NCT02167945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91967644|NCT02167945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91967645|NCT02167945|Antiviral Agents|antiviral agents|mesh-ancestor
91967646|NCT02167945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967647|NCT02167945|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91967648|NCT02167945|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91967649|NCT02167945|Antimetabolites|antimetabolites|mesh-ancestor
91967650|NCT03328481|Anesthetics|anesthetics|mesh-list
91967651|NCT03328481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967652|NCT03328481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967653|NCT02452879|Solifenacin Succinate|solifenacin succinate|mesh-list
91967654|NCT02452879|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91967655|NCT02452879|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91967656|NCT02452879|Cholinergic Agents|cholinergic agents|mesh-ancestor
91967657|NCT02452879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967658|NCT02452879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967659|NCT02452879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967660|NCT02452879|Urological Agents|urological agents|mesh-ancestor
91967661|NCT01191697|Bevacizumab|bevacizumab|mesh-list
91967662|NCT01191697|Trastuzumab|trastuzumab|mesh-list
91967663|NCT01191697|Capecitabine|capecitabine|mesh-list
91967664|NCT01191697|Oxaliplatin|oxaliplatin|mesh-list
91967665|NCT01191697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967666|NCT01191697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967667|NCT01191697|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91967668|NCT01191697|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91967669|NCT01191697|Growth Substances|growth substances|mesh-ancestor
91967670|NCT01191697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967671|NCT01191697|Growth Inhibitors|growth inhibitors|mesh-ancestor
91967672|NCT01191697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91967673|NCT01191697|Antimetabolites|antimetabolites|mesh-ancestor
91967674|NCT01191697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967675|NCT05024799|Fentanyl|fentanyl|mesh-list
91967676|NCT05024799|Butorphanol|butorphanol|mesh-list
91967677|NCT05024799|Propofol|propofol|mesh-list
91967678|NCT05024799|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91967679|NCT05024799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967680|NCT05024799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967681|NCT05024799|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91967682|NCT05024799|Anesthetics, General|anesthetics, general|mesh-ancestor
91967683|NCT05024799|Anesthetics|anesthetics|mesh-ancestor
91967684|NCT05024799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967685|NCT05024799|Narcotics|narcotics|mesh-ancestor
91967686|NCT05024799|Analgesics|analgesics|mesh-ancestor
91945487|NCT04192019|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91945488|NCT04192019|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945489|NCT04192019|Hormones|hormones|mesh-ancestor
92090400|NCT04382014|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967687|NCT05024799|Sensory System Agents|sensory system agents|mesh-ancestor
91967688|NCT05024799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967689|NCT05024799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91967690|NCT05024799|Antitussive Agents|antitussive agents|mesh-ancestor
91967691|NCT05024799|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967692|NCT05024799|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91967694|NCT05018637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91967696|NCT05018637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91967697|NCT03327701|Benralizumab|benralizumab|mesh-list
91967698|NCT03327701|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91967699|NCT03327701|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967700|NCT03327389|Dexmedetomidine|dexmedetomidine|mesh-list
91967701|NCT03327389|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91967702|NCT03327389|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967703|NCT03327389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967704|NCT03327389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967706|NCT03327389|Sensory System Agents|sensory system agents|mesh-ancestor
91967707|NCT03327389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967708|NCT03327389|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91967709|NCT03327389|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91967710|NCT03327389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91967711|NCT03327389|Adrenergic Agents|adrenergic agents|mesh-ancestor
91967712|NCT03327389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967713|NCT03327389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967714|NCT03333083|Lamivudine|lamivudine|mesh-list
91967715|NCT03333083|Raltegravir Potassium|raltegravir potassium|mesh-list
91967716|NCT03333083|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91967717|NCT03333083|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91967718|NCT03333083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967719|NCT03333083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967720|NCT03333083|Antiviral Agents|antiviral agents|mesh-ancestor
91967721|NCT03333083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967722|NCT03333083|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91967723|NCT03333083|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91967724|NCT03333083|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91967725|NCT03333083|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91967726|NCT03093597|Petrolatum|petrolatum|mesh-list
91967727|NCT03093597|Emollients|emollients|mesh-ancestor
91967728|NCT03093597|Dermatologic Agents|dermatologic agents|mesh-ancestor
91967729|NCT03327155|Tenofovir|tenofovir|mesh-list
91967730|NCT03327155|Emtricitabine|emtricitabine|mesh-list
91967731|NCT03327155|Antiviral Agents|antiviral agents|mesh-ancestor
91967732|NCT03327155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967733|NCT03327155|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91967734|NCT03327155|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91967735|NCT03327155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967736|NCT03327155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967737|NCT03327155|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91967738|NCT03327155|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91967739|NCT05024877|Stanozolol|stanozolol|mesh-list
91967740|NCT05024877|Androgens|androgens|mesh-ancestor
91967741|NCT05024877|Hormones|hormones|mesh-ancestor
91967742|NCT05024877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967743|NCT05024877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967744|NCT05024877|Anabolic Agents|anabolic agents|mesh-ancestor
91967745|NCT03079557|Botulinum Toxins|botulinum toxins|mesh-list
91967746|NCT03079557|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91967747|NCT03079557|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91967748|NCT03079557|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91967749|NCT03079557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967750|NCT03079557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967751|NCT03079557|Cholinergic Agents|cholinergic agents|mesh-ancestor
91967752|NCT03079557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967753|NCT03079557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967754|NCT03079557|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91967755|NCT03079557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967756|NCT03230851|Aspirin|aspirin|mesh-list
91945490|NCT04192019|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967757|NCT03230851|Indobufen|indobufen|mesh-list
91967758|NCT03230851|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91967759|NCT03230851|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967760|NCT03230851|Analgesics|analgesics|mesh-ancestor
91967761|NCT03230851|Sensory System Agents|sensory system agents|mesh-ancestor
91967762|NCT03230851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967763|NCT03230851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967764|NCT03230851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967765|NCT03230851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967766|NCT03230851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91967783|NCT05464433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967784|NCT05464433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967785|NCT03229135|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91967786|NCT03229135|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967787|NCT05024565|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91967788|NCT05024565|Lactams|lactams|mesh-list
91967789|NCT05024565|beta-Lactams|beta-lactams|mesh-list
91967790|NCT05024565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967791|NCT03228901|Oxytocin|oxytocin|mesh-list
91967792|NCT03228901|Oxytocics|oxytocics|mesh-ancestor
91967793|NCT03228901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91967794|NCT03228901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967795|NCT03228823|Amiodarone|amiodarone|mesh-list
91967796|NCT03228823|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
91967797|NCT03228823|Vasodilator Agents|vasodilator agents|mesh-ancestor
91967798|NCT03228823|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91967799|NCT03228823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967800|NCT03228823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967801|NCT03228823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91967802|NCT03228823|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91967803|NCT03228823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91967804|NCT03228823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967805|NCT03228823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91967806|NCT03228823|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91967807|NCT03228823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91967808|NCT03332225|Interferons|interferons|mesh-list
91967809|NCT03332225|Interferon-gamma|interferon-gamma|mesh-list
91967810|NCT03332225|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91967811|NCT03332225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967812|NCT03332225|Antiviral Agents|antiviral agents|mesh-ancestor
91967813|NCT03332225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967814|NCT03332225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967815|NCT05023941|Acetazolamide|acetazolamide|mesh-list
91967816|NCT05023941|Anticonvulsants|anticonvulsants|mesh-ancestor
91967817|NCT05023941|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91967818|NCT05023941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967819|NCT05023941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967820|NCT05023941|Diuretics|diuretics|mesh-ancestor
91967821|NCT05023941|Natriuretic Agents|natriuretic agents|mesh-ancestor
91967822|NCT05023941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967823|NCT03332069|Cisplatin|cisplatin|mesh-list
91967824|NCT03332069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967827|NCT03090087|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91967828|NCT03090087|Purinergic Agonists|purinergic agonists|mesh-ancestor
91967829|NCT03090087|Purinergic Agents|purinergic agents|mesh-ancestor
91967830|NCT03090087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967831|NCT03090087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967832|NCT03090087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967833|NCT03326609|Ropivacaine|ropivacaine|mesh-list
91967834|NCT03326609|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967835|NCT03326609|Anesthetics|anesthetics|mesh-ancestor
91967836|NCT03326609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967837|NCT03326609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967838|NCT03326609|Sensory System Agents|sensory system agents|mesh-ancestor
91967839|NCT03326609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967840|NCT03331913|Botulinum Toxins|botulinum toxins|mesh-list
91967841|NCT03331913|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91967842|NCT03331913|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91967843|NCT03331913|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91967844|NCT03331913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91945491|NCT04192019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945492|NCT04192019|Incretins|incretins|mesh-ancestor
91945493|NCT05455931|Mogamulizumab|mogamulizumab|mesh-list
91945494|NCT05455931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945495|NCT05062031|Atropine|atropine|mesh-list
91967845|NCT03331913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967846|NCT03331913|Cholinergic Agents|cholinergic agents|mesh-ancestor
91967847|NCT03331913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967848|NCT03331913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967849|NCT03331913|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91968338|NCT05006235|Sympathomimetics|sympathomimetics|mesh-ancestor
91967850|NCT03331913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967851|NCT03090009|Flurbiprofen|flurbiprofen|mesh-list
91967852|NCT03090009|Analgesics|analgesics|mesh-ancestor
91967853|NCT03090009|Sensory System Agents|sensory system agents|mesh-ancestor
91967854|NCT03090009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967855|NCT03090009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967856|NCT03090009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91967857|NCT03090009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967858|NCT03090009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967859|NCT03090009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967860|NCT03090009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967861|NCT03090009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967862|NCT03090009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967863|NCT02492087|Tranexamic Acid|tranexamic acid|mesh-list
91967864|NCT02492087|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91967865|NCT02492087|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91967866|NCT02492087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967867|NCT02492087|Hemostatics|hemostatics|mesh-ancestor
91967868|NCT02492087|Coagulants|coagulants|mesh-ancestor
91967869|NCT03093129|Artesunate|artesunate|mesh-list
91967870|NCT03093129|Antimalarials|antimalarials|mesh-ancestor
91967871|NCT03093129|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91967872|NCT03093129|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91967873|NCT03093129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967874|NCT03093129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967875|NCT03093129|Antiviral Agents|antiviral agents|mesh-ancestor
91967876|NCT03093129|Schistosomicides|schistosomicides|mesh-ancestor
91967877|NCT03093129|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91967878|NCT03093129|Anthelmintics|anthelmintics|mesh-ancestor
91967879|NCT02491697|Capecitabine|capecitabine|mesh-list
91967880|NCT02491697|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91967881|NCT02491697|Antimetabolites|antimetabolites|mesh-ancestor
91967882|NCT02491697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967883|NCT02491697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967884|NCT05024019|Nimotuzumab|nimotuzumab|mesh-list
91967885|NCT05024019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967886|NCT05024019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967887|NCT05008731|Botulinum Toxins|botulinum toxins|mesh-list
91967888|NCT05008731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91967889|NCT05008731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967890|NCT05008731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967891|NCT05008731|Cholinergic Agents|cholinergic agents|mesh-ancestor
91967892|NCT05008731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967893|NCT05008731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967894|NCT03331523|Betamethasone|betamethasone|mesh-list
91967895|NCT03331523|Betamethasone Valerate|betamethasone valerate|mesh-list
92090439|NCT04381858|Immunologic Factors|immunologic factors|mesh-ancestor
91967899|NCT03331523|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91967901|NCT03331523|Glucocorticoids|glucocorticoids|mesh-ancestor
91967902|NCT03331523|Hormones|hormones|mesh-ancestor
91967903|NCT03331523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967904|NCT03331523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967905|NCT03331523|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91967906|NCT03331523|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967907|NCT03331523|Dermatologic Agents|dermatologic agents|mesh-ancestor
91967908|NCT05023863|Thioctic Acid|thioctic acid|mesh-list
91967909|NCT05023863|Antioxidants|antioxidants|mesh-ancestor
91967910|NCT05023863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967911|NCT05023863|Protective Agents|protective agents|mesh-ancestor
91967912|NCT05023863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945496|NCT05062031|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91967913|NCT05023863|Vitamin B Complex|vitamin b complex|mesh-ancestor
91967914|NCT05023863|Vitamins|vitamins|mesh-ancestor
91967915|NCT05023863|Micronutrients|micronutrients|mesh-ancestor
91967916|NCT05463809|Oxycodone|oxycodone|mesh-list
91967917|NCT05463809|Analgesics|analgesics|mesh-list
91967918|NCT05463809|Ropivacaine|ropivacaine|mesh-list
91967919|NCT05463809|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967920|NCT05463809|Anesthetics|anesthetics|mesh-ancestor
91967921|NCT05463809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967922|NCT05463809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967923|NCT05463809|Sensory System Agents|sensory system agents|mesh-ancestor
91967924|NCT05463809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967925|NCT05463809|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91967926|NCT05463809|Narcotics|narcotics|mesh-ancestor
91967927|NCT03331445|Nitric Oxide|nitric oxide|mesh-list
91967928|NCT03331445|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91967929|NCT03331445|Autonomic Agents|autonomic agents|mesh-ancestor
91967930|NCT03331445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967931|NCT03331445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967932|NCT03331445|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91967933|NCT03331445|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967934|NCT03331445|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91967936|NCT03331445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967937|NCT03331445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967938|NCT03331445|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91967939|NCT03331445|Vasodilator Agents|vasodilator agents|mesh-ancestor
91967940|NCT03331445|Gasotransmitters|gasotransmitters|mesh-ancestor
91967941|NCT03331445|Protective Agents|protective agents|mesh-ancestor
91967942|NCT05008029|Anesthetics|anesthetics|mesh-list
91967943|NCT05008029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967944|NCT05008029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967945|NCT05008263|Liver Extracts|liver extracts|mesh-list
91967946|NCT05008263|Technetium Tc 99m mebrofenin|technetium tc 99m mebrofenin|mesh-list
91967947|NCT05008263|Hematinics|hematinics|mesh-ancestor
91967948|NCT05008263|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91967949|NCT05008263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967950|NCT03325127|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
91967951|NCT03325127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967953|NCT05016063|Cyclophosphamide|cyclophosphamide|mesh-list
91967954|NCT05016063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967955|NCT05016063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967956|NCT05016063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91967957|NCT05016063|Immunologic Factors|immunologic factors|mesh-ancestor
91967958|NCT05016063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967959|NCT05016063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967960|NCT05016063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91967961|NCT05016063|Alkylating Agents|alkylating agents|mesh-ancestor
91967962|NCT05016063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91967963|NCT03078933|Nitric Oxide|nitric oxide|mesh-list
91967964|NCT03078933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91967965|NCT03078933|Autonomic Agents|autonomic agents|mesh-ancestor
91967966|NCT03078933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967967|NCT03078933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967968|NCT03078933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91967983|NCT03092193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967984|NCT03092193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967985|NCT03092193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91967986|NCT03092193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967987|NCT03092193|Analgesics|analgesics|mesh-ancestor
91967988|NCT03092193|Sensory System Agents|sensory system agents|mesh-ancestor
91967989|NCT03092193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967990|NCT03092193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967991|NCT03092193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967992|NCT03092193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967993|NCT03092193|Gout Suppressants|gout suppressants|mesh-ancestor
91967994|NCT03092193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967995|NCT05015907|Ropivacaine|ropivacaine|mesh-list
91967996|NCT05015907|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967997|NCT05015907|Anesthetics|anesthetics|mesh-ancestor
91967998|NCT05015907|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967999|NCT05015907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968000|NCT05015907|Sensory System Agents|sensory system agents|mesh-ancestor
91945497|NCT05062031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91945498|NCT05062031|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91945499|NCT05062031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91968001|NCT05015907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968003|NCT05015595|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91968004|NCT05015595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91968005|NCT05015595|Dopamine Agents|dopamine agents|mesh-ancestor
91968006|NCT05015595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968007|NCT05015595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968008|NCT05015595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968009|NCT05015595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91968010|NCT05015595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91968011|NCT05015829|Dobutamine|dobutamine|mesh-list
91968012|NCT05015829|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91968013|NCT05015829|Sympathomimetics|sympathomimetics|mesh-ancestor
91968014|NCT05015829|Autonomic Agents|autonomic agents|mesh-ancestor
91968015|NCT05015829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968016|NCT05015829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968017|NCT05015829|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91968018|NCT05015829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91968019|NCT05015829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91968020|NCT05015829|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968021|NCT05015829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968022|NCT05015829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968023|NCT05015829|Protective Agents|protective agents|mesh-ancestor
91968024|NCT05015361|Propofol|propofol|mesh-list
91968025|NCT05015361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91968026|NCT05015361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968027|NCT05015361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968028|NCT05015361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968048|NCT03240055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968049|NCT03240055|Anesthetics, General|anesthetics, general|mesh-ancestor
91968050|NCT03087201|Nabiximols|nabiximols|mesh-list
91968052|NCT03087201|Sensory System Agents|sensory system agents|mesh-ancestor
91968053|NCT03087201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968054|NCT03087201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968055|NCT03230539|Ulipristal acetate|ulipristal acetate|mesh-list
91968056|NCT03230539|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91968057|NCT03230539|Contraceptive Agents|contraceptive agents|mesh-ancestor
91968058|NCT03230539|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91968059|NCT03230539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968060|NCT03230539|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91968061|NCT03239743|Midazolam|midazolam|mesh-list
91968062|NCT03239743|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91968063|NCT03239743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91968064|NCT03239743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968065|NCT03239743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968066|NCT03239743|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91968067|NCT03239743|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91968068|NCT03239743|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91968069|NCT03239743|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968070|NCT03239743|Anesthetics, General|anesthetics, general|mesh-ancestor
91968071|NCT03239743|Anesthetics|anesthetics|mesh-ancestor
91968072|NCT03239743|GABA Modulators|gaba modulators|mesh-ancestor
91968073|NCT03239743|GABA Agents|gaba agents|mesh-ancestor
91968074|NCT03239743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968075|NCT03239743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968076|NCT03239821|Codeine|codeine|mesh-list
91968077|NCT03239821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91968078|NCT03239821|Narcotics|narcotics|mesh-ancestor
91968079|NCT03239821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968080|NCT03239821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968081|NCT03239821|Analgesics|analgesics|mesh-ancestor
91968082|NCT03239821|Sensory System Agents|sensory system agents|mesh-ancestor
91968083|NCT03239821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968084|NCT03239821|Antitussive Agents|antitussive agents|mesh-ancestor
91968087|NCT03230227|Anesthetics, Local|anesthetics, local|mesh-ancestor
91968088|NCT03230227|Anesthetics|anesthetics|mesh-ancestor
91968089|NCT03230227|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945500|NCT05062031|Autonomic Agents|autonomic agents|mesh-ancestor
91945501|NCT05062031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090401|NCT04382014|Analgesics|analgesics|mesh-ancestor
91968090|NCT03230227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968091|NCT03230227|Sensory System Agents|sensory system agents|mesh-ancestor
91968092|NCT03230227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968093|NCT03078465|Clopidogrel|clopidogrel|mesh-list
91968095|NCT03078465|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91968096|NCT03078465|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91968097|NCT03078465|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91968098|NCT03078465|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91968099|NCT03078465|Purinergic Agents|purinergic agents|mesh-ancestor
91968100|NCT03078465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968101|NCT03078465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968102|NCT03078465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968103|NCT03324815|Morphine|morphine|mesh-list
91968104|NCT03324815|Methadone|methadone|mesh-list
91968105|NCT03324815|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91968106|NCT03324815|Narcotics|narcotics|mesh-ancestor
91968107|NCT03324815|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968108|NCT03324815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968109|NCT03324815|Analgesics|analgesics|mesh-ancestor
91968110|NCT03324815|Sensory System Agents|sensory system agents|mesh-ancestor
91968111|NCT03324815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968112|NCT03324815|Antitussive Agents|antitussive agents|mesh-ancestor
91968113|NCT03324815|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968114|NCT05006469|Dexamethasone|dexamethasone|mesh-list
91968115|NCT05006469|Doxorubicin|doxorubicin|mesh-list
91968116|NCT05006469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91968117|NCT05006469|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91968118|NCT05006469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968119|NCT05006469|Antiemetics|antiemetics|mesh-ancestor
91968120|NCT05006469|Autonomic Agents|autonomic agents|mesh-ancestor
91968121|NCT05006469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968122|NCT05006469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968123|NCT05006469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968124|NCT05006469|Glucocorticoids|glucocorticoids|mesh-ancestor
91968125|NCT05006469|Hormones|hormones|mesh-ancestor
91968126|NCT05006469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968127|NCT05006469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91968128|NCT05006469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968129|NCT05006469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968130|NCT05006469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968131|NCT05006469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91968132|NCT05006469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91968133|NCT05006469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91968134|NCT05006469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91968135|NCT05006469|Alkylating Agents|alkylating agents|mesh-ancestor
91968136|NCT03084783|Dexamethasone|dexamethasone|mesh-list
91968137|NCT03084783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968138|NCT03084783|Antiemetics|antiemetics|mesh-ancestor
91968139|NCT03084783|Autonomic Agents|autonomic agents|mesh-ancestor
91968140|NCT03084783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968141|NCT03084783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968142|NCT03084783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968143|NCT03084783|Glucocorticoids|glucocorticoids|mesh-ancestor
91968144|NCT03084783|Hormones|hormones|mesh-ancestor
91968145|NCT03084783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968146|NCT03084783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91968147|NCT03084783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968148|NCT03228355|Cromakalim|cromakalim|mesh-list
91968149|NCT03228355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91968150|NCT03228355|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91968151|NCT03228355|Autonomic Agents|autonomic agents|mesh-ancestor
91968152|NCT03228355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968153|NCT03228355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968155|NCT03228355|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968156|NCT03228355|Parasympatholytics|parasympatholytics|mesh-ancestor
91968157|NCT03228355|Vasodilator Agents|vasodilator agents|mesh-ancestor
91968158|NCT03324503|Prednisone|prednisone|mesh-list
91968165|NCT03324503|Prednisolone phosphate|prednisolone phosphate|mesh-list
91968166|NCT03324503|Glucocorticoids|glucocorticoids|mesh-list
91945502|NCT05062031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945503|NCT05062031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91945504|NCT05062031|Respiratory System Agents|respiratory system agents|mesh-ancestor
91945505|NCT05062031|Mydriatics|mydriatics|mesh-ancestor
91968167|NCT03324503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968168|NCT03324503|Hormones|hormones|mesh-ancestor
91968169|NCT03324503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968170|NCT03324503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968171|NCT03324503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91968172|NCT03324503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968173|NCT03324503|Antiemetics|antiemetics|mesh-ancestor
91968174|NCT03324503|Autonomic Agents|autonomic agents|mesh-ancestor
91968175|NCT03324503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968176|NCT03324503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968177|NCT03324503|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91968178|NCT03324503|Protective Agents|protective agents|mesh-ancestor
91968179|NCT05006001|Colchicine|colchicine|mesh-list
91968180|NCT05006001|Gout Suppressants|gout suppressants|mesh-ancestor
91968181|NCT05006001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968182|NCT05006001|Tubulin Modulators|tubulin modulators|mesh-ancestor
91968183|NCT05006001|Antimitotic Agents|antimitotic agents|mesh-ancestor
91968184|NCT05006001|Mitosis Modulators|mitosis modulators|mesh-ancestor
91968185|NCT05006001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968186|NCT05006001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968187|NCT04493489|Propranolol|propranolol|mesh-list
91968890|NCT03205033|Protective Agents|protective agents|mesh-ancestor
91968188|NCT04493489|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91968189|NCT04493489|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91968190|NCT04493489|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968191|NCT04493489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968192|NCT04493489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968193|NCT04493489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968194|NCT04493489|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91968195|NCT04493489|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91968196|NCT04493489|Vasodilator Agents|vasodilator agents|mesh-ancestor
91968197|NCT03228043|Apatinib|apatinib|mesh-list
91968198|NCT03228043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968199|NCT03228043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91968200|NCT03228043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968201|NCT03228043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968202|NCT03119857|Docetaxel|docetaxel|mesh-list
91968203|NCT03119857|Androgen Antagonists|androgen antagonists|mesh-list
91968204|NCT03119857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968205|NCT03119857|Tubulin Modulators|tubulin modulators|mesh-ancestor
91968206|NCT03119857|Antimitotic Agents|antimitotic agents|mesh-ancestor
91968207|NCT03119857|Mitosis Modulators|mitosis modulators|mesh-ancestor
91968208|NCT03119857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968209|NCT03119857|Hormone Antagonists|hormone antagonists|mesh-ancestor
91968210|NCT03119857|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968211|NCT03119857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968213|NCT03320603|Hemostatics|hemostatics|mesh-ancestor
91968214|NCT03320603|Coagulants|coagulants|mesh-ancestor
91968215|NCT03227653|Ritonavir|ritonavir|mesh-list
91968216|NCT03227653|Lopinavir|lopinavir|mesh-list
91968217|NCT03227653|Nevirapine|nevirapine|mesh-list
91968218|NCT03227653|Efavirenz|efavirenz|mesh-list
91968219|NCT03227653|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91968220|NCT03227653|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91968221|NCT03227653|Protease Inhibitors|protease inhibitors|mesh-ancestor
91968222|NCT03227653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968223|NCT03227653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968224|NCT03227653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91968225|NCT03227653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91968226|NCT03227653|Antiviral Agents|antiviral agents|mesh-ancestor
91968227|NCT03227653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968230|NCT03227653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91968231|NCT03227653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91968232|NCT03227653|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91968233|NCT03227653|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91945506|NCT05062031|Parasympatholytics|parasympatholytics|mesh-ancestor
91945507|NCT05062031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91945508|NCT05062031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91945509|NCT05062031|Cholinergic Agents|cholinergic agents|mesh-ancestor
91945510|NCT05062031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968234|NCT03227653|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91968235|NCT03227653|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91968236|NCT03227653|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91968237|NCT03320447|Lidocaine|lidocaine|mesh-list
91968238|NCT03320447|Prilocaine|prilocaine|mesh-list
91968239|NCT03320447|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
91968240|NCT03320447|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91968241|NCT03320447|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
91968242|NCT03320447|Anesthetics, Local|anesthetics, local|mesh-ancestor
91968243|NCT03320447|Anesthetics|anesthetics|mesh-ancestor
91968244|NCT03320447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968245|NCT03320447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968246|NCT03320447|Sensory System Agents|sensory system agents|mesh-ancestor
91968247|NCT03320447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968248|NCT03320447|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91968249|NCT03320447|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91968250|NCT03320447|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91968251|NCT03320447|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968252|NCT03320447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968253|NCT03320447|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91968254|NCT03320447|Dermatologic Agents|dermatologic agents|mesh-ancestor
91968255|NCT03320447|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
91968256|NCT04434105|Triamcinolone|triamcinolone|mesh-list
91968257|NCT04434105|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91968258|NCT04434105|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91968259|NCT04434105|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91968260|NCT04434105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968261|NCT04434105|Glucocorticoids|glucocorticoids|mesh-ancestor
91968262|NCT04434105|Hormones|hormones|mesh-ancestor
91968263|NCT04434105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968264|NCT04434105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968266|NCT04434105|Immunologic Factors|immunologic factors|mesh-ancestor
91968267|NCT04434105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968268|NCT04434105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968269|NCT03078777|Fexofenadine|fexofenadine|mesh-list
91968270|NCT03078777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91968271|NCT03078777|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91968272|NCT03078777|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91968273|NCT03078777|Histamine Antagonists|histamine antagonists|mesh-ancestor
91968274|NCT03078777|Histamine Agents|histamine agents|mesh-ancestor
91968275|NCT03078777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968276|NCT03078777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968277|NCT03078777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968278|NCT03078309|Cannabidiol|cannabidiol|mesh-list
91968279|NCT03078309|Anticonvulsants|anticonvulsants|mesh-ancestor
91968280|NCT03227419|Abatacept|abatacept|mesh-list
91968281|NCT03227419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91968282|NCT03227419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968283|NCT03227419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91968284|NCT03227419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968285|NCT03227419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91968286|NCT03227419|Immunologic Factors|immunologic factors|mesh-ancestor
91968287|NCT03227419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968288|NCT03227419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968289|NCT03208309|Diacerein|diacerein|mesh-list
91968290|NCT03208309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968291|NCT03091803|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
91968292|NCT03091803|Chelating Agents|chelating agents|mesh-ancestor
91968293|NCT03091803|Sequestering Agents|sequestering agents|mesh-ancestor
91968294|NCT03091803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945511|NCT05062031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968296|NCT03323567|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91968302|NCT03323567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968303|NCT03323567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91968304|NCT03323567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91968305|NCT03323567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91968306|NCT03323567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968307|NCT03323567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968308|NCT04492709|Midazolam|midazolam|mesh-list
91968309|NCT04492709|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91968310|NCT04492709|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91968311|NCT04492709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968312|NCT04492709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968313|NCT04492709|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91968314|NCT04492709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91968315|NCT04492709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91968316|NCT04492709|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968317|NCT04492709|Anesthetics, General|anesthetics, general|mesh-ancestor
91968318|NCT04492709|Anesthetics|anesthetics|mesh-ancestor
91968319|NCT04492709|GABA Modulators|gaba modulators|mesh-ancestor
91968320|NCT04492709|GABA Agents|gaba agents|mesh-ancestor
91968321|NCT04492709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968322|NCT04492709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968323|NCT05006235|Epinephrine|epinephrine|mesh-list
91968324|NCT05006235|Albuterol|albuterol|mesh-list
91968325|NCT05006235|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91968326|NCT05006235|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91968327|NCT05006235|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968328|NCT05006235|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968329|NCT05006235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968330|NCT05006235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968331|NCT05006235|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91968332|NCT05006235|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91968333|NCT05006235|Autonomic Agents|autonomic agents|mesh-ancestor
91968334|NCT05006235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968335|NCT05006235|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91968336|NCT05006235|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968337|NCT05006235|Mydriatics|mydriatics|mesh-ancestor
91968339|NCT05006235|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91968340|NCT05006235|Tocolytic Agents|tocolytic agents|mesh-ancestor
91968341|NCT05006235|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91968342|NCT05006235|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91968343|NCT03319823|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
91968344|NCT03319823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968345|NCT03319823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968346|NCT03319823|Diuretics|diuretics|mesh-ancestor
91968347|NCT03319823|Natriuretic Agents|natriuretic agents|mesh-ancestor
91968348|NCT03319823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968350|NCT02487953|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91968351|NCT02487953|Autonomic Agents|autonomic agents|mesh-ancestor
91968352|NCT02487953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968353|NCT02487953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968354|NCT02487953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91968355|NCT02487953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91968356|NCT02487953|Cholinergic Agents|cholinergic agents|mesh-ancestor
91968357|NCT02487953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968358|NCT02487953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968359|NCT03091569|Vitamin K|vitamin k|mesh-list
91968360|NCT03091569|Vitamins|vitamins|mesh-ancestor
91968361|NCT03091569|Micronutrients|micronutrients|mesh-ancestor
91968362|NCT03091569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968363|NCT03091569|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91968364|NCT03091569|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91968365|NCT03091569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968370|NCT04948749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968371|NCT04948749|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91968372|NCT04948749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968373|NCT04948749|Antifungal Agents|antifungal agents|mesh-ancestor
91968374|NCT04948749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91968375|NCT04948749|Immunologic Factors|immunologic factors|mesh-ancestor
91968376|NCT04948749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968377|NCT03226717|Antiviral Agents|antiviral agents|mesh-list
91968378|NCT03226717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968379|NCT02487719|Teferrol|teferrol|mesh-list
91968380|NCT02487719|Hematinics|hematinics|mesh-ancestor
91968381|NCT03207295|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
91968382|NCT03207295|Natriuretic Agents|natriuretic agents|mesh-ancestor
91968383|NCT03207295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968384|NCT04940871|Favipiravir|favipiravir|mesh-list
91968385|NCT04940871|Antiviral Agents|antiviral agents|mesh-ancestor
91968386|NCT04940871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968387|NCT03207139|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91968388|NCT03207139|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91968389|NCT03207139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968390|NCT03080415|Sofosbuvir|sofosbuvir|mesh-list
91968391|NCT03080415|Antiviral Agents|antiviral agents|mesh-ancestor
91968392|NCT03080415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968393|NCT03221881|Docetaxel|docetaxel|mesh-list
91968394|NCT03221881|Doxorubicin|doxorubicin|mesh-list
91968395|NCT03221881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91968396|NCT03221881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968397|NCT03221881|Tubulin Modulators|tubulin modulators|mesh-ancestor
91968398|NCT03221881|Antimitotic Agents|antimitotic agents|mesh-ancestor
91968399|NCT03221881|Mitosis Modulators|mitosis modulators|mesh-ancestor
91968400|NCT03221881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968401|NCT03221881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91968402|NCT03221881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91968403|NCT03221881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91968404|NCT03221881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968405|NCT03091257|Trametinib|trametinib|mesh-list
91968406|NCT03091257|Dabrafenib|dabrafenib|mesh-list
91968407|NCT03091257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968408|NCT03091257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91968409|NCT03091257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968410|NCT03091257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968411|NCT03206671|Cytarabine|cytarabine|mesh-list
91968412|NCT03206671|Dexamethasone|dexamethasone|mesh-list
91968413|NCT03206671|Prednisolone|prednisolone|mesh-list
91968414|NCT03206671|Cyclophosphamide|cyclophosphamide|mesh-list
91968416|NCT03206671|Rituximab|rituximab|mesh-list
91968417|NCT03206671|Doxorubicin|doxorubicin|mesh-list
91968418|NCT03206671|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91968419|NCT03206671|Methotrexate|methotrexate|mesh-list
91968420|NCT03206671|Etoposide|etoposide|mesh-list
91968421|NCT03206671|Vincristine|vincristine|mesh-list
91968422|NCT03206671|Vindesine|vindesine|mesh-list
91968423|NCT03206671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91968424|NCT03206671|Immunologic Factors|immunologic factors|mesh-ancestor
91968425|NCT03206671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968426|NCT03206671|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968427|NCT03206671|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91968428|NCT03206671|Alkylating Agents|alkylating agents|mesh-ancestor
91968429|NCT03206671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968430|NCT03206671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968431|NCT03206671|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91968432|NCT03206671|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91968433|NCT03206671|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968434|NCT03206671|Antiemetics|antiemetics|mesh-ancestor
91968435|NCT03206671|Autonomic Agents|autonomic agents|mesh-ancestor
91968436|NCT03206671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968437|NCT03206671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968438|NCT03206671|Glucocorticoids|glucocorticoids|mesh-ancestor
91968439|NCT03206671|Hormones|hormones|mesh-ancestor
91968440|NCT03206671|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968441|NCT03206671|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91968443|NCT03206671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91968444|NCT03206671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91968446|NCT03206671|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91968447|NCT03206671|Abortifacient Agents|abortifacient agents|mesh-ancestor
91968448|NCT03206671|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91968449|NCT03206671|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91968450|NCT03206671|Antimetabolites|antimetabolites|mesh-ancestor
91968451|NCT03206671|Dermatologic Agents|dermatologic agents|mesh-ancestor
91968452|NCT03206671|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91945512|NCT05062031|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91945513|NCT05446571|Valacyclovir|valacyclovir|mesh-list
91945515|NCT05446571|Antiviral Agents|antiviral agents|mesh-ancestor
91968453|NCT03206671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91968454|NCT03206671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91968455|NCT03206671|Antiviral Agents|antiviral agents|mesh-ancestor
91968456|NCT03206671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968457|NCT03206671|Tubulin Modulators|tubulin modulators|mesh-ancestor
91968458|NCT03206671|Antimitotic Agents|antimitotic agents|mesh-ancestor
91968459|NCT03206671|Mitosis Modulators|mitosis modulators|mesh-ancestor
91968460|NCT03078231|Mydriatics|mydriatics|mesh-list
91968461|NCT03078231|Autonomic Agents|autonomic agents|mesh-ancestor
91968462|NCT03078231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968463|NCT03078231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968464|NCT03319121|Theophylline|theophylline|mesh-list
91968465|NCT03319121|Dexlansoprazole|dexlansoprazole|mesh-list
91968466|NCT03319121|Lansoprazole|lansoprazole|mesh-list
91968467|NCT03319121|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91968468|NCT03319121|Autonomic Agents|autonomic agents|mesh-ancestor
91968469|NCT03319121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968470|NCT03319121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968471|NCT03319121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91968472|NCT03319121|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968473|NCT03319121|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91968474|NCT03319121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968475|NCT03319121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968476|NCT03319121|Vasodilator Agents|vasodilator agents|mesh-ancestor
91968477|NCT03319121|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91968478|NCT03319121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91968479|NCT03319121|Purinergic Agents|purinergic agents|mesh-ancestor
91968480|NCT03319121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968481|NCT03319121|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91968482|NCT03319121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968483|NCT03319121|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91968484|NCT02487407|Simendan|simendan|mesh-list
91968485|NCT02487407|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91968486|NCT02487407|Vasodilator Agents|vasodilator agents|mesh-ancestor
91968487|NCT02487407|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91968488|NCT02487407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91968489|NCT02487407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968490|NCT02487407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968491|NCT02487407|Protective Agents|protective agents|mesh-ancestor
91968492|NCT02487407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968493|NCT03221569|Ketorolac|ketorolac|mesh-list
91968494|NCT03221569|Ketamine|ketamine|mesh-list
91968495|NCT03221569|Analgesics|analgesics|mesh-ancestor
91968496|NCT03221569|Sensory System Agents|sensory system agents|mesh-ancestor
91968497|NCT03221569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968498|NCT03221569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968499|NCT03221569|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91968500|NCT03221569|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968501|NCT03221569|Anesthetics, General|anesthetics, general|mesh-ancestor
91968502|NCT03221569|Anesthetics|anesthetics|mesh-ancestor
91968503|NCT03221569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968504|NCT03221569|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91968505|NCT03221569|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91968506|NCT03221569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968507|NCT03221569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968508|NCT03221569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91968509|NCT03221569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91968510|NCT03221569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968511|NCT03221569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968512|NCT03221569|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91968513|NCT03221569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968514|NCT03319043|Budesonide|budesonide|mesh-list
91968525|NCT03319043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968526|NCT03319043|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91968528|NCT03319043|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91968530|NCT03319043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945516|NCT05446571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968531|NCT03319043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968532|NCT02451475|Amitriptyline|amitriptyline|mesh-list
91968533|NCT02451475|Paroxetine|paroxetine|mesh-list
91968534|NCT02451475|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91968535|NCT02451475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91968536|NCT02451475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91968537|NCT02451475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968538|NCT02451475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968539|NCT02451475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968540|NCT02451475|Serotonin Agents|serotonin agents|mesh-ancestor
91968541|NCT02451475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968542|NCT02451475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91968543|NCT02451475|Antidepressive Agents|antidepressive agents|mesh-ancestor
91968544|NCT02451475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91968545|NCT02451475|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91968546|NCT02451475|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91968547|NCT02451475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968548|NCT02451475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91968549|NCT02451475|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91968550|NCT02451475|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91968551|NCT02451475|Analgesics|analgesics|mesh-ancestor
91968552|NCT02451475|Sensory System Agents|sensory system agents|mesh-ancestor
91968553|NCT02451475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968554|NCT02451475|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91968555|NCT02451475|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968556|NCT05019417|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
91968557|NCT05019417|Glycerol|glycerol|mesh-list
91968558|NCT05019417|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91968559|NCT05019417|Protective Agents|protective agents|mesh-ancestor
91968560|NCT05019417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968561|NCT05019417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968562|NCT03225937|Trastuzumab|trastuzumab|mesh-list
91968563|NCT03225937|Pertuzumab|pertuzumab|mesh-list
91968564|NCT03225937|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
91968565|NCT03225937|Lapatinib|lapatinib|mesh-list
91968566|NCT03225937|Maytansine|maytansine|mesh-list
91968567|NCT03225937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91968568|NCT03225937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968569|NCT03225937|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91968570|NCT03225937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968571|NCT03225937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968572|NCT03225937|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91968573|NCT03225937|Tubulin Modulators|tubulin modulators|mesh-ancestor
91968574|NCT03225937|Antimitotic Agents|antimitotic agents|mesh-ancestor
91968575|NCT03225937|Mitosis Modulators|mitosis modulators|mesh-ancestor
91968576|NCT03225937|Immunotoxins|immunotoxins|mesh-ancestor
91968577|NCT03225937|Immunoconjugates|immunoconjugates|mesh-ancestor
91968578|NCT03225937|Immunologic Factors|immunologic factors|mesh-ancestor
91968593|NCT03119077|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91968595|NCT03119077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968596|NCT03119077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968597|NCT03119077|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91968598|NCT02487329|Calcium, Dietary|calcium, dietary|mesh-list
91968599|NCT02487329|Calcium|calcium|mesh-list
91968600|NCT02487329|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91968601|NCT02487329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968602|NCT02487329|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91968603|NCT03318731|Fenugreek seed meal|fenugreek seed meal|mesh-list
91968604|NCT03318731|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91968605|NCT03318731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968606|NCT03080103|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91968607|NCT03080103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968608|NCT04493099|Decitabine|decitabine|mesh-list
91968609|NCT04493099|Venetoclax|venetoclax|mesh-list
91968610|NCT04493099|Alvocidib|alvocidib|mesh-list
91968611|NCT04493099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91968612|NCT04493099|Antimetabolites|antimetabolites|mesh-ancestor
91968613|NCT04493099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968614|NCT04493099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968615|NCT04493099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968616|NCT04493099|Growth Inhibitors|growth inhibitors|mesh-ancestor
91945517|NCT05446571|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91945518|NCT05446571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945519|NCT05446571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968617|NCT04493099|Growth Substances|growth substances|mesh-ancestor
91968618|NCT04493099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968619|NCT04493099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91968620|NCT05004909|Tretinoin|tretinoin|mesh-list
91968621|NCT05004909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968622|NCT05004909|Keratolytic Agents|keratolytic agents|mesh-ancestor
91968623|NCT05004909|Dermatologic Agents|dermatologic agents|mesh-ancestor
91968624|NCT03119623|Valsartan|valsartan|mesh-list
91968625|NCT03119623|Enalapril|enalapril|mesh-list
92074258|NCT00072514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968626|NCT03119623|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91968627|NCT03119623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91968628|NCT03119623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91968629|NCT03119623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91968630|NCT03119623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968631|NCT03119623|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91968632|NCT03119623|Protease Inhibitors|protease inhibitors|mesh-ancestor
91968633|NCT03119623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968635|NCT03318419|Pegaspargase|pegaspargase|mesh-list
91968636|NCT03318419|Asparaginase|asparaginase|mesh-list
91968637|NCT03318419|Cladribine|cladribine|mesh-list
91968648|NCT03321773|Metronidazole|metronidazole|mesh-list
91968649|NCT03321773|Clarithromycin|clarithromycin|mesh-list
91968650|NCT03321773|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
91968651|NCT03321773|Pantoprazole|pantoprazole|mesh-list
91968652|NCT03321773|Bismuth|bismuth|mesh-list
91968653|NCT03321773|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91968654|NCT03321773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968655|NCT03321773|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91968656|NCT03321773|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91968657|NCT03321773|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91968658|NCT03321773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968659|NCT03321773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968660|NCT03321773|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91968661|NCT03321773|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91968662|NCT03321773|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91968663|NCT03321773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968664|NCT03321773|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91968665|NCT03321773|Antacids|antacids|mesh-ancestor
91968666|NCT03077217|Rifaximin|rifaximin|mesh-list
91968667|NCT03077217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91968668|NCT03077217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968669|NCT03077217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968670|NCT05001243|Bromfenac|bromfenac|mesh-list
91968671|NCT05001243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91968672|NCT05001243|Phenylephrine|phenylephrine|mesh-list
91968673|NCT05001243|Oxymetazoline|oxymetazoline|mesh-list
91968674|NCT05001243|Hyaluronic Acid|hyaluronic acid|mesh-list
91968675|NCT05001243|Pilocarpine|pilocarpine|mesh-list
91968676|NCT05001243|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91968677|NCT05001243|Immunologic Factors|immunologic factors|mesh-ancestor
91968678|NCT05001243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968679|NCT05001243|Viscosupplements|viscosupplements|mesh-ancestor
91968680|NCT05001243|Protective Agents|protective agents|mesh-ancestor
91968681|NCT05001243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91968682|NCT05001243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91968683|NCT05001243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91968684|NCT05001243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91968685|NCT05001243|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968686|NCT05001243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968687|NCT05001243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968688|NCT05001243|Sympathomimetics|sympathomimetics|mesh-ancestor
91968689|NCT05001243|Autonomic Agents|autonomic agents|mesh-ancestor
91968690|NCT05001243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968691|NCT05001243|Nasal Decongestants|nasal decongestants|mesh-ancestor
91968692|NCT05001243|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91968693|NCT05001243|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968694|NCT05001243|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91968695|NCT05001243|Mydriatics|mydriatics|mesh-ancestor
91968696|NCT05001243|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91968697|NCT05001243|Miotics|miotics|mesh-ancestor
91968698|NCT05001243|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91968699|NCT05001243|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91968700|NCT05001243|Cholinergic Agents|cholinergic agents|mesh-ancestor
91968701|NCT05001243|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91968702|NCT05001243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91968703|NCT05001243|Analgesics|analgesics|mesh-ancestor
91968716|NCT03205891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968718|NCT03221023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91968719|NCT03221023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968720|NCT02490839|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91968721|NCT02490839|Amoxicillin|amoxicillin|mesh-list
91968722|NCT02490839|Metronidazole|metronidazole|mesh-list
91968723|NCT02490839|Tetracycline|tetracycline|mesh-list
91968724|NCT02490839|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91968726|NCT02490839|Bismuth|bismuth|mesh-list
91968727|NCT02490839|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91968728|NCT02490839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968729|NCT02490839|Antitubercular Agents|antitubercular agents|mesh-ancestor
91968730|NCT02490839|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91968731|NCT02490839|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91968732|NCT02490839|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91968733|NCT02490839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968734|NCT02490839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968735|NCT02490839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968736|NCT02490839|Antacids|antacids|mesh-ancestor
91968737|NCT02490839|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91968738|NCT02490527|Simvastatin|simvastatin|mesh-list
91968739|NCT02490527|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91968740|NCT02490527|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91968741|NCT02490527|Antimetabolites|antimetabolites|mesh-ancestor
91968742|NCT02490527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968743|NCT02490527|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91968744|NCT02490527|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91968745|NCT02490527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968746|NCT02490449|Dexlansoprazole|dexlansoprazole|mesh-list
91968747|NCT02490449|Lansoprazole|lansoprazole|mesh-list
91968748|NCT02490449|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91968749|NCT02490449|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968750|NCT02490449|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91968751|NCT02490449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968752|NCT02490449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968753|NCT02452177|Vitamin D|vitamin d|mesh-list
91968754|NCT02452177|Vitamins|vitamins|mesh-ancestor
91968755|NCT02452177|Micronutrients|micronutrients|mesh-ancestor
91968756|NCT02452177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968757|NCT02452177|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91968758|NCT05000697|Oxaliplatin|oxaliplatin|mesh-list
91968759|NCT05000697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968760|NCT03224923|Aspirin|aspirin|mesh-list
91968761|NCT03224923|Clopidogrel|clopidogrel|mesh-list
91968762|NCT03224923|Ticagrelor|ticagrelor|mesh-list
91968763|NCT03224923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91968764|NCT03224923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91968765|NCT03224923|Analgesics|analgesics|mesh-ancestor
91968766|NCT03224923|Sensory System Agents|sensory system agents|mesh-ancestor
91968767|NCT03224923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968768|NCT03224923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968769|NCT03224923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968803|NCT05004519|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91968804|NCT05004519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968805|NCT05004519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968806|NCT05004519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91968807|NCT05004519|Analgesics|analgesics|mesh-ancestor
91968808|NCT05004519|Sensory System Agents|sensory system agents|mesh-ancestor
91968809|NCT05004519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968810|NCT05004519|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91968829|NCT02490605|Dermatologic Agents|dermatologic agents|mesh-ancestor
91968830|NCT04485403|Ibuprofen|ibuprofen|mesh-list
91968831|NCT04485403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91968832|NCT04485403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91968833|NCT04485403|Analgesics|analgesics|mesh-ancestor
91968834|NCT04485403|Sensory System Agents|sensory system agents|mesh-ancestor
91968835|NCT04485403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945520|NCT05446571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945521|NCT05439005|Dexmedetomidine|dexmedetomidine|mesh-list
91945522|NCT05439005|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91945523|NCT05439005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945524|NCT05439005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945525|NCT05439005|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91945526|NCT05439005|Analgesics|analgesics|mesh-ancestor
91968836|NCT04485403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968837|NCT04485403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968838|NCT04485403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968839|NCT04485403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91968840|NCT04485403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968841|NCT04485403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968842|NCT03220867|Risperidone|risperidone|mesh-list
91968843|NCT03220867|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91968844|NCT03220867|Serotonin Agents|serotonin agents|mesh-ancestor
91968845|NCT03220867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968846|NCT03220867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968847|NCT03220867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968848|NCT03220867|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91968849|NCT03220867|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91968850|NCT03220867|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968851|NCT03220867|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91968852|NCT03220867|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91968853|NCT03220867|Dopamine Agents|dopamine agents|mesh-ancestor
91968854|NCT03318029|Vitamin D|vitamin d|mesh-list
91968855|NCT03318029|Vitamins|vitamins|mesh-ancestor
91968856|NCT03318029|Micronutrients|micronutrients|mesh-ancestor
91968857|NCT03318029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968858|NCT03318029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91968859|NCT03076281|Metformin|metformin|mesh-list
91968860|NCT03076281|Doxycycline|doxycycline|mesh-list
91968861|NCT03076281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91968862|NCT03076281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968863|NCT03076281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91968864|NCT03076281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968865|NCT03076281|Antimalarials|antimalarials|mesh-ancestor
91968866|NCT03076281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91968867|NCT03076281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91968868|NCT02452255|Propranolol|propranolol|mesh-list
91968871|NCT02452255|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91968872|NCT02452255|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91968873|NCT02452255|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968874|NCT02452255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968875|NCT02452255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968876|NCT02452255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968877|NCT02452255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91968878|NCT02452255|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91968879|NCT02452255|Vasodilator Agents|vasodilator agents|mesh-ancestor
91968880|NCT02452255|Sympatholytics|sympatholytics|mesh-ancestor
91968881|NCT02452255|Autonomic Agents|autonomic agents|mesh-ancestor
91968882|NCT02452255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968883|NCT02452255|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91968884|NCT02452255|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91968885|NCT02452255|Antimetabolites|antimetabolites|mesh-ancestor
91968886|NCT02452255|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91968887|NCT03205033|Melatonin|melatonin|mesh-list
91968888|NCT03205033|Antioxidants|antioxidants|mesh-ancestor
91968889|NCT03205033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968891|NCT03205033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968892|NCT03205033|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968893|NCT03076905|Olorofim|olorofim|mesh-list
91968894|NCT03076905|Antifungal Agents|antifungal agents|mesh-ancestor
91968895|NCT03076905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968896|NCT02452099|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
91968897|NCT02452099|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91945527|NCT05439005|Sensory System Agents|sensory system agents|mesh-ancestor
91945528|NCT05439005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945529|NCT05439005|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91945530|NCT05439005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91945531|NCT05439005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91945532|NCT05439005|Adrenergic Agents|adrenergic agents|mesh-ancestor
91945533|NCT05439005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945534|NCT05439005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945535|NCT04468139|Quercetin|quercetin|mesh-list
91945536|NCT04468139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945537|NCT04468139|Antioxidants|antioxidants|mesh-ancestor
91945538|NCT04468139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945539|NCT04468139|Protective Agents|protective agents|mesh-ancestor
91945540|NCT03526445|Glucagon|glucagon|mesh-list
91945541|NCT03526445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945542|NCT03526445|Hormones|hormones|mesh-ancestor
91945543|NCT03526445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945544|NCT03526445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945546|NCT04939649|Ketamine|ketamine|mesh-list
91945547|NCT04939649|Analgesics|analgesics|mesh-ancestor
91945548|NCT04939649|Sensory System Agents|sensory system agents|mesh-ancestor
91945549|NCT04939649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945550|NCT04939649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945551|NCT04939649|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91945552|NCT04939649|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968898|NCT02452099|Protective Agents|protective agents|mesh-ancestor
91968899|NCT02452099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968900|NCT02452099|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91968901|NCT02452099|Antioxidants|antioxidants|mesh-ancestor
91968902|NCT02452099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968903|NCT03317717|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91968904|NCT03317717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91968905|NCT03317717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968906|NCT03317717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968907|NCT03317717|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91968908|NCT03317717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968909|NCT03317717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968910|NCT03317717|Cholinergic Agents|cholinergic agents|mesh-ancestor
91968911|NCT03317717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968912|NCT03220789|Methamphetamine|methamphetamine|mesh-list
91968913|NCT03220789|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91968914|NCT03220789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968915|NCT03220789|Sympathomimetics|sympathomimetics|mesh-ancestor
91968916|NCT03220789|Autonomic Agents|autonomic agents|mesh-ancestor
91968917|NCT03220789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945553|NCT04939649|Anesthetics, General|anesthetics, general|mesh-ancestor
91945554|NCT04939649|Anesthetics|anesthetics|mesh-ancestor
91945555|NCT04939649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945556|NCT04939649|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91945557|NCT04939649|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91945558|NCT04939649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945559|NCT04939649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945560|NCT04939649|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91945561|NCT04939649|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91945562|NCT04939649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91945563|NCT04939649|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91945564|NCT04939649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91945565|NCT04939649|GABA Modulators|gaba modulators|mesh-ancestor
91945566|NCT04939649|GABA Agents|gaba agents|mesh-ancestor
91945567|NCT04927949|Cangrelor|cangrelor|mesh-list
91945568|NCT04927949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91945569|NCT04927949|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91945570|NCT04927949|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91945571|NCT04927949|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91945572|NCT04927949|Purinergic Agents|purinergic agents|mesh-ancestor
91945573|NCT04927949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945574|NCT04927949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945575|NCT04927949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945576|NCT04589819|Teriparatide|teriparatide|mesh-list
91945577|NCT04589819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91945578|NCT04589819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945579|NCT04589819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91945580|NCT03526367|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91945581|NCT03526367|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91945582|NCT03526367|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91945583|NCT03526367|Antimetabolites|antimetabolites|mesh-ancestor
91945584|NCT03526367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945585|NCT03526367|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91945586|NCT03526367|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91968918|NCT03220789|Dopamine Agents|dopamine agents|mesh-ancestor
91968919|NCT03220789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945587|NCT03526367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945588|NCT04467983|Denosumab|denosumab|mesh-list
91945589|NCT04467983|Abaloparatide|abaloparatide|mesh-list
91945590|NCT04467983|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91945591|NCT04467983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945592|NCT04839731|Fluorouracil|fluorouracil|mesh-list
91945593|NCT04839731|Calcipotriene|calcipotriene|mesh-list
91945594|NCT04839731|Antimetabolites|antimetabolites|mesh-ancestor
91945595|NCT04839731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945596|NCT04839731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91945597|NCT04839731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945598|NCT04839731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945599|NCT04839731|Immunologic Factors|immunologic factors|mesh-ancestor
91945600|NCT04839731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945601|NCT04839731|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945602|NCT03525509|Morphine|morphine|mesh-list
91945603|NCT03525509|Methadone|methadone|mesh-list
91945604|NCT03525509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91945605|NCT03525509|Narcotics|narcotics|mesh-ancestor
91945606|NCT03525509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945607|NCT03525509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945608|NCT03525509|Analgesics|analgesics|mesh-ancestor
91945609|NCT03525509|Sensory System Agents|sensory system agents|mesh-ancestor
91945610|NCT03525509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945611|NCT03525509|Antitussive Agents|antitussive agents|mesh-ancestor
91945612|NCT03525509|Respiratory System Agents|respiratory system agents|mesh-ancestor
91945613|NCT04699721|Paclitaxel|paclitaxel|mesh-list
91945614|NCT04699721|Carboplatin|carboplatin|mesh-list
91945615|NCT04699721|Nivolumab|nivolumab|mesh-list
91945616|NCT04699721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945617|NCT04699721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968920|NCT03220789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968921|NCT03220789|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968922|NCT03220789|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91968923|NCT03220789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91968924|NCT03220789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968925|NCT03220789|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91968926|NCT03220555|Lidocaine|lidocaine|mesh-list
91968927|NCT03220555|Prilocaine|prilocaine|mesh-list
91968928|NCT03220555|Anesthetics, Local|anesthetics, local|mesh-ancestor
91968929|NCT03220555|Anesthetics|anesthetics|mesh-ancestor
91968930|NCT03220555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968931|NCT03220555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968932|NCT03220555|Sensory System Agents|sensory system agents|mesh-ancestor
91968933|NCT03220555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945618|NCT04699721|Tubulin Modulators|tubulin modulators|mesh-ancestor
91945619|NCT04699721|Antimitotic Agents|antimitotic agents|mesh-ancestor
91945620|NCT04699721|Mitosis Modulators|mitosis modulators|mesh-ancestor
91945621|NCT04699721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945622|NCT04699721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91945623|NCT04699721|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945624|NCT05179499|Norepinephrine|norepinephrine|mesh-list
91945625|NCT05179499|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91945626|NCT05179499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91945627|NCT05179499|Adrenergic Agents|adrenergic agents|mesh-ancestor
91945628|NCT05179499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945629|NCT05179499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945630|NCT05179499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945631|NCT05179499|Sympathomimetics|sympathomimetics|mesh-ancestor
91945632|NCT05179499|Autonomic Agents|autonomic agents|mesh-ancestor
91945633|NCT05179499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945634|NCT05179499|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91945635|NCT03525821|Ketamine|ketamine|mesh-list
91945636|NCT03525821|Analgesics|analgesics|mesh-ancestor
91945637|NCT03525821|Sensory System Agents|sensory system agents|mesh-ancestor
91945638|NCT03525821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945639|NCT03525821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945640|NCT03525821|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91945641|NCT03525821|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91968934|NCT03220555|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91968935|NCT03220555|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91968936|NCT03220555|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91968937|NCT03220555|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91968938|NCT03220555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968939|NCT03204877|Melatonin|melatonin|mesh-list
91968940|NCT03204877|Antioxidants|antioxidants|mesh-ancestor
91968943|NCT03204877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968944|NCT03204877|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968946|NCT03204799|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91968947|NCT03204799|Ezetimibe|ezetimibe|mesh-list
91968948|NCT03204799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91968949|NCT03204799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968950|NCT03204799|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91968951|NCT03204799|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91968952|NCT03204799|Antimetabolites|antimetabolites|mesh-ancestor
91968953|NCT03204799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968954|NCT03204799|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91968955|NCT03317327|Nivolumab|nivolumab|mesh-list
91968956|NCT03317327|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91968957|NCT03317327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968958|NCT03317327|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91968959|NCT03317327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945642|NCT03525821|Anesthetics, General|anesthetics, general|mesh-ancestor
91945643|NCT03525821|Anesthetics|anesthetics|mesh-ancestor
91945644|NCT03525821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945645|NCT03525821|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91945646|NCT03525821|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91945647|NCT03525821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945648|NCT03525821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945650|NCT04221035|Cyclophosphamide|cyclophosphamide|mesh-list
91945651|NCT04221035|Temozolomide|temozolomide|mesh-list
91945652|NCT04221035|Melphalan|melphalan|mesh-list
91945653|NCT04221035|Busulfan|busulfan|mesh-list
91945654|NCT04221035|Ifosfamide|ifosfamide|mesh-list
91945655|NCT04221035|Thiotepa|thiotepa|mesh-list
91945656|NCT04221035|Dacarbazine|dacarbazine|mesh-list
91945657|NCT04221035|Carboplatin|carboplatin|mesh-list
91945658|NCT04221035|Doxorubicin|doxorubicin|mesh-list
91945659|NCT04221035|Irinotecan|irinotecan|mesh-list
91945660|NCT04221035|Etoposide|etoposide|mesh-list
91945661|NCT04221035|Vincristine|vincristine|mesh-list
91945662|NCT04221035|Vindesine|vindesine|mesh-list
91945663|NCT04221035|Dinutuximab|dinutuximab|mesh-list
91945664|NCT04221035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945665|NCT04221035|Immunologic Factors|immunologic factors|mesh-ancestor
91945666|NCT04221035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945667|NCT04221035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945668|NCT04221035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945669|NCT04221035|Alkylating Agents|alkylating agents|mesh-ancestor
91945670|NCT04221035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945671|NCT04221035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945672|NCT04221035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91945673|NCT04221035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91968960|NCT03204331|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91968961|NCT03204331|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91968962|NCT03204331|Norethindrone|norethindrone|mesh-list
91968963|NCT03204331|Norethindrone Acetate|norethindrone acetate|mesh-list
91968964|NCT03204331|Estradiol|estradiol|mesh-list
91968965|NCT03204331|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91968966|NCT03204331|Relugolix|relugolix|mesh-list
91968967|NCT03204331|Estrogens|estrogens|mesh-ancestor
91968968|NCT03204331|Hormones|hormones|mesh-ancestor
91968969|NCT03204331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968970|NCT03204331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968971|NCT03204331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91968972|NCT03204331|Contraceptive Agents|contraceptive agents|mesh-ancestor
91968973|NCT03204331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91968974|NCT03204331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91945674|NCT04221035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91945675|NCT04221035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945676|NCT04221035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945677|NCT04221035|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91945678|NCT04221035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945679|NCT04221035|Tubulin Modulators|tubulin modulators|mesh-ancestor
91945680|NCT04221035|Antimitotic Agents|antimitotic agents|mesh-ancestor
91945681|NCT04221035|Mitosis Modulators|mitosis modulators|mesh-ancestor
91945682|NCT01601704|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
91945683|NCT01601704|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91945684|NCT04842682|Diazepam|diazepam|mesh-list
91945685|NCT04842682|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91945686|NCT04842682|Anticonvulsants|anticonvulsants|mesh-ancestor
91945687|NCT04842682|Antiemetics|antiemetics|mesh-ancestor
91945688|NCT04842682|Autonomic Agents|autonomic agents|mesh-ancestor
91945689|NCT04842682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945690|NCT04842682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945691|NCT04842682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945692|NCT04842682|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91945693|NCT04842682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945694|NCT04842682|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91945695|NCT04842682|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91945696|NCT04842682|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91968975|NCT03204331|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91968976|NCT03204331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91968977|NCT03204331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91968978|NCT03204331|Androgen Antagonists|androgen antagonists|mesh-ancestor
91968979|NCT03204331|Hormone Antagonists|hormone antagonists|mesh-ancestor
91968980|NCT03072849|Fluticasone|fluticasone|mesh-list
91968981|NCT03072849|Azithromycin|azithromycin|mesh-list
91968982|NCT03072849|Montelukast|montelukast|mesh-list
91968983|NCT03072849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968984|NCT03072849|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91968985|NCT03072849|Autonomic Agents|autonomic agents|mesh-ancestor
91968986|NCT03072849|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968987|NCT03072849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968988|NCT03072849|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91968989|NCT03072849|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968990|NCT03072849|Dermatologic Agents|dermatologic agents|mesh-ancestor
91968991|NCT03072849|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91968992|NCT03072849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91968993|NCT03072849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968994|NCT03072849|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91968995|NCT03072849|Hormone Antagonists|hormone antagonists|mesh-ancestor
91968996|NCT03072849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968997|NCT03072849|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91968998|NCT03072849|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91968999|NCT03072849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969000|NCT03220321|Lithium Carbonate|lithium carbonate|mesh-list
91945697|NCT04842682|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91945698|NCT04842682|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969001|NCT03220321|Antidepressive Agents|antidepressive agents|mesh-ancestor
91969002|NCT03220321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969003|NCT03220321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969004|NCT03220321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969005|NCT03220321|Antimanic Agents|antimanic agents|mesh-ancestor
91969006|NCT03220321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91969007|NCT03220321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969008|NCT03220321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969009|NCT03075657|Haloperidol|haloperidol|mesh-list
91969010|NCT03075657|Risperidone|risperidone|mesh-list
91969011|NCT03075657|Haloperidol decanoate|haloperidol decanoate|mesh-list
91969015|NCT03075657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969016|NCT03075657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969017|NCT03075657|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91969018|NCT03075657|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91969019|NCT03075657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969020|NCT03075657|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969021|NCT03075657|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91969022|NCT03075657|Dopamine Agents|dopamine agents|mesh-ancestor
91969023|NCT03075657|Antiemetics|antiemetics|mesh-ancestor
91969024|NCT03075657|Autonomic Agents|autonomic agents|mesh-ancestor
91969025|NCT03075657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969026|NCT03075657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91969027|NCT03075657|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91969028|NCT02451865|Docetaxel|docetaxel|mesh-list
91969029|NCT02451865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969030|NCT02451865|Tubulin Modulators|tubulin modulators|mesh-ancestor
91969031|NCT02451865|Antimitotic Agents|antimitotic agents|mesh-ancestor
91969032|NCT02451865|Mitosis Modulators|mitosis modulators|mesh-ancestor
91969033|NCT02451865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969034|NCT05004207|Lactulose|lactulose|mesh-list
91969035|NCT05004207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91969036|NCT03317093|Ceftobiprole|ceftobiprole|mesh-list
91969037|NCT03317093|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
91969038|NCT03317093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91969039|NCT03317093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969040|NCT02489513|Ivosidenib|ivosidenib|mesh-list
91969042|NCT02489513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969043|NCT02489513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969044|NCT03317015|Fluticasone|fluticasone|mesh-list
91969045|NCT03317015|Triamcinolone|triamcinolone|mesh-list
91969046|NCT03317015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969047|NCT03317015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91969048|NCT03317015|Autonomic Agents|autonomic agents|mesh-ancestor
91969049|NCT03317015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969050|NCT03317015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969051|NCT03317015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91969052|NCT03317015|Respiratory System Agents|respiratory system agents|mesh-ancestor
91969053|NCT03317015|Dermatologic Agents|dermatologic agents|mesh-ancestor
91969054|NCT03317015|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91969055|NCT03317015|Glucocorticoids|glucocorticoids|mesh-ancestor
91969056|NCT03317015|Hormones|hormones|mesh-ancestor
91969057|NCT03317015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969058|NCT03204565|Hyaluronic Acid|hyaluronic acid|mesh-list
91969059|NCT03204565|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91969060|NCT03204565|Immunologic Factors|immunologic factors|mesh-ancestor
91969061|NCT03204565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969062|NCT03204565|Viscosupplements|viscosupplements|mesh-ancestor
91969063|NCT03204565|Protective Agents|protective agents|mesh-ancestor
91969064|NCT03224377|Antibodies|antibodies|mesh-list
91969065|NCT03224377|Immunoglobulins|immunoglobulins|mesh-list
91969066|NCT03224377|Immunologic Factors|immunologic factors|mesh-ancestor
91969067|NCT03224377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969068|NCT02451787|Vitamin D|vitamin d|mesh-list
91969069|NCT02451787|Cholecalciferol|cholecalciferol|mesh-list
91969070|NCT02451787|Vitamins|vitamins|mesh-ancestor
91969071|NCT02451787|Micronutrients|micronutrients|mesh-ancestor
91969072|NCT02451787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969073|NCT02451787|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91969074|NCT02451787|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91969075|NCT03224221|Fluorouracil|fluorouracil|mesh-list
91969076|NCT03224221|Apatinib|apatinib|mesh-list
91969077|NCT03224221|Antimetabolites|antimetabolites|mesh-ancestor
91945699|NCT04842682|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91969078|NCT03224221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969079|NCT03224221|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91969080|NCT03224221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969081|NCT03224221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969082|NCT03224221|Immunologic Factors|immunologic factors|mesh-ancestor
91969083|NCT03224221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969084|NCT03224221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969085|NCT03224221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969109|NCT02488889|Varenicline|varenicline|mesh-list
91969110|NCT02488889|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91969111|NCT02488889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969112|NCT02488889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969113|NCT02488889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969114|NCT02488889|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91969115|NCT02488889|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91969116|NCT02488889|Cholinergic Agents|cholinergic agents|mesh-ancestor
91969117|NCT02488889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969118|NCT02488889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969119|NCT03220009|Nivolumab|nivolumab|mesh-list
91969120|NCT03220009|Ipilimumab|ipilimumab|mesh-list
91969121|NCT03220009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969122|NCT03220009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969123|NCT03220009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945849|NCT04546126|Cosyntropin|cosyntropin|mesh-list
91969124|NCT03220009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969125|NCT02485613|Dexamethasone|dexamethasone|mesh-list
91969126|NCT02485613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969127|NCT02485613|Antiemetics|antiemetics|mesh-ancestor
91969128|NCT02485613|Autonomic Agents|autonomic agents|mesh-ancestor
91969129|NCT02485613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969130|NCT02485613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969131|NCT02485613|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91969132|NCT02485613|Glucocorticoids|glucocorticoids|mesh-ancestor
91969133|NCT02485613|Hormones|hormones|mesh-ancestor
91969134|NCT02485613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969135|NCT02485613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91969136|NCT02485613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969137|NCT02484833|Cetuximab|cetuximab|mesh-list
91969139|NCT02484833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969140|NCT03204019|Thalidomide|thalidomide|mesh-list
91969141|NCT03204019|Temozolomide|temozolomide|mesh-list
91969143|NCT03204019|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91969144|NCT03204019|Alkylating Agents|alkylating agents|mesh-ancestor
91969145|NCT03204019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969146|NCT03204019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969147|NCT03204019|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969148|NCT03204019|Immunologic Factors|immunologic factors|mesh-ancestor
91969149|NCT03204019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969150|NCT03204019|Leprostatic Agents|leprostatic agents|mesh-ancestor
91969151|NCT03204019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91969152|NCT03204019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969153|NCT03204019|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91969154|NCT03204019|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91969155|NCT03204019|Growth Substances|growth substances|mesh-ancestor
91969156|NCT03204019|Growth Inhibitors|growth inhibitors|mesh-ancestor
91969157|NCT03204019|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91969158|NCT03204019|Antimetabolites|antimetabolites|mesh-ancestor
91969159|NCT02485145|Diclofenac|diclofenac|mesh-list
91969160|NCT02485145|Orphenadrine|orphenadrine|mesh-list
91969161|NCT02485145|Bupivacaine|bupivacaine|mesh-list
91969162|NCT02485145|Baclofen|baclofen|mesh-list
91969163|NCT02485145|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969164|NCT02485145|Anesthetics|anesthetics|mesh-ancestor
91969165|NCT02485145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969166|NCT02485145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969167|NCT02485145|Sensory System Agents|sensory system agents|mesh-ancestor
91969168|NCT02485145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969169|NCT02485145|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969170|NCT02485145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91969171|NCT02485145|Analgesics|analgesics|mesh-ancestor
91969172|NCT02485145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969173|NCT02485145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945700|NCT04842682|Anesthetics, General|anesthetics, general|mesh-ancestor
91945701|NCT04842682|Anesthetics|anesthetics|mesh-ancestor
91945702|NCT04842682|GABA Modulators|gaba modulators|mesh-ancestor
91945703|NCT04842682|GABA Agents|gaba agents|mesh-ancestor
91945704|NCT04842682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945705|NCT04842682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969174|NCT02485145|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91969175|NCT02485145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969176|NCT02485145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969177|NCT02485145|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91969178|NCT02485145|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91969179|NCT02485145|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91969180|NCT02485145|GABA Agonists|gaba agonists|mesh-ancestor
91969181|NCT02485145|GABA Agents|gaba agents|mesh-ancestor
91969182|NCT02485145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969183|NCT02485145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91969184|NCT02485145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91969185|NCT02485145|Parasympatholytics|parasympatholytics|mesh-ancestor
91969186|NCT02485145|Autonomic Agents|autonomic agents|mesh-ancestor
91969187|NCT02485145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91969188|NCT02485145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91969189|NCT02485145|Cholinergic Agents|cholinergic agents|mesh-ancestor
91969190|NCT02485145|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
91969191|NCT02485145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91969192|NCT02484755|Gefitinib|gefitinib|mesh-list
91969193|NCT02484755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969194|NCT02484755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969195|NCT02484755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969196|NCT02484755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969197|NCT03316469|Clomiphene|clomiphene|mesh-list
91969198|NCT03316469|Enclomiphene|enclomiphene|mesh-list
91969199|NCT03316469|Zuclomiphene|zuclomiphene|mesh-list
91969200|NCT03316469|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91969201|NCT03316469|Hormone Antagonists|hormone antagonists|mesh-ancestor
91969202|NCT03316469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969203|NCT03316469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969204|NCT03316469|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91969205|NCT03316469|Fertility Agents|fertility agents|mesh-ancestor
91969206|NCT03316469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91969207|NCT03316469|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91969208|NCT03316469|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91969211|NCT02485067|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91969212|NCT02485067|Cholinergic Agents|cholinergic agents|mesh-ancestor
91969217|NCT03075579|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91969218|NCT03075579|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91969219|NCT03075579|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91969220|NCT03075579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91969221|NCT03075579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969222|NCT03075579|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969223|NCT03075579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969224|NCT03075579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969225|NCT03203317|Insulin|insulin|mesh-list
91969226|NCT03203317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91969227|NCT03203317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969228|NCT03316313|Antibodies|antibodies|mesh-list
91969229|NCT03316313|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
91969230|NCT03316313|Immunologic Factors|immunologic factors|mesh-ancestor
91969231|NCT03316313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969232|NCT03201601|Inositol|inositol|mesh-list
91969233|NCT03201601|Vitamin B Complex|vitamin b complex|mesh-ancestor
91969234|NCT03201601|Vitamins|vitamins|mesh-ancestor
91969235|NCT03201601|Micronutrients|micronutrients|mesh-ancestor
91969236|NCT03201601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969237|NCT02480387|Sofosbuvir|sofosbuvir|mesh-list
91969238|NCT02480387|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91969239|NCT02480387|Ledipasvir|ledipasvir|mesh-list
91969240|NCT02480387|Antiviral Agents|antiviral agents|mesh-ancestor
91969241|NCT02480387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969242|NCT04999293|Clopidogrel|clopidogrel|mesh-list
91945706|NCT04969276|Vaccines|vaccines|mesh-list
91945707|NCT04969276|Immunologic Factors|immunologic factors|mesh-ancestor
91945708|NCT04969276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945709|NCT04969198|Nicotine|nicotine|mesh-list
91945710|NCT04969198|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91945711|NCT04969198|Autonomic Agents|autonomic agents|mesh-ancestor
91945712|NCT04969198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945713|NCT04969198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945714|NCT04969198|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91945715|NCT04969198|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91945716|NCT04969198|Cholinergic Agents|cholinergic agents|mesh-ancestor
91945717|NCT04969198|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945718|NCT04969198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945719|NCT04666636|Mirabegron|mirabegron|mesh-list
91969243|NCT04999293|Ticagrelor|ticagrelor|mesh-list
91969244|NCT04999293|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91969245|NCT04999293|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91969246|NCT04999293|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91969247|NCT04999293|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91969248|NCT04999293|Purinergic Agents|purinergic agents|mesh-ancestor
91969249|NCT04999293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969250|NCT04999293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969251|NCT04999293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969252|NCT03315923|Rituximab|rituximab|mesh-list
91969253|NCT03315923|Glatiramer Acetate|glatiramer acetate|mesh-list
91969254|NCT03315923|(T,G)-A-L|(t,g)-a-l|mesh-list
91969255|NCT03315923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969256|NCT03315923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969257|NCT03315923|Immunologic Factors|immunologic factors|mesh-ancestor
91969258|NCT03315923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969259|NCT03315923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969260|NCT03315923|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91969261|NCT03315923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969262|NCT03315845|Anesthetics|anesthetics|mesh-list
91969263|NCT03315845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969264|NCT03315845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969265|NCT03201367|Rivaroxaban|rivaroxaban|mesh-list
91969266|NCT03201367|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91969267|NCT03201367|Antithrombins|antithrombins|mesh-ancestor
91969268|NCT03201367|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91969269|NCT03201367|Protease Inhibitors|protease inhibitors|mesh-ancestor
91969270|NCT03201367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969271|NCT03201367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969272|NCT03201367|Anticoagulants|anticoagulants|mesh-ancestor
91969273|NCT04998903|Dimercaprol|dimercaprol|mesh-list
91969274|NCT04998903|Chelating Agents|chelating agents|mesh-ancestor
91969275|NCT04998903|Sequestering Agents|sequestering agents|mesh-ancestor
91969276|NCT04998903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969277|NCT04991961|Antihypertensive Agents|antihypertensive agents|mesh-list
91969278|NCT03203005|Cyclophosphamide|cyclophosphamide|mesh-list
91969279|NCT03203005|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969280|NCT03203005|Immunologic Factors|immunologic factors|mesh-ancestor
91969281|NCT03203005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969282|NCT03203005|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969302|NCT02484053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969303|NCT02484053|Immunologic Factors|immunologic factors|mesh-ancestor
91969304|NCT02484053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969305|NCT02484053|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969306|NCT03200821|Gemcitabine|gemcitabine|mesh-list
91969307|NCT03200821|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91969308|NCT03200821|Antimetabolites|antimetabolites|mesh-ancestor
91945720|NCT04666636|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91945721|NCT04666636|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91969309|NCT03200821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969310|NCT03200821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969312|NCT05353361|Pertuzumab|pertuzumab|mesh-list
91969313|NCT05353361|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91969314|NCT05353361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969315|NCT05353361|Tubulin Modulators|tubulin modulators|mesh-ancestor
91969316|NCT05353361|Antimitotic Agents|antimitotic agents|mesh-ancestor
91969317|NCT05353361|Mitosis Modulators|mitosis modulators|mesh-ancestor
91969318|NCT05353361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969319|NCT05353361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969320|NCT02483897|Tetracaine|tetracaine|mesh-list
91969321|NCT02483897|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91969322|NCT02483897|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969323|NCT02483897|Anesthetics|anesthetics|mesh-ancestor
91969324|NCT02483897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969325|NCT02483897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969326|NCT02483897|Sensory System Agents|sensory system agents|mesh-ancestor
91969327|NCT02483897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969328|NCT02483897|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91969329|NCT01374919|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91969330|NCT01374919|Hematinics|hematinics|mesh-ancestor
91969331|NCT01374919|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91969332|NCT01374919|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91969333|NCT03202615|Lactoferrin|lactoferrin|mesh-list
91969334|NCT03202615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969335|NCT03202459|Pregabalin|pregabalin|mesh-list
91969336|NCT03202459|Gabapentin|gabapentin|mesh-list
91969337|NCT03202459|Analgesics|analgesics|mesh-ancestor
91969338|NCT03202459|Sensory System Agents|sensory system agents|mesh-ancestor
91969339|NCT03202459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969360|NCT04492319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969362|NCT04492319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969363|NCT04492319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969364|NCT04492319|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91969365|NCT04492319|Autonomic Agents|autonomic agents|mesh-ancestor
91969366|NCT04492319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969367|NCT04456959|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
91969368|NCT04456959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969369|NCT04456959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969370|NCT04456959|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91969371|NCT04456959|Immunotoxins|immunotoxins|mesh-ancestor
91969372|NCT04456959|Immunoconjugates|immunoconjugates|mesh-ancestor
91969373|NCT04456959|Immunologic Factors|immunologic factors|mesh-ancestor
91969374|NCT04456959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969376|NCT05713721|Dopamine Agonists|dopamine agonists|mesh-list
91969377|NCT05713721|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91969378|NCT05713721|Sympathomimetics|sympathomimetics|mesh-ancestor
91969379|NCT05713721|Autonomic Agents|autonomic agents|mesh-ancestor
91969380|NCT05713721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969381|NCT05713721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969382|NCT05713721|Dopamine Agents|dopamine agents|mesh-ancestor
91969383|NCT05713721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969384|NCT05713721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969385|NCT05713721|Protective Agents|protective agents|mesh-ancestor
91969386|NCT05002725|Lidocaine|lidocaine|mesh-list
91969387|NCT05002725|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969388|NCT05002725|Anesthetics|anesthetics|mesh-ancestor
91969389|NCT05002725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969390|NCT05002725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969587|NCT03201835|Analgesics|analgesics|mesh-ancestor
91969588|NCT03201835|Sensory System Agents|sensory system agents|mesh-ancestor
91969589|NCT03201835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969590|NCT02478515|Ranibizumab|ranibizumab|mesh-list
91969591|NCT02478515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91969592|NCT02478515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91969593|NCT02478515|Growth Substances|growth substances|mesh-ancestor
91970861|NCT02467907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970862|NCT02467907|Growth Inhibitors|growth inhibitors|mesh-ancestor
91970863|NCT02467127|Vitamin D|vitamin d|mesh-list
91945722|NCT04666636|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91945723|NCT04666636|Adrenergic Agents|adrenergic agents|mesh-ancestor
91945724|NCT04666636|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945725|NCT04666636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970864|NCT02467127|Vitamins|vitamins|mesh-ancestor
91970865|NCT02467127|Micronutrients|micronutrients|mesh-ancestor
91970866|NCT02467127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970867|NCT02467127|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91970868|NCT03302585|Vitamin D|vitamin d|mesh-list
91970869|NCT03302585|Ergocalciferols|ergocalciferols|mesh-list
91970870|NCT03302585|Cholecalciferol|cholecalciferol|mesh-list
91970871|NCT03302585|Vitamins|vitamins|mesh-list
91970872|NCT03302585|Micronutrients|micronutrients|mesh-ancestor
91970873|NCT03302585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970874|NCT03302585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91970875|NCT03302585|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91970876|NCT05727761|Metformin|metformin|mesh-list
91970877|NCT05727761|Pioglitazone|pioglitazone|mesh-list
91970878|NCT05727761|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91970879|NCT05727761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970880|NCT03302351|Dexmedetomidine|dexmedetomidine|mesh-list
91970881|NCT03302351|Ketamine|ketamine|mesh-list
91970905|NCT05727683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970906|NCT05727683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970907|NCT05727683|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91970908|NCT05727683|Alkylating Agents|alkylating agents|mesh-ancestor
91970909|NCT05727683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970910|NCT05727683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970911|NCT05727683|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91970912|NCT03302039|Phenylephrine|phenylephrine|mesh-list
91970913|NCT03302039|Oxymetazoline|oxymetazoline|mesh-list
91970914|NCT03302039|Bupivacaine|bupivacaine|mesh-list
91970915|NCT03302039|Anesthetics, Local|anesthetics, local|mesh-ancestor
91970916|NCT03302039|Anesthetics|anesthetics|mesh-ancestor
91970917|NCT03302039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970918|NCT03302039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970919|NCT03302039|Sensory System Agents|sensory system agents|mesh-ancestor
91970920|NCT03302039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970921|NCT03302039|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91970922|NCT03302039|Mydriatics|mydriatics|mesh-ancestor
91970923|NCT03302039|Autonomic Agents|autonomic agents|mesh-ancestor
91970924|NCT03302039|Sympathomimetics|sympathomimetics|mesh-ancestor
91970925|NCT03302039|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91970926|NCT03302039|Nasal Decongestants|nasal decongestants|mesh-ancestor
91970927|NCT03302039|Respiratory System Agents|respiratory system agents|mesh-ancestor
91970928|NCT03302039|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91970929|NCT03302039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91970930|NCT03302039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970931|NCT03302039|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970944|NCT02466503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970945|NCT02466503|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91970946|NCT02466503|Autonomic Agents|autonomic agents|mesh-ancestor
91970947|NCT02466503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970948|NCT02466503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970949|NCT02466503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91945851|NCT04546126|Antiemetics|antiemetics|mesh-ancestor
91970950|NCT02466503|Respiratory System Agents|respiratory system agents|mesh-ancestor
91970951|NCT02466503|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970952|NCT02466503|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91970953|NCT02466503|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91970954|NCT02466503|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91970955|NCT02466503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970956|NCT02466503|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970957|NCT02466503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970958|NCT02466503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970959|NCT03301181|Itraconazole|itraconazole|mesh-list
91970961|NCT03301181|Zanubrutinib|zanubrutinib|mesh-list
91970962|NCT03301181|Antifungal Agents|antifungal agents|mesh-ancestor
91970963|NCT03301181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970964|NCT03301181|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91970965|NCT03301181|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91970966|NCT03301181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945726|NCT04666636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945727|NCT04666636|Urological Agents|urological agents|mesh-ancestor
91945728|NCT04890106|Bimatoprost|bimatoprost|mesh-list
91945729|NCT04890106|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91945730|NCT04890106|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91945731|NCT04890106|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91970967|NCT03301181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970968|NCT03301181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91970969|NCT03301181|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970970|NCT03301181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970971|NCT03301181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970972|NCT03301181|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91970973|NCT03301181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91970974|NCT03301181|Antitubercular Agents|antitubercular agents|mesh-ancestor
91970975|NCT03301181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91970976|NCT03301181|Leprostatic Agents|leprostatic agents|mesh-ancestor
91970977|NCT03301181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91970978|NCT03301181|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91970979|NCT03301181|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91970980|NCT03301181|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91970981|NCT03301181|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91970982|NCT03301181|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91970983|NCT03301181|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91970984|NCT03301181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970985|NCT03301181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91970986|NCT00702221|Vaccines|vaccines|mesh-list
91970987|NCT00702221|Immunologic Factors|immunologic factors|mesh-ancestor
91970988|NCT00702221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970989|NCT03301025|Pregabalin|pregabalin|mesh-list
91970990|NCT03301025|Analgesics|analgesics|mesh-ancestor
91970991|NCT03301025|Sensory System Agents|sensory system agents|mesh-ancestor
92090413|NCT00892606|Narcotics|narcotics|mesh-ancestor
91970995|NCT03301025|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91970996|NCT03301025|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970997|NCT03301025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970998|NCT03301025|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91970999|NCT03301025|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91971000|NCT03301025|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91971001|NCT03301025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971002|NCT03301025|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971003|NCT05726903|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
91971004|NCT05726903|Medroxyprogesterone|medroxyprogesterone|mesh-list
91971005|NCT05726903|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91971006|NCT05726903|Contraceptive Agents|contraceptive agents|mesh-ancestor
91971007|NCT05726903|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91971008|NCT05726903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971009|NCT05726903|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91971010|NCT05726903|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91971011|NCT05726903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91971012|NCT05726903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971013|NCT05726903|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91971014|NCT05726903|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91971015|NCT05726903|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91971017|NCT02467595|Bromides|bromides|mesh-list
91971018|NCT02467595|Propofol|propofol|mesh-list
91971019|NCT02467595|Sevoflurane|sevoflurane|mesh-list
91971020|NCT02467595|Rocuronium|rocuronium|mesh-list
91971021|NCT02467595|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91971022|NCT02467595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971023|NCT02467595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971024|NCT02467595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971025|NCT02467595|Anesthetics, General|anesthetics, general|mesh-ancestor
91971026|NCT02467595|Anesthetics|anesthetics|mesh-ancestor
91971027|NCT02467595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91971028|NCT02467595|Narcotics|narcotics|mesh-ancestor
91971029|NCT02467595|Analgesics|analgesics|mesh-ancestor
91945732|NCT04640194|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91945733|NCT04640194|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91945734|NCT04640194|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91945735|NCT04640194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945736|NCT05214664|Anesthetics|anesthetics|mesh-list
91945737|NCT05214664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945738|NCT05214664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945739|NCT05206084|Sirolimus|sirolimus|mesh-list
91945740|NCT05206084|Everolimus|everolimus|mesh-list
91945741|NCT05206084|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91945742|NCT05206084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91945743|NCT05206084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945744|NCT05206084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945745|NCT05206084|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945746|NCT05206084|Immunologic Factors|immunologic factors|mesh-ancestor
91945747|NCT05206084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945748|NCT05206084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945749|NCT05206084|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91945750|NCT05206084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945751|NCT05206084|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91945752|NCT05206084|Antifungal Agents|antifungal agents|mesh-ancestor
91945753|NCT05198362|Metoprolol|metoprolol|mesh-list
91945754|NCT05198362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91945755|NCT05198362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91945756|NCT05198362|Sympatholytics|sympatholytics|mesh-ancestor
91945757|NCT05198362|Autonomic Agents|autonomic agents|mesh-ancestor
91945758|NCT05198362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971030|NCT02467595|Sensory System Agents|sensory system agents|mesh-ancestor
91971031|NCT02467595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971032|NCT02467595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91971033|NCT02467595|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91971034|NCT02467595|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91971035|NCT02467595|Anticonvulsants|anticonvulsants|mesh-ancestor
91971036|NCT02467595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91971037|NCT02467595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91971038|NCT02467595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91971039|NCT02467517|Magnesium Sulfate|magnesium sulfate|mesh-list
91971040|NCT02467517|Ketamine|ketamine|mesh-list
91971041|NCT02467517|Analgesics|analgesics|mesh-ancestor
91971042|NCT02467517|Sensory System Agents|sensory system agents|mesh-ancestor
91971043|NCT02467517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971044|NCT02467517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971045|NCT02467517|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91971046|NCT02467517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971047|NCT02467517|Anesthetics, General|anesthetics, general|mesh-ancestor
91971048|NCT02467517|Anesthetics|anesthetics|mesh-ancestor
91971049|NCT02467517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91945759|NCT05198362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945760|NCT05198362|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91945762|NCT05198362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91945763|NCT05198362|Adrenergic Agents|adrenergic agents|mesh-ancestor
91945764|NCT05198362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91945765|NCT05198362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945766|NCT05188222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91945768|NCT04810156|Prednisone|prednisone|mesh-list
91945769|NCT04810156|Methylprednisolone|methylprednisolone|mesh-list
91945770|NCT04810156|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91945771|NCT04810156|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91945772|NCT04810156|Prednisolone|prednisolone|mesh-list
91945773|NCT04810156|Prednisolone acetate|prednisolone acetate|mesh-list
91945774|NCT04810156|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91945775|NCT04810156|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91945776|NCT04810156|Prednisolone phosphate|prednisolone phosphate|mesh-list
91945777|NCT04810156|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91945778|NCT04810156|Glucocorticoids|glucocorticoids|mesh-ancestor
91945779|NCT04810156|Hormones|hormones|mesh-ancestor
91945850|NCT04546126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91945780|NCT04810156|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971050|NCT02467517|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91971051|NCT02467517|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91971052|NCT02467517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971053|NCT02467517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971054|NCT02467517|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91971055|NCT02467517|Anticonvulsants|anticonvulsants|mesh-ancestor
91971056|NCT02467517|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91971057|NCT02467517|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971058|NCT02467517|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91971059|NCT02467517|Tocolytic Agents|tocolytic agents|mesh-ancestor
91971060|NCT02467517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91971061|NCT02467673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91971062|NCT02467673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91971063|NCT02467673|Estradiol|estradiol|mesh-list
91971069|NCT02467673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971070|NCT02467673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91971071|NCT02467673|Contraceptive Agents|contraceptive agents|mesh-ancestor
91971072|NCT02467673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91971073|NCT02467673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91971075|NCT02953145|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91971076|NCT02953145|Hemostatics|hemostatics|mesh-ancestor
91971077|NCT02953145|Coagulants|coagulants|mesh-ancestor
91971078|NCT03300089|Anesthetics|anesthetics|mesh-list
91971079|NCT03300089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971080|NCT03300089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971081|NCT05725031|Ephedrine|ephedrine|mesh-list
91971082|NCT05725031|Rocuronium|rocuronium|mesh-list
91971083|NCT05725031|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91945781|NCT04810156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945782|NCT04810156|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91945783|NCT04810156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945784|NCT04810156|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91945785|NCT04810156|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91945786|NCT04810156|Antitubercular Agents|antitubercular agents|mesh-ancestor
91945787|NCT04810156|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91945788|NCT04810156|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945789|NCT04810156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945790|NCT04810156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945791|NCT04810156|Antiemetics|antiemetics|mesh-ancestor
91945792|NCT04810156|Autonomic Agents|autonomic agents|mesh-ancestor
91945793|NCT04810156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945794|NCT04810156|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945795|NCT04810156|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91945796|NCT04810156|Protective Agents|protective agents|mesh-ancestor
91945797|NCT04810156|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91945798|NCT04837924|Acetaminophen|acetaminophen|mesh-list
91945799|NCT04837924|Tramadol|tramadol|mesh-list
91945800|NCT04837924|Analgesics|analgesics|mesh-list
91945801|NCT04837924|Levobupivacaine|levobupivacaine|mesh-list
91945802|NCT04837924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91945803|NCT04837924|Sensory System Agents|sensory system agents|mesh-ancestor
91945804|NCT04837924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945805|NCT04837924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945806|NCT04837924|Antipyretics|antipyretics|mesh-ancestor
91945807|NCT04837924|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91945830|NCT01601470|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91945831|NCT01601470|Vasodilator Agents|vasodilator agents|mesh-ancestor
91945832|NCT01601470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91945833|NCT01601470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91945834|NCT01601470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945835|NCT01601470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945836|NCT01601470|Urological Agents|urological agents|mesh-ancestor
91945837|NCT01601470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91945839|NCT04418908|Estradiol|estradiol|mesh-list
91945840|NCT04418908|Estrogens|estrogens|mesh-ancestor
91945841|NCT04418908|Hormones|hormones|mesh-ancestor
91945842|NCT04418908|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945843|NCT04418908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945844|NCT04418908|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91945845|NCT04418908|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91945846|NCT04418908|Fertility Agents|fertility agents|mesh-ancestor
91945847|NCT04418908|Hormone Antagonists|hormone antagonists|mesh-ancestor
91945848|NCT04546126|Dexamethasone|dexamethasone|mesh-list
91945852|NCT04546126|Autonomic Agents|autonomic agents|mesh-ancestor
91971084|NCT05725031|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91971085|NCT05725031|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91971086|NCT05725031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971087|NCT05725031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971088|NCT05725031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91971089|NCT05725031|Sympathomimetics|sympathomimetics|mesh-ancestor
91971090|NCT05725031|Autonomic Agents|autonomic agents|mesh-ancestor
91971091|NCT05725031|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91971092|NCT05725031|Adrenergic Agents|adrenergic agents|mesh-ancestor
91971093|NCT05725031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971094|NCT05725031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971095|NCT04983615|Fentanyl|fentanyl|mesh-list
91971096|NCT04983615|Midazolam|midazolam|mesh-list
91971097|NCT04983615|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91971098|NCT04983615|Narcotics|narcotics|mesh-ancestor
91971099|NCT04983615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971100|NCT04983615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971101|NCT04983615|Analgesics|analgesics|mesh-ancestor
91971102|NCT04983615|Sensory System Agents|sensory system agents|mesh-ancestor
91971103|NCT04983615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971104|NCT04983615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91971105|NCT04983615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971106|NCT04983615|Anesthetics, General|anesthetics, general|mesh-ancestor
91971107|NCT04983615|Anesthetics|anesthetics|mesh-ancestor
91971108|NCT04983615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91971109|NCT04983615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91971110|NCT04983615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91971111|NCT04983615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971112|NCT04983615|GABA Modulators|gaba modulators|mesh-ancestor
91945853|NCT04546126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945854|NCT04546126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945855|NCT04546126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945856|NCT04546126|Glucocorticoids|glucocorticoids|mesh-ancestor
91945857|NCT04546126|Hormones|hormones|mesh-ancestor
91945858|NCT04546126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945859|NCT04546126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91945860|NCT04546126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945861|NCT04762498|Methotrexate|methotrexate|mesh-list
91945862|NCT04762498|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91945863|NCT04762498|Abortifacient Agents|abortifacient agents|mesh-ancestor
91945864|NCT04762498|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91945865|NCT04762498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945866|NCT04762498|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91945867|NCT04762498|Antimetabolites|antimetabolites|mesh-ancestor
91945868|NCT04762498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945869|NCT04762498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945870|NCT04762498|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945871|NCT04762498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945872|NCT04762498|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91945873|NCT04762498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945874|NCT04762498|Immunologic Factors|immunologic factors|mesh-ancestor
91945875|NCT04762498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945876|NCT04762498|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91945878|NCT04831450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91945879|NCT04831450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945880|NCT04830982|Diazoxide|diazoxide|mesh-list
91971113|NCT04983615|GABA Agents|gaba agents|mesh-ancestor
91971114|NCT04983615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971115|NCT04983615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971116|NCT00702923|Tremelimumab|tremelimumab|mesh-list
91971117|NCT00702923|Bicalutamide|bicalutamide|mesh-list
91971118|NCT00702923|Ipilimumab|ipilimumab|mesh-list
91971119|NCT00702923|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91971120|NCT00702923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971121|NCT00702923|Immunologic Factors|immunologic factors|mesh-ancestor
91971122|NCT00702923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971123|NCT00702923|Androgen Antagonists|androgen antagonists|mesh-ancestor
91971124|NCT00702923|Hormone Antagonists|hormone antagonists|mesh-ancestor
91971125|NCT00702923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971126|NCT00702923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971127|NCT00702923|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91971128|NCT00702923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945881|NCT04830982|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91945882|NCT04830982|Vasodilator Agents|vasodilator agents|mesh-ancestor
91945883|NCT04466423|Sulfamethazine|sulfamethazine|mesh-list
91945884|NCT04466423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945885|NCT05302804|Menthol|menthol|mesh-list
91945886|NCT05302804|Antipruritics|antipruritics|mesh-ancestor
91945887|NCT05302804|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945888|NCT04508140|Pembrolizumab|pembrolizumab|mesh-list
91945889|NCT04508140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91945890|NCT04508140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945891|NCT04508140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945892|NCT04508140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945893|NCT04820452|Aflibercept|aflibercept|mesh-list
91945894|NCT04820452|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91945895|NCT04820452|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91945896|NCT04820452|Growth Substances|growth substances|mesh-ancestor
91971129|NCT05294055|Cyclophosphamide|cyclophosphamide|mesh-list
91971130|NCT05294055|Etoposide|etoposide|mesh-list
91971131|NCT05294055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91971132|NCT05294055|Immunologic Factors|immunologic factors|mesh-ancestor
91971133|NCT05294055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971134|NCT05294055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91971135|NCT05294055|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91971143|NCT05294055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971144|NCT03299621|Rocuronium|rocuronium|mesh-list
91971145|NCT03299621|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91971146|NCT03299621|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91971147|NCT03299621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91971148|NCT03299621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971149|NCT03299621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971150|NCT05718167|Tislelizumab|tislelizumab|mesh-list
91971151|NCT05718167|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971152|NCT05718167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971153|NCT03299387|Gentamicins|gentamicins|mesh-list
91971154|NCT03299387|Nitrofurantoin|nitrofurantoin|mesh-list
91971155|NCT03299387|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91971156|NCT03299387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971157|NCT03299387|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91971158|NCT03299387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971159|NCT03299387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971160|NCT03299387|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91971161|NCT04954313|Chlorhexidine|chlorhexidine|mesh-list
91971162|NCT04954313|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91971163|NCT04954313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971164|NCT04954313|Disinfectants|disinfectants|mesh-ancestor
91971165|NCT02658981|Nivolumab|nivolumab|mesh-list
91971166|NCT02658981|Relatlimab|relatlimab|mesh-list
91971167|NCT02658981|Antibodies|antibodies|mesh-list
91971168|NCT02658981|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91971169|NCT02658981|Immunologic Factors|immunologic factors|mesh-ancestor
91971170|NCT02658981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971171|NCT02658981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971172|NCT02658981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971173|NCT02658981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91971174|NCT02658981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971175|NCT04794699|Paclitaxel|paclitaxel|mesh-list
91971176|NCT04794699|Docetaxel|docetaxel|mesh-list
91971177|NCT04794699|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91971178|NCT04794699|Gemcitabine|gemcitabine|mesh-list
91945897|NCT04820452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945898|NCT04820452|Growth Inhibitors|growth inhibitors|mesh-ancestor
91945899|NCT04820452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945900|NCT05298202|Capsaicin|capsaicin|mesh-list
91945901|NCT05298202|Antipruritics|antipruritics|mesh-ancestor
91945902|NCT05298202|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945903|NCT05298202|Sensory System Agents|sensory system agents|mesh-ancestor
91945904|NCT05298202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91945905|NCT05298202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945906|NCT01637272|Pasireotide|pasireotide|mesh-list
91945907|NCT01637272|Hormones|hormones|mesh-ancestor
91945908|NCT01637272|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91945909|NCT01637272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945910|NCT04458922|Atezolizumab|atezolizumab|mesh-list
91945911|NCT04458922|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91945912|NCT04458922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91945913|NCT04458922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945914|NCT04458922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91945915|NCT04458922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945916|NCT04458922|Immunologic Factors|immunologic factors|mesh-ancestor
91945917|NCT04458922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945919|NCT03178864|Rivaroxaban|rivaroxaban|mesh-list
91945920|NCT03178864|Anticoagulants|anticoagulants|mesh-ancestor
91945921|NCT03178864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91945922|NCT03178864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91945923|NCT03178864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945924|NCT03178864|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91945925|NCT03178864|Antithrombins|antithrombins|mesh-ancestor
91945926|NCT03178864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91945927|NCT03178864|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945928|NCT03178864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945929|NCT01636960|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91945930|NCT01636960|Antiviral Agents|antiviral agents|mesh-ancestor
91945931|NCT01636960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945932|NCT04009876|Oxaliplatin|oxaliplatin|mesh-list
91945933|NCT04009876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971179|NCT04794699|Pemetrexed|pemetrexed|mesh-list
91971180|NCT04794699|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91945934|NCT05309902|Moxifloxacin|moxifloxacin|mesh-list
91945935|NCT05309902|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91945936|NCT05309902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945937|NCT05309902|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91945938|NCT05309902|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91945939|NCT05309902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945940|NCT05309902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945941|NCT05309902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945942|NCT02987686|Infliximab|infliximab|mesh-list
91945943|NCT02987686|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91945944|NCT02987686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91945945|NCT02987686|Dermatologic Agents|dermatologic agents|mesh-ancestor
91945946|NCT02987686|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91945947|NCT02987686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945948|NCT02504216|Rivaroxaban|rivaroxaban|mesh-list
91945949|NCT02504216|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91945950|NCT02504216|Antithrombins|antithrombins|mesh-ancestor
91971181|NCT04794699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971182|NCT04794699|Tubulin Modulators|tubulin modulators|mesh-ancestor
91971183|NCT04794699|Antimitotic Agents|antimitotic agents|mesh-ancestor
91971184|NCT04794699|Mitosis Modulators|mitosis modulators|mesh-ancestor
91971185|NCT04794699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971186|NCT04794699|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91971187|NCT04794699|Antimetabolites|antimetabolites|mesh-ancestor
91971188|NCT04794699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971189|NCT04794699|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91971190|NCT04794699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91971191|NCT04782687|Dexamethasone|dexamethasone|mesh-list
91971192|NCT04782687|Lenalidomide|lenalidomide|mesh-list
91971193|NCT04782687|Daratumumab|daratumumab|mesh-list
91971194|NCT04782687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971195|NCT04782687|Antiemetics|antiemetics|mesh-ancestor
91971196|NCT04782687|Autonomic Agents|autonomic agents|mesh-ancestor
91971197|NCT04782687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971198|NCT04782687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971199|NCT04782687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971200|NCT04782687|Glucocorticoids|glucocorticoids|mesh-ancestor
91971201|NCT04782687|Hormones|hormones|mesh-ancestor
91971202|NCT04782687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971203|NCT04782687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91971229|NCT05655689|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91971230|NCT05655689|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91971231|NCT05655689|Hormone Antagonists|hormone antagonists|mesh-ancestor
91971232|NCT05655689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971233|NCT05655689|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91971234|NCT05655689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91971235|NCT02466347|Fluticasone|fluticasone|mesh-list
91971237|NCT02466347|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91971238|NCT02466347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971239|NCT02466347|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91971240|NCT02466347|Autonomic Agents|autonomic agents|mesh-ancestor
91971241|NCT02466347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971242|NCT02466347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971243|NCT02466347|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91971244|NCT02466347|Respiratory System Agents|respiratory system agents|mesh-ancestor
91971245|NCT02466347|Dermatologic Agents|dermatologic agents|mesh-ancestor
91971246|NCT02466347|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91945951|NCT02504216|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91945952|NCT02504216|Protease Inhibitors|protease inhibitors|mesh-ancestor
91945953|NCT02504216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945954|NCT02504216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945955|NCT02504216|Anticoagulants|anticoagulants|mesh-ancestor
91945956|NCT05277922|Nitroprusside|nitroprusside|mesh-list
91945957|NCT05277922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91945958|NCT05277922|Vasodilator Agents|vasodilator agents|mesh-ancestor
91945959|NCT05277922|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91945960|NCT05277922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945961|NCT04354870|Hydroxychloroquine|hydroxychloroquine|mesh-list
91945962|NCT04354870|Antimalarials|antimalarials|mesh-ancestor
91945963|NCT04354870|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91945964|NCT04354870|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91945965|NCT04354870|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945966|NCT04354870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945967|NCT04354870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945968|NCT04354870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91945969|NCT02917096|Vidarabine|vidarabine|mesh-list
91945970|NCT02917096|Sirolimus|sirolimus|mesh-list
91945971|NCT02917096|Fludarabine|fludarabine|mesh-list
91945972|NCT02917096|Fludarabine phosphate|fludarabine phosphate|mesh-list
91945973|NCT02917096|Melphalan|melphalan|mesh-list
91945974|NCT02917096|Mechlorethamine|mechlorethamine|mesh-list
91945975|NCT02917096|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
91945976|NCT02917096|Tacrolimus|tacrolimus|mesh-list
91945977|NCT02917096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91945978|NCT02917096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91945979|NCT02917096|Antimetabolites|antimetabolites|mesh-ancestor
91945980|NCT02917096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91945981|NCT02917096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91945982|NCT02917096|Immunologic Factors|immunologic factors|mesh-ancestor
91945983|NCT02917096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971247|NCT02466347|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91971248|NCT02466347|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91971249|NCT02466347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91971250|NCT02466347|Adrenergic Agents|adrenergic agents|mesh-ancestor
91971251|NCT02466347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971260|NCT02466191|Memantine|memantine|mesh-list
91971261|NCT02466191|Analgesics|analgesics|mesh-ancestor
91971262|NCT02466191|Sensory System Agents|sensory system agents|mesh-ancestor
91945985|NCT02917096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91945986|NCT02917096|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91945987|NCT02917096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91945988|NCT02917096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91945989|NCT02917096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91945990|NCT02917096|Antifungal Agents|antifungal agents|mesh-ancestor
91945991|NCT02917096|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91945992|NCT02917096|Alkylating Agents|alkylating agents|mesh-ancestor
91945993|NCT02917096|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91971263|NCT02466191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971264|NCT02466191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971265|NCT02466191|Anticonvulsants|anticonvulsants|mesh-ancestor
91971266|NCT02466191|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91971267|NCT02466191|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91971268|NCT02466191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971269|NCT02466191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971270|NCT02466191|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91971271|NCT02466191|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91971272|NCT02466191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971273|NCT02466191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971274|NCT02466191|Antimanic Agents|antimanic agents|mesh-ancestor
91971275|NCT02466191|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91971276|NCT02466191|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91971277|NCT02466191|Dopamine Agents|dopamine agents|mesh-ancestor
91971279|NCT05555069|Antipruritics|antipruritics|mesh-ancestor
91971280|NCT05555069|Dermatologic Agents|dermatologic agents|mesh-ancestor
91971281|NCT03067701|Carbon Monoxide|carbon monoxide|mesh-list
91971282|NCT03067701|Antimetabolites|antimetabolites|mesh-ancestor
91971283|NCT03067701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971284|NCT03067701|Gasotransmitters|gasotransmitters|mesh-ancestor
91971285|NCT03067701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971286|NCT03067701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971287|NCT03069339|Carvedilol|carvedilol|mesh-list
91971288|NCT03069339|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91971289|NCT03069339|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91971290|NCT03069339|Adrenergic Agents|adrenergic agents|mesh-ancestor
91971291|NCT03069339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971292|NCT03069339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971293|NCT03069339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971294|NCT03069339|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91971295|NCT03069339|Antioxidants|antioxidants|mesh-ancestor
91971296|NCT03069339|Protective Agents|protective agents|mesh-ancestor
91971297|NCT03069339|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91971298|NCT03069339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971299|NCT03069339|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91971300|NCT03069339|Vasodilator Agents|vasodilator agents|mesh-ancestor
91971301|NCT03069339|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91971302|NCT03069339|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91971303|NCT05546411|Leucovorin|leucovorin|mesh-list
91971304|NCT05546411|Fluorouracil|fluorouracil|mesh-list
91971305|NCT05546411|Oxaliplatin|oxaliplatin|mesh-list
91971306|NCT05546411|Irinotecan|irinotecan|mesh-list
91971307|NCT05546411|Camptothecin|camptothecin|mesh-list
91971308|NCT05546411|Levoleucovorin|levoleucovorin|mesh-list
91971309|NCT05546411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971310|NCT05546411|Antimetabolites|antimetabolites|mesh-ancestor
91971311|NCT05546411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971312|NCT05546411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91971313|NCT05546411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971314|NCT05546411|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91971315|NCT05546411|Immunologic Factors|immunologic factors|mesh-ancestor
91971316|NCT05546411|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91945994|NCT04194424|Metformin|metformin|mesh-list
91945995|NCT04194424|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91945996|NCT04194424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91945997|NCT02473640|Ceftriaxone|ceftriaxone|mesh-list
91945998|NCT02473640|Esomeprazole|esomeprazole|mesh-list
91945999|NCT02473640|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91946000|NCT02473640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946001|NCT02473640|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91946002|NCT02473640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946003|NCT02473640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946004|NCT02473640|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946005|NCT02473640|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946007|NCT01637584|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91946008|NCT01637584|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91946009|NCT01637584|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91946010|NCT01637584|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91946011|NCT01637584|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946012|NCT01637584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946013|NCT01637584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946014|NCT01637584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946015|NCT03875092|Paclitaxel|paclitaxel|mesh-list
91946016|NCT03875092|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91946017|NCT03875092|Carboplatin|carboplatin|mesh-list
91946018|NCT03875092|Pembrolizumab|pembrolizumab|mesh-list
91946019|NCT03875092|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91946020|NCT03875092|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946021|NCT03875092|Tubulin Modulators|tubulin modulators|mesh-ancestor
91971317|NCT05546411|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971318|NCT05546411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971325|NCT05542589|Phenytoin|phenytoin|mesh-list
91971326|NCT05542589|Anticonvulsants|anticonvulsants|mesh-ancestor
91971327|NCT05542589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91971328|NCT05542589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91971329|NCT05542589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971330|NCT05542589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971331|NCT05542589|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91971332|NCT05542589|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91971333|NCT03069027|Lidocaine|lidocaine|mesh-list
91971334|NCT03069027|Epinephrine|epinephrine|mesh-list
91971335|NCT03069027|Racepinephrine|racepinephrine|mesh-list
91971336|NCT03069027|Epinephryl borate|epinephryl borate|mesh-list
91971337|NCT03069027|Anesthetics, Local|anesthetics, local|mesh-ancestor
91971338|NCT03069027|Anesthetics|anesthetics|mesh-ancestor
91971339|NCT03069027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971340|NCT03069027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971341|NCT03069027|Sensory System Agents|sensory system agents|mesh-ancestor
91946022|NCT03875092|Antimitotic Agents|antimitotic agents|mesh-ancestor
91946023|NCT03875092|Mitosis Modulators|mitosis modulators|mesh-ancestor
91971342|NCT03069027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971343|NCT03069027|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91971344|NCT03069027|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91971345|NCT03069027|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91971346|NCT03069027|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971347|NCT03069027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971348|NCT03069027|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91971349|NCT03069027|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91971350|NCT03069027|Adrenergic Agents|adrenergic agents|mesh-ancestor
91971351|NCT03069027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971352|NCT03069027|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91971353|NCT03069027|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91971354|NCT03069027|Autonomic Agents|autonomic agents|mesh-ancestor
91971355|NCT03069027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91971356|NCT03069027|Respiratory System Agents|respiratory system agents|mesh-ancestor
91971357|NCT03069027|Mydriatics|mydriatics|mesh-ancestor
91971358|NCT03069027|Sympathomimetics|sympathomimetics|mesh-ancestor
91971359|NCT03069027|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91971360|NCT05635071|Nintedanib|nintedanib|mesh-list
91971361|NCT05635071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971362|NCT05635071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91971363|NCT05635071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971364|NCT05635071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971365|NCT04489979|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91971366|NCT04489979|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971368|NCT02720081|Montelukast|montelukast|mesh-list
91971369|NCT02720081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91971370|NCT02720081|Respiratory System Agents|respiratory system agents|mesh-ancestor
91971371|NCT02720081|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91971372|NCT02720081|Hormone Antagonists|hormone antagonists|mesh-ancestor
91971373|NCT02720081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971374|NCT02720081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971375|NCT02720081|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91971376|NCT02720081|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91971377|NCT02720081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971378|NCT02720081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91971380|NCT02720081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971381|NCT02720081|Tocolytic Agents|tocolytic agents|mesh-ancestor
91971382|NCT02720081|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91971383|NCT02720081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91971384|NCT02720081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91971385|NCT02720081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91971386|NCT02720081|Adrenergic Agents|adrenergic agents|mesh-ancestor
91971387|NCT02720081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971392|NCT04552197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971393|NCT05244473|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91971394|NCT05244473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971395|NCT05244473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971397|NCT05244473|Immunoconjugates|immunoconjugates|mesh-ancestor
91971398|NCT05244473|Immunologic Factors|immunologic factors|mesh-ancestor
91971399|NCT05244473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971400|NCT05634759|Azithromycin|azithromycin|mesh-list
91971401|NCT05634759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91971402|NCT05634759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971403|NCT04809233|Tipifarnib|tipifarnib|mesh-list
91971404|NCT04809233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971405|NCT02310269|Pasireotide|pasireotide|mesh-list
91971406|NCT02310269|Hormones|hormones|mesh-ancestor
91971407|NCT02310269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971408|NCT02310269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971409|NCT03069183|Ropivacaine|ropivacaine|mesh-list
91971410|NCT03069183|Anesthetics, Local|anesthetics, local|mesh-ancestor
91971411|NCT03069183|Anesthetics|anesthetics|mesh-ancestor
91971412|NCT03069183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971413|NCT03069183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971414|NCT03069183|Sensory System Agents|sensory system agents|mesh-ancestor
91946024|NCT03875092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946025|NCT03875092|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946026|NCT03875092|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91946028|NCT02728102|Melphalan|melphalan|mesh-list
91946029|NCT02728102|Molgramostim|molgramostim|mesh-list
91946030|NCT02728102|Vaccines|vaccines|mesh-list
91946031|NCT02728102|Sargramostim|sargramostim|mesh-list
91946032|NCT02728102|Immunologic Factors|immunologic factors|mesh-ancestor
91946033|NCT02728102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946034|NCT02728102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91946035|NCT02728102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91946036|NCT02728102|Growth Substances|growth substances|mesh-ancestor
91971415|NCT03069183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971416|NCT04489745|Androgens|androgens|mesh-list
91971417|NCT04489745|Hormones|hormones|mesh-ancestor
91971418|NCT04489745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971419|NCT04489745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971420|NCT02464865|Thiamine|thiamine|mesh-list
91971421|NCT02464865|Vitamin B Complex|vitamin b complex|mesh-ancestor
91971422|NCT02464865|Vitamins|vitamins|mesh-ancestor
91971423|NCT02464865|Micronutrients|micronutrients|mesh-ancestor
91971424|NCT02464865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971425|NCT02466035|Caseins|caseins|mesh-list
91971426|NCT02466035|Chelating Agents|chelating agents|mesh-ancestor
91971427|NCT02466035|Sequestering Agents|sequestering agents|mesh-ancestor
91971428|NCT02466035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971429|NCT05173337|Nefopam|nefopam|mesh-list
91971430|NCT05173337|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91971431|NCT05173337|Analgesics|analgesics|mesh-ancestor
91971432|NCT05173337|Sensory System Agents|sensory system agents|mesh-ancestor
91971433|NCT05173337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971434|NCT05173337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971435|NCT02464631|Ribavirin|ribavirin|mesh-list
91971436|NCT02464631|Sofosbuvir|sofosbuvir|mesh-list
91971437|NCT02464631|Antimetabolites|antimetabolites|mesh-ancestor
91971438|NCT02464631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971439|NCT02464631|Antiviral Agents|antiviral agents|mesh-ancestor
91971440|NCT02464631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971441|NCT04880577|Tenofovir|tenofovir|mesh-list
91971442|NCT04880577|Rituximab|rituximab|mesh-list
91971443|NCT04880577|Ocrelizumab|ocrelizumab|mesh-list
91971444|NCT04880577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971445|NCT04880577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971446|NCT04880577|Immunologic Factors|immunologic factors|mesh-ancestor
91971447|NCT04880577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971448|NCT04880577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91971449|NCT04880577|Antiviral Agents|antiviral agents|mesh-ancestor
91971450|NCT04880577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971451|NCT04880577|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91971452|NCT04880577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91971453|NCT04880577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971454|NCT04880577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971455|NCT04880577|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91971456|NCT04880577|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91971457|NCT04490213|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91971458|NCT04490213|Laxatives|laxatives|mesh-ancestor
91971459|NCT04490213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971469|NCT04562597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971470|NCT04562597|Protective Agents|protective agents|mesh-ancestor
91971471|NCT04562597|Antidotes|antidotes|mesh-ancestor
91971472|NCT04504175|Ketamine|ketamine|mesh-list
91971473|NCT04504175|Analgesics|analgesics|mesh-ancestor
91971474|NCT04504175|Sensory System Agents|sensory system agents|mesh-ancestor
91946037|NCT02728102|Growth Inhibitors|growth inhibitors|mesh-ancestor
91946038|NCT02728102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946039|NCT02728102|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91946040|NCT02728102|Alkylating Agents|alkylating agents|mesh-ancestor
91946041|NCT02728102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946042|NCT02728102|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91946043|NCT02728102|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946044|NCT02502734|Fluticasone|fluticasone|mesh-list
91946045|NCT02502734|Xhance|xhance|mesh-list
91946046|NCT02502734|Albuterol|albuterol|mesh-list
91946047|NCT02502734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971475|NCT04504175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971476|NCT04504175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971477|NCT04504175|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91971478|NCT04504175|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971479|NCT04504175|Anesthetics, General|anesthetics, general|mesh-ancestor
91971480|NCT04504175|Anesthetics|anesthetics|mesh-ancestor
91971481|NCT04504175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971482|NCT04504175|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91971483|NCT04504175|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91971484|NCT04504175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971485|NCT04504175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971486|NCT05723367|Anesthetics|anesthetics|mesh-list
91971487|NCT05723367|Anesthetics, Local|anesthetics, local|mesh-list
91971488|NCT05723367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971489|NCT05723367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971490|NCT05723367|Sensory System Agents|sensory system agents|mesh-ancestor
91971491|NCT05723367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971492|NCT03853395|Antibodies|antibodies|mesh-list
91971493|NCT03853395|Immunologic Factors|immunologic factors|mesh-ancestor
91971494|NCT03853395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971495|NCT04433169|Tretinoin|tretinoin|mesh-list
91971496|NCT04433169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971497|NCT04433169|Keratolytic Agents|keratolytic agents|mesh-ancestor
91971498|NCT04433169|Dermatologic Agents|dermatologic agents|mesh-ancestor
91971499|NCT02717195|Olanzapine|olanzapine|mesh-list
91971500|NCT02717195|Risperidone|risperidone|mesh-list
91971501|NCT02717195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91971502|NCT02717195|Serotonin Agents|serotonin agents|mesh-ancestor
91971503|NCT02717195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971504|NCT02717195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971505|NCT02717195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971506|NCT02717195|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91971507|NCT02717195|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91971508|NCT02717195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971509|NCT02717195|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971510|NCT02717195|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91971511|NCT02717195|Dopamine Agents|dopamine agents|mesh-ancestor
91971512|NCT02717195|Antiemetics|antiemetics|mesh-ancestor
91971513|NCT02717195|Autonomic Agents|autonomic agents|mesh-ancestor
91971514|NCT02717195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971515|NCT02717195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971516|NCT02717195|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91971517|NCT02717195|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91971518|NCT02717195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971519|NCT04969991|Varespladib methyl|varespladib methyl|mesh-list
91971520|NCT04969991|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
91971521|NCT04969991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971522|NCT04969991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971523|NCT05582811|Riociguat|riociguat|mesh-list
91971524|NCT05582811|Enzyme Activators|enzyme activators|mesh-ancestor
91971525|NCT05582811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971526|NCT05582031|Tislelizumab|tislelizumab|mesh-list
91971548|NCT05626101|Gemcitabine|gemcitabine|mesh-list
91946049|NCT02502734|Autonomic Agents|autonomic agents|mesh-ancestor
91946050|NCT02502734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946051|NCT02502734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971549|NCT05626101|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91971550|NCT05626101|Antimetabolites|antimetabolites|mesh-ancestor
91971551|NCT05626101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971552|NCT05626101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971560|NCT02465801|Lenograstim|lenograstim|mesh-list
91971561|NCT02465801|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91971562|NCT02465801|Immunologic Factors|immunologic factors|mesh-ancestor
91971563|NCT02465801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971564|NCT02465645|Carvedilol|carvedilol|mesh-list
91971565|NCT02465645|Simvastatin|simvastatin|mesh-list
91971566|NCT02465645|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91971567|NCT02465645|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91971568|NCT02465645|Antimetabolites|antimetabolites|mesh-ancestor
91971569|NCT02465645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971570|NCT02465645|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91971571|NCT02465645|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91971572|NCT02465645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971573|NCT02465645|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91971574|NCT02465645|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91971575|NCT02465645|Adrenergic Agents|adrenergic agents|mesh-ancestor
91971576|NCT02465645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971577|NCT02465645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971578|NCT02465645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91971580|NCT02465645|Protective Agents|protective agents|mesh-ancestor
91971581|NCT02465645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91971582|NCT02465645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971594|NCT05565495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971595|NCT04872257|Vitamin D|vitamin d|mesh-list
91971596|NCT04872257|Vitamins|vitamins|mesh-ancestor
91971597|NCT04872257|Micronutrients|micronutrients|mesh-ancestor
91971598|NCT04872257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971599|NCT04872257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91971600|NCT04970121|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91971601|NCT04970121|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91971602|NCT04970121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91971603|NCT04970121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971604|NCT04970121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971605|NCT04970121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971606|NCT04970121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971607|NCT04970121|Analgesics|analgesics|mesh-ancestor
91971608|NCT04970121|Sensory System Agents|sensory system agents|mesh-ancestor
91971609|NCT04970121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971610|NCT04970121|Antidepressive Agents|antidepressive agents|mesh-ancestor
91971611|NCT04970121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971612|NCT04970121|Dopamine Agents|dopamine agents|mesh-ancestor
91971613|NCT02463929|Diphenhydramine|diphenhydramine|mesh-list
91971614|NCT02463929|Promethazine|promethazine|mesh-list
91971615|NCT02463929|Ketamine|ketamine|mesh-list
91971616|NCT02463929|Bupivacaine|bupivacaine|mesh-list
91971617|NCT02463929|Sevoflurane|sevoflurane|mesh-list
91971618|NCT02463929|Anesthetics, Local|anesthetics, local|mesh-ancestor
91971619|NCT02463929|Anesthetics|anesthetics|mesh-ancestor
91971620|NCT02463929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971621|NCT02463929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971622|NCT02463929|Sensory System Agents|sensory system agents|mesh-ancestor
91971623|NCT02463929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971624|NCT02463929|Analgesics|analgesics|mesh-ancestor
91971625|NCT02463929|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91971626|NCT02463929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971627|NCT02463929|Anesthetics, General|anesthetics, general|mesh-ancestor
91971628|NCT02463929|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91971629|NCT02463929|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91971630|NCT02463929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946052|NCT02502734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946053|NCT02502734|Respiratory System Agents|respiratory system agents|mesh-ancestor
91971631|NCT02463929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971632|NCT02463929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91971633|NCT02463929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91971634|NCT02463929|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91971635|NCT02463929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91971637|NCT02463929|Autonomic Agents|autonomic agents|mesh-ancestor
91971638|NCT02463929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971639|NCT02463929|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91971640|NCT02463929|Histamine Antagonists|histamine antagonists|mesh-ancestor
91971641|NCT02463929|Histamine Agents|histamine agents|mesh-ancestor
91971642|NCT02463929|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91971643|NCT02463929|Antipruritics|antipruritics|mesh-ancestor
91971644|NCT02463929|Dermatologic Agents|dermatologic agents|mesh-ancestor
91971645|NCT02465255|Acetaminophen|acetaminophen|mesh-list
91971657|NCT02465255|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91971658|NCT02465255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971659|NCT02465255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971660|NCT02465255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91971661|NCT02465255|Narcotics|narcotics|mesh-ancestor
91971662|NCT02465255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971663|NCT02464709|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91971664|NCT02464709|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
91971665|NCT02464709|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91971666|NCT02464709|Dermatologic Agents|dermatologic agents|mesh-ancestor
91971667|NCT02462915|Lidocaine|lidocaine|mesh-list
91971668|NCT02462915|Fentanyl|fentanyl|mesh-list
91971669|NCT02462915|Propofol|propofol|mesh-list
91971670|NCT02462915|Cisatracurium|cisatracurium|mesh-list
91971671|NCT02462915|Anesthetics, Local|anesthetics, local|mesh-ancestor
91971672|NCT02462915|Anesthetics|anesthetics|mesh-ancestor
91971673|NCT02462915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971674|NCT02462915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971675|NCT02462915|Sensory System Agents|sensory system agents|mesh-ancestor
91971676|NCT02462915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971677|NCT02462915|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91971678|NCT02462915|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91971679|NCT02462915|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91971680|NCT02462915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971681|NCT02462915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971682|NCT02462915|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91971683|NCT02462915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971684|NCT02462915|Anesthetics, General|anesthetics, general|mesh-ancestor
91971685|NCT02462915|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91971686|NCT02462915|Narcotics|narcotics|mesh-ancestor
91971687|NCT02462915|Analgesics|analgesics|mesh-ancestor
91971688|NCT02462915|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91971689|NCT02462915|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91971690|NCT02462915|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91971691|NCT05505123|Propofol|propofol|mesh-list
91971692|NCT05505123|Sevoflurane|sevoflurane|mesh-list
91971693|NCT05505123|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91971694|NCT05505123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971695|NCT05505123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971696|NCT05505123|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971697|NCT05505123|Anesthetics, General|anesthetics, general|mesh-ancestor
91971698|NCT05505123|Anesthetics|anesthetics|mesh-ancestor
91971699|NCT05505123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91971700|NCT05505123|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91971701|NCT04914897|Pembrolizumab|pembrolizumab|mesh-list
91971702|NCT04914897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971703|NCT04914897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971704|NCT04914897|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91971705|NCT04914897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971706|NCT02462525|Dexamethasone|dexamethasone|mesh-list
91971707|NCT02462525|Pomalidomide|pomalidomide|mesh-list
91971708|NCT02462525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971709|NCT02462525|Antiemetics|antiemetics|mesh-ancestor
91971710|NCT02462525|Autonomic Agents|autonomic agents|mesh-ancestor
91971711|NCT02462525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971712|NCT02462525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946054|NCT02502734|Dermatologic Agents|dermatologic agents|mesh-ancestor
91946055|NCT02502734|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91946057|NCT02502734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91946058|NCT02502734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91946059|NCT02502734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91946060|NCT02502734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91946061|NCT02502734|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946062|NCT02502734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946063|NCT02502734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946065|NCT04193878|Formoterol Fumarate|formoterol fumarate|mesh-list
91946066|NCT04193878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946067|NCT04193878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946068|NCT04193878|Autonomic Agents|autonomic agents|mesh-ancestor
91946069|NCT04193878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946070|NCT04193878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946071|NCT04193878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946072|NCT04193878|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946073|NCT04193878|Glucocorticoids|glucocorticoids|mesh-ancestor
91971713|NCT02462525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971714|NCT02462525|Glucocorticoids|glucocorticoids|mesh-ancestor
91971715|NCT02462525|Hormones|hormones|mesh-ancestor
91971716|NCT02462525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971717|NCT02462525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91971718|NCT02462525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971719|NCT02462525|Immunologic Factors|immunologic factors|mesh-ancestor
91971720|NCT02462525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91971721|NCT02462525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91971722|NCT02462525|Growth Substances|growth substances|mesh-ancestor
91971723|NCT02462525|Growth Inhibitors|growth inhibitors|mesh-ancestor
91971724|NCT04111419|Amlodipine|amlodipine|mesh-list
91971725|NCT04111419|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
91971726|NCT04111419|Atorvastatin|atorvastatin|mesh-list
91971727|NCT04111419|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91971728|NCT04111419|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91971729|NCT04111419|Antimetabolites|antimetabolites|mesh-ancestor
91971730|NCT04111419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971731|NCT04111419|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91971732|NCT04111419|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91971733|NCT04111419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971734|NCT04111419|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91971735|NCT04111419|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91971736|NCT04111419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971737|NCT04111419|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91971738|NCT04111419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971739|NCT04111419|Vasodilator Agents|vasodilator agents|mesh-ancestor
91971740|NCT02462447|Choline|choline|mesh-list
91971741|NCT02462447|Lipotropic Agents|lipotropic agents|mesh-ancestor
91971742|NCT02462447|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91971743|NCT02462447|Antimetabolites|antimetabolites|mesh-ancestor
91971744|NCT02462447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971745|NCT02462447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91971746|NCT02462447|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91971747|NCT02462447|Nootropic Agents|nootropic agents|mesh-ancestor
91971748|NCT02462681|Ketamine|ketamine|mesh-list
91946074|NCT04193878|Hormones|hormones|mesh-ancestor
91946075|NCT04193878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946076|NCT04193878|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91946077|NCT04193878|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91946078|NCT04193878|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91946079|NCT04193878|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946080|NCT04193878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946081|NCT04193878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946082|NCT02473250|Fluoxetine|fluoxetine|mesh-list
91946083|NCT02473250|Citalopram|citalopram|mesh-list
91946084|NCT02473250|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91946085|NCT02473250|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91946086|NCT02473250|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946087|NCT02473250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971749|NCT02462681|Analgesics|analgesics|mesh-ancestor
91971750|NCT02462681|Sensory System Agents|sensory system agents|mesh-ancestor
91971751|NCT02462681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971752|NCT02462681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971753|NCT02462681|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91971754|NCT02462681|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91971755|NCT02462681|Anesthetics, General|anesthetics, general|mesh-ancestor
91971756|NCT02462681|Anesthetics|anesthetics|mesh-ancestor
91971757|NCT02462681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971758|NCT02462681|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91971759|NCT02462681|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91971760|NCT02462681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971761|NCT02462681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971762|NCT04129151|Palbociclib|palbociclib|mesh-list
91971763|NCT04129151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971764|NCT04129151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91971765|NCT04129151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971766|NCT04129151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971767|NCT02462369|Glimepiride|glimepiride|mesh-list
91971768|NCT02462369|Saxagliptin|saxagliptin|mesh-list
91971769|NCT02462369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91971770|NCT02462369|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91971771|NCT02462369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971772|NCT02462369|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91971773|NCT02462369|Immunologic Factors|immunologic factors|mesh-ancestor
91971774|NCT02462369|Incretins|incretins|mesh-ancestor
91971776|NCT02462369|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971777|NCT02462369|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91971778|NCT02462369|Protease Inhibitors|protease inhibitors|mesh-ancestor
91971779|NCT02462369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971780|NCT02462369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971781|NCT04072835|Etripamil|etripamil|mesh-list
91971782|NCT04072835|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91971783|NCT04072835|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971784|NCT04072835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971800|NCT04083963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91971801|NCT04083963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91971802|NCT04083963|Alkylating Agents|alkylating agents|mesh-ancestor
91971803|NCT04083963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91971804|NCT04083963|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91971805|NCT04083963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91946089|NCT02473250|Serotonin Agents|serotonin agents|mesh-ancestor
91946090|NCT02473250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946091|NCT02473250|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91946092|NCT02473250|Antidepressive Agents|antidepressive agents|mesh-ancestor
91946093|NCT02473250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91946094|NCT02473250|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91946095|NCT02473250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91946096|NCT02473250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946097|NCT04253626|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91946098|NCT04253626|Hematinics|hematinics|mesh-ancestor
91946099|NCT04253626|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91971806|NCT04083963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971807|NCT04083963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971808|NCT02463383|Ibuprofen|ibuprofen|mesh-list
91971809|NCT02463383|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91971810|NCT02463383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91971811|NCT02463383|Analgesics|analgesics|mesh-ancestor
91971812|NCT02463383|Sensory System Agents|sensory system agents|mesh-ancestor
91971813|NCT02463383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971814|NCT02463383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971815|NCT02463383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971816|NCT02463383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91971817|NCT02463383|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91971818|NCT02463383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971819|NCT02463383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971820|NCT03433469|Osimertinib|osimertinib|mesh-list
91971821|NCT03433469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971822|NCT03433469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91971823|NCT03433469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971824|NCT03433469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971825|NCT03108365|Hemostatics|hemostatics|mesh-list
91971826|NCT03108365|Chitosan|chitosan|mesh-list
91971827|NCT03108365|Coagulants|coagulants|mesh-ancestor
91971828|NCT03108365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91971829|NCT03108365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91971830|NCT03108365|Antimetabolites|antimetabolites|mesh-ancestor
91971831|NCT03108365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971832|NCT03108365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91971833|NCT03108365|Chelating Agents|chelating agents|mesh-ancestor
91971834|NCT03108365|Sequestering Agents|sequestering agents|mesh-ancestor
91971835|NCT05345457|Amoxicillin|amoxicillin|mesh-list
91971836|NCT05345457|Azithromycin|azithromycin|mesh-list
91971837|NCT05345457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91971838|NCT05345457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971839|NCT03922139|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91971840|NCT03922139|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91971841|NCT03922139|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91971842|NCT03922139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971843|NCT03922139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971848|NCT03922139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971849|NCT04729179|Cannabidiol|cannabidiol|mesh-list
91971850|NCT04729179|Anticonvulsants|anticonvulsants|mesh-ancestor
91971851|NCT04706715|Cemiplimab|cemiplimab|mesh-list
91971852|NCT04706715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971853|NCT04706715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971854|NCT03064191|Calcium, Dietary|calcium, dietary|mesh-list
91971855|NCT03064191|Chlorhexidine|chlorhexidine|mesh-list
91971856|NCT03064191|Calcium|calcium|mesh-list
91971857|NCT03064191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91971858|NCT03064191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971859|NCT03064191|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91946100|NCT04253626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91946101|NCT03840148|Meropenem|meropenem|mesh-list
91946102|NCT03840148|Cefepime|cefepime|mesh-list
91946103|NCT03840148|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946104|NCT03840148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946105|NCT04821778|Paclitaxel|paclitaxel|mesh-list
91946106|NCT04821778|Nimotuzumab|nimotuzumab|mesh-list
91946107|NCT04821778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91946108|NCT04821778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971860|NCT03064191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91971861|NCT03064191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971863|NCT02629965|Tiotropium Bromide|tiotropium bromide|mesh-list
91971864|NCT02629965|Olodaterol|olodaterol|mesh-list
91971865|NCT02629965|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91971866|NCT02629965|Autonomic Agents|autonomic agents|mesh-ancestor
91971867|NCT02629965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971868|NCT02629965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971869|NCT02629965|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91971870|NCT02629965|Respiratory System Agents|respiratory system agents|mesh-ancestor
91971871|NCT02629965|Parasympatholytics|parasympatholytics|mesh-ancestor
91971872|NCT02629965|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91971873|NCT02629965|Cholinergic Agents|cholinergic agents|mesh-ancestor
91971874|NCT02629965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91971875|NCT02629965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971876|NCT03062787|Triamcinolone|triamcinolone|mesh-list
91971877|NCT03062787|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91971878|NCT03062787|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91971879|NCT03062787|Hyaluronic Acid|hyaluronic acid|mesh-list
91971880|NCT03062787|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91971881|NCT03062787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971882|NCT03062787|Glucocorticoids|glucocorticoids|mesh-ancestor
91971883|NCT03062787|Hormones|hormones|mesh-ancestor
91971884|NCT03062787|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971885|NCT03062787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971886|NCT03062787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91971887|NCT03062787|Immunologic Factors|immunologic factors|mesh-ancestor
91971888|NCT03062787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971889|NCT03062787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971890|NCT03062787|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91971891|NCT03062787|Viscosupplements|viscosupplements|mesh-ancestor
91971892|NCT03062787|Protective Agents|protective agents|mesh-ancestor
91971893|NCT04601883|Colchicine|colchicine|mesh-list
91971894|NCT04601883|Gout Suppressants|gout suppressants|mesh-ancestor
91971895|NCT04601883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91971896|NCT04601883|Tubulin Modulators|tubulin modulators|mesh-ancestor
91971897|NCT04601883|Antimitotic Agents|antimitotic agents|mesh-ancestor
91971898|NCT04601883|Mitosis Modulators|mitosis modulators|mesh-ancestor
91971899|NCT04601883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971901|NCT05223075|Lidocaine|lidocaine|mesh-list
91971902|NCT05223075|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91971903|NCT05223075|Carticaine|carticaine|mesh-list
91971904|NCT05223075|Anesthetics, Local|anesthetics, local|mesh-ancestor
91971905|NCT05223075|Anesthetics|anesthetics|mesh-ancestor
91971906|NCT05223075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971907|NCT05223075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971908|NCT05223075|Sensory System Agents|sensory system agents|mesh-ancestor
91971909|NCT05223075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971910|NCT05223075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91971911|NCT05223075|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91971912|NCT05223075|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91971913|NCT05223075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971914|NCT05223075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971919|NCT03719313|Interferon alpha-2|interferon alpha-2|mesh-list
91971920|NCT03719313|Lonafarnib|lonafarnib|mesh-list
91971921|NCT03719313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971922|NCT03719313|Antiviral Agents|antiviral agents|mesh-ancestor
91971923|NCT03719313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946109|NCT04821778|Tubulin Modulators|tubulin modulators|mesh-ancestor
91946110|NCT04821778|Antimitotic Agents|antimitotic agents|mesh-ancestor
91946111|NCT04821778|Mitosis Modulators|mitosis modulators|mesh-ancestor
91946112|NCT04821778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946113|NCT04821778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946114|NCT02611024|Irinotecan|irinotecan|mesh-list
91946115|NCT02611024|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91946116|NCT02611024|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91946117|NCT02611024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946118|NCT02611024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946119|NCT02611024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946120|NCT04222504|Tenofovir|tenofovir|mesh-list
91946121|NCT04222504|Emtricitabine|emtricitabine|mesh-list
91946122|NCT04222504|Antiviral Agents|antiviral agents|mesh-ancestor
91946123|NCT04222504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946124|NCT04222504|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91946125|NCT04222504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91946126|NCT04222504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946127|NCT04222504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946128|NCT04222504|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91946129|NCT04222504|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91946131|NCT02500706|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91946132|NCT02500706|Insulin Aspart|insulin aspart|mesh-list
91971924|NCT03719313|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91971925|NCT03719313|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91971926|NCT03719313|Protease Inhibitors|protease inhibitors|mesh-ancestor
91971927|NCT03719313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971928|NCT03719313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971929|NCT03719313|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91971930|NCT03719313|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91971931|NCT03719313|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91971932|NCT03719313|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91971933|NCT03719313|Immunologic Factors|immunologic factors|mesh-ancestor
91971934|NCT03719313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971935|NCT03063879|Sofosbuvir|sofosbuvir|mesh-list
91971936|NCT03063879|Antiviral Agents|antiviral agents|mesh-ancestor
91971937|NCT03063879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971938|NCT03063723|Sofosbuvir|sofosbuvir|mesh-list
91971939|NCT03063723|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91971940|NCT03063723|Ledipasvir|ledipasvir|mesh-list
91971941|NCT03063723|Antiviral Agents|antiviral agents|mesh-ancestor
91971942|NCT03063723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971943|NCT04338321|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91971944|NCT04338321|Esketamine|esketamine|mesh-list
91971945|NCT04338321|Antidepressive Agents|antidepressive agents|mesh-ancestor
91971946|NCT04338321|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971947|NCT04338321|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91971948|NCT04338321|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91971949|NCT04338321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971950|NCT04338321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946134|NCT02500706|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
91946135|NCT02500706|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91946136|NCT02500706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946137|NCT04201496|Empagliflozin|empagliflozin|mesh-list
91946138|NCT04201496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91946139|NCT04201496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946141|NCT04201496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946142|NCT02456974|Amoxicillin|amoxicillin|mesh-list
91946143|NCT02456974|Vancomycin|vancomycin|mesh-list
91946144|NCT02456974|Ciprofloxacin|ciprofloxacin|mesh-list
91946145|NCT02456974|Meropenem|meropenem|mesh-list
91946146|NCT02456974|Tazobactam|tazobactam|mesh-list
91946147|NCT02456974|Clavulanic Acid|clavulanic acid|mesh-list
91946148|NCT02456974|Amikacin|amikacin|mesh-list
91946149|NCT02456974|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
91946150|NCT02456974|Teicoplanin|teicoplanin|mesh-list
91946151|NCT02456974|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946152|NCT02456974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946153|NCT02456974|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91946154|NCT02456974|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91946155|NCT02456974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946156|NCT02456974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946157|NCT02456974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971951|NCT00379041|Prednisone|prednisone|mesh-list
91971952|NCT00379041|Doxorubicin|doxorubicin|mesh-list
91971953|NCT00379041|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91971954|NCT00379041|Bleomycin|bleomycin|mesh-list
91971955|NCT00379041|Vincristine|vincristine|mesh-list
91971956|NCT00379041|Vinblastine|vinblastine|mesh-list
91971957|NCT00379041|Procarbazine|procarbazine|mesh-list
91971958|NCT00379041|Mechlorethamine|mechlorethamine|mesh-list
91971959|NCT00379041|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91971960|NCT00379041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971961|NCT00379041|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91971962|NCT00379041|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971963|NCT00379041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971964|NCT00379041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971965|NCT00379041|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971966|NCT00379041|Glucocorticoids|glucocorticoids|mesh-ancestor
91971967|NCT00379041|Hormones|hormones|mesh-ancestor
91971968|NCT00379041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971969|NCT00379041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971970|NCT00379041|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91971971|NCT00379041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91971972|NCT00379041|Tubulin Modulators|tubulin modulators|mesh-ancestor
91971973|NCT00379041|Antimitotic Agents|antimitotic agents|mesh-ancestor
91971974|NCT00379041|Mitosis Modulators|mitosis modulators|mesh-ancestor
91971975|NCT00379041|Alkylating Agents|alkylating agents|mesh-ancestor
91971976|NCT00379041|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91946158|NCT02456974|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91946159|NCT02456974|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91946160|NCT02456974|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91946161|NCT04797286|Sildenafil Citrate|sildenafil citrate|mesh-list
91946162|NCT04797286|Vasodilator Agents|vasodilator agents|mesh-ancestor
91946163|NCT04797286|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91946164|NCT04797286|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91946165|NCT04797286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946166|NCT04797286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946167|NCT04797286|Urological Agents|urological agents|mesh-ancestor
91946168|NCT03682276|Nivolumab|nivolumab|mesh-list
91946169|NCT03682276|Ipilimumab|ipilimumab|mesh-list
91946170|NCT03682276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946171|NCT03682276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946172|NCT03682276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91971977|NCT03063489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
91971978|NCT03063489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91971980|NCT03305445|Ipilimumab|ipilimumab|mesh-list
91971981|NCT03305445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971982|NCT03305445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971983|NCT03305445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91971984|NCT03305445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971985|NCT04436913|Fluorides|fluorides|mesh-list
91971986|NCT04436913|Fluorides, Topical|fluorides, topical|mesh-list
91971987|NCT04436913|Cariostatic Agents|cariostatic agents|mesh-ancestor
91971988|NCT04436913|Protective Agents|protective agents|mesh-ancestor
91972007|NCT03742193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972008|NCT03742193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91972009|NCT03742193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972010|NCT03742193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972011|NCT03108287|Amoxicillin|amoxicillin|mesh-list
91972012|NCT03108287|Clarithromycin|clarithromycin|mesh-list
91972013|NCT03108287|Bismuth tripotassium dicitrate|bismuth tripotassium dicitrate|mesh-list
91972014|NCT03108287|Rabeprazole|rabeprazole|mesh-list
91972015|NCT03108287|Bismuth|bismuth|mesh-list
91972016|NCT03108287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972017|NCT03108287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972018|NCT03108287|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91972019|NCT03108287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972020|NCT03108287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972021|NCT03108287|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91972022|NCT03108287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91972023|NCT03108287|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91972024|NCT03108287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972025|NCT03108287|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91972026|NCT03108287|Antacids|antacids|mesh-ancestor
91972027|NCT02461121|Cyclosporine|cyclosporine|mesh-list
91972028|NCT02461121|Mycophenolic Acid|mycophenolic acid|mesh-list
91972029|NCT02461121|Cyclophosphamide|cyclophosphamide|mesh-list
91972030|NCT02461121|Fludarabine|fludarabine|mesh-list
91972031|NCT02461121|Cyclosporins|cyclosporins|mesh-list
91972032|NCT02461121|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91972033|NCT02461121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972034|NCT02461121|Immunologic Factors|immunologic factors|mesh-ancestor
91972035|NCT02461121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972036|NCT02461121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972037|NCT02461121|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91972038|NCT02461121|Alkylating Agents|alkylating agents|mesh-ancestor
91946173|NCT03682276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946175|NCT05653024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946176|NCT05653024|Autonomic Agents|autonomic agents|mesh-ancestor
91946177|NCT05653024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946178|NCT05653024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946179|NCT05653024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946180|NCT05653024|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946181|NCT05653024|Tocolytic Agents|tocolytic agents|mesh-ancestor
91946182|NCT05653024|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972039|NCT02461121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972040|NCT02461121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972041|NCT02461121|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91972042|NCT02461121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972043|NCT02461121|Antifungal Agents|antifungal agents|mesh-ancestor
91972044|NCT02461121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972045|NCT02461121|Dermatologic Agents|dermatologic agents|mesh-ancestor
91972054|NCT02461043|Cisplatin|cisplatin|mesh-list
91972055|NCT02461043|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91972056|NCT02461043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972057|NCT02461043|Tubulin Modulators|tubulin modulators|mesh-ancestor
91972058|NCT02461043|Antimitotic Agents|antimitotic agents|mesh-ancestor
91972059|NCT02461043|Mitosis Modulators|mitosis modulators|mesh-ancestor
91972060|NCT02461043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972061|NCT03296657|Fluorides|fluorides|mesh-list
91972062|NCT03296657|Tin Fluorides|tin fluorides|mesh-list
91972063|NCT03296657|Cariostatic Agents|cariostatic agents|mesh-ancestor
91972064|NCT03296657|Protective Agents|protective agents|mesh-ancestor
91972065|NCT03296657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972066|NCT03296579|Magnesium Sulfate|magnesium sulfate|mesh-list
91972067|NCT03296579|Aminophylline|aminophylline|mesh-list
91972068|NCT03296579|Albuterol|albuterol|mesh-list
91972069|NCT03296579|Ipratropium|ipratropium|mesh-list
91972070|NCT03296579|Analgesics|analgesics|mesh-ancestor
91972071|NCT03296579|Sensory System Agents|sensory system agents|mesh-ancestor
91972072|NCT03296579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972073|NCT03296579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972074|NCT03296579|Anesthetics|anesthetics|mesh-ancestor
91972075|NCT03296579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972076|NCT03296579|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91972077|NCT03296579|Anticonvulsants|anticonvulsants|mesh-ancestor
91972078|NCT03296579|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91972079|NCT03296579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91972080|NCT03296579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972081|NCT03296579|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91972082|NCT03296579|Tocolytic Agents|tocolytic agents|mesh-ancestor
91972083|NCT03296579|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972084|NCT03296579|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91972085|NCT03296579|Autonomic Agents|autonomic agents|mesh-ancestor
91972086|NCT03296579|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91972087|NCT03296579|Respiratory System Agents|respiratory system agents|mesh-ancestor
91972088|NCT03296579|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91972089|NCT03296579|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91972090|NCT03296579|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91972091|NCT03296579|Adrenergic Agents|adrenergic agents|mesh-ancestor
91972092|NCT03296579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972093|NCT03296579|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91972094|NCT03296579|Cholinergic Agents|cholinergic agents|mesh-ancestor
91972095|NCT03296579|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91972096|NCT03296579|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91972097|NCT03296579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972098|NCT03296579|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91972099|NCT03296579|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91946183|NCT05653024|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91946184|NCT05653024|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91946185|NCT05653024|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91946186|NCT05653024|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946187|NCT05653024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946188|NCT05653024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946189|NCT02499770|Carboplatin|carboplatin|mesh-list
91946191|NCT02499770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946192|NCT02499770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91946193|NCT02499770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91972100|NCT03296579|Purinergic Agents|purinergic agents|mesh-ancestor
91972101|NCT03296579|Protective Agents|protective agents|mesh-ancestor
91972102|NCT02461667|Alendronate|alendronate|mesh-list
91972103|NCT02461667|Metformin|metformin|mesh-list
91972104|NCT02461667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91972105|NCT02461667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972106|NCT02461667|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91972107|NCT01670877|Trastuzumab|trastuzumab|mesh-list
91972108|NCT01670877|Fulvestrant|fulvestrant|mesh-list
91972109|NCT01670877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972110|NCT01670877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972111|NCT01670877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972112|NCT01670877|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91972113|NCT01670877|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91972114|NCT01670877|Hormone Antagonists|hormone antagonists|mesh-ancestor
91972117|NCT00701129|Rituximab|rituximab|mesh-list
91972118|NCT00701129|Methotrexate|methotrexate|mesh-list
91972119|NCT00701129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972120|NCT00701129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972121|NCT00701129|Immunologic Factors|immunologic factors|mesh-ancestor
91972122|NCT00701129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972123|NCT00701129|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972124|NCT00701129|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91972125|NCT00701129|Abortifacient Agents|abortifacient agents|mesh-ancestor
91972126|NCT00701129|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972127|NCT00701129|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91972128|NCT00701129|Antimetabolites|antimetabolites|mesh-ancestor
91972225|NCT04982211|Adrenergic Agents|adrenergic agents|mesh-ancestor
91972129|NCT00701129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972130|NCT00701129|Dermatologic Agents|dermatologic agents|mesh-ancestor
91972131|NCT00701129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972132|NCT00701129|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91972133|NCT00701129|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972134|NCT00701129|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91972135|NCT03296189|Dexamethasone|dexamethasone|mesh-list
91972136|NCT03296189|Dexamethasone acetate|dexamethasone acetate|mesh-list
91972137|NCT03296189|Levobupivacaine|levobupivacaine|mesh-list
91972138|NCT03296189|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91972139|NCT03296189|BB 1101|bb 1101|mesh-list
91972140|NCT03296189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972141|NCT03296189|Antiemetics|antiemetics|mesh-ancestor
91972142|NCT03296189|Autonomic Agents|autonomic agents|mesh-ancestor
91972143|NCT03296189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972144|NCT03296189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972145|NCT03296189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972146|NCT03296189|Glucocorticoids|glucocorticoids|mesh-ancestor
91972147|NCT03296189|Hormones|hormones|mesh-ancestor
91972148|NCT03296189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972149|NCT03296189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972150|NCT03296189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972151|NCT03296189|Anesthetics, Local|anesthetics, local|mesh-ancestor
91972152|NCT03296189|Anesthetics|anesthetics|mesh-ancestor
91972153|NCT03296189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972154|NCT03296189|Sensory System Agents|sensory system agents|mesh-ancestor
91946194|NCT02499770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91946195|NCT02499770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946196|NCT02499770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946198|NCT04418674|Ketamine|ketamine|mesh-list
91946199|NCT04418674|Analgesics|analgesics|mesh-ancestor
91946200|NCT04418674|Sensory System Agents|sensory system agents|mesh-ancestor
91946201|NCT04418674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946202|NCT04418674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946203|NCT04418674|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91946204|NCT04418674|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91946205|NCT04418674|Anesthetics, General|anesthetics, general|mesh-ancestor
91946206|NCT04418674|Anesthetics|anesthetics|mesh-ancestor
91946207|NCT04418674|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946208|NCT04418674|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91946209|NCT04418674|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91972155|NCT03296189|Protease Inhibitors|protease inhibitors|mesh-ancestor
91972156|NCT03296189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972157|NCT03296189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972158|NCT03295955|Amoxicillin|amoxicillin|mesh-list
91972159|NCT03295955|Clavulanic Acid|clavulanic acid|mesh-list
91972160|NCT03295955|Clavulanic Acids|clavulanic acids|mesh-list
91972161|NCT03295955|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
91972162|NCT03295955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972163|NCT03295955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972164|NCT03295955|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91972165|NCT03295955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972166|NCT03295955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972167|NCT03298373|Nandrolone Decanoate|nandrolone decanoate|mesh-list
91972168|NCT03298373|Nandrolone|nandrolone|mesh-list
91972169|NCT03298373|Nandrolone phenpropionate|nandrolone phenpropionate|mesh-list
91972170|NCT03298373|Androgens|androgens|mesh-ancestor
91972171|NCT03298373|Hormones|hormones|mesh-ancestor
91972172|NCT03298373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972173|NCT03298373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972174|NCT03298373|Anabolic Agents|anabolic agents|mesh-ancestor
91972175|NCT03298373|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91972176|NCT01670721|Leucovorin|leucovorin|mesh-list
91972177|NCT01670721|Fluorouracil|fluorouracil|mesh-list
91972178|NCT01670721|Irinotecan|irinotecan|mesh-list
91972179|NCT01670721|Aflibercept|aflibercept|mesh-list
91972180|NCT01670721|Antimetabolites|antimetabolites|mesh-ancestor
91972181|NCT01670721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972182|NCT01670721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91972183|NCT01670721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972184|NCT01670721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972185|NCT01670721|Immunologic Factors|immunologic factors|mesh-ancestor
91972186|NCT01670721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972193|NCT01670721|Vitamins|vitamins|mesh-ancestor
91972194|NCT01670721|Micronutrients|micronutrients|mesh-ancestor
91972195|NCT01670721|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91972196|NCT01670721|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91972197|NCT01670721|Growth Substances|growth substances|mesh-ancestor
91972198|NCT01670721|Growth Inhibitors|growth inhibitors|mesh-ancestor
91972199|NCT03287427|Tislelizumab|tislelizumab|mesh-list
91972200|NCT03287427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972201|NCT03287427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972202|NCT04491695|Tirofiban|tirofiban|mesh-list
91972203|NCT04491695|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91946210|NCT04418674|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946211|NCT04418674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946212|NCT04418674|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91946213|NCT04418674|Narcotics|narcotics|mesh-ancestor
91946214|NCT04418674|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91946216|NCT02442284|Ribavirin|ribavirin|mesh-list
91946217|NCT02442284|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91946218|NCT02442284|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91946219|NCT02442284|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946220|NCT02442284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946221|NCT02442284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946222|NCT02442284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91946223|NCT02442284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91946224|NCT02442284|Antiviral Agents|antiviral agents|mesh-ancestor
91946225|NCT02442284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946226|NCT02442284|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91946227|NCT02442284|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91946228|NCT02442284|Antimetabolites|antimetabolites|mesh-ancestor
91946229|NCT03781960|Nivolumab|nivolumab|mesh-list
91946230|NCT03781960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946231|NCT03781960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946232|NCT03781960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91946233|NCT03781960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946234|NCT02499146|Letrozole|letrozole|mesh-list
91946235|NCT02499146|Palbociclib|palbociclib|mesh-list
91946236|NCT02499146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946237|NCT02499146|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91946238|NCT02499146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91946239|NCT02499146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946240|NCT02499146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972204|NCT04491695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91972205|NCT04491695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972206|NCT04491695|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91972207|NCT04982055|Nadroparin|nadroparin|mesh-list
91972208|NCT04982055|Anticoagulants|anticoagulants|mesh-ancestor
91972209|NCT04982055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91972210|NCT04982055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91972211|NCT04982055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972212|NCT04981743|Vitamin D|vitamin d|mesh-list
91972213|NCT04981743|Vitamins|vitamins|mesh-ancestor
91946241|NCT02499146|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91946242|NCT02499146|Hormone Antagonists|hormone antagonists|mesh-ancestor
91946243|NCT02499146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946244|NCT02499146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946245|NCT02499146|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946246|NCT01634854|Misoprostol|misoprostol|mesh-list
91946247|NCT01634854|Oxytocin|oxytocin|mesh-list
91946248|NCT01634854|Oxytocics|oxytocics|mesh-ancestor
91946249|NCT01634854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91946250|NCT01634854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946251|NCT01634854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91946252|NCT01634854|Abortifacient Agents|abortifacient agents|mesh-ancestor
91946253|NCT01634854|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91946254|NCT01634854|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946255|NCT05651464|Vancomycin|vancomycin|mesh-list
91946256|NCT05651464|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972214|NCT04981743|Micronutrients|micronutrients|mesh-ancestor
91972215|NCT04981743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972216|NCT04981743|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91972217|NCT04489121|Omalizumab|omalizumab|mesh-list
91972218|NCT04489121|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91972219|NCT04489121|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91972220|NCT04489121|Respiratory System Agents|respiratory system agents|mesh-ancestor
91972221|NCT04973787|Antirheumatic Agents|antirheumatic agents|mesh-list
91972222|NCT04982211|Propranolol|propranolol|mesh-list
91972223|NCT04982211|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91972224|NCT04982211|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91972226|NCT04982211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972227|NCT04982211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972228|NCT04982211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972229|NCT04982211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91972230|NCT04982211|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91972231|NCT04982211|Vasodilator Agents|vasodilator agents|mesh-ancestor
91972232|NCT03290963|Ketamine|ketamine|mesh-list
91972233|NCT03290963|Analgesics|analgesics|mesh-ancestor
91972234|NCT03290963|Sensory System Agents|sensory system agents|mesh-ancestor
91972235|NCT03290963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972236|NCT03290963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972237|NCT03290963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91972238|NCT03290963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91972239|NCT03290963|Anesthetics, General|anesthetics, general|mesh-ancestor
91972240|NCT03290963|Anesthetics|anesthetics|mesh-ancestor
91972241|NCT03290963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972242|NCT03290963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91972243|NCT03290963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91972244|NCT03290963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972245|NCT03290963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972246|NCT03294707|Coal Tar|coal tar|mesh-list
91972247|NCT03294707|Keratolytic Agents|keratolytic agents|mesh-ancestor
91972248|NCT03294707|Dermatologic Agents|dermatologic agents|mesh-ancestor
91972249|NCT03062319|Anticoagulants|anticoagulants|mesh-list
91972250|NCT03062319|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91972251|NCT03290495|Ketamine|ketamine|mesh-list
91972252|NCT03290495|Analgesics|analgesics|mesh-ancestor
91972253|NCT03290495|Sensory System Agents|sensory system agents|mesh-ancestor
91972254|NCT03290495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946257|NCT05651464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946258|NCT01897480|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91946259|NCT01897480|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946260|NCT01897480|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946261|NCT01897480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946262|NCT01897480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946263|NCT02441114|Fluticasone|fluticasone|mesh-list
91946264|NCT02441114|Tiotropium Bromide|tiotropium bromide|mesh-list
91946265|NCT02441114|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91946266|NCT02441114|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91946267|NCT02441114|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946268|NCT02441114|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946269|NCT02441114|Autonomic Agents|autonomic agents|mesh-ancestor
91946270|NCT02441114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946271|NCT02441114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946272|NCT02441114|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946273|NCT02441114|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946274|NCT02441114|Dermatologic Agents|dermatologic agents|mesh-ancestor
91946275|NCT02441114|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91946276|NCT02441114|Parasympatholytics|parasympatholytics|mesh-ancestor
91946277|NCT02441114|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91946278|NCT02441114|Cholinergic Agents|cholinergic agents|mesh-ancestor
91946279|NCT02441114|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946280|NCT02441114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946281|NCT02441114|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91946282|NCT02441114|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91946283|NCT02441114|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91946284|NCT02441114|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946285|NCT02441114|Glucocorticoids|glucocorticoids|mesh-ancestor
91972255|NCT03290495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972256|NCT03290495|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91972257|NCT03290495|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91972262|NCT03290495|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91972263|NCT03290495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972264|NCT03290495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972265|NCT04429893|Magnesium Sulfate|magnesium sulfate|mesh-list
91972266|NCT04429893|Bupivacaine|bupivacaine|mesh-list
91972267|NCT04429893|Anesthetics, Local|anesthetics, local|mesh-ancestor
91972268|NCT04429893|Anesthetics|anesthetics|mesh-ancestor
91972269|NCT04429893|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972270|NCT04429893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972271|NCT04429893|Sensory System Agents|sensory system agents|mesh-ancestor
91946287|NCT02441114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946288|NCT02441114|Sympathomimetics|sympathomimetics|mesh-ancestor
91946289|NCT02498444|Treprostinil|treprostinil|mesh-list
91946290|NCT02498444|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91946291|NCT05235256|Dexamethasone|dexamethasone|mesh-list
91946292|NCT05235256|Lidocaine|lidocaine|mesh-list
91946293|NCT05235256|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946294|NCT05235256|Antiemetics|antiemetics|mesh-ancestor
91946295|NCT05235256|Autonomic Agents|autonomic agents|mesh-ancestor
91946296|NCT05235256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946297|NCT05235256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946298|NCT05235256|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946299|NCT05235256|Glucocorticoids|glucocorticoids|mesh-ancestor
91946300|NCT05235256|Hormones|hormones|mesh-ancestor
91946301|NCT05235256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946302|NCT05235256|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91946303|NCT05235256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946304|NCT05235256|Anesthetics, Local|anesthetics, local|mesh-ancestor
91946305|NCT05235256|Anesthetics|anesthetics|mesh-ancestor
91946306|NCT05235256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946307|NCT05235256|Sensory System Agents|sensory system agents|mesh-ancestor
91946308|NCT05235256|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91946309|NCT05235256|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91946310|NCT05235256|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91946311|NCT05235256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946312|NCT05235256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946313|NCT02497976|Certolizumab Pegol|certolizumab pegol|mesh-list
91946314|NCT02497976|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91946315|NCT02497976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946316|NCT02497976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946317|NCT02497976|Immunologic Factors|immunologic factors|mesh-ancestor
91946318|NCT02497976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946319|NCT02497976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946320|NCT04791514|Treprostinil|treprostinil|mesh-list
91946326|NCT04596826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946327|NCT04596826|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91946328|NCT04596826|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91946329|NCT04596826|Analgesics|analgesics|mesh-ancestor
91946330|NCT04596826|Sensory System Agents|sensory system agents|mesh-ancestor
91946331|NCT04596826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946332|NCT04596826|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91946333|NCT04596826|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91946334|NCT04596826|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946335|NCT04596826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946337|NCT04596826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946338|NCT02440568|Cytarabine|cytarabine|mesh-list
91946339|NCT02440568|Idarubicin|idarubicin|mesh-list
91946340|NCT02440568|Homoharringtonine|homoharringtonine|mesh-list
91946341|NCT02440568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91972272|NCT04429893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972273|NCT04429893|Analgesics|analgesics|mesh-ancestor
91972274|NCT04429893|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91972275|NCT04429893|Anticonvulsants|anticonvulsants|mesh-ancestor
91972276|NCT04429893|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91972277|NCT04429893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91972278|NCT04429893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972279|NCT04429893|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91972280|NCT04429893|Tocolytic Agents|tocolytic agents|mesh-ancestor
91972281|NCT04429893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972282|NCT03290417|Vitamin D|vitamin d|mesh-list
91972283|NCT03290417|Ergocalciferols|ergocalciferols|mesh-list
91972284|NCT03290417|Cholecalciferol|cholecalciferol|mesh-list
91972285|NCT03290417|Vitamins|vitamins|mesh-list
91972286|NCT03290417|Curcumin|curcumin|mesh-list
91972287|NCT03290417|Turmeric extract|turmeric extract|mesh-list
91972288|NCT03290417|Micronutrients|micronutrients|mesh-ancestor
91972289|NCT03290417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972290|NCT03290417|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91972291|NCT03290417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91972292|NCT03290417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91972293|NCT03290417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972294|NCT03290417|Analgesics|analgesics|mesh-ancestor
91972295|NCT03290417|Sensory System Agents|sensory system agents|mesh-ancestor
91972296|NCT03290417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972297|NCT03290417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972298|NCT03290417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972299|NCT03290417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972300|NCT03290417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972301|NCT03290417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972302|NCT03290417|Antioxidants|antioxidants|mesh-ancestor
91972303|NCT03290417|Protective Agents|protective agents|mesh-ancestor
91972304|NCT04429347|Gabapentin|gabapentin|mesh-list
91972305|NCT04429347|Tizanidine|tizanidine|mesh-list
91972306|NCT04429347|Analgesics|analgesics|mesh-ancestor
91972307|NCT04429347|Sensory System Agents|sensory system agents|mesh-ancestor
91972308|NCT04429347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972309|NCT04429347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972310|NCT04429347|Anticonvulsants|anticonvulsants|mesh-ancestor
91972311|NCT04429347|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91972312|NCT04429347|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91972313|NCT04429347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946342|NCT02440568|Antimetabolites|antimetabolites|mesh-ancestor
91946343|NCT02440568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946344|NCT02440568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946345|NCT02440568|Antiviral Agents|antiviral agents|mesh-ancestor
91946346|NCT02440568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946347|NCT02440568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946348|NCT02440568|Immunologic Factors|immunologic factors|mesh-ancestor
91946349|NCT02440568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946350|NCT02440568|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91946351|NCT02440568|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91946352|NCT02440568|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91946353|NCT02440568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946354|NCT02440568|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91946355|NCT02440568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91946357|NCT00679120|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91972314|NCT04429347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91972315|NCT04429347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91972316|NCT04429347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91972317|NCT04429347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972318|NCT04429347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972319|NCT04429347|Antimanic Agents|antimanic agents|mesh-ancestor
91972320|NCT04429347|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91972321|NCT04429347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91972322|NCT04429347|Parasympatholytics|parasympatholytics|mesh-ancestor
91972323|NCT04429347|Autonomic Agents|autonomic agents|mesh-ancestor
91972324|NCT04429347|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91972325|NCT04429347|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91972326|NCT04429347|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91972327|NCT04429347|Adrenergic Agents|adrenergic agents|mesh-ancestor
91972330|NCT03294551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972332|NCT04156581|Bupivacaine|bupivacaine|mesh-list
91972333|NCT04156581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972334|NCT04156581|Antiemetics|antiemetics|mesh-ancestor
91972335|NCT04156581|Autonomic Agents|autonomic agents|mesh-ancestor
91972336|NCT04156581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972337|NCT04156581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972338|NCT04156581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972339|NCT04156581|Glucocorticoids|glucocorticoids|mesh-ancestor
91972340|NCT04156581|Hormones|hormones|mesh-ancestor
91972341|NCT04156581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972342|NCT04156581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972343|NCT04156581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972344|NCT04156581|Anesthetics, Local|anesthetics, local|mesh-ancestor
91972345|NCT04156581|Anesthetics|anesthetics|mesh-ancestor
91972346|NCT04156581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972347|NCT04156581|Sensory System Agents|sensory system agents|mesh-ancestor
91972348|NCT02983071|Fulvestrant|fulvestrant|mesh-list
91972349|NCT02983071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972350|NCT02983071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972351|NCT02983071|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91972352|NCT02983071|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91972353|NCT02983071|Hormone Antagonists|hormone antagonists|mesh-ancestor
91972354|NCT02983071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972355|NCT02983071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972356|NCT03294395|Gentamicins|gentamicins|mesh-list
91946358|NCT00679120|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946359|NCT00679120|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91946360|NCT00679120|Histamine Antagonists|histamine antagonists|mesh-ancestor
91946362|NCT00679120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946363|NCT00679120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946364|NCT00679120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946365|NCT00679120|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91946366|NCT00679120|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91946367|NCT00679120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946368|NCT04420624|Colchicine|colchicine|mesh-list
91946369|NCT04420624|Gout Suppressants|gout suppressants|mesh-ancestor
91946370|NCT04420624|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946371|NCT04420624|Tubulin Modulators|tubulin modulators|mesh-ancestor
91946372|NCT04420624|Antimitotic Agents|antimitotic agents|mesh-ancestor
91946373|NCT04420624|Mitosis Modulators|mitosis modulators|mesh-ancestor
91946374|NCT04420624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946375|NCT04420624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946376|NCT04782778|Bupivacaine|bupivacaine|mesh-list
91946377|NCT04782778|Anesthetics, Local|anesthetics, local|mesh-ancestor
91946378|NCT04782778|Anesthetics|anesthetics|mesh-ancestor
91946379|NCT04782778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946380|NCT04782778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946381|NCT04782778|Sensory System Agents|sensory system agents|mesh-ancestor
91946382|NCT04782778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946383|NCT00434434|Omalizumab|omalizumab|mesh-list
91972357|NCT03294395|Ceftriaxone|ceftriaxone|mesh-list
91972358|NCT03294395|Ertapenem|ertapenem|mesh-list
91972359|NCT03294395|Fosfomycin|fosfomycin|mesh-list
91972360|NCT03294395|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972361|NCT03294395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972362|NCT03294395|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91972363|NCT03294395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972364|NCT03294395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972365|NCT04980105|Methylprednisolone|methylprednisolone|mesh-list
91972366|NCT04980105|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91972367|NCT04980105|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91972368|NCT04980105|Prednisolone|prednisolone|mesh-list
91972369|NCT04980105|Prednisolone acetate|prednisolone acetate|mesh-list
91972370|NCT04980105|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91972371|NCT04980105|Prednisolone phosphate|prednisolone phosphate|mesh-list
91972372|NCT04980105|Hyaluronic Acid|hyaluronic acid|mesh-list
91972373|NCT04980105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972374|NCT04980105|Antiemetics|antiemetics|mesh-ancestor
91972375|NCT04980105|Autonomic Agents|autonomic agents|mesh-ancestor
91972376|NCT04980105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972377|NCT04980105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972378|NCT04980105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972379|NCT04980105|Glucocorticoids|glucocorticoids|mesh-ancestor
91972380|NCT04980105|Hormones|hormones|mesh-ancestor
91946384|NCT00434434|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91946385|NCT00434434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91946386|NCT00434434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946387|NCT00434434|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946388|NCT00434434|Immunologic Factors|immunologic factors|mesh-ancestor
91946389|NCT00434434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946390|NCT04047797|Rituximab|rituximab|mesh-list
91946391|NCT04047797|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91946392|NCT04047797|Ixazomib|ixazomib|mesh-list
91946393|NCT04047797|Antibodies|antibodies|mesh-list
91946394|NCT04047797|Immunoglobulins|immunoglobulins|mesh-list
91946395|NCT04047797|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91946396|NCT04047797|Glycine|glycine|mesh-list
91946397|NCT04047797|Immunologic Factors|immunologic factors|mesh-ancestor
91946398|NCT04047797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946399|NCT04047797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946400|NCT04047797|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946401|NCT04047797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946402|NCT04047797|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946403|NCT04047797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946404|NCT04047797|Glycine Agents|glycine agents|mesh-ancestor
91946405|NCT04047797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946406|NCT04002401|Cyclophosphamide|cyclophosphamide|mesh-list
91946407|NCT04002401|Rituximab|rituximab|mesh-list
91946408|NCT04002401|Fludarabine|fludarabine|mesh-list
91946409|NCT04002401|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
91946410|NCT04002401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946411|NCT04002401|Immunologic Factors|immunologic factors|mesh-ancestor
91946412|NCT04002401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946413|NCT04002401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946414|NCT04002401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91946415|NCT04002401|Alkylating Agents|alkylating agents|mesh-ancestor
91972381|NCT04980105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972382|NCT04980105|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91972383|NCT04980105|Protective Agents|protective agents|mesh-ancestor
91972384|NCT04980105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972385|NCT04980105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972386|NCT04980105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91972387|NCT04980105|Immunologic Factors|immunologic factors|mesh-ancestor
91972388|NCT04980105|Viscosupplements|viscosupplements|mesh-ancestor
91972389|NCT04973319|Trastuzumab|trastuzumab|mesh-list
91972390|NCT04973319|Pertuzumab|pertuzumab|mesh-list
91972391|NCT04973319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972392|NCT04973319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972393|NCT03294161|Meglumine Antimoniate|meglumine antimoniate|mesh-list
91946416|NCT04002401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946417|NCT04002401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946418|NCT04002401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91946419|NCT04002401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946420|NCT03046511|Cefazolin|cefazolin|mesh-list
91946421|NCT03046511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91946422|NCT03046511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946423|NCT02439320|Lasmiditan|lasmiditan|mesh-list
91946424|NCT02439320|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91946425|NCT02439320|Serotonin Agents|serotonin agents|mesh-ancestor
91946426|NCT02439320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946427|NCT02439320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946428|NCT02439320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946429|NCT02468648|Sofosbuvir|sofosbuvir|mesh-list
91946430|NCT02468648|Velpatasvir|velpatasvir|mesh-list
91946431|NCT02468648|Antiviral Agents|antiviral agents|mesh-ancestor
91946432|NCT02468648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946433|NCT02466386|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
91946434|NCT02466386|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91946436|NCT02466386|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91946437|NCT02466386|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91946438|NCT02466386|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946439|NCT02466386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946440|NCT02466386|Dopamine Agents|dopamine agents|mesh-ancestor
91946441|NCT02466386|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946442|NCT01633060|Fulvestrant|fulvestrant|mesh-list
91946443|NCT01633060|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91946444|NCT01633060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946445|NCT01633060|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91946446|NCT01633060|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91972394|NCT03294161|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91972395|NCT03294161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91972396|NCT03294161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972397|NCT03289871|Amorolfine|amorolfine|mesh-list
91972398|NCT03289871|Antifungal Agents|antifungal agents|mesh-ancestor
91972399|NCT03289871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972400|NCT03289637|Vitamin D|vitamin d|mesh-list
91972401|NCT03289637|Vitamins|vitamins|mesh-ancestor
91972402|NCT03289637|Micronutrients|micronutrients|mesh-ancestor
91972403|NCT03289637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972409|NCT04854837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972410|NCT02460497|Minoxidil|minoxidil|mesh-list
91946447|NCT01633060|Hormone Antagonists|hormone antagonists|mesh-ancestor
91946448|NCT01633060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946449|NCT01633060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946450|NCT03906695|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
91946451|NCT03906695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91946452|NCT03906695|Antimetabolites|antimetabolites|mesh-ancestor
91946453|NCT03906695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946454|NCT03906695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946455|NCT03878459|Pioglitazone|pioglitazone|mesh-list
91946456|NCT03878459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91946457|NCT03878459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946458|NCT02819141|Dexmedetomidine|dexmedetomidine|mesh-list
91946459|NCT02819141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91946460|NCT02819141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946461|NCT02819141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946462|NCT02819141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91946463|NCT02819141|Analgesics|analgesics|mesh-ancestor
91946464|NCT02819141|Sensory System Agents|sensory system agents|mesh-ancestor
91946465|NCT02819141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946466|NCT02819141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91946467|NCT02819141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91946468|NCT02819141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91946469|NCT02819141|Adrenergic Agents|adrenergic agents|mesh-ancestor
91972411|NCT02460497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91972412|NCT02460497|Vasodilator Agents|vasodilator agents|mesh-ancestor
91972413|NCT03289559|Testosterone|testosterone|mesh-list
91972414|NCT03289559|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91972415|NCT03289559|Androgens|androgens|mesh-ancestor
91972416|NCT03289559|Hormones|hormones|mesh-ancestor
91972417|NCT03289559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972418|NCT03289559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972419|NCT03289559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91972420|NCT03289559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972421|NCT03289559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972422|NCT03289559|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91972423|NCT03289559|Hormone Antagonists|hormone antagonists|mesh-ancestor
91972424|NCT03293927|Fentanyl|fentanyl|mesh-list
91972425|NCT03293927|Dexmedetomidine|dexmedetomidine|mesh-list
91972426|NCT03293927|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91972427|NCT03293927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972428|NCT03293927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972429|NCT03293927|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972430|NCT03293927|Analgesics|analgesics|mesh-ancestor
91972431|NCT03293927|Sensory System Agents|sensory system agents|mesh-ancestor
91972432|NCT03293927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972433|NCT03293927|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91972434|NCT03293927|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91972436|NCT03293927|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946470|NCT02819141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946471|NCT02819141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946473|NCT01632904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946474|NCT01632904|Antisickling Agents|antisickling agents|mesh-ancestor
91946475|NCT01632904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946476|NCT01632904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946477|NCT01632904|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91946478|NCT04240756|Amphetamine|amphetamine|mesh-list
91946479|NCT04240756|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91972437|NCT03293927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972438|NCT03293927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972439|NCT03293927|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91972440|NCT03293927|Narcotics|narcotics|mesh-ancestor
91972441|NCT03293927|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91972442|NCT03293927|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91972443|NCT03293927|Anesthetics, General|anesthetics, general|mesh-ancestor
91972444|NCT03293927|Anesthetics|anesthetics|mesh-ancestor
91972445|NCT02730429|Letrozole|letrozole|mesh-list
91972446|NCT02730429|Palbociclib|palbociclib|mesh-list
91972447|NCT02730429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972448|NCT02730429|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91972449|NCT02730429|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91972450|NCT02730429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972451|NCT02730429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972452|NCT02730429|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91972453|NCT02730429|Hormone Antagonists|hormone antagonists|mesh-ancestor
91972454|NCT02730429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972455|NCT02730429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972456|NCT02730429|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91972457|NCT04971759|Fentanyl|fentanyl|mesh-list
91972458|NCT04971759|Dexmedetomidine|dexmedetomidine|mesh-list
91972459|NCT04971759|Levobupivacaine|levobupivacaine|mesh-list
91972460|NCT04971759|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91972461|NCT04971759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972462|NCT04971759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972463|NCT04971759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972464|NCT04971759|Analgesics|analgesics|mesh-ancestor
91972465|NCT04971759|Sensory System Agents|sensory system agents|mesh-ancestor
91972466|NCT04971759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972467|NCT04971759|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91972468|NCT04971759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91972469|NCT04971759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91972470|NCT04971759|Adrenergic Agents|adrenergic agents|mesh-ancestor
91972471|NCT04971759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972472|NCT04971759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972473|NCT04971759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91972474|NCT04971759|Narcotics|narcotics|mesh-ancestor
91972480|NCT03289169|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91972481|NCT03289169|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91972482|NCT03289169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972483|NCT03289169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972484|NCT03289169|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91972485|NCT03289169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91972486|NCT03289169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972487|NCT03289169|Cholinergic Agents|cholinergic agents|mesh-ancestor
91972488|NCT03289169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972490|NCT04979091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972491|NCT04979091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972492|NCT04971291|Bupropion|bupropion|mesh-list
91972493|NCT04971291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91946480|NCT04240756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946481|NCT04240756|Sympathomimetics|sympathomimetics|mesh-ancestor
91946482|NCT04240756|Autonomic Agents|autonomic agents|mesh-ancestor
91946483|NCT04240756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946484|NCT04240756|Dopamine Agents|dopamine agents|mesh-ancestor
91946485|NCT04240756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972494|NCT04971291|Antidepressive Agents|antidepressive agents|mesh-ancestor
91972495|NCT04971291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91972496|NCT04971291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91972497|NCT04971291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91972498|NCT04971291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91972499|NCT04971291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972500|NCT04971291|Dopamine Agents|dopamine agents|mesh-ancestor
91972501|NCT04971291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972502|NCT04971291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972503|NCT04971291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91972504|NCT04971291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91972505|NCT04971291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972506|NCT03107507|Levetiracetam|levetiracetam|mesh-list
91972507|NCT03107507|Phenobarbital|phenobarbital|mesh-list
91972508|NCT03107507|Anticonvulsants|anticonvulsants|mesh-ancestor
91972509|NCT03107507|Nootropic Agents|nootropic agents|mesh-ancestor
91972510|NCT03107507|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91972511|NCT03107507|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972512|NCT03107507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972513|NCT03107507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91972514|NCT03107507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91972515|NCT03107507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972516|NCT03107507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972517|NCT03107507|GABA Modulators|gaba modulators|mesh-ancestor
91972518|NCT03107507|GABA Agents|gaba agents|mesh-ancestor
91972519|NCT03107507|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91972520|NCT03107507|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91972521|NCT03107507|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91972522|NCT02711137|Paclitaxel|paclitaxel|mesh-list
91972523|NCT02711137|Gemcitabine|gemcitabine|mesh-list
91972524|NCT02711137|Azacitidine|azacitidine|mesh-list
91972525|NCT02711137|Rucaparib|rucaparib|mesh-list
91972526|NCT02711137|INCB057643|incb057643|mesh-list
91972527|NCT02711137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91972528|NCT02711137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972529|NCT02711137|Tubulin Modulators|tubulin modulators|mesh-ancestor
91972530|NCT02711137|Antimitotic Agents|antimitotic agents|mesh-ancestor
91972531|NCT02711137|Mitosis Modulators|mitosis modulators|mesh-ancestor
91972532|NCT02711137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972533|NCT02711137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91972534|NCT02711137|Antimetabolites|antimetabolites|mesh-ancestor
91972535|NCT02711137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972536|NCT02711137|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91972537|NCT04155411|Dasatinib|dasatinib|mesh-list
91972538|NCT04155411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972539|NCT04155411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91972540|NCT04155411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972541|NCT04155411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972542|NCT04970667|Flupenthixol|flupenthixol|mesh-list
91972543|NCT04970667|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
91972544|NCT04970667|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91972545|NCT04970667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91972546|NCT04970667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972547|NCT04970667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972548|NCT04970667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91972549|NCT04970667|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91972550|NCT04970667|Dopamine Agents|dopamine agents|mesh-ancestor
91972551|NCT04970667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972552|NCT04970667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972553|NCT03288233|Carbon Monoxide|carbon monoxide|mesh-list
91972554|NCT03288233|Antimetabolites|antimetabolites|mesh-ancestor
91946486|NCT04240756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946487|NCT04240756|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946488|NCT04240756|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91946489|NCT04240756|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91946490|NCT04240756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946491|NCT04240756|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91946492|NCT04467125|Lidocaine|lidocaine|mesh-list
91946493|NCT04467125|Prilocaine|prilocaine|mesh-list
91946494|NCT04467125|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
91946495|NCT04467125|Anesthetics, Local|anesthetics, local|mesh-ancestor
91946496|NCT04467125|Anesthetics|anesthetics|mesh-ancestor
91946497|NCT04467125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946498|NCT04467125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946499|NCT04467125|Sensory System Agents|sensory system agents|mesh-ancestor
91972555|NCT03288233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972556|NCT03288233|Gasotransmitters|gasotransmitters|mesh-ancestor
91972557|NCT03288233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972558|NCT03288233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972559|NCT03288077|Tryptophan|tryptophan|mesh-list
91972560|NCT03288077|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91972561|NCT03288077|Antidepressive Agents|antidepressive agents|mesh-ancestor
91972562|NCT03288077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91972563|NCT00777127|Diclofenac|diclofenac|mesh-list
91972564|NCT00777127|Imiquimod|imiquimod|mesh-list
91972565|NCT00777127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91972566|NCT00777127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972567|NCT00777127|Analgesics|analgesics|mesh-ancestor
91972568|NCT00777127|Sensory System Agents|sensory system agents|mesh-ancestor
91972569|NCT00777127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972570|NCT00777127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972571|NCT00777127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972572|NCT00777127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972573|NCT00777127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91972574|NCT00777127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972575|NCT00777127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972576|NCT00777127|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91972577|NCT00777127|Immunologic Factors|immunologic factors|mesh-ancestor
91972578|NCT00777127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972579|NCT00777127|Interferon Inducers|interferon inducers|mesh-ancestor
91972580|NCT00761371|Imiquimod|imiquimod|mesh-list
91972581|NCT00761371|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91972582|NCT00761371|Immunologic Factors|immunologic factors|mesh-ancestor
91972583|NCT00761371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972584|NCT00761371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972585|NCT00761371|Interferon Inducers|interferon inducers|mesh-ancestor
91972586|NCT03287921|Bronchodilator Agents|bronchodilator agents|mesh-list
91972587|NCT03287921|Autonomic Agents|autonomic agents|mesh-ancestor
91972588|NCT03287921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972589|NCT03287921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972590|NCT03287921|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91972591|NCT03287921|Respiratory System Agents|respiratory system agents|mesh-ancestor
91972592|NCT03287609|Evolocumab|evolocumab|mesh-list
91972593|NCT03287609|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91972594|NCT03287609|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91972595|NCT03287609|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91972596|NCT03287609|Antimetabolites|antimetabolites|mesh-ancestor
91972597|NCT03287609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972598|NCT03287609|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91972599|NCT03287609|Protease Inhibitors|protease inhibitors|mesh-ancestor
91972600|NCT03287609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946500|NCT04467125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946501|NCT04467125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91946502|NCT04467125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91946503|NCT04467125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91946504|NCT04467125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946505|NCT04467125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946506|NCT04467125|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
91946508|NCT02692313|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91946509|NCT02692313|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91946510|NCT02692313|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946511|NCT02692313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946512|NCT02692313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946513|NCT02692313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946514|NCT02692313|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91946515|NCT02692313|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946516|NCT02692313|Autonomic Agents|autonomic agents|mesh-ancestor
91946517|NCT02692313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972601|NCT03287609|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91972602|NCT03291899|Folfirinox|folfirinox|mesh-list
91972603|NCT03291899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972604|NCT03194815|Rituximab|rituximab|mesh-list
91972605|NCT03194815|Immunoglobulins|immunoglobulins|mesh-list
91972606|NCT03194815|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91972607|NCT03194815|Antibodies|antibodies|mesh-list
91972608|NCT03194815|gamma-Globulins|gamma-globulins|mesh-list
91972609|NCT03194815|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91972610|NCT03194815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972611|NCT03194815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972612|NCT03194815|Immunologic Factors|immunologic factors|mesh-ancestor
91972613|NCT03194815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972614|NCT03194815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972615|NCT03291821|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91972616|NCT03291821|Cetrorelix|cetrorelix|mesh-list
91972617|NCT03291821|Menotropins|menotropins|mesh-list
91972618|NCT03291821|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
91972642|NCT03291353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972643|NCT03291353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972644|NCT03291353|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91972645|NCT03291353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972646|NCT02460341|Ondansetron|ondansetron|mesh-list
91972647|NCT02460341|Antiemetics|antiemetics|mesh-ancestor
91972648|NCT02460341|Autonomic Agents|autonomic agents|mesh-ancestor
91972649|NCT02460341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972650|NCT02460341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972651|NCT02460341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972652|NCT02460341|Antipruritics|antipruritics|mesh-ancestor
91972653|NCT02460341|Dermatologic Agents|dermatologic agents|mesh-ancestor
91972654|NCT02460341|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91972655|NCT02460341|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91972657|NCT02460341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972658|NCT02460341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972660|NCT00189319|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91946518|NCT02692313|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91972661|NCT00189319|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91972662|NCT00189319|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91972663|NCT00189319|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91972664|NCT00189319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972666|NCT00189241|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91972667|NCT00189241|Immunologic Factors|immunologic factors|mesh-ancestor
91972668|NCT00189241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972669|NCT00189241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972670|NCT00189241|Interferon Inducers|interferon inducers|mesh-ancestor
91972673|NCT02460107|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91972674|NCT02460107|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91972675|NCT02460107|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91972676|NCT02460107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972677|NCT02460107|Cholinergic Agents|cholinergic agents|mesh-ancestor
91972678|NCT02460107|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972679|NCT02460107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972680|NCT02460107|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91972681|NCT02460107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972682|NCT03286673|Calcium, Dietary|calcium, dietary|mesh-list
91972683|NCT03286673|Calcium Carbonate|calcium carbonate|mesh-list
91972684|NCT03286673|Calcium|calcium|mesh-list
91972685|NCT03286673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91972686|NCT03286673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972687|NCT03286673|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91972688|NCT03286673|Antacids|antacids|mesh-ancestor
91972689|NCT03286673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972690|NCT03286673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972691|NCT02448589|TAS-119|tas-119|mesh-list
91972692|NCT02448589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972693|NCT02448589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91972694|NCT02448589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972695|NCT02448589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972696|NCT02445703|Vaccines|vaccines|mesh-list
91972697|NCT02445703|Immunologic Factors|immunologic factors|mesh-ancestor
91972698|NCT02445703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972699|NCT03194659|Choline|choline|mesh-list
91972700|NCT03194659|Lipotropic Agents|lipotropic agents|mesh-ancestor
91972701|NCT03194659|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91972702|NCT03194659|Antimetabolites|antimetabolites|mesh-ancestor
91972703|NCT03194659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972704|NCT03194659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972705|NCT03194659|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91972706|NCT03194659|Nootropic Agents|nootropic agents|mesh-ancestor
91972707|NCT02445547|Hormones|hormones|mesh-list
91972708|NCT02445547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972709|NCT02445547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972710|NCT03190603|Celecoxib|celecoxib|mesh-list
91972711|NCT03190603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91972712|NCT03190603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972713|NCT03190603|Analgesics|analgesics|mesh-ancestor
91972714|NCT03190603|Sensory System Agents|sensory system agents|mesh-ancestor
91972715|NCT03190603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972716|NCT03190603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972717|NCT03190603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972718|NCT03190603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972719|NCT03190603|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91972720|NCT03190603|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91972721|NCT03190603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972722|NCT03190603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972723|NCT03285503|Aripiprazole|aripiprazole|mesh-list
91972724|NCT03285503|Antidepressive Agents|antidepressive agents|mesh-ancestor
91972725|NCT03285503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91972726|NCT03285503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91972727|NCT03285503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91972728|NCT03285503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972729|NCT03285503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972730|NCT03285503|Dopamine Agonists|dopamine agonists|mesh-ancestor
91972731|NCT03285503|Dopamine Agents|dopamine agents|mesh-ancestor
91946519|NCT02692313|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946520|NCT02692313|Mydriatics|mydriatics|mesh-ancestor
91946521|NCT02692313|Sympathomimetics|sympathomimetics|mesh-ancestor
91972732|NCT03285503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972733|NCT03285503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972734|NCT03285503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91972735|NCT03285503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91972736|NCT03285503|Serotonin Agents|serotonin agents|mesh-ancestor
91972737|NCT03285503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91972738|NCT03285503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91972739|NCT03285503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91972740|NCT03285503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91972741|NCT02439697|Darbepoetin alfa|darbepoetin alfa|mesh-list
91972742|NCT02439697|Hematinics|hematinics|mesh-ancestor
91972752|NCT03284645|Abacavir|abacavir|mesh-list
91972753|NCT03284645|Antiviral Agents|antiviral agents|mesh-ancestor
91972754|NCT03284645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972755|NCT03284645|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91972756|NCT03284645|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91972757|NCT03284645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972758|NCT03284645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972759|NCT03284645|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91972760|NCT03284645|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91972761|NCT03284645|Antimetabolites|antimetabolites|mesh-ancestor
91972762|NCT03284645|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91972763|NCT03284645|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91972764|NCT03284645|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91972765|NCT03284645|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91972766|NCT03284645|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91972767|NCT03284645|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91972768|NCT03190447|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91972769|NCT03190447|Laxatives|laxatives|mesh-ancestor
91972770|NCT03190447|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972772|NCT03284177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91972773|NCT03284177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972774|NCT03192709|Sildenafil Citrate|sildenafil citrate|mesh-list
91972775|NCT03192709|Vasodilator Agents|vasodilator agents|mesh-ancestor
91972776|NCT03192709|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91972777|NCT03192709|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91972778|NCT03192709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972779|NCT03192709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972780|NCT03192709|Urological Agents|urological agents|mesh-ancestor
91972781|NCT03283943|Durvalumab|durvalumab|mesh-list
91972782|NCT03283943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972783|NCT03283943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972784|NCT02710045|Vaccines|vaccines|mesh-list
91972785|NCT02710045|Immunologic Factors|immunologic factors|mesh-ancestor
91972786|NCT02710045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972787|NCT02444767|Bimatoprost|bimatoprost|mesh-list
91972788|NCT02444767|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91972789|NCT02443285|Ceftriaxone|ceftriaxone|mesh-list
91972790|NCT02443285|Cefotaxime|cefotaxime|mesh-list
91972791|NCT02443285|Cefoxitin|cefoxitin|mesh-list
91972792|NCT02443285|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972793|NCT02443285|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972794|NCT03193957|Etanercept|etanercept|mesh-list
91972795|NCT03193957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91972796|NCT03193957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972797|NCT03193957|Analgesics|analgesics|mesh-ancestor
91972798|NCT03193957|Sensory System Agents|sensory system agents|mesh-ancestor
91972799|NCT03193957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972800|NCT03193957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972801|NCT03193957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972802|NCT03193957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972803|NCT03193957|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972804|NCT03193957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972805|NCT03193957|Immunologic Factors|immunologic factors|mesh-ancestor
91972806|NCT03281681|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
91972807|NCT03281681|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91972808|NCT03281681|Alkylating Agents|alkylating agents|mesh-ancestor
91946523|NCT02465528|Ceritinib|ceritinib|mesh-list
91946524|NCT02465528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946525|NCT02465528|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946526|NCT02465528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946527|NCT02465528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946528|NCT03524261|Antibodies|antibodies|mesh-list
91946529|NCT03524261|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91972809|NCT03281681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972815|NCT02444611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91972816|NCT02438761|Gedatolisib|gedatolisib|mesh-list
91972817|NCT02438761|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91972818|NCT02438761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972819|NCT02438761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972820|NCT03536429|Acetazolamide|acetazolamide|mesh-list
91972821|NCT03536429|Anticonvulsants|anticonvulsants|mesh-ancestor
91972822|NCT03536429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91972823|NCT03536429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972824|NCT03536429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972825|NCT03536429|Diuretics|diuretics|mesh-ancestor
91972826|NCT03536429|Natriuretic Agents|natriuretic agents|mesh-ancestor
91972827|NCT03536429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972828|NCT02438683|BI 409306|bi 409306|mesh-list
91972829|NCT02438683|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91972830|NCT02438683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972831|NCT02438683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972832|NCT03270839|Meclizine|meclizine|mesh-list
91972833|NCT03270839|Scopolamine|scopolamine|mesh-list
91972834|NCT03270839|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91972835|NCT03270839|Antiemetics|antiemetics|mesh-ancestor
91972836|NCT03270839|Autonomic Agents|autonomic agents|mesh-ancestor
91972837|NCT03270839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972838|NCT03270839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972839|NCT03270839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972840|NCT03270839|Mydriatics|mydriatics|mesh-ancestor
91972841|NCT03270839|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91972842|NCT03270839|Cholinergic Agents|cholinergic agents|mesh-ancestor
91972843|NCT03270839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972844|NCT03270839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972845|NCT03270839|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91972846|NCT03270839|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91972847|NCT03270839|Histamine Antagonists|histamine antagonists|mesh-ancestor
91972848|NCT03270839|Histamine Agents|histamine agents|mesh-ancestor
91972849|NCT03270839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91972850|NCT02458547|Bupivacaine|bupivacaine|mesh-list
91972851|NCT02458547|Propofol|propofol|mesh-list
91972852|NCT02458547|Desflurane|desflurane|mesh-list
91972853|NCT02458547|Anesthetics, Local|anesthetics, local|mesh-ancestor
91972854|NCT02458547|Anesthetics|anesthetics|mesh-ancestor
91972855|NCT02458547|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972856|NCT02458547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972857|NCT02458547|Sensory System Agents|sensory system agents|mesh-ancestor
91972858|NCT02458547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972859|NCT02458547|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91972860|NCT02458547|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91972861|NCT02458547|Anesthetics, General|anesthetics, general|mesh-ancestor
91972862|NCT02458547|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91972864|NCT02458625|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
91972865|NCT02458625|Trace Elements|trace elements|mesh-ancestor
91972866|NCT02458625|Micronutrients|micronutrients|mesh-ancestor
91972867|NCT02458625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972868|NCT02458625|Hematinics|hematinics|mesh-ancestor
91972869|NCT04978155|Anesthetics|anesthetics|mesh-list
91972870|NCT04978155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972871|NCT04978155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972872|NCT04970043|Pemetrexed|pemetrexed|mesh-list
91972873|NCT04970043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972874|NCT04970043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946530|NCT03524261|Immunologic Factors|immunologic factors|mesh-ancestor
91946531|NCT03524261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946532|NCT03386721|Gemcitabine|gemcitabine|mesh-list
91946533|NCT03386721|Atezolizumab|atezolizumab|mesh-list
91946534|NCT03386721|Vinorelbine|vinorelbine|mesh-list
91946535|NCT03386721|Antibodies|antibodies|mesh-list
91946536|NCT03386721|Immunologic Factors|immunologic factors|mesh-ancestor
91946537|NCT03386721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946538|NCT03386721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91946539|NCT03386721|Antimetabolites|antimetabolites|mesh-ancestor
91946540|NCT03386721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946541|NCT03386721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972875|NCT04970043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972876|NCT04970043|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91972877|NCT04970043|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91972878|NCT04977843|Dimercaprol|dimercaprol|mesh-list
91972879|NCT04977843|Chelating Agents|chelating agents|mesh-ancestor
91972880|NCT04977843|Sequestering Agents|sequestering agents|mesh-ancestor
91972881|NCT04977843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972889|NCT04432233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91972890|NCT04432233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972891|NCT04432233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91972892|NCT04432233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972893|NCT04432233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972894|NCT04432233|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91972895|NCT04432233|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91972896|NCT04432233|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91972897|NCT04432233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972898|NCT04432233|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91972899|NCT04432233|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91972900|NCT03269747|Prednisone|prednisone|mesh-list
91972901|NCT03269747|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972902|NCT03269747|Glucocorticoids|glucocorticoids|mesh-ancestor
91972903|NCT03269747|Hormones|hormones|mesh-ancestor
91972904|NCT03269747|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972905|NCT03269747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972906|NCT03269747|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972907|NCT03269747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972908|NCT04369469|Ravulizumab|ravulizumab|mesh-list
91972909|NCT04369469|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91972910|NCT04369469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972911|NCT04369469|Immunologic Factors|immunologic factors|mesh-ancestor
91972912|NCT04369469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972913|NCT03269591|Diclofenac|diclofenac|mesh-list
91972914|NCT03269591|Progesterone|progesterone|mesh-list
91972915|NCT03269591|Progestins|progestins|mesh-ancestor
91972916|NCT03269591|Hormones|hormones|mesh-ancestor
91972917|NCT03269591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972918|NCT03269591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972919|NCT03269591|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91972920|NCT03269591|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972921|NCT03269591|Analgesics|analgesics|mesh-ancestor
91972922|NCT03269591|Sensory System Agents|sensory system agents|mesh-ancestor
91972923|NCT03269591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972924|NCT03269591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91972925|NCT03269591|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91972926|NCT03269591|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91972927|NCT03269591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972928|NCT03269591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972929|NCT03989609|Midazolam|midazolam|mesh-list
91946543|NCT03386721|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946544|NCT03386721|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91946545|NCT03386721|Tubulin Modulators|tubulin modulators|mesh-ancestor
91946546|NCT03386721|Antimitotic Agents|antimitotic agents|mesh-ancestor
91946547|NCT03386721|Mitosis Modulators|mitosis modulators|mesh-ancestor
91946549|NCT02462720|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
91946550|NCT02462720|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91946551|NCT02246218|Glycerol|glycerol|mesh-list
91946552|NCT02246218|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91946553|NCT02246218|Protective Agents|protective agents|mesh-ancestor
91972930|NCT03989609|Dexmedetomidine|dexmedetomidine|mesh-list
91972931|NCT03989609|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91972932|NCT03989609|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972933|NCT03989609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972934|NCT03989609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91972935|NCT03989609|Analgesics|analgesics|mesh-ancestor
91972936|NCT03989609|Sensory System Agents|sensory system agents|mesh-ancestor
91972937|NCT03989609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91972938|NCT03989609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91972939|NCT03989609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91972940|NCT03989609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91972941|NCT03989609|Adrenergic Agents|adrenergic agents|mesh-ancestor
91972942|NCT03989609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91972943|NCT03989609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972944|NCT03989609|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91972945|NCT03989609|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91972946|NCT03989609|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91972947|NCT03989609|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91972948|NCT03989609|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91972949|NCT03989609|Anesthetics, General|anesthetics, general|mesh-ancestor
91972952|NCT03989609|GABA Agents|gaba agents|mesh-ancestor
91972953|NCT03988205|Cytarabine|cytarabine|mesh-list
91972954|NCT03988205|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91972955|NCT03988205|Antimetabolites|antimetabolites|mesh-ancestor
91972956|NCT03988205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972957|NCT03988205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972958|NCT03988205|Antiviral Agents|antiviral agents|mesh-ancestor
91972959|NCT03988205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972960|NCT03988205|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91972961|NCT03988205|Immunologic Factors|immunologic factors|mesh-ancestor
91972962|NCT03988205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972963|NCT03280277|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91972964|NCT03280277|Hematinics|hematinics|mesh-ancestor
91972965|NCT03280277|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91972966|NCT03280277|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91972967|NCT03269357|Contraceptive Agents|contraceptive agents|mesh-list
91972968|NCT03269357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972969|NCT03269357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972970|NCT03269279|Misoprostol|misoprostol|mesh-list
91972971|NCT03269279|Mifepristone|mifepristone|mesh-list
91972972|NCT03269279|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91972973|NCT03269279|Abortifacient Agents|abortifacient agents|mesh-ancestor
91972974|NCT03269279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972975|NCT03269279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972976|NCT03269279|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91972977|NCT03269279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91972978|NCT03269279|Oxytocics|oxytocics|mesh-ancestor
91972979|NCT03269279|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91972980|NCT03269279|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91972981|NCT03269279|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91972982|NCT03269279|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91972983|NCT03269279|Contraceptive Agents|contraceptive agents|mesh-ancestor
91973066|NCT03272711|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91972984|NCT03269279|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91972985|NCT03269279|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91972986|NCT03269279|Hormone Antagonists|hormone antagonists|mesh-ancestor
91972987|NCT03269279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972988|NCT03269279|Luteolytic Agents|luteolytic agents|mesh-ancestor
91972989|NCT03269279|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91972990|NCT03269279|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91972991|NCT03278483|Rifampin|rifampin|mesh-list
91972992|NCT03278483|Isoniazid|isoniazid|mesh-list
91972993|NCT03278483|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91972994|NCT03278483|Antitubercular Agents|antitubercular agents|mesh-ancestor
91972995|NCT03278483|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972996|NCT03278483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972997|NCT03278483|Leprostatic Agents|leprostatic agents|mesh-ancestor
91972998|NCT03278483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91972999|NCT03278483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973000|NCT03278483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973001|NCT03278483|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91973002|NCT03278483|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91973003|NCT03278483|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91973004|NCT03278483|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91973005|NCT03278483|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91973006|NCT03278483|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91973007|NCT03278483|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91973008|NCT03278483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91973009|NCT03278483|Antimetabolites|antimetabolites|mesh-ancestor
91973010|NCT03278483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91973012|NCT03268733|Hematinics|hematinics|mesh-ancestor
91973013|NCT03268733|Vitamin B Complex|vitamin b complex|mesh-ancestor
91973014|NCT03268733|Vitamins|vitamins|mesh-ancestor
91973015|NCT03268733|Micronutrients|micronutrients|mesh-ancestor
91973016|NCT03268733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973017|NCT03277391|Droperidol|droperidol|mesh-list
91973018|NCT03277391|Morphine|morphine|mesh-list
91973019|NCT03277391|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91973020|NCT03277391|Narcotics|narcotics|mesh-ancestor
91973021|NCT03277391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973032|NCT03277391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91973033|NCT03277391|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91973034|NCT03277391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91973035|NCT03277391|Dopamine Agents|dopamine agents|mesh-ancestor
91973036|NCT03277391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973037|NCT03277391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973039|NCT03277001|Rivaroxaban|rivaroxaban|mesh-list
91973040|NCT03277001|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91973041|NCT03277001|Antithrombins|antithrombins|mesh-ancestor
91973042|NCT03277001|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91973043|NCT03277001|Protease Inhibitors|protease inhibitors|mesh-ancestor
91973044|NCT03277001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973045|NCT03277001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973046|NCT03277001|Anticoagulants|anticoagulants|mesh-ancestor
91973047|NCT03277001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91973048|NCT03277001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91973049|NCT03273881|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91973050|NCT03272711|Vortioxetine|vortioxetine|mesh-list
91973051|NCT03272711|Antidepressive Agents|antidepressive agents|mesh-ancestor
91973052|NCT03272711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91973053|NCT03272711|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91973054|NCT03272711|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973055|NCT03272711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973056|NCT03272711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973057|NCT03272711|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91973058|NCT03272711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91973059|NCT03272711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973060|NCT03272711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973061|NCT03272711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946554|NCT02246218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946555|NCT05073939|Oxytocin|oxytocin|mesh-list
91946556|NCT05073939|Oxytocics|oxytocics|mesh-ancestor
91973062|NCT03272711|Serotonin Agents|serotonin agents|mesh-ancestor
91973063|NCT03272711|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91973064|NCT03272711|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91973065|NCT03272711|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91973067|NCT03961919|Fludarabine|fludarabine|mesh-list
91973068|NCT03961919|Treosulfan|treosulfan|mesh-list
91973069|NCT03961919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973070|NCT03961919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973071|NCT03961919|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91973072|NCT03961919|Alkylating Agents|alkylating agents|mesh-ancestor
91973073|NCT03267407|Fluconazole|fluconazole|mesh-list
91973074|NCT03267407|Antifungal Agents|antifungal agents|mesh-ancestor
91973075|NCT03267407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973076|NCT03267407|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91973077|NCT03267407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973078|NCT03267407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973079|NCT03267407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973080|NCT03267407|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91973081|NCT03267407|Hormone Antagonists|hormone antagonists|mesh-ancestor
91973082|NCT03267407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973083|NCT03267407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973084|NCT03267407|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91973085|NCT03267407|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91973089|NCT03267329|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91973090|NCT03267329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973091|NCT05074589|Leucovorin|leucovorin|mesh-list
91973092|NCT05074589|Fluorouracil|fluorouracil|mesh-list
91973093|NCT05074589|Irinotecan|irinotecan|mesh-list
91973094|NCT05074589|Levoleucovorin|levoleucovorin|mesh-list
91973095|NCT05074589|Antimetabolites|antimetabolites|mesh-ancestor
91973096|NCT05074589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973097|NCT05074589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91973098|NCT05074589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973099|NCT05074589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91973100|NCT05074589|Immunologic Factors|immunologic factors|mesh-ancestor
91973101|NCT05074589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973102|NCT05074589|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91973103|NCT05074589|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91973104|NCT05074589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973105|NCT05074589|Antidotes|antidotes|mesh-ancestor
91973106|NCT05074589|Protective Agents|protective agents|mesh-ancestor
91973107|NCT05074589|Vitamin B Complex|vitamin b complex|mesh-ancestor
91973108|NCT05074589|Vitamins|vitamins|mesh-ancestor
91973109|NCT05074589|Micronutrients|micronutrients|mesh-ancestor
91973110|NCT05074043|Antiviral Agents|antiviral agents|mesh-list
91973111|NCT05074043|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973112|NCT05073965|Vitamin D|vitamin d|mesh-list
91973113|NCT05073965|Vitamins|vitamins|mesh-ancestor
91973114|NCT05073965|Micronutrients|micronutrients|mesh-ancestor
91973115|NCT05073965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973116|NCT05073965|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91973117|NCT03266549|Botulinum Toxins|botulinum toxins|mesh-list
91973118|NCT03266549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91973119|NCT03266549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973120|NCT03266549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973121|NCT03266549|Cholinergic Agents|cholinergic agents|mesh-ancestor
91973122|NCT03266549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973123|NCT03266549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973124|NCT05065775|Dexmedetomidine|dexmedetomidine|mesh-list
91973125|NCT05065775|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973126|NCT05065775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973127|NCT05065775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973128|NCT05065775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91973129|NCT05065775|Analgesics|analgesics|mesh-ancestor
91973130|NCT05065775|Sensory System Agents|sensory system agents|mesh-ancestor
91973131|NCT05065775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973132|NCT05065775|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91946558|NCT05073939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973133|NCT05065775|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91973134|NCT05065775|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91973135|NCT05065775|Adrenergic Agents|adrenergic agents|mesh-ancestor
91973136|NCT05065775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973137|NCT05065775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973138|NCT03266159|Trametinib|trametinib|mesh-list
91973139|NCT03266159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973140|NCT03266159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973141|NCT03266159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973142|NCT03266159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973143|NCT02458781|Metronidazole|metronidazole|mesh-list
91973144|NCT02458781|Ciprofloxacin|ciprofloxacin|mesh-list
91973145|NCT02458781|Fluoroquinolones|fluoroquinolones|mesh-list
91973146|NCT02458781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973147|NCT02458781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973148|NCT02458781|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91973149|NCT02458781|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91973150|NCT02458781|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91973151|NCT02458781|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91973152|NCT02458781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973153|NCT02458781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973154|NCT02458781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973155|NCT02458781|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91973156|NCT02458781|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973160|NCT04647383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973161|NCT04647383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973162|NCT04647383|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91973163|NCT04647383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973164|NCT04647383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973165|NCT04647383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973167|NCT02458157|Diuretics|diuretics|mesh-ancestor
91973168|NCT02458157|Natriuretic Agents|natriuretic agents|mesh-ancestor
91973169|NCT02458157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973170|NCT02458157|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91973171|NCT02458157|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973172|NCT02458157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973173|NCT02458079|Pentoxifylline|pentoxifylline|mesh-list
91973174|NCT02458079|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91973175|NCT02458079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973176|NCT02458079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973177|NCT02458079|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91973178|NCT02458079|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91973179|NCT02458079|Protective Agents|protective agents|mesh-ancestor
91973180|NCT02458079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973181|NCT02458079|Vasodilator Agents|vasodilator agents|mesh-ancestor
91973182|NCT02458079|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91973183|NCT02458079|Antioxidants|antioxidants|mesh-ancestor
91973184|NCT03264911|Amoxicillin|amoxicillin|mesh-list
91973185|NCT03264911|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973186|NCT03264911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973187|NCT03265223|Ropivacaine|ropivacaine|mesh-list
91973188|NCT03265223|Anesthetics, Local|anesthetics, local|mesh-ancestor
91973189|NCT03265223|Anesthetics|anesthetics|mesh-ancestor
91973190|NCT03265223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973191|NCT03265223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973192|NCT03265223|Sensory System Agents|sensory system agents|mesh-ancestor
91973193|NCT03265223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973194|NCT02456363|Sulfasalazine|sulfasalazine|mesh-list
91973195|NCT02456363|Adalimumab|adalimumab|mesh-list
91973196|NCT02456363|Golimumab|golimumab|mesh-list
91973197|NCT02456363|Etanercept|etanercept|mesh-list
91973198|NCT02456363|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91973199|NCT02456363|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973200|NCT02456363|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91973201|NCT02456363|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91973202|NCT02456363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91973203|NCT02456363|Analgesics|analgesics|mesh-ancestor
91973204|NCT02456363|Sensory System Agents|sensory system agents|mesh-ancestor
91946559|NCT04192630|Hyaluronic Acid|hyaluronic acid|mesh-list
91946560|NCT04192630|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91946561|NCT04192630|Immunologic Factors|immunologic factors|mesh-ancestor
91973205|NCT02456363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973206|NCT02456363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973207|NCT02456363|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973208|NCT02456363|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91973209|NCT02456363|Immunologic Factors|immunologic factors|mesh-ancestor
91973210|NCT02456363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973211|NCT03259607|Nicotine|nicotine|mesh-list
91973212|NCT03259607|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91973213|NCT03259607|Autonomic Agents|autonomic agents|mesh-ancestor
91973214|NCT03259607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973215|NCT03259607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973216|NCT03259607|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91973217|NCT03259607|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91973218|NCT03259607|Cholinergic Agents|cholinergic agents|mesh-ancestor
91973219|NCT03259607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973220|NCT03259607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973221|NCT02456129|Itraconazole|itraconazole|mesh-list
91973222|NCT02456129|Antifungal Agents|antifungal agents|mesh-ancestor
91973223|NCT02456129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973224|NCT02456129|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91973225|NCT02456129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973226|NCT02456129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973231|NCT02456129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973232|NCT02456129|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91973233|NCT03263741|Paclitaxel|paclitaxel|mesh-list
91973234|NCT03263741|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91973235|NCT03263741|Oxaliplatin|oxaliplatin|mesh-list
91973236|NCT03263741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91973237|NCT03263741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973238|NCT03263741|Tubulin Modulators|tubulin modulators|mesh-ancestor
91973239|NCT03263741|Antimitotic Agents|antimitotic agents|mesh-ancestor
91973240|NCT03263741|Mitosis Modulators|mitosis modulators|mesh-ancestor
91973241|NCT03263741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973242|NCT02456207|Rituximab|rituximab|mesh-list
91973243|NCT02456207|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973244|NCT02456207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973245|NCT02456207|Immunologic Factors|immunologic factors|mesh-ancestor
91973246|NCT02456207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973247|NCT02456207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91973248|NCT03258749|Formoterol Fumarate|formoterol fumarate|mesh-list
91973249|NCT03258749|Tiotropium Bromide|tiotropium bromide|mesh-list
91973250|NCT03258749|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91973251|NCT03258749|Autonomic Agents|autonomic agents|mesh-ancestor
91973252|NCT03258749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973253|NCT03258749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973254|NCT03258749|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91973255|NCT03258749|Respiratory System Agents|respiratory system agents|mesh-ancestor
91973256|NCT03258749|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91973257|NCT03258749|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91973258|NCT03258749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91973259|NCT03258749|Adrenergic Agents|adrenergic agents|mesh-ancestor
91973260|NCT03258749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973261|NCT03258749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973262|NCT03258749|Parasympatholytics|parasympatholytics|mesh-ancestor
91973263|NCT03258749|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91973264|NCT03258749|Cholinergic Agents|cholinergic agents|mesh-ancestor
91973265|NCT03258515|Moxifloxacin|moxifloxacin|mesh-list
91973266|NCT03258515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973267|NCT03258515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973268|NCT03258515|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91973269|NCT03258515|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91973270|NCT03258515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973271|NCT03258515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973272|NCT03258515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973273|NCT04976673|Triamcinolone|triamcinolone|mesh-list
91973274|NCT04976673|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91973275|NCT04976673|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91973276|NCT04976673|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91946562|NCT04192630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946563|NCT04192630|Viscosupplements|viscosupplements|mesh-ancestor
91946564|NCT04192630|Protective Agents|protective agents|mesh-ancestor
91946565|NCT00159783|Olanzapine|olanzapine|mesh-list
91946566|NCT00159783|Asenapine|asenapine|mesh-list
91946567|NCT00159783|Antiemetics|antiemetics|mesh-ancestor
91973277|NCT04976673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973278|NCT04976673|Glucocorticoids|glucocorticoids|mesh-ancestor
91973279|NCT04976673|Hormones|hormones|mesh-ancestor
91973280|NCT04976673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973281|NCT04976673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973282|NCT04976673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91973283|NCT04976673|Immunologic Factors|immunologic factors|mesh-ancestor
91973284|NCT04976673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973285|NCT04976673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973286|NCT04969497|Zolmitriptan|zolmitriptan|mesh-list
91973287|NCT04969497|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91973288|NCT04969497|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91973289|NCT04969497|Serotonin Agents|serotonin agents|mesh-ancestor
91973290|NCT04969497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973534|NCT03254849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91973291|NCT04969497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973292|NCT04969497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973293|NCT04976829|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91973298|NCT03263039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91973299|NCT03263039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973300|NCT03262961|Sildenafil Citrate|sildenafil citrate|mesh-list
91973301|NCT03262961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973302|NCT03262961|Vasodilator Agents|vasodilator agents|mesh-ancestor
91973303|NCT03262961|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91973304|NCT03262961|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91973305|NCT03262961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973306|NCT03262961|Urological Agents|urological agents|mesh-ancestor
91973307|NCT01670097|Dexamethasone|dexamethasone|mesh-list
91973308|NCT01670097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973309|NCT01670097|Antiemetics|antiemetics|mesh-ancestor
91973310|NCT01670097|Autonomic Agents|autonomic agents|mesh-ancestor
91973311|NCT01670097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973312|NCT01670097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973313|NCT01670097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973314|NCT01670097|Glucocorticoids|glucocorticoids|mesh-ancestor
91973315|NCT01670097|Hormones|hormones|mesh-ancestor
91973316|NCT01670097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973317|NCT01670097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91973318|NCT01670097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973319|NCT03257423|Moxifloxacin|moxifloxacin|mesh-list
91973320|NCT03257423|Metronidazole|metronidazole|mesh-list
91973321|NCT03257423|Levofloxacin|levofloxacin|mesh-list
91973322|NCT03257423|Ertapenem|ertapenem|mesh-list
91973323|NCT03257423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973324|NCT03257423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973326|NCT03257423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91973327|NCT03257423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973328|NCT03257423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973329|NCT03257423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973330|NCT03257423|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91973331|NCT03257423|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91973332|NCT03257423|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91973333|NCT03257423|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91973334|NCT03257423|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973335|NCT01670019|Asenapine|asenapine|mesh-list
91973336|NCT01670019|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91973337|NCT01670019|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973338|NCT01670019|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973339|NCT01670019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973340|NCT01670019|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91973341|NCT03262727|Deucravacitinib|deucravacitinib|mesh-list
91973342|NCT03262727|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91973343|NCT03262727|Norethindrone|norethindrone|mesh-list
91973345|NCT03262727|Norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|norethindrone acetate, ethinyl estradiol, ferrous fumarate drug combination|mesh-list
91973346|NCT03262727|Estradiol|estradiol|mesh-list
91973347|NCT03262727|Estrogens|estrogens|mesh-ancestor
91973348|NCT03262727|Hormones|hormones|mesh-ancestor
91973349|NCT03262727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973350|NCT03262727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973351|NCT03262727|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91973353|NCT03262727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91973354|NCT03262727|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91973355|NCT03262727|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91973356|NCT03262727|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91973357|NCT03262727|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91973358|NCT03262727|Dermatologic Agents|dermatologic agents|mesh-ancestor
91973359|NCT03262727|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973360|NCT03262727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973361|NCT03262727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973362|NCT03262727|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91973363|NCT03262727|Contraceptives, Oral, Sequential|contraceptives, oral, sequential|mesh-ancestor
91973368|NCT04975971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973369|NCT04975971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973370|NCT04975971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973371|NCT04975971|Glucocorticoids|glucocorticoids|mesh-ancestor
91973372|NCT04975971|Hormones|hormones|mesh-ancestor
91973373|NCT04975971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973374|NCT04975971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91973375|NCT04975971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973376|NCT03062163|Thioctic Acid|thioctic acid|mesh-list
91973377|NCT03062163|Resveratrol|resveratrol|mesh-list
91973378|NCT03062163|Antioxidants|antioxidants|mesh-ancestor
91973379|NCT03062163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973380|NCT03062163|Protective Agents|protective agents|mesh-ancestor
91973381|NCT03062163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973382|NCT03062163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973383|NCT03062163|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91973384|NCT03062163|Vitamin B Complex|vitamin b complex|mesh-ancestor
91973385|NCT03062163|Vitamins|vitamins|mesh-ancestor
91973386|NCT03062163|Micronutrients|micronutrients|mesh-ancestor
91973387|NCT02456597|Lidocaine|lidocaine|mesh-list
91973388|NCT02456597|Anesthetics, Local|anesthetics, local|mesh-ancestor
91973389|NCT02456597|Anesthetics|anesthetics|mesh-ancestor
91973390|NCT02456597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973391|NCT02456597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973392|NCT02456597|Sensory System Agents|sensory system agents|mesh-ancestor
91973393|NCT02456597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973394|NCT02456597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91973395|NCT02456597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91973396|NCT02456597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91973397|NCT02456597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973398|NCT02456597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973400|NCT03261635|Ranibizumab|ranibizumab|mesh-list
91973401|NCT03261635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91973402|NCT03261635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91973403|NCT03261635|Growth Substances|growth substances|mesh-ancestor
91973404|NCT03261635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973405|NCT03261635|Growth Inhibitors|growth inhibitors|mesh-ancestor
91973406|NCT03261635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973407|NCT03261635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91973408|NCT03261635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91973409|NCT03261635|Analgesics|analgesics|mesh-ancestor
91973410|NCT03261635|Sensory System Agents|sensory system agents|mesh-ancestor
91973411|NCT03261635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973412|NCT03261635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973413|NCT03261635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91973414|NCT03261635|Gout Suppressants|gout suppressants|mesh-ancestor
91973415|NCT03261635|Tocolytic Agents|tocolytic agents|mesh-ancestor
91973416|NCT03261635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91973417|NCT03261635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91973418|NCT03261635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946568|NCT00159783|Autonomic Agents|autonomic agents|mesh-ancestor
91946569|NCT00159783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973419|NCT03261635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973420|NCT03059979|Methylprednisolone|methylprednisolone|mesh-list
91973421|NCT03059979|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91973422|NCT03059979|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91973423|NCT03059979|Prednisolone|prednisolone|mesh-list
91973424|NCT03059979|Prednisolone acetate|prednisolone acetate|mesh-list
91973425|NCT03059979|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91973426|NCT03059979|Prednisolone phosphate|prednisolone phosphate|mesh-list
91973427|NCT03059979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973428|NCT03059979|Antiemetics|antiemetics|mesh-ancestor
91973429|NCT03059979|Autonomic Agents|autonomic agents|mesh-ancestor
91973430|NCT03059979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973431|NCT03059979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973432|NCT03059979|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973433|NCT03059979|Glucocorticoids|glucocorticoids|mesh-ancestor
91973434|NCT03059979|Hormones|hormones|mesh-ancestor
92090414|NCT00892606|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973437|NCT03059979|Protective Agents|protective agents|mesh-ancestor
91973438|NCT03059979|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91973439|NCT03059979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973441|NCT03256721|Pemetrexed|pemetrexed|mesh-list
91973442|NCT03256721|Apatinib|apatinib|mesh-list
91973443|NCT03256721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973444|NCT03256721|Tubulin Modulators|tubulin modulators|mesh-ancestor
91973445|NCT03256721|Antimitotic Agents|antimitotic agents|mesh-ancestor
91973446|NCT03256721|Mitosis Modulators|mitosis modulators|mesh-ancestor
91973447|NCT03256721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973448|NCT03256721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973449|NCT03256721|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91973535|NCT04963881|Antibodies|antibodies|mesh-list
91973450|NCT03256721|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91973451|NCT03256721|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973452|NCT04967859|Gentamicins|gentamicins|mesh-list
91973453|NCT04967859|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973454|NCT04967859|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973455|NCT04967859|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91973456|NCT04967859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973457|NCT04967859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973458|NCT03256487|Morphine|morphine|mesh-list
91973459|NCT03256487|Buprenorphine|buprenorphine|mesh-list
91973460|NCT03256487|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91973461|NCT03256487|Narcotics|narcotics|mesh-ancestor
91973462|NCT03256487|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973463|NCT03256487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973464|NCT03256487|Analgesics|analgesics|mesh-ancestor
91973465|NCT03256487|Sensory System Agents|sensory system agents|mesh-ancestor
91973466|NCT03256487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973467|NCT03256487|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91973468|NCT03061227|Glucagon|glucagon|mesh-list
91973469|NCT03061227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973470|NCT03061227|Hormones|hormones|mesh-ancestor
91973471|NCT03061227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973472|NCT03061227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973474|NCT03261791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973475|NCT03261791|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973476|NCT03261791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973477|NCT03261791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973478|NCT03643367|Propofol|propofol|mesh-list
91973479|NCT03643367|Sevoflurane|sevoflurane|mesh-list
91973480|NCT03643367|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973481|NCT03643367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973482|NCT03643367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973483|NCT03643367|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91973484|NCT03643367|Anesthetics, General|anesthetics, general|mesh-ancestor
91973485|NCT03643367|Anesthetics|anesthetics|mesh-ancestor
91973486|NCT03643367|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91973487|NCT03643367|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91973488|NCT03060603|Epoetin Alfa|epoetin alfa|mesh-list
91973489|NCT03060603|Hematinics|hematinics|mesh-ancestor
91973490|NCT04488107|Letrozole|letrozole|mesh-list
91973491|NCT04488107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973492|NCT04488107|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91973493|NCT04488107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91946570|NCT00159783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946571|NCT00159783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946572|NCT00159783|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91946573|NCT00159783|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973494|NCT04488107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973495|NCT04488107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973496|NCT04488107|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91973497|NCT04488107|Hormone Antagonists|hormone antagonists|mesh-ancestor
91973498|NCT04488107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973499|NCT04488107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973500|NCT04974723|Teriparatide|teriparatide|mesh-list
91973501|NCT04974723|Abaloparatide|abaloparatide|mesh-list
91973502|NCT04974723|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91973503|NCT04974723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973504|NCT04974723|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91973505|NCT03060681|Bupivacaine|bupivacaine|mesh-list
91973506|NCT03060681|Anesthetics, Local|anesthetics, local|mesh-ancestor
91973507|NCT03060681|Anesthetics|anesthetics|mesh-ancestor
91973520|NCT04967469|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91973521|NCT04967469|Vitamins|vitamins|mesh-ancestor
91973522|NCT04967469|Micronutrients|micronutrients|mesh-ancestor
91973523|NCT04967469|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91973524|NCT03254849|Empagliflozin|empagliflozin|mesh-list
91973525|NCT03254849|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91973526|NCT03254849|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91973527|NCT03254849|Diuretics|diuretics|mesh-ancestor
91973528|NCT03254849|Natriuretic Agents|natriuretic agents|mesh-ancestor
91973529|NCT03254849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973530|NCT03254849|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91973531|NCT03254849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973532|NCT03254849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973533|NCT03254849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91973536|NCT04963881|Immunologic Factors|immunologic factors|mesh-ancestor
91973537|NCT04963881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973539|NCT04432155|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91973540|NCT04432155|Anesthetics, General|anesthetics, general|mesh-ancestor
91973542|NCT04432155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973543|NCT04432155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973544|NCT04487951|Vitamin D|vitamin d|mesh-list
91973545|NCT04487951|Vitamins|vitamins|mesh-ancestor
91973546|NCT04487951|Micronutrients|micronutrients|mesh-ancestor
91973547|NCT04487951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973548|NCT04487951|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91973549|NCT04963257|Aripiprazole|aripiprazole|mesh-list
91973550|NCT04963257|Fluvoxamine|fluvoxamine|mesh-list
91973551|NCT04963257|Sertraline|sertraline|mesh-list
91973552|NCT04963257|Antidepressive Agents|antidepressive agents|mesh-ancestor
91973553|NCT04963257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91973554|NCT04963257|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91973555|NCT04963257|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973556|NCT04963257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973557|NCT04963257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973558|NCT04963257|Dopamine Agonists|dopamine agonists|mesh-ancestor
91973559|NCT04963257|Dopamine Agents|dopamine agents|mesh-ancestor
91973560|NCT04963257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973561|NCT04963257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973562|NCT04963257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91973563|NCT04963257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91973564|NCT04963257|Serotonin Agents|serotonin agents|mesh-ancestor
91973565|NCT04963257|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91973566|NCT04963257|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91973567|NCT04963257|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91973568|NCT04963257|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91973575|NCT04963257|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973577|NCT04963257|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91973578|NCT04966845|Carbon Monoxide|carbon monoxide|mesh-list
91973579|NCT04966845|Antimetabolites|antimetabolites|mesh-ancestor
91946574|NCT00159783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946575|NCT00159783|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91946576|NCT00159783|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91973580|NCT04966845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973581|NCT04966845|Gasotransmitters|gasotransmitters|mesh-ancestor
91973582|NCT04966845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973583|NCT04966845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973584|NCT04953741|Fluticasone|fluticasone|mesh-list
91973585|NCT04953741|Xhance|xhance|mesh-list
91973586|NCT04953741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973587|NCT04953741|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91973588|NCT04953741|Autonomic Agents|autonomic agents|mesh-ancestor
91973589|NCT04953741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973590|NCT04953741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973591|NCT04953741|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91973592|NCT04953741|Respiratory System Agents|respiratory system agents|mesh-ancestor
91973593|NCT04953741|Dermatologic Agents|dermatologic agents|mesh-ancestor
91973594|NCT04953741|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91973595|NCT03259919|Metformin|metformin|mesh-list
91973596|NCT03259919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91973597|NCT03259919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973598|NCT04965831|Aflutinib|aflutinib|mesh-list
91973599|NCT04965831|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973600|NCT04965831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973601|NCT04965831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973602|NCT04953117|Paclitaxel|paclitaxel|mesh-list
91973603|NCT04953117|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91973604|NCT04953117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973605|NCT04953117|Tubulin Modulators|tubulin modulators|mesh-ancestor
91973606|NCT04953117|Antimitotic Agents|antimitotic agents|mesh-ancestor
91973607|NCT04953117|Mitosis Modulators|mitosis modulators|mesh-ancestor
91973608|NCT04953117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973609|NCT03259529|Rituximab|rituximab|mesh-list
91973610|NCT03259529|Nivolumab|nivolumab|mesh-list
91973611|NCT03259529|Gemcitabine|gemcitabine|mesh-list
91973612|NCT03259529|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91973613|NCT03259529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973614|NCT03259529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973615|NCT03259529|Immunologic Factors|immunologic factors|mesh-ancestor
91973616|NCT03259529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973617|NCT03259529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91973618|NCT03259529|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91973619|NCT03259529|Antimetabolites|antimetabolites|mesh-ancestor
91973620|NCT03259529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973621|NCT03259529|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91973622|NCT03259529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91973623|NCT03259529|Alkylating Agents|alkylating agents|mesh-ancestor
91973624|NCT03252665|Nicorandil|nicorandil|mesh-list
91973625|NCT03252665|Nitroglycerin|nitroglycerin|mesh-list
91973626|NCT03252665|Alprostadil|alprostadil|mesh-list
91973627|NCT03252665|Vasodilator Agents|vasodilator agents|mesh-ancestor
91973628|NCT03252665|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91973629|NCT03252665|Urological Agents|urological agents|mesh-ancestor
91973630|NCT03252665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91973631|NCT03252665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91973632|NCT03252665|Vitamin B Complex|vitamin b complex|mesh-ancestor
91973633|NCT03252665|Vitamins|vitamins|mesh-ancestor
91973634|NCT03252665|Micronutrients|micronutrients|mesh-ancestor
91973635|NCT03252665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973645|NCT03059667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973646|NCT03059667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91973647|NCT03059667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973648|NCT03059667|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91973649|NCT03058419|Midazolam|midazolam|mesh-list
91973650|NCT03058419|Dextromethorphan|dextromethorphan|mesh-list
91973651|NCT03058419|Caffeine|caffeine|mesh-list
91973652|NCT03058419|Bupropion|bupropion|mesh-list
91973653|NCT03058419|Omeprazole|omeprazole|mesh-list
91973654|NCT03058419|Warfarin|warfarin|mesh-list
91973655|NCT03058419|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91973656|NCT03058419|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91946577|NCT00159783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91973657|NCT03058419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973658|NCT03058419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973659|NCT03058419|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91973660|NCT03058419|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973661|NCT03058419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91973662|NCT03058419|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91973663|NCT03058419|Anesthetics, General|anesthetics, general|mesh-ancestor
91973664|NCT03058419|Anesthetics|anesthetics|mesh-ancestor
91973665|NCT03058419|GABA Modulators|gaba modulators|mesh-ancestor
91973666|NCT03058419|GABA Agents|gaba agents|mesh-ancestor
91973667|NCT03058419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973668|NCT03058419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973669|NCT03058419|Anticoagulants|anticoagulants|mesh-ancestor
91973670|NCT03058419|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91973671|NCT03058419|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91973672|NCT03058419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973673|NCT03058419|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91973674|NCT03058419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91973675|NCT03058419|Purinergic Agents|purinergic agents|mesh-ancestor
91973676|NCT03058419|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91973677|NCT03058419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973678|NCT03058419|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91973679|NCT03058419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91973680|NCT03058419|Antidepressive Agents|antidepressive agents|mesh-ancestor
91973681|NCT03058419|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91973682|NCT03058419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91973683|NCT03058419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973684|NCT03058419|Dopamine Agents|dopamine agents|mesh-ancestor
91973685|NCT03058419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91973686|NCT03058419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973687|NCT03058419|Antitussive Agents|antitussive agents|mesh-ancestor
91973688|NCT03058419|Respiratory System Agents|respiratory system agents|mesh-ancestor
91973689|NCT03058419|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91973690|NCT03058419|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91973691|NCT04965051|Insulin|insulin|mesh-list
91973692|NCT04965051|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91973693|NCT04965051|Insulin Aspart|insulin aspart|mesh-list
91973694|NCT04965051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91973695|NCT04965051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973696|NCT02455271|Eszopiclone|eszopiclone|mesh-list
91973697|NCT02455271|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973698|NCT02455271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973699|NCT02455271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973700|NCT04964583|Azithromycin|azithromycin|mesh-list
91973701|NCT04964583|Hydroxychloroquine|hydroxychloroquine|mesh-list
91973702|NCT04964583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973703|NCT04964583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973714|NCT03251417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973715|NCT03251417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973716|NCT03251417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973717|NCT03251417|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973719|NCT04961931|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91973720|NCT04961931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973721|NCT04961931|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91973722|NCT04961931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973723|NCT02454881|Dexmedetomidine|dexmedetomidine|mesh-list
91973724|NCT02454881|Oxycodone|oxycodone|mesh-list
91973725|NCT02454881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973726|NCT02454881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973727|NCT02454881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973728|NCT02454881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91973729|NCT02454881|Analgesics|analgesics|mesh-ancestor
91973730|NCT02454881|Sensory System Agents|sensory system agents|mesh-ancestor
91973731|NCT02454881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973732|NCT02454881|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91973733|NCT02454881|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91973734|NCT02454881|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91973735|NCT02454881|Adrenergic Agents|adrenergic agents|mesh-ancestor
91973736|NCT02454881|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973737|NCT02454881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973738|NCT02454881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91973740|NCT03058341|Propofol|propofol|mesh-list
91973741|NCT03058341|Sevoflurane|sevoflurane|mesh-list
91973742|NCT03058341|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973743|NCT03058341|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973744|NCT03058341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973745|NCT03058341|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91973746|NCT03058341|Anesthetics, General|anesthetics, general|mesh-ancestor
91973747|NCT03058341|Anesthetics|anesthetics|mesh-ancestor
91973748|NCT03058341|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91973749|NCT03058341|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91973750|NCT04951791|SMOFlipid|smoflipid|mesh-list
91973751|NCT04951791|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91973752|NCT04951791|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91973753|NCT04951791|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91973754|NCT04951713|Clarithromycin|clarithromycin|mesh-list
91973755|NCT04951713|Rifampin|rifampin|mesh-list
91973756|NCT04951713|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973757|NCT04951713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973758|NCT04951713|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91973759|NCT04951713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973760|NCT04951713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973761|NCT04951713|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91973762|NCT04951713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973763|NCT04951713|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91973764|NCT04951713|Antitubercular Agents|antitubercular agents|mesh-ancestor
91973765|NCT04951713|Leprostatic Agents|leprostatic agents|mesh-ancestor
91973766|NCT04951713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91973767|NCT04951713|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91973773|NCT04944069|Bevacizumab|bevacizumab|mesh-list
91973774|NCT04944069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973775|NCT04944069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973776|NCT04944069|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91973777|NCT04944069|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91973778|NCT04944069|Growth Substances|growth substances|mesh-ancestor
91973779|NCT04944069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973780|NCT04944069|Growth Inhibitors|growth inhibitors|mesh-ancestor
91973781|NCT04951167|Norepinephrine|norepinephrine|mesh-list
91973782|NCT04951167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91973783|NCT04951167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91973784|NCT04951167|Adrenergic Agents|adrenergic agents|mesh-ancestor
91973785|NCT04951167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973786|NCT04951167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973787|NCT04951167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973788|NCT04951167|Sympathomimetics|sympathomimetics|mesh-ancestor
91973789|NCT04951167|Autonomic Agents|autonomic agents|mesh-ancestor
91973790|NCT04951167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973791|NCT04951167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91973793|NCT04950933|Anticonvulsants|anticonvulsants|mesh-ancestor
91973794|NCT04950933|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91973796|NCT04950933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973797|NCT04950933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973798|NCT04950933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973799|NCT04950933|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91973800|NCT04950933|Protective Agents|protective agents|mesh-ancestor
91973801|NCT04961307|Trastuzumab|trastuzumab|mesh-list
91973802|NCT04961307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973803|NCT04961307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973804|NCT03058263|Neostigmine|neostigmine|mesh-list
91973805|NCT03058263|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91973806|NCT03058263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973807|NCT03058263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973808|NCT03058263|Cholinergic Agents|cholinergic agents|mesh-ancestor
91973809|NCT03058263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973810|NCT03058263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973811|NCT03058263|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91973812|NCT03058263|Autonomic Agents|autonomic agents|mesh-ancestor
91973813|NCT03058263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973814|NCT04415853|Irinotecan|irinotecan|mesh-list
91973815|NCT04415853|Tegafur|tegafur|mesh-list
91973816|NCT04415853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91973817|NCT04415853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91946578|NCT00159783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946579|NCT00159783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946580|NCT00159783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973818|NCT04415853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973819|NCT04415853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973820|NCT04415853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973821|NCT04415853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91973822|NCT04415853|Antimetabolites|antimetabolites|mesh-ancestor
91973823|NCT04415151|Tofacitinib|tofacitinib|mesh-list
91973824|NCT04415151|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91973825|NCT04415151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973826|NCT04415151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973827|NCT04415151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973828|NCT03059277|Aflibercept|aflibercept|mesh-list
91973829|NCT03059277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91973830|NCT03059277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91973831|NCT03059277|Growth Substances|growth substances|mesh-ancestor
91973832|NCT03059277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973833|NCT03059277|Growth Inhibitors|growth inhibitors|mesh-ancestor
91973834|NCT03059277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973841|NCT00700817|Hormones|hormones|mesh-ancestor
91973842|NCT00700817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973843|NCT00700817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91973844|NCT00700817|Protease Inhibitors|protease inhibitors|mesh-ancestor
91973845|NCT00700817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973846|NCT00700817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973847|NCT04960293|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
91973848|NCT04960293|Hemostatics|hemostatics|mesh-ancestor
91973849|NCT04960293|Coagulants|coagulants|mesh-ancestor
91973850|NCT04941417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91973851|NCT04941417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973852|NCT04941417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973853|NCT04941417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973854|NCT04948125|Apatinib|apatinib|mesh-list
91973855|NCT04948125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973856|NCT04948125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91973857|NCT04948125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973858|NCT04948125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973859|NCT02455115|Chromium|chromium|mesh-list
91973860|NCT02455115|Norepinephrine|norepinephrine|mesh-list
91973861|NCT02455115|Edetic Acid|edetic acid|mesh-list
91973862|NCT02455115|Pentetic Acid|pentetic acid|mesh-list
91973863|NCT02455115|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91973864|NCT02455115|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91973865|NCT02455115|Adrenergic Agents|adrenergic agents|mesh-ancestor
91973866|NCT02455115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973867|NCT02455115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973868|NCT02455115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973869|NCT02455115|Sympathomimetics|sympathomimetics|mesh-ancestor
91973870|NCT02455115|Autonomic Agents|autonomic agents|mesh-ancestor
91973871|NCT02455115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973872|NCT02455115|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91973873|NCT02455115|Trace Elements|trace elements|mesh-ancestor
91973874|NCT02455115|Micronutrients|micronutrients|mesh-ancestor
91973875|NCT02455115|Anticoagulants|anticoagulants|mesh-ancestor
91973876|NCT02455115|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91973877|NCT02455115|Chelating Agents|chelating agents|mesh-ancestor
91973878|NCT02455115|Sequestering Agents|sequestering agents|mesh-ancestor
91973880|NCT02455115|Protective Agents|protective agents|mesh-ancestor
91973881|NCT02455115|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91973882|NCT03094247|Amoxicillin|amoxicillin|mesh-list
91973883|NCT03094247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91973884|NCT03094247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973885|NCT04947423|Scopolamine|scopolamine|mesh-list
91973886|NCT04947423|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91973887|NCT04947423|Antiemetics|antiemetics|mesh-ancestor
91973888|NCT04947423|Autonomic Agents|autonomic agents|mesh-ancestor
91973889|NCT04947423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946582|NCT01023737|Hydroxychloroquine|hydroxychloroquine|mesh-list
91973890|NCT04947423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973891|NCT04947423|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973892|NCT04947423|Mydriatics|mydriatics|mesh-ancestor
91973893|NCT04947423|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91973894|NCT04947423|Cholinergic Agents|cholinergic agents|mesh-ancestor
91973895|NCT04947423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973896|NCT04947423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973897|NCT04947423|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91973898|NCT03250481|Oxycodone|oxycodone|mesh-list
91973899|NCT03250481|Propofol|propofol|mesh-list
91973900|NCT03250481|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973901|NCT03250481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973902|NCT03250481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973903|NCT03250481|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91973904|NCT03250481|Anesthetics, General|anesthetics, general|mesh-ancestor
91973905|NCT03250481|Anesthetics|anesthetics|mesh-ancestor
91973908|NCT03250481|Analgesics|analgesics|mesh-ancestor
91973909|NCT03250481|Sensory System Agents|sensory system agents|mesh-ancestor
91973910|NCT03250481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973911|NCT04947267|Epinephrine|epinephrine|mesh-list
91973912|NCT04947267|Mepivacaine|mepivacaine|mesh-list
91973913|NCT04947267|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91973914|NCT04947267|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91973915|NCT04947267|Adrenergic Agents|adrenergic agents|mesh-ancestor
91973916|NCT04947267|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91973917|NCT04947267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973918|NCT04947267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973919|NCT04947267|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91973920|NCT04947267|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91973921|NCT04947267|Autonomic Agents|autonomic agents|mesh-ancestor
91973922|NCT04947267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973923|NCT04947267|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91973924|NCT04947267|Respiratory System Agents|respiratory system agents|mesh-ancestor
91973925|NCT04947267|Mydriatics|mydriatics|mesh-ancestor
91973926|NCT04947267|Sympathomimetics|sympathomimetics|mesh-ancestor
91973927|NCT04947267|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91973928|NCT04947267|Anesthetics, Local|anesthetics, local|mesh-ancestor
91973929|NCT04947267|Anesthetics|anesthetics|mesh-ancestor
91973930|NCT04947267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973931|NCT04947267|Sensory System Agents|sensory system agents|mesh-ancestor
91973932|NCT04941885|Cyclophosphamide|cyclophosphamide|mesh-list
91973933|NCT04941885|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91973934|NCT04941885|Immunologic Factors|immunologic factors|mesh-ancestor
91973935|NCT04941885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973936|NCT04941885|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91973937|NCT04941885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91973938|NCT04941885|Alkylating Agents|alkylating agents|mesh-ancestor
91973939|NCT04941885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973940|NCT04941885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973941|NCT04941885|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91973942|NCT04423731|Leucovorin|leucovorin|mesh-list
91973943|NCT04423731|Paclitaxel|paclitaxel|mesh-list
91973944|NCT04423731|Gemcitabine|gemcitabine|mesh-list
91973945|NCT04423731|Fluorouracil|fluorouracil|mesh-list
91973946|NCT04423731|Folfirinox|folfirinox|mesh-list
91973947|NCT04423731|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91973948|NCT04423731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973949|NCT04423731|Tubulin Modulators|tubulin modulators|mesh-ancestor
91973950|NCT04423731|Antimitotic Agents|antimitotic agents|mesh-ancestor
91973951|NCT04423731|Mitosis Modulators|mitosis modulators|mesh-ancestor
91973952|NCT04423731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973953|NCT04423731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91973954|NCT04423731|Antimetabolites|antimetabolites|mesh-ancestor
91973955|NCT04423731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91973956|NCT04423731|Immunologic Factors|immunologic factors|mesh-ancestor
91973957|NCT04423731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973958|NCT04423731|Antidotes|antidotes|mesh-ancestor
91973959|NCT04423731|Protective Agents|protective agents|mesh-ancestor
91973960|NCT04423731|Vitamin B Complex|vitamin b complex|mesh-ancestor
91973961|NCT04423731|Vitamins|vitamins|mesh-ancestor
91973962|NCT04423731|Micronutrients|micronutrients|mesh-ancestor
91973963|NCT04947111|Antibodies|antibodies|mesh-list
91973964|NCT04947111|Immunoglobulins|immunoglobulins|mesh-list
91973965|NCT04947111|Antibodies, Blocking|antibodies, blocking|mesh-list
91946583|NCT01023737|Vorinostat|vorinostat|mesh-list
91946584|NCT01023737|Antimalarials|antimalarials|mesh-ancestor
91973966|NCT04947111|Immunologic Factors|immunologic factors|mesh-ancestor
91973967|NCT04947111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973968|NCT04947345|Propofol|propofol|mesh-list
91973969|NCT04947345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91973970|NCT04947345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973971|NCT04947345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973972|NCT04947345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91973973|NCT04947345|Anesthetics, General|anesthetics, general|mesh-ancestor
91973974|NCT04947345|Anesthetics|anesthetics|mesh-ancestor
91973975|NCT04947189|Dexamethasone|dexamethasone|mesh-list
91973976|NCT04947189|Docetaxel|docetaxel|mesh-list
91973977|NCT04947189|Seviteronel|seviteronel|mesh-list
91973978|NCT04947189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973979|NCT04947189|Antiemetics|antiemetics|mesh-ancestor
91973980|NCT04947189|Autonomic Agents|autonomic agents|mesh-ancestor
91973981|NCT04947189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973982|NCT04947189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973986|NCT04947189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973987|NCT04947189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91973988|NCT04947189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973989|NCT04947189|Tubulin Modulators|tubulin modulators|mesh-ancestor
91973990|NCT04947189|Antimitotic Agents|antimitotic agents|mesh-ancestor
91973991|NCT04947189|Mitosis Modulators|mitosis modulators|mesh-ancestor
91973992|NCT04947189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973993|NCT04947189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91973994|NCT04947189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973995|NCT03249311|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91973996|NCT03249311|Milnacipran|milnacipran|mesh-list
91973997|NCT03249311|Levomilnacipran|levomilnacipran|mesh-list
92081626|NCT01392963|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91973998|NCT03249311|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91973999|NCT03249311|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91974000|NCT03249311|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974001|NCT03249311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974002|NCT03249311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974003|NCT03249311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974004|NCT03249311|Analgesics|analgesics|mesh-ancestor
91974005|NCT03249311|Sensory System Agents|sensory system agents|mesh-ancestor
91974006|NCT03249311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974007|NCT03249311|Antidepressive Agents|antidepressive agents|mesh-ancestor
91974008|NCT03249311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91974009|NCT03249311|Dopamine Agents|dopamine agents|mesh-ancestor
91974010|NCT03249311|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91974011|NCT04413123|Nivolumab|nivolumab|mesh-list
91974012|NCT04413123|Ipilimumab|ipilimumab|mesh-list
91974013|NCT04413123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974014|NCT04413123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974015|NCT04413123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91974016|NCT04413123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974017|NCT02454491|Verapamil|verapamil|mesh-list
91974018|NCT02454491|Heparin|heparin|mesh-list
91974019|NCT02454491|Anticoagulants|anticoagulants|mesh-ancestor
91974020|NCT02454491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91974021|NCT02454491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91974022|NCT02454491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974023|NCT02454491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91974024|NCT02454491|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91974025|NCT02454491|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974026|NCT02454491|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91974027|NCT02454491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974028|NCT02454491|Vasodilator Agents|vasodilator agents|mesh-ancestor
91974029|NCT03248765|Analgesics, Opioid|analgesics, opioid|mesh-list
91974030|NCT03248765|Narcotics|narcotics|mesh-ancestor
91974031|NCT03248765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974032|NCT03248765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974033|NCT03248765|Analgesics|analgesics|mesh-ancestor
91974034|NCT03248765|Sensory System Agents|sensory system agents|mesh-ancestor
91974035|NCT03248765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974036|NCT04939857|Trimetazidine|trimetazidine|mesh-list
91946585|NCT01023737|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91946586|NCT01023737|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91946587|NCT01023737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946588|NCT01023737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974037|NCT04939857|Vasodilator Agents|vasodilator agents|mesh-ancestor
91974039|NCT04939779|Oxazolidinones|oxazolidinones|mesh-list
91974040|NCT04939779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974041|NCT04939779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974042|NCT04939779|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91974043|NCT04939779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974044|NCT04939779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974045|NCT03247595|Magnesium citrate|magnesium citrate|mesh-list
91974046|NCT03247595|Bisacodyl|bisacodyl|mesh-list
91974047|NCT03247595|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
91974048|NCT03247595|Cathartics|cathartics|mesh-ancestor
91974049|NCT03247595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974050|NCT03247595|Laxatives|laxatives|mesh-ancestor
91974052|NCT03247283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974053|NCT03247283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974054|NCT04938297|Rituximab|rituximab|mesh-list
91974068|NCT04938297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974070|NCT04937907|Benazepril|benazepril|mesh-list
91974071|NCT04937907|Antimalarials|antimalarials|mesh-ancestor
91974072|NCT04937907|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91974073|NCT04937907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91974074|NCT04937907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974075|NCT04937907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974076|NCT04937907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974077|NCT04937907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974078|NCT04937907|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91974079|NCT04937907|Protease Inhibitors|protease inhibitors|mesh-ancestor
91974080|NCT04937907|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91974081|NCT02625909|Sofosbuvir|sofosbuvir|mesh-list
91974082|NCT02625909|Velpatasvir|velpatasvir|mesh-list
91974083|NCT02625909|Antiviral Agents|antiviral agents|mesh-ancestor
91974084|NCT02625909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974085|NCT03246659|Polygeline|polygeline|mesh-list
91974086|NCT03246659|Gastrins|gastrins|mesh-list
91974087|NCT03246659|Plasma Substitutes|plasma substitutes|mesh-ancestor
91974088|NCT03246659|Blood Substitutes|blood substitutes|mesh-ancestor
91974089|NCT03246659|Hormones|hormones|mesh-ancestor
91974090|NCT03246659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974091|NCT03246659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974092|NCT03246581|Tiotropium Bromide|tiotropium bromide|mesh-list
91974093|NCT03246581|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91974094|NCT03246581|Autonomic Agents|autonomic agents|mesh-ancestor
91974095|NCT03246581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974096|NCT03246581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974097|NCT03246581|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91974098|NCT03246581|Respiratory System Agents|respiratory system agents|mesh-ancestor
91974099|NCT03246581|Parasympatholytics|parasympatholytics|mesh-ancestor
91974100|NCT03246581|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91974101|NCT03246581|Cholinergic Agents|cholinergic agents|mesh-ancestor
91974102|NCT03246581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974103|NCT03246581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974104|NCT03246113|Temozolomide|temozolomide|mesh-list
91974105|NCT03246113|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91974106|NCT03246113|Alkylating Agents|alkylating agents|mesh-ancestor
91974107|NCT03246113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974108|NCT03246113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974109|NCT04937673|Paclitaxel|paclitaxel|mesh-list
91974110|NCT04937673|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91974111|NCT04937673|Cisplatin|cisplatin|mesh-list
91974112|NCT04937673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91974113|NCT04937673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974114|NCT04937673|Tubulin Modulators|tubulin modulators|mesh-ancestor
91974115|NCT04937673|Antimitotic Agents|antimitotic agents|mesh-ancestor
91974122|NCT03245177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946589|NCT01023737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946590|NCT01023737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946591|NCT01023737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946592|NCT01023737|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91946593|NCT00646204|Memantine|memantine|mesh-list
91974124|NCT03245177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91974125|NCT03245177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974126|NCT03245333|Hormones|hormones|mesh-list
91974127|NCT03245333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974128|NCT03245333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974129|NCT04958187|Mitogens|mitogens|mesh-list
91974130|NCT04958187|Mitosis Modulators|mitosis modulators|mesh-ancestor
91974131|NCT04958187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974132|NCT03244319|Warfarin|warfarin|mesh-list
91974133|NCT03244319|Edoxaban|edoxaban|mesh-list
91974134|NCT03244319|Anticoagulants|anticoagulants|mesh-list
91974135|NCT03244319|Coagulants|coagulants|mesh-list
91974136|NCT03244319|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91974137|NCT03244319|Antithrombins|antithrombins|mesh-ancestor
91974138|NCT03244319|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91974139|NCT03244319|Protease Inhibitors|protease inhibitors|mesh-ancestor
91974140|NCT03244319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974141|NCT03244319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974142|NCT03244553|Prucalopride|prucalopride|mesh-list
91974143|NCT03244553|Laxatives|laxatives|mesh-ancestor
91974144|NCT03244553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974145|NCT03244553|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
91974146|NCT03244553|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91974147|NCT03244553|Serotonin Agents|serotonin agents|mesh-ancestor
91974148|NCT03244553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974149|NCT03244553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974150|NCT03244553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974151|NCT03244241|Insulin|insulin|mesh-list
91974152|NCT03244241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91974153|NCT03244241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974154|NCT03243851|Metformin|metformin|mesh-list
91974155|NCT03243851|Temozolomide|temozolomide|mesh-list
91974156|NCT03243851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91974157|NCT03243851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974158|NCT03243851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91974159|NCT03243851|Alkylating Agents|alkylating agents|mesh-ancestor
91974160|NCT03243851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974161|NCT03243851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974162|NCT02623959|Doxycycline|doxycycline|mesh-list
91974163|NCT02623959|Fentanyl|fentanyl|mesh-list
91974164|NCT02623959|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91974165|NCT02623959|Narcotics|narcotics|mesh-ancestor
91974166|NCT02623959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974167|NCT02623959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974168|NCT02623959|Analgesics|analgesics|mesh-ancestor
91974169|NCT02623959|Sensory System Agents|sensory system agents|mesh-ancestor
91974170|NCT02623959|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974171|NCT02623959|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91974172|NCT02623959|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91974173|NCT02623959|Anesthetics, General|anesthetics, general|mesh-ancestor
91974174|NCT02623959|Anesthetics|anesthetics|mesh-ancestor
91974175|NCT02623959|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974176|NCT02623959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974177|NCT02623959|Antimalarials|antimalarials|mesh-ancestor
91974178|NCT02623959|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91974179|NCT02623959|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91974180|NCT03242993|Folic Acid|folic acid|mesh-list
91974181|NCT03242993|Hematinics|hematinics|mesh-ancestor
91974182|NCT03242993|Vitamin B Complex|vitamin b complex|mesh-ancestor
91974183|NCT03242993|Vitamins|vitamins|mesh-ancestor
91974184|NCT03242993|Micronutrients|micronutrients|mesh-ancestor
91974185|NCT03242993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974206|NCT04931433|Anesthetics|anesthetics|mesh-ancestor
91974207|NCT04931433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974208|NCT04931433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974209|NCT04931433|Sensory System Agents|sensory system agents|mesh-ancestor
91946594|NCT00646204|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91946595|NCT00646204|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91974210|NCT04931433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974211|NCT04931433|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91974212|NCT04931433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91974213|NCT04931433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91974214|NCT04931433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974215|NCT04931433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974216|NCT04931121|Viscosupplements|viscosupplements|mesh-list
91974217|NCT04931121|Protective Agents|protective agents|mesh-ancestor
91974218|NCT04931121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974219|NCT03241901|Lumefantrine|lumefantrine|mesh-list
91974220|NCT03241901|Artemether|artemether|mesh-list
91974221|NCT03241901|Primaquine|primaquine|mesh-list
91974222|NCT03241901|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91974223|NCT03241901|Antimalarials|antimalarials|mesh-ancestor
91974224|NCT03241901|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91974225|NCT03241901|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91974226|NCT03241901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974227|NCT03241199|Imatinib Mesylate|imatinib mesylate|mesh-list
91974228|NCT03241199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974229|NCT03241199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974230|NCT03241199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974231|NCT03241199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974232|NCT03241043|Tacrolimus|tacrolimus|mesh-list
91974233|NCT03241043|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974234|NCT03241043|Immunologic Factors|immunologic factors|mesh-ancestor
91974235|NCT03241043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974236|NCT03241043|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91974237|NCT03241043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974238|NCT03241043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974239|NCT02453867|Tacrolimus|tacrolimus|mesh-list
91974240|NCT02453867|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974244|NCT02453867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974245|NCT02453867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974246|NCT03057561|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
91974247|NCT03057561|Chelating Agents|chelating agents|mesh-ancestor
91974248|NCT03057561|Sequestering Agents|sequestering agents|mesh-ancestor
91974249|NCT03057561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974250|NCT03239327|Alprostadil|alprostadil|mesh-list
91974251|NCT03239327|Misoprostol|misoprostol|mesh-list
91974252|NCT03239327|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91974253|NCT03239327|Abortifacient Agents|abortifacient agents|mesh-ancestor
91974254|NCT03239327|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91974255|NCT03239327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974256|NCT03239327|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91974257|NCT03239327|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974258|NCT03239327|Oxytocics|oxytocics|mesh-ancestor
91974259|NCT03239327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91974260|NCT03239327|Vasodilator Agents|vasodilator agents|mesh-ancestor
91974261|NCT03239327|Urological Agents|urological agents|mesh-ancestor
91974262|NCT04930185|Vaccines|vaccines|mesh-list
91974263|NCT04930185|Immunologic Factors|immunologic factors|mesh-ancestor
91974264|NCT04930185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974265|NCT02314559|Propofol|propofol|mesh-list
91974266|NCT02314559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91974267|NCT02314559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974268|NCT02314559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974269|NCT02314559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91974270|NCT02314559|Anesthetics, General|anesthetics, general|mesh-ancestor
91974271|NCT02314559|Anesthetics|anesthetics|mesh-ancestor
91974272|NCT03238703|Tamoxifen|tamoxifen|mesh-list
91974273|NCT03238703|Toremifene|toremifene|mesh-list
91974274|NCT03238703|Letrozole|letrozole|mesh-list
91974275|NCT03238703|Anastrozole|anastrozole|mesh-list
91974276|NCT03238703|Exemestane|exemestane|mesh-list
91974277|NCT03238703|Citric Acid|citric acid|mesh-list
91974278|NCT03238703|Sodium Citrate|sodium citrate|mesh-list
91974279|NCT03238703|Anticoagulants|anticoagulants|mesh-ancestor
91974280|NCT03238703|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91974281|NCT03238703|Chelating Agents|chelating agents|mesh-ancestor
91974282|NCT03238703|Sequestering Agents|sequestering agents|mesh-ancestor
91974283|NCT03238703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974284|NCT03238703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946596|NCT00646204|Dopamine Agents|dopamine agents|mesh-ancestor
91946597|NCT00646204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946598|NCT00646204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946599|NCT00646204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974285|NCT03238703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91974286|NCT03238703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91974287|NCT03238703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974288|NCT03238703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91974289|NCT03238703|Hormone Antagonists|hormone antagonists|mesh-ancestor
91974290|NCT03238703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974291|NCT03238703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974292|NCT03238703|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974293|NCT03238703|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91974294|NCT03238703|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91974295|NCT03238703|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91974297|NCT03238625|Anesthetics, Local|anesthetics, local|mesh-ancestor
91974298|NCT03238625|Anesthetics|anesthetics|mesh-ancestor
91974299|NCT03238625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974300|NCT03238625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974301|NCT03238625|Sensory System Agents|sensory system agents|mesh-ancestor
91974302|NCT03238625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974303|NCT03238625|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91974304|NCT03238625|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91974305|NCT03238625|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91974306|NCT03238625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974307|NCT03238625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974308|NCT03238079|Immunoglobulins|immunoglobulins|mesh-list
91974309|NCT03238079|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91974310|NCT03238079|Immunologic Factors|immunologic factors|mesh-ancestor
91974311|NCT03238079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974316|NCT05387681|Growth Substances|growth substances|mesh-ancestor
91974317|NCT05387681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974318|NCT05387681|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974319|NCT03238157|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
91974320|NCT03238157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974321|NCT03238157|Glucocorticoids|glucocorticoids|mesh-ancestor
91974322|NCT03238157|Hormones|hormones|mesh-ancestor
91974323|NCT03238157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974324|NCT03238157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974325|NCT04485845|Metformin|metformin|mesh-list
91974326|NCT04485845|Vildagliptin|vildagliptin|mesh-list
91974327|NCT04485845|Captopril|captopril|mesh-list
91974328|NCT04485845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91974329|NCT04485845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974330|NCT04485845|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91974331|NCT04485845|Protease Inhibitors|protease inhibitors|mesh-ancestor
91974332|NCT04485845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974333|NCT04485845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974334|NCT04485845|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91974335|NCT04485845|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91974336|NCT00700427|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91974337|NCT00700427|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91974338|NCT00700427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91974339|NCT00700427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974340|NCT00700427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974341|NCT00700427|Adrenergic Agents|adrenergic agents|mesh-ancestor
91974342|NCT00700427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974343|NCT00700427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974344|NCT03237533|Promethazine|promethazine|mesh-list
91974345|NCT03237533|Doxycycline|doxycycline|mesh-list
91974346|NCT03237533|Nystatin|nystatin|mesh-list
91974347|NCT03237533|Dexamethasone|dexamethasone|mesh-list
91974348|NCT03237533|Triamcinolone|triamcinolone|mesh-list
91974349|NCT03237533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974350|NCT03237533|Antiemetics|antiemetics|mesh-ancestor
91974351|NCT03237533|Autonomic Agents|autonomic agents|mesh-ancestor
91974352|NCT03237533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946600|NCT00646204|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91974353|NCT03237533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974354|NCT03237533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974355|NCT03237533|Glucocorticoids|glucocorticoids|mesh-ancestor
91974356|NCT03237533|Hormones|hormones|mesh-ancestor
91974357|NCT03237533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974358|NCT03237533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974359|NCT03237533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974360|NCT03237533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974361|NCT03237533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974362|NCT03237533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974363|NCT03237533|Antimalarials|antimalarials|mesh-ancestor
91974364|NCT03237533|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91974365|NCT03237533|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91974366|NCT03237533|Antipruritics|antipruritics|mesh-ancestor
91974367|NCT03237533|Dermatologic Agents|dermatologic agents|mesh-ancestor
91974368|NCT03237533|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91974369|NCT03237533|Histamine Antagonists|histamine antagonists|mesh-ancestor
91974370|NCT03237533|Histamine Agents|histamine agents|mesh-ancestor
91974371|NCT03237533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974372|NCT03237533|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91974373|NCT03237533|Antifungal Agents|antifungal agents|mesh-ancestor
91974374|NCT03237533|Ionophores|ionophores|mesh-ancestor
91974375|NCT03237533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974377|NCT03235973|Busulfan|busulfan|mesh-list
91974378|NCT03235973|Cladribine|cladribine|mesh-list
91974379|NCT03235973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974380|NCT03235973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974381|NCT03235973|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974382|NCT03235973|Immunologic Factors|immunologic factors|mesh-ancestor
91974383|NCT03235973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974391|NCT02453087|Immunologic Factors|immunologic factors|mesh-ancestor
91974392|NCT02453087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974393|NCT02453087|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974394|NCT02124772|Trametinib|trametinib|mesh-list
91974395|NCT02124772|Dabrafenib|dabrafenib|mesh-list
91974396|NCT02124772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974397|NCT02124772|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974398|NCT02124772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974399|NCT02124772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974400|NCT02159482|Interferons|interferons|mesh-list
91974401|NCT02159482|Interferon-alpha|interferon-alpha|mesh-list
91974402|NCT02159482|Interferon alpha-2|interferon alpha-2|mesh-list
91974403|NCT02159482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974404|NCT02159482|Antiviral Agents|antiviral agents|mesh-ancestor
91974405|NCT02159482|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974406|NCT02159482|Immunologic Factors|immunologic factors|mesh-ancestor
91974407|NCT02159482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974408|NCT05269030|Ivermectin|ivermectin|mesh-list
91974409|NCT05269030|Budesonide|budesonide|mesh-list
91974410|NCT05269030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974411|NCT05269030|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91974412|NCT05269030|Autonomic Agents|autonomic agents|mesh-ancestor
91974413|NCT05269030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974414|NCT05269030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974415|NCT05269030|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91974416|NCT05269030|Respiratory System Agents|respiratory system agents|mesh-ancestor
91974417|NCT05269030|Glucocorticoids|glucocorticoids|mesh-ancestor
91974418|NCT05269030|Hormones|hormones|mesh-ancestor
91974419|NCT05269030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974420|NCT05269030|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91974421|NCT05269030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974422|NCT02622321|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
91974423|NCT02622321|Coagulants|coagulants|mesh-ancestor
91974424|NCT02187172|Ustekinumab|ustekinumab|mesh-list
91974425|NCT02187172|Dermatologic Agents|dermatologic agents|mesh-ancestor
91974426|NCT03057015|Dexamethasone|dexamethasone|mesh-list
91974427|NCT03057015|Clonidine|clonidine|mesh-list
91974428|NCT03057015|Epinephrine|epinephrine|mesh-list
91974429|NCT03057015|Ropivacaine|ropivacaine|mesh-list
91974430|NCT03057015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974431|NCT03057015|Antiemetics|antiemetics|mesh-ancestor
91974432|NCT03057015|Autonomic Agents|autonomic agents|mesh-ancestor
91974433|NCT03057015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974434|NCT03057015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974435|NCT03057015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974436|NCT03057015|Glucocorticoids|glucocorticoids|mesh-ancestor
91974437|NCT03057015|Hormones|hormones|mesh-ancestor
91974438|NCT03057015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974439|NCT03057015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974440|NCT03057015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974441|NCT03057015|Anesthetics, Local|anesthetics, local|mesh-ancestor
91974442|NCT03057015|Anesthetics|anesthetics|mesh-ancestor
91974443|NCT03057015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974444|NCT03057015|Sensory System Agents|sensory system agents|mesh-ancestor
91974445|NCT03057015|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91974446|NCT03057015|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91974447|NCT03057015|Adrenergic Agents|adrenergic agents|mesh-ancestor
91974448|NCT03057015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974449|NCT03057015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974450|NCT03057015|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91974451|NCT03057015|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91974452|NCT03057015|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91974456|NCT03057015|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91974457|NCT03057015|Analgesics|analgesics|mesh-ancestor
91974458|NCT03057015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91974459|NCT03057015|Sympatholytics|sympatholytics|mesh-ancestor
91974460|NCT03057015|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91974461|NCT04934475|Lenalidomide|lenalidomide|mesh-list
91974462|NCT04934475|Immunologic Factors|immunologic factors|mesh-ancestor
91974463|NCT04934475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974464|NCT04934475|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974465|NCT04934475|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91974466|NCT04934475|Growth Substances|growth substances|mesh-ancestor
91974467|NCT04934475|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974468|NCT04934475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974470|NCT03057483|Immunologic Factors|immunologic factors|mesh-ancestor
91974471|NCT03057483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974472|NCT04922151|Ranibizumab|ranibizumab|mesh-list
91974473|NCT04922151|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974474|NCT04922151|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91974475|NCT04922151|Growth Substances|growth substances|mesh-ancestor
91974476|NCT04922151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974477|NCT04922151|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974478|NCT04922151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974479|NCT04928313|Glatiramer Acetate|glatiramer acetate|mesh-list
91974480|NCT04928313|(T,G)-A-L|(t,g)-a-l|mesh-list
91974481|NCT04928313|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91974482|NCT04928313|Immunologic Factors|immunologic factors|mesh-ancestor
91974483|NCT04928313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974484|NCT04928313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974485|NCT04928313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974486|NCT04928079|Antiparkinson Agents|antiparkinson agents|mesh-list
91974487|NCT04928079|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91974488|NCT04920747|Taxane|taxane|mesh-list
91974489|NCT04920747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974490|NCT04927299|Losartan|losartan|mesh-list
91974491|NCT04927299|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91974492|NCT04927299|Chlorthalidone|chlorthalidone|mesh-list
91974493|NCT04927299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91974494|NCT04927299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91974495|NCT04927299|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91974496|NCT04927299|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91974497|NCT04927299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974498|NCT04927299|Diuretics|diuretics|mesh-ancestor
91974499|NCT04927299|Natriuretic Agents|natriuretic agents|mesh-ancestor
91974500|NCT04927299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974501|NCT04927299|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91974502|NCT04927299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974503|NCT03056625|Vitamin A|vitamin a|mesh-list
91974504|NCT03056625|Vitamins|vitamins|mesh-ancestor
91974505|NCT03056625|Micronutrients|micronutrients|mesh-ancestor
91974506|NCT03056625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974507|NCT04913103|Rituximab|rituximab|mesh-list
91974508|NCT04913103|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91974509|NCT04913103|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
91974510|NCT04913103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946601|NCT00646204|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91974511|NCT04913103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974512|NCT04913103|Immunologic Factors|immunologic factors|mesh-ancestor
91974513|NCT04913103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974514|NCT04913103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974515|NCT04913103|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91974516|NCT04913103|Alkylating Agents|alkylating agents|mesh-ancestor
91974517|NCT04913103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974518|NCT04913103|Immunoconjugates|immunoconjugates|mesh-ancestor
91974519|NCT04920669|Dexmedetomidine|dexmedetomidine|mesh-list
91974520|NCT04920669|Bupivacaine|bupivacaine|mesh-list
91974521|NCT04920669|Anesthetics, Local|anesthetics, local|mesh-ancestor
91974522|NCT04920669|Anesthetics|anesthetics|mesh-ancestor
91974523|NCT04920669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974524|NCT04920669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974525|NCT04920669|Sensory System Agents|sensory system agents|mesh-ancestor
91974530|NCT04920669|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91974531|NCT04920669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91974532|NCT04920669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91974533|NCT04920669|Adrenergic Agents|adrenergic agents|mesh-ancestor
91974534|NCT04920669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974535|NCT04920669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974537|NCT04926753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974538|NCT04926753|Antimetabolites|antimetabolites|mesh-ancestor
91974539|NCT04926753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974540|NCT04926753|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91974541|NCT04926753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974542|NCT04926753|Immunologic Factors|immunologic factors|mesh-ancestor
91974543|NCT04926753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974544|NCT02621931|Calcitonin|calcitonin|mesh-list
91974545|NCT02621931|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
91974546|NCT02621931|Katacalcin|katacalcin|mesh-list
91974547|NCT02621931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91974548|NCT02621931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974549|NCT02621931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91974550|NCT02621931|Vasodilator Agents|vasodilator agents|mesh-ancestor
91974551|NCT04925973|Tofacitinib|tofacitinib|mesh-list
91974552|NCT04925973|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91974553|NCT04925973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974554|NCT04925973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974555|NCT04925973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974556|NCT04400175|Silicon|silicon|mesh-list
91974557|NCT04400175|Trace Elements|trace elements|mesh-ancestor
91974558|NCT04400175|Micronutrients|micronutrients|mesh-ancestor
91974559|NCT04400175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974560|NCT04912167|Valsartan|valsartan|mesh-list
91974561|NCT04912167|Enalapril|enalapril|mesh-list
91974562|NCT04912167|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91974563|NCT04912167|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91974564|NCT04912167|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91974565|NCT04912167|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91974566|NCT04912167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974567|NCT04912167|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91974568|NCT04912167|Protease Inhibitors|protease inhibitors|mesh-ancestor
91974569|NCT04912167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974570|NCT03056703|Aspirin|aspirin|mesh-list
91974571|NCT03056703|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91974572|NCT03056703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91974573|NCT03056703|Analgesics|analgesics|mesh-ancestor
91974574|NCT03056703|Sensory System Agents|sensory system agents|mesh-ancestor
91974575|NCT03056703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974576|NCT03056703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974577|NCT03056703|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974578|NCT03056703|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974579|NCT03056703|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91974580|NCT03056703|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91974581|NCT03056703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974582|NCT03056703|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91974583|NCT03056703|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91974584|NCT03056703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946602|NCT04105270|Carboplatin|carboplatin|mesh-list
91946603|NCT04105270|Pemetrexed|pemetrexed|mesh-list
91946605|NCT04105270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946606|NCT04105270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090402|NCT04382014|Sensory System Agents|sensory system agents|mesh-ancestor
91974585|NCT03056703|Antipyretics|antipyretics|mesh-ancestor
91974586|NCT02158936|Azacitidine|azacitidine|mesh-list
91974587|NCT02158936|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91974588|NCT02158936|Antimetabolites|antimetabolites|mesh-ancestor
91974589|NCT02158936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974590|NCT02158936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974591|NCT02158936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974592|NCT04924647|Dexamethasone|dexamethasone|mesh-list
91974593|NCT04924647|Lenalidomide|lenalidomide|mesh-list
91974594|NCT04924647|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974598|NCT04924647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974599|NCT04924647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974600|NCT04924647|Glucocorticoids|glucocorticoids|mesh-ancestor
91974602|NCT04924647|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974603|NCT04924647|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974604|NCT04924647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974605|NCT04924647|Immunologic Factors|immunologic factors|mesh-ancestor
91974606|NCT04924647|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974607|NCT04924647|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91974608|NCT04924647|Growth Substances|growth substances|mesh-ancestor
91974609|NCT04924647|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974610|NCT04912011|Canrenoic Acid|canrenoic acid|mesh-list
91974611|NCT04912011|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91974612|NCT04912011|Hormone Antagonists|hormone antagonists|mesh-ancestor
91974613|NCT04912011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974614|NCT04912011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974615|NCT04912011|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91974616|NCT04912011|Diuretics|diuretics|mesh-ancestor
91974617|NCT04912011|Natriuretic Agents|natriuretic agents|mesh-ancestor
91974618|NCT04918719|Acetylcysteine|acetylcysteine|mesh-list
91974619|NCT04918719|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91974620|NCT04918719|Antiviral Agents|antiviral agents|mesh-ancestor
91974621|NCT04918719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974622|NCT04918719|Expectorants|expectorants|mesh-ancestor
91974623|NCT04918719|Respiratory System Agents|respiratory system agents|mesh-ancestor
91974624|NCT04918719|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91974625|NCT04918719|Antioxidants|antioxidants|mesh-ancestor
91974626|NCT04918719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974627|NCT04918719|Protective Agents|protective agents|mesh-ancestor
91974628|NCT04918719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974629|NCT04918719|Antidotes|antidotes|mesh-ancestor
91974630|NCT03056391|Acetaminophen|acetaminophen|mesh-list
91974631|NCT03056391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91974632|NCT03056391|Analgesics|analgesics|mesh-ancestor
91974633|NCT03056391|Sensory System Agents|sensory system agents|mesh-ancestor
91974634|NCT03056391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974635|NCT03056391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974636|NCT03056391|Antipyretics|antipyretics|mesh-ancestor
91974637|NCT04924413|Tislelizumab|tislelizumab|mesh-list
91974638|NCT04924413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974639|NCT04924413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974640|NCT04747054|Pembrolizumab|pembrolizumab|mesh-list
91974641|NCT04747054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974642|NCT04747054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974643|NCT04747054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91974644|NCT04747054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974645|NCT04918563|Nitroglycerin|nitroglycerin|mesh-list
91974646|NCT04918563|Acetylcholine|acetylcholine|mesh-list
91974647|NCT04918563|Vasodilator Agents|vasodilator agents|mesh-ancestor
91974648|NCT04918563|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91974649|NCT04918563|Cholinergic Agents|cholinergic agents|mesh-ancestor
91974650|NCT04918563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974651|NCT04918563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974652|NCT04918563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974653|NCT02123446|Cephalexin|cephalexin|mesh-list
91946607|NCT04105270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946608|NCT04105270|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91974654|NCT02123446|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974655|NCT02123446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974656|NCT04918953|Methylprednisolone|methylprednisolone|mesh-list
91974657|NCT04918953|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91974658|NCT04918953|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91974659|NCT04918953|Prednisolone|prednisolone|mesh-list
91974660|NCT04918953|Prednisolone acetate|prednisolone acetate|mesh-list
91974662|NCT04918953|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91974663|NCT04918953|Prednisolone phosphate|prednisolone phosphate|mesh-list
91974664|NCT04918953|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974665|NCT04918953|Antiemetics|antiemetics|mesh-ancestor
91974666|NCT04918953|Autonomic Agents|autonomic agents|mesh-ancestor
91974685|NCT03054207|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91974686|NCT03054207|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91974687|NCT03054207|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91974688|NCT03054207|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91974689|NCT03054207|Purinergic Agents|purinergic agents|mesh-ancestor
91974690|NCT03054207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974691|NCT03054207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974692|NCT03054207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974693|NCT02185534|Clopidogrel|clopidogrel|mesh-list
91974694|NCT02185534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91974695|NCT02185534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91974696|NCT02185534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91974697|NCT02185534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91974698|NCT02185534|Purinergic Agents|purinergic agents|mesh-ancestor
91974699|NCT02185534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974700|NCT02185534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974701|NCT02185534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974702|NCT03056079|Aflibercept|aflibercept|mesh-list
91974703|NCT03056079|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974704|NCT03056079|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91974705|NCT03056079|Growth Substances|growth substances|mesh-ancestor
91974706|NCT03056079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974707|NCT03056079|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974708|NCT03056079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974709|NCT03055767|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91974710|NCT03055767|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91974711|NCT03055767|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91974712|NCT03055767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974713|NCT03055767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974714|NCT03055767|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91974715|NCT03055767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974716|NCT03055767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974717|NCT03055767|Cholinergic Agents|cholinergic agents|mesh-ancestor
91974718|NCT03055767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974719|NCT02157376|Esomeprazole|esomeprazole|mesh-list
91974720|NCT02157376|Cimetidine|cimetidine|mesh-list
91974725|NCT02157376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974726|NCT02157376|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91974727|NCT02157376|Histamine Antagonists|histamine antagonists|mesh-ancestor
91974728|NCT02157376|Histamine Agents|histamine agents|mesh-ancestor
91974729|NCT02157376|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974730|NCT02157376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974731|NCT02157376|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91974732|NCT02157376|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91974733|NCT04922541|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91974734|NCT04922541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974735|NCT04922541|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974736|NCT04922541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974737|NCT02157298|Dapagliflozin|dapagliflozin|mesh-list
91974738|NCT02157298|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91974739|NCT02157298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974740|NCT02157298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91974741|NCT02157298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946609|NCT04105270|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91946610|NCT04105270|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946612|NCT02243176|Acarbose|acarbose|mesh-list
91946613|NCT02243176|Incretins|incretins|mesh-ancestor
91946614|NCT02243176|Hormones|hormones|mesh-ancestor
91946615|NCT02243176|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946616|NCT02243176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946617|NCT02243176|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91946618|NCT02243176|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946619|NCT02243176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946620|NCT02243176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946621|NCT02243176|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91946622|NCT02243176|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91946623|NCT00692939|Cyclophosphamide|cyclophosphamide|mesh-list
91946625|NCT00692939|Thiotepa|thiotepa|mesh-list
91946626|NCT00692939|Rituximab|rituximab|mesh-list
91946627|NCT00692939|Alemtuzumab|alemtuzumab|mesh-list
91946628|NCT00692939|Thymoglobulin|thymoglobulin|mesh-list
91946629|NCT00692939|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91946630|NCT00692939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91946631|NCT00692939|Immunologic Factors|immunologic factors|mesh-ancestor
91946632|NCT00692939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946633|NCT00692939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946634|NCT00692939|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91974742|NCT03054285|Levetiracetam|levetiracetam|mesh-list
91974743|NCT03054285|Anticonvulsants|anticonvulsants|mesh-ancestor
91974744|NCT03054285|Nootropic Agents|nootropic agents|mesh-ancestor
91974745|NCT04917627|Vancomycin|vancomycin|mesh-list
91974746|NCT04917627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974747|NCT04917627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974748|NCT04903743|Magnesium Sulfate|magnesium sulfate|mesh-list
91974749|NCT04903743|Bupivacaine|bupivacaine|mesh-list
91974750|NCT04903743|Anesthetics, Local|anesthetics, local|mesh-ancestor
91974751|NCT04903743|Anesthetics|anesthetics|mesh-ancestor
91974752|NCT04903743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974753|NCT04903743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974754|NCT04903743|Sensory System Agents|sensory system agents|mesh-ancestor
91974755|NCT04903743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974756|NCT04903743|Analgesics|analgesics|mesh-ancestor
91974757|NCT04903743|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91974758|NCT04903743|Anticonvulsants|anticonvulsants|mesh-ancestor
91974759|NCT04903743|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91974760|NCT04903743|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974761|NCT04903743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974762|NCT04903743|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91974763|NCT04903743|Tocolytic Agents|tocolytic agents|mesh-ancestor
91946636|NCT00692939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946637|NCT00692939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946638|NCT00692939|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91946639|NCT00692939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91946640|NCT04551261|Ritonavir|ritonavir|mesh-list
91946641|NCT04551261|Tenofovir|tenofovir|mesh-list
91946642|NCT04551261|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91946643|NCT04551261|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91946644|NCT04551261|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946645|NCT04551261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946646|NCT04551261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946647|NCT04551261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91946648|NCT04551261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91946649|NCT04551261|Antiviral Agents|antiviral agents|mesh-ancestor
91946650|NCT04551261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946651|NCT04551261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91946652|NCT04551261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91946653|NCT04551261|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91946690|NCT02240680|Incretins|incretins|mesh-ancestor
91946691|NCT02240680|Hormones|hormones|mesh-ancestor
91946692|NCT02240680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946693|NCT02240680|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91946694|NCT02240680|Protease Inhibitors|protease inhibitors|mesh-ancestor
91946695|NCT02240680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946696|NCT02240680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946697|NCT05391867|Sorafenib|sorafenib|mesh-list
91946698|NCT05391867|Lenvatinib|lenvatinib|mesh-list
91946699|NCT05391867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91946700|NCT05391867|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91946701|NCT05391867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91946703|NCT03110679|Hyaluronic Acid|hyaluronic acid|mesh-list
91946753|NCT03962062|Anthelmintics|anthelmintics|mesh-ancestor
91946754|NCT03962062|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91946755|NCT03962062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946756|NCT03962062|Antinematodal Agents|antinematodal agents|mesh-ancestor
91946757|NCT03140085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91946758|NCT03140085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91946759|NCT02239510|Linaclotide|linaclotide|mesh-list
91946760|NCT02239510|Sennosides|sennosides|mesh-list
91946761|NCT02239510|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91946762|NCT02239510|Enzyme Activators|enzyme activators|mesh-ancestor
91946763|NCT02239510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946764|NCT02239510|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946765|NCT02239510|Laxatives|laxatives|mesh-ancestor
91946766|NCT04507581|Anesthetics|anesthetics|mesh-list
91946767|NCT04507581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91946768|NCT04507581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946770|NCT02291471|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
91946771|NCT02291471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91946772|NCT02291471|Immunologic Factors|immunologic factors|mesh-ancestor
91946773|NCT02291471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946774|NCT03899961|Oxytocin|oxytocin|mesh-list
91946808|NCT05318157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91946809|NCT05318157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946810|NCT05318157|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91946811|NCT02294279|Beclomethasone|beclomethasone|mesh-list
91946812|NCT02294279|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946813|NCT02294279|Glucocorticoids|glucocorticoids|mesh-ancestor
91946814|NCT02294279|Hormones|hormones|mesh-ancestor
91946815|NCT02294279|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946816|NCT02294279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946817|NCT02294279|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946819|NCT02294357|Dexamethasone|dexamethasone|mesh-list
91946873|NCT02294591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946874|NCT02294591|Protective Agents|protective agents|mesh-ancestor
91946875|NCT02294591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946876|NCT02294591|Antidotes|antidotes|mesh-ancestor
91946877|NCT03521063|Budesonide|budesonide|mesh-list
91946878|NCT03521063|Poractant alfa|poractant alfa|mesh-list
91946879|NCT03521063|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946880|NCT03521063|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91946881|NCT03521063|Autonomic Agents|autonomic agents|mesh-ancestor
91946882|NCT03521063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946883|NCT03521063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946884|NCT03521063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946885|NCT03521063|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946886|NCT03521063|Glucocorticoids|glucocorticoids|mesh-ancestor
91946887|NCT03521063|Hormones|hormones|mesh-ancestor
91946888|NCT03521063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946889|NCT03521063|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
91946890|NCT03520985|Dexamethasone|dexamethasone|mesh-list
91946891|NCT03520985|Pomalidomide|pomalidomide|mesh-list
91946892|NCT03520985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91946893|NCT03520985|Antiemetics|antiemetics|mesh-ancestor
91946894|NCT03520985|Autonomic Agents|autonomic agents|mesh-ancestor
91946895|NCT03520985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946896|NCT03520985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946897|NCT03520985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91946898|NCT03520985|Glucocorticoids|glucocorticoids|mesh-ancestor
91946922|NCT03517943|Autonomic Agents|autonomic agents|mesh-ancestor
91946923|NCT03517943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91946924|NCT03517943|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91946925|NCT03517943|Respiratory System Agents|respiratory system agents|mesh-ancestor
91946926|NCT03517943|Nasal Decongestants|nasal decongestants|mesh-ancestor
91946927|NCT03517943|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91946928|NCT03517943|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91946929|NCT03517943|Sympathomimetics|sympathomimetics|mesh-ancestor
91946930|NCT03517943|Adrenergic Agents|adrenergic agents|mesh-ancestor
91946931|NCT03823521|Cardioplegic Solutions|cardioplegic solutions|mesh-list
91946932|NCT03823521|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91946933|NCT03136341|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91946934|NCT03136341|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91946935|NCT03136341|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91946936|NCT03136341|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91946937|NCT03136341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91946943|NCT04465175|Magnesium Sulfate|magnesium sulfate|mesh-list
91946979|NCT03520439|Mifepristone|mifepristone|mesh-list
91946980|NCT03520439|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91946981|NCT03520439|Abortifacient Agents|abortifacient agents|mesh-ancestor
91946982|NCT03520439|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91946983|NCT03520439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91946984|NCT03520439|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91946985|NCT03520439|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91946986|NCT03520439|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91946987|NCT03520439|Contraceptive Agents|contraceptive agents|mesh-ancestor
91946988|NCT03520439|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91946989|NCT03520439|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91946990|NCT03520439|Hormone Antagonists|hormone antagonists|mesh-ancestor
91946991|NCT03520439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91946992|NCT03520439|Luteolytic Agents|luteolytic agents|mesh-ancestor
91946993|NCT03520439|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91946994|NCT03520439|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91947036|NCT03520049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947037|NCT03520049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947038|NCT03520049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947039|NCT03517631|Busulfan|busulfan|mesh-list
91947040|NCT03517631|Alkylating Agents|alkylating agents|mesh-ancestor
91947041|NCT03517631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947042|NCT03517631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91947043|NCT03517631|Immunologic Factors|immunologic factors|mesh-ancestor
91947044|NCT03517631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947045|NCT03517631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91947046|NCT03517631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947047|NCT03517631|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91947048|NCT03516773|Parathyroid Hormone|parathyroid hormone|mesh-list
91947049|NCT03516773|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947095|NCT03132779|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91947096|NCT03132779|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91947097|NCT02293187|Vitamin D|vitamin d|mesh-list
91947098|NCT02293187|Cholecalciferol|cholecalciferol|mesh-list
91947099|NCT02293187|Vitamins|vitamins|mesh-ancestor
91947100|NCT02293187|Micronutrients|micronutrients|mesh-ancestor
91947101|NCT02293187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947102|NCT02293187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947103|NCT02293187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947104|NCT02296463|Vaccines|vaccines|mesh-list
91947105|NCT02296463|Immunologic Factors|immunologic factors|mesh-ancestor
91947106|NCT02296463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947107|NCT02495168|Budesonide|budesonide|mesh-list
91947108|NCT02495168|Formoterol Fumarate|formoterol fumarate|mesh-list
91947109|NCT02495168|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
91947110|NCT02495168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947111|NCT02495168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91947112|NCT02495168|Autonomic Agents|autonomic agents|mesh-ancestor
91947113|NCT02495168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947114|NCT02495168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947115|NCT02495168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91947116|NCT02495168|Respiratory System Agents|respiratory system agents|mesh-ancestor
91947117|NCT02495168|Glucocorticoids|glucocorticoids|mesh-ancestor
91947118|NCT02495168|Hormones|hormones|mesh-ancestor
91947119|NCT02495168|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947120|NCT02495168|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91947144|NCT02293889|Ergocalciferols|ergocalciferols|mesh-list
91947145|NCT02293889|Cholecalciferol|cholecalciferol|mesh-list
91947146|NCT02293889|Vitamins|vitamins|mesh-list
91947147|NCT02293889|Micronutrients|micronutrients|mesh-ancestor
91947148|NCT02293889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947149|NCT02293889|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91947150|NCT02293889|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947151|NCT02298335|Prednisone|prednisone|mesh-list
91947152|NCT02298335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947153|NCT02298335|Glucocorticoids|glucocorticoids|mesh-ancestor
91947154|NCT02298335|Hormones|hormones|mesh-ancestor
91947155|NCT02298335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947156|NCT02298335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947157|NCT02298335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91947158|NCT02298335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947159|NCT03514667|Curcumin|curcumin|mesh-list
91947160|NCT03514667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947161|NCT03514667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947162|NCT03514667|Analgesics|analgesics|mesh-ancestor
91947163|NCT03514667|Sensory System Agents|sensory system agents|mesh-ancestor
91947164|NCT03514667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947165|NCT03514667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947166|NCT03514667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947167|NCT03514667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947193|NCT02493764|Protease Inhibitors|protease inhibitors|mesh-ancestor
91947194|NCT02297477|Artesunate|artesunate|mesh-list
91947195|NCT02297477|Atovaquone|atovaquone|mesh-list
91947196|NCT02297477|Proguanil|proguanil|mesh-list
91947197|NCT02297477|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
91947198|NCT02297477|Antimalarials|antimalarials|mesh-ancestor
91947199|NCT02297477|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91947200|NCT02297477|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91947201|NCT02297477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947202|NCT02297477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947203|NCT02297477|Antiviral Agents|antiviral agents|mesh-ancestor
91947204|NCT02297477|Schistosomicides|schistosomicides|mesh-ancestor
91947205|NCT02297477|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91947206|NCT02297477|Anthelmintics|anthelmintics|mesh-ancestor
91947207|NCT02297477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947208|NCT02297477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947209|NCT02297477|Antimetabolites|antimetabolites|mesh-ancestor
91947210|NCT02460380|Vitamin D|vitamin d|mesh-list
91947211|NCT02460380|Cholecalciferol|cholecalciferol|mesh-list
91947212|NCT02460380|Vitamins|vitamins|mesh-ancestor
91947252|NCT02492984|Factor VIII|factor viii|mesh-list
91947253|NCT02492984|Coagulants|coagulants|mesh-ancestor
91947254|NCT03132623|Andrographolide|andrographolide|mesh-list
91947255|NCT03132623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947256|NCT03132623|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947257|NCT03132623|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947258|NCT03132623|Analgesics|analgesics|mesh-ancestor
91947259|NCT03132623|Sensory System Agents|sensory system agents|mesh-ancestor
91947260|NCT03132623|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947261|NCT03132623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947262|NCT03132623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947263|NCT03132623|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91947264|NCT03132623|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91947265|NCT03132623|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947266|NCT03132623|Antiviral Agents|antiviral agents|mesh-ancestor
91947267|NCT03132623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91947268|NCT03514979|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91947269|NCT03514979|Immunologic Factors|immunologic factors|mesh-ancestor
91947270|NCT03514979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947271|NCT02298101|Edetic Acid|edetic acid|mesh-list
91947272|NCT02298101|Pentetic Acid|pentetic acid|mesh-list
91947273|NCT02298101|Antidotes|antidotes|mesh-ancestor
91947274|NCT02298101|Protective Agents|protective agents|mesh-ancestor
91947275|NCT02298101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947276|NCT02298101|Chelating Agents|chelating agents|mesh-ancestor
91947277|NCT02298101|Sequestering Agents|sequestering agents|mesh-ancestor
91947278|NCT02298101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947279|NCT02298101|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91947280|NCT02298101|Anticoagulants|anticoagulants|mesh-ancestor
91947281|NCT02298101|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91947282|NCT02491892|Pertuzumab|pertuzumab|mesh-list
91947297|NCT02834403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947298|NCT02834403|Tubulin Modulators|tubulin modulators|mesh-ancestor
91947299|NCT02834403|Antimitotic Agents|antimitotic agents|mesh-ancestor
91947300|NCT02834403|Mitosis Modulators|mitosis modulators|mesh-ancestor
91947301|NCT02834403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947302|NCT02834403|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947303|NCT02834403|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947304|NCT02834403|Analgesics|analgesics|mesh-ancestor
91947305|NCT02834403|Sensory System Agents|sensory system agents|mesh-ancestor
91947306|NCT02834403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947307|NCT02834403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947308|NCT02834403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947309|NCT02834403|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947310|NCT02834403|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91947311|NCT02834403|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91947312|NCT02834403|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91947313|NCT02834403|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91947314|NCT02834403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947315|NCT02834403|Antipyretics|antipyretics|mesh-ancestor
91947320|NCT02834403|Vasodilator Agents|vasodilator agents|mesh-ancestor
91947353|NCT02302547|Enfuvirtide|enfuvirtide|mesh-list
91947354|NCT02302547|Elvitegravir|elvitegravir|mesh-list
91947355|NCT02302547|Efavirenz|efavirenz|mesh-list
91947356|NCT02302547|Etravirine|etravirine|mesh-list
91947357|NCT02302547|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
91947358|NCT02302547|Protease Inhibitors|protease inhibitors|mesh-list
91947359|NCT02302547|Integrase Inhibitors|integrase inhibitors|mesh-list
91947360|NCT02302547|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91947361|NCT02302547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947362|NCT02302547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947363|NCT02302547|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91947364|NCT02302547|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91947365|NCT02302547|Antiviral Agents|antiviral agents|mesh-ancestor
91947366|NCT02302547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947367|NCT02302547|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91947368|NCT02302547|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91947369|NCT02302547|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91947404|NCT03513575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91947405|NCT03513575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947406|NCT03513575|Disinfectants|disinfectants|mesh-ancestor
91947407|NCT03334461|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
91947408|NCT03334461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947409|NCT03252093|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
91947410|NCT03252093|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91947411|NCT03252093|Vasodilator Agents|vasodilator agents|mesh-ancestor
91947413|NCT03510611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947414|NCT03510611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947415|NCT03510611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947416|NCT03510611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947417|NCT02299817|Denosumab|denosumab|mesh-list
91947462|NCT03510533|Immunologic Factors|immunologic factors|mesh-ancestor
91947463|NCT03510533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947464|NCT03510533|Hormones|hormones|mesh-ancestor
91947465|NCT03510533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947466|NCT03512873|Tranilast|tranilast|mesh-list
91947467|NCT03512873|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947468|NCT03512873|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947469|NCT03512873|Analgesics|analgesics|mesh-ancestor
91947470|NCT03512873|Sensory System Agents|sensory system agents|mesh-ancestor
91947471|NCT03512873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947472|NCT03512873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947473|NCT03512873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947474|NCT03512873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947475|NCT03512873|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91947476|NCT03512873|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947477|NCT03512873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947478|NCT03512873|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947479|NCT03512873|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91947480|NCT03512873|Histamine Antagonists|histamine antagonists|mesh-ancestor
91947481|NCT03512873|Histamine Agents|histamine agents|mesh-ancestor
91947482|NCT03512873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947483|NCT03512873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91947484|NCT03512873|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91947510|NCT03132701|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016000|NCT05553665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947511|NCT03132701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947512|NCT03132701|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947513|NCT03132701|Tocolytic Agents|tocolytic agents|mesh-ancestor
91947514|NCT03132701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91947515|NCT02322099|Alendronate|alendronate|mesh-list
91947516|NCT02322099|Cholecalciferol|cholecalciferol|mesh-list
91947518|NCT02322099|Tenofovir|tenofovir|mesh-list
91947519|NCT02322099|Calcium Carbonate|calcium carbonate|mesh-list
91947520|NCT02322099|Calcium|calcium|mesh-list
91947521|NCT02322099|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91947522|NCT02322099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947523|NCT02322099|Antiviral Agents|antiviral agents|mesh-ancestor
91947524|NCT02322099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947525|NCT02322099|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91947526|NCT02322099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91947527|NCT02322099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947565|NCT04464005|Tocolytic Agents|tocolytic agents|mesh-ancestor
91947567|NCT02303327|Androgens|androgens|mesh-list
91947638|NCT04757493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947639|NCT04757493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947640|NCT04757493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947641|NCT02303951|Atezolizumab|atezolizumab|mesh-list
91947642|NCT02303951|Vemurafenib|vemurafenib|mesh-list
91947643|NCT02303951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91947644|NCT02303951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947645|NCT02303951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91947646|NCT02303951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947647|NCT02303951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91947648|NCT02303951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947650|NCT04406415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91947651|NCT04406415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947652|NCT04406415|Analgesics|analgesics|mesh-ancestor
91947653|NCT04406415|Sensory System Agents|sensory system agents|mesh-ancestor
91947654|NCT04406415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947655|NCT04406415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947656|NCT04406415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947657|NCT04406415|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947658|NCT04406415|Anticoagulants|anticoagulants|mesh-ancestor
91947659|NCT04406415|Protease Inhibitors|protease inhibitors|mesh-ancestor
91947660|NCT04406415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947662|NCT04406415|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91947687|NCT03509285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947688|NCT03509285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947689|NCT03509285|Anticonvulsants|anticonvulsants|mesh-ancestor
91947804|NCT04464863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947690|NCT02300363|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
91947691|NCT02300363|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91947692|NCT02300363|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91947693|NCT02300363|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91947694|NCT02300363|Antimetabolites|antimetabolites|mesh-ancestor
91947695|NCT02300363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947696|NCT02300363|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91947697|NCT02300363|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91947698|NCT02300363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947699|NCT02300363|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91947700|NCT02300363|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91947701|NCT02300363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947703|NCT03135795|Sufentanil|sufentanil|mesh-list
91947704|NCT03135795|Dexmedetomidine|dexmedetomidine|mesh-list
91947705|NCT03135795|Remifentanil|remifentanil|mesh-list
91947706|NCT03135795|Dsuvia|dsuvia|mesh-list
91947707|NCT03135795|Bromides|bromides|mesh-list
91947708|NCT03135795|Propofol|propofol|mesh-list
91947709|NCT03135795|Sevoflurane|sevoflurane|mesh-list
91947710|NCT03135795|Citric Acid|citric acid|mesh-list
91947711|NCT03135795|Sodium Citrate|sodium citrate|mesh-list
91947712|NCT03135795|Rocuronium|rocuronium|mesh-list
91947713|NCT03135795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91947714|NCT03135795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91947715|NCT03135795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947716|NCT03135795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91947717|NCT03135795|Analgesics|analgesics|mesh-ancestor
91947718|NCT03135795|Sensory System Agents|sensory system agents|mesh-ancestor
91947719|NCT03135795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974764|NCT04903743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91974765|NCT04753840|Antihypertensive Agents|antihypertensive agents|mesh-list
91974767|NCT04903275|Fluorides, Topical|fluorides, topical|mesh-list
91974768|NCT04903275|Cariostatic Agents|cariostatic agents|mesh-ancestor
91974769|NCT04903275|Protective Agents|protective agents|mesh-ancestor
91974770|NCT04903275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974771|NCT02121262|Dexamethasone|dexamethasone|mesh-list
91974772|NCT02121262|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91947720|NCT03135795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91947721|NCT03135795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91947722|NCT03135795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91947723|NCT03135795|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947724|NCT03135795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947725|NCT03135795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947726|NCT03135795|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91947727|NCT03135795|Anesthetics, General|anesthetics, general|mesh-ancestor
91947728|NCT03135795|Anesthetics|anesthetics|mesh-ancestor
91947729|NCT03135795|Anticoagulants|anticoagulants|mesh-ancestor
91947730|NCT03135795|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91947731|NCT03135795|Chelating Agents|chelating agents|mesh-ancestor
91947732|NCT03135795|Sequestering Agents|sequestering agents|mesh-ancestor
91947733|NCT03135795|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91947780|NCT03508817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947781|NCT05158777|Vaccines|vaccines|mesh-list
91947782|NCT05158777|Immunologic Factors|immunologic factors|mesh-ancestor
91947783|NCT05158777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947784|NCT01678209|Methylphenidate|methylphenidate|mesh-list
91947785|NCT01678209|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91947786|NCT01678209|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91947787|NCT01678209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947788|NCT01678209|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91947789|NCT01678209|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91947790|NCT01678209|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91947791|NCT01678209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947792|NCT01678209|Dopamine Agents|dopamine agents|mesh-ancestor
91947793|NCT01678209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947794|NCT01678209|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91947795|NCT01678209|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947796|NCT02239120|Dabigatran|dabigatran|mesh-list
91947797|NCT02239120|Antithrombins|antithrombins|mesh-ancestor
91947798|NCT02239120|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91947799|NCT02239120|Protease Inhibitors|protease inhibitors|mesh-ancestor
91947800|NCT02239120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947801|NCT02239120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947802|NCT02239120|Anticoagulants|anticoagulants|mesh-ancestor
91947803|NCT04464863|Metronidazole|metronidazole|mesh-list
91947805|NCT04464863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91947806|NCT04464863|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91947807|NCT04464863|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91947808|NCT05158699|Dexamethasone|dexamethasone|mesh-list
91947809|NCT05158699|Dexamethasone acetate|dexamethasone acetate|mesh-list
91947810|NCT05158699|Triamcinolone|triamcinolone|mesh-list
91947811|NCT05158699|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91947812|NCT05158699|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91947822|NCT05158699|Autonomic Agents|autonomic agents|mesh-ancestor
91947823|NCT05158699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947824|NCT05158699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947825|NCT05158699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91947826|NCT05158699|Glucocorticoids|glucocorticoids|mesh-ancestor
91947827|NCT05158699|Hormones|hormones|mesh-ancestor
91947828|NCT05158699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91947829|NCT05158699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91947830|NCT05158699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947831|NCT05158699|Protease Inhibitors|protease inhibitors|mesh-ancestor
91947832|NCT05158699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947833|NCT05158699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947834|NCT05158699|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91947835|NCT05158699|Immunologic Factors|immunologic factors|mesh-ancestor
91947883|NCT03474133|Immunoconjugates|immunoconjugates|mesh-ancestor
91947884|NCT03474133|Immunologic Factors|immunologic factors|mesh-ancestor
91947885|NCT03474133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947887|NCT03512171|Dextroamphetamine|dextroamphetamine|mesh-list
91947888|NCT03512171|Fallypride|fallypride|mesh-list
91947889|NCT03512171|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91947890|NCT03512171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947891|NCT03512171|Sympathomimetics|sympathomimetics|mesh-ancestor
91947892|NCT03512171|Autonomic Agents|autonomic agents|mesh-ancestor
91947893|NCT03512171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91947894|NCT03512171|Dopamine Agents|dopamine agents|mesh-ancestor
91947895|NCT03512171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947897|NCT03512171|Adrenergic Agents|adrenergic agents|mesh-ancestor
91947943|NCT05157295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91947944|NCT05157295|Cholinergic Agents|cholinergic agents|mesh-ancestor
91947945|NCT05157295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91947946|NCT02301221|Vancomycin|vancomycin|mesh-list
91947947|NCT02301221|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91947948|NCT02301221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947949|NCT03122431|Hydroxychloroquine|hydroxychloroquine|mesh-list
91947950|NCT03122431|Thalidomide|thalidomide|mesh-list
91947951|NCT03122431|Antimalarials|antimalarials|mesh-ancestor
91947952|NCT03122431|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91947953|NCT03122431|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91947954|NCT03122431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947955|NCT03122431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91947956|NCT03122431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974773|NCT02121262|Antiemetics|antiemetics|mesh-ancestor
91974774|NCT02121262|Autonomic Agents|autonomic agents|mesh-ancestor
91974775|NCT02121262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974776|NCT02121262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974777|NCT02121262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974778|NCT02121262|Glucocorticoids|glucocorticoids|mesh-ancestor
91974779|NCT02121262|Hormones|hormones|mesh-ancestor
91974780|NCT02121262|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974781|NCT02121262|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974782|NCT02121262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974783|NCT03053739|Bosentan|bosentan|mesh-list
91974784|NCT03053739|Sildenafil Citrate|sildenafil citrate|mesh-list
91974785|NCT03053739|Vasodilator Agents|vasodilator agents|mesh-ancestor
91974786|NCT03053739|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91974787|NCT03053739|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91974788|NCT03053739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974789|NCT03053739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974790|NCT03053739|Urological Agents|urological agents|mesh-ancestor
91974792|NCT03053739|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91974794|NCT04916925|Vitamins|vitamins|mesh-ancestor
91974795|NCT04916925|Micronutrients|micronutrients|mesh-ancestor
91974796|NCT04916925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974797|NCT04916925|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91974798|NCT04902261|Paclitaxel|paclitaxel|mesh-list
91974799|NCT04902261|Gemcitabine|gemcitabine|mesh-list
91974800|NCT04902261|Tislelizumab|tislelizumab|mesh-list
91974801|NCT04902261|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91974802|NCT04902261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974803|NCT04902261|Tubulin Modulators|tubulin modulators|mesh-ancestor
91974804|NCT04902261|Antimitotic Agents|antimitotic agents|mesh-ancestor
91974805|NCT04902261|Mitosis Modulators|mitosis modulators|mesh-ancestor
91974806|NCT04902261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974807|NCT04902261|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91974808|NCT04902261|Antimetabolites|antimetabolites|mesh-ancestor
91974809|NCT04902261|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974810|NCT04902027|Mitoxantrone|mitoxantrone|mesh-list
91974811|NCT04902027|Analgesics|analgesics|mesh-ancestor
91974812|NCT04902027|Sensory System Agents|sensory system agents|mesh-ancestor
91974813|NCT04902027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974814|NCT04902027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974815|NCT04902027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974816|NCT04902027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91974817|NCT04902027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91974818|NCT04902027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974819|NCT04902027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974820|NCT04902105|Mefenamic Acid|mefenamic acid|mesh-list
91974821|NCT04902105|Valproic Acid|valproic acid|mesh-list
91974822|NCT04902105|Ecopipam|ecopipam|mesh-list
91947957|NCT03122431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91947958|NCT03122431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91947959|NCT03122431|Immunologic Factors|immunologic factors|mesh-ancestor
91947960|NCT03122431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91947961|NCT03122431|Leprostatic Agents|leprostatic agents|mesh-ancestor
91947962|NCT03122431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91947963|NCT03122431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91947964|NCT03122431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91947965|NCT03122431|Growth Substances|growth substances|mesh-ancestor
91947966|NCT03122431|Growth Inhibitors|growth inhibitors|mesh-ancestor
91947967|NCT03122431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91947968|NCT05248360|Hydrogen Peroxide|hydrogen peroxide|mesh-list
91947969|NCT05248360|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91947970|NCT05248360|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91947971|NCT02305823|Aripiprazole|aripiprazole|mesh-list
91947972|NCT02305823|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91947973|NCT02305823|Ziprasidone|ziprasidone|mesh-list
91947974|NCT02305823|Antidepressive Agents|antidepressive agents|mesh-ancestor
91947975|NCT02305823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91947976|NCT02305823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91947977|NCT02305823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91948012|NCT02305901|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948013|NCT02305901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948014|NCT02305901|Dopamine Agents|dopamine agents|mesh-ancestor
91948015|NCT02305901|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948016|NCT02305901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948017|NCT02305901|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91948018|NCT02305901|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91948019|NCT02305901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948020|NCT02305901|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948021|NCT03942887|Methylprednisolone|methylprednisolone|mesh-list
91948022|NCT03942887|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91948023|NCT03942887|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91948024|NCT03942887|Prednisolone|prednisolone|mesh-list
91948025|NCT03942887|Prednisolone acetate|prednisolone acetate|mesh-list
91948026|NCT03942887|Cyclophosphamide|cyclophosphamide|mesh-list
91948027|NCT03942887|Rituximab|rituximab|mesh-list
91948028|NCT03942887|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91948029|NCT03942887|Prednisolone phosphate|prednisolone phosphate|mesh-list
91948030|NCT03942887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91948031|NCT03942887|Immunologic Factors|immunologic factors|mesh-ancestor
91948032|NCT03942887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948033|NCT03942887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91948034|NCT03942887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91948035|NCT03942887|Alkylating Agents|alkylating agents|mesh-ancestor
91948036|NCT03942887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948037|NCT03942887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948038|NCT03942887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91948039|NCT03942887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948040|NCT03942887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948041|NCT03942887|Antiemetics|antiemetics|mesh-ancestor
91948042|NCT03942887|Autonomic Agents|autonomic agents|mesh-ancestor
91974823|NCT04902105|Anticonvulsants|anticonvulsants|mesh-ancestor
91974824|NCT04902105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948228|NCT05174026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974825|NCT04902105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974827|NCT04902105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974828|NCT04902105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974829|NCT04902105|Antimanic Agents|antimanic agents|mesh-ancestor
91974830|NCT04902105|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91974831|NCT04902105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974832|NCT04902105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91974833|NCT04902105|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91974834|NCT04902105|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91948043|NCT03942887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948044|NCT03942887|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948046|NCT03942887|Hormones|hormones|mesh-ancestor
91948047|NCT03942887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948048|NCT03942887|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91948049|NCT03942887|Protective Agents|protective agents|mesh-ancestor
91948050|NCT03942887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91948051|NCT02234596|Nintedanib|nintedanib|mesh-list
91948052|NCT02234596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948053|NCT02234596|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91948054|NCT02234596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948055|NCT02234596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948056|NCT02305979|Loratadine|loratadine|mesh-list
91948057|NCT02305979|Antipruritics|antipruritics|mesh-ancestor
91948058|NCT02305979|Dermatologic Agents|dermatologic agents|mesh-ancestor
91948059|NCT02305979|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91948060|NCT02305979|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91948061|NCT02305979|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91948062|NCT02305979|Histamine Antagonists|histamine antagonists|mesh-ancestor
91948063|NCT02305979|Histamine Agents|histamine agents|mesh-ancestor
91948095|NCT04539951|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91948096|NCT04539951|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91948097|NCT04539951|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91948098|NCT04539951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91948099|NCT04539951|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91948100|NCT04539951|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91948101|NCT04539951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948102|NCT04539951|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91948103|NCT04539327|Rucaparib|rucaparib|mesh-list
91948104|NCT04539327|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91948105|NCT04539327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948106|NCT04539327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948107|NCT04539327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948108|NCT02234362|Vortioxetine|vortioxetine|mesh-list
91948109|NCT02234362|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948110|NCT02234362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948126|NCT05091177|Antibodies|antibodies|mesh-list
91948149|NCT05197426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948150|NCT03505151|BI 409306|bi 409306|mesh-list
91948151|NCT03505151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91948152|NCT03505151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948153|NCT03505151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948154|NCT02232880|Abatacept|abatacept|mesh-list
91948155|NCT02232880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91948156|NCT02232880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948157|NCT02232880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948158|NCT02232880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948159|NCT02232880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91948163|NCT02896855|Docetaxel|docetaxel|mesh-list
91948213|NCT04778176|Carbidopa|carbidopa|mesh-list
91948214|NCT04778176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91948215|NCT04778176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91948216|NCT04778176|Dopamine Agents|dopamine agents|mesh-ancestor
91948217|NCT04778176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948218|NCT04778176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948219|NCT04778176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948220|NCT04778176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
91948221|NCT04778176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948222|NCT05174026|Deoxyglucose|deoxyglucose|mesh-list
91948223|NCT05174026|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91948224|NCT05174026|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91948225|NCT05174026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948226|NCT05174026|Antimetabolites|antimetabolites|mesh-ancestor
91948227|NCT05174026|Antiviral Agents|antiviral agents|mesh-ancestor
91948229|NCT05076253|Ivermectin|ivermectin|mesh-list
91948230|NCT05076253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91948231|NCT05076253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948232|NCT05077839|Trifluridine|trifluridine|mesh-list
91948233|NCT05077839|Antimetabolites|antimetabolites|mesh-ancestor
91948234|NCT05077839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948235|NCT05077839|Antiviral Agents|antiviral agents|mesh-ancestor
91948236|NCT05077839|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948237|NCT05077683|Rivaroxaban|rivaroxaban|mesh-list
91948238|NCT05077683|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91948239|NCT05077683|Antithrombins|antithrombins|mesh-ancestor
92016001|NCT05553665|Immunologic Factors|immunologic factors|mesh-ancestor
91948240|NCT05077683|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91948241|NCT05077683|Protease Inhibitors|protease inhibitors|mesh-ancestor
91948242|NCT05077683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948258|NCT02307227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91948259|NCT02307227|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91948260|NCT02307227|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91948261|NCT02307227|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91948262|NCT02307227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948263|NCT02307305|Acetaminophen|acetaminophen|mesh-list
91948265|NCT02307305|Naproxen|naproxen|mesh-list
91948266|NCT02307305|Oxycodone|oxycodone|mesh-list
91948267|NCT02307305|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91948268|NCT02307305|Tramadol|tramadol|mesh-list
91948269|NCT02307305|Naloxone|naloxone|mesh-list
91948270|NCT02307305|Esomeprazole|esomeprazole|mesh-list
91948324|NCT04457323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948325|NCT04457323|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91948326|NCT04457323|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91948327|NCT04457323|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91948328|NCT04457323|Adrenergic Agents|adrenergic agents|mesh-ancestor
91948329|NCT04457323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948330|NCT04457323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948331|NCT04448431|Vortioxetine|vortioxetine|mesh-list
91948332|NCT04448431|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
91948333|NCT04448431|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948334|NCT04448431|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948335|NCT04448431|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91948336|NCT04448431|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91948337|NCT04448431|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948338|NCT04448431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948339|NCT04448431|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91948340|NCT04448431|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91948341|NCT04448431|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91948344|NCT04448431|Serotonin Agents|serotonin agents|mesh-ancestor
91948377|NCT03504527|Autonomic Agents|autonomic agents|mesh-ancestor
91948378|NCT03504527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948379|NCT03504527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948380|NCT03504527|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91948381|NCT03504527|Respiratory System Agents|respiratory system agents|mesh-ancestor
91948382|NCT03504527|Glucocorticoids|glucocorticoids|mesh-ancestor
91948383|NCT03504527|Hormones|hormones|mesh-ancestor
91948384|NCT03504527|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948385|NCT03504527|Parasympatholytics|parasympatholytics|mesh-ancestor
91948386|NCT03504527|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91948387|NCT03504527|Cholinergic Agents|cholinergic agents|mesh-ancestor
91948388|NCT03504527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948389|NCT03504527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948390|NCT03504527|Anticonvulsants|anticonvulsants|mesh-ancestor
91948391|NCT01678131|Ribavirin|ribavirin|mesh-list
91948392|NCT01678131|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91948393|NCT01678131|Interferon alpha-2|interferon alpha-2|mesh-list
91948394|NCT01678131|Liver Extracts|liver extracts|mesh-list
91948395|NCT01678131|Antimetabolites|antimetabolites|mesh-ancestor
91948407|NCT04579783|Hormones|hormones|mesh-ancestor
91948433|NCT03506789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91948434|NCT03506789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948436|NCT02312297|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948437|NCT02312297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948438|NCT05108974|Choline|choline|mesh-list
91948439|NCT05108974|Lipotropic Agents|lipotropic agents|mesh-ancestor
91948440|NCT05108974|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91948441|NCT05108974|Antimetabolites|antimetabolites|mesh-ancestor
91948442|NCT05108974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948443|NCT05108974|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948444|NCT05108974|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91948445|NCT05108974|Nootropic Agents|nootropic agents|mesh-ancestor
91948446|NCT03473431|Ketamine|ketamine|mesh-list
91948447|NCT03473431|Analgesics|analgesics|mesh-ancestor
91948448|NCT03473431|Sensory System Agents|sensory system agents|mesh-ancestor
91948449|NCT03473431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948450|NCT03473431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948451|NCT03473431|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91948452|NCT03473431|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91948453|NCT03473431|Anesthetics, General|anesthetics, general|mesh-ancestor
91948486|NCT04345861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948487|NCT04345861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948488|NCT04345861|Antimalarials|antimalarials|mesh-ancestor
91948489|NCT04345861|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91948490|NCT04345861|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91948491|NCT04345861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948492|NCT04345861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948493|NCT04345861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91948494|NCT02067819|Salicylic Acid|salicylic acid|mesh-list
91948495|NCT02067819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948496|NCT02067819|Antifungal Agents|antifungal agents|mesh-ancestor
91948497|NCT02067819|Keratolytic Agents|keratolytic agents|mesh-ancestor
91948498|NCT02067819|Dermatologic Agents|dermatologic agents|mesh-ancestor
91948499|NCT02230306|Vemurafenib|vemurafenib|mesh-list
91948500|NCT02230306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948501|NCT02230306|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91948502|NCT02230306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948503|NCT02230306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948504|NCT04266379|Insulin|insulin|mesh-list
91948505|NCT04266379|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91948506|NCT04266379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948507|NCT04266379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948508|NCT02308319|Tenofovir|tenofovir|mesh-list
91948509|NCT02308319|Antiviral Agents|antiviral agents|mesh-ancestor
91948510|NCT02308319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948513|NCT02308319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948535|NCT05062174|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91948536|NCT05062174|Hormone Antagonists|hormone antagonists|mesh-ancestor
91948537|NCT05062174|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948538|NCT05062174|Luteolytic Agents|luteolytic agents|mesh-ancestor
91948539|NCT05062174|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91948540|NCT05062174|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91948541|NCT05095467|Paclitaxel|paclitaxel|mesh-list
91948542|NCT05095467|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91948543|NCT05095467|Tegafur|tegafur|mesh-list
91948544|NCT05095467|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91948545|NCT05095467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948546|NCT05095467|Tubulin Modulators|tubulin modulators|mesh-ancestor
91948547|NCT05095467|Antimitotic Agents|antimitotic agents|mesh-ancestor
91948548|NCT05095467|Mitosis Modulators|mitosis modulators|mesh-ancestor
91948549|NCT05095467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948550|NCT05095467|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91948594|NCT01680861|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91948595|NCT01680861|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91948596|NCT01680861|Antitubercular Agents|antitubercular agents|mesh-ancestor
91948597|NCT01680861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948598|NCT01680861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948599|NCT01680861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91948600|NCT01680861|Antiemetics|antiemetics|mesh-ancestor
91948601|NCT01680861|Autonomic Agents|autonomic agents|mesh-ancestor
91948602|NCT01680861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948603|NCT01680861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91948606|NCT01680861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948607|NCT01680861|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91948608|NCT01680861|Protective Agents|protective agents|mesh-ancestor
91948609|NCT02229214|Topiramate|topiramate|mesh-list
91948610|NCT02229214|Phentermine|phentermine|mesh-list
91948611|NCT02229214|Anticonvulsants|anticonvulsants|mesh-ancestor
91948612|NCT02229214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948613|NCT02229214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948653|NCT05057481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948654|NCT05057481|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91948655|NCT05057481|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91948656|NCT05057481|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91948657|NCT05057481|Antitubercular Agents|antitubercular agents|mesh-ancestor
91948658|NCT05057481|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948659|NCT05057481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948660|NCT05057481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948661|NCT05057481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948718|NCT02227108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948719|NCT02227108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948720|NCT03564145|Benzoyl Peroxide|benzoyl peroxide|mesh-list
91948721|NCT03564145|Dermatologic Agents|dermatologic agents|mesh-ancestor
91948722|NCT02312999|Plasma-lyte 148|plasma-lyte 148|mesh-list
91948723|NCT02312999|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91948724|NCT02312999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91948725|NCT04863261|Cabotegravir, rilpivirine drug combination|cabotegravir, rilpivirine drug combination|mesh-list
91948726|NCT04863261|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91948727|NCT04863261|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91948728|NCT04863261|Antiviral Agents|antiviral agents|mesh-ancestor
91948729|NCT04863261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948730|NCT02313077|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91948731|NCT02313077|Antiviral Agents|antiviral agents|mesh-ancestor
91948732|NCT02313077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948733|NCT03423355|Dapagliflozin|dapagliflozin|mesh-list
91948734|NCT03423355|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91948737|NCT03423355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91948775|NCT03365635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948776|NCT03365635|Antiviral Agents|antiviral agents|mesh-ancestor
91948777|NCT03365635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948778|NCT04658277|Clarithromycin|clarithromycin|mesh-list
91948779|NCT04658277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91948780|NCT04658277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91948781|NCT04658277|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91948782|NCT04658277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948783|NCT04658277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948784|NCT04658277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91948785|NCT04658277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91948786|NCT04456777|Vortioxetine|vortioxetine|mesh-list
91948787|NCT04456777|Antidepressive Agents|antidepressive agents|mesh-ancestor
91948788|NCT04456777|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948789|NCT04456777|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91948790|NCT04456777|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91948797|NCT04456777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948830|NCT03506009|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91948831|NCT03130855|Carticaine|carticaine|mesh-list
91948832|NCT03130855|Anesthetics, Local|anesthetics, local|mesh-ancestor
91948833|NCT03130855|Anesthetics|anesthetics|mesh-ancestor
91948834|NCT03130855|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948835|NCT03130855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948836|NCT03130855|Sensory System Agents|sensory system agents|mesh-ancestor
91948837|NCT03130855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948838|NCT02309801|Daidzin|daidzin|mesh-list
91948839|NCT02309801|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91948840|NCT02309801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948841|NCT02309801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948842|NCT04456387|Factor VIII|factor viii|mesh-list
91948843|NCT04456387|Immunoglobulin Fc Fragments|immunoglobulin fc fragments|mesh-list
91948844|NCT04456387|Coagulants|coagulants|mesh-ancestor
91948845|NCT04456387|Immunologic Factors|immunologic factors|mesh-ancestor
91948846|NCT04456387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948888|NCT02820961|Exemestane|exemestane|mesh-list
91948889|NCT02820961|Entinostat|entinostat|mesh-list
91948890|NCT02820961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91948891|NCT02820961|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91948892|NCT02820961|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91948893|NCT02820961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91948894|NCT02820961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948895|NCT02820961|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91948896|NCT02820961|Hormone Antagonists|hormone antagonists|mesh-ancestor
91948897|NCT02820961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948898|NCT02820961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948899|NCT02820961|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91948900|NCT04658173|Alfentanil|alfentanil|mesh-list
91948901|NCT04658173|Propofol|propofol|mesh-list
91948902|NCT04658173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91948903|NCT04658173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948948|NCT02310347|Hallucinogens|hallucinogens|mesh-ancestor
91948949|NCT02310347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948950|NCT02310347|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91948951|NCT02310347|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91948952|NCT02310347|Analgesics|analgesics|mesh-ancestor
91948953|NCT02310347|Sensory System Agents|sensory system agents|mesh-ancestor
91948954|NCT02310347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91948955|NCT02310347|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91948956|NCT02310347|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91948957|NCT02310347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91948958|NCT02310347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91948959|NCT02310347|Hormones|hormones|mesh-ancestor
91948960|NCT02310347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91948961|NCT04429425|Anesthetics|anesthetics|mesh-list
91948962|NCT04429425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91948963|NCT04429425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91948964|NCT03502889|Ropivacaine|ropivacaine|mesh-list
91949005|NCT03253913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91949006|NCT03253913|Immunologic Factors|immunologic factors|mesh-ancestor
91949007|NCT03253913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949008|NCT03253913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949009|NCT03253913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949011|NCT03253913|Protective Agents|protective agents|mesh-ancestor
91949012|NCT03253913|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91949013|NCT03237819|Magnesium Sulfate|magnesium sulfate|mesh-list
91949014|NCT03237819|Analgesics|analgesics|mesh-ancestor
91949015|NCT03237819|Sensory System Agents|sensory system agents|mesh-ancestor
91949016|NCT03237819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949017|NCT03237819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949018|NCT03237819|Anesthetics|anesthetics|mesh-ancestor
91949019|NCT03237819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949028|NCT03468907|Tenofovir|tenofovir|mesh-list
91949063|NCT02311205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949064|NCT05390749|Rituximab|rituximab|mesh-list
91949065|NCT05390749|Methotrexate|methotrexate|mesh-list
91949066|NCT05390749|Pomalidomide|pomalidomide|mesh-list
91949067|NCT05390749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949068|NCT05390749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949069|NCT05390749|Immunologic Factors|immunologic factors|mesh-ancestor
91949070|NCT05390749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949071|NCT05390749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949072|NCT05390749|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91949073|NCT05390749|Abortifacient Agents|abortifacient agents|mesh-ancestor
91949074|NCT05390749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91949075|NCT05390749|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91949076|NCT05390749|Antimetabolites|antimetabolites|mesh-ancestor
91949077|NCT05390749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949078|NCT05390749|Dermatologic Agents|dermatologic agents|mesh-ancestor
91949079|NCT05390749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949080|NCT05390749|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91949081|NCT05390749|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91949083|NCT05390749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91949118|NCT05331807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91949119|NCT02314325|Factor VIII|factor viii|mesh-list
91949120|NCT02314325|Coagulants|coagulants|mesh-ancestor
91949121|NCT04707261|Dapagliflozin|dapagliflozin|mesh-list
91949122|NCT04707261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91949123|NCT04707261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949124|NCT04707261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91949125|NCT04707261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949126|NCT02314481|Trastuzumab|trastuzumab|mesh-list
91949127|NCT02314481|Atezolizumab|atezolizumab|mesh-list
91949128|NCT02314481|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
91949129|NCT02314481|Vemurafenib|vemurafenib|mesh-list
91949130|NCT02314481|Maytansine|maytansine|mesh-list
91949131|NCT02314481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949132|NCT02314481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949133|NCT02314481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91949175|NCT04345887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91949176|NCT04345887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949177|NCT04345887|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91949178|NCT04345887|Diuretics|diuretics|mesh-ancestor
91949179|NCT04345887|Natriuretic Agents|natriuretic agents|mesh-ancestor
91949180|NCT02316899|Linaclotide|linaclotide|mesh-list
91949181|NCT02316899|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91949182|NCT02316899|Enzyme Activators|enzyme activators|mesh-ancestor
91949183|NCT02316899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949184|NCT02316899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949186|NCT02314871|Pirinitramide|pirinitramide|mesh-list
91949187|NCT02314871|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91949188|NCT02314871|Narcotics|narcotics|mesh-ancestor
91949189|NCT02314871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949190|NCT02314871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949191|NCT02314871|Analgesics|analgesics|mesh-ancestor
91949192|NCT02314871|Sensory System Agents|sensory system agents|mesh-ancestor
91949193|NCT02314871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949194|NCT02224846|Tadalafil|tadalafil|mesh-list
91949195|NCT02224846|Vasodilator Agents|vasodilator agents|mesh-ancestor
91949196|NCT02224846|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91949197|NCT02224846|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91949198|NCT02224846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949199|NCT02224846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949200|NCT02224846|Urological Agents|urological agents|mesh-ancestor
91949201|NCT03470077|Nalbuphine|nalbuphine|mesh-list
91949202|NCT03470077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949203|NCT03470077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949204|NCT03470077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91949205|NCT03470077|Narcotics|narcotics|mesh-ancestor
91949206|NCT03470077|Analgesics|analgesics|mesh-ancestor
91949207|NCT03470077|Sensory System Agents|sensory system agents|mesh-ancestor
91949208|NCT03470077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974835|NCT04902105|Dopamine Agents|dopamine agents|mesh-ancestor
91974836|NCT04902105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91974837|NCT04902105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91974838|NCT04902105|Analgesics|analgesics|mesh-ancestor
91974839|NCT04902105|Sensory System Agents|sensory system agents|mesh-ancestor
91949209|NCT03519295|Atezolizumab|atezolizumab|mesh-list
91949210|NCT03519295|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91949211|NCT03519295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949212|NCT03519295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91949213|NCT03519295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949214|NCT02224690|Cannabidiol|cannabidiol|mesh-list
91949215|NCT02224690|Anticonvulsants|anticonvulsants|mesh-ancestor
91949216|NCT05150431|Parecoxib|parecoxib|mesh-list
91949217|NCT05150431|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91949218|NCT05150431|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91949219|NCT05150431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949220|NCT05150431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949221|NCT05150431|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91949222|NCT05150431|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91949223|NCT05150431|Analgesics|analgesics|mesh-ancestor
91949224|NCT05150431|Sensory System Agents|sensory system agents|mesh-ancestor
91949225|NCT05150431|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949226|NCT05150431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949227|NCT05150431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949228|NCT05150431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949229|NCT03501251|Albendazole|albendazole|mesh-list
91949230|NCT03501251|Moxidectin|moxidectin|mesh-list
91949231|NCT03501251|Anthelmintics|anthelmintics|mesh-ancestor
91949232|NCT03501251|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91949233|NCT03501251|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949234|NCT03501251|Anticestodal Agents|anticestodal agents|mesh-ancestor
91949257|NCT01634152|Tiotropium Bromide|tiotropium bromide|mesh-list
91949334|NCT02315573|Anesthetics, Local|anesthetics, local|mesh-ancestor
91949335|NCT02315573|Anesthetics|anesthetics|mesh-ancestor
91949336|NCT02315573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949337|NCT02315573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949338|NCT02315573|Sensory System Agents|sensory system agents|mesh-ancestor
91949339|NCT02315573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949340|NCT02315573|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91949341|NCT02315573|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91949342|NCT02315573|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91949397|NCT04535505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91949398|NCT04535505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949399|NCT04535505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949400|NCT04535505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91949469|NCT02318537|Cannabidiol|cannabidiol|mesh-list
91949470|NCT02318537|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91949471|NCT02318537|Anticonvulsants|anticonvulsants|mesh-ancestor
91949472|NCT04642261|Empagliflozin|empagliflozin|mesh-list
91949473|NCT04642261|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91949539|NCT03497351|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91949615|NCT05398861|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91949616|NCT05398861|Growth Substances|growth substances|mesh-ancestor
91949617|NCT05398861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949618|NCT05398861|Growth Inhibitors|growth inhibitors|mesh-ancestor
91949619|NCT02448329|Paclitaxel|paclitaxel|mesh-list
91949620|NCT02448329|Adavosertib|adavosertib|mesh-list
91949621|NCT02448329|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91949622|NCT02448329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949623|NCT02448329|Tubulin Modulators|tubulin modulators|mesh-ancestor
91949624|NCT02448329|Antimitotic Agents|antimitotic agents|mesh-ancestor
91949625|NCT02448329|Mitosis Modulators|mitosis modulators|mesh-ancestor
91949626|NCT02448329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949627|NCT02448329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949628|NCT05398393|Tenofovir|tenofovir|mesh-list
91949629|NCT05398393|Amlodipine|amlodipine|mesh-list
91949630|NCT05398393|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
91949631|NCT05398393|Atorvastatin|atorvastatin|mesh-list
91949632|NCT05398393|Hypolipidemic Agents|hypolipidemic agents|mesh-list
91949633|NCT05398393|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91949634|NCT05398393|Antimetabolites|antimetabolites|mesh-ancestor
91949669|NCT05164627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949670|NCT05164627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949671|NCT05164627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91949672|NCT05164627|Analgesics|analgesics|mesh-ancestor
91949673|NCT05164627|Sensory System Agents|sensory system agents|mesh-ancestor
91949674|NCT05164627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949675|NCT05164627|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91949676|NCT05164627|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91949677|NCT05164627|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91949678|NCT05164627|Adrenergic Agents|adrenergic agents|mesh-ancestor
91949679|NCT05164627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91949680|NCT05164627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949681|NCT05164627|Anesthetics|anesthetics|mesh-ancestor
91949682|NCT05164627|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91949683|NCT05164627|Anticonvulsants|anticonvulsants|mesh-ancestor
91949724|NCT03496649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949725|NCT02324621|TIC10 compound|tic10 compound|mesh-list
91949726|NCT02324621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949728|NCT03821545|Ketamine|ketamine|mesh-list
91949729|NCT03821545|Anesthetics, Local|anesthetics, local|mesh-ancestor
91949730|NCT03821545|Anesthetics|anesthetics|mesh-ancestor
91949731|NCT03821545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949732|NCT03821545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949733|NCT03821545|Sensory System Agents|sensory system agents|mesh-ancestor
91949734|NCT03821545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949735|NCT03821545|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91949736|NCT03821545|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91949737|NCT03821545|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91949738|NCT03821545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91949739|NCT03821545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949740|NCT03821545|Analgesics|analgesics|mesh-ancestor
91949741|NCT03821545|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91949742|NCT03821545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91949743|NCT03821545|Anesthetics, General|anesthetics, general|mesh-ancestor
91949747|NCT02324933|Fentanyl|fentanyl|mesh-list
91949774|NCT02323139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949775|NCT02323139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949776|NCT02323139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949777|NCT02325245|Metformin|metformin|mesh-list
91949778|NCT02325245|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91949779|NCT02325245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949780|NCT02323373|Tranexamic Acid|tranexamic acid|mesh-list
91949781|NCT02323373|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91949782|NCT02323373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91949783|NCT02323373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949784|NCT02323373|Hemostatics|hemostatics|mesh-ancestor
91949785|NCT02323373|Coagulants|coagulants|mesh-ancestor
91949786|NCT02325479|Enoxaparin|enoxaparin|mesh-list
91949787|NCT02325479|Anticoagulants|anticoagulants|mesh-ancestor
91949788|NCT02325479|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91949789|NCT02325479|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91949828|NCT02323529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949829|NCT02323529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949830|NCT02323607|Cytarabine|cytarabine|mesh-list
91949831|NCT02323607|Decitabine|decitabine|mesh-list
91949832|NCT02323607|Daunorubicin|daunorubicin|mesh-list
91949833|NCT02323607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91949834|NCT02323607|Antimetabolites|antimetabolites|mesh-ancestor
91949835|NCT02323607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949836|NCT02323607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949837|NCT02323607|Antiviral Agents|antiviral agents|mesh-ancestor
91949838|NCT02323607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949839|NCT02323607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91949840|NCT02323607|Immunologic Factors|immunologic factors|mesh-ancestor
91949841|NCT02323607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949842|NCT02323607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91949843|NCT02323607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91949844|NCT02323607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91949845|NCT02323607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91949846|NCT03493841|Thioctic Acid|thioctic acid|mesh-list
91949847|NCT03493841|Antioxidants|antioxidants|mesh-ancestor
91949848|NCT03493841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949852|NCT03493841|Vitamins|vitamins|mesh-ancestor
91949871|NCT03492827|Disinfectants|disinfectants|mesh-ancestor
91949872|NCT03492827|Dermatologic Agents|dermatologic agents|mesh-ancestor
91949874|NCT03491579|Cladribine|cladribine|mesh-list
91949875|NCT03491579|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91949876|NCT03491579|Antimetabolites|antimetabolites|mesh-ancestor
91949877|NCT03491579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949878|NCT03491579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91949879|NCT03491579|Antiviral Agents|antiviral agents|mesh-ancestor
91949880|NCT03491579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91949881|NCT03491579|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91949882|NCT03491579|Immunologic Factors|immunologic factors|mesh-ancestor
91949884|NCT04600895|Favipiravir|favipiravir|mesh-list
91949937|NCT03914885|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91949938|NCT03914885|Alkylating Agents|alkylating agents|mesh-ancestor
91949940|NCT03779243|Antioxidants|antioxidants|mesh-ancestor
91949941|NCT03779243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949942|NCT03779243|Protective Agents|protective agents|mesh-ancestor
91949943|NCT03779243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949944|NCT03779243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91949945|NCT03757013|Apremilast|apremilast|mesh-list
91949946|NCT03757013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91949947|NCT03757013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91949948|NCT03757013|Analgesics|analgesics|mesh-ancestor
91949949|NCT03757013|Sensory System Agents|sensory system agents|mesh-ancestor
91949950|NCT03757013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91949951|NCT03757013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91949952|NCT03757013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91949953|NCT03757013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91949993|NCT02837783|Enzyme Activators|enzyme activators|mesh-ancestor
91949994|NCT02837783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91949995|NCT02837783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91949996|NCT02221648|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91949997|NCT02221648|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91949998|NCT02221648|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91949999|NCT02221648|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950000|NCT02221648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950001|NCT02221648|Cholinergic Agents|cholinergic agents|mesh-ancestor
91950002|NCT02221648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950003|NCT02221648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950004|NCT02221648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91950005|NCT02221648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950006|NCT05007145|Paclitaxel|paclitaxel|mesh-list
91950049|NCT05396209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950050|NCT05396209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950051|NCT05396209|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91950052|NCT05396209|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91950053|NCT05396209|Histamine Antagonists|histamine antagonists|mesh-ancestor
91950054|NCT05396209|Histamine Agents|histamine agents|mesh-ancestor
91950055|NCT05396209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950056|NCT05396209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950057|NCT02219932|4-Aminopyridine|4-aminopyridine|mesh-list
91950058|NCT02219932|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91950059|NCT02219932|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950060|NCT02219932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950061|NCT00846430|Interferons|interferons|mesh-list
91950062|NCT00846430|Interferon-alpha|interferon-alpha|mesh-list
91950063|NCT00846430|Interferon alpha-2|interferon alpha-2|mesh-list
91950064|NCT00846430|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91950065|NCT00846430|Celecoxib|celecoxib|mesh-list
91950066|NCT00846430|Vincristine|vincristine|mesh-list
91950106|NCT05385523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950107|NCT05385523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91950108|NCT05385523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950109|NCT03910621|Miglustat|miglustat|mesh-list
91950110|NCT03910621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950111|NCT03910621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950112|NCT03910621|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91950113|NCT03910621|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91950114|NCT03910621|Antiviral Agents|antiviral agents|mesh-ancestor
91950115|NCT03910621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950116|NCT03910621|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91950117|NCT03910621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950118|NCT03910621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950119|NCT02218372|Vancomycin|vancomycin|mesh-list
91950120|NCT02218372|Fidaxomicin|fidaxomicin|mesh-list
91950121|NCT02218372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91950122|NCT02218372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950123|NCT02217982|Simethicone|simethicone|mesh-list
91950124|NCT02217982|Loperamide|loperamide|mesh-list
91950162|NCT03530995|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91950163|NCT03530995|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91950164|NCT03530995|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91950165|NCT03530995|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91950166|NCT03530995|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91950167|NCT03530995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950168|NCT05438875|Tretinoin|tretinoin|mesh-list
91950169|NCT05438875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950170|NCT05438875|Keratolytic Agents|keratolytic agents|mesh-ancestor
91950171|NCT05438875|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950228|NCT04461665|Cholecalciferol|cholecalciferol|mesh-list
91950229|NCT04461665|Vitamins|vitamins|mesh-list
91950230|NCT04461665|Micronutrients|micronutrients|mesh-ancestor
91950231|NCT04461665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950232|NCT04461665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91950233|NCT04461665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91950234|NCT02252536|Gabapentin|gabapentin|mesh-list
91950235|NCT02252536|Analgesics|analgesics|mesh-ancestor
91950236|NCT02252536|Sensory System Agents|sensory system agents|mesh-ancestor
91950237|NCT02252536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950238|NCT02252536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950239|NCT02252536|Anticonvulsants|anticonvulsants|mesh-ancestor
91950240|NCT02252536|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91950241|NCT02252536|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91950242|NCT02252536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950243|NCT02252536|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950244|NCT02252536|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91950245|NCT02252536|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91950246|NCT02252536|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950247|NCT02252536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950281|NCT05271331|Anesthetics, Local|anesthetics, local|mesh-list
91950282|NCT05271331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950283|NCT05271331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950284|NCT05271331|Sensory System Agents|sensory system agents|mesh-ancestor
91950285|NCT05271331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950286|NCT03466567|Cyclosporine|cyclosporine|mesh-list
91950287|NCT03466567|Probenecid|probenecid|mesh-list
91950288|NCT03466567|Cyclosporins|cyclosporins|mesh-list
91950289|NCT03466567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950290|NCT03466567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950291|NCT03466567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91950292|NCT03466567|Immunologic Factors|immunologic factors|mesh-ancestor
91950293|NCT03466567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950294|NCT03466567|Antifungal Agents|antifungal agents|mesh-ancestor
91950295|NCT03466567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950296|NCT03466567|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950297|NCT03466567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91950298|NCT03466567|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91950299|NCT03466567|Uricosuric Agents|uricosuric agents|mesh-ancestor
91950300|NCT03466567|Gout Suppressants|gout suppressants|mesh-ancestor
91950337|NCT03492047|Paclitaxel|paclitaxel|mesh-list
91950338|NCT03492047|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91950339|NCT03492047|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91950340|NCT03492047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950341|NCT03492047|Tubulin Modulators|tubulin modulators|mesh-ancestor
91950342|NCT03492047|Antimitotic Agents|antimitotic agents|mesh-ancestor
91950343|NCT03492047|Mitosis Modulators|mitosis modulators|mesh-ancestor
91950344|NCT03492047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950345|NCT03492047|Antiviral Agents|antiviral agents|mesh-ancestor
91950346|NCT03492047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950347|NCT03492047|Expectorants|expectorants|mesh-ancestor
91950348|NCT03492047|Respiratory System Agents|respiratory system agents|mesh-ancestor
91950399|NCT01976273|Dermatologic Agents|dermatologic agents|mesh-ancestor
91950400|NCT02206048|Proflavine|proflavine|mesh-list
91950401|NCT02206048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91950402|NCT02206048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950403|NCT03466021|Liraglutide|liraglutide|mesh-list
91950404|NCT03466021|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950405|NCT03466021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950406|NCT03466021|Incretins|incretins|mesh-ancestor
91950407|NCT03466021|Hormones|hormones|mesh-ancestor
91950408|NCT03466021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950460|NCT02204410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950461|NCT02204410|Dopamine Agents|dopamine agents|mesh-ancestor
91950462|NCT02204410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950463|NCT02204410|Sympathomimetics|sympathomimetics|mesh-ancestor
91950464|NCT02204410|Autonomic Agents|autonomic agents|mesh-ancestor
91950465|NCT02204410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950466|NCT02204410|Adrenergic Agents|adrenergic agents|mesh-ancestor
91950471|NCT03461575|Cyclosporine|cyclosporine|mesh-list
91950527|NCT03489317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950528|NCT03489317|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91950529|NCT03489317|Vasodilator Agents|vasodilator agents|mesh-ancestor
91950530|NCT03489317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91950531|NCT03489317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91950532|NCT03489317|Antimetabolites|antimetabolites|mesh-ancestor
91950533|NCT03489317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91950534|NCT03489317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91950535|NCT03489317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950536|NCT02212678|Acetylcysteine|acetylcysteine|mesh-list
91950537|NCT02212678|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91950538|NCT02212678|Antiviral Agents|antiviral agents|mesh-ancestor
91950539|NCT02212678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950540|NCT02212678|Expectorants|expectorants|mesh-ancestor
91950541|NCT02212678|Respiratory System Agents|respiratory system agents|mesh-ancestor
91950542|NCT02212678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91950543|NCT02212678|Antioxidants|antioxidants|mesh-ancestor
91950544|NCT02212678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950545|NCT02212678|Protective Agents|protective agents|mesh-ancestor
91950546|NCT02212678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950547|NCT02212678|Antidotes|antidotes|mesh-ancestor
91950548|NCT03489239|Tenofovir|tenofovir|mesh-list
91950549|NCT03489239|Antiviral Agents|antiviral agents|mesh-ancestor
91950579|NCT03104075|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91950581|NCT03104075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950582|NCT02907983|Bupivacaine|bupivacaine|mesh-list
91950583|NCT02907983|Anesthetics, Local|anesthetics, local|mesh-ancestor
91950584|NCT02907983|Anesthetics|anesthetics|mesh-ancestor
91950585|NCT02907983|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950586|NCT02907983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950587|NCT02907983|Sensory System Agents|sensory system agents|mesh-ancestor
91950588|NCT02907983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950589|NCT02841215|Ivermectin|ivermectin|mesh-list
91950590|NCT02841215|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91950591|NCT02841215|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950592|NCT02799641|Lidocaine|lidocaine|mesh-list
91950593|NCT02799641|Diazepam|diazepam|mesh-list
91950594|NCT02799641|Anesthetics, Local|anesthetics, local|mesh-ancestor
91950595|NCT02799641|Anesthetics|anesthetics|mesh-ancestor
91950596|NCT02799641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950597|NCT02799641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950635|NCT02249182|Antiviral Agents|antiviral agents|mesh-ancestor
91950636|NCT02249182|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950637|NCT04006769|Imatinib Mesylate|imatinib mesylate|mesh-list
91950638|NCT04006769|Entacapone|entacapone|mesh-list
91950639|NCT04006769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950640|NCT04006769|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950641|NCT04006769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950642|NCT04006769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950643|NCT04006769|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91950644|NCT04006769|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91951143|NCT04339049|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91950645|NCT04006769|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
91950646|NCT03487211|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91950647|NCT03487211|Escitalopram|escitalopram|mesh-list
91950648|NCT03487211|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91950649|NCT03487211|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91950650|NCT03487211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91950651|NCT03487211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950652|NCT03487211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91950653|NCT03487211|Serotonin Agents|serotonin agents|mesh-ancestor
91950654|NCT03487211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950655|NCT03487211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950656|NCT03487211|Antidepressive Agents|antidepressive agents|mesh-ancestor
91950663|NCT03487133|Bortezomib|bortezomib|mesh-list
91950684|NCT02248480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950685|NCT02248480|Antidepressive Agents|antidepressive agents|mesh-ancestor
91950686|NCT02248480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91950688|NCT01653158|Docetaxel|docetaxel|mesh-list
91950689|NCT01653158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950753|NCT02455076|Insulin, Short-Acting|insulin, short-acting|mesh-list
91950754|NCT02455076|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950755|NCT02455076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950756|NCT02455076|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91950757|NCT02455076|Incretins|incretins|mesh-ancestor
91950759|NCT02455076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950760|NCT02432846|Sunitinib|sunitinib|mesh-list
91950761|NCT02432846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950762|NCT02432846|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91950763|NCT02432846|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91950764|NCT02432846|Growth Substances|growth substances|mesh-ancestor
91950765|NCT02432846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950766|NCT02432846|Growth Inhibitors|growth inhibitors|mesh-ancestor
91950767|NCT02432846|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950768|NCT02432846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950769|NCT02432846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950770|NCT03486509|Afatinib|afatinib|mesh-list
91950771|NCT03486509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950772|NCT03486509|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950773|NCT03486509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950774|NCT03486509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950775|NCT04460807|Exemestane|exemestane|mesh-list
91950776|NCT04460807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950777|NCT04460807|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91950778|NCT04460807|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91950779|NCT04460807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950780|NCT04460807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950781|NCT04460807|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91950782|NCT04460807|Hormone Antagonists|hormone antagonists|mesh-ancestor
91950783|NCT04460807|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91950784|NCT04460807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950785|NCT02246998|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91950787|NCT02246998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91950788|NCT02246998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91950789|NCT02246998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91950790|NCT04928222|Doxorubicin|doxorubicin|mesh-list
91950791|NCT04928222|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91950792|NCT04928222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950793|NCT04928222|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91950794|NCT04928222|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91950795|NCT04928222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950796|NCT04928222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950797|NCT00805961|Bevacizumab|bevacizumab|mesh-list
91950798|NCT00805961|Everolimus|everolimus|mesh-list
91950799|NCT00805961|Temozolomide|temozolomide|mesh-list
91950800|NCT00805961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91950801|NCT00805961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950802|NCT00805961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91950846|NCT03484091|Viscosupplements|viscosupplements|mesh-ancestor
91950847|NCT03484091|Protective Agents|protective agents|mesh-ancestor
91950848|NCT03484091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950849|NCT03486353|Azacitidine|azacitidine|mesh-list
91950850|NCT03486353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91950851|NCT03486353|Antimetabolites|antimetabolites|mesh-ancestor
91950852|NCT03486353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950853|NCT03486353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950854|NCT03486353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950855|NCT04460651|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
91950856|NCT04460651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91950857|NCT04460651|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91950858|NCT04492241|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91950907|NCT01652690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91950908|NCT01652690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950909|NCT03481517|Bupivacaine|bupivacaine|mesh-list
91950910|NCT03481517|Anesthetics, Local|anesthetics, local|mesh-ancestor
91950911|NCT03481517|Anesthetics|anesthetics|mesh-ancestor
91950912|NCT03481517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91950913|NCT03481517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950914|NCT03481517|Sensory System Agents|sensory system agents|mesh-ancestor
91950915|NCT03481517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91950916|NCT02429258|Metformin|metformin|mesh-list
91950917|NCT02429258|Dapagliflozin|dapagliflozin|mesh-list
91950918|NCT02429258|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91950919|NCT02429258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950920|NCT02429258|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91950921|NCT02429258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91950922|NCT02201524|Abrocitinib|abrocitinib|mesh-list
91950923|NCT02201524|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950924|NCT02201524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91950926|NCT05153603|Olaparib|olaparib|mesh-list
91950960|NCT05152511|Protective Agents|protective agents|mesh-ancestor
91950961|NCT05152511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91950962|NCT05152511|Vasodilator Agents|vasodilator agents|mesh-ancestor
91950963|NCT05152511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91950964|NCT05152511|Antioxidants|antioxidants|mesh-ancestor
91950965|NCT02568449|Nintedanib|nintedanib|mesh-list
91950966|NCT02568449|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91950967|NCT02568449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91950968|NCT02568449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91950971|NCT02738333|Sofosbuvir|sofosbuvir|mesh-list
91951025|NCT03475589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91951026|NCT03475589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951027|NCT03475589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951028|NCT03478709|Norepinephrine|norepinephrine|mesh-list
91951029|NCT03478709|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91951030|NCT03478709|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91951031|NCT03478709|Adrenergic Agents|adrenergic agents|mesh-ancestor
91951032|NCT03478709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951033|NCT03478709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951034|NCT03478709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951035|NCT03478709|Sympathomimetics|sympathomimetics|mesh-ancestor
91951036|NCT03478709|Autonomic Agents|autonomic agents|mesh-ancestor
91951037|NCT03478709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951038|NCT03478709|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91951039|NCT03478475|Cholecalciferol|cholecalciferol|mesh-list
91951040|NCT03478475|Vitamin D|vitamin d|mesh-list
91951041|NCT03478475|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91951043|NCT03478475|Vitamins|vitamins|mesh-ancestor
91951080|NCT05258045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951081|NCT03477929|Cetrorelix|cetrorelix|mesh-list
91951082|NCT03477929|Ganirelix|ganirelix|mesh-list
91951083|NCT03477929|Hormone Antagonists|hormone antagonists|mesh-ancestor
91951084|NCT03477929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951085|NCT03477929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951086|NCT03477929|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91951087|NCT03477929|Fertility Agents|fertility agents|mesh-ancestor
91951088|NCT03477929|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91951089|NCT03474341|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91951090|NCT03474341|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91951091|NCT03474341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951092|NCT03474263|Antibodies|antibodies|mesh-list
91951093|NCT03474263|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91951094|NCT03474263|Immunologic Factors|immunologic factors|mesh-ancestor
91951138|NCT04339049|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951139|NCT04339049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951140|NCT04339049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91951141|NCT04339049|Abortifacient Agents|abortifacient agents|mesh-ancestor
91951142|NCT04339049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91951144|NCT04339049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951145|NCT04339049|Oxytocics|oxytocics|mesh-ancestor
91951146|NCT02133664|Thioctic Acid|thioctic acid|mesh-list
91951147|NCT02133664|Antioxidants|antioxidants|mesh-ancestor
91951148|NCT02133664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951149|NCT02133664|Protective Agents|protective agents|mesh-ancestor
91951150|NCT02133664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951151|NCT02133664|Vitamin B Complex|vitamin b complex|mesh-ancestor
91951152|NCT02133664|Vitamins|vitamins|mesh-ancestor
91951153|NCT02133664|Micronutrients|micronutrients|mesh-ancestor
91951196|NCT02195518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951197|NCT02195518|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91951198|NCT02195518|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91951199|NCT03990077|Docetaxel|docetaxel|mesh-list
91951200|NCT03990077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951201|NCT03990077|Tubulin Modulators|tubulin modulators|mesh-ancestor
91951202|NCT03990077|Antimitotic Agents|antimitotic agents|mesh-ancestor
91951203|NCT03990077|Mitosis Modulators|mitosis modulators|mesh-ancestor
91951204|NCT03990077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951205|NCT05134415|Menthol|menthol|mesh-list
91951206|NCT05134415|Antipruritics|antipruritics|mesh-ancestor
91951207|NCT05134415|Dermatologic Agents|dermatologic agents|mesh-ancestor
91951208|NCT03380507|Thiamine|thiamine|mesh-list
91951209|NCT03380507|Hydrocortisone|hydrocortisone|mesh-list
91951210|NCT03380507|Vitamins|vitamins|mesh-ancestor
91951211|NCT03380507|Micronutrients|micronutrients|mesh-ancestor
91951212|NCT03380507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951213|NCT03380507|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951214|NCT03380507|Vitamin B Complex|vitamin b complex|mesh-ancestor
91951215|NCT03471455|Itraconazole|itraconazole|mesh-list
91951216|NCT03471455|Terbinafine|terbinafine|mesh-list
91951217|NCT03471455|Isotretinoin|isotretinoin|mesh-list
91951218|NCT03471455|Antifungal Agents|antifungal agents|mesh-ancestor
91951219|NCT03471455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951248|NCT03202667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91951249|NCT03202667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951250|NCT02133742|Pembrolizumab|pembrolizumab|mesh-list
91951251|NCT02133742|Axitinib|axitinib|mesh-list
91951252|NCT02133742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951253|NCT02133742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951254|NCT02133742|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91951255|NCT02133742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951256|NCT02133742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91951257|NCT02133742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951258|NCT05157893|Analgesics|analgesics|mesh-list
91951259|NCT05157893|Sensory System Agents|sensory system agents|mesh-ancestor
91951260|NCT05157893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951261|NCT05157893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951262|NCT02523053|Fluorouracil|fluorouracil|mesh-list
91951263|NCT02523053|Antimetabolites|antimetabolites|mesh-ancestor
91951264|NCT02523053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951265|NCT02523053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91951266|NCT02523053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951267|NCT02523053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91951268|NCT02523053|Immunologic Factors|immunologic factors|mesh-ancestor
91951269|NCT02523053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951289|NCT03645863|Iron|iron|mesh-list
91951300|NCT03470597|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91951301|NCT03470597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951302|NCT03470597|Trace Elements|trace elements|mesh-ancestor
91951303|NCT03470597|Micronutrients|micronutrients|mesh-ancestor
91951304|NCT03470597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951305|NCT02522897|Ranibizumab|ranibizumab|mesh-list
91951306|NCT02522897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91951307|NCT02522897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91951308|NCT02522897|Growth Substances|growth substances|mesh-ancestor
91951309|NCT02522897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951310|NCT02522897|Growth Inhibitors|growth inhibitors|mesh-ancestor
91951311|NCT02522897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951312|NCT04351061|Acetazolamide|acetazolamide|mesh-list
91951313|NCT04351061|Anticonvulsants|anticonvulsants|mesh-ancestor
91951314|NCT04351061|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91951315|NCT04351061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951316|NCT04351061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951317|NCT04351061|Diuretics|diuretics|mesh-ancestor
91951318|NCT04351061|Natriuretic Agents|natriuretic agents|mesh-ancestor
91951319|NCT04351061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951320|NCT03130829|Fucoidan|fucoidan|mesh-list
91951321|NCT03130829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91951322|NCT03130829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951323|NCT03130829|Anticoagulants|anticoagulants|mesh-ancestor
91951324|NCT03130829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951325|NCT04318145|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91951326|NCT04206761|Mometasone Furoate|mometasone furoate|mesh-list
91951327|NCT04206761|Glycopyrrolate|glycopyrrolate|mesh-list
91951328|NCT04206761|Bromides|bromides|mesh-list
91951329|NCT04206761|Anticonvulsants|anticonvulsants|mesh-ancestor
91951330|NCT04206761|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951331|NCT04206761|Dermatologic Agents|dermatologic agents|mesh-ancestor
91951332|NCT04206761|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91951333|NCT04206761|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91951334|NCT04206761|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91951335|NCT04206761|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91951341|NCT03181529|Hallucinogens|hallucinogens|mesh-ancestor
91951342|NCT03181529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951343|NCT03181529|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91951344|NCT03668639|Dexamethasone|dexamethasone|mesh-list
91951345|NCT03668639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951346|NCT03668639|Antiemetics|antiemetics|mesh-ancestor
91951347|NCT03668639|Autonomic Agents|autonomic agents|mesh-ancestor
91951348|NCT03668639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951349|NCT03668639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951350|NCT03668639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951351|NCT03668639|Glucocorticoids|glucocorticoids|mesh-ancestor
91951353|NCT03668639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951354|NCT03668639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91951355|NCT03668639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951357|NCT03470363|Bupivacaine|bupivacaine|mesh-list
91951358|NCT03470363|Sevoflurane|sevoflurane|mesh-list
91951359|NCT03470363|Anesthetics, Local|anesthetics, local|mesh-ancestor
91951360|NCT03470363|Anesthetics|anesthetics|mesh-ancestor
91951399|NCT05096039|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91951400|NCT05096039|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91951401|NCT05096039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951402|NCT05604131|Deferiprone|deferiprone|mesh-list
91951403|NCT05604131|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91951404|NCT05604131|Chelating Agents|chelating agents|mesh-ancestor
91951405|NCT05604131|Sequestering Agents|sequestering agents|mesh-ancestor
91951406|NCT05604131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951408|NCT03469271|Dihydroxycholecalciferols|dihydroxycholecalciferols|mesh-list
91951409|NCT03469271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91951410|NCT03469271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951411|NCT03469271|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
91951412|NCT03469271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951451|NCT05162417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951452|NCT05162417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951453|NCT05162417|Hemostatics|hemostatics|mesh-ancestor
91951454|NCT05162417|Coagulants|coagulants|mesh-ancestor
91951455|NCT05162417|Heparin Antagonists|heparin antagonists|mesh-ancestor
91951466|NCT05161403|Hyaluronic Acid|hyaluronic acid|mesh-list
91951467|NCT05161403|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91951468|NCT05161403|Immunologic Factors|immunologic factors|mesh-ancestor
91951469|NCT05161403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951470|NCT05161403|Viscosupplements|viscosupplements|mesh-ancestor
91951471|NCT05161403|Protective Agents|protective agents|mesh-ancestor
91951472|NCT03205553|Dialysis Solutions|dialysis solutions|mesh-list
91951473|NCT03205553|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91951474|NCT03166085|Paclitaxel|paclitaxel|mesh-list
91951475|NCT03166085|9H-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|9h-purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-n-(1-methylethyl)-|mesh-list
91951476|NCT03166085|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91951507|NCT02492867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951508|NCT02492867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951509|NCT02458313|3-(2,4-dimethoxybenzylidene)anabaseine|3-(2,4-dimethoxybenzylidene)anabaseine|mesh-list
91951510|NCT02458313|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91951511|NCT02458313|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91951512|NCT02458313|Cholinergic Agents|cholinergic agents|mesh-ancestor
91951513|NCT02458313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951514|NCT02458313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951515|NCT02458313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951516|NCT02522221|Warfarin|warfarin|mesh-list
91951517|NCT02522221|Anticoagulants|anticoagulants|mesh-ancestor
91951518|NCT05389943|Vitamin D|vitamin d|mesh-list
91951519|NCT05389943|Ergocalciferols|ergocalciferols|mesh-list
91951520|NCT05389943|Cholecalciferol|cholecalciferol|mesh-list
91951521|NCT05389943|Vitamins|vitamins|mesh-list
91951566|NCT04453189|Famotidine|famotidine|mesh-list
91951567|NCT04453189|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91951568|NCT04453189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91951569|NCT04453189|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91951570|NCT04453189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951571|NCT04453189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951572|NCT04453189|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91951573|NCT04453189|Histamine Antagonists|histamine antagonists|mesh-ancestor
91951574|NCT04453189|Histamine Agents|histamine agents|mesh-ancestor
91951575|NCT04453189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951576|NCT04453189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951629|NCT04453345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074259|NCT00074308|Bevacizumab|bevacizumab|mesh-list
91951630|NCT04453345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91951631|NCT04453345|Leprostatic Agents|leprostatic agents|mesh-ancestor
91951632|NCT04453345|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91951633|NCT04453345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951634|NCT04453345|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91951635|NCT04453345|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91951636|NCT04453345|Growth Substances|growth substances|mesh-ancestor
91951637|NCT04453345|Growth Inhibitors|growth inhibitors|mesh-ancestor
91951638|NCT02322593|Oxaliplatin|oxaliplatin|mesh-list
91951639|NCT02322593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951640|NCT03464539|Chitosan|chitosan|mesh-list
91951641|NCT03464539|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91951642|NCT03464539|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91951643|NCT03464539|Antimetabolites|antimetabolites|mesh-ancestor
91951692|NCT05165303|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91951693|NCT05165303|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91951694|NCT05165303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951695|NCT05165303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951696|NCT05165303|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91951697|NCT05165303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91951698|NCT05165303|Anesthetics, General|anesthetics, general|mesh-ancestor
91951699|NCT03376763|Aripiprazole|aripiprazole|mesh-list
91951700|NCT03376763|Antidepressive Agents|antidepressive agents|mesh-ancestor
91951701|NCT03376763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91951702|NCT03376763|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91951703|NCT03376763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91951753|NCT01857115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91951754|NCT01857115|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91951755|NCT01857115|Alkylating Agents|alkylating agents|mesh-ancestor
91951756|NCT01857115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951757|NCT01857115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951758|NCT01857115|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91951759|NCT01857115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91951761|NCT01857115|Autonomic Agents|autonomic agents|mesh-ancestor
91951762|NCT01857115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951764|NCT01857115|Glucocorticoids|glucocorticoids|mesh-ancestor
91951816|NCT03449173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951817|NCT03449173|Growth Inhibitors|growth inhibitors|mesh-ancestor
91951818|NCT03449173|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91951819|NCT03449173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951820|NCT03449173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951821|NCT04760041|Midazolam|midazolam|mesh-list
91951822|NCT04760041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91951823|NCT04760041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91951824|NCT04760041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951825|NCT04760041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951826|NCT04760041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91951827|NCT04760041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91951828|NCT04760041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91951829|NCT04760041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91951830|NCT04760041|Anesthetics, General|anesthetics, general|mesh-ancestor
91951831|NCT04760041|Anesthetics|anesthetics|mesh-ancestor
91951876|NCT02164864|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91951877|NCT02164864|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91951878|NCT02164864|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91951879|NCT02164864|Purinergic Agents|purinergic agents|mesh-ancestor
91951880|NCT02164864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951881|NCT02164864|Anticoagulants|anticoagulants|mesh-ancestor
91951882|NCT02164864|Antithrombins|antithrombins|mesh-ancestor
91951883|NCT02164864|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91951884|NCT02164864|Protease Inhibitors|protease inhibitors|mesh-ancestor
91951885|NCT05579249|Liraglutide|liraglutide|mesh-list
91951887|NCT05579249|Orlistat|orlistat|mesh-list
91951888|NCT05579249|Phentermine|phentermine|mesh-list
91951889|NCT05579249|Naltrexone|naltrexone|mesh-list
91951890|NCT05579249|Bupropion|bupropion|mesh-list
91951891|NCT05579249|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91951892|NCT05579249|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91951893|NCT05579249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91951894|NCT05579249|Sensory System Agents|sensory system agents|mesh-ancestor
91951895|NCT05579249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91951896|NCT05579249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91951897|NCT05579249|Incretins|incretins|mesh-ancestor
91951899|NCT05579249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91951900|NCT05579249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91951901|NCT05579249|Antidepressive Agents|antidepressive agents|mesh-ancestor
91951902|NCT05579249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91951903|NCT05579249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91951904|NCT05579249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91951905|NCT05579249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91951906|NCT05579249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951907|NCT05579249|Dopamine Agents|dopamine agents|mesh-ancestor
91951908|NCT05579249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951909|NCT05579249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92090408|NCT04382014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974840|NCT04902105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974841|NCT04902105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91974842|NCT04902105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974843|NCT04902105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91974844|NCT02120950|Aflibercept|aflibercept|mesh-list
91974845|NCT02120950|Verteporfin|verteporfin|mesh-list
91951910|NCT05579249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91951911|NCT05579249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951912|NCT05579249|Anticonvulsants|anticonvulsants|mesh-ancestor
91951913|NCT05579249|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91951914|NCT05579249|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91951915|NCT05579249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91951916|NCT05579249|Appetite Depressants|appetite depressants|mesh-ancestor
91951917|NCT05579249|Sympathomimetics|sympathomimetics|mesh-ancestor
91951918|NCT05579249|Autonomic Agents|autonomic agents|mesh-ancestor
91951919|NCT05579249|Adrenergic Agents|adrenergic agents|mesh-ancestor
91951920|NCT02419807|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91951921|NCT02419807|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
91951922|NCT02419807|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91951924|NCT05386589|Molnupiravir|molnupiravir|mesh-list
91951971|NCT05313659|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91951972|NCT05313659|Anesthetics, General|anesthetics, general|mesh-ancestor
91951974|NCT05313659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91951975|NCT05313659|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91951976|NCT05313659|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91951977|NCT05313659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951978|NCT05313659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951979|NCT05322187|Pembrolizumab|pembrolizumab|mesh-list
91951980|NCT05322187|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91951981|NCT05322187|Lenvatinib|lenvatinib|mesh-list
91951982|NCT05322187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91951983|NCT05322187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91951984|NCT05322187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91951985|NCT05322187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91951986|NCT05322187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91951987|NCT02164318|Nitroglycerin|nitroglycerin|mesh-list
91951988|NCT02164318|Vasodilator Agents|vasodilator agents|mesh-ancestor
91951989|NCT03436199|Amantadine|amantadine|mesh-list
91951990|NCT03436199|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91951991|NCT03436199|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91951992|NCT03436199|Antiviral Agents|antiviral agents|mesh-ancestor
91951993|NCT03436199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91951994|NCT03436199|Dopamine Agents|dopamine agents|mesh-ancestor
91951995|NCT03436199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91951996|NCT03436199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952019|NCT02193880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952020|NCT02193880|Immunologic Factors|immunologic factors|mesh-ancestor
91952021|NCT02193880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952022|NCT02193880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952023|NCT02193880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91952024|NCT02193880|Alkylating Agents|alkylating agents|mesh-ancestor
91952025|NCT02193880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952026|NCT02193880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952027|NCT02193880|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91952028|NCT05159219|Colchicine|colchicine|mesh-list
91952029|NCT05159219|Gout Suppressants|gout suppressants|mesh-ancestor
91952030|NCT05159219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952031|NCT05159219|Tubulin Modulators|tubulin modulators|mesh-ancestor
91952032|NCT05159219|Antimitotic Agents|antimitotic agents|mesh-ancestor
91952033|NCT05159219|Mitosis Modulators|mitosis modulators|mesh-ancestor
91952034|NCT05159219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952035|NCT05159219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952077|NCT04928183|Nitroprusside|nitroprusside|mesh-list
91952078|NCT04928183|Phenylephrine|phenylephrine|mesh-list
91952079|NCT04928183|Oxymetazoline|oxymetazoline|mesh-list
91952080|NCT04928183|Carbon Monoxide|carbon monoxide|mesh-list
91952081|NCT04928183|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91952082|NCT04928183|Mydriatics|mydriatics|mesh-ancestor
91952083|NCT04928183|Autonomic Agents|autonomic agents|mesh-ancestor
91952084|NCT04928183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952085|NCT04928183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952086|NCT04928183|Sympathomimetics|sympathomimetics|mesh-ancestor
91952087|NCT04928183|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91952088|NCT04928183|Nasal Decongestants|nasal decongestants|mesh-ancestor
91952089|NCT04928183|Respiratory System Agents|respiratory system agents|mesh-ancestor
91952090|NCT04928183|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91952091|NCT04928183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91952092|NCT04928183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91952093|NCT04928183|Adrenergic Agents|adrenergic agents|mesh-ancestor
91952094|NCT04928183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952095|NCT04928183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952096|NCT04928183|Protective Agents|protective agents|mesh-ancestor
91952097|NCT04928183|Antimetabolites|antimetabolites|mesh-ancestor
91952098|NCT04928183|Gasotransmitters|gasotransmitters|mesh-ancestor
91952099|NCT04928183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91952106|NCT04311073|Hemostatics|hemostatics|mesh-ancestor
91952132|NCT04923659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952133|NCT04923659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952134|NCT04923659|Anticonvulsants|anticonvulsants|mesh-ancestor
91952135|NCT04923659|Antiemetics|antiemetics|mesh-ancestor
91952136|NCT04923659|Autonomic Agents|autonomic agents|mesh-ancestor
91952137|NCT04923659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952138|NCT04923659|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91952139|NCT04923659|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91952140|NCT04923659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952141|NCT04923659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91952142|NCT04923659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91952143|NCT04923659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91952144|NCT04923659|GABA Modulators|gaba modulators|mesh-ancestor
91952145|NCT04923659|GABA Agents|gaba agents|mesh-ancestor
91952146|NCT04923659|Antimanic Agents|antimanic agents|mesh-ancestor
91952147|NCT04923659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91952148|NCT04923659|Analgesics|analgesics|mesh-ancestor
91952149|NCT04923659|Sensory System Agents|sensory system agents|mesh-ancestor
91952150|NCT04923659|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91952151|NCT04923659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91952152|NCT04923659|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91952153|NCT04923659|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91952154|NCT04923659|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91952155|NCT04923659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91952156|NCT04923659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91952157|NCT04923659|Vasodilator Agents|vasodilator agents|mesh-ancestor
91952158|NCT05398679|Amoxicillin|amoxicillin|mesh-list
91952159|NCT05398679|Moxifloxacin|moxifloxacin|mesh-list
91952160|NCT05398679|Ciprofloxacin|ciprofloxacin|mesh-list
91952161|NCT05398679|Levofloxacin|levofloxacin|mesh-list
91952162|NCT05398679|Ofloxacin|ofloxacin|mesh-list
91952178|NCT05398679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952179|NCT05398679|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91952180|NCT05398679|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91952181|NCT05398679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952182|NCT05398679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952183|NCT05398679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952184|NCT05398679|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91952185|NCT05398679|Contraceptive Agents|contraceptive agents|mesh-ancestor
91952186|NCT05398679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91952340|NCT05102071|Metformin|metformin|mesh-list
91952187|NCT05398679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952188|NCT05398679|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91952189|NCT05398679|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91952190|NCT05398679|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91952191|NCT05398679|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91952192|NCT05398679|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91952205|NCT05398679|Antimalarials|antimalarials|mesh-ancestor
91952234|NCT01378325|Respiratory System Agents|respiratory system agents|mesh-ancestor
91952235|NCT01378325|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91952236|NCT01378325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91952237|NCT01378325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91952238|NCT01378325|Adrenergic Agents|adrenergic agents|mesh-ancestor
91952239|NCT01378325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952240|NCT01378325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952241|NCT01378325|Protective Agents|protective agents|mesh-ancestor
91952243|NCT03854903|Palbociclib|palbociclib|mesh-list
91952244|NCT03854903|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91952245|NCT03854903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952246|NCT03854903|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91952247|NCT03854903|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91952248|NCT03854903|Hormone Antagonists|hormone antagonists|mesh-ancestor
91952249|NCT03854903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952250|NCT03854903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952251|NCT03854903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952252|NCT03854903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952253|NCT03854903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952254|NCT01093573|Azacitidine|azacitidine|mesh-list
91952255|NCT01093573|Midostaurin|midostaurin|mesh-list
91952256|NCT01093573|Staurosporine|staurosporine|mesh-list
91952257|NCT01093573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91952258|NCT01093573|Antimetabolites|antimetabolites|mesh-ancestor
91952259|NCT01093573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952260|NCT01093573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952261|NCT01093573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952262|NCT01093573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952263|NCT03367741|Nivolumab|nivolumab|mesh-list
91952264|NCT03367741|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952265|NCT03367741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952266|NCT03367741|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91952267|NCT03367741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974846|NCT02120950|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974847|NCT02120950|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91952268|NCT03402503|Montelukast|montelukast|mesh-list
91952269|NCT03402503|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91952270|NCT03402503|Respiratory System Agents|respiratory system agents|mesh-ancestor
91952271|NCT03402503|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91952272|NCT03402503|Hormone Antagonists|hormone antagonists|mesh-ancestor
91952273|NCT03402503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952274|NCT03402503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952275|NCT03402503|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91952276|NCT03402503|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91952277|NCT03402503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952278|NCT05174845|Ascorbic Acid|ascorbic acid|mesh-list
91952279|NCT05174845|Antioxidants|antioxidants|mesh-ancestor
91952280|NCT05174845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952281|NCT05174845|Protective Agents|protective agents|mesh-ancestor
91952283|NCT05174845|Vitamins|vitamins|mesh-ancestor
91952325|NCT03446599|Hematinics|hematinics|mesh-ancestor
91952326|NCT03446599|Vitamin B Complex|vitamin b complex|mesh-ancestor
91952327|NCT03446599|Vitamins|vitamins|mesh-ancestor
91952328|NCT03446599|Micronutrients|micronutrients|mesh-ancestor
91952329|NCT03446599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952330|NCT02856451|Nivolumab|nivolumab|mesh-list
91952331|NCT02856451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952332|NCT02856451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952333|NCT02856451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91952334|NCT02856451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952335|NCT03446443|Metronidazole|metronidazole|mesh-list
91952336|NCT03446443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952337|NCT03446443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91952338|NCT03446443|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91952339|NCT03446443|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91952341|NCT05102071|Empagliflozin|empagliflozin|mesh-list
91952342|NCT05102071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91952343|NCT05102071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952344|NCT05102071|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91952345|NCT05102071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952346|NCT03443869|Acyclovir|acyclovir|mesh-list
91952347|NCT03443869|Valganciclovir|valganciclovir|mesh-list
91952348|NCT03443869|Letermovir|letermovir|mesh-list
91952349|NCT03443869|Antiviral Agents|antiviral agents|mesh-ancestor
91952352|NCT03443869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952378|NCT03237611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952379|NCT03237611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91952380|NCT03237611|Glucocorticoids|glucocorticoids|mesh-ancestor
91952382|NCT03237611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952383|NCT03237611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91952384|NCT03237611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952385|NCT03237611|Antipruritics|antipruritics|mesh-ancestor
91952386|NCT03237611|Dermatologic Agents|dermatologic agents|mesh-ancestor
91952387|NCT03237611|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91952388|NCT03237611|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91952389|NCT03237611|Serotonin Agents|serotonin agents|mesh-ancestor
91952390|NCT03237611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952391|NCT03237611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952392|NCT03237611|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91952393|NCT03234491|Insulin|insulin|mesh-list
91952394|NCT03234491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91952395|NCT03234491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91952396|NCT03234491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952397|NCT01961063|Busulfan|busulfan|mesh-list
91952430|NCT05082259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952431|NCT05082259|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91952432|NCT05082259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952433|NCT03109717|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-list
91952434|NCT03109717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952435|NCT03109717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952436|NCT03442621|Cortisone|cortisone|mesh-list
91952437|NCT03442621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952438|NCT03444649|Cytarabine|cytarabine|mesh-list
91952439|NCT03444649|Daunorubicin|daunorubicin|mesh-list
91952440|NCT03444649|Idarubicin|idarubicin|mesh-list
91952441|NCT03444649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91952442|NCT03444649|Antimetabolites|antimetabolites|mesh-ancestor
91952443|NCT03444649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952444|NCT03444649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952445|NCT03444649|Antiviral Agents|antiviral agents|mesh-ancestor
91952446|NCT03444649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952447|NCT03444649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91952448|NCT03444649|Immunologic Factors|immunologic factors|mesh-ancestor
91952449|NCT03444649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952450|NCT03444649|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91952451|NCT03444649|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91952452|NCT03444649|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91952453|NCT03444649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952454|NCT01328951|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91952455|NCT01328951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952456|NCT01328951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952457|NCT01328951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952458|NCT01328951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952459|NCT03466775|Angiotensin II|angiotensin ii|mesh-list
91952460|NCT03466775|Giapreza|giapreza|mesh-list
91952461|NCT03466775|Antibodies|antibodies|mesh-list
91952472|NCT05430893|Botulinum Toxins|botulinum toxins|mesh-list
91952473|NCT05430893|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91952474|NCT05430893|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91952475|NCT05430893|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91952476|NCT05430893|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91952477|NCT05430893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952478|NCT05430893|Cholinergic Agents|cholinergic agents|mesh-ancestor
91952479|NCT05430893|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952480|NCT05430893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952481|NCT05430893|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91952483|NCT02557139|Belumosudil|belumosudil|mesh-list
91952533|NCT03268083|Immunologic Factors|immunologic factors|mesh-ancestor
91952534|NCT03268083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952535|NCT03465059|Zanubrutinib|zanubrutinib|mesh-list
91952536|NCT03465059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952537|NCT03465059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91952538|NCT03465059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952539|NCT03465059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952540|NCT03170817|Regadenoson|regadenoson|mesh-list
91952541|NCT03170817|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
91952542|NCT03170817|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91952543|NCT03170817|Purinergic Agonists|purinergic agonists|mesh-ancestor
91952544|NCT03170817|Purinergic Agents|purinergic agents|mesh-ancestor
91952545|NCT03170817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952546|NCT03170817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952547|NCT03170817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952590|NCT03464435|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91952591|NCT03464279|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91952592|NCT03464279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952593|NCT03463967|Lycopene|lycopene|mesh-list
91952594|NCT03463967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952595|NCT03463967|Antioxidants|antioxidants|mesh-ancestor
91952596|NCT03463967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952597|NCT03463967|Protective Agents|protective agents|mesh-ancestor
91952598|NCT03463967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952599|NCT03463967|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91952600|NCT03463967|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91952601|NCT03463967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952602|NCT03463733|Temozolomide|temozolomide|mesh-list
91952603|NCT03463733|Hydroxyurea|hydroxyurea|mesh-list
91952604|NCT03463733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91952605|NCT03463733|Alkylating Agents|alkylating agents|mesh-ancestor
91952606|NCT03463733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952607|NCT03463733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952608|NCT03463733|Antisickling Agents|antisickling agents|mesh-ancestor
91952609|NCT03463733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952610|NCT03463733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91952611|NCT04222595|Vaccines|vaccines|mesh-list
91952612|NCT04222595|Immunologic Factors|immunologic factors|mesh-ancestor
91952613|NCT04222595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952614|NCT03468023|Calpastatin|calpastatin|mesh-list
91952615|NCT03468023|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
91952616|NCT03468023|Protease Inhibitors|protease inhibitors|mesh-ancestor
91952638|NCT05100303|Sensory System Agents|sensory system agents|mesh-ancestor
91952639|NCT05100303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952640|NCT05100303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91952641|NCT05100303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91952642|NCT05100303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952643|NCT03462173|Yimitasvir|yimitasvir|mesh-list
91952644|NCT03462173|Antiviral Agents|antiviral agents|mesh-ancestor
91952645|NCT03462173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91952646|NCT05096715|Bevacizumab|bevacizumab|mesh-list
91952647|NCT05096715|Atezolizumab|atezolizumab|mesh-list
91952648|NCT05096715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952649|NCT05096715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952650|NCT05096715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91952651|NCT05096715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91952657|NCT04984889|Protein C|protein c|mesh-list
91952687|NCT04796363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952688|NCT04796363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952689|NCT03593109|Immunomodulating Agents|immunomodulating agents|mesh-list
91952690|NCT03593109|Immunologic Factors|immunologic factors|mesh-ancestor
91952691|NCT03593109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952692|NCT03522753|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91952693|NCT03522753|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
91952694|NCT03522753|beta-Endorphin|beta-endorphin|mesh-list
91952695|NCT03522753|Hormones|hormones|mesh-ancestor
91952696|NCT03522753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91952697|NCT03522753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952700|NCT05103813|Beraprost|beraprost|mesh-list
91952747|NCT04452929|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91952748|NCT04452929|Analgesics|analgesics|mesh-ancestor
91952749|NCT04452929|Sensory System Agents|sensory system agents|mesh-ancestor
91952750|NCT04452929|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91952751|NCT04452929|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91952752|NCT05103501|Pembrolizumab|pembrolizumab|mesh-list
91952753|NCT05103501|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91952754|NCT05103501|Fluorouracil|fluorouracil|mesh-list
91952755|NCT05103501|Cisplatin|cisplatin|mesh-list
91952756|NCT05103501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91952757|NCT05103501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952758|NCT05103501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952759|NCT05103501|Antimetabolites|antimetabolites|mesh-ancestor
91952760|NCT05103501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91952804|NCT03461081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91952806|NCT02522039|Dorzolamide|dorzolamide|mesh-list
91952807|NCT02522039|Latanoprost|latanoprost|mesh-list
91952808|NCT02522039|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91952809|NCT02522039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91952810|NCT02522039|Adrenergic Agents|adrenergic agents|mesh-ancestor
91952811|NCT02522039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952812|NCT02522039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952813|NCT02522039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952814|NCT02522039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91952815|NCT02522039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91952816|NCT02522039|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91952817|NCT02522039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91952818|NCT02522039|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91952819|NCT02522039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952861|NCT03460145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952862|NCT03460145|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91952863|NCT03460145|Anesthetics, General|anesthetics, general|mesh-ancestor
91952864|NCT03460145|Anesthetics|anesthetics|mesh-ancestor
91952865|NCT04125771|Diclofenac|diclofenac|mesh-list
91952866|NCT04125771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91952867|NCT04125771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91952868|NCT04125771|Analgesics|analgesics|mesh-ancestor
91952869|NCT04125771|Sensory System Agents|sensory system agents|mesh-ancestor
91952870|NCT04125771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952871|NCT04125771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952872|NCT04125771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952873|NCT04125771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952874|NCT04125771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91952875|NCT04125771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952876|NCT04125771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952918|NCT03645603|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91952919|NCT03645603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952920|NCT03645603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952921|NCT03645603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91952922|NCT03645603|Analgesics|analgesics|mesh-ancestor
91952923|NCT03645603|Sensory System Agents|sensory system agents|mesh-ancestor
91952924|NCT03645603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91952925|NCT03645603|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91952926|NCT03645603|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91952927|NCT03645603|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91952928|NCT03645603|Adrenergic Agents|adrenergic agents|mesh-ancestor
91952929|NCT03645603|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91952930|NCT03645603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952931|NCT04019873|Lamivudine|lamivudine|mesh-list
91952932|NCT04019873|Rilpivirine|rilpivirine|mesh-list
91952933|NCT04019873|Dolutegravir|dolutegravir|mesh-list
91952934|NCT04019873|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91952935|NCT04019873|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91952973|NCT04576767|Anesthetics|anesthetics|mesh-list
91952974|NCT04576767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91952975|NCT04576767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91952976|NCT03248531|Adalimumab|adalimumab|mesh-list
91952977|NCT03248531|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91952978|NCT03248531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91952979|NCT03248531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91952981|NCT03866525|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91952982|NCT03866525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91952983|NCT03866525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91952984|NCT03866525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91952985|NCT03866525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91952986|NCT03129347|Nalmefene|nalmefene|mesh-list
91952987|NCT03129347|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91952991|NCT02262923|Metoclopramide|metoclopramide|mesh-list
91953036|NCT01166633|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91953037|NCT01166633|Antimetabolites|antimetabolites|mesh-ancestor
91953038|NCT01166633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953039|NCT01166633|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91953040|NCT01166633|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91953041|NCT01166633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953042|NCT04315311|Pancrelipase|pancrelipase|mesh-list
91953043|NCT04315311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91953044|NCT03596073|Calcipotriene|calcipotriene|mesh-list
91953045|NCT03596073|Petrolatum|petrolatum|mesh-list
91953046|NCT03596073|Dermatologic Agents|dermatologic agents|mesh-ancestor
91953047|NCT03596073|Emollients|emollients|mesh-ancestor
91953099|NCT04528173|Anesthetics, General|anesthetics, general|mesh-ancestor
91953100|NCT04528173|Anesthetics|anesthetics|mesh-ancestor
91953101|NCT04528173|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91953102|NCT04528173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953103|NCT04528173|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953104|NCT04528173|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91953105|NCT04528173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953107|NCT05114499|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91953108|NCT05114499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953109|NCT05114499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953110|NCT05114499|Cholinergic Agents|cholinergic agents|mesh-ancestor
91953111|NCT05114499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953112|NCT05114499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953113|NCT05114499|Nootropic Agents|nootropic agents|mesh-ancestor
91953114|NCT04520997|Hyaluronic Acid|hyaluronic acid|mesh-list
91953115|NCT04520997|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91953116|NCT04520997|Immunologic Factors|immunologic factors|mesh-ancestor
91953117|NCT04520997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953118|NCT04520997|Viscosupplements|viscosupplements|mesh-ancestor
91953119|NCT04520997|Protective Agents|protective agents|mesh-ancestor
91953120|NCT05109585|Antibodies|antibodies|mesh-list
91953121|NCT05109585|Immunoglobulins|immunoglobulins|mesh-list
91953122|NCT05109585|Immunoglobulin G|immunoglobulin g|mesh-list
91974848|NCT02120950|Growth Substances|growth substances|mesh-ancestor
91974849|NCT02120950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974850|NCT02120950|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974851|NCT02120950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974852|NCT02120950|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91974853|NCT02120950|Dermatologic Agents|dermatologic agents|mesh-ancestor
91974854|NCT02120794|Insulin|insulin|mesh-list
91974855|NCT02120794|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91974856|NCT02120794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974857|NCT03053583|Pyrithione zinc|pyrithione zinc|mesh-list
91974858|NCT03053583|Keratolytic Agents|keratolytic agents|mesh-ancestor
91974859|NCT03053583|Dermatologic Agents|dermatologic agents|mesh-ancestor
91974860|NCT04900311|Paclitaxel|paclitaxel|mesh-list
91974861|NCT04900311|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91974862|NCT04900311|Trastuzumab|trastuzumab|mesh-list
91974863|NCT04900311|Pertuzumab|pertuzumab|mesh-list
91974864|NCT04900311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91974865|NCT04900311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974866|NCT04900311|Tubulin Modulators|tubulin modulators|mesh-ancestor
91974867|NCT04900311|Antimitotic Agents|antimitotic agents|mesh-ancestor
91974874|NCT04900155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91974875|NCT04900155|Antimetabolites|antimetabolites|mesh-ancestor
91974876|NCT04900155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974877|NCT04900155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91974878|NCT04900155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91974879|NCT04900155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974881|NCT02155738|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91974883|NCT02155738|Sensory System Agents|sensory system agents|mesh-ancestor
91953123|NCT05109585|Immunologic Factors|immunologic factors|mesh-ancestor
91953124|NCT05109585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953125|NCT02142803|Bevacizumab|bevacizumab|mesh-list
91953126|NCT02142803|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91953127|NCT02142803|Endothelial Growth Factors|endothelial growth factors|mesh-list
91953128|NCT02142803|Antibodies|antibodies|mesh-list
91953129|NCT02142803|Immunoglobulins|immunoglobulins|mesh-list
91953130|NCT02142803|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91953131|NCT02142803|Immunoglobulin G|immunoglobulin g|mesh-list
91953132|NCT02142803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953133|NCT02142803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91953134|NCT02142803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91953135|NCT02142803|Growth Substances|growth substances|mesh-ancestor
91953136|NCT02142803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953137|NCT02142803|Growth Inhibitors|growth inhibitors|mesh-ancestor
91953138|NCT02142803|Immunologic Factors|immunologic factors|mesh-ancestor
91953139|NCT05283161|Dronabinol|dronabinol|mesh-list
91953140|NCT05283161|Cannabidiol|cannabidiol|mesh-list
91953141|NCT05283161|Anticonvulsants|anticonvulsants|mesh-ancestor
91953142|NCT05283161|Hallucinogens|hallucinogens|mesh-ancestor
91953181|NCT05184335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91953182|NCT05184335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953183|NCT05184335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953184|NCT05184335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953185|NCT05184335|Serotonin Agents|serotonin agents|mesh-ancestor
91953186|NCT05184335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953187|NCT05184335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953188|NCT03443609|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91953189|NCT03443609|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91953190|NCT03443609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953191|NCT01709123|Chromium|chromium|mesh-list
91953192|NCT01709123|Trace Elements|trace elements|mesh-ancestor
91953193|NCT01709123|Micronutrients|micronutrients|mesh-ancestor
91953194|NCT01709123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953241|NCT04923737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953242|NCT04923737|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91953243|NCT04923737|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91953244|NCT04923737|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91953245|NCT04923737|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953246|NCT04923737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953247|NCT04923737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953248|NCT02452424|Pembrolizumab|pembrolizumab|mesh-list
91953249|NCT02452424|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953250|NCT02452424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953251|NCT02452424|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953252|NCT02452424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953253|NCT04921943|Azithromycin|azithromycin|mesh-list
91953254|NCT04921943|Rifampin|rifampin|mesh-list
91953255|NCT04921943|Ethambutol|ethambutol|mesh-list
91953298|NCT03441815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953299|NCT02426918|Vancomycin|vancomycin|mesh-list
91953300|NCT02426918|Linezolid|linezolid|mesh-list
91953301|NCT02426918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91953302|NCT02426918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953303|NCT02426918|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91953304|NCT02426918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953305|NCT02426918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953306|NCT02387762|Methotrexate|methotrexate|mesh-list
91953307|NCT02387762|Acalabrutinib|acalabrutinib|mesh-list
91953308|NCT02387762|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91953309|NCT02387762|Abortifacient Agents|abortifacient agents|mesh-ancestor
91953310|NCT02387762|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91953311|NCT02387762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953357|NCT04807673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953358|NCT04807673|Tubulin Modulators|tubulin modulators|mesh-ancestor
91953359|NCT04807673|Antimitotic Agents|antimitotic agents|mesh-ancestor
91953360|NCT04807673|Mitosis Modulators|mitosis modulators|mesh-ancestor
91953361|NCT04807673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953362|NCT04807673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91953363|NCT04807673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91953364|NCT02656173|Tamsulosin|tamsulosin|mesh-list
91953365|NCT02656173|Mirabegron|mirabegron|mesh-list
91953423|NCT03439787|Respiratory System Agents|respiratory system agents|mesh-ancestor
91953425|NCT03439787|Sympathomimetics|sympathomimetics|mesh-ancestor
91953426|NCT03439787|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91953427|NCT05082155|Bupivacaine|bupivacaine|mesh-list
91953428|NCT05082155|Anesthetics, Local|anesthetics, local|mesh-ancestor
91953429|NCT05082155|Anesthetics|anesthetics|mesh-ancestor
91953430|NCT05082155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953431|NCT05082155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953432|NCT05082155|Sensory System Agents|sensory system agents|mesh-ancestor
91953433|NCT05082155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953434|NCT02656017|Metformin|metformin|mesh-list
91953435|NCT02656017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91953436|NCT02656017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953437|NCT03439709|Lanreotide|lanreotide|mesh-list
91953438|NCT03439709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953439|NCT04451447|SMOFlipid|smoflipid|mesh-list
91953440|NCT04451447|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91953441|NCT04451447|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91953479|NCT04542837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953480|NCT02655237|Leuprolide|leuprolide|mesh-list
91953481|NCT02655237|Relugolix|relugolix|mesh-list
91953482|NCT02655237|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91953483|NCT02655237|Fertility Agents|fertility agents|mesh-ancestor
91953484|NCT02655237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91953485|NCT02655237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953486|NCT02655237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91953487|NCT02655237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91953488|NCT02655237|Androgen Antagonists|androgen antagonists|mesh-ancestor
91953489|NCT02655237|Hormone Antagonists|hormone antagonists|mesh-ancestor
91953490|NCT02655237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91953491|NCT03890133|Pregabalin|pregabalin|mesh-list
91953492|NCT03890133|Analgesics|analgesics|mesh-ancestor
91953493|NCT03890133|Sensory System Agents|sensory system agents|mesh-ancestor
91953494|NCT03890133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953495|NCT03890133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953537|NCT03443843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953538|NCT03443843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953539|NCT03443843|Nasal Decongestants|nasal decongestants|mesh-ancestor
91953540|NCT03443843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91953541|NCT03443843|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91953543|NCT03443843|Adrenergic Agents|adrenergic agents|mesh-ancestor
91953544|NCT03438227|Dextrans|dextrans|mesh-list
91953545|NCT03438227|Iron-Dextran Complex|iron-dextran complex|mesh-list
91953546|NCT03438227|Anticoagulants|anticoagulants|mesh-ancestor
91953547|NCT03438227|Plasma Substitutes|plasma substitutes|mesh-ancestor
91953548|NCT03438227|Blood Substitutes|blood substitutes|mesh-ancestor
91953599|NCT02657031|Antipruritics|antipruritics|mesh-ancestor
91953600|NCT02657031|Dermatologic Agents|dermatologic agents|mesh-ancestor
91953601|NCT02657031|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91953602|NCT02657031|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91953603|NCT02657031|Serotonin Agents|serotonin agents|mesh-ancestor
91953604|NCT02657031|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91953605|NCT02657031|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91953606|NCT02657031|Anesthetics, Local|anesthetics, local|mesh-ancestor
91953607|NCT02657031|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91953608|NCT02657031|Histamine Antagonists|histamine antagonists|mesh-ancestor
91953609|NCT02657031|Histamine Agents|histamine agents|mesh-ancestor
91953610|NCT02657031|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91953611|NCT02657031|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91953612|NCT02657031|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91953650|NCT03797469|Niacin|niacin|mesh-list
91953660|NCT03797469|Vasodilator Agents|vasodilator agents|mesh-ancestor
91953662|NCT03432923|Anesthetics, Local|anesthetics, local|mesh-ancestor
91953663|NCT03432923|Anesthetics|anesthetics|mesh-ancestor
91953664|NCT03432923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953665|NCT03432923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953666|NCT03432923|Sensory System Agents|sensory system agents|mesh-ancestor
91953667|NCT03432923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953668|NCT02384577|Budesonide|budesonide|mesh-list
91953669|NCT02384577|Formoterol Fumarate|formoterol fumarate|mesh-list
91953670|NCT02384577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953671|NCT02384577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91953672|NCT02384577|Autonomic Agents|autonomic agents|mesh-ancestor
91953673|NCT02384577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953674|NCT02384577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953720|NCT03437057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953721|NCT03437057|Antipyretics|antipyretics|mesh-ancestor
91953722|NCT03579693|Niacinamide|niacinamide|mesh-list
91953723|NCT03579693|Niacin|niacin|mesh-list
91953724|NCT03579693|Nicotinic Acids|nicotinic acids|mesh-list
91953725|NCT03579693|Coenzyme Q10|coenzyme q10|mesh-list
91953726|NCT03579693|Vitamin B Complex|vitamin b complex|mesh-ancestor
91953727|NCT03579693|Vitamins|vitamins|mesh-ancestor
91953728|NCT03579693|Micronutrients|micronutrients|mesh-ancestor
91953729|NCT03579693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953730|NCT03579693|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91953731|NCT03579693|Antimetabolites|antimetabolites|mesh-ancestor
91953732|NCT03579693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953733|NCT03579693|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91953734|NCT03579693|Vasodilator Agents|vasodilator agents|mesh-ancestor
91953736|NCT03432689|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91953737|NCT03432689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953743|NCT02991807|Everolimus|everolimus|mesh-list
91953777|NCT03432221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953778|NCT03432221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953779|NCT03432221|Antidepressive Agents|antidepressive agents|mesh-ancestor
91953780|NCT03432221|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953782|NCT05112471|Vasodilator Agents|vasodilator agents|mesh-ancestor
91953783|NCT04360421|Bupivacaine|bupivacaine|mesh-list
91953784|NCT04360421|Anesthetics, Local|anesthetics, local|mesh-ancestor
91953785|NCT04360421|Anesthetics|anesthetics|mesh-ancestor
91953786|NCT04360421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953787|NCT04360421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953841|NCT03436121|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91953842|NCT03436121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953843|NCT03436121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953844|NCT03436121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91953845|NCT03436121|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91953846|NCT03436121|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91953847|NCT03436121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91953848|NCT03436121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91953850|NCT03436121|GABA Agents|gaba agents|mesh-ancestor
91953851|NCT02417246|Metoprolol|metoprolol|mesh-list
91953852|NCT02417246|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91953853|NCT02417246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91953854|NCT02417246|Sympatholytics|sympatholytics|mesh-ancestor
91953855|NCT02417246|Autonomic Agents|autonomic agents|mesh-ancestor
91953856|NCT02417246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953864|NCT03431675|Ciprofloxacin|ciprofloxacin|mesh-list
91953900|NCT03431285|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91953901|NCT03431285|Anesthetics, General|anesthetics, general|mesh-ancestor
91953902|NCT03431285|Anesthetics|anesthetics|mesh-ancestor
91953903|NCT03431285|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91953904|NCT03431285|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91953905|NCT03431285|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91953906|NCT03431285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953907|NCT03431285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953908|NCT03431285|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91953909|NCT03431285|Narcotics|narcotics|mesh-ancestor
91953910|NCT02416934|Dexamethasone|dexamethasone|mesh-list
91953911|NCT02416934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953912|NCT02416934|Antiemetics|antiemetics|mesh-ancestor
91953913|NCT02416934|Autonomic Agents|autonomic agents|mesh-ancestor
91953914|NCT02416934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953915|NCT02416934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953916|NCT02416934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91953917|NCT02416934|Glucocorticoids|glucocorticoids|mesh-ancestor
91953918|NCT02416934|Hormones|hormones|mesh-ancestor
91953920|NCT02416934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91953954|NCT02424344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953955|NCT02424344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953956|NCT03861611|Ibuprofen|ibuprofen|mesh-list
91953957|NCT03861611|Diclofenac|diclofenac|mesh-list
91953958|NCT03861611|Ketorolac|ketorolac|mesh-list
91953959|NCT03861611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91953960|NCT03861611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91953961|NCT03861611|Analgesics|analgesics|mesh-ancestor
91953962|NCT03861611|Sensory System Agents|sensory system agents|mesh-ancestor
91953963|NCT03861611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91953964|NCT03861611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91953965|NCT03861611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91953966|NCT03861611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91953967|NCT03861611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91953968|NCT03861611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91953969|NCT03861611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91953970|NCT03430817|Amantadine|amantadine|mesh-list
91953971|NCT03430817|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
91953972|NCT03430817|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91953973|NCT03430817|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91953974|NCT03430817|Antiviral Agents|antiviral agents|mesh-ancestor
91953975|NCT03430817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91953976|NCT03430817|Dopamine Agents|dopamine agents|mesh-ancestor
91953977|NCT03430817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91953978|NCT03430817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954001|NCT03430505|Autonomic Agents|autonomic agents|mesh-ancestor
91954002|NCT03430505|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954003|NCT03430505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954004|NCT03430505|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91954005|NCT03430505|Respiratory System Agents|respiratory system agents|mesh-ancestor
91954006|NCT03430505|Tocolytic Agents|tocolytic agents|mesh-ancestor
91954007|NCT03430505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91954008|NCT03430505|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91954009|NCT03430505|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91954010|NCT03430505|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91954011|NCT03430505|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954012|NCT03430505|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954013|NCT03430505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954014|NCT03434951|Morphine|morphine|mesh-list
91954015|NCT03434951|Bupivacaine|bupivacaine|mesh-list
91954016|NCT03434951|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954017|NCT03434951|Anesthetics|anesthetics|mesh-ancestor
91954018|NCT03434951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954019|NCT03434951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954020|NCT03434951|Sensory System Agents|sensory system agents|mesh-ancestor
91954021|NCT03434951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954022|NCT03434951|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954023|NCT03434951|Narcotics|narcotics|mesh-ancestor
91954024|NCT03434951|Analgesics|analgesics|mesh-ancestor
91954025|NCT02234323|Factor VIII|factor viii|mesh-list
91954026|NCT02234323|Coagulants|coagulants|mesh-ancestor
91954027|NCT03434405|Psychotropic Drugs|psychotropic drugs|mesh-list
91954028|NCT02413346|Sarecycline|sarecycline|mesh-list
91954029|NCT02413346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954030|NCT02413346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954031|NCT02413346|Dermatologic Agents|dermatologic agents|mesh-ancestor
91954032|NCT03433859|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91954033|NCT03433859|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91954034|NCT03433859|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91954035|NCT03433859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954036|NCT03433859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954037|NCT03433859|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91954038|NCT03433859|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954039|NCT03433859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954040|NCT03433859|Cholinergic Agents|cholinergic agents|mesh-ancestor
91954041|NCT03433859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954043|NCT03429179|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954096|NCT02412878|Antiemetics|antiemetics|mesh-ancestor
91954097|NCT02412878|Autonomic Agents|autonomic agents|mesh-ancestor
91954098|NCT02412878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954099|NCT02412878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954100|NCT02412878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954101|NCT02412878|Glucocorticoids|glucocorticoids|mesh-ancestor
91954103|NCT02412878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954104|NCT02412878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91954105|NCT02412878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954106|NCT03423329|Ibuprofen|ibuprofen|mesh-list
91954107|NCT03423329|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954108|NCT03423329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954118|NCT02380742|Lidocaine|lidocaine|mesh-list
91954155|NCT02922725|Antidepressive Agents|antidepressive agents|mesh-ancestor
91954156|NCT02922725|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91954157|NCT03422315|Propofol|propofol|mesh-list
91954158|NCT03422315|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91954159|NCT03422315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954160|NCT03422315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954161|NCT03422315|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91954162|NCT03422315|Anesthetics, General|anesthetics, general|mesh-ancestor
91954163|NCT03422315|Anesthetics|anesthetics|mesh-ancestor
91954164|NCT03427385|Ropivacaine|ropivacaine|mesh-list
91954165|NCT03427385|Anesthetics, Local|anesthetics, local|mesh-ancestor
91954166|NCT03427385|Anesthetics|anesthetics|mesh-ancestor
91954220|NCT02636387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954221|NCT03425747|Calcium, Dietary|calcium, dietary|mesh-list
91954222|NCT03425747|Calcium Carbonate|calcium carbonate|mesh-list
91954223|NCT03425747|Calcium|calcium|mesh-list
91954224|NCT03425747|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91954225|NCT03425747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954226|NCT03425747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91954227|NCT03425747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954228|NCT03425747|Antacids|antacids|mesh-ancestor
91954229|NCT03425747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954230|NCT03425669|Methylphenidate|methylphenidate|mesh-list
91954231|NCT03425669|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91954232|NCT03425669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954233|NCT03425669|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91954234|NCT03425669|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91954278|NCT03441841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954279|NCT03441841|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
91954280|NCT02692339|Dexamethasone|dexamethasone|mesh-list
91954281|NCT02692339|Lenalidomide|lenalidomide|mesh-list
91954282|NCT02692339|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954283|NCT02692339|Antiemetics|antiemetics|mesh-ancestor
91954284|NCT02692339|Autonomic Agents|autonomic agents|mesh-ancestor
91954285|NCT02692339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954286|NCT02692339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954287|NCT02692339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954288|NCT02692339|Glucocorticoids|glucocorticoids|mesh-ancestor
91954290|NCT02692339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954291|NCT02692339|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91954292|NCT02692339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954293|NCT02692339|Immunologic Factors|immunologic factors|mesh-ancestor
91954294|NCT02692339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91954295|NCT02692339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91954334|NCT03449719|Abiraterone Acetate|abiraterone acetate|mesh-list
91954335|NCT03449719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954336|NCT03449719|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91954337|NCT03449719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954338|NCT03449719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954339|NCT03449719|Hormone Antagonists|hormone antagonists|mesh-ancestor
91954340|NCT03449719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954341|NCT03449719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954342|NCT03449719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91954344|NCT03437785|Rebamipide|rebamipide|mesh-list
91954345|NCT03437785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91954346|NCT03437785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954347|NCT03437785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954348|NCT03437785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954349|NCT03437785|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91954350|NCT03437785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954351|NCT03437785|Antioxidants|antioxidants|mesh-ancestor
91954355|NCT03437707|Acetaminophen|acetaminophen|mesh-list
91954388|NCT03441217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954389|NCT03441217|Mydriatics|mydriatics|mesh-ancestor
91954390|NCT03441217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91954391|NCT03441217|Cholinergic Agents|cholinergic agents|mesh-ancestor
91954392|NCT03441217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954393|NCT03441217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954394|NCT03441217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91954395|NCT03441217|Parasympatholytics|parasympatholytics|mesh-ancestor
91954396|NCT03128515|Hydroxyurea|hydroxyurea|mesh-list
91954397|NCT03128515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954402|NCT02521441|Lenograstim|lenograstim|mesh-list
91954450|NCT03432793|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91954451|NCT03432793|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91954452|NCT03432793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91954453|NCT03432793|Serotonin Agents|serotonin agents|mesh-ancestor
91954454|NCT03432793|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91954455|NCT03432793|Antidepressive Agents|antidepressive agents|mesh-ancestor
91954456|NCT03432793|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91954457|NCT03432793|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91954458|NCT03436693|Canagliflozin|canagliflozin|mesh-list
91954459|NCT03436693|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91954460|NCT03436693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954461|NCT03436693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91954462|NCT03436693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954463|NCT03432637|Anesthetics|anesthetics|mesh-list
91954464|NCT03432637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954465|NCT03432637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954466|NCT03436303|Dydrogesterone|dydrogesterone|mesh-list
91954504|NCT03440359|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91954505|NCT03440359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954506|NCT03440359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954507|NCT03440359|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91954508|NCT03440359|Hormone Antagonists|hormone antagonists|mesh-ancestor
91954509|NCT03440359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954510|NCT03440359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954511|NCT03440359|Progestins|progestins|mesh-ancestor
91954512|NCT03440359|Hormones|hormones|mesh-ancestor
91954513|NCT03431701|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91954514|NCT03431701|Chlorhexidine|chlorhexidine|mesh-list
91954515|NCT03431701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954516|NCT03431701|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91954517|NCT03431701|Disinfectants|disinfectants|mesh-ancestor
91954518|NCT03431623|Darbepoetin alfa|darbepoetin alfa|mesh-list
91954519|NCT03431623|Hematinics|hematinics|mesh-ancestor
91954520|NCT04451395|Micronutrients|micronutrients|mesh-list
91954521|NCT04451395|Trace Elements|trace elements|mesh-list
91954522|NCT04451395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954523|NCT04451083|Camostat|camostat|mesh-list
91954524|NCT04451083|Protease Inhibitors|protease inhibitors|mesh-ancestor
91954558|NCT03439501|Avelumab|avelumab|mesh-list
91954559|NCT03439501|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91954560|NCT03439501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954561|NCT03430687|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
91954562|NCT03430687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91954563|NCT03430687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954564|NCT04255381|Pancrelipase|pancrelipase|mesh-list
91954565|NCT04255381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91954566|NCT03757897|Dexmedetomidine|dexmedetomidine|mesh-list
91954567|NCT03757897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91954568|NCT03757897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954569|NCT03757897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954570|NCT03757897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954571|NCT03757897|Analgesics|analgesics|mesh-ancestor
91954572|NCT03757897|Sensory System Agents|sensory system agents|mesh-ancestor
91954573|NCT03757897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954574|NCT03757897|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91954575|NCT03757897|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91954576|NCT03757897|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91954577|NCT03757897|Adrenergic Agents|adrenergic agents|mesh-ancestor
91954578|NCT03757897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954579|NCT03757897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954580|NCT03434197|Diclofenac|diclofenac|mesh-list
91954581|NCT03434197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954582|NCT03434197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954583|NCT03434197|Analgesics|analgesics|mesh-ancestor
91954584|NCT03434197|Sensory System Agents|sensory system agents|mesh-ancestor
91954585|NCT03434197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954586|NCT03434197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954587|NCT03434197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954588|NCT03434197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954589|NCT03434197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91954590|NCT03434197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954597|NCT03438955|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91954598|NCT03438955|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91954599|NCT03438955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954600|NCT03430297|Dacarbazine|dacarbazine|mesh-list
91954601|NCT03430297|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91954602|NCT03430297|Alkylating Agents|alkylating agents|mesh-ancestor
91954603|NCT03430297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954604|NCT03430297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954605|NCT04219735|Minocycline|minocycline|mesh-list
91954606|NCT04219735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954607|NCT04219735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954608|NCT04449757|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91954610|NCT03621553|Ergocalciferols|ergocalciferols|mesh-list
91954611|NCT03621553|Cholecalciferol|cholecalciferol|mesh-list
91954612|NCT03621553|Vitamins|vitamins|mesh-list
91954613|NCT03621553|Micronutrients|micronutrients|mesh-ancestor
91954614|NCT03621553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954615|NCT03621553|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91954616|NCT03621553|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91954629|NCT01559363|XL647|xl647|mesh-list
91954650|NCT01504919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954651|NCT02732327|Vancomycin|vancomycin|mesh-list
91954652|NCT02732327|Meropenem|meropenem|mesh-list
91954653|NCT02732327|Linezolid|linezolid|mesh-list
91954654|NCT02732327|Tazobactam|tazobactam|mesh-list
91954655|NCT02732327|Piperacillin|piperacillin|mesh-list
91954656|NCT02732327|Cefepime|cefepime|mesh-list
91954657|NCT02732327|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
91954658|NCT02732327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954659|NCT02732327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954660|NCT02732327|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91954661|NCT02732327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954662|NCT02732327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954663|NCT02732327|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91954664|NCT03428503|Acetaminophen|acetaminophen|mesh-list
91954665|NCT03428503|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91954666|NCT03428503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954667|NCT03428503|Analgesics|analgesics|mesh-ancestor
91954709|NCT03422887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954710|NCT03422887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954711|NCT03422887|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91954712|NCT03422887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954713|NCT03422887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954714|NCT02521207|Ibuprofen|ibuprofen|mesh-list
91954715|NCT02521207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91954716|NCT02521207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91954717|NCT02521207|Analgesics|analgesics|mesh-ancestor
91954718|NCT02521207|Sensory System Agents|sensory system agents|mesh-ancestor
91954719|NCT02521207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954720|NCT02521207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954721|NCT02521207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954722|NCT02521207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954723|NCT02521207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91954724|NCT02521207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954725|NCT02521207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954727|NCT03179605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91954728|NCT03179605|Glucocorticoids|glucocorticoids|mesh-ancestor
91954729|NCT03179605|Hormones|hormones|mesh-ancestor
91954730|NCT03179605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91954760|NCT03173053|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91954761|NCT03173053|Antitubercular Agents|antitubercular agents|mesh-ancestor
91954762|NCT03173053|Leprostatic Agents|leprostatic agents|mesh-ancestor
91954763|NCT03173053|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91954764|NCT03173053|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91954765|NCT03173053|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91954766|NCT03173053|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91954767|NCT03173053|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91954768|NCT03173053|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91954821|NCT03422575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91954822|NCT03422575|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91954823|NCT03422575|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91954824|NCT03422575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954825|NCT03422575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954826|NCT02412722|Paclitaxel|paclitaxel|mesh-list
91954827|NCT02412722|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91954828|NCT02412722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954829|NCT02412722|Tubulin Modulators|tubulin modulators|mesh-ancestor
91954830|NCT02412722|Antimitotic Agents|antimitotic agents|mesh-ancestor
91954831|NCT02412722|Mitosis Modulators|mitosis modulators|mesh-ancestor
91954832|NCT02412722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954833|NCT03422419|Heparin|heparin|mesh-list
91954834|NCT03422419|Anticoagulants|anticoagulants|mesh-ancestor
91954835|NCT03422419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91954836|NCT03422419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91954838|NCT04449289|Lidocaine|lidocaine|mesh-list
91954878|NCT03463993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954879|NCT03463993|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91954880|NCT03463993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91954881|NCT03463993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954883|NCT03463993|Coagulants|coagulants|mesh-ancestor
91954884|NCT03422029|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
91954885|NCT03422029|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91954886|NCT03422029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954887|NCT03417037|Nivolumab|nivolumab|mesh-list
91954888|NCT03417037|Linrodostat|linrodostat|mesh-list
91954889|NCT03417037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91954890|NCT03417037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954891|NCT03417037|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91954892|NCT03417037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954937|NCT03416491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954938|NCT03420937|Atropine|atropine|mesh-list
91954939|NCT03420937|Neostigmine|neostigmine|mesh-list
91954940|NCT03420937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91954941|NCT03420937|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91954942|NCT03420937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91954943|NCT03420937|Autonomic Agents|autonomic agents|mesh-ancestor
91954944|NCT03420937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954945|NCT03420937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954946|NCT03420937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91954947|NCT03420937|Respiratory System Agents|respiratory system agents|mesh-ancestor
91954948|NCT03420937|Mydriatics|mydriatics|mesh-ancestor
91954949|NCT03420937|Parasympatholytics|parasympatholytics|mesh-ancestor
91954950|NCT03420937|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91954951|NCT03420937|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91954952|NCT03420937|Cholinergic Agents|cholinergic agents|mesh-ancestor
91954953|NCT03420937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954954|NCT03420937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91954955|NCT03420937|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91954956|NCT03420937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954957|NCT03420937|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91954958|NCT02900443|Mycophenolic Acid|mycophenolic acid|mesh-list
91954960|NCT02900443|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91954961|NCT02900443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91954962|NCT02900443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91954963|NCT02900443|Antitubercular Agents|antitubercular agents|mesh-ancestor
91954964|NCT02900443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91954965|NCT02900443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91954966|NCT02900443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91954982|NCT04594213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91954983|NCT04594213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954984|NCT04594213|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91954985|NCT04594213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954986|NCT03420703|Morphine|morphine|mesh-list
91954987|NCT03420703|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91954988|NCT03420703|Narcotics|narcotics|mesh-ancestor
91954989|NCT03420703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91954990|NCT03420703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91954992|NCT03420703|Sensory System Agents|sensory system agents|mesh-ancestor
91954993|NCT03420703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91954994|NCT03420469|Bupropion|bupropion|mesh-list
91954995|NCT03420469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91954996|NCT03420469|Antidepressive Agents|antidepressive agents|mesh-ancestor
91954997|NCT03420469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91954998|NCT03420469|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91954999|NCT03420469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91955000|NCT03420469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91955001|NCT03420469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955002|NCT03420469|Dopamine Agents|dopamine agents|mesh-ancestor
91955003|NCT03420469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955004|NCT03420469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955005|NCT03420469|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91955006|NCT03420469|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91955007|NCT03420469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955008|NCT03427021|Oxaliplatin|oxaliplatin|mesh-list
91955009|NCT03427021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955010|NCT03415711|Mesalamine|mesalamine|mesh-list
91955013|NCT03415711|Analgesics|analgesics|mesh-ancestor
91955027|NCT03420313|Sensory System Agents|sensory system agents|mesh-ancestor
91955028|NCT03420313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955029|NCT03420313|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91955030|NCT03415555|Acetaminophen|acetaminophen|mesh-list
91955031|NCT03415555|Oxycodone|oxycodone|mesh-list
91955032|NCT03415555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955033|NCT03415555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955034|NCT03415555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91955035|NCT03415555|Analgesics|analgesics|mesh-ancestor
91955036|NCT03415555|Sensory System Agents|sensory system agents|mesh-ancestor
91955037|NCT03415555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955038|NCT03415555|Antipyretics|antipyretics|mesh-ancestor
91955039|NCT03415555|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91955040|NCT03415555|Narcotics|narcotics|mesh-ancestor
91955041|NCT03415477|Denosumab|denosumab|mesh-list
91955042|NCT03415477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91955087|NCT03419767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955088|NCT03419767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955089|NCT03414931|Sertraline|sertraline|mesh-list
91955090|NCT03414931|Antidepressive Agents|antidepressive agents|mesh-ancestor
91955091|NCT03414931|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91955092|NCT03414931|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91955093|NCT03414931|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91955094|NCT03414931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91955095|NCT03414931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955096|NCT03414931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955097|NCT03414931|Serotonin Agents|serotonin agents|mesh-ancestor
91955897|NCT03407521|Abortifacient Agents|abortifacient agents|mesh-ancestor
91955098|NCT03414931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955099|NCT04448821|Metformin|metformin|mesh-list
91955145|NCT03127189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91955146|NCT02521051|Bevacizumab|bevacizumab|mesh-list
91955147|NCT02521051|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91955148|NCT02521051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955149|NCT02521051|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91955150|NCT02521051|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91955151|NCT02521051|Growth Substances|growth substances|mesh-ancestor
91955152|NCT02521051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955153|NCT02521051|Growth Inhibitors|growth inhibitors|mesh-ancestor
91955154|NCT01239797|Dexamethasone|dexamethasone|mesh-list
91955155|NCT01239797|Dexamethasone acetate|dexamethasone acetate|mesh-list
91955156|NCT01239797|Lenalidomide|lenalidomide|mesh-list
91955157|NCT01239797|Elotuzumab|elotuzumab|mesh-list
91955158|NCT01239797|BB 1101|bb 1101|mesh-list
91955159|NCT01239797|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91955160|NCT01239797|Antiemetics|antiemetics|mesh-ancestor
91955161|NCT01239797|Autonomic Agents|autonomic agents|mesh-ancestor
91955164|NCT01239797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955205|NCT00950989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955206|NCT00950989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955207|NCT00950989|Dermatologic Agents|dermatologic agents|mesh-ancestor
91955208|NCT00950989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955209|NCT00950989|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91955210|NCT00950989|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91955211|NCT00950989|Immunologic Factors|immunologic factors|mesh-ancestor
91955212|NCT00950989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91955213|NCT00950989|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955214|NCT00950989|Hematinics|hematinics|mesh-ancestor
91955215|NCT00950989|Vitamin B Complex|vitamin b complex|mesh-ancestor
91955216|NCT00950989|Vitamins|vitamins|mesh-ancestor
91955217|NCT00950989|Micronutrients|micronutrients|mesh-ancestor
91955218|NCT03420911|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91955219|NCT03420911|Midazolam|midazolam|mesh-list
91955220|NCT03420911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91955221|NCT03420911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91955222|NCT03420911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955223|NCT03420911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955224|NCT03420911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91955229|NCT03420911|Anesthetics|anesthetics|mesh-ancestor
91955262|NCT03415763|Micronutrients|micronutrients|mesh-ancestor
91955263|NCT00593567|Levofloxacin|levofloxacin|mesh-list
91955264|NCT00593567|Gentamicins|gentamicins|mesh-list
91955265|NCT00593567|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91955266|NCT00593567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955267|NCT00593567|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91955268|NCT00593567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91955269|NCT00593567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91955270|NCT00593567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955271|NCT00593567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955272|NCT00593567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955273|NCT00593567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91955274|NCT00593567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91955275|NCT00593567|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91955276|NCT03419975|Latanoprost|latanoprost|mesh-list
91955277|NCT03419975|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91955278|NCT03419975|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91955279|NCT00006455|Leucovorin|leucovorin|mesh-list
91955318|NCT00006455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955319|NCT00006455|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91955320|NCT00006455|Antimetabolites|antimetabolites|mesh-ancestor
91955321|NCT00006455|Dermatologic Agents|dermatologic agents|mesh-ancestor
91955322|NCT00006455|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91955323|NCT00006455|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91955324|NCT00006455|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91955325|NCT00006455|Antiviral Agents|antiviral agents|mesh-ancestor
91955326|NCT00006455|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955327|NCT00006455|Antidotes|antidotes|mesh-ancestor
91955328|NCT00006455|Protective Agents|protective agents|mesh-ancestor
91955329|NCT00006455|Vitamin B Complex|vitamin b complex|mesh-ancestor
91955330|NCT00006455|Vitamins|vitamins|mesh-ancestor
91955331|NCT00006455|Micronutrients|micronutrients|mesh-ancestor
91955332|NCT00006455|Tubulin Modulators|tubulin modulators|mesh-ancestor
91955333|NCT00006455|Antimitotic Agents|antimitotic agents|mesh-ancestor
91955334|NCT00006455|Mitosis Modulators|mitosis modulators|mesh-ancestor
91955335|NCT01602315|Cetuximab|cetuximab|mesh-list
91955336|NCT01602315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91955337|NCT01602315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955338|NCT02537197|Naltrexone|naltrexone|mesh-list
91955339|NCT02537197|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91955340|NCT02537197|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91955341|NCT02537197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955369|NCT05116995|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91955370|NCT05116995|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91955371|NCT05116995|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91955372|NCT05116995|Purinergic Agents|purinergic agents|mesh-ancestor
91955373|NCT05116995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955374|NCT05116995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955375|NCT05116995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955376|NCT05116995|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91955377|NCT05116995|Antithrombins|antithrombins|mesh-ancestor
91955378|NCT05116995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91955431|NCT01328093|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91955432|NCT03417427|Cytarabine|cytarabine|mesh-list
91955433|NCT03417427|Decitabine|decitabine|mesh-list
91955434|NCT03417427|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91955435|NCT03417427|Antimetabolites|antimetabolites|mesh-ancestor
91955436|NCT03417427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955437|NCT03417427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955438|NCT03417427|Antiviral Agents|antiviral agents|mesh-ancestor
91955439|NCT03417427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91955440|NCT03417427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91955441|NCT03417427|Immunologic Factors|immunologic factors|mesh-ancestor
91955445|NCT03425617|Olodaterol|olodaterol|mesh-list
91955493|NCT05122455|Antithrombins|antithrombins|mesh-ancestor
91955494|NCT05122455|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91955495|NCT05122455|Protease Inhibitors|protease inhibitors|mesh-ancestor
91955496|NCT05122455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955497|NCT05122455|Anticoagulants|anticoagulants|mesh-ancestor
91955498|NCT03413059|Triamcinolone|triamcinolone|mesh-list
91955499|NCT03413059|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91955500|NCT03413059|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91955501|NCT03413059|Morphine|morphine|mesh-list
91955502|NCT03413059|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91955503|NCT03413059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91955504|NCT03413059|Narcotics|narcotics|mesh-ancestor
91955505|NCT03413059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955506|NCT03413059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955557|NCT04753437|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955558|NCT03411109|Hydromorphone|hydromorphone|mesh-list
91955559|NCT03411109|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91955560|NCT03411109|Narcotics|narcotics|mesh-ancestor
91955561|NCT03411109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955562|NCT03411109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955563|NCT03411109|Analgesics|analgesics|mesh-ancestor
91955564|NCT03411109|Sensory System Agents|sensory system agents|mesh-ancestor
91955565|NCT03411109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955566|NCT01111565|Aripiprazole|aripiprazole|mesh-list
91955567|NCT01111565|Escitalopram|escitalopram|mesh-list
91955568|NCT01111565|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91955569|NCT01111565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91955570|NCT01111565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91955571|NCT01111565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955572|NCT01111565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955573|NCT01111565|Serotonin Agents|serotonin agents|mesh-ancestor
91955574|NCT01111565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955575|NCT01111565|Antidepressive Agents|antidepressive agents|mesh-ancestor
91955576|NCT01111565|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91955577|NCT01111565|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91955578|NCT01111565|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91955579|NCT01111565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91955580|NCT01111565|Dopamine Agonists|dopamine agonists|mesh-ancestor
91955581|NCT01111565|Dopamine Agents|dopamine agents|mesh-ancestor
91955582|NCT01111565|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91955583|NCT01111565|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91955584|NCT01111565|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91955585|NCT01111565|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91955586|NCT01111565|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91955587|NCT01111565|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91955596|NCT03412513|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91955597|NCT03412513|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91955598|NCT03412513|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956199|NCT05188053|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91955599|NCT03412513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955600|NCT03412513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955601|NCT03412513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955602|NCT03412513|Urological Agents|urological agents|mesh-ancestor
91955603|NCT04370379|Aflibercept|aflibercept|mesh-list
91955604|NCT04370379|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91955605|NCT04370379|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91955606|NCT04370379|Growth Substances|growth substances|mesh-ancestor
91955607|NCT04370379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955608|NCT04370379|Growth Inhibitors|growth inhibitors|mesh-ancestor
91955614|NCT03413891|Hemostatics|hemostatics|mesh-ancestor
91955657|NCT02343458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955658|NCT02343458|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91955659|NCT02343458|Respiratory System Agents|respiratory system agents|mesh-ancestor
91955660|NCT02343458|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91955661|NCT02343458|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91955662|NCT02343458|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91955663|NCT02343458|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955664|NCT02343458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955665|NCT02343458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955666|NCT02343458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91955667|NCT02343458|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91955668|NCT02343458|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91955669|NCT02343458|Cholinergic Agents|cholinergic agents|mesh-ancestor
91955671|NCT03424759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955672|NCT03424759|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955673|NCT03424759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955674|NCT03424759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955715|NCT04431141|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91955716|NCT04431141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955717|NCT05229627|Methylphenidate|methylphenidate|mesh-list
91955718|NCT05229627|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91955719|NCT05229627|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91955720|NCT05229627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955721|NCT05229627|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91955722|NCT05229627|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91955723|NCT05229627|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91955724|NCT05229627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955725|NCT05229627|Dopamine Agents|dopamine agents|mesh-ancestor
91955726|NCT05229627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91955727|NCT05229627|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91955728|NCT05229627|Adrenergic Agents|adrenergic agents|mesh-ancestor
91955729|NCT01976169|Palbociclib|palbociclib|mesh-list
91955736|NCT01976169|Immunotoxins|immunotoxins|mesh-ancestor
91955774|NCT03412721|Sensory System Agents|sensory system agents|mesh-ancestor
91955775|NCT03412721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91955776|NCT03412721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955777|NCT03418337|Lansoprazole|lansoprazole|mesh-list
91955778|NCT03418337|Dexlansoprazole|dexlansoprazole|mesh-list
91955779|NCT03418337|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91955780|NCT03418337|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955781|NCT03418337|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91955782|NCT03418337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955783|NCT03418337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955784|NCT03411967|Docetaxel|docetaxel|mesh-list
91955785|NCT03411967|Apatinib|apatinib|mesh-list
91955786|NCT03411967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955836|NCT02410772|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91955837|NCT03814317|Treprostinil|treprostinil|mesh-list
91955838|NCT03814317|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91955839|NCT03127319|Docetaxel|docetaxel|mesh-list
91955840|NCT03127319|Apatinib|apatinib|mesh-list
91955841|NCT03127319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91955842|NCT03127319|Tubulin Modulators|tubulin modulators|mesh-ancestor
91955843|NCT03127319|Antimitotic Agents|antimitotic agents|mesh-ancestor
91955844|NCT03127319|Mitosis Modulators|mitosis modulators|mesh-ancestor
91955845|NCT03127319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955846|NCT03127319|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91955847|NCT03127319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91955848|NCT03417947|Vitamin D|vitamin d|mesh-list
91955849|NCT03417947|Cholecalciferol|cholecalciferol|mesh-list
91955850|NCT03417947|Vitamins|vitamins|mesh-ancestor
91955852|NCT03417947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955855|NCT03905811|Terazosin|terazosin|mesh-list
91955896|NCT03407521|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91955898|NCT03407521|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91955899|NCT03407521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91955900|NCT03407521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91955901|NCT03407521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91955903|NCT03407521|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91955904|NCT03407521|Diuretics|diuretics|mesh-ancestor
91955905|NCT03407521|Natriuretic Agents|natriuretic agents|mesh-ancestor
91955906|NCT03407521|Vasodilator Agents|vasodilator agents|mesh-ancestor
91955907|NCT03407521|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91955908|NCT03407521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955909|NCT03424135|Diphenhydramine|diphenhydramine|mesh-list
91955910|NCT03424135|Promethazine|promethazine|mesh-list
91955911|NCT03424135|Naproxen|naproxen|mesh-list
91955912|NCT03424135|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91955913|NCT03424135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91955951|NCT03406819|Tirofiban|tirofiban|mesh-list
91955954|NCT03406819|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91955955|NCT03406819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91955956|NCT03406819|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91955957|NCT03406819|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91955958|NCT03406819|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91955959|NCT05170217|Cannabidiol|cannabidiol|mesh-list
91955960|NCT05170217|Anticonvulsants|anticonvulsants|mesh-ancestor
91955961|NCT03411551|Anesthetics|anesthetics|mesh-list
91955962|NCT03411551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956019|NCT04737603|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956020|NCT04737603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956021|NCT04737603|Analgesics|analgesics|mesh-ancestor
91956022|NCT04737603|Sensory System Agents|sensory system agents|mesh-ancestor
91956023|NCT04737603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956024|NCT04737603|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91956026|NCT05168137|Gout Suppressants|gout suppressants|mesh-ancestor
91956027|NCT05168137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956084|NCT03393949|Protective Agents|protective agents|mesh-ancestor
91956085|NCT03393949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91956086|NCT03393949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956087|NCT05169125|Dialysis Solutions|dialysis solutions|mesh-list
91956088|NCT05169125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91956089|NCT03818061|Bevacizumab|bevacizumab|mesh-list
91956090|NCT03818061|Atezolizumab|atezolizumab|mesh-list
91956091|NCT03818061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956092|NCT03818061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956093|NCT03818061|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91956094|NCT03818061|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91956095|NCT03818061|Growth Substances|growth substances|mesh-ancestor
91956096|NCT03818061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956097|NCT03818061|Growth Inhibitors|growth inhibitors|mesh-ancestor
91956098|NCT03818061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91956099|NCT03818061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956100|NCT03397615|Povidone-Iodine|povidone-iodine|mesh-list
91956101|NCT03397615|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91956102|NCT03397615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956103|NCT04435743|Lenalidomide|lenalidomide|mesh-list
91956104|NCT04435743|Immunologic Factors|immunologic factors|mesh-ancestor
91956105|NCT04435743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956106|NCT04435743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91956107|NCT04435743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91956108|NCT04435743|Growth Substances|growth substances|mesh-ancestor
91956132|NCT03612921|Dopamine Agents|dopamine agents|mesh-ancestor
91956133|NCT03612921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956134|NCT03612921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956135|NCT03612921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956136|NCT03612921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956137|NCT03612921|Analgesics|analgesics|mesh-ancestor
91956138|NCT03612921|Sensory System Agents|sensory system agents|mesh-ancestor
91956139|NCT03612921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956141|NCT03393481|Anticoagulants|anticoagulants|mesh-ancestor
91956142|NCT03393481|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91956143|NCT03393481|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91956144|NCT03393481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956195|NCT05188053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956196|NCT05188053|Sensory System Agents|sensory system agents|mesh-ancestor
91956197|NCT05188053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956198|NCT05188053|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91956200|NCT05188053|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956201|NCT05188053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956202|NCT05188053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956203|NCT05188053|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91956204|NCT05188053|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91956205|NCT05188053|Autonomic Agents|autonomic agents|mesh-ancestor
91956206|NCT05188053|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91956207|NCT05188053|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956208|NCT05188053|Mydriatics|mydriatics|mesh-ancestor
91956213|NCT05188053|Analgesics|analgesics|mesh-ancestor
91956254|NCT03407027|Immunologic Factors|immunologic factors|mesh-ancestor
91956255|NCT03407027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956256|NCT03407027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956257|NCT03343197|Ivosidenib|ivosidenib|mesh-list
91956258|NCT03343197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956259|NCT03343197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956260|NCT03343197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956261|NCT01602224|Dexamethasone|dexamethasone|mesh-list
91956262|NCT01602224|Bortezomib|bortezomib|mesh-list
91956263|NCT01602224|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956264|NCT01602224|Antiemetics|antiemetics|mesh-ancestor
91956265|NCT01602224|Autonomic Agents|autonomic agents|mesh-ancestor
91956266|NCT01602224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956267|NCT01602224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956268|NCT01602224|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91956270|NCT01602224|Hormones|hormones|mesh-ancestor
91956271|NCT01602224|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956272|NCT01602224|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91956273|NCT01602224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956274|NCT03399487|Ceritinib|ceritinib|mesh-list
91956275|NCT03399487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956276|NCT03399487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91956277|NCT03399487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956278|NCT03399487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956279|NCT05161429|Insulin|insulin|mesh-list
91956280|NCT05161429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91956303|NCT03984045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956304|NCT03661047|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
91956305|NCT03661047|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91956306|NCT03661047|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91956307|NCT05060991|Antimetabolites|antimetabolites|mesh-list
91956308|NCT05060991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956309|NCT03399409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91956310|NCT03397069|Midazolam|midazolam|mesh-list
91956311|NCT03397069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91956312|NCT03397069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956313|NCT03397069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956314|NCT03397069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956315|NCT03397069|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91956316|NCT03397069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956317|NCT03397069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956318|NCT03397069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956319|NCT03397069|Anesthetics, General|anesthetics, general|mesh-ancestor
91956330|NCT03399019|Midazolam|midazolam|mesh-list
91956360|NCT04452383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956361|NCT04452383|Anesthetics, General|anesthetics, general|mesh-ancestor
91956362|NCT04452383|Anesthetics|anesthetics|mesh-ancestor
91956363|NCT04452383|Analgesics|analgesics|mesh-ancestor
91956364|NCT04452383|Sensory System Agents|sensory system agents|mesh-ancestor
91956365|NCT04452383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956366|NCT04452383|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91956367|NCT04452383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91956368|NCT04452383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91956369|NCT04452383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956371|NCT02520479|Pegaspargase|pegaspargase|mesh-list
91956425|NCT03396107|Hormones|hormones|mesh-ancestor
91956426|NCT03396107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956427|NCT03396107|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91956428|NCT03396107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956429|NCT03398785|Epinephrine|epinephrine|mesh-list
91956430|NCT03398785|Racepinephrine|racepinephrine|mesh-list
91956431|NCT03398785|Epinephryl borate|epinephryl borate|mesh-list
91956432|NCT03398785|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91956433|NCT03398785|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91956434|NCT03398785|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956435|NCT03398785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956436|NCT03398785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956437|NCT03398785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956438|NCT03398785|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91956439|NCT03398785|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91956440|NCT03398785|Autonomic Agents|autonomic agents|mesh-ancestor
91956441|NCT03398785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956442|NCT03398785|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91956443|NCT03398785|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956444|NCT03398785|Mydriatics|mydriatics|mesh-ancestor
91956477|NCT03401177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956478|NCT03401177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956479|NCT03401177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956480|NCT03401177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956481|NCT03401177|Gout Suppressants|gout suppressants|mesh-ancestor
91956482|NCT03401177|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91956483|NCT03401177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956484|NCT03401177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956485|NCT04446715|Sufentanil|sufentanil|mesh-list
91956543|NCT03126097|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91956544|NCT03126097|Hormone Antagonists|hormone antagonists|mesh-ancestor
91956545|NCT03126097|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91956546|NCT03126097|Diuretics|diuretics|mesh-ancestor
91956547|NCT03126097|Natriuretic Agents|natriuretic agents|mesh-ancestor
91956548|NCT03398083|Alprazolam|alprazolam|mesh-list
91956549|NCT03398083|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956550|NCT03398083|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956551|NCT03398083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956552|NCT03398083|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91956555|NCT03398083|GABA Modulators|gaba modulators|mesh-ancestor
91956609|NCT04446637|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91956610|NCT04446637|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91956611|NCT04446637|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91956612|NCT04446637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91956613|NCT04446637|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956614|NCT04446637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956615|NCT04446637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956616|NCT04446637|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91956617|NCT04446637|Cholinergic Agents|cholinergic agents|mesh-ancestor
91956618|NCT03395171|Vitamin D|vitamin d|mesh-list
91956619|NCT03395171|Cholecalciferol|cholecalciferol|mesh-list
91956620|NCT03395171|Vitamins|vitamins|mesh-ancestor
91956621|NCT03395171|Micronutrients|micronutrients|mesh-ancestor
91956622|NCT03395171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956623|NCT03395171|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91956624|NCT03395171|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91956625|NCT03395977|Febuxostat|febuxostat|mesh-list
91956626|NCT03395977|Rasburicase|rasburicase|mesh-list
91956667|NCT03395093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956668|NCT03395093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956669|NCT03395093|GABA Modulators|gaba modulators|mesh-ancestor
91956670|NCT03395093|GABA Agents|gaba agents|mesh-ancestor
91956671|NCT03395093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956672|NCT03395093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956673|NCT03389191|Acyclovir|acyclovir|mesh-list
91956674|NCT03389191|Antiviral Agents|antiviral agents|mesh-ancestor
91956675|NCT03389191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956676|NCT04330183|Ketamine|ketamine|mesh-list
91956677|NCT04330183|Analgesics|analgesics|mesh-ancestor
91956678|NCT04330183|Sensory System Agents|sensory system agents|mesh-ancestor
91956679|NCT04330183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956680|NCT04330183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956681|NCT04330183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91956682|NCT04330183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956683|NCT04330183|Anesthetics, General|anesthetics, general|mesh-ancestor
91956684|NCT04330183|Anesthetics|anesthetics|mesh-ancestor
91956685|NCT04330183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956686|NCT04330183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91956687|NCT04330183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91956688|NCT04330183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956689|NCT04330183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956690|NCT03398993|Clomiphene|clomiphene|mesh-list
91956691|NCT03398993|Enclomiphene|enclomiphene|mesh-list
91956692|NCT03398993|Zuclomiphene|zuclomiphene|mesh-list
91956693|NCT03398993|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91956694|NCT03398993|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91956695|NCT03398993|Hormone Antagonists|hormone antagonists|mesh-ancestor
91956698|NCT03398993|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91956712|NCT03391609|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956714|NCT03391609|Sensory System Agents|sensory system agents|mesh-ancestor
91956715|NCT03391609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956716|NCT03391609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91956717|NCT03391609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91956718|NCT03391609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91956719|NCT03391609|Adrenergic Agents|adrenergic agents|mesh-ancestor
91956720|NCT03391609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956721|NCT03391609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956722|NCT03398837|Dronabinol|dronabinol|mesh-list
91956723|NCT03398837|Lenabasum|lenabasum|mesh-list
91956724|NCT03398837|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91956725|NCT03398837|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91956726|NCT03398837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956768|NCT04446923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91956769|NCT04446923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956770|NCT04446923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956771|NCT04446923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91956772|NCT04446923|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91956773|NCT04446923|Vasodilator Agents|vasodilator agents|mesh-ancestor
91956774|NCT05237843|Hydroxychloroquine|hydroxychloroquine|mesh-list
91956775|NCT05237843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956776|NCT05237843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956777|NCT05237843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956778|NCT05237843|Antimalarials|antimalarials|mesh-ancestor
91956779|NCT05237843|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91956780|NCT05237843|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91956781|NCT05237843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91956782|NCT04447105|Anesthetics|anesthetics|mesh-list
91956783|NCT04447105|Propofol|propofol|mesh-list
91956784|NCT04447105|Desflurane|desflurane|mesh-list
91956785|NCT04447105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956786|NCT04447105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956787|NCT04447105|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956788|NCT04447105|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91956789|NCT04447105|Anesthetics, General|anesthetics, general|mesh-ancestor
91956790|NCT04447105|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91956791|NCT03126461|Nivolumab|nivolumab|mesh-list
91956792|NCT03126461|Ipilimumab|ipilimumab|mesh-list
91956793|NCT03126461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91956795|NCT03126461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91956796|NCT03126461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956797|NCT03389789|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91956798|NCT03394001|Ketorolac|ketorolac|mesh-list
91956799|NCT03394001|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
91956800|NCT03394001|Lidocaine|lidocaine|mesh-list
91956801|NCT03394001|Anesthetics, Local|anesthetics, local|mesh-ancestor
91956811|NCT03394001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956812|NCT03394001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91956813|NCT03394001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91956814|NCT03394001|Analgesics|analgesics|mesh-ancestor
91956815|NCT03394001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956816|NCT03394001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91956817|NCT03394001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91956818|NCT03394001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956819|NCT03393767|Ranibizumab|ranibizumab|mesh-list
91956820|NCT03393767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91956821|NCT03393767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91956822|NCT03393767|Growth Substances|growth substances|mesh-ancestor
91956823|NCT03393767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956824|NCT03393767|Growth Inhibitors|growth inhibitors|mesh-ancestor
91956825|NCT03393767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91956826|NCT03389321|Macitentan|macitentan|mesh-list
91956827|NCT03389321|Riociguat|riociguat|mesh-list
91956829|NCT03389321|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
91956866|NCT00664937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956867|NCT00540839|Fluticasone|fluticasone|mesh-list
91956869|NCT00540839|Montelukast|montelukast|mesh-list
91956870|NCT00540839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91956871|NCT00540839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91956872|NCT00540839|Autonomic Agents|autonomic agents|mesh-ancestor
91956873|NCT00540839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91956874|NCT00540839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956875|NCT00540839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91956876|NCT00540839|Respiratory System Agents|respiratory system agents|mesh-ancestor
91956877|NCT00540839|Dermatologic Agents|dermatologic agents|mesh-ancestor
91956878|NCT00540839|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91956879|NCT00540839|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91956925|NCT03388697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91956926|NCT03388697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956927|NCT03987919|Tirzepatide|tirzepatide|mesh-list
91956928|NCT03987919|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91956929|NCT03987919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956930|NCT03987919|Incretins|incretins|mesh-ancestor
91956932|NCT03987919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91956933|NCT03388957|Propranolol|propranolol|mesh-list
91956934|NCT03388957|Midazolam|midazolam|mesh-list
91956935|NCT03388957|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91956936|NCT03388957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91956937|NCT03388957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91956938|NCT03388957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956939|NCT03388957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91956940|NCT03388957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91956941|NCT03388957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91956985|NCT00271817|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
91956986|NCT00271817|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91956987|NCT00271817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91956988|NCT00271817|Antimetabolites|antimetabolites|mesh-ancestor
91956989|NCT00271817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91956990|NCT00271817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91956991|NCT00271817|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91956992|NCT00271817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91956993|NCT00271817|Vasodilator Agents|vasodilator agents|mesh-ancestor
91956994|NCT00271817|Vitamin B Complex|vitamin b complex|mesh-ancestor
91956995|NCT00271817|Vitamins|vitamins|mesh-ancestor
91956996|NCT00271817|Micronutrients|micronutrients|mesh-ancestor
91956997|NCT00271817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91956998|NCT03388541|Dexmedetomidine|dexmedetomidine|mesh-list
91956999|NCT03388541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91957000|NCT03388541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957001|NCT03388541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957041|NCT03388151|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91957042|NCT03388151|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91957043|NCT03388151|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91957044|NCT03388151|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91957045|NCT03388151|GABA Modulators|gaba modulators|mesh-ancestor
91957046|NCT03388151|GABA Agents|gaba agents|mesh-ancestor
91957047|NCT03388151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957048|NCT03388151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957049|NCT03392909|Gentamicins|gentamicins|mesh-list
91957050|NCT03392909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957051|NCT03392909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957052|NCT03392909|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91957053|NCT03392909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957054|NCT03392909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957055|NCT04501211|Granisetron|granisetron|mesh-list
91957056|NCT04501211|Antiemetics|antiemetics|mesh-ancestor
91957057|NCT04501211|Autonomic Agents|autonomic agents|mesh-ancestor
91957058|NCT04501211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957059|NCT04501211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957095|NCT04446533|Hydrogen Peroxide|hydrogen peroxide|mesh-list
91957096|NCT04446533|Hyaluronic Acid|hyaluronic acid|mesh-list
91957097|NCT04446533|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91957098|NCT04446533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957099|NCT04446533|Disinfectants|disinfectants|mesh-ancestor
91957100|NCT04446533|Dermatologic Agents|dermatologic agents|mesh-ancestor
91957101|NCT04446533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91957102|NCT04446533|Immunologic Factors|immunologic factors|mesh-ancestor
91957103|NCT04446533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957104|NCT04446533|Viscosupplements|viscosupplements|mesh-ancestor
91957105|NCT04446533|Protective Agents|protective agents|mesh-ancestor
91957106|NCT03386591|Naloxone|naloxone|mesh-list
91957163|NCT02732015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957164|NCT02732015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957165|NCT02732015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957166|NCT02732015|Glucocorticoids|glucocorticoids|mesh-ancestor
91957167|NCT02732015|Hormones|hormones|mesh-ancestor
91957168|NCT02732015|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957169|NCT02732015|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91957170|NCT02732015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957171|NCT02732015|Protease Inhibitors|protease inhibitors|mesh-ancestor
91957172|NCT02732015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957173|NCT02732015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957174|NCT02732015|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91957175|NCT02732015|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91957221|NCT01964807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91957222|NCT01964807|Cholinergic Agents|cholinergic agents|mesh-ancestor
91957223|NCT01964807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957224|NCT01964807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957225|NCT01164995|Carboplatin|carboplatin|mesh-list
91957226|NCT01164995|Adavosertib|adavosertib|mesh-list
91957227|NCT01164995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957228|NCT01164995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957229|NCT01164995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957230|NCT00999401|Roscovitine|roscovitine|mesh-list
91957231|NCT00999401|Sapacitabine|sapacitabine|mesh-list
91957232|NCT00999401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957233|NCT00999401|Antiviral Agents|antiviral agents|mesh-ancestor
91957234|NCT00999401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957235|NCT00999401|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957236|NCT00999401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957237|NCT00999401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957277|NCT05174195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91957278|NCT05174195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957279|NCT05174195|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91957280|NCT05174195|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91957281|NCT05174195|Progestins|progestins|mesh-ancestor
91957282|NCT05174195|Hormones|hormones|mesh-ancestor
91957283|NCT05174195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91957284|NCT05238727|Carticaine|carticaine|mesh-list
91957285|NCT05238727|Mepivacaine|mepivacaine|mesh-list
91957286|NCT05238727|Anesthetics, Local|anesthetics, local|mesh-ancestor
91957287|NCT05238727|Anesthetics|anesthetics|mesh-ancestor
91957290|NCT05238727|Sensory System Agents|sensory system agents|mesh-ancestor
91957341|NCT03379181|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91957342|NCT03379181|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91957343|NCT03379181|Adrenergic Agents|adrenergic agents|mesh-ancestor
91957344|NCT03379181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957345|NCT03379181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957346|NCT03379181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957347|NCT03379181|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91957348|NCT03379181|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91957349|NCT03379181|Vasodilator Agents|vasodilator agents|mesh-ancestor
91957350|NCT03383939|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
91957351|NCT03383939|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91957352|NCT03383939|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91957353|NCT03383939|Protease Inhibitors|protease inhibitors|mesh-ancestor
91957404|NCT03383315|Autonomic Agents|autonomic agents|mesh-ancestor
91957405|NCT03383315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957406|NCT03383315|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91957407|NCT03383315|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91957408|NCT03383315|Dopamine Agents|dopamine agents|mesh-ancestor
91957409|NCT03383315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91957410|NCT03383315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957412|NCT03394729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957413|NCT03252925|Acetylcysteine|acetylcysteine|mesh-list
91957414|NCT03252925|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91957415|NCT03252925|Antiviral Agents|antiviral agents|mesh-ancestor
91957416|NCT03252925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957417|NCT03252925|Expectorants|expectorants|mesh-ancestor
91957418|NCT03252925|Respiratory System Agents|respiratory system agents|mesh-ancestor
91957419|NCT03252925|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91957420|NCT03252925|Antioxidants|antioxidants|mesh-ancestor
91957464|NCT03383003|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91957465|NCT03383003|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91957466|NCT03383003|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91957467|NCT03383003|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91957468|NCT03383003|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91957469|NCT03383003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957470|NCT03383003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957471|NCT03383003|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91957472|NCT03383003|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91957473|NCT03383003|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91957474|NCT03378713|Methyltestosterone|methyltestosterone|mesh-list
91957475|NCT03378713|Testosterone|testosterone|mesh-list
91957476|NCT03378713|Testosterone undecanoate|testosterone undecanoate|mesh-list
91957477|NCT03378713|Testosterone enanthate|testosterone enanthate|mesh-list
91957478|NCT03378713|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
91957479|NCT03378713|Androgens|androgens|mesh-ancestor
91957521|NCT03381755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957522|NCT03387163|Valsartan|valsartan|mesh-list
91957523|NCT03387163|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91957524|NCT03387163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91957525|NCT03387163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91957526|NCT03387163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91957527|NCT03387163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957528|NCT04446403|Anesthetics|anesthetics|mesh-list
91957529|NCT04446403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957530|NCT04446403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957531|NCT05237791|Magnesium Sulfate|magnesium sulfate|mesh-list
91957533|NCT05237791|Sensory System Agents|sensory system agents|mesh-ancestor
91957534|NCT05237791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957535|NCT05237791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957536|NCT05237791|Anesthetics|anesthetics|mesh-ancestor
91957539|NCT05237791|Anticonvulsants|anticonvulsants|mesh-ancestor
91957575|NCT03460015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957576|NCT03460015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957578|NCT03460015|Anesthetics, General|anesthetics, general|mesh-ancestor
91957579|NCT03460015|Anesthetics|anesthetics|mesh-ancestor
91957580|NCT03460015|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957581|NCT03460015|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91957582|NCT03376841|Cenicriviroc|cenicriviroc|mesh-list
91957583|NCT03376841|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91957584|NCT03376841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957585|NCT03376841|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91957586|NCT03376841|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91957587|NCT03376841|Antiviral Agents|antiviral agents|mesh-ancestor
91957588|NCT03376841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957589|NCT03375515|Hydromorphone|hydromorphone|mesh-list
91957590|NCT03375515|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91957591|NCT03375515|Narcotics|narcotics|mesh-ancestor
91957592|NCT03375515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957594|NCT03375515|Analgesics|analgesics|mesh-ancestor
91957629|NCT03386227|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957630|NCT05237323|Mycophenolic Acid|mycophenolic acid|mesh-list
91957631|NCT05237323|Azathioprine|azathioprine|mesh-list
91957632|NCT05237323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91957633|NCT05237323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957634|NCT05237323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91957635|NCT05237323|Antitubercular Agents|antitubercular agents|mesh-ancestor
91957636|NCT05237323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957637|NCT05237323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957638|NCT05237323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957639|NCT05237323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957640|NCT05237323|Antimetabolites|antimetabolites|mesh-ancestor
91957641|NCT05237323|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91957642|NCT05237323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91957690|NCT03386149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91957691|NCT03386149|Analgesics|analgesics|mesh-ancestor
91957692|NCT03386149|Sensory System Agents|sensory system agents|mesh-ancestor
91957693|NCT03386149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957694|NCT03386149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957695|NCT03386149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91957696|NCT03386149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91957697|NCT03386071|Trametinib|trametinib|mesh-list
91957698|NCT03386071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91957699|NCT03386071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91957700|NCT03386071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957701|NCT03386071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957753|NCT04446091|Growth Substances|growth substances|mesh-ancestor
91957754|NCT04446091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957755|NCT04446091|Growth Inhibitors|growth inhibitors|mesh-ancestor
91957756|NCT04445935|Bivalirudin|bivalirudin|mesh-list
91957757|NCT04445935|Antithrombins|antithrombins|mesh-ancestor
91957758|NCT04445935|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91957759|NCT04445935|Protease Inhibitors|protease inhibitors|mesh-ancestor
91957760|NCT04445935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957761|NCT04445935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957762|NCT04445935|Anticoagulants|anticoagulants|mesh-ancestor
91957763|NCT03385057|Acetaminophen|acetaminophen|mesh-list
91957764|NCT03385057|Ibuprofen|ibuprofen|mesh-list
91957765|NCT03385057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91957766|NCT03385057|Analgesics|analgesics|mesh-ancestor
91957767|NCT03385057|Sensory System Agents|sensory system agents|mesh-ancestor
91957768|NCT03385057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957769|NCT03385057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957770|NCT03385057|Antipyretics|antipyretics|mesh-ancestor
91957772|NCT03385057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91957809|NCT03379987|Bupivacaine|bupivacaine|mesh-list
91957810|NCT03379987|Anesthetics, Local|anesthetics, local|mesh-ancestor
91957811|NCT03379987|Anesthetics|anesthetics|mesh-ancestor
91957812|NCT03379987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91957813|NCT03379987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957814|NCT03379987|Sensory System Agents|sensory system agents|mesh-ancestor
91957815|NCT03379987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91957816|NCT03379987|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91957818|NCT03379987|Analgesics|analgesics|mesh-ancestor
91957819|NCT02730793|Aztreonam|aztreonam|mesh-list
91957820|NCT02730793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957821|NCT02730793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957822|NCT03379909|Metformin|metformin|mesh-list
91957823|NCT03379909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91957824|NCT03379909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957825|NCT02678533|Plerixafor|plerixafor|mesh-list
91957826|NCT02678533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91957827|NCT02678533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91957828|NCT02678533|Antiviral Agents|antiviral agents|mesh-ancestor
91957829|NCT02678533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957865|NCT04445623|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91957866|NCT04445623|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91957867|NCT04445311|Ivermectin|ivermectin|mesh-list
91957868|NCT04445311|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91957869|NCT04445311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957870|NCT03384121|Rifampin|rifampin|mesh-list
91957871|NCT03384121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91957872|NCT03384121|Antitubercular Agents|antitubercular agents|mesh-ancestor
91957873|NCT03384121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91957874|NCT03384121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91957875|NCT03384121|Leprostatic Agents|leprostatic agents|mesh-ancestor
91957876|NCT03384121|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91957877|NCT03384121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957878|NCT03384121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957879|NCT03384121|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91957880|NCT03384121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91957881|NCT03384121|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91957896|NCT03378427|Ofloxacin|ofloxacin|mesh-list
91957922|NCT03378427|Leprostatic Agents|leprostatic agents|mesh-ancestor
91957923|NCT03378427|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91957924|NCT03378427|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91957925|NCT03378427|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91957926|NCT03378427|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91957927|NCT03378427|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91957928|NCT03378427|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91957929|NCT03378427|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91957930|NCT03378427|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91957931|NCT03378427|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91957985|NCT02730871|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91957986|NCT02730871|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91957987|NCT02730871|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91957988|NCT02730871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91957989|NCT03377335|Metformin|metformin|mesh-list
91957990|NCT03377335|Dapagliflozin|dapagliflozin|mesh-list
91957991|NCT03377335|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91957992|NCT03377335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91957993|NCT03377335|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91957994|NCT03377335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91957995|NCT03377257|Oxazolidinones|oxazolidinones|mesh-list
91957996|NCT03377257|Zolmitriptan|zolmitriptan|mesh-list
91957997|NCT03377257|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91957998|NCT03377257|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91957999|NCT03377257|Serotonin Agents|serotonin agents|mesh-ancestor
91958000|NCT03377257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958001|NCT03377257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958351|NCT04525495|Protective Agents|protective agents|mesh-ancestor
91958002|NCT03377257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958042|NCT03377101|Palbociclib|palbociclib|mesh-list
91958043|NCT03377101|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91958044|NCT03377101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958045|NCT03377101|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91958046|NCT03377101|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91958047|NCT03377101|Hormone Antagonists|hormone antagonists|mesh-ancestor
91958048|NCT03377101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958049|NCT03377101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958050|NCT03377101|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91958051|NCT03377101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958052|NCT03377101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958053|NCT04445467|Favipiravir|favipiravir|mesh-list
91958054|NCT04445467|Antiviral Agents|antiviral agents|mesh-ancestor
91958055|NCT04445467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958104|NCT03381781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91958105|NCT03381781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958106|NCT03381781|Immunologic Factors|immunologic factors|mesh-ancestor
91958107|NCT03381781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958108|NCT03381781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958109|NCT03381703|YH12852|yh12852|mesh-list
91958110|NCT03381703|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
91958111|NCT03381703|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91958112|NCT03381703|Serotonin Agents|serotonin agents|mesh-ancestor
91958113|NCT03381703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958114|NCT03381703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958166|NCT02520115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958167|NCT02520115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91958168|NCT02520115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958169|NCT02520115|Protease Inhibitors|protease inhibitors|mesh-ancestor
91958170|NCT02520115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958171|NCT02520115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958172|NCT02520115|Anticonvulsants|anticonvulsants|mesh-ancestor
91958173|NCT02520115|GABA Agents|gaba agents|mesh-ancestor
91958174|NCT02520115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958175|NCT02520115|Antimanic Agents|antimanic agents|mesh-ancestor
91958176|NCT02520115|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91958177|NCT02520115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958178|NCT02520115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91958179|NCT02520115|Dermatologic Agents|dermatologic agents|mesh-ancestor
91958180|NCT03375775|Immunomodulating Agents|immunomodulating agents|mesh-list
91958181|NCT03375775|Immunologic Factors|immunologic factors|mesh-list
91958182|NCT03375775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958183|NCT04527133|Aprotinin|aprotinin|mesh-list
91958222|NCT03371095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91958223|NCT03371095|Immunologic Factors|immunologic factors|mesh-ancestor
91958224|NCT03371095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958225|NCT03371095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958226|NCT03371095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91958227|NCT03371095|Alkylating Agents|alkylating agents|mesh-ancestor
91958228|NCT03371095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958229|NCT03371095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958230|NCT03371095|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91958231|NCT03371095|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91958232|NCT03371095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91958284|NCT03362905|Anesthetics|anesthetics|mesh-ancestor
91958285|NCT03362905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958286|NCT03362905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958287|NCT03362905|Sensory System Agents|sensory system agents|mesh-ancestor
91958288|NCT03362905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958289|NCT03362905|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91958290|NCT03362905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91958291|NCT03362905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91958292|NCT03362905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91958293|NCT03362905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958295|NCT03370159|Docetaxel|docetaxel|mesh-list
91958296|NCT03370159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958346|NCT04525495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958347|NCT04525495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958349|NCT04525495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958350|NCT04525495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958352|NCT03362359|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91958355|NCT03362281|Amoxicillin|amoxicillin|mesh-list
91958414|NCT03357757|GABA Agents|gaba agents|mesh-ancestor
91958415|NCT03357757|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958416|NCT03357757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958417|NCT03357757|Antimanic Agents|antimanic agents|mesh-ancestor
91958418|NCT03357757|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91958419|NCT03357757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958420|NCT03357757|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91958421|NCT02929485|Bromocriptine|bromocriptine|mesh-list
91958422|NCT02929485|Tolcapone|tolcapone|mesh-list
91958423|NCT02929485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91958424|NCT02929485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91958425|NCT02929485|Hormone Antagonists|hormone antagonists|mesh-ancestor
91958426|NCT02929485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91958427|NCT02929485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958428|NCT02929485|Dopamine Agonists|dopamine agonists|mesh-ancestor
91958472|NCT04521517|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958473|NCT04521517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958474|NCT04521517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958475|NCT01675167|Buprenorphine|buprenorphine|mesh-list
91958476|NCT01675167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91958477|NCT01675167|Narcotics|narcotics|mesh-ancestor
91958478|NCT01675167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958479|NCT01675167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958480|NCT01675167|Analgesics|analgesics|mesh-ancestor
91958481|NCT01675167|Sensory System Agents|sensory system agents|mesh-ancestor
91958482|NCT01675167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958483|NCT01675167|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91958533|NCT03357055|Sensory System Agents|sensory system agents|mesh-ancestor
91958534|NCT03357055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958535|NCT03357055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958536|NCT03357055|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91958537|NCT03357055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958538|NCT03357055|Anesthetics, General|anesthetics, general|mesh-ancestor
91958539|NCT03357055|Anesthetics|anesthetics|mesh-ancestor
91958540|NCT03357055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958541|NCT03357055|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91958542|NCT03357055|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91958543|NCT03357055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958544|NCT03357055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958545|NCT03367585|Vitamin D|vitamin d|mesh-list
91958546|NCT03367585|Cholecalciferol|cholecalciferol|mesh-list
91958547|NCT03367585|Vitamins|vitamins|mesh-ancestor
91958548|NCT03367585|Micronutrients|micronutrients|mesh-ancestor
91958552|NCT03360955|Anesthetics|anesthetics|mesh-list
91958591|NCT05405049|Analgesics|analgesics|mesh-ancestor
91958592|NCT05405049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91958593|NCT05405049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958594|NCT05405049|Anesthetics, General|anesthetics, general|mesh-ancestor
91958596|NCT04520503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91958597|NCT04520503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958598|NCT04520503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958599|NCT04520503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958600|NCT04520503|Anesthetics, General|anesthetics, general|mesh-ancestor
91958601|NCT04520503|Anesthetics|anesthetics|mesh-ancestor
91958602|NCT02871843|Temozolomide|temozolomide|mesh-list
91958603|NCT02871843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91958604|NCT02871843|Alkylating Agents|alkylating agents|mesh-ancestor
91958605|NCT02871843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958606|NCT02871843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958607|NCT03356899|Bupivacaine|bupivacaine|mesh-list
91958608|NCT03356899|Anesthetics|anesthetics|mesh-list
91958609|NCT03356899|Anesthetics, Local|anesthetics, local|mesh-ancestor
91958615|NCT04523467|Ginsenoside Rg3|ginsenoside rg3|mesh-list
91958647|NCT05127369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958648|NCT05127369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91958649|NCT05127369|Antidepressive Agents|antidepressive agents|mesh-ancestor
91958650|NCT05127369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91958651|NCT05127369|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91958652|NCT05127369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91958653|NCT05127369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958654|NCT05126901|Ferric maltol|ferric maltol|mesh-list
91958655|NCT05126901|Hematinics|hematinics|mesh-ancestor
91958656|NCT03356353|Sildenafil Citrate|sildenafil citrate|mesh-list
91958953|NCT03364075|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958657|NCT03356353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958658|NCT03356353|Vasodilator Agents|vasodilator agents|mesh-ancestor
91958707|NCT04518475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91958708|NCT04518475|Immunologic Factors|immunologic factors|mesh-ancestor
91958709|NCT04518475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958710|NCT04518475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958711|NCT04278651|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91958712|NCT04278651|Hematinics|hematinics|mesh-ancestor
91958713|NCT04278651|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91958714|NCT04278651|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91958716|NCT05125575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91958717|NCT05125575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958718|NCT03366883|Paclitaxel|paclitaxel|mesh-list
91958719|NCT03366883|Cisplatin|cisplatin|mesh-list
91958720|NCT03366883|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91958726|NCT03366571|Entecavir|entecavir|mesh-list
91958769|NCT03366025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958770|NCT05115591|Anesthetics|anesthetics|mesh-list
91958771|NCT05115591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958772|NCT05115591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958773|NCT05403099|Hyaluronic Acid|hyaluronic acid|mesh-list
91958774|NCT05403099|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91958775|NCT05403099|Immunologic Factors|immunologic factors|mesh-ancestor
91958776|NCT05403099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958777|NCT05403099|Viscosupplements|viscosupplements|mesh-ancestor
91958778|NCT05403099|Protective Agents|protective agents|mesh-ancestor
91958779|NCT03365869|Sirolimus|sirolimus|mesh-list
91958835|NCT03828045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91958837|NCT03828045|Analgesics|analgesics|mesh-ancestor
91958838|NCT03828045|Sensory System Agents|sensory system agents|mesh-ancestor
91958839|NCT03828045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958840|NCT03828045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958841|NCT03828045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91958842|NCT03828045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91958843|NCT03828045|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91958844|NCT03828045|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91958845|NCT03828045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91958846|NCT03828045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958847|NCT03123679|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
91958848|NCT03123679|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91958849|NCT03123679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958850|NCT02519413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91958890|NCT03350659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91958891|NCT03350659|Adrenergic Agents|adrenergic agents|mesh-ancestor
91958892|NCT03350659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91958893|NCT03350659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958894|NCT03350659|Sympathomimetics|sympathomimetics|mesh-ancestor
91958895|NCT03350659|Autonomic Agents|autonomic agents|mesh-ancestor
91958896|NCT03350659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958897|NCT03350659|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91958898|NCT03350659|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91958899|NCT03350659|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91958900|NCT03350659|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91958901|NCT04443517|Propofol|propofol|mesh-list
91958902|NCT04443517|Anesthetics|anesthetics|mesh-ancestor
91958903|NCT04443517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91958904|NCT04443517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958905|NCT04443517|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91958906|NCT04443517|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91958907|NCT04443517|Anesthetics, General|anesthetics, general|mesh-ancestor
91958908|NCT03350347|Darbepoetin alfa|darbepoetin alfa|mesh-list
91958909|NCT03350347|Hematinics|hematinics|mesh-ancestor
91958910|NCT03350191|Exenatide|exenatide|mesh-list
91958941|NCT03364075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91958942|NCT03364075|Analgesics|analgesics|mesh-ancestor
91958943|NCT03364075|Sensory System Agents|sensory system agents|mesh-ancestor
91958944|NCT03364075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91958945|NCT03364075|Antidepressive Agents|antidepressive agents|mesh-ancestor
91958946|NCT03364075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91958947|NCT03364075|Dopamine Agents|dopamine agents|mesh-ancestor
91958948|NCT03364075|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91958949|NCT03364075|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91958950|NCT03364075|Adrenergic Agents|adrenergic agents|mesh-ancestor
91958951|NCT03364075|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91958952|NCT03364075|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91958954|NCT03364075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91959002|NCT04773405|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91959003|NCT04773405|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91959004|NCT04773405|Adrenergic Agents|adrenergic agents|mesh-ancestor
91959005|NCT04773405|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959006|NCT04773405|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91959007|NCT04773405|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91959008|NCT04773405|Autonomic Agents|autonomic agents|mesh-ancestor
91959009|NCT04773405|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91959010|NCT04773405|Respiratory System Agents|respiratory system agents|mesh-ancestor
91959012|NCT04773405|Sympathomimetics|sympathomimetics|mesh-ancestor
91959013|NCT04773405|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91959014|NCT04991571|Dapagliflozin|dapagliflozin|mesh-list
91959015|NCT04991571|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91959016|NCT04991571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959017|NCT04991571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959018|NCT04991571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959019|NCT01376245|Fluticasone|fluticasone|mesh-list
91959061|NCT03349177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959062|NCT03349177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91959063|NCT03349177|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91959064|NCT03349177|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91959065|NCT03349177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959066|NCT04691505|Hydroxychloroquine|hydroxychloroquine|mesh-list
91959067|NCT04691505|Methotrexate|methotrexate|mesh-list
91959068|NCT04691505|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91959069|NCT04691505|Abortifacient Agents|abortifacient agents|mesh-ancestor
91959070|NCT04691505|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91959071|NCT04691505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959072|NCT04691505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959073|NCT04691505|Antimetabolites|antimetabolites|mesh-ancestor
91959074|NCT04691505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959075|NCT04691505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959076|NCT04691505|Dermatologic Agents|dermatologic agents|mesh-ancestor
91959077|NCT04691505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959078|NCT04691505|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91959079|NCT04691505|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91959080|NCT04691505|Immunologic Factors|immunologic factors|mesh-ancestor
91959081|NCT04691505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959082|NCT04691505|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91959083|NCT04691505|Antimalarials|antimalarials|mesh-ancestor
91959114|NCT03353857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91959115|NCT03353857|Anesthetics, General|anesthetics, general|mesh-ancestor
91959116|NCT03353857|Anesthetics|anesthetics|mesh-ancestor
91959117|NCT03353857|GABA Modulators|gaba modulators|mesh-ancestor
91959118|NCT03353857|GABA Agents|gaba agents|mesh-ancestor
91959119|NCT03353857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959120|NCT03353857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959121|NCT03353857|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91959122|NCT03353857|Contraceptive Agents|contraceptive agents|mesh-ancestor
91959123|NCT03353857|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91959124|NCT03353857|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91959125|NCT03353857|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91959126|NCT03353857|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91959127|NCT03353857|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91959128|NCT03353857|Antitubercular Agents|antitubercular agents|mesh-ancestor
91959129|NCT03353857|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959130|NCT03353857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959131|NCT03353857|Leprostatic Agents|leprostatic agents|mesh-ancestor
91959132|NCT03353857|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91959133|NCT03353857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959134|NCT03353857|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91959135|NCT03353857|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91959136|NCT03353857|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91959162|NCT05306899|Ketamine|ketamine|mesh-list
91959163|NCT05306899|Analgesics|analgesics|mesh-ancestor
91959164|NCT05306899|Sensory System Agents|sensory system agents|mesh-ancestor
91959165|NCT05306899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959166|NCT05306899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959167|NCT05306899|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91959168|NCT05306899|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91959169|NCT05306899|Anesthetics, General|anesthetics, general|mesh-ancestor
91959170|NCT05306899|Anesthetics|anesthetics|mesh-ancestor
91959171|NCT05306899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959172|NCT05306899|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91959173|NCT05306899|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91959176|NCT00807651|Insulin|insulin|mesh-list
91959225|NCT04644705|Anticestodal Agents|anticestodal agents|mesh-ancestor
91959226|NCT04644705|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91959227|NCT04644705|Anthelmintics|anthelmintics|mesh-ancestor
91959228|NCT04644705|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91959229|NCT04644705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959230|NCT04644705|Antinematodal Agents|antinematodal agents|mesh-ancestor
91959232|NCT04038489|Tamoxifen|tamoxifen|mesh-list
91959233|NCT04038489|Paclitaxel|paclitaxel|mesh-list
91959234|NCT04038489|Cyclophosphamide|cyclophosphamide|mesh-list
91959235|NCT04038489|Doxorubicin|doxorubicin|mesh-list
91959236|NCT04038489|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91959237|NCT04038489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959238|NCT04038489|Tubulin Modulators|tubulin modulators|mesh-ancestor
91959239|NCT04038489|Antimitotic Agents|antimitotic agents|mesh-ancestor
91959240|NCT04038489|Mitosis Modulators|mitosis modulators|mesh-ancestor
91959241|NCT04038489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959242|NCT04038489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91959243|NCT04038489|Immunologic Factors|immunologic factors|mesh-ancestor
91959244|NCT04038489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959245|NCT04038489|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959246|NCT04038489|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91959247|NCT04038489|Alkylating Agents|alkylating agents|mesh-ancestor
91959248|NCT04038489|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91959249|NCT04038489|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91959250|NCT04038489|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91959251|NCT04038489|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91959252|NCT04038489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959253|NCT04038489|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91959254|NCT04038489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91959255|NCT04038489|Analgesics|analgesics|mesh-ancestor
91959256|NCT04038489|Sensory System Agents|sensory system agents|mesh-ancestor
91959257|NCT04038489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959258|NCT04038489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959266|NCT04038489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959267|NCT04038489|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959268|NCT04038489|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91959269|NCT04038489|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91959270|NCT04038489|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959271|NCT04468425|Tofacitinib|tofacitinib|mesh-list
91959272|NCT04468425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959273|NCT04468425|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91959274|NCT04468425|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91959275|NCT04468425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959276|NCT04287855|Dexamethasone|dexamethasone|mesh-list
91959277|NCT04287855|Pomalidomide|pomalidomide|mesh-list
91959278|NCT04287855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959279|NCT04287855|Antiemetics|antiemetics|mesh-ancestor
91959280|NCT04287855|Autonomic Agents|autonomic agents|mesh-ancestor
91959281|NCT04287855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959282|NCT04287855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959283|NCT04287855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959284|NCT04287855|Glucocorticoids|glucocorticoids|mesh-ancestor
91959285|NCT04287855|Hormones|hormones|mesh-ancestor
91959286|NCT04287855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959287|NCT04287855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959288|NCT04287855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959289|NCT04287855|Immunologic Factors|immunologic factors|mesh-ancestor
91959290|NCT04287855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91959291|NCT04287855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91959292|NCT04287855|Growth Substances|growth substances|mesh-ancestor
91959293|NCT04287855|Growth Inhibitors|growth inhibitors|mesh-ancestor
91959294|NCT04435587|Ritonavir|ritonavir|mesh-list
91959295|NCT04435587|Darunavir|darunavir|mesh-list
91959296|NCT04435587|Hydroxychloroquine|hydroxychloroquine|mesh-list
91959297|NCT04435587|Ivermectin|ivermectin|mesh-list
91959298|NCT04435587|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91959299|NCT04435587|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91974884|NCT02155738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974885|NCT02155738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974886|NCT02155738|Antipyretics|antipyretics|mesh-ancestor
91974887|NCT03053505|Vancomycin|vancomycin|mesh-list
91959300|NCT04435587|Protease Inhibitors|protease inhibitors|mesh-ancestor
91959301|NCT04435587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959302|NCT04435587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959303|NCT04435587|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91959304|NCT04435587|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91959305|NCT04435587|Antiviral Agents|antiviral agents|mesh-ancestor
91959306|NCT04435587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959307|NCT04435587|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91959308|NCT04435587|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91959309|NCT04435587|Antimalarials|antimalarials|mesh-ancestor
91959310|NCT04435587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91959311|NCT04435587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91959312|NCT04435587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959313|NCT05131893|Tamoxifen|tamoxifen|mesh-list
91959314|NCT05131893|Docetaxel|docetaxel|mesh-list
91959315|NCT05131893|Cyclophosphamide|cyclophosphamide|mesh-list
91959316|NCT05131893|Capecitabine|capecitabine|mesh-list
91959317|NCT05131893|Trastuzumab|trastuzumab|mesh-list
91959318|NCT05131893|Letrozole|letrozole|mesh-list
91959319|NCT05131893|Epirubicin|epirubicin|mesh-list
91959320|NCT05131893|Pertuzumab|pertuzumab|mesh-list
91959321|NCT05131893|Goserelin|goserelin|mesh-list
91959322|NCT05131893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959323|NCT05131893|Tubulin Modulators|tubulin modulators|mesh-ancestor
91959324|NCT05131893|Antimitotic Agents|antimitotic agents|mesh-ancestor
91959325|NCT05131893|Mitosis Modulators|mitosis modulators|mesh-ancestor
91959326|NCT05131893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959327|NCT05131893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91959328|NCT05131893|Immunologic Factors|immunologic factors|mesh-ancestor
91959329|NCT05131893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959330|NCT05131893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959331|NCT05131893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91959332|NCT05131893|Alkylating Agents|alkylating agents|mesh-ancestor
91959333|NCT05131893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91974888|NCT03053505|Fidaxomicin|fidaxomicin|mesh-list
91959343|NCT05131893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91959344|NCT05131893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91959345|NCT05131893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91959346|NCT05131893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959347|NCT05131893|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91959348|NCT05131893|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91959349|NCT05131893|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91959408|NCT05059587|Cholinergic Agents|cholinergic agents|mesh-ancestor
91959409|NCT05059587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959410|NCT05137197|Antidepressive Agents|antidepressive agents|mesh-list
91959411|NCT05137197|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91959412|NCT05135715|Trastuzumab|trastuzumab|mesh-list
91959413|NCT05135715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91959414|NCT05135715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959415|NCT05185167|Propofol|propofol|mesh-list
91959416|NCT05185167|Anesthetics|anesthetics|mesh-list
91959417|NCT05185167|Desflurane|desflurane|mesh-list
91959418|NCT05185167|Anesthetics, General|anesthetics, general|mesh-list
91959419|NCT05185167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91959420|NCT05185167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959421|NCT05185167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959422|NCT05185167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91959423|NCT05185167|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91959424|NCT05133453|Pirfenidone|pirfenidone|mesh-list
91959425|NCT05133453|Analgesics|analgesics|mesh-ancestor
91959426|NCT05133453|Sensory System Agents|sensory system agents|mesh-ancestor
91959427|NCT05133453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959428|NCT05133453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959429|NCT05133453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91959430|NCT05133453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91959431|NCT05133453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959432|NCT05133453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959433|NCT05133453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959434|NCT05125185|Insulin|insulin|mesh-list
91959435|NCT05125185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91959436|NCT05125185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959437|NCT04244877|Rifaximin|rifaximin|mesh-list
91959438|NCT04244877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959439|NCT04244877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959454|NCT05305131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91959455|NCT05305131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91959456|NCT05305131|Growth Substances|growth substances|mesh-ancestor
91959457|NCT05305131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959458|NCT05305131|Growth Inhibitors|growth inhibitors|mesh-ancestor
91962337|NCT03101085|Equol|equol|mesh-list
91959459|NCT05305131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91959460|NCT05305131|Antimetabolites|antimetabolites|mesh-ancestor
91959461|NCT05305131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959462|NCT05305131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91959464|NCT03122665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91959465|NCT03122665|Analgesics|analgesics|mesh-ancestor
91959466|NCT03122665|Sensory System Agents|sensory system agents|mesh-ancestor
91959467|NCT03122665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959512|NCT04564521|Vasodilator Agents|vasodilator agents|mesh-ancestor
91959513|NCT05303961|Rebamipide|rebamipide|mesh-list
91959514|NCT05303961|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91959515|NCT05303961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959516|NCT05303961|Antioxidants|antioxidants|mesh-ancestor
91959517|NCT05303961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959518|NCT05303961|Protective Agents|protective agents|mesh-ancestor
91959519|NCT05303961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959520|NCT05303961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959521|NCT03122353|Calcitriol|calcitriol|mesh-list
91959522|NCT03122353|Betamethasone|betamethasone|mesh-list
91959523|NCT03122353|Betamethasone Valerate|betamethasone valerate|mesh-list
91959524|NCT03122353|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91959525|NCT03122353|Betamethasone benzoate|betamethasone benzoate|mesh-list
91959526|NCT03122353|Calcipotriene|calcipotriene|mesh-list
91959527|NCT03122353|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91959528|NCT03122353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959530|NCT03122353|Hormones|hormones|mesh-ancestor
91959531|NCT03122353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959532|NCT03122353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959567|NCT03121963|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91959568|NCT03121963|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91959569|NCT03121963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959570|NCT03121963|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91959571|NCT03121963|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91959572|NCT03121963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91959573|NCT03121963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91959574|NCT03121963|Anticonvulsants|anticonvulsants|mesh-ancestor
91959575|NCT03121963|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91959576|NCT03121963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91959630|NCT04475991|Antiviral Agents|antiviral agents|mesh-ancestor
91959631|NCT04475991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959703|NCT04488315|Anesthetics|anesthetics|mesh-ancestor
91959704|NCT04488315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91959705|NCT04488315|Sensory System Agents|sensory system agents|mesh-ancestor
91959706|NCT00709735|Propranolol|propranolol|mesh-list
91959707|NCT00709735|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91959708|NCT00709735|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91959709|NCT00709735|Adrenergic Agents|adrenergic agents|mesh-ancestor
91959715|NCT00709735|Vasodilator Agents|vasodilator agents|mesh-ancestor
91959770|NCT04505917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959771|NCT04505917|Oxytocics|oxytocics|mesh-ancestor
91959840|NCT05060523|Autonomic Agents|autonomic agents|mesh-ancestor
91959841|NCT05060523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959842|NCT05060523|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91959843|NCT05060523|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91959844|NCT05060523|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91959845|NCT05060523|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91959846|NCT05060523|Adrenergic Agents|adrenergic agents|mesh-ancestor
91959847|NCT05060523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91959848|NCT04502641|Docetaxel|docetaxel|mesh-list
91959849|NCT04502641|Fluorouracil|fluorouracil|mesh-list
91959850|NCT04502641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959851|NCT04502641|Tubulin Modulators|tubulin modulators|mesh-ancestor
91959904|NCT03351205|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91959905|NCT03351205|Progestins|progestins|mesh-ancestor
91959906|NCT04698057|Amoxicillin|amoxicillin|mesh-list
91959907|NCT04698057|Ciprofloxacin|ciprofloxacin|mesh-list
91959908|NCT04698057|Clavulanic Acid|clavulanic acid|mesh-list
91959909|NCT04698057|Clavulanic Acids|clavulanic acids|mesh-list
91959910|NCT04698057|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
91959911|NCT04698057|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91959912|NCT04698057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91959914|NCT04698057|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91959972|NCT02517619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91959973|NCT02517619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91959974|NCT02517619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91959975|NCT02517619|Glucocorticoids|glucocorticoids|mesh-ancestor
91959976|NCT02517619|Hormones|hormones|mesh-ancestor
91959977|NCT02517619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91959978|NCT02517619|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91959979|NCT02517619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91959980|NCT02517619|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91959981|NCT02517619|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91959982|NCT02517619|Protective Agents|protective agents|mesh-ancestor
91959983|NCT03968913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91959984|NCT03968913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91959985|NCT03892395|Vitamin D|vitamin d|mesh-list
91959986|NCT03892395|Vitamins|vitamins|mesh-list
91959987|NCT03892395|Vitamin B Complex|vitamin b complex|mesh-list
91959988|NCT03892395|Micronutrients|micronutrients|mesh-ancestor
91960029|NCT03660813|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91960030|NCT03660813|Luteolytic Agents|luteolytic agents|mesh-ancestor
91960101|NCT02507479|Alkylating Agents|alkylating agents|mesh-ancestor
91960102|NCT02507479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960103|NCT02507479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960104|NCT02507479|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91960105|NCT02507479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91960106|NCT02507479|Immunologic Factors|immunologic factors|mesh-ancestor
91960107|NCT02507479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960108|NCT02512315|Cisplatin|cisplatin|mesh-list
91960109|NCT02512315|Docetaxel|docetaxel|mesh-list
91960110|NCT02512315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960111|NCT02512315|Tubulin Modulators|tubulin modulators|mesh-ancestor
91960112|NCT02512315|Antimitotic Agents|antimitotic agents|mesh-ancestor
91960163|NCT02507167|Rifampin|rifampin|mesh-list
91960237|NCT02506777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960314|NCT02505841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960315|NCT02505841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960327|NCT03345667|Ranibizumab|ranibizumab|mesh-list
91960386|NCT03121807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91960388|NCT03121807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960392|NCT03121807|Vitamins|vitamins|mesh-ancestor
91960460|NCT02504983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960461|NCT02504983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91960462|NCT02504983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960463|NCT02504983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960464|NCT02510053|Caspofungin|caspofungin|mesh-list
91960465|NCT02510053|Antifungal Agents|antifungal agents|mesh-ancestor
91960466|NCT02510053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960467|NCT02510053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91960468|NCT02510053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960528|NCT02729545|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91960529|NCT02504125|Tranexamic Acid|tranexamic acid|mesh-list
91960530|NCT02504125|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91960531|NCT02504125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91960532|NCT02504125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960533|NCT02504125|Hemostatics|hemostatics|mesh-ancestor
91960534|NCT02504125|Coagulants|coagulants|mesh-ancestor
91960535|NCT02509429|Insulin|insulin|mesh-list
91960536|NCT02509429|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91960537|NCT02509429|Insulin Aspart|insulin aspart|mesh-list
91960538|NCT02509429|Insulin, Long-Acting|insulin, long-acting|mesh-list
91960539|NCT02509429|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
91960540|NCT02509429|Insulin Lispro|insulin lispro|mesh-list
91960541|NCT02509429|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91960590|NCT02514421|Tubulin Modulators|tubulin modulators|mesh-ancestor
91960591|NCT02514421|Antimitotic Agents|antimitotic agents|mesh-ancestor
91960592|NCT02514421|Mitosis Modulators|mitosis modulators|mesh-ancestor
91960593|NCT02514421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960594|NCT02514421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91960595|NCT02514421|Antimetabolites|antimetabolites|mesh-ancestor
91960596|NCT04499209|Naproxen|naproxen|mesh-list
91960597|NCT04499209|Pregabalin|pregabalin|mesh-list
91960598|NCT04499209|Analgesics|analgesics|mesh-ancestor
91960599|NCT04499209|Sensory System Agents|sensory system agents|mesh-ancestor
91960600|NCT04499209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91960654|NCT02508805|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91960655|NCT02508805|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91960656|NCT02508805|Parasympatholytics|parasympatholytics|mesh-ancestor
91960657|NCT02508805|Autonomic Agents|autonomic agents|mesh-ancestor
91960658|NCT02508805|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91960659|NCT02508805|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91960660|NCT02508805|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91960661|NCT02508805|Adrenergic Agents|adrenergic agents|mesh-ancestor
91960662|NCT02508805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960663|NCT03121573|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91960664|NCT03121573|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91960665|NCT03121573|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91960666|NCT03121573|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91960715|NCT02502877|Anesthetics, General|anesthetics, general|mesh-ancestor
91960716|NCT02502877|Anesthetics|anesthetics|mesh-ancestor
91960717|NCT02502877|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91960788|NCT02500225|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91960792|NCT02507635|Levocetirizine|levocetirizine|mesh-list
91960862|NCT04443049|Anthelmintics|anthelmintics|mesh-ancestor
91960863|NCT04443049|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91960864|NCT04443049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960865|NCT04443049|Tubulin Modulators|tubulin modulators|mesh-ancestor
91960866|NCT04443049|Antimitotic Agents|antimitotic agents|mesh-ancestor
91960867|NCT04443049|Mitosis Modulators|mitosis modulators|mesh-ancestor
91960868|NCT02494999|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91960869|NCT02494999|Immunologic Factors|immunologic factors|mesh-ancestor
91960870|NCT02494999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960871|NCT03341845|Avelumab|avelumab|mesh-list
91960872|NCT03341845|Axitinib|axitinib|mesh-list
91960873|NCT03341845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91960874|NCT03341845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91960923|NCT03341767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91960924|NCT02498509|Mometasone Furoate|mometasone furoate|mesh-list
91960925|NCT02498509|Levocabastine|levocabastine|mesh-list
91960926|NCT02498509|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91960927|NCT02498509|Dermatologic Agents|dermatologic agents|mesh-ancestor
91960928|NCT02498509|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91960929|NCT02498509|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91960930|NCT02498509|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91960931|NCT02498509|Histamine Antagonists|histamine antagonists|mesh-ancestor
91960932|NCT02498509|Histamine Agents|histamine agents|mesh-ancestor
91960933|NCT02498509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91960934|NCT02498509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960935|NCT02498509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960936|NCT03342859|Ulipristal acetate|ulipristal acetate|mesh-list
91960942|NCT02493283|Dapsone|dapsone|mesh-list
91960984|NCT03120715|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91960985|NCT03120715|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91960986|NCT03120715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91960987|NCT03120715|Progestins|progestins|mesh-ancestor
91960988|NCT03120715|Hormones|hormones|mesh-ancestor
91960989|NCT03120715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91960990|NCT03120715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91960991|NCT03120715|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961050|NCT03335059|Mitomycin|mitomycin|mesh-list
91961051|NCT03335059|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91961123|NCT02496715|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91961124|NCT02496715|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91961125|NCT02496715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961126|NCT02496715|Adrenergic Agents|adrenergic agents|mesh-ancestor
91961193|NCT03332953|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91961194|NCT03332953|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91961195|NCT03332953|Cholinergic Agents|cholinergic agents|mesh-ancestor
91961196|NCT03332953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91961197|NCT03332953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961198|NCT02491723|Azithromycin|azithromycin|mesh-list
91961199|NCT02491723|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91961200|NCT02491723|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961201|NCT03332719|Etanercept|etanercept|mesh-list
91961202|NCT03332719|Methotrexate|methotrexate|mesh-list
91961203|NCT03332719|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91961204|NCT03332719|Abortifacient Agents|abortifacient agents|mesh-ancestor
91961205|NCT03332719|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91961206|NCT03332719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961207|NCT03332719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91961208|NCT03332719|Antimetabolites|antimetabolites|mesh-ancestor
91961209|NCT03332719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961210|NCT03332719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961211|NCT03332719|Dermatologic Agents|dermatologic agents|mesh-ancestor
91961212|NCT03332719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961213|NCT03332719|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91961214|NCT03332719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91961215|NCT03332719|Immunologic Factors|immunologic factors|mesh-ancestor
91961216|NCT03332719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961245|NCT03330223|Purinergic Agents|purinergic agents|mesh-ancestor
91961318|NCT03328117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961319|NCT03328117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91961389|NCT02499003|Pixantrone|pixantrone|mesh-list
91961390|NCT02499003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91961391|NCT02499003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961393|NCT02499003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91961464|NCT03323047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961465|NCT03323047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961466|NCT03323047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91961536|NCT03318835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961537|NCT03318835|Leprostatic Agents|leprostatic agents|mesh-ancestor
91961538|NCT03318835|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91961539|NCT03318835|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961540|NCT03318835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91961541|NCT03318835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91961542|NCT03318835|Growth Substances|growth substances|mesh-ancestor
91961543|NCT03318835|Growth Inhibitors|growth inhibitors|mesh-ancestor
91961544|NCT03318835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961545|NCT03318835|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91961546|NCT03318835|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91961547|NCT03318835|Alkylating Agents|alkylating agents|mesh-ancestor
91961548|NCT03318835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961596|NCT03325465|Pembrolizumab|pembrolizumab|mesh-list
91961597|NCT03325465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91961598|NCT03325465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91961601|NCT01876953|Cytarabine|cytarabine|mesh-list
91961666|NCT03316339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961667|NCT03316339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91961668|NCT03316339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91961669|NCT03316339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91961674|NCT03316339|Narcotics|narcotics|mesh-ancestor
91961736|NCT04916691|Anesthetics, Local|anesthetics, local|mesh-ancestor
91961737|NCT04916691|Anesthetics|anesthetics|mesh-ancestor
91961738|NCT04916691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91961739|NCT04916691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961740|NCT04916691|Sensory System Agents|sensory system agents|mesh-ancestor
91961741|NCT04916691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91961742|NCT05105139|Triclosan|triclosan|mesh-list
91961743|NCT05105139|Coal Tar|coal tar|mesh-list
91961744|NCT05105139|Allantoin|allantoin|mesh-list
91961745|NCT05105139|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91961746|NCT05105139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91961747|NCT05105139|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91961748|NCT05105139|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91961749|NCT05105139|Antimetabolites|antimetabolites|mesh-ancestor
91961750|NCT05105139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961751|NCT05105139|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91961796|NCT01597479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961870|NCT02485873|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91961871|NCT02485873|Antithrombins|antithrombins|mesh-ancestor
91961872|NCT02485873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91961873|NCT02485873|Protease Inhibitors|protease inhibitors|mesh-ancestor
91961874|NCT02485873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961875|NCT02485873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961876|NCT02485873|Anticoagulants|anticoagulants|mesh-ancestor
91961877|NCT02485873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91961878|NCT02485873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91961879|NCT02485873|Hemostatics|hemostatics|mesh-ancestor
91961880|NCT02485873|Coagulants|coagulants|mesh-ancestor
91961881|NCT04412421|Vitamins|vitamins|mesh-list
91961882|NCT04412421|Micronutrients|micronutrients|mesh-ancestor
91961883|NCT04412421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91961884|NCT03315091|Adavosertib|adavosertib|mesh-list
91961885|NCT03315091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91961886|NCT03315091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91961887|NCT02488993|Rifaximin|rifaximin|mesh-list
91961929|NCT02482207|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91962004|NCT05245227|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91962005|NCT05245227|Abortifacient Agents|abortifacient agents|mesh-ancestor
91962006|NCT05245227|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91962008|NCT02479867|Cefadroxil|cefadroxil|mesh-list
91962075|NCT05196945|Amoxicillin|amoxicillin|mesh-list
91962076|NCT05196945|Clarithromycin|clarithromycin|mesh-list
91962077|NCT05196945|Potassium Citrate|potassium citrate|mesh-list
91962078|NCT05196945|Esomeprazole|esomeprazole|mesh-list
91962079|NCT05196945|Bismuth|bismuth|mesh-list
91962080|NCT05196945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962081|NCT05196945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91962082|NCT05196945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962083|NCT05196945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91962084|NCT05196945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962085|NCT05196945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91962086|NCT05196945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962090|NCT05196945|Antacids|antacids|mesh-ancestor
91962138|NCT02479555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962139|NCT02479555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962140|NCT02479555|Glucocorticoids|glucocorticoids|mesh-ancestor
91962141|NCT02479555|Hormones|hormones|mesh-ancestor
91962142|NCT02479555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91962143|NCT02479555|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91962144|NCT02479555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962145|NCT02479555|Protease Inhibitors|protease inhibitors|mesh-ancestor
91962146|NCT02479555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962147|NCT02479555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962148|NCT02476045|Leucovorin|leucovorin|mesh-list
91962149|NCT02476045|Fluorouracil|fluorouracil|mesh-list
91962150|NCT02476045|Oxaliplatin|oxaliplatin|mesh-list
91962151|NCT02476045|Panitumumab|panitumumab|mesh-list
91962198|NCT02480881|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91962199|NCT02480881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962200|NCT02480647|Levonorgestrel|levonorgestrel|mesh-list
91962201|NCT02480647|Etonogestrel|etonogestrel|mesh-list
91962202|NCT02480647|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91962203|NCT02480647|Contraceptive Agents|contraceptive agents|mesh-ancestor
91962204|NCT02480647|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91962205|NCT02480647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962206|NCT02480647|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91962207|NCT02480647|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91962208|NCT02480647|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91962209|NCT03100071|Apixaban|apixaban|mesh-list
91962210|NCT03100071|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91962211|NCT03100071|Antithrombins|antithrombins|mesh-ancestor
91962212|NCT03100071|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91962213|NCT03100071|Protease Inhibitors|protease inhibitors|mesh-ancestor
91962214|NCT03100071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962256|NCT05377255|Sensory System Agents|sensory system agents|mesh-ancestor
91962257|NCT05377255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962258|NCT02475499|Metformin|metformin|mesh-list
91962259|NCT02475499|Pioglitazone|pioglitazone|mesh-list
91962260|NCT02475499|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91962261|NCT02475499|Liraglutide|liraglutide|mesh-list
91962262|NCT02475499|Exenatide|exenatide|mesh-list
91962263|NCT02475499|Glimepiride|glimepiride|mesh-list
91962264|NCT02475499|Rosiglitazone|rosiglitazone|mesh-list
91962265|NCT02475499|Vildagliptin|vildagliptin|mesh-list
91962266|NCT02475499|Saxagliptin|saxagliptin|mesh-list
91962267|NCT02475499|Acarbose|acarbose|mesh-list
91962268|NCT02475499|Hypoglycemic Agents|hypoglycemic agents|mesh-list
91962269|NCT02475499|Repaglinide|repaglinide|mesh-list
91962270|NCT02475499|Gliclazide|gliclazide|mesh-list
91962271|NCT02475499|Glipizide|glipizide|mesh-list
91962272|NCT02475499|Biguanides|biguanides|mesh-list
91962273|NCT02475499|Tolbutamide|tolbutamide|mesh-list
91962274|NCT02475499|Voglibose|voglibose|mesh-list
91962275|NCT02475499|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
91962276|NCT02475499|Nateglinide|nateglinide|mesh-list
91962277|NCT02475499|Miglitol|miglitol|mesh-list
91962278|NCT02475499|Meglitinide|meglitinide|mesh-list
91962319|NCT03646617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962321|NCT03646617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962322|NCT03646617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962323|NCT02475343|Riboflavin|riboflavin|mesh-list
91962324|NCT02475343|Vitamin B Complex|vitamin b complex|mesh-ancestor
91962325|NCT02475343|Vitamins|vitamins|mesh-ancestor
91962326|NCT02475343|Micronutrients|micronutrients|mesh-ancestor
91962327|NCT02475343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962328|NCT02475343|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91962329|NCT02475343|Dermatologic Agents|dermatologic agents|mesh-ancestor
91962330|NCT02475109|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91962331|NCT02475109|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91962332|NCT04492501|Remdesivir|remdesivir|mesh-list
91962333|NCT04492501|Antimetabolites|antimetabolites|mesh-ancestor
91962334|NCT04492501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962335|NCT04492501|Antiviral Agents|antiviral agents|mesh-ancestor
91962336|NCT04492501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962338|NCT03101085|Phytoestrogens|phytoestrogens|mesh-ancestor
91962339|NCT03101085|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91962340|NCT03101085|Estrogens|estrogens|mesh-ancestor
91962374|NCT05714371|Trametinib|trametinib|mesh-list
91962376|NCT05714371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962377|NCT05714371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962378|NCT05714371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962379|NCT05714371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962380|NCT05714371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91962381|NCT05714371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962382|NCT02472613|Fluoxetine|fluoxetine|mesh-list
91962388|NCT02472613|Serotonin Agents|serotonin agents|mesh-ancestor
91962439|NCT05244577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91962513|NCT03098823|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91962514|NCT03098823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962515|NCT03108937|Dexmedetomidine|dexmedetomidine|mesh-list
91962516|NCT03108937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91962517|NCT03108937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962518|NCT03108937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962519|NCT03108937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91962520|NCT03108937|Analgesics|analgesics|mesh-ancestor
91962521|NCT03108937|Sensory System Agents|sensory system agents|mesh-ancestor
91962522|NCT03108937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91962523|NCT03108937|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91962524|NCT03108937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91962525|NCT03108937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91962526|NCT03108937|Adrenergic Agents|adrenergic agents|mesh-ancestor
91962573|NCT05010681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91962574|NCT05010681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962575|NCT05010681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962576|NCT02725411|Celecoxib|celecoxib|mesh-list
91962577|NCT02725411|Tanezumab|tanezumab|mesh-list
91962643|NCT05395507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962644|NCT05395507|Immunologic Factors|immunologic factors|mesh-ancestor
91962645|NCT05395507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962646|NCT04470843|Acetazolamide|acetazolamide|mesh-list
91962647|NCT04470843|Anticonvulsants|anticonvulsants|mesh-ancestor
91962648|NCT04470843|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91962649|NCT04470843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962650|NCT04470843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962651|NCT04470843|Diuretics|diuretics|mesh-ancestor
91962652|NCT04470843|Natriuretic Agents|natriuretic agents|mesh-ancestor
91962653|NCT04470843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962654|NCT05161741|Insulin|insulin|mesh-list
91962655|NCT05161741|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91962656|NCT05161741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962657|NCT02473627|Pioglitazone|pioglitazone|mesh-list
91962658|NCT02473627|Tolbutamide|tolbutamide|mesh-list
91962659|NCT02473627|DS-1971a|ds-1971a|mesh-list
91962660|NCT02473627|Midazolam|midazolam|mesh-list
91962661|NCT02473627|Omeprazole|omeprazole|mesh-list
91962662|NCT02473627|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91962698|NCT05035953|Protective Agents|protective agents|mesh-ancestor
91962699|NCT05035953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962700|NCT02471209|Sevoflurane|sevoflurane|mesh-list
91962701|NCT02471209|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91962702|NCT02471209|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91962703|NCT02471209|Anesthetics, General|anesthetics, general|mesh-ancestor
91962704|NCT02471209|Anesthetics|anesthetics|mesh-ancestor
91962705|NCT02471209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91962706|NCT02471209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962707|NCT02476903|Hyaluronic Acid|hyaluronic acid|mesh-list
91962708|NCT02476903|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91962709|NCT02476903|Immunologic Factors|immunologic factors|mesh-ancestor
91962710|NCT02476903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962761|NCT02472691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962762|NCT02472691|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91962763|NCT02472691|Antimetabolites|antimetabolites|mesh-ancestor
91962834|NCT03900949|Calicheamicins|calicheamicins|mesh-list
91962835|NCT03900949|Staurosporine|staurosporine|mesh-list
91962836|NCT03900949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91962837|NCT03900949|Antimetabolites|antimetabolites|mesh-ancestor
91962838|NCT03900949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962839|NCT03900949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962840|NCT03900949|Antiviral Agents|antiviral agents|mesh-ancestor
91962841|NCT03900949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91962842|NCT03900949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91962843|NCT03900949|Immunologic Factors|immunologic factors|mesh-ancestor
91962844|NCT03900949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962845|NCT03900949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91962846|NCT03900949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91962847|NCT03900949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91962848|NCT03900949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962849|NCT03900949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962850|NCT03900949|Immunotoxins|immunotoxins|mesh-ancestor
91962851|NCT03900949|Immunoconjugates|immunoconjugates|mesh-ancestor
91962852|NCT03900949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91962853|NCT02864251|Carboplatin|carboplatin|mesh-list
91962854|NCT02864251|Nivolumab|nivolumab|mesh-list
91962855|NCT02864251|Pemetrexed|pemetrexed|mesh-list
91962856|NCT02864251|Ipilimumab|ipilimumab|mesh-list
91962857|NCT02864251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962858|NCT02864251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962859|NCT02864251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91962860|NCT02864251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91962861|NCT02864251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91962862|NCT02864251|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91962863|NCT02864251|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91962867|NCT02468791|Rituximab|rituximab|mesh-list
91962868|NCT02468791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91962869|NCT02468791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91962870|NCT02468791|Immunologic Factors|immunologic factors|mesh-ancestor
91974889|NCT03053505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974890|NCT03053505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974891|NCT02181790|Acitretin|acitretin|mesh-list
91974892|NCT02181790|Keratolytic Agents|keratolytic agents|mesh-ancestor
91974893|NCT02181790|Dermatologic Agents|dermatologic agents|mesh-ancestor
91962871|NCT02468791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91962872|NCT02468791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91962873|NCT02693821|Gabapentin|gabapentin|mesh-list
91962874|NCT02693821|Analgesics|analgesics|mesh-ancestor
91962875|NCT02693821|Sensory System Agents|sensory system agents|mesh-ancestor
91962945|NCT02299999|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91962946|NCT02299999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91962947|NCT02299999|Androgen Antagonists|androgen antagonists|mesh-ancestor
91963017|NCT03174847|Amiloride|amiloride|mesh-list
91963018|NCT03174847|Spironolactone|spironolactone|mesh-list
91963019|NCT03174847|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
91963020|NCT03174847|Mineralocorticoids|mineralocorticoids|mesh-list
91963088|NCT02468323|Ondansetron|ondansetron|mesh-list
91963089|NCT02468323|Palonosetron|palonosetron|mesh-list
91963090|NCT02468323|Antiemetics|antiemetics|mesh-ancestor
91963164|NCT03312283|Growth Substances|growth substances|mesh-ancestor
91963165|NCT03312283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963166|NCT03312283|Growth Inhibitors|growth inhibitors|mesh-ancestor
91963167|NCT03312283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963168|NCT03301285|Zoledronic Acid|zoledronic acid|mesh-list
91963169|NCT03301285|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91963170|NCT03301285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963171|NCT03301207|Midazolam|midazolam|mesh-list
91963172|NCT03301207|Bupropion|bupropion|mesh-list
91963173|NCT03301207|Levonorgestrel|levonorgestrel|mesh-list
91963174|NCT03301207|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91963228|NCT02467543|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91963303|NCT00702949|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91963304|NCT00702949|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91963305|NCT00702949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963306|NCT00702949|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91963307|NCT00702949|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91963308|NCT00702949|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91963370|NCT02466373|Sensory System Agents|sensory system agents|mesh-ancestor
91963371|NCT02466373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963372|NCT02466373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963442|NCT05727163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91963443|NCT05727163|Antidotes|antidotes|mesh-ancestor
91963444|NCT05727163|Protective Agents|protective agents|mesh-ancestor
91963446|NCT05727163|Vitamins|vitamins|mesh-ancestor
91963514|NCT02719171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963590|NCT02465983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91963591|NCT02465983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91963662|NCT03297073|Analgesics|analgesics|mesh-ancestor
91963663|NCT03297073|Sensory System Agents|sensory system agents|mesh-ancestor
91963664|NCT03297073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91963665|NCT03297073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963736|NCT03296137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91963737|NCT03296137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91963811|NCT03289819|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91963812|NCT03289819|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91963881|NCT03289429|Magnesium Sulfate|magnesium sulfate|mesh-list
91963882|NCT03289429|Atorvastatin|atorvastatin|mesh-list
91963883|NCT03289429|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91963885|NCT03289429|Antimetabolites|antimetabolites|mesh-ancestor
91963951|NCT03294577|Docetaxel|docetaxel|mesh-list
91964025|NCT03376529|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91964026|NCT03376529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964098|NCT03293641|Hydroxyurea|hydroxyurea|mesh-list
91964099|NCT03293641|Zinc Sulfate|zinc sulfate|mesh-list
91964173|NCT03375671|Autonomic Agents|autonomic agents|mesh-ancestor
91964174|NCT03375671|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91964177|NCT03375671|Dopamine Agents|dopamine agents|mesh-ancestor
91964245|NCT04525235|Antitussive Agents|antitussive agents|mesh-ancestor
91964246|NCT04525235|Respiratory System Agents|respiratory system agents|mesh-ancestor
91964247|NCT04525235|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91964248|NCT04525235|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91964319|NCT03363425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964391|NCT03285607|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91964392|NCT03285607|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91964393|NCT03285607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91964394|NCT03285607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91964395|NCT03285607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964468|NCT04523675|Antidotes|antidotes|mesh-ancestor
91964540|NCT02460055|Fentanyl|fentanyl|mesh-list
91964541|NCT02460055|Nitrous Oxide|nitrous oxide|mesh-list
91964542|NCT02460055|Ondansetron|ondansetron|mesh-list
91964543|NCT02460055|Propofol|propofol|mesh-list
91964544|NCT02460055|Sevoflurane|sevoflurane|mesh-list
91964611|NCT03282643|Dalteparin|dalteparin|mesh-list
91964686|NCT02459509|Adrenergic Agents|adrenergic agents|mesh-ancestor
91964759|NCT03365141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964831|NCT03359057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91964832|NCT03359057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964833|NCT03359057|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91964834|NCT03359057|Contraceptive Agents|contraceptive agents|mesh-ancestor
91964835|NCT03359057|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91964836|NCT03359057|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91964837|NCT03359057|Hematinics|hematinics|mesh-ancestor
91964838|NCT03359057|Vitamins|vitamins|mesh-ancestor
91964839|NCT03359057|Micronutrients|micronutrients|mesh-ancestor
91964840|NCT03359057|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91964841|NCT03359057|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91964843|NCT02714569|Atorvastatin|atorvastatin|mesh-list
91964894|NCT04521491|Leucovorin|leucovorin|mesh-list
91964895|NCT04521491|Fluorouracil|fluorouracil|mesh-list
91964896|NCT04521491|Oxaliplatin|oxaliplatin|mesh-list
91964897|NCT04521491|Antimetabolites|antimetabolites|mesh-ancestor
91964898|NCT04521491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91964899|NCT04521491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91964900|NCT04521491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964901|NCT04521491|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964902|NCT04521491|Immunologic Factors|immunologic factors|mesh-ancestor
91964903|NCT04521491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964904|NCT04521491|Antidotes|antidotes|mesh-ancestor
91964905|NCT04521491|Protective Agents|protective agents|mesh-ancestor
91964954|NCT02458339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91964955|NCT02458339|Dermatologic Agents|dermatologic agents|mesh-ancestor
91964956|NCT02458339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91964957|NCT02458339|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91964958|NCT02458339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91964959|NCT02458339|Immunologic Factors|immunologic factors|mesh-ancestor
91964960|NCT02458339|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91964961|NCT02458339|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91964963|NCT03268525|Anesthetics, Local|anesthetics, local|mesh-ancestor
91964964|NCT03268525|Anesthetics|anesthetics|mesh-ancestor
91964965|NCT03268525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91964966|NCT03268525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91964967|NCT03268525|Sensory System Agents|sensory system agents|mesh-ancestor
91964968|NCT03268525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965013|NCT03263299|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91965014|NCT03263299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965016|NCT03263299|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91965017|NCT03263299|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91965018|NCT03263299|Dopamine Agonists|dopamine agonists|mesh-ancestor
91965019|NCT03263299|Dopamine Agents|dopamine agents|mesh-ancestor
91965021|NCT04444349|Ubiquinone|ubiquinone|mesh-list
91965084|NCT03946969|Antimitotic Agents|antimitotic agents|mesh-ancestor
91965090|NCT03277573|Analgesics|analgesics|mesh-ancestor
91965156|NCT04507607|Antiviral Agents|antiviral agents|mesh-ancestor
91965157|NCT04507607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965229|NCT03350633|Antimetabolites|antimetabolites|mesh-ancestor
91965230|NCT03350633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965231|NCT03350633|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91965232|NCT03350633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965233|NCT03350633|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91965234|NCT03350633|Immunologic Factors|immunologic factors|mesh-ancestor
91965235|NCT03350633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965236|NCT03350633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91965237|NCT03265795|Ether|ether|mesh-list
91965238|NCT03265795|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91965239|NCT03265795|Anesthetics, General|anesthetics, general|mesh-ancestor
91965240|NCT03265795|Anesthetics|anesthetics|mesh-ancestor
91965241|NCT03265795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965242|NCT03265795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965243|NCT03350399|Mitogens|mitogens|mesh-list
91965244|NCT03350399|Mitosis Modulators|mitosis modulators|mesh-ancestor
91965246|NCT03350321|Darbepoetin alfa|darbepoetin alfa|mesh-list
91965286|NCT03252457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91965287|NCT03252457|Antiemetics|antiemetics|mesh-ancestor
91965288|NCT03252457|Autonomic Agents|autonomic agents|mesh-ancestor
91965289|NCT03252457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965290|NCT03252457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965291|NCT03252457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91965292|NCT03252457|Glucocorticoids|glucocorticoids|mesh-ancestor
91965294|NCT03252457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965295|NCT03252457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91965350|NCT02455609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91965351|NCT02455609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91965352|NCT05723627|Propofol|propofol|mesh-list
91965353|NCT05723627|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91965354|NCT05723627|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91965355|NCT05723627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965356|NCT05723627|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91965417|NCT05513807|Nicotinic Acids|nicotinic acids|mesh-list
91965418|NCT05513807|Vitamin B Complex|vitamin b complex|mesh-ancestor
91965419|NCT05513807|Vitamins|vitamins|mesh-ancestor
91965420|NCT05513807|Micronutrients|micronutrients|mesh-ancestor
91965421|NCT05513807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965422|NCT05513807|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91965423|NCT05513807|Antimetabolites|antimetabolites|mesh-ancestor
91965424|NCT05513807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965425|NCT05513807|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91965426|NCT05513807|Vasodilator Agents|vasodilator agents|mesh-ancestor
91965427|NCT04504877|Cannabidiol|cannabidiol|mesh-list
91965428|NCT04504877|Anticonvulsants|anticonvulsants|mesh-ancestor
91965429|NCT02518295|Sulfalene|sulfalene|mesh-list
91965430|NCT02518295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965431|NCT02518295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91965432|NCT02518295|Antimalarials|antimalarials|mesh-ancestor
91965433|NCT02518295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91965434|NCT02518295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91965435|NCT03257683|Ranolazine|ranolazine|mesh-list
91965436|NCT03257683|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91965437|NCT03257683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965438|NCT03257683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965448|NCT03351569|Antibodies|antibodies|mesh-list
91965541|NCT05196191|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91965542|NCT05196191|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91965543|NCT05196191|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91965544|NCT05196191|Dermatologic Agents|dermatologic agents|mesh-ancestor
91965545|NCT03467113|Cannabidiol|cannabidiol|mesh-list
91965546|NCT03467113|Anticonvulsants|anticonvulsants|mesh-ancestor
91965547|NCT03434041|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91965548|NCT03434041|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91965549|NCT03434041|Sertraline|sertraline|mesh-list
91965550|NCT03434041|Antidepressive Agents|antidepressive agents|mesh-list
91965551|NCT03434041|Esketamine|esketamine|mesh-list
91965552|NCT03434041|Escitalopram|escitalopram|mesh-list
91965553|NCT03434041|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91965554|NCT03434041|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91967249|NCT02138955|Curcumin|curcumin|mesh-list
91965555|NCT03434041|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91965556|NCT03434041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965557|NCT03434041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965558|NCT03434041|Serotonin Agents|serotonin agents|mesh-ancestor
91965559|NCT03434041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965560|NCT03434041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91965561|NCT03434041|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91965562|NCT03434041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91965592|NCT03250039|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91965593|NCT03250039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965594|NCT03250039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965595|NCT02517827|Paclitaxel|paclitaxel|mesh-list
91965664|NCT03346187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91965665|NCT03346187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91965666|NCT04487743|Liraglutide|liraglutide|mesh-list
91965667|NCT04487743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91965668|NCT04487743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91965669|NCT04487743|Incretins|incretins|mesh-ancestor
91965671|NCT04487743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91965672|NCT05010629|Carboplatin|carboplatin|mesh-list
91965673|NCT05010629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91965674|NCT05584631|Immunoglobulins|immunoglobulins|mesh-list
91965675|NCT05584631|Antibodies|antibodies|mesh-list
91965676|NCT05584631|gamma-Globulins|gamma-globulins|mesh-list
91965678|NCT05584631|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91965729|NCT02455921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965733|NCT04786613|Hyaluronic Acid|hyaluronic acid|mesh-list
91965798|NCT03249025|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91965799|NCT03249025|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91965800|NCT03249025|Anesthetics, General|anesthetics, general|mesh-ancestor
91965801|NCT03249025|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91965802|NCT03249025|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91965803|NCT03249025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965804|NCT03248713|Mifepristone|mifepristone|mesh-list
91965866|NCT03363503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91965867|NCT03363503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91965868|NCT03248791|Phenylephrine|phenylephrine|mesh-list
91965869|NCT03248791|Oxymetazoline|oxymetazoline|mesh-list
91965870|NCT03248791|Norepinephrine|norepinephrine|mesh-list
91965933|NCT03248401|Vasodilator Agents|vasodilator agents|mesh-ancestor
91965934|NCT03248401|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91965935|NCT03248401|Protective Agents|protective agents|mesh-ancestor
91965936|NCT03248401|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91965939|NCT02516423|Dexamethasone|dexamethasone|mesh-list
91966003|NCT04500743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966078|NCT03952091|Autonomic Agents|autonomic agents|mesh-ancestor
91966079|NCT03952091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966080|NCT03952091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966081|NCT03952091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91966082|NCT03952091|Glucocorticoids|glucocorticoids|mesh-ancestor
91966083|NCT03952091|Hormones|hormones|mesh-ancestor
91966084|NCT03952091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91966085|NCT03952091|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91966086|NCT03952091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966087|NCT03952091|Protease Inhibitors|protease inhibitors|mesh-ancestor
91966088|NCT03952091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966089|NCT03952091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966090|NCT03952091|Immunologic Factors|immunologic factors|mesh-ancestor
91966091|NCT03952091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91966092|NCT03952091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91966093|NCT03952091|Growth Substances|growth substances|mesh-ancestor
91966094|NCT03952091|Growth Inhibitors|growth inhibitors|mesh-ancestor
91966137|NCT03246685|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91966211|NCT03234673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966212|NCT03234673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966213|NCT03234673|Dermatologic Agents|dermatologic agents|mesh-ancestor
91966214|NCT03148613|Carbon Monoxide|carbon monoxide|mesh-list
91966215|NCT03148613|Antimetabolites|antimetabolites|mesh-ancestor
91966216|NCT03148613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966217|NCT03148613|Gasotransmitters|gasotransmitters|mesh-ancestor
91966218|NCT03148613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966219|NCT03148613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967625|NCT03329183|Irinotecan|irinotecan|mesh-list
91966221|NCT03243643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91966222|NCT03243643|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91966223|NCT03243643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966224|NCT03243643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966225|NCT03234517|Clindamycin|clindamycin|mesh-list
91966226|NCT03234517|Clindamycin palmitate|clindamycin palmitate|mesh-list
91966227|NCT03234517|Clindamycin phosphate|clindamycin phosphate|mesh-list
91966228|NCT03234517|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91966229|NCT03234517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966230|NCT03234517|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91966231|NCT03234517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966232|NCT03234517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966233|NCT03238183|Hyaluronic Acid|hyaluronic acid|mesh-list
91966234|NCT03238183|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91966235|NCT03238183|Immunologic Factors|immunologic factors|mesh-ancestor
91966236|NCT03238183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966258|NCT03237637|Adrenergic Agents|adrenergic agents|mesh-ancestor
91966259|NCT03237637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966260|NCT03237637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91966262|NCT03237637|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91966329|NCT02512523|Protease Inhibitors|protease inhibitors|mesh-ancestor
91966330|NCT02512523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91966332|NCT03233893|Calcium, Dietary|calcium, dietary|mesh-list
91966402|NCT02511665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966403|NCT02514629|Metformin|metformin|mesh-list
91966476|NCT03232957|Morphine|morphine|mesh-list
91966477|NCT03232957|Bupivacaine|bupivacaine|mesh-list
91966478|NCT03232957|Anesthetics, Local|anesthetics, local|mesh-ancestor
91966479|NCT03232957|Anesthetics|anesthetics|mesh-ancestor
91966480|NCT03232957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91966481|NCT03232957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91966482|NCT03232957|Sensory System Agents|sensory system agents|mesh-ancestor
91966483|NCT03232957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966484|NCT03232957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91966485|NCT03232957|Narcotics|narcotics|mesh-ancestor
91966486|NCT03232957|Analgesics|analgesics|mesh-ancestor
91966487|NCT02513849|Tamoxifen|tamoxifen|mesh-list
91966540|NCT02513693|Cholinergic Agents|cholinergic agents|mesh-ancestor
91966541|NCT02513693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966613|NCT03235609|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91966614|NCT03235609|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91966615|NCT03235609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91966683|NCT02509559|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91966756|NCT03344393|Sensory System Agents|sensory system agents|mesh-ancestor
91966757|NCT03344393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91966760|NCT03344393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91966827|NCT05504057|Antiviral Agents|antiviral agents|mesh-ancestor
91966828|NCT05504057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91966829|NCT05504057|Dopamine Agents|dopamine agents|mesh-ancestor
91966902|NCT02495363|Bupivacaine|bupivacaine|mesh-list
91966903|NCT02495363|Anesthetics, Local|anesthetics, local|mesh-ancestor
91966976|NCT04494659|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91967049|NCT05035485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967051|NCT02498015|Ribavirin|ribavirin|mesh-list
91967052|NCT02498015|Antimetabolites|antimetabolites|mesh-ancestor
91967053|NCT02498015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967054|NCT02498015|Antiviral Agents|antiviral agents|mesh-ancestor
91967055|NCT02498015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967056|NCT02494505|Mycophenolic Acid|mycophenolic acid|mesh-list
91967057|NCT02494505|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91967058|NCT02494505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967059|NCT02494505|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91967060|NCT02494505|Antitubercular Agents|antitubercular agents|mesh-ancestor
91967061|NCT02494505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967062|NCT02494505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967063|NCT02494505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967106|NCT03095469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967107|NCT03095469|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91967181|NCT03120923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91967182|NCT03120923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91967183|NCT03120923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967184|NCT03120923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967186|NCT03120923|Hormones|hormones|mesh-ancestor
91967188|NCT03120923|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91967248|NCT05042271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967250|NCT02138955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91967251|NCT02138955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967252|NCT02138955|Analgesics|analgesics|mesh-ancestor
91967253|NCT02138955|Sensory System Agents|sensory system agents|mesh-ancestor
91967254|NCT02138955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967255|NCT02138955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967256|NCT02138955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967311|NCT02496299|Anesthetics, Local|anesthetics, local|mesh-ancestor
91967312|NCT02496299|Anesthetics|anesthetics|mesh-ancestor
91967313|NCT02496299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91967314|NCT02496299|Sensory System Agents|sensory system agents|mesh-ancestor
91967315|NCT02493725|Eculizumab|eculizumab|mesh-list
91967316|NCT02493725|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91967317|NCT02493725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91967318|NCT02493725|Immunologic Factors|immunologic factors|mesh-ancestor
91967319|NCT02493725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967376|NCT02493179|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91967377|NCT02493179|Analgesics|analgesics|mesh-ancestor
91967378|NCT02493179|Sensory System Agents|sensory system agents|mesh-ancestor
91967379|NCT02493179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967380|NCT02493179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967381|NCT02493179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967382|NCT02493179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967383|NCT03336437|Estradiol|estradiol|mesh-list
91967384|NCT03336437|Estrogens|estrogens|mesh-ancestor
91967385|NCT03336437|Hormones|hormones|mesh-ancestor
91967386|NCT03336437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967387|NCT03336437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967388|NCT03337373|Cisatracurium|cisatracurium|mesh-list
91967441|NCT03094533|Propofol|propofol|mesh-list
91967442|NCT03094533|Sevoflurane|sevoflurane|mesh-list
91967514|NCT03329729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91967515|NCT03329729|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91967516|NCT03329729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967517|NCT02492477|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91967518|NCT02492477|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91967519|NCT02492477|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91967520|NCT02492477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967521|NCT03095547|Cyclosporine|cyclosporine|mesh-list
91967522|NCT03095547|Posaconazole|posaconazole|mesh-list
91967523|NCT03095547|Olorofim|olorofim|mesh-list
91967524|NCT03095547|Pantoprazole|pantoprazole|mesh-list
91967525|NCT03095547|Tacrolimus|tacrolimus|mesh-list
91967526|NCT03095547|Cyclosporins|cyclosporins|mesh-list
91967527|NCT03095547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91967528|NCT03095547|Immunologic Factors|immunologic factors|mesh-ancestor
91967529|NCT03095547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967530|NCT03095547|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91967531|NCT03095547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967532|NCT03095547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967533|NCT03095547|Antifungal Agents|antifungal agents|mesh-ancestor
91967534|NCT03095547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967569|NCT03334487|Autonomic Agents|autonomic agents|mesh-ancestor
91967570|NCT03334487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967571|NCT03334487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967572|NCT03334487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967573|NCT03334487|Glucocorticoids|glucocorticoids|mesh-ancestor
91967575|NCT03334487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91967576|NCT03334487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91967577|NCT03334487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967578|NCT03334487|Immunoconjugates|immunoconjugates|mesh-ancestor
91967579|NCT03334487|Immunologic Factors|immunologic factors|mesh-ancestor
91967580|NCT05038449|Colchicine|colchicine|mesh-list
91967581|NCT05038449|Gout Suppressants|gout suppressants|mesh-ancestor
91967582|NCT05038449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91967583|NCT05038449|Tubulin Modulators|tubulin modulators|mesh-ancestor
91967584|NCT05038449|Antimitotic Agents|antimitotic agents|mesh-ancestor
91967585|NCT05038449|Mitosis Modulators|mitosis modulators|mesh-ancestor
91967586|NCT05038449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967587|NCT05038449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967588|NCT05038059|Acetic Acid|acetic acid|mesh-list
91967589|NCT05038059|Retinol acetate|retinol acetate|mesh-list
91967590|NCT05038059|Ethylene|ethylene|mesh-list
91967591|NCT05038059|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91967592|NCT05038059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91967619|NCT03329261|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91967693|NCT05018637|Teriparatide|teriparatide|mesh-list
91967695|NCT05018637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967767|NCT03230851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91967768|NCT03230851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967769|NCT03230851|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91967770|NCT03230851|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91967771|NCT03230851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91967772|NCT03230851|Antipyretics|antipyretics|mesh-ancestor
91967773|NCT05464433|Tislelizumab|tislelizumab|mesh-list
91967774|NCT05464433|Mitoxantrone|mitoxantrone|mesh-list
91967775|NCT05464433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91967776|NCT05464433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91967777|NCT05464433|Analgesics|analgesics|mesh-ancestor
91967778|NCT05464433|Sensory System Agents|sensory system agents|mesh-ancestor
91967779|NCT05464433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91967780|NCT05464433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91967781|NCT05464433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91967782|NCT05464433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91967825|NCT03090087|Regadenoson|regadenoson|mesh-list
91967826|NCT03090087|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
91967896|NCT03331523|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91967897|NCT03331523|Betamethasone benzoate|betamethasone benzoate|mesh-list
91967900|NCT03331523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91967969|NCT03078933|Respiratory System Agents|respiratory system agents|mesh-ancestor
91967970|NCT03078933|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91967971|NCT03078933|Antioxidants|antioxidants|mesh-ancestor
91967972|NCT03078933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91967973|NCT03078933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91967974|NCT03078933|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91967975|NCT03078933|Vasodilator Agents|vasodilator agents|mesh-ancestor
91967976|NCT03078933|Gasotransmitters|gasotransmitters|mesh-ancestor
91967977|NCT03078933|Protective Agents|protective agents|mesh-ancestor
91967978|NCT03092193|Naproxen|naproxen|mesh-list
91967979|NCT03092193|Esomeprazole|esomeprazole|mesh-list
91967980|NCT03092193|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91967981|NCT03092193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91967982|NCT03092193|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91968029|NCT05015361|Anesthetics, General|anesthetics, general|mesh-ancestor
91968030|NCT05015361|Anesthetics|anesthetics|mesh-ancestor
91968031|NCT01375075|Atorvastatin|atorvastatin|mesh-list
91968032|NCT01375075|Evacetrapib|evacetrapib|mesh-list
91968033|NCT01375075|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91968034|NCT01375075|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91968035|NCT01375075|Antimetabolites|antimetabolites|mesh-ancestor
91968036|NCT01375075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968037|NCT01375075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91968038|NCT01375075|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91968039|NCT01375075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968040|NCT00706433|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91968041|NCT00706433|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91968042|NCT00706433|Dermatologic Agents|dermatologic agents|mesh-ancestor
91968043|NCT03240055|Etomidate|etomidate|mesh-list
91968044|NCT03240055|Anesthetics|anesthetics|mesh-ancestor
91968045|NCT03240055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968046|NCT03240055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968047|NCT03240055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91968085|NCT03239821|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968086|NCT03230227|Bupivacaine|bupivacaine|mesh-list
91968094|NCT03078465|Ticagrelor|ticagrelor|mesh-list
91968159|NCT03324503|Prednisolone|prednisolone|mesh-list
91968160|NCT03324503|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91968161|NCT03324503|Methylprednisolone|methylprednisolone|mesh-list
91968162|NCT03324503|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91968163|NCT03324503|Prednisolone acetate|prednisolone acetate|mesh-list
91968164|NCT03324503|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91968228|NCT03227653|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91968229|NCT03227653|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91968297|NCT03323567|Anesthetics, Local|anesthetics, local|mesh-ancestor
91968298|NCT03323567|Anesthetics|anesthetics|mesh-ancestor
91968299|NCT03323567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968300|NCT03323567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968301|NCT03323567|Sensory System Agents|sensory system agents|mesh-ancestor
91968366|NCT03091569|Hemostatics|hemostatics|mesh-ancestor
91968367|NCT03091569|Coagulants|coagulants|mesh-ancestor
91968368|NCT04948749|Sirolimus|sirolimus|mesh-list
91968369|NCT04948749|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91968442|NCT03206671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91968445|NCT03206671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968515|NCT03319043|Formoterol Fumarate|formoterol fumarate|mesh-list
91968516|NCT03319043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968517|NCT03319043|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91968518|NCT03319043|Autonomic Agents|autonomic agents|mesh-ancestor
91968519|NCT03319043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968520|NCT03319043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968521|NCT03319043|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91968522|NCT03319043|Respiratory System Agents|respiratory system agents|mesh-ancestor
91968523|NCT03319043|Glucocorticoids|glucocorticoids|mesh-ancestor
91968527|NCT03319043|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91968579|NCT03225937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968580|NCT03318887|Ribavirin|ribavirin|mesh-list
91968581|NCT03318887|Sofosbuvir|sofosbuvir|mesh-list
91968582|NCT03318887|Antimetabolites|antimetabolites|mesh-ancestor
91968583|NCT03318887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968584|NCT03318887|Antiviral Agents|antiviral agents|mesh-ancestor
91968585|NCT03318887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968586|NCT03119077|Itraconazole|itraconazole|mesh-list
91968587|NCT03119077|Antifungal Agents|antifungal agents|mesh-ancestor
91968588|NCT03119077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968589|NCT03119077|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91968590|NCT03119077|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91968591|NCT03119077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968592|NCT03119077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968594|NCT03119077|Hormone Antagonists|hormone antagonists|mesh-ancestor
91968638|NCT03318419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91968639|NCT03318419|Antimetabolites|antimetabolites|mesh-ancestor
91968640|NCT03318419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968641|NCT03318419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968642|NCT03318419|Antiviral Agents|antiviral agents|mesh-ancestor
91968643|NCT03318419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968644|NCT03318419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91968645|NCT03318419|Immunologic Factors|immunologic factors|mesh-ancestor
91968646|NCT03318419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968647|NCT03321773|Amoxicillin|amoxicillin|mesh-list
91968704|NCT05001243|Sensory System Agents|sensory system agents|mesh-ancestor
91968705|NCT05001243|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968706|NCT05001243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968708|NCT03225781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91968709|NCT03225781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968710|NCT03205891|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91968711|NCT03205891|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91968712|NCT03205891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968713|NCT03205891|Immunotoxins|immunotoxins|mesh-ancestor
91968714|NCT03205891|Immunoconjugates|immunoconjugates|mesh-ancestor
91968715|NCT03205891|Immunologic Factors|immunologic factors|mesh-ancestor
91968717|NCT03221023|Vancomycin|vancomycin|mesh-list
91968770|NCT03224923|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91968771|NCT03224923|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91968772|NCT03224923|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91968773|NCT03224923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968774|NCT03224923|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91968775|NCT03224923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91968776|NCT03224923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91968777|NCT03224923|Antipyretics|antipyretics|mesh-ancestor
91968778|NCT03224923|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91968779|NCT03224923|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91968780|NCT03224923|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91968781|NCT03224923|Purinergic Agents|purinergic agents|mesh-ancestor
91968782|NCT03224923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968783|NCT05004753|Artemisinins|artemisinins|mesh-list
91968784|NCT05004753|Artemisinin|artemisinin|mesh-list
91968785|NCT05004753|Dexamethasone|dexamethasone|mesh-list
91968786|NCT05004753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91968787|NCT05004753|Antiemetics|antiemetics|mesh-ancestor
91968788|NCT05004753|Autonomic Agents|autonomic agents|mesh-ancestor
91968789|NCT05004753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968790|NCT05004753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968791|NCT05004753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91968792|NCT05004753|Glucocorticoids|glucocorticoids|mesh-ancestor
91968793|NCT05004753|Hormones|hormones|mesh-ancestor
91968794|NCT05004753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91968795|NCT05004753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91968796|NCT05004753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91968797|NCT05004753|Antimalarials|antimalarials|mesh-ancestor
91968798|NCT05004753|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91968799|NCT05004753|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91968800|NCT05004753|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968801|NCT05004519|Dexmedetomidine|dexmedetomidine|mesh-list
91968802|NCT05004519|Remifentanil|remifentanil|mesh-list
91968811|NCT05004519|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91968812|NCT05004519|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91968813|NCT05004519|Adrenergic Agents|adrenergic agents|mesh-ancestor
91968814|NCT05004519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91968815|NCT05004519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968816|NCT05004519|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91968818|NCT02486549|Bupivacaine|bupivacaine|mesh-list
91968819|NCT02486549|Anesthetics, Local|anesthetics, local|mesh-ancestor
91968820|NCT02486549|Anesthetics|anesthetics|mesh-ancestor
91968821|NCT02486549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91968822|NCT02486549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91968823|NCT02486549|Sensory System Agents|sensory system agents|mesh-ancestor
91968824|NCT02486549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91968825|NCT02490605|Salicylic Acid|salicylic acid|mesh-list
91968826|NCT02490605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91968827|NCT02490605|Antifungal Agents|antifungal agents|mesh-ancestor
91968828|NCT02490605|Keratolytic Agents|keratolytic agents|mesh-ancestor
91968869|NCT02452255|Metoprolol|metoprolol|mesh-list
91968870|NCT02452255|Fenofibrate|fenofibrate|mesh-list
91968941|NCT03204877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91968942|NCT03204877|Protective Agents|protective agents|mesh-ancestor
91969012|NCT03075657|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91969013|NCT03075657|Serotonin Agents|serotonin agents|mesh-ancestor
91969014|NCT03075657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969087|NCT03204097|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91969088|NCT03204097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969089|NCT03223519|Ibuprofen|ibuprofen|mesh-list
91969090|NCT03223519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969091|NCT03223519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969092|NCT03223519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91969093|NCT03223519|Analgesics|analgesics|mesh-ancestor
91969094|NCT03223519|Sensory System Agents|sensory system agents|mesh-ancestor
91969095|NCT03223519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969096|NCT03223519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969097|NCT03223519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969098|NCT03223519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91969099|NCT03223519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969100|NCT03223519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969101|NCT03320915|Cholecalciferol|cholecalciferol|mesh-list
91969102|NCT03320915|Vitamin D|vitamin d|mesh-list
91969103|NCT03320915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91969104|NCT03320915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969105|NCT03320915|Vitamins|vitamins|mesh-ancestor
91969106|NCT03320915|Micronutrients|micronutrients|mesh-ancestor
91969107|NCT03320915|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91969138|NCT02484833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969142|NCT03204019|Tegafur|tegafur|mesh-list
91969213|NCT02485067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969214|NCT02485067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969215|NCT02485067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969216|NCT02485067|Urological Agents|urological agents|mesh-ancestor
91969283|NCT03203005|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91969284|NCT03203005|Alkylating Agents|alkylating agents|mesh-ancestor
91969285|NCT03203005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969286|NCT03203005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969287|NCT03203005|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91969288|NCT02484209|Metformin|metformin|mesh-list
91969289|NCT02484209|Glimepiride|glimepiride|mesh-list
91969290|NCT02484209|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91969291|NCT02484209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969292|NCT02484209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91969293|NCT02484209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969294|NCT02484209|Immunologic Factors|immunologic factors|mesh-ancestor
91969295|NCT04999137|Vitamins|vitamins|mesh-list
91969296|NCT04999137|Thiamine|thiamine|mesh-list
91969297|NCT04999137|Micronutrients|micronutrients|mesh-ancestor
91969298|NCT04999137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969299|NCT04999137|Vitamin B Complex|vitamin b complex|mesh-ancestor
91969300|NCT02484053|Rituximab|rituximab|mesh-list
91969301|NCT02484053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969340|NCT03202459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969342|NCT03202459|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91969343|NCT03202459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91969344|NCT03202459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969345|NCT03202459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91969346|NCT03202459|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91969347|NCT03202459|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91969348|NCT03202459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969349|NCT03202459|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969350|NCT03202459|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91969351|NCT03202459|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91969352|NCT03202459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969353|NCT03202459|Antimanic Agents|antimanic agents|mesh-ancestor
91969354|NCT04991181|Zamicastat|zamicastat|mesh-list
91969355|NCT04991181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969356|NCT04991181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969357|NCT04492319|Neostigmine|neostigmine|mesh-list
91969358|NCT04492319|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91969359|NCT04492319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969361|NCT04492319|Cholinergic Agents|cholinergic agents|mesh-ancestor
91969392|NCT05002725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969393|NCT05002725|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91969394|NCT05002725|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91969395|NCT05002725|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91969396|NCT05002725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91974894|NCT03051945|Ketamine|ketamine|mesh-list
91974895|NCT03051945|Analgesics|analgesics|mesh-ancestor
91974896|NCT03051945|Sensory System Agents|sensory system agents|mesh-ancestor
91974897|NCT03051945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974898|NCT03051945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974900|NCT03051945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91974901|NCT03051945|Anesthetics, General|anesthetics, general|mesh-ancestor
91974902|NCT03051945|Anesthetics|anesthetics|mesh-ancestor
91974903|NCT03051945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974904|NCT03051945|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91974905|NCT03051945|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91974906|NCT03051945|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91974907|NCT03051945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974908|NCT04899765|Vaccines|vaccines|mesh-list
91974909|NCT04899765|BCG Vaccine|bcg vaccine|mesh-list
91974910|NCT04899765|Immunologic Factors|immunologic factors|mesh-ancestor
91974911|NCT04899765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974912|NCT04899765|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91974913|NCT04899453|Rituximab|rituximab|mesh-list
91974914|NCT04899453|Methotrexate|methotrexate|mesh-list
91974915|NCT04899453|Zanubrutinib|zanubrutinib|mesh-list
91974916|NCT04899453|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974917|NCT04899453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974918|NCT04899453|Immunologic Factors|immunologic factors|mesh-ancestor
91974919|NCT04899453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974920|NCT04899453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974921|NCT04899453|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91974922|NCT04899453|Abortifacient Agents|abortifacient agents|mesh-ancestor
91974923|NCT04899453|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91974924|NCT04899453|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91974925|NCT04899453|Antimetabolites|antimetabolites|mesh-ancestor
91974926|NCT04899453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974927|NCT04899453|Dermatologic Agents|dermatologic agents|mesh-ancestor
91974928|NCT04899453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974929|NCT04899453|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91974930|NCT04899453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974931|NCT04899453|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91974932|NCT04899453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974933|NCT03051555|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91974934|NCT03051555|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92090415|NCT00892606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974937|NCT04898751|Nivolumab|nivolumab|mesh-list
91974938|NCT04898751|Ipilimumab|ipilimumab|mesh-list
91974939|NCT04898751|Atezolizumab|atezolizumab|mesh-list
91974940|NCT04898751|Durvalumab|durvalumab|mesh-list
91974941|NCT04898751|Avelumab|avelumab|mesh-list
91974942|NCT04898751|Cemiplimab|cemiplimab|mesh-list
91974943|NCT04898751|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91974944|NCT04898751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974945|NCT04898751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975026|NCT04897269|Hormones|hormones|mesh-ancestor
91974946|NCT04898751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974947|NCT04898907|Moxifloxacin|moxifloxacin|mesh-list
91974948|NCT04898907|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91974949|NCT04898907|Mitogens|mitogens|mesh-list
91974950|NCT04898907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974951|NCT04898907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974952|NCT04898907|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91974953|NCT04898907|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91974954|NCT04898907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974955|NCT04898907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969397|NCT05002725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969398|NCT03315533|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91974956|NCT04898907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974957|NCT04898907|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91974958|NCT04898907|Contraceptive Agents|contraceptive agents|mesh-ancestor
91974959|NCT04898907|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91974960|NCT04898907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974961|NCT04898907|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91974962|NCT04898907|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91974963|NCT04898907|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91974964|NCT04898907|Mitosis Modulators|mitosis modulators|mesh-ancestor
91974965|NCT04908813|Capecitabine|capecitabine|mesh-list
91974967|NCT04908813|Trastuzumab|trastuzumab|mesh-list
91974968|NCT04908813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91974969|NCT04908813|Antimetabolites|antimetabolites|mesh-ancestor
91974970|NCT04908813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974971|NCT04908813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974972|NCT04908813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974973|NCT04913571|Tislelizumab|tislelizumab|mesh-list
91974974|NCT04913571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974975|NCT04913571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974977|NCT03051711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974978|NCT03051711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974980|NCT04908345|Methadone|methadone|mesh-list
91974981|NCT04908345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91974982|NCT04908345|Narcotics|narcotics|mesh-ancestor
91974983|NCT04908345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91974984|NCT04908345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974985|NCT04908345|Analgesics|analgesics|mesh-ancestor
91974986|NCT04908345|Sensory System Agents|sensory system agents|mesh-ancestor
91974987|NCT04908345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974988|NCT04908345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91974989|NCT04908345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91974990|NCT04908345|Anesthetics, General|anesthetics, general|mesh-ancestor
91974991|NCT04908345|Anesthetics|anesthetics|mesh-ancestor
91974992|NCT04908345|Antitussive Agents|antitussive agents|mesh-ancestor
91974993|NCT04908345|Respiratory System Agents|respiratory system agents|mesh-ancestor
91974994|NCT04893993|Thiamine|thiamine|mesh-list
91974995|NCT04893993|Vitamin B Complex|vitamin b complex|mesh-ancestor
91974996|NCT04893993|Vitamins|vitamins|mesh-ancestor
91974997|NCT04893993|Micronutrients|micronutrients|mesh-ancestor
91974998|NCT04893993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974999|NCT03051243|Insulin|insulin|mesh-list
91975000|NCT03051243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91975001|NCT03051243|Linagliptin|linagliptin|mesh-list
91975002|NCT03051243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91975003|NCT03051243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975004|NCT03051243|Incretins|incretins|mesh-ancestor
91975005|NCT03051243|Hormones|hormones|mesh-ancestor
91975006|NCT03051243|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975007|NCT03051243|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91975008|NCT03051243|Protease Inhibitors|protease inhibitors|mesh-ancestor
91975009|NCT03051243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975015|NCT04897737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91975016|NCT04897737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975017|NCT04897737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975018|NCT04897737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91975019|NCT04897737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91975020|NCT04148781|4-Aminopyridine|4-aminopyridine|mesh-list
91975021|NCT04148781|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91975022|NCT04148781|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975023|NCT04148781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975024|NCT04897269|Progesterone|progesterone|mesh-list
91975025|NCT04897269|Progestins|progestins|mesh-ancestor
91975027|NCT04897269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975028|NCT04897269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975029|NCT04891497|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91969399|NCT03315533|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91975030|NCT04891497|Dermatologic Agents|dermatologic agents|mesh-ancestor
91975031|NCT04891497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975032|NCT04891497|Immunologic Factors|immunologic factors|mesh-ancestor
91975033|NCT04891497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975034|NCT04896177|Sirolimus|sirolimus|mesh-list
91975035|NCT04896177|Paclitaxel|paclitaxel|mesh-list
91975036|NCT04896177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91975037|NCT04896177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975038|NCT04896177|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975039|NCT04896177|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975040|NCT04896177|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975041|NCT04896177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975042|NCT04896177|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91975043|NCT04896177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975044|NCT04896177|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91975045|NCT04896177|Antifungal Agents|antifungal agents|mesh-ancestor
91975046|NCT04896177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975047|NCT04896177|Immunologic Factors|immunologic factors|mesh-ancestor
91975048|NCT04896177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975049|NCT03052569|Agerafenib|agerafenib|mesh-list
91975050|NCT03052569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91975051|NCT03052569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975052|NCT03052569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975053|NCT04906317|Midazolam|midazolam|mesh-list
91975054|NCT04906317|Dezocine|dezocine|mesh-list
91975055|NCT04906317|Propofol|propofol|mesh-list
91975056|NCT04906317|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975057|NCT04906317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975058|NCT04906317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975059|NCT04906317|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975060|NCT04906317|Anesthetics, General|anesthetics, general|mesh-ancestor
91975061|NCT04906317|Anesthetics|anesthetics|mesh-ancestor
91975062|NCT04906317|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91975063|NCT04906317|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91975064|NCT04906317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91975065|NCT04906317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975066|NCT04906317|GABA Modulators|gaba modulators|mesh-ancestor
91975067|NCT04906317|GABA Agents|gaba agents|mesh-ancestor
91975068|NCT04906317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975069|NCT04906317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975070|NCT04906317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91975071|NCT04906317|Narcotics|narcotics|mesh-ancestor
91975072|NCT04906317|Analgesics|analgesics|mesh-ancestor
91975073|NCT04906317|Sensory System Agents|sensory system agents|mesh-ancestor
91975074|NCT04906317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975075|NCT03051087|Ganirelix|ganirelix|mesh-list
91975076|NCT03051087|Hormone Antagonists|hormone antagonists|mesh-ancestor
91975077|NCT03051087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975078|NCT03051087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975086|NCT04430361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975087|NCT04430361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975088|NCT04430361|Glucocorticoids|glucocorticoids|mesh-ancestor
91975089|NCT04430361|Hormones|hormones|mesh-ancestor
91975090|NCT04430361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975091|NCT04430361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975092|NCT04430361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975093|NCT04430361|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91975094|NCT04430361|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91975095|NCT04430361|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91975096|NCT04430361|Contraceptive Agents|contraceptive agents|mesh-ancestor
91975097|NCT04430361|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91975098|NCT04430361|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91975099|NCT04430361|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91975100|NCT04430361|Appetite Stimulants|appetite stimulants|mesh-ancestor
91975101|NCT04430361|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91975102|NCT04906083|Mitogens|mitogens|mesh-list
91975103|NCT04906083|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975104|NCT04906083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975105|NCT02616783|Lamivudine|lamivudine|mesh-list
91975106|NCT02616783|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91969400|NCT03315533|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91969401|NCT03315533|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975107|NCT02616783|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91975108|NCT02616783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975109|NCT02616783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975110|NCT02616783|Antiviral Agents|antiviral agents|mesh-ancestor
91975111|NCT02616783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975112|NCT02616783|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91975113|NCT02616783|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91975114|NCT04895007|Vaccines|vaccines|mesh-list
91975115|NCT04895007|Immunologic Factors|immunologic factors|mesh-ancestor
91975116|NCT04895007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975117|NCT04890561|Lemborexant|lemborexant|mesh-list
91975118|NCT04890561|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
91975119|NCT04890561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975120|NCT04890561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975121|NCT04890561|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91975122|NCT04890561|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975123|NCT04890561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975124|NCT04890561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975125|NCT04894617|Amantadine|amantadine|mesh-list
91975126|NCT04894617|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91975127|NCT04894617|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91975128|NCT04894617|Antiviral Agents|antiviral agents|mesh-ancestor
91975129|NCT04894617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975130|NCT04894617|Dopamine Agents|dopamine agents|mesh-ancestor
91975131|NCT04894617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975132|NCT04894617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975133|NCT04894617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975134|NCT04894617|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91975135|NCT04894617|Analgesics|analgesics|mesh-ancestor
91975136|NCT04894617|Sensory System Agents|sensory system agents|mesh-ancestor
91975137|NCT04894617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975138|NCT04398537|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91975139|NCT04398537|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
91975140|NCT04398537|beta-Endorphin|beta-endorphin|mesh-list
91975141|NCT04398537|Hormones|hormones|mesh-ancestor
91975142|NCT04398537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975143|NCT04398537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975144|NCT04398537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975145|NCT04398537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975159|NCT04906161|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91975160|NCT03051009|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
91975162|NCT03051009|Coagulants|coagulants|mesh-ancestor
91975163|NCT03051009|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
91975164|NCT03051009|Natriuretic Agents|natriuretic agents|mesh-ancestor
91975165|NCT03051009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975166|NCT04889781|Dexamethasone|dexamethasone|mesh-list
91975167|NCT04889781|Dexamethasone acetate|dexamethasone acetate|mesh-list
91975168|NCT04889781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975169|NCT04889781|Antiemetics|antiemetics|mesh-ancestor
91975170|NCT04889781|Autonomic Agents|autonomic agents|mesh-ancestor
91975171|NCT04889781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975172|NCT04889781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975173|NCT04889781|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975174|NCT04889781|Glucocorticoids|glucocorticoids|mesh-ancestor
91975175|NCT04889781|Hormones|hormones|mesh-ancestor
91975176|NCT04889781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975177|NCT04889781|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975178|NCT04889781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975179|NCT02616393|XL647|xl647|mesh-list
91975180|NCT02616393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975181|NCT02616393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91975182|NCT02616393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975183|NCT02616393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975184|NCT04905147|Mosapride|mosapride|mesh-list
91975185|NCT04905147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975186|NCT04905147|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91975187|NCT04905147|Serotonin Agents|serotonin agents|mesh-ancestor
91969402|NCT03315533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969403|NCT03315533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969404|NCT03315533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969405|NCT03315533|Analgesics|analgesics|mesh-ancestor
91969406|NCT03315533|Sensory System Agents|sensory system agents|mesh-ancestor
91969407|NCT03315533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969408|NCT03315533|Antidepressive Agents|antidepressive agents|mesh-ancestor
91969409|NCT03315533|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969410|NCT03315533|Dopamine Agents|dopamine agents|mesh-ancestor
91969411|NCT05437835|Ropivacaine|ropivacaine|mesh-list
91969412|NCT05437835|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969413|NCT05437835|Anesthetics|anesthetics|mesh-ancestor
91969414|NCT05437835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969415|NCT05437835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969416|NCT05437835|Sensory System Agents|sensory system agents|mesh-ancestor
91969417|NCT05437835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969418|NCT03200197|Menthol|menthol|mesh-list
91969419|NCT03200197|Antipruritics|antipruritics|mesh-ancestor
91969420|NCT03200197|Dermatologic Agents|dermatologic agents|mesh-ancestor
91969421|NCT04997967|Ketamine|ketamine|mesh-list
91969422|NCT04997967|Propofol|propofol|mesh-list
91969423|NCT04997967|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91969424|NCT04997967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969425|NCT04997967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969426|NCT04997967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91969427|NCT04997967|Anesthetics, General|anesthetics, general|mesh-ancestor
91969428|NCT04997967|Anesthetics|anesthetics|mesh-ancestor
91969429|NCT04997967|Analgesics|analgesics|mesh-ancestor
91975188|NCT04905147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975189|NCT04905147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975190|NCT04905147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975191|NCT03050229|Empagliflozin|empagliflozin|mesh-list
91975192|NCT03050229|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91975193|NCT03050229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975194|NCT03050229|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91975195|NCT03050229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975196|NCT04882683|Prednisone|prednisone|mesh-list
91975197|NCT04882683|Adalimumab|adalimumab|mesh-list
91975198|NCT04882683|Azathioprine|azathioprine|mesh-list
91975199|NCT04882683|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975200|NCT04882683|Glucocorticoids|glucocorticoids|mesh-ancestor
91975201|NCT04882683|Hormones|hormones|mesh-ancestor
91975202|NCT04882683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975203|NCT04882683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975204|NCT04882683|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91969430|NCT04997967|Sensory System Agents|sensory system agents|mesh-ancestor
91975205|NCT04882683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975206|NCT04882683|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91975210|NCT04882683|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91975211|NCT04882683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975212|NCT04882683|Immunologic Factors|immunologic factors|mesh-ancestor
91975213|NCT02155660|Benralizumab|benralizumab|mesh-list
91975214|NCT02155660|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91975215|NCT02155660|Respiratory System Agents|respiratory system agents|mesh-ancestor
91975217|NCT04753372|Rivaroxaban|rivaroxaban|mesh-list
91975218|NCT04753372|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91975219|NCT04753372|Antithrombins|antithrombins|mesh-ancestor
91975220|NCT04753372|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91975221|NCT04753372|Protease Inhibitors|protease inhibitors|mesh-ancestor
91975222|NCT04753372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975223|NCT04753372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975224|NCT04753372|Anticoagulants|anticoagulants|mesh-ancestor
91975225|NCT04753372|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91975226|NCT04753372|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91975227|NCT04753372|Analgesics|analgesics|mesh-ancestor
91975228|NCT04753372|Sensory System Agents|sensory system agents|mesh-ancestor
91975229|NCT04753372|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975230|NCT04753372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975231|NCT04753372|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975232|NCT04753372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91975233|NCT04753372|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91975234|NCT04753372|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91975235|NCT04753372|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91975236|NCT04753372|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91975237|NCT04753372|Antipyretics|antipyretics|mesh-ancestor
91975238|NCT05154123|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91975239|NCT05154123|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91975240|NCT05154123|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91975241|NCT05154123|Antimetabolites|antimetabolites|mesh-ancestor
91975322|NCT04885413|Immunologic Factors|immunologic factors|mesh-ancestor
91975242|NCT05154123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975243|NCT05154123|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91975244|NCT05154123|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91975245|NCT05154123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975246|NCT04880811|Afatinib|afatinib|mesh-list
91975247|NCT04880811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975248|NCT04880811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91975249|NCT04880811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975250|NCT04880811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975251|NCT02181634|Paclitaxel|paclitaxel|mesh-list
91975252|NCT02181634|Gemcitabine|gemcitabine|mesh-list
91975253|NCT02181634|Antimetabolites|antimetabolites|mesh-list
91975254|NCT02181634|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91975255|NCT02181634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975256|NCT02181634|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975257|NCT02181634|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975258|NCT02181634|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975259|NCT02181634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975260|NCT02181634|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91975261|NCT04569045|Lidocaine|lidocaine|mesh-list
91975262|NCT04569045|Anesthetics, Local|anesthetics, local|mesh-ancestor
91975263|NCT04569045|Anesthetics|anesthetics|mesh-ancestor
91975264|NCT04569045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975265|NCT04569045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975266|NCT04569045|Sensory System Agents|sensory system agents|mesh-ancestor
91975267|NCT04569045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975268|NCT04569045|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91975269|NCT04569045|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91975270|NCT04569045|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91975271|NCT04569045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975272|NCT04569045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975273|NCT04425291|Vaccines|vaccines|mesh-list
91975274|NCT04425291|Immunologic Factors|immunologic factors|mesh-ancestor
91975275|NCT04425291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975276|NCT04879407|Warfarin|warfarin|mesh-list
91969431|NCT04997967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969432|NCT04997967|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91969433|NCT04997967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91975283|NCT04879407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975284|NCT04879407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975285|NCT04886193|Leucovorin|leucovorin|mesh-list
91975286|NCT04886193|Docetaxel|docetaxel|mesh-list
91975287|NCT04886193|Oxaliplatin|oxaliplatin|mesh-list
91975288|NCT04886193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975289|NCT04886193|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975290|NCT04886193|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975291|NCT04886193|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975292|NCT04886193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975293|NCT04886193|Antidotes|antidotes|mesh-ancestor
91975294|NCT04886193|Protective Agents|protective agents|mesh-ancestor
91975295|NCT04886193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975296|NCT04886193|Vitamin B Complex|vitamin b complex|mesh-ancestor
91975298|NCT04886193|Micronutrients|micronutrients|mesh-ancestor
91975299|NCT04337073|Propofol|propofol|mesh-list
91975300|NCT04337073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975301|NCT04337073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975302|NCT04337073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975303|NCT04337073|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975304|NCT04337073|Anesthetics, General|anesthetics, general|mesh-ancestor
91975305|NCT04337073|Anesthetics|anesthetics|mesh-ancestor
91975306|NCT04885803|Vitamin D|vitamin d|mesh-list
91975307|NCT04885803|Ergocalciferols|ergocalciferols|mesh-list
91975308|NCT04885803|Cholecalciferol|cholecalciferol|mesh-list
91975309|NCT04885803|Vitamins|vitamins|mesh-list
91975310|NCT04885803|Micronutrients|micronutrients|mesh-ancestor
91975311|NCT04885803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975312|NCT04885803|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91975313|NCT04885803|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91975314|NCT03049059|Hydroquinone|hydroquinone|mesh-list
91975315|NCT03049059|Antioxidants|antioxidants|mesh-ancestor
91975316|NCT03049059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975318|NCT03049059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975319|NCT03049059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91975320|NCT04885413|Niraparib|niraparib|mesh-list
91975321|NCT04885413|Antibodies|antibodies|mesh-list
91975323|NCT04885413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975324|NCT04885413|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91975325|NCT04885413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975326|NCT04885413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975327|NCT04885413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975328|NCT03049293|Midazolam|midazolam|mesh-list
91975329|NCT03049293|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91975330|NCT03049293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975331|NCT03049293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975332|NCT03049293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975333|NCT03049293|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91975334|NCT03049293|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91975335|NCT03049293|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975336|NCT03049293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975337|NCT03049293|Anesthetics, General|anesthetics, general|mesh-ancestor
91975338|NCT03049293|Anesthetics|anesthetics|mesh-ancestor
91975339|NCT03049293|GABA Modulators|gaba modulators|mesh-ancestor
91975340|NCT03049293|GABA Agents|gaba agents|mesh-ancestor
91975341|NCT03049293|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975342|NCT03049293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975343|NCT01595529|Trimethoprim|trimethoprim|mesh-list
91975344|NCT01595529|Sulfamethoxazole|sulfamethoxazole|mesh-list
91975345|NCT01595529|Cephalexin|cephalexin|mesh-list
91975346|NCT01595529|Cefixime|cefixime|mesh-list
91975347|NCT01595529|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91975348|NCT01595529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975349|NCT01595529|Antimalarials|antimalarials|mesh-ancestor
91975356|NCT01595529|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91975357|NCT01595529|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91975358|NCT01595529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91969434|NCT04997967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91969435|NCT04997967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969436|NCT04997967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975359|NCT04368507|Monoclonal antibody YYB-101|monoclonal antibody yyb-101|mesh-list
91975360|NCT04368507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975363|NCT05257395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975364|NCT05257395|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91975365|NCT05257395|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91975366|NCT05257395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975367|NCT05257395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975368|NCT05257395|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91975369|NCT05257395|Hormone Antagonists|hormone antagonists|mesh-ancestor
91975370|NCT05257395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975371|NCT05257395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975372|NCT05257395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975373|NCT05256693|Vancomycin|vancomycin|mesh-list
91975374|NCT05256693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91975375|NCT05256693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975376|NCT03046953|Avelumab|avelumab|mesh-list
91975377|NCT03046953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975378|NCT03046953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975379|NCT03047109|Phenylephrine|phenylephrine|mesh-list
91975380|NCT03047109|Oxymetazoline|oxymetazoline|mesh-list
91975381|NCT03047109|Ephedrine|ephedrine|mesh-list
91975382|NCT03047109|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91975383|NCT03047109|Mydriatics|mydriatics|mesh-ancestor
91975384|NCT03047109|Autonomic Agents|autonomic agents|mesh-ancestor
91975385|NCT03047109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975386|NCT03047109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975387|NCT03047109|Sympathomimetics|sympathomimetics|mesh-ancestor
91975388|NCT03047109|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91975389|NCT03047109|Nasal Decongestants|nasal decongestants|mesh-ancestor
91975390|NCT03047109|Respiratory System Agents|respiratory system agents|mesh-ancestor
91975391|NCT03047109|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91975392|NCT03047109|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91975393|NCT03047109|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91975394|NCT03047109|Adrenergic Agents|adrenergic agents|mesh-ancestor
91975395|NCT03047109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975396|NCT03047109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975397|NCT03047109|Protective Agents|protective agents|mesh-ancestor
91975398|NCT03047109|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91975399|NCT03047265|Paclitaxel|paclitaxel|mesh-list
91975400|NCT03047265|Cisplatin|cisplatin|mesh-list
91975401|NCT03047265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91975402|NCT03047265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975403|NCT03047265|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975404|NCT03047265|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975405|NCT03047265|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975406|NCT03047265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975407|NCT05256147|Ibuprofen|ibuprofen|mesh-list
91975408|NCT05256147|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91975409|NCT05256147|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91975410|NCT05256147|Analgesics|analgesics|mesh-ancestor
91975411|NCT05256147|Sensory System Agents|sensory system agents|mesh-ancestor
91975412|NCT05256147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975413|NCT05256147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975414|NCT05256147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975419|NCT05255913|Fluorides|fluorides|mesh-list
91975420|NCT05255913|Cariostatic Agents|cariostatic agents|mesh-ancestor
91975421|NCT05255913|Protective Agents|protective agents|mesh-ancestor
91975422|NCT05255913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975423|NCT05214417|Ketamine|ketamine|mesh-list
91975424|NCT05214417|Analgesics|analgesics|mesh-ancestor
91975425|NCT05214417|Sensory System Agents|sensory system agents|mesh-ancestor
91975426|NCT05214417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975427|NCT05214417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975428|NCT05214417|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91975429|NCT05214417|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975430|NCT05214417|Anesthetics, General|anesthetics, general|mesh-ancestor
91975431|NCT05214417|Anesthetics|anesthetics|mesh-ancestor
91969438|NCT02483195|Spironolactone|spironolactone|mesh-list
91969439|NCT02483195|Finasteride|finasteride|mesh-list
91969440|NCT02483195|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91969441|NCT02483195|Hormone Antagonists|hormone antagonists|mesh-ancestor
91969442|NCT02483195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969443|NCT02483195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969444|NCT02483195|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91969445|NCT02483195|Diuretics|diuretics|mesh-ancestor
91969446|NCT02483195|Natriuretic Agents|natriuretic agents|mesh-ancestor
91969447|NCT02483195|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91969448|NCT02483195|Vasodilator Agents|vasodilator agents|mesh-ancestor
91969449|NCT02483195|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91975432|NCT05214417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975433|NCT05214417|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91975434|NCT05214417|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91975435|NCT05214417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975436|NCT05214417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975437|NCT04870671|Tenofovir|tenofovir|mesh-list
91975438|NCT04870671|Antiviral Agents|antiviral agents|mesh-ancestor
91975439|NCT04870671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975440|NCT04870671|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91975441|NCT04870671|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91975442|NCT04870671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975443|NCT04870671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975444|NCT04870671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91975445|NCT04870671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91975446|NCT04387461|Pembrolizumab|pembrolizumab|mesh-list
91975447|NCT04387461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975448|NCT04387461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975449|NCT04387461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91975450|NCT04387461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975451|NCT03046719|Bupivacaine|bupivacaine|mesh-list
91975452|NCT03046719|Anesthetics, Local|anesthetics, local|mesh-ancestor
91975453|NCT03046719|Anesthetics|anesthetics|mesh-ancestor
91975454|NCT03046719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975455|NCT03046719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975456|NCT03046719|Sensory System Agents|sensory system agents|mesh-ancestor
91975457|NCT03046719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975458|NCT04876755|TEMPO|tempo|mesh-list
91975459|NCT04876755|TEMPOL-H|tempol-h|mesh-list
91975460|NCT04876755|Antioxidants|antioxidants|mesh-ancestor
91975461|NCT04876755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975462|NCT04876755|Protective Agents|protective agents|mesh-ancestor
91975463|NCT04876755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975464|NCT04876755|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91975465|NCT04876521|Olanzapine|olanzapine|mesh-list
91975466|NCT04876521|Amisulpride|amisulpride|mesh-list
91975467|NCT04876521|Fluoxetine|fluoxetine|mesh-list
91975468|NCT04876521|Antiemetics|antiemetics|mesh-ancestor
91975469|NCT04876521|Autonomic Agents|autonomic agents|mesh-ancestor
91975470|NCT04876521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975471|NCT04876521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975472|NCT04876521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975473|NCT04876521|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91975474|NCT04876521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91975475|NCT04876521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975476|NCT04876521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975477|NCT04876521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91975478|NCT04876521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91969450|NCT02483195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91969451|NCT02483195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975479|NCT04876521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975480|NCT04876521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975481|NCT04876521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975482|NCT04876521|Serotonin Agents|serotonin agents|mesh-ancestor
91975483|NCT04876521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91975503|NCT04865991|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975504|NCT04865991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975505|NCT04865991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975506|NCT04865991|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975507|NCT04865991|Anesthetics, General|anesthetics, general|mesh-ancestor
91975509|NCT04865991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91975510|NCT04865991|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91975511|NCT04865211|Bupivacaine|bupivacaine|mesh-list
91975512|NCT04865211|Anesthetics, Local|anesthetics, local|mesh-ancestor
91975513|NCT04865211|Anesthetics|anesthetics|mesh-ancestor
91975514|NCT04865211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975515|NCT04865211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975516|NCT04865211|Sensory System Agents|sensory system agents|mesh-ancestor
91975517|NCT04865211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975518|NCT04865445|Midazolam|midazolam|mesh-list
91975519|NCT04865445|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91975520|NCT04865445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975521|NCT04865445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975522|NCT04865445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975523|NCT04865445|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91975524|NCT04865445|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91975525|NCT04865445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975526|NCT04865445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975527|NCT04865445|Anesthetics, General|anesthetics, general|mesh-ancestor
91975528|NCT04865445|Anesthetics|anesthetics|mesh-ancestor
91975529|NCT04865445|GABA Modulators|gaba modulators|mesh-ancestor
91975530|NCT04865445|GABA Agents|gaba agents|mesh-ancestor
91975531|NCT04865445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975532|NCT04865445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975533|NCT04875819|Vaccines|vaccines|mesh-list
91975534|NCT04875819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91975535|NCT04875819|Immunologic Factors|immunologic factors|mesh-ancestor
91975536|NCT04875819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975537|NCT04864977|Insulin|insulin|mesh-list
91975538|NCT04864977|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91975546|NCT04869579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975548|NCT04869579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975549|NCT04869579|Trace Elements|trace elements|mesh-ancestor
91975550|NCT04869579|Micronutrients|micronutrients|mesh-ancestor
91975551|NCT03235037|Levodopa|levodopa|mesh-list
91975552|NCT03235037|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91975553|NCT03235037|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91975554|NCT03235037|Dopamine Agents|dopamine agents|mesh-ancestor
91975555|NCT03235037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975556|NCT03235037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975557|NCT03235037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975558|NCT00700271|Amlodipine|amlodipine|mesh-list
91975559|NCT00700271|Valsartan|valsartan|mesh-list
91975560|NCT00700271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91975561|NCT00700271|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91975562|NCT00700271|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975563|NCT00700271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975564|NCT00700271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91975565|NCT00700271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975566|NCT00700271|Vasodilator Agents|vasodilator agents|mesh-ancestor
91975567|NCT00700271|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91975568|NCT00700271|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91975569|NCT02613507|Docetaxel|docetaxel|mesh-list
91975570|NCT02613507|Nivolumab|nivolumab|mesh-list
91975571|NCT02613507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975572|NCT02613507|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975573|NCT02613507|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975574|NCT02613507|Mitosis Modulators|mitosis modulators|mesh-ancestor
91969452|NCT02483195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969454|NCT02450149|Sorafenib|sorafenib|mesh-list
91969455|NCT02450149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975575|NCT02613507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975576|NCT02613507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975577|NCT02613507|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91975578|NCT03228797|Ropivacaine|ropivacaine|mesh-list
91975579|NCT03228797|Anesthetics, Local|anesthetics, local|mesh-ancestor
91975580|NCT03228797|Anesthetics|anesthetics|mesh-ancestor
91975581|NCT03228797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975582|NCT03228797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975583|NCT03228797|Sensory System Agents|sensory system agents|mesh-ancestor
91975584|NCT03228797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975585|NCT03044379|Dapivirine|dapivirine|mesh-list
91975586|NCT03044379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91975587|NCT03044379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91975588|NCT03044379|Antiviral Agents|antiviral agents|mesh-ancestor
91975589|NCT03044379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975590|NCT04864509|Melatonin|melatonin|mesh-list
91975591|NCT04864509|Antioxidants|antioxidants|mesh-ancestor
91975592|NCT04864509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975593|NCT04864509|Protective Agents|protective agents|mesh-ancestor
91975594|NCT04864509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975595|NCT04864509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975596|NCT04875039|Dexamethasone|dexamethasone|mesh-list
91975597|NCT04875039|Dexamethasone acetate|dexamethasone acetate|mesh-list
91975598|NCT04875039|Dexmedetomidine|dexmedetomidine|mesh-list
91975599|NCT04875039|BB 1101|bb 1101|mesh-list
91975600|NCT04875039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975601|NCT04875039|Antiemetics|antiemetics|mesh-ancestor
91975602|NCT04875039|Autonomic Agents|autonomic agents|mesh-ancestor
91975603|NCT04875039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975604|NCT04875039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975605|NCT04875039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975606|NCT04875039|Glucocorticoids|glucocorticoids|mesh-ancestor
91975607|NCT04875039|Hormones|hormones|mesh-ancestor
91975612|NCT04875039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975613|NCT04875039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975614|NCT04875039|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975615|NCT04875039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975616|NCT04875039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91975617|NCT04875039|Analgesics|analgesics|mesh-ancestor
91975618|NCT04875039|Sensory System Agents|sensory system agents|mesh-ancestor
91975619|NCT04875039|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91975620|NCT04875039|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91975621|NCT04875039|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91975622|NCT04875039|Adrenergic Agents|adrenergic agents|mesh-ancestor
91975623|NCT04875039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975624|NCT02452385|Vorolanib|vorolanib|mesh-list
91975625|NCT02452385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91975626|NCT02452385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975627|NCT02452385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975628|NCT03045783|Cefotiam|cefotiam|mesh-list
91975629|NCT03045783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91975630|NCT03045783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975631|NCT01375049|Aztreonam|aztreonam|mesh-list
91975632|NCT01375049|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91975633|NCT01375049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975634|NCT04146207|Prednisone|prednisone|mesh-list
91975635|NCT04146207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975636|NCT04146207|Glucocorticoids|glucocorticoids|mesh-ancestor
91975637|NCT04146207|Hormones|hormones|mesh-ancestor
91975638|NCT04146207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975639|NCT04146207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975640|NCT04146207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975641|NCT04146207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975642|NCT04863807|Anesthetics|anesthetics|mesh-list
91975643|NCT04863807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975644|NCT04863807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975645|NCT02452307|Imiquimod|imiquimod|mesh-list
91975646|NCT02452307|Molgramostim|molgramostim|mesh-list
91969456|NCT02450149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969457|NCT02450149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969458|NCT02450149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969459|NCT02479217|Docetaxel|docetaxel|mesh-list
91975647|NCT02452307|Protamines|protamines|mesh-list
91975648|NCT02452307|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
91975649|NCT02452307|Sargramostim|sargramostim|mesh-list
91975650|NCT02452307|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91975651|NCT02452307|Immunologic Factors|immunologic factors|mesh-ancestor
91975652|NCT02452307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975653|NCT02452307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975654|NCT02452307|Interferon Inducers|interferon inducers|mesh-ancestor
91975655|NCT02452307|Heparin Antagonists|heparin antagonists|mesh-ancestor
91975656|NCT02452307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975657|NCT02452307|Coagulants|coagulants|mesh-ancestor
91975658|NCT02452151|Infliximab|infliximab|mesh-list
91975659|NCT02452151|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91975660|NCT02452151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975661|NCT02452151|Dermatologic Agents|dermatologic agents|mesh-ancestor
91975662|NCT02452151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975663|NCT02452151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91975664|NCT04485299|Listerine|listerine|mesh-list
91975665|NCT04485299|Fluorides|fluorides|mesh-list
91975666|NCT04485299|Sodium Fluoride|sodium fluoride|mesh-list
91975667|NCT04485299|Fluorides, Topical|fluorides, topical|mesh-list
91975668|NCT04485299|Cariostatic Agents|cariostatic agents|mesh-ancestor
91975669|NCT04485299|Protective Agents|protective agents|mesh-ancestor
91975670|NCT04485299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975671|NCT04485299|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91975672|NCT04485299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975673|NCT01594749|Dexamethasone|dexamethasone|mesh-list
91975674|NCT01594749|Dexamethasone acetate|dexamethasone acetate|mesh-list
91975675|NCT01594749|Ondansetron|ondansetron|mesh-list
91975676|NCT01594749|Fosaprepitant|fosaprepitant|mesh-list
91975677|NCT01594749|Aprepitant|aprepitant|mesh-list
91975678|NCT01594749|BB 1101|bb 1101|mesh-list
91975679|NCT01594749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975695|NCT01594749|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91975696|NCT01594749|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91975697|NCT01594749|Serotonin Agents|serotonin agents|mesh-ancestor
91975698|NCT01594749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975699|NCT01594749|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91975700|NCT03226145|Scopolamine|scopolamine|mesh-list
91975701|NCT03226145|Bisacodyl|bisacodyl|mesh-list
91975702|NCT03226145|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
91975703|NCT03226145|Cathartics|cathartics|mesh-ancestor
91975704|NCT03226145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975705|NCT03226145|Laxatives|laxatives|mesh-ancestor
91975706|NCT03226145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91975707|NCT03226145|Antiemetics|antiemetics|mesh-ancestor
91975708|NCT03226145|Autonomic Agents|autonomic agents|mesh-ancestor
91975709|NCT03226145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975710|NCT03226145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975711|NCT03226145|Mydriatics|mydriatics|mesh-ancestor
91975712|NCT03226145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91975713|NCT03226145|Cholinergic Agents|cholinergic agents|mesh-ancestor
91975714|NCT03226145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975715|NCT03226145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975716|NCT03226145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91975717|NCT03226145|Parasympatholytics|parasympatholytics|mesh-ancestor
91975718|NCT04863183|Triamcinolone|triamcinolone|mesh-list
91975719|NCT04863183|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91975720|NCT04863183|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91975721|NCT04863183|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91975722|NCT04863183|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975723|NCT04863183|Glucocorticoids|glucocorticoids|mesh-ancestor
91975724|NCT04863183|Hormones|hormones|mesh-ancestor
91975725|NCT04863183|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975726|NCT04863183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975727|NCT04863183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975728|NCT04863183|Immunologic Factors|immunologic factors|mesh-ancestor
91975729|NCT04863183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975730|NCT04863183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969460|NCT02479217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969461|NCT02479217|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975732|NCT03234413|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91975733|NCT03234413|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91975734|NCT03234413|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91975735|NCT03234413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975736|NCT03234413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975737|NCT03234413|Cholinergic Agents|cholinergic agents|mesh-ancestor
91975738|NCT03234413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975746|NCT04380753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975747|NCT04379973|Ethiodized Oil|ethiodized oil|mesh-list
91975748|NCT04379973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975750|NCT02453009|Docetaxel|docetaxel|mesh-list
91975751|NCT02453009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975752|NCT02453009|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975753|NCT02453009|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975754|NCT02453009|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975755|NCT02453009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975756|NCT02453009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975757|NCT02453009|Glucocorticoids|glucocorticoids|mesh-ancestor
91975758|NCT02453009|Hormones|hormones|mesh-ancestor
91975759|NCT02453009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975760|NCT02453009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975761|NCT02453009|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975762|NCT04868175|Timolol|timolol|mesh-list
91975763|NCT04868175|Travoprost|travoprost|mesh-list
91975764|NCT04868175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91975765|NCT04868175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91975766|NCT04868175|Adrenergic Agents|adrenergic agents|mesh-ancestor
91975767|NCT04868175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975768|NCT04868175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975769|NCT04868175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975770|NCT04868175|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91975771|NCT04868175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91975772|NCT02452775|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
91975773|NCT02452775|Poly ICLC|poly iclc|mesh-list
91975774|NCT02452775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91975775|NCT02452775|Immunologic Factors|immunologic factors|mesh-ancestor
91975776|NCT02452775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975777|NCT02452775|Interferon Inducers|interferon inducers|mesh-ancestor
91975778|NCT03045627|Cytarabine|cytarabine|mesh-list
91975779|NCT03045627|Aclarubicin|aclarubicin|mesh-list
91975780|NCT03045627|Lenograstim|lenograstim|mesh-list
91975781|NCT03045627|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91975782|NCT03045627|Antimetabolites|antimetabolites|mesh-ancestor
91975783|NCT03045627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975784|NCT03045627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975785|NCT03045627|Antiviral Agents|antiviral agents|mesh-ancestor
91975786|NCT03045627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975787|NCT03045627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975788|NCT03045627|Immunologic Factors|immunologic factors|mesh-ancestor
91975789|NCT03045627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975790|NCT03045627|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91975791|NCT03045627|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91975792|NCT03045627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91975793|NCT03045627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91975795|NCT04868019|Fenofibrate|fenofibrate|mesh-list
91975796|NCT04868019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91975797|NCT04868019|Antimetabolites|antimetabolites|mesh-ancestor
91975798|NCT04868019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975799|NCT04868019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91975800|NCT04863105|Abiraterone Acetate|abiraterone acetate|mesh-list
91975801|NCT04863105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975802|NCT04863105|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91975803|NCT04863105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975804|NCT04863105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975824|NCT04868253|Antimetabolites|antimetabolites|mesh-ancestor
91975825|NCT04868253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975826|NCT04868253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969462|NCT02479217|Antimitotic Agents|antimitotic agents|mesh-ancestor
91969463|NCT02479217|Mitosis Modulators|mitosis modulators|mesh-ancestor
91969464|NCT02479217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975827|NCT04868253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975828|NCT04868253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975829|NCT04868253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975830|NCT04868253|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91975831|NCT04868253|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91975832|NCT04868253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975833|NCT04868253|GABA Modulators|gaba modulators|mesh-ancestor
91975834|NCT04868253|GABA Agents|gaba agents|mesh-ancestor
91975835|NCT04868253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975836|NCT02153788|Temazepam|temazepam|mesh-list
91975837|NCT02153788|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975838|NCT02153788|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975839|NCT02153788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975840|NCT02153788|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91975841|NCT02153788|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91975842|NCT02153788|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975843|NCT02153788|GABA Modulators|gaba modulators|mesh-ancestor
91975844|NCT02153788|GABA Agents|gaba agents|mesh-ancestor
91975845|NCT02153788|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975846|NCT02153788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975847|NCT03224039|Sufentanil|sufentanil|mesh-list
91975848|NCT03224039|Morphine|morphine|mesh-list
91975849|NCT03224039|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91975850|NCT03224039|Narcotics|narcotics|mesh-ancestor
91975851|NCT03224039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975852|NCT03224039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975853|NCT03224039|Analgesics|analgesics|mesh-ancestor
91975854|NCT03224039|Sensory System Agents|sensory system agents|mesh-ancestor
91975855|NCT03224039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975856|NCT03224039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91975857|NCT03224039|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975858|NCT03224039|Anesthetics, General|anesthetics, general|mesh-ancestor
91975859|NCT03224039|Anesthetics|anesthetics|mesh-ancestor
91975860|NCT04862091|Abiraterone Acetate|abiraterone acetate|mesh-list
91975867|NCT04862091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975868|NCT04862091|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91975870|NCT03223961|Hematinics|hematinics|mesh-ancestor
91975871|NCT03045471|Prednisolone|prednisolone|mesh-list
91975872|NCT03045471|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91975873|NCT03045471|Methylprednisolone|methylprednisolone|mesh-list
91975874|NCT03045471|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91975875|NCT03045471|Prednisolone acetate|prednisolone acetate|mesh-list
91975876|NCT03045471|Cyclophosphamide|cyclophosphamide|mesh-list
91975878|NCT03045471|Etoposide|etoposide|mesh-list
91975879|NCT03045471|Vincristine|vincristine|mesh-list
91975880|NCT03045471|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91975881|NCT03045471|Prednisolone phosphate|prednisolone phosphate|mesh-list
91975882|NCT03045471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975883|NCT03045471|Immunologic Factors|immunologic factors|mesh-ancestor
91975884|NCT03045471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975885|NCT03045471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91975886|NCT03045471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91975887|NCT03045471|Alkylating Agents|alkylating agents|mesh-ancestor
91975888|NCT03045471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975889|NCT03045471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975890|NCT03045471|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91975891|NCT03045471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975892|NCT03045471|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91975893|NCT03045471|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91975894|NCT03045471|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91975895|NCT03045471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975896|NCT03045471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975898|NCT03045471|Hormones|hormones|mesh-ancestor
91975899|NCT03045471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975900|NCT03045471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975901|NCT03045471|Antiemetics|antiemetics|mesh-ancestor
91975902|NCT03045471|Autonomic Agents|autonomic agents|mesh-ancestor
91975903|NCT03045471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969465|NCT02479529|Norepinephrine|norepinephrine|mesh-list
91969466|NCT02479529|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91969467|NCT02479529|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91969468|NCT02479529|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969469|NCT02479529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969470|NCT02479529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969471|NCT02479529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975904|NCT03045471|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975905|NCT03045471|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91975906|NCT03045471|Protective Agents|protective agents|mesh-ancestor
91975907|NCT03045471|Tubulin Modulators|tubulin modulators|mesh-ancestor
91975908|NCT03045471|Antimitotic Agents|antimitotic agents|mesh-ancestor
91975909|NCT03045471|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975910|NCT03047499|Botulinum Toxins|botulinum toxins|mesh-list
91975911|NCT03047499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91975912|NCT03047499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91975913|NCT03047499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91975914|NCT03047499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975915|NCT03047499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975916|NCT03047499|Cholinergic Agents|cholinergic agents|mesh-ancestor
91975917|NCT03047499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975918|NCT03047499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975919|NCT03047499|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91975920|NCT03047499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975921|NCT03223025|Hormones|hormones|mesh-list
91975922|NCT03223025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975923|NCT03223025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975924|NCT04867941|Acalabrutinib|acalabrutinib|mesh-list
91975925|NCT04867941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975926|NCT04873479|Ketamine|ketamine|mesh-list
91975927|NCT04873479|Esketamine|esketamine|mesh-list
91975930|NCT04873479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975931|NCT04873479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975932|NCT04873479|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91975933|NCT04873479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91975934|NCT04873479|Anesthetics, General|anesthetics, general|mesh-ancestor
91975936|NCT04873479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975937|NCT04873479|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91975938|NCT04873479|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91975939|NCT04873479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975940|NCT04873479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975941|NCT04873479|Antidepressive Agents|antidepressive agents|mesh-ancestor
91975942|NCT04873479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91975943|NCT02451527|Digoxin|digoxin|mesh-list
91975944|NCT02451527|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91975945|NCT02451527|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91975946|NCT02451527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975947|NCT02451527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975948|NCT02451527|Protective Agents|protective agents|mesh-ancestor
91975949|NCT02451527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975950|NCT04873011|Quinine|quinine|mesh-list
91975951|NCT04873011|Antimalarials|antimalarials|mesh-ancestor
91975952|NCT04873011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91975953|NCT04873011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91975954|NCT04873011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975955|NCT04873011|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91975956|NCT04873011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975958|NCT04873011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975959|NCT04873011|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91975960|NCT04873011|Analgesics|analgesics|mesh-ancestor
91975961|NCT04873011|Sensory System Agents|sensory system agents|mesh-ancestor
91975962|NCT02451605|Analgesics|analgesics|mesh-list
91975963|NCT02451605|Ropivacaine|ropivacaine|mesh-list
91975964|NCT02451605|Anesthetics, Local|anesthetics, local|mesh-ancestor
91975965|NCT02451605|Anesthetics|anesthetics|mesh-ancestor
91975966|NCT02451605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975967|NCT02451605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969472|NCT02479529|Sympathomimetics|sympathomimetics|mesh-ancestor
91969473|NCT02479529|Autonomic Agents|autonomic agents|mesh-ancestor
91969474|NCT02479529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969475|NCT02479529|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91975968|NCT02451605|Sensory System Agents|sensory system agents|mesh-ancestor
91975969|NCT02451605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975970|NCT03222323|Dexmedetomidine|dexmedetomidine|mesh-list
91975971|NCT03222323|Ropivacaine|ropivacaine|mesh-list
91975972|NCT03222323|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91975973|NCT03222323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91975974|NCT03222323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975975|NCT03222323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91975976|NCT03222323|Analgesics|analgesics|mesh-ancestor
91975977|NCT03222323|Sensory System Agents|sensory system agents|mesh-ancestor
91975978|NCT03222323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975979|NCT03222323|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91975980|NCT03222323|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91975981|NCT03222323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91975982|NCT03222323|Adrenergic Agents|adrenergic agents|mesh-ancestor
91975983|NCT03222323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91975984|NCT03222323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975985|NCT03222323|Anesthetics, Local|anesthetics, local|mesh-ancestor
91975986|NCT03222323|Anesthetics|anesthetics|mesh-ancestor
91975987|NCT03043677|Adalimumab|adalimumab|mesh-list
91975988|NCT03043677|Infliximab|infliximab|mesh-list
91975989|NCT03043677|Golimumab|golimumab|mesh-list
91975990|NCT03043677|Ustekinumab|ustekinumab|mesh-list
91975991|NCT03043677|Vedolizumab|vedolizumab|mesh-list
91975992|NCT03043677|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91975993|NCT03043677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975994|NCT03043677|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91975995|NCT03043677|Dermatologic Agents|dermatologic agents|mesh-ancestor
91975996|NCT03043677|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975997|NCT03043677|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975998|NCT03043677|Immunologic Factors|immunologic factors|mesh-ancestor
91975999|NCT03043677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976000|NCT03222089|Leucovorin|leucovorin|mesh-list
91976001|NCT03222089|Fluorouracil|fluorouracil|mesh-list
91976002|NCT03222089|Oxaliplatin|oxaliplatin|mesh-list
91976003|NCT03222089|Irinotecan|irinotecan|mesh-list
91976010|NCT03222089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91976011|NCT03222089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976012|NCT03222089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976013|NCT03222089|Immunologic Factors|immunologic factors|mesh-ancestor
91976014|NCT03222089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976015|NCT03222089|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91976016|NCT03222089|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91976017|NCT03222089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976018|NCT03222089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976020|NCT03222089|Sensory System Agents|sensory system agents|mesh-ancestor
91976021|NCT03222089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976022|NCT03222089|Antidotes|antidotes|mesh-ancestor
91976023|NCT03222089|Protective Agents|protective agents|mesh-ancestor
91976024|NCT03222089|Vitamin B Complex|vitamin b complex|mesh-ancestor
91976025|NCT03222089|Vitamins|vitamins|mesh-ancestor
91976026|NCT03222089|Micronutrients|micronutrients|mesh-ancestor
91976027|NCT03043989|Clarithromycin|clarithromycin|mesh-list
91976028|NCT03043989|Docetaxel|docetaxel|mesh-list
91976029|NCT03043989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976030|NCT03043989|Tubulin Modulators|tubulin modulators|mesh-ancestor
91976031|NCT03043989|Antimitotic Agents|antimitotic agents|mesh-ancestor
91976032|NCT03043989|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976033|NCT03043989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976034|NCT03043989|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976035|NCT03043989|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976036|NCT03043989|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91976037|NCT03043989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976038|NCT03043989|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91976039|NCT03043989|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91976041|NCT03222167|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91976042|NCT03222167|Antiviral Agents|antiviral agents|mesh-ancestor
91976043|NCT03222167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976044|NCT03221855|Domperidone|domperidone|mesh-list
91969476|NCT03202147|Cromolyn Sodium|cromolyn sodium|mesh-list
91976045|NCT03221855|Antiemetics|antiemetics|mesh-ancestor
91976046|NCT03221855|Autonomic Agents|autonomic agents|mesh-ancestor
91976047|NCT03221855|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976048|NCT03221855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976049|NCT03221855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976050|NCT03221855|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91976051|NCT03221855|Dopamine Agents|dopamine agents|mesh-ancestor
91976052|NCT03221855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976053|NCT03221855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976054|NCT03043521|Dexlansoprazole|dexlansoprazole|mesh-list
91976055|NCT03043521|Lansoprazole|lansoprazole|mesh-list
91976056|NCT03043521|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91976057|NCT03043521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976058|NCT03043521|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91976059|NCT03043521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976060|NCT03043521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976061|NCT03047733|Tacrolimus|tacrolimus|mesh-list
91976062|NCT03047733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976063|NCT03047733|Immunologic Factors|immunologic factors|mesh-ancestor
91976064|NCT03047733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976065|NCT03047733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91976066|NCT03047733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976067|NCT03047733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976068|NCT03221231|Acetylcysteine|acetylcysteine|mesh-list
91976069|NCT03221231|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91976070|NCT03221231|Antiviral Agents|antiviral agents|mesh-ancestor
91976164|NCT02504333|Paclitaxel|paclitaxel|mesh-list
91976071|NCT03221231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976072|NCT03221231|Expectorants|expectorants|mesh-ancestor
91976073|NCT03221231|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976074|NCT03221231|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91976089|NCT03045393|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
91976090|NCT03045393|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91976091|NCT03045393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976092|NCT03045393|Tubulin Modulators|tubulin modulators|mesh-ancestor
91976093|NCT03045393|Antimitotic Agents|antimitotic agents|mesh-ancestor
91976094|NCT03045393|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976095|NCT03045393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976096|NCT03045393|Immunoconjugates|immunoconjugates|mesh-ancestor
91976097|NCT03045393|Immunologic Factors|immunologic factors|mesh-ancestor
91976098|NCT03045393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976099|NCT01374971|Certolizumab Pegol|certolizumab pegol|mesh-list
91976100|NCT01374971|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91976101|NCT01374971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976102|NCT01374971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976103|NCT01374971|Immunologic Factors|immunologic factors|mesh-ancestor
91976104|NCT01374971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976105|NCT01374971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976106|NCT02505815|Hydrocortisone|hydrocortisone|mesh-list
91976107|NCT02505815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976108|NCT02505971|Propranolol|propranolol|mesh-list
91976109|NCT02505971|Nadolol|nadolol|mesh-list
91976110|NCT02505971|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91976111|NCT02505971|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91976112|NCT02505971|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976113|NCT02505971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976114|NCT02505971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976115|NCT02505971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976116|NCT02505971|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91976117|NCT02505971|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91976118|NCT02505971|Vasodilator Agents|vasodilator agents|mesh-ancestor
91976119|NCT02505971|Sympatholytics|sympatholytics|mesh-ancestor
91976120|NCT02505971|Autonomic Agents|autonomic agents|mesh-ancestor
91976121|NCT02505971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976122|NCT02505581|Metronidazole|metronidazole|mesh-list
91976123|NCT02505581|Ciprofloxacin|ciprofloxacin|mesh-list
91976124|NCT02505581|Cefuroxime|cefuroxime|mesh-list
91976125|NCT02505581|Cefuroxime axetil|cefuroxime axetil|mesh-list
91976126|NCT02505581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976127|NCT02505581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976128|NCT02505581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91976129|NCT02505581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91976130|NCT02505581|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91976131|NCT02505581|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91969477|NCT03202147|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
91969478|NCT03202147|Immunologic Factors|immunologic factors|mesh-ancestor
91976132|NCT02505581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976133|NCT02505581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976134|NCT02505581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976135|NCT02505581|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91976136|NCT02505581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91976143|NCT02505113|Montelukast|montelukast|mesh-list
91976144|NCT02505113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91976145|NCT02505113|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976146|NCT02505113|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91976147|NCT02505113|Hormone Antagonists|hormone antagonists|mesh-ancestor
91976148|NCT02505113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976149|NCT02505113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976150|NCT02505113|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91976151|NCT02505113|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91976152|NCT02505113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976154|NCT02504801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976155|NCT02504801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91976156|NCT02504801|Autonomic Agents|autonomic agents|mesh-ancestor
91976157|NCT02504801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976158|NCT02504801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976159|NCT02504801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91976160|NCT02504801|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976161|NCT02504801|Glucocorticoids|glucocorticoids|mesh-ancestor
91976162|NCT02504801|Hormones|hormones|mesh-ancestor
91976163|NCT02504801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976165|NCT02504333|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91976166|NCT02504333|Gemcitabine|gemcitabine|mesh-list
91976167|NCT02504333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91976168|NCT02504333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976169|NCT02504333|Tubulin Modulators|tubulin modulators|mesh-ancestor
91976170|NCT02504333|Antimitotic Agents|antimitotic agents|mesh-ancestor
91976171|NCT02504333|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976172|NCT02504333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976173|NCT02504333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91976174|NCT02504333|Antimetabolites|antimetabolites|mesh-ancestor
91976175|NCT02504177|Anticoagulants|anticoagulants|mesh-list
91976176|NCT02450981|Bevacizumab|bevacizumab|mesh-list
91976177|NCT02450981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91976178|NCT02450981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976179|NCT02450981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91976180|NCT02450981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91976181|NCT02450981|Growth Substances|growth substances|mesh-ancestor
91976182|NCT02450981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976183|NCT02450981|Growth Inhibitors|growth inhibitors|mesh-ancestor
91976185|NCT02503943|Liraglutide|liraglutide|mesh-list
91976186|NCT02503943|Mitiglinide|mitiglinide|mesh-list
91976187|NCT02503943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91976188|NCT02503943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976189|NCT02503943|Incretins|incretins|mesh-ancestor
91976190|NCT02503943|Hormones|hormones|mesh-ancestor
91976191|NCT02503943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976192|NCT03213743|Dexmedetomidine|dexmedetomidine|mesh-list
91976193|NCT03213743|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91976194|NCT03213743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976195|NCT03213743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976196|NCT03213743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976197|NCT03213743|Analgesics|analgesics|mesh-ancestor
91976198|NCT03213743|Sensory System Agents|sensory system agents|mesh-ancestor
91976199|NCT03213743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976200|NCT03213743|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91976201|NCT03213743|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91976202|NCT03213743|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91976203|NCT03213743|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976204|NCT03213743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976205|NCT03213743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976206|NCT03212495|Neostigmine|neostigmine|mesh-list
91976207|NCT03212495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976208|NCT03212495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976209|NCT03212495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976210|NCT03212495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976211|NCT03212495|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91976212|NCT03212495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976213|NCT03212495|Cholinergic Agents|cholinergic agents|mesh-ancestor
91976214|NCT03212495|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91976215|NCT03212495|Autonomic Agents|autonomic agents|mesh-ancestor
91976216|NCT02503319|Tranexamic Acid|tranexamic acid|mesh-list
91976218|NCT02503319|Oxytocics|oxytocics|mesh-ancestor
91976219|NCT02503319|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976220|NCT02503319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976221|NCT02503319|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91976222|NCT02503319|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91976223|NCT02503319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976224|NCT02503319|Hemostatics|hemostatics|mesh-ancestor
91976225|NCT02503319|Coagulants|coagulants|mesh-ancestor
91976226|NCT02610777|Azacitidine|azacitidine|mesh-list
91976227|NCT02610777|Pevonedistat|pevonedistat|mesh-list
91976228|NCT02610777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91976229|NCT02610777|Antimetabolites|antimetabolites|mesh-ancestor
91976230|NCT02610777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976231|NCT02610777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976232|NCT02610777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976234|NCT01628692|Simeprevir|simeprevir|mesh-list
91976235|NCT01628692|Antimetabolites|antimetabolites|mesh-ancestor
91976236|NCT01628692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976237|NCT01628692|Antiviral Agents|antiviral agents|mesh-ancestor
91976238|NCT01628692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976239|NCT01628692|Protease Inhibitors|protease inhibitors|mesh-ancestor
91976240|NCT01628692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976241|NCT02503163|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91976242|NCT02503163|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91976243|NCT04496921|Vitamins|vitamins|mesh-list
91976244|NCT04496921|Vitamin K|vitamin k|mesh-list
91976245|NCT04496921|Micronutrients|micronutrients|mesh-ancestor
91976246|NCT04496921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976247|NCT04496921|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91976248|NCT04496921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91976249|NCT04496921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976250|NCT04496921|Hemostatics|hemostatics|mesh-ancestor
91976251|NCT04496921|Coagulants|coagulants|mesh-ancestor
91976252|NCT03043287|Botulinum Toxins|botulinum toxins|mesh-list
91976253|NCT03043287|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91976254|NCT03043287|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91976255|NCT03043287|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91976256|NCT03043287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91976257|NCT03043287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976258|NCT03043287|Cholinergic Agents|cholinergic agents|mesh-ancestor
91976259|NCT03043287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976260|NCT03043287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976261|NCT03043287|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91976262|NCT03043287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976263|NCT03043443|Melatonin|melatonin|mesh-list
91976264|NCT03043443|Antioxidants|antioxidants|mesh-ancestor
91976265|NCT03043443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976266|NCT03043443|Protective Agents|protective agents|mesh-ancestor
91976267|NCT03043443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976268|NCT03043443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976269|NCT04383795|Antithyroid Agents|antithyroid agents|mesh-list
91976270|NCT04383795|Hormone Antagonists|hormone antagonists|mesh-ancestor
91976271|NCT04383795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976272|NCT04383795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976273|NCT03043131|Plasma-lyte 148|plasma-lyte 148|mesh-list
91976274|NCT03043131|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91976275|NCT03043131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91976276|NCT03209297|Salicylic Acid|salicylic acid|mesh-list
91976277|NCT03209297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976278|NCT03209297|Antifungal Agents|antifungal agents|mesh-ancestor
91976279|NCT03209297|Keratolytic Agents|keratolytic agents|mesh-ancestor
91976280|NCT03209297|Dermatologic Agents|dermatologic agents|mesh-ancestor
91976284|NCT03209219|Cyclosporine|cyclosporine|mesh-list
91976285|NCT03209219|Cyclosporins|cyclosporins|mesh-list
91969479|NCT03202147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969480|NCT03202147|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91969481|NCT03202147|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969482|NCT03202147|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91969483|NCT03202147|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976286|NCT03209219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976287|NCT03209219|Antiviral Agents|antiviral agents|mesh-ancestor
91976288|NCT03209219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976289|NCT03209219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976290|NCT03209219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976291|NCT03209219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976292|NCT03209219|Immunologic Factors|immunologic factors|mesh-ancestor
91976293|NCT03209219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976294|NCT03209219|Antifungal Agents|antifungal agents|mesh-ancestor
91976295|NCT03209219|Dermatologic Agents|dermatologic agents|mesh-ancestor
91976296|NCT03209219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976297|NCT03209219|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91976298|NCT04872231|Voriconazole|voriconazole|mesh-list
91976299|NCT04872231|Antifungal Agents|antifungal agents|mesh-ancestor
91976300|NCT04872231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976301|NCT04872231|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91976302|NCT04872231|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91976303|NCT04872231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976304|NCT04872231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976305|NCT04872231|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91976306|NCT04872231|Hormone Antagonists|hormone antagonists|mesh-ancestor
91976307|NCT04872231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976308|NCT04872231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976309|NCT04872231|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91976311|NCT04860531|Lidocaine|lidocaine|mesh-list
91976312|NCT04860531|Anesthetics, Local|anesthetics, local|mesh-ancestor
91976313|NCT04860531|Anesthetics|anesthetics|mesh-ancestor
91976314|NCT04860531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976315|NCT04860531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976316|NCT04860531|Sensory System Agents|sensory system agents|mesh-ancestor
91976317|NCT04860531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976318|NCT04860531|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91976319|NCT04860531|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91976320|NCT04860531|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91976321|NCT04860531|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91976322|NCT04860531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976323|NCT04860531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976324|NCT04860531|Glucocorticoids|glucocorticoids|mesh-ancestor
91976325|NCT04860531|Hormones|hormones|mesh-ancestor
91976326|NCT04860531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976327|NCT04860531|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91976328|NCT04860531|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976329|NCT01594827|Chlorhexidine|chlorhexidine|mesh-list
91976330|NCT01594827|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91976331|NCT01594827|Vancomycin|vancomycin|mesh-list
91976332|NCT01594827|Doxycycline|doxycycline|mesh-list
91976333|NCT01594827|Rifampin|rifampin|mesh-list
91976334|NCT01594827|Trimethoprim|trimethoprim|mesh-list
91976335|NCT01594827|Sulfamethoxazole|sulfamethoxazole|mesh-list
91976336|NCT01594827|Mupirocin|mupirocin|mesh-list
91976337|NCT01594827|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91976338|NCT01594827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976339|NCT01594827|Disinfectants|disinfectants|mesh-ancestor
91976340|NCT01594827|Dermatologic Agents|dermatologic agents|mesh-ancestor
91976341|NCT01594827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976342|NCT01594827|Antimalarials|antimalarials|mesh-ancestor
91976343|NCT01594827|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91976344|NCT01594827|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91976345|NCT01594827|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91976346|NCT01594827|Antitubercular Agents|antitubercular agents|mesh-ancestor
91976347|NCT01594827|Leprostatic Agents|leprostatic agents|mesh-ancestor
91969485|NCT03213769|Coenzyme Q10|coenzyme q10|mesh-list
91969486|NCT03213769|Micronutrients|micronutrients|mesh-ancestor
91969487|NCT03213769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969488|NCT03213769|Vitamins|vitamins|mesh-ancestor
91976348|NCT01594827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91976349|NCT01594827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976350|NCT01594827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976351|NCT01594827|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91976352|NCT01594827|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91976358|NCT01594827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91976359|NCT01594827|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91976360|NCT01594827|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91976361|NCT01594827|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91976362|NCT01594827|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91976364|NCT04849845|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91976365|NCT04849845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91976366|NCT04849845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976367|NCT04429191|Antibodies|antibodies|mesh-list
91976368|NCT04429191|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91976369|NCT04429191|Immunologic Factors|immunologic factors|mesh-ancestor
91976370|NCT04429191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976371|NCT02610231|Istradefylline|istradefylline|mesh-list
91976372|NCT02610231|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
91976373|NCT02610231|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91976374|NCT02610231|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91976375|NCT02610231|Purinergic Agents|purinergic agents|mesh-ancestor
91976376|NCT02610231|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976377|NCT02610231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976378|NCT02610231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976379|NCT04850157|Tislelizumab|tislelizumab|mesh-list
91976380|NCT04850157|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91976381|NCT04850157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976382|NCT04849533|Mycophenolic Acid|mycophenolic acid|mesh-list
91976383|NCT04849533|Prednisone|prednisone|mesh-list
91976384|NCT04849533|Everolimus|everolimus|mesh-list
91976385|NCT04849533|Abatacept|abatacept|mesh-list
91976386|NCT04849533|Thymoglobulin|thymoglobulin|mesh-list
91976387|NCT04849533|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91976388|NCT04849533|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976389|NCT04849533|Glucocorticoids|glucocorticoids|mesh-ancestor
91976390|NCT04849533|Hormones|hormones|mesh-ancestor
91976391|NCT04849533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976392|NCT04849533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976393|NCT04849533|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91976394|NCT04849533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976395|NCT04849533|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91976396|NCT04849533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91976397|NCT04849533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976398|NCT04849533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976399|NCT04849533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976400|NCT04849533|Immunologic Factors|immunologic factors|mesh-ancestor
91976401|NCT04849533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91976402|NCT04849533|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91976403|NCT04849533|Antitubercular Agents|antitubercular agents|mesh-ancestor
91976404|NCT04849533|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976405|NCT04849533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976406|NCT04849533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91976407|NCT04849533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91976408|NCT04849533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976409|NCT03040635|Risdiplam|risdiplam|mesh-list
91976410|NCT03040635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91976411|NCT03040635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976412|NCT03040635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976413|NCT02178358|Sorafenib|sorafenib|mesh-list
91976414|NCT02178358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976415|NCT02178358|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91976416|NCT02178358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976417|NCT02178358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976418|NCT01598896|Clonidine|clonidine|mesh-list
91976419|NCT01598896|Dronabinol|dronabinol|mesh-list
91976420|NCT01598896|Analgesics|analgesics|mesh-ancestor
91969489|NCT05002101|Zinc|zinc|mesh-list
91976421|NCT01598896|Sensory System Agents|sensory system agents|mesh-ancestor
91976426|NCT01598896|Autonomic Agents|autonomic agents|mesh-ancestor
91976427|NCT01598896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91976428|NCT01598896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91976429|NCT01598896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91976430|NCT01598896|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976431|NCT01598896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976432|NCT01598896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976433|NCT01598896|Hallucinogens|hallucinogens|mesh-ancestor
91976434|NCT01598896|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91976435|NCT01598896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976436|NCT01598896|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91976437|NCT01598896|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91976438|NCT01598896|Hormones|hormones|mesh-ancestor
91976439|NCT01598896|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976440|NCT01598662|Levonorgestrel|levonorgestrel|mesh-list
91976441|NCT01598662|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91976442|NCT01598662|Contraceptive Agents|contraceptive agents|mesh-ancestor
91976443|NCT01598662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976444|NCT01598662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976445|NCT01598662|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91976446|NCT01598662|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91976447|NCT01598662|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91976448|NCT03042429|Cyclophosphamide|cyclophosphamide|mesh-list
91976449|NCT03042429|Ifosfamide|ifosfamide|mesh-list
91976450|NCT03042429|Cisplatin|cisplatin|mesh-list
91976451|NCT03042429|Doxorubicin|doxorubicin|mesh-list
91976452|NCT03042429|Etoposide|etoposide|mesh-list
91976453|NCT03042429|Topotecan|topotecan|mesh-list
91976454|NCT03042429|Vindesine|vindesine|mesh-list
91976455|NCT03042429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976456|NCT03042429|Immunologic Factors|immunologic factors|mesh-ancestor
91976457|NCT03042429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976458|NCT03042429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976459|NCT03042429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91976460|NCT03042429|Alkylating Agents|alkylating agents|mesh-ancestor
91976461|NCT03042429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976462|NCT03042429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976463|NCT03042429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91976464|NCT03042429|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91976465|NCT03042429|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91976466|NCT03042429|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91976467|NCT03042429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976468|NCT03042429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91976469|NCT03042429|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91976470|NCT03042429|Tubulin Modulators|tubulin modulators|mesh-ancestor
91976471|NCT03042429|Antimitotic Agents|antimitotic agents|mesh-ancestor
91976472|NCT03042429|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976473|NCT04849299|Cyclosporine|cyclosporine|mesh-list
91976474|NCT04849299|Cyclosporins|cyclosporins|mesh-list
91976475|NCT04849299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976476|NCT04849299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976477|NCT04849299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976478|NCT04849299|Immunologic Factors|immunologic factors|mesh-ancestor
91976479|NCT04849299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976480|NCT04849299|Antifungal Agents|antifungal agents|mesh-ancestor
91976481|NCT04849299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976482|NCT04849299|Dermatologic Agents|dermatologic agents|mesh-ancestor
91976483|NCT04849299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976484|NCT04849299|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91976486|NCT02117050|Interferon-beta|interferon-beta|mesh-list
91976487|NCT02117050|Interferon beta-1a|interferon beta-1a|mesh-list
91976488|NCT02117050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976489|NCT02117050|Antiviral Agents|antiviral agents|mesh-ancestor
91976490|NCT02117050|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976491|NCT02117050|Immunologic Factors|immunologic factors|mesh-ancestor
91976492|NCT02117050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976493|NCT02117050|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91976494|NCT04860219|Lactoferrin|lactoferrin|mesh-list
91976496|NCT02728895|Vedolizumab|vedolizumab|mesh-list
91976497|NCT02728895|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976498|NCT04847895|Ranibizumab|ranibizumab|mesh-list
91976499|NCT04847895|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91976500|NCT04847895|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91976501|NCT04847895|Growth Substances|growth substances|mesh-ancestor
91969491|NCT05002101|Trace Elements|trace elements|mesh-ancestor
91969492|NCT05002101|Micronutrients|micronutrients|mesh-ancestor
91969493|NCT05002101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969494|NCT05002101|Astringents|astringents|mesh-ancestor
91969495|NCT05002101|Dermatologic Agents|dermatologic agents|mesh-ancestor
91969496|NCT03201913|Estrogens|estrogens|mesh-list
91976502|NCT04847895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976503|NCT04847895|Growth Inhibitors|growth inhibitors|mesh-ancestor
91976504|NCT04847895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976505|NCT02450513|Adalimumab|adalimumab|mesh-list
91976506|NCT02450513|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91976507|NCT02450513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976508|NCT02450513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976509|NCT04859283|Dexmedetomidine|dexmedetomidine|mesh-list
91976510|NCT04859283|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91976511|NCT04859283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976512|NCT04859283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976513|NCT04859283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976514|NCT04859283|Analgesics|analgesics|mesh-ancestor
91976515|NCT04859283|Sensory System Agents|sensory system agents|mesh-ancestor
91976516|NCT04859283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976517|NCT04859283|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91976518|NCT04859283|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91976519|NCT04859283|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91976520|NCT04859283|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976521|NCT04859283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976522|NCT04859283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976523|NCT04857801|Teduglutide|teduglutide|mesh-list
91976524|NCT04857801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976525|NCT04857801|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91976526|NCT04857801|Protective Agents|protective agents|mesh-ancestor
91976527|NCT04857801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976528|NCT03208361|Amoxicillin|amoxicillin|mesh-list
91976529|NCT03208361|Penicillins|penicillins|mesh-list
91976530|NCT03208361|Penicillin V|penicillin v|mesh-list
91976531|NCT03208361|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976532|NCT03208361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976533|NCT02501837|Oxytocin|oxytocin|mesh-list
91976534|NCT02501837|Oxytocics|oxytocics|mesh-ancestor
91976535|NCT02501837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976536|NCT02501837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976537|NCT04859361|Imiquimod|imiquimod|mesh-list
91976538|NCT04859361|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91976539|NCT04859361|Immunologic Factors|immunologic factors|mesh-ancestor
91976540|NCT04859361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976541|NCT04859361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976542|NCT04859361|Interferon Inducers|interferon inducers|mesh-ancestor
91976543|NCT04496141|Antibodies|antibodies|mesh-list
91976544|NCT04496141|Immunologic Factors|immunologic factors|mesh-ancestor
91976545|NCT04496141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976546|NCT03039075|Metformin|metformin|mesh-list
91976547|NCT03039075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91976548|NCT03039075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976549|NCT04857177|Ranibizumab|ranibizumab|mesh-list
91976550|NCT04857177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91976551|NCT04857177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91976552|NCT04857177|Growth Substances|growth substances|mesh-ancestor
91976553|NCT04857177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976554|NCT04857177|Growth Inhibitors|growth inhibitors|mesh-ancestor
91976555|NCT04857177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976556|NCT02606877|Pirfenidone|pirfenidone|mesh-list
91976557|NCT02606877|Nintedanib|nintedanib|mesh-list
91976558|NCT02606877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976559|NCT02606877|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91976560|NCT02606877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976561|NCT02606877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976563|NCT02606877|Sensory System Agents|sensory system agents|mesh-ancestor
91976564|NCT02606877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976565|NCT02606877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969498|NCT03201913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969499|NCT03201913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969500|NCT03199729|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91976566|NCT02606877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91976567|NCT02606877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976568|NCT02606877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976569|NCT02606877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976575|NCT03206957|Growth Substances|growth substances|mesh-ancestor
91976576|NCT03206957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976577|NCT03206957|Growth Inhibitors|growth inhibitors|mesh-ancestor
91976578|NCT03206723|Hydrocodone|hydrocodone|mesh-list
91976579|NCT03206723|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91976580|NCT03206723|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91976581|NCT03206723|Narcotics|narcotics|mesh-ancestor
91976582|NCT03206723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976583|NCT03206723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976584|NCT03206723|Analgesics|analgesics|mesh-ancestor
91976585|NCT03206723|Sensory System Agents|sensory system agents|mesh-ancestor
91976586|NCT03206723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976587|NCT03206723|Antitussive Agents|antitussive agents|mesh-ancestor
91976588|NCT03206723|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976589|NCT03206723|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91976590|NCT03201185|Ramipril|ramipril|mesh-list
91976591|NCT03201185|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91976592|NCT03201185|Protease Inhibitors|protease inhibitors|mesh-ancestor
91976593|NCT03201185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976594|NCT03201185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976595|NCT03201185|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91976596|NCT04856787|Fluorouracil|fluorouracil|mesh-list
91976597|NCT04856787|Antimetabolites|antimetabolites|mesh-ancestor
91976598|NCT04856787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976599|NCT04856787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91976600|NCT04856787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976601|NCT04856787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976602|NCT04856787|Immunologic Factors|immunologic factors|mesh-ancestor
91976603|NCT04856787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976604|NCT03206177|Paclitaxel|paclitaxel|mesh-list
91976605|NCT03206177|Carboplatin|carboplatin|mesh-list
91976606|NCT03206177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91976607|NCT03206177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976608|NCT03206177|Tubulin Modulators|tubulin modulators|mesh-ancestor
91976609|NCT03206177|Antimitotic Agents|antimitotic agents|mesh-ancestor
91976610|NCT03206177|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976611|NCT03206177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976612|NCT04839627|Progesterone|progesterone|mesh-list
91976613|NCT04839627|Progestins|progestins|mesh-ancestor
91976614|NCT04839627|Hormones|hormones|mesh-ancestor
91976615|NCT04839627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976616|NCT04839627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976617|NCT04845399|Factor VIII|factor viii|mesh-list
91976618|NCT04845399|Coagulants|coagulants|mesh-ancestor
91976619|NCT04839471|Afatinib|afatinib|mesh-list
91976620|NCT04839471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976621|NCT04839471|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91976622|NCT04839471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976623|NCT04839471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976624|NCT04839237|Metformin|metformin|mesh-list
91976625|NCT04839237|Liraglutide|liraglutide|mesh-list
91976626|NCT04839237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91976627|NCT04839237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976628|NCT04839237|Incretins|incretins|mesh-ancestor
91976629|NCT04839237|Hormones|hormones|mesh-ancestor
91976630|NCT04839237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976631|NCT04844775|Monophosphoryl lipid A|monophosphoryl lipid a|mesh-list
91976632|NCT04844775|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91976633|NCT04844775|Immunologic Factors|immunologic factors|mesh-ancestor
91969501|NCT03199729|Luteolytic Agents|luteolytic agents|mesh-ancestor
91969502|NCT03199729|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91969503|NCT03199729|Contraceptive Agents|contraceptive agents|mesh-ancestor
91969504|NCT03199729|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976634|NCT04844775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976636|NCT03038607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91976637|NCT03038607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976638|NCT03038607|Analgesics|analgesics|mesh-ancestor
91976639|NCT03038607|Sensory System Agents|sensory system agents|mesh-ancestor
91976640|NCT03038607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090416|NCT00892606|Analgesics|analgesics|mesh-ancestor
91976645|NCT03038607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91976646|NCT03038607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976647|NCT03038607|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91976648|NCT03038607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91976649|NCT03038607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976650|NCT03038607|Antipyretics|antipyretics|mesh-ancestor
91976651|NCT03038451|Amlodipine|amlodipine|mesh-list
91976652|NCT03038451|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91976653|NCT03038451|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91976654|NCT03038451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91976655|NCT03038451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976656|NCT03038451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91976657|NCT03038451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976658|NCT03038451|Vasodilator Agents|vasodilator agents|mesh-ancestor
91976659|NCT03040401|Aldesleukin|aldesleukin|mesh-list
91976660|NCT03040401|Interleukin-2|interleukin-2|mesh-list
91976661|NCT03040401|Histamine|histamine|mesh-list
91976662|NCT03040401|Histamine phosphate|histamine phosphate|mesh-list
91976663|NCT03040401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976664|NCT03040401|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91976665|NCT03040401|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91976666|NCT03040401|Antiviral Agents|antiviral agents|mesh-ancestor
91976667|NCT03040401|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976668|NCT03040401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976669|NCT03040401|Analgesics|analgesics|mesh-ancestor
91976670|NCT03040401|Sensory System Agents|sensory system agents|mesh-ancestor
91976671|NCT03040401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976672|NCT03040401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976673|NCT03040401|Histamine Agonists|histamine agonists|mesh-ancestor
91976674|NCT03040401|Histamine Agents|histamine agents|mesh-ancestor
91976675|NCT03040401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976676|NCT03040401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976677|NCT03038295|Propranolol|propranolol|mesh-list
91976678|NCT03038295|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91976679|NCT03038295|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91976680|NCT03038295|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976681|NCT03038295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976682|NCT03038295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976683|NCT03038295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976684|NCT03038295|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91976685|NCT03038295|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91976686|NCT03038295|Vasodilator Agents|vasodilator agents|mesh-ancestor
91976687|NCT03038217|Capecitabine|capecitabine|mesh-list
91976688|NCT03038217|Oxaliplatin|oxaliplatin|mesh-list
91976689|NCT03038217|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91976690|NCT03038217|Antimetabolites|antimetabolites|mesh-ancestor
91976691|NCT03038217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976692|NCT03038217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976693|NCT02609607|Bisacodyl|bisacodyl|mesh-list
91976694|NCT02609607|Cathartics|cathartics|mesh-ancestor
91976695|NCT02609607|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976696|NCT02609607|Laxatives|laxatives|mesh-ancestor
91976697|NCT03040167|Epinephrine|epinephrine|mesh-list
91976698|NCT03040167|Bupivacaine|bupivacaine|mesh-list
91976699|NCT03040167|Anesthetics, Local|anesthetics, local|mesh-ancestor
91976700|NCT03040167|Anesthetics|anesthetics|mesh-ancestor
91976701|NCT03040167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976702|NCT03040167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976703|NCT03040167|Sensory System Agents|sensory system agents|mesh-ancestor
91969505|NCT03199729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969506|NCT03199729|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91969507|NCT03199729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91969508|NCT03199729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976704|NCT03040167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976705|NCT03040167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91976706|NCT03040167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91976707|NCT03040167|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976708|NCT03040167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976709|NCT03040167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976710|NCT03040167|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91976711|NCT03040167|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91976720|NCT04843839|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91976721|NCT04843839|Lubricant Eye Drops|lubricant eye drops|mesh-list
91976722|NCT04843839|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91976723|NCT04843839|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91976724|NCT04843839|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976725|NCT04843839|Analgesics|analgesics|mesh-ancestor
91976726|NCT04843839|Sensory System Agents|sensory system agents|mesh-ancestor
91976727|NCT04843839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976728|NCT04843839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976729|NCT04843839|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976730|NCT04843839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976731|NCT04843839|Laxatives|laxatives|mesh-ancestor
91976732|NCT04843839|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976733|NCT04838145|Ribavirin|ribavirin|mesh-list
91976734|NCT04838145|Pleconaril|pleconaril|mesh-list
91976735|NCT04838145|Antimetabolites|antimetabolites|mesh-ancestor
91976736|NCT04838145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976737|NCT04838145|Antiviral Agents|antiviral agents|mesh-ancestor
91976738|NCT04838145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976739|NCT04855383|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91976740|NCT04855383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976741|NCT04855383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976742|NCT03041259|Ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium D-pantothenate drug combination|ascorbic acid, magnesium sulfate heptahydrate, cyanocobalamin, thiamine hydrochloride, riboflavin 5' phosphate, niacinamide, pyridoxine hydrochloride, and calcium d-pantothenate drug combination|mesh-list
91976743|NCT03041259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976744|NCT03041259|Antioxidants|antioxidants|mesh-ancestor
91976745|NCT03041259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976746|NCT03041259|Protective Agents|protective agents|mesh-ancestor
91976747|NCT03041259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976748|NCT04429035|Vitamin K|vitamin k|mesh-list
91976749|NCT04429035|Vitamin K 2|vitamin k 2|mesh-list
91976750|NCT04429035|Vitamins|vitamins|mesh-ancestor
91976751|NCT04429035|Micronutrients|micronutrients|mesh-ancestor
91976752|NCT04429035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976753|NCT04429035|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91976754|NCT04429035|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91976755|NCT04429035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976756|NCT04429035|Hemostatics|hemostatics|mesh-ancestor
91976757|NCT04429035|Coagulants|coagulants|mesh-ancestor
91976758|NCT04843449|Itraconazole|itraconazole|mesh-list
91976759|NCT04843449|Rifampin|rifampin|mesh-list
91976760|NCT04843449|Antifungal Agents|antifungal agents|mesh-ancestor
91976761|NCT04843449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976762|NCT04843449|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91976763|NCT04843449|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91976764|NCT04843449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976765|NCT04843449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976766|NCT04843449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91976767|NCT04843449|Hormone Antagonists|hormone antagonists|mesh-ancestor
91976768|NCT04843449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976769|NCT04843449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976770|NCT04843449|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91969510|NCT03212677|Trace Elements|trace elements|mesh-ancestor
91969511|NCT03212677|Micronutrients|micronutrients|mesh-ancestor
91969512|NCT03212677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969513|NCT03199339|Midazolam|midazolam|mesh-list
91976771|NCT04843449|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91976772|NCT04843449|Antitubercular Agents|antitubercular agents|mesh-ancestor
91976773|NCT04843449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91976774|NCT04843449|Leprostatic Agents|leprostatic agents|mesh-ancestor
91976775|NCT04843449|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91976776|NCT04843449|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91976793|NCT03037515|Hemostatics|hemostatics|mesh-ancestor
91976794|NCT03037515|Coagulants|coagulants|mesh-ancestor
91976795|NCT04842825|Cetrorelix|cetrorelix|mesh-list
91976796|NCT04842825|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91976797|NCT04842825|Hormones|hormones|mesh-ancestor
91976798|NCT04842825|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976799|NCT04842825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976800|NCT04842825|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91976801|NCT04842825|Fertility Agents|fertility agents|mesh-ancestor
91976802|NCT04842825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976803|NCT04842825|Hormone Antagonists|hormone antagonists|mesh-ancestor
91976804|NCT02606253|Metolazone|metolazone|mesh-list
91976805|NCT02606253|Chlorothiazide|chlorothiazide|mesh-list
91976806|NCT02606253|Tolvaptan|tolvaptan|mesh-list
91976807|NCT02606253|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91976808|NCT02606253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976809|NCT02606253|Natriuretic Agents|natriuretic agents|mesh-ancestor
91976810|NCT02606253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976811|NCT02606253|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91976812|NCT02606253|Diuretics|diuretics|mesh-ancestor
91976813|NCT02606253|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91976814|NCT02606253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91976815|NCT04779645|Volagidemab|volagidemab|mesh-list
91976816|NCT04779645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91976817|NCT04779645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976818|NCT04854759|Amantadine|amantadine|mesh-list
91976819|NCT04854759|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91976820|NCT04854759|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91976821|NCT04854759|Antiviral Agents|antiviral agents|mesh-ancestor
91976822|NCT04854759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976823|NCT04854759|Dopamine Agents|dopamine agents|mesh-ancestor
91976824|NCT04854759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976825|NCT04854759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976826|NCT04854759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976827|NCT04854759|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976828|NCT04854759|Analgesics|analgesics|mesh-ancestor
91976829|NCT04854759|Sensory System Agents|sensory system agents|mesh-ancestor
91976830|NCT04854759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976831|NCT04842435|Immunoglobulins|immunoglobulins|mesh-list
91976832|NCT04842435|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91976833|NCT04842435|Immunologic Factors|immunologic factors|mesh-ancestor
91976867|NCT04428879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976868|NCT04836819|Lidocaine|lidocaine|mesh-list
91976869|NCT04836819|Dexmedetomidine|dexmedetomidine|mesh-list
91976870|NCT04836819|Ketamine|ketamine|mesh-list
91976871|NCT04836819|Anesthetics, Local|anesthetics, local|mesh-ancestor
91976872|NCT04836819|Anesthetics|anesthetics|mesh-ancestor
91976873|NCT04836819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976874|NCT04836819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976875|NCT04836819|Sensory System Agents|sensory system agents|mesh-ancestor
91976876|NCT04836819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976877|NCT04836819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91976878|NCT04836819|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91976879|NCT04836819|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91976880|NCT04836819|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91976881|NCT04836819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976882|NCT04836819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91976883|NCT04836819|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91976884|NCT04836819|Analgesics|analgesics|mesh-ancestor
91976885|NCT04836819|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91976886|NCT04836819|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91969515|NCT03199339|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91969516|NCT03199339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91976887|NCT04836819|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91976888|NCT04836819|Adrenergic Agents|adrenergic agents|mesh-ancestor
91976889|NCT04836819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91976890|NCT04836819|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91976891|NCT04836819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91976892|NCT04836819|Anesthetics, General|anesthetics, general|mesh-ancestor
91976893|NCT04836819|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91976894|NCT04836819|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91976895|NCT04836507|Cyclophosphamide|cyclophosphamide|mesh-list
91976896|NCT04836507|Fludarabine|fludarabine|mesh-list
91976897|NCT04836507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976898|NCT04836507|Immunologic Factors|immunologic factors|mesh-ancestor
91976899|NCT04836507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976900|NCT04836507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976901|NCT04836507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91976902|NCT04836507|Alkylating Agents|alkylating agents|mesh-ancestor
91976903|NCT04836507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976904|NCT04836507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976905|NCT04836507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91976906|NCT04835259|Selenium|selenium|mesh-list
91976908|NCT04835259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976909|NCT04835259|Protective Agents|protective agents|mesh-ancestor
91976910|NCT04835259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976911|NCT04835259|Trace Elements|trace elements|mesh-ancestor
91976912|NCT04835259|Micronutrients|micronutrients|mesh-ancestor
91976913|NCT04853901|Remdesivir|remdesivir|mesh-list
91976914|NCT04853901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976915|NCT04853901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976916|NCT04853901|Antimetabolites|antimetabolites|mesh-ancestor
91976917|NCT04853901|Antiviral Agents|antiviral agents|mesh-ancestor
91976918|NCT01668537|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91976919|NCT01668537|Antiviral Agents|antiviral agents|mesh-ancestor
91976920|NCT01668537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976921|NCT04834791|Letrozole|letrozole|mesh-list
91976922|NCT04834791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976923|NCT04834791|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91976924|NCT04834791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91976925|NCT04834791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976926|NCT04834791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976930|NCT04834791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976931|NCT04835025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91976932|NCT04835025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976933|NCT04835025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91976934|NCT04835025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976935|NCT03038919|Methyltestosterone|methyltestosterone|mesh-list
91976936|NCT03038919|Testosterone|testosterone|mesh-list
91976937|NCT03038919|Testosterone undecanoate|testosterone undecanoate|mesh-list
91976938|NCT03038919|Testosterone enanthate|testosterone enanthate|mesh-list
91976939|NCT03038919|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
91976940|NCT03038919|Androgens|androgens|mesh-ancestor
91976941|NCT03038919|Hormones|hormones|mesh-ancestor
91976942|NCT03038919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976943|NCT03038919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976944|NCT03038919|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91976945|NCT03038919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976946|NCT03038919|Anabolic Agents|anabolic agents|mesh-ancestor
91976947|NCT03036891|Naloxegol|naloxegol|mesh-list
91976948|NCT03036891|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91976949|NCT03036891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976950|NCT03036891|Sensory System Agents|sensory system agents|mesh-ancestor
91976951|NCT03036891|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976952|NCT01668147|Ritonavir|ritonavir|mesh-list
91976953|NCT01668147|Efavirenz|efavirenz|mesh-list
91976954|NCT01668147|Loperamide|loperamide|mesh-list
91976955|NCT01668147|Antidiarrheals|antidiarrheals|mesh-list
91976956|NCT01668147|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91969517|NCT03199339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969518|NCT03199339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976957|NCT01668147|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91976958|NCT01668147|Protease Inhibitors|protease inhibitors|mesh-ancestor
91976959|NCT01668147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976960|NCT01668147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976961|NCT01668147|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91976962|NCT01668147|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91976963|NCT01668147|Antiviral Agents|antiviral agents|mesh-ancestor
91976964|NCT01668147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976965|NCT01668147|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91976966|NCT01668147|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91976967|NCT01668147|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91977410|NCT04806945|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976968|NCT01668147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91976969|NCT01668147|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91976970|NCT01668147|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91976971|NCT01668147|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91976972|NCT01668147|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91976973|NCT01668147|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91976974|NCT01668147|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91976975|NCT04833777|Lidocaine|lidocaine|mesh-list
91976976|NCT04833777|Bupivacaine|bupivacaine|mesh-list
91976977|NCT04833777|Anesthetics, Local|anesthetics, local|mesh-list
91976978|NCT04833777|Anesthetics|anesthetics|mesh-list
91976979|NCT04833777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976980|NCT04833777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976981|NCT04833777|Sensory System Agents|sensory system agents|mesh-ancestor
91976982|NCT04833777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976983|NCT04833777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91976984|NCT04833777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91976985|NCT04833777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91976986|NCT04833777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91976987|NCT04833777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976988|NCT03036501|Risdiplam|risdiplam|mesh-list
91976989|NCT03036501|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91976990|NCT03036501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976991|NCT03036501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976992|NCT04851015|Trimethoprim|trimethoprim|mesh-list
91976993|NCT04851015|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91976994|NCT04851015|Sulfamethoxazole|sulfamethoxazole|mesh-list
91976995|NCT04851015|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91977001|NCT04851015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977002|NCT04851015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977003|NCT04851015|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91977004|NCT04851015|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91977005|NCT04851015|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91977006|NCT04851015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91977008|NCT04365933|Interferon-alpha|interferon-alpha|mesh-list
91977009|NCT04365933|Interferon alpha-2|interferon alpha-2|mesh-list
91977010|NCT04365933|Entecavir|entecavir|mesh-list
91977011|NCT04365933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91977012|NCT04365933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977013|NCT04365933|Antiviral Agents|antiviral agents|mesh-ancestor
91977014|NCT04365933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977015|NCT04365933|Immunologic Factors|immunologic factors|mesh-ancestor
91977016|NCT04365933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977017|NCT04824261|Clotrimazole|clotrimazole|mesh-list
91977018|NCT04824261|Miconazole|miconazole|mesh-list
91977019|NCT04824261|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91977020|NCT04824261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977021|NCT04824261|Antifungal Agents|antifungal agents|mesh-ancestor
91977022|NCT04824261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91977023|NCT04824261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91977024|NCT04824261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977025|NCT04824261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977026|NCT04824261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91977027|NCT04824261|Hormone Antagonists|hormone antagonists|mesh-ancestor
91969519|NCT03199339|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91969520|NCT03199339|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91969521|NCT03199339|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91977028|NCT04824261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977029|NCT04824261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977030|NCT04824261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91977031|NCT04824261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91977033|NCT04850235|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977034|NCT04850235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977035|NCT04850235|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977036|NCT04850235|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977037|NCT04850235|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977038|NCT04850235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977040|NCT04850001|Clopidogrel|clopidogrel|mesh-list
91977041|NCT04850001|Atorvastatin|atorvastatin|mesh-list
91977042|NCT04850001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91977043|NCT04850001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977044|NCT04850001|Analgesics|analgesics|mesh-ancestor
91977045|NCT04850001|Sensory System Agents|sensory system agents|mesh-ancestor
91977046|NCT04850001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977047|NCT04850001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977048|NCT04850001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977049|NCT04850001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977050|NCT04850001|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91977051|NCT04850001|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91977052|NCT04850001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977053|NCT04850001|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91977054|NCT04850001|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91977055|NCT04850001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977056|NCT04850001|Antipyretics|antipyretics|mesh-ancestor
91977057|NCT04850001|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91977058|NCT04850001|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91977059|NCT04850001|Antimetabolites|antimetabolites|mesh-ancestor
91977060|NCT04850001|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91977061|NCT04850001|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91977062|NCT04850001|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91977063|NCT04850001|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91977064|NCT04850001|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91977065|NCT04850001|Purinergic Agents|purinergic agents|mesh-ancestor
91977072|NCT03036111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977073|NCT04830579|Etoricoxib|etoricoxib|mesh-list
91977074|NCT04830579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91977075|NCT04830579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977076|NCT04830579|Analgesics|analgesics|mesh-ancestor
91977077|NCT04830579|Sensory System Agents|sensory system agents|mesh-ancestor
91977078|NCT04830579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977079|NCT04830579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977080|NCT04830579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977081|NCT04830579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977082|NCT04830579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91977083|NCT04830579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91977084|NCT04830579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977085|NCT04830579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977086|NCT04816461|Piperaquine|piperaquine|mesh-list
91977087|NCT04816461|Sulfadoxine|sulfadoxine|mesh-list
91977088|NCT04816461|Amodiaquine|amodiaquine|mesh-list
91977089|NCT04816461|Artenimol|artenimol|mesh-list
91977090|NCT04816461|Antimalarials|antimalarials|mesh-ancestor
91977091|NCT04816461|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91977092|NCT04816461|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91977093|NCT04816461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977094|NCT04816461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91977095|NCT04427865|Lactoferrin|lactoferrin|mesh-list
91977096|NCT04427865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977097|NCT02600559|Ciprofloxacin|ciprofloxacin|mesh-list
91977098|NCT02600559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91977099|NCT02600559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977100|NCT02600559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91977101|NCT02600559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91977102|NCT02600559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969522|NCT03199339|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91969523|NCT03199339|Anesthetics, General|anesthetics, general|mesh-ancestor
91969524|NCT03199339|Anesthetics|anesthetics|mesh-ancestor
91977103|NCT02600559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977104|NCT02600559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977105|NCT02600559|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91977106|NCT02600559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91977107|NCT04427787|Lanreotide|lanreotide|mesh-list
91977108|NCT04427787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977109|NCT04821843|Paclitaxel|paclitaxel|mesh-list
91977110|NCT04821843|Nimotuzumab|nimotuzumab|mesh-list
91977111|NCT04821843|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977112|NCT04821843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977113|NCT04821843|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977114|NCT04821843|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977115|NCT04821843|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977116|NCT04821843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977117|NCT04821843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977118|NCT04829487|Vitamin D|vitamin d|mesh-list
91977119|NCT04829487|Ergocalciferols|ergocalciferols|mesh-list
91977120|NCT04829487|Vitamins|vitamins|mesh-ancestor
91977121|NCT04829487|Micronutrients|micronutrients|mesh-ancestor
91977122|NCT04829487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977123|NCT04829487|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91977124|NCT04829487|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91977125|NCT04829565|Botulinum Toxins|botulinum toxins|mesh-list
91977126|NCT04829565|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91977127|NCT04829565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977128|NCT04829565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977129|NCT04829565|Cholinergic Agents|cholinergic agents|mesh-ancestor
91977130|NCT04829565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977131|NCT04829565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977132|NCT04821765|Paclitaxel|paclitaxel|mesh-list
91977133|NCT04821765|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91977134|NCT04821765|Antibodies|antibodies|mesh-list
91977147|NCT04829097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977148|NCT04829019|Osimertinib|osimertinib|mesh-list
91977149|NCT04829019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977150|NCT04829019|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977151|NCT04829019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977152|NCT04829019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977153|NCT04821063|Moxifloxacin|moxifloxacin|mesh-list
91977154|NCT04821063|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91977155|NCT04821063|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
91977156|NCT04821063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91977157|NCT04821063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977158|NCT04821063|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91977159|NCT04821063|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91977160|NCT04821063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977161|NCT04821063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977162|NCT04821063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977163|NCT04821063|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91977164|NCT04821063|Contraceptive Agents|contraceptive agents|mesh-ancestor
91977165|NCT04821063|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91977166|NCT04821063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977167|NCT04821063|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91977168|NCT04821063|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91977169|NCT04821063|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91977170|NCT04821063|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91977171|NCT03976245|Etanercept|etanercept|mesh-list
91977172|NCT03976245|Tofacitinib|tofacitinib|mesh-list
91977173|NCT03976245|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91977174|NCT03976245|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977175|NCT03976245|Analgesics|analgesics|mesh-ancestor
91977176|NCT03976245|Sensory System Agents|sensory system agents|mesh-ancestor
91977177|NCT03976245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977178|NCT03976245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977179|NCT03976245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977180|NCT03976245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977181|NCT03976245|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91969525|NCT03199339|GABA Modulators|gaba modulators|mesh-ancestor
91969526|NCT03199339|GABA Agents|gaba agents|mesh-ancestor
91969527|NCT03199339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969528|NCT03199339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977182|NCT03976245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91977183|NCT03976245|Immunologic Factors|immunologic factors|mesh-ancestor
91977184|NCT03976245|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91977185|NCT03976245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977186|NCT03976245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977187|NCT03976245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977189|NCT04820751|Antipruritics|antipruritics|mesh-ancestor
91977190|NCT04820751|Dermatologic Agents|dermatologic agents|mesh-ancestor
91977191|NCT04820751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977192|NCT04820751|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91977193|NCT04820751|Histamine Antagonists|histamine antagonists|mesh-ancestor
91977194|NCT04820751|Histamine Agents|histamine agents|mesh-ancestor
91977200|NCT04820751|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91977201|NCT04828395|Paclitaxel|paclitaxel|mesh-list
91977202|NCT04828395|Etoposide|etoposide|mesh-list
91977203|NCT04828395|Cisplatin|cisplatin|mesh-list
91977204|NCT04828395|Carboplatin|carboplatin|mesh-list
91977205|NCT04828395|Pemetrexed|pemetrexed|mesh-list
91977206|NCT04828395|Fluzoparib|fluzoparib|mesh-list
91977207|NCT04828395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977208|NCT04828395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977209|NCT04828395|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977210|NCT04828395|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977211|NCT04828395|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977212|NCT04828395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977213|NCT04828395|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91977214|NCT04828395|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91977215|NCT04828395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977216|NCT04828395|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91977217|NCT04828395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91977218|NCT04828395|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91977219|NCT04820439|Pertuzumab|pertuzumab|mesh-list
91977220|NCT04820439|Antibodies|antibodies|mesh-list
91977221|NCT04820439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91977222|NCT04820439|Mitogens|mitogens|mesh-list
91977223|NCT04820439|Immunologic Factors|immunologic factors|mesh-ancestor
91977224|NCT04820439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977225|NCT04820439|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977226|NCT04820439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977227|NCT04820439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977228|NCT04820439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977229|NCT05619315|Calcium Carbonate|calcium carbonate|mesh-list
91977230|NCT05619315|Calcium|calcium|mesh-list
91977231|NCT05619315|Charcoal|charcoal|mesh-list
91977232|NCT05619315|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91977233|NCT05619315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977234|NCT05619315|Antacids|antacids|mesh-ancestor
91977235|NCT05619315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977236|NCT05619315|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977237|NCT05619315|Antidotes|antidotes|mesh-ancestor
91977238|NCT05619315|Protective Agents|protective agents|mesh-ancestor
91977239|NCT04814511|Permethrin|permethrin|mesh-list
91977240|NCT04814511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977241|NCT04814511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977242|NCT04814043|Lenvatinib|lenvatinib|mesh-list
91977243|NCT04814043|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91977244|NCT04814043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977245|NCT04814043|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977246|NCT04814043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977247|NCT04814043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977248|NCT04814043|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977249|NCT04814589|Ezetimibe|ezetimibe|mesh-list
91977250|NCT04814589|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91977251|NCT04814589|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91977252|NCT04814589|Antimetabolites|antimetabolites|mesh-ancestor
91977253|NCT04814589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969529|NCT03199339|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91969530|NCT03199339|Antidepressive Agents|antidepressive agents|mesh-ancestor
91977254|NCT04814589|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91977255|NCT04819503|Anesthetics|anesthetics|mesh-list
91977256|NCT04819503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977257|NCT04819503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977258|NCT04826679|Paclitaxel|paclitaxel|mesh-list
91977259|NCT04826679|Cisplatin|cisplatin|mesh-list
91977260|NCT04826679|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977261|NCT04826679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977262|NCT04826679|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977263|NCT04826679|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977264|NCT04826679|Mitosis Modulators|mitosis modulators|mesh-ancestor
92090417|NCT00892606|Sensory System Agents|sensory system agents|mesh-ancestor
91977282|NCT04818723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977284|NCT02601027|Oxycodone|oxycodone|mesh-list
91977285|NCT02601027|Hydromorphone|hydromorphone|mesh-list
91977286|NCT02601027|Ondansetron|ondansetron|mesh-list
91977287|NCT02601027|Bupivacaine|bupivacaine|mesh-list
91977288|NCT02601027|Anesthetics, Local|anesthetics, local|mesh-ancestor
91977289|NCT02601027|Anesthetics|anesthetics|mesh-ancestor
91977290|NCT02601027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977291|NCT02601027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977292|NCT02601027|Sensory System Agents|sensory system agents|mesh-ancestor
91977293|NCT02601027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977294|NCT02601027|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91977295|NCT02601027|Narcotics|narcotics|mesh-ancestor
91977296|NCT02601027|Analgesics|analgesics|mesh-ancestor
91977297|NCT02601027|Antiemetics|antiemetics|mesh-ancestor
91977298|NCT02601027|Autonomic Agents|autonomic agents|mesh-ancestor
91977299|NCT02601027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977300|NCT02601027|Antipruritics|antipruritics|mesh-ancestor
91977301|NCT02601027|Dermatologic Agents|dermatologic agents|mesh-ancestor
91977302|NCT02601027|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91977303|NCT02601027|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91977304|NCT02601027|Serotonin Agents|serotonin agents|mesh-ancestor
91977305|NCT02601027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977306|NCT02601027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977307|NCT02601027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977308|NCT02601027|Antipyretics|antipyretics|mesh-ancestor
91977310|NCT04411875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91977311|NCT04411875|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91977312|NCT04411875|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977313|NCT04411875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977314|NCT04411875|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91977315|NCT04411875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977316|NCT04411875|Vasodilator Agents|vasodilator agents|mesh-ancestor
91977317|NCT02600871|Povidone-Iodine|povidone-iodine|mesh-list
91977318|NCT02600871|Povidone|povidone|mesh-list
91977319|NCT02600871|Plasma Substitutes|plasma substitutes|mesh-ancestor
91977320|NCT02600871|Blood Substitutes|blood substitutes|mesh-ancestor
91977339|NCT04818099|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91977340|NCT04818099|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91977341|NCT04818099|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91977342|NCT04357899|Hypolipidemic Agents|hypolipidemic agents|mesh-list
91977343|NCT04357899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977345|NCT04357899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91977346|NCT04807569|Tamsulosin|tamsulosin|mesh-list
91977347|NCT04807569|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91977348|NCT04807569|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91977349|NCT04807569|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91977350|NCT04807569|Adrenergic Agents|adrenergic agents|mesh-ancestor
91977351|NCT04807569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977352|NCT04807569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977353|NCT04807569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977354|NCT04807569|Urological Agents|urological agents|mesh-ancestor
91977355|NCT04807413|Nitric Oxide|nitric oxide|mesh-list
91977356|NCT04807413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91977357|NCT04807413|Autonomic Agents|autonomic agents|mesh-ancestor
91977358|NCT04807413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977359|NCT04807413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969531|NCT03199339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91977360|NCT04807413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91977361|NCT04807413|Respiratory System Agents|respiratory system agents|mesh-ancestor
91977362|NCT04807413|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91977363|NCT04807413|Antioxidants|antioxidants|mesh-ancestor
91977364|NCT04807413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977365|NCT04807413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977366|NCT04807413|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91977367|NCT04807413|Vasodilator Agents|vasodilator agents|mesh-ancestor
91977369|NCT04807413|Protective Agents|protective agents|mesh-ancestor
91977370|NCT04356729|Bevacizumab|bevacizumab|mesh-list
91977371|NCT04356729|Atezolizumab|atezolizumab|mesh-list
91977372|NCT04356729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977385|NCT04807335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977386|NCT04807335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977387|NCT04807335|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91977389|NCT04807335|Anesthetics, General|anesthetics, general|mesh-ancestor
91977390|NCT04807335|Anesthetics|anesthetics|mesh-ancestor
91977391|NCT04807335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977392|NCT04807335|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91977393|NCT04807335|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91977394|NCT04807335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977395|NCT04807335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977396|NCT04807335|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91977397|NCT04807335|Narcotics|narcotics|mesh-ancestor
91977398|NCT04807335|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91977399|NCT05616507|Fucoidan|fucoidan|mesh-list
91977400|NCT05616507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91977401|NCT05616507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977402|NCT05616507|Anticoagulants|anticoagulants|mesh-ancestor
91977403|NCT05616507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977404|NCT04806945|Paclitaxel|paclitaxel|mesh-list
91977405|NCT04806945|Carboplatin|carboplatin|mesh-list
91977406|NCT04806945|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977407|NCT04806945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977408|NCT04806945|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977409|NCT04806945|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977411|NCT04806945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977412|NCT04806633|Dapagliflozin|dapagliflozin|mesh-list
91977413|NCT04806633|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91977414|NCT04806633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977415|NCT04806633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91977416|NCT04806633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977417|NCT04805229|Analgesics, Opioid|analgesics, opioid|mesh-list
91977418|NCT04805229|Narcotics|narcotics|mesh-ancestor
91977419|NCT04805229|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977420|NCT04805229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977421|NCT04805229|Analgesics|analgesics|mesh-ancestor
91977422|NCT04805229|Sensory System Agents|sensory system agents|mesh-ancestor
91977423|NCT04805229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977424|NCT04811313|Bupivacaine|bupivacaine|mesh-list
91977425|NCT04811313|Tranexamic Acid|tranexamic acid|mesh-list
91977426|NCT04811313|Anesthetics, Local|anesthetics, local|mesh-ancestor
91977427|NCT04811313|Anesthetics|anesthetics|mesh-ancestor
91977428|NCT04811313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977429|NCT04811313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977430|NCT04811313|Sensory System Agents|sensory system agents|mesh-ancestor
91977431|NCT04811313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977432|NCT04811313|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91977433|NCT04811313|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91977438|NCT04352439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91977439|NCT04352439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977440|NCT04352439|Analgesics|analgesics|mesh-ancestor
91977441|NCT04352439|Sensory System Agents|sensory system agents|mesh-ancestor
91977442|NCT04352439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977443|NCT04352439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977444|NCT04352439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977445|NCT04352439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977446|NCT04352439|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91969532|NCT03199339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91977447|NCT04352439|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91977448|NCT04352439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977449|NCT04352439|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91977450|NCT04352439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91977451|NCT04352439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977453|NCT04796025|Bevacizumab|bevacizumab|mesh-list
91977454|NCT04796025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977455|NCT04796025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977456|NCT04796025|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91977457|NCT04796025|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91977458|NCT04796025|Growth Substances|growth substances|mesh-ancestor
91977459|NCT04796025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977460|NCT04796025|Growth Inhibitors|growth inhibitors|mesh-ancestor
91977461|NCT04795479|Moxifloxacin|moxifloxacin|mesh-list
91977462|NCT04795479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91977463|NCT04795479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977464|NCT04795479|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91977465|NCT04795479|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91977466|NCT04795479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977467|NCT04795479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977468|NCT04795479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977470|NCT02595723|Megestrol Acetate|megestrol acetate|mesh-list
91977471|NCT02595723|Phenytoin|phenytoin|mesh-list
91977472|NCT02595723|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91977473|NCT02595723|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91977474|NCT02595723|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91977475|NCT02595723|Contraceptive Agents|contraceptive agents|mesh-ancestor
91977476|NCT02595723|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91977477|NCT02595723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977478|NCT02595723|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91977479|NCT02595723|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91977480|NCT02595723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91977481|NCT02595723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977482|NCT02595723|Appetite Stimulants|appetite stimulants|mesh-ancestor
91977483|NCT02595723|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91977484|NCT02595723|Anticonvulsants|anticonvulsants|mesh-ancestor
91977485|NCT02595723|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91977486|NCT02595723|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91977487|NCT02595723|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977488|NCT02595723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977489|NCT02595723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91977490|NCT02595723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91977491|NCT01667679|Sumatriptan|sumatriptan|mesh-list
91977492|NCT01667679|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91977493|NCT01667679|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91977494|NCT01667679|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91977495|NCT01667679|Serotonin Agents|serotonin agents|mesh-ancestor
91977496|NCT01667679|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977497|NCT01667679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977498|NCT01667679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977499|NCT02597049|Metformin|metformin|mesh-list
91977500|NCT02597049|Dapagliflozin|dapagliflozin|mesh-list
91977501|NCT02597049|Empagliflozin|empagliflozin|mesh-list
91977502|NCT02597049|Canagliflozin|canagliflozin|mesh-list
91977503|NCT02597049|Dulaglutide|dulaglutide|mesh-list
91977524|NCT04802967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91977525|NCT04802967|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91977526|NCT04802967|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91977527|NCT04802967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977528|NCT04802967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977529|NCT04802967|Antimanic Agents|antimanic agents|mesh-ancestor
91977530|NCT04802967|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91977531|NCT04802967|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977532|NCT04802967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977533|NCT04802967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977534|NCT04802967|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91977535|NCT04802967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969533|NCT03199339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91969534|NCT03199339|Dopamine Agents|dopamine agents|mesh-ancestor
91977536|NCT04282785|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91977537|NCT04282785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977538|NCT05616117|Vitamin D|vitamin d|mesh-list
91977539|NCT05616117|Vitamins|vitamins|mesh-list
91977540|NCT05616117|Micronutrients|micronutrients|mesh-ancestor
91977541|NCT05616117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977542|NCT05616117|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91977543|NCT02594163|Rituximab|rituximab|mesh-list
91977544|NCT02594163|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91977545|NCT02594163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91977546|NCT02594163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977547|NCT02594163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977548|NCT02594163|Immunologic Factors|immunologic factors|mesh-ancestor
91977549|NCT02594163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977550|NCT02594163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977551|NCT02594163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91977552|NCT02594163|Alkylating Agents|alkylating agents|mesh-ancestor
91977553|NCT02594163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977554|NCT02594163|Immunotoxins|immunotoxins|mesh-ancestor
91977555|NCT02594163|Immunoconjugates|immunoconjugates|mesh-ancestor
91977556|NCT03206255|Vaccines|vaccines|mesh-list
91977557|NCT03206255|Immunologic Factors|immunologic factors|mesh-ancestor
91977558|NCT03206255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977571|NCT03200561|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91977573|NCT03200561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977574|NCT03200561|Glucocorticoids|glucocorticoids|mesh-ancestor
91977575|NCT03200561|Hormones|hormones|mesh-ancestor
91977576|NCT03200561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977577|NCT03200561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977578|NCT03200561|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91977579|NCT03200561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977580|NCT03200561|Immunologic Factors|immunologic factors|mesh-ancestor
91977581|NCT02449811|Amlodipine|amlodipine|mesh-list
91977582|NCT02449811|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91977583|NCT02449811|Olmesartan|olmesartan|mesh-list
91977584|NCT02449811|Perindopril|perindopril|mesh-list
91977585|NCT02449811|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91977586|NCT02449811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91977587|NCT02449811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977588|NCT02449811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977589|NCT02449811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91977590|NCT02449811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977591|NCT02449811|Vasodilator Agents|vasodilator agents|mesh-ancestor
91977592|NCT02449811|Diuretics|diuretics|mesh-ancestor
91977593|NCT02449811|Natriuretic Agents|natriuretic agents|mesh-ancestor
91977594|NCT02449811|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91977595|NCT02449811|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91977596|NCT02449811|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91977597|NCT02449811|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91977598|NCT02449811|Protease Inhibitors|protease inhibitors|mesh-ancestor
91977599|NCT02449811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977601|NCT03200093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91977602|NCT03200093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977604|NCT03204929|Trace Elements|trace elements|mesh-ancestor
91977605|NCT03204929|Micronutrients|micronutrients|mesh-ancestor
91977606|NCT03204929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977607|NCT02596971|Prednisone|prednisone|mesh-list
91977608|NCT02596971|Cyclophosphamide|cyclophosphamide|mesh-list
91977609|NCT02596971|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91977610|NCT02596971|Rituximab|rituximab|mesh-list
91977611|NCT02596971|Doxorubicin|doxorubicin|mesh-list
91977612|NCT02596971|Vincristine|vincristine|mesh-list
91977613|NCT02596971|Atezolizumab|atezolizumab|mesh-list
91977614|NCT02596971|Obinutuzumab|obinutuzumab|mesh-list
91977615|NCT02596971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91977616|NCT02596971|Immunologic Factors|immunologic factors|mesh-ancestor
91977617|NCT02596971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977618|NCT02596971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977619|NCT02596971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91977620|NCT02596971|Alkylating Agents|alkylating agents|mesh-ancestor
91977621|NCT02596971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969535|NCT03199339|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91977622|NCT02596971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977625|NCT02596971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91977626|NCT02596971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91977627|NCT02596971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91977628|NCT02596971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977629|NCT02596971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977630|NCT02596971|Glucocorticoids|glucocorticoids|mesh-ancestor
91977631|NCT02596971|Hormones|hormones|mesh-ancestor
91977632|NCT02596971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977633|NCT02596971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91977634|NCT02596971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977635|NCT02596971|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977636|NCT02596971|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977637|NCT02596971|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977638|NCT02596971|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91977639|NCT04808739|Adalimumab|adalimumab|mesh-list
91977640|NCT04808739|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91977641|NCT04808739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977642|NCT04808739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977643|NCT04808895|Aspirin|aspirin|mesh-list
91977644|NCT04808895|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91977645|NCT04808895|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977646|NCT04808895|Analgesics|analgesics|mesh-ancestor
91977647|NCT04808895|Sensory System Agents|sensory system agents|mesh-ancestor
91977648|NCT04808895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977649|NCT04808895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977650|NCT04808895|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977651|NCT04808895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977652|NCT04808895|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91977653|NCT04808895|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91977654|NCT04808895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977655|NCT04808895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91977656|NCT04808895|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91977657|NCT04808895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977658|NCT04808895|Antipyretics|antipyretics|mesh-ancestor
91977659|NCT04485689|Capsaicin|capsaicin|mesh-list
91977660|NCT04485689|Antipruritics|antipruritics|mesh-ancestor
91977661|NCT04485689|Dermatologic Agents|dermatologic agents|mesh-ancestor
91977662|NCT04485689|Sensory System Agents|sensory system agents|mesh-ancestor
91977663|NCT04485689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977664|NCT04485689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977665|NCT03204071|Metformin|metformin|mesh-list
91977666|NCT03204071|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91977667|NCT03204071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977668|NCT04801017|Artemisinins|artemisinins|mesh-list
91977669|NCT04801017|Artemisinin|artemisinin|mesh-list
91977670|NCT04801017|Trabedersen|trabedersen|mesh-list
91977671|NCT04801017|Antimalarials|antimalarials|mesh-ancestor
91977672|NCT04801017|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91977674|NCT04801017|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977675|NCT04801017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977676|NCT03107429|Acetazolamide|acetazolamide|mesh-list
91977677|NCT03107429|Anticonvulsants|anticonvulsants|mesh-ancestor
91977678|NCT03107429|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91977679|NCT03107429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977680|NCT03107429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977681|NCT03107429|Diuretics|diuretics|mesh-ancestor
91977682|NCT03107429|Natriuretic Agents|natriuretic agents|mesh-ancestor
91977683|NCT03107429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977684|NCT04794231|Chlorhexidine|chlorhexidine|mesh-list
91977685|NCT04794231|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91977686|NCT04794231|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91977687|NCT04794231|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977688|NCT04794231|Disinfectants|disinfectants|mesh-ancestor
91977689|NCT04794231|Dermatologic Agents|dermatologic agents|mesh-ancestor
91977690|NCT04800081|Valsartan|valsartan|mesh-list
91977691|NCT04800081|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91977692|NCT04800081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92074260|NCT00074308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91977693|NCT04800081|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91977694|NCT04800081|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91977695|NCT04800081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969536|NCT03199339|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91969537|NCT03199339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969538|NCT03071679|Antimicrobial Cationic Peptides|antimicrobial cationic peptides|mesh-list
91969539|NCT03071679|Imiquimod|imiquimod|mesh-list
91969540|NCT03071679|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91969541|NCT03071679|Immunologic Factors|immunologic factors|mesh-ancestor
91977696|NCT03202979|Trazodone|trazodone|mesh-list
91977706|NCT03202979|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977707|NCT03202979|Serotonin Agents|serotonin agents|mesh-ancestor
91977708|NCT03202979|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91977709|NCT03202979|Antidepressive Agents|antidepressive agents|mesh-ancestor
91977710|NCT04799925|Febuxostat|febuxostat|mesh-list
91977711|NCT04799925|Gout Suppressants|gout suppressants|mesh-ancestor
91977712|NCT04799925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977720|NCT03232307|Dexamethasone|dexamethasone|mesh-list
91977721|NCT03232307|Dexamethasone acetate|dexamethasone acetate|mesh-list
91977722|NCT03232307|Rituximab|rituximab|mesh-list
91977723|NCT03232307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91977724|NCT03232307|Lenalidomide|lenalidomide|mesh-list
91977725|NCT03232307|Antibodies|antibodies|mesh-list
91977726|NCT03232307|Immunoglobulins|immunoglobulins|mesh-list
91977727|NCT03232307|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91977728|NCT03232307|BB 1101|bb 1101|mesh-list
91977729|NCT03232307|Immunologic Factors|immunologic factors|mesh-ancestor
91977730|NCT03232307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977731|NCT03232307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977732|NCT03232307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91977733|NCT03232307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91977734|NCT03232307|Antiemetics|antiemetics|mesh-ancestor
91977735|NCT03232307|Autonomic Agents|autonomic agents|mesh-ancestor
91977736|NCT03232307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977737|NCT03232307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977738|NCT03232307|Glucocorticoids|glucocorticoids|mesh-ancestor
91977739|NCT03232307|Hormones|hormones|mesh-ancestor
91977740|NCT03232307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977741|NCT03232307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91977742|NCT03232307|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91977743|NCT03232307|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91977744|NCT03232307|Growth Substances|growth substances|mesh-ancestor
91977745|NCT03232307|Growth Inhibitors|growth inhibitors|mesh-ancestor
91977746|NCT03232307|Protease Inhibitors|protease inhibitors|mesh-ancestor
91977747|NCT03232307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977748|NCT03232307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977749|NCT05615727|Dexmedetomidine|dexmedetomidine|mesh-list
91977750|NCT05615727|Zolpidem|zolpidem|mesh-list
91977751|NCT05615727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91977752|NCT05615727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977753|NCT05615727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977754|NCT05615727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91977755|NCT05615727|Analgesics|analgesics|mesh-ancestor
91977756|NCT05615727|Sensory System Agents|sensory system agents|mesh-ancestor
91977757|NCT05615727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977758|NCT05615727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91977759|NCT05615727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91977760|NCT05615727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91977761|NCT05615727|Adrenergic Agents|adrenergic agents|mesh-ancestor
91977762|NCT05615727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977763|NCT05615727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977764|NCT05615727|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91977765|NCT05615727|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91977766|NCT05615727|GABA Agonists|gaba agonists|mesh-ancestor
91977767|NCT05615727|GABA Agents|gaba agents|mesh-ancestor
91977768|NCT02450279|Edetic Acid|edetic acid|mesh-list
91977770|NCT02450279|Antidotes|antidotes|mesh-ancestor
91977771|NCT02450279|Protective Agents|protective agents|mesh-ancestor
91977772|NCT02450279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977773|NCT02450279|Chelating Agents|chelating agents|mesh-ancestor
91977774|NCT02450279|Sequestering Agents|sequestering agents|mesh-ancestor
91977775|NCT02450279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969542|NCT03071679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969543|NCT03071679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969544|NCT03071679|Interferon Inducers|interferon inducers|mesh-ancestor
91969545|NCT03071679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969546|NCT03199261|Exenatide|exenatide|mesh-list
91969547|NCT03199261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91977776|NCT02450279|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91977777|NCT02450279|Anticoagulants|anticoagulants|mesh-ancestor
91977778|NCT02450279|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91977779|NCT03231683|Ketamine|ketamine|mesh-list
91977780|NCT03231683|Remifentanil|remifentanil|mesh-list
91977781|NCT03231683|Propofol|propofol|mesh-list
91977782|NCT03231683|Esketamine|esketamine|mesh-list
91977783|NCT03231683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91977784|NCT03231683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977785|NCT03231683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977786|NCT03231683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91977787|NCT03231683|Anesthetics, General|anesthetics, general|mesh-ancestor
91977788|NCT03231683|Anesthetics|anesthetics|mesh-ancestor
91977789|NCT03231683|Analgesics|analgesics|mesh-ancestor
91977790|NCT03231683|Sensory System Agents|sensory system agents|mesh-ancestor
91977791|NCT03231683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977792|NCT03231683|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91977793|NCT03231683|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91977794|NCT03231683|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91977795|NCT03231683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977796|NCT03231683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977797|NCT03231683|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91977798|NCT03231683|Narcotics|narcotics|mesh-ancestor
91977799|NCT03231683|Antidepressive Agents|antidepressive agents|mesh-ancestor
91977800|NCT03231683|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91977801|NCT02593773|Interferons|interferons|mesh-list
91977802|NCT02593773|Interferon-gamma|interferon-gamma|mesh-list
91977803|NCT02593773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977804|NCT02593773|Antiviral Agents|antiviral agents|mesh-ancestor
91977805|NCT02593773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977806|NCT04798443|Hyaluronic Acid|hyaluronic acid|mesh-list
91977807|NCT04798443|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91977808|NCT04798443|Immunologic Factors|immunologic factors|mesh-ancestor
91977809|NCT04798443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977810|NCT04798443|Viscosupplements|viscosupplements|mesh-ancestor
91977811|NCT04798443|Protective Agents|protective agents|mesh-ancestor
91977812|NCT02450045|Bupivacaine|bupivacaine|mesh-list
91977813|NCT02450045|Ropivacaine|ropivacaine|mesh-list
91977814|NCT02450045|Anesthetics, Local|anesthetics, local|mesh-list
91977815|NCT02450045|Anesthetics|anesthetics|mesh-list
91977816|NCT02450045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977817|NCT02450045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977818|NCT02450045|Sensory System Agents|sensory system agents|mesh-ancestor
91977819|NCT02450045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977820|NCT02593539|Nemiralisib|nemiralisib|mesh-list
91977821|NCT02593539|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977822|NCT02593539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977823|NCT02593539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977824|NCT02593305|Methamphetamine|methamphetamine|mesh-list
91977825|NCT02593305|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91977826|NCT02593305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977827|NCT02593305|Sympathomimetics|sympathomimetics|mesh-ancestor
91977828|NCT02593305|Autonomic Agents|autonomic agents|mesh-ancestor
91977829|NCT02593305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977830|NCT02593305|Dopamine Agents|dopamine agents|mesh-ancestor
91977831|NCT02593305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977832|NCT02593305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977833|NCT02593305|Adrenergic Agents|adrenergic agents|mesh-ancestor
91977834|NCT02593305|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91977835|NCT02593305|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91977836|NCT02593305|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977837|NCT02593305|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91977838|NCT04389411|Montelukast|montelukast|mesh-list
91969548|NCT03199261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969549|NCT03199261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91977839|NCT04389411|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91977840|NCT04389411|Respiratory System Agents|respiratory system agents|mesh-ancestor
91977841|NCT04389411|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91977842|NCT04389411|Hormone Antagonists|hormone antagonists|mesh-ancestor
91977843|NCT04389411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977846|NCT04389411|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91977847|NCT04389411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977849|NCT02448251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977850|NCT02448251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977851|NCT02448251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977852|NCT03195569|Paclitaxel|paclitaxel|mesh-list
91977853|NCT03195569|Bevacizumab|bevacizumab|mesh-list
91977854|NCT03195569|Carboplatin|carboplatin|mesh-list
91977855|NCT03195569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977856|NCT03195569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977857|NCT03195569|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977858|NCT03195569|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977859|NCT03195569|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977860|NCT03195569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977861|NCT03195569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977862|NCT03195569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91977863|NCT03195569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91977864|NCT03195569|Growth Substances|growth substances|mesh-ancestor
91977865|NCT03195569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977866|NCT03195569|Growth Inhibitors|growth inhibitors|mesh-ancestor
91977867|NCT02447939|Trametinib|trametinib|mesh-list
91977868|NCT02447939|Dabrafenib|dabrafenib|mesh-list
91977869|NCT02447939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977870|NCT02447939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977871|NCT02447939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977872|NCT02447939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977873|NCT04785183|Melatonin|melatonin|mesh-list
91977874|NCT04785183|Antioxidants|antioxidants|mesh-ancestor
91977875|NCT04785183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977876|NCT04785183|Protective Agents|protective agents|mesh-ancestor
91977877|NCT04785183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977878|NCT04785183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977879|NCT03195491|Nivolumab|nivolumab|mesh-list
91977880|NCT03195491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977881|NCT03195491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977882|NCT03195491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91977883|NCT03195491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977884|NCT03195413|Lidocaine|lidocaine|mesh-list
91977885|NCT03195413|Epinephrine|epinephrine|mesh-list
91977886|NCT03195413|Racepinephrine|racepinephrine|mesh-list
91977887|NCT03195413|Bupivacaine|bupivacaine|mesh-list
91977888|NCT03195413|Epinephryl borate|epinephryl borate|mesh-list
91977889|NCT03195413|Anesthetics, Local|anesthetics, local|mesh-ancestor
91977890|NCT03195413|Anesthetics|anesthetics|mesh-ancestor
91977891|NCT03195413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977892|NCT03195413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977893|NCT03195413|Sensory System Agents|sensory system agents|mesh-ancestor
91977894|NCT03195413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977895|NCT03195413|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91977896|NCT03195413|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91977897|NCT03195413|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91977898|NCT03195413|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977899|NCT03195413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977900|NCT03195413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91977901|NCT03195413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91977902|NCT03195413|Adrenergic Agents|adrenergic agents|mesh-ancestor
91977903|NCT03195413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977904|NCT03195413|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91977905|NCT03195413|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91977907|NCT03195413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91977908|NCT03195413|Respiratory System Agents|respiratory system agents|mesh-ancestor
91977909|NCT03195413|Mydriatics|mydriatics|mesh-ancestor
91977910|NCT03195413|Sympathomimetics|sympathomimetics|mesh-ancestor
91969550|NCT03199261|Incretins|incretins|mesh-ancestor
91977911|NCT03195413|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91977912|NCT04338399|Paclitaxel|paclitaxel|mesh-list
91977913|NCT04338399|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977914|NCT04338399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977917|NCT04338399|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977918|NCT04338399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977919|NCT02447705|Telbivudine|telbivudine|mesh-list
91977920|NCT02447705|Antiviral Agents|antiviral agents|mesh-ancestor
91977921|NCT02447705|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977922|NCT02447705|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91977923|NCT02447705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977924|NCT02447705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977926|NCT03195257|Gastric Inhibitory Polypeptide|gastric inhibitory polypeptide|mesh-list
91977927|NCT03195257|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91977928|NCT03195257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977929|NCT03195257|Hormones|hormones|mesh-ancestor
91977930|NCT03195257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977931|NCT03195257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977932|NCT03195257|Incretins|incretins|mesh-ancestor
91977933|NCT02447393|Cetirizine|cetirizine|mesh-list
91977934|NCT02447393|Levocetirizine|levocetirizine|mesh-list
91977935|NCT02447393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91977936|NCT02447393|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91977937|NCT02447393|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91977938|NCT02447393|Histamine Antagonists|histamine antagonists|mesh-ancestor
91977939|NCT02447393|Histamine Agents|histamine agents|mesh-ancestor
91977940|NCT02447393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977941|NCT02447393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977942|NCT02447393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977943|NCT02447315|Pilocarpine|pilocarpine|mesh-list
91977944|NCT02447315|Miotics|miotics|mesh-ancestor
91977945|NCT02447315|Autonomic Agents|autonomic agents|mesh-ancestor
91977946|NCT02447315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977947|NCT02447315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977948|NCT02447315|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91977949|NCT02447315|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91977950|NCT02447315|Cholinergic Agents|cholinergic agents|mesh-ancestor
91977951|NCT02447315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977952|NCT02447315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977953|NCT04792515|Apatinib|apatinib|mesh-list
91977954|NCT04792515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977955|NCT04792515|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91977956|NCT04792515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977957|NCT04792515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977958|NCT02446379|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91977959|NCT02446379|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91977960|NCT02446379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977961|NCT03195023|Amlodipine|amlodipine|mesh-list
91977962|NCT03195023|Lisinopril|lisinopril|mesh-list
91977963|NCT03195023|Lercanidipine|lercanidipine|mesh-list
91977964|NCT03195023|Furosemide|furosemide|mesh-list
91977965|NCT03195023|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91977966|NCT03195023|Enzyme Inhibitors|enzyme inhibitors|mesh-list
91977967|NCT03195023|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91977968|NCT03195023|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91977969|NCT03195023|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977970|NCT03195023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977971|NCT03195023|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91977972|NCT03195023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977973|NCT03195023|Vasodilator Agents|vasodilator agents|mesh-ancestor
91977974|NCT03195023|Diuretics|diuretics|mesh-ancestor
91977975|NCT03195023|Natriuretic Agents|natriuretic agents|mesh-ancestor
91977976|NCT03195023|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91977977|NCT03195023|Protease Inhibitors|protease inhibitors|mesh-ancestor
91977978|NCT03195023|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91977979|NCT03195023|Protective Agents|protective agents|mesh-ancestor
91977980|NCT02446301|Nalbuphine|nalbuphine|mesh-list
91977981|NCT02446301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91977982|NCT02446301|Narcotics|narcotics|mesh-ancestor
91969552|NCT03199261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969553|NCT02482961|Colistin|colistin|mesh-list
91977983|NCT02446301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977984|NCT02446301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977985|NCT02446301|Analgesics|analgesics|mesh-ancestor
91977986|NCT02446301|Sensory System Agents|sensory system agents|mesh-ancestor
91977992|NCT04791345|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91977994|NCT04791345|Prednisolone acetate|prednisolone acetate|mesh-list
91977995|NCT04791345|Deflazacort|deflazacort|mesh-list
91977996|NCT04791345|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91977997|NCT04791345|Prednisolone phosphate|prednisolone phosphate|mesh-list
91977998|NCT04791345|BB 1101|bb 1101|mesh-list
91977999|NCT04791345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978000|NCT04791345|Antiemetics|antiemetics|mesh-ancestor
91978001|NCT04791345|Autonomic Agents|autonomic agents|mesh-ancestor
91978002|NCT04791345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978003|NCT04791345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978004|NCT04791345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978005|NCT04791345|Glucocorticoids|glucocorticoids|mesh-ancestor
91978006|NCT04791345|Hormones|hormones|mesh-ancestor
91978007|NCT04791345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978008|NCT04791345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978009|NCT04791345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978010|NCT04791345|Protease Inhibitors|protease inhibitors|mesh-ancestor
91978011|NCT04791345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978012|NCT04791345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978013|NCT04791345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91978014|NCT04791345|Protective Agents|protective agents|mesh-ancestor
91978015|NCT04791345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91978016|NCT04791345|Immunologic Factors|immunologic factors|mesh-ancestor
91978017|NCT02445989|Contraceptive Agents|contraceptive agents|mesh-list
91978018|NCT02445989|NuvaRing|nuvaring|mesh-list
91978019|NCT02445989|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978020|NCT02445989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978021|NCT02445989|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91978022|NCT03674853|Gamma-oryzanol|gamma-oryzanol|mesh-list
91978023|NCT03674853|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91978024|NCT03674853|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978025|NCT03674853|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91978026|NCT03674853|Antimetabolites|antimetabolites|mesh-ancestor
91978027|NCT03674853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978028|NCT03674853|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91978029|NCT03231215|Dexamethasone|dexamethasone|mesh-list
91978030|NCT03231215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978031|NCT03231215|Antiemetics|antiemetics|mesh-ancestor
91978032|NCT03231215|Autonomic Agents|autonomic agents|mesh-ancestor
91978033|NCT03231215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978034|NCT03231215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978035|NCT03231215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978036|NCT03231215|Glucocorticoids|glucocorticoids|mesh-ancestor
91978037|NCT03231215|Hormones|hormones|mesh-ancestor
91978038|NCT03231215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978039|NCT03231215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978040|NCT03231215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978041|NCT04784481|Ivermectin|ivermectin|mesh-list
91978042|NCT04784481|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91978043|NCT04784481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978044|NCT03230825|Contraceptive Agents|contraceptive agents|mesh-list
91978045|NCT03230825|Contraceptives, Oral|contraceptives, oral|mesh-list
91978046|NCT03230825|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978047|NCT03230825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978048|NCT03230825|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91978049|NCT03526185|Nivolumab|nivolumab|mesh-list
91978050|NCT03526185|Ipilimumab|ipilimumab|mesh-list
91978051|NCT03526185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91978052|NCT03526185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978053|NCT03526185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91978054|NCT03526185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978055|NCT02445599|Dipyrone|dipyrone|mesh-list
91978056|NCT02445599|Diclofenac|diclofenac|mesh-list
91978057|NCT02445599|Atropine|atropine|mesh-list
91978058|NCT02445599|Fentanyl|fentanyl|mesh-list
91969554|NCT02482961|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91969555|NCT02482961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969556|NCT04990713|Ropivacaine|ropivacaine|mesh-list
91969557|NCT04990713|Anesthetics, Local|anesthetics, local|mesh-list
91969558|NCT04990713|Anesthetics|anesthetics|mesh-list
91969559|NCT04990713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969560|NCT04990713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969561|NCT04990713|Sensory System Agents|sensory system agents|mesh-ancestor
91969562|NCT04990713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969563|NCT04990791|Aspirin|aspirin|mesh-list
91969564|NCT04990791|Rivaroxaban|rivaroxaban|mesh-list
91969565|NCT04990791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969566|NCT04990791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91969567|NCT04990791|Analgesics|analgesics|mesh-ancestor
91969568|NCT04990791|Sensory System Agents|sensory system agents|mesh-ancestor
91969569|NCT04990791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969570|NCT04990791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969571|NCT04990791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969572|NCT04990791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969573|NCT04990791|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91969574|NCT04990791|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91969575|NCT04990791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969576|NCT04990791|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91969577|NCT04990791|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91969578|NCT04990791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969579|NCT04990791|Antipyretics|antipyretics|mesh-ancestor
91969580|NCT04990791|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91969581|NCT04990791|Antithrombins|antithrombins|mesh-ancestor
91969582|NCT04990791|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91969583|NCT04990791|Protease Inhibitors|protease inhibitors|mesh-ancestor
91969584|NCT04990791|Anticoagulants|anticoagulants|mesh-ancestor
91969585|NCT03201835|Nabiximols|nabiximols|mesh-list
91969586|NCT03201835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969594|NCT02478515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969595|NCT02478515|Growth Inhibitors|growth inhibitors|mesh-ancestor
91969596|NCT02478515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969597|NCT02448199|Meloxicam|meloxicam|mesh-list
91969598|NCT02448199|Antirheumatic Agents|antirheumatic agents|mesh-list
91969599|NCT02448199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969600|NCT02448199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91969601|NCT02448199|Analgesics|analgesics|mesh-ancestor
91969602|NCT02448199|Sensory System Agents|sensory system agents|mesh-ancestor
91969603|NCT02448199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969604|NCT02448199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969605|NCT02448199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969606|NCT02448199|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91978065|NCT02445599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978066|NCT02445599|Analgesics|analgesics|mesh-ancestor
91978067|NCT02445599|Sensory System Agents|sensory system agents|mesh-ancestor
91978068|NCT02445599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978069|NCT02445599|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91978070|NCT02445599|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91978071|NCT02445599|Anesthetics, General|anesthetics, general|mesh-ancestor
91978072|NCT02445599|Anesthetics|anesthetics|mesh-ancestor
91978073|NCT02445599|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91978074|NCT02445599|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91978075|NCT02445599|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91978076|NCT02445599|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91978077|NCT02445599|GABA Modulators|gaba modulators|mesh-ancestor
91978078|NCT02445599|GABA Agents|gaba agents|mesh-ancestor
91978079|NCT02445599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978080|NCT02445599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978081|NCT02445599|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978082|NCT02445599|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978083|NCT02445599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978084|NCT02445599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978085|NCT02445599|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91978086|NCT02445599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978087|NCT02445599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91978088|NCT02445599|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91978089|NCT02445599|Autonomic Agents|autonomic agents|mesh-ancestor
91978090|NCT02445599|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91978091|NCT02445599|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978092|NCT02445599|Mydriatics|mydriatics|mesh-ancestor
91978093|NCT02445599|Parasympatholytics|parasympatholytics|mesh-ancestor
91978094|NCT02445599|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91978095|NCT02445599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91978096|NCT02445599|Cholinergic Agents|cholinergic agents|mesh-ancestor
91978097|NCT02445599|Antipyretics|antipyretics|mesh-ancestor
91978099|NCT03194633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91978100|NCT03194633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978101|NCT03194633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978102|NCT03194633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91978103|NCT03194633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978104|NCT03194633|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978105|NCT03194633|Tocolytic Agents|tocolytic agents|mesh-ancestor
91978106|NCT03194633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978107|NCT03194555|Acetaminophen|acetaminophen|mesh-list
91978108|NCT03194555|Naltrexone|naltrexone|mesh-list
91978109|NCT03194555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978110|NCT03194555|Analgesics|analgesics|mesh-ancestor
91978111|NCT03194555|Sensory System Agents|sensory system agents|mesh-ancestor
91978112|NCT03194555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978113|NCT03194555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969607|NCT02448199|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91969608|NCT02448199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978114|NCT03194555|Antipyretics|antipyretics|mesh-ancestor
91978115|NCT03194555|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91978116|NCT03194555|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91978117|NCT04344717|Apixaban|apixaban|mesh-list
91978118|NCT04344717|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91978119|NCT04344717|Antithrombins|antithrombins|mesh-ancestor
91978120|NCT04344717|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91978121|NCT04344717|Protease Inhibitors|protease inhibitors|mesh-ancestor
91978122|NCT04344717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978123|NCT04344717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978124|NCT04344717|Anticoagulants|anticoagulants|mesh-ancestor
91978125|NCT04790487|Chlorpheniramine|chlorpheniramine|mesh-list
91978126|NCT04790487|Antipruritics|antipruritics|mesh-ancestor
91978127|NCT04790487|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978128|NCT04790487|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91978129|NCT04790487|Histamine Antagonists|histamine antagonists|mesh-ancestor
91978130|NCT04790487|Histamine Agents|histamine agents|mesh-ancestor
91978138|NCT04790331|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91978139|NCT04790331|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978140|NCT04790331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978141|NCT04790331|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91978142|NCT04790331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978143|NCT04790331|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978144|NCT04790331|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91978145|NCT04789941|Irinotecan|irinotecan|mesh-list
91978146|NCT04789941|Cisplatin|cisplatin|mesh-list
91978147|NCT04789941|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91978148|NCT04789941|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91978149|NCT04789941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978150|NCT04789941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978151|NCT04789941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978152|NCT02445053|Ivacaftor|ivacaftor|mesh-list
91978153|NCT02445053|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91978154|NCT02445053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978155|NCT02445053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978156|NCT02444897|Fentanyl|fentanyl|mesh-list
91978157|NCT02444897|Nefopam|nefopam|mesh-list
91978158|NCT02444897|Ramosetron|ramosetron|mesh-list
91978160|NCT02444897|Anesthetics, Local|anesthetics, local|mesh-ancestor
91978161|NCT02444897|Anesthetics|anesthetics|mesh-ancestor
91978162|NCT02444897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978163|NCT02444897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978164|NCT02444897|Sensory System Agents|sensory system agents|mesh-ancestor
91978165|NCT02444897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978166|NCT02444897|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91978167|NCT02444897|Narcotics|narcotics|mesh-ancestor
91978168|NCT02444897|Analgesics|analgesics|mesh-ancestor
91978169|NCT02444897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91978170|NCT02444897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91978171|NCT02444897|Anesthetics, General|anesthetics, general|mesh-ancestor
91978172|NCT02444897|Antiemetics|antiemetics|mesh-ancestor
91978173|NCT02444897|Autonomic Agents|autonomic agents|mesh-ancestor
91978174|NCT02444897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978175|NCT02444897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91978176|NCT02444897|Serotonin Agents|serotonin agents|mesh-ancestor
91978177|NCT02444897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978178|NCT02444897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978179|NCT02444897|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978180|NCT03016533|Lamivudine|lamivudine|mesh-list
91978181|NCT03016533|Dolutegravir|dolutegravir|mesh-list
91978302|NCT02177266|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978182|NCT03016533|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91978183|NCT03016533|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91978184|NCT03016533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978185|NCT03016533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978186|NCT03016533|Antiviral Agents|antiviral agents|mesh-ancestor
91978187|NCT03016533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978188|NCT03016533|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91978189|NCT03016533|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91978190|NCT03016533|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91978191|NCT03016533|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91969609|NCT02448199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969611|NCT03071289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978192|NCT03229889|Tadalafil|tadalafil|mesh-list
91978193|NCT03229889|Tamsulosin|tamsulosin|mesh-list
91978194|NCT03229889|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978195|NCT03229889|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91978196|NCT03229889|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91978197|NCT03229889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978198|NCT03229889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978199|NCT03229889|Urological Agents|urological agents|mesh-ancestor
91978232|NCT02444507|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91978233|NCT02444507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978234|NCT02444507|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91978235|NCT02444507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978236|NCT02444507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978237|NCT02572791|Chlorhexidine|chlorhexidine|mesh-list
91978238|NCT02572791|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91978239|NCT02572791|Mupirocin|mupirocin|mesh-list
91978240|NCT02572791|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91978241|NCT02572791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978242|NCT02572791|Disinfectants|disinfectants|mesh-ancestor
91978243|NCT02572791|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978244|NCT02572791|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91978245|NCT02572791|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91978246|NCT02572791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978247|NCT02572791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978248|NCT01626352|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91978250|NCT01626352|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91978251|NCT01626352|Alkylating Agents|alkylating agents|mesh-ancestor
91978252|NCT01626352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978253|NCT01626352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978254|NCT02080767|Tecovirimat|tecovirimat|mesh-list
91978255|NCT02080767|Antiviral Agents|antiviral agents|mesh-ancestor
91978256|NCT02080767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978257|NCT01626118|Indomethacin|indomethacin|mesh-list
91978258|NCT01626118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978259|NCT01626118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978260|NCT01626118|Analgesics|analgesics|mesh-ancestor
91978261|NCT01626118|Sensory System Agents|sensory system agents|mesh-ancestor
91978262|NCT01626118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978263|NCT01626118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978264|NCT01626118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978265|NCT01626118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978279|NCT04789005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978281|NCT04789005|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91978282|NCT04789005|Nasal Decongestants|nasal decongestants|mesh-ancestor
91978283|NCT04789005|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978284|NCT04789005|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91978285|NCT04789005|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91978286|NCT04789005|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91978287|NCT04789005|Adrenergic Agents|adrenergic agents|mesh-ancestor
91978288|NCT04789005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978289|NCT04789005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978290|NCT04789005|Protective Agents|protective agents|mesh-ancestor
91978291|NCT02152384|Insulin|insulin|mesh-list
91978292|NCT02152384|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91978293|NCT02152384|Insulin Glargine|insulin glargine|mesh-list
91978294|NCT02152384|Insulin Lispro|insulin lispro|mesh-list
91978295|NCT02152384|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91978296|NCT02152384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978297|NCT05469243|Hallucinogens|hallucinogens|mesh-list
91978298|NCT05469243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978299|NCT05469243|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91978300|NCT02177266|Colchicine|colchicine|mesh-list
91978301|NCT02177266|Gout Suppressants|gout suppressants|mesh-ancestor
91978303|NCT02177266|Tubulin Modulators|tubulin modulators|mesh-ancestor
91978304|NCT02177266|Antimitotic Agents|antimitotic agents|mesh-ancestor
91978305|NCT02177266|Mitosis Modulators|mitosis modulators|mesh-ancestor
91978306|NCT02177266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969612|NCT03199105|Tetracaine|tetracaine|mesh-list
91969613|NCT03199105|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969614|NCT03199105|Anesthetics|anesthetics|mesh-ancestor
91978307|NCT02177266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978308|NCT04788381|Bevacizumab|bevacizumab|mesh-list
91978309|NCT04788381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91978310|NCT04788381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978311|NCT04788381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91978312|NCT04788381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91978313|NCT04788381|Growth Substances|growth substances|mesh-ancestor
91978314|NCT04788381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978315|NCT04788381|Growth Inhibitors|growth inhibitors|mesh-ancestor
91978316|NCT05474937|Midazolam|midazolam|mesh-list
91978317|NCT05474937|Ketamine|ketamine|mesh-list
91978318|NCT05474937|Propofol|propofol|mesh-list
91978319|NCT05474937|Sevoflurane|sevoflurane|mesh-list
91978320|NCT05474937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91978321|NCT05474937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978322|NCT05474937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978323|NCT05474937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91978324|NCT05474937|Anesthetics, General|anesthetics, general|mesh-ancestor
91978325|NCT05474937|Anesthetics|anesthetics|mesh-ancestor
91978326|NCT05474937|Analgesics|analgesics|mesh-ancestor
91978327|NCT05474937|Sensory System Agents|sensory system agents|mesh-ancestor
91978328|NCT05474937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978329|NCT05474937|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91978341|NCT05474937|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91978350|NCT05474781|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
91978351|NCT05474781|Antiviral Agents|antiviral agents|mesh-ancestor
91978352|NCT05474781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978353|NCT02177032|Vaccines|vaccines|mesh-list
91978354|NCT02177032|Immunoglobulins|immunoglobulins|mesh-list
91978355|NCT02177032|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91978356|NCT02177032|Antibodies|antibodies|mesh-list
91978357|NCT02177032|Immunologic Factors|immunologic factors|mesh-ancestor
91978358|NCT02177032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978359|NCT02116972|FX006|fx006|mesh-list
91978360|NCT02116972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978361|NCT02116972|Glucocorticoids|glucocorticoids|mesh-ancestor
91978362|NCT02116972|Hormones|hormones|mesh-ancestor
91978363|NCT02116972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978364|NCT02116972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978365|NCT02116972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91978366|NCT02116972|Immunologic Factors|immunologic factors|mesh-ancestor
91978367|NCT02176642|Oxybutynin|oxybutynin|mesh-list
91978368|NCT02176642|Parasympatholytics|parasympatholytics|mesh-ancestor
91978369|NCT02176642|Autonomic Agents|autonomic agents|mesh-ancestor
91978370|NCT02176642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978371|NCT02176642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978372|NCT02176642|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91978373|NCT02176642|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91978374|NCT02176642|Cholinergic Agents|cholinergic agents|mesh-ancestor
91978375|NCT02176642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978376|NCT02176642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978377|NCT02176642|Urological Agents|urological agents|mesh-ancestor
91978379|NCT02116660|Lopinavir|lopinavir|mesh-list
91978380|NCT02116660|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91978381|NCT02116660|Darunavir|darunavir|mesh-list
91978382|NCT02116660|Tenofovir|tenofovir|mesh-list
91978383|NCT02116660|Lamivudine|lamivudine|mesh-list
91978384|NCT02116660|Emtricitabine|emtricitabine|mesh-list
91978385|NCT02116660|Raltegravir Potassium|raltegravir potassium|mesh-list
91978386|NCT02116660|Nevirapine|nevirapine|mesh-list
91978387|NCT02116660|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91978388|NCT02116660|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91978389|NCT02116660|Protease Inhibitors|protease inhibitors|mesh-ancestor
91978390|NCT02116660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978391|NCT02116660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978392|NCT02116660|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91978393|NCT02116660|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91978394|NCT02116660|Antiviral Agents|antiviral agents|mesh-ancestor
91978395|NCT02116660|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978396|NCT02116660|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91969615|NCT03199105|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969616|NCT03199105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978397|NCT02116660|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91978398|NCT02116660|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91978399|NCT02116660|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91978400|NCT02116660|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91978401|NCT02116660|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91978404|NCT02589405|Benzoyl Peroxide|benzoyl peroxide|mesh-list
91978405|NCT02589405|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978406|NCT02176018|Quinidine|quinidine|mesh-list
91978407|NCT02176018|Dextromethorphan|dextromethorphan|mesh-list
91978408|NCT02176018|Antitussive Agents|antitussive agents|mesh-ancestor
91978409|NCT02176018|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978410|NCT02176018|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91978411|NCT02176018|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91978412|NCT02176018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978413|NCT02176018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978414|NCT02176018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978415|NCT02176018|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91978416|NCT02176018|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91978417|NCT02176018|Adrenergic Agents|adrenergic agents|mesh-ancestor
91978418|NCT02176018|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91978420|NCT02176018|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91978421|NCT02176018|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91978422|NCT02176018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978423|NCT02176018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978424|NCT02176018|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91978425|NCT02176018|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91978426|NCT02176018|Cholinergic Agents|cholinergic agents|mesh-ancestor
91978427|NCT02176018|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91978428|NCT02176018|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91978429|NCT02176018|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978430|NCT02176018|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91978431|NCT02176018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91978432|NCT05611827|Quercetin|quercetin|mesh-list
91978433|NCT05611827|Antioxidants|antioxidants|mesh-ancestor
91978434|NCT05611827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978435|NCT05611827|Protective Agents|protective agents|mesh-ancestor
91978436|NCT05611827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978437|NCT05612607|Immunoglobulins|immunoglobulins|mesh-list
91978438|NCT05612607|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91978439|NCT05612607|Antibodies|antibodies|mesh-list
91978440|NCT05612607|Immunologic Factors|immunologic factors|mesh-ancestor
91978441|NCT05612607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978442|NCT02589639|Empagliflozin|empagliflozin|mesh-list
91978443|NCT02589639|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91978444|NCT02589639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978445|NCT02589639|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91978446|NCT02589639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978447|NCT05611749|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91978448|NCT05611749|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91978449|NCT05611749|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91978450|NCT05611749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978451|NCT05611749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978452|NCT05611749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978453|NCT05611749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978454|NCT05611749|Analgesics|analgesics|mesh-ancestor
91978455|NCT05611749|Sensory System Agents|sensory system agents|mesh-ancestor
91978456|NCT05611749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978457|NCT05611749|Antidepressive Agents|antidepressive agents|mesh-ancestor
91978458|NCT05611749|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91978459|NCT05611749|Dopamine Agents|dopamine agents|mesh-ancestor
91978460|NCT00555555|Factor VIII|factor viii|mesh-list
91978461|NCT00555555|Coagulants|coagulants|mesh-ancestor
91978462|NCT05611593|Finasteride|finasteride|mesh-list
91978463|NCT05611593|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91978464|NCT05611593|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91978465|NCT05611593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969617|NCT03199105|Sensory System Agents|sensory system agents|mesh-ancestor
91969618|NCT03199105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969619|NCT02482649|Methylphenidate|methylphenidate|mesh-list
91978466|NCT05611593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978467|NCT05611593|Hormone Antagonists|hormone antagonists|mesh-ancestor
91978560|NCT05610969|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91978468|NCT05611593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978469|NCT05611593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978470|NCT05611593|Urological Agents|urological agents|mesh-ancestor
91978471|NCT05612451|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91978490|NCT02151682|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978491|NCT04331691|Amiloride|amiloride|mesh-list
91978492|NCT04331691|Spironolactone|spironolactone|mesh-list
91978493|NCT04331691|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91978494|NCT04331691|Hormone Antagonists|hormone antagonists|mesh-ancestor
91978495|NCT04331691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978496|NCT04331691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978497|NCT04331691|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91978498|NCT04331691|Diuretics|diuretics|mesh-ancestor
91978499|NCT04331691|Natriuretic Agents|natriuretic agents|mesh-ancestor
91978500|NCT04331691|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
91978501|NCT04331691|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91978502|NCT04331691|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978503|NCT04331691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978504|NCT04331691|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
91978505|NCT05304273|Letrozole|letrozole|mesh-list
91978506|NCT05304273|Misoprostol|misoprostol|mesh-list
91978507|NCT05304273|Mifepristone|mifepristone|mesh-list
91978508|NCT05304273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978509|NCT05304273|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91978510|NCT05304273|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91978511|NCT05304273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978512|NCT05304273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978513|NCT05304273|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91978514|NCT05304273|Hormone Antagonists|hormone antagonists|mesh-ancestor
91978515|NCT05304273|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978516|NCT05304273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978517|NCT05304273|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91978518|NCT05304273|Abortifacient Agents|abortifacient agents|mesh-ancestor
91978519|NCT05304273|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978520|NCT05304273|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91978521|NCT05304273|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978522|NCT05304273|Oxytocics|oxytocics|mesh-ancestor
91978523|NCT05304273|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91978524|NCT05304273|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91978525|NCT05304273|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91978531|NCT05304273|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91978532|NCT05304273|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91978533|NCT02174848|Deferiprone|deferiprone|mesh-list
91978534|NCT02174848|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91978535|NCT02174848|Chelating Agents|chelating agents|mesh-ancestor
91978536|NCT02174848|Sequestering Agents|sequestering agents|mesh-ancestor
91978537|NCT02174848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978538|NCT02151058|Listerine|listerine|mesh-list
91978539|NCT02151058|Sodium Fluoride|sodium fluoride|mesh-list
91978540|NCT02151058|Cariostatic Agents|cariostatic agents|mesh-ancestor
91978541|NCT02151058|Protective Agents|protective agents|mesh-ancestor
91978542|NCT02151058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978543|NCT02151058|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91978544|NCT02151058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978545|NCT05205759|Sotrovimab|sotrovimab|mesh-list
91978546|NCT05205759|Bamlanivimab|bamlanivimab|mesh-list
91978547|NCT05205759|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
91978548|NCT05205759|Antiviral Agents|antiviral agents|mesh-ancestor
91978549|NCT05205759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978550|NCT02149264|Testosterone|testosterone|mesh-list
91978551|NCT02149264|Androgens|androgens|mesh-ancestor
91978552|NCT02149264|Hormones|hormones|mesh-ancestor
91978553|NCT02149264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969620|NCT02482649|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
91969621|NCT02482649|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91969622|NCT02482649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969623|NCT02482649|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91978554|NCT02149264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978555|NCT05610969|Midazolam|midazolam|mesh-list
91978556|NCT05610969|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91978557|NCT05610969|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91978558|NCT05610969|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978559|NCT05610969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978561|NCT05610969|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91978562|NCT05610969|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91978563|NCT05610969|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91978564|NCT05610969|Anesthetics, General|anesthetics, general|mesh-ancestor
91978565|NCT05610969|Anesthetics|anesthetics|mesh-ancestor
91978566|NCT05610969|GABA Modulators|gaba modulators|mesh-ancestor
91978567|NCT05610969|GABA Agents|gaba agents|mesh-ancestor
91978568|NCT05610969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978569|NCT05610969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978570|NCT05557149|Cocaine|cocaine|mesh-list
91978571|NCT05557149|Anesthetics, Local|anesthetics, local|mesh-ancestor
91978572|NCT05557149|Anesthetics|anesthetics|mesh-ancestor
91978573|NCT05557149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978574|NCT05557149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978575|NCT05557149|Sensory System Agents|sensory system agents|mesh-ancestor
91978576|NCT05557149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978577|NCT05557149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91978578|NCT05557149|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91978579|NCT05557149|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91978580|NCT05557149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978581|NCT05557149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978582|NCT05557149|Dopamine Agents|dopamine agents|mesh-ancestor
91978583|NCT05557149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978584|NCT02115256|Nitroglycerin|nitroglycerin|mesh-list
91978585|NCT02115256|Terbutaline|terbutaline|mesh-list
91978586|NCT02115256|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978587|NCT02115256|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91978588|NCT02115256|Autonomic Agents|autonomic agents|mesh-ancestor
91978589|NCT02115256|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978590|NCT02115256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978591|NCT02115256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91978592|NCT02115256|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978593|NCT02115256|Sympathomimetics|sympathomimetics|mesh-ancestor
91978594|NCT02115256|Tocolytic Agents|tocolytic agents|mesh-ancestor
91978595|NCT02115256|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978601|NCT02115256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978602|NCT02173054|Adapalene|adapalene|mesh-list
91978603|NCT02173054|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978604|NCT02173054|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978605|NCT02173054|Analgesics|analgesics|mesh-ancestor
91978606|NCT02173054|Sensory System Agents|sensory system agents|mesh-ancestor
91978607|NCT02173054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978608|NCT02173054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978609|NCT02173054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978610|NCT02173054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978611|NCT02173054|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978612|NCT04225221|Leuprolide|leuprolide|mesh-list
91978613|NCT04225221|Estradiol|estradiol|mesh-list
91978614|NCT04225221|Progesterone|progesterone|mesh-list
91978615|NCT04225221|Estrogens|estrogens|mesh-ancestor
91978616|NCT04225221|Hormones|hormones|mesh-ancestor
91978617|NCT04225221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978618|NCT04225221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978619|NCT04225221|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978620|NCT04225221|Progestins|progestins|mesh-ancestor
91978621|NCT04225221|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91978622|NCT04225221|Fertility Agents|fertility agents|mesh-ancestor
91978623|NCT04225221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978624|NCT04225221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978625|NCT04425993|Indomethacin|indomethacin|mesh-list
91969624|NCT02482649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91969625|NCT02482649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91969626|NCT02482649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978626|NCT04425993|Isosorbide|isosorbide|mesh-list
91978627|NCT04425993|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
91978628|NCT04425993|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91978629|NCT04425993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978630|NCT04425993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978631|NCT04425993|Analgesics|analgesics|mesh-ancestor
91978632|NCT04425993|Sensory System Agents|sensory system agents|mesh-ancestor
91978633|NCT04425993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978634|NCT04425993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978635|NCT04425993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978636|NCT04425993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978637|NCT04425993|Gout Suppressants|gout suppressants|mesh-ancestor
91978638|NCT04425993|Tocolytic Agents|tocolytic agents|mesh-ancestor
91978639|NCT04425993|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978640|NCT04425993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91978641|NCT04425993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978642|NCT04425993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978643|NCT04425993|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91978644|NCT04425993|Diuretics|diuretics|mesh-ancestor
91978645|NCT04425993|Natriuretic Agents|natriuretic agents|mesh-ancestor
91978646|NCT04425993|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978647|NCT04425993|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91978648|NCT03971643|Vilobelimab|vilobelimab|mesh-list
91978649|NCT03971643|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91978650|NCT03971643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91978651|NCT03971643|Immunologic Factors|immunologic factors|mesh-ancestor
91978652|NCT03971643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978653|NCT04745559|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91978655|NCT04745559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978656|NCT02149108|Nintedanib|nintedanib|mesh-list
91978657|NCT02149108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978658|NCT02149108|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91978659|NCT02149108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978660|NCT02149108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978661|NCT02148718|Adalimumab|adalimumab|mesh-list
91978662|NCT02148718|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91978663|NCT02148718|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978664|NCT02148718|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978665|NCT03397953|Vinorelbine|vinorelbine|mesh-list
91978670|NCT03397953|Mitosis Modulators|mitosis modulators|mesh-ancestor
91978671|NCT03397953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978672|NCT05549973|Dexamethasone|dexamethasone|mesh-list
91978673|NCT05549973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978674|NCT05549973|Antiemetics|antiemetics|mesh-ancestor
91978675|NCT05549973|Autonomic Agents|autonomic agents|mesh-ancestor
91978676|NCT05549973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978677|NCT05549973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978678|NCT05549973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978679|NCT05549973|Glucocorticoids|glucocorticoids|mesh-ancestor
91978680|NCT05549973|Hormones|hormones|mesh-ancestor
91978681|NCT05549973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978682|NCT05549973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978683|NCT05549973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978684|NCT02148250|Insulin|insulin|mesh-list
91978685|NCT02148250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91978686|NCT02148250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91978687|NCT02148250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978688|NCT04870359|Prednisolone|prednisolone|mesh-list
91978689|NCT04870359|Immunosuppressive Agents|immunosuppressive agents|mesh-list
91978690|NCT04870359|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978691|NCT04870359|Glucocorticoids|glucocorticoids|mesh-ancestor
91978692|NCT04870359|Hormones|hormones|mesh-ancestor
91978693|NCT04870359|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978694|NCT04870359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978695|NCT04870359|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978696|NCT04870359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969627|NCT02482649|Dopamine Agents|dopamine agents|mesh-ancestor
91969628|NCT02482649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978697|NCT04870359|Immunologic Factors|immunologic factors|mesh-ancestor
91978699|NCT02705859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91978700|NCT02705859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978701|NCT05549583|Metformin|metformin|mesh-list
91978702|NCT05549583|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91978703|NCT05549583|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91978704|NCT05549583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978705|NCT05549583|Incretins|incretins|mesh-ancestor
91978706|NCT05549583|Hormones|hormones|mesh-ancestor
91978707|NCT05549583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978708|NCT05549583|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91978709|NCT05549583|Protease Inhibitors|protease inhibitors|mesh-ancestor
91978710|NCT05549583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978711|NCT05549583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978712|NCT05554731|Hemostatics|hemostatics|mesh-list
91978713|NCT05554731|Coagulants|coagulants|mesh-ancestor
91978714|NCT02172040|Celecoxib|celecoxib|mesh-list
91978715|NCT02172040|Amlodipine|amlodipine|mesh-list
91978716|NCT02172040|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91978717|NCT02172040|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91978718|NCT02172040|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978719|NCT02172040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978720|NCT02172040|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91978721|NCT02172040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978722|NCT02172040|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978723|NCT02172040|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978724|NCT02172040|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978725|NCT02172040|Analgesics|analgesics|mesh-ancestor
91978726|NCT02172040|Sensory System Agents|sensory system agents|mesh-ancestor
91978727|NCT02172040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978728|NCT02172040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978729|NCT02172040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978730|NCT02172040|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91978731|NCT02172040|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91978732|NCT02172040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978734|NCT02367105|Androgens|androgens|mesh-ancestor
91978735|NCT02367105|Hormones|hormones|mesh-ancestor
91978736|NCT02367105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978740|NCT02153229|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978741|NCT02153229|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91978742|NCT01318317|Plerixafor|plerixafor|mesh-list
91978743|NCT01318317|Rituximab|rituximab|mesh-list
91978744|NCT01318317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91978745|NCT01318317|Antibodies|antibodies|mesh-list
91978746|NCT01318317|Immunoglobulins|immunoglobulins|mesh-list
91978747|NCT01318317|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91978748|NCT01318317|Lenograstim|lenograstim|mesh-list
91978749|NCT01318317|Immunologic Factors|immunologic factors|mesh-ancestor
91978750|NCT01318317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978751|NCT01318317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978752|NCT01318317|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978753|NCT01318317|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91978754|NCT01318317|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91978755|NCT01318317|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91978756|NCT01318317|Antiviral Agents|antiviral agents|mesh-ancestor
91978757|NCT01318317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978758|NCT05554185|Aspirin|aspirin|mesh-list
91978759|NCT05554185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978760|NCT05554185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978761|NCT05554185|Analgesics|analgesics|mesh-ancestor
91978762|NCT05554185|Sensory System Agents|sensory system agents|mesh-ancestor
91978763|NCT05554185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978764|NCT05554185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978765|NCT05554185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978766|NCT05554185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978767|NCT05554185|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91978768|NCT05554185|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91978769|NCT05554185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978770|NCT05554185|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91978771|NCT05554185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91978772|NCT05554185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969630|NCT02482649|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969631|NCT03198637|Cisatracurium|cisatracurium|mesh-list
91969632|NCT03198637|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91969633|NCT03198637|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91978773|NCT05554185|Antipyretics|antipyretics|mesh-ancestor
91978774|NCT05558397|Morphine|morphine|mesh-list
91978775|NCT05558397|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91978776|NCT05558397|Narcotics|narcotics|mesh-ancestor
91978777|NCT05558397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978778|NCT05558397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978779|NCT05558397|Analgesics|analgesics|mesh-ancestor
91978780|NCT05558397|Sensory System Agents|sensory system agents|mesh-ancestor
91978781|NCT05558397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978782|NCT05558319|Dexamethasone|dexamethasone|mesh-list
91978783|NCT05558319|Lenalidomide|lenalidomide|mesh-list
91978784|NCT05558319|Bortezomib|bortezomib|mesh-list
91978785|NCT05558319|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978786|NCT05558319|Antiemetics|antiemetics|mesh-ancestor
91978787|NCT05558319|Autonomic Agents|autonomic agents|mesh-ancestor
91978788|NCT05558319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978789|NCT05558319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978790|NCT05558319|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978791|NCT05558319|Glucocorticoids|glucocorticoids|mesh-ancestor
91978792|NCT05558319|Hormones|hormones|mesh-ancestor
91978793|NCT05558319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978794|NCT05558319|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978795|NCT05558319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978796|NCT05558319|Immunologic Factors|immunologic factors|mesh-ancestor
91978797|NCT05558319|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91978798|NCT05558319|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91978799|NCT05558319|Growth Substances|growth substances|mesh-ancestor
91978800|NCT05558319|Growth Inhibitors|growth inhibitors|mesh-ancestor
91978801|NCT05553717|Carvedilol|carvedilol|mesh-list
91978802|NCT05553717|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91978803|NCT05553717|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91978804|NCT05553717|Adrenergic Agents|adrenergic agents|mesh-ancestor
91978805|NCT05553717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978806|NCT05553717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978807|NCT05553717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978808|NCT05553717|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91978809|NCT05553717|Antioxidants|antioxidants|mesh-ancestor
91978810|NCT05553717|Protective Agents|protective agents|mesh-ancestor
91978825|NCT05553093|Insulin Glargine|insulin glargine|mesh-list
91978826|NCT05553093|Tirzepatide|tirzepatide|mesh-list
91978827|NCT05553093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91978828|NCT05553093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978829|NCT05553093|Incretins|incretins|mesh-ancestor
91978830|NCT05553093|Hormones|hormones|mesh-ancestor
91978831|NCT05553093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978832|NCT04757740|Methylprednisolone|methylprednisolone|mesh-list
91978833|NCT04757740|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91978834|NCT04757740|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91978835|NCT04757740|Prednisolone|prednisolone|mesh-list
91978836|NCT04757740|Prednisolone acetate|prednisolone acetate|mesh-list
91978837|NCT04757740|Lidocaine|lidocaine|mesh-list
91978838|NCT04757740|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91978839|NCT04757740|Prednisolone phosphate|prednisolone phosphate|mesh-list
91978840|NCT04757740|Anesthetics, Local|anesthetics, local|mesh-ancestor
91978841|NCT04757740|Anesthetics|anesthetics|mesh-ancestor
91978842|NCT04757740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978843|NCT04757740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978844|NCT04757740|Sensory System Agents|sensory system agents|mesh-ancestor
91978845|NCT04757740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978846|NCT04757740|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91978847|NCT04757740|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91978848|NCT04757740|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91978849|NCT04757740|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978850|NCT04757740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969634|NCT03198637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969635|NCT03198637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978851|NCT04757740|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978853|NCT04757740|Autonomic Agents|autonomic agents|mesh-ancestor
91978854|NCT04757740|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978855|NCT04757740|Glucocorticoids|glucocorticoids|mesh-ancestor
91978857|NCT04757740|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978858|NCT04757740|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91978859|NCT04757740|Protective Agents|protective agents|mesh-ancestor
91978860|NCT04757740|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978861|NCT04757740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978862|NCT05552937|Lenalidomide|lenalidomide|mesh-list
91978863|NCT05552937|Immunologic Factors|immunologic factors|mesh-ancestor
91978864|NCT05552937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978865|NCT05552937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91978866|NCT05552937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91978867|NCT05552937|Growth Substances|growth substances|mesh-ancestor
91978868|NCT05552937|Growth Inhibitors|growth inhibitors|mesh-ancestor
91978869|NCT05552937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978870|NCT02112448|Acetaminophen|acetaminophen|mesh-list
91978873|NCT02112448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91978875|NCT02112448|Sensory System Agents|sensory system agents|mesh-ancestor
91978876|NCT02112448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978877|NCT02112448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978878|NCT02112448|Antipyretics|antipyretics|mesh-ancestor
91978879|NCT02112448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91978880|NCT02112448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978881|NCT02112448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91978882|NCT02112448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91978883|NCT02112448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978884|NCT02112448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978885|NCT02109562|Risperidone|risperidone|mesh-list
91978886|NCT02109562|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91978887|NCT02109562|Serotonin Agents|serotonin agents|mesh-ancestor
91978888|NCT02109562|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978889|NCT02109562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978890|NCT02109562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978891|NCT02109562|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91978892|NCT02109562|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91978893|NCT02109562|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978894|NCT02109562|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91978895|NCT02109562|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91978896|NCT02109562|Dopamine Agents|dopamine agents|mesh-ancestor
91978897|NCT02109484|Vaccines|vaccines|mesh-list
91978898|NCT02109484|Immunologic Factors|immunologic factors|mesh-ancestor
91978899|NCT02109484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978900|NCT05134792|Immunoglobulins|immunoglobulins|mesh-list
91978901|NCT05134792|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91978902|NCT05134792|Antibodies|antibodies|mesh-list
91978903|NCT05134792|gamma-Globulins|gamma-globulins|mesh-list
91978904|NCT05134792|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91978905|NCT05134792|Immunologic Factors|immunologic factors|mesh-ancestor
91978906|NCT05134792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978907|NCT04738318|Dexamethasone|dexamethasone|mesh-list
91978908|NCT04738318|Methylprednisolone|methylprednisolone|mesh-list
91978909|NCT04738318|Glucocorticoids|glucocorticoids|mesh-list
91978910|NCT04738318|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978911|NCT04738318|Antiemetics|antiemetics|mesh-ancestor
91978912|NCT04738318|Autonomic Agents|autonomic agents|mesh-ancestor
91978913|NCT04738318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978914|NCT04738318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978915|NCT04738318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978916|NCT04738318|Hormones|hormones|mesh-ancestor
91978917|NCT04738318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91978918|NCT04738318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91978919|NCT04738318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978920|NCT04738318|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91978921|NCT04738318|Protective Agents|protective agents|mesh-ancestor
91978922|NCT02105974|Fluticasone|fluticasone|mesh-list
91978924|NCT02105974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978925|NCT02105974|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91978926|NCT02105974|Autonomic Agents|autonomic agents|mesh-ancestor
91969636|NCT02478281|Methylene Blue|methylene blue|mesh-list
91969637|NCT02478281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969638|NCT02478281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969639|NCT02478125|Docetaxel|docetaxel|mesh-list
91969640|NCT02478125|Lenograstim|lenograstim|mesh-list
91969641|NCT02478125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969642|NCT02478125|Tubulin Modulators|tubulin modulators|mesh-ancestor
91969643|NCT02478125|Antimitotic Agents|antimitotic agents|mesh-ancestor
91978927|NCT02105974|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978928|NCT02105974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978929|NCT02105974|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91978930|NCT02105974|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978931|NCT02105974|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978932|NCT02105974|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91978933|NCT02105662|Grazoprevir|grazoprevir|mesh-list
91978934|NCT02105662|Antiviral Agents|antiviral agents|mesh-ancestor
91978935|NCT02105662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978936|NCT02142712|Diphenhydramine|diphenhydramine|mesh-list
91978937|NCT02142712|Promethazine|promethazine|mesh-list
91978938|NCT02142712|Dextromethorphan|dextromethorphan|mesh-list
91978939|NCT02142712|Pantoprazole|pantoprazole|mesh-list
91978940|NCT02142712|Famotidine|famotidine|mesh-list
91978941|NCT02142712|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91978942|NCT02142712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91978943|NCT02142712|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91978944|NCT02142712|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978945|NCT02142712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978946|NCT02142712|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91978954|NCT02142712|Antiemetics|antiemetics|mesh-ancestor
91978955|NCT02142712|Autonomic Agents|autonomic agents|mesh-ancestor
91978956|NCT02142712|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91978957|NCT02142712|Histamine Antagonists|histamine antagonists|mesh-ancestor
91978958|NCT02142712|Histamine Agents|histamine agents|mesh-ancestor
91978959|NCT02142712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978960|NCT02142712|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91978961|NCT02142712|Antipruritics|antipruritics|mesh-ancestor
91978962|NCT02142712|Dermatologic Agents|dermatologic agents|mesh-ancestor
91978963|NCT02142712|Antitussive Agents|antitussive agents|mesh-ancestor
91978964|NCT02142712|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978965|NCT02142712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91978966|NCT02142712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91978967|NCT02142712|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91978968|NCT02105272|Carteolol|carteolol|mesh-list
91978969|NCT02105272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91978970|NCT02105272|Latanoprost|latanoprost|mesh-list
91978971|NCT02105272|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91978972|NCT02105272|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91978973|NCT02105272|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91978974|NCT02105272|Adrenergic Agents|adrenergic agents|mesh-ancestor
91978975|NCT02105272|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074261|NCT00074308|Imatinib Mesylate|imatinib mesylate|mesh-list
91978976|NCT02105272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978977|NCT02105272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978978|NCT02105272|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91978979|NCT02105272|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91978980|NCT02105272|Sympatholytics|sympatholytics|mesh-ancestor
91978981|NCT02105272|Autonomic Agents|autonomic agents|mesh-ancestor
91978982|NCT02105272|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978983|NCT02141854|Fluticasone|fluticasone|mesh-list
91978985|NCT02141854|Albuterol|albuterol|mesh-list
91978986|NCT02141854|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91978987|NCT02141854|Adrenergic Agonists|adrenergic agonists|mesh-list
91978988|NCT02141854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91978989|NCT02141854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91978990|NCT02141854|Autonomic Agents|autonomic agents|mesh-ancestor
91978991|NCT02141854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978992|NCT02141854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978993|NCT02141854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91978994|NCT02141854|Respiratory System Agents|respiratory system agents|mesh-ancestor
91978995|NCT02141854|Dermatologic Agents|dermatologic agents|mesh-ancestor
91969644|NCT02478125|Mitosis Modulators|mitosis modulators|mesh-ancestor
91978996|NCT02141854|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91978997|NCT02141854|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91978998|NCT02141854|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91978999|NCT02141854|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979000|NCT02141854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979001|NCT02141854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979002|NCT02141854|Tocolytic Agents|tocolytic agents|mesh-ancestor
91979003|NCT02141854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91979004|NCT02141620|Acetylcysteine|acetylcysteine|mesh-list
91979005|NCT02141620|Cocaine|cocaine|mesh-list
91979006|NCT02141620|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91979007|NCT02141620|Antiviral Agents|antiviral agents|mesh-ancestor
91979008|NCT02141620|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979009|NCT02141620|Expectorants|expectorants|mesh-ancestor
91979010|NCT02141620|Respiratory System Agents|respiratory system agents|mesh-ancestor
91979011|NCT02141620|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91979012|NCT02141620|Antioxidants|antioxidants|mesh-ancestor
91979013|NCT02141620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979014|NCT02141620|Protective Agents|protective agents|mesh-ancestor
91979015|NCT02141620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979032|NCT01664949|Laxatives|laxatives|mesh-ancestor
91979033|NCT01664949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91979034|NCT02587143|Ethyl Chloride|ethyl chloride|mesh-list
91979035|NCT02587143|Anesthetics, Local|anesthetics, local|mesh-ancestor
91979036|NCT02587143|Anesthetics|anesthetics|mesh-ancestor
91979037|NCT02587143|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979038|NCT02587143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979039|NCT02587143|Sensory System Agents|sensory system agents|mesh-ancestor
91979040|NCT02587143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979041|NCT02587065|Interferons|interferons|mesh-list
91979042|NCT02587065|Interferon-beta|interferon-beta|mesh-list
91979043|NCT02587065|Interferon beta-1a|interferon beta-1a|mesh-list
91979044|NCT02587065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979045|NCT02587065|Antiviral Agents|antiviral agents|mesh-ancestor
91979046|NCT02587065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979047|NCT02587065|Immunologic Factors|immunologic factors|mesh-ancestor
91979048|NCT02587065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979049|NCT02587065|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91979050|NCT02106832|Ciprofloxacin|ciprofloxacin|mesh-list
91979051|NCT02106832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91979052|NCT02106832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979053|NCT02106832|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91979054|NCT02106832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91979055|NCT02106832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979056|NCT02106832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979057|NCT02106832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979058|NCT02106832|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91979059|NCT02106832|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91979060|NCT05552391|Dexmedetomidine|dexmedetomidine|mesh-list
91979062|NCT05552391|Bupivacaine|bupivacaine|mesh-list
91979063|NCT05552391|Anesthetics, Local|anesthetics, local|mesh-ancestor
91979064|NCT05552391|Anesthetics|anesthetics|mesh-ancestor
91979065|NCT05552391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979066|NCT05552391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979067|NCT05552391|Sensory System Agents|sensory system agents|mesh-ancestor
91979068|NCT05552391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979069|NCT05552391|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91979070|NCT05552391|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91979071|NCT05552391|Analgesics|analgesics|mesh-ancestor
91979072|NCT05552391|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91979073|NCT05552391|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91979091|NCT04740814|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91979092|NCT04740814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979093|NCT04740814|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91979094|NCT04740814|Immunologic Factors|immunologic factors|mesh-ancestor
91979095|NCT04740814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979096|NCT04740814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979098|NCT02105116|Fludarabine|fludarabine|mesh-list
91979099|NCT02105116|Fludarabine phosphate|fludarabine phosphate|mesh-list
91979100|NCT02105116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979101|NCT02105116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91979102|NCT02105116|Antimetabolites|antimetabolites|mesh-ancestor
91969645|NCT02478125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969646|NCT02478125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91979103|NCT02105116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979104|NCT02105116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91979105|NCT02105116|Immunologic Factors|immunologic factors|mesh-ancestor
91979106|NCT02105116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979107|NCT02105116|Antiviral Agents|antiviral agents|mesh-ancestor
91979108|NCT02105116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979109|NCT05551767|Cisplatin|cisplatin|mesh-list
91979110|NCT05551767|Pembrolizumab|pembrolizumab|mesh-list
91979111|NCT05551767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979112|NCT05551767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979113|NCT05551767|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91979114|NCT05551767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979115|NCT05551689|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
91979116|NCT05551689|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91979117|NCT05551689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979118|NCT05551689|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91979119|NCT05551689|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91979120|NCT05551689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979121|NCT05551689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979122|NCT05551689|Dopamine Agents|dopamine agents|mesh-ancestor
91979123|NCT05551689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979124|NCT05547789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91979125|NCT05547789|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
91979126|NCT05547789|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91979131|NCT05547789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979132|NCT05542095|Simvastatin|simvastatin|mesh-list
91979133|NCT05542095|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91979134|NCT05542095|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91979135|NCT05542095|Antimetabolites|antimetabolites|mesh-ancestor
91979136|NCT05542095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979137|NCT05542095|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91979138|NCT05542095|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91979139|NCT05542095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979140|NCT05551221|Tamsulosin|tamsulosin|mesh-list
91979141|NCT05551221|Silodosin|silodosin|mesh-list
91979142|NCT05551221|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91979143|NCT05551221|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91979144|NCT05551221|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91979145|NCT05551221|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979146|NCT05551221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979147|NCT05551221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979223|NCT05592171|Chlorotrianisene|chlorotrianisene|mesh-list
91979148|NCT05551221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979149|NCT05551221|Urological Agents|urological agents|mesh-ancestor
91979150|NCT02104804|Insulin|insulin|mesh-list
91979151|NCT02104804|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91979152|NCT02104804|Metformin|metformin|mesh-list
91979153|NCT02104804|Saxagliptin|saxagliptin|mesh-list
91979154|NCT02104804|Insulin, Short-Acting|insulin, short-acting|mesh-list
91979155|NCT02104804|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979156|NCT02104804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979157|NCT02104804|Incretins|incretins|mesh-ancestor
91979158|NCT02104804|Hormones|hormones|mesh-ancestor
91979159|NCT02104804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979160|NCT02104804|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91979161|NCT02104804|Protease Inhibitors|protease inhibitors|mesh-ancestor
91979162|NCT02104804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979163|NCT02104804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979164|NCT05550441|Dapagliflozin|dapagliflozin|mesh-list
91979165|NCT05550441|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91979166|NCT05550441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979167|NCT05550441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979168|NCT05550441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979169|NCT05550207|Meloxicam|meloxicam|mesh-list
91979170|NCT05550207|Rizatriptan|rizatriptan|mesh-list
91979171|NCT05550207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91979172|NCT05550207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91969647|NCT02478125|Immunologic Factors|immunologic factors|mesh-ancestor
91969648|NCT02478125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969649|NCT02478047|Dexamethasone|dexamethasone|mesh-list
91969650|NCT02478047|Ramosetron|ramosetron|mesh-list
91969651|NCT02478047|Antiemetics|antiemetics|mesh-list
91969652|NCT02478047|Tropisetron|tropisetron|mesh-list
91969653|NCT02478047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969654|NCT02478047|Autonomic Agents|autonomic agents|mesh-ancestor
91979173|NCT05550207|Analgesics|analgesics|mesh-ancestor
91979174|NCT05550207|Sensory System Agents|sensory system agents|mesh-ancestor
91979175|NCT05550207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979176|NCT05550207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979177|NCT05550207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979178|NCT05550207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979179|NCT05550207|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91979180|NCT05550207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91979181|NCT05550207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979182|NCT05550207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979183|NCT05550207|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91979184|NCT05550207|Serotonin Agents|serotonin agents|mesh-ancestor
91979185|NCT05550207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979186|NCT05546853|Leucovorin|leucovorin|mesh-list
91979187|NCT05546853|Oxaliplatin|oxaliplatin|mesh-list
91979188|NCT05546853|Irinotecan|irinotecan|mesh-list
91979189|NCT05546853|Calcium|calcium|mesh-list
91979190|NCT05546853|Levoleucovorin|levoleucovorin|mesh-list
91979191|NCT05546853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91979192|NCT05546853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979193|NCT05546853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979194|NCT05546853|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91979195|NCT05546853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91979196|NCT05546853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979203|NCT05546619|Tislelizumab|tislelizumab|mesh-list
91979204|NCT05546619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979205|NCT05546619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979206|NCT05540145|Paclitaxel|paclitaxel|mesh-list
91979207|NCT05540145|Antibodies|antibodies|mesh-list
91979208|NCT05540145|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91979209|NCT05540145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979210|NCT05540145|Tubulin Modulators|tubulin modulators|mesh-ancestor
91979211|NCT05540145|Antimitotic Agents|antimitotic agents|mesh-ancestor
91979212|NCT05540145|Mitosis Modulators|mitosis modulators|mesh-ancestor
91979213|NCT05540145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979214|NCT05540145|Immunologic Factors|immunologic factors|mesh-ancestor
91979215|NCT05540145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979216|NCT05592327|Citric Acid|citric acid|mesh-list
91979217|NCT05592327|Sodium Citrate|sodium citrate|mesh-list
91979218|NCT05592327|Anticoagulants|anticoagulants|mesh-ancestor
91979219|NCT05592327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91979220|NCT05592327|Chelating Agents|chelating agents|mesh-ancestor
91979221|NCT05592327|Sequestering Agents|sequestering agents|mesh-ancestor
91979222|NCT05592327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979224|NCT05592171|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91979225|NCT05592171|Estrogens|estrogens|mesh-ancestor
91979226|NCT05592171|Hormones|hormones|mesh-ancestor
91979227|NCT05592171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979228|NCT05592171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979229|NCT05592171|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979230|NCT05592171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979231|NCT05539521|Propofol|propofol|mesh-list
91979232|NCT05539521|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91979233|NCT05539521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979234|NCT05539521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979235|NCT05539521|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91979236|NCT05539521|Anesthetics, General|anesthetics, general|mesh-ancestor
91979237|NCT05539521|Anesthetics|anesthetics|mesh-ancestor
91979238|NCT05592015|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
91979239|NCT05592015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969655|NCT02478047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969656|NCT02478047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979240|NCT05592015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979241|NCT05592015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979242|NCT05538507|Memantine|memantine|mesh-list
91979243|NCT05538507|Donepezil|donepezil|mesh-list
91979244|NCT05538507|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91979245|NCT05538507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979246|NCT05538507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979247|NCT05538507|Cholinergic Agents|cholinergic agents|mesh-ancestor
91979248|NCT05538507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979249|NCT05538507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979250|NCT05538507|Nootropic Agents|nootropic agents|mesh-ancestor
91979251|NCT05538507|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91979252|NCT05538507|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91979253|NCT05538507|Dopamine Agents|dopamine agents|mesh-ancestor
91979254|NCT05538507|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91979255|NCT05538507|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91979257|NCT05591235|Pioglitazone|pioglitazone|mesh-list
91979258|NCT05591235|Dapagliflozin|dapagliflozin|mesh-list
91979259|NCT05591235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979260|NCT05591235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979261|NCT05591235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91979262|NCT05591235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979263|NCT05545527|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
91979264|NCT05545527|Ferric Compounds|ferric compounds|mesh-list
91979266|NCT01666119|Buprenorphine|buprenorphine|mesh-list
91979267|NCT01666119|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91979282|NCT05361993|Dopamine Agonists|dopamine agonists|mesh-ancestor
91979283|NCT05361993|Dopamine Agents|dopamine agents|mesh-ancestor
91979284|NCT05361993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979285|NCT05361993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979286|NCT05361993|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91979287|NCT05361993|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91979288|NCT05361993|Serotonin Agents|serotonin agents|mesh-ancestor
91979289|NCT05361993|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91979290|NCT05361993|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91979291|NCT05361993|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91979292|NCT05361993|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91979293|NCT04425681|Bevacizumab|bevacizumab|mesh-list
91979294|NCT04425681|Osimertinib|osimertinib|mesh-list
91979295|NCT04425681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979296|NCT04425681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979297|NCT04425681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91979298|NCT04425681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91979299|NCT04425681|Growth Substances|growth substances|mesh-ancestor
91979300|NCT04425681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979301|NCT04425681|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074262|NCT00074308|Antibodies|antibodies|mesh-list
91979302|NCT04425681|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91979303|NCT04425681|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979304|NCT04425681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979305|NCT05545059|Amlodipine|amlodipine|mesh-list
91979306|NCT05545059|Valsartan|valsartan|mesh-list
91979307|NCT05545059|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91979308|NCT05545059|Spironolactone|spironolactone|mesh-list
91979309|NCT05545059|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91979310|NCT05545059|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91979311|NCT05545059|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91979312|NCT05545059|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979313|NCT05545059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979314|NCT05545059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91979315|NCT05545059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979316|NCT05545059|Vasodilator Agents|vasodilator agents|mesh-ancestor
91979317|NCT05545059|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91979318|NCT05545059|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91979319|NCT05545059|Diuretics|diuretics|mesh-ancestor
91979320|NCT05545059|Natriuretic Agents|natriuretic agents|mesh-ancestor
91979321|NCT05545059|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91969658|NCT02478047|Glucocorticoids|glucocorticoids|mesh-ancestor
91969659|NCT02478047|Hormones|hormones|mesh-ancestor
91969660|NCT02478047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979322|NCT05545059|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91979323|NCT05545059|Hormone Antagonists|hormone antagonists|mesh-ancestor
91979324|NCT05545059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979344|NCT05536011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979345|NCT05536011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979346|NCT05536011|Dopamine Agents|dopamine agents|mesh-ancestor
91979347|NCT05536011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979348|NCT05536011|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
91979349|NCT05536011|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91979350|NCT05536011|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91979351|NCT05536011|Sympathomimetics|sympathomimetics|mesh-ancestor
91979352|NCT05536011|Autonomic Agents|autonomic agents|mesh-ancestor
91979353|NCT05536011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979354|NCT05536011|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979355|NCT05536011|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91979356|NCT05536011|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91979357|NCT05536011|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91979358|NCT05536011|Anesthetics, General|anesthetics, general|mesh-ancestor
91979360|NCT05536011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979361|NCT04809051|Metronidazole|metronidazole|mesh-list
91979362|NCT04809051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979363|NCT04809051|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91979364|NCT04809051|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91979365|NCT04809051|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91979366|NCT04015869|Pregnanolone|pregnanolone|mesh-list
91979367|NCT04015869|Anesthetics|anesthetics|mesh-ancestor
91979368|NCT04015869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979369|NCT04015869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979371|NCT04677855|Dutasteride|dutasteride|mesh-list
91979372|NCT04677855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979373|NCT04677855|Glucocorticoids|glucocorticoids|mesh-ancestor
91979374|NCT04677855|Hormones|hormones|mesh-ancestor
91979375|NCT04677855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979376|NCT04677855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979377|NCT04677855|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979405|NCT02584257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91979406|NCT02584257|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91979407|NCT02584257|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91979408|NCT02584257|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91979409|NCT02584257|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979410|NCT02584257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979411|NCT02584257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979412|NCT02584257|Miotics|miotics|mesh-ancestor
91979413|NCT02584257|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91979414|NCT02584257|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
91979415|NCT02584257|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91979416|NCT02584257|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91979417|NCT02584257|Cholinergic Agents|cholinergic agents|mesh-ancestor
91979418|NCT02584257|Sympathomimetics|sympathomimetics|mesh-ancestor
91979419|NCT04090203|Immunomodulating Agents|immunomodulating agents|mesh-list
91979420|NCT04090203|Immunologic Factors|immunologic factors|mesh-ancestor
91979421|NCT04090203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979422|NCT04062201|Levofloxacin|levofloxacin|mesh-list
91979423|NCT04062201|Ofloxacin|ofloxacin|mesh-list
91979436|NCT04062201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979437|NCT04062201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979438|NCT04062201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91979439|NCT04062201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91979440|NCT04062201|Antitubercular Agents|antitubercular agents|mesh-ancestor
91979441|NCT04062201|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91979442|NCT04062201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91979443|NCT04062201|Antimetabolites|antimetabolites|mesh-ancestor
91979444|NCT04062201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91969661|NCT02478047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979445|NCT04062201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91979446|NCT04062201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979447|NCT04062201|Leprostatic Agents|leprostatic agents|mesh-ancestor
91979448|NCT02583477|Paclitaxel|paclitaxel|mesh-list
91979449|NCT02583477|Gemcitabine|gemcitabine|mesh-list
91979450|NCT02583477|Durvalumab|durvalumab|mesh-list
91979451|NCT02583477|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91979452|NCT02583477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91979453|NCT02583477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979454|NCT02583477|Tubulin Modulators|tubulin modulators|mesh-ancestor
91979455|NCT02583477|Antimitotic Agents|antimitotic agents|mesh-ancestor
91979456|NCT02583477|Mitosis Modulators|mitosis modulators|mesh-ancestor
91979457|NCT02583477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979458|NCT02583477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91979459|NCT02583477|Antimetabolites|antimetabolites|mesh-ancestor
91979460|NCT02583477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979461|NCT02583477|Immunologic Factors|immunologic factors|mesh-ancestor
91979462|NCT02583477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979463|NCT02583399|Ibuprofen|ibuprofen|mesh-list
91979464|NCT02583399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91979465|NCT02583399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91979466|NCT02583399|Analgesics|analgesics|mesh-ancestor
91979467|NCT02583399|Sensory System Agents|sensory system agents|mesh-ancestor
91979468|NCT02583399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979469|NCT02583399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979470|NCT02583399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979471|NCT02583399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979472|NCT02583399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91979473|NCT02583399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979474|NCT02583399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979475|NCT02580591|Empagliflozin|empagliflozin|mesh-list
91979476|NCT02580591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91979477|NCT02580591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979478|NCT02580591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979479|NCT02580591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979480|NCT05552001|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
91979481|NCT05552001|Immunoconjugates|immunoconjugates|mesh-ancestor
91979482|NCT05552001|Immunologic Factors|immunologic factors|mesh-ancestor
91979483|NCT05552001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979484|NCT05390307|Dapagliflozin|dapagliflozin|mesh-list
91979485|NCT05390307|Liraglutide|liraglutide|mesh-list
91979486|NCT05390307|Glucagon|glucagon|mesh-list
91979487|NCT05390307|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91979488|NCT05390307|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91979489|NCT05390307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979491|NCT05390307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979492|NCT05390307|Incretins|incretins|mesh-ancestor
91979493|NCT05390307|Hormones|hormones|mesh-ancestor
91979494|NCT05390307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979495|NCT05390307|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91979496|NCT05319249|Talazoparib|talazoparib|mesh-list
91979497|NCT05319249|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91979498|NCT05319249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979499|NCT05319249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979500|NCT05319249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979501|NCT03849885|Benzoyl Peroxide|benzoyl peroxide|mesh-list
91979502|NCT03849885|Dermatologic Agents|dermatologic agents|mesh-ancestor
91979503|NCT02577315|Metformin|metformin|mesh-list
91979504|NCT02577315|Empagliflozin|empagliflozin|mesh-list
91979505|NCT02577315|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979506|NCT02577315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979507|NCT02577315|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91979508|NCT02577315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979509|NCT05529069|Venetoclax|venetoclax|mesh-list
91979510|NCT05529069|Pirtobrutinib|pirtobrutinib|mesh-list
91979511|NCT05529069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979512|NCT05529069|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969663|NCT02478047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91969664|NCT02478047|Serotonin Agents|serotonin agents|mesh-ancestor
91969665|NCT02478047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979513|NCT05529069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979514|NCT05529069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979515|NCT01582269|Lomustine|lomustine|mesh-list
91979516|NCT01582269|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91979517|NCT01582269|Alkylating Agents|alkylating agents|mesh-ancestor
91979518|NCT01582269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979519|NCT01582269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979520|NCT03526887|Pembrolizumab|pembrolizumab|mesh-list
91979521|NCT03526887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979522|NCT03526887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979523|NCT03526887|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91979524|NCT03526887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979525|NCT03496779|Gemcitabine|gemcitabine|mesh-list
91979526|NCT03496779|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91979527|NCT03496779|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91979528|NCT03496779|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91979529|NCT03496779|Antimetabolites|antimetabolites|mesh-ancestor
91979530|NCT03496779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979531|NCT03496779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979532|NCT03496779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979533|NCT03496779|Immunotoxins|immunotoxins|mesh-ancestor
91979534|NCT03496779|Immunoconjugates|immunoconjugates|mesh-ancestor
91979535|NCT03496779|Immunologic Factors|immunologic factors|mesh-ancestor
91979536|NCT03496779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979537|NCT03398655|Paclitaxel|paclitaxel|mesh-list
91979538|NCT03398655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91979539|NCT03398655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91979540|NCT03398655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979541|NCT03398655|Tubulin Modulators|tubulin modulators|mesh-ancestor
91979542|NCT03398655|Antimitotic Agents|antimitotic agents|mesh-ancestor
91979543|NCT03398655|Mitosis Modulators|mitosis modulators|mesh-ancestor
91979544|NCT03398655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979546|NCT05695287|Sevoflurane|sevoflurane|mesh-list
91979547|NCT05695287|Isoflurane|isoflurane|mesh-list
91979548|NCT05695287|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91979549|NCT05695287|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979550|NCT05695287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979551|NCT05695287|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91979552|NCT05695287|Anesthetics, General|anesthetics, general|mesh-ancestor
91979553|NCT05695287|Anesthetics|anesthetics|mesh-ancestor
91979554|NCT05695287|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91979555|NCT05695287|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91979556|NCT03808025|Analgesics, Opioid|analgesics, opioid|mesh-list
91979557|NCT03808025|Narcotics|narcotics|mesh-ancestor
91979558|NCT03808025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979559|NCT03808025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979560|NCT03808025|Analgesics|analgesics|mesh-ancestor
91979590|NCT00328601|Micronutrients|micronutrients|mesh-ancestor
91979592|NCT00189293|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91979593|NCT00189293|Immunologic Factors|immunologic factors|mesh-ancestor
91979594|NCT00189293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979595|NCT00189293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979596|NCT00189293|Interferon Inducers|interferon inducers|mesh-ancestor
91979597|NCT03194009|Metformin|metformin|mesh-list
91979598|NCT03194009|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979599|NCT03194009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979600|NCT02581995|Aflibercept|aflibercept|mesh-list
91979601|NCT02581995|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91979602|NCT02581995|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91979603|NCT02581995|Growth Substances|growth substances|mesh-ancestor
91979604|NCT02581995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979605|NCT02581995|Growth Inhibitors|growth inhibitors|mesh-ancestor
91979611|NCT03193307|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979612|NCT03193307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969666|NCT02478047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969667|NCT02478047|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91969668|NCT04996485|Ustekinumab|ustekinumab|mesh-list
91969669|NCT04996485|Dermatologic Agents|dermatologic agents|mesh-ancestor
91969670|NCT02447965|Bupivacaine|bupivacaine|mesh-list
91969671|NCT02447965|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969672|NCT02447965|Anesthetics|anesthetics|mesh-ancestor
91979613|NCT03193307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91979614|NCT03193307|Contraceptive Agents|contraceptive agents|mesh-ancestor
91979615|NCT03193307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91979616|NCT03193307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979617|NCT03193307|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91979618|NCT03193307|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91979619|NCT03193307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91979620|NCT03193307|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91979621|NCT03193307|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91979622|NCT03193307|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
91979623|NCT03193307|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91979624|NCT03193307|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91979625|NCT02910843|Capecitabine|capecitabine|mesh-list
91979626|NCT02910843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91979627|NCT02910843|Antimetabolites|antimetabolites|mesh-ancestor
91979628|NCT02910843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979629|NCT02910843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979630|NCT03192527|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91979631|NCT03192527|Luteolytic Agents|luteolytic agents|mesh-ancestor
91979632|NCT03192527|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91979633|NCT03192527|Contraceptive Agents|contraceptive agents|mesh-ancestor
91979634|NCT03192527|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91979635|NCT03192527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979636|NCT03192527|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91979637|NCT03192527|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979638|NCT03192527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979639|NCT02444351|Botulinum Toxins|botulinum toxins|mesh-list
91979640|NCT02444351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91979641|NCT02444351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91979642|NCT02444351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91979643|NCT02444351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979644|NCT02444351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979645|NCT02444351|Cholinergic Agents|cholinergic agents|mesh-ancestor
91979646|NCT02444351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979647|NCT02444351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979648|NCT02444351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91979649|NCT02444351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979650|NCT03193463|Topotecan|topotecan|mesh-list
91979651|NCT03193463|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91979652|NCT03193463|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91979653|NCT03193463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979654|NCT03193463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979655|NCT03193463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979656|NCT02577003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91979657|NCT02577003|Ipragliflozin|ipragliflozin|mesh-list
91979658|NCT02577003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979659|NCT02577003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979660|NCT02577003|Incretins|incretins|mesh-ancestor
91979661|NCT02577003|Hormones|hormones|mesh-ancestor
91979662|NCT02577003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979663|NCT02577003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91979664|NCT02577003|Protease Inhibitors|protease inhibitors|mesh-ancestor
91979665|NCT02577003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979666|NCT02577003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979667|NCT02577003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91979668|NCT05487417|Minocycline|minocycline|mesh-list
91969673|NCT02447965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969674|NCT02447965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969675|NCT02447965|Sensory System Agents|sensory system agents|mesh-ancestor
91969676|NCT02447965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979669|NCT05487417|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91979670|NCT05487417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979671|NCT03471611|Lenograstim|lenograstim|mesh-list
91979684|NCT02600897|Immunologic Factors|immunologic factors|mesh-ancestor
91979685|NCT02600897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979686|NCT02600897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979687|NCT02600897|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91979688|NCT02600897|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91979689|NCT02600897|Growth Substances|growth substances|mesh-ancestor
91979690|NCT02600897|Growth Inhibitors|growth inhibitors|mesh-ancestor
91979691|NCT02600897|Immunoconjugates|immunoconjugates|mesh-ancestor
91979692|NCT05674305|Cisplatin|cisplatin|mesh-list
91979693|NCT05674305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979694|NCT03192449|Albendazole|albendazole|mesh-list
91979695|NCT03192449|Anthelmintics|anthelmintics|mesh-ancestor
91979696|NCT03192449|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91979697|NCT03192449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979699|NCT03192449|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91979700|NCT03192449|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91979701|NCT03192449|Tubulin Modulators|tubulin modulators|mesh-ancestor
91979702|NCT03192449|Antimitotic Agents|antimitotic agents|mesh-ancestor
91979703|NCT03192449|Mitosis Modulators|mitosis modulators|mesh-ancestor
91979704|NCT03192449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979705|NCT03192449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979706|NCT05691933|Morphine|morphine|mesh-list
91979707|NCT05691933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91979708|NCT05691933|Narcotics|narcotics|mesh-ancestor
91979709|NCT05691933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979710|NCT05691933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979711|NCT05691933|Analgesics|analgesics|mesh-ancestor
91979712|NCT05691933|Sensory System Agents|sensory system agents|mesh-ancestor
91979713|NCT05691933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979714|NCT00977483|Thioctic Acid|thioctic acid|mesh-list
91979715|NCT00977483|Antioxidants|antioxidants|mesh-ancestor
91979716|NCT00977483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979717|NCT00977483|Protective Agents|protective agents|mesh-ancestor
91979718|NCT00977483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979719|NCT00977483|Vitamin B Complex|vitamin b complex|mesh-ancestor
91979720|NCT00977483|Vitamins|vitamins|mesh-ancestor
91979721|NCT00977483|Micronutrients|micronutrients|mesh-ancestor
91979722|NCT02439905|Dexmedetomidine|dexmedetomidine|mesh-list
91979723|NCT02439905|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91979724|NCT02439905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979725|NCT02439905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979726|NCT02439905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91979728|NCT02439905|Sensory System Agents|sensory system agents|mesh-ancestor
91979729|NCT02439905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979730|NCT02439905|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91979731|NCT02439905|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91979732|NCT02439905|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91979733|NCT02439905|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979734|NCT02439905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979735|NCT02439905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979736|NCT03192371|Vaccines|vaccines|mesh-list
91979737|NCT03192371|Immunologic Factors|immunologic factors|mesh-ancestor
91979750|NCT05663073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979751|NCT05663073|Vasodilator Agents|vasodilator agents|mesh-ancestor
91979752|NCT05663073|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91979753|NCT05663073|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91979754|NCT02442791|Exenatide|exenatide|mesh-list
91979755|NCT02442791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979756|NCT02442791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979757|NCT02442791|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91979758|NCT02442791|Incretins|incretins|mesh-ancestor
91979759|NCT02442791|Hormones|hormones|mesh-ancestor
91979760|NCT02442791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969677|NCT03070275|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91969678|NCT03070275|Hemostatics|hemostatics|mesh-ancestor
91969679|NCT03070275|Coagulants|coagulants|mesh-ancestor
91969680|NCT05713019|Adenosine|adenosine|mesh-list
91969681|NCT05713019|Capsaicin|capsaicin|mesh-list
91979761|NCT04756557|Fluorides|fluorides|mesh-list
91979762|NCT04756557|Sodium Fluoride|sodium fluoride|mesh-list
91979763|NCT04756557|Cariostatic Agents|cariostatic agents|mesh-ancestor
91979764|NCT04756557|Protective Agents|protective agents|mesh-ancestor
91979765|NCT04756557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979766|NCT04742673|Guanfacine|guanfacine|mesh-list
91979767|NCT04742673|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91979768|NCT04742673|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91979769|NCT04742673|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91979770|NCT04742673|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91979771|NCT04742673|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979772|NCT04742673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979773|NCT04742673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979774|NCT04742673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979775|NCT02442713|Fluvoxamine|fluvoxamine|mesh-list
91979776|NCT02442713|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91979777|NCT02442713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91979778|NCT02442713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979779|NCT02442713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979780|NCT02442713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91979781|NCT02442713|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91979782|NCT02442713|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91979783|NCT02442713|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979784|NCT02442713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979785|NCT02442713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979786|NCT02442713|Serotonin Agents|serotonin agents|mesh-ancestor
91979787|NCT02442713|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91979788|NCT02442713|Antidepressive Agents|antidepressive agents|mesh-ancestor
91979789|NCT02442713|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91979790|NCT02442713|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91979791|NCT02442713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979792|NCT02442713|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91979793|NCT03189953|Exenatide|exenatide|mesh-list
91979794|NCT03189953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979795|NCT03189953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979796|NCT03189953|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91979797|NCT03189953|Incretins|incretins|mesh-ancestor
91979798|NCT03189953|Hormones|hormones|mesh-ancestor
91979810|NCT04314843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91979811|NCT04314843|Immunologic Factors|immunologic factors|mesh-ancestor
91979812|NCT04314843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979813|NCT04314843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979814|NCT04314843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91979815|NCT04314843|Alkylating Agents|alkylating agents|mesh-ancestor
91979816|NCT04314843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979817|NCT04314843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979818|NCT04314843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91979819|NCT04314843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979820|NCT04314843|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979822|NCT03192293|Fulvestrant|fulvestrant|mesh-list
91979823|NCT03192293|Simvastatin|simvastatin|mesh-list
91979824|NCT03192293|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979825|NCT03192293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979826|NCT03192293|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91979827|NCT03192293|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91979828|NCT03192293|Antimetabolites|antimetabolites|mesh-ancestor
91979829|NCT03192293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979830|NCT03192293|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91979831|NCT03192293|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91979832|NCT03192293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979833|NCT03192293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979834|NCT03192293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979835|NCT03192293|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91979836|NCT03192293|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91969682|NCT05713019|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91969683|NCT05713019|Antipruritics|antipruritics|mesh-ancestor
91969684|NCT05713019|Dermatologic Agents|dermatologic agents|mesh-ancestor
91969685|NCT05713019|Sensory System Agents|sensory system agents|mesh-ancestor
91979837|NCT03192293|Hormone Antagonists|hormone antagonists|mesh-ancestor
91979838|NCT03192293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979839|NCT02439125|Eltoprazine|eltoprazine|mesh-list
91979840|NCT02439125|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91979841|NCT02439125|Serotonin Agents|serotonin agents|mesh-ancestor
91979842|NCT02439125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979843|NCT02439125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979844|NCT02439125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979845|NCT02441933|Carboplatin|carboplatin|mesh-list
91979846|NCT02441933|Taxane|taxane|mesh-list
91979847|NCT02441933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979848|NCT01604265|Nabiximols|nabiximols|mesh-list
91979849|NCT01604265|Analgesics|analgesics|mesh-ancestor
91979850|NCT01604265|Sensory System Agents|sensory system agents|mesh-ancestor
91979851|NCT01604265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979852|NCT01604265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979853|NCT04483427|Ketorolac|ketorolac|mesh-list
91979854|NCT04483427|Nalbuphine|nalbuphine|mesh-list
91979855|NCT04483427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91979856|NCT04483427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91979857|NCT04483427|Analgesics|analgesics|mesh-ancestor
91979858|NCT04483427|Sensory System Agents|sensory system agents|mesh-ancestor
91979859|NCT04483427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979860|NCT04483427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979864|NCT04483427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979865|NCT04483427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979866|NCT04483427|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91979867|NCT04483427|Narcotics|narcotics|mesh-ancestor
91979868|NCT04483427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979869|NCT01664247|Liraglutide|liraglutide|mesh-list
91979870|NCT01664247|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979871|NCT01664247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979873|NCT01664247|Hormones|hormones|mesh-ancestor
91979874|NCT01664247|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979875|NCT02441465|Vemurafenib|vemurafenib|mesh-list
91979876|NCT02441465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979877|NCT02441465|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91979878|NCT02441465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979879|NCT02441465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979880|NCT02438657|Lidocaine|lidocaine|mesh-list
91979881|NCT02438657|Epinephrine|epinephrine|mesh-list
91979882|NCT02438657|Anesthetics, Local|anesthetics, local|mesh-ancestor
91979883|NCT02438657|Anesthetics|anesthetics|mesh-ancestor
91979884|NCT02438657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979885|NCT02438657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979886|NCT02438657|Sensory System Agents|sensory system agents|mesh-ancestor
91979887|NCT02438657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979888|NCT02438657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91979889|NCT02438657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91979890|NCT02438657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91979891|NCT02438657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979892|NCT02438657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979893|NCT02438657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91979894|NCT02438657|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91979895|NCT02438657|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979896|NCT02438657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979897|NCT02438657|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91979898|NCT02438657|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91979899|NCT02438657|Autonomic Agents|autonomic agents|mesh-ancestor
91979900|NCT02438657|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91979901|NCT02438657|Respiratory System Agents|respiratory system agents|mesh-ancestor
91979902|NCT02438657|Mydriatics|mydriatics|mesh-ancestor
91979903|NCT02438657|Sympathomimetics|sympathomimetics|mesh-ancestor
91979904|NCT02438657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91979905|NCT02441387|Antidepressive Agents|antidepressive agents|mesh-list
91979906|NCT02441387|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969686|NCT05713019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969687|NCT05713019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969688|NCT05713019|Analgesics|analgesics|mesh-ancestor
91979907|NCT01441947|Fulvestrant|fulvestrant|mesh-list
91979908|NCT01441947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979909|NCT01441947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979910|NCT01441947|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91979911|NCT01441947|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91979912|NCT01441947|Hormone Antagonists|hormone antagonists|mesh-ancestor
91979913|NCT01441947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979914|NCT01441947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979915|NCT03192059|Aspirin|aspirin|mesh-list
91979916|NCT03192059|Vitamin D|vitamin d|mesh-list
91979917|NCT03192059|Curcumin|curcumin|mesh-list
91979918|NCT03192059|Cyclophosphamide|cyclophosphamide|mesh-list
91979919|NCT03192059|Pembrolizumab|pembrolizumab|mesh-list
91979920|NCT03192059|Lansoprazole|lansoprazole|mesh-list
91979921|NCT03192059|Dexlansoprazole|dexlansoprazole|mesh-list
91979922|NCT03192059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91979923|NCT03192059|Immunologic Factors|immunologic factors|mesh-ancestor
91979924|NCT03192059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979925|NCT03192059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979926|NCT03192059|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91979927|NCT03192059|Alkylating Agents|alkylating agents|mesh-ancestor
91979928|NCT03192059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979929|NCT03192059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979930|NCT03192059|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91979931|NCT03192059|Vitamins|vitamins|mesh-ancestor
91979932|NCT03192059|Micronutrients|micronutrients|mesh-ancestor
91979936|NCT03192059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91979937|NCT03192059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91979938|NCT03192059|Analgesics|analgesics|mesh-ancestor
91979939|NCT03192059|Sensory System Agents|sensory system agents|mesh-ancestor
91979940|NCT03192059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979941|NCT03192059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979942|NCT03192059|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91979943|NCT03192059|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91979944|NCT03192059|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91979945|NCT03192059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91979946|NCT03192059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979947|NCT03192059|Antipyretics|antipyretics|mesh-ancestor
91979948|NCT03192059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91979949|NCT03192059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91979950|NCT03192059|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91979951|NCT02441075|Ethanol|ethanol|mesh-list
91979952|NCT02441075|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91979953|NCT02441075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979954|NCT02441075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979955|NCT02441075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979956|NCT05562999|Bromides|bromides|mesh-list
91979957|NCT05562999|Rocuronium|rocuronium|mesh-list
91979958|NCT05562999|Anticonvulsants|anticonvulsants|mesh-ancestor
91979959|NCT05562999|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91979960|NCT05562999|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91979961|NCT05562999|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91979962|NCT05562999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979963|NCT05562999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979964|NCT02438345|Leronlimab|leronlimab|mesh-list
91979965|NCT02438345|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91979966|NCT02438345|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91979967|NCT02438345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979968|NCT02438345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91979969|NCT02438345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91979970|NCT02438345|Antiviral Agents|antiviral agents|mesh-ancestor
91979971|NCT02438345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979972|NCT03191981|Cyclophosphamide|cyclophosphamide|mesh-list
91979973|NCT03191981|Pembrolizumab|pembrolizumab|mesh-list
91979974|NCT03191981|Lenalidomide|lenalidomide|mesh-list
91979975|NCT03191981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91979976|NCT03191981|Immunologic Factors|immunologic factors|mesh-ancestor
91979977|NCT03191981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969689|NCT05713019|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91969690|NCT05713019|Vasodilator Agents|vasodilator agents|mesh-ancestor
91979978|NCT03191981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979979|NCT03191981|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91979980|NCT03191981|Alkylating Agents|alkylating agents|mesh-ancestor
91979981|NCT03191981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979982|NCT03191981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979983|NCT03191981|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91979984|NCT03191981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979985|NCT03191981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91979986|NCT03191981|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91979987|NCT03191981|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91979988|NCT03191981|Growth Substances|growth substances|mesh-ancestor
91979989|NCT03191981|Growth Inhibitors|growth inhibitors|mesh-ancestor
91979990|NCT05535075|Vancomycin|vancomycin|mesh-list
91979991|NCT05535075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91979992|NCT05535075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979993|NCT05530785|Bevacizumab|bevacizumab|mesh-list
91979994|NCT05530785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979995|NCT05530785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979996|NCT05530785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91979997|NCT05530785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91979998|NCT05530785|Growth Substances|growth substances|mesh-ancestor
91979999|NCT05530785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980000|NCT05530785|Growth Inhibitors|growth inhibitors|mesh-ancestor
91980002|NCT05530395|Androgens|androgens|mesh-ancestor
91980003|NCT05530395|Hormones|hormones|mesh-ancestor
91980004|NCT05530395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980017|NCT05389995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980018|NCT05389995|Expectorants|expectorants|mesh-ancestor
91980019|NCT05389995|Respiratory System Agents|respiratory system agents|mesh-ancestor
91980020|NCT05389995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91980021|NCT05389995|Sympathomimetics|sympathomimetics|mesh-ancestor
91980022|NCT05389995|Autonomic Agents|autonomic agents|mesh-ancestor
91980023|NCT05389995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980024|NCT05389995|Dopamine Agents|dopamine agents|mesh-ancestor
91980025|NCT05389995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980026|NCT05389995|Adrenergic Agents|adrenergic agents|mesh-ancestor
91980027|NCT05389995|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91980028|NCT05389995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91980029|NCT05389995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980030|NCT05389995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91980032|NCT04529265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980033|NCT04529265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980034|NCT03191903|Triamcinolone|triamcinolone|mesh-list
91980035|NCT03191903|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91980036|NCT03191903|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91980037|NCT03191903|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91980038|NCT03191903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980039|NCT03191903|Glucocorticoids|glucocorticoids|mesh-ancestor
91980041|NCT03191903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980042|NCT03191903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980043|NCT03191903|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980044|NCT03191903|Immunologic Factors|immunologic factors|mesh-ancestor
91980045|NCT03191903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980046|NCT03191903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980047|NCT05534685|Budesonide|budesonide|mesh-list
91980048|NCT05534685|Pulmonary Surfactants|pulmonary surfactants|mesh-list
91980049|NCT05534685|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980050|NCT05534685|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91980052|NCT05534685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980053|NCT05534685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980054|NCT05534685|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91980055|NCT05534685|Respiratory System Agents|respiratory system agents|mesh-ancestor
91980056|NCT05534685|Glucocorticoids|glucocorticoids|mesh-ancestor
91980057|NCT05534685|Hormones|hormones|mesh-ancestor
91980058|NCT05534685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980059|NCT02437955|Ferrous fumarate|ferrous fumarate|mesh-list
91980060|NCT02437955|Trace Elements|trace elements|mesh-ancestor
91980061|NCT02437955|Micronutrients|micronutrients|mesh-ancestor
91969691|NCT05713019|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91969692|NCT05713019|Purinergic Agonists|purinergic agonists|mesh-ancestor
91969693|NCT05713019|Purinergic Agents|purinergic agents|mesh-ancestor
91980062|NCT02437955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980063|NCT05529927|Dextroamphetamine|dextroamphetamine|mesh-list
91980064|NCT05529927|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91980065|NCT05529927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980066|NCT05529927|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91980067|NCT05529927|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91980110|NCT02435927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980112|NCT02435927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980113|NCT02435927|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980114|NCT02435927|Immunologic Factors|immunologic factors|mesh-ancestor
91980115|NCT02435927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980116|NCT02435927|Antidotes|antidotes|mesh-ancestor
91980117|NCT02435927|Protective Agents|protective agents|mesh-ancestor
91980118|NCT02435927|Vitamin B Complex|vitamin b complex|mesh-ancestor
91980119|NCT02435927|Vitamins|vitamins|mesh-ancestor
91980120|NCT02435927|Micronutrients|micronutrients|mesh-ancestor
91980121|NCT02435771|Ergocalciferols|ergocalciferols|mesh-list
91980122|NCT02435771|Vitamin D|vitamin d|mesh-list
91980123|NCT02435771|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91980124|NCT02435771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980125|NCT02435771|Vitamins|vitamins|mesh-ancestor
91980126|NCT02435771|Micronutrients|micronutrients|mesh-ancestor
91980127|NCT02435771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91980128|NCT02440841|Itraconazole|itraconazole|mesh-list
91980129|NCT02440841|Rifampin|rifampin|mesh-list
91980130|NCT02440841|Antifungal Agents|antifungal agents|mesh-ancestor
91980131|NCT02440841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980132|NCT02440841|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91980133|NCT02440841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91980134|NCT02440841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980135|NCT02440841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980136|NCT02440841|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91980137|NCT02440841|Hormone Antagonists|hormone antagonists|mesh-ancestor
91980138|NCT02440841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980139|NCT02440841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980140|NCT02440841|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91980142|NCT02440841|Antitubercular Agents|antitubercular agents|mesh-ancestor
91980143|NCT02440841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980144|NCT02440841|Leprostatic Agents|leprostatic agents|mesh-ancestor
91980145|NCT02440841|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91980146|NCT02440841|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91980147|NCT02440841|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91980148|NCT02440841|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91980149|NCT02440841|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91980150|NCT02440841|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91980151|NCT02440841|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91980153|NCT02576145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980154|NCT02576145|Immunologic Factors|immunologic factors|mesh-ancestor
91980155|NCT02576145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980156|NCT02435537|Dexmedetomidine|dexmedetomidine|mesh-list
91980157|NCT02435537|Morphine|morphine|mesh-list
91980158|NCT02435537|Bupivacaine|bupivacaine|mesh-list
91980159|NCT02435537|Anesthetics, Local|anesthetics, local|mesh-ancestor
91980160|NCT02435537|Anesthetics|anesthetics|mesh-ancestor
91980161|NCT02435537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980162|NCT02435537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980163|NCT02435537|Sensory System Agents|sensory system agents|mesh-ancestor
91980164|NCT02435537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980165|NCT02435537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91980166|NCT02435537|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91980167|NCT02435537|Analgesics|analgesics|mesh-ancestor
91980168|NCT02435537|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91980169|NCT02435537|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91980170|NCT02435537|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91980171|NCT02435537|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969694|NCT05713019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090440|NCT04381858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980172|NCT02435537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980173|NCT02435537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980174|NCT02435537|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91980176|NCT02576067|Methotrexate|methotrexate|mesh-list
91980177|NCT02576067|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91980180|NCT02576067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980181|NCT02576067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91980182|NCT02576067|Antimetabolites|antimetabolites|mesh-ancestor
91980183|NCT02576067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980184|NCT02576067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980185|NCT02576067|Dermatologic Agents|dermatologic agents|mesh-ancestor
91980186|NCT02576067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980187|NCT02576067|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91980188|NCT02576067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980189|NCT02576067|Immunologic Factors|immunologic factors|mesh-ancestor
91980190|NCT02576067|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980191|NCT02576067|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91980193|NCT02435459|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91980194|NCT02435459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980195|NCT05199909|Zanubrutinib|zanubrutinib|mesh-list
91980196|NCT05199909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980197|NCT05199909|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91980198|NCT05199909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980199|NCT05199909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980200|NCT02435303|Sildenafil Citrate|sildenafil citrate|mesh-list
91980201|NCT02435303|Vasodilator Agents|vasodilator agents|mesh-ancestor
91980202|NCT02435303|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91980203|NCT02435303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91980204|NCT02435303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980205|NCT02435303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980206|NCT02435303|Urological Agents|urological agents|mesh-ancestor
91980207|NCT02434757|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91980208|NCT02434757|Hormones|hormones|mesh-ancestor
91980209|NCT02434757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980210|NCT02434757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980211|NCT03189329|Lidocaine|lidocaine|mesh-list
91980212|NCT03189329|Levobupivacaine|levobupivacaine|mesh-list
91980213|NCT03189329|Anesthetics, Local|anesthetics, local|mesh-ancestor
91980215|NCT03189329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980216|NCT03189329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980217|NCT03189329|Sensory System Agents|sensory system agents|mesh-ancestor
91980218|NCT03189329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980219|NCT03189329|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91980220|NCT03189329|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91980221|NCT03189329|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91980222|NCT03189329|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980223|NCT03189329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980224|NCT02575833|Erenumab|erenumab|mesh-list
91980225|NCT02575833|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91980226|NCT02575833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980227|NCT02575833|Analgesics|analgesics|mesh-ancestor
91980228|NCT02575833|Sensory System Agents|sensory system agents|mesh-ancestor
91980229|NCT02575833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980230|NCT02575833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980231|NCT02709083|Imatinib Mesylate|imatinib mesylate|mesh-list
91980232|NCT02709083|Dasatinib|dasatinib|mesh-list
91980233|NCT02709083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980234|NCT02709083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91980235|NCT02709083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980236|NCT02709083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980237|NCT02709005|Monolaurin|monolaurin|mesh-list
91980238|NCT02709005|Cariostatic Agents|cariostatic agents|mesh-ancestor
91980239|NCT02709005|Protective Agents|protective agents|mesh-ancestor
91980240|NCT02709005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980241|NCT05353335|Antihypertensive Agents|antihypertensive agents|mesh-list
91980242|NCT03188471|Aspirin|aspirin|mesh-list
91969695|NCT05713019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969696|NCT03198403|Epinephrine|epinephrine|mesh-list
91969697|NCT03198403|Bupivacaine|bupivacaine|mesh-list
91969698|NCT03198403|Anesthetics, Local|anesthetics, local|mesh-ancestor
91969699|NCT03198403|Anesthetics|anesthetics|mesh-ancestor
91980243|NCT03188471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980244|NCT03188471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91980245|NCT03188471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91980246|NCT03188471|Analgesics|analgesics|mesh-ancestor
91980247|NCT03188471|Sensory System Agents|sensory system agents|mesh-ancestor
91980253|NCT03188471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980254|NCT03188471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91980255|NCT03188471|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91980256|NCT03188471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980257|NCT03188471|Antipyretics|antipyretics|mesh-ancestor
91980258|NCT04650087|Apixaban|apixaban|mesh-list
91980259|NCT04650087|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91980260|NCT04650087|Antithrombins|antithrombins|mesh-ancestor
91980261|NCT04650087|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91980262|NCT04650087|Protease Inhibitors|protease inhibitors|mesh-ancestor
91980263|NCT04650087|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980264|NCT04650087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980265|NCT04650087|Anticoagulants|anticoagulants|mesh-ancestor
91980266|NCT03188159|Vinorelbine|vinorelbine|mesh-list
91980267|NCT03188159|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91980268|NCT03188159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980269|NCT03188159|Tubulin Modulators|tubulin modulators|mesh-ancestor
91980270|NCT03188159|Antimitotic Agents|antimitotic agents|mesh-ancestor
91980271|NCT03188159|Mitosis Modulators|mitosis modulators|mesh-ancestor
91980272|NCT03188159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980273|NCT05532501|Oxytocin|oxytocin|mesh-list
91980274|NCT05532501|Oxytocics|oxytocics|mesh-ancestor
91980275|NCT05532501|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91980276|NCT05532501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980277|NCT05524857|Decitabine|decitabine|mesh-list
91980278|NCT05524857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91980279|NCT05524857|Antimetabolites|antimetabolites|mesh-ancestor
91980280|NCT05524857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980281|NCT05524857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980282|NCT05524857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980283|NCT05192889|Leucovorin|leucovorin|mesh-list
91980284|NCT05192889|Cytarabine|cytarabine|mesh-list
91980285|NCT05192889|Dexamethasone|dexamethasone|mesh-list
91980286|NCT05192889|Hydrocortisone|hydrocortisone|mesh-list
91980287|NCT05192889|Cyclophosphamide|cyclophosphamide|mesh-list
91980288|NCT05192889|Methotrexate|methotrexate|mesh-list
91980289|NCT05192889|Etoposide|etoposide|mesh-list
91980290|NCT05192889|Vincristine|vincristine|mesh-list
91980291|NCT05192889|Venetoclax|venetoclax|mesh-list
91980292|NCT05192889|Asparaginase|asparaginase|mesh-list
91980293|NCT05192889|Dasatinib|dasatinib|mesh-list
91980294|NCT05192889|Mercaptopurine|mercaptopurine|mesh-list
91980295|NCT05192889|Pegaspargase|pegaspargase|mesh-list
91980296|NCT05192889|Blinatumomab|blinatumomab|mesh-list
91980297|NCT05192889|Navitoclax|navitoclax|mesh-list
91980298|NCT05192889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980299|NCT05192889|Immunologic Factors|immunologic factors|mesh-ancestor
91980300|NCT05192889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980301|NCT05192889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980302|NCT05192889|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91980303|NCT05192889|Alkylating Agents|alkylating agents|mesh-ancestor
91980304|NCT05192889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980305|NCT05192889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980306|NCT05192889|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91980307|NCT05192889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980308|NCT05192889|Antiemetics|antiemetics|mesh-ancestor
91980309|NCT05192889|Autonomic Agents|autonomic agents|mesh-ancestor
91980310|NCT05192889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980311|NCT05192889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980312|NCT05192889|Glucocorticoids|glucocorticoids|mesh-ancestor
91980313|NCT05192889|Hormones|hormones|mesh-ancestor
91980314|NCT05192889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969700|NCT03198403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969701|NCT03198403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980315|NCT05192889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980316|NCT05192889|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91980317|NCT05192889|Abortifacient Agents|abortifacient agents|mesh-ancestor
91980318|NCT05192889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91980319|NCT05192889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91980325|NCT05192889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91980326|NCT05192889|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91980327|NCT05192889|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91980329|NCT05192889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980330|NCT05192889|Antidotes|antidotes|mesh-ancestor
91980331|NCT05192889|Protective Agents|protective agents|mesh-ancestor
91980332|NCT05192889|Vitamin B Complex|vitamin b complex|mesh-ancestor
91980333|NCT05192889|Vitamins|vitamins|mesh-ancestor
91980334|NCT05192889|Micronutrients|micronutrients|mesh-ancestor
91980335|NCT05192889|Tubulin Modulators|tubulin modulators|mesh-ancestor
91980336|NCT05192889|Antimitotic Agents|antimitotic agents|mesh-ancestor
91980337|NCT05192889|Mitosis Modulators|mitosis modulators|mesh-ancestor
91980338|NCT05192889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91980339|NCT05327439|Nicotine|nicotine|mesh-list
91980340|NCT05327439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91980341|NCT05327439|Autonomic Agents|autonomic agents|mesh-ancestor
91980342|NCT05327439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980343|NCT05327439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980344|NCT05327439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91980345|NCT05327439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91980346|NCT05327439|Cholinergic Agents|cholinergic agents|mesh-ancestor
91980347|NCT05327439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980348|NCT05327439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980349|NCT03187691|Amphotericin B|amphotericin b|mesh-list
91980350|NCT03187691|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91980351|NCT03187691|Amebicides|amebicides|mesh-ancestor
91980352|NCT03187691|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91980353|NCT03187691|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91980354|NCT03187691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980355|NCT03187691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980356|NCT03187691|Antifungal Agents|antifungal agents|mesh-ancestor
91980357|NCT02433899|Chlorhexidine|chlorhexidine|mesh-list
91980358|NCT02433899|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91980359|NCT02433899|Dexamethasone|dexamethasone|mesh-list
91980360|NCT02433899|Epinephrine|epinephrine|mesh-list
91980361|NCT02433899|Mepivacaine|mepivacaine|mesh-list
91980362|NCT02433899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980363|NCT02433899|Antiemetics|antiemetics|mesh-ancestor
91980364|NCT02433899|Autonomic Agents|autonomic agents|mesh-ancestor
91980365|NCT02433899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980366|NCT02433899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980367|NCT02433899|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980369|NCT02433899|Hormones|hormones|mesh-ancestor
91980370|NCT02433899|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980371|NCT02433899|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980372|NCT02433899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980373|NCT02433899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91980375|NCT02433899|Disinfectants|disinfectants|mesh-ancestor
91980376|NCT02433899|Dermatologic Agents|dermatologic agents|mesh-ancestor
91980377|NCT02433899|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91980378|NCT02433899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91980379|NCT02433899|Adrenergic Agents|adrenergic agents|mesh-ancestor
91980380|NCT02433899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980381|NCT02433899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980382|NCT02433899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91980383|NCT02433899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91980384|NCT02433899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91980385|NCT02433899|Respiratory System Agents|respiratory system agents|mesh-ancestor
91980386|NCT02433899|Mydriatics|mydriatics|mesh-ancestor
91980387|NCT02433899|Sympathomimetics|sympathomimetics|mesh-ancestor
91980388|NCT02433899|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91980389|NCT02433899|Anesthetics, Local|anesthetics, local|mesh-ancestor
91980390|NCT02433899|Anesthetics|anesthetics|mesh-ancestor
91980391|NCT02433899|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969702|NCT03198403|Sensory System Agents|sensory system agents|mesh-ancestor
91969703|NCT03198403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090441|NCT01903031|Ritonavir|ritonavir|mesh-list
91980392|NCT02433899|Sensory System Agents|sensory system agents|mesh-ancestor
91980411|NCT03187223|Alkylating Agents|alkylating agents|mesh-ancestor
91980412|NCT03187223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980413|NCT03187223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980414|NCT03187223|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91980415|NCT03187223|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980416|NCT03187223|Immunologic Factors|immunologic factors|mesh-ancestor
91980417|NCT03187223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980419|NCT05532111|Rituximab|rituximab|mesh-list
91980420|NCT05532111|Tacrolimus|tacrolimus|mesh-list
91980421|NCT05532111|Glucocorticoids|glucocorticoids|mesh-list
91980422|NCT05532111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980423|NCT05532111|Immunologic Factors|immunologic factors|mesh-ancestor
91980424|NCT05532111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980425|NCT05532111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980426|NCT05532111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91980427|NCT05532111|Alkylating Agents|alkylating agents|mesh-ancestor
91980428|NCT05532111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980429|NCT05532111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980430|NCT05532111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91980431|NCT05532111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91980432|NCT05532111|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91980433|NCT05532111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980434|NCT05532111|Hormones|hormones|mesh-ancestor
91980435|NCT05532111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980436|NCT05524077|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
91980437|NCT04299867|Metronidazole|metronidazole|mesh-list
91980438|NCT04299867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980439|NCT04299867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980440|NCT04299867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91980441|NCT04299867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91980442|NCT02433587|Aspirin|aspirin|mesh-list
91980443|NCT02433587|Clopidogrel|clopidogrel|mesh-list
91980444|NCT02433587|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91980445|NCT02433587|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91980446|NCT02433587|Analgesics|analgesics|mesh-ancestor
91980447|NCT02433587|Sensory System Agents|sensory system agents|mesh-ancestor
91980464|NCT02433353|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91980465|NCT02433353|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91980466|NCT02433353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91980467|NCT02433353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980468|NCT02433353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980469|NCT02433353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980470|NCT02433353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980471|NCT02433353|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91980472|NCT02433353|Antidepressive Agents|antidepressive agents|mesh-ancestor
91980473|NCT02433353|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91980475|NCT05307627|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91980476|NCT05307627|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91980477|NCT05307627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980478|NCT05307627|Sensory System Agents|sensory system agents|mesh-ancestor
91980479|NCT05307627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980480|NCT03190733|Fludarabine|fludarabine|mesh-list
91980481|NCT03190733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980482|NCT04425135|Carboplatin|carboplatin|mesh-list
91980483|NCT04425135|Apatinib|apatinib|mesh-list
91980484|NCT04425135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980485|NCT04425135|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91980486|NCT04425135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980487|NCT04425135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980488|NCT02573883|Clobetasol|clobetasol|mesh-list
91980489|NCT02573883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980490|NCT02573883|Glucocorticoids|glucocorticoids|mesh-ancestor
91980491|NCT02573883|Hormones|hormones|mesh-ancestor
91980492|NCT02573883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980493|NCT02573883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980494|NCT02432885|Enalapril|enalapril|mesh-list
91969704|NCT03198403|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91969705|NCT03198403|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91969706|NCT03198403|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969707|NCT03198403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980495|NCT02432885|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
91980496|NCT02432885|Protease Inhibitors|protease inhibitors|mesh-ancestor
91980497|NCT02432885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980498|NCT02432885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980499|NCT02432885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91980500|NCT02433041|Ketamine|ketamine|mesh-list
91980501|NCT02433041|Haloperidol|haloperidol|mesh-list
91980502|NCT02433041|Haloperidol decanoate|haloperidol decanoate|mesh-list
91980503|NCT02433041|Analgesics|analgesics|mesh-ancestor
91980504|NCT02433041|Sensory System Agents|sensory system agents|mesh-ancestor
91980507|NCT02433041|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91980508|NCT02433041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91980509|NCT02433041|Anesthetics, General|anesthetics, general|mesh-ancestor
91980510|NCT02433041|Anesthetics|anesthetics|mesh-ancestor
91980511|NCT02433041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980512|NCT02433041|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91980513|NCT02433041|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91980514|NCT02433041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980515|NCT02433041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980516|NCT02433041|Antiemetics|antiemetics|mesh-ancestor
91980517|NCT02433041|Autonomic Agents|autonomic agents|mesh-ancestor
91980518|NCT02433041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980519|NCT02433041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91980520|NCT02433041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91980521|NCT02433041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91980522|NCT02433041|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91980524|NCT02433041|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91980525|NCT02429921|Selenium|selenium|mesh-list
91980526|NCT02429921|Antioxidants|antioxidants|mesh-ancestor
91980527|NCT02429921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980528|NCT02429921|Protective Agents|protective agents|mesh-ancestor
91980529|NCT02429921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980530|NCT02429921|Trace Elements|trace elements|mesh-ancestor
91980531|NCT02429921|Micronutrients|micronutrients|mesh-ancestor
91980532|NCT04298697|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91980533|NCT04298697|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91980534|NCT04298697|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91980535|NCT04298697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980536|NCT04298697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980537|NCT04298697|Antiviral Agents|antiviral agents|mesh-ancestor
91980538|NCT04298697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980539|NCT04298697|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91980540|NCT04298697|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91980541|NCT02575365|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91980542|NCT02575365|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91980543|NCT02575365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980544|NCT02575365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980545|NCT02575365|Immunologic Factors|immunologic factors|mesh-ancestor
91980546|NCT02575365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980547|NCT02432807|Vancomycin|vancomycin|mesh-list
91980548|NCT02432807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980549|NCT02432807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980550|NCT05527275|Mitoxantrone|mitoxantrone|mesh-list
91980551|NCT05527275|Analgesics|analgesics|mesh-ancestor
91980552|NCT05527275|Sensory System Agents|sensory system agents|mesh-ancestor
91980553|NCT05527275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980554|NCT05527275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980555|NCT05527275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980556|NCT05527275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91980557|NCT05527275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91980558|NCT05527275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980559|NCT05527275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980560|NCT02429765|Formoterol Fumarate|formoterol fumarate|mesh-list
91980561|NCT02429765|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91980562|NCT02429765|Autonomic Agents|autonomic agents|mesh-ancestor
91980563|NCT02429765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980564|NCT02429765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980565|NCT02429765|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91980566|NCT02429765|Respiratory System Agents|respiratory system agents|mesh-ancestor
91980567|NCT02429765|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91980568|NCT02429765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91980569|NCT02429765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91980570|NCT02429765|Adrenergic Agents|adrenergic agents|mesh-ancestor
91980571|NCT02429765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980572|NCT02429765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980573|NCT03186053|Phosphocreatine|phosphocreatine|mesh-list
91980574|NCT03186053|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91980575|NCT03186053|Protective Agents|protective agents|mesh-ancestor
91980602|NCT02428751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980603|NCT02428751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980604|NCT02428751|Glucocorticoids|glucocorticoids|mesh-ancestor
91980606|NCT02428751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980607|NCT02428751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980608|NCT02428751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91980609|NCT02428751|Tubulin Modulators|tubulin modulators|mesh-ancestor
91980610|NCT02428751|Antimitotic Agents|antimitotic agents|mesh-ancestor
91980611|NCT02428751|Mitosis Modulators|mitosis modulators|mesh-ancestor
91980612|NCT05526807|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91980613|NCT05526807|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91980614|NCT05526807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980615|NCT03185195|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91980616|NCT03186365|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
91980617|NCT03186365|Antiviral Agents|antiviral agents|mesh-ancestor
91980618|NCT03186365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980619|NCT02432651|Xanthohumol|xanthohumol|mesh-list
91980620|NCT02432651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980621|NCT02432651|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91980622|NCT02432651|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91980623|NCT02432651|Growth Substances|growth substances|mesh-ancestor
91980624|NCT02432651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980625|NCT02432651|Growth Inhibitors|growth inhibitors|mesh-ancestor
91980633|NCT02432339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980634|NCT02432339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980635|NCT02432339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980636|NCT02432339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980637|NCT03184805|Aspirin|aspirin|mesh-list
91980638|NCT03184805|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91980639|NCT03184805|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91980640|NCT03184805|Analgesics|analgesics|mesh-ancestor
91980641|NCT03184805|Sensory System Agents|sensory system agents|mesh-ancestor
91980642|NCT03184805|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980643|NCT03184805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980644|NCT03184805|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980645|NCT03184805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980646|NCT03184805|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91980647|NCT03184805|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91980648|NCT03184805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980649|NCT03184805|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91980650|NCT03184805|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91980651|NCT03184805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980652|NCT03184805|Antipyretics|antipyretics|mesh-ancestor
91980653|NCT05518383|Cytarabine|cytarabine|mesh-list
91980654|NCT05518383|Dexamethasone|dexamethasone|mesh-list
91980655|NCT05518383|Dexamethasone acetate|dexamethasone acetate|mesh-list
91980656|NCT05518383|Cyclophosphamide|cyclophosphamide|mesh-list
91980657|NCT05518383|Melphalan|melphalan|mesh-list
91980658|NCT05518383|Ifosfamide|ifosfamide|mesh-list
91980659|NCT05518383|Isophosphamide mustard|isophosphamide mustard|mesh-list
91980660|NCT05518383|Doxorubicin|doxorubicin|mesh-list
91980661|NCT05518383|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91980662|NCT05518383|Methotrexate|methotrexate|mesh-list
91980663|NCT05518383|Etoposide|etoposide|mesh-list
91980664|NCT05518383|Etoposide phosphate|etoposide phosphate|mesh-list
91980665|NCT05518383|Vincristine|vincristine|mesh-list
91980666|NCT05518383|Idarubicin|idarubicin|mesh-list
91980667|NCT05518383|Carboplatin|carboplatin|mesh-list
91980668|NCT05518383|BB 1101|bb 1101|mesh-list
91969708|NCT03198403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969709|NCT03198403|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91969710|NCT03198403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91969711|NCT03198403|Autonomic Agents|autonomic agents|mesh-ancestor
91969712|NCT03198403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91980669|NCT05518383|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980670|NCT05518383|Immunologic Factors|immunologic factors|mesh-ancestor
91980671|NCT05518383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980672|NCT05518383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980673|NCT05518383|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91980674|NCT05518383|Alkylating Agents|alkylating agents|mesh-ancestor
91980675|NCT05518383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980676|NCT05518383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980677|NCT05518383|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91980678|NCT05518383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980679|NCT05518383|Antiemetics|antiemetics|mesh-ancestor
91980680|NCT05518383|Autonomic Agents|autonomic agents|mesh-ancestor
91980681|NCT05518383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980682|NCT05518383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980683|NCT05518383|Glucocorticoids|glucocorticoids|mesh-ancestor
91980684|NCT05518383|Hormones|hormones|mesh-ancestor
91980685|NCT05518383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980686|NCT05518383|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980687|NCT05518383|Protease Inhibitors|protease inhibitors|mesh-ancestor
91980688|NCT05518383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980689|NCT05518383|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91980690|NCT05518383|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91980691|NCT05518383|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91980692|NCT05518383|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91980693|NCT05518383|Abortifacient Agents|abortifacient agents|mesh-ancestor
91980694|NCT05518383|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91980695|NCT05518383|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91980712|NCT02432027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980713|NCT02432027|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91980714|NCT02432027|Respiratory System Agents|respiratory system agents|mesh-ancestor
91980715|NCT02432027|Dermatologic Agents|dermatologic agents|mesh-ancestor
91980716|NCT02428439|Lamotrigine|lamotrigine|mesh-list
91980717|NCT02428439|Bupropion|bupropion|mesh-list
91980718|NCT02428439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91980719|NCT02428439|Antidepressive Agents|antidepressive agents|mesh-ancestor
91980720|NCT02428439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91980721|NCT02428439|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91980722|NCT02428439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91980723|NCT02428439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980724|NCT02428439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980725|NCT02428439|Dopamine Agents|dopamine agents|mesh-ancestor
91980726|NCT02428439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980727|NCT02428439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980728|NCT02428439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91980729|NCT02428439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91980730|NCT02428439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980731|NCT02428439|Anticonvulsants|anticonvulsants|mesh-ancestor
91980732|NCT02428439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91980733|NCT02428439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91980734|NCT02428439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91980735|NCT02428439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91980736|NCT02428439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980737|NCT02428439|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91980738|NCT03186443|Pregabalin|pregabalin|mesh-list
91980739|NCT03186443|Gabapentin|gabapentin|mesh-list
91980740|NCT03186443|Analgesics|analgesics|mesh-ancestor
91980741|NCT03186443|Sensory System Agents|sensory system agents|mesh-ancestor
91980742|NCT03186443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980743|NCT03186443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980744|NCT03186443|Anticonvulsants|anticonvulsants|mesh-ancestor
91980746|NCT03186443|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980747|NCT03186443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969713|NCT03198403|Respiratory System Agents|respiratory system agents|mesh-ancestor
91969714|NCT03198403|Mydriatics|mydriatics|mesh-ancestor
91969715|NCT03198403|Sympathomimetics|sympathomimetics|mesh-ancestor
91980748|NCT03186443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91980749|NCT03186443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91980750|NCT03186443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92074263|NCT00074308|Immunoglobulins|immunoglobulins|mesh-list
91980751|NCT03186443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980752|NCT03186443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91980753|NCT03186443|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91980754|NCT03186443|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91980762|NCT03186131|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91980763|NCT03184649|Acetaminophen|acetaminophen|mesh-list
91980765|NCT03184649|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91980766|NCT03184649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91980767|NCT03184649|Analgesics|analgesics|mesh-ancestor
91980768|NCT03184649|Sensory System Agents|sensory system agents|mesh-ancestor
91980769|NCT03184649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980770|NCT03184649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980771|NCT03184649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980772|NCT03184649|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980773|NCT03184649|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91980774|NCT03184649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980775|NCT03184649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980776|NCT03184649|Antipyretics|antipyretics|mesh-ancestor
91980778|NCT05105841|Obinutuzumab|obinutuzumab|mesh-list
91980779|NCT05105841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980780|NCT05105841|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91980781|NCT02432261|Methyltestosterone|methyltestosterone|mesh-list
91980782|NCT02432261|ST 1435|st 1435|mesh-list
91980783|NCT02432261|Testosterone|testosterone|mesh-list
91980784|NCT02432261|Testosterone undecanoate|testosterone undecanoate|mesh-list
91980785|NCT02432261|Testosterone enanthate|testosterone enanthate|mesh-list
91980786|NCT02432261|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
91980787|NCT02432261|Androgens|androgens|mesh-ancestor
91980788|NCT02432261|Hormones|hormones|mesh-ancestor
91980789|NCT02432261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980790|NCT02432261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980791|NCT02432261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980792|NCT02432261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980793|NCT02432261|Anabolic Agents|anabolic agents|mesh-ancestor
91980794|NCT02432261|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91980795|NCT02432261|Contraceptive Agents|contraceptive agents|mesh-ancestor
91980796|NCT02432261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91980797|NCT02432261|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91980798|NCT02428283|Remifentanil|remifentanil|mesh-list
91980799|NCT02428283|Ropivacaine|ropivacaine|mesh-list
91980800|NCT02428283|Sevoflurane|sevoflurane|mesh-list
91980801|NCT02428283|Anesthetics, Local|anesthetics, local|mesh-ancestor
91980802|NCT02428283|Anesthetics|anesthetics|mesh-ancestor
91980803|NCT02428283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980804|NCT02428283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980805|NCT02428283|Sensory System Agents|sensory system agents|mesh-ancestor
91980806|NCT02428283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980807|NCT02428283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91980808|NCT02428283|Narcotics|narcotics|mesh-ancestor
91980809|NCT02428283|Analgesics|analgesics|mesh-ancestor
91980810|NCT02428283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91980811|NCT02428283|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91980812|NCT02428283|Anesthetics, General|anesthetics, general|mesh-ancestor
91980813|NCT02427893|Vemurafenib|vemurafenib|mesh-list
91980814|NCT02427893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980815|NCT02427893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91980816|NCT02427893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980817|NCT02427893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980818|NCT03184493|Metformin|metformin|mesh-list
91980819|NCT03184493|Celecoxib|celecoxib|mesh-list
91980820|NCT03184493|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91980821|NCT03184493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980822|NCT03184493|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91980823|NCT03184493|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91980825|NCT03184493|Sensory System Agents|sensory system agents|mesh-ancestor
91969716|NCT03198403|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91969717|NCT03198949|Everolimus|everolimus|mesh-list
91969718|NCT03198949|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91980846|NCT03184103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980848|NCT02103478|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92074264|NCT00074308|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91980849|NCT02103478|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91980850|NCT02103478|Antimetabolites|antimetabolites|mesh-ancestor
91980851|NCT02103478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980852|NCT02103478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980853|NCT02103478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980854|NCT02431013|Cilostazol|cilostazol|mesh-list
91980855|NCT02431013|Simvastatin|simvastatin|mesh-list
91980856|NCT02431013|Pravastatin|pravastatin|mesh-list
91980857|NCT02431013|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91980858|NCT02431013|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91980859|NCT02431013|Antimetabolites|antimetabolites|mesh-ancestor
91980860|NCT02431013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980861|NCT02431013|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91980862|NCT02431013|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91980863|NCT02431013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980864|NCT02431013|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91980865|NCT02431013|Autonomic Agents|autonomic agents|mesh-ancestor
91980866|NCT02431013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980867|NCT02431013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980868|NCT02431013|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91980869|NCT02431013|Respiratory System Agents|respiratory system agents|mesh-ancestor
91980870|NCT02431013|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91980871|NCT02431013|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91980872|NCT02431013|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91980873|NCT02431013|Vasodilator Agents|vasodilator agents|mesh-ancestor
91980874|NCT02431013|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91980875|NCT02431013|Protective Agents|protective agents|mesh-ancestor
91980876|NCT02431013|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91980877|NCT02431013|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91980885|NCT03185429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980887|NCT03185429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91980888|NCT02430545|Rifampin|rifampin|mesh-list
91980889|NCT02430545|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91980890|NCT02430545|Antitubercular Agents|antitubercular agents|mesh-ancestor
91980891|NCT02430545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980892|NCT02430545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980893|NCT02430545|Leprostatic Agents|leprostatic agents|mesh-ancestor
91980894|NCT02430545|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91980895|NCT02430545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980896|NCT02430545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980897|NCT02430545|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91980898|NCT02430545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91980899|NCT02430545|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91980900|NCT02430545|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91980901|NCT02430545|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91980902|NCT02430545|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91980903|NCT03117725|Melatonin|melatonin|mesh-list
91980904|NCT03117725|Antioxidants|antioxidants|mesh-ancestor
91980905|NCT03117725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980906|NCT03117725|Protective Agents|protective agents|mesh-ancestor
91980907|NCT03117725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980908|NCT03117725|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980909|NCT03185351|Midazolam|midazolam|mesh-list
91980910|NCT03185351|Bupivacaine|bupivacaine|mesh-list
91980911|NCT03185351|Anesthetics, Local|anesthetics, local|mesh-ancestor
91980912|NCT03185351|Anesthetics|anesthetics|mesh-ancestor
91980913|NCT03185351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980914|NCT03185351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980915|NCT03185351|Sensory System Agents|sensory system agents|mesh-ancestor
91980916|NCT03185351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980917|NCT03185351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91980918|NCT03185351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91980919|NCT03185351|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91980920|NCT03185351|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91980921|NCT03185351|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969719|NCT03198949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969720|NCT03198949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969721|NCT03198949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980922|NCT03185351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91980923|NCT03185351|Anesthetics, General|anesthetics, general|mesh-ancestor
91980925|NCT03185351|GABA Agents|gaba agents|mesh-ancestor
91980926|NCT03185351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980927|NCT03185351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980928|NCT02707601|Sofosbuvir|sofosbuvir|mesh-list
91980929|NCT02707601|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91980930|NCT02707601|Ledipasvir|ledipasvir|mesh-list
91981003|NCT02426177|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91980931|NCT02707601|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91980932|NCT02707601|Antiviral Agents|antiviral agents|mesh-ancestor
91980933|NCT02707601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980934|NCT02707601|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91980935|NCT02707601|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91980936|NCT03183557|Vitamin D|vitamin d|mesh-list
91980937|NCT03183557|Zoledronic Acid|zoledronic acid|mesh-list
91980938|NCT03183557|Alfacalcidol|alfacalcidol|mesh-list
91980939|NCT03183557|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
91980940|NCT03183557|Vitamins|vitamins|mesh-ancestor
91980941|NCT03183557|Micronutrients|micronutrients|mesh-ancestor
91980942|NCT03183557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980943|NCT03183557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91980947|NCT02426723|Antiemetics|antiemetics|mesh-ancestor
91980948|NCT02426723|Autonomic Agents|autonomic agents|mesh-ancestor
91980949|NCT02426723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980950|NCT02426723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980951|NCT02426723|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980952|NCT02426723|Glucocorticoids|glucocorticoids|mesh-ancestor
91980953|NCT02426723|Hormones|hormones|mesh-ancestor
91980954|NCT02426723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980955|NCT02426723|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91980956|NCT02426723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980957|NCT02426723|Immunologic Factors|immunologic factors|mesh-ancestor
91980958|NCT02426723|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91980959|NCT02426723|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91980960|NCT02426723|Growth Substances|growth substances|mesh-ancestor
91980961|NCT02426723|Growth Inhibitors|growth inhibitors|mesh-ancestor
91980962|NCT00709865|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|1,3-dipropyl-8-(2-(5,6-epoxy)norbornyl)xanthine|mesh-list
91980963|NCT00709865|Adenosine A1 Receptor Antagonists|adenosine a1 receptor antagonists|mesh-ancestor
91980964|NCT00709865|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91980965|NCT00709865|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91980966|NCT00709865|Purinergic Agents|purinergic agents|mesh-ancestor
91980967|NCT00709865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980968|NCT00709865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980969|NCT00709865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980970|NCT02425241|Vaccines|vaccines|mesh-list
91980971|NCT02425241|Immunologic Factors|immunologic factors|mesh-ancestor
91980972|NCT02425241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980973|NCT03182855|Ticagrelor|ticagrelor|mesh-list
91980974|NCT03182855|Cangrelor|cangrelor|mesh-list
91980975|NCT03182855|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91980976|NCT03182855|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91980977|NCT03182855|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91980978|NCT03182855|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91980979|NCT03182855|Purinergic Agents|purinergic agents|mesh-ancestor
91980980|NCT03182855|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980981|NCT03182855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980982|NCT03182855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980983|NCT02426333|Abiraterone Acetate|abiraterone acetate|mesh-list
91980984|NCT02426333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980985|NCT02426333|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91980986|NCT02426333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980987|NCT02426333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980988|NCT02426333|Hormone Antagonists|hormone antagonists|mesh-ancestor
91969722|NCT03198949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969723|NCT03198949|Immunologic Factors|immunologic factors|mesh-ancestor
91969724|NCT03198949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980989|NCT02426333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980990|NCT02426333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980991|NCT02426333|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91980992|NCT02426177|Labetalol|labetalol|mesh-list
91980993|NCT02426177|Nifedipine|nifedipine|mesh-list
91980994|NCT02426177|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91980995|NCT02426177|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980996|NCT02426177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980997|NCT02426177|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91980998|NCT02426177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980999|NCT02426177|Vasodilator Agents|vasodilator agents|mesh-ancestor
91981000|NCT02426177|Tocolytic Agents|tocolytic agents|mesh-ancestor
91981001|NCT02426177|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91981002|NCT02426177|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91981004|NCT02426177|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981005|NCT02426177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981006|NCT02426177|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91981008|NCT02426177|Autonomic Agents|autonomic agents|mesh-ancestor
91981009|NCT02426177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981010|NCT02426177|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91981011|NCT02426177|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91981014|NCT02426099|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91981016|NCT02426099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981017|NCT02426099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981018|NCT02426099|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91981019|NCT02426099|Diuretics|diuretics|mesh-ancestor
91981020|NCT02426099|Natriuretic Agents|natriuretic agents|mesh-ancestor
91981021|NCT02426021|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91981022|NCT02426021|Immunologic Factors|immunologic factors|mesh-ancestor
91981023|NCT02426021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981024|NCT02425709|Diclofenac|diclofenac|mesh-list
91981025|NCT02425709|Tramadol|tramadol|mesh-list
91981026|NCT02425709|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91981027|NCT02425709|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981028|NCT02425709|Analgesics|analgesics|mesh-ancestor
91981029|NCT02425709|Sensory System Agents|sensory system agents|mesh-ancestor
91981030|NCT02425709|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981031|NCT02425709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981032|NCT02425709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981033|NCT02425709|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981034|NCT02425709|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91981035|NCT02425709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981036|NCT02425709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981037|NCT02425709|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91981038|NCT02425709|Narcotics|narcotics|mesh-ancestor
91981039|NCT02425709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981040|NCT02073682|Heparin|heparin|mesh-list
91981041|NCT02073682|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91981042|NCT02073682|Tinzaparin|tinzaparin|mesh-list
91981043|NCT02073682|Dalteparin|dalteparin|mesh-list
91981044|NCT02073682|Edoxaban|edoxaban|mesh-list
91981045|NCT02073682|Anticoagulants|anticoagulants|mesh-ancestor
91981046|NCT02073682|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91981047|NCT02073682|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91981048|NCT02073682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981049|NCT02073682|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91981050|NCT02073682|Antithrombins|antithrombins|mesh-ancestor
91981051|NCT02073682|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91981052|NCT02073682|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981053|NCT02073682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981054|NCT03181919|Letrozole|letrozole|mesh-list
91981055|NCT03181919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981056|NCT03181919|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91981057|NCT03181919|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91981058|NCT03181919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969725|NCT03198949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969726|NCT02447809|Aspirin|aspirin|mesh-list
91969727|NCT02447809|Clopidogrel|clopidogrel|mesh-list
91981059|NCT03181919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981060|NCT03181919|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91981061|NCT03181919|Hormone Antagonists|hormone antagonists|mesh-ancestor
91981062|NCT03181919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981063|NCT03181919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981064|NCT02706899|Azacitidine|azacitidine|mesh-list
91981065|NCT02706899|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981066|NCT02706899|Antimetabolites|antimetabolites|mesh-ancestor
91981067|NCT02706899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981068|NCT02706899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981069|NCT02706899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981070|NCT02421575|Hydroxychloroquine|hydroxychloroquine|mesh-list
91981071|NCT02421575|Antimalarials|antimalarials|mesh-ancestor
91981072|NCT02421575|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91981073|NCT02421575|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91981074|NCT02421575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981075|NCT02421575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981076|NCT02421575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981077|NCT02421575|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981078|NCT02424695|Gabapentin|gabapentin|mesh-list
91981079|NCT02424695|Analgesics|analgesics|mesh-ancestor
91981080|NCT02424695|Sensory System Agents|sensory system agents|mesh-ancestor
91981081|NCT02424695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981082|NCT02424695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981083|NCT02424695|Anticonvulsants|anticonvulsants|mesh-ancestor
91981084|NCT02424695|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91981089|NCT02424695|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91981090|NCT02424695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981091|NCT02424695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981092|NCT02424695|Antimanic Agents|antimanic agents|mesh-ancestor
91981093|NCT02422277|Sildenafil Citrate|sildenafil citrate|mesh-list
91981094|NCT02422277|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-list
91981095|NCT02422277|Vasodilator Agents|vasodilator agents|mesh-ancestor
91981096|NCT02422277|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91981097|NCT02422277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981098|NCT02422277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981099|NCT02422277|Urological Agents|urological agents|mesh-ancestor
91981100|NCT02422121|RNS60|rns60|mesh-list
91981101|NCT02422121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91981102|NCT02422121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981103|NCT02422121|Analgesics|analgesics|mesh-ancestor
91981104|NCT02422121|Sensory System Agents|sensory system agents|mesh-ancestor
91981105|NCT02422121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981106|NCT02422121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981107|NCT02422121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981108|NCT02422121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981109|NCT02422121|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91981110|NCT02424461|Ceftriaxone|ceftriaxone|mesh-list
91981111|NCT02424461|Ofloxacin|ofloxacin|mesh-list
91981112|NCT02424461|Levofloxacin|levofloxacin|mesh-list
91981113|NCT02424461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91981114|NCT02424461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981115|NCT02424461|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91981116|NCT02424461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91981117|NCT02424461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91981118|NCT02424461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981119|NCT02424461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981120|NCT02424461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981121|NCT02424461|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91981122|NCT02424461|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91981123|NCT02072824|Pregabalin|pregabalin|mesh-list
91981124|NCT02072824|Analgesics|analgesics|mesh-ancestor
91981125|NCT02072824|Sensory System Agents|sensory system agents|mesh-ancestor
91981126|NCT02072824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981127|NCT02072824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981128|NCT02072824|Anticonvulsants|anticonvulsants|mesh-ancestor
91981129|NCT02072824|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91981130|NCT02072824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91981131|NCT02072824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981132|NCT02072824|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91981133|NCT02072824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91981134|NCT02072824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91981135|NCT02072824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981136|NCT02072824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91981137|NCT03117257|Cisplatin|cisplatin|mesh-list
91981138|NCT03117257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981139|NCT02072668|Rivaroxaban|rivaroxaban|mesh-list
91981140|NCT02072668|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91981141|NCT02072668|Antithrombins|antithrombins|mesh-ancestor
91981142|NCT02072668|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91981143|NCT02072668|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981144|NCT02072668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981145|NCT02072668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981146|NCT02072668|Anticoagulants|anticoagulants|mesh-ancestor
91981147|NCT03181685|Cetrorelix|cetrorelix|mesh-list
91981148|NCT03181685|Progesterone|progesterone|mesh-list
91981149|NCT03181685|Progestins|progestins|mesh-ancestor
91981150|NCT03181685|Hormones|hormones|mesh-ancestor
91981151|NCT03181685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981152|NCT03181685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981153|NCT03181685|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91981154|NCT03181685|Fertility Agents|fertility agents|mesh-ancestor
91981161|NCT02424071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981162|NCT02424071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981164|NCT03178955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91981165|NCT03178955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981166|NCT03178955|Analgesics|analgesics|mesh-ancestor
91981167|NCT03178955|Sensory System Agents|sensory system agents|mesh-ancestor
91981168|NCT03178955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981169|NCT03178955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981170|NCT03178955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981171|NCT03178955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981172|NCT03178955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981173|NCT03178955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981174|NCT03178955|Immunologic Factors|immunologic factors|mesh-ancestor
91981175|NCT01598506|Hydromorphone|hydromorphone|mesh-list
91981176|NCT01598506|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91981177|NCT01598506|Narcotics|narcotics|mesh-ancestor
91981178|NCT01598506|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981179|NCT01598506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981180|NCT01598506|Analgesics|analgesics|mesh-ancestor
91981181|NCT01598506|Sensory System Agents|sensory system agents|mesh-ancestor
91981182|NCT01598506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981183|NCT02423915|Mycophenolic Acid|mycophenolic acid|mesh-list
91981184|NCT02423915|Sirolimus|sirolimus|mesh-list
91981185|NCT02423915|Cyclophosphamide|cyclophosphamide|mesh-list
91981186|NCT02423915|Rituximab|rituximab|mesh-list
91981187|NCT02423915|Fludarabine|fludarabine|mesh-list
91981188|NCT02423915|Fludarabine phosphate|fludarabine phosphate|mesh-list
91981189|NCT02423915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981190|NCT02423915|Immunologic Factors|immunologic factors|mesh-ancestor
91981191|NCT02423915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981192|NCT02423915|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981193|NCT02423915|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981194|NCT02423915|Alkylating Agents|alkylating agents|mesh-ancestor
91981195|NCT02423915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981196|NCT02423915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981197|NCT02423915|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91981198|NCT02423915|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981199|NCT02423915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981200|NCT02423915|Antimetabolites|antimetabolites|mesh-ancestor
91981201|NCT02423915|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981202|NCT02423915|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91981203|NCT02423915|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91981204|NCT02423915|Antitubercular Agents|antitubercular agents|mesh-ancestor
91981205|NCT02423915|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91981206|NCT02423915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981207|NCT02423915|Antifungal Agents|antifungal agents|mesh-ancestor
91981209|NCT02423837|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91981210|NCT02423837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969728|NCT02447809|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91969729|NCT02447809|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91981211|NCT02423837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981213|NCT02423837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981214|NCT02423837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981215|NCT02423837|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981216|NCT02423837|Alkylating Agents|alkylating agents|mesh-ancestor
91981217|NCT02423837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981218|NCT02140060|Travoprost|travoprost|mesh-list
91981219|NCT02140060|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91981220|NCT02140060|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91981221|NCT02140060|Brinzolamide|brinzolamide|mesh-list
91981222|NCT02140060|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91981223|NCT02140060|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91981224|NCT02140060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981230|NCT02421029|Edetic Acid|edetic acid|mesh-list
91981231|NCT02421029|Calcium|calcium|mesh-list
91981232|NCT02421029|Pentetic Acid|pentetic acid|mesh-list
91981233|NCT02421029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91981234|NCT02421029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981235|NCT02421029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91981236|NCT02421029|Anticoagulants|anticoagulants|mesh-ancestor
91981237|NCT02421029|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91981238|NCT02421029|Chelating Agents|chelating agents|mesh-ancestor
91981239|NCT02421029|Sequestering Agents|sequestering agents|mesh-ancestor
91981240|NCT02421029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981241|NCT02421029|Antidotes|antidotes|mesh-ancestor
91981242|NCT02421029|Protective Agents|protective agents|mesh-ancestor
91981243|NCT02421029|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91981245|NCT02139982|Anesthetics, Local|anesthetics, local|mesh-ancestor
91981246|NCT02139982|Anesthetics|anesthetics|mesh-ancestor
91981247|NCT02139982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981248|NCT02139982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981249|NCT02139982|Sensory System Agents|sensory system agents|mesh-ancestor
91981250|NCT02139982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981251|NCT03178643|Piperaquine|piperaquine|mesh-list
91981252|NCT03178643|Sulfadoxine|sulfadoxine|mesh-list
91981253|NCT03178643|Amodiaquine|amodiaquine|mesh-list
91981254|NCT03178643|Artenimol|artenimol|mesh-list
91981255|NCT03178643|Proguanil|proguanil|mesh-list
91981256|NCT03178643|Antimalarials|antimalarials|mesh-ancestor
91981257|NCT03178643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91981258|NCT03178643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91981259|NCT03178643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981260|NCT03178643|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91981261|NCT03178643|Antimetabolites|antimetabolites|mesh-ancestor
91981262|NCT03178643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981263|NCT02139592|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91981264|NCT02139592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981265|NCT02139592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981266|NCT02139592|Immunotoxins|immunotoxins|mesh-ancestor
91981267|NCT02139592|Immunoconjugates|immunoconjugates|mesh-ancestor
91981268|NCT02139592|Immunologic Factors|immunologic factors|mesh-ancestor
91981269|NCT02139592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981270|NCT02139280|Cyclophosphamide|cyclophosphamide|mesh-list
91981271|NCT02139280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981272|NCT02139280|Immunologic Factors|immunologic factors|mesh-ancestor
91981273|NCT02139280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981274|NCT02139280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981275|NCT02139280|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981276|NCT02139280|Alkylating Agents|alkylating agents|mesh-ancestor
91981277|NCT02139280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981278|NCT02139280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981279|NCT02139280|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91981280|NCT02072434|Enoxaparin|enoxaparin|mesh-list
91981281|NCT02072434|Warfarin|warfarin|mesh-list
91981282|NCT02072434|Edoxaban|edoxaban|mesh-list
91981283|NCT02072434|Anticoagulants|anticoagulants|mesh-ancestor
91981284|NCT02072434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91981285|NCT02072434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91969730|NCT02447809|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91969731|NCT02447809|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91969732|NCT02447809|Purinergic Agents|purinergic agents|mesh-ancestor
91981286|NCT02072434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981287|NCT02072434|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91981288|NCT02072434|Antithrombins|antithrombins|mesh-ancestor
91981289|NCT02072434|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91981290|NCT02072434|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981291|NCT02072434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981292|NCT04725994|Irinotecan|irinotecan|mesh-list
91981293|NCT04725994|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91981294|NCT04725994|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91981295|NCT04725994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981300|NCT02139046|Febuxostat|febuxostat|mesh-list
91981301|NCT02139046|Lansoprazole|lansoprazole|mesh-list
91981302|NCT02139046|Dexlansoprazole|dexlansoprazole|mesh-list
91981303|NCT02139046|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91981304|NCT02139046|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981305|NCT02139046|Analgesics|analgesics|mesh-ancestor
91981306|NCT02139046|Sensory System Agents|sensory system agents|mesh-ancestor
91981307|NCT02139046|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981308|NCT02139046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981309|NCT02139046|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981310|NCT02139046|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981311|NCT02139046|Gout Suppressants|gout suppressants|mesh-ancestor
91981312|NCT02139046|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91981313|NCT02139046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981314|NCT02139046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981315|NCT02139046|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981316|NCT02139046|Antimitotic Agents|antimitotic agents|mesh-ancestor
91981317|NCT02139046|Mitosis Modulators|mitosis modulators|mesh-ancestor
91981318|NCT02139046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981319|NCT02139046|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91981320|NCT02139046|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981321|NCT02139046|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91981323|NCT04734262|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91981324|NCT04734262|Tislelizumab|tislelizumab|mesh-list
91981325|NCT04734262|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91981326|NCT04734262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981327|NCT04734262|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981328|NCT04734262|Antimitotic Agents|antimitotic agents|mesh-ancestor
91981329|NCT04734262|Mitosis Modulators|mitosis modulators|mesh-ancestor
91981330|NCT04734262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981331|NCT04734262|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981332|NCT02100670|Diclofenac|diclofenac|mesh-list
91981333|NCT02100670|Menthol|menthol|mesh-list
91981334|NCT02100670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91981335|NCT02100670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981336|NCT02100670|Analgesics|analgesics|mesh-ancestor
91981337|NCT02100670|Sensory System Agents|sensory system agents|mesh-ancestor
91981338|NCT02100670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981339|NCT02100670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981340|NCT02100670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981341|NCT02100670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981342|NCT02100670|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91981343|NCT02100670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981344|NCT02100670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981345|NCT02100670|Antipruritics|antipruritics|mesh-ancestor
91981346|NCT02100670|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981347|NCT02100514|Bococizumab|bococizumab|mesh-list
91981348|NCT02100514|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91981349|NCT02100514|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91981350|NCT02100514|Antimetabolites|antimetabolites|mesh-ancestor
91981351|NCT02100514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981352|NCT02100514|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91981353|NCT02069392|Nicotine|nicotine|mesh-list
91981354|NCT02069392|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91981355|NCT02069392|Autonomic Agents|autonomic agents|mesh-ancestor
91969733|NCT02447809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969734|NCT02447809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981356|NCT02069392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981357|NCT02069392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981358|NCT02069392|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91981359|NCT02069392|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91981360|NCT02069392|Cholinergic Agents|cholinergic agents|mesh-ancestor
91981361|NCT02069392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981362|NCT02069392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981363|NCT05522361|Risdiplam|risdiplam|mesh-list
91981364|NCT05522361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91981365|NCT05522361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981366|NCT05522361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981372|NCT02046616|Abortifacient Agents|abortifacient agents|mesh-ancestor
91981373|NCT02046616|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91981374|NCT02046616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981375|NCT02046616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981376|NCT02046616|Antimetabolites|antimetabolites|mesh-ancestor
91981377|NCT02046616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981378|NCT02046616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981379|NCT02046616|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981380|NCT02046616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981381|NCT02046616|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91981382|NCT02046616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981383|NCT02046616|Immunologic Factors|immunologic factors|mesh-ancestor
91981384|NCT02046616|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981385|NCT02046616|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91981386|NCT05525481|Tamoxifen|tamoxifen|mesh-list
91981387|NCT05525481|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91981388|NCT05525481|Hormone Antagonists|hormone antagonists|mesh-ancestor
91981389|NCT05525481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981390|NCT05525481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981391|NCT05525481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91981392|NCT05525481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981393|NCT05525481|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91981394|NCT05525481|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91981395|NCT05525481|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91981396|NCT04706026|Anesthetics|anesthetics|mesh-list
91981397|NCT04706026|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981398|NCT04706026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981400|NCT02068222|Ribavirin|ribavirin|mesh-list
91981401|NCT02068222|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91981402|NCT02068222|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91981403|NCT02068222|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981404|NCT02068222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981405|NCT02068222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981406|NCT02068222|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91981407|NCT02068222|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91981408|NCT02068222|Antiviral Agents|antiviral agents|mesh-ancestor
91981409|NCT02068222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981410|NCT02068222|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91981411|NCT02068222|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91981412|NCT02068222|Antimetabolites|antimetabolites|mesh-ancestor
91981413|NCT05517213|Cyclophosphamide|cyclophosphamide|mesh-list
91981414|NCT05517213|Etoposide|etoposide|mesh-list
91981415|NCT05517213|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981416|NCT05517213|Immunologic Factors|immunologic factors|mesh-ancestor
91981417|NCT05517213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981418|NCT05517213|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981419|NCT05517213|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981420|NCT05517213|Alkylating Agents|alkylating agents|mesh-ancestor
91981421|NCT05517213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981422|NCT05517213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981423|NCT05517213|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91981424|NCT05517213|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91981425|NCT05517213|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91969735|NCT02447809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981426|NCT05517213|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91981427|NCT05517213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981428|NCT05516745|Respiratory System Agents|respiratory system agents|mesh-list
91981429|NCT05516589|Paclitaxel|paclitaxel|mesh-list
91981430|NCT05516589|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91981431|NCT05516589|Tislelizumab|tislelizumab|mesh-list
91981432|NCT05516589|Afatinib|afatinib|mesh-list
91981433|NCT05516589|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91981434|NCT05516589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981441|NCT05516589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981442|NCT02099110|Metformin|metformin|mesh-list
91981443|NCT02099110|Insulin Glargine|insulin glargine|mesh-list
91981444|NCT02099110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91981445|NCT02099110|Glimepiride|glimepiride|mesh-list
91981446|NCT02099110|Ertugliflozin|ertugliflozin|mesh-list
91981447|NCT02099110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91981448|NCT02099110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981449|NCT02099110|Incretins|incretins|mesh-ancestor
91981450|NCT02099110|Hormones|hormones|mesh-ancestor
91981451|NCT02099110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981453|NCT02099110|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981454|NCT02099110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981455|NCT02099110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981456|NCT02099110|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91981457|NCT02099110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981458|NCT02099110|Immunologic Factors|immunologic factors|mesh-ancestor
91981459|NCT02099110|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91981460|NCT02098876|Everolimus|everolimus|mesh-list
91981461|NCT02098876|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91981462|NCT02098876|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91981463|NCT02098876|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981464|NCT02098876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981465|NCT02098876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981466|NCT02098876|Immunologic Factors|immunologic factors|mesh-ancestor
91981467|NCT02098876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981468|NCT02098876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981469|NCT01624090|Plicamycin|plicamycin|mesh-list
91981470|NCT01624090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91981471|NCT01624090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981472|NCT01624090|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91981473|NCT01624090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981474|NCT01624090|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91981475|NCT01624090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981476|NCT01624090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981477|NCT01624090|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91981479|NCT02571777|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91981480|NCT02571777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981481|NCT02571777|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91981482|NCT02571777|Autonomic Agents|autonomic agents|mesh-ancestor
91981483|NCT02571777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981484|NCT02571777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981485|NCT02571777|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91981486|NCT02571777|Respiratory System Agents|respiratory system agents|mesh-ancestor
91981487|NCT02571777|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981488|NCT02571777|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91981489|NCT02571777|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91981490|NCT02571777|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91981491|NCT02571777|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91981492|NCT02571777|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981493|NCT02571777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981494|NCT02571777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981496|NCT05511831|Antipruritics|antipruritics|mesh-ancestor
91981497|NCT05511831|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981498|NCT05511831|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91981499|NCT05511831|Histamine Antagonists|histamine antagonists|mesh-ancestor
91981500|NCT05511831|Histamine Agents|histamine agents|mesh-ancestor
91981501|NCT05511831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981502|NCT05511831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969736|NCT02447809|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91981517|NCT05521347|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91981518|NCT05521347|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91981520|NCT05521347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981521|NCT02097472|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91981522|NCT02097472|Immunologic Factors|immunologic factors|mesh-ancestor
91981523|NCT02097472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981524|NCT03180671|Salicylic Acid|salicylic acid|mesh-list
91981525|NCT03180671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981526|NCT03180671|Antifungal Agents|antifungal agents|mesh-ancestor
91981527|NCT03180671|Keratolytic Agents|keratolytic agents|mesh-ancestor
91981528|NCT03180671|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981529|NCT05093517|Volagidemab|volagidemab|mesh-list
91981530|NCT05093517|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91981531|NCT05093517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981532|NCT02420171|Insulin|insulin|mesh-list
91981533|NCT02420171|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91981534|NCT02420171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981535|NCT03180593|Valsartan|valsartan|mesh-list
91981536|NCT03180593|Nebivolol|nebivolol|mesh-list
91981537|NCT03180593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91981538|NCT03180593|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91981539|NCT03180593|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91981540|NCT03180593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981541|NCT03180593|Vasodilator Agents|vasodilator agents|mesh-ancestor
91981542|NCT03180593|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91981543|NCT03180593|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91981544|NCT03180593|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91981545|NCT03180593|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981546|NCT03180593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981547|NCT03180593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981548|NCT02423759|Ciprofloxacin|ciprofloxacin|mesh-list
91981549|NCT02423759|Gentamicins|gentamicins|mesh-list
91981550|NCT02423759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91981551|NCT02423759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981552|NCT02423759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91981553|NCT02423759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91981554|NCT02423759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981555|NCT02423759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981556|NCT02423759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981557|NCT02423759|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91981558|NCT02423759|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91981559|NCT02423759|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91981560|NCT01623310|Fluticasone|fluticasone|mesh-list
91981564|NCT01623310|Autonomic Agents|autonomic agents|mesh-ancestor
91981565|NCT01623310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981566|NCT01623310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981567|NCT01623310|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91981568|NCT01623310|Respiratory System Agents|respiratory system agents|mesh-ancestor
91981569|NCT01623310|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981570|NCT01623310|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91981571|NCT03180125|Lidocaine|lidocaine|mesh-list
91981572|NCT03180125|Hyaluronic Acid|hyaluronic acid|mesh-list
91981573|NCT03180125|Anesthetics, Local|anesthetics, local|mesh-ancestor
91981574|NCT03180125|Anesthetics|anesthetics|mesh-ancestor
91981575|NCT03180125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981576|NCT03180125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981577|NCT03180125|Sensory System Agents|sensory system agents|mesh-ancestor
91981578|NCT03180125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981579|NCT03180125|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91981580|NCT03180125|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91981581|NCT03180125|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91981582|NCT03180125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91981583|NCT03180125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981584|NCT03180125|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91981585|NCT03180125|Immunologic Factors|immunologic factors|mesh-ancestor
91981586|NCT03180125|Viscosupplements|viscosupplements|mesh-ancestor
91981587|NCT03180125|Protective Agents|protective agents|mesh-ancestor
91981588|NCT02423603|Paclitaxel|paclitaxel|mesh-list
91981589|NCT02423603|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91981590|NCT02423603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981591|NCT02423603|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981592|NCT02423603|Antimitotic Agents|antimitotic agents|mesh-ancestor
91969737|NCT02447809|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981593|NCT02423603|Mitosis Modulators|mitosis modulators|mesh-ancestor
91981594|NCT02423603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981595|NCT03178409|Liver Extracts|liver extracts|mesh-list
91981596|NCT03178409|Hematinics|hematinics|mesh-ancestor
91981597|NCT03180281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91981598|NCT03180281|Glimepiride|glimepiride|mesh-list
91981599|NCT03180281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91981600|NCT03180281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981601|NCT03180281|Incretins|incretins|mesh-ancestor
91981603|NCT03180281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981604|NCT03180281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91981605|NCT03180281|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981606|NCT03180281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981607|NCT03180281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981608|NCT03180281|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91981609|NCT03180281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981610|NCT03180281|Immunologic Factors|immunologic factors|mesh-ancestor
91981611|NCT03116945|Gallium citrate|gallium citrate|mesh-list
91981612|NCT03116945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981613|NCT03116945|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91981614|NCT03117023|Dexmedetomidine|dexmedetomidine|mesh-list
91981615|NCT03117023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91981616|NCT03117023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981617|NCT03117023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981618|NCT03117023|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981619|NCT03117023|Analgesics|analgesics|mesh-ancestor
91981620|NCT03117023|Sensory System Agents|sensory system agents|mesh-ancestor
91981621|NCT03117023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981622|NCT03117023|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91981623|NCT03117023|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91981624|NCT03117023|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91981625|NCT03117023|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981626|NCT03117023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981627|NCT03117023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981628|NCT02097238|Halichondrin B|halichondrin b|mesh-list
91981629|NCT02097238|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981630|NCT02097238|Antimitotic Agents|antimitotic agents|mesh-ancestor
91981631|NCT02097238|Mitosis Modulators|mitosis modulators|mesh-ancestor
91981646|NCT02419235|Ethanol|ethanol|mesh-list
91981647|NCT02419235|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91981648|NCT02419235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981649|NCT02419235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981650|NCT02419235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981651|NCT02422823|Epinephrine|epinephrine|mesh-list
91981652|NCT02422823|Carticaine|carticaine|mesh-list
91981653|NCT02422823|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91981654|NCT02422823|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91981655|NCT02422823|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981656|NCT02422823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981657|NCT02422823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981658|NCT02422823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981659|NCT02422823|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91981660|NCT02422823|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91981662|NCT02422823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981663|NCT02422823|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91981664|NCT02422823|Respiratory System Agents|respiratory system agents|mesh-ancestor
91981665|NCT02422823|Mydriatics|mydriatics|mesh-ancestor
91981666|NCT02422823|Sympathomimetics|sympathomimetics|mesh-ancestor
91981667|NCT02422823|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91981668|NCT02422823|Anesthetics, Local|anesthetics, local|mesh-ancestor
91981669|NCT02422823|Anesthetics|anesthetics|mesh-ancestor
91981670|NCT02422823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981671|NCT02422823|Sensory System Agents|sensory system agents|mesh-ancestor
91981672|NCT02422589|Ceritinib|ceritinib|mesh-list
91981675|NCT02422589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91981676|NCT02422589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91981677|NCT02422589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981678|NCT02422589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969739|NCT02447809|Sensory System Agents|sensory system agents|mesh-ancestor
91969740|NCT02447809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969741|NCT02447809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981679|NCT02422589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91981680|NCT02422589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91981681|NCT02422589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91981682|NCT02422589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91981683|NCT02422589|Anesthetics, General|anesthetics, general|mesh-ancestor
91981684|NCT02422589|Anesthetics|anesthetics|mesh-ancestor
91981685|NCT02422589|GABA Modulators|gaba modulators|mesh-ancestor
91981686|NCT02422589|GABA Agents|gaba agents|mesh-ancestor
91981687|NCT02422589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981688|NCT02422589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981689|NCT02422589|Anticoagulants|anticoagulants|mesh-ancestor
91981690|NCT02422589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981691|NCT02422589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91981692|NCT02422589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981700|NCT02422199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981701|NCT02416739|Niacinamide|niacinamide|mesh-list
91981703|NCT02416739|Nicotinic Acids|nicotinic acids|mesh-list
91981704|NCT02416739|Vitamin B Complex|vitamin b complex|mesh-ancestor
91981706|NCT02416739|Micronutrients|micronutrients|mesh-ancestor
91981707|NCT02416739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981708|NCT02416739|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91981709|NCT02416739|Antimetabolites|antimetabolites|mesh-ancestor
91981710|NCT02416739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981711|NCT02416739|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91981712|NCT02416739|Vasodilator Agents|vasodilator agents|mesh-ancestor
91981714|NCT02416583|Dinoprostone|dinoprostone|mesh-list
91981715|NCT02416583|Oxytocics|oxytocics|mesh-ancestor
91981716|NCT02416583|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91981717|NCT02416583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981718|NCT02416427|Atorvastatin|atorvastatin|mesh-list
91981719|NCT02416427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91981720|NCT02416427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91981721|NCT02416427|Antimetabolites|antimetabolites|mesh-ancestor
91981722|NCT02416427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981723|NCT02416427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91981724|NCT02416427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91981725|NCT02416427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981726|NCT02416271|Vitamin D|vitamin d|mesh-list
91981727|NCT02416271|Alendronate|alendronate|mesh-list
91981728|NCT02416271|Teriparatide|teriparatide|mesh-list
91981729|NCT02416271|Calcium|calcium|mesh-list
91981730|NCT02416271|Vitamins|vitamins|mesh-ancestor
91981731|NCT02416271|Micronutrients|micronutrients|mesh-ancestor
91981732|NCT02416271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981733|NCT02416271|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91981734|NCT02416271|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91981735|NCT02416115|Morphine|morphine|mesh-list
91981736|NCT02416115|Ramosetron|ramosetron|mesh-list
91981737|NCT02416115|Naloxone|naloxone|mesh-list
91981738|NCT02416115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91981739|NCT02416115|Narcotics|narcotics|mesh-ancestor
91981740|NCT02416115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981741|NCT02416115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981742|NCT02416115|Analgesics|analgesics|mesh-ancestor
91981743|NCT02416115|Sensory System Agents|sensory system agents|mesh-ancestor
91981744|NCT02416115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981745|NCT02416115|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91981746|NCT02416115|Antiemetics|antiemetics|mesh-ancestor
91981747|NCT02416115|Autonomic Agents|autonomic agents|mesh-ancestor
91981748|NCT02416115|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981749|NCT02416115|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91981750|NCT02416115|Serotonin Agents|serotonin agents|mesh-ancestor
91981751|NCT02416115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981829|NCT02415179|Autonomic Agents|autonomic agents|mesh-ancestor
91981752|NCT02416115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981753|NCT02415881|Panitumumab|panitumumab|mesh-list
91981754|NCT02415881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981755|NCT02415881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981756|NCT02415803|Clopidogrel|clopidogrel|mesh-list
91981757|NCT02415803|Ticagrelor|ticagrelor|mesh-list
91981758|NCT02415803|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91981759|NCT02415803|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91969742|NCT02447809|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969743|NCT02447809|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91981760|NCT02415803|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91981761|NCT02415803|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91981762|NCT02415803|Purinergic Agents|purinergic agents|mesh-ancestor
91981763|NCT02415803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981764|NCT02415803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981768|NCT04482881|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91981769|NCT04482881|Misoprostol|misoprostol|mesh-list
91981770|NCT04482881|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91981771|NCT04482881|Abortifacient Agents|abortifacient agents|mesh-ancestor
91981772|NCT04482881|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91981773|NCT04482881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981774|NCT04482881|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91981775|NCT04482881|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981776|NCT04482881|Oxytocics|oxytocics|mesh-ancestor
91981777|NCT04482881|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91981778|NCT04482881|Diuretics|diuretics|mesh-ancestor
91981779|NCT04482881|Natriuretic Agents|natriuretic agents|mesh-ancestor
91981780|NCT04482881|Vasodilator Agents|vasodilator agents|mesh-ancestor
91981781|NCT04482881|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91981782|NCT04482881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981783|NCT03176693|Doxazosin|doxazosin|mesh-list
91981784|NCT03176693|Phenoxybenzamine|phenoxybenzamine|mesh-list
91981785|NCT03176693|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91981786|NCT03176693|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91981787|NCT03176693|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91981788|NCT03176693|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91981789|NCT03176693|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981790|NCT03176693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981791|NCT03176693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981792|NCT03176693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981793|NCT03176693|Vasodilator Agents|vasodilator agents|mesh-ancestor
91981794|NCT02415569|Bisacodyl|bisacodyl|mesh-list
91981795|NCT02415569|Cathartics|cathartics|mesh-ancestor
91981796|NCT02415569|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981797|NCT02415569|Laxatives|laxatives|mesh-ancestor
91981798|NCT02415335|Dexamethasone|dexamethasone|mesh-list
91981799|NCT02415335|Dexamethasone acetate|dexamethasone acetate|mesh-list
91981800|NCT02415335|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
91981801|NCT02415335|BB 1101|bb 1101|mesh-list
91981802|NCT02415335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981803|NCT02415335|Antiemetics|antiemetics|mesh-ancestor
91981804|NCT02415335|Autonomic Agents|autonomic agents|mesh-ancestor
91981805|NCT02415335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981806|NCT02415335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981807|NCT02415335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981808|NCT02415335|Glucocorticoids|glucocorticoids|mesh-ancestor
91981809|NCT02415335|Hormones|hormones|mesh-ancestor
91981810|NCT02415335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981811|NCT02415335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91981812|NCT02415335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981813|NCT02415335|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981814|NCT02415335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981815|NCT02415335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981817|NCT02415257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91981818|NCT02415257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981819|NCT02415257|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91981820|NCT02415257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981821|NCT02415257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981822|NCT02415179|Fluticasone|fluticasone|mesh-list
91981823|NCT02415179|Mometasone Furoate|mometasone furoate|mesh-list
91981824|NCT02415179|Formoterol Fumarate|formoterol fumarate|mesh-list
91981825|NCT02415179|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91981826|NCT02415179|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91981827|NCT02415179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981828|NCT02415179|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91981830|NCT02415179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981831|NCT02415179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981832|NCT02415179|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91981833|NCT02415179|Respiratory System Agents|respiratory system agents|mesh-ancestor
91969744|NCT02447809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91969745|NCT02447809|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91981834|NCT02415179|Dermatologic Agents|dermatologic agents|mesh-ancestor
91981835|NCT02415179|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91981836|NCT02415179|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91981837|NCT02415179|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91981844|NCT02415179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981845|NCT02415179|Sympathomimetics|sympathomimetics|mesh-ancestor
91981846|NCT02415023|Paclitaxel|paclitaxel|mesh-list
91981847|NCT02415023|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91981848|NCT02415023|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91981849|NCT02415023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981850|NCT02415023|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981851|NCT02415023|Antimitotic Agents|antimitotic agents|mesh-ancestor
91981852|NCT02415023|Mitosis Modulators|mitosis modulators|mesh-ancestor
91981853|NCT02415023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981854|NCT02414945|Cyclophosphamide|cyclophosphamide|mesh-list
91981855|NCT02414945|Fludarabine|fludarabine|mesh-list
91981856|NCT02414945|Interleukin-2|interleukin-2|mesh-list
91981857|NCT02414945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981858|NCT02414945|Immunologic Factors|immunologic factors|mesh-ancestor
91981859|NCT02414945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981860|NCT02414945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981861|NCT02414945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981862|NCT02414945|Alkylating Agents|alkylating agents|mesh-ancestor
91981863|NCT02414945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981864|NCT02414945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981865|NCT02414945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91981866|NCT02414945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91981868|NCT02414945|Sensory System Agents|sensory system agents|mesh-ancestor
91981869|NCT02414945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981870|NCT02414555|Phenylephrine|phenylephrine|mesh-list
91981871|NCT02414555|Norepinephrine|norepinephrine|mesh-list
91981872|NCT02414555|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91981873|NCT02414555|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91981874|NCT02414555|Mydriatics|mydriatics|mesh-ancestor
91981875|NCT02414555|Autonomic Agents|autonomic agents|mesh-ancestor
91981876|NCT02414555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981877|NCT02414555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981878|NCT02414555|Sympathomimetics|sympathomimetics|mesh-ancestor
91981879|NCT02414555|Nasal Decongestants|nasal decongestants|mesh-ancestor
91981880|NCT02414555|Respiratory System Agents|respiratory system agents|mesh-ancestor
91981881|NCT02414555|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91981882|NCT02414555|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91981883|NCT02414555|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91981884|NCT02414555|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981885|NCT02414555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981886|NCT02414555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981887|NCT02414555|Protective Agents|protective agents|mesh-ancestor
91981888|NCT02414399|Azithromycin|azithromycin|mesh-list
91981889|NCT02414399|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91981890|NCT02414399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981891|NCT02046070|Dexamethasone|dexamethasone|mesh-list
91981892|NCT02046070|Cyclophosphamide|cyclophosphamide|mesh-list
91981893|NCT02046070|Ixazomib|ixazomib|mesh-list
91981894|NCT02046070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981895|NCT02046070|Immunologic Factors|immunologic factors|mesh-ancestor
91981896|NCT02046070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981897|NCT02046070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91981898|NCT02046070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981899|NCT02046070|Alkylating Agents|alkylating agents|mesh-ancestor
91981900|NCT02046070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981901|NCT02046070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981902|NCT02046070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91981903|NCT02046070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981904|NCT02046070|Antiemetics|antiemetics|mesh-ancestor
91981905|NCT02046070|Autonomic Agents|autonomic agents|mesh-ancestor
91981906|NCT02046070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981907|NCT02046070|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91981908|NCT02046070|Glucocorticoids|glucocorticoids|mesh-ancestor
91981917|NCT01663857|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981918|NCT01663857|Antimetabolites|antimetabolites|mesh-ancestor
91969746|NCT02447809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969747|NCT02447809|Antipyretics|antipyretics|mesh-ancestor
91969748|NCT04989855|Tislelizumab|tislelizumab|mesh-list
91969749|NCT04989855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981919|NCT01663857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981921|NCT02414165|Bevacizumab|bevacizumab|mesh-list
91981922|NCT02414165|Temozolomide|temozolomide|mesh-list
91981923|NCT02414165|Lomustine|lomustine|mesh-list
91981924|NCT02414165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981925|NCT02414165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981926|NCT02414165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91981927|NCT02414165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91981928|NCT02414165|Growth Substances|growth substances|mesh-ancestor
91981929|NCT02414165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981930|NCT02414165|Growth Inhibitors|growth inhibitors|mesh-ancestor
91981931|NCT02414165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981932|NCT02414165|Alkylating Agents|alkylating agents|mesh-ancestor
91981933|NCT02414165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981934|NCT02414165|Antifungal Agents|antifungal agents|mesh-ancestor
91981935|NCT02414165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981936|NCT02414165|Antimetabolites|antimetabolites|mesh-ancestor
91981937|NCT02094898|Ketamine|ketamine|mesh-list
91981938|NCT02094898|Analgesics|analgesics|mesh-ancestor
91981939|NCT02094898|Sensory System Agents|sensory system agents|mesh-ancestor
91981940|NCT02094898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91981941|NCT02094898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981942|NCT02094898|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91981943|NCT02094898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91981944|NCT02094898|Anesthetics, General|anesthetics, general|mesh-ancestor
91981945|NCT02094898|Anesthetics|anesthetics|mesh-ancestor
91981946|NCT02094898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981947|NCT02094898|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91981948|NCT02094898|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91981949|NCT02094898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981950|NCT02094898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981951|NCT04887831|Carboplatin|carboplatin|mesh-list
91981952|NCT04887831|Gemcitabine|gemcitabine|mesh-list
91981953|NCT04887831|Avelumab|avelumab|mesh-list
91981954|NCT04887831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981955|NCT04887831|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981956|NCT04887831|Antimetabolites|antimetabolites|mesh-ancestor
91981957|NCT04887831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981958|NCT04887831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981959|NCT02414009|Leucovorin|leucovorin|mesh-list
91981960|NCT02414009|Fluorouracil|fluorouracil|mesh-list
91981961|NCT02414009|Capecitabine|capecitabine|mesh-list
91981962|NCT02414009|Irinotecan|irinotecan|mesh-list
91981963|NCT02414009|Temozolomide|temozolomide|mesh-list
91981964|NCT02414009|Antimetabolites|antimetabolites|mesh-ancestor
91981965|NCT02414009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981966|NCT02414009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981967|NCT02414009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981968|NCT02414009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981969|NCT02414009|Immunologic Factors|immunologic factors|mesh-ancestor
91981970|NCT02414009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981971|NCT02414009|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91981972|NCT02414009|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91981973|NCT02414009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981974|NCT02414009|Antidotes|antidotes|mesh-ancestor
91981975|NCT02414009|Protective Agents|protective agents|mesh-ancestor
91981976|NCT02414009|Vitamin B Complex|vitamin b complex|mesh-ancestor
91981984|NCT02413853|Oxaliplatin|oxaliplatin|mesh-list
91981985|NCT02413853|Calcium|calcium|mesh-list
91981986|NCT02413853|Levoleucovorin|levoleucovorin|mesh-list
91981987|NCT02413853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981988|NCT02413853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981989|NCT02413853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91981990|NCT02413853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91981991|NCT02413853|Growth Substances|growth substances|mesh-ancestor
91981992|NCT02413853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981993|NCT02413853|Growth Inhibitors|growth inhibitors|mesh-ancestor
91969750|NCT04989855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969751|NCT04915287|Maleic acid|maleic acid|mesh-list
91969752|NCT04915287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981994|NCT02413853|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91981995|NCT02413853|Antimetabolites|antimetabolites|mesh-ancestor
91981996|NCT02413853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981997|NCT02413853|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981998|NCT02413853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91981999|NCT02413853|Immunologic Factors|immunologic factors|mesh-ancestor
91982000|NCT02413853|Antidotes|antidotes|mesh-ancestor
91982001|NCT02413853|Protective Agents|protective agents|mesh-ancestor
91982002|NCT02413853|Vitamin B Complex|vitamin b complex|mesh-ancestor
91982003|NCT02413853|Vitamins|vitamins|mesh-ancestor
91982004|NCT02413853|Micronutrients|micronutrients|mesh-ancestor
91982005|NCT00704483|Ferric Compounds|ferric compounds|mesh-list
91982006|NCT00704483|Sevelamer|sevelamer|mesh-list
91982007|NCT00704483|Chelating Agents|chelating agents|mesh-ancestor
91982008|NCT00704483|Sequestering Agents|sequestering agents|mesh-ancestor
91982009|NCT00704483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982010|NCT00704483|Hematinics|hematinics|mesh-ancestor
91982011|NCT04596189|Mometasone Furoate|mometasone furoate|mesh-list
91982012|NCT04596189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982013|NCT04596189|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982014|NCT04596189|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91982015|NCT03176537|Testosterone|testosterone|mesh-list
91982016|NCT03176537|Androgens|androgens|mesh-ancestor
91982017|NCT03176537|Hormones|hormones|mesh-ancestor
91982018|NCT03176537|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982019|NCT03176537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982021|NCT05511441|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91982022|NCT05511441|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91982023|NCT05511441|Analgesics|analgesics|mesh-ancestor
91982024|NCT05511441|Sensory System Agents|sensory system agents|mesh-ancestor
91982025|NCT05511441|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982026|NCT05511441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982027|NCT05511441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982028|NCT05511441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982029|NCT05511441|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91982030|NCT05511441|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91982031|NCT05511441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982032|NCT05511441|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982033|NCT05511441|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91982034|NCT05511441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982035|NCT05511441|Antipyretics|antipyretics|mesh-ancestor
91982036|NCT05515731|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91982037|NCT05515731|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91982038|NCT02413541|Polymyxins|polymyxins|mesh-list
91982039|NCT02413541|Polymyxin B|polymyxin b|mesh-list
91982040|NCT02413541|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91982041|NCT02413541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982042|NCT02045836|Vaccines|vaccines|mesh-list
91982043|NCT02045836|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91982044|NCT02045836|Immunologic Factors|immunologic factors|mesh-ancestor
91982045|NCT02045836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982046|NCT02412917|Valacyclovir|valacyclovir|mesh-list
91982047|NCT02412917|Antiviral Agents|antiviral agents|mesh-ancestor
91982048|NCT02412917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982049|NCT02412683|Oxaliplatin|oxaliplatin|mesh-list
91982057|NCT02569437|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91982058|NCT02569437|Prednisolone|prednisolone|mesh-list
91982059|NCT02569437|Prednisolone acetate|prednisolone acetate|mesh-list
91982060|NCT02569437|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91982061|NCT02569437|Prednisolone phosphate|prednisolone phosphate|mesh-list
91982062|NCT02569437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982063|NCT02569437|Antiemetics|antiemetics|mesh-ancestor
91982064|NCT02569437|Autonomic Agents|autonomic agents|mesh-ancestor
91982065|NCT02569437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982066|NCT02569437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982067|NCT02569437|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982068|NCT02569437|Glucocorticoids|glucocorticoids|mesh-ancestor
91982069|NCT02569437|Hormones|hormones|mesh-ancestor
91982070|NCT02569437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982071|NCT02569437|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91982072|NCT02569437|Protective Agents|protective agents|mesh-ancestor
91969753|NCT04915287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982073|NCT02569437|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91982074|NCT02569437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982075|NCT02569437|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91982076|NCT02569437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982077|NCT02569437|Antimalarials|antimalarials|mesh-ancestor
91982078|NCT02569437|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91982079|NCT02569437|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91982080|NCT02569437|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91982081|NCT02569437|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91982082|NCT02569437|Respiratory System Agents|respiratory system agents|mesh-ancestor
91982083|NCT02569437|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982084|NCT02569437|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91982086|NCT02412449|Glycine Agents|glycine agents|mesh-ancestor
91982087|NCT02412449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982088|NCT02412449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982089|NCT02412449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982090|NCT02412059|Prednisolone|prednisolone|mesh-list
91982091|NCT02412059|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91982092|NCT02412059|Methylprednisolone|methylprednisolone|mesh-list
91982093|NCT02412059|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91982094|NCT02412059|Prednisolone acetate|prednisolone acetate|mesh-list
91982095|NCT02412059|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91982096|NCT02412059|Prednisolone phosphate|prednisolone phosphate|mesh-list
91982097|NCT02412059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982098|NCT02412059|Glucocorticoids|glucocorticoids|mesh-ancestor
91982100|NCT02412059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982101|NCT02412059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982102|NCT02412059|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91982103|NCT02412059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982104|NCT02412059|Antiemetics|antiemetics|mesh-ancestor
91982105|NCT02412059|Autonomic Agents|autonomic agents|mesh-ancestor
91982106|NCT02412059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982107|NCT02412059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982108|NCT02412059|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91982109|NCT02412059|Protective Agents|protective agents|mesh-ancestor
91982110|NCT05090085|Z 350|z 350|mesh-list
91982111|NCT05090085|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91982112|NCT05090085|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91982113|NCT05090085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982114|NCT05090085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982115|NCT05090085|Hormone Antagonists|hormone antagonists|mesh-ancestor
91982116|NCT05090085|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982117|NCT05090085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982118|NCT03175679|Interleukin-2|interleukin-2|mesh-list
91982119|NCT03175679|Tegafur|tegafur|mesh-list
91982120|NCT03175679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982121|NCT03175679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91982122|NCT03175679|Analgesics|analgesics|mesh-ancestor
91982126|NCT03175679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91982127|NCT03175679|Antimetabolites|antimetabolites|mesh-ancestor
91982128|NCT03175679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982129|NCT05520645|Propofol|propofol|mesh-list
91982130|NCT05520645|Etomidate|etomidate|mesh-list
91982131|NCT05520645|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982132|NCT05520645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982133|NCT05520645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982134|NCT05520645|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91982136|NCT05520645|Anesthetics|anesthetics|mesh-ancestor
91982137|NCT03175835|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91982138|NCT03175835|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91982139|NCT03175835|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91982140|NCT03175835|Antimetabolites|antimetabolites|mesh-ancestor
91982141|NCT03175835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982142|NCT03175835|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91982143|NCT03175835|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91982144|NCT03175835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982145|NCT05515185|Cyclophosphamide|cyclophosphamide|mesh-list
91969755|NCT05709353|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91969756|NCT05709353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982146|NCT05515185|Fludarabine|fludarabine|mesh-list
91982147|NCT05515185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982148|NCT05515185|Immunologic Factors|immunologic factors|mesh-ancestor
91982149|NCT05515185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982150|NCT05515185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982151|NCT05515185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91982152|NCT05515185|Alkylating Agents|alkylating agents|mesh-ancestor
91982153|NCT05515185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982154|NCT05515185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982155|NCT05515185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91982156|NCT02044822|Rituximab|rituximab|mesh-list
91982157|NCT02044822|Idelalisib|idelalisib|mesh-list
91982158|NCT02044822|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91982159|NCT02044822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982160|NCT02044822|Immunologic Factors|immunologic factors|mesh-ancestor
91982161|NCT02044822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982162|NCT02044822|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982163|NCT02044822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982164|NCT02044822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982165|NCT03116555|Irinotecan|irinotecan|mesh-list
91982166|NCT03116555|Apatinib|apatinib|mesh-list
91982167|NCT03116555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91982168|NCT03116555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91982169|NCT03116555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982170|NCT03116555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982171|NCT03116555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982172|NCT03116555|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91982173|NCT02044510|Mirabegron|mirabegron|mesh-list
91982174|NCT02044510|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91982175|NCT02044510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91982176|NCT02044510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91982177|NCT02044510|Adrenergic Agents|adrenergic agents|mesh-ancestor
91982178|NCT02044510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982179|NCT02044510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982180|NCT02044510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982181|NCT02044510|Urological Agents|urological agents|mesh-ancestor
91982182|NCT02411903|Clopidogrel|clopidogrel|mesh-list
91982183|NCT02411903|Atorvastatin|atorvastatin|mesh-list
91982184|NCT02411903|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91982185|NCT02411903|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91982186|NCT02411903|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91982187|NCT02411903|Antimetabolites|antimetabolites|mesh-ancestor
91982188|NCT02411903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982189|NCT02411903|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91982190|NCT02411903|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91982191|NCT02411903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982192|NCT02411903|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982195|NCT02411903|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91982196|NCT02411903|Purinergic Agents|purinergic agents|mesh-ancestor
91982197|NCT02411903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982198|NCT02411903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982199|NCT02411825|Metformin|metformin|mesh-list
91982200|NCT02411825|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982201|NCT02411825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982202|NCT03174977|Raltegravir Potassium|raltegravir potassium|mesh-list
91982203|NCT03174977|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91982204|NCT03174977|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91982205|NCT03174977|Antiviral Agents|antiviral agents|mesh-ancestor
91982206|NCT03174977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982207|NCT03174977|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91982208|NCT03174977|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91982209|NCT03174977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982210|NCT03174977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982211|NCT05514405|Propofol|propofol|mesh-list
91982212|NCT05514405|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982213|NCT05514405|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982214|NCT05514405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969758|NCT05709353|Autonomic Agents|autonomic agents|mesh-ancestor
91969759|NCT05709353|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969760|NCT05709353|Dopamine Agents|dopamine agents|mesh-ancestor
91969761|NCT05709353|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982215|NCT05514405|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91982216|NCT05514405|Anesthetics, General|anesthetics, general|mesh-ancestor
91982217|NCT05514405|Anesthetics|anesthetics|mesh-ancestor
91982218|NCT02410655|Oxytocin|oxytocin|mesh-list
91982219|NCT02410655|Oxytocics|oxytocics|mesh-ancestor
91982220|NCT02410655|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982221|NCT02410655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982222|NCT02410499|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91982223|NCT02410499|Immunologic Factors|immunologic factors|mesh-ancestor
91982224|NCT02410499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982225|NCT05510505|Antibodies|antibodies|mesh-list
91982226|NCT05510505|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91982227|NCT05510505|Immunologic Factors|immunologic factors|mesh-ancestor
91982228|NCT05510505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982229|NCT05514015|Cyclophosphamide|cyclophosphamide|mesh-list
91982230|NCT05514015|Rituximab|rituximab|mesh-list
91982231|NCT05514015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982232|NCT05514015|Immunologic Factors|immunologic factors|mesh-ancestor
91982233|NCT05514015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982234|NCT05514015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982235|NCT05514015|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91982236|NCT05514015|Alkylating Agents|alkylating agents|mesh-ancestor
91982237|NCT05514015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982238|NCT05514015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982239|NCT05514015|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91982240|NCT05514015|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91982241|NCT03174821|Insulin|insulin|mesh-list
91982242|NCT03174821|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91982243|NCT03174821|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982244|NCT03174821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982245|NCT05520021|Magnesium Sulfate|magnesium sulfate|mesh-list
91982246|NCT05520021|Nifedipine|nifedipine|mesh-list
91982247|NCT05520021|Analgesics|analgesics|mesh-ancestor
91982248|NCT05520021|Sensory System Agents|sensory system agents|mesh-ancestor
91982249|NCT05520021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982250|NCT05520021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982251|NCT05520021|Anesthetics|anesthetics|mesh-ancestor
91982252|NCT05520021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982253|NCT05520021|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91982254|NCT05520021|Anticonvulsants|anticonvulsants|mesh-ancestor
91982255|NCT05520021|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91982256|NCT05520021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982257|NCT05520021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982258|NCT05520021|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91982259|NCT05520021|Tocolytic Agents|tocolytic agents|mesh-ancestor
91982260|NCT05520021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982261|NCT05520021|Vasodilator Agents|vasodilator agents|mesh-ancestor
91982262|NCT02410031|Cyproterone Acetate|cyproterone acetate|mesh-list
91982263|NCT02410031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91982264|NCT02410031|Cyproterone|cyproterone|mesh-list
91982265|NCT02410031|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
91982269|NCT02410031|Contraceptive Agents|contraceptive agents|mesh-ancestor
91982270|NCT02410031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982271|NCT02410031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982272|NCT02410031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91982273|NCT02410031|Estrogens|estrogens|mesh-ancestor
91982275|NCT02410031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982276|NCT02410031|Androgen Antagonists|androgen antagonists|mesh-ancestor
91982277|NCT02410031|Hormone Antagonists|hormone antagonists|mesh-ancestor
91982278|NCT02410031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982279|NCT02410031|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91982280|NCT05513625|Pritelivir|pritelivir|mesh-list
91982281|NCT05513625|Antiviral Agents|antiviral agents|mesh-ancestor
91982282|NCT05513625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982283|NCT05513625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969762|NCT05709353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969764|NCT05709353|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91969765|NCT05709353|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91969766|NCT05709353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982284|NCT05513625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982285|NCT02409641|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91982286|NCT02409641|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91982287|NCT02067676|Aluminum Hydroxide|aluminum hydroxide|mesh-list
91982288|NCT02067676|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91982289|NCT02067676|Immunologic Factors|immunologic factors|mesh-ancestor
91982290|NCT02067676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982291|NCT02067676|Antacids|antacids|mesh-ancestor
91982292|NCT02067676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982293|NCT02067676|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982294|NCT02409407|Alprostadil|alprostadil|mesh-list
91982295|NCT02409407|Misoprostol|misoprostol|mesh-list
91982296|NCT02409407|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91982297|NCT02409407|Abortifacient Agents|abortifacient agents|mesh-ancestor
91982298|NCT02409407|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982299|NCT02409407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982300|NCT02409407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91982301|NCT02409407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982302|NCT02409407|Oxytocics|oxytocics|mesh-ancestor
91982303|NCT02409407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982304|NCT02409407|Vasodilator Agents|vasodilator agents|mesh-ancestor
91982305|NCT02409407|Urological Agents|urological agents|mesh-ancestor
91982306|NCT02409563|Budesonide|budesonide|mesh-list
91982307|NCT02409563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982308|NCT02409563|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91982309|NCT02409563|Autonomic Agents|autonomic agents|mesh-ancestor
91982310|NCT02409563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982311|NCT02409563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982312|NCT02409563|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91982313|NCT02409563|Respiratory System Agents|respiratory system agents|mesh-ancestor
91982314|NCT02409563|Glucocorticoids|glucocorticoids|mesh-ancestor
91982315|NCT02409563|Hormones|hormones|mesh-ancestor
91982316|NCT02409563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982317|NCT05513313|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91982318|NCT05513313|Antiviral Agents|antiviral agents|mesh-ancestor
91982319|NCT05513313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982320|NCT02409017|Insulin|insulin|mesh-list
91982321|NCT02409017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982322|NCT02409017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982323|NCT00702689|Imatinib Mesylate|imatinib mesylate|mesh-list
91982324|NCT00702689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982325|NCT00702689|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91982326|NCT00702689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982327|NCT00702689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982328|NCT02065570|Adalimumab|adalimumab|mesh-list
91982329|NCT02065570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91982330|NCT02065570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982331|NCT02065570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982332|NCT02408705|Acetaminophen|acetaminophen|mesh-list
91982333|NCT02408705|Liraglutide|liraglutide|mesh-list
91982334|NCT02408705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91982335|NCT02408705|Analgesics|analgesics|mesh-ancestor
91982336|NCT02408705|Sensory System Agents|sensory system agents|mesh-ancestor
91982337|NCT02408705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982340|NCT02408705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982341|NCT02408705|Incretins|incretins|mesh-ancestor
91982342|NCT02408705|Hormones|hormones|mesh-ancestor
91982343|NCT02408705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982344|NCT05509569|Icatibant|icatibant|mesh-list
91982345|NCT05509569|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91982346|NCT05509569|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91982347|NCT05509569|Analgesics|analgesics|mesh-ancestor
91982348|NCT05509569|Sensory System Agents|sensory system agents|mesh-ancestor
91969767|NCT05709353|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91982349|NCT05509569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982350|NCT05509569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982351|NCT05509569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982352|NCT05509569|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982353|NCT05509569|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
91982354|NCT05509569|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
91982355|NCT05509569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982356|NCT05509569|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91982357|NCT05509569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982358|NCT05509569|Immunologic Factors|immunologic factors|mesh-ancestor
91982359|NCT02408939|Hydrocortisone|hydrocortisone|mesh-list
91982360|NCT02408939|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91982361|NCT02408939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982362|NCT05507697|Thioctic Acid|thioctic acid|mesh-list
91982363|NCT05507697|Antioxidants|antioxidants|mesh-ancestor
91982364|NCT05507697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982365|NCT05507697|Protective Agents|protective agents|mesh-ancestor
91982366|NCT05507697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982367|NCT05507697|Vitamin B Complex|vitamin b complex|mesh-ancestor
91982368|NCT05507697|Vitamins|vitamins|mesh-ancestor
91982369|NCT05507697|Micronutrients|micronutrients|mesh-ancestor
91982370|NCT04292223|Pimavanserin|pimavanserin|mesh-list
91982371|NCT04292223|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91982372|NCT04292223|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91982373|NCT04292223|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91982374|NCT04292223|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91982375|NCT04292223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982376|NCT04292223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982377|NCT04292223|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91982378|NCT04292223|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91982379|NCT04292223|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91982380|NCT04292223|Serotonin Agents|serotonin agents|mesh-ancestor
91982381|NCT04292223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982382|NCT04292223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982383|NCT03116321|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
91982384|NCT03116321|Anticonvulsants|anticonvulsants|mesh-ancestor
91982385|NCT03116321|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91982386|NCT03116321|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91982387|NCT03116321|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982388|NCT03116321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982390|NCT03174041|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
91982391|NCT03174041|Midazolam|midazolam|mesh-list
91982392|NCT03174041|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91982393|NCT03174041|Simvastatin|simvastatin|mesh-list
91982394|NCT03174041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91982395|NCT03174041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982396|NCT03174041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982397|NCT03174041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982398|NCT03174041|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91982399|NCT03174041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91982400|NCT03174041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91982401|NCT03174041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91982402|NCT03174041|Anesthetics, General|anesthetics, general|mesh-ancestor
91982403|NCT03174041|Anesthetics|anesthetics|mesh-ancestor
91982404|NCT03174041|GABA Modulators|gaba modulators|mesh-ancestor
91982405|NCT03174041|GABA Agents|gaba agents|mesh-ancestor
91982406|NCT03174041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982407|NCT03174041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982408|NCT03174041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91982409|NCT03174041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91982417|NCT03174041|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91982418|NCT03174041|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91982419|NCT03174041|Hormone Antagonists|hormone antagonists|mesh-ancestor
91982420|NCT03174041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982421|NCT03174041|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91982422|NCT02566005|Misoprostol|misoprostol|mesh-list
91982423|NCT02566005|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91982424|NCT02566005|Abortifacient Agents|abortifacient agents|mesh-ancestor
91982425|NCT02566005|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982426|NCT02566005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982427|NCT02566005|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91982428|NCT02566005|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982429|NCT02566005|Oxytocics|oxytocics|mesh-ancestor
91982430|NCT02408393|Ropivacaine|ropivacaine|mesh-list
91982431|NCT02408393|Anesthetics, Local|anesthetics, local|mesh-ancestor
91982432|NCT02408393|Anesthetics|anesthetics|mesh-ancestor
91982433|NCT02408393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982434|NCT02408393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982435|NCT02408393|Sensory System Agents|sensory system agents|mesh-ancestor
91982436|NCT02408393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982437|NCT05041335|Heparin|heparin|mesh-list
91982438|NCT05041335|Anticoagulants|anticoagulants|mesh-ancestor
91982439|NCT05041335|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91982440|NCT05041335|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91982441|NCT05041335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982442|NCT03173963|Empagliflozin|empagliflozin|mesh-list
91982443|NCT03173963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91982444|NCT03173963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982445|NCT03173963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982446|NCT03173963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982447|NCT05507229|Vaccines|vaccines|mesh-list
91982448|NCT05507229|Immunologic Factors|immunologic factors|mesh-ancestor
91982449|NCT05507229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982450|NCT03173417|Cyclophosphamide|cyclophosphamide|mesh-list
91982451|NCT03173417|Fludarabine|fludarabine|mesh-list
91982452|NCT03173417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982453|NCT03173417|Immunologic Factors|immunologic factors|mesh-ancestor
91982454|NCT03173417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982455|NCT03173417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982456|NCT03173417|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91982457|NCT03173417|Alkylating Agents|alkylating agents|mesh-ancestor
91982458|NCT03173417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982459|NCT03173417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982460|NCT03173417|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91982461|NCT03173339|Remifentanil|remifentanil|mesh-list
91982462|NCT03173339|Sevoflurane|sevoflurane|mesh-list
91982463|NCT03173339|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91982464|NCT03173339|Narcotics|narcotics|mesh-ancestor
91982465|NCT03173339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982466|NCT03173339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982467|NCT03173339|Analgesics|analgesics|mesh-ancestor
91982468|NCT03173339|Sensory System Agents|sensory system agents|mesh-ancestor
91982469|NCT03173339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982470|NCT03173339|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982471|NCT03173339|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91982472|NCT03173339|Anesthetics, General|anesthetics, general|mesh-ancestor
91982473|NCT03173339|Anesthetics|anesthetics|mesh-ancestor
91982474|NCT03172871|Aripiprazole|aripiprazole|mesh-list
91982475|NCT03172871|Antidepressive Agents|antidepressive agents|mesh-ancestor
91982476|NCT03172871|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91982482|NCT03172871|Dopamine Agents|dopamine agents|mesh-ancestor
91982483|NCT03172871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982484|NCT03172871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982485|NCT03172871|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91982486|NCT03172871|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91982487|NCT03172871|Serotonin Agents|serotonin agents|mesh-ancestor
91982488|NCT03172871|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91982489|NCT03172871|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91982490|NCT03172871|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91982491|NCT03172871|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91982492|NCT02065336|Chlorpheniramine|chlorpheniramine|mesh-list
91982493|NCT02065336|Entecavir|entecavir|mesh-list
91982494|NCT02065336|Antiviral Agents|antiviral agents|mesh-ancestor
91982495|NCT02065336|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982496|NCT02065336|Antipruritics|antipruritics|mesh-ancestor
91982497|NCT02065336|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982498|NCT02065336|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91982499|NCT02065336|Histamine Antagonists|histamine antagonists|mesh-ancestor
91982500|NCT02065336|Histamine Agents|histamine agents|mesh-ancestor
91982501|NCT02065336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969769|NCT03195673|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91969771|NCT03195673|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91969772|NCT03195673|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969773|NCT03195673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982502|NCT02065336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982503|NCT02065336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982504|NCT02065336|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91982505|NCT02408003|Simendan|simendan|mesh-list
91982506|NCT02408003|Milrinone|milrinone|mesh-list
91982507|NCT02408003|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91982508|NCT02408003|Vasodilator Agents|vasodilator agents|mesh-ancestor
91982509|NCT02408003|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91982510|NCT02408003|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91982511|NCT02408003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982512|NCT02408003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982513|NCT02408003|Protective Agents|protective agents|mesh-ancestor
91982514|NCT02408003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982515|NCT02408003|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982516|NCT05518929|Propofol|propofol|mesh-list
91982517|NCT05518929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982518|NCT05518929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982519|NCT05518929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982520|NCT05518929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91982521|NCT05518929|Anesthetics, General|anesthetics, general|mesh-ancestor
91982522|NCT05518929|Anesthetics|anesthetics|mesh-ancestor
91982523|NCT02406911|Ticagrelor|ticagrelor|mesh-list
91982524|NCT02406911|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982525|NCT02406911|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91982526|NCT02406911|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91982527|NCT02406911|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91982528|NCT02406911|Purinergic Agents|purinergic agents|mesh-ancestor
91982529|NCT02406911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982530|NCT02406911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982531|NCT02406911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982532|NCT03172793|Telavancin|telavancin|mesh-list
91982533|NCT03172793|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91982534|NCT03172793|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982535|NCT03116087|Methyltestosterone|methyltestosterone|mesh-list
91982536|NCT03116087|Testosterone|testosterone|mesh-list
91982537|NCT03116087|Testosterone undecanoate|testosterone undecanoate|mesh-list
91982538|NCT03116087|Testosterone enanthate|testosterone enanthate|mesh-list
91982539|NCT03116087|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
91982540|NCT03116087|Androgens|androgens|mesh-ancestor
91982541|NCT03116087|Hormones|hormones|mesh-ancestor
92081628|NCT01392963|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91982542|NCT03116087|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982543|NCT03116087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982553|NCT02406521|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91982555|NCT02406521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982556|NCT02406287|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91982557|NCT02406287|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91982558|NCT02406053|Antioxidants|antioxidants|mesh-list
91982559|NCT02406053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982560|NCT02406053|Protective Agents|protective agents|mesh-ancestor
91982561|NCT02406053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982562|NCT02064166|Insulin|insulin|mesh-list
91982563|NCT02064166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982564|NCT02064166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982565|NCT03171623|Globalagliatin|globalagliatin|mesh-list
91982566|NCT03171623|Enzyme Activators|enzyme activators|mesh-ancestor
91982567|NCT03171623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982568|NCT03171389|Ponatinib|ponatinib|mesh-list
91982569|NCT03171389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982570|NCT03171389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91982571|NCT03171389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982572|NCT03171389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969774|NCT03195673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982573|NCT05508633|Mebeverine|mebeverine|mesh-list
91982574|NCT05508633|Alverine|alverine|mesh-list
91982575|NCT05508633|Parasympatholytics|parasympatholytics|mesh-ancestor
91982576|NCT05508633|Autonomic Agents|autonomic agents|mesh-ancestor
91982577|NCT05508633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982578|NCT05508633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982579|NCT05508633|Anticonvulsants|anticonvulsants|mesh-ancestor
91982580|NCT04482257|Irinotecan|irinotecan|mesh-list
91982581|NCT04482257|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91982582|NCT04482257|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91982583|NCT04482257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982584|NCT04482257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982585|NCT04482257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982586|NCT05502705|Lidocaine|lidocaine|mesh-list
91982587|NCT05502705|Anesthetics, Local|anesthetics, local|mesh-ancestor
91982588|NCT05502705|Anesthetics|anesthetics|mesh-ancestor
91982589|NCT05502705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982590|NCT05502705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982591|NCT05502705|Sensory System Agents|sensory system agents|mesh-ancestor
91982592|NCT05502705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982593|NCT05502705|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91982594|NCT05502705|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91982595|NCT05502705|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91982596|NCT05502705|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982597|NCT05502705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982598|NCT05506137|Pilocarpine|pilocarpine|mesh-list
91982599|NCT05506137|Miotics|miotics|mesh-ancestor
91982600|NCT05506137|Autonomic Agents|autonomic agents|mesh-ancestor
91982601|NCT05506137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982602|NCT05506137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982603|NCT05506137|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91982604|NCT05506137|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91982605|NCT05506137|Cholinergic Agents|cholinergic agents|mesh-ancestor
91982606|NCT05506137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982607|NCT05506137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982608|NCT04742283|Timolol|timolol|mesh-list
91982627|NCT04289805|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982628|NCT04289805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982629|NCT05505591|Cangrelor|cangrelor|mesh-list
91982630|NCT05505591|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91982631|NCT05505591|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91982632|NCT05505591|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91982633|NCT05505591|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91982634|NCT05505591|Purinergic Agents|purinergic agents|mesh-ancestor
91982635|NCT05505591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982817|NCT05016297|Antimalarials|antimalarials|mesh-ancestor
91982636|NCT05505591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982637|NCT05505591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982638|NCT05448807|Phentolamine|phentolamine|mesh-list
91982639|NCT05448807|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91982640|NCT05448807|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91982641|NCT05448807|Adrenergic Agents|adrenergic agents|mesh-ancestor
91982642|NCT05448807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982643|NCT05448807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982644|NCT05448807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982645|NCT05448807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91982646|NCT01662999|Dapagliflozin|dapagliflozin|mesh-list
91982647|NCT01662999|Saxagliptin|saxagliptin|mesh-list
91982648|NCT01662999|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91982649|NCT01662999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982650|NCT01662999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982651|NCT01662999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982652|NCT01662999|Incretins|incretins|mesh-ancestor
91982653|NCT01662999|Hormones|hormones|mesh-ancestor
91982654|NCT01662999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982655|NCT01662999|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91982656|NCT01662999|Protease Inhibitors|protease inhibitors|mesh-ancestor
91982657|NCT01662999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982658|NCT05366283|Sargramostim|sargramostim|mesh-list
91982659|NCT05366283|Immunologic Factors|immunologic factors|mesh-ancestor
91969775|NCT03195673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969776|NCT03195673|Urological Agents|urological agents|mesh-ancestor
91969777|NCT02481791|Remifentanil|remifentanil|mesh-list
91982660|NCT05366283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982668|NCT02565381|Cholinergic Agents|cholinergic agents|mesh-ancestor
91982669|NCT02565381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982670|NCT02565381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982673|NCT02063854|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91982674|NCT02063854|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982675|NCT02063854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982676|NCT02063854|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91982677|NCT02063854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982678|NCT02063854|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91982679|NCT02063698|Auranofin|auranofin|mesh-list
91982680|NCT02063698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982681|NCT04701333|Cabergoline|cabergoline|mesh-list
91982682|NCT04701333|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91982683|NCT04701333|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91982684|NCT04701333|Dopamine Agonists|dopamine agonists|mesh-ancestor
91982685|NCT04701333|Dopamine Agents|dopamine agents|mesh-ancestor
91982686|NCT04701333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081629|NCT01392963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982687|NCT04701333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982688|NCT04701333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982689|NCT04701034|Prednisolone|prednisolone|mesh-list
91982690|NCT04701034|Immunoglobulins|immunoglobulins|mesh-list
91982691|NCT04701034|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91982692|NCT04701034|Antibodies|antibodies|mesh-list
91982693|NCT04701034|gamma-Globulins|gamma-globulins|mesh-list
91982694|NCT04701034|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91982695|NCT04701034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982696|NCT04701034|Glucocorticoids|glucocorticoids|mesh-ancestor
91982697|NCT04701034|Hormones|hormones|mesh-ancestor
91982698|NCT04701034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982699|NCT04701034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982700|NCT04701034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91982701|NCT04701034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982702|NCT04701034|Immunologic Factors|immunologic factors|mesh-ancestor
91982703|NCT01663623|Azathioprine|azathioprine|mesh-list
91982704|NCT01663623|Belimumab|belimumab|mesh-list
91982705|NCT01663623|Antimetabolites|antimetabolites|mesh-ancestor
91982706|NCT01663623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982707|NCT01663623|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91982708|NCT01663623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982709|NCT01663623|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982710|NCT01663623|Immunologic Factors|immunologic factors|mesh-ancestor
91982711|NCT01663623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982712|NCT01663623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982713|NCT04582305|Bleomycin|bleomycin|mesh-list
91982714|NCT04582305|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91982715|NCT04582305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982716|NCT05504967|Dexamethasone|dexamethasone|mesh-list
91982717|NCT05504967|Ropivacaine|ropivacaine|mesh-list
91982718|NCT05504967|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982719|NCT05504967|Antiemetics|antiemetics|mesh-ancestor
91982720|NCT05504967|Autonomic Agents|autonomic agents|mesh-ancestor
91982721|NCT05504967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982722|NCT05504967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982723|NCT05504967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982724|NCT05504967|Glucocorticoids|glucocorticoids|mesh-ancestor
91982725|NCT05504967|Hormones|hormones|mesh-ancestor
91982726|NCT05504967|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982727|NCT05504967|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91982756|NCT02061280|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91982757|NCT02061280|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91982758|NCT02061280|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91982759|NCT02061280|Adrenergic Agents|adrenergic agents|mesh-ancestor
91982760|NCT02061280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982761|NCT02061280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982762|NCT02061280|Glucocorticoids|glucocorticoids|mesh-ancestor
91982763|NCT02061280|Hormones|hormones|mesh-ancestor
91969779|NCT02481791|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91969780|NCT02481791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969781|NCT02481791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969782|NCT02481791|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91969783|NCT02481791|Anesthetics, General|anesthetics, general|mesh-ancestor
91982764|NCT02061280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982765|NCT02061280|Sympathomimetics|sympathomimetics|mesh-ancestor
91982766|NCT02061202|Mometasone Furoate|mometasone furoate|mesh-list
91982767|NCT02061202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982768|NCT02061202|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982769|NCT02061202|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91982770|NCT04664361|Niacinamide|niacinamide|mesh-list
91982771|NCT04664361|Niacin|niacin|mesh-list
91982772|NCT04664361|Nicotinic Acids|nicotinic acids|mesh-list
91982773|NCT04664361|Vitamin B Complex|vitamin b complex|mesh-ancestor
91982774|NCT04664361|Vitamins|vitamins|mesh-ancestor
91982775|NCT04664361|Micronutrients|micronutrients|mesh-ancestor
91982779|NCT04664361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982781|NCT04664361|Vasodilator Agents|vasodilator agents|mesh-ancestor
91982782|NCT04698850|Ranibizumab|ranibizumab|mesh-list
91982783|NCT04698850|Aflibercept|aflibercept|mesh-list
91982784|NCT04698850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91982785|NCT04698850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91982786|NCT04698850|Growth Substances|growth substances|mesh-ancestor
91982787|NCT04698850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982788|NCT04698850|Growth Inhibitors|growth inhibitors|mesh-ancestor
91982789|NCT04698850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982790|NCT04698226|Temazepam|temazepam|mesh-list
91982791|NCT04698226|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982792|NCT04698226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982793|NCT04698226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982794|NCT04698226|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91982795|NCT04698226|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91982796|NCT04698226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91982797|NCT04698226|GABA Modulators|gaba modulators|mesh-ancestor
91982798|NCT04698226|GABA Agents|gaba agents|mesh-ancestor
91982799|NCT04698226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982800|NCT04698226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982801|NCT05504577|Tranylcypromine|tranylcypromine|mesh-list
91982802|NCT05504577|Tranexamic Acid|tranexamic acid|mesh-list
91982803|NCT05504577|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91982804|NCT05504577|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91982805|NCT05504577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982806|NCT05504577|Hemostatics|hemostatics|mesh-ancestor
91982807|NCT05504577|Coagulants|coagulants|mesh-ancestor
91982808|NCT05504577|Antidepressive Agents|antidepressive agents|mesh-ancestor
91982809|NCT05504577|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91982810|NCT05504577|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91982811|NCT05504577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982812|NCT05504577|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91982813|NCT05504577|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91982814|NCT05504577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982815|NCT05504577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982816|NCT05016297|Hydroxychloroquine|hydroxychloroquine|mesh-list
91982818|NCT05016297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91982819|NCT05016297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91982820|NCT05016297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982821|NCT05016297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982822|NCT05016297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982823|NCT05016297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982824|NCT05504265|Flurbiprofen|flurbiprofen|mesh-list
91982825|NCT05504265|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
91982826|NCT05504265|Analgesics|analgesics|mesh-ancestor
91982827|NCT05504265|Sensory System Agents|sensory system agents|mesh-ancestor
91982828|NCT05504265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982829|NCT05504265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982830|NCT05504265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969784|NCT02481791|Anesthetics|anesthetics|mesh-ancestor
91969785|NCT02481791|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91969786|NCT02481791|Narcotics|narcotics|mesh-ancestor
91969787|NCT02481791|Analgesics|analgesics|mesh-ancestor
91969788|NCT02481791|Sensory System Agents|sensory system agents|mesh-ancestor
91982831|NCT05504265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91982832|NCT05504265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982833|NCT05504265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982834|NCT05504265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91982835|NCT05504265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982836|NCT05504265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982837|NCT01625338|Sofosbuvir|sofosbuvir|mesh-list
91982838|NCT01625338|Antiviral Agents|antiviral agents|mesh-ancestor
91982839|NCT01625338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982840|NCT04740099|Naloxone|naloxone|mesh-list
91982841|NCT04740099|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91982842|NCT04740099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982843|NCT04740099|Sensory System Agents|sensory system agents|mesh-ancestor
91982844|NCT04740099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982845|NCT02560389|Levodopa|levodopa|mesh-list
91982846|NCT02560389|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91982851|NCT02560389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982852|NCT02564211|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91982853|NCT02564211|Ipragliflozin|ipragliflozin|mesh-list
91982854|NCT02564211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982855|NCT02564211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982856|NCT02564211|Incretins|incretins|mesh-ancestor
91982857|NCT02564211|Hormones|hormones|mesh-ancestor
91982858|NCT02564211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982859|NCT02564211|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91982860|NCT02564211|Protease Inhibitors|protease inhibitors|mesh-ancestor
91982861|NCT02564211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982862|NCT02564211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982863|NCT02564211|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91982864|NCT04639245|Cyclophosphamide|cyclophosphamide|mesh-list
91982865|NCT04639245|Fludarabine|fludarabine|mesh-list
91982866|NCT04639245|Atezolizumab|atezolizumab|mesh-list
91982867|NCT04639245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91982868|NCT04639245|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91982869|NCT04639245|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982870|NCT04639245|Immunologic Factors|immunologic factors|mesh-ancestor
91982871|NCT04639245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982872|NCT04639245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982873|NCT04639245|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91982874|NCT04639245|Alkylating Agents|alkylating agents|mesh-ancestor
91982875|NCT04639245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982876|NCT04639245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982877|NCT04639245|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91982878|NCT04639245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91982879|NCT04596579|Antibodies|antibodies|mesh-list
91982880|NCT04596579|Immunologic Factors|immunologic factors|mesh-ancestor
91982881|NCT04596579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982882|NCT04465383|Propofol|propofol|mesh-list
91982883|NCT04465383|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91982884|NCT04465383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982885|NCT04465383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982886|NCT04465383|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91982887|NCT04465383|Anesthetics, General|anesthetics, general|mesh-ancestor
91982888|NCT04465383|Anesthetics|anesthetics|mesh-ancestor
91982889|NCT05500677|Lidocaine|lidocaine|mesh-list
91982890|NCT05500677|Fentanyl|fentanyl|mesh-list
91982891|NCT05500677|Tramadol|tramadol|mesh-list
91982892|NCT05500677|Anesthetics, Local|anesthetics, local|mesh-ancestor
91982893|NCT05500677|Anesthetics|anesthetics|mesh-ancestor
91982894|NCT05500677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982895|NCT05500677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982896|NCT05500677|Sensory System Agents|sensory system agents|mesh-ancestor
91982897|NCT05500677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982898|NCT05500677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91969789|NCT02481791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982899|NCT05500677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91982900|NCT05500677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91982901|NCT05500677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91982902|NCT05500677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982903|NCT05500677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91982904|NCT05500677|Narcotics|narcotics|mesh-ancestor
91982905|NCT05500677|Analgesics|analgesics|mesh-ancestor
91982906|NCT05500677|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91982907|NCT05500677|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91982908|NCT05500677|Anesthetics, General|anesthetics, general|mesh-ancestor
91982909|NCT02093026|Folic Acid|folic acid|mesh-list
91982910|NCT02093026|Methylprednisolone|methylprednisolone|mesh-list
91982911|NCT02093026|Rituximab|rituximab|mesh-list
91982912|NCT02093026|Methotrexate|methotrexate|mesh-list
91982913|NCT02093026|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91982914|NCT02093026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982915|NCT02093026|Immunologic Factors|immunologic factors|mesh-ancestor
91982916|NCT02093026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982917|NCT02093026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982922|NCT02093026|Antimetabolites|antimetabolites|mesh-ancestor
91982923|NCT02093026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982924|NCT02093026|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982925|NCT02093026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982926|NCT02093026|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91982927|NCT02093026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91982928|NCT02093026|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91982929|NCT02093026|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982930|NCT02093026|Antiemetics|antiemetics|mesh-ancestor
91982931|NCT02093026|Autonomic Agents|autonomic agents|mesh-ancestor
91982932|NCT02093026|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982933|NCT02093026|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91982934|NCT02093026|Glucocorticoids|glucocorticoids|mesh-ancestor
91982935|NCT02093026|Hormones|hormones|mesh-ancestor
91982936|NCT02093026|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982937|NCT02093026|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91982938|NCT02093026|Protective Agents|protective agents|mesh-ancestor
91982939|NCT02093026|Hematinics|hematinics|mesh-ancestor
91982940|NCT02093026|Vitamin B Complex|vitamin b complex|mesh-ancestor
91982941|NCT02093026|Vitamins|vitamins|mesh-ancestor
91982942|NCT02093026|Micronutrients|micronutrients|mesh-ancestor
91982943|NCT04697602|Colchicine|colchicine|mesh-list
91982944|NCT04697602|Febuxostat|febuxostat|mesh-list
91982945|NCT04697602|Gout Suppressants|gout suppressants|mesh-ancestor
91982946|NCT04697602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91982947|NCT04697602|Tubulin Modulators|tubulin modulators|mesh-ancestor
91982948|NCT04697602|Antimitotic Agents|antimitotic agents|mesh-ancestor
91982949|NCT04697602|Mitosis Modulators|mitosis modulators|mesh-ancestor
91982950|NCT04697602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982951|NCT04697602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982952|NCT02059174|Insulin Aspart|insulin aspart|mesh-list
91982953|NCT02059174|MK-1293|mk-1293|mesh-list
91982954|NCT02059174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982955|NCT02059174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982956|NCT02059174|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91982957|NCT02059174|Antimetabolites|antimetabolites|mesh-ancestor
91982958|NCT02059174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982959|NCT02059174|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91982960|NCT04417582|Liraglutide|liraglutide|mesh-list
91982961|NCT04417582|Orlistat|orlistat|mesh-list
91982962|NCT04417582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91982963|NCT04417582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982964|NCT04417582|Incretins|incretins|mesh-ancestor
91982965|NCT04417582|Hormones|hormones|mesh-ancestor
91982966|NCT04417582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982967|NCT04417582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982968|NCT04417582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982969|NCT04417582|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91982970|NCT04417582|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91982971|NCT02040766|Beclomethasone|beclomethasone|mesh-list
91982972|NCT02040766|Albuterol|albuterol|mesh-list
91982973|NCT02040766|Bronchodilator Agents|bronchodilator agents|mesh-list
91982974|NCT02040766|Autonomic Agents|autonomic agents|mesh-ancestor
91982975|NCT02040766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982976|NCT02040766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982977|NCT02040766|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91969790|NCT04484467|Menthol|menthol|mesh-list
91969791|NCT04484467|Antipruritics|antipruritics|mesh-ancestor
91969792|NCT04484467|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982978|NCT02040766|Respiratory System Agents|respiratory system agents|mesh-ancestor
91982979|NCT02040766|Tocolytic Agents|tocolytic agents|mesh-ancestor
91982980|NCT02040766|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982981|NCT02040766|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91982982|NCT02040766|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91982983|NCT02040766|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91982984|NCT02040766|Adrenergic Agents|adrenergic agents|mesh-ancestor
91982985|NCT02040766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982986|NCT02040766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982987|NCT02040766|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982988|NCT02040766|Glucocorticoids|glucocorticoids|mesh-ancestor
91982989|NCT02040766|Hormones|hormones|mesh-ancestor
91982995|NCT02040532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982997|NCT02040532|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91982998|NCT02040532|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91982999|NCT02040532|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983000|NCT02040532|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91983001|NCT02040532|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91983002|NCT02040532|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91983003|NCT02040532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983004|NCT02040532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983005|NCT02040532|Antimanic Agents|antimanic agents|mesh-ancestor
91983006|NCT02039908|Methylphenidate|methylphenidate|mesh-list
91983007|NCT02039908|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91983008|NCT02039908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983009|NCT02039908|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91983010|NCT02039908|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91983011|NCT02039908|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983012|NCT02039908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983013|NCT02039908|Dopamine Agents|dopamine agents|mesh-ancestor
91983014|NCT02039908|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983016|NCT04417348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983017|NCT04417348|Keratolytic Agents|keratolytic agents|mesh-ancestor
91983018|NCT04417348|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983019|NCT02058940|Exenatide|exenatide|mesh-list
91983020|NCT02058940|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91983021|NCT02058940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983022|NCT02058940|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91983023|NCT02058940|Incretins|incretins|mesh-ancestor
91983024|NCT02058940|Hormones|hormones|mesh-ancestor
91983025|NCT02058940|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983026|NCT02058628|Clindamycin|clindamycin|mesh-list
91983027|NCT02058628|Clindamycin palmitate|clindamycin palmitate|mesh-list
91983028|NCT02058628|Clindamycin phosphate|clindamycin phosphate|mesh-list
91983029|NCT02058628|Azelaic acid|azelaic acid|mesh-list
91983030|NCT02058628|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91983031|NCT02058628|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983032|NCT02058628|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91983033|NCT02058628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983034|NCT02058628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983035|NCT02058628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983036|NCT02058628|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983037|NCT02058160|Insulin|insulin|mesh-list
91983038|NCT02058160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91983039|NCT02058160|Metformin|metformin|mesh-list
91983040|NCT02058160|Insulin Glargine|insulin glargine|mesh-list
91983041|NCT02058160|Lixisenatide|lixisenatide|mesh-list
91983042|NCT02058160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91983043|NCT02058160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983044|NCT02090764|Ozenoxacin|ozenoxacin|mesh-list
91983045|NCT02090764|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91983046|NCT02090764|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983047|NCT02090764|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91983048|NCT02090764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983049|NCT02090764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983050|NCT02090764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983051|NCT02088034|Metformin|metformin|mesh-list
91983052|NCT02088034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91983663|NCT01918527|Antimetabolites|antimetabolites|mesh-ancestor
91983053|NCT02088034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969793|NCT03198169|Anti-Infective Agents|anti-infective agents|mesh-list
91969794|NCT03198169|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91969795|NCT02726399|Capecitabine|capecitabine|mesh-list
91969796|NCT02726399|Trastuzumab|trastuzumab|mesh-list
91983054|NCT02037256|Bortezomib|bortezomib|mesh-list
91983055|NCT02037256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983056|NCT02035696|Vaccines|vaccines|mesh-list
91983057|NCT02035696|Immunologic Factors|immunologic factors|mesh-ancestor
91983058|NCT02035696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983059|NCT02057458|Sildenafil Citrate|sildenafil citrate|mesh-list
91983060|NCT02057458|Vasodilator Agents|vasodilator agents|mesh-ancestor
91983063|NCT02057458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983064|NCT02057458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983065|NCT02057458|Urological Agents|urological agents|mesh-ancestor
91983066|NCT02087176|Antimitotic Agents|antimitotic agents|mesh-list
91983067|NCT02087176|Adavosertib|adavosertib|mesh-list
91983068|NCT02087176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983069|NCT02087176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983070|NCT02087176|Mitosis Modulators|mitosis modulators|mesh-ancestor
91983071|NCT02087176|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983072|NCT02056288|Fentanyl|fentanyl|mesh-list
91983073|NCT02056288|Ropivacaine|ropivacaine|mesh-list
91983074|NCT02056288|Anesthetics, Local|anesthetics, local|mesh-ancestor
91983075|NCT02056288|Anesthetics|anesthetics|mesh-ancestor
91983076|NCT02056288|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983077|NCT02056288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983078|NCT02056288|Sensory System Agents|sensory system agents|mesh-ancestor
91983079|NCT02056288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983080|NCT02056288|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91983081|NCT02056288|Narcotics|narcotics|mesh-ancestor
91983082|NCT02056288|Analgesics|analgesics|mesh-ancestor
91983083|NCT02056288|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91983084|NCT02056288|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91983085|NCT02056288|Anesthetics, General|anesthetics, general|mesh-ancestor
91983086|NCT03115697|Rifaximin|rifaximin|mesh-list
91983087|NCT03115697|Lactulose|lactulose|mesh-list
91983088|NCT03115697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91983089|NCT03115697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983090|NCT03115697|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983091|NCT03115775|Vitamin D|vitamin d|mesh-list
91983092|NCT03115775|Ergocalciferols|ergocalciferols|mesh-list
91983093|NCT03115775|Cholecalciferol|cholecalciferol|mesh-list
91983094|NCT03115775|Vitamins|vitamins|mesh-list
91983095|NCT03115775|Micronutrients|micronutrients|mesh-ancestor
91983096|NCT03115775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983097|NCT03115775|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91983098|NCT03115775|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91983099|NCT02404259|Ritonavir|ritonavir|mesh-list
91983100|NCT02404259|Lopinavir|lopinavir|mesh-list
91983101|NCT02404259|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91983102|NCT02404259|Tenofovir|tenofovir|mesh-list
91983103|NCT02404259|Efavirenz|efavirenz|mesh-list
91983104|NCT02404259|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91983105|NCT02404259|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91983106|NCT02404259|Protease Inhibitors|protease inhibitors|mesh-ancestor
91983107|NCT02404259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983108|NCT02404259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983109|NCT02404259|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91983110|NCT02404259|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91983111|NCT02404259|Antiviral Agents|antiviral agents|mesh-ancestor
91983112|NCT02404259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983113|NCT02404259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91983114|NCT02404259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91983115|NCT02404259|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91983116|NCT02404259|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91983117|NCT02404259|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91983118|NCT02404259|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91983119|NCT02404259|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91983120|NCT02404259|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91983121|NCT02404259|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91983122|NCT03170687|Calpastatin|calpastatin|mesh-list
91983123|NCT03170687|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
91983124|NCT03170687|Protease Inhibitors|protease inhibitors|mesh-ancestor
91983125|NCT03170687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969797|NCT02726399|Ramucirumab|ramucirumab|mesh-list
91969798|NCT02726399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969799|NCT02726399|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983126|NCT03170687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983127|NCT03169751|Caffeine|caffeine|mesh-list
91983128|NCT03169751|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91983129|NCT03169751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983130|NCT03169751|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91983131|NCT03169751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983132|NCT03169751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983136|NCT03169751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983138|NCT02403713|Xhance|xhance|mesh-list
91983139|NCT02403713|Formoterol Fumarate|formoterol fumarate|mesh-list
91983140|NCT02403713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983141|NCT02403713|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91983142|NCT02403713|Autonomic Agents|autonomic agents|mesh-ancestor
91983143|NCT02403713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983144|NCT02403713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983145|NCT02403713|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91983146|NCT02403713|Respiratory System Agents|respiratory system agents|mesh-ancestor
91983147|NCT02403713|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983148|NCT02403713|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91983149|NCT02403713|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91983150|NCT02403713|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91983151|NCT02403713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91983152|NCT02403713|Adrenergic Agents|adrenergic agents|mesh-ancestor
91983153|NCT02403713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983154|NCT02403713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983156|NCT02700815|Capsaicin|capsaicin|mesh-list
91983157|NCT02700815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91983158|NCT02700815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983159|NCT02700815|Analgesics|analgesics|mesh-ancestor
91983160|NCT02700815|Sensory System Agents|sensory system agents|mesh-ancestor
91983161|NCT02700815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983162|NCT02700815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983163|NCT02700815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983164|NCT02700815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983165|NCT02700815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91983166|NCT02700815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983167|NCT02700815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983168|NCT02700815|Antipruritics|antipruritics|mesh-ancestor
91983169|NCT02700815|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983170|NCT02403401|Levonorgestrel|levonorgestrel|mesh-list
91983171|NCT02403401|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91983172|NCT02403401|Contraceptive Agents|contraceptive agents|mesh-ancestor
91983173|NCT02403401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983174|NCT02403401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983175|NCT02403401|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91983176|NCT02403401|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91983177|NCT02403401|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91983178|NCT02402621|Fentanyl|fentanyl|mesh-list
91983179|NCT02402621|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91983180|NCT02402621|Narcotics|narcotics|mesh-ancestor
91983181|NCT02402621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983182|NCT02402621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983183|NCT02402621|Analgesics|analgesics|mesh-ancestor
91983184|NCT02402621|Sensory System Agents|sensory system agents|mesh-ancestor
91983185|NCT02402621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983186|NCT02402621|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91983187|NCT02402621|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91983189|NCT02402621|Anesthetics|anesthetics|mesh-ancestor
91983190|NCT04481789|Furosemide|furosemide|mesh-list
91983191|NCT04481789|Sildenafil Citrate|sildenafil citrate|mesh-list
91983192|NCT04481789|Edaravone|edaravone|mesh-list
91983193|NCT04481789|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91983194|NCT04481789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91983195|NCT04481789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91983196|NCT04481789|Antimetabolites|antimetabolites|mesh-ancestor
91983197|NCT04481789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969800|NCT02726399|Antimetabolites|antimetabolites|mesh-ancestor
91969801|NCT02726399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969802|NCT02726399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91969804|NCT02477969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91983198|NCT04481789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91983199|NCT04481789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91983200|NCT04481789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983201|NCT04481789|Vasodilator Agents|vasodilator agents|mesh-ancestor
91983202|NCT04481789|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91983203|NCT04481789|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91983204|NCT04481789|Urological Agents|urological agents|mesh-ancestor
91983231|NCT02402465|Histamine Antagonists|histamine antagonists|mesh-ancestor
91983232|NCT02402465|Histamine Agents|histamine agents|mesh-ancestor
91983233|NCT02402465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983234|NCT02402231|Omalizumab|omalizumab|mesh-list
91983235|NCT02402231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91983236|NCT02402231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91983237|NCT02402231|Respiratory System Agents|respiratory system agents|mesh-ancestor
91983238|NCT02402543|Acetaminophen|acetaminophen|mesh-list
91983239|NCT02402543|Dexamethasone|dexamethasone|mesh-list
91983240|NCT02402543|Ketamine|ketamine|mesh-list
91983241|NCT02402543|Gabapentin|gabapentin|mesh-list
91983242|NCT02402543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983243|NCT02402543|Antiemetics|antiemetics|mesh-ancestor
91983244|NCT02402543|Autonomic Agents|autonomic agents|mesh-ancestor
91983245|NCT02402543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983246|NCT02402543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983247|NCT02402543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983248|NCT02402543|Glucocorticoids|glucocorticoids|mesh-ancestor
91983249|NCT02402543|Hormones|hormones|mesh-ancestor
91983250|NCT02402543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983251|NCT02402543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983252|NCT02402543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983253|NCT02402543|Analgesics|analgesics|mesh-ancestor
91983254|NCT02402543|Sensory System Agents|sensory system agents|mesh-ancestor
91983271|NCT02401295|Itraconazole|itraconazole|mesh-list
91983272|NCT02401295|Celecoxib|celecoxib|mesh-list
91983273|NCT02401295|Tretinoin|tretinoin|mesh-list
91983274|NCT02401295|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91983275|NCT02401295|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983276|NCT02401295|Analgesics|analgesics|mesh-ancestor
91983277|NCT02401295|Sensory System Agents|sensory system agents|mesh-ancestor
91983278|NCT02401295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983279|NCT02401295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983280|NCT02401295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983281|NCT02401295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983282|NCT02401295|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91983283|NCT02401295|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91983284|NCT02401295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983285|NCT02401295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983286|NCT02401295|Antifungal Agents|antifungal agents|mesh-ancestor
91983287|NCT02401295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983288|NCT02401295|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91983289|NCT02401295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91983290|NCT02401295|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91983291|NCT02401295|Hormone Antagonists|hormone antagonists|mesh-ancestor
91983292|NCT02401295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983293|NCT02401295|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91983294|NCT02401295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983295|NCT02401295|Keratolytic Agents|keratolytic agents|mesh-ancestor
91983296|NCT02401295|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983297|NCT00708305|Listerine|listerine|mesh-list
91983298|NCT00708305|Fluorides|fluorides|mesh-list
91983299|NCT00708305|Sodium Fluoride|sodium fluoride|mesh-list
91983300|NCT00708305|Cariostatic Agents|cariostatic agents|mesh-ancestor
91983301|NCT00708305|Protective Agents|protective agents|mesh-ancestor
91983302|NCT00708305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983303|NCT00708305|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91969805|NCT02477969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983304|NCT00708305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983306|NCT03169127|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91983307|NCT03169127|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983308|NCT03169127|Analgesics|analgesics|mesh-ancestor
91983309|NCT03169127|Sensory System Agents|sensory system agents|mesh-ancestor
91983310|NCT03169127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983311|NCT03169127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983312|NCT03169127|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983321|NCT03115307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983322|NCT03115307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983323|NCT03115307|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91983324|NCT03115307|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983325|NCT03115307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983327|NCT02418533|Hormones|hormones|mesh-list
91983741|NCT01663233|Vasodilator Agents|vasodilator agents|mesh-ancestor
91983328|NCT02418533|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91983329|NCT02418533|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983330|NCT02418533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983331|NCT02418533|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91983332|NCT02418533|Fertility Agents|fertility agents|mesh-ancestor
91983333|NCT02418533|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983334|NCT02418065|Testosterone|testosterone|mesh-list
91983335|NCT02418065|Androgens|androgens|mesh-ancestor
91983336|NCT02418065|Hormones|hormones|mesh-ancestor
91983337|NCT02418065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983338|NCT02418065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983339|NCT05058443|Denosumab|denosumab|mesh-list
91983340|NCT05058443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91983341|NCT05058443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983343|NCT02400281|Fludarabine|fludarabine|mesh-list
91983344|NCT02400281|Fludarabine phosphate|fludarabine phosphate|mesh-list
91983345|NCT02400281|Etoposide|etoposide|mesh-list
91983346|NCT02400281|Etoposide phosphate|etoposide phosphate|mesh-list
91983347|NCT02400281|Azacitidine|azacitidine|mesh-list
91983348|NCT02400281|Mitoxantrone|mitoxantrone|mesh-list
91983349|NCT02400281|Idarubicin|idarubicin|mesh-list
91983350|NCT02400281|Crenolanib|crenolanib|mesh-list
91983351|NCT02400281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983352|NCT02400281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983353|NCT02400281|Antimetabolites|antimetabolites|mesh-ancestor
91983354|NCT02400281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983355|NCT02400281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91983356|NCT02400281|Immunologic Factors|immunologic factors|mesh-ancestor
91983357|NCT02400281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983358|NCT02400281|Antiviral Agents|antiviral agents|mesh-ancestor
91983359|NCT02400281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983360|NCT02400281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91983361|NCT02400281|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91983362|NCT02400281|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91983363|NCT02400281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983364|NCT02400281|Analgesics|analgesics|mesh-ancestor
91983365|NCT02400281|Sensory System Agents|sensory system agents|mesh-ancestor
91983366|NCT02400281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983367|NCT02400281|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91983368|NCT02055976|Ezetimibe|ezetimibe|mesh-list
91983369|NCT02055976|Bococizumab|bococizumab|mesh-list
91983370|NCT02055976|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91983371|NCT02055976|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91983373|NCT02055976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983374|NCT02055976|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91983375|NCT02055898|Sodium Oxybate|sodium oxybate|mesh-list
91983376|NCT02055898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91983377|NCT02055898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91983378|NCT02055898|Anesthetics, General|anesthetics, general|mesh-ancestor
91983379|NCT02055898|Anesthetics|anesthetics|mesh-ancestor
91983380|NCT02055898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983399|NCT04603911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983400|NCT04603911|Glucocorticoids|glucocorticoids|mesh-ancestor
91983401|NCT04603911|Hormones|hormones|mesh-ancestor
91983402|NCT04603911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983403|NCT04603911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983404|NCT04603911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969807|NCT03195205|Immunologic Factors|immunologic factors|mesh-ancestor
91969808|NCT03195205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969809|NCT03209011|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91969810|NCT03209011|Antiviral Agents|antiviral agents|mesh-ancestor
91969811|NCT03209011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969812|NCT02481323|Cilostazol|cilostazol|mesh-list
91969813|NCT02481323|Isosorbide|isosorbide|mesh-list
91969814|NCT02481323|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
91969815|NCT02481323|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91969816|NCT02481323|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91969817|NCT02481323|Autonomic Agents|autonomic agents|mesh-ancestor
91969818|NCT02481323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969819|NCT02481323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969820|NCT02481323|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91969821|NCT02481323|Respiratory System Agents|respiratory system agents|mesh-ancestor
91969822|NCT02481323|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91983405|NCT04603911|Anesthetics, Local|anesthetics, local|mesh-ancestor
91983406|NCT04603911|Anesthetics|anesthetics|mesh-ancestor
91983407|NCT04603911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983408|NCT04603911|Sensory System Agents|sensory system agents|mesh-ancestor
91983409|NCT04603911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91983410|NCT04603911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91983411|NCT04603911|Adrenergic Agents|adrenergic agents|mesh-ancestor
91983412|NCT04603911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983413|NCT04603911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983414|NCT04603911|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91983415|NCT04603911|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91983416|NCT04603911|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91983417|NCT04603911|Respiratory System Agents|respiratory system agents|mesh-ancestor
91983418|NCT04603911|Mydriatics|mydriatics|mesh-ancestor
91983419|NCT04603911|Sympathomimetics|sympathomimetics|mesh-ancestor
91983420|NCT04603911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91983421|NCT04603911|Analgesics|analgesics|mesh-ancestor
91983422|NCT04603911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91983423|NCT04603911|Sympatholytics|sympatholytics|mesh-ancestor
91983424|NCT04603911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91983426|NCT05498025|Antidotes|antidotes|mesh-ancestor
91983427|NCT05498025|Protective Agents|protective agents|mesh-ancestor
91983428|NCT05498025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983429|NCT03972111|Tecovirimat|tecovirimat|mesh-list
91983430|NCT03972111|Antiviral Agents|antiviral agents|mesh-ancestor
91983431|NCT03972111|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983432|NCT02699099|Vitamin A|vitamin a|mesh-list
91983433|NCT02699099|Vaccines|vaccines|mesh-list
91983434|NCT02699099|Immunologic Factors|immunologic factors|mesh-ancestor
91983435|NCT02699099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983436|NCT02699099|Vitamins|vitamins|mesh-ancestor
91983437|NCT02699099|Micronutrients|micronutrients|mesh-ancestor
91983438|NCT02400047|Dexamethasone|dexamethasone|mesh-list
91983439|NCT02400047|Dexamethasone acetate|dexamethasone acetate|mesh-list
91983454|NCT02400047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983455|NCT02400047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983456|NCT02400047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91983457|NCT02400047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983458|NCT02400047|Analgesics|analgesics|mesh-ancestor
91983459|NCT02400047|Sensory System Agents|sensory system agents|mesh-ancestor
91983460|NCT02400047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983461|NCT02400047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91983462|NCT02698865|Hyaluronic Acid|hyaluronic acid|mesh-list
91969823|NCT02481323|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91969824|NCT02481323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969825|NCT02481323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91969826|NCT02481323|Vasodilator Agents|vasodilator agents|mesh-ancestor
91969827|NCT02481323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91969828|NCT02481323|Protective Agents|protective agents|mesh-ancestor
91969829|NCT02481323|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91983463|NCT02698865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91983464|NCT02698865|Immunologic Factors|immunologic factors|mesh-ancestor
91983465|NCT02698865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983466|NCT02698865|Viscosupplements|viscosupplements|mesh-ancestor
91983467|NCT02698865|Protective Agents|protective agents|mesh-ancestor
91983468|NCT05499897|Anesthetics|anesthetics|mesh-list
91983469|NCT05499897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983470|NCT05499897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983471|NCT02417207|Entecavir|entecavir|mesh-list
91983472|NCT02417207|Antiviral Agents|antiviral agents|mesh-ancestor
91983473|NCT02417207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983474|NCT02698475|Ustekinumab|ustekinumab|mesh-list
91983475|NCT02698475|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983476|NCT02399657|Dexamethasone|dexamethasone|mesh-list
91983477|NCT02399657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983478|NCT02399657|Antiemetics|antiemetics|mesh-ancestor
91983479|NCT02399657|Autonomic Agents|autonomic agents|mesh-ancestor
91983480|NCT02399657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983481|NCT02399657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983482|NCT02399657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983483|NCT02399657|Glucocorticoids|glucocorticoids|mesh-ancestor
91983484|NCT02399657|Hormones|hormones|mesh-ancestor
91983485|NCT02399657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983486|NCT02399657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983487|NCT02399657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983488|NCT02559687|Pembrolizumab|pembrolizumab|mesh-list
91983489|NCT02559687|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91983490|NCT02559687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983491|NCT02559687|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91983586|NCT03106571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91983492|NCT02559687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983493|NCT04278729|Apixaban|apixaban|mesh-list
91983494|NCT04278729|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91983495|NCT04278729|Antithrombins|antithrombins|mesh-ancestor
91983496|NCT04278729|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91983497|NCT04278729|Protease Inhibitors|protease inhibitors|mesh-ancestor
91983498|NCT04278729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983499|NCT04278729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983500|NCT04278729|Anticoagulants|anticoagulants|mesh-ancestor
91983501|NCT03177317|Dexamethasone|dexamethasone|mesh-list
91983519|NCT04480775|Methylprednisolone|methylprednisolone|mesh-list
91983520|NCT04480775|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91983521|NCT04480775|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91983522|NCT04480775|Prednisolone|prednisolone|mesh-list
91983523|NCT04480775|Prednisolone acetate|prednisolone acetate|mesh-list
91983524|NCT04480775|Triamcinolone|triamcinolone|mesh-list
91983525|NCT04480775|Bupivacaine|bupivacaine|mesh-list
91983526|NCT04480775|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91983527|NCT04480775|Prednisolone phosphate|prednisolone phosphate|mesh-list
91983528|NCT04480775|Anesthetics, Local|anesthetics, local|mesh-ancestor
91983529|NCT04480775|Anesthetics|anesthetics|mesh-ancestor
91983530|NCT04480775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983531|NCT04480775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983532|NCT04480775|Sensory System Agents|sensory system agents|mesh-ancestor
91983533|NCT04480775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983534|NCT04480775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983535|NCT04480775|Antiemetics|antiemetics|mesh-ancestor
91983536|NCT04480775|Autonomic Agents|autonomic agents|mesh-ancestor
91983537|NCT04480775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983538|NCT04480775|Glucocorticoids|glucocorticoids|mesh-ancestor
91983539|NCT04480775|Hormones|hormones|mesh-ancestor
91969831|NCT02481323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983540|NCT04480775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983541|NCT04480775|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91983542|NCT04480775|Protective Agents|protective agents|mesh-ancestor
91983543|NCT04480775|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983544|NCT04480775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983545|NCT02416817|Thrombin|thrombin|mesh-list
91983546|NCT02416817|Hemostatics|hemostatics|mesh-ancestor
91983547|NCT02416817|Coagulants|coagulants|mesh-ancestor
91983548|NCT02399189|Methotrexate|methotrexate|mesh-list
91983549|NCT02399189|Temozolomide|temozolomide|mesh-list
91983550|NCT02399189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983551|NCT02399189|Immunologic Factors|immunologic factors|mesh-ancestor
91983552|NCT02399189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983553|NCT02399189|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983554|NCT02399189|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91983555|NCT02399189|Abortifacient Agents|abortifacient agents|mesh-ancestor
91983556|NCT02399189|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983557|NCT02399189|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983558|NCT02399189|Antimetabolites|antimetabolites|mesh-ancestor
91983559|NCT02399189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983562|NCT02399189|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91983563|NCT02399189|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91983564|NCT02399189|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91983565|NCT02399189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91983566|NCT02399189|Alkylating Agents|alkylating agents|mesh-ancestor
91983567|NCT03176849|Vitamin D|vitamin d|mesh-list
91983568|NCT03176849|Ergocalciferols|ergocalciferols|mesh-list
91983569|NCT03176849|Cholecalciferol|cholecalciferol|mesh-list
91983570|NCT03176849|Vitamins|vitamins|mesh-list
91983571|NCT03176849|Micronutrients|micronutrients|mesh-ancestor
91983572|NCT03176849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983573|NCT03176849|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91983574|NCT03176849|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91983575|NCT03106571|Methamphetamine|methamphetamine|mesh-list
91983576|NCT03106571|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91983577|NCT03106571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983578|NCT03106571|Sympathomimetics|sympathomimetics|mesh-ancestor
91983579|NCT03106571|Autonomic Agents|autonomic agents|mesh-ancestor
91983580|NCT03106571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983581|NCT03106571|Dopamine Agents|dopamine agents|mesh-ancestor
91983582|NCT03106571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983583|NCT03106571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983584|NCT03106571|Adrenergic Agents|adrenergic agents|mesh-ancestor
91983585|NCT03106571|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91983587|NCT03106571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983588|NCT03106571|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91983589|NCT03177083|Interferons|interferons|mesh-list
91983590|NCT03177083|Interferon-beta|interferon-beta|mesh-list
91983591|NCT03177083|Interferon beta-1a|interferon beta-1a|mesh-list
91983592|NCT03177083|Interferon beta-1b|interferon beta-1b|mesh-list
91983593|NCT03177083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983594|NCT03177083|Antiviral Agents|antiviral agents|mesh-ancestor
91983595|NCT03177083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983596|NCT03177083|Immunologic Factors|immunologic factors|mesh-ancestor
91983597|NCT03177083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983598|NCT03177083|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91983599|NCT03629925|Carboplatin|carboplatin|mesh-list
91983600|NCT03629925|Gemcitabine|gemcitabine|mesh-list
91983601|NCT03629925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983602|NCT03629925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983603|NCT03629925|Antimetabolites|antimetabolites|mesh-ancestor
91983604|NCT03629925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983605|NCT02398487|Nicotine|nicotine|mesh-list
91983606|NCT02398487|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91983607|NCT02398487|Autonomic Agents|autonomic agents|mesh-ancestor
91983608|NCT02398487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983609|NCT02398487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983610|NCT02398487|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91969832|NCT02481323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91969833|NCT02481323|Diuretics|diuretics|mesh-ancestor
91969834|NCT02481323|Natriuretic Agents|natriuretic agents|mesh-ancestor
91983611|NCT02398487|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91983612|NCT02398487|Cholinergic Agents|cholinergic agents|mesh-ancestor
91983613|NCT02398487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983614|NCT02398487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983615|NCT03250299|Lisavanbulin|lisavanbulin|mesh-list
91983616|NCT03250299|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91983617|NCT03250299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983618|NCT03250299|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91983619|NCT03250299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983620|NCT02697617|Pioglitazone|pioglitazone|mesh-list
91983621|NCT02697617|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91983622|NCT02697617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983623|NCT02868567|4-Aminopyridine|4-aminopyridine|mesh-list
91983624|NCT02868567|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
91983625|NCT02868567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983626|NCT02868567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983627|NCT02396225|Voriconazole|voriconazole|mesh-list
91983628|NCT02396225|Antifungal Agents|antifungal agents|mesh-ancestor
91983629|NCT02396225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983630|NCT02396225|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91983631|NCT02396225|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91983636|NCT02396225|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983638|NCT02396225|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91983639|NCT04272801|Tamoxifen|tamoxifen|mesh-list
91983640|NCT04272801|Letrozole|letrozole|mesh-list
91983641|NCT04272801|Anastrozole|anastrozole|mesh-list
91983642|NCT04272801|Exemestane|exemestane|mesh-list
91983643|NCT04272801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983644|NCT04272801|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91983645|NCT04272801|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91983646|NCT04272801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983647|NCT04272801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983648|NCT04272801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91983649|NCT04272801|Hormone Antagonists|hormone antagonists|mesh-ancestor
91983650|NCT04272801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983651|NCT04272801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983652|NCT04272801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983653|NCT04272801|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91983654|NCT04272801|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91983655|NCT04272801|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91983656|NCT02396303|Carbetocin|carbetocin|mesh-list
91983657|NCT02396303|Oxytocics|oxytocics|mesh-ancestor
91983658|NCT02396303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983659|NCT02396303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983660|NCT01918527|Capecitabine|capecitabine|mesh-list
91983661|NCT01918527|Oxaliplatin|oxaliplatin|mesh-list
91983662|NCT01918527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983664|NCT01918527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983665|NCT01918527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983666|NCT04362111|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91983667|NCT04362111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983668|NCT02397863|Cannabidiol|cannabidiol|mesh-list
91983669|NCT02397863|Anticonvulsants|anticonvulsants|mesh-ancestor
91983670|NCT04058717|Nicotine|nicotine|mesh-list
91983671|NCT04058717|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91983672|NCT04058717|Autonomic Agents|autonomic agents|mesh-ancestor
91983673|NCT04058717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983674|NCT04058717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983675|NCT04058717|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91983676|NCT04058717|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91983677|NCT04058717|Cholinergic Agents|cholinergic agents|mesh-ancestor
91983678|NCT04058717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983679|NCT04058717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983680|NCT03168035|NC-4016|nc-4016|mesh-list
91983681|NCT03168035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983682|NCT02397395|Simeprevir|simeprevir|mesh-list
91983683|NCT02397395|Antiviral Agents|antiviral agents|mesh-ancestor
91969835|NCT02481323|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91969836|NCT03197779|Aspirin|aspirin|mesh-list
91983684|NCT02397395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983685|NCT02397395|Protease Inhibitors|protease inhibitors|mesh-ancestor
91983686|NCT02397395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983687|NCT02397395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983688|NCT02397551|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91983689|NCT02397551|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983690|NCT02397551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983691|NCT03168191|Menthol|menthol|mesh-list
91983692|NCT03168191|Nicotine|nicotine|mesh-list
91983693|NCT03168191|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91983694|NCT03168191|Autonomic Agents|autonomic agents|mesh-ancestor
91983695|NCT03168191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983696|NCT03168191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983697|NCT03168191|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91983698|NCT03168191|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91983699|NCT03168191|Cholinergic Agents|cholinergic agents|mesh-ancestor
91983700|NCT03168191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983706|NCT05496075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983708|NCT05496075|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91983709|NCT04280055|Psilocybin|psilocybin|mesh-list
91983710|NCT04280055|Hallucinogens|hallucinogens|mesh-ancestor
91983711|NCT04280055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983712|NCT04280055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91983713|NCT05499117|Fluoxetine|fluoxetine|mesh-list
91983714|NCT05499117|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91983715|NCT05499117|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91983716|NCT05499117|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983717|NCT05499117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983718|NCT05499117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983719|NCT05499117|Serotonin Agents|serotonin agents|mesh-ancestor
91983720|NCT05499117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983721|NCT05499117|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91983722|NCT05499117|Antidepressive Agents|antidepressive agents|mesh-ancestor
91983723|NCT05499117|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91983724|NCT05499117|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91983725|NCT05499117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91983726|NCT05499117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983727|NCT04311723|Anesthetics|anesthetics|mesh-list
91983728|NCT04311723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983729|NCT04311723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983730|NCT05498337|Calcium|calcium|mesh-list
91983731|NCT05498337|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91983732|NCT05498337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983733|NCT01663233|Amlodipine|amlodipine|mesh-list
91983734|NCT01663233|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91983735|NCT01663233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91983736|NCT01663233|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91983737|NCT01663233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983738|NCT01663233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983739|NCT01663233|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91983740|NCT01663233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983742|NCT01663233|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91983743|NCT05494281|Anesthetics|anesthetics|mesh-list
91983744|NCT05494281|Anesthetics, Local|anesthetics, local|mesh-list
91983745|NCT05494281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983746|NCT05494281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983747|NCT05494281|Sensory System Agents|sensory system agents|mesh-ancestor
91983748|NCT05494281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983749|NCT05494047|Vaccines|vaccines|mesh-list
91983750|NCT05494047|Immunologic Factors|immunologic factors|mesh-ancestor
91983751|NCT05494047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983752|NCT05493969|Lamivudine|lamivudine|mesh-list
91983753|NCT05493969|Dolutegravir|dolutegravir|mesh-list
91983754|NCT05493969|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91983755|NCT05493969|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91983756|NCT05493969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983757|NCT05493969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969837|NCT03197779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969839|NCT03197779|Analgesics|analgesics|mesh-ancestor
91969840|NCT03197779|Sensory System Agents|sensory system agents|mesh-ancestor
91983758|NCT05493969|Antiviral Agents|antiviral agents|mesh-ancestor
91983759|NCT05493969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983760|NCT05493969|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91983761|NCT05493969|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91983762|NCT05493969|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91983763|NCT05493969|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91983764|NCT05493657|Aspirin|aspirin|mesh-list
91983765|NCT05493657|Clopidogrel|clopidogrel|mesh-list
91983766|NCT05493657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91983772|NCT05493657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983773|NCT05493657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983774|NCT05493657|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91983775|NCT05493657|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91983776|NCT05493657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983777|NCT05493657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91983778|NCT05493657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91983779|NCT05493657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983780|NCT05493657|Antipyretics|antipyretics|mesh-ancestor
91983781|NCT05493657|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91983782|NCT05493657|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91983783|NCT05493657|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91983784|NCT05493657|Purinergic Agents|purinergic agents|mesh-ancestor
91983785|NCT05493657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983786|NCT05493267|Zoledronic Acid|zoledronic acid|mesh-list
91983787|NCT05493267|Interleukin-2|interleukin-2|mesh-list
91983788|NCT05493267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983789|NCT05493267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983790|NCT05493267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983791|NCT05493267|Analgesics|analgesics|mesh-ancestor
91983792|NCT05493267|Sensory System Agents|sensory system agents|mesh-ancestor
91983793|NCT05493267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983794|NCT05493267|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91983795|NCT05492565|Tenofovir|tenofovir|mesh-list
91983796|NCT05492565|Emtricitabine|emtricitabine|mesh-list
91983797|NCT05492565|Antiviral Agents|antiviral agents|mesh-ancestor
91983798|NCT05492565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983799|NCT05492565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91983800|NCT05492565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91983801|NCT05492565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983802|NCT05492565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983803|NCT05492565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91983804|NCT05492565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91983805|NCT05492487|Megestrol Acetate|megestrol acetate|mesh-list
91983806|NCT05492487|Levonorgestrel|levonorgestrel|mesh-list
91983807|NCT05492487|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91983808|NCT05492487|Contraceptive Agents|contraceptive agents|mesh-ancestor
91983809|NCT05492487|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91983810|NCT05492487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983811|NCT05492487|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91983812|NCT05492487|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91983813|NCT05492487|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91983814|NCT05492487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983815|NCT05492487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983816|NCT05492487|Appetite Stimulants|appetite stimulants|mesh-ancestor
91983817|NCT05492487|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91983818|NCT05492019|Doxycycline|doxycycline|mesh-list
91983819|NCT05492019|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91983820|NCT05492019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983821|NCT05492019|Antimalarials|antimalarials|mesh-ancestor
91983822|NCT05492019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91983823|NCT05492019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91983824|NCT05491785|Oxycodone|oxycodone|mesh-list
91983825|NCT05491785|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91983826|NCT05491785|Narcotics|narcotics|mesh-ancestor
91983827|NCT05491785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983828|NCT05491785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983829|NCT05491785|Analgesics|analgesics|mesh-ancestor
91969841|NCT03197779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969842|NCT03197779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969843|NCT03197779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969844|NCT03197779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91969845|NCT03197779|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91983831|NCT05491785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983832|NCT05484687|Anesthetics|anesthetics|mesh-list
91983833|NCT05484687|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983834|NCT05484687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983835|NCT05484375|Capecitabine|capecitabine|mesh-list
91983836|NCT05484375|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983843|NCT05480007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983844|NCT05480007|Incretins|incretins|mesh-ancestor
91983845|NCT05480007|Hormones|hormones|mesh-ancestor
91983846|NCT05480007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983847|NCT05480007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91983848|NCT05480007|Protease Inhibitors|protease inhibitors|mesh-ancestor
91983849|NCT05480007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983850|NCT05480007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983851|NCT05489601|Oxycodone|oxycodone|mesh-list
91983852|NCT05489601|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91983853|NCT05489601|Narcotics|narcotics|mesh-ancestor
91983854|NCT05489601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983855|NCT05489601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983856|NCT05489601|Analgesics|analgesics|mesh-ancestor
91983857|NCT05489601|Sensory System Agents|sensory system agents|mesh-ancestor
91983858|NCT05489601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983859|NCT04276155|Anticoagulants|anticoagulants|mesh-list
91983861|NCT05488899|Cadexomer iodine|cadexomer iodine|mesh-list
91983862|NCT05488899|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91983863|NCT05488899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983864|NCT05488899|Trace Elements|trace elements|mesh-ancestor
91983865|NCT05488899|Micronutrients|micronutrients|mesh-ancestor
91983866|NCT05488899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983867|NCT05483439|Cyclophosphamide|cyclophosphamide|mesh-list
91983868|NCT05483439|Carboplatin|carboplatin|mesh-list
91983869|NCT05483439|Docetaxel|docetaxel|mesh-list
91983870|NCT05483439|Trastuzumab|trastuzumab|mesh-list
91983871|NCT05483439|Epirubicin|epirubicin|mesh-list
91983872|NCT05483439|Pertuzumab|pertuzumab|mesh-list
91983873|NCT05483439|Antibodies|antibodies|mesh-list
91983874|NCT05483439|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91983875|NCT05483439|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91983876|NCT05483439|Immunologic Factors|immunologic factors|mesh-ancestor
91983877|NCT05483439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983878|NCT05483439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91983879|NCT05483439|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91983880|NCT05483439|Alkylating Agents|alkylating agents|mesh-ancestor
91983881|NCT05483439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983882|NCT05483439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983883|NCT05483439|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91983884|NCT05483439|Tubulin Modulators|tubulin modulators|mesh-ancestor
91983885|NCT05483439|Antimitotic Agents|antimitotic agents|mesh-ancestor
91983886|NCT05483439|Mitosis Modulators|mitosis modulators|mesh-ancestor
91983887|NCT05483439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91983888|NCT05483439|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91983889|NCT05483439|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91983890|NCT05483439|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91983891|NCT05483439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983892|NCT03748095|Tazobactam|tazobactam|mesh-list
91983893|NCT03748095|Piperacillin|piperacillin|mesh-list
91983894|NCT03748095|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91983895|NCT03748095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983896|NCT03748095|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91983897|NCT03748095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983898|NCT03748095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983899|NCT04275375|Anesthetics|anesthetics|mesh-list
91983900|NCT04275375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983901|NCT04275375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983902|NCT05488353|Disitamab vedotin|disitamab vedotin|mesh-list
91969846|NCT03197779|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91983903|NCT05488353|Immunoconjugates|immunoconjugates|mesh-ancestor
91983904|NCT05488353|Immunologic Factors|immunologic factors|mesh-ancestor
91983905|NCT05488353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983907|NCT04543071|Gemcitabine|gemcitabine|mesh-list
91983908|NCT04543071|Cemiplimab|cemiplimab|mesh-list
91983927|NCT05487885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983928|NCT05487885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91983929|NCT05487885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91983930|NCT05487885|Anesthetics, General|anesthetics, general|mesh-ancestor
91983931|NCT05487885|Anesthetics|anesthetics|mesh-ancestor
91983932|NCT05487885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983933|NCT05487885|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91983934|NCT05487885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91983935|NCT05487885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983936|NCT05487885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983937|NCT05487807|Nicotine|nicotine|mesh-list
91983938|NCT05487807|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91983939|NCT05487807|Autonomic Agents|autonomic agents|mesh-ancestor
91983940|NCT05487807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983941|NCT05487807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983942|NCT05487807|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91983943|NCT05487807|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91983944|NCT05487807|Cholinergic Agents|cholinergic agents|mesh-ancestor
91983945|NCT05487807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983946|NCT05487807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983947|NCT03602859|Niraparib|niraparib|mesh-list
91983948|NCT03602859|Dostarlimab|dostarlimab|mesh-list
91983949|NCT03602859|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91983950|NCT03602859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983951|NCT03602859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983952|NCT03602859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983953|NCT04274595|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
91983954|NCT04274595|Antiviral Agents|antiviral agents|mesh-ancestor
91983955|NCT04274595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983956|NCT05476731|Antifungal Agents|antifungal agents|mesh-list
91983957|NCT05476731|Clotrimazole|clotrimazole|mesh-list
91983958|NCT05476731|Miconazole|miconazole|mesh-list
91983959|NCT05476731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91983960|NCT05476731|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91983961|NCT05476731|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91983962|NCT05476731|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91983963|NCT05476731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983968|NCT05476731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983969|NCT05476731|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91983970|NCT05476731|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91983971|NCT05482113|Bupivacaine|bupivacaine|mesh-list
91983972|NCT05482113|Anesthetics, Local|anesthetics, local|mesh-ancestor
91983973|NCT05482113|Anesthetics|anesthetics|mesh-ancestor
91983974|NCT05482113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983975|NCT05482113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983976|NCT05482113|Sensory System Agents|sensory system agents|mesh-ancestor
91983977|NCT05482113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983978|NCT05481957|Vortioxetine|vortioxetine|mesh-list
91983979|NCT05481957|Antidepressive Agents|antidepressive agents|mesh-ancestor
91983980|NCT05481957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91983981|NCT05481957|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91983982|NCT05481957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91983983|NCT05481957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983984|NCT05481957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983985|NCT05481957|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91983986|NCT05481957|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91983987|NCT05481957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983988|NCT05481957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983989|NCT05481957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983990|NCT05481957|Serotonin Agents|serotonin agents|mesh-ancestor
91983991|NCT05481957|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91983992|NCT05481957|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91983993|NCT05481957|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91969847|NCT03197779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969848|NCT03197779|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91969849|NCT03197779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91969850|NCT03197779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983994|NCT05481957|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91983995|NCT05475561|Bupivacaine|bupivacaine|mesh-list
91983996|NCT05475561|Anesthetics, Local|anesthetics, local|mesh-ancestor
91983997|NCT05475561|Anesthetics|anesthetics|mesh-ancestor
91983998|NCT05475561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983999|NCT05475561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984000|NCT05475561|Sensory System Agents|sensory system agents|mesh-ancestor
91984001|NCT05475561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984003|NCT05476341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984004|NCT05476341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984005|NCT05476341|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91984006|NCT05476341|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91984007|NCT05476341|Growth Substances|growth substances|mesh-ancestor
91984008|NCT05476341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984009|NCT05476341|Growth Inhibitors|growth inhibitors|mesh-ancestor
91984010|NCT05481723|Norepinephrine|norepinephrine|mesh-list
91984011|NCT05481723|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91984012|NCT05481723|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91984013|NCT05481723|Adrenergic Agents|adrenergic agents|mesh-ancestor
91984014|NCT05481723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984015|NCT05481723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984016|NCT05481723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984017|NCT05481723|Sympathomimetics|sympathomimetics|mesh-ancestor
91984018|NCT05481723|Autonomic Agents|autonomic agents|mesh-ancestor
91984019|NCT05481723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984020|NCT05481723|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91984021|NCT04272021|Methylphenidate|methylphenidate|mesh-list
91984022|NCT04272021|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91984023|NCT04272021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984024|NCT04272021|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91984025|NCT04272021|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91984026|NCT04272021|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91984027|NCT04272021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984028|NCT04272021|Dopamine Agents|dopamine agents|mesh-ancestor
91984034|NCT03434769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984035|NCT03434769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984036|NCT03434769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984037|NCT03434769|Alkylating Agents|alkylating agents|mesh-ancestor
91984038|NCT03434769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984039|NCT03434769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984040|NCT03434769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91984041|NCT02697773|Tanezumab|tanezumab|mesh-list
91984042|NCT02697773|Analgesics|analgesics|mesh-ancestor
91984043|NCT02697773|Sensory System Agents|sensory system agents|mesh-ancestor
91984044|NCT02697773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984045|NCT02697773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984047|NCT02394821|Polihexanide|polihexanide|mesh-list
91984048|NCT02394821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984049|NCT02394821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984050|NCT02394821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91984051|NCT02394821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91984052|NCT02394821|Disinfectants|disinfectants|mesh-ancestor
91984053|NCT02394743|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91984054|NCT02394743|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984055|NCT02394743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984056|NCT05745857|Bevacizumab|bevacizumab|mesh-list
91984057|NCT05745857|Cetuximab|cetuximab|mesh-list
91984058|NCT05745857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984059|NCT05745857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984060|NCT05745857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91984061|NCT05745857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91984062|NCT05745857|Growth Substances|growth substances|mesh-ancestor
91969851|NCT03197779|Antipyretics|antipyretics|mesh-ancestor
91969852|NCT03197623|Alendronate|alendronate|mesh-list
91969853|NCT03197623|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91984063|NCT05745857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984064|NCT05745857|Growth Inhibitors|growth inhibitors|mesh-ancestor
91984065|NCT05745779|Vitamin D|vitamin d|mesh-list
91984066|NCT05745779|Vitamins|vitamins|mesh-list
91984067|NCT05745779|Vitamin B 12|vitamin b 12|mesh-list
91984068|NCT05745779|Hydroxocobalamin|hydroxocobalamin|mesh-list
91984069|NCT05745779|Micronutrients|micronutrients|mesh-ancestor
91984070|NCT05745779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984071|NCT05745779|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91984072|NCT05745779|Vitamin B Complex|vitamin b complex|mesh-ancestor
91984073|NCT05745779|Hematinics|hematinics|mesh-ancestor
91984074|NCT02394197|Chloroquine|chloroquine|mesh-list
91984075|NCT02394197|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
91984076|NCT02394197|Primaquine|primaquine|mesh-list
91984077|NCT02394197|Amebicides|amebicides|mesh-ancestor
91984078|NCT02394197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91984079|NCT02394197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91984080|NCT02394197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984081|NCT02394197|Antimalarials|antimalarials|mesh-ancestor
91984082|NCT02394197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984083|NCT02394197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91984084|NCT02394197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91984085|NCT02394197|Analgesics|analgesics|mesh-ancestor
91984086|NCT02394197|Sensory System Agents|sensory system agents|mesh-ancestor
91984087|NCT02394197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984088|NCT02394197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984089|NCT02394197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984090|NCT02394197|Filaricides|filaricides|mesh-ancestor
91984091|NCT02394197|Antinematodal Agents|antinematodal agents|mesh-ancestor
91984092|NCT02394197|Anthelmintics|anthelmintics|mesh-ancestor
91984093|NCT02394119|Rituximab|rituximab|mesh-list
91984094|NCT02394119|Ofatumumab|ofatumumab|mesh-list
91984095|NCT02394119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984096|NCT02394119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984097|NCT02394119|Immunologic Factors|immunologic factors|mesh-ancestor
91984098|NCT02394119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984099|NCT02394119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984100|NCT03167333|Hyaluronic Acid|hyaluronic acid|mesh-list
91984101|NCT03167333|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91984102|NCT03167333|Immunologic Factors|immunologic factors|mesh-ancestor
91984129|NCT05745467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91984130|NCT05745467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984131|NCT02393261|Dialysis Solutions|dialysis solutions|mesh-list
91984132|NCT02393261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91984133|NCT02693171|Dinutuximab|dinutuximab|mesh-list
91984134|NCT02693171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984135|NCT05745233|Pembrolizumab|pembrolizumab|mesh-list
91984136|NCT05745233|Nivolumab|nivolumab|mesh-list
91984137|NCT05745233|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984138|NCT05745233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984139|NCT05745233|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984140|NCT05745233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984141|NCT02392793|Irinotecan|irinotecan|mesh-list
91984142|NCT02392793|Temozolomide|temozolomide|mesh-list
91984143|NCT02392793|Talazoparib|talazoparib|mesh-list
91984144|NCT02392793|Lenograstim|lenograstim|mesh-list
91984145|NCT02392793|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91984146|NCT02392793|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91984147|NCT02392793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984148|NCT02392793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984149|NCT02392793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984150|NCT02392793|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91984151|NCT02392793|Immunologic Factors|immunologic factors|mesh-ancestor
91984162|NCT03167177|Nivolumab|nivolumab|mesh-list
91984163|NCT03167177|Avelumab|avelumab|mesh-list
91984164|NCT03167177|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91984165|NCT03167177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984166|NCT03167177|Tubulin Modulators|tubulin modulators|mesh-ancestor
91984167|NCT03167177|Antimitotic Agents|antimitotic agents|mesh-ancestor
91984168|NCT03167177|Mitosis Modulators|mitosis modulators|mesh-ancestor
91984169|NCT03167177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984170|NCT03167177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984171|NCT03167177|Immunologic Factors|immunologic factors|mesh-ancestor
91969854|NCT03197623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969856|NCT02449603|Exenatide|exenatide|mesh-list
91984172|NCT03167177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984173|NCT03167177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984174|NCT03167177|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984175|NCT03167177|Alkylating Agents|alkylating agents|mesh-ancestor
91984176|NCT03167177|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91984177|NCT03167177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984178|NCT03167177|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91984179|NCT03167177|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91984180|NCT03167177|Growth Substances|growth substances|mesh-ancestor
91984181|NCT03167177|Growth Inhibitors|growth inhibitors|mesh-ancestor
91984182|NCT03167177|Antimetabolites|antimetabolites|mesh-ancestor
91984183|NCT03167177|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91984184|NCT03167177|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984185|NCT03167177|Antidotes|antidotes|mesh-ancestor
91984186|NCT03167177|Protective Agents|protective agents|mesh-ancestor
91984187|NCT03167177|Vitamin B Complex|vitamin b complex|mesh-ancestor
91984188|NCT03167177|Vitamins|vitamins|mesh-ancestor
91984189|NCT03167177|Micronutrients|micronutrients|mesh-ancestor
91984190|NCT02392169|Methylphenidate|methylphenidate|mesh-list
91984191|NCT02392169|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91984192|NCT02392169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984193|NCT02392169|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91984194|NCT02392169|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91984195|NCT02392169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91984196|NCT02392169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984197|NCT02392169|Dopamine Agents|dopamine agents|mesh-ancestor
91984198|NCT02392169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984199|NCT03166865|Hyaluronic Acid|hyaluronic acid|mesh-list
91984200|NCT03166865|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91984201|NCT03166865|Immunologic Factors|immunologic factors|mesh-ancestor
91984202|NCT03166865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984203|NCT03166865|Viscosupplements|viscosupplements|mesh-ancestor
91984204|NCT03166865|Protective Agents|protective agents|mesh-ancestor
91984205|NCT03166787|Tadalafil|tadalafil|mesh-list
91984206|NCT03166787|Charcoal|charcoal|mesh-list
91984207|NCT03166787|Carbon Monoxide|carbon monoxide|mesh-list
91984208|NCT03166787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984209|NCT03166787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984210|NCT03166787|Protective Agents|protective agents|mesh-ancestor
91984211|NCT03166787|Vasodilator Agents|vasodilator agents|mesh-ancestor
91984212|NCT03166787|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91984213|NCT03166787|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91984214|NCT03166787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984215|NCT03166787|Urological Agents|urological agents|mesh-ancestor
91984216|NCT03166787|Antidotes|antidotes|mesh-ancestor
91984217|NCT03166787|Antimetabolites|antimetabolites|mesh-ancestor
91984218|NCT03166787|Gasotransmitters|gasotransmitters|mesh-ancestor
91984223|NCT03167957|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91984224|NCT03167957|Amebicides|amebicides|mesh-ancestor
91984225|NCT03167957|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91984226|NCT03167957|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91984227|NCT03167957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984228|NCT03167957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984229|NCT03167957|Antifungal Agents|antifungal agents|mesh-ancestor
91984230|NCT03166397|Cyclophosphamide|cyclophosphamide|mesh-list
91984231|NCT03166397|Nivolumab|nivolumab|mesh-list
91984232|NCT03166397|Fludarabine|fludarabine|mesh-list
91984233|NCT03166397|Ipilimumab|ipilimumab|mesh-list
91984234|NCT03166397|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984235|NCT03166397|Immunologic Factors|immunologic factors|mesh-ancestor
91984236|NCT03166397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984237|NCT03166397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984238|NCT03166397|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984239|NCT03166397|Alkylating Agents|alkylating agents|mesh-ancestor
91984240|NCT03166397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984241|NCT03166397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984242|NCT03166397|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91984243|NCT03166397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984244|NCT03166397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984245|NCT05745935|Oxytocin|oxytocin|mesh-list
91984246|NCT05745935|Oxytocics|oxytocics|mesh-ancestor
91969857|NCT02449603|Biphasic Insulins|biphasic insulins|mesh-list
91969858|NCT02449603|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
91984247|NCT05745935|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91984248|NCT05745935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984249|NCT02552121|Tisotumab vedotin|tisotumab vedotin|mesh-list
91984250|NCT02552121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984251|NCT02552121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984253|NCT02552355|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984254|NCT02552355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984255|NCT02551731|Cannabidiol|cannabidiol|mesh-list
91984256|NCT02551731|Anticonvulsants|anticonvulsants|mesh-ancestor
91984257|NCT04479657|Cefuroxime|cefuroxime|mesh-list
91984258|NCT04479657|Cefuroxime axetil|cefuroxime axetil|mesh-list
91984259|NCT04479657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984260|NCT04479657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984261|NCT05475873|Ondansetron|ondansetron|mesh-list
91984262|NCT05475873|Antiemetics|antiemetics|mesh-ancestor
91984263|NCT05475873|Autonomic Agents|autonomic agents|mesh-ancestor
91984264|NCT05475873|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984265|NCT05475873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984266|NCT05475873|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984267|NCT05475873|Antipruritics|antipruritics|mesh-ancestor
91984268|NCT05475873|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984269|NCT05475873|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91984270|NCT05475873|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91984271|NCT05475873|Serotonin Agents|serotonin agents|mesh-ancestor
91984272|NCT05475873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984273|NCT05475873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984275|NCT05471661|Anticoagulants|anticoagulants|mesh-ancestor
91984276|NCT05471661|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91984277|NCT05471661|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91984278|NCT05471661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984279|NCT05480631|Mitogens|mitogens|mesh-list
91984280|NCT05480631|Mitosis Modulators|mitosis modulators|mesh-ancestor
91984281|NCT05480631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984282|NCT02542605|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
91984283|NCT02542605|Erenumab|erenumab|mesh-list
91984284|NCT02542605|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
91984285|NCT02542605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984286|NCT02542605|Analgesics|analgesics|mesh-ancestor
91984287|NCT02542605|Sensory System Agents|sensory system agents|mesh-ancestor
91984288|NCT02542605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984289|NCT02542605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984290|NCT02542605|Growth Substances|growth substances|mesh-ancestor
91984321|NCT03299049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984322|NCT03299049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984323|NCT03299049|Antiviral Agents|antiviral agents|mesh-ancestor
91984324|NCT03299049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984325|NCT03299049|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91984326|NCT03299049|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91984327|NCT03299049|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91984328|NCT03299049|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91984329|NCT02550795|Dexamethasone|dexamethasone|mesh-list
91984330|NCT02550795|Dexmedetomidine|dexmedetomidine|mesh-list
91984331|NCT02550795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984332|NCT02550795|Antiemetics|antiemetics|mesh-ancestor
91984333|NCT02550795|Autonomic Agents|autonomic agents|mesh-ancestor
91984334|NCT02550795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984335|NCT02550795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984336|NCT02550795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984337|NCT02550795|Glucocorticoids|glucocorticoids|mesh-ancestor
91984390|NCT02548455|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91984391|NCT02548455|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91984392|NCT05451615|Abatacept|abatacept|mesh-list
91984393|NCT05451615|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
91984394|NCT05451615|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984395|NCT05451615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984397|NCT05451615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969859|NCT02449603|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91969860|NCT02449603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969861|NCT02449603|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91969862|NCT02449603|Incretins|incretins|mesh-ancestor
91969863|NCT02449603|Hormones|hormones|mesh-ancestor
91969864|NCT02449603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969865|NCT02481479|Saxagliptin|saxagliptin|mesh-list
91969866|NCT02481479|Incretins|incretins|mesh-ancestor
91984398|NCT05451615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984399|NCT05451615|Immunologic Factors|immunologic factors|mesh-ancestor
91984400|NCT05451615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984401|NCT05451615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985310|NCT02388581|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91985311|NCT02388581|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91985312|NCT02387567|Lidocaine|lidocaine|mesh-list
91985313|NCT02387567|Anesthetics, Local|anesthetics, local|mesh-ancestor
91985314|NCT02387567|Anesthetics|anesthetics|mesh-ancestor
91985315|NCT02387567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985316|NCT02387567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985317|NCT02387567|Sensory System Agents|sensory system agents|mesh-ancestor
91985318|NCT02387567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985319|NCT02387567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91985320|NCT02387567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91985321|NCT02387567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91985322|NCT02387567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985323|NCT02387567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985324|NCT02383121|Midodrine|midodrine|mesh-list
91985325|NCT02383121|Sympathomimetics|sympathomimetics|mesh-ancestor
91985326|NCT02383121|Autonomic Agents|autonomic agents|mesh-ancestor
91985327|NCT02383121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985328|NCT02383121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985329|NCT02383121|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91985330|NCT02383121|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91985331|NCT02383121|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91985332|NCT02383121|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91985333|NCT02383121|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985334|NCT02383121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985335|NCT02383121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985336|NCT02387021|Ropivacaine|ropivacaine|mesh-list
91985337|NCT02387021|Anesthetics, Local|anesthetics, local|mesh-ancestor
91985338|NCT02387021|Anesthetics|anesthetics|mesh-ancestor
91985339|NCT02387021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985340|NCT02387021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985341|NCT02387021|Sensory System Agents|sensory system agents|mesh-ancestor
91985342|NCT02387021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985343|NCT02386943|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91985344|NCT02386943|Saxagliptin|saxagliptin|mesh-list
91985345|NCT02386943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91985346|NCT02386943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985347|NCT02386943|Incretins|incretins|mesh-ancestor
91985348|NCT02386943|Hormones|hormones|mesh-ancestor
91985349|NCT02386943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985350|NCT02386943|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91985351|NCT02386943|Protease Inhibitors|protease inhibitors|mesh-ancestor
91985352|NCT02386943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985353|NCT02386943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985354|NCT02084056|Metformin|metformin|mesh-list
91985355|NCT02084056|Linagliptin|linagliptin|mesh-list
91985356|NCT02084056|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91985357|NCT02084056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985358|NCT02084056|Incretins|incretins|mesh-ancestor
91985359|NCT02084056|Hormones|hormones|mesh-ancestor
91985360|NCT02084056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985361|NCT02084056|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91985362|NCT02084056|Protease Inhibitors|protease inhibitors|mesh-ancestor
91969867|NCT02481479|Hormones|hormones|mesh-ancestor
91969868|NCT02481479|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969869|NCT02481479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969870|NCT02481479|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91969871|NCT02481479|Protease Inhibitors|protease inhibitors|mesh-ancestor
91985364|NCT02084056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985365|NCT04714372|Cyclophosphamide|cyclophosphamide|mesh-list
91985366|NCT04714372|Fludarabine|fludarabine|mesh-list
91985367|NCT04714372|Daratumumab|daratumumab|mesh-list
91985368|NCT04714372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985369|NCT04714372|Immunologic Factors|immunologic factors|mesh-ancestor
91985370|NCT04714372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985371|NCT04714372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985372|NCT04714372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91985373|NCT04714372|Alkylating Agents|alkylating agents|mesh-ancestor
91985375|NCT04714372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985376|NCT04714372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91985377|NCT04787471|Riboflavin|riboflavin|mesh-list
91985378|NCT04787471|Vitamin B Complex|vitamin b complex|mesh-ancestor
91985379|NCT04787471|Vitamins|vitamins|mesh-ancestor
91985380|NCT04787471|Micronutrients|micronutrients|mesh-ancestor
91985381|NCT04787471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985382|NCT04787471|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91985383|NCT04787471|Dermatologic Agents|dermatologic agents|mesh-ancestor
91985384|NCT02386397|Gemcitabine|gemcitabine|mesh-list
91985385|NCT02386397|Oxaliplatin|oxaliplatin|mesh-list
91985386|NCT02386397|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91985387|NCT02386397|Antimetabolites|antimetabolites|mesh-ancestor
91985388|NCT02386397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985389|NCT02386397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985390|NCT02386475|Dexetimide|dexetimide|mesh-list
91985391|NCT02386475|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
91985392|NCT02386475|Citalopram|citalopram|mesh-list
91985394|NCT02386475|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91985395|NCT02386475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91985396|NCT02386475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985397|NCT02386475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985398|NCT02386475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985399|NCT02386475|Serotonin Agents|serotonin agents|mesh-ancestor
91985400|NCT02386475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985401|NCT02386475|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91985402|NCT02386475|Antidepressive Agents|antidepressive agents|mesh-ancestor
91985403|NCT02386475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91985404|NCT02386475|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91985405|NCT02386475|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91985406|NCT02386475|Parasympatholytics|parasympatholytics|mesh-ancestor
91985407|NCT02386475|Autonomic Agents|autonomic agents|mesh-ancestor
91985408|NCT02386475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985409|NCT02386475|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91985410|NCT02386475|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91985411|NCT02386475|Cholinergic Agents|cholinergic agents|mesh-ancestor
91985412|NCT02386475|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91985413|NCT02386475|Immunologic Factors|immunologic factors|mesh-ancestor
91985414|NCT02386475|Dopamine Agonists|dopamine agonists|mesh-ancestor
91985415|NCT02386475|Dopamine Agents|dopamine agents|mesh-ancestor
91985416|NCT05136443|Loteprednol Etabonate|loteprednol etabonate|mesh-list
91985417|NCT05136443|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91985418|NCT02382653|Piroxicam|piroxicam|mesh-list
91985419|NCT02382653|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91985420|NCT02382653|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91985421|NCT02382653|Analgesics|analgesics|mesh-ancestor
91985422|NCT02382653|Sensory System Agents|sensory system agents|mesh-ancestor
91985423|NCT02382653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985424|NCT02382653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985425|NCT02382653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985426|NCT02382653|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985427|NCT02382653|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91969872|NCT02481479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969873|NCT02481479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969874|NCT02481479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91969875|NCT03195049|Bilirubin|bilirubin|mesh-list
91969876|NCT03195049|Antioxidants|antioxidants|mesh-ancestor
91985428|NCT02382653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985429|NCT02382653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985430|NCT02382263|Paclitaxel|paclitaxel|mesh-list
91985431|NCT02382263|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91985432|NCT02382263|Gemcitabine|gemcitabine|mesh-list
91985433|NCT02382263|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91985434|NCT02382263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985435|NCT02382263|Tubulin Modulators|tubulin modulators|mesh-ancestor
91985436|NCT02382263|Antimitotic Agents|antimitotic agents|mesh-ancestor
91985437|NCT02382263|Mitosis Modulators|mitosis modulators|mesh-ancestor
91985438|NCT02382263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985439|NCT02382263|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91985440|NCT02382263|Antimetabolites|antimetabolites|mesh-ancestor
91985441|NCT02382029|Clonazepam|clonazepam|mesh-list
91985442|NCT02382029|Anticonvulsants|anticonvulsants|mesh-ancestor
91985443|NCT02382029|GABA Modulators|gaba modulators|mesh-ancestor
91985444|NCT02382029|GABA Agents|gaba agents|mesh-ancestor
91985445|NCT02382029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985446|NCT02382029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985447|NCT02382029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985452|NCT02385539|Levobupivacaine|levobupivacaine|mesh-list
91985453|NCT02385539|Anesthetics, Local|anesthetics, local|mesh-ancestor
91985454|NCT02385539|Anesthetics|anesthetics|mesh-ancestor
91985455|NCT02385539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985456|NCT02385539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985457|NCT02385539|Sensory System Agents|sensory system agents|mesh-ancestor
91985458|NCT02385539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985459|NCT02385461|Heparin|heparin|mesh-list
91985460|NCT02385461|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91985461|NCT02385461|Tinzaparin|tinzaparin|mesh-list
91985462|NCT02385461|Dalteparin|dalteparin|mesh-list
91985463|NCT02385461|Anticoagulants|anticoagulants|mesh-ancestor
91985464|NCT02385461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91985465|NCT02385461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91985466|NCT02385461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985468|NCT02381717|Bupivacaine|bupivacaine|mesh-list
91985469|NCT02381717|Anesthetics, Local|anesthetics, local|mesh-ancestor
91985470|NCT02381717|Anesthetics|anesthetics|mesh-ancestor
91985471|NCT02381717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985472|NCT02381717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985473|NCT02381717|Sensory System Agents|sensory system agents|mesh-ancestor
91985474|NCT02381717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985475|NCT02381717|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91985476|NCT02381717|Narcotics|narcotics|mesh-ancestor
91985477|NCT02381717|Analgesics|analgesics|mesh-ancestor
91985478|NCT02385305|Anesthetics|anesthetics|mesh-list
91985479|NCT02385305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985480|NCT02385305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985481|NCT02385227|Nicotine|nicotine|mesh-list
91985482|NCT02385227|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91985483|NCT02385227|Autonomic Agents|autonomic agents|mesh-ancestor
91985484|NCT02385227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985485|NCT02385227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985486|NCT02385227|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91985487|NCT02385227|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91985488|NCT02385227|Cholinergic Agents|cholinergic agents|mesh-ancestor
91985489|NCT02385227|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985490|NCT02385227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985491|NCT02381249|Octreotide|octreotide|mesh-list
91985492|NCT02381249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91985493|NCT02381249|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985494|NCT02381249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985495|NCT02385071|Simeprevir|simeprevir|mesh-list
91985496|NCT02385071|Antiviral Agents|antiviral agents|mesh-ancestor
91985497|NCT02385071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985498|NCT02385071|Protease Inhibitors|protease inhibitors|mesh-ancestor
91969877|NCT03195049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985500|NCT02385071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985501|NCT02384915|Prilocaine|prilocaine|mesh-list
91985502|NCT02384915|Mepivacaine|mepivacaine|mesh-list
91985503|NCT02384915|Anesthetics|anesthetics|mesh-ancestor
91985505|NCT02384915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985506|NCT02384915|Anesthetics, Local|anesthetics, local|mesh-ancestor
91985507|NCT02384915|Sensory System Agents|sensory system agents|mesh-ancestor
91985508|NCT02384915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985509|NCT04895735|Pembrolizumab|pembrolizumab|mesh-list
91985510|NCT04895735|Pemetrexed|pemetrexed|mesh-list
91985511|NCT04895735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985512|NCT04895735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985513|NCT04895735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91985514|NCT04895735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985515|NCT04895735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985516|NCT04895735|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91985517|NCT04895735|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91985518|NCT02384837|Sirolimus|sirolimus|mesh-list
91985519|NCT02384837|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91985520|NCT02384837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985523|NCT02384837|Antifungal Agents|antifungal agents|mesh-ancestor
91985524|NCT02384837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985525|NCT02384837|Immunologic Factors|immunologic factors|mesh-ancestor
91985526|NCT02384837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985527|NCT03105791|Analgesics, Opioid|analgesics, opioid|mesh-list
91985528|NCT03105791|Narcotics|narcotics|mesh-ancestor
91985529|NCT03105791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985530|NCT03105791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985531|NCT03105791|Analgesics|analgesics|mesh-ancestor
91985532|NCT03105791|Sensory System Agents|sensory system agents|mesh-ancestor
91985533|NCT03105791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985534|NCT02384135|Fibrin fragment D|fibrin fragment d|mesh-list
91985535|NCT02384135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91985536|NCT02384135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91985537|NCT02384135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985538|NCT02384135|Hemostatics|hemostatics|mesh-ancestor
91985539|NCT02384135|Coagulants|coagulants|mesh-ancestor
91985540|NCT02380625|Azithromycin|azithromycin|mesh-list
91985541|NCT02380625|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91985542|NCT02380625|Sunitinib|sunitinib|mesh-list
91985543|NCT02380625|Irbesartan|irbesartan|mesh-list
91985544|NCT02380625|Atorvastatin|atorvastatin|mesh-list
91985545|NCT02380625|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91985546|NCT02380625|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91985547|NCT02380625|Antimetabolites|antimetabolites|mesh-ancestor
91985548|NCT02380625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985549|NCT02380625|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91985550|NCT02380625|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91985551|NCT02380625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985552|NCT02380625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985553|NCT02380625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985554|NCT02380625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91985555|NCT02380625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985556|NCT02380625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91985557|NCT02380625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91985558|NCT02380625|Growth Substances|growth substances|mesh-ancestor
91985559|NCT02380625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985560|NCT02380625|Growth Inhibitors|growth inhibitors|mesh-ancestor
91985561|NCT02380625|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91985562|NCT02380625|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91985563|NCT02380625|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91985564|NCT02380313|Prednisone|prednisone|mesh-list
91985565|NCT02380313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985566|NCT02380313|Glucocorticoids|glucocorticoids|mesh-ancestor
91985567|NCT02380313|Hormones|hormones|mesh-ancestor
91985568|NCT02380313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985569|NCT02380313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985570|NCT02380313|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985571|NCT02380313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985572|NCT01625182|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
91969879|NCT03195049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969880|NCT03198013|Prednisolone|prednisolone|mesh-list
91985573|NCT01625182|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
91985574|NCT01625182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985575|NCT01625182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985576|NCT01625182|Immunologic Factors|immunologic factors|mesh-ancestor
91985577|NCT01625182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985578|NCT02383901|Methotrexate|methotrexate|mesh-list
91985579|NCT02383901|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91985580|NCT02383901|Abortifacient Agents|abortifacient agents|mesh-ancestor
91985581|NCT02383901|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91985582|NCT02383901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985583|NCT02383901|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91985584|NCT02383901|Antimetabolites|antimetabolites|mesh-ancestor
91985585|NCT02383901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985586|NCT02383901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985587|NCT02383901|Dermatologic Agents|dermatologic agents|mesh-ancestor
91985588|NCT02383901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985589|NCT02383901|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91985590|NCT02383901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985591|NCT02383901|Immunologic Factors|immunologic factors|mesh-ancestor
91985592|NCT02383901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985598|NCT02383823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985599|NCT02380001|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91985600|NCT02380001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91985601|NCT02380001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91985603|NCT02380001|Sensory System Agents|sensory system agents|mesh-ancestor
91985604|NCT02380001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985605|NCT02380001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985606|NCT02380001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985607|NCT02380001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985608|NCT02379767|Harmine|harmine|mesh-list
91985609|NCT02379767|Hallucinogens|hallucinogens|mesh-ancestor
91985610|NCT02379767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985611|NCT02379767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91985612|NCT02379767|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91985613|NCT02379767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985614|NCT02379767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985615|NCT02661815|Paclitaxel|paclitaxel|mesh-list
91985616|NCT02661815|Bevacizumab|bevacizumab|mesh-list
91985617|NCT02661815|Ricolinostat|ricolinostat|mesh-list
91985618|NCT02661815|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91985619|NCT02661815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985620|NCT02661815|Tubulin Modulators|tubulin modulators|mesh-ancestor
91985621|NCT02661815|Antimitotic Agents|antimitotic agents|mesh-ancestor
91985622|NCT02661815|Mitosis Modulators|mitosis modulators|mesh-ancestor
91985850|NCT02377661|Vasodilator Agents|vasodilator agents|mesh-ancestor
91985623|NCT02661815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985624|NCT02661815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985625|NCT02661815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91985626|NCT02661815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91985627|NCT02661815|Growth Substances|growth substances|mesh-ancestor
91985628|NCT02661815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985629|NCT02661815|Growth Inhibitors|growth inhibitors|mesh-ancestor
91985630|NCT02661815|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91985631|NCT02661815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985632|NCT02377193|Mycophenolic Acid|mycophenolic acid|mesh-list
91985633|NCT02377193|Tacrolimus|tacrolimus|mesh-list
91985634|NCT02377193|Basiliximab|basiliximab|mesh-list
91985635|NCT02377193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985636|NCT02377193|Immunologic Factors|immunologic factors|mesh-ancestor
91985637|NCT02377193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985638|NCT02377193|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91985639|NCT02377193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985640|NCT02377193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985641|NCT02377193|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91985642|NCT02377193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985643|NCT02377193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91985644|NCT02377193|Antitubercular Agents|antitubercular agents|mesh-ancestor
91985645|NCT02377193|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91969882|NCT03198013|Glucocorticoids|glucocorticoids|mesh-ancestor
91969883|NCT03198013|Hormones|hormones|mesh-ancestor
91985646|NCT02377193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985647|NCT04688021|Cytarabine|cytarabine|mesh-list
91985648|NCT04688021|Cyclosporine|cyclosporine|mesh-list
91985649|NCT04688021|Mycophenolic Acid|mycophenolic acid|mesh-list
91985650|NCT04688021|Cyclophosphamide|cyclophosphamide|mesh-list
91985651|NCT04688021|Busulfan|busulfan|mesh-list
91985652|NCT04688021|Cyclosporins|cyclosporins|mesh-list
91985653|NCT04688021|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91985654|NCT04688021|Thymoglobulin|thymoglobulin|mesh-list
91985655|NCT04688021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985656|NCT04688021|Immunologic Factors|immunologic factors|mesh-ancestor
91985657|NCT04688021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985658|NCT04688021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985659|NCT04688021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91985660|NCT04688021|Alkylating Agents|alkylating agents|mesh-ancestor
91985661|NCT04688021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985662|NCT04688021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985668|NCT04688021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985669|NCT04688021|Antifungal Agents|antifungal agents|mesh-ancestor
91985670|NCT04688021|Dermatologic Agents|dermatologic agents|mesh-ancestor
91985671|NCT04688021|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91985672|NCT04688021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91985673|NCT04688021|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91985674|NCT04688021|Antitubercular Agents|antitubercular agents|mesh-ancestor
91985675|NCT04688021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91985676|NCT02053246|Nebivolol|nebivolol|mesh-list
91985677|NCT02053246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91985678|NCT02053246|Vasodilator Agents|vasodilator agents|mesh-ancestor
91985679|NCT02053246|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
91985680|NCT02053246|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91985681|NCT02053246|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91985682|NCT02053246|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985683|NCT02053246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985684|NCT02053246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985685|NCT02053246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985686|NCT04678661|Insulin|insulin|mesh-list
91985687|NCT04678661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91985688|NCT04678661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985689|NCT02379299|Hormones|hormones|mesh-list
91985690|NCT02379299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985691|NCT02379299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985692|NCT02376881|Epoetin Alfa|epoetin alfa|mesh-list
91985693|NCT02376881|Hematinics|hematinics|mesh-ancestor
91985694|NCT02032888|Sofosbuvir|sofosbuvir|mesh-list
91985695|NCT02032888|Antiviral Agents|antiviral agents|mesh-ancestor
91985696|NCT02032888|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985697|NCT02376803|Warfarin|warfarin|mesh-list
91985698|NCT02376803|Anticoagulants|anticoagulants|mesh-ancestor
91985699|NCT04132427|Vancomycin|vancomycin|mesh-list
91985700|NCT04132427|Magnesium citrate|magnesium citrate|mesh-list
91985701|NCT04132427|Citric Acid|citric acid|mesh-list
91985702|NCT04132427|Sodium Citrate|sodium citrate|mesh-list
91985703|NCT04132427|Anticoagulants|anticoagulants|mesh-ancestor
91985704|NCT04132427|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91985705|NCT04132427|Chelating Agents|chelating agents|mesh-ancestor
91985706|NCT04132427|Sequestering Agents|sequestering agents|mesh-ancestor
91985707|NCT04132427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985708|NCT04132427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91985709|NCT04132427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985710|NCT04132427|Cathartics|cathartics|mesh-ancestor
91985711|NCT04132427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91985712|NCT02031640|Beclomethasone|beclomethasone|mesh-list
91985713|NCT02031640|Albuterol|albuterol|mesh-list
91985714|NCT02031640|Bronchodilator Agents|bronchodilator agents|mesh-list
91985715|NCT02031640|Autonomic Agents|autonomic agents|mesh-ancestor
91985716|NCT02031640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985717|NCT02031640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985718|NCT02031640|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91985719|NCT02031640|Respiratory System Agents|respiratory system agents|mesh-ancestor
91985720|NCT02031640|Tocolytic Agents|tocolytic agents|mesh-ancestor
91985721|NCT02031640|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91985722|NCT02031640|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91985723|NCT02031640|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91969884|NCT03198013|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985724|NCT02031640|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91985725|NCT02031640|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985726|NCT02031640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985727|NCT02031640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985728|NCT02031640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985729|NCT02031640|Glucocorticoids|glucocorticoids|mesh-ancestor
91985730|NCT02031640|Hormones|hormones|mesh-ancestor
91985731|NCT02031640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985732|NCT02376413|Trastuzumab|trastuzumab|mesh-list
91985733|NCT02376413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090426|NCT04416035|Tubulin Modulators|tubulin modulators|mesh-ancestor
91985736|NCT02378441|Atorvastatin|atorvastatin|mesh-list
91985737|NCT02378441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91985738|NCT02378441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985739|NCT02378441|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91985740|NCT02378441|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91985741|NCT02378441|Antimetabolites|antimetabolites|mesh-ancestor
91985742|NCT02378441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985743|NCT02378441|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91985744|NCT02378441|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91985745|NCT02378441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985746|NCT04072445|Trifluridine|trifluridine|mesh-list
91985747|NCT04072445|Irinotecan|irinotecan|mesh-list
91985748|NCT04072445|Camptothecin|camptothecin|mesh-list
91985749|NCT04072445|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91985751|NCT04072445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985752|NCT04072445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985753|NCT04072445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985754|NCT04072445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91985755|NCT04072445|Antimetabolites|antimetabolites|mesh-ancestor
91985756|NCT04072445|Antiviral Agents|antiviral agents|mesh-ancestor
91985757|NCT04072445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985758|NCT04600427|Anesthetics|anesthetics|mesh-list
91985759|NCT04600427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985760|NCT04600427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985761|NCT04595981|Cisplatin|cisplatin|mesh-list
91985762|NCT04595981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985763|NCT02378129|Methamphetamine|methamphetamine|mesh-list
91985764|NCT02378129|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91985765|NCT02378129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985766|NCT02378129|Sympathomimetics|sympathomimetics|mesh-ancestor
91985767|NCT02378129|Autonomic Agents|autonomic agents|mesh-ancestor
91985768|NCT02378129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985769|NCT02378129|Dopamine Agents|dopamine agents|mesh-ancestor
91985770|NCT02378129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985771|NCT02378129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985772|NCT02378129|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985773|NCT02378129|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91985774|NCT02378129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91985775|NCT02378129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985776|NCT02378129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91985777|NCT02376335|Rituximab|rituximab|mesh-list
91985778|NCT02376335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985779|NCT02376335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985780|NCT02376335|Immunologic Factors|immunologic factors|mesh-ancestor
91985781|NCT02376335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985782|NCT02376335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985783|NCT02375867|Methylprednisolone|methylprednisolone|mesh-list
91985784|NCT02375867|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91985785|NCT02375867|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91985786|NCT02375867|Prednisolone|prednisolone|mesh-list
91985787|NCT02375867|Prednisolone acetate|prednisolone acetate|mesh-list
91985788|NCT02375867|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91985789|NCT02375867|Prednisolone phosphate|prednisolone phosphate|mesh-list
91985790|NCT02375867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985791|NCT02375867|Antiemetics|antiemetics|mesh-ancestor
91985792|NCT02375867|Autonomic Agents|autonomic agents|mesh-ancestor
91985793|NCT02375867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985794|NCT02375867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985795|NCT02375867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91969885|NCT03198013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969886|NCT03198013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91969887|NCT03198013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969888|NCT05651399|Propofol|propofol|mesh-list
91969889|NCT05651399|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91969890|NCT05651399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985796|NCT02375867|Glucocorticoids|glucocorticoids|mesh-ancestor
91985797|NCT02375867|Hormones|hormones|mesh-ancestor
91985798|NCT02375867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985799|NCT02375867|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91985800|NCT02375867|Protective Agents|protective agents|mesh-ancestor
91985801|NCT02375867|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985802|NCT02375867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985803|NCT04540133|Dexamethasone|dexamethasone|mesh-list
91985804|NCT04540133|Dexamethasone acetate|dexamethasone acetate|mesh-list
91985805|NCT04540133|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91985806|NCT04540133|BB 1101|bb 1101|mesh-list
91985807|NCT04540133|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985811|NCT04540133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985812|NCT04540133|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91985813|NCT04540133|Glucocorticoids|glucocorticoids|mesh-ancestor
91985814|NCT04540133|Hormones|hormones|mesh-ancestor
91985815|NCT04540133|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985816|NCT04540133|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985817|NCT04540133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985818|NCT04540133|Protease Inhibitors|protease inhibitors|mesh-ancestor
91985819|NCT04540133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985820|NCT04540133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985821|NCT02375243|Dexmedetomidine|dexmedetomidine|mesh-list
91985822|NCT02375243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91985823|NCT02375243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985824|NCT02375243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985825|NCT02375243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91985826|NCT02375243|Analgesics|analgesics|mesh-ancestor
91985827|NCT02375243|Sensory System Agents|sensory system agents|mesh-ancestor
91985828|NCT02375243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985829|NCT02375243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91985830|NCT02375243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91985831|NCT02375243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91985832|NCT02375243|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985833|NCT02375243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985834|NCT02375243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985835|NCT02374931|Estradiol|estradiol|mesh-list
91985836|NCT02374931|Estrogens|estrogens|mesh-ancestor
91985837|NCT02374931|Hormones|hormones|mesh-ancestor
91985838|NCT02374931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985839|NCT02374931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985840|NCT02377661|Amlodipine|amlodipine|mesh-list
91985841|NCT02377661|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91985842|NCT02377661|Olmesartan|olmesartan|mesh-list
91985843|NCT02377661|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91985844|NCT02377661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91985845|NCT02377661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91985846|NCT02377661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985847|NCT02377661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985848|NCT02377661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91985849|NCT02377661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985851|NCT02377661|Diuretics|diuretics|mesh-ancestor
91985852|NCT02377661|Natriuretic Agents|natriuretic agents|mesh-ancestor
91985853|NCT02377661|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91985854|NCT02377661|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91985855|NCT02377661|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91985856|NCT02372357|Posaconazole|posaconazole|mesh-list
91985857|NCT02372357|Antifungal Agents|antifungal agents|mesh-ancestor
91985858|NCT02372357|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985859|NCT02372357|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91969891|NCT05651399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969892|NCT05651399|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91985860|NCT02372357|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91985861|NCT02372357|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91985862|NCT02372357|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91985863|NCT02372357|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91985864|NCT02372357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985865|NCT02372357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985866|NCT02372357|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91985867|NCT02372357|Hormone Antagonists|hormone antagonists|mesh-ancestor
91985868|NCT02372357|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985869|NCT02372357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985871|NCT03672773|Talazoparib|talazoparib|mesh-list
91985872|NCT03672773|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91985873|NCT03672773|Alkylating Agents|alkylating agents|mesh-ancestor
91985874|NCT03672773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985875|NCT03672773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985876|NCT03672773|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91985943|NCT03785249|Cetuximab|cetuximab|mesh-list
91985944|NCT03785249|Afatinib|afatinib|mesh-list
91985945|NCT03785249|Adagrasib|adagrasib|mesh-list
91985946|NCT03785249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985948|NCT03785249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91985949|NCT03785249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985950|NCT03785249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985951|NCT03785249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985952|NCT03765983|Trastuzumab|trastuzumab|mesh-list
91985953|NCT03765983|GDC-0084|gdc-0084|mesh-list
91985954|NCT03765983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985955|NCT03765983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985956|NCT03765983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985957|NCT03765983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985958|NCT02372903|Palmidrol|palmidrol|mesh-list
91985959|NCT02372903|Analgesics|analgesics|mesh-ancestor
91985960|NCT02372903|Sensory System Agents|sensory system agents|mesh-ancestor
91985961|NCT02372903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985962|NCT02372903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985963|NCT02372903|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91985964|NCT02372903|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91985965|NCT02372903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985966|NCT02372903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985967|NCT02372903|Antiviral Agents|antiviral agents|mesh-ancestor
91985968|NCT02372903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985969|NCT02372903|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91985970|NCT02372903|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91985971|NCT02372903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985972|NCT02372903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985973|NCT02372903|Hormones|hormones|mesh-ancestor
91985974|NCT02372903|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985975|NCT02372591|Buprenorphine|buprenorphine|mesh-list
91985976|NCT02372591|Hydromorphone|hydromorphone|mesh-list
91985977|NCT02372591|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91985978|NCT02372591|Narcotics|narcotics|mesh-ancestor
91985979|NCT02372591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985980|NCT02372591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985981|NCT02372591|Analgesics|analgesics|mesh-ancestor
91985982|NCT02372591|Sensory System Agents|sensory system agents|mesh-ancestor
91985983|NCT02372591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985984|NCT02372591|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91985985|NCT02372669|Chitosan|chitosan|mesh-list
91985986|NCT02372669|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91985987|NCT02372669|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91985988|NCT02372669|Antimetabolites|antimetabolites|mesh-ancestor
91985989|NCT02372669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985990|NCT02372669|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91985991|NCT02372669|Chelating Agents|chelating agents|mesh-ancestor
91985992|NCT02372669|Sequestering Agents|sequestering agents|mesh-ancestor
91985993|NCT02372669|Hemostatics|hemostatics|mesh-ancestor
91985994|NCT02372669|Coagulants|coagulants|mesh-ancestor
91985995|NCT02369861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91969893|NCT05651399|Anesthetics, General|anesthetics, general|mesh-ancestor
91969894|NCT05651399|Anesthetics|anesthetics|mesh-ancestor
91969895|NCT02477891|Daratumumab|daratumumab|mesh-list
91969896|NCT02477891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985996|NCT02369861|Lubricant Eye Drops|lubricant eye drops|mesh-list
91985997|NCT02369861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91985998|NCT02369939|Fluorouracil|fluorouracil|mesh-list
91986000|NCT02369939|Mitomycin|mitomycin|mesh-list
91986001|NCT02369939|Antimetabolites|antimetabolites|mesh-ancestor
91986002|NCT02369939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986003|NCT02369939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986004|NCT02369939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986005|NCT02369939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986006|NCT02369939|Immunologic Factors|immunologic factors|mesh-ancestor
91986007|NCT02369939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986008|NCT02369939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91986009|NCT02369939|Alkylating Agents|alkylating agents|mesh-ancestor
91986010|NCT02369939|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91986011|NCT02369939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986013|NCT02369549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986014|NCT02369549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986015|NCT02369549|Analgesics|analgesics|mesh-ancestor
91986016|NCT02369549|Sensory System Agents|sensory system agents|mesh-ancestor
91986017|NCT02369549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986018|NCT02369549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986019|NCT02369549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986020|NCT02369549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986022|NCT02369549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986023|NCT02369549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986024|NCT02365415|Sirolimus|sirolimus|mesh-list
91986025|NCT02365415|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986026|NCT02365415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986027|NCT02365415|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91986028|NCT02365415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986029|NCT02365415|Antifungal Agents|antifungal agents|mesh-ancestor
91986030|NCT02365415|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986031|NCT02365415|Immunologic Factors|immunologic factors|mesh-ancestor
91986032|NCT02365415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986033|NCT02369081|Bisoprolol|bisoprolol|mesh-list
91986034|NCT02369081|Doxazosin|doxazosin|mesh-list
91986035|NCT02369081|Spironolactone|spironolactone|mesh-list
91986036|NCT02369081|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91986037|NCT02369081|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986038|NCT02369081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986039|NCT02369081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986040|NCT02369081|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91986041|NCT02369081|Diuretics|diuretics|mesh-ancestor
91986042|NCT02369081|Natriuretic Agents|natriuretic agents|mesh-ancestor
91986043|NCT02369081|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91986044|NCT02369081|Sympatholytics|sympatholytics|mesh-ancestor
91986045|NCT02369081|Autonomic Agents|autonomic agents|mesh-ancestor
91986046|NCT02369081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986047|NCT02369081|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91986048|NCT02369081|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91986049|NCT02369081|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91986050|NCT02369081|Adrenergic Agents|adrenergic agents|mesh-ancestor
91986051|NCT02369081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986052|NCT02369081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986053|NCT02369081|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91986054|NCT02369081|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91986055|NCT02365493|Cefazolin|cefazolin|mesh-list
91986056|NCT02365493|Lactams|lactams|mesh-list
91986057|NCT02365493|beta-Lactams|beta-lactams|mesh-list
91986058|NCT02365493|Floxacillin|floxacillin|mesh-list
91986059|NCT02365493|Cloxacillin|cloxacillin|mesh-list
91986060|NCT02365493|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986061|NCT02365493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986062|NCT02365181|Ropivacaine|ropivacaine|mesh-list
91986063|NCT02365181|Anesthetics, Local|anesthetics, local|mesh-list
91986064|NCT02365181|Anesthetics|anesthetics|mesh-list
91986065|NCT02365181|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91969897|NCT02477813|Temozolomide|temozolomide|mesh-list
91969898|NCT02477813|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91969899|NCT02477813|Alkylating Agents|alkylating agents|mesh-ancestor
91969900|NCT02477813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969901|NCT02477813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986066|NCT02365181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986067|NCT02365181|Sensory System Agents|sensory system agents|mesh-ancestor
91986068|NCT02365181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986069|NCT05653895|Metformin|metformin|mesh-list
91986071|NCT05653895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91986072|NCT05653895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986073|NCT05653895|Antioxidants|antioxidants|mesh-ancestor
91986074|NCT05653895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986075|NCT05653895|Protective Agents|protective agents|mesh-ancestor
91986076|NCT05653895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986077|NCT05653895|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91986078|NCT02364479|Etanercept|etanercept|mesh-list
91986079|NCT02364479|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986080|NCT02364479|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986081|NCT02364479|Analgesics|analgesics|mesh-ancestor
91986082|NCT02364479|Sensory System Agents|sensory system agents|mesh-ancestor
91986083|NCT02364479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986084|NCT02364479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986085|NCT02364479|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986086|NCT02364479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986087|NCT02364479|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986088|NCT02364479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986089|NCT02364479|Immunologic Factors|immunologic factors|mesh-ancestor
91986090|NCT05653817|Paclitaxel|paclitaxel|mesh-list
91986091|NCT05653817|Apatinib|apatinib|mesh-list
91986092|NCT05653817|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91986093|NCT05653817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91986094|NCT05653817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986095|NCT05653817|Tubulin Modulators|tubulin modulators|mesh-ancestor
91986098|NCT05653817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986100|NCT05653817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986101|NCT02052310|Epoetin Alfa|epoetin alfa|mesh-list
91986102|NCT02052310|Hematinics|hematinics|mesh-ancestor
91986103|NCT02368379|Metyrapone|metyrapone|mesh-list
91986104|NCT02368379|Antimetabolites|antimetabolites|mesh-ancestor
91986105|NCT02368379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986106|NCT02368379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986107|NCT02051296|Minocycline|minocycline|mesh-list
91986108|NCT02051296|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986109|NCT02051296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986110|NCT02367755|Lorazepam|lorazepam|mesh-list
91986111|NCT02367755|Propofol|propofol|mesh-list
91986112|NCT02367755|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91986113|NCT02367755|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986114|NCT02367755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986115|NCT02367755|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91986116|NCT02367755|Anesthetics, General|anesthetics, general|mesh-ancestor
91986117|NCT02367755|Anesthetics|anesthetics|mesh-ancestor
91986118|NCT02367755|Anticonvulsants|anticonvulsants|mesh-ancestor
91986119|NCT02367755|Antiemetics|antiemetics|mesh-ancestor
91986120|NCT02367755|Autonomic Agents|autonomic agents|mesh-ancestor
91986121|NCT02367755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986122|NCT02367755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986123|NCT02367755|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91986124|NCT02367755|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91986125|NCT02367755|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986126|NCT02367755|GABA Modulators|gaba modulators|mesh-ancestor
91986127|NCT02367755|GABA Agents|gaba agents|mesh-ancestor
91986128|NCT02367755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986129|NCT02367755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986130|NCT02363699|Lidocaine|lidocaine|mesh-list
91986131|NCT02363699|Anesthetics, Local|anesthetics, local|mesh-ancestor
91986132|NCT02363699|Anesthetics|anesthetics|mesh-ancestor
91986133|NCT02363699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986134|NCT02363699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969902|NCT02480543|Misoprostol|misoprostol|mesh-list
91986135|NCT02363699|Sensory System Agents|sensory system agents|mesh-ancestor
91986136|NCT02363699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986137|NCT02363699|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91986138|NCT02363699|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91986139|NCT02363699|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91986140|NCT02363699|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986141|NCT02363699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986142|NCT02049814|Metformin|metformin|mesh-list
91986143|NCT02049814|Acarbose|acarbose|mesh-list
91986145|NCT02049814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91986146|NCT02049814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986147|NCT02049814|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91986148|NCT02049814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986149|NCT02049814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986151|NCT03344159|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91986152|NCT03344159|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986153|NCT03344159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986154|NCT03344159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986155|NCT03344159|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91986156|NCT03344159|Diuretics|diuretics|mesh-ancestor
91986157|NCT03344159|Natriuretic Agents|natriuretic agents|mesh-ancestor
91986158|NCT03324113|Diphenhydramine|diphenhydramine|mesh-list
91986159|NCT03324113|Promethazine|promethazine|mesh-list
91986160|NCT03324113|Dexamethasone|dexamethasone|mesh-list
91986161|NCT03324113|Naphazoline|naphazoline|mesh-list
91986162|NCT03324113|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91986163|NCT03324113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986164|NCT03324113|Antiemetics|antiemetics|mesh-ancestor
91986165|NCT03324113|Autonomic Agents|autonomic agents|mesh-ancestor
91986166|NCT03324113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986167|NCT03324113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986168|NCT03324113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986169|NCT03324113|Glucocorticoids|glucocorticoids|mesh-ancestor
91986182|NCT03324113|Histamine Antagonists|histamine antagonists|mesh-ancestor
91986183|NCT03324113|Histamine Agents|histamine agents|mesh-ancestor
91986184|NCT03324113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986185|NCT03324113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986186|NCT03324113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91986187|NCT03324113|Antipruritics|antipruritics|mesh-ancestor
91986188|NCT03324113|Dermatologic Agents|dermatologic agents|mesh-ancestor
91986189|NCT03324113|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91986190|NCT03324113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91986191|NCT03324113|Adrenergic Agents|adrenergic agents|mesh-ancestor
91986192|NCT03324113|Nasal Decongestants|nasal decongestants|mesh-ancestor
91986193|NCT03324113|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91986194|NCT03324113|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986195|NCT02079844|Antipsychotic Agents|antipsychotic agents|mesh-list
91986196|NCT02079844|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91986197|NCT02079844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986198|NCT02079844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986199|NCT02079844|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986200|NCT02363075|Dextroamphetamine|dextroamphetamine|mesh-list
91986201|NCT02363075|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91986202|NCT02363075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986203|NCT02363075|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91986204|NCT02363075|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91986205|NCT02363075|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986206|NCT02363075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986208|NCT02363075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986209|NCT02367053|Glucagon|glucagon|mesh-list
91986210|NCT02367053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986211|NCT02367053|Hormones|hormones|mesh-ancestor
91986212|NCT02367053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986213|NCT02367053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986214|NCT04417114|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91986215|NCT04417114|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91986216|NCT04417114|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91969903|NCT02480543|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91986217|NCT04417114|Antimetabolites|antimetabolites|mesh-ancestor
91986218|NCT04417114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986219|NCT04417114|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91986220|NCT04417114|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91986221|NCT04417114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986222|NCT02366975|Testosterone|testosterone|mesh-list
91986223|NCT02366975|Androgens|androgens|mesh-ancestor
91986224|NCT02366975|Hormones|hormones|mesh-ancestor
91986225|NCT02366975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986226|NCT02366975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986227|NCT04479371|Bupivacaine|bupivacaine|mesh-list
91986228|NCT04479371|Anesthetics, Local|anesthetics, local|mesh-ancestor
91986229|NCT04479371|Anesthetics|anesthetics|mesh-ancestor
91986244|NCT02366585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986245|NCT02366585|Antifungal Agents|antifungal agents|mesh-ancestor
91986246|NCT02366585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986247|NCT02366585|Dermatologic Agents|dermatologic agents|mesh-ancestor
91986248|NCT02366585|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986249|NCT02366585|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91986250|NCT02079532|Rituximab|rituximab|mesh-list
91986251|NCT02079532|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91986252|NCT02079532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986253|NCT02079532|Immunologic Factors|immunologic factors|mesh-ancestor
91986254|NCT02079532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986255|NCT02079532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986256|NCT02958917|Pirfenidone|pirfenidone|mesh-list
91986257|NCT02958917|Analgesics|analgesics|mesh-ancestor
91986258|NCT02958917|Sensory System Agents|sensory system agents|mesh-ancestor
91986259|NCT02958917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986260|NCT02958917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986261|NCT02958917|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986262|NCT02958917|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986263|NCT02958917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986264|NCT02958917|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986265|NCT02958917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986266|NCT02362529|Minocycline|minocycline|mesh-list
91986267|NCT02362529|Celecoxib|celecoxib|mesh-list
91986268|NCT02362529|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986269|NCT02362529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986270|NCT02362529|Analgesics|analgesics|mesh-ancestor
91986271|NCT02362529|Sensory System Agents|sensory system agents|mesh-ancestor
91986272|NCT02362529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986273|NCT02362529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986274|NCT02362529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986275|NCT02362529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986276|NCT02362529|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91986277|NCT02362529|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91986278|NCT02362529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986279|NCT02362529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986280|NCT02362529|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986281|NCT02362529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986282|NCT02794571|Paclitaxel|paclitaxel|mesh-list
91986283|NCT02794571|Etoposide|etoposide|mesh-list
91986284|NCT02794571|Bevacizumab|bevacizumab|mesh-list
91986285|NCT02794571|Carboplatin|carboplatin|mesh-list
91986286|NCT02794571|Pembrolizumab|pembrolizumab|mesh-list
91986287|NCT02794571|Capecitabine|capecitabine|mesh-list
91986288|NCT02794571|Pemetrexed|pemetrexed|mesh-list
91986289|NCT02794571|Atezolizumab|atezolizumab|mesh-list
91986290|NCT02794571|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91986303|NCT02794571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986304|NCT02794571|Antimetabolites|antimetabolites|mesh-ancestor
91986305|NCT02794571|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91986306|NCT02794571|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91986307|NCT02794571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986308|NCT02794571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91986309|NCT02794571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91986310|NCT02769689|Methylprednisolone|methylprednisolone|mesh-list
91986311|NCT02769689|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91986312|NCT02769689|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91986313|NCT02769689|Prednisolone|prednisolone|mesh-list
91986314|NCT02769689|Prednisolone acetate|prednisolone acetate|mesh-list
91986315|NCT02769689|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91986316|NCT02769689|Prednisolone phosphate|prednisolone phosphate|mesh-list
91969904|NCT02480543|Abortifacient Agents|abortifacient agents|mesh-ancestor
91969905|NCT02480543|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91969906|NCT02480543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969907|NCT02480543|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91969908|NCT02480543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91969909|NCT02480543|Oxytocics|oxytocics|mesh-ancestor
91986317|NCT02769689|Natalizumab|natalizumab|mesh-list
91986318|NCT02769689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986319|NCT02769689|Antiemetics|antiemetics|mesh-ancestor
91986320|NCT02769689|Autonomic Agents|autonomic agents|mesh-ancestor
91986321|NCT02769689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986322|NCT02769689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986323|NCT02769689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986324|NCT02769689|Glucocorticoids|glucocorticoids|mesh-ancestor
91986325|NCT02769689|Hormones|hormones|mesh-ancestor
91986326|NCT02769689|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986327|NCT02769689|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91986328|NCT02769689|Protective Agents|protective agents|mesh-ancestor
91986329|NCT02769689|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91986330|NCT02769689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986331|NCT02769689|Immunologic Factors|immunologic factors|mesh-ancestor
91986332|NCT02365571|Itraconazole|itraconazole|mesh-list
91986333|NCT02365571|Antifungal Agents|antifungal agents|mesh-ancestor
91986334|NCT02365571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986335|NCT02365571|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91986336|NCT02365571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986337|NCT02365571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986338|NCT02365571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986339|NCT02365571|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91986340|NCT02365571|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986341|NCT02365571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986342|NCT02365571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986343|NCT02365571|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91986344|NCT02365727|Clonidine|clonidine|mesh-list
91986345|NCT02365727|Epinephrine|epinephrine|mesh-list
91986346|NCT02365727|Bupivacaine|bupivacaine|mesh-list
91986347|NCT02365727|Ropivacaine|ropivacaine|mesh-list
91986348|NCT02365727|Anesthetics, Local|anesthetics, local|mesh-ancestor
91986349|NCT02365727|Anesthetics|anesthetics|mesh-ancestor
92090427|NCT04416035|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986360|NCT02365727|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91986361|NCT02365727|Autonomic Agents|autonomic agents|mesh-ancestor
91986362|NCT02365727|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91986363|NCT02365727|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986364|NCT02365727|Mydriatics|mydriatics|mesh-ancestor
91986365|NCT02365727|Sympathomimetics|sympathomimetics|mesh-ancestor
91986366|NCT02365727|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91986367|NCT02365727|Analgesics|analgesics|mesh-ancestor
91986368|NCT02365727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91986369|NCT02365727|Sympatholytics|sympatholytics|mesh-ancestor
91986370|NCT02365727|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91986372|NCT02365805|Docetaxel|docetaxel|mesh-list
91986373|NCT02365805|Fluorouracil|fluorouracil|mesh-list
91986375|NCT02365805|Cyclophosphamide|cyclophosphamide|mesh-list
91986376|NCT02365805|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91986377|NCT02365805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986378|NCT02365805|Tubulin Modulators|tubulin modulators|mesh-ancestor
91986379|NCT02365805|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986380|NCT02365805|Mitosis Modulators|mitosis modulators|mesh-ancestor
91986381|NCT02365805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986382|NCT02365805|Antimetabolites|antimetabolites|mesh-ancestor
91986383|NCT02365805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986384|NCT02365805|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986385|NCT02365805|Immunologic Factors|immunologic factors|mesh-ancestor
91986386|NCT02365805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986387|NCT02365805|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91986388|NCT02365805|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91986389|NCT02365805|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91986390|NCT02365805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969911|NCT03197233|Vitamins|vitamins|mesh-list
91969912|NCT03197233|Vitamin A|vitamin a|mesh-list
91969913|NCT03197233|Retinol palmitate|retinol palmitate|mesh-list
91969914|NCT03197233|Micronutrients|micronutrients|mesh-ancestor
91986391|NCT02365805|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986392|NCT02365805|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91986393|NCT02365805|Alkylating Agents|alkylating agents|mesh-ancestor
91986394|NCT02365805|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91986395|NCT03112889|Valproic Acid|valproic acid|mesh-list
91986396|NCT03112889|Anticonvulsants|anticonvulsants|mesh-ancestor
91986397|NCT03112889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986398|NCT03112889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986399|NCT03112889|GABA Agents|gaba agents|mesh-ancestor
91986400|NCT03112889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986401|NCT03112889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986402|NCT03112889|Antimanic Agents|antimanic agents|mesh-ancestor
91986403|NCT03112889|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91986404|NCT03112889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986405|NCT03112889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986406|NCT03112577|Fluticasone|fluticasone|mesh-list
91986408|NCT03112577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986409|NCT03112577|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91986410|NCT03112577|Autonomic Agents|autonomic agents|mesh-ancestor
91986411|NCT03112577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986412|NCT03112577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986413|NCT03112577|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91986414|NCT03112577|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986417|NCT02361905|Leuprolide|leuprolide|mesh-list
91986418|NCT02361905|Ulipristal acetate|ulipristal acetate|mesh-list
91986419|NCT02361905|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91986420|NCT02361905|Fertility Agents|fertility agents|mesh-ancestor
91986421|NCT02361905|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91986422|NCT02361905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986423|NCT02361905|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91986424|NCT02361905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986425|NCT02361905|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91986426|NCT02361905|Contraceptive Agents|contraceptive agents|mesh-ancestor
91986427|NCT02361905|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91986428|NCT02361749|Botulinum Toxins|botulinum toxins|mesh-list
91986429|NCT02361749|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91986430|NCT02361749|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986431|NCT02361749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986432|NCT02361749|Cholinergic Agents|cholinergic agents|mesh-ancestor
91986433|NCT02361749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986434|NCT02361749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986435|NCT04372433|Azacitidine|azacitidine|mesh-list
91986436|NCT04372433|Venetoclax|venetoclax|mesh-list
91986437|NCT04372433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986438|NCT04372433|Antimetabolites|antimetabolites|mesh-ancestor
91986439|NCT04372433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986440|NCT04372433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986441|NCT04372433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986442|NCT02358707|Ibuprofen|ibuprofen|mesh-list
91986443|NCT02358707|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986444|NCT02358707|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986446|NCT02358707|Sensory System Agents|sensory system agents|mesh-ancestor
91986447|NCT02358707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986448|NCT02358707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986449|NCT02358707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986450|NCT02358707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986451|NCT02358707|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91986452|NCT02358707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986453|NCT02358707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986454|NCT02360501|Docetaxel|docetaxel|mesh-list
91986455|NCT02360501|Capecitabine|capecitabine|mesh-list
91986456|NCT02360501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986457|NCT02360501|Tubulin Modulators|tubulin modulators|mesh-ancestor
91986458|NCT02360501|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986459|NCT02360501|Mitosis Modulators|mitosis modulators|mesh-ancestor
91986460|NCT02360501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969915|NCT03197233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969916|NCT03197233|Antioxidants|antioxidants|mesh-ancestor
91969917|NCT03197233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986461|NCT02360501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986462|NCT02360501|Antimetabolites|antimetabolites|mesh-ancestor
91986463|NCT02360423|Sirolimus|sirolimus|mesh-list
91986464|NCT02360423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986465|NCT02360423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986466|NCT02360423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91986467|NCT02360423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986468|NCT02360423|Antifungal Agents|antifungal agents|mesh-ancestor
91986469|NCT02360423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986470|NCT02360423|Immunologic Factors|immunologic factors|mesh-ancestor
91986471|NCT02360423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986472|NCT02358161|Paclitaxel|paclitaxel|mesh-list
91986473|NCT02358161|Gemcitabine|gemcitabine|mesh-list
91986474|NCT02358161|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91986475|NCT02358161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986476|NCT02358161|Tubulin Modulators|tubulin modulators|mesh-ancestor
91986477|NCT02358161|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986478|NCT02358161|Mitosis Modulators|mitosis modulators|mesh-ancestor
91986479|NCT02358161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986480|NCT02358161|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986481|NCT02358161|Antimetabolites|antimetabolites|mesh-ancestor
91986482|NCT02357849|Aripiprazole|aripiprazole|mesh-list
91986483|NCT02357849|Fluoxetine|fluoxetine|mesh-list
91986484|NCT02357849|Antidepressive Agents|antidepressive agents|mesh-ancestor
91986485|NCT02357849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986486|NCT02357849|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91986487|NCT02357849|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91986488|NCT02357849|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986491|NCT02357849|Dopamine Agents|dopamine agents|mesh-ancestor
91986492|NCT02357849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986493|NCT02357849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986494|NCT02357849|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91986495|NCT02357849|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91986496|NCT02357849|Serotonin Agents|serotonin agents|mesh-ancestor
91986497|NCT02357849|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91986498|NCT02357849|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91986499|NCT02357849|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91986500|NCT02357849|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91986501|NCT02357849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91986502|NCT02357849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91986503|NCT02357849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986504|NCT02357849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91986505|NCT02357849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91986506|NCT02357849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986507|NCT02357849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986508|NCT02357693|Aprepitant|aprepitant|mesh-list
91986509|NCT02357693|Antiemetics|antiemetics|mesh-ancestor
91986510|NCT02357693|Autonomic Agents|autonomic agents|mesh-ancestor
91986511|NCT02357693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986512|NCT02357693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986513|NCT02357693|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986514|NCT02357693|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91986515|NCT02357693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986516|NCT02357693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986517|NCT02357537|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91986519|NCT02357615|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91986520|NCT02357615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986521|NCT02357615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986522|NCT02357615|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91986523|NCT02357615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986524|NCT02357615|Vasodilator Agents|vasodilator agents|mesh-ancestor
91986525|NCT02357615|Tocolytic Agents|tocolytic agents|mesh-ancestor
91986526|NCT02357615|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91986527|NCT03160001|Niclosamide|niclosamide|mesh-list
91986528|NCT03160001|Etanercept|etanercept|mesh-list
91986529|NCT03160001|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91969918|NCT03197233|Protective Agents|protective agents|mesh-ancestor
91969919|NCT03197233|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91969920|NCT03197233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986530|NCT03160001|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986531|NCT03160001|Analgesics|analgesics|mesh-ancestor
91986532|NCT03160001|Sensory System Agents|sensory system agents|mesh-ancestor
91986533|NCT03160001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986534|NCT03160001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986535|NCT03160001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986536|NCT03160001|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986537|NCT03160001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986538|NCT03160001|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986539|NCT03160001|Immunologic Factors|immunologic factors|mesh-ancestor
91986540|NCT03160001|Anticestodal Agents|anticestodal agents|mesh-ancestor
91986541|NCT03160001|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91986542|NCT03160001|Anthelmintics|anthelmintics|mesh-ancestor
91986543|NCT03160001|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91986544|NCT03160001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986545|NCT03160001|Antinematodal Agents|antinematodal agents|mesh-ancestor
91986546|NCT02359643|Aspirin|aspirin|mesh-list
91986547|NCT02359643|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986548|NCT02359643|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986549|NCT02359643|Analgesics|analgesics|mesh-ancestor
91986550|NCT02359643|Sensory System Agents|sensory system agents|mesh-ancestor
91986551|NCT02359643|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986552|NCT02359643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986553|NCT02359643|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986554|NCT02359643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986555|NCT02359643|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91986556|NCT02359643|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91986837|NCT02350439|Adenosine|adenosine|mesh-list
91986557|NCT02359643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986558|NCT02359643|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91986559|NCT02359643|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91986563|NCT02359721|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986564|NCT02359721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986565|NCT02359721|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91986566|NCT02359721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986567|NCT02359721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986568|NCT02359721|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91986569|NCT02359721|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986570|NCT02357303|Acetylcysteine|acetylcysteine|mesh-list
91986571|NCT02357303|Simethicone|simethicone|mesh-list
91986572|NCT02357303|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91986573|NCT02357303|Antiviral Agents|antiviral agents|mesh-ancestor
91986574|NCT02357303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986575|NCT02357303|Expectorants|expectorants|mesh-ancestor
91986576|NCT02357303|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986577|NCT02357303|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91986578|NCT02357303|Antioxidants|antioxidants|mesh-ancestor
91986579|NCT02357303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986580|NCT02357303|Protective Agents|protective agents|mesh-ancestor
91986581|NCT02357303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986583|NCT02357303|Antifoaming Agents|antifoaming agents|mesh-ancestor
91986584|NCT02357303|Emollients|emollients|mesh-ancestor
91986585|NCT02357303|Dermatologic Agents|dermatologic agents|mesh-ancestor
91986586|NCT02357225|Bromides|bromides|mesh-list
91986587|NCT02357225|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
91986588|NCT02357225|Anticonvulsants|anticonvulsants|mesh-ancestor
91986589|NCT02357225|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91986590|NCT02357225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986591|NCT02357225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986592|NCT02357225|Cholinergic Agents|cholinergic agents|mesh-ancestor
91986593|NCT02357225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986594|NCT02357225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986595|NCT02357069|Etanercept|etanercept|mesh-list
91986596|NCT02357069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91986597|NCT02357069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91986598|NCT02357069|Analgesics|analgesics|mesh-ancestor
91986599|NCT02357069|Sensory System Agents|sensory system agents|mesh-ancestor
91986600|NCT02357069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986601|NCT02357069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969921|NCT03197233|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91969922|NCT02447185|Triamcinolone|triamcinolone|mesh-list
91986602|NCT02357069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986603|NCT02357069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986604|NCT02357069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986605|NCT02357069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986606|NCT02357069|Immunologic Factors|immunologic factors|mesh-ancestor
91986607|NCT02356913|Nicotine|nicotine|mesh-list
91986608|NCT02356913|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91986609|NCT02356913|Autonomic Agents|autonomic agents|mesh-ancestor
91986610|NCT02356913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986611|NCT02356913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986612|NCT02356913|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91986613|NCT02356913|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91986614|NCT02356913|Cholinergic Agents|cholinergic agents|mesh-ancestor
91986615|NCT02356913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986616|NCT02356913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986617|NCT02352545|Montelukast|montelukast|mesh-list
91986618|NCT02352545|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91986619|NCT02352545|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986620|NCT02352545|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91986621|NCT02352545|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986622|NCT02352545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986623|NCT02352545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986624|NCT02352545|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91986625|NCT02352545|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91986626|NCT02352545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986627|NCT02356835|Nitric Oxide|nitric oxide|mesh-list
91986628|NCT02356835|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91986629|NCT02356835|Autonomic Agents|autonomic agents|mesh-ancestor
91986630|NCT02356835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986631|NCT02356835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986632|NCT02356835|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91986633|NCT02356835|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986634|NCT02356835|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91986635|NCT02356835|Antioxidants|antioxidants|mesh-ancestor
91986636|NCT02356835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986637|NCT02356835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986638|NCT02356835|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91986639|NCT02356835|Vasodilator Agents|vasodilator agents|mesh-ancestor
91986640|NCT02356835|Gasotransmitters|gasotransmitters|mesh-ancestor
91986641|NCT02356835|Protective Agents|protective agents|mesh-ancestor
91986642|NCT02352701|Amoxicillin|amoxicillin|mesh-list
91986643|NCT02352701|Levofloxacin|levofloxacin|mesh-list
91986644|NCT02352701|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986645|NCT02352701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986646|NCT02352701|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91986647|NCT02352701|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91986648|NCT02352701|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91986649|NCT02352701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986650|NCT02352701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986651|NCT02352701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986652|NCT02352701|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91986653|NCT02352701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986655|NCT02356445|Methotrexate|methotrexate|mesh-list
91986656|NCT02356445|Azathioprine|azathioprine|mesh-list
91986657|NCT02356445|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91986658|NCT02356445|Abortifacient Agents|abortifacient agents|mesh-ancestor
91986659|NCT02356445|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91986660|NCT02356445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986661|NCT02356445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986662|NCT02356445|Antimetabolites|antimetabolites|mesh-ancestor
91986663|NCT02356445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986664|NCT02356445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986665|NCT02356445|Dermatologic Agents|dermatologic agents|mesh-ancestor
91986666|NCT02356445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986667|NCT02356445|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91986668|NCT02356445|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986669|NCT02356445|Immunologic Factors|immunologic factors|mesh-ancestor
91969923|NCT02447185|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91969924|NCT02447185|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91969925|NCT02447185|Ranibizumab|ranibizumab|mesh-list
91969926|NCT02447185|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91969927|NCT02447185|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91969928|NCT02447185|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91969929|NCT02447185|Growth Substances|growth substances|mesh-ancestor
91969930|NCT02447185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969931|NCT02447185|Growth Inhibitors|growth inhibitors|mesh-ancestor
91969932|NCT02447185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969933|NCT02447185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91969934|NCT02447185|Glucocorticoids|glucocorticoids|mesh-ancestor
91969935|NCT02447185|Hormones|hormones|mesh-ancestor
91969936|NCT02447185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969937|NCT02447185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91969938|NCT02447185|Immunologic Factors|immunologic factors|mesh-ancestor
91969939|NCT02447185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969940|NCT02447185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986670|NCT02356445|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986671|NCT02356445|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91986672|NCT02356445|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91986673|NCT02356445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91986674|NCT02356445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986675|NCT02356679|Ethanol|ethanol|mesh-list
91986676|NCT02356679|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91986677|NCT02356679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986678|NCT02356679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986679|NCT02356679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986680|NCT02352155|Epinephrine|epinephrine|mesh-list
91986681|NCT02352155|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91986682|NCT02352155|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91986683|NCT02352155|Adrenergic Agents|adrenergic agents|mesh-ancestor
91986684|NCT02352155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986685|NCT02352155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986686|NCT02352155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986687|NCT02352155|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91986688|NCT02352155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91986689|NCT02352155|Autonomic Agents|autonomic agents|mesh-ancestor
91986690|NCT02352155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986691|NCT02352155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91986692|NCT02352155|Respiratory System Agents|respiratory system agents|mesh-ancestor
91986693|NCT02352155|Mydriatics|mydriatics|mesh-ancestor
91986694|NCT02352155|Sympathomimetics|sympathomimetics|mesh-ancestor
91986695|NCT02352155|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91986697|NCT02352311|Dutasteride|dutasteride|mesh-list
91986698|NCT02352311|Vasodilator Agents|vasodilator agents|mesh-ancestor
91986699|NCT02352311|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91986700|NCT02352311|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91986701|NCT02352311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986702|NCT02352311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986703|NCT02352311|Urological Agents|urological agents|mesh-ancestor
91986704|NCT02352311|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91986705|NCT02352311|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91969941|NCT03196921|Amphotericin B|amphotericin b|mesh-list
91969942|NCT03196921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91986707|NCT02352311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986708|NCT02352311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986711|NCT02355431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91986712|NCT02355431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986713|NCT02355431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986714|NCT02351687|Pyrimethamine|pyrimethamine|mesh-list
91986715|NCT02351687|Sulfadoxine|sulfadoxine|mesh-list
91986716|NCT02351687|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
91986717|NCT02351687|Albendazole|albendazole|mesh-list
91986718|NCT02351687|Antimalarials|antimalarials|mesh-ancestor
91986719|NCT02351687|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91986720|NCT02351687|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91986721|NCT02351687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986722|NCT02351687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91986723|NCT02351687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986724|NCT02351687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986725|NCT02351687|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91986726|NCT02351687|Anthelmintics|anthelmintics|mesh-ancestor
91986727|NCT02351687|Anticestodal Agents|anticestodal agents|mesh-ancestor
91986728|NCT02351687|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91986729|NCT02351687|Tubulin Modulators|tubulin modulators|mesh-ancestor
91986730|NCT02351687|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986731|NCT02351687|Mitosis Modulators|mitosis modulators|mesh-ancestor
91986732|NCT02351687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986733|NCT02355509|Acarbose|acarbose|mesh-list
91986734|NCT02355509|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
91986735|NCT02355509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986736|NCT02355509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986737|NCT02355509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91986738|NCT02355509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986740|NCT02355197|Vitamins|vitamins|mesh-ancestor
91986741|NCT02355197|Micronutrients|micronutrients|mesh-ancestor
91986742|NCT02355197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986743|NCT02355197|Antioxidants|antioxidants|mesh-ancestor
91986744|NCT02355197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986745|NCT02355197|Protective Agents|protective agents|mesh-ancestor
91986746|NCT02351297|Caseins|caseins|mesh-list
91986747|NCT02351297|Chelating Agents|chelating agents|mesh-ancestor
91986748|NCT02351297|Sequestering Agents|sequestering agents|mesh-ancestor
91986749|NCT02351297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986750|NCT02355119|Gemcitabine|gemcitabine|mesh-list
91986751|NCT02355119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91986752|NCT02355119|Antimetabolites|antimetabolites|mesh-ancestor
91986753|NCT02355119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986754|NCT02355119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986755|NCT03149939|Febuxostat|febuxostat|mesh-list
91986756|NCT03149939|Gout Suppressants|gout suppressants|mesh-ancestor
91986757|NCT03149939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986758|NCT03149783|Ropivacaine|ropivacaine|mesh-list
91986759|NCT03149783|Anesthetics, Local|anesthetics, local|mesh-ancestor
91986760|NCT03149783|Anesthetics|anesthetics|mesh-ancestor
91986761|NCT03149783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986762|NCT03149783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986763|NCT03149783|Sensory System Agents|sensory system agents|mesh-ancestor
91986764|NCT03149783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986765|NCT02354885|Tranexamic Acid|tranexamic acid|mesh-list
91986766|NCT02354885|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91986767|NCT02354885|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91986768|NCT02354885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986769|NCT02354885|Hemostatics|hemostatics|mesh-ancestor
91986770|NCT02354885|Coagulants|coagulants|mesh-ancestor
91986771|NCT02354807|Mirabegron|mirabegron|mesh-list
91986772|NCT02354807|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91986773|NCT02354807|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91986774|NCT02354807|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91986775|NCT02354807|Adrenergic Agents|adrenergic agents|mesh-ancestor
91986776|NCT02354807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986777|NCT02354807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986778|NCT02354807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986779|NCT02354807|Urological Agents|urological agents|mesh-ancestor
91969943|NCT03196921|Amebicides|amebicides|mesh-ancestor
91969944|NCT03196921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91969945|NCT03196921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91986782|NCT03159845|Acyclovir|acyclovir|mesh-list
91986783|NCT03159845|Zinc Sulfate|zinc sulfate|mesh-list
91986784|NCT03159845|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91986785|NCT03159845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986786|NCT03159845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91986787|NCT03159845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91986788|NCT03159845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91986789|NCT03159845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986790|NCT03159845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986791|NCT03159845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986792|NCT03159845|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91986793|NCT03159845|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986794|NCT03159845|Antifungal Agents|antifungal agents|mesh-ancestor
91986795|NCT03159845|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91986796|NCT03159845|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91986797|NCT03159845|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986798|NCT03159845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986799|NCT03159845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986800|NCT03159845|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91986801|NCT03159845|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91986802|NCT03159845|Antiviral Agents|antiviral agents|mesh-ancestor
91986803|NCT03159845|Astringents|astringents|mesh-ancestor
91986804|NCT03159845|Dermatologic Agents|dermatologic agents|mesh-ancestor
91986805|NCT02350751|MEDI8852|medi8852|mesh-list
91986806|NCT02350751|Antiviral Agents|antiviral agents|mesh-ancestor
91986807|NCT02350751|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986808|NCT02350985|Propranolol|propranolol|mesh-list
91986809|NCT02350985|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91986810|NCT02350985|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91986811|NCT02350985|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91986812|NCT02350985|Adrenergic Agents|adrenergic agents|mesh-ancestor
91986813|NCT02350985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986814|NCT02350985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986815|NCT02350985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986816|NCT02350985|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91986817|NCT02350985|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91986818|NCT02350985|Vasodilator Agents|vasodilator agents|mesh-ancestor
91986819|NCT02350985|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91986820|NCT02350985|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91986821|NCT02350985|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986822|NCT02350985|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91986823|NCT02350985|Antidepressive Agents|antidepressive agents|mesh-ancestor
91986824|NCT02350985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986825|NCT02354261|Itraconazole|itraconazole|mesh-list
91986826|NCT02354261|Antifungal Agents|antifungal agents|mesh-ancestor
91986827|NCT02354261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91986828|NCT02354261|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91986829|NCT02354261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986830|NCT02354261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986831|NCT02354261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986832|NCT02354261|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91986833|NCT02354261|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986834|NCT02354261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986835|NCT02354261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986836|NCT02354261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91986838|NCT02350439|Analgesics|analgesics|mesh-ancestor
91986839|NCT02350439|Sensory System Agents|sensory system agents|mesh-ancestor
91986840|NCT02350439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986841|NCT02350439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986842|NCT02350439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91986843|NCT02350439|Vasodilator Agents|vasodilator agents|mesh-ancestor
91986844|NCT02350439|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91986845|NCT02350439|Purinergic Agonists|purinergic agonists|mesh-ancestor
91986846|NCT02350439|Purinergic Agents|purinergic agents|mesh-ancestor
91986847|NCT02350439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969946|NCT03196921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969947|NCT03196921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91969948|NCT03196921|Antifungal Agents|antifungal agents|mesh-ancestor
91986848|NCT02350439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986855|NCT02350361|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91986856|NCT02350361|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91986857|NCT02350361|Growth Substances|growth substances|mesh-ancestor
91986858|NCT02350361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986859|NCT02350361|Growth Inhibitors|growth inhibitors|mesh-ancestor
91986860|NCT02350361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986862|NCT02353949|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91986863|NCT02353949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986864|NCT02354027|Metformin|metformin|mesh-list
91986865|NCT02354027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91986866|NCT02354027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986867|NCT03149393|Mosapride|mosapride|mesh-list
91986868|NCT03149393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986869|NCT03149393|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91986870|NCT03149393|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91986871|NCT03149393|Serotonin Agents|serotonin agents|mesh-ancestor
91986872|NCT03149393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986873|NCT03149393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986874|NCT02353715|Abiraterone Acetate|abiraterone acetate|mesh-list
91986875|NCT02353715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986876|NCT02353715|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91986877|NCT02353715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986878|NCT02353715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986879|NCT02353715|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986880|NCT02353715|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986881|NCT02353715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986882|NCT02353715|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91986883|NCT02353325|Ascorbic Acid|ascorbic acid|mesh-list
91986884|NCT02353325|Fesoterodine|fesoterodine|mesh-list
91986885|NCT02353325|Antioxidants|antioxidants|mesh-ancestor
91986886|NCT02353325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986887|NCT02353325|Protective Agents|protective agents|mesh-ancestor
91986888|NCT02353325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986889|NCT02353325|Vitamins|vitamins|mesh-ancestor
91986890|NCT02353325|Micronutrients|micronutrients|mesh-ancestor
91986891|NCT02353325|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91986892|NCT02353325|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91986893|NCT02353325|Cholinergic Agents|cholinergic agents|mesh-ancestor
91986894|NCT02353325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986895|NCT02353325|Urological Agents|urological agents|mesh-ancestor
91986896|NCT03157505|Immunomodulating Agents|immunomodulating agents|mesh-list
91986897|NCT03157505|Immunologic Factors|immunologic factors|mesh-list
91986898|NCT03157505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986899|NCT03157193|Hyaluronic Acid|hyaluronic acid|mesh-list
91986900|NCT03157193|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91986901|NCT03157193|Immunologic Factors|immunologic factors|mesh-ancestor
91986902|NCT03157193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986903|NCT03157193|Viscosupplements|viscosupplements|mesh-ancestor
91986904|NCT03157193|Protective Agents|protective agents|mesh-ancestor
91986905|NCT03149159|Nivolumab|nivolumab|mesh-list
91986906|NCT03149159|Ipilimumab|ipilimumab|mesh-list
91986907|NCT03149159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91986908|NCT03149159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986909|NCT03149159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91986910|NCT03149159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986911|NCT03155477|Cholecalciferol|cholecalciferol|mesh-list
91986912|NCT03155477|Vitamin D|vitamin d|mesh-list
91986913|NCT03155477|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91986914|NCT03155477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986915|NCT03155477|Vitamins|vitamins|mesh-ancestor
91986916|NCT03155477|Micronutrients|micronutrients|mesh-ancestor
91986917|NCT03155477|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91986920|NCT02349581|Anesthetics|anesthetics|mesh-ancestor
91986921|NCT02349581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986922|NCT02349581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969949|NCT02480465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91969950|NCT02480465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91986923|NCT02349581|Sensory System Agents|sensory system agents|mesh-ancestor
91986924|NCT02349581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986925|NCT03154385|Rituximab|rituximab|mesh-list
91986926|NCT03154385|Belimumab|belimumab|mesh-list
91986927|NCT03154385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91986928|NCT03154385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986929|NCT03154385|Immunologic Factors|immunologic factors|mesh-ancestor
91986930|NCT03154385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986931|NCT03154385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91986932|NCT03154385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986934|NCT03112187|Trace Elements|trace elements|mesh-ancestor
91986935|NCT03112187|Micronutrients|micronutrients|mesh-ancestor
91986936|NCT03112187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986937|NCT03147677|Alfacalcidol|alfacalcidol|mesh-list
91986938|NCT03147677|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
91986939|NCT03147677|Irbesartan|irbesartan|mesh-list
91986940|NCT03147677|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91986941|NCT03147677|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91986942|NCT03147677|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91986943|NCT03147677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986944|NCT03147677|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91986945|NCT03147677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986946|NCT03147677|Vitamins|vitamins|mesh-ancestor
91986947|NCT03147677|Micronutrients|micronutrients|mesh-ancestor
91986948|NCT03148535|Lithium Carbonate|lithium carbonate|mesh-list
91986949|NCT03148535|Antidepressive Agents|antidepressive agents|mesh-list
91986950|NCT03148535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986951|NCT03148535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986952|NCT03148535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986953|NCT03148535|Antimanic Agents|antimanic agents|mesh-ancestor
91986954|NCT03148535|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91986955|NCT03148535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986956|NCT03148535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986957|NCT03147599|Mebeverine|mebeverine|mesh-list
91986958|NCT03147599|Anticonvulsants|anticonvulsants|mesh-ancestor
91986959|NCT03147599|Parasympatholytics|parasympatholytics|mesh-ancestor
91986960|NCT03147599|Autonomic Agents|autonomic agents|mesh-ancestor
91986961|NCT03147599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986962|NCT03147599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986963|NCT02349113|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91986964|NCT02349113|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91986966|NCT02349113|Estradiol|estradiol|mesh-list
91986967|NCT02349113|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91986968|NCT02349113|Hormones|hormones|mesh-ancestor
91986969|NCT02349113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986970|NCT02349113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986971|NCT02349113|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91986972|NCT02349113|Contraceptive Agents|contraceptive agents|mesh-ancestor
91986973|NCT02349113|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91986974|NCT02349113|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91986975|NCT04183205|Sertraline|sertraline|mesh-list
91986976|NCT04183205|Antidepressive Agents|antidepressive agents|mesh-ancestor
91986977|NCT04183205|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986978|NCT04183205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91986979|NCT04183205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91986980|NCT04183205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91986981|NCT04183205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986982|NCT04183205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986983|NCT04183205|Serotonin Agents|serotonin agents|mesh-ancestor
91986984|NCT04183205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986985|NCT04151849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91986986|NCT04151849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986987|NCT04151849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91986988|NCT04151849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986989|NCT02348177|Ritonavir|ritonavir|mesh-list
91986990|NCT02348177|Lopinavir|lopinavir|mesh-list
91986991|NCT02348177|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91986992|NCT02348177|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91969951|NCT02480465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969952|NCT02480465|Incretins|incretins|mesh-ancestor
91969953|NCT02480465|Hormones|hormones|mesh-ancestor
91969954|NCT02480465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986993|NCT02348177|Protease Inhibitors|protease inhibitors|mesh-ancestor
91986994|NCT02348177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986995|NCT02348177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986997|NCT02348177|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91986998|NCT02348177|Antiviral Agents|antiviral agents|mesh-ancestor
91986999|NCT02348177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987000|NCT02348177|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91987001|NCT02348177|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987002|NCT02348255|Bevacizumab|bevacizumab|mesh-list
91987003|NCT02348255|Carmustine|carmustine|mesh-list
91987004|NCT02348255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91987005|NCT02348255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987006|NCT02348255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91987007|NCT02348255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91987008|NCT02348255|Growth Substances|growth substances|mesh-ancestor
91987009|NCT02348255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987010|NCT02348255|Growth Inhibitors|growth inhibitors|mesh-ancestor
91987011|NCT02348255|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91987012|NCT02348255|Alkylating Agents|alkylating agents|mesh-ancestor
91987013|NCT02348255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987014|NCT02348333|Dotinurad|dotinurad|mesh-list
91987015|NCT02348333|Uricosuric Agents|uricosuric agents|mesh-ancestor
91987016|NCT02348333|Gout Suppressants|gout suppressants|mesh-ancestor
91987017|NCT02348333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91987018|NCT02343419|Methacholine Chloride|methacholine chloride|mesh-list
91987019|NCT02343419|Miotics|miotics|mesh-ancestor
91987020|NCT02343419|Autonomic Agents|autonomic agents|mesh-ancestor
91987021|NCT02343419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987022|NCT02343419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987023|NCT02343419|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91987024|NCT02343419|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
91987025|NCT02343419|Respiratory System Agents|respiratory system agents|mesh-ancestor
91987026|NCT02343419|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
91987027|NCT02343419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91987028|NCT02343419|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987029|NCT02343419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987030|NCT02343419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987031|NCT02342717|Itraconazole|itraconazole|mesh-list
91987032|NCT02342717|BI 425809|bi 425809|mesh-list
91987033|NCT02342717|Antifungal Agents|antifungal agents|mesh-ancestor
91987034|NCT02342717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987035|NCT02342717|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91987036|NCT02342717|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987037|NCT02342717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987038|NCT02342717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987039|NCT02342717|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91987040|NCT02342717|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987041|NCT02342717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987042|NCT02342717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987043|NCT02342717|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91987044|NCT02342717|Nootropic Agents|nootropic agents|mesh-ancestor
91987045|NCT04478357|Fesoterodine|fesoterodine|mesh-list
91987046|NCT04478357|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91987047|NCT04478357|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91987048|NCT04478357|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987049|NCT04478357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987050|NCT04478357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987051|NCT04478357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987052|NCT04478357|Urological Agents|urological agents|mesh-ancestor
91987053|NCT04478513|Fluvoxamine|fluvoxamine|mesh-list
91987054|NCT04478513|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987055|NCT04478513|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987056|NCT04478513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987057|NCT04478513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987058|NCT04478513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91969955|NCT02480465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91969956|NCT02480465|Protease Inhibitors|protease inhibitors|mesh-ancestor
91969957|NCT02480465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91969958|NCT02480465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969959|NCT03208465|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91969960|NCT03208465|Empagliflozin|empagliflozin|mesh-list
91969961|NCT03208465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91969962|NCT03208465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969963|NCT03208465|Incretins|incretins|mesh-ancestor
91969964|NCT03208465|Hormones|hormones|mesh-ancestor
91969965|NCT03208465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91969966|NCT03208465|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91969967|NCT03208465|Protease Inhibitors|protease inhibitors|mesh-ancestor
91969968|NCT03208465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987059|NCT04478513|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91987060|NCT04478513|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91987061|NCT04478513|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987062|NCT04478513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987067|NCT04478513|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91987068|NCT04478513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987069|NCT04478513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987070|NCT04478513|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91987072|NCT02342093|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91987073|NCT02342093|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987074|NCT02342093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987075|NCT02342093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987076|NCT02342093|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91987077|NCT02342093|Diuretics|diuretics|mesh-ancestor
91987078|NCT02342093|Natriuretic Agents|natriuretic agents|mesh-ancestor
91987079|NCT02347319|Silymarin|silymarin|mesh-list
91987080|NCT02347319|Antioxidants|antioxidants|mesh-ancestor
91987081|NCT02347319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987082|NCT02347319|Protective Agents|protective agents|mesh-ancestor
91987083|NCT02347319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987084|NCT02347163|Zoledronic Acid|zoledronic acid|mesh-list
91987085|NCT02347163|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91987086|NCT02347163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987087|NCT02341703|Metformin|metformin|mesh-list
91987088|NCT02341703|Pioglitazone|pioglitazone|mesh-list
91987089|NCT02341703|Letrozole|letrozole|mesh-list
91987090|NCT02341703|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91987091|NCT02341703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987092|NCT02341703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987093|NCT02341703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91987094|NCT02341703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91987095|NCT02341703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987096|NCT02341703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987097|NCT02341703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91987098|NCT02341703|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987099|NCT02341703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987100|NCT02341547|Epoetin Alfa|epoetin alfa|mesh-list
91987101|NCT02341547|Hematinics|hematinics|mesh-ancestor
91987102|NCT02341079|Bupivacaine|bupivacaine|mesh-list
91987103|NCT02341079|Anesthetics, Local|anesthetics, local|mesh-ancestor
91987104|NCT02341079|Anesthetics|anesthetics|mesh-ancestor
91987105|NCT02341079|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987106|NCT02341079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987107|NCT02341079|Sensory System Agents|sensory system agents|mesh-ancestor
91969969|NCT03208465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969970|NCT03208465|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91969972|NCT03197155|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91969973|NCT04484779|Insulin|insulin|mesh-list
91987108|NCT02341079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987109|NCT02346539|Nicotine|nicotine|mesh-list
91987110|NCT02346539|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91987111|NCT02346539|Autonomic Agents|autonomic agents|mesh-ancestor
91987112|NCT02346539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987113|NCT02346539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987114|NCT02346539|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91987115|NCT02346539|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91987116|NCT02346539|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987117|NCT02346539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987118|NCT02346539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987119|NCT05254223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91987120|NCT02340455|Pregabalin|pregabalin|mesh-list
91987121|NCT02340455|Analgesics|analgesics|mesh-ancestor
91987122|NCT02340455|Sensory System Agents|sensory system agents|mesh-ancestor
91987123|NCT02340455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987124|NCT02340455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987125|NCT02340455|Anticonvulsants|anticonvulsants|mesh-ancestor
91987126|NCT02340455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91987127|NCT02340455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987128|NCT02340455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987129|NCT02340455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91987130|NCT02340455|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987131|NCT02340455|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987149|NCT02345993|Autonomic Agents|autonomic agents|mesh-ancestor
91987150|NCT02345993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987151|NCT02345993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987152|NCT02345993|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91987153|NCT02345993|Respiratory System Agents|respiratory system agents|mesh-ancestor
91987154|NCT02345993|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91987155|NCT02345993|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91987156|NCT02345993|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91987157|NCT02345993|Adrenergic Agents|adrenergic agents|mesh-ancestor
91987158|NCT02345993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987159|NCT02345993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987160|NCT02345993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987161|NCT02345993|Glucocorticoids|glucocorticoids|mesh-ancestor
91987162|NCT02345993|Hormones|hormones|mesh-ancestor
91987163|NCT02345993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987164|NCT02345681|Furosemide|furosemide|mesh-list
91987165|NCT02345681|Diuretics|diuretics|mesh-ancestor
91987166|NCT02345681|Natriuretic Agents|natriuretic agents|mesh-ancestor
91987167|NCT02345681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987168|NCT02345681|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91987169|NCT02345681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987170|NCT02345681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987171|NCT02340611|Olaparib|olaparib|mesh-list
91987172|NCT02340611|Cediranib|cediranib|mesh-list
91987173|NCT02340611|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91987174|NCT02340611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987175|NCT02340611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987176|NCT02340611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987177|NCT02340611|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91987178|NCT03145649|Insulin|insulin|mesh-list
91987179|NCT03145649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91987180|NCT03145649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987181|NCT02345213|Donepezil|donepezil|mesh-list
91987182|NCT02345213|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91987183|NCT02345213|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987184|NCT02345213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987185|NCT02345213|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987186|NCT02345213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969974|NCT04484779|Insulin Glargine|insulin glargine|mesh-list
91969976|NCT04484779|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91969977|NCT04484779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987187|NCT02345213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987198|NCT02339441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91987199|NCT02339441|Alkylating Agents|alkylating agents|mesh-ancestor
91987200|NCT02339441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987201|NCT02339441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987202|NCT02339441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91987203|NCT02339441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91987204|NCT02339441|Abortifacient Agents|abortifacient agents|mesh-ancestor
91987205|NCT02339441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91987206|NCT02339441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91987207|NCT02339441|Antimetabolites|antimetabolites|mesh-ancestor
91987208|NCT02339441|Dermatologic Agents|dermatologic agents|mesh-ancestor
91987209|NCT02339441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987210|NCT02339441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91987211|NCT02339441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91987212|NCT02339441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91987213|NCT02339441|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91987214|NCT02339441|Antitubercular Agents|antitubercular agents|mesh-ancestor
91987215|NCT02339441|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987216|NCT02339441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987217|NCT02344823|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
91987219|NCT02344823|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91987220|NCT02344823|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91987221|NCT02344823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987222|NCT02344823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987223|NCT02344823|Urological Agents|urological agents|mesh-ancestor
91987224|NCT03145961|Pembrolizumab|pembrolizumab|mesh-list
91987225|NCT03145961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91987226|NCT03145961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987227|NCT03145961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91987228|NCT03145961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987229|NCT02339207|Adafosbuvir|adafosbuvir|mesh-list
91987230|NCT02339207|Antiviral Agents|antiviral agents|mesh-ancestor
91987231|NCT02339207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987232|NCT02344511|Vancomycin|vancomycin|mesh-list
91987233|NCT02344511|Cefazolin|cefazolin|mesh-list
91987234|NCT02344511|Dalbavancin|dalbavancin|mesh-list
91987235|NCT02344511|Oxacillin|oxacillin|mesh-list
91987236|NCT02344511|Nafcillin|nafcillin|mesh-list
91987237|NCT02344511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987238|NCT02344511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987239|NCT02344589|Lidocaine|lidocaine|mesh-list
91987240|NCT02344589|Anesthetics, Local|anesthetics, local|mesh-ancestor
91987241|NCT02344589|Anesthetics|anesthetics|mesh-ancestor
91987242|NCT02344589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987243|NCT02344589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987244|NCT02344589|Sensory System Agents|sensory system agents|mesh-ancestor
91987245|NCT02344589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987246|NCT02344589|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91987247|NCT02344589|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91987248|NCT02344589|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91987249|NCT02344589|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987250|NCT02344589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987251|NCT02338115|Paclitaxel|paclitaxel|mesh-list
91987252|NCT02338115|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91987254|NCT02338115|Tubulin Modulators|tubulin modulators|mesh-ancestor
91987255|NCT02338115|Antimitotic Agents|antimitotic agents|mesh-ancestor
91987256|NCT02338115|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987257|NCT02338115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987258|NCT02337881|Sildenafil Citrate|sildenafil citrate|mesh-list
91987259|NCT02337881|Vasodilator Agents|vasodilator agents|mesh-ancestor
91987260|NCT02337881|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91987261|NCT02337881|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91969978|NCT02477501|Norepinephrine|norepinephrine|mesh-list
91969979|NCT02477501|Ephedrine|ephedrine|mesh-list
91969980|NCT02477501|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91969981|NCT02477501|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91987262|NCT02337881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987263|NCT02337881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987264|NCT02337881|Urological Agents|urological agents|mesh-ancestor
91987265|NCT02337257|Vitamin D|vitamin d|mesh-list
91987266|NCT02337257|Cholecalciferol|cholecalciferol|mesh-list
91987267|NCT02337257|Vitamins|vitamins|mesh-ancestor
91987268|NCT02337257|Micronutrients|micronutrients|mesh-ancestor
91987269|NCT02337257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987270|NCT02337257|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91987271|NCT02337257|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91987272|NCT02337413|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
91987273|NCT02337413|Laxatives|laxatives|mesh-ancestor
91987274|NCT02337413|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91987275|NCT02337023|Technetium Tc 99m bicisate|technetium tc 99m bicisate|mesh-list
91987276|NCT02337023|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91987277|NCT02337023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987278|NCT04477811|Vitamins|vitamins|mesh-list
91987280|NCT04477811|Vitamin K 2|vitamin k 2|mesh-list
91987281|NCT04477811|Vitamin K 1|vitamin k 1|mesh-list
91987282|NCT04477811|Micronutrients|micronutrients|mesh-ancestor
91987283|NCT04477811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987284|NCT04477811|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91987285|NCT04477811|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91987286|NCT04477811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987287|NCT04477811|Hemostatics|hemostatics|mesh-ancestor
91987288|NCT04477811|Coagulants|coagulants|mesh-ancestor
91987289|NCT02332031|Sorafenib|sorafenib|mesh-list
91987290|NCT02332031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987291|NCT02332031|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91987292|NCT02332031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987293|NCT02332031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987294|NCT03112031|Tamoxifen|tamoxifen|mesh-list
91987295|NCT03112031|Fluconazole|fluconazole|mesh-list
91987296|NCT03112031|Amphotericin B|amphotericin b|mesh-list
91987297|NCT03112031|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91987298|NCT03112031|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91987299|NCT03112031|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987300|NCT03112031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987301|NCT03112031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987302|NCT03112031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91987303|NCT03112031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987304|NCT03112031|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91987305|NCT03112031|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91987306|NCT03112031|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91987307|NCT03112031|Antifungal Agents|antifungal agents|mesh-ancestor
91987308|NCT03112031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987309|NCT03112031|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91987310|NCT03112031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987311|NCT03112031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987312|NCT03112031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987313|NCT03112031|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91987314|NCT03112031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91987315|NCT03112031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91987316|NCT03112031|Amebicides|amebicides|mesh-ancestor
91987317|NCT03112031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91987318|NCT03112031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91987319|NCT03112031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987320|NCT03111797|Morphine|morphine|mesh-list
91987321|NCT03111797|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91987322|NCT03111797|Narcotics|narcotics|mesh-ancestor
91987323|NCT03111797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987324|NCT03111797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987325|NCT03111797|Analgesics|analgesics|mesh-ancestor
91987326|NCT03111797|Sensory System Agents|sensory system agents|mesh-ancestor
91987329|NCT02938013|Velpatasvir|velpatasvir|mesh-list
91987330|NCT02938013|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
91969982|NCT02477501|Adrenergic Agents|adrenergic agents|mesh-ancestor
91969983|NCT02477501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91969984|NCT02477501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91969985|NCT02477501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969986|NCT02477501|Sympathomimetics|sympathomimetics|mesh-ancestor
91969987|NCT02477501|Autonomic Agents|autonomic agents|mesh-ancestor
91969988|NCT02477501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91969989|NCT02477501|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91969990|NCT02477501|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91969991|NCT02446795|Sunitinib|sunitinib|mesh-list
91969992|NCT02446795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91969993|NCT02446795|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91969994|NCT02446795|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91987331|NCT02938013|Antiviral Agents|antiviral agents|mesh-ancestor
91987332|NCT02938013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987333|NCT02820311|Moxifloxacin|moxifloxacin|mesh-list
91987334|NCT02820311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987335|NCT02820311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987336|NCT02820311|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91987337|NCT02820311|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91987338|NCT02820311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987339|NCT02820311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987340|NCT02820311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987341|NCT02336633|Resveratrol|resveratrol|mesh-list
91987342|NCT02336633|Antioxidants|antioxidants|mesh-ancestor
91987343|NCT02336633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987344|NCT02336633|Protective Agents|protective agents|mesh-ancestor
91987345|NCT02336633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987346|NCT02336633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987347|NCT02336633|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91987348|NCT02336477|Mexiletine|mexiletine|mesh-list
91987349|NCT02336477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91987350|NCT02336477|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91987351|NCT02336477|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91987352|NCT02336477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987353|NCT02336477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987354|NCT04624451|Dalbavancin|dalbavancin|mesh-list
91987355|NCT04624451|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987356|NCT04624451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987357|NCT02642315|Gabapentin|gabapentin|mesh-list
91987358|NCT02642315|Analgesics|analgesics|mesh-ancestor
91987359|NCT02642315|Sensory System Agents|sensory system agents|mesh-ancestor
91987360|NCT02642315|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987361|NCT02642315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987362|NCT02642315|Anticonvulsants|anticonvulsants|mesh-ancestor
91987363|NCT02642315|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987364|NCT02642315|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987365|NCT02642315|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987366|NCT02642315|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987367|NCT02642315|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91987368|NCT02642315|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91987369|NCT02642315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987370|NCT02642315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987371|NCT02642315|Antimanic Agents|antimanic agents|mesh-ancestor
91987373|NCT02518139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91987374|NCT02518139|Autonomic Agents|autonomic agents|mesh-ancestor
91987375|NCT02518139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987376|NCT02518139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969995|NCT02446795|Growth Substances|growth substances|mesh-ancestor
91969996|NCT02446795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91969997|NCT02446795|Growth Inhibitors|growth inhibitors|mesh-ancestor
91969998|NCT02446795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91969999|NCT02446795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987377|NCT02518139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91987378|NCT02518139|Respiratory System Agents|respiratory system agents|mesh-ancestor
91987379|NCT02518139|Parasympatholytics|parasympatholytics|mesh-ancestor
91987380|NCT02518139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91987381|NCT02518139|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987382|NCT02518139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987383|NCT02518139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987384|NCT02709889|Dexamethasone|dexamethasone|mesh-list
91987385|NCT02709889|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
91987386|NCT02709889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987387|NCT02709889|Antiemetics|antiemetics|mesh-ancestor
91987388|NCT02709889|Autonomic Agents|autonomic agents|mesh-ancestor
91987389|NCT02709889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987390|NCT02709889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987391|NCT02709889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91987392|NCT02709889|Glucocorticoids|glucocorticoids|mesh-ancestor
91987393|NCT02709889|Hormones|hormones|mesh-ancestor
91987394|NCT02709889|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987395|NCT02709889|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91987396|NCT02709889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987397|NCT02709889|Immunoconjugates|immunoconjugates|mesh-ancestor
91987398|NCT02709889|Immunologic Factors|immunologic factors|mesh-ancestor
91987399|NCT03189901|Simendan|simendan|mesh-list
91987400|NCT03189901|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91987401|NCT03189901|Vasodilator Agents|vasodilator agents|mesh-ancestor
91987402|NCT03189901|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91987403|NCT03189901|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91987404|NCT03189901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987405|NCT03189901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987407|NCT03189901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987408|NCT02711995|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91987409|NCT02711995|Botulinum Toxins|botulinum toxins|mesh-list
91987410|NCT02711995|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91987411|NCT02711995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987412|NCT02711995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987413|NCT02711995|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987414|NCT02711995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987415|NCT02711995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987416|NCT02711995|Laxatives|laxatives|mesh-ancestor
91987417|NCT02711995|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91987418|NCT03193723|Anesthetics|anesthetics|mesh-list
91987419|NCT03193723|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987420|NCT03193723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987421|NCT02437825|Octreotide|octreotide|mesh-list
91987422|NCT02437825|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91987423|NCT02437825|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91987424|NCT02437825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987425|NCT02442817|Linagliptin|linagliptin|mesh-list
91987426|NCT02442817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91987427|NCT02442817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987428|NCT02442817|Incretins|incretins|mesh-ancestor
91987429|NCT02442817|Hormones|hormones|mesh-ancestor
91987430|NCT02442817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987431|NCT02442817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91987432|NCT02442817|Protease Inhibitors|protease inhibitors|mesh-ancestor
91987433|NCT02442817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987434|NCT02442817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987435|NCT02437591|Fidaxomicin|fidaxomicin|mesh-list
91987436|NCT02437591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987437|NCT02437591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987438|NCT02442739|Ketamine|ketamine|mesh-list
91987439|NCT02442739|Analgesics|analgesics|mesh-ancestor
91970000|NCT02446795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970001|NCT02477267|Buprenorphine|buprenorphine|mesh-list
91970002|NCT02477267|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
91970003|NCT02477267|Naloxone|naloxone|mesh-list
91987440|NCT02442739|Sensory System Agents|sensory system agents|mesh-ancestor
91987441|NCT02442739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987442|NCT02442739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987443|NCT02442739|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91987444|NCT02442739|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91987445|NCT02442739|Anesthetics, General|anesthetics, general|mesh-ancestor
91987446|NCT02442739|Anesthetics|anesthetics|mesh-ancestor
91987447|NCT02442739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987448|NCT02442739|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91987449|NCT02442739|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91987450|NCT02442739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987451|NCT02442739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987452|NCT03022903|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91987453|NCT03022903|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91987454|NCT03022903|Dermatologic Agents|dermatologic agents|mesh-ancestor
91987455|NCT02442427|Palivizumab|palivizumab|mesh-list
91987456|NCT02442427|Antiviral Agents|antiviral agents|mesh-ancestor
91987457|NCT02442427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987458|NCT03189043|Anti-Infective Agents|anti-infective agents|mesh-list
91987459|NCT03189043|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91987460|NCT05233735|Betamethasone|betamethasone|mesh-list
91987461|NCT05233735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987462|NCT05233735|Glucocorticoids|glucocorticoids|mesh-ancestor
91987463|NCT05233735|Hormones|hormones|mesh-ancestor
91987464|NCT05233735|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987465|NCT05233735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987466|NCT05233735|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91987467|NCT05233735|Respiratory System Agents|respiratory system agents|mesh-ancestor
91987468|NCT02436499|Botulinum Toxins|botulinum toxins|mesh-list
91987469|NCT02436499|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91987470|NCT02436499|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91987471|NCT02436499|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91987472|NCT02436499|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987473|NCT02436499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987485|NCT02331563|Sensory System Agents|sensory system agents|mesh-ancestor
91987486|NCT02331563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987487|NCT02331563|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91987488|NCT02331563|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91987489|NCT02331563|Analgesics|analgesics|mesh-ancestor
91987490|NCT02331563|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91987491|NCT02331563|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91987492|NCT02331563|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91987493|NCT02331563|Adrenergic Agents|adrenergic agents|mesh-ancestor
91987494|NCT02331563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987495|NCT02331563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987496|NCT02331173|Dorzolamide|dorzolamide|mesh-list
91987497|NCT02331173|Brinzolamide|brinzolamide|mesh-list
91987498|NCT02331173|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91987499|NCT02331173|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91987500|NCT02331173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987501|NCT02331173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987502|NCT02709109|Ivacaftor|ivacaftor|mesh-list
91987503|NCT02709109|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
91987504|NCT02709109|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987505|NCT02709109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987506|NCT03117595|Fentanyl|fentanyl|mesh-list
91987507|NCT03117595|Morphine|morphine|mesh-list
91987508|NCT03117595|Bupivacaine|bupivacaine|mesh-list
91987509|NCT03117595|Anesthetics, Local|anesthetics, local|mesh-ancestor
91987510|NCT03117595|Anesthetics|anesthetics|mesh-ancestor
91987511|NCT03117595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987512|NCT03117595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987513|NCT03117595|Sensory System Agents|sensory system agents|mesh-ancestor
91987514|NCT03117595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987515|NCT03117595|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91970004|NCT02477267|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91970005|NCT02477267|Narcotics|narcotics|mesh-ancestor
91970006|NCT02477267|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970007|NCT02477267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987516|NCT03117595|Narcotics|narcotics|mesh-ancestor
91987517|NCT03117595|Analgesics|analgesics|mesh-ancestor
91987518|NCT03117595|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91987519|NCT03117595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91987520|NCT03117595|Anesthetics, General|anesthetics, general|mesh-ancestor
91987521|NCT02039531|Mitogens|mitogens|mesh-list
91987522|NCT02039531|Hyaluronic Acid|hyaluronic acid|mesh-list
91987523|NCT02039531|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987524|NCT02039531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987525|NCT02039531|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91987526|NCT02039531|Immunologic Factors|immunologic factors|mesh-ancestor
91987527|NCT02039531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987528|NCT02039531|Viscosupplements|viscosupplements|mesh-ancestor
91987529|NCT02039531|Protective Agents|protective agents|mesh-ancestor
91987530|NCT02331251|Paclitaxel|paclitaxel|mesh-list
91987531|NCT02331251|Vinorelbine|vinorelbine|mesh-list
91987532|NCT02331251|Docetaxel|docetaxel|mesh-list
91987533|NCT02331251|Gemcitabine|gemcitabine|mesh-list
91987534|NCT02331251|Doxorubicin|doxorubicin|mesh-list
91987535|NCT02331251|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91987536|NCT02331251|Pembrolizumab|pembrolizumab|mesh-list
91987537|NCT02331251|Irinotecan|irinotecan|mesh-list
91987538|NCT02331251|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91987539|NCT02331251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987541|NCT02331251|Antimitotic Agents|antimitotic agents|mesh-ancestor
91987542|NCT02331251|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987543|NCT02331251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987544|NCT02331251|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91987545|NCT02331251|Antimetabolites|antimetabolites|mesh-ancestor
91987546|NCT02331251|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91987547|NCT02331251|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91987548|NCT02331251|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91987549|NCT02331251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987550|NCT02331251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91987551|NCT02331251|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91987552|NCT02331251|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91987554|NCT02435797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91987555|NCT02435797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91987556|NCT02435797|Vasodilator Agents|vasodilator agents|mesh-ancestor
91987557|NCT02435797|Vitamin B Complex|vitamin b complex|mesh-ancestor
91987559|NCT02435797|Micronutrients|micronutrients|mesh-ancestor
91987560|NCT02435797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987561|NCT02330705|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91987562|NCT02330705|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91987563|NCT02330705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987564|NCT02330783|Bevacizumab|bevacizumab|mesh-list
91987565|NCT02330783|Sorafenib|sorafenib|mesh-list
91987566|NCT02330783|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91987567|NCT02330783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987568|NCT02330783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91987569|NCT02330783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91987570|NCT02330783|Growth Substances|growth substances|mesh-ancestor
91987571|NCT02330783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987572|NCT02330783|Growth Inhibitors|growth inhibitors|mesh-ancestor
91987573|NCT02330783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91987574|NCT02330783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987575|NCT02330783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987576|NCT02335151|Desflurane|desflurane|mesh-list
91987577|NCT02335151|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91987578|NCT02335151|Anesthetics, General|anesthetics, general|mesh-ancestor
91987579|NCT02335151|Anesthetics|anesthetics|mesh-ancestor
91987580|NCT02335151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987581|NCT02335151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987582|NCT02441803|Cytarabine|cytarabine|mesh-list
91987583|NCT02441803|Mycophenolic Acid|mycophenolic acid|mesh-list
91987584|NCT02441803|Cyclophosphamide|cyclophosphamide|mesh-list
91987585|NCT02441803|Busulfan|busulfan|mesh-list
91987586|NCT02441803|Fludarabine|fludarabine|mesh-list
91987587|NCT02441803|Fludarabine phosphate|fludarabine phosphate|mesh-list
91987588|NCT02441803|Decitabine|decitabine|mesh-list
91970009|NCT02477267|Sensory System Agents|sensory system agents|mesh-ancestor
91970010|NCT02477267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987589|NCT02441803|Idarubicin|idarubicin|mesh-list
91987590|NCT02441803|Clofarabine|clofarabine|mesh-list
91987591|NCT02441803|Tacrolimus|tacrolimus|mesh-list
91987592|NCT02441803|Thymoglobulin|thymoglobulin|mesh-list
91987593|NCT02441803|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91987594|NCT02441803|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91987595|NCT02441803|Immunologic Factors|immunologic factors|mesh-ancestor
91987596|NCT02441803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987597|NCT02441803|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91987598|NCT02441803|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91987599|NCT02441803|Alkylating Agents|alkylating agents|mesh-ancestor
91987600|NCT02441803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987601|NCT02441803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987602|NCT02441803|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91987603|NCT02441803|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91987604|NCT02441803|Antimetabolites|antimetabolites|mesh-ancestor
91987605|NCT02441803|Antiviral Agents|antiviral agents|mesh-ancestor
91987606|NCT02441803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987607|NCT02441803|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91987608|NCT02441803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987609|NCT02441803|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91987610|NCT02441803|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91987611|NCT02441803|Antitubercular Agents|antitubercular agents|mesh-ancestor
91987612|NCT02441803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987613|NCT02441803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91987614|NCT02441803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91987615|NCT02709655|Vortioxetine|vortioxetine|mesh-list
91987616|NCT02709655|Fluoxetine|fluoxetine|mesh-list
91987618|NCT02709655|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91987619|NCT02709655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987620|NCT02709655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987621|NCT02709655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987623|NCT02709655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987624|NCT02709655|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91987625|NCT02709655|Antidepressive Agents|antidepressive agents|mesh-ancestor
91987626|NCT02709655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987627|NCT02709655|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91987628|NCT02709655|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987629|NCT02709655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987630|NCT02709655|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987631|NCT02709655|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987632|NCT02709655|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987633|NCT02709655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91987634|NCT02709655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91987635|NCT02709655|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91987636|NCT02709655|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91987638|NCT02334605|Antipruritics|antipruritics|mesh-ancestor
91987639|NCT02334605|Dermatologic Agents|dermatologic agents|mesh-ancestor
91987640|NCT02334605|Sensory System Agents|sensory system agents|mesh-ancestor
91987641|NCT02334605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987642|NCT02334605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987643|NCT02329535|Progesterone|progesterone|mesh-list
91987644|NCT02329535|Progestins|progestins|mesh-ancestor
91987645|NCT02329535|Hormones|hormones|mesh-ancestor
91987646|NCT02329535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987647|NCT02329535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987648|NCT03187795|Mirabegron|mirabegron|mesh-list
91987649|NCT03187795|Oxybutynin|oxybutynin|mesh-list
91987650|NCT03187795|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91987651|NCT03187795|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91987652|NCT03187795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91987653|NCT03187795|Adrenergic Agents|adrenergic agents|mesh-ancestor
91987654|NCT03187795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987655|NCT03187795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987656|NCT03187795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987657|NCT03187795|Urological Agents|urological agents|mesh-ancestor
91987658|NCT03187795|Parasympatholytics|parasympatholytics|mesh-ancestor
91987659|NCT03187795|Autonomic Agents|autonomic agents|mesh-ancestor
91970011|NCT02477267|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91970012|NCT03196843|Raltitrexed|raltitrexed|mesh-list
91987660|NCT03187795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987661|NCT03187795|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91987662|NCT03187795|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91987663|NCT03187795|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987664|NCT02435563|Ritonavir|ritonavir|mesh-list
91987665|NCT02435563|Ticagrelor|ticagrelor|mesh-list
91987666|NCT02435563|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91987667|NCT02435563|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91987668|NCT02435563|Protease Inhibitors|protease inhibitors|mesh-ancestor
91987669|NCT02435563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987670|NCT02435563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987671|NCT02435563|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91987672|NCT02435563|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91987673|NCT02435563|Antiviral Agents|antiviral agents|mesh-ancestor
91987674|NCT02435563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987675|NCT02435563|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91987676|NCT02435563|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987677|NCT02435563|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91987678|NCT02435563|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91987679|NCT02435563|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91987680|NCT02435563|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91987681|NCT02435563|Purinergic Agents|purinergic agents|mesh-ancestor
91987682|NCT02435563|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987683|NCT02435563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987684|NCT04031729|Aspirin|aspirin|mesh-list
91987685|NCT04031729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91987686|NCT04031729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91987687|NCT04031729|Analgesics|analgesics|mesh-ancestor
91987691|NCT04031729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987692|NCT04031729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91987693|NCT04031729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91987694|NCT04031729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91987695|NCT04031729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987696|NCT04031729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91987697|NCT04031729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91987698|NCT04031729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987700|NCT02433847|Mosapride|mosapride|mesh-list
91987701|NCT02433847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91987702|NCT02433847|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91987703|NCT02433847|Serotonin Agents|serotonin agents|mesh-ancestor
91987704|NCT02433847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987705|NCT02433847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987706|NCT02433847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987707|NCT02435095|Antipsychotic Agents|antipsychotic agents|mesh-list
91987708|NCT02435095|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987709|NCT02435095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987710|NCT02435095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987711|NCT02435095|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987712|NCT02328521|Nicorandil|nicorandil|mesh-list
91987713|NCT02328521|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91987714|NCT02328521|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91987715|NCT02328521|Vasodilator Agents|vasodilator agents|mesh-ancestor
91987716|NCT02328521|Vitamin B Complex|vitamin b complex|mesh-ancestor
91987717|NCT02328521|Vitamins|vitamins|mesh-ancestor
91987718|NCT02328521|Micronutrients|micronutrients|mesh-ancestor
91987719|NCT02328521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987720|NCT03831503|Antibodies|antibodies|mesh-list
91987721|NCT03831503|Immunologic Factors|immunologic factors|mesh-ancestor
91987722|NCT03831503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987723|NCT03187093|Vortioxetine|vortioxetine|mesh-list
91987724|NCT03187093|Escitalopram|escitalopram|mesh-list
91987725|NCT03187093|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91987726|NCT03187093|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91987727|NCT03187093|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987728|NCT03187093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987729|NCT03187093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987730|NCT03187093|Serotonin Agents|serotonin agents|mesh-ancestor
91987731|NCT03187093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987732|NCT03187093|Antidepressive Agents|antidepressive agents|mesh-ancestor
91970013|NCT03196843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91970014|NCT03196843|Antimetabolites|antimetabolites|mesh-ancestor
91987733|NCT03187093|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987734|NCT03187093|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987735|NCT03187093|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987736|NCT03187093|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987737|NCT03187093|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91987738|NCT03187093|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91987739|NCT03187093|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91987740|NCT03187093|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91987741|NCT02039999|Citric Acid|citric acid|mesh-list
91987742|NCT02039999|Sodium Citrate|sodium citrate|mesh-list
91987743|NCT02039999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91987744|NCT02039999|Anticoagulants|anticoagulants|mesh-ancestor
91987745|NCT02039999|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91987746|NCT02039999|Chelating Agents|chelating agents|mesh-ancestor
91987747|NCT02039999|Sequestering Agents|sequestering agents|mesh-ancestor
91987748|NCT02039999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987749|NCT02434861|Sulfasalazine|sulfasalazine|mesh-list
91987750|NCT02434861|Digoxin|digoxin|mesh-list
91987751|NCT02434861|Rolapitant|rolapitant|mesh-list
91987752|NCT02434861|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91987753|NCT02434861|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91987754|NCT02434861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987755|NCT02434861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987756|NCT02434861|Protective Agents|protective agents|mesh-ancestor
91987757|NCT02434861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987758|NCT02434861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987763|NCT02434861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987764|NCT02434861|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987765|NCT02434861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91987766|NCT02434861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91987767|NCT02434861|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
91987768|NCT02434861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987769|NCT03187015|Entinostat|entinostat|mesh-list
91987770|NCT03187015|Midazolam|midazolam|mesh-list
91987771|NCT03187015|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91987772|NCT03187015|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91987773|NCT03187015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987774|NCT03187015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987775|NCT03187015|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987776|NCT03187015|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987777|NCT03187015|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987778|NCT03187015|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91987779|NCT03187015|Anesthetics, General|anesthetics, general|mesh-ancestor
91987780|NCT03187015|Anesthetics|anesthetics|mesh-ancestor
91987781|NCT03187015|GABA Modulators|gaba modulators|mesh-ancestor
91987782|NCT03187015|GABA Agents|gaba agents|mesh-ancestor
91987783|NCT03187015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987784|NCT03187015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987785|NCT03187015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987786|NCT03187015|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91987787|NCT03187015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987788|NCT02328053|Voriconazole|voriconazole|mesh-list
91987789|NCT02328053|Natamycin|natamycin|mesh-list
91987790|NCT02328053|Antifungal Agents|antifungal agents|mesh-list
91987791|NCT02328053|Clotrimazole|clotrimazole|mesh-list
91987792|NCT02328053|Miconazole|miconazole|mesh-list
91987793|NCT02328053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987794|NCT02328053|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91987795|NCT02328053|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987796|NCT02328053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987797|NCT02328053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987798|NCT02328053|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91987799|NCT02328053|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987800|NCT02328053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987801|NCT02328053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987802|NCT02328053|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91987803|NCT02328053|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91987804|NCT02328053|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987805|NCT02328053|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91987806|NCT02022748|Ticagrelor|ticagrelor|mesh-list
91987807|NCT02022748|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91970015|NCT03196843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970016|NCT03196843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970017|NCT03196843|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91987808|NCT02022748|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91987809|NCT02022748|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91987810|NCT02022748|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91987811|NCT02022748|Purinergic Agents|purinergic agents|mesh-ancestor
91987812|NCT02022748|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987813|NCT02022748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987814|NCT02022748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987815|NCT02333513|Vincristine|vincristine|mesh-list
91987816|NCT02333513|Lomustine|lomustine|mesh-list
91987817|NCT02333513|Procarbazine|procarbazine|mesh-list
91987818|NCT02333513|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91987819|NCT02333513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987820|NCT02333513|Tubulin Modulators|tubulin modulators|mesh-ancestor
91987821|NCT02333513|Antimitotic Agents|antimitotic agents|mesh-ancestor
91987822|NCT02333513|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987823|NCT02333513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987824|NCT02333513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91987825|NCT02333513|Alkylating Agents|alkylating agents|mesh-ancestor
91987826|NCT02434549|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91987827|NCT02434549|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91987828|NCT02434549|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91987850|NCT02328443|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91987852|NCT02328443|Anesthetics|anesthetics|mesh-ancestor
91987853|NCT02328443|GABA Modulators|gaba modulators|mesh-ancestor
91987854|NCT02328443|GABA Agents|gaba agents|mesh-ancestor
91987855|NCT02328443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987856|NCT02328443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987857|NCT02328443|Antifungal Agents|antifungal agents|mesh-ancestor
91987858|NCT02328443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987859|NCT02328443|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91987860|NCT02328443|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91987861|NCT02328443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987862|NCT02328443|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91987863|NCT02328443|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987864|NCT02328443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987865|NCT02328443|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91987866|NCT02328443|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91987867|NCT02328443|Antitubercular Agents|antitubercular agents|mesh-ancestor
91987868|NCT02328443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987869|NCT02328443|Leprostatic Agents|leprostatic agents|mesh-ancestor
91987870|NCT02328443|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91987871|NCT02328443|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91987872|NCT02328443|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91987873|NCT02328443|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91987874|NCT02328443|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91987875|NCT02328443|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91987876|NCT02328443|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91987877|NCT02039765|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91987878|NCT02039765|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91987879|NCT02039765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91987880|NCT02039765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91987895|NCT03191539|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91987896|NCT03191539|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91987897|NCT03191539|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987898|NCT03191539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987899|NCT02433925|Resveratrol|resveratrol|mesh-list
91987900|NCT02433925|Antioxidants|antioxidants|mesh-ancestor
91987901|NCT02433925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987902|NCT02433925|Protective Agents|protective agents|mesh-ancestor
91987903|NCT02433925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987904|NCT02433925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987905|NCT02433925|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91987906|NCT02332967|Palmitic Acid|palmitic acid|mesh-list
91970018|NCT03196843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970019|NCT02476955|Paclitaxel|paclitaxel|mesh-list
91970020|NCT02476955|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91987907|NCT02332967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987908|NCT02332967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987909|NCT02327663|Emtricitabine|emtricitabine|mesh-list
91987910|NCT02327663|Antiviral Agents|antiviral agents|mesh-ancestor
91987911|NCT02327663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987912|NCT02327663|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91987913|NCT02327663|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91987914|NCT02327663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987915|NCT02327663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987916|NCT02327663|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91987917|NCT02327663|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91987918|NCT02333123|Aspirin|aspirin|mesh-list
91987919|NCT02333123|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91987920|NCT02333123|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91987921|NCT02333123|Analgesics|analgesics|mesh-ancestor
91987922|NCT02333123|Sensory System Agents|sensory system agents|mesh-ancestor
91987923|NCT02333123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987924|NCT02333123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987925|NCT02333123|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987927|NCT02333123|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91987928|NCT02333123|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91987929|NCT02333123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987930|NCT02333123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91987931|NCT02333123|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91987932|NCT02333123|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987933|NCT02333123|Antipyretics|antipyretics|mesh-ancestor
91987934|NCT02332811|Sevelamer|sevelamer|mesh-list
91987935|NCT02332811|Chelating Agents|chelating agents|mesh-ancestor
91987936|NCT02332811|Sequestering Agents|sequestering agents|mesh-ancestor
91987937|NCT02332811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987938|NCT02433457|Omeprazole|omeprazole|mesh-list
91987939|NCT02433457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92090428|NCT04416035|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987941|NCT02433457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91987942|NCT02433457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987943|NCT02433457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987944|NCT02021656|Sofosbuvir|sofosbuvir|mesh-list
91987945|NCT02021656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
91987946|NCT02021656|Ledipasvir|ledipasvir|mesh-list
91987947|NCT02021656|Antiviral Agents|antiviral agents|mesh-ancestor
91987948|NCT02021656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91987949|NCT03145025|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
91987950|NCT03145025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987951|NCT03145025|Glucocorticoids|glucocorticoids|mesh-ancestor
91987952|NCT03145025|Hormones|hormones|mesh-ancestor
91987953|NCT03145025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987954|NCT03145025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987955|NCT03144947|Docetaxel|docetaxel|mesh-list
91987956|NCT03144947|Trastuzumab|trastuzumab|mesh-list
91987957|NCT03144947|Pertuzumab|pertuzumab|mesh-list
91987958|NCT03144947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987959|NCT03144947|Tubulin Modulators|tubulin modulators|mesh-ancestor
91987960|NCT03144947|Antimitotic Agents|antimitotic agents|mesh-ancestor
91987961|NCT03144947|Mitosis Modulators|mitosis modulators|mesh-ancestor
91987962|NCT03144947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987963|NCT03144947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91987964|NCT02433535|Simvastatin|simvastatin|mesh-list
91987965|NCT02433535|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91987966|NCT02433535|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91987967|NCT02433535|Antimetabolites|antimetabolites|mesh-ancestor
91987968|NCT02433535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987969|NCT02433535|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91987970|NCT02433535|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91987971|NCT02433535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91987972|NCT03144713|Terlipressin|terlipressin|mesh-list
91987973|NCT03144713|Midodrine|midodrine|mesh-list
91987974|NCT03144713|Sympathomimetics|sympathomimetics|mesh-ancestor
91987975|NCT03144713|Autonomic Agents|autonomic agents|mesh-ancestor
91987976|NCT03144713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987977|NCT03144713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970021|NCT02476955|Carboplatin|carboplatin|mesh-list
91970022|NCT02476955|Anastrozole|anastrozole|mesh-list
91970023|NCT02476955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91970024|NCT02476955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987978|NCT03144713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91987979|NCT03144713|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91987980|NCT03144713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91987981|NCT03144713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91987982|NCT03144713|Adrenergic Agents|adrenergic agents|mesh-ancestor
91987983|NCT03144713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987984|NCT03144713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987985|NCT03144713|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91987986|NCT03191383|Vaccines|vaccines|mesh-list
91987987|NCT03191383|Immunologic Factors|immunologic factors|mesh-ancestor
91987988|NCT03191383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987989|NCT02075632|Alclometasone dipropionate|alclometasone dipropionate|mesh-list
91987990|NCT02075632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987991|NCT02075632|Glucocorticoids|glucocorticoids|mesh-ancestor
91987992|NCT02075632|Hormones|hormones|mesh-ancestor
91987993|NCT02075632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987994|NCT02075632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987995|NCT02430259|Isoniazid|isoniazid|mesh-list
91987996|NCT02430259|Rifapentine|rifapentine|mesh-list
91987997|NCT02430259|Antitubercular Agents|antitubercular agents|mesh-ancestor
91987998|NCT02430259|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91987999|NCT02430259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988000|NCT02430259|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91988001|NCT02430259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91988002|NCT02430259|Antimetabolites|antimetabolites|mesh-ancestor
91988003|NCT02430259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988004|NCT02430259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91988005|NCT02430259|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91988006|NCT02430259|Leprostatic Agents|leprostatic agents|mesh-ancestor
91988007|NCT02327039|Dapagliflozin|dapagliflozin|mesh-list
91988008|NCT02327039|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91988009|NCT02327039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988010|NCT02327039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91988011|NCT02327039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988012|NCT03142607|Chlorhexidine|chlorhexidine|mesh-list
91988013|NCT03142607|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91988024|NCT03186547|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91988025|NCT03186547|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91988026|NCT03186547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988027|NCT03186547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988028|NCT03186547|Cholinergic Agents|cholinergic agents|mesh-ancestor
91988029|NCT03186547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988030|NCT03186547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988031|NCT03186547|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91988032|NCT03186547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988033|NCT05077475|Cryptophycin 52|cryptophycin 52|mesh-list
91988034|NCT05077475|Antimitotic Agents|antimitotic agents|mesh-ancestor
91988035|NCT05077475|Mitosis Modulators|mitosis modulators|mesh-ancestor
91988036|NCT05077475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988037|NCT05077475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988038|NCT02326727|Fentanyl|fentanyl|mesh-list
91988039|NCT02326727|Nitrous Oxide|nitrous oxide|mesh-list
91988040|NCT02326727|Propofol|propofol|mesh-list
91988041|NCT02326727|Ropivacaine|ropivacaine|mesh-list
91988042|NCT02326727|Isoflurane|isoflurane|mesh-list
91988043|NCT02326727|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91988044|NCT02326727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988045|NCT02326727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988046|NCT02326727|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91988047|NCT02326727|Anesthetics, General|anesthetics, general|mesh-ancestor
91988048|NCT02326727|Anesthetics|anesthetics|mesh-ancestor
91988049|NCT02326727|Anesthetics, Local|anesthetics, local|mesh-ancestor
91988050|NCT02326727|Sensory System Agents|sensory system agents|mesh-ancestor
91988051|NCT02326727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988052|NCT02326727|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91988053|NCT02326727|Narcotics|narcotics|mesh-ancestor
91988054|NCT02326727|Analgesics|analgesics|mesh-ancestor
91970026|NCT02476955|Antimitotic Agents|antimitotic agents|mesh-ancestor
91970027|NCT02476955|Mitosis Modulators|mitosis modulators|mesh-ancestor
91988055|NCT02326727|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91988056|NCT02326727|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91988057|NCT02326727|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988058|NCT02432911|Cytarabine|cytarabine|mesh-list
91988059|NCT02432911|Aclacinomycins|aclacinomycins|mesh-list
91988060|NCT02432911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91988061|NCT02432911|Antimetabolites|antimetabolites|mesh-ancestor
91988062|NCT02432911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988063|NCT02432911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988064|NCT02432911|Antiviral Agents|antiviral agents|mesh-ancestor
91988065|NCT02432911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988066|NCT02432911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91988067|NCT02432911|Immunologic Factors|immunologic factors|mesh-ancestor
91988068|NCT02432911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988069|NCT02432911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91988070|NCT02432911|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91988071|NCT03588767|Vitamin D|vitamin d|mesh-list
91988072|NCT03588767|Ergocalciferols|ergocalciferols|mesh-list
91988073|NCT03588767|Cholecalciferol|cholecalciferol|mesh-list
91988074|NCT03588767|Vitamins|vitamins|mesh-list
91988075|NCT03588767|Anabolic Androgenic Steroids|anabolic androgenic steroids|mesh-list
91988076|NCT03588767|Testosterone Congeners|testosterone congeners|mesh-list
91988077|NCT03588767|Micronutrients|micronutrients|mesh-ancestor
91988078|NCT03588767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988079|NCT03588767|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91988080|NCT03588767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91988081|NCT03588767|Anabolic Agents|anabolic agents|mesh-ancestor
91988095|NCT02440399|Sensory System Agents|sensory system agents|mesh-ancestor
91988096|NCT02440399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988097|NCT02440399|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988098|NCT02440399|Antipyretics|antipyretics|mesh-ancestor
91988099|NCT02440399|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91988100|NCT02440399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988101|NCT02440399|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988102|NCT02440399|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91988103|NCT02440399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988104|NCT02440399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988105|NCT03574571|Docetaxel|docetaxel|mesh-list
91988106|NCT03574571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988107|NCT03574571|Tubulin Modulators|tubulin modulators|mesh-ancestor
91988108|NCT03574571|Antimitotic Agents|antimitotic agents|mesh-ancestor
91988109|NCT03574571|Mitosis Modulators|mitosis modulators|mesh-ancestor
91988110|NCT03574571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988111|NCT02429713|Oxymetazoline|oxymetazoline|mesh-list
91988112|NCT02429713|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91988113|NCT02429713|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91988114|NCT02429713|Adrenergic Agents|adrenergic agents|mesh-ancestor
91988115|NCT02429713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988116|NCT02429713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988117|NCT02429713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988118|NCT02429713|Sympathomimetics|sympathomimetics|mesh-ancestor
91988119|NCT02429713|Autonomic Agents|autonomic agents|mesh-ancestor
91988120|NCT02429713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988121|NCT02429713|Nasal Decongestants|nasal decongestants|mesh-ancestor
91988122|NCT02429713|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91988123|NCT02429713|Respiratory System Agents|respiratory system agents|mesh-ancestor
91988124|NCT03191305|Warfarin|warfarin|mesh-list
91988125|NCT03191305|Anticoagulants|anticoagulants|mesh-ancestor
91988126|NCT03144401|Misoprostol|misoprostol|mesh-list
91988127|NCT03144401|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91988128|NCT03144401|Abortifacient Agents|abortifacient agents|mesh-ancestor
91988129|NCT03144401|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91988130|NCT03144401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988131|NCT03144401|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91988132|NCT03144401|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988133|NCT03144401|Oxytocics|oxytocics|mesh-ancestor
91988134|NCT04483765|Anesthetics|anesthetics|mesh-list
91988135|NCT04483765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970028|NCT02476955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970029|NCT02476955|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91988136|NCT04483765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988138|NCT03186313|Sofosbuvir|sofosbuvir|mesh-list
91988139|NCT03186313|Antimetabolites|antimetabolites|mesh-ancestor
91988140|NCT03186313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988141|NCT03186313|Antiviral Agents|antiviral agents|mesh-ancestor
91988142|NCT03186313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988143|NCT03144245|Pembrolizumab|pembrolizumab|mesh-list
91988144|NCT03144245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91988145|NCT03144245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988164|NCT04996199|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91988165|NCT04996199|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91988166|NCT04996199|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91988167|NCT04996199|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91988168|NCT04996199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988169|NCT04996199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988170|NCT04996199|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
91988171|NCT04996199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988172|NCT04996199|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91988173|NCT04996199|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988174|NCT04996199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988176|NCT02432833|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91988177|NCT02432833|Immunologic Factors|immunologic factors|mesh-ancestor
91988178|NCT02432833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988179|NCT02432833|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91988180|NCT02432833|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988181|NCT02432833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988182|NCT02429323|Sevoflurane|sevoflurane|mesh-list
91988183|NCT02429323|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91988184|NCT02429323|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91988185|NCT02429323|Anesthetics, General|anesthetics, general|mesh-ancestor
91988186|NCT02429323|Anesthetics|anesthetics|mesh-ancestor
91988187|NCT02429323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988188|NCT02429323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988189|NCT02326103|Ciprofloxacin|ciprofloxacin|mesh-list
91988190|NCT02326103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91988191|NCT02326103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988192|NCT02326103|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91988193|NCT02326103|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91988194|NCT02326103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988195|NCT02326103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988196|NCT02326103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988197|NCT02326103|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91988198|NCT02326103|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988199|NCT04984733|Nivolumab|nivolumab|mesh-list
91988201|NCT04984733|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91988202|NCT04984733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988203|NCT04984733|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91988204|NCT04984733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988205|NCT04984733|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91988206|NCT04984733|Alkylating Agents|alkylating agents|mesh-ancestor
91988207|NCT02707861|Ibalizumab|ibalizumab|mesh-list
91988208|NCT02707861|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91988209|NCT02707861|Antiviral Agents|antiviral agents|mesh-ancestor
91988210|NCT02707861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988211|NCT02707861|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91988212|NCT02432599|Choline|choline|mesh-list
91988213|NCT02432599|Lipotropic Agents|lipotropic agents|mesh-ancestor
91988214|NCT02432599|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91988215|NCT02432599|Antimetabolites|antimetabolites|mesh-ancestor
91988216|NCT02432599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988217|NCT02432599|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988218|NCT02432599|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91988219|NCT02432599|Nootropic Agents|nootropic agents|mesh-ancestor
91988220|NCT03185143|Acetaminophen|acetaminophen|mesh-list
91988221|NCT03185143|Sumatriptan|sumatriptan|mesh-list
91988222|NCT03185143|Naltrexone|naltrexone|mesh-list
91988223|NCT03185143|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988224|NCT03185143|Analgesics|analgesics|mesh-ancestor
91970030|NCT02476955|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91970031|NCT02476955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91970032|NCT02476955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970033|NCT02476955|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91970034|NCT02476955|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970035|NCT02476955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988225|NCT03185143|Sensory System Agents|sensory system agents|mesh-ancestor
91988226|NCT03185143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988227|NCT03185143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988228|NCT03185143|Antipyretics|antipyretics|mesh-ancestor
91988229|NCT03185143|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91988230|NCT03185143|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91988231|NCT03185143|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91988232|NCT03185143|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91988233|NCT03185143|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91988234|NCT03185143|Serotonin Agents|serotonin agents|mesh-ancestor
91988235|NCT03185143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988236|NCT03185143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988237|NCT05076773|Morphine|morphine|mesh-list
91988238|NCT05076773|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91988239|NCT05076773|Narcotics|narcotics|mesh-ancestor
91988240|NCT05076773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988241|NCT05076773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988242|NCT05076773|Analgesics|analgesics|mesh-ancestor
91988243|NCT05076773|Sensory System Agents|sensory system agents|mesh-ancestor
91988244|NCT05076773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988245|NCT02432677|Remifentanil|remifentanil|mesh-list
91988246|NCT02432677|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91988247|NCT02432677|Narcotics|narcotics|mesh-ancestor
91988248|NCT02432677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988249|NCT02432677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988250|NCT02432677|Analgesics|analgesics|mesh-ancestor
91988251|NCT02432677|Sensory System Agents|sensory system agents|mesh-ancestor
91988252|NCT02432677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988253|NCT03442673|Gemcitabine|gemcitabine|mesh-list
91988254|NCT03442673|Vinorelbine|vinorelbine|mesh-list
91988255|NCT03442673|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91988256|NCT03442673|Antimetabolites|antimetabolites|mesh-ancestor
91988257|NCT03442673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988258|NCT03442673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988259|NCT03442673|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91988260|NCT03442673|Tubulin Modulators|tubulin modulators|mesh-ancestor
91988261|NCT03442673|Antimitotic Agents|antimitotic agents|mesh-ancestor
91988262|NCT03442673|Mitosis Modulators|mitosis modulators|mesh-ancestor
91988263|NCT02432365|Paclitaxel|paclitaxel|mesh-list
91988264|NCT02432365|Cisplatin|cisplatin|mesh-list
91988265|NCT02432365|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91988266|NCT02432365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988267|NCT02432365|Tubulin Modulators|tubulin modulators|mesh-ancestor
91988268|NCT02432365|Antimitotic Agents|antimitotic agents|mesh-ancestor
91988269|NCT02432365|Mitosis Modulators|mitosis modulators|mesh-ancestor
91988270|NCT02432365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988271|NCT05076695|Trastuzumab|trastuzumab|mesh-list
91988272|NCT05076695|Fulvestrant|fulvestrant|mesh-list
91988273|NCT05076695|Palbociclib|palbociclib|mesh-list
91988274|NCT05076695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91988275|NCT05076695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988287|NCT03143933|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91988288|NCT03143933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988289|NCT03143933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988290|NCT03143933|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91988291|NCT03143933|Anesthetics, General|anesthetics, general|mesh-ancestor
91988292|NCT03143933|Anesthetics|anesthetics|mesh-ancestor
91988293|NCT03143933|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91988294|NCT03143933|Narcotics|narcotics|mesh-ancestor
91988295|NCT03143933|Analgesics|analgesics|mesh-ancestor
91988296|NCT03143933|Sensory System Agents|sensory system agents|mesh-ancestor
91988297|NCT03143933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988298|NCT03143933|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91970036|NCT02476955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970037|NCT02634801|Methotrexate|methotrexate|mesh-list
91970038|NCT02634801|Ixekizumab|ixekizumab|mesh-list
91970039|NCT02634801|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91988300|NCT02440243|Immunologic Factors|immunologic factors|mesh-ancestor
91988301|NCT02440243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988302|NCT04705259|Anti-Infective Agents|anti-infective agents|mesh-list
91988303|NCT04705259|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91988304|NCT05076461|Ondansetron|ondansetron|mesh-list
91988305|NCT05076461|Antiemetics|antiemetics|mesh-ancestor
91988306|NCT05076461|Autonomic Agents|autonomic agents|mesh-ancestor
91988307|NCT05076461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988308|NCT05076461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988309|NCT05076461|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988310|NCT05076461|Antipruritics|antipruritics|mesh-ancestor
91988311|NCT05076461|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988312|NCT05076461|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91988313|NCT05076461|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91988314|NCT05076461|Serotonin Agents|serotonin agents|mesh-ancestor
91988315|NCT05076461|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988316|NCT05076461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988317|NCT02428933|Bromocriptine|bromocriptine|mesh-list
91988318|NCT02428933|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91988319|NCT02428933|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91988320|NCT02428933|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988321|NCT02428933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988322|NCT02428933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988323|NCT02428933|Dopamine Agonists|dopamine agonists|mesh-ancestor
91988324|NCT02428933|Dopamine Agents|dopamine agents|mesh-ancestor
91988325|NCT02428933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988326|NCT02428933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988328|NCT02428777|Tramadol|tramadol|mesh-list
91988329|NCT02428777|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91988330|NCT02428777|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988331|NCT02428777|Analgesics|analgesics|mesh-ancestor
91988332|NCT02428777|Sensory System Agents|sensory system agents|mesh-ancestor
91988333|NCT02428777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988334|NCT02428777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988335|NCT02428777|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988336|NCT02428777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988337|NCT02428777|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91988338|NCT02428777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988341|NCT02428777|Narcotics|narcotics|mesh-ancestor
91988342|NCT02428777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988343|NCT02432053|Tacrolimus|tacrolimus|mesh-list
91988344|NCT02432053|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91988345|NCT02432053|Immunologic Factors|immunologic factors|mesh-ancestor
91988346|NCT02432053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988347|NCT02432053|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91988348|NCT02432053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988349|NCT02432053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988350|NCT03141827|Insulin|insulin|mesh-list
91988351|NCT03141827|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91988352|NCT03141827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988353|NCT03190681|Methylphenidate|methylphenidate|mesh-list
91988354|NCT03190681|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91988355|NCT03190681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988356|NCT03190681|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91988357|NCT03190681|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91988358|NCT03190681|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988359|NCT03190681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988360|NCT03190681|Dopamine Agents|dopamine agents|mesh-ancestor
91988361|NCT03190681|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988362|NCT03186001|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91988363|NCT03186001|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91988364|NCT03186001|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91988365|NCT03186001|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988366|NCT03186001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970040|NCT02634801|Abortifacient Agents|abortifacient agents|mesh-ancestor
91970041|NCT02634801|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91970042|NCT02634801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988367|NCT03186001|Cholinergic Agents|cholinergic agents|mesh-ancestor
91988368|NCT03186001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988369|NCT03186001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988370|NCT03186001|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91988371|NCT03186001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988372|NCT04593563|Psilocybin|psilocybin|mesh-list
91988373|NCT04593563|Hallucinogens|hallucinogens|mesh-ancestor
91988374|NCT04593563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988375|NCT04593563|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91988376|NCT04551911|Calcifediol|calcifediol|mesh-list
91988377|NCT04551911|Vitamins|vitamins|mesh-ancestor
91988378|NCT04551911|Micronutrients|micronutrients|mesh-ancestor
91988379|NCT04551911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988380|NCT04551911|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91988381|NCT02431975|Ritonavir|ritonavir|mesh-list
91988382|NCT02431975|Lopinavir|lopinavir|mesh-list
91988383|NCT02431975|Lamivudine|lamivudine|mesh-list
91988384|NCT02431975|Zidovudine|zidovudine|mesh-list
91988385|NCT02431975|Nevirapine|nevirapine|mesh-list
91988386|NCT02431975|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91988387|NCT02431975|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91988388|NCT02431975|Protease Inhibitors|protease inhibitors|mesh-ancestor
91988389|NCT02431975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988390|NCT02431975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988391|NCT02431975|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91988392|NCT02431975|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91988393|NCT02431975|Antiviral Agents|antiviral agents|mesh-ancestor
91988394|NCT02431975|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988395|NCT02431975|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91988396|NCT02431975|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988397|NCT02431975|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91988398|NCT02431975|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91988399|NCT02431975|Antimetabolites|antimetabolites|mesh-ancestor
91988400|NCT02431975|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91988401|NCT02431975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91988402|NCT03143465|Calcitonin|calcitonin|mesh-list
91988403|NCT03143465|Salmon calcitonin|salmon calcitonin|mesh-list
91988404|NCT03143465|Sildenafil Citrate|sildenafil citrate|mesh-list
91988405|NCT03143465|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
91988406|NCT03143465|Katacalcin|katacalcin|mesh-list
91988407|NCT03143465|Vasodilator Agents|vasodilator agents|mesh-ancestor
91988408|NCT03143465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91988409|NCT03143465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91988410|NCT03143465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988425|NCT02428543|Antimetabolites|antimetabolites|mesh-ancestor
91988426|NCT02428543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988427|NCT02428543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988428|NCT02428543|Antiviral Agents|antiviral agents|mesh-ancestor
91988429|NCT02428543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988430|NCT02428543|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91988431|NCT02428543|Immunologic Factors|immunologic factors|mesh-ancestor
91988432|NCT02428543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988433|NCT02428543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91988434|NCT02428543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988436|NCT04428203|Anticonvulsants|anticonvulsants|mesh-ancestor
91988438|NCT02431663|Analgesics|analgesics|mesh-ancestor
91988439|NCT02431663|Sensory System Agents|sensory system agents|mesh-ancestor
91988440|NCT02431663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988441|NCT02431663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988442|NCT02431663|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91988443|NCT02431663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91988444|NCT02431663|Anesthetics, General|anesthetics, general|mesh-ancestor
91988445|NCT02431663|Anesthetics|anesthetics|mesh-ancestor
91988446|NCT02431663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988447|NCT02431663|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91988448|NCT02431663|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91988449|NCT02431663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988450|NCT02431663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970043|NCT02634801|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91988451|NCT03185845|Warfarin|warfarin|mesh-list
91988452|NCT03185845|Anticoagulants|anticoagulants|mesh-ancestor
91988453|NCT03182803|Antibodies|antibodies|mesh-list
91988454|NCT03182803|Immunologic Factors|immunologic factors|mesh-ancestor
91988455|NCT03182803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988456|NCT04596917|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
91988457|NCT04596917|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988458|NCT04596917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988459|NCT03185611|Rifaximin|rifaximin|mesh-list
91988460|NCT03185611|Azathioprine|azathioprine|mesh-list
91988461|NCT03185611|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91988462|NCT03185611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988463|NCT03185611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988464|NCT03185611|Antimetabolites|antimetabolites|mesh-ancestor
91988465|NCT03185611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988466|NCT03185611|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91988467|NCT03185611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988468|NCT03185611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91988469|NCT03185611|Immunologic Factors|immunologic factors|mesh-ancestor
91988474|NCT02431429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988475|NCT02431429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988476|NCT02431429|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91988477|NCT02431429|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91988479|NCT02027428|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91988480|NCT02027428|Carboplatin|carboplatin|mesh-list
91988481|NCT02027428|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91988482|NCT02027428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988483|NCT02027428|Tubulin Modulators|tubulin modulators|mesh-ancestor
91988484|NCT02027428|Antimitotic Agents|antimitotic agents|mesh-ancestor
91988485|NCT02027428|Mitosis Modulators|mitosis modulators|mesh-ancestor
91988486|NCT02027428|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988487|NCT03184363|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91988488|NCT03184363|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91988489|NCT03184363|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91988490|NCT03184363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988491|NCT03184363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988492|NCT03184363|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91988493|NCT03184363|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988494|NCT03184363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988495|NCT03184363|Cholinergic Agents|cholinergic agents|mesh-ancestor
91988496|NCT03184363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988497|NCT02431039|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91988498|NCT02431039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988499|NCT01995136|Travoprost|travoprost|mesh-list
91988500|NCT01995136|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91988501|NCT01995136|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91988502|NCT01995136|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91988503|NCT03141593|Vitamin D|vitamin d|mesh-list
91988504|NCT03141593|Ergocalciferols|ergocalciferols|mesh-list
91988505|NCT03141593|Cholecalciferol|cholecalciferol|mesh-list
91988506|NCT03141593|Vitamins|vitamins|mesh-list
91988507|NCT03141593|Micronutrients|micronutrients|mesh-ancestor
91988508|NCT03141593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988509|NCT03141593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91988510|NCT03141593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91988511|NCT04102241|Hemay005|hemay005|mesh-list
91988512|NCT04102241|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988513|NCT04102241|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91988514|NCT04102241|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91988515|NCT04102241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988516|NCT04102241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988517|NCT03576443|Idelalisib|idelalisib|mesh-list
91988518|NCT03576443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988519|NCT03576443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988520|NCT03576443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988521|NCT02427529|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
91988522|NCT02427529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91988523|NCT02427529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988524|NCT04667572|Riboflavin|riboflavin|mesh-list
91988525|NCT04667572|Vitamin B Complex|vitamin b complex|mesh-ancestor
91970045|NCT02634801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970046|NCT02634801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988526|NCT04667572|Vitamins|vitamins|mesh-ancestor
91988527|NCT04667572|Micronutrients|micronutrients|mesh-ancestor
91988528|NCT04667572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988529|NCT04667572|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91988530|NCT04667572|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988531|NCT04438733|Anastrozole|anastrozole|mesh-list
91988532|NCT04438733|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91988533|NCT04438733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988534|NCT04438733|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91988535|NCT04438733|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91988536|NCT04438733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988537|NCT04438733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988538|NCT04438733|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91988539|NCT04438733|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988540|NCT04438733|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988544|NCT04438811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988546|NCT02427295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988547|NCT02427295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91988548|NCT02427295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988549|NCT01994590|Prednisone|prednisone|mesh-list
91988550|NCT01994590|Abiraterone Acetate|abiraterone acetate|mesh-list
91988551|NCT01994590|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988552|NCT01994590|Glucocorticoids|glucocorticoids|mesh-ancestor
91988553|NCT01994590|Hormones|hormones|mesh-ancestor
91988554|NCT01994590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988555|NCT01994590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988556|NCT01994590|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91988557|NCT01994590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988558|NCT01994590|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91988559|NCT01994590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988560|NCT01994590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988561|NCT01994590|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988562|NCT01994590|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988563|NCT05387603|Capecitabine|capecitabine|mesh-list
91988564|NCT05387603|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
91988565|NCT05387603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91988566|NCT05387603|Antimetabolites|antimetabolites|mesh-ancestor
91988567|NCT05387603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988568|NCT05387603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988569|NCT05387603|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91988570|NCT03182413|Modafinil|modafinil|mesh-list
91988571|NCT03182413|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91988572|NCT03182413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988573|NCT03182413|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
91988574|NCT03182413|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91988575|NCT03182413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91988576|NCT03182413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988577|NCT03182257|ONO-7579|ono-7579|mesh-list
91988578|NCT03182257|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91988579|NCT03182257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988580|NCT03182257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988581|NCT03183739|ASP8062|asp8062|mesh-list
91988582|NCT03183739|Analgesics|analgesics|mesh-ancestor
91988583|NCT03183739|Sensory System Agents|sensory system agents|mesh-ancestor
91988584|NCT03183739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988585|NCT03183739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988586|NCT03183739|GABA Modulators|gaba modulators|mesh-ancestor
91988587|NCT03183739|GABA Agents|gaba agents|mesh-ancestor
91988588|NCT03183739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988589|NCT03183739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988590|NCT03117439|Antifungal Agents|antifungal agents|mesh-list
91988591|NCT03117439|Clotrimazole|clotrimazole|mesh-list
91988592|NCT03117439|Miconazole|miconazole|mesh-list
91988593|NCT03117439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988594|NCT03117439|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91988595|NCT03117439|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91988596|NCT03117439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91970047|NCT02634801|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988597|NCT03117439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988598|NCT03117439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988599|NCT03117439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91988600|NCT03117439|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988601|NCT03117439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988602|NCT03117439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988603|NCT03117439|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91988604|NCT03117439|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91988605|NCT02426905|Trientine|trientine|mesh-list
91988606|NCT02426905|Chelating Agents|chelating agents|mesh-ancestor
91988607|NCT02426905|Sequestering Agents|sequestering agents|mesh-ancestor
91988608|NCT02426905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988609|NCT02421289|Efavirenz|efavirenz|mesh-list
91988614|NCT02421289|Antiviral Agents|antiviral agents|mesh-ancestor
91988615|NCT02421289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988616|NCT02421289|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91988617|NCT02421289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988618|NCT02421289|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91988619|NCT02421289|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91988620|NCT02421289|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91988621|NCT02421289|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91988622|NCT03141125|Ethanol|ethanol|mesh-list
91988623|NCT03141125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91988624|NCT03141125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988625|NCT03141125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988626|NCT03141125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988627|NCT02426983|Dextromethorphan|dextromethorphan|mesh-list
91988628|NCT02426983|Antitussive Agents|antitussive agents|mesh-ancestor
91988629|NCT02426983|Respiratory System Agents|respiratory system agents|mesh-ancestor
91988630|NCT02426983|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91988631|NCT02426983|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91988632|NCT02426983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988633|NCT02426983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988634|NCT02426983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988635|NCT03142763|Choline|choline|mesh-list
91988636|NCT03142763|Lipotropic Agents|lipotropic agents|mesh-ancestor
91988637|NCT03142763|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91988638|NCT03142763|Antimetabolites|antimetabolites|mesh-ancestor
91988639|NCT03142763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988640|NCT03142763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988641|NCT03142763|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91988642|NCT03142763|Nootropic Agents|nootropic agents|mesh-ancestor
91988643|NCT03511391|Pembrolizumab|pembrolizumab|mesh-list
91988644|NCT03511391|Nivolumab|nivolumab|mesh-list
91988645|NCT03511391|Atezolizumab|atezolizumab|mesh-list
91988646|NCT03511391|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91988647|NCT03511391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91988648|NCT03511391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988649|NCT03511391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988650|NCT05081765|Olaparib|olaparib|mesh-list
91988651|NCT05081765|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91988652|NCT05081765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988653|NCT05081765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988654|NCT05081765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988655|NCT05078177|Rituximab|rituximab|mesh-list
91988656|NCT05078177|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91988657|NCT05078177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988658|NCT05078177|Immunologic Factors|immunologic factors|mesh-ancestor
91988659|NCT05078177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988660|NCT05078177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988661|NCT05081687|Oxaliplatin|oxaliplatin|mesh-list
91988662|NCT05081687|Irinotecan|irinotecan|mesh-list
91988663|NCT05081687|Folfirinox|folfirinox|mesh-list
91988664|NCT05081687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988665|NCT05081687|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91988666|NCT05081687|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91988667|NCT05081687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988668|NCT05081687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988669|NCT05387369|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
91988670|NCT05387369|Antiviral Agents|antiviral agents|mesh-ancestor
91988671|NCT05387369|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988673|NCT05080985|Anesthetics, Local|anesthetics, local|mesh-ancestor
91988674|NCT05080985|Anesthetics|anesthetics|mesh-ancestor
91988675|NCT05080985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988676|NCT05080985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988680|NCT03139487|Tinzaparin|tinzaparin|mesh-list
91988681|NCT03139487|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91988682|NCT03139487|Rivaroxaban|rivaroxaban|mesh-list
91988683|NCT03139487|Apixaban|apixaban|mesh-list
91988684|NCT03139487|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91988685|NCT03139487|Antithrombins|antithrombins|mesh-ancestor
91988686|NCT03139487|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91988687|NCT03139487|Protease Inhibitors|protease inhibitors|mesh-ancestor
91988688|NCT03139487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988689|NCT03139487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988690|NCT03139487|Anticoagulants|anticoagulants|mesh-ancestor
91988691|NCT03139487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91988692|NCT03139487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91988693|NCT04976387|Acetaminophen|acetaminophen|mesh-list
91988694|NCT04976387|Ibuprofen|ibuprofen|mesh-list
91988695|NCT04976387|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
91988696|NCT04976387|Hydrocodone|hydrocodone|mesh-list
91988697|NCT04976387|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988698|NCT04976387|Analgesics|analgesics|mesh-ancestor
91988699|NCT04976387|Sensory System Agents|sensory system agents|mesh-ancestor
91988700|NCT04976387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988701|NCT04976387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988702|NCT04976387|Antipyretics|antipyretics|mesh-ancestor
91988703|NCT04976387|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91988704|NCT04976387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988705|NCT04976387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988706|NCT04976387|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91988707|NCT04976387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988708|NCT04976387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988709|NCT04976387|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91988710|NCT04976387|Narcotics|narcotics|mesh-ancestor
91988711|NCT04976387|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988712|NCT04976387|Antitussive Agents|antitussive agents|mesh-ancestor
91988713|NCT04976387|Respiratory System Agents|respiratory system agents|mesh-ancestor
91988714|NCT03139253|Amoxicillin|amoxicillin|mesh-list
91988715|NCT03139253|Clarithromycin|clarithromycin|mesh-list
91988716|NCT03139253|Levofloxacin|levofloxacin|mesh-list
91988717|NCT03139253|Tetracycline|tetracycline|mesh-list
91988718|NCT03139253|Tinidazole|tinidazole|mesh-list
91988719|NCT03139253|Furazolidone|furazolidone|mesh-list
91988720|NCT03139253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91988721|NCT03139253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988722|NCT03139253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91988723|NCT03139253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988724|NCT03139253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988725|NCT03139253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91988726|NCT03139253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988727|NCT03139253|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91988728|NCT03139253|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91988729|NCT03139253|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91988730|NCT03139253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988731|NCT03139253|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91988732|NCT03139253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91988733|NCT03139253|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
91988734|NCT03139253|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91988735|NCT03139253|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91988736|NCT03139253|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91988737|NCT03139253|Alkylating Agents|alkylating agents|mesh-ancestor
91988738|NCT03139409|Chlorhexidine|chlorhexidine|mesh-list
91988739|NCT03139409|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91988740|NCT03139409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988741|NCT03139409|Disinfectants|disinfectants|mesh-ancestor
91988742|NCT02019472|Adalimumab|adalimumab|mesh-list
91988743|NCT02019472|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91988744|NCT02019472|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91988745|NCT02019472|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988746|NCT02019472|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988747|NCT02019472|Immunologic Factors|immunologic factors|mesh-ancestor
91988748|NCT02019472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988749|NCT00157937|Theophylline|theophylline|mesh-list
91970048|NCT02634801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970049|NCT02634801|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91970050|NCT02634801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91988750|NCT00157937|Montelukast|montelukast|mesh-list
91988751|NCT00157937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988763|NCT00157937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91988764|NCT00157937|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91988765|NCT00157937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988766|NCT00157937|Vasodilator Agents|vasodilator agents|mesh-ancestor
91988767|NCT00157937|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91988768|NCT00157937|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91988769|NCT00157937|Purinergic Agents|purinergic agents|mesh-ancestor
91988770|NCT03139565|Vaccines|vaccines|mesh-list
91988771|NCT03139565|Immunologic Factors|immunologic factors|mesh-ancestor
91988772|NCT03139565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988773|NCT03139331|Irinotecan|irinotecan|mesh-list
91988774|NCT03139331|Temozolomide|temozolomide|mesh-list
91988775|NCT03139331|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91988776|NCT03139331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91988777|NCT03139331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988778|NCT03139331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988779|NCT03139331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988780|NCT03139331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91988781|NCT03139331|Alkylating Agents|alkylating agents|mesh-ancestor
91988782|NCT04423601|Itraconazole|itraconazole|mesh-list
91988783|NCT04423601|Antifungal Agents|antifungal agents|mesh-ancestor
91988784|NCT04423601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988785|NCT04423601|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91988786|NCT04423601|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988787|NCT04423601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988788|NCT04423601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988789|NCT04423601|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91988790|NCT04423601|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988791|NCT04423601|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988792|NCT04423601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988793|NCT04423601|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91988794|NCT05022563|Warfarin|warfarin|mesh-list
91988795|NCT05022563|Rivaroxaban|rivaroxaban|mesh-list
91988796|NCT05022563|Dabigatran|dabigatran|mesh-list
91988797|NCT05022563|Apixaban|apixaban|mesh-list
91988798|NCT05022563|Anticoagulants|anticoagulants|mesh-list
91988799|NCT05022563|Edoxaban|edoxaban|mesh-list
91988800|NCT05022563|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91988801|NCT05022563|Antithrombins|antithrombins|mesh-ancestor
91988802|NCT05022563|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91988803|NCT05022563|Protease Inhibitors|protease inhibitors|mesh-ancestor
91988804|NCT05022563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988805|NCT05022563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988806|NCT04983095|Hormones|hormones|mesh-list
91988807|NCT04983095|Androgens|androgens|mesh-list
91988808|NCT04983095|Hormone Antagonists|hormone antagonists|mesh-list
91988809|NCT04983095|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988810|NCT04983095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988811|NCT02936687|Ambrisentan|ambrisentan|mesh-list
91988812|NCT02936687|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91988814|NCT04722809|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91988815|NCT04722809|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988816|NCT04722809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988817|NCT04722809|Cholinergic Agents|cholinergic agents|mesh-ancestor
91988818|NCT04722809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988819|NCT04722809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988821|NCT05083793|Analgesics|analgesics|mesh-ancestor
91988822|NCT05083793|Sensory System Agents|sensory system agents|mesh-ancestor
91988823|NCT05083793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988824|NCT05083793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988825|NCT05083793|Anticonvulsants|anticonvulsants|mesh-ancestor
91988826|NCT05083793|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91988827|NCT05083793|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91988828|NCT05083793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988829|NCT05083793|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91988830|NCT05083793|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91970051|NCT02634801|Immunologic Factors|immunologic factors|mesh-ancestor
91970052|NCT02634801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970053|NCT02634801|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91970054|NCT03196531|Loratadine|loratadine|mesh-list
91970055|NCT03196531|Antipruritics|antipruritics|mesh-ancestor
91988831|NCT05083793|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91988832|NCT05083793|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988833|NCT05083793|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91988834|NCT05083013|Chrysarobin|chrysarobin|mesh-list
91988835|NCT05083013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91988836|NCT05083013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988837|NCT05083013|Analgesics|analgesics|mesh-ancestor
91988838|NCT05083013|Sensory System Agents|sensory system agents|mesh-ancestor
91988839|NCT05083013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988840|NCT05083013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988841|NCT05083013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988842|NCT05083013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988843|NCT05073653|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91988844|NCT05073653|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91988845|NCT05073653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988846|NCT03223883|Curcumin|curcumin|mesh-list
91988847|NCT03223883|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91988848|NCT03223883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988849|NCT03223883|Analgesics|analgesics|mesh-ancestor
91988850|NCT03223883|Sensory System Agents|sensory system agents|mesh-ancestor
91988851|NCT03223883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988852|NCT03223883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988853|NCT03223883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988854|NCT03223883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988855|NCT03223883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988856|NCT03223883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988857|NCT03223883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988858|NCT02420899|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91988859|NCT02420899|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91988860|NCT02420899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91988861|NCT02420899|Antimetabolites|antimetabolites|mesh-ancestor
91988862|NCT02420899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988863|NCT02420899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91988864|NCT02420899|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91988865|NCT02420899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988866|NCT05048069|Rebamipide|rebamipide|mesh-list
91988867|NCT05048069|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91988868|NCT05048069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988869|NCT05048069|Antioxidants|antioxidants|mesh-ancestor
91988870|NCT05048069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988871|NCT05048069|Protective Agents|protective agents|mesh-ancestor
91988872|NCT05048069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988873|NCT05048069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988874|NCT03194165|Ritonavir|ritonavir|mesh-list
91988875|NCT03194165|Atazanavir Sulfate|atazanavir sulfate|mesh-list
91988876|NCT03194165|Darunavir|darunavir|mesh-list
91988877|NCT03194165|Raltegravir Potassium|raltegravir potassium|mesh-list
91988878|NCT03194165|Nevirapine|nevirapine|mesh-list
91988879|NCT03194165|Dolutegravir|dolutegravir|mesh-list
91988880|NCT03194165|Rilpivirine|rilpivirine|mesh-list
91988881|NCT03194165|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91988882|NCT03194165|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91988883|NCT03194165|Protease Inhibitors|protease inhibitors|mesh-ancestor
91988884|NCT03194165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988885|NCT03194165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988896|NCT03194165|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91988897|NCT03194165|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91988899|NCT04065113|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91988900|NCT04065113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988901|NCT04065113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988902|NCT04065113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988904|NCT03116737|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91988905|NCT03116737|Anesthetics, Local|anesthetics, local|mesh-ancestor
91988906|NCT03116737|Anesthetics|anesthetics|mesh-ancestor
91988907|NCT03116737|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970056|NCT03196531|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988908|NCT03116737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988909|NCT03116737|Sensory System Agents|sensory system agents|mesh-ancestor
91988910|NCT03116737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988911|NCT03116659|Doxycycline|doxycycline|mesh-list
91988912|NCT03116659|Imiquimod|imiquimod|mesh-list
91988913|NCT03116659|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91988914|NCT03116659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988915|NCT03116659|Antimalarials|antimalarials|mesh-ancestor
91988916|NCT03116659|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91988917|NCT03116659|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91988918|NCT03116659|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91988919|NCT03116659|Immunologic Factors|immunologic factors|mesh-ancestor
91988920|NCT03116659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988921|NCT03116659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988922|NCT03116659|Interferon Inducers|interferon inducers|mesh-ancestor
91988923|NCT01993888|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
91988924|NCT01993888|Hemostatics|hemostatics|mesh-ancestor
91988925|NCT01993888|Coagulants|coagulants|mesh-ancestor
91988926|NCT02425813|Methylprednisolone|methylprednisolone|mesh-list
91988927|NCT02425813|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91988928|NCT02425813|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91988929|NCT02425813|Prednisolone|prednisolone|mesh-list
91988930|NCT02425813|Prednisolone acetate|prednisolone acetate|mesh-list
91988931|NCT02425813|Budesonide|budesonide|mesh-list
91988932|NCT02425813|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91988933|NCT02425813|Prednisolone phosphate|prednisolone phosphate|mesh-list
91988934|NCT02425813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91988935|NCT02425813|Antiemetics|antiemetics|mesh-ancestor
91988936|NCT02425813|Autonomic Agents|autonomic agents|mesh-ancestor
91988937|NCT02425813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988938|NCT02425813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988939|NCT02425813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988940|NCT02425813|Glucocorticoids|glucocorticoids|mesh-ancestor
91988941|NCT02425813|Hormones|hormones|mesh-ancestor
91988942|NCT02425813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988944|NCT02425813|Protective Agents|protective agents|mesh-ancestor
91988945|NCT02425813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91988946|NCT02425813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988947|NCT02425813|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91988948|NCT02425813|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91988949|NCT02425813|Respiratory System Agents|respiratory system agents|mesh-ancestor
91988950|NCT03106831|Norepinephrine|norepinephrine|mesh-list
91988955|NCT03106831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988957|NCT03106831|Sympathomimetics|sympathomimetics|mesh-ancestor
91988958|NCT03106831|Autonomic Agents|autonomic agents|mesh-ancestor
91988959|NCT03106831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988960|NCT03106831|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91988961|NCT03138785|Itraconazole|itraconazole|mesh-list
91988962|NCT03138785|Voriconazole|voriconazole|mesh-list
91988963|NCT03138785|Levofloxacin|levofloxacin|mesh-list
91988964|NCT03138785|Antifungal Agents|antifungal agents|mesh-ancestor
91988965|NCT03138785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988966|NCT03138785|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91988967|NCT03138785|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988968|NCT03138785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988969|NCT03138785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988970|NCT03138785|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91988971|NCT03138785|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988972|NCT03138785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988973|NCT03138785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988974|NCT03138785|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91988975|NCT03138785|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91988977|NCT03138785|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91988978|NCT03138785|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91988979|NCT03138785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91988980|NCT03138785|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91988981|NCT03106597|Amlodipine|amlodipine|mesh-list
91988982|NCT03106597|Manidipine|manidipine|mesh-list
91988983|NCT03106597|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91988984|NCT03106597|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91988985|NCT03106597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970058|NCT03196531|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91970059|NCT03196531|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91970060|NCT03196531|Histamine Antagonists|histamine antagonists|mesh-ancestor
91970061|NCT03196531|Histamine Agents|histamine agents|mesh-ancestor
91970062|NCT03196531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970063|NCT03196531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970064|NCT03196531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970065|NCT02476799|Ketorolac|ketorolac|mesh-list
91970066|NCT02476799|Fentanyl|fentanyl|mesh-list
91970067|NCT02476799|Ropivacaine|ropivacaine|mesh-list
91970068|NCT02476799|Anesthetics, Local|anesthetics, local|mesh-ancestor
91970069|NCT02476799|Anesthetics|anesthetics|mesh-ancestor
91970070|NCT02476799|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970071|NCT02476799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988986|NCT03106597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988987|NCT03106597|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91988988|NCT03106597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988989|NCT03106597|Vasodilator Agents|vasodilator agents|mesh-ancestor
91988990|NCT02018458|Paclitaxel|paclitaxel|mesh-list
91988991|NCT02018458|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91988992|NCT02018458|Cyclophosphamide|cyclophosphamide|mesh-list
91988993|NCT02018458|Carboplatin|carboplatin|mesh-list
91988994|NCT02018458|Doxorubicin|doxorubicin|mesh-list
91988995|NCT02018458|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91988996|NCT02018458|Vaccines|vaccines|mesh-list
91988997|NCT02018458|Immunologic Factors|immunologic factors|mesh-ancestor
91988998|NCT02018458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988999|NCT02018458|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989000|NCT02018458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989001|NCT02018458|Tubulin Modulators|tubulin modulators|mesh-ancestor
91989002|NCT02018458|Antimitotic Agents|antimitotic agents|mesh-ancestor
91989003|NCT02018458|Mitosis Modulators|mitosis modulators|mesh-ancestor
91989004|NCT02018458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989005|NCT02018458|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91989006|NCT02018458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91989007|NCT02018458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91989008|NCT02018458|Alkylating Agents|alkylating agents|mesh-ancestor
91989009|NCT02018458|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91989010|NCT02018458|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91989011|NCT02018458|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91989012|NCT02018458|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91989013|NCT02018458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989014|NCT02423083|Guanabenz|guanabenz|mesh-list
91989015|NCT02423083|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91989016|NCT02423083|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91989017|NCT02423083|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91989018|NCT02423083|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91989019|NCT02423083|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989023|NCT02423863|Pembrolizumab|pembrolizumab|mesh-list
91989024|NCT02423863|Nivolumab|nivolumab|mesh-list
91989025|NCT02423863|Atezolizumab|atezolizumab|mesh-list
91989026|NCT02423863|Durvalumab|durvalumab|mesh-list
91989027|NCT02423863|Cemiplimab|cemiplimab|mesh-list
91989028|NCT02423863|Poly ICLC|poly iclc|mesh-list
91989029|NCT02423863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91989030|NCT02423863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989031|NCT02423863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91989032|NCT02423863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989033|NCT02423863|Interferon Inducers|interferon inducers|mesh-ancestor
91970072|NCT02476799|Sensory System Agents|sensory system agents|mesh-ancestor
91970073|NCT02476799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970074|NCT02476799|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91989034|NCT02423863|Immunologic Factors|immunologic factors|mesh-ancestor
91989035|NCT02423863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989036|NCT03178747|Methylene Blue|methylene blue|mesh-list
91989037|NCT03178747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989038|NCT03178747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989039|NCT05392673|Bilirubin|bilirubin|mesh-list
91989040|NCT05392673|Antioxidants|antioxidants|mesh-ancestor
91989041|NCT05392673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989042|NCT05392673|Protective Agents|protective agents|mesh-ancestor
91989043|NCT05392673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989044|NCT02425579|Carbon Monoxide|carbon monoxide|mesh-list
91989045|NCT02425579|Antimetabolites|antimetabolites|mesh-ancestor
91989046|NCT02425579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989047|NCT02425579|Gasotransmitters|gasotransmitters|mesh-ancestor
91989048|NCT02425579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989049|NCT02425579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989050|NCT03178591|Dapagliflozin|dapagliflozin|mesh-list
91989051|NCT03178591|Vildagliptin|vildagliptin|mesh-list
91989052|NCT03178591|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91989053|NCT03178591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989054|NCT03178591|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91989055|NCT03178591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989056|NCT03178591|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91989057|NCT03178591|Protease Inhibitors|protease inhibitors|mesh-ancestor
91989058|NCT03178591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989059|NCT01993186|Glycerol|glycerol|mesh-list
91989060|NCT01993186|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91989061|NCT01993186|Protective Agents|protective agents|mesh-ancestor
91989062|NCT01993186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989063|NCT03181243|Anesthetics|anesthetics|mesh-list
91989064|NCT03181243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989065|NCT03181243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989066|NCT02420665|Acetic Acid|acetic acid|mesh-list
91989067|NCT02420665|Proflavine|proflavine|mesh-list
91989068|NCT02420665|Retinol acetate|retinol acetate|mesh-list
91989069|NCT02420665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91989070|NCT02420665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989071|NCT02420665|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91989072|NCT02420665|Immunologic Factors|immunologic factors|mesh-ancestor
91989073|NCT02420665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989074|NCT02420665|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91989075|NCT02420665|Protective Agents|protective agents|mesh-ancestor
91989076|NCT02420665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989077|NCT02420665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91989078|NCT02016898|Mitomycins|mitomycins|mesh-list
91989079|NCT02016898|Mitomycin|mitomycin|mesh-list
91989080|NCT02016898|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91989081|NCT02016898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989082|NCT02016898|Alkylating Agents|alkylating agents|mesh-ancestor
91989083|NCT02016898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989084|NCT02016898|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91989085|NCT02016898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989086|NCT04482907|Hormones|hormones|mesh-list
91989087|NCT04482907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989088|NCT04482907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989089|NCT02420509|Leucovorin|leucovorin|mesh-list
91989090|NCT02420509|Capecitabine|capecitabine|mesh-list
91989091|NCT02420509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989116|NCT02416141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989117|NCT02416141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989118|NCT02416141|Analgesics|analgesics|mesh-ancestor
91989119|NCT02416141|Sensory System Agents|sensory system agents|mesh-ancestor
91989120|NCT02416141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989121|NCT03138239|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91989122|NCT03138239|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91989123|NCT03138239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989124|NCT02416063|Dexmedetomidine|dexmedetomidine|mesh-list
91970076|NCT02476799|Analgesics|analgesics|mesh-ancestor
91970077|NCT02476799|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91989125|NCT02416063|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91989126|NCT02416063|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989127|NCT02416063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989128|NCT02416063|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91989129|NCT02416063|Analgesics|analgesics|mesh-ancestor
91989130|NCT02416063|Sensory System Agents|sensory system agents|mesh-ancestor
91989131|NCT02416063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989132|NCT02416063|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91989133|NCT02416063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91989134|NCT02416063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91989135|NCT02416063|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989136|NCT02416063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989137|NCT02416063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989138|NCT01828697|Enoxaparin|enoxaparin|mesh-list
91989139|NCT01828697|Dalteparin|dalteparin|mesh-list
91989140|NCT01828697|Tinzaparin|tinzaparin|mesh-list
91989141|NCT01828697|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91989142|NCT01828697|Nadroparin|nadroparin|mesh-list
91989143|NCT01828697|Enoxaparin sodium|enoxaparin sodium|mesh-list
91989180|NCT04631393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989181|NCT04631393|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91989182|NCT04631393|Anesthetics, General|anesthetics, general|mesh-ancestor
91989183|NCT04631393|Anesthetics|anesthetics|mesh-ancestor
91989184|NCT04631393|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91989185|NCT04631393|Narcotics|narcotics|mesh-ancestor
91989186|NCT04631393|Analgesics|analgesics|mesh-ancestor
91989187|NCT04631393|Sensory System Agents|sensory system agents|mesh-ancestor
91989188|NCT04631393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989189|NCT03180775|Glycine|glycine|mesh-list
91989190|NCT03180775|Glycine Agents|glycine agents|mesh-ancestor
91989191|NCT03180775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989192|NCT03180775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989193|NCT03180775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989194|NCT03137927|Vaccines|vaccines|mesh-list
91989195|NCT03137927|Immunologic Factors|immunologic factors|mesh-ancestor
91989196|NCT03137927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989197|NCT04482985|Meclizine|meclizine|mesh-list
91989198|NCT04482985|Antiemetics|antiemetics|mesh-ancestor
91989199|NCT04482985|Autonomic Agents|autonomic agents|mesh-ancestor
91989200|NCT04482985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989201|NCT04482985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989202|NCT04482985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989203|NCT04482985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91989204|NCT04482985|Histamine Antagonists|histamine antagonists|mesh-ancestor
91989205|NCT04482985|Histamine Agents|histamine agents|mesh-ancestor
91989206|NCT04482985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989207|NCT04482985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989208|NCT04482985|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91989209|NCT04482985|Cholinergic Agents|cholinergic agents|mesh-ancestor
91989210|NCT04482985|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91989211|NCT05385263|Nivolumab|nivolumab|mesh-list
91989212|NCT05385263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91989213|NCT05385263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989214|NCT05385263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91989215|NCT05385263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989216|NCT03180229|Granisetron|granisetron|mesh-list
91989217|NCT03180229|Antiemetics|antiemetics|mesh-ancestor
91989218|NCT03180229|Autonomic Agents|autonomic agents|mesh-ancestor
91989219|NCT03180229|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989220|NCT03180229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989221|NCT03180229|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989222|NCT03180229|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91989223|NCT03180229|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91989224|NCT03180229|Serotonin Agents|serotonin agents|mesh-ancestor
91989225|NCT03180229|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989226|NCT03180229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989227|NCT03178123|Interferons|interferons|mesh-list
91989228|NCT03178123|Antibodies|antibodies|mesh-list
91989229|NCT03178123|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91989230|NCT03178123|Immunologic Factors|immunologic factors|mesh-ancestor
91989231|NCT03178123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989232|NCT03178123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989233|NCT03178123|Antiviral Agents|antiviral agents|mesh-ancestor
91989234|NCT03178123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989235|NCT03820817|Rifaximin|rifaximin|mesh-list
91989236|NCT03820817|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91989237|NCT03820817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989238|NCT03820817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989239|NCT05111197|Immunomodulating Agents|immunomodulating agents|mesh-list
91989240|NCT05111197|Immunologic Factors|immunologic factors|mesh-ancestor
91989241|NCT05111197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989242|NCT05106517|Zoledronic Acid|zoledronic acid|mesh-list
91989243|NCT05106517|Denosumab|denosumab|mesh-list
91989244|NCT05106517|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91989245|NCT05106517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989246|NCT03140033|Misoprostol|misoprostol|mesh-list
91989247|NCT03140033|Ranitidine|ranitidine|mesh-list
91989248|NCT03140033|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
91989249|NCT03140033|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91989250|NCT03140033|Abortifacient Agents|abortifacient agents|mesh-ancestor
91989251|NCT03140033|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91989252|NCT03140033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989253|NCT03140033|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91989254|NCT03140033|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989255|NCT03140033|Oxytocics|oxytocics|mesh-ancestor
91989256|NCT03140033|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91989257|NCT03140033|Histamine Antagonists|histamine antagonists|mesh-ancestor
91989258|NCT03140033|Histamine Agents|histamine agents|mesh-ancestor
91989259|NCT03140033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989260|NCT03140033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989261|NCT05338931|Gossypol acetic acid|gossypol acetic acid|mesh-list
91989263|NCT05338931|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989264|NCT05338931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989265|NCT05338931|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91989266|NCT05338931|Contraceptive Agents|contraceptive agents|mesh-ancestor
91989267|NCT05338931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91989268|NCT05338931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989269|NCT05338931|Spermatocidal Agents|spermatocidal agents|mesh-ancestor
91989270|NCT05338931|Antispermatogenic Agents|antispermatogenic agents|mesh-ancestor
91989271|NCT05338931|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91989272|NCT02706691|Infigratinib|infigratinib|mesh-list
91989273|NCT02706691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989274|NCT02419729|Estrogens|estrogens|mesh-list
91989275|NCT02419729|Hormones|hormones|mesh-ancestor
91989276|NCT02419729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989277|NCT02419729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989278|NCT03697031|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
91989279|NCT03697031|Hormones|hormones|mesh-ancestor
91989280|NCT03697031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989281|NCT03697031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989282|NCT02419651|Diclofenac|diclofenac|mesh-list
91989283|NCT02419651|Tramadol|tramadol|mesh-list
91989284|NCT02419651|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91989285|NCT02419651|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91989286|NCT02419651|Analgesics|analgesics|mesh-ancestor
91989287|NCT02419651|Sensory System Agents|sensory system agents|mesh-ancestor
91989288|NCT02419651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989289|NCT02419651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989290|NCT02419651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91989291|NCT02419651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91989292|NCT02419651|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91989293|NCT02419651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989294|NCT02419651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989295|NCT02419651|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91989296|NCT02419651|Narcotics|narcotics|mesh-ancestor
91989297|NCT02419651|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989298|NCT05088239|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91989299|NCT05088239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989300|NCT02419261|Analgesics|analgesics|mesh-list
91989301|NCT02419261|Ropivacaine|ropivacaine|mesh-list
91989302|NCT02419261|Anesthetics, Local|anesthetics, local|mesh-ancestor
91989303|NCT02419261|Anesthetics|anesthetics|mesh-ancestor
91989304|NCT02419261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989305|NCT02419261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970079|NCT02476799|Anesthetics, General|anesthetics, general|mesh-ancestor
91970080|NCT02476799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91970081|NCT02476799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91989306|NCT02419261|Sensory System Agents|sensory system agents|mesh-ancestor
91989307|NCT02419261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989308|NCT02414503|Oxytocin|oxytocin|mesh-list
91989309|NCT02414503|Oxytocics|oxytocics|mesh-ancestor
91989310|NCT02414503|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91989311|NCT02414503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989312|NCT03137615|Anesthetics|anesthetics|mesh-list
91989313|NCT03137615|Anesthetics, Local|anesthetics, local|mesh-list
91989314|NCT03137615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989315|NCT03137615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989316|NCT03137615|Sensory System Agents|sensory system agents|mesh-ancestor
91989317|NCT03137615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989318|NCT03415061|Insulin|insulin|mesh-list
91989319|NCT03415061|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91989320|NCT03415061|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91989321|NCT03415061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989322|NCT05088083|Paclitaxel|paclitaxel|mesh-list
91989323|NCT05088083|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989324|NCT05088083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989325|NCT05088083|Tubulin Modulators|tubulin modulators|mesh-ancestor
91989328|NCT05088083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989330|NCT03110159|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91989331|NCT03110159|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989332|NCT01990768|Tranexamic Acid|tranexamic acid|mesh-list
91989333|NCT01990768|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91989334|NCT01990768|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91989335|NCT01990768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989336|NCT01990768|Hemostatics|hemostatics|mesh-ancestor
91989337|NCT01990768|Coagulants|coagulants|mesh-ancestor
91989338|NCT05228327|Salicylic Acid|salicylic acid|mesh-list
91989339|NCT05228327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989340|NCT05228327|Antifungal Agents|antifungal agents|mesh-ancestor
91989341|NCT05228327|Keratolytic Agents|keratolytic agents|mesh-ancestor
91989342|NCT05228327|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989344|NCT02624765|Sotalol|sotalol|mesh-list
91989345|NCT02624765|Flecainide|flecainide|mesh-list
91989346|NCT02624765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91989347|NCT02624765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91989348|NCT02624765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989349|NCT02624765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989350|NCT02624765|Protective Agents|protective agents|mesh-ancestor
91989351|NCT02624765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989352|NCT02624765|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91989353|NCT02624765|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91989354|NCT02624765|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989355|NCT02624765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989356|NCT02624765|Sympatholytics|sympatholytics|mesh-ancestor
91989357|NCT02624765|Autonomic Agents|autonomic agents|mesh-ancestor
91989358|NCT02624765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989359|NCT02624765|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91989360|NCT02624765|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91989361|NCT02624765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91989362|NCT05085587|Fluticasone|fluticasone|mesh-list
91989364|NCT05085587|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91989365|NCT05085587|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91989366|NCT05085587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91989367|NCT05085587|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91989368|NCT05085587|Autonomic Agents|autonomic agents|mesh-ancestor
91989369|NCT05085587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989370|NCT05085587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989371|NCT05085587|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91989372|NCT05085587|Respiratory System Agents|respiratory system agents|mesh-ancestor
91989373|NCT05085587|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989374|NCT05085587|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91989375|NCT05085587|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91989376|NCT05085587|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91970082|NCT02476799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970083|NCT02476799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970084|NCT02476799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91989377|NCT05085587|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91989378|NCT05085587|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989379|NCT05085587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989380|NCT05085587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989381|NCT05085587|Glucocorticoids|glucocorticoids|mesh-ancestor
91989383|NCT05085587|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989384|NCT05085587|Sympathomimetics|sympathomimetics|mesh-ancestor
91989385|NCT01990534|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91989386|NCT01990534|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91989387|NCT01990534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989388|NCT01990534|Immunotoxins|immunotoxins|mesh-ancestor
91989389|NCT01990534|Immunoconjugates|immunoconjugates|mesh-ancestor
91989390|NCT01990534|Immunologic Factors|immunologic factors|mesh-ancestor
91989391|NCT01990534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989392|NCT05084573|Bupivacaine|bupivacaine|mesh-list
91989393|NCT05084573|Anesthetics, Local|anesthetics, local|mesh-ancestor
91989394|NCT05084573|Anesthetics|anesthetics|mesh-ancestor
91989395|NCT05084573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989396|NCT05084573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989397|NCT05084573|Sensory System Agents|sensory system agents|mesh-ancestor
91989398|NCT05084573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989399|NCT05088707|Misoprostol|misoprostol|mesh-list
91989402|NCT05088707|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91989403|NCT05088707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989404|NCT05088707|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91989405|NCT05088707|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989406|NCT05088707|Oxytocics|oxytocics|mesh-ancestor
91989407|NCT05028257|Vaccines|vaccines|mesh-list
91989408|NCT05028257|Immunologic Factors|immunologic factors|mesh-ancestor
91989409|NCT05028257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989410|NCT01990300|Pioglitazone|pioglitazone|mesh-list
91989411|NCT01990300|Alogliptin|alogliptin|mesh-list
91989412|NCT01990300|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91989413|NCT01990300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989414|NCT01990300|Incretins|incretins|mesh-ancestor
91989415|NCT01990300|Hormones|hormones|mesh-ancestor
91989416|NCT01990300|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989417|NCT01990300|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91989418|NCT01990300|Protease Inhibitors|protease inhibitors|mesh-ancestor
91989419|NCT01990300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989420|NCT01990300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989421|NCT03135977|Etoposide|etoposide|mesh-list
91989422|NCT03135977|Apatinib|apatinib|mesh-list
91989423|NCT03135977|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989424|NCT03135977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989425|NCT03135977|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91989426|NCT03135977|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91989427|NCT03135977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989428|NCT03135977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989429|NCT03135977|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91989430|NCT01966120|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91989431|NCT01966120|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91989432|NCT01966120|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989433|NCT04850651|Fluconazole|fluconazole|mesh-list
91989434|NCT04850651|Antifungal Agents|antifungal agents|mesh-ancestor
91989435|NCT04850651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989436|NCT04850651|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91989437|NCT04850651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989438|NCT04850651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989439|NCT04850651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989440|NCT04850651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91989441|NCT04850651|Hormone Antagonists|hormone antagonists|mesh-ancestor
91989442|NCT04850651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989443|NCT04850651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989444|NCT04850651|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91989445|NCT04850651|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91989446|NCT04837235|Hemay005|hemay005|mesh-list
91970085|NCT02476799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970086|NCT02476799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989447|NCT04837235|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989448|NCT04837235|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91989449|NCT04837235|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91989450|NCT04837235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989451|NCT04837235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989452|NCT02702401|Pembrolizumab|pembrolizumab|mesh-list
91989453|NCT02702401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91989454|NCT02702401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989455|NCT02702401|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91989456|NCT02702401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989457|NCT03116971|Etoposide|etoposide|mesh-list
91989458|NCT03116971|Peposertib|peposertib|mesh-list
91989459|NCT03116971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989460|NCT03116971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989461|NCT03116971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91989462|NCT03116971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91989463|NCT03116971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989464|NCT03116971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989465|NCT03116971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91989467|NCT02414581|Chlorhexidine|chlorhexidine|mesh-list
91989468|NCT02414581|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91989469|NCT02414581|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91989470|NCT02414581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989472|NCT02414581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989473|NCT02414581|Disinfectants|disinfectants|mesh-ancestor
91989474|NCT02414581|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989475|NCT02419105|Vitamin D|vitamin d|mesh-list
91989476|NCT02419105|Cholecalciferol|cholecalciferol|mesh-list
91989477|NCT02419105|Testosterone|testosterone|mesh-list
91989478|NCT02419105|Vitamins|vitamins|mesh-ancestor
91989479|NCT02419105|Micronutrients|micronutrients|mesh-ancestor
91989480|NCT02419105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989481|NCT02419105|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91989482|NCT02419105|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91989483|NCT02419105|Androgens|androgens|mesh-ancestor
91989484|NCT02419105|Hormones|hormones|mesh-ancestor
91989485|NCT02419105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989486|NCT04643249|Repaglinide|repaglinide|mesh-list
91989487|NCT04643249|Flurbiprofen|flurbiprofen|mesh-list
91989488|NCT04643249|Midazolam|midazolam|mesh-list
91989489|NCT04643249|Dextromethorphan|dextromethorphan|mesh-list
91989490|NCT04643249|Caffeine|caffeine|mesh-list
91989491|NCT04643249|Bupropion|bupropion|mesh-list
91989492|NCT04643249|Omeprazole|omeprazole|mesh-list
91989493|NCT04643249|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91989494|NCT04643249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91989495|NCT04643249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989496|NCT04643249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989498|NCT04643249|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91989499|NCT04643249|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91989500|NCT04643249|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91989501|NCT04643249|Anesthetics, General|anesthetics, general|mesh-ancestor
91989502|NCT04643249|Anesthetics|anesthetics|mesh-ancestor
91989503|NCT04643249|GABA Modulators|gaba modulators|mesh-ancestor
91989504|NCT04643249|GABA Agents|gaba agents|mesh-ancestor
91989505|NCT04643249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989506|NCT04643249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989507|NCT04643249|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91989508|NCT04643249|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91989509|NCT04643249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989510|NCT04643249|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91989511|NCT04643249|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91989512|NCT04643249|Purinergic Agents|purinergic agents|mesh-ancestor
91989513|NCT04643249|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91989514|NCT04643249|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989515|NCT04643249|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91989516|NCT04643249|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91989517|NCT04643249|Antidepressive Agents|antidepressive agents|mesh-ancestor
91989518|NCT04643249|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91989519|NCT04643249|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91989520|NCT04643249|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91989521|NCT04643249|Dopamine Agents|dopamine agents|mesh-ancestor
91989522|NCT04643249|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91989523|NCT04643249|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989524|NCT04643249|Antitussive Agents|antitussive agents|mesh-ancestor
91989525|NCT04643249|Respiratory System Agents|respiratory system agents|mesh-ancestor
91989526|NCT04643249|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91989527|NCT04643249|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91989529|NCT04643249|Sensory System Agents|sensory system agents|mesh-ancestor
91989530|NCT04643249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989531|NCT04643249|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91989532|NCT04643249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91989533|NCT04643249|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91989534|NCT04643249|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91989535|NCT04643249|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91989536|NCT04643249|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91989537|NCT02414425|Botulinum Toxins|botulinum toxins|mesh-list
91989538|NCT02414425|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91989539|NCT02414425|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91989540|NCT02414425|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91989541|NCT02414425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91989542|NCT02414425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989543|NCT02414425|Cholinergic Agents|cholinergic agents|mesh-ancestor
91989544|NCT02414425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989550|NCT03116893|Antifungal Agents|antifungal agents|mesh-ancestor
91989551|NCT03116893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989552|NCT03116893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91989553|NCT03116893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989554|NCT03116893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989734|NCT02423395|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91989555|NCT03116893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989556|NCT03116893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91989557|NCT03116893|Hormone Antagonists|hormone antagonists|mesh-ancestor
91989558|NCT03116893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989559|NCT03116893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989560|NCT03116893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91989561|NCT03116893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91989562|NCT03116893|Antitubercular Agents|antitubercular agents|mesh-ancestor
91989563|NCT03116893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91989564|NCT03116893|Leprostatic Agents|leprostatic agents|mesh-ancestor
91989565|NCT03116893|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91989566|NCT03116893|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91989567|NCT03116893|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91989568|NCT03116893|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91989569|NCT03116893|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91989570|NCT03116893|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91989571|NCT03116893|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91989572|NCT05737511|Diazepam|diazepam|mesh-list
91989573|NCT05737511|Gabapentin|gabapentin|mesh-list
91989574|NCT05737511|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91989575|NCT05737511|Milnacipran|milnacipran|mesh-list
91989576|NCT05737511|Levetiracetam|levetiracetam|mesh-list
91989577|NCT05737511|Lorazepam|lorazepam|mesh-list
91989578|NCT05737511|Clonazepam|clonazepam|mesh-list
91989579|NCT05737511|Dexetimide|dexetimide|mesh-list
91989580|NCT05737511|Olanzapine|olanzapine|mesh-list
91989581|NCT05737511|Alprazolam|alprazolam|mesh-list
91989582|NCT05737511|Mirtazapine|mirtazapine|mesh-list
91989583|NCT05737511|Fluvoxamine|fluvoxamine|mesh-list
91989584|NCT05737511|Tranylcypromine|tranylcypromine|mesh-list
91989585|NCT05737511|Risperidone|risperidone|mesh-list
91989586|NCT05737511|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91989587|NCT05737511|Citalopram|citalopram|mesh-list
91989588|NCT05737511|Bupropion|bupropion|mesh-list
91989589|NCT05737511|Sertraline|sertraline|mesh-list
91989590|NCT05737511|Fluoxetine|fluoxetine|mesh-list
91989591|NCT05737511|Paroxetine|paroxetine|mesh-list
91989592|NCT05737511|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91989593|NCT05737511|Reboxetine|reboxetine|mesh-list
91989594|NCT05737511|Imipramine|imipramine|mesh-list
91989595|NCT05737511|Clomipramine|clomipramine|mesh-list
91989596|NCT05737511|Phenelzine|phenelzine|mesh-list
91989597|NCT05737511|Moclobemide|moclobemide|mesh-list
91989598|NCT05737511|Hydroxyzine|hydroxyzine|mesh-list
91989599|NCT05737511|Escitalopram|escitalopram|mesh-list
91989600|NCT05737511|Analgesics|analgesics|mesh-ancestor
91989601|NCT05737511|Sensory System Agents|sensory system agents|mesh-ancestor
91989602|NCT05737511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989603|NCT05737511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989604|NCT05737511|Anticonvulsants|anticonvulsants|mesh-ancestor
91989605|NCT05737511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91989606|NCT05737511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91989607|NCT05737511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989608|NCT05737511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91989609|NCT05737511|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91989610|NCT05737511|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91989611|NCT05737511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989612|NCT05737511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989613|NCT05737511|Antimanic Agents|antimanic agents|mesh-ancestor
91989614|NCT05737511|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91989615|NCT05737511|Serotonin Agents|serotonin agents|mesh-ancestor
91989616|NCT05737511|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91989617|NCT05737511|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91989618|NCT05737511|Dopamine Agents|dopamine agents|mesh-ancestor
91989619|NCT05737511|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91989623|NCT05737511|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91989625|NCT05737511|Autonomic Agents|autonomic agents|mesh-ancestor
91989626|NCT05737511|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91989627|NCT05737511|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91989628|NCT05737511|Cholinergic Agents|cholinergic agents|mesh-ancestor
91989629|NCT05737511|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91989630|NCT05737511|Antidepressive Agents|antidepressive agents|mesh-ancestor
91989631|NCT05737511|Antiemetics|antiemetics|mesh-ancestor
91989632|NCT05737511|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989633|NCT05737511|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91989634|NCT05737511|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91989635|NCT05737511|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989636|NCT05737511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990211|NCT02449655|Antimitotic Agents|antimitotic agents|mesh-ancestor
91989637|NCT05737511|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91989638|NCT05737511|Nootropic Agents|nootropic agents|mesh-ancestor
91989639|NCT05737511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91989640|NCT05737511|GABA Modulators|gaba modulators|mesh-ancestor
91989641|NCT05737511|GABA Agents|gaba agents|mesh-ancestor
91989642|NCT05737511|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91989643|NCT05737511|Histamine Antagonists|histamine antagonists|mesh-ancestor
91989644|NCT05737511|Histamine Agents|histamine agents|mesh-ancestor
91989645|NCT05737511|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91989646|NCT05737511|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91989647|NCT05737511|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91989648|NCT05737511|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989649|NCT05737511|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91989650|NCT05737511|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91989651|NCT05737511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91989652|NCT05737511|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91989653|NCT05737511|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91989654|NCT05737511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91989655|NCT05737511|Anesthetics, General|anesthetics, general|mesh-ancestor
91989657|NCT05737511|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91989658|NCT05737511|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91989659|NCT05737511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91989660|NCT05737511|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91989661|NCT05737511|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91989662|NCT05737511|Antipruritics|antipruritics|mesh-ancestor
91989663|NCT05737511|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989664|NCT05737511|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91989665|NCT03179839|Fluvoxamine|fluvoxamine|mesh-list
91989667|NCT03179839|Antidepressive Agents|antidepressive agents|mesh-ancestor
91989668|NCT03179839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91989669|NCT03179839|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91989670|NCT03179839|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91989671|NCT03179839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91989672|NCT03179839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989673|NCT03179839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989674|NCT03179839|Serotonin Agents|serotonin agents|mesh-ancestor
91989675|NCT03179839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989676|NCT03179839|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91970088|NCT02449369|Oxycodone|oxycodone|mesh-list
91970089|NCT02449369|Hydromorphone|hydromorphone|mesh-list
91970090|NCT02449369|Orphenadrine|orphenadrine|mesh-list
91970091|NCT02449369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91970092|NCT02449369|Analgesics|analgesics|mesh-ancestor
91989677|NCT03179839|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91989678|NCT03179839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989679|NCT03179839|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91989680|NCT03179839|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91989681|NCT03179839|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989682|NCT03179839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989683|NCT03179839|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91989684|NCT05736887|Acetylcysteine|acetylcysteine|mesh-list
91989685|NCT05736887|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91989686|NCT05736887|Antiviral Agents|antiviral agents|mesh-ancestor
91989687|NCT05736887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989688|NCT05736887|Expectorants|expectorants|mesh-ancestor
91989714|NCT05735639|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91989715|NCT05735639|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91989716|NCT04483219|Antibodies|antibodies|mesh-list
91989717|NCT04483219|Immunologic Factors|immunologic factors|mesh-ancestor
91989718|NCT04483219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989719|NCT03176563|Fosfomycin|fosfomycin|mesh-list
91989720|NCT03176563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91989721|NCT03176563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989722|NCT03827447|Vancomycin|vancomycin|mesh-list
91989723|NCT03827447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91989724|NCT03827447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989725|NCT01680497|Hyaluronic Acid|hyaluronic acid|mesh-list
91989726|NCT01680497|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91989727|NCT01680497|Immunologic Factors|immunologic factors|mesh-ancestor
91989728|NCT01680497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989729|NCT01680497|Viscosupplements|viscosupplements|mesh-ancestor
91989730|NCT01680497|Protective Agents|protective agents|mesh-ancestor
91989731|NCT02423395|Orphenadrine|orphenadrine|mesh-list
91989732|NCT02423395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989733|NCT02423395|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91989735|NCT02423395|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91989736|NCT02423395|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91989737|NCT02423395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989738|NCT02423395|Parasympatholytics|parasympatholytics|mesh-ancestor
91989739|NCT02423395|Autonomic Agents|autonomic agents|mesh-ancestor
91989740|NCT02423395|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91989741|NCT02423395|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91989742|NCT02423395|Cholinergic Agents|cholinergic agents|mesh-ancestor
91989743|NCT02423395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989747|NCT02423395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989748|NCT05694689|Vitamin D|vitamin d|mesh-list
91989749|NCT05694689|Cholecalciferol|cholecalciferol|mesh-list
91989750|NCT05694689|Vitamins|vitamins|mesh-ancestor
91989751|NCT05694689|Micronutrients|micronutrients|mesh-ancestor
91989752|NCT05694689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989753|NCT05694689|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91989754|NCT05694689|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91989755|NCT02423239|Paclitaxel|paclitaxel|mesh-list
91989756|NCT02423239|Gemcitabine|gemcitabine|mesh-list
91989757|NCT02423239|Sorafenib|sorafenib|mesh-list
91989758|NCT02423239|HU 211|hu 211|mesh-list
91989759|NCT02423239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989760|NCT02423239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989761|NCT02423239|Tubulin Modulators|tubulin modulators|mesh-ancestor
91989762|NCT02423239|Antimitotic Agents|antimitotic agents|mesh-ancestor
91989763|NCT02423239|Mitosis Modulators|mitosis modulators|mesh-ancestor
91989764|NCT02423239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989765|NCT02423239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989766|NCT02423239|Antimetabolites|antimetabolites|mesh-ancestor
91989767|NCT02423239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91989768|NCT02423239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989769|NCT02423239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91989770|NCT02423239|Antiemetics|antiemetics|mesh-ancestor
91989771|NCT02423239|Autonomic Agents|autonomic agents|mesh-ancestor
91970093|NCT02449369|Sensory System Agents|sensory system agents|mesh-ancestor
91970094|NCT02449369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989772|NCT02423239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989773|NCT02423239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989774|NCT02423239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989775|NCT02423239|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91989776|NCT02423239|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91989777|NCT02423239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989778|NCT02423239|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91989779|NCT02423239|Protective Agents|protective agents|mesh-ancestor
91989781|NCT02449733|Emtricitabine|emtricitabine|mesh-list
91989782|NCT02449733|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91989783|NCT02449733|Antiviral Agents|antiviral agents|mesh-ancestor
91989784|NCT02449733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989785|NCT02449733|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91989786|NCT02449733|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91989787|NCT02449733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989788|NCT02449733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989789|NCT02449733|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91989790|NCT02449733|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91989791|NCT02417467|Nicotine|nicotine|mesh-list
91989792|NCT02417467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91989793|NCT02417467|Autonomic Agents|autonomic agents|mesh-ancestor
91989794|NCT02417467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989795|NCT02417467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989796|NCT02417467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91989797|NCT02417467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91989798|NCT02417467|Cholinergic Agents|cholinergic agents|mesh-ancestor
91989799|NCT02417467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989800|NCT02417467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989801|NCT02417389|Alendronate|alendronate|mesh-list
91989803|NCT02417389|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91989804|NCT02417389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989805|NCT02417389|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91989806|NCT02417389|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
91989807|NCT02417389|Hormone Antagonists|hormone antagonists|mesh-ancestor
91989808|NCT02417389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989809|NCT02413021|Cytarabine|cytarabine|mesh-list
91989810|NCT02413021|Deferasirox|deferasirox|mesh-list
91989811|NCT02413021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989812|NCT02413021|Antimetabolites|antimetabolites|mesh-ancestor
91989813|NCT02413021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989828|NCT01680341|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91989829|NCT01680341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989830|NCT03177811|Acetazolamide|acetazolamide|mesh-list
91989831|NCT03177811|Anticonvulsants|anticonvulsants|mesh-ancestor
91989832|NCT03177811|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91989833|NCT03177811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989834|NCT03177811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989835|NCT03177811|Diuretics|diuretics|mesh-ancestor
91989836|NCT03177811|Natriuretic Agents|natriuretic agents|mesh-ancestor
91989837|NCT03177811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989838|NCT03175939|Fluorouracil|fluorouracil|mesh-list
91989839|NCT03175939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989840|NCT03175939|Antimetabolites|antimetabolites|mesh-ancestor
91989841|NCT03175939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989842|NCT03175939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989843|NCT03175939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91989844|NCT03175939|Immunologic Factors|immunologic factors|mesh-ancestor
91989845|NCT03175939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989846|NCT03199625|Antidepressive Agents|antidepressive agents|mesh-list
91989847|NCT03199625|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91989848|NCT02417077|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91989849|NCT02417077|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91989850|NCT02417077|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91989851|NCT02417077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989852|NCT02417077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989853|NCT02417077|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91989854|NCT02417077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970095|NCT02449369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970096|NCT02449369|Antipyretics|antipyretics|mesh-ancestor
91970097|NCT02449369|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91989855|NCT02417077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989856|NCT02417077|Cholinergic Agents|cholinergic agents|mesh-ancestor
91989857|NCT02417077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989858|NCT03179527|Vasodilator Agents|vasodilator agents|mesh-list
91989859|NCT03179527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91989860|NCT03179527|Lipid Regulating Agents|lipid regulating agents|mesh-list
91989862|NCT02412475|Fludarabine|fludarabine|mesh-list
91989863|NCT02412475|Sorafenib|sorafenib|mesh-list
91989864|NCT02412475|Decitabine|decitabine|mesh-list
91989865|NCT02412475|Vorinostat|vorinostat|mesh-list
91989866|NCT02412475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989867|NCT02412475|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989868|NCT02412475|Antimetabolites|antimetabolites|mesh-ancestor
91989869|NCT02412475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989870|NCT02412475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91989871|NCT02412475|Immunologic Factors|immunologic factors|mesh-ancestor
91989872|NCT02412475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989873|NCT02412475|Antiviral Agents|antiviral agents|mesh-ancestor
91989874|NCT02412475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989875|NCT02412475|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91989880|NCT04543643|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91989881|NCT04543643|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989882|NCT04543643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989883|NCT04543643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989884|NCT04543643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989885|NCT04543643|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91989886|NCT04543643|Antioxidants|antioxidants|mesh-ancestor
91989887|NCT04543643|Protective Agents|protective agents|mesh-ancestor
91989888|NCT04543643|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91989889|NCT04543643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91989890|NCT04543643|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91989891|NCT04543643|Vasodilator Agents|vasodilator agents|mesh-ancestor
91989892|NCT04543643|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91989893|NCT04543643|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91989894|NCT05377619|Buspirone|buspirone|mesh-list
91989895|NCT05377619|Prucalopride|prucalopride|mesh-list
91989896|NCT05377619|Laxatives|laxatives|mesh-ancestor
91989897|NCT05377619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91989898|NCT05377619|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
91989899|NCT05377619|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91989900|NCT05377619|Serotonin Agents|serotonin agents|mesh-ancestor
91989901|NCT05377619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989902|NCT05377619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989903|NCT05377619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989904|NCT05377619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91989905|NCT05377619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91989906|NCT05377619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989907|NCT05377619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91989908|NCT03199157|Fentanyl|fentanyl|mesh-list
91989909|NCT03199157|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91989910|NCT03199157|Narcotics|narcotics|mesh-ancestor
91989911|NCT03199157|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989912|NCT03199157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989913|NCT03199157|Analgesics|analgesics|mesh-ancestor
91989914|NCT03199157|Sensory System Agents|sensory system agents|mesh-ancestor
91989915|NCT03199157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989916|NCT03199157|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91989917|NCT03199157|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91989918|NCT03199157|Anesthetics, General|anesthetics, general|mesh-ancestor
91989919|NCT03199157|Anesthetics|anesthetics|mesh-ancestor
91989920|NCT00641381|Cyclophosphamide|cyclophosphamide|mesh-list
91989921|NCT00641381|Carmustine|carmustine|mesh-list
91989922|NCT00641381|Etoposide|etoposide|mesh-list
91989923|NCT00641381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91989924|NCT00641381|Immunologic Factors|immunologic factors|mesh-ancestor
91989925|NCT00641381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989926|NCT00641381|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91989927|NCT00641381|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91989928|NCT00641381|Alkylating Agents|alkylating agents|mesh-ancestor
91970098|NCT02449369|Narcotics|narcotics|mesh-ancestor
91970099|NCT02449369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989929|NCT00641381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989930|NCT00641381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989931|NCT00641381|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91989932|NCT00641381|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91989933|NCT00641381|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91989934|NCT00641381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91989935|NCT00641381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989936|NCT02416999|Bevacizumab|bevacizumab|mesh-list
91989937|NCT02416999|Temozolomide|temozolomide|mesh-list
91989938|NCT02416999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91989939|NCT02416999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989940|NCT02416999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91989941|NCT02416999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91989942|NCT02416999|Growth Substances|growth substances|mesh-ancestor
91989943|NCT02416999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989944|NCT02416999|Growth Inhibitors|growth inhibitors|mesh-ancestor
91989945|NCT02416999|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91989946|NCT02416999|Alkylating Agents|alkylating agents|mesh-ancestor
91989947|NCT02416999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989952|NCT02412085|Immunologic Factors|immunologic factors|mesh-ancestor
91989953|NCT02412085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989954|NCT01679405|Cisplatin|cisplatin|mesh-list
91989955|NCT01679405|Gemcitabine|gemcitabine|mesh-list
91989956|NCT01679405|Afatinib|afatinib|mesh-list
91989957|NCT01679405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989958|NCT01679405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989959|NCT01679405|Antimetabolites|antimetabolites|mesh-ancestor
91989960|NCT01679405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989961|NCT01679405|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91989962|NCT01679405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989963|NCT03175705|Interleukin-2|interleukin-2|mesh-list
91989964|NCT03175705|Tegafur|tegafur|mesh-list
91989965|NCT03175705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989966|NCT03175705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91989967|NCT03175705|Analgesics|analgesics|mesh-ancestor
91989968|NCT03175705|Sensory System Agents|sensory system agents|mesh-ancestor
91989969|NCT03175705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989970|NCT03175705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989971|NCT03175705|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989972|NCT03175705|Antimetabolites|antimetabolites|mesh-ancestor
91989973|NCT03175705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989974|NCT00301457|Anastrozole|anastrozole|mesh-list
91989975|NCT00301457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91989976|NCT00301457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989977|NCT00301457|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91989978|NCT00301457|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91989979|NCT00301457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990212|NCT02449655|Mitosis Modulators|mitosis modulators|mesh-ancestor
91989980|NCT00301457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989981|NCT00301457|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91989982|NCT00301457|Hormone Antagonists|hormone antagonists|mesh-ancestor
91989983|NCT00301457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989984|NCT00301457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989985|NCT03177109|Fluorides|fluorides|mesh-list
91989986|NCT03177109|Fluorides, Topical|fluorides, topical|mesh-list
91989987|NCT03177109|Cariostatic Agents|cariostatic agents|mesh-ancestor
91989988|NCT03177109|Protective Agents|protective agents|mesh-ancestor
91989989|NCT03177109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989990|NCT05094947|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-list
91989991|NCT05094947|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91989992|NCT05094947|Adrenergic Agents|adrenergic agents|mesh-ancestor
91989993|NCT05094947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989994|NCT05094947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989995|NCT05094947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989996|NCT02421913|Ketamine|ketamine|mesh-list
91989997|NCT02421913|Analgesics|analgesics|mesh-ancestor
91989998|NCT02421913|Sensory System Agents|sensory system agents|mesh-ancestor
91989999|NCT02421913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990000|NCT02421913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990001|NCT02421913|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91970100|NCT02449369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91990002|NCT02421913|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91990003|NCT02421913|Anesthetics, General|anesthetics, general|mesh-ancestor
91990004|NCT02421913|Anesthetics|anesthetics|mesh-ancestor
91990005|NCT02421913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990006|NCT02421913|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91990007|NCT02421913|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91990008|NCT02421913|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990009|NCT02421913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990010|NCT03179293|Propofol|propofol|mesh-list
91990011|NCT03179293|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91990012|NCT03179293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990013|NCT03179293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990014|NCT03179293|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91990015|NCT03179293|Anesthetics, General|anesthetics, general|mesh-ancestor
91990016|NCT03179293|Anesthetics|anesthetics|mesh-ancestor
91990017|NCT02416765|Glucagon|glucagon|mesh-list
91990018|NCT02416765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990019|NCT02416765|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91990023|NCT02703259|Celecoxib|celecoxib|mesh-list
91990024|NCT02703259|Gabapentin|gabapentin|mesh-list
91990025|NCT02703259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990026|NCT02703259|Analgesics|analgesics|mesh-ancestor
91990027|NCT02703259|Sensory System Agents|sensory system agents|mesh-ancestor
91990028|NCT02703259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990029|NCT02703259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990030|NCT02703259|Antipyretics|antipyretics|mesh-ancestor
91990031|NCT02703259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91990032|NCT02703259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990033|NCT02703259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990034|NCT02703259|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91990035|NCT02703259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91990036|NCT02703259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990037|NCT02703259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990038|NCT02703259|Anticonvulsants|anticonvulsants|mesh-ancestor
91990039|NCT02703259|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91990040|NCT02703259|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91990041|NCT02703259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990042|NCT02703259|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91990043|NCT02703259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91990044|NCT02703259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91990045|NCT02703259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990046|NCT02703259|Antimanic Agents|antimanic agents|mesh-ancestor
91990047|NCT02416687|Etonogestrel|etonogestrel|mesh-list
91990048|NCT02416687|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91990049|NCT02416687|Contraceptive Agents|contraceptive agents|mesh-ancestor
91990050|NCT02416687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91990051|NCT02416687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990052|NCT02416687|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91990053|NCT02411695|Brexpiprazole|brexpiprazole|mesh-list
91990054|NCT02411695|Serotonin Agents|serotonin agents|mesh-ancestor
91990055|NCT02411695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990056|NCT02411695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990057|NCT02411695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990058|NCT02411695|Dopamine Agonists|dopamine agonists|mesh-ancestor
91990059|NCT02411695|Dopamine Agents|dopamine agents|mesh-ancestor
91990060|NCT05093231|Pembrolizumab|pembrolizumab|mesh-list
91990061|NCT05093231|Olaparib|olaparib|mesh-list
91990062|NCT05093231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91990063|NCT05093231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990064|NCT05093231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91990065|NCT05093231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990066|NCT05093231|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91990067|NCT05093231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990068|NCT02411149|Epinephrine|epinephrine|mesh-list
91990069|NCT02411149|Racepinephrine|racepinephrine|mesh-list
91990070|NCT02411149|Morphine|morphine|mesh-list
91990071|NCT02411149|Ropivacaine|ropivacaine|mesh-list
91990072|NCT02411149|Epinephryl borate|epinephryl borate|mesh-list
91990073|NCT02411149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91990074|NCT02411149|Narcotics|narcotics|mesh-ancestor
91990075|NCT02411149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990076|NCT02411149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970101|NCT02449369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91990077|NCT02411149|Analgesics|analgesics|mesh-ancestor
91990078|NCT02411149|Sensory System Agents|sensory system agents|mesh-ancestor
91990079|NCT02411149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990080|NCT02411149|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990081|NCT02411149|Anesthetics|anesthetics|mesh-ancestor
91990082|NCT02411149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91990083|NCT02411149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91990084|NCT02411149|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990085|NCT02411149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990086|NCT02411149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990087|NCT02411149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91990088|NCT02411149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91990089|NCT02411149|Autonomic Agents|autonomic agents|mesh-ancestor
91990090|NCT02411149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91990091|NCT02411149|Respiratory System Agents|respiratory system agents|mesh-ancestor
91990092|NCT02411149|Mydriatics|mydriatics|mesh-ancestor
91990097|NCT04413227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990098|NCT04413227|Tubulin Modulators|tubulin modulators|mesh-ancestor
91990099|NCT04413227|Antimitotic Agents|antimitotic agents|mesh-ancestor
91990100|NCT04413227|Mitosis Modulators|mitosis modulators|mesh-ancestor
91990101|NCT04413227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990102|NCT04413227|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91990103|NCT04413227|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91990104|NCT04413227|Growth Substances|growth substances|mesh-ancestor
91990105|NCT04413227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990106|NCT04413227|Growth Inhibitors|growth inhibitors|mesh-ancestor
91990107|NCT02410135|Mirabegron|mirabegron|mesh-list
91990108|NCT02410135|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91990109|NCT02410135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91990110|NCT02410135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91990111|NCT02410135|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990112|NCT02410135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990113|NCT02410135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990114|NCT02410135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990115|NCT02410135|Urological Agents|urological agents|mesh-ancestor
91990117|NCT02410759|Ergonovine|ergonovine|mesh-list
91990118|NCT02410759|Oxytocics|oxytocics|mesh-ancestor
91990119|NCT02410759|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91990120|NCT02410759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990121|NCT03175081|Ropivacaine|ropivacaine|mesh-list
91990122|NCT03175081|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990123|NCT03175081|Anesthetics|anesthetics|mesh-ancestor
91990124|NCT03175081|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990125|NCT03175081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990126|NCT03175081|Sensory System Agents|sensory system agents|mesh-ancestor
91990127|NCT03175081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990128|NCT02409823|Antipsychotic Agents|antipsychotic agents|mesh-list
91990129|NCT02409823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91990130|NCT02409823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990131|NCT02409823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990132|NCT02409823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91990133|NCT02401477|Amoxicillin|amoxicillin|mesh-list
91990134|NCT02401477|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91990135|NCT02401477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990136|NCT03174457|Micafungin|micafungin|mesh-list
91990137|NCT03174457|Antifungal Agents|antifungal agents|mesh-ancestor
91990138|NCT03174457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990139|NCT02401243|Insulin Glargine|insulin glargine|mesh-list
91990140|NCT02401243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91990141|NCT02401243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990142|NCT02409433|Lacosamide|lacosamide|mesh-list
91990143|NCT02409433|Phenytoin|phenytoin|mesh-list
91990144|NCT02409433|Anticonvulsants|anticonvulsants|mesh-ancestor
91990145|NCT02409433|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91990146|NCT02409433|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91990147|NCT02409433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990148|NCT02409433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990149|NCT02409433|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91990150|NCT02409433|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91990151|NCT01989754|Canagliflozin|canagliflozin|mesh-list
91990152|NCT01989754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91990153|NCT01989754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970102|NCT02449369|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91990154|NCT01989754|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91990155|NCT01989754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990157|NCT01619878|Artemether|artemether|mesh-list
91990158|NCT01619878|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
91990159|NCT01619878|Antimalarials|antimalarials|mesh-ancestor
91990160|NCT01619878|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91990161|NCT01619878|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91990162|NCT01619878|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990163|NCT02015104|BCG Vaccine|bcg vaccine|mesh-list
91990164|NCT02015104|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91990166|NCT02015104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990167|NCT01989208|Sodium sulfate|sodium sulfate|mesh-list
91990168|NCT01989208|Cathartics|cathartics|mesh-ancestor
91990169|NCT01989208|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91990170|NCT01619410|Clindamycin|clindamycin|mesh-list
91990171|NCT01619410|Clindamycin palmitate|clindamycin palmitate|mesh-list
91990172|NCT01619410|Clindamycin phosphate|clindamycin phosphate|mesh-list
91990173|NCT01619410|Linezolid|linezolid|mesh-list
91990174|NCT01619410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91990175|NCT01619410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990176|NCT01619410|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91990177|NCT01619410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990178|NCT01619410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990179|NCT04666714|Pregabalin|pregabalin|mesh-list
91990180|NCT04666714|Analgesics|analgesics|mesh-ancestor
91990181|NCT04666714|Sensory System Agents|sensory system agents|mesh-ancestor
91990182|NCT04666714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990183|NCT04666714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990184|NCT04666714|Anticonvulsants|anticonvulsants|mesh-ancestor
91990185|NCT04666714|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91990186|NCT04666714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990187|NCT04666714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990188|NCT04666714|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91990189|NCT04666714|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91990190|NCT04666714|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91990191|NCT04666714|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990192|NCT04666714|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91990193|NCT01261247|Panobinostat|panobinostat|mesh-list
91990194|NCT01261247|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
91990195|NCT01261247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990196|NCT01261247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990197|NCT01261247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990198|NCT03233243|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91990199|NCT03233243|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91990200|NCT03233243|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91990201|NCT03233243|Antimetabolites|antimetabolites|mesh-ancestor
91990202|NCT03233243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990203|NCT03233243|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91990204|NCT03233243|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91990205|NCT03233243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990207|NCT02449655|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91990208|NCT02449655|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91990209|NCT02449655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990210|NCT02449655|Tubulin Modulators|tubulin modulators|mesh-ancestor
91990213|NCT02449655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990214|NCT04254731|Methadone|methadone|mesh-list
91990215|NCT04254731|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91990216|NCT04254731|Narcotics|narcotics|mesh-ancestor
91990217|NCT04254731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990218|NCT04254731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990219|NCT04254731|Analgesics|analgesics|mesh-ancestor
91990220|NCT04254731|Sensory System Agents|sensory system agents|mesh-ancestor
91990221|NCT04254731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990222|NCT04254731|Antitussive Agents|antitussive agents|mesh-ancestor
91990223|NCT04254731|Respiratory System Agents|respiratory system agents|mesh-ancestor
91990224|NCT01603277|Antibodies|antibodies|mesh-list
91990225|NCT01603277|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91990226|NCT01603277|Immunologic Factors|immunologic factors|mesh-ancestor
91990227|NCT01603277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970103|NCT02449369|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91970104|NCT02449369|Parasympatholytics|parasympatholytics|mesh-ancestor
91990228|NCT01678313|Celecoxib|celecoxib|mesh-list
91990229|NCT01678313|Doxazosin|doxazosin|mesh-list
91990230|NCT01678313|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91990231|NCT01678313|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990232|NCT01678313|Analgesics|analgesics|mesh-ancestor
91990233|NCT01678313|Sensory System Agents|sensory system agents|mesh-ancestor
91990234|NCT01678313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990235|NCT01678313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990236|NCT01678313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990237|NCT01678313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990238|NCT01678313|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91990240|NCT01678313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990241|NCT01678313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990242|NCT01678313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91990243|NCT01678313|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91990244|NCT01678313|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91990245|NCT01678313|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91990246|NCT01678313|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990247|NCT01678313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990249|NCT03197207|Salicylates|salicylates|mesh-list
91990250|NCT03197207|Methyl salicylate|methyl salicylate|mesh-list
91990251|NCT03197207|Menthol|menthol|mesh-list
91990252|NCT03197207|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91990253|NCT03197207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990254|NCT03197207|Antipruritics|antipruritics|mesh-ancestor
91990255|NCT03197207|Dermatologic Agents|dermatologic agents|mesh-ancestor
91990256|NCT03197207|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91990257|NCT03197207|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990258|NCT03197207|Analgesics|analgesics|mesh-ancestor
91990259|NCT03197207|Sensory System Agents|sensory system agents|mesh-ancestor
91990260|NCT03197207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990261|NCT03197207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990262|NCT03197207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990263|NCT03197207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990264|NCT03197207|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91990265|NCT03197207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990266|NCT03197207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990267|NCT01603121|Lisofylline|lisofylline|mesh-list
91990268|NCT01603121|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91990269|NCT01603121|Immunologic Factors|immunologic factors|mesh-ancestor
91990270|NCT01603121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990271|NCT01603121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91990272|NCT01603121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990273|NCT01603121|Analgesics|analgesics|mesh-ancestor
91990274|NCT01603121|Sensory System Agents|sensory system agents|mesh-ancestor
91990275|NCT01603121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990276|NCT01603121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990277|NCT01603121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990278|NCT01603121|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990279|NCT02449265|Prednisone|prednisone|mesh-list
91990280|NCT02449265|Cyclophosphamide|cyclophosphamide|mesh-list
91990281|NCT02449265|Doxorubicin|doxorubicin|mesh-list
91990282|NCT02449265|Vincristine|vincristine|mesh-list
91990283|NCT02449265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990284|NCT02449265|Immunologic Factors|immunologic factors|mesh-ancestor
91990285|NCT02449265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990286|NCT02449265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990287|NCT02449265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91990288|NCT02449265|Alkylating Agents|alkylating agents|mesh-ancestor
91990289|NCT02449265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990290|NCT02449265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990291|NCT02449265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91990292|NCT02449265|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91990293|NCT02449265|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91990294|NCT02449265|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91990295|NCT02449265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990296|NCT02449265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990297|NCT02449265|Glucocorticoids|glucocorticoids|mesh-ancestor
91990298|NCT02449265|Hormones|hormones|mesh-ancestor
91990299|NCT02449265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91990300|NCT02449265|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91970105|NCT02449369|Autonomic Agents|autonomic agents|mesh-ancestor
91970106|NCT02449369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91990301|NCT02449265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91990302|NCT02449265|Tubulin Modulators|tubulin modulators|mesh-ancestor
91990303|NCT02449265|Antimitotic Agents|antimitotic agents|mesh-ancestor
91990304|NCT02449265|Mitosis Modulators|mitosis modulators|mesh-ancestor
91990305|NCT03196817|Betamethasone|betamethasone|mesh-list
91990306|NCT03196817|Betamethasone Valerate|betamethasone valerate|mesh-list
91990307|NCT03196817|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91990308|NCT03196817|Betamethasone benzoate|betamethasone benzoate|mesh-list
91990309|NCT03196817|Lidocaine|lidocaine|mesh-list
91990310|NCT03196817|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91990311|NCT03196817|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990312|NCT03196817|Anesthetics|anesthetics|mesh-ancestor
91990314|NCT03196817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990315|NCT03196817|Sensory System Agents|sensory system agents|mesh-ancestor
91990316|NCT03196817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990317|NCT03196817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91990318|NCT03196817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91990319|NCT03196817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91990320|NCT03196817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990321|NCT03196817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990322|NCT03196817|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990323|NCT03196817|Glucocorticoids|glucocorticoids|mesh-ancestor
91990325|NCT03196817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91990326|NCT03196817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91990327|NCT03196817|Respiratory System Agents|respiratory system agents|mesh-ancestor
91990329|NCT05091359|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91990330|NCT05091359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990331|NCT03564821|Ivosidenib|ivosidenib|mesh-list
91990332|NCT03564821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990333|NCT03564821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990334|NCT03564821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990335|NCT02014402|Thrombin|thrombin|mesh-list
91990336|NCT02014402|Hemostatics|hemostatics|mesh-ancestor
91990337|NCT02014402|Coagulants|coagulants|mesh-ancestor
91990338|NCT01988662|Ranibizumab|ranibizumab|mesh-list
91990339|NCT01988662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91990340|NCT01988662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91990341|NCT01988662|Growth Substances|growth substances|mesh-ancestor
91990342|NCT01988662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990343|NCT01988662|Growth Inhibitors|growth inhibitors|mesh-ancestor
91990344|NCT01988662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990345|NCT00127673|Sertraline|sertraline|mesh-list
91990346|NCT00127673|Antidepressive Agents|antidepressive agents|mesh-ancestor
91990347|NCT00127673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91990348|NCT00127673|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91990349|NCT00127673|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91990350|NCT00127673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990351|NCT00127673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990352|NCT00127673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990353|NCT00127673|Serotonin Agents|serotonin agents|mesh-ancestor
91990354|NCT00127673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990355|NCT02449187|Calcium, Dietary|calcium, dietary|mesh-list
91990356|NCT02449187|Metformin|metformin|mesh-list
91990357|NCT02449187|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91990358|NCT02449187|Calcium|calcium|mesh-list
91990359|NCT02449187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91990360|NCT02449187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990361|NCT02449187|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91990362|NCT02449187|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91990363|NCT02449187|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91990364|NCT02449187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91990365|NCT02449187|Antimetabolites|antimetabolites|mesh-ancestor
91990366|NCT02449187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990367|NCT02449187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91990368|NCT02449187|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91990369|NCT02449187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990370|NCT05095571|Niacinamide|niacinamide|mesh-list
91990371|NCT05095571|Niacin|niacin|mesh-list
91990372|NCT05095571|Nicotinic Acids|nicotinic acids|mesh-list
91990373|NCT05095571|Vitamin B Complex|vitamin b complex|mesh-ancestor
91990374|NCT05095571|Vitamins|vitamins|mesh-ancestor
91990375|NCT05095571|Micronutrients|micronutrients|mesh-ancestor
91990376|NCT05095571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990377|NCT05095571|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91990378|NCT05095571|Antimetabolites|antimetabolites|mesh-ancestor
91990379|NCT05095571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990380|NCT05095571|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91990381|NCT05095571|Vasodilator Agents|vasodilator agents|mesh-ancestor
91990382|NCT02677181|Mycophenolic Acid|mycophenolic acid|mesh-list
91990383|NCT02677181|Methotrexate|methotrexate|mesh-list
91990384|NCT02677181|Thymoglobulin|thymoglobulin|mesh-list
91990385|NCT02677181|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91990386|NCT02677181|Abortifacient Agents|abortifacient agents|mesh-ancestor
91990387|NCT02677181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91990388|NCT02677181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990389|NCT02677181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91990390|NCT02677181|Antimetabolites|antimetabolites|mesh-ancestor
91990391|NCT02677181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990392|NCT02677181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990393|NCT02677181|Dermatologic Agents|dermatologic agents|mesh-ancestor
91990394|NCT02677181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990395|NCT02677181|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91990396|NCT02677181|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990397|NCT02677181|Immunologic Factors|immunologic factors|mesh-ancestor
91990398|NCT02677181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990399|NCT02677181|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91990400|NCT02677181|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91990401|NCT02677181|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91990402|NCT02677181|Antitubercular Agents|antitubercular agents|mesh-ancestor
91990403|NCT02677181|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91990404|NCT02677181|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990405|NCT05095025|Bupivacaine|bupivacaine|mesh-list
91990406|NCT05095025|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990407|NCT05095025|Anesthetics|anesthetics|mesh-ancestor
91990408|NCT05095025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990409|NCT05095025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990410|NCT05095025|Sensory System Agents|sensory system agents|mesh-ancestor
91990411|NCT05095025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990412|NCT05056259|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91990413|NCT05056259|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91990414|NCT05056259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990415|NCT01987960|Brexpiprazole|brexpiprazole|mesh-list
91990416|NCT01987960|Serotonin Agents|serotonin agents|mesh-ancestor
91990417|NCT01987960|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990418|NCT01987960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990419|NCT01987960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990420|NCT01987960|Dopamine Agonists|dopamine agonists|mesh-ancestor
91990421|NCT01987960|Dopamine Agents|dopamine agents|mesh-ancestor
91990422|NCT05084027|Fludarabine|fludarabine|mesh-list
91990423|NCT05084027|Melphalan|melphalan|mesh-list
91990424|NCT05084027|Venetoclax|venetoclax|mesh-list
91990425|NCT05084027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990426|NCT05084027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990427|NCT05084027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990428|NCT05084027|Immunologic Factors|immunologic factors|mesh-ancestor
91990429|NCT05084027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990430|NCT05084027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91990431|NCT05084027|Alkylating Agents|alkylating agents|mesh-ancestor
91990432|NCT05084027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91990433|NCT02013622|Brexpiprazole|brexpiprazole|mesh-list
91990434|NCT02013622|Serotonin Agents|serotonin agents|mesh-ancestor
91990435|NCT02013622|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990436|NCT02013622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990437|NCT02013622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990438|NCT02013622|Dopamine Agonists|dopamine agonists|mesh-ancestor
91990439|NCT02013622|Dopamine Agents|dopamine agents|mesh-ancestor
91990440|NCT02448797|Vinorelbine|vinorelbine|mesh-list
91990441|NCT02448797|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91990442|NCT02448797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990443|NCT02448797|Tubulin Modulators|tubulin modulators|mesh-ancestor
91990444|NCT02448797|Antimitotic Agents|antimitotic agents|mesh-ancestor
91990445|NCT02448797|Mitosis Modulators|mitosis modulators|mesh-ancestor
91990446|NCT02448797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990447|NCT04438421|Chlorhexidine|chlorhexidine|mesh-list
91970107|NCT02449369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91990448|NCT04438421|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91990450|NCT04438421|Hyaluronic Acid|hyaluronic acid|mesh-list
91990451|NCT04438421|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91990452|NCT04438421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990453|NCT04438421|Disinfectants|disinfectants|mesh-ancestor
91990454|NCT04438421|Dermatologic Agents|dermatologic agents|mesh-ancestor
91990455|NCT04438421|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91990456|NCT04438421|Immunologic Factors|immunologic factors|mesh-ancestor
91990457|NCT04438421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990458|NCT04438421|Viscosupplements|viscosupplements|mesh-ancestor
91990459|NCT04438421|Protective Agents|protective agents|mesh-ancestor
91990461|NCT05099081|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
91990462|NCT05099081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91990464|NCT04438577|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990465|NCT04438577|Anesthetics|anesthetics|mesh-ancestor
91990466|NCT04438577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990467|NCT04438577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990468|NCT04438577|Sensory System Agents|sensory system agents|mesh-ancestor
91990469|NCT04438577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990470|NCT04438577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91990471|NCT04438577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91990472|NCT04438577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91990473|NCT04438577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990474|NCT04438577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990475|NCT05087615|Ondansetron|ondansetron|mesh-list
91990476|NCT05087615|Metoclopramide|metoclopramide|mesh-list
91990477|NCT05087615|Granisetron|granisetron|mesh-list
91990478|NCT05087615|Antiemetics|antiemetics|mesh-ancestor
91990479|NCT05087615|Autonomic Agents|autonomic agents|mesh-ancestor
91990480|NCT05087615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990481|NCT05087615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990482|NCT05087615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91990483|NCT05087615|Antipruritics|antipruritics|mesh-ancestor
91990484|NCT05087615|Dermatologic Agents|dermatologic agents|mesh-ancestor
91990485|NCT05087615|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91990486|NCT05087615|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91990487|NCT05087615|Serotonin Agents|serotonin agents|mesh-ancestor
91990488|NCT05087615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990489|NCT05087615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990490|NCT05087615|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91990491|NCT05087615|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91990492|NCT05087615|Dopamine Agents|dopamine agents|mesh-ancestor
91990493|NCT01987102|Leucovorin|leucovorin|mesh-list
91990494|NCT01987102|Calcium|calcium|mesh-list
91990495|NCT01987102|Levoleucovorin|levoleucovorin|mesh-list
91990496|NCT01987102|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91990497|NCT01987102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990498|NCT01987102|Antidotes|antidotes|mesh-ancestor
91990499|NCT01987102|Protective Agents|protective agents|mesh-ancestor
91990500|NCT01987102|Vitamin B Complex|vitamin b complex|mesh-ancestor
91990501|NCT01987102|Vitamins|vitamins|mesh-ancestor
91990502|NCT01987102|Micronutrients|micronutrients|mesh-ancestor
91990503|NCT02013544|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
91990504|NCT02013544|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91990505|NCT02013544|Immunologic Factors|immunologic factors|mesh-ancestor
91990506|NCT02013544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990507|NCT03968939|Diphenhydramine|diphenhydramine|mesh-list
91990508|NCT03968939|Promethazine|promethazine|mesh-list
91990509|NCT03968939|Melatonin|melatonin|mesh-list
91990510|NCT03968939|Antioxidants|antioxidants|mesh-ancestor
91990511|NCT03968939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990512|NCT03968939|Protective Agents|protective agents|mesh-ancestor
91990513|NCT03968939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990514|NCT03968939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990515|NCT03968939|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91990516|NCT03968939|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91990517|NCT03968939|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990518|NCT03968939|Anesthetics|anesthetics|mesh-ancestor
91990519|NCT03968939|Sensory System Agents|sensory system agents|mesh-ancestor
91990520|NCT03968939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990521|NCT03968939|Antiemetics|antiemetics|mesh-ancestor
91990522|NCT03968939|Autonomic Agents|autonomic agents|mesh-ancestor
91990523|NCT03968939|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91970108|NCT02449369|Cholinergic Agents|cholinergic agents|mesh-ancestor
91970109|NCT02449369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970110|NCT02449369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970111|NCT02449369|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
91990524|NCT03968939|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91990525|NCT03968939|Histamine Antagonists|histamine antagonists|mesh-ancestor
91990526|NCT03968939|Histamine Agents|histamine agents|mesh-ancestor
91990527|NCT03968939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990528|NCT03968939|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91990529|NCT03968939|Antipruritics|antipruritics|mesh-ancestor
91990530|NCT03968939|Dermatologic Agents|dermatologic agents|mesh-ancestor
91990531|NCT03856619|Teriflunomide|teriflunomide|mesh-list
91990532|NCT03856619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91990533|NCT03856619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990534|NCT03856619|Analgesics|analgesics|mesh-ancestor
91990535|NCT03856619|Sensory System Agents|sensory system agents|mesh-ancestor
91990539|NCT03856619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990540|NCT03856619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990541|NCT03856619|Immunologic Factors|immunologic factors|mesh-ancestor
91990542|NCT02448407|Hyaluronic Acid|hyaluronic acid|mesh-list
91990543|NCT02448407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91990544|NCT02448407|Immunologic Factors|immunologic factors|mesh-ancestor
91990545|NCT02448407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990546|NCT02448407|Viscosupplements|viscosupplements|mesh-ancestor
91990547|NCT02448407|Protective Agents|protective agents|mesh-ancestor
91990548|NCT05098847|Lenvatinib|lenvatinib|mesh-list
91990549|NCT05098847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990550|NCT05098847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91990551|NCT05098847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990552|NCT05098847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990554|NCT04517357|Fluzoparib|fluzoparib|mesh-list
91990555|NCT04517357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990556|NCT04517357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91990557|NCT04517357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990558|NCT04517357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990559|NCT04517357|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91990560|NCT02012296|Mifepristone|mifepristone|mesh-list
91990561|NCT02012296|Androgens|androgens|mesh-list
91990562|NCT02012296|Hormones|hormones|mesh-ancestor
91990563|NCT02012296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91990564|NCT02012296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990565|NCT02012296|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91990566|NCT02012296|Abortifacient Agents|abortifacient agents|mesh-ancestor
91990567|NCT02012296|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91990568|NCT02012296|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91990569|NCT02012296|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91990570|NCT02012296|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91990571|NCT02012296|Contraceptive Agents|contraceptive agents|mesh-ancestor
91990572|NCT02012296|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91990573|NCT02012296|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91990574|NCT02012296|Hormone Antagonists|hormone antagonists|mesh-ancestor
91990575|NCT02012296|Luteolytic Agents|luteolytic agents|mesh-ancestor
91990576|NCT02012296|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91990577|NCT02012296|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91990579|NCT02012218|Serotonin Agents|serotonin agents|mesh-ancestor
91990580|NCT02012218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990581|NCT02012218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990582|NCT02012218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990583|NCT02012218|Dopamine Agonists|dopamine agonists|mesh-ancestor
91990584|NCT02012218|Dopamine Agents|dopamine agents|mesh-ancestor
91990585|NCT04177498|ON 01910|on 01910|mesh-list
91990586|NCT04177498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990587|NCT04177498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91990588|NCT04177498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990589|NCT04177498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990590|NCT04658836|Triamcinolone|triamcinolone|mesh-list
91990591|NCT04658836|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91970112|NCT02449369|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91970113|NCT02449369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990592|NCT04658836|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91990593|NCT04658836|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91990594|NCT04658836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990596|NCT04658836|Hormones|hormones|mesh-ancestor
91990597|NCT04658836|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91990598|NCT04658836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990599|NCT04658836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990600|NCT04658836|Immunologic Factors|immunologic factors|mesh-ancestor
91990601|NCT04658836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990602|NCT04658836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990603|NCT01677377|Risperidone|risperidone|mesh-list
91990604|NCT01677377|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91990605|NCT01677377|Serotonin Agents|serotonin agents|mesh-ancestor
91990606|NCT01677377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990619|NCT05097911|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91990620|NCT05097911|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91990621|NCT05097911|Growth Substances|growth substances|mesh-ancestor
91990622|NCT05097911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990623|NCT05097911|Growth Inhibitors|growth inhibitors|mesh-ancestor
91990624|NCT05097911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91990625|NCT05097911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990626|NCT05097365|Folic Acid|folic acid|mesh-list
91990627|NCT05097365|Vitamin B 12|vitamin b 12|mesh-list
91990628|NCT05097365|Hydroxocobalamin|hydroxocobalamin|mesh-list
91990629|NCT05097365|Vitamins|vitamins|mesh-ancestor
91990630|NCT05097365|Micronutrients|micronutrients|mesh-ancestor
91990631|NCT05097365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990632|NCT05097365|Hematinics|hematinics|mesh-ancestor
91990633|NCT05097365|Vitamin B Complex|vitamin b complex|mesh-ancestor
91990634|NCT01964716|Vaccines|vaccines|mesh-list
91990635|NCT01964716|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91990636|NCT01964716|Immunologic Factors|immunologic factors|mesh-ancestor
91990637|NCT01964716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990638|NCT01964560|Lacosamide|lacosamide|mesh-list
91990639|NCT01964560|Anticonvulsants|anticonvulsants|mesh-ancestor
91990640|NCT01964560|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91990641|NCT01964560|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91990642|NCT01964560|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990643|NCT01964560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990644|NCT02659943|Cyclophosphamide|cyclophosphamide|mesh-list
91990645|NCT02659943|Fludarabine|fludarabine|mesh-list
91990646|NCT02659943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990647|NCT02659943|Immunologic Factors|immunologic factors|mesh-ancestor
91990648|NCT02659943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990649|NCT02659943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990650|NCT02659943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91990651|NCT02659943|Alkylating Agents|alkylating agents|mesh-ancestor
91990652|NCT02659943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990653|NCT02659943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990654|NCT02659943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91990655|NCT05083325|Oseltamivir|oseltamivir|mesh-list
91990656|NCT05083325|Antiviral Agents|antiviral agents|mesh-ancestor
91990657|NCT05083325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990658|NCT05083325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990659|NCT05083325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990660|NCT01677299|Metformin|metformin|mesh-list
91990661|NCT01677299|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91990662|NCT01677299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990663|NCT04999631|Ethanol|ethanol|mesh-list
91990664|NCT04999631|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
91990665|NCT04999631|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91990666|NCT04999631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990667|NCT04999631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990668|NCT04999631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990692|NCT04908293|Sodium Fluoride|sodium fluoride|mesh-list
91990693|NCT04908293|Cariostatic Agents|cariostatic agents|mesh-ancestor
91990694|NCT04908293|Protective Agents|protective agents|mesh-ancestor
91990695|NCT04908293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970115|NCT03192943|Linrodostat|linrodostat|mesh-list
91970116|NCT03192943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970117|NCT03192943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970118|NCT03192943|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91970119|NCT03192943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990696|NCT04908293|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91990697|NCT04908293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990698|NCT01964326|Atorvastatin|atorvastatin|mesh-list
91990699|NCT01964326|Calcium|calcium|mesh-list
91990700|NCT01964326|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91990701|NCT01964326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990702|NCT01964326|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91990703|NCT01964326|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91990704|NCT01964326|Antimetabolites|antimetabolites|mesh-ancestor
91990705|NCT01964326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990706|NCT01964326|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91990707|NCT01964326|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91990708|NCT01964326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990709|NCT05102045|Memantine|memantine|mesh-list
91990710|NCT05102045|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-list
91990711|NCT05102045|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91990712|NCT05102045|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91990713|NCT05102045|Dopamine Agents|dopamine agents|mesh-ancestor
91990714|NCT05102045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990715|NCT05102045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990716|NCT05102045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990717|NCT05102045|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91990718|NCT05102045|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91990719|NCT05102045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990720|NCT05102045|Cholinergic Agents|cholinergic agents|mesh-ancestor
91990723|NCT04414241|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91990724|NCT04414241|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91990725|NCT04414241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990726|NCT04414241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990727|NCT04414241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990728|NCT04414241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990729|NCT04531553|Levobupivacaine|levobupivacaine|mesh-list
91990730|NCT04531553|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990731|NCT04531553|Anesthetics|anesthetics|mesh-ancestor
91990732|NCT04531553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990733|NCT04531553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990734|NCT04531553|Sensory System Agents|sensory system agents|mesh-ancestor
91990735|NCT04531553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990736|NCT05101811|Vitamin D|vitamin d|mesh-list
91990737|NCT05101811|Ergocalciferols|ergocalciferols|mesh-list
91990738|NCT05101811|Cholecalciferol|cholecalciferol|mesh-list
91990739|NCT05101811|Vitamins|vitamins|mesh-list
91990740|NCT05101811|Micronutrients|micronutrients|mesh-ancestor
91990741|NCT05101811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990742|NCT05101811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91990743|NCT05101811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91990744|NCT04088123|Ticagrelor|ticagrelor|mesh-list
91990745|NCT04088123|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91990746|NCT04088123|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91990747|NCT04088123|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91990748|NCT04088123|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91990749|NCT04088123|Purinergic Agents|purinergic agents|mesh-ancestor
91990750|NCT04088123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990751|NCT04088123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990752|NCT04088123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990753|NCT05164367|Atropine|atropine|mesh-list
91990754|NCT05164367|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91990755|NCT05164367|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91990756|NCT05164367|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91990757|NCT05164367|Autonomic Agents|autonomic agents|mesh-ancestor
91990758|NCT05164367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990759|NCT05164367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970121|NCT04986813|Tranexamic Acid|tranexamic acid|mesh-list
91990760|NCT05164367|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91990761|NCT05164367|Respiratory System Agents|respiratory system agents|mesh-ancestor
91990762|NCT05164367|Mydriatics|mydriatics|mesh-ancestor
91990763|NCT05164367|Parasympatholytics|parasympatholytics|mesh-ancestor
91990764|NCT05164367|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91990765|NCT05164367|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91990766|NCT05164367|Cholinergic Agents|cholinergic agents|mesh-ancestor
91990767|NCT05164367|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990768|NCT05164367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990769|NCT03847181|Vitamin K|vitamin k|mesh-list
91990770|NCT03847181|Warfarin|warfarin|mesh-list
91990771|NCT03847181|Rivaroxaban|rivaroxaban|mesh-list
91990772|NCT03847181|Apixaban|apixaban|mesh-list
91990773|NCT03847181|Anticoagulants|anticoagulants|mesh-list
91990774|NCT03847181|Vitamins|vitamins|mesh-ancestor
91990775|NCT03847181|Micronutrients|micronutrients|mesh-ancestor
91990776|NCT03847181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990777|NCT03847181|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91990778|NCT03847181|Antithrombins|antithrombins|mesh-ancestor
91990779|NCT03847181|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91990780|NCT03847181|Protease Inhibitors|protease inhibitors|mesh-ancestor
91990781|NCT03847181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990782|NCT03847181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990783|NCT03847181|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91990784|NCT03847181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91990785|NCT03847181|Hemostatics|hemostatics|mesh-ancestor
91990786|NCT03847181|Coagulants|coagulants|mesh-ancestor
91990787|NCT03477851|Tramadol|tramadol|mesh-list
91990788|NCT03477851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91990789|NCT03477851|Narcotics|narcotics|mesh-ancestor
91990790|NCT03477851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990791|NCT03477851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990792|NCT03477851|Analgesics|analgesics|mesh-ancestor
91990793|NCT03477851|Sensory System Agents|sensory system agents|mesh-ancestor
91990794|NCT03477851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990795|NCT02409199|Docetaxel|docetaxel|mesh-list
91990796|NCT02409199|Apatinib|apatinib|mesh-list
91990800|NCT02409199|Mitosis Modulators|mitosis modulators|mesh-ancestor
91990801|NCT02409199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990802|NCT02409199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91990803|NCT02409199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990804|NCT03115489|Ketamine|ketamine|mesh-list
91990805|NCT03115489|Propofol|propofol|mesh-list
91990806|NCT03115489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91990807|NCT03115489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990808|NCT03115489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990809|NCT03115489|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91990810|NCT03115489|Anesthetics, General|anesthetics, general|mesh-ancestor
91990811|NCT03115489|Anesthetics|anesthetics|mesh-ancestor
91990812|NCT03115489|Analgesics|analgesics|mesh-ancestor
91990813|NCT03115489|Sensory System Agents|sensory system agents|mesh-ancestor
91990814|NCT03115489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990815|NCT03115489|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91990816|NCT03115489|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91990817|NCT03115489|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91990818|NCT03115489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990819|NCT03115489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990820|NCT03168997|Memantine|memantine|mesh-list
91990821|NCT03168997|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91990822|NCT03168997|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91990823|NCT03168997|Dopamine Agents|dopamine agents|mesh-ancestor
91990824|NCT03168997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990825|NCT03168997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990826|NCT03168997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990827|NCT03168997|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91990828|NCT03168997|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91990829|NCT03171727|Heparin|heparin|mesh-list
91990830|NCT03171727|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91990831|NCT03171727|Tinzaparin|tinzaparin|mesh-list
91990832|NCT03171727|Dalteparin|dalteparin|mesh-list
91990833|NCT03171727|Anticoagulants|anticoagulants|mesh-ancestor
91990834|NCT03171727|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91990835|NCT03171727|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91990836|NCT03171727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970122|NCT04986813|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91990837|NCT02400931|Rocuronium|rocuronium|mesh-list
91990838|NCT02400931|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91990839|NCT02400931|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91990840|NCT02400931|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91990841|NCT02400931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990842|NCT02400931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990843|NCT03116269|Aspirin|aspirin|mesh-list
91990844|NCT03116269|Cilostazol|cilostazol|mesh-list
91990845|NCT03116269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91990846|NCT03116269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990847|NCT03116269|Analgesics|analgesics|mesh-ancestor
91990848|NCT03116269|Sensory System Agents|sensory system agents|mesh-ancestor
91990849|NCT03116269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990850|NCT03116269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990851|NCT03116269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990852|NCT03116269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91990853|NCT03116269|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91990854|NCT03116269|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91990855|NCT03116269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990856|NCT03116269|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91990857|NCT03116269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91990858|NCT03116269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990859|NCT03116269|Antipyretics|antipyretics|mesh-ancestor
91990860|NCT03116269|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91990861|NCT03116269|Autonomic Agents|autonomic agents|mesh-ancestor
91990862|NCT03116269|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91990863|NCT03116269|Respiratory System Agents|respiratory system agents|mesh-ancestor
91990864|NCT03116269|Vasodilator Agents|vasodilator agents|mesh-ancestor
91990865|NCT03116269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91990866|NCT03116269|Protective Agents|protective agents|mesh-ancestor
91990867|NCT03116269|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91990868|NCT03116269|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91990888|NCT02408185|Colistin|colistin|mesh-list
91990889|NCT02408185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91990890|NCT02408185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91990891|NCT02408419|Bupivacaine|bupivacaine|mesh-list
91990892|NCT02408419|Anesthetics, Local|anesthetics, local|mesh-ancestor
91990893|NCT02408419|Anesthetics|anesthetics|mesh-ancestor
91990894|NCT02408419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990895|NCT02408419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990896|NCT02408419|Sensory System Agents|sensory system agents|mesh-ancestor
91990897|NCT02408419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990898|NCT00708097|Fluorides|fluorides|mesh-list
91990899|NCT00708097|Cariostatic Agents|cariostatic agents|mesh-ancestor
91990900|NCT00708097|Protective Agents|protective agents|mesh-ancestor
91990901|NCT00708097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990902|NCT02400775|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
91990903|NCT02400775|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91990904|NCT02400775|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91990905|NCT02400775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990906|NCT02405689|Dexmedetomidine|dexmedetomidine|mesh-list
91990907|NCT02405689|Remifentanil|remifentanil|mesh-list
91990908|NCT02405689|Sevoflurane|sevoflurane|mesh-list
91990909|NCT02405689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91990910|NCT02405689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990911|NCT02405689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990912|NCT02405689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91990913|NCT02405689|Analgesics|analgesics|mesh-ancestor
91990914|NCT02405689|Sensory System Agents|sensory system agents|mesh-ancestor
91990915|NCT02405689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990916|NCT02405689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91990917|NCT02405689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91990918|NCT02405689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91990919|NCT02405689|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990920|NCT02405689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990921|NCT02405689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990922|NCT02405689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91990923|NCT02405689|Narcotics|narcotics|mesh-ancestor
91990924|NCT02405689|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91990936|NCT02400619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990937|NCT02400619|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91970123|NCT04986813|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91970124|NCT04986813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970125|NCT04986813|Hemostatics|hemostatics|mesh-ancestor
91990938|NCT02400619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990945|NCT02699125|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91990947|NCT02699125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91990948|NCT02699125|Diuretics|diuretics|mesh-ancestor
91990949|NCT02699125|Natriuretic Agents|natriuretic agents|mesh-ancestor
91990950|NCT02699125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990951|NCT02699125|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91990952|NCT02699125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990953|NCT02699125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990954|NCT02699125|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91990955|NCT02699125|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91990956|NCT02699125|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91990957|NCT02699125|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990958|NCT02699125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990959|NCT04279535|Ascorbic Acid|ascorbic acid|mesh-list
91990960|NCT04279535|Antioxidants|antioxidants|mesh-ancestor
91990961|NCT04279535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990962|NCT04279535|Protective Agents|protective agents|mesh-ancestor
91990963|NCT04279535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990964|NCT04279535|Vitamins|vitamins|mesh-ancestor
91990965|NCT04279535|Micronutrients|micronutrients|mesh-ancestor
91990966|NCT02400151|Vitamin D|vitamin d|mesh-list
91990967|NCT02400151|Vitamins|vitamins|mesh-ancestor
91990968|NCT02400151|Micronutrients|micronutrients|mesh-ancestor
91990969|NCT02400151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990970|NCT02400151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91990971|NCT02400385|Nivolumab|nivolumab|mesh-list
91990972|NCT02400385|Sunitinib|sunitinib|mesh-list
91990973|NCT02400385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91990974|NCT02400385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990975|NCT02400385|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91990976|NCT02400385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990977|NCT02400385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91990978|NCT02400385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91990979|NCT02400385|Growth Substances|growth substances|mesh-ancestor
91990980|NCT02400385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990981|NCT02400385|Growth Inhibitors|growth inhibitors|mesh-ancestor
91990982|NCT02400385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91990983|NCT02400385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990984|NCT03173365|Brimonidine Tartrate|brimonidine tartrate|mesh-list
91990985|NCT03173365|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91990986|NCT03173365|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91990987|NCT03173365|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91990988|NCT03173365|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91990989|NCT03173365|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990990|NCT03173365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990991|NCT03173365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990992|NCT03173365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990993|NCT05100719|Mebeverine|mebeverine|mesh-list
91990994|NCT05100719|Simethicone|simethicone|mesh-list
91990995|NCT05100719|Citric Acid|citric acid|mesh-list
91991002|NCT05100719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991003|NCT05100719|Antifoaming Agents|antifoaming agents|mesh-ancestor
91991004|NCT05100719|Emollients|emollients|mesh-ancestor
91991005|NCT05100719|Dermatologic Agents|dermatologic agents|mesh-ancestor
91991006|NCT05100719|Parasympatholytics|parasympatholytics|mesh-ancestor
91991007|NCT05100719|Autonomic Agents|autonomic agents|mesh-ancestor
91991008|NCT05100719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991009|NCT05100719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991010|NCT05100719|Anticonvulsants|anticonvulsants|mesh-ancestor
91991011|NCT05100563|Naltrexone|naltrexone|mesh-list
91991012|NCT05100563|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91991013|NCT05100563|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91991014|NCT05100563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991015|NCT05100563|Sensory System Agents|sensory system agents|mesh-ancestor
91991016|NCT05100563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991017|NCT05100329|Mitoxantrone|mitoxantrone|mesh-list
91991018|NCT05100329|Analgesics|analgesics|mesh-ancestor
91970126|NCT04986813|Coagulants|coagulants|mesh-ancestor
91970127|NCT04986735|Empagliflozin|empagliflozin|mesh-list
91970128|NCT04986735|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91970129|NCT04986735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970130|NCT04986735|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91970131|NCT04986735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970132|NCT02475863|Warfarin|warfarin|mesh-list
91970133|NCT02475863|Anticoagulants|anticoagulants|mesh-ancestor
91970134|NCT03071055|Ranibizumab|ranibizumab|mesh-list
91970135|NCT03071055|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91970136|NCT03071055|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91970137|NCT03071055|Growth Substances|growth substances|mesh-ancestor
91970138|NCT03071055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970139|NCT03071055|Growth Inhibitors|growth inhibitors|mesh-ancestor
91970140|NCT03071055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970141|NCT04433559|Tadalafil|tadalafil|mesh-list
91970142|NCT04433559|Vasodilator Agents|vasodilator agents|mesh-ancestor
91970143|NCT04433559|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91991019|NCT05100329|Sensory System Agents|sensory system agents|mesh-ancestor
91991020|NCT05100329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991021|NCT05100329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991022|NCT05100329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991023|NCT05100329|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91991024|NCT05100329|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91991025|NCT05100329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991026|NCT05100329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991027|NCT04530539|Ascorbic Acid|ascorbic acid|mesh-list
91991028|NCT04530539|Melatonin|melatonin|mesh-list
91991029|NCT04530539|Vitamins|vitamins|mesh-ancestor
91991030|NCT04530539|Micronutrients|micronutrients|mesh-ancestor
91991031|NCT04530539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991032|NCT04530539|Antioxidants|antioxidants|mesh-ancestor
91991033|NCT04530539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991034|NCT04530539|Protective Agents|protective agents|mesh-ancestor
91991035|NCT04530539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991036|NCT02698891|Paclitaxel|paclitaxel|mesh-list
91991037|NCT02698891|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91991038|NCT02698891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991039|NCT02698891|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991040|NCT02698891|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991041|NCT02698891|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991042|NCT02698891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991043|NCT04719065|Mitoxantrone|mitoxantrone|mesh-list
91991044|NCT04719065|Analgesics|analgesics|mesh-ancestor
91991045|NCT04719065|Sensory System Agents|sensory system agents|mesh-ancestor
91991046|NCT04719065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991047|NCT04719065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991048|NCT04719065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991049|NCT04719065|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91991050|NCT04719065|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91991051|NCT04719065|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991052|NCT04719065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991053|NCT02399059|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91991054|NCT02399059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991055|NCT05108051|Oseltamivir|oseltamivir|mesh-list
91991056|NCT05108051|Antiviral Agents|antiviral agents|mesh-ancestor
91991057|NCT05108051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970144|NCT04433559|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91970145|NCT04433559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090445|NCT01903031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
91991058|NCT05108051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991059|NCT05108051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991060|NCT03765359|Metformin|metformin|mesh-list
91991061|NCT03765359|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91991062|NCT03765359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991063|NCT04351295|Chloroquine|chloroquine|mesh-list
91991064|NCT04351295|Favipiravir|favipiravir|mesh-list
91991065|NCT04351295|Amebicides|amebicides|mesh-ancestor
91991066|NCT04351295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91991069|NCT04351295|Antimalarials|antimalarials|mesh-ancestor
91991070|NCT04351295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991071|NCT04351295|Antiviral Agents|antiviral agents|mesh-ancestor
91991073|NCT02399137|Gemcitabine|gemcitabine|mesh-list
91991074|NCT02399137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91991075|NCT02399137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991076|NCT02399137|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991077|NCT02399137|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991078|NCT02399137|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991079|NCT02399137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991080|NCT02399137|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91991081|NCT02399137|Antimetabolites|antimetabolites|mesh-ancestor
91991082|NCT05093387|Carboplatin|carboplatin|mesh-list
91991083|NCT05093387|Pembrolizumab|pembrolizumab|mesh-list
91991084|NCT05093387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991085|NCT05093387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991086|NCT05093387|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91991087|NCT05093387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991088|NCT02407171|Pembrolizumab|pembrolizumab|mesh-list
91991089|NCT02407171|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991090|NCT02407171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991091|NCT02407171|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91991092|NCT02407171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991093|NCT02850263|Aflibercept|aflibercept|mesh-list
91991094|NCT02850263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991095|NCT02850263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91991096|NCT02850263|Growth Substances|growth substances|mesh-ancestor
91991097|NCT02850263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991098|NCT02850263|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991099|NCT02850263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991101|NCT04481815|Methotrexate|methotrexate|mesh-list
91991102|NCT04481815|Lenalidomide|lenalidomide|mesh-list
91991103|NCT04481815|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991104|NCT04481815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991105|NCT04481815|Immunologic Factors|immunologic factors|mesh-ancestor
91991106|NCT04481815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991107|NCT04481815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991108|NCT04481815|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91991109|NCT04481815|Abortifacient Agents|abortifacient agents|mesh-ancestor
91991110|NCT04481815|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91991111|NCT04481815|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91991113|NCT04481815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991114|NCT04481815|Dermatologic Agents|dermatologic agents|mesh-ancestor
91991115|NCT04481815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991116|NCT04481815|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91991117|NCT04481815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991118|NCT04481815|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91991119|NCT04481815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991120|NCT04481815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91991121|NCT04481815|Growth Substances|growth substances|mesh-ancestor
91991122|NCT04481815|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991123|NCT05106803|Amoxicillin|amoxicillin|mesh-list
91991124|NCT05106803|Vancomycin|vancomycin|mesh-list
91991125|NCT05106803|Ciprofloxacin|ciprofloxacin|mesh-list
91991126|NCT05106803|Clindamycin|clindamycin|mesh-list
91991127|NCT05106803|Gentamicins|gentamicins|mesh-list
91991128|NCT05106803|Tetracycline|tetracycline|mesh-list
91991129|NCT05106803|Penicillins|penicillins|mesh-list
91991130|NCT05106803|Erythromycin|erythromycin|mesh-list
91991131|NCT05106803|Clavulanic Acids|clavulanic acids|mesh-list
91970146|NCT04433559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970147|NCT04433559|Urological Agents|urological agents|mesh-ancestor
91991132|NCT05106803|Clavulanic Acid|clavulanic acid|mesh-list
91991133|NCT05106803|Ampicillin|ampicillin|mesh-list
91991134|NCT05106803|Cefepime|cefepime|mesh-list
91991135|NCT05106803|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91991136|NCT05106803|Norfloxacin|norfloxacin|mesh-list
91991137|NCT05106803|Oxacillin|oxacillin|mesh-list
91991138|NCT05106803|Chloramphenicol|chloramphenicol|mesh-list
91991139|NCT05106803|Trimethoprim|trimethoprim|mesh-list
91991140|NCT05106803|Sulfamethoxazole|sulfamethoxazole|mesh-list
91991141|NCT05106803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91991142|NCT05106803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991143|NCT05106803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91991145|NCT05106803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991146|NCT05106803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991147|NCT05106803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991148|NCT05106803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91991149|NCT05106803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91991150|NCT05106803|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91991151|NCT05106803|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91991152|NCT05106803|Antimalarials|antimalarials|mesh-ancestor
91991153|NCT05106803|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91991154|NCT05106803|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91991155|NCT05106803|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91991156|NCT05106803|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91991157|NCT05106803|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91991158|NCT05106803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91991159|NCT05106803|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91991160|NCT02398357|Nadroparin|nadroparin|mesh-list
91991161|NCT02398357|Warfarin|warfarin|mesh-list
91991162|NCT02398357|Calcium|calcium|mesh-list
91991163|NCT02398357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91991164|NCT02398357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991165|NCT02398357|Anticoagulants|anticoagulants|mesh-ancestor
91991166|NCT02398357|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91991167|NCT02398357|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91991168|NCT02398357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991169|NCT02398201|Bezafibrate|bezafibrate|mesh-list
91991170|NCT02398201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91991171|NCT02398201|Antimetabolites|antimetabolites|mesh-ancestor
91991172|NCT02398201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991173|NCT02398201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91991174|NCT05106179|Propranolol|propranolol|mesh-list
91991175|NCT05106179|Atenolol|atenolol|mesh-list
91991176|NCT05106179|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91991177|NCT05106179|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91991178|NCT05106179|Adrenergic Agents|adrenergic agents|mesh-ancestor
91991179|NCT05106179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991180|NCT05106179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991181|NCT05106179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991182|NCT05106179|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91991183|NCT05106179|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91991184|NCT05106179|Vasodilator Agents|vasodilator agents|mesh-ancestor
91991185|NCT05106179|Sympatholytics|sympatholytics|mesh-ancestor
91991186|NCT05106179|Autonomic Agents|autonomic agents|mesh-ancestor
91991187|NCT05106179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991188|NCT05106179|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91991189|NCT04670471|Remifentanil|remifentanil|mesh-list
91991190|NCT04670471|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91991191|NCT04670471|Narcotics|narcotics|mesh-ancestor
91991192|NCT04670471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991193|NCT04670471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991194|NCT04670471|Analgesics|analgesics|mesh-ancestor
91991195|NCT04670471|Sensory System Agents|sensory system agents|mesh-ancestor
91991196|NCT04670471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991197|NCT02406781|Pembrolizumab|pembrolizumab|mesh-list
91991198|NCT02406781|Cyclophosphamide|cyclophosphamide|mesh-list
91991199|NCT02406781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991200|NCT02406781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970149|NCT04911959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970150|NCT04911959|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91991201|NCT02406781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91991202|NCT02406781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991203|NCT02406781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991204|NCT02406781|Immunologic Factors|immunologic factors|mesh-ancestor
91991205|NCT02406781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991206|NCT02406781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991207|NCT02406781|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91991208|NCT02406781|Alkylating Agents|alkylating agents|mesh-ancestor
91991209|NCT02406781|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91991210|NCT05106023|Temozolomide|temozolomide|mesh-list
91991211|NCT05106023|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91991212|NCT05106023|Alkylating Agents|alkylating agents|mesh-ancestor
91991213|NCT05106023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991214|NCT05106023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991215|NCT02398123|Bupivacaine|bupivacaine|mesh-list
91991216|NCT02398123|Anesthetics, Local|anesthetics, local|mesh-ancestor
91991218|NCT02398123|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991219|NCT02398123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991220|NCT02398123|Sensory System Agents|sensory system agents|mesh-ancestor
91991221|NCT02398123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991223|NCT04486625|Avibactam|avibactam|mesh-list
91991224|NCT04486625|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91991225|NCT04486625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991226|NCT04486625|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91991227|NCT04486625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991228|NCT04486625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991229|NCT02404363|Clopidogrel|clopidogrel|mesh-list
91991230|NCT02404363|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91991231|NCT02404363|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91991232|NCT02404363|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91991233|NCT02404363|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91991234|NCT02404363|Purinergic Agents|purinergic agents|mesh-ancestor
91991235|NCT02404363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991236|NCT02404363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991237|NCT02404363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991238|NCT02404519|Vitamin K 2|vitamin k 2|mesh-list
91991239|NCT02404519|Vitamin K|vitamin k|mesh-list
91991240|NCT02404519|Menaquinone 7|menaquinone 7|mesh-list
91991241|NCT02404519|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91991242|NCT02404519|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91991243|NCT02404519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991244|NCT02404519|Hemostatics|hemostatics|mesh-ancestor
91991245|NCT02404519|Coagulants|coagulants|mesh-ancestor
91991246|NCT02404519|Vitamins|vitamins|mesh-ancestor
91991247|NCT02404519|Micronutrients|micronutrients|mesh-ancestor
91991248|NCT02404519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991249|NCT03173131|Analgesics, Opioid|analgesics, opioid|mesh-list
91991250|NCT03173131|Narcotics|narcotics|mesh-ancestor
91991251|NCT03173131|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991252|NCT03173131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991253|NCT03173131|Analgesics|analgesics|mesh-ancestor
91991254|NCT03173131|Sensory System Agents|sensory system agents|mesh-ancestor
91991255|NCT03173131|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991256|NCT04524611|Ustekinumab|ustekinumab|mesh-list
91991257|NCT04524611|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91991258|NCT04524611|Dermatologic Agents|dermatologic agents|mesh-ancestor
91991259|NCT04524611|Immunologic Factors|immunologic factors|mesh-ancestor
91991260|NCT04524611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991261|NCT02658149|Ketorolac|ketorolac|mesh-list
91991262|NCT02658149|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
91991263|NCT02658149|Epinephrine|epinephrine|mesh-list
91991264|NCT02658149|Morphine|morphine|mesh-list
91991265|NCT02658149|Ropivacaine|ropivacaine|mesh-list
91991266|NCT02658149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91991267|NCT02658149|Narcotics|narcotics|mesh-ancestor
91991268|NCT02658149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991269|NCT02658149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991270|NCT02658149|Analgesics|analgesics|mesh-ancestor
91991271|NCT02658149|Sensory System Agents|sensory system agents|mesh-ancestor
91991272|NCT02658149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991273|NCT02658149|Anesthetics, Local|anesthetics, local|mesh-ancestor
91970151|NCT04911959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970152|NCT04911959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970153|NCT03070665|Norepinephrine|norepinephrine|mesh-list
91970154|NCT03070665|Ephedrine|ephedrine|mesh-list
91970155|NCT03070665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91970156|NCT03070665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91991274|NCT02658149|Anesthetics|anesthetics|mesh-ancestor
91991275|NCT02658149|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91991276|NCT02658149|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91991277|NCT02658149|Adrenergic Agents|adrenergic agents|mesh-ancestor
91991278|NCT02658149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991279|NCT02658149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991280|NCT02658149|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91991281|NCT02658149|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91991282|NCT02658149|Autonomic Agents|autonomic agents|mesh-ancestor
91991283|NCT02658149|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91991284|NCT02658149|Respiratory System Agents|respiratory system agents|mesh-ancestor
91991285|NCT02658149|Mydriatics|mydriatics|mesh-ancestor
91991286|NCT02658149|Sympathomimetics|sympathomimetics|mesh-ancestor
91991287|NCT02658149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91991288|NCT02658149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91991289|NCT02658149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991290|NCT02658149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991291|NCT02658149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991293|NCT02658149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991295|NCT03701711|Immunologic Factors|immunologic factors|mesh-ancestor
91991296|NCT03701711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991297|NCT03701711|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991298|NCT03701711|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91991299|NCT03701711|Growth Substances|growth substances|mesh-ancestor
91991300|NCT03701711|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991301|NCT03701711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991302|NCT04481971|Prednisolone|prednisolone|mesh-list
91991303|NCT04481971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991304|NCT04481971|Glucocorticoids|glucocorticoids|mesh-ancestor
91991305|NCT04481971|Hormones|hormones|mesh-ancestor
91991306|NCT04481971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991307|NCT04481971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991308|NCT04481971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91991309|NCT04481971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991310|NCT03172741|Dronabinol|dronabinol|mesh-list
91991311|NCT03172741|Cannabidiol|cannabidiol|mesh-list
91991312|NCT03172741|Anticonvulsants|anticonvulsants|mesh-ancestor
91991313|NCT03172741|Hallucinogens|hallucinogens|mesh-ancestor
91991314|NCT03172741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991315|NCT03172741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91991316|NCT03172741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991317|NCT03172741|Analgesics|analgesics|mesh-ancestor
91991318|NCT03172741|Sensory System Agents|sensory system agents|mesh-ancestor
91991319|NCT03172741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991320|NCT03172741|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91991321|NCT03172741|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91991322|NCT03172741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991323|NCT03172741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991325|NCT03172741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991326|NCT02702011|Empagliflozin|empagliflozin|mesh-list
91991327|NCT02702011|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91991328|NCT02702011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991329|NCT02702011|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91991330|NCT02702011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991331|NCT03170713|Ibuprofen|ibuprofen|mesh-list
91991332|NCT03170713|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
91991333|NCT03170713|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91991334|NCT03170713|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991335|NCT03170713|Analgesics|analgesics|mesh-ancestor
91991336|NCT03170713|Sensory System Agents|sensory system agents|mesh-ancestor
91991337|NCT03170713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970157|NCT03070665|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970158|NCT03070665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090446|NCT01903031|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91991338|NCT03170713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991339|NCT03170713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991340|NCT03170713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991341|NCT03170713|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91991342|NCT03170713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991343|NCT03170713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991344|NCT02657369|Lenvatinib|lenvatinib|mesh-list
91991345|NCT02657369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991346|NCT02657369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91991347|NCT02657369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991348|NCT02657369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991349|NCT02397421|Dapagliflozin|dapagliflozin|mesh-list
91991350|NCT02397421|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91991351|NCT02397421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991352|NCT02397421|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91991353|NCT02397421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991354|NCT04832009|Ascorbic Acid|ascorbic acid|mesh-list
91991355|NCT04832009|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
91991356|NCT04832009|Antioxidants|antioxidants|mesh-ancestor
91991357|NCT04832009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991358|NCT04832009|Protective Agents|protective agents|mesh-ancestor
91991359|NCT04832009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991360|NCT04832009|Vitamins|vitamins|mesh-ancestor
91991361|NCT04832009|Micronutrients|micronutrients|mesh-ancestor
91991363|NCT04832009|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91991364|NCT04832009|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91991365|NCT03129113|Metformin|metformin|mesh-list
91991366|NCT03129113|Maraviroc|maraviroc|mesh-list
91991368|NCT03129113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991369|NCT03129113|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91991370|NCT03129113|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91991371|NCT03129113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991372|NCT03129113|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91991373|NCT03129113|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91991374|NCT03129113|Antiviral Agents|antiviral agents|mesh-ancestor
91991375|NCT03129113|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991376|NCT03129113|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91991377|NCT05105009|Furosemide|furosemide|mesh-list
91991378|NCT05105009|Diuretics|diuretics|mesh-ancestor
91991379|NCT05105009|Natriuretic Agents|natriuretic agents|mesh-ancestor
91991380|NCT05105009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991381|NCT05105009|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91991382|NCT05105009|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91991383|NCT05105009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991384|NCT05104931|Piroxicam|piroxicam|mesh-list
91991385|NCT05104931|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91991386|NCT05104931|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991387|NCT05104931|Analgesics|analgesics|mesh-ancestor
91991388|NCT05104931|Sensory System Agents|sensory system agents|mesh-ancestor
91991389|NCT05104931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991390|NCT05104931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991391|NCT05104931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991392|NCT05104931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991393|NCT05104931|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91991394|NCT05104931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991395|NCT05104931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991396|NCT02397499|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91991397|NCT02397499|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91991398|NCT02397499|Autonomic Agents|autonomic agents|mesh-ancestor
91991399|NCT02397499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991400|NCT02397499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991401|NCT02397499|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91991402|NCT02397499|Respiratory System Agents|respiratory system agents|mesh-ancestor
91991403|NCT02397499|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91991404|NCT02397499|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91970159|NCT03070665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970160|NCT03070665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970161|NCT03070665|Sympathomimetics|sympathomimetics|mesh-ancestor
91970162|NCT03070665|Autonomic Agents|autonomic agents|mesh-ancestor
91991405|NCT02397499|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91991406|NCT02397499|Adrenergic Agents|adrenergic agents|mesh-ancestor
91991407|NCT02397499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991408|NCT02397499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991409|NCT02406703|Mepivacaine|mepivacaine|mesh-list
91991410|NCT02406703|Chloroprocaine|chloroprocaine|mesh-list
91991411|NCT02406703|Anesthetics, Local|anesthetics, local|mesh-ancestor
91991412|NCT02406703|Anesthetics|anesthetics|mesh-ancestor
91991413|NCT02406703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991414|NCT02406703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991415|NCT02406703|Sensory System Agents|sensory system agents|mesh-ancestor
91991416|NCT02406703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991417|NCT02682641|Rituximab|rituximab|mesh-list
91991418|NCT02682641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991419|NCT02682641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991420|NCT02682641|Immunologic Factors|immunologic factors|mesh-ancestor
91991421|NCT02682641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991422|NCT02682641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991423|NCT05110469|Magnesium Sulfate|magnesium sulfate|mesh-list
91991424|NCT05110469|Meperidine|meperidine|mesh-list
91991425|NCT05110469|Analgesics|analgesics|mesh-ancestor
91991426|NCT05110469|Sensory System Agents|sensory system agents|mesh-ancestor
91991427|NCT05110469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991428|NCT05110469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991429|NCT05110469|Anesthetics|anesthetics|mesh-ancestor
91991430|NCT05110469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991431|NCT05110469|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91991432|NCT05110469|Anticonvulsants|anticonvulsants|mesh-ancestor
91991433|NCT05110469|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91991434|NCT05110469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91991436|NCT05110469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91991437|NCT05110469|Tocolytic Agents|tocolytic agents|mesh-ancestor
91991438|NCT05110469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91991439|NCT05110469|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91991441|NCT05110469|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91991442|NCT02404051|Everolimus|everolimus|mesh-list
91991443|NCT02404051|Fulvestrant|fulvestrant|mesh-list
91991444|NCT02404051|Exemestane|exemestane|mesh-list
91991445|NCT02404051|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91991446|NCT02404051|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91991447|NCT02404051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991448|NCT02404051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991449|NCT02404051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991450|NCT02404051|Immunologic Factors|immunologic factors|mesh-ancestor
91991451|NCT02404051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991452|NCT02404051|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991453|NCT02404051|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91991454|NCT02404051|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91991455|NCT02404051|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91991456|NCT02404051|Hormone Antagonists|hormone antagonists|mesh-ancestor
91991457|NCT02404051|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991458|NCT02404051|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91991459|NCT02404051|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91991460|NCT05101109|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91991461|NCT05101109|Immunologic Factors|immunologic factors|mesh-ancestor
91991462|NCT05101109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991463|NCT05094323|Bupivacaine|bupivacaine|mesh-list
91991464|NCT05094323|Anesthetics, Local|anesthetics, local|mesh-ancestor
91991465|NCT05094323|Anesthetics|anesthetics|mesh-ancestor
91991551|NCT04522739|Spironolactone|spironolactone|mesh-list
91991466|NCT05094323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991467|NCT05094323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991468|NCT05094323|Sensory System Agents|sensory system agents|mesh-ancestor
91991469|NCT05094323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991470|NCT03170323|Cyclosporine|cyclosporine|mesh-list
91991471|NCT03170323|Mycophenolic Acid|mycophenolic acid|mesh-list
91970163|NCT03070665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970164|NCT03070665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91970165|NCT03070665|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91970166|NCT04891809|Dexamethasone|dexamethasone|mesh-list
91970167|NCT04891809|Lenalidomide|lenalidomide|mesh-list
91991472|NCT03170323|Cyclosporins|cyclosporins|mesh-list
91991473|NCT03170323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991474|NCT03170323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991475|NCT03170323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991476|NCT03170323|Immunologic Factors|immunologic factors|mesh-ancestor
91991477|NCT03170323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991478|NCT03170323|Antifungal Agents|antifungal agents|mesh-ancestor
91991479|NCT03170323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991480|NCT03170323|Dermatologic Agents|dermatologic agents|mesh-ancestor
91991481|NCT03170323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991482|NCT03170323|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91991483|NCT03170323|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91991484|NCT03170323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991485|NCT03170323|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91991486|NCT03170323|Antitubercular Agents|antitubercular agents|mesh-ancestor
91991487|NCT03170323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91991488|NCT02396563|Ropivacaine|ropivacaine|mesh-list
91991489|NCT02396563|Anesthetics, Local|anesthetics, local|mesh-ancestor
91991490|NCT02396563|Anesthetics|anesthetics|mesh-ancestor
91991491|NCT02396563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991492|NCT02396563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991494|NCT02396563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991495|NCT05109377|Tadalafil|tadalafil|mesh-list
91991496|NCT05109377|Vasodilator Agents|vasodilator agents|mesh-ancestor
91991497|NCT05109377|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91991498|NCT05109377|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91991499|NCT05109377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991500|NCT05109377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991501|NCT05109377|Urological Agents|urological agents|mesh-ancestor
91991502|NCT05109299|Fluorides|fluorides|mesh-list
91991503|NCT05109299|Cariostatic Agents|cariostatic agents|mesh-ancestor
91991504|NCT05109299|Protective Agents|protective agents|mesh-ancestor
91991505|NCT05109299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991506|NCT05108597|Misoprostol|misoprostol|mesh-list
91991507|NCT05108597|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91991520|NCT02396329|Plasma Substitutes|plasma substitutes|mesh-ancestor
91991521|NCT02396329|Blood Substitutes|blood substitutes|mesh-ancestor
91991522|NCT03168139|Pembrolizumab|pembrolizumab|mesh-list
91991523|NCT03168139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991524|NCT03168139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991525|NCT03168139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91991526|NCT03168139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991527|NCT02395783|Melatonin|melatonin|mesh-list
91991529|NCT02395783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991530|NCT02395783|Protective Agents|protective agents|mesh-ancestor
91991531|NCT02395783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991532|NCT02395783|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991533|NCT04555343|Tranexamic Acid|tranexamic acid|mesh-list
91991534|NCT04555343|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91991535|NCT04555343|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91991536|NCT04555343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991538|NCT04555343|Coagulants|coagulants|mesh-ancestor
91991539|NCT04528667|Abivertinib|abivertinib|mesh-list
91991540|NCT04528667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991541|NCT04528667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991542|NCT04528667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91991543|NCT04383119|Gemcitabine|gemcitabine|mesh-list
91991544|NCT04383119|Trabectedin|trabectedin|mesh-list
91991545|NCT04383119|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91991546|NCT04383119|Antimetabolites|antimetabolites|mesh-ancestor
91991547|NCT04383119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991549|NCT04383119|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91991550|NCT04383119|Alkylating Agents|alkylating agents|mesh-ancestor
91991552|NCT04522739|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91991553|NCT04522739|Hormone Antagonists|hormone antagonists|mesh-ancestor
91991554|NCT04522739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991555|NCT04522739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991556|NCT04522739|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91991557|NCT04522739|Diuretics|diuretics|mesh-ancestor
91991558|NCT04522739|Natriuretic Agents|natriuretic agents|mesh-ancestor
91991559|NCT04309877|Theophylline|theophylline|mesh-list
91991560|NCT04309877|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91991561|NCT04309877|Autonomic Agents|autonomic agents|mesh-ancestor
91991562|NCT04309877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991563|NCT04309877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991564|NCT04309877|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91991565|NCT04309877|Respiratory System Agents|respiratory system agents|mesh-ancestor
91991566|NCT04309877|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91991567|NCT04309877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991568|NCT04309877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991569|NCT04309877|Vasodilator Agents|vasodilator agents|mesh-ancestor
91991583|NCT04058873|Levonorgestrel|levonorgestrel|mesh-list
91991584|NCT04058873|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91991585|NCT04058873|Contraceptive Agents|contraceptive agents|mesh-ancestor
91991586|NCT04058873|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91991587|NCT04058873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991588|NCT04058873|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91991589|NCT04058873|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91991590|NCT04058873|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91991591|NCT04196075|Andrographolide|andrographolide|mesh-list
91991592|NCT04196075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991593|NCT04196075|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91991594|NCT04196075|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991595|NCT04196075|Analgesics|analgesics|mesh-ancestor
91991596|NCT04196075|Sensory System Agents|sensory system agents|mesh-ancestor
91991597|NCT04196075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991598|NCT04196075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991599|NCT04196075|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991600|NCT04196075|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91991601|NCT04196075|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91991602|NCT04196075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991603|NCT04196075|Antiviral Agents|antiviral agents|mesh-ancestor
91991604|NCT04196075|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91991605|NCT03863483|Docetaxel|docetaxel|mesh-list
91991606|NCT03863483|Pemetrexed|pemetrexed|mesh-list
91991607|NCT03863483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991608|NCT03863483|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991609|NCT03863483|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991610|NCT03863483|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991611|NCT03863483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991612|NCT03863483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991613|NCT03863483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91991614|NCT03863483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91991615|NCT03830411|Docetaxel|docetaxel|mesh-list
91991616|NCT03830411|Pemetrexed|pemetrexed|mesh-list
91991617|NCT03830411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991618|NCT03830411|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991619|NCT03830411|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991620|NCT03830411|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991621|NCT03830411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991622|NCT03830411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991623|NCT03830411|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91991624|NCT03830411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91991625|NCT03300479|Urapidil|urapidil|mesh-list
91991626|NCT03300479|Clevidipine|clevidipine|mesh-list
91991627|NCT03300479|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91991628|NCT03300479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91991629|NCT03300479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991630|NCT03300479|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91991631|NCT03300479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991663|NCT03536507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991664|NCT04765787|Acetaminophen|acetaminophen|mesh-list
91970168|NCT04891809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970169|NCT04891809|Antiemetics|antiemetics|mesh-ancestor
91970170|NCT04891809|Autonomic Agents|autonomic agents|mesh-ancestor
91970171|NCT04891809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970172|NCT04891809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991665|NCT04765787|Orphenadrine|orphenadrine|mesh-list
91991666|NCT04765787|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991667|NCT04765787|Analgesics|analgesics|mesh-ancestor
91991668|NCT04765787|Sensory System Agents|sensory system agents|mesh-ancestor
91991669|NCT04765787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991670|NCT04765787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991671|NCT04765787|Antipyretics|antipyretics|mesh-ancestor
91991672|NCT04765787|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91991673|NCT04765787|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91991674|NCT04765787|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91991675|NCT04765787|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91991676|NCT04765787|Parasympatholytics|parasympatholytics|mesh-ancestor
91991677|NCT04765787|Autonomic Agents|autonomic agents|mesh-ancestor
91991681|NCT04765787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991682|NCT04765787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991683|NCT04765787|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
91991684|NCT04765787|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91991685|NCT04765787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991686|NCT02944799|Vitamin D|vitamin d|mesh-list
91991687|NCT02944799|Alendronate|alendronate|mesh-list
91991688|NCT02944799|Calcium|calcium|mesh-list
91991689|NCT02944799|Vitamins|vitamins|mesh-ancestor
91991690|NCT02944799|Micronutrients|micronutrients|mesh-ancestor
91991691|NCT02944799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991692|NCT02944799|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91991693|NCT02944799|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91991694|NCT05115149|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
91991695|NCT05115149|Antioxidants|antioxidants|mesh-ancestor
91991696|NCT05115149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991697|NCT05115149|Protective Agents|protective agents|mesh-ancestor
91991698|NCT05115149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991699|NCT05115149|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91991700|NCT05115149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991701|NCT04638803|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
91991702|NCT04638803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991703|NCT04592783|Antihypertensive Agents|antihypertensive agents|mesh-list
91991704|NCT04521881|Tranexamic Acid|tranexamic acid|mesh-list
91991705|NCT04521881|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91991706|NCT04521881|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91991707|NCT04521881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991708|NCT04521881|Hemostatics|hemostatics|mesh-ancestor
91991709|NCT04521881|Coagulants|coagulants|mesh-ancestor
91991710|NCT04305899|Deucravacitinib|deucravacitinib|mesh-list
91991711|NCT04305899|Dermatologic Agents|dermatologic agents|mesh-ancestor
91991712|NCT04305899|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91991713|NCT04305899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991714|NCT04305899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991715|NCT01675661|Acetylcysteine|acetylcysteine|mesh-list
91991716|NCT01675661|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91991717|NCT01675661|Antiviral Agents|antiviral agents|mesh-ancestor
91991718|NCT01675661|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991719|NCT01675661|Expectorants|expectorants|mesh-ancestor
91991720|NCT01675661|Respiratory System Agents|respiratory system agents|mesh-ancestor
91991721|NCT01675661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91991722|NCT01675661|Antioxidants|antioxidants|mesh-ancestor
91991723|NCT01675661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991724|NCT01675661|Protective Agents|protective agents|mesh-ancestor
91991725|NCT01675661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991726|NCT01675661|Antidotes|antidotes|mesh-ancestor
91991727|NCT05113511|Bevacizumab|bevacizumab|mesh-list
91991728|NCT05113511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991729|NCT05113511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991730|NCT05113511|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991731|NCT05113511|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91991732|NCT05113511|Growth Substances|growth substances|mesh-ancestor
91970174|NCT04891809|Glucocorticoids|glucocorticoids|mesh-ancestor
91970175|NCT04891809|Hormones|hormones|mesh-ancestor
91991733|NCT05113511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991734|NCT05113511|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991735|NCT03169985|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91991736|NCT03169985|Ezetimibe|ezetimibe|mesh-list
91991737|NCT03169985|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91991738|NCT03169985|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91991739|NCT03169985|Antimetabolites|antimetabolites|mesh-ancestor
91991740|NCT03169985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991741|NCT03169985|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91991742|NCT03169985|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91991743|NCT03169985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991744|NCT04161989|Progesterone|progesterone|mesh-list
91991745|NCT04161989|Progestins|progestins|mesh-ancestor
91991746|NCT04161989|Hormones|hormones|mesh-ancestor
91991747|NCT04161989|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991748|NCT04161989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991749|NCT01986010|Aluminum phosphate|aluminum phosphate|mesh-list
91991767|NCT04414631|Immunologic Factors|immunologic factors|mesh-ancestor
91991768|NCT04414631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991769|NCT03115255|Ranibizumab|ranibizumab|mesh-list
91991770|NCT03115255|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991771|NCT03115255|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91991772|NCT03115255|Growth Substances|growth substances|mesh-ancestor
91991773|NCT03115255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991774|NCT03115255|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991775|NCT03115255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991776|NCT02009878|Tolvaptan|tolvaptan|mesh-list
91991777|NCT02009878|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
91991778|NCT02009878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991779|NCT02009878|Natriuretic Agents|natriuretic agents|mesh-ancestor
91991780|NCT02009878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991781|NCT02009722|Morphine|morphine|mesh-list
91991782|NCT02009722|Hydromorphone|hydromorphone|mesh-list
91991783|NCT02009722|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91991784|NCT02009722|Narcotics|narcotics|mesh-ancestor
91991785|NCT02009722|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991786|NCT02009722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991787|NCT02009722|Analgesics|analgesics|mesh-ancestor
91991788|NCT02009722|Sensory System Agents|sensory system agents|mesh-ancestor
91991789|NCT02009722|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991790|NCT02655419|Metronidazole|metronidazole|mesh-list
91991791|NCT02655419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991792|NCT02655419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91991793|NCT02655419|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91991794|NCT02655419|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91991795|NCT01962922|Tacrolimus|tacrolimus|mesh-list
91991796|NCT01962922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991797|NCT01962922|Immunologic Factors|immunologic factors|mesh-ancestor
91991798|NCT01962922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991799|NCT01962922|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91991800|NCT01962922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991801|NCT01962922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991802|NCT04198961|Analgesics, Opioid|analgesics, opioid|mesh-list
91991803|NCT04198961|Narcotics|narcotics|mesh-ancestor
91991804|NCT04198961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991805|NCT04198961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991806|NCT04198961|Analgesics|analgesics|mesh-ancestor
91991807|NCT04198961|Sensory System Agents|sensory system agents|mesh-ancestor
91991827|NCT05038475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991828|NCT02009332|Sirolimus|sirolimus|mesh-list
91991829|NCT02009332|Gemcitabine|gemcitabine|mesh-list
91991830|NCT02009332|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91991831|NCT02009332|Antimetabolites|antimetabolites|mesh-ancestor
91991832|NCT02009332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991833|NCT02009332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991834|NCT02009332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91991835|NCT02009332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991836|NCT02009332|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91991837|NCT02009332|Antifungal Agents|antifungal agents|mesh-ancestor
91970176|NCT04891809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970177|NCT04891809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91970178|NCT04891809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970179|NCT04891809|Immunologic Factors|immunologic factors|mesh-ancestor
91970180|NCT04891809|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991838|NCT02009332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991839|NCT02009332|Immunologic Factors|immunologic factors|mesh-ancestor
91991840|NCT02009332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991841|NCT04518293|Amlodipine|amlodipine|mesh-list
91991842|NCT04518293|Telmisartan|telmisartan|mesh-list
91991843|NCT04518293|Indapamide|indapamide|mesh-list
91991844|NCT04518293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91991845|NCT04518293|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91991846|NCT04518293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91991847|NCT04518293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991848|NCT04518293|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91991849|NCT04518293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991850|NCT04518293|Vasodilator Agents|vasodilator agents|mesh-ancestor
91991851|NCT04518293|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91991852|NCT04518293|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91991853|NCT04518293|Diuretics|diuretics|mesh-ancestor
91991854|NCT04518293|Natriuretic Agents|natriuretic agents|mesh-ancestor
91991855|NCT04518293|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91991856|NCT01984294|Ribavirin|ribavirin|mesh-list
91991857|NCT01984294|Antiviral Agents|antiviral agents|mesh-ancestor
91991858|NCT01984294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991859|NCT01984294|Antimetabolites|antimetabolites|mesh-ancestor
91991860|NCT01984294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991861|NCT03170479|Vitamin D|vitamin d|mesh-list
91991862|NCT03170479|Vitamins|vitamins|mesh-ancestor
91991863|NCT03170479|Micronutrients|micronutrients|mesh-ancestor
91991864|NCT03170479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991865|NCT03170479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91991866|NCT01962298|Rocuronium|rocuronium|mesh-list
91991867|NCT01962298|Neostigmine|neostigmine|mesh-list
91991868|NCT01962298|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91991869|NCT01962298|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91991870|NCT01962298|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91991873|NCT01962298|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91991874|NCT01962298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991875|NCT01962298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991876|NCT01962298|Cholinergic Agents|cholinergic agents|mesh-ancestor
91991877|NCT01962298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991878|NCT01962298|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91991879|NCT01962298|Autonomic Agents|autonomic agents|mesh-ancestor
91991880|NCT03169933|Androgens|androgens|mesh-list
91991881|NCT03169933|Hormones|hormones|mesh-ancestor
91991882|NCT03169933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991883|NCT03169933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991884|NCT04416334|Acetaminophen|acetaminophen|mesh-list
91991885|NCT04416334|Colchicine|colchicine|mesh-list
91991886|NCT04416334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91991887|NCT04416334|Analgesics|analgesics|mesh-ancestor
91991888|NCT04416334|Sensory System Agents|sensory system agents|mesh-ancestor
91991889|NCT04416334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991890|NCT04416334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991891|NCT04416334|Antipyretics|antipyretics|mesh-ancestor
91991892|NCT04416334|Gout Suppressants|gout suppressants|mesh-ancestor
91991893|NCT04416334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991894|NCT04416334|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991895|NCT04416334|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991896|NCT04416334|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991897|NCT04416334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991898|NCT04416334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991899|NCT02403349|Atenolol|atenolol|mesh-list
91991900|NCT02403349|Valsartan|valsartan|mesh-list
91991901|NCT02403349|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91991902|NCT02403349|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91991903|NCT02403349|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91970181|NCT04891809|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91970182|NCT04891809|Growth Substances|growth substances|mesh-ancestor
91970183|NCT04891809|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991904|NCT02403349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991906|NCT02403349|Sympatholytics|sympatholytics|mesh-ancestor
91991907|NCT02403349|Autonomic Agents|autonomic agents|mesh-ancestor
91991908|NCT02403349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991909|NCT02403349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991910|NCT02403349|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91991911|NCT02403349|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91991912|NCT02403349|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91991913|NCT02403349|Adrenergic Agents|adrenergic agents|mesh-ancestor
91991914|NCT02403349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991915|NCT04735822|Belumosudil|belumosudil|mesh-list
91991916|NCT04735822|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91991917|NCT04735822|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991918|NCT04735822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991919|NCT01984138|Estradiol|estradiol|mesh-list
91991920|NCT01984138|Estrogens|estrogens|mesh-ancestor
91991921|NCT01984138|Hormones|hormones|mesh-ancestor
91991922|NCT01984138|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991923|NCT01984138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991924|NCT01982812|Levetiracetam|levetiracetam|mesh-list
91991925|NCT01982812|Anticonvulsants|anticonvulsants|mesh-ancestor
91991926|NCT01982812|Nootropic Agents|nootropic agents|mesh-ancestor
91991927|NCT02007070|Pembrolizumab|pembrolizumab|mesh-list
91991928|NCT02007070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991929|NCT02007070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991930|NCT02007070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91991931|NCT02007070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991932|NCT03906617|Dexamethasone|dexamethasone|mesh-list
91991933|NCT03906617|Epinephrine|epinephrine|mesh-list
91991934|NCT03906617|Bupivacaine|bupivacaine|mesh-list
91991935|NCT03906617|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991936|NCT03906617|Antiemetics|antiemetics|mesh-ancestor
91991937|NCT03906617|Autonomic Agents|autonomic agents|mesh-ancestor
91991938|NCT03906617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991939|NCT03906617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991940|NCT03906617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91991941|NCT03906617|Glucocorticoids|glucocorticoids|mesh-ancestor
91991942|NCT03906617|Hormones|hormones|mesh-ancestor
91991943|NCT03906617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91991944|NCT03906617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91991949|NCT03906617|Sensory System Agents|sensory system agents|mesh-ancestor
91991950|NCT03906617|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91991951|NCT03906617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91991952|NCT03906617|Adrenergic Agents|adrenergic agents|mesh-ancestor
91991953|NCT03906617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991954|NCT03906617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991955|NCT03906617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91991956|NCT03906617|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91991957|NCT03906617|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91991958|NCT03906617|Respiratory System Agents|respiratory system agents|mesh-ancestor
91991959|NCT03906617|Mydriatics|mydriatics|mesh-ancestor
91991960|NCT03906617|Sympathomimetics|sympathomimetics|mesh-ancestor
91991961|NCT03906617|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91991962|NCT04655482|Aflibercept|aflibercept|mesh-list
91991963|NCT04655482|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91991964|NCT04655482|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91991965|NCT04655482|Growth Substances|growth substances|mesh-ancestor
91991966|NCT04655482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991967|NCT04655482|Growth Inhibitors|growth inhibitors|mesh-ancestor
91991968|NCT04655482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991969|NCT04515797|Antiviral Agents|antiviral agents|mesh-list
91991970|NCT04515797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991971|NCT02184767|Loxapine|loxapine|mesh-list
91991972|NCT02184767|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91991973|NCT02184767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91991974|NCT02184767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991975|NCT02184767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991976|NCT02184767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91970184|NCT02472509|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
91970185|NCT02472509|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91970186|NCT02472509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91970188|NCT02475161|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91970189|NCT02475161|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91970190|NCT02475161|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91970191|NCT02475161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090447|NCT01903031|Etonogestrel|etonogestrel|mesh-list
91991977|NCT02184767|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91991978|NCT02184767|Dopamine Agents|dopamine agents|mesh-ancestor
91991979|NCT02184767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991980|NCT02184767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991981|NCT01981954|Solifenacin Succinate|solifenacin succinate|mesh-list
91991982|NCT01981954|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91991983|NCT01981954|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91991984|NCT01981954|Cholinergic Agents|cholinergic agents|mesh-ancestor
91991985|NCT01981954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991986|NCT01981954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991987|NCT01981954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991988|NCT01981954|Urological Agents|urological agents|mesh-ancestor
91991989|NCT03727139|Rasagiline|rasagiline|mesh-list
91991990|NCT03727139|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91991991|NCT03727139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991992|NCT03727139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991993|NCT03727139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91991994|NCT03727139|Protective Agents|protective agents|mesh-ancestor
91991995|NCT03727139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991996|NCT05120687|Cyclosporine|cyclosporine|mesh-list
91991997|NCT05120687|Mycophenolic Acid|mycophenolic acid|mesh-list
91991998|NCT05120687|Adalimumab|adalimumab|mesh-list
91991999|NCT05120687|Cyclophosphamide|cyclophosphamide|mesh-list
91992000|NCT05120687|Methotrexate|methotrexate|mesh-list
91992001|NCT05120687|Cyclosporins|cyclosporins|mesh-list
91992002|NCT05120687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91992003|NCT05120687|Immunologic Factors|immunologic factors|mesh-ancestor
91992004|NCT05120687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992005|NCT05120687|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992006|NCT05120687|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91992007|NCT05120687|Alkylating Agents|alkylating agents|mesh-ancestor
91992008|NCT05120687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992009|NCT05120687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992010|NCT05120687|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91992011|NCT05120687|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91992012|NCT05120687|Abortifacient Agents|abortifacient agents|mesh-ancestor
91992013|NCT05120687|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91992014|NCT05120687|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91992015|NCT05120687|Antimetabolites|antimetabolites|mesh-ancestor
91992029|NCT03416855|Insulin|insulin|mesh-list
91992030|NCT03416855|Insulin Aspart|insulin aspart|mesh-list
91992031|NCT03416855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992032|NCT03416855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992033|NCT05121779|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91992034|NCT05121779|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91992035|NCT05121779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992036|NCT02693119|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91992037|NCT02693119|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91992038|NCT04224545|Colchicine|colchicine|mesh-list
91992039|NCT04224545|Gout Suppressants|gout suppressants|mesh-ancestor
91992040|NCT04224545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992041|NCT04224545|Tubulin Modulators|tubulin modulators|mesh-ancestor
91992042|NCT04224545|Antimitotic Agents|antimitotic agents|mesh-ancestor
91992043|NCT04224545|Mitosis Modulators|mitosis modulators|mesh-ancestor
91992044|NCT04224545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992045|NCT04224545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992046|NCT05121233|Diclofenac|diclofenac|mesh-list
91992047|NCT05121233|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91970192|NCT02475161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970194|NCT03074097|Anesthetics, Local|anesthetics, local|mesh-ancestor
91970195|NCT03074097|Anesthetics|anesthetics|mesh-ancestor
91970196|NCT03074097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970197|NCT03074097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970198|NCT03074097|Sensory System Agents|sensory system agents|mesh-ancestor
91970199|NCT03074097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992048|NCT05121233|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992049|NCT05121233|Analgesics|analgesics|mesh-ancestor
91992050|NCT05121233|Sensory System Agents|sensory system agents|mesh-ancestor
91992051|NCT05121233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992052|NCT05121233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992053|NCT05121233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992054|NCT05121233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992055|NCT05121233|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91992056|NCT05121233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992057|NCT05121233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992058|NCT05745259|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91992059|NCT05745259|Tenecteplase|tenecteplase|mesh-list
91992060|NCT05745259|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91992061|NCT05745259|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91992062|NCT05745259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992063|NCT02893241|Cafedrine|cafedrine|mesh-list
91992064|NCT02893241|Theodrenaline|theodrenaline|mesh-list
91992065|NCT02893241|Ephedrine|ephedrine|mesh-list
91992066|NCT02893241|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91992067|NCT02893241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992068|NCT02893241|Sympathomimetics|sympathomimetics|mesh-ancestor
91992069|NCT02893241|Autonomic Agents|autonomic agents|mesh-ancestor
91992070|NCT02893241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992071|NCT02893241|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91992072|NCT02893241|Adrenergic Agents|adrenergic agents|mesh-ancestor
91992073|NCT02893241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992074|NCT02893241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992075|NCT02893241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91992076|NCT02893241|Vasodilator Agents|vasodilator agents|mesh-ancestor
91992097|NCT05021861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992098|NCT05021861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992099|NCT05021861|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91992100|NCT05021861|Contraceptive Agents|contraceptive agents|mesh-ancestor
91992101|NCT05021861|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91992102|NCT05021861|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91992103|NCT05021861|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91992104|NCT05021861|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91992105|NCT05021861|Androgen Antagonists|androgen antagonists|mesh-ancestor
91992106|NCT05021861|Hormone Antagonists|hormone antagonists|mesh-ancestor
91992107|NCT05021861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992108|NCT05021861|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
91992109|NCT02403037|Dexamethasone|dexamethasone|mesh-list
91992110|NCT02403037|Dexamethasone acetate|dexamethasone acetate|mesh-list
91992111|NCT02403037|Antiemetics|antiemetics|mesh-list
91992112|NCT02403037|Emetics|emetics|mesh-list
91992113|NCT02403037|BB 1101|bb 1101|mesh-list
91992114|NCT02403037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992115|NCT02403037|Autonomic Agents|autonomic agents|mesh-ancestor
91992116|NCT02403037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992117|NCT02403037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992118|NCT02403037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91992119|NCT02403037|Glucocorticoids|glucocorticoids|mesh-ancestor
91992120|NCT02403037|Hormones|hormones|mesh-ancestor
91992121|NCT02403037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992122|NCT02403037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91992123|NCT02403037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992124|NCT02403037|Protease Inhibitors|protease inhibitors|mesh-ancestor
91970200|NCT04433481|Dabigatran|dabigatran|mesh-list
91970201|NCT04433481|Antithrombins|antithrombins|mesh-ancestor
91970202|NCT04433481|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91970203|NCT04433481|Protease Inhibitors|protease inhibitors|mesh-ancestor
91970204|NCT04433481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970205|NCT04433481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970206|NCT04433481|Anticoagulants|anticoagulants|mesh-ancestor
91970207|NCT04860635|Celecoxib|celecoxib|mesh-list
91970208|NCT04860635|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91992125|NCT02403037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992126|NCT02403037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992127|NCT02653625|Cenicriviroc|cenicriviroc|mesh-list
91992128|NCT02653625|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91992129|NCT02653625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992130|NCT02653625|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91992131|NCT02653625|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91992132|NCT02653625|Antiviral Agents|antiviral agents|mesh-ancestor
91992138|NCT04480333|Antimetabolites|antimetabolites|mesh-ancestor
91992139|NCT04480333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992140|NCT04480333|Protective Agents|protective agents|mesh-ancestor
91992141|NCT04480333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992143|NCT03166891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992144|NCT03166891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992145|NCT03166891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992146|NCT03166891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992147|NCT01980940|Etoricoxib|etoricoxib|mesh-list
91992148|NCT01980940|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
91992149|NCT01980940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91992150|NCT01980940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992151|NCT01980940|Analgesics|analgesics|mesh-ancestor
91992152|NCT01980940|Sensory System Agents|sensory system agents|mesh-ancestor
91992153|NCT01980940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992154|NCT01980940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992155|NCT01980940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992156|NCT01980940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992157|NCT01980940|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91992158|NCT01980940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91992159|NCT01980940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992160|NCT01980940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992161|NCT01980940|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91992162|NCT01980940|Protective Agents|protective agents|mesh-ancestor
91992163|NCT01980940|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91992164|NCT01980940|Antioxidants|antioxidants|mesh-ancestor
91992165|NCT01960114|Acetaminophen|acetaminophen|mesh-list
91992166|NCT01960114|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992167|NCT01960114|Analgesics|analgesics|mesh-ancestor
91992168|NCT01960114|Sensory System Agents|sensory system agents|mesh-ancestor
91992169|NCT01960114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992170|NCT01960114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992171|NCT01960114|Antipyretics|antipyretics|mesh-ancestor
91992172|NCT04752527|Sorafenib|sorafenib|mesh-list
91992173|NCT04752527|Decitabine|decitabine|mesh-list
91992174|NCT04752527|Venetoclax|venetoclax|mesh-list
91992175|NCT04752527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992176|NCT04752527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992177|NCT04752527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992178|NCT04752527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992179|NCT04752527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91992180|NCT04752527|Antimetabolites|antimetabolites|mesh-ancestor
91992181|NCT05229497|Carboplatin|carboplatin|mesh-list
91992182|NCT05229497|Fluorouracil|fluorouracil|mesh-list
91992183|NCT05229497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992184|NCT05229497|Antimetabolites|antimetabolites|mesh-ancestor
91992185|NCT05229497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992186|NCT05229497|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91970209|NCT04860635|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91970210|NCT04860635|Analgesics|analgesics|mesh-ancestor
91970211|NCT04860635|Sensory System Agents|sensory system agents|mesh-ancestor
91970212|NCT04860635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970213|NCT04860635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970214|NCT04860635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970215|NCT04860635|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970216|NCT04860635|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91970217|NCT04860635|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91970218|NCT04860635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970219|NCT04860635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992187|NCT05229497|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91992188|NCT05229497|Immunologic Factors|immunologic factors|mesh-ancestor
91992189|NCT05229497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992191|NCT03169777|Cyclophosphamide|cyclophosphamide|mesh-list
91992192|NCT03169777|Bevacizumab|bevacizumab|mesh-list
91992193|NCT03169777|Fluorouracil|fluorouracil|mesh-list
91992194|NCT03169777|Capecitabine|capecitabine|mesh-list
91992195|NCT03169777|Oxaliplatin|oxaliplatin|mesh-list
91992196|NCT03169777|Nivolumab|nivolumab|mesh-list
91992197|NCT03169777|Cetuximab|cetuximab|mesh-list
91992198|NCT03169777|Fulvestrant|fulvestrant|mesh-list
91992199|NCT03169777|Avelumab|avelumab|mesh-list
91992200|NCT03169777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992201|NCT03169777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992202|NCT03169777|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91992203|NCT03169777|Immunologic Factors|immunologic factors|mesh-ancestor
91992204|NCT03169777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992205|NCT03169777|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992206|NCT03169777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91992207|NCT03169777|Alkylating Agents|alkylating agents|mesh-ancestor
91992208|NCT03169777|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91992209|NCT03169777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91992214|NCT03169777|Antimetabolites|antimetabolites|mesh-ancestor
91992215|NCT03169777|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91992216|NCT03169777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91992217|NCT03169777|Antidotes|antidotes|mesh-ancestor
91992218|NCT03169777|Protective Agents|protective agents|mesh-ancestor
91992219|NCT03169777|Vitamin B Complex|vitamin b complex|mesh-ancestor
91992220|NCT03169777|Vitamins|vitamins|mesh-ancestor
91992221|NCT03169777|Micronutrients|micronutrients|mesh-ancestor
91992222|NCT03169777|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91992223|NCT03169777|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91992224|NCT03169777|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91992225|NCT03169777|Hormone Antagonists|hormone antagonists|mesh-ancestor
91992226|NCT03169777|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992227|NCT01980706|Baclofen|baclofen|mesh-list
91992228|NCT01980706|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91992229|NCT01980706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992230|NCT01980706|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91992231|NCT01980706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992232|NCT01980706|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
91992233|NCT01980706|GABA Agonists|gaba agonists|mesh-ancestor
91992234|NCT01980706|GABA Agents|gaba agents|mesh-ancestor
91992235|NCT01980706|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970230|NCT04988607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992236|NCT01980706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992237|NCT02092571|Progesterone|progesterone|mesh-list
91992238|NCT02092571|Progestins|progestins|mesh-ancestor
91992239|NCT02092571|Hormones|hormones|mesh-ancestor
91992240|NCT02092571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992241|NCT02092571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992242|NCT02402725|Dexamethasone|dexamethasone|mesh-list
91992243|NCT02402725|Dexamethasone acetate|dexamethasone acetate|mesh-list
91970220|NCT04988607|Bevacizumab|bevacizumab|mesh-list
91970221|NCT04988607|Osimertinib|osimertinib|mesh-list
91970222|NCT04988607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970223|NCT04988607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970224|NCT04988607|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91970225|NCT04988607|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91970226|NCT04988607|Growth Substances|growth substances|mesh-ancestor
91970227|NCT04988607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992244|NCT02402725|BB 1101|bb 1101|mesh-list
91992245|NCT02402725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992246|NCT02402725|Antiemetics|antiemetics|mesh-ancestor
91992247|NCT02402725|Autonomic Agents|autonomic agents|mesh-ancestor
91992248|NCT02402725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992249|NCT02402725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992250|NCT02402725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91992251|NCT02402725|Glucocorticoids|glucocorticoids|mesh-ancestor
91992252|NCT02402725|Hormones|hormones|mesh-ancestor
91992253|NCT02402725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992254|NCT02402725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91992255|NCT02402725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992256|NCT02402725|Protease Inhibitors|protease inhibitors|mesh-ancestor
91992257|NCT02402725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992258|NCT02402725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992259|NCT02394145|Clopidogrel|clopidogrel|mesh-list
91992260|NCT02394145|Ticagrelor|ticagrelor|mesh-list
91992261|NCT02394145|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91992262|NCT02394145|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91992263|NCT02394145|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91992264|NCT02394145|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91992265|NCT02394145|Purinergic Agents|purinergic agents|mesh-ancestor
91992266|NCT02394145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992267|NCT02394145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992268|NCT02394145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992269|NCT02004886|Metformin|metformin|mesh-list
91992270|NCT02004886|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992271|NCT02004886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992272|NCT05228483|Mometasone Furoate|mometasone furoate|mesh-list
91992273|NCT05228483|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91992274|NCT05228483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992275|NCT05228483|Dermatologic Agents|dermatologic agents|mesh-ancestor
91992276|NCT05228483|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91992277|NCT05228483|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91992278|NCT04255277|Moxifloxacin|moxifloxacin|mesh-list
91992279|NCT04255277|Levonorgestrel|levonorgestrel|mesh-list
91992280|NCT04255277|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91992283|NCT04255277|Contraceptives, Oral|contraceptives, oral|mesh-list
91992285|NCT04255277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992286|NCT04255277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992287|NCT04255277|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91992288|NCT04255277|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91992289|NCT04255277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992290|NCT04255277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992291|NCT04255277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992292|NCT04255277|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91992293|NCT04255277|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91992294|NCT04255277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992295|NCT04255277|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91992296|NCT04255277|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91992297|NCT04255277|Antidotes|antidotes|mesh-ancestor
91992298|NCT04255277|Protective Agents|protective agents|mesh-ancestor
91992299|NCT04255277|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91992301|NCT04255277|Hormones|hormones|mesh-ancestor
91992302|NCT04255277|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992303|NCT04007705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91992304|NCT04435925|Fentanyl|fentanyl|mesh-list
91970228|NCT04988607|Growth Inhibitors|growth inhibitors|mesh-ancestor
91970229|NCT04988607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91970231|NCT04988607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992306|NCT04435925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91992307|NCT04435925|Narcotics|narcotics|mesh-ancestor
91992308|NCT04435925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992309|NCT04435925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992310|NCT04435925|Analgesics|analgesics|mesh-ancestor
91992311|NCT04435925|Sensory System Agents|sensory system agents|mesh-ancestor
91992312|NCT04435925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992313|NCT04435925|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91992314|NCT04435925|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91992315|NCT04435925|Anesthetics, General|anesthetics, general|mesh-ancestor
91992316|NCT04435925|Anesthetics|anesthetics|mesh-ancestor
91992317|NCT04649476|Cisplatin|cisplatin|mesh-list
91992318|NCT04649476|Docetaxel|docetaxel|mesh-list
91992319|NCT04649476|Fluorouracil|fluorouracil|mesh-list
91992320|NCT04649476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992321|NCT04649476|Tubulin Modulators|tubulin modulators|mesh-ancestor
91992322|NCT04649476|Antimitotic Agents|antimitotic agents|mesh-ancestor
91992323|NCT04649476|Mitosis Modulators|mitosis modulators|mesh-ancestor
91992324|NCT04649476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992325|NCT04649476|Antimetabolites|antimetabolites|mesh-ancestor
91992326|NCT04649476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91992327|NCT04649476|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91992328|NCT04649476|Immunologic Factors|immunologic factors|mesh-ancestor
91992329|NCT04649476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992330|NCT05117957|Sorafenib|sorafenib|mesh-list
91992331|NCT05117957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992332|NCT05117957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992333|NCT05117957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992334|NCT05117957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992335|NCT03343301|Bemarituzumab|bemarituzumab|mesh-list
91992336|NCT03343301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91992337|NCT03343301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992339|NCT04507919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992340|NCT04507919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992341|NCT04507919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992342|NCT04507919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992343|NCT03251729|Progesterone|progesterone|mesh-list
91992344|NCT03251729|Progestins|progestins|mesh-ancestor
91992345|NCT03251729|Hormones|hormones|mesh-ancestor
91992346|NCT03251729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992347|NCT03251729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992348|NCT02696785|Adalimumab|adalimumab|mesh-list
91992349|NCT02696785|Ixekizumab|ixekizumab|mesh-list
91992350|NCT02696785|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91992351|NCT02696785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992352|NCT02696785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992353|NCT02696785|Dermatologic Agents|dermatologic agents|mesh-ancestor
91992354|NCT02004262|Cyclophosphamide|cyclophosphamide|mesh-list
91992358|NCT02004262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992359|NCT02004262|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992360|NCT02004262|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91992361|NCT02004262|Alkylating Agents|alkylating agents|mesh-ancestor
91992362|NCT02004262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992363|NCT02004262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992364|NCT02004262|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91992365|NCT02004262|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91992367|NCT02393599|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992368|NCT02393599|Anesthetics|anesthetics|mesh-ancestor
91992369|NCT02393599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992370|NCT02393599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992371|NCT02393599|Sensory System Agents|sensory system agents|mesh-ancestor
91992372|NCT02393599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992373|NCT02393599|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91992374|NCT02393599|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91970232|NCT02475317|Volixibat|volixibat|mesh-list
91970233|NCT02475317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91970234|NCT03070509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
91970235|NCT03070509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91992375|NCT02393599|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91992376|NCT02393599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91992377|NCT02393599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992378|NCT02393599|Dopamine Agents|dopamine agents|mesh-ancestor
91992379|NCT02393599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992380|NCT02402491|Aspirin|aspirin|mesh-list
91992381|NCT02402491|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
91992382|NCT02402491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91992383|NCT02402491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992384|NCT02402491|Analgesics|analgesics|mesh-ancestor
91992385|NCT02402491|Sensory System Agents|sensory system agents|mesh-ancestor
91992386|NCT02402491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992387|NCT02402491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992388|NCT02402491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992389|NCT02402491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992390|NCT02402491|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91992391|NCT02402491|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91992392|NCT02402491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992393|NCT02402491|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91992394|NCT02402491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91992395|NCT02402491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992396|NCT02402491|Antipyretics|antipyretics|mesh-ancestor
91992397|NCT02402491|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91992398|NCT02402491|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91992399|NCT02402491|Purinergic Agents|purinergic agents|mesh-ancestor
91992400|NCT02402491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992401|NCT02402413|Androgens|androgens|mesh-list
91992402|NCT02402413|Hormones|hormones|mesh-ancestor
91992403|NCT02402413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992404|NCT02402413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992405|NCT02393443|Oxytocin|oxytocin|mesh-list
91992406|NCT02393443|Oxytocics|oxytocics|mesh-ancestor
91992407|NCT02393443|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91992408|NCT02393443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992409|NCT01977898|Morphine|morphine|mesh-list
91992410|NCT01977898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91992411|NCT01977898|Narcotics|narcotics|mesh-ancestor
91992412|NCT01977898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992413|NCT01977898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992414|NCT01977898|Analgesics|analgesics|mesh-ancestor
91992415|NCT01977898|Sensory System Agents|sensory system agents|mesh-ancestor
91992416|NCT01977898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992417|NCT05744479|Metformin|metformin|mesh-list
91992418|NCT05744479|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992419|NCT05744479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992420|NCT02003638|Niacin|niacin|mesh-list
91992421|NCT02003638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91992422|NCT02003638|Antimetabolites|antimetabolites|mesh-ancestor
91992423|NCT02003638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992425|NCT02003638|Vasodilator Agents|vasodilator agents|mesh-ancestor
91992426|NCT02003638|Vitamin B Complex|vitamin b complex|mesh-ancestor
91992427|NCT02003638|Vitamins|vitamins|mesh-ancestor
91992428|NCT02003638|Micronutrients|micronutrients|mesh-ancestor
91992429|NCT02003638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992430|NCT04649398|Nimodipine|nimodipine|mesh-list
91992431|NCT04649398|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91992432|NCT04649398|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91992433|NCT04649398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91992434|NCT04649398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992435|NCT04649398|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91992436|NCT04649398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992437|NCT04649398|Vasodilator Agents|vasodilator agents|mesh-ancestor
91992438|NCT02402179|Tryptophan|tryptophan|mesh-list
91992439|NCT02402179|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91992440|NCT02402179|Antidepressive Agents|antidepressive agents|mesh-ancestor
91970236|NCT03070509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970237|NCT03070509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91970238|NCT03070509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91970239|NCT03070509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91992441|NCT02402179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91992442|NCT02401945|Aflibercept|aflibercept|mesh-list
91992443|NCT02401945|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91992444|NCT02401945|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91992445|NCT02401945|Growth Substances|growth substances|mesh-ancestor
91992446|NCT02401945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992447|NCT02401945|Growth Inhibitors|growth inhibitors|mesh-ancestor
91992448|NCT02401945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992449|NCT02003014|Pioglitazone|pioglitazone|mesh-list
91992450|NCT02003014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992451|NCT02003014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992452|NCT01977352|Bupivacaine|bupivacaine|mesh-list
91992453|NCT01977352|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992454|NCT01977352|Anesthetics|anesthetics|mesh-ancestor
91992455|NCT01977352|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992456|NCT01977352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992457|NCT01977352|Sensory System Agents|sensory system agents|mesh-ancestor
91992458|NCT01977352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992460|NCT03166111|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992461|NCT03166111|Anesthetics|anesthetics|mesh-ancestor
91992462|NCT03166111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992463|NCT03166111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992464|NCT03166111|Sensory System Agents|sensory system agents|mesh-ancestor
91992465|NCT03166111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992466|NCT03166111|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91992467|NCT03166111|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91992468|NCT03166111|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91992469|NCT03166111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91992470|NCT03166111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992471|NCT05117021|Bupivacaine|bupivacaine|mesh-list
91992472|NCT05117021|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992473|NCT05117021|Anesthetics|anesthetics|mesh-ancestor
91992474|NCT05117021|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992475|NCT05117021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992476|NCT05117021|Sensory System Agents|sensory system agents|mesh-ancestor
91992477|NCT05117021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992478|NCT02392663|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91992479|NCT02392117|Insulin|insulin|mesh-list
91992480|NCT02392117|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992481|NCT02392117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992482|NCT02812433|Sildenafil Citrate|sildenafil citrate|mesh-list
91992483|NCT02812433|Vasodilator Agents|vasodilator agents|mesh-ancestor
91992484|NCT02812433|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91992485|NCT02812433|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91992486|NCT02812433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992487|NCT02812433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992488|NCT02812433|Urological Agents|urological agents|mesh-ancestor
91992489|NCT02392039|Loratadine|loratadine|mesh-list
91992490|NCT02392039|Antipruritics|antipruritics|mesh-ancestor
91992491|NCT02392039|Dermatologic Agents|dermatologic agents|mesh-ancestor
91992492|NCT02392039|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91992493|NCT02392039|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91992494|NCT02392039|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91992495|NCT02392039|Histamine Antagonists|histamine antagonists|mesh-ancestor
91992496|NCT02392039|Histamine Agents|histamine agents|mesh-ancestor
91992500|NCT03106363|Ethanol|ethanol|mesh-list
91992501|NCT03106363|Dronabinol|dronabinol|mesh-list
91992502|NCT03106363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91992503|NCT03106363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992504|NCT03106363|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992505|NCT03106363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992506|NCT03106363|Hallucinogens|hallucinogens|mesh-ancestor
91992507|NCT03106363|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91992508|NCT03106363|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992509|NCT03106363|Analgesics|analgesics|mesh-ancestor
91970240|NCT03070509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970242|NCT03070509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992510|NCT03106363|Sensory System Agents|sensory system agents|mesh-ancestor
91992511|NCT03106363|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992512|NCT03106363|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91992513|NCT03106363|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91992514|NCT03106363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992515|NCT03106363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992516|NCT03106363|Hormones|hormones|mesh-ancestor
91992517|NCT03106363|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992518|NCT03106519|Bupivacaine|bupivacaine|mesh-list
91992519|NCT03106519|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992520|NCT03106519|Anesthetics|anesthetics|mesh-ancestor
91992521|NCT03106519|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992522|NCT03106519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992523|NCT03106519|Sensory System Agents|sensory system agents|mesh-ancestor
91992524|NCT03106519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992525|NCT02687815|Vitamin D|vitamin d|mesh-list
91992526|NCT02687815|Cholecalciferol|cholecalciferol|mesh-list
91992527|NCT02687815|Vitamins|vitamins|mesh-ancestor
91992528|NCT02687815|Micronutrients|micronutrients|mesh-ancestor
91992529|NCT02687815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992530|NCT02687815|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91992531|NCT02687815|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91992532|NCT03915665|Chlorhexidine|chlorhexidine|mesh-list
91992533|NCT03915665|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91992534|NCT03915665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992535|NCT03915665|Disinfectants|disinfectants|mesh-ancestor
91992536|NCT01959334|Glucagon|glucagon|mesh-list
91992537|NCT01959334|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
91992538|NCT01959334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91992539|NCT01959334|Hormones|hormones|mesh-ancestor
91992540|NCT01959334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992541|NCT01959334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992542|NCT01959334|Incretins|incretins|mesh-ancestor
91992544|NCT01958476|Methadone|methadone|mesh-list
91992545|NCT01958476|Phenobarbital|phenobarbital|mesh-list
91992546|NCT01958476|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91992547|NCT01958476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91992548|NCT01958476|Narcotics|narcotics|mesh-ancestor
91992549|NCT01958476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992550|NCT01958476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992551|NCT01958476|Analgesics|analgesics|mesh-ancestor
91992552|NCT01958476|Sensory System Agents|sensory system agents|mesh-ancestor
91992553|NCT01958476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992554|NCT01958476|Antitussive Agents|antitussive agents|mesh-ancestor
91992555|NCT01958476|Respiratory System Agents|respiratory system agents|mesh-ancestor
91992556|NCT01958476|Anticonvulsants|anticonvulsants|mesh-ancestor
91992557|NCT01958476|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91992558|NCT01958476|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91992559|NCT01958476|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91992560|NCT01958476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992561|NCT01958476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992562|NCT01958476|GABA Modulators|gaba modulators|mesh-ancestor
91992563|NCT01958476|GABA Agents|gaba agents|mesh-ancestor
91992564|NCT01958476|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91992565|NCT01958476|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91992566|NCT01958476|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91992567|NCT04809181|Azacitidine|azacitidine|mesh-list
91992568|NCT04809181|Venetoclax|venetoclax|mesh-list
91992572|NCT04809181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992573|NCT04809181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992574|NCT05734807|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
91992575|NCT05734807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91992576|NCT05734807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992577|NCT05734807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992579|NCT05734807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992580|NCT01057121|Lenalidomide|lenalidomide|mesh-list
91992581|NCT01057121|Immunologic Factors|immunologic factors|mesh-ancestor
91970243|NCT05322473|Adalimumab|adalimumab|mesh-list
91970244|NCT05322473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91992582|NCT01057121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992583|NCT01057121|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91992584|NCT01057121|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91992585|NCT01057121|Growth Substances|growth substances|mesh-ancestor
91992586|NCT01057121|Growth Inhibitors|growth inhibitors|mesh-ancestor
91992587|NCT01057121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992588|NCT02695537|Cannabidiol|cannabidiol|mesh-list
91992589|NCT02695537|Anticonvulsants|anticonvulsants|mesh-ancestor
91992590|NCT04620941|Chrysarobin|chrysarobin|mesh-list
91992591|NCT04620941|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91992592|NCT04620941|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992593|NCT04620941|Analgesics|analgesics|mesh-ancestor
91992594|NCT04620941|Sensory System Agents|sensory system agents|mesh-ancestor
91992595|NCT04620941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992596|NCT04620941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992597|NCT04620941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992598|NCT04620941|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992599|NCT04210349|Vaccines|vaccines|mesh-list
91992600|NCT04210349|Immunologic Factors|immunologic factors|mesh-ancestor
91992601|NCT04210349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992602|NCT01353313|Hydrocortisone|hydrocortisone|mesh-list
91992603|NCT01353313|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992604|NCT04746989|Allopurinol|allopurinol|mesh-list
91992605|NCT04746989|Probenecid|probenecid|mesh-list
91992606|NCT04746989|Antimetabolites|antimetabolites|mesh-ancestor
91992721|NCT05746351|Narcotics|narcotics|mesh-ancestor
91992607|NCT04746989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992608|NCT04746989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992609|NCT04746989|Gout Suppressants|gout suppressants|mesh-ancestor
91992610|NCT04746989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992611|NCT04746989|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91992612|NCT04746989|Antioxidants|antioxidants|mesh-ancestor
91992613|NCT04746989|Protective Agents|protective agents|mesh-ancestor
91992614|NCT04746989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992615|NCT04746989|Uricosuric Agents|uricosuric agents|mesh-ancestor
91992616|NCT04671953|Metformin|metformin|mesh-list
91992617|NCT04671953|Deucravacitinib|deucravacitinib|mesh-list
91992618|NCT04671953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992619|NCT04671953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992620|NCT04671953|Dermatologic Agents|dermatologic agents|mesh-ancestor
91992621|NCT04671953|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992622|NCT04671953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992623|NCT04671953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992624|NCT04585061|Lidocaine|lidocaine|mesh-list
91992625|NCT04585061|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992626|NCT04585061|Anesthetics|anesthetics|mesh-ancestor
91992627|NCT04585061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992628|NCT04585061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992629|NCT04585061|Sensory System Agents|sensory system agents|mesh-ancestor
91992630|NCT04585061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992631|NCT04585061|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91992632|NCT04585061|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91992633|NCT04585061|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91992634|NCT04585061|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91992635|NCT04585061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992636|NCT03874091|Epinephrine|epinephrine|mesh-list
91992637|NCT03874091|Racepinephrine|racepinephrine|mesh-list
91992638|NCT03874091|Morphine|morphine|mesh-list
91992639|NCT03874091|Bupivacaine|bupivacaine|mesh-list
91992640|NCT03874091|Epinephryl borate|epinephryl borate|mesh-list
91992683|NCT03560297|GABA Modulators|gaba modulators|mesh-ancestor
91992685|NCT03560297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992686|NCT03560297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992687|NCT04965389|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91992688|NCT04122287|Levofloxacin|levofloxacin|mesh-list
91992689|NCT04122287|Tinidazole|tinidazole|mesh-list
91992690|NCT04122287|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91992691|NCT04122287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992692|NCT04122287|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992693|NCT04122287|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91992694|NCT04122287|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91992695|NCT04122287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992696|NCT04122287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992697|NCT04122287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970245|NCT05322473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970246|NCT05322473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970247|NCT02472275|Ascorbic Acid|ascorbic acid|mesh-list
91970248|NCT02472275|Methyltestosterone|methyltestosterone|mesh-list
91992698|NCT04122287|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91992699|NCT04122287|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91992700|NCT04122287|Alkylating Agents|alkylating agents|mesh-ancestor
91992701|NCT04122287|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
91992702|NCT04122287|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91992703|NCT04122287|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91992704|NCT05746351|Fentanyl|fentanyl|mesh-list
91992705|NCT05746351|Dexmedetomidine|dexmedetomidine|mesh-list
91992706|NCT05746351|Nalbuphine|nalbuphine|mesh-list
91992707|NCT05746351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91992708|NCT05746351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992709|NCT05746351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992710|NCT05746351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992711|NCT05746351|Analgesics|analgesics|mesh-ancestor
91992712|NCT05746351|Sensory System Agents|sensory system agents|mesh-ancestor
91992713|NCT05746351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992714|NCT05746351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91992715|NCT05746351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91992716|NCT05746351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91992717|NCT05746351|Adrenergic Agents|adrenergic agents|mesh-ancestor
91992718|NCT05746351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992719|NCT05746351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992720|NCT05746351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91992722|NCT05746351|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91992723|NCT05746351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91992724|NCT05746351|Anesthetics, General|anesthetics, general|mesh-ancestor
91992725|NCT05746351|Anesthetics|anesthetics|mesh-ancestor
91992726|NCT05403281|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91992727|NCT05403281|Dapagliflozin|dapagliflozin|mesh-list
91992728|NCT05403281|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992729|NCT05403281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992730|NCT05403281|Incretins|incretins|mesh-ancestor
91992731|NCT05403281|Hormones|hormones|mesh-ancestor
91992732|NCT05403281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992733|NCT05403281|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91992734|NCT05403281|Protease Inhibitors|protease inhibitors|mesh-ancestor
91992735|NCT05403281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992736|NCT05403281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992737|NCT05403281|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91992738|NCT03115099|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91992739|NCT03115099|Liraglutide|liraglutide|mesh-list
91992740|NCT03115099|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992741|NCT03115099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992742|NCT03115099|Incretins|incretins|mesh-ancestor
91992743|NCT03115099|Hormones|hormones|mesh-ancestor
91992744|NCT03115099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992745|NCT03115099|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91992748|NCT03115099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992749|NCT03165097|ACT-709478|act-709478|mesh-list
91992750|NCT03165097|Midazolam|midazolam|mesh-list
91992751|NCT03165097|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91992752|NCT03165097|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91992753|NCT03165097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992754|NCT03165097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992755|NCT03165097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91992756|NCT03165097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91992757|NCT03165097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91992758|NCT03165097|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91992759|NCT03165097|Anesthetics, General|anesthetics, general|mesh-ancestor
91992760|NCT03165097|Anesthetics|anesthetics|mesh-ancestor
91992761|NCT03165097|GABA Modulators|gaba modulators|mesh-ancestor
91992762|NCT03165097|GABA Agents|gaba agents|mesh-ancestor
91992763|NCT03165097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992764|NCT03165097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992765|NCT03165097|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91992766|NCT03165097|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970249|NCT02472275|Hormones|hormones|mesh-list
91970250|NCT02472275|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
91970251|NCT02472275|Androgens|androgens|mesh-list
91970252|NCT02472275|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91992767|NCT03165097|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91992768|NCT03165409|Nivolumab|nivolumab|mesh-list
91992769|NCT03165409|Ipilimumab|ipilimumab|mesh-list
91992770|NCT03165409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91992771|NCT03165409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992772|NCT03165409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91992773|NCT03165409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992774|NCT05403125|Listerine|listerine|mesh-list
91992775|NCT05403125|Fluorides|fluorides|mesh-list
91992776|NCT05403125|Sodium Fluoride|sodium fluoride|mesh-list
91992777|NCT05403125|Cariostatic Agents|cariostatic agents|mesh-ancestor
91992778|NCT05403125|Protective Agents|protective agents|mesh-ancestor
91992779|NCT05403125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992780|NCT05403125|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91992781|NCT05403125|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992783|NCT05701423|Immunologic Factors|immunologic factors|mesh-ancestor
91992784|NCT05701423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992785|NCT02795351|Sildenafil Citrate|sildenafil citrate|mesh-list
91992786|NCT02795351|Vasodilator Agents|vasodilator agents|mesh-ancestor
91992787|NCT02795351|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91992788|NCT02795351|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91992789|NCT02795351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992790|NCT02795351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992791|NCT02795351|Urological Agents|urological agents|mesh-ancestor
91992792|NCT05403047|Tenofovir|tenofovir|mesh-list
91992793|NCT05403047|Antiviral Agents|antiviral agents|mesh-ancestor
91992794|NCT05403047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992795|NCT05403047|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91992796|NCT05403047|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91992797|NCT05403047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992798|NCT05403047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992799|NCT05403047|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91992800|NCT05403047|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91992801|NCT04563845|Moxifloxacin|moxifloxacin|mesh-list
91992802|NCT04563845|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992803|NCT04563845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992804|NCT04563845|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91992805|NCT04563845|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91992806|NCT04563845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992807|NCT04563845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992808|NCT04563845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992809|NCT03927443|Bimatoprost|bimatoprost|mesh-list
91992810|NCT03927443|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91992811|NCT05124353|Cerebrolysin|cerebrolysin|mesh-list
91992812|NCT05124353|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91992813|NCT05124353|Protective Agents|protective agents|mesh-ancestor
91992814|NCT05124353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992815|NCT05124353|Nootropic Agents|nootropic agents|mesh-ancestor
91992816|NCT03913247|Metronidazole|metronidazole|mesh-list
91992817|NCT03913247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992818|NCT03913247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992822|NCT03805841|Anticonvulsants|anticonvulsants|mesh-ancestor
91992823|NCT02684617|Pembrolizumab|pembrolizumab|mesh-list
91992824|NCT02684617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91992825|NCT02684617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992826|NCT02684617|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91992827|NCT02684617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992828|NCT01999972|Axitinib|axitinib|mesh-list
91992829|NCT01999972|Crizotinib|crizotinib|mesh-list
91992830|NCT01999972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992831|NCT01999972|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992832|NCT01999972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992833|NCT01999972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992834|NCT04055389|Antithrombins|antithrombins|mesh-list
91992835|NCT04055389|Antithrombin III|antithrombin iii|mesh-list
91992836|NCT04055389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91992837|NCT04055389|Protease Inhibitors|protease inhibitors|mesh-ancestor
91970254|NCT02472275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970255|NCT02472275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970256|NCT02472275|Antioxidants|antioxidants|mesh-ancestor
91970257|NCT02472275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970258|NCT02472275|Protective Agents|protective agents|mesh-ancestor
91970259|NCT02472275|Vitamins|vitamins|mesh-ancestor
91970260|NCT02472275|Micronutrients|micronutrients|mesh-ancestor
91970261|NCT02472275|Estrogens|estrogens|mesh-ancestor
91970262|NCT02472275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91992838|NCT04055389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992839|NCT04055389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992840|NCT04055389|Anticoagulants|anticoagulants|mesh-ancestor
91992841|NCT05697055|Ritonavir|ritonavir|mesh-list
91992842|NCT05697055|Nirmatrelvir|nirmatrelvir|mesh-list
91992843|NCT05697055|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
91992844|NCT05697055|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91992845|NCT05697055|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91992846|NCT05697055|Protease Inhibitors|protease inhibitors|mesh-ancestor
91992847|NCT05697055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992848|NCT05697055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992849|NCT05697055|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91992850|NCT05697055|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91992851|NCT05697055|Antiviral Agents|antiviral agents|mesh-ancestor
91992852|NCT05697055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992853|NCT05697055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91992854|NCT05697055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91992855|NCT03162367|Sulfadiazine|sulfadiazine|mesh-list
91992856|NCT03162367|Silver Sulfadiazine|silver sulfadiazine|mesh-list
91992857|NCT03162367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992858|NCT03162367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992859|NCT03162367|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91992860|NCT03162367|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91992861|NCT03162367|Coccidiostats|coccidiostats|mesh-ancestor
91992862|NCT03162367|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91992863|NCT01999894|Memantine|memantine|mesh-list
91992864|NCT01999894|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91992865|NCT01999894|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91992866|NCT01999894|Dopamine Agents|dopamine agents|mesh-ancestor
91992867|NCT01999894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992868|NCT01999894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992869|NCT01999894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992870|NCT01999894|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91992871|NCT01999894|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91992872|NCT01976806|Aspirin|aspirin|mesh-list
91992873|NCT01976806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91992874|NCT01976806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992875|NCT01976806|Analgesics|analgesics|mesh-ancestor
91992876|NCT01976806|Sensory System Agents|sensory system agents|mesh-ancestor
91992877|NCT01976806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992878|NCT01976806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992879|NCT01976806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992880|NCT01976806|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992881|NCT01976806|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91992882|NCT01976806|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91992883|NCT01976806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992884|NCT01976806|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91992885|NCT01976806|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91992886|NCT01976806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992887|NCT01976806|Antipyretics|antipyretics|mesh-ancestor
91992888|NCT01976728|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
91992889|NCT01976728|Hormones|hormones|mesh-ancestor
91992890|NCT01976728|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970263|NCT02472275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970264|NCT02472275|Anabolic Agents|anabolic agents|mesh-ancestor
91970265|NCT02472275|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91970266|NCT02472275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992895|NCT02689219|Immunotoxins|immunotoxins|mesh-ancestor
91992896|NCT02689219|Immunoconjugates|immunoconjugates|mesh-ancestor
91992897|NCT02689219|Immunologic Factors|immunologic factors|mesh-ancestor
91992898|NCT02689219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992899|NCT03165253|Amoxicillin|amoxicillin|mesh-list
91992900|NCT03165253|Clarithromycin|clarithromycin|mesh-list
91992901|NCT03165253|Omeprazole|omeprazole|mesh-list
91992902|NCT03165253|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992903|NCT03165253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992904|NCT03165253|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91992905|NCT03165253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91992906|NCT03165253|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91992907|NCT03165253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992908|NCT03165253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992909|NCT03165253|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91992910|NCT03165253|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91992911|NCT03165253|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91992912|NCT05543317|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91992913|NCT05543317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91992914|NCT05543317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992915|NCT04718389|Benralizumab|benralizumab|mesh-list
91992916|NCT04718389|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91992917|NCT04718389|Respiratory System Agents|respiratory system agents|mesh-ancestor
91992918|NCT03161977|Mannitol|mannitol|mesh-list
91992919|NCT03161977|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91992920|NCT03161977|Diuretics|diuretics|mesh-ancestor
91992921|NCT03161977|Natriuretic Agents|natriuretic agents|mesh-ancestor
91992922|NCT03161977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992923|NCT02683525|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91992924|NCT02683525|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992925|NCT02683525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992926|NCT02683525|Incretins|incretins|mesh-ancestor
91992927|NCT02683525|Hormones|hormones|mesh-ancestor
91992928|NCT02683525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992929|NCT02683525|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91992930|NCT02683525|Protease Inhibitors|protease inhibitors|mesh-ancestor
91992931|NCT02683525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992932|NCT02683525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992933|NCT01976338|Ranibizumab|ranibizumab|mesh-list
91992934|NCT01976338|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91992935|NCT01976338|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91992936|NCT01976338|Growth Substances|growth substances|mesh-ancestor
91992937|NCT01976338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992938|NCT01976338|Growth Inhibitors|growth inhibitors|mesh-ancestor
91992939|NCT01976338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992940|NCT02651987|Lanreotide|lanreotide|mesh-list
91992941|NCT02651987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992942|NCT05115773|Anesthetics|anesthetics|mesh-list
91992943|NCT05115773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992944|NCT05115773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992945|NCT02506517|Afatinib|afatinib|mesh-list
91992946|NCT02506517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992947|NCT02506517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91992948|NCT02506517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992949|NCT02506517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992950|NCT04657939|Pioglitazone|pioglitazone|mesh-list
91992951|NCT04657939|Liraglutide|liraglutide|mesh-list
91992952|NCT04657939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992953|NCT04657939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992954|NCT04657939|Incretins|incretins|mesh-ancestor
91992955|NCT04657939|Hormones|hormones|mesh-ancestor
91992956|NCT04657939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992957|NCT01999114|Moxifloxacin|moxifloxacin|mesh-list
91992958|NCT01999114|Naltrexone|naltrexone|mesh-list
91992959|NCT01999114|Buprenorphine|buprenorphine|mesh-list
91992960|NCT01999114|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91992961|NCT01999114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992965|NCT01999114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970267|NCT02472275|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970268|NCT04491773|Tadalafil|tadalafil|mesh-list
91970269|NCT04491773|Vasodilator Agents|vasodilator agents|mesh-ancestor
91970270|NCT04491773|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91970271|NCT04491773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91992966|NCT01999114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992967|NCT01999114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992968|NCT01999114|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91992969|NCT01999114|Contraceptive Agents|contraceptive agents|mesh-ancestor
91992970|NCT01999114|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91992971|NCT01999114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992972|NCT01999114|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91992973|NCT01999114|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91992974|NCT01999114|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91992975|NCT01999114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91992977|NCT01999114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992978|NCT01999114|Analgesics|analgesics|mesh-ancestor
91992979|NCT01999114|Sensory System Agents|sensory system agents|mesh-ancestor
91992980|NCT01999114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992981|NCT01999114|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91992982|NCT01999114|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91992983|NCT04500275|Vancomycin|vancomycin|mesh-list
91992984|NCT04500275|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992985|NCT04500275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992986|NCT04503161|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
91992987|NCT04503161|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
91992988|NCT04503161|Estradiol|estradiol|mesh-list
91992989|NCT04503161|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91992990|NCT04503161|Estrogens|estrogens|mesh-ancestor
91992991|NCT04503161|Hormones|hormones|mesh-ancestor
91992992|NCT04503161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91992993|NCT04503161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992994|NCT04503161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91992995|NCT04503161|Contraceptive Agents|contraceptive agents|mesh-ancestor
91992996|NCT04503161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91992997|NCT04503161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91992999|NCT02214407|Hydroxyurea|hydroxyurea|mesh-list
91993000|NCT02214407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91993001|NCT02214407|Antimetabolites|antimetabolites|mesh-ancestor
91993002|NCT02214407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993003|NCT02214407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993004|NCT02214407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993005|NCT02214407|Antisickling Agents|antisickling agents|mesh-ancestor
91993006|NCT02214407|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91993007|NCT01899989|Carboplatin|carboplatin|mesh-list
91993008|NCT01899989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993009|NCT02261285|Nivolumab|nivolumab|mesh-list
91993010|NCT02261285|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993011|NCT02261285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993012|NCT02261285|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91993013|NCT02261285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993014|NCT01288625|Amifostine|amifostine|mesh-list
91993015|NCT01288625|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91993016|NCT01288625|Protective Agents|protective agents|mesh-ancestor
91993017|NCT01288625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993018|NCT01374451|Everolimus|everolimus|mesh-list
91993019|NCT01374451|Pasireotide|pasireotide|mesh-list
91993020|NCT01374451|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91993021|NCT01374451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993022|NCT01374451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993023|NCT01374451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993024|NCT01374451|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993025|NCT01374451|Immunologic Factors|immunologic factors|mesh-ancestor
91993026|NCT01374451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993027|NCT01374451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993028|NCT01374451|Hormones|hormones|mesh-ancestor
91993029|NCT01374451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993031|NCT02674399|Viscosupplements|viscosupplements|mesh-ancestor
91993032|NCT02674399|Protective Agents|protective agents|mesh-ancestor
91993033|NCT02674399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993036|NCT03161509|Carbamazepine|carbamazepine|mesh-list
91993037|NCT03161509|Phenytoin|phenytoin|mesh-list
91993038|NCT03161509|Valproic Acid|valproic acid|mesh-list
91993039|NCT03161509|Anticonvulsants|anticonvulsants|mesh-list
91993040|NCT03161509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91993041|NCT03161509|Analgesics|analgesics|mesh-ancestor
91993042|NCT03161509|Sensory System Agents|sensory system agents|mesh-ancestor
91993043|NCT03161509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993044|NCT03161509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993045|NCT03161509|Antipyretics|antipyretics|mesh-ancestor
91993046|NCT03161509|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91993047|NCT03161509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993048|NCT03161509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993049|NCT03161509|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91993050|NCT03161509|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91993051|NCT03161509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91993052|NCT03161509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993053|NCT03161509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91993054|NCT03161509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91993055|NCT03161509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993056|NCT03161509|GABA Agents|gaba agents|mesh-ancestor
91993057|NCT03161509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993058|NCT03161509|Antimanic Agents|antimanic agents|mesh-ancestor
91993059|NCT03161509|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91993060|NCT03161509|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91993061|NCT03161509|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91993062|NCT03161509|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91993063|NCT02676895|Vaccines|vaccines|mesh-list
91993064|NCT02676895|Immunologic Factors|immunologic factors|mesh-ancestor
91993065|NCT02676895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993066|NCT04440085|Midodrine|midodrine|mesh-list
91993067|NCT04440085|Sympathomimetics|sympathomimetics|mesh-ancestor
91993068|NCT04440085|Autonomic Agents|autonomic agents|mesh-ancestor
91993069|NCT04440085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993070|NCT04440085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993071|NCT04440085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91993072|NCT04440085|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91993073|NCT04440085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91993074|NCT04440085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91993075|NCT04440085|Adrenergic Agents|adrenergic agents|mesh-ancestor
91993076|NCT04440085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993077|NCT04440085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993078|NCT05129033|Omalizumab|omalizumab|mesh-list
91993079|NCT05129033|Itraconazole|itraconazole|mesh-list
91993080|NCT05129033|Prednisone|prednisone|mesh-list
91993081|NCT05129033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993082|NCT05129033|Glucocorticoids|glucocorticoids|mesh-ancestor
91993083|NCT05129033|Hormones|hormones|mesh-ancestor
91993084|NCT05129033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993085|NCT05129033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993086|NCT05129033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993087|NCT05129033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993088|NCT05129033|Antifungal Agents|antifungal agents|mesh-ancestor
91993089|NCT05129033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993090|NCT05129033|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91993091|NCT05129033|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91993092|NCT05129033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993093|NCT05129033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993094|NCT05129033|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91993095|NCT05129033|Hormone Antagonists|hormone antagonists|mesh-ancestor
91993096|NCT05129033|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91993097|NCT05129033|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91993098|NCT05129033|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91993099|NCT05129033|Respiratory System Agents|respiratory system agents|mesh-ancestor
91993100|NCT05128721|Vaccines|vaccines|mesh-list
91993101|NCT05128721|Immunologic Factors|immunologic factors|mesh-ancestor
91993102|NCT05128721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993103|NCT05128175|Levodopa|levodopa|mesh-list
91993104|NCT05128175|Carbidopa|carbidopa|mesh-list
91993105|NCT05128175|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
91993106|NCT05128175|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91993107|NCT05128175|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91993108|NCT05128175|Dopamine Agents|dopamine agents|mesh-ancestor
91970272|NCT04491773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970273|NCT04491773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970274|NCT04491773|Urological Agents|urological agents|mesh-ancestor
91993110|NCT05128175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993111|NCT05128175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993112|NCT05128175|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
91993113|NCT05128175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993114|NCT05128175|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91993115|NCT05128175|Immunologic Factors|immunologic factors|mesh-ancestor
91993116|NCT05128175|Dopamine Agonists|dopamine agonists|mesh-ancestor
91993118|NCT04184453|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91993119|NCT04184453|Chelating Agents|chelating agents|mesh-ancestor
91993120|NCT04184453|Sequestering Agents|sequestering agents|mesh-ancestor
91993121|NCT04184453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993122|NCT05127707|Analgesics, Opioid|analgesics, opioid|mesh-list
91993124|NCT05127707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993125|NCT05127707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993126|NCT05127707|Analgesics|analgesics|mesh-ancestor
91993127|NCT05127707|Sensory System Agents|sensory system agents|mesh-ancestor
91993128|NCT05127707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993129|NCT05205109|Pembrolizumab|pembrolizumab|mesh-list
91993130|NCT05205109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993131|NCT05205109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993132|NCT05205109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91993133|NCT05205109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993134|NCT02207465|Paclitaxel|paclitaxel|mesh-list
91993135|NCT02207465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91993136|NCT02207465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91993137|NCT02207465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993138|NCT02207465|Tubulin Modulators|tubulin modulators|mesh-ancestor
91993139|NCT02207465|Antimitotic Agents|antimitotic agents|mesh-ancestor
91993140|NCT02207465|Mitosis Modulators|mitosis modulators|mesh-ancestor
91993141|NCT02207465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993142|NCT00719225|Abatacept|abatacept|mesh-list
91993143|NCT00719225|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91993144|NCT00719225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993145|NCT00719225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993146|NCT00719225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993147|NCT00719225|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993148|NCT00719225|Immunologic Factors|immunologic factors|mesh-ancestor
91993149|NCT00719225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993150|NCT00719225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993151|NCT05134337|Itraconazole|itraconazole|mesh-list
91993152|NCT05134337|Rifampin|rifampin|mesh-list
91993153|NCT05134337|Antifungal Agents|antifungal agents|mesh-ancestor
91993154|NCT05134337|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993155|NCT05134337|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91993156|NCT05134337|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91993157|NCT05134337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993158|NCT05134337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993159|NCT05134337|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91993160|NCT05134337|Hormone Antagonists|hormone antagonists|mesh-ancestor
91993161|NCT05134337|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993162|NCT05134337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993163|NCT05134337|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91993164|NCT05134337|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91993165|NCT05134337|Antitubercular Agents|antitubercular agents|mesh-ancestor
91993166|NCT05134337|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993167|NCT05134337|Leprostatic Agents|leprostatic agents|mesh-ancestor
91993168|NCT05134337|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91993169|NCT05134337|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91993170|NCT05134337|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91993171|NCT05134337|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91993172|NCT05134337|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91993173|NCT05134337|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91993174|NCT05134337|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91970275|NCT03070353|Dextrans|dextrans|mesh-list
91970276|NCT03070353|Anticoagulants|anticoagulants|mesh-ancestor
91970277|NCT03070353|Plasma Substitutes|plasma substitutes|mesh-ancestor
91970278|NCT03070353|Blood Substitutes|blood substitutes|mesh-ancestor
91993175|NCT04499495|Aminosalicylic Acid|aminosalicylic acid|mesh-list
91993176|NCT04499495|Mesalamine|mesalamine|mesh-list
91993177|NCT04499495|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91993178|NCT04499495|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91993179|NCT04499495|Analgesics|analgesics|mesh-ancestor
91993181|NCT04499495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993182|NCT04499495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993183|NCT04499495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993184|NCT04499495|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993185|NCT04499495|Antitubercular Agents|antitubercular agents|mesh-ancestor
91993186|NCT04499495|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993187|NCT04499495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993188|NCT05323175|Ropivacaine|ropivacaine|mesh-list
91993189|NCT05323175|Anesthetics, Local|anesthetics, local|mesh-ancestor
91993190|NCT05323175|Anesthetics|anesthetics|mesh-ancestor
91993191|NCT05323175|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993192|NCT05323175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993193|NCT05323175|Sensory System Agents|sensory system agents|mesh-ancestor
91993194|NCT05323175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993195|NCT05279963|Amitriptyline|amitriptyline|mesh-list
91993196|NCT05279963|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91993197|NCT05279963|Antidepressive Agents|antidepressive agents|mesh-ancestor
91993198|NCT05279963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91993199|NCT05279963|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91993200|NCT05279963|Analgesics|analgesics|mesh-ancestor
91993201|NCT05279963|Sensory System Agents|sensory system agents|mesh-ancestor
91993202|NCT05279963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993203|NCT05279963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993204|NCT05279963|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91993205|NCT05279963|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91993206|NCT05279963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993207|NCT05279963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993208|NCT05279963|Adrenergic Agents|adrenergic agents|mesh-ancestor
91993209|NCT05279963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993210|NCT05126693|Botulinum Toxins|botulinum toxins|mesh-list
91993211|NCT05126693|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91993212|NCT05126693|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993213|NCT05126693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993214|NCT05126693|Cholinergic Agents|cholinergic agents|mesh-ancestor
91993215|NCT05126693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993216|NCT05126693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993217|NCT05133791|Annexin A5|annexin a5|mesh-list
91993218|NCT05133791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993219|NCT05133791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993220|NCT05133635|Methylprednisolone|methylprednisolone|mesh-list
91993221|NCT05133635|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91993222|NCT05133635|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91993223|NCT05133635|Prednisolone|prednisolone|mesh-list
91993224|NCT05133635|Prednisolone acetate|prednisolone acetate|mesh-list
91993225|NCT05133635|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91993226|NCT05133635|Prednisolone phosphate|prednisolone phosphate|mesh-list
91993227|NCT05133635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993228|NCT05133635|Antiemetics|antiemetics|mesh-ancestor
91993229|NCT05133635|Autonomic Agents|autonomic agents|mesh-ancestor
91993230|NCT05133635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993231|NCT05133635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993232|NCT05133635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993233|NCT05133635|Glucocorticoids|glucocorticoids|mesh-ancestor
91993234|NCT05133635|Hormones|hormones|mesh-ancestor
91993235|NCT05133635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993236|NCT05133635|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91993237|NCT05133635|Protective Agents|protective agents|mesh-ancestor
91993238|NCT05133635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993239|NCT05133635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993240|NCT04219969|Deoxyglucose|deoxyglucose|mesh-list
91993241|NCT04219969|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91993242|NCT04219969|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91970279|NCT03073863|Atorvastatin|atorvastatin|mesh-list
91970280|NCT03073863|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91970281|NCT03073863|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91993243|NCT04219969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993244|NCT04219969|Antimetabolites|antimetabolites|mesh-ancestor
91993245|NCT04219969|Antiviral Agents|antiviral agents|mesh-ancestor
91993246|NCT04219969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993247|NCT05132777|Osimertinib|osimertinib|mesh-list
91993248|NCT05132777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993249|NCT05132777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993250|NCT05132777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993251|NCT05132777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993252|NCT05422027|Dexamethasone|dexamethasone|mesh-list
91993257|NCT05422027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993258|NCT05422027|Antiemetics|antiemetics|mesh-ancestor
91993259|NCT05422027|Autonomic Agents|autonomic agents|mesh-ancestor
91993260|NCT05422027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993261|NCT05422027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993262|NCT05422027|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993263|NCT05422027|Glucocorticoids|glucocorticoids|mesh-ancestor
91993264|NCT05422027|Hormones|hormones|mesh-ancestor
91993265|NCT05422027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993266|NCT05422027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993267|NCT05422027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993268|NCT05422027|Protease Inhibitors|protease inhibitors|mesh-ancestor
91993269|NCT05422027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993270|NCT05422027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993271|NCT05422027|Immunologic Factors|immunologic factors|mesh-ancestor
91993272|NCT05422027|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993273|NCT05422027|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993274|NCT05422027|Growth Substances|growth substances|mesh-ancestor
91993275|NCT05422027|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993276|NCT05072821|Botulinum Toxins|botulinum toxins|mesh-list
91993277|NCT05072821|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91993278|NCT05072821|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91993279|NCT05072821|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91993280|NCT05072821|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993281|NCT05072821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993282|NCT05072821|Cholinergic Agents|cholinergic agents|mesh-ancestor
91993283|NCT05072821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993284|NCT05072821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993285|NCT05072821|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91993286|NCT05072821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993287|NCT01674725|Ribavirin|ribavirin|mesh-list
91993288|NCT01674725|Antimetabolites|antimetabolites|mesh-ancestor
91993289|NCT01674725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993290|NCT01674725|Antiviral Agents|antiviral agents|mesh-ancestor
91993291|NCT01674725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993292|NCT05404061|Hormones|hormones|mesh-list
91993293|NCT05404061|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993294|NCT05404061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993295|NCT05051293|Testosterone|testosterone|mesh-list
91993296|NCT05051293|Estrogens|estrogens|mesh-list
91993297|NCT05051293|Androgens|androgens|mesh-ancestor
91993298|NCT05051293|Hormones|hormones|mesh-ancestor
91993299|NCT05051293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993300|NCT05051293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993301|NCT03161041|Bevacizumab|bevacizumab|mesh-list
91993302|NCT03161041|Oxaliplatin|oxaliplatin|mesh-list
91993303|NCT03161041|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993304|NCT03161041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993305|NCT03161041|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993306|NCT03161041|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993307|NCT03161041|Growth Substances|growth substances|mesh-ancestor
91993308|NCT03161041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993309|NCT03161041|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993310|NCT04139317|Pembrolizumab|pembrolizumab|mesh-list
91993311|NCT04139317|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993312|NCT04139317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993313|NCT04139317|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91993314|NCT04139317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970282|NCT03073863|Antimetabolites|antimetabolites|mesh-ancestor
91970283|NCT03073863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993315|NCT03163693|Dexmedetomidine|dexmedetomidine|mesh-list
91993316|NCT03163693|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91993317|NCT03163693|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993318|NCT03163693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993319|NCT03163693|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91993320|NCT03163693|Analgesics|analgesics|mesh-ancestor
91993321|NCT03163693|Sensory System Agents|sensory system agents|mesh-ancestor
91993322|NCT03163693|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993323|NCT03163693|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91993325|NCT03163693|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91993326|NCT03163693|Adrenergic Agents|adrenergic agents|mesh-ancestor
91993327|NCT03163693|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993328|NCT03163693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993330|NCT05030545|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
91993331|NCT05030545|Mineralocorticoids|mineralocorticoids|mesh-list
91993332|NCT05030545|Hormone Antagonists|hormone antagonists|mesh-ancestor
91993333|NCT05030545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993334|NCT05030545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993335|NCT05030545|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91993336|NCT05030545|Diuretics|diuretics|mesh-ancestor
91993337|NCT05030545|Natriuretic Agents|natriuretic agents|mesh-ancestor
91993338|NCT05030545|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91993339|NCT05030545|Hormones|hormones|mesh-ancestor
91993340|NCT03164161|Endorphins|endorphins|mesh-list
91993341|NCT03164161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993342|NCT03164161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993343|NCT03164161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993344|NCT00754949|Azithromycin|azithromycin|mesh-list
91993345|NCT00754949|Dexamethasone|dexamethasone|mesh-list
91993346|NCT00754949|Dexamethasone acetate|dexamethasone acetate|mesh-list
91993347|NCT00754949|BB 1101|bb 1101|mesh-list
91993348|NCT00754949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993349|NCT00754949|Antiemetics|antiemetics|mesh-ancestor
91993350|NCT00754949|Autonomic Agents|autonomic agents|mesh-ancestor
91993351|NCT00754949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993352|NCT00754949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993353|NCT00754949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993354|NCT00754949|Glucocorticoids|glucocorticoids|mesh-ancestor
91993355|NCT00754949|Hormones|hormones|mesh-ancestor
91993356|NCT00754949|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993357|NCT00754949|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993358|NCT00754949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993359|NCT00754949|Protease Inhibitors|protease inhibitors|mesh-ancestor
91993360|NCT00754949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993361|NCT00754949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993362|NCT00754949|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993363|NCT00754949|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993364|NCT03160807|Levofloxacin|levofloxacin|mesh-list
91993365|NCT03160807|Ofloxacin|ofloxacin|mesh-list
91993366|NCT03160807|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91993367|NCT03160807|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993368|NCT03160807|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993369|NCT03160807|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91993370|NCT03160807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91993371|NCT03160807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993372|NCT03160807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993373|NCT03160807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993374|NCT03160807|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91993375|NCT03160807|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91993376|NCT01674569|Ranibizumab|ranibizumab|mesh-list
91993377|NCT01674569|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993378|NCT01674569|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993379|NCT01674569|Growth Substances|growth substances|mesh-ancestor
91993380|NCT01674569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993381|NCT01674569|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993382|NCT01674569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993383|NCT03160729|Dexamethasone|dexamethasone|mesh-list
91993384|NCT03160729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993385|NCT03160729|Antiemetics|antiemetics|mesh-ancestor
91993386|NCT03160729|Autonomic Agents|autonomic agents|mesh-ancestor
91970284|NCT03073863|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92090448|NCT01903031|NuvaRing|nuvaring|mesh-list
91993387|NCT03160729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993388|NCT03160729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993389|NCT03160729|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993390|NCT03160729|Glucocorticoids|glucocorticoids|mesh-ancestor
91993391|NCT03160729|Hormones|hormones|mesh-ancestor
91993392|NCT03160729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993393|NCT03160729|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993394|NCT03160729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993395|NCT04439929|Adalimumab|adalimumab|mesh-list
91993396|NCT04439929|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91993401|NCT05131841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993402|NCT05131841|Tubulin Modulators|tubulin modulators|mesh-ancestor
91993403|NCT05131841|Antimitotic Agents|antimitotic agents|mesh-ancestor
91993404|NCT05131841|Mitosis Modulators|mitosis modulators|mesh-ancestor
91993405|NCT05131841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993407|NCT03163849|Antiviral Agents|antiviral agents|mesh-ancestor
91993408|NCT03163849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993409|NCT03163381|Apatinib|apatinib|mesh-list
91993410|NCT03163381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993411|NCT03163381|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993412|NCT03163381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993413|NCT03163381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993415|NCT05131295|Aluminum Hydroxide|aluminum hydroxide|mesh-list
91993416|NCT05131295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993417|NCT05131295|Antimalarials|antimalarials|mesh-ancestor
91993418|NCT05131295|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91993419|NCT05131295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91993420|NCT05131295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91993421|NCT05131295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993422|NCT05131295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993423|NCT05131295|Leprostatic Agents|leprostatic agents|mesh-ancestor
91993424|NCT05131295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993425|NCT05131295|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91993426|NCT05131295|Immunologic Factors|immunologic factors|mesh-ancestor
91993427|NCT05131295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993428|NCT05131295|Antacids|antacids|mesh-ancestor
91993429|NCT05131295|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993430|NCT01374217|Clarithromycin|clarithromycin|mesh-list
91993431|NCT01374217|Dexamethasone|dexamethasone|mesh-list
91993432|NCT01374217|Lenalidomide|lenalidomide|mesh-list
91993433|NCT01374217|Tadalafil|tadalafil|mesh-list
91993434|NCT01374217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993435|NCT01374217|Antiemetics|antiemetics|mesh-ancestor
91993436|NCT01374217|Autonomic Agents|autonomic agents|mesh-ancestor
91993437|NCT01374217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993438|NCT01374217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993439|NCT01374217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993440|NCT01374217|Glucocorticoids|glucocorticoids|mesh-ancestor
91993441|NCT01374217|Hormones|hormones|mesh-ancestor
91993442|NCT01374217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993443|NCT01374217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993444|NCT01374217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993445|NCT01374217|Immunologic Factors|immunologic factors|mesh-ancestor
91993446|NCT01374217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993447|NCT01374217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993448|NCT01374217|Growth Substances|growth substances|mesh-ancestor
91993449|NCT01374217|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993450|NCT01374217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993451|NCT01374217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993452|NCT01374217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91993453|NCT01374217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993454|NCT01374217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993455|NCT01374217|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91993456|NCT01374217|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91993457|NCT01374217|Vasodilator Agents|vasodilator agents|mesh-ancestor
91993458|NCT01374217|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91993459|NCT01374217|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91993460|NCT01374217|Urological Agents|urological agents|mesh-ancestor
91993462|NCT04494503|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993463|NCT04494503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970285|NCT03073863|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91970286|NCT03073863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970287|NCT02471963|Empagliflozin|empagliflozin|mesh-list
92090449|NCT01903031|Estradiol|estradiol|mesh-list
91993464|NCT04494503|Immunologic Factors|immunologic factors|mesh-ancestor
91993465|NCT04494503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993466|NCT04494503|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993467|NCT04941937|Thalidomide|thalidomide|mesh-list
91993471|NCT04941937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993472|NCT04941937|Antiemetics|antiemetics|mesh-ancestor
91993473|NCT04941937|Autonomic Agents|autonomic agents|mesh-ancestor
91993474|NCT04941937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993475|NCT04941937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993476|NCT04941937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993477|NCT04941937|Glucocorticoids|glucocorticoids|mesh-ancestor
91993478|NCT04941937|Hormones|hormones|mesh-ancestor
91993479|NCT04941937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993480|NCT04941937|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993481|NCT04941937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993482|NCT04941937|Immunologic Factors|immunologic factors|mesh-ancestor
91993483|NCT04941937|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993484|NCT04941937|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993485|NCT04941937|Growth Substances|growth substances|mesh-ancestor
91993486|NCT04941937|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993487|NCT04941937|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993488|NCT04941937|Leprostatic Agents|leprostatic agents|mesh-ancestor
91993489|NCT04941937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993490|NCT04941937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993491|NCT02959619|Ensartinib|ensartinib|mesh-list
91993492|NCT02959619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993493|NCT02959619|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993494|NCT02959619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993495|NCT02959619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993496|NCT04935931|Naltrexone|naltrexone|mesh-list
91993497|NCT04935931|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91993498|NCT04935931|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91993499|NCT04935931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993500|NCT04935931|Sensory System Agents|sensory system agents|mesh-ancestor
91993501|NCT04935931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993502|NCT05124431|Everolimus|everolimus|mesh-list
91993503|NCT05124431|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91993504|NCT05124431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993505|NCT05124431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993506|NCT05124431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993507|NCT05124431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993508|NCT05124431|Immunologic Factors|immunologic factors|mesh-ancestor
91993509|NCT05124431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993510|NCT05124431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993511|NCT04877275|Dexamethasone|dexamethasone|mesh-list
91993512|NCT04877275|Cyclophosphamide|cyclophosphamide|mesh-list
91993513|NCT04877275|Doxorubicin|doxorubicin|mesh-list
91993514|NCT04877275|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91993515|NCT04877275|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993516|NCT04877275|Immunologic Factors|immunologic factors|mesh-ancestor
91993517|NCT04877275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993518|NCT04877275|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993519|NCT04877275|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91993520|NCT04877275|Alkylating Agents|alkylating agents|mesh-ancestor
91993521|NCT04877275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993522|NCT04877275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993523|NCT04877275|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91993524|NCT04877275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993525|NCT04877275|Antiemetics|antiemetics|mesh-ancestor
91993526|NCT04877275|Autonomic Agents|autonomic agents|mesh-ancestor
91993527|NCT04877275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993528|NCT04877275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993529|NCT04877275|Glucocorticoids|glucocorticoids|mesh-ancestor
91993530|NCT04877275|Hormones|hormones|mesh-ancestor
91993531|NCT04877275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993532|NCT04877275|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993533|NCT04877275|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91993534|NCT04877275|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91993535|NCT04877275|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91993536|NCT04877275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993537|NCT04955249|Dexmedetomidine|dexmedetomidine|mesh-list
91993538|NCT04955249|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91993539|NCT04955249|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993540|NCT04955249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993543|NCT04955249|Sensory System Agents|sensory system agents|mesh-ancestor
91993544|NCT04955249|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993545|NCT04955249|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91993546|NCT04955249|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91993547|NCT04955249|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91993548|NCT04955249|Adrenergic Agents|adrenergic agents|mesh-ancestor
91993549|NCT04955249|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993550|NCT04955249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993551|NCT05676463|Ascorbic Acid|ascorbic acid|mesh-list
91993553|NCT05676463|Hormones|hormones|mesh-list
91993554|NCT05676463|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
91993555|NCT05676463|Androgens|androgens|mesh-list
91993556|NCT05676463|Androgen Antagonists|androgen antagonists|mesh-list
91993557|NCT05676463|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993558|NCT05676463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993559|NCT05676463|Antioxidants|antioxidants|mesh-ancestor
91993560|NCT05676463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993561|NCT05676463|Protective Agents|protective agents|mesh-ancestor
91993563|NCT05676463|Micronutrients|micronutrients|mesh-ancestor
91993564|NCT05676463|Estrogens|estrogens|mesh-ancestor
91993565|NCT05676463|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993566|NCT05676463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993567|NCT05676463|Anabolic Agents|anabolic agents|mesh-ancestor
91993568|NCT05676463|Hormone Antagonists|hormone antagonists|mesh-ancestor
91993569|NCT03114085|Capecitabine|capecitabine|mesh-list
91993570|NCT03114085|Apatinib|apatinib|mesh-list
91993571|NCT03114085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91993572|NCT03114085|Antimetabolites|antimetabolites|mesh-ancestor
91993573|NCT03114085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993574|NCT03114085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993575|NCT03114085|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993576|NCT03114085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993577|NCT04886453|Morphine|morphine|mesh-list
91993578|NCT04886453|Anesthetics|anesthetics|mesh-list
91993579|NCT04886453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993580|NCT04886453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993581|NCT04886453|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91993582|NCT04886453|Narcotics|narcotics|mesh-ancestor
91993583|NCT04886453|Analgesics|analgesics|mesh-ancestor
91993584|NCT04886453|Sensory System Agents|sensory system agents|mesh-ancestor
91993585|NCT04886453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993586|NCT05136521|Trazodone|trazodone|mesh-list
91993587|NCT05136521|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91993588|NCT05136521|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91993589|NCT05136521|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993590|NCT05136521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993591|NCT05136521|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91993592|NCT05136521|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91993593|NCT05136521|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91993594|NCT05136521|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993595|NCT05136521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993596|NCT05136521|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993597|NCT05136521|Serotonin Agents|serotonin agents|mesh-ancestor
91993598|NCT05136521|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91993599|NCT05136521|Antidepressive Agents|antidepressive agents|mesh-ancestor
91993600|NCT05343013|Trifluridine|trifluridine|mesh-list
91993601|NCT05343013|Antimetabolites|antimetabolites|mesh-ancestor
91993602|NCT05343013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993603|NCT05343013|Antiviral Agents|antiviral agents|mesh-ancestor
91993604|NCT05343013|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993605|NCT02388373|Fluticasone|fluticasone|mesh-list
91993607|NCT02388373|Formoterol Fumarate|formoterol fumarate|mesh-list
91993608|NCT02388373|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91993609|NCT02388373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993610|NCT02388373|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91993611|NCT02388373|Autonomic Agents|autonomic agents|mesh-ancestor
91970288|NCT02471963|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91993612|NCT02388373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993613|NCT02388373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993614|NCT02388373|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91993618|NCT02388373|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91993619|NCT02388373|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91993620|NCT02388373|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91993621|NCT02388373|Adrenergic Agents|adrenergic agents|mesh-ancestor
91993622|NCT02388373|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993623|NCT02388373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993624|NCT01674647|Vitamin K|vitamin k|mesh-list
91993625|NCT01674647|Rivaroxaban|rivaroxaban|mesh-list
91993626|NCT01674647|Vitamins|vitamins|mesh-ancestor
91993627|NCT01674647|Micronutrients|micronutrients|mesh-ancestor
91993628|NCT01674647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993629|NCT01674647|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91993630|NCT01674647|Antithrombins|antithrombins|mesh-ancestor
91993631|NCT01674647|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91993632|NCT01674647|Protease Inhibitors|protease inhibitors|mesh-ancestor
91993633|NCT01674647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993634|NCT01674647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993635|NCT01674647|Anticoagulants|anticoagulants|mesh-ancestor
91993636|NCT01674647|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91993637|NCT01674647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91993638|NCT01674647|Hemostatics|hemostatics|mesh-ancestor
91993639|NCT01674647|Coagulants|coagulants|mesh-ancestor
91993640|NCT02669407|Lidocaine|lidocaine|mesh-list
91993641|NCT02669407|Anesthetics, Local|anesthetics, local|mesh-list
91993642|NCT02669407|Anesthetics|anesthetics|mesh-list
91993643|NCT02669407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993644|NCT02669407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993645|NCT02669407|Sensory System Agents|sensory system agents|mesh-ancestor
91993646|NCT02669407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993647|NCT02669407|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91993648|NCT02669407|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91993649|NCT02669407|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91993650|NCT02669407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993651|NCT02669407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993652|NCT04909853|Ritonavir|ritonavir|mesh-list
91993653|NCT04909853|Nirmatrelvir|nirmatrelvir|mesh-list
91993654|NCT04909853|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91993655|NCT04909853|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91993656|NCT04909853|Protease Inhibitors|protease inhibitors|mesh-ancestor
91993657|NCT04909853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993658|NCT04909853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993659|NCT04909853|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91993660|NCT04909853|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91993661|NCT04909853|Antiviral Agents|antiviral agents|mesh-ancestor
91993662|NCT04909853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993663|NCT04909853|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91993664|NCT04909853|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91993666|NCT04637555|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91993667|NCT04637555|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91993668|NCT04637555|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91993669|NCT04637555|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91993670|NCT04637555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993671|NCT02388061|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91993672|NCT02388061|Plasminogen|plasminogen|mesh-list
91993673|NCT02388061|Tenecteplase|tenecteplase|mesh-list
91993674|NCT02388061|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91993675|NCT02388061|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91993676|NCT02388061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993677|NCT04556357|Phenylephrine|phenylephrine|mesh-list
91993678|NCT04556357|Oxymetazoline|oxymetazoline|mesh-list
91993679|NCT04556357|Norepinephrine|norepinephrine|mesh-list
91993680|NCT04556357|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
91993681|NCT04556357|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91993682|NCT04556357|Mydriatics|mydriatics|mesh-ancestor
91993683|NCT04556357|Autonomic Agents|autonomic agents|mesh-ancestor
91993684|NCT04556357|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970289|NCT02471963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970290|NCT02471963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91970291|NCT02471963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970292|NCT01375751|Evolocumab|evolocumab|mesh-list
91970293|NCT01375751|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91970294|NCT01375751|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91970295|NCT01375751|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91993685|NCT04556357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993686|NCT04556357|Sympathomimetics|sympathomimetics|mesh-ancestor
91993689|NCT04556357|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91993691|NCT04556357|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91993692|NCT04556357|Adrenergic Agents|adrenergic agents|mesh-ancestor
91993693|NCT04556357|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993694|NCT04556357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993695|NCT04556357|Protective Agents|protective agents|mesh-ancestor
91993696|NCT04553939|Gemcitabine|gemcitabine|mesh-list
91993697|NCT04553939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91993698|NCT04553939|Antimetabolites|antimetabolites|mesh-ancestor
91993699|NCT04553939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993700|NCT04553939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993701|NCT02790853|Proflavine|proflavine|mesh-list
91993702|NCT02790853|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91993703|NCT02790853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993705|NCT03113773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993706|NCT03113773|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91993707|NCT03113773|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91993708|NCT03113773|Antiviral Agents|antiviral agents|mesh-ancestor
91993709|NCT03113773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993710|NCT05306041|Inavolisib|inavolisib|mesh-list
91993711|NCT05306041|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
91993712|NCT05306041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993713|NCT05306041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993714|NCT04874831|Avelumab|avelumab|mesh-list
91993715|NCT04874831|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993716|NCT04874831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993717|NCT05122169|Iodine|iodine|mesh-list
91993718|NCT05122169|Chlorhexidine|chlorhexidine|mesh-list
91993719|NCT05122169|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91993720|NCT05122169|Povidone-Iodine|povidone-iodine|mesh-list
91993721|NCT05122169|Povidone|povidone|mesh-list
91993722|NCT05122169|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91993723|NCT05122169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993725|NCT05122169|Dermatologic Agents|dermatologic agents|mesh-ancestor
91993726|NCT05122169|Trace Elements|trace elements|mesh-ancestor
91993727|NCT05122169|Micronutrients|micronutrients|mesh-ancestor
91993728|NCT05122169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993729|NCT05122169|Plasma Substitutes|plasma substitutes|mesh-ancestor
91993730|NCT05122169|Blood Substitutes|blood substitutes|mesh-ancestor
91993731|NCT04359329|Estradiol|estradiol|mesh-list
91993732|NCT04359329|Estrogens|estrogens|mesh-ancestor
91993733|NCT04359329|Hormones|hormones|mesh-ancestor
91993734|NCT04359329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993735|NCT04359329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993736|NCT05403749|Aflibercept|aflibercept|mesh-list
91993737|NCT05403749|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993738|NCT05403749|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993739|NCT05403749|Growth Substances|growth substances|mesh-ancestor
91993740|NCT05403749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993741|NCT05403749|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993742|NCT05403749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993743|NCT04203875|Abatacept|abatacept|mesh-list
91993744|NCT04203875|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91993745|NCT04203875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993746|NCT04203875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993747|NCT04203875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970297|NCT01375751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970298|NCT01375751|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91993748|NCT04203875|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993749|NCT04203875|Immunologic Factors|immunologic factors|mesh-ancestor
91993750|NCT04203875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993751|NCT04203875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993752|NCT04491383|Tocovid|tocovid|mesh-list
91993753|NCT04491383|Vitamins|vitamins|mesh-ancestor
91993754|NCT04491383|Micronutrients|micronutrients|mesh-ancestor
91993755|NCT04491383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993756|NCT05900674|Reteplase|reteplase|mesh-list
91993757|NCT05900674|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91993758|NCT05900674|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91993759|NCT05900674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993761|NCT05900661|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
91993763|NCT05900661|Vitamins|vitamins|mesh-ancestor
91993764|NCT05900661|Micronutrients|micronutrients|mesh-ancestor
91993765|NCT05900661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993766|NCT05900661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91993767|NCT05900661|Immunologic Factors|immunologic factors|mesh-ancestor
91993768|NCT05900635|Lactoferrin|lactoferrin|mesh-list
91993769|NCT05900635|Glycine|glycine|mesh-list
91993770|NCT05900635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91993771|NCT05900635|Glycine Agents|glycine agents|mesh-ancestor
91993772|NCT05900635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993773|NCT05900635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993774|NCT05900635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993775|NCT05900531|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91993776|NCT05900531|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91993777|NCT05900531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993778|NCT05900531|Incretins|incretins|mesh-ancestor
91993779|NCT05900531|Hormones|hormones|mesh-ancestor
91993780|NCT05900531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993781|NCT05900531|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91993782|NCT05900531|Protease Inhibitors|protease inhibitors|mesh-ancestor
91993783|NCT05900531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993784|NCT05900531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993785|NCT05900401|Cyclophosphamide|cyclophosphamide|mesh-list
91993786|NCT05900401|Rituximab|rituximab|mesh-list
91993787|NCT05900401|Fludarabine|fludarabine|mesh-list
91993788|NCT05900401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993789|NCT05900401|Immunologic Factors|immunologic factors|mesh-ancestor
91993790|NCT05900401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993791|NCT05900401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993792|NCT05900401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91993793|NCT05900401|Alkylating Agents|alkylating agents|mesh-ancestor
91993794|NCT05900401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993795|NCT05900401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993796|NCT05900401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91993797|NCT05900401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993798|NCT05900349|Caffeine|caffeine|mesh-list
91993799|NCT05900349|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91993800|NCT05900349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993801|NCT05900349|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91993802|NCT05900349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993803|NCT05900349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993804|NCT05900349|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91993805|NCT05900349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91993806|NCT05900349|Purinergic Agents|purinergic agents|mesh-ancestor
91993807|NCT05900349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993808|NCT05900336|Naproxen|naproxen|mesh-list
91993809|NCT05900336|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91993810|NCT05900336|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91993811|NCT05900336|Analgesics|analgesics|mesh-ancestor
91993812|NCT05900336|Sensory System Agents|sensory system agents|mesh-ancestor
91993813|NCT05900336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993814|NCT05900336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993815|NCT05900336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993816|NCT05900336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970300|NCT01375751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970301|NCT01375751|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91970302|NCT05249621|Mannitol|mannitol|mesh-list
91993817|NCT05900336|Gout Suppressants|gout suppressants|mesh-ancestor
91993818|NCT05900336|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91993819|NCT05900336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993820|NCT05900336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993821|NCT05900258|Tirbanibulin|tirbanibulin|mesh-list
91993822|NCT05900258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993823|NCT05900258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993824|NCT05900245|Propofol|propofol|mesh-list
91993825|NCT05900245|Anesthetics|anesthetics|mesh-list
91993826|NCT05900245|Succinylcholine|succinylcholine|mesh-list
91993827|NCT05900245|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91993828|NCT05900245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993829|NCT05900245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993830|NCT05900245|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91993831|NCT05900245|Anesthetics, General|anesthetics, general|mesh-ancestor
91993832|NCT05900245|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
91993833|NCT05900245|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91993834|NCT05900245|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91993836|NCT05900232|Antibodies|antibodies|mesh-list
91993837|NCT05900232|Immunologic Factors|immunologic factors|mesh-ancestor
91993838|NCT05900232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993839|NCT05900219|Vemurafenib|vemurafenib|mesh-list
91993840|NCT05900219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993841|NCT05900219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993842|NCT05900219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993843|NCT05900219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993844|NCT05900206|Paclitaxel|paclitaxel|mesh-list
91993845|NCT05900206|Docetaxel|docetaxel|mesh-list
91993846|NCT05900206|Cyclophosphamide|cyclophosphamide|mesh-list
91993847|NCT05900206|Carboplatin|carboplatin|mesh-list
91993848|NCT05900206|Trastuzumab|trastuzumab|mesh-list
91993849|NCT05900206|Letrozole|letrozole|mesh-list
91993850|NCT05900206|Epirubicin|epirubicin|mesh-list
91993851|NCT05900206|Pertuzumab|pertuzumab|mesh-list
91993852|NCT05900206|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
91993853|NCT05900206|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91993854|NCT05900206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993855|NCT05900206|Tubulin Modulators|tubulin modulators|mesh-ancestor
91993856|NCT05900206|Antimitotic Agents|antimitotic agents|mesh-ancestor
91993857|NCT05900206|Mitosis Modulators|mitosis modulators|mesh-ancestor
91993858|NCT05900206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993859|NCT05900206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993860|NCT05900206|Immunologic Factors|immunologic factors|mesh-ancestor
91993861|NCT05900206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993862|NCT05900206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993863|NCT05900206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91993864|NCT05900206|Alkylating Agents|alkylating agents|mesh-ancestor
91993865|NCT05900206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91993866|NCT05900206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993867|NCT05900206|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91993868|NCT05900206|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91993869|NCT05900206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993870|NCT05900206|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91993871|NCT05900206|Hormone Antagonists|hormone antagonists|mesh-ancestor
91993872|NCT05900206|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993873|NCT05900206|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91993874|NCT05900206|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91993875|NCT05900206|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91993876|NCT05900206|Immunoconjugates|immunoconjugates|mesh-ancestor
91993877|NCT05899829|Rifampin|rifampin|mesh-list
91993878|NCT05899829|Rabeprazole|rabeprazole|mesh-list
91993879|NCT05899829|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91993880|NCT05899829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91993881|NCT05899829|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91993882|NCT05899829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993883|NCT05899829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993884|NCT05899829|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91993885|NCT05899829|Antitubercular Agents|antitubercular agents|mesh-ancestor
91993886|NCT05899829|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91993887|NCT05899829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970303|NCT05249621|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91970304|NCT05249621|Diuretics|diuretics|mesh-ancestor
91970305|NCT05249621|Natriuretic Agents|natriuretic agents|mesh-ancestor
91993888|NCT05899829|Leprostatic Agents|leprostatic agents|mesh-ancestor
91993889|NCT05899829|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91993890|NCT05899829|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91993891|NCT05899829|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91993892|NCT05899829|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91993893|NCT05899829|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91993894|NCT05899829|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91993895|NCT05899829|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91993896|NCT05899764|Brivaracetam|brivaracetam|mesh-list
91993897|NCT05899764|Anticonvulsants|anticonvulsants|mesh-ancestor
91993898|NCT05899751|Methotrexate|methotrexate|mesh-list
91993899|NCT05899751|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91993900|NCT05899751|Abortifacient Agents|abortifacient agents|mesh-ancestor
91993901|NCT05899751|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91993902|NCT05899751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993903|NCT05899751|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91993904|NCT05899751|Antimetabolites|antimetabolites|mesh-ancestor
91993905|NCT05899751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993906|NCT05899751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993907|NCT05899751|Dermatologic Agents|dermatologic agents|mesh-ancestor
91993908|NCT05899751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993910|NCT05899751|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993911|NCT05899751|Immunologic Factors|immunologic factors|mesh-ancestor
91993912|NCT05899751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993913|NCT05899751|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91993914|NCT05899621|Prednisone|prednisone|mesh-list
91993915|NCT05899621|Cyclophosphamide|cyclophosphamide|mesh-list
91993916|NCT05899621|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91993917|NCT05899621|Doxorubicin|doxorubicin|mesh-list
91993918|NCT05899621|Vincristine|vincristine|mesh-list
91993919|NCT05899621|Lenalidomide|lenalidomide|mesh-list
91993920|NCT05899621|Obinutuzumab|obinutuzumab|mesh-list
91993921|NCT05899621|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91993922|NCT05899621|Immunologic Factors|immunologic factors|mesh-ancestor
91993923|NCT05899621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993924|NCT05899621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993925|NCT05899621|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91993926|NCT05899621|Alkylating Agents|alkylating agents|mesh-ancestor
91993927|NCT05899621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993928|NCT05899621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993929|NCT05899621|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91993930|NCT05899621|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91993931|NCT05899621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91993932|NCT05899621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91993934|NCT05899621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993935|NCT05899621|Glucocorticoids|glucocorticoids|mesh-ancestor
91993937|NCT05899621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91993938|NCT05899621|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91993939|NCT05899621|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91993940|NCT05899621|Tubulin Modulators|tubulin modulators|mesh-ancestor
91993941|NCT05899621|Antimitotic Agents|antimitotic agents|mesh-ancestor
91993942|NCT05899621|Mitosis Modulators|mitosis modulators|mesh-ancestor
91993943|NCT05899621|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91993944|NCT05899621|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91993945|NCT05899621|Growth Substances|growth substances|mesh-ancestor
91993946|NCT05899621|Growth Inhibitors|growth inhibitors|mesh-ancestor
91993947|NCT05899621|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993948|NCT05899517|Oxytocin|oxytocin|mesh-list
91993949|NCT05899517|Oxytocics|oxytocics|mesh-ancestor
91993950|NCT05899517|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91993951|NCT05899517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993952|NCT05899465|Tranexamic Acid|tranexamic acid|mesh-list
91993953|NCT05899465|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91993954|NCT05899465|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91993955|NCT05899465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993956|NCT05899465|Hemostatics|hemostatics|mesh-ancestor
91970306|NCT05249621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970307|NCT00705575|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91970308|NCT00705575|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91993958|NCT05899127|Lidocaine|lidocaine|mesh-list
91993959|NCT05899127|Sufentanil|sufentanil|mesh-list
91993960|NCT05899127|Remifentanil|remifentanil|mesh-list
91993961|NCT05899127|Dsuvia|dsuvia|mesh-list
91993962|NCT05899127|Propofol|propofol|mesh-list
91993963|NCT05899127|Etomidate|etomidate|mesh-list
91993964|NCT05899127|Rocuronium|rocuronium|mesh-list
91993965|NCT05899127|Anesthetics, Local|anesthetics, local|mesh-ancestor
91993966|NCT05899127|Anesthetics|anesthetics|mesh-ancestor
91993967|NCT05899127|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91993968|NCT05899127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91993969|NCT05899127|Sensory System Agents|sensory system agents|mesh-ancestor
91993970|NCT05899127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993971|NCT05899127|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91993972|NCT05899127|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91993973|NCT05899127|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91993974|NCT05899127|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91993975|NCT05899127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993976|NCT05899127|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91993977|NCT05899127|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91993978|NCT05899127|Anesthetics, General|anesthetics, general|mesh-ancestor
91993979|NCT05899127|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91993980|NCT05899127|Narcotics|narcotics|mesh-ancestor
91993981|NCT05899127|Analgesics|analgesics|mesh-ancestor
91993982|NCT05899127|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91993983|NCT05899127|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91993984|NCT05899127|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91993985|NCT05899127|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91993989|NCT05899049|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91993990|NCT05899049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91993991|NCT05899049|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91993992|NCT05899049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91993993|NCT05899049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91993994|NCT05899049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91993995|NCT05898984|Beclomethasone|beclomethasone|mesh-list
91993996|NCT05898984|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91993997|NCT05898984|Glucocorticoids|glucocorticoids|mesh-ancestor
91993998|NCT05898984|Hormones|hormones|mesh-ancestor
91993999|NCT05898984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994000|NCT05898984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994001|NCT05898984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994002|NCT05898984|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994003|NCT05898763|Pembrolizumab|pembrolizumab|mesh-list
91994004|NCT05898763|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
91994005|NCT05898763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994006|NCT05898763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994007|NCT05898763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994008|NCT05898763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994009|NCT05898763|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91994010|NCT05898763|Immunologic Factors|immunologic factors|mesh-ancestor
91994011|NCT05898763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994012|NCT05898672|Ritonavir|ritonavir|mesh-list
91994013|NCT05898672|Nirmatrelvir|nirmatrelvir|mesh-list
91994014|NCT05898672|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
91994015|NCT05898672|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91994016|NCT05898672|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91994017|NCT05898672|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91994018|NCT05898672|Protease Inhibitors|protease inhibitors|mesh-ancestor
91994019|NCT05898672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994020|NCT05898672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994021|NCT05898672|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91994022|NCT05898672|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91994023|NCT05898672|Antiviral Agents|antiviral agents|mesh-ancestor
91994024|NCT05898672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994025|NCT05898672|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91994026|NCT05898672|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91994027|NCT05898672|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91994028|NCT05898672|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91970309|NCT00705575|Diuretics|diuretics|mesh-ancestor
91970310|NCT00705575|Natriuretic Agents|natriuretic agents|mesh-ancestor
91994029|NCT05898672|Antimetabolites|antimetabolites|mesh-ancestor
91994030|NCT05898672|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91994031|NCT05898672|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91994032|NCT05898633|Pulmonary Surfactants|pulmonary surfactants|mesh-list
91994033|NCT05898633|Pulmonary Surfactant-Associated Protein D|pulmonary surfactant-associated protein d|mesh-list
91994034|NCT05898633|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994035|NCT05898451|Cisplatin|cisplatin|mesh-list
91994036|NCT05898451|Dacarbazine|dacarbazine|mesh-list
91994037|NCT05898451|Lomustine|lomustine|mesh-list
91994038|NCT05898451|Thymalfasin|thymalfasin|mesh-list
91994039|NCT05898451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994040|NCT05898451|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994041|NCT05898451|Alkylating Agents|alkylating agents|mesh-ancestor
91994042|NCT05898451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994043|NCT05898451|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91994044|NCT05898451|Immunologic Factors|immunologic factors|mesh-ancestor
91994045|NCT05898451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994046|NCT05898373|Antineoplastic Agents|antineoplastic agents|mesh-list
91994047|NCT05898321|Goserelin|goserelin|mesh-list
91994048|NCT05898321|Mifepristone|mifepristone|mesh-list
91994049|NCT05898321|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91994050|NCT05898321|Abortifacient Agents|abortifacient agents|mesh-ancestor
91994051|NCT05898321|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91994052|NCT05898321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994053|NCT05898321|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91994054|NCT05898321|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91994055|NCT05898321|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91994056|NCT05898321|Contraceptive Agents|contraceptive agents|mesh-ancestor
91994057|NCT05898321|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91994061|NCT05898321|Luteolytic Agents|luteolytic agents|mesh-ancestor
91994062|NCT05898321|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91994063|NCT05898321|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91994064|NCT05898321|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994065|NCT05898321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994066|NCT05898308|Rituximab|rituximab|mesh-list
91994067|NCT05898308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994068|NCT05898308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994069|NCT05898308|Immunologic Factors|immunologic factors|mesh-ancestor
91994070|NCT05898308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994071|NCT05898308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994072|NCT05898256|Gemcitabine|gemcitabine|mesh-list
91994073|NCT05898256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994074|NCT05898256|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91994075|NCT05898256|Antimetabolites|antimetabolites|mesh-ancestor
91994076|NCT05898256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994077|NCT05898087|Bupivacaine|bupivacaine|mesh-list
91994078|NCT05898087|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91994079|NCT05898087|Anesthetics, Local|anesthetics, local|mesh-ancestor
91994081|NCT05898087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994082|NCT05898087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994083|NCT05898087|Sensory System Agents|sensory system agents|mesh-ancestor
91994084|NCT05898087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994085|NCT05898022|Furosemide|furosemide|mesh-list
91994086|NCT05898022|Diuretics|diuretics|mesh-ancestor
91994087|NCT05898022|Natriuretic Agents|natriuretic agents|mesh-ancestor
91994088|NCT05898022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994089|NCT05898022|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91994090|NCT05898022|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91994091|NCT05898022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994093|NCT05897918|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91994094|NCT05897918|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91994095|NCT05897918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994096|NCT05897918|Hemostatics|hemostatics|mesh-ancestor
91994097|NCT05897918|Coagulants|coagulants|mesh-ancestor
91994098|NCT05897034|Doxycycline|doxycycline|mesh-list
91994099|NCT05897034|Nitazoxanide|nitazoxanide|mesh-list
91994100|NCT05897034|Pentoxifylline|pentoxifylline|mesh-list
91994101|NCT05897034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91970311|NCT00705575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994102|NCT05897034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994103|NCT05897034|Antimalarials|antimalarials|mesh-ancestor
91994104|NCT05897034|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91994105|NCT05897034|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91994106|NCT05897034|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91994107|NCT05897034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994108|NCT05897034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994109|NCT05897034|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91994110|NCT05897034|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91994111|NCT05897034|Protective Agents|protective agents|mesh-ancestor
91994112|NCT05897034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994113|NCT05897034|Vasodilator Agents|vasodilator agents|mesh-ancestor
91994114|NCT05897034|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91994116|NCT05897008|Omalizumab|omalizumab|mesh-list
91994117|NCT05897008|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91994118|NCT05897008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994119|NCT05897008|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994120|NCT05892939|Oxytocin|oxytocin|mesh-list
91994121|NCT05892939|Oxytocics|oxytocics|mesh-ancestor
91994122|NCT05892939|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91994123|NCT05892939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994124|NCT05890534|Pycnogenols|pycnogenols|mesh-list
91994125|NCT05890534|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91994126|NCT05890534|Immunologic Factors|immunologic factors|mesh-ancestor
91994127|NCT05890534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994128|NCT05890534|Antioxidants|antioxidants|mesh-ancestor
91994129|NCT05890534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994135|NCT05888896|Autonomic Agents|autonomic agents|mesh-ancestor
91994136|NCT05888896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994137|NCT05888896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994138|NCT05888896|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91994139|NCT05888896|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91994140|NCT05888896|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91994141|NCT05888896|Adrenergic Agents|adrenergic agents|mesh-ancestor
91994142|NCT05888896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994143|NCT05888896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994144|NCT05886049|Cytarabine|cytarabine|mesh-list
91994145|NCT05886049|Daunorubicin|daunorubicin|mesh-list
91994146|NCT05886049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91994147|NCT05886049|Antimetabolites|antimetabolites|mesh-ancestor
91994148|NCT05886049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994149|NCT05886049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994150|NCT05886049|Antiviral Agents|antiviral agents|mesh-ancestor
91994151|NCT05886049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994152|NCT05886049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994153|NCT05886049|Immunologic Factors|immunologic factors|mesh-ancestor
91994154|NCT05886049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994155|NCT05886049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91994156|NCT05886049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91994157|NCT05886049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91994158|NCT05886049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994159|NCT05876754|Ivosidenib|ivosidenib|mesh-list
91994160|NCT05876754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994161|NCT05876754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994162|NCT05876754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994163|NCT05861765|Papaverine|papaverine|mesh-list
91994164|NCT05861765|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91994165|NCT05861765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994166|NCT05861765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994167|NCT05861765|Vasodilator Agents|vasodilator agents|mesh-ancestor
91994168|NCT05861765|Urological Agents|urological agents|mesh-ancestor
91994169|NCT05849207|Cyclophosphamide|cyclophosphamide|mesh-list
91994170|NCT05849207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994171|NCT05849207|Immunologic Factors|immunologic factors|mesh-ancestor
91994172|NCT05849207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994173|NCT05849207|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994174|NCT05849207|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994175|NCT05849207|Alkylating Agents|alkylating agents|mesh-ancestor
91994176|NCT05849207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970312|NCT00705575|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91970313|NCT00705575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970314|NCT00705575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970315|NCT03068247|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91970316|NCT03068247|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91994177|NCT05849207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994178|NCT05849207|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91994179|NCT05818618|Clobetasol|clobetasol|mesh-list
91994180|NCT05818618|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994181|NCT05818618|Glucocorticoids|glucocorticoids|mesh-ancestor
91994182|NCT05818618|Hormones|hormones|mesh-ancestor
91994183|NCT05818618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994184|NCT05818618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994185|NCT05809921|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91994186|NCT05809921|Tenecteplase|tenecteplase|mesh-list
91994187|NCT05809921|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91994188|NCT05809921|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91994189|NCT05809921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994190|NCT05804513|Lixisenatide|lixisenatide|mesh-list
91994191|NCT05804513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91994192|NCT05804513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994193|NCT05783219|Lidocaine|lidocaine|mesh-list
91994194|NCT05783219|Anesthetics, Local|anesthetics, local|mesh-ancestor
91994195|NCT05783219|Anesthetics|anesthetics|mesh-ancestor
91994196|NCT05783219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994197|NCT05783219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994198|NCT05783219|Sensory System Agents|sensory system agents|mesh-ancestor
91994199|NCT05783219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994211|NCT05765851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994212|NCT05747352|Insulin|insulin|mesh-list
91994213|NCT05747352|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91994214|NCT05747352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994215|NCT05746520|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91994216|NCT05746520|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91994217|NCT05746520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994218|NCT05746520|Antitubercular Agents|antitubercular agents|mesh-ancestor
91994220|NCT05741060|Phytoestrogens|phytoestrogens|mesh-ancestor
91994221|NCT05741060|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91994222|NCT05741060|Estrogens|estrogens|mesh-ancestor
91994223|NCT05741060|Hormones|hormones|mesh-ancestor
91994224|NCT05741060|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994225|NCT05741060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994226|NCT05733598|Bevacizumab|bevacizumab|mesh-list
91994227|NCT05733598|Atezolizumab|atezolizumab|mesh-list
91994228|NCT05733598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994229|NCT05733598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994230|NCT05733598|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91994231|NCT05733598|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91994232|NCT05733598|Growth Substances|growth substances|mesh-ancestor
91994233|NCT05733598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994234|NCT05733598|Growth Inhibitors|growth inhibitors|mesh-ancestor
91994235|NCT05733598|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92074265|NCT00074308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994236|NCT05733598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994237|NCT05733507|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91994238|NCT05733507|Tenecteplase|tenecteplase|mesh-list
91994239|NCT05733507|Tirofiban|tirofiban|mesh-list
91994240|NCT05733507|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91994241|NCT05733507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91994242|NCT05733507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994243|NCT05733507|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91994244|NCT05709444|Angiotensin II|angiotensin ii|mesh-list
91994245|NCT05709444|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
91994246|NCT05709444|alpha-MSH|alpha-msh|mesh-list
91994247|NCT05709444|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
91994248|NCT05709444|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91970317|NCT03068247|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91994249|NCT05709444|Protease Inhibitors|protease inhibitors|mesh-ancestor
91994250|NCT05709444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994251|NCT05709444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994253|NCT05709444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994254|NCT05709444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994255|NCT05704036|Estradiol|estradiol|mesh-list
91994256|NCT05704036|Estrogens|estrogens|mesh-list
91994257|NCT05704036|Progesterone|progesterone|mesh-list
91994258|NCT05704036|Hormones|hormones|mesh-ancestor
91994259|NCT05704036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994260|NCT05704036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994261|NCT05704036|Progestins|progestins|mesh-ancestor
91994272|NCT05668585|Trametinib|trametinib|mesh-list
91994276|NCT05668585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994277|NCT05658575|Dapansutrile|dapansutrile|mesh-list
91994278|NCT05658575|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994279|NCT05583110|Trastuzumab|trastuzumab|mesh-list
91994280|NCT05583110|Vinorelbine|vinorelbine|mesh-list
91994281|NCT05583110|Tucatinib|tucatinib|mesh-list
91994282|NCT05583110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994283|NCT05583110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994284|NCT05583110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91994285|NCT05583110|Tubulin Modulators|tubulin modulators|mesh-ancestor
91994286|NCT05583110|Antimitotic Agents|antimitotic agents|mesh-ancestor
91994287|NCT05583110|Mitosis Modulators|mitosis modulators|mesh-ancestor
91994288|NCT05583110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994289|NCT05583110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994290|NCT05583110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994291|NCT05565937|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91994292|NCT05537935|Naltrexone|naltrexone|mesh-list
91994293|NCT05537935|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91994294|NCT05537935|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91994295|NCT05537935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994296|NCT05537935|Sensory System Agents|sensory system agents|mesh-ancestor
91994297|NCT05537935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994298|NCT05522673|Rolipram|rolipram|mesh-list
91994299|NCT05522673|Antidepressive Agents|antidepressive agents|mesh-ancestor
91994300|NCT05522673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91994301|NCT05522673|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
91994302|NCT05522673|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91994303|NCT05522673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994304|NCT05522673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994305|NCT05478499|Deucravacitinib|deucravacitinib|mesh-list
91994306|NCT05478499|Dermatologic Agents|dermatologic agents|mesh-ancestor
91994307|NCT05478499|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994308|NCT05478499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994309|NCT05478499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994310|NCT05456256|Carboplatin|carboplatin|mesh-list
91994311|NCT05456256|Pemetrexed|pemetrexed|mesh-list
91994312|NCT05456256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994313|NCT05456256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994314|NCT05456256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994315|NCT05456256|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91994316|NCT05456256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91994317|NCT05455697|Prednisone|prednisone|mesh-list
91994318|NCT05455697|Cyclophosphamide|cyclophosphamide|mesh-list
91994319|NCT05455697|Rituximab|rituximab|mesh-list
91994320|NCT05455697|Doxorubicin|doxorubicin|mesh-list
91994321|NCT05455697|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91994322|NCT05455697|Vincristine|vincristine|mesh-list
91994323|NCT05455697|Daunorubicin|daunorubicin|mesh-list
91994324|NCT05455697|Immunoglobulins|immunoglobulins|mesh-list
91994325|NCT05455697|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91994326|NCT05455697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994327|NCT05455697|Immunologic Factors|immunologic factors|mesh-ancestor
91994328|NCT05455697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994329|NCT05455697|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994330|NCT05455697|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994331|NCT05455697|Alkylating Agents|alkylating agents|mesh-ancestor
91994332|NCT05455697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994333|NCT05455697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970318|NCT03068247|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970319|NCT03068247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994335|NCT05455697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994336|NCT05455697|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91994337|NCT05455697|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91994338|NCT05455697|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91994339|NCT05455697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994340|NCT05455697|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994341|NCT05455697|Glucocorticoids|glucocorticoids|mesh-ancestor
91994342|NCT05455697|Hormones|hormones|mesh-ancestor
91994343|NCT05455697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994344|NCT05455697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994347|NCT05455697|Antimitotic Agents|antimitotic agents|mesh-ancestor
91994348|NCT05455697|Mitosis Modulators|mitosis modulators|mesh-ancestor
91994349|NCT05455697|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91994351|NCT05411679|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91994352|NCT05411679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994353|NCT05411679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994354|NCT05411679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994355|NCT05407636|Aflibercept|aflibercept|mesh-list
91994356|NCT05407636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91994357|NCT05407636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91994358|NCT05407636|Growth Substances|growth substances|mesh-ancestor
91994359|NCT05407636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994360|NCT05407636|Growth Inhibitors|growth inhibitors|mesh-ancestor
91994361|NCT05407636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994362|NCT05406479|Bedaquiline|bedaquiline|mesh-list
91994363|NCT05406479|Antitubercular Agents|antitubercular agents|mesh-ancestor
91994364|NCT05406479|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91994365|NCT05406479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994366|NCT05384665|Sufentanil|sufentanil|mesh-list
91994367|NCT05384665|Remifentanil|remifentanil|mesh-list
91994368|NCT05384665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91994369|NCT05384665|Narcotics|narcotics|mesh-ancestor
91994370|NCT05384665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994371|NCT05384665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994372|NCT05384665|Analgesics|analgesics|mesh-ancestor
91994373|NCT05384665|Sensory System Agents|sensory system agents|mesh-ancestor
91994374|NCT05384665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994375|NCT05384665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91994376|NCT05384665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91994377|NCT05384665|Anesthetics, General|anesthetics, general|mesh-ancestor
91994378|NCT05384665|Anesthetics|anesthetics|mesh-ancestor
91994379|NCT05363319|Cemiplimab|cemiplimab|mesh-list
91994380|NCT05363319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994381|NCT05363319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994382|NCT05325281|Thioctic Acid|thioctic acid|mesh-list
91994383|NCT05325281|Gemcitabine|gemcitabine|mesh-list
91994384|NCT05325281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91994385|NCT05325281|Antimetabolites|antimetabolites|mesh-ancestor
91994386|NCT05325281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994387|NCT05325281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994388|NCT05325281|Antioxidants|antioxidants|mesh-ancestor
91994389|NCT05325281|Protective Agents|protective agents|mesh-ancestor
91994390|NCT05325281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994391|NCT05325281|Vitamin B Complex|vitamin b complex|mesh-ancestor
91994392|NCT05325281|Vitamins|vitamins|mesh-ancestor
91994393|NCT05325281|Micronutrients|micronutrients|mesh-ancestor
91994394|NCT05260008|Epinephrine|epinephrine|mesh-list
91994395|NCT05260008|Bupivacaine|bupivacaine|mesh-list
91994396|NCT05260008|Anesthetics, Local|anesthetics, local|mesh-ancestor
91994397|NCT05260008|Anesthetics|anesthetics|mesh-ancestor
91994398|NCT05260008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994399|NCT05260008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994400|NCT05260008|Sensory System Agents|sensory system agents|mesh-ancestor
91994401|NCT05260008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994402|NCT05260008|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91994403|NCT05260008|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91994404|NCT05260008|Adrenergic Agents|adrenergic agents|mesh-ancestor
91994405|NCT05260008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994406|NCT05260008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970320|NCT03068247|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970321|NCT03068247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970323|NCT03068247|Sensory System Agents|sensory system agents|mesh-ancestor
91970324|NCT03068247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970325|NCT03068247|Antidepressive Agents|antidepressive agents|mesh-ancestor
91970326|NCT03068247|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91970327|NCT03068247|Dopamine Agents|dopamine agents|mesh-ancestor
91970328|NCT03108833|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91970329|NCT03108833|Saruplase|saruplase|mesh-list
91970330|NCT03108833|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91970332|NCT03108833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970333|NCT02636361|Insulin Lispro|insulin lispro|mesh-list
91970334|NCT02636361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91970335|NCT02636361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970336|NCT02636283|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91970337|NCT02636283|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91970338|NCT02636283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970339|NCT04450953|Eplerenone|eplerenone|mesh-list
91994407|NCT05260008|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91994408|NCT05260008|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91994409|NCT05260008|Autonomic Agents|autonomic agents|mesh-ancestor
91994410|NCT05260008|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994411|NCT05260008|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994412|NCT05260008|Mydriatics|mydriatics|mesh-ancestor
91994413|NCT05260008|Sympathomimetics|sympathomimetics|mesh-ancestor
91994414|NCT05260008|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91994415|NCT05254275|Chlorhexidine|chlorhexidine|mesh-list
91994416|NCT05254275|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91994417|NCT05254275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994418|NCT05254275|Disinfectants|disinfectants|mesh-ancestor
91994419|NCT05220046|Psilocybin|psilocybin|mesh-list
91994422|NCT05220046|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91994423|NCT05204927|Prednisone|prednisone|mesh-list
91994424|NCT05204927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994425|NCT05204927|Glucocorticoids|glucocorticoids|mesh-ancestor
91994426|NCT05204927|Hormones|hormones|mesh-ancestor
91994427|NCT05204927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994428|NCT05204927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994429|NCT05204927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994430|NCT05204927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994431|NCT05193994|Lamivudine|lamivudine|mesh-list
91994432|NCT05193994|Abacavir|abacavir|mesh-list
91994433|NCT05193994|Dolutegravir|dolutegravir|mesh-list
91994434|NCT05193994|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91994435|NCT05193994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91994436|NCT05193994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994437|NCT05193994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994439|NCT05193994|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994440|NCT05193994|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91994441|NCT05193994|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91994442|NCT05193994|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91994443|NCT05193994|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91994444|NCT05191784|Bevacizumab|bevacizumab|mesh-list
91994445|NCT05191784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970340|NCT04450953|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
91970341|NCT04450953|Hormone Antagonists|hormone antagonists|mesh-ancestor
91994446|NCT05191784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994447|NCT05191784|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91994448|NCT05191784|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91994449|NCT05191784|Growth Substances|growth substances|mesh-ancestor
91994450|NCT05191784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994451|NCT05191784|Growth Inhibitors|growth inhibitors|mesh-ancestor
91994452|NCT05177263|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91994453|NCT05159934|Nicotine|nicotine|mesh-list
91994454|NCT05159934|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91994455|NCT05159934|Autonomic Agents|autonomic agents|mesh-ancestor
91994456|NCT05159934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994457|NCT05159934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994458|NCT05159934|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91994459|NCT05159934|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91994460|NCT05159934|Cholinergic Agents|cholinergic agents|mesh-ancestor
91994461|NCT05159934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994462|NCT05159934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994463|NCT05137717|Maribavir|maribavir|mesh-list
91994464|NCT05137717|Antiviral Agents|antiviral agents|mesh-ancestor
91994465|NCT05137717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994466|NCT05077709|Pembrolizumab|pembrolizumab|mesh-list
91994467|NCT05077709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994468|NCT05077709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994469|NCT05077709|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994470|NCT05077709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994471|NCT05020821|Dexmedetomidine|dexmedetomidine|mesh-list
91994472|NCT05020821|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91994473|NCT05020821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994474|NCT05020821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994475|NCT05020821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91994476|NCT05020821|Analgesics|analgesics|mesh-ancestor
91994477|NCT05020821|Sensory System Agents|sensory system agents|mesh-ancestor
91994478|NCT05020821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994479|NCT05020821|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91994480|NCT05020821|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91994481|NCT05020821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91994482|NCT05020821|Adrenergic Agents|adrenergic agents|mesh-ancestor
91994483|NCT05020821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994484|NCT05020821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994485|NCT05020665|Cytarabine|cytarabine|mesh-list
91994486|NCT05020665|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91994487|NCT05020665|Antimetabolites|antimetabolites|mesh-ancestor
91994488|NCT05020665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994489|NCT05020665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994490|NCT05020665|Antiviral Agents|antiviral agents|mesh-ancestor
91994491|NCT05020665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994494|NCT05020665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994496|NCT04996264|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
91994497|NCT04996264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994498|NCT04996264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994499|NCT04941716|Venetoclax|venetoclax|mesh-list
91994500|NCT04941716|Acalabrutinib|acalabrutinib|mesh-list
91994501|NCT04941716|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
91994502|NCT04941716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994503|NCT04941716|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994504|NCT04941716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994505|NCT04941716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994506|NCT04911062|Epinephrine|epinephrine|mesh-list
91994507|NCT04911062|Bupivacaine|bupivacaine|mesh-list
91994508|NCT04911062|Anesthetics, Local|anesthetics, local|mesh-ancestor
91994509|NCT04911062|Anesthetics|anesthetics|mesh-ancestor
91994510|NCT04911062|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994511|NCT04911062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994512|NCT04911062|Sensory System Agents|sensory system agents|mesh-ancestor
91994513|NCT04911062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994514|NCT04911062|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91994515|NCT04911062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970342|NCT04450953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970343|NCT04450953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970344|NCT04450953|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91970345|NCT04450953|Diuretics|diuretics|mesh-ancestor
91994516|NCT04911062|Adrenergic Agents|adrenergic agents|mesh-ancestor
91994517|NCT04911062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994518|NCT04911062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994519|NCT04911062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91994520|NCT04911062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91994521|NCT04911062|Autonomic Agents|autonomic agents|mesh-ancestor
91994522|NCT04911062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994523|NCT04911062|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994524|NCT04911062|Mydriatics|mydriatics|mesh-ancestor
91994525|NCT04911062|Sympathomimetics|sympathomimetics|mesh-ancestor
91994526|NCT04911062|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91994527|NCT04892472|Pembrolizumab|pembrolizumab|mesh-list
91994528|NCT04892472|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994529|NCT04892472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994530|NCT04892472|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994531|NCT04892472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994532|NCT04818749|Dexamethasone|dexamethasone|mesh-list
91994533|NCT04818749|Dexamethasone acetate|dexamethasone acetate|mesh-list
91994534|NCT04818749|Dexmedetomidine|dexmedetomidine|mesh-list
91994535|NCT04818749|BB 1101|bb 1101|mesh-list
91994536|NCT04818749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994537|NCT04818749|Antiemetics|antiemetics|mesh-ancestor
91994538|NCT04818749|Autonomic Agents|autonomic agents|mesh-ancestor
91994539|NCT04818749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994540|NCT04818749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994541|NCT04818749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91994542|NCT04818749|Glucocorticoids|glucocorticoids|mesh-ancestor
91994543|NCT04818749|Hormones|hormones|mesh-ancestor
91994544|NCT04818749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994545|NCT04818749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994546|NCT04818749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994547|NCT04818749|Protease Inhibitors|protease inhibitors|mesh-ancestor
91994548|NCT04818749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994549|NCT04818749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994550|NCT04818749|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91994551|NCT04818749|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994552|NCT04818749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91994553|NCT04818749|Analgesics|analgesics|mesh-ancestor
91994554|NCT04818749|Sensory System Agents|sensory system agents|mesh-ancestor
91994555|NCT04818749|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91994556|NCT04818749|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91994557|NCT04818749|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91994558|NCT04818749|Adrenergic Agents|adrenergic agents|mesh-ancestor
91994559|NCT04818749|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994560|NCT04776395|Dexamethasone|dexamethasone|mesh-list
91994561|NCT04776395|Dexamethasone acetate|dexamethasone acetate|mesh-list
91994562|NCT04776395|Ichthammol|ichthammol|mesh-list
91994563|NCT04776395|BB 1101|bb 1101|mesh-list
91994564|NCT04776395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994568|NCT04776395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994569|NCT04776395|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91994570|NCT04776395|Glucocorticoids|glucocorticoids|mesh-ancestor
91994571|NCT04776395|Hormones|hormones|mesh-ancestor
91994572|NCT04776395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994573|NCT04776395|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994574|NCT04776395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994575|NCT04776395|Protease Inhibitors|protease inhibitors|mesh-ancestor
91994576|NCT04776395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994577|NCT04776395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994578|NCT04776395|Dermatologic Agents|dermatologic agents|mesh-ancestor
91994579|NCT04738643|Varenicline|varenicline|mesh-list
91994580|NCT04738643|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91994581|NCT04738643|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91994582|NCT04738643|Cholinergic Agents|cholinergic agents|mesh-ancestor
91994583|NCT04738643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970346|NCT04450953|Natriuretic Agents|natriuretic agents|mesh-ancestor
91970347|NCT04450953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91970348|NCT04983849|Metronidazole|metronidazole|mesh-list
91970349|NCT04983849|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970350|NCT04983849|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91970351|NCT04983849|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91994584|NCT04738643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994585|NCT04738643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994587|NCT04733534|Quercetin|quercetin|mesh-list
91994588|NCT04733534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994589|NCT04733534|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994590|NCT04733534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994591|NCT04733534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994592|NCT04733534|Antioxidants|antioxidants|mesh-ancestor
91994593|NCT04733534|Protective Agents|protective agents|mesh-ancestor
91994594|NCT04733534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994595|NCT04704661|Trastuzumab|trastuzumab|mesh-list
91994596|NCT04704661|Camptothecin|camptothecin|mesh-list
91994597|NCT04704661|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
91994598|NCT04704661|Immunoconjugates|immunoconjugates|mesh-list
91994599|NCT04704661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994600|NCT04704661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994601|NCT04704661|Immunologic Factors|immunologic factors|mesh-ancestor
91994602|NCT04704661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994603|NCT04704661|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91994604|NCT04704661|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91994605|NCT04704661|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91994606|NCT04704661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994607|NCT04704661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994608|NCT04588688|Mifepristone|mifepristone|mesh-list
91994609|NCT04588688|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91994610|NCT04588688|Abortifacient Agents|abortifacient agents|mesh-ancestor
91994611|NCT04588688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91994612|NCT04588688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994613|NCT04588688|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91994614|NCT04588688|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91994615|NCT04588688|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91994616|NCT04588688|Contraceptive Agents|contraceptive agents|mesh-ancestor
91994617|NCT04588688|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91994618|NCT04588688|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91994619|NCT04588688|Hormone Antagonists|hormone antagonists|mesh-ancestor
91994620|NCT04588688|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994621|NCT04588688|Luteolytic Agents|luteolytic agents|mesh-ancestor
91994622|NCT04588688|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91994623|NCT04588688|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91994624|NCT04587830|Temozolomide|temozolomide|mesh-list
91994625|NCT04587830|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994626|NCT04587830|Alkylating Agents|alkylating agents|mesh-ancestor
91994627|NCT04587830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994628|NCT04587830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994629|NCT04558281|Ropivacaine|ropivacaine|mesh-list
91994630|NCT04558281|Anesthetics, Local|anesthetics, local|mesh-ancestor
91994631|NCT04558281|Anesthetics|anesthetics|mesh-ancestor
91994632|NCT04558281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91994633|NCT04558281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994634|NCT04558281|Sensory System Agents|sensory system agents|mesh-ancestor
91994641|NCT04498468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994642|NCT04498468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91994643|NCT04498468|Glucocorticoids|glucocorticoids|mesh-ancestor
91994644|NCT04498468|Hormones|hormones|mesh-ancestor
91994645|NCT04498468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994646|NCT04498468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994647|NCT04498468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994651|NCT04401267|Antihypertensive Agents|antihypertensive agents|mesh-list
91994652|NCT04343222|Bromfenac|bromfenac|mesh-list
91994653|NCT04343222|Lubricant Eye Drops|lubricant eye drops|mesh-list
91970352|NCT04983849|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92074266|NCT00074308|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91970353|NCT02474303|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
91970354|NCT02474303|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91970355|NCT02474303|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91970356|NCT02474303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970357|NCT02474303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970358|NCT02474303|Antiviral Agents|antiviral agents|mesh-ancestor
91970359|NCT02474303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970360|NCT02474303|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91970361|NCT02474303|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91970362|NCT02474225|Bevacizumab|bevacizumab|mesh-list
91970363|NCT02474225|Ranibizumab|ranibizumab|mesh-list
91970364|NCT02474225|Endothelial Growth Factors|endothelial growth factors|mesh-list
91994654|NCT04343222|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
91994655|NCT04343222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91994656|NCT04343222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91994657|NCT04343222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91994658|NCT04343222|Analgesics|analgesics|mesh-ancestor
91994659|NCT04343222|Sensory System Agents|sensory system agents|mesh-ancestor
91994660|NCT04343222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994661|NCT04343222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994662|NCT04343222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994663|NCT04343222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994664|NCT04342039|Budesonide|budesonide|mesh-list
91994665|NCT04342039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994666|NCT04342039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91994667|NCT04342039|Autonomic Agents|autonomic agents|mesh-ancestor
91994668|NCT04342039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994669|NCT04342039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994670|NCT04342039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994671|NCT04342039|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994672|NCT04342039|Glucocorticoids|glucocorticoids|mesh-ancestor
91994673|NCT04342039|Hormones|hormones|mesh-ancestor
91994674|NCT04342039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994675|NCT04311671|Ivermectin|ivermectin|mesh-list
91994676|NCT04311671|Albendazole|albendazole|mesh-list
91994677|NCT04311671|Moxidectin|moxidectin|mesh-list
91994678|NCT04311671|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91994679|NCT04311671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994680|NCT04311671|Anthelmintics|anthelmintics|mesh-ancestor
91994681|NCT04311671|Anticestodal Agents|anticestodal agents|mesh-ancestor
91994682|NCT04311671|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91994683|NCT04311671|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91994684|NCT04311671|Tubulin Modulators|tubulin modulators|mesh-ancestor
91994685|NCT04311671|Antimitotic Agents|antimitotic agents|mesh-ancestor
91994686|NCT04311671|Mitosis Modulators|mitosis modulators|mesh-ancestor
91994687|NCT04311671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994688|NCT04311671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994689|NCT04311671|Antinematodal Agents|antinematodal agents|mesh-ancestor
91994691|NCT04281108|Xhance|xhance|mesh-list
91994692|NCT04281108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994693|NCT04281108|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91994694|NCT04281108|Autonomic Agents|autonomic agents|mesh-ancestor
91994695|NCT04281108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994696|NCT04281108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994697|NCT04281108|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994698|NCT04281108|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994699|NCT04281108|Dermatologic Agents|dermatologic agents|mesh-ancestor
91994700|NCT04281108|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91994701|NCT04268849|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
91970365|NCT02474225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970366|NCT02474225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970367|NCT02474225|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91994703|NCT04268849|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91994704|NCT04268849|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91994705|NCT04258046|Trametinib|trametinib|mesh-list
91994706|NCT04258046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994707|NCT04258046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994708|NCT04258046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994709|NCT04258046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994714|NCT04230265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994715|NCT04230265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994716|NCT04230265|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994717|NCT04230265|Alkylating Agents|alkylating agents|mesh-ancestor
91994718|NCT04230265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994719|NCT04230265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994720|NCT04230265|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91994722|NCT04215978|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994723|NCT04215978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994724|NCT04210115|Calcium, Dietary|calcium, dietary|mesh-list
91994725|NCT04210115|Leucovorin|leucovorin|mesh-list
91994726|NCT04210115|Pembrolizumab|pembrolizumab|mesh-list
91994727|NCT04210115|Oxaliplatin|oxaliplatin|mesh-list
91994728|NCT04210115|Calcium|calcium|mesh-list
91994729|NCT04210115|Levoleucovorin|levoleucovorin|mesh-list
91994730|NCT04210115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994731|NCT04210115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994732|NCT04210115|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994733|NCT04210115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994734|NCT04210115|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91994735|NCT04210115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994736|NCT04210115|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91994737|NCT04210115|Antidotes|antidotes|mesh-ancestor
91994738|NCT04210115|Protective Agents|protective agents|mesh-ancestor
91994739|NCT04210115|Vitamin B Complex|vitamin b complex|mesh-ancestor
91994740|NCT04210115|Vitamins|vitamins|mesh-ancestor
91994741|NCT04210115|Micronutrients|micronutrients|mesh-ancestor
91994742|NCT04189055|Irinotecan|irinotecan|mesh-list
91994743|NCT04189055|Cetuximab|cetuximab|mesh-list
91994744|NCT04189055|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91994745|NCT04189055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91994746|NCT04189055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994747|NCT04189055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994748|NCT04189055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994749|NCT04189055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994750|NCT04147806|Dexamethasone|dexamethasone|mesh-list
91994751|NCT04147806|Tamsulosin|tamsulosin|mesh-list
91994752|NCT04147806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994753|NCT04147806|Antiemetics|antiemetics|mesh-ancestor
91994754|NCT04147806|Autonomic Agents|autonomic agents|mesh-ancestor
91994755|NCT04147806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994756|NCT04147806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994757|NCT04147806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91994758|NCT04147806|Glucocorticoids|glucocorticoids|mesh-ancestor
91994759|NCT04147806|Hormones|hormones|mesh-ancestor
91994760|NCT04147806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994761|NCT04147806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994762|NCT04147806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994763|NCT04147806|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91994764|NCT04147806|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91994765|NCT04147806|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91994766|NCT04147806|Adrenergic Agents|adrenergic agents|mesh-ancestor
91994767|NCT04147806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994768|NCT04147806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994769|NCT04147806|Urological Agents|urological agents|mesh-ancestor
91994770|NCT04122625|Nivolumab|nivolumab|mesh-list
91994771|NCT04122625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994772|NCT04122625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994773|NCT04122625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91970368|NCT02474225|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91970369|NCT02474225|Growth Substances|growth substances|mesh-ancestor
91970370|NCT02474225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970371|NCT02474225|Growth Inhibitors|growth inhibitors|mesh-ancestor
91994774|NCT04122625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994775|NCT04117945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91994776|NCT04117945|Cetuximab|cetuximab|mesh-list
91994777|NCT04117945|Panitumumab|panitumumab|mesh-list
91994778|NCT04117945|Irinotecan|irinotecan|mesh-list
91994779|NCT04117945|Antibodies|antibodies|mesh-list
91994780|NCT04117945|Immunoglobulins|immunoglobulins|mesh-list
91994781|NCT04117945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91994785|NCT04117945|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91994786|NCT04117945|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91994787|NCT04117945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994788|NCT04117945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994789|NCT04097561|Belimumab|belimumab|mesh-list
91994790|NCT04097561|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994791|NCT04097561|Immunologic Factors|immunologic factors|mesh-ancestor
91994792|NCT04097561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994793|NCT04077346|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
91994794|NCT04077346|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91994795|NCT04077346|Immunologic Factors|immunologic factors|mesh-ancestor
91994796|NCT04077346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994797|NCT04076462|Octreotide|octreotide|mesh-list
91994798|NCT04076462|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91994799|NCT04076462|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994800|NCT04076462|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994801|NCT04066348|Etanercept|etanercept|mesh-list
91994802|NCT04066348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91994803|NCT04066348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91994804|NCT04066348|Analgesics|analgesics|mesh-ancestor
91994805|NCT04066348|Sensory System Agents|sensory system agents|mesh-ancestor
91994806|NCT04066348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994807|NCT04066348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994808|NCT04066348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994809|NCT04066348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994810|NCT04066348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91994811|NCT04066348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994812|NCT04066348|Immunologic Factors|immunologic factors|mesh-ancestor
91994813|NCT04057898|Ibudilast|ibudilast|mesh-list
91994814|NCT04057898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91994815|NCT04057898|Autonomic Agents|autonomic agents|mesh-ancestor
91994816|NCT04057898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994889|NCT03766581|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91994817|NCT04057898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994818|NCT04057898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91994819|NCT04057898|Respiratory System Agents|respiratory system agents|mesh-ancestor
91994820|NCT04057898|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91994821|NCT04057898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994822|NCT04057898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994823|NCT04057898|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91994824|NCT04057898|Vasodilator Agents|vasodilator agents|mesh-ancestor
91994825|NCT04044313|Lenvatinib|lenvatinib|mesh-list
91994826|NCT04044313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994827|NCT04044313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994828|NCT04044313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994829|NCT04044313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994830|NCT04032990|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
91994831|NCT04032990|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91994832|NCT04032990|Immunologic Factors|immunologic factors|mesh-ancestor
91994833|NCT04032990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994834|NCT03847428|Bevacizumab|bevacizumab|mesh-list
91994835|NCT03847428|Durvalumab|durvalumab|mesh-list
91994836|NCT03847428|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994837|NCT03847428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994838|NCT03847428|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91994839|NCT03847428|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91994840|NCT03847428|Growth Substances|growth substances|mesh-ancestor
91994841|NCT03847428|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970373|NCT04448873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91970374|NCT04448873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970375|NCT04448873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91970376|NCT04448873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994842|NCT03847428|Growth Inhibitors|growth inhibitors|mesh-ancestor
91994843|NCT03828201|Levofloxacin|levofloxacin|mesh-list
91994844|NCT03828201|Linezolid|linezolid|mesh-list
91994845|NCT03828201|Bedaquiline|bedaquiline|mesh-list
91994846|NCT03828201|Clofazimine|clofazimine|mesh-list
91994847|NCT03828201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91994848|NCT03828201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994849|NCT03828201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91994850|NCT03828201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91994851|NCT03828201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91994852|NCT03828201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994854|NCT03828201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994855|NCT03828201|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91994856|NCT03828201|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91994857|NCT03828201|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91994858|NCT03828201|Antitubercular Agents|antitubercular agents|mesh-ancestor
91994859|NCT03828201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994860|NCT03828201|Leprostatic Agents|leprostatic agents|mesh-ancestor
91994862|NCT03824704|Rucaparib|rucaparib|mesh-list
91994863|NCT03824704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994864|NCT03824704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994865|NCT03824704|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994866|NCT03824704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994867|NCT03824704|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91994868|NCT03824704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994869|NCT03798106|Durvalumab|durvalumab|mesh-list
91994870|NCT03798106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994871|NCT03798106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994872|NCT03767075|Atezolizumab|atezolizumab|mesh-list
91994873|NCT03767075|Amivantamab-vmjw|amivantamab-vmjw|mesh-list
91994874|NCT03767075|Futibatinib|futibatinib|mesh-list
91994875|NCT03767075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994876|NCT03767075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994877|NCT03767075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994878|NCT03767075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994879|NCT03766581|Aspirin|aspirin|mesh-list
91994880|NCT03766581|Clopidogrel|clopidogrel|mesh-list
91994881|NCT03766581|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91994882|NCT03766581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91994883|NCT03766581|Analgesics|analgesics|mesh-ancestor
91994884|NCT03766581|Sensory System Agents|sensory system agents|mesh-ancestor
91994885|NCT03766581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994886|NCT03766581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994887|NCT03766581|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994888|NCT03766581|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994890|NCT03766581|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91994891|NCT03766581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994892|NCT03766581|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91994893|NCT03766581|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91994894|NCT03766581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994895|NCT03766581|Antipyretics|antipyretics|mesh-ancestor
91994896|NCT03766581|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91994897|NCT03766581|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91994898|NCT03766581|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91994899|NCT03766581|Purinergic Agents|purinergic agents|mesh-ancestor
91994900|NCT03766581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91994901|NCT03702725|Dexamethasone|dexamethasone|mesh-list
91994902|NCT03702725|Lenalidomide|lenalidomide|mesh-list
91994903|NCT03702725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994904|NCT03702725|Antiemetics|antiemetics|mesh-ancestor
91994905|NCT03702725|Autonomic Agents|autonomic agents|mesh-ancestor
91994906|NCT03702725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994907|NCT03702725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994908|NCT03702725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91970378|NCT04448873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970379|NCT04448873|Immunologic Factors|immunologic factors|mesh-ancestor
91970380|NCT04448873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994909|NCT03702725|Glucocorticoids|glucocorticoids|mesh-ancestor
91994910|NCT03702725|Hormones|hormones|mesh-ancestor
91994911|NCT03702725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994912|NCT03702725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91994913|NCT03702725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994914|NCT03702725|Immunologic Factors|immunologic factors|mesh-ancestor
91994915|NCT03702725|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91994916|NCT03702725|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91994917|NCT03702725|Growth Substances|growth substances|mesh-ancestor
91994918|NCT03702725|Growth Inhibitors|growth inhibitors|mesh-ancestor
91994919|NCT03670966|Mycophenolic Acid|mycophenolic acid|mesh-list
91994920|NCT03670966|Cyclophosphamide|cyclophosphamide|mesh-list
91994921|NCT03670966|Fludarabine|fludarabine|mesh-list
91994922|NCT03670966|Fludarabine phosphate|fludarabine phosphate|mesh-list
91994923|NCT03670966|Tacrolimus|tacrolimus|mesh-list
91994924|NCT03670966|Antibodies|antibodies|mesh-list
91994925|NCT03670966|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91994930|NCT03670966|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91994931|NCT03670966|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994932|NCT03670966|Alkylating Agents|alkylating agents|mesh-ancestor
91994933|NCT03670966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994934|NCT03670966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994935|NCT03670966|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91994936|NCT03670966|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91994937|NCT03670966|Antimetabolites|antimetabolites|mesh-ancestor
91994938|NCT03670966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994939|NCT03670966|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91994940|NCT03670966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994941|NCT03670966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91994942|NCT03670966|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91994943|NCT03670966|Antitubercular Agents|antitubercular agents|mesh-ancestor
91994944|NCT03670966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91994945|NCT03670966|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91994946|NCT03653247|Plerixafor|plerixafor|mesh-list
91994947|NCT03653247|Busulfan|busulfan|mesh-list
91994948|NCT03653247|Alkylating Agents|alkylating agents|mesh-ancestor
91994949|NCT03653247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994950|NCT03653247|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994951|NCT03653247|Immunologic Factors|immunologic factors|mesh-ancestor
91994952|NCT03653247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994953|NCT03653247|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91994954|NCT03653247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994955|NCT03653247|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91994956|NCT03653247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91994957|NCT03653247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91994958|NCT03653247|Antiviral Agents|antiviral agents|mesh-ancestor
91994959|NCT03653247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994960|NCT03635983|Nivolumab|nivolumab|mesh-list
91994961|NCT03635983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994962|NCT03635983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994963|NCT03635983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994964|NCT03635983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994965|NCT03527745|Albendazole|albendazole|mesh-list
91994966|NCT03527745|Anthelmintics|anthelmintics|mesh-ancestor
91994967|NCT03527745|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91994968|NCT03527745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91994969|NCT03527745|Anticestodal Agents|anticestodal agents|mesh-ancestor
91994970|NCT03527745|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
91994971|NCT03527745|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91994972|NCT03527745|Tubulin Modulators|tubulin modulators|mesh-ancestor
91994973|NCT03527745|Antimitotic Agents|antimitotic agents|mesh-ancestor
91994974|NCT03527745|Mitosis Modulators|mitosis modulators|mesh-ancestor
91994975|NCT03527745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994976|NCT03527745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994977|NCT03522584|Durvalumab|durvalumab|mesh-list
91994978|NCT03522584|Ipilimumab|ipilimumab|mesh-list
91994979|NCT03522584|Tremelimumab|tremelimumab|mesh-list
91994980|NCT03522584|Immunoglobulins|immunoglobulins|mesh-list
91970381|NCT04430855|Upadacitinib|upadacitinib|mesh-list
91970382|NCT04430855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91994981|NCT03522584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91994982|NCT03522584|Immunoglobulin G|immunoglobulin g|mesh-list
91994983|NCT03522584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994984|NCT03522584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994985|NCT03522584|Immunologic Factors|immunologic factors|mesh-ancestor
91994986|NCT03522584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994987|NCT03522584|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994988|NCT03522584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994990|NCT03377361|Ipilimumab|ipilimumab|mesh-list
91994991|NCT03377361|Trametinib|trametinib|mesh-list
91994992|NCT03377361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994993|NCT03377361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994994|NCT03377361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91994995|NCT03377361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995000|NCT03330405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91995001|NCT03330405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995002|NCT03330405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995003|NCT03330405|Immunologic Factors|immunologic factors|mesh-ancestor
91995004|NCT03330405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995005|NCT03330405|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91995006|NCT03330405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995007|NCT03330405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995009|NCT03284463|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91995010|NCT03284463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995011|NCT03223103|Poly ICLC|poly iclc|mesh-list
91995012|NCT03223103|Interferon Inducers|interferon inducers|mesh-ancestor
91995013|NCT03223103|Immunologic Factors|immunologic factors|mesh-ancestor
91995014|NCT03223103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995015|NCT03215030|Dexamethasone|dexamethasone|mesh-list
91995016|NCT03215030|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995017|NCT03215030|Antiemetics|antiemetics|mesh-ancestor
91995018|NCT03215030|Autonomic Agents|autonomic agents|mesh-ancestor
91995019|NCT03215030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995020|NCT03215030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995021|NCT03215030|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995022|NCT03215030|Glucocorticoids|glucocorticoids|mesh-ancestor
91995023|NCT03215030|Hormones|hormones|mesh-ancestor
91995024|NCT03215030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995025|NCT03215030|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995026|NCT03215030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995027|NCT03174782|Bupivacaine|bupivacaine|mesh-list
91995028|NCT03174782|Anesthetics, Local|anesthetics, local|mesh-ancestor
91995029|NCT03174782|Anesthetics|anesthetics|mesh-ancestor
91995030|NCT03174782|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995031|NCT03174782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995032|NCT03174782|Sensory System Agents|sensory system agents|mesh-ancestor
91995033|NCT03174782|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995034|NCT03128034|Cyclosporine|cyclosporine|mesh-list
91995035|NCT03128034|Mycophenolic Acid|mycophenolic acid|mesh-list
91995036|NCT03128034|Fludarabine|fludarabine|mesh-list
91995037|NCT03128034|Fludarabine phosphate|fludarabine phosphate|mesh-list
91995038|NCT03128034|Cyclosporins|cyclosporins|mesh-list
91995039|NCT03128034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995040|NCT03128034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995041|NCT03128034|Antimetabolites|antimetabolites|mesh-ancestor
91995042|NCT03128034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995043|NCT03128034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995044|NCT03128034|Immunologic Factors|immunologic factors|mesh-ancestor
91995194|NCT01176006|Fludarabine phosphate|fludarabine phosphate|mesh-list
91995045|NCT03128034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995046|NCT03128034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995047|NCT03128034|Antifungal Agents|antifungal agents|mesh-ancestor
91995048|NCT03128034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995049|NCT03128034|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995050|NCT03128034|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995051|NCT03128034|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91995052|NCT03128034|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91995053|NCT03128034|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91995054|NCT03128034|Antitubercular Agents|antitubercular agents|mesh-ancestor
91995055|NCT03128034|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91970383|NCT04430855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91970384|NCT04430855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970385|NCT04430855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970386|NCT04430855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970387|NCT02471105|Bimatoprost|bimatoprost|mesh-list
91995056|NCT03064490|Pembrolizumab|pembrolizumab|mesh-list
91995057|NCT03064490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995058|NCT03064490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995059|NCT03064490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91995060|NCT03064490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995062|NCT02953509|Magrolimab|magrolimab|mesh-list
91995063|NCT02953509|Gemcitabine|gemcitabine|mesh-list
91995064|NCT02953509|Oxaliplatin|oxaliplatin|mesh-list
91995065|NCT02953509|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995066|NCT02953509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995067|NCT02953509|Immunologic Factors|immunologic factors|mesh-ancestor
91995072|NCT02953509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995073|NCT02919969|Pembrolizumab|pembrolizumab|mesh-list
91995074|NCT02919969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995075|NCT02919969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995076|NCT02919969|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91995077|NCT02919969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995078|NCT02837263|Pembrolizumab|pembrolizumab|mesh-list
91995079|NCT02837263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995080|NCT02837263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995081|NCT02837263|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91995082|NCT02837263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995083|NCT02670707|Cytarabine|cytarabine|mesh-list
91995084|NCT02670707|Prednisone|prednisone|mesh-list
91995085|NCT02670707|Vinblastine|vinblastine|mesh-list
91995086|NCT02670707|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995087|NCT02670707|Glucocorticoids|glucocorticoids|mesh-ancestor
91995088|NCT02670707|Hormones|hormones|mesh-ancestor
91995089|NCT02670707|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995090|NCT02670707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995091|NCT02670707|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995092|NCT02670707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995093|NCT02670707|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995094|NCT02670707|Antimetabolites|antimetabolites|mesh-ancestor
91995095|NCT02670707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995096|NCT02670707|Antiviral Agents|antiviral agents|mesh-ancestor
91995097|NCT02670707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995098|NCT02670707|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995099|NCT02670707|Immunologic Factors|immunologic factors|mesh-ancestor
91995100|NCT02670707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91995101|NCT02670707|Tubulin Modulators|tubulin modulators|mesh-ancestor
91995102|NCT02670707|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995103|NCT02670707|Mitosis Modulators|mitosis modulators|mesh-ancestor
91995104|NCT02616640|Dexamethasone|dexamethasone|mesh-list
91995106|NCT02616640|Pomalidomide|pomalidomide|mesh-list
91995107|NCT02616640|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995108|NCT02616640|Antiemetics|antiemetics|mesh-ancestor
91995109|NCT02616640|Autonomic Agents|autonomic agents|mesh-ancestor
91995110|NCT02616640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995111|NCT02616640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995112|NCT02616640|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995113|NCT02616640|Glucocorticoids|glucocorticoids|mesh-ancestor
91995114|NCT02616640|Hormones|hormones|mesh-ancestor
91995115|NCT02616640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995116|NCT02616640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995117|NCT02616640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995118|NCT02616640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995119|NCT02616640|Immunologic Factors|immunologic factors|mesh-ancestor
91995120|NCT02616640|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91995121|NCT02616640|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91995122|NCT02616640|Growth Substances|growth substances|mesh-ancestor
91995123|NCT02616640|Growth Inhibitors|growth inhibitors|mesh-ancestor
91970388|NCT02471105|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91995124|NCT02352883|Hormones|hormones|mesh-list
91995125|NCT02352883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995126|NCT02352883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995127|NCT02270632|Methotrexate|methotrexate|mesh-list
91995128|NCT02270632|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91995129|NCT02270632|Abortifacient Agents|abortifacient agents|mesh-ancestor
91995130|NCT02270632|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91995131|NCT02270632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995132|NCT02270632|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995133|NCT02270632|Antimetabolites|antimetabolites|mesh-ancestor
91995134|NCT02270632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995135|NCT02270632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995136|NCT02270632|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995137|NCT02270632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995138|NCT02270632|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91995139|NCT02270632|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995140|NCT02270632|Immunologic Factors|immunologic factors|mesh-ancestor
91995141|NCT02270632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995142|NCT02270632|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91995143|NCT02003209|Carboplatin|carboplatin|mesh-list
91995145|NCT02003209|Trastuzumab|trastuzumab|mesh-list
91995146|NCT02003209|Pertuzumab|pertuzumab|mesh-list
91995147|NCT02003209|Goserelin|goserelin|mesh-list
91995148|NCT02003209|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
91995149|NCT02003209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
91995150|NCT02003209|Antibodies|antibodies|mesh-list
91995151|NCT02003209|Immunoglobulins|immunoglobulins|mesh-list
91995152|NCT02003209|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91995153|NCT02003209|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91995154|NCT02003209|Immunologic Factors|immunologic factors|mesh-ancestor
91995155|NCT02003209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995156|NCT02003209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995157|NCT02003209|Tubulin Modulators|tubulin modulators|mesh-ancestor
91995158|NCT02003209|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995159|NCT02003209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074267|NCT00074308|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91995160|NCT02003209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995161|NCT02003209|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995162|NCT02003209|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91995163|NCT02003209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995164|NCT02003209|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91995165|NCT02003209|Hormone Antagonists|hormone antagonists|mesh-ancestor
91995166|NCT02003209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995167|NCT01968109|Nivolumab|nivolumab|mesh-list
91995168|NCT01968109|Relatlimab|relatlimab|mesh-list
91995169|NCT01968109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995170|NCT01968109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995171|NCT01968109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91995172|NCT01968109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995173|NCT01891344|Rucaparib|rucaparib|mesh-list
91995174|NCT01891344|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91995175|NCT01891344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995176|NCT01891344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995177|NCT01891344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995178|NCT01828099|Carboplatin|carboplatin|mesh-list
91995179|NCT01828099|Pemetrexed|pemetrexed|mesh-list
91995180|NCT01828099|Ceritinib|ceritinib|mesh-list
91995181|NCT01828099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995182|NCT01828099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995183|NCT01828099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995184|NCT01828099|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91995185|NCT01828099|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91995186|NCT01828099|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995187|NCT01188096|Poly ICLC|poly iclc|mesh-list
91995188|NCT01188096|Interferon Inducers|interferon inducers|mesh-ancestor
91995189|NCT01188096|Immunologic Factors|immunologic factors|mesh-ancestor
91995190|NCT01188096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995191|NCT01176006|Cyclophosphamide|cyclophosphamide|mesh-list
91995192|NCT01176006|Busulfan|busulfan|mesh-list
91995193|NCT01176006|Fludarabine|fludarabine|mesh-list
91970390|NCT03108989|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91970391|NCT03108989|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970392|NCT03108989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970393|NCT03108989|Cholinergic Agents|cholinergic agents|mesh-ancestor
91970394|NCT03108989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970395|NCT03108989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970396|NCT03108989|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91970398|NCT03108989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970399|NCT02473601|Mivacurium|mivacurium|mesh-list
91970400|NCT02473601|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91970401|NCT02473601|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91970402|NCT02473601|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91970403|NCT02473601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970404|NCT02473601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970405|NCT04359017|Lidocaine|lidocaine|mesh-list
91995195|NCT01176006|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995196|NCT01176006|Immunologic Factors|immunologic factors|mesh-ancestor
91995197|NCT01176006|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995198|NCT01176006|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995199|NCT01176006|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91995200|NCT01176006|Alkylating Agents|alkylating agents|mesh-ancestor
91995201|NCT01176006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995202|NCT01176006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995203|NCT01176006|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91995204|NCT01176006|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995205|NCT01176006|Antimetabolites|antimetabolites|mesh-ancestor
91995207|NCT01121588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995208|NCT01121588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995209|NCT01121588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995210|NCT01121588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995211|NCT00632853|Carboplatin|carboplatin|mesh-list
91995212|NCT00632853|Etoposide|etoposide|mesh-list
91995213|NCT00632853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995215|NCT00632853|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91995216|NCT00632853|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91995217|NCT00632853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995218|NCT00632853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995219|NCT00579826|Letrozole|letrozole|mesh-list
91995220|NCT00579826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995221|NCT00579826|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91995222|NCT00579826|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91995223|NCT00579826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995224|NCT00579826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995225|NCT00579826|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91995226|NCT00579826|Hormone Antagonists|hormone antagonists|mesh-ancestor
91995227|NCT00579826|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995228|NCT00579826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995229|NCT00106691|Toremifene|toremifene|mesh-list
91995230|NCT00106691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995231|NCT00106691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995232|NCT00106691|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91995233|NCT00106691|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91995234|NCT00106691|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970406|NCT04359017|Anesthetics, Local|anesthetics, local|mesh-ancestor
91970407|NCT04359017|Anesthetics|anesthetics|mesh-ancestor
91995235|NCT00106691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995236|NCT00106691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995237|NCT00106691|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91995238|NCT04576325|Voriconazole|voriconazole|mesh-list
91995239|NCT04576325|Antifungal Agents|antifungal agents|mesh-ancestor
91995240|NCT04576325|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995241|NCT04576325|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91995242|NCT04576325|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91995243|NCT04576325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995244|NCT04576325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995245|NCT04576325|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91995246|NCT04576325|Hormone Antagonists|hormone antagonists|mesh-ancestor
91995247|NCT04576325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995248|NCT04576325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995249|NCT04576325|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91995250|NCT03126617|Elotuzumab|elotuzumab|mesh-list
91995251|NCT03126617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995252|NCT04422743|Tramiprosate|tramiprosate|mesh-list
91995253|NCT04422743|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
91995254|NCT04422743|Nootropic Agents|nootropic agents|mesh-ancestor
91995255|NCT04422743|Anticonvulsants|anticonvulsants|mesh-ancestor
91995256|NCT04422743|GABA Agonists|gaba agonists|mesh-ancestor
91995257|NCT04422743|GABA Agents|gaba agents|mesh-ancestor
91995258|NCT04422743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995259|NCT04422743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995260|NCT04422743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995261|NCT02535221|Epirubicin|epirubicin|mesh-list
91995262|NCT02535221|Goserelin|goserelin|mesh-list
91995263|NCT02535221|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91995264|NCT02535221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995265|NCT02535221|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91995266|NCT02535221|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91995267|NCT02535221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995268|NCT02535221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995269|NCT02535221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995270|NCT00000587|Epoetin Alfa|epoetin alfa|mesh-list
91995271|NCT00000587|Hematinics|hematinics|mesh-ancestor
91995272|NCT04592159|Nabiximols|nabiximols|mesh-list
91995273|NCT04592159|Analgesics|analgesics|mesh-ancestor
91995274|NCT04592159|Sensory System Agents|sensory system agents|mesh-ancestor
91995275|NCT04592159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995276|NCT04592159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995277|NCT05137145|Linaclotide|linaclotide|mesh-list
91995278|NCT05137145|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
91995279|NCT05137145|Enzyme Activators|enzyme activators|mesh-ancestor
91995280|NCT05137145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995281|NCT05137145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995282|NCT04419389|Rituximab|rituximab|mesh-list
91995283|NCT04419389|Venetoclax|venetoclax|mesh-list
91995284|NCT04419389|Acalabrutinib|acalabrutinib|mesh-list
91995285|NCT04419389|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995289|NCT04419389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995290|NCT05304845|Aspirin|aspirin|mesh-list
91995291|NCT05304845|Fexuprazan|fexuprazan|mesh-list
91995292|NCT05304845|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91995293|NCT05304845|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995294|NCT05304845|Analgesics|analgesics|mesh-ancestor
91995295|NCT05304845|Sensory System Agents|sensory system agents|mesh-ancestor
91995296|NCT05304845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995297|NCT05304845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995298|NCT05304845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995299|NCT05304845|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995300|NCT05304845|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91995301|NCT05304845|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91995302|NCT05304845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995303|NCT05304845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91995304|NCT05304845|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91995305|NCT05304845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995306|NCT05304845|Antipyretics|antipyretics|mesh-ancestor
91995307|NCT05304845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995308|NCT05303597|Lidocaine|lidocaine|mesh-list
91970408|NCT04359017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074268|NCT00074308|Growth Substances|growth substances|mesh-ancestor
91970409|NCT04359017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995309|NCT05303597|Anesthetics, Local|anesthetics, local|mesh-ancestor
91995310|NCT05303597|Anesthetics|anesthetics|mesh-ancestor
91995311|NCT05303597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995312|NCT05303597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995313|NCT05303597|Sensory System Agents|sensory system agents|mesh-ancestor
91995314|NCT05303597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995315|NCT05303597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91995316|NCT05303597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91995317|NCT05303597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91995318|NCT05303597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91995319|NCT05303597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995320|NCT04892459|Vaccines|vaccines|mesh-list
91995321|NCT04892459|Immunologic Factors|immunologic factors|mesh-ancestor
91995322|NCT04892459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995323|NCT04881539|Cannabidiol|cannabidiol|mesh-list
91995324|NCT04881539|Anticonvulsants|anticonvulsants|mesh-ancestor
91995325|NCT05303285|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91995326|NCT05303285|Immunologic Factors|immunologic factors|mesh-ancestor
91995327|NCT05303285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995328|NCT04280939|Anesthetics|anesthetics|mesh-list
91995329|NCT04280939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995330|NCT04280939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995331|NCT04489589|Midodrine|midodrine|mesh-list
91995332|NCT04489589|Sympathomimetics|sympathomimetics|mesh-ancestor
91995333|NCT04489589|Autonomic Agents|autonomic agents|mesh-ancestor
91995334|NCT04489589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995335|NCT04489589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995336|NCT04489589|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91995337|NCT04489589|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
91995338|NCT04489589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91995339|NCT04489589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91995340|NCT04489589|Adrenergic Agents|adrenergic agents|mesh-ancestor
91995341|NCT04489589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995342|NCT04489589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995343|NCT04328441|BCG Vaccine|bcg vaccine|mesh-list
91995344|NCT04328441|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91995345|NCT04328441|Immunologic Factors|immunologic factors|mesh-ancestor
91995346|NCT04328441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995347|NCT04314713|Scopolamine|scopolamine|mesh-list
91995348|NCT04314713|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
91995349|NCT04314713|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91995350|NCT04314713|Antiemetics|antiemetics|mesh-ancestor
91995351|NCT04314713|Autonomic Agents|autonomic agents|mesh-ancestor
91995352|NCT04314713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995353|NCT04314713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995354|NCT04314713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995355|NCT04314713|Mydriatics|mydriatics|mesh-ancestor
91995356|NCT04314713|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91995357|NCT04314713|Cholinergic Agents|cholinergic agents|mesh-ancestor
91995358|NCT04314713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995359|NCT04314713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995360|NCT04314713|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91995361|NCT04314713|Parasympatholytics|parasympatholytics|mesh-ancestor
91995362|NCT04121507|Cyclophosphamide|cyclophosphamide|mesh-list
91995364|NCT04121507|Fludarabine|fludarabine|mesh-list
91995365|NCT04121507|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995366|NCT04121507|Immunologic Factors|immunologic factors|mesh-ancestor
91995367|NCT04121507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995368|NCT04121507|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995369|NCT04121507|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91995370|NCT04121507|Alkylating Agents|alkylating agents|mesh-ancestor
91995371|NCT04121507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995372|NCT04121507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995373|NCT04121507|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91995374|NCT04719221|Evolocumab|evolocumab|mesh-list
91995375|NCT04719221|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91995376|NCT04719221|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91970410|NCT04359017|Sensory System Agents|sensory system agents|mesh-ancestor
91970411|NCT04359017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995377|NCT04719221|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995378|NCT04719221|Antimetabolites|antimetabolites|mesh-ancestor
91995379|NCT04719221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995380|NCT04719221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91995381|NCT04719221|Protease Inhibitors|protease inhibitors|mesh-ancestor
91995382|NCT04719221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995383|NCT04719221|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995384|NCT03790397|Osimertinib|osimertinib|mesh-list
91995385|NCT03790397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995386|NCT03790397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995387|NCT03790397|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995388|NCT03790397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995389|NCT03718559|Edoxaban|edoxaban|mesh-list
91995390|NCT03718559|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
91995391|NCT03718559|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91995392|NCT03718559|Antithrombins|antithrombins|mesh-ancestor
91995393|NCT03718559|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91995394|NCT03718559|Protease Inhibitors|protease inhibitors|mesh-ancestor
91995395|NCT03718559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995396|NCT03718559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995397|NCT03718559|Anticoagulants|anticoagulants|mesh-ancestor
91995398|NCT01228331|Cytarabine|cytarabine|mesh-list
91995399|NCT01228331|Dexamethasone|dexamethasone|mesh-list
91995400|NCT01228331|Methylprednisolone|methylprednisolone|mesh-list
91995401|NCT01228331|Cyclophosphamide|cyclophosphamide|mesh-list
91995402|NCT01228331|Doxorubicin|doxorubicin|mesh-list
91995403|NCT01228331|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91995404|NCT01228331|Methotrexate|methotrexate|mesh-list
91995405|NCT01228331|Etoposide|etoposide|mesh-list
91995406|NCT01228331|Vincristine|vincristine|mesh-list
91995407|NCT01228331|Daunorubicin|daunorubicin|mesh-list
91995408|NCT01228331|Mercaptopurine|mercaptopurine|mesh-list
91995409|NCT01228331|Clofarabine|clofarabine|mesh-list
91995410|NCT01228331|Pegaspargase|pegaspargase|mesh-list
91995411|NCT01228331|Thioguanine|thioguanine|mesh-list
91995412|NCT01228331|Etoposide phosphate|etoposide phosphate|mesh-list
91995413|NCT01228331|Amsacrine|amsacrine|mesh-list
91995414|NCT01228331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995415|NCT01228331|Immunologic Factors|immunologic factors|mesh-ancestor
91995416|NCT01228331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995417|NCT01228331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995418|NCT01228331|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91995419|NCT01228331|Alkylating Agents|alkylating agents|mesh-ancestor
91995420|NCT01228331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995421|NCT01228331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995422|NCT01228331|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91995423|NCT01228331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995424|NCT01228331|Antiemetics|antiemetics|mesh-ancestor
91995425|NCT01228331|Autonomic Agents|autonomic agents|mesh-ancestor
91995426|NCT01228331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995427|NCT01228331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995428|NCT01228331|Glucocorticoids|glucocorticoids|mesh-ancestor
91995430|NCT01228331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995431|NCT01228331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995432|NCT01228331|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91995433|NCT01228331|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91995434|NCT01228331|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91995438|NCT01228331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91995439|NCT01228331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995441|NCT01228331|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995442|NCT01228331|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91995443|NCT01228331|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91995444|NCT01228331|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91995445|NCT01228331|Antiviral Agents|antiviral agents|mesh-ancestor
91995446|NCT01228331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995447|NCT01228331|Tubulin Modulators|tubulin modulators|mesh-ancestor
91995448|NCT01228331|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995449|NCT01228331|Mitosis Modulators|mitosis modulators|mesh-ancestor
91995450|NCT01228331|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91995451|NCT01228331|Protective Agents|protective agents|mesh-ancestor
91995452|NCT01171937|Risperidone|risperidone|mesh-list
91995453|NCT01171937|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91995454|NCT01171937|Serotonin Agents|serotonin agents|mesh-ancestor
91970412|NCT04359017|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91970413|NCT04359017|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91970414|NCT04359017|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91970415|NCT04359017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91995455|NCT01171937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995456|NCT01171937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995457|NCT01171937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995459|NCT01171937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91995460|NCT01171937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995461|NCT01171937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91995462|NCT01171937|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91995463|NCT01171937|Dopamine Agents|dopamine agents|mesh-ancestor
91995464|NCT03136445|Tranexamic Acid|tranexamic acid|mesh-list
91995465|NCT03136445|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91995466|NCT03136445|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91995467|NCT03136445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995469|NCT03136445|Coagulants|coagulants|mesh-ancestor
91995470|NCT00887783|Vinorelbine|vinorelbine|mesh-list
91995471|NCT00887783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91995472|NCT00887783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995473|NCT00887783|Tubulin Modulators|tubulin modulators|mesh-ancestor
91995474|NCT00887783|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995475|NCT00887783|Mitosis Modulators|mitosis modulators|mesh-ancestor
91995476|NCT00887783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995477|NCT02047097|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91995478|NCT02047097|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995479|NCT02047097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995480|NCT02047097|Immunologic Factors|immunologic factors|mesh-ancestor
91995481|NCT02047097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995482|NCT01125371|Ethanol|ethanol|mesh-list
91995483|NCT01125371|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91995484|NCT01125371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995485|NCT01125371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995486|NCT01125371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995487|NCT03199547|Azithromycin|azithromycin|mesh-list
91995488|NCT03199547|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91995489|NCT03199547|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995490|NCT03189641|Cilostazol|cilostazol|mesh-list
91995491|NCT03189641|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91995492|NCT03189641|Autonomic Agents|autonomic agents|mesh-ancestor
91995493|NCT03189641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995494|NCT03189641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995495|NCT03189641|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91995496|NCT03189641|Respiratory System Agents|respiratory system agents|mesh-ancestor
91995497|NCT03189641|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91995498|NCT03189641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91995499|NCT03189641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995500|NCT03189641|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91995501|NCT03189641|Vasodilator Agents|vasodilator agents|mesh-ancestor
91995502|NCT03189641|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91995503|NCT03189641|Protective Agents|protective agents|mesh-ancestor
91995504|NCT03189641|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
91995505|NCT03189641|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91995510|NCT00416351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995511|NCT00416351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995512|NCT03938831|Fentanyl|fentanyl|mesh-list
91995513|NCT03938831|Dexmedetomidine|dexmedetomidine|mesh-list
91995514|NCT03938831|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91995515|NCT03938831|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995516|NCT03938831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995517|NCT03938831|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995518|NCT03938831|Analgesics|analgesics|mesh-ancestor
91995519|NCT03938831|Sensory System Agents|sensory system agents|mesh-ancestor
91995520|NCT03938831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995521|NCT03938831|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91995522|NCT03938831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91995523|NCT03938831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970416|NCT04359017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970417|NCT02470559|Aldesleukin|aldesleukin|mesh-list
91970418|NCT02470559|Interleukin-2|interleukin-2|mesh-list
91970419|NCT02470559|Sargramostim|sargramostim|mesh-list
91995524|NCT03938831|Adrenergic Agents|adrenergic agents|mesh-ancestor
91995525|NCT03938831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995526|NCT03938831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995527|NCT03938831|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91995528|NCT03938831|Narcotics|narcotics|mesh-ancestor
91995529|NCT03938831|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91995530|NCT03938831|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91995531|NCT03938831|Anesthetics, General|anesthetics, general|mesh-ancestor
91995532|NCT03938831|Anesthetics|anesthetics|mesh-ancestor
91995533|NCT03855917|Sofosbuvir|sofosbuvir|mesh-list
91995534|NCT03855917|Antiviral Agents|antiviral agents|mesh-ancestor
91995535|NCT03855917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995536|NCT03104855|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
91995537|NCT03104855|Calcifediol|calcifediol|mesh-list
91995538|NCT03104855|Vitamins|vitamins|mesh-ancestor
91995539|NCT03104855|Micronutrients|micronutrients|mesh-ancestor
91995540|NCT03104855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995541|NCT03104855|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91995542|NCT03104621|Benzalkonium Compounds|benzalkonium compounds|mesh-list
91995543|NCT03104621|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91995544|NCT03104621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995545|NCT03102359|Dexmedetomidine|dexmedetomidine|mesh-list
91995546|NCT03102359|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91995547|NCT03102359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995548|NCT03102359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995549|NCT03102359|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995550|NCT03102359|Analgesics|analgesics|mesh-ancestor
91995551|NCT03102359|Sensory System Agents|sensory system agents|mesh-ancestor
91995552|NCT03102359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995553|NCT03102359|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91995554|NCT03102359|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91995555|NCT03102359|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91995556|NCT03102359|Adrenergic Agents|adrenergic agents|mesh-ancestor
91995557|NCT03102359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995558|NCT03102359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995559|NCT03104309|Levonorgestrel|levonorgestrel|mesh-list
91995560|NCT03104309|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91995561|NCT03104309|Contraceptive Agents|contraceptive agents|mesh-ancestor
91995562|NCT03104309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91995563|NCT03104309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995564|NCT03104309|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91995565|NCT03104309|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91995566|NCT03104309|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91995567|NCT03832049|Vaccines|vaccines|mesh-list
91995568|NCT03832049|Immunologic Factors|immunologic factors|mesh-ancestor
91995569|NCT03832049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995570|NCT02102477|Androgens|androgens|mesh-list
91995571|NCT02102477|Hormones|hormones|mesh-ancestor
91995572|NCT02102477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995573|NCT02102477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995574|NCT03103685|Clopidogrel|clopidogrel|mesh-list
91995575|NCT03103685|Ticagrelor|ticagrelor|mesh-list
91995576|NCT03103685|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91995577|NCT03103685|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91995578|NCT03103685|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91995583|NCT03103685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995584|NCT03103685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995586|NCT03748433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91995587|NCT03748433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995588|NCT00540995|Etoposide|etoposide|mesh-list
91995589|NCT00540995|Podophyllotoxin|podophyllotoxin|mesh-list
91995590|NCT00540995|Etoposide phosphate|etoposide phosphate|mesh-list
91995591|NCT00540995|Busulfan|busulfan|mesh-list
91995592|NCT00540995|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91995593|NCT00540995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995594|NCT00540995|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91995595|NCT00540995|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91995596|NCT00540995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970420|NCT02470559|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91970421|NCT02470559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970422|NCT02470559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995597|NCT00540995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995598|NCT00540995|Alkylating Agents|alkylating agents|mesh-ancestor
91995599|NCT00540995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995600|NCT00540995|Immunologic Factors|immunologic factors|mesh-ancestor
91995601|NCT00540995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995602|NCT00540995|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91995603|NCT00540995|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91995604|NCT00540995|Keratolytic Agents|keratolytic agents|mesh-ancestor
91995605|NCT00540995|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995606|NCT00540995|Tubulin Modulators|tubulin modulators|mesh-ancestor
91995607|NCT00540995|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995608|NCT00540995|Mitosis Modulators|mitosis modulators|mesh-ancestor
91995609|NCT03103451|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91995610|NCT03103451|Immunologic Factors|immunologic factors|mesh-ancestor
91995611|NCT03103451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995612|NCT05103215|Lidocaine|lidocaine|mesh-list
91995613|NCT05103215|Anesthetics, Local|anesthetics, local|mesh-ancestor
91995615|NCT05103215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995616|NCT05103215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995617|NCT05103215|Sensory System Agents|sensory system agents|mesh-ancestor
91995618|NCT05103215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995619|NCT05103215|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91995620|NCT05103215|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91995621|NCT05103215|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91995622|NCT05103215|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91995623|NCT05103215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995624|NCT05001815|Insulin|insulin|mesh-list
91995625|NCT05001815|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91995626|NCT05001815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91995627|NCT05001815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995628|NCT02644967|Ipilimumab|ipilimumab|mesh-list
91995629|NCT02644967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995630|NCT02644967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995631|NCT02644967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91995714|NCT03101423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995632|NCT02644967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995633|NCT04771637|Dexmedetomidine|dexmedetomidine|mesh-list
91995634|NCT04771637|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91995635|NCT04771637|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995636|NCT04771637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995637|NCT04771637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995638|NCT04771637|Analgesics|analgesics|mesh-ancestor
91995639|NCT04771637|Sensory System Agents|sensory system agents|mesh-ancestor
91995640|NCT04771637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995641|NCT04771637|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91995642|NCT04771637|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91995643|NCT04771637|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91995644|NCT04771637|Adrenergic Agents|adrenergic agents|mesh-ancestor
91995645|NCT04771637|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995646|NCT04771637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995647|NCT03101735|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91995648|NCT03101735|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995657|NCT04701593|Glucocorticoids|glucocorticoids|mesh-ancestor
91995658|NCT04701593|Hormones|hormones|mesh-ancestor
91995659|NCT04701593|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995660|NCT04701593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995661|NCT04701593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995662|NCT04701593|Immunologic Factors|immunologic factors|mesh-ancestor
91995663|NCT04701593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995664|NCT04701593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995665|NCT05243693|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91995666|NCT05243693|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995667|NCT05243693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995668|NCT05243693|Immunotoxins|immunotoxins|mesh-ancestor
91995669|NCT05243693|Immunoconjugates|immunoconjugates|mesh-ancestor
91995670|NCT05243693|Immunologic Factors|immunologic factors|mesh-ancestor
91995671|NCT05243693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970424|NCT02470559|Sensory System Agents|sensory system agents|mesh-ancestor
91995672|NCT04552847|Octreotide|octreotide|mesh-list
91995673|NCT04552847|Al18F-NOTA-octreotide|al18f-nota-octreotide|mesh-list
91995674|NCT04552847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995675|NCT04552847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995676|NCT04552847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995677|NCT04552847|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91995678|NCT04552847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995679|NCT05167331|Nitrous Oxide|nitrous oxide|mesh-list
91995680|NCT05167331|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91995681|NCT05167331|Anesthetics, General|anesthetics, general|mesh-ancestor
91995682|NCT05167331|Anesthetics|anesthetics|mesh-ancestor
91995683|NCT05167331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995684|NCT05167331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995685|NCT05167331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995686|NCT05167331|Analgesics|analgesics|mesh-ancestor
91995687|NCT05167331|Sensory System Agents|sensory system agents|mesh-ancestor
91995688|NCT05167331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995689|NCT04509401|Vitamins|vitamins|mesh-list
91995690|NCT04509401|Vitamin B 6|vitamin b 6|mesh-list
91995691|NCT04509401|Pyridoxal|pyridoxal|mesh-list
91995692|NCT04509401|Pyridoxine|pyridoxine|mesh-list
91995693|NCT04509401|Vitamin B Complex|vitamin b complex|mesh-list
91995694|NCT04509401|Micronutrients|micronutrients|mesh-ancestor
91995695|NCT04509401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995696|NCT05155007|Cyclosporine|cyclosporine|mesh-list
91995697|NCT05155007|Cyclosporins|cyclosporins|mesh-list
91995698|NCT05155007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995699|NCT05155007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995700|NCT05155007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995701|NCT05155007|Immunologic Factors|immunologic factors|mesh-ancestor
91995702|NCT05155007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995703|NCT05155007|Antifungal Agents|antifungal agents|mesh-ancestor
91995704|NCT05155007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995705|NCT05155007|Dermatologic Agents|dermatologic agents|mesh-ancestor
91995706|NCT05155007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995707|NCT05155007|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91995708|NCT01641107|Ponatinib|ponatinib|mesh-list
91995709|NCT01641107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995710|NCT01641107|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995711|NCT01641107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995712|NCT01641107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995713|NCT03101423|Interleukin-2|interleukin-2|mesh-list
91995715|NCT03101423|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91995716|NCT03101423|Analgesics|analgesics|mesh-ancestor
91995717|NCT03101423|Sensory System Agents|sensory system agents|mesh-ancestor
91995724|NCT05073029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995725|NCT05073029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91995726|NCT05073029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91995727|NCT02642159|Nicotinic Acids|nicotinic acids|mesh-list
91995729|NCT02642159|Niacinamide|niacinamide|mesh-list
91995730|NCT02642159|Hypoglycemic Agents|hypoglycemic agents|mesh-list
91995731|NCT02642159|Ezetimibe|ezetimibe|mesh-list
91995732|NCT02642159|Alirocumab|alirocumab|mesh-list
91995733|NCT02642159|Fenofibrate|fenofibrate|mesh-list
91995734|NCT02642159|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91995735|NCT02642159|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995736|NCT02642159|Antimetabolites|antimetabolites|mesh-ancestor
91995737|NCT02642159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995738|NCT02642159|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995739|NCT02642159|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91995740|NCT02642159|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91995741|NCT02642159|Protease Inhibitors|protease inhibitors|mesh-ancestor
91995742|NCT02642159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995743|NCT02642159|Vitamin B Complex|vitamin b complex|mesh-ancestor
91995744|NCT02642159|Vitamins|vitamins|mesh-ancestor
91995745|NCT02642159|Micronutrients|micronutrients|mesh-ancestor
91995746|NCT02642159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995747|NCT02642159|Vasodilator Agents|vasodilator agents|mesh-ancestor
91995748|NCT05072873|Tranexamic Acid|tranexamic acid|mesh-list
91995749|NCT05072873|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91995750|NCT05072873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91995751|NCT05072873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995752|NCT05072873|Hemostatics|hemostatics|mesh-ancestor
91995753|NCT05072873|Coagulants|coagulants|mesh-ancestor
91995754|NCT05072405|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91995755|NCT05072405|Simvastatin|simvastatin|mesh-list
91995756|NCT05072405|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91995757|NCT05072405|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995758|NCT05072405|Antimetabolites|antimetabolites|mesh-ancestor
91995759|NCT05072405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995760|NCT05072405|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995761|NCT05072405|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91995762|NCT05072405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995764|NCT03101579|Vitamin B 12|vitamin b 12|mesh-list
91995765|NCT03101579|Dexamethasone|dexamethasone|mesh-list
91995766|NCT03101579|Pemetrexed|pemetrexed|mesh-list
91995767|NCT03101579|Vitamins|vitamins|mesh-ancestor
91995768|NCT03101579|Micronutrients|micronutrients|mesh-ancestor
91995769|NCT03101579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995770|NCT03101579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995771|NCT03101579|Antiemetics|antiemetics|mesh-ancestor
91995772|NCT03101579|Autonomic Agents|autonomic agents|mesh-ancestor
91995773|NCT03101579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995774|NCT03101579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91995775|NCT03101579|Glucocorticoids|glucocorticoids|mesh-ancestor
91995776|NCT03101579|Hormones|hormones|mesh-ancestor
91995777|NCT03101579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995778|NCT03101579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91995779|NCT03101579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995780|NCT03101579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995781|NCT03101579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995782|NCT03101579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91995783|NCT03101579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91995784|NCT03101579|Hematinics|hematinics|mesh-ancestor
91995785|NCT03101579|Vitamin B Complex|vitamin b complex|mesh-ancestor
91995786|NCT05071781|Hormones|hormones|mesh-list
91995787|NCT05071781|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91995788|NCT05071781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995789|NCT05071781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995790|NCT03882905|Ezetimibe|ezetimibe|mesh-list
91995794|NCT03882905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995795|NCT03882905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995796|NCT02669017|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
91995797|NCT02669017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995798|NCT02669017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995799|NCT04479865|Donepezil|donepezil|mesh-list
91995800|NCT04479865|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91995801|NCT04479865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996230|NCT02370433|Neostigmine|neostigmine|mesh-list
91995802|NCT04479865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995803|NCT04479865|Cholinergic Agents|cholinergic agents|mesh-ancestor
91995804|NCT04479865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995805|NCT04479865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995806|NCT04479865|Nootropic Agents|nootropic agents|mesh-ancestor
91995807|NCT02668393|Docetaxel|docetaxel|mesh-list
91995808|NCT02668393|Nintedanib|nintedanib|mesh-list
91995809|NCT02668393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995810|NCT02668393|Tubulin Modulators|tubulin modulators|mesh-ancestor
91995811|NCT02668393|Antimitotic Agents|antimitotic agents|mesh-ancestor
91995812|NCT02668393|Mitosis Modulators|mitosis modulators|mesh-ancestor
91995813|NCT02668393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995814|NCT02668393|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995815|NCT02668393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995816|NCT05251129|Atorvastatin|atorvastatin|mesh-list
91995817|NCT05251129|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91995818|NCT05251129|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995819|NCT05251129|Antimetabolites|antimetabolites|mesh-ancestor
91995820|NCT05251129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995821|NCT05251129|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995822|NCT05251129|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91995823|NCT05251129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995825|NCT01797523|Everolimus|everolimus|mesh-list
91995826|NCT01797523|Letrozole|letrozole|mesh-list
91995827|NCT01797523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91995828|NCT01797523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995829|NCT01797523|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91995830|NCT01797523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91970425|NCT02470559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970426|NCT02470559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970427|NCT02470559|Immunologic Factors|immunologic factors|mesh-ancestor
91995831|NCT01797523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995832|NCT01797523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995833|NCT01797523|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91995834|NCT01797523|Immunologic Factors|immunologic factors|mesh-ancestor
91995835|NCT01797523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995836|NCT01797523|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91995837|NCT01797523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91995838|NCT01797523|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91995839|NCT01797523|Hormone Antagonists|hormone antagonists|mesh-ancestor
91995840|NCT01797523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995842|NCT03412591|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91995843|NCT03412591|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91995844|NCT03412591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995845|NCT03412591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995846|NCT03412591|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
91995847|NCT03412591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995848|NCT03412591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995849|NCT03377023|Nivolumab|nivolumab|mesh-list
91995850|NCT03377023|Ipilimumab|ipilimumab|mesh-list
91995851|NCT03377023|Nintedanib|nintedanib|mesh-list
91995852|NCT03377023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995853|NCT03377023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995854|NCT03377023|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91995855|NCT03377023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995856|NCT03377023|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995857|NCT03377023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995858|NCT01226563|Calcium|calcium|mesh-list
91995859|NCT01226563|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91995860|NCT01226563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995861|NCT02382757|Insulin|insulin|mesh-list
91995862|NCT02382757|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91995866|NCT02382679|Micronutrients|micronutrients|mesh-ancestor
91995867|NCT02382679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995868|NCT00916747|Zoledronic Acid|zoledronic acid|mesh-list
91995869|NCT00916747|Pravastatin|pravastatin|mesh-list
91995870|NCT00916747|Lonafarnib|lonafarnib|mesh-list
91995871|NCT00916747|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91995872|NCT00916747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995873|NCT00916747|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91995874|NCT00916747|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995875|NCT00916747|Antimetabolites|antimetabolites|mesh-ancestor
91995876|NCT00916747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995877|NCT00916747|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995878|NCT00916747|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91995879|NCT00916747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995880|NCT02391883|Clopidogrel|clopidogrel|mesh-list
91995881|NCT02391883|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91995882|NCT02391883|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91995883|NCT02391883|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91995884|NCT02391883|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91995885|NCT02391883|Purinergic Agents|purinergic agents|mesh-ancestor
91995886|NCT02391883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995887|NCT02391883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995888|NCT02391883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995889|NCT02382523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91995890|NCT02382523|Hormones|hormones|mesh-ancestor
91995891|NCT02382523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995892|NCT02382523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995893|NCT02391805|Tenofovir|tenofovir|mesh-list
91995894|NCT02391805|Entecavir|entecavir|mesh-list
91995895|NCT02391805|Antiviral Agents|antiviral agents|mesh-ancestor
91995896|NCT02391805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995897|NCT02391805|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91995898|NCT02391805|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91995899|NCT02391805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970428|NCT02470559|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91970429|NCT02470559|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91970430|NCT02470559|Antiviral Agents|antiviral agents|mesh-ancestor
91970431|NCT02470559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970432|NCT02473211|Sofosbuvir|sofosbuvir|mesh-list
91970433|NCT02473211|Antiviral Agents|antiviral agents|mesh-ancestor
91970434|NCT02473211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970435|NCT02470637|Insulin|insulin|mesh-list
91970436|NCT02470637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91970437|NCT02470637|Insulin Lispro|insulin lispro|mesh-list
91970438|NCT02470637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91970439|NCT02470637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970440|NCT03652961|Abatacept|abatacept|mesh-list
91970441|NCT03652961|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91970442|NCT03652961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970443|NCT03652961|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970444|NCT03652961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970445|NCT03652961|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970446|NCT03652961|Immunologic Factors|immunologic factors|mesh-ancestor
91970447|NCT03652961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970448|NCT03652961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970449|NCT03948347|Liraglutide|liraglutide|mesh-list
91970450|NCT03948347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91995900|NCT02391805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995901|NCT02391805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91995902|NCT02391805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91995903|NCT02391181|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
91995904|NCT02391181|Hematinics|hematinics|mesh-ancestor
91995905|NCT02381899|Rituximab|rituximab|mesh-list
91995906|NCT02381899|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91995907|NCT02381899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995908|NCT02381899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995909|NCT02381899|Immunologic Factors|immunologic factors|mesh-ancestor
91995910|NCT02381899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995911|NCT02381899|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995912|NCT02381899|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91995913|NCT02381899|Alkylating Agents|alkylating agents|mesh-ancestor
91995914|NCT02381899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995915|NCT01998958|Esketamine|esketamine|mesh-list
91995916|NCT01998958|Antidepressive Agents|antidepressive agents|mesh-ancestor
91995917|NCT01998958|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91995918|NCT02386111|Sunitinib|sunitinib|mesh-list
91995919|NCT02386111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995920|NCT02386111|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91995921|NCT02386111|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91995922|NCT02386111|Growth Substances|growth substances|mesh-ancestor
91995923|NCT02386111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995924|NCT02386111|Growth Inhibitors|growth inhibitors|mesh-ancestor
91995925|NCT02386111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91995926|NCT02386111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995927|NCT02386111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995928|NCT02386033|Atorvastatin|atorvastatin|mesh-list
91995929|NCT02386033|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91970451|NCT03948347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970453|NCT03948347|Hormones|hormones|mesh-ancestor
91995930|NCT02386033|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995931|NCT02386033|Antimetabolites|antimetabolites|mesh-ancestor
91995932|NCT02386033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995933|NCT02386033|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91995935|NCT02386033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995936|NCT01958164|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91995937|NCT01958164|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91995938|NCT01958164|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91995939|NCT01958164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995941|NCT02381275|Antiviral Agents|antiviral agents|mesh-ancestor
91995942|NCT02381275|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91995943|NCT02381275|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91995944|NCT02381275|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91995945|NCT02381275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995946|NCT02381275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995947|NCT02381275|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91995948|NCT02381275|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91995949|NCT04693507|Antarelix|antarelix|mesh-list
91995950|NCT04693507|Hormone Antagonists|hormone antagonists|mesh-ancestor
91995951|NCT04693507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91995952|NCT04693507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995953|NCT03105661|Atenolol|atenolol|mesh-list
91995954|NCT03105661|Labetalol|labetalol|mesh-list
91995955|NCT03105661|Nifedipine|nifedipine|mesh-list
91995956|NCT03105661|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91995957|NCT03105661|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91995958|NCT03105661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995959|NCT03105661|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91995960|NCT03105661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995961|NCT03105661|Vasodilator Agents|vasodilator agents|mesh-ancestor
91995962|NCT03105661|Tocolytic Agents|tocolytic agents|mesh-ancestor
91995963|NCT03105661|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91995964|NCT03105661|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91995965|NCT03105661|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91995966|NCT03105661|Sympatholytics|sympatholytics|mesh-ancestor
91995967|NCT03105661|Autonomic Agents|autonomic agents|mesh-ancestor
91995968|NCT03105661|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995969|NCT03105661|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91995970|NCT03105661|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91995971|NCT03105661|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91995972|NCT03105661|Adrenergic Agents|adrenergic agents|mesh-ancestor
91995973|NCT03105661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995974|NCT03105661|Sympathomimetics|sympathomimetics|mesh-ancestor
91995975|NCT03105661|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91995976|NCT03105661|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91995977|NCT01998880|Rituximab|rituximab|mesh-list
91995978|NCT01998880|Obinutuzumab|obinutuzumab|mesh-list
91995979|NCT01998880|Chlorambucil|chlorambucil|mesh-list
91995980|NCT01998880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91995981|NCT01998880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995982|NCT01998880|Immunologic Factors|immunologic factors|mesh-ancestor
91995983|NCT01998880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995984|NCT01998880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995985|NCT01998880|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91995986|NCT01998880|Alkylating Agents|alkylating agents|mesh-ancestor
91995987|NCT01998880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995988|NCT04747561|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91995989|NCT04747561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91995990|NCT04747561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91995991|NCT02385019|Immunomodulating Agents|immunomodulating agents|mesh-list
91995992|NCT02385019|Immunologic Factors|immunologic factors|mesh-ancestor
91995993|NCT02385019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995994|NCT02380417|Ropivacaine|ropivacaine|mesh-list
91995995|NCT02380417|Anesthetics, Local|anesthetics, local|mesh-ancestor
91995996|NCT02380417|Anesthetics|anesthetics|mesh-ancestor
91995997|NCT02380417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91995998|NCT02380417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995999|NCT02380417|Sensory System Agents|sensory system agents|mesh-ancestor
91996000|NCT02380417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996001|NCT02390089|Capsaicin|capsaicin|mesh-list
91996002|NCT02390089|Antipruritics|antipruritics|mesh-ancestor
91996003|NCT02390089|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996004|NCT02390089|Sensory System Agents|sensory system agents|mesh-ancestor
91996009|NCT02379793|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996010|NCT01975246|Amlodipine|amlodipine|mesh-list
91996011|NCT01975246|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91996012|NCT01975246|Telmisartan|telmisartan|mesh-list
91996013|NCT01975246|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
91996014|NCT01975246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91996015|NCT01975246|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91996016|NCT01975246|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91996017|NCT01975246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996018|NCT01975246|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91996019|NCT01975246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996020|NCT01975246|Vasodilator Agents|vasodilator agents|mesh-ancestor
91996021|NCT01975246|Diuretics|diuretics|mesh-ancestor
91996022|NCT01975246|Natriuretic Agents|natriuretic agents|mesh-ancestor
91996023|NCT01975246|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91996024|NCT01975246|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91996025|NCT01975246|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91996026|NCT02389933|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91996027|NCT02389933|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91996028|NCT02389933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996029|NCT02379715|Remifentanil|remifentanil|mesh-list
91996030|NCT02379715|Desflurane|desflurane|mesh-list
91996031|NCT02379715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91996032|NCT02379715|Narcotics|narcotics|mesh-ancestor
91996033|NCT02379715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996034|NCT02379715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996035|NCT02379715|Analgesics|analgesics|mesh-ancestor
91996036|NCT02379715|Sensory System Agents|sensory system agents|mesh-ancestor
91996037|NCT02379715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996038|NCT02379715|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91996039|NCT02379715|Anesthetics, General|anesthetics, general|mesh-ancestor
91996040|NCT02379715|Anesthetics|anesthetics|mesh-ancestor
91996041|NCT04439773|Lidocaine|lidocaine|mesh-list
91996042|NCT04439773|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996043|NCT04439773|Anesthetics|anesthetics|mesh-ancestor
91996044|NCT04439773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996045|NCT04439773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996046|NCT04439773|Sensory System Agents|sensory system agents|mesh-ancestor
91996047|NCT04439773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996048|NCT04439773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91996049|NCT04439773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91996050|NCT04439773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91996051|NCT04439773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91996052|NCT04439773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996053|NCT02389231|Interleukin-2|interleukin-2|mesh-list
91996054|NCT02389231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996055|NCT02389231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996056|NCT02389231|Analgesics|analgesics|mesh-ancestor
91996057|NCT02389231|Sensory System Agents|sensory system agents|mesh-ancestor
91996058|NCT02389231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996059|NCT02389231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996060|NCT02383927|Tipifarnib|tipifarnib|mesh-list
91996061|NCT02383927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996062|NCT02383771|Aspirin|aspirin|mesh-list
91996063|NCT02383771|Ticagrelor|ticagrelor|mesh-list
91996064|NCT02383771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996065|NCT02383771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996066|NCT02383771|Analgesics|analgesics|mesh-ancestor
91996067|NCT02383771|Sensory System Agents|sensory system agents|mesh-ancestor
91996068|NCT02383771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996069|NCT02383771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996070|NCT02383771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996071|NCT02383771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996072|NCT02383771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91970454|NCT03948347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970455|NCT02723591|Tacrolimus|tacrolimus|mesh-list
91970456|NCT02723591|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970457|NCT02723591|Immunologic Factors|immunologic factors|mesh-ancestor
91996073|NCT02383771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91996074|NCT02383771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996078|NCT02383771|Antipyretics|antipyretics|mesh-ancestor
91996079|NCT02383771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91996080|NCT02383771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91996081|NCT02383771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91996082|NCT02383771|Purinergic Agents|purinergic agents|mesh-ancestor
91996083|NCT02383771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996084|NCT02378623|Apixaban|apixaban|mesh-list
91996085|NCT02378623|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91996086|NCT02378623|Antithrombins|antithrombins|mesh-ancestor
91996087|NCT02378623|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91996088|NCT02378623|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996089|NCT02378623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996090|NCT02378623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996091|NCT02378623|Anticoagulants|anticoagulants|mesh-ancestor
91996092|NCT02372149|Immunoglobulins|immunoglobulins|mesh-list
91996093|NCT02372149|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91996094|NCT02372149|Antibodies|antibodies|mesh-list
91996095|NCT02372149|gamma-Globulins|gamma-globulins|mesh-list
91996096|NCT02372149|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
91996097|NCT02372149|Immunologic Factors|immunologic factors|mesh-ancestor
91996098|NCT02372149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996099|NCT02661061|Midazolam|midazolam|mesh-list
91996100|NCT02661061|Ketamine|ketamine|mesh-list
91996101|NCT02661061|Analgesics|analgesics|mesh-ancestor
91996102|NCT02661061|Sensory System Agents|sensory system agents|mesh-ancestor
91996103|NCT02661061|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996104|NCT02661061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996105|NCT02661061|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91996106|NCT02661061|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91996107|NCT02661061|Anesthetics, General|anesthetics, general|mesh-ancestor
91996108|NCT02661061|Anesthetics|anesthetics|mesh-ancestor
91996109|NCT02661061|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996110|NCT02661061|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91996111|NCT02661061|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91996112|NCT02661061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996113|NCT02661061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996114|NCT02661061|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91996115|NCT02661061|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91996116|NCT02661061|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91996117|NCT02661061|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91996118|NCT02661061|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91996119|NCT02661061|GABA Modulators|gaba modulators|mesh-ancestor
91996120|NCT02661061|GABA Agents|gaba agents|mesh-ancestor
91996121|NCT02376985|Everolimus|everolimus|mesh-list
91996122|NCT02376985|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91996123|NCT02376985|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996124|NCT02376985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996125|NCT02376985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996126|NCT02376985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91996127|NCT02376985|Immunologic Factors|immunologic factors|mesh-ancestor
91996128|NCT02376985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996129|NCT02376985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996130|NCT02371993|Choline|choline|mesh-list
91996131|NCT02371993|Lipotropic Agents|lipotropic agents|mesh-ancestor
91996132|NCT02371993|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91996133|NCT02371993|Antimetabolites|antimetabolites|mesh-ancestor
91996134|NCT02371993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996135|NCT02371993|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91996136|NCT02371993|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91996137|NCT02371993|Nootropic Agents|nootropic agents|mesh-ancestor
91996138|NCT02371603|Pioglitazone|pioglitazone|mesh-list
91996139|NCT02371603|Trimethoprim|trimethoprim|mesh-list
91996140|NCT02371603|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91996141|NCT02371603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91996142|NCT02371603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91970458|NCT02723591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970459|NCT02723591|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91996143|NCT02371603|Antimetabolites|antimetabolites|mesh-ancestor
91996144|NCT02371603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996145|NCT02371603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91996146|NCT02371603|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91996147|NCT02371603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996150|NCT02371603|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91996151|NCT02371603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996152|NCT02371603|Antimalarials|antimalarials|mesh-ancestor
91996153|NCT02371603|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91996154|NCT02371603|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91996155|NCT02371603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91996156|NCT02371603|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91996157|NCT02371603|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91996158|NCT02371603|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91996160|NCT04230109|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
91996161|NCT04230109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91996162|NCT04230109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996163|NCT04230109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91996164|NCT04230109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996165|NCT04230109|Immunoconjugates|immunoconjugates|mesh-ancestor
91996166|NCT04230109|Immunologic Factors|immunologic factors|mesh-ancestor
91996167|NCT04230109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996168|NCT04149145|Niraparib|niraparib|mesh-list
91996169|NCT04149145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91996170|NCT04149145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996171|NCT04149145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996172|NCT04149145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996173|NCT02378389|Docetaxel|docetaxel|mesh-list
91996174|NCT02378389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996175|NCT02378389|Tubulin Modulators|tubulin modulators|mesh-ancestor
91996176|NCT02378389|Antimitotic Agents|antimitotic agents|mesh-ancestor
91996177|NCT02378389|Mitosis Modulators|mitosis modulators|mesh-ancestor
91996178|NCT02378389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996179|NCT02376595|Bromides|bromides|mesh-list
91996180|NCT02376595|Rocuronium|rocuronium|mesh-list
91996181|NCT02376595|Anticonvulsants|anticonvulsants|mesh-ancestor
91996182|NCT02376595|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
91996183|NCT02376595|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
91996184|NCT02376595|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91996185|NCT02376595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996186|NCT02376595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996187|NCT02370745|Insulin|insulin|mesh-list
91996188|NCT02370745|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91996189|NCT02370745|Incretins|incretins|mesh-list
91996190|NCT02370745|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91996191|NCT02370745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996192|NCT02370745|Hormones|hormones|mesh-ancestor
91996193|NCT02370745|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91996194|NCT02376049|Betamethasone|betamethasone|mesh-list
91996195|NCT02376049|Betamethasone Valerate|betamethasone valerate|mesh-list
91996196|NCT02376049|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91996197|NCT02376049|Betamethasone benzoate|betamethasone benzoate|mesh-list
91996198|NCT02376049|Clobetasol|clobetasol|mesh-list
91996199|NCT02376049|Pimecrolimus|pimecrolimus|mesh-list
91996200|NCT02376049|Emollients|emollients|mesh-list
91996201|NCT02376049|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91996202|NCT02376049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996203|NCT02376049|Glucocorticoids|glucocorticoids|mesh-ancestor
91996204|NCT02376049|Hormones|hormones|mesh-ancestor
91996205|NCT02376049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91996206|NCT02376049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996207|NCT02376049|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91996208|NCT02376049|Respiratory System Agents|respiratory system agents|mesh-ancestor
91996209|NCT02376049|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996210|NCT02376049|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996211|NCT02376049|Analgesics|analgesics|mesh-ancestor
91996212|NCT02376049|Sensory System Agents|sensory system agents|mesh-ancestor
91996213|NCT02376049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996214|NCT02376049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970460|NCT02723591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970461|NCT02723591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970462|NCT00705341|Fluticasone|fluticasone|mesh-list
91970463|NCT00705341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970464|NCT00705341|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91970465|NCT00705341|Autonomic Agents|autonomic agents|mesh-ancestor
91996215|NCT02376049|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996216|NCT02376049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91996217|NCT02376049|Immunologic Factors|immunologic factors|mesh-ancestor
91996218|NCT02376049|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91996219|NCT02376049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996220|NCT02376049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996225|NCT02376205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996226|NCT02376205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996227|NCT02376205|Sensory System Agents|sensory system agents|mesh-ancestor
91996228|NCT02376205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996231|NCT02370433|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91996232|NCT02370433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996233|NCT02370433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996234|NCT02370433|Cholinergic Agents|cholinergic agents|mesh-ancestor
91996235|NCT02370433|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996236|NCT02370433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996237|NCT02370433|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91996238|NCT02370433|Autonomic Agents|autonomic agents|mesh-ancestor
91996239|NCT02370433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996240|NCT02370433|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91996241|NCT02370433|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91996242|NCT02370433|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91996243|NCT01957150|Fluticasone|fluticasone|mesh-list
91996244|NCT01957150|Xhance|xhance|mesh-list
91996245|NCT01957150|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996246|NCT01957150|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91996247|NCT01957150|Autonomic Agents|autonomic agents|mesh-ancestor
91996248|NCT01957150|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996249|NCT01957150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996250|NCT01957150|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91996251|NCT01957150|Respiratory System Agents|respiratory system agents|mesh-ancestor
91996253|NCT01957150|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91996254|NCT01995526|Insulin|insulin|mesh-list
91996255|NCT01995526|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91996256|NCT01995526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996257|NCT01973218|Vaccines|vaccines|mesh-list
91996258|NCT01973218|Immunologic Factors|immunologic factors|mesh-ancestor
91996259|NCT01973218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996260|NCT01946152|Dexamethasone|dexamethasone|mesh-list
91996261|NCT01946152|Dexamethasone acetate|dexamethasone acetate|mesh-list
91996262|NCT01946152|Pomalidomide|pomalidomide|mesh-list
91996263|NCT01946152|Ichthammol|ichthammol|mesh-list
91996264|NCT01946152|Lenograstim|lenograstim|mesh-list
91996265|NCT01946152|BB 1101|bb 1101|mesh-list
91996266|NCT01946152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996267|NCT01946152|Antiemetics|antiemetics|mesh-ancestor
91996268|NCT01946152|Autonomic Agents|autonomic agents|mesh-ancestor
91996269|NCT01946152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996270|NCT01946152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996271|NCT01946152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91996272|NCT01946152|Glucocorticoids|glucocorticoids|mesh-ancestor
91996273|NCT01946152|Hormones|hormones|mesh-ancestor
91996274|NCT01946152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91996275|NCT01946152|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91996276|NCT01946152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996277|NCT01946152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91996278|NCT01946152|Immunologic Factors|immunologic factors|mesh-ancestor
91996279|NCT01946152|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996280|NCT01946152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996281|NCT01946152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970466|NCT00705341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970467|NCT00705341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970468|NCT00705341|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91996282|NCT01946152|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91996283|NCT01946152|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91996284|NCT01946152|Growth Substances|growth substances|mesh-ancestor
91996285|NCT01946152|Growth Inhibitors|growth inhibitors|mesh-ancestor
91996286|NCT01946152|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996288|NCT01971346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996289|NCT01971346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996290|NCT01971346|Analgesics|analgesics|mesh-ancestor
91996291|NCT01971346|Sensory System Agents|sensory system agents|mesh-ancestor
91996292|NCT01971346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996293|NCT01971346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996297|NCT01971346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91996298|NCT01971346|Immunologic Factors|immunologic factors|mesh-ancestor
91996299|NCT01945216|Alogliptin|alogliptin|mesh-list
91996300|NCT01945216|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91996301|NCT01945216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996302|NCT01945216|Incretins|incretins|mesh-ancestor
91996303|NCT01945216|Hormones|hormones|mesh-ancestor
91996304|NCT01945216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91996305|NCT01945216|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91996306|NCT01945216|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996307|NCT01945216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996308|NCT01945216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996309|NCT02641379|Ribavirin|ribavirin|mesh-list
91996310|NCT02641379|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91996311|NCT02641379|Antimetabolites|antimetabolites|mesh-ancestor
91996312|NCT02641379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996313|NCT02641379|Antiviral Agents|antiviral agents|mesh-ancestor
91996314|NCT02641379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996315|NCT02660983|Donepezil|donepezil|mesh-list
91996316|NCT02660983|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91996317|NCT02660983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996318|NCT02660983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996319|NCT02660983|Cholinergic Agents|cholinergic agents|mesh-ancestor
91996320|NCT02660983|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996321|NCT02660983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996322|NCT02660983|Nootropic Agents|nootropic agents|mesh-ancestor
91996323|NCT05070221|Axitinib|axitinib|mesh-list
91996324|NCT05070221|Antibodies|antibodies|mesh-list
91996325|NCT05070221|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91996326|NCT05070221|Immunologic Factors|immunologic factors|mesh-ancestor
91996327|NCT05070221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996328|NCT05070221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996329|NCT05070221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996330|NCT05070221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996331|NCT05070221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996332|NCT04404439|Topiramate|topiramate|mesh-list
91996333|NCT04404439|Verapamil|verapamil|mesh-list
91996334|NCT04404439|Paroxetine|paroxetine|mesh-list
91996335|NCT04404439|Nortriptyline|nortriptyline|mesh-list
91996336|NCT04404439|Anticonvulsants|anticonvulsants|mesh-ancestor
91996337|NCT04404439|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91996338|NCT04404439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996339|NCT04404439|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91996340|NCT04404439|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91996341|NCT04404439|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91996342|NCT04404439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996343|NCT04404439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996344|NCT04404439|Serotonin Agents|serotonin agents|mesh-ancestor
91996345|NCT04404439|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91996346|NCT04404439|Antidepressive Agents|antidepressive agents|mesh-ancestor
91996347|NCT04404439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91996348|NCT04404439|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91996349|NCT04404439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91996350|NCT04404439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996351|NCT04404439|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91996352|NCT04404439|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91996353|NCT04404439|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91996354|NCT04404439|Vasodilator Agents|vasodilator agents|mesh-ancestor
91996355|NCT04404439|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91996356|NCT04404439|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91996357|NCT04404439|Adrenergic Agents|adrenergic agents|mesh-ancestor
91996358|NCT01953328|Atorvastatin|atorvastatin|mesh-list
91996360|NCT01953328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91996361|NCT01953328|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91996362|NCT01953328|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91996363|NCT01953328|Antimetabolites|antimetabolites|mesh-ancestor
91996364|NCT01953328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996366|NCT01953328|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91996368|NCT01953328|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91996369|NCT01953328|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91996370|NCT01953328|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996371|NCT01953328|Immunologic Factors|immunologic factors|mesh-ancestor
91996372|NCT01953328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996373|NCT03100955|Cisplatin|cisplatin|mesh-list
91996374|NCT03100955|Etoposide|etoposide|mesh-list
91996375|NCT03100955|Etoposide phosphate|etoposide phosphate|mesh-list
91996376|NCT03100955|Apatinib|apatinib|mesh-list
91996377|NCT03100955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996378|NCT03100955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91996379|NCT03100955|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91996380|NCT03100955|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91996381|NCT03100955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996382|NCT03100955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996383|NCT03100955|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996384|NCT02377609|Tacrolimus|tacrolimus|mesh-list
91996385|NCT02377609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91996386|NCT02377609|Immunologic Factors|immunologic factors|mesh-ancestor
91996387|NCT02377609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996388|NCT02377609|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91996389|NCT02377609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996390|NCT02377609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996391|NCT02369965|Ritonavir|ritonavir|mesh-list
91996392|NCT02369965|Lopinavir|lopinavir|mesh-list
91996393|NCT02369965|Tenofovir|tenofovir|mesh-list
91996394|NCT02369965|Lamivudine|lamivudine|mesh-list
91996395|NCT02369965|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91996396|NCT02369965|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91996397|NCT02369965|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996398|NCT02369965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996399|NCT02369965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996400|NCT02369965|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91996401|NCT02369965|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91996403|NCT02369965|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996404|NCT02369965|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91996405|NCT02369965|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91996406|NCT02369965|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91996407|NCT02369965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91996408|NCT02640755|Paclitaxel|paclitaxel|mesh-list
91996409|NCT02640755|Fulvestrant|fulvestrant|mesh-list
91996410|NCT02640755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91996411|NCT02640755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996412|NCT02640755|Tubulin Modulators|tubulin modulators|mesh-ancestor
91996413|NCT02640755|Antimitotic Agents|antimitotic agents|mesh-ancestor
91996414|NCT02640755|Mitosis Modulators|mitosis modulators|mesh-ancestor
91996415|NCT02640755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996416|NCT02640755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91996417|NCT02640755|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91996418|NCT02640755|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91996419|NCT02640755|Hormone Antagonists|hormone antagonists|mesh-ancestor
91996420|NCT02640755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91996421|NCT02640755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996422|NCT04400539|Nivolumab|nivolumab|mesh-list
91996423|NCT04400539|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91996424|NCT04400539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996425|NCT04400539|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91996426|NCT04400539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996427|NCT03099785|Rifamycins|rifamycins|mesh-list
91996428|NCT03099785|Rifamycin SV|rifamycin sv|mesh-list
91970469|NCT00705341|Respiratory System Agents|respiratory system agents|mesh-ancestor
91970470|NCT00705341|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970471|NCT00705341|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91970472|NCT03193931|Pembrolizumab|pembrolizumab|mesh-list
91970473|NCT03193931|Methotrexate|methotrexate|mesh-list
91996429|NCT03099785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91996430|NCT03099785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996431|NCT03099785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996432|NCT02375503|Vitamin D|vitamin d|mesh-list
91996433|NCT02375503|Calcium|calcium|mesh-list
91996434|NCT02375503|Vitamins|vitamins|mesh-ancestor
91996435|NCT02375503|Micronutrients|micronutrients|mesh-ancestor
91996436|NCT02375503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996437|NCT02375503|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91996438|NCT02375503|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91996443|NCT00867191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996444|NCT00867191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996445|NCT00867191|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91996446|NCT00867191|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91996447|NCT00867191|Histamine Antagonists|histamine antagonists|mesh-ancestor
91996448|NCT00867191|Histamine Agents|histamine agents|mesh-ancestor
91996449|NCT00834119|Mometasone Furoate|mometasone furoate|mesh-list
91996450|NCT00834119|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996451|NCT00834119|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996452|NCT00834119|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91996454|NCT02299141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996455|NCT02299141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996456|NCT02299141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996457|NCT02299141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996458|NCT02643251|Clonidine|clonidine|mesh-list
91996459|NCT02643251|Analgesics|analgesics|mesh-ancestor
91996460|NCT02643251|Sensory System Agents|sensory system agents|mesh-ancestor
91996461|NCT02643251|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996617|NCT00650663|Antimetabolites|antimetabolites|mesh-ancestor
91996462|NCT02643251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996463|NCT02643251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91996464|NCT02643251|Sympatholytics|sympatholytics|mesh-ancestor
91996465|NCT02643251|Autonomic Agents|autonomic agents|mesh-ancestor
91996466|NCT02643251|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91996467|NCT02643251|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91996468|NCT02643251|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91996469|NCT02643251|Adrenergic Agents|adrenergic agents|mesh-ancestor
91996470|NCT02643251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996471|NCT02643251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996473|NCT02375191|Dexmedetomidine|dexmedetomidine|mesh-list
91996474|NCT02375191|Ropivacaine|ropivacaine|mesh-list
91996475|NCT02375191|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91996476|NCT02375191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996477|NCT02375191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996479|NCT02375191|Analgesics|analgesics|mesh-ancestor
91996480|NCT02375191|Sensory System Agents|sensory system agents|mesh-ancestor
91996481|NCT02375191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996482|NCT02375191|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91996483|NCT02375191|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91996484|NCT02375191|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91996485|NCT02375191|Adrenergic Agents|adrenergic agents|mesh-ancestor
91996486|NCT02375191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996487|NCT02375191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996488|NCT02375191|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996489|NCT02375191|Anesthetics|anesthetics|mesh-ancestor
91996490|NCT02375191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91996491|NCT02375191|Narcotics|narcotics|mesh-ancestor
91996492|NCT02375191|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91996493|NCT02375191|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91996494|NCT02375191|Anesthetics, General|anesthetics, general|mesh-ancestor
91996495|NCT03100877|Cyclophosphamide|cyclophosphamide|mesh-list
91996496|NCT03100877|Melphalan|melphalan|mesh-list
91996497|NCT03100877|Mechlorethamine|mechlorethamine|mesh-list
91996498|NCT03100877|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
91996499|NCT03100877|Lenalidomide|lenalidomide|mesh-list
91970474|NCT03193931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970475|NCT03193931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970476|NCT03193931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91970477|NCT03193931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996500|NCT03100877|Lenograstim|lenograstim|mesh-list
91996501|NCT03100877|Mitogens|mitogens|mesh-list
91996502|NCT03100877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91996503|NCT03100877|Immunologic Factors|immunologic factors|mesh-ancestor
91996504|NCT03100877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996505|NCT03100877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996506|NCT03100877|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91996507|NCT03100877|Alkylating Agents|alkylating agents|mesh-ancestor
91996508|NCT03100877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996509|NCT03100877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996510|NCT03100877|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91996513|NCT03100877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91996515|NCT03100877|Growth Inhibitors|growth inhibitors|mesh-ancestor
91996516|NCT03100877|Mitosis Modulators|mitosis modulators|mesh-ancestor
91996517|NCT00794495|Cetirizine|cetirizine|mesh-list
91996518|NCT00794495|Desloratadine|desloratadine|mesh-list
91996519|NCT00794495|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91996520|NCT00794495|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91996521|NCT00794495|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91996522|NCT00794495|Histamine Antagonists|histamine antagonists|mesh-ancestor
91996523|NCT00794495|Histamine Agents|histamine agents|mesh-ancestor
91996524|NCT00794495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996525|NCT00794495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996526|NCT00794495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996527|NCT00794495|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91996528|NCT00794495|Cholinergic Agents|cholinergic agents|mesh-ancestor
91996529|NCT04157075|Bupivacaine|bupivacaine|mesh-list
91996530|NCT04157075|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996531|NCT04157075|Anesthetics|anesthetics|mesh-ancestor
91996532|NCT04157075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996533|NCT04157075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996534|NCT04157075|Sensory System Agents|sensory system agents|mesh-ancestor
91996535|NCT04157075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996536|NCT00763529|Fluticasone|fluticasone|mesh-list
91996537|NCT00763529|Mometasone Furoate|mometasone furoate|mesh-list
91996538|NCT00763529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996539|NCT00763529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91996540|NCT00763529|Autonomic Agents|autonomic agents|mesh-ancestor
91996541|NCT00763529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996542|NCT00763529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996543|NCT00763529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91996544|NCT00763529|Respiratory System Agents|respiratory system agents|mesh-ancestor
91996546|NCT00763529|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91996547|NCT03105505|Fusidic Acid|fusidic acid|mesh-list
91996548|NCT03105505|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91996549|NCT03105505|Permethrin|permethrin|mesh-list
91996550|NCT03105505|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91996551|NCT03105505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996552|NCT03105505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996553|NCT03105505|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91996554|NCT03105505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996555|NCT03105505|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91996556|NCT03105193|Lidocaine|lidocaine|mesh-list
91996557|NCT03105193|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996558|NCT03105193|Anesthetics|anesthetics|mesh-ancestor
91996559|NCT03105193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996560|NCT03105193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996561|NCT03105193|Sensory System Agents|sensory system agents|mesh-ancestor
91996562|NCT03105193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996563|NCT03105193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91996564|NCT03105193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91996565|NCT03105193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91996566|NCT03105193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970478|NCT03193931|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91970479|NCT03193931|Abortifacient Agents|abortifacient agents|mesh-ancestor
91996567|NCT03105193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996568|NCT05066633|Metoprolol|metoprolol|mesh-list
91996569|NCT05066633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91996570|NCT05066633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91996571|NCT05066633|Sympatholytics|sympatholytics|mesh-ancestor
91996572|NCT05066633|Autonomic Agents|autonomic agents|mesh-ancestor
91996573|NCT05066633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996574|NCT05066633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996575|NCT05066633|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91996576|NCT05066633|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91996577|NCT05066633|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91996578|NCT05066633|Adrenergic Agents|adrenergic agents|mesh-ancestor
91996579|NCT05066633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996580|NCT05066633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996581|NCT04439305|Dasatinib|dasatinib|mesh-list
91996582|NCT04439305|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996586|NCT02368951|Aprutumab ixadotin|aprutumab ixadotin|mesh-list
91996587|NCT02368951|Immunoconjugates|immunoconjugates|mesh-ancestor
91996588|NCT02368951|Immunologic Factors|immunologic factors|mesh-ancestor
91996589|NCT02368951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996591|NCT02368795|Isosorbide|isosorbide|mesh-list
91996592|NCT02368795|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
91996593|NCT02368795|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
91996594|NCT02368795|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996595|NCT02368795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996596|NCT02368795|Analgesics|analgesics|mesh-ancestor
91996597|NCT02368795|Sensory System Agents|sensory system agents|mesh-ancestor
91996598|NCT02368795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996599|NCT02368795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996600|NCT02368795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996601|NCT02368795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996602|NCT02368795|Gout Suppressants|gout suppressants|mesh-ancestor
91996603|NCT02368795|Tocolytic Agents|tocolytic agents|mesh-ancestor
91996604|NCT02368795|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91996605|NCT02368795|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91996606|NCT02368795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996607|NCT02368795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996608|NCT02368795|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91996610|NCT02368795|Natriuretic Agents|natriuretic agents|mesh-ancestor
91996611|NCT02368795|Vasodilator Agents|vasodilator agents|mesh-ancestor
91996612|NCT02368795|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
91996613|NCT00650663|Simvastatin|simvastatin|mesh-list
91996614|NCT00650663|Ezetimibe|ezetimibe|mesh-list
91996615|NCT00650663|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91996616|NCT00650663|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91996618|NCT00650663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996619|NCT00650663|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91996620|NCT00650663|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91996621|NCT00650663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996622|NCT02368717|Mesalamine|mesalamine|mesh-list
91996623|NCT02368717|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996624|NCT02368717|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996625|NCT02368717|Analgesics|analgesics|mesh-ancestor
91996626|NCT02368717|Sensory System Agents|sensory system agents|mesh-ancestor
91996627|NCT02368717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996628|NCT02368717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996629|NCT02368717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996630|NCT02368717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996631|NCT04231565|Tenofovir|tenofovir|mesh-list
91996632|NCT04231565|Antiviral Agents|antiviral agents|mesh-ancestor
91996633|NCT04231565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996634|NCT04231565|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91996635|NCT04231565|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91996636|NCT04231565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996637|NCT04231565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970480|NCT03193931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91970481|NCT03193931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970482|NCT03193931|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91970483|NCT03193931|Antimetabolites|antimetabolites|mesh-ancestor
91996638|NCT04231565|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91996639|NCT04231565|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91996640|NCT03100565|Lidocaine|lidocaine|mesh-list
91996641|NCT03100565|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996642|NCT03100565|Anesthetics|anesthetics|mesh-ancestor
91996643|NCT03100565|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996644|NCT03100565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996645|NCT03100565|Sensory System Agents|sensory system agents|mesh-ancestor
91996646|NCT03100565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996647|NCT03100565|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91996648|NCT03100565|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91996649|NCT03100565|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91996650|NCT03100565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91996651|NCT03100565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996652|NCT05035277|Aspirin|aspirin|mesh-list
91996653|NCT05035277|Rivaroxaban|rivaroxaban|mesh-list
91996657|NCT05035277|Antithrombins|antithrombins|mesh-ancestor
91996658|NCT05035277|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91996659|NCT05035277|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996660|NCT05035277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996661|NCT05035277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996662|NCT05035277|Anticoagulants|anticoagulants|mesh-ancestor
92074269|NCT00074308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996663|NCT05035277|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996664|NCT05035277|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996665|NCT05035277|Analgesics|analgesics|mesh-ancestor
91996666|NCT05035277|Sensory System Agents|sensory system agents|mesh-ancestor
91996667|NCT05035277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996668|NCT05035277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996669|NCT05035277|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996670|NCT05035277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996671|NCT05035277|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91996672|NCT05035277|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91996673|NCT05035277|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91996674|NCT05035277|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91996675|NCT05035277|Antipyretics|antipyretics|mesh-ancestor
91996676|NCT02374645|Gefitinib|gefitinib|mesh-list
91996677|NCT02374645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996678|NCT02374645|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996679|NCT02374645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996680|NCT02374645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996681|NCT02368561|Hyaluronic Acid|hyaluronic acid|mesh-list
91996683|NCT02368561|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91996684|NCT02368561|Immunologic Factors|immunologic factors|mesh-ancestor
91996685|NCT02368561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996686|NCT02368561|Viscosupplements|viscosupplements|mesh-ancestor
91996687|NCT02368561|Protective Agents|protective agents|mesh-ancestor
91996688|NCT04095845|Tacrine|tacrine|mesh-list
91996689|NCT04095845|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91996690|NCT04095845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996691|NCT04095845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996692|NCT04095845|Cholinergic Agents|cholinergic agents|mesh-ancestor
91996693|NCT04095845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996694|NCT04095845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996695|NCT04095845|Parasympathomimetics|parasympathomimetics|mesh-ancestor
91996696|NCT04095845|Autonomic Agents|autonomic agents|mesh-ancestor
91996697|NCT04095845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996698|NCT04095845|Nootropic Agents|nootropic agents|mesh-ancestor
91996699|NCT02374489|Ceritinib|ceritinib|mesh-list
91996700|NCT02374489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996701|NCT02374489|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996702|NCT02374489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996703|NCT02374489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996704|NCT02374567|Topiramate|topiramate|mesh-list
91996705|NCT02374567|Diphenhydramine|diphenhydramine|mesh-list
91996706|NCT02374567|Promethazine|promethazine|mesh-list
91996707|NCT02374567|Pregabalin|pregabalin|mesh-list
91970484|NCT03193931|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970485|NCT03193931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996708|NCT02374567|Lamotrigine|lamotrigine|mesh-list
91996709|NCT02374567|Lacosamide|lacosamide|mesh-list
91996710|NCT02374567|Carbamazepine|carbamazepine|mesh-list
91996711|NCT02374567|Phenytoin|phenytoin|mesh-list
91996712|NCT02374567|Oxcarbazepine|oxcarbazepine|mesh-list
91996713|NCT02374567|Nicergoline|nicergoline|mesh-list
91996714|NCT02374567|Midazolam|midazolam|mesh-list
91996715|NCT02374567|Diazepam|diazepam|mesh-list
91996716|NCT02374567|Triazolam|triazolam|mesh-list
91996717|NCT02374567|Acamprosate|acamprosate|mesh-list
91996718|NCT02374567|Gabapentin|gabapentin|mesh-list
91996719|NCT02374567|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
91996720|NCT02374567|Amitriptyline|amitriptyline|mesh-list
91996721|NCT02374567|Methotrimeprazine|methotrimeprazine|mesh-list
91996722|NCT02374567|Levetiracetam|levetiracetam|mesh-list
91996723|NCT02374567|Valproic Acid|valproic acid|mesh-list
91996724|NCT02374567|Lorazepam|lorazepam|mesh-list
91996725|NCT02374567|Clonazepam|clonazepam|mesh-list
91996726|NCT02374567|Phenobarbital|phenobarbital|mesh-list
91996727|NCT02374567|Clobazam|clobazam|mesh-list
91996728|NCT02374567|Zaleplon|zaleplon|mesh-list
91996729|NCT02374567|Nitrazepam|nitrazepam|mesh-list
91996730|NCT02374567|Chlormethiazole|chlormethiazole|mesh-list
91996731|NCT02374567|Memantine|memantine|mesh-list
91996733|NCT02374567|Haloperidol|haloperidol|mesh-list
91996734|NCT02374567|Pimozide|pimozide|mesh-list
91996742|NCT02374567|Oxazepam|oxazepam|mesh-list
91996743|NCT02374567|Temazepam|temazepam|mesh-list
91996744|NCT02374567|Brotizolam|brotizolam|mesh-list
91996745|NCT02374567|Lormetazepam|lormetazepam|mesh-list
91996746|NCT02374567|Flurazepam|flurazepam|mesh-list
91996747|NCT02374567|Mirtazapine|mirtazapine|mesh-list
91996748|NCT02374567|Fluvoxamine|fluvoxamine|mesh-list
91996749|NCT02374567|Buspirone|buspirone|mesh-list
91996750|NCT02374567|Trazodone|trazodone|mesh-list
91996751|NCT02374567|Tranylcypromine|tranylcypromine|mesh-list
91996752|NCT02374567|Bromazepam|bromazepam|mesh-list
91996753|NCT02374567|Risperidone|risperidone|mesh-list
91996754|NCT02374567|Melatonin|melatonin|mesh-list
91996755|NCT02374567|Aripiprazole|aripiprazole|mesh-list
91996756|NCT02374567|Quetiapine Fumarate|quetiapine fumarate|mesh-list
91996757|NCT02374567|Paliperidone Palmitate|paliperidone palmitate|mesh-list
91996758|NCT02374567|Ziprasidone|ziprasidone|mesh-list
91996759|NCT02374567|Clozapine|clozapine|mesh-list
91996760|NCT02374567|Amisulpride|amisulpride|mesh-list
91996761|NCT02374567|Flupenthixol|flupenthixol|mesh-list
91996762|NCT02374567|Flupenthixol decanoate|flupenthixol decanoate|mesh-list
91996763|NCT02374567|Perphenazine|perphenazine|mesh-list
91996764|NCT02374567|Sertindole|sertindole|mesh-list
91996765|NCT02374567|Fluphenazine|fluphenazine|mesh-list
91996766|NCT02374567|Fluphenazine depot|fluphenazine depot|mesh-list
91996767|NCT02374567|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
91996768|NCT02374567|Sulpiride|sulpiride|mesh-list
91996769|NCT02374567|Thioridazine|thioridazine|mesh-list
91996770|NCT02374567|Pipamperone|pipamperone|mesh-list
91996771|NCT02374567|Clopenthixol|clopenthixol|mesh-list
91996772|NCT02374567|Chlorprothixene|chlorprothixene|mesh-list
91996773|NCT02374567|Tiapride Hydrochloride|tiapride hydrochloride|mesh-list
91996774|NCT02374567|Fluspirilene|fluspirilene|mesh-list
91996775|NCT02374567|Benperidol|benperidol|mesh-list
91996776|NCT02374567|Bromperidol|bromperidol|mesh-list
91996777|NCT02374567|Perazine|perazine|mesh-list
91996778|NCT02374567|Rivastigmine|rivastigmine|mesh-list
91996779|NCT02374567|Piracetam|piracetam|mesh-list
91996780|NCT02374567|Donepezil|donepezil|mesh-list
91996781|NCT02374567|Galantamine|galantamine|mesh-list
91996782|NCT02374567|Citalopram|citalopram|mesh-list
91996783|NCT02374567|Bupropion|bupropion|mesh-list
91996784|NCT02374567|Sertraline|sertraline|mesh-list
91996785|NCT02374567|Fluoxetine|fluoxetine|mesh-list
91996786|NCT02374567|Paroxetine|paroxetine|mesh-list
91996787|NCT02374567|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
91996788|NCT02374567|Nortriptyline|nortriptyline|mesh-list
91996789|NCT02374567|Reboxetine|reboxetine|mesh-list
91996790|NCT02374567|Imipramine|imipramine|mesh-list
91996791|NCT02374567|Clomipramine|clomipramine|mesh-list
91996792|NCT02374567|Moclobemide|moclobemide|mesh-list
91996793|NCT02374567|Mianserin|mianserin|mesh-list
91996794|NCT02374567|Opipramol|opipramol|mesh-list
91996795|NCT02374567|Maprotiline|maprotiline|mesh-list
91996796|NCT02374567|Trimipramine|trimipramine|mesh-list
91996797|NCT02374567|Hydroxyzine|hydroxyzine|mesh-list
91996798|NCT02374567|Escitalopram|escitalopram|mesh-list
91996799|NCT02374567|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91996800|NCT02374567|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91996801|NCT02374567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996802|NCT02374567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996803|NCT02374567|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91996804|NCT02374567|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91996805|NCT02374567|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91970486|NCT03193931|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91970487|NCT03193931|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970488|NCT03193931|Immunologic Factors|immunologic factors|mesh-ancestor
91970489|NCT03193931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970490|NCT03193931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91996806|NCT02374567|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91996807|NCT02374567|Anesthetics, General|anesthetics, general|mesh-ancestor
91996809|NCT02374567|GABA Modulators|gaba modulators|mesh-ancestor
91996810|NCT02374567|GABA Agents|gaba agents|mesh-ancestor
91996811|NCT02374567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996812|NCT02374567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996814|NCT02374567|Sensory System Agents|sensory system agents|mesh-ancestor
91996815|NCT02374567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996816|NCT02374567|Anticonvulsants|anticonvulsants|mesh-ancestor
91996817|NCT02374567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91996818|NCT02374567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91996823|NCT02374567|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91996824|NCT02374567|Serotonin Agents|serotonin agents|mesh-ancestor
91996825|NCT02374567|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91996826|NCT02374567|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91996827|NCT02374567|Dopamine Agents|dopamine agents|mesh-ancestor
91996828|NCT02374567|Antioxidants|antioxidants|mesh-ancestor
91996829|NCT02374567|Protective Agents|protective agents|mesh-ancestor
91996830|NCT02374567|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91996831|NCT02374567|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91996832|NCT02374567|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91996833|NCT02374567|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91996834|NCT02374567|Parasympatholytics|parasympatholytics|mesh-ancestor
91996835|NCT02374567|Autonomic Agents|autonomic agents|mesh-ancestor
91996836|NCT02374567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91996837|NCT02374567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91996838|NCT02374567|Cholinergic Agents|cholinergic agents|mesh-ancestor
91996839|NCT02374567|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91996840|NCT02374567|Antidepressive Agents|antidepressive agents|mesh-ancestor
91996841|NCT02374567|Antiemetics|antiemetics|mesh-ancestor
91996842|NCT02374567|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91996843|NCT02374567|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91996844|NCT02374567|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91996845|NCT02374567|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91996846|NCT02374567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996847|NCT02374567|Dopamine Agonists|dopamine agonists|mesh-ancestor
91996848|NCT02374567|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91996849|NCT02374567|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91996850|NCT02374567|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91996851|NCT02374567|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91996852|NCT02374567|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
91996853|NCT02374567|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
91996854|NCT02374567|Nootropic Agents|nootropic agents|mesh-ancestor
91996855|NCT02374567|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91996856|NCT02374567|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91996857|NCT02374567|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91996858|NCT02374567|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996859|NCT02374567|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91996860|NCT02374567|Histamine Antagonists|histamine antagonists|mesh-ancestor
91996861|NCT02374567|Histamine Agents|histamine agents|mesh-ancestor
91996862|NCT02374567|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91996863|NCT02374567|Antipruritics|antipruritics|mesh-ancestor
91996864|NCT02374567|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996865|NCT02374567|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
91996866|NCT02374567|GABA Agonists|gaba agonists|mesh-ancestor
91996867|NCT02374567|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91996868|NCT02374567|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91996869|NCT02374567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91996870|NCT02374567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91996871|NCT02374567|Adrenergic Agents|adrenergic agents|mesh-ancestor
91996872|NCT02374567|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91970491|NCT00705263|Ribavirin|ribavirin|mesh-list
91970492|NCT00705263|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
91970493|NCT00705263|Antimetabolites|antimetabolites|mesh-ancestor
91996873|NCT02374567|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996874|NCT02374567|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91996875|NCT02374567|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91996876|NCT02374567|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92074270|NCT00074308|Growth Inhibitors|growth inhibitors|mesh-ancestor
91996877|NCT02374567|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
91996878|NCT02374567|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91996879|NCT02374567|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91996880|NCT02374567|GABA Antagonists|gaba antagonists|mesh-ancestor
91996881|NCT02374567|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91996882|NCT02374567|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91996883|NCT02374567|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91996884|NCT02374567|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91996885|NCT02374567|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91996886|NCT02374567|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
91996890|NCT03965741|Rivaroxaban|rivaroxaban|mesh-list
91996891|NCT03965741|Apixaban|apixaban|mesh-list
91996892|NCT03965741|Dabigatran|dabigatran|mesh-list
91996893|NCT03965741|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91996894|NCT03965741|Antithrombins|antithrombins|mesh-ancestor
91996895|NCT03965741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91996896|NCT03965741|Protease Inhibitors|protease inhibitors|mesh-ancestor
91996897|NCT03965741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996898|NCT03965741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996899|NCT03965741|Anticoagulants|anticoagulants|mesh-ancestor
91996901|NCT02368171|Carbon Monoxide|carbon monoxide|mesh-list
91996902|NCT02368171|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91996903|NCT02368171|Autonomic Agents|autonomic agents|mesh-ancestor
91996904|NCT02368171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996905|NCT02368171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996906|NCT02368171|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91996907|NCT02368171|Respiratory System Agents|respiratory system agents|mesh-ancestor
91996908|NCT02368171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91996909|NCT02368171|Antioxidants|antioxidants|mesh-ancestor
91996910|NCT02368171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996911|NCT02368171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996912|NCT02368171|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
91996913|NCT02368171|Vasodilator Agents|vasodilator agents|mesh-ancestor
91996914|NCT02368171|Gasotransmitters|gasotransmitters|mesh-ancestor
91996915|NCT02368171|Protective Agents|protective agents|mesh-ancestor
91996916|NCT02368171|Antimetabolites|antimetabolites|mesh-ancestor
91996917|NCT05063513|Mycophenolic Acid|mycophenolic acid|mesh-list
91996918|NCT05063513|Rituximab|rituximab|mesh-list
91996919|NCT05063513|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91996920|NCT05063513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996921|NCT05063513|Immunologic Factors|immunologic factors|mesh-ancestor
91996922|NCT05063513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996923|NCT05063513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996924|NCT05063513|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91996925|NCT05063513|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91996926|NCT05063513|Antitubercular Agents|antitubercular agents|mesh-ancestor
91996927|NCT05063513|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91996928|NCT05063513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996929|NCT05063513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996930|NCT05063513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996931|NCT02364583|Primaquine|primaquine|mesh-list
91996932|NCT02364583|Antimalarials|antimalarials|mesh-ancestor
91996933|NCT02364583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91996934|NCT02364583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91996935|NCT02364583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996936|NCT02368015|Cefazolin|cefazolin|mesh-list
91996937|NCT02368015|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91996938|NCT02368015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91996939|NCT02373943|Carotenoids|carotenoids|mesh-list
91996940|NCT02373943|Antioxidants|antioxidants|mesh-ancestor
91996941|NCT02373943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996942|NCT02373943|Protective Agents|protective agents|mesh-ancestor
91996943|NCT02373943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996945|NCT04632433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91996946|NCT04632433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970494|NCT00705263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970495|NCT00705263|Antiviral Agents|antiviral agents|mesh-ancestor
91970496|NCT00705263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970497|NCT02767427|Chlorhexidine|chlorhexidine|mesh-list
91996947|NCT02368249|Terlipressin|terlipressin|mesh-list
91996948|NCT02368249|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91996949|NCT02368249|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91996950|NCT02367937|Flurbiprofen|flurbiprofen|mesh-list
91996951|NCT02367937|Midazolam|midazolam|mesh-list
91996952|NCT02367937|Omeprazole|omeprazole|mesh-list
91996953|NCT02367937|Simvastatin|simvastatin|mesh-list
91996954|NCT02367937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91996955|NCT02367937|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91996956|NCT02367937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91996957|NCT02367937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996958|NCT02367937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91996959|NCT02367937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91996960|NCT02367937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91996966|NCT02367937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996967|NCT02367937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996968|NCT02367937|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91996969|NCT02367937|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91996970|NCT02367937|Antimetabolites|antimetabolites|mesh-ancestor
91996971|NCT02367937|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91996972|NCT02367937|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91996973|NCT02367937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996974|NCT02367937|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91996975|NCT02367937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91996976|NCT02367937|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91996977|NCT02367937|Analgesics|analgesics|mesh-ancestor
91996978|NCT02367937|Sensory System Agents|sensory system agents|mesh-ancestor
91996979|NCT02367937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996980|NCT02367937|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91996981|NCT02367937|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91996982|NCT02367937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996983|NCT02367937|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996984|NCT02367937|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91996985|NCT05011487|Pemetrexed|pemetrexed|mesh-list
91996986|NCT05011487|Osimertinib|osimertinib|mesh-list
91996987|NCT05011487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91996988|NCT05011487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996989|NCT05011487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996990|NCT05011487|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91996991|NCT05011487|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91996992|NCT05011487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996993|NCT02367547|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91996994|NCT02367547|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
91996995|NCT02367547|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
91996996|NCT02367547|Dermatologic Agents|dermatologic agents|mesh-ancestor
91996997|NCT05061641|Progesterone|progesterone|mesh-list
91996998|NCT05061641|Progestins|progestins|mesh-ancestor
91996999|NCT05061641|Hormones|hormones|mesh-ancestor
91997000|NCT05061641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997001|NCT05061641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997002|NCT03100019|Resveratrol|resveratrol|mesh-list
91997003|NCT03100019|Antioxidants|antioxidants|mesh-ancestor
91997004|NCT03100019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997006|NCT03100019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997007|NCT03100019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997008|NCT03100019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91997009|NCT05047055|Moxifloxacin|moxifloxacin|mesh-list
91997010|NCT05047055|Rifampin|rifampin|mesh-list
91997011|NCT05047055|Isoniazid|isoniazid|mesh-list
91997012|NCT05047055|Pyrazinamide|pyrazinamide|mesh-list
91997013|NCT05047055|Ethambutol|ethambutol|mesh-list
91997014|NCT05047055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91997015|NCT05047055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997016|NCT05047055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997017|NCT05047055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997018|NCT05047055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970498|NCT02767427|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91970499|NCT02767427|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91997019|NCT05047055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997020|NCT05047055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997021|NCT05047055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91997022|NCT05047055|Antitubercular Agents|antitubercular agents|mesh-ancestor
91997023|NCT05047055|Leprostatic Agents|leprostatic agents|mesh-ancestor
91997024|NCT05047055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91997025|NCT05047055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91997026|NCT05047055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91997027|NCT05047055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91997028|NCT05047055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91997029|NCT05047055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91997030|NCT05047055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91997032|NCT05047055|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91997033|NCT05047055|Antimetabolites|antimetabolites|mesh-ancestor
91997034|NCT05047055|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91997035|NCT03098537|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
91997036|NCT03098537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997037|NCT03098537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997038|NCT05046041|Misoprostol|misoprostol|mesh-list
91997039|NCT05046041|Mifepristone|mifepristone|mesh-list
91997040|NCT05046041|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91997041|NCT05046041|Abortifacient Agents|abortifacient agents|mesh-ancestor
91997042|NCT05046041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997043|NCT05046041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997044|NCT05046041|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91997045|NCT05046041|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997047|NCT05046041|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
91997048|NCT05046041|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91997049|NCT05046041|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91997050|NCT05046041|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91997051|NCT05046041|Contraceptive Agents|contraceptive agents|mesh-ancestor
91997052|NCT05046041|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91997053|NCT05046041|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91997054|NCT05046041|Hormone Antagonists|hormone antagonists|mesh-ancestor
91997055|NCT05046041|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997056|NCT05046041|Luteolytic Agents|luteolytic agents|mesh-ancestor
91997057|NCT05046041|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91997058|NCT05046041|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
91997059|NCT01970878|Bromides|bromides|mesh-list
91997060|NCT01970878|Tiotropium Bromide|tiotropium bromide|mesh-list
91997061|NCT01970878|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91997062|NCT01970878|Autonomic Agents|autonomic agents|mesh-ancestor
91997063|NCT01970878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997064|NCT01970878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997065|NCT01970878|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91997066|NCT01970878|Respiratory System Agents|respiratory system agents|mesh-ancestor
91997067|NCT01970878|Parasympatholytics|parasympatholytics|mesh-ancestor
91997068|NCT01970878|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91997069|NCT01970878|Cholinergic Agents|cholinergic agents|mesh-ancestor
91997070|NCT01970878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997071|NCT01970878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997072|NCT01970878|Anticonvulsants|anticonvulsants|mesh-ancestor
91997073|NCT05045651|Cimetidine|cimetidine|mesh-list
91997074|NCT05045651|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91997075|NCT05045651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997076|NCT05045651|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
91997077|NCT05045651|Histamine Antagonists|histamine antagonists|mesh-ancestor
91997078|NCT05045651|Histamine Agents|histamine agents|mesh-ancestor
91997079|NCT05045651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997080|NCT05045651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997081|NCT05045651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997082|NCT05045651|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91997083|NCT05045651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91997084|NCT05045651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997085|NCT05059145|Chlorhexidine|chlorhexidine|mesh-list
91970500|NCT02767427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970501|NCT02767427|Disinfectants|disinfectants|mesh-ancestor
91970502|NCT02767427|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970503|NCT03310463|Durlobactam|durlobactam|mesh-list
91970504|NCT03310463|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91970505|NCT03310463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090450|NCT01903031|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91997086|NCT05059145|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91997087|NCT05059145|Fluconazole|fluconazole|mesh-list
91997088|NCT05059145|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91997089|NCT05059145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997090|NCT05059145|Disinfectants|disinfectants|mesh-ancestor
91997091|NCT05059145|Dermatologic Agents|dermatologic agents|mesh-ancestor
91997092|NCT05059145|Antifungal Agents|antifungal agents|mesh-ancestor
91997093|NCT05059145|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91997094|NCT05059145|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91997095|NCT05059145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997096|NCT05059145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997098|NCT05059145|Hormone Antagonists|hormone antagonists|mesh-ancestor
91997099|NCT05059145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997100|NCT05059145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997101|NCT05059145|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91997102|NCT05059145|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
91997106|NCT05058677|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997107|NCT05058677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997108|NCT05058677|Sensory System Agents|sensory system agents|mesh-ancestor
91997109|NCT05058677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997110|NCT05058677|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91997111|NCT05058677|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91997112|NCT05058677|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91997113|NCT05058677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91997114|NCT05058677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997115|NCT01970488|Adalimumab|adalimumab|mesh-list
91997116|NCT01970488|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91997117|NCT01970488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997118|NCT01970488|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997119|NCT03097835|Anesthetics|anesthetics|mesh-list
91997120|NCT03097835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997121|NCT03097835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997122|NCT03097601|Sunitinib|sunitinib|mesh-list
91997123|NCT03097601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997124|NCT03097601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91997125|NCT03097601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91997126|NCT03097601|Growth Substances|growth substances|mesh-ancestor
91997127|NCT03097601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997128|NCT03097601|Growth Inhibitors|growth inhibitors|mesh-ancestor
91997129|NCT03097601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91997130|NCT03097601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997131|NCT03097601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997132|NCT05058755|Etoposide|etoposide|mesh-list
91997133|NCT05058755|Lenalidomide|lenalidomide|mesh-list
91997134|NCT05058755|Azacitidine|azacitidine|mesh-list
91997135|NCT05058755|Tislelizumab|tislelizumab|mesh-list
91997136|NCT05058755|Pegaspargase|pegaspargase|mesh-list
91997137|NCT05058755|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997138|NCT05058755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997139|NCT05058755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997140|NCT05058755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997141|NCT05058755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997142|NCT05058755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997143|NCT05058755|Immunologic Factors|immunologic factors|mesh-ancestor
91997144|NCT05058755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997145|NCT05058755|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91997146|NCT05058755|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91997147|NCT05058755|Growth Substances|growth substances|mesh-ancestor
91970506|NCT03310463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970507|NCT03310463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91970508|NCT03310463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970509|NCT00704405|Interferons|interferons|mesh-list
91970511|NCT00704405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970512|NCT00704405|Antiviral Agents|antiviral agents|mesh-ancestor
91970513|NCT00704405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970514|NCT00704405|Antimetabolites|antimetabolites|mesh-ancestor
91970515|NCT00704405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970516|NCT01470755|Albuterol|albuterol|mesh-list
91970517|NCT01470755|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91970518|NCT01470755|Autonomic Agents|autonomic agents|mesh-ancestor
91970519|NCT01470755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997148|NCT05058755|Growth Inhibitors|growth inhibitors|mesh-ancestor
91997149|NCT05058755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997150|NCT05058755|Antimetabolites|antimetabolites|mesh-ancestor
91997151|NCT05058755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91997152|NCT05044169|Broncho-Vaxom|broncho-vaxom|mesh-list
91997153|NCT05044169|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91997154|NCT05044169|Immunologic Factors|immunologic factors|mesh-ancestor
91997155|NCT05044169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997156|NCT05058209|Triamcinolone|triamcinolone|mesh-list
91997157|NCT05058209|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91997158|NCT05058209|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91997159|NCT05058209|Betamethasone|betamethasone|mesh-list
91997160|NCT05058209|Betamethasone Valerate|betamethasone valerate|mesh-list
91997161|NCT05058209|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
91997162|NCT05058209|Betamethasone benzoate|betamethasone benzoate|mesh-list
91997163|NCT05058209|Betamethasone acetate|betamethasone acetate|mesh-list
91997164|NCT05058209|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
91997165|NCT05058209|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91997166|NCT05058209|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997167|NCT05058209|Glucocorticoids|glucocorticoids|mesh-ancestor
91997168|NCT05058209|Hormones|hormones|mesh-ancestor
91997169|NCT05058209|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997170|NCT05058209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997171|NCT05058209|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997172|NCT05058209|Immunologic Factors|immunologic factors|mesh-ancestor
91997173|NCT05058209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997174|NCT05058209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997180|NCT05057663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997181|NCT05057663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997182|NCT05057663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997183|NCT05057663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997184|NCT05057663|Immunologic Factors|immunologic factors|mesh-ancestor
91997185|NCT05057663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997186|NCT05057663|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91997188|NCT03097445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91997189|NCT03097445|Autonomic Agents|autonomic agents|mesh-ancestor
91997190|NCT03097445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997191|NCT03097445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997192|NCT03097445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91997193|NCT03097445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91997194|NCT03097445|Cholinergic Agents|cholinergic agents|mesh-ancestor
91997195|NCT03097445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997196|NCT03097445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970520|NCT01470755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970521|NCT01470755|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91970522|NCT01470755|Respiratory System Agents|respiratory system agents|mesh-ancestor
91970524|NCT01470755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91970525|NCT01470755|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91970526|NCT01470755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91997197|NCT05057351|Glycerol|glycerol|mesh-list
91997198|NCT05057351|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
91997199|NCT05057351|Protective Agents|protective agents|mesh-ancestor
91997200|NCT05057351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997201|NCT03097211|Levodopa|levodopa|mesh-list
91997202|NCT03097211|Benserazide|benserazide|mesh-list
91997203|NCT03097211|Resveratrol|resveratrol|mesh-list
91997204|NCT03097211|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
91997205|NCT03097211|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91997206|NCT03097211|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91997207|NCT03097211|Dopamine Agents|dopamine agents|mesh-ancestor
91997208|NCT03097211|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997209|NCT03097211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997210|NCT03097211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997211|NCT03097211|Antioxidants|antioxidants|mesh-ancestor
91997212|NCT03097211|Protective Agents|protective agents|mesh-ancestor
91997213|NCT03097211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997214|NCT03097211|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91997215|NCT05043935|Anti-Infective Agents|anti-infective agents|mesh-list
91997216|NCT05043935|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91997217|NCT05056337|Lenvatinib|lenvatinib|mesh-list
91997218|NCT05056337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997219|NCT05056337|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91997220|NCT05056337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997221|NCT05056337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997222|NCT05056025|Vitamins|vitamins|mesh-list
91997223|NCT05056025|Micronutrients|micronutrients|mesh-ancestor
91997224|NCT05056025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997225|NCT02661217|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
91997226|NCT02661217|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91997227|NCT02661217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997228|NCT05044091|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
91997229|NCT05044091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997230|NCT05044091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997231|NCT05044091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997232|NCT01952080|Teduglutide|teduglutide|mesh-list
91997233|NCT01952080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997234|NCT01952080|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91997235|NCT01952080|Protective Agents|protective agents|mesh-ancestor
91997236|NCT01952080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997237|NCT01951378|Albuterol|albuterol|mesh-list
91997238|NCT01951378|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91997239|NCT01951378|Autonomic Agents|autonomic agents|mesh-ancestor
91997240|NCT01951378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997241|NCT01951378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997242|NCT01951378|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91997243|NCT01951378|Respiratory System Agents|respiratory system agents|mesh-ancestor
91997244|NCT01951378|Tocolytic Agents|tocolytic agents|mesh-ancestor
91997248|NCT01951378|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91997249|NCT01951378|Adrenergic Agents|adrenergic agents|mesh-ancestor
91997250|NCT01951378|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997251|NCT01951378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997253|NCT05043233|Antithyroid Agents|antithyroid agents|mesh-ancestor
91997254|NCT05043233|Hormone Antagonists|hormone antagonists|mesh-ancestor
91997255|NCT05043233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997256|NCT05043233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997257|NCT05054465|Venetoclax|venetoclax|mesh-list
91997258|NCT05054465|Navitoclax|navitoclax|mesh-list
91997259|NCT05054465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997260|NCT03860233|Oxytocin|oxytocin|mesh-list
91970527|NCT01470755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970528|NCT01470755|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970529|NCT01470755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970530|NCT01470755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997261|NCT03860233|Oxytocics|oxytocics|mesh-ancestor
91997262|NCT03860233|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997263|NCT03860233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997264|NCT04154189|Etoposide|etoposide|mesh-list
91997265|NCT04154189|Ifosfamide|ifosfamide|mesh-list
91997266|NCT04154189|Lenvatinib|lenvatinib|mesh-list
91997267|NCT04154189|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997268|NCT04154189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997269|NCT04154189|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997270|NCT04154189|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997271|NCT04154189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997272|NCT04154189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997273|NCT04154189|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91997274|NCT04154189|Alkylating Agents|alkylating agents|mesh-ancestor
91997275|NCT04154189|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91997276|NCT02373085|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91997277|NCT02373085|Anti-Infective Agents|anti-infective agents|mesh-list
91997278|NCT01361009|Pramipexole|pramipexole|mesh-list
91997279|NCT01361009|Antioxidants|antioxidants|mesh-ancestor
91997280|NCT01361009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997281|NCT01361009|Protective Agents|protective agents|mesh-ancestor
91997282|NCT01361009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997283|NCT01361009|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91997284|NCT01361009|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91997285|NCT01361009|Dopamine Agonists|dopamine agonists|mesh-ancestor
91997286|NCT01361009|Dopamine Agents|dopamine agents|mesh-ancestor
91997287|NCT01361009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997288|NCT02373163|Amlodipine|amlodipine|mesh-list
91997289|NCT02373163|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91997291|NCT02373163|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91997292|NCT02373163|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91997293|NCT02373163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91997294|NCT02373163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997295|NCT02373163|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91997296|NCT02373163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997297|NCT02373163|Vasodilator Agents|vasodilator agents|mesh-ancestor
91997298|NCT02373163|Diuretics|diuretics|mesh-ancestor
91997299|NCT02373163|Natriuretic Agents|natriuretic agents|mesh-ancestor
91997300|NCT02373163|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91997301|NCT02373163|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91997302|NCT02373163|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91997303|NCT02366377|Metformin|metformin|mesh-list
91997304|NCT02366377|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91997305|NCT02366377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997306|NCT02366299|Dexmedetomidine|dexmedetomidine|mesh-list
91997307|NCT02366299|Propofol|propofol|mesh-list
91997308|NCT02366299|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91997309|NCT02366299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997310|NCT02366299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997311|NCT02366299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91997312|NCT02366299|Analgesics|analgesics|mesh-ancestor
91997313|NCT02366299|Sensory System Agents|sensory system agents|mesh-ancestor
91997314|NCT02366299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997315|NCT02366299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91997317|NCT02366299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91997318|NCT02366299|Adrenergic Agents|adrenergic agents|mesh-ancestor
91997319|NCT02366299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997320|NCT02366299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997321|NCT02366299|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91997322|NCT02366299|Anesthetics, General|anesthetics, general|mesh-ancestor
91997324|NCT05041985|Diazepam|diazepam|mesh-list
91997325|NCT05041985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91997326|NCT05041985|Anticonvulsants|anticonvulsants|mesh-ancestor
91997327|NCT05041985|Antiemetics|antiemetics|mesh-ancestor
91997328|NCT05041985|Autonomic Agents|autonomic agents|mesh-ancestor
91997329|NCT05041985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970531|NCT03310073|Vaccines|vaccines|mesh-list
91970532|NCT03310073|Immunologic Factors|immunologic factors|mesh-ancestor
91970533|NCT03310073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970534|NCT03309527|Diphenhydramine|diphenhydramine|mesh-list
91970535|NCT03309527|Promethazine|promethazine|mesh-list
91997330|NCT05041985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997331|NCT05041985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997332|NCT05041985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91997333|NCT05041985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997334|NCT05041985|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
91997335|NCT05041985|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91997336|NCT05041985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91997337|NCT05041985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91997338|NCT05041985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91997339|NCT05041985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91997340|NCT05041985|Anesthetics, General|anesthetics, general|mesh-ancestor
91997341|NCT05041985|Anesthetics|anesthetics|mesh-ancestor
91997342|NCT05041985|GABA Modulators|gaba modulators|mesh-ancestor
91997343|NCT05041985|GABA Agents|gaba agents|mesh-ancestor
91997344|NCT05041985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997345|NCT05041985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997346|NCT05053841|Metformin|metformin|mesh-list
91997347|NCT05053841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91997348|NCT05053841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997349|NCT02372461|Amoxicillin|amoxicillin|mesh-list
91997350|NCT02372461|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91997351|NCT02372461|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997352|NCT02859337|Ulipristal acetate|ulipristal acetate|mesh-list
91997353|NCT02859337|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91997354|NCT02859337|Contraceptive Agents|contraceptive agents|mesh-ancestor
91997355|NCT02859337|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997356|NCT02859337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997357|NCT02859337|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91997358|NCT04499131|Progesterone|progesterone|mesh-list
91997359|NCT04499131|Progestins|progestins|mesh-ancestor
91997360|NCT04499131|Hormones|hormones|mesh-ancestor
91997361|NCT04499131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997362|NCT04499131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997363|NCT02366065|Acetaminophen|acetaminophen|mesh-list
91997364|NCT02366065|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91997365|NCT02366065|Analgesics|analgesics|mesh-ancestor
91997366|NCT02366065|Sensory System Agents|sensory system agents|mesh-ancestor
91997367|NCT02366065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997368|NCT02366065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997369|NCT02366065|Antipyretics|antipyretics|mesh-ancestor
91997370|NCT02362945|Oxytocin|oxytocin|mesh-list
91997371|NCT02362945|Oxytocics|oxytocics|mesh-ancestor
91997372|NCT02362945|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997373|NCT02362945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997374|NCT02365909|Bupivacaine|bupivacaine|mesh-list
91997375|NCT02365909|Anesthetics, Local|anesthetics, local|mesh-ancestor
91997376|NCT02365909|Anesthetics|anesthetics|mesh-ancestor
91997377|NCT02365909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997378|NCT02365909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997379|NCT02365909|Sensory System Agents|sensory system agents|mesh-ancestor
91997380|NCT02365909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997381|NCT05052515|Choline|choline|mesh-list
91997382|NCT05052515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997383|NCT05052515|Lipotropic Agents|lipotropic agents|mesh-ancestor
91997384|NCT05052515|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91997385|NCT05052515|Antimetabolites|antimetabolites|mesh-ancestor
91997386|NCT05052515|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997387|NCT05052515|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91997388|NCT05052515|Nootropic Agents|nootropic agents|mesh-ancestor
91997389|NCT02365675|Petrolatum|petrolatum|mesh-list
91997390|NCT02365675|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91997391|NCT02365675|Laxatives|laxatives|mesh-ancestor
91997394|NCT02365675|Dermatologic Agents|dermatologic agents|mesh-ancestor
91997395|NCT05052437|Capecitabine|capecitabine|mesh-list
91997396|NCT05052437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997397|NCT05052437|Antimetabolites|antimetabolites|mesh-ancestor
91997398|NCT05052437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997399|NCT05052437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970536|NCT03309527|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91970537|NCT03309527|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91970538|NCT03309527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997401|NCT05052359|Agglutinins|agglutinins|mesh-ancestor
91997402|NCT05052359|Immunologic Factors|immunologic factors|mesh-ancestor
91997403|NCT05052359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997404|NCT05052359|Coagulants|coagulants|mesh-ancestor
91997405|NCT02362711|Levonorgestrel|levonorgestrel|mesh-list
91997406|NCT02362711|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91997407|NCT02362711|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91997408|NCT02362711|Contraceptive Agents|contraceptive agents|mesh-ancestor
91997409|NCT02362711|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997410|NCT02362711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997411|NCT02362711|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91997412|NCT02362711|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91997413|NCT02362711|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91997414|NCT02362711|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91997415|NCT02362711|Estrogens|estrogens|mesh-ancestor
91997416|NCT02362711|Hormones|hormones|mesh-ancestor
91997417|NCT02362711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997419|NCT01944046|Oxytocics|oxytocics|mesh-ancestor
91997420|NCT01944046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997421|NCT01944046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997422|NCT00773695|Paclitaxel|paclitaxel|mesh-list
91997423|NCT00773695|Docetaxel|docetaxel|mesh-list
91997424|NCT00773695|Cyclophosphamide|cyclophosphamide|mesh-list
91997425|NCT00773695|Bevacizumab|bevacizumab|mesh-list
91997426|NCT00773695|Fluorouracil|fluorouracil|mesh-list
91997427|NCT00773695|Epirubicin|epirubicin|mesh-list
91997428|NCT00773695|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91997429|NCT00773695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997430|NCT00773695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997431|NCT00773695|Tubulin Modulators|tubulin modulators|mesh-ancestor
91997432|NCT00773695|Antimitotic Agents|antimitotic agents|mesh-ancestor
91997433|NCT00773695|Mitosis Modulators|mitosis modulators|mesh-ancestor
91997434|NCT00773695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997435|NCT00773695|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997436|NCT00773695|Immunologic Factors|immunologic factors|mesh-ancestor
91997437|NCT00773695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997438|NCT00773695|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997439|NCT00773695|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91997440|NCT00773695|Alkylating Agents|alkylating agents|mesh-ancestor
91997441|NCT00773695|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91997442|NCT00773695|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91997443|NCT00773695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91997444|NCT00773695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91997445|NCT00773695|Growth Substances|growth substances|mesh-ancestor
91997446|NCT00773695|Growth Inhibitors|growth inhibitors|mesh-ancestor
91997447|NCT00773695|Antimetabolites|antimetabolites|mesh-ancestor
91997448|NCT00773695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997449|NCT00773695|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91997450|NCT00773695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997451|NCT00773695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91997452|NCT00773695|Hormone Antagonists|hormone antagonists|mesh-ancestor
91997453|NCT00773695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997454|NCT00773695|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91997455|NCT00773695|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997456|NCT00773695|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997457|NCT01969084|Linagliptin|linagliptin|mesh-list
91997458|NCT01969084|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91997459|NCT01969084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997460|NCT01969084|Incretins|incretins|mesh-ancestor
91997461|NCT01969084|Hormones|hormones|mesh-ancestor
91997462|NCT01969084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997463|NCT01969084|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91997464|NCT01969084|Protease Inhibitors|protease inhibitors|mesh-ancestor
91997466|NCT01969084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997467|NCT02362399|Sildenafil Citrate|sildenafil citrate|mesh-list
91997468|NCT02362399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997469|NCT02362399|Vasodilator Agents|vasodilator agents|mesh-ancestor
91970539|NCT03309527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970540|NCT03309527|Anesthetics, Local|anesthetics, local|mesh-ancestor
91997470|NCT02362399|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91997471|NCT02362399|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91997472|NCT02362399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997473|NCT02362399|Urological Agents|urological agents|mesh-ancestor
91997475|NCT04410887|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91997476|NCT04410887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997477|NCT04410887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997478|NCT04410887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997479|NCT02358499|Posaconazole|posaconazole|mesh-list
91997480|NCT02358499|Antifungal Agents|antifungal agents|mesh-ancestor
91997481|NCT02358499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997482|NCT02358499|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
91997483|NCT02358499|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91997484|NCT02358499|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91997485|NCT02358499|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91997486|NCT02358499|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91997487|NCT02358499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997488|NCT02358499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997489|NCT02358499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91997490|NCT02358499|Hormone Antagonists|hormone antagonists|mesh-ancestor
91997491|NCT02358499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997492|NCT02358499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997493|NCT02358265|Cyproheptadine|cyproheptadine|mesh-list
91997494|NCT02358265|Antipruritics|antipruritics|mesh-ancestor
91997495|NCT02358265|Dermatologic Agents|dermatologic agents|mesh-ancestor
91997496|NCT02358265|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997497|NCT02358265|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91997498|NCT02358265|Histamine Antagonists|histamine antagonists|mesh-ancestor
91997499|NCT02358265|Histamine Agents|histamine agents|mesh-ancestor
91997500|NCT02358265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997501|NCT02358265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997502|NCT02358265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997503|NCT02358265|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91997504|NCT02358265|Serotonin Agents|serotonin agents|mesh-ancestor
91997505|NCT02358265|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91997506|NCT01968694|Diphenhydramine|diphenhydramine|mesh-list
91997507|NCT01968694|Promethazine|promethazine|mesh-list
91997508|NCT01968694|Lidocaine|lidocaine|mesh-list
91997509|NCT01968694|Anesthetics, Local|anesthetics, local|mesh-ancestor
91997510|NCT01968694|Anesthetics|anesthetics|mesh-ancestor
91997511|NCT01968694|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997512|NCT01968694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997513|NCT01968694|Sensory System Agents|sensory system agents|mesh-ancestor
91997514|NCT01968694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997515|NCT01968694|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91997516|NCT01968694|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91997517|NCT01968694|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91997518|NCT01968694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91997519|NCT01968694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997520|NCT01968694|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91997521|NCT01968694|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91997522|NCT01968694|Antiemetics|antiemetics|mesh-ancestor
91997523|NCT01968694|Autonomic Agents|autonomic agents|mesh-ancestor
91997524|NCT01968694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997525|NCT01968694|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91997526|NCT01968694|Histamine Antagonists|histamine antagonists|mesh-ancestor
91997527|NCT01968694|Histamine Agents|histamine agents|mesh-ancestor
91997528|NCT01968694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997529|NCT01968694|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91997530|NCT01968694|Antipruritics|antipruritics|mesh-ancestor
91997531|NCT01968694|Dermatologic Agents|dermatologic agents|mesh-ancestor
91997532|NCT05038007|Bupivacaine|bupivacaine|mesh-list
91997533|NCT05038007|Anesthetics, Local|anesthetics, local|mesh-ancestor
91997534|NCT05038007|Anesthetics|anesthetics|mesh-ancestor
91997535|NCT05038007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997536|NCT05038007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997537|NCT05038007|Sensory System Agents|sensory system agents|mesh-ancestor
91997543|NCT02362165|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970542|NCT03309527|Sensory System Agents|sensory system agents|mesh-ancestor
91970543|NCT03309527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997544|NCT02362165|Immunologic Factors|immunologic factors|mesh-ancestor
91997545|NCT02362165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997546|NCT02362165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997547|NCT02362165|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91997548|NCT02362165|Alkylating Agents|alkylating agents|mesh-ancestor
91997549|NCT02362165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997550|NCT02362165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997551|NCT02362165|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91997552|NCT02362165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997553|NCT02362165|Antiemetics|antiemetics|mesh-ancestor
91997554|NCT02362165|Autonomic Agents|autonomic agents|mesh-ancestor
91997555|NCT02362165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997556|NCT02362165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997557|NCT02362165|Glucocorticoids|glucocorticoids|mesh-ancestor
91997559|NCT02362165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997560|NCT02362165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91997561|NCT02362165|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91997562|NCT02362165|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997563|NCT02362165|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997564|NCT02362165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997565|NCT05049473|Cytarabine|cytarabine|mesh-list
91997566|NCT05049473|Dexamethasone|dexamethasone|mesh-list
91997567|NCT05049473|Prednisone|prednisone|mesh-list
91997568|NCT05049473|Hydrocortisone|hydrocortisone|mesh-list
91997569|NCT05049473|Cyclophosphamide|cyclophosphamide|mesh-list
91997570|NCT05049473|Rituximab|rituximab|mesh-list
91997571|NCT05049473|Doxorubicin|doxorubicin|mesh-list
91997572|NCT05049473|Methotrexate|methotrexate|mesh-list
91997573|NCT05049473|Etoposide|etoposide|mesh-list
91997574|NCT05049473|Vincristine|vincristine|mesh-list
91997575|NCT05049473|Vindesine|vindesine|mesh-list
91997576|NCT05049473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997577|NCT05049473|Immunologic Factors|immunologic factors|mesh-ancestor
91997578|NCT05049473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997579|NCT05049473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997580|NCT05049473|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91997581|NCT05049473|Alkylating Agents|alkylating agents|mesh-ancestor
91997582|NCT05049473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997583|NCT05049473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997584|NCT05049473|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91997585|NCT05049473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91997586|NCT05049473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997587|NCT05049473|Antiemetics|antiemetics|mesh-ancestor
91997588|NCT05049473|Autonomic Agents|autonomic agents|mesh-ancestor
91997589|NCT05049473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997590|NCT05049473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997591|NCT05049473|Glucocorticoids|glucocorticoids|mesh-ancestor
91997592|NCT05049473|Hormones|hormones|mesh-ancestor
91997593|NCT05049473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997594|NCT05049473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91997595|NCT05049473|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91997596|NCT05049473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997597|NCT05049473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997598|NCT05049473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997599|NCT05049473|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91997600|NCT05049473|Abortifacient Agents|abortifacient agents|mesh-ancestor
91997601|NCT05049473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997602|NCT05049473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997603|NCT05049473|Antimetabolites|antimetabolites|mesh-ancestor
91997604|NCT05049473|Dermatologic Agents|dermatologic agents|mesh-ancestor
91997605|NCT05049473|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91997606|NCT05049473|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91997607|NCT05049473|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997608|NCT05049473|Antiviral Agents|antiviral agents|mesh-ancestor
91997609|NCT05049473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997614|NCT02357797|Antidepressive Agents|antidepressive agents|mesh-ancestor
91997615|NCT02357797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91997616|NCT02357797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91997617|NCT02357797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91970544|NCT03309527|Antiemetics|antiemetics|mesh-ancestor
91970545|NCT03309527|Autonomic Agents|autonomic agents|mesh-ancestor
91970546|NCT03309527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91970547|NCT03309527|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91970548|NCT03309527|Histamine Antagonists|histamine antagonists|mesh-ancestor
91970549|NCT03309527|Histamine Agents|histamine agents|mesh-ancestor
91970550|NCT03309527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997618|NCT02357797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997619|NCT02357797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997620|NCT02357797|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91997621|NCT02357797|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91997622|NCT02357797|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91997623|NCT02357797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997624|NCT02357797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997625|NCT02357797|Serotonin Agents|serotonin agents|mesh-ancestor
91997626|NCT02357797|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91997627|NCT02357797|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91997628|NCT02357797|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
91997629|NCT02357797|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91997630|NCT02361931|Epoetin Alfa|epoetin alfa|mesh-list
91997631|NCT02361931|Hematinics|hematinics|mesh-ancestor
91997632|NCT05037695|Empagliflozin|empagliflozin|mesh-list
91997633|NCT05037695|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91997634|NCT05037695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997635|NCT05037695|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91997636|NCT05037695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997637|NCT02357563|Leuprolide|leuprolide|mesh-list
91997638|NCT02357563|Ulipristal acetate|ulipristal acetate|mesh-list
91997639|NCT02357563|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91997640|NCT02357563|Fertility Agents|fertility agents|mesh-ancestor
91997641|NCT02357563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997642|NCT02357563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997643|NCT02357563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91997644|NCT02357563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997645|NCT02357563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91997646|NCT02357563|Contraceptive Agents|contraceptive agents|mesh-ancestor
91997647|NCT02357563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91997648|NCT02640053|Paclitaxel|paclitaxel|mesh-list
91997649|NCT02640053|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91997650|NCT02640053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997651|NCT02640053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997652|NCT02640053|Tubulin Modulators|tubulin modulators|mesh-ancestor
91997653|NCT02640053|Antimitotic Agents|antimitotic agents|mesh-ancestor
91997654|NCT02640053|Mitosis Modulators|mitosis modulators|mesh-ancestor
91997655|NCT02640053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997656|NCT03160261|Exenatide|exenatide|mesh-list
91997657|NCT03160261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91997658|NCT03160261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997659|NCT03160261|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91997660|NCT03160261|Incretins|incretins|mesh-ancestor
91997661|NCT03160261|Hormones|hormones|mesh-ancestor
91997662|NCT03160261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997663|NCT02361775|Ropivacaine|ropivacaine|mesh-list
91997664|NCT02361775|Anesthetics, Local|anesthetics, local|mesh-ancestor
91997665|NCT02361775|Anesthetics|anesthetics|mesh-ancestor
91997666|NCT02361775|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997667|NCT02361775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997668|NCT02361775|Sensory System Agents|sensory system agents|mesh-ancestor
91997669|NCT02361775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997670|NCT02361619|Clarithromycin|clarithromycin|mesh-list
91997671|NCT02361619|Diclofenac|diclofenac|mesh-list
91997672|NCT02361619|Metoprolol|metoprolol|mesh-list
91997673|NCT02361619|Midazolam|midazolam|mesh-list
91997674|NCT02361619|Caffeine|caffeine|mesh-list
91997675|NCT02361619|Esomeprazole|esomeprazole|mesh-list
91997676|NCT02361619|Dabigatran|dabigatran|mesh-list
91997677|NCT02361619|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91997678|NCT02361619|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91970551|NCT03309527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970552|NCT03309527|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91997679|NCT02361619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997680|NCT02361619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997683|NCT02361619|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91997684|NCT02361619|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91997685|NCT02361619|Anesthetics, General|anesthetics, general|mesh-ancestor
91997686|NCT02361619|Anesthetics|anesthetics|mesh-ancestor
91997687|NCT02361619|GABA Modulators|gaba modulators|mesh-ancestor
91997688|NCT02361619|GABA Agents|gaba agents|mesh-ancestor
91997689|NCT02361619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997690|NCT02361619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997691|NCT02361619|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91997692|NCT02361619|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91997693|NCT02361619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997694|NCT02361619|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91997695|NCT02361619|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91997696|NCT02361619|Purinergic Agents|purinergic agents|mesh-ancestor
91997697|NCT02361619|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91997698|NCT02361619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997699|NCT02361619|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91997700|NCT02361619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91997701|NCT02361619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91997702|NCT02361619|Analgesics|analgesics|mesh-ancestor
91997703|NCT02361619|Sensory System Agents|sensory system agents|mesh-ancestor
91997704|NCT02361619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997705|NCT02361619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997706|NCT02361619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997707|NCT02361619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91997708|NCT02361619|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91997709|NCT02361619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997710|NCT02361619|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91997711|NCT02361619|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91997712|NCT02361619|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91997713|NCT02361619|Antithrombins|antithrombins|mesh-ancestor
91997714|NCT02361619|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91997715|NCT02361619|Protease Inhibitors|protease inhibitors|mesh-ancestor
91997716|NCT02361619|Anticoagulants|anticoagulants|mesh-ancestor
91997717|NCT02361619|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91997718|NCT02361619|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91997719|NCT02361619|Sympatholytics|sympatholytics|mesh-ancestor
91997720|NCT02361619|Autonomic Agents|autonomic agents|mesh-ancestor
91997721|NCT02361619|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
91997722|NCT02361619|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91997723|NCT02361619|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91997724|NCT02361619|Adrenergic Agents|adrenergic agents|mesh-ancestor
91997725|NCT02352025|Equol|equol|mesh-list
91997726|NCT02352025|Phytoestrogens|phytoestrogens|mesh-ancestor
91997727|NCT02352025|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
91997728|NCT02352025|Estrogens|estrogens|mesh-ancestor
91997729|NCT02352025|Hormones|hormones|mesh-ancestor
91997730|NCT02352025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997731|NCT02352025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997732|NCT01950364|Rifampin|rifampin|mesh-list
91997733|NCT01950364|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91997734|NCT01950364|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91997735|NCT01950364|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91997736|NCT01950364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997737|NCT01950364|Immunotoxins|immunotoxins|mesh-ancestor
91997738|NCT01950364|Immunoconjugates|immunoconjugates|mesh-ancestor
91997739|NCT01950364|Immunologic Factors|immunologic factors|mesh-ancestor
91997740|NCT01950364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997741|NCT01950364|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91997742|NCT01950364|Antitubercular Agents|antitubercular agents|mesh-ancestor
91997743|NCT01950364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91997744|NCT01950364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997745|NCT01950364|Leprostatic Agents|leprostatic agents|mesh-ancestor
91997746|NCT01950364|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91997747|NCT01950364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997748|NCT01950364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970553|NCT03309527|Antipruritics|antipruritics|mesh-ancestor
91970554|NCT03309527|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970556|NCT03313661|Cabergoline|cabergoline|mesh-list
91997749|NCT01950364|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91997750|NCT01950364|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91997751|NCT01950364|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91997752|NCT01950364|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91997755|NCT05047991|Leucovorin|leucovorin|mesh-list
91997756|NCT05047991|Paclitaxel|paclitaxel|mesh-list
91997757|NCT05047991|Gemcitabine|gemcitabine|mesh-list
91997758|NCT05047991|Fluorouracil|fluorouracil|mesh-list
91997759|NCT05047991|Oxaliplatin|oxaliplatin|mesh-list
91997760|NCT05047991|Irinotecan|irinotecan|mesh-list
91997761|NCT05047991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91997762|NCT05047991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997763|NCT05047991|Tubulin Modulators|tubulin modulators|mesh-ancestor
91997764|NCT05047991|Antimitotic Agents|antimitotic agents|mesh-ancestor
91997765|NCT05047991|Mitosis Modulators|mitosis modulators|mesh-ancestor
91997766|NCT05047991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997767|NCT05047991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997768|NCT05047991|Antimetabolites|antimetabolites|mesh-ancestor
91997769|NCT05047991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997770|NCT05047991|Immunologic Factors|immunologic factors|mesh-ancestor
91997771|NCT05047991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997772|NCT05047991|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91997773|NCT05047991|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997774|NCT05047991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997776|NCT05047991|Protective Agents|protective agents|mesh-ancestor
91997777|NCT05047991|Vitamin B Complex|vitamin b complex|mesh-ancestor
91997778|NCT05047991|Vitamins|vitamins|mesh-ancestor
91997779|NCT05047991|Micronutrients|micronutrients|mesh-ancestor
91997780|NCT00014443|Thalidomide|thalidomide|mesh-list
91997781|NCT00014443|Topotecan|topotecan|mesh-list
91997782|NCT00014443|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91997783|NCT00014443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997784|NCT00014443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997785|NCT00014443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997786|NCT00014443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997787|NCT00014443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997788|NCT00014443|Immunologic Factors|immunologic factors|mesh-ancestor
91997789|NCT00014443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997790|NCT00014443|Leprostatic Agents|leprostatic agents|mesh-ancestor
91997791|NCT00014443|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91997792|NCT00014443|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997793|NCT00014443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91997794|NCT00014443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91997795|NCT00014443|Growth Substances|growth substances|mesh-ancestor
91997796|NCT00014443|Growth Inhibitors|growth inhibitors|mesh-ancestor
91997797|NCT05047133|Tranexamic Acid|tranexamic acid|mesh-list
91997798|NCT05047133|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91997799|NCT05047133|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91997800|NCT05047133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997801|NCT05047133|Hemostatics|hemostatics|mesh-ancestor
91997802|NCT05047133|Coagulants|coagulants|mesh-ancestor
91997803|NCT04334863|Tyrphostins|tyrphostins|mesh-list
91997804|NCT04334863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997805|NCT04334863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074271|NCT00074308|Immunologic Factors|immunologic factors|mesh-ancestor
91997806|NCT04334863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997807|NCT02357407|Ciprofloxacin|ciprofloxacin|mesh-list
91997808|NCT02357407|Ofloxacin|ofloxacin|mesh-list
91997809|NCT02357407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91997810|NCT02357407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91997811|NCT02357407|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91997812|NCT02357407|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91997813|NCT02357407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997814|NCT02357407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997815|NCT02357407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997816|NCT02357407|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91997817|NCT02357407|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91997818|NCT02357407|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91997819|NCT02038699|TIC10 compound|tic10 compound|mesh-list
91970557|NCT03313661|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91970558|NCT03313661|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91970559|NCT03313661|Dopamine Agonists|dopamine agonists|mesh-ancestor
91997820|NCT02038699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997821|NCT03160651|Methylprednisolone|methylprednisolone|mesh-list
91997822|NCT03160651|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91997823|NCT03160651|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91997824|NCT03160651|Prednisolone|prednisolone|mesh-list
91997825|NCT03160651|Prednisolone acetate|prednisolone acetate|mesh-list
91997826|NCT03160651|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91997830|NCT03160651|Autonomic Agents|autonomic agents|mesh-ancestor
91997831|NCT03160651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997832|NCT03160651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997833|NCT03160651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997834|NCT03160651|Glucocorticoids|glucocorticoids|mesh-ancestor
91997835|NCT03160651|Hormones|hormones|mesh-ancestor
91997836|NCT03160651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91997837|NCT03160651|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91997838|NCT03160651|Protective Agents|protective agents|mesh-ancestor
91997839|NCT03160651|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91997840|NCT03160651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997841|NCT05034965|Hyaluronic Acid|hyaluronic acid|mesh-list
91997842|NCT05034965|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91997843|NCT05034965|Immunologic Factors|immunologic factors|mesh-ancestor
91997845|NCT05034965|Viscosupplements|viscosupplements|mesh-ancestor
91997846|NCT05034965|Protective Agents|protective agents|mesh-ancestor
91997847|NCT03160339|Vaccines|vaccines|mesh-list
91997848|NCT03160339|Immunologic Factors|immunologic factors|mesh-ancestor
91997849|NCT03160339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997850|NCT05034887|Trastuzumab|trastuzumab|mesh-list
91997851|NCT05034887|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
91997852|NCT05034887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91997853|NCT05034887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997854|NCT05034887|Immunoconjugates|immunoconjugates|mesh-ancestor
91997855|NCT05034887|Immunologic Factors|immunologic factors|mesh-ancestor
91997856|NCT05034887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997857|NCT02039011|Tiotropium Bromide|tiotropium bromide|mesh-list
91997858|NCT02039011|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91997859|NCT02039011|Autonomic Agents|autonomic agents|mesh-ancestor
91997860|NCT02039011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997861|NCT02039011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997862|NCT02039011|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91997863|NCT02039011|Respiratory System Agents|respiratory system agents|mesh-ancestor
91997864|NCT02039011|Parasympatholytics|parasympatholytics|mesh-ancestor
91997865|NCT02039011|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91997866|NCT02039011|Cholinergic Agents|cholinergic agents|mesh-ancestor
91997867|NCT02039011|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997868|NCT02039011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997869|NCT05024825|Acetaminophen|acetaminophen|mesh-list
91997870|NCT05024825|Ibuprofen|ibuprofen|mesh-list
91997872|NCT05024825|Hydrocodone|hydrocodone|mesh-list
91997873|NCT05024825|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91997874|NCT05024825|Analgesics|analgesics|mesh-ancestor
91997875|NCT05024825|Sensory System Agents|sensory system agents|mesh-ancestor
91997876|NCT05024825|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997877|NCT05024825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997878|NCT05024825|Antipyretics|antipyretics|mesh-ancestor
91997879|NCT05024825|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91997880|NCT05024825|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997881|NCT05024825|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997882|NCT05024825|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91997883|NCT05024825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997884|NCT05024825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997885|NCT05024825|Anticonvulsants|anticonvulsants|mesh-ancestor
91997886|NCT05024825|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91997887|NCT05024825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91997888|NCT05024825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997889|NCT05024825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91997890|NCT05024825|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91997891|NCT05024825|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91970560|NCT03313661|Dopamine Agents|dopamine agents|mesh-ancestor
91970561|NCT03313661|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997892|NCT05024825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997893|NCT05024825|Antimanic Agents|antimanic agents|mesh-ancestor
91997894|NCT05024825|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91997895|NCT05024825|Narcotics|narcotics|mesh-ancestor
91997896|NCT05024825|Antitussive Agents|antitussive agents|mesh-ancestor
91997897|NCT05024825|Respiratory System Agents|respiratory system agents|mesh-ancestor
91997898|NCT05024435|Pulmonary Surfactants|pulmonary surfactants|mesh-list
91997899|NCT05024435|Respiratory System Agents|respiratory system agents|mesh-ancestor
91997900|NCT03093467|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
91997904|NCT03093467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91997905|NCT03093467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997906|NCT03093467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997908|NCT03149653|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91997909|NCT03149653|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91997910|NCT03149653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91997911|NCT03093545|Immunoglobulins|immunoglobulins|mesh-list
91997912|NCT03093545|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91997913|NCT03093545|Antibodies|antibodies|mesh-list
91997914|NCT03093545|Immunologic Factors|immunologic factors|mesh-ancestor
91997915|NCT03093545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997916|NCT05024357|Dasatinib|dasatinib|mesh-list
91997917|NCT05024357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997918|NCT05024357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91997919|NCT05024357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997920|NCT05024357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997921|NCT03095105|Resveratrol|resveratrol|mesh-list
91997922|NCT03095105|Antioxidants|antioxidants|mesh-ancestor
91997923|NCT03095105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997924|NCT03095105|Protective Agents|protective agents|mesh-ancestor
91997925|NCT03095105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997926|NCT03095105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997927|NCT03095105|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91997928|NCT01968070|Celecoxib|celecoxib|mesh-list
91997929|NCT01968070|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91997930|NCT01968070|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91997931|NCT01968070|Analgesics|analgesics|mesh-ancestor
91997932|NCT01968070|Sensory System Agents|sensory system agents|mesh-ancestor
91997933|NCT01968070|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997934|NCT01968070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997935|NCT01968070|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997936|NCT01968070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997937|NCT01968070|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91997938|NCT01968070|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91997939|NCT01968070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997940|NCT01968070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997941|NCT01949662|Lorazepam|lorazepam|mesh-list
91997942|NCT01949662|Haloperidol|haloperidol|mesh-list
91997943|NCT01949662|Haloperidol decanoate|haloperidol decanoate|mesh-list
91997944|NCT01949662|Antiemetics|antiemetics|mesh-ancestor
91997945|NCT01949662|Autonomic Agents|autonomic agents|mesh-ancestor
91997946|NCT01949662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997947|NCT01949662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997948|NCT01949662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997949|NCT01949662|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91997950|NCT01949662|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91997951|NCT01949662|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91997952|NCT01949662|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91997953|NCT01949662|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91997954|NCT01949662|Dopamine Agents|dopamine agents|mesh-ancestor
91997955|NCT01949662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91997956|NCT01949662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997957|NCT01949662|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91997958|NCT01949662|Anticonvulsants|anticonvulsants|mesh-ancestor
91997959|NCT01949662|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91997960|NCT01949662|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91997961|NCT01949662|GABA Modulators|gaba modulators|mesh-ancestor
91997962|NCT01949662|GABA Agents|gaba agents|mesh-ancestor
91997963|NCT03093389|Resveratrol|resveratrol|mesh-list
91997964|NCT03093389|Antioxidants|antioxidants|mesh-ancestor
92090451|NCT01903031|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91997965|NCT03093389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997966|NCT03093389|Protective Agents|protective agents|mesh-ancestor
91997967|NCT03093389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91997968|NCT03093389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997969|NCT03093389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91997971|NCT01949116|Methotrexate|methotrexate|mesh-list
91997972|NCT01949116|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91997976|NCT01949116|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91997977|NCT01949116|Antimetabolites|antimetabolites|mesh-ancestor
91997978|NCT01949116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997979|NCT01949116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997980|NCT01949116|Dermatologic Agents|dermatologic agents|mesh-ancestor
91997981|NCT01949116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997982|NCT01949116|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91997983|NCT01949116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91997984|NCT01949116|Immunologic Factors|immunologic factors|mesh-ancestor
91997985|NCT01949116|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91997986|NCT01949116|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91997987|NCT01949116|Hematinics|hematinics|mesh-ancestor
91997988|NCT01949116|Vitamin B Complex|vitamin b complex|mesh-ancestor
91997990|NCT01949116|Micronutrients|micronutrients|mesh-ancestor
91997991|NCT01673009|Imatinib Mesylate|imatinib mesylate|mesh-list
91997992|NCT01673009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91997993|NCT01673009|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91997994|NCT01673009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997995|NCT01673009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91997996|NCT02350387|Oxymetazoline|oxymetazoline|mesh-list
91997997|NCT02350387|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91997998|NCT02350387|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91997999|NCT02350387|Adrenergic Agents|adrenergic agents|mesh-ancestor
91998000|NCT02350387|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998001|NCT02350387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998002|NCT02350387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998003|NCT02350387|Sympathomimetics|sympathomimetics|mesh-ancestor
91998004|NCT02350387|Autonomic Agents|autonomic agents|mesh-ancestor
91998005|NCT02350387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998006|NCT02350387|Nasal Decongestants|nasal decongestants|mesh-ancestor
91998007|NCT02350387|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91998008|NCT02350387|Respiratory System Agents|respiratory system agents|mesh-ancestor
91998010|NCT02350543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91998011|NCT02350543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998012|NCT02350543|Analgesics|analgesics|mesh-ancestor
91998013|NCT02350543|Sensory System Agents|sensory system agents|mesh-ancestor
91998014|NCT02350543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998015|NCT02350543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998016|NCT02350543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998017|NCT02350543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998018|NCT02350543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91998019|NCT02350543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91998020|NCT02350543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998021|NCT02350543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91998022|NCT02350543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91998023|NCT02350543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998024|NCT02350543|Antipyretics|antipyretics|mesh-ancestor
91998025|NCT05023577|Metronidazole|metronidazole|mesh-list
91998027|NCT05023577|Levofloxacin|levofloxacin|mesh-list
91998028|NCT05023577|Potassium Citrate|potassium citrate|mesh-list
91998029|NCT05023577|Rabeprazole|rabeprazole|mesh-list
91998030|NCT05023577|Bismuth|bismuth|mesh-list
91998031|NCT05023577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998032|NCT05023577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998033|NCT05023577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998034|NCT05023577|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91998035|NCT05023577|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91998036|NCT05023577|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91998037|NCT05023577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998038|NCT05023577|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91970562|NCT03313661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970563|NCT03313661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970564|NCT03313661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91998039|NCT05023577|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91998040|NCT05023577|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91998041|NCT05023577|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91998042|NCT05023577|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91998047|NCT05023577|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91998048|NCT05023577|Antacids|antacids|mesh-ancestor
91998049|NCT05023577|Diuretics|diuretics|mesh-ancestor
91998050|NCT05023577|Natriuretic Agents|natriuretic agents|mesh-ancestor
91998051|NCT05023577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998052|NCT05023577|Expectorants|expectorants|mesh-ancestor
91998053|NCT05023577|Respiratory System Agents|respiratory system agents|mesh-ancestor
91998054|NCT03149419|Paroxetine|paroxetine|mesh-list
91998055|NCT03149419|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91998056|NCT03149419|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91998057|NCT03149419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998058|NCT03149419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998059|NCT03149419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998060|NCT03149419|Serotonin Agents|serotonin agents|mesh-ancestor
91998061|NCT03149419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998062|NCT03149419|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91998063|NCT03149419|Antidepressive Agents|antidepressive agents|mesh-ancestor
91998064|NCT03149419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91998065|NCT03149419|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91998066|NCT03149419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91998068|NCT03092765|Quetmolimab|quetmolimab|mesh-list
91998069|NCT03092765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998071|NCT01939366|Analgesics|analgesics|mesh-ancestor
91998072|NCT01939366|Sensory System Agents|sensory system agents|mesh-ancestor
91998073|NCT01939366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998074|NCT01939366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998075|NCT01939366|Anticonvulsants|anticonvulsants|mesh-ancestor
91998076|NCT01939366|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91998077|NCT01939366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998078|NCT01939366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998079|NCT01939366|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91998080|NCT01939366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91998081|NCT01939366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91998082|NCT01939366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998083|NCT01939366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91998084|NCT04434365|Aspirin|aspirin|mesh-list
91998085|NCT04434365|Clopidogrel|clopidogrel|mesh-list
91998086|NCT04434365|Atorvastatin|atorvastatin|mesh-list
91998087|NCT04434365|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91998088|NCT04434365|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91998089|NCT04434365|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998090|NCT04434365|Analgesics|analgesics|mesh-ancestor
91998091|NCT04434365|Sensory System Agents|sensory system agents|mesh-ancestor
91998092|NCT04434365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998093|NCT04434365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998094|NCT04434365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998095|NCT04434365|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998096|NCT04434365|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91998097|NCT04434365|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91998098|NCT04434365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998099|NCT04434365|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91998100|NCT04434365|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91998101|NCT04434365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998102|NCT04434365|Antipyretics|antipyretics|mesh-ancestor
91998103|NCT04434365|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91998104|NCT04434365|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91998105|NCT04434365|Antimetabolites|antimetabolites|mesh-ancestor
91998106|NCT04434365|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91970566|NCT00703781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91970567|NCT00703781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91970568|NCT00703781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91970569|NCT00703781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91970570|NCT00703781|Analgesics|analgesics|mesh-ancestor
91970571|NCT00703781|Sensory System Agents|sensory system agents|mesh-ancestor
92090452|NCT01903031|Protease Inhibitors|protease inhibitors|mesh-ancestor
91998107|NCT04434365|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91998108|NCT04434365|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91998109|NCT04434365|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91998110|NCT04434365|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91998111|NCT04434365|Purinergic Agents|purinergic agents|mesh-ancestor
91998112|NCT04434365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998114|NCT05032235|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91998115|NCT05032235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998116|NCT05032235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998117|NCT05032235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998118|NCT05031923|Anti-Infective Agents|anti-infective agents|mesh-list
91998119|NCT05031923|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91998120|NCT03149575|Carboplatin|carboplatin|mesh-list
91998121|NCT03149575|Temozolomide|temozolomide|mesh-list
91998123|NCT03149575|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
91998124|NCT03149575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998125|NCT03149575|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91998126|NCT03149575|Alkylating Agents|alkylating agents|mesh-ancestor
91998127|NCT03149575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998128|NCT05032001|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91998129|NCT05032001|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
91998130|NCT05032001|Biguanides|biguanides|mesh-list
91998131|NCT05032001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998132|NCT05032001|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91998133|NCT05032001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998134|NCT05032001|Protease Inhibitors|protease inhibitors|mesh-ancestor
91998135|NCT05032001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998136|NCT05031689|Sunscreening Agents|sunscreening agents|mesh-list
91998137|NCT05031689|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91998138|NCT05031689|Protective Agents|protective agents|mesh-ancestor
91998139|NCT05031689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998140|NCT05031689|Dermatologic Agents|dermatologic agents|mesh-ancestor
91998141|NCT02350231|Progesterone|progesterone|mesh-list
91998142|NCT02350231|Progestins|progestins|mesh-ancestor
91998143|NCT02350231|Hormones|hormones|mesh-ancestor
91998144|NCT02350231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998145|NCT02350231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998146|NCT01918306|Cisplatin|cisplatin|mesh-list
91998147|NCT01918306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998148|NCT05031143|Triamcinolone|triamcinolone|mesh-list
91998149|NCT05031143|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91998150|NCT05031143|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91998151|NCT05031143|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91998152|NCT05031143|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998153|NCT05031143|Glucocorticoids|glucocorticoids|mesh-ancestor
91998154|NCT05031143|Hormones|hormones|mesh-ancestor
91998155|NCT05031143|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998156|NCT05031143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998157|NCT05031143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998158|NCT05031143|Immunologic Factors|immunologic factors|mesh-ancestor
91998159|NCT05031143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998160|NCT05031143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998161|NCT01916980|Desloratadine|desloratadine|mesh-list
91998162|NCT01916980|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91998163|NCT01916980|Cholinergic Agents|cholinergic agents|mesh-ancestor
91998164|NCT01916980|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998165|NCT01916980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998166|NCT01916980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970572|NCT00703781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970573|NCT00703781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998167|NCT01916980|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91998168|NCT01916980|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91998169|NCT01916980|Histamine Antagonists|histamine antagonists|mesh-ancestor
91998170|NCT01916980|Histamine Agents|histamine agents|mesh-ancestor
91998171|NCT02348281|Bicalutamide|bicalutamide|mesh-list
91998172|NCT02348281|Androgen Antagonists|androgen antagonists|mesh-ancestor
91998173|NCT02348281|Hormone Antagonists|hormone antagonists|mesh-ancestor
91998174|NCT02348281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998175|NCT02348281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998176|NCT02348281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998177|NCT04638400|Simvastatin|simvastatin|mesh-list
91998178|NCT04638400|Ezetimibe|ezetimibe|mesh-list
91998179|NCT04638400|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91998180|NCT04638400|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91998181|NCT04638400|Antimetabolites|antimetabolites|mesh-ancestor
91998182|NCT04638400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998183|NCT04638400|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91998184|NCT04638400|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91998189|NCT02349919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998190|NCT02349919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998191|NCT02349919|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91998192|NCT02349919|Respiratory System Agents|respiratory system agents|mesh-ancestor
91998193|NCT02349919|Sympathomimetics|sympathomimetics|mesh-ancestor
91998194|NCT02349919|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91998195|NCT02349919|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91998196|NCT02349919|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91998197|NCT02349919|Adrenergic Agents|adrenergic agents|mesh-ancestor
91998198|NCT02349919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998199|NCT02349919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998200|NCT02349763|Dexamethasone|dexamethasone|mesh-list
91998201|NCT02349763|Dexamethasone acetate|dexamethasone acetate|mesh-list
91998203|NCT02349763|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998204|NCT02349763|Antiemetics|antiemetics|mesh-ancestor
91998205|NCT02349763|Autonomic Agents|autonomic agents|mesh-ancestor
91998206|NCT02349763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998207|NCT02349763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998208|NCT02349763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998209|NCT02349763|Glucocorticoids|glucocorticoids|mesh-ancestor
91998210|NCT02349763|Hormones|hormones|mesh-ancestor
91998211|NCT02349763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998212|NCT02349763|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91998213|NCT02349763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998214|NCT02349763|Protease Inhibitors|protease inhibitors|mesh-ancestor
91998215|NCT02349763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998216|NCT02349763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998217|NCT02349841|Amoxicillin|amoxicillin|mesh-list
91998218|NCT02349841|Meropenem|meropenem|mesh-list
91998219|NCT02349841|Clavulanic Acids|clavulanic acids|mesh-list
91998220|NCT02349841|Clavulanic Acid|clavulanic acid|mesh-list
91998221|NCT02349841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998222|NCT02349841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998223|NCT02349841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998224|NCT02349841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998225|NCT02349841|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
91998226|NCT02354053|Abacavir, dolutegravir, and lamivudine drug combination|abacavir, dolutegravir, and lamivudine drug combination|mesh-list
91998227|NCT02354053|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91998228|NCT02354053|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91998229|NCT02354053|Antiviral Agents|antiviral agents|mesh-ancestor
91998230|NCT02354053|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998231|NCT05028803|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
91998232|NCT05028803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998233|NCT03094481|Epinephrine|epinephrine|mesh-list
91998234|NCT03094481|Bupivacaine|bupivacaine|mesh-list
91998235|NCT03094481|Anesthetics, Local|anesthetics, local|mesh-ancestor
91998236|NCT03094481|Anesthetics|anesthetics|mesh-ancestor
91998237|NCT03094481|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998238|NCT03094481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998239|NCT03094481|Sensory System Agents|sensory system agents|mesh-ancestor
91998240|NCT03094481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970574|NCT00703781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970575|NCT00703781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970577|NCT03309215|Trace Elements|trace elements|mesh-ancestor
91970578|NCT03309215|Micronutrients|micronutrients|mesh-ancestor
91970579|NCT03309215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970580|NCT03309059|Zinc Oxide|zinc oxide|mesh-list
91998241|NCT03094481|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91998242|NCT03094481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91998243|NCT03094481|Adrenergic Agents|adrenergic agents|mesh-ancestor
91998244|NCT03094481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998245|NCT03094481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998246|NCT03094481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91998247|NCT03094481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91998248|NCT03094481|Autonomic Agents|autonomic agents|mesh-ancestor
91998249|NCT03094481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91998250|NCT03094481|Respiratory System Agents|respiratory system agents|mesh-ancestor
91998251|NCT03094481|Mydriatics|mydriatics|mesh-ancestor
91998252|NCT03094481|Sympathomimetics|sympathomimetics|mesh-ancestor
91998253|NCT03094481|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91998254|NCT04438837|Hydroxychloroquine|hydroxychloroquine|mesh-list
91998255|NCT04438837|Antimalarials|antimalarials|mesh-ancestor
91998256|NCT04438837|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91998261|NCT04438837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998262|NCT02348125|Thioctic Acid|thioctic acid|mesh-list
91998263|NCT02348125|Antioxidants|antioxidants|mesh-ancestor
91998264|NCT02348125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998265|NCT02348125|Protective Agents|protective agents|mesh-ancestor
91998266|NCT02348125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998267|NCT02348125|Vitamin B Complex|vitamin b complex|mesh-ancestor
91998268|NCT02348125|Vitamins|vitamins|mesh-ancestor
91998269|NCT02348125|Micronutrients|micronutrients|mesh-ancestor
91998270|NCT05028335|Carbamide Peroxide|carbamide peroxide|mesh-list
91998271|NCT05028335|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91998272|NCT05028335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998273|NCT03094403|Azelaic acid|azelaic acid|mesh-list
91998274|NCT03094403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998275|NCT03094403|Dermatologic Agents|dermatologic agents|mesh-ancestor
91998276|NCT02347891|Belimumab|belimumab|mesh-list
91998277|NCT02347891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998278|NCT02347891|Immunologic Factors|immunologic factors|mesh-ancestor
91998279|NCT02347891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998280|NCT03147157|Tacrolimus|tacrolimus|mesh-list
91998281|NCT03147157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998282|NCT03147157|Immunologic Factors|immunologic factors|mesh-ancestor
91998283|NCT03147157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998284|NCT03147157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91998285|NCT03147157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998286|NCT03147157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998287|NCT02347501|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91998288|NCT02347501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91998289|NCT02347501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998290|NCT02347501|Incretins|incretins|mesh-ancestor
91998291|NCT02347501|Hormones|hormones|mesh-ancestor
91998292|NCT02347501|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998293|NCT02347501|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91998294|NCT02347501|Protease Inhibitors|protease inhibitors|mesh-ancestor
91998295|NCT02347501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998296|NCT02347501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998297|NCT03148717|Misoprostol|misoprostol|mesh-list
91998298|NCT03148717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91998299|NCT03148717|Abortifacient Agents|abortifacient agents|mesh-ancestor
91998300|NCT03148717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91998301|NCT03148717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998302|NCT03148717|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91998303|NCT03148717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998304|NCT03148717|Oxytocics|oxytocics|mesh-ancestor
91998305|NCT02349607|Ibuprofen|ibuprofen|mesh-list
91998306|NCT02349607|Pregabalin|pregabalin|mesh-list
91998307|NCT02349607|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91970581|NCT03309059|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970582|NCT03309059|Sunscreening Agents|sunscreening agents|mesh-ancestor
91970583|NCT03309059|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91970584|NCT03309059|Protective Agents|protective agents|mesh-ancestor
91970585|NCT03309059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970586|NCT02469545|Sertraline|sertraline|mesh-list
91970587|NCT02469545|Escitalopram|escitalopram|mesh-list
91998308|NCT02349607|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998309|NCT02349607|Analgesics|analgesics|mesh-ancestor
91998310|NCT02349607|Sensory System Agents|sensory system agents|mesh-ancestor
91998311|NCT02349607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998312|NCT02349607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998313|NCT02349607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998314|NCT02349607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998315|NCT02349607|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91998316|NCT02349607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998317|NCT02349607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998318|NCT02349607|Anticonvulsants|anticonvulsants|mesh-ancestor
91998319|NCT02349607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91998320|NCT02349607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998321|NCT02349607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91998322|NCT02349607|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91998323|NCT02349607|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91998324|NCT02349607|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998325|NCT02349607|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91998326|NCT05019755|Varespladib methyl|varespladib methyl|mesh-list
91998329|NCT05019755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998330|NCT04478461|Antibodies|antibodies|mesh-list
91998331|NCT04478461|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91998332|NCT04478461|Immunologic Factors|immunologic factors|mesh-ancestor
91998333|NCT04478461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998334|NCT04108481|Durvalumab|durvalumab|mesh-list
91998335|NCT04108481|Methamphetamine|methamphetamine|mesh-list
91998336|NCT04108481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91998337|NCT04108481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91998338|NCT04108481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998339|NCT04108481|Immunologic Factors|immunologic factors|mesh-ancestor
91998340|NCT04108481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998341|NCT04108481|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91998342|NCT04108481|Sympathomimetics|sympathomimetics|mesh-ancestor
91998343|NCT04108481|Autonomic Agents|autonomic agents|mesh-ancestor
91998344|NCT04108481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998345|NCT04108481|Dopamine Agents|dopamine agents|mesh-ancestor
91998346|NCT04108481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998347|NCT04108481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998348|NCT04108481|Adrenergic Agents|adrenergic agents|mesh-ancestor
91998349|NCT04108481|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91998350|NCT04108481|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91998351|NCT04108481|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998352|NCT04108481|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91998353|NCT02353507|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91998354|NCT02353507|Laxatives|laxatives|mesh-ancestor
91998355|NCT02353507|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998356|NCT03148561|Misoprostol|misoprostol|mesh-list
91998357|NCT03148561|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91998358|NCT03148561|Abortifacient Agents|abortifacient agents|mesh-ancestor
91998359|NCT03148561|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91998360|NCT03148561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998361|NCT03148561|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91998362|NCT03148561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998363|NCT03148561|Oxytocics|oxytocics|mesh-ancestor
91998364|NCT02353429|Toremifene|toremifene|mesh-list
91998365|NCT02353429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91998366|NCT02353429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998367|NCT02353429|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91998368|NCT02353429|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91998369|NCT02353429|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970588|NCT02469545|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91970589|NCT02469545|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91970590|NCT02469545|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970591|NCT02469545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998370|NCT02353429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998371|NCT02353429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998372|NCT02353429|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91998373|NCT05027243|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
91998374|NCT05027243|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91998375|NCT05027243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998376|NCT05027243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998377|NCT05027243|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91998378|NCT05027243|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998379|NCT05027243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998380|NCT05027243|Cholinergic Agents|cholinergic agents|mesh-ancestor
91998381|NCT05027243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998383|NCT03112135|Tranexamic Acid|tranexamic acid|mesh-list
91998384|NCT03112135|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91998385|NCT03112135|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91998386|NCT03112135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998387|NCT03112135|Hemostatics|hemostatics|mesh-ancestor
91998388|NCT03112135|Coagulants|coagulants|mesh-ancestor
91998389|NCT03112135|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91998390|NCT03112135|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91998391|NCT03112135|Adrenergic Agents|adrenergic agents|mesh-ancestor
91998392|NCT03112135|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998393|NCT03112135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998394|NCT03112135|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91998395|NCT03112135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91998396|NCT03112135|Autonomic Agents|autonomic agents|mesh-ancestor
91998397|NCT03112135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998402|NCT03112135|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91998403|NCT04477993|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
91998404|NCT04477993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998405|NCT04477993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998406|NCT04477993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998407|NCT03146533|Cyclophosphamide|cyclophosphamide|mesh-list
91998408|NCT03146533|Fludarabine|fludarabine|mesh-list
91998409|NCT03146533|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998410|NCT03146533|Immunologic Factors|immunologic factors|mesh-ancestor
91998411|NCT03146533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998412|NCT03146533|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998413|NCT03146533|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91998414|NCT03146533|Alkylating Agents|alkylating agents|mesh-ancestor
91998415|NCT03146533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998416|NCT03146533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998417|NCT03146533|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91998419|NCT03090971|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91998420|NCT03090971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998421|NCT03090971|Analgesics|analgesics|mesh-ancestor
91998422|NCT03090971|Sensory System Agents|sensory system agents|mesh-ancestor
91998423|NCT03090971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998424|NCT03090971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998425|NCT03090971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998426|NCT03090971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998427|NCT03090971|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91998428|NCT03090971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998429|NCT03090971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998430|NCT03146689|Ibuprofen|ibuprofen|mesh-list
91998431|NCT03146689|Capsaicin|capsaicin|mesh-list
91998432|NCT03146689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91998433|NCT03146689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998434|NCT03146689|Analgesics|analgesics|mesh-ancestor
91998435|NCT03146689|Sensory System Agents|sensory system agents|mesh-ancestor
91998436|NCT03146689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998437|NCT03146689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998438|NCT03146689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998439|NCT03146689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998440|NCT03146689|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91998441|NCT03146689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998442|NCT03146689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998443|NCT03146689|Antipruritics|antipruritics|mesh-ancestor
91998444|NCT03146689|Dermatologic Agents|dermatologic agents|mesh-ancestor
91998445|NCT05255575|Ertapenem|ertapenem|mesh-list
91998446|NCT05255575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998447|NCT05255575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998448|NCT05026229|Cytarabine|cytarabine|mesh-list
91998449|NCT05026229|Prednisone|prednisone|mesh-list
91998450|NCT05026229|Methotrexate|methotrexate|mesh-list
91998451|NCT05026229|Vincristine|vincristine|mesh-list
91998452|NCT05026229|Dasatinib|dasatinib|mesh-list
91998453|NCT05026229|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998454|NCT05026229|Glucocorticoids|glucocorticoids|mesh-ancestor
91998455|NCT05026229|Hormones|hormones|mesh-ancestor
91998456|NCT05026229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998457|NCT05026229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998458|NCT05026229|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91998459|NCT05026229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998460|NCT05026229|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91998461|NCT05026229|Abortifacient Agents|abortifacient agents|mesh-ancestor
91998462|NCT05026229|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91998463|NCT05026229|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91998464|NCT05026229|Antimetabolites|antimetabolites|mesh-ancestor
91998465|NCT05026229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998466|NCT05026229|Dermatologic Agents|dermatologic agents|mesh-ancestor
91998467|NCT05026229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998468|NCT05026229|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91998473|NCT05026229|Antiviral Agents|antiviral agents|mesh-ancestor
91998474|NCT05026229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998475|NCT05026229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91998476|NCT05026229|Tubulin Modulators|tubulin modulators|mesh-ancestor
91998477|NCT05026229|Antimitotic Agents|antimitotic agents|mesh-ancestor
91998478|NCT05026229|Mitosis Modulators|mitosis modulators|mesh-ancestor
91998479|NCT05026229|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998480|NCT02343679|Ceritinib|ceritinib|mesh-list
91998481|NCT02343679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998482|NCT02343679|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998483|NCT02343679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998484|NCT02343679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998485|NCT04954781|Tislelizumab|tislelizumab|mesh-list
91998486|NCT04954781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91998487|NCT04954781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998488|NCT02348905|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
91998489|NCT02348905|Hormones|hormones|mesh-ancestor
91998490|NCT02348905|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998491|NCT02348905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998492|NCT02347033|Sertraline|sertraline|mesh-list
91998493|NCT02347033|Antidepressive Agents|antidepressive agents|mesh-ancestor
91998494|NCT02347033|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91998495|NCT02347033|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91998496|NCT02347033|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91998497|NCT02347033|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998498|NCT02347033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998499|NCT02347033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998500|NCT02347033|Serotonin Agents|serotonin agents|mesh-ancestor
91998501|NCT02347033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998503|NCT04949633|Oxytocics|oxytocics|mesh-ancestor
91998504|NCT04949633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91998505|NCT04949633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998506|NCT03146377|Capecitabine|capecitabine|mesh-list
91998507|NCT03146377|Oxaliplatin|oxaliplatin|mesh-list
91998508|NCT03146377|Irinotecan|irinotecan|mesh-list
91998509|NCT03146377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91998510|NCT03146377|Antimetabolites|antimetabolites|mesh-ancestor
91998511|NCT03146377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998512|NCT03146377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998513|NCT03146377|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91970594|NCT02469545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970595|NCT02469545|Antidepressive Agents|antidepressive agents|mesh-ancestor
91998514|NCT03146377|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91998515|NCT03146377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998516|NCT02346955|Pembrolizumab|pembrolizumab|mesh-list
91998517|NCT02346955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91998518|NCT02346955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998519|NCT02346955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91998520|NCT02346955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998521|NCT03079505|Dasatinib|dasatinib|mesh-list
91998522|NCT03079505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998523|NCT03079505|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998524|NCT03079505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998525|NCT03079505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998526|NCT02343211|Immunoglobulins|immunoglobulins|mesh-list
91998527|NCT02343211|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91998528|NCT02343211|Antibodies|antibodies|mesh-list
91998529|NCT02343211|Immunologic Factors|immunologic factors|mesh-ancestor
91998530|NCT02343211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998531|NCT03090503|Risperidone|risperidone|mesh-list
91998532|NCT03090503|Aripiprazole|aripiprazole|mesh-list
91998533|NCT03090503|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91998534|NCT03090503|Serotonin Agents|serotonin agents|mesh-ancestor
91998535|NCT03090503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998536|NCT03090503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998537|NCT03090503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998538|NCT03090503|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91998542|NCT03090503|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91998543|NCT03090503|Dopamine Agents|dopamine agents|mesh-ancestor
91998544|NCT03090503|Antidepressive Agents|antidepressive agents|mesh-ancestor
91998545|NCT03090503|Dopamine Agonists|dopamine agonists|mesh-ancestor
91998546|NCT03090503|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91998547|NCT03090503|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91998548|NCT03090503|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91998549|NCT03090503|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91998550|NCT02343289|Clarithromycin|clarithromycin|mesh-list
91998551|NCT02343289|Esketamine|esketamine|mesh-list
91998552|NCT02343289|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998553|NCT02343289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998554|NCT02343289|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91998555|NCT02343289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998556|NCT02343289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998557|NCT02343289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91998558|NCT02343289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91998559|NCT02343289|Antidepressive Agents|antidepressive agents|mesh-ancestor
91998560|NCT02343289|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91998561|NCT05008523|Analgesics, Opioid|analgesics, opioid|mesh-list
91998562|NCT05008523|Narcotics|narcotics|mesh-ancestor
91998563|NCT05008523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998564|NCT05008523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998565|NCT05008523|Analgesics|analgesics|mesh-ancestor
91998566|NCT05008523|Sensory System Agents|sensory system agents|mesh-ancestor
91998567|NCT05008523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998568|NCT03090269|Methylphenidate|methylphenidate|mesh-list
91998569|NCT03090269|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91998570|NCT03090269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998571|NCT03090269|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91998572|NCT03090269|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91998573|NCT03090269|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998574|NCT03090269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998575|NCT03090269|Dopamine Agents|dopamine agents|mesh-ancestor
91998576|NCT03090269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998577|NCT05008679|Oseltamivir|oseltamivir|mesh-list
91998578|NCT05008679|Antiviral Agents|antiviral agents|mesh-ancestor
91998579|NCT05008679|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998580|NCT05008679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998581|NCT05008679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998582|NCT03090035|Interferons|interferons|mesh-list
91970596|NCT02469545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91970597|NCT03308357|Infliximab|infliximab|mesh-list
91970598|NCT03308357|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91970599|NCT03308357|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970600|NCT03308357|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970601|NCT03308357|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998583|NCT03090035|Ribavirin|ribavirin|mesh-list
91998584|NCT03090035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998585|NCT03090035|Antiviral Agents|antiviral agents|mesh-ancestor
91998586|NCT03090035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998587|NCT03090035|Antimetabolites|antimetabolites|mesh-ancestor
91998588|NCT03090035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998589|NCT05008367|Dexamethasone|dexamethasone|mesh-list
91998590|NCT05008367|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998591|NCT05008367|Antiemetics|antiemetics|mesh-ancestor
91998592|NCT05008367|Autonomic Agents|autonomic agents|mesh-ancestor
91998593|NCT05008367|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998594|NCT05008367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998595|NCT05008367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998596|NCT05008367|Glucocorticoids|glucocorticoids|mesh-ancestor
91998597|NCT05008367|Hormones|hormones|mesh-ancestor
91998598|NCT05008367|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998599|NCT05008367|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91998600|NCT05008367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998601|NCT02342587|Lapatinib|lapatinib|mesh-list
91998602|NCT02342587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998603|NCT02342587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998604|NCT02342587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998605|NCT02342587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998606|NCT02346331|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91998607|NCT02346331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998608|NCT02342509|Sevoflurane|sevoflurane|mesh-list
91998609|NCT02342509|Desflurane|desflurane|mesh-list
91998614|NCT02342509|Anesthetics|anesthetics|mesh-ancestor
91998615|NCT02342509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998616|NCT02342509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998617|NCT03079271|Benzocaine|benzocaine|mesh-list
91998618|NCT03079271|Anesthetics, Local|anesthetics, local|mesh-ancestor
91998619|NCT03079271|Anesthetics|anesthetics|mesh-ancestor
91998620|NCT03079271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998621|NCT03079271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998622|NCT03079271|Sensory System Agents|sensory system agents|mesh-ancestor
91998623|NCT03079271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998624|NCT02342353|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91998625|NCT02342353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998626|NCT02342353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998627|NCT02342353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998628|NCT02342353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998629|NCT02337127|Lamivudine|lamivudine|mesh-list
91998630|NCT02337127|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91998631|NCT02337127|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91998632|NCT02337127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998633|NCT02337127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998634|NCT02337127|Antiviral Agents|antiviral agents|mesh-ancestor
91998635|NCT02337127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998636|NCT02337127|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91998637|NCT02337127|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91998638|NCT02337205|Tirbanibulin|tirbanibulin|mesh-list
91998639|NCT02337205|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998640|NCT02337205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998641|NCT05007587|Leucovorin|leucovorin|mesh-list
91998642|NCT05007587|Fluorouracil|fluorouracil|mesh-list
91998643|NCT05007587|Raltitrexed|raltitrexed|mesh-list
91998644|NCT05007587|Oxaliplatin|oxaliplatin|mesh-list
91998645|NCT05007587|Lenvatinib|lenvatinib|mesh-list
91998646|NCT05007587|Antimetabolites|antimetabolites|mesh-ancestor
91998647|NCT05007587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998648|NCT05007587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91998649|NCT05007587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998650|NCT05007587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970602|NCT03308357|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970603|NCT02469311|Chlorhexidine|chlorhexidine|mesh-list
91970604|NCT02469311|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91970605|NCT02469311|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91970606|NCT02469311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970607|NCT02469311|Disinfectants|disinfectants|mesh-ancestor
91970609|NCT03308201|Fulvestrant|fulvestrant|mesh-list
91970610|NCT03308201|Exemestane|exemestane|mesh-list
91970611|NCT03308201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998651|NCT05007587|Immunologic Factors|immunologic factors|mesh-ancestor
91998652|NCT05007587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998653|NCT05007587|Antidotes|antidotes|mesh-ancestor
91998654|NCT05007587|Protective Agents|protective agents|mesh-ancestor
91998655|NCT05007587|Vitamin B Complex|vitamin b complex|mesh-ancestor
91998656|NCT05007587|Vitamins|vitamins|mesh-ancestor
91998657|NCT05007587|Micronutrients|micronutrients|mesh-ancestor
91998658|NCT05007587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91998659|NCT05007587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998660|NCT05007587|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91998661|NCT03945643|Sildenafil Citrate|sildenafil citrate|mesh-list
91998662|NCT03945643|Vasodilator Agents|vasodilator agents|mesh-ancestor
91998663|NCT03945643|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91998664|NCT03945643|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91998665|NCT03945643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998666|NCT03945643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998667|NCT03945643|Urological Agents|urological agents|mesh-ancestor
91998668|NCT02039323|Tenofovir|tenofovir|mesh-list
91998669|NCT02039323|Maraviroc|maraviroc|mesh-list
91998670|NCT02039323|Antiviral Agents|antiviral agents|mesh-ancestor
91998671|NCT02039323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998672|NCT02039323|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91998673|NCT02039323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91998674|NCT02039323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998675|NCT02039323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998676|NCT02039323|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91998677|NCT02039323|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91998678|NCT02039323|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91998679|NCT02039323|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91998680|NCT02039323|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91998681|NCT03079115|Atorvastatin|atorvastatin|mesh-list
91998683|NCT03079115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91998685|NCT03079115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998686|NCT03079115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91998687|NCT03079115|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91998688|NCT03079115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998689|NCT05917431|Tislelizumab|tislelizumab|mesh-list
91998690|NCT05917431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91998691|NCT05917431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998692|NCT05917405|Fludarabine|fludarabine|mesh-list
91998693|NCT05917405|Busulfan|busulfan|mesh-list
91998694|NCT05917405|Clofarabine|clofarabine|mesh-list
91998695|NCT05917405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998696|NCT05917405|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91998697|NCT05917405|Antimetabolites|antimetabolites|mesh-ancestor
91998698|NCT05917405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998699|NCT05917405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998700|NCT05917405|Immunologic Factors|immunologic factors|mesh-ancestor
91998701|NCT05917405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998702|NCT05917405|Alkylating Agents|alkylating agents|mesh-ancestor
91998703|NCT05917405|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91998704|NCT05917405|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91998705|NCT05917340|Aspirin|aspirin|mesh-list
91998706|NCT05917340|Moxifloxacin|moxifloxacin|mesh-list
91998707|NCT05917340|Rifampin|rifampin|mesh-list
91998708|NCT05917340|Isoniazid|isoniazid|mesh-list
91998709|NCT05917340|Pyrazinamide|pyrazinamide|mesh-list
91998710|NCT05917340|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91970612|NCT03308201|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91970613|NCT03308201|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91970614|NCT03308201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970615|NCT03308201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998711|NCT05917340|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998712|NCT05917340|Analgesics|analgesics|mesh-ancestor
91998713|NCT05917340|Sensory System Agents|sensory system agents|mesh-ancestor
91998714|NCT05917340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998715|NCT05917340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998716|NCT05917340|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998717|NCT05917340|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998718|NCT05917340|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91998719|NCT05917340|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91998720|NCT05917340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998721|NCT05917340|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91998722|NCT05917340|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91998723|NCT05917340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998724|NCT05917340|Antipyretics|antipyretics|mesh-ancestor
91998725|NCT05917340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998726|NCT05917340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998727|NCT05917340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91998728|NCT05917340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91998729|NCT05917340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998730|NCT05917340|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91998731|NCT05917340|Antitubercular Agents|antitubercular agents|mesh-ancestor
91998732|NCT05917340|Leprostatic Agents|leprostatic agents|mesh-ancestor
91998733|NCT05917340|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91998734|NCT05917340|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91998735|NCT05917340|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91998736|NCT05917340|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91998737|NCT05917340|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91998738|NCT05917340|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91998739|NCT05917340|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91998740|NCT05917340|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91998741|NCT05917340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91998742|NCT05917340|Antimetabolites|antimetabolites|mesh-ancestor
91998743|NCT05917340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91998744|NCT05917288|Belimumab|belimumab|mesh-list
91998745|NCT05917288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998746|NCT05917288|Immunologic Factors|immunologic factors|mesh-ancestor
91998747|NCT05917288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998748|NCT05917275|Amlodipine|amlodipine|mesh-list
91998749|NCT05917275|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
91998750|NCT05917275|Olmesartan|olmesartan|mesh-list
91998751|NCT05917275|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
91998752|NCT05917275|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91998753|NCT05917275|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91998754|NCT05917275|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998757|NCT05917275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998758|NCT05917275|Vasodilator Agents|vasodilator agents|mesh-ancestor
91998759|NCT05917275|Diuretics|diuretics|mesh-ancestor
91998760|NCT05917275|Natriuretic Agents|natriuretic agents|mesh-ancestor
91998761|NCT05917275|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91998762|NCT05917275|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91998763|NCT05917275|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91998764|NCT05917223|Caseins|caseins|mesh-list
91998765|NCT05917223|Chelating Agents|chelating agents|mesh-ancestor
91998766|NCT05917223|Sequestering Agents|sequestering agents|mesh-ancestor
91998767|NCT05917223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998768|NCT05917067|Parathyroid Hormone|parathyroid hormone|mesh-list
91998769|NCT05917067|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91998770|NCT05917067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998771|NCT05916963|Furosemide|furosemide|mesh-list
91998772|NCT05916963|Diuretics|diuretics|mesh-ancestor
91998773|NCT05916963|Natriuretic Agents|natriuretic agents|mesh-ancestor
91998774|NCT05916963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998775|NCT05916963|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91998776|NCT05916963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970616|NCT03308201|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91970617|NCT03308201|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970618|NCT03308201|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090453|NCT01903031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998777|NCT05916963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998778|NCT05916937|Omalizumab|omalizumab|mesh-list
91998779|NCT05916937|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91998780|NCT05916937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91998781|NCT05916937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91998782|NCT05916937|Respiratory System Agents|respiratory system agents|mesh-ancestor
91998783|NCT05916937|Immunologic Factors|immunologic factors|mesh-ancestor
91998784|NCT05916937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998785|NCT02342977|Lacosamide|lacosamide|mesh-list
91998786|NCT02342977|Anticonvulsants|anticonvulsants|mesh-ancestor
91998787|NCT02342977|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91998788|NCT02342977|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91998789|NCT02342977|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998790|NCT02342977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998791|NCT05916781|Mycophenolic Acid|mycophenolic acid|mesh-list
91998792|NCT05916781|Tacrolimus|tacrolimus|mesh-list
91998793|NCT05916781|Glucocorticoids|glucocorticoids|mesh-list
91998794|NCT05916781|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998795|NCT05916781|Immunologic Factors|immunologic factors|mesh-ancestor
91998796|NCT05916781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998797|NCT05916781|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91998798|NCT05916781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998799|NCT05916781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998800|NCT05916781|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91998801|NCT05916781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998802|NCT05916781|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91998803|NCT05916781|Antitubercular Agents|antitubercular agents|mesh-ancestor
91998804|NCT05916781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998805|NCT05916781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998806|NCT05916781|Hormones|hormones|mesh-ancestor
91998807|NCT05916781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998808|NCT05916755|Cyclophosphamide|cyclophosphamide|mesh-list
91998809|NCT05916755|Carboplatin|carboplatin|mesh-list
91998810|NCT05916755|Pembrolizumab|pembrolizumab|mesh-list
91998811|NCT05916755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998812|NCT05916755|Immunologic Factors|immunologic factors|mesh-ancestor
91998813|NCT05916755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998814|NCT05916755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998815|NCT05916755|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91998816|NCT05916755|Alkylating Agents|alkylating agents|mesh-ancestor
91998817|NCT05916755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998818|NCT05916755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998819|NCT05916755|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91998820|NCT05916755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91998821|NCT05916755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91998822|NCT05916742|Dipyrone|dipyrone|mesh-list
91998823|NCT05916742|Amoxicillin|amoxicillin|mesh-list
91998824|NCT05916742|Chlorhexidine|chlorhexidine|mesh-list
91998827|NCT05916742|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91998828|NCT05916742|Disinfectants|disinfectants|mesh-ancestor
91998829|NCT05916742|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91998830|NCT05916742|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998832|NCT05916742|Sensory System Agents|sensory system agents|mesh-ancestor
91998833|NCT05916742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998834|NCT05916742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998835|NCT05916742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998836|NCT05916742|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998837|NCT05916742|Antipyretics|antipyretics|mesh-ancestor
91998838|NCT05916729|Miconazole|miconazole|mesh-list
91998839|NCT05916729|Antifungal Agents|antifungal agents|mesh-ancestor
91998840|NCT05916729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998841|NCT05916729|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91998842|NCT05916729|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91998843|NCT05916729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998844|NCT05916729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970619|NCT03308201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970620|NCT03308201|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91970621|NCT03308201|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91970622|NCT03312413|Dexmedetomidine|dexmedetomidine|mesh-list
91970623|NCT03312413|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91998845|NCT05916729|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91998846|NCT05916729|Hormone Antagonists|hormone antagonists|mesh-ancestor
91998847|NCT05916729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998848|NCT05916729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998849|NCT05916729|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91998850|NCT05916729|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91998852|NCT05916716|Amoxicillin|amoxicillin|mesh-list
91998853|NCT05916716|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998854|NCT05916716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998855|NCT05916716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91998856|NCT05916716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998857|NCT05916716|Analgesics|analgesics|mesh-ancestor
91998858|NCT05916716|Sensory System Agents|sensory system agents|mesh-ancestor
91998859|NCT05916716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998860|NCT05916716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998861|NCT05916716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998862|NCT05916716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998863|NCT05916716|Antipyretics|antipyretics|mesh-ancestor
91998864|NCT05916690|Bleomycin|bleomycin|mesh-list
91998865|NCT05916690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998866|NCT05916690|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91998867|NCT05916586|Prednisone|prednisone|mesh-list
91998868|NCT05916586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91998869|NCT05916586|Glucocorticoids|glucocorticoids|mesh-ancestor
91998870|NCT05916586|Hormones|hormones|mesh-ancestor
91998871|NCT05916586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91998872|NCT05916586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998873|NCT05916586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91998874|NCT05916586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998875|NCT05916521|Fluorides|fluorides|mesh-list
91998876|NCT05916521|Tin Fluorides|tin fluorides|mesh-list
91998877|NCT05916521|Fluorophosphate|fluorophosphate|mesh-list
91998878|NCT05916521|Cariostatic Agents|cariostatic agents|mesh-ancestor
91998879|NCT05916521|Protective Agents|protective agents|mesh-ancestor
91998880|NCT05916521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998881|NCT05916508|Fluorides|fluorides|mesh-list
91998882|NCT05916508|Tin Fluorides|tin fluorides|mesh-list
91998883|NCT05916508|Fluorophosphate|fluorophosphate|mesh-list
91998884|NCT05916508|Cariostatic Agents|cariostatic agents|mesh-ancestor
91998885|NCT05916508|Protective Agents|protective agents|mesh-ancestor
91998886|NCT05916508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998887|NCT05916469|Levonorgestrel|levonorgestrel|mesh-list
91998888|NCT05916469|Norethindrone|norethindrone|mesh-list
91998889|NCT05916469|Norethindrone Acetate|norethindrone acetate|mesh-list
91998890|NCT05916469|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91998891|NCT05916469|Contraceptive Agents|contraceptive agents|mesh-ancestor
91998892|NCT05916469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91998893|NCT05916469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998894|NCT05916469|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91998895|NCT05916469|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91998896|NCT05916469|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91998897|NCT05916469|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91998903|NCT05916352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998904|NCT05916352|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91998905|NCT05916352|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91998906|NCT05916352|Purinergic Agents|purinergic agents|mesh-ancestor
91998907|NCT05916352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998908|NCT05916339|Methylphenidate|methylphenidate|mesh-list
91998910|NCT05916339|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
91998911|NCT05916339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998912|NCT05916339|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91998913|NCT05916339|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91998914|NCT05916339|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970624|NCT03312413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970625|NCT03312413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970626|NCT03312413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91998915|NCT05916339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998917|NCT05916339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91998918|NCT05916339|Sympathomimetics|sympathomimetics|mesh-ancestor
91998919|NCT05916339|Autonomic Agents|autonomic agents|mesh-ancestor
91998920|NCT05916339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91998921|NCT05916339|Adrenergic Agents|adrenergic agents|mesh-ancestor
91998922|NCT05916339|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91998923|NCT05916287|Antihypertensive Agents|antihypertensive agents|mesh-list
91998924|NCT05916105|Ciprofloxacin|ciprofloxacin|mesh-list
91998925|NCT05916105|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998926|NCT05916105|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998927|NCT05916105|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91998928|NCT05916105|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91998929|NCT05916105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998930|NCT05916105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998931|NCT05916105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998932|NCT05916105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91998933|NCT05916105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91998934|NCT05916066|Niacinamide|niacinamide|mesh-list
91998935|NCT05916066|Niacin|niacin|mesh-list
91998936|NCT05916066|Nicotinic Acids|nicotinic acids|mesh-list
91998937|NCT05916066|Vitamin B Complex|vitamin b complex|mesh-ancestor
91998938|NCT05916066|Vitamins|vitamins|mesh-ancestor
91998939|NCT05916066|Micronutrients|micronutrients|mesh-ancestor
91998940|NCT05916066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998941|NCT05916066|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91998942|NCT05916066|Antimetabolites|antimetabolites|mesh-ancestor
91998943|NCT05916066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998944|NCT05916066|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91998945|NCT05916066|Vasodilator Agents|vasodilator agents|mesh-ancestor
91998946|NCT05915949|Dapagliflozin|dapagliflozin|mesh-list
91998947|NCT05915949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
91998948|NCT05915949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998949|NCT05915949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91998950|NCT05915949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998951|NCT05915884|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91998952|NCT05915884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998953|NCT05915884|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91998954|NCT05915884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998955|NCT05915871|Clarithromycin|clarithromycin|mesh-list
91998956|NCT05915871|Bismuth|bismuth|mesh-list
91998957|NCT05915871|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998958|NCT05915871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998959|NCT05915871|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91998960|NCT05915871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998961|NCT05915871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998962|NCT05915871|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91998963|NCT05915871|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91998985|NCT05915481|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91998986|NCT05915481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998987|NCT05915481|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91998988|NCT05915481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998990|NCT05915286|Furosemide|furosemide|mesh-list
91998991|NCT05915286|Diuretics|diuretics|mesh-ancestor
91998992|NCT05915286|Natriuretic Agents|natriuretic agents|mesh-ancestor
91998993|NCT05915286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998994|NCT05915286|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91998995|NCT05915286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91998996|NCT05915286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998997|NCT05915286|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91998998|NCT05915286|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
91998999|NCT05915260|Adenosine|adenosine|mesh-list
91999000|NCT05915260|Analgesics|analgesics|mesh-ancestor
91999001|NCT05915260|Sensory System Agents|sensory system agents|mesh-ancestor
91970627|NCT03312413|Analgesics|analgesics|mesh-ancestor
91970628|NCT03312413|Sensory System Agents|sensory system agents|mesh-ancestor
91970629|NCT03312413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999002|NCT05915260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999003|NCT05915260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999004|NCT05915260|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91999005|NCT05915260|Vasodilator Agents|vasodilator agents|mesh-ancestor
91999006|NCT05915260|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
91999007|NCT05915260|Purinergic Agonists|purinergic agonists|mesh-ancestor
91999008|NCT05915260|Purinergic Agents|purinergic agents|mesh-ancestor
91999009|NCT05915260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999010|NCT05915260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999011|NCT05915182|Budesonide|budesonide|mesh-list
91999012|NCT05915182|Glycopyrrolate|glycopyrrolate|mesh-list
91999013|NCT05915182|Bromides|bromides|mesh-list
91999014|NCT05915182|Formoterol Fumarate|formoterol fumarate|mesh-list
91999015|NCT05915182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999016|NCT05915182|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91999017|NCT05915182|Autonomic Agents|autonomic agents|mesh-ancestor
91999018|NCT05915182|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999019|NCT05915182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999020|NCT05915182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91999021|NCT05915182|Respiratory System Agents|respiratory system agents|mesh-ancestor
91999022|NCT05915182|Glucocorticoids|glucocorticoids|mesh-ancestor
91999023|NCT05915182|Hormones|hormones|mesh-ancestor
91999024|NCT05915182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999025|NCT05915182|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91999026|NCT05915182|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91999027|NCT05915182|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91999028|NCT05915182|Adrenergic Agents|adrenergic agents|mesh-ancestor
91999029|NCT05915182|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999030|NCT05915182|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999031|NCT05915182|Anticonvulsants|anticonvulsants|mesh-ancestor
91999032|NCT05915182|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91999033|NCT05915182|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91999034|NCT05915182|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91999035|NCT05915182|Cholinergic Agents|cholinergic agents|mesh-ancestor
91999036|NCT05915169|Chrysarobin|chrysarobin|mesh-list
91999039|NCT05915169|Analgesics|analgesics|mesh-ancestor
91999040|NCT05915169|Sensory System Agents|sensory system agents|mesh-ancestor
91999041|NCT05915169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999042|NCT05915169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999043|NCT05915169|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999044|NCT05915169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999046|NCT05915104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999047|NCT05915104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91999048|NCT05915104|Autonomic Agents|autonomic agents|mesh-ancestor
91999049|NCT05915104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999050|NCT05915104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999051|NCT05915104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91999052|NCT05915104|Respiratory System Agents|respiratory system agents|mesh-ancestor
91999053|NCT05915104|Glucocorticoids|glucocorticoids|mesh-ancestor
91999055|NCT05915104|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999056|NCT05915013|Ketamine|ketamine|mesh-list
91999057|NCT05915013|Analgesics|analgesics|mesh-ancestor
91999058|NCT05915013|Sensory System Agents|sensory system agents|mesh-ancestor
91999059|NCT05915013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999060|NCT05915013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999061|NCT05915013|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91999062|NCT05915013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91999063|NCT05915013|Anesthetics, General|anesthetics, general|mesh-ancestor
91999064|NCT05915013|Anesthetics|anesthetics|mesh-ancestor
91999065|NCT05915013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999066|NCT05915013|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91999067|NCT05915013|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91999068|NCT05915013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999069|NCT05915013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999070|NCT05914805|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91970630|NCT03312413|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91970631|NCT03312413|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91970632|NCT03312413|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970633|NCT03312413|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970634|NCT03312413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999071|NCT05914779|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91999072|NCT05914779|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91999073|NCT05914779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999074|NCT05914779|Antitubercular Agents|antitubercular agents|mesh-ancestor
91999075|NCT05914753|Cyclophosphamide|cyclophosphamide|mesh-list
91999076|NCT05914753|Docetaxel|docetaxel|mesh-list
91999077|NCT05914753|Epirubicin|epirubicin|mesh-list
91999078|NCT05914753|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999079|NCT05914753|Immunologic Factors|immunologic factors|mesh-ancestor
91999080|NCT05914753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999081|NCT05914753|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999082|NCT05914753|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999083|NCT05914753|Alkylating Agents|alkylating agents|mesh-ancestor
91999084|NCT05914753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999085|NCT05914753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999086|NCT05914753|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91999087|NCT05914753|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999088|NCT05914753|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999089|NCT05914753|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999090|NCT05914753|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91999091|NCT05914753|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91999092|NCT05914753|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91999093|NCT05914753|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999094|NCT05914701|Letermovir|letermovir|mesh-list
91999095|NCT05914701|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91999096|NCT05914701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999097|NCT05914701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999098|NCT05914701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999099|NCT05914701|Antiviral Agents|antiviral agents|mesh-ancestor
91999100|NCT05914701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999101|NCT05914675|Letermovir|letermovir|mesh-list
91999102|NCT05914675|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91999103|NCT05914675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999104|NCT05914675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999105|NCT05914675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999106|NCT05914675|Antiviral Agents|antiviral agents|mesh-ancestor
91999107|NCT05914675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999108|NCT05914662|Rituximab|rituximab|mesh-list
91999109|NCT05914662|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91999114|NCT05914662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999115|NCT05914662|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999116|NCT05914662|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999117|NCT05914662|Alkylating Agents|alkylating agents|mesh-ancestor
91999118|NCT05914662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999119|NCT05914662|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91999120|NCT05914662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999121|NCT05914610|Oxaliplatin|oxaliplatin|mesh-list
91999122|NCT05914610|Tegafur|tegafur|mesh-list
91999123|NCT05914610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999124|NCT05914610|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91999125|NCT05914610|Antimetabolites|antimetabolites|mesh-ancestor
91999126|NCT05914610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999127|NCT05914545|Immunoconjugates|immunoconjugates|mesh-list
91999128|NCT05914545|Immunologic Factors|immunologic factors|mesh-ancestor
91999129|NCT05914545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999130|NCT05914454|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
91999131|NCT05914454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999132|NCT05914389|Capecitabine|capecitabine|mesh-list
91999133|NCT05914389|Oxaliplatin|oxaliplatin|mesh-list
91999134|NCT05914389|Antibodies|antibodies|mesh-list
91999135|NCT05914389|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91999136|NCT05914389|Immunologic Factors|immunologic factors|mesh-ancestor
91999137|NCT05914389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999138|NCT05914389|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91999139|NCT05914389|Antimetabolites|antimetabolites|mesh-ancestor
91970635|NCT03312413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970636|NCT02722967|Aripiprazole|aripiprazole|mesh-list
91970637|NCT02722967|Antidepressive Agents|antidepressive agents|mesh-ancestor
91970638|NCT02722967|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91970639|NCT02722967|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91999140|NCT05914389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999141|NCT05914389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999142|NCT05914350|Methylprednisolone|methylprednisolone|mesh-list
91999143|NCT05914350|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91999144|NCT05914350|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91999145|NCT05914350|Prednisolone|prednisolone|mesh-list
91999146|NCT05914350|Prednisolone acetate|prednisolone acetate|mesh-list
91999147|NCT05914350|Lidocaine|lidocaine|mesh-list
91999148|NCT05914350|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
91999149|NCT05914350|Prednisolone phosphate|prednisolone phosphate|mesh-list
91999150|NCT05914350|Anesthetics, Local|anesthetics, local|mesh-ancestor
91999151|NCT05914350|Anesthetics|anesthetics|mesh-ancestor
91999152|NCT05914350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999153|NCT05914350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999154|NCT05914350|Sensory System Agents|sensory system agents|mesh-ancestor
91999155|NCT05914350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999156|NCT05914350|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91999157|NCT05914350|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91999158|NCT05914350|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91999159|NCT05914350|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91999160|NCT05914350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999161|NCT05914350|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999162|NCT05914350|Antiemetics|antiemetics|mesh-ancestor
91999163|NCT05914350|Autonomic Agents|autonomic agents|mesh-ancestor
91999164|NCT05914350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999165|NCT05914350|Glucocorticoids|glucocorticoids|mesh-ancestor
91999166|NCT05914350|Hormones|hormones|mesh-ancestor
91999167|NCT05914350|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999168|NCT05914350|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91999169|NCT05914350|Protective Agents|protective agents|mesh-ancestor
91999170|NCT05914350|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91999171|NCT05914350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999172|NCT05914285|Albuterol|albuterol|mesh-list
91999173|NCT05914285|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91999174|NCT05914285|Autonomic Agents|autonomic agents|mesh-ancestor
91999175|NCT05914285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999176|NCT05914285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999177|NCT05914285|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91999178|NCT05914285|Respiratory System Agents|respiratory system agents|mesh-ancestor
91999180|NCT05914285|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91999183|NCT05914285|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91999184|NCT05914285|Adrenergic Agents|adrenergic agents|mesh-ancestor
91999423|NCT05911503|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91999185|NCT05914285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999186|NCT05914285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999187|NCT05914194|Mazindol|mazindol|mesh-list
91999188|NCT05914194|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91999189|NCT05914194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999190|NCT05914194|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91999191|NCT05914194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91999192|NCT05914194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91999193|NCT05914194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999194|NCT05914194|Adrenergic Agents|adrenergic agents|mesh-ancestor
91999195|NCT05914194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999196|NCT05914194|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91999197|NCT05914194|Dopamine Agents|dopamine agents|mesh-ancestor
91999198|NCT05914129|Liver Extracts|liver extracts|mesh-list
91999199|NCT05914129|Hematinics|hematinics|mesh-ancestor
91999200|NCT05914077|Secretin|secretin|mesh-list
91999201|NCT05914077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999202|NCT05914077|Hormones|hormones|mesh-ancestor
91999203|NCT05914077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999204|NCT05914077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999205|NCT05913947|Cariprazine|cariprazine|mesh-list
91970640|NCT02722967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91999206|NCT05913947|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91999207|NCT05913947|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91999208|NCT05913947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999209|NCT05913947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999210|NCT05913947|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91999211|NCT05913921|Amphotericin B|amphotericin b|mesh-list
91999212|NCT05913921|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
91999213|NCT05913921|Amebicides|amebicides|mesh-ancestor
91999214|NCT05913921|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91999215|NCT05913921|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91999216|NCT05913921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999217|NCT05913921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91999218|NCT05913921|Antifungal Agents|antifungal agents|mesh-ancestor
91999219|NCT05913856|Chlorhexidine|chlorhexidine|mesh-list
91999220|NCT05913856|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91999221|NCT05913856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999222|NCT05913856|Disinfectants|disinfectants|mesh-ancestor
91999223|NCT05913661|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91999224|NCT05913661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999225|NCT05913661|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999226|NCT05913661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999227|NCT05913596|Daratumumab|daratumumab|mesh-list
91999228|NCT05913596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999229|NCT05913583|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91999230|NCT05913583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999231|NCT05913583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999232|NCT05913583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999233|NCT05913570|Antibodies|antibodies|mesh-list
91999234|NCT05913570|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91999235|NCT05913570|Immunologic Factors|immunologic factors|mesh-ancestor
91999236|NCT05913570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999237|NCT05913466|Tranexamic Acid|tranexamic acid|mesh-list
91999238|NCT05913466|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91999239|NCT05913466|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91999240|NCT05913466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999241|NCT05913466|Hemostatics|hemostatics|mesh-ancestor
91999242|NCT05913466|Coagulants|coagulants|mesh-ancestor
91999243|NCT05913427|Cisplatin|cisplatin|mesh-list
91999244|NCT05913427|Doxorubicin|doxorubicin|mesh-list
91999245|NCT05913427|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91999246|NCT05913427|Etoposide|etoposide|mesh-list
91999247|NCT05913427|Etoposide phosphate|etoposide phosphate|mesh-list
91999248|NCT05913427|Megestrol|megestrol|mesh-list
91999249|NCT05913427|Megestrol Acetate|megestrol acetate|mesh-list
91999250|NCT05913427|Mitotane|mitotane|mesh-list
91999251|NCT05913427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999252|NCT05913427|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91999253|NCT05913427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91999254|NCT05913427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91999257|NCT05913427|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91999258|NCT05913427|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91999259|NCT05913427|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91999260|NCT05913427|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91999261|NCT05913427|Contraceptive Agents|contraceptive agents|mesh-ancestor
91999262|NCT05913427|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91999263|NCT05913427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999264|NCT05913427|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91999265|NCT05913427|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91999266|NCT05913427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91999267|NCT05913427|Appetite Stimulants|appetite stimulants|mesh-ancestor
91999268|NCT05913427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91999270|NCT05913414|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
91999271|NCT05913414|Ferric Compounds|ferric compounds|mesh-list
91999272|NCT05913414|Trace Elements|trace elements|mesh-ancestor
91999273|NCT05913414|Micronutrients|micronutrients|mesh-ancestor
91999274|NCT05913414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999275|NCT05913414|Hematinics|hematinics|mesh-ancestor
91999276|NCT05913388|Pembrolizumab|pembrolizumab|mesh-list
91999277|NCT05913388|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999278|NCT05913388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999279|NCT05913388|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91999280|NCT05913388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999281|NCT05913284|Morphine|morphine|mesh-list
91999282|NCT05913284|Methadone|methadone|mesh-list
91970641|NCT02722967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970642|NCT02722967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970643|NCT02722967|Dopamine Agonists|dopamine agonists|mesh-ancestor
91970644|NCT02722967|Dopamine Agents|dopamine agents|mesh-ancestor
91970645|NCT02722967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999283|NCT05913284|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91999284|NCT05913284|Narcotics|narcotics|mesh-ancestor
91999285|NCT05913284|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999286|NCT05913284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999287|NCT05913284|Analgesics|analgesics|mesh-ancestor
91999288|NCT05913284|Sensory System Agents|sensory system agents|mesh-ancestor
91999289|NCT05913284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999290|NCT05913284|Antitussive Agents|antitussive agents|mesh-ancestor
91999291|NCT05913284|Respiratory System Agents|respiratory system agents|mesh-ancestor
91999292|NCT05913232|Timolol|timolol|mesh-list
91999293|NCT05913232|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91999294|NCT05913232|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91999295|NCT05913232|Adrenergic Agents|adrenergic agents|mesh-ancestor
91999296|NCT05913232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999297|NCT05913232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999298|NCT05913232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999299|NCT05913232|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91999300|NCT05913232|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91999301|NCT05913180|Ascorbic Acid|ascorbic acid|mesh-list
91999302|NCT05913180|Vitamins|vitamins|mesh-ancestor
91999303|NCT05913180|Micronutrients|micronutrients|mesh-ancestor
91999304|NCT05913180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999305|NCT05913180|Antioxidants|antioxidants|mesh-ancestor
91999306|NCT05913180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999307|NCT05913180|Protective Agents|protective agents|mesh-ancestor
91999308|NCT05913115|Bemarituzumab|bemarituzumab|mesh-list
91999309|NCT05913115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999310|NCT05913115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999311|NCT05912946|Interferons|interferons|mesh-list
91999312|NCT05912946|Hyaluronic Acid|hyaluronic acid|mesh-list
91999313|NCT05912946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999314|NCT05912946|Antiviral Agents|antiviral agents|mesh-ancestor
91999315|NCT05912946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999316|NCT05912946|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91999317|NCT05912946|Immunologic Factors|immunologic factors|mesh-ancestor
91999318|NCT05912946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999319|NCT05912946|Viscosupplements|viscosupplements|mesh-ancestor
91999320|NCT05912946|Protective Agents|protective agents|mesh-ancestor
91999321|NCT05912816|Tislelizumab|tislelizumab|mesh-list
91999322|NCT05912816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999323|NCT05912816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999325|NCT05912712|Mesalamine|mesalamine|mesh-list
91999326|NCT05912712|Thrombin|thrombin|mesh-list
91999327|NCT05912712|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91999328|NCT05912712|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999329|NCT05912712|Dermatologic Agents|dermatologic agents|mesh-ancestor
91999330|NCT05912712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999331|NCT05912712|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999332|NCT05912712|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91999333|NCT05912712|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91999335|NCT05912712|Sensory System Agents|sensory system agents|mesh-ancestor
91999336|NCT05912712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999337|NCT05912712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999338|NCT05912712|Hemostatics|hemostatics|mesh-ancestor
91999339|NCT05912712|Coagulants|coagulants|mesh-ancestor
91999340|NCT05912686|Atorvastatin|atorvastatin|mesh-list
91999341|NCT05912686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91999342|NCT05912686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91999343|NCT05912686|Antimetabolites|antimetabolites|mesh-ancestor
91999344|NCT05912686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999345|NCT05912686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91999346|NCT05912686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91999347|NCT05912686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999348|NCT05912621|Tirzepatide|tirzepatide|mesh-list
91970646|NCT02722967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970647|NCT02722967|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91970648|NCT02722967|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91970649|NCT02722967|Serotonin Agents|serotonin agents|mesh-ancestor
91970650|NCT02722967|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91999349|NCT05912621|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91999350|NCT05912621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999351|NCT05912621|Incretins|incretins|mesh-ancestor
91999352|NCT05912621|Hormones|hormones|mesh-ancestor
91999353|NCT05912621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999354|NCT05912387|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
91999355|NCT05912387|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91999356|NCT05912387|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91999358|NCT05912387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999359|NCT05912387|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91999360|NCT05912387|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91999361|NCT05912387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999363|NCT05912335|Anesthetics, Local|anesthetics, local|mesh-list
91999364|NCT05912335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999365|NCT05912335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999366|NCT05912335|Sensory System Agents|sensory system agents|mesh-ancestor
91999367|NCT05912335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999368|NCT05912205|Disitamab vedotin|disitamab vedotin|mesh-list
91999369|NCT05912205|Immunoconjugates|immunoconjugates|mesh-ancestor
91999370|NCT05912205|Immunologic Factors|immunologic factors|mesh-ancestor
91999371|NCT05912205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999372|NCT05912192|Mometasone Furoate|mometasone furoate|mesh-list
91999373|NCT05912192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999374|NCT05912192|Dermatologic Agents|dermatologic agents|mesh-ancestor
91999375|NCT05912192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91999376|NCT05912179|Liver Extracts|liver extracts|mesh-list
91999377|NCT05912179|Hematinics|hematinics|mesh-ancestor
91999378|NCT05912114|Mannitol|mannitol|mesh-list
91999379|NCT05912114|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
91999380|NCT05912114|Diuretics|diuretics|mesh-ancestor
91999381|NCT05912114|Natriuretic Agents|natriuretic agents|mesh-ancestor
91999382|NCT05912114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999383|NCT05912075|Capecitabine|capecitabine|mesh-list
91999384|NCT05912075|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91999385|NCT05912075|Antimetabolites|antimetabolites|mesh-ancestor
91999386|NCT05912075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999387|NCT05912075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999388|NCT05911906|Remdesivir|remdesivir|mesh-list
91999389|NCT05911906|Antimetabolites|antimetabolites|mesh-ancestor
91999390|NCT05911906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999391|NCT05911906|Antiviral Agents|antiviral agents|mesh-ancestor
91999392|NCT05911906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999393|NCT05911828|Ferroquine|ferroquine|mesh-list
91999394|NCT05911828|Antimalarials|antimalarials|mesh-ancestor
91999395|NCT05911828|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91999396|NCT05911828|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91999397|NCT05911828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999398|NCT05911659|Ticagrelor|ticagrelor|mesh-list
91999399|NCT05911659|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91999400|NCT05911659|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91999401|NCT05911659|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91999402|NCT05911659|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91999403|NCT05911659|Purinergic Agents|purinergic agents|mesh-ancestor
91999404|NCT05911659|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999420|NCT05911594|Urological Agents|urological agents|mesh-ancestor
91999421|NCT05911503|Ganciclovir|ganciclovir|mesh-list
91999422|NCT05911503|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
91999424|NCT05911503|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91999425|NCT05911503|Antiviral Agents|antiviral agents|mesh-ancestor
91999426|NCT05911503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999427|NCT05911503|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91970651|NCT02722967|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91970652|NCT02722967|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91999428|NCT05911503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999429|NCT05911503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999430|NCT05911438|Epoetin Alfa|epoetin alfa|mesh-list
91999431|NCT05911438|Hematinics|hematinics|mesh-ancestor
91999433|NCT05911347|Cathartics|cathartics|mesh-ancestor
91999434|NCT05911347|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999435|NCT05911308|Paclitaxel|paclitaxel|mesh-list
91999436|NCT05911308|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91999437|NCT05911308|Carboplatin|carboplatin|mesh-list
91999438|NCT05911308|Pemetrexed|pemetrexed|mesh-list
91999439|NCT05911308|Durvalumab|durvalumab|mesh-list
91999440|NCT05911308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91999441|NCT05911308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999442|NCT05911308|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999443|NCT05911308|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999444|NCT05911308|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999445|NCT05911308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999446|NCT05911308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999447|NCT05911308|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91999448|NCT05911308|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91999449|NCT05911308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999463|NCT05911282|Acetylcysteine|acetylcysteine|mesh-list
91999464|NCT05911282|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91999465|NCT05911282|Antiviral Agents|antiviral agents|mesh-ancestor
91999466|NCT05911282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999467|NCT05911282|Expectorants|expectorants|mesh-ancestor
91999468|NCT05911282|Respiratory System Agents|respiratory system agents|mesh-ancestor
91999469|NCT05911282|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91999470|NCT05911282|Antioxidants|antioxidants|mesh-ancestor
91999471|NCT05911282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999472|NCT05911282|Protective Agents|protective agents|mesh-ancestor
91999473|NCT05911282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999474|NCT05911282|Antidotes|antidotes|mesh-ancestor
91999475|NCT05911022|Colchicine|colchicine|mesh-list
91999476|NCT05911022|Gout Suppressants|gout suppressants|mesh-ancestor
91999485|NCT05910970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999486|NCT05910970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91999487|NCT05910970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999488|NCT05910970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999489|NCT05910970|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999491|NCT05910827|Cetuximab|cetuximab|mesh-list
91999492|NCT05910827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999493|NCT05910827|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999494|NCT05910827|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999495|NCT05910827|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999496|NCT05910827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999497|NCT05910827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999498|NCT05910801|Lenalidomide|lenalidomide|mesh-list
91999499|NCT05910801|Venetoclax|venetoclax|mesh-list
91999500|NCT05910801|Immunoglobulins|immunoglobulins|mesh-list
91999501|NCT05910801|Immunologic Factors|immunologic factors|mesh-ancestor
91999502|NCT05910801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999503|NCT05910801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91999504|NCT05910801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91999505|NCT05910801|Growth Substances|growth substances|mesh-ancestor
91999506|NCT05910801|Growth Inhibitors|growth inhibitors|mesh-ancestor
91999507|NCT05910801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999508|NCT05909553|Venetoclax|venetoclax|mesh-list
91999509|NCT05909553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999510|NCT05909150|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91999511|NCT05907655|Nitroglycerin|nitroglycerin|mesh-list
91999512|NCT05907655|Vasodilator Agents|vasodilator agents|mesh-ancestor
91999513|NCT05907525|Propofol|propofol|mesh-list
91999514|NCT05907525|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91999515|NCT05907525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999516|NCT05907525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999517|NCT05907525|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91999518|NCT05907525|Anesthetics, General|anesthetics, general|mesh-ancestor
91970655|NCT04442633|Antifungal Agents|antifungal agents|mesh-ancestor
91970656|NCT04442633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999519|NCT05907525|Anesthetics|anesthetics|mesh-ancestor
91999520|NCT05907512|Endostar protein|endostar protein|mesh-list
91999521|NCT05907512|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91999522|NCT05907512|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91999523|NCT05907512|Growth Substances|growth substances|mesh-ancestor
91999524|NCT05907512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999525|NCT05907512|Growth Inhibitors|growth inhibitors|mesh-ancestor
91999526|NCT05907512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999533|NCT05906303|Caffeine, sodium benzoate drug combination|caffeine, sodium benzoate drug combination|mesh-list
91999534|NCT05906303|Caffeine|caffeine|mesh-list
91999535|NCT05906303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91999536|NCT05906303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999537|NCT05906303|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91999538|NCT05906303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999539|NCT05906303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999540|NCT05906303|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91999541|NCT05906303|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91999542|NCT05906303|Purinergic Agents|purinergic agents|mesh-ancestor
91999543|NCT05906303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999544|NCT05906303|Antifungal Agents|antifungal agents|mesh-ancestor
91999545|NCT05906303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999546|NCT05906303|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
91999547|NCT05906303|Protective Agents|protective agents|mesh-ancestor
91999548|NCT05906303|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91999549|NCT05906303|Analgesics|analgesics|mesh-ancestor
91999558|NCT05905510|Anesthetics|anesthetics|mesh-list
91999559|NCT05905510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999560|NCT05905510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999561|NCT05904964|Disitamab vedotin|disitamab vedotin|mesh-list
91999562|NCT05904964|Immunoconjugates|immunoconjugates|mesh-ancestor
91999563|NCT05904964|Immunologic Factors|immunologic factors|mesh-ancestor
91999564|NCT05904964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999565|NCT05904353|Zoledronic Acid|zoledronic acid|mesh-list
91999566|NCT05904353|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91999567|NCT05904353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999568|NCT05903417|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91999569|NCT05903417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91999570|NCT05903417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91999571|NCT05903417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999572|NCT05903014|Acetylcysteine|acetylcysteine|mesh-list
91999573|NCT05903014|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91999574|NCT05903014|Antiviral Agents|antiviral agents|mesh-ancestor
91999575|NCT05903014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999576|NCT05903014|Expectorants|expectorants|mesh-ancestor
91999577|NCT05903014|Respiratory System Agents|respiratory system agents|mesh-ancestor
91999578|NCT05903014|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91999579|NCT05903014|Antioxidants|antioxidants|mesh-ancestor
91999580|NCT05903014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999581|NCT05903014|Protective Agents|protective agents|mesh-ancestor
91999582|NCT05903014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999583|NCT05903014|Antidotes|antidotes|mesh-ancestor
91999584|NCT05897554|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
91999585|NCT05897554|Plasminogen|plasminogen|mesh-list
91999586|NCT05897554|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91999587|NCT05897554|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91999588|NCT05897554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999589|NCT05896566|Anastrozole|anastrozole|mesh-list
91999590|NCT05896566|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91999591|NCT05896566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91999592|NCT05896566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999593|NCT05896566|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91999594|NCT05896566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91999595|NCT05896566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999596|NCT05896566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999597|NCT05896566|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91999598|NCT05896566|Hormone Antagonists|hormone antagonists|mesh-ancestor
91999599|NCT05896566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999600|NCT05896566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999601|NCT05896566|Luteolytic Agents|luteolytic agents|mesh-ancestor
91970657|NCT04442633|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91970658|NCT04442633|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91970659|NCT04442633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970660|NCT04442633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999602|NCT05896566|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91999603|NCT05896566|Contraceptive Agents|contraceptive agents|mesh-ancestor
91999604|NCT05896566|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91999605|NCT05896566|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91999612|NCT05888870|Daratumumab|daratumumab|mesh-list
91999613|NCT05888870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999615|NCT05888532|Trace Elements|trace elements|mesh-ancestor
91999616|NCT05888532|Micronutrients|micronutrients|mesh-ancestor
91999617|NCT05888532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999627|NCT05875857|Sensory System Agents|sensory system agents|mesh-ancestor
91999628|NCT05875857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999629|NCT05875727|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91999630|NCT05875727|Immunologic Factors|immunologic factors|mesh-ancestor
91999631|NCT05875727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999632|NCT05874492|Dermatologic Agents|dermatologic agents|mesh-list
91999633|NCT05872854|Hypericin|hypericin|mesh-list
91999634|NCT05872854|Antidepressive Agents|antidepressive agents|mesh-ancestor
91999635|NCT05872854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91999636|NCT05872854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999637|NCT05872854|Antiviral Agents|antiviral agents|mesh-ancestor
91999638|NCT05872854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999639|NCT05872854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999640|NCT05872854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999641|NCT05872854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999642|NCT05872854|Immunologic Factors|immunologic factors|mesh-ancestor
91999643|NCT05872854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999644|NCT05867329|Cyclosporine|cyclosporine|mesh-list
91999645|NCT05867329|Prednisone|prednisone|mesh-list
91999646|NCT05867329|Methylprednisolone|methylprednisolone|mesh-list
91999647|NCT05867329|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
91999648|NCT05867329|Upadacitinib|upadacitinib|mesh-list
91999649|NCT05867329|Cyclosporins|cyclosporins|mesh-list
91999650|NCT05867329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91999651|NCT05867329|Glucocorticoids|glucocorticoids|mesh-ancestor
91999652|NCT05867329|Hormones|hormones|mesh-ancestor
91999653|NCT05867329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999654|NCT05867329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999655|NCT05867329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91999656|NCT05867329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999657|NCT05867329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999658|NCT05867329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999659|NCT05867329|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999660|NCT05867329|Immunologic Factors|immunologic factors|mesh-ancestor
91999661|NCT05867329|Antifungal Agents|antifungal agents|mesh-ancestor
91999662|NCT05867329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999663|NCT05867329|Dermatologic Agents|dermatologic agents|mesh-ancestor
91999664|NCT05867329|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999665|NCT05867329|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91999666|NCT05867329|Antiemetics|antiemetics|mesh-ancestor
91999667|NCT05867329|Autonomic Agents|autonomic agents|mesh-ancestor
91999668|NCT05867329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999669|NCT05867329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999670|NCT05867329|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91999671|NCT05867329|Protective Agents|protective agents|mesh-ancestor
91999672|NCT05867329|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91999673|NCT05867329|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91999674|NCT05860881|Sirolimus|sirolimus|mesh-list
91999675|NCT05860881|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91999676|NCT05860881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999677|NCT05860881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91999678|NCT05860881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999679|NCT05860881|Antifungal Agents|antifungal agents|mesh-ancestor
91999680|NCT05860881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999681|NCT05860881|Immunologic Factors|immunologic factors|mesh-ancestor
91999682|NCT05860881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970661|NCT04442633|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91970662|NCT04442633|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970663|NCT04442633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970664|NCT04442633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970665|NCT04442633|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91999684|NCT05859464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999685|NCT05859464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999686|NCT05859464|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91999687|NCT05859464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999689|NCT05856305|Chlorophyllin|chlorophyllin|mesh-list
91999690|NCT05856305|Trace Elements|trace elements|mesh-ancestor
91999691|NCT05856305|Micronutrients|micronutrients|mesh-ancestor
91999692|NCT05856305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999693|NCT05856305|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
91999698|NCT05848375|Anesthetics|anesthetics|mesh-ancestor
91999699|NCT05848375|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999700|NCT05848375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999701|NCT05848375|Sensory System Agents|sensory system agents|mesh-ancestor
91999702|NCT05848375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999703|NCT05845450|Trastuzumab|trastuzumab|mesh-list
91999704|NCT05845450|Durvalumab|durvalumab|mesh-list
91999705|NCT05845450|Panitumumab|panitumumab|mesh-list
91999706|NCT05845450|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
91999707|NCT05845450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999708|NCT05845450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999709|NCT05845450|Immunoconjugates|immunoconjugates|mesh-ancestor
91999710|NCT05845450|Immunologic Factors|immunologic factors|mesh-ancestor
91999711|NCT05845450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999712|NCT05845138|Capecitabine|capecitabine|mesh-list
91999713|NCT05845138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91999714|NCT05845138|Antimetabolites|antimetabolites|mesh-ancestor
91999715|NCT05845138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999716|NCT05845138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999717|NCT05838664|Rivaroxaban|rivaroxaban|mesh-list
91999718|NCT05838664|Apixaban|apixaban|mesh-list
91999719|NCT05838664|Dabigatran|dabigatran|mesh-list
91999720|NCT05838664|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91999721|NCT05838664|Antithrombins|antithrombins|mesh-ancestor
91999722|NCT05838664|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91999723|NCT05838664|Protease Inhibitors|protease inhibitors|mesh-ancestor
91999724|NCT05838664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999725|NCT05838664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999726|NCT05838664|Anticoagulants|anticoagulants|mesh-ancestor
91999727|NCT05823896|Ritonavir|ritonavir|mesh-list
91999728|NCT05823896|Nirmatrelvir|nirmatrelvir|mesh-list
91999729|NCT05823896|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
91999730|NCT05823896|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91999731|NCT05823896|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91999732|NCT05823896|Protease Inhibitors|protease inhibitors|mesh-ancestor
91999733|NCT05823896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999734|NCT05823896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999735|NCT05823896|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91999736|NCT05823896|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91999737|NCT05823896|Antiviral Agents|antiviral agents|mesh-ancestor
91999738|NCT05823896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999739|NCT05823896|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91999740|NCT05823896|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91999741|NCT05821088|Carboplatin|carboplatin|mesh-list
91999742|NCT05821088|Etoposide|etoposide|mesh-list
91999743|NCT05821088|Lenalidomide|lenalidomide|mesh-list
91999744|NCT05821088|Etoposide phosphate|etoposide phosphate|mesh-list
91999745|NCT05821088|Ifosfamide|ifosfamide|mesh-list
91999746|NCT05821088|Isophosphamide mustard|isophosphamide mustard|mesh-list
91999747|NCT05821088|Podophyllotoxin|podophyllotoxin|mesh-list
91999748|NCT05821088|Immunoglobulins|immunoglobulins|mesh-list
91999749|NCT05821088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999750|NCT05821088|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91970666|NCT04442633|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91970668|NCT03312335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970669|NCT03312335|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91999751|NCT05821088|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91999752|NCT05821088|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91999753|NCT05821088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999754|NCT05821088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999755|NCT05821088|Immunologic Factors|immunologic factors|mesh-ancestor
91999756|NCT05821088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999757|NCT05821088|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91999758|NCT05821088|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91999759|NCT05821088|Growth Substances|growth substances|mesh-ancestor
91999760|NCT05821088|Growth Inhibitors|growth inhibitors|mesh-ancestor
91999761|NCT05821088|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999762|NCT05821088|Alkylating Agents|alkylating agents|mesh-ancestor
91999763|NCT05821088|Keratolytic Agents|keratolytic agents|mesh-ancestor
91999764|NCT05821088|Dermatologic Agents|dermatologic agents|mesh-ancestor
91999765|NCT05821088|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999766|NCT05821088|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999767|NCT05821088|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999772|NCT05813288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999773|NCT05813288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91999774|NCT05813288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91999775|NCT05813288|Dopamine Agonists|dopamine agonists|mesh-ancestor
91999777|NCT05813288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999778|NCT05808764|Risdiplam|risdiplam|mesh-list
91999779|NCT05808764|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91999780|NCT05808764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999781|NCT05808764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999782|NCT05794581|Liraglutide|liraglutide|mesh-list
91999783|NCT05794581|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91999784|NCT05794581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999785|NCT05794581|Incretins|incretins|mesh-ancestor
91999786|NCT05794581|Hormones|hormones|mesh-ancestor
91999787|NCT05794581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999788|NCT05794555|Lactulose|lactulose|mesh-list
91999789|NCT05794555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91999791|NCT05784012|Dostarlimab|dostarlimab|mesh-list
91999792|NCT05784012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999793|NCT05784012|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91999794|NCT05784012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999795|NCT05784012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999796|NCT05780710|Antihypertensive Agents|antihypertensive agents|mesh-list
91999797|NCT05777993|Mitapivat|mitapivat|mesh-list
91999798|NCT05777993|Enzyme Activators|enzyme activators|mesh-ancestor
91999799|NCT05777993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999800|NCT05776524|Paclitaxel|paclitaxel|mesh-list
91999801|NCT05776524|Gemcitabine|gemcitabine|mesh-list
91999802|NCT05776524|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91999803|NCT05776524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999804|NCT05776524|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999805|NCT05776524|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999806|NCT05776524|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999807|NCT05776524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999808|NCT05776524|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91999809|NCT05776524|Antimetabolites|antimetabolites|mesh-ancestor
91999810|NCT05769153|Aflibercept|aflibercept|mesh-list
91999811|NCT05769153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91999812|NCT05769153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91999813|NCT05769153|Growth Substances|growth substances|mesh-ancestor
91999814|NCT05769153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999815|NCT05769153|Growth Inhibitors|growth inhibitors|mesh-ancestor
91999816|NCT05769153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999817|NCT05767944|Anesthetics|anesthetics|mesh-list
91999818|NCT05767944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999819|NCT05767944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999820|NCT05763121|Pramipexole|pramipexole|mesh-list
91999821|NCT05763121|Antioxidants|antioxidants|mesh-ancestor
91970670|NCT03312335|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91970671|NCT03312335|Antiviral Agents|antiviral agents|mesh-ancestor
91970672|NCT03312335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970673|NCT03312179|Incretins|incretins|mesh-list
91970674|NCT03312179|Hormones|hormones|mesh-ancestor
91999822|NCT05763121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999823|NCT05763121|Protective Agents|protective agents|mesh-ancestor
91999824|NCT05763121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999825|NCT05763121|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91999826|NCT05763121|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91999827|NCT05763121|Dopamine Agonists|dopamine agonists|mesh-ancestor
91999828|NCT05763121|Dopamine Agents|dopamine agents|mesh-ancestor
91999829|NCT05763121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999830|NCT05751265|Paclitaxel|paclitaxel|mesh-list
91999831|NCT05751265|Tislelizumab|tislelizumab|mesh-list
91999832|NCT05751265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91999833|NCT05751265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999834|NCT05751265|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999835|NCT05751265|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999836|NCT05751265|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999837|NCT05751265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999838|NCT05751265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999839|NCT05748600|Pramipexole|pramipexole|mesh-list
91999840|NCT05748600|Antioxidants|antioxidants|mesh-ancestor
91999864|NCT05722418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999865|NCT05722418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999866|NCT05722418|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999867|NCT05722418|Alkylating Agents|alkylating agents|mesh-ancestor
91999868|NCT05722418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999869|NCT05722418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999870|NCT05722418|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91999871|NCT05716854|Moxifloxacin|moxifloxacin|mesh-list
91999872|NCT05716854|Clarithromycin|clarithromycin|mesh-list
91999873|NCT05716854|Cobicistat|cobicistat|mesh-list
91999874|NCT05716854|Pimozide|pimozide|mesh-list
91999875|NCT05716854|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
91999876|NCT05716854|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91999877|NCT05716854|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999878|NCT05716854|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91999879|NCT05716854|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91999880|NCT05716854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999881|NCT05716854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999882|NCT05716854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999883|NCT05716854|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91999884|NCT05716854|Contraceptive Agents|contraceptive agents|mesh-ancestor
91999885|NCT05716854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91999886|NCT05716854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999887|NCT05716854|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91999888|NCT05716854|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91999889|NCT05716854|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91999890|NCT05716854|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91999891|NCT05716854|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91999892|NCT05716854|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91999893|NCT05716854|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91999894|NCT05716854|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91999895|NCT05716854|Antiviral Agents|antiviral agents|mesh-ancestor
91999896|NCT05716854|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91999897|NCT05716854|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91999898|NCT05716854|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999899|NCT05716854|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91999900|NCT05716854|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91999901|NCT05716854|Dopamine Agents|dopamine agents|mesh-ancestor
91999902|NCT05716854|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999903|NCT05716854|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91999904|NCT05714553|Leucovorin|leucovorin|mesh-list
91999905|NCT05714553|Docetaxel|docetaxel|mesh-list
91999906|NCT05714553|Pembrolizumab|pembrolizumab|mesh-list
91999907|NCT05714553|Levoleucovorin|levoleucovorin|mesh-list
91999908|NCT05714553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999909|NCT05714553|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999910|NCT05714553|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999911|NCT05714553|Mitosis Modulators|mitosis modulators|mesh-ancestor
91970675|NCT03312179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91999912|NCT05714553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999916|NCT05714553|Protective Agents|protective agents|mesh-ancestor
91999917|NCT05714553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999918|NCT05714553|Vitamin B Complex|vitamin b complex|mesh-ancestor
91999920|NCT05714553|Micronutrients|micronutrients|mesh-ancestor
91999921|NCT05713760|Tirbanibulin|tirbanibulin|mesh-list
91999922|NCT05713760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999923|NCT05713760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999924|NCT05713630|Tranexamic Acid|tranexamic acid|mesh-list
91999925|NCT05713630|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91999926|NCT05713630|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91999927|NCT05713630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999928|NCT05713630|Hemostatics|hemostatics|mesh-ancestor
91999929|NCT05713630|Coagulants|coagulants|mesh-ancestor
91999930|NCT05710783|Vaccines|vaccines|mesh-list
91999931|NCT05710783|Immunologic Factors|immunologic factors|mesh-ancestor
91999932|NCT05710783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999933|NCT05702853|Cyclophosphamide|cyclophosphamide|mesh-list
91999934|NCT05702853|Fludarabine|fludarabine|mesh-list
91999935|NCT05702853|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999936|NCT05702853|Immunologic Factors|immunologic factors|mesh-ancestor
91999937|NCT05702853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999938|NCT05702853|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999939|NCT05702853|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999940|NCT05702853|Alkylating Agents|alkylating agents|mesh-ancestor
91999941|NCT05702853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999942|NCT05702853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999943|NCT05702853|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91999944|NCT05701488|Durvalumab|durvalumab|mesh-list
91999945|NCT05701488|Tremelimumab|tremelimumab|mesh-list
91999946|NCT05701488|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999947|NCT05701488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999948|NCT05695261|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91999949|NCT05695261|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
91999950|NCT05695261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91999951|NCT05695261|Antitubercular Agents|antitubercular agents|mesh-ancestor
91999952|NCT05685407|Caffeine|caffeine|mesh-list
91999953|NCT05685407|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91999954|NCT05685407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999955|NCT05685407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91999956|NCT05685407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91999957|NCT05685407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999958|NCT05685407|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91999959|NCT05685407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91999960|NCT05685407|Purinergic Agents|purinergic agents|mesh-ancestor
91999961|NCT05685407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999962|NCT05684276|Paclitaxel|paclitaxel|mesh-list
91999963|NCT05684276|Carboplatin|carboplatin|mesh-list
91999964|NCT05684276|Nivolumab|nivolumab|mesh-list
91999965|NCT05684276|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91999966|NCT05684276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999967|NCT05684276|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999968|NCT05684276|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999969|NCT05684276|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999970|NCT05684276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999971|NCT05684276|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999972|NCT05684276|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91999973|NCT05672459|Cyclophosphamide|cyclophosphamide|mesh-list
91999975|NCT05672459|Fludarabine phosphate|fludarabine phosphate|mesh-list
91999976|NCT05672459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999977|NCT05672459|Immunologic Factors|immunologic factors|mesh-ancestor
91999978|NCT05672459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999979|NCT05672459|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999980|NCT05672459|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91999981|NCT05672459|Alkylating Agents|alkylating agents|mesh-ancestor
91999982|NCT05672459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999983|NCT05672459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999984|NCT05672459|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91999987|NCT05672342|Dronabinol|dronabinol|mesh-list
91999988|NCT05672342|Cannabidiol|cannabidiol|mesh-list
91999989|NCT05672342|Anticonvulsants|anticonvulsants|mesh-ancestor
91999990|NCT05672342|Hallucinogens|hallucinogens|mesh-ancestor
91999991|NCT05672342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999992|NCT05672342|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91999993|NCT05672342|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91999994|NCT05672342|Analgesics|analgesics|mesh-ancestor
91999995|NCT05672342|Sensory System Agents|sensory system agents|mesh-ancestor
91999996|NCT05672342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999997|NCT05672342|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
91999998|NCT05672342|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
91999999|NCT05672342|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000000|NCT05672342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000001|NCT05672342|Hormones|hormones|mesh-ancestor
92000002|NCT05672342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000003|NCT05672095|Selenium|selenium|mesh-list
92000004|NCT05672095|Niraparib|niraparib|mesh-list
92000005|NCT05672095|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92000006|NCT05672095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000007|NCT05672095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000008|NCT05672095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000009|NCT05672095|Antioxidants|antioxidants|mesh-ancestor
92000010|NCT05672095|Protective Agents|protective agents|mesh-ancestor
92000011|NCT05672095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000012|NCT05672095|Trace Elements|trace elements|mesh-ancestor
92000013|NCT05672095|Micronutrients|micronutrients|mesh-ancestor
92000014|NCT05669820|Antisecretory factor|antisecretory factor|mesh-list
92000015|NCT05669820|Antidiarrheals|antidiarrheals|mesh-ancestor
92000016|NCT05669820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92000017|NCT05667116|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92000018|NCT05667116|Antiviral Agents|antiviral agents|mesh-ancestor
92000019|NCT05667116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000020|NCT05655182|Vaccines|vaccines|mesh-list
92000021|NCT05655182|Immunologic Factors|immunologic factors|mesh-ancestor
92000022|NCT05655182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000023|NCT05644600|Nintedanib|nintedanib|mesh-list
92000024|NCT05644600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000025|NCT05644600|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92000026|NCT05644600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000027|NCT05644600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000028|NCT05641051|Metoclopramide|metoclopramide|mesh-list
92000029|NCT05641051|Antiemetics|antiemetics|mesh-ancestor
92000030|NCT05641051|Autonomic Agents|autonomic agents|mesh-ancestor
92000031|NCT05641051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000032|NCT05641051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000033|NCT05641051|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92000034|NCT05641051|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92000035|NCT05641051|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92000036|NCT05641051|Dopamine Agents|dopamine agents|mesh-ancestor
92000037|NCT05641051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000038|NCT05641051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000039|NCT05633615|Cyclophosphamide|cyclophosphamide|mesh-list
92000040|NCT05633615|Fludarabine|fludarabine|mesh-list
92000041|NCT05633615|Tisagenlecleucel|tisagenlecleucel|mesh-list
92000042|NCT05633615|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92000043|NCT05633615|Antibodies|antibodies|mesh-list
92000044|NCT05633615|Immunoglobulins|immunoglobulins|mesh-list
92000045|NCT05633615|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000046|NCT05633615|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92000047|NCT05633615|Immunoconjugates|immunoconjugates|mesh-list
92000048|NCT05633615|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92000049|NCT05633615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000050|NCT05633615|Immunologic Factors|immunologic factors|mesh-ancestor
92000051|NCT05633615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000052|NCT05633615|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000053|NCT05633615|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000054|NCT05633615|Alkylating Agents|alkylating agents|mesh-ancestor
92000055|NCT05633615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000056|NCT05633615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000057|NCT05633615|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92000061|NCT05631626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000062|NCT05631626|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92000063|NCT05631626|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92000064|NCT05631626|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000065|NCT05631626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000067|NCT05631626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000068|NCT05625932|Tinzaparin|tinzaparin|mesh-list
92000069|NCT05625932|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92000070|NCT05625932|Dalteparin|dalteparin|mesh-list
92000071|NCT05625932|Anticoagulants|anticoagulants|mesh-ancestor
92000072|NCT05625932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92000073|NCT05625932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92000074|NCT05625932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000075|NCT05624996|Paclitaxel|paclitaxel|mesh-list
92000076|NCT05624996|Etoposide|etoposide|mesh-list
92000077|NCT05624996|Podophyllotoxin|podophyllotoxin|mesh-list
92000078|NCT05624996|Cisplatin|cisplatin|mesh-list
92000079|NCT05624996|Carboplatin|carboplatin|mesh-list
92000080|NCT05624996|Pemetrexed|pemetrexed|mesh-list
92000081|NCT05624996|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92000082|NCT05624996|Etoposide phosphate|etoposide phosphate|mesh-list
92000083|NCT05624996|Durvalumab|durvalumab|mesh-list
92000084|NCT05624996|Immunoglobulins|immunoglobulins|mesh-list
92000085|NCT05624996|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000086|NCT05624996|Immunoglobulin G|immunoglobulin g|mesh-list
92000087|NCT05624996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000088|NCT05624996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000089|NCT05624996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92000090|NCT05624996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92000091|NCT05624996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92000092|NCT05624996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000093|NCT05624996|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92000094|NCT05624996|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000095|NCT05624996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000096|NCT05624996|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92000097|NCT05624996|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92000098|NCT05624996|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000099|NCT05624996|Immunologic Factors|immunologic factors|mesh-ancestor
92000100|NCT05624996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000101|NCT05624996|Keratolytic Agents|keratolytic agents|mesh-ancestor
92000102|NCT05624996|Dermatologic Agents|dermatologic agents|mesh-ancestor
92000103|NCT05618808|Enoxaparin|enoxaparin|mesh-list
92000104|NCT05618808|Anticoagulants|anticoagulants|mesh-ancestor
92000105|NCT05618808|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92000106|NCT05618808|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92000107|NCT05618808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000108|NCT05618366|Venetoclax|venetoclax|mesh-list
92000109|NCT05618366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000110|NCT05617820|Estradiol|estradiol|mesh-list
92000111|NCT05617820|Estrogens|estrogens|mesh-ancestor
92000112|NCT05617820|Hormones|hormones|mesh-ancestor
92000113|NCT05617820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000114|NCT05617820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000115|NCT05587998|Morphine|morphine|mesh-list
92000116|NCT05587998|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92000117|NCT05587998|Narcotics|narcotics|mesh-ancestor
92000118|NCT05587998|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000119|NCT05587998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000120|NCT05587998|Analgesics|analgesics|mesh-ancestor
92000121|NCT05587998|Sensory System Agents|sensory system agents|mesh-ancestor
92000122|NCT05587998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000123|NCT05585398|Botulinum Toxins|botulinum toxins|mesh-list
92000124|NCT05585398|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92000125|NCT05585398|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92000126|NCT05585398|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92000127|NCT05585398|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92000128|NCT05585398|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000132|NCT05585398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000133|NCT05585398|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92000134|NCT05585398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000135|NCT05576077|Pembrolizumab|pembrolizumab|mesh-list
92000136|NCT05576077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000137|NCT05576077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000138|NCT05576077|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000139|NCT05576077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970680|NCT02468531|Anesthetics|anesthetics|mesh-ancestor
91970681|NCT02468531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000140|NCT05571735|Vaccines|vaccines|mesh-list
92000141|NCT05571735|Immunologic Factors|immunologic factors|mesh-ancestor
92000142|NCT05571735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000143|NCT05570812|Neurosteroids|neurosteroids|mesh-list
92000144|NCT05570812|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000145|NCT05570812|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000146|NCT05570812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000147|NCT05569512|Fludarabine|fludarabine|mesh-list
92000148|NCT05569512|Busulfan|busulfan|mesh-list
92000149|NCT05569512|Clofarabine|clofarabine|mesh-list
92000150|NCT05569512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000151|NCT05569512|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92000152|NCT05569512|Antimetabolites|antimetabolites|mesh-ancestor
92000153|NCT05569512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000154|NCT05569512|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000155|NCT05569512|Immunologic Factors|immunologic factors|mesh-ancestor
92000156|NCT05569512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000157|NCT05569512|Alkylating Agents|alkylating agents|mesh-ancestor
92000158|NCT05569512|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000159|NCT05569512|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92000160|NCT05561387|Dexamethasone|dexamethasone|mesh-list
92000161|NCT05561387|Dexamethasone acetate|dexamethasone acetate|mesh-list
92000162|NCT05561387|Lenalidomide|lenalidomide|mesh-list
92000163|NCT05561387|Bortezomib|bortezomib|mesh-list
92000164|NCT05561387|Daratumumab|daratumumab|mesh-list
92000165|NCT05561387|Ichthammol|ichthammol|mesh-list
92000166|NCT05561387|BB 1101|bb 1101|mesh-list
92000167|NCT05561387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000168|NCT05561387|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92000169|NCT05561387|Antiemetics|antiemetics|mesh-ancestor
92000170|NCT05561387|Autonomic Agents|autonomic agents|mesh-ancestor
92000171|NCT05561387|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000172|NCT05561387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000173|NCT05561387|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92000174|NCT05561387|Glucocorticoids|glucocorticoids|mesh-ancestor
92000175|NCT05561387|Hormones|hormones|mesh-ancestor
92000176|NCT05561387|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000177|NCT05561387|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92000178|NCT05561387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000179|NCT05561387|Protease Inhibitors|protease inhibitors|mesh-ancestor
92000180|NCT05561387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000181|NCT05561387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000182|NCT05561387|Immunologic Factors|immunologic factors|mesh-ancestor
92000183|NCT05561387|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92000184|NCT05561387|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92000185|NCT05561387|Growth Substances|growth substances|mesh-ancestor
92000186|NCT05561387|Growth Inhibitors|growth inhibitors|mesh-ancestor
92000187|NCT05561387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92000188|NCT05558982|Pembrolizumab|pembrolizumab|mesh-list
92000189|NCT05558982|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000190|NCT05558982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000191|NCT05558982|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000192|NCT05558982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000194|NCT05556616|Pomalidomide|pomalidomide|mesh-list
92000195|NCT05556616|Bortezomib|bortezomib|mesh-list
92000196|NCT05556616|Daratumumab|daratumumab|mesh-list
92000197|NCT05556616|Immunologic Factors|immunologic factors|mesh-ancestor
92000198|NCT05556616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000199|NCT05556616|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92000200|NCT05556616|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92000201|NCT05556616|Growth Substances|growth substances|mesh-ancestor
92000202|NCT05556616|Growth Inhibitors|growth inhibitors|mesh-ancestor
92000203|NCT05556616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000204|NCT05554237|Ceftibuten|ceftibuten|mesh-list
92000205|NCT05554237|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92000206|NCT05554237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000207|NCT05550870|Fenugreek seed meal|fenugreek seed meal|mesh-list
92000208|NCT05550870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92000209|NCT05550870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000210|NCT05544695|Hyaluronic Acid|hyaluronic acid|mesh-list
92000211|NCT05544695|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92000212|NCT05544695|Immunologic Factors|immunologic factors|mesh-ancestor
92000213|NCT05544695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000214|NCT05544695|Viscosupplements|viscosupplements|mesh-ancestor
92000215|NCT05544695|Protective Agents|protective agents|mesh-ancestor
92000216|NCT05543278|Amiodarone|amiodarone|mesh-list
92000217|NCT05543278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92000218|NCT05543278|Vasodilator Agents|vasodilator agents|mesh-ancestor
92000219|NCT05543278|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92000220|NCT05543278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000221|NCT05543278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000222|NCT05543278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92000223|NCT05543278|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92000224|NCT05543278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92000225|NCT05543278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000226|NCT05543278|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92000227|NCT05543278|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92000228|NCT05543278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92000229|NCT05538312|Itraconazole|itraconazole|mesh-list
92000230|NCT05538312|Antifungal Agents|antifungal agents|mesh-ancestor
92000231|NCT05538312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000232|NCT05538312|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92000233|NCT05538312|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92000234|NCT05538312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000235|NCT05538312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000236|NCT05538312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92000237|NCT05538312|Hormone Antagonists|hormone antagonists|mesh-ancestor
92000238|NCT05538312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000239|NCT05538312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000240|NCT05538312|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92000241|NCT05533775|Rituximab|rituximab|mesh-list
92000242|NCT05533775|Obinutuzumab|obinutuzumab|mesh-list
92000243|NCT05533775|Carboplatin|carboplatin|mesh-list
92000244|NCT05533775|Etoposide|etoposide|mesh-list
92000245|NCT05533775|Ifosfamide|ifosfamide|mesh-list
92000246|NCT05533775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000247|NCT05533775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000248|NCT05533775|Immunologic Factors|immunologic factors|mesh-ancestor
92000249|NCT05533775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000250|NCT05533775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000251|NCT05533775|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000252|NCT05533775|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92000253|NCT05533775|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000254|NCT05533775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000255|NCT05533775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000256|NCT05533775|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000257|NCT05533775|Alkylating Agents|alkylating agents|mesh-ancestor
92000258|NCT05512819|Vaccines|vaccines|mesh-list
92000259|NCT05512819|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92000260|NCT05512819|Immunologic Factors|immunologic factors|mesh-ancestor
92000261|NCT05512819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000262|NCT05507476|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92000263|NCT05507476|Epinephrine|epinephrine|mesh-list
92000264|NCT05507476|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92000265|NCT05507476|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92000266|NCT05507476|Adrenergic Agents|adrenergic agents|mesh-ancestor
92000267|NCT05507476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000268|NCT05507476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000269|NCT05507476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000270|NCT05507476|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92000271|NCT05507476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92000272|NCT05507476|Autonomic Agents|autonomic agents|mesh-ancestor
92000273|NCT05507476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000276|NCT05507476|Mydriatics|mydriatics|mesh-ancestor
92000277|NCT05507476|Sympathomimetics|sympathomimetics|mesh-ancestor
92000278|NCT05507476|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92000279|NCT05507476|Hemostatics|hemostatics|mesh-ancestor
92000280|NCT05507476|Coagulants|coagulants|mesh-ancestor
92000281|NCT05507476|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92000282|NCT05507476|Natriuretic Agents|natriuretic agents|mesh-ancestor
92000283|NCT05503797|Cobicistat|cobicistat|mesh-list
92000284|NCT05503797|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91970682|NCT02468531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970683|NCT03311945|Lamivudine|lamivudine|mesh-list
92000285|NCT05503797|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92000286|NCT05503797|Antiviral Agents|antiviral agents|mesh-ancestor
92000287|NCT05503797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000288|NCT05503797|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92000289|NCT05503797|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92000290|NCT05503797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000291|NCT05503797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000292|NCT05501756|Alemtuzumab|alemtuzumab|mesh-list
92000293|NCT05501756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000294|NCT05501756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000295|NCT05500326|Ivermectin|ivermectin|mesh-list
92000296|NCT05500326|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92000297|NCT05500326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000298|NCT05494125|Ropivacaine|ropivacaine|mesh-list
92000299|NCT05494125|Anesthetics, Local|anesthetics, local|mesh-ancestor
92000300|NCT05494125|Anesthetics|anesthetics|mesh-ancestor
92000301|NCT05494125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000302|NCT05494125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000303|NCT05494125|Sensory System Agents|sensory system agents|mesh-ancestor
92000304|NCT05494125|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000305|NCT05484401|Ibuprofen|ibuprofen|mesh-list
92000306|NCT05484401|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92000307|NCT05484401|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92000308|NCT05484401|Analgesics|analgesics|mesh-ancestor
92000310|NCT05484401|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000311|NCT05484401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000312|NCT05484401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92000313|NCT05484401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000314|NCT05484401|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92000315|NCT05484401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000316|NCT05484401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000317|NCT05453396|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92000318|NCT05453396|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000319|NCT05453396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000320|NCT05447676|4-Aminopyridine|4-aminopyridine|mesh-list
92000321|NCT05447676|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92000322|NCT05447676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000323|NCT05447676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000324|NCT05443555|Gabapentin|gabapentin|mesh-list
92000325|NCT05443555|Analgesics|analgesics|mesh-ancestor
92000326|NCT05443555|Sensory System Agents|sensory system agents|mesh-ancestor
92000327|NCT05443555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000328|NCT05443555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000329|NCT05443555|Anticonvulsants|anticonvulsants|mesh-ancestor
92000330|NCT05443555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92000331|NCT05443555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92000332|NCT05443555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000333|NCT05443555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92000334|NCT05443555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92000335|NCT05443555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92000336|NCT05443555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000337|NCT05443555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000338|NCT05443555|Antimanic Agents|antimanic agents|mesh-ancestor
92000339|NCT05442580|Cyclophosphamide|cyclophosphamide|mesh-list
92000340|NCT05442580|Fludarabine|fludarabine|mesh-list
92000341|NCT05442580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000342|NCT05442580|Immunologic Factors|immunologic factors|mesh-ancestor
92000343|NCT05442580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000344|NCT05442580|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000345|NCT05442580|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000350|NCT05435573|Hydroxyethyl Starch Derivatives|hydroxyethyl starch derivatives|mesh-list
92000351|NCT05435573|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92000352|NCT05435573|Plasma Substitutes|plasma substitutes|mesh-ancestor
92000353|NCT05435573|Blood Substitutes|blood substitutes|mesh-ancestor
92000354|NCT05428969|Azacitidine|azacitidine|mesh-list
92000355|NCT05428969|Venetoclax|venetoclax|mesh-list
92000356|NCT05428969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91970684|NCT03311945|Raltegravir Potassium|raltegravir potassium|mesh-list
91970685|NCT03311945|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91970686|NCT03311945|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91970687|NCT03311945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000357|NCT05428969|Antimetabolites|antimetabolites|mesh-ancestor
92000358|NCT05428969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000359|NCT05428969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000360|NCT05428969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000361|NCT05423340|Nicotine|nicotine|mesh-list
92000362|NCT05423340|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92000363|NCT05423340|Autonomic Agents|autonomic agents|mesh-ancestor
92000364|NCT05423340|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000365|NCT05423340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000366|NCT05423340|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92000367|NCT05423340|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92000368|NCT05423340|Cholinergic Agents|cholinergic agents|mesh-ancestor
92000369|NCT05423340|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000370|NCT05423340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000371|NCT05419505|Antifibrinolytic Agents|antifibrinolytic agents|mesh-list
92000372|NCT05419505|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92000373|NCT05419505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000374|NCT05419505|Hemostatics|hemostatics|mesh-ancestor
92000375|NCT05419505|Coagulants|coagulants|mesh-ancestor
92000376|NCT05418582|Carbamazepine|carbamazepine|mesh-list
92000377|NCT05418582|Anticonvulsants|anticonvulsants|mesh-ancestor
92000378|NCT05418582|Antimanic Agents|antimanic agents|mesh-ancestor
92000379|NCT05418582|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92000380|NCT05418582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000381|NCT05418582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000382|NCT05418582|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92000383|NCT05418582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92000384|NCT05418582|Analgesics|analgesics|mesh-ancestor
92000385|NCT05418582|Sensory System Agents|sensory system agents|mesh-ancestor
92000386|NCT05418582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000387|NCT05418582|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92000388|NCT05418582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000389|NCT05418582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000391|NCT05418582|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92000392|NCT05417425|Lidocaine|lidocaine|mesh-list
92000393|NCT05417425|Protective Agents|protective agents|mesh-list
92000394|NCT05417425|Anesthetics, Local|anesthetics, local|mesh-ancestor
92000395|NCT05417425|Anesthetics|anesthetics|mesh-ancestor
92000396|NCT05417425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000397|NCT05417425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000398|NCT05417425|Sensory System Agents|sensory system agents|mesh-ancestor
92000399|NCT05417425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000400|NCT05417425|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92000401|NCT05417425|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92000402|NCT05417425|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92000403|NCT05417425|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000404|NCT05417425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000405|NCT05413915|Imatinib Mesylate|imatinib mesylate|mesh-list
92000406|NCT05413915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000407|NCT05413915|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92000408|NCT05413915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000486|NCT05371093|Vincristine|vincristine|mesh-list
92000409|NCT05413915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000410|NCT05408845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92000411|NCT05408845|Trastuzumab|trastuzumab|mesh-list
92000412|NCT05408845|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92000413|NCT05408845|Docetaxel|docetaxel|mesh-list
92000414|NCT05408845|Maytansine|maytansine|mesh-list
92000418|NCT05408845|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000419|NCT05408845|Immunoconjugates|immunoconjugates|mesh-list
92000420|NCT05408845|Immunologic Factors|immunologic factors|mesh-ancestor
92000421|NCT05408845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000422|NCT05408845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000423|NCT05408845|Tubulin Modulators|tubulin modulators|mesh-ancestor
92000424|NCT05408845|Antimitotic Agents|antimitotic agents|mesh-ancestor
91970688|NCT03311945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970689|NCT03311945|Antiviral Agents|antiviral agents|mesh-ancestor
91970690|NCT03311945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000425|NCT05408845|Mitosis Modulators|mitosis modulators|mesh-ancestor
92000426|NCT05408845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000427|NCT05408845|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000428|NCT05408845|Immunotoxins|immunotoxins|mesh-ancestor
92000429|NCT05407675|Nivolumab|nivolumab|mesh-list
92000430|NCT05407675|Ipilimumab|ipilimumab|mesh-list
92000431|NCT05407675|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000432|NCT05407675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000433|NCT05407675|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000434|NCT05407675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000435|NCT05407441|Nivolumab|nivolumab|mesh-list
92000436|NCT05407441|Ipilimumab|ipilimumab|mesh-list
92000437|NCT05407441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000438|NCT05407441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000439|NCT05407441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000440|NCT05407441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000441|NCT05406401|Prednisone|prednisone|mesh-list
92000442|NCT05406401|Prednisolone|prednisolone|mesh-list
92000443|NCT05406401|Cyclophosphamide|cyclophosphamide|mesh-list
92000444|NCT05406401|Rituximab|rituximab|mesh-list
92000445|NCT05406401|Doxorubicin|doxorubicin|mesh-list
92000446|NCT05406401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000447|NCT05406401|Immunologic Factors|immunologic factors|mesh-ancestor
92000448|NCT05406401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000449|NCT05406401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000450|NCT05406401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000451|NCT05406401|Alkylating Agents|alkylating agents|mesh-ancestor
92000452|NCT05406401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000453|NCT05406401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000454|NCT05406401|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92000455|NCT05406401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000456|NCT05406401|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92000457|NCT05406401|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92000458|NCT05406401|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000459|NCT05406401|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000460|NCT05406401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92000461|NCT05406401|Glucocorticoids|glucocorticoids|mesh-ancestor
92000462|NCT05406401|Hormones|hormones|mesh-ancestor
92000463|NCT05406401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000464|NCT05406401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92000465|NCT05394103|Pembrolizumab|pembrolizumab|mesh-list
92000466|NCT05394103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000467|NCT05394103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000468|NCT05394103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000469|NCT05394103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000470|NCT05388474|Ibalizumab|ibalizumab|mesh-list
92000471|NCT05388474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000472|NCT05388474|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92000473|NCT05388474|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92000475|NCT05388474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000476|NCT05388474|Immunologic Factors|immunologic factors|mesh-ancestor
92000477|NCT05388474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000478|NCT05372744|Antidepressive Agents|antidepressive agents|mesh-list
92000479|NCT05372744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92000480|NCT05371093|Prednisone|prednisone|mesh-list
92000481|NCT05371093|Cyclophosphamide|cyclophosphamide|mesh-list
92000482|NCT05371093|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92000483|NCT05371093|Rituximab|rituximab|mesh-list
92000484|NCT05371093|Doxorubicin|doxorubicin|mesh-list
92000485|NCT05371093|Fludarabine|fludarabine|mesh-list
92000487|NCT05371093|Lenalidomide|lenalidomide|mesh-list
92000488|NCT05371093|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92000491|NCT05371093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000492|NCT05371093|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000493|NCT05371093|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91970691|NCT03311945|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91970692|NCT03311945|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91970693|NCT03311945|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92000494|NCT05371093|Alkylating Agents|alkylating agents|mesh-ancestor
92000495|NCT05371093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000496|NCT05371093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000497|NCT05371093|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92000498|NCT05371093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000499|NCT05371093|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92000500|NCT05371093|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92000501|NCT05371093|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000502|NCT05371093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000503|NCT05371093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92000504|NCT05371093|Glucocorticoids|glucocorticoids|mesh-ancestor
92000505|NCT05371093|Hormones|hormones|mesh-ancestor
92000506|NCT05371093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000507|NCT05371093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92000508|NCT05371093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000509|NCT05371093|Tubulin Modulators|tubulin modulators|mesh-ancestor
92000510|NCT05371093|Antimitotic Agents|antimitotic agents|mesh-ancestor
92000511|NCT05371093|Mitosis Modulators|mitosis modulators|mesh-ancestor
92000512|NCT05371093|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92000513|NCT05371093|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92000514|NCT05371093|Growth Substances|growth substances|mesh-ancestor
92000515|NCT05371093|Growth Inhibitors|growth inhibitors|mesh-ancestor
92000516|NCT05362318|Nicotine|nicotine|mesh-list
92000517|NCT05362318|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92000518|NCT05362318|Autonomic Agents|autonomic agents|mesh-ancestor
92000519|NCT05362318|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000520|NCT05362318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000521|NCT05362318|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92000522|NCT05362318|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92000523|NCT05362318|Cholinergic Agents|cholinergic agents|mesh-ancestor
92000524|NCT05362318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000525|NCT05362318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000526|NCT05359068|Valsartan|valsartan|mesh-list
92000527|NCT05359068|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92000528|NCT05359068|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92000529|NCT05359068|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92000530|NCT05359068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000531|NCT05358886|BPN14770|bpn14770|mesh-list
92000532|NCT05358886|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92000533|NCT05358886|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92000534|NCT05358886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000535|NCT05358886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000536|NCT05357794|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92000537|NCT05357794|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000538|NCT05357794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000539|NCT05357794|Immunotoxins|immunotoxins|mesh-ancestor
92000540|NCT05357794|Immunoconjugates|immunoconjugates|mesh-ancestor
92000541|NCT05357794|Immunologic Factors|immunologic factors|mesh-ancestor
92000542|NCT05357794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000543|NCT05347771|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000544|NCT05347771|Immunologic Factors|immunologic factors|mesh-ancestor
92000545|NCT05347771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000547|NCT05346484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000548|NCT05346484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000549|NCT05346484|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000550|NCT05346484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000551|NCT05342844|Dexmedetomidine|dexmedetomidine|mesh-list
92000552|NCT05342844|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92000553|NCT05342844|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000554|NCT05342844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000555|NCT05342844|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92000556|NCT05342844|Analgesics|analgesics|mesh-ancestor
92000557|NCT05342844|Sensory System Agents|sensory system agents|mesh-ancestor
92000558|NCT05342844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000579|NCT05327686|Nivolumab|nivolumab|mesh-list
92000580|NCT05327686|Ipilimumab|ipilimumab|mesh-list
91970695|NCT03311789|Gemcitabine|gemcitabine|mesh-list
91970696|NCT03311789|Nivolumab|nivolumab|mesh-list
92000581|NCT05327686|Avelumab|avelumab|mesh-list
92000582|NCT05327686|Lenvatinib|lenvatinib|mesh-list
92000583|NCT05327686|Axitinib|axitinib|mesh-list
92000584|NCT05327686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000585|NCT05327686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000586|NCT05327686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000587|NCT05327686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000588|NCT05327686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000589|NCT05327686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92000590|NCT05327686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000591|NCT05327686|Immunologic Factors|immunologic factors|mesh-ancestor
92000592|NCT05327686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000593|NCT05323617|Cyclosporine|cyclosporine|mesh-list
92000594|NCT05323617|Cyclosporins|cyclosporins|mesh-list
92000595|NCT05323617|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92000596|NCT05323617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000597|NCT05323617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000598|NCT05323617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000599|NCT05323617|Immunologic Factors|immunologic factors|mesh-ancestor
92000600|NCT05323617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000601|NCT05323617|Antifungal Agents|antifungal agents|mesh-ancestor
92000602|NCT05323617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000603|NCT05323617|Dermatologic Agents|dermatologic agents|mesh-ancestor
92000604|NCT05323617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000605|NCT05323617|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92000606|NCT05306873|Mycophenolic Acid|mycophenolic acid|mesh-list
92000607|NCT05306873|Cyclosporine|cyclosporine|mesh-list
92000608|NCT05306873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92000609|NCT05306873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000610|NCT05306873|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92000611|NCT05306873|Antitubercular Agents|antitubercular agents|mesh-ancestor
92000612|NCT05306873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92000613|NCT05306873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000614|NCT05306873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000615|NCT05306873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000616|NCT05306873|Antifungal Agents|antifungal agents|mesh-ancestor
92000617|NCT05306873|Dermatologic Agents|dermatologic agents|mesh-ancestor
92000618|NCT05306873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000619|NCT05306873|Immunologic Factors|immunologic factors|mesh-ancestor
92000620|NCT05306873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000621|NCT05306873|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000622|NCT05306873|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92000623|NCT05289687|Daratumumab|daratumumab|mesh-list
92000624|NCT05289687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000625|NCT05289687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000626|NCT05289687|Immunologic Factors|immunologic factors|mesh-ancestor
92000627|NCT05289687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000628|NCT05286762|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92000629|NCT05286762|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92000630|NCT05286762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000631|NCT05286762|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92000632|NCT05286762|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92000634|NCT05286762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000636|NCT05286762|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000638|NCT05272384|Decitabine|decitabine|mesh-list
92000639|NCT05272384|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92000640|NCT05272384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000641|NCT05272384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000642|NCT05272384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000643|NCT05272384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000644|NCT05272384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92000645|NCT05272384|Antimetabolites|antimetabolites|mesh-ancestor
92000646|NCT05272384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000647|NCT05251233|Pantoprazole|pantoprazole|mesh-list
92000648|NCT05251233|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92000649|NCT05251233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92000650|NCT05251233|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92000651|NCT05251233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000652|NCT05251233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000653|NCT05239728|Pembrolizumab|pembrolizumab|mesh-list
92000654|NCT05239728|Belzutifan|belzutifan|mesh-list
92000655|NCT05239728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000656|NCT05239728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000657|NCT05239728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000658|NCT05239728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000659|NCT05231629|Dexamethasone|dexamethasone|mesh-list
92000660|NCT05231629|Dexamethasone acetate|dexamethasone acetate|mesh-list
92000661|NCT05231629|Melphalan|melphalan|mesh-list
92000662|NCT05231629|Lenalidomide|lenalidomide|mesh-list
92000663|NCT05231629|Bortezomib|bortezomib|mesh-list
92000664|NCT05231629|Daratumumab|daratumumab|mesh-list
92000665|NCT05231629|BB 1101|bb 1101|mesh-list
92000666|NCT05231629|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92000667|NCT05231629|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92000668|NCT05231629|Antiemetics|antiemetics|mesh-ancestor
92000669|NCT05231629|Autonomic Agents|autonomic agents|mesh-ancestor
92000670|NCT05231629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000671|NCT05231629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000672|NCT05231629|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92000673|NCT05231629|Glucocorticoids|glucocorticoids|mesh-ancestor
92000674|NCT05231629|Hormones|hormones|mesh-ancestor
92000675|NCT05231629|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000676|NCT05231629|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92000677|NCT05231629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000678|NCT05231629|Protease Inhibitors|protease inhibitors|mesh-ancestor
92000679|NCT05231629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000680|NCT05231629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000681|NCT05231629|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000682|NCT05231629|Alkylating Agents|alkylating agents|mesh-ancestor
92000683|NCT05231629|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92000684|NCT05231629|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000685|NCT05231629|Immunologic Factors|immunologic factors|mesh-ancestor
92000687|NCT05231629|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92000688|NCT05231629|Growth Substances|growth substances|mesh-ancestor
92000689|NCT05231629|Growth Inhibitors|growth inhibitors|mesh-ancestor
92000690|NCT05229965|Acetaminophen|acetaminophen|mesh-list
92000691|NCT05229965|Codeine|codeine|mesh-list
92000692|NCT05229965|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92000693|NCT05229965|Analgesics|analgesics|mesh-ancestor
92000694|NCT05229965|Sensory System Agents|sensory system agents|mesh-ancestor
92000695|NCT05229965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92000696|NCT05229965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000697|NCT05229965|Antipyretics|antipyretics|mesh-ancestor
92000698|NCT05229965|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92000699|NCT05229965|Narcotics|narcotics|mesh-ancestor
92000700|NCT05229965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000701|NCT05229965|Antitussive Agents|antitussive agents|mesh-ancestor
92000702|NCT05229965|Respiratory System Agents|respiratory system agents|mesh-ancestor
92000703|NCT05227391|Letrozole|letrozole|mesh-list
92000704|NCT05227391|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92000705|NCT05227391|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92000706|NCT05227391|Estradiol|estradiol|mesh-list
92000707|NCT05227391|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92000708|NCT05227391|Estrogens|estrogens|mesh-ancestor
92000709|NCT05227391|Hormones|hormones|mesh-ancestor
92000719|NCT05227391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000720|NCT05227391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000721|NCT05227391|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92000722|NCT05227391|Hormone Antagonists|hormone antagonists|mesh-ancestor
92000723|NCT05224141|Carboplatin|carboplatin|mesh-list
92000724|NCT05224141|Pembrolizumab|pembrolizumab|mesh-list
92000725|NCT05224141|Etoposide|etoposide|mesh-list
92000726|NCT05224141|Atezolizumab|atezolizumab|mesh-list
92000727|NCT05224141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000728|NCT05224141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000729|NCT05224141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000730|NCT05224141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000731|NCT05224141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000732|NCT05224141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92000733|NCT05224141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000734|NCT05224141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000735|NCT05207709|Paclitaxel|paclitaxel|mesh-list
92000736|NCT05207709|Letrozole|letrozole|mesh-list
92000737|NCT05207709|Fulvestrant|fulvestrant|mesh-list
92000738|NCT05207709|Tislelizumab|tislelizumab|mesh-list
92000739|NCT05207709|Palbociclib|palbociclib|mesh-list
91970697|NCT03311789|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
91970698|NCT03311789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970699|NCT03311789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92000740|NCT05207709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000741|NCT05207709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000742|NCT05207709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92000743|NCT05207709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92000744|NCT05207709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92000745|NCT05207709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000746|NCT05207709|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92000747|NCT05207709|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92000748|NCT05207709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000749|NCT05207709|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92000750|NCT05207709|Hormone Antagonists|hormone antagonists|mesh-ancestor
92000751|NCT05207709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000752|NCT05207709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000753|NCT05207709|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92000754|NCT05207709|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92000755|NCT05207709|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000756|NCT05207709|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92000757|NCT05203276|Endostar protein|endostar protein|mesh-list
92000758|NCT05203276|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92000759|NCT05203276|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92000760|NCT05203276|Growth Substances|growth substances|mesh-ancestor
92000761|NCT05203276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000762|NCT05203276|Growth Inhibitors|growth inhibitors|mesh-ancestor
92000763|NCT05203276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000773|NCT05201066|Azacitidine|azacitidine|mesh-list
92000774|NCT05201066|Decitabine|decitabine|mesh-list
92000775|NCT05201066|Venetoclax|venetoclax|mesh-list
92000776|NCT05201066|Spartalizumab|spartalizumab|mesh-list
92000777|NCT05201066|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92000778|NCT05201066|Antimetabolites|antimetabolites|mesh-ancestor
92000779|NCT05201066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000780|NCT05201066|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000781|NCT05201066|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000782|NCT05201066|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000794|NCT05169437|Niraparib|niraparib|mesh-list
92000795|NCT05169437|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92000796|NCT05169437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000797|NCT05169437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000798|NCT05169437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000799|NCT05167487|Cisplatin|cisplatin|mesh-list
92000800|NCT05167487|Carboplatin|carboplatin|mesh-list
92000801|NCT05167487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000802|NCT05163808|BPN14770|bpn14770|mesh-list
92000803|NCT05163808|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92000804|NCT05163808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92000805|NCT05163808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000806|NCT05163808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000816|NCT05159778|Pembrolizumab|pembrolizumab|mesh-list
92000817|NCT05159778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000818|NCT05159778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000819|NCT05159778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000820|NCT05159778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000821|NCT05159050|Paclitaxel|paclitaxel|mesh-list
92000822|NCT05159050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000823|NCT05159050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000824|NCT05159050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92000825|NCT05159050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92000826|NCT05159050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92000827|NCT05159050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000829|NCT05153915|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000830|NCT05153915|Immunologic Factors|immunologic factors|mesh-ancestor
92000831|NCT05153915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000832|NCT05153915|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92000833|NCT05153915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970700|NCT03311789|Antimetabolites|antimetabolites|mesh-ancestor
91970701|NCT03311789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970702|NCT03311789|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970704|NCT02468999|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92000834|NCT05153915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000835|NCT05152888|Evolocumab|evolocumab|mesh-list
92000836|NCT05152888|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92000837|NCT05152888|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92000838|NCT05152888|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92000839|NCT05152888|Antimetabolites|antimetabolites|mesh-ancestor
92000840|NCT05152888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000841|NCT05152888|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92000842|NCT05152888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92000843|NCT05152888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000844|NCT05152888|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92000846|NCT05152628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000847|NCT05152628|Immunologic Factors|immunologic factors|mesh-ancestor
92000848|NCT05152628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000849|NCT05152628|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92000850|NCT05152628|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000851|NCT05152628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000852|NCT05151484|Alendronate|alendronate|mesh-list
92000853|NCT05151484|Teriparatide|teriparatide|mesh-list
92000854|NCT05151484|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92000856|NCT05151484|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92000858|NCT05145010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000859|NCT05144256|Mitapivat|mitapivat|mesh-list
92000860|NCT05144256|Enzyme Activators|enzyme activators|mesh-ancestor
92000861|NCT05144256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000862|NCT05144009|Rituximab|rituximab|mesh-list
92000863|NCT05144009|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92000864|NCT05144009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000865|NCT05144009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000866|NCT05144009|Immunologic Factors|immunologic factors|mesh-ancestor
92000867|NCT05144009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000868|NCT05144009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92000869|NCT05142189|Docetaxel|docetaxel|mesh-list
92000870|NCT05142189|Cemiplimab|cemiplimab|mesh-list
92000871|NCT05142189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000872|NCT05142189|Tubulin Modulators|tubulin modulators|mesh-ancestor
92000873|NCT05142189|Antimitotic Agents|antimitotic agents|mesh-ancestor
92000874|NCT05142189|Mitosis Modulators|mitosis modulators|mesh-ancestor
92000875|NCT05142189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000876|NCT05142189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000877|NCT05131828|Metformin|metformin|mesh-list
92000878|NCT05131828|Clemastine|clemastine|mesh-list
92000879|NCT05131828|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92000880|NCT05131828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000881|NCT05131828|Antipruritics|antipruritics|mesh-ancestor
92000882|NCT05131828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92000883|NCT05131828|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92000884|NCT05131828|Histamine Antagonists|histamine antagonists|mesh-ancestor
92000885|NCT05131828|Histamine Agents|histamine agents|mesh-ancestor
92000886|NCT05131828|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000887|NCT05131828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000888|NCT05131828|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92000889|NCT05122546|Nivolumab|nivolumab|mesh-list
92000890|NCT05122546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000891|NCT05122546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000892|NCT05122546|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000893|NCT05122546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000894|NCT05120895|Pravastatin|pravastatin|mesh-list
92000895|NCT05120895|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92000896|NCT05120895|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92000897|NCT05120895|Antimetabolites|antimetabolites|mesh-ancestor
92000898|NCT05120895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000899|NCT05120895|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92000900|NCT05120895|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91970706|NCT02468999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000901|NCT05120895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000902|NCT05117476|Pembrolizumab|pembrolizumab|mesh-list
92000903|NCT05117476|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000904|NCT05117476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000905|NCT05117476|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000906|NCT05117476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000907|NCT05113537|177Lu-PSMA-617|177lu-psma-617|mesh-list
92000908|NCT05113537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000909|NCT05113537|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92000910|NCT05110300|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92000911|NCT05110300|Luteolytic Agents|luteolytic agents|mesh-ancestor
92000912|NCT05110300|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92000913|NCT05110300|Contraceptive Agents|contraceptive agents|mesh-ancestor
92000914|NCT05110300|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92000996|NCT05050084|Tryptophan|tryptophan|mesh-list
92000915|NCT05110300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000916|NCT05110300|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92000917|NCT05110300|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92000918|NCT05110300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000919|NCT05104554|Folic Acid|folic acid|mesh-list
92000920|NCT05104554|Micronutrients|micronutrients|mesh-list
92000921|NCT05104554|Trace Elements|trace elements|mesh-list
92000922|NCT05104554|Hematinics|hematinics|mesh-ancestor
92000923|NCT05104554|Vitamin B Complex|vitamin b complex|mesh-ancestor
92000924|NCT05104554|Vitamins|vitamins|mesh-ancestor
92000925|NCT05104554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000926|NCT05101551|Gemcitabine|gemcitabine|mesh-list
92000927|NCT05101551|Topotecan|topotecan|mesh-list
92000928|NCT05101551|Talazoparib|talazoparib|mesh-list
92000933|NCT05101551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92000934|NCT05101551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000935|NCT05101551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000936|NCT05101551|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92000937|NCT05095376|Temozolomide|temozolomide|mesh-list
92000938|NCT05095376|Lomustine|lomustine|mesh-list
92000939|NCT05095376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92000940|NCT05095376|Alkylating Agents|alkylating agents|mesh-ancestor
92000941|NCT05095376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000942|NCT05095376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000943|NCT05091567|Carboplatin|carboplatin|mesh-list
92000944|NCT05091567|Etoposide|etoposide|mesh-list
92000945|NCT05091567|Atezolizumab|atezolizumab|mesh-list
92000946|NCT05091567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000947|NCT05091567|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000948|NCT05091567|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92000949|NCT05091567|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92000950|NCT05091567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92000951|NCT05091567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000952|NCT05091567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92000953|NCT05091567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000954|NCT05088252|Propofol|propofol|mesh-list
92000955|NCT05088252|Desflurane|desflurane|mesh-list
92000956|NCT05088252|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92000957|NCT05088252|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92000958|NCT05088252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000959|NCT05088252|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92000960|NCT05088252|Anesthetics, General|anesthetics, general|mesh-ancestor
92000961|NCT05088252|Anesthetics|anesthetics|mesh-ancestor
92000962|NCT05088252|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92000963|NCT05073575|Hyaluronic Acid|hyaluronic acid|mesh-list
92000964|NCT05073575|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92000965|NCT05073575|Immunologic Factors|immunologic factors|mesh-ancestor
92000966|NCT05073575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000967|NCT05073575|Viscosupplements|viscosupplements|mesh-ancestor
92000968|NCT05073575|Protective Agents|protective agents|mesh-ancestor
92000969|NCT05073003|Vaccines|vaccines|mesh-list
92000970|NCT05073003|Immunologic Factors|immunologic factors|mesh-ancestor
92000971|NCT05073003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000972|NCT05069298|Silybin|silybin|mesh-list
92000973|NCT05069298|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92000974|NCT05069298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000975|NCT05069298|Protective Agents|protective agents|mesh-ancestor
92000976|NCT05069298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000977|NCT05053867|Tranexamic Acid|tranexamic acid|mesh-list
91970707|NCT03311321|Vitamin K|vitamin k|mesh-list
91970708|NCT03311321|Vitamin K 2|vitamin k 2|mesh-list
91970709|NCT03311321|Menaquinone 7|menaquinone 7|mesh-list
92000978|NCT05053867|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92000979|NCT05053867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92000980|NCT05053867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000981|NCT05053867|Hemostatics|hemostatics|mesh-ancestor
92000982|NCT05053867|Coagulants|coagulants|mesh-ancestor
92000983|NCT05053152|Relugolix|relugolix|mesh-list
92000984|NCT05053152|Androgen Antagonists|androgen antagonists|mesh-ancestor
92000985|NCT05053152|Hormone Antagonists|hormone antagonists|mesh-ancestor
92000986|NCT05053152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000987|NCT05053152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000989|NCT05050162|1,2-diaminocyclohexaneplatinum II citrate|1,2-diaminocyclohexaneplatinum ii citrate|mesh-list
92000990|NCT05050162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000991|NCT05050084|Leuprolide|leuprolide|mesh-list
92000992|NCT05050084|Goserelin|goserelin|mesh-list
92000993|NCT05050084|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92000994|NCT05050084|Flutamide|flutamide|mesh-list
92000995|NCT05050084|Bicalutamide|bicalutamide|mesh-list
92000997|NCT05050084|Buserelin|buserelin|mesh-list
92000998|NCT05050084|Hormones|hormones|mesh-list
92000999|NCT05050084|Relugolix|relugolix|mesh-list
92001000|NCT05050084|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001001|NCT05050084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001007|NCT05050084|Androgen Antagonists|androgen antagonists|mesh-ancestor
92001008|NCT05050084|Hormone Antagonists|hormone antagonists|mesh-ancestor
92001009|NCT05050084|Luteolytic Agents|luteolytic agents|mesh-ancestor
92001010|NCT05050084|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92001011|NCT05050084|Contraceptive Agents|contraceptive agents|mesh-ancestor
92001012|NCT05050084|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92001013|NCT05050084|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92001014|NCT05050084|Antidepressive Agents|antidepressive agents|mesh-ancestor
92001015|NCT05050084|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001016|NCT05047640|Vaccines|vaccines|mesh-list
92001017|NCT05047640|Immunologic Factors|immunologic factors|mesh-ancestor
92001018|NCT05047640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001019|NCT05047250|Atezolizumab|atezolizumab|mesh-list
92001020|NCT05047250|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001021|NCT05047250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001022|NCT05047250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001023|NCT05047250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001024|NCT05046314|Vincristine|vincristine|mesh-list
92001025|NCT05046314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001026|NCT05046314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001027|NCT05046314|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001028|NCT05046314|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001029|NCT05046314|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001030|NCT05046314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001031|NCT05043714|Nivolumab|nivolumab|mesh-list
92001032|NCT05043714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001033|NCT05043714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001034|NCT05043714|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001035|NCT05043714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001036|NCT05039073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92001037|NCT05039073|Nivolumab|nivolumab|mesh-list
92001038|NCT05039073|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92001039|NCT05039073|Antibodies|antibodies|mesh-list
92001040|NCT05039073|Immunoglobulins|immunoglobulins|mesh-list
92001041|NCT05039073|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92001042|NCT05039073|Immunoconjugates|immunoconjugates|mesh-list
92001043|NCT05039073|Immunologic Factors|immunologic factors|mesh-ancestor
92001044|NCT05039073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001045|NCT05039073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001046|NCT05039073|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001047|NCT05039073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001048|NCT05039073|Immunotoxins|immunotoxins|mesh-ancestor
92001049|NCT05038228|Vitamin K|vitamin k|mesh-list
92001051|NCT05038228|Apixaban|apixaban|mesh-list
92001052|NCT05038228|Dabigatran|dabigatran|mesh-list
92001053|NCT05038228|Vitamins|vitamins|mesh-ancestor
92001054|NCT05038228|Micronutrients|micronutrients|mesh-ancestor
92001055|NCT05038228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970710|NCT03311321|Vitamins|vitamins|mesh-ancestor
91970711|NCT03311321|Micronutrients|micronutrients|mesh-ancestor
92001056|NCT05038228|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92001057|NCT05038228|Antithrombins|antithrombins|mesh-ancestor
92001058|NCT05038228|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92001059|NCT05038228|Protease Inhibitors|protease inhibitors|mesh-ancestor
92001060|NCT05038228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001061|NCT05038228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001062|NCT05038228|Anticoagulants|anticoagulants|mesh-ancestor
92001063|NCT05038228|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92001064|NCT05038228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92001065|NCT05038228|Hemostatics|hemostatics|mesh-ancestor
92001066|NCT05038228|Coagulants|coagulants|mesh-ancestor
92001067|NCT05031780|Mitapivat|mitapivat|mesh-list
92001068|NCT05031780|Enzyme Activators|enzyme activators|mesh-ancestor
92001069|NCT05031780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001070|NCT05029999|Doxorubicin|doxorubicin|mesh-list
92001071|NCT05029999|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92001072|NCT05029999|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92001092|NCT05012254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001093|NCT05012254|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001094|NCT05012254|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001095|NCT05012254|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001096|NCT05012254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001097|NCT05012254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001098|NCT05012254|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001099|NCT05012254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001100|NCT05012254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92001101|NCT05012254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92001102|NCT05009069|Fluorouracil|fluorouracil|mesh-list
92001103|NCT05009069|Capecitabine|capecitabine|mesh-list
92001104|NCT05009069|Atezolizumab|atezolizumab|mesh-list
92001105|NCT05009069|Antimetabolites|antimetabolites|mesh-ancestor
92001106|NCT05009069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001107|NCT05009069|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001108|NCT05009069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001109|NCT05009069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001110|NCT05009069|Immunologic Factors|immunologic factors|mesh-ancestor
92001111|NCT05009069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001112|NCT05009069|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001113|NCT05009069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001120|NCT04995978|Pioglitazone|pioglitazone|mesh-list
92001121|NCT04995978|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92001122|NCT04995978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001133|NCT04987294|Rasburicase|rasburicase|mesh-list
92001134|NCT04987294|Gout Suppressants|gout suppressants|mesh-ancestor
92001135|NCT04987294|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001136|NCT04987242|Rasburicase|rasburicase|mesh-list
92001137|NCT04987242|Gout Suppressants|gout suppressants|mesh-ancestor
92001138|NCT04987242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001139|NCT04976192|Omalizumab|omalizumab|mesh-list
92001140|NCT04976192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92001141|NCT04976192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92001142|NCT04976192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92001143|NCT04958486|Trastuzumab|trastuzumab|mesh-list
92001144|NCT04958486|Azacitidine|azacitidine|mesh-list
92001145|NCT04958486|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001146|NCT04958486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001149|NCT04958486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001150|NCT04958486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001151|NCT04942210|Vaccines|vaccines|mesh-list
92001152|NCT04942210|Immunologic Factors|immunologic factors|mesh-ancestor
92001153|NCT04942210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001154|NCT04940767|Minocycline|minocycline|mesh-list
92001155|NCT04940767|Isotretinoin|isotretinoin|mesh-list
92001156|NCT04940767|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92001157|NCT04940767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001158|NCT04940767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92001159|NCT04929223|Bevacizumab|bevacizumab|mesh-list
92001160|NCT04929223|Cetuximab|cetuximab|mesh-list
92001161|NCT04929223|Atezolizumab|atezolizumab|mesh-list
92001162|NCT04929223|Inavolisib|inavolisib|mesh-list
92001163|NCT04929223|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001164|NCT04929223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001165|NCT04929223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91970712|NCT03311321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970713|NCT03311321|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92001166|NCT04929223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92001167|NCT04929223|Growth Substances|growth substances|mesh-ancestor
92001168|NCT04929223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001169|NCT04929223|Growth Inhibitors|growth inhibitors|mesh-ancestor
92001170|NCT04929223|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001171|NCT04929223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001172|NCT04929223|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92001173|NCT04929223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001174|NCT04925986|Pembrolizumab|pembrolizumab|mesh-list
92001175|NCT04925986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001176|NCT04925986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001177|NCT04925986|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001178|NCT04925986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001179|NCT04913805|Niacinamide|niacinamide|mesh-list
92001181|NCT04913805|Nicotinic Acids|nicotinic acids|mesh-list
92001182|NCT04913805|Vitamin B Complex|vitamin b complex|mesh-ancestor
92001183|NCT04913805|Vitamins|vitamins|mesh-ancestor
92001184|NCT04913805|Micronutrients|micronutrients|mesh-ancestor
92001185|NCT04913805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001187|NCT04913805|Antimetabolites|antimetabolites|mesh-ancestor
92001188|NCT04913805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001189|NCT04913805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92001190|NCT04913805|Vasodilator Agents|vasodilator agents|mesh-ancestor
92001191|NCT04907968|Carboplatin|carboplatin|mesh-list
92001192|NCT04907968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001193|NCT04900220|Methylprednisolone|methylprednisolone|mesh-list
92001194|NCT04900220|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92001195|NCT04900220|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92001196|NCT04900220|Prednisolone|prednisolone|mesh-list
92001197|NCT04900220|Prednisolone acetate|prednisolone acetate|mesh-list
92001198|NCT04900220|Betamethasone|betamethasone|mesh-list
92001199|NCT04900220|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92001200|NCT04900220|Prednisolone phosphate|prednisolone phosphate|mesh-list
92001201|NCT04900220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92001202|NCT04900220|Antiemetics|antiemetics|mesh-ancestor
92001203|NCT04900220|Autonomic Agents|autonomic agents|mesh-ancestor
92001204|NCT04900220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001205|NCT04900220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001206|NCT04900220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92001207|NCT04900220|Glucocorticoids|glucocorticoids|mesh-ancestor
92001208|NCT04900220|Hormones|hormones|mesh-ancestor
92001209|NCT04900220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001210|NCT04900220|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92001211|NCT04900220|Protective Agents|protective agents|mesh-ancestor
92001212|NCT04900220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001213|NCT04900220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001214|NCT04900220|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92001215|NCT04900220|Respiratory System Agents|respiratory system agents|mesh-ancestor
92001216|NCT04896320|Tucatinib|tucatinib|mesh-list
92001217|NCT04896320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001218|NCT04896320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001219|NCT04896320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001220|NCT04896320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001221|NCT04887259|Interleukin-2|interleukin-2|mesh-list
92001224|NCT04887259|Analgesics|analgesics|mesh-ancestor
92001225|NCT04887259|Sensory System Agents|sensory system agents|mesh-ancestor
92001226|NCT04887259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001227|NCT04887259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001228|NCT04877613|Cyclophosphamide|cyclophosphamide|mesh-list
92001229|NCT04877613|Fludarabine|fludarabine|mesh-list
92001230|NCT04877613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001231|NCT04877613|Immunologic Factors|immunologic factors|mesh-ancestor
92001232|NCT04877613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001233|NCT04877613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001234|NCT04877613|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92001235|NCT04877613|Alkylating Agents|alkylating agents|mesh-ancestor
92001236|NCT04877613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970715|NCT03311321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970716|NCT03311321|Hemostatics|hemostatics|mesh-ancestor
92001237|NCT04877613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001238|NCT04877613|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92001239|NCT04875195|Pembrolizumab|pembrolizumab|mesh-list
92001240|NCT04875195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001241|NCT04875195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001242|NCT04875195|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001243|NCT04875195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001244|NCT04871607|Cytarabine|cytarabine|mesh-list
92001245|NCT04871607|Etoposide|etoposide|mesh-list
92001246|NCT04871607|Podophyllotoxin|podophyllotoxin|mesh-list
92001247|NCT04871607|Etoposide phosphate|etoposide phosphate|mesh-list
92001248|NCT04871607|Carmustine|carmustine|mesh-list
92001249|NCT04871607|Basiliximab|basiliximab|mesh-list
92001250|NCT04871607|Lenograstim|lenograstim|mesh-list
92001251|NCT04871607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001252|NCT04871607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001253|NCT04871607|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92001254|NCT04871607|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92001255|NCT04871607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001256|NCT04871607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001257|NCT04871607|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001258|NCT04871607|Antimetabolites|antimetabolites|mesh-ancestor
92001259|NCT04871607|Antiviral Agents|antiviral agents|mesh-ancestor
92001260|NCT04871607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001261|NCT04871607|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001262|NCT04871607|Immunologic Factors|immunologic factors|mesh-ancestor
92001263|NCT04871607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001264|NCT04871607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92001265|NCT04871607|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92001266|NCT04871607|Alkylating Agents|alkylating agents|mesh-ancestor
92001267|NCT04871607|Keratolytic Agents|keratolytic agents|mesh-ancestor
92001268|NCT04871607|Dermatologic Agents|dermatologic agents|mesh-ancestor
92001269|NCT04871607|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001270|NCT04871607|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001271|NCT04871607|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001272|NCT04865042|Gabapentin|gabapentin|mesh-list
92001273|NCT04865042|Analgesics|analgesics|mesh-ancestor
92001274|NCT04865042|Sensory System Agents|sensory system agents|mesh-ancestor
92001275|NCT04865042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001276|NCT04865042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001277|NCT04865042|Anticonvulsants|anticonvulsants|mesh-ancestor
92001278|NCT04865042|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92001279|NCT04865042|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92001280|NCT04865042|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001281|NCT04865042|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001282|NCT04865042|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92001283|NCT04865042|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92001284|NCT04865042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001285|NCT04865042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001286|NCT04865042|Antimanic Agents|antimanic agents|mesh-ancestor
92001287|NCT04851964|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92001288|NCT04851964|Immunologic Factors|immunologic factors|mesh-ancestor
92001289|NCT04851964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001290|NCT04833790|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92001291|NCT04833790|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001292|NCT04830592|Pembrolizumab|pembrolizumab|mesh-list
92001293|NCT04830592|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001294|NCT04830592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001297|NCT04824794|Daratumumab|daratumumab|mesh-list
92001298|NCT04824794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001299|NCT04824131|Tenofovir|tenofovir|mesh-list
92001300|NCT04824131|Emtricitabine|emtricitabine|mesh-list
92001301|NCT04824131|Cabotegravir|cabotegravir|mesh-list
92001302|NCT04824131|Antiviral Agents|antiviral agents|mesh-ancestor
92001303|NCT04824131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001304|NCT04824131|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92001305|NCT04824131|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92001306|NCT04824131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001307|NCT04824131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970718|NCT02468297|Ibuprofen|ibuprofen|mesh-list
91970719|NCT02468297|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91970720|NCT02468297|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92001308|NCT04824131|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92001309|NCT04824131|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92001310|NCT04824131|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92001311|NCT04824131|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92001312|NCT04812028|Magnesium Sulfate|magnesium sulfate|mesh-list
92001313|NCT04812028|Analgesics|analgesics|mesh-ancestor
92001314|NCT04812028|Sensory System Agents|sensory system agents|mesh-ancestor
92001315|NCT04812028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001316|NCT04812028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001317|NCT04812028|Anesthetics|anesthetics|mesh-ancestor
92001318|NCT04812028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001319|NCT04812028|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92001320|NCT04812028|Anticonvulsants|anticonvulsants|mesh-ancestor
92001321|NCT04812028|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92001322|NCT04812028|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92001323|NCT04812028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001324|NCT04812028|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92001325|NCT04812028|Tocolytic Agents|tocolytic agents|mesh-ancestor
92001326|NCT04812028|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92001327|NCT04804644|Memantine|memantine|mesh-list
92001328|NCT04804644|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92001329|NCT04804644|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92001330|NCT04804644|Dopamine Agents|dopamine agents|mesh-ancestor
92001331|NCT04804644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001332|NCT04804644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001333|NCT04804644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001334|NCT04804644|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92001335|NCT04804644|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92001336|NCT04776447|Carboplatin|carboplatin|mesh-list
92001337|NCT04776447|Atezolizumab|atezolizumab|mesh-list
92001338|NCT04776447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001339|NCT04776447|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001340|NCT04776447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001341|NCT04776447|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001342|NCT04770896|Sorafenib|sorafenib|mesh-list
92001343|NCT04770896|Atezolizumab|atezolizumab|mesh-list
92001344|NCT04770896|Lenvatinib|lenvatinib|mesh-list
92001345|NCT04770896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001346|NCT04770896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001347|NCT04770896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001348|NCT04770896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001349|NCT04770896|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001350|NCT04770896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001351|NCT04770779|Mitapivat|mitapivat|mesh-list
92001352|NCT04770779|Enzyme Activators|enzyme activators|mesh-ancestor
92001353|NCT04770779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001354|NCT04770753|Mitapivat|mitapivat|mesh-list
92001355|NCT04770753|Enzyme Activators|enzyme activators|mesh-ancestor
92001356|NCT04770753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001357|NCT04768504|Tofacitinib|tofacitinib|mesh-list
92001358|NCT04768504|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92001359|NCT04768504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001360|NCT04768504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001361|NCT04768504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001362|NCT04748172|Antibodies|antibodies|mesh-list
92001363|NCT04748172|Immunologic Factors|immunologic factors|mesh-ancestor
92001364|NCT04748172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001365|NCT04736823|Paclitaxel|paclitaxel|mesh-list
92001366|NCT04736823|Docetaxel|docetaxel|mesh-list
92001371|NCT04736823|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001372|NCT04736823|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001373|NCT04736823|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001374|NCT04736823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001375|NCT04736823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001376|NCT04736823|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92001377|NCT04736823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92001378|NCT04729621|Denosumab|denosumab|mesh-list
91970722|NCT02468297|Sensory System Agents|sensory system agents|mesh-ancestor
91970723|NCT02468297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001379|NCT04729621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92001380|NCT04729621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001382|NCT04725383|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92001383|NCT04725383|Antidepressive Agents|antidepressive agents|mesh-ancestor
92001384|NCT04725383|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001385|NCT04725383|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92001386|NCT04725383|Analgesics|analgesics|mesh-ancestor
92001387|NCT04725383|Sensory System Agents|sensory system agents|mesh-ancestor
92001388|NCT04725383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001389|NCT04725383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001390|NCT04725383|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92001391|NCT04725383|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92001392|NCT04725383|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92001393|NCT04725383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001394|NCT04725383|Adrenergic Agents|adrenergic agents|mesh-ancestor
92001395|NCT04725383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001396|NCT04664023|Vaccines|vaccines|mesh-list
92001397|NCT04664023|Immunologic Factors|immunologic factors|mesh-ancestor
92001398|NCT04664023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001399|NCT04655755|Decitabine|decitabine|mesh-list
92001400|NCT04655755|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92001401|NCT04655755|Venetoclax|venetoclax|mesh-list
92001402|NCT04655755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001403|NCT04655755|Antimetabolites|antimetabolites|mesh-ancestor
92001404|NCT04655755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001405|NCT04655755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001406|NCT04655755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001407|NCT04633889|Deferoxamine|deferoxamine|mesh-list
92001408|NCT04633889|Siderophores|siderophores|mesh-ancestor
92001409|NCT04633889|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92001410|NCT04633889|Chelating Agents|chelating agents|mesh-ancestor
92001411|NCT04633889|Sequestering Agents|sequestering agents|mesh-ancestor
92001412|NCT04633889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001413|NCT04630886|Lidocaine|lidocaine|mesh-list
92001414|NCT04630886|Epinephrine|epinephrine|mesh-list
92001415|NCT04630886|Tranexamic Acid|tranexamic acid|mesh-list
92001416|NCT04630886|Anesthetics, Local|anesthetics, local|mesh-ancestor
92001417|NCT04630886|Anesthetics|anesthetics|mesh-ancestor
92001418|NCT04630886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001419|NCT04630886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001420|NCT04630886|Sensory System Agents|sensory system agents|mesh-ancestor
92001421|NCT04630886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001422|NCT04630886|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92001423|NCT04630886|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92001424|NCT04630886|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92001425|NCT04630886|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92001426|NCT04630886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001427|NCT04630886|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92001428|NCT04630886|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92001429|NCT04630886|Hemostatics|hemostatics|mesh-ancestor
92001430|NCT04630886|Coagulants|coagulants|mesh-ancestor
92001431|NCT04630886|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92001432|NCT04630886|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92001433|NCT04630886|Adrenergic Agents|adrenergic agents|mesh-ancestor
92001434|NCT04630886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001435|NCT04630886|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92001436|NCT04630886|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92001437|NCT04630886|Autonomic Agents|autonomic agents|mesh-ancestor
92001439|NCT04630886|Respiratory System Agents|respiratory system agents|mesh-ancestor
92001440|NCT04630886|Mydriatics|mydriatics|mesh-ancestor
92001442|NCT04630886|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92001443|NCT04622228|Carboplatin|carboplatin|mesh-list
92001445|NCT04622228|Atezolizumab|atezolizumab|mesh-list
92001446|NCT04622228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001447|NCT04622228|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001448|NCT04622228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91970724|NCT02468297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970725|NCT02468297|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970726|NCT02468297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001449|NCT04622228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92001450|NCT04622228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001451|NCT04622228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001452|NCT04622228|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001453|NCT04622228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001454|NCT04619316|Trametinib|trametinib|mesh-list
92001455|NCT04619316|Dabrafenib|dabrafenib|mesh-list
92001456|NCT04619316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001457|NCT04619316|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001458|NCT04619316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001459|NCT04619316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001460|NCT04610528|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92001461|NCT04610528|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92001462|NCT04610528|Immunologic Factors|immunologic factors|mesh-ancestor
92001463|NCT04610528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001464|NCT04610528|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001465|NCT04610528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001466|NCT04609111|Aspirin|aspirin|mesh-list
92001467|NCT04609111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92001468|NCT04609111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92001469|NCT04609111|Analgesics|analgesics|mesh-ancestor
92001470|NCT04609111|Sensory System Agents|sensory system agents|mesh-ancestor
92001471|NCT04609111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001472|NCT04609111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001473|NCT04609111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92001474|NCT04609111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001475|NCT04609111|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92001476|NCT04609111|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92001477|NCT04609111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001478|NCT04609111|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92001479|NCT04609111|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92001480|NCT04609111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001481|NCT04609111|Antipyretics|antipyretics|mesh-ancestor
92001482|NCT04607421|Leucovorin|leucovorin|mesh-list
92001483|NCT04607421|Bevacizumab|bevacizumab|mesh-list
92001484|NCT04607421|Cetuximab|cetuximab|mesh-list
92001485|NCT04607421|Fluorouracil|fluorouracil|mesh-list
92001486|NCT04607421|Capecitabine|capecitabine|mesh-list
92001487|NCT04607421|Oxaliplatin|oxaliplatin|mesh-list
92001488|NCT04607421|Irinotecan|irinotecan|mesh-list
92001489|NCT04607421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001490|NCT04607421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001491|NCT04607421|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92001492|NCT04607421|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92001493|NCT04607421|Growth Substances|growth substances|mesh-ancestor
92001494|NCT04607421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001495|NCT04607421|Growth Inhibitors|growth inhibitors|mesh-ancestor
92001496|NCT04607421|Antimetabolites|antimetabolites|mesh-ancestor
92001497|NCT04607421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001498|NCT04607421|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001499|NCT04607421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001500|NCT04607421|Immunologic Factors|immunologic factors|mesh-ancestor
92001501|NCT04607421|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92001502|NCT04607421|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92001503|NCT04607421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001504|NCT04607421|Antidotes|antidotes|mesh-ancestor
92001505|NCT04607421|Protective Agents|protective agents|mesh-ancestor
92001506|NCT04607421|Vitamin B Complex|vitamin b complex|mesh-ancestor
92001507|NCT04607421|Vitamins|vitamins|mesh-ancestor
92001508|NCT04607421|Micronutrients|micronutrients|mesh-ancestor
92001509|NCT04599062|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92001510|NCT04599062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001511|NCT04599062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001512|NCT04590196|Curcumin|curcumin|mesh-list
92001514|NCT04590196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92001515|NCT04590196|Analgesics|analgesics|mesh-ancestor
92001516|NCT04590196|Sensory System Agents|sensory system agents|mesh-ancestor
92001517|NCT04590196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001518|NCT04590196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970727|NCT02468297|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91970728|NCT02468297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001519|NCT04590196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92001520|NCT04590196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001521|NCT04590196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001522|NCT04590196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001523|NCT04590196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001525|NCT04589208|Analgesics|analgesics|mesh-ancestor
92001526|NCT04589208|Sensory System Agents|sensory system agents|mesh-ancestor
92001527|NCT04589208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001528|NCT04589208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001529|NCT04589208|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92001530|NCT04589208|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92001531|NCT04589208|Anesthetics, General|anesthetics, general|mesh-ancestor
92001532|NCT04589208|Anesthetics|anesthetics|mesh-ancestor
92001533|NCT04589208|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001534|NCT04589208|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92001535|NCT04589208|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92001536|NCT04589208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001537|NCT04589208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001538|NCT04588246|Memantine|memantine|mesh-list
92001539|NCT04588246|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92001540|NCT04588246|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92001541|NCT04588246|Dopamine Agents|dopamine agents|mesh-ancestor
92001542|NCT04588246|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001543|NCT04588246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001544|NCT04588246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001545|NCT04588246|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92001546|NCT04588246|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92001547|NCT04585815|Axitinib|axitinib|mesh-list
92001548|NCT04585815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001549|NCT04585815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001550|NCT04585815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001551|NCT04585815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001552|NCT04573192|Lomustine|lomustine|mesh-list
92001553|NCT04573192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92001554|NCT04573192|Alkylating Agents|alkylating agents|mesh-ancestor
92001555|NCT04573192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001556|NCT04573192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001557|NCT04566328|Dexamethasone|dexamethasone|mesh-list
92001558|NCT04566328|Dexamethasone acetate|dexamethasone acetate|mesh-list
92001559|NCT04566328|Lenalidomide|lenalidomide|mesh-list
92001560|NCT04566328|Bortezomib|bortezomib|mesh-list
92001561|NCT04566328|Daratumumab|daratumumab|mesh-list
92001562|NCT04566328|Ichthammol|ichthammol|mesh-list
92001563|NCT04566328|BB 1101|bb 1101|mesh-list
92001564|NCT04566328|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92001565|NCT04566328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92001566|NCT04566328|Antiemetics|antiemetics|mesh-ancestor
92001567|NCT04566328|Autonomic Agents|autonomic agents|mesh-ancestor
92001568|NCT04566328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001645|NCT04556773|Immunologic Factors|immunologic factors|mesh-ancestor
92001569|NCT04566328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001570|NCT04566328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92001571|NCT04566328|Glucocorticoids|glucocorticoids|mesh-ancestor
92001572|NCT04566328|Hormones|hormones|mesh-ancestor
92001573|NCT04566328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001574|NCT04566328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001575|NCT04566328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001576|NCT04566328|Protease Inhibitors|protease inhibitors|mesh-ancestor
92001577|NCT04566328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001578|NCT04566328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001579|NCT04566328|Immunologic Factors|immunologic factors|mesh-ancestor
92001580|NCT04566328|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92001581|NCT04566328|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92001582|NCT04566328|Growth Substances|growth substances|mesh-ancestor
92001583|NCT04566328|Growth Inhibitors|growth inhibitors|mesh-ancestor
92001584|NCT04566328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92001585|NCT04563520|Coagulants|coagulants|mesh-list
92001586|NCT04563520|Anti-inhibitor coagulant complex|anti-inhibitor coagulant complex|mesh-list
92001590|NCT04559139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001591|NCT04559139|Antimetabolites|antimetabolites|mesh-ancestor
92001592|NCT04559139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970729|NCT02468297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970730|NCT02468375|Mirabegron|mirabegron|mesh-list
92001594|NCT04557449|Fulvestrant|fulvestrant|mesh-list
92001595|NCT04557449|Midazolam|midazolam|mesh-list
92001596|NCT04557449|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92001597|NCT04557449|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92001598|NCT04557449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001599|NCT04557449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001600|NCT04557449|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92001601|NCT04557449|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92001602|NCT04557449|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001603|NCT04557449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92001604|NCT04557449|Anesthetics, General|anesthetics, general|mesh-ancestor
92001605|NCT04557449|Anesthetics|anesthetics|mesh-ancestor
92001606|NCT04557449|GABA Modulators|gaba modulators|mesh-ancestor
92001607|NCT04557449|GABA Agents|gaba agents|mesh-ancestor
92001608|NCT04557449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92001609|NCT04557449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001610|NCT04557449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001611|NCT04557449|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92001612|NCT04557449|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92001613|NCT04557449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001614|NCT04557449|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92001615|NCT04557449|Hormone Antagonists|hormone antagonists|mesh-ancestor
92001616|NCT04557449|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001617|NCT04557449|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001618|NCT04557449|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92001619|NCT04556773|Paclitaxel|paclitaxel|mesh-list
92001620|NCT04556773|Capecitabine|capecitabine|mesh-list
92001621|NCT04556773|Trastuzumab|trastuzumab|mesh-list
92001622|NCT04556773|Durvalumab|durvalumab|mesh-list
92001623|NCT04556773|Fulvestrant|fulvestrant|mesh-list
92001624|NCT04556773|Anastrozole|anastrozole|mesh-list
92001625|NCT04556773|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92001626|NCT04556773|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001627|NCT04556773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001628|NCT04556773|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001629|NCT04556773|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001630|NCT04556773|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001631|NCT04556773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001632|NCT04556773|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001633|NCT04556773|Antimetabolites|antimetabolites|mesh-ancestor
92001634|NCT04556773|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001635|NCT04556773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001636|NCT04556773|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92001637|NCT04556773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92001638|NCT04556773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92001639|NCT04556773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001640|NCT04556773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001641|NCT04556773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92001642|NCT04556773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92001643|NCT04556773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001644|NCT04556773|Immunoconjugates|immunoconjugates|mesh-ancestor
92001646|NCT04551222|Probenecid|probenecid|mesh-list
92001647|NCT04551222|Uricosuric Agents|uricosuric agents|mesh-ancestor
92001648|NCT04551222|Gout Suppressants|gout suppressants|mesh-ancestor
92001649|NCT04551222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001650|NCT04542148|Insulin|insulin|mesh-list
92001651|NCT04542148|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92001652|NCT04542148|Insulin Aspart|insulin aspart|mesh-list
92001653|NCT04542148|Insulin Lispro|insulin lispro|mesh-list
92001654|NCT04542148|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92001655|NCT04542148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001656|NCT04527991|Paclitaxel|paclitaxel|mesh-list
92001657|NCT04527991|Docetaxel|docetaxel|mesh-list
92001658|NCT04527991|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92001659|NCT04527991|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001662|NCT04527991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001663|NCT04527991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001664|NCT04527991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001665|NCT04527991|Immunoconjugates|immunoconjugates|mesh-ancestor
92001666|NCT04527991|Immunologic Factors|immunologic factors|mesh-ancestor
92001667|NCT04527991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001668|NCT04527549|Hydroxychloroquine|hydroxychloroquine|mesh-list
91970731|NCT02468375|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
91970732|NCT02468375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91970733|NCT02468375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970734|NCT02468375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92001669|NCT04527549|Trametinib|trametinib|mesh-list
92001670|NCT04527549|Dabrafenib|dabrafenib|mesh-list
92001671|NCT04527549|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92001672|NCT04527549|Antimalarials|antimalarials|mesh-ancestor
92001673|NCT04527549|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92001674|NCT04527549|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92001675|NCT04527549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001676|NCT04527549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001677|NCT04527549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001678|NCT04527549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001679|NCT04527549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001680|NCT04527549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001681|NCT04527549|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92001682|NCT04527549|Protective Agents|protective agents|mesh-ancestor
92001683|NCT04527549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001684|NCT04527549|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92001685|NCT04527549|Antioxidants|antioxidants|mesh-ancestor
92001686|NCT04513717|Leuprolide|leuprolide|mesh-list
92001687|NCT04513717|Goserelin|goserelin|mesh-list
92001688|NCT04513717|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92001689|NCT04513717|Flutamide|flutamide|mesh-list
92001690|NCT04513717|Bicalutamide|bicalutamide|mesh-list
92001691|NCT04513717|Tryptophan|tryptophan|mesh-list
92001692|NCT04513717|Buserelin|buserelin|mesh-list
92001693|NCT04513717|Hormones|hormones|mesh-list
92001694|NCT04513717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001695|NCT04513717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001696|NCT04513717|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92001697|NCT04513717|Fertility Agents|fertility agents|mesh-ancestor
92001698|NCT04513717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92001699|NCT04513717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001700|NCT04513717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001701|NCT04513717|Androgen Antagonists|androgen antagonists|mesh-ancestor
92001702|NCT04513717|Hormone Antagonists|hormone antagonists|mesh-ancestor
92001703|NCT04513717|Luteolytic Agents|luteolytic agents|mesh-ancestor
92001704|NCT04513717|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92001705|NCT04513717|Contraceptive Agents|contraceptive agents|mesh-ancestor
92001706|NCT04513717|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92001707|NCT04513717|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92001708|NCT04513717|Antidepressive Agents|antidepressive agents|mesh-ancestor
92001709|NCT04513717|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001710|NCT04512430|Bevacizumab|bevacizumab|mesh-list
92001711|NCT04512430|Atezolizumab|atezolizumab|mesh-list
92001712|NCT04512430|Carboplatin|carboplatin|mesh-list
92001713|NCT04512430|Pemetrexed|pemetrexed|mesh-list
92001714|NCT04512430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001715|NCT04512430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001716|NCT04512430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92001717|NCT04512430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92001718|NCT04512430|Growth Substances|growth substances|mesh-ancestor
92001719|NCT04512430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001720|NCT04512430|Growth Inhibitors|growth inhibitors|mesh-ancestor
92001721|NCT04512430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001722|NCT04512430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001723|NCT04512430|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92001724|NCT04512430|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92001725|NCT04512430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001726|NCT04504669|Durvalumab|durvalumab|mesh-list
92001727|NCT04504669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001728|NCT04504669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001729|NCT04502433|Poractant alfa|poractant alfa|mesh-list
92001730|NCT04502433|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92001731|NCT04502433|Respiratory System Agents|respiratory system agents|mesh-ancestor
92001732|NCT04484818|Leuprolide|leuprolide|mesh-list
92001733|NCT04484818|Goserelin|goserelin|mesh-list
92001734|NCT04484818|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92001735|NCT04484818|Tryptophan|tryptophan|mesh-list
92001737|NCT04484818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001738|NCT04484818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970735|NCT02468375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970736|NCT02468375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970737|NCT02468375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970738|NCT02468375|Urological Agents|urological agents|mesh-ancestor
91970739|NCT03304457|Olanzapine|olanzapine|mesh-list
92001739|NCT04484818|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92001740|NCT04484818|Fertility Agents|fertility agents|mesh-ancestor
92001741|NCT04484818|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92001742|NCT04484818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001743|NCT04484818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001744|NCT04484818|Luteolytic Agents|luteolytic agents|mesh-ancestor
92001745|NCT04484818|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92001746|NCT04484818|Contraceptive Agents|contraceptive agents|mesh-ancestor
92001747|NCT04484818|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92001748|NCT04484818|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92001749|NCT04484818|Antidepressive Agents|antidepressive agents|mesh-ancestor
92001750|NCT04484818|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001751|NCT04484818|Hormone Antagonists|hormone antagonists|mesh-ancestor
92001753|NCT04484012|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92001754|NCT04484012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001755|NCT04484012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001756|NCT04484012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001757|NCT04484012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001758|NCT04477200|Mycophenolic Acid|mycophenolic acid|mesh-list
92001759|NCT04477200|Temozolomide|temozolomide|mesh-list
92001760|NCT04477200|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92001761|NCT04477200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001762|NCT04477200|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92001763|NCT04477200|Antitubercular Agents|antitubercular agents|mesh-ancestor
92001764|NCT04477200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92001765|NCT04477200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001766|NCT04477200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001767|NCT04477200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001768|NCT04477200|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92001769|NCT04477200|Alkylating Agents|alkylating agents|mesh-ancestor
92001770|NCT04455802|Morphine|morphine|mesh-list
92001771|NCT04455802|Buprenorphine|buprenorphine|mesh-list
92001772|NCT04455802|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92001773|NCT04455802|Narcotics|narcotics|mesh-ancestor
92001774|NCT04455802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001775|NCT04455802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001776|NCT04455802|Analgesics|analgesics|mesh-ancestor
92001777|NCT04455802|Sensory System Agents|sensory system agents|mesh-ancestor
92001778|NCT04455802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92001779|NCT04455802|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92001780|NCT04454437|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92001781|NCT04454437|Immunoconjugates|immunoconjugates|mesh-ancestor
92001782|NCT04454437|Immunologic Factors|immunologic factors|mesh-ancestor
92001783|NCT04454437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001784|NCT04443088|Pembrolizumab|pembrolizumab|mesh-list
92001785|NCT04443088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001786|NCT04443088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001787|NCT04443088|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001788|NCT04443088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001789|NCT04438382|Prednisone|prednisone|mesh-list
92001790|NCT04438382|Infliximab|infliximab|mesh-list
92001791|NCT04438382|Cortisone|cortisone|mesh-list
92001792|NCT04438382|Immunoglobulins|immunoglobulins|mesh-list
92001793|NCT04438382|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92001794|NCT04438382|Antibodies|antibodies|mesh-list
92001795|NCT04438382|gamma-Globulins|gamma-globulins|mesh-list
92001796|NCT04438382|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92001797|NCT04438382|Immunoglobulin G|immunoglobulin g|mesh-list
92001798|NCT04438382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92001799|NCT04438382|Glucocorticoids|glucocorticoids|mesh-ancestor
92001800|NCT04438382|Hormones|hormones|mesh-ancestor
92001801|NCT04438382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001802|NCT04438382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970740|NCT03304457|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
91970741|NCT03304457|Antiemetics|antiemetics|mesh-ancestor
91970742|NCT03304457|Autonomic Agents|autonomic agents|mesh-ancestor
92001803|NCT04438382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001804|NCT04438382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001805|NCT04438382|Immunologic Factors|immunologic factors|mesh-ancestor
92001806|NCT04438382|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92001807|NCT04438382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92001808|NCT04438382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92001813|NCT04434040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001814|NCT04434040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001815|NCT04434040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001816|NCT04434040|Immunoconjugates|immunoconjugates|mesh-ancestor
92001817|NCT04434040|Immunologic Factors|immunologic factors|mesh-ancestor
92001818|NCT04434040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001819|NCT04426890|Omalizumab|omalizumab|mesh-list
92001820|NCT04426890|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92001821|NCT04426890|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92001822|NCT04426890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92001823|NCT04426890|Respiratory System Agents|respiratory system agents|mesh-ancestor
92001824|NCT04426890|Immunologic Factors|immunologic factors|mesh-ancestor
92001825|NCT04426890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001827|NCT04417062|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92001828|NCT04417062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001829|NCT04417062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001830|NCT04417062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001831|NCT04416984|Cyclophosphamide|cyclophosphamide|mesh-list
92001832|NCT04416984|Fludarabine|fludarabine|mesh-list
92001833|NCT04416984|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001834|NCT04416984|Immunologic Factors|immunologic factors|mesh-ancestor
92001835|NCT04416984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001836|NCT04416984|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001837|NCT04416984|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92001838|NCT04416984|Alkylating Agents|alkylating agents|mesh-ancestor
92001839|NCT04416984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001840|NCT04416984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001841|NCT04416984|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92001842|NCT04411914|Clavulanic Acids|clavulanic acids|mesh-list
92001843|NCT04411914|Clavulanic Acid|clavulanic acid|mesh-list
92001844|NCT04411914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92001845|NCT04411914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001846|NCT04411914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001847|NCT04411914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001848|NCT04411914|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92001849|NCT04411836|Primaquine|primaquine|mesh-list
92001850|NCT04411836|Tafenoquine|tafenoquine|mesh-list
92001851|NCT04411836|Antimalarials|antimalarials|mesh-ancestor
92001852|NCT04411836|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92001853|NCT04411836|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92001854|NCT04411836|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001855|NCT04395365|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92001856|NCT04395365|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92001857|NCT04395365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001858|NCT04395365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92001859|NCT04395365|Antimalarials|antimalarials|mesh-ancestor
92001860|NCT04395365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92001861|NCT04395365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92001862|NCT04389671|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92001863|NCT04389671|Respiratory System Agents|respiratory system agents|mesh-ancestor
92001864|NCT04386057|Hydroxychloroquine|hydroxychloroquine|mesh-list
92001865|NCT04386057|Antimalarials|antimalarials|mesh-ancestor
92001866|NCT04386057|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92001867|NCT04386057|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92001868|NCT04386057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001869|NCT04386057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001870|NCT04386057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001871|NCT04386057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001872|NCT04380545|Interferons|interferons|mesh-list
92001873|NCT04380545|Interferon-alpha|interferon-alpha|mesh-list
92001874|NCT04380545|Interferon alpha-2|interferon alpha-2|mesh-list
92001875|NCT04380545|Fluorouracil|fluorouracil|mesh-list
92001876|NCT04380545|Nivolumab|nivolumab|mesh-list
92001877|NCT04380545|Antimetabolites|antimetabolites|mesh-ancestor
91970743|NCT03304457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970744|NCT03304457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970746|NCT03304457|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91970747|NCT03304457|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92001878|NCT04380545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001879|NCT04380545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001880|NCT04380545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001881|NCT04380545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001883|NCT04380545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001884|NCT04380545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001885|NCT04380545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001886|NCT04380545|Antiviral Agents|antiviral agents|mesh-ancestor
92001887|NCT04380545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001889|NCT04368559|Posaconazole|posaconazole|mesh-list
92001890|NCT04368559|Rezafungin|rezafungin|mesh-list
92001891|NCT04368559|Trimethoprim|trimethoprim|mesh-list
92001892|NCT04368559|Sulfamethoxazole|sulfamethoxazole|mesh-list
92001893|NCT04368559|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92001894|NCT04368559|Antifungal Agents|antifungal agents|mesh-ancestor
92001895|NCT04368559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001896|NCT04368559|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92001897|NCT04368559|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92001898|NCT04368559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001899|NCT04368559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001900|NCT04368559|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92001901|NCT04368559|Hormone Antagonists|hormone antagonists|mesh-ancestor
92001902|NCT04368559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92001903|NCT04368559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001904|NCT04368559|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92001905|NCT04368559|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92001906|NCT04368559|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92001907|NCT04368559|Antimalarials|antimalarials|mesh-ancestor
92001908|NCT04368559|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92001909|NCT04368559|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92001910|NCT04368559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92001911|NCT04368559|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92001912|NCT04368559|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92001913|NCT04368559|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92001914|NCT04368559|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92001915|NCT04364048|Cisplatin|cisplatin|mesh-list
92001916|NCT04364048|Carboplatin|carboplatin|mesh-list
92001917|NCT04364048|Etoposide|etoposide|mesh-list
92001918|NCT04364048|Pemetrexed|pemetrexed|mesh-list
92001919|NCT04364048|Durvalumab|durvalumab|mesh-list
92001920|NCT04364048|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92001921|NCT04364048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001922|NCT04364048|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001923|NCT04364048|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92001924|NCT04364048|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92001925|NCT04364048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001926|NCT04364048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001927|NCT04364048|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92001928|NCT04364048|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92001929|NCT04364048|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001930|NCT04364048|Immunologic Factors|immunologic factors|mesh-ancestor
92001931|NCT04364048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001932|NCT04338269|Atezolizumab|atezolizumab|mesh-list
92001933|NCT04338269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001934|NCT04338269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001935|NCT04338269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001936|NCT04338269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001937|NCT04336098|Paclitaxel|paclitaxel|mesh-list
92001938|NCT04336098|Gemcitabine|gemcitabine|mesh-list
92001939|NCT04336098|Pembrolizumab|pembrolizumab|mesh-list
92001940|NCT04336098|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92001941|NCT04336098|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91970748|NCT03304457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970750|NCT03304457|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92002014|NCT04301076|Etoposide phosphate|etoposide phosphate|mesh-list
92001942|NCT04336098|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001943|NCT04336098|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001944|NCT04336098|Antimitotic Agents|antimitotic agents|mesh-ancestor
92001945|NCT04336098|Mitosis Modulators|mitosis modulators|mesh-ancestor
92001946|NCT04336098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001947|NCT04336098|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001948|NCT04336098|Antimetabolites|antimetabolites|mesh-ancestor
92001949|NCT04336098|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92001950|NCT04336098|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001951|NCT04328727|Cyclosporine|cyclosporine|mesh-list
92001952|NCT04328727|Cyclosporins|cyclosporins|mesh-list
92001954|NCT04328727|Thymoglobulin|thymoglobulin|mesh-list
92001955|NCT04328727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001956|NCT04328727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001957|NCT04328727|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92001958|NCT04328727|Immunologic Factors|immunologic factors|mesh-ancestor
92001959|NCT04328727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001960|NCT04328727|Antifungal Agents|antifungal agents|mesh-ancestor
92001961|NCT04328727|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001962|NCT04328727|Dermatologic Agents|dermatologic agents|mesh-ancestor
92001963|NCT04328727|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001964|NCT04328727|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92001965|NCT04316117|Deoxyglucose|deoxyglucose|mesh-list
92001966|NCT04316117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92001967|NCT04316117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92001968|NCT04316117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001969|NCT04316117|Antimetabolites|antimetabolites|mesh-ancestor
92001970|NCT04316117|Antiviral Agents|antiviral agents|mesh-ancestor
92001971|NCT04316117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92001972|NCT04313634|Dasatinib|dasatinib|mesh-list
92001973|NCT04313634|Quercetin|quercetin|mesh-list
92001974|NCT04313634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001975|NCT04313634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001976|NCT04313634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001977|NCT04313634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001978|NCT04313634|Antioxidants|antioxidants|mesh-ancestor
92001979|NCT04313634|Protective Agents|protective agents|mesh-ancestor
92001980|NCT04313634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001981|NCT04311580|Mitomycins|mitomycins|mesh-list
92001982|NCT04311580|Mitomycin|mitomycin|mesh-list
92001983|NCT04311580|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92001984|NCT04311580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001985|NCT04311580|Alkylating Agents|alkylating agents|mesh-ancestor
92001986|NCT04311580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001987|NCT04311580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92001988|NCT04311580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001989|NCT04301492|Vortioxetine|vortioxetine|mesh-list
92001990|NCT04301492|Antidepressive Agents|antidepressive agents|mesh-ancestor
92001991|NCT04301492|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92001992|NCT04301492|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92001993|NCT04301492|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92001994|NCT04301492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92001995|NCT04301492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001996|NCT04301492|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92001997|NCT04301492|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92001998|NCT04301492|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074272|NCT00074308|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92001999|NCT04301492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002000|NCT04301492|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002002|NCT04301492|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92002003|NCT04301492|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92002004|NCT04301492|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92002005|NCT04301492|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92002006|NCT04301076|Prednisone|prednisone|mesh-list
92002007|NCT04301076|Cortisone|cortisone|mesh-list
91970751|NCT03304457|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91970752|NCT03304457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91970753|NCT03304457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970754|NCT03304457|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002008|NCT04301076|Cyclophosphamide|cyclophosphamide|mesh-list
92002009|NCT04301076|Doxorubicin|doxorubicin|mesh-list
92002010|NCT04301076|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92002011|NCT04301076|Etoposide|etoposide|mesh-list
92002012|NCT04301076|Vincristine|vincristine|mesh-list
92002013|NCT04301076|Lenalidomide|lenalidomide|mesh-list
92002015|NCT04301076|Podophyllotoxin|podophyllotoxin|mesh-list
92002016|NCT04301076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002017|NCT04301076|Immunologic Factors|immunologic factors|mesh-ancestor
92002018|NCT04301076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002019|NCT04301076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002020|NCT04301076|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002021|NCT04301076|Alkylating Agents|alkylating agents|mesh-ancestor
92002022|NCT04301076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002023|NCT04301076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002024|NCT04301076|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92002025|NCT04301076|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92002026|NCT04301076|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92002027|NCT04301076|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92002033|NCT04301076|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92002034|NCT04301076|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002036|NCT04301076|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002037|NCT04301076|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002038|NCT04301076|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002039|NCT04301076|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002040|NCT04301076|Growth Substances|growth substances|mesh-ancestor
92002041|NCT04301076|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002042|NCT04301076|Keratolytic Agents|keratolytic agents|mesh-ancestor
92002043|NCT04301076|Dermatologic Agents|dermatologic agents|mesh-ancestor
92002044|NCT04290039|Atropine|atropine|mesh-list
92002045|NCT04290039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92002046|NCT04290039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92002047|NCT04290039|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92002048|NCT04290039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92002049|NCT04290039|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92002050|NCT04290039|Autonomic Agents|autonomic agents|mesh-ancestor
92002051|NCT04290039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002052|NCT04290039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002053|NCT04290039|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92002054|NCT04290039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92002055|NCT04290039|Mydriatics|mydriatics|mesh-ancestor
92002056|NCT04290039|Parasympatholytics|parasympatholytics|mesh-ancestor
92002057|NCT04290039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92002058|NCT04290039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92002059|NCT04290039|Cholinergic Agents|cholinergic agents|mesh-ancestor
92002060|NCT04290039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002061|NCT04290039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002062|NCT04266249|Paclitaxel|paclitaxel|mesh-list
92002063|NCT04266249|Maytansine|maytansine|mesh-list
92002064|NCT04266249|Docetaxel|docetaxel|mesh-list
92002065|NCT04266249|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92002066|NCT04266249|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92002067|NCT04266249|Trastuzumab|trastuzumab|mesh-list
92002068|NCT04266249|Pertuzumab|pertuzumab|mesh-list
92002069|NCT04266249|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92002070|NCT04266249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92002071|NCT04266249|Antibodies|antibodies|mesh-list
92002072|NCT04266249|Immunoglobulins|immunoglobulins|mesh-list
92002073|NCT04266249|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92002074|NCT04266249|Immunoconjugates|immunoconjugates|mesh-list
92002075|NCT04266249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002076|NCT04266249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002077|NCT04266249|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002078|NCT04266249|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002079|NCT04266249|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002080|NCT04266249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970756|NCT03304457|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
91970757|NCT03304457|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91970758|NCT03304457|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92002081|NCT04266249|Immunologic Factors|immunologic factors|mesh-ancestor
92002082|NCT04266249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002083|NCT04266249|Immunotoxins|immunotoxins|mesh-ancestor
92002084|NCT04260126|Pembrolizumab|pembrolizumab|mesh-list
92002085|NCT04260126|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002086|NCT04260126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002087|NCT04260126|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002088|NCT04260126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002089|NCT04248452|Calcium, Dietary|calcium, dietary|mesh-list
92002090|NCT04248452|Leucovorin|leucovorin|mesh-list
92002091|NCT04248452|Folic Acid|folic acid|mesh-list
92002092|NCT04248452|Fluorouracil|fluorouracil|mesh-list
92002093|NCT04248452|Capecitabine|capecitabine|mesh-list
92002094|NCT04248452|Oxaliplatin|oxaliplatin|mesh-list
92002095|NCT04248452|Calcium|calcium|mesh-list
92002096|NCT04248452|Levoleucovorin|levoleucovorin|mesh-list
92002097|NCT04248452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92002098|NCT04248452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002101|NCT04248452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002102|NCT04248452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002103|NCT04248452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002104|NCT04248452|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002105|NCT04248452|Immunologic Factors|immunologic factors|mesh-ancestor
92002107|NCT04248452|Protective Agents|protective agents|mesh-ancestor
92002108|NCT04248452|Vitamin B Complex|vitamin b complex|mesh-ancestor
92002109|NCT04248452|Vitamins|vitamins|mesh-ancestor
92002110|NCT04248452|Micronutrients|micronutrients|mesh-ancestor
92002111|NCT04248452|Hematinics|hematinics|mesh-ancestor
92002112|NCT04240054|Dexamethasone|dexamethasone|mesh-list
92002113|NCT04240054|Cyclophosphamide|cyclophosphamide|mesh-list
92002114|NCT04240054|Bortezomib|bortezomib|mesh-list
92002115|NCT04240054|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002116|NCT04240054|Immunologic Factors|immunologic factors|mesh-ancestor
92002117|NCT04240054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002118|NCT04240054|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002119|NCT04240054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002120|NCT04240054|Alkylating Agents|alkylating agents|mesh-ancestor
92002121|NCT04240054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002122|NCT04240054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002123|NCT04240054|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92002124|NCT04240054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002125|NCT04240054|Antiemetics|antiemetics|mesh-ancestor
92002126|NCT04240054|Autonomic Agents|autonomic agents|mesh-ancestor
92002127|NCT04240054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002128|NCT04240054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002129|NCT04240054|Glucocorticoids|glucocorticoids|mesh-ancestor
92002130|NCT04240054|Hormones|hormones|mesh-ancestor
92002131|NCT04240054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002132|NCT04240054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92002133|NCT04233866|Calcium, Dietary|calcium, dietary|mesh-list
92002134|NCT04233866|Leucovorin|leucovorin|mesh-list
92002135|NCT04233866|Folic Acid|folic acid|mesh-list
92002136|NCT04233866|Paclitaxel|paclitaxel|mesh-list
92002137|NCT04233866|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92002138|NCT04233866|Gemcitabine|gemcitabine|mesh-list
92002139|NCT04233866|Fluorouracil|fluorouracil|mesh-list
92002140|NCT04233866|Irinotecan|irinotecan|mesh-list
92002141|NCT04233866|Calcium|calcium|mesh-list
92002142|NCT04233866|Levoleucovorin|levoleucovorin|mesh-list
92002143|NCT04233866|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002144|NCT04233866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002145|NCT04233866|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002146|NCT04233866|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002147|NCT04233866|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002148|NCT04233866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002149|NCT04233866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002150|NCT04233866|Antimetabolites|antimetabolites|mesh-ancestor
92002151|NCT04233866|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92002152|NCT04233866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970759|NCT03304457|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970760|NCT03304457|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
91970761|NCT03304457|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91970762|NCT03304457|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
91970763|NCT03304457|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91970764|NCT03304457|Dopamine Agents|dopamine agents|mesh-ancestor
91970765|NCT04490837|Antibodies|antibodies|mesh-list
92002153|NCT04233866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92002154|NCT04233866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002155|NCT04233866|Immunologic Factors|immunologic factors|mesh-ancestor
92002156|NCT04233866|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92002157|NCT04233866|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92002158|NCT04233866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002159|NCT04233866|Antidotes|antidotes|mesh-ancestor
92002160|NCT04233866|Protective Agents|protective agents|mesh-ancestor
92002161|NCT04233866|Vitamin B Complex|vitamin b complex|mesh-ancestor
92002162|NCT04233866|Vitamins|vitamins|mesh-ancestor
92002163|NCT04233866|Micronutrients|micronutrients|mesh-ancestor
92002164|NCT04233866|Hematinics|hematinics|mesh-ancestor
92002165|NCT04233112|Melatonin|melatonin|mesh-list
92002166|NCT04233112|Antioxidants|antioxidants|mesh-ancestor
92002167|NCT04233112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002168|NCT04233112|Protective Agents|protective agents|mesh-ancestor
92002169|NCT04233112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002170|NCT04233112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92002171|NCT04221438|Alovudine|alovudine|mesh-list
92002172|NCT04221438|Antiviral Agents|antiviral agents|mesh-ancestor
92002173|NCT04221438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002174|NCT04217954|Bevacizumab|bevacizumab|mesh-list
92002177|NCT04217954|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002178|NCT04217954|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002179|NCT04217954|Growth Substances|growth substances|mesh-ancestor
92002180|NCT04217954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002181|NCT04217954|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002182|NCT04216316|Carboplatin|carboplatin|mesh-list
92002183|NCT04216316|Gemcitabine|gemcitabine|mesh-list
92002184|NCT04216316|Pembrolizumab|pembrolizumab|mesh-list
92002185|NCT04216316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002186|NCT04216316|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002187|NCT04216316|Antimetabolites|antimetabolites|mesh-ancestor
92002188|NCT04216316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002189|NCT04216316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002190|NCT04216316|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002191|NCT04214249|Cytarabine|cytarabine|mesh-list
92002192|NCT04214249|Pembrolizumab|pembrolizumab|mesh-list
92002193|NCT04214249|Daunorubicin|daunorubicin|mesh-list
92002194|NCT04214249|Idarubicin|idarubicin|mesh-list
92002195|NCT04214249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002196|NCT04214249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002197|NCT04214249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002198|NCT04214249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002199|NCT04214249|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002200|NCT04214249|Antimetabolites|antimetabolites|mesh-ancestor
92002201|NCT04214249|Antiviral Agents|antiviral agents|mesh-ancestor
92002202|NCT04214249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002203|NCT04214249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002204|NCT04214249|Immunologic Factors|immunologic factors|mesh-ancestor
92002205|NCT04214249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002206|NCT04214249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92002207|NCT04214249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92002208|NCT04214249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92002209|NCT04214249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002210|NCT04210427|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92002211|NCT04210427|Laxatives|laxatives|mesh-ancestor
92002212|NCT04210427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002213|NCT04209114|Nivolumab|nivolumab|mesh-list
92002214|NCT04209114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002215|NCT04209114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970766|NCT04490837|Immunologic Factors|immunologic factors|mesh-ancestor
91970767|NCT04490837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970768|NCT03305471|Sevelamer|sevelamer|mesh-list
91970769|NCT03305471|Chelating Agents|chelating agents|mesh-ancestor
92002216|NCT04209114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002217|NCT04209114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002218|NCT04200443|Temozolomide|temozolomide|mesh-list
92002219|NCT04200443|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002220|NCT04200443|Alkylating Agents|alkylating agents|mesh-ancestor
92002221|NCT04200443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002222|NCT04200443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002223|NCT04194034|Flucytosine|flucytosine|mesh-list
92002224|NCT04194034|Antifungal Agents|antifungal agents|mesh-ancestor
92002225|NCT04194034|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002226|NCT04194034|Antimetabolites|antimetabolites|mesh-ancestor
92002227|NCT04194034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002228|NCT04191187|Fludarabine|fludarabine|mesh-list
92002229|NCT04191187|Melphalan|melphalan|mesh-list
92002230|NCT04191187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002231|NCT04191187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002232|NCT04191187|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002233|NCT04191187|Immunologic Factors|immunologic factors|mesh-ancestor
92002234|NCT04191187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002235|NCT04191187|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002236|NCT04191187|Alkylating Agents|alkylating agents|mesh-ancestor
92002237|NCT04191187|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92002238|NCT04191135|Carboplatin|carboplatin|mesh-list
92002239|NCT04191135|Gemcitabine|gemcitabine|mesh-list
92002240|NCT04191135|Pembrolizumab|pembrolizumab|mesh-list
92002241|NCT04191135|Olaparib|olaparib|mesh-list
92002242|NCT04191135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002243|NCT04191135|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002244|NCT04191135|Antimetabolites|antimetabolites|mesh-ancestor
92002245|NCT04191135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002246|NCT04191135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002249|NCT04191135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002250|NCT04356170|Docetaxel|docetaxel|mesh-list
92002251|NCT04356170|Fluorouracil|fluorouracil|mesh-list
92002252|NCT04356170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002253|NCT04356170|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002254|NCT04356170|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002255|NCT04356170|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074273|NCT00074308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002256|NCT04356170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002257|NCT04356170|Antimetabolites|antimetabolites|mesh-ancestor
92002258|NCT04356170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002259|NCT04356170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002260|NCT04356170|Immunologic Factors|immunologic factors|mesh-ancestor
92002261|NCT04356170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002262|NCT04188418|Fentanyl|fentanyl|mesh-list
92002263|NCT04188418|Morphine|morphine|mesh-list
92002264|NCT04188418|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92002265|NCT04188418|Narcotics|narcotics|mesh-ancestor
92002266|NCT04188418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92002267|NCT04188418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002268|NCT04188418|Analgesics|analgesics|mesh-ancestor
92002269|NCT04188418|Sensory System Agents|sensory system agents|mesh-ancestor
92002270|NCT04188418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002271|NCT04188418|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92002272|NCT04188418|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92002273|NCT04188418|Anesthetics, General|anesthetics, general|mesh-ancestor
92002274|NCT04188418|Anesthetics|anesthetics|mesh-ancestor
92002275|NCT04166318|Fluorouracil|fluorouracil|mesh-list
92002276|NCT04166318|Capecitabine|capecitabine|mesh-list
92002277|NCT04166318|Mitomycins|mitomycins|mesh-list
92002278|NCT04166318|Mitomycin|mitomycin|mesh-list
92002279|NCT04166318|Antimetabolites|antimetabolites|mesh-ancestor
92002280|NCT04166318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002281|NCT04166318|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002282|NCT04166318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002283|NCT04166318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002284|NCT04166318|Immunologic Factors|immunologic factors|mesh-ancestor
92002285|NCT04166318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002286|NCT04166318|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91970770|NCT03305471|Sequestering Agents|sequestering agents|mesh-ancestor
91970771|NCT03305471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970772|NCT03303677|Vancomycin|vancomycin|mesh-list
91970773|NCT03303677|Ciprofloxacin|ciprofloxacin|mesh-list
92002287|NCT04166318|Alkylating Agents|alkylating agents|mesh-ancestor
92002288|NCT04166318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92002289|NCT04166318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002290|NCT04150614|Dexamethasone|dexamethasone|mesh-list
92002291|NCT04150614|Ondansetron|ondansetron|mesh-list
92002292|NCT04150614|Granisetron|granisetron|mesh-list
92002293|NCT04150614|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002294|NCT04150614|Antiemetics|antiemetics|mesh-ancestor
92002295|NCT04150614|Autonomic Agents|autonomic agents|mesh-ancestor
92002296|NCT04150614|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002297|NCT04150614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002298|NCT04150614|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002299|NCT04150614|Glucocorticoids|glucocorticoids|mesh-ancestor
92002300|NCT04150614|Hormones|hormones|mesh-ancestor
92002301|NCT04150614|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002302|NCT04150614|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92002303|NCT04150614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002304|NCT04150614|Antipruritics|antipruritics|mesh-ancestor
92002305|NCT04150614|Dermatologic Agents|dermatologic agents|mesh-ancestor
92002306|NCT04150614|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92002307|NCT04150614|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92002308|NCT04150614|Serotonin Agents|serotonin agents|mesh-ancestor
92002309|NCT04150614|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002310|NCT04150614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002311|NCT04148911|Paclitaxel|paclitaxel|mesh-list
92002312|NCT04148911|Atezolizumab|atezolizumab|mesh-list
92002313|NCT04148911|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002315|NCT04148911|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002316|NCT04148911|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002317|NCT04148911|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002318|NCT04148911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002319|NCT04148911|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002320|NCT04148911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002323|NCT04145297|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92002324|NCT04145297|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92002325|NCT04145297|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002326|NCT04145297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002327|NCT04145297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002328|NCT04145297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002329|NCT04134260|Hormones|hormones|mesh-list
92002330|NCT04134260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002331|NCT04134260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002332|NCT04126096|Lactams|lactams|mesh-list
92002333|NCT04126096|beta-Lactams|beta-lactams|mesh-list
92002334|NCT04126096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92002335|NCT04126096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002336|NCT04125836|Octreotide|octreotide|mesh-list
92002337|NCT04125836|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002338|NCT04125836|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92002339|NCT04125836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002340|NCT04123795|Certolizumab Pegol|certolizumab pegol|mesh-list
92002341|NCT04123795|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92002342|NCT04123795|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002343|NCT04123795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002344|NCT04123795|Immunologic Factors|immunologic factors|mesh-ancestor
92002345|NCT04123795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002346|NCT04123795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002347|NCT04121455|Bevacizumab|bevacizumab|mesh-list
92002348|NCT04121455|Pembrolizumab|pembrolizumab|mesh-list
92002349|NCT04121455|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002350|NCT04121455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002351|NCT04121455|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002352|NCT04121455|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002353|NCT04121455|Growth Substances|growth substances|mesh-ancestor
92002354|NCT04121455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970774|NCT03303677|Gentamicins|gentamicins|mesh-list
91970775|NCT03303677|Mupirocin|mupirocin|mesh-list
91970776|NCT03303677|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92002355|NCT04121455|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002356|NCT04121455|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002357|NCT04121455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002358|NCT04117672|Antisecretory factor|antisecretory factor|mesh-list
92002359|NCT04117672|Antidiarrheals|antidiarrheals|mesh-ancestor
92002360|NCT04117672|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002361|NCT04115631|Cytarabine|cytarabine|mesh-list
92002362|NCT04115631|Rituximab|rituximab|mesh-list
92002363|NCT04115631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92002364|NCT04115631|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92002365|NCT04115631|Acalabrutinib|acalabrutinib|mesh-list
92002366|NCT04115631|Antibodies|antibodies|mesh-list
92002367|NCT04115631|Immunoglobulins|immunoglobulins|mesh-list
92002368|NCT04115631|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92002369|NCT04115631|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92002370|NCT04115631|Immunologic Factors|immunologic factors|mesh-ancestor
92002371|NCT04115631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002372|NCT04115631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002373|NCT04115631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002374|NCT04115631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002375|NCT04115631|Antimetabolites|antimetabolites|mesh-ancestor
92002376|NCT04115631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002377|NCT04115631|Antiviral Agents|antiviral agents|mesh-ancestor
92002378|NCT04115631|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002379|NCT04115631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002380|NCT04115631|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002381|NCT04115631|Alkylating Agents|alkylating agents|mesh-ancestor
92002382|NCT04115631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92002383|NCT04115631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002384|NCT04109482|Cyclophosphamide|cyclophosphamide|mesh-list
92002385|NCT04109482|Fludarabine|fludarabine|mesh-list
92002386|NCT04109482|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002387|NCT04109482|Immunologic Factors|immunologic factors|mesh-ancestor
92002388|NCT04109482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002389|NCT04109482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002390|NCT04109482|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002391|NCT04109482|Alkylating Agents|alkylating agents|mesh-ancestor
92002622|NCT03887780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002392|NCT04109482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002393|NCT04109482|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002396|NCT04094584|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92002397|NCT04094584|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92002398|NCT04094584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002399|NCT04094584|Sensory System Agents|sensory system agents|mesh-ancestor
92002400|NCT04094584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002401|NCT04086264|Azacitidine|azacitidine|mesh-list
92002402|NCT04086264|Decitabine|decitabine|mesh-list
92002403|NCT04086264|Venetoclax|venetoclax|mesh-list
92002404|NCT04086264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002405|NCT04086264|Antimetabolites|antimetabolites|mesh-ancestor
92002406|NCT04086264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002407|NCT04086264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002408|NCT04086264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002409|NCT04082754|Antibodies|antibodies|mesh-list
92002410|NCT04082754|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92002411|NCT04082754|Immunologic Factors|immunologic factors|mesh-ancestor
92002412|NCT04082754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002413|NCT04076059|Androgens|androgens|mesh-list
92002414|NCT04076059|Hormones|hormones|mesh-ancestor
92002415|NCT04076059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002416|NCT04076059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002417|NCT04075292|Rituximab|rituximab|mesh-list
92002418|NCT04075292|Acalabrutinib|acalabrutinib|mesh-list
92002419|NCT04075292|Chlorambucil|chlorambucil|mesh-list
92002420|NCT04075292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002421|NCT04075292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002422|NCT04075292|Immunologic Factors|immunologic factors|mesh-ancestor
92002423|NCT04075292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002424|NCT04075292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002425|NCT04075292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002426|NCT04075292|Alkylating Agents|alkylating agents|mesh-ancestor
92002427|NCT04075292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970777|NCT03303677|Trimethoprim|trimethoprim|mesh-list
91970778|NCT03303677|Sulfamethoxazole|sulfamethoxazole|mesh-list
91970779|NCT03303677|Budesonide|budesonide|mesh-list
91970780|NCT03303677|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970781|NCT03303677|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92002428|NCT04064359|Antibodies|antibodies|mesh-list
92002429|NCT04064359|Immunoconjugates|immunoconjugates|mesh-list
92002430|NCT04064359|Immunologic Factors|immunologic factors|mesh-ancestor
92002431|NCT04064359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002432|NCT04047628|Alemtuzumab|alemtuzumab|mesh-list
92002433|NCT04047628|Ofatumumab|ofatumumab|mesh-list
92002434|NCT04047628|Cladribine|cladribine|mesh-list
92002435|NCT04047628|Ocrelizumab|ocrelizumab|mesh-list
92002436|NCT04047628|Natalizumab|natalizumab|mesh-list
92002437|NCT04047628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002438|NCT04047628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002440|NCT04047628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002441|NCT04047628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002442|NCT04047472|Aflibercept|aflibercept|mesh-list
92002443|NCT04047472|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002444|NCT04047472|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002445|NCT04047472|Growth Substances|growth substances|mesh-ancestor
92002446|NCT04047472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002447|NCT04047472|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002448|NCT04047472|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002449|NCT04047355|Propranolol|propranolol|mesh-list
92002450|NCT04047355|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92002451|NCT04047355|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92002452|NCT04047355|Adrenergic Agents|adrenergic agents|mesh-ancestor
92002453|NCT04047355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002454|NCT04047355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002455|NCT04047355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002456|NCT04047355|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92002457|NCT04047355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92002458|NCT04047355|Vasodilator Agents|vasodilator agents|mesh-ancestor
92002460|NCT04045431|Viscosupplements|viscosupplements|mesh-ancestor
92002461|NCT04045431|Protective Agents|protective agents|mesh-ancestor
92002462|NCT04045431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002463|NCT04037254|Niraparib|niraparib|mesh-list
92002464|NCT04037254|Hormones|hormones|mesh-list
92002465|NCT04037254|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92002466|NCT04037254|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92002467|NCT04037254|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002468|NCT04037254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002469|NCT04037254|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92002470|NCT04037254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002471|NCT04037254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002472|NCT04037254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002474|NCT04022239|Cyclophosphamide|cyclophosphamide|mesh-list
92002475|NCT04022239|Melphalan|melphalan|mesh-list
92002476|NCT04022239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92002477|NCT04022239|Mechlorethamine|mechlorethamine|mesh-list
92002478|NCT04022239|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92002479|NCT04022239|Rituximab|rituximab|mesh-list
92002480|NCT04022239|Fludarabine|fludarabine|mesh-list
92002481|NCT04022239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92002483|NCT04022239|Antibodies|antibodies|mesh-list
92002484|NCT04022239|Immunoglobulins|immunoglobulins|mesh-list
92002485|NCT04022239|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92002486|NCT04022239|Lenograstim|lenograstim|mesh-list
92002487|NCT04022239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002488|NCT04022239|Immunologic Factors|immunologic factors|mesh-ancestor
92002489|NCT04022239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002490|NCT04022239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002491|NCT04022239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002492|NCT04022239|Alkylating Agents|alkylating agents|mesh-ancestor
92002493|NCT04022239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002494|NCT04022239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002495|NCT04022239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91970782|NCT03303677|Autonomic Agents|autonomic agents|mesh-ancestor
91970783|NCT03303677|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970784|NCT03303677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970785|NCT03303677|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91970786|NCT03303677|Respiratory System Agents|respiratory system agents|mesh-ancestor
92002496|NCT04022239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92002497|NCT04022239|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92002498|NCT04022239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002499|NCT04022239|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92002500|NCT04022239|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92002501|NCT04022239|Antitubercular Agents|antitubercular agents|mesh-ancestor
92002502|NCT04022239|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92002503|NCT04022239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002505|NCT04020341|Gepotidacin|gepotidacin|mesh-list
92002506|NCT04020341|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92002507|NCT04020341|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002508|NCT04020341|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92002509|NCT04020341|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92002510|NCT04020341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002511|NCT04020341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002512|NCT04020341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002513|NCT04012138|Insulin|insulin|mesh-list
92002514|NCT04012138|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92002515|NCT04012138|Insulin Aspart|insulin aspart|mesh-list
92002516|NCT04012138|Albuterol|albuterol|mesh-list
92002517|NCT04012138|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92002518|NCT04012138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002519|NCT04012138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92002520|NCT04012138|Autonomic Agents|autonomic agents|mesh-ancestor
92002521|NCT04012138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002522|NCT04012138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92002523|NCT04012138|Respiratory System Agents|respiratory system agents|mesh-ancestor
92002524|NCT04012138|Tocolytic Agents|tocolytic agents|mesh-ancestor
92002525|NCT04012138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92002526|NCT04012138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92002527|NCT04012138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92002528|NCT04012138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92002529|NCT04012138|Adrenergic Agents|adrenergic agents|mesh-ancestor
92002530|NCT04012138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002531|NCT04012138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002532|NCT04011280|Varenicline|varenicline|mesh-list
92002533|NCT04011280|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92002534|NCT04011280|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92002535|NCT04011280|Cholinergic Agents|cholinergic agents|mesh-ancestor
92002536|NCT04011280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002537|NCT04011280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002538|NCT04011280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002539|NCT04002934|Bazedoxifene|bazedoxifene|mesh-list
92002540|NCT04002934|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92002541|NCT04002934|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92002542|NCT04002934|Hormone Antagonists|hormone antagonists|mesh-ancestor
92002543|NCT04002934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002545|NCT04002934|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92002547|NCT04001829|Docetaxel|docetaxel|mesh-list
92002548|NCT04001829|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92002549|NCT04001829|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002550|NCT04001829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002551|NCT04001829|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002552|NCT04001829|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002553|NCT04001829|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002554|NCT04001829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002556|NCT03989271|Antioxidants|antioxidants|mesh-ancestor
92002557|NCT03989271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002558|NCT03989271|Protective Agents|protective agents|mesh-ancestor
92090409|NCT04382014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002559|NCT03989271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002560|NCT03987711|Warfarin|warfarin|mesh-list
92002561|NCT03987711|Apixaban|apixaban|mesh-list
92002562|NCT03987711|Anticoagulants|anticoagulants|mesh-ancestor
92002563|NCT03987711|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92002564|NCT03987711|Antithrombins|antithrombins|mesh-ancestor
92002565|NCT03987711|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92002566|NCT03987711|Protease Inhibitors|protease inhibitors|mesh-ancestor
92002567|NCT03987711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002568|NCT03987711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002569|NCT03969212|Baloxavir|baloxavir|mesh-list
92002570|NCT03969212|Antiviral Agents|antiviral agents|mesh-ancestor
92002571|NCT03969212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002572|NCT03969212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002573|NCT03969212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002574|NCT03953898|Olaparib|olaparib|mesh-list
92002575|NCT03953898|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92002576|NCT03953898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002577|NCT03953898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002578|NCT03953898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002579|NCT03950739|Treprostinil|treprostinil|mesh-list
92002580|NCT03950739|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92002581|NCT03937635|Dexamethasone|dexamethasone|mesh-list
92002582|NCT03937635|Dexamethasone acetate|dexamethasone acetate|mesh-list
92002583|NCT03937635|Lenalidomide|lenalidomide|mesh-list
92002584|NCT03937635|Daratumumab|daratumumab|mesh-list
92002585|NCT03937635|Ichthammol|ichthammol|mesh-list
92002586|NCT03937635|BB 1101|bb 1101|mesh-list
92002587|NCT03937635|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002588|NCT03937635|Antiemetics|antiemetics|mesh-ancestor
92002589|NCT03937635|Autonomic Agents|autonomic agents|mesh-ancestor
92002590|NCT03937635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002591|NCT03937635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002592|NCT03937635|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002593|NCT03937635|Glucocorticoids|glucocorticoids|mesh-ancestor
92002594|NCT03937635|Hormones|hormones|mesh-ancestor
92002595|NCT03937635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002596|NCT03937635|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92002597|NCT03937635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002598|NCT03937635|Immunologic Factors|immunologic factors|mesh-ancestor
92002599|NCT03937635|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002600|NCT03937635|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002601|NCT03937635|Growth Substances|growth substances|mesh-ancestor
92002602|NCT03937635|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002603|NCT03937635|Protease Inhibitors|protease inhibitors|mesh-ancestor
92002604|NCT03937635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002605|NCT03937635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002606|NCT03937635|Dermatologic Agents|dermatologic agents|mesh-ancestor
92002607|NCT03892044|Nivolumab|nivolumab|mesh-list
92002608|NCT03892044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002609|NCT03892044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002610|NCT03892044|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002611|NCT03892044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002612|NCT03891953|Spartalizumab|spartalizumab|mesh-list
92002613|NCT03891953|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002614|NCT03891953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002615|NCT03891953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002616|NCT03891953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002623|NCT03887780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002624|NCT03887780|Anticoagulants|anticoagulants|mesh-ancestor
92002625|NCT03885037|Infliximab|infliximab|mesh-list
92002626|NCT03885037|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92002627|NCT03885037|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002628|NCT03885037|Dermatologic Agents|dermatologic agents|mesh-ancestor
92002629|NCT03885037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002630|NCT03885037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002631|NCT03884439|Infliximab|infliximab|mesh-list
92002632|NCT03884439|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92002633|NCT03884439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002634|NCT03884439|Dermatologic Agents|dermatologic agents|mesh-ancestor
91970789|NCT03303677|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970790|NCT03303677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91970791|NCT03303677|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91970792|NCT03303677|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91970793|NCT03303677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970794|NCT03303677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002635|NCT03884439|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002636|NCT03884439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002637|NCT03879629|Carvedilol|carvedilol|mesh-list
92002638|NCT03879629|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92002639|NCT03879629|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92002640|NCT03879629|Adrenergic Agents|adrenergic agents|mesh-ancestor
92002641|NCT03879629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002642|NCT03879629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002643|NCT03879629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002644|NCT03879629|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92002645|NCT03879629|Antioxidants|antioxidants|mesh-ancestor
92002646|NCT03879629|Protective Agents|protective agents|mesh-ancestor
92002647|NCT03879629|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92002648|NCT03879629|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92002649|NCT03879629|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92002650|NCT03879629|Vasodilator Agents|vasodilator agents|mesh-ancestor
92002651|NCT03879629|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92002652|NCT03879629|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92002653|NCT03873389|Ocrelizumab|ocrelizumab|mesh-list
92002654|NCT03873389|Immunologic Factors|immunologic factors|mesh-ancestor
92002655|NCT03873389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002656|NCT03869190|Gemcitabine|gemcitabine|mesh-list
92002657|NCT03869190|Atezolizumab|atezolizumab|mesh-list
92002658|NCT03869190|Niraparib|niraparib|mesh-list
92002659|NCT03869190|Magrolimab|magrolimab|mesh-list
92002660|NCT03869190|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92002661|NCT03869190|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002662|NCT03869190|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002663|NCT03869190|Antimetabolites|antimetabolites|mesh-ancestor
92002664|NCT03869190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002665|NCT03869190|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002666|NCT03869190|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002667|NCT03869190|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92002668|NCT03869190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002669|NCT03869190|Immunoconjugates|immunoconjugates|mesh-ancestor
92002670|NCT03869190|Immunologic Factors|immunologic factors|mesh-ancestor
92002671|NCT03869190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002672|NCT03867851|Heparin|heparin|mesh-list
92002673|NCT03867851|Anticoagulants|anticoagulants|mesh-ancestor
92002674|NCT03867851|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92002675|NCT03867851|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92002676|NCT03867851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002677|NCT03860207|Antibodies|antibodies|mesh-list
92002678|NCT03860207|Immunoglobulins|immunoglobulins|mesh-list
92002679|NCT03860207|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92002680|NCT03860207|Immunologic Factors|immunologic factors|mesh-ancestor
92002681|NCT03860207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002682|NCT03850691|Aldesleukin|aldesleukin|mesh-list
92002683|NCT03850691|Nivolumab|nivolumab|mesh-list
92002684|NCT03850691|Ipilimumab|ipilimumab|mesh-list
92002685|NCT03850691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002686|NCT03850691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002687|NCT03850691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002688|NCT03850691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002689|NCT03850691|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92002693|NCT03822793|Tranexamic Acid|tranexamic acid|mesh-list
92002694|NCT03822793|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92002695|NCT03822793|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92002696|NCT03822793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002697|NCT03822793|Hemostatics|hemostatics|mesh-ancestor
92002698|NCT03822793|Coagulants|coagulants|mesh-ancestor
92002699|NCT03816163|Paclitaxel|paclitaxel|mesh-list
91970795|NCT03303677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970796|NCT03303677|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91970797|NCT03303677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92002700|NCT03816163|Gemcitabine|gemcitabine|mesh-list
92002701|NCT03816163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002702|NCT03816163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002703|NCT03816163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002704|NCT03816163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002705|NCT03816163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002706|NCT03816163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002707|NCT03816163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002708|NCT03816163|Antimetabolites|antimetabolites|mesh-ancestor
92002709|NCT03809780|Dexamethasone|dexamethasone|mesh-list
92002710|NCT03809780|Lenalidomide|lenalidomide|mesh-list
92002711|NCT03809780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002712|NCT03809780|Antiemetics|antiemetics|mesh-ancestor
92002713|NCT03809780|Autonomic Agents|autonomic agents|mesh-ancestor
92002714|NCT03809780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002715|NCT03809780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002716|NCT03809780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92002717|NCT03809780|Glucocorticoids|glucocorticoids|mesh-ancestor
92002718|NCT03809780|Hormones|hormones|mesh-ancestor
92002719|NCT03809780|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002720|NCT03809780|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92002721|NCT03809780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002722|NCT03809780|Immunologic Factors|immunologic factors|mesh-ancestor
92002723|NCT03809780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002725|NCT03809780|Growth Substances|growth substances|mesh-ancestor
92002726|NCT03809780|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002727|NCT03808818|Nicotine|nicotine|mesh-list
92002728|NCT03808818|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92002729|NCT03808818|Autonomic Agents|autonomic agents|mesh-ancestor
92002730|NCT03808818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002731|NCT03808818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002732|NCT03808818|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92002733|NCT03808818|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92002734|NCT03808818|Cholinergic Agents|cholinergic agents|mesh-ancestor
92002735|NCT03808818|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92002736|NCT03808818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002737|NCT03802604|Atezolizumab|atezolizumab|mesh-list
92002738|NCT03802604|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92002739|NCT03802604|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002740|NCT03802604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002741|NCT03802604|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002742|NCT03802604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002743|NCT03801876|Paclitaxel|paclitaxel|mesh-list
92002744|NCT03801876|Docetaxel|docetaxel|mesh-list
92002745|NCT03801876|Carboplatin|carboplatin|mesh-list
92002746|NCT03801876|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92002747|NCT03801876|Fluorouracil|fluorouracil|mesh-list
92002748|NCT03801876|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92002749|NCT03801876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002750|NCT03801876|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002751|NCT03801876|Antimitotic Agents|antimitotic agents|mesh-ancestor
92002752|NCT03801876|Mitosis Modulators|mitosis modulators|mesh-ancestor
92002753|NCT03801876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002754|NCT03801876|Antimetabolites|antimetabolites|mesh-ancestor
92002755|NCT03801876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002756|NCT03801876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002757|NCT03801876|Immunologic Factors|immunologic factors|mesh-ancestor
92002758|NCT03801876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002759|NCT03785873|Leucovorin|leucovorin|mesh-list
92002760|NCT03785873|Fluorouracil|fluorouracil|mesh-list
92002761|NCT03785873|Nivolumab|nivolumab|mesh-list
92002762|NCT03785873|Irinotecan|irinotecan|mesh-list
92002763|NCT03785873|Antimetabolites|antimetabolites|mesh-ancestor
92002766|NCT03785873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002767|NCT03785873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002768|NCT03785873|Immunologic Factors|immunologic factors|mesh-ancestor
92002769|NCT03785873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970798|NCT03303677|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91970799|NCT03303677|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92002770|NCT03785873|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002771|NCT03785873|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002772|NCT03785873|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92002773|NCT03785873|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92002774|NCT03785873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002775|NCT03785873|Antidotes|antidotes|mesh-ancestor
92002776|NCT03785873|Protective Agents|protective agents|mesh-ancestor
92002777|NCT03785873|Vitamin B Complex|vitamin b complex|mesh-ancestor
92002779|NCT03785873|Micronutrients|micronutrients|mesh-ancestor
92002780|NCT03784677|SOR-C13|sor-c13|mesh-list
92002781|NCT03784677|Calcium|calcium|mesh-list
92002782|NCT03784677|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92002783|NCT03784677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002784|NCT03784677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002785|NCT03784677|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92002786|NCT03784677|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92002787|NCT03784677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002788|NCT03782064|Nivolumab|nivolumab|mesh-list
92002789|NCT03782064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002790|NCT03782064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002791|NCT03782064|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002792|NCT03782064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002793|NCT03766126|Cyclophosphamide|cyclophosphamide|mesh-list
92002794|NCT03766126|Fludarabine|fludarabine|mesh-list
92002795|NCT03766126|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002796|NCT03766126|Immunologic Factors|immunologic factors|mesh-ancestor
92002797|NCT03766126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002798|NCT03766126|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002799|NCT03766126|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002800|NCT03766126|Alkylating Agents|alkylating agents|mesh-ancestor
92002801|NCT03766126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002802|NCT03766126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002803|NCT03766126|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92002804|NCT03764488|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
92002805|NCT03764488|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92002806|NCT03764488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002807|NCT03764293|Sorafenib|sorafenib|mesh-list
92002808|NCT03764293|Apatinib|apatinib|mesh-list
92002809|NCT03764293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002810|NCT03764293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92002811|NCT03764293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002812|NCT03764293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002813|NCT03763643|Rituximab|rituximab|mesh-list
92002814|NCT03763643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002815|NCT03763643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002816|NCT03763643|Immunologic Factors|immunologic factors|mesh-ancestor
92002817|NCT03763643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002818|NCT03763643|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002819|NCT03761095|Dacarbazine|dacarbazine|mesh-list
92002820|NCT03761095|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92002821|NCT03761095|Alkylating Agents|alkylating agents|mesh-ancestor
92002822|NCT03761095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002823|NCT03761095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002824|NCT03747042|Letrozole|letrozole|mesh-list
92002825|NCT03747042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002826|NCT03747042|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92002827|NCT03747042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92002828|NCT03747042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002829|NCT03747042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002830|NCT03747042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92002831|NCT03747042|Hormone Antagonists|hormone antagonists|mesh-ancestor
92002832|NCT03747042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002833|NCT03747042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002838|NCT03734237|Immunologic Factors|immunologic factors|mesh-ancestor
92002839|NCT03734237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002840|NCT03724071|Flucytosine|flucytosine|mesh-list
91970801|NCT03303677|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91970802|NCT03303677|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91970803|NCT03303677|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91970804|NCT03303677|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92002841|NCT03724071|Antifungal Agents|antifungal agents|mesh-ancestor
92002842|NCT03724071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002843|NCT03724071|Antimetabolites|antimetabolites|mesh-ancestor
92002844|NCT03724071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002845|NCT03709446|Leflunomide|leflunomide|mesh-list
92002846|NCT03709446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002847|NCT03709446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002848|NCT03709446|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002849|NCT03709446|Immunologic Factors|immunologic factors|mesh-ancestor
92002850|NCT03709446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002851|NCT03705169|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92002852|NCT03705169|Antiviral Agents|antiviral agents|mesh-ancestor
92002853|NCT03705169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002854|NCT03678350|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92002856|NCT03678350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002857|NCT03678350|Dermatologic Agents|dermatologic agents|mesh-ancestor
92002858|NCT03678350|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92002859|NCT03671525|Nimodipine|nimodipine|mesh-list
92002860|NCT03671525|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92002861|NCT03671525|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92002862|NCT03671525|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92002863|NCT03671525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002864|NCT03671525|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92002865|NCT03671525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002866|NCT03671525|Vasodilator Agents|vasodilator agents|mesh-ancestor
92002867|NCT03654716|Cytarabine|cytarabine|mesh-list
92002868|NCT03654716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002869|NCT03654716|Antimetabolites|antimetabolites|mesh-ancestor
92002870|NCT03654716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002871|NCT03654716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002872|NCT03654716|Antiviral Agents|antiviral agents|mesh-ancestor
92002873|NCT03654716|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002874|NCT03654716|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002875|NCT03654716|Immunologic Factors|immunologic factors|mesh-ancestor
92002876|NCT03654716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002877|NCT03648437|Acetaminophen|acetaminophen|mesh-list
92002879|NCT03648437|Indomethacin|indomethacin|mesh-list
92002880|NCT03648437|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92002881|NCT03648437|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92002882|NCT03648437|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92002883|NCT03648437|Analgesics|analgesics|mesh-ancestor
92002884|NCT03648437|Sensory System Agents|sensory system agents|mesh-ancestor
92002885|NCT03648437|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002886|NCT03648437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002887|NCT03648437|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002888|NCT03648437|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92002889|NCT03648437|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92002890|NCT03648437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002891|NCT03648437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002892|NCT03648437|Antipyretics|antipyretics|mesh-ancestor
92002893|NCT03648437|Gout Suppressants|gout suppressants|mesh-ancestor
92002894|NCT03648437|Tocolytic Agents|tocolytic agents|mesh-ancestor
92002895|NCT03648437|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92002896|NCT03646058|Buprenorphine|buprenorphine|mesh-list
92002897|NCT03646058|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92002898|NCT03646058|Narcotics|narcotics|mesh-ancestor
92002899|NCT03646058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92002900|NCT03646058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002901|NCT03646058|Analgesics|analgesics|mesh-ancestor
92002902|NCT03646058|Sensory System Agents|sensory system agents|mesh-ancestor
92002903|NCT03646058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002904|NCT03646058|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92002905|NCT03644485|Mycophenolic Acid|mycophenolic acid|mesh-list
92002906|NCT03644485|Tacrolimus|tacrolimus|mesh-list
91970805|NCT03303677|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91970807|NCT02468063|Norepinephrine|norepinephrine|mesh-list
91970808|NCT02468063|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92002908|NCT03644485|Immunologic Factors|immunologic factors|mesh-ancestor
92002909|NCT03644485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002910|NCT03644485|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92002911|NCT03644485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002912|NCT03644485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002913|NCT03644485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92002914|NCT03644485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002915|NCT03644485|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92002916|NCT03644485|Antitubercular Agents|antitubercular agents|mesh-ancestor
92002917|NCT03644485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92002918|NCT03644485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002919|NCT03641560|Androgens|androgens|mesh-list
92002920|NCT03641560|Hormones|hormones|mesh-ancestor
92002921|NCT03641560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002922|NCT03641560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002923|NCT03641209|Acetaminophen|acetaminophen|mesh-list
92002924|NCT03641209|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92002925|NCT03641209|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92002926|NCT03641209|Analgesics|analgesics|mesh-ancestor
92002927|NCT03641209|Sensory System Agents|sensory system agents|mesh-ancestor
92002928|NCT03641209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92002929|NCT03641209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002930|NCT03641209|Antipyretics|antipyretics|mesh-ancestor
92002931|NCT03622593|Aflibercept|aflibercept|mesh-list
92002932|NCT03622593|Faricimab|faricimab|mesh-list
92002933|NCT03622593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002934|NCT03622593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002935|NCT03622593|Growth Substances|growth substances|mesh-ancestor
92002936|NCT03622593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002937|NCT03622593|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002938|NCT03622593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002939|NCT03602066|Chlorine dioxide|chlorine dioxide|mesh-list
92002940|NCT03602066|Dental Disinfectants|dental disinfectants|mesh-ancestor
92002941|NCT03602066|Disinfectants|disinfectants|mesh-ancestor
92002942|NCT03602066|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002943|NCT03597581|Bevacizumab|bevacizumab|mesh-list
92002944|NCT03597581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002945|NCT03597581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002946|NCT03597581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92002947|NCT03597581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92002948|NCT03597581|Growth Substances|growth substances|mesh-ancestor
92002949|NCT03597581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002950|NCT03597581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92002951|NCT03593655|Tenofovir|tenofovir|mesh-list
92002952|NCT03593655|Emtricitabine|emtricitabine|mesh-list
92002953|NCT03593655|Dapivirine|dapivirine|mesh-list
92002954|NCT03593655|Antiviral Agents|antiviral agents|mesh-ancestor
92002955|NCT03593655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002956|NCT03593655|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92002957|NCT03593655|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92002958|NCT03593655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002959|NCT03593655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002960|NCT03593655|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92002961|NCT03593655|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92002962|NCT03586661|Niraparib|niraparib|mesh-list
92002963|NCT03586661|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92002964|NCT03586661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002965|NCT03586661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002966|NCT03586661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002967|NCT03572530|Azacitidine|azacitidine|mesh-list
92002968|NCT03572530|Decitabine|decitabine|mesh-list
92002969|NCT03572530|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002970|NCT03572530|Antimetabolites|antimetabolites|mesh-ancestor
92002971|NCT03572530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002972|NCT03572530|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002973|NCT03572530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002974|NCT03570619|Nivolumab|nivolumab|mesh-list
92002975|NCT03570619|Ipilimumab|ipilimumab|mesh-list
91970809|NCT02468063|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91970810|NCT02468063|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91970811|NCT02468063|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970812|NCT02468063|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970813|NCT02468063|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090410|NCT00892606|Morphine|morphine|mesh-list
92002976|NCT03570619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002977|NCT03570619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002978|NCT03570619|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002979|NCT03570619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002980|NCT03568383|Pyridoxine|pyridoxine|mesh-list
92002981|NCT03568383|Pyridoxal|pyridoxal|mesh-list
92002985|NCT03568383|Micronutrients|micronutrients|mesh-ancestor
92002986|NCT03568383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002987|NCT03568383|Vitamin B Complex|vitamin b complex|mesh-ancestor
92002988|NCT03568383|Antitubercular Agents|antitubercular agents|mesh-ancestor
92002989|NCT03568383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92002990|NCT03568383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002991|NCT03568383|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92002992|NCT03568383|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92002993|NCT03568383|Antimetabolites|antimetabolites|mesh-ancestor
92002994|NCT03568383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002995|NCT03568383|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92002997|NCT03558087|Nivolumab|nivolumab|mesh-list
92002998|NCT03558087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002999|NCT03558087|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003000|NCT03558087|Antimetabolites|antimetabolites|mesh-ancestor
92003001|NCT03558087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003002|NCT03558087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003003|NCT03558087|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003004|NCT03542695|Alendronate|alendronate|mesh-list
92003005|NCT03542695|Copper|copper|mesh-list
92003006|NCT03542695|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92003007|NCT03542695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003008|NCT03542695|Trace Elements|trace elements|mesh-ancestor
92003009|NCT03542695|Micronutrients|micronutrients|mesh-ancestor
92003010|NCT03541902|Sunitinib|sunitinib|mesh-list
92003011|NCT03541902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003012|NCT03541902|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003013|NCT03541902|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003014|NCT03541902|Growth Substances|growth substances|mesh-ancestor
92003015|NCT03541902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003016|NCT03541902|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003017|NCT03541902|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003018|NCT03541902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003019|NCT03541902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003020|NCT03534180|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92003021|NCT03534180|Venetoclax|venetoclax|mesh-list
92003022|NCT03534180|Romidepsin|romidepsin|mesh-list
92003023|NCT03534180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003024|NCT03534180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003025|NCT03534180|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92003026|NCT03534180|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92003027|NCT03534180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003028|NCT03534180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003029|NCT03516279|Pembrolizumab|pembrolizumab|mesh-list
92003030|NCT03516279|Imatinib Mesylate|imatinib mesylate|mesh-list
92003031|NCT03516279|Dasatinib|dasatinib|mesh-list
92003032|NCT03516279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003033|NCT03516279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003034|NCT03516279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003035|NCT03516279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003036|NCT03516279|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003037|NCT03516279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003038|NCT03512405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92003039|NCT03512405|Pembrolizumab|pembrolizumab|mesh-list
92003040|NCT03512405|Blinatumomab|blinatumomab|mesh-list
92003041|NCT03512405|Antibodies|antibodies|mesh-list
92003042|NCT03512405|Immunoglobulins|immunoglobulins|mesh-list
92003043|NCT03512405|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91970814|NCT02468063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970815|NCT02468063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970816|NCT02468063|Sympathomimetics|sympathomimetics|mesh-ancestor
91970817|NCT02468063|Autonomic Agents|autonomic agents|mesh-ancestor
92003044|NCT03512405|Muromonab-CD3|muromonab-cd3|mesh-list
92003045|NCT03512405|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92003046|NCT03512405|Immunologic Factors|immunologic factors|mesh-ancestor
92003047|NCT03512405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003048|NCT03512405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003049|NCT03512405|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003050|NCT03512405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003051|NCT03512405|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003052|NCT03505320|Leucovorin|leucovorin|mesh-list
92003053|NCT03505320|Folic Acid|folic acid|mesh-list
92003054|NCT03505320|Pembrolizumab|pembrolizumab|mesh-list
92003055|NCT03505320|Nivolumab|nivolumab|mesh-list
92003056|NCT03505320|Fluorouracil|fluorouracil|mesh-list
92003061|NCT03505320|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003062|NCT03505320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003063|NCT03505320|Antimetabolites|antimetabolites|mesh-ancestor
92003064|NCT03505320|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003065|NCT03505320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003066|NCT03505320|Immunologic Factors|immunologic factors|mesh-ancestor
92003067|NCT03505320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003068|NCT03505320|Antidotes|antidotes|mesh-ancestor
92003069|NCT03505320|Protective Agents|protective agents|mesh-ancestor
92003070|NCT03505320|Vitamin B Complex|vitamin b complex|mesh-ancestor
92003071|NCT03505320|Vitamins|vitamins|mesh-ancestor
92003072|NCT03505320|Micronutrients|micronutrients|mesh-ancestor
92003073|NCT03505320|Hematinics|hematinics|mesh-ancestor
92003074|NCT03497676|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92003075|NCT03497676|Rilpivirine|rilpivirine|mesh-list
92003076|NCT03497676|Cabotegravir|cabotegravir|mesh-list
92003077|NCT03497676|Antiviral Agents|antiviral agents|mesh-ancestor
92003078|NCT03497676|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003079|NCT03497676|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92003080|NCT03497676|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92003081|NCT03497676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003082|NCT03497676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003084|NCT03497676|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92003085|NCT03497676|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92003086|NCT03493425|Cisplatin|cisplatin|mesh-list
92003087|NCT03493425|Carboplatin|carboplatin|mesh-list
92003088|NCT03493425|Docetaxel|docetaxel|mesh-list
92003089|NCT03493425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003090|NCT03493425|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003091|NCT03493425|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003092|NCT03493425|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003093|NCT03493425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003094|NCT03478865|Vitamin A|vitamin a|mesh-list
92003095|NCT03478865|Retinol palmitate|retinol palmitate|mesh-list
92003096|NCT03478865|Vitamins|vitamins|mesh-ancestor
92003097|NCT03478865|Micronutrients|micronutrients|mesh-ancestor
92003098|NCT03478865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003099|NCT03478865|Antioxidants|antioxidants|mesh-ancestor
92003100|NCT03478865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003101|NCT03478865|Protective Agents|protective agents|mesh-ancestor
92003102|NCT03478865|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92003103|NCT03478865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003104|NCT03464045|Empagliflozin|empagliflozin|mesh-list
92003105|NCT03464045|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92003106|NCT03464045|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92003107|NCT03464045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003108|NCT03464045|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92003109|NCT03464045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003110|NCT03464045|Protease Inhibitors|protease inhibitors|mesh-ancestor
92003111|NCT03464045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003112|NCT03458416|Cannabidiol|cannabidiol|mesh-list
92003113|NCT03458416|Anticonvulsants|anticonvulsants|mesh-ancestor
92003114|NCT03452332|Durvalumab|durvalumab|mesh-list
92003115|NCT03452332|Ipilimumab|ipilimumab|mesh-list
92003116|NCT03452332|Tremelimumab|tremelimumab|mesh-list
92003117|NCT03452332|Immunoglobulins|immunoglobulins|mesh-list
91970818|NCT02468063|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970819|NCT04490681|Ertugliflozin|ertugliflozin|mesh-list
92090411|NCT00892606|Methadone|methadone|mesh-list
92003118|NCT03452332|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92003119|NCT03452332|Immunoglobulin G|immunoglobulin g|mesh-list
92003120|NCT03452332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003121|NCT03452332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003122|NCT03452332|Immunologic Factors|immunologic factors|mesh-ancestor
92003123|NCT03452332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003124|NCT03452332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003125|NCT03452332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003126|NCT03441113|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92003127|NCT03441113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003128|NCT03441113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003135|NCT03419234|Cortisone|cortisone|mesh-list
92003136|NCT03419234|Methyltestosterone|methyltestosterone|mesh-list
92003137|NCT03419234|Abiraterone Acetate|abiraterone acetate|mesh-list
92003138|NCT03419234|Hormones|hormones|mesh-list
92003139|NCT03419234|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92003140|NCT03419234|Androgens|androgens|mesh-list
92003141|NCT03419234|Androgen Antagonists|androgen antagonists|mesh-list
92003142|NCT03419234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003143|NCT03419234|Glucocorticoids|glucocorticoids|mesh-ancestor
92003144|NCT03419234|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003145|NCT03419234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003146|NCT03419234|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003147|NCT03419234|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003148|NCT03419234|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92003149|NCT03419234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003150|NCT03419234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003151|NCT03419234|Hormone Antagonists|hormone antagonists|mesh-ancestor
92003152|NCT03419234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92003153|NCT03419234|Antioxidants|antioxidants|mesh-ancestor
92003154|NCT03419234|Protective Agents|protective agents|mesh-ancestor
92003155|NCT03419234|Vitamins|vitamins|mesh-ancestor
92003156|NCT03419234|Micronutrients|micronutrients|mesh-ancestor
92003157|NCT03419234|Estrogens|estrogens|mesh-ancestor
92003158|NCT03419234|Anabolic Agents|anabolic agents|mesh-ancestor
92003159|NCT03384914|Vaccines|vaccines|mesh-list
92003160|NCT03384914|Immunologic Factors|immunologic factors|mesh-list
92003161|NCT03384914|Immunomodulating Agents|immunomodulating agents|mesh-list
92003162|NCT03384914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003163|NCT03382561|Cisplatin|cisplatin|mesh-list
92003164|NCT03382561|Carboplatin|carboplatin|mesh-list
92003165|NCT03382561|Nivolumab|nivolumab|mesh-list
92003166|NCT03382561|Etoposide|etoposide|mesh-list
92003167|NCT03382561|Etoposide phosphate|etoposide phosphate|mesh-list
92003168|NCT03382561|Podophyllotoxin|podophyllotoxin|mesh-list
92003169|NCT03382561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003170|NCT03382561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003171|NCT03382561|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003172|NCT03382561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003173|NCT03382561|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003174|NCT03382561|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92003175|NCT03382561|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92003176|NCT03382561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003177|NCT03382561|Keratolytic Agents|keratolytic agents|mesh-ancestor
92003178|NCT03382561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92003179|NCT03382561|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003180|NCT03382561|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003181|NCT03382561|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003182|NCT03346135|Melphalan|melphalan|mesh-list
92003183|NCT03346135|Mechlorethamine|mechlorethamine|mesh-list
92003184|NCT03346135|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92003185|NCT03346135|Daratumumab|daratumumab|mesh-list
92003186|NCT03346135|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003187|NCT03346135|Alkylating Agents|alkylating agents|mesh-ancestor
92003188|NCT03346135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003189|NCT03346135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003190|NCT03346135|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92003191|NCT03346135|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970820|NCT04490681|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92003192|NCT03346135|Immunologic Factors|immunologic factors|mesh-ancestor
92003193|NCT03346135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003194|NCT03339128|Eluxadoline|eluxadoline|mesh-list
92003195|NCT03339128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92003196|NCT03337698|Linagliptin|linagliptin|mesh-list
92003197|NCT03337698|Bevacizumab|bevacizumab|mesh-list
92003198|NCT03337698|Atezolizumab|atezolizumab|mesh-list
92003199|NCT03337698|Carboplatin|carboplatin|mesh-list
92003202|NCT03337698|Pemetrexed|pemetrexed|mesh-list
92003203|NCT03337698|Ipatasertib|ipatasertib|mesh-list
92003204|NCT03337698|Evolocumab|evolocumab|mesh-list
92003205|NCT03337698|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92003206|NCT03337698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003207|NCT03337698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003208|NCT03337698|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003209|NCT03337698|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003210|NCT03337698|Growth Substances|growth substances|mesh-ancestor
92003211|NCT03337698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003212|NCT03337698|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003213|NCT03337698|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003214|NCT03337698|Antimetabolites|antimetabolites|mesh-ancestor
92003215|NCT03337698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003216|NCT03337698|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003217|NCT03337698|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003218|NCT03337698|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003219|NCT03337698|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003220|NCT03337698|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92003221|NCT03337698|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92003222|NCT03337698|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003223|NCT03337698|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92003224|NCT03337698|Incretins|incretins|mesh-ancestor
92003225|NCT03337698|Hormones|hormones|mesh-ancestor
92003226|NCT03337698|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970940|NCT02721875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003227|NCT03337698|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92003228|NCT03337698|Protease Inhibitors|protease inhibitors|mesh-ancestor
92003229|NCT03337698|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92003230|NCT03337698|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92003231|NCT03337698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92003232|NCT03337698|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92003233|NCT03337698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92003234|NCT03337698|Immunoconjugates|immunoconjugates|mesh-ancestor
92003235|NCT03337698|Immunologic Factors|immunologic factors|mesh-ancestor
92003236|NCT03337698|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003237|NCT03280563|Tamoxifen|tamoxifen|mesh-list
92003238|NCT03280563|Bevacizumab|bevacizumab|mesh-list
92003239|NCT03280563|Atezolizumab|atezolizumab|mesh-list
92003240|NCT03280563|Fulvestrant|fulvestrant|mesh-list
92003241|NCT03280563|Exemestane|exemestane|mesh-list
92003242|NCT03280563|Entinostat|entinostat|mesh-list
92003243|NCT03280563|Ipatasertib|ipatasertib|mesh-list
92003244|NCT03280563|Antibodies|antibodies|mesh-list
92003245|NCT03280563|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003246|NCT03280563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003247|NCT03280563|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003248|NCT03280563|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003249|NCT03280563|Growth Substances|growth substances|mesh-ancestor
92003250|NCT03280563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003251|NCT03280563|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003252|NCT03280563|Immunologic Factors|immunologic factors|mesh-ancestor
92003253|NCT03280563|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003254|NCT03280563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003255|NCT03280563|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92003256|NCT03280563|Hormone Antagonists|hormone antagonists|mesh-ancestor
92003257|NCT03280563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003258|NCT03280563|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003259|NCT03280563|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92003260|NCT03280563|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92003261|NCT03280563|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92003262|NCT03280563|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92003263|NCT03280563|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92003264|NCT03280563|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92003265|NCT03280563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970821|NCT04490681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970822|NCT04490681|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91970823|NCT04490681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970824|NCT03303209|Analgesics, Opioid|analgesics, opioid|mesh-list
91970825|NCT03303209|Narcotics|narcotics|mesh-ancestor
92090412|NCT00892606|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92003266|NCT03280563|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92003267|NCT03280563|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003268|NCT03267433|Rituximab|rituximab|mesh-list
92003269|NCT03267433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003270|NCT03267433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003271|NCT03267433|Immunologic Factors|immunologic factors|mesh-ancestor
92003272|NCT03267433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003273|NCT03267433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003274|NCT03238300|Acetylcysteine|acetylcysteine|mesh-list
92003275|NCT03238300|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92003276|NCT03238300|Antiviral Agents|antiviral agents|mesh-ancestor
92003277|NCT03238300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003278|NCT03238300|Expectorants|expectorants|mesh-ancestor
92003279|NCT03238300|Respiratory System Agents|respiratory system agents|mesh-ancestor
92003280|NCT03238300|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92003281|NCT03238300|Antioxidants|antioxidants|mesh-ancestor
92003282|NCT03238300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003283|NCT03238300|Protective Agents|protective agents|mesh-ancestor
92003284|NCT03238300|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003285|NCT03238300|Antidotes|antidotes|mesh-ancestor
92003286|NCT03215511|Selitrectinib|selitrectinib|mesh-list
92003287|NCT03215511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003288|NCT03215511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003290|NCT03214003|Etoposide|etoposide|mesh-list
92003291|NCT03214003|Etoposide phosphate|etoposide phosphate|mesh-list
92003292|NCT03214003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003293|NCT03214003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003294|NCT03214003|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92003295|NCT03214003|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92003296|NCT03214003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91970941|NCT02466503|Fluticasone|fluticasone|mesh-list
92003297|NCT03214003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003298|NCT03181100|Paclitaxel|paclitaxel|mesh-list
92003299|NCT03181100|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92003300|NCT03181100|Bevacizumab|bevacizumab|mesh-list
92003301|NCT03181100|Atezolizumab|atezolizumab|mesh-list
92003302|NCT03181100|Vemurafenib|vemurafenib|mesh-list
92003303|NCT03181100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92003304|NCT03181100|Endothelial Growth Factors|endothelial growth factors|mesh-list
92003305|NCT03181100|Antibodies|antibodies|mesh-list
92003306|NCT03181100|Immunoglobulins|immunoglobulins|mesh-list
92003307|NCT03181100|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92003308|NCT03181100|Immunoglobulin G|immunoglobulin g|mesh-list
92003309|NCT03181100|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003310|NCT03181100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003311|NCT03181100|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003312|NCT03181100|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003313|NCT03181100|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003314|NCT03181100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003315|NCT03181100|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003316|NCT03181100|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003317|NCT03181100|Growth Substances|growth substances|mesh-ancestor
92003318|NCT03181100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003319|NCT03181100|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003320|NCT03181100|Immunologic Factors|immunologic factors|mesh-ancestor
92003321|NCT03181100|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003322|NCT03181100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003323|NCT03181100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003324|NCT03180502|Temozolomide|temozolomide|mesh-list
92003325|NCT03180502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003326|NCT03180502|Alkylating Agents|alkylating agents|mesh-ancestor
92003327|NCT03180502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003328|NCT03180502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003329|NCT03160079|Pembrolizumab|pembrolizumab|mesh-list
91970826|NCT03303209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92003331|NCT03160079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003332|NCT03160079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003333|NCT03160079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003334|NCT03160079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003335|NCT03139370|Cyclophosphamide|cyclophosphamide|mesh-list
92003336|NCT03139370|Fludarabine|fludarabine|mesh-list
92003337|NCT03139370|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003338|NCT03139370|Immunologic Factors|immunologic factors|mesh-ancestor
92003339|NCT03139370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003340|NCT03139370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003341|NCT03139370|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003342|NCT03139370|Alkylating Agents|alkylating agents|mesh-ancestor
92003343|NCT03139370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003344|NCT03139370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003345|NCT03139370|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92003346|NCT03133221|Idelalisib|idelalisib|mesh-list
92003347|NCT03133221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003349|NCT03133221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003351|NCT03113500|Cortisone|cortisone|mesh-list
92003352|NCT03113500|Cyclophosphamide|cyclophosphamide|mesh-list
92003353|NCT03113500|Doxorubicin|doxorubicin|mesh-list
92003354|NCT03113500|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92003355|NCT03113500|Etoposide|etoposide|mesh-list
92003356|NCT03113500|Etoposide phosphate|etoposide phosphate|mesh-list
92003357|NCT03113500|Daunorubicin|daunorubicin|mesh-list
92003358|NCT03113500|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92003359|NCT03113500|Podophyllotoxin|podophyllotoxin|mesh-list
92003360|NCT03113500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92003361|NCT03113500|Antibodies|antibodies|mesh-list
92003362|NCT03113500|Immunoglobulins|immunoglobulins|mesh-list
92003363|NCT03113500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92003364|NCT03113500|Immunoconjugates|immunoconjugates|mesh-list
92003365|NCT03113500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003366|NCT03113500|Immunologic Factors|immunologic factors|mesh-ancestor
92003367|NCT03113500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003368|NCT03113500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003369|NCT03113500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003370|NCT03113500|Alkylating Agents|alkylating agents|mesh-ancestor
92003371|NCT03113500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003372|NCT03113500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003373|NCT03113500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91970942|NCT02466503|Xhance|xhance|mesh-list
92003374|NCT03113500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92003375|NCT03113500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92003376|NCT03113500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92003377|NCT03113500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003378|NCT03113500|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003379|NCT03113500|Glucocorticoids|glucocorticoids|mesh-ancestor
92003381|NCT03113500|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003382|NCT03113500|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003383|NCT03113500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003384|NCT03113500|Immunotoxins|immunotoxins|mesh-ancestor
92003385|NCT03113500|Keratolytic Agents|keratolytic agents|mesh-ancestor
92003386|NCT03113500|Dermatologic Agents|dermatologic agents|mesh-ancestor
92003387|NCT03113500|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003388|NCT03113500|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003389|NCT03113500|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003390|NCT03108131|Atezolizumab|atezolizumab|mesh-list
92003391|NCT03108131|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92003392|NCT03108131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003393|NCT03108131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003394|NCT03108131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003395|NCT03108131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003396|NCT03108131|Immunologic Factors|immunologic factors|mesh-ancestor
92003397|NCT03108131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003398|NCT03089203|Cyclophosphamide|cyclophosphamide|mesh-list
92003399|NCT03089203|Fludarabine|fludarabine|mesh-list
92003400|NCT03089203|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003401|NCT03089203|Immunologic Factors|immunologic factors|mesh-ancestor
92003402|NCT03089203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003403|NCT03089203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91970827|NCT03303209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970828|NCT03303209|Analgesics|analgesics|mesh-ancestor
91970829|NCT03303209|Sensory System Agents|sensory system agents|mesh-ancestor
91970830|NCT03303209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003404|NCT03089203|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003405|NCT03089203|Alkylating Agents|alkylating agents|mesh-ancestor
92003406|NCT03089203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003407|NCT03089203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003408|NCT03089203|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92003409|NCT03087071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92003412|NCT03087071|Antibodies|antibodies|mesh-list
92003413|NCT03087071|Immunoglobulins|immunoglobulins|mesh-list
92003414|NCT03087071|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92003415|NCT03087071|Immunologic Factors|immunologic factors|mesh-ancestor
92003416|NCT03087071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003417|NCT03087071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003418|NCT03087071|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003419|NCT03087071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003420|NCT03087071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003421|NCT03049540|Tadalafil|tadalafil|mesh-list
92003422|NCT03049540|Vasodilator Agents|vasodilator agents|mesh-ancestor
92003423|NCT03049540|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92003424|NCT03049540|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92003425|NCT03049540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003426|NCT03049540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003427|NCT03049540|Urological Agents|urological agents|mesh-ancestor
92003428|NCT03040596|Fluticasone|fluticasone|mesh-list
92003430|NCT03040596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003431|NCT03040596|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92003432|NCT03040596|Autonomic Agents|autonomic agents|mesh-ancestor
92003433|NCT03040596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003434|NCT03040596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003435|NCT03040596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92003436|NCT03040596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92003437|NCT03040596|Dermatologic Agents|dermatologic agents|mesh-ancestor
92003438|NCT03040596|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92003439|NCT03012880|Dexamethasone|dexamethasone|mesh-list
92003440|NCT03012880|Dexamethasone acetate|dexamethasone acetate|mesh-list
92003441|NCT03012880|Lenalidomide|lenalidomide|mesh-list
92003442|NCT03012880|Daratumumab|daratumumab|mesh-list
92003443|NCT03012880|Ixazomib|ixazomib|mesh-list
92003444|NCT03012880|Ichthammol|ichthammol|mesh-list
92003445|NCT03012880|BB 1101|bb 1101|mesh-list
92003446|NCT03012880|Glycine|glycine|mesh-list
92003447|NCT03012880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003448|NCT03012880|Antiemetics|antiemetics|mesh-ancestor
92003449|NCT03012880|Autonomic Agents|autonomic agents|mesh-ancestor
92003450|NCT03012880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003451|NCT03012880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003452|NCT03012880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92003453|NCT03012880|Glucocorticoids|glucocorticoids|mesh-ancestor
92003454|NCT03012880|Hormones|hormones|mesh-ancestor
92003455|NCT03012880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003456|NCT03012880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003457|NCT03012880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003458|NCT03012880|Immunologic Factors|immunologic factors|mesh-ancestor
92003459|NCT03012880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003460|NCT03012880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003461|NCT03012880|Growth Substances|growth substances|mesh-ancestor
92003462|NCT03012880|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003463|NCT03012880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003464|NCT03012880|Protease Inhibitors|protease inhibitors|mesh-ancestor
92003465|NCT03012880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003466|NCT03012880|Dermatologic Agents|dermatologic agents|mesh-ancestor
92003467|NCT03012880|Glycine Agents|glycine agents|mesh-ancestor
92003468|NCT03012880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92003469|NCT02999087|Cetuximab|cetuximab|mesh-list
92003470|NCT02999087|Avelumab|avelumab|mesh-list
92003471|NCT02999087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003472|NCT02999087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970832|NCT03303053|Cholestyramine Resin|cholestyramine resin|mesh-list
91970833|NCT03303053|Carbimazole|carbimazole|mesh-list
92003473|NCT02983461|Sildenafil Citrate|sildenafil citrate|mesh-list
92003474|NCT02983461|Vasodilator Agents|vasodilator agents|mesh-ancestor
92003475|NCT02983461|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92003476|NCT02983461|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92003477|NCT02983461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003478|NCT02983461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003479|NCT02983461|Urological Agents|urological agents|mesh-ancestor
92003480|NCT02936102|Spartalizumab|spartalizumab|mesh-list
92003481|NCT02936102|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003482|NCT02936102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003483|NCT02936102|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003484|NCT02936102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003485|NCT02927301|Atezolizumab|atezolizumab|mesh-list
92003486|NCT02927301|Antibodies|antibodies|mesh-list
92003487|NCT02927301|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92003488|NCT02927301|Immunologic Factors|immunologic factors|mesh-ancestor
92003489|NCT02927301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003490|NCT02927301|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003491|NCT02927301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003492|NCT02927301|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003493|NCT02927301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003495|NCT02924727|Ramipril|ramipril|mesh-list
92003496|NCT02924727|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92003497|NCT02924727|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92003500|NCT02924727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003501|NCT02924727|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92003502|NCT02924727|Protease Inhibitors|protease inhibitors|mesh-ancestor
92003503|NCT02924727|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003505|NCT02905110|Etoposide|etoposide|mesh-list
92003506|NCT02905110|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92003507|NCT02905110|Abortifacient Agents|abortifacient agents|mesh-ancestor
92003508|NCT02905110|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92003509|NCT02905110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003510|NCT02905110|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003511|NCT02905110|Antimetabolites|antimetabolites|mesh-ancestor
92003512|NCT02905110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003513|NCT02905110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003514|NCT02905110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92003515|NCT02905110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003516|NCT02905110|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92003517|NCT02905110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003518|NCT02905110|Immunologic Factors|immunologic factors|mesh-ancestor
92003519|NCT02905110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003520|NCT02905110|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92003521|NCT02905110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003522|NCT02905110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92003523|NCT02905110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92003524|NCT02798523|Methylprednisolone|methylprednisolone|mesh-list
92003525|NCT02798523|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92003526|NCT02798523|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92003527|NCT02798523|Prednisolone|prednisolone|mesh-list
92003528|NCT02798523|Prednisolone acetate|prednisolone acetate|mesh-list
92003529|NCT02798523|Methylprednisolone aceponate|methylprednisolone aceponate|mesh-list
92003530|NCT02798523|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92003531|NCT02798523|Prednisolone phosphate|prednisolone phosphate|mesh-list
92003532|NCT02798523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003534|NCT02798523|Autonomic Agents|autonomic agents|mesh-ancestor
92003535|NCT02798523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003536|NCT02798523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003537|NCT02798523|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92003538|NCT02798523|Glucocorticoids|glucocorticoids|mesh-ancestor
92003540|NCT02798523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003541|NCT02798523|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92003542|NCT02798523|Protective Agents|protective agents|mesh-ancestor
92003543|NCT02798523|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91970834|NCT03303053|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91970836|NCT03303053|Hormones|hormones|mesh-ancestor
91970837|NCT03303053|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91970838|NCT03303053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970839|NCT03303053|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91970840|NCT03303053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970841|NCT03303053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91970842|NCT03303053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91970843|NCT03303053|Antimetabolites|antimetabolites|mesh-ancestor
91970844|NCT03303053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970845|NCT03303053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91970846|NCT03303053|Antithyroid Agents|antithyroid agents|mesh-ancestor
91970847|NCT03303053|Hormone Antagonists|hormone antagonists|mesh-ancestor
91970848|NCT02467907|Paclitaxel|paclitaxel|mesh-list
91970849|NCT02467907|Bevacizumab|bevacizumab|mesh-list
91970850|NCT02467907|Carboplatin|carboplatin|mesh-list
91970851|NCT02467907|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91970852|NCT02467907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970853|NCT02467907|Tubulin Modulators|tubulin modulators|mesh-ancestor
91970854|NCT02467907|Antimitotic Agents|antimitotic agents|mesh-ancestor
91970855|NCT02467907|Mitosis Modulators|mitosis modulators|mesh-ancestor
91970856|NCT02467907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970857|NCT02467907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91970858|NCT02467907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91970859|NCT02467907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91970860|NCT02467907|Growth Substances|growth substances|mesh-ancestor
91970882|NCT03302351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91970883|NCT03302351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91970884|NCT03302351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970885|NCT03302351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91970886|NCT03302351|Analgesics|analgesics|mesh-ancestor
91970887|NCT03302351|Sensory System Agents|sensory system agents|mesh-ancestor
91970888|NCT03302351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970889|NCT03302351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91970890|NCT03302351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91970891|NCT03302351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91970892|NCT03302351|Adrenergic Agents|adrenergic agents|mesh-ancestor
91970893|NCT03302351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970894|NCT03302351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970895|NCT03302351|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91970896|NCT03302351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91970897|NCT03302351|Anesthetics, General|anesthetics, general|mesh-ancestor
91970898|NCT03302351|Anesthetics|anesthetics|mesh-ancestor
91970899|NCT03302351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91970900|NCT03302351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91970902|NCT05727683|Fludarabine|fludarabine|mesh-list
91970903|NCT05727683|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91970904|NCT05727683|Immunologic Factors|immunologic factors|mesh-ancestor
91970932|NCT03302039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91970933|NCT03302039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970934|NCT03302039|Protective Agents|protective agents|mesh-ancestor
91970935|NCT02721875|Azacitidine|azacitidine|mesh-list
91970936|NCT02721875|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91970937|NCT02721875|Antimetabolites|antimetabolites|mesh-ancestor
91970938|NCT02721875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91970939|NCT02721875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91970943|NCT02466503|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91970960|NCT03301181|Rifampin|rifampin|mesh-list
91970992|NCT03301025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91970993|NCT03301025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91970994|NCT03301025|Anticonvulsants|anticonvulsants|mesh-ancestor
91971064|NCT02467673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
91971065|NCT02467673|Progesterone|progesterone|mesh-list
91971066|NCT02467673|Estrogens|estrogens|mesh-ancestor
91971067|NCT02467673|Hormones|hormones|mesh-ancestor
91971068|NCT02467673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91971136|NCT05294055|Alkylating Agents|alkylating agents|mesh-ancestor
91971137|NCT05294055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971138|NCT05294055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971139|NCT05294055|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91971140|NCT05294055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91971141|NCT05294055|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91971142|NCT05294055|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971204|NCT04782687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971205|NCT04782687|Immunologic Factors|immunologic factors|mesh-ancestor
91971206|NCT04782687|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91971207|NCT04782687|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91971208|NCT04782687|Growth Substances|growth substances|mesh-ancestor
91971209|NCT04782687|Growth Inhibitors|growth inhibitors|mesh-ancestor
91971210|NCT05655689|Moxifloxacin|moxifloxacin|mesh-list
91971211|NCT05655689|Vancomycin|vancomycin|mesh-list
91971212|NCT05655689|Gentamicins|gentamicins|mesh-list
91971213|NCT05655689|Ceftazidime|ceftazidime|mesh-list
91971214|NCT05655689|Natamycin|natamycin|mesh-list
91971215|NCT05655689|Voriconazole|voriconazole|mesh-list
91971216|NCT05655689|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91971217|NCT05655689|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91971218|NCT05655689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91971219|NCT05655689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971220|NCT05655689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91971221|NCT05655689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971222|NCT05655689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971223|NCT05655689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971224|NCT05655689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971225|NCT05655689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971226|NCT05655689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91971227|NCT05655689|Antifungal Agents|antifungal agents|mesh-ancestor
91971228|NCT05655689|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91971252|NCT02466347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971253|NCT03067935|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
91971254|NCT03067935|Immunoconjugates|immunoconjugates|mesh-ancestor
91971255|NCT03067935|Immunologic Factors|immunologic factors|mesh-ancestor
91971256|NCT03067935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971257|NCT03067935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971258|NCT03067935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971259|NCT02466191|Gabapentin|gabapentin|mesh-list
91971319|NCT05546411|Antidotes|antidotes|mesh-ancestor
91971320|NCT05546411|Protective Agents|protective agents|mesh-ancestor
91971321|NCT05546411|Vitamin B Complex|vitamin b complex|mesh-ancestor
91971322|NCT05546411|Vitamins|vitamins|mesh-ancestor
91971323|NCT05546411|Micronutrients|micronutrients|mesh-ancestor
91971324|NCT05546411|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91971388|NCT04552197|Tofacitinib|tofacitinib|mesh-list
91971389|NCT04552197|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91971390|NCT04552197|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91971391|NCT04552197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971396|NCT05244473|Immunotoxins|immunotoxins|mesh-ancestor
91971460|NCT04562597|Acetylcysteine|acetylcysteine|mesh-list
91971461|NCT04562597|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91971462|NCT04562597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971463|NCT04562597|Antiviral Agents|antiviral agents|mesh-ancestor
91971464|NCT04562597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91971465|NCT04562597|Expectorants|expectorants|mesh-ancestor
91971466|NCT04562597|Respiratory System Agents|respiratory system agents|mesh-ancestor
91971467|NCT04562597|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91971468|NCT04562597|Antioxidants|antioxidants|mesh-ancestor
91971527|NCT05582031|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971528|NCT05582031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971530|NCT04424225|Psilocybin|psilocybin|mesh-list
91971531|NCT04424225|Vitamins|vitamins|mesh-ancestor
91971532|NCT04424225|Micronutrients|micronutrients|mesh-ancestor
91971533|NCT04424225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971534|NCT04424225|Vitamin B Complex|vitamin b complex|mesh-ancestor
91971535|NCT04424225|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91971536|NCT04424225|Antimetabolites|antimetabolites|mesh-ancestor
91971537|NCT04424225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971538|NCT04424225|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91971539|NCT04424225|Vasodilator Agents|vasodilator agents|mesh-ancestor
91971540|NCT04424225|Hallucinogens|hallucinogens|mesh-ancestor
91971541|NCT04424225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91971542|NCT05581719|Nivolumab|nivolumab|mesh-list
91971543|NCT05581719|Tislelizumab|tislelizumab|mesh-list
91971544|NCT05581719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91971545|NCT05581719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971546|NCT05581719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91971547|NCT05581719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971583|NCT02465645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91971584|NCT02465645|Vasodilator Agents|vasodilator agents|mesh-ancestor
91971585|NCT02465645|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91971586|NCT02465645|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91971587|NCT05565495|Hydromorphone|hydromorphone|mesh-list
91971588|NCT05565495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91971589|NCT05565495|Narcotics|narcotics|mesh-ancestor
91971590|NCT05565495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91971591|NCT05565495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971592|NCT05565495|Analgesics|analgesics|mesh-ancestor
91971593|NCT05565495|Sensory System Agents|sensory system agents|mesh-ancestor
91971647|NCT02465255|Tramadol|tramadol|mesh-list
91971648|NCT02465255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91971649|NCT02465255|Analgesics|analgesics|mesh-ancestor
91971650|NCT02465255|Sensory System Agents|sensory system agents|mesh-ancestor
91971651|NCT02465255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91971652|NCT02465255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971653|NCT02465255|Antipyretics|antipyretics|mesh-ancestor
91971654|NCT02465255|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91971655|NCT02465255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91971656|NCT02465255|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91971785|NCT04072835|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91971786|NCT04072835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971787|NCT04083963|Paclitaxel|paclitaxel|mesh-list
91971788|NCT04083963|Cyclophosphamide|cyclophosphamide|mesh-list
91971789|NCT04083963|Carboplatin|carboplatin|mesh-list
91971790|NCT04083963|Doxorubicin|doxorubicin|mesh-list
91971791|NCT04083963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91971792|NCT04083963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971793|NCT04083963|Tubulin Modulators|tubulin modulators|mesh-ancestor
91971794|NCT04083963|Antimitotic Agents|antimitotic agents|mesh-ancestor
91971795|NCT04083963|Mitosis Modulators|mitosis modulators|mesh-ancestor
91971796|NCT04083963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971797|NCT04083963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91971798|NCT04083963|Immunologic Factors|immunologic factors|mesh-ancestor
91971799|NCT04083963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971844|NCT03922139|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91971845|NCT03922139|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91971846|NCT03922139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971847|NCT03922139|Cholinergic Agents|cholinergic agents|mesh-ancestor
91971915|NCT03719313|Interferons|interferons|mesh-list
91971916|NCT03719313|Ritonavir|ritonavir|mesh-list
91971917|NCT03719313|Interferon-alpha|interferon-alpha|mesh-list
91971918|NCT03719313|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
91971989|NCT04436913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91971990|NCT02487095|Topotecan|topotecan|mesh-list
91971991|NCT02487095|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91971992|NCT02487095|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91971993|NCT02487095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91971994|NCT02487095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91971995|NCT02487095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91971996|NCT03837899|Durvalumab|durvalumab|mesh-list
91971997|NCT03837899|Tremelimumab|tremelimumab|mesh-list
91971998|NCT03837899|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91971999|NCT03837899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972000|NCT03837899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972001|NCT03837899|Immunologic Factors|immunologic factors|mesh-ancestor
91972002|NCT03837899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972003|NCT03756077|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
91972004|NCT03756077|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91972005|NCT03756077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972006|NCT03742193|Apatinib|apatinib|mesh-list
91972046|NCT02461121|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91972047|NCT02461121|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91972048|NCT02461121|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91972049|NCT02461121|Antitubercular Agents|antitubercular agents|mesh-ancestor
91972050|NCT02461121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972051|NCT00701363|Lanreotide|lanreotide|mesh-list
91972052|NCT00701363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972053|NCT02461043|Paclitaxel|paclitaxel|mesh-list
91972115|NCT01670877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972116|NCT01670877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972187|NCT01670721|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91972188|NCT01670721|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91972189|NCT01670721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972190|NCT01670721|Antidotes|antidotes|mesh-ancestor
91972191|NCT01670721|Protective Agents|protective agents|mesh-ancestor
91972192|NCT01670721|Vitamin B Complex|vitamin b complex|mesh-ancestor
91972258|NCT03290495|Anesthetics, General|anesthetics, general|mesh-ancestor
91972259|NCT03290495|Anesthetics|anesthetics|mesh-ancestor
91972260|NCT03290495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91972261|NCT03290495|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91972329|NCT03294551|Immunologic Factors|immunologic factors|mesh-ancestor
91972404|NCT03289637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91972405|NCT04854837|Remdesivir|remdesivir|mesh-list
91972406|NCT04854837|Antimetabolites|antimetabolites|mesh-ancestor
91972407|NCT04854837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972408|NCT04854837|Antiviral Agents|antiviral agents|mesh-ancestor
91972475|NCT04971759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91972476|NCT04971759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91972477|NCT04971759|Anesthetics, General|anesthetics, general|mesh-ancestor
91972478|NCT04971759|Anesthetics|anesthetics|mesh-ancestor
91972479|NCT04971759|Anesthetics, Local|anesthetics, local|mesh-ancestor
91972489|NCT04979091|Hormones|hormones|mesh-list
91972620|NCT03291821|Hormones|hormones|mesh-ancestor
91972621|NCT03291821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91972622|NCT03291821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972623|NCT03291821|Luteolytic Agents|luteolytic agents|mesh-ancestor
91972624|NCT03291821|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91972625|NCT03291821|Contraceptive Agents|contraceptive agents|mesh-ancestor
91972626|NCT03291821|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91972627|NCT03291821|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91972628|NCT03291821|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91972629|NCT03291821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972630|NCT03291821|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91972631|NCT03291821|Fertility Agents|fertility agents|mesh-ancestor
91972632|NCT03291821|Hormone Antagonists|hormone antagonists|mesh-ancestor
91972633|NCT02448901|Edoxaban|edoxaban|mesh-list
91972634|NCT02448901|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91972635|NCT02448901|Antithrombins|antithrombins|mesh-ancestor
91972636|NCT02448901|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91972637|NCT02448901|Protease Inhibitors|protease inhibitors|mesh-ancestor
91972638|NCT02448901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91972639|NCT02448901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972640|NCT02448901|Anticoagulants|anticoagulants|mesh-ancestor
91972641|NCT03291353|Pembrolizumab|pembrolizumab|mesh-list
91972671|NCT02460107|Botulinum Toxins|botulinum toxins|mesh-list
91972672|NCT02460107|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91972743|NCT05179603|Pembrolizumab|pembrolizumab|mesh-list
91972744|NCT05179603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91972745|NCT05179603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972746|NCT05179603|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91972747|NCT05179603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91972749|NCT03284645|Lamivudine|lamivudine|mesh-list
91972750|NCT03284645|Zidovudine|zidovudine|mesh-list
91972810|NCT03281681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91972811|NCT02444611|Vaccines|vaccines|mesh-list
91972812|NCT02444611|BCG Vaccine|bcg vaccine|mesh-list
91972813|NCT02444611|Immunologic Factors|immunologic factors|mesh-ancestor
91972814|NCT02444611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91972882|NCT04432233|Metronidazole|metronidazole|mesh-list
91972883|NCT04432233|Levofloxacin|levofloxacin|mesh-list
91972884|NCT04432233|Esomeprazole|esomeprazole|mesh-list
91972885|NCT04432233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91972886|NCT04432233|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91972887|NCT04432233|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91972888|NCT04432233|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91972950|NCT03989609|Anesthetics|anesthetics|mesh-ancestor
91972951|NCT03989609|GABA Modulators|gaba modulators|mesh-ancestor
91973022|NCT03277391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973023|NCT03277391|Analgesics|analgesics|mesh-ancestor
91973024|NCT03277391|Sensory System Agents|sensory system agents|mesh-ancestor
91973025|NCT03277391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973026|NCT03277391|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91973027|NCT03277391|Antiemetics|antiemetics|mesh-ancestor
91973028|NCT03277391|Autonomic Agents|autonomic agents|mesh-ancestor
91973029|NCT03277391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91973030|NCT03277391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91973031|NCT03277391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91973086|NCT03267329|Telmisartan|telmisartan|mesh-list
91973087|NCT03267329|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91973088|NCT03267329|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
91973157|NCT02458781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91973158|NCT04647383|Lemborexant|lemborexant|mesh-list
91973159|NCT04647383|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
91973166|NCT02458157|Furosemide|furosemide|mesh-list
91973227|NCT02456129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973228|NCT02456129|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91973229|NCT02456129|Hormone Antagonists|hormone antagonists|mesh-ancestor
91973230|NCT02456129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973294|NCT04976829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91973295|NCT03263039|Pembrolizumab|pembrolizumab|mesh-list
91973296|NCT03263039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91973297|NCT03263039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973365|NCT04975971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91973366|NCT04975971|Antiemetics|antiemetics|mesh-ancestor
91973367|NCT04975971|Autonomic Agents|autonomic agents|mesh-ancestor
91973435|NCT03059979|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91973436|NCT03059979|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91973440|NCT03256721|Docetaxel|docetaxel|mesh-list
91973508|NCT03060681|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91973509|NCT03060681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973510|NCT03060681|Sensory System Agents|sensory system agents|mesh-ancestor
91973511|NCT03060681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91973513|NCT04967469|Alfacalcidol|alfacalcidol|mesh-list
91973514|NCT04967469|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
91973515|NCT04967469|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91973516|NCT04967469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973517|NCT04967469|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
91973518|NCT04967469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973519|NCT04967469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973538|NCT04432155|Xenon|xenon|mesh-list
91973569|NCT04963257|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91973570|NCT04963257|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91973571|NCT04963257|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91973572|NCT04963257|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91973573|NCT04963257|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91973574|NCT04963257|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91973576|NCT04963257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973636|NCT03059667|Carboplatin|carboplatin|mesh-list
91973637|NCT03059667|Etoposide|etoposide|mesh-list
91973638|NCT03059667|Atezolizumab|atezolizumab|mesh-list
91973639|NCT03059667|Topotecan|topotecan|mesh-list
91973640|NCT03059667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91973641|NCT03059667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91973642|NCT03059667|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91973643|NCT03059667|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91973644|NCT03059667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973705|NCT04964583|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91973706|NCT04964583|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91973707|NCT04964583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91973708|NCT04964583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91973709|NCT04964583|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91973710|NCT03251417|Irinotecan|irinotecan|mesh-list
91973711|NCT03251417|Apatinib|apatinib|mesh-list
91973712|NCT03251417|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91973713|NCT03251417|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91973718|NCT04961931|Empagliflozin|empagliflozin|mesh-list
91973768|NCT04951713|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91973769|NCT04951713|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91973770|NCT04951713|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91973771|NCT04951713|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91973772|NCT04951713|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91973836|NCT00700817|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91973838|NCT00700817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91973839|NCT00700817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91973840|NCT00700817|Incretins|incretins|mesh-ancestor
91973906|NCT03250481|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91973907|NCT03250481|Narcotics|narcotics|mesh-ancestor
91973983|NCT04947189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974055|NCT04938297|Lenalidomide|lenalidomide|mesh-list
91974056|NCT04938297|Zanubrutinib|zanubrutinib|mesh-list
91974057|NCT04938297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974058|NCT04938297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974059|NCT04938297|Immunologic Factors|immunologic factors|mesh-ancestor
91974060|NCT04938297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974061|NCT04938297|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91974062|NCT04938297|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974063|NCT04938297|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91974064|NCT04938297|Growth Substances|growth substances|mesh-ancestor
91974065|NCT04938297|Growth Inhibitors|growth inhibitors|mesh-ancestor
91974066|NCT04938297|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974067|NCT04938297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974069|NCT04937907|Hydroxychloroquine|hydroxychloroquine|mesh-list
91974116|NCT04937673|Mitosis Modulators|mitosis modulators|mesh-ancestor
91974117|NCT04937673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974118|NCT04944381|Vaccines|vaccines|mesh-list
91974119|NCT04944381|Immunologic Factors|immunologic factors|mesh-ancestor
91974120|NCT04944381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974121|NCT03245177|Pembrolizumab|pembrolizumab|mesh-list
91974123|NCT03245177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974186|NCT04487093|Vaccines|vaccines|mesh-list
91974187|NCT04487093|Immunologic Factors|immunologic factors|mesh-ancestor
91974188|NCT04487093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974189|NCT04936971|Mycophenolic Acid|mycophenolic acid|mesh-list
91974190|NCT04936971|Everolimus|everolimus|mesh-list
91974191|NCT04936971|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91974192|NCT04936971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91974193|NCT04936971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974194|NCT04936971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974195|NCT04936971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91974196|NCT04936971|Immunologic Factors|immunologic factors|mesh-ancestor
91974197|NCT04936971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974198|NCT04936971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974199|NCT04936971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91974200|NCT04936971|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91974201|NCT04936971|Antitubercular Agents|antitubercular agents|mesh-ancestor
91974202|NCT04936971|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91974203|NCT04936971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91974204|NCT04931433|Lidocaine|lidocaine|mesh-list
91974205|NCT04931433|Anesthetics, Local|anesthetics, local|mesh-ancestor
91974241|NCT02453867|Immunologic Factors|immunologic factors|mesh-ancestor
91974242|NCT02453867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974243|NCT02453867|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91974312|NCT05387681|Endostatins|endostatins|mesh-list
91974313|NCT05387681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974314|NCT05387681|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91974315|NCT05387681|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91974384|NCT03235973|Alkylating Agents|alkylating agents|mesh-ancestor
91974385|NCT03235973|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91974386|NCT03235973|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91974388|NCT02453087|Obinutuzumab|obinutuzumab|mesh-list
91974389|NCT02453087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974390|NCT02453087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974453|NCT03057015|Respiratory System Agents|respiratory system agents|mesh-ancestor
91974454|NCT03057015|Mydriatics|mydriatics|mesh-ancestor
91974455|NCT03057015|Sympathomimetics|sympathomimetics|mesh-ancestor
91974469|NCT03057483|Vaccines|vaccines|mesh-list
91974526|NCT04920669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974527|NCT04920669|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91974528|NCT04920669|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91974529|NCT04920669|Analgesics|analgesics|mesh-ancestor
91974536|NCT04926753|Fluorouracil|fluorouracil|mesh-list
91974595|NCT04924647|Antiemetics|antiemetics|mesh-ancestor
91974596|NCT04924647|Autonomic Agents|autonomic agents|mesh-ancestor
91974597|NCT04924647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974667|NCT04918953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91974668|NCT04918953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91974669|NCT04918953|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974670|NCT04918953|Glucocorticoids|glucocorticoids|mesh-ancestor
91974672|NCT04918953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91974673|NCT04918953|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91974674|NCT04918953|Protective Agents|protective agents|mesh-ancestor
91974675|NCT04918953|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91974676|NCT04918953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91974677|NCT04918953|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91974678|NCT04918953|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91974679|NCT04918953|Respiratory System Agents|respiratory system agents|mesh-ancestor
91974680|NCT02123134|Deoxycholic Acid|deoxycholic acid|mesh-list
91974681|NCT02123134|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
91974682|NCT02123134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974684|NCT03054207|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
91974721|NCT02157376|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91974722|NCT02157376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91974723|NCT02157376|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91974724|NCT02157376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91974793|NCT04916925|Vitamin D|vitamin d|mesh-list
91974868|NCT04900311|Mitosis Modulators|mitosis modulators|mesh-ancestor
91974869|NCT04900311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974870|NCT04900311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91974871|NCT04900155|Atorvastatin|atorvastatin|mesh-list
91974872|NCT04900155|Ezetimibe|ezetimibe|mesh-list
91974873|NCT04900155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91974880|NCT02155738|Acetaminophen|acetaminophen|mesh-list
91974935|NCT03051555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91974936|NCT04898751|Pembrolizumab|pembrolizumab|mesh-list
91975010|NCT03051243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975011|NCT04897737|Tenofovir|tenofovir|mesh-list
91975012|NCT04897737|Antiviral Agents|antiviral agents|mesh-ancestor
91975013|NCT04897737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91975014|NCT04897737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91975080|NCT04430361|Megestrol|megestrol|mesh-list
91975081|NCT04430361|Megestrol Acetate|megestrol acetate|mesh-list
91975082|NCT04430361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91975083|NCT04430361|Antiemetics|antiemetics|mesh-ancestor
91975084|NCT04430361|Autonomic Agents|autonomic agents|mesh-ancestor
91975085|NCT04430361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975146|NCT04397991|Furosemide|furosemide|mesh-list
91975147|NCT04397991|Diuretics|diuretics|mesh-ancestor
91975148|NCT04397991|Natriuretic Agents|natriuretic agents|mesh-ancestor
91975149|NCT04397991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975150|NCT04397991|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91975151|NCT04397991|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91975152|NCT04397991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975153|NCT04906161|Vitamin D|vitamin d|mesh-list
91975154|NCT04906161|Calcium|calcium|mesh-list
91975155|NCT04906161|Vitamins|vitamins|mesh-ancestor
91975156|NCT04906161|Micronutrients|micronutrients|mesh-ancestor
91975157|NCT04906161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975158|NCT04906161|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91975161|NCT03051009|Hemostatics|hemostatics|mesh-ancestor
91975207|NCT04882683|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91975208|NCT04882683|Antimetabolites|antimetabolites|mesh-ancestor
91975209|NCT04882683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975216|NCT04753372|Aspirin|aspirin|mesh-list
91975277|NCT04879407|Rivaroxaban|rivaroxaban|mesh-list
91975278|NCT04879407|Anticoagulants|anticoagulants|mesh-ancestor
91975279|NCT04879407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91975280|NCT04879407|Antithrombins|antithrombins|mesh-ancestor
91975281|NCT04879407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91975282|NCT04879407|Protease Inhibitors|protease inhibitors|mesh-ancestor
91975350|NCT01595529|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91975351|NCT01595529|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91975352|NCT01595529|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91975353|NCT01595529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081627|NCT01392963|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91975354|NCT01595529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975355|NCT01595529|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91975415|NCT05256147|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91975416|NCT05256147|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91975417|NCT05256147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975418|NCT05256147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975484|NCT04876521|Antidepressive Agents|antidepressive agents|mesh-ancestor
91975485|NCT04876521|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
91975486|NCT04876521|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91975487|NCT04876521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975488|NCT04876521|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91975489|NCT04876521|Dopamine Agents|dopamine agents|mesh-ancestor
91975490|NCT02119156|Belimumab|belimumab|mesh-list
91975491|NCT02119156|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91975492|NCT02119156|Immunologic Factors|immunologic factors|mesh-ancestor
91975493|NCT02119156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975494|NCT02181556|Aflibercept|aflibercept|mesh-list
91975495|NCT02181556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91975496|NCT02181556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91975497|NCT02181556|Growth Substances|growth substances|mesh-ancestor
91975498|NCT02181556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975499|NCT02181556|Growth Inhibitors|growth inhibitors|mesh-ancestor
91975500|NCT02181556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975501|NCT04865991|Propofol|propofol|mesh-list
91975502|NCT04865991|Sevoflurane|sevoflurane|mesh-list
91975508|NCT04865991|Anesthetics|anesthetics|mesh-ancestor
91975539|NCT04864977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975541|NCT03046173|Mitosis Modulators|mitosis modulators|mesh-ancestor
91975542|NCT03046173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975543|NCT04869579|Selenium|selenium|mesh-list
91975544|NCT04869579|Selenious Acid|selenious acid|mesh-list
91975545|NCT04869579|Antioxidants|antioxidants|mesh-ancestor
91975547|NCT04869579|Protective Agents|protective agents|mesh-ancestor
91975608|NCT04875039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975609|NCT04875039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975610|NCT04875039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975611|NCT04875039|Protease Inhibitors|protease inhibitors|mesh-ancestor
91975681|NCT01594749|Autonomic Agents|autonomic agents|mesh-ancestor
91975682|NCT01594749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975683|NCT01594749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975684|NCT01594749|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91975685|NCT01594749|Glucocorticoids|glucocorticoids|mesh-ancestor
91975686|NCT01594749|Hormones|hormones|mesh-ancestor
91975687|NCT01594749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975688|NCT01594749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91975689|NCT01594749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975690|NCT01594749|Protease Inhibitors|protease inhibitors|mesh-ancestor
91975691|NCT01594749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975692|NCT01594749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975693|NCT01594749|Antipruritics|antipruritics|mesh-ancestor
91975694|NCT01594749|Dermatologic Agents|dermatologic agents|mesh-ancestor
91975739|NCT03234413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975741|NCT03234413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91975742|NCT04380753|Sotorasib|sotorasib|mesh-list
91975743|NCT04380753|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91975744|NCT04380753|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975745|NCT04380753|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975749|NCT02453009|Prednisone|prednisone|mesh-list
91975805|NCT04863105|Hormone Antagonists|hormone antagonists|mesh-ancestor
91975806|NCT04863105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975807|NCT04863105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91975808|NCT04863105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91975809|NCT02179918|Pembrolizumab|pembrolizumab|mesh-list
91975810|NCT02179918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91975811|NCT02179918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975812|NCT02179918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91975813|NCT02179918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975814|NCT03233321|Heparin|heparin|mesh-list
91975815|NCT03233321|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91975816|NCT03233321|Tinzaparin|tinzaparin|mesh-list
91975817|NCT03233321|Dalteparin|dalteparin|mesh-list
91975818|NCT03233321|Anticoagulants|anticoagulants|mesh-ancestor
91975819|NCT03233321|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91975820|NCT03233321|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91975821|NCT03233321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975822|NCT04868253|Oxazepam|oxazepam|mesh-list
91975823|NCT04868253|Metyrapone|metyrapone|mesh-list
91975861|NCT04862091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91975862|NCT04862091|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91975863|NCT04862091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91975864|NCT04862091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91975865|NCT04862091|Hormone Antagonists|hormone antagonists|mesh-ancestor
91975866|NCT04862091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91975929|NCT04873479|Sensory System Agents|sensory system agents|mesh-ancestor
91975935|NCT04873479|Anesthetics|anesthetics|mesh-ancestor
91976004|NCT03222089|Interleukin-2|interleukin-2|mesh-list
91976005|NCT03222089|Molgramostim|molgramostim|mesh-list
91976006|NCT03222089|Sargramostim|sargramostim|mesh-list
91976007|NCT03222089|Levoleucovorin|levoleucovorin|mesh-list
91976008|NCT03222089|Antimetabolites|antimetabolites|mesh-ancestor
91976009|NCT03222089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976019|NCT03222089|Analgesics|analgesics|mesh-ancestor
91976075|NCT03221231|Antioxidants|antioxidants|mesh-ancestor
91976076|NCT03221231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976077|NCT03221231|Protective Agents|protective agents|mesh-ancestor
91976078|NCT03221231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976079|NCT03221231|Antidotes|antidotes|mesh-ancestor
91976080|NCT03221621|Adalimumab|adalimumab|mesh-list
91976081|NCT03221621|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91976082|NCT03221621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976083|NCT03221621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976084|NCT03220841|Adalimumab|adalimumab|mesh-list
91976085|NCT03220841|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91976086|NCT03220841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976087|NCT03220841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976088|NCT03045393|Maytansine|maytansine|mesh-list
91976137|NCT02451293|Melatonin|melatonin|mesh-list
91976138|NCT02451293|Antioxidants|antioxidants|mesh-ancestor
91976139|NCT02451293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976140|NCT02451293|Protective Agents|protective agents|mesh-ancestor
91976141|NCT02451293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976142|NCT02451293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91976282|NCT03209219|Interferon-alpha|interferon-alpha|mesh-list
91976283|NCT03209219|Interferon alpha-2|interferon alpha-2|mesh-list
91976353|NCT01594827|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91976354|NCT01594827|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91976355|NCT01594827|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91976356|NCT01594827|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91976357|NCT01594827|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91976422|NCT01598896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91976423|NCT01598896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976424|NCT01598896|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91976425|NCT01598896|Sympatholytics|sympatholytics|mesh-ancestor
91976495|NCT04860219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976571|NCT03206957|Angiogenesis Inducing Agents|angiogenesis inducing agents|mesh-list
91976572|NCT03206957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976573|NCT03206957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91976574|NCT03206957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91976641|NCT03038607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976642|NCT03038607|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91976643|NCT03038607|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976644|NCT03038607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91976712|NCT03040167|Autonomic Agents|autonomic agents|mesh-ancestor
91976713|NCT03040167|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91976714|NCT03040167|Respiratory System Agents|respiratory system agents|mesh-ancestor
91976715|NCT03040167|Mydriatics|mydriatics|mesh-ancestor
91976716|NCT03040167|Sympathomimetics|sympathomimetics|mesh-ancestor
91976717|NCT03040167|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91976718|NCT04843839|Nepafenac|nepafenac|mesh-list
91976719|NCT04843839|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91976777|NCT04843449|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91976778|NCT04843449|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
91976779|NCT04843449|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
91976780|NCT04843449|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91976781|NCT04843449|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91976783|NCT03037593|Cholecalciferol|cholecalciferol|mesh-list
91976784|NCT03037593|Vitamins|vitamins|mesh-ancestor
91976785|NCT03037593|Micronutrients|micronutrients|mesh-ancestor
91976786|NCT03037593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976787|NCT03037593|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91976788|NCT03037593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91976789|NCT03037515|Tranexamic Acid|tranexamic acid|mesh-list
91976790|NCT03037515|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91976791|NCT03037515|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91976792|NCT03037515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976834|NCT04842435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976835|NCT04774419|Dostarlimab|dostarlimab|mesh-list
91976836|NCT04774419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976837|NCT02607735|Sofosbuvir|sofosbuvir|mesh-list
91976838|NCT02607735|Velpatasvir|velpatasvir|mesh-list
91976839|NCT02607735|Antiviral Agents|antiviral agents|mesh-ancestor
91976840|NCT02607735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976841|NCT04772313|Methotrexate|methotrexate|mesh-list
91976842|NCT04772313|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91976843|NCT04772313|Abortifacient Agents|abortifacient agents|mesh-ancestor
91976844|NCT04772313|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91976845|NCT04772313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91976846|NCT04772313|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91976847|NCT04772313|Antimetabolites|antimetabolites|mesh-ancestor
91976848|NCT04772313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976849|NCT04772313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976850|NCT04772313|Dermatologic Agents|dermatologic agents|mesh-ancestor
91976851|NCT04772313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976852|NCT04772313|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91976853|NCT04772313|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91976854|NCT04772313|Immunologic Factors|immunologic factors|mesh-ancestor
91976855|NCT04772313|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91976856|NCT04772313|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91976858|NCT03040791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91976859|NCT03040791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91976860|NCT03040791|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003544|NCT02798523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003545|NCT02797977|Gemcitabine|gemcitabine|mesh-list
92003546|NCT02797977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003547|NCT02797977|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003548|NCT02797977|Antimetabolites|antimetabolites|mesh-ancestor
92003549|NCT02797977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003550|NCT02772588|Leuprolide|leuprolide|mesh-list
92003551|NCT02772588|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92003552|NCT02772588|Fertility Agents|fertility agents|mesh-ancestor
92003553|NCT02772588|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92003554|NCT02772588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003555|NCT02772588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003556|NCT02772588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003557|NCT02766582|Paclitaxel|paclitaxel|mesh-list
92003558|NCT02766582|Carboplatin|carboplatin|mesh-list
92003559|NCT02766582|Pembrolizumab|pembrolizumab|mesh-list
92003560|NCT02766582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003561|NCT02766582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003562|NCT02766582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003563|NCT02766582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003564|NCT02766582|Mitosis Modulators|mitosis modulators|mesh-ancestor
91976861|NCT03040791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976863|NCT04428879|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91976864|NCT04428879|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91976865|NCT04428879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91976866|NCT04428879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91976928|NCT04834791|Hormone Antagonists|hormone antagonists|mesh-ancestor
91976929|NCT04834791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91976996|NCT04851015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91976997|NCT04851015|Antimalarials|antimalarials|mesh-ancestor
91976998|NCT04851015|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91976999|NCT04851015|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91977000|NCT04851015|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91977066|NCT04850001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977067|NCT03036111|Trimebutine|trimebutine|mesh-list
91977068|NCT03036111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91977069|NCT03036111|Parasympatholytics|parasympatholytics|mesh-ancestor
91977070|NCT03036111|Autonomic Agents|autonomic agents|mesh-ancestor
91977071|NCT03036111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977135|NCT04821765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91977136|NCT04821765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977137|NCT04821765|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977138|NCT04821765|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977139|NCT04821765|Mitosis Modulators|mitosis modulators|mesh-ancestor
91977140|NCT04821765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977141|NCT04821765|Immunologic Factors|immunologic factors|mesh-ancestor
91977142|NCT04821765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977143|NCT04829097|Temozolomide|temozolomide|mesh-list
91977144|NCT04829097|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91977145|NCT04829097|Alkylating Agents|alkylating agents|mesh-ancestor
91977146|NCT04829097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977195|NCT04820751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977196|NCT04820751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977197|NCT04820751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977198|NCT04820751|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91977199|NCT04820751|Serotonin Agents|serotonin agents|mesh-ancestor
91977265|NCT04826679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977267|NCT02601573|Sofosbuvir|sofosbuvir|mesh-list
91977268|NCT02601573|Grazoprevir|grazoprevir|mesh-list
91977269|NCT02601573|Antimetabolites|antimetabolites|mesh-ancestor
91977270|NCT02601573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977271|NCT02601573|Antiviral Agents|antiviral agents|mesh-ancestor
91977272|NCT02601573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977273|NCT04818723|Montelukast|montelukast|mesh-list
91977274|NCT04818723|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91977275|NCT04818723|Respiratory System Agents|respiratory system agents|mesh-ancestor
91977276|NCT04818723|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91977277|NCT04818723|Hormone Antagonists|hormone antagonists|mesh-ancestor
91977278|NCT04818723|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977279|NCT04818723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977280|NCT04818723|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91977281|NCT04818723|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91977283|NCT02601027|Acetaminophen|acetaminophen|mesh-list
91977321|NCT02600871|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91977322|NCT02600871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977323|NCT04817865|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91977324|NCT04817865|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977325|NCT04818099|Vortioxetine|vortioxetine|mesh-list
91977326|NCT04818099|Antidepressive Agents|antidepressive agents|mesh-ancestor
91977327|NCT04818099|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91977328|NCT04818099|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91977329|NCT04818099|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91977330|NCT04818099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977331|NCT04818099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977332|NCT04818099|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91977333|NCT04818099|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91977334|NCT04818099|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977335|NCT04818099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977336|NCT04818099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91977337|NCT04818099|Serotonin Agents|serotonin agents|mesh-ancestor
91977338|NCT04818099|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
91977344|NCT04357899|Antimetabolites|antimetabolites|mesh-ancestor
91977373|NCT04356729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977374|NCT04356729|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91977375|NCT04356729|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91977376|NCT04356729|Growth Substances|growth substances|mesh-ancestor
91977377|NCT04356729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977378|NCT04356729|Growth Inhibitors|growth inhibitors|mesh-ancestor
91977379|NCT04356729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91977380|NCT04356729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977381|NCT04807335|Sufentanil|sufentanil|mesh-list
91977382|NCT04807335|Ketamine|ketamine|mesh-list
91977383|NCT04807335|Analgesics|analgesics|mesh-ancestor
91977384|NCT04807335|Sensory System Agents|sensory system agents|mesh-ancestor
91977388|NCT04807335|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91977434|NCT04811313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977435|NCT04811313|Hemostatics|hemostatics|mesh-ancestor
91977436|NCT04811313|Coagulants|coagulants|mesh-ancestor
91977504|NCT02597049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
91977505|NCT02597049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91977506|NCT02597049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977507|NCT02597049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977508|NCT04809675|Salicylic Acid|salicylic acid|mesh-list
91977509|NCT04809675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91977510|NCT04809675|Antifungal Agents|antifungal agents|mesh-ancestor
91977511|NCT04809675|Keratolytic Agents|keratolytic agents|mesh-ancestor
91977512|NCT04809675|Dermatologic Agents|dermatologic agents|mesh-ancestor
91977513|NCT04802967|Ketoprofen|ketoprofen|mesh-list
91977514|NCT04802967|Ketoprofen lysine|ketoprofen lysine|mesh-list
91977515|NCT04802967|Gabapentin|gabapentin|mesh-list
91977516|NCT04802967|Analgesics|analgesics|mesh-ancestor
91977517|NCT04802967|Sensory System Agents|sensory system agents|mesh-ancestor
91977518|NCT04802967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977519|NCT04802967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977520|NCT04802967|Anticonvulsants|anticonvulsants|mesh-ancestor
91977521|NCT04802967|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91977522|NCT04802967|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91977523|NCT04802967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977560|NCT03206411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91977561|NCT03206411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977562|NCT03206021|Carboplatin|carboplatin|mesh-list
91977563|NCT03206021|Azacitidine|azacitidine|mesh-list
91977564|NCT03206021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91977565|NCT03206021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91977566|NCT03206021|Antimetabolites|antimetabolites|mesh-ancestor
91977567|NCT03206021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977568|NCT03206021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91977569|NCT03200561|Prednisolone|prednisolone|mesh-list
91977570|NCT03200561|Immunoglobulins|immunoglobulins|mesh-list
91977572|NCT03200561|Antibodies|antibodies|mesh-list
91977623|NCT02596971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91977624|NCT02596971|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91977697|NCT03202979|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91977698|NCT03202979|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91977699|NCT03202979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91977700|NCT03202979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977701|NCT03202979|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91977702|NCT03202979|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91977703|NCT03202979|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91977704|NCT03202979|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91977705|NCT03202979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91977844|NCT04389411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91977845|NCT04389411|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91977848|NCT02448251|Abivertinib|abivertinib|mesh-list
91977915|NCT04338399|Tubulin Modulators|tubulin modulators|mesh-ancestor
91977916|NCT04338399|Antimitotic Agents|antimitotic agents|mesh-ancestor
91977987|NCT02446301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91977988|NCT04791345|Dexamethasone|dexamethasone|mesh-list
91977989|NCT04791345|Dexamethasone acetate|dexamethasone acetate|mesh-list
91977990|NCT04791345|Methylprednisolone|methylprednisolone|mesh-list
91977991|NCT04791345|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91977993|NCT04791345|Prednisolone|prednisolone|mesh-list
91978059|NCT02445599|Midazolam|midazolam|mesh-list
91978060|NCT02445599|Tramadol|tramadol|mesh-list
91978061|NCT02445599|Nalbuphine|nalbuphine|mesh-list
91978062|NCT02445599|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91978063|NCT02445599|Narcotics|narcotics|mesh-ancestor
91978064|NCT02445599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978131|NCT04790487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978132|NCT04790487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978133|NCT04790487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978134|NCT04790487|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91978137|NCT04790331|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91978200|NCT03229889|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91978201|NCT03229889|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91978202|NCT03229889|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91978203|NCT03229889|Adrenergic Agents|adrenergic agents|mesh-ancestor
91978204|NCT03229889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978205|NCT03229889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978206|NCT02444585|Denosumab|denosumab|mesh-list
91978207|NCT02444585|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91978208|NCT02444585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978209|NCT03120221|Iodine|iodine|mesh-list
91978210|NCT03120221|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91978211|NCT03120221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978212|NCT03120221|Trace Elements|trace elements|mesh-ancestor
91978213|NCT03120221|Micronutrients|micronutrients|mesh-ancestor
91978214|NCT03120221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978215|NCT03193073|Mitogens|mitogens|mesh-list
91978216|NCT03193073|Mitosis Modulators|mitosis modulators|mesh-ancestor
91978217|NCT03193073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978231|NCT02444507|Esomeprazole|esomeprazole|mesh-list
91978266|NCT01626118|Gout Suppressants|gout suppressants|mesh-ancestor
91978267|NCT01626118|Tocolytic Agents|tocolytic agents|mesh-ancestor
91978268|NCT01626118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978269|NCT01626118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91978270|NCT01626118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91978271|NCT01626118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978272|NCT04789005|Phenylephrine|phenylephrine|mesh-list
91978273|NCT04789005|Oxymetazoline|oxymetazoline|mesh-list
91978274|NCT04789005|Norepinephrine|norepinephrine|mesh-list
91978275|NCT04789005|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
91978276|NCT04789005|Mydriatics|mydriatics|mesh-ancestor
91978277|NCT04789005|Autonomic Agents|autonomic agents|mesh-ancestor
91978278|NCT04789005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978280|NCT04789005|Sympathomimetics|sympathomimetics|mesh-ancestor
91978330|NCT05474937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91978331|NCT05474937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91978332|NCT05474937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978333|NCT05474937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978334|NCT05474937|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91978335|NCT05474937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91978336|NCT05474937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91978337|NCT05474937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91978338|NCT05474937|GABA Modulators|gaba modulators|mesh-ancestor
91978339|NCT05474937|GABA Agents|gaba agents|mesh-ancestor
91978340|NCT05474937|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91978402|NCT02116660|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91978403|NCT02116660|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91978473|NCT05612451|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91978474|NCT05612451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978475|NCT05612451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91978476|NCT02151682|Morphine|morphine|mesh-list
91978477|NCT02151682|Tapentadol|tapentadol|mesh-list
91978478|NCT02151682|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91978479|NCT02151682|Narcotics|narcotics|mesh-ancestor
91978480|NCT02151682|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978481|NCT02151682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978482|NCT02151682|Analgesics|analgesics|mesh-ancestor
91978483|NCT02151682|Sensory System Agents|sensory system agents|mesh-ancestor
91978484|NCT02151682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91978485|NCT02151682|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91978486|NCT02151682|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91978487|NCT02151682|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978488|NCT02151682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91978526|NCT05304273|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91978527|NCT05304273|Contraceptive Agents|contraceptive agents|mesh-ancestor
91978528|NCT05304273|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
91978529|NCT05304273|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91978530|NCT05304273|Luteolytic Agents|luteolytic agents|mesh-ancestor
91978596|NCT02115256|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91978597|NCT02115256|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91978598|NCT02115256|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91978599|NCT02115256|Adrenergic Agents|adrenergic agents|mesh-ancestor
91978600|NCT02115256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91978666|NCT03397953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91978667|NCT03397953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978669|NCT03397953|Antimitotic Agents|antimitotic agents|mesh-ancestor
91978737|NCT02367105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978738|NCT02153229|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
91978739|NCT02153229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91978811|NCT05553717|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91978812|NCT05553717|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91978813|NCT05553717|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91978814|NCT05553717|Vasodilator Agents|vasodilator agents|mesh-ancestor
91978815|NCT05553717|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
91978816|NCT05553717|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91978817|NCT02147158|Ulipristal acetate|ulipristal acetate|mesh-list
91978818|NCT02147158|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91978819|NCT02147158|Contraceptive Agents|contraceptive agents|mesh-ancestor
91978820|NCT02147158|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91978821|NCT02147158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978822|NCT02147158|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91978823|NCT05553093|Insulin|insulin|mesh-list
91978824|NCT05553093|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91978872|NCT02112448|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
91978874|NCT02112448|Analgesics|analgesics|mesh-ancestor
91978947|NCT02142712|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91978948|NCT02142712|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91978949|NCT02142712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91978950|NCT02142712|Anesthetics, Local|anesthetics, local|mesh-ancestor
91978951|NCT02142712|Anesthetics|anesthetics|mesh-ancestor
91978952|NCT02142712|Sensory System Agents|sensory system agents|mesh-ancestor
91978953|NCT02142712|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979017|NCT02141620|Anesthetics, Local|anesthetics, local|mesh-ancestor
91979018|NCT02141620|Anesthetics|anesthetics|mesh-ancestor
91979019|NCT02141620|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979020|NCT02141620|Sensory System Agents|sensory system agents|mesh-ancestor
91979021|NCT02141620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979022|NCT02141620|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91979023|NCT02141620|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91979024|NCT02141620|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91979025|NCT02141620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979026|NCT02141620|Dopamine Agents|dopamine agents|mesh-ancestor
91979027|NCT02141620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979028|NCT01664949|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
91979029|NCT01664949|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91979030|NCT01664949|Lubricant Eye Drops|lubricant eye drops|mesh-list
91979031|NCT01664949|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91979074|NCT05552391|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91979075|NCT05552391|Adrenergic Agents|adrenergic agents|mesh-ancestor
91979076|NCT05552391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91979077|NCT05552391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979078|NCT05552391|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91979079|NCT05552391|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91979080|NCT05552391|Anesthetics, General|anesthetics, general|mesh-ancestor
91979081|NCT05552391|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91979082|NCT05552391|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91979083|NCT02106442|Risedronic Acid|risedronic acid|mesh-list
91979084|NCT02106442|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91979085|NCT02106442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979086|NCT02106442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979087|NCT02106442|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91979088|NCT02106442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979089|NCT02106442|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91979090|NCT04740814|Certolizumab Pegol|certolizumab pegol|mesh-list
91979128|NCT05547789|Sensory System Agents|sensory system agents|mesh-ancestor
91979129|NCT05547789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979130|NCT05547789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979197|NCT05546853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979198|NCT05546853|Antidotes|antidotes|mesh-ancestor
91979199|NCT05546853|Protective Agents|protective agents|mesh-ancestor
91979200|NCT05546853|Vitamin B Complex|vitamin b complex|mesh-ancestor
91979202|NCT05546853|Micronutrients|micronutrients|mesh-ancestor
91979268|NCT01666119|Narcotics|narcotics|mesh-ancestor
91979269|NCT01666119|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979270|NCT01666119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979271|NCT01666119|Analgesics|analgesics|mesh-ancestor
91979272|NCT01666119|Sensory System Agents|sensory system agents|mesh-ancestor
91979273|NCT01666119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979274|NCT01666119|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91979275|NCT05361993|Aripiprazole|aripiprazole|mesh-list
91979276|NCT05361993|Antidepressive Agents|antidepressive agents|mesh-ancestor
91979277|NCT05361993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91979278|NCT05361993|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91979279|NCT05361993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91979280|NCT05361993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91979281|NCT05361993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979325|NCT05545059|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
91979326|NCT05128773|Tamoxifen|tamoxifen|mesh-list
91979328|NCT05128773|Hormone Antagonists|hormone antagonists|mesh-ancestor
91979329|NCT05128773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979330|NCT05128773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979331|NCT05128773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979332|NCT05128773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979333|NCT05128773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91979334|NCT05128773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91979335|NCT05128773|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91979336|NCT05536011|Sodium Oxybate|sodium oxybate|mesh-list
91979337|NCT05536011|Methylphenidate|methylphenidate|mesh-list
91979338|NCT05536011|Modafinil|modafinil|mesh-list
91979339|NCT05536011|Amphetamine|amphetamine|mesh-list
91979340|NCT05536011|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91979341|NCT05536011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979342|NCT05536011|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
91979343|NCT05536011|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91979359|NCT05536011|Anesthetics|anesthetics|mesh-ancestor
91980589|NCT02428751|Rituximab|rituximab|mesh-list
91979378|NCT04677855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979379|NCT04677855|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
91979380|NCT04677855|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91979381|NCT04677855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979382|NCT04677855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979383|NCT04677855|Hormone Antagonists|hormone antagonists|mesh-ancestor
91979385|NCT02584959|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
91979386|NCT02584959|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
91979387|NCT02584959|Immunologic Factors|immunologic factors|mesh-ancestor
91979388|NCT02584959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979389|NCT02584959|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91979390|NCT02584959|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91979391|NCT05544045|Calcium Carbonate|calcium carbonate|mesh-list
91979392|NCT05544045|Antacids|antacids|mesh-ancestor
91979393|NCT05544045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979394|NCT05544045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91979395|NCT02584257|Albuterol|albuterol|mesh-list
91979396|NCT02584257|Procaterol|procaterol|mesh-list
91979397|NCT02584257|Methacholine Chloride|methacholine chloride|mesh-list
91979398|NCT02584257|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91979399|NCT02584257|Autonomic Agents|autonomic agents|mesh-ancestor
91979400|NCT02584257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979401|NCT02584257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979402|NCT02584257|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91979403|NCT02584257|Respiratory System Agents|respiratory system agents|mesh-ancestor
91979404|NCT02584257|Tocolytic Agents|tocolytic agents|mesh-ancestor
91979425|NCT04062201|Linezolid|linezolid|mesh-list
91979426|NCT04062201|Pyrazinamide|pyrazinamide|mesh-list
91979427|NCT04062201|Ethambutol|ethambutol|mesh-list
91979428|NCT04062201|Bedaquiline|bedaquiline|mesh-list
91979429|NCT04062201|Clofazimine|clofazimine|mesh-list
91979430|NCT04062201|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91979431|NCT04062201|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979432|NCT04062201|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91979433|NCT04062201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91979434|NCT04062201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91979435|NCT04062201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979490|NCT05390307|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979561|NCT03808025|Sensory System Agents|sensory system agents|mesh-ancestor
91979562|NCT03808025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91979563|NCT03009201|Doxorubicin|doxorubicin|mesh-list
91979564|NCT03009201|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91979565|NCT03009201|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91979566|NCT03009201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979567|NCT03009201|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91979568|NCT03009201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91979569|NCT03009201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979570|NCT03009201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979571|NCT00591227|Insulin|insulin|mesh-list
91979572|NCT00591227|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91979573|NCT00591227|Insulin Aspart|insulin aspart|mesh-list
91979574|NCT00591227|Insulin Detemir|insulin detemir|mesh-list
91979575|NCT00591227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91979576|NCT00591227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979577|NCT00408473|Flecainide|flecainide|mesh-list
91979578|NCT00408473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91979579|NCT00408473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91979580|NCT00408473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91979581|NCT00408473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979582|NCT00408473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979583|NCT00328601|Thioctic Acid|thioctic acid|mesh-list
91979584|NCT00328601|Antioxidants|antioxidants|mesh-ancestor
91979585|NCT00328601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979586|NCT00328601|Protective Agents|protective agents|mesh-ancestor
91979587|NCT00328601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979588|NCT00328601|Vitamin B Complex|vitamin b complex|mesh-ancestor
91979589|NCT00328601|Vitamins|vitamins|mesh-ancestor
91979606|NCT02581995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979607|NCT03193307|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
91979608|NCT03193307|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
91979609|NCT03193307|BI 409306|bi 409306|mesh-list
91979610|NCT03193307|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91979672|NCT03471611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91979673|NCT03471611|Immunologic Factors|immunologic factors|mesh-ancestor
91979674|NCT03471611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979675|NCT05694819|Goserelin|goserelin|mesh-list
91979676|NCT05694819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91979677|NCT05694819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979678|NCT02600897|Rituximab|rituximab|mesh-list
91979679|NCT02600897|Obinutuzumab|obinutuzumab|mesh-list
91979680|NCT02600897|Lenalidomide|lenalidomide|mesh-list
91979681|NCT02600897|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
91979682|NCT02600897|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979683|NCT02600897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979738|NCT03192371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91979740|NCT02709785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91979741|NCT02709785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91979742|NCT02709785|Disinfectants|disinfectants|mesh-ancestor
91979743|NCT05663073|Amlodipine|amlodipine|mesh-list
91979744|NCT05663073|Irbesartan|irbesartan|mesh-list
91979745|NCT05663073|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91979746|NCT05663073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91979747|NCT05663073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91979748|NCT05663073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979749|NCT05663073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91979799|NCT03189953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91979801|NCT02204085|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91979802|NCT02204085|Antimetabolites|antimetabolites|mesh-ancestor
91979803|NCT02204085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91979804|NCT02204085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91979805|NCT02204085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91979806|NCT04314843|Lenzilumab|lenzilumab|mesh-list
91979807|NCT04314843|Cyclophosphamide|cyclophosphamide|mesh-list
91979808|NCT04314843|Fludarabine|fludarabine|mesh-list
91979809|NCT04314843|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
91979821|NCT03192293|Metformin|metformin|mesh-list
91979861|NCT04483427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91979862|NCT04483427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91979863|NCT04483427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91979933|NCT03192059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91979934|NCT03192059|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91979935|NCT03192059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91980005|NCT05530395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980006|NCT05389995|Potassium Citrate|potassium citrate|mesh-list
91980007|NCT05389995|Methamphetamine|methamphetamine|mesh-list
91980008|NCT05389995|Citric Acid|citric acid|mesh-list
91980009|NCT05389995|Sodium Citrate|sodium citrate|mesh-list
91980010|NCT05389995|Anticoagulants|anticoagulants|mesh-ancestor
91980011|NCT05389995|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91980012|NCT05389995|Chelating Agents|chelating agents|mesh-ancestor
91980013|NCT05389995|Sequestering Agents|sequestering agents|mesh-ancestor
91980014|NCT05389995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980015|NCT05389995|Diuretics|diuretics|mesh-ancestor
91980016|NCT05389995|Natriuretic Agents|natriuretic agents|mesh-ancestor
91980040|NCT03191903|Hormones|hormones|mesh-ancestor
91980068|NCT05529927|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91980069|NCT05529927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980070|NCT05529927|Dopamine Agents|dopamine agents|mesh-ancestor
91980071|NCT05529927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980073|NCT02437721|Vitamin B Complex|vitamin b complex|mesh-list
91980074|NCT02437721|Hematinics|hematinics|mesh-ancestor
91980075|NCT02437721|Vitamins|vitamins|mesh-ancestor
91980076|NCT02437721|Micronutrients|micronutrients|mesh-ancestor
91980077|NCT02437721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980078|NCT02437565|Salicylic Acid|salicylic acid|mesh-list
91980079|NCT02437565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980080|NCT02437565|Antifungal Agents|antifungal agents|mesh-ancestor
91980081|NCT02437565|Keratolytic Agents|keratolytic agents|mesh-ancestor
91980082|NCT02437565|Dermatologic Agents|dermatologic agents|mesh-ancestor
91980083|NCT05533983|Nivolumab|nivolumab|mesh-list
91980084|NCT05533983|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91980085|NCT05533983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980086|NCT05533983|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91980087|NCT05533983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980088|NCT02436395|Povidone-Iodine|povidone-iodine|mesh-list
91980089|NCT02436395|Povidone|povidone|mesh-list
91980090|NCT02436395|Plasma Substitutes|plasma substitutes|mesh-ancestor
91980091|NCT02436395|Blood Substitutes|blood substitutes|mesh-ancestor
91980092|NCT02436395|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91980093|NCT02436395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980094|NCT02436083|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91980095|NCT02436083|Cefuroxime|cefuroxime|mesh-list
91980096|NCT02436083|Cefuroxime axetil|cefuroxime axetil|mesh-list
91980097|NCT02436083|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980098|NCT03117335|Endostatins|endostatins|mesh-list
91980099|NCT03117335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980100|NCT03117335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91980101|NCT03117335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91980102|NCT03117335|Growth Substances|growth substances|mesh-ancestor
91980103|NCT03117335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980104|NCT03117335|Growth Inhibitors|growth inhibitors|mesh-ancestor
91980105|NCT02435927|Leucovorin|leucovorin|mesh-list
91980106|NCT02435927|Fluorouracil|fluorouracil|mesh-list
92003565|NCT02766582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980107|NCT02435927|Capecitabine|capecitabine|mesh-list
91980108|NCT02435927|Oxaliplatin|oxaliplatin|mesh-list
91980109|NCT02435927|Antimetabolites|antimetabolites|mesh-ancestor
91980111|NCT02435927|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91980178|NCT02576067|Abortifacient Agents|abortifacient agents|mesh-ancestor
91980179|NCT02576067|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91980248|NCT03188471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980249|NCT03188471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980250|NCT03188471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980251|NCT03188471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91980252|NCT03188471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91980320|NCT05192889|Antimetabolites|antimetabolites|mesh-ancestor
91980321|NCT05192889|Dermatologic Agents|dermatologic agents|mesh-ancestor
91980322|NCT05192889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980323|NCT05192889|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91980324|NCT05192889|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91980328|NCT05192889|Antiviral Agents|antiviral agents|mesh-ancestor
91980394|NCT05532267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980395|NCT05532267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980396|NCT05532267|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91980397|NCT05532267|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91980398|NCT05532267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980399|NCT05532267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980400|NCT05532267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980401|NCT05532267|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91980402|NCT05532267|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91980403|NCT03187457|Metronidazole|metronidazole|mesh-list
91980404|NCT03187457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980405|NCT03187457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91980406|NCT03187457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91980407|NCT03187457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91980408|NCT03187223|Melphalan|melphalan|mesh-list
91980409|NCT03187223|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
91980410|NCT03187223|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91980418|NCT05532111|Cyclophosphamide|cyclophosphamide|mesh-list
91980448|NCT02433587|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980449|NCT02433587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980450|NCT02433587|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980451|NCT02433587|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980452|NCT02433587|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91980453|NCT02433587|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91980454|NCT02433587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980455|NCT02433587|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91980456|NCT02433587|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91980457|NCT02433587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980459|NCT02433587|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91980460|NCT02433587|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91980461|NCT02433587|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91980462|NCT02433587|Purinergic Agents|purinergic agents|mesh-ancestor
91980463|NCT02433587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980505|NCT02433041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980506|NCT02433041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980576|NCT03186053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980578|NCT02429219|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91980579|NCT02429219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980580|NCT02429219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91980581|NCT02429219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980582|NCT02429531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
91980583|NCT02429531|Immunologic Factors|immunologic factors|mesh-ancestor
91980584|NCT02429531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980586|NCT02429453|Hemostatics|hemostatics|mesh-ancestor
91980587|NCT02429453|Coagulants|coagulants|mesh-ancestor
91980588|NCT02428751|Prednisone|prednisone|mesh-list
91980590|NCT02428751|Doxorubicin|doxorubicin|mesh-list
91980591|NCT02428751|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
91980592|NCT02428751|Vincristine|vincristine|mesh-list
91980593|NCT02428751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91980594|NCT02428751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980595|NCT02428751|Immunologic Factors|immunologic factors|mesh-ancestor
91980596|NCT02428751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980597|NCT02428751|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980598|NCT02428751|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91980599|NCT02428751|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91980600|NCT02428751|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91980601|NCT02428751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980626|NCT02707757|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
91980627|NCT02707757|Hematinics|hematinics|mesh-ancestor
91980628|NCT02432339|Mycophenolic Acid|mycophenolic acid|mesh-list
91980629|NCT02432339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91980630|NCT02432339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980631|NCT02432339|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91980632|NCT02432339|Antitubercular Agents|antitubercular agents|mesh-ancestor
91980697|NCT05518383|Dermatologic Agents|dermatologic agents|mesh-ancestor
91980698|NCT05518383|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91980699|NCT05518383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91980700|NCT05518383|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91980701|NCT05518383|Antiviral Agents|antiviral agents|mesh-ancestor
91980702|NCT05518383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91980703|NCT05518383|Tubulin Modulators|tubulin modulators|mesh-ancestor
91980704|NCT05518383|Antimitotic Agents|antimitotic agents|mesh-ancestor
91980705|NCT05518383|Mitosis Modulators|mitosis modulators|mesh-ancestor
91980706|NCT02432027|Betamethasone|betamethasone|mesh-list
91980707|NCT02432027|Calcipotriene|calcipotriene|mesh-list
91980708|NCT02432027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980709|NCT02432027|Glucocorticoids|glucocorticoids|mesh-ancestor
91980710|NCT02432027|Hormones|hormones|mesh-ancestor
91980711|NCT02432027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91980755|NCT03186443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91980756|NCT03186443|Antimanic Agents|antimanic agents|mesh-ancestor
91980757|NCT03186131|Vitamin D|vitamin d|mesh-list
91980758|NCT03186131|Ibandronic Acid|ibandronic acid|mesh-list
91980759|NCT03186131|Vitamins|vitamins|mesh-ancestor
91980760|NCT03186131|Micronutrients|micronutrients|mesh-ancestor
91980761|NCT03186131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980764|NCT03184649|Ibuprofen|ibuprofen|mesh-list
91980826|NCT03184493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91980827|NCT03184493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91980828|NCT03184493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980829|NCT03184493|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91980830|NCT03184493|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91980831|NCT03184493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980832|NCT03184493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980833|NCT02431403|Imatinib Mesylate|imatinib mesylate|mesh-list
91980834|NCT02431403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980835|NCT02431403|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91980836|NCT02431403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91980837|NCT02431403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91980838|NCT02431325|Teduglutide|teduglutide|mesh-list
91980839|NCT02431325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91980840|NCT02431325|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
91980841|NCT02431325|Protective Agents|protective agents|mesh-ancestor
91980842|NCT02431325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980843|NCT03184103|Complement System Proteins|complement system proteins|mesh-list
91980844|NCT03184103|Antistreptolysin|antistreptolysin|mesh-list
91980845|NCT03184103|Immunologic Factors|immunologic factors|mesh-ancestor
91980847|NCT02103478|Decitabine|decitabine|mesh-list
91980878|NCT03185429|Cyclophosphamide|cyclophosphamide|mesh-list
91980879|NCT03185429|Immunologic Factors|immunologic factors|mesh-ancestor
91980880|NCT03185429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91980881|NCT03185429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91980882|NCT03185429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91980883|NCT03185429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91980884|NCT03185429|Alkylating Agents|alkylating agents|mesh-ancestor
91980886|NCT03185429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91980944|NCT02426723|Dexamethasone|dexamethasone|mesh-list
91980945|NCT02426723|Lenalidomide|lenalidomide|mesh-list
91980946|NCT02426723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981012|NCT02426099|Antihypertensive Agents|antihypertensive agents|mesh-list
91981013|NCT02426099|Spironolactone|spironolactone|mesh-list
91981015|NCT02426099|Hormone Antagonists|hormone antagonists|mesh-ancestor
91981085|NCT02424695|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91981086|NCT02424695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91981087|NCT02424695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91981088|NCT02424695|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91981155|NCT03181685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91981156|NCT03181685|Hormone Antagonists|hormone antagonists|mesh-ancestor
91981157|NCT02424071|Melatonin|melatonin|mesh-list
91981158|NCT02424071|Antioxidants|antioxidants|mesh-ancestor
91981159|NCT02424071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981160|NCT02424071|Protective Agents|protective agents|mesh-ancestor
91981225|NCT02140060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981227|NCT03178721|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91981228|NCT03178721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981229|NCT02421029|Calcium, Dietary|calcium, dietary|mesh-list
91981296|NCT04725994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981297|NCT04725994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981298|NCT02139046|Naproxen|naproxen|mesh-list
91981299|NCT02139046|Colchicine|colchicine|mesh-list
91981367|NCT02100124|Contraceptive Agents|contraceptive agents|mesh-list
91981368|NCT02100124|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91981369|NCT02100124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981370|NCT02046616|Methotrexate|methotrexate|mesh-list
91981371|NCT02046616|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91981435|NCT05516589|Tubulin Modulators|tubulin modulators|mesh-ancestor
91981436|NCT05516589|Antimitotic Agents|antimitotic agents|mesh-ancestor
91981437|NCT05516589|Mitosis Modulators|mitosis modulators|mesh-ancestor
91981438|NCT05516589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981439|NCT05516589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981440|NCT05516589|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91981503|NCT05511831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981504|NCT05511831|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91981505|NCT02705105|Nivolumab|nivolumab|mesh-list
91981506|NCT02705105|Mogamulizumab|mogamulizumab|mesh-list
91981507|NCT02705105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91981508|NCT02705105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981509|NCT02705105|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91981510|NCT02705105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981511|NCT05521347|Caffeine|caffeine|mesh-list
91981512|NCT05521347|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91981513|NCT05521347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981514|NCT05521347|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91981515|NCT05521347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981516|NCT05521347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981519|NCT05521347|Purinergic Agents|purinergic agents|mesh-ancestor
91981561|NCT01623310|Xhance|xhance|mesh-list
91981562|NCT01623310|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981563|NCT01623310|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91981632|NCT02097238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981633|NCT02097238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981634|NCT03179813|Hydrocortisone|hydrocortisone|mesh-list
91981635|NCT03179813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91981636|NCT03179735|Cetylpyridinium|cetylpyridinium|mesh-list
91981637|NCT03179735|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91981638|NCT03179735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981640|NCT02419859|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91981641|NCT02419859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91981642|NCT02419859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981643|NCT02419391|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
91981644|NCT02419391|Antiviral Agents|antiviral agents|mesh-ancestor
91981645|NCT02419391|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91981693|NCT02422199|Capecitabine|capecitabine|mesh-list
91981695|NCT02422199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91981696|NCT02422199|Antimetabolites|antimetabolites|mesh-ancestor
91981697|NCT02422199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981698|NCT02422199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981699|NCT02422199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91981765|NCT02415803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91981767|NCT04482881|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
91981838|NCT02415179|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91981839|NCT02415179|Adrenergic Agents|adrenergic agents|mesh-ancestor
91981840|NCT02415179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91981841|NCT02415179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91981842|NCT02415179|Glucocorticoids|glucocorticoids|mesh-ancestor
91981909|NCT02046070|Hormones|hormones|mesh-ancestor
91981910|NCT02046070|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91981911|NCT02046070|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91981912|NCT02046070|Protease Inhibitors|protease inhibitors|mesh-ancestor
91981913|NCT02046070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91981914|NCT01663857|Carboplatin|carboplatin|mesh-list
91981915|NCT01663857|Gemcitabine|gemcitabine|mesh-list
91981916|NCT01663857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91981977|NCT02414009|Vitamins|vitamins|mesh-ancestor
91981978|NCT02414009|Micronutrients|micronutrients|mesh-ancestor
91981979|NCT02414009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91981980|NCT02414009|Alkylating Agents|alkylating agents|mesh-ancestor
91981981|NCT02413853|Leucovorin|leucovorin|mesh-list
91981982|NCT02413853|Bevacizumab|bevacizumab|mesh-list
91981983|NCT02413853|Fluorouracil|fluorouracil|mesh-list
91982050|NCT02412683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982053|NCT02569437|Fluticasone|fluticasone|mesh-list
91982054|NCT02569437|Doxycycline|doxycycline|mesh-list
91982055|NCT02569437|Methylprednisolone|methylprednisolone|mesh-list
91982056|NCT02569437|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
91982124|NCT03175679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982125|NCT03175679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982193|NCT02411903|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91982194|NCT02411903|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91982266|NCT02410031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
91982267|NCT02410031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91982268|NCT02410031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91982338|NCT02408705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982339|NCT02408705|Antipyretics|antipyretics|mesh-ancestor
91982410|NCT03174041|Antimetabolites|antimetabolites|mesh-ancestor
91982411|NCT03174041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91982412|NCT03174041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91982413|NCT03174041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982414|NCT03174041|Antifungal Agents|antifungal agents|mesh-ancestor
91982415|NCT03174041|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91982416|NCT03174041|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91982477|NCT03172871|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91982478|NCT03172871|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91982479|NCT03172871|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982480|NCT03172871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982481|NCT03172871|Dopamine Agonists|dopamine agonists|mesh-ancestor
91982544|NCT03116087|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91982545|NCT03116087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982546|NCT03116087|Anabolic Agents|anabolic agents|mesh-ancestor
91982547|NCT02701985|Petesicatib|petesicatib|mesh-list
91982548|NCT02701985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982549|NCT02701985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982550|NCT02406521|Sorafenib|sorafenib|mesh-list
91982551|NCT02406521|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
91982552|NCT02406521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982554|NCT02406521|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982609|NCT04742283|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91982610|NCT04742283|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91982611|NCT04742283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982612|NCT04742283|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91982613|NCT04742283|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91982614|NCT04742283|Adrenergic Agents|adrenergic agents|mesh-ancestor
91982615|NCT04742283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982616|NCT04742283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982617|NCT04742283|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91982618|NCT04742283|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91982619|NCT04289805|Letrozole|letrozole|mesh-list
91982620|NCT04289805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982621|NCT04289805|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91982622|NCT04289805|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91982623|NCT04289805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982624|NCT04289805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982625|NCT04289805|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91982626|NCT04289805|Hormone Antagonists|hormone antagonists|mesh-ancestor
91982661|NCT02565381|Nicotine|nicotine|mesh-list
91982662|NCT02565381|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
91982663|NCT02565381|Autonomic Agents|autonomic agents|mesh-ancestor
91982664|NCT02565381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982665|NCT02565381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982666|NCT02565381|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91982667|NCT02565381|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
91982671|NCT02063854|Risedronic Acid|risedronic acid|mesh-list
91982728|NCT05504967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91982729|NCT05504967|Anesthetics, Local|anesthetics, local|mesh-ancestor
91982731|NCT05504967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91982732|NCT05504967|Sensory System Agents|sensory system agents|mesh-ancestor
91982733|NCT02565147|Heparin|heparin|mesh-list
91982734|NCT02565147|Bivalirudin|bivalirudin|mesh-list
91982735|NCT02565147|Anticoagulants|anticoagulants|mesh-ancestor
91982736|NCT02565147|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91982737|NCT02565147|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91982738|NCT02565147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982739|NCT02565147|Antithrombins|antithrombins|mesh-ancestor
91982740|NCT02565147|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91982741|NCT02565147|Protease Inhibitors|protease inhibitors|mesh-ancestor
91982742|NCT02565147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91982743|NCT02061280|Fluticasone|fluticasone|mesh-list
91982744|NCT02061280|Xhance|xhance|mesh-list
91982745|NCT02061280|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91982746|NCT02061280|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
91982747|NCT02061280|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91982748|NCT02061280|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91982749|NCT02061280|Autonomic Agents|autonomic agents|mesh-ancestor
91982750|NCT02061280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982751|NCT02061280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982752|NCT02061280|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91982753|NCT02061280|Respiratory System Agents|respiratory system agents|mesh-ancestor
91982754|NCT02061280|Dermatologic Agents|dermatologic agents|mesh-ancestor
91982755|NCT02061280|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91982776|NCT04664361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91982777|NCT04664361|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91982778|NCT04664361|Antimetabolites|antimetabolites|mesh-ancestor
91982780|NCT04664361|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91982847|NCT02560389|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91982848|NCT02560389|Dopamine Agents|dopamine agents|mesh-ancestor
91982849|NCT02560389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91982850|NCT02560389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91982918|NCT02093026|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91982919|NCT02093026|Abortifacient Agents|abortifacient agents|mesh-ancestor
91982920|NCT02093026|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91982921|NCT02093026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91982990|NCT02040766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91982992|NCT02040532|Analgesics|analgesics|mesh-ancestor
91982993|NCT02040532|Sensory System Agents|sensory system agents|mesh-ancestor
91982994|NCT02040532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91982996|NCT02040532|Anticonvulsants|anticonvulsants|mesh-ancestor
91983061|NCT02057458|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91983062|NCT02057458|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91983133|NCT03169751|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91983135|NCT03169751|Purinergic Agents|purinergic agents|mesh-ancestor
91983137|NCT02403713|Fluticasone|fluticasone|mesh-list
91983205|NCT04481789|Diuretics|diuretics|mesh-ancestor
91983206|NCT04481789|Natriuretic Agents|natriuretic agents|mesh-ancestor
91983207|NCT04481789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983208|NCT04481789|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
91983209|NCT04481789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983210|NCT04481789|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91983211|NCT04481789|Antioxidants|antioxidants|mesh-ancestor
91983212|NCT04481789|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
91983213|NCT04481789|Protective Agents|protective agents|mesh-ancestor
91983214|NCT02402465|Fluticasone|fluticasone|mesh-list
91983215|NCT02402465|Xhance|xhance|mesh-list
91983216|NCT02402465|Azelastine|azelastine|mesh-list
91983217|NCT02402465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983218|NCT02402465|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91983219|NCT02402465|Autonomic Agents|autonomic agents|mesh-ancestor
91983220|NCT02402465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983221|NCT02402465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983222|NCT02402465|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91983223|NCT02402465|Respiratory System Agents|respiratory system agents|mesh-ancestor
91983224|NCT02402465|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983225|NCT02402465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91983226|NCT02402465|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
91983227|NCT02402465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983228|NCT02402465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983229|NCT02402465|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91983230|NCT02402465|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91983255|NCT02402543|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91983256|NCT02402543|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91983257|NCT02402543|Anesthetics, General|anesthetics, general|mesh-ancestor
91983258|NCT02402543|Anesthetics|anesthetics|mesh-ancestor
91983259|NCT02402543|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91983260|NCT02402543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91983261|NCT02402543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91983262|NCT02402543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91983263|NCT02402543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983264|NCT02402543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983265|NCT02402543|Antipyretics|antipyretics|mesh-ancestor
91983266|NCT02402543|Anticonvulsants|anticonvulsants|mesh-ancestor
91983267|NCT02402543|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91983268|NCT02402543|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91983269|NCT02402543|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91983270|NCT02402543|Antimanic Agents|antimanic agents|mesh-ancestor
91983314|NCT03169127|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91983315|NCT03169127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983316|NCT03169127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983317|NCT03115307|Triptorelin Pamoate|triptorelin pamoate|mesh-list
91983318|NCT03115307|Luteolytic Agents|luteolytic agents|mesh-ancestor
91983319|NCT03115307|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91983320|NCT03115307|Contraceptive Agents|contraceptive agents|mesh-ancestor
91983326|NCT02418533|Menotropins|menotropins|mesh-list
91983381|NCT02055898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983382|NCT04406259|Verapamil|verapamil|mesh-list
91983383|NCT04406259|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91983384|NCT04406259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
91983385|NCT04406259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91983386|NCT04406259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983387|NCT04406259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91983388|NCT04406259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983389|NCT04406259|Vasodilator Agents|vasodilator agents|mesh-ancestor
91983390|NCT04603911|Dexamethasone|dexamethasone|mesh-list
91983391|NCT04603911|Clonidine|clonidine|mesh-list
91983393|NCT04603911|Bupivacaine|bupivacaine|mesh-list
91983394|NCT04603911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983395|NCT04603911|Antiemetics|antiemetics|mesh-ancestor
91983396|NCT04603911|Autonomic Agents|autonomic agents|mesh-ancestor
91983397|NCT04603911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983398|NCT04603911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983440|NCT02400047|Ketoprofen|ketoprofen|mesh-list
91983441|NCT02400047|BB 1101|bb 1101|mesh-list
91983442|NCT02400047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983443|NCT02400047|Antiemetics|antiemetics|mesh-ancestor
91983444|NCT02400047|Autonomic Agents|autonomic agents|mesh-ancestor
91983445|NCT02400047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983446|NCT02400047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983447|NCT02400047|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983448|NCT02400047|Glucocorticoids|glucocorticoids|mesh-ancestor
91983449|NCT02400047|Hormones|hormones|mesh-ancestor
91983450|NCT02400047|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983451|NCT02400047|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983452|NCT02400047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983453|NCT02400047|Protease Inhibitors|protease inhibitors|mesh-ancestor
91983502|NCT03177317|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91983503|NCT03177317|Antiemetics|antiemetics|mesh-ancestor
91983504|NCT03177317|Autonomic Agents|autonomic agents|mesh-ancestor
91983505|NCT03177317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983506|NCT03177317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983507|NCT03177317|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91983508|NCT03177317|Glucocorticoids|glucocorticoids|mesh-ancestor
91983509|NCT03177317|Hormones|hormones|mesh-ancestor
91983510|NCT03177317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91983511|NCT03177317|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91983512|NCT03177317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983513|NCT03177239|Nivolumab|nivolumab|mesh-list
91983514|NCT03177239|Ipilimumab|ipilimumab|mesh-list
91983515|NCT03177239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91983516|NCT03177239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983517|NCT03177239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91983518|NCT03177239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983560|NCT02399189|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983561|NCT02399189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983632|NCT02396225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983633|NCT02396225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983634|NCT02396225|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91983635|NCT02396225|Hormone Antagonists|hormone antagonists|mesh-ancestor
91983637|NCT02396225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983701|NCT03168191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983702|NCT03168191|Antipruritics|antipruritics|mesh-ancestor
91983703|NCT03168191|Dermatologic Agents|dermatologic agents|mesh-ancestor
91983704|NCT05496075|Orlistat|orlistat|mesh-list
91983705|NCT05496075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91983707|NCT05496075|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
91983767|NCT05493657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91983768|NCT05493657|Analgesics|analgesics|mesh-ancestor
91983769|NCT05493657|Sensory System Agents|sensory system agents|mesh-ancestor
91983770|NCT05493657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983771|NCT05493657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91983837|NCT05484375|Antimetabolites|antimetabolites|mesh-ancestor
91983838|NCT05484375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983839|NCT05484375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983840|NCT05480007|Metformin|metformin|mesh-list
91983841|NCT05480007|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91983842|NCT05480007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91983909|NCT04543071|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91983910|NCT04543071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91983911|NCT04543071|Tubulin Modulators|tubulin modulators|mesh-ancestor
91983912|NCT04543071|Antimitotic Agents|antimitotic agents|mesh-ancestor
91983913|NCT04543071|Mitosis Modulators|mitosis modulators|mesh-ancestor
91983914|NCT04543071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983915|NCT04543071|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91983916|NCT04543071|Antimetabolites|antimetabolites|mesh-ancestor
91983917|NCT04543071|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91983919|NCT05487963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983920|NCT05487963|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
91983921|NCT05487963|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91983923|NCT05487885|Ketamine|ketamine|mesh-list
91983924|NCT05487885|Analgesics|analgesics|mesh-ancestor
91983925|NCT05487885|Sensory System Agents|sensory system agents|mesh-ancestor
91983926|NCT05487885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91983964|NCT05476731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91983965|NCT05476731|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91983967|NCT05476731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984029|NCT04272021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984031|NCT03434769|Fludarabine|fludarabine|mesh-list
91984032|NCT03434769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984033|NCT03434769|Immunologic Factors|immunologic factors|mesh-ancestor
91984103|NCT03167333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984104|NCT03167333|Viscosupplements|viscosupplements|mesh-ancestor
91984105|NCT03167333|Protective Agents|protective agents|mesh-ancestor
91984106|NCT02393963|Tranexamic Acid|tranexamic acid|mesh-list
91984107|NCT02393963|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
91984108|NCT02393963|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91984109|NCT02393963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984110|NCT02393963|Hemostatics|hemostatics|mesh-ancestor
91984111|NCT02393963|Coagulants|coagulants|mesh-ancestor
91984112|NCT03115619|Pirfenidone|pirfenidone|mesh-list
91984113|NCT03115619|Analgesics|analgesics|mesh-ancestor
91984114|NCT03115619|Sensory System Agents|sensory system agents|mesh-ancestor
91984115|NCT03115619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984116|NCT03115619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984117|NCT03115619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91984118|NCT03115619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91984119|NCT03115619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984120|NCT03115619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984121|NCT03115619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984122|NCT02393573|Metformin|metformin|mesh-list
91984123|NCT02393573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984124|NCT02393573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984125|NCT05745467|Povidone-Iodine|povidone-iodine|mesh-list
91984126|NCT05745467|Povidone|povidone|mesh-list
91984127|NCT05745467|Plasma Substitutes|plasma substitutes|mesh-ancestor
91984128|NCT05745467|Blood Substitutes|blood substitutes|mesh-ancestor
91984152|NCT02392793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984153|NCT02392793|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984154|NCT02392793|Alkylating Agents|alkylating agents|mesh-ancestor
91984155|NCT02392793|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91984156|NCT03167177|Leucovorin|leucovorin|mesh-list
91984157|NCT03167177|Paclitaxel|paclitaxel|mesh-list
91984158|NCT03167177|Cyclophosphamide|cyclophosphamide|mesh-list
91984159|NCT03167177|Bevacizumab|bevacizumab|mesh-list
91984160|NCT03167177|Fluorouracil|fluorouracil|mesh-list
91984161|NCT03167177|Capecitabine|capecitabine|mesh-list
91984219|NCT03166787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984220|NCT03166553|Oxaliplatin|oxaliplatin|mesh-list
91984221|NCT03166553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984222|NCT03167957|Amphotericin B|amphotericin b|mesh-list
91984291|NCT02542605|Vasodilator Agents|vasodilator agents|mesh-ancestor
91984292|NCT02542605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984294|NCT02723955|Docetaxel|docetaxel|mesh-list
91984295|NCT02723955|Carboplatin|carboplatin|mesh-list
91984296|NCT02723955|Gemcitabine|gemcitabine|mesh-list
91984297|NCT02723955|Pembrolizumab|pembrolizumab|mesh-list
91984298|NCT02723955|Fluorouracil|fluorouracil|mesh-list
91984299|NCT02723955|Pemetrexed|pemetrexed|mesh-list
91984300|NCT02723955|Dostarlimab|dostarlimab|mesh-list
91984301|NCT02723955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91984302|NCT02723955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984303|NCT02723955|Tubulin Modulators|tubulin modulators|mesh-ancestor
91984304|NCT02723955|Antimitotic Agents|antimitotic agents|mesh-ancestor
91984305|NCT02723955|Mitosis Modulators|mitosis modulators|mesh-ancestor
91984306|NCT02723955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984307|NCT02723955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91984308|NCT02723955|Antimetabolites|antimetabolites|mesh-ancestor
91984309|NCT02723955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984310|NCT02723955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984311|NCT02723955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984312|NCT02723955|Immunologic Factors|immunologic factors|mesh-ancestor
91984313|NCT02723955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984314|NCT02723955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984315|NCT02723955|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91984316|NCT02723955|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91984317|NCT03299049|Rilpivirine|rilpivirine|mesh-list
91984318|NCT03299049|Cabotegravir|cabotegravir|mesh-list
91984319|NCT03299049|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91984320|NCT03299049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91984338|NCT02550795|Hormones|hormones|mesh-ancestor
91984339|NCT02550795|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984340|NCT02550795|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003566|NCT02766582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003567|NCT02766582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003568|NCT02720692|Meloxicam|meloxicam|mesh-list
92003571|NCT02720692|Analgesics|analgesics|mesh-ancestor
92003572|NCT02720692|Sensory System Agents|sensory system agents|mesh-ancestor
92003573|NCT02720692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003574|NCT02720692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003575|NCT02720692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003576|NCT02720692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003577|NCT02720692|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92003578|NCT02720692|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92003579|NCT02720692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003580|NCT02720692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003581|NCT02712151|Ropivacaine|ropivacaine|mesh-list
92003582|NCT02712151|Anesthetics, Local|anesthetics, local|mesh-ancestor
92003583|NCT02712151|Anesthetics|anesthetics|mesh-ancestor
92003584|NCT02712151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92003585|NCT02712151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003586|NCT02712151|Sensory System Agents|sensory system agents|mesh-ancestor
92003587|NCT02712151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003588|NCT02707484|Thalidomide|thalidomide|mesh-list
92003589|NCT02707484|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003590|NCT02707484|Immunologic Factors|immunologic factors|mesh-ancestor
92003591|NCT02707484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003592|NCT02707484|Leprostatic Agents|leprostatic agents|mesh-ancestor
92003593|NCT02707484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92003594|NCT02707484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003595|NCT02707484|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003596|NCT02707484|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003597|NCT02707484|Growth Substances|growth substances|mesh-ancestor
92003598|NCT02707484|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003599|NCT02707484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003601|NCT02703623|Cortisone|cortisone|mesh-list
92003602|NCT02703623|Carboplatin|carboplatin|mesh-list
92003603|NCT02703623|Ipilimumab|ipilimumab|mesh-list
92003604|NCT02703623|Abiraterone Acetate|abiraterone acetate|mesh-list
92003605|NCT02703623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003606|NCT02703623|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92003607|NCT02703623|Glucocorticoids|glucocorticoids|mesh-ancestor
92003608|NCT02703623|Hormones|hormones|mesh-ancestor
92003609|NCT02703623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003610|NCT02703623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003611|NCT02703623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003612|NCT02703623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003613|NCT02703623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003614|NCT02703623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003615|NCT02703623|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92003616|NCT02703623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003617|NCT02703623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92003618|NCT02703623|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92003619|NCT02651662|Cemiplimab|cemiplimab|mesh-list
92003620|NCT02651662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003621|NCT02651662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003622|NCT02646683|Vedolizumab|vedolizumab|mesh-list
92003623|NCT02646683|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92003624|NCT02628626|Clonidine|clonidine|mesh-list
92003625|NCT02628626|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92003626|NCT02628626|Analgesics|analgesics|mesh-ancestor
92003627|NCT02628626|Sensory System Agents|sensory system agents|mesh-ancestor
92003628|NCT02628626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003629|NCT02628626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003630|NCT02628626|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92003631|NCT02628626|Sympatholytics|sympatholytics|mesh-ancestor
92003632|NCT02628626|Autonomic Agents|autonomic agents|mesh-ancestor
92003633|NCT02628626|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92003634|NCT02628626|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92003635|NCT02628626|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92003636|NCT02628626|Adrenergic Agents|adrenergic agents|mesh-ancestor
91984341|NCT02550795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984342|NCT02550795|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91984343|NCT02550795|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984344|NCT02550795|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92003637|NCT02628626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92003638|NCT02628626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003639|NCT02628626|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92003640|NCT02628626|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92003643|NCT02616965|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92003644|NCT02616965|Romidepsin|romidepsin|mesh-list
92003645|NCT02616965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003646|NCT02616965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003647|NCT02616965|Immunotoxins|immunotoxins|mesh-ancestor
92003648|NCT02616965|Immunoconjugates|immunoconjugates|mesh-ancestor
92003649|NCT02616965|Immunologic Factors|immunologic factors|mesh-ancestor
92003650|NCT02616965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003651|NCT02616965|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92003652|NCT02616965|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92003653|NCT02616965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003654|NCT02616965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003655|NCT02595424|Carboplatin|carboplatin|mesh-list
92003656|NCT02595424|Capecitabine|capecitabine|mesh-list
92003658|NCT02595424|Temozolomide|temozolomide|mesh-list
92003659|NCT02595424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003660|NCT02595424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003661|NCT02595424|Antimetabolites|antimetabolites|mesh-ancestor
92003662|NCT02595424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003663|NCT02595424|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003664|NCT02595424|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92003665|NCT02595424|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92003666|NCT02595424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003667|NCT02595424|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003668|NCT02595424|Alkylating Agents|alkylating agents|mesh-ancestor
92003669|NCT02554812|Avelumab|avelumab|mesh-list
92003670|NCT02554812|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003671|NCT02554812|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003672|NCT02544815|Digoxin|digoxin|mesh-list
92003673|NCT02544815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92003674|NCT02544815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92003675|NCT02544815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003676|NCT02544815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003677|NCT02544815|Protective Agents|protective agents|mesh-ancestor
92003678|NCT02544815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003679|NCT02527707|Ritonavir|ritonavir|mesh-list
92003680|NCT02527707|Lonafarnib|lonafarnib|mesh-list
92003681|NCT02527707|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92003682|NCT02527707|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92003683|NCT02527707|Protease Inhibitors|protease inhibitors|mesh-ancestor
92003684|NCT02527707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003685|NCT02527707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003686|NCT02527707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92003687|NCT02527707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92003688|NCT02527707|Antiviral Agents|antiviral agents|mesh-ancestor
92003689|NCT02527707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003690|NCT02527707|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92003691|NCT02527707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92003692|NCT02453191|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92003693|NCT02453191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003694|NCT02453191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003695|NCT02437136|Pembrolizumab|pembrolizumab|mesh-list
92003696|NCT02437136|Entinostat|entinostat|mesh-list
92003697|NCT02437136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003698|NCT02437136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003699|NCT02437136|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003700|NCT02437136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003701|NCT02437136|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92003702|NCT02437136|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003703|NCT02367924|Trabectedin|trabectedin|mesh-list
92003704|NCT02367924|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003705|NCT02367924|Alkylating Agents|alkylating agents|mesh-ancestor
92003706|NCT02367924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003707|NCT02367924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003708|NCT02352090|Dienogest|dienogest|mesh-list
92003709|NCT02352090|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92003710|NCT02352090|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92003711|NCT02352090|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92003712|NCT02352090|Estradiol|estradiol|mesh-list
92003713|NCT02352090|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92003731|NCT02261883|Treprostinil|treprostinil|mesh-list
92003732|NCT02261883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92003733|NCT02135107|Rabeprazole|rabeprazole|mesh-list
92003734|NCT02135107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92003735|NCT02135107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92003736|NCT02135107|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92003737|NCT02135107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003738|NCT02135107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003756|NCT02081378|Imatinib Mesylate|imatinib mesylate|mesh-list
92003757|NCT02081378|Dasatinib|dasatinib|mesh-list
92003758|NCT02081378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003759|NCT02081378|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003760|NCT02081378|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003761|NCT02081378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003762|NCT02081378|Vitamin B Complex|vitamin b complex|mesh-ancestor
92003763|NCT02081378|Vitamins|vitamins|mesh-ancestor
92003764|NCT02081378|Micronutrients|micronutrients|mesh-ancestor
92003765|NCT02081378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003766|NCT02025010|Abiraterone Acetate|abiraterone acetate|mesh-list
92003767|NCT02025010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003768|NCT02025010|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92003769|NCT02025010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003770|NCT02025010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003771|NCT02025010|Hormone Antagonists|hormone antagonists|mesh-ancestor
92003772|NCT02025010|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003773|NCT02025010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003774|NCT02025010|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92003775|NCT01982448|Paclitaxel|paclitaxel|mesh-list
92003776|NCT01982448|Cisplatin|cisplatin|mesh-list
92003777|NCT01982448|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003778|NCT01982448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003779|NCT01982448|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003780|NCT01982448|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003781|NCT01982448|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003782|NCT01982448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003783|NCT01938261|Acetaminophen|acetaminophen|mesh-list
92003784|NCT01938261|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92003785|NCT01938261|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92003786|NCT01938261|Analgesics|analgesics|mesh-ancestor
92003795|NCT01844986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003796|NCT01809041|Remifentanil|remifentanil|mesh-list
92003797|NCT01809041|Propofol|propofol|mesh-list
92003798|NCT01809041|Sevoflurane|sevoflurane|mesh-list
92003799|NCT01809041|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92003800|NCT01809041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92003801|NCT01809041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003802|NCT01809041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92003803|NCT01809041|Anesthetics, General|anesthetics, general|mesh-ancestor
92003804|NCT01809041|Anesthetics|anesthetics|mesh-ancestor
92003805|NCT01809041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92003806|NCT01809041|Narcotics|narcotics|mesh-ancestor
92003807|NCT01809041|Analgesics|analgesics|mesh-ancestor
92003808|NCT01809041|Sensory System Agents|sensory system agents|mesh-ancestor
92003809|NCT01809041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003810|NCT01809041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92003811|NCT01809041|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92003818|NCT01689727|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
92003819|NCT01689727|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92003820|NCT01689727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003821|NCT01689714|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
92003822|NCT01689714|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984346|NCT02550795|Sensory System Agents|sensory system agents|mesh-ancestor
91984347|NCT02550795|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91984348|NCT02550795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91984349|NCT02550795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91984350|NCT02550795|Adrenergic Agents|adrenergic agents|mesh-ancestor
91984351|NCT02550795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984352|NCT02550795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984354|NCT02541903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984355|NCT02541903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984356|NCT02541903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984357|NCT02541903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984358|NCT02541669|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
91984359|NCT02541669|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92003823|NCT01689714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003824|NCT01689662|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
92003826|NCT01689662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003827|NCT01689636|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
92003828|NCT01689636|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92003829|NCT01689636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003830|NCT01686256|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
92003831|NCT01686256|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92003832|NCT01686256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003833|NCT01684098|Technetium Tc 99m-ethylenedicysteine|technetium tc 99m-ethylenedicysteine|mesh-list
92003834|NCT01684098|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92003835|NCT01684098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003836|NCT01659151|Aldesleukin|aldesleukin|mesh-list
92003837|NCT01659151|Cyclophosphamide|cyclophosphamide|mesh-list
92003838|NCT01659151|Fludarabine|fludarabine|mesh-list
92003839|NCT01659151|Interleukin-2|interleukin-2|mesh-list
92003840|NCT01659151|Vemurafenib|vemurafenib|mesh-list
92003841|NCT01659151|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92003842|NCT01659151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003843|NCT01659151|Immunologic Factors|immunologic factors|mesh-ancestor
92003844|NCT01659151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003845|NCT01659151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003846|NCT01659151|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92003847|NCT01659151|Alkylating Agents|alkylating agents|mesh-ancestor
92003848|NCT01659151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003849|NCT01659151|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003850|NCT01659151|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92003851|NCT01659151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92003852|NCT01659151|Analgesics|analgesics|mesh-ancestor
92003853|NCT01659151|Sensory System Agents|sensory system agents|mesh-ancestor
92003854|NCT01659151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003855|NCT01659151|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92003856|NCT01659151|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92003860|NCT01593254|Imatinib Mesylate|imatinib mesylate|mesh-list
92003861|NCT01593254|Dasatinib|dasatinib|mesh-list
92003862|NCT01593254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003863|NCT01593254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003864|NCT01593254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003865|NCT01593254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003866|NCT01537601|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92003867|NCT01537601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003868|NCT01525394|Moxifloxacin|moxifloxacin|mesh-list
91984360|NCT02541669|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91984361|NCT02541669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984362|NCT05455047|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91984363|NCT05455047|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984364|NCT05455047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984365|NCT05454891|Insulin|insulin|mesh-list
91984366|NCT05454891|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91984367|NCT05454891|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984368|NCT05454891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984369|NCT02688647|Belumosudil|belumosudil|mesh-list
91984370|NCT02688647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984371|NCT02688647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984372|NCT02688647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984373|NCT05453799|Antibodies|antibodies|mesh-list
91984374|NCT05453799|Immunoglobulins|immunoglobulins|mesh-list
91984375|NCT05453799|Antibodies, Bispecific|antibodies, bispecific|mesh-list
91984376|NCT05453799|Immunologic Factors|immunologic factors|mesh-ancestor
91984377|NCT05453799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984378|NCT05453487|Vaccines|vaccines|mesh-list
91984379|NCT05453487|Immunologic Factors|immunologic factors|mesh-ancestor
91984380|NCT05453487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984381|NCT05431725|Vaccines|vaccines|mesh-list
91984382|NCT05431725|Immunologic Factors|immunologic factors|mesh-ancestor
91984383|NCT05431725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984384|NCT02548455|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
91984385|NCT02548455|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91984387|NCT02548455|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91984388|NCT02548455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984389|NCT02548455|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
91984402|NCT05451615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984403|NCT05451615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003869|NCT01525394|Lenvatinib|lenvatinib|mesh-list
92003870|NCT01525394|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92003871|NCT01525394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003872|NCT01525394|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92003873|NCT01525394|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92003874|NCT01525394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003875|NCT01525394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003876|NCT01525394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003877|NCT01525394|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003878|NCT01454934|Gemcitabine|gemcitabine|mesh-list
92003879|NCT01454934|Docetaxel|docetaxel|mesh-list
92003880|NCT01454934|Pemetrexed|pemetrexed|mesh-list
92003881|NCT01454934|Vinorelbine|vinorelbine|mesh-list
92003882|NCT01454934|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003883|NCT01454934|Antimetabolites|antimetabolites|mesh-ancestor
92003884|NCT01454934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003885|NCT01454934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003886|NCT01454934|Tubulin Modulators|tubulin modulators|mesh-ancestor
92003887|NCT01454934|Antimitotic Agents|antimitotic agents|mesh-ancestor
92003888|NCT01454934|Mitosis Modulators|mitosis modulators|mesh-ancestor
92003889|NCT01454934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003890|NCT01454934|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92003891|NCT01454934|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92003892|NCT01454934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92003893|NCT01442246|Leuprolide|leuprolide|mesh-list
92003894|NCT01442246|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92003895|NCT01442246|Fertility Agents|fertility agents|mesh-ancestor
92003896|NCT01442246|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92003897|NCT01442246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003898|NCT01442246|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003899|NCT01442246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003901|NCT01439282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003902|NCT01439282|Antimetabolites|antimetabolites|mesh-ancestor
92003903|NCT01439282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003904|NCT01439282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003905|NCT01391962|Sunitinib|sunitinib|mesh-list
92003906|NCT01391962|Cediranib|cediranib|mesh-list
92003907|NCT01391962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003908|NCT01391962|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92003909|NCT01391962|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92003910|NCT01391962|Growth Substances|growth substances|mesh-ancestor
92003911|NCT01391962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003912|NCT01391962|Growth Inhibitors|growth inhibitors|mesh-ancestor
92003913|NCT01391962|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003914|NCT01391962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003915|NCT01391962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003916|NCT01352520|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92003917|NCT01352520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003918|NCT01352520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003919|NCT01352520|Immunotoxins|immunotoxins|mesh-ancestor
92003920|NCT01352520|Immunoconjugates|immunoconjugates|mesh-ancestor
92003921|NCT01352520|Immunologic Factors|immunologic factors|mesh-ancestor
92003922|NCT01352520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003923|NCT01351103|Spartalizumab|spartalizumab|mesh-list
92003925|NCT01351103|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92003926|NCT01351103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003927|NCT01351103|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003928|NCT01351103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003929|NCT01351103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003948|NCT01268293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003949|NCT01268293|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003950|NCT01268293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003951|NCT01268293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003952|NCT01267175|Insulin|insulin|mesh-list
92003953|NCT01267175|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92003954|NCT01267175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003955|NCT01231841|Cyclosporine|cyclosporine|mesh-list
92003956|NCT01231841|Cyclosporins|cyclosporins|mesh-list
92003957|NCT01231841|Thymoglobulin|thymoglobulin|mesh-list
92003958|NCT01231841|Antilymphocyte Serum|antilymphocyte serum|mesh-list
91984404|NCT05727527|Anesthetics|anesthetics|mesh-list
91984405|NCT05727527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984406|NCT05727527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984407|NCT02534883|Misoprostol|misoprostol|mesh-list
92003959|NCT01231841|Immunoglobulins|immunoglobulins|mesh-list
92003960|NCT01231841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003961|NCT01231841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003962|NCT01231841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92003963|NCT01231841|Immunologic Factors|immunologic factors|mesh-ancestor
92003964|NCT01231841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003965|NCT01231841|Antifungal Agents|antifungal agents|mesh-ancestor
92003966|NCT01231841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003967|NCT01231841|Dermatologic Agents|dermatologic agents|mesh-ancestor
92003968|NCT01231841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92003969|NCT01231841|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92003970|NCT01133756|Carboplatin|carboplatin|mesh-list
92003971|NCT01133756|Gemcitabine|gemcitabine|mesh-list
92003972|NCT01133756|Lenvatinib|lenvatinib|mesh-list
92003973|NCT01133756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003974|NCT01133756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92003975|NCT01133756|Antimetabolites|antimetabolites|mesh-ancestor
92003976|NCT01133756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003977|NCT01133756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003978|NCT01133756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003979|NCT01126736|Pemetrexed|pemetrexed|mesh-list
92003980|NCT01126736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003981|NCT01126736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003982|NCT01126736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003983|NCT01126736|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92003984|NCT01126736|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92003985|NCT01111461|Lenvatinib|lenvatinib|mesh-list
92003986|NCT01111461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003987|NCT01111461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92004002|NCT01005745|Analgesics|analgesics|mesh-ancestor
92004003|NCT01005745|Sensory System Agents|sensory system agents|mesh-ancestor
92004004|NCT01005745|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004005|NCT01005745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004006|NCT01005745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92004007|NCT01005745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92004008|NCT01005745|Antiviral Agents|antiviral agents|mesh-ancestor
92004009|NCT01005745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004010|NCT00978458|Temozolomide|temozolomide|mesh-list
92004011|NCT00978458|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004012|NCT00978458|Alkylating Agents|alkylating agents|mesh-ancestor
92004013|NCT00978458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004014|NCT00978458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004015|NCT00956007|Cetuximab|cetuximab|mesh-list
92004016|NCT00956007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004017|NCT00956007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004018|NCT00832429|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92004019|NCT00832429|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92004020|NCT00832429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004021|NCT00796263|Dolutegravir|dolutegravir|mesh-list
92004022|NCT00796263|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92004023|NCT00796263|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92004024|NCT00796263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004025|NCT00796263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004026|NCT00796263|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92004027|NCT00796263|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92004028|NCT00796263|Antiviral Agents|antiviral agents|mesh-ancestor
92004029|NCT00796263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004030|NCT00715442|Sunitinib|sunitinib|mesh-list
92004031|NCT00715442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004032|NCT00715442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92004033|NCT00715442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92004034|NCT00715442|Growth Substances|growth substances|mesh-ancestor
92004035|NCT00715442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004036|NCT00715442|Growth Inhibitors|growth inhibitors|mesh-ancestor
92004037|NCT00715442|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92004038|NCT00715442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984408|NCT02534883|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91984409|NCT02534883|Abortifacient Agents|abortifacient agents|mesh-ancestor
92004039|NCT00715442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004040|NCT00697684|Clofarabine|clofarabine|mesh-list
92004041|NCT00697684|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92004042|NCT00697684|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004043|NCT00697684|Antimetabolites|antimetabolites|mesh-ancestor
92004044|NCT00697684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004045|NCT00697684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004050|NCT00675922|Mafenide|mafenide|mesh-list
92004051|NCT00675922|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92004052|NCT00675922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004053|NCT00675922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004054|NCT00675922|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92004055|NCT00675922|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004056|NCT00675922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004057|NCT00466531|Cyclophosphamide|cyclophosphamide|mesh-list
92004058|NCT00466531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004059|NCT00466531|Immunologic Factors|immunologic factors|mesh-ancestor
92004060|NCT00466531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004061|NCT00466531|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004062|NCT00466531|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004063|NCT00466531|Alkylating Agents|alkylating agents|mesh-ancestor
92004064|NCT00466531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004065|NCT00466531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004066|NCT00466531|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004067|NCT00244933|Gemcitabine|gemcitabine|mesh-list
92004068|NCT00244933|Genistein|genistein|mesh-list
92004069|NCT00244933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004070|NCT00244933|Antimetabolites|antimetabolites|mesh-ancestor
92004071|NCT00244933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004072|NCT00244933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004073|NCT00244933|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92004074|NCT00244933|Protective Agents|protective agents|mesh-ancestor
92004075|NCT00244933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004076|NCT00244933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92004077|NCT00244933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004078|NCT00244933|Phytoestrogens|phytoestrogens|mesh-ancestor
92004079|NCT00244933|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92004080|NCT00244933|Estrogens|estrogens|mesh-ancestor
92004081|NCT00244933|Hormones|hormones|mesh-ancestor
92004082|NCT00244933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004083|NCT00121719|Lenvatinib|lenvatinib|mesh-list
92004084|NCT00121719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004085|NCT00121719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92004086|NCT00121719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004087|NCT00121719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004088|NCT00053209|Gemcitabine|gemcitabine|mesh-list
92004089|NCT00053209|Pemetrexed|pemetrexed|mesh-list
92004090|NCT00053209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004091|NCT00053209|Antimetabolites|antimetabolites|mesh-ancestor
92004092|NCT00053209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004093|NCT00053209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004094|NCT00053209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004095|NCT00053209|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92004096|NCT00053209|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92004097|NCT00039429|Atrasentan|atrasentan|mesh-list
92004098|NCT00039429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004099|NCT00039429|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92004100|NCT00039429|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92004101|NCT00039429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004102|NCT00014508|Cyclosporine|cyclosporine|mesh-list
92004103|NCT00014508|Cyclophosphamide|cyclophosphamide|mesh-list
92004104|NCT00014508|Melphalan|melphalan|mesh-list
92004105|NCT00014508|Fludarabine|fludarabine|mesh-list
92004106|NCT00014508|Fludarabine phosphate|fludarabine phosphate|mesh-list
92004107|NCT00014508|Cyclosporins|cyclosporins|mesh-list
92004108|NCT00014508|Sargramostim|sargramostim|mesh-list
92004109|NCT00014508|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004110|NCT00014508|Immunologic Factors|immunologic factors|mesh-ancestor
92004111|NCT00014508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004112|NCT00014508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004113|NCT00014508|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004114|NCT00014508|Alkylating Agents|alkylating agents|mesh-ancestor
92004115|NCT00014508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004116|NCT00014508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004120|NCT00014508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004121|NCT00014508|Antifungal Agents|antifungal agents|mesh-ancestor
92004122|NCT00014508|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004123|NCT00014508|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004124|NCT00014508|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92004125|NCT00006390|Cyclophosphamide|cyclophosphamide|mesh-list
92004126|NCT00006390|Alemtuzumab|alemtuzumab|mesh-list
92004127|NCT00006390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004128|NCT00006390|Immunologic Factors|immunologic factors|mesh-ancestor
92004129|NCT00006390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004130|NCT00006390|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004131|NCT00006390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004132|NCT00006390|Alkylating Agents|alkylating agents|mesh-ancestor
92004133|NCT00006390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004134|NCT00006390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004135|NCT00006390|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004136|NCT00006390|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004137|NCT00005962|Cytarabine|cytarabine|mesh-list
92004138|NCT00005962|Cyclophosphamide|cyclophosphamide|mesh-list
92004139|NCT00005962|Daunorubicin|daunorubicin|mesh-list
92004140|NCT00005962|Topotecan|topotecan|mesh-list
92004141|NCT00005962|Gemtuzumab|gemtuzumab|mesh-list
92004142|NCT00005962|Sargramostim|sargramostim|mesh-list
92004143|NCT00005962|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004144|NCT00005962|Immunologic Factors|immunologic factors|mesh-ancestor
92004145|NCT00005962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004146|NCT00005962|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004147|NCT00005962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004148|NCT00005962|Alkylating Agents|alkylating agents|mesh-ancestor
92004149|NCT00005962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004150|NCT00005962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004151|NCT00005962|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004152|NCT00005962|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004153|NCT00005962|Antimetabolites|antimetabolites|mesh-ancestor
92004154|NCT00005962|Antiviral Agents|antiviral agents|mesh-ancestor
92004155|NCT00005962|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004156|NCT00005962|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92004157|NCT00005962|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004158|NCT00005962|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004159|NCT00005962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004160|NCT00005962|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92004161|NCT00005962|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004162|NCT00005962|Immunotoxins|immunotoxins|mesh-ancestor
92004163|NCT00005962|Immunoconjugates|immunoconjugates|mesh-ancestor
92004164|NCT00005847|Interferons|interferons|mesh-list
92004165|NCT00005847|Interferon-alpha|interferon-alpha|mesh-list
92004166|NCT00005847|Paclitaxel|paclitaxel|mesh-list
92004167|NCT00005847|Vinorelbine|vinorelbine|mesh-list
92004168|NCT00005847|Mitoxantrone|mitoxantrone|mesh-list
92004169|NCT00005847|Estramustine|estramustine|mesh-list
92004170|NCT00005847|Isotretinoin|isotretinoin|mesh-list
92004171|NCT00005847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004172|NCT00005847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004173|NCT00005847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004174|NCT00005847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004175|NCT00005847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004176|NCT00005847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004177|NCT00005847|Antiviral Agents|antiviral agents|mesh-ancestor
92004178|NCT00005847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004179|NCT00005847|Immunologic Factors|immunologic factors|mesh-ancestor
92004180|NCT00005847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004181|NCT00005847|Analgesics|analgesics|mesh-ancestor
92004182|NCT00005847|Sensory System Agents|sensory system agents|mesh-ancestor
92004183|NCT00005847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004184|NCT00005847|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004185|NCT00005847|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004186|NCT00005847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004187|NCT00005847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004188|NCT00005847|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004189|NCT00005847|Alkylating Agents|alkylating agents|mesh-ancestor
92004190|NCT00005847|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004193|NCT00005644|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004194|NCT00005644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004195|NCT00005644|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004196|NCT00005644|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004197|NCT00005644|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004198|NCT00005644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004199|NCT00005644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004200|NCT00005644|Antimetabolites|antimetabolites|mesh-ancestor
92004201|NCT00003871|Vaccines|vaccines|mesh-list
92004202|NCT00003871|Immunologic Factors|immunologic factors|mesh-ancestor
92004203|NCT00003871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004204|NCT00003809|Cetuximab|cetuximab|mesh-list
92004205|NCT00003809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004206|NCT00003809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004207|NCT00003808|Theophylline|theophylline|mesh-list
92004208|NCT00003808|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92004209|NCT00003808|Autonomic Agents|autonomic agents|mesh-ancestor
92004210|NCT00003808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004211|NCT00003808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004212|NCT00003808|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92004213|NCT00003808|Respiratory System Agents|respiratory system agents|mesh-ancestor
92004214|NCT00003808|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92004215|NCT00003808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004216|NCT00003808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004217|NCT00003808|Vasodilator Agents|vasodilator agents|mesh-ancestor
92004218|NCT00003808|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92004219|NCT00003808|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92004220|NCT00003808|Purinergic Agents|purinergic agents|mesh-ancestor
92004221|NCT00003808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004222|NCT00003592|Paclitaxel|paclitaxel|mesh-list
92004223|NCT00003592|Methotrexate|methotrexate|mesh-list
92004224|NCT00003592|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004225|NCT00003592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004226|NCT00003592|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004227|NCT00003592|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004228|NCT00003592|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004229|NCT00003592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004230|NCT00003592|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92004231|NCT00003592|Abortifacient Agents|abortifacient agents|mesh-ancestor
92004232|NCT00003592|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004233|NCT00003592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004234|NCT00003592|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004235|NCT00003592|Antimetabolites|antimetabolites|mesh-ancestor
92004236|NCT00003592|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004237|NCT00003592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004238|NCT00003592|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92004239|NCT00003592|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004240|NCT00003592|Immunologic Factors|immunologic factors|mesh-ancestor
92004241|NCT00003592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004242|NCT00003592|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92004243|NCT00003518|Paclitaxel|paclitaxel|mesh-list
92004244|NCT00003518|Gemcitabine|gemcitabine|mesh-list
92004245|NCT00003518|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004246|NCT00003518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004247|NCT00003518|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004248|NCT00003518|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004249|NCT00003518|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004250|NCT00003518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004251|NCT00003518|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004252|NCT00003518|Antimetabolites|antimetabolites|mesh-ancestor
92004253|NCT00003444|Interferons|interferons|mesh-list
92004254|NCT00003444|Interferon-alpha|interferon-alpha|mesh-list
92004255|NCT00003444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004256|NCT00003444|Antiviral Agents|antiviral agents|mesh-ancestor
92004257|NCT00003444|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004258|NCT00003444|Immunologic Factors|immunologic factors|mesh-ancestor
92004259|NCT00003444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004260|NCT00003388|Cytarabine|cytarabine|mesh-list
92004261|NCT00003388|Prednisone|prednisone|mesh-list
92004262|NCT00003388|Cyclophosphamide|cyclophosphamide|mesh-list
92004263|NCT00003388|Doxorubicin|doxorubicin|mesh-list
92004264|NCT00003388|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92004265|NCT00003388|Methotrexate|methotrexate|mesh-list
92004270|NCT00003388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004271|NCT00003388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004272|NCT00003388|Alkylating Agents|alkylating agents|mesh-ancestor
91984410|NCT02534883|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91984411|NCT02534883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004273|NCT00003388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004274|NCT00003388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004275|NCT00003388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004276|NCT00003388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92004277|NCT00003388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004278|NCT00003388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004279|NCT00003388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004280|NCT00003388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004281|NCT00003388|Glucocorticoids|glucocorticoids|mesh-ancestor
92004282|NCT00003388|Hormones|hormones|mesh-ancestor
92004283|NCT00003388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004284|NCT00003388|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004285|NCT00003388|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92004286|NCT00003388|Abortifacient Agents|abortifacient agents|mesh-ancestor
92004287|NCT00003388|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004288|NCT00003388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004289|NCT00003388|Antimetabolites|antimetabolites|mesh-ancestor
92004290|NCT00003388|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004291|NCT00003388|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92004292|NCT00003388|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92004293|NCT00003388|Antiviral Agents|antiviral agents|mesh-ancestor
92004294|NCT00003388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004295|NCT00003388|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004296|NCT00003388|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004297|NCT00003388|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004298|NCT00003388|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004299|NCT00003376|Paclitaxel|paclitaxel|mesh-list
92004300|NCT00003376|Vinblastine|vinblastine|mesh-list
92004301|NCT00003376|Carboplatin|carboplatin|mesh-list
92004302|NCT00003376|Doxorubicin|doxorubicin|mesh-list
92004303|NCT00003376|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92004304|NCT00003376|Methotrexate|methotrexate|mesh-list
92004305|NCT00003376|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004306|NCT00003376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004307|NCT00003376|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004308|NCT00003376|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004309|NCT00003376|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004310|NCT00003376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004311|NCT00003376|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92004312|NCT00003376|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004313|NCT00003376|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004314|NCT00003376|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004315|NCT00003376|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92004316|NCT00003376|Abortifacient Agents|abortifacient agents|mesh-ancestor
92004317|NCT00003376|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004318|NCT00003376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004319|NCT00003376|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004320|NCT00003376|Antimetabolites|antimetabolites|mesh-ancestor
92004321|NCT00003376|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004322|NCT00003376|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92004323|NCT00003376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004324|NCT00003376|Immunologic Factors|immunologic factors|mesh-ancestor
92004325|NCT00003376|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004326|NCT00003376|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92004327|NCT00003353|Melphalan|melphalan|mesh-list
92004328|NCT00003353|Immunologic Factors|immunologic factors|mesh-ancestor
92004329|NCT00003353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004330|NCT00003353|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004331|NCT00003353|Alkylating Agents|alkylating agents|mesh-ancestor
92004332|NCT00003353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004333|NCT00003353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004334|NCT00003353|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004335|NCT00003353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004341|NCT00003309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004342|NCT00003309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004343|NCT00003309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004344|NCT00003309|Alkylating Agents|alkylating agents|mesh-ancestor
92004345|NCT00003309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004346|NCT00003309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984412|NCT02534883|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91984413|NCT02534883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984414|NCT02534883|Oxytocics|oxytocics|mesh-ancestor
91984415|NCT05626439|Alprazolam|alprazolam|mesh-list
92004347|NCT00003309|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004348|NCT00003309|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004349|NCT00003309|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004350|NCT00003309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004351|NCT00003309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004352|NCT00003309|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004353|NCT00003309|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004354|NCT00003309|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004355|NCT00003237|Paclitaxel|paclitaxel|mesh-list
92004356|NCT00003237|Cisplatin|cisplatin|mesh-list
92004357|NCT00003237|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004358|NCT00003237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004359|NCT00003237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004360|NCT00003237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004361|NCT00003237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004362|NCT00003237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004363|NCT00003129|Valrubicin|valrubicin|mesh-list
92004364|NCT00003129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004365|NCT00003129|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004366|NCT00003129|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004367|NCT00003129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004368|NCT00003129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004369|NCT00003027|Interferons|interferons|mesh-list
92004370|NCT00003027|Interferon-alpha|interferon-alpha|mesh-list
92004371|NCT00003027|Aldesleukin|aldesleukin|mesh-list
92004372|NCT00003027|Dacarbazine|dacarbazine|mesh-list
92004373|NCT00003027|Vinblastine|vinblastine|mesh-list
92004374|NCT00003027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004375|NCT00003027|Antiviral Agents|antiviral agents|mesh-ancestor
92004376|NCT00003027|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004377|NCT00003027|Immunologic Factors|immunologic factors|mesh-ancestor
92004378|NCT00003027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004379|NCT00003027|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92004380|NCT00003027|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92004381|NCT00003027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004382|NCT00003027|Alkylating Agents|alkylating agents|mesh-ancestor
92004383|NCT00003027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004384|NCT00003027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004385|NCT00003027|Tubulin Modulators|tubulin modulators|mesh-ancestor
92004386|NCT00003027|Antimitotic Agents|antimitotic agents|mesh-ancestor
92004387|NCT00003027|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004388|NCT00002914|Piritrexim|piritrexim|mesh-list
92004389|NCT00002914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004390|NCT00002914|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92004391|NCT00002914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004392|NCT00002914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004393|NCT00002872|Doxycycline|doxycycline|mesh-list
92004394|NCT00002872|Bleomycin|bleomycin|mesh-list
92004395|NCT00002872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004396|NCT00002872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004397|NCT00002872|Antimalarials|antimalarials|mesh-ancestor
92004398|NCT00002872|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92004399|NCT00002872|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92004400|NCT00002872|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92004401|NCT00002872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004402|NCT00002868|Interferons|interferons|mesh-list
92004403|NCT00002868|Cytarabine|cytarabine|mesh-list
92004404|NCT00002868|Interferon-alpha|interferon-alpha|mesh-list
92004405|NCT00002868|Etoposide|etoposide|mesh-list
92004406|NCT00002868|Idarubicin|idarubicin|mesh-list
92004407|NCT00002868|Busulfan|busulfan|mesh-list
92004408|NCT00002868|Hydroxyurea|hydroxyurea|mesh-list
92004412|NCT00002868|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004413|NCT00002868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004414|NCT00002868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004416|NCT00002868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004417|NCT00002868|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004418|NCT00002868|Antimetabolites|antimetabolites|mesh-ancestor
92004419|NCT00002868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984416|NCT05626439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91984417|NCT05626439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984418|NCT05626439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004420|NCT00002868|Immunologic Factors|immunologic factors|mesh-ancestor
92004421|NCT00002868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004422|NCT00002868|Alkylating Agents|alkylating agents|mesh-ancestor
92004423|NCT00002868|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004424|NCT00002868|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004425|NCT00002868|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92004426|NCT00002868|Antisickling Agents|antisickling agents|mesh-ancestor
92004427|NCT00002868|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92004429|NCT00002650|Hematinics|hematinics|mesh-ancestor
92004430|NCT00002650|Vitamin B Complex|vitamin b complex|mesh-ancestor
92004431|NCT00002650|Vitamins|vitamins|mesh-ancestor
92004432|NCT00002650|Micronutrients|micronutrients|mesh-ancestor
92004433|NCT00002650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004434|NCT03078725|Metformin|metformin|mesh-list
92004435|NCT03078725|Glyburide|glyburide|mesh-list
92004436|NCT03078725|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92004437|NCT03078725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004438|NCT02341963|Ketamine|ketamine|mesh-list
92004439|NCT02341963|Analgesics|analgesics|mesh-ancestor
92004440|NCT02341963|Sensory System Agents|sensory system agents|mesh-ancestor
92004441|NCT02341963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004442|NCT02341963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004443|NCT02341963|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92004444|NCT02341963|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92004445|NCT02341963|Anesthetics, General|anesthetics, general|mesh-ancestor
92004446|NCT02341963|Anesthetics|anesthetics|mesh-ancestor
92004447|NCT02341963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004448|NCT02341963|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92004449|NCT02341963|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92004450|NCT02341963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004451|NCT02341963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004452|NCT05014685|Amoxicillin|amoxicillin|mesh-list
92004453|NCT05014685|Metronidazole|metronidazole|mesh-list
92004454|NCT05014685|Potassium Citrate|potassium citrate|mesh-list
92004455|NCT05014685|Rabeprazole|rabeprazole|mesh-list
92004457|NCT05014685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004458|NCT05014685|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004459|NCT05014685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004460|NCT05014685|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92004461|NCT05014685|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92004462|NCT05014685|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92004463|NCT05014685|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004464|NCT05014685|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92004465|NCT05014685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004466|NCT05014685|Antacids|antacids|mesh-ancestor
92004467|NCT05014685|Diuretics|diuretics|mesh-ancestor
92004468|NCT05014685|Natriuretic Agents|natriuretic agents|mesh-ancestor
92004469|NCT05014685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004470|NCT05014685|Expectorants|expectorants|mesh-ancestor
92004471|NCT05014685|Respiratory System Agents|respiratory system agents|mesh-ancestor
92004472|NCT03111901|Pembrolizumab|pembrolizumab|mesh-list
92004473|NCT03111901|Interleukin-2|interleukin-2|mesh-list
92004474|NCT03111901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004475|NCT03111901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004476|NCT03111901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92004477|NCT03111901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004478|NCT03111901|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92004479|NCT03111901|Analgesics|analgesics|mesh-ancestor
92004704|NCT02340481|Antidiarrheals|antidiarrheals|mesh-list
92004480|NCT03111901|Sensory System Agents|sensory system agents|mesh-ancestor
92004483|NCT05014607|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92004484|NCT05014607|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92004485|NCT05014607|Immunologic Factors|immunologic factors|mesh-ancestor
92004486|NCT05014607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004488|NCT02341729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92004489|NCT02341729|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92004490|NCT02341729|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92004491|NCT02341729|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91984420|NCT05626439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91984421|NCT05626439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92004492|NCT02341729|Purinergic Agents|purinergic agents|mesh-ancestor
92004493|NCT02341729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004494|NCT02341729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004495|NCT02341729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004496|NCT05014373|Favipiravir|favipiravir|mesh-list
92004497|NCT05014373|Antiviral Agents|antiviral agents|mesh-ancestor
92004498|NCT05014373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004499|NCT04762459|Pemetrexed|pemetrexed|mesh-list
92004500|NCT04762459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004501|NCT04762459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004502|NCT04762459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004503|NCT04762459|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92004504|NCT04762459|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92004505|NCT03078569|Testosterone|testosterone|mesh-list
92004506|NCT03078569|Androgens|androgens|mesh-ancestor
92004507|NCT03078569|Hormones|hormones|mesh-ancestor
92004508|NCT03078569|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004509|NCT03078569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004510|NCT02345863|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92004511|NCT02345863|Obinutuzumab|obinutuzumab|mesh-list
92004512|NCT02345863|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92004513|NCT02345863|Alkylating Agents|alkylating agents|mesh-ancestor
92004514|NCT02345863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004515|NCT02345863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004516|NCT02345863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004517|NCT03078257|Aspirin|aspirin|mesh-list
92004519|NCT03078257|Fibrinolysin|fibrinolysin|mesh-list
92004520|NCT03078257|Clopidogrel|clopidogrel|mesh-list
92004521|NCT03078257|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92004522|NCT03078257|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92004523|NCT03078257|Analgesics|analgesics|mesh-ancestor
92004524|NCT03078257|Sensory System Agents|sensory system agents|mesh-ancestor
92004525|NCT03078257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004526|NCT03078257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004527|NCT03078257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004528|NCT03078257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004529|NCT03078257|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92004530|NCT03078257|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92004531|NCT03078257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004532|NCT03078257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92004533|NCT03078257|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92004534|NCT03078257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004536|NCT03078257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92004537|NCT03078257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92004538|NCT03078257|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92004539|NCT03078257|Purinergic Agents|purinergic agents|mesh-ancestor
92004540|NCT03078257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004541|NCT02341573|Leukotriene Antagonists|leukotriene antagonists|mesh-list
92004542|NCT02341573|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92004543|NCT02341573|Respiratory System Agents|respiratory system agents|mesh-ancestor
92004544|NCT02341573|Hormone Antagonists|hormone antagonists|mesh-ancestor
92004545|NCT02341573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004546|NCT02341573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004547|NCT05005715|Dexmedetomidine|dexmedetomidine|mesh-list
92004548|NCT05005715|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92004549|NCT05005715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004550|NCT05005715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004551|NCT05005715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92004553|NCT05005715|Sensory System Agents|sensory system agents|mesh-ancestor
92004554|NCT05005715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004555|NCT05005715|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92004556|NCT05005715|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91984422|NCT05626439|GABA Modulators|gaba modulators|mesh-ancestor
91984423|NCT05626439|GABA Agents|gaba agents|mesh-ancestor
91984424|NCT05626439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004557|NCT05005715|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92004558|NCT05005715|Adrenergic Agents|adrenergic agents|mesh-ancestor
92004559|NCT05005715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004560|NCT05005715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004561|NCT02345707|Cabotegravir|cabotegravir|mesh-list
92004562|NCT02345707|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92004563|NCT02345707|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92004564|NCT02345707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004565|NCT02345707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004566|NCT02345707|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92004567|NCT02345707|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92004568|NCT02345707|Antiviral Agents|antiviral agents|mesh-ancestor
92004569|NCT02345707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004570|NCT05005637|Antitubercular Agents|antitubercular agents|mesh-list
92004571|NCT05005637|Prednisone|prednisone|mesh-list
92004572|NCT05005637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004573|NCT05005637|Glucocorticoids|glucocorticoids|mesh-ancestor
92004574|NCT05005637|Hormones|hormones|mesh-ancestor
92004575|NCT05005637|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004576|NCT05005637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004577|NCT05005637|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004578|NCT05005637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004579|NCT05005637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004580|NCT05005637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004581|NCT02336659|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92004582|NCT02336659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92004583|NCT02336659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004584|NCT02336659|Incretins|incretins|mesh-ancestor
92004585|NCT02336659|Hormones|hormones|mesh-ancestor
92004586|NCT02336659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004587|NCT02336659|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92004588|NCT02336659|Protease Inhibitors|protease inhibitors|mesh-ancestor
92004589|NCT02336659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004590|NCT02336659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004591|NCT03081923|Durvalumab|durvalumab|mesh-list
92004592|NCT03081923|Tremelimumab|tremelimumab|mesh-list
92004593|NCT03081923|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92004594|NCT03081923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004595|NCT02341105|Amiodarone|amiodarone|mesh-list
92004596|NCT02341105|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92004597|NCT02341105|Vasodilator Agents|vasodilator agents|mesh-ancestor
92004598|NCT02341105|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92004599|NCT02341105|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92004600|NCT02341105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004601|NCT02341105|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92004602|NCT02341105|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92004603|NCT02341105|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92004604|NCT02341105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004605|NCT02341105|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92004606|NCT02341105|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92004607|NCT02341105|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92004608|NCT03078101|Empagliflozin|empagliflozin|mesh-list
92004609|NCT03078101|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92004610|NCT03078101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004611|NCT03078101|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92004612|NCT03078101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004613|NCT02345239|Pantoprazole|pantoprazole|mesh-list
92004614|NCT02345239|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92004615|NCT02345239|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004616|NCT02345239|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92004617|NCT02345239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004618|NCT02345239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004619|NCT04688203|Magnesium Sulfate|magnesium sulfate|mesh-list
92004620|NCT04688203|Labetalol|labetalol|mesh-list
92004621|NCT04688203|Analgesics|analgesics|mesh-ancestor
91984425|NCT05626439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004622|NCT04688203|Sensory System Agents|sensory system agents|mesh-ancestor
92004624|NCT04688203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004625|NCT04688203|Anesthetics|anesthetics|mesh-ancestor
92004626|NCT04688203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004627|NCT04688203|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92004628|NCT04688203|Anticonvulsants|anticonvulsants|mesh-ancestor
92004629|NCT04688203|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92004630|NCT04688203|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92004631|NCT04688203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004632|NCT04688203|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92004633|NCT04688203|Tocolytic Agents|tocolytic agents|mesh-ancestor
92004634|NCT04688203|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004635|NCT04688203|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92004636|NCT04688203|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92004637|NCT04688203|Adrenergic Agents|adrenergic agents|mesh-ancestor
92004638|NCT04688203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004639|NCT04688203|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92004640|NCT04688203|Sympathomimetics|sympathomimetics|mesh-ancestor
92004641|NCT04688203|Autonomic Agents|autonomic agents|mesh-ancestor
92004642|NCT04688203|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92004643|NCT04688203|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92004644|NCT05254561|Immunomodulating Agents|immunomodulating agents|mesh-list
92004645|NCT05254561|Immunologic Factors|immunologic factors|mesh-ancestor
92004646|NCT05254561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004647|NCT04509973|Dexamethasone|dexamethasone|mesh-list
92004648|NCT04509973|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004649|NCT04509973|Antiemetics|antiemetics|mesh-ancestor
92004650|NCT04509973|Autonomic Agents|autonomic agents|mesh-ancestor
92004651|NCT04509973|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004652|NCT04509973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004653|NCT04509973|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004654|NCT04509973|Glucocorticoids|glucocorticoids|mesh-ancestor
92004655|NCT04509973|Hormones|hormones|mesh-ancestor
92004656|NCT04509973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004657|NCT04509973|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004658|NCT04509973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004659|NCT02336347|Quinidine|quinidine|mesh-list
92004660|NCT02336347|Dextromethorphan|dextromethorphan|mesh-list
92004661|NCT02336347|Antitussive Agents|antitussive agents|mesh-ancestor
92004662|NCT02336347|Respiratory System Agents|respiratory system agents|mesh-ancestor
92004663|NCT02336347|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92004664|NCT02336347|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92004665|NCT02336347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004666|NCT02336347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004667|NCT02336347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004668|NCT02336347|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92004669|NCT02336347|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92004670|NCT02336347|Adrenergic Agents|adrenergic agents|mesh-ancestor
92004671|NCT02336347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92004672|NCT02336347|Antimalarials|antimalarials|mesh-ancestor
92004673|NCT02336347|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92004674|NCT02336347|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92004675|NCT02336347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004676|NCT02336347|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004677|NCT02336347|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92004678|NCT02336347|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92004679|NCT02336347|Cholinergic Agents|cholinergic agents|mesh-ancestor
92004680|NCT02336347|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92004681|NCT02336347|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92004682|NCT02336347|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92004683|NCT02336347|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92004684|NCT02336347|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92004685|NCT02341027|Levonorgestrel|levonorgestrel|mesh-list
92004686|NCT02341027|Contraceptive Agents|contraceptive agents|mesh-list
92004687|NCT02341027|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92004688|NCT02341027|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004689|NCT02341027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004691|NCT02341027|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92004693|NCT02039479|Lithium Carbonate|lithium carbonate|mesh-list
92004694|NCT02039479|Antidepressive Agents|antidepressive agents|mesh-ancestor
92004695|NCT02039479|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92004698|NCT02039479|Antimanic Agents|antimanic agents|mesh-ancestor
92004699|NCT02039479|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92004700|NCT02039479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004701|NCT02039479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004702|NCT02340481|Simethicone|simethicone|mesh-list
92004703|NCT02340481|Loperamide|loperamide|mesh-list
92004705|NCT02340481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004706|NCT02340481|Antifoaming Agents|antifoaming agents|mesh-ancestor
92004707|NCT02340481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004708|NCT02340481|Emollients|emollients|mesh-ancestor
92004709|NCT02340481|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004710|NCT03077633|Progesterone|progesterone|mesh-list
92004711|NCT03077633|Progestins|progestins|mesh-ancestor
92004712|NCT03077633|Hormones|hormones|mesh-ancestor
92004713|NCT03077633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004714|NCT03077633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004715|NCT05253781|Aspirin|aspirin|mesh-list
92004716|NCT05253781|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92004717|NCT05253781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92004718|NCT05253781|Analgesics|analgesics|mesh-ancestor
92004719|NCT05253781|Sensory System Agents|sensory system agents|mesh-ancestor
92004720|NCT05253781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004721|NCT05253781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004722|NCT05253781|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004723|NCT05253781|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004724|NCT05253781|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92004725|NCT05253781|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92004726|NCT05253781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004727|NCT05253781|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92004728|NCT05253781|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92004729|NCT05253781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004730|NCT05253781|Antipyretics|antipyretics|mesh-ancestor
92004731|NCT02340325|Kynurenic Acid|kynurenic acid|mesh-list
92004732|NCT02340325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92004733|NCT02340325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92004734|NCT02340325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004735|NCT02340325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004736|NCT02340325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004737|NCT02340247|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92004738|NCT02340247|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92004739|NCT02340247|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92004740|NCT02340247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004741|NCT02340247|Cathartics|cathartics|mesh-ancestor
92004742|NCT02340013|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92004743|NCT02340013|Medroxyprogesterone|medroxyprogesterone|mesh-list
92004744|NCT02340013|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92004745|NCT02340013|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92004746|NCT02340013|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92004747|NCT02340013|Contraceptive Agents|contraceptive agents|mesh-ancestor
92004748|NCT02340013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004749|NCT02340013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004750|NCT02340013|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92004751|NCT02340013|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92004752|NCT02340013|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92004753|NCT02340013|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004754|NCT02340013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004755|NCT05178823|Chlorhexidine|chlorhexidine|mesh-list
92004756|NCT05178823|Chlorine dioxide|chlorine dioxide|mesh-list
92004757|NCT05178823|Fluorides|fluorides|mesh-list
92004758|NCT05178823|Sodium Fluoride|sodium fluoride|mesh-list
92004759|NCT05178823|Cariostatic Agents|cariostatic agents|mesh-ancestor
92004760|NCT05178823|Protective Agents|protective agents|mesh-ancestor
92004761|NCT05178823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004762|NCT05178823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92004763|NCT05178823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004764|NCT05178823|Disinfectants|disinfectants|mesh-ancestor
92004765|NCT05178823|Dental Disinfectants|dental disinfectants|mesh-ancestor
92004766|NCT03105583|Vitamins|vitamins|mesh-list
92004767|NCT03105583|Micronutrients|micronutrients|mesh-ancestor
91984427|NCT05430009|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984428|NCT05430009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004768|NCT03105583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004771|NCT03105115|Anesthetics, Local|anesthetics, local|mesh-ancestor
92004772|NCT03105115|Anesthetics|anesthetics|mesh-ancestor
92004773|NCT03105115|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004774|NCT03105115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004775|NCT03105115|Sensory System Agents|sensory system agents|mesh-ancestor
92004776|NCT03105115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004777|NCT03105115|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92004778|NCT03105115|Narcotics|narcotics|mesh-ancestor
92004779|NCT03105115|Analgesics|analgesics|mesh-ancestor
92004780|NCT03105115|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92004781|NCT03105115|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92004782|NCT03105115|Anesthetics, General|anesthetics, general|mesh-ancestor
92004783|NCT03105349|Ribavirin|ribavirin|mesh-list
92004784|NCT03105349|Sofosbuvir|sofosbuvir|mesh-list
92004785|NCT03105349|Grazoprevir|grazoprevir|mesh-list
92004786|NCT03105349|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92004787|NCT03105349|Antimetabolites|antimetabolites|mesh-ancestor
92004788|NCT03105349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004789|NCT03105349|Antiviral Agents|antiviral agents|mesh-ancestor
92004790|NCT03105349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004791|NCT03077555|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92004792|NCT03077555|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92004793|NCT03077555|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92004794|NCT03077555|Estradiol|estradiol|mesh-list
92004795|NCT03077555|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92004796|NCT03077555|Estrogens|estrogens|mesh-ancestor
92004797|NCT03077555|Hormones|hormones|mesh-ancestor
92004798|NCT03077555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004799|NCT03077555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004800|NCT03077555|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92004801|NCT03077555|Contraceptive Agents|contraceptive agents|mesh-ancestor
92004802|NCT03077555|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92004803|NCT03077555|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92004804|NCT03077555|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92004805|NCT03077555|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92004806|NCT02335255|Naftifine|naftifine|mesh-list
92004807|NCT02335255|Antifungal Agents|antifungal agents|mesh-ancestor
92004808|NCT02335255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004809|NCT05012033|Prednisolone|prednisolone|mesh-list
92004810|NCT05012033|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004811|NCT05012033|Glucocorticoids|glucocorticoids|mesh-ancestor
92004812|NCT05012033|Hormones|hormones|mesh-ancestor
92004813|NCT05012033|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004814|NCT05012033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004815|NCT05012033|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004816|NCT05012033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004817|NCT02344303|Moxifloxacin|moxifloxacin|mesh-list
92004818|NCT02344303|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004819|NCT02344303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004820|NCT02344303|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004821|NCT02344303|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004822|NCT02344303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004823|NCT02344303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004824|NCT02344303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004825|NCT02334475|Methylprednisolone|methylprednisolone|mesh-list
92004826|NCT02334475|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92004827|NCT02334475|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92004828|NCT02334475|Prednisolone|prednisolone|mesh-list
92004829|NCT02334475|Prednisolone acetate|prednisolone acetate|mesh-list
92004830|NCT02334475|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92004831|NCT02334475|Prednisolone phosphate|prednisolone phosphate|mesh-list
92004832|NCT02334475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004833|NCT02334475|Antiemetics|antiemetics|mesh-ancestor
92004834|NCT02334475|Autonomic Agents|autonomic agents|mesh-ancestor
92004835|NCT02334475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004836|NCT02334475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004837|NCT02334475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004838|NCT02334475|Glucocorticoids|glucocorticoids|mesh-ancestor
92004839|NCT02334475|Hormones|hormones|mesh-ancestor
91984429|NCT05430009|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92004840|NCT02334475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004841|NCT02334475|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92004842|NCT02334475|Protective Agents|protective agents|mesh-ancestor
92004843|NCT02334475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92004852|NCT02338687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004853|NCT02338531|Nirogacestat|nirogacestat|mesh-list
92004854|NCT02338531|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92004855|NCT02338531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004856|NCT02338531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004857|NCT02332135|Vitamin D|vitamin d|mesh-list
92004858|NCT02332135|Vitamins|vitamins|mesh-ancestor
92004859|NCT02332135|Micronutrients|micronutrients|mesh-ancestor
92004860|NCT02332135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004861|NCT02332135|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92004862|NCT02334163|Metronidazole|metronidazole|mesh-list
92004863|NCT02334163|Nitazoxanide|nitazoxanide|mesh-list
92004864|NCT02334163|Lactulose|lactulose|mesh-list
92004865|NCT02334163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004866|NCT02334163|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004867|NCT02334163|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92004868|NCT02334163|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92004869|NCT02334163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92004870|NCT02332057|Diclofenac|diclofenac|mesh-list
92004871|NCT02332057|Lidocaine|lidocaine|mesh-list
92004872|NCT02332057|Anesthetics, Local|anesthetics, local|mesh-ancestor
92004873|NCT02332057|Anesthetics|anesthetics|mesh-ancestor
92004874|NCT02332057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004875|NCT02332057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004876|NCT02332057|Sensory System Agents|sensory system agents|mesh-ancestor
92004877|NCT02332057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004878|NCT02332057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92004879|NCT02332057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92004880|NCT02332057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92004881|NCT02332057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92004882|NCT02332057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004883|NCT02332057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92004884|NCT02332057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92004885|NCT02332057|Analgesics|analgesics|mesh-ancestor
92004886|NCT02332057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004887|NCT02332057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92004888|NCT02332057|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92004889|NCT02332057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004890|NCT02331745|Lenograstim|lenograstim|mesh-list
92004891|NCT02331745|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92004892|NCT02331745|Immunologic Factors|immunologic factors|mesh-ancestor
92004893|NCT02331745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004895|NCT02638259|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004896|NCT02333929|Rivaroxaban|rivaroxaban|mesh-list
92004897|NCT02333929|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92004898|NCT02333929|Antithrombins|antithrombins|mesh-ancestor
92004899|NCT02333929|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92004900|NCT02333929|Protease Inhibitors|protease inhibitors|mesh-ancestor
92004901|NCT02333929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004902|NCT02333929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004903|NCT02333929|Anticoagulants|anticoagulants|mesh-ancestor
92004904|NCT02333851|Insulin, pork; isophane insulin, pork drug combination 30:70|insulin, pork; isophane insulin, pork drug combination 30:70|mesh-list
92004905|NCT02333851|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92004906|NCT02333851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004907|NCT02334007|Dalteparin|dalteparin|mesh-list
92004908|NCT02334007|Tinzaparin|tinzaparin|mesh-list
92004909|NCT02334007|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92004910|NCT02334007|Anticoagulants|anticoagulants|mesh-ancestor
92004911|NCT02334007|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92004919|NCT02637323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92004920|NCT02637323|Glucocorticoids|glucocorticoids|mesh-ancestor
92004922|NCT02637323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92004923|NCT02637323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004924|NCT02637323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004925|NCT02637323|Immunologic Factors|immunologic factors|mesh-ancestor
92004926|NCT02637323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004927|NCT02637323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004928|NCT02331823|Moxifloxacin|moxifloxacin|mesh-list
91984430|NCT05430009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984431|NCT05429697|Pembrolizumab|pembrolizumab|mesh-list
91984432|NCT05429697|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984433|NCT05429697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984434|NCT05429697|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984435|NCT05429697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984437|NCT02540265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91984438|NCT02540265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91984439|NCT02540265|Analgesics|analgesics|mesh-ancestor
91984440|NCT02540265|Sensory System Agents|sensory system agents|mesh-ancestor
91984441|NCT02540265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984442|NCT02540265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984443|NCT02540265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984444|NCT02540265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984445|NCT02540265|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91984446|NCT02540265|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92004929|NCT02331823|Isoniazid|isoniazid|mesh-list
92004930|NCT02331823|Pyrazinamide|pyrazinamide|mesh-list
92004931|NCT02331823|Ethambutol|ethambutol|mesh-list
92004932|NCT02331823|Rifabutin|rifabutin|mesh-list
92004933|NCT02331823|Streptomycin|streptomycin|mesh-list
92004934|NCT02331823|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92004935|NCT02331823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92004936|NCT02331823|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004937|NCT02331823|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92004938|NCT02331823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004939|NCT02331823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004940|NCT02331823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004941|NCT02331823|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92004942|NCT02331823|Antitubercular Agents|antitubercular agents|mesh-ancestor
92004943|NCT02331823|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92004944|NCT02331823|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92004945|NCT02331823|Antimetabolites|antimetabolites|mesh-ancestor
92004946|NCT02331823|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92004947|NCT02331823|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92004948|NCT02890459|Denatonium|denatonium|mesh-list
92004949|NCT02890459|Aversive Agents|aversive agents|mesh-ancestor
92004950|NCT02890459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004951|NCT02890459|Abuse-Deterrent Formulations|abuse-deterrent formulations|mesh-ancestor
92004952|NCT02890459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004953|NCT02890459|Sensory System Agents|sensory system agents|mesh-ancestor
92004954|NCT02890459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004955|NCT03077009|Hyaluronic Acid|hyaluronic acid|mesh-list
92004956|NCT03077009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92004957|NCT03077009|Immunologic Factors|immunologic factors|mesh-ancestor
92004958|NCT03077009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004959|NCT03077009|Viscosupplements|viscosupplements|mesh-ancestor
92004960|NCT03077009|Protective Agents|protective agents|mesh-ancestor
92004961|NCT04477525|Bupivacaine|bupivacaine|mesh-list
92004962|NCT04477525|Anesthetics, Local|anesthetics, local|mesh-ancestor
92004963|NCT04477525|Anesthetics|anesthetics|mesh-ancestor
92004964|NCT04477525|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004965|NCT04477525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004966|NCT04477525|Sensory System Agents|sensory system agents|mesh-ancestor
92004967|NCT04477525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004968|NCT03079973|Calcipotriene|calcipotriene|mesh-list
92004969|NCT03079973|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984447|NCT02540265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984448|NCT02540265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984449|NCT02684357|Ustekinumab|ustekinumab|mesh-list
92004970|NCT03861871|Fenfluramine|fenfluramine|mesh-list
92004971|NCT03861871|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92004972|NCT03861871|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92004973|NCT03861871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92004974|NCT03861871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004975|NCT03861871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004976|NCT03861871|Serotonin Agents|serotonin agents|mesh-ancestor
92004977|NCT03861871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004978|NCT05004545|Propofol|propofol|mesh-list
92004998|NCT04463615|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004999|NCT04463615|Immunologic Factors|immunologic factors|mesh-ancestor
92005000|NCT04463615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005001|NCT05003765|Magnesium Sulfate|magnesium sulfate|mesh-list
92005002|NCT05003765|Buprenorphine|buprenorphine|mesh-list
92005003|NCT05003765|Bupivacaine|bupivacaine|mesh-list
92005004|NCT05003765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92005005|NCT05003765|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005006|NCT05003765|Anesthetics|anesthetics|mesh-ancestor
92005007|NCT05003765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005008|NCT05003765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005009|NCT05003765|Sensory System Agents|sensory system agents|mesh-ancestor
92005010|NCT05003765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005011|NCT05003765|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92005012|NCT05003765|Narcotics|narcotics|mesh-ancestor
92005013|NCT05003765|Analgesics|analgesics|mesh-ancestor
92005014|NCT05003765|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92005015|NCT05003765|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92005016|NCT05003765|Anticonvulsants|anticonvulsants|mesh-ancestor
92005017|NCT05003765|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92005018|NCT05003765|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005019|NCT05003765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005020|NCT05003765|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92005021|NCT05003765|Tocolytic Agents|tocolytic agents|mesh-ancestor
92005022|NCT05003765|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92005024|NCT02337283|Nootropic Agents|nootropic agents|mesh-ancestor
92005025|NCT02333305|Coenzyme Q10|coenzyme q10|mesh-list
92005026|NCT02333305|Vitamins|vitamins|mesh-ancestor
92005027|NCT02333305|Micronutrients|micronutrients|mesh-ancestor
92005028|NCT02333305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005029|NCT02326987|Pregabalin|pregabalin|mesh-list
92005030|NCT02326987|Analgesics|analgesics|mesh-ancestor
92005031|NCT02326987|Sensory System Agents|sensory system agents|mesh-ancestor
92005032|NCT02326987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005033|NCT02326987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005034|NCT02326987|Anticonvulsants|anticonvulsants|mesh-ancestor
92005042|NCT02326987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92005043|NCT02331511|Aspirin|aspirin|mesh-list
92005044|NCT02331511|Clopidogrel|clopidogrel|mesh-list
92005045|NCT02331511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005046|NCT02331511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92005047|NCT02331511|Analgesics|analgesics|mesh-ancestor
92005048|NCT02331511|Sensory System Agents|sensory system agents|mesh-ancestor
92005049|NCT02331511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005050|NCT02331511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005051|NCT02331511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005052|NCT02331511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92005053|NCT02331511|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92005054|NCT02331511|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92005055|NCT02331511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005056|NCT02331511|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92005057|NCT02331511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92005058|NCT02331511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005059|NCT02331511|Antipyretics|antipyretics|mesh-ancestor
92005060|NCT02331511|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92005061|NCT02331511|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92005062|NCT02331511|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92005063|NCT02331511|Purinergic Agents|purinergic agents|mesh-ancestor
92005064|NCT02331511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984450|NCT02684357|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91984451|NCT02684357|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984452|NCT02684357|Immunologic Factors|immunologic factors|mesh-ancestor
91984453|NCT02684357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005066|NCT02326441|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92005067|NCT02326441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005068|NCT02326441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005069|NCT02326441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92005070|NCT02326441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005071|NCT02326441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92005072|NCT02326441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005073|NCT02039791|Paclitaxel|paclitaxel|mesh-list
92005074|NCT02039791|Carboplatin|carboplatin|mesh-list
92005075|NCT02039791|Nimotuzumab|nimotuzumab|mesh-list
92005076|NCT02039791|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92005077|NCT02039791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005078|NCT02039791|Tubulin Modulators|tubulin modulators|mesh-ancestor
92005079|NCT02039791|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005080|NCT02039791|Mitosis Modulators|mitosis modulators|mesh-ancestor
92005081|NCT02039791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005082|NCT02039791|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92005083|NCT03573817|Formoterol Fumarate|formoterol fumarate|mesh-list
92005084|NCT03573817|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92005085|NCT03573817|Autonomic Agents|autonomic agents|mesh-ancestor
92005086|NCT03573817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005087|NCT03573817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005088|NCT03573817|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92005089|NCT03573817|Respiratory System Agents|respiratory system agents|mesh-ancestor
92005090|NCT03573817|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92005091|NCT03573817|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92005092|NCT03573817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92005093|NCT03573817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92005094|NCT03573817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005095|NCT03573817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005096|NCT03111511|JNJ-56136379|jnj-56136379|mesh-list
92005097|NCT03111511|Drospirenone|drospirenone|mesh-list
92005098|NCT03111511|Midazolam|midazolam|mesh-list
92005099|NCT03111511|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92005100|NCT03111511|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92005112|NCT03111511|GABA Modulators|gaba modulators|mesh-ancestor
92005113|NCT03111511|GABA Agents|gaba agents|mesh-ancestor
92005114|NCT03111511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005115|NCT03111511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005116|NCT03111511|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92005117|NCT03111511|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92005118|NCT03111511|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92005119|NCT03111511|Contraceptive Agents|contraceptive agents|mesh-ancestor
92005120|NCT03111511|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92005121|NCT03111511|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92005122|NCT03111511|Estrogens|estrogens|mesh-ancestor
92005123|NCT03111511|Hormones|hormones|mesh-ancestor
92005124|NCT03111511|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005125|NCT03111511|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92005126|NCT03111511|Hormone Antagonists|hormone antagonists|mesh-ancestor
92005127|NCT03111511|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92005128|NCT03111511|Diuretics|diuretics|mesh-ancestor
92005129|NCT03111511|Natriuretic Agents|natriuretic agents|mesh-ancestor
92005130|NCT03111511|Antiviral Agents|antiviral agents|mesh-ancestor
92005131|NCT03111511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005132|NCT03111511|Sequestering Agents|sequestering agents|mesh-ancestor
92005134|NCT03144115|Oxytocics|oxytocics|mesh-ancestor
92005135|NCT03144115|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92005136|NCT03144115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005137|NCT02326285|Docetaxel|docetaxel|mesh-list
92005138|NCT02326285|Gefitinib|gefitinib|mesh-list
92005139|NCT02326285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005140|NCT02326285|Tubulin Modulators|tubulin modulators|mesh-ancestor
92005141|NCT02326285|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005142|NCT02326285|Mitosis Modulators|mitosis modulators|mesh-ancestor
91984454|NCT03115073|Clotrimazole|clotrimazole|mesh-list
91984455|NCT03115073|Miconazole|miconazole|mesh-list
91984456|NCT03115073|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91984457|NCT03115073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005143|NCT02326285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005144|NCT02326285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92005145|NCT02326285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005146|NCT02332603|Methylprednisolone|methylprednisolone|mesh-list
92005147|NCT02332603|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92005148|NCT02332603|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92005150|NCT02332603|Prednisolone acetate|prednisolone acetate|mesh-list
92005151|NCT02332603|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92005152|NCT02332603|Prednisolone phosphate|prednisolone phosphate|mesh-list
92005153|NCT02332603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005154|NCT02332603|Antiemetics|antiemetics|mesh-ancestor
92005155|NCT02332603|Autonomic Agents|autonomic agents|mesh-ancestor
92005156|NCT02332603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005157|NCT02332603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005158|NCT02332603|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005159|NCT02332603|Glucocorticoids|glucocorticoids|mesh-ancestor
92005160|NCT02332603|Hormones|hormones|mesh-ancestor
92005161|NCT02332603|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005162|NCT02332603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92005163|NCT02332603|Protective Agents|protective agents|mesh-ancestor
92005164|NCT02332603|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92005165|NCT02332603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005166|NCT02332447|Naloxone|naloxone|mesh-list
92005168|NCT02332447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005169|NCT02332447|Sensory System Agents|sensory system agents|mesh-ancestor
92005170|NCT02332447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005172|NCT05077813|Ergocalciferols|ergocalciferols|mesh-list
92005173|NCT05077813|Cholecalciferol|cholecalciferol|mesh-list
92005174|NCT05077813|Vitamins|vitamins|mesh-list
92005175|NCT05077813|Minocycline|minocycline|mesh-list
92005176|NCT05077813|Tretinoin|tretinoin|mesh-list
92005177|NCT05077813|Alitretinoin|alitretinoin|mesh-list
92005178|NCT05077813|Isotretinoin|isotretinoin|mesh-list
92005179|NCT05077813|Micronutrients|micronutrients|mesh-ancestor
92005180|NCT05077813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005181|NCT05077813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92005182|NCT05077813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92005183|NCT05077813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005184|NCT05077813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005185|NCT05077813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005186|NCT05077813|Keratolytic Agents|keratolytic agents|mesh-ancestor
92005187|NCT05077813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92005188|NCT02326051|Enoxaparin|enoxaparin|mesh-list
92005189|NCT02326051|Enoxaparin sodium|enoxaparin sodium|mesh-list
92005190|NCT02326051|Anticoagulants|anticoagulants|mesh-ancestor
92005191|NCT02326051|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92005192|NCT02326051|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92005193|NCT02326051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005194|NCT05076955|Vancomycin|vancomycin|mesh-list
92005195|NCT05076955|Tobramycin|tobramycin|mesh-list
92005196|NCT05076955|Itraconazole|itraconazole|mesh-list
92005197|NCT05076955|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005198|NCT05076955|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005199|NCT05076955|Antifungal Agents|antifungal agents|mesh-ancestor
92005200|NCT05076955|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92005201|NCT05076955|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92005202|NCT05076955|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005203|NCT05076955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005204|NCT05076955|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92005205|NCT05076955|Hormone Antagonists|hormone antagonists|mesh-ancestor
92005206|NCT05076955|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005207|NCT05076955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005208|NCT05076955|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92005209|NCT05077111|Anesthetics|anesthetics|mesh-list
92005210|NCT05077111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005211|NCT05077111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005212|NCT05075863|Letrozole|letrozole|mesh-list
92005213|NCT05075863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984458|NCT03115073|Antifungal Agents|antifungal agents|mesh-ancestor
91984459|NCT03115073|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
91984460|NCT03115073|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91984461|NCT03115073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005214|NCT05075863|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92005215|NCT05075863|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92005216|NCT05075863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005217|NCT05075863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005218|NCT05075863|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92005219|NCT05075863|Hormone Antagonists|hormone antagonists|mesh-ancestor
92005220|NCT05075863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005221|NCT05075863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005223|NCT02330419|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92005224|NCT02330419|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92005225|NCT02330419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005226|NCT02330419|Sensory System Agents|sensory system agents|mesh-ancestor
92005227|NCT02330419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005228|NCT05068141|Paclitaxel|paclitaxel|mesh-list
92005229|NCT05068141|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92005230|NCT05068141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005231|NCT05068141|Tubulin Modulators|tubulin modulators|mesh-ancestor
92005232|NCT05068141|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005233|NCT05068141|Mitosis Modulators|mitosis modulators|mesh-ancestor
92005234|NCT05068141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005235|NCT03142165|Diphenhydramine|diphenhydramine|mesh-list
92005236|NCT03142165|Promethazine|promethazine|mesh-list
92005237|NCT03142165|Famotidine|famotidine|mesh-list
92005238|NCT03142165|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92005239|NCT03142165|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92005240|NCT03142165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005244|NCT03142165|Sensory System Agents|sensory system agents|mesh-ancestor
92005245|NCT03142165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005246|NCT03142165|Antiemetics|antiemetics|mesh-ancestor
92005247|NCT03142165|Autonomic Agents|autonomic agents|mesh-ancestor
92005248|NCT03142165|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005249|NCT03142165|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92005250|NCT03142165|Histamine Antagonists|histamine antagonists|mesh-ancestor
92005251|NCT03142165|Histamine Agents|histamine agents|mesh-ancestor
92005252|NCT03142165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005253|NCT03142165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005254|NCT03142165|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92005255|NCT03142165|Antipruritics|antipruritics|mesh-ancestor
92005256|NCT03142165|Dermatologic Agents|dermatologic agents|mesh-ancestor
92005257|NCT03142165|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92005258|NCT03142165|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92005259|NCT02330029|Pinaverium|pinaverium|mesh-list
92005260|NCT02330029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92005261|NCT02330029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005262|NCT02330029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005263|NCT02330029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92005264|NCT02330029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005265|NCT02330029|Parasympatholytics|parasympatholytics|mesh-ancestor
92005267|NCT02330029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005268|NCT04988971|Corticosterone|corticosterone|mesh-list
92005269|NCT04988971|Fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|fluoromethyl 2,2-difluoro-1-(trifluoromethyl)vinyl ether|mesh-list
92005270|NCT04988971|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005271|NCT04988971|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92005272|NCT04988971|Anesthetics, General|anesthetics, general|mesh-ancestor
92005273|NCT04988971|Anesthetics|anesthetics|mesh-ancestor
92005274|NCT04988971|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005275|NCT04988971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005276|NCT02329795|Temozolomide|temozolomide|mesh-list
92005277|NCT02329795|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92005278|NCT02329795|Alkylating Agents|alkylating agents|mesh-ancestor
92005279|NCT02329795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005280|NCT02329795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005282|NCT02329561|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92005283|NCT02329561|Narcotics|narcotics|mesh-ancestor
92005284|NCT02329561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005285|NCT02329561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005286|NCT02329561|Analgesics|analgesics|mesh-ancestor
92005287|NCT02329561|Sensory System Agents|sensory system agents|mesh-ancestor
92005288|NCT02329561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005289|NCT03143491|Paclitaxel|paclitaxel|mesh-list
92005290|NCT03143491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92005291|NCT03143491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005292|NCT03143491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92005293|NCT03143491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005294|NCT03143491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92005295|NCT03143491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005296|NCT05002673|Anesthetics|anesthetics|mesh-list
92005297|NCT05002673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005298|NCT05002673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005299|NCT03076151|Tacrolimus|tacrolimus|mesh-list
92005300|NCT03076151|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005301|NCT03076151|Immunologic Factors|immunologic factors|mesh-ancestor
92005302|NCT03076151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005303|NCT03076151|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92005304|NCT03076151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005305|NCT03076151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005306|NCT05002517|Methylprednisolone|methylprednisolone|mesh-list
92005307|NCT05002517|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92005308|NCT05002517|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92005309|NCT05002517|Prednisolone|prednisolone|mesh-list
92005310|NCT05002517|Prednisolone acetate|prednisolone acetate|mesh-list
92005312|NCT05002517|Prednisolone phosphate|prednisolone phosphate|mesh-list
92005313|NCT05002517|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005314|NCT05002517|Antiemetics|antiemetics|mesh-ancestor
92005315|NCT05002517|Autonomic Agents|autonomic agents|mesh-ancestor
92005316|NCT05002517|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005317|NCT05002517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005318|NCT05002517|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005319|NCT05002517|Glucocorticoids|glucocorticoids|mesh-ancestor
92005320|NCT05002517|Hormones|hormones|mesh-ancestor
92005321|NCT05002517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005322|NCT05002517|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92005323|NCT05002517|Protective Agents|protective agents|mesh-ancestor
92005324|NCT05002517|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92005325|NCT05002517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005326|NCT05002361|Dexamethasone|dexamethasone|mesh-list
92005327|NCT05002361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005328|NCT05002361|Antiemetics|antiemetics|mesh-ancestor
92005329|NCT05002361|Autonomic Agents|autonomic agents|mesh-ancestor
92005330|NCT05002361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005331|NCT05002361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005332|NCT05002361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005333|NCT05002361|Glucocorticoids|glucocorticoids|mesh-ancestor
92005334|NCT05002361|Hormones|hormones|mesh-ancestor
92005335|NCT05002361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005336|NCT05002361|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92005337|NCT05002361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005338|NCT02329405|Rifampin|rifampin|mesh-list
92005339|NCT02329405|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92005340|NCT02329405|Antitubercular Agents|antitubercular agents|mesh-ancestor
92005341|NCT02329405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005342|NCT02329405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005343|NCT02329405|Leprostatic Agents|leprostatic agents|mesh-ancestor
92005344|NCT02329405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92005345|NCT02329405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005346|NCT02329405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005347|NCT02329405|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92005348|NCT02329405|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92005349|NCT02329405|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92005350|NCT02329405|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92005351|NCT02329405|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91984462|NCT03115073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005352|NCT02329405|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92005353|NCT02329171|Imiquimod|imiquimod|mesh-list
92005354|NCT02329171|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92005355|NCT02329171|Immunologic Factors|immunologic factors|mesh-ancestor
92005356|NCT02329171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005357|NCT02329171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005358|NCT02329171|Interferon Inducers|interferon inducers|mesh-ancestor
92005359|NCT04498741|Midazolam|midazolam|mesh-list
92005360|NCT04498741|Dabigatran|dabigatran|mesh-list
92005361|NCT04498741|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92005362|NCT04498741|Tacrolimus|tacrolimus|mesh-list
92005363|NCT04498741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005364|NCT04498741|Immunologic Factors|immunologic factors|mesh-ancestor
92005365|NCT04498741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005366|NCT04498741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92005367|NCT04498741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005368|NCT04498741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005369|NCT04498741|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92005370|NCT04498741|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92005371|NCT04498741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005372|NCT04498741|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92005373|NCT04498741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92005374|NCT04498741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92005375|NCT04498741|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92005376|NCT04498741|Anesthetics, General|anesthetics, general|mesh-ancestor
92005378|NCT04498741|GABA Modulators|gaba modulators|mesh-ancestor
92005379|NCT04498741|GABA Agents|gaba agents|mesh-ancestor
92005380|NCT04498741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005381|NCT04498741|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92005382|NCT04498741|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92005383|NCT04498741|Antimetabolites|antimetabolites|mesh-ancestor
92005384|NCT04498741|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92005406|NCT04654429|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92005408|NCT04654429|Serotonin Agents|serotonin agents|mesh-ancestor
92005409|NCT04654429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005410|NCT04654429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005411|NCT03111121|Glycopyrrolate|glycopyrrolate|mesh-list
92005412|NCT03111121|Neostigmine|neostigmine|mesh-list
92005413|NCT03111121|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92005414|NCT03111121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005415|NCT03111121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005416|NCT03111121|Cholinergic Agents|cholinergic agents|mesh-ancestor
92005417|NCT03111121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005418|NCT03111121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005419|NCT03111121|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92005420|NCT03111121|Autonomic Agents|autonomic agents|mesh-ancestor
92005421|NCT03111121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005422|NCT03111121|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92005423|NCT03111121|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92005424|NCT03111121|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92005425|NCT02328469|Doxycycline|doxycycline|mesh-list
92005426|NCT02328469|Ceftriaxone|ceftriaxone|mesh-list
92005427|NCT02328469|Acyclovir|acyclovir|mesh-list
92005428|NCT02328469|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005429|NCT02328469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005430|NCT02328469|Antimalarials|antimalarials|mesh-ancestor
92005431|NCT02328469|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92005432|NCT02328469|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92005433|NCT02328469|Antiviral Agents|antiviral agents|mesh-ancestor
92005434|NCT04998071|Bupivacaine|bupivacaine|mesh-list
92005435|NCT04998071|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005436|NCT04998071|Anesthetics|anesthetics|mesh-ancestor
92005437|NCT04998071|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005438|NCT04998071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005456|NCT03073265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005458|NCT04997837|Capecitabine|capecitabine|mesh-list
92005459|NCT04997837|Tegafur|tegafur|mesh-list
92005460|NCT04997837|Oxaliplatin|oxaliplatin|mesh-list
92005461|NCT04997837|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92005462|NCT04997837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92005463|NCT04997837|Antimetabolites|antimetabolites|mesh-ancestor
92005464|NCT04997837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984463|NCT03115073|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91984464|NCT03115073|Hormone Antagonists|hormone antagonists|mesh-ancestor
92005465|NCT04997837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005466|NCT04997837|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92005467|NCT04202263|Minocycline|minocycline|mesh-list
92005468|NCT04202263|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005469|NCT04202263|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005470|NCT04996979|Ropivacaine|ropivacaine|mesh-list
92005471|NCT04996979|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005472|NCT04996979|Anesthetics|anesthetics|mesh-ancestor
92005473|NCT04996979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005474|NCT04996979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005475|NCT04996979|Sensory System Agents|sensory system agents|mesh-ancestor
92005476|NCT04996979|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005477|NCT03145285|Abiraterone Acetate|abiraterone acetate|mesh-list
92005478|NCT03145285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005479|NCT03145285|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92005480|NCT03145285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005481|NCT03145285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005482|NCT03145285|Hormone Antagonists|hormone antagonists|mesh-ancestor
92005483|NCT03145285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005484|NCT03145285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005485|NCT03145285|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92005486|NCT04997291|Dexrazoxane|dexrazoxane|mesh-list
92005488|NCT04997291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005489|NCT04997291|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92005490|NCT04997291|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92005491|NCT04997291|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92005492|NCT04997291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005493|NCT04997291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005494|NCT04997291|Protective Agents|protective agents|mesh-ancestor
92005495|NCT04997291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005496|NCT04997291|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005507|NCT02328079|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005509|NCT02328079|Hormones|hormones|mesh-ancestor
92005510|NCT02328079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005511|NCT02328079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005512|NCT02328079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92005513|NCT02328079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005514|NCT02328079|Antiemetics|antiemetics|mesh-ancestor
92005516|NCT02328079|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005517|NCT02328079|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005518|NCT02328079|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92005519|NCT02328079|Protective Agents|protective agents|mesh-ancestor
92005520|NCT02328079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005521|NCT04992533|Oxymetazoline|oxymetazoline|mesh-list
92005522|NCT04992533|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92005523|NCT04992533|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92005524|NCT04992533|Adrenergic Agents|adrenergic agents|mesh-ancestor
92005525|NCT04992533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005526|NCT04992533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005527|NCT04992533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005528|NCT04992533|Sympathomimetics|sympathomimetics|mesh-ancestor
92005529|NCT04992533|Autonomic Agents|autonomic agents|mesh-ancestor
92005530|NCT04992533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005531|NCT04992533|Nasal Decongestants|nasal decongestants|mesh-ancestor
92005532|NCT04992533|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92005533|NCT04992533|Respiratory System Agents|respiratory system agents|mesh-ancestor
92005534|NCT02578069|Sirolimus|sirolimus|mesh-list
92005535|NCT02578069|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005536|NCT02578069|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005537|NCT02578069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92005538|NCT02578069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005539|NCT02578069|Antifungal Agents|antifungal agents|mesh-ancestor
92005540|NCT02578069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005541|NCT02578069|Immunologic Factors|immunologic factors|mesh-ancestor
92005542|NCT02578069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005543|NCT03074825|Chiauranib|chiauranib|mesh-list
92005544|NCT03074825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005545|NCT03074825|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984465|NCT03115073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984466|NCT03115073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005546|NCT03074825|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005547|NCT03074825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005548|NCT03072485|Metformin|metformin|mesh-list
92005549|NCT03072485|Sirolimus|sirolimus|mesh-list
92005550|NCT03072485|Diclofenac|diclofenac|mesh-list
92005551|NCT03072485|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92005552|NCT03072485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005553|NCT03072485|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005554|NCT03072485|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005555|NCT03072485|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92005556|NCT03072485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005557|NCT03072485|Antifungal Agents|antifungal agents|mesh-ancestor
92005558|NCT03072485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005559|NCT03072485|Immunologic Factors|immunologic factors|mesh-ancestor
92005560|NCT03072485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005561|NCT03072485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005562|NCT03072485|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005563|NCT03072485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92005579|NCT03111433|Coenzyme Q10|coenzyme q10|mesh-list
92005580|NCT03111433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005581|NCT03111433|Micronutrients|micronutrients|mesh-ancestor
92005582|NCT03111433|Vitamins|vitamins|mesh-ancestor
92005583|NCT03143023|Fluorides|fluorides|mesh-list
92005584|NCT03143023|Cariostatic Agents|cariostatic agents|mesh-ancestor
92005585|NCT03143023|Protective Agents|protective agents|mesh-ancestor
92005586|NCT03143023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005587|NCT03074435|Ivermectin|ivermectin|mesh-list
92005588|NCT03074435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92005589|NCT03074435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005590|NCT03142789|Cerivastatin|cerivastatin|mesh-list
92005591|NCT03142789|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92005592|NCT03142789|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92005593|NCT03142789|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92005594|NCT03142789|Antimetabolites|antimetabolites|mesh-ancestor
92005595|NCT03142789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005596|NCT03142789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005597|NCT03142789|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92005598|NCT03072329|Bupivacaine|bupivacaine|mesh-list
92005599|NCT03072329|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005600|NCT03072329|Anesthetics|anesthetics|mesh-ancestor
92005601|NCT03072329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005602|NCT03072329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005603|NCT03072329|Sensory System Agents|sensory system agents|mesh-ancestor
92005604|NCT03072329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005605|NCT02327689|Emtricitabine|emtricitabine|mesh-list
92005606|NCT02327689|Adefovir|adefovir|mesh-list
92005607|NCT02327689|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92005608|NCT02327689|Antiviral Agents|antiviral agents|mesh-ancestor
92005609|NCT02327689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005610|NCT02327689|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92005611|NCT02327689|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92005612|NCT02327689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005613|NCT02327689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005614|NCT02327689|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92005615|NCT02327689|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92005616|NCT02327923|Ketorolac|ketorolac|mesh-list
92005617|NCT02327923|Lidocaine|lidocaine|mesh-list
92005618|NCT02327923|Atropine|atropine|mesh-list
92005619|NCT02327923|Ephedrine|ephedrine|mesh-list
92005620|NCT02327923|Fentanyl|fentanyl|mesh-list
92005621|NCT02327923|Glycopyrrolate|glycopyrrolate|mesh-list
92005622|NCT02327923|Morphine|morphine|mesh-list
92005623|NCT02327923|Tramadol|tramadol|mesh-list
92005624|NCT02327923|Ondansetron|ondansetron|mesh-list
92005625|NCT02327923|Bupivacaine|bupivacaine|mesh-list
92005626|NCT02327923|Propofol|propofol|mesh-list
92005627|NCT02327923|Neostigmine|neostigmine|mesh-list
92005628|NCT02327923|Vecuronium Bromide|vecuronium bromide|mesh-list
92005629|NCT02327923|Esmolol|esmolol|mesh-list
92005630|NCT02327923|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005652|NCT02327923|Antipruritics|antipruritics|mesh-ancestor
92005653|NCT02327923|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984467|NCT03115073|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
91984468|NCT03115073|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92005654|NCT02327923|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92005655|NCT02327923|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92005656|NCT02327923|Serotonin Agents|serotonin agents|mesh-ancestor
92005657|NCT02327923|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005658|NCT02327923|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005659|NCT02327923|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005661|NCT02327923|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92005662|NCT02327923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005663|NCT02327923|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92005664|NCT02327923|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92005665|NCT02327923|Respiratory System Agents|respiratory system agents|mesh-ancestor
92005666|NCT02327923|Mydriatics|mydriatics|mesh-ancestor
92005667|NCT02327923|Parasympatholytics|parasympatholytics|mesh-ancestor
92005668|NCT02327923|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92005669|NCT02327923|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92005670|NCT02327923|Cholinergic Agents|cholinergic agents|mesh-ancestor
92005671|NCT02327923|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92005673|NCT02327923|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92005674|NCT02327923|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92005675|NCT02327923|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92005676|NCT02327923|Adrenergic Agents|adrenergic agents|mesh-ancestor
92005677|NCT02327923|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92005678|NCT02327923|Sympathomimetics|sympathomimetics|mesh-ancestor
92005679|NCT02327923|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92005680|NCT02327923|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92005681|NCT02327923|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92005682|NCT02327923|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92005683|NCT02327923|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92005696|NCT03074123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005697|NCT03074123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005698|NCT02327299|Fesoterodine|fesoterodine|mesh-list
92005699|NCT02327299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92005700|NCT02327299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92005701|NCT02327299|Cholinergic Agents|cholinergic agents|mesh-ancestor
92005702|NCT02327299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005703|NCT02327299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005704|NCT02327299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005705|NCT02327299|Urological Agents|urological agents|mesh-ancestor
92005706|NCT03494569|Fludarabine|fludarabine|mesh-list
92005707|NCT03494569|Melphalan|melphalan|mesh-list
92005708|NCT03494569|Mechlorethamine|mechlorethamine|mesh-list
92005709|NCT03494569|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92005710|NCT03494569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005711|NCT03494569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005712|NCT03494569|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005713|NCT03494569|Immunologic Factors|immunologic factors|mesh-ancestor
92005714|NCT03494569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005715|NCT03494569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92005716|NCT03494569|Alkylating Agents|alkylating agents|mesh-ancestor
92005717|NCT03494569|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92005718|NCT03071549|Salicylic Acid|salicylic acid|mesh-list
92005719|NCT03071549|Salicylates|salicylates|mesh-list
92005720|NCT03071549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005722|NCT03071549|Keratolytic Agents|keratolytic agents|mesh-ancestor
92005723|NCT03071549|Dermatologic Agents|dermatologic agents|mesh-ancestor
92005724|NCT03071549|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005725|NCT03071549|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92005726|NCT03071549|Analgesics|analgesics|mesh-ancestor
92005727|NCT03071549|Sensory System Agents|sensory system agents|mesh-ancestor
92005728|NCT03071549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005729|NCT03071549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005730|NCT03071549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005731|NCT03071549|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92005732|NCT03071549|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92005733|NCT03071549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005734|NCT03071549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984469|NCT03166163|Chlorhexidine|chlorhexidine|mesh-list
91984470|NCT03166163|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91984471|NCT03166163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984472|NCT03166163|Disinfectants|disinfectants|mesh-ancestor
92005735|NCT03144817|Dialysis Solutions|dialysis solutions|mesh-list
92005736|NCT03144817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92005737|NCT04994951|Triamcinolone|triamcinolone|mesh-list
92005738|NCT04994951|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92005739|NCT04994951|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92005740|NCT04994951|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92005741|NCT04994951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005742|NCT04994951|Glucocorticoids|glucocorticoids|mesh-ancestor
92005743|NCT04994951|Hormones|hormones|mesh-ancestor
92005744|NCT04994951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005745|NCT04994951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005746|NCT04994951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005747|NCT04994951|Immunologic Factors|immunologic factors|mesh-ancestor
92005755|NCT03073889|Sensory System Agents|sensory system agents|mesh-ancestor
92005756|NCT03073889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005757|NCT03071705|Metformin|metformin|mesh-list
92005758|NCT03071705|Gefitinib|gefitinib|mesh-list
92005759|NCT03071705|Afatinib|afatinib|mesh-list
92005760|NCT03071705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92005761|NCT03071705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005762|NCT03071705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005763|NCT03071705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92005764|NCT03071705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005765|NCT03071705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005766|NCT03351439|Celecoxib|celecoxib|mesh-list
92005767|NCT03351439|Naproxen|naproxen|mesh-list
92005768|NCT03351439|Gabapentin|gabapentin|mesh-list
92005769|NCT03351439|Zopiclone|zopiclone|mesh-list
92005770|NCT03351439|Analgesics|analgesics|mesh-ancestor
92005771|NCT03351439|Sensory System Agents|sensory system agents|mesh-ancestor
92005772|NCT03351439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005773|NCT03351439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005774|NCT03351439|Anticonvulsants|anticonvulsants|mesh-ancestor
92005775|NCT03351439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92005776|NCT03351439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92005777|NCT03351439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005778|NCT03351439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92005779|NCT03351439|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92005780|NCT03351439|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92005781|NCT03351439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005782|NCT03351439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005783|NCT03351439|Antimanic Agents|antimanic agents|mesh-ancestor
92005784|NCT03351439|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005785|NCT03351439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92005786|NCT03351439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005787|NCT03351439|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92005788|NCT03351439|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92005789|NCT03351439|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92005790|NCT03351439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005791|NCT03351439|Gout Suppressants|gout suppressants|mesh-ancestor
92005792|NCT03351439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92005793|NCT03139747|Everolimus|everolimus|mesh-list
92005794|NCT03139747|Lenvatinib|lenvatinib|mesh-list
92005795|NCT03139747|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92005796|NCT03139747|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92005797|NCT03139747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005798|NCT03139747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005799|NCT03139747|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005800|NCT03139747|Immunologic Factors|immunologic factors|mesh-ancestor
92005801|NCT03139747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005802|NCT03139747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005803|NCT02037919|Etonogestrel|etonogestrel|mesh-list
92005804|NCT02037919|Desogestrel|desogestrel|mesh-list
92005805|NCT02037919|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92005806|NCT02037919|Contraceptive Agents|contraceptive agents|mesh-ancestor
92005807|NCT02037919|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92005808|NCT02037919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005809|NCT02037919|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91984473|NCT03165929|Flurbiprofen|flurbiprofen|mesh-list
91984474|NCT03165929|Analgesics|analgesics|mesh-ancestor
91984475|NCT03165929|Sensory System Agents|sensory system agents|mesh-ancestor
92005810|NCT02037919|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92005811|NCT02037919|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92005812|NCT02037919|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92005813|NCT02037919|Progestins|progestins|mesh-ancestor
92005814|NCT02037919|Hormones|hormones|mesh-ancestor
92005895|NCT04989257|Purinergic Agents|purinergic agents|mesh-ancestor
92005815|NCT02037919|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005821|NCT03139591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005822|NCT03139591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005823|NCT03139591|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005825|NCT03139591|Hormones|hormones|mesh-ancestor
92005826|NCT03139591|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005827|NCT03139591|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92005828|NCT03139591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005829|NCT03139591|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005830|NCT03139591|Anesthetics|anesthetics|mesh-ancestor
92005831|NCT03139591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005832|NCT03139591|Sensory System Agents|sensory system agents|mesh-ancestor
92005833|NCT03139591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92005834|NCT03139591|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92005835|NCT03139591|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92005836|NCT03139591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005837|NCT03139591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005838|NCT04412291|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92005839|NCT04412291|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92005840|NCT04412291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005841|NCT04412291|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92005842|NCT03139513|Vemurafenib|vemurafenib|mesh-list
92005843|NCT03139513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005844|NCT03139513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92005845|NCT03139513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005846|NCT03139513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005848|NCT04986995|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92005849|NCT04986995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005850|NCT04986995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005851|NCT04986995|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92005852|NCT04986995|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92005853|NCT03971929|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92005854|NCT03971929|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92005855|NCT03971929|Diuretics|diuretics|mesh-ancestor
92005856|NCT03971929|Natriuretic Agents|natriuretic agents|mesh-ancestor
92005857|NCT03971929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005858|NCT03971929|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92005859|NCT03971929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005860|NCT03971929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005861|NCT03070925|Anti-Infective Agents|anti-infective agents|mesh-list
92005862|NCT03070925|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92005863|NCT04986371|Niraparib|niraparib|mesh-list
92005864|NCT04986371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92005865|NCT04986371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005866|NCT04986371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005867|NCT04986371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005868|NCT04988945|Durvalumab|durvalumab|mesh-list
92005869|NCT04988945|Tremelimumab|tremelimumab|mesh-list
92005870|NCT04988945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92005871|NCT04988945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005872|NCT03070847|Tranexamic Acid|tranexamic acid|mesh-list
92005873|NCT03070847|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92005874|NCT03070847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92005875|NCT03070847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005876|NCT03070847|Hemostatics|hemostatics|mesh-ancestor
92005877|NCT03070847|Coagulants|coagulants|mesh-ancestor
92005878|NCT03069911|Botulinum Toxins|botulinum toxins|mesh-list
92005879|NCT03069911|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92005880|NCT03069911|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92005881|NCT03069911|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92005882|NCT03069911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91984476|NCT03165929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984477|NCT03165929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005883|NCT03069911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005887|NCT03069911|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92005888|NCT03069911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005889|NCT04989257|Clopidogrel|clopidogrel|mesh-list
92005890|NCT04989257|Ticagrelor|ticagrelor|mesh-list
92005891|NCT04989257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92005892|NCT04989257|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92005893|NCT04989257|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92005896|NCT04989257|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005897|NCT04989257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005898|NCT04989257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005900|NCT04892069|Insulin Aspart|insulin aspart|mesh-list
92005901|NCT04892069|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92005902|NCT04892069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005903|NCT03140449|Calcitriol|calcitriol|mesh-list
92005904|NCT03140449|Sirolimus|sirolimus|mesh-list
92005905|NCT03140449|Temsirolimus|temsirolimus|mesh-list
92005906|NCT03140449|MTOR Inhibitors|mtor inhibitors|mesh-list
92005907|NCT03140449|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92005908|NCT03140449|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92005909|NCT03140449|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92005910|NCT03140449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005911|NCT03140449|Antifungal Agents|antifungal agents|mesh-ancestor
92005912|NCT03140449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005913|NCT03140449|Immunologic Factors|immunologic factors|mesh-ancestor
92005914|NCT03140449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005915|NCT03140449|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92005916|NCT03140449|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005917|NCT03140449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005918|NCT03140449|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92005919|NCT03140449|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92005920|NCT03140449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005921|NCT03140449|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92005922|NCT03140449|Vitamins|vitamins|mesh-ancestor
92005923|NCT03140449|Micronutrients|micronutrients|mesh-ancestor
92005924|NCT03140449|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92005925|NCT02659813|Copper|copper|mesh-list
92005926|NCT02659813|Nickel|nickel|mesh-list
92005927|NCT02659813|Trace Elements|trace elements|mesh-ancestor
92005928|NCT02659813|Micronutrients|micronutrients|mesh-ancestor
92005929|NCT02659813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005930|NCT04985435|Adalimumab|adalimumab|mesh-list
92005931|NCT04985435|Etanercept|etanercept|mesh-list
92005932|NCT04985435|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92005933|NCT04985435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005934|NCT04985435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92005935|NCT04985435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005936|NCT04985435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92005937|NCT04985435|Analgesics|analgesics|mesh-ancestor
92005938|NCT04985435|Sensory System Agents|sensory system agents|mesh-ancestor
92005939|NCT04985435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005940|NCT04985435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005941|NCT04985435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005942|NCT04985435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92005943|NCT04985435|Immunologic Factors|immunologic factors|mesh-ancestor
92005944|NCT03070613|Lectins|lectins|mesh-list
92005945|NCT03070613|Agglutinins|agglutinins|mesh-ancestor
92005946|NCT03070613|Immunologic Factors|immunologic factors|mesh-ancestor
92005947|NCT03070613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005948|NCT03070613|Coagulants|coagulants|mesh-ancestor
92005949|NCT03441139|Analgesics|analgesics|mesh-list
92005950|NCT03441139|Sensory System Agents|sensory system agents|mesh-ancestor
92005951|NCT03441139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005952|NCT03441139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005953|NCT04988789|Paclitaxel|paclitaxel|mesh-list
92005954|NCT04988789|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92005955|NCT04988789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005956|NCT04988789|Tubulin Modulators|tubulin modulators|mesh-ancestor
92005957|NCT04988789|Antimitotic Agents|antimitotic agents|mesh-ancestor
92005958|NCT04988789|Mitosis Modulators|mitosis modulators|mesh-ancestor
91984478|NCT03165929|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92005963|NCT04985669|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92005965|NCT04985669|Serotonin Agents|serotonin agents|mesh-ancestor
92005966|NCT04985669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005967|NCT04985669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005968|NCT04985669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005969|NCT04753957|Progesterone|progesterone|mesh-list
92005970|NCT04753957|Progestins|progestins|mesh-ancestor
92005971|NCT04753957|Hormones|hormones|mesh-ancestor
92005972|NCT04753957|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92005973|NCT04753957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005974|NCT03070379|Lidocaine|lidocaine|mesh-list
92005975|NCT03070379|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005976|NCT03070379|Anesthetics|anesthetics|mesh-ancestor
92006163|NCT03013933|Immunotoxins|immunotoxins|mesh-ancestor
92005977|NCT03070379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005978|NCT03070379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005979|NCT03070379|Sensory System Agents|sensory system agents|mesh-ancestor
92005980|NCT03070379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005981|NCT03070379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92005982|NCT03070379|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92005983|NCT03070379|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92005984|NCT03070379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005985|NCT03070379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005986|NCT03227263|Bevacizumab|bevacizumab|mesh-list
92005987|NCT03227263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92005988|NCT03227263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005989|NCT03227263|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92005990|NCT03227263|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92005991|NCT03227263|Growth Substances|growth substances|mesh-ancestor
92005992|NCT03227263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005993|NCT03227263|Growth Inhibitors|growth inhibitors|mesh-ancestor
92005994|NCT04985201|Irinotecan|irinotecan|mesh-list
92005995|NCT04985201|Simvastatin|simvastatin|mesh-list
92005996|NCT04985201|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92005997|NCT04985201|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92005998|NCT04985201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005999|NCT04985201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006000|NCT04985201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006001|NCT04985201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92006002|NCT04985201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92006003|NCT04985201|Antimetabolites|antimetabolites|mesh-ancestor
92006004|NCT04985201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92006005|NCT04985201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92006006|NCT02031601|Carboplatin|carboplatin|mesh-list
92006007|NCT02031601|Docetaxel|docetaxel|mesh-list
92006008|NCT02031601|Pemetrexed|pemetrexed|mesh-list
92006009|NCT02031601|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92006010|NCT02031601|Gefitinib|gefitinib|mesh-list
92006011|NCT02031601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006012|NCT02031601|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006013|NCT02031601|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006014|NCT02031601|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006015|NCT02031601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006016|NCT02031601|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006017|NCT02031601|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92006018|NCT02031601|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92006019|NCT02031601|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92006020|NCT04984577|Edaravone|edaravone|mesh-list
92006021|NCT04984577|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92006022|NCT04984577|Antioxidants|antioxidants|mesh-ancestor
92006023|NCT04984577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006024|NCT04984577|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92006025|NCT04984577|Protective Agents|protective agents|mesh-ancestor
92006026|NCT04984577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006063|NCT03068351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006064|NCT03140293|Lidocaine|lidocaine|mesh-list
92006065|NCT03140293|Ethyl Chloride|ethyl chloride|mesh-list
92006066|NCT03140293|Anesthetics, Local|anesthetics, local|mesh-ancestor
92006067|NCT03140293|Anesthetics|anesthetics|mesh-ancestor
92006068|NCT03140293|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006069|NCT03140293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006070|NCT03140293|Sensory System Agents|sensory system agents|mesh-ancestor
91984479|NCT03165929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91984480|NCT03165929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984481|NCT03165929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984482|NCT03165929|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91984483|NCT03165929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984484|NCT03165929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984485|NCT03206073|Durvalumab|durvalumab|mesh-list
91984486|NCT03206073|Tremelimumab|tremelimumab|mesh-list
91984487|NCT03206073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006071|NCT03140293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006072|NCT03140293|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006073|NCT03140293|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92006074|NCT03140293|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92006075|NCT03140293|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006076|NCT03140293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006077|NCT04982861|Cefixime|cefixime|mesh-list
92006078|NCT04982861|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92006079|NCT04982861|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006080|NCT04572217|Topiramate|topiramate|mesh-list
92006081|NCT04572217|Phentermine|phentermine|mesh-list
92006082|NCT04572217|Anticonvulsants|anticonvulsants|mesh-ancestor
92006083|NCT04572217|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92006084|NCT04572217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006085|NCT04572217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92006086|NCT04572217|Appetite Depressants|appetite depressants|mesh-ancestor
92006087|NCT04572217|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92006088|NCT04572217|Sympathomimetics|sympathomimetics|mesh-ancestor
92006089|NCT04572217|Autonomic Agents|autonomic agents|mesh-ancestor
92006090|NCT04572217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006091|NCT04572217|Adrenergic Agents|adrenergic agents|mesh-ancestor
92006092|NCT04572217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006093|NCT04572217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006094|NCT05635955|Propofol|propofol|mesh-list
92006095|NCT05635955|Esketamine|esketamine|mesh-list
92006096|NCT05635955|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006097|NCT05635955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006108|NCT04452461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006109|NCT04452461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006110|NCT04452461|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006111|NCT04452461|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006112|NCT04452461|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006113|NCT04452461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006114|NCT04452461|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92006115|NCT04452461|Antimetabolites|antimetabolites|mesh-ancestor
92006116|NCT04452461|Antidotes|antidotes|mesh-ancestor
92006118|NCT04452461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006119|NCT04452461|Vitamin B Complex|vitamin b complex|mesh-ancestor
92006120|NCT04452461|Vitamins|vitamins|mesh-ancestor
92006121|NCT04452461|Micronutrients|micronutrients|mesh-ancestor
92006122|NCT03137017|Acetaminophen|acetaminophen|mesh-list
92006123|NCT03137017|Hydrocodone|hydrocodone|mesh-list
92006124|NCT03137017|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006125|NCT03137017|Analgesics|analgesics|mesh-ancestor
92006126|NCT03137017|Sensory System Agents|sensory system agents|mesh-ancestor
92006127|NCT03137017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006128|NCT03137017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006129|NCT03137017|Antipyretics|antipyretics|mesh-ancestor
92006130|NCT03137017|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92006131|NCT03137017|Narcotics|narcotics|mesh-ancestor
92006132|NCT03137017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006133|NCT03137017|Antitussive Agents|antitussive agents|mesh-ancestor
92006134|NCT03137017|Respiratory System Agents|respiratory system agents|mesh-ancestor
92006135|NCT03019003|Durvalumab|durvalumab|mesh-list
92006136|NCT03019003|Decitabine|decitabine|mesh-list
92006137|NCT03019003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984488|NCT03206073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984489|NCT03190941|Aldesleukin|aldesleukin|mesh-list
91984490|NCT03190941|Cyclophosphamide|cyclophosphamide|mesh-list
91984491|NCT03190941|Fludarabine|fludarabine|mesh-list
92006138|NCT03019003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006139|NCT03019003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92006140|NCT03019003|Antimetabolites|antimetabolites|mesh-ancestor
92006141|NCT03019003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006142|NCT03019003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006143|NCT03013933|Cyclosporine|cyclosporine|mesh-list
92006144|NCT03013933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92006145|NCT03013933|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92006146|NCT03013933|Verapamil|verapamil|mesh-list
92006147|NCT03013933|Antibodies|antibodies|mesh-list
92006148|NCT03013933|Immunoglobulins|immunoglobulins|mesh-list
92006149|NCT03013933|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92006150|NCT03013933|Cyclosporins|cyclosporins|mesh-list
92006151|NCT03013933|Immunoconjugates|immunoconjugates|mesh-list
92006152|NCT03013933|Immunologic Factors|immunologic factors|mesh-ancestor
92006153|NCT03013933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006154|NCT03013933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006155|NCT03013933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006156|NCT03013933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006157|NCT03013933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92006158|NCT03013933|Antifungal Agents|antifungal agents|mesh-ancestor
92006159|NCT03013933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006160|NCT03013933|Dermatologic Agents|dermatologic agents|mesh-ancestor
92006161|NCT03013933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92006162|NCT03013933|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92006164|NCT03013933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006165|NCT03013933|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92006166|NCT03013933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006167|NCT03013933|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92006181|NCT03217825|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006182|NCT03217825|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92006183|NCT03217825|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92006184|NCT03217825|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92006185|NCT03217825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006187|NCT04035187|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92006188|NCT04035187|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92006189|NCT04035187|Antifungal Agents|antifungal agents|mesh-ancestor
92006190|NCT04035187|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006191|NCT04035187|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92006192|NCT04035187|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92006193|NCT04035187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006194|NCT04035187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006195|NCT04035187|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92006196|NCT04035187|Hormone Antagonists|hormone antagonists|mesh-ancestor
92006197|NCT04035187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006198|NCT04035187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006199|NCT04035187|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92006201|NCT00157963|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92006202|NCT00157963|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006203|NCT00157963|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92006204|NCT00157963|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92006205|NCT00157963|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92006206|NCT00157963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006207|NCT00157963|Diuretics|diuretics|mesh-ancestor
92006208|NCT00157963|Natriuretic Agents|natriuretic agents|mesh-ancestor
92006209|NCT00157963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006210|NCT00157963|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92006211|NCT00157963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006212|NCT05087797|Nicorandil|nicorandil|mesh-list
92006213|NCT05087797|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006214|NCT05087797|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92006215|NCT05087797|Vasodilator Agents|vasodilator agents|mesh-ancestor
92006216|NCT05087797|Vitamin B Complex|vitamin b complex|mesh-ancestor
92006217|NCT05087797|Vitamins|vitamins|mesh-ancestor
91984492|NCT03190941|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984493|NCT03190941|Immunologic Factors|immunologic factors|mesh-ancestor
91984494|NCT03190941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006218|NCT05087797|Micronutrients|micronutrients|mesh-ancestor
92006219|NCT05087797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006220|NCT03906877|Hyaluronic Acid|hyaluronic acid|mesh-list
92006221|NCT03906877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92006222|NCT03906877|Immunologic Factors|immunologic factors|mesh-ancestor
92006223|NCT03906877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006224|NCT03906877|Viscosupplements|viscosupplements|mesh-ancestor
92006225|NCT03906877|Protective Agents|protective agents|mesh-ancestor
92006226|NCT03867799|Nivolumab|nivolumab|mesh-list
92006227|NCT03867799|Relatlimab|relatlimab|mesh-list
92006228|NCT03867799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006229|NCT03867799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006230|NCT03867799|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006259|NCT05634473|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92006260|NCT05634473|Respiratory System Agents|respiratory system agents|mesh-ancestor
92006261|NCT05634473|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92006262|NCT05634473|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92006263|NCT05634473|Cholinergic Agents|cholinergic agents|mesh-ancestor
92006264|NCT05634473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006265|NCT05634473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006266|NCT03138499|Nivolumab|nivolumab|mesh-list
92006267|NCT03138499|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92006268|NCT03138499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006269|NCT03138499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006270|NCT03138499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006271|NCT03138499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006272|NCT03138499|Immunotoxins|immunotoxins|mesh-ancestor
92006273|NCT03138499|Immunoconjugates|immunoconjugates|mesh-ancestor
92006274|NCT03138499|Immunologic Factors|immunologic factors|mesh-ancestor
92006275|NCT03138499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006276|NCT04858711|Lidocaine|lidocaine|mesh-list
92006277|NCT04858711|Fentanyl|fentanyl|mesh-list
92006278|NCT04858711|Dexmedetomidine|dexmedetomidine|mesh-list
92006279|NCT04858711|Ketamine|ketamine|mesh-list
92006280|NCT04858711|Anesthetics, Local|anesthetics, local|mesh-ancestor
92006281|NCT04858711|Anesthetics|anesthetics|mesh-ancestor
92006282|NCT04858711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006283|NCT04858711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006284|NCT04858711|Sensory System Agents|sensory system agents|mesh-ancestor
92006285|NCT04858711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006286|NCT04858711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006287|NCT04858711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92006288|NCT04858711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92006289|NCT04858711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006290|NCT04858711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006291|NCT04858711|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006292|NCT04858711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006293|NCT04858711|Analgesics|analgesics|mesh-ancestor
92006294|NCT04858711|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92006295|NCT04858711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92006296|NCT04858711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92006327|NCT03067883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92006329|NCT03285763|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006330|NCT03285763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006331|NCT03285763|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006332|NCT03285763|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006333|NCT05393011|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92006334|NCT05393011|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92006335|NCT05393011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006359|NCT03085771|Deferoxamine|deferoxamine|mesh-list
92006360|NCT03085771|Siderophores|siderophores|mesh-ancestor
92006361|NCT03085771|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92006362|NCT03085771|Chelating Agents|chelating agents|mesh-ancestor
92006363|NCT03085771|Sequestering Agents|sequestering agents|mesh-ancestor
92006367|NCT05619965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006368|NCT04659629|Pembrolizumab|pembrolizumab|mesh-list
91984496|NCT03190941|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984497|NCT03190941|Alkylating Agents|alkylating agents|mesh-ancestor
92006369|NCT04659629|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006370|NCT04659629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006371|NCT04659629|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006372|NCT04659629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006373|NCT02998567|Pembrolizumab|pembrolizumab|mesh-list
92006374|NCT02998567|Guadecitabine|guadecitabine|mesh-list
92006375|NCT02998567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006376|NCT02998567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006377|NCT02998567|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006378|NCT02998567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006380|NCT02985619|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92006381|NCT02985619|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92006382|NCT02985619|Bevacizumab|bevacizumab|mesh-list
92006383|NCT02985619|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92006384|NCT02985619|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006385|NCT02985619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006386|NCT02985619|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92006387|NCT02985619|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92006388|NCT02985619|Growth Substances|growth substances|mesh-ancestor
92006389|NCT02985619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006390|NCT02985619|Growth Inhibitors|growth inhibitors|mesh-ancestor
92006391|NCT02985619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006392|NCT02985619|Glucocorticoids|glucocorticoids|mesh-ancestor
92006393|NCT02985619|Hormones|hormones|mesh-ancestor
92006394|NCT02985619|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006395|NCT02985619|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92006396|NCT02985619|Immunologic Factors|immunologic factors|mesh-ancestor
92006397|NCT02985619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006398|NCT02985619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006399|NCT03110653|Remifentanil|remifentanil|mesh-list
92006400|NCT03110653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92006401|NCT03110653|Narcotics|narcotics|mesh-ancestor
92006402|NCT03110653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006403|NCT03110653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006404|NCT03110653|Analgesics|analgesics|mesh-ancestor
92006405|NCT03110653|Sensory System Agents|sensory system agents|mesh-ancestor
92006406|NCT03110653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006407|NCT05392387|Antiviral Agents|antiviral agents|mesh-list
92006408|NCT05392387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006409|NCT02037529|Paclitaxel|paclitaxel|mesh-list
92006410|NCT02037529|Halichondrin B|halichondrin b|mesh-list
92006411|NCT02037529|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92006412|NCT02037529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006413|NCT02037529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006414|NCT02037529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006415|NCT02037529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006416|NCT02037529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006417|NCT02037529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006418|NCT04450199|Vitamin D|vitamin d|mesh-list
92006419|NCT04450199|Ergocalciferols|ergocalciferols|mesh-list
92006420|NCT04450199|Cholecalciferol|cholecalciferol|mesh-list
92006421|NCT04450199|Vitamins|vitamins|mesh-list
92006422|NCT04450199|Micronutrients|micronutrients|mesh-ancestor
92006423|NCT04450199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006424|NCT04450199|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92006425|NCT04450199|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92006426|NCT01884259|Docetaxel|docetaxel|mesh-list
92006427|NCT01884259|Fluorouracil|fluorouracil|mesh-list
92006428|NCT01884259|Cetuximab|cetuximab|mesh-list
92006429|NCT01884259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006430|NCT01884259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006431|NCT01884259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006432|NCT01884259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006433|NCT01884259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006434|NCT01884259|Antimetabolites|antimetabolites|mesh-ancestor
92006438|NCT01884259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006439|NCT01884259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090418|NCT00892606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006441|NCT04930549|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92006442|NCT04930549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006444|NCT04930549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006445|NCT04508621|Cyclobenzaprine|cyclobenzaprine|mesh-list
92006446|NCT04508621|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92006447|NCT04508621|Antidepressive Agents|antidepressive agents|mesh-ancestor
92006448|NCT04508621|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92006449|NCT04508621|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92006450|NCT04508621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006451|NCT04508621|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92006452|NCT04508621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006453|NCT04508621|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92006454|NCT04508621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006455|NCT03067727|Dinoprostone|dinoprostone|mesh-list
92006456|NCT03067727|Oxytocics|oxytocics|mesh-ancestor
92006457|NCT03067727|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92006458|NCT03067727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006459|NCT01794793|Cabergoline|cabergoline|mesh-list
92006460|NCT01794793|Pasireotide|pasireotide|mesh-list
92006461|NCT01794793|Somatostatin|somatostatin|mesh-list
92006462|NCT01794793|Hormones|hormones|mesh-ancestor
92006463|NCT01794793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006464|NCT01794793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006465|NCT01794793|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92006466|NCT01794793|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92006467|NCT01794793|Dopamine Agonists|dopamine agonists|mesh-ancestor
92006468|NCT01794793|Dopamine Agents|dopamine agents|mesh-ancestor
92006469|NCT01794793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006470|NCT01794793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006471|NCT03067103|Ketamine|ketamine|mesh-list
92006472|NCT03067103|Tramadol|tramadol|mesh-list
92006473|NCT03067103|Analgesics|analgesics|mesh-ancestor
92006474|NCT03067103|Sensory System Agents|sensory system agents|mesh-ancestor
92006475|NCT03067103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006476|NCT03067103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006477|NCT03067103|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92006478|NCT03067103|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92006479|NCT03067103|Anesthetics, General|anesthetics, general|mesh-ancestor
92006480|NCT03067103|Anesthetics|anesthetics|mesh-ancestor
92006481|NCT03067103|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006482|NCT03067103|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92006483|NCT03067103|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92006484|NCT03067103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006485|NCT03067103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006486|NCT03067103|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92006487|NCT03067103|Narcotics|narcotics|mesh-ancestor
92006488|NCT05492123|Cisplatin|cisplatin|mesh-list
92006489|NCT05492123|Nivolumab|nivolumab|mesh-list
92006490|NCT05492123|Ipilimumab|ipilimumab|mesh-list
92006492|NCT05492123|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006493|NCT05492123|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006494|NCT05492123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006496|NCT01398319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92006497|NCT01398319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006498|NCT01398319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006499|NCT01398319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006500|NCT01305889|Sertraline|sertraline|mesh-list
92006501|NCT01305889|Antidepressive Agents|antidepressive agents|mesh-ancestor
92006502|NCT01305889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92006503|NCT01305889|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92006504|NCT01305889|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92006505|NCT01305889|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006509|NCT01305889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006511|NCT05392075|Immunologic Factors|immunologic factors|mesh-ancestor
92006512|NCT05392075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006513|NCT00223171|Androgens|androgens|mesh-list
92006514|NCT00223171|Hormones|hormones|mesh-ancestor
92006515|NCT00223171|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006516|NCT00223171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984498|NCT03190941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984499|NCT03190941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006518|NCT03138031|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92006519|NCT03138031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006520|NCT03138031|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006521|NCT03138031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006522|NCT02735057|Paclitaxel|paclitaxel|mesh-list
92006523|NCT02735057|Carboplatin|carboplatin|mesh-list
92006524|NCT02735057|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006525|NCT02735057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006526|NCT02735057|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006527|NCT02735057|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006528|NCT02735057|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006529|NCT02735057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006530|NCT05431283|Tofacitinib|tofacitinib|mesh-list
92006531|NCT05431283|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92006532|NCT05431283|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92006533|NCT05431283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006534|NCT05431283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006535|NCT03208985|Ulipristal acetate|ulipristal acetate|mesh-list
92006536|NCT03208985|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92006537|NCT03208985|Contraceptive Agents|contraceptive agents|mesh-ancestor
92006538|NCT03208985|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92006539|NCT03208985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006540|NCT03208985|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92006541|NCT03644953|Hydroxyurea|hydroxyurea|mesh-list
92006542|NCT03644953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006543|NCT03644953|Antisickling Agents|antisickling agents|mesh-ancestor
92006544|NCT03644953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006545|NCT03644953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006546|NCT03644953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92006547|NCT03630835|Annexin A5|annexin a5|mesh-list
92006548|NCT03630835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006549|NCT03630835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006550|NCT04764097|Dapagliflozin|dapagliflozin|mesh-list
92006551|NCT04764097|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92006552|NCT04764097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006553|NCT04764097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92006554|NCT04764097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006555|NCT02902757|Deoxyglucose|deoxyglucose|mesh-list
92006556|NCT02902757|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92006557|NCT02902757|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92006558|NCT02902757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006559|NCT02902757|Antimetabolites|antimetabolites|mesh-ancestor
92006560|NCT02902757|Antiviral Agents|antiviral agents|mesh-ancestor
92006561|NCT02902757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006562|NCT05391451|Anesthetics|anesthetics|mesh-list
92006563|NCT05391451|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006564|NCT05391451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006565|NCT03110341|Epoetin Alfa|epoetin alfa|mesh-list
92006566|NCT03110341|Hematinics|hematinics|mesh-ancestor
92006567|NCT04648189|Cetuximab|cetuximab|mesh-list
92006568|NCT04648189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006569|NCT04648189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006570|NCT04537897|Midazolam|midazolam|mesh-list
92006571|NCT04537897|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92006572|NCT04537897|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006573|NCT04537897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006574|NCT04537897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006575|NCT04537897|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92006582|NCT04537897|GABA Agents|gaba agents|mesh-ancestor
92006583|NCT04537897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006584|NCT04537897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006585|NCT04405063|Paclitaxel|paclitaxel|mesh-list
92006586|NCT04405063|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006587|NCT04405063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006588|NCT04405063|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006589|NCT04405063|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006590|NCT04405063|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006591|NCT04405063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984500|NCT03190941|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91984502|NCT03190941|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91984503|NCT03190941|Antiviral Agents|antiviral agents|mesh-ancestor
91984504|NCT03190941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984505|NCT03142893|Ketoconazole|ketoconazole|mesh-list
92006592|NCT05090449|Losartan|losartan|mesh-list
92006593|NCT05090449|Chlorthalidone|chlorthalidone|mesh-list
92006594|NCT05090449|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006595|NCT05090449|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92006596|NCT05090449|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92006597|NCT05090449|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92006598|NCT05090449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006599|NCT05090449|Diuretics|diuretics|mesh-ancestor
92006600|NCT05090449|Natriuretic Agents|natriuretic agents|mesh-ancestor
92006601|NCT05090449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006602|NCT05090449|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92006603|NCT05090449|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006604|NCT05090137|Diuretics|diuretics|mesh-list
92006605|NCT05090137|Natriuretic Agents|natriuretic agents|mesh-ancestor
92006606|NCT05090137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006607|NCT03067415|Latanoprost|latanoprost|mesh-list
92006608|NCT03067415|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92006609|NCT03067415|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92006610|NCT05089981|Acetylcysteine|acetylcysteine|mesh-list
92006611|NCT05089981|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92006612|NCT05089981|Antiviral Agents|antiviral agents|mesh-ancestor
92006613|NCT05089981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006614|NCT05089981|Expectorants|expectorants|mesh-ancestor
92006615|NCT05089981|Respiratory System Agents|respiratory system agents|mesh-ancestor
92006616|NCT05089981|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92006617|NCT05089981|Antioxidants|antioxidants|mesh-ancestor
92006618|NCT05089981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006619|NCT05089981|Protective Agents|protective agents|mesh-ancestor
92006620|NCT05089981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006621|NCT05089981|Antidotes|antidotes|mesh-ancestor
92006622|NCT05730413|Bisoprolol|bisoprolol|mesh-list
92006623|NCT05730413|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92006624|NCT05730413|Sympatholytics|sympatholytics|mesh-ancestor
92006625|NCT05730413|Autonomic Agents|autonomic agents|mesh-ancestor
92006626|NCT05730413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006627|NCT05730413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006628|NCT05730413|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92006629|NCT05730413|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92006630|NCT05730413|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92006631|NCT05730413|Adrenergic Agents|adrenergic agents|mesh-ancestor
92006632|NCT05730413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006633|NCT05730413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006634|NCT04206059|Dexmedetomidine|dexmedetomidine|mesh-list
92006635|NCT04206059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006636|NCT04206059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006889|NCT05520749|Hematinics|hematinics|mesh-ancestor
92006637|NCT04206059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006638|NCT04206059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006640|NCT04206059|Sensory System Agents|sensory system agents|mesh-ancestor
92006641|NCT04206059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006642|NCT04206059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92006643|NCT04206059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92006644|NCT04206059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92006645|NCT04206059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92006650|NCT05431049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006652|NCT04132817|Nivolumab|nivolumab|mesh-list
92006653|NCT04132817|Ipilimumab|ipilimumab|mesh-list
92006654|NCT04132817|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006655|NCT04132817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006656|NCT04132817|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006657|NCT04132817|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006658|NCT04132817|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006659|NCT04132817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006660|NCT04132817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006661|NCT04132817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984506|NCT03142893|Dexamethasone|dexamethasone|mesh-list
91984507|NCT03142893|Dexamethasone acetate|dexamethasone acetate|mesh-list
91984508|NCT03142893|Hydrocortisone|hydrocortisone|mesh-list
91984509|NCT03142893|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
91984510|NCT03142893|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92006662|NCT03066635|Botulinum Toxins|botulinum toxins|mesh-list
92006663|NCT03066635|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92006664|NCT03066635|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92006665|NCT03066635|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92006666|NCT03066635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006667|NCT03066635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006668|NCT03066635|Cholinergic Agents|cholinergic agents|mesh-ancestor
92006669|NCT03066635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006670|NCT03066635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006671|NCT03066635|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92006672|NCT03066635|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006673|NCT03136237|Cyclosporine|cyclosporine|mesh-list
92006674|NCT03136237|Digoxin|digoxin|mesh-list
92006675|NCT03136237|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92006676|NCT03136237|Cyclosporins|cyclosporins|mesh-list
92006677|NCT03136237|Berotralstat|berotralstat|mesh-list
92006678|NCT03136237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006679|NCT03136237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006680|NCT03136237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92006681|NCT03136237|Immunologic Factors|immunologic factors|mesh-ancestor
92006682|NCT03136237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006683|NCT03136237|Antifungal Agents|antifungal agents|mesh-ancestor
92006684|NCT03136237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006685|NCT03136237|Dermatologic Agents|dermatologic agents|mesh-ancestor
92006686|NCT03136237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92006687|NCT03136237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92006688|NCT03136237|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92006689|NCT03136237|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92006690|NCT03136237|Antimetabolites|antimetabolites|mesh-ancestor
92006691|NCT03136237|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92006692|NCT03136237|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92006693|NCT03136237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92006694|NCT03136237|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92006695|NCT03136237|Protective Agents|protective agents|mesh-ancestor
92006696|NCT03136237|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92006697|NCT03136237|Protease Inhibitors|protease inhibitors|mesh-ancestor
92006698|NCT04001309|Anti-Infective Agents|anti-infective agents|mesh-list
92006699|NCT04001309|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92006700|NCT04021381|Magnesium citrate|magnesium citrate|mesh-list
92006701|NCT04021381|Cathartics|cathartics|mesh-ancestor
92006702|NCT04021381|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92006703|NCT03066791|Curcumin|curcumin|mesh-list
92006704|NCT03066791|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92006705|NCT03066791|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006706|NCT03066791|Analgesics|analgesics|mesh-ancestor
92006707|NCT03066791|Sensory System Agents|sensory system agents|mesh-ancestor
92006708|NCT03066791|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006709|NCT03066791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006710|NCT03066791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006711|NCT03066791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92006712|NCT03066791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006713|NCT03066791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006714|NCT03066791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006733|NCT05729555|Anesthetics|anesthetics|mesh-ancestor
92006734|NCT05729555|Antiemetics|antiemetics|mesh-ancestor
92006735|NCT05729555|Autonomic Agents|autonomic agents|mesh-ancestor
92006736|NCT05729555|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92006737|NCT05729555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92006738|NCT05729555|Histamine Antagonists|histamine antagonists|mesh-ancestor
92006739|NCT05729555|Histamine Agents|histamine agents|mesh-ancestor
92006740|NCT05729555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006741|NCT05729555|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92006742|NCT05729555|Antipruritics|antipruritics|mesh-ancestor
92006743|NCT05729555|Dermatologic Agents|dermatologic agents|mesh-ancestor
92006744|NCT01603459|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92006745|NCT01603459|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92006746|NCT01603459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984511|NCT03142893|Hormones|hormones|mesh-list
91984512|NCT03142893|Cosyntropin|cosyntropin|mesh-list
91984513|NCT03142893|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
91984514|NCT03142893|BB 1101|bb 1101|mesh-list
91984515|NCT03142893|Ganirelix|ganirelix|mesh-list
92006747|NCT01603459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006748|NCT01603459|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92006749|NCT01603459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006750|NCT01603459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006751|NCT01603459|Cholinergic Agents|cholinergic agents|mesh-ancestor
92006752|NCT01603459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006753|NCT02926027|Eicosapentaenoic acid ethyl ester|eicosapentaenoic acid ethyl ester|mesh-list
92006754|NCT02926027|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92006755|NCT02926027|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92006756|NCT03136003|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92006757|NCT03136003|Hemostatics|hemostatics|mesh-ancestor
92006758|NCT03136003|Coagulants|coagulants|mesh-ancestor
92006759|NCT03136003|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92006760|NCT03136003|Natriuretic Agents|natriuretic agents|mesh-ancestor
92006761|NCT03136003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006774|NCT05410847|Paclitaxel|paclitaxel|mesh-list
92006775|NCT05410847|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006776|NCT05410847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006777|NCT05410847|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006778|NCT05410847|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006779|NCT05410847|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006780|NCT05410847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006781|NCT04750291|Botulinum Toxins|botulinum toxins|mesh-list
92006782|NCT04750291|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92006783|NCT04750291|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92006784|NCT04750291|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92006785|NCT04750291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006786|NCT04750291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006788|NCT04750291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006789|NCT04750291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006790|NCT04750291|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92006791|NCT04750291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006792|NCT03726749|Prednisone|prednisone|mesh-list
92006793|NCT03726749|Glucocorticoids|glucocorticoids|mesh-list
92006794|NCT03726749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006795|NCT03726749|Hormones|hormones|mesh-ancestor
92006796|NCT03726749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006797|NCT03726749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006798|NCT03726749|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92006799|NCT03726749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006800|NCT03821077|Immunomodulating Agents|immunomodulating agents|mesh-list
92006801|NCT03821077|Immunologic Factors|immunologic factors|mesh-ancestor
92006802|NCT03821077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006803|NCT03136705|Niacinamide|niacinamide|mesh-list
92006805|NCT03136705|Nicotinic Acids|nicotinic acids|mesh-list
92006806|NCT03136705|Vitamin B Complex|vitamin b complex|mesh-ancestor
92006807|NCT03136705|Vitamins|vitamins|mesh-ancestor
92006808|NCT03136705|Micronutrients|micronutrients|mesh-ancestor
92006809|NCT03136705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006810|NCT03136705|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92006811|NCT03136705|Antimetabolites|antimetabolites|mesh-ancestor
92006812|NCT03136705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006813|NCT03136705|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92006814|NCT03136705|Vasodilator Agents|vasodilator agents|mesh-ancestor
92006815|NCT04540861|Siponimod|siponimod|mesh-list
92006890|NCT03073525|Atezolizumab|atezolizumab|mesh-list
92006816|NCT04540861|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92006817|NCT04540861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006818|NCT04540861|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92006819|NCT04540861|Immunologic Factors|immunologic factors|mesh-ancestor
92006820|NCT04540861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006821|NCT03066557|Apatinib|apatinib|mesh-list
92006822|NCT03066557|Chlorotrianisene|chlorotrianisene|mesh-list
92006823|NCT03066557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006824|NCT03066557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92006825|NCT03066557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984516|NCT03142893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984517|NCT03142893|Antiemetics|antiemetics|mesh-ancestor
91984518|NCT03142893|Autonomic Agents|autonomic agents|mesh-ancestor
91984519|NCT03142893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006826|NCT03066557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006827|NCT03066557|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92006828|NCT03066557|Estrogens|estrogens|mesh-ancestor
92006829|NCT03066557|Hormones|hormones|mesh-ancestor
92006830|NCT03066557|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006831|NCT03066557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006832|NCT03066557|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92006833|NCT05728619|Temozolomide|temozolomide|mesh-list
92006834|NCT05728619|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92006835|NCT05728619|Alkylating Agents|alkylating agents|mesh-ancestor
92006836|NCT05728619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006837|NCT05728619|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006838|NCT05737303|Paclitaxel|paclitaxel|mesh-list
92006839|NCT05737303|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92006840|NCT05737303|Carboplatin|carboplatin|mesh-list
92006841|NCT05737303|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006842|NCT05737303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006843|NCT05737303|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006844|NCT05737303|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006845|NCT05737303|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006846|NCT05737303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006847|NCT03066089|Fenugreek seed meal|fenugreek seed meal|mesh-list
92006848|NCT03066089|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92006849|NCT03066089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006850|NCT05188313|Paclitaxel|paclitaxel|mesh-list
92006851|NCT05188313|Carboplatin|carboplatin|mesh-list
92006852|NCT05188313|Trastuzumab|trastuzumab|mesh-list
92006853|NCT05188313|Pertuzumab|pertuzumab|mesh-list
92006854|NCT05188313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92006855|NCT05188313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006856|NCT05188313|Tubulin Modulators|tubulin modulators|mesh-ancestor
92006857|NCT05188313|Antimitotic Agents|antimitotic agents|mesh-ancestor
92006860|NCT05188313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006862|NCT02514655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006863|NCT03066011|Voriconazole|voriconazole|mesh-list
92006864|NCT03066011|Posaconazole|posaconazole|mesh-list
92006865|NCT03066011|Isavuconazole|isavuconazole|mesh-list
92006866|NCT03066011|Antifungal Agents|antifungal agents|mesh-ancestor
92006867|NCT03066011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006868|NCT03066011|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92006869|NCT03066011|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92006870|NCT03066011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006871|NCT03066011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006872|NCT03066011|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92006873|NCT03066011|Hormone Antagonists|hormone antagonists|mesh-ancestor
92006874|NCT03066011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006875|NCT03066011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006876|NCT03066011|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92006877|NCT03066011|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92006878|NCT03066011|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92006879|NCT03066011|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92006880|NCT03135769|Avelumab|avelumab|mesh-list
92006881|NCT03135769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006882|NCT03135769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006883|NCT03123211|Veliparib|veliparib|mesh-list
92006884|NCT03123211|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92006885|NCT03123211|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006886|NCT03123211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006887|NCT03123211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006888|NCT05520749|Luspatercept|luspatercept|mesh-list
92006891|NCT03073525|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92006892|NCT03073525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006893|NCT03073525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92006894|NCT03073525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984520|NCT03142893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984521|NCT03142893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92006895|NCT02563015|Vitamin D|vitamin d|mesh-list
92006896|NCT02563015|Cholecalciferol|cholecalciferol|mesh-list
92006897|NCT02563015|Vitamins|vitamins|mesh-ancestor
92006898|NCT02563015|Micronutrients|micronutrients|mesh-ancestor
92006899|NCT02563015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006900|NCT02563015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92006901|NCT02563015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92006902|NCT02382445|Anesthetics|anesthetics|mesh-list
92006903|NCT02382445|Propofol|propofol|mesh-list
92006904|NCT02382445|Sevoflurane|sevoflurane|mesh-list
92006905|NCT02382445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006906|NCT02382445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006907|NCT02382445|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006908|NCT02382445|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92006909|NCT02382445|Anesthetics, General|anesthetics, general|mesh-ancestor
92006910|NCT02382445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92006911|NCT02382445|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92006912|NCT05736757|Plasminogen|plasminogen|mesh-list
92006913|NCT05736757|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92006914|NCT05736757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92006915|NCT05736757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92006916|NCT05736757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006917|NCT04483739|Dexamethasone|dexamethasone|mesh-list
92006918|NCT04483739|Dexamethasone acetate|dexamethasone acetate|mesh-list
92006919|NCT04483739|Lenalidomide|lenalidomide|mesh-list
92006920|NCT04483739|BB 1101|bb 1101|mesh-list
92006921|NCT04483739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006922|NCT04483739|Antiemetics|antiemetics|mesh-ancestor
92006923|NCT04483739|Autonomic Agents|autonomic agents|mesh-ancestor
92006924|NCT04483739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006925|NCT04483739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006926|NCT04483739|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92006928|NCT04483739|Hormones|hormones|mesh-ancestor
92006931|NCT04483739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92006932|NCT04483739|Protease Inhibitors|protease inhibitors|mesh-ancestor
92006933|NCT04483739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006934|NCT04483739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006935|NCT04483739|Immunologic Factors|immunologic factors|mesh-ancestor
92006936|NCT04483739|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92006937|NCT04483739|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92006938|NCT04483739|Growth Substances|growth substances|mesh-ancestor
92006939|NCT04483739|Growth Inhibitors|growth inhibitors|mesh-ancestor
92006940|NCT05727475|Fluorides|fluorides|mesh-list
92006941|NCT05727475|Cariostatic Agents|cariostatic agents|mesh-ancestor
92006942|NCT05727475|Protective Agents|protective agents|mesh-ancestor
92006943|NCT05727475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006944|NCT05091775|Mesalamine|mesalamine|mesh-list
92006945|NCT05091775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92006946|NCT05091775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006947|NCT05091775|Analgesics|analgesics|mesh-ancestor
92006948|NCT05091775|Sensory System Agents|sensory system agents|mesh-ancestor
92006949|NCT05091775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006950|NCT05091775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006951|NCT05091775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006952|NCT05091775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92006953|NCT04821869|Albuterol|albuterol|mesh-list
92006954|NCT04821869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92006955|NCT04821869|Autonomic Agents|autonomic agents|mesh-ancestor
92006956|NCT04821869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006957|NCT04821869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006958|NCT04821869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92006959|NCT04821869|Respiratory System Agents|respiratory system agents|mesh-ancestor
92006960|NCT04821869|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92006961|NCT04821869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92006962|NCT04821869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92006963|NCT04821869|Adrenergic Agents|adrenergic agents|mesh-ancestor
92006964|NCT04821869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006965|NCT04821869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006966|NCT04821869|Tocolytic Agents|tocolytic agents|mesh-ancestor
91984522|NCT03142893|Glucocorticoids|glucocorticoids|mesh-ancestor
91984523|NCT03142893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090419|NCT00892606|Antitussive Agents|antitussive agents|mesh-ancestor
92006967|NCT04821869|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92006968|NCT05091463|Glycoprotein, Klebsiella pneumoniae|glycoprotein, klebsiella pneumoniae|mesh-list
92006969|NCT05091463|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92006970|NCT05091463|Immunologic Factors|immunologic factors|mesh-ancestor
92006971|NCT05091463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006972|NCT02631551|Mometasone Furoate|mometasone furoate|mesh-list
92006973|NCT02631551|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92006974|NCT02631551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006975|NCT02631551|Dermatologic Agents|dermatologic agents|mesh-ancestor
92006976|NCT02631551|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92006977|NCT02631551|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92006978|NCT02631551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006979|NCT02631551|Analgesics|analgesics|mesh-ancestor
92006980|NCT02631551|Sensory System Agents|sensory system agents|mesh-ancestor
92006981|NCT02631551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006982|NCT02631551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006983|NCT02631551|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92006984|NCT02631551|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92006985|NCT02631551|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92006986|NCT02631551|Histamine Antagonists|histamine antagonists|mesh-ancestor
92006987|NCT02631551|Histamine Agents|histamine agents|mesh-ancestor
92006988|NCT02631551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006989|NCT02631551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006990|NCT05091151|Dexmedetomidine|dexmedetomidine|mesh-list
92006991|NCT05091151|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006992|NCT05091151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006993|NCT05091151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006994|NCT05091151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006995|NCT05091151|Analgesics|analgesics|mesh-ancestor
92006996|NCT05091151|Sensory System Agents|sensory system agents|mesh-ancestor
92006997|NCT05091151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006998|NCT05091151|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92007001|NCT05091151|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007002|NCT05091151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007003|NCT05091151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007004|NCT05466539|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92007005|NCT05466539|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92007006|NCT05466539|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92007007|NCT05466539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92007008|NCT05466539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007009|NCT05466539|Cholinergic Agents|cholinergic agents|mesh-ancestor
92007010|NCT05466539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007011|NCT05466539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007012|NCT05466539|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92007013|NCT05466539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007014|NCT04447469|Mavrilimumab|mavrilimumab|mesh-list
92007015|NCT04447469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007017|NCT04447235|Losartan|losartan|mesh-list
92007018|NCT04447235|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92007019|NCT04447235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92007020|NCT04447235|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92007021|NCT04447235|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92007022|NCT04447235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007023|NCT04447235|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92007024|NCT04447235|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007025|NCT01680991|Obinutuzumab|obinutuzumab|mesh-list
92007026|NCT01680991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007027|NCT01680991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007028|NCT01700569|Leucovorin|leucovorin|mesh-list
92007029|NCT01700569|Folic Acid|folic acid|mesh-list
92007030|NCT01700569|Temozolomide|temozolomide|mesh-list
92007031|NCT01700569|Levoleucovorin|levoleucovorin|mesh-list
92007032|NCT01700569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007033|NCT01700569|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92007034|NCT01700569|Alkylating Agents|alkylating agents|mesh-ancestor
92007035|NCT01700569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984524|NCT03142893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91984525|NCT03142893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984526|NCT03142893|Protease Inhibitors|protease inhibitors|mesh-ancestor
91984527|NCT03142893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007036|NCT01700569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007037|NCT01700569|Antidotes|antidotes|mesh-ancestor
92007038|NCT01700569|Protective Agents|protective agents|mesh-ancestor
92007039|NCT01700569|Vitamin B Complex|vitamin b complex|mesh-ancestor
92007040|NCT01700569|Vitamins|vitamins|mesh-ancestor
92007041|NCT01700569|Micronutrients|micronutrients|mesh-ancestor
92007042|NCT01700569|Hematinics|hematinics|mesh-ancestor
92007043|NCT05090761|Magnesium Sulfate|magnesium sulfate|mesh-list
92007044|NCT05090761|Buprenorphine|buprenorphine|mesh-list
92007045|NCT05090761|Bupivacaine|bupivacaine|mesh-list
92007046|NCT05090761|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92007047|NCT05090761|Anesthetics, Local|anesthetics, local|mesh-ancestor
92007048|NCT05090761|Anesthetics|anesthetics|mesh-ancestor
92007049|NCT05090761|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007050|NCT05090761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007051|NCT05090761|Sensory System Agents|sensory system agents|mesh-ancestor
92007052|NCT05090761|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007053|NCT05090761|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92007054|NCT05090761|Narcotics|narcotics|mesh-ancestor
92007055|NCT05090761|Analgesics|analgesics|mesh-ancestor
92007056|NCT05090761|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92007057|NCT05090761|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92007058|NCT05090761|Anticonvulsants|anticonvulsants|mesh-ancestor
92007059|NCT05090761|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92007060|NCT05090761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92007061|NCT05090761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007062|NCT05090761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92007063|NCT05090761|Tocolytic Agents|tocolytic agents|mesh-ancestor
92007064|NCT05090761|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007065|NCT03065309|Remifentanil|remifentanil|mesh-list
92007066|NCT03065309|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92007067|NCT03065309|Narcotics|narcotics|mesh-ancestor
92007068|NCT03065309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007069|NCT03065309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007070|NCT03065309|Analgesics|analgesics|mesh-ancestor
92007071|NCT03065309|Sensory System Agents|sensory system agents|mesh-ancestor
92007072|NCT03065309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007074|NCT02819479|Mannitol|mannitol|mesh-list
92007075|NCT02819479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007076|NCT02819479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007077|NCT02819479|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92007078|NCT02819479|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92007079|NCT02819479|Growth Substances|growth substances|mesh-ancestor
92007080|NCT02819479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007081|NCT02819479|Growth Inhibitors|growth inhibitors|mesh-ancestor
92007082|NCT02819479|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92007083|NCT02819479|Diuretics|diuretics|mesh-ancestor
92007084|NCT02819479|Natriuretic Agents|natriuretic agents|mesh-ancestor
92007085|NCT05376943|Antiviral Agents|antiviral agents|mesh-list
92007086|NCT05376943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007087|NCT04074785|Bevacizumab|bevacizumab|mesh-list
92007088|NCT04074785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007089|NCT04074785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007090|NCT04074785|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92007091|NCT04074785|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92007092|NCT04074785|Growth Substances|growth substances|mesh-ancestor
92007093|NCT04074785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007094|NCT04074785|Growth Inhibitors|growth inhibitors|mesh-ancestor
92007095|NCT04533841|Propranolol|propranolol|mesh-list
92007096|NCT04533841|Misoprostol|misoprostol|mesh-list
92007097|NCT04533841|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92007098|NCT04533841|Abortifacient Agents|abortifacient agents|mesh-ancestor
92007099|NCT04533841|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007100|NCT04533841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007101|NCT04533841|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92007102|NCT04533841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007103|NCT04533841|Oxytocics|oxytocics|mesh-ancestor
92007104|NCT04533841|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92007105|NCT04533841|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91984528|NCT03142893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984529|NCT03142893|Antifungal Agents|antifungal agents|mesh-ancestor
91984530|NCT03142893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984531|NCT03142893|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92007106|NCT04533841|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007107|NCT04533841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007108|NCT04533841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007109|NCT04533841|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92007110|NCT04533841|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92007111|NCT04533841|Vasodilator Agents|vasodilator agents|mesh-ancestor
92007113|NCT04536805|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92007114|NCT04536805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007116|NCT05376865|Vitamins|vitamins|mesh-ancestor
92007117|NCT05376865|Micronutrients|micronutrients|mesh-ancestor
92007118|NCT05376865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007119|NCT05376865|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92007120|NCT04064411|Abaloparatide|abaloparatide|mesh-list
92007121|NCT04064411|Parathyroid Hormone-Related Protein|parathyroid hormone-related protein|mesh-list
92007122|NCT04064411|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92007123|NCT04064411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007124|NCT04064411|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92007125|NCT04012931|Rilpivirine|rilpivirine|mesh-list
92007126|NCT04012931|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92007127|NCT04012931|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007128|NCT04012931|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007129|NCT04012931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007130|NCT04012931|Antiviral Agents|antiviral agents|mesh-ancestor
92007131|NCT04012931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007132|NCT04012931|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92007133|NCT04012931|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92007134|NCT03063359|Fentanyl|fentanyl|mesh-list
92007135|NCT03063359|Morphine|morphine|mesh-list
92007136|NCT03063359|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92007137|NCT03063359|Narcotics|narcotics|mesh-ancestor
92007138|NCT03063359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007139|NCT03063359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007140|NCT03063359|Analgesics|analgesics|mesh-ancestor
92007141|NCT03063359|Sensory System Agents|sensory system agents|mesh-ancestor
92007142|NCT03063359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007143|NCT03063359|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92007144|NCT03063359|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92007145|NCT03063359|Anesthetics, General|anesthetics, general|mesh-ancestor
92007146|NCT03063359|Anesthetics|anesthetics|mesh-ancestor
92007147|NCT02660359|Hemagglutinins|hemagglutinins|mesh-list
92007150|NCT02660359|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92007151|NCT02660359|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92007152|NCT02660359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92007153|NCT02660359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007154|NCT02660359|Cholinergic Agents|cholinergic agents|mesh-ancestor
92007155|NCT02660359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007156|NCT02660359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007157|NCT02660359|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92007158|NCT02660359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007159|NCT02660359|Agglutinins|agglutinins|mesh-ancestor
92007160|NCT02660359|Immunologic Factors|immunologic factors|mesh-ancestor
92007161|NCT02660359|Coagulants|coagulants|mesh-ancestor
92007162|NCT04901299|Fulvestrant|fulvestrant|mesh-list
92007163|NCT04901299|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007164|NCT04901299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007165|NCT04901299|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92007166|NCT04901299|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92007167|NCT04901299|Hormone Antagonists|hormone antagonists|mesh-ancestor
92007168|NCT04901299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007169|NCT04901299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007170|NCT05067985|Anesthetics|anesthetics|mesh-list
92007171|NCT05067985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007172|NCT05067985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984532|NCT03142893|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92007174|NCT04262869|Carboplatin|carboplatin|mesh-list
92007176|NCT04262869|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92007177|NCT04262869|Durvalumab|durvalumab|mesh-list
92007178|NCT04262869|Immunoglobulins|immunoglobulins|mesh-list
92007179|NCT04262869|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92007180|NCT04262869|Immunoglobulin G|immunoglobulin g|mesh-list
92007181|NCT04262869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007182|NCT04262869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007183|NCT04262869|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007184|NCT04262869|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007185|NCT04262869|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007186|NCT04262869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007187|NCT04262869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007188|NCT04262869|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92007189|NCT04262869|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007190|NCT04262869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007191|NCT04262869|Immunologic Factors|immunologic factors|mesh-ancestor
92007192|NCT04262869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007193|NCT05092165|Methylene Blue|methylene blue|mesh-list
92007194|NCT05092165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007195|NCT05092165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007196|NCT03062813|Entecavir|entecavir|mesh-list
92007197|NCT03062813|Tacrolimus|tacrolimus|mesh-list
92007198|NCT03062813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007199|NCT03062813|Immunologic Factors|immunologic factors|mesh-ancestor
92007200|NCT03062813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007201|NCT03062813|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92007202|NCT03062813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007203|NCT03062813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007204|NCT03062813|Antiviral Agents|antiviral agents|mesh-ancestor
92007205|NCT03062813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007206|NCT04893161|Belimumab|belimumab|mesh-list
92007207|NCT04893161|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007208|NCT04893161|Immunologic Factors|immunologic factors|mesh-ancestor
92007209|NCT04893161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007210|NCT04884035|Prednisone|prednisone|mesh-list
92007211|NCT04884035|Prednisolone|prednisolone|mesh-list
92007212|NCT04884035|Cyclophosphamide|cyclophosphamide|mesh-list
92007213|NCT04884035|Rituximab|rituximab|mesh-list
92007214|NCT04884035|Doxorubicin|doxorubicin|mesh-list
92007215|NCT04884035|Vincristine|vincristine|mesh-list
92007216|NCT04884035|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92007217|NCT04884035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007218|NCT04884035|Immunologic Factors|immunologic factors|mesh-ancestor
92007219|NCT04884035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007220|NCT04884035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007221|NCT04884035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92007222|NCT04884035|Alkylating Agents|alkylating agents|mesh-ancestor
92007224|NCT04884035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007225|NCT04884035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92007226|NCT04884035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007227|NCT04884035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92007228|NCT04884035|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92007229|NCT04884035|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92007230|NCT04884035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007231|NCT04884035|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007232|NCT04884035|Glucocorticoids|glucocorticoids|mesh-ancestor
92007233|NCT04884035|Hormones|hormones|mesh-ancestor
92007234|NCT04884035|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007235|NCT04884035|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007236|NCT04884035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007237|NCT04884035|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007238|NCT04884035|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007239|NCT04884035|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007240|NCT04884035|Immunoconjugates|immunoconjugates|mesh-ancestor
92007241|NCT04582981|Raltitrexed|raltitrexed|mesh-list
92007242|NCT04582981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007243|NCT04582981|Antimetabolites|antimetabolites|mesh-ancestor
92007244|NCT04582981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007245|NCT04582981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007246|NCT04582981|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91984533|NCT03142893|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91984534|NCT03142893|Hormone Antagonists|hormone antagonists|mesh-ancestor
92007247|NCT04582981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007248|NCT04469179|Immunoglobulins|immunoglobulins|mesh-list
92007249|NCT04469179|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92007250|NCT04469179|Immunologic Factors|immunologic factors|mesh-ancestor
92007251|NCT04469179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007252|NCT04531579|Valproic Acid|valproic acid|mesh-list
92007253|NCT04531579|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92007254|NCT04531579|Anticonvulsants|anticonvulsants|mesh-ancestor
92007255|NCT04531579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007256|NCT04531579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007257|NCT04531579|GABA Agents|gaba agents|mesh-ancestor
92007258|NCT04531579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007259|NCT04531579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007260|NCT04531579|Antimanic Agents|antimanic agents|mesh-ancestor
92007261|NCT04531579|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92007262|NCT04531579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007263|NCT04531579|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92007264|NCT03839459|Denosumab|denosumab|mesh-list
92007265|NCT03839459|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92007266|NCT03839459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007267|NCT05097781|Antibodies|antibodies|mesh-list
92007268|NCT05097781|Antibodies, Blocking|antibodies, blocking|mesh-list
92007269|NCT05097781|Immunologic Factors|immunologic factors|mesh-ancestor
92007270|NCT05097781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007271|NCT01117441|Cytarabine|cytarabine|mesh-list
92007272|NCT01117441|Dexamethasone|dexamethasone|mesh-list
92007273|NCT01117441|Prednisone|prednisone|mesh-list
92007274|NCT01117441|Cyclophosphamide|cyclophosphamide|mesh-list
92007275|NCT01117441|Ifosfamide|ifosfamide|mesh-list
92007276|NCT01117441|Doxorubicin|doxorubicin|mesh-list
92007277|NCT01117441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92007278|NCT01117441|Methotrexate|methotrexate|mesh-list
92007280|NCT01117441|Etoposide|etoposide|mesh-list
92007281|NCT01117441|Vincristine|vincristine|mesh-list
92007282|NCT01117441|Daunorubicin|daunorubicin|mesh-list
92007283|NCT01117441|Asparaginase|asparaginase|mesh-list
92007284|NCT01117441|Mercaptopurine|mercaptopurine|mesh-list
92007285|NCT01117441|Thioguanine|thioguanine|mesh-list
92007286|NCT01117441|Pegaspargase|pegaspargase|mesh-list
92007287|NCT01117441|Vindesine|vindesine|mesh-list
92007288|NCT01117441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007289|NCT01117441|Immunologic Factors|immunologic factors|mesh-ancestor
92007290|NCT01117441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007291|NCT01117441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007292|NCT01117441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92007293|NCT01117441|Alkylating Agents|alkylating agents|mesh-ancestor
92007294|NCT01117441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007295|NCT01117441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007296|NCT01117441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92007297|NCT01117441|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007298|NCT01117441|Antiemetics|antiemetics|mesh-ancestor
92007299|NCT01117441|Autonomic Agents|autonomic agents|mesh-ancestor
92007304|NCT01117441|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007305|NCT01117441|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007306|NCT01117441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92007307|NCT01117441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92007309|NCT01117441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007310|NCT01117441|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92007311|NCT01117441|Abortifacient Agents|abortifacient agents|mesh-ancestor
92007312|NCT01117441|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007313|NCT01117441|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007314|NCT01117441|Antimetabolites|antimetabolites|mesh-ancestor
92007315|NCT01117441|Dermatologic Agents|dermatologic agents|mesh-ancestor
92007316|NCT01117441|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92007317|NCT01117441|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007318|NCT01117441|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007319|NCT01117441|Antiviral Agents|antiviral agents|mesh-ancestor
92007320|NCT01117441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007321|NCT01117441|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007322|NCT01117441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007323|NCT01117441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007324|NCT01101451|Cisplatin|cisplatin|mesh-list
92007325|NCT01101451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984535|NCT03142893|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92007327|NCT03656627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007328|NCT03656627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007329|NCT03656627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92007330|NCT03656627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007331|NCT04759703|Pramipexole|pramipexole|mesh-list
92007332|NCT04759703|Antioxidants|antioxidants|mesh-ancestor
92007333|NCT04759703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007334|NCT04759703|Protective Agents|protective agents|mesh-ancestor
92007335|NCT04759703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007336|NCT04759703|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92007337|NCT04759703|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92007338|NCT04759703|Dopamine Agonists|dopamine agonists|mesh-ancestor
92007339|NCT04759703|Dopamine Agents|dopamine agents|mesh-ancestor
92007340|NCT04759703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007341|NCT05026801|Azithromycin|azithromycin|mesh-list
92007342|NCT05026801|Hydroxychloroquine|hydroxychloroquine|mesh-list
92007343|NCT05026801|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92007344|NCT05026801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007345|NCT05026801|Antimalarials|antimalarials|mesh-ancestor
92007346|NCT05026801|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92007347|NCT05026801|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92007348|NCT05026801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007349|NCT05026801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007350|NCT05026801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007351|NCT03511625|Methylprednisolone|methylprednisolone|mesh-list
92007352|NCT03511625|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92007353|NCT03511625|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92007354|NCT03511625|Prednisolone|prednisolone|mesh-list
92007355|NCT03511625|Prednisolone acetate|prednisolone acetate|mesh-list
92007356|NCT03511625|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92007357|NCT03511625|Prednisolone phosphate|prednisolone phosphate|mesh-list
92007358|NCT03511625|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92007359|NCT03511625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007360|NCT03511625|Antiemetics|antiemetics|mesh-ancestor
92007361|NCT03511625|Autonomic Agents|autonomic agents|mesh-ancestor
92007362|NCT03511625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007363|NCT03511625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007364|NCT03511625|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007365|NCT03511625|Glucocorticoids|glucocorticoids|mesh-ancestor
92007366|NCT03511625|Hormones|hormones|mesh-ancestor
92007367|NCT03511625|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007368|NCT03511625|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92007369|NCT03511625|Protective Agents|protective agents|mesh-ancestor
92007375|NCT03493061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007376|NCT03493061|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92007377|NCT03493061|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92007379|NCT03493061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007380|NCT03493061|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007381|NCT03493061|Antimetabolites|antimetabolites|mesh-ancestor
92007382|NCT04523935|Topiramate|topiramate|mesh-list
92007383|NCT04523935|Lamotrigine|lamotrigine|mesh-list
92007384|NCT04523935|Diazepam|diazepam|mesh-list
92007385|NCT04523935|Gabapentin|gabapentin|mesh-list
92007386|NCT04523935|Amitriptyline|amitriptyline|mesh-list
92007387|NCT04523935|Anticonvulsants|anticonvulsants|mesh-list
92007388|NCT04523935|Clonazepam|clonazepam|mesh-list
92007389|NCT04523935|Trihexyphenidyl|trihexyphenidyl|mesh-list
92007390|NCT04523935|Baclofen|baclofen|mesh-list
92007391|NCT04523935|Tetrabenazine|tetrabenazine|mesh-list
92007392|NCT04523935|Analgesics|analgesics|mesh-ancestor
92007393|NCT04523935|Sensory System Agents|sensory system agents|mesh-ancestor
92007394|NCT04523935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007395|NCT04523935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007396|NCT04523935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92007397|NCT04523935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92007398|NCT04523935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007399|NCT04523935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92007400|NCT04523935|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92007401|NCT04523935|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92007402|NCT04523935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007403|NCT04523935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007404|NCT04523935|Antimanic Agents|antimanic agents|mesh-ancestor
92007405|NCT04523935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92007406|NCT04523935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92007407|NCT04523935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92007408|NCT04523935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92007409|NCT04523935|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92007410|NCT04523935|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92007411|NCT04523935|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92007412|NCT04523935|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92007413|NCT04523935|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92007414|NCT04523935|GABA Agonists|gaba agonists|mesh-ancestor
92007415|NCT04523935|GABA Agents|gaba agents|mesh-ancestor
92007416|NCT04523935|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92007417|NCT04523935|Antidepressive Agents|antidepressive agents|mesh-ancestor
92007418|NCT04523935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92007419|NCT04523935|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92007420|NCT04523935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92007421|NCT04523935|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007422|NCT04523935|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92007423|NCT04523935|Antiemetics|antiemetics|mesh-ancestor
92007424|NCT04523935|Autonomic Agents|autonomic agents|mesh-ancestor
92007425|NCT04523935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007426|NCT04523935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92007427|NCT04523935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92007428|NCT04523935|Anesthetics, General|anesthetics, general|mesh-ancestor
92007429|NCT04523935|Anesthetics|anesthetics|mesh-ancestor
92007430|NCT04523935|GABA Modulators|gaba modulators|mesh-ancestor
92007431|NCT04523935|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92007432|NCT04523935|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92007433|NCT04523935|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92007434|NCT04523935|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92007435|NCT04523935|Cholinergic Agents|cholinergic agents|mesh-ancestor
92007437|NCT02630693|Fulvestrant|fulvestrant|mesh-list
92007438|NCT02630693|Palbociclib|palbociclib|mesh-list
92007439|NCT02630693|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92007440|NCT02630693|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92007441|NCT02630693|Hormone Antagonists|hormone antagonists|mesh-ancestor
92007443|NCT02630693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007444|NCT02630693|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007445|NCT02630693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007446|NCT02630693|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92007447|NCT02630693|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92007448|NCT02630693|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92007449|NCT02630693|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92007450|NCT02630693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92007451|NCT02630693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007452|NCT02630693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007453|NCT02630693|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92007454|NCT01938430|Sofosbuvir|sofosbuvir|mesh-list
92007455|NCT01938430|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92007456|NCT01938430|Ledipasvir|ledipasvir|mesh-list
92007457|NCT01938430|Antiviral Agents|antiviral agents|mesh-ancestor
92007458|NCT01938430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007459|NCT04625530|Tranexamic Acid|tranexamic acid|mesh-list
92007460|NCT04625530|Ferric Compounds|ferric compounds|mesh-list
92007461|NCT04625530|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92007462|NCT04625530|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92007463|NCT04625530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007464|NCT04625530|Hemostatics|hemostatics|mesh-ancestor
92007465|NCT04625530|Coagulants|coagulants|mesh-ancestor
92007466|NCT04625530|Hematinics|hematinics|mesh-ancestor
92007467|NCT01916824|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92007468|NCT01916824|Mirtazapine|mirtazapine|mesh-list
92007469|NCT01916824|Citalopram|citalopram|mesh-list
92007470|NCT01916824|Bupropion|bupropion|mesh-list
92007471|NCT01916824|Fluoxetine|fluoxetine|mesh-list
92007472|NCT01916824|Paroxetine|paroxetine|mesh-list
92007473|NCT01916824|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92007474|NCT01916824|Sertraline|sertraline|mesh-list
92007475|NCT01916824|Antidepressive Agents|antidepressive agents|mesh-list
92007476|NCT01916824|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92007477|NCT01916824|Escitalopram|escitalopram|mesh-list
92007478|NCT01916824|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92007479|NCT01916824|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92007480|NCT01916824|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92007481|NCT01916824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007482|NCT01916824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007483|NCT01916824|Serotonin Agents|serotonin agents|mesh-ancestor
92007484|NCT01916824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007485|NCT01916824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007486|NCT01916824|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92007487|NCT01916824|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92007488|NCT01916824|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92007489|NCT01916824|Dopamine Agents|dopamine agents|mesh-ancestor
92007490|NCT01916824|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92007491|NCT01916824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92007492|NCT01916824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007493|NCT01916824|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92007494|NCT01916824|Analgesics|analgesics|mesh-ancestor
92007495|NCT01916824|Sensory System Agents|sensory system agents|mesh-ancestor
92007496|NCT01916824|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92007497|NCT01916824|Histamine Antagonists|histamine antagonists|mesh-ancestor
92007498|NCT01916824|Histamine Agents|histamine agents|mesh-ancestor
92007499|NCT01916824|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92007500|NCT01916824|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92007501|NCT01916824|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007502|NCT01916824|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92007503|NCT01916824|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92007504|NCT01916824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92007505|NCT01916824|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007506|NCT01916824|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92007507|NCT01916824|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92007508|NCT01916824|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92007509|NCT01915732|Clindamycin|clindamycin|mesh-list
92007510|NCT01915732|Clindamycin palmitate|clindamycin palmitate|mesh-list
92007511|NCT01915732|Clindamycin phosphate|clindamycin phosphate|mesh-list
92007512|NCT01915732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92007513|NCT01915732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007514|NCT01915732|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92007516|NCT01915732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007517|NCT01936870|Fesoterodine|fesoterodine|mesh-list
92007518|NCT01936870|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92007519|NCT01936870|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92007520|NCT01936870|Cholinergic Agents|cholinergic agents|mesh-ancestor
92007521|NCT01936870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007522|NCT01936870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007523|NCT01936870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007524|NCT01936870|Urological Agents|urological agents|mesh-ancestor
92007525|NCT01618708|Hylan|hylan|mesh-list
92007526|NCT01618708|Viscosupplements|viscosupplements|mesh-ancestor
92007527|NCT01618708|Protective Agents|protective agents|mesh-ancestor
92007528|NCT01618708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007529|NCT02229149|Paclitaxel|paclitaxel|mesh-list
92007530|NCT02229149|Vinorelbine|vinorelbine|mesh-list
92007531|NCT02229149|Docetaxel|docetaxel|mesh-list
92007532|NCT02229149|Capecitabine|capecitabine|mesh-list
92007533|NCT02229149|Trastuzumab|trastuzumab|mesh-list
92007534|NCT02229149|Pertuzumab|pertuzumab|mesh-list
92007535|NCT02229149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007536|NCT02229149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007537|NCT02229149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007538|NCT02229149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007539|NCT02229149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007540|NCT02229149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007541|NCT02229149|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007542|NCT02229149|Antimetabolites|antimetabolites|mesh-ancestor
92007543|NCT02229149|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007544|NCT04642469|Durvalumab|durvalumab|mesh-list
91984548|NCT02547129|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
91984549|NCT02547129|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92007545|NCT04642469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007546|NCT04642469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007547|NCT04440371|Betamethasone|betamethasone|mesh-list
92007548|NCT04440371|Calcipotriene|calcipotriene|mesh-list
92007550|NCT04440371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007551|NCT04440371|Immunologic Factors|immunologic factors|mesh-ancestor
92007552|NCT04440371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007553|NCT04440371|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92007554|NCT04440371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007555|NCT04440371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007556|NCT04440371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007557|NCT04440371|Glucocorticoids|glucocorticoids|mesh-ancestor
92007558|NCT04440371|Hormones|hormones|mesh-ancestor
92007559|NCT04440371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007560|NCT04440371|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92007561|NCT04440371|Respiratory System Agents|respiratory system agents|mesh-ancestor
92007562|NCT04440371|Dermatologic Agents|dermatologic agents|mesh-ancestor
92007563|NCT03118037|Zaleplon|zaleplon|mesh-list
92007564|NCT03118037|Anticonvulsants|anticonvulsants|mesh-ancestor
92007565|NCT03118037|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92007566|NCT03118037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007567|NCT03118037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007568|NCT03118037|GABA Modulators|gaba modulators|mesh-ancestor
92007569|NCT03118037|GABA Agents|gaba agents|mesh-ancestor
92007570|NCT03118037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007571|NCT03118037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007572|NCT00694655|Vaccines|vaccines|mesh-list
92007573|NCT00694655|Immunologic Factors|immunologic factors|mesh-ancestor
92007574|NCT00694655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007575|NCT04982939|Oxaliplatin|oxaliplatin|mesh-list
92007576|NCT04982939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007577|NCT04982549|Paclitaxel|paclitaxel|mesh-list
92007578|NCT04982549|Carboplatin|carboplatin|mesh-list
92007579|NCT04982549|Pemetrexed|pemetrexed|mesh-list
92007580|NCT04982549|Durvalumab|durvalumab|mesh-list
92007581|NCT04982549|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007582|NCT04982549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007583|NCT04982549|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007584|NCT04982549|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007585|NCT04982549|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007586|NCT04982549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007587|NCT04982549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007588|NCT04982549|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92007593|NCT02621021|Pembrolizumab|pembrolizumab|mesh-list
92007594|NCT02621021|Fludarabine|fludarabine|mesh-list
92007595|NCT02621021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007596|NCT02621021|Immunologic Factors|immunologic factors|mesh-ancestor
92007597|NCT02621021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007598|NCT02621021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007599|NCT02621021|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92007600|NCT02621021|Alkylating Agents|alkylating agents|mesh-ancestor
92007601|NCT02621021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007602|NCT02621021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007603|NCT02621021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92007604|NCT02621021|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007605|NCT02621021|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92007607|NCT02621021|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92007608|NCT02621021|Antiviral Agents|antiviral agents|mesh-ancestor
92007609|NCT02621021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007610|NCT02592317|Pioglitazone|pioglitazone|mesh-list
92007611|NCT02592317|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92007612|NCT02592317|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92007613|NCT02592317|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92007614|NCT02592317|Antimetabolites|antimetabolites|mesh-ancestor
92007615|NCT02592317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007616|NCT02592317|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92007617|NCT02592317|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92007618|NCT02592317|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984550|NCT02547129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984551|NCT02547129|Antitubercular Agents|antitubercular agents|mesh-ancestor
91984552|NCT02420613|Sirolimus|sirolimus|mesh-list
92007619|NCT02592317|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92007620|NCT02592317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007621|NCT03062423|Sofosbuvir|sofosbuvir|mesh-list
92007622|NCT03062423|Antiviral Agents|antiviral agents|mesh-ancestor
92007623|NCT03062423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007624|NCT00790933|Vedolizumab|vedolizumab|mesh-list
92007625|NCT00790933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007626|NCT04981457|Misoprostol|misoprostol|mesh-list
92007627|NCT04981457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92007628|NCT04981457|Abortifacient Agents|abortifacient agents|mesh-ancestor
92007629|NCT04981457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007630|NCT04981457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007631|NCT04981457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92007632|NCT04981457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007633|NCT04981457|Oxytocics|oxytocics|mesh-ancestor
92007634|NCT01676701|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92007635|NCT01676701|Immunologic Factors|immunologic factors|mesh-ancestor
92007636|NCT01676701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007637|NCT04981379|Hydroxychloroquine|hydroxychloroquine|mesh-list
92007638|NCT04981379|Favipiravir|favipiravir|mesh-list
92007639|NCT04981379|Antimalarials|antimalarials|mesh-ancestor
92007640|NCT04981379|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92007641|NCT04981379|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92007642|NCT04981379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007643|NCT04981379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007644|NCT04981379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007645|NCT04981379|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007646|NCT04981379|Antiviral Agents|antiviral agents|mesh-ancestor
92007647|NCT04389775|Glucagon|glucagon|mesh-list
92007648|NCT04389775|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92007649|NCT04389775|Incretins|incretins|mesh-ancestor
92007650|NCT04389775|Hormones|hormones|mesh-ancestor
92007651|NCT04389775|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007652|NCT04389775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007653|NCT04389775|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007654|NCT03062501|Hydroxyurea|hydroxyurea|mesh-list
92007655|NCT03062501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007656|NCT03062501|Antisickling Agents|antisickling agents|mesh-ancestor
92007657|NCT03062501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007658|NCT03062501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007674|NCT02102789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007675|NCT02102789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007676|NCT02102789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007677|NCT02102789|Antimetabolites|antimetabolites|mesh-ancestor
92007678|NCT02102789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007679|NCT02102789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007680|NCT02102789|Immunologic Factors|immunologic factors|mesh-ancestor
92007681|NCT02102789|Antidotes|antidotes|mesh-ancestor
92007682|NCT02102789|Protective Agents|protective agents|mesh-ancestor
92007683|NCT02102789|Vitamin B Complex|vitamin b complex|mesh-ancestor
92007684|NCT02102789|Vitamins|vitamins|mesh-ancestor
92007685|NCT02102789|Micronutrients|micronutrients|mesh-ancestor
92007686|NCT02926651|Tranexamic Acid|tranexamic acid|mesh-list
92007687|NCT02926651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92007688|NCT02926651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92007689|NCT02926651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007690|NCT02926651|Hemostatics|hemostatics|mesh-ancestor
92007691|NCT02926651|Coagulants|coagulants|mesh-ancestor
92007693|NCT04305145|Methylprednisolone|methylprednisolone|mesh-list
92007694|NCT04305145|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92007695|NCT04305145|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92007696|NCT04305145|Prednisolone|prednisolone|mesh-list
92007697|NCT04305145|Prednisolone acetate|prednisolone acetate|mesh-list
92007698|NCT04305145|Infliximab|infliximab|mesh-list
92007699|NCT04305145|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92007700|NCT04305145|Prednisolone phosphate|prednisolone phosphate|mesh-list
92007701|NCT04305145|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007702|NCT04305145|Glucocorticoids|glucocorticoids|mesh-ancestor
92007704|NCT04305145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984553|NCT02420613|Temsirolimus|temsirolimus|mesh-list
92007705|NCT04305145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007706|NCT04305145|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007707|NCT04305145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007708|NCT04305145|Antiemetics|antiemetics|mesh-ancestor
92007709|NCT04305145|Autonomic Agents|autonomic agents|mesh-ancestor
92007710|NCT04305145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007711|NCT04305145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007712|NCT04305145|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92007713|NCT04305145|Protective Agents|protective agents|mesh-ancestor
92007714|NCT04305145|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92007715|NCT04305145|Dermatologic Agents|dermatologic agents|mesh-ancestor
92007716|NCT04305145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007717|NCT01670279|Brexpiprazole|brexpiprazole|mesh-list
92007718|NCT01670279|Serotonin Agents|serotonin agents|mesh-ancestor
92007719|NCT01670279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007720|NCT01670279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007721|NCT01670279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007724|NCT04188145|Bevacizumab|bevacizumab|mesh-list
92007725|NCT04188145|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007726|NCT04188145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007727|NCT04188145|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92007728|NCT04188145|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92007729|NCT04188145|Growth Substances|growth substances|mesh-ancestor
92007730|NCT04188145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007731|NCT04188145|Growth Inhibitors|growth inhibitors|mesh-ancestor
92007732|NCT03063983|Cyclophosphamide|cyclophosphamide|mesh-list
92007733|NCT03063983|Methotrexate|methotrexate|mesh-list
92007734|NCT03063983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92007735|NCT03063983|Immunologic Factors|immunologic factors|mesh-ancestor
92007736|NCT03063983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007737|NCT03063983|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007738|NCT03063983|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92007739|NCT03063983|Alkylating Agents|alkylating agents|mesh-ancestor
92007740|NCT03063983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007741|NCT03063983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007742|NCT03063983|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92007743|NCT03063983|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92007744|NCT03063983|Abortifacient Agents|abortifacient agents|mesh-ancestor
92007745|NCT03063983|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007746|NCT03063983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007747|NCT03063983|Antimetabolites|antimetabolites|mesh-ancestor
92007748|NCT03063983|Dermatologic Agents|dermatologic agents|mesh-ancestor
92007749|NCT03063983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007750|NCT03063983|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92007751|NCT03063983|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007752|NCT03945721|Niraparib|niraparib|mesh-list
92007753|NCT03945721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92007754|NCT03945721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007820|NCT03063671|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92007755|NCT03945721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007756|NCT03945721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007757|NCT01876355|Clonidine|clonidine|mesh-list
92007758|NCT01876355|Analgesics|analgesics|mesh-ancestor
92007759|NCT01876355|Sensory System Agents|sensory system agents|mesh-ancestor
92007760|NCT01876355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007761|NCT01876355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007762|NCT01876355|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92007763|NCT01876355|Sympatholytics|sympatholytics|mesh-ancestor
92007764|NCT01876355|Autonomic Agents|autonomic agents|mesh-ancestor
92007765|NCT01876355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92007766|NCT01876355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92007767|NCT01876355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92007768|NCT01876355|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007769|NCT01876355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007770|NCT01876355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007771|NCT02747407|Vaccines|vaccines|mesh-list
92007772|NCT02747407|Immunologic Factors|immunologic factors|mesh-ancestor
92007773|NCT02747407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007775|NCT01870193|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92007776|NCT01870193|Glycine|glycine|mesh-list
92007777|NCT01870193|Antiviral Agents|antiviral agents|mesh-ancestor
92007778|NCT01870193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007779|NCT01870193|Expectorants|expectorants|mesh-ancestor
92007780|NCT01870193|Respiratory System Agents|respiratory system agents|mesh-ancestor
91984554|NCT02420613|Vorinostat|vorinostat|mesh-list
91984555|NCT02420613|MTOR Inhibitors|mtor inhibitors|mesh-list
91984556|NCT02420613|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984557|NCT02420613|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984558|NCT02420613|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91984559|NCT02420613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984560|NCT02420613|Antifungal Agents|antifungal agents|mesh-ancestor
91984561|NCT02420613|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984562|NCT02420613|Immunologic Factors|immunologic factors|mesh-ancestor
91984563|NCT02420613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984564|NCT02420613|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984565|NCT02420613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984566|NCT02420613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984567|NCT02420613|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91984568|NCT02546193|Misoprostol|misoprostol|mesh-list
91984569|NCT02546193|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92007781|NCT01870193|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92007782|NCT01870193|Antioxidants|antioxidants|mesh-ancestor
92007783|NCT01870193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007784|NCT01870193|Protective Agents|protective agents|mesh-ancestor
92007785|NCT01870193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007786|NCT01870193|Antidotes|antidotes|mesh-ancestor
92007787|NCT01870193|Glycine Agents|glycine agents|mesh-ancestor
92007788|NCT01870193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007789|NCT03063905|Buprenorphine|buprenorphine|mesh-list
92007790|NCT03063905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92007791|NCT03063905|Narcotics|narcotics|mesh-ancestor
92007792|NCT03063905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007793|NCT03063905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007794|NCT03063905|Analgesics|analgesics|mesh-ancestor
92007795|NCT03063905|Sensory System Agents|sensory system agents|mesh-ancestor
92007796|NCT03063905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007801|NCT04432415|Protective Agents|protective agents|mesh-ancestor
92007802|NCT04432415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007803|NCT01402271|Paclitaxel|paclitaxel|mesh-list
92007804|NCT01402271|Carboplatin|carboplatin|mesh-list
92007805|NCT01402271|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007806|NCT01402271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007807|NCT01402271|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007808|NCT01402271|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007809|NCT01402271|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007810|NCT01402271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007811|NCT03063671|Dexmedetomidine|dexmedetomidine|mesh-list
92007812|NCT03063671|Ketamine|ketamine|mesh-list
92007813|NCT03063671|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92007814|NCT03063671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007815|NCT03063671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007816|NCT03063671|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92007817|NCT03063671|Analgesics|analgesics|mesh-ancestor
92007818|NCT03063671|Sensory System Agents|sensory system agents|mesh-ancestor
92007819|NCT03063671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007821|NCT03063671|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92007822|NCT03063671|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92007823|NCT03063671|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007824|NCT03063671|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984570|NCT02546193|Abortifacient Agents|abortifacient agents|mesh-ancestor
91984571|NCT02546193|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007825|NCT03063671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007826|NCT03063671|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92007827|NCT03063671|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92007828|NCT03063671|Anesthetics, General|anesthetics, general|mesh-ancestor
92007829|NCT03063671|Anesthetics|anesthetics|mesh-ancestor
92007830|NCT03063671|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92007831|NCT03063671|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92007832|NCT03063827|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92007833|NCT03063827|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92007834|NCT03063827|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92007835|NCT03063827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007836|NCT03063827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007837|NCT03063827|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92007838|NCT03063827|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92007839|NCT03063827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007840|NCT03063827|Cholinergic Agents|cholinergic agents|mesh-ancestor
92007841|NCT03063827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007842|NCT01669421|Protease Inhibitors|protease inhibitors|mesh-list
92007843|NCT01669421|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92007844|NCT01669421|Protein C Inhibitor|protein c inhibitor|mesh-list
92007845|NCT01669421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007846|NCT01669421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007847|NCT01669421|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92007848|NCT01669421|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92007850|NCT04973969|Luteolytic Agents|luteolytic agents|mesh-ancestor
92007851|NCT04973969|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92007852|NCT04973969|Contraceptive Agents|contraceptive agents|mesh-ancestor
92007853|NCT04973969|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007854|NCT04973969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007855|NCT04973969|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92007856|NCT04973969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007857|NCT04973969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007858|NCT02958709|Rifampin|rifampin|mesh-list
92007859|NCT02958709|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92007860|NCT02958709|Antitubercular Agents|antitubercular agents|mesh-ancestor
92007861|NCT02958709|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92007862|NCT02958709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007863|NCT02958709|Leprostatic Agents|leprostatic agents|mesh-ancestor
92007864|NCT02958709|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007865|NCT02958709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007866|NCT02958709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007867|NCT02958709|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92007870|NCT02958709|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92007871|NCT02958709|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92007872|NCT02958709|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92007873|NCT04979663|Gemcitabine|gemcitabine|mesh-list
92007874|NCT04979663|Oxaliplatin|oxaliplatin|mesh-list
92007875|NCT04979663|Tislelizumab|tislelizumab|mesh-list
92007876|NCT04979663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92007877|NCT04979663|Antimetabolites|antimetabolites|mesh-ancestor
92007878|NCT04979663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007879|NCT04979663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007880|NCT04979663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007881|NCT04979585|Paclitaxel|paclitaxel|mesh-list
92007882|NCT04979585|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92007883|NCT04979585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007884|NCT04979585|Tubulin Modulators|tubulin modulators|mesh-ancestor
92007885|NCT04979585|Antimitotic Agents|antimitotic agents|mesh-ancestor
92007886|NCT04979585|Mitosis Modulators|mitosis modulators|mesh-ancestor
92007887|NCT04979585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007888|NCT05103397|Prednisolone|prednisolone|mesh-list
92007889|NCT05103397|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92007890|NCT05103397|Methylprednisolone|methylprednisolone|mesh-list
92007891|NCT05103397|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92007892|NCT05103397|Prednisolone acetate|prednisolone acetate|mesh-list
92007893|NCT05103397|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92007967|NCT05036473|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91984572|NCT02546193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984574|NCT02546193|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984575|NCT02546193|Oxytocics|oxytocics|mesh-ancestor
92007894|NCT05103397|Prednisolone phosphate|prednisolone phosphate|mesh-list
92007895|NCT05103397|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007896|NCT05103397|Glucocorticoids|glucocorticoids|mesh-ancestor
92007897|NCT05103397|Hormones|hormones|mesh-ancestor
92007898|NCT05103397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007899|NCT05103397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007900|NCT05103397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007901|NCT05103397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007902|NCT05103397|Antiemetics|antiemetics|mesh-ancestor
92007903|NCT05103397|Autonomic Agents|autonomic agents|mesh-ancestor
92007904|NCT05103397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007905|NCT05103397|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007906|NCT05103397|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92007907|NCT05103397|Protective Agents|protective agents|mesh-ancestor
92007908|NCT05101447|Mycophenolic Acid|mycophenolic acid|mesh-list
92007909|NCT05101447|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92007910|NCT05101447|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007911|NCT05101447|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92007912|NCT05101447|Antitubercular Agents|antitubercular agents|mesh-ancestor
92007913|NCT05101447|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92007914|NCT05101447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007915|NCT05101447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007916|NCT05101447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007917|NCT05101291|Bupivacaine|bupivacaine|mesh-list
92007918|NCT05101291|Anesthetics, Local|anesthetics, local|mesh-ancestor
92007919|NCT05101291|Anesthetics|anesthetics|mesh-ancestor
92007920|NCT05101291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007921|NCT05101291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007922|NCT05101291|Sensory System Agents|sensory system agents|mesh-ancestor
92007923|NCT05101291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007924|NCT04342169|Hydroxychloroquine|hydroxychloroquine|mesh-list
92007925|NCT04342169|Antimalarials|antimalarials|mesh-ancestor
92007926|NCT04342169|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92007927|NCT04342169|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92007928|NCT04342169|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92007929|NCT04342169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007930|NCT04342169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007931|NCT04342169|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92007933|NCT04979273|Racepinephrine|racepinephrine|mesh-list
92007934|NCT04979273|Epinephryl borate|epinephryl borate|mesh-list
92007935|NCT04979273|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92007936|NCT04979273|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92007937|NCT04979273|Adrenergic Agents|adrenergic agents|mesh-ancestor
92007938|NCT04979273|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007939|NCT04979273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007942|NCT04979273|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92007943|NCT04979273|Autonomic Agents|autonomic agents|mesh-ancestor
92007944|NCT04979273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007945|NCT04979273|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92007946|NCT04979273|Respiratory System Agents|respiratory system agents|mesh-ancestor
92007947|NCT04979273|Mydriatics|mydriatics|mesh-ancestor
92007948|NCT04979273|Sympathomimetics|sympathomimetics|mesh-ancestor
92007949|NCT04979273|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92007950|NCT05103007|Chlorotrianisene|chlorotrianisene|mesh-list
92007951|NCT05103007|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92007952|NCT05103007|Estrogens|estrogens|mesh-ancestor
92007953|NCT05103007|Hormones|hormones|mesh-ancestor
92007954|NCT05103007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007955|NCT05103007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007956|NCT05103007|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007957|NCT05103007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007958|NCT05092555|Fibrin fragment D|fibrin fragment d|mesh-list
92007959|NCT05092555|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92007960|NCT05092555|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92007961|NCT05092555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007962|NCT05092555|Hemostatics|hemostatics|mesh-ancestor
92007963|NCT05092555|Coagulants|coagulants|mesh-ancestor
91984576|NCT01661595|Sildenafil Citrate|sildenafil citrate|mesh-list
91984577|NCT01661595|Tadalafil|tadalafil|mesh-list
91984578|NCT01661595|Vasodilator Agents|vasodilator agents|mesh-ancestor
92007964|NCT05036473|Levodopa|levodopa|mesh-list
92007965|NCT05036473|Carbidopa|carbidopa|mesh-list
92007966|NCT05036473|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92007968|NCT05036473|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92007969|NCT05036473|Dopamine Agents|dopamine agents|mesh-ancestor
92007970|NCT05036473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007971|NCT05036473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007972|NCT05036473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007973|NCT05036473|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92007974|NCT05036473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007975|NCT05036473|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92007976|NCT05036473|Immunologic Factors|immunologic factors|mesh-ancestor
92007977|NCT05036473|Dopamine Agonists|dopamine agonists|mesh-ancestor
92007978|NCT04985851|Durvalumab|durvalumab|mesh-list
92007979|NCT04985851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92007980|NCT04985851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007981|NCT04985851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007982|NCT04985851|Immunologic Factors|immunologic factors|mesh-ancestor
92007983|NCT04985851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007984|NCT05099575|Oxytocin|oxytocin|mesh-list
92007985|NCT05099575|Oxytocics|oxytocics|mesh-ancestor
92007986|NCT05099575|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92007987|NCT05099575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007988|NCT03063515|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92007989|NCT03063515|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92007990|NCT03063515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007991|NCT03063515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007992|NCT03063515|Cholinergic Agents|cholinergic agents|mesh-ancestor
92007993|NCT03063515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92007994|NCT03063515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007995|NCT04973579|Anesthetics|anesthetics|mesh-list
92007996|NCT04973579|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92007997|NCT04973579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007998|NCT04834063|Selenium|selenium|mesh-list
92007999|NCT04834063|Antioxidants|antioxidants|mesh-ancestor
92008000|NCT04834063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008001|NCT04834063|Protective Agents|protective agents|mesh-ancestor
92008002|NCT04834063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008003|NCT04834063|Trace Elements|trace elements|mesh-ancestor
92008004|NCT04834063|Micronutrients|micronutrients|mesh-ancestor
92008005|NCT04794205|Caryophyllene|caryophyllene|mesh-list
92008006|NCT04794205|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92008007|NCT04794205|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008008|NCT04794205|Analgesics|analgesics|mesh-ancestor
92008009|NCT04794205|Sensory System Agents|sensory system agents|mesh-ancestor
92008010|NCT04794205|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008011|NCT04794205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008012|NCT04794205|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008028|NCT02660281|Immunologic Factors|immunologic factors|mesh-ancestor
92008029|NCT02660281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008030|NCT02660281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008031|NCT02660281|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92008032|NCT02660281|Alkylating Agents|alkylating agents|mesh-ancestor
92008033|NCT02660281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008034|NCT02660281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008035|NCT02660281|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92008036|NCT02660281|Protective Agents|protective agents|mesh-ancestor
92008037|NCT02438995|Cetuximab|cetuximab|mesh-list
92008038|NCT02438995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008039|NCT02438995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008040|NCT05107921|Bromfenac|bromfenac|mesh-list
92008041|NCT05107921|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92008042|NCT05107921|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008043|NCT05107921|Analgesics|analgesics|mesh-ancestor
92008044|NCT05107921|Sensory System Agents|sensory system agents|mesh-ancestor
92008045|NCT05107921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008046|NCT05107921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008047|NCT05107921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984579|NCT01661595|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91984580|NCT01661595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91984581|NCT01661595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008048|NCT05107921|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008049|NCT01669811|Esomeprazole|esomeprazole|mesh-list
92008050|NCT01669811|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92008051|NCT01669811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008052|NCT01669811|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92008053|NCT01669811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008054|NCT01669811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008066|NCT04978181|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92008068|NCT04978181|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92008069|NCT04978181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008070|NCT04437017|Dexamethasone|dexamethasone|mesh-list
92008071|NCT04437017|Fluprednisolone|fluprednisolone|mesh-list
92008072|NCT04437017|Olanzapine|olanzapine|mesh-list
92008073|NCT04437017|Serotonin|serotonin|mesh-list
92008074|NCT04437017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008075|NCT04437017|Antiemetics|antiemetics|mesh-ancestor
92008076|NCT04437017|Autonomic Agents|autonomic agents|mesh-ancestor
92008077|NCT04437017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008078|NCT04437017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008079|NCT04437017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008080|NCT04437017|Glucocorticoids|glucocorticoids|mesh-ancestor
92008081|NCT04437017|Hormones|hormones|mesh-ancestor
92008082|NCT04437017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008083|NCT04437017|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92008084|NCT04437017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008085|NCT04437017|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92008086|NCT04437017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92008092|NCT04437017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008093|NCT04437017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008094|NCT04437017|Serotonin Agents|serotonin agents|mesh-ancestor
92008095|NCT04437017|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92008096|NCT03061253|Nicotine|nicotine|mesh-list
92008097|NCT03061253|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92008098|NCT03061253|Autonomic Agents|autonomic agents|mesh-ancestor
92008099|NCT03061253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008100|NCT03061253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008101|NCT03061253|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92008102|NCT03061253|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92008103|NCT03061253|Cholinergic Agents|cholinergic agents|mesh-ancestor
92008104|NCT03061253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008105|NCT03061253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008106|NCT05107063|Pravastatin|pravastatin|mesh-list
92008107|NCT05107063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92008108|NCT05107063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92008109|NCT05107063|Antimetabolites|antimetabolites|mesh-ancestor
92008110|NCT05107063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008111|NCT05107063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92008112|NCT05107063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92008113|NCT05107063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008114|NCT04977401|Glycerol|glycerol|mesh-list
92008115|NCT04977401|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92008116|NCT04977401|Protective Agents|protective agents|mesh-ancestor
92008117|NCT04977401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008118|NCT05106751|Hyaluronic Acid|hyaluronic acid|mesh-list
92008119|NCT05106751|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92008120|NCT05106751|Immunologic Factors|immunologic factors|mesh-ancestor
92008121|NCT05106751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008122|NCT05106751|Viscosupplements|viscosupplements|mesh-ancestor
92008123|NCT05106751|Protective Agents|protective agents|mesh-ancestor
92008124|NCT04977557|Thiamine|thiamine|mesh-list
92008125|NCT04977557|Vitamin B Complex|vitamin b complex|mesh-ancestor
92008126|NCT04977557|Vitamins|vitamins|mesh-ancestor
92008127|NCT04977557|Micronutrients|micronutrients|mesh-ancestor
92008128|NCT04977557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008129|NCT04316143|Zamicastat|zamicastat|mesh-list
92008130|NCT04316143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008131|NCT04316143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008132|NCT05104801|Tislelizumab|tislelizumab|mesh-list
91984582|NCT01661595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984583|NCT01661595|Urological Agents|urological agents|mesh-ancestor
91984584|NCT04262661|Insulin Glargine|insulin glargine|mesh-list
92008133|NCT05104801|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008134|NCT05104801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008135|NCT04530877|Infliximab|infliximab|mesh-list
92008136|NCT04530877|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92008137|NCT04530877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008138|NCT04530877|Dermatologic Agents|dermatologic agents|mesh-ancestor
92008139|NCT04530877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008140|NCT04530877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008141|NCT04274023|Dostarlimab|dostarlimab|mesh-list
92008142|NCT04274023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008143|NCT04971239|Methotrexate|methotrexate|mesh-list
92008144|NCT04971239|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92008145|NCT04971239|Abortifacient Agents|abortifacient agents|mesh-ancestor
92008146|NCT04971239|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92008147|NCT04971239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008148|NCT04971239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92008149|NCT04971239|Antimetabolites|antimetabolites|mesh-ancestor
92008150|NCT04971239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008151|NCT04971239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008152|NCT04971239|Dermatologic Agents|dermatologic agents|mesh-ancestor
92008153|NCT04971239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008154|NCT04971239|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92008155|NCT04971239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92008161|NCT04903093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92008162|NCT04903093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008163|NCT04903093|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92008164|NCT04903093|Histamine Antagonists|histamine antagonists|mesh-ancestor
92008165|NCT04903093|Histamine Agents|histamine agents|mesh-ancestor
92008166|NCT04903093|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008167|NCT04903093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008168|NCT04903093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008169|NCT04903093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92008170|NCT04903093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008171|NCT04529785|Ethanol|ethanol|mesh-list
92008172|NCT04529785|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92008173|NCT04529785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008174|NCT04529785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008175|NCT04529785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008176|NCT04271293|Edoxaban|edoxaban|mesh-list
92008177|NCT04271293|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92008178|NCT04271293|Antithrombins|antithrombins|mesh-ancestor
92008179|NCT04271293|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92008180|NCT04271293|Protease Inhibitors|protease inhibitors|mesh-ancestor
92008181|NCT04271293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008182|NCT04271293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008183|NCT04271293|Anticoagulants|anticoagulants|mesh-ancestor
92008184|NCT03059849|Adalimumab|adalimumab|mesh-list
92008185|NCT03059849|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92008186|NCT03059849|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008187|NCT03059849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008188|NCT04970693|Aflutinib|aflutinib|mesh-list
92008189|NCT04970693|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92008190|NCT04970693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008191|NCT04970693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008192|NCT04970069|Analgesics|analgesics|mesh-list
92008193|NCT04970069|Sensory System Agents|sensory system agents|mesh-ancestor
92008194|NCT04970069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008195|NCT04970069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008197|NCT04970303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92008198|NCT04970303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008199|NCT04970303|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92008200|NCT04970303|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92008201|NCT04970303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92008202|NCT04970303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008203|NCT04970303|Dopamine Agents|dopamine agents|mesh-ancestor
92008204|NCT04970303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984585|NCT04262661|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984586|NCT04262661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984588|NCT02957097|Analgesics|analgesics|mesh-ancestor
91984589|NCT02957097|Sensory System Agents|sensory system agents|mesh-ancestor
92008206|NCT04432259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008207|NCT04432259|Antiemetics|antiemetics|mesh-ancestor
92008208|NCT04432259|Autonomic Agents|autonomic agents|mesh-ancestor
92008209|NCT04432259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008210|NCT04432259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008211|NCT04432259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008212|NCT04432259|Glucocorticoids|glucocorticoids|mesh-ancestor
92008213|NCT04432259|Hormones|hormones|mesh-ancestor
92008214|NCT04432259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008215|NCT04432259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92008216|NCT04432259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008217|NCT04964219|Ketamine|ketamine|mesh-list
92008218|NCT04964219|Esketamine|esketamine|mesh-list
92008219|NCT04964219|Analgesics|analgesics|mesh-ancestor
92008220|NCT04964219|Sensory System Agents|sensory system agents|mesh-ancestor
92008221|NCT04964219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008222|NCT04964219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008223|NCT04964219|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92008224|NCT04964219|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92008225|NCT04964219|Anesthetics, General|anesthetics, general|mesh-ancestor
92008226|NCT04964219|Anesthetics|anesthetics|mesh-ancestor
92008228|NCT04964219|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92008229|NCT04964219|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92008231|NCT04964219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008232|NCT04964219|Antidepressive Agents|antidepressive agents|mesh-ancestor
92008233|NCT04964219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92008234|NCT04975373|Hyaluronic Acid|hyaluronic acid|mesh-list
92008235|NCT04975373|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92008236|NCT04975373|Immunologic Factors|immunologic factors|mesh-ancestor
92008237|NCT04975373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008238|NCT04975373|Viscosupplements|viscosupplements|mesh-ancestor
92008239|NCT04975373|Protective Agents|protective agents|mesh-ancestor
92008240|NCT04974827|Carboplatin|carboplatin|mesh-list
92008241|NCT04974827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008242|NCT04963595|Vinorelbine|vinorelbine|mesh-list
92008243|NCT04963595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92008244|NCT04963595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008245|NCT04963595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92008246|NCT04963595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92008247|NCT04963595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92008248|NCT04963595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008249|NCT04968509|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92008250|NCT04968509|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92008251|NCT04968509|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92008252|NCT04968509|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92008253|NCT04968509|Antimetabolites|antimetabolites|mesh-ancestor
92008254|NCT04968509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008255|NCT04968509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008256|NCT04968509|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92008257|NCT04968509|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92008258|NCT04968509|Protease Inhibitors|protease inhibitors|mesh-ancestor
92008259|NCT04962425|Trastuzumab|trastuzumab|mesh-list
92008260|NCT04962425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008261|NCT04962425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008262|NCT03060707|Bromides|bromides|mesh-list
92008263|NCT03060707|Rocuronium|rocuronium|mesh-list
92008264|NCT03060707|Anticonvulsants|anticonvulsants|mesh-ancestor
92008265|NCT03060707|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92008266|NCT03060707|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92008267|NCT03060707|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92008268|NCT03060707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008269|NCT03060707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008270|NCT04967417|Paclitaxel|paclitaxel|mesh-list
92008271|NCT04967417|Carboplatin|carboplatin|mesh-list
92008273|NCT04967417|Pemetrexed|pemetrexed|mesh-list
92008274|NCT04967417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92008275|NCT04967417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008276|NCT04967417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92008277|NCT04967417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92008278|NCT04967417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92008279|NCT04967417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008280|NCT04967417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008281|NCT04967417|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92008282|NCT04967417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008283|NCT04967417|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92008284|NCT04967417|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92008285|NCT03060005|Dextrans|dextrans|mesh-list
92008286|NCT03060005|Anticoagulants|anticoagulants|mesh-ancestor
92008287|NCT03060005|Plasma Substitutes|plasma substitutes|mesh-ancestor
92008288|NCT03060005|Blood Substitutes|blood substitutes|mesh-ancestor
92008289|NCT04210141|Antivenins|antivenins|mesh-list
92008290|NCT04210141|Immunologic Factors|immunologic factors|mesh-ancestor
92008291|NCT04210141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008292|NCT04418531|Antibodies|antibodies|mesh-list
92008293|NCT04418531|Immunoglobulins|immunoglobulins|mesh-list
92008294|NCT04418531|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92008295|NCT04418531|Immunologic Factors|immunologic factors|mesh-ancestor
92008296|NCT04418531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008297|NCT02615119|Isoproterenol|isoproterenol|mesh-list
92008298|NCT02615119|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92008300|NCT02615119|Adrenergic Agents|adrenergic agents|mesh-ancestor
92008301|NCT02615119|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008302|NCT02615119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008304|NCT02615119|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92008305|NCT02615119|Autonomic Agents|autonomic agents|mesh-ancestor
92008306|NCT02615119|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008307|NCT02615119|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92008308|NCT02615119|Respiratory System Agents|respiratory system agents|mesh-ancestor
92008309|NCT02615119|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92008310|NCT02615119|Sympathomimetics|sympathomimetics|mesh-ancestor
92008311|NCT02615119|Protective Agents|protective agents|mesh-ancestor
92008312|NCT02555293|Rifaximin|rifaximin|mesh-list
92008313|NCT02555293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92008314|NCT02555293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008315|NCT02555293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008316|NCT05104255|Anesthetics|anesthetics|mesh-list
92008317|NCT05104255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008318|NCT05104255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008319|NCT03293017|Diazepam|diazepam|mesh-list
92008320|NCT03293017|Baclofen|baclofen|mesh-list
92008321|NCT03293017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92008322|NCT03293017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008323|NCT03293017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92008324|NCT03293017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008325|NCT03293017|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92008326|NCT03293017|GABA Agonists|gaba agonists|mesh-ancestor
92008327|NCT03293017|GABA Agents|gaba agents|mesh-ancestor
92008328|NCT03293017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008329|NCT03293017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008330|NCT03293017|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92008331|NCT03293017|Anticonvulsants|anticonvulsants|mesh-ancestor
92008332|NCT03293017|Antiemetics|antiemetics|mesh-ancestor
92008333|NCT03293017|Autonomic Agents|autonomic agents|mesh-ancestor
92008334|NCT03293017|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008335|NCT03293017|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92008336|NCT03293017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008337|NCT03293017|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92008338|NCT03293017|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92008339|NCT03293017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92008340|NCT03293017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92008341|NCT03293017|Anesthetics, General|anesthetics, general|mesh-ancestor
92008342|NCT03293017|Anesthetics|anesthetics|mesh-ancestor
92008343|NCT03293017|GABA Modulators|gaba modulators|mesh-ancestor
92008344|NCT03198559|Vorinostat|vorinostat|mesh-list
92008345|NCT03198559|Disulfiram|disulfiram|mesh-list
92008346|NCT03198559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008347|NCT03198559|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92008348|NCT03198559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008349|NCT03198559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984590|NCT02957097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008350|NCT03198559|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92008351|NCT03198559|Acetaldehyde Dehydrogenase Inhibitors|acetaldehyde dehydrogenase inhibitors|mesh-ancestor
92008352|NCT02625623|Paclitaxel|paclitaxel|mesh-list
92008353|NCT02625623|Irinotecan|irinotecan|mesh-list
92008354|NCT02625623|Avelumab|avelumab|mesh-list
92008355|NCT02625623|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92008356|NCT02625623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008357|NCT02625623|Tubulin Modulators|tubulin modulators|mesh-ancestor
92008358|NCT02625623|Antimitotic Agents|antimitotic agents|mesh-ancestor
92008359|NCT02625623|Mitosis Modulators|mitosis modulators|mesh-ancestor
92008360|NCT02625623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008361|NCT02625623|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92008362|NCT02625623|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92008363|NCT02625623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008364|NCT02625623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008365|NCT02749513|Itraconazole|itraconazole|mesh-list
92008366|NCT02749513|Antifungal Agents|antifungal agents|mesh-ancestor
92008367|NCT02749513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008368|NCT02749513|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92008369|NCT02749513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92008370|NCT02749513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008371|NCT02749513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008372|NCT02749513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92008373|NCT02749513|Hormone Antagonists|hormone antagonists|mesh-ancestor
92008374|NCT02749513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008375|NCT02749513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008378|NCT02684227|Carboplatin|carboplatin|mesh-list
92008379|NCT02684227|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92008380|NCT02684227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92008381|NCT02684227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008382|NCT02684227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92008383|NCT02684227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92008384|NCT02684227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92008385|NCT02684227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008386|NCT05110339|Dexmedetomidine|dexmedetomidine|mesh-list
92008387|NCT05110339|Ropivacaine|ropivacaine|mesh-list
92008388|NCT05110339|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92008389|NCT05110339|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008390|NCT05110339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008391|NCT05110339|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008392|NCT05110339|Analgesics|analgesics|mesh-ancestor
92008393|NCT05110339|Sensory System Agents|sensory system agents|mesh-ancestor
92008394|NCT05110339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008395|NCT05110339|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92008396|NCT05110339|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92008397|NCT05110339|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92008398|NCT05110339|Adrenergic Agents|adrenergic agents|mesh-ancestor
92008399|NCT05110339|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008400|NCT05110339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008401|NCT05110339|Anesthetics, Local|anesthetics, local|mesh-ancestor
92008402|NCT05110339|Anesthetics|anesthetics|mesh-ancestor
92008404|NCT04965545|Trace Elements|trace elements|mesh-ancestor
92008405|NCT04965545|Micronutrients|micronutrients|mesh-ancestor
92008406|NCT04965545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008407|NCT04425629|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92008408|NCT04425629|Antiviral Agents|antiviral agents|mesh-ancestor
92008409|NCT04425629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008410|NCT05105347|Prednisone|prednisone|mesh-list
92008411|NCT05105347|Adalimumab|adalimumab|mesh-list
92008412|NCT05105347|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008413|NCT05105347|Glucocorticoids|glucocorticoids|mesh-ancestor
92008414|NCT05105347|Hormones|hormones|mesh-ancestor
92008415|NCT05105347|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008416|NCT05105347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008417|NCT05105347|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92008418|NCT05105347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008419|NCT05105347|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92008420|NCT05105347|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008421|NCT05110651|Hydroxychloroquine|hydroxychloroquine|mesh-list
92008422|NCT05110651|Antimalarials|antimalarials|mesh-ancestor
92008423|NCT05110651|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91984591|NCT02957097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984592|NCT02957097|Anticonvulsants|anticonvulsants|mesh-ancestor
92008424|NCT05110651|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92008425|NCT05110651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008426|NCT05110651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008427|NCT05110651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008428|NCT05110651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008429|NCT03060785|Tenofovir|tenofovir|mesh-list
92008430|NCT03060785|Emtricitabine|emtricitabine|mesh-list
92008431|NCT03060785|Antiviral Agents|antiviral agents|mesh-ancestor
92008432|NCT03060785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008433|NCT03060785|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92008434|NCT03060785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92008435|NCT03060785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008436|NCT03060785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008437|NCT03060785|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92008438|NCT03060785|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92008439|NCT04952207|Sofosbuvir|sofosbuvir|mesh-list
92008440|NCT04952207|Antiviral Agents|antiviral agents|mesh-list
92008441|NCT04952207|Grazoprevir|grazoprevir|mesh-list
92008442|NCT04952207|Ledipasvir|ledipasvir|mesh-list
92008443|NCT04952207|Velpatasvir|velpatasvir|mesh-list
92008444|NCT04952207|Asunaprevir|asunaprevir|mesh-list
92008445|NCT04952207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008446|NCT04952207|Protease Inhibitors|protease inhibitors|mesh-ancestor
92008447|NCT04952207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008448|NCT04952207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008449|NCT04632589|Losartan|losartan|mesh-list
92008451|NCT04632589|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92008455|NCT05108545|Amphotericin B|amphotericin b|mesh-list
92008456|NCT05108545|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92008457|NCT05108545|Amebicides|amebicides|mesh-ancestor
92008458|NCT05108545|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92008459|NCT05108545|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92008461|NCT05108545|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92008462|NCT05108545|Antifungal Agents|antifungal agents|mesh-ancestor
92008463|NCT05102695|Fibrin fragment D|fibrin fragment d|mesh-list
92008464|NCT05102695|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92008465|NCT05102695|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92008466|NCT05102695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008467|NCT05102695|Hemostatics|hemostatics|mesh-ancestor
92008468|NCT05102695|Coagulants|coagulants|mesh-ancestor
92008469|NCT04952129|Selenium|selenium|mesh-list
92008470|NCT04952129|Selenomethylselenocysteine|selenomethylselenocysteine|mesh-list
92008471|NCT04952129|Antioxidants|antioxidants|mesh-ancestor
92008472|NCT04952129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008473|NCT04952129|Protective Agents|protective agents|mesh-ancestor
92008474|NCT04952129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008475|NCT04952129|Trace Elements|trace elements|mesh-ancestor
92008476|NCT04952129|Micronutrients|micronutrients|mesh-ancestor
92008477|NCT04952129|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92008478|NCT04952129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008479|NCT05007769|Atezolizumab|atezolizumab|mesh-list
92008480|NCT05007769|Ramucirumab|ramucirumab|mesh-list
92008481|NCT05007769|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92008482|NCT05007769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008483|NCT05007769|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008484|NCT05007769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008485|NCT04952051|Folic Acid|folic acid|mesh-list
92008486|NCT04952051|Vitamin B Complex|vitamin b complex|mesh-list
92008487|NCT04952051|Amlodipine|amlodipine|mesh-list
92008488|NCT04952051|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92008489|NCT04952051|Enalapril|enalapril|mesh-list
92008490|NCT04952051|Enalaprilat|enalaprilat|mesh-list
92008491|NCT04952051|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92008492|NCT04952051|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92008493|NCT04952051|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92008494|NCT04952051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008495|NCT04952051|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92008496|NCT04952051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008497|NCT04952051|Vasodilator Agents|vasodilator agents|mesh-ancestor
92008498|NCT04952051|Hematinics|hematinics|mesh-ancestor
92008499|NCT04952051|Vitamins|vitamins|mesh-ancestor
92008500|NCT04952051|Micronutrients|micronutrients|mesh-ancestor
91984593|NCT02957097|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91984594|NCT02957097|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92008502|NCT04952051|Natriuretic Agents|natriuretic agents|mesh-ancestor
92008503|NCT04952051|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92008504|NCT04952051|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92008505|NCT04952051|Protease Inhibitors|protease inhibitors|mesh-ancestor
92008506|NCT04952051|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008507|NCT04960943|Trastuzumab|trastuzumab|mesh-list
92008508|NCT04960943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008509|NCT04960943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008510|NCT04431713|Exenatide|exenatide|mesh-list
92008511|NCT04431713|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92008512|NCT04431713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008513|NCT04431713|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92008514|NCT04431713|Incretins|incretins|mesh-ancestor
92008515|NCT04431713|Hormones|hormones|mesh-ancestor
92008516|NCT04431713|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008517|NCT05104333|Vaccines|vaccines|mesh-list
92008518|NCT05104333|Immunologic Factors|immunologic factors|mesh-ancestor
92008519|NCT05104333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008520|NCT03059615|Doxorubicin|doxorubicin|mesh-list
92008521|NCT03059615|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92008522|NCT03059615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008523|NCT03059615|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92008527|NCT04951505|Cefepime|cefepime|mesh-list
92008529|NCT04951505|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008530|NCT04951349|Petrolatum|petrolatum|mesh-list
92008531|NCT04951349|Emollients|emollients|mesh-ancestor
92008532|NCT04951349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92008533|NCT02658019|Pembrolizumab|pembrolizumab|mesh-list
92008534|NCT02658019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008535|NCT02658019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008536|NCT02658019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92008537|NCT02658019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008538|NCT03059303|Simeprevir|simeprevir|mesh-list
92008539|NCT03059303|Odalasvir|odalasvir|mesh-list
92008540|NCT03059303|Omeprazole|omeprazole|mesh-list
92008541|NCT03059303|Lansoprazole|lansoprazole|mesh-list
92008542|NCT03059303|Dexlansoprazole|dexlansoprazole|mesh-list
92008543|NCT03059303|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92008544|NCT03059303|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008545|NCT03059303|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92008546|NCT03059303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008547|NCT03059303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008548|NCT03059303|Antiviral Agents|antiviral agents|mesh-ancestor
92008549|NCT03059303|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008550|NCT03059303|Protease Inhibitors|protease inhibitors|mesh-ancestor
92008551|NCT03059537|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92008552|NCT03059537|Cathartics|cathartics|mesh-ancestor
92008553|NCT03059537|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008554|NCT04428775|Cromolyn Sodium|cromolyn sodium|mesh-list
92008555|NCT04428775|Mast Cell Stabilizers|mast cell stabilizers|mesh-ancestor
92008556|NCT04428775|Immunologic Factors|immunologic factors|mesh-ancestor
92008557|NCT04428775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008558|NCT04428775|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92008559|NCT04428775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008560|NCT04428775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92008561|NCT04428775|Respiratory System Agents|respiratory system agents|mesh-ancestor
92008562|NCT04950569|Simendan|simendan|mesh-list
92008563|NCT04950569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92008564|NCT04950569|Vasodilator Agents|vasodilator agents|mesh-ancestor
92008565|NCT04950569|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92008566|NCT04950569|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92008567|NCT04950569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008568|NCT04950569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008569|NCT04950569|Protective Agents|protective agents|mesh-ancestor
92008570|NCT04950569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008571|NCT04944641|Anticonvulsants|anticonvulsants|mesh-list
92008572|NCT04436419|Thioctic Acid|thioctic acid|mesh-list
92008573|NCT04436419|Antioxidants|antioxidants|mesh-ancestor
92008574|NCT04436419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008575|NCT04436419|Protective Agents|protective agents|mesh-ancestor
91984595|NCT02957097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984596|NCT02957097|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92008576|NCT04436419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008577|NCT04436419|Vitamin B Complex|vitamin b complex|mesh-ancestor
92008579|NCT04436419|Micronutrients|micronutrients|mesh-ancestor
92008580|NCT04944173|Durvalumab|durvalumab|mesh-list
92008581|NCT04944173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008582|NCT04944173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008583|NCT04950647|Nitrofurazone|nitrofurazone|mesh-list
92008584|NCT04950647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008585|NCT01675765|Cyclophosphamide|cyclophosphamide|mesh-list
92008586|NCT01675765|Cisplatin|cisplatin|mesh-list
92008587|NCT01675765|Pemetrexed|pemetrexed|mesh-list
92008588|NCT01675765|Immunologic Factors|immunologic factors|mesh-list
92008589|NCT01675765|Immunomodulating Agents|immunomodulating agents|mesh-list
92008590|NCT01675765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92008591|NCT01675765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008592|NCT01675765|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008593|NCT01675765|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92008594|NCT01675765|Alkylating Agents|alkylating agents|mesh-ancestor
92008595|NCT01675765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008596|NCT01675765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008597|NCT01675765|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92008601|NCT04943237|Sulfasalazine|sulfasalazine|mesh-list
92008602|NCT04943237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92008603|NCT04943237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008604|NCT04943237|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92008605|NCT04943237|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008606|NCT04943237|Analgesics|analgesics|mesh-ancestor
92008607|NCT04943237|Sensory System Agents|sensory system agents|mesh-ancestor
92008608|NCT04943237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008609|NCT04943237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008610|NCT04943237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008611|NCT04943237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008612|NCT04285255|Lidocaine|lidocaine|mesh-list
92008613|NCT04285255|Fentanyl|fentanyl|mesh-list
92008614|NCT04285255|Dexmedetomidine|dexmedetomidine|mesh-list
92008615|NCT04285255|Ketamine|ketamine|mesh-list
92008616|NCT04285255|Anesthetics, Local|anesthetics, local|mesh-ancestor
92008617|NCT04285255|Anesthetics|anesthetics|mesh-ancestor
92008618|NCT04285255|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008996|NCT05015335|Antimetabolites|antimetabolites|mesh-ancestor
92008619|NCT04285255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008620|NCT04285255|Sensory System Agents|sensory system agents|mesh-ancestor
92008621|NCT04285255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008622|NCT04285255|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92008623|NCT04285255|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92008624|NCT04285255|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92008625|NCT04285255|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92008626|NCT04285255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008627|NCT04285255|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92008628|NCT04285255|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008629|NCT04285255|Analgesics|analgesics|mesh-ancestor
92008630|NCT04285255|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92008631|NCT04285255|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92008632|NCT04285255|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92008633|NCT04285255|Adrenergic Agents|adrenergic agents|mesh-ancestor
92008634|NCT04285255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008635|NCT04285255|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92008636|NCT04285255|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92008637|NCT04285255|Anesthetics, General|anesthetics, general|mesh-ancestor
92008638|NCT04285255|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92008639|NCT04285255|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92008640|NCT04285255|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92008641|NCT04285255|Narcotics|narcotics|mesh-ancestor
92008642|NCT04285255|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92008643|NCT04121299|Amlodipine|amlodipine|mesh-list
92008644|NCT04121299|Carvedilol|carvedilol|mesh-list
92008645|NCT04121299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92008646|NCT04121299|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92008647|NCT04121299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92008648|NCT04121299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008649|NCT04121299|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91984597|NCT02957097|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91984598|NCT02957097|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91984599|NCT02957097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008650|NCT04121299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008651|NCT04121299|Vasodilator Agents|vasodilator agents|mesh-ancestor
92008652|NCT04121299|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92008653|NCT04121299|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92008654|NCT04121299|Adrenergic Agents|adrenergic agents|mesh-ancestor
92008655|NCT04121299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008656|NCT04121299|Antioxidants|antioxidants|mesh-ancestor
92008657|NCT04121299|Protective Agents|protective agents|mesh-ancestor
92008658|NCT04121299|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92008659|NCT04121299|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92008660|NCT04942769|Selenium|selenium|mesh-list
92008661|NCT04942769|Antioxidants|antioxidants|mesh-ancestor
92008662|NCT04942769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008663|NCT04942769|Protective Agents|protective agents|mesh-ancestor
92008664|NCT04942769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008665|NCT04942769|Trace Elements|trace elements|mesh-ancestor
92008666|NCT04942769|Micronutrients|micronutrients|mesh-ancestor
92008667|NCT04942301|Endostar protein|endostar protein|mesh-list
92008668|NCT04942301|Endostatins|endostatins|mesh-list
92008671|NCT04942301|Growth Substances|growth substances|mesh-ancestor
92008672|NCT04942301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008673|NCT04942301|Growth Inhibitors|growth inhibitors|mesh-ancestor
92008674|NCT04942301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008675|NCT03057899|Fenugreek seed meal|fenugreek seed meal|mesh-list
92008676|NCT03057899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92008677|NCT03057899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008678|NCT04434001|Thrombin|thrombin|mesh-list
92008679|NCT04434001|Hemostatics|hemostatics|mesh-ancestor
92008680|NCT04434001|Coagulants|coagulants|mesh-ancestor
92008681|NCT03540901|Acetazolamide|acetazolamide|mesh-list
92008682|NCT03540901|Anticonvulsants|anticonvulsants|mesh-ancestor
92008683|NCT03540901|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92008684|NCT03540901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008685|NCT03540901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008686|NCT03540901|Diuretics|diuretics|mesh-ancestor
92008687|NCT03540901|Natriuretic Agents|natriuretic agents|mesh-ancestor
92008688|NCT03540901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008689|NCT03517735|Remifentanil|remifentanil|mesh-list
92008690|NCT03517735|Propofol|propofol|mesh-list
92008691|NCT03517735|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92008692|NCT03517735|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008693|NCT03517735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008694|NCT03517735|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92008695|NCT03517735|Anesthetics, General|anesthetics, general|mesh-ancestor
92008696|NCT03517735|Anesthetics|anesthetics|mesh-ancestor
92008697|NCT03517735|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92008698|NCT03517735|Narcotics|narcotics|mesh-ancestor
92008699|NCT03517735|Analgesics|analgesics|mesh-ancestor
92008700|NCT03517735|Sensory System Agents|sensory system agents|mesh-ancestor
92008701|NCT03517735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008702|NCT04941131|Chlorhexidine|chlorhexidine|mesh-list
92008703|NCT04941131|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92008704|NCT04941131|Povidone-Iodine|povidone-iodine|mesh-list
92008705|NCT04941131|Povidone|povidone|mesh-list
92008706|NCT04941131|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92008707|NCT04941131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008708|NCT04941131|Disinfectants|disinfectants|mesh-ancestor
92008709|NCT04941131|Dermatologic Agents|dermatologic agents|mesh-ancestor
92008710|NCT04941131|Plasma Substitutes|plasma substitutes|mesh-ancestor
92008711|NCT04941131|Blood Substitutes|blood substitutes|mesh-ancestor
92008712|NCT03400501|Insulin|insulin|mesh-list
92008713|NCT03400501|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92008714|NCT03400501|Insulin Glargine|insulin glargine|mesh-list
92008715|NCT03400501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92008716|NCT03400501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008717|NCT04426591|Biotin|biotin|mesh-list
92008718|NCT04426591|Vitamin B Complex|vitamin b complex|mesh-ancestor
92008719|NCT04426591|Vitamins|vitamins|mesh-ancestor
92008720|NCT04426591|Micronutrients|micronutrients|mesh-ancestor
92008721|NCT04426591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008722|NCT04940273|Remifentanil|remifentanil|mesh-list
92008723|NCT04940273|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92008724|NCT04940273|Narcotics|narcotics|mesh-ancestor
92008725|NCT04940273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008726|NCT04940273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008727|NCT04940273|Analgesics|analgesics|mesh-ancestor
92008728|NCT04940273|Sensory System Agents|sensory system agents|mesh-ancestor
92008729|NCT04940273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008730|NCT04948385|Propofol|propofol|mesh-list
92008731|NCT04948385|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92008732|NCT04948385|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008733|NCT04948385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008734|NCT04948385|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92008735|NCT04948385|Anesthetics, General|anesthetics, general|mesh-ancestor
92008736|NCT04948385|Anesthetics|anesthetics|mesh-ancestor
92008737|NCT03057821|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92008738|NCT03057821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92008739|NCT03057821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008740|NCT04948151|Sildenafil Citrate|sildenafil citrate|mesh-list
92008741|NCT04948151|Vasodilator Agents|vasodilator agents|mesh-ancestor
92008742|NCT04948151|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92008743|NCT04948151|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92008744|NCT04948151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008746|NCT04948151|Urological Agents|urological agents|mesh-ancestor
92008748|NCT02633293|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92008749|NCT04938713|Ketamine|ketamine|mesh-list
92008750|NCT04938713|Esketamine|esketamine|mesh-list
92008751|NCT04938713|Analgesics|analgesics|mesh-ancestor
92008752|NCT04938713|Sensory System Agents|sensory system agents|mesh-ancestor
92008753|NCT04938713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008754|NCT04938713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008755|NCT04938713|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92008756|NCT04938713|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92008757|NCT04938713|Anesthetics, General|anesthetics, general|mesh-ancestor
92008758|NCT04938713|Anesthetics|anesthetics|mesh-ancestor
92008759|NCT04938713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008760|NCT04938713|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92008761|NCT04938713|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92008762|NCT04938713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008763|NCT04938713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008764|NCT04938713|Antidepressive Agents|antidepressive agents|mesh-ancestor
92008765|NCT04938713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92008766|NCT04938011|Progesterone|progesterone|mesh-list
92008767|NCT04938011|Progestins|progestins|mesh-ancestor
92008768|NCT04938011|Hormones|hormones|mesh-ancestor
92008769|NCT04938011|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008770|NCT04938011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008771|NCT03057509|Octreotide|octreotide|mesh-list
92008772|NCT03057509|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009486|NCT04781725|Mitosis Modulators|mitosis modulators|mesh-ancestor
92008773|NCT03057509|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92008774|NCT03057509|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008775|NCT03572413|Bromides|bromides|mesh-list
92008776|NCT03572413|Rocuronium|rocuronium|mesh-list
92008777|NCT03572413|Anticonvulsants|anticonvulsants|mesh-ancestor
92008778|NCT03572413|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92008779|NCT03572413|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92008780|NCT03572413|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92008781|NCT03572413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008782|NCT03572413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008783|NCT04956419|Fluconazole|fluconazole|mesh-list
92008784|NCT04956419|Antifungal Agents|antifungal agents|mesh-ancestor
92008785|NCT04956419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008786|NCT04956419|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92008787|NCT04956419|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92008788|NCT04956419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008789|NCT04956419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008790|NCT04956419|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92008791|NCT04956419|Hormone Antagonists|hormone antagonists|mesh-ancestor
92008792|NCT04956419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008793|NCT04956419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008794|NCT04956419|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92008795|NCT04956419|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92008797|NCT04946669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92008798|NCT04946669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984600|NCT02957097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984601|NCT02957097|Antimanic Agents|antimanic agents|mesh-ancestor
91984602|NCT03165383|Morphine|morphine|mesh-list
92008799|NCT04946669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008800|NCT04946669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008801|NCT04946669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92008802|NCT04946669|Immunologic Factors|immunologic factors|mesh-ancestor
92008803|NCT04946669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008804|NCT04946669|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008805|NCT03219775|Nivolumab|nivolumab|mesh-list
92008806|NCT03219775|Ipilimumab|ipilimumab|mesh-list
92008807|NCT03219775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92008808|NCT03219775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008809|NCT03219775|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92008810|NCT03219775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008811|NCT03100045|Artesunate|artesunate|mesh-list
92008812|NCT03100045|Artemisinins|artemisinins|mesh-list
92008813|NCT03100045|Artemisinin|artemisinin|mesh-list
92008814|NCT03100045|Antimalarials|antimalarials|mesh-ancestor
92008815|NCT03100045|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92008816|NCT03100045|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92008821|NCT03100045|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92008822|NCT03100045|Anthelmintics|anthelmintics|mesh-ancestor
92008823|NCT04946123|Selenium|selenium|mesh-list
92008824|NCT04946123|Antioxidants|antioxidants|mesh-ancestor
92008825|NCT04946123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008826|NCT04946123|Protective Agents|protective agents|mesh-ancestor
92008827|NCT04946123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008828|NCT04946123|Trace Elements|trace elements|mesh-ancestor
92008829|NCT04946123|Micronutrients|micronutrients|mesh-ancestor
92008830|NCT04945577|Vitamin D|vitamin d|mesh-list
92008831|NCT04945577|Vitamins|vitamins|mesh-ancestor
92008832|NCT04945577|Micronutrients|micronutrients|mesh-ancestor
92008833|NCT04945577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008834|NCT04945577|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92008835|NCT02623829|Botulinum Toxins|botulinum toxins|mesh-list
92008836|NCT02623829|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92008837|NCT02623829|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92008838|NCT02623829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92008839|NCT02623829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008840|NCT02623829|Cholinergic Agents|cholinergic agents|mesh-ancestor
92008841|NCT02623829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008842|NCT02623829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008843|NCT02623829|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92008844|NCT02623829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008845|NCT02655679|Ether|ether|mesh-list
92008846|NCT02655679|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92008847|NCT02655679|Anesthetics, General|anesthetics, general|mesh-ancestor
92008848|NCT02655679|Anesthetics|anesthetics|mesh-ancestor
92008849|NCT02655679|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008850|NCT02655679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008851|NCT04936295|Fulvestrant|fulvestrant|mesh-list
92008852|NCT04936295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92008853|NCT04936295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008854|NCT04936295|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92008855|NCT04936295|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92008856|NCT04936295|Hormone Antagonists|hormone antagonists|mesh-ancestor
92008857|NCT04936295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008858|NCT04936295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008859|NCT05114239|Timolol|timolol|mesh-list
92008860|NCT05114239|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92008861|NCT05114239|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92008862|NCT05114239|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92008863|NCT05114239|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92008864|NCT05114239|Adrenergic Agents|adrenergic agents|mesh-ancestor
92008865|NCT05114239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008866|NCT05114239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008867|NCT05114239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008868|NCT05114239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92008869|NCT05114239|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92008870|NCT04418999|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92008871|NCT04418999|Dexamethasone|dexamethasone|mesh-list
91984603|NCT03165383|Bupivacaine|bupivacaine|mesh-list
91984604|NCT03165383|Anesthetics, Local|anesthetics, local|mesh-ancestor
91984605|NCT03165383|Anesthetics|anesthetics|mesh-ancestor
91984606|NCT03165383|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984607|NCT03165383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984608|NCT03165383|Sensory System Agents|sensory system agents|mesh-ancestor
92008872|NCT04418999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008873|NCT04418999|Antiemetics|antiemetics|mesh-ancestor
92008874|NCT04418999|Autonomic Agents|autonomic agents|mesh-ancestor
92008875|NCT04418999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008876|NCT04418999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008877|NCT04418999|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008878|NCT04418999|Glucocorticoids|glucocorticoids|mesh-ancestor
92008879|NCT04418999|Hormones|hormones|mesh-ancestor
92008880|NCT04418999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008881|NCT04418999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92008882|NCT04418999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008883|NCT04418999|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92008884|NCT05113459|Disitamab vedotin|disitamab vedotin|mesh-list
92008885|NCT05113459|Immunoconjugates|immunoconjugates|mesh-ancestor
92008886|NCT05113459|Immunologic Factors|immunologic factors|mesh-ancestor
92008887|NCT05113459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008888|NCT04526197|Celecoxib|celecoxib|mesh-list
92008892|NCT04526197|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008893|NCT04526197|Analgesics|analgesics|mesh-ancestor
92008894|NCT04526197|Sensory System Agents|sensory system agents|mesh-ancestor
92008895|NCT04526197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008896|NCT04526197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008897|NCT04526197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008898|NCT04526197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008899|NCT04526197|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92008900|NCT04526197|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92008901|NCT04526197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008902|NCT04526197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008903|NCT04526197|Lipotropic Agents|lipotropic agents|mesh-ancestor
92008904|NCT04526197|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92008905|NCT04526197|Antimetabolites|antimetabolites|mesh-ancestor
92008906|NCT04526197|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92008907|NCT04526197|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92008908|NCT04526197|Nootropic Agents|nootropic agents|mesh-ancestor
92008909|NCT04526197|Chelating Agents|chelating agents|mesh-ancestor
92008910|NCT04526197|Sequestering Agents|sequestering agents|mesh-ancestor
92008911|NCT04526197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92008912|NCT04526197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92008913|NCT04526197|Growth Substances|growth substances|mesh-ancestor
92008914|NCT04526197|Growth Inhibitors|growth inhibitors|mesh-ancestor
92008915|NCT04526197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008916|NCT04933019|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92008917|NCT04933019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008918|NCT05060965|Nicotine|nicotine|mesh-list
92008919|NCT05060965|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92008920|NCT05060965|Autonomic Agents|autonomic agents|mesh-ancestor
92008921|NCT05060965|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008922|NCT05060965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008923|NCT05060965|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92008924|NCT05060965|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92008925|NCT05060965|Cholinergic Agents|cholinergic agents|mesh-ancestor
92008926|NCT05060965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008927|NCT05060965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008928|NCT04935515|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92008929|NCT04935515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92008930|NCT04935515|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92008931|NCT04935515|Anticoagulants|anticoagulants|mesh-list
92008932|NCT04935515|Coagulants|coagulants|mesh-list
92008933|NCT04935515|Histamine Antagonists|histamine antagonists|mesh-list
92008934|NCT04935515|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92008935|NCT04935515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008936|NCT04935515|Antitubercular Agents|antitubercular agents|mesh-ancestor
92008937|NCT04935515|Histamine Agents|histamine agents|mesh-ancestor
92008938|NCT04935515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984609|NCT03165383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984610|NCT03165383|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92008939|NCT04935515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008940|NCT04935515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008941|NCT04376281|Norepinephrine|norepinephrine|mesh-list
92008942|NCT04376281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92008943|NCT04376281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92008944|NCT04376281|Adrenergic Agents|adrenergic agents|mesh-ancestor
92008945|NCT04376281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008946|NCT04376281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008947|NCT04376281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008948|NCT04376281|Sympathomimetics|sympathomimetics|mesh-ancestor
92008949|NCT04376281|Autonomic Agents|autonomic agents|mesh-ancestor
92008950|NCT04376281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008951|NCT04376281|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92008952|NCT04332445|Hyaluronic Acid|hyaluronic acid|mesh-list
92008953|NCT04332445|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92008954|NCT04332445|Immunologic Factors|immunologic factors|mesh-ancestor
92008955|NCT04332445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008956|NCT04332445|Viscosupplements|viscosupplements|mesh-ancestor
92008957|NCT04332445|Protective Agents|protective agents|mesh-ancestor
92008958|NCT03890887|Itraconazole|itraconazole|mesh-list
92008959|NCT03890887|Antifungal Agents|antifungal agents|mesh-ancestor
92008960|NCT03890887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008963|NCT03890887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008964|NCT03890887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008965|NCT03890887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92008966|NCT03890887|Hormone Antagonists|hormone antagonists|mesh-ancestor
92008967|NCT03890887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92008968|NCT03890887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008969|NCT03890887|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92008970|NCT04516993|Aspirin|aspirin|mesh-list
92008971|NCT04516993|Plasminogen|plasminogen|mesh-list
92008972|NCT04516993|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92008973|NCT04516993|Tenecteplase|tenecteplase|mesh-list
92008974|NCT04516993|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92008975|NCT04516993|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92008976|NCT04516993|Analgesics|analgesics|mesh-ancestor
92008977|NCT04516993|Sensory System Agents|sensory system agents|mesh-ancestor
92008978|NCT04516993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92008979|NCT04516993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008980|NCT04516993|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92008981|NCT04516993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008982|NCT04516993|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92008983|NCT04516993|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92008984|NCT04516993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008985|NCT04516993|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92008986|NCT04516993|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92008987|NCT04516993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008988|NCT04516993|Antipyretics|antipyretics|mesh-ancestor
92008990|NCT05015335|Methotrexate|methotrexate|mesh-list
92008991|NCT05015335|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92008992|NCT05015335|Abortifacient Agents|abortifacient agents|mesh-ancestor
92008993|NCT05015335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92008994|NCT05015335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008995|NCT05015335|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92008997|NCT05015335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008998|NCT05015335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008999|NCT05015335|Dermatologic Agents|dermatologic agents|mesh-ancestor
92009000|NCT05015335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009001|NCT05015335|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92009002|NCT05015335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92009003|NCT05015335|Immunologic Factors|immunologic factors|mesh-ancestor
92009004|NCT05015335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009005|NCT05015335|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92009006|NCT05015335|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92009007|NCT05015335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009008|NCT03056261|Anesthetics|anesthetics|mesh-list
92009009|NCT03056261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984611|NCT03165383|Narcotics|narcotics|mesh-ancestor
91984612|NCT03165383|Analgesics|analgesics|mesh-ancestor
92009010|NCT03056261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009011|NCT03533257|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92009012|NCT03533257|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92009013|NCT03533257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009014|NCT03533257|Antiviral Agents|antiviral agents|mesh-ancestor
92009015|NCT03533257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009016|NCT03533257|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92009017|NCT03533257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009018|NCT04574479|Morphine|morphine|mesh-list
92009019|NCT04574479|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92009020|NCT04574479|Narcotics|narcotics|mesh-ancestor
92009021|NCT04574479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009022|NCT04574479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009023|NCT04574479|Analgesics|analgesics|mesh-ancestor
92009024|NCT04574479|Sensory System Agents|sensory system agents|mesh-ancestor
92009025|NCT04574479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009027|NCT04931225|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92009028|NCT04931225|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92009029|NCT04931225|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009030|NCT04931225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009031|NCT04931225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009032|NCT04931225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009036|NCT02195947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009037|NCT01698307|Adalimumab|adalimumab|mesh-list
92009038|NCT01698307|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92009039|NCT01698307|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009040|NCT01698307|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009041|NCT04954339|Bevacizumab|bevacizumab|mesh-list
92009042|NCT04954339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009043|NCT04954339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009044|NCT04954339|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92009045|NCT04954339|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92009046|NCT04954339|Growth Substances|growth substances|mesh-ancestor
92009047|NCT04954339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009048|NCT04954339|Growth Inhibitors|growth inhibitors|mesh-ancestor
92009049|NCT01966263|Epinephrine|epinephrine|mesh-list
92009050|NCT01966263|Racepinephrine|racepinephrine|mesh-list
92009051|NCT01966263|Ropivacaine|ropivacaine|mesh-list
92009052|NCT01966263|Epinephryl borate|epinephryl borate|mesh-list
92009053|NCT01966263|Anesthetics, Local|anesthetics, local|mesh-ancestor
92009054|NCT01966263|Anesthetics|anesthetics|mesh-ancestor
92009055|NCT01966263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009056|NCT01966263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009057|NCT01966263|Sensory System Agents|sensory system agents|mesh-ancestor
92009058|NCT01966263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009059|NCT01966263|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92009060|NCT01966263|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92009061|NCT01966263|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009062|NCT01966263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009063|NCT01966263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009064|NCT01966263|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92009065|NCT01966263|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92009066|NCT01966263|Autonomic Agents|autonomic agents|mesh-ancestor
92009067|NCT01966263|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92009068|NCT01966263|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009069|NCT01966263|Mydriatics|mydriatics|mesh-ancestor
92009070|NCT01966263|Sympathomimetics|sympathomimetics|mesh-ancestor
92009071|NCT01966263|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92009073|NCT04400201|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92009074|NCT04400201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009075|NCT04400201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009076|NCT04400201|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92009077|NCT04400201|Anesthetics, General|anesthetics, general|mesh-ancestor
92009078|NCT04400201|Anesthetics|anesthetics|mesh-ancestor
92009079|NCT04423107|Acetaminophen|acetaminophen|mesh-list
92009080|NCT04423107|Ibuprofen|ibuprofen|mesh-list
92009081|NCT04423107|Oxycodone|oxycodone|mesh-list
92009082|NCT04423107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92009083|NCT04423107|Analgesics|analgesics|mesh-ancestor
92009084|NCT04423107|Sensory System Agents|sensory system agents|mesh-ancestor
92009085|NCT04423107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009086|NCT04423107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984613|NCT03162185|Escitalopram|escitalopram|mesh-list
92009087|NCT04423107|Antipyretics|antipyretics|mesh-ancestor
92009088|NCT04423107|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92009089|NCT04423107|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009090|NCT04423107|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009091|NCT04423107|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92009092|NCT04423107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009093|NCT04423107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009094|NCT04423107|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92009095|NCT04423107|Narcotics|narcotics|mesh-ancestor
92009096|NCT04423107|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009097|NCT01675531|Oxycodone|oxycodone|mesh-list
92009098|NCT01675531|Naloxone|naloxone|mesh-list
92009099|NCT01675531|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92009100|NCT01675531|Narcotics|narcotics|mesh-ancestor
92009101|NCT01675531|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009102|NCT01675531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009103|NCT01675531|Analgesics|analgesics|mesh-ancestor
92009104|NCT01675531|Sensory System Agents|sensory system agents|mesh-ancestor
92009105|NCT01675531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009109|NCT05406999|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92009111|NCT05406999|Glucocorticoids|glucocorticoids|mesh-ancestor
92009112|NCT05406999|Hormones|hormones|mesh-ancestor
92009113|NCT05406999|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009114|NCT05406999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009115|NCT05406999|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009116|NCT05406999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009117|NCT05406999|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92009118|NCT05406999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009119|NCT05406999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009120|NCT05406999|Hormone Antagonists|hormone antagonists|mesh-ancestor
92009121|NCT05406999|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92009122|NCT04930211|Dexamethasone|dexamethasone|mesh-list
92009123|NCT04930211|Lidocaine|lidocaine|mesh-list
92009124|NCT04930211|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009125|NCT04930211|Antiemetics|antiemetics|mesh-ancestor
92009126|NCT04930211|Autonomic Agents|autonomic agents|mesh-ancestor
92009127|NCT04930211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009128|NCT04930211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009129|NCT04930211|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009130|NCT04930211|Glucocorticoids|glucocorticoids|mesh-ancestor
92009131|NCT04930211|Hormones|hormones|mesh-ancestor
92009132|NCT04930211|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009133|NCT04930211|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009134|NCT04930211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009135|NCT04930211|Anesthetics, Local|anesthetics, local|mesh-ancestor
92009136|NCT04930211|Anesthetics|anesthetics|mesh-ancestor
92009137|NCT04930211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009138|NCT04930211|Sensory System Agents|sensory system agents|mesh-ancestor
92009139|NCT04930211|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009140|NCT04930211|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92009141|NCT04930211|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92009142|NCT04930211|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009143|NCT04930211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009144|NCT04912271|Dexamethasone|dexamethasone|mesh-list
92009145|NCT04912271|Aprepitant|aprepitant|mesh-list
92009146|NCT04912271|Fosaprepitant|fosaprepitant|mesh-list
92009147|NCT04912271|Palonosetron|palonosetron|mesh-list
92009148|NCT04912271|Granisetron|granisetron|mesh-list
92009149|NCT04912271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009150|NCT04912271|Antiemetics|antiemetics|mesh-ancestor
92009151|NCT04912271|Autonomic Agents|autonomic agents|mesh-ancestor
92009152|NCT04912271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009153|NCT04912271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009154|NCT04912271|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009155|NCT04912271|Glucocorticoids|glucocorticoids|mesh-ancestor
92009156|NCT04912271|Hormones|hormones|mesh-ancestor
92009157|NCT04912271|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009158|NCT04912271|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009159|NCT04912271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009160|NCT04912271|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92009161|NCT04912271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984614|NCT03162185|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91984615|NCT03162185|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92009162|NCT04912271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009163|NCT04912271|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92009165|NCT04912271|Serotonin Agents|serotonin agents|mesh-ancestor
92009166|NCT02807779|Dexamethasone|dexamethasone|mesh-list
92009167|NCT02807779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009168|NCT02807779|Antiemetics|antiemetics|mesh-ancestor
92009169|NCT02807779|Autonomic Agents|autonomic agents|mesh-ancestor
92009170|NCT02807779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009171|NCT02807779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009172|NCT02807779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009173|NCT02807779|Glucocorticoids|glucocorticoids|mesh-ancestor
92009174|NCT02807779|Hormones|hormones|mesh-ancestor
92009175|NCT02807779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009180|NCT04912193|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92009181|NCT04912193|Protease Inhibitors|protease inhibitors|mesh-ancestor
92009182|NCT04912193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009183|NCT04912193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009184|NCT04912193|Anticoagulants|anticoagulants|mesh-ancestor
92009185|NCT02680561|Fluticasone|fluticasone|mesh-list
92009187|NCT02680561|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92009188|NCT02680561|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92009189|NCT02680561|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009190|NCT02680561|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92009191|NCT02680561|Autonomic Agents|autonomic agents|mesh-ancestor
92009192|NCT02680561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009193|NCT02680561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009194|NCT02680561|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92009195|NCT02680561|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009196|NCT02680561|Dermatologic Agents|dermatologic agents|mesh-ancestor
92009197|NCT02680561|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92009198|NCT02680561|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92009199|NCT02680561|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92009200|NCT02680561|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92009201|NCT02680561|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009202|NCT02680561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009203|NCT02680561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009204|NCT02680561|Glucocorticoids|glucocorticoids|mesh-ancestor
92009205|NCT02680561|Hormones|hormones|mesh-ancestor
92009206|NCT02680561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009208|NCT05025163|Fluorides|fluorides|mesh-list
92009209|NCT05025163|Fluorides, Topical|fluorides, topical|mesh-list
92009210|NCT05025163|Cariostatic Agents|cariostatic agents|mesh-ancestor
92009211|NCT05025163|Protective Agents|protective agents|mesh-ancestor
92009212|NCT05025163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009213|NCT02592031|Goserelin|goserelin|mesh-list
92009214|NCT02592031|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009215|NCT02592031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009216|NCT04784299|Lidocaine|lidocaine|mesh-list
92009217|NCT04784299|Anesthetics, Local|anesthetics, local|mesh-ancestor
92009218|NCT04784299|Anesthetics|anesthetics|mesh-ancestor
92009219|NCT04784299|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009220|NCT04784299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009221|NCT04784299|Sensory System Agents|sensory system agents|mesh-ancestor
92009222|NCT04784299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009223|NCT04784299|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009224|NCT04784299|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92009225|NCT04784299|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92009226|NCT04784299|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009227|NCT04784299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009228|NCT02333149|Melatonin|melatonin|mesh-list
92009229|NCT02333149|Antioxidants|antioxidants|mesh-ancestor
92009230|NCT02333149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009231|NCT02333149|Protective Agents|protective agents|mesh-ancestor
92009232|NCT02333149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009233|NCT02333149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984616|NCT03162185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009234|NCT05117983|Antidepressive Agents|antidepressive agents|mesh-list
92009235|NCT05117983|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92009236|NCT03807817|Ethanol|ethanol|mesh-list
92009237|NCT03807817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92009238|NCT03807817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009239|NCT03807817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009240|NCT03807817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009241|NCT05122117|Methylene Blue|methylene blue|mesh-list
92009242|NCT05122117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009243|NCT05122117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009244|NCT05117125|Heparin|heparin|mesh-list
92009245|NCT05117125|Anticoagulants|anticoagulants|mesh-ancestor
92009246|NCT05117125|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92009247|NCT05117125|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92009260|NCT05116345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009261|NCT05116345|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009262|NCT05116345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009263|NCT05116345|Protease Inhibitors|protease inhibitors|mesh-ancestor
92009264|NCT05116345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009265|NCT05116345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009266|NCT05076097|Rituximab|rituximab|mesh-list
92009267|NCT05076097|Lenalidomide|lenalidomide|mesh-list
92009268|NCT05076097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009269|NCT05076097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009270|NCT05076097|Immunologic Factors|immunologic factors|mesh-ancestor
92009271|NCT05076097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009272|NCT05076097|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009273|NCT05076097|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92009274|NCT05076097|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92009275|NCT05076097|Growth Substances|growth substances|mesh-ancestor
92009276|NCT05076097|Growth Inhibitors|growth inhibitors|mesh-ancestor
92009277|NCT04513639|Dexamethasone|dexamethasone|mesh-list
92009278|NCT04513639|Dexamethasone acetate|dexamethasone acetate|mesh-list
92009279|NCT04513639|Daratumumab|daratumumab|mesh-list
92009280|NCT04513639|BB 1101|bb 1101|mesh-list
92009281|NCT04513639|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92009282|NCT04513639|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009284|NCT04513639|Autonomic Agents|autonomic agents|mesh-ancestor
92009285|NCT04513639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009286|NCT04513639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009287|NCT04513639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009288|NCT04513639|Glucocorticoids|glucocorticoids|mesh-ancestor
92009289|NCT04513639|Hormones|hormones|mesh-ancestor
92009290|NCT04513639|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009291|NCT04513639|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009292|NCT04513639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009293|NCT04513639|Protease Inhibitors|protease inhibitors|mesh-ancestor
92009294|NCT04513639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009295|NCT04513639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009296|NCT04513639|Immunologic Factors|immunologic factors|mesh-ancestor
92009298|NCT05229913|Antidepressive Agents|antidepressive agents|mesh-ancestor
92009299|NCT05229913|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92009300|NCT05108155|Tacrine|tacrine|mesh-list
92009301|NCT05108155|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92009302|NCT05108155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009303|NCT05108155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009304|NCT05108155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009305|NCT05108155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009306|NCT05108155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009307|NCT05108155|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92009308|NCT05108155|Autonomic Agents|autonomic agents|mesh-ancestor
92009309|NCT05108155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009310|NCT05108155|Nootropic Agents|nootropic agents|mesh-ancestor
92009311|NCT04375735|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92009312|NCT04375735|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009320|NCT01362439|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92009322|NCT01362439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009323|NCT01362439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009324|NCT01362439|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92009325|NCT01362439|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92009326|NCT01362439|Dopamine Agents|dopamine agents|mesh-ancestor
91984617|NCT03162185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009327|NCT05228743|Paclitaxel|paclitaxel|mesh-list
92009328|NCT05228743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92009329|NCT05228743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009330|NCT05228743|Tubulin Modulators|tubulin modulators|mesh-ancestor
92009331|NCT05228743|Antimitotic Agents|antimitotic agents|mesh-ancestor
92009332|NCT05228743|Mitosis Modulators|mitosis modulators|mesh-ancestor
92009333|NCT05228743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009334|NCT03321019|Capsaicin|capsaicin|mesh-list
92009335|NCT03321019|Antipruritics|antipruritics|mesh-ancestor
92009336|NCT03321019|Dermatologic Agents|dermatologic agents|mesh-ancestor
92009337|NCT03321019|Sensory System Agents|sensory system agents|mesh-ancestor
92009338|NCT03321019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009339|NCT03321019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009340|NCT04990921|Pembrolizumab|pembrolizumab|mesh-list
92009341|NCT04990921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009342|NCT04990921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009343|NCT04990921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92009344|NCT04990921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009345|NCT04507477|Rituximab|rituximab|mesh-list
92009346|NCT04507477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009347|NCT04507477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009348|NCT04507477|Immunologic Factors|immunologic factors|mesh-ancestor
92009349|NCT04507477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009350|NCT04507477|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009351|NCT01675141|Lenalidomide|lenalidomide|mesh-list
92009352|NCT01675141|Immunologic Factors|immunologic factors|mesh-ancestor
92009353|NCT01675141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009354|NCT01675141|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92009355|NCT01675141|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92009356|NCT01675141|Growth Substances|growth substances|mesh-ancestor
92009357|NCT01675141|Growth Inhibitors|growth inhibitors|mesh-ancestor
92009358|NCT01675141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009359|NCT05102149|Vildagliptin|vildagliptin|mesh-list
92009360|NCT05102149|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92009361|NCT05102149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009362|NCT05102149|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92009363|NCT05102149|Protease Inhibitors|protease inhibitors|mesh-ancestor
92009364|NCT05102149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009365|NCT05102149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009366|NCT04412395|Lactoferrin|lactoferrin|mesh-list
92009367|NCT04412395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009368|NCT04987099|Choline|choline|mesh-list
92009369|NCT04987099|Lipotropic Agents|lipotropic agents|mesh-ancestor
92009370|NCT04987099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92009371|NCT04987099|Antimetabolites|antimetabolites|mesh-ancestor
92009372|NCT04987099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009373|NCT04987099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009374|NCT04987099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92009376|NCT03906721|Oxycodone|oxycodone|mesh-list
92009377|NCT03906721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92009378|NCT03906721|Narcotics|narcotics|mesh-ancestor
92009379|NCT03906721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009385|NCT04663711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009386|NCT04663711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009387|NCT04529863|Abatacept|abatacept|mesh-list
92009388|NCT04529863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92009389|NCT04529863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009390|NCT04529863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009391|NCT04529863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009392|NCT04529863|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92009393|NCT04529863|Immunologic Factors|immunologic factors|mesh-ancestor
92009394|NCT04529863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009395|NCT04529863|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009396|NCT04582591|Cannabidiol|cannabidiol|mesh-list
92009397|NCT04582591|Anticonvulsants|anticonvulsants|mesh-ancestor
92009398|NCT04497883|Maribavir|maribavir|mesh-list
92009399|NCT04497883|Antiviral Agents|antiviral agents|mesh-ancestor
92009400|NCT04497883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009401|NCT03688633|Candesartan|candesartan|mesh-list
92009402|NCT03688633|Candesartan cilexetil|candesartan cilexetil|mesh-list
92009403|NCT03688633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91984618|NCT03162185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984619|NCT03162185|Serotonin Agents|serotonin agents|mesh-ancestor
92009404|NCT03688633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92009405|NCT03688633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92009406|NCT03688633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009407|NCT03963895|Thrombin|thrombin|mesh-list
92009408|NCT03963895|Hemostatics|hemostatics|mesh-ancestor
92009409|NCT03963895|Coagulants|coagulants|mesh-ancestor
92009410|NCT03662815|Molgramostim|molgramostim|mesh-list
92009411|NCT03662815|Sargramostim|sargramostim|mesh-list
92009412|NCT03662815|Immunologic Factors|immunologic factors|mesh-ancestor
92009413|NCT03662815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009414|NCT03662815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009415|NCT03490903|Fentanyl|fentanyl|mesh-list
92009416|NCT03490903|Midazolam|midazolam|mesh-list
92009417|NCT03490903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92009418|NCT03490903|Narcotics|narcotics|mesh-ancestor
92009419|NCT03490903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009420|NCT03490903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009421|NCT03490903|Analgesics|analgesics|mesh-ancestor
92009422|NCT03490903|Sensory System Agents|sensory system agents|mesh-ancestor
92009423|NCT03490903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009424|NCT03490903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92009425|NCT03490903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92009426|NCT03490903|Anesthetics, General|anesthetics, general|mesh-ancestor
92009427|NCT03490903|Anesthetics|anesthetics|mesh-ancestor
92009428|NCT03490903|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92009429|NCT03490903|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92009430|NCT03490903|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92009431|NCT03490903|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92009433|NCT03490903|GABA Agents|gaba agents|mesh-ancestor
92009434|NCT03490903|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009435|NCT03490903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009436|NCT04169191|Sildenafil Citrate|sildenafil citrate|mesh-list
92009437|NCT04169191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009438|NCT04169191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92009439|NCT04169191|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92009440|NCT04169191|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92009441|NCT04169191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009442|NCT04169191|Urological Agents|urological agents|mesh-ancestor
92009443|NCT03954613|Memantine|memantine|mesh-list
92009444|NCT03954613|Donepezil|donepezil|mesh-list
92009445|NCT03954613|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92009447|NCT03954613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009448|NCT03954613|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009449|NCT03954613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009450|NCT03954613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009451|NCT03954613|Nootropic Agents|nootropic agents|mesh-ancestor
92009455|NCT03954613|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92009456|NCT03954613|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92009458|NCT03367819|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009459|NCT03367819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009460|NCT04023253|Solifenacin Succinate|solifenacin succinate|mesh-list
92009461|NCT04023253|Mirabegron|mirabegron|mesh-list
92009462|NCT04023253|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92009463|NCT04023253|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92009464|NCT04023253|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009465|NCT04023253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009466|NCT04023253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009467|NCT04023253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009468|NCT04023253|Urological Agents|urological agents|mesh-ancestor
92009469|NCT04023253|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92009470|NCT04023253|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92009471|NCT04023253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92009472|NCT04023253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009474|NCT04875871|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92009475|NCT04875871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92009476|NCT04875871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009477|NCT04875871|Trace Elements|trace elements|mesh-ancestor
92009478|NCT04875871|Micronutrients|micronutrients|mesh-ancestor
92009479|NCT04875871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009480|NCT04781725|Cisplatin|cisplatin|mesh-list
91984620|NCT03162185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984621|NCT02678351|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92009481|NCT04781725|Vinblastine|vinblastine|mesh-list
92009482|NCT04781725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009483|NCT04781725|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92009484|NCT04781725|Tubulin Modulators|tubulin modulators|mesh-ancestor
92009485|NCT04781725|Antimitotic Agents|antimitotic agents|mesh-ancestor
92009487|NCT04781725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009488|NCT03580525|Nicotine|nicotine|mesh-list
92009489|NCT03580525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92009490|NCT03580525|Autonomic Agents|autonomic agents|mesh-ancestor
92009491|NCT03580525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009492|NCT03580525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009493|NCT03580525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92009494|NCT03580525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92009495|NCT03580525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009496|NCT03580525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009497|NCT03580525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009498|NCT03554707|Bevacizumab|bevacizumab|mesh-list
92009499|NCT03554707|Irinotecan|irinotecan|mesh-list
92009500|NCT03554707|Temozolomide|temozolomide|mesh-list
92009501|NCT03554707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009502|NCT03554707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009503|NCT03554707|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92009504|NCT03554707|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92009505|NCT03554707|Growth Substances|growth substances|mesh-ancestor
92009506|NCT03554707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009507|NCT03554707|Growth Inhibitors|growth inhibitors|mesh-ancestor
92009508|NCT03554707|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92009509|NCT03554707|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92009510|NCT03554707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009511|NCT03554707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009512|NCT03554707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92009513|NCT03554707|Alkylating Agents|alkylating agents|mesh-ancestor
92009515|NCT04264663|Tinidazole|tinidazole|mesh-list
92009516|NCT04264663|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92009517|NCT04264663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009518|NCT04264663|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92009519|NCT04264663|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92009520|NCT04264663|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92009521|NCT04264663|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92009522|NCT04264663|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92009523|NCT04264663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009527|NCT05403307|Vaccines|vaccines|mesh-list
92009528|NCT05403307|Immunologic Factors|immunologic factors|mesh-ancestor
92009529|NCT05403307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009530|NCT04563559|Prednisolone|prednisolone|mesh-list
92009531|NCT04563559|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92009532|NCT04563559|Methylprednisolone|methylprednisolone|mesh-list
92009533|NCT04563559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92009534|NCT04563559|Prednisolone acetate|prednisolone acetate|mesh-list
92009535|NCT04563559|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92009536|NCT04563559|Prednisolone phosphate|prednisolone phosphate|mesh-list
92009537|NCT04563559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009538|NCT04563559|Glucocorticoids|glucocorticoids|mesh-ancestor
92009539|NCT04563559|Hormones|hormones|mesh-ancestor
92009540|NCT04563559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009541|NCT04563559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009542|NCT04563559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009543|NCT04563559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009544|NCT04563559|Antiemetics|antiemetics|mesh-ancestor
92009545|NCT04563559|Autonomic Agents|autonomic agents|mesh-ancestor
92009546|NCT04563559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009547|NCT04563559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009548|NCT04563559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92009549|NCT04563559|Protective Agents|protective agents|mesh-ancestor
92009550|NCT02124187|Nicotine|nicotine|mesh-list
92009551|NCT02124187|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92009552|NCT02124187|Autonomic Agents|autonomic agents|mesh-ancestor
92009553|NCT02124187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009554|NCT02124187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009555|NCT02124187|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
91984622|NCT02678351|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984623|NCT02678351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984624|NCT05286437|Pembrolizumab|pembrolizumab|mesh-list
92009556|NCT02124187|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92009557|NCT02124187|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009558|NCT02124187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009559|NCT02124187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009560|NCT02002819|Levetiracetam|levetiracetam|mesh-list
92009561|NCT02002819|Anticonvulsants|anticonvulsants|mesh-ancestor
92009562|NCT02002819|Nootropic Agents|nootropic agents|mesh-ancestor
92009563|NCT01597193|Fulvestrant|fulvestrant|mesh-list
92009564|NCT01597193|Anastrozole|anastrozole|mesh-list
92009565|NCT01597193|Exemestane|exemestane|mesh-list
92009566|NCT01597193|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009567|NCT01597193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009568|NCT01597193|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92009569|NCT01597193|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92009570|NCT01597193|Hormone Antagonists|hormone antagonists|mesh-ancestor
92009571|NCT01597193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009572|NCT01597193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009573|NCT01597193|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92009574|NCT01597193|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92009575|NCT01597193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009576|NCT01597193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009577|NCT04930133|Afatinib|afatinib|mesh-list
92009578|NCT04930133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009579|NCT04930133|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92009580|NCT04930133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009581|NCT04930133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009582|NCT03057041|Fentanyl|fentanyl|mesh-list
92009583|NCT03057041|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92009584|NCT03057041|Narcotics|narcotics|mesh-ancestor
92009585|NCT03057041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009586|NCT03057041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009587|NCT03057041|Analgesics|analgesics|mesh-ancestor
92009588|NCT03057041|Sensory System Agents|sensory system agents|mesh-ancestor
92009589|NCT03057041|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009590|NCT03057041|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92009591|NCT03057041|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92009592|NCT03057041|Anesthetics, General|anesthetics, general|mesh-ancestor
92009593|NCT03057041|Anesthetics|anesthetics|mesh-ancestor
92009594|NCT05123287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92009605|NCT04911413|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92009606|NCT04911413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92009607|NCT04911413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009609|NCT04911413|Coagulants|coagulants|mesh-ancestor
92081630|NCT01392963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081631|NCT01392963|Cholinergic Agents|cholinergic agents|mesh-ancestor
92081632|NCT01392963|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081633|NCT01392963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081634|NCT01392963|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92081635|NCT01392963|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081636|NCT01392573|Insulin|insulin|mesh-list
92081637|NCT01392573|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92081638|NCT01392573|Liraglutide|liraglutide|mesh-list
92081639|NCT01392573|Insulin, Long-Acting|insulin, long-acting|mesh-list
92081640|NCT01392573|Xultophy|xultophy|mesh-list
92081641|NCT01392573|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92081642|NCT01392573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081643|NCT01392573|Incretins|incretins|mesh-ancestor
92081644|NCT01392573|Hormones|hormones|mesh-ancestor
92081645|NCT01392573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081646|NCT01392495|Imatinib Mesylate|imatinib mesylate|mesh-list
92081647|NCT01392495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081648|NCT01392495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081649|NCT01392495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081650|NCT01392495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081651|NCT01405053|Rufinamide|rufinamide|mesh-list
92081652|NCT01405053|Anticonvulsants|anticonvulsants|mesh-list
92081653|NCT01405053|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92081654|NCT01405053|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91984625|NCT05286437|Letrozole|letrozole|mesh-list
91984626|NCT05286437|Lenvatinib|lenvatinib|mesh-list
91984627|NCT05286437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984628|NCT05286437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081655|NCT01405053|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081656|NCT01405053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081657|NCT01403805|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92081658|NCT01403805|Immunologic Factors|immunologic factors|mesh-ancestor
92081659|NCT01403805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081660|NCT01392183|Diphenhydramine|diphenhydramine|mesh-list
92081661|NCT01392183|Sirolimus|sirolimus|mesh-list
92081662|NCT01392183|Temsirolimus|temsirolimus|mesh-list
92081663|NCT01392183|MTOR Inhibitors|mtor inhibitors|mesh-list
92081664|NCT01392183|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081665|NCT01392183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081666|NCT01392183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081667|NCT01392183|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081668|NCT01392183|Immunologic Factors|immunologic factors|mesh-ancestor
92081669|NCT01392183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081670|NCT01392183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081671|NCT01392183|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92081672|NCT01392183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081673|NCT01392183|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92081674|NCT01392183|Antifungal Agents|antifungal agents|mesh-ancestor
92081675|NCT01392183|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92081676|NCT01392183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92009610|NCT03889795|Metformin|metformin|mesh-list
92009613|NCT03889795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92009614|NCT03889795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009615|NCT03889795|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92009616|NCT03889795|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92009617|NCT03889795|Antimetabolites|antimetabolites|mesh-ancestor
92009618|NCT03889795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009619|NCT03889795|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92009620|NCT03889795|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92009621|NCT03889795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009622|NCT03889795|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009623|NCT03889795|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92009624|NCT03889795|Protective Agents|protective agents|mesh-ancestor
92009625|NCT02622113|Canagliflozin|canagliflozin|mesh-list
92009626|NCT02622113|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92009627|NCT02622113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009628|NCT02622113|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92009629|NCT02622113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009630|NCT04430777|Tranexamic Acid|tranexamic acid|mesh-list
92009631|NCT04430777|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92009632|NCT04430777|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92009633|NCT04430777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009634|NCT04430777|Hemostatics|hemostatics|mesh-ancestor
92009635|NCT04430777|Coagulants|coagulants|mesh-ancestor
92009636|NCT04910477|Atropine|atropine|mesh-list
92009637|NCT04910477|Dexmedetomidine|dexmedetomidine|mesh-list
92009638|NCT04910477|Neostigmine|neostigmine|mesh-list
92009639|NCT04910477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92009640|NCT04910477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009641|NCT04910477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009642|NCT04910477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92009643|NCT04910477|Analgesics|analgesics|mesh-ancestor
92009644|NCT04910477|Sensory System Agents|sensory system agents|mesh-ancestor
92009645|NCT04910477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009646|NCT04910477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92009647|NCT04910477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92009648|NCT04910477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92009649|NCT04910477|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009650|NCT04910477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009651|NCT04910477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009652|NCT04910477|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92009653|NCT04910477|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009654|NCT04910477|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91984629|NCT05286437|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92090420|NCT00892606|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009655|NCT04910477|Autonomic Agents|autonomic agents|mesh-ancestor
92009656|NCT04910477|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92009657|NCT04910477|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009658|NCT04910477|Mydriatics|mydriatics|mesh-ancestor
92009659|NCT04910477|Parasympatholytics|parasympatholytics|mesh-ancestor
92009660|NCT04910477|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92009661|NCT04910477|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92009662|NCT04910477|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009663|NCT04910477|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92009664|NCT04910477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009665|NCT04910477|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92009666|NCT03843151|Itraconazole|itraconazole|mesh-list
92009667|NCT03843151|Antifungal Agents|antifungal agents|mesh-ancestor
92009668|NCT03843151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009669|NCT03843151|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92009670|NCT03843151|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92009671|NCT03843151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009672|NCT03843151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009673|NCT03843151|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92009674|NCT03843151|Hormone Antagonists|hormone antagonists|mesh-ancestor
92009675|NCT03843151|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009676|NCT03843151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009677|NCT03843151|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92009678|NCT04929509|Listerine|listerine|mesh-list
92009679|NCT04929509|Fluorides|fluorides|mesh-list
92009680|NCT04929509|Sodium Fluoride|sodium fluoride|mesh-list
92009681|NCT04929509|Fluorides, Topical|fluorides, topical|mesh-list
92009682|NCT04929509|Cariostatic Agents|cariostatic agents|mesh-ancestor
92009683|NCT04929509|Protective Agents|protective agents|mesh-ancestor
92009686|NCT04929509|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009688|NCT03054467|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92009689|NCT03054467|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92009690|NCT03054467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009691|NCT03054467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009692|NCT03054467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92009693|NCT03054467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009694|NCT03054467|Vasodilator Agents|vasodilator agents|mesh-ancestor
92009696|NCT04910165|Anesthetics, Local|anesthetics, local|mesh-ancestor
92009697|NCT04910165|Anesthetics|anesthetics|mesh-ancestor
92009698|NCT04910165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009699|NCT04910165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009700|NCT04910165|Sensory System Agents|sensory system agents|mesh-ancestor
92009701|NCT04910165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009702|NCT02730325|Immunoglobulins|immunoglobulins|mesh-list
92009703|NCT02730325|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92009704|NCT02730325|Antibodies|antibodies|mesh-list
92009705|NCT02730325|Immunologic Factors|immunologic factors|mesh-ancestor
92009706|NCT02730325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009707|NCT04928495|Acetylcysteine|acetylcysteine|mesh-list
92009708|NCT04928495|Bromhexine|bromhexine|mesh-list
92009709|NCT04928495|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92009710|NCT04928495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009711|NCT04928495|Antioxidants|antioxidants|mesh-ancestor
92009712|NCT04928495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009713|NCT04928495|Protective Agents|protective agents|mesh-ancestor
92009714|NCT04928495|Antiviral Agents|antiviral agents|mesh-ancestor
92009715|NCT04928495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009716|NCT04928495|Expectorants|expectorants|mesh-ancestor
92009717|NCT04928495|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009718|NCT04928495|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92009719|NCT04928495|Antidotes|antidotes|mesh-ancestor
92009720|NCT01573429|Bisphenol A|bisphenol a|mesh-list
92009721|NCT01573429|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92009722|NCT01573429|Estrogens|estrogens|mesh-ancestor
92009724|NCT01573429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009725|NCT01573429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009726|NCT01573429|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92009727|NCT01573429|Antioxidants|antioxidants|mesh-ancestor
92009728|NCT01573429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009729|NCT01573429|Protective Agents|protective agents|mesh-ancestor
91984630|NCT05286437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984631|NCT05286437|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91984632|NCT05286437|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91984633|NCT05286437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984634|NCT05286437|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92009730|NCT04909931|Vitamin D|vitamin d|mesh-list
92009731|NCT04909931|Ergocalciferols|ergocalciferols|mesh-list
92009732|NCT04909931|Vitamins|vitamins|mesh-ancestor
92009733|NCT04909931|Micronutrients|micronutrients|mesh-ancestor
92009734|NCT04909931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009735|NCT04909931|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92009736|NCT04909931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92009737|NCT04918589|Tranexamic Acid|tranexamic acid|mesh-list
92009738|NCT04918589|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92009739|NCT04918589|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92009740|NCT04918589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009741|NCT04918589|Hemostatics|hemostatics|mesh-ancestor
92009742|NCT04918589|Coagulants|coagulants|mesh-ancestor
92009743|NCT04928651|Clonidine|clonidine|mesh-list
92009744|NCT04928651|Analgesics|analgesics|mesh-ancestor
92009745|NCT04928651|Sensory System Agents|sensory system agents|mesh-ancestor
92009746|NCT04928651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009747|NCT04928651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009748|NCT04928651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92009749|NCT04928651|Sympatholytics|sympatholytics|mesh-ancestor
92009750|NCT04928651|Autonomic Agents|autonomic agents|mesh-ancestor
92009751|NCT04928651|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92009752|NCT04928651|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92009753|NCT04928651|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92009754|NCT04928651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009755|NCT04928651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009756|NCT04928651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009757|NCT04101643|Evolocumab|evolocumab|mesh-list
92009760|NCT04101643|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92009761|NCT04101643|Antimetabolites|antimetabolites|mesh-ancestor
92009762|NCT04101643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009763|NCT04101643|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92009764|NCT04101643|Protease Inhibitors|protease inhibitors|mesh-ancestor
92009765|NCT04101643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009766|NCT04101643|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92009768|NCT02620787|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92009769|NCT02620787|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009770|NCT04909619|Anesthetics|anesthetics|mesh-list
92009771|NCT04909619|Anesthetics, Local|anesthetics, local|mesh-list
92009772|NCT04909619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009773|NCT04909619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009774|NCT04909619|Sensory System Agents|sensory system agents|mesh-ancestor
92009775|NCT04909619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009776|NCT03520231|Vitamin D|vitamin d|mesh-list
92009777|NCT03520231|Denosumab|denosumab|mesh-list
92009778|NCT03520231|Carboplatin|carboplatin|mesh-list
92009779|NCT03520231|Gemcitabine|gemcitabine|mesh-list
92009780|NCT03520231|Calcium|calcium|mesh-list
92009781|NCT03520231|Vitamins|vitamins|mesh-ancestor
92009782|NCT03520231|Micronutrients|micronutrients|mesh-ancestor
92009783|NCT03520231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009784|NCT03520231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009785|NCT03520231|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92009786|NCT03520231|Antimetabolites|antimetabolites|mesh-ancestor
92009787|NCT03520231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009788|NCT03520231|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92009789|NCT03520231|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92009790|NCT04927481|Mitoxantrone|mitoxantrone|mesh-list
92009791|NCT04927481|Analgesics|analgesics|mesh-ancestor
92009792|NCT04927481|Sensory System Agents|sensory system agents|mesh-ancestor
92009793|NCT04927481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009794|NCT04927481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009795|NCT04927481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009796|NCT04927481|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92009797|NCT04927481|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92009798|NCT04927481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009799|NCT04927481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009801|NCT03056495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009802|NCT03056495|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92009803|NCT03056495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009804|NCT03056495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009805|NCT03171805|Propranolol|propranolol|mesh-list
92009806|NCT03171805|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92009807|NCT03171805|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92009808|NCT03171805|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009809|NCT03171805|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009810|NCT03171805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009811|NCT03171805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009812|NCT03171805|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009813|NCT03171805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92009814|NCT03171805|Vasodilator Agents|vasodilator agents|mesh-ancestor
92009815|NCT04918433|Anesthetics|anesthetics|mesh-list
92009816|NCT04918433|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009817|NCT04918433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009818|NCT04926467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92009819|NCT04926467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009820|NCT03053219|Abivertinib|abivertinib|mesh-list
92009821|NCT03053219|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92009822|NCT03053219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009823|NCT03053219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009824|NCT03055793|Budesonide|budesonide|mesh-list
92009825|NCT03055793|Formoterol Fumarate|formoterol fumarate|mesh-list
92009826|NCT03055793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009827|NCT03055793|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92009828|NCT03055793|Autonomic Agents|autonomic agents|mesh-ancestor
92009829|NCT03055793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009830|NCT03055793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009831|NCT03055793|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92009835|NCT03055793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009836|NCT03055793|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92009837|NCT03055793|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92009838|NCT03055793|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92009839|NCT03055793|Adrenergic Agents|adrenergic agents|mesh-ancestor
92009840|NCT03055793|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009841|NCT03055793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009842|NCT04926155|Metformin|metformin|mesh-list
92009843|NCT04926155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92009844|NCT04926155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009845|NCT04909775|Gemcitabine|gemcitabine|mesh-list
92009846|NCT04909775|Tislelizumab|tislelizumab|mesh-list
92009847|NCT04909775|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009848|NCT04909775|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92009849|NCT04909775|Antimetabolites|antimetabolites|mesh-ancestor
92009850|NCT04909775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009851|NCT04909775|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009852|NCT04925141|Dasatinib|dasatinib|mesh-list
92009853|NCT04925141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009854|NCT04925141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92009855|NCT04925141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009856|NCT04925141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009857|NCT02651155|Lubiprostone|lubiprostone|mesh-list
92009858|NCT02651155|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92009859|NCT02651155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009860|NCT02651155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009861|NCT04925063|Metformin|metformin|mesh-list
92009862|NCT04925063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92009863|NCT04925063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009864|NCT04909151|Methamphetamine|methamphetamine|mesh-list
92009865|NCT04909151|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92009866|NCT04909151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009867|NCT04909151|Sympathomimetics|sympathomimetics|mesh-ancestor
92009868|NCT04909151|Autonomic Agents|autonomic agents|mesh-ancestor
92009869|NCT04909151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009870|NCT04909151|Dopamine Agents|dopamine agents|mesh-ancestor
92009871|NCT04909151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009872|NCT04909151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009873|NCT04909151|Adrenergic Agents|adrenergic agents|mesh-ancestor
91984635|NCT05286437|Hormone Antagonists|hormone antagonists|mesh-ancestor
91984636|NCT05286437|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009874|NCT04909151|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92009875|NCT04909151|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92009876|NCT04909151|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009877|NCT04909151|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92009878|NCT05132413|Bevacizumab|bevacizumab|mesh-list
92009879|NCT05132413|Cisplatin|cisplatin|mesh-list
92009880|NCT05132413|Carboplatin|carboplatin|mesh-list
92009881|NCT05132413|Pemetrexed|pemetrexed|mesh-list
92009882|NCT05132413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009883|NCT05132413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009884|NCT05132413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92009885|NCT05132413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92009886|NCT05132413|Growth Substances|growth substances|mesh-ancestor
92009887|NCT05132413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009888|NCT05132413|Growth Inhibitors|growth inhibitors|mesh-ancestor
92009889|NCT05132413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009890|NCT05132413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009891|NCT05132413|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92009892|NCT05132413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92009893|NCT04435717|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92009894|NCT04075981|Botulinum Toxins|botulinum toxins|mesh-list
92009895|NCT04075981|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92009896|NCT04075981|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92009897|NCT04075981|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92009898|NCT04075981|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92010451|NCT03050177|Gefitinib|gefitinib|mesh-list
92009899|NCT04075981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92009900|NCT04075981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009906|NCT04917497|Simendan|simendan|mesh-list
92009907|NCT04917497|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92009908|NCT04917497|Vasodilator Agents|vasodilator agents|mesh-ancestor
92009909|NCT04917497|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92009910|NCT04917497|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92009911|NCT04917497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009912|NCT04917497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009913|NCT04917497|Protective Agents|protective agents|mesh-ancestor
92009914|NCT04917497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009916|NCT03933007|Colchicine|colchicine|mesh-list
92009917|NCT03933007|Midazolam|midazolam|mesh-list
92009918|NCT03933007|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92009919|NCT03933007|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92009920|NCT03933007|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009921|NCT03933007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009922|NCT03933007|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92009923|NCT03933007|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92009924|NCT03933007|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92009925|NCT03933007|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92009926|NCT03933007|Anesthetics, General|anesthetics, general|mesh-ancestor
92009927|NCT03933007|Anesthetics|anesthetics|mesh-ancestor
92009928|NCT03933007|GABA Modulators|gaba modulators|mesh-ancestor
92009929|NCT03933007|GABA Agents|gaba agents|mesh-ancestor
92009930|NCT03933007|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009931|NCT03933007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009932|NCT03933007|Gout Suppressants|gout suppressants|mesh-ancestor
92009933|NCT03933007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92009934|NCT03933007|Tubulin Modulators|tubulin modulators|mesh-ancestor
92009935|NCT03933007|Antimitotic Agents|antimitotic agents|mesh-ancestor
92009936|NCT03933007|Mitosis Modulators|mitosis modulators|mesh-ancestor
92009937|NCT03933007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009938|NCT03933007|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92009939|NCT03933007|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92009940|NCT03933007|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92009941|NCT03933007|Histamine Antagonists|histamine antagonists|mesh-ancestor
92009942|NCT03933007|Histamine Agents|histamine agents|mesh-ancestor
92009943|NCT04907747|Amoxicillin|amoxicillin|mesh-list
92009944|NCT04907747|Furazolidone|furazolidone|mesh-list
92009945|NCT04907747|Esomeprazole|esomeprazole|mesh-list
92009946|NCT04907747|Bismuth|bismuth|mesh-list
92009947|NCT04907747|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92009948|NCT04907747|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92009949|NCT04907747|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92009950|NCT04907747|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984637|NCT05286437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009951|NCT04907747|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92009952|NCT04907747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92009953|NCT04907747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009954|NCT04907747|Antacids|antacids|mesh-ancestor
92009955|NCT04907747|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92009956|NCT04907747|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92009957|NCT04907747|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92009958|NCT04907747|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92009959|NCT04907747|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92009960|NCT04907747|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92009961|NCT03052673|Fentanyl|fentanyl|mesh-list
92009962|NCT03052673|Ketamine|ketamine|mesh-list
92009963|NCT03052673|Analgesics|analgesics|mesh-ancestor
92009964|NCT03052673|Sensory System Agents|sensory system agents|mesh-ancestor
92009965|NCT03052673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009966|NCT03052673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009967|NCT03052673|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92009968|NCT03052673|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92009969|NCT03052673|Anesthetics, General|anesthetics, general|mesh-ancestor
92009970|NCT03052673|Anesthetics|anesthetics|mesh-ancestor
92009971|NCT03052673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009972|NCT03052673|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92009975|NCT03052673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009977|NCT03052673|Narcotics|narcotics|mesh-ancestor
92009978|NCT03052673|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92009979|NCT04907123|Diuretics|diuretics|mesh-list
92009980|NCT04907123|Natriuretic Agents|natriuretic agents|mesh-ancestor
92009981|NCT04907123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009982|NCT05030857|Midazolam|midazolam|mesh-list
92009983|NCT05030857|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92009984|NCT05030857|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92009985|NCT05030857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009986|NCT05030857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009987|NCT05030857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92009988|NCT05030857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92009989|NCT05030857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92009990|NCT05030857|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92009991|NCT05030857|Anesthetics, General|anesthetics, general|mesh-ancestor
92009992|NCT05030857|Anesthetics|anesthetics|mesh-ancestor
92009993|NCT05030857|GABA Modulators|gaba modulators|mesh-ancestor
92009994|NCT05030857|GABA Agents|gaba agents|mesh-ancestor
92009995|NCT05030857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009996|NCT05030857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009997|NCT03319459|Trastuzumab|trastuzumab|mesh-list
92009998|NCT03319459|Cetuximab|cetuximab|mesh-list
92009999|NCT03319459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010000|NCT03319459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010001|NCT04916951|Amoxicillin|amoxicillin|mesh-list
92010002|NCT04916951|Cephalexin|cephalexin|mesh-list
92010003|NCT04916951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010004|NCT04916951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010005|NCT04430933|Paclitaxel|paclitaxel|mesh-list
92010006|NCT04430933|Docetaxel|docetaxel|mesh-list
92010007|NCT04430933|Carboplatin|carboplatin|mesh-list
92010008|NCT04430933|Pemetrexed|pemetrexed|mesh-list
92010009|NCT04430933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010010|NCT04430933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010011|NCT04430933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92010012|NCT04430933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010013|NCT04430933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010014|NCT04430933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010015|NCT04430933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010016|NCT04430933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92010017|NCT04430933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92010018|NCT04906655|Glycopyrrolate|glycopyrrolate|mesh-list
92010019|NCT04906655|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92010020|NCT04906655|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92010021|NCT04906655|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92010022|NCT04906655|Cholinergic Agents|cholinergic agents|mesh-ancestor
92010023|NCT04906655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010024|NCT04906655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984638|NCT05286437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984639|NCT05464173|Fulvestrant|fulvestrant|mesh-list
91984640|NCT05464173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91984641|NCT05464173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010025|NCT04906655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010026|NCT03055091|Sorbitol|sorbitol|mesh-list
92010027|NCT03055091|Cathartics|cathartics|mesh-ancestor
92010028|NCT03055091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010029|NCT02648581|Ustekinumab|ustekinumab|mesh-list
92010030|NCT02648581|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010031|NCT02609815|Metformin|metformin|mesh-list
92010032|NCT02609815|Glimepiride|glimepiride|mesh-list
92010033|NCT02609815|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010034|NCT02609815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010035|NCT02609815|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92010036|NCT02609815|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92010037|NCT02609815|Immunologic Factors|immunologic factors|mesh-ancestor
92010038|NCT05132023|Metformin|metformin|mesh-list
92010039|NCT05132023|Empagliflozin|empagliflozin|mesh-list
92010040|NCT05132023|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010041|NCT05132023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010042|NCT05132023|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92010043|NCT05132023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010044|NCT05131711|Immunomodulating Agents|immunomodulating agents|mesh-list
92010045|NCT05131711|Immunologic Factors|immunologic factors|mesh-ancestor
92010046|NCT05131711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010048|NCT02619617|Hormones|hormones|mesh-ancestor
92010049|NCT02619617|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010050|NCT02619617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010051|NCT04012957|Darbepoetin alfa|darbepoetin alfa|mesh-list
92010052|NCT04012957|Hematinics|hematinics|mesh-ancestor
92010053|NCT04906031|Antimony Sodium Gluconate|antimony sodium gluconate|mesh-list
92010054|NCT04906031|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92010055|NCT04906031|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92010056|NCT04906031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010057|NCT04906031|Schistosomicides|schistosomicides|mesh-ancestor
92010528|NCT04882163|Dexamethasone|dexamethasone|mesh-list
92010058|NCT04906031|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92010059|NCT04906031|Anthelmintics|anthelmintics|mesh-ancestor
92010060|NCT05125627|Progesterone|progesterone|mesh-list
92010061|NCT05125627|Progestins|progestins|mesh-ancestor
92010062|NCT05125627|Hormones|hormones|mesh-ancestor
92010063|NCT05125627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010064|NCT05125627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010065|NCT05125549|Clopidogrel|clopidogrel|mesh-list
92010066|NCT05125549|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92010067|NCT05125549|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92010068|NCT05125549|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92010069|NCT05125549|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92010070|NCT05125549|Purinergic Agents|purinergic agents|mesh-ancestor
92010071|NCT05125549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010072|NCT05125549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010073|NCT05125549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010075|NCT04903847|Lamivudine|lamivudine|mesh-list
92010076|NCT04903847|Dolutegravir|dolutegravir|mesh-list
92010077|NCT04903847|Antiviral Agents|antiviral agents|mesh-ancestor
92010078|NCT04903847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010079|NCT04903847|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92010080|NCT04903847|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92010081|NCT04903847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010082|NCT04903847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010083|NCT04903847|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92010084|NCT04903847|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92010085|NCT04903847|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92010086|NCT04903847|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92010087|NCT04905953|Neostigmine|neostigmine|mesh-list
92010088|NCT04905953|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92010089|NCT04905953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984642|NCT05464173|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91984643|NCT05464173|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91984644|NCT05464173|Hormone Antagonists|hormone antagonists|mesh-ancestor
92010090|NCT04905953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010091|NCT04905953|Cholinergic Agents|cholinergic agents|mesh-ancestor
92010092|NCT04905953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010093|NCT04905953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010094|NCT04905953|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92010095|NCT04905953|Autonomic Agents|autonomic agents|mesh-ancestor
92010096|NCT04905953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010098|NCT04916093|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92010099|NCT04916093|Vildagliptin|vildagliptin|mesh-list
92010100|NCT04916093|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010101|NCT04916093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010102|NCT04916093|Incretins|incretins|mesh-ancestor
92010103|NCT04916093|Hormones|hormones|mesh-ancestor
92010104|NCT04916093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010105|NCT04916093|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92010106|NCT04916093|Protease Inhibitors|protease inhibitors|mesh-ancestor
92010107|NCT04916093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010108|NCT04916093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010109|NCT05130619|Ethanol|ethanol|mesh-list
92010110|NCT05130619|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92010111|NCT05130619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010112|NCT05130619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010113|NCT05130619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010114|NCT03512119|Ivacaftor|ivacaftor|mesh-list
92010115|NCT03512119|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92010116|NCT03512119|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92010117|NCT03512119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010118|NCT02642809|Pembrolizumab|pembrolizumab|mesh-list
92010122|NCT02642809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010124|NCT03052361|Antiemetics|antiemetics|mesh-ancestor
92010125|NCT03052361|Autonomic Agents|autonomic agents|mesh-ancestor
92010126|NCT03052361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010127|NCT03052361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010128|NCT03052361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010129|NCT03052361|Antipruritics|antipruritics|mesh-ancestor
92010130|NCT03052361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010131|NCT03052361|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92010132|NCT03052361|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92010133|NCT03052361|Serotonin Agents|serotonin agents|mesh-ancestor
92010134|NCT03052361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010135|NCT03052361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010136|NCT02370589|Vaccines|vaccines|mesh-list
92010137|NCT02370589|Immunologic Factors|immunologic factors|mesh-ancestor
92010138|NCT02370589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010139|NCT01752049|Timolol|timolol|mesh-list
92010140|NCT01752049|Maleic acid|maleic acid|mesh-list
92010141|NCT01752049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010142|NCT01752049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010143|NCT01752049|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92010144|NCT01752049|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92010145|NCT01752049|Adrenergic Agents|adrenergic agents|mesh-ancestor
92010146|NCT01752049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010147|NCT01752049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010148|NCT01752049|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92010149|NCT01752049|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92010150|NCT04966507|Listerine|listerine|mesh-list
92010151|NCT04966507|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92010152|NCT04966507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010153|NCT04949113|Nivolumab|nivolumab|mesh-list
92010154|NCT04949113|Ipilimumab|ipilimumab|mesh-list
92010155|NCT04949113|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010156|NCT04949113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010157|NCT04949113|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92010158|NCT04949113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010159|NCT05057845|Lenvatinib|lenvatinib|mesh-list
92010160|NCT05057845|Tislelizumab|tislelizumab|mesh-list
92010161|NCT05057845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010162|NCT05057845|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010163|NCT05057845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010164|NCT05057845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010165|NCT05057845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010166|NCT05109949|Dapagliflozin|dapagliflozin|mesh-list
92010167|NCT05109949|Empagliflozin|empagliflozin|mesh-list
92010168|NCT05109949|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92010169|NCT05109949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010170|NCT05109949|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010171|NCT05109949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010172|NCT04901663|Amoxicillin|amoxicillin|mesh-list
92010173|NCT04901663|Clarithromycin|clarithromycin|mesh-list
92010174|NCT04901663|Omeprazole|omeprazole|mesh-list
92010175|NCT04901663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010176|NCT04901663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010177|NCT04901663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92010178|NCT04901663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010179|NCT04901663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92010180|NCT04901663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010181|NCT04901663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010182|NCT04901663|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92010183|NCT04901663|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92010184|NCT04901663|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92010185|NCT05134519|Trastuzumab|trastuzumab|mesh-list
92010186|NCT05134519|Antibodies|antibodies|mesh-list
92010187|NCT05134519|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92010188|NCT05134519|Immunologic Factors|immunologic factors|mesh-ancestor
92010189|NCT05134519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010195|NCT04394663|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92010196|NCT04394663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010197|NCT04394663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010198|NCT05133193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92010199|NCT05133193|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92010200|NCT05133193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010201|NCT05133193|Antitubercular Agents|antitubercular agents|mesh-ancestor
92010202|NCT04901117|Amoxicillin|amoxicillin|mesh-list
92010203|NCT04901117|Metronidazole|metronidazole|mesh-list
92010204|NCT04901117|Clarithromycin|clarithromycin|mesh-list
92010205|NCT04901117|Tetracycline|tetracycline|mesh-list
92010206|NCT04901117|Potassium Citrate|potassium citrate|mesh-list
92010207|NCT04901117|Bismuth|bismuth|mesh-list
92010208|NCT04901117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010209|NCT04901117|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010210|NCT04901117|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010211|NCT04901117|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92010212|NCT04901117|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92010213|NCT04901117|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92010214|NCT04901117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010215|NCT04901117|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92010216|NCT04901117|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92010218|NCT04901117|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010219|NCT04901117|Diuretics|diuretics|mesh-ancestor
92010220|NCT04901117|Natriuretic Agents|natriuretic agents|mesh-ancestor
92010221|NCT04901117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010222|NCT04901117|Expectorants|expectorants|mesh-ancestor
92010223|NCT04901117|Respiratory System Agents|respiratory system agents|mesh-ancestor
92010224|NCT05121571|Sorafenib|sorafenib|mesh-list
92010225|NCT05121571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010226|NCT05121571|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010227|NCT05121571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010228|NCT05121571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010229|NCT03051269|Calcium, Dietary|calcium, dietary|mesh-list
92010230|NCT03051269|Calcium|calcium|mesh-list
92010231|NCT03051269|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92010232|NCT03051269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010233|NCT03051269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92010234|NCT04576663|Phenylephrine|phenylephrine|mesh-list
92010235|NCT04576663|Oxymetazoline|oxymetazoline|mesh-list
92010236|NCT04576663|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92010237|NCT04576663|Mydriatics|mydriatics|mesh-ancestor
92010238|NCT04576663|Autonomic Agents|autonomic agents|mesh-ancestor
92010239|NCT04576663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010240|NCT04576663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010241|NCT04576663|Sympathomimetics|sympathomimetics|mesh-ancestor
92010242|NCT04576663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91984645|NCT05464173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984646|NCT05464173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984647|NCT02683187|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92010243|NCT04576663|Nasal Decongestants|nasal decongestants|mesh-ancestor
92010244|NCT04576663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92010245|NCT04576663|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92010246|NCT04576663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92010247|NCT04576663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92010248|NCT04576663|Adrenergic Agents|adrenergic agents|mesh-ancestor
92010249|NCT04576663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010250|NCT04576663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010251|NCT04576663|Protective Agents|protective agents|mesh-ancestor
92010252|NCT05281549|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92010253|NCT05281549|Tenecteplase|tenecteplase|mesh-list
92010254|NCT05281549|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92010255|NCT05281549|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92010256|NCT05281549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010257|NCT04400695|Paclitaxel|paclitaxel|mesh-list
92010258|NCT04400695|Vinorelbine|vinorelbine|mesh-list
92010259|NCT04400695|Docetaxel|docetaxel|mesh-list
92010260|NCT04400695|Capecitabine|capecitabine|mesh-list
92010265|NCT04400695|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010266|NCT04400695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010267|NCT04400695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92010269|NCT05205499|Sirolimus|sirolimus|mesh-list
92010270|NCT05205499|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010271|NCT05205499|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010272|NCT05205499|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92010273|NCT05205499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010274|NCT05205499|Antifungal Agents|antifungal agents|mesh-ancestor
92010275|NCT05205499|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92010276|NCT05205499|Immunologic Factors|immunologic factors|mesh-ancestor
92010277|NCT05205499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010278|NCT05191225|Rituximab|rituximab|mesh-list
92010279|NCT05191225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010280|NCT05191225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010281|NCT05191225|Immunologic Factors|immunologic factors|mesh-ancestor
92010282|NCT05191225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010283|NCT05191225|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010284|NCT03909217|Dexetimide|dexetimide|mesh-list
92010285|NCT03909217|Citalopram|citalopram|mesh-list
92010286|NCT03909217|Escitalopram|escitalopram|mesh-list
92010287|NCT03909217|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92010288|NCT03909217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92010289|NCT03909217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92010290|NCT03909217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010291|NCT03909217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010292|NCT03909217|Serotonin Agents|serotonin agents|mesh-ancestor
92010293|NCT03909217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010294|NCT03909217|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92010295|NCT03909217|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92010296|NCT03909217|Parasympatholytics|parasympatholytics|mesh-ancestor
92010297|NCT03909217|Autonomic Agents|autonomic agents|mesh-ancestor
92010298|NCT03909217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010299|NCT03909217|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92010300|NCT03909217|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92010301|NCT03909217|Cholinergic Agents|cholinergic agents|mesh-ancestor
92010302|NCT03909217|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92010303|NCT03909217|Antidepressive Agents|antidepressive agents|mesh-ancestor
92010304|NCT03909217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92010305|NCT02650921|Lidocaine|lidocaine|mesh-list
92010306|NCT02650921|Anesthetics, Local|anesthetics, local|mesh-ancestor
92010307|NCT02650921|Anesthetics|anesthetics|mesh-ancestor
92010308|NCT02650921|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010309|NCT02650921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010310|NCT02650921|Sensory System Agents|sensory system agents|mesh-ancestor
92010311|NCT02650921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010312|NCT02650921|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92010313|NCT02650921|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92010314|NCT02650921|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92010315|NCT02650921|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92010316|NCT02650921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010318|NCT04913987|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92010319|NCT04913987|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010320|NCT04913987|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92010321|NCT04913987|Histamine Antagonists|histamine antagonists|mesh-ancestor
92010322|NCT04913987|Histamine Agents|histamine agents|mesh-ancestor
92010323|NCT04913987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010324|NCT04913987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010325|NCT04913987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010326|NCT04913987|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92010327|NCT04913987|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92010328|NCT04913987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010329|NCT01596335|Immunoglobulins|immunoglobulins|mesh-list
92010333|NCT01596335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010334|NCT04891679|Misoprostol|misoprostol|mesh-list
92010335|NCT04891679|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92010336|NCT04891679|Abortifacient Agents|abortifacient agents|mesh-ancestor
92010337|NCT04891679|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92010338|NCT04891679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010339|NCT04891679|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92010340|NCT04891679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010341|NCT04891679|Oxytocics|oxytocics|mesh-ancestor
92010342|NCT04913831|Cerebrolysin|cerebrolysin|mesh-list
92010343|NCT04913831|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92010344|NCT04913831|Protective Agents|protective agents|mesh-ancestor
92010345|NCT04913831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010346|NCT04913831|Nootropic Agents|nootropic agents|mesh-ancestor
92010347|NCT04900415|Vitamin A|vitamin a|mesh-list
92010348|NCT04900415|Vitamins|vitamins|mesh-ancestor
92010349|NCT04900415|Micronutrients|micronutrients|mesh-ancestor
92010350|NCT04900415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010351|NCT04900571|Nitrofurantoin|nitrofurantoin|mesh-list
92010352|NCT04900571|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92010353|NCT04900571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010354|NCT04900571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010355|NCT04891211|Vitamin D|vitamin d|mesh-list
92010356|NCT04891211|Vitamins|vitamins|mesh-ancestor
92010357|NCT04891211|Micronutrients|micronutrients|mesh-ancestor
92010358|NCT04891211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010359|NCT04891211|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92010360|NCT04817189|Dexamethasone|dexamethasone|mesh-list
92010361|NCT04817189|Ondansetron|ondansetron|mesh-list
92010362|NCT04817189|Palonosetron|palonosetron|mesh-list
92010363|NCT04817189|Granisetron|granisetron|mesh-list
92010366|NCT04817189|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010367|NCT04817189|Antiemetics|antiemetics|mesh-ancestor
92010368|NCT04817189|Autonomic Agents|autonomic agents|mesh-ancestor
92010369|NCT04817189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010370|NCT04817189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010371|NCT04817189|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010372|NCT04817189|Glucocorticoids|glucocorticoids|mesh-ancestor
92010373|NCT04817189|Hormones|hormones|mesh-ancestor
92010374|NCT04817189|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010375|NCT04817189|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92010376|NCT04817189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010377|NCT04817189|Antipruritics|antipruritics|mesh-ancestor
92010378|NCT04817189|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010379|NCT04817189|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92010380|NCT04817189|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92010381|NCT04817189|Serotonin Agents|serotonin agents|mesh-ancestor
92010382|NCT04817189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010383|NCT04817189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010384|NCT03050957|Menthol|menthol|mesh-list
92010385|NCT03050957|Antipruritics|antipruritics|mesh-ancestor
92010386|NCT03050957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010387|NCT04885049|Racecadotril|racecadotril|mesh-list
92010388|NCT04885049|Antidiarrheals|antidiarrheals|mesh-ancestor
92010389|NCT04885049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010390|NCT04885049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92010391|NCT04885049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010392|NCT04885049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010393|NCT04890353|Dimethyl Fumarate|dimethyl fumarate|mesh-list
91984648|NCT02683187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984649|NCT02683187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010394|NCT04890353|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010395|NCT04890353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92010396|NCT04890353|Immunologic Factors|immunologic factors|mesh-ancestor
92010397|NCT04890353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010398|NCT04430621|Hormones|hormones|mesh-list
92010399|NCT04430621|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92010400|NCT04430621|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010401|NCT04430621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010402|NCT04884503|Clonazepam|clonazepam|mesh-list
92010403|NCT04884503|Anticonvulsants|anticonvulsants|mesh-ancestor
92010404|NCT04884503|GABA Modulators|gaba modulators|mesh-ancestor
92010405|NCT04884503|GABA Agents|gaba agents|mesh-ancestor
92010410|NCT04889651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010411|NCT04889651|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92010412|NCT04889651|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010413|NCT04889651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010414|NCT04889651|Hormone Antagonists|hormone antagonists|mesh-ancestor
92010415|NCT04889651|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010416|NCT04889651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010417|NCT04889651|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92010418|NCT04898699|Tenofovir|tenofovir|mesh-list
92010419|NCT04898699|Emtricitabine|emtricitabine|mesh-list
92010420|NCT04898699|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92010421|NCT04898699|Antiviral Agents|antiviral agents|mesh-ancestor
92010422|NCT04898699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010423|NCT04898699|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92010424|NCT04898699|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92010425|NCT04898699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010426|NCT04898699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010427|NCT04898699|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92010428|NCT04898699|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92010429|NCT04888715|Pirfenidone|pirfenidone|mesh-list
92010430|NCT04888715|Nintedanib|nintedanib|mesh-list
92010431|NCT04888715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010432|NCT04888715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010433|NCT04888715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010434|NCT04888715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010435|NCT04888715|Analgesics|analgesics|mesh-ancestor
92010436|NCT04888715|Sensory System Agents|sensory system agents|mesh-ancestor
92010437|NCT04888715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010438|NCT04888715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010439|NCT04888715|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92010440|NCT04888715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92010441|NCT04888715|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010442|NCT04888715|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010443|NCT04888403|Paclitaxel|paclitaxel|mesh-list
92010444|NCT04888403|Nedaplatin|nedaplatin|mesh-list
92010445|NCT04888403|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010446|NCT04888403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010447|NCT04888403|Tubulin Modulators|tubulin modulators|mesh-ancestor
92010448|NCT04888403|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010449|NCT04888403|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010450|NCT04888403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010452|NCT03050177|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010453|NCT03050177|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010454|NCT03050177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010455|NCT03050177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010456|NCT03051581|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92010457|NCT03051581|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92010458|NCT03051581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010459|NCT03050411|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92010460|NCT03050411|Apatinib|apatinib|mesh-list
92010461|NCT03050411|Gefitinib|gefitinib|mesh-list
92010462|NCT03050411|Osimertinib|osimertinib|mesh-list
92010463|NCT03050411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010464|NCT03050411|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010465|NCT03050411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010466|NCT03050411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984650|NCT02683187|Incretins|incretins|mesh-ancestor
91984651|NCT02683187|Hormones|hormones|mesh-ancestor
91984652|NCT02683187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010467|NCT04887311|Tempol|tempol|mesh-list
92010468|NCT04887311|Antioxidants|antioxidants|mesh-ancestor
92010469|NCT04887311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010470|NCT04887311|Protective Agents|protective agents|mesh-ancestor
92010471|NCT04887311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010472|NCT04887311|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92010473|NCT04887311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010476|NCT03051503|Fentanyl|fentanyl|mesh-list
92010477|NCT03051503|Morphine|morphine|mesh-list
92010478|NCT03051503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92010479|NCT03051503|Narcotics|narcotics|mesh-ancestor
92010480|NCT03051503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010481|NCT03051503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010482|NCT03051503|Analgesics|analgesics|mesh-ancestor
92010483|NCT03051503|Sensory System Agents|sensory system agents|mesh-ancestor
92010484|NCT03051503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010485|NCT03051503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92010486|NCT03051503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92010487|NCT03051503|Anesthetics, General|anesthetics, general|mesh-ancestor
92010488|NCT03051503|Anesthetics|anesthetics|mesh-ancestor
92010489|NCT04896125|Bimatoprost|bimatoprost|mesh-list
92010490|NCT04896125|Latanoprost|latanoprost|mesh-list
92010491|NCT04896125|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92010492|NCT04896125|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92010493|NCT04896125|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92010494|NCT04895657|Tazobactam|tazobactam|mesh-list
92010495|NCT04895657|Piperacillin|piperacillin|mesh-list
92010496|NCT04895657|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92010497|NCT04895657|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010498|NCT04895657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010499|NCT04895657|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92010500|NCT04895657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010501|NCT04895657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010503|NCT04895423|Mycophenolic Acid|mycophenolic acid|mesh-list
92010504|NCT04895423|Methotrexate|methotrexate|mesh-list
92010505|NCT04895423|Cyclosporins|cyclosporins|mesh-list
92010506|NCT04895423|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92010507|NCT04895423|Abortifacient Agents|abortifacient agents|mesh-ancestor
92010508|NCT04895423|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92010509|NCT04895423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010510|NCT04895423|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92010511|NCT04895423|Antimetabolites|antimetabolites|mesh-ancestor
92010512|NCT04895423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010513|NCT04895423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010514|NCT04895423|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010515|NCT04895423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010516|NCT04895423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92010517|NCT04895423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92010518|NCT04895423|Immunologic Factors|immunologic factors|mesh-ancestor
92010519|NCT04895423|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010520|NCT04895423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92010521|NCT04895423|Antifungal Agents|antifungal agents|mesh-ancestor
92010522|NCT04895423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010523|NCT04895423|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92010524|NCT04895423|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92010525|NCT04895423|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92010526|NCT04895423|Antitubercular Agents|antitubercular agents|mesh-ancestor
92010527|NCT04895423|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010529|NCT04882163|Rituximab|rituximab|mesh-list
92010530|NCT04882163|Gemcitabine|gemcitabine|mesh-list
92010531|NCT04882163|Lenalidomide|lenalidomide|mesh-list
92010532|NCT04882163|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92010533|NCT04882163|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92010534|NCT04882163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010535|NCT04882163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010536|NCT04882163|Immunologic Factors|immunologic factors|mesh-ancestor
92010537|NCT04882163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010538|NCT04882163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984653|NCT02683187|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91984654|NCT02683187|Protease Inhibitors|protease inhibitors|mesh-ancestor
91984655|NCT02683187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984656|NCT02683187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090421|NCT04416035|Paclitaxel|paclitaxel|mesh-list
92010539|NCT04882163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010540|NCT04882163|Antiemetics|antiemetics|mesh-ancestor
92010541|NCT04882163|Autonomic Agents|autonomic agents|mesh-ancestor
92010542|NCT04882163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010543|NCT04882163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010544|NCT04882163|Glucocorticoids|glucocorticoids|mesh-ancestor
92010545|NCT04882163|Hormones|hormones|mesh-ancestor
92010546|NCT04882163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010547|NCT04882163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92010548|NCT04882163|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92010550|NCT04882163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010551|NCT04882163|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92010552|NCT04882163|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92010553|NCT04882163|Growth Substances|growth substances|mesh-ancestor
92010554|NCT04882163|Growth Inhibitors|growth inhibitors|mesh-ancestor
92010555|NCT04882163|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92010556|NCT04882163|Alkylating Agents|alkylating agents|mesh-ancestor
92010557|NCT04882163|Immunoconjugates|immunoconjugates|mesh-ancestor
92010558|NCT04885751|Rebamipide|rebamipide|mesh-list
92010559|NCT04885751|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92010560|NCT04885751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010561|NCT04885751|Antioxidants|antioxidants|mesh-ancestor
92010562|NCT04885751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010563|NCT04885751|Protective Agents|protective agents|mesh-ancestor
92010564|NCT04885751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010565|NCT04885751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010566|NCT03049163|Proxymetacaine|proxymetacaine|mesh-list
92010567|NCT03049163|Propoxycaine|propoxycaine|mesh-list
92010568|NCT03049163|Anesthetics|anesthetics|mesh-ancestor
92010569|NCT03049163|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010570|NCT03049163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010571|NCT03049163|Anesthetics, Local|anesthetics, local|mesh-ancestor
92010572|NCT03049163|Sensory System Agents|sensory system agents|mesh-ancestor
92010573|NCT03049163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010575|NCT04881851|Thioctic Acid|thioctic acid|mesh-list
92010576|NCT04881851|Inositol|inositol|mesh-list
92010577|NCT04881851|Hematinics|hematinics|mesh-ancestor
92010578|NCT04881851|Vitamin B Complex|vitamin b complex|mesh-ancestor
92010579|NCT04881851|Vitamins|vitamins|mesh-ancestor
92010580|NCT04881851|Micronutrients|micronutrients|mesh-ancestor
92010581|NCT04881851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010582|NCT04881851|Antioxidants|antioxidants|mesh-ancestor
92010583|NCT04881851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010584|NCT04881851|Protective Agents|protective agents|mesh-ancestor
92010585|NCT04871633|Azithromycin|azithromycin|mesh-list
92010586|NCT04871633|Remdesivir|remdesivir|mesh-list
92010587|NCT04871633|Dexamethasone|dexamethasone|mesh-list
92010588|NCT04871633|Prednisolone|prednisolone|mesh-list
92010589|NCT04871633|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92010590|NCT04871633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010591|NCT04871633|Antiemetics|antiemetics|mesh-ancestor
92010592|NCT04871633|Autonomic Agents|autonomic agents|mesh-ancestor
92010593|NCT04871633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010594|NCT04871633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010595|NCT04871633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010596|NCT04871633|Glucocorticoids|glucocorticoids|mesh-ancestor
92010598|NCT04871633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010599|NCT04871633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92010600|NCT04871633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010601|NCT04871633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010602|NCT04871633|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92010603|NCT04871633|Protective Agents|protective agents|mesh-ancestor
92010604|NCT04871633|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984658|NCT05515601|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91984659|NCT05515601|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91984660|NCT05515601|Analgesics|analgesics|mesh-ancestor
91984661|NCT05515601|Sensory System Agents|sensory system agents|mesh-ancestor
91984662|NCT05515601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984663|NCT05515601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984664|NCT05515601|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984665|NCT05515601|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984666|NCT05515601|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91984667|NCT05515601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984668|NCT02683109|Tiotropium Bromide|tiotropium bromide|mesh-list
91984670|NCT02683109|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91984671|NCT02683109|Autonomic Agents|autonomic agents|mesh-ancestor
91984672|NCT02683109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984673|NCT02683109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010606|NCT04871633|Antimetabolites|antimetabolites|mesh-ancestor
92010607|NCT04871633|Antiviral Agents|antiviral agents|mesh-ancestor
92010608|NCT04880993|Dapagliflozin|dapagliflozin|mesh-list
92010609|NCT04880993|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92010610|NCT04880993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010611|NCT04880993|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010612|NCT04880993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010613|NCT03046979|Apatinib|apatinib|mesh-list
92010614|NCT03046979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010615|NCT03046979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010616|NCT03046979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010617|NCT03046979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010618|NCT04676399|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92010619|NCT04676399|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92010620|NCT04676399|Diuretics|diuretics|mesh-ancestor
92010621|NCT04676399|Natriuretic Agents|natriuretic agents|mesh-ancestor
92010622|NCT04676399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010623|NCT04676399|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92010624|NCT04676399|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92010629|NCT03047057|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010630|NCT03047057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010631|NCT03047057|Sensory System Agents|sensory system agents|mesh-ancestor
92010632|NCT03047057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010633|NCT03047057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92010634|NCT03047057|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92010635|NCT03047057|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92010636|NCT03047057|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92010637|NCT03047057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010638|NCT04550195|Famotidine|famotidine|mesh-list
92010639|NCT04550195|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92010640|NCT04550195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010641|NCT04550195|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92010642|NCT04550195|Histamine Antagonists|histamine antagonists|mesh-ancestor
92010643|NCT04550195|Histamine Agents|histamine agents|mesh-ancestor
92010644|NCT04550195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010645|NCT04550195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010646|NCT04550195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010647|NCT04525391|Durvalumab|durvalumab|mesh-list
92010648|NCT04525391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984674|NCT02683109|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91984675|NCT02683109|Respiratory System Agents|respiratory system agents|mesh-ancestor
91984676|NCT02683109|Parasympatholytics|parasympatholytics|mesh-ancestor
91984677|NCT02683109|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91984678|NCT02683109|Cholinergic Agents|cholinergic agents|mesh-ancestor
91984679|NCT02683109|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984680|NCT02683109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984681|NCT02544321|Bromocriptine|bromocriptine|mesh-list
91984682|NCT02544321|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91984683|NCT02544321|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91984684|NCT02544321|Hormone Antagonists|hormone antagonists|mesh-ancestor
92010649|NCT04525391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010650|NCT04879511|Metformin|metformin|mesh-list
92010651|NCT04879511|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010652|NCT04879511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010653|NCT04361825|Durvalumab|durvalumab|mesh-list
92010654|NCT04361825|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010655|NCT04361825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010656|NCT03046901|Vancomycin|vancomycin|mesh-list
92010657|NCT03046901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010658|NCT03046901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010659|NCT03871049|Dexamethasone|dexamethasone|mesh-list
92010660|NCT03871049|Bupivacaine|bupivacaine|mesh-list
92010661|NCT03871049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010662|NCT03871049|Antiemetics|antiemetics|mesh-ancestor
92010663|NCT03871049|Autonomic Agents|autonomic agents|mesh-ancestor
92010664|NCT03871049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010665|NCT03871049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010667|NCT03871049|Glucocorticoids|glucocorticoids|mesh-ancestor
92010669|NCT03871049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010670|NCT03871049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92010671|NCT03871049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010672|NCT03871049|Anesthetics, Local|anesthetics, local|mesh-ancestor
92010673|NCT03871049|Anesthetics|anesthetics|mesh-ancestor
92010674|NCT03871049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010675|NCT03871049|Sensory System Agents|sensory system agents|mesh-ancestor
92010676|NCT04870541|Nefopam|nefopam|mesh-list
92010677|NCT04870541|Ondansetron|ondansetron|mesh-list
92010678|NCT04870541|Antiemetics|antiemetics|mesh-ancestor
92010679|NCT04870541|Autonomic Agents|autonomic agents|mesh-ancestor
92010680|NCT04870541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010681|NCT04870541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010682|NCT04870541|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010683|NCT04870541|Antipruritics|antipruritics|mesh-ancestor
92010684|NCT04870541|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010685|NCT04870541|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92010686|NCT04870541|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92010687|NCT04870541|Serotonin Agents|serotonin agents|mesh-ancestor
92010688|NCT04870541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010689|NCT04870541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010690|NCT04870541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92010691|NCT04870541|Analgesics|analgesics|mesh-ancestor
92010692|NCT04870541|Sensory System Agents|sensory system agents|mesh-ancestor
92010693|NCT04870073|Mannitol|mannitol|mesh-list
92010694|NCT04870073|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92010695|NCT04870073|Diuretics|diuretics|mesh-ancestor
92010696|NCT04870073|Natriuretic Agents|natriuretic agents|mesh-ancestor
92010698|NCT02616029|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92010701|NCT02616029|Antiviral Agents|antiviral agents|mesh-ancestor
92010702|NCT02616029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010703|NCT04878497|Warfarin|warfarin|mesh-list
92010704|NCT04878497|Rivaroxaban|rivaroxaban|mesh-list
92010705|NCT04878497|Dabigatran|dabigatran|mesh-list
91984685|NCT02544321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984686|NCT02544321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010706|NCT04878497|Apixaban|apixaban|mesh-list
92010707|NCT04878497|Edoxaban|edoxaban|mesh-list
92010708|NCT04878497|Anticoagulants|anticoagulants|mesh-ancestor
92010709|NCT04878497|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92010710|NCT04878497|Antithrombins|antithrombins|mesh-ancestor
92010711|NCT04878497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92010712|NCT04878497|Protease Inhibitors|protease inhibitors|mesh-ancestor
92010713|NCT04878497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010714|NCT04878497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010715|NCT03257033|Paclitaxel|paclitaxel|mesh-list
92010716|NCT03257033|Gemcitabine|gemcitabine|mesh-list
92010717|NCT03257033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010718|NCT03257033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010719|NCT03257033|Tubulin Modulators|tubulin modulators|mesh-ancestor
92010720|NCT03257033|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010721|NCT03257033|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010722|NCT03257033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010723|NCT03257033|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92010724|NCT03257033|Antimetabolites|antimetabolites|mesh-ancestor
92010725|NCT03250169|Alemtuzumab|alemtuzumab|mesh-list
92010726|NCT03250169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010727|NCT03250169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010728|NCT02614859|Metformin|metformin|mesh-list
92010729|NCT02614859|Bicalutamide|bicalutamide|mesh-list
92010730|NCT02614859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010731|NCT02614859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010732|NCT02614859|Androgen Antagonists|androgen antagonists|mesh-ancestor
92010733|NCT02614859|Hormone Antagonists|hormone antagonists|mesh-ancestor
92010810|NCT04868513|Protective Agents|protective agents|mesh-ancestor
92010734|NCT02614859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010735|NCT02614859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010736|NCT01495637|Sargramostim|sargramostim|mesh-list
92010737|NCT01495637|Immunologic Factors|immunologic factors|mesh-ancestor
92010738|NCT01495637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010739|NCT04876859|Anesthetics|anesthetics|mesh-list
92010740|NCT04876859|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010741|NCT04876859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010743|NCT04876313|Nivolumab|nivolumab|mesh-list
92010744|NCT04876313|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010745|NCT04876313|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010746|NCT04876313|Tubulin Modulators|tubulin modulators|mesh-ancestor
92010747|NCT04876313|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010748|NCT04876313|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010749|NCT04876313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010750|NCT04876313|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010751|NCT04876313|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92010752|NCT03049085|Aspirin|aspirin|mesh-list
92010753|NCT03049085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010754|NCT03049085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92010755|NCT03049085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92010756|NCT03049085|Analgesics|analgesics|mesh-ancestor
92010757|NCT03049085|Sensory System Agents|sensory system agents|mesh-ancestor
92010758|NCT03049085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010759|NCT03049085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010760|NCT03049085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010761|NCT03049085|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92010762|NCT03049085|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92010763|NCT03049085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010764|NCT03049085|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92010765|NCT03049085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92010766|NCT03049085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010767|NCT03049085|Antipyretics|antipyretics|mesh-ancestor
92010768|NCT04875611|Nivolumab|nivolumab|mesh-list
92010769|NCT04875611|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010771|NCT04875611|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92010772|NCT04875611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010774|NCT04386317|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92010775|NCT04386317|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92010776|NCT04386317|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92010777|NCT04386317|Adrenergic Agents|adrenergic agents|mesh-ancestor
91984687|NCT02544321|Dopamine Agonists|dopamine agonists|mesh-ancestor
91984689|NCT02544321|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010778|NCT04386317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010779|NCT04386317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010780|NCT04386317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010781|NCT04386317|Urological Agents|urological agents|mesh-ancestor
92010783|NCT05256953|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010784|NCT05256953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010785|NCT04874675|Acetaminophen|acetaminophen|mesh-list
92010786|NCT04874675|Ibuprofen|ibuprofen|mesh-list
92010787|NCT04874675|Diclofenac|diclofenac|mesh-list
92010788|NCT04874675|Codeine|codeine|mesh-list
92010789|NCT04874675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92010790|NCT04874675|Analgesics|analgesics|mesh-ancestor
92010791|NCT04874675|Sensory System Agents|sensory system agents|mesh-ancestor
92010792|NCT04874675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010793|NCT04874675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010794|NCT04874675|Antipyretics|antipyretics|mesh-ancestor
92010795|NCT04874675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92010796|NCT04874675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010797|NCT04874675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010798|NCT04874675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92010799|NCT04874675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010800|NCT04874675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010801|NCT04874675|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92010802|NCT04874675|Narcotics|narcotics|mesh-ancestor
92010803|NCT04874675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010804|NCT04874675|Antitussive Agents|antitussive agents|mesh-ancestor
92010805|NCT04874675|Respiratory System Agents|respiratory system agents|mesh-ancestor
92010806|NCT04868513|Chlorhexidine|chlorhexidine|mesh-list
92010807|NCT04868513|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92010808|NCT04868513|Fluorides|fluorides|mesh-list
92010809|NCT04868513|Cariostatic Agents|cariostatic agents|mesh-ancestor
92010811|NCT04868513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010812|NCT04868513|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92010813|NCT04868513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010814|NCT04868513|Disinfectants|disinfectants|mesh-ancestor
92010815|NCT04868513|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010817|NCT03047837|Metformin|metformin|mesh-list
92010818|NCT03047837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92010819|NCT03047837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010820|NCT03047837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92010821|NCT03047837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92010822|NCT03047837|Analgesics|analgesics|mesh-ancestor
92010823|NCT03047837|Sensory System Agents|sensory system agents|mesh-ancestor
92010824|NCT03047837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010825|NCT03047837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010826|NCT03047837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010827|NCT03047837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92010828|NCT03047837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92010829|NCT03047837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010830|NCT03047837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92010831|NCT03047837|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92010832|NCT03047837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010833|NCT03047837|Antipyretics|antipyretics|mesh-ancestor
92010834|NCT05256173|Melatonin|melatonin|mesh-list
92010835|NCT05256173|Antioxidants|antioxidants|mesh-ancestor
92010836|NCT05256173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010837|NCT05256173|Protective Agents|protective agents|mesh-ancestor
92010838|NCT05256173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010839|NCT05256173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010840|NCT02648347|Darbepoetin alfa|darbepoetin alfa|mesh-list
92010841|NCT02648347|Hematinics|hematinics|mesh-ancestor
92010842|NCT02614703|Acetic Acid|acetic acid|mesh-list
92010843|NCT02614703|Retinol acetate|retinol acetate|mesh-list
92010848|NCT02614703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010850|NCT02614703|Protective Agents|protective agents|mesh-ancestor
92010851|NCT02614703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984690|NCT02544321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984691|NCT02533401|Cyclophosphamide|cyclophosphamide|mesh-list
92010852|NCT01669343|Letrozole|letrozole|mesh-list
92010853|NCT01669343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010854|NCT01669343|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92010855|NCT01669343|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92010856|NCT01669343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010857|NCT01669343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010858|NCT01669343|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92010859|NCT01669343|Hormone Antagonists|hormone antagonists|mesh-ancestor
92010860|NCT01669343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92010861|NCT01669343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010862|NCT04383743|Cisplatin|cisplatin|mesh-list
92010863|NCT04383743|Doxorubicin|doxorubicin|mesh-list
92010864|NCT04383743|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92010865|NCT04383743|Pembrolizumab|pembrolizumab|mesh-list
92010866|NCT04383743|Methotrexate|methotrexate|mesh-list
92010867|NCT04383743|Daunorubicin|daunorubicin|mesh-list
92010868|NCT04383743|Vinblastine|vinblastine|mesh-list
92010869|NCT04383743|Lenograstim|lenograstim|mesh-list
92010870|NCT04383743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010871|NCT04383743|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92010872|NCT04383743|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92010873|NCT04383743|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92010874|NCT04383743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010875|NCT04383743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010876|NCT04383743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010877|NCT04383743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92010878|NCT04383743|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92010879|NCT04383743|Abortifacient Agents|abortifacient agents|mesh-ancestor
92010880|NCT04383743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92010881|NCT04383743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010882|NCT04383743|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92010883|NCT04383743|Antimetabolites|antimetabolites|mesh-ancestor
92010884|NCT04383743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010885|NCT04383743|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92010886|NCT04383743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92010887|NCT04383743|Immunologic Factors|immunologic factors|mesh-ancestor
92010888|NCT04383743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92010889|NCT04383743|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92010890|NCT04383743|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92010891|NCT04383743|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010892|NCT04383743|Tubulin Modulators|tubulin modulators|mesh-ancestor
92010893|NCT04383743|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010894|NCT04383743|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010895|NCT03126643|Nivolumab|nivolumab|mesh-list
92010896|NCT03126643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010897|NCT03126643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010898|NCT03126643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92010899|NCT03126643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010901|NCT04617067|Gemcitabine|gemcitabine|mesh-list
92010902|NCT04617067|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010903|NCT04617067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010904|NCT04617067|Tubulin Modulators|tubulin modulators|mesh-ancestor
92010905|NCT04617067|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010906|NCT04617067|Mitosis Modulators|mitosis modulators|mesh-ancestor
92010907|NCT04617067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010908|NCT04617067|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92010909|NCT04617067|Antimetabolites|antimetabolites|mesh-ancestor
92010910|NCT01594931|Artesunate|artesunate|mesh-list
92010911|NCT01594931|Pyronaridine|pyronaridine|mesh-list
92010912|NCT01594931|Antimalarials|antimalarials|mesh-ancestor
92010913|NCT01594931|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92010917|NCT01594931|Antiviral Agents|antiviral agents|mesh-ancestor
92010918|NCT01594931|Schistosomicides|schistosomicides|mesh-ancestor
92010919|NCT01594931|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92010920|NCT01594931|Anthelmintics|anthelmintics|mesh-ancestor
92010921|NCT03045185|Metronidazole|metronidazole|mesh-list
92010922|NCT03045185|Ciprofloxacin|ciprofloxacin|mesh-list
92010923|NCT03045185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010924|NCT03045185|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010925|NCT03045185|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91984693|NCT02533401|Fludarabine|fludarabine|mesh-list
91984694|NCT02533401|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92010926|NCT03045185|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92010927|NCT03045185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92010928|NCT03045185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92010929|NCT03045185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010930|NCT03045185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010931|NCT03045185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010932|NCT03045185|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92010933|NCT03045185|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92010934|NCT04969237|Vitamin D|vitamin d|mesh-list
92010935|NCT04969237|Vitamins|vitamins|mesh-ancestor
92010936|NCT04969237|Micronutrients|micronutrients|mesh-ancestor
92010937|NCT04969237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010938|NCT04969237|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92010939|NCT04341467|Olanzapine|olanzapine|mesh-list
92010940|NCT04341467|Amisulpride|amisulpride|mesh-list
92010941|NCT04341467|Antiemetics|antiemetics|mesh-ancestor
92010942|NCT04341467|Autonomic Agents|autonomic agents|mesh-ancestor
92010943|NCT04341467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010944|NCT04341467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010945|NCT04341467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010946|NCT04341467|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92010947|NCT04341467|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92010948|NCT04341467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010949|NCT04341467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92010950|NCT04341467|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92010951|NCT04341467|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92010952|NCT04341467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92010953|NCT04341467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010954|NCT04341467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92010955|NCT04341467|Serotonin Agents|serotonin agents|mesh-ancestor
92010956|NCT04341467|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92010957|NCT04341467|Dopamine Agents|dopamine agents|mesh-ancestor
92010958|NCT04341467|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92010959|NCT04341467|Antidepressive Agents|antidepressive agents|mesh-ancestor
92010960|NCT04872881|Fentanyl|fentanyl|mesh-list
92010961|NCT04872881|Propofol|propofol|mesh-list
92010962|NCT04872881|Rocuronium|rocuronium|mesh-list
92010963|NCT04872881|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92010964|NCT04872881|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92010965|NCT04872881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010966|NCT04872881|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92010967|NCT04872881|Anesthetics, General|anesthetics, general|mesh-ancestor
92010968|NCT04872881|Anesthetics|anesthetics|mesh-ancestor
92010969|NCT04872881|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92010970|NCT04872881|Narcotics|narcotics|mesh-ancestor
92010971|NCT04872881|Analgesics|analgesics|mesh-ancestor
92010972|NCT04872881|Sensory System Agents|sensory system agents|mesh-ancestor
92010973|NCT04872881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92010974|NCT04872881|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92010975|NCT04872881|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92010976|NCT04872881|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92010977|NCT04872881|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92010978|NCT03044873|Deucravacitinib|deucravacitinib|mesh-list
92010979|NCT03044873|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92010980|NCT03044873|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92010981|NCT03044873|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92010982|NCT03044873|Antimetabolites|antimetabolites|mesh-ancestor
92010983|NCT03044873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010984|NCT03044873|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92010985|NCT03044873|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92010986|NCT03044873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92010992|NCT03044795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010993|NCT03044795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010994|NCT04341155|Dexamethasone|dexamethasone|mesh-list
92010995|NCT04341155|Dexamethasone acetate|dexamethasone acetate|mesh-list
92010996|NCT04341155|BB 1101|bb 1101|mesh-list
92010997|NCT04341155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92010998|NCT04341155|Antiemetics|antiemetics|mesh-ancestor
92010999|NCT04341155|Autonomic Agents|autonomic agents|mesh-ancestor
91984695|NCT02533401|Immunologic Factors|immunologic factors|mesh-ancestor
92011000|NCT04341155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011001|NCT04341155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011002|NCT04341155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011003|NCT04341155|Glucocorticoids|glucocorticoids|mesh-ancestor
92011004|NCT04341155|Hormones|hormones|mesh-ancestor
92011005|NCT04341155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011006|NCT04341155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011007|NCT04341155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011008|NCT04341155|Protease Inhibitors|protease inhibitors|mesh-ancestor
92011009|NCT04341155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011010|NCT04341155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011011|NCT04865705|Paclitaxel|paclitaxel|mesh-list
92011012|NCT04865705|Cisplatin|cisplatin|mesh-list
92011013|NCT04865705|Carboplatin|carboplatin|mesh-list
92011014|NCT04865705|Tislelizumab|tislelizumab|mesh-list
92011015|NCT04865705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92011016|NCT04865705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011017|NCT04865705|Tubulin Modulators|tubulin modulators|mesh-ancestor
92011018|NCT04865705|Antimitotic Agents|antimitotic agents|mesh-ancestor
92011019|NCT04865705|Mitosis Modulators|mitosis modulators|mesh-ancestor
92011020|NCT04865705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011021|NCT04865705|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011022|NCT04858997|Palbociclib|palbociclib|mesh-list
92011023|NCT04858997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011024|NCT04858997|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011025|NCT04858997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011026|NCT04858997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011027|NCT05135143|Antioxidants|antioxidants|mesh-list
92011028|NCT05135143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011029|NCT05135143|Protective Agents|protective agents|mesh-ancestor
92011030|NCT05135143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011031|NCT04865653|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92011032|NCT04865653|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92011033|NCT04865653|Hallucinogens|hallucinogens|mesh-ancestor
92011034|NCT04865653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011035|NCT04865653|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92011036|NCT04865653|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92011037|NCT04865653|Serotonin Agents|serotonin agents|mesh-ancestor
92011038|NCT04865653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081677|NCT01392183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011039|NCT04865653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011040|NCT04865653|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92011041|NCT05305183|Alendronate|alendronate|mesh-list
92011042|NCT05305183|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92011043|NCT05305183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011044|NCT01668797|Brexpiprazole|brexpiprazole|mesh-list
92011045|NCT01668797|Serotonin Agents|serotonin agents|mesh-ancestor
92011046|NCT01668797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011047|NCT01668797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011048|NCT01668797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011049|NCT01668797|Dopamine Agonists|dopamine agonists|mesh-ancestor
92011050|NCT01668797|Dopamine Agents|dopamine agents|mesh-ancestor
92011051|NCT05304559|Ketamine|ketamine|mesh-list
92011052|NCT05304559|Esketamine|esketamine|mesh-list
92011053|NCT05304559|Analgesics|analgesics|mesh-ancestor
92011054|NCT05304559|Sensory System Agents|sensory system agents|mesh-ancestor
92011059|NCT05304559|Anesthetics, General|anesthetics, general|mesh-ancestor
92011060|NCT05304559|Anesthetics|anesthetics|mesh-ancestor
92011061|NCT05304559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011062|NCT05304559|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92011063|NCT05304559|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92011064|NCT05304559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011065|NCT05304559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011066|NCT05304559|Antidepressive Agents|antidepressive agents|mesh-ancestor
92011067|NCT05304559|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92011069|NCT02613221|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011070|NCT02613221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011071|NCT05304169|Leuprolide|leuprolide|mesh-list
92011072|NCT05304169|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92011073|NCT05304169|Fertility Agents|fertility agents|mesh-ancestor
92011075|NCT05304169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011076|NCT05304169|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011077|NCT05304169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011078|NCT04858841|Levetiracetam|levetiracetam|mesh-list
92011079|NCT04858841|Anticonvulsants|anticonvulsants|mesh-ancestor
92011080|NCT04858841|Nootropic Agents|nootropic agents|mesh-ancestor
92011081|NCT04858529|Carboplatin|carboplatin|mesh-list
92011082|NCT04858529|Docetaxel|docetaxel|mesh-list
92011083|NCT04858529|Trastuzumab|trastuzumab|mesh-list
92011084|NCT04858529|Pertuzumab|pertuzumab|mesh-list
92011085|NCT04858529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011086|NCT04858529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92011087|NCT04858529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92011088|NCT04858529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92011089|NCT04858529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011090|NCT04858529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011091|NCT05302921|Nivolumab|nivolumab|mesh-list
92011092|NCT05302921|Ipilimumab|ipilimumab|mesh-list
92011093|NCT05302921|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011094|NCT05302921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011095|NCT05302921|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92011096|NCT05302921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011097|NCT04682743|Acetaminophen|acetaminophen|mesh-list
92011098|NCT04682743|Ondansetron|ondansetron|mesh-list
92011099|NCT04682743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011100|NCT04682743|Analgesics|analgesics|mesh-ancestor
92011101|NCT04682743|Sensory System Agents|sensory system agents|mesh-ancestor
92011102|NCT04682743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011103|NCT04682743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011104|NCT04682743|Antipyretics|antipyretics|mesh-ancestor
92011105|NCT04682743|Antiemetics|antiemetics|mesh-ancestor
92011106|NCT04682743|Autonomic Agents|autonomic agents|mesh-ancestor
92011107|NCT04682743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011108|NCT04682743|Antipruritics|antipruritics|mesh-ancestor
92011109|NCT04682743|Dermatologic Agents|dermatologic agents|mesh-ancestor
92011110|NCT04682743|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92011111|NCT04682743|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92011112|NCT04682743|Serotonin Agents|serotonin agents|mesh-ancestor
92011113|NCT04682743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011114|NCT04682743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011115|NCT03472573|Dexamethasone|dexamethasone|mesh-list
92011116|NCT03472573|Palbociclib|palbociclib|mesh-list
92011117|NCT03472573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011118|NCT03472573|Antiemetics|antiemetics|mesh-ancestor
92011119|NCT03472573|Autonomic Agents|autonomic agents|mesh-ancestor
92011120|NCT03472573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011121|NCT03472573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011122|NCT03472573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011123|NCT03472573|Glucocorticoids|glucocorticoids|mesh-ancestor
92011124|NCT03472573|Hormones|hormones|mesh-ancestor
92011125|NCT03472573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011126|NCT03472573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011129|NCT03472573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011130|NCT03472573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011131|NCT04636333|Vaccines|vaccines|mesh-list
92011132|NCT04636333|Immunologic Factors|immunologic factors|mesh-ancestor
92011133|NCT04636333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011134|NCT03103009|Pasireotide|pasireotide|mesh-list
92011135|NCT03103009|Hormones|hormones|mesh-ancestor
92011136|NCT03103009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011137|NCT03103009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011138|NCT03694249|Ifetroban|ifetroban|mesh-list
92011139|NCT03694249|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92011140|NCT03020875|Acetaminophen|acetaminophen|mesh-list
92011141|NCT03020875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011142|NCT03020875|Analgesics|analgesics|mesh-ancestor
92011143|NCT03020875|Sensory System Agents|sensory system agents|mesh-ancestor
92011144|NCT03020875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011145|NCT03020875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011147|NCT02996305|Gaboxadol|gaboxadol|mesh-list
92011148|NCT02996305|Analgesics|analgesics|mesh-ancestor
92011149|NCT02996305|Sensory System Agents|sensory system agents|mesh-ancestor
92011150|NCT02996305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011151|NCT02996305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984696|NCT02533401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011152|NCT02996305|Anticonvulsants|anticonvulsants|mesh-ancestor
92011153|NCT02996305|GABA Agonists|gaba agonists|mesh-ancestor
92011154|NCT02996305|GABA Agents|gaba agents|mesh-ancestor
92011155|NCT02996305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011156|NCT02996305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011157|NCT04866485|Pembrolizumab|pembrolizumab|mesh-list
92011158|NCT04866485|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011159|NCT04866485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011160|NCT04866485|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92011161|NCT04866485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011162|NCT02888041|Dinoprostone|dinoprostone|mesh-list
92011163|NCT02888041|Oxytocics|oxytocics|mesh-ancestor
92011164|NCT02888041|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011165|NCT02888041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011166|NCT02838745|Pemetrexed|pemetrexed|mesh-list
92011167|NCT02838745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011168|NCT02838745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011169|NCT02838745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011170|NCT02838745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92011171|NCT02838745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92011172|NCT00136435|Leucovorin|leucovorin|mesh-list
92011173|NCT00136435|Cytarabine|cytarabine|mesh-list
92011174|NCT00136435|Dexamethasone|dexamethasone|mesh-list
92011175|NCT00136435|Prednisone|prednisone|mesh-list
92011176|NCT00136435|Hydrocortisone|hydrocortisone|mesh-list
92011177|NCT00136435|Doxorubicin|doxorubicin|mesh-list
92011178|NCT00136435|Methotrexate|methotrexate|mesh-list
92011179|NCT00136435|Vincristine|vincristine|mesh-list
92011180|NCT00136435|Asparaginase|asparaginase|mesh-list
92011181|NCT00136435|Mercaptopurine|mercaptopurine|mesh-list
92011182|NCT00136435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011183|NCT00136435|Antiemetics|antiemetics|mesh-ancestor
92011184|NCT00136435|Autonomic Agents|autonomic agents|mesh-ancestor
92011185|NCT00136435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011186|NCT00136435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011187|NCT00136435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011188|NCT00136435|Glucocorticoids|glucocorticoids|mesh-ancestor
92011189|NCT00136435|Hormones|hormones|mesh-ancestor
92011190|NCT00136435|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011191|NCT00136435|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011192|NCT00136435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011193|NCT00136435|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92011194|NCT00136435|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92011195|NCT00136435|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92011196|NCT00136435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011197|NCT00136435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011198|NCT00136435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92011199|NCT00136435|Abortifacient Agents|abortifacient agents|mesh-ancestor
92011208|NCT00136435|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92011209|NCT00136435|Antiviral Agents|antiviral agents|mesh-ancestor
92011210|NCT00136435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011211|NCT00136435|Antidotes|antidotes|mesh-ancestor
92011212|NCT00136435|Protective Agents|protective agents|mesh-ancestor
92011213|NCT00136435|Vitamin B Complex|vitamin b complex|mesh-ancestor
92011214|NCT00136435|Vitamins|vitamins|mesh-ancestor
92011215|NCT00136435|Micronutrients|micronutrients|mesh-ancestor
92011216|NCT00136435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92011217|NCT00136435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92011218|NCT00136435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92011219|NCT00136435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92011220|NCT04864379|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92011221|NCT04864379|Molgramostim|molgramostim|mesh-list
92011222|NCT04864379|Sargramostim|sargramostim|mesh-list
92011223|NCT04864379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011224|NCT04864379|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011225|NCT04864379|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011226|NCT04864379|Immunologic Factors|immunologic factors|mesh-ancestor
92011227|NCT04864379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011233|NCT03044561|Sildenafil Citrate|sildenafil citrate|mesh-list
92011234|NCT03044561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011235|NCT03044561|Vasodilator Agents|vasodilator agents|mesh-ancestor
92011236|NCT03044561|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
91984697|NCT02533401|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984698|NCT02533401|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984699|NCT02533401|Alkylating Agents|alkylating agents|mesh-ancestor
92011237|NCT03044561|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92011238|NCT03044561|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011239|NCT03044561|Urological Agents|urological agents|mesh-ancestor
92011240|NCT02455141|Cyclophosphamide|cyclophosphamide|mesh-list
92011241|NCT02455141|Carboplatin|carboplatin|mesh-list
92011242|NCT02455141|Epirubicin|epirubicin|mesh-list
92011243|NCT02455141|Taxane|taxane|mesh-list
92011244|NCT02455141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011245|NCT02455141|Immunologic Factors|immunologic factors|mesh-ancestor
92011246|NCT02455141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011247|NCT02455141|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011248|NCT02455141|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92011249|NCT02455141|Alkylating Agents|alkylating agents|mesh-ancestor
92011250|NCT02455141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011251|NCT02455141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011252|NCT02455141|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92011253|NCT02455141|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92011254|NCT02455141|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92011255|NCT02455141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92011256|NCT02455141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011257|NCT03044639|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-list
92011258|NCT03044639|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92011259|NCT03044639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92011260|NCT02439385|Curcumin|curcumin|mesh-list
92011261|NCT02439385|Bevacizumab|bevacizumab|mesh-list
92011262|NCT02439385|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011263|NCT02439385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011264|NCT02439385|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92011265|NCT02439385|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92011266|NCT02439385|Growth Substances|growth substances|mesh-ancestor
92011267|NCT02439385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011268|NCT02439385|Growth Inhibitors|growth inhibitors|mesh-ancestor
92011269|NCT02439385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92011270|NCT02439385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011271|NCT02439385|Analgesics|analgesics|mesh-ancestor
92011276|NCT02439385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011277|NCT02439385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011278|NCT03104959|Acetylcysteine|acetylcysteine|mesh-list
92011279|NCT03104959|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92011280|NCT03104959|Antiviral Agents|antiviral agents|mesh-ancestor
92011281|NCT03104959|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011282|NCT03104959|Expectorants|expectorants|mesh-ancestor
92011283|NCT03104959|Respiratory System Agents|respiratory system agents|mesh-ancestor
92011284|NCT03104959|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92011285|NCT03104959|Antioxidants|antioxidants|mesh-ancestor
92011286|NCT03104959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011287|NCT03104959|Protective Agents|protective agents|mesh-ancestor
92011288|NCT03104959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011289|NCT03104959|Antidotes|antidotes|mesh-ancestor
92011290|NCT03044171|Listerine|listerine|mesh-list
92011291|NCT03044171|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92011292|NCT03044171|Fluorides|fluorides|mesh-list
92011293|NCT03044171|Sodium Fluoride|sodium fluoride|mesh-list
92011294|NCT03044171|Cariostatic Agents|cariostatic agents|mesh-ancestor
92011295|NCT03044171|Protective Agents|protective agents|mesh-ancestor
92011296|NCT03044171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011297|NCT03044171|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92011298|NCT03044171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011299|NCT04856969|Dapagliflozin|dapagliflozin|mesh-list
92011300|NCT04856969|Olmesartan|olmesartan|mesh-list
92011301|NCT04856969|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92011302|NCT04856969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011303|NCT04856969|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92011304|NCT04856969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011305|NCT04856969|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92011306|NCT04856969|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92011307|NCT04856969|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92011309|NCT03981211|Antiviral Agents|antiviral agents|mesh-ancestor
92011310|NCT03981211|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011312|NCT04856111|Nintedanib|nintedanib|mesh-list
92011313|NCT04856111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011314|NCT04856111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011315|NCT04856111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011316|NCT04856111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011317|NCT04856111|Analgesics|analgesics|mesh-ancestor
92011318|NCT04856111|Sensory System Agents|sensory system agents|mesh-ancestor
92011319|NCT04856111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011320|NCT04856111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011321|NCT04856111|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92011322|NCT04856111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011323|NCT04856111|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011324|NCT04856111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011325|NCT02053051|Insulin Aspart|insulin aspart|mesh-list
92011326|NCT02053051|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92011327|NCT02053051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011328|NCT01371981|Cytarabine|cytarabine|mesh-list
92011329|NCT01371981|Etoposide|etoposide|mesh-list
92011330|NCT01371981|Podophyllotoxin|podophyllotoxin|mesh-list
92011331|NCT01371981|Daunorubicin|daunorubicin|mesh-list
92011332|NCT01371981|Mitoxantrone|mitoxantrone|mesh-list
92011333|NCT01371981|Etoposide phosphate|etoposide phosphate|mesh-list
92011334|NCT01371981|Bortezomib|bortezomib|mesh-list
92011335|NCT01371981|Sorafenib|sorafenib|mesh-list
92011336|NCT01371981|Asparaginase|asparaginase|mesh-list
92011337|NCT01371981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92011338|NCT01371981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011339|NCT01371981|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92011340|NCT01371981|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92011341|NCT01371981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011342|NCT01371981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011343|NCT01371981|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011346|NCT01371981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011347|NCT01371981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011348|NCT01371981|Immunologic Factors|immunologic factors|mesh-ancestor
92011349|NCT01371981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011350|NCT01371981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011351|NCT01371981|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92011353|NCT01371981|Sensory System Agents|sensory system agents|mesh-ancestor
92011354|NCT01371981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011355|NCT01371981|Keratolytic Agents|keratolytic agents|mesh-ancestor
92011356|NCT01371981|Dermatologic Agents|dermatologic agents|mesh-ancestor
92011357|NCT01371981|Tubulin Modulators|tubulin modulators|mesh-ancestor
92011358|NCT01371981|Antimitotic Agents|antimitotic agents|mesh-ancestor
92011359|NCT01371981|Mitosis Modulators|mitosis modulators|mesh-ancestor
92011360|NCT02845453|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92011361|NCT02845453|Antidepressive Agents|antidepressive agents|mesh-ancestor
92011362|NCT02845453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92011363|NCT02845453|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92011364|NCT02845453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92011365|NCT02845453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011366|NCT02845453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011367|NCT01799629|Glycerol|glycerol|mesh-list
92011368|NCT01799629|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92011369|NCT01799629|Protective Agents|protective agents|mesh-ancestor
92011370|NCT01799629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011371|NCT01597375|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92011372|NCT01597375|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92011373|NCT03044093|Misoprostol|misoprostol|mesh-list
92011374|NCT03044093|Mifepristone|mifepristone|mesh-list
92011375|NCT03044093|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92011376|NCT03044093|Abortifacient Agents|abortifacient agents|mesh-ancestor
92011377|NCT03044093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011378|NCT03044093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011379|NCT03044093|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92011380|NCT03044093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011381|NCT03044093|Oxytocics|oxytocics|mesh-ancestor
92011382|NCT03044093|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92011383|NCT03044093|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92011384|NCT03044093|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92011385|NCT03044093|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
91984700|NCT02533401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984701|NCT02533401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011386|NCT03044093|Contraceptive Agents|contraceptive agents|mesh-ancestor
92011387|NCT03044093|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92011388|NCT03044093|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92011389|NCT03044093|Hormone Antagonists|hormone antagonists|mesh-ancestor
92011390|NCT03044093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011391|NCT03044093|Luteolytic Agents|luteolytic agents|mesh-ancestor
92011392|NCT03044093|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92011393|NCT03044093|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92011394|NCT01553071|Fenretinide|fenretinide|mesh-list
92011396|NCT01553071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011397|NCT01553071|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92011398|NCT01553071|Protective Agents|protective agents|mesh-ancestor
92011399|NCT01553071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011400|NCT01553071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011401|NCT01553071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011402|NCT01506973|Hydroxychloroquine|hydroxychloroquine|mesh-list
92011403|NCT01506973|Gemcitabine|gemcitabine|mesh-list
92011404|NCT01506973|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92011405|NCT01506973|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011406|NCT01506973|Antimetabolites|antimetabolites|mesh-ancestor
92011407|NCT01506973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011408|NCT01506973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011409|NCT01506973|Antimalarials|antimalarials|mesh-ancestor
92011410|NCT01506973|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92011411|NCT01506973|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92011412|NCT01506973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011413|NCT01506973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011414|NCT01506973|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011415|NCT03041207|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92011424|NCT04848467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011426|NCT03104335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011427|NCT03104335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011428|NCT03104335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011429|NCT03104335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011430|NCT04863365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92011431|NCT04863365|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92011432|NCT00484471|Valproic Acid|valproic acid|mesh-list
92011433|NCT00484471|Aripiprazole|aripiprazole|mesh-list
92011434|NCT00484471|Antidepressive Agents|antidepressive agents|mesh-ancestor
92011435|NCT00484471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92011436|NCT00484471|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92011437|NCT00484471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92011438|NCT00484471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011439|NCT00484471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011440|NCT00484471|Dopamine Agonists|dopamine agonists|mesh-ancestor
92011441|NCT00484471|Dopamine Agents|dopamine agents|mesh-ancestor
92011442|NCT00484471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011443|NCT00484471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011444|NCT00484471|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92011445|NCT00484471|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92011446|NCT00484471|Serotonin Agents|serotonin agents|mesh-ancestor
92011447|NCT00484471|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92011448|NCT00484471|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92011449|NCT00484471|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92011450|NCT00484471|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92011451|NCT00484471|Anticonvulsants|anticonvulsants|mesh-ancestor
92011452|NCT00484471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011453|NCT00484471|GABA Agents|gaba agents|mesh-ancestor
92011454|NCT00484471|Antimanic Agents|antimanic agents|mesh-ancestor
92011455|NCT05430841|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92011456|NCT05430841|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92011457|NCT05430841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011458|NCT01746849|Cyclophosphamide|cyclophosphamide|mesh-list
92011459|NCT01746849|Thiotepa|thiotepa|mesh-list
92011460|NCT01746849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011461|NCT01746849|Immunologic Factors|immunologic factors|mesh-ancestor
92011462|NCT01746849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984703|NCT02533401|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011463|NCT01746849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011464|NCT01746849|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92011465|NCT01746849|Alkylating Agents|alkylating agents|mesh-ancestor
92011466|NCT01746849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011467|NCT01746849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011468|NCT01746849|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92011469|NCT04847921|Dalbavancin|dalbavancin|mesh-list
92011470|NCT04847921|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92011471|NCT04847921|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011472|NCT04847687|Methylprednisolone|methylprednisolone|mesh-list
92011473|NCT04847687|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92011474|NCT04847687|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92011475|NCT04847687|Prednisolone|prednisolone|mesh-list
92011476|NCT04847687|Prednisolone acetate|prednisolone acetate|mesh-list
92011477|NCT04847687|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92011478|NCT04847687|Prednisolone phosphate|prednisolone phosphate|mesh-list
92011479|NCT04847687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011480|NCT04847687|Antiemetics|antiemetics|mesh-ancestor
92011481|NCT04847687|Autonomic Agents|autonomic agents|mesh-ancestor
92011482|NCT04847687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011484|NCT04847687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011485|NCT04847687|Glucocorticoids|glucocorticoids|mesh-ancestor
92011486|NCT04847687|Hormones|hormones|mesh-ancestor
92011487|NCT04847687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011488|NCT04847687|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92011489|NCT04847687|Protective Agents|protective agents|mesh-ancestor
92011490|NCT04847687|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011491|NCT04847687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011492|NCT01729455|Belimumab|belimumab|mesh-list
92011493|NCT01729455|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011494|NCT01729455|Immunologic Factors|immunologic factors|mesh-ancestor
92011495|NCT01729455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011496|NCT03103867|Insulin|insulin|mesh-list
92011497|NCT03103867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92011498|NCT03103867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011499|NCT04847375|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92011500|NCT04847375|Respiratory System Agents|respiratory system agents|mesh-ancestor
92011501|NCT04737343|Azathioprine|azathioprine|mesh-list
92011502|NCT04737343|Leflunomide|leflunomide|mesh-list
92011503|NCT04737343|Antimetabolites|antimetabolites|mesh-ancestor
92011504|NCT04737343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011505|NCT04737343|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011506|NCT04737343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011507|NCT04737343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011508|NCT04737343|Immunologic Factors|immunologic factors|mesh-ancestor
92011509|NCT04737343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011510|NCT04737343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011511|NCT04737343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011512|NCT05579769|Cyclosporine|cyclosporine|mesh-list
92011513|NCT05579769|Cyclophosphamide|cyclophosphamide|mesh-list
92011514|NCT05579769|Busulfan|busulfan|mesh-list
92011515|NCT05579769|Thiotepa|thiotepa|mesh-list
92011516|NCT05579769|Methotrexate|methotrexate|mesh-list
92011517|NCT05579769|Fludarabine|fludarabine|mesh-list
92011518|NCT05579769|Cyclosporins|cyclosporins|mesh-list
92011519|NCT05579769|Thymoglobulin|thymoglobulin|mesh-list
92011520|NCT05579769|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92011521|NCT05579769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011522|NCT05579769|Immunologic Factors|immunologic factors|mesh-ancestor
92011523|NCT05579769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011524|NCT05579769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011525|NCT05579769|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92011526|NCT05579769|Alkylating Agents|alkylating agents|mesh-ancestor
92011527|NCT05579769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011528|NCT05579769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011529|NCT05579769|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92011530|NCT05579769|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92011531|NCT05579769|Abortifacient Agents|abortifacient agents|mesh-ancestor
92011532|NCT05579769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011533|NCT05579769|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011534|NCT05579769|Antimetabolites|antimetabolites|mesh-ancestor
91984704|NCT03164837|68Ga-NOTA-RM26|68ga-nota-rm26|mesh-list
91984705|NCT03164837|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984706|NCT03164837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011535|NCT05579769|Dermatologic Agents|dermatologic agents|mesh-ancestor
92011536|NCT05579769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011537|NCT05579769|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92011538|NCT05579769|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92011539|NCT05579769|Antifungal Agents|antifungal agents|mesh-ancestor
92011540|NCT05579769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011541|NCT05579769|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92011542|NCT02609399|Oseltamivir|oseltamivir|mesh-list
92011543|NCT02609399|Peramivir|peramivir|mesh-list
92011544|NCT02609399|Antiviral Agents|antiviral agents|mesh-ancestor
92011545|NCT02609399|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011546|NCT02609399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011547|NCT02609399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011548|NCT05430217|Buspirone|buspirone|mesh-list
92011549|NCT05430217|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92011550|NCT05430217|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92011551|NCT05430217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011552|NCT05430217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011553|NCT05430217|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92011554|NCT05430217|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92011555|NCT05430217|Serotonin Agents|serotonin agents|mesh-ancestor
92011556|NCT05430217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011561|NCT03103555|Immunologic Factors|immunologic factors|mesh-ancestor
92011562|NCT03103555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011563|NCT03103555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011564|NCT03103555|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92011565|NCT03103555|Alkylating Agents|alkylating agents|mesh-ancestor
92011566|NCT03103555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011567|NCT03103555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011568|NCT03103555|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92011569|NCT02720185|Dasatinib|dasatinib|mesh-list
92011570|NCT02720185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011571|NCT02720185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011572|NCT02720185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011573|NCT02720185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011574|NCT04846673|Thioctic Acid|thioctic acid|mesh-list
92011575|NCT04846673|Pregabalin|pregabalin|mesh-list
92011576|NCT04846673|Analgesics|analgesics|mesh-ancestor
92011577|NCT04846673|Sensory System Agents|sensory system agents|mesh-ancestor
92011578|NCT04846673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011579|NCT04846673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011580|NCT04846673|Anticonvulsants|anticonvulsants|mesh-ancestor
92011581|NCT04846673|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92011582|NCT04846673|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92011583|NCT04846673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011584|NCT04846673|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92011585|NCT04846673|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92011586|NCT04846673|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92011587|NCT04846673|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011588|NCT04846673|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92011589|NCT04846673|Antioxidants|antioxidants|mesh-ancestor
92011590|NCT04846673|Protective Agents|protective agents|mesh-ancestor
92011591|NCT04846673|Vitamin B Complex|vitamin b complex|mesh-ancestor
92011592|NCT04846673|Vitamins|vitamins|mesh-ancestor
92011593|NCT04846673|Micronutrients|micronutrients|mesh-ancestor
92011594|NCT04498273|Aspirin|aspirin|mesh-list
92011595|NCT04498273|Apixaban|apixaban|mesh-list
92011596|NCT04498273|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92011597|NCT04498273|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011598|NCT04498273|Analgesics|analgesics|mesh-ancestor
92011599|NCT04498273|Sensory System Agents|sensory system agents|mesh-ancestor
92011600|NCT04498273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011601|NCT04498273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011602|NCT04498273|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011603|NCT04498273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011604|NCT04498273|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92011605|NCT04498273|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92011606|NCT04498273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011607|NCT04498273|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92011608|NCT04498273|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92011609|NCT04498273|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011610|NCT04498273|Antipyretics|antipyretics|mesh-ancestor
92011611|NCT04498273|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92011612|NCT04498273|Antithrombins|antithrombins|mesh-ancestor
92011613|NCT04498273|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92011614|NCT04498273|Protease Inhibitors|protease inhibitors|mesh-ancestor
92011615|NCT04498273|Anticoagulants|anticoagulants|mesh-ancestor
92011616|NCT01660971|Gemcitabine|gemcitabine|mesh-list
92011617|NCT01660971|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92011618|NCT01660971|Dasatinib|dasatinib|mesh-list
92011619|NCT01660971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011620|NCT01660971|Antimetabolites|antimetabolites|mesh-ancestor
92011621|NCT01660971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011622|NCT01660971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011623|NCT01660971|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011624|NCT01660971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011625|NCT04853615|Empagliflozin|empagliflozin|mesh-list
92011626|NCT04853615|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92011629|NCT04853615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011631|NCT05573607|Trace Elements|trace elements|mesh-ancestor
92011632|NCT05573607|Micronutrients|micronutrients|mesh-ancestor
92011633|NCT05573607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011634|NCT04435483|Acalabrutinib|acalabrutinib|mesh-list
92011635|NCT04435483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011636|NCT04862117|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92011637|NCT04862117|Cholinergic Agents|cholinergic agents|mesh-list
92011638|NCT04862117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011639|NCT04862117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011640|NCT04862117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011641|NCT03040817|Esomeprazole|esomeprazole|mesh-list
92011642|NCT03040817|Mosapride|mosapride|mesh-list
92011643|NCT03040817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011644|NCT03040817|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92011645|NCT03040817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92011646|NCT03040817|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92011647|NCT03040817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011648|NCT03040817|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92011649|NCT03040817|Serotonin Agents|serotonin agents|mesh-ancestor
92011650|NCT03040817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011651|NCT03040817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011652|NCT04853069|Estradiol|estradiol|mesh-list
92011653|NCT04853069|Estrogens|estrogens|mesh-ancestor
92011654|NCT04853069|Hormones|hormones|mesh-ancestor
92011655|NCT04853069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011656|NCT04853069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011657|NCT05416125|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92011658|NCT05416125|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92011659|NCT05416125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011660|NCT05416125|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92011661|NCT05416125|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92011662|NCT05416125|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92011663|NCT05416125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011664|NCT05416125|Dopamine Agents|dopamine agents|mesh-ancestor
92011665|NCT05416125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011666|NCT05244811|Contraceptive Agents|contraceptive agents|mesh-list
92011667|NCT05244811|Contraceptives, Oral|contraceptives, oral|mesh-list
92011668|NCT05244811|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92011669|NCT05244811|Progestins|progestins|mesh-list
92011670|NCT05244811|Estradiol|estradiol|mesh-list
92011671|NCT05244811|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011672|NCT05244811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011673|NCT05244811|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92011674|NCT05244811|Hormones|hormones|mesh-ancestor
92011675|NCT05244811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011676|NCT05244811|Estrogens|estrogens|mesh-ancestor
92011677|NCT05395065|Listerine|listerine|mesh-list
92011678|NCT05395065|Fluorides|fluorides|mesh-list
92011679|NCT05395065|Sodium Fluoride|sodium fluoride|mesh-list
92011680|NCT05395065|Fluorides, Topical|fluorides, topical|mesh-list
91984709|NCT05178173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92011681|NCT05395065|Cariostatic Agents|cariostatic agents|mesh-ancestor
92011682|NCT05395065|Protective Agents|protective agents|mesh-ancestor
92011683|NCT05395065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011684|NCT05395065|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92011685|NCT05395065|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011686|NCT02710669|Propafenone|propafenone|mesh-list
92011687|NCT02710669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92011688|NCT02710669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92011689|NCT02710669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92011690|NCT02710669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92011691|NCT02710669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011692|NCT05392959|Dapagliflozin|dapagliflozin|mesh-list
92011693|NCT05392959|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92011694|NCT05392959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011695|NCT05392959|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92011696|NCT05392959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011697|NCT04851977|Vaccines|vaccines|mesh-list
92011702|NCT05370417|Fluorides|fluorides|mesh-list
92011703|NCT05370417|Cariostatic Agents|cariostatic agents|mesh-ancestor
92011704|NCT05370417|Protective Agents|protective agents|mesh-ancestor
92011705|NCT05370417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011706|NCT05369793|Thioctic Acid|thioctic acid|mesh-list
92011707|NCT05369793|Antioxidants|antioxidants|mesh-ancestor
92011708|NCT05369793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011709|NCT05369793|Protective Agents|protective agents|mesh-ancestor
92011710|NCT05369793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011711|NCT05369793|Vitamin B Complex|vitamin b complex|mesh-ancestor
92011712|NCT05369793|Vitamins|vitamins|mesh-ancestor
92011713|NCT05369793|Micronutrients|micronutrients|mesh-ancestor
92011714|NCT04844333|Anesthetics|anesthetics|mesh-list
92011715|NCT04844333|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011716|NCT04844333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011717|NCT04423185|Atezolizumab|atezolizumab|mesh-list
92011718|NCT04423185|Imatinib Mesylate|imatinib mesylate|mesh-list
92011719|NCT04423185|Palbociclib|palbociclib|mesh-list
92011720|NCT04423185|Niraparib|niraparib|mesh-list
92011721|NCT04423185|Vemurafenib|vemurafenib|mesh-list
92011722|NCT04423185|Crizotinib|crizotinib|mesh-list
92011723|NCT04423185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92011724|NCT04423185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011725|NCT04423185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011726|NCT04423185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011727|NCT04423185|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011728|NCT04423185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011729|NCT04423185|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92011730|NCT05414877|Phenylephrine|phenylephrine|mesh-list
92011731|NCT05414877|Oxymetazoline|oxymetazoline|mesh-list
92011732|NCT05414877|Norepinephrine|norepinephrine|mesh-list
92011733|NCT05414877|Ephedrine|ephedrine|mesh-list
92011734|NCT05414877|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92011735|NCT05414877|Mydriatics|mydriatics|mesh-ancestor
92011736|NCT05414877|Autonomic Agents|autonomic agents|mesh-ancestor
92011737|NCT05414877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011738|NCT05414877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011739|NCT05414877|Sympathomimetics|sympathomimetics|mesh-ancestor
92011740|NCT05414877|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92011741|NCT05414877|Nasal Decongestants|nasal decongestants|mesh-ancestor
92011742|NCT05414877|Respiratory System Agents|respiratory system agents|mesh-ancestor
92011743|NCT05414877|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92011744|NCT05414877|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92011745|NCT05414877|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92011746|NCT05414877|Adrenergic Agents|adrenergic agents|mesh-ancestor
92011747|NCT05414877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011748|NCT05414877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011749|NCT05414877|Protective Agents|protective agents|mesh-ancestor
92011750|NCT05414877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92011752|NCT04850885|Lidocaine|lidocaine|mesh-list
92011753|NCT04850885|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011754|NCT04850885|Antiemetics|antiemetics|mesh-ancestor
92011755|NCT04850885|Autonomic Agents|autonomic agents|mesh-ancestor
92011756|NCT04850885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011757|NCT04850885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011758|NCT04850885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984710|NCT05178173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984711|NCT05178173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984712|NCT05178173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011759|NCT04850885|Glucocorticoids|glucocorticoids|mesh-ancestor
92011760|NCT04850885|Hormones|hormones|mesh-ancestor
92011761|NCT04850885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011762|NCT04850885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011763|NCT04850885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011764|NCT04850885|Anesthetics, Local|anesthetics, local|mesh-ancestor
92011765|NCT04850885|Anesthetics|anesthetics|mesh-ancestor
92011766|NCT04850885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011767|NCT04850885|Sensory System Agents|sensory system agents|mesh-ancestor
92011768|NCT04850885|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92011769|NCT04850885|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92011770|NCT04850885|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92011779|NCT04850417|Sensory System Agents|sensory system agents|mesh-ancestor
92011780|NCT04850417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011781|NCT04850417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011782|NCT04850417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011783|NCT04850417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011784|NCT04850417|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92011785|NCT04850417|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92011786|NCT04850417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011787|NCT04850417|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92011788|NCT04850417|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92011789|NCT04850417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011790|NCT04850417|Antipyretics|antipyretics|mesh-ancestor
92011791|NCT04850417|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92011792|NCT04850417|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92011793|NCT04850417|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92011794|NCT04850417|Purinergic Agents|purinergic agents|mesh-ancestor
92011795|NCT04850417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011796|NCT04850417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92011797|NCT04850417|Adrenergic Agents|adrenergic agents|mesh-ancestor
92011798|NCT04843943|Bevacizumab|bevacizumab|mesh-list
92011799|NCT04843943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011800|NCT04843943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011801|NCT04843943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92011802|NCT04843943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92011803|NCT04843943|Growth Substances|growth substances|mesh-ancestor
92011804|NCT04843943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011805|NCT04843943|Growth Inhibitors|growth inhibitors|mesh-ancestor
92011806|NCT04850261|Nafarelin|nafarelin|mesh-list
92011807|NCT04850261|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92011808|NCT04850261|Fertility Agents|fertility agents|mesh-ancestor
92011809|NCT04850261|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011810|NCT04850261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011811|NCT04843553|Niacinamide|niacinamide|mesh-list
92011812|NCT04843553|Niacin|niacin|mesh-list
92011813|NCT04843553|Nicotinic Acids|nicotinic acids|mesh-list
92011814|NCT04843553|Vitamins|vitamins|mesh-ancestor
92011815|NCT04843553|Micronutrients|micronutrients|mesh-ancestor
92011816|NCT04843553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011817|NCT04843553|Vitamin B Complex|vitamin b complex|mesh-ancestor
92011818|NCT04843553|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92011820|NCT04843553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011821|NCT04843553|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92011822|NCT04843553|Vasodilator Agents|vasodilator agents|mesh-ancestor
92011823|NCT02684461|Paclitaxel|paclitaxel|mesh-list
92011824|NCT02684461|Pembrolizumab|pembrolizumab|mesh-list
92011825|NCT02684461|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92011826|NCT02684461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011827|NCT02684461|Tubulin Modulators|tubulin modulators|mesh-ancestor
92011828|NCT02684461|Antimitotic Agents|antimitotic agents|mesh-ancestor
92011829|NCT02684461|Mitosis Modulators|mitosis modulators|mesh-ancestor
92011830|NCT02684461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011831|NCT02684461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92011832|NCT02684461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92011833|NCT03040193|Lidocaine|lidocaine|mesh-list
91984714|NCT02536833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984715|NCT02680847|Naltrexone|naltrexone|mesh-list
91984716|NCT02680847|Oxycodone|oxycodone|mesh-list
92011834|NCT03040193|Anesthetics, Local|anesthetics, local|mesh-ancestor
92011835|NCT03040193|Anesthetics|anesthetics|mesh-ancestor
92011836|NCT03040193|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013328|NCT05016349|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013329|NCT05016349|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92013330|NCT05016349|Abortifacient Agents|abortifacient agents|mesh-ancestor
92013331|NCT05016349|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92013332|NCT05016349|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92013333|NCT05016349|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92013334|NCT05016349|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92013335|NCT05016349|Contraceptive Agents|contraceptive agents|mesh-ancestor
92013336|NCT05016349|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92013337|NCT05016349|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92013338|NCT05016349|Luteolytic Agents|luteolytic agents|mesh-ancestor
92013697|NCT05554419|Venetoclax|venetoclax|mesh-list
92018871|NCT02419755|Doxorubicin|doxorubicin|mesh-list
92013698|NCT05554419|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92013699|NCT05554419|Antimetabolites|antimetabolites|mesh-ancestor
92013700|NCT05554419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013701|NCT05554419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013853|NCT04998253|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92013855|NCT02638129|Bupropion|bupropion|mesh-list
92013856|NCT02638129|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92013857|NCT02638129|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92013858|NCT02638129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013859|NCT02638129|Sensory System Agents|sensory system agents|mesh-ancestor
92013860|NCT02638129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013861|NCT02638129|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92013862|NCT02638129|Antidepressive Agents|antidepressive agents|mesh-ancestor
92013863|NCT02638129|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92013864|NCT02638129|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92013865|NCT02638129|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92013866|NCT02638129|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92013867|NCT02638129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013868|NCT02638129|Dopamine Agents|dopamine agents|mesh-ancestor
92013869|NCT02638129|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013870|NCT02638129|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92013871|NCT02638129|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92013872|NCT02638129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013873|NCT02524275|Docetaxel|docetaxel|mesh-list
92013874|NCT02524275|Capecitabine|capecitabine|mesh-list
92013875|NCT02524275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013876|NCT02524275|Tubulin Modulators|tubulin modulators|mesh-ancestor
92013877|NCT02524275|Antimitotic Agents|antimitotic agents|mesh-ancestor
92013878|NCT02524275|Mitosis Modulators|mitosis modulators|mesh-ancestor
92013879|NCT02524275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018753|NCT02436759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018754|NCT02436759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018755|NCT02436759|Sympathomimetics|sympathomimetics|mesh-ancestor
92018756|NCT02436759|Autonomic Agents|autonomic agents|mesh-ancestor
92018757|NCT02436759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018758|NCT02436759|Nasal Decongestants|nasal decongestants|mesh-ancestor
92018759|NCT02436759|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92018760|NCT02436759|Respiratory System Agents|respiratory system agents|mesh-ancestor
92018761|NCT02436759|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92018762|NCT02436759|Mydriatics|mydriatics|mesh-ancestor
92018763|NCT02436759|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92018764|NCT02436759|Protective Agents|protective agents|mesh-ancestor
92018765|NCT04888741|Cyclosporine|cyclosporine|mesh-list
92018766|NCT04888741|Sirolimus|sirolimus|mesh-list
92018767|NCT04888741|Mycophenolic Acid|mycophenolic acid|mesh-list
92018768|NCT04888741|Cyclophosphamide|cyclophosphamide|mesh-list
92018769|NCT04888741|Cyclosporins|cyclosporins|mesh-list
92018770|NCT04888741|Thymoglobulin|thymoglobulin|mesh-list
92018771|NCT04888741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018772|NCT04888741|Immunologic Factors|immunologic factors|mesh-ancestor
92018773|NCT04888741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018774|NCT04888741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984717|NCT02680847|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91984718|NCT02680847|Narcotics|narcotics|mesh-ancestor
92018775|NCT04888741|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92018776|NCT04888741|Alkylating Agents|alkylating agents|mesh-ancestor
92018777|NCT04888741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018778|NCT04888741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018779|NCT04888741|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92018780|NCT04888741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018781|NCT04888741|Antifungal Agents|antifungal agents|mesh-ancestor
92018782|NCT04888741|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018783|NCT04888741|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018784|NCT04888741|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92018785|NCT04888741|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92018786|NCT04888741|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92018787|NCT04888741|Antitubercular Agents|antitubercular agents|mesh-ancestor
92018788|NCT04888741|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92018790|NCT04888819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018791|NCT04904185|Cyclophosphamide|cyclophosphamide|mesh-list
92018792|NCT04904185|Pembrolizumab|pembrolizumab|mesh-list
92018793|NCT04904185|Fludarabine|fludarabine|mesh-list
92018794|NCT04904185|Fludarabine phosphate|fludarabine phosphate|mesh-list
92018795|NCT04904185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018796|NCT04904185|Immunologic Factors|immunologic factors|mesh-ancestor
92018797|NCT04904185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018798|NCT04904185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92018799|NCT04904185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92018800|NCT04904185|Alkylating Agents|alkylating agents|mesh-ancestor
92018801|NCT04904185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018802|NCT04904185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018803|NCT04904185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92018804|NCT04904185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018805|NCT04904185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92018806|NCT04904185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018807|NCT04904185|Antimetabolites|antimetabolites|mesh-ancestor
92018808|NCT04887961|Trabectedin|trabectedin|mesh-list
92018809|NCT04887961|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92018810|NCT04887961|Alkylating Agents|alkylating agents|mesh-ancestor
92018811|NCT04887961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018812|NCT04887961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018813|NCT04887649|Morphine|morphine|mesh-list
92018814|NCT04887649|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92018815|NCT04887649|Narcotics|narcotics|mesh-ancestor
92018816|NCT04887649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018817|NCT04887649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018818|NCT04887649|Analgesics|analgesics|mesh-ancestor
92018819|NCT04887649|Sensory System Agents|sensory system agents|mesh-ancestor
92018820|NCT04887649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018821|NCT03050437|Pemetrexed|pemetrexed|mesh-list
92018822|NCT03050437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018823|NCT03050437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018824|NCT03050437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018829|NCT02436135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018830|NCT02436135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018831|NCT04917861|Vaccines|vaccines|mesh-list
92018832|NCT04917861|Immunologic Factors|immunologic factors|mesh-ancestor
92018833|NCT04917861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018834|NCT02435277|Metformin|metformin|mesh-list
92018835|NCT02435277|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92018836|NCT02435277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018837|NCT02420223|Propranolol|propranolol|mesh-list
92018838|NCT02420223|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92018839|NCT02420223|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92018840|NCT02420223|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018841|NCT02420223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018842|NCT02420223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018843|NCT02420223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018844|NCT02420223|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92018845|NCT02420223|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92018846|NCT02420223|Vasodilator Agents|vasodilator agents|mesh-ancestor
92018847|NCT02433483|Cytarabine|cytarabine|mesh-list
92018848|NCT02433483|Hydrocortisone|hydrocortisone|mesh-list
91984719|NCT02680847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984720|NCT02680847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984721|NCT02680847|Analgesics|analgesics|mesh-ancestor
91984722|NCT02680847|Sensory System Agents|sensory system agents|mesh-ancestor
92090422|NCT04416035|Bevacizumab|bevacizumab|mesh-list
92018849|NCT02433483|Methotrexate|methotrexate|mesh-list
92018850|NCT02433483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92018851|NCT02433483|Abortifacient Agents|abortifacient agents|mesh-ancestor
92018852|NCT02433483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018853|NCT02433483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018854|NCT02433483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018855|NCT02433483|Antimetabolites|antimetabolites|mesh-ancestor
92018856|NCT02433483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018857|NCT02433483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018858|NCT02433483|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018859|NCT02433483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018860|NCT02433483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92018861|NCT02433483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018862|NCT02433483|Immunologic Factors|immunologic factors|mesh-ancestor
92018863|NCT02433483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92018864|NCT02433483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92018865|NCT02433483|Antiviral Agents|antiviral agents|mesh-ancestor
92018866|NCT02433483|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018867|NCT02433483|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018868|NCT02419755|Cytarabine|cytarabine|mesh-list
92018869|NCT02419755|Dexamethasone|dexamethasone|mesh-list
92018870|NCT02419755|Hydrocortisone|hydrocortisone|mesh-list
92018872|NCT02419755|Methotrexate|methotrexate|mesh-list
92018873|NCT02419755|Bortezomib|bortezomib|mesh-list
92018874|NCT02419755|Asparaginase|asparaginase|mesh-list
92018875|NCT02419755|Mitoxantrone|mitoxantrone|mesh-list
92018876|NCT02419755|Mercaptopurine|mercaptopurine|mesh-list
92018877|NCT02419755|Vorinostat|vorinostat|mesh-list
92018878|NCT02419755|Pegaspargase|pegaspargase|mesh-list
92018879|NCT02419755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018880|NCT02419755|Antiemetics|antiemetics|mesh-ancestor
92018881|NCT02419755|Autonomic Agents|autonomic agents|mesh-ancestor
92018882|NCT02419755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018883|NCT02419755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018884|NCT02419755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018885|NCT02419755|Glucocorticoids|glucocorticoids|mesh-ancestor
92018886|NCT02419755|Hormones|hormones|mesh-ancestor
92018887|NCT02419755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018888|NCT02419755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92018889|NCT02419755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018890|NCT02419755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92018891|NCT02419755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92018892|NCT02419755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92018893|NCT02419755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018894|NCT02419755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018895|NCT02419755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92018896|NCT02419755|Abortifacient Agents|abortifacient agents|mesh-ancestor
92018903|NCT02419755|Immunologic Factors|immunologic factors|mesh-ancestor
92018904|NCT02419755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92018905|NCT02419755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92018906|NCT02419755|Antiviral Agents|antiviral agents|mesh-ancestor
92018907|NCT02419755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018908|NCT02419755|Analgesics|analgesics|mesh-ancestor
92018909|NCT02419755|Sensory System Agents|sensory system agents|mesh-ancestor
92018910|NCT02419755|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92018911|NCT04914195|Leuprolide|leuprolide|mesh-list
92018912|NCT04914195|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92018913|NCT04914195|Fertility Agents|fertility agents|mesh-ancestor
92018914|NCT04914195|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018915|NCT04914195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018916|NCT04914195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92018917|NCT04914195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018918|NCT04913025|Pembrolizumab|pembrolizumab|mesh-list
92018919|NCT04913025|Nivolumab|nivolumab|mesh-list
92018920|NCT04913025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984723|NCT02680847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984725|NCT02680847|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91984726|NCT03959241|Mycophenolic Acid|mycophenolic acid|mesh-list
92018921|NCT04913025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018922|NCT04913025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92018923|NCT04913025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018925|NCT04898101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018926|NCT02432703|JNJ-42165279|jnj-42165279|mesh-list
92018927|NCT02432703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018928|NCT02432703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018929|NCT04887493|Alprostadil|alprostadil|mesh-list
92018930|NCT04887493|Misoprostol|misoprostol|mesh-list
92018931|NCT04887493|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92018932|NCT04887493|Abortifacient Agents|abortifacient agents|mesh-ancestor
92018933|NCT04887493|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018934|NCT04887493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018935|NCT04887493|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92018936|NCT04887493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018937|NCT04887493|Oxytocics|oxytocics|mesh-ancestor
92018938|NCT04887493|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92018939|NCT04887493|Vasodilator Agents|vasodilator agents|mesh-ancestor
92018940|NCT04887493|Urological Agents|urological agents|mesh-ancestor
92018941|NCT02486757|Estradiol|estradiol|mesh-list
92018942|NCT02486757|Progesterone|progesterone|mesh-list
92018943|NCT02486757|Estrogens|estrogens|mesh-ancestor
92018944|NCT02486757|Hormones|hormones|mesh-ancestor
92018945|NCT02486757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018946|NCT02486757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018947|NCT02486757|Progestins|progestins|mesh-ancestor
92018948|NCT04883203|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92018949|NCT04883203|Plasma-lyte 148|plasma-lyte 148|mesh-list
92018950|NCT04883203|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92018951|NCT03051529|Anesthetics|anesthetics|mesh-list
92018952|NCT03051529|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018953|NCT03051529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018954|NCT04886869|Caffeine|caffeine|mesh-list
92018955|NCT04886869|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92018956|NCT04886869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018957|NCT04886869|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92018958|NCT04886869|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018959|NCT04886869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018960|NCT04886869|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92018961|NCT04886869|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92018962|NCT04886869|Purinergic Agents|purinergic agents|mesh-ancestor
92018963|NCT04886869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018964|NCT04897477|Azacitidine|azacitidine|mesh-list
92018965|NCT04897477|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92018972|NCT04897477|Alkylating Agents|alkylating agents|mesh-ancestor
92018973|NCT04882813|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92018974|NCT04882813|Dapagliflozin|dapagliflozin|mesh-list
92018975|NCT04882813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92018976|NCT04882813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018977|NCT04882813|Incretins|incretins|mesh-ancestor
92018979|NCT04882813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018980|NCT04882813|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92018981|NCT04882813|Protease Inhibitors|protease inhibitors|mesh-ancestor
92018982|NCT04882813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018983|NCT04882813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018984|NCT04882813|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92018986|NCT02576639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018987|NCT02576639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018988|NCT02418585|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92018989|NCT02418585|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92018990|NCT02418585|Sertraline|sertraline|mesh-list
92018991|NCT02418585|Antidepressive Agents|antidepressive agents|mesh-list
92018992|NCT02418585|Esketamine|esketamine|mesh-list
92018993|NCT02418585|Escitalopram|escitalopram|mesh-list
91984727|NCT03959241|Cyclophosphamide|cyclophosphamide|mesh-list
91984728|NCT03959241|Methotrexate|methotrexate|mesh-list
91984729|NCT03959241|Tacrolimus|tacrolimus|mesh-list
92018994|NCT02418585|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92018995|NCT02418585|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92018996|NCT02418585|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018997|NCT02418585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018998|NCT02418585|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018999|NCT02418585|Serotonin Agents|serotonin agents|mesh-ancestor
92019000|NCT02418585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019001|NCT02418585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019002|NCT02418585|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92019003|NCT02418585|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92019004|NCT02418585|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92019005|NCT02418585|Analgesics|analgesics|mesh-ancestor
92019006|NCT02418585|Sensory System Agents|sensory system agents|mesh-ancestor
92019007|NCT02418585|Dopamine Agents|dopamine agents|mesh-ancestor
92019008|NCT05529875|Propofol|propofol|mesh-list
92019009|NCT05529875|Sevoflurane|sevoflurane|mesh-list
92019010|NCT05529875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92019011|NCT05529875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019012|NCT05529875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019013|NCT05529875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92019014|NCT05529875|Anesthetics, General|anesthetics, general|mesh-ancestor
92019015|NCT05529875|Anesthetics|anesthetics|mesh-ancestor
92019016|NCT05529875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92019017|NCT05529875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92019018|NCT03051451|Metformin|metformin|mesh-list
92019019|NCT03051451|Fluoxetine|fluoxetine|mesh-list
92019020|NCT03051451|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92019021|NCT03051451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019022|NCT03051451|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92019023|NCT03051451|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92019024|NCT03051451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019025|NCT03051451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019026|NCT03051451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019027|NCT03051451|Serotonin Agents|serotonin agents|mesh-ancestor
92019028|NCT03051451|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92019029|NCT03051451|Antidepressive Agents|antidepressive agents|mesh-ancestor
92019030|NCT03051451|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92019031|NCT03051451|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92019036|NCT02417961|Respiratory System Agents|respiratory system agents|mesh-ancestor
92019037|NCT02869217|Cyclophosphamide|cyclophosphamide|mesh-list
92019038|NCT02869217|Fludarabine|fludarabine|mesh-list
92019039|NCT02869217|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019040|NCT02869217|Immunologic Factors|immunologic factors|mesh-ancestor
92019041|NCT02869217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019042|NCT02869217|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019043|NCT02869217|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019044|NCT02869217|Alkylating Agents|alkylating agents|mesh-ancestor
92019045|NCT02869217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019046|NCT02869217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019047|NCT02869217|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92019048|NCT04883125|Pioglitazone|pioglitazone|mesh-list
92019049|NCT04883125|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92019050|NCT04883125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019051|NCT05474183|Dexmedetomidine|dexmedetomidine|mesh-list
92019053|NCT05474183|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92019054|NCT05474183|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019055|NCT05474183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019056|NCT05474183|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019057|NCT05474183|Analgesics|analgesics|mesh-ancestor
92019058|NCT05474183|Sensory System Agents|sensory system agents|mesh-ancestor
92019059|NCT05474183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019060|NCT05474183|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92019061|NCT05474183|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92019062|NCT05474183|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92019063|NCT05474183|Adrenergic Agents|adrenergic agents|mesh-ancestor
92019064|NCT05474183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019065|NCT05474183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984730|NCT03959241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984731|NCT03959241|Immunologic Factors|immunologic factors|mesh-ancestor
91984732|NCT03959241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984733|NCT03959241|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019066|NCT05474183|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92019067|NCT05474183|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92019068|NCT05474183|Anesthetics, General|anesthetics, general|mesh-ancestor
92019069|NCT05474183|Anesthetics|anesthetics|mesh-ancestor
92019070|NCT05474183|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92019071|NCT05474183|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92019072|NCT04885777|Lidocaine|lidocaine|mesh-list
92019073|NCT04885777|Anesthetics, Local|anesthetics, local|mesh-ancestor
92019074|NCT04885777|Anesthetics|anesthetics|mesh-ancestor
92019075|NCT04885777|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019076|NCT04885777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019077|NCT04885777|Sensory System Agents|sensory system agents|mesh-ancestor
92019078|NCT04885777|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019079|NCT04885777|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92019080|NCT04885777|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92019081|NCT04885777|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92019082|NCT04885777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019083|NCT04885777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019084|NCT04885855|Sofosbuvir|sofosbuvir|mesh-list
92019085|NCT04885855|Antiviral Agents|antiviral agents|mesh-ancestor
92019086|NCT04885855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019087|NCT02632721|Decitabine|decitabine|mesh-list
92019088|NCT02632721|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019089|NCT02632721|Antimetabolites|antimetabolites|mesh-ancestor
92019090|NCT02632721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019091|NCT02632721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019092|NCT02632721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019093|NCT05529095|Apomorphine|apomorphine|mesh-list
92019094|NCT05529095|Emetics|emetics|mesh-ancestor
92019095|NCT05529095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019096|NCT05529095|Autonomic Agents|autonomic agents|mesh-ancestor
92019097|NCT05529095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019098|NCT05529095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019099|NCT05529095|Dopamine Agonists|dopamine agonists|mesh-ancestor
92019100|NCT05529095|Dopamine Agents|dopamine agents|mesh-ancestor
92019101|NCT05529095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019102|NCT05529095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019104|NCT01596127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019105|NCT01596127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019106|NCT01596127|Immunologic Factors|immunologic factors|mesh-ancestor
92019107|NCT01596127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019108|NCT01596127|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019109|NCT03051373|Paclitaxel|paclitaxel|mesh-list
92019110|NCT03051373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92019111|NCT03051373|Gemcitabine|gemcitabine|mesh-list
92019112|NCT03051373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019113|NCT03051373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019114|NCT03051373|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019115|NCT03051373|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019116|NCT03051373|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019117|NCT03051373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019118|NCT03051373|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019119|NCT03051373|Antimetabolites|antimetabolites|mesh-ancestor
92019120|NCT04895059|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92019121|NCT04895059|Ezetimibe|ezetimibe|mesh-list
92019122|NCT04895059|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92019123|NCT04895059|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92019124|NCT04895059|Antimetabolites|antimetabolites|mesh-ancestor
92019125|NCT04895059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019126|NCT04895059|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92019127|NCT04895059|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92019128|NCT04895059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019129|NCT05467475|Esomeprazole|esomeprazole|mesh-list
92019130|NCT05467475|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92019131|NCT05467475|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019132|NCT05467475|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91984734|NCT03959241|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019133|NCT05467475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019134|NCT05467475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019135|NCT05534165|Tecovirimat|tecovirimat|mesh-list
92019136|NCT05534165|Antiviral Agents|antiviral agents|mesh-ancestor
92019137|NCT05534165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019138|NCT01595581|Methyltestosterone|methyltestosterone|mesh-list
92019139|NCT01595581|Testosterone|testosterone|mesh-list
92019140|NCT01595581|Testosterone undecanoate|testosterone undecanoate|mesh-list
92019141|NCT01595581|Testosterone enanthate|testosterone enanthate|mesh-list
92019142|NCT01595581|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92019143|NCT01595581|Androgens|androgens|mesh-ancestor
92019144|NCT01595581|Hormones|hormones|mesh-ancestor
92019145|NCT01595581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019146|NCT01595581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019147|NCT01595581|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92019148|NCT01595581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019149|NCT01595581|Anabolic Agents|anabolic agents|mesh-ancestor
92019150|NCT04885153|Fenofibrate|fenofibrate|mesh-list
92019151|NCT04885153|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92019152|NCT04885153|Antimetabolites|antimetabolites|mesh-ancestor
92019153|NCT04885153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019154|NCT04885153|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92019155|NCT03048643|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92019156|NCT03048643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019157|NCT04884997|Temozolomide|temozolomide|mesh-list
92019158|NCT04884997|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019159|NCT04884997|Alkylating Agents|alkylating agents|mesh-ancestor
92019160|NCT04884997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019161|NCT04884997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019162|NCT04885075|Midazolam|midazolam|mesh-list
92019163|NCT04885075|Diazepam|diazepam|mesh-list
92019164|NCT04885075|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92019165|NCT04885075|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92019166|NCT04885075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019167|NCT04885075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019168|NCT04885075|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92019169|NCT04885075|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92019170|NCT04885075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92019171|NCT04885075|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92019172|NCT04885075|Anesthetics, General|anesthetics, general|mesh-ancestor
92019173|NCT04885075|Anesthetics|anesthetics|mesh-ancestor
92019174|NCT04885075|GABA Modulators|gaba modulators|mesh-ancestor
92019175|NCT04885075|GABA Agents|gaba agents|mesh-ancestor
92019176|NCT04885075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019185|NCT01610687|Nabiximols|nabiximols|mesh-list
92019186|NCT01610687|Analgesics|analgesics|mesh-ancestor
92019187|NCT01610687|Sensory System Agents|sensory system agents|mesh-ancestor
92019188|NCT01610687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019189|NCT01610687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019190|NCT04884919|Chitosan|chitosan|mesh-list
92019191|NCT04884919|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92019192|NCT04884919|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92019193|NCT04884919|Antimetabolites|antimetabolites|mesh-ancestor
92019194|NCT04884919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019195|NCT04884919|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92019196|NCT04884919|Chelating Agents|chelating agents|mesh-ancestor
92019197|NCT04884919|Sequestering Agents|sequestering agents|mesh-ancestor
92019198|NCT04884919|Hemostatics|hemostatics|mesh-ancestor
92019199|NCT04884919|Coagulants|coagulants|mesh-ancestor
92019200|NCT04878835|Ranibizumab|ranibizumab|mesh-list
92019201|NCT04878835|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019202|NCT04878835|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92019203|NCT04878835|Growth Substances|growth substances|mesh-ancestor
92019204|NCT04878835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019205|NCT04878835|Growth Inhibitors|growth inhibitors|mesh-ancestor
92019206|NCT04878835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019207|NCT04872283|Aspirin|aspirin|mesh-list
92019208|NCT04872283|Acetaminophen|acetaminophen|mesh-list
92019209|NCT04872283|Ketorolac|ketorolac|mesh-list
92019210|NCT04872283|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92019211|NCT04872283|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92019212|NCT04872283|Oxycodone|oxycodone|mesh-list
92019213|NCT04872283|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92019214|NCT04872283|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019215|NCT04872283|Analgesics|analgesics|mesh-ancestor
91984735|NCT03959241|Alkylating Agents|alkylating agents|mesh-ancestor
91984736|NCT03959241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984737|NCT03959241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019216|NCT04872283|Sensory System Agents|sensory system agents|mesh-ancestor
92019217|NCT04872283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019218|NCT04872283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019219|NCT04872283|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019220|NCT04872283|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019221|NCT04872283|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92019222|NCT04872283|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92019223|NCT04872283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019224|NCT04872283|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92019225|NCT04872283|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92019226|NCT04872283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019228|NCT04872283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92019229|NCT04872283|Narcotics|narcotics|mesh-ancestor
92019230|NCT04872283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019231|NCT05182385|Venetoclax|venetoclax|mesh-list
92019232|NCT05182385|Blinatumomab|blinatumomab|mesh-list
92019233|NCT05182385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019234|NCT05533619|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92019235|NCT05533619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019236|NCT05533619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019237|NCT04389073|Cyclophosphamide|cyclophosphamide|mesh-list
92019238|NCT04389073|Bevacizumab|bevacizumab|mesh-list
92019239|NCT04389073|Capecitabine|capecitabine|mesh-list
92019240|NCT04389073|Vinorelbine|vinorelbine|mesh-list
92019241|NCT04389073|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019242|NCT04389073|Immunologic Factors|immunologic factors|mesh-ancestor
92019243|NCT04389073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019244|NCT04389073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019245|NCT04389073|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019248|NCT04389073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019249|NCT04389073|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92019250|NCT04389073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019251|NCT04389073|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019252|NCT04389073|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92019253|NCT04389073|Growth Substances|growth substances|mesh-ancestor
92019254|NCT04389073|Growth Inhibitors|growth inhibitors|mesh-ancestor
92019255|NCT04389073|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019256|NCT04389073|Antimetabolites|antimetabolites|mesh-ancestor
92019257|NCT04389073|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019258|NCT04389073|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019259|NCT04389073|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019260|NCT04389073|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019261|NCT04371445|Dexamethasone|dexamethasone|mesh-list
92019262|NCT04371445|Prednisolone|prednisolone|mesh-list
92019263|NCT04371445|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92019264|NCT04371445|Methylprednisolone|methylprednisolone|mesh-list
92019265|NCT04371445|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92019266|NCT04371445|Prednisolone acetate|prednisolone acetate|mesh-list
92019267|NCT04371445|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92019268|NCT04371445|Prednisolone phosphate|prednisolone phosphate|mesh-list
92019269|NCT04371445|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019270|NCT04371445|Antiemetics|antiemetics|mesh-ancestor
92019271|NCT04371445|Autonomic Agents|autonomic agents|mesh-ancestor
92019272|NCT04371445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019273|NCT04371445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019274|NCT04371445|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019275|NCT04371445|Glucocorticoids|glucocorticoids|mesh-ancestor
92019276|NCT04371445|Hormones|hormones|mesh-ancestor
92019277|NCT04371445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019278|NCT04371445|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92019279|NCT04371445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019280|NCT04371445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92019281|NCT04371445|Protective Agents|protective agents|mesh-ancestor
92019282|NCT03049267|Apremilast|apremilast|mesh-list
92019283|NCT03049267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92019284|NCT03049267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019285|NCT03049267|Analgesics|analgesics|mesh-ancestor
91984738|NCT03959241|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91984739|NCT03959241|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91984740|NCT03959241|Abortifacient Agents|abortifacient agents|mesh-ancestor
91984741|NCT03959241|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91984742|NCT03959241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91984743|NCT03959241|Antimetabolites|antimetabolites|mesh-ancestor
92019286|NCT03049267|Sensory System Agents|sensory system agents|mesh-ancestor
92019287|NCT03049267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019288|NCT03049267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019289|NCT03049267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019290|NCT03049267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019291|NCT03049267|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92019292|NCT03049267|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92019293|NCT03049267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019294|NCT03049267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019295|NCT05524259|Folic Acid|folic acid|mesh-list
92019296|NCT05524259|Vitamin B Complex|vitamin b complex|mesh-list
92019297|NCT05524259|Inositol|inositol|mesh-list
92019298|NCT05524259|Hematinics|hematinics|mesh-ancestor
92019299|NCT05524259|Vitamins|vitamins|mesh-ancestor
92019300|NCT05524259|Micronutrients|micronutrients|mesh-ancestor
92019301|NCT05524259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019302|NCT04112095|Norgestrel|norgestrel|mesh-list
92019303|NCT04112095|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92019304|NCT04112095|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92019305|NCT04112095|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92019306|NCT04112095|Contraceptive Agents|contraceptive agents|mesh-ancestor
92019307|NCT04112095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92019308|NCT04112095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019309|NCT04112095|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92019310|NCT04112095|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92019311|NCT05257993|Paclitaxel|paclitaxel|mesh-list
92019312|NCT05257993|Gemcitabine|gemcitabine|mesh-list
92019313|NCT05257993|Folfirinox|folfirinox|mesh-list
92019314|NCT05257993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019315|NCT05257993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019316|NCT05257993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019317|NCT05257993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019318|NCT05257993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019323|NCT05533073|Tramadol|tramadol|mesh-list
92019324|NCT05533073|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92019325|NCT05533073|Narcotics|narcotics|mesh-ancestor
92019326|NCT05533073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019327|NCT05533073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019328|NCT05533073|Analgesics|analgesics|mesh-ancestor
92019329|NCT05533073|Sensory System Agents|sensory system agents|mesh-ancestor
92019330|NCT05533073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019331|NCT05533073|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92019332|NCT05533073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019333|NCT05533073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019334|NCT05533073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019335|NCT05533073|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92019336|NCT05533073|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92019337|NCT05533073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019338|NCT05533073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019339|NCT04050553|Tirzepatide|tirzepatide|mesh-list
92019340|NCT04050553|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92019341|NCT04050553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019342|NCT04050553|Incretins|incretins|mesh-ancestor
92019343|NCT04050553|Hormones|hormones|mesh-ancestor
92019344|NCT04050553|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019345|NCT03946891|Furosemide|furosemide|mesh-list
92019346|NCT03946891|Diuretics|diuretics|mesh-ancestor
92019347|NCT03946891|Natriuretic Agents|natriuretic agents|mesh-ancestor
92019348|NCT03946891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019349|NCT03946891|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92019350|NCT03946891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019351|NCT03946891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984744|NCT03959241|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984745|NCT03959241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984746|NCT03959241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91984747|NCT03959241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91984748|NCT03959241|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92019352|NCT04300049|Glucagon|glucagon|mesh-list
92019353|NCT04300049|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92019354|NCT04300049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019355|NCT04300049|Hormones|hormones|mesh-ancestor
92019356|NCT04300049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019357|NCT04300049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019358|NCT04300049|Incretins|incretins|mesh-ancestor
92019359|NCT03849625|Aspirin|aspirin|mesh-list
92019360|NCT03849625|Acetaminophen|acetaminophen|mesh-list
92019361|NCT03849625|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92019362|NCT03849625|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019363|NCT03849625|Analgesics|analgesics|mesh-ancestor
92019364|NCT03849625|Sensory System Agents|sensory system agents|mesh-ancestor
92019365|NCT03849625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019366|NCT03849625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019367|NCT03849625|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019369|NCT03849625|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92019370|NCT03849625|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92019371|NCT03849625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019372|NCT03849625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92019373|NCT03849625|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92019374|NCT03849625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019375|NCT03849625|Antipyretics|antipyretics|mesh-ancestor
92019376|NCT03046693|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92019377|NCT03046693|Nootropic Agents|nootropic agents|mesh-ancestor
92019378|NCT03049345|Methylene Blue|methylene blue|mesh-list
92019379|NCT03049345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019380|NCT03049345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019381|NCT05526911|Tenofovir|tenofovir|mesh-list
92019382|NCT05526911|Lamivudine|lamivudine|mesh-list
92019383|NCT05526911|Dolutegravir|dolutegravir|mesh-list
92019384|NCT05526911|Digoxin|digoxin|mesh-list
92019385|NCT05526911|Midazolam|midazolam|mesh-list
92019386|NCT05526911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92019387|NCT05526911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92019388|NCT05526911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019391|NCT05526911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92019392|NCT05526911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92019393|NCT05526911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92019394|NCT05526911|Anesthetics, General|anesthetics, general|mesh-ancestor
92019395|NCT05526911|Anesthetics|anesthetics|mesh-ancestor
92019396|NCT05526911|GABA Modulators|gaba modulators|mesh-ancestor
92019397|NCT05526911|GABA Agents|gaba agents|mesh-ancestor
92019398|NCT05526911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019399|NCT05526911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019400|NCT05526911|Antiviral Agents|antiviral agents|mesh-ancestor
92019401|NCT05526911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019402|NCT05526911|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92019403|NCT05526911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92019404|NCT05526911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019405|NCT05526911|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92019406|NCT05526911|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92019407|NCT05526911|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92019408|NCT05526911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92019409|NCT05526911|Protective Agents|protective agents|mesh-ancestor
92019410|NCT05526911|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92019411|NCT05526911|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92019412|NCT04870489|Isotretinoin|isotretinoin|mesh-list
92019413|NCT04870489|Dermatologic Agents|dermatologic agents|mesh-ancestor
92019414|NCT02574845|Metformin|metformin|mesh-list
92019415|NCT02574845|Furosemide|furosemide|mesh-list
92019416|NCT02574845|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92019417|NCT02574845|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92019418|NCT02574845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019419|NCT02574845|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92019420|NCT02574845|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92019421|NCT02574845|Antimetabolites|antimetabolites|mesh-ancestor
91984749|NCT03959241|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91984750|NCT03959241|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91984751|NCT03959241|Antitubercular Agents|antitubercular agents|mesh-ancestor
92019422|NCT02574845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019423|NCT02574845|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92019424|NCT02574845|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92019425|NCT02574845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019426|NCT02574845|Diuretics|diuretics|mesh-ancestor
92019427|NCT02574845|Natriuretic Agents|natriuretic agents|mesh-ancestor
92019428|NCT02574845|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92019429|NCT02574845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019430|NCT05334485|Bromides|bromides|mesh-list
92019431|NCT05334485|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92019432|NCT05334485|Anticonvulsants|anticonvulsants|mesh-ancestor
92019433|NCT05334485|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92019434|NCT05334485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019435|NCT05334485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019436|NCT05334485|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019437|NCT05334485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019438|NCT05334485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019440|NCT05231941|Ropivacaine|ropivacaine|mesh-list
92019441|NCT05231941|Anesthetics, Local|anesthetics, local|mesh-ancestor
92019442|NCT05231941|Anesthetics|anesthetics|mesh-ancestor
92019443|NCT05231941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019444|NCT05231941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019445|NCT05231941|Sensory System Agents|sensory system agents|mesh-ancestor
92019446|NCT05231941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019447|NCT05231941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92019448|NCT05231941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92019449|NCT05231941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92019450|NCT05231941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019451|NCT05231941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019452|NCT05216575|Almitrine|almitrine|mesh-list
92019453|NCT05216575|Respiratory System Agents|respiratory system agents|mesh-ancestor
92019454|NCT04877509|Vitamin D|vitamin d|mesh-list
92019455|NCT04877509|Vitamin A|vitamin a|mesh-list
92019456|NCT04877509|Selenium|selenium|mesh-list
92019458|NCT04877509|Vitamins|vitamins|mesh-ancestor
92019459|NCT04877509|Micronutrients|micronutrients|mesh-ancestor
92019460|NCT04877509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019461|NCT04877509|Antioxidants|antioxidants|mesh-ancestor
92019462|NCT04877509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019463|NCT04877509|Protective Agents|protective agents|mesh-ancestor
92019472|NCT03044743|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019473|NCT03044743|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019474|NCT03044743|Alkylating Agents|alkylating agents|mesh-ancestor
92019475|NCT03044743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019476|NCT03044743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019477|NCT03044743|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92019478|NCT03044743|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019479|NCT03044743|Analgesics|analgesics|mesh-ancestor
92019480|NCT03044743|Sensory System Agents|sensory system agents|mesh-ancestor
92019481|NCT03044743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019482|NCT03044665|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92019483|NCT03044665|Ezetimibe|ezetimibe|mesh-list
92019484|NCT03044665|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92019485|NCT03044665|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92019486|NCT03044665|Antimetabolites|antimetabolites|mesh-ancestor
92081684|NCT01392183|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019487|NCT03044665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019488|NCT03044665|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92019489|NCT03044665|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92019490|NCT03044665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019491|NCT05525351|Dexmedetomidine|dexmedetomidine|mesh-list
92019492|NCT05525351|Alfentanil|alfentanil|mesh-list
92019493|NCT05525351|Propofol|propofol|mesh-list
92019494|NCT05525351|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92019495|NCT05525351|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984752|NCT03959241|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984753|NCT03959241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984755|NCT02532855|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92019496|NCT05525351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019497|NCT05525351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019498|NCT05525351|Analgesics|analgesics|mesh-ancestor
92019499|NCT05525351|Sensory System Agents|sensory system agents|mesh-ancestor
92019500|NCT05525351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019501|NCT05525351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92019502|NCT05525351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92019503|NCT05525351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92019504|NCT05525351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92019505|NCT05525351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019506|NCT05525351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019507|NCT05525351|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92019508|NCT05525351|Anesthetics, General|anesthetics, general|mesh-ancestor
92019509|NCT05525351|Anesthetics|anesthetics|mesh-ancestor
92019510|NCT05525351|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92019511|NCT05525351|Narcotics|narcotics|mesh-ancestor
92019512|NCT04869475|Arsenic Trioxide|arsenic trioxide|mesh-list
92019513|NCT04869475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019514|NCT05521763|Vaccines|vaccines|mesh-list
92019515|NCT05521763|Immunologic Factors|immunologic factors|mesh-ancestor
92019516|NCT05521763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019517|NCT05100017|Methocarbamol|methocarbamol|mesh-list
92019518|NCT05100017|Oxybutynin|oxybutynin|mesh-list
92019519|NCT05100017|Parasympatholytics|parasympatholytics|mesh-ancestor
92019520|NCT05100017|Autonomic Agents|autonomic agents|mesh-ancestor
92019521|NCT05100017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019522|NCT05100017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019523|NCT05100017|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92019524|NCT05100017|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92019525|NCT05100017|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019526|NCT05100017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019527|NCT05100017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019528|NCT05100017|Urological Agents|urological agents|mesh-ancestor
92019529|NCT05100017|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92019530|NCT05100017|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92019531|NCT04865185|Ethanol|ethanol|mesh-list
92019533|NCT04865185|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92019534|NCT04865185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019535|NCT04865185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019536|NCT04865185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019537|NCT04865185|Anesthetics, Local|anesthetics, local|mesh-ancestor
92019539|NCT04865185|Sensory System Agents|sensory system agents|mesh-ancestor
92019540|NCT04865185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019541|NCT04865185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92019542|NCT04865185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92019543|NCT04865185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92019544|NCT04865185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019545|NCT04865185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019546|NCT04876807|Acalabrutinib|acalabrutinib|mesh-list
92019547|NCT04876807|Omeprazole|omeprazole|mesh-list
92019548|NCT04876807|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92019549|NCT04876807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019550|NCT04876807|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92019551|NCT04876807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019552|NCT04876807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019553|NCT04876807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019554|NCT05518409|Donepezil|donepezil|mesh-list
92019555|NCT05518409|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92019556|NCT05518409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019557|NCT05518409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019558|NCT05518409|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019559|NCT05518409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019560|NCT05518409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019561|NCT05518409|Nootropic Agents|nootropic agents|mesh-ancestor
92019563|NCT04876573|Antipruritics|antipruritics|mesh-ancestor
92019564|NCT04876573|Dermatologic Agents|dermatologic agents|mesh-ancestor
92019565|NCT04876573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984756|NCT02532855|Dapagliflozin|dapagliflozin|mesh-list
91984757|NCT02532855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984758|NCT02532855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984759|NCT02532855|Incretins|incretins|mesh-ancestor
92019566|NCT04876573|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92019567|NCT04876573|Histamine Antagonists|histamine antagonists|mesh-ancestor
92019568|NCT04876573|Histamine Agents|histamine agents|mesh-ancestor
92019569|NCT04876573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019570|NCT04876573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019571|NCT04876573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019572|NCT04876573|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92019573|NCT04876573|Serotonin Agents|serotonin agents|mesh-ancestor
92019574|NCT04876573|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92019575|NCT04864717|Doxycycline|doxycycline|mesh-list
92019576|NCT04864717|Isotretinoin|isotretinoin|mesh-list
92019577|NCT04864717|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92019578|NCT04864717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019579|NCT04864717|Antimalarials|antimalarials|mesh-ancestor
92019580|NCT04864717|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92019581|NCT04864717|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92019582|NCT04864717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92019583|NCT04876261|3,4-dihydroxyphenylethanol|3,4-dihydroxyphenylethanol|mesh-list
92019584|NCT04876261|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019585|NCT04876261|Antioxidants|antioxidants|mesh-ancestor
92019586|NCT04876261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019587|NCT04876261|Protective Agents|protective agents|mesh-ancestor
92019588|NCT04876261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019589|NCT04876261|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92019590|NCT02613871|Sofosbuvir|sofosbuvir|mesh-list
92019591|NCT02613871|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92019592|NCT02613871|Ledipasvir|ledipasvir|mesh-list
92019593|NCT02613871|Antiviral Agents|antiviral agents|mesh-ancestor
92019594|NCT02613871|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019595|NCT04869709|Betamethasone|betamethasone|mesh-list
92019596|NCT04869709|Betamethasone Valerate|betamethasone valerate|mesh-list
92019597|NCT04869709|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92019598|NCT04869709|Betamethasone benzoate|betamethasone benzoate|mesh-list
92019599|NCT04869709|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92019600|NCT04869709|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019601|NCT04869709|Glucocorticoids|glucocorticoids|mesh-ancestor
92019602|NCT04869709|Hormones|hormones|mesh-ancestor
92019603|NCT04869709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019604|NCT04869709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019605|NCT04869709|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92019606|NCT04869709|Respiratory System Agents|respiratory system agents|mesh-ancestor
92019610|NCT02612077|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019611|NCT02612077|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92019612|NCT02612077|Growth Substances|growth substances|mesh-ancestor
92019613|NCT02612077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019614|NCT02612077|Growth Inhibitors|growth inhibitors|mesh-ancestor
92019615|NCT04622735|Acetaminophen|acetaminophen|mesh-list
92019616|NCT04622735|Nefopam|nefopam|mesh-list
92019617|NCT04622735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019618|NCT04622735|Analgesics|analgesics|mesh-ancestor
92019619|NCT04622735|Sensory System Agents|sensory system agents|mesh-ancestor
92019620|NCT04622735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019621|NCT04622735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019623|NCT05531591|Aripiprazole|aripiprazole|mesh-list
92019624|NCT05531591|Lithium Carbonate|lithium carbonate|mesh-list
92019625|NCT05531591|Bupropion|bupropion|mesh-list
92019626|NCT05531591|Nortriptyline|nortriptyline|mesh-list
92019627|NCT05531591|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92019628|NCT05531591|Antidepressive Agents|antidepressive agents|mesh-ancestor
92019629|NCT05531591|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92019630|NCT05531591|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92019631|NCT05531591|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92019632|NCT05531591|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019633|NCT05531591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019634|NCT05531591|Dopamine Agents|dopamine agents|mesh-ancestor
92019635|NCT05531591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984761|NCT02532855|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090423|NCT04416035|Carboplatin|carboplatin|mesh-list
92019636|NCT05531591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019637|NCT05531591|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92019638|NCT05531591|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92019640|NCT05531591|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92019641|NCT05531591|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92019642|NCT05531591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019643|NCT05531591|Dopamine Agonists|dopamine agonists|mesh-ancestor
92019644|NCT05531591|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92019645|NCT05531591|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92019647|NCT05531591|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92019648|NCT05531591|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92019649|NCT05531591|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92019650|NCT05531591|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92019651|NCT05531591|Antimanic Agents|antimanic agents|mesh-ancestor
92019652|NCT05531591|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92019653|NCT05531591|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92019654|NCT05531591|Adrenergic Agents|adrenergic agents|mesh-ancestor
92019655|NCT05048615|Itraconazole|itraconazole|mesh-list
92019656|NCT05048615|Azacitidine|azacitidine|mesh-list
92019657|NCT05048615|Venetoclax|venetoclax|mesh-list
92019658|NCT05048615|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019659|NCT05048615|Antimetabolites|antimetabolites|mesh-ancestor
92019660|NCT05048615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019661|NCT05048615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019662|NCT05048615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019663|NCT05048615|Antifungal Agents|antifungal agents|mesh-ancestor
92019664|NCT05048615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019665|NCT05048615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92019666|NCT05048615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92019667|NCT05048615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92019668|NCT05048615|Hormone Antagonists|hormone antagonists|mesh-ancestor
92019669|NCT05048615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019670|NCT05048615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019671|NCT05048615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92019672|NCT05531435|Anesthetics|anesthetics|mesh-list
92019673|NCT05531435|Anesthetics, Local|anesthetics, local|mesh-list
92019674|NCT05531435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92019675|NCT05531435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019676|NCT05531435|Sensory System Agents|sensory system agents|mesh-ancestor
92019677|NCT05531435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019682|NCT05517239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019683|NCT05517239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019684|NCT05519813|Metformin|metformin|mesh-list
92019685|NCT05519813|Pioglitazone|pioglitazone|mesh-list
92019686|NCT05519813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92019687|NCT05519813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019688|NCT02613403|Ribavirin|ribavirin|mesh-list
92019689|NCT02613403|Uprifosbuvir|uprifosbuvir|mesh-list
92019691|NCT02613403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019692|NCT02613403|Antiviral Agents|antiviral agents|mesh-ancestor
92019693|NCT02613403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019694|NCT05002127|Paclitaxel|paclitaxel|mesh-list
92019695|NCT05002127|Trastuzumab|trastuzumab|mesh-list
92019696|NCT05002127|Ramucirumab|ramucirumab|mesh-list
92019697|NCT05002127|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019698|NCT05002127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019699|NCT05002127|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019700|NCT05002127|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019701|NCT05002127|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019702|NCT05002127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019703|NCT05002127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019704|NCT04429867|Hydroxychloroquine|hydroxychloroquine|mesh-list
92019705|NCT04429867|Antimalarials|antimalarials|mesh-ancestor
92019706|NCT04429867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92019707|NCT04429867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92019708|NCT04429867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984762|NCT02532855|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91984763|NCT02532855|Protease Inhibitors|protease inhibitors|mesh-ancestor
91984764|NCT02532855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984765|NCT02532855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984766|NCT02532855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92019709|NCT04429867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019710|NCT04429867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019711|NCT04429867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019712|NCT03044041|Tranexamic Acid|tranexamic acid|mesh-list
92019713|NCT03044041|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92019714|NCT03044041|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92019715|NCT03044041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019717|NCT03044041|Coagulants|coagulants|mesh-ancestor
92019718|NCT03048097|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92019719|NCT03048097|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92019791|NCT04867993|Amikacin|amikacin|mesh-list
92019720|NCT03048097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019721|NCT05516303|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92019722|NCT05516303|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92019723|NCT05516303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019724|NCT05516303|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019725|NCT05516303|Immunologic Factors|immunologic factors|mesh-ancestor
92019726|NCT05516303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019727|NCT04863079|Pembrolizumab|pembrolizumab|mesh-list
92019728|NCT04863079|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019729|NCT04863079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019730|NCT04863079|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92019731|NCT04863079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019732|NCT05512325|Bevacizumab|bevacizumab|mesh-list
92019733|NCT05512325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019734|NCT05512325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019735|NCT05512325|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019736|NCT05512325|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92019737|NCT05512325|Growth Substances|growth substances|mesh-ancestor
92019738|NCT05512325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019739|NCT05512325|Growth Inhibitors|growth inhibitors|mesh-ancestor
92019741|NCT04868227|Cholecalciferol|cholecalciferol|mesh-list
92019743|NCT04868227|Micronutrients|micronutrients|mesh-ancestor
92019744|NCT04868227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019745|NCT04868227|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92019746|NCT04868227|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92019747|NCT04863001|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-list
92019751|NCT04873531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019752|NCT04873531|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019753|NCT04873531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019754|NCT04873531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019755|NCT04873531|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92019756|NCT04873531|Autonomic Agents|autonomic agents|mesh-ancestor
92019757|NCT04873531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019758|NCT04862845|Pregabalin|pregabalin|mesh-list
92019759|NCT04862845|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92019760|NCT04862845|Analgesics|analgesics|mesh-ancestor
92019761|NCT04862845|Sensory System Agents|sensory system agents|mesh-ancestor
92019762|NCT04862845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019763|NCT04862845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019764|NCT04862845|Anticonvulsants|anticonvulsants|mesh-ancestor
92019765|NCT04862845|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92019766|NCT04862845|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92019767|NCT04862845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019768|NCT04862845|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92019769|NCT04862845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92019770|NCT04862845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92019771|NCT04862845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91984767|NCT04262427|Cyclophosphamide|cyclophosphamide|mesh-list
91984768|NCT04262427|Pembrolizumab|pembrolizumab|mesh-list
91984769|NCT04262427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984770|NCT04262427|Immunologic Factors|immunologic factors|mesh-ancestor
91984771|NCT04262427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984772|NCT04262427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019772|NCT04862845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92019773|NCT04862845|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92019774|NCT04862845|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92019775|NCT04862845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019776|NCT04862845|Antidepressive Agents|antidepressive agents|mesh-ancestor
92019777|NCT04862845|Dopamine Agents|dopamine agents|mesh-ancestor
92019778|NCT04862377|Budesonide|budesonide|mesh-list
92019779|NCT04862377|Poractant alfa|poractant alfa|mesh-list
92019780|NCT04862377|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019781|NCT04862377|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92019782|NCT04862377|Autonomic Agents|autonomic agents|mesh-ancestor
92019783|NCT04862377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019784|NCT04862377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019785|NCT04862377|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92019786|NCT04862377|Respiratory System Agents|respiratory system agents|mesh-ancestor
92019787|NCT04862377|Glucocorticoids|glucocorticoids|mesh-ancestor
92019788|NCT04862377|Hormones|hormones|mesh-ancestor
92019789|NCT04862377|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019790|NCT04862377|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92019792|NCT04867993|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92019793|NCT04867993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92019794|NCT04872985|Paclitaxel|paclitaxel|mesh-list
92019795|NCT04872985|Docetaxel|docetaxel|mesh-list
92019796|NCT04872985|Cyclophosphamide|cyclophosphamide|mesh-list
92019797|NCT04872985|Doxorubicin|doxorubicin|mesh-list
92019798|NCT04872985|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92019799|NCT04872985|Epirubicin|epirubicin|mesh-list
92019800|NCT04872985|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019801|NCT04872985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019802|NCT04872985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019803|NCT04872985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019804|NCT04872985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019805|NCT04872985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019806|NCT04872985|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019807|NCT04872985|Immunologic Factors|immunologic factors|mesh-ancestor
92019808|NCT04872985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019809|NCT04872985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019810|NCT04872985|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019811|NCT04872985|Alkylating Agents|alkylating agents|mesh-ancestor
92019812|NCT04872985|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92019813|NCT04872985|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92019814|NCT04872985|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92019815|NCT04872985|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92019816|NCT04872985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019817|NCT04872907|Fluorides|fluorides|mesh-list
92019818|NCT04872907|Fluorides, Topical|fluorides, topical|mesh-list
92019819|NCT04872907|Cariostatic Agents|cariostatic agents|mesh-ancestor
92019820|NCT04872907|Protective Agents|protective agents|mesh-ancestor
92019824|NCT02566031|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92019825|NCT02566031|Autonomic Agents|autonomic agents|mesh-ancestor
92019826|NCT02566031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019827|NCT02566031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019828|NCT02566031|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92019829|NCT02566031|Respiratory System Agents|respiratory system agents|mesh-ancestor
92019830|NCT02566031|Parasympatholytics|parasympatholytics|mesh-ancestor
92019831|NCT02566031|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92019832|NCT02566031|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019833|NCT02566031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019834|NCT02566031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019835|NCT02566031|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92019836|NCT02566031|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92019837|NCT05507411|Immunomodulating Agents|immunomodulating agents|mesh-list
91984773|NCT04262427|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984774|NCT04262427|Alkylating Agents|alkylating agents|mesh-ancestor
91984775|NCT04262427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984776|NCT04262427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019838|NCT05507411|Immunologic Factors|immunologic factors|mesh-ancestor
92019839|NCT05507411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019840|NCT05512013|Ibuprofen|ibuprofen|mesh-list
92019841|NCT05512013|Celecoxib|celecoxib|mesh-list
92019842|NCT05512013|Flurbiprofen|flurbiprofen|mesh-list
92019843|NCT05512013|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92019844|NCT05512013|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92019845|NCT05512013|Analgesics|analgesics|mesh-ancestor
92019846|NCT05512013|Sensory System Agents|sensory system agents|mesh-ancestor
92019847|NCT05512013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019848|NCT05512013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019849|NCT05512013|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019850|NCT05512013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019851|NCT05512013|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92019852|NCT05512013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019853|NCT05512013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019854|NCT05512013|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92019855|NCT04894643|Paclitaxel|paclitaxel|mesh-list
92019856|NCT04894643|Gemcitabine|gemcitabine|mesh-list
92019857|NCT04894643|Capecitabine|capecitabine|mesh-list
92019858|NCT04894643|Pancrelipase|pancrelipase|mesh-list
92019859|NCT04894643|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019860|NCT04894643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019861|NCT04894643|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019862|NCT04894643|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019863|NCT04894643|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019864|NCT04894643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019865|NCT04894643|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019867|NCT04894643|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019869|NCT05511623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019870|NCT05511623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019871|NCT05506865|Tiotropium Bromide|tiotropium bromide|mesh-list
92019872|NCT05506865|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92019873|NCT05506865|Autonomic Agents|autonomic agents|mesh-ancestor
92019874|NCT05506865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019875|NCT05506865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019876|NCT05506865|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92019877|NCT05506865|Respiratory System Agents|respiratory system agents|mesh-ancestor
92019878|NCT05506865|Parasympatholytics|parasympatholytics|mesh-ancestor
92019879|NCT05506865|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92019880|NCT05506865|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019881|NCT05506865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019882|NCT05506865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019883|NCT03048019|Tirofiban|tirofiban|mesh-list
92019884|NCT03048019|Cangrelor|cangrelor|mesh-list
92019885|NCT03048019|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92019886|NCT03048019|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92019887|NCT03048019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019888|NCT03048019|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92019889|NCT03048019|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92019890|NCT03048019|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92019891|NCT03048019|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92019892|NCT03048019|Purinergic Agents|purinergic agents|mesh-ancestor
92019903|NCT05506319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019904|NCT05506319|Sympathomimetics|sympathomimetics|mesh-ancestor
92019905|NCT05506319|Autonomic Agents|autonomic agents|mesh-ancestor
92019906|NCT05506319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019907|NCT05506319|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92019908|NCT05506319|Hemostatics|hemostatics|mesh-ancestor
92019909|NCT05506319|Coagulants|coagulants|mesh-ancestor
92019910|NCT05506319|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92019911|NCT05506319|Natriuretic Agents|natriuretic agents|mesh-ancestor
92019912|NCT05505539|Fluorouracil|fluorouracil|mesh-list
92019913|NCT05505539|Antimetabolites|antimetabolites|mesh-ancestor
91984777|NCT04262427|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91984778|NCT04262427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019914|NCT05505539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019915|NCT05505539|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019916|NCT05505539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019917|NCT05505539|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019918|NCT05505539|Immunologic Factors|immunologic factors|mesh-ancestor
92019919|NCT05505539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019921|NCT05505461|Immunologic Factors|immunologic factors|mesh-ancestor
92019922|NCT05505461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019923|NCT05514275|Capecitabine|capecitabine|mesh-list
92019924|NCT05514275|Endostatins|endostatins|mesh-list
92019925|NCT05514275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019926|NCT05514275|Antimetabolites|antimetabolites|mesh-ancestor
92019927|NCT05514275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019928|NCT05514275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019929|NCT05514275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019930|NCT05514275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92019932|NCT05514275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019933|NCT05514275|Growth Inhibitors|growth inhibitors|mesh-ancestor
92019934|NCT05514119|Fenofibrate|fenofibrate|mesh-list
92019935|NCT05514119|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92019936|NCT05514119|Antimetabolites|antimetabolites|mesh-ancestor
92019937|NCT05514119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019938|NCT05514119|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92019939|NCT05514041|Varenicline|varenicline|mesh-list
92019940|NCT05514041|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92019941|NCT05514041|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92019942|NCT05514041|Cholinergic Agents|cholinergic agents|mesh-ancestor
92019943|NCT05514041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019944|NCT05514041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019945|NCT05514041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019946|NCT04667663|Dexamethasone|dexamethasone|mesh-list
92019947|NCT04667663|Cyclophosphamide|cyclophosphamide|mesh-list
92019948|NCT04667663|Daratumumab|daratumumab|mesh-list
92019949|NCT04667663|Pomalidomide|pomalidomide|mesh-list
92019950|NCT04667663|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019951|NCT04667663|Immunologic Factors|immunologic factors|mesh-ancestor
92019952|NCT04667663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019953|NCT04667663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019954|NCT04667663|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019955|NCT04667663|Alkylating Agents|alkylating agents|mesh-ancestor
92019956|NCT04667663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019957|NCT04667663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019959|NCT04667663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92019960|NCT04667663|Antiemetics|antiemetics|mesh-ancestor
92019961|NCT04667663|Autonomic Agents|autonomic agents|mesh-ancestor
92019962|NCT04667663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019963|NCT04667663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019964|NCT04667663|Glucocorticoids|glucocorticoids|mesh-ancestor
92019965|NCT04667663|Hormones|hormones|mesh-ancestor
92019966|NCT04667663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92019967|NCT04667663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92019968|NCT04667663|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92019969|NCT04667663|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92019970|NCT04667663|Growth Substances|growth substances|mesh-ancestor
92019971|NCT04667663|Growth Inhibitors|growth inhibitors|mesh-ancestor
92019972|NCT02570711|Paclitaxel|paclitaxel|mesh-list
92019973|NCT02570711|Gemcitabine|gemcitabine|mesh-list
92019974|NCT02570711|Acalabrutinib|acalabrutinib|mesh-list
92019975|NCT02570711|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92019976|NCT02570711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019977|NCT02570711|Tubulin Modulators|tubulin modulators|mesh-ancestor
92019978|NCT02570711|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019979|NCT02570711|Mitosis Modulators|mitosis modulators|mesh-ancestor
92019980|NCT02570711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019981|NCT02570711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019982|NCT02570711|Antimetabolites|antimetabolites|mesh-ancestor
92019983|NCT05513729|Pioglitazone|pioglitazone|mesh-list
92019984|NCT05513729|Canagliflozin|canagliflozin|mesh-list
92019985|NCT05513729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91984779|NCT04262427|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984780|NCT02530125|Pidilizumab|pidilizumab|mesh-list
91984781|NCT02530125|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984782|NCT02530125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019986|NCT05513729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019987|NCT05513729|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92019988|NCT05513729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019989|NCT05504603|Rituximab|rituximab|mesh-list
92019990|NCT05504603|Zanubrutinib|zanubrutinib|mesh-list
92019991|NCT05504603|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019992|NCT05504603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019993|NCT05504603|Immunologic Factors|immunologic factors|mesh-ancestor
92019994|NCT05504603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019995|NCT05504603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92019996|NCT05504603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92019997|NCT05504603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019998|NCT05504603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019999|NCT05504213|Fulvestrant|fulvestrant|mesh-list
92020000|NCT05504213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020001|NCT05504213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020002|NCT05504213|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92020003|NCT05504213|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92020004|NCT05504213|Hormone Antagonists|hormone antagonists|mesh-ancestor
92020005|NCT05504213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020006|NCT05504213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020007|NCT05510219|Obinutuzumab|obinutuzumab|mesh-list
92020008|NCT05510219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020009|NCT05510219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020010|NCT02564471|Doxycycline|doxycycline|mesh-list
92020011|NCT02564471|Chloroquine|chloroquine|mesh-list
92020012|NCT02564471|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92020013|NCT02564471|Atovaquone|atovaquone|mesh-list
92020014|NCT02564471|Proguanil|proguanil|mesh-list
92020015|NCT02564471|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92020016|NCT02564471|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020017|NCT02564471|Antimalarials|antimalarials|mesh-ancestor
92020018|NCT02564471|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92020019|NCT02564471|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92020020|NCT02564471|Amebicides|amebicides|mesh-ancestor
92020021|NCT02564471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020022|NCT02564471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92020023|NCT02564471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92020024|NCT02564471|Analgesics|analgesics|mesh-ancestor
92020025|NCT02564471|Sensory System Agents|sensory system agents|mesh-ancestor
92020026|NCT02564471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020027|NCT02564471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020028|NCT02564471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020029|NCT02564471|Filaricides|filaricides|mesh-ancestor
92020030|NCT02564471|Antinematodal Agents|antinematodal agents|mesh-ancestor
92020031|NCT02564471|Anthelmintics|anthelmintics|mesh-ancestor
92020032|NCT02564471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020039|NCT05503667|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92020040|NCT05503667|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92020042|NCT05503667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020043|NCT05503667|Growth Inhibitors|growth inhibitors|mesh-ancestor
92020044|NCT05503667|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92020045|NCT05503667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020046|NCT05503667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020047|NCT02563067|Indoleacetic Acids|indoleacetic acids|mesh-list
92020048|NCT02563067|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92020049|NCT02563067|Growth Substances|growth substances|mesh-ancestor
92020050|NCT02563067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020051|NCT02568683|Vincristine|vincristine|mesh-list
92020052|NCT02568683|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92020053|NCT02568683|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020054|NCT02568683|Tubulin Modulators|tubulin modulators|mesh-ancestor
92020055|NCT02568683|Antimitotic Agents|antimitotic agents|mesh-ancestor
92020056|NCT02568683|Mitosis Modulators|mitosis modulators|mesh-ancestor
92020057|NCT02568683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020058|NCT05502731|Adalimumab|adalimumab|mesh-list
91984783|NCT05422521|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91984784|NCT05422521|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984785|NCT05422521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984786|NCT05421819|Calcium, Dietary|calcium, dietary|mesh-list
91984787|NCT05421819|Vitamin D|vitamin d|mesh-list
91984788|NCT05421819|Ergocalciferols|ergocalciferols|mesh-list
92020059|NCT05502731|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92020060|NCT05502731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020061|NCT05502731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020062|NCT05503043|Lidocaine|lidocaine|mesh-list
92020063|NCT05503043|Anesthetics, Local|anesthetics, local|mesh-ancestor
92020064|NCT05503043|Anesthetics|anesthetics|mesh-ancestor
92020065|NCT05503043|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020066|NCT05503043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020067|NCT05503043|Sensory System Agents|sensory system agents|mesh-ancestor
92020068|NCT05503043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020069|NCT05503043|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92020070|NCT05503043|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92020071|NCT05503043|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92020072|NCT05503043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020073|NCT05503043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020074|NCT02563925|Durvalumab|durvalumab|mesh-list
92020075|NCT02563925|Tremelimumab|tremelimumab|mesh-list
92020076|NCT02563925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020077|NCT02563925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020078|NCT01663727|Paclitaxel|paclitaxel|mesh-list
92020079|NCT01663727|Bevacizumab|bevacizumab|mesh-list
92020080|NCT01663727|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92020081|NCT01663727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020082|NCT01663727|Tubulin Modulators|tubulin modulators|mesh-ancestor
92020083|NCT01663727|Antimitotic Agents|antimitotic agents|mesh-ancestor
92020084|NCT01663727|Mitosis Modulators|mitosis modulators|mesh-ancestor
92020085|NCT01663727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020086|NCT01663727|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020087|NCT01663727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92020088|NCT01663727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92020089|NCT01663727|Growth Substances|growth substances|mesh-ancestor
92020090|NCT01663727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020091|NCT01663727|Growth Inhibitors|growth inhibitors|mesh-ancestor
92020092|NCT03042325|Alogliptin|alogliptin|mesh-list
92020093|NCT03042325|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92020094|NCT03042325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020095|NCT03042325|Incretins|incretins|mesh-ancestor
92020096|NCT03042325|Hormones|hormones|mesh-ancestor
92020097|NCT03042325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020098|NCT03042325|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92020099|NCT03042325|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020106|NCT01594333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020107|NCT01594333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92020108|NCT01594333|Antimetabolites|antimetabolites|mesh-ancestor
92020109|NCT01594333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020110|NCT01594333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020111|NCT01594333|Dermatologic Agents|dermatologic agents|mesh-ancestor
92020112|NCT01594333|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020113|NCT01594333|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92020114|NCT01594333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020115|NCT01594333|Immunologic Factors|immunologic factors|mesh-ancestor
92020116|NCT01594333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020117|NCT01594333|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92020118|NCT04338529|Cholecalciferol|cholecalciferol|mesh-list
92020119|NCT04338529|Calcium Carbonate|calcium carbonate|mesh-list
92020120|NCT04338529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020121|NCT04338529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020122|NCT04338529|Vitamins|vitamins|mesh-ancestor
92020123|NCT04338529|Micronutrients|micronutrients|mesh-ancestor
92020124|NCT04338529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92020125|NCT04338529|Antacids|antacids|mesh-ancestor
92020126|NCT04338529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984789|NCT05421819|Cholecalciferol|cholecalciferol|mesh-list
91984790|NCT05421819|Vitamins|vitamins|mesh-list
91984792|NCT05421819|Micronutrients|micronutrients|mesh-ancestor
91984793|NCT05421819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984794|NCT05421819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020127|NCT04338529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020128|NCT04858633|Hydroxychloroquine|hydroxychloroquine|mesh-list
92020129|NCT04858633|Antimalarials|antimalarials|mesh-ancestor
92020130|NCT04858633|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92020131|NCT04858633|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92020132|NCT04858633|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020133|NCT04858633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020134|NCT04858633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020135|NCT04858633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020136|NCT03043495|Dexamethasone|dexamethasone|mesh-list
92020137|NCT03043495|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020138|NCT03043495|Antiemetics|antiemetics|mesh-ancestor
92020139|NCT03043495|Autonomic Agents|autonomic agents|mesh-ancestor
92020140|NCT03043495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020141|NCT03043495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020142|NCT03043495|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020143|NCT03043495|Glucocorticoids|glucocorticoids|mesh-ancestor
92020144|NCT03043495|Hormones|hormones|mesh-ancestor
92020145|NCT03043495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020146|NCT03043495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020147|NCT03043495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020148|NCT03043027|Bupivacaine|bupivacaine|mesh-list
92020149|NCT03043027|Anesthetics, Local|anesthetics, local|mesh-ancestor
92020150|NCT03043027|Anesthetics|anesthetics|mesh-ancestor
92020151|NCT03043027|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020152|NCT03043027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020153|NCT03043027|Sensory System Agents|sensory system agents|mesh-ancestor
92020154|NCT03043027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020155|NCT04861207|Cladribine|cladribine|mesh-list
92020156|NCT04861207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020157|NCT04861207|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020158|NCT04861207|Immunologic Factors|immunologic factors|mesh-ancestor
92020159|NCT04861207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020162|NCT04858087|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92020163|NCT04858087|Antimalarials|antimalarials|mesh-ancestor
92020164|NCT04858087|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92020165|NCT04858087|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92020166|NCT04858087|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020167|NCT03041935|Acetaminophen|acetaminophen|mesh-list
92020168|NCT03041935|Dexamethasone|dexamethasone|mesh-list
92020169|NCT03041935|Ketorolac|ketorolac|mesh-list
92020184|NCT03041935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020185|NCT03041935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020186|NCT03041935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020187|NCT03041935|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92020188|NCT03041935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020189|NCT03041935|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92020190|NCT03041935|Anesthetics, General|anesthetics, general|mesh-ancestor
92020191|NCT03041935|Anesthetics|anesthetics|mesh-ancestor
92020192|NCT03041935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92020193|NCT03041935|Narcotics|narcotics|mesh-ancestor
92020194|NCT03041935|Analgesics|analgesics|mesh-ancestor
92020195|NCT03041935|Sensory System Agents|sensory system agents|mesh-ancestor
92020196|NCT03041935|Anesthetics, Local|anesthetics, local|mesh-ancestor
92020197|NCT03041935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92020198|NCT03041935|Antipyretics|antipyretics|mesh-ancestor
92020199|NCT03041935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92020200|NCT03041935|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92020201|NCT03041935|Antipruritics|antipruritics|mesh-ancestor
92020202|NCT03041935|Dermatologic Agents|dermatologic agents|mesh-ancestor
92020203|NCT03041935|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92020204|NCT03041935|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92020205|NCT03041935|Serotonin Agents|serotonin agents|mesh-ancestor
92020206|NCT03041935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984795|NCT05421819|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91984796|NCT02055820|Prednisone|prednisone|mesh-list
92020207|NCT03041935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020208|NCT03041935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92020209|NCT03041935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020210|NCT03041935|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92020211|NCT03041935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020212|NCT03042013|Naquotinib|naquotinib|mesh-list
92020213|NCT03042013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020214|NCT03042013|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92020215|NCT03042013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020216|NCT03042013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020217|NCT03042871|Ranibizumab|ranibizumab|mesh-list
92020218|NCT03042871|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92020219|NCT03042871|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92020220|NCT03042871|Growth Substances|growth substances|mesh-ancestor
92020221|NCT03042871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020222|NCT03042871|Growth Inhibitors|growth inhibitors|mesh-ancestor
92020223|NCT03042871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020224|NCT03042637|Tacrolimus|tacrolimus|mesh-list
92020225|NCT03042637|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020226|NCT03042637|Immunologic Factors|immunologic factors|mesh-ancestor
92020227|NCT03042637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020228|NCT03042637|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92020229|NCT03042637|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020230|NCT03042637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020231|NCT03045133|Morphine|morphine|mesh-list
92020232|NCT03045133|Methadone|methadone|mesh-list
92020233|NCT03045133|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92020234|NCT03045133|Narcotics|narcotics|mesh-ancestor
92020242|NCT02609659|Ritonavir|ritonavir|mesh-list
92020243|NCT02609659|Ribavirin|ribavirin|mesh-list
92020244|NCT02609659|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92020245|NCT02609659|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92020246|NCT02609659|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020247|NCT02609659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020248|NCT02609659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020249|NCT02609659|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92020250|NCT02609659|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92020251|NCT02609659|Antiviral Agents|antiviral agents|mesh-ancestor
92020252|NCT02609659|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020253|NCT02609659|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92020254|NCT02609659|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92020255|NCT02609659|Antimetabolites|antimetabolites|mesh-ancestor
92020256|NCT04429711|Ivermectin|ivermectin|mesh-list
92020258|NCT04429711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020259|NCT04429633|Candesartan|candesartan|mesh-list
92020260|NCT04429633|Candesartan cilexetil|candesartan cilexetil|mesh-list
92020261|NCT04429633|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92020262|NCT04429633|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92020263|NCT04429633|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92020264|NCT04429633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020265|NCT03042091|Metronidazole|metronidazole|mesh-list
92020266|NCT03042091|Ethanol|ethanol|mesh-list
92020267|NCT03042091|Neomycin|neomycin|mesh-list
92020268|NCT03042091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020269|NCT03042091|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92020270|NCT03042091|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92020271|NCT03042091|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92020272|NCT03042091|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92020273|NCT03042091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020274|NCT03042091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020275|NCT03042091|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92020276|NCT03042091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020277|NCT03042091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020278|NCT04859569|Denosumab|denosumab|mesh-list
92020279|NCT04859569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92020280|NCT04859569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020281|NCT04856371|Letrozole|letrozole|mesh-list
92020282|NCT04856371|Fulvestrant|fulvestrant|mesh-list
92020283|NCT04856371|Palbociclib|palbociclib|mesh-list
92020284|NCT04856371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984797|NCT02055820|Cyclophosphamide|cyclophosphamide|mesh-list
91984798|NCT02055820|Rituximab|rituximab|mesh-list
91984799|NCT02055820|Doxorubicin|doxorubicin|mesh-list
91984800|NCT02055820|Vincristine|vincristine|mesh-list
92020285|NCT04856371|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92020286|NCT04856371|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92020287|NCT04856371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020288|NCT04856371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020289|NCT04856371|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92020290|NCT04856371|Hormone Antagonists|hormone antagonists|mesh-ancestor
92020291|NCT04856371|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020292|NCT04856371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020293|NCT04856371|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020294|NCT04856371|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92020295|NCT04856371|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92020296|NCT03041779|Acetaminophen|acetaminophen|mesh-list
92020297|NCT03041779|Diclofenac|diclofenac|mesh-list
92020298|NCT03041779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92020299|NCT03041779|Analgesics|analgesics|mesh-ancestor
92020300|NCT03041779|Sensory System Agents|sensory system agents|mesh-ancestor
92020301|NCT03041779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020305|NCT03041779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020306|NCT03041779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020307|NCT03041779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92020308|NCT03041779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020309|NCT03041779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020312|NCT02612779|Pomalidomide|pomalidomide|mesh-list
92020313|NCT02612779|Elotuzumab|elotuzumab|mesh-list
92020314|NCT02612779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020315|NCT02612779|Antiemetics|antiemetics|mesh-ancestor
92020316|NCT02612779|Autonomic Agents|autonomic agents|mesh-ancestor
92020317|NCT02612779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020318|NCT02612779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020319|NCT02612779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020320|NCT02612779|Glucocorticoids|glucocorticoids|mesh-ancestor
92020321|NCT02612779|Hormones|hormones|mesh-ancestor
92020322|NCT02612779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020323|NCT02612779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020324|NCT02612779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020325|NCT02612779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020326|NCT02612779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92020327|NCT02612779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020328|NCT02612779|Immunologic Factors|immunologic factors|mesh-ancestor
92020329|NCT02612779|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92020330|NCT02612779|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92020331|NCT02612779|Growth Substances|growth substances|mesh-ancestor
92020332|NCT02612779|Growth Inhibitors|growth inhibitors|mesh-ancestor
92020333|NCT04866355|Ibuprofen|ibuprofen|mesh-list
92020334|NCT04866355|Scopolamine|scopolamine|mesh-list
92020335|NCT04866355|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92020336|NCT04866355|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92020337|NCT04866355|Analgesics|analgesics|mesh-ancestor
92020338|NCT04866355|Sensory System Agents|sensory system agents|mesh-ancestor
92020339|NCT04866355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020340|NCT04866355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020341|NCT04866355|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020342|NCT04866355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020343|NCT04866355|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92020344|NCT04866355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020345|NCT04866355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020346|NCT04866355|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92020347|NCT04866355|Antiemetics|antiemetics|mesh-ancestor
92020348|NCT04866355|Autonomic Agents|autonomic agents|mesh-ancestor
92020349|NCT04866355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020350|NCT04866355|Mydriatics|mydriatics|mesh-ancestor
92020351|NCT04866355|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92020352|NCT04866355|Cholinergic Agents|cholinergic agents|mesh-ancestor
92020353|NCT04866355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020354|NCT04866355|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92020355|NCT02607865|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
91984801|NCT02055820|Venetoclax|venetoclax|mesh-list
92020356|NCT02607865|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92020357|NCT02607865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020358|NCT02607865|Incretins|incretins|mesh-ancestor
92020359|NCT02607865|Hormones|hormones|mesh-ancestor
92020360|NCT02607865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020361|NCT02607865|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92020362|NCT02607865|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020363|NCT02607865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020364|NCT02607865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020365|NCT04856137|Paclitaxel|paclitaxel|mesh-list
92020366|NCT04856137|Rituximab|rituximab|mesh-list
92020367|NCT04856137|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92020368|NCT04856137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020369|NCT04856137|Tubulin Modulators|tubulin modulators|mesh-ancestor
92020370|NCT04856137|Antimitotic Agents|antimitotic agents|mesh-ancestor
92020371|NCT04856137|Mitosis Modulators|mitosis modulators|mesh-ancestor
92020372|NCT04856137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020376|NCT04856137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020377|NCT04855279|Listerine|listerine|mesh-list
92020378|NCT04855279|Fluorides|fluorides|mesh-list
92020379|NCT04855279|Sodium Fluoride|sodium fluoride|mesh-list
92020380|NCT04855279|Glycerol|glycerol|mesh-list
92020381|NCT04855279|Cariostatic Agents|cariostatic agents|mesh-ancestor
92020382|NCT04855279|Protective Agents|protective agents|mesh-ancestor
92020383|NCT04855279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020384|NCT04855279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92020385|NCT04855279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020386|NCT04855279|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92020387|NCT04848259|Dexamethasone|dexamethasone|mesh-list
92020388|NCT04848259|Dexamethasone acetate|dexamethasone acetate|mesh-list
92020389|NCT04848259|BB 1101|bb 1101|mesh-list
92020390|NCT04848259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020391|NCT04848259|Antiemetics|antiemetics|mesh-ancestor
92020392|NCT04848259|Autonomic Agents|autonomic agents|mesh-ancestor
92020393|NCT04848259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020394|NCT04848259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020395|NCT04848259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020396|NCT04848259|Glucocorticoids|glucocorticoids|mesh-ancestor
92020397|NCT04848259|Hormones|hormones|mesh-ancestor
92020398|NCT04848259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020399|NCT04848259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020400|NCT04848259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020401|NCT04848259|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020402|NCT04848259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020403|NCT04848259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020404|NCT03039049|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92020405|NCT03039049|Luteolytic Agents|luteolytic agents|mesh-ancestor
92020406|NCT03039049|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92020407|NCT03039049|Contraceptive Agents|contraceptive agents|mesh-ancestor
92020408|NCT03039049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92020409|NCT03039049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020410|NCT03039049|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92020411|NCT03039049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020412|NCT03039049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020413|NCT04848181|Cyproterone Acetate|cyproterone acetate|mesh-list
92020414|NCT04848181|Finasteride|finasteride|mesh-list
92020415|NCT04848181|Cyproterone|cyproterone|mesh-list
92020416|NCT04848181|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92020417|NCT04848181|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92020418|NCT04848181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020419|NCT04848181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020420|NCT04848181|Hormone Antagonists|hormone antagonists|mesh-ancestor
92020421|NCT04848181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020422|NCT04848181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020423|NCT04848181|Urological Agents|urological agents|mesh-ancestor
92020424|NCT04848181|Androgen Antagonists|androgen antagonists|mesh-ancestor
92020425|NCT04848181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020426|NCT04848181|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92020427|NCT04848181|Contraceptive Agents|contraceptive agents|mesh-ancestor
92020428|NCT04848181|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92020429|NCT04847791|Lactoferrin|lactoferrin|mesh-list
92020430|NCT04847791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020431|NCT04375813|Sirolimus|sirolimus|mesh-list
92020432|NCT04375813|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984802|NCT02055820|Obinutuzumab|obinutuzumab|mesh-list
91984803|NCT02055820|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984804|NCT02055820|Immunologic Factors|immunologic factors|mesh-ancestor
92020433|NCT04375813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020434|NCT04375813|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92020435|NCT04375813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020436|NCT04375813|Antifungal Agents|antifungal agents|mesh-ancestor
92020437|NCT04375813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020438|NCT04375813|Immunologic Factors|immunologic factors|mesh-ancestor
92020439|NCT04375813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020440|NCT04847245|Pregabalin|pregabalin|mesh-list
92020441|NCT04847245|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92020442|NCT04847245|Esketamine|esketamine|mesh-list
92020443|NCT04847245|Analgesics|analgesics|mesh-ancestor
92020444|NCT04847245|Sensory System Agents|sensory system agents|mesh-ancestor
92020445|NCT04847245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020450|NCT04847245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020451|NCT04847245|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020452|NCT04847245|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92020453|NCT04847245|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92020454|NCT04847245|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020455|NCT04847245|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92020456|NCT04847245|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92020457|NCT04847245|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92020458|NCT04847245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020459|NCT04847245|Antidepressive Agents|antidepressive agents|mesh-ancestor
92020460|NCT04847245|Dopamine Agents|dopamine agents|mesh-ancestor
92020462|NCT04839913|Immunologic Factors|immunologic factors|mesh-ancestor
92020463|NCT04839913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020464|NCT04846621|Calcium Channel Blockers|calcium channel blockers|mesh-list
92020465|NCT04846621|Calcium|calcium|mesh-list
92020466|NCT04846621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020467|NCT04846621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020468|NCT04846621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020469|NCT04846621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020470|NCT04854577|Anesthetics|anesthetics|mesh-list
92020471|NCT04854577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020472|NCT04854577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020473|NCT04839445|Anesthetics|anesthetics|mesh-list
92020474|NCT04839445|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020475|NCT04839445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020476|NCT04845607|Amiodarone|amiodarone|mesh-list
92020477|NCT04845607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92020478|NCT04845607|Vasodilator Agents|vasodilator agents|mesh-ancestor
92020479|NCT04845607|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92020480|NCT04845607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020481|NCT04845607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020482|NCT04845607|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92020483|NCT04845607|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92020484|NCT04845607|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92020485|NCT04845607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020486|NCT04845607|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92020487|NCT04845607|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92020488|NCT04845607|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92020489|NCT04853797|Calcium|calcium|mesh-list
92020490|NCT04853797|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020491|NCT04853797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020492|NCT03040531|Vitamin D|vitamin d|mesh-list
92020493|NCT03040531|Cholecalciferol|cholecalciferol|mesh-list
92020494|NCT03040531|Alendronate|alendronate|mesh-list
92020495|NCT03040531|Genistein|genistein|mesh-list
92020496|NCT03040531|Calcium|calcium|mesh-list
92020497|NCT03040531|Vitamins|vitamins|mesh-ancestor
92020498|NCT03040531|Micronutrients|micronutrients|mesh-ancestor
92020499|NCT03040531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020500|NCT03040531|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020501|NCT03040531|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92020502|NCT03040531|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92020503|NCT03040531|Protective Agents|protective agents|mesh-ancestor
92020504|NCT03040531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020505|NCT03040531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92020506|NCT03040531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020507|NCT03040531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020508|NCT03040531|Phytoestrogens|phytoestrogens|mesh-ancestor
92020509|NCT03040531|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92020510|NCT03040531|Estrogens|estrogens|mesh-ancestor
92020511|NCT03040531|Hormones|hormones|mesh-ancestor
92020512|NCT03040531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020513|NCT04838665|Phenylephrine|phenylephrine|mesh-list
92020514|NCT04838665|Oxymetazoline|oxymetazoline|mesh-list
92020519|NCT04838665|Autonomic Agents|autonomic agents|mesh-ancestor
92020520|NCT04838665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020521|NCT04838665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020522|NCT04838665|Sympathomimetics|sympathomimetics|mesh-ancestor
92020523|NCT04838665|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92020524|NCT04838665|Nasal Decongestants|nasal decongestants|mesh-ancestor
92020525|NCT04838665|Respiratory System Agents|respiratory system agents|mesh-ancestor
92020526|NCT04838665|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92020527|NCT04838665|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92020528|NCT04838665|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92020529|NCT04838665|Adrenergic Agents|adrenergic agents|mesh-ancestor
92020530|NCT04838665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020531|NCT04838665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020532|NCT04838665|Protective Agents|protective agents|mesh-ancestor
92020533|NCT04838665|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92020534|NCT04838665|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92020535|NCT04838665|Cholinergic Agents|cholinergic agents|mesh-ancestor
92020536|NCT04838665|Parasympatholytics|parasympatholytics|mesh-ancestor
92020537|NCT04845061|Nebivolol|nebivolol|mesh-list
92020538|NCT04845061|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92020539|NCT04845061|Vasodilator Agents|vasodilator agents|mesh-ancestor
92020540|NCT04845061|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92020541|NCT04845061|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92020542|NCT04845061|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92020543|NCT04845061|Adrenergic Agents|adrenergic agents|mesh-ancestor
92020544|NCT04845061|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020545|NCT04845061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020546|NCT04845061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020547|NCT03040765|Zoledronic Acid|zoledronic acid|mesh-list
92020548|NCT03040765|Denosumab|denosumab|mesh-list
92020549|NCT03040765|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92020550|NCT03040765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020551|NCT01668667|Gabapentin|gabapentin|mesh-list
92020552|NCT01668667|Analgesics|analgesics|mesh-ancestor
92020553|NCT01668667|Sensory System Agents|sensory system agents|mesh-ancestor
92020554|NCT01668667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020555|NCT01668667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020556|NCT01668667|Anticonvulsants|anticonvulsants|mesh-ancestor
92020557|NCT01668667|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92020558|NCT01668667|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92020559|NCT01668667|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020560|NCT01668667|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92020561|NCT01668667|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92020562|NCT01668667|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92020563|NCT01668667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020564|NCT01668667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020565|NCT01668667|Antimanic Agents|antimanic agents|mesh-ancestor
92020566|NCT03040219|Folic Acid|folic acid|mesh-list
92020567|NCT03040219|Hematinics|hematinics|mesh-ancestor
92020568|NCT03040219|Vitamin B Complex|vitamin b complex|mesh-ancestor
92020569|NCT03040219|Vitamins|vitamins|mesh-ancestor
92020570|NCT03040219|Micronutrients|micronutrients|mesh-ancestor
92020571|NCT03040219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020572|NCT03038503|Terlipressin|terlipressin|mesh-list
92020573|NCT03038503|Methylene Blue|methylene blue|mesh-list
92020574|NCT03038503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020575|NCT03038503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020576|NCT03038503|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92020577|NCT03038503|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92020578|NCT02608879|Chlorhexidine|chlorhexidine|mesh-list
92020579|NCT02608879|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92020580|NCT02608879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020581|NCT02608879|Disinfectants|disinfectants|mesh-ancestor
92020582|NCT04142125|Rivaroxaban|rivaroxaban|mesh-list
92020583|NCT04142125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020584|NCT04142125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020585|NCT04142125|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92020587|NCT04142125|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92020592|NCT04852315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020593|NCT04852315|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92020594|NCT04852315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020595|NCT04852315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020596|NCT04852315|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92020597|NCT04852315|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92020598|NCT04852315|Purinergic Agents|purinergic agents|mesh-ancestor
92020599|NCT04852315|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020600|NCT03038425|Ropivacaine|ropivacaine|mesh-list
92020601|NCT03038425|Anesthetics, Local|anesthetics, local|mesh-ancestor
92020602|NCT03038425|Anesthetics|anesthetics|mesh-ancestor
92020603|NCT03038425|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020604|NCT03038425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020605|NCT03038425|Sensory System Agents|sensory system agents|mesh-ancestor
92020606|NCT03038425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020607|NCT04851769|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92020608|NCT04851769|Alirocumab|alirocumab|mesh-list
92020609|NCT04851769|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92020610|NCT04851769|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92020611|NCT04851769|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92020612|NCT04851769|Antimetabolites|antimetabolites|mesh-ancestor
92020613|NCT04851769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020614|NCT04851769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020615|NCT04851769|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92020616|NCT04851769|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92020617|NCT04851769|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020618|NCT04843267|Tislelizumab|tislelizumab|mesh-list
92020619|NCT04843267|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020620|NCT04843267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020621|NCT04852081|Tamoxifen|tamoxifen|mesh-list
92020622|NCT04852081|Letrozole|letrozole|mesh-list
92020623|NCT04852081|Fulvestrant|fulvestrant|mesh-list
92020624|NCT04852081|Palbociclib|palbociclib|mesh-list
92020625|NCT04852081|Anastrozole|anastrozole|mesh-list
92020626|NCT04852081|Exemestane|exemestane|mesh-list
92020627|NCT04852081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020628|NCT04852081|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92020629|NCT04852081|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92020630|NCT04852081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020631|NCT04852081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020632|NCT04852081|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92020633|NCT04852081|Hormone Antagonists|hormone antagonists|mesh-ancestor
92020634|NCT04852081|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020635|NCT04852081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020636|NCT04852081|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020637|NCT04852081|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92020638|NCT04852081|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92020639|NCT04852081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92020640|NCT04852081|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92020641|NCT04852081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92020642|NCT04851457|Tirofiban|tirofiban|mesh-list
92020643|NCT04851457|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92020644|NCT04851457|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92020645|NCT04851457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020646|NCT04851457|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92020647|NCT02608099|Apixaban|apixaban|mesh-list
92020648|NCT02608099|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92020649|NCT02608099|Antithrombins|antithrombins|mesh-ancestor
92020650|NCT02608099|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92020651|NCT02608099|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020652|NCT02608099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020653|NCT02608099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020654|NCT02608099|Anticoagulants|anticoagulants|mesh-ancestor
92020655|NCT04850755|Nivolumab|nivolumab|mesh-list
92020656|NCT04850755|Ipilimumab|ipilimumab|mesh-list
92020657|NCT04850755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020658|NCT04850755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020661|NCT04842487|Prednisone|prednisone|mesh-list
91984805|NCT02055820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984806|NCT02055820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020662|NCT04842487|Cyclophosphamide|cyclophosphamide|mesh-list
92020663|NCT04842487|Rituximab|rituximab|mesh-list
92020664|NCT04842487|Vincristine|vincristine|mesh-list
92020665|NCT04842487|Lenalidomide|lenalidomide|mesh-list
92020666|NCT04842487|Doxorubicin|doxorubicin|mesh-list
92020667|NCT04842487|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92020668|NCT04842487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020669|NCT04842487|Immunologic Factors|immunologic factors|mesh-ancestor
92020670|NCT04842487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020671|NCT04842487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020672|NCT04842487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92020673|NCT04842487|Alkylating Agents|alkylating agents|mesh-ancestor
92020674|NCT04842487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020675|NCT04842487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020676|NCT04842487|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92020677|NCT04842487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020678|NCT04842487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020679|NCT04842487|Glucocorticoids|glucocorticoids|mesh-ancestor
92020680|NCT04842487|Hormones|hormones|mesh-ancestor
92020681|NCT04842487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020682|NCT04842487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020683|NCT04842487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92020684|NCT04842487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92020685|NCT04842487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92020686|NCT04842487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92020687|NCT04842487|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92020688|NCT04842487|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92020689|NCT04842487|Growth Substances|growth substances|mesh-ancestor
92020690|NCT04842487|Growth Inhibitors|growth inhibitors|mesh-ancestor
92020691|NCT04842487|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92020692|NCT04842487|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92020693|NCT04842487|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92020694|NCT04842487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020695|NCT04842331|Nitric Oxide|nitric oxide|mesh-list
92020696|NCT04842331|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92020697|NCT04842331|Autonomic Agents|autonomic agents|mesh-ancestor
92020698|NCT04842331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020699|NCT04842331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020700|NCT04842331|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92020701|NCT04842331|Respiratory System Agents|respiratory system agents|mesh-ancestor
92020702|NCT04842331|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92020703|NCT04842331|Antioxidants|antioxidants|mesh-ancestor
92020704|NCT04842331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020705|NCT04842331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020706|NCT04842331|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92020707|NCT04842331|Vasodilator Agents|vasodilator agents|mesh-ancestor
92020708|NCT04842331|Gasotransmitters|gasotransmitters|mesh-ancestor
92020709|NCT04842331|Protective Agents|protective agents|mesh-ancestor
92020710|NCT04837885|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92020711|NCT04837885|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92020712|NCT04837885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020713|NCT04833205|Nimotuzumab|nimotuzumab|mesh-list
92020714|NCT04833205|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020715|NCT04833205|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020717|NCT04312243|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92020718|NCT04312243|Autonomic Agents|autonomic agents|mesh-ancestor
92020719|NCT04312243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020720|NCT04312243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020721|NCT04312243|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92020722|NCT04312243|Respiratory System Agents|respiratory system agents|mesh-ancestor
92020723|NCT04312243|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92020724|NCT04312243|Antioxidants|antioxidants|mesh-ancestor
92020725|NCT04312243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020726|NCT04312243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020727|NCT04312243|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92020728|NCT04312243|Vasodilator Agents|vasodilator agents|mesh-ancestor
92020729|NCT04312243|Gasotransmitters|gasotransmitters|mesh-ancestor
92020733|NCT04841551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020735|NCT04837651|Immunologic Factors|immunologic factors|mesh-ancestor
92020736|NCT04837651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020738|NCT03039205|Ticagrelor|ticagrelor|mesh-list
92020739|NCT03039205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92020740|NCT03039205|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92020741|NCT03039205|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92020742|NCT03039205|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92020743|NCT03039205|Purinergic Agents|purinergic agents|mesh-ancestor
92020744|NCT03039205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020745|NCT03039205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020746|NCT03039205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020747|NCT04837261|Propranolol|propranolol|mesh-list
92020748|NCT04837261|Amiodarone|amiodarone|mesh-list
92020749|NCT04837261|Flecainide|flecainide|mesh-list
92020750|NCT04837261|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92020751|NCT04837261|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92020752|NCT04837261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92020753|NCT04837261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020754|NCT04837261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020755|NCT04837261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020756|NCT04837261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92020757|NCT04837261|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92020758|NCT04837261|Vasodilator Agents|vasodilator agents|mesh-ancestor
92020759|NCT04837261|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92020760|NCT04837261|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020761|NCT04837261|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92020762|NCT04837261|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92020763|NCT04837261|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92020764|NCT04837261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020765|NCT04837261|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92020766|NCT04837261|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92020767|NCT04837261|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92020768|NCT04837261|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92020770|NCT04792645|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92020771|NCT04792645|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92020772|NCT04792645|Dopamine Agents|dopamine agents|mesh-ancestor
92020773|NCT04792645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020774|NCT04792645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020775|NCT04792645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020776|NCT04792645|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92020777|NCT04792645|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92020778|NCT04832035|Psychotropic Drugs|psychotropic drugs|mesh-list
92020779|NCT04824937|Talazoparib|talazoparib|mesh-list
92020780|NCT04824937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92020781|NCT04824937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020782|NCT04824937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020783|NCT04824937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020784|NCT03036085|Epinephrine|epinephrine|mesh-list
92020785|NCT03036085|Bupivacaine|bupivacaine|mesh-list
92020786|NCT03036085|Anesthetics, Local|anesthetics, local|mesh-ancestor
92020787|NCT03036085|Anesthetics|anesthetics|mesh-ancestor
92020788|NCT03036085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020789|NCT03036085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020790|NCT03036085|Sensory System Agents|sensory system agents|mesh-ancestor
92020791|NCT03036085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020792|NCT03036085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92020793|NCT03036085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92020794|NCT03036085|Adrenergic Agents|adrenergic agents|mesh-ancestor
92020795|NCT03036085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020796|NCT03036085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020797|NCT03036085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92020798|NCT03036085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92020799|NCT03036085|Autonomic Agents|autonomic agents|mesh-ancestor
92020800|NCT03036085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92020819|NCT02431533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92020820|NCT02431533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020822|NCT02413593|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92020823|NCT02413593|Ledipasvir|ledipasvir|mesh-list
92020824|NCT02413593|Antiviral Agents|antiviral agents|mesh-ancestor
92020825|NCT02413593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020826|NCT01652703|Evolocumab|evolocumab|mesh-list
92020827|NCT01652703|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
91984807|NCT02055820|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91984808|NCT02055820|Alkylating Agents|alkylating agents|mesh-ancestor
92020828|NCT01652703|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92020829|NCT01652703|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92020830|NCT01652703|Antimetabolites|antimetabolites|mesh-ancestor
92020831|NCT01652703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020832|NCT01652703|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92020833|NCT01652703|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020834|NCT01652703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020835|NCT01652703|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92020836|NCT01652469|Docetaxel|docetaxel|mesh-list
92020837|NCT01652469|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92020838|NCT01652469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020839|NCT01652469|Tubulin Modulators|tubulin modulators|mesh-ancestor
92020840|NCT01652469|Antimitotic Agents|antimitotic agents|mesh-ancestor
92020841|NCT01652469|Mitosis Modulators|mitosis modulators|mesh-ancestor
92020842|NCT01652469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020843|NCT01652469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92020844|NCT01652469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020845|NCT02429427|Celecoxib|celecoxib|mesh-list
92020846|NCT02429427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92020847|NCT02429427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92020848|NCT02429427|Analgesics|analgesics|mesh-ancestor
92020849|NCT02429427|Sensory System Agents|sensory system agents|mesh-ancestor
92020850|NCT02429427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020851|NCT02429427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020852|NCT02429427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020854|NCT02429427|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92020855|NCT02429427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92020856|NCT02429427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020863|NCT02412657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020864|NCT02412657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020865|NCT02412657|Glucocorticoids|glucocorticoids|mesh-ancestor
92020866|NCT02412657|Hormones|hormones|mesh-ancestor
92020867|NCT02412657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020868|NCT02412657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92020869|NCT02412657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020870|NCT02412111|Ivacaftor|ivacaftor|mesh-list
92020871|NCT02412111|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92020872|NCT02412111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020873|NCT02412111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020874|NCT02426541|Dapagliflozin|dapagliflozin|mesh-list
92020875|NCT02426541|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92020876|NCT02426541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020877|NCT02426541|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92020878|NCT02426541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020879|NCT02484651|Rocuronium|rocuronium|mesh-list
92020880|NCT02484651|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92020881|NCT02484651|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92020882|NCT02484651|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92020883|NCT02484651|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020884|NCT02484651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020885|NCT02410551|Fludarabine|fludarabine|mesh-list
92020886|NCT02410551|Fludarabine phosphate|fludarabine phosphate|mesh-list
92020887|NCT02410551|Busulfan|busulfan|mesh-list
92020888|NCT02410551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020889|NCT02410551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92020890|NCT02410551|Antimetabolites|antimetabolites|mesh-ancestor
92020891|NCT02410551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020892|NCT02410551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020893|NCT02410551|Immunologic Factors|immunologic factors|mesh-ancestor
92020894|NCT02410551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020895|NCT02410551|Alkylating Agents|alkylating agents|mesh-ancestor
92020896|NCT02410551|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92020897|NCT02410551|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92020898|NCT02424591|Ketamine|ketamine|mesh-list
92020899|NCT02424591|Analgesics|analgesics|mesh-ancestor
92020900|NCT02424591|Sensory System Agents|sensory system agents|mesh-ancestor
92020901|NCT02424591|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984809|NCT02055820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984810|NCT02055820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984811|NCT02055820|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92020902|NCT02424591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020903|NCT02424591|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92020904|NCT02424591|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92020905|NCT02424591|Anesthetics, General|anesthetics, general|mesh-ancestor
92020906|NCT02424591|Anesthetics|anesthetics|mesh-ancestor
92020907|NCT02424591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020908|NCT02424591|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92020909|NCT02424591|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92020910|NCT02424591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020989|NCT04829695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92020911|NCT02424591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020913|NCT02408523|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92020914|NCT02408523|Anticonvulsants|anticonvulsants|mesh-ancestor
92020915|NCT02408523|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92020916|NCT02408523|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92020917|NCT02408523|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020918|NCT02408523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020919|NCT04822909|Thalidomide|thalidomide|mesh-list
92020920|NCT04822909|Apremilast|apremilast|mesh-list
92020921|NCT04822909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92020922|NCT04822909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92020923|NCT04822909|Analgesics|analgesics|mesh-ancestor
92020926|NCT04822909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020927|NCT04822909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020928|NCT04822909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92020929|NCT04822909|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92020930|NCT04822909|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92020931|NCT04822909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020932|NCT04822909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020933|NCT04822909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020934|NCT04822909|Immunologic Factors|immunologic factors|mesh-ancestor
92020935|NCT04822909|Leprostatic Agents|leprostatic agents|mesh-ancestor
92020936|NCT04822909|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92020937|NCT04822909|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020938|NCT04822909|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92020939|NCT04822909|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92020940|NCT04822909|Growth Substances|growth substances|mesh-ancestor
92020941|NCT04822909|Growth Inhibitors|growth inhibitors|mesh-ancestor
92020942|NCT04822909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020943|NCT04831099|Testosterone|testosterone|mesh-list
92020944|NCT04831099|Androgens|androgens|mesh-ancestor
92020946|NCT04831099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020947|NCT04831099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020948|NCT04830241|Antidepressive Agents|antidepressive agents|mesh-list
92020949|NCT04830241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92020950|NCT02603419|Avelumab|avelumab|mesh-list
92020951|NCT02603419|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92020952|NCT02603419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020953|NCT02603419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020954|NCT02603419|Immunologic Factors|immunologic factors|mesh-ancestor
92020955|NCT02603419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020956|NCT04367935|Pentoxifylline|pentoxifylline|mesh-list
92020957|NCT04367935|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92020958|NCT04367935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020959|NCT04367935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020960|NCT04367935|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92020961|NCT04367935|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92020962|NCT04367935|Protective Agents|protective agents|mesh-ancestor
92020963|NCT04367935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020964|NCT04367935|Vasodilator Agents|vasodilator agents|mesh-ancestor
92020965|NCT04367935|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92020966|NCT04367935|Antioxidants|antioxidants|mesh-ancestor
92020967|NCT04829773|Midazolam|midazolam|mesh-list
92020968|NCT04829773|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92020969|NCT04829773|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91984812|NCT02055820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020970|NCT04829773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020971|NCT04829773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020972|NCT04829773|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92020973|NCT04829773|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92020974|NCT04829773|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92020975|NCT04829773|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92020976|NCT04829773|Anesthetics, General|anesthetics, general|mesh-ancestor
92020977|NCT04829773|Anesthetics|anesthetics|mesh-ancestor
92020978|NCT04829773|GABA Modulators|gaba modulators|mesh-ancestor
92020979|NCT04829773|GABA Agents|gaba agents|mesh-ancestor
92020980|NCT04829773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92020981|NCT04829773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020983|NCT04829695|Lumefantrine|lumefantrine|mesh-list
92020984|NCT04829695|Artemether|artemether|mesh-list
92020985|NCT04829695|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92020986|NCT04829695|Amodiaquine|amodiaquine|mesh-list
92020987|NCT04829695|Antimalarials|antimalarials|mesh-ancestor
92020988|NCT04829695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92020990|NCT04829695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92020991|NCT04829695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020992|NCT04829695|Antiviral Agents|antiviral agents|mesh-ancestor
92020993|NCT04829695|Schistosomicides|schistosomicides|mesh-ancestor
92020994|NCT04829695|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92020995|NCT04829695|Anthelmintics|anthelmintics|mesh-ancestor
92020996|NCT04835233|Methyldopa|methyldopa|mesh-list
92020997|NCT04835233|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021002|NCT04835233|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92021003|NCT04835233|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92021004|NCT04835233|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92021005|NCT04835233|Adrenergic Agents|adrenergic agents|mesh-ancestor
92021006|NCT04835233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021007|NCT04835233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021008|NCT03035695|Hemostatics|hemostatics|mesh-list
92021009|NCT03035695|Coagulants|coagulants|mesh-ancestor
92021010|NCT04821583|Hydrocortisone|hydrocortisone|mesh-list
92021011|NCT04821583|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021012|NCT01667731|Sofosbuvir|sofosbuvir|mesh-list
92021013|NCT01667731|Antiviral Agents|antiviral agents|mesh-ancestor
92021014|NCT01667731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021015|NCT04828525|Dexamethasone|dexamethasone|mesh-list
92021016|NCT04828525|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021017|NCT04828525|Antiemetics|antiemetics|mesh-ancestor
92021018|NCT04828525|Autonomic Agents|autonomic agents|mesh-ancestor
92021019|NCT04828525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021020|NCT04828525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021021|NCT04828525|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021022|NCT04828525|Glucocorticoids|glucocorticoids|mesh-ancestor
92021023|NCT04828525|Hormones|hormones|mesh-ancestor
92021024|NCT04828525|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021025|NCT04828525|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92021026|NCT04828525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021027|NCT04821193|Chlorhexidine|chlorhexidine|mesh-list
92021028|NCT04821193|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92021029|NCT04821193|Disinfectants|disinfectants|mesh-list
92021030|NCT04821193|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92021031|NCT04821193|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92021032|NCT04821193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021033|NCT04821193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021034|NCT04820803|Cetylpyridinium|cetylpyridinium|mesh-list
92021035|NCT04820803|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92021036|NCT04820803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021037|NCT04827667|Dimercaprol|dimercaprol|mesh-list
92021038|NCT04827667|Chelating Agents|chelating agents|mesh-ancestor
92021039|NCT04827667|Sequestering Agents|sequestering agents|mesh-ancestor
92021040|NCT04827667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021041|NCT04360135|Acetaminophen|acetaminophen|mesh-list
92021042|NCT04360135|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021043|NCT04360135|Analgesics|analgesics|mesh-ancestor
92021044|NCT04360135|Sensory System Agents|sensory system agents|mesh-ancestor
92021045|NCT04360135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021046|NCT04360135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021047|NCT04360135|Antipyretics|antipyretics|mesh-ancestor
92021049|NCT05617885|Goserelin|goserelin|mesh-list
91984813|NCT02055820|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91984814|NCT02055820|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91984815|NCT02055820|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92021050|NCT05617885|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92021051|NCT05617885|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92021052|NCT05617885|Fertility Agents|fertility agents|mesh-ancestor
92021053|NCT05617885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92021054|NCT05617885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021055|NCT05617885|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92021056|NCT05617885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021057|NCT05617885|Hormones|hormones|mesh-ancestor
92021058|NCT05617885|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021059|NCT02605837|Budesonide|budesonide|mesh-list
92021060|NCT02605837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021061|NCT02605837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92021062|NCT02605837|Autonomic Agents|autonomic agents|mesh-ancestor
92021063|NCT02605837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021064|NCT02605837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021065|NCT02605837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92021066|NCT02605837|Respiratory System Agents|respiratory system agents|mesh-ancestor
92021067|NCT02605837|Glucocorticoids|glucocorticoids|mesh-ancestor
92021068|NCT02605837|Hormones|hormones|mesh-ancestor
92021069|NCT02605837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021072|NCT04820101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021073|NCT04820101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021074|NCT04820101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021075|NCT04820101|Analgesics|analgesics|mesh-ancestor
92021076|NCT04820101|Sensory System Agents|sensory system agents|mesh-ancestor
92021077|NCT04820101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021078|NCT04820101|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92021079|NCT04820101|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92021080|NCT04820101|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92021081|NCT04820101|Adrenergic Agents|adrenergic agents|mesh-ancestor
92021082|NCT04820101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021083|NCT04820101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021084|NCT04819867|Propolis|propolis|mesh-list
92021085|NCT04819867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021086|NCT02423343|Nivolumab|nivolumab|mesh-list
92021087|NCT02423343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021088|NCT02423343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021089|NCT02423343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92021090|NCT02423343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021091|NCT04909515|Isotretinoin|isotretinoin|mesh-list
92021092|NCT04909515|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021093|NCT05617729|Povidone-Iodine|povidone-iodine|mesh-list
92021094|NCT05617729|Povidone|povidone|mesh-list
92021095|NCT05617729|Plasma Substitutes|plasma substitutes|mesh-ancestor
92021096|NCT05617729|Blood Substitutes|blood substitutes|mesh-ancestor
92021097|NCT05617729|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92021098|NCT05617729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021099|NCT04818931|Cefazolin|cefazolin|mesh-list
92021100|NCT04818931|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92021101|NCT04818931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021102|NCT02406261|Midazolam|midazolam|mesh-list
92021103|NCT02406261|Donepezil|donepezil|mesh-list
92021104|NCT02406261|Simvastatin|simvastatin|mesh-list
92021105|NCT02406261|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92021106|NCT02406261|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92021107|NCT02406261|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021108|NCT02406261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021109|NCT02406261|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92021110|NCT02406261|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92021111|NCT02406261|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92021112|NCT02406261|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92021113|NCT02406261|Anesthetics, General|anesthetics, general|mesh-ancestor
92021114|NCT02406261|Anesthetics|anesthetics|mesh-ancestor
92021115|NCT02406261|GABA Modulators|gaba modulators|mesh-ancestor
92021116|NCT02406261|GABA Agents|gaba agents|mesh-ancestor
92021117|NCT02406261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021118|NCT02406261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021119|NCT02406261|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91984816|NCT02055820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984817|NCT02055820|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984818|NCT02055820|Glucocorticoids|glucocorticoids|mesh-ancestor
91984819|NCT02055820|Hormones|hormones|mesh-ancestor
92021120|NCT02406261|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92021121|NCT02406261|Antimetabolites|antimetabolites|mesh-ancestor
92021122|NCT02406261|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92021123|NCT02406261|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92021124|NCT02406261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021125|NCT02406261|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92021126|NCT02406261|Cholinergic Agents|cholinergic agents|mesh-ancestor
92021127|NCT02406261|Nootropic Agents|nootropic agents|mesh-ancestor
92021128|NCT02485353|Cytarabine|cytarabine|mesh-list
92021129|NCT02485353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92021130|NCT02485353|Antimetabolites|antimetabolites|mesh-ancestor
92021131|NCT02485353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021132|NCT02485353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021133|NCT02485353|Antiviral Agents|antiviral agents|mesh-ancestor
92021134|NCT02485353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021135|NCT02485353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92021136|NCT02485353|Immunologic Factors|immunologic factors|mesh-ancestor
92021137|NCT02485353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021138|NCT02603107|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92021139|NCT02603107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021140|NCT02603107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021141|NCT02603107|Antiviral Agents|antiviral agents|mesh-ancestor
92021142|NCT02603107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021143|NCT02603107|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92021147|NCT02603107|Protease Inhibitors|protease inhibitors|mesh-ancestor
92021148|NCT02601625|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92021149|NCT02601625|Immunologic Factors|immunologic factors|mesh-ancestor
92021150|NCT02601625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021151|NCT04826497|Nicorandil|nicorandil|mesh-list
92021152|NCT04826497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92021153|NCT04826497|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021154|NCT04826497|Vasodilator Agents|vasodilator agents|mesh-ancestor
92021155|NCT04826497|Vitamin B Complex|vitamin b complex|mesh-ancestor
92021156|NCT04826497|Vitamins|vitamins|mesh-ancestor
92021157|NCT04826497|Micronutrients|micronutrients|mesh-ancestor
92021158|NCT04826497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021159|NCT04819243|Atezolizumab|atezolizumab|mesh-list
92021160|NCT04819243|Talazoparib|talazoparib|mesh-list
92021161|NCT04819243|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92021162|NCT04819243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021163|NCT04819243|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021164|NCT04819243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021165|NCT04819243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92021166|NCT04819243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021167|NCT02604589|Hydromorphone|hydromorphone|mesh-list
92021168|NCT02604589|Bupivacaine|bupivacaine|mesh-list
92021169|NCT02604589|Anesthetics, Local|anesthetics, local|mesh-ancestor
92021170|NCT02604589|Anesthetics|anesthetics|mesh-ancestor
92021171|NCT02604589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021172|NCT02604589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021173|NCT02604589|Sensory System Agents|sensory system agents|mesh-ancestor
92021174|NCT02604589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021175|NCT02604589|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92021176|NCT02604589|Narcotics|narcotics|mesh-ancestor
92021177|NCT02604589|Analgesics|analgesics|mesh-ancestor
92021178|NCT04818151|Warfarin|warfarin|mesh-list
92021179|NCT04818151|Apixaban|apixaban|mesh-list
92021180|NCT04818151|Anticoagulants|anticoagulants|mesh-ancestor
92021181|NCT04818151|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92021182|NCT04818151|Antithrombins|antithrombins|mesh-ancestor
92021183|NCT04818151|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92021184|NCT04818151|Protease Inhibitors|protease inhibitors|mesh-ancestor
92021185|NCT04818151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021186|NCT04818151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021187|NCT04817527|Edaravone|edaravone|mesh-list
92021188|NCT04817527|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92021189|NCT04817527|Antioxidants|antioxidants|mesh-ancestor
92021190|NCT04817527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021191|NCT04817527|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92021192|NCT04817527|Protective Agents|protective agents|mesh-ancestor
91984820|NCT02055820|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984821|NCT02055820|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92021193|NCT04817527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021195|NCT04357795|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92021196|NCT04357795|Cyclosporins|cyclosporins|mesh-list
92021197|NCT04357795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021198|NCT04357795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021199|NCT04357795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92021200|NCT04357795|Immunologic Factors|immunologic factors|mesh-ancestor
92021201|NCT04357795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021202|NCT04357795|Antifungal Agents|antifungal agents|mesh-ancestor
92021203|NCT04357795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021204|NCT04357795|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021205|NCT04357795|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021206|NCT04357795|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92021207|NCT04357795|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92021208|NCT02604199|Tenofovir|tenofovir|mesh-list
92021209|NCT02604199|Entecavir|entecavir|mesh-list
92021210|NCT02604199|Histamine Antagonists|histamine antagonists|mesh-list
92021211|NCT02604199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92021212|NCT02604199|Antiviral Agents|antiviral agents|mesh-ancestor
92021213|NCT02604199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021214|NCT02604199|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92021215|NCT02604199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92021216|NCT02604199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021218|NCT02604199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92021219|NCT02604199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92021220|NCT02604199|Histamine Agents|histamine agents|mesh-ancestor
92021221|NCT02604199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021222|NCT02604199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021224|NCT04807543|17 alpha-Hydroxyprogesterone Caproate|17 alpha-hydroxyprogesterone caproate|mesh-list
92021225|NCT04807543|11-hydroxyprogesterone|11-hydroxyprogesterone|mesh-list
92021226|NCT04807543|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92021227|NCT04807543|Hormone Antagonists|hormone antagonists|mesh-ancestor
92021228|NCT04807543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021229|NCT04807543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021230|NCT04807543|Progestins|progestins|mesh-ancestor
92021231|NCT04807543|Hormones|hormones|mesh-ancestor
92021232|NCT04807543|Cathartics|cathartics|mesh-ancestor
92021233|NCT04807543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021234|NCT04797949|Aspirin|aspirin|mesh-list
92021235|NCT04797949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021236|NCT04797949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021237|NCT04797949|Analgesics|analgesics|mesh-ancestor
92021238|NCT04797949|Sensory System Agents|sensory system agents|mesh-ancestor
92021239|NCT04797949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021240|NCT04797949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021241|NCT04797949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021242|NCT04797949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021243|NCT04797949|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92021244|NCT04797949|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92021245|NCT04797949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021246|NCT04797949|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92021247|NCT04797949|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92021248|NCT04797949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021249|NCT04797949|Antipyretics|antipyretics|mesh-ancestor
92021250|NCT04797793|Adapalene|adapalene|mesh-list
92021251|NCT04797793|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021252|NCT04797793|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021253|NCT04797793|Analgesics|analgesics|mesh-ancestor
92021254|NCT04797793|Sensory System Agents|sensory system agents|mesh-ancestor
92021255|NCT04797793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021256|NCT04797793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021257|NCT04797793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021258|NCT04797793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021259|NCT04797793|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021260|NCT04796857|Lenalidomide|lenalidomide|mesh-list
92021262|NCT04796857|Antibodies|antibodies|mesh-list
92021263|NCT04796857|Immunologic Factors|immunologic factors|mesh-ancestor
91984822|NCT02055820|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91984823|NCT02055820|Tubulin Modulators|tubulin modulators|mesh-ancestor
92021264|NCT04796857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021265|NCT04796857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92021266|NCT04796857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92021267|NCT04796857|Growth Substances|growth substances|mesh-ancestor
92021268|NCT04796857|Growth Inhibitors|growth inhibitors|mesh-ancestor
92021269|NCT04796857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021270|NCT04796857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021271|NCT04796623|Fulvestrant|fulvestrant|mesh-list
92021272|NCT04796623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92021273|NCT04796623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021274|NCT04796623|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92021275|NCT04796623|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92021276|NCT04796623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92021277|NCT04796623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021278|NCT04796623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021279|NCT04815265|Dexmedetomidine|dexmedetomidine|mesh-list
92021280|NCT04815265|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92021281|NCT04815265|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021282|NCT04815265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021283|NCT04815265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021284|NCT04815265|Analgesics|analgesics|mesh-ancestor
92021285|NCT04815265|Sensory System Agents|sensory system agents|mesh-ancestor
92021286|NCT04815265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021287|NCT04815265|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92021288|NCT04815265|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92021289|NCT04815265|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92021293|NCT04815187|Montelukast|montelukast|mesh-list
92021294|NCT04815187|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92021295|NCT04815187|Respiratory System Agents|respiratory system agents|mesh-ancestor
92021296|NCT04815187|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92021297|NCT04815187|Hormone Antagonists|hormone antagonists|mesh-ancestor
92021298|NCT04815187|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021448|NCT04802785|Autonomic Agents|autonomic agents|mesh-ancestor
92021299|NCT04815187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021300|NCT04815187|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92021301|NCT04815187|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92021302|NCT04815187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021303|NCT04814719|Pentosan Sulfuric Polyester|pentosan sulfuric polyester|mesh-list
92021304|NCT04814719|Anticoagulants|anticoagulants|mesh-ancestor
92021305|NCT04805827|Gabapentin|gabapentin|mesh-list
92021306|NCT04805827|Analgesics|analgesics|mesh-ancestor
92021307|NCT04805827|Sensory System Agents|sensory system agents|mesh-ancestor
92021308|NCT04805827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021309|NCT04805827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021310|NCT04805827|Anticonvulsants|anticonvulsants|mesh-ancestor
92021311|NCT04805827|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92021312|NCT04805827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92021313|NCT04805827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021314|NCT04805827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92021315|NCT04805827|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92021316|NCT04805827|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92021317|NCT04805827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021318|NCT04805827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021319|NCT04805827|Antimanic Agents|antimanic agents|mesh-ancestor
92021320|NCT02596711|Nicotine|nicotine|mesh-list
92021321|NCT02596711|Carbon Monoxide|carbon monoxide|mesh-list
92021322|NCT02596711|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92021323|NCT02596711|Autonomic Agents|autonomic agents|mesh-ancestor
92021324|NCT02596711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021325|NCT02596711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021327|NCT02596711|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92021328|NCT02596711|Cholinergic Agents|cholinergic agents|mesh-ancestor
92021329|NCT02596711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021330|NCT02596711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021331|NCT02596711|Antimetabolites|antimetabolites|mesh-ancestor
92021332|NCT02596711|Gasotransmitters|gasotransmitters|mesh-ancestor
92021333|NCT04805281|Lithium Carbonate|lithium carbonate|mesh-list
91984824|NCT02055820|Antimitotic Agents|antimitotic agents|mesh-ancestor
91984825|NCT02055820|Mitosis Modulators|mitosis modulators|mesh-ancestor
91984826|NCT05408559|Sulforaphane|sulforaphane|mesh-list
91984827|NCT05408559|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
91984828|NCT05408559|Protective Agents|protective agents|mesh-ancestor
91984829|NCT05408559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021334|NCT04805281|Antidepressive Agents|antidepressive agents|mesh-ancestor
92021335|NCT04805281|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92021336|NCT04805281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021337|NCT04805281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021338|NCT04805281|Antimanic Agents|antimanic agents|mesh-ancestor
92021339|NCT04805281|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92021340|NCT04805281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021341|NCT04805281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021342|NCT04814485|Paclitaxel|paclitaxel|mesh-list
92021343|NCT04814485|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92021344|NCT04814485|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92021345|NCT04814485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021346|NCT04814485|Tubulin Modulators|tubulin modulators|mesh-ancestor
92021347|NCT04814485|Antimitotic Agents|antimitotic agents|mesh-ancestor
92021348|NCT04814485|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021349|NCT04814485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021350|NCT04804423|Listerine|listerine|mesh-list
92021351|NCT04804423|Fluorides|fluorides|mesh-list
92021352|NCT04804423|Sodium Fluoride|sodium fluoride|mesh-list
92021353|NCT04804423|Fluorides, Topical|fluorides, topical|mesh-list
92021354|NCT04804423|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92021355|NCT04804423|Cariostatic Agents|cariostatic agents|mesh-ancestor
92021356|NCT04804423|Protective Agents|protective agents|mesh-ancestor
92021357|NCT04804423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021358|NCT04804423|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92021359|NCT04804423|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021360|NCT04794049|Lactulose|lactulose|mesh-list
92021363|NCT04794127|Trabectedin|trabectedin|mesh-list
92021364|NCT04794127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92021365|NCT04794127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021366|NCT04794127|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92021367|NCT04794127|Alkylating Agents|alkylating agents|mesh-ancestor
92021368|NCT04794127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021369|NCT04794127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021370|NCT04804267|Linaclotide|linaclotide|mesh-list
92021371|NCT04804267|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92021372|NCT04804267|Enzyme Activators|enzyme activators|mesh-ancestor
92021373|NCT04804267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021374|NCT04804267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021375|NCT04813471|Folic Acid|folic acid|mesh-list
92021376|NCT04813471|Nicorandil|nicorandil|mesh-list
92021377|NCT04813471|Vitamin B Complex|vitamin b complex|mesh-list
92021378|NCT04813471|Atorvastatin|atorvastatin|mesh-list
92021379|NCT04813471|Vitamins|vitamins|mesh-ancestor
92021380|NCT04813471|Micronutrients|micronutrients|mesh-ancestor
92021381|NCT04813471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021382|NCT04813471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92021383|NCT04813471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92021384|NCT04813471|Antimetabolites|antimetabolites|mesh-ancestor
92021385|NCT04813471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021386|NCT04813471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92021387|NCT04813471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92021388|NCT04813471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021389|NCT04813471|Hematinics|hematinics|mesh-ancestor
92021390|NCT04813471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92021391|NCT04813471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021392|NCT04813471|Vasodilator Agents|vasodilator agents|mesh-ancestor
92021393|NCT04803175|Valsartan|valsartan|mesh-list
92021394|NCT04803175|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92021395|NCT04803175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021396|NCT04803175|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92021397|NCT04803175|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
91984830|NCT05408559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984832|NCT02055352|Budesonide|budesonide|mesh-list
92021398|NCT04803175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021399|NCT04792723|Aspirin|aspirin|mesh-list
92021400|NCT04792723|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021401|NCT04792723|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021402|NCT04792723|Analgesics|analgesics|mesh-ancestor
92021403|NCT04792723|Sensory System Agents|sensory system agents|mesh-ancestor
92021404|NCT04792723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021405|NCT04792723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021406|NCT04792723|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021407|NCT04792723|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021408|NCT04792723|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92021409|NCT04792723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92021410|NCT04792723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021411|NCT04792723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92021412|NCT04792723|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92021413|NCT04792723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021414|NCT04792723|Antipyretics|antipyretics|mesh-ancestor
92021416|NCT04792333|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021417|NCT04802785|Aspirin|aspirin|mesh-list
92021418|NCT04802785|Domperidone|domperidone|mesh-list
92021419|NCT04802785|Melatonin|melatonin|mesh-list
92021420|NCT04802785|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92021421|NCT04802785|Simethicone|simethicone|mesh-list
92021422|NCT04802785|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92021423|NCT04802785|Citric Acid|citric acid|mesh-list
92021424|NCT04802785|Sodium Citrate|sodium citrate|mesh-list
92021425|NCT04802785|Anticoagulants|anticoagulants|mesh-ancestor
92021426|NCT04802785|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92021427|NCT04802785|Chelating Agents|chelating agents|mesh-ancestor
92021428|NCT04802785|Sequestering Agents|sequestering agents|mesh-ancestor
92021429|NCT04802785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021430|NCT04802785|Antioxidants|antioxidants|mesh-ancestor
92021431|NCT04802785|Protective Agents|protective agents|mesh-ancestor
92021432|NCT04802785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021433|NCT04802785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021435|NCT04802785|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021436|NCT04802785|Analgesics|analgesics|mesh-ancestor
92021437|NCT04802785|Sensory System Agents|sensory system agents|mesh-ancestor
92021438|NCT04802785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021439|NCT04802785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021440|NCT04802785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021441|NCT04802785|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92021442|NCT04802785|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92021443|NCT04802785|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92021444|NCT04802785|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92021445|NCT04802785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021446|NCT04802785|Antipyretics|antipyretics|mesh-ancestor
92021449|NCT04802785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021450|NCT04802785|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92021451|NCT04802785|Dopamine Agents|dopamine agents|mesh-ancestor
92021452|NCT04802785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021453|NCT04802785|Antifoaming Agents|antifoaming agents|mesh-ancestor
92021454|NCT04802785|Emollients|emollients|mesh-ancestor
92021455|NCT04802785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021456|NCT04802785|Nootropic Agents|nootropic agents|mesh-ancestor
92021457|NCT04802785|Antacids|antacids|mesh-ancestor
92021458|NCT02598193|Pirfenidone|pirfenidone|mesh-list
92021459|NCT02598193|Nintedanib|nintedanib|mesh-list
92021460|NCT02598193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021461|NCT02598193|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92021462|NCT02598193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021463|NCT02598193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021464|NCT02598193|Analgesics|analgesics|mesh-ancestor
92021465|NCT02598193|Sensory System Agents|sensory system agents|mesh-ancestor
92021466|NCT02598193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021467|NCT02598193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021468|NCT02598193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91984833|NCT02055352|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
91984834|NCT02055352|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91984835|NCT02055352|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92021469|NCT02598193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021470|NCT02598193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021471|NCT02598193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021473|NCT04802083|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92021474|NCT04802083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92021475|NCT04802083|Immunologic Factors|immunologic factors|mesh-ancestor
92021476|NCT04802083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021477|NCT04801303|Calcitriol|calcitriol|mesh-list
92021478|NCT04801303|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92021479|NCT04801303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021480|NCT04801303|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92021481|NCT04801303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92021482|NCT04801303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021483|NCT04801303|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92021484|NCT04801303|Vitamins|vitamins|mesh-ancestor
92021485|NCT04801303|Micronutrients|micronutrients|mesh-ancestor
92021486|NCT04801303|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92021487|NCT04790383|Polymethyl Methacrylate|polymethyl methacrylate|mesh-list
92021488|NCT04790383|Vasodilator Agents|vasodilator agents|mesh-ancestor
92021489|NCT04790383|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92021490|NCT04790383|Protective Agents|protective agents|mesh-ancestor
92021491|NCT04790383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021492|NCT02388165|Vaccines|vaccines|mesh-list
92021493|NCT02388165|Immunologic Factors|immunologic factors|mesh-ancestor
92021494|NCT02388165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021495|NCT04811911|Methotrexate|methotrexate|mesh-list
92021496|NCT04811911|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92021497|NCT04811911|Abortifacient Agents|abortifacient agents|mesh-ancestor
92021498|NCT04811911|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92021499|NCT04811911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021500|NCT04811911|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92021501|NCT04811911|Antimetabolites|antimetabolites|mesh-ancestor
92021502|NCT04811911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021503|NCT04811911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021504|NCT04811911|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021505|NCT04811911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021506|NCT04811911|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92021507|NCT04811911|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92021508|NCT04811911|Immunologic Factors|immunologic factors|mesh-ancestor
92021514|NCT04788979|Protective Agents|protective agents|mesh-ancestor
92021515|NCT04788979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021516|NCT04788979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021517|NCT04811209|Analgesics|analgesics|mesh-list
92021518|NCT04811209|Anesthetics|anesthetics|mesh-list
92021519|NCT04811209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021520|NCT04811209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021521|NCT04811209|Sensory System Agents|sensory system agents|mesh-ancestor
92021522|NCT04811209|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021523|NCT04788355|Hydroxychloroquine|hydroxychloroquine|mesh-list
92021525|NCT04788355|Antimalarials|antimalarials|mesh-ancestor
92021526|NCT04788355|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92021527|NCT04788355|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92022259|NCT05679037|Thioctic Acid|thioctic acid|mesh-list
92021528|NCT04788355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021529|NCT04788355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021530|NCT04788355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021531|NCT04788355|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021532|NCT04788355|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92021533|NCT04788355|Antithrombins|antithrombins|mesh-ancestor
92021534|NCT04788355|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92021535|NCT04788355|Protease Inhibitors|protease inhibitors|mesh-ancestor
92021536|NCT04788355|Anticoagulants|anticoagulants|mesh-ancestor
92021537|NCT04799743|Resveratrol|resveratrol|mesh-list
92021538|NCT04799743|Antioxidants|antioxidants|mesh-ancestor
92021539|NCT04799743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021540|NCT04799743|Protective Agents|protective agents|mesh-ancestor
92021541|NCT04799743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021542|NCT04799743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984836|NCT02055352|Autonomic Agents|autonomic agents|mesh-ancestor
91984837|NCT02055352|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984838|NCT02055352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021543|NCT04799743|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92021544|NCT04788121|Tranexamic Acid|tranexamic acid|mesh-list
92021545|NCT04788121|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92021546|NCT04788121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92021547|NCT04788121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021548|NCT04788121|Hemostatics|hemostatics|mesh-ancestor
92021549|NCT04788121|Coagulants|coagulants|mesh-ancestor
92021550|NCT04810819|Methylprednisolone|methylprednisolone|mesh-list
92021551|NCT04810819|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92021552|NCT04810819|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92021553|NCT04810819|Prednisolone|prednisolone|mesh-list
92021554|NCT04810819|Prednisolone acetate|prednisolone acetate|mesh-list
92021555|NCT04810819|Dyphylline|dyphylline|mesh-list
92021556|NCT04810819|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92021557|NCT04810819|Prednisolone phosphate|prednisolone phosphate|mesh-list
92021558|NCT04810819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021559|NCT04810819|Antiemetics|antiemetics|mesh-ancestor
92021560|NCT04810819|Autonomic Agents|autonomic agents|mesh-ancestor
92021561|NCT04810819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021562|NCT04810819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021563|NCT04810819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021564|NCT04810819|Glucocorticoids|glucocorticoids|mesh-ancestor
92021565|NCT04810819|Hormones|hormones|mesh-ancestor
92021566|NCT04810819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021567|NCT04810819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92021568|NCT04810819|Protective Agents|protective agents|mesh-ancestor
92021569|NCT04810819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92021570|NCT04810819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021571|NCT04810819|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92021572|NCT04810819|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92021573|NCT04810819|Respiratory System Agents|respiratory system agents|mesh-ancestor
92021574|NCT04810819|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92021575|NCT04810819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021576|NCT04810819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021577|NCT04810819|Vasodilator Agents|vasodilator agents|mesh-ancestor
92021578|NCT04810507|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92021579|NCT04810507|Anagliptin|anagliptin|mesh-list
92021934|NCT05700955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021935|NCT05700955|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92021936|NCT05700955|Alkylating Agents|alkylating agents|mesh-ancestor
92021937|NCT01650519|Ibuprofen|ibuprofen|mesh-list
92021938|NCT01650519|Ketorolac|ketorolac|mesh-list
92021939|NCT01650519|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021940|NCT01650519|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021941|NCT01650519|Analgesics|analgesics|mesh-ancestor
92021942|NCT01650519|Sensory System Agents|sensory system agents|mesh-ancestor
92021943|NCT01650519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021944|NCT01650519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021945|NCT01650519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021946|NCT01650519|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021947|NCT01650519|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92021948|NCT01650519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021949|NCT01650519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021950|NCT02197039|Esomeprazole|esomeprazole|mesh-list
92021951|NCT02197039|Pantoprazole|pantoprazole|mesh-list
92021952|NCT02197039|Hemostatics|hemostatics|mesh-list
92021953|NCT02197039|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92021954|NCT02197039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021955|NCT02197039|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92021956|NCT02197039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021957|NCT02197039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021958|NCT02197039|Coagulants|coagulants|mesh-ancestor
92021959|NCT05557903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92021960|NCT05557903|Alemtuzumab|alemtuzumab|mesh-list
92021961|NCT05557903|Antibodies|antibodies|mesh-list
92021962|NCT05557903|Immunoglobulins|immunoglobulins|mesh-list
92021963|NCT05557903|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92021964|NCT05557903|Immunologic Factors|immunologic factors|mesh-ancestor
92021965|NCT05557903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984839|NCT02055352|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91984840|NCT02055352|Respiratory System Agents|respiratory system agents|mesh-ancestor
91984841|NCT02055352|Dermatologic Agents|dermatologic agents|mesh-ancestor
91984842|NCT02055352|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92021966|NCT05557903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021967|NCT02386839|Mecasermin|mecasermin|mesh-list
92021968|NCT02386839|Growth Substances|growth substances|mesh-ancestor
92021969|NCT02386839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021970|NCT05347459|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92021971|NCT05347459|Dapagliflozin|dapagliflozin|mesh-list
92021972|NCT05347459|Empagliflozin|empagliflozin|mesh-list
92021973|NCT05347459|Linagliptin|linagliptin|mesh-list
92021974|NCT05347459|Canagliflozin|canagliflozin|mesh-list
92021975|NCT05347459|Vildagliptin|vildagliptin|mesh-list
92021976|NCT05347459|Saxagliptin|saxagliptin|mesh-list
92021977|NCT05347459|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92021978|NCT05347459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021979|NCT05347459|Incretins|incretins|mesh-ancestor
92021980|NCT05347459|Hormones|hormones|mesh-ancestor
92021981|NCT05347459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021982|NCT05347459|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92021983|NCT05347459|Protease Inhibitors|protease inhibitors|mesh-ancestor
92021984|NCT05347459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021985|NCT05347459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021986|NCT05347459|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92021987|NCT05346445|Fluoxetine|fluoxetine|mesh-list
92021988|NCT05346445|Citalopram|citalopram|mesh-list
92021989|NCT05346445|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92021990|NCT05346445|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92021991|NCT05346445|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92021992|NCT05346445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021993|NCT05346445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021994|NCT05346445|Serotonin Agents|serotonin agents|mesh-ancestor
92021995|NCT05346445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021996|NCT05346445|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92021997|NCT05346445|Antidepressive Agents|antidepressive agents|mesh-ancestor
92021998|NCT05346445|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92021999|NCT05346445|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92022000|NCT05346445|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92022001|NCT05346445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022002|NCT01649271|Trastuzumab|trastuzumab|mesh-list
92022003|NCT01649271|Afatinib|afatinib|mesh-list
92022004|NCT01649271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022005|NCT01649271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022006|NCT01649271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92022008|NCT01649271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022010|NCT02385669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022011|NCT02385669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022012|NCT02385669|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022013|NCT02385669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022014|NCT02402907|Chlorhexidine|chlorhexidine|mesh-list
92022015|NCT02402907|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92022016|NCT02402907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92022017|NCT02402907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022018|NCT02402907|Disinfectants|disinfectants|mesh-ancestor
92022019|NCT02402907|Dermatologic Agents|dermatologic agents|mesh-ancestor
92022020|NCT02400333|Ticagrelor|ticagrelor|mesh-list
92022021|NCT02400333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92022022|NCT02400333|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92022023|NCT02400333|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92022024|NCT02400333|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92022025|NCT02400333|Purinergic Agents|purinergic agents|mesh-ancestor
92022026|NCT02400333|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022027|NCT02400333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022028|NCT02400333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022029|NCT02399475|Hormones|hormones|mesh-list
92022030|NCT02399475|Thyrotropin-Releasing Hormone|thyrotropin-releasing hormone|mesh-list
92022031|NCT02399475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022032|NCT02399475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022033|NCT02399163|Fluorides|fluorides|mesh-list
92022034|NCT02399163|Cariostatic Agents|cariostatic agents|mesh-ancestor
92022035|NCT02399163|Protective Agents|protective agents|mesh-ancestor
92022036|NCT02399163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022037|NCT02397837|Pramipexole|pramipexole|mesh-list
92022038|NCT02397837|Antioxidants|antioxidants|mesh-ancestor
92022039|NCT02397837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022040|NCT02397837|Protective Agents|protective agents|mesh-ancestor
92022041|NCT02397837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022042|NCT02397837|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92022043|NCT02397837|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92022044|NCT02397837|Dopamine Agonists|dopamine agonists|mesh-ancestor
92022045|NCT02397837|Dopamine Agents|dopamine agents|mesh-ancestor
92022046|NCT02397837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022047|NCT05549167|Sirolimus|sirolimus|mesh-list
92022048|NCT05549167|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92022049|NCT05549167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022050|NCT05549167|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92022051|NCT05549167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022052|NCT05549167|Antifungal Agents|antifungal agents|mesh-ancestor
92022053|NCT05549167|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022054|NCT05549167|Immunologic Factors|immunologic factors|mesh-ancestor
92022055|NCT05549167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022056|NCT05700721|Niraparib|niraparib|mesh-list
92022057|NCT05700721|Dostarlimab|dostarlimab|mesh-list
92022058|NCT05700721|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92022059|NCT05700721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022060|NCT05700721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022061|NCT05700721|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022062|NCT04134559|Pembrolizumab|pembrolizumab|mesh-list
92022063|NCT04134559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022064|NCT04134559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022065|NCT04134559|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022066|NCT04134559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022067|NCT05542147|Fenofibrate|fenofibrate|mesh-list
92022068|NCT05542147|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92022069|NCT05542147|Antimetabolites|antimetabolites|mesh-ancestor
92022070|NCT05542147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022071|NCT05542147|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92022073|NCT05548465|Remifentanil|remifentanil|mesh-list
92022074|NCT05548465|Dsuvia|dsuvia|mesh-list
92022075|NCT05548465|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92022076|NCT05548465|Narcotics|narcotics|mesh-ancestor
92022077|NCT05548465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022078|NCT05548465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022079|NCT05548465|Analgesics|analgesics|mesh-ancestor
92022081|NCT05548465|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022082|NCT05548465|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92022083|NCT05548465|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92022084|NCT05548465|Anesthetics, General|anesthetics, general|mesh-ancestor
92022085|NCT05548465|Anesthetics|anesthetics|mesh-ancestor
92022086|NCT05548075|Psilocybin|psilocybin|mesh-list
92022087|NCT05548075|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92022088|NCT05548075|Hallucinogens|hallucinogens|mesh-ancestor
92022089|NCT05548075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022090|NCT05548075|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92022091|NCT05548075|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92022092|NCT05548075|Serotonin Agents|serotonin agents|mesh-ancestor
92022093|NCT05548075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022094|NCT05548075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022095|NCT05548075|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92022096|NCT05554003|Temozolomide|temozolomide|mesh-list
92022097|NCT05554003|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92022098|NCT05554003|Alkylating Agents|alkylating agents|mesh-ancestor
92022099|NCT05554003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022100|NCT05554003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022101|NCT05541757|Heparin|heparin|mesh-list
92022102|NCT05541757|Anticoagulants|anticoagulants|mesh-ancestor
92022103|NCT05541757|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92022104|NCT05541757|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92022105|NCT05541757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022106|NCT05700565|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92022107|NCT05700565|Immunomodulating Agents|immunomodulating agents|mesh-list
92022108|NCT05700565|Immunologic Factors|immunologic factors|mesh-ancestor
91984844|NCT02055352|Hormones|hormones|mesh-ancestor
92022109|NCT05700565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022110|NCT05541445|Pembrolizumab|pembrolizumab|mesh-list
92022111|NCT05541445|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022112|NCT05541445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022113|NCT05541445|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022114|NCT05541445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022115|NCT04325503|Levodopa|levodopa|mesh-list
92022116|NCT04325503|Carbidopa|carbidopa|mesh-list
92022117|NCT04325503|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92022118|NCT04325503|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92022119|NCT04325503|Dopamine Agents|dopamine agents|mesh-ancestor
92022120|NCT04325503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022121|NCT04325503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022122|NCT04325503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022123|NCT04325503|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92022124|NCT04325503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022125|NCT05540977|Donepezil|donepezil|mesh-list
92022126|NCT05540977|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92022127|NCT05540977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022128|NCT05540977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022129|NCT05540977|Cholinergic Agents|cholinergic agents|mesh-ancestor
92022130|NCT05540977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022131|NCT05540977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022132|NCT05540977|Nootropic Agents|nootropic agents|mesh-ancestor
92022133|NCT05547685|Methylene Blue|methylene blue|mesh-list
92022134|NCT05547685|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022135|NCT05547685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022136|NCT05540587|Warfarin|warfarin|mesh-list
92022137|NCT05540587|Edoxaban|edoxaban|mesh-list
92022138|NCT05540587|Anticoagulants|anticoagulants|mesh-ancestor
92022139|NCT05540587|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92022140|NCT05540587|Antithrombins|antithrombins|mesh-ancestor
92022141|NCT05540587|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92022142|NCT05540587|Protease Inhibitors|protease inhibitors|mesh-ancestor
92022143|NCT05540587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022144|NCT05540587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022145|NCT05540431|Charcoal|charcoal|mesh-list
92022146|NCT05540431|Antidotes|antidotes|mesh-ancestor
92022147|NCT05540431|Protective Agents|protective agents|mesh-ancestor
92022148|NCT05540431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022149|NCT05553067|Antibodies|antibodies|mesh-list
92022150|NCT05553067|Immunologic Factors|immunologic factors|mesh-ancestor
92022151|NCT05553067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022152|NCT05540275|Bevacizumab|bevacizumab|mesh-list
92022153|NCT05540275|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022156|NCT05540275|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022157|NCT05540275|Growth Substances|growth substances|mesh-ancestor
92022158|NCT05540275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022159|NCT05540275|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022160|NCT04426123|Botulinum Toxins|botulinum toxins|mesh-list
92022161|NCT04426123|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92022162|NCT04426123|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92022163|NCT04426123|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92022164|NCT04426123|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92022165|NCT04426123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022166|NCT04426123|Cholinergic Agents|cholinergic agents|mesh-ancestor
92022167|NCT04426123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022168|NCT04426123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022169|NCT04426123|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92022170|NCT04426123|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022171|NCT01666951|Tacrolimus|tacrolimus|mesh-list
92022172|NCT01666951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022173|NCT01666951|Immunologic Factors|immunologic factors|mesh-ancestor
92022174|NCT01666951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022175|NCT01666951|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92022176|NCT01666951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022177|NCT01666951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022178|NCT02586805|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92022179|NCT02586805|Immunologic Factors|immunologic factors|mesh-ancestor
92022180|NCT02586805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022181|NCT05550415|Simvastatin|simvastatin|mesh-list
91984845|NCT02055352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022182|NCT05550415|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92022183|NCT05550415|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92022184|NCT05550415|Antimetabolites|antimetabolites|mesh-ancestor
92022185|NCT05550415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022186|NCT05550415|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92022187|NCT05550415|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92022188|NCT05550415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022189|NCT02586727|Aflibercept|aflibercept|mesh-list
92022190|NCT02586727|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022191|NCT02586727|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022192|NCT02586727|Growth Substances|growth substances|mesh-ancestor
92022193|NCT02586727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022194|NCT02586727|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022195|NCT02586727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022196|NCT05550025|Apatinib|apatinib|mesh-list
92022197|NCT05550025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022198|NCT05550025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92022199|NCT05550025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022200|NCT05550025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022201|NCT05700253|Hyaluronic Acid|hyaluronic acid|mesh-list
92022202|NCT05700253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92022203|NCT05700253|Immunologic Factors|immunologic factors|mesh-ancestor
92022204|NCT05700253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022205|NCT05700253|Viscosupplements|viscosupplements|mesh-ancestor
92022206|NCT05700253|Protective Agents|protective agents|mesh-ancestor
92022207|NCT05544253|Mitomycins|mitomycins|mesh-list
92022208|NCT05544253|Mitomycin|mitomycin|mesh-list
92022209|NCT05544253|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92022210|NCT05544253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022211|NCT05544253|Alkylating Agents|alkylating agents|mesh-ancestor
92022212|NCT05544253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022213|NCT05544253|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92022214|NCT05544253|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022216|NCT05535517|Dermatologic Agents|dermatologic agents|mesh-ancestor
92022217|NCT05543941|Povidone-Iodine|povidone-iodine|mesh-list
92022218|NCT05543941|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92022219|NCT05543941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022220|NCT02580877|Insulin|insulin|mesh-list
92022221|NCT02580877|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92022222|NCT02580877|Insulin, Isophane|insulin, isophane|mesh-list
92022223|NCT02580877|Methamphetamine|methamphetamine|mesh-list
92022224|NCT02580877|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92022225|NCT02580877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022226|NCT02580877|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92022231|NCT02580877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022232|NCT02580877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022233|NCT02580877|Adrenergic Agents|adrenergic agents|mesh-ancestor
92022234|NCT02580877|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92022235|NCT02580877|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92022236|NCT02580877|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92022237|NCT02580877|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92022238|NCT01905631|Diphenhydramine|diphenhydramine|mesh-list
92022239|NCT01905631|Promethazine|promethazine|mesh-list
92022240|NCT01905631|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92022241|NCT01905631|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92022242|NCT01905631|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022243|NCT01905631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022244|NCT01905631|Anesthetics, Local|anesthetics, local|mesh-ancestor
92022245|NCT01905631|Anesthetics|anesthetics|mesh-ancestor
92022246|NCT01905631|Sensory System Agents|sensory system agents|mesh-ancestor
92022247|NCT01905631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022248|NCT01905631|Antiemetics|antiemetics|mesh-ancestor
92022249|NCT01905631|Autonomic Agents|autonomic agents|mesh-ancestor
92022250|NCT01905631|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92022251|NCT01905631|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92022252|NCT01905631|Histamine Antagonists|histamine antagonists|mesh-ancestor
92022253|NCT01905631|Histamine Agents|histamine agents|mesh-ancestor
92022254|NCT01905631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022255|NCT01905631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022256|NCT01905631|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92022257|NCT01905631|Antipruritics|antipruritics|mesh-ancestor
92022260|NCT05679037|Antioxidants|antioxidants|mesh-ancestor
92022261|NCT05679037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022262|NCT05679037|Protective Agents|protective agents|mesh-ancestor
92022263|NCT05679037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022264|NCT05679037|Vitamin B Complex|vitamin b complex|mesh-ancestor
92022265|NCT05679037|Vitamins|vitamins|mesh-ancestor
92022266|NCT05679037|Micronutrients|micronutrients|mesh-ancestor
92022267|NCT05197621|Vaccines|vaccines|mesh-list
92022268|NCT05197621|Immunologic Factors|immunologic factors|mesh-ancestor
92022269|NCT05197621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022270|NCT05672407|Tranexamic Acid|tranexamic acid|mesh-list
92022271|NCT05672407|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92022272|NCT05672407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92022273|NCT05672407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022274|NCT05672407|Hemostatics|hemostatics|mesh-ancestor
92022275|NCT05672407|Coagulants|coagulants|mesh-ancestor
92022276|NCT02582983|Enfuvirtide|enfuvirtide|mesh-list
92022277|NCT02582983|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92022278|NCT02582983|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92022279|NCT02582983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022280|NCT02582983|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92022281|NCT02582983|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92022282|NCT02582983|Antiviral Agents|antiviral agents|mesh-ancestor
92022283|NCT02582983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022284|NCT02582749|Bicalutamide|bicalutamide|mesh-list
92022285|NCT02582749|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92022286|NCT02582749|Androgen Antagonists|androgen antagonists|mesh-ancestor
92022287|NCT02582749|Hormone Antagonists|hormone antagonists|mesh-ancestor
92022288|NCT02582749|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022289|NCT02582749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022290|NCT02582749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022291|NCT05695495|N,N-Dimethyltryptamine|n,n-dimethyltryptamine|mesh-list
92022293|NCT05695495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022294|NCT05695495|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92022295|NCT05695495|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92022296|NCT05695495|Serotonin Agents|serotonin agents|mesh-ancestor
92022297|NCT05695495|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022301|NCT05461261|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92022302|NCT05461261|Methylprednisolone|methylprednisolone|mesh-list
92022303|NCT05461261|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92022304|NCT05461261|Prednisolone acetate|prednisolone acetate|mesh-list
92022305|NCT05461261|Docetaxel|docetaxel|mesh-list
92022306|NCT05461261|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92022307|NCT05461261|Prednisolone phosphate|prednisolone phosphate|mesh-list
92022308|NCT05461261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022309|NCT05461261|Tubulin Modulators|tubulin modulators|mesh-ancestor
92022310|NCT05461261|Antimitotic Agents|antimitotic agents|mesh-ancestor
92022311|NCT05461261|Mitosis Modulators|mitosis modulators|mesh-ancestor
92022312|NCT05461261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022313|NCT05461261|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022314|NCT05461261|Glucocorticoids|glucocorticoids|mesh-ancestor
92022315|NCT05461261|Hormones|hormones|mesh-ancestor
92022316|NCT05461261|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022317|NCT05461261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022318|NCT05461261|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022319|NCT05461261|Antiemetics|antiemetics|mesh-ancestor
92022320|NCT05461261|Autonomic Agents|autonomic agents|mesh-ancestor
92022321|NCT05461261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022322|NCT05461261|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92022323|NCT05461261|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92022324|NCT05461261|Protective Agents|protective agents|mesh-ancestor
92022325|NCT05678413|Paclitaxel|paclitaxel|mesh-list
92022326|NCT05678413|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92022327|NCT05678413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022328|NCT05678413|Tubulin Modulators|tubulin modulators|mesh-ancestor
92022329|NCT05678413|Antimitotic Agents|antimitotic agents|mesh-ancestor
92022330|NCT05678413|Mitosis Modulators|mitosis modulators|mesh-ancestor
92022331|NCT05678413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022332|NCT05123365|Acetylcysteine|acetylcysteine|mesh-list
92022333|NCT05123365|N-monoacetylcystine|n-monoacetylcystine|mesh-list
91984846|NCT02055352|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91984847|NCT02055352|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91984848|NCT02055352|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91984849|NCT02055352|Adrenergic Agents|adrenergic agents|mesh-ancestor
91984850|NCT02055352|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022335|NCT05123365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022336|NCT05123365|Expectorants|expectorants|mesh-ancestor
92022337|NCT05123365|Respiratory System Agents|respiratory system agents|mesh-ancestor
92022338|NCT05123365|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92022339|NCT05123365|Antioxidants|antioxidants|mesh-ancestor
92022340|NCT05123365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022341|NCT05123365|Protective Agents|protective agents|mesh-ancestor
92022342|NCT05123365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022343|NCT05123365|Antidotes|antidotes|mesh-ancestor
92022344|NCT05678335|Hydroxychloroquine|hydroxychloroquine|mesh-list
92022345|NCT05678335|Tacrolimus|tacrolimus|mesh-list
92022346|NCT05678335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022347|NCT05678335|Immunologic Factors|immunologic factors|mesh-ancestor
92022348|NCT05678335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022349|NCT05678335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92022350|NCT05678335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022351|NCT05678335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022352|NCT05678335|Antimalarials|antimalarials|mesh-ancestor
92022353|NCT05678335|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92022354|NCT05678335|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92022355|NCT05678335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022356|NCT05678335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022357|NCT02582671|Ritonavir|ritonavir|mesh-list
92022358|NCT02582671|Ribavirin|ribavirin|mesh-list
92022359|NCT02582671|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92022360|NCT02582671|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92022361|NCT02582671|Protease Inhibitors|protease inhibitors|mesh-ancestor
92022362|NCT02582671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022363|NCT02582671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022364|NCT02582671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92022365|NCT02582671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92022366|NCT02582671|Antiviral Agents|antiviral agents|mesh-ancestor
92022367|NCT02582671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022368|NCT02582671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92022369|NCT02582671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92022373|NCT05696977|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022374|NCT05696977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022375|NCT05696977|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022376|NCT05696977|Immunologic Factors|immunologic factors|mesh-ancestor
92022377|NCT05696977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022378|NCT05696977|Antifungal Agents|antifungal agents|mesh-ancestor
92022379|NCT05696977|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022380|NCT05696977|Dermatologic Agents|dermatologic agents|mesh-ancestor
92022381|NCT05696977|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022382|NCT05696977|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92022383|NCT05051449|Ketamine|ketamine|mesh-list
92022384|NCT05051449|Analgesics|analgesics|mesh-ancestor
92022385|NCT05051449|Sensory System Agents|sensory system agents|mesh-ancestor
92022386|NCT05051449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022387|NCT05051449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022388|NCT05051449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92022389|NCT05051449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92022390|NCT05051449|Anesthetics, General|anesthetics, general|mesh-ancestor
92022391|NCT05051449|Anesthetics|anesthetics|mesh-ancestor
92022392|NCT05051449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022393|NCT05051449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92022394|NCT05051449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92022395|NCT05051449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022396|NCT05051449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022397|NCT02585713|Dalteparin|dalteparin|mesh-list
92022398|NCT02585713|Tinzaparin|tinzaparin|mesh-list
92022399|NCT02585713|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92022400|NCT02585713|Apixaban|apixaban|mesh-list
91984851|NCT02055352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984852|NCT02034916|Talazoparib|talazoparib|mesh-list
91984853|NCT02034916|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
91984854|NCT02034916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984855|NCT02034916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022401|NCT02585713|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92022402|NCT02585713|Antithrombins|antithrombins|mesh-ancestor
92022403|NCT02585713|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92022404|NCT02585713|Protease Inhibitors|protease inhibitors|mesh-ancestor
92022405|NCT02585713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022406|NCT02585713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022407|NCT02585713|Anticoagulants|anticoagulants|mesh-ancestor
92022408|NCT02585713|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92022409|NCT02585713|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92022410|NCT05078671|Cobicistat|cobicistat|mesh-list
92022411|NCT05078671|Olaparib|olaparib|mesh-list
92022412|NCT05078671|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92022413|NCT05078671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022414|NCT05078671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022415|NCT05078671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022416|NCT05078671|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92022417|NCT05078671|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92022418|NCT05078671|Antiviral Agents|antiviral agents|mesh-ancestor
92022419|NCT05078671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022420|NCT05078671|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92022421|NCT05078671|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92022422|NCT02579863|Dexamethasone|dexamethasone|mesh-list
92022423|NCT02579863|Pembrolizumab|pembrolizumab|mesh-list
92022424|NCT02579863|Lenalidomide|lenalidomide|mesh-list
92022425|NCT02579863|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022426|NCT02579863|Antiemetics|antiemetics|mesh-ancestor
92022427|NCT02579863|Autonomic Agents|autonomic agents|mesh-ancestor
92022428|NCT02579863|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022429|NCT02579863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022430|NCT02579863|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92022431|NCT02579863|Glucocorticoids|glucocorticoids|mesh-ancestor
92022432|NCT02579863|Hormones|hormones|mesh-ancestor
92022433|NCT02579863|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022434|NCT02579863|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022435|NCT02579863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022436|NCT02579863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022437|NCT02579863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022438|NCT02579863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022439|NCT02579863|Immunologic Factors|immunologic factors|mesh-ancestor
92022440|NCT02579863|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022441|NCT02579863|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022442|NCT02579863|Growth Substances|growth substances|mesh-ancestor
92022447|NCT05677945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022448|NCT05677945|Antitubercular Agents|antitubercular agents|mesh-ancestor
92022449|NCT05677945|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92022450|NCT05677945|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92022451|NCT05677945|Antimetabolites|antimetabolites|mesh-ancestor
92022452|NCT05677945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022453|NCT05677945|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92022454|NCT05677945|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92022455|NCT05677945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022456|NCT04964947|Tobramycin|tobramycin|mesh-list
92022457|NCT04964947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92022458|NCT04964947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022459|NCT02582515|Cycloserine|cycloserine|mesh-list
92022460|NCT02582515|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92022461|NCT02582515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022462|NCT02582515|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92022463|NCT02582515|Antitubercular Agents|antitubercular agents|mesh-ancestor
92022464|NCT02582515|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92022465|NCT02582515|Antimetabolites|antimetabolites|mesh-ancestor
91984856|NCT02034916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984857|NCT01374425|Leucovorin|leucovorin|mesh-list
91984858|NCT01374425|Bevacizumab|bevacizumab|mesh-list
91984859|NCT01374425|Fluorouracil|fluorouracil|mesh-list
91984860|NCT01374425|Capecitabine|capecitabine|mesh-list
92022466|NCT02582515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022467|NCT02579629|Ropivacaine|ropivacaine|mesh-list
92022468|NCT02579629|Anesthetics, Local|anesthetics, local|mesh-ancestor
92022469|NCT02579629|Anesthetics|anesthetics|mesh-ancestor
92022470|NCT02579629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022471|NCT02579629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022472|NCT02579629|Sensory System Agents|sensory system agents|mesh-ancestor
92022473|NCT02579629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022474|NCT05677555|Colchicine|colchicine|mesh-list
92022475|NCT05677555|Gout Suppressants|gout suppressants|mesh-ancestor
92022476|NCT05677555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022477|NCT05677555|Tubulin Modulators|tubulin modulators|mesh-ancestor
92022478|NCT05677555|Antimitotic Agents|antimitotic agents|mesh-ancestor
92022479|NCT05677555|Mitosis Modulators|mitosis modulators|mesh-ancestor
92022480|NCT05677555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022481|NCT05677555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022482|NCT02343939|Cytarabine|cytarabine|mesh-list
92022483|NCT02343939|Azacitidine|azacitidine|mesh-list
92022484|NCT02343939|Decitabine|decitabine|mesh-list
92022485|NCT02343939|Daunorubicin|daunorubicin|mesh-list
92022486|NCT02343939|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92022488|NCT02343939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022489|NCT02343939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022490|NCT02343939|Antiviral Agents|antiviral agents|mesh-ancestor
92022491|NCT02343939|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022492|NCT02343939|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022493|NCT02343939|Immunologic Factors|immunologic factors|mesh-ancestor
92022494|NCT02343939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022495|NCT02343939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022496|NCT02343939|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92022497|NCT02343939|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92022498|NCT02343939|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92022500|NCT02343549|Temozolomide|temozolomide|mesh-list
92022501|NCT02343549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022502|NCT02343549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022503|NCT02343549|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022504|NCT02343549|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022505|NCT02343549|Growth Substances|growth substances|mesh-ancestor
92022506|NCT02343549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022507|NCT02343549|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022508|NCT02343549|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92022509|NCT02343549|Alkylating Agents|alkylating agents|mesh-ancestor
92022510|NCT02343549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022511|NCT02343159|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92022512|NCT02343159|Dermatologic Agents|dermatologic agents|mesh-ancestor
92022513|NCT02343159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022514|NCT02343159|Immunologic Factors|immunologic factors|mesh-ancestor
92022527|NCT02395653|Anesthetics|anesthetics|mesh-ancestor
92022528|NCT01664923|Bicalutamide|bicalutamide|mesh-list
92022529|NCT01664923|Androgen Antagonists|androgen antagonists|mesh-ancestor
92022530|NCT01664923|Hormone Antagonists|hormone antagonists|mesh-ancestor
92022531|NCT01664923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022532|NCT01664923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022533|NCT01664923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022534|NCT04778527|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92022535|NCT04778527|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92022536|NCT04778527|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92022537|NCT04778527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022538|NCT04778527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022539|NCT04778527|Antiviral Agents|antiviral agents|mesh-ancestor
92022540|NCT04778527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022541|NCT04778527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92022542|NCT04778527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92022543|NCT04403347|Losartan|losartan|mesh-list
91984861|NCT01374425|Oxaliplatin|oxaliplatin|mesh-list
91984862|NCT01374425|Irinotecan|irinotecan|mesh-list
91984863|NCT01374425|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984864|NCT01374425|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984865|NCT01374425|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91984866|NCT01374425|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022544|NCT04403347|Antihypertensive Agents|antihypertensive agents|mesh-list
92022545|NCT04403347|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92022546|NCT04403347|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92022547|NCT04403347|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92022548|NCT04403347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022549|NCT01664533|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92022550|NCT01664533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022551|NCT01664533|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92022552|NCT01664533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022553|NCT01664533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022554|NCT05673655|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92022555|NCT05673655|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92022556|NCT05673655|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92022557|NCT05673655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022558|NCT05673655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022559|NCT05673655|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92022560|NCT05673655|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92022561|NCT05673655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022562|NCT05673655|Cholinergic Agents|cholinergic agents|mesh-ancestor
92022563|NCT05673655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022564|NCT05692297|Denosumab|denosumab|mesh-list
92022565|NCT05692297|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92022566|NCT05692297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022567|NCT05696509|Anesthetics|anesthetics|mesh-list
92022568|NCT05696509|Propofol|propofol|mesh-list
92022569|NCT05696509|Sevoflurane|sevoflurane|mesh-list
92022570|NCT05696509|Isoflurane|isoflurane|mesh-list
92022571|NCT05696509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022572|NCT05696509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022573|NCT05696509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92022574|NCT05696509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92022577|NCT05696509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92022578|NCT02584855|Ixekizumab|ixekizumab|mesh-list
92022579|NCT02584855|Dermatologic Agents|dermatologic agents|mesh-ancestor
92022580|NCT02581891|Aflibercept|aflibercept|mesh-list
92022581|NCT02581891|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022582|NCT02581891|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022583|NCT02581891|Growth Substances|growth substances|mesh-ancestor
92022584|NCT02581891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022585|NCT02581891|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022586|NCT02581891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022587|NCT04523857|Hydroxychloroquine|hydroxychloroquine|mesh-list
92022588|NCT04523857|Antimalarials|antimalarials|mesh-ancestor
92022589|NCT04523857|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92022590|NCT04523857|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92022591|NCT04523857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022592|NCT04523857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022593|NCT04523857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022594|NCT04523857|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022595|NCT02581345|Adalimumab|adalimumab|mesh-list
92022596|NCT02581345|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92022597|NCT02581345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022598|NCT02581345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022599|NCT05579509|Fentanyl|fentanyl|mesh-list
92022600|NCT05579509|Midazolam|midazolam|mesh-list
92022601|NCT05579509|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92022602|NCT05579509|Narcotics|narcotics|mesh-ancestor
92022603|NCT05579509|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022604|NCT05579509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022605|NCT05579509|Analgesics|analgesics|mesh-ancestor
92022606|NCT05579509|Sensory System Agents|sensory system agents|mesh-ancestor
91984867|NCT01374425|Growth Substances|growth substances|mesh-ancestor
91984868|NCT01374425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022607|NCT05579509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022608|NCT05579509|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92022609|NCT05579509|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92022610|NCT05579509|Anesthetics, General|anesthetics, general|mesh-ancestor
92022611|NCT05579509|Anesthetics|anesthetics|mesh-ancestor
92022612|NCT05579509|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92022613|NCT05579509|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92022614|NCT05579509|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92022615|NCT05579509|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92022616|NCT05579509|GABA Modulators|gaba modulators|mesh-ancestor
92022617|NCT05579509|GABA Agents|gaba agents|mesh-ancestor
92022618|NCT05579509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022619|NCT05579509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022620|NCT05696431|Fluorides|fluorides|mesh-list
92022621|NCT05696431|Cariostatic Agents|cariostatic agents|mesh-ancestor
92022622|NCT05696431|Protective Agents|protective agents|mesh-ancestor
92022623|NCT05696431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022624|NCT05628883|Cyclophosphamide|cyclophosphamide|mesh-list
92022625|NCT05628883|Fludarabine|fludarabine|mesh-list
92022626|NCT05628883|Interleukin-2|interleukin-2|mesh-list
92022627|NCT05628883|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022628|NCT05628883|Immunologic Factors|immunologic factors|mesh-ancestor
92022629|NCT05628883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022630|NCT05628883|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022631|NCT05628883|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92022632|NCT05628883|Alkylating Agents|alkylating agents|mesh-ancestor
92022633|NCT05628883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022634|NCT05628883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022635|NCT05628883|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92022636|NCT05628883|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92022638|NCT05628883|Sensory System Agents|sensory system agents|mesh-ancestor
92022639|NCT05628883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022640|NCT05575219|Clonidine|clonidine|mesh-list
92022641|NCT05575219|Analgesics|analgesics|mesh-ancestor
92022642|NCT05575219|Sensory System Agents|sensory system agents|mesh-ancestor
92022643|NCT05575219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022644|NCT05575219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022645|NCT05575219|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92022646|NCT05575219|Sympatholytics|sympatholytics|mesh-ancestor
92022647|NCT05575219|Autonomic Agents|autonomic agents|mesh-ancestor
92022648|NCT05575219|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92022649|NCT05575219|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92022666|NCT04314895|Paclitaxel|paclitaxel|mesh-list
92022667|NCT04314895|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92022668|NCT04314895|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92022669|NCT04314895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022670|NCT04314895|Tubulin Modulators|tubulin modulators|mesh-ancestor
92022671|NCT04314895|Antimitotic Agents|antimitotic agents|mesh-ancestor
92022672|NCT04314895|Mitosis Modulators|mitosis modulators|mesh-ancestor
92022673|NCT04314895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022674|NCT02581189|Ritonavir|ritonavir|mesh-list
92022675|NCT02581189|Ribavirin|ribavirin|mesh-list
92022676|NCT02581189|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92022677|NCT02581189|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92022678|NCT02581189|Protease Inhibitors|protease inhibitors|mesh-ancestor
92022679|NCT02581189|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022680|NCT02581189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022681|NCT02581189|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92022682|NCT02581189|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92022683|NCT02581189|Antiviral Agents|antiviral agents|mesh-ancestor
92022684|NCT02581189|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022685|NCT02581189|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92022686|NCT02581189|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92022687|NCT02581189|Antimetabolites|antimetabolites|mesh-ancestor
92022688|NCT05569681|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92022689|NCT05569681|Bemiparin|bemiparin|mesh-list
92022690|NCT05569681|Anticoagulants|anticoagulants|mesh-ancestor
92022691|NCT05569681|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92022692|NCT05569681|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92022693|NCT05569681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022694|NCT00352027|Prednisone|prednisone|mesh-list
91984869|NCT01374425|Growth Inhibitors|growth inhibitors|mesh-ancestor
91984871|NCT01374425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984872|NCT01374425|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92022695|NCT00352027|Hydrocortisone|hydrocortisone|mesh-list
92022696|NCT00352027|Cyclophosphamide|cyclophosphamide|mesh-list
92022697|NCT00352027|Mechlorethamine|mechlorethamine|mesh-list
92022698|NCT00352027|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92022699|NCT00352027|Doxorubicin|doxorubicin|mesh-list
92022700|NCT00352027|Etoposide|etoposide|mesh-list
92022701|NCT00352027|Vincristine|vincristine|mesh-list
92022702|NCT00352027|Bleomycin|bleomycin|mesh-list
92022703|NCT00352027|Vinblastine|vinblastine|mesh-list
92022704|NCT00352027|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92022706|NCT00352027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022707|NCT00352027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022708|NCT00352027|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92022709|NCT00352027|Alkylating Agents|alkylating agents|mesh-ancestor
92022710|NCT00352027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022713|NCT00352027|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92022714|NCT00352027|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92022715|NCT00352027|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92022716|NCT00352027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022717|NCT00352027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022718|NCT00352027|Glucocorticoids|glucocorticoids|mesh-ancestor
92022719|NCT00352027|Hormones|hormones|mesh-ancestor
92022720|NCT00352027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022721|NCT00352027|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022722|NCT00352027|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92022723|NCT00352027|Tubulin Modulators|tubulin modulators|mesh-ancestor
92022724|NCT00352027|Antimitotic Agents|antimitotic agents|mesh-ancestor
92022725|NCT00352027|Mitosis Modulators|mitosis modulators|mesh-ancestor
92022726|NCT02576977|Dexamethasone|dexamethasone|mesh-list
92022727|NCT02576977|Pembrolizumab|pembrolizumab|mesh-list
92022728|NCT02576977|Pomalidomide|pomalidomide|mesh-list
92022729|NCT02576977|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022730|NCT02576977|Antiemetics|antiemetics|mesh-ancestor
92022731|NCT02576977|Autonomic Agents|autonomic agents|mesh-ancestor
92022732|NCT02576977|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022733|NCT02576977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022734|NCT02576977|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92022735|NCT02576977|Glucocorticoids|glucocorticoids|mesh-ancestor
92022736|NCT02576977|Hormones|hormones|mesh-ancestor
92022737|NCT02576977|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022738|NCT02576977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022739|NCT02576977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022740|NCT02576977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022741|NCT02576977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022742|NCT02576977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022743|NCT02576977|Immunologic Factors|immunologic factors|mesh-ancestor
92022744|NCT02576977|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022745|NCT02576977|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022746|NCT02576977|Growth Substances|growth substances|mesh-ancestor
92022747|NCT02576977|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022748|NCT05867251|Carboplatin|carboplatin|mesh-list
92022749|NCT05867251|Letrozole|letrozole|mesh-list
92022750|NCT05867251|Fulvestrant|fulvestrant|mesh-list
92022751|NCT05867251|Palbociclib|palbociclib|mesh-list
92022752|NCT05867251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022753|NCT05867251|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92022754|NCT05867251|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92022755|NCT05867251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022756|NCT05867251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022757|NCT05867251|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92022758|NCT05867251|Hormone Antagonists|hormone antagonists|mesh-ancestor
92022759|NCT05867251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022760|NCT05867251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022761|NCT05867251|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022762|NCT05867251|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91984873|NCT01374425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91984874|NCT01374425|Immunologic Factors|immunologic factors|mesh-ancestor
91984875|NCT01374425|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91984876|NCT01374425|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92022763|NCT05867251|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92022764|NCT05867212|Cabotegravir|cabotegravir|mesh-list
92022765|NCT05867212|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92022766|NCT05867212|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92022767|NCT05867212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022768|NCT05867212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022769|NCT05867212|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92022770|NCT05867212|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92022771|NCT05867212|Antiviral Agents|antiviral agents|mesh-ancestor
92022772|NCT05867212|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022773|NCT05867056|Cysteamine|cysteamine|mesh-list
92022774|NCT05867056|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92022775|NCT05867056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022776|NCT05867030|Rituximab|rituximab|mesh-list
92022777|NCT05867030|Lenalidomide|lenalidomide|mesh-list
92022778|NCT05867030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022779|NCT05867030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022780|NCT05867030|Immunologic Factors|immunologic factors|mesh-ancestor
92022781|NCT05867030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022782|NCT05867030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022784|NCT05867030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92022785|NCT05867030|Growth Substances|growth substances|mesh-ancestor
92022786|NCT05867030|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022787|NCT05866848|Caffeine|caffeine|mesh-list
92022788|NCT05866848|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92022789|NCT05866848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022790|NCT05866848|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92022791|NCT05866848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022792|NCT05866848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022793|NCT05866848|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92022794|NCT05866848|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92022795|NCT05866848|Purinergic Agents|purinergic agents|mesh-ancestor
92022796|NCT05866848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022797|NCT05866614|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92022798|NCT05866614|Immunologic Factors|immunologic factors|mesh-ancestor
92022799|NCT05866614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022800|NCT05866588|Coal Tar|coal tar|mesh-list
92022801|NCT05866588|Keratolytic Agents|keratolytic agents|mesh-ancestor
92022802|NCT05866588|Dermatologic Agents|dermatologic agents|mesh-ancestor
92022803|NCT05866575|Vortioxetine|vortioxetine|mesh-list
92022804|NCT05866575|Escitalopram|escitalopram|mesh-list
92022805|NCT05866575|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92022806|NCT05866575|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92022807|NCT05866575|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92022808|NCT05866575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022809|NCT05866575|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022810|NCT05866575|Serotonin Agents|serotonin agents|mesh-ancestor
92022811|NCT05866575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022812|NCT05866575|Antidepressive Agents|antidepressive agents|mesh-ancestor
92022813|NCT05866575|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92022814|NCT05866575|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92022815|NCT05866575|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92022816|NCT05866575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022817|NCT05866575|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92022818|NCT05866575|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92022819|NCT05866575|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92022820|NCT05866575|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92022821|NCT05866172|Zoledronic Acid|zoledronic acid|mesh-list
92022822|NCT05866172|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92022823|NCT05866172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022824|NCT05866068|Clomiphene|clomiphene|mesh-list
92022825|NCT05866068|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92022826|NCT05866068|Hormone Antagonists|hormone antagonists|mesh-ancestor
91984877|NCT01374425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984878|NCT01374425|Antidotes|antidotes|mesh-ancestor
92022827|NCT05866068|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022828|NCT05866068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022829|NCT05866068|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92022830|NCT05866068|Fertility Agents|fertility agents|mesh-ancestor
92022831|NCT05866068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92022832|NCT05866068|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92022833|NCT05866068|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92022834|NCT05866055|Midazolam|midazolam|mesh-list
92022835|NCT05866055|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92022836|NCT05866055|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92022837|NCT05866055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022838|NCT05866055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022839|NCT05866055|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92022840|NCT05866055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92022841|NCT05866055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92022842|NCT05866055|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92022843|NCT05866055|Anesthetics, General|anesthetics, general|mesh-ancestor
92022844|NCT05866055|Anesthetics|anesthetics|mesh-ancestor
92022845|NCT05866055|GABA Modulators|gaba modulators|mesh-ancestor
92022846|NCT05866055|GABA Agents|gaba agents|mesh-ancestor
92022847|NCT05866055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022848|NCT05866055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022849|NCT05866029|Denosumab|denosumab|mesh-list
92022850|NCT05866029|Teriparatide|teriparatide|mesh-list
92022851|NCT05866029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92022852|NCT05866029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022853|NCT05866029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92022864|NCT05865925|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92022865|NCT05865925|Antimetabolites|antimetabolites|mesh-ancestor
92022867|NCT05865548|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92022868|NCT05865548|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92022869|NCT05865548|Analgesics|analgesics|mesh-ancestor
92022870|NCT05865548|Sensory System Agents|sensory system agents|mesh-ancestor
92022871|NCT05865548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022872|NCT05865548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022873|NCT05865548|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022874|NCT05865548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92022875|NCT05865548|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92022876|NCT05865548|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92022877|NCT05865548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022878|NCT05865548|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92022879|NCT05865548|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92022880|NCT05865548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022881|NCT05865548|Antipyretics|antipyretics|mesh-ancestor
92022882|NCT05861440|Antitubercular Agents|antitubercular agents|mesh-list
92022883|NCT05861440|Prednisolone|prednisolone|mesh-list
92022884|NCT05861440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92022885|NCT05861440|Glucocorticoids|glucocorticoids|mesh-ancestor
92022886|NCT05861440|Hormones|hormones|mesh-ancestor
92022887|NCT05861440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022888|NCT05861440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022889|NCT05861440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022890|NCT05861440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022891|NCT05861440|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92022892|NCT05861440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92022893|NCT05859074|Pembrolizumab|pembrolizumab|mesh-list
92022894|NCT05859074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022895|NCT05859074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022896|NCT05859074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022897|NCT05859074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022898|NCT05827068|Vaccines|vaccines|mesh-list
92022899|NCT05827068|Immunologic Factors|immunologic factors|mesh-ancestor
92022900|NCT05827068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022901|NCT05819710|Zopiclone|zopiclone|mesh-list
92022902|NCT05819710|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92022903|NCT05819710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022904|NCT05819710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022905|NCT05816356|Decitabine|decitabine|mesh-list
92022906|NCT05816356|Tetrahydrouridine|tetrahydrouridine|mesh-list
92022907|NCT05816356|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91984879|NCT01374425|Protective Agents|protective agents|mesh-ancestor
91984880|NCT01374425|Vitamin B Complex|vitamin b complex|mesh-ancestor
92022908|NCT05816356|Antimetabolites|antimetabolites|mesh-ancestor
92022909|NCT05816356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022910|NCT05816356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022911|NCT05816356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022912|NCT05815680|Metformin|metformin|mesh-list
92022913|NCT05815680|Digoxin|digoxin|mesh-list
92022914|NCT05815680|Warfarin|warfarin|mesh-list
92022915|NCT05815680|Atorvastatin|atorvastatin|mesh-list
92022916|NCT05815680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92022917|NCT05815680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022919|NCT05815680|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92022920|NCT05815680|Antimetabolites|antimetabolites|mesh-ancestor
92022921|NCT05815680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022922|NCT05815680|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92022923|NCT05815680|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92022924|NCT05815680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022925|NCT05815680|Anticoagulants|anticoagulants|mesh-ancestor
92022926|NCT05815680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92022927|NCT05815680|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92022928|NCT05815680|Protective Agents|protective agents|mesh-ancestor
92022929|NCT05801419|Nicotine|nicotine|mesh-list
92022930|NCT05801419|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92022931|NCT05801419|Autonomic Agents|autonomic agents|mesh-ancestor
92022932|NCT05801419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022933|NCT05801419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022934|NCT05801419|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92022935|NCT05801419|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92022936|NCT05801419|Cholinergic Agents|cholinergic agents|mesh-ancestor
92022937|NCT05801419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022938|NCT05801419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022939|NCT05786417|Calcium Channel Blockers|calcium channel blockers|mesh-list
92022941|NCT05786417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92022942|NCT05786417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92022943|NCT05786417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022944|NCT05786417|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92022945|NCT05786417|Adrenergic Agents|adrenergic agents|mesh-ancestor
92022946|NCT05786417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022947|NCT05786417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022948|NCT05786417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92022949|NCT05781217|Goserelin|goserelin|mesh-list
92022950|NCT05781217|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92022951|NCT05781217|Leuprolide|leuprolide|mesh-list
92022952|NCT05781217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92022953|NCT05781217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022954|NCT05781217|Luteolytic Agents|luteolytic agents|mesh-ancestor
92022955|NCT05781217|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92022956|NCT05781217|Contraceptive Agents|contraceptive agents|mesh-ancestor
92022957|NCT05781217|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92022958|NCT05781217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022959|NCT05781217|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92022960|NCT05781217|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92022961|NCT05781217|Fertility Agents|fertility agents|mesh-ancestor
92022962|NCT05776823|Naloxone|naloxone|mesh-list
92022963|NCT05776823|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92022964|NCT05776823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022965|NCT05776823|Sensory System Agents|sensory system agents|mesh-ancestor
92022966|NCT05776823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022967|NCT05769530|Dexmedetomidine|dexmedetomidine|mesh-list
92022968|NCT05769530|Nalbuphine|nalbuphine|mesh-list
92022969|NCT05769530|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92022970|NCT05769530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022971|NCT05769530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022972|NCT05769530|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92022973|NCT05769530|Analgesics|analgesics|mesh-ancestor
92022974|NCT05769530|Sensory System Agents|sensory system agents|mesh-ancestor
92022975|NCT05769530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022976|NCT05769530|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92022977|NCT05769530|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92022978|NCT05769530|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92022979|NCT05769530|Adrenergic Agents|adrenergic agents|mesh-ancestor
92022980|NCT05769530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022981|NCT05769530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022982|NCT05769530|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92022983|NCT05769530|Narcotics|narcotics|mesh-ancestor
92022984|NCT05740618|Mannitol|mannitol|mesh-list
92022985|NCT05740618|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92022986|NCT05740618|Diuretics|diuretics|mesh-ancestor
92022987|NCT05740618|Natriuretic Agents|natriuretic agents|mesh-ancestor
92022988|NCT05740618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022989|NCT05705505|Letrozole|letrozole|mesh-list
92022990|NCT05705505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022991|NCT05705505|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92022994|NCT05705505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022996|NCT05705505|Hormone Antagonists|hormone antagonists|mesh-ancestor
92022997|NCT05705505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92022998|NCT05705505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022999|NCT05677295|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92023000|NCT05677295|Imipramine|imipramine|mesh-list
92023001|NCT05677295|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92023002|NCT05677295|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92023003|NCT05677295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92023004|NCT05677295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023005|NCT05677295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023006|NCT05677295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023007|NCT05677295|Analgesics|analgesics|mesh-ancestor
92023008|NCT05677295|Sensory System Agents|sensory system agents|mesh-ancestor
92023009|NCT05677295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023010|NCT05677295|Antidepressive Agents|antidepressive agents|mesh-ancestor
92023011|NCT05677295|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023012|NCT05677295|Dopamine Agents|dopamine agents|mesh-ancestor
92023013|NCT05677295|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92023014|NCT05677295|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92023015|NCT05677295|Adrenergic Agents|adrenergic agents|mesh-ancestor
92023016|NCT05665387|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92023017|NCT05665387|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92023018|NCT05664750|Immunoglobulins|immunoglobulins|mesh-list
92023019|NCT05664750|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92023021|NCT05664750|Immunologic Factors|immunologic factors|mesh-ancestor
92023022|NCT05664750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023023|NCT05621616|Mirabegron|mirabegron|mesh-list
92023024|NCT05621616|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92023025|NCT05621616|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92023026|NCT05621616|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92023027|NCT05621616|Adrenergic Agents|adrenergic agents|mesh-ancestor
92023028|NCT05621616|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023029|NCT05621616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023030|NCT05621616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023031|NCT05621616|Urological Agents|urological agents|mesh-ancestor
92023032|NCT05580523|Aspirin|aspirin|mesh-list
92023033|NCT05580523|Metformin|metformin|mesh-list
92023034|NCT05580523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92023035|NCT05580523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023036|NCT05580523|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023037|NCT05580523|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023038|NCT05580523|Analgesics|analgesics|mesh-ancestor
92023039|NCT05580523|Sensory System Agents|sensory system agents|mesh-ancestor
92023040|NCT05580523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023041|NCT05580523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023042|NCT05580523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023043|NCT05580523|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92023044|NCT05580523|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92023045|NCT05580523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023046|NCT05580523|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92023047|NCT05580523|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92023048|NCT05580523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023049|NCT05580523|Antipyretics|antipyretics|mesh-ancestor
92023050|NCT05557877|Aspirin|aspirin|mesh-list
92023051|NCT05557877|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023052|NCT05557877|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023053|NCT05557877|Analgesics|analgesics|mesh-ancestor
92023054|NCT05557877|Sensory System Agents|sensory system agents|mesh-ancestor
92023055|NCT05557877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984882|NCT01374425|Micronutrients|micronutrients|mesh-ancestor
91984883|NCT02085460|Rebamipide|rebamipide|mesh-list
91984884|NCT02085460|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91984885|NCT02085460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91984886|NCT02085460|Antioxidants|antioxidants|mesh-ancestor
92023056|NCT05557877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023057|NCT05557877|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023058|NCT05557877|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023059|NCT05557877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92023060|NCT05557877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92023061|NCT05557877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023066|NCT05512039|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92023067|NCT05512039|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92023068|NCT05512039|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92023069|NCT05512039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023070|NCT05512039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023071|NCT05512039|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92023072|NCT05512039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92023073|NCT05512039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023074|NCT05512039|Cholinergic Agents|cholinergic agents|mesh-ancestor
92023075|NCT05512039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023076|NCT05476991|Aspirin|aspirin|mesh-list
92023077|NCT05476991|Colchicine|colchicine|mesh-list
92023078|NCT05476991|Ticagrelor|ticagrelor|mesh-list
92023079|NCT05476991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023081|NCT05476991|Analgesics|analgesics|mesh-ancestor
92023082|NCT05476991|Sensory System Agents|sensory system agents|mesh-ancestor
92023083|NCT05476991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023084|NCT05476991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023085|NCT05476991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023086|NCT05476991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023087|NCT05476991|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92023088|NCT05476991|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92023089|NCT05476991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023090|NCT05476991|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92023091|NCT05476991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92023092|NCT05476991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023093|NCT05476991|Antipyretics|antipyretics|mesh-ancestor
92023094|NCT05476991|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92023095|NCT05476991|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92023096|NCT05476991|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92023097|NCT05476991|Purinergic Agents|purinergic agents|mesh-ancestor
92023098|NCT05476991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023099|NCT05476991|Gout Suppressants|gout suppressants|mesh-ancestor
92023100|NCT05476991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023101|NCT05476991|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023102|NCT05476991|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023103|NCT05476991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023104|NCT05465226|Analgesics, Opioid|analgesics, opioid|mesh-list
92023105|NCT05465226|Narcotics|narcotics|mesh-ancestor
92023106|NCT05465226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023107|NCT05465226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023108|NCT05465226|Analgesics|analgesics|mesh-ancestor
92023109|NCT05465226|Sensory System Agents|sensory system agents|mesh-ancestor
92023110|NCT05465226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023111|NCT05463393|Xanthohumol|xanthohumol|mesh-list
92023112|NCT05463393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023113|NCT05463393|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92023114|NCT05463393|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92023115|NCT05463393|Growth Substances|growth substances|mesh-ancestor
92023116|NCT05463393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023117|NCT05463393|Growth Inhibitors|growth inhibitors|mesh-ancestor
92023118|NCT05419050|Denosumab|denosumab|mesh-list
92023119|NCT05419050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92023120|NCT05419050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023121|NCT05382806|Flumazenil|flumazenil|mesh-list
92023122|NCT05382806|Antidotes|antidotes|mesh-ancestor
92023123|NCT05382806|Protective Agents|protective agents|mesh-ancestor
92023124|NCT05382806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984887|NCT02085460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023125|NCT05382806|GABA Modulators|gaba modulators|mesh-ancestor
92023126|NCT05382806|GABA Agents|gaba agents|mesh-ancestor
92023127|NCT05382806|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023128|NCT05382806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023129|NCT05379972|Pembrolizumab|pembrolizumab|mesh-list
92023130|NCT05379972|Olaparib|olaparib|mesh-list
92023131|NCT05379972|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023132|NCT05379972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023133|NCT05379972|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023138|NCT05367245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023139|NCT05367245|Histamine Antagonists|histamine antagonists|mesh-ancestor
92023141|NCT05367245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023142|NCT05367245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023144|NCT05312008|Oxytocics|oxytocics|mesh-ancestor
92023145|NCT05312008|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92023146|NCT05312008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023147|NCT05265546|Psilocybin|psilocybin|mesh-list
92023148|NCT05265546|Hallucinogens|hallucinogens|mesh-ancestor
92023149|NCT05265546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023150|NCT05265546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023151|NCT05246670|Palmidrol|palmidrol|mesh-list
92023152|NCT05246670|Analgesics|analgesics|mesh-ancestor
92023153|NCT05246670|Sensory System Agents|sensory system agents|mesh-ancestor
92023154|NCT05246670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023155|NCT05246670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023156|NCT05246670|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023157|NCT05246670|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023158|NCT05246670|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023159|NCT05246670|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023160|NCT05246670|Antiviral Agents|antiviral agents|mesh-ancestor
92023161|NCT05246670|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023162|NCT05246670|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92023163|NCT05246670|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92023164|NCT05246670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023165|NCT05246670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023166|NCT05246670|Hormones|hormones|mesh-ancestor
92023167|NCT05246670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023168|NCT05238883|Tislelizumab|tislelizumab|mesh-list
92023169|NCT05238883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023170|NCT05238883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023171|NCT05227742|Psilocybin|psilocybin|mesh-list
92023172|NCT05227742|Hallucinogens|hallucinogens|mesh-ancestor
92023173|NCT05227742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023174|NCT05227742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023175|NCT05163496|Psilocybin|psilocybin|mesh-list
92023176|NCT05163496|Hallucinogens|hallucinogens|mesh-ancestor
92023177|NCT05163496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023178|NCT05163496|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023179|NCT05162443|Adagrasib|adagrasib|mesh-list
92023180|NCT05162443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023181|NCT05107960|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92023182|NCT05107960|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92023183|NCT05107960|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92023184|NCT05107960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023185|NCT05097599|Pembrolizumab|pembrolizumab|mesh-list
92023186|NCT05097599|Trastuzumab|trastuzumab|mesh-list
92023187|NCT05097599|Axitinib|axitinib|mesh-list
92023188|NCT05097599|Talazoparib|talazoparib|mesh-list
92023189|NCT05097599|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92023190|NCT05097599|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92023191|NCT05097599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023192|NCT05097599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023193|NCT05097599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023194|NCT05097599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023195|NCT05097599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023196|NCT05097599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023197|NCT05097599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92023198|NCT05097599|Immunoconjugates|immunoconjugates|mesh-ancestor
92023199|NCT05097599|Immunologic Factors|immunologic factors|mesh-ancestor
91984889|NCT02085460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984890|NCT02085460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984891|NCT03164291|Rifabutin|rifabutin|mesh-list
91984892|NCT03164291|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91984893|NCT03164291|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023200|NCT05097599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023201|NCT05068791|Dextromethorphan|dextromethorphan|mesh-list
92023202|NCT05068791|Psilocybin|psilocybin|mesh-list
92023203|NCT05068791|Hallucinogens|hallucinogens|mesh-ancestor
92023207|NCT05068791|Respiratory System Agents|respiratory system agents|mesh-ancestor
92023208|NCT05068791|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92023209|NCT05068791|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92023210|NCT05068791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023211|NCT05068791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023213|NCT05002465|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92023214|NCT05002465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023215|NCT04996004|Doxorubicin|doxorubicin|mesh-list
92023216|NCT04996004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92023217|NCT04996004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023218|NCT04996004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92023219|NCT04996004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92023220|NCT04996004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023221|NCT04996004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023222|NCT04952402|Vaccines|vaccines|mesh-list
92023223|NCT04952402|Immunologic Factors|immunologic factors|mesh-ancestor
92023224|NCT04952402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023225|NCT04941144|Vaccines|vaccines|mesh-list
92023226|NCT04941144|Immunologic Factors|immunologic factors|mesh-ancestor
92023227|NCT04941144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023228|NCT04907227|Dexamethasone|dexamethasone|mesh-list
92023229|NCT04907227|Prednisone|prednisone|mesh-list
92023230|NCT04907227|Docetaxel|docetaxel|mesh-list
92023231|NCT04907227|Pembrolizumab|pembrolizumab|mesh-list
92023232|NCT04907227|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023233|NCT04907227|Antiemetics|antiemetics|mesh-ancestor
92023234|NCT04907227|Autonomic Agents|autonomic agents|mesh-ancestor
92023235|NCT04907227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023236|NCT04907227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023237|NCT04907227|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92023238|NCT04907227|Glucocorticoids|glucocorticoids|mesh-ancestor
92023239|NCT04907227|Hormones|hormones|mesh-ancestor
92023240|NCT04907227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023241|NCT04907227|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92023242|NCT04907227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023243|NCT04907227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023244|NCT04907227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023245|NCT04907227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023246|NCT04907227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023247|NCT04907227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023248|NCT04907227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023249|NCT04892277|Cyclophosphamide|cyclophosphamide|mesh-list
92023250|NCT04892277|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92023251|NCT04892277|Fludarabine|fludarabine|mesh-list
92023252|NCT04892277|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023253|NCT04892277|Immunologic Factors|immunologic factors|mesh-ancestor
92023254|NCT04892277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023255|NCT04892277|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023256|NCT04892277|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92023257|NCT04892277|Alkylating Agents|alkylating agents|mesh-ancestor
92023258|NCT04892277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023259|NCT04892277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023260|NCT04892277|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92023261|NCT04842045|Midazolam|midazolam|mesh-list
92023262|NCT04842045|Psilocybin|psilocybin|mesh-list
92023263|NCT04842045|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92023264|NCT04842045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92023265|NCT04842045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023266|NCT04842045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023267|NCT04842045|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91984894|NCT03164291|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91984895|NCT03164291|Antitubercular Agents|antitubercular agents|mesh-ancestor
92023268|NCT04842045|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92023269|NCT04842045|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023270|NCT04842045|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92023271|NCT04842045|Anesthetics, General|anesthetics, general|mesh-ancestor
92023272|NCT04842045|Anesthetics|anesthetics|mesh-ancestor
92023273|NCT04842045|GABA Modulators|gaba modulators|mesh-ancestor
92023274|NCT04842045|GABA Agents|gaba agents|mesh-ancestor
92023275|NCT04842045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023283|NCT04754945|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92023285|NCT04754945|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023286|NCT04754945|Immunologic Factors|immunologic factors|mesh-ancestor
92023287|NCT04754945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023288|NCT04754945|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023289|NCT04754945|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92023290|NCT04754945|Alkylating Agents|alkylating agents|mesh-ancestor
92023291|NCT04754945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023292|NCT04754945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023293|NCT04754945|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92023294|NCT04754945|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023295|NCT04754945|Antiemetics|antiemetics|mesh-ancestor
92023296|NCT04754945|Autonomic Agents|autonomic agents|mesh-ancestor
92023297|NCT04754945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023298|NCT04754945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92023299|NCT04754945|Glucocorticoids|glucocorticoids|mesh-ancestor
92023301|NCT04754945|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023302|NCT04754945|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92023303|NCT04754945|Protease Inhibitors|protease inhibitors|mesh-ancestor
92023304|NCT04754945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023305|NCT04754945|Dermatologic Agents|dermatologic agents|mesh-ancestor
92023306|NCT04730037|Warfarin|warfarin|mesh-list
92023307|NCT04730037|Edoxaban|edoxaban|mesh-list
92023308|NCT04730037|Anticoagulants|anticoagulants|mesh-ancestor
92023309|NCT04730037|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92023310|NCT04730037|Antithrombins|antithrombins|mesh-ancestor
92023311|NCT04730037|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92023312|NCT04730037|Protease Inhibitors|protease inhibitors|mesh-ancestor
92023313|NCT04730037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023314|NCT04730037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023315|NCT04715646|Brivaracetam|brivaracetam|mesh-list
92023316|NCT04715646|Anticonvulsants|anticonvulsants|mesh-ancestor
92023317|NCT04699188|Tislelizumab|tislelizumab|mesh-list
92023318|NCT04699188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023319|NCT04699188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023320|NCT04640779|Salicylates|salicylates|mesh-list
92023321|NCT04640779|Choline|choline|mesh-list
92023322|NCT04640779|Lipotropic Agents|lipotropic agents|mesh-ancestor
92023323|NCT04640779|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92023324|NCT04640779|Antimetabolites|antimetabolites|mesh-ancestor
92023325|NCT04640779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023326|NCT04640779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92023327|NCT04640779|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92023328|NCT04640779|Nootropic Agents|nootropic agents|mesh-ancestor
92023329|NCT04640779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023330|NCT04640779|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023331|NCT04640779|Analgesics|analgesics|mesh-ancestor
92023332|NCT04640779|Sensory System Agents|sensory system agents|mesh-ancestor
92023333|NCT04640779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023334|NCT04640779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023335|NCT04640779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023336|NCT04640779|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023337|NCT04640779|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92023338|NCT04640779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023339|NCT04612751|Carboplatin|carboplatin|mesh-list
92023340|NCT04612751|Durvalumab|durvalumab|mesh-list
92023341|NCT04612751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023342|NCT04612751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023343|NCT04582669|Triamcinolone|triamcinolone|mesh-list
92023344|NCT04582669|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92023345|NCT04582669|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92023372|NCT04428385|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91984896|NCT02084134|Dexamethasone|dexamethasone|mesh-list
91984897|NCT02084134|Dexamethasone acetate|dexamethasone acetate|mesh-list
91984898|NCT02084134|Hydrocortisone|hydrocortisone|mesh-list
92023373|NCT04428385|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92023374|NCT04428385|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023375|NCT04074161|Liraglutide|liraglutide|mesh-list
92023376|NCT04074161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92023377|NCT04074161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023378|NCT04074161|Incretins|incretins|mesh-ancestor
92023379|NCT04074161|Hormones|hormones|mesh-ancestor
92081685|NCT01392183|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92023380|NCT04074161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023382|NCT04046575|Carboplatin|carboplatin|mesh-list
92023383|NCT04046575|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023384|NCT04046575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023385|NCT04046575|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023386|NCT04046575|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023387|NCT04046575|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023388|NCT04046575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023389|NCT03997903|Imatinib Mesylate|imatinib mesylate|mesh-list
92023390|NCT03997903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023391|NCT03997903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023392|NCT03997903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023402|NCT03913559|Diphenhydramine|diphenhydramine|mesh-list
92023403|NCT03913559|Promethazine|promethazine|mesh-list
92023404|NCT03913559|Cytarabine|cytarabine|mesh-list
92023405|NCT03913559|Methylprednisolone|methylprednisolone|mesh-list
92023406|NCT03913559|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92023407|NCT03913559|Hydrocortisone|hydrocortisone|mesh-list
92023408|NCT03913559|Methotrexate|methotrexate|mesh-list
92023409|NCT03913559|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92023410|NCT03913559|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92023411|NCT03913559|Abortifacient Agents|abortifacient agents|mesh-ancestor
92023412|NCT03913559|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92023413|NCT03913559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023414|NCT03913559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92023415|NCT03913559|Antimetabolites|antimetabolites|mesh-ancestor
92023416|NCT03913559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023417|NCT03913559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023418|NCT03913559|Dermatologic Agents|dermatologic agents|mesh-ancestor
92023419|NCT03913559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023420|NCT03913559|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92023421|NCT03913559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023422|NCT03913559|Immunologic Factors|immunologic factors|mesh-ancestor
92023423|NCT03913559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023424|NCT03913559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92023425|NCT03913559|Antiviral Agents|antiviral agents|mesh-ancestor
92023426|NCT03913559|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023427|NCT03913559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023428|NCT03913559|Analgesics|analgesics|mesh-ancestor
92023429|NCT03913559|Sensory System Agents|sensory system agents|mesh-ancestor
92023430|NCT03913559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023431|NCT03913559|Antipyretics|antipyretics|mesh-ancestor
92023432|NCT03913559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023433|NCT03913559|Antiemetics|antiemetics|mesh-ancestor
92023434|NCT03913559|Autonomic Agents|autonomic agents|mesh-ancestor
92023435|NCT03913559|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92023436|NCT03913559|Glucocorticoids|glucocorticoids|mesh-ancestor
92023437|NCT03913559|Hormones|hormones|mesh-ancestor
92023438|NCT03913559|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023439|NCT03913559|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92023440|NCT03913559|Protective Agents|protective agents|mesh-ancestor
92023441|NCT03913559|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92023442|NCT03913559|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92023443|NCT03913559|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92023444|NCT03913559|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023445|NCT03913559|Anesthetics, Local|anesthetics, local|mesh-ancestor
92023446|NCT03913559|Anesthetics|anesthetics|mesh-ancestor
92023447|NCT03913559|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92023448|NCT03913559|Histamine Antagonists|histamine antagonists|mesh-ancestor
92023449|NCT03913559|Histamine Agents|histamine agents|mesh-ancestor
92023450|NCT03913559|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023451|NCT03913559|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92023452|NCT03913559|Antipruritics|antipruritics|mesh-ancestor
91984899|NCT02084134|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
91984900|NCT02084134|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92023453|NCT03913559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023454|NCT03913559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92023455|NCT03913559|Immunotoxins|immunotoxins|mesh-ancestor
92023456|NCT03913559|Immunoconjugates|immunoconjugates|mesh-ancestor
92023457|NCT03843528|Azacitidine|azacitidine|mesh-list
92023458|NCT03843528|Vorinostat|vorinostat|mesh-list
92023459|NCT03843528|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92023460|NCT03843528|Antimetabolites|antimetabolites|mesh-ancestor
92023545|NCT03588039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023461|NCT03843528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023472|NCT03779789|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92023473|NCT03779789|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92023474|NCT03779789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92023475|NCT03779789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023476|NCT03779789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023477|NCT03779789|Serotonin Agents|serotonin agents|mesh-ancestor
92023478|NCT03779789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023479|NCT03779789|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92023480|NCT03779789|Antidepressive Agents|antidepressive agents|mesh-ancestor
92023481|NCT03779789|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023482|NCT03779789|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92023483|NCT03779789|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92023484|NCT03779789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023485|NCT03779789|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92023486|NCT03779789|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92023487|NCT03779789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023488|NCT03779789|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92023489|NCT03779789|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92023490|NCT03779789|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92023491|NCT03779789|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92023492|NCT03779789|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92023493|NCT03779789|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92023494|NCT03733210|Panitumumab|panitumumab|mesh-list
92023495|NCT03733210|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023496|NCT03733210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023498|NCT03733132|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92023499|NCT03733132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023500|NCT03667820|Osimertinib|osimertinib|mesh-list
92023501|NCT03667820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023502|NCT03667820|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023503|NCT03667820|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023504|NCT03667820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023505|NCT03654053|Simvastatin|simvastatin|mesh-list
92023506|NCT03654053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92023507|NCT03654053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92023508|NCT03654053|Antimetabolites|antimetabolites|mesh-ancestor
92023509|NCT03654053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023510|NCT03654053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92023511|NCT03654053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92023512|NCT03654053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023513|NCT03627468|Bromides|bromides|mesh-list
92023514|NCT03627468|Anticonvulsants|anticonvulsants|mesh-ancestor
92023515|NCT03620019|Denosumab|denosumab|mesh-list
92023516|NCT03620019|Pembrolizumab|pembrolizumab|mesh-list
92023517|NCT03620019|Nivolumab|nivolumab|mesh-list
92023518|NCT03620019|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023519|NCT03620019|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023520|NCT03620019|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023521|NCT03620019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023522|NCT03620019|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92023523|NCT03620019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023524|NCT03614949|Atezolizumab|atezolizumab|mesh-list
92023525|NCT03614949|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023526|NCT03614949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023528|NCT03614949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023531|NCT03613116|Vitamins|vitamins|mesh-ancestor
92023532|NCT03613116|Micronutrients|micronutrients|mesh-ancestor
91984901|NCT02084134|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92023533|NCT03613116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023534|NCT03613116|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92023535|NCT03613116|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92023536|NCT03588039|Paclitaxel|paclitaxel|mesh-list
92023537|NCT03588039|Pembrolizumab|pembrolizumab|mesh-list
92023538|NCT03588039|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023539|NCT03588039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023540|NCT03588039|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023541|NCT03588039|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023542|NCT03588039|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023543|NCT03588039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023544|NCT03588039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023546|NCT03553004|Niraparib|niraparib|mesh-list
92023547|NCT03553004|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92023548|NCT03553004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023549|NCT03553004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023550|NCT03553004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023551|NCT03516617|Obinutuzumab|obinutuzumab|mesh-list
92023552|NCT03516617|Acalabrutinib|acalabrutinib|mesh-list
92023553|NCT03516617|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92023554|NCT03516617|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023555|NCT03516617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023556|NCT03516617|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023557|NCT03516617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023558|NCT03516617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023559|NCT03488667|Pembrolizumab|pembrolizumab|mesh-list
92023560|NCT03488667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023561|NCT03488667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023562|NCT03488667|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023563|NCT03488667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023564|NCT03406247|Nivolumab|nivolumab|mesh-list
92023565|NCT03406247|Ipilimumab|ipilimumab|mesh-list
92023566|NCT03406247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023567|NCT03406247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023568|NCT03406247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023569|NCT03406247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023570|NCT03399175|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92023571|NCT03399175|Immunologic Factors|immunologic factors|mesh-ancestor
92023572|NCT03399175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023573|NCT03317535|Anesthetics|anesthetics|mesh-list
92023574|NCT03317535|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023575|NCT03317535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023576|NCT03313206|Pembrolizumab|pembrolizumab|mesh-list
92023577|NCT03313206|Lenvatinib|lenvatinib|mesh-list
92023578|NCT03313206|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023579|NCT03313206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023580|NCT03313206|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023581|NCT03313206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023582|NCT03313206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023583|NCT03313206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023584|NCT03250377|Brivaracetam|brivaracetam|mesh-list
92023585|NCT03250377|Anticonvulsants|anticonvulsants|mesh-ancestor
92023586|NCT03077542|Sirolimus|sirolimus|mesh-list
92023587|NCT03077542|Cyclophosphamide|cyclophosphamide|mesh-list
92023588|NCT03077542|Alemtuzumab|alemtuzumab|mesh-list
92023589|NCT03077542|Hydroxyurea|hydroxyurea|mesh-list
92023590|NCT03077542|Pentostatin|pentostatin|mesh-list
92023591|NCT03077542|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023592|NCT03077542|Immunologic Factors|immunologic factors|mesh-ancestor
92023594|NCT03077542|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023595|NCT03077542|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92023596|NCT03077542|Alkylating Agents|alkylating agents|mesh-ancestor
92023597|NCT03077542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023598|NCT03077542|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023601|NCT03077542|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023602|NCT03077542|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91984904|NCT02084134|Antiemetics|antiemetics|mesh-ancestor
91984905|NCT02084134|Autonomic Agents|autonomic agents|mesh-ancestor
91984906|NCT02084134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91984907|NCT02084134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023603|NCT03077542|Antifungal Agents|antifungal agents|mesh-ancestor
92023604|NCT03077542|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023605|NCT03077542|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023606|NCT03077542|Antisickling Agents|antisickling agents|mesh-ancestor
92023607|NCT03077542|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92023608|NCT03077542|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92023609|NCT03066648|Azacitidine|azacitidine|mesh-list
92023610|NCT03066648|Decitabine|decitabine|mesh-list
92023611|NCT03066648|Spartalizumab|spartalizumab|mesh-list
92023612|NCT03066648|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92023613|NCT03066648|Antimetabolites|antimetabolites|mesh-ancestor
92023614|NCT03066648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023615|NCT03066648|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023616|NCT03066648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023617|NCT03066648|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023618|NCT03066648|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023619|NCT03052816|Hydromorphone|hydromorphone|mesh-list
92023620|NCT03052816|Analgesics|analgesics|mesh-ancestor
92023621|NCT03052816|Sensory System Agents|sensory system agents|mesh-ancestor
92023622|NCT03052816|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023623|NCT03052816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023624|NCT03052816|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92023625|NCT03052816|Narcotics|narcotics|mesh-ancestor
92023626|NCT03052816|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023627|NCT03005145|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92023628|NCT03005145|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92023629|NCT03005145|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023630|NCT03005145|Antitubercular Agents|antitubercular agents|mesh-ancestor
92023631|NCT02955940|Capecitabine|capecitabine|mesh-list
92023632|NCT02955940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92023633|NCT02955940|Antimetabolites|antimetabolites|mesh-ancestor
92023634|NCT02955940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023635|NCT02955940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023636|NCT02883062|Paclitaxel|paclitaxel|mesh-list
92023637|NCT02883062|Carboplatin|carboplatin|mesh-list
92023638|NCT02883062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92023639|NCT02883062|Atezolizumab|atezolizumab|mesh-list
92023640|NCT02883062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92023641|NCT02883062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023642|NCT02883062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023643|NCT02883062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023644|NCT02883062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023645|NCT02883062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023646|NCT02883062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023647|NCT02883062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023648|NCT02883062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023649|NCT02883062|Immunologic Factors|immunologic factors|mesh-ancestor
92023650|NCT02883062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023651|NCT02721732|Pembrolizumab|pembrolizumab|mesh-list
92023652|NCT02721732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023653|NCT02721732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023654|NCT02721732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023655|NCT02721732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023656|NCT02684058|Carboplatin|carboplatin|mesh-list
92023657|NCT02684058|Vincristine|vincristine|mesh-list
92023658|NCT02684058|Trametinib|trametinib|mesh-list
92023659|NCT02684058|Dabrafenib|dabrafenib|mesh-list
92023660|NCT02684058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023661|NCT02684058|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023662|NCT02684058|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023663|NCT02684058|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023664|NCT02684058|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023665|NCT02684058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023666|NCT02684058|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023667|NCT02684058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984908|NCT02084134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92023668|NCT02393625|Nivolumab|nivolumab|mesh-list
92023669|NCT02393625|Ceritinib|ceritinib|mesh-list
92023670|NCT02393625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023680|NCT02168829|Rivaroxaban|rivaroxaban|mesh-list
92023681|NCT02168829|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023682|NCT02168829|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023683|NCT02168829|Analgesics|analgesics|mesh-ancestor
92023684|NCT02168829|Sensory System Agents|sensory system agents|mesh-ancestor
92023685|NCT02168829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023686|NCT02168829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023687|NCT02168829|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023688|NCT02168829|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023689|NCT02168829|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92023690|NCT02168829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92023691|NCT02168829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023692|NCT02168829|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92023693|NCT02168829|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92023694|NCT02168829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023695|NCT02168829|Antipyretics|antipyretics|mesh-ancestor
92023696|NCT02168829|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92023697|NCT02168829|Antithrombins|antithrombins|mesh-ancestor
92023698|NCT02168829|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92023699|NCT02168829|Protease Inhibitors|protease inhibitors|mesh-ancestor
92023700|NCT02168829|Anticoagulants|anticoagulants|mesh-ancestor
92023701|NCT01433289|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92024032|NCT02342223|Viscosupplements|viscosupplements|mesh-ancestor
92023703|NCT01433289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023704|NCT01433289|Protective Agents|protective agents|mesh-ancestor
92023705|NCT01433289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023706|NCT01433289|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92023707|NCT01433289|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92023708|NCT01433289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023709|NCT01433289|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92023710|NCT00995475|Fluticasone|fluticasone|mesh-list
92023711|NCT00995475|Xhance|xhance|mesh-list
92023712|NCT00995475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023713|NCT00995475|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92023714|NCT00995475|Autonomic Agents|autonomic agents|mesh-ancestor
92023715|NCT00995475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023716|NCT00995475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023717|NCT00995475|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92023718|NCT00995475|Respiratory System Agents|respiratory system agents|mesh-ancestor
92023719|NCT00995475|Dermatologic Agents|dermatologic agents|mesh-ancestor
92023720|NCT00995475|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92023721|NCT00980460|Sirolimus|sirolimus|mesh-list
92023722|NCT00980460|Cisplatin|cisplatin|mesh-list
92023723|NCT00980460|Doxorubicin|doxorubicin|mesh-list
92023724|NCT00980460|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92023725|NCT00980460|Fluorouracil|fluorouracil|mesh-list
92023726|NCT00980460|Irinotecan|irinotecan|mesh-list
92023727|NCT00980460|Vincristine|vincristine|mesh-list
92023728|NCT00980460|Temsirolimus|temsirolimus|mesh-list
92023729|NCT00980460|Camptothecin|camptothecin|mesh-list
92023730|NCT00980460|Dexrazoxane|dexrazoxane|mesh-list
92023731|NCT00980460|Razoxane|razoxane|mesh-list
92023732|NCT00980460|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione|mesh-list
92023733|NCT00980460|MTOR Inhibitors|mtor inhibitors|mesh-list
92023734|NCT00980460|Liver Extracts|liver extracts|mesh-list
92023735|NCT00980460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023736|NCT00980460|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92023737|NCT00980460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92023750|NCT00980460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023751|NCT00980460|Hematinics|hematinics|mesh-ancestor
92023752|NCT00980460|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92023753|NCT00980460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023754|NCT00980460|Antifungal Agents|antifungal agents|mesh-ancestor
92023755|NCT00980460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023756|NCT00980460|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92023757|NCT00980460|Protective Agents|protective agents|mesh-ancestor
92023758|NCT00945529|Nitric Oxide|nitric oxide|mesh-list
92023759|NCT00945529|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92023760|NCT00945529|Autonomic Agents|autonomic agents|mesh-ancestor
92023761|NCT00945529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023762|NCT00945529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984910|NCT02084134|Hormones|hormones|mesh-ancestor
91984911|NCT02084134|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984912|NCT02084134|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92023763|NCT00945529|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92023764|NCT00945529|Respiratory System Agents|respiratory system agents|mesh-ancestor
92023765|NCT00945529|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92023766|NCT00945529|Antioxidants|antioxidants|mesh-ancestor
92023767|NCT00945529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023768|NCT00945529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023769|NCT00945529|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92023770|NCT00945529|Vasodilator Agents|vasodilator agents|mesh-ancestor
92023771|NCT00945529|Gasotransmitters|gasotransmitters|mesh-ancestor
92023772|NCT00945529|Protective Agents|protective agents|mesh-ancestor
92023773|NCT00921115|Fulvestrant|fulvestrant|mesh-list
92023774|NCT00921115|Anastrozole|anastrozole|mesh-list
92023775|NCT00921115|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92023776|NCT00921115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023777|NCT00921115|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92023778|NCT00921115|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92023779|NCT00921115|Hormone Antagonists|hormone antagonists|mesh-ancestor
92023780|NCT00921115|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023781|NCT00921115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023782|NCT00921115|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92023783|NCT00921115|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92023784|NCT00921115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023785|NCT00921115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023786|NCT00130351|Formoterol Fumarate|formoterol fumarate|mesh-list
92023787|NCT00130351|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92023788|NCT00130351|Autonomic Agents|autonomic agents|mesh-ancestor
92023789|NCT00130351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023790|NCT00130351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023791|NCT00130351|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92023792|NCT00130351|Respiratory System Agents|respiratory system agents|mesh-ancestor
92023793|NCT00130351|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92023794|NCT00130351|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92023795|NCT00130351|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92023796|NCT00130351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92023797|NCT00130351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023798|NCT00130351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023800|NCT04028401|Dermatologic Agents|dermatologic agents|mesh-ancestor
92023801|NCT04425187|Bevacizumab|bevacizumab|mesh-list
92023802|NCT04425187|Gefitinib|gefitinib|mesh-list
92023803|NCT04425187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023804|NCT04425187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023805|NCT04425187|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92023806|NCT04425187|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92023807|NCT04425187|Growth Substances|growth substances|mesh-ancestor
92023808|NCT04425187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023809|NCT04425187|Growth Inhibitors|growth inhibitors|mesh-ancestor
92023810|NCT04425187|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023811|NCT04425187|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023812|NCT04425187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023813|NCT05519839|Vaccines|vaccines|mesh-list
92023814|NCT05519839|Immunologic Factors|immunologic factors|mesh-ancestor
92023815|NCT05519839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023816|NCT05529667|Paclitaxel|paclitaxel|mesh-list
92023817|NCT05529667|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023818|NCT05529667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023819|NCT05529667|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023820|NCT05529667|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023821|NCT05529667|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023822|NCT05529667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023823|NCT03571633|Paclitaxel|paclitaxel|mesh-list
92023824|NCT03571633|Trastuzumab|trastuzumab|mesh-list
92023825|NCT03571633|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023826|NCT03571633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023827|NCT03571633|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023828|NCT03571633|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023829|NCT03571633|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023830|NCT03571633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023831|NCT03571633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023832|NCT03519685|Contraceptive Agents|contraceptive agents|mesh-list
92023833|NCT03519685|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92023834|NCT03519685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023835|NCT05533255|Z 350|z 350|mesh-list
92023836|NCT05533255|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92023837|NCT05533255|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92023838|NCT05533255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023839|NCT05533255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023840|NCT05533255|Hormone Antagonists|hormone antagonists|mesh-ancestor
92023841|NCT05533255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023842|NCT05533255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023843|NCT05529355|Tegafur|tegafur|mesh-list
92023844|NCT05529355|Endostar protein|endostar protein|mesh-list
92023845|NCT05529355|Endostatins|endostatins|mesh-list
92023846|NCT05529355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92023847|NCT05529355|Antimetabolites|antimetabolites|mesh-ancestor
92023848|NCT05529355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023849|NCT05529355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023850|NCT05529355|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92023851|NCT05529355|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92023852|NCT05529355|Growth Substances|growth substances|mesh-ancestor
92023853|NCT05529355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023854|NCT05529355|Growth Inhibitors|growth inhibitors|mesh-ancestor
92023855|NCT05528887|Cyclophosphamide|cyclophosphamide|mesh-list
92023856|NCT05528887|Fludarabine|fludarabine|mesh-list
92023857|NCT05528887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023858|NCT05528887|Immunologic Factors|immunologic factors|mesh-ancestor
92023859|NCT05528887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023860|NCT05528887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023861|NCT05528887|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92023862|NCT05528887|Alkylating Agents|alkylating agents|mesh-ancestor
92023863|NCT05528887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023864|NCT05528887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023865|NCT05528887|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92023866|NCT05501821|Pembrolizumab|pembrolizumab|mesh-list
92023867|NCT05501821|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023868|NCT05501821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023869|NCT05501821|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023879|NCT05528653|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92023880|NCT03009019|Celecoxib|celecoxib|mesh-list
92023881|NCT03009019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92023882|NCT03009019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92023883|NCT03009019|Analgesics|analgesics|mesh-ancestor
92023884|NCT03009019|Sensory System Agents|sensory system agents|mesh-ancestor
92023885|NCT03009019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023886|NCT03009019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023887|NCT03009019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023888|NCT03009019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023889|NCT03009019|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92023890|NCT03009019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92023891|NCT03009019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023892|NCT03009019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023893|NCT02575807|Pembrolizumab|pembrolizumab|mesh-list
92023894|NCT02575807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023895|NCT02575807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023896|NCT02575807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023897|NCT02575807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023898|NCT02813785|Docetaxel|docetaxel|mesh-list
92023899|NCT02813785|Atezolizumab|atezolizumab|mesh-list
92023900|NCT02813785|Antibodies|antibodies|mesh-list
92023901|NCT02813785|Immunologic Factors|immunologic factors|mesh-ancestor
92023902|NCT02813785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023903|NCT02813785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023904|NCT02813785|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023905|NCT02813785|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023906|NCT02813785|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023907|NCT02813785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023908|NCT02813785|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023909|NCT02813785|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023910|NCT04302181|Ropivacaine|ropivacaine|mesh-list
92023911|NCT04302181|Anesthetics, Local|anesthetics, local|mesh-ancestor
92023914|NCT04302181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023915|NCT04302181|Sensory System Agents|sensory system agents|mesh-ancestor
92023916|NCT04302181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023917|NCT02644369|Pembrolizumab|pembrolizumab|mesh-list
92023918|NCT02644369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023919|NCT02644369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023920|NCT02644369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023921|NCT02644369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023922|NCT05527795|Oxymetazoline|oxymetazoline|mesh-list
92023923|NCT05527795|Immunomodulating Agents|immunomodulating agents|mesh-list
92023924|NCT05527795|Immunologic Factors|immunologic factors|mesh-ancestor
92023925|NCT05527795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023926|NCT05527795|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92023927|NCT05527795|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92023928|NCT05527795|Adrenergic Agents|adrenergic agents|mesh-ancestor
92023929|NCT05527795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92023930|NCT05527795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023935|NCT05527795|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92023936|NCT05527795|Respiratory System Agents|respiratory system agents|mesh-ancestor
92023938|NCT05532241|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92023939|NCT05532241|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023941|NCT02431897|Estrogens|estrogens|mesh-list
92023942|NCT02431897|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92023943|NCT02431897|Hormones|hormones|mesh-ancestor
92023944|NCT02431897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023945|NCT02431897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023946|NCT05532085|Analgesics|analgesics|mesh-list
92023947|NCT05532085|Anesthetics|anesthetics|mesh-list
92023948|NCT05532085|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92023949|NCT05532085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023950|NCT05532085|Sensory System Agents|sensory system agents|mesh-ancestor
92023951|NCT05532085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023952|NCT02303119|Rituximab|rituximab|mesh-list
92023953|NCT02303119|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023954|NCT02303119|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023955|NCT02303119|Immunologic Factors|immunologic factors|mesh-ancestor
92023956|NCT02303119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023957|NCT02303119|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023958|NCT02575339|Sorafenib|sorafenib|mesh-list
92023959|NCT02575339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023960|NCT02575339|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023961|NCT02575339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023962|NCT02575339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023963|NCT01640587|Artesunate|artesunate|mesh-list
92023964|NCT01640587|Piperaquine|piperaquine|mesh-list
92023965|NCT01640587|Artenimol|artenimol|mesh-list
92023966|NCT01640587|Mefloquine|mefloquine|mesh-list
92023967|NCT01640587|Antimalarials|antimalarials|mesh-ancestor
92023968|NCT01640587|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92023969|NCT01640587|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92023970|NCT01640587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023971|NCT01640587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023972|NCT01640587|Antiviral Agents|antiviral agents|mesh-ancestor
92023973|NCT01640587|Schistosomicides|schistosomicides|mesh-ancestor
92023974|NCT01640587|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92023976|NCT01610713|Nabiximols|nabiximols|mesh-list
92023977|NCT01610713|Analgesics|analgesics|mesh-ancestor
92023978|NCT01610713|Sensory System Agents|sensory system agents|mesh-ancestor
92023979|NCT01610713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023980|NCT01610713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023981|NCT01606189|Nabiximols|nabiximols|mesh-list
92023982|NCT01606189|Analgesics|analgesics|mesh-ancestor
92023983|NCT01606189|Sensory System Agents|sensory system agents|mesh-ancestor
92023984|NCT01606189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023985|NCT01606189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023986|NCT05525065|Glucocorticoids|glucocorticoids|mesh-list
92023987|NCT05525065|Hormones|hormones|mesh-ancestor
92023988|NCT05525065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023989|NCT05525065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023990|NCT01663987|Bromides|bromides|mesh-list
91984913|NCT02084134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984914|NCT02084134|Protease Inhibitors|protease inhibitors|mesh-ancestor
91984915|NCT02084134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023991|NCT01663987|Tiotropium Bromide|tiotropium bromide|mesh-list
92023992|NCT01663987|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92023993|NCT01663987|Autonomic Agents|autonomic agents|mesh-ancestor
92023994|NCT01663987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023995|NCT01663987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023996|NCT01663987|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92023997|NCT01663987|Respiratory System Agents|respiratory system agents|mesh-ancestor
92023998|NCT01663987|Parasympatholytics|parasympatholytics|mesh-ancestor
92023999|NCT01663987|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92024000|NCT01663987|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024001|NCT01663987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024002|NCT01663987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024003|NCT01663987|Anticonvulsants|anticonvulsants|mesh-ancestor
92024004|NCT05305651|Sotrovimab|sotrovimab|mesh-list
92024005|NCT05305651|Antiviral Agents|antiviral agents|mesh-ancestor
92024009|NCT05526469|Anesthetics|anesthetics|mesh-ancestor
92024010|NCT05526469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024011|NCT05526469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024012|NCT05526469|Sensory System Agents|sensory system agents|mesh-ancestor
92024013|NCT05526469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024014|NCT05155033|Aldesleukin|aldesleukin|mesh-list
92024015|NCT05155033|Pembrolizumab|pembrolizumab|mesh-list
92024016|NCT05155033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024017|NCT05155033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024018|NCT05155033|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92024019|NCT05155033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024020|NCT05155033|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92024021|NCT05155033|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92024022|NCT05155033|Antiviral Agents|antiviral agents|mesh-ancestor
92024023|NCT05155033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024025|NCT02380287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92024026|NCT02380287|Immunologic Factors|immunologic factors|mesh-ancestor
92024027|NCT02380287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024028|NCT02342223|Hyaluronic Acid|hyaluronic acid|mesh-list
92024029|NCT02342223|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92024030|NCT02342223|Immunologic Factors|immunologic factors|mesh-ancestor
92024031|NCT02342223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024033|NCT02342223|Protective Agents|protective agents|mesh-ancestor
92024034|NCT02393547|Varenicline|varenicline|mesh-list
92024035|NCT02393547|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92024036|NCT02393547|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92024037|NCT02393547|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024038|NCT02393547|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024039|NCT02393547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024040|NCT02393547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024041|NCT02574637|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92024042|NCT02574637|Immunologic Factors|immunologic factors|mesh-ancestor
92024043|NCT02574637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024044|NCT05531383|Memantine|memantine|mesh-list
92024045|NCT05531383|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92024046|NCT05531383|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92024047|NCT05531383|Dopamine Agents|dopamine agents|mesh-ancestor
92024048|NCT05531383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024049|NCT05531383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024050|NCT05531383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024051|NCT05531383|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92024052|NCT05531383|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92024053|NCT02392611|Fulvestrant|fulvestrant|mesh-list
92024054|NCT02392611|Exemestane|exemestane|mesh-list
92024055|NCT02392611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024056|NCT02392611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024057|NCT02392611|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92024058|NCT02392611|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92024059|NCT02392611|Hormone Antagonists|hormone antagonists|mesh-ancestor
92024060|NCT02392611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984916|NCT02084134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984917|NCT01374269|Acetaminophen|acetaminophen|mesh-list
91984918|NCT01374269|Celecoxib|celecoxib|mesh-list
91984919|NCT01374269|Naproxen|naproxen|mesh-list
92024061|NCT02392611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024062|NCT02392611|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92024063|NCT02392611|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92024064|NCT02392611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024065|NCT02392611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024066|NCT02378961|Sofosbuvir|sofosbuvir|mesh-list
92024067|NCT02378961|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92024068|NCT02378961|Velpatasvir|velpatasvir|mesh-list
92024070|NCT02378961|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024071|NCT05140525|Macitentan|macitentan|mesh-list
92024072|NCT05140525|Riociguat|riociguat|mesh-list
92024073|NCT05140525|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92024074|NCT05140525|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92024075|NCT05140525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024076|NCT05140525|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92024079|NCT05518513|Anesthetics, Local|anesthetics, local|mesh-ancestor
92024080|NCT05518513|Anesthetics|anesthetics|mesh-ancestor
92024081|NCT05518513|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024082|NCT05518513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024083|NCT05518513|Sensory System Agents|sensory system agents|mesh-ancestor
92024084|NCT05518513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024085|NCT05518279|Tranexamic Acid|tranexamic acid|mesh-list
92024086|NCT05518279|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92024087|NCT05518279|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92024088|NCT05518279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024089|NCT05518279|Hemostatics|hemostatics|mesh-ancestor
92024090|NCT05518279|Coagulants|coagulants|mesh-ancestor
92024092|NCT05523661|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024093|NCT05523661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92024094|NCT05523661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024095|NCT05523661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024096|NCT05523037|Sevoflurane|sevoflurane|mesh-list
92024097|NCT05523037|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92024098|NCT05523037|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92024099|NCT05523037|Anesthetics, General|anesthetics, general|mesh-ancestor
92024100|NCT05523037|Anesthetics|anesthetics|mesh-ancestor
92024101|NCT05523037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024102|NCT05523037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024103|NCT04625647|Sotorasib|sotorasib|mesh-list
92024104|NCT04625647|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92024105|NCT04625647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024106|NCT04625647|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024107|NCT04625647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024108|NCT05122741|Aspirin|aspirin|mesh-list
92024109|NCT05122741|Clopidogrel|clopidogrel|mesh-list
92024110|NCT05122741|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92024111|NCT05122741|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92024112|NCT05122741|Analgesics|analgesics|mesh-ancestor
92024113|NCT05122741|Sensory System Agents|sensory system agents|mesh-ancestor
92024114|NCT05122741|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024115|NCT05122741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024116|NCT05122741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024117|NCT05122741|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92024118|NCT05122741|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92024119|NCT05122741|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92024120|NCT05122741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024121|NCT05122741|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92024122|NCT05122741|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92024123|NCT05122741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024125|NCT05122741|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92024126|NCT05122741|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92024127|NCT05122741|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92024128|NCT05122741|Purinergic Agents|purinergic agents|mesh-ancestor
92024129|NCT05122741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91984920|NCT01374269|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
91984921|NCT01374269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
91984922|NCT01374269|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91984923|NCT01374269|Analgesics|analgesics|mesh-ancestor
92024130|NCT05525767|Bevacizumab|bevacizumab|mesh-list
92024131|NCT05525767|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024132|NCT05525767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024133|NCT05525767|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024134|NCT05525767|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024135|NCT05525767|Growth Substances|growth substances|mesh-ancestor
92024136|NCT05525767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024137|NCT05525767|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024138|NCT05025085|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92024139|NCT05025085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024140|NCT05025085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024141|NCT05025085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024142|NCT05522491|Olaparib|olaparib|mesh-list
92024143|NCT05522491|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92024144|NCT05522491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024145|NCT05522491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024146|NCT05522491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024147|NCT02340975|Durvalumab|durvalumab|mesh-list
92024148|NCT02340975|Tremelimumab|tremelimumab|mesh-list
92024149|NCT02340975|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92024154|NCT02392377|Leucovorin|leucovorin|mesh-list
92024155|NCT02392377|Paclitaxel|paclitaxel|mesh-list
92024156|NCT02392377|Carboplatin|carboplatin|mesh-list
92024157|NCT02392377|Fluorouracil|fluorouracil|mesh-list
92024158|NCT02392377|Oxaliplatin|oxaliplatin|mesh-list
92024159|NCT02392377|Calcium|calcium|mesh-list
92024160|NCT02392377|Levoleucovorin|levoleucovorin|mesh-list
92024161|NCT02392377|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024162|NCT02392377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024163|NCT02392377|Tubulin Modulators|tubulin modulators|mesh-ancestor
92024164|NCT02392377|Antimitotic Agents|antimitotic agents|mesh-ancestor
92024165|NCT02392377|Mitosis Modulators|mitosis modulators|mesh-ancestor
92024166|NCT02392377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024167|NCT02392377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92024168|NCT02392377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024169|NCT02392377|Antimetabolites|antimetabolites|mesh-ancestor
92024170|NCT02392377|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92024171|NCT02392377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92024172|NCT02392377|Immunologic Factors|immunologic factors|mesh-ancestor
92024173|NCT02392377|Antidotes|antidotes|mesh-ancestor
92024174|NCT02392377|Protective Agents|protective agents|mesh-ancestor
92024175|NCT02392377|Vitamin B Complex|vitamin b complex|mesh-ancestor
92024176|NCT02392377|Vitamins|vitamins|mesh-ancestor
92024177|NCT02392377|Micronutrients|micronutrients|mesh-ancestor
92024178|NCT02340819|Teduglutide|teduglutide|mesh-list
92024179|NCT02340819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024180|NCT02340819|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92024181|NCT02340819|Protective Agents|protective agents|mesh-ancestor
92024491|NCT04812379|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92024182|NCT02340819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024183|NCT04903899|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92024184|NCT04903899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92024185|NCT04903899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024186|NCT04903509|Acetaminophen|acetaminophen|mesh-list
92024187|NCT04903509|Liraglutide|liraglutide|mesh-list
92024188|NCT04903509|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92024189|NCT04903509|Analgesics|analgesics|mesh-ancestor
92024190|NCT04903509|Sensory System Agents|sensory system agents|mesh-ancestor
92024191|NCT04903509|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024192|NCT04903509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024193|NCT04903509|Antipyretics|antipyretics|mesh-ancestor
92024194|NCT04903509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92024195|NCT04903509|Incretins|incretins|mesh-ancestor
92024196|NCT04903509|Hormones|hormones|mesh-ancestor
92024197|NCT04903509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024198|NCT05517499|Dexamethasone|dexamethasone|mesh-list
92024199|NCT05517499|Dexamethasone acetate|dexamethasone acetate|mesh-list
92024200|NCT05517499|BB 1101|bb 1101|mesh-list
92024201|NCT05517499|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024202|NCT05517499|Antiemetics|antiemetics|mesh-ancestor
91984924|NCT01374269|Sensory System Agents|sensory system agents|mesh-ancestor
91984925|NCT01374269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024204|NCT05517499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024205|NCT05517499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024206|NCT05517499|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024207|NCT05517499|Glucocorticoids|glucocorticoids|mesh-ancestor
92024208|NCT05517499|Hormones|hormones|mesh-ancestor
92024209|NCT05517499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024210|NCT05517499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024211|NCT05517499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024212|NCT05517499|Protease Inhibitors|protease inhibitors|mesh-ancestor
92024213|NCT05517499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024214|NCT05517499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024215|NCT05512351|Bevacizumab|bevacizumab|mesh-list
92024216|NCT05512351|Tislelizumab|tislelizumab|mesh-list
92024217|NCT05512351|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024218|NCT05512351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024219|NCT05512351|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024220|NCT05512351|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024221|NCT05512351|Growth Substances|growth substances|mesh-ancestor
92024222|NCT05512351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024226|NCT02569957|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92024227|NCT02569957|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92024228|NCT02569957|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92024229|NCT02569957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024230|NCT02569957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024231|NCT02569957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024232|NCT02569957|Antiviral Agents|antiviral agents|mesh-ancestor
92024233|NCT02569957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024234|NCT02569957|Expectorants|expectorants|mesh-ancestor
92024235|NCT02569957|Respiratory System Agents|respiratory system agents|mesh-ancestor
92024236|NCT02569957|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92024237|NCT02569957|Antioxidants|antioxidants|mesh-ancestor
92024238|NCT02569957|Protective Agents|protective agents|mesh-ancestor
92024239|NCT02569957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024240|NCT02569957|Antidotes|antidotes|mesh-ancestor
92024241|NCT01649427|Tacrolimus|tacrolimus|mesh-list
92024242|NCT01649427|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92024243|NCT01649427|Immunologic Factors|immunologic factors|mesh-ancestor
92024244|NCT01649427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024245|NCT01649427|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92024246|NCT01649427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024247|NCT01649427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024248|NCT05521633|Metformin|metformin|mesh-list
92024249|NCT05521633|Pioglitazone|pioglitazone|mesh-list
92024250|NCT05521633|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92024251|NCT05521633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024252|NCT02336607|Metoprolol|metoprolol|mesh-list
92024253|NCT02336607|Felodipine|felodipine|mesh-list
92024254|NCT02336607|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92024255|NCT02336607|Lisinopril|lisinopril|mesh-list
92024256|NCT02336607|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92024257|NCT02336607|Diuretics|diuretics|mesh-ancestor
92024258|NCT02336607|Natriuretic Agents|natriuretic agents|mesh-ancestor
92024259|NCT02336607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024492|NCT04757857|Rivaroxaban|rivaroxaban|mesh-list
92024260|NCT02336607|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92024261|NCT02336607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024262|NCT02336607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024263|NCT02336607|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92024264|NCT02336607|Sympatholytics|sympatholytics|mesh-ancestor
92024265|NCT02336607|Autonomic Agents|autonomic agents|mesh-ancestor
92024266|NCT02336607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024267|NCT02336607|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92024268|NCT02336607|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92024269|NCT02336607|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92024270|NCT02336607|Adrenergic Agents|adrenergic agents|mesh-ancestor
92024271|NCT02336607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024272|NCT02336607|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92024273|NCT02336607|Protease Inhibitors|protease inhibitors|mesh-ancestor
92024274|NCT02336607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024275|NCT02336607|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92024276|NCT02336607|Protective Agents|protective agents|mesh-ancestor
91984926|NCT01374269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984928|NCT01374269|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92024277|NCT02336607|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92024278|NCT02336607|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92024279|NCT02336607|Vasodilator Agents|vasodilator agents|mesh-ancestor
92024280|NCT02569801|Fulvestrant|fulvestrant|mesh-list
92024281|NCT02569801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024282|NCT02569801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024283|NCT02569801|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92024284|NCT02569801|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92024285|NCT02569801|Hormone Antagonists|hormone antagonists|mesh-ancestor
92024286|NCT02569801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024287|NCT02569801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024288|NCT02573311|Tamsulosin|tamsulosin|mesh-list
92024289|NCT02573311|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92024290|NCT02573311|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92024291|NCT02573311|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92024292|NCT02573311|Adrenergic Agents|adrenergic agents|mesh-ancestor
92024293|NCT02573311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024294|NCT02573311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024306|NCT05086393|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92024307|NCT05086393|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92024308|NCT05086393|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024309|NCT05086393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024310|NCT05086393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024311|NCT05086393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024312|NCT05086393|Analgesics|analgesics|mesh-ancestor
92024313|NCT05086393|Sensory System Agents|sensory system agents|mesh-ancestor
92024314|NCT05086393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024315|NCT05086393|Antidepressive Agents|antidepressive agents|mesh-ancestor
92024316|NCT05086393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92024317|NCT05086393|Dopamine Agents|dopamine agents|mesh-ancestor
92024318|NCT02571049|Sumatriptan|sumatriptan|mesh-list
92024319|NCT02571049|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92024320|NCT02571049|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92024321|NCT02571049|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92024322|NCT02571049|Serotonin Agents|serotonin agents|mesh-ancestor
92024323|NCT02571049|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024324|NCT02571049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024325|NCT02571049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024326|NCT05515939|Insulin|insulin|mesh-list
92024327|NCT05515939|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92024328|NCT05515939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024329|NCT04295941|Trazodone|trazodone|mesh-list
92024330|NCT04295941|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92024331|NCT04295941|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92024332|NCT04295941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024333|NCT04295941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024334|NCT04295941|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92024335|NCT04295941|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92024336|NCT04295941|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92024337|NCT04295941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024338|NCT04295941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024339|NCT04295941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024340|NCT04295941|Serotonin Agents|serotonin agents|mesh-ancestor
92024341|NCT04295941|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92024342|NCT04295941|Antidepressive Agents|antidepressive agents|mesh-ancestor
92024343|NCT04294771|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92081686|NCT01392183|Histamine Antagonists|histamine antagonists|mesh-ancestor
92024344|NCT04294771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024345|NCT04294771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024346|NCT04294771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024347|NCT02573155|Tiotropium Bromide|tiotropium bromide|mesh-list
92024348|NCT02573155|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92024349|NCT02573155|Autonomic Agents|autonomic agents|mesh-ancestor
91984929|NCT01374269|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
91984930|NCT01374269|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91984931|NCT01374269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024350|NCT02573155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024351|NCT02573155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024352|NCT02573155|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92024355|NCT02573155|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92024356|NCT02573155|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024357|NCT02573155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024358|NCT02573155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024359|NCT05515471|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92024360|NCT05515471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92024362|NCT05515315|Tislelizumab|tislelizumab|mesh-list
92024363|NCT05515315|Nedaplatin|nedaplatin|mesh-list
92024364|NCT05515315|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024365|NCT05515315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024366|NCT05515315|Tubulin Modulators|tubulin modulators|mesh-ancestor
92024367|NCT05515315|Antimitotic Agents|antimitotic agents|mesh-ancestor
92024368|NCT05515315|Mitosis Modulators|mitosis modulators|mesh-ancestor
92024369|NCT05515315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024370|NCT05515315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024371|NCT05519371|Propofol|propofol|mesh-list
92024372|NCT05519371|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92024373|NCT05519371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024374|NCT05519371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024375|NCT05519371|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92024376|NCT05519371|Anesthetics, General|anesthetics, general|mesh-ancestor
92024377|NCT05519371|Anesthetics|anesthetics|mesh-ancestor
92024378|NCT04847947|Vitamin D|vitamin d|mesh-list
92024379|NCT04847947|Cholecalciferol|cholecalciferol|mesh-list
92024380|NCT04847947|Vitamins|vitamins|mesh-ancestor
92024381|NCT04847947|Micronutrients|micronutrients|mesh-ancestor
92024382|NCT04847947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024383|NCT04847947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92024384|NCT04847947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92024385|NCT05514925|Bevacizumab|bevacizumab|mesh-list
92024386|NCT05514925|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024387|NCT05514925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024388|NCT05514925|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024389|NCT05514925|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024390|NCT05514925|Growth Substances|growth substances|mesh-ancestor
92024391|NCT05514925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024392|NCT05514925|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024393|NCT05514847|Aspirin|aspirin|mesh-list
92024394|NCT05514847|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92024395|NCT05514847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92024396|NCT05514847|Analgesics|analgesics|mesh-ancestor
92024397|NCT05514847|Sensory System Agents|sensory system agents|mesh-ancestor
92024398|NCT05514847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024399|NCT05514847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024400|NCT05514847|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024401|NCT05514847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92024402|NCT05514847|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92024403|NCT05514847|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92024404|NCT05514847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024405|NCT05514847|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92024406|NCT05514847|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92024407|NCT05514847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024408|NCT05514847|Antipyretics|antipyretics|mesh-ancestor
92024409|NCT05510323|Prednisolone|prednisolone|mesh-list
92024410|NCT05510323|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92024411|NCT05510323|Methylprednisolone|methylprednisolone|mesh-list
92024412|NCT05510323|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92024413|NCT05510323|Prednisolone acetate|prednisolone acetate|mesh-list
92024414|NCT05510323|Cyclophosphamide|cyclophosphamide|mesh-list
92024415|NCT05510323|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92024416|NCT05510323|Prednisolone phosphate|prednisolone phosphate|mesh-list
92024417|NCT05510323|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92024418|NCT05510323|Immunologic Factors|immunologic factors|mesh-ancestor
92024419|NCT05510323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024420|NCT05510323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92024421|NCT05510323|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92024422|NCT05510323|Alkylating Agents|alkylating agents|mesh-ancestor
92024423|NCT05510323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024424|NCT05510323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024425|NCT05510323|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92024430|NCT05510323|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024431|NCT05510323|Antiemetics|antiemetics|mesh-ancestor
92024432|NCT05510323|Autonomic Agents|autonomic agents|mesh-ancestor
92024433|NCT05510323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024434|NCT05510323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024435|NCT05510323|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92024436|NCT05510323|Protective Agents|protective agents|mesh-ancestor
92024437|NCT04843579|Clarithromycin|clarithromycin|mesh-list
92024438|NCT04843579|Dexamethasone|dexamethasone|mesh-list
92024439|NCT04843579|Pomalidomide|pomalidomide|mesh-list
92024440|NCT04843579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024441|NCT04843579|Antiemetics|antiemetics|mesh-ancestor
92024442|NCT04843579|Autonomic Agents|autonomic agents|mesh-ancestor
92024443|NCT04843579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024444|NCT04843579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024445|NCT04843579|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024447|NCT04843579|Hormones|hormones|mesh-ancestor
92024448|NCT04843579|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024449|NCT04843579|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024450|NCT04843579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024451|NCT04843579|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92024452|NCT04843579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024453|NCT04843579|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92024454|NCT04843579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024455|NCT04843579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024456|NCT04843579|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92024457|NCT04843579|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92024458|NCT04843579|Immunologic Factors|immunologic factors|mesh-ancestor
92024459|NCT04843579|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024460|NCT04843579|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024461|NCT04843579|Growth Substances|growth substances|mesh-ancestor
92024462|NCT04843579|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024463|NCT05507671|BCG Vaccine|bcg vaccine|mesh-list
92024464|NCT05507671|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92024465|NCT05507671|Immunologic Factors|immunologic factors|mesh-ancestor
92024466|NCT05507671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024467|NCT02568397|Dabigatran|dabigatran|mesh-list
92024468|NCT02568397|Antithrombins|antithrombins|mesh-ancestor
92024469|NCT02568397|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92024470|NCT02568397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92024471|NCT02568397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024472|NCT02568397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024473|NCT02568397|Anticoagulants|anticoagulants|mesh-ancestor
92024474|NCT04812379|Aripiprazole|aripiprazole|mesh-list
92024475|NCT04812379|Antidepressive Agents|antidepressive agents|mesh-ancestor
92024476|NCT04812379|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92024477|NCT04812379|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92024478|NCT04812379|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92024479|NCT04812379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024480|NCT04812379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024481|NCT04812379|Dopamine Agonists|dopamine agonists|mesh-ancestor
92024482|NCT04812379|Dopamine Agents|dopamine agents|mesh-ancestor
92024483|NCT04812379|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024484|NCT04812379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024485|NCT04812379|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92024486|NCT04812379|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92024487|NCT04812379|Serotonin Agents|serotonin agents|mesh-ancestor
92024488|NCT04812379|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92024489|NCT04812379|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92024490|NCT04812379|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92024493|NCT04757857|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92024494|NCT04757857|Antithrombins|antithrombins|mesh-ancestor
92024495|NCT04757857|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92024496|NCT04757857|Protease Inhibitors|protease inhibitors|mesh-ancestor
92024501|NCT04755283|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92024502|NCT04755283|Antithrombins|antithrombins|mesh-ancestor
92024503|NCT04755283|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91984932|NCT01374269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984933|NCT01374269|Gout Suppressants|gout suppressants|mesh-ancestor
91984934|NCT05036681|Pembrolizumab|pembrolizumab|mesh-list
92024504|NCT04755283|Protease Inhibitors|protease inhibitors|mesh-ancestor
92024505|NCT04755283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024506|NCT04755283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024507|NCT04755283|Anticoagulants|anticoagulants|mesh-ancestor
92024509|NCT05506969|1018 oligonucleotide|1018 oligonucleotide|mesh-list
92024510|NCT05506969|Immunologic Factors|immunologic factors|mesh-ancestor
92024511|NCT05506969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024512|NCT05506969|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92024513|NCT04291885|Avelumab|avelumab|mesh-list
92024514|NCT04291885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024515|NCT04291885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024516|NCT05513209|Anesthetics|anesthetics|mesh-list
92024517|NCT05513209|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024518|NCT05513209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024519|NCT05513131|Azacitidine|azacitidine|mesh-list
92024520|NCT05513131|Venetoclax|venetoclax|mesh-list
92024521|NCT05513131|Homoharringtonine|homoharringtonine|mesh-list
92024522|NCT05513131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92024523|NCT05513131|Antimetabolites|antimetabolites|mesh-ancestor
92024524|NCT05513131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024525|NCT05513131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024526|NCT05513131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024527|NCT05513131|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024528|NCT05513131|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92024529|NCT05506501|Anesthetics|anesthetics|mesh-list
92024530|NCT05506501|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024531|NCT05506501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024532|NCT05502913|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92024533|NCT05502913|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92024534|NCT05502913|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024535|NCT05502913|Antitubercular Agents|antitubercular agents|mesh-ancestor
92024536|NCT05509153|Acetylcysteine|acetylcysteine|mesh-list
92024537|NCT05509153|Antiviral Agents|antiviral agents|mesh-ancestor
92024538|NCT05509153|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024539|NCT05509153|Expectorants|expectorants|mesh-ancestor
92024540|NCT05509153|Respiratory System Agents|respiratory system agents|mesh-ancestor
92024541|NCT05509153|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92024542|NCT05509153|Antioxidants|antioxidants|mesh-ancestor
92024543|NCT05509153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024544|NCT05509153|Protective Agents|protective agents|mesh-ancestor
92024545|NCT05509153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024546|NCT04735393|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92024547|NCT04735393|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92024548|NCT04584853|Tamoxifen|tamoxifen|mesh-list
92024549|NCT04584853|Letrozole|letrozole|mesh-list
92024550|NCT04584853|Anastrozole|anastrozole|mesh-list
92024551|NCT04584853|Exemestane|exemestane|mesh-list
92024552|NCT04584853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024553|NCT04584853|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92024554|NCT04584853|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92024555|NCT04584853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024556|NCT04584853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024557|NCT04584853|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92024558|NCT04584853|Hormone Antagonists|hormone antagonists|mesh-ancestor
92024559|NCT04584853|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024560|NCT04584853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024561|NCT04584853|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024562|NCT04584853|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92024563|NCT04584853|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92024564|NCT04584853|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92024565|NCT05505877|Tislelizumab|tislelizumab|mesh-list
92024566|NCT05505877|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024567|NCT05505877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024568|NCT04712851|Pembrolizumab|pembrolizumab|mesh-list
92024570|NCT04712851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024571|NCT04712851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92024572|NCT04712851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024574|NCT02336451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984935|NCT05036681|Futibatinib|futibatinib|mesh-list
91984936|NCT05036681|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984937|NCT05036681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024575|NCT02336451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92024576|NCT02336451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024577|NCT02336451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024578|NCT01648101|Ezogabine|ezogabine|mesh-list
92024579|NCT01648101|Anticonvulsants|anticonvulsants|mesh-ancestor
92024580|NCT01648101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024581|NCT01648101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024582|NCT02336373|Hydroxyurea|hydroxyurea|mesh-list
92024583|NCT02336373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024584|NCT02336373|Antisickling Agents|antisickling agents|mesh-ancestor
92024585|NCT02336373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024586|NCT02336373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024587|NCT02336373|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92024588|NCT02372799|Fluoxetine|fluoxetine|mesh-list
92024589|NCT02372799|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92024590|NCT02372799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92024591|NCT02372799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92024592|NCT02372799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024593|NCT02372799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024594|NCT02372799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024595|NCT02372799|Serotonin Agents|serotonin agents|mesh-ancestor
92024596|NCT02372799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024597|NCT02372799|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92024598|NCT02372799|Antidepressive Agents|antidepressive agents|mesh-ancestor
92024599|NCT02372799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92024600|NCT02372799|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92024601|NCT02372799|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92024602|NCT02372799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024603|NCT02372799|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92024604|NCT02372799|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92024605|NCT02566993|Cyclophosphamide|cyclophosphamide|mesh-list
92024606|NCT02566993|Doxorubicin|doxorubicin|mesh-list
92024607|NCT02566993|Vincristine|vincristine|mesh-list
92024608|NCT02566993|Topotecan|topotecan|mesh-list
92024609|NCT02566993|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92024610|NCT02566993|Immunologic Factors|immunologic factors|mesh-ancestor
92024611|NCT02566993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024612|NCT02566993|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92024613|NCT02566993|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92024614|NCT02566993|Alkylating Agents|alkylating agents|mesh-ancestor
92024615|NCT02566993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024616|NCT02566993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024617|NCT02566993|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92024618|NCT02566993|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92024619|NCT02566993|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92024620|NCT02566993|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92024621|NCT02566993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024622|NCT02566993|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024623|NCT02566993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92024624|NCT02566993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92024625|NCT02566993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92024626|NCT02566993|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92024627|NCT02311881|Acetaminophen|acetaminophen|mesh-list
92024628|NCT02311881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92024629|NCT02311881|Analgesics|analgesics|mesh-ancestor
92024630|NCT02311881|Sensory System Agents|sensory system agents|mesh-ancestor
92024631|NCT02311881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024632|NCT02311881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024633|NCT02311881|Antipyretics|antipyretics|mesh-ancestor
92024634|NCT02565511|Umibecestat|umibecestat|mesh-list
92024635|NCT02565511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024636|NCT02565511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024637|NCT04549051|Anesthetics|anesthetics|mesh-list
92024638|NCT04549051|Anesthetics, Local|anesthetics, local|mesh-list
92024651|NCT04697719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92024653|NCT04697719|Sensory System Agents|sensory system agents|mesh-ancestor
92024654|NCT04697719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024655|NCT04697719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024656|NCT04697719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024657|NCT04697719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92024658|NCT04697719|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92024659|NCT04697719|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92024660|NCT04697719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024661|NCT04697719|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92024662|NCT04697719|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92024663|NCT04697719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024664|NCT04697719|Antipyretics|antipyretics|mesh-ancestor
92024665|NCT05504863|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92024666|NCT05504863|Ferric Compounds|ferric compounds|mesh-list
92024667|NCT05504863|Hematinics|hematinics|mesh-ancestor
92024668|NCT05507983|Tranexamic Acid|tranexamic acid|mesh-list
92024669|NCT05507983|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92024670|NCT05507983|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92024671|NCT05507983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024672|NCT05507983|Hemostatics|hemostatics|mesh-ancestor
92024673|NCT05507983|Coagulants|coagulants|mesh-ancestor
92024674|NCT02335983|Dexamethasone|dexamethasone|mesh-list
92024675|NCT02335983|Lenalidomide|lenalidomide|mesh-list
92024676|NCT02335983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024677|NCT02335983|Antiemetics|antiemetics|mesh-ancestor
92024678|NCT02335983|Autonomic Agents|autonomic agents|mesh-ancestor
92024679|NCT02335983|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024680|NCT02335983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024681|NCT02335983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024682|NCT02335983|Glucocorticoids|glucocorticoids|mesh-ancestor
92024683|NCT02335983|Hormones|hormones|mesh-ancestor
92024684|NCT02335983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024685|NCT02335983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024686|NCT02335983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024687|NCT02335983|Immunologic Factors|immunologic factors|mesh-ancestor
92024688|NCT02335983|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024689|NCT02335983|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024690|NCT02335983|Growth Substances|growth substances|mesh-ancestor
92024691|NCT02335983|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024692|NCT04578691|Titanium dioxide|titanium dioxide|mesh-list
92024693|NCT04578691|Sunscreening Agents|sunscreening agents|mesh-ancestor
92024694|NCT04578691|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92024695|NCT04578691|Protective Agents|protective agents|mesh-ancestor
92024696|NCT04578691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024697|NCT04578691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92024698|NCT04578691|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92024699|NCT02334423|Botulinum Toxins|botulinum toxins|mesh-list
92024700|NCT02334423|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92024701|NCT02334423|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92024703|NCT02334423|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024704|NCT02334423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024705|NCT02334423|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024706|NCT02334423|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024707|NCT02334423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024708|NCT02334423|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92024709|NCT02334423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024710|NCT02310789|Ivacaftor|ivacaftor|mesh-list
92024711|NCT02310789|Pilocarpine|pilocarpine|mesh-list
92024712|NCT02310789|Adrenergic Agents|adrenergic agents|mesh-list
92024713|NCT02310789|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92024714|NCT02310789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024715|NCT02310789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024716|NCT02310789|Miotics|miotics|mesh-ancestor
92024717|NCT02310789|Autonomic Agents|autonomic agents|mesh-ancestor
92024718|NCT02310789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024719|NCT02310789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024720|NCT02310789|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92024721|NCT02310789|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92024722|NCT02310789|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024723|NCT02310789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024724|NCT02372253|Verapamil|verapamil|mesh-list
92024725|NCT02372253|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92024726|NCT02372253|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92024727|NCT02372253|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91984938|NCT05036681|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984939|NCT05036681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024728|NCT02372253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024729|NCT02372253|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92024730|NCT02372253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024731|NCT02372253|Vasodilator Agents|vasodilator agents|mesh-ancestor
92024732|NCT02371629|Glycopyrrolate|glycopyrrolate|mesh-list
92024733|NCT02371629|Bromides|bromides|mesh-list
92024734|NCT02371629|Albuterol|albuterol|mesh-list
92024735|NCT02371629|Anticonvulsants|anticonvulsants|mesh-ancestor
92024736|NCT02371629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92024737|NCT02371629|Autonomic Agents|autonomic agents|mesh-ancestor
92024738|NCT02371629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024739|NCT02371629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024740|NCT02371629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92024741|NCT02371629|Respiratory System Agents|respiratory system agents|mesh-ancestor
92024742|NCT02371629|Tocolytic Agents|tocolytic agents|mesh-ancestor
92024743|NCT02371629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92024744|NCT02371629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92024745|NCT02371629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92024746|NCT02371629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92024747|NCT02371629|Adrenergic Agents|adrenergic agents|mesh-ancestor
92024748|NCT02371629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024749|NCT02371629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024750|NCT02371629|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92024751|NCT02371629|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92024752|NCT02371629|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92024753|NCT02371629|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024754|NCT02559817|Linaclotide|linaclotide|mesh-list
92024755|NCT02559817|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92024756|NCT02559817|Enzyme Activators|enzyme activators|mesh-ancestor
92024757|NCT02559817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024758|NCT02559817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024759|NCT04577443|Adenosine|adenosine|mesh-list
92024760|NCT04577443|Analgesics|analgesics|mesh-ancestor
92024761|NCT04577443|Sensory System Agents|sensory system agents|mesh-ancestor
92024762|NCT04577443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024763|NCT04577443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024764|NCT04577443|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92024765|NCT04577443|Vasodilator Agents|vasodilator agents|mesh-ancestor
92024766|NCT04577443|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92024767|NCT04577443|Purinergic Agonists|purinergic agonists|mesh-ancestor
92024768|NCT04577443|Purinergic Agents|purinergic agents|mesh-ancestor
92024769|NCT04577443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024770|NCT04577443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024771|NCT04411537|Capecitabine|capecitabine|mesh-list
92024772|NCT04411537|Irinotecan|irinotecan|mesh-list
92024773|NCT04411537|Antibodies|antibodies|mesh-list
92024791|NCT04619095|Psyllium|psyllium|mesh-list
92024792|NCT04619095|Cathartics|cathartics|mesh-ancestor
92024793|NCT04619095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024794|NCT04631185|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92024795|NCT04631185|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92024796|NCT04631185|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024797|NCT04631185|Antitubercular Agents|antitubercular agents|mesh-ancestor
92024798|NCT05502991|Bevacizumab|bevacizumab|mesh-list
92024799|NCT05502991|Tislelizumab|tislelizumab|mesh-list
92024800|NCT05502991|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024801|NCT05502991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024802|NCT05502991|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024803|NCT05502991|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024804|NCT05502991|Growth Substances|growth substances|mesh-ancestor
92024805|NCT05502991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024806|NCT05502991|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024808|NCT02563561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024824|NCT05499481|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92024825|NCT05499481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024826|NCT05497843|Chiauranib|chiauranib|mesh-list
92024827|NCT05497843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024828|NCT05497843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92024829|NCT05497843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91984940|NCT03163979|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
91984941|NCT03163979|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
91984942|NCT03163979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984943|NCT03163589|Epoetin Alfa|epoetin alfa|mesh-list
91984944|NCT03163589|Hematinics|hematinics|mesh-ancestor
91984945|NCT03163277|Emtricitabine|emtricitabine|mesh-list
92024830|NCT05497843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024831|NCT05497765|Silybin|silybin|mesh-list
92024832|NCT05497765|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024833|NCT05497765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024834|NCT05497765|Protective Agents|protective agents|mesh-ancestor
92024835|NCT05497765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024836|NCT04424875|Melatonin|melatonin|mesh-list
92024837|NCT04424875|Antioxidants|antioxidants|mesh-ancestor
92024838|NCT04424875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024839|NCT04424875|Protective Agents|protective agents|mesh-ancestor
92024840|NCT04424875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024841|NCT04424875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024843|NCT04277845|Dexamethasone acetate|dexamethasone acetate|mesh-list
92024844|NCT04277845|Lenalidomide|lenalidomide|mesh-list
92024845|NCT04277845|Bortezomib|bortezomib|mesh-list
92024846|NCT04277845|BB 1101|bb 1101|mesh-list
92024847|NCT04277845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024851|NCT04277845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024852|NCT04277845|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92024854|NCT04277845|Hormones|hormones|mesh-ancestor
92024855|NCT04277845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024856|NCT04277845|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92024857|NCT04277845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024858|NCT04277845|Protease Inhibitors|protease inhibitors|mesh-ancestor
92024859|NCT04277845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024860|NCT04277845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024861|NCT04277845|Immunologic Factors|immunologic factors|mesh-ancestor
92024862|NCT04277845|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92024863|NCT04277845|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92024864|NCT04277845|Growth Substances|growth substances|mesh-ancestor
92024865|NCT04277845|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024866|NCT02559505|Vaccines|vaccines|mesh-list
92024867|NCT02559505|Immunologic Factors|immunologic factors|mesh-ancestor
92024868|NCT02559505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024869|NCT05497063|Pyrimethamine|pyrimethamine|mesh-list
92024870|NCT05497063|Sulfadoxine|sulfadoxine|mesh-list
92024871|NCT05497063|Antimalarials|antimalarials|mesh-ancestor
92024872|NCT05497063|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92024873|NCT05497063|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92024874|NCT05497063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024875|NCT05497063|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92024876|NCT05497063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024877|NCT05497063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024878|NCT05497063|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92024879|NCT05560945|Listerine|listerine|mesh-list
92024880|NCT05560945|Fluorides|fluorides|mesh-list
92024881|NCT05560945|Sodium Fluoride|sodium fluoride|mesh-list
92024882|NCT05560945|Cariostatic Agents|cariostatic agents|mesh-ancestor
92024883|NCT05560945|Protective Agents|protective agents|mesh-ancestor
92024884|NCT05560945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024885|NCT05560945|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92024886|NCT05560945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024887|NCT04424563|Aminocaproic Acid|aminocaproic acid|mesh-list
92024888|NCT04424563|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92024889|NCT04424563|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92024890|NCT04424563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024891|NCT04424563|Hemostatics|hemostatics|mesh-ancestor
92024892|NCT04424563|Coagulants|coagulants|mesh-ancestor
92024893|NCT05495893|Mycophenolic Acid|mycophenolic acid|mesh-list
92024894|NCT05495893|Cyclophosphamide|cyclophosphamide|mesh-list
92024895|NCT05495893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92024896|NCT05495893|Immunologic Factors|immunologic factors|mesh-ancestor
92024897|NCT05495893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024898|NCT05495893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91984947|NCT03163277|Darunavir|darunavir|mesh-list
91984948|NCT03163277|Cobicistat|cobicistat|mesh-list
92024899|NCT05495893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92024900|NCT05495893|Alkylating Agents|alkylating agents|mesh-ancestor
92024901|NCT05495893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024902|NCT05495893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024903|NCT05495893|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92024904|NCT05495893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92024905|NCT05495893|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92024906|NCT05495893|Antitubercular Agents|antitubercular agents|mesh-ancestor
92024907|NCT05495893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92024908|NCT05495893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024909|NCT05495893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024911|NCT03542461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024912|NCT03542461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024913|NCT03542461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92024914|NCT03542461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024915|NCT02556307|Ribavirin|ribavirin|mesh-list
92024916|NCT02556307|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92024917|NCT02556307|Antimetabolites|antimetabolites|mesh-ancestor
92024918|NCT02556307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024919|NCT02556307|Antiviral Agents|antiviral agents|mesh-ancestor
92024923|NCT04352101|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92024924|NCT04352101|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92024925|NCT04352101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92024926|NCT04352101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024927|NCT04352101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024928|NCT04352101|Serotonin Agents|serotonin agents|mesh-ancestor
92024929|NCT04352101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024930|NCT04352101|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92024931|NCT04352101|Antidepressive Agents|antidepressive agents|mesh-ancestor
92024932|NCT04352101|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92024933|NCT04352101|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92024934|NCT04352101|Dopamine Agents|dopamine agents|mesh-ancestor
92024935|NCT04352101|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92024936|NCT04352101|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92024937|NCT04352101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024938|NCT04424485|Parathyroid Hormone|parathyroid hormone|mesh-list
92024939|NCT04424485|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92024940|NCT04424485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024941|NCT05494645|Bupivacaine|bupivacaine|mesh-list
92024942|NCT05494645|Anesthetics, Local|anesthetics, local|mesh-ancestor
92024943|NCT05494645|Anesthetics|anesthetics|mesh-ancestor
92024944|NCT05494645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024945|NCT05494645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024946|NCT05494645|Sensory System Agents|sensory system agents|mesh-ancestor
92024947|NCT05494645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024948|NCT05494567|Tadalafil|tadalafil|mesh-list
92024949|NCT05494567|Tamsulosin|tamsulosin|mesh-list
92024950|NCT05494567|Solifenacin Succinate|solifenacin succinate|mesh-list
92024951|NCT05494567|Vasodilator Agents|vasodilator agents|mesh-ancestor
92024952|NCT05494567|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92024953|NCT05494567|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92024954|NCT05494567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024955|NCT05494567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024956|NCT05494567|Urological Agents|urological agents|mesh-ancestor
92024957|NCT05494567|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92024958|NCT05494567|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92024959|NCT05494567|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92024960|NCT05494567|Adrenergic Agents|adrenergic agents|mesh-ancestor
92024961|NCT05494567|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92024962|NCT05494567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024963|NCT05494567|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92024964|NCT05494567|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92024965|NCT05494567|Cholinergic Agents|cholinergic agents|mesh-ancestor
92024966|NCT00609115|Methylamphotericin B|methylamphotericin b|mesh-list
92024967|NCT00609115|Antifungal Agents|antifungal agents|mesh-ancestor
92024968|NCT00609115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024969|NCT05494411|Mitomycins|mitomycins|mesh-list
91984949|NCT03163277|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
91984950|NCT03163277|Antiviral Agents|antiviral agents|mesh-ancestor
92024971|NCT05494411|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92024972|NCT05494411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024973|NCT05494411|Alkylating Agents|alkylating agents|mesh-ancestor
92024974|NCT05494411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024975|NCT05494411|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92024976|NCT05494411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024977|NCT04085887|Panitumumab|panitumumab|mesh-list
92024978|NCT04085887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024979|NCT04085887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024980|NCT04080895|Lumefantrine|lumefantrine|mesh-list
92024981|NCT04080895|Artemether|artemether|mesh-list
92024982|NCT04080895|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92024983|NCT04080895|Amodiaquine|amodiaquine|mesh-list
92024984|NCT04080895|Antimalarials|antimalarials|mesh-ancestor
92024985|NCT04080895|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92024986|NCT04080895|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92024987|NCT04080895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024988|NCT04251169|Paclitaxel|paclitaxel|mesh-list
92024989|NCT04251169|Pembrolizumab|pembrolizumab|mesh-list
92024990|NCT04251169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92024991|NCT04251169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025001|NCT04279561|Sequestering Agents|sequestering agents|mesh-ancestor
92025002|NCT04279561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025003|NCT04279561|Anticoagulants|anticoagulants|mesh-ancestor
92025004|NCT04279561|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92025005|NCT04279561|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92025006|NCT01662895|Deferoxamine|deferoxamine|mesh-list
92025007|NCT01662895|Siderophores|siderophores|mesh-ancestor
92025008|NCT01662895|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92025009|NCT01662895|Chelating Agents|chelating agents|mesh-ancestor
92025010|NCT01662895|Sequestering Agents|sequestering agents|mesh-ancestor
92025011|NCT01662895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025012|NCT05498857|Ephedrine|ephedrine|mesh-list
92025013|NCT05498857|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92025014|NCT05498857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025015|NCT05498857|Sympathomimetics|sympathomimetics|mesh-ancestor
92025016|NCT05498857|Autonomic Agents|autonomic agents|mesh-ancestor
92025017|NCT05498857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025018|NCT05498857|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92025019|NCT05498857|Adrenergic Agents|adrenergic agents|mesh-ancestor
92025020|NCT05498857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025021|NCT05498857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025022|NCT05498467|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92025023|NCT05498467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025024|NCT04139395|Citric Acid|citric acid|mesh-list
92025025|NCT04139395|Sodium Citrate|sodium citrate|mesh-list
92025026|NCT04139395|Gallium citrate|gallium citrate|mesh-list
92025027|NCT04139395|Anticoagulants|anticoagulants|mesh-ancestor
92025028|NCT04139395|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92025029|NCT04139395|Chelating Agents|chelating agents|mesh-ancestor
92025030|NCT04139395|Sequestering Agents|sequestering agents|mesh-ancestor
92025031|NCT04139395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025032|NCT04139395|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92025033|NCT02555215|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92025034|NCT02555215|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025035|NCT02555215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025036|NCT02555215|Immunologic Factors|immunologic factors|mesh-ancestor
92025037|NCT02555215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025038|NCT02555683|Indoleacetic Acids|indoleacetic acids|mesh-list
92025039|NCT02555683|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92025040|NCT02555683|Growth Substances|growth substances|mesh-ancestor
92025041|NCT02555683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025042|NCT02554981|Cyclosporine|cyclosporine|mesh-list
92025043|NCT02554981|Cyclosporins|cyclosporins|mesh-list
92025044|NCT02554981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025045|NCT02554981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025046|NCT02554981|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025047|NCT02554981|Immunologic Factors|immunologic factors|mesh-ancestor
92025048|NCT02554981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025049|NCT02554981|Antifungal Agents|antifungal agents|mesh-ancestor
92025050|NCT02554981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984951|NCT03163277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984952|NCT03163277|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91984953|NCT03163277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91984954|NCT03163277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025051|NCT02554981|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025052|NCT02554981|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025053|NCT02554981|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92025054|NCT02556775|Immunoglobulins|immunoglobulins|mesh-list
92025055|NCT02556775|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92025056|NCT02556775|Antibodies|antibodies|mesh-list
92025057|NCT02556775|gamma-Globulins|gamma-globulins|mesh-list
92025062|NCT04080739|Anesthetics, Local|anesthetics, local|mesh-ancestor
92025063|NCT04080739|Anesthetics|anesthetics|mesh-ancestor
92025064|NCT04080739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025065|NCT04080739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025066|NCT04080739|Sensory System Agents|sensory system agents|mesh-ancestor
92025067|NCT04080739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025068|NCT05485207|Botulinum Toxins|botulinum toxins|mesh-list
92025069|NCT05485207|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92025070|NCT05485207|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92025071|NCT05485207|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92025072|NCT05485207|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92025137|NCT05487391|Carboplatin|carboplatin|mesh-list
92025073|NCT05485207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025074|NCT05485207|Cholinergic Agents|cholinergic agents|mesh-ancestor
92025075|NCT05485207|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025076|NCT05485207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025077|NCT05485207|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92025078|NCT05485207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025079|NCT03879109|Folfirinox|folfirinox|mesh-list
92025080|NCT03879109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025081|NCT05488327|Lenalidomide|lenalidomide|mesh-list
92025082|NCT05488327|Immunologic Factors|immunologic factors|mesh-ancestor
92025083|NCT05488327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025084|NCT05488327|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92025085|NCT05488327|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92025086|NCT05488327|Growth Substances|growth substances|mesh-ancestor
92025087|NCT05488327|Growth Inhibitors|growth inhibitors|mesh-ancestor
92025088|NCT05488327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025089|NCT05488171|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92025090|NCT05488171|Hallucinogens|hallucinogens|mesh-ancestor
92025091|NCT05488171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025092|NCT05488171|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92025093|NCT05488171|Serotonin Agents|serotonin agents|mesh-ancestor
92025094|NCT05488171|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025095|NCT05488171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025096|NCT05488171|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92025097|NCT05488171|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92025098|NCT05488171|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92025099|NCT05488171|Adrenergic Agents|adrenergic agents|mesh-ancestor
92025100|NCT05485051|Chlorhexidine|chlorhexidine|mesh-list
92025101|NCT05485051|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92025102|NCT05485051|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92025103|NCT05485051|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025104|NCT05485051|Disinfectants|disinfectants|mesh-ancestor
92025105|NCT05485051|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025107|NCT05484817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025108|NCT05484817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025109|NCT05484583|Carboplatin|carboplatin|mesh-list
92025110|NCT05484583|Etoposide|etoposide|mesh-list
92025111|NCT05484583|Durvalumab|durvalumab|mesh-list
92025112|NCT05484583|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92025113|NCT05484583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025114|NCT05484583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025115|NCT05484583|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92025116|NCT05484583|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92025117|NCT05484583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025118|NCT05484583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025119|NCT05484583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025120|NCT05484583|Immunologic Factors|immunologic factors|mesh-ancestor
91984955|NCT03163277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984956|NCT03163277|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91984957|NCT03163277|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91984958|NCT03163277|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
91984959|NCT03163277|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
91984960|NCT03163277|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
91984961|NCT03163277|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91984962|NCT03163277|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91984963|NCT03163277|Protease Inhibitors|protease inhibitors|mesh-ancestor
91984964|NCT03163277|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91984965|NCT03163277|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91984966|NCT05419817|Pembrolizumab|pembrolizumab|mesh-list
91984967|NCT05419817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984968|NCT05419817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025121|NCT05484583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025122|NCT05479747|Analgesics|analgesics|mesh-list
92025123|NCT05479747|Sensory System Agents|sensory system agents|mesh-ancestor
92025124|NCT05479747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025125|NCT05479747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025126|NCT05487469|Thymalfasin|thymalfasin|mesh-list
92025127|NCT05487469|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92025128|NCT05487469|Immunologic Factors|immunologic factors|mesh-ancestor
92025132|NCT05479357|Oxytocics|oxytocics|mesh-ancestor
92025133|NCT05479357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92025134|NCT05479357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025135|NCT05487391|Paclitaxel|paclitaxel|mesh-list
92025136|NCT05487391|Vinorelbine|vinorelbine|mesh-list
92025138|NCT05487391|Pemetrexed|pemetrexed|mesh-list
92025139|NCT05487391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025140|NCT05487391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025141|NCT05487391|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025142|NCT05487391|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025143|NCT05487391|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025144|NCT05487391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025145|NCT05487391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025146|NCT05487391|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92025147|NCT05487391|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92025148|NCT05484193|Progesterone|progesterone|mesh-list
92025149|NCT05484193|Progestins|progestins|mesh-ancestor
92025150|NCT05484193|Hormones|hormones|mesh-ancestor
92025151|NCT05484193|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025152|NCT05484193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025153|NCT03796195|Bupivacaine|bupivacaine|mesh-list
92025154|NCT03796195|Anesthetics, Local|anesthetics, local|mesh-ancestor
92025155|NCT03796195|Anesthetics|anesthetics|mesh-ancestor
92025156|NCT03796195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025157|NCT03796195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025158|NCT03796195|Sensory System Agents|sensory system agents|mesh-ancestor
92025159|NCT03796195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025160|NCT04274179|Lamotrigine|lamotrigine|mesh-list
92025161|NCT04274179|Valproic Acid|valproic acid|mesh-list
92025162|NCT04274179|Ethosuximide|ethosuximide|mesh-list
92025163|NCT04274179|Anticonvulsants|anticonvulsants|mesh-ancestor
92025164|NCT04274179|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92025165|NCT04274179|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92025166|NCT04274179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025167|NCT04274179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92025168|NCT04274179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984969|NCT05419817|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984970|NCT05419817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025169|NCT04274179|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92025170|NCT04274179|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92025171|NCT04274179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025172|NCT04274179|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92025173|NCT04274179|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92025174|NCT04274179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025175|NCT04274179|GABA Agents|gaba agents|mesh-ancestor
92025176|NCT04274179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025177|NCT04274179|Antimanic Agents|antimanic agents|mesh-ancestor
92025178|NCT05479123|Timolol|timolol|mesh-list
92025179|NCT05479123|Propranolol|propranolol|mesh-list
92025180|NCT05479123|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92025181|NCT05479123|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92025182|NCT05479123|Adrenergic Agents|adrenergic agents|mesh-ancestor
92025183|NCT05479123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025184|NCT05479123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025185|NCT05479123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025186|NCT05479123|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92025188|NCT05479123|Vasodilator Agents|vasodilator agents|mesh-ancestor
92025190|NCT04268407|Clavulanic Acid|clavulanic acid|mesh-list
92025191|NCT04268407|Clavulanic Acids|clavulanic acids|mesh-list
92025192|NCT04268407|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92025193|NCT04268407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92025194|NCT04268407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025195|NCT04268407|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92025196|NCT04268407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025197|NCT04268407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025198|NCT05487001|Dexamethasone|dexamethasone|mesh-list
92025199|NCT05487001|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025200|NCT05487001|Antiemetics|antiemetics|mesh-ancestor
92025201|NCT05487001|Autonomic Agents|autonomic agents|mesh-ancestor
92025204|NCT05487001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025206|NCT05487001|Hormones|hormones|mesh-ancestor
92025207|NCT05487001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025208|NCT05487001|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92025209|NCT05487001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025210|NCT05483647|Anesthetics|anesthetics|mesh-list
92025211|NCT05483647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025212|NCT05483647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025213|NCT05475379|Vaccines|vaccines|mesh-list
92025214|NCT05475379|Immunologic Factors|immunologic factors|mesh-ancestor
92025215|NCT05475379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025216|NCT05475223|Carbon Monoxide|carbon monoxide|mesh-list
92025217|NCT05475223|Antimetabolites|antimetabolites|mesh-ancestor
92025218|NCT05475223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025219|NCT05475223|Gasotransmitters|gasotransmitters|mesh-ancestor
92025220|NCT05475223|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025221|NCT05475223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025222|NCT03684811|Gemcitabine|gemcitabine|mesh-list
92025223|NCT03684811|Nivolumab|nivolumab|mesh-list
92025224|NCT03684811|Azacitidine|azacitidine|mesh-list
92025225|NCT03684811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025226|NCT03684811|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025227|NCT03684811|Antimetabolites|antimetabolites|mesh-ancestor
92025228|NCT03684811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025229|NCT03684811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025230|NCT03684811|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025231|NCT03684811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025232|NCT04542733|Everolimus|everolimus|mesh-list
92025233|NCT04542733|Tacrolimus|tacrolimus|mesh-list
92025234|NCT04542733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025235|NCT04542733|Immunologic Factors|immunologic factors|mesh-ancestor
92025236|NCT04542733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025237|NCT04542733|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92025238|NCT04542733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025239|NCT04542733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025240|NCT04542733|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92025241|NCT04542733|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984972|NCT05676749|Pembrolizumab|pembrolizumab|mesh-list
91984973|NCT05676749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025242|NCT04542733|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025243|NCT04424017|Antibodies|antibodies|mesh-list
92025244|NCT04424017|Immunologic Factors|immunologic factors|mesh-ancestor
92025245|NCT04424017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025246|NCT05477797|Lenalidomide|lenalidomide|mesh-list
92025247|NCT05477797|Ixazomib|ixazomib|mesh-list
92025248|NCT05477797|Immunologic Factors|immunologic factors|mesh-ancestor
92025249|NCT05477797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025250|NCT05477797|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92025251|NCT05477797|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92025252|NCT05477797|Growth Substances|growth substances|mesh-ancestor
92025253|NCT05477797|Growth Inhibitors|growth inhibitors|mesh-ancestor
92025254|NCT05477797|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025255|NCT05477797|Protease Inhibitors|protease inhibitors|mesh-ancestor
92025256|NCT05477797|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025257|NCT05477797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025258|NCT03386929|Palbociclib|palbociclib|mesh-list
92025259|NCT03386929|Avelumab|avelumab|mesh-list
92025260|NCT03386929|Axitinib|axitinib|mesh-list
92025261|NCT03386929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025262|NCT03386929|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92025263|NCT03386929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025264|NCT03386929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025265|NCT03386929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025266|NCT05472337|Colchicine|colchicine|mesh-list
92025267|NCT05472337|Gout Suppressants|gout suppressants|mesh-ancestor
92025268|NCT05472337|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025269|NCT05472337|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025270|NCT05472337|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025271|NCT05472337|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025272|NCT05472337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025273|NCT05472337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025274|NCT05472259|Leucovorin|leucovorin|mesh-list
92025285|NCT05472259|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92025286|NCT05472259|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92025287|NCT05472259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025288|NCT05472259|Antidotes|antidotes|mesh-ancestor
92025289|NCT05472259|Protective Agents|protective agents|mesh-ancestor
92025290|NCT05472259|Vitamin B Complex|vitamin b complex|mesh-ancestor
92025291|NCT05472259|Vitamins|vitamins|mesh-ancestor
92025292|NCT05472259|Micronutrients|micronutrients|mesh-ancestor
92025293|NCT04266145|Dexmedetomidine|dexmedetomidine|mesh-list
92025294|NCT04266145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92025295|NCT04266145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025296|NCT04266145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025297|NCT04266145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025298|NCT04266145|Analgesics|analgesics|mesh-ancestor
92025299|NCT04266145|Sensory System Agents|sensory system agents|mesh-ancestor
92025300|NCT04266145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025301|NCT04266145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92025302|NCT04266145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92025303|NCT04266145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92025304|NCT04266145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92025305|NCT04266145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025306|NCT04266145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025307|NCT03383419|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92025308|NCT03383419|Antiviral Agents|antiviral agents|mesh-ancestor
92025309|NCT03383419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025310|NCT05477017|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92025311|NCT05477017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025312|NCT05477017|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92025313|NCT05477017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025314|NCT02554279|Menotropins|menotropins|mesh-list
92025315|NCT02554279|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92025316|NCT02554279|Fertility Agents|fertility agents|mesh-ancestor
92025317|NCT02554279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92025318|NCT02554279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025319|NCT02554903|Macitentan|macitentan|mesh-list
92025320|NCT02554903|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92081687|NCT01392183|Histamine Agents|histamine agents|mesh-ancestor
91984974|NCT05676749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984975|NCT05676749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91984976|NCT05676749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025321|NCT02554903|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92025322|NCT02554903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025323|NCT02554903|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92025325|NCT02332707|Grazoprevir|grazoprevir|mesh-list
92025326|NCT02332707|Uprifosbuvir|uprifosbuvir|mesh-list
92025328|NCT02332707|Antimetabolites|antimetabolites|mesh-ancestor
92025329|NCT02332707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025330|NCT02332707|Antiviral Agents|antiviral agents|mesh-ancestor
92025331|NCT02332707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025332|NCT02370615|Itraconazole|itraconazole|mesh-list
92025333|NCT02370615|Digoxin|digoxin|mesh-list
92025334|NCT02370615|Midazolam|midazolam|mesh-list
92025335|NCT02370615|Imarikiren hydrochloride|imarikiren hydrochloride|mesh-list
92025336|NCT02370615|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92025337|NCT02370615|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92025338|NCT02370615|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025365|NCT02307513|Analgesics|analgesics|mesh-ancestor
92025366|NCT02307513|Sensory System Agents|sensory system agents|mesh-ancestor
92025367|NCT02307513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025368|NCT02307513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025369|NCT02307513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025370|NCT02307513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025371|NCT02307513|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92025372|NCT02307513|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92025373|NCT02307513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025374|NCT02307513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025375|NCT02328105|Paclitaxel|paclitaxel|mesh-list
92025376|NCT02328105|Carboplatin|carboplatin|mesh-list
92025377|NCT02328105|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92025378|NCT02328105|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025379|NCT02328105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025380|NCT02328105|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025381|NCT02328105|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025382|NCT02328105|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025383|NCT02328105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025384|NCT02305797|Lorazepam|lorazepam|mesh-list
92025399|NCT02305797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025401|NCT01646073|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92025402|NCT01646073|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025403|NCT01646073|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025404|NCT02551159|Carboplatin|carboplatin|mesh-list
92025405|NCT02551159|Fluorouracil|fluorouracil|mesh-list
92025406|NCT02551159|Cetuximab|cetuximab|mesh-list
92025407|NCT02551159|Durvalumab|durvalumab|mesh-list
92025408|NCT02551159|Tremelimumab|tremelimumab|mesh-list
92025409|NCT02551159|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92025410|NCT02551159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025411|NCT02551159|Antimetabolites|antimetabolites|mesh-ancestor
92025412|NCT02551159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025413|NCT02551159|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025414|NCT02551159|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025415|NCT02551159|Immunologic Factors|immunologic factors|mesh-ancestor
92025416|NCT02551159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025417|NCT02551159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025418|NCT04539379|Magnesium Sulfate|magnesium sulfate|mesh-list
92025419|NCT04539379|Analgesics|analgesics|mesh-ancestor
92025420|NCT04539379|Sensory System Agents|sensory system agents|mesh-ancestor
92025421|NCT04539379|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025422|NCT04539379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025423|NCT04539379|Anesthetics|anesthetics|mesh-ancestor
92025424|NCT04539379|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025425|NCT04539379|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92025426|NCT04539379|Anticonvulsants|anticonvulsants|mesh-ancestor
92025427|NCT04539379|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92025428|NCT04539379|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91984977|NCT05676749|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91984978|NCT05676749|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91984979|NCT05676749|Antiviral Agents|antiviral agents|mesh-ancestor
92025429|NCT04539379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025430|NCT04539379|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92025431|NCT04539379|Tocolytic Agents|tocolytic agents|mesh-ancestor
92025432|NCT04539379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92025433|NCT05470075|Tramadol|tramadol|mesh-list
92025434|NCT05470075|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92025435|NCT05470075|Narcotics|narcotics|mesh-ancestor
92025436|NCT05470075|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025437|NCT05470075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025438|NCT05470075|Analgesics|analgesics|mesh-ancestor
92025439|NCT05470075|Sensory System Agents|sensory system agents|mesh-ancestor
92025440|NCT05470075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025441|NCT05481619|Vedolizumab|vedolizumab|mesh-list
92025442|NCT05481619|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025443|NCT02305563|Cytarabine|cytarabine|mesh-list
92025444|NCT02305563|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025445|NCT02305563|Antimetabolites|antimetabolites|mesh-ancestor
92025450|NCT02305563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025451|NCT02305563|Immunologic Factors|immunologic factors|mesh-ancestor
92025452|NCT02305563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025453|NCT02304705|Sildenafil Citrate|sildenafil citrate|mesh-list
92025454|NCT02304705|Vasodilator Agents|vasodilator agents|mesh-ancestor
92025455|NCT02304705|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92025456|NCT02304705|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92025457|NCT02304705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025458|NCT02304705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025459|NCT02304705|Urological Agents|urological agents|mesh-ancestor
92025461|NCT02553499|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025462|NCT02553499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025463|NCT02553499|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025464|NCT02553499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025465|NCT02553265|Carbidopa|carbidopa|mesh-list
92025466|NCT02553265|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92025467|NCT02553265|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92025468|NCT02553265|Dopamine Agents|dopamine agents|mesh-ancestor
92025469|NCT02553265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081688|NCT01392183|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025470|NCT02553265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025471|NCT02553265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025472|NCT02553265|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92025473|NCT02553265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025474|NCT03215095|Durvalumab|durvalumab|mesh-list
92025475|NCT03215095|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025476|NCT03215095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025477|NCT01663103|Rilonacept|rilonacept|mesh-list
92025478|NCT01663103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025479|NCT05501639|Tiotropium Bromide|tiotropium bromide|mesh-list
92025480|NCT05501639|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92025481|NCT05501639|Autonomic Agents|autonomic agents|mesh-ancestor
92025482|NCT05501639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025483|NCT05501639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025484|NCT05501639|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92025485|NCT05501639|Respiratory System Agents|respiratory system agents|mesh-ancestor
92025486|NCT05501639|Parasympatholytics|parasympatholytics|mesh-ancestor
92025487|NCT05501639|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92025488|NCT05501639|Cholinergic Agents|cholinergic agents|mesh-ancestor
92025489|NCT05501639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025490|NCT05501639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025491|NCT05284643|Bevacizumab|bevacizumab|mesh-list
92025492|NCT05284643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025493|NCT05284643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025494|NCT05284643|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92025495|NCT05284643|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92025496|NCT05284643|Growth Substances|growth substances|mesh-ancestor
92025497|NCT05284643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025498|NCT05284643|Growth Inhibitors|growth inhibitors|mesh-ancestor
92025499|NCT04577963|Tislelizumab|tislelizumab|mesh-list
91984980|NCT05676749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91984981|NCT05392205|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92025500|NCT04577963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025501|NCT04577963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025502|NCT05092373|Paclitaxel|paclitaxel|mesh-list
92025503|NCT05092373|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92025504|NCT05092373|Atezolizumab|atezolizumab|mesh-list
92025505|NCT05092373|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92025506|NCT05092373|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025507|NCT05092373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025508|NCT05092373|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025509|NCT05092373|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025510|NCT05092373|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025511|NCT05092373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025512|NCT05092373|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025526|NCT02560025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025527|NCT02560025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025528|NCT02560025|Antiviral Agents|antiviral agents|mesh-ancestor
92025529|NCT02560025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025530|NCT02560025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025531|NCT02560025|Immunologic Factors|immunologic factors|mesh-ancestor
92025532|NCT02560025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025533|NCT02560025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92025534|NCT02560025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92025535|NCT02560025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92025536|NCT02560025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025537|NCT05500937|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92025538|NCT05500937|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92025539|NCT05500937|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025540|NCT04524455|Dexamethasone|dexamethasone|mesh-list
92025541|NCT04524455|Blinatumomab|blinatumomab|mesh-list
92025542|NCT04524455|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025543|NCT04524455|Antiemetics|antiemetics|mesh-ancestor
92025544|NCT04524455|Autonomic Agents|autonomic agents|mesh-ancestor
92025545|NCT04524455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025546|NCT04524455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025547|NCT04524455|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025548|NCT04524455|Glucocorticoids|glucocorticoids|mesh-ancestor
92025549|NCT04524455|Hormones|hormones|mesh-ancestor
92025550|NCT04524455|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025551|NCT04524455|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92025552|NCT04524455|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025553|NCT04411901|Cholecalciferol|cholecalciferol|mesh-list
92025554|NCT04411901|Vitamin D|vitamin d|mesh-list
92025555|NCT04411901|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92025556|NCT04411901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025557|NCT04411901|Vitamins|vitamins|mesh-ancestor
92025558|NCT04411901|Micronutrients|micronutrients|mesh-ancestor
92025559|NCT04411901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92025560|NCT05508737|Trifluridine|trifluridine|mesh-list
92025561|NCT05508737|Pembrolizumab|pembrolizumab|mesh-list
92025562|NCT05508737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025563|NCT05508737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025564|NCT05508737|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025565|NCT05508737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025566|NCT05508737|Antimetabolites|antimetabolites|mesh-ancestor
92025567|NCT05508737|Antiviral Agents|antiviral agents|mesh-ancestor
92025568|NCT05508737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025569|NCT05508035|Valsartan|valsartan|mesh-list
92025570|NCT05508035|Ramipril|ramipril|mesh-list
92025571|NCT05508035|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92025572|NCT05508035|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92025573|NCT05508035|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92025574|NCT05508035|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92025578|NCT05508035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025579|NCT02566889|Infliximab|infliximab|mesh-list
92025580|NCT02566889|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92025581|NCT02566889|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025582|NCT02566889|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025583|NCT02566889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025584|NCT02566889|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025585|NCT05507957|Chlorhexidine|chlorhexidine|mesh-list
92025586|NCT05507957|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92025587|NCT05507957|Ethanol|ethanol|mesh-list
91984982|NCT05392205|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92025588|NCT05507957|Povidone-Iodine|povidone-iodine|mesh-list
92025589|NCT05507957|Disinfectants|disinfectants|mesh-list
92025591|NCT05507957|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92025592|NCT05507957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025593|NCT05507957|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025594|NCT05507957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025595|NCT05507957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025596|NCT05507957|Plasma Substitutes|plasma substitutes|mesh-ancestor
92025597|NCT05507957|Blood Substitutes|blood substitutes|mesh-ancestor
92025598|NCT04282109|Paclitaxel|paclitaxel|mesh-list
92025599|NCT04282109|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92025600|NCT04282109|Nivolumab|nivolumab|mesh-list
92025601|NCT04282109|Cetuximab|cetuximab|mesh-list
92025602|NCT04282109|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025603|NCT04282109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025604|NCT04282109|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025605|NCT04282109|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025606|NCT04282109|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025607|NCT04282109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025608|NCT04282109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025609|NCT04282109|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025610|NCT03150173|Buprenorphine|buprenorphine|mesh-list
92025611|NCT03150173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92025612|NCT03150173|Narcotics|narcotics|mesh-ancestor
92025613|NCT03150173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025614|NCT03150173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025615|NCT03150173|Analgesics|analgesics|mesh-ancestor
92025616|NCT03150173|Sensory System Agents|sensory system agents|mesh-ancestor
92025617|NCT03150173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025618|NCT03150173|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92025619|NCT05563571|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92025620|NCT05563571|Methylprednisolone|methylprednisolone|mesh-list
92025621|NCT05563571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92025623|NCT05563571|Prednisolone acetate|prednisolone acetate|mesh-list
92025624|NCT05563571|Lidocaine|lidocaine|mesh-list
92025625|NCT05563571|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92025626|NCT05563571|Prednisolone phosphate|prednisolone phosphate|mesh-list
92025627|NCT05563571|Anesthetics, Local|anesthetics, local|mesh-ancestor
92025628|NCT05563571|Anesthetics|anesthetics|mesh-ancestor
92025629|NCT05563571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025630|NCT05563571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025631|NCT05563571|Sensory System Agents|sensory system agents|mesh-ancestor
92025632|NCT05563571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025633|NCT05563571|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92025634|NCT05563571|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92025635|NCT05563571|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92025636|NCT05563571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92025637|NCT05563571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025638|NCT05563571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025639|NCT05563571|Antiemetics|antiemetics|mesh-ancestor
92025640|NCT05563571|Autonomic Agents|autonomic agents|mesh-ancestor
92025641|NCT05563571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025642|NCT05563571|Glucocorticoids|glucocorticoids|mesh-ancestor
92025643|NCT05563571|Hormones|hormones|mesh-ancestor
92025644|NCT05563571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025645|NCT05563571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92025646|NCT05563571|Protective Agents|protective agents|mesh-ancestor
92025647|NCT05563571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92025653|NCT02717507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025654|NCT02717507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025655|NCT02717507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025656|NCT02717507|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92025657|NCT02717507|Antioxidants|antioxidants|mesh-ancestor
92025658|NCT02717507|Protective Agents|protective agents|mesh-ancestor
92025659|NCT02717507|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92025660|NCT02717507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92025661|NCT02717507|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92025662|NCT02717507|Vasodilator Agents|vasodilator agents|mesh-ancestor
92025663|NCT02717507|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92025664|NCT02717507|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92025666|NCT02489903|Etoposide|etoposide|mesh-list
91984983|NCT05392205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984984|NCT02679755|Letrozole|letrozole|mesh-list
92025667|NCT02489903|Vinorelbine|vinorelbine|mesh-list
92025668|NCT02489903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92025669|NCT02489903|Carboplatin|carboplatin|mesh-list
92025670|NCT02489903|Gemcitabine|gemcitabine|mesh-list
92025671|NCT02489903|Irinotecan|irinotecan|mesh-list
92025672|NCT02489903|Pemetrexed|pemetrexed|mesh-list
92025673|NCT02489903|Taxane|taxane|mesh-list
92025674|NCT02489903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025675|NCT02489903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025676|NCT02489903|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025677|NCT02489903|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025678|NCT02489903|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025679|NCT02489903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025680|NCT02489903|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025681|NCT02489903|Antimetabolites|antimetabolites|mesh-ancestor
92025682|NCT02489903|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92025683|NCT02489903|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92025684|NCT02489903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025685|NCT02489903|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92025686|NCT02489903|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92025687|NCT02489903|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92025688|NCT01174199|Sirolimus|sirolimus|mesh-list
92025689|NCT01174199|Vorinostat|vorinostat|mesh-list
92025690|NCT01174199|Temsirolimus|temsirolimus|mesh-list
92025691|NCT01174199|MTOR Inhibitors|mtor inhibitors|mesh-list
92025692|NCT01174199|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92025693|NCT01174199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025694|NCT01174199|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92025695|NCT01174199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025696|NCT01174199|Antifungal Agents|antifungal agents|mesh-ancestor
92025697|NCT01174199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025698|NCT01174199|Immunologic Factors|immunologic factors|mesh-ancestor
92025699|NCT01174199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025700|NCT01174199|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92025701|NCT01174199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025702|NCT01174199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025703|NCT01174199|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92025704|NCT04356599|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92025705|NCT04356599|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92025706|NCT04356599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025708|NCT05562869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025709|NCT05562869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025710|NCT05562869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025711|NCT05562869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025712|NCT05562869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025713|NCT05562869|Immunologic Factors|immunologic factors|mesh-ancestor
92025714|NCT05562869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025715|NCT05562869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025716|NCT04085237|Ropivacaine|ropivacaine|mesh-list
92025717|NCT04085237|Anesthetics, Local|anesthetics, local|mesh-ancestor
92025718|NCT04085237|Anesthetics|anesthetics|mesh-ancestor
92025740|NCT00560495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025741|NCT00560495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025742|NCT00560495|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92025743|NCT00560495|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92025744|NCT00560495|Growth Substances|growth substances|mesh-ancestor
92025745|NCT00560495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025746|NCT00560495|Growth Inhibitors|growth inhibitors|mesh-ancestor
92025747|NCT00560495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025748|NCT00560495|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92025749|NCT02559713|Vedolizumab|vedolizumab|mesh-list
92025750|NCT02559713|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025751|NCT05499065|Cetuximab|cetuximab|mesh-list
92025752|NCT05499065|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025753|NCT05499065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025754|NCT04230161|Milbemycin oxime|milbemycin oxime|mesh-list
92025755|NCT04230161|Anthelmintics|anthelmintics|mesh-ancestor
92025756|NCT04230161|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92025757|NCT04230161|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025759|NCT04038437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984986|NCT02679755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91984987|NCT02679755|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
91984988|NCT02679755|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92025760|NCT05498675|Valsartan|valsartan|mesh-list
92025761|NCT05498675|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92025762|NCT05498675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92025763|NCT05498675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92025764|NCT05498675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92025765|NCT05498675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025766|NCT05491343|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92025767|NCT05491343|Medroxyprogesterone|medroxyprogesterone|mesh-list
92025768|NCT05491343|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92025769|NCT05491343|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92025770|NCT05491343|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92025771|NCT05491343|Contraceptive Agents|contraceptive agents|mesh-ancestor
92025772|NCT05491343|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92025775|NCT05491343|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92025777|NCT05491343|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92025778|NCT05491343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025779|NCT05498441|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92025780|NCT05498441|Antidepressive Agents|antidepressive agents|mesh-ancestor
92025781|NCT05498441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92025782|NCT05498441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92025783|NCT05498441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92025784|NCT05498441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025785|NCT05498441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025786|NCT05485883|Lenvatinib|lenvatinib|mesh-list
92025787|NCT05485883|Tislelizumab|tislelizumab|mesh-list
92025788|NCT05485883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025789|NCT05485883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92025790|NCT05485883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025791|NCT05485883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025792|NCT05485883|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025793|NCT04273607|Heparin|heparin|mesh-list
92025794|NCT04273607|Calcium heparin|calcium heparin|mesh-list
92025795|NCT04273607|Enoxaparin|enoxaparin|mesh-list
92025796|NCT04273607|Anticoagulants|anticoagulants|mesh-ancestor
92025797|NCT04273607|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92025798|NCT04273607|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92025799|NCT04273607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025800|NCT05476081|Aspirin|aspirin|mesh-list
92025801|NCT05476081|Clopidogrel|clopidogrel|mesh-list
92025802|NCT05476081|Ticagrelor|ticagrelor|mesh-list
92025803|NCT05476081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92025804|NCT05476081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025805|NCT05476081|Analgesics|analgesics|mesh-ancestor
92025806|NCT05476081|Sensory System Agents|sensory system agents|mesh-ancestor
92025807|NCT05476081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025808|NCT05476081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025809|NCT05476081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025810|NCT05476081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025811|NCT05476081|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92025812|NCT05476081|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92025813|NCT05476081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025814|NCT05476081|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92025815|NCT05476081|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92025816|NCT05476081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025817|NCT05476081|Antipyretics|antipyretics|mesh-ancestor
92025818|NCT05476081|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92025819|NCT05476081|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92025820|NCT05476081|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92025821|NCT05476081|Purinergic Agents|purinergic agents|mesh-ancestor
92025822|NCT05476081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025823|NCT05476003|Midazolam|midazolam|mesh-list
92025824|NCT05476003|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92025825|NCT05476003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92025826|NCT05476003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025827|NCT05476003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91984989|NCT02679755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025828|NCT05476003|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92025829|NCT05476003|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92025830|NCT05476003|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92025831|NCT05476003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92025832|NCT05476003|Anesthetics, General|anesthetics, general|mesh-ancestor
92025833|NCT05476003|Anesthetics|anesthetics|mesh-ancestor
92025834|NCT05476003|GABA Modulators|gaba modulators|mesh-ancestor
92025835|NCT05476003|GABA Agents|gaba agents|mesh-ancestor
92025836|NCT05476003|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025837|NCT05476003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025838|NCT02547649|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92025839|NCT02547649|Immunologic Factors|immunologic factors|mesh-ancestor
92025840|NCT02547649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025841|NCT03209479|Glatiramer Acetate|glatiramer acetate|mesh-list
92025842|NCT03209479|(T,G)-A-L|(t,g)-a-l|mesh-list
92025843|NCT03209479|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92025844|NCT03209479|Immunologic Factors|immunologic factors|mesh-ancestor
92025847|NCT03209479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025848|NCT02535715|Insulin|insulin|mesh-list
92025849|NCT02535715|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92025850|NCT02535715|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92025851|NCT02535715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025852|NCT02336815|Dexamethasone|dexamethasone|mesh-list
92025853|NCT02336815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025854|NCT02336815|Antiemetics|antiemetics|mesh-ancestor
92025855|NCT02336815|Autonomic Agents|autonomic agents|mesh-ancestor
92025856|NCT02336815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025857|NCT02336815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025858|NCT02336815|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025859|NCT02336815|Glucocorticoids|glucocorticoids|mesh-ancestor
92025860|NCT02336815|Hormones|hormones|mesh-ancestor
92025861|NCT02336815|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025862|NCT02336815|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92025863|NCT02336815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025864|NCT05434039|Diclofenac|diclofenac|mesh-list
92025865|NCT05434039|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92025866|NCT05434039|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025867|NCT05434039|Analgesics|analgesics|mesh-ancestor
92025868|NCT05434039|Sensory System Agents|sensory system agents|mesh-ancestor
92025869|NCT05434039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025870|NCT05434039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025871|NCT05434039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025872|NCT05434039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025873|NCT05434039|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92025874|NCT05434039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025875|NCT05434039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025876|NCT05466175|Prednisone|prednisone|mesh-list
92025877|NCT05466175|Vincristine|vincristine|mesh-list
92025878|NCT05466175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025879|NCT05466175|Glucocorticoids|glucocorticoids|mesh-ancestor
92025880|NCT05466175|Hormones|hormones|mesh-ancestor
92025881|NCT05466175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025882|NCT05466175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025883|NCT05466175|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92025884|NCT05466175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025885|NCT05466175|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92025886|NCT05466175|Tubulin Modulators|tubulin modulators|mesh-ancestor
92025887|NCT05466175|Antimitotic Agents|antimitotic agents|mesh-ancestor
92025888|NCT05466175|Mitosis Modulators|mitosis modulators|mesh-ancestor
92025889|NCT05466175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025890|NCT02546323|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92025891|NCT02546323|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92025892|NCT02546323|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92025893|NCT02546323|Antimetabolites|antimetabolites|mesh-ancestor
92025894|NCT02546323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025895|NCT02546323|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92025896|NCT02546323|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92025897|NCT02546323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025898|NCT02545933|Aspirin|aspirin|mesh-list
92025899|NCT02545933|Ticagrelor|ticagrelor|mesh-list
92025900|NCT02545933|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92025901|NCT02545933|Vorapaxar|vorapaxar|mesh-list
92025902|NCT02545933|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92025903|NCT02545933|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025904|NCT02545933|Analgesics|analgesics|mesh-ancestor
92025905|NCT02545933|Sensory System Agents|sensory system agents|mesh-ancestor
92026360|NCT05479175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025906|NCT02545933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025907|NCT02545933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025908|NCT02545933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025909|NCT02545933|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025910|NCT02545933|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92025911|NCT02545933|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92025912|NCT02545933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025913|NCT02545933|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92025914|NCT02545933|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92025915|NCT02545933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025919|NCT02545933|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92025920|NCT02545933|Purinergic Agents|purinergic agents|mesh-ancestor
92025921|NCT02545933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025923|NCT02545075|Dacarbazine|dacarbazine|mesh-list
92025924|NCT02545075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025925|NCT02545075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025926|NCT02545075|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025927|NCT02545075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025928|NCT02545075|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92025929|NCT02545075|Alkylating Agents|alkylating agents|mesh-ancestor
92025930|NCT03007537|Epoetin Alfa|epoetin alfa|mesh-list
92025931|NCT03007537|Hematinics|hematinics|mesh-ancestor
92025932|NCT03004183|Valacyclovir|valacyclovir|mesh-list
92025933|NCT03004183|Pembrolizumab|pembrolizumab|mesh-list
92025934|NCT03004183|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025935|NCT03004183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025936|NCT03004183|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92025937|NCT03004183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025938|NCT03004183|Antiviral Agents|antiviral agents|mesh-ancestor
92025939|NCT03004183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025940|NCT02544763|Cannabidiol|cannabidiol|mesh-list
92025941|NCT02544763|Anticonvulsants|anticonvulsants|mesh-ancestor
92025942|NCT02556203|Aspirin|aspirin|mesh-list
92025943|NCT02556203|Vitamin K|vitamin k|mesh-list
92025944|NCT02556203|Rivaroxaban|rivaroxaban|mesh-list
92025945|NCT02556203|Clopidogrel|clopidogrel|mesh-list
92025946|NCT02556203|Vitamins|vitamins|mesh-ancestor
92025947|NCT02556203|Micronutrients|micronutrients|mesh-ancestor
92025948|NCT02556203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025949|NCT02556203|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92025950|NCT02556203|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92025951|NCT02556203|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92025952|NCT02556203|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92025953|NCT02556203|Purinergic Agents|purinergic agents|mesh-ancestor
92025954|NCT02556203|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025955|NCT02556203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025956|NCT02556203|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92025957|NCT02556203|Antithrombins|antithrombins|mesh-ancestor
92025958|NCT02556203|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92025959|NCT02556203|Protease Inhibitors|protease inhibitors|mesh-ancestor
92025960|NCT02556203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025961|NCT02556203|Anticoagulants|anticoagulants|mesh-ancestor
92025962|NCT02556203|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92025963|NCT02556203|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025964|NCT02556203|Analgesics|analgesics|mesh-ancestor
92025965|NCT02556203|Sensory System Agents|sensory system agents|mesh-ancestor
92025966|NCT02556203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025967|NCT02556203|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92025968|NCT02556203|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025969|NCT02556203|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92025970|NCT02556203|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92025971|NCT02556203|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92025972|NCT02556203|Antipyretics|antipyretics|mesh-ancestor
92025973|NCT02556203|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92025974|NCT02556203|Hemostatics|hemostatics|mesh-ancestor
92025975|NCT02556203|Coagulants|coagulants|mesh-ancestor
92025976|NCT05485571|Methotrexate|methotrexate|mesh-list
92025977|NCT05485571|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92025978|NCT05485571|Abortifacient Agents|abortifacient agents|mesh-ancestor
92025979|NCT05485571|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91984990|NCT02679755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91984992|NCT02679755|Hormone Antagonists|hormone antagonists|mesh-ancestor
91984993|NCT02679755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91984994|NCT02679755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025980|NCT05485571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025981|NCT05485571|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025982|NCT05485571|Antimetabolites|antimetabolites|mesh-ancestor
92025983|NCT05485571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025984|NCT05485571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025985|NCT05485571|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025986|NCT05485571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025987|NCT05485571|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92025988|NCT05485571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025990|NCT05485571|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92025991|NCT05485571|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92025992|NCT05496725|Micafungin|micafungin|mesh-list
92025993|NCT05496725|Antifungal Agents|antifungal agents|mesh-ancestor
92025994|NCT05496725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025995|NCT05490719|Cisplatin|cisplatin|mesh-list
92025996|NCT05490719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025997|NCT04424459|Analgesics, Opioid|analgesics, opioid|mesh-list
92025998|NCT04424459|Narcotics|narcotics|mesh-ancestor
92025999|NCT04424459|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026000|NCT04424459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026001|NCT04424459|Analgesics|analgesics|mesh-ancestor
92026002|NCT04424459|Sensory System Agents|sensory system agents|mesh-ancestor
92026003|NCT04424459|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026004|NCT05485259|Thioctic Acid|thioctic acid|mesh-list
92026005|NCT05485259|Antioxidants|antioxidants|mesh-ancestor
92026006|NCT05485259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026007|NCT05485259|Protective Agents|protective agents|mesh-ancestor
92026008|NCT05485259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026009|NCT05485259|Vitamin B Complex|vitamin b complex|mesh-ancestor
92026010|NCT05485259|Vitamins|vitamins|mesh-ancestor
92026011|NCT05485259|Micronutrients|micronutrients|mesh-ancestor
92026012|NCT05490485|Cisplatin|cisplatin|mesh-list
92026013|NCT05490485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026014|NCT05485103|Glycerol|glycerol|mesh-list
92026015|NCT05485103|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92026016|NCT05485103|Protective Agents|protective agents|mesh-ancestor
92026017|NCT05485103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026018|NCT05490407|Carboplatin|carboplatin|mesh-list
92026019|NCT05490407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026020|NCT05490095|Everolimus|everolimus|mesh-list
92026021|NCT05490095|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92026022|NCT05490095|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92026023|NCT05490095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026024|NCT05490095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026025|NCT05490095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026026|NCT05490095|Immunologic Factors|immunologic factors|mesh-ancestor
92026027|NCT05490095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026028|NCT05490095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026029|NCT04424381|Rivaroxaban|rivaroxaban|mesh-list
92026030|NCT04424381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92026031|NCT04424381|Antithrombins|antithrombins|mesh-ancestor
92026032|NCT04424381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92026033|NCT04424381|Protease Inhibitors|protease inhibitors|mesh-ancestor
92026034|NCT04424381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026035|NCT04424381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026036|NCT04424381|Anticoagulants|anticoagulants|mesh-ancestor
92026037|NCT05496179|Metoclopramide|metoclopramide|mesh-list
92026038|NCT05496179|Prucalopride|prucalopride|mesh-list
92026039|NCT05496179|Antiemetics|antiemetics|mesh-ancestor
92026040|NCT05496179|Autonomic Agents|autonomic agents|mesh-ancestor
92026041|NCT05496179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026042|NCT05496179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026043|NCT05496179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92026044|NCT05496179|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92026045|NCT05496179|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91984995|NCT02679755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91984996|NCT02675231|Trastuzumab|trastuzumab|mesh-list
91984997|NCT02675231|Fulvestrant|fulvestrant|mesh-list
92026046|NCT05496179|Dopamine Agents|dopamine agents|mesh-ancestor
92026047|NCT05496179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026048|NCT05496179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026049|NCT05496179|Laxatives|laxatives|mesh-ancestor
92026050|NCT05496179|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92026051|NCT05496179|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92026052|NCT05496179|Serotonin Agents|serotonin agents|mesh-ancestor
92026053|NCT05489939|Salicylates|salicylates|mesh-list
92026054|NCT05489939|Methyl salicylate|methyl salicylate|mesh-list
92026055|NCT05489939|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026683|NCT02366091|Colchicine|colchicine|mesh-list
92026056|NCT05489939|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026057|NCT05489939|Analgesics|analgesics|mesh-ancestor
92026058|NCT05489939|Sensory System Agents|sensory system agents|mesh-ancestor
92026059|NCT05489939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026060|NCT05489939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026061|NCT05489939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026062|NCT05489939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026063|NCT05489939|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026064|NCT05489939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026065|NCT05489939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026067|NCT05495945|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92026068|NCT05495945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026069|NCT05495945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026070|NCT05495945|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92026071|NCT05495945|Anesthetics, General|anesthetics, general|mesh-ancestor
92026072|NCT05495945|Anesthetics|anesthetics|mesh-ancestor
92026073|NCT03999749|Nivolumab|nivolumab|mesh-list
92026074|NCT03999749|Ipilimumab|ipilimumab|mesh-list
92026075|NCT03999749|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026076|NCT03999749|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026077|NCT03999749|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92026078|NCT03999749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026079|NCT05483543|Pamiparib|pamiparib|mesh-list
92026080|NCT05483543|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92026081|NCT05483543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026082|NCT05483543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026083|NCT05483543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026084|NCT04139213|Naltrexone|naltrexone|mesh-list
92026085|NCT04139213|Buprenorphine|buprenorphine|mesh-list
92026086|NCT04139213|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92026087|NCT04139213|Naloxone|naloxone|mesh-list
92026088|NCT04139213|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92026089|NCT04139213|Narcotics|narcotics|mesh-ancestor
92026090|NCT04139213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026091|NCT04139213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026092|NCT04139213|Analgesics|analgesics|mesh-ancestor
92026093|NCT04139213|Sensory System Agents|sensory system agents|mesh-ancestor
92026094|NCT04139213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026095|NCT04139213|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92026096|NCT04139213|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92026097|NCT05494775|Mitogens|mitogens|mesh-list
92026098|NCT05494775|Endothelial Growth Factors|endothelial growth factors|mesh-list
92026099|NCT05494775|Mitosis Modulators|mitosis modulators|mesh-ancestor
92026100|NCT05494775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026101|NCT05494775|Growth Substances|growth substances|mesh-ancestor
92026102|NCT05494775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026103|NCT05488925|Vitamin E|vitamin e|mesh-list
92026104|NCT05488925|Diclofenac|diclofenac|mesh-list
92026105|NCT05488925|Piroxicam|piroxicam|mesh-list
92026106|NCT05488925|Tramadol|tramadol|mesh-list
92026107|NCT05488925|Vitamins|vitamins|mesh-ancestor
92026108|NCT05488925|Micronutrients|micronutrients|mesh-ancestor
92026109|NCT05488925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026110|NCT05488925|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026112|NCT05488925|Analgesics|analgesics|mesh-ancestor
92026113|NCT05488925|Sensory System Agents|sensory system agents|mesh-ancestor
92026114|NCT05488925|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026115|NCT05488925|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026116|NCT05488925|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026117|NCT05488925|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026118|NCT05488925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026119|NCT05488925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026120|NCT05488925|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92026121|NCT05488925|Narcotics|narcotics|mesh-ancestor
92026122|NCT05488925|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026123|NCT05488925|Antioxidants|antioxidants|mesh-ancestor
92026124|NCT05488925|Protective Agents|protective agents|mesh-ancestor
92026125|NCT05482763|Itraconazole|itraconazole|mesh-list
92026126|NCT05482763|Terbinafine|terbinafine|mesh-list
92026127|NCT05482763|Ciclopirox|ciclopirox|mesh-list
92026128|NCT05482763|Amorolfine|amorolfine|mesh-list
92026129|NCT05482763|Antifungal Agents|antifungal agents|mesh-ancestor
92026130|NCT05482763|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026131|NCT05482763|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92026132|NCT05482763|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92026133|NCT05482763|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026760|NCT02325219|Immunologic Factors|immunologic factors|mesh-ancestor
92026134|NCT05482763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026135|NCT05482763|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92026136|NCT05482763|Hormone Antagonists|hormone antagonists|mesh-ancestor
92026137|NCT05482763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026138|NCT05482763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026141|NCT05482373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026142|NCT05482373|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92026143|NCT05482373|Vasodilator Agents|vasodilator agents|mesh-ancestor
92026145|NCT05482295|Immunologic Factors|immunologic factors|mesh-ancestor
92026146|NCT05482295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026147|NCT04245839|Cyclophosphamide|cyclophosphamide|mesh-list
92026148|NCT04245839|Fludarabine|fludarabine|mesh-list
92026149|NCT04245839|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026150|NCT04245839|Immunologic Factors|immunologic factors|mesh-ancestor
92026151|NCT04245839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026152|NCT04245839|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026153|NCT04245839|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92026154|NCT04245839|Alkylating Agents|alkylating agents|mesh-ancestor
92026155|NCT04245839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026156|NCT04245839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026157|NCT04245839|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92026158|NCT05494307|Terbutaline|terbutaline|mesh-list
92026159|NCT05494307|Danazol|danazol|mesh-list
92026160|NCT05494307|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92026161|NCT05494307|Autonomic Agents|autonomic agents|mesh-ancestor
92026162|NCT05494307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026163|NCT05494307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026164|NCT05494307|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92026165|NCT05494307|Respiratory System Agents|respiratory system agents|mesh-ancestor
92026166|NCT05494307|Sympathomimetics|sympathomimetics|mesh-ancestor
92026167|NCT05494307|Tocolytic Agents|tocolytic agents|mesh-ancestor
92026168|NCT05494307|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92026169|NCT05494307|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92026170|NCT05494307|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92026171|NCT05494307|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92026172|NCT05494307|Adrenergic Agents|adrenergic agents|mesh-ancestor
92026173|NCT05494307|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026174|NCT05494307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026175|NCT05494307|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92026176|NCT05494307|Hormone Antagonists|hormone antagonists|mesh-ancestor
92026177|NCT05494307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026178|NCT04051619|Oxytocin|oxytocin|mesh-list
92026179|NCT04051619|Oxytocics|oxytocics|mesh-ancestor
92026180|NCT04051619|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92026181|NCT04051619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026182|NCT05481437|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92026183|NCT05481437|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026184|NCT05481437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026185|NCT05481437|Immunotoxins|immunotoxins|mesh-ancestor
92026186|NCT05481437|Immunoconjugates|immunoconjugates|mesh-ancestor
92026187|NCT05481437|Immunologic Factors|immunologic factors|mesh-ancestor
92026188|NCT05481437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026189|NCT05487521|Methylprednisolone|methylprednisolone|mesh-list
91984998|NCT02675231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91984999|NCT02675231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985000|NCT02675231|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985001|NCT02675231|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92026190|NCT05487521|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92026191|NCT05487521|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92026192|NCT05487521|Prednisolone|prednisolone|mesh-list
92026193|NCT05487521|Prednisolone acetate|prednisolone acetate|mesh-list
92026194|NCT05487521|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92026195|NCT05487521|Prednisolone phosphate|prednisolone phosphate|mesh-list
92026196|NCT05487521|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026197|NCT05487521|Antiemetics|antiemetics|mesh-ancestor
92026198|NCT05487521|Autonomic Agents|autonomic agents|mesh-ancestor
92026199|NCT05487521|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026200|NCT05487521|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026201|NCT05487521|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92026202|NCT05487521|Glucocorticoids|glucocorticoids|mesh-ancestor
92026203|NCT05487521|Hormones|hormones|mesh-ancestor
92026204|NCT05487521|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026205|NCT05487521|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92026206|NCT05487521|Protective Agents|protective agents|mesh-ancestor
92026207|NCT05487521|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92026208|NCT05487521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026209|NCT05481281|Dexmedetomidine|dexmedetomidine|mesh-list
92026210|NCT05481281|Ketamine|ketamine|mesh-list
92026211|NCT05481281|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92026215|NCT05481281|Analgesics|analgesics|mesh-ancestor
92026216|NCT05481281|Sensory System Agents|sensory system agents|mesh-ancestor
92026217|NCT05481281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026218|NCT05481281|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92026219|NCT05481281|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92026220|NCT05481281|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92026221|NCT05481281|Adrenergic Agents|adrenergic agents|mesh-ancestor
92026222|NCT05481281|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081689|NCT01392183|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92026223|NCT05481281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026224|NCT05481281|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92026225|NCT05481281|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92026226|NCT05481281|Anesthetics, General|anesthetics, general|mesh-ancestor
92026227|NCT05481281|Anesthetics|anesthetics|mesh-ancestor
92026228|NCT05481281|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92026229|NCT05481281|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92026230|NCT05487443|Gemcitabine|gemcitabine|mesh-list
92026231|NCT05487443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026232|NCT05487443|Antimetabolites|antimetabolites|mesh-ancestor
92026233|NCT05487443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026234|NCT05487443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026235|NCT02558231|Selexipag|selexipag|mesh-list
92026236|NCT02558231|Tadalafil|tadalafil|mesh-list
92026237|NCT02558231|Macitentan|macitentan|mesh-list
92026238|NCT02558231|Vasodilator Agents|vasodilator agents|mesh-ancestor
92026239|NCT02558231|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92026240|NCT02558231|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92026241|NCT02558231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026242|NCT02558231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026243|NCT02558231|Urological Agents|urological agents|mesh-ancestor
92026244|NCT02558231|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92026245|NCT02558231|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92026246|NCT02558231|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92026247|NCT02558231|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92026248|NCT05486819|Propofol|propofol|mesh-list
92026249|NCT05486819|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92026250|NCT05486819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026251|NCT05486819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026252|NCT05486819|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92026253|NCT05486819|Anesthetics, General|anesthetics, general|mesh-ancestor
92026254|NCT05486819|Anesthetics|anesthetics|mesh-ancestor
92026255|NCT03860987|Prednisone|prednisone|mesh-list
92026256|NCT03860987|Goserelin|goserelin|mesh-list
92026257|NCT03860987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026258|NCT03860987|Glucocorticoids|glucocorticoids|mesh-ancestor
91985002|NCT02675231|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91985003|NCT02675231|Hormone Antagonists|hormone antagonists|mesh-ancestor
91985004|NCT02675231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985005|NCT02675231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026259|NCT03860987|Hormones|hormones|mesh-ancestor
92026260|NCT03860987|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026261|NCT03860987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026262|NCT03860987|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92026263|NCT03860987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026264|NCT05480111|Anesthetics|anesthetics|mesh-list
92026265|NCT05480111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026266|NCT05480111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026267|NCT05475431|Bismuth|bismuth|mesh-list
92026268|NCT05475431|Antacids|antacids|mesh-ancestor
92026269|NCT05475431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026270|NCT05475431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92026271|NCT05492669|Lidocaine|lidocaine|mesh-list
92026272|NCT05492669|Anesthetics, Local|anesthetics, local|mesh-ancestor
92026273|NCT05492669|Anesthetics|anesthetics|mesh-ancestor
92026274|NCT05492669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026275|NCT05492669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026276|NCT05492669|Sensory System Agents|sensory system agents|mesh-ancestor
92026277|NCT05492669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026278|NCT05492669|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92026279|NCT05492669|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92026280|NCT05492669|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92026288|NCT02554721|Clopidogrel|clopidogrel|mesh-list
92026289|NCT02554721|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92026290|NCT02554721|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92026291|NCT02554721|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92026292|NCT02554721|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92026293|NCT02554721|Purinergic Agents|purinergic agents|mesh-ancestor
92026294|NCT02554721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026295|NCT02554721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026296|NCT02554721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026297|NCT02554721|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026298|NCT02554721|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026299|NCT02554721|Analgesics|analgesics|mesh-ancestor
92026300|NCT02554721|Sensory System Agents|sensory system agents|mesh-ancestor
92026301|NCT02554721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026302|NCT02554721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026303|NCT02554721|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026304|NCT02554721|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92026305|NCT02554721|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92026306|NCT02554721|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026307|NCT02554721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026308|NCT02554721|Antipyretics|antipyretics|mesh-ancestor
92026309|NCT02554721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92026310|NCT02554721|Autonomic Agents|autonomic agents|mesh-ancestor
92026311|NCT02554721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92026312|NCT02554721|Respiratory System Agents|respiratory system agents|mesh-ancestor
92026313|NCT02554721|Vasodilator Agents|vasodilator agents|mesh-ancestor
92026314|NCT02554721|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92026315|NCT02554721|Protective Agents|protective agents|mesh-ancestor
92026316|NCT02554721|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92026317|NCT02554721|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92026318|NCT03810911|Darbepoetin alfa|darbepoetin alfa|mesh-list
92026319|NCT03810911|Hematinics|hematinics|mesh-ancestor
92026320|NCT02552225|Amitriptyline|amitriptyline|mesh-list
92026321|NCT02552225|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92026322|NCT02552225|Antidepressive Agents|antidepressive agents|mesh-ancestor
92026323|NCT02552225|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92026324|NCT02552225|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026325|NCT02552225|Analgesics|analgesics|mesh-ancestor
92026326|NCT02552225|Sensory System Agents|sensory system agents|mesh-ancestor
92026327|NCT02552225|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026328|NCT02552225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026329|NCT02552225|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
91985006|NCT03163121|Vaccines|vaccines|mesh-list
91985007|NCT03163121|Immunologic Factors|immunologic factors|mesh-ancestor
92026330|NCT02552225|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92026331|NCT02552225|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92026332|NCT02552225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026333|NCT02552225|Adrenergic Agents|adrenergic agents|mesh-ancestor
92026334|NCT02552225|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026335|NCT02552147|Nicotine|nicotine|mesh-list
92026336|NCT02552147|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92026337|NCT02552147|Autonomic Agents|autonomic agents|mesh-ancestor
92026338|NCT02552147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026339|NCT02552147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026340|NCT02552147|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92026341|NCT02552147|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92026342|NCT02552147|Cholinergic Agents|cholinergic agents|mesh-ancestor
92026343|NCT02552147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026344|NCT02552147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026345|NCT05479487|Apatinib|apatinib|mesh-list
92026346|NCT05479487|Fluzoparib|fluzoparib|mesh-list
92026347|NCT05479487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026348|NCT05479487|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92026350|NCT05479487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026352|NCT05479175|Ibuprofen|ibuprofen|mesh-list
92026353|NCT05479175|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026354|NCT05479175|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026355|NCT05479175|Analgesics|analgesics|mesh-ancestor
92026356|NCT05479175|Sensory System Agents|sensory system agents|mesh-ancestor
92026357|NCT05479175|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026358|NCT05479175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026359|NCT05479175|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026361|NCT05479175|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026362|NCT05479175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026363|NCT05479175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026364|NCT02534935|Vaccines|vaccines|mesh-list
92026365|NCT02534935|Immunologic Factors|immunologic factors|mesh-ancestor
92026366|NCT02534935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026367|NCT02544451|Ivacaftor|ivacaftor|mesh-list
92026368|NCT02544451|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92026369|NCT02544451|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92026370|NCT02544451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026372|NCT02551991|Fluorouracil|fluorouracil|mesh-list
92026373|NCT02551991|Oxaliplatin|oxaliplatin|mesh-list
92026374|NCT02551991|Antimetabolites|antimetabolites|mesh-ancestor
92026375|NCT02551991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026376|NCT02551991|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026377|NCT02551991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026378|NCT02551991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026379|NCT02551991|Immunologic Factors|immunologic factors|mesh-ancestor
92026380|NCT02551991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026381|NCT02551991|Antidotes|antidotes|mesh-ancestor
92026382|NCT02551991|Protective Agents|protective agents|mesh-ancestor
92026383|NCT02551991|Vitamin B Complex|vitamin b complex|mesh-ancestor
92026384|NCT02551991|Vitamins|vitamins|mesh-ancestor
92026385|NCT02551991|Micronutrients|micronutrients|mesh-ancestor
92026386|NCT05491811|Bevacizumab|bevacizumab|mesh-list
92026387|NCT05491811|Ensartinib|ensartinib|mesh-list
92026388|NCT05491811|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026389|NCT05491811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026390|NCT05491811|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92026391|NCT05491811|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92026392|NCT05491811|Growth Substances|growth substances|mesh-ancestor
92026393|NCT05491811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026394|NCT05491811|Growth Inhibitors|growth inhibitors|mesh-ancestor
92026395|NCT05491811|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92026396|NCT05491811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026397|NCT05491811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026398|NCT05478785|Cisplatin|cisplatin|mesh-list
92026399|NCT05478785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026400|NCT02880293|Mycophenolic Acid|mycophenolic acid|mesh-list
92026401|NCT02880293|Cyclophosphamide|cyclophosphamide|mesh-list
92026402|NCT02880293|Melphalan|melphalan|mesh-list
91985008|NCT03163121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985009|NCT03114371|Oxytocin|oxytocin|mesh-list
91985010|NCT03114371|Oxytocics|oxytocics|mesh-ancestor
91985011|NCT03114371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92026403|NCT02880293|Thiotepa|thiotepa|mesh-list
92026405|NCT02880293|Tacrolimus|tacrolimus|mesh-list
92026406|NCT02880293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026407|NCT02880293|Immunologic Factors|immunologic factors|mesh-ancestor
92026408|NCT02880293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026409|NCT02880293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026410|NCT02880293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92026411|NCT02880293|Alkylating Agents|alkylating agents|mesh-ancestor
92026412|NCT02880293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026413|NCT02880293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026414|NCT02880293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92026415|NCT02880293|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92026416|NCT02880293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026417|NCT02880293|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92026418|NCT02880293|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92026419|NCT02880293|Antitubercular Agents|antitubercular agents|mesh-ancestor
92026420|NCT02880293|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92026421|NCT02880293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026422|NCT02865551|Anesthetics|anesthetics|mesh-list
92026440|NCT05427565|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92026441|NCT05427565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026442|NCT05427565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026443|NCT05427565|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92026444|NCT05427565|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92026445|NCT05427565|Purinergic Agents|purinergic agents|mesh-ancestor
92026446|NCT05427565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026447|NCT02533453|Exenatide|exenatide|mesh-list
92026448|NCT02533453|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92026449|NCT02533453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026450|NCT02533453|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92026451|NCT02533453|Incretins|incretins|mesh-ancestor
92026452|NCT02533453|Hormones|hormones|mesh-ancestor
92026453|NCT02533453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026454|NCT05424835|Capecitabine|capecitabine|mesh-list
92026455|NCT05424835|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026456|NCT05424835|Antimetabolites|antimetabolites|mesh-ancestor
92026457|NCT05424835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026458|NCT05424835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026459|NCT02533375|Adalimumab|adalimumab|mesh-list
92026460|NCT02533375|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92026461|NCT02533375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026462|NCT02533375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026463|NCT01553149|Lenalidomide|lenalidomide|mesh-list
92026464|NCT01553149|Immunologic Factors|immunologic factors|mesh-ancestor
92026465|NCT01553149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026466|NCT01553149|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92026467|NCT01553149|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92026468|NCT01553149|Growth Substances|growth substances|mesh-ancestor
92026469|NCT01553149|Growth Inhibitors|growth inhibitors|mesh-ancestor
92026470|NCT01553149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026471|NCT02551055|Paclitaxel|paclitaxel|mesh-list
92026472|NCT02551055|Docetaxel|docetaxel|mesh-list
92026473|NCT02551055|Serabelisib|serabelisib|mesh-list
92026474|NCT02551055|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92026475|NCT02551055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026476|NCT02551055|Tubulin Modulators|tubulin modulators|mesh-ancestor
92026477|NCT02551055|Antimitotic Agents|antimitotic agents|mesh-ancestor
92026478|NCT02551055|Mitosis Modulators|mitosis modulators|mesh-ancestor
92026486|NCT05459285|Dulaglutide|dulaglutide|mesh-list
92026487|NCT05459285|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92026488|NCT05459285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026489|NCT02542943|Fluorides|fluorides|mesh-list
92026490|NCT02542943|Cariostatic Agents|cariostatic agents|mesh-ancestor
92026491|NCT02542943|Protective Agents|protective agents|mesh-ancestor
92026492|NCT02542943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026493|NCT03284957|Everolimus|everolimus|mesh-list
91985012|NCT03114371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985013|NCT04905407|Azacitidine|azacitidine|mesh-list
92026494|NCT03284957|Palbociclib|palbociclib|mesh-list
92026495|NCT03284957|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92026496|NCT03284957|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92026497|NCT03284957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026498|NCT03284957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026499|NCT03284957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026500|NCT03284957|Immunologic Factors|immunologic factors|mesh-ancestor
92026501|NCT03284957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026502|NCT03284957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026503|NCT05469893|Dexamethasone|dexamethasone|mesh-list
92026504|NCT05469893|Lenalidomide|lenalidomide|mesh-list
92026505|NCT05469893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026506|NCT05469893|Antiemetics|antiemetics|mesh-ancestor
92026507|NCT05469893|Autonomic Agents|autonomic agents|mesh-ancestor
92026508|NCT05469893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026509|NCT05469893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026510|NCT05469893|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92026511|NCT05469893|Glucocorticoids|glucocorticoids|mesh-ancestor
92026513|NCT05469893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026514|NCT05469893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92026515|NCT05469893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026516|NCT05469893|Immunologic Factors|immunologic factors|mesh-ancestor
92026517|NCT05469893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92026518|NCT05469893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92026519|NCT05469893|Growth Substances|growth substances|mesh-ancestor
92026520|NCT05469893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92026521|NCT03629171|Cytarabine|cytarabine|mesh-list
92026522|NCT03629171|Daunorubicin|daunorubicin|mesh-list
92026523|NCT03629171|Venetoclax|venetoclax|mesh-list
92026524|NCT03629171|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026525|NCT03629171|Antimetabolites|antimetabolites|mesh-ancestor
92026526|NCT03629171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026527|NCT03629171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026528|NCT03629171|Antiviral Agents|antiviral agents|mesh-ancestor
92026529|NCT03629171|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026530|NCT03629171|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026531|NCT03629171|Immunologic Factors|immunologic factors|mesh-ancestor
92026532|NCT03629171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026533|NCT03629171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92026534|NCT03629171|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92026842|NCT05405725|Denosumab|denosumab|mesh-list
92026535|NCT03629171|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92026536|NCT03629171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026537|NCT02542631|Insulin|insulin|mesh-list
92026538|NCT02542631|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92026539|NCT02542631|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92026540|NCT02542631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026541|NCT02549573|Apomorphine|apomorphine|mesh-list
92026542|NCT02549573|Emetics|emetics|mesh-ancestor
92026543|NCT02549573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026544|NCT02549573|Autonomic Agents|autonomic agents|mesh-ancestor
92026545|NCT02549573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026546|NCT02549573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92026547|NCT02549573|Dopamine Agonists|dopamine agonists|mesh-ancestor
92026550|NCT02549573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026551|NCT05477615|Carboplatin|carboplatin|mesh-list
92026553|NCT05477615|Lazertinib|lazertinib|mesh-list
92026554|NCT05477615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026555|NCT05477615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026556|NCT05477615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026557|NCT05477615|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92026558|NCT05477615|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92026559|NCT05477615|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92026560|NCT02710097|Ethanol|ethanol|mesh-list
92026561|NCT02710097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92026562|NCT02710097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026563|NCT02710097|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026564|NCT02710097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026565|NCT05468957|Hemostatics|hemostatics|mesh-list
92026566|NCT05468957|Coagulants|coagulants|mesh-ancestor
92026567|NCT02529553|LY3076226|ly3076226|mesh-list
92026568|NCT02529553|Immunoconjugates|immunoconjugates|mesh-ancestor
91985014|NCT04905407|Venetoclax|venetoclax|mesh-list
91985015|NCT04905407|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91985016|NCT04905407|Antimetabolites|antimetabolites|mesh-ancestor
91985017|NCT04905407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985018|NCT04905407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026569|NCT02529553|Immunologic Factors|immunologic factors|mesh-ancestor
92026570|NCT02529553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026571|NCT02547935|Dapagliflozin|dapagliflozin|mesh-list
92026572|NCT02547935|Saxagliptin|saxagliptin|mesh-list
92026573|NCT02547935|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92026574|NCT02547935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026575|NCT02547935|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92026576|NCT02547935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026577|NCT02547935|Incretins|incretins|mesh-ancestor
92026578|NCT02547935|Hormones|hormones|mesh-ancestor
92026579|NCT02547935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026580|NCT02547935|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92026581|NCT02547935|Protease Inhibitors|protease inhibitors|mesh-ancestor
92026582|NCT02547935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026583|NCT04258111|Antibodies|antibodies|mesh-list
92026584|NCT04258111|Immunoglobulins|immunoglobulins|mesh-list
92026585|NCT04258111|Immunologic Factors|immunologic factors|mesh-ancestor
92026586|NCT04258111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026587|NCT02327169|Paclitaxel|paclitaxel|mesh-list
92026588|NCT02327169|Irinotecan|irinotecan|mesh-list
92026589|NCT02327169|Cetuximab|cetuximab|mesh-list
92026590|NCT02327169|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92026591|NCT02327169|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026592|NCT02327169|Tubulin Modulators|tubulin modulators|mesh-ancestor
92026593|NCT02327169|Antimitotic Agents|antimitotic agents|mesh-ancestor
92026594|NCT02327169|Mitosis Modulators|mitosis modulators|mesh-ancestor
92026595|NCT02327169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026596|NCT02327169|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92026597|NCT02327169|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92026598|NCT02327169|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081690|NCT01402947|Ciprofloxacin|ciprofloxacin|mesh-list
92026599|NCT02327169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026600|NCT02327013|Vortioxetine|vortioxetine|mesh-list
92026601|NCT02327013|Antidepressive Agents|antidepressive agents|mesh-ancestor
92026602|NCT02327013|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92026603|NCT02327013|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92026604|NCT02327013|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92026605|NCT02327013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026606|NCT02327013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026607|NCT02327013|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92026608|NCT02327013|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92026609|NCT02327013|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92026610|NCT02327013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026611|NCT02327013|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026612|NCT02327013|Serotonin Agents|serotonin agents|mesh-ancestor
92026613|NCT02327013|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92026614|NCT02327013|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92026615|NCT02327013|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92026616|NCT02327013|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92026617|NCT02301975|Fluticasone|fluticasone|mesh-list
92026619|NCT02301975|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92026623|NCT02301975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026624|NCT02301975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026625|NCT02301975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92026626|NCT02301975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92026627|NCT02301975|Dermatologic Agents|dermatologic agents|mesh-ancestor
92026628|NCT02301975|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92026629|NCT02301975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92026630|NCT02301975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92026631|NCT02301975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92026632|NCT02301975|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985019|NCT04905407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985020|NCT04708067|Atezolizumab|atezolizumab|mesh-list
91985021|NCT04708067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92026633|NCT02301975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026634|NCT02301975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026636|NCT04882839|Hallucinogens|hallucinogens|mesh-ancestor
92026637|NCT04882839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026638|NCT04882839|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92026639|NCT02300259|Itraconazole|itraconazole|mesh-list
92026640|NCT02300259|Diltiazem|diltiazem|mesh-list
92026641|NCT02300259|Tadalafil|tadalafil|mesh-list
92026642|NCT02300259|Simvastatin|simvastatin|mesh-list
92026643|NCT02300259|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92026644|NCT02300259|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92026645|NCT02300259|Antimetabolites|antimetabolites|mesh-ancestor
92026646|NCT02300259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026647|NCT02300259|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92026648|NCT02300259|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92026649|NCT02300259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026650|NCT02300259|Antifungal Agents|antifungal agents|mesh-ancestor
92026651|NCT02300259|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026652|NCT02300259|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92026653|NCT02300259|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92026654|NCT02300259|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92026655|NCT02300259|Hormone Antagonists|hormone antagonists|mesh-ancestor
92026656|NCT02300259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026657|NCT02300259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026658|NCT02300259|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92026659|NCT02300259|Vasodilator Agents|vasodilator agents|mesh-ancestor
92026660|NCT02300259|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92026661|NCT02300259|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92026662|NCT02300259|Urological Agents|urological agents|mesh-ancestor
92026663|NCT02300259|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92026664|NCT02300259|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92026665|NCT02300259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92026666|NCT02300259|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92026667|NCT02300103|Sofosbuvir|sofosbuvir|mesh-list
92026668|NCT02300103|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92026669|NCT02300103|Velpatasvir|velpatasvir|mesh-list
92026670|NCT02300103|Antiviral Agents|antiviral agents|mesh-ancestor
92026671|NCT02300103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026672|NCT02326467|Chlorhexidine|chlorhexidine|mesh-list
92026673|NCT02326467|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92026674|NCT02326467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92026675|NCT02326467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026676|NCT02326467|Disinfectants|disinfectants|mesh-ancestor
92026677|NCT02326467|Dermatologic Agents|dermatologic agents|mesh-ancestor
92026678|NCT02299635|Nirogacestat|nirogacestat|mesh-list
92026679|NCT02299635|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92026680|NCT02299635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026681|NCT02299635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026682|NCT02366091|Methotrexate|methotrexate|mesh-list
92026684|NCT02366091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92026685|NCT02366091|Abortifacient Agents|abortifacient agents|mesh-ancestor
92026686|NCT02366091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92026687|NCT02366091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026688|NCT02366091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026689|NCT02366091|Antimetabolites|antimetabolites|mesh-ancestor
92026690|NCT02366091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026693|NCT02366091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026694|NCT02366091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92026695|NCT02366091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026696|NCT02366091|Immunologic Factors|immunologic factors|mesh-ancestor
92026697|NCT02366091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026698|NCT02366091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92026699|NCT02366091|Gout Suppressants|gout suppressants|mesh-ancestor
92026700|NCT02366091|Tubulin Modulators|tubulin modulators|mesh-ancestor
92026701|NCT02366091|Antimitotic Agents|antimitotic agents|mesh-ancestor
92026702|NCT02366091|Mitosis Modulators|mitosis modulators|mesh-ancestor
91985022|NCT04708067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026704|NCT05476679|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026705|NCT05476679|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026706|NCT05476679|Analgesics|analgesics|mesh-ancestor
92026707|NCT05476679|Sensory System Agents|sensory system agents|mesh-ancestor
92026708|NCT05476679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026709|NCT05476679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026710|NCT05476679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026711|NCT05476679|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026712|NCT05476679|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92026713|NCT05476679|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026714|NCT05476679|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026715|NCT05476679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026717|NCT02546765|Dexmedetomidine|dexmedetomidine|mesh-list
92026718|NCT02546765|Propofol|propofol|mesh-list
92026719|NCT02546765|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92026720|NCT02546765|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026721|NCT02546765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026722|NCT02546765|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026723|NCT02546765|Analgesics|analgesics|mesh-ancestor
92026724|NCT02546765|Sensory System Agents|sensory system agents|mesh-ancestor
92026725|NCT02546765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026726|NCT02546765|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92026727|NCT02546765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92026728|NCT02546765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92026729|NCT02546765|Adrenergic Agents|adrenergic agents|mesh-ancestor
92026730|NCT02546765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026731|NCT02546765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026732|NCT02546765|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92026733|NCT02546765|Anesthetics, General|anesthetics, general|mesh-ancestor
92026734|NCT02546765|Anesthetics|anesthetics|mesh-ancestor
92026735|NCT02546765|Antipyretics|antipyretics|mesh-ancestor
92026736|NCT02553629|Rocuronium|rocuronium|mesh-list
92026737|NCT02553629|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92026738|NCT02553629|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92026739|NCT02553629|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92026740|NCT02553629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026741|NCT02553629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026742|NCT03555851|Cyclophosphamide|cyclophosphamide|mesh-list
92026743|NCT03555851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026744|NCT03555851|Immunologic Factors|immunologic factors|mesh-ancestor
92026745|NCT03555851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026746|NCT03555851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026747|NCT03555851|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92026748|NCT03555851|Alkylating Agents|alkylating agents|mesh-ancestor
92026749|NCT03555851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026750|NCT03555851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026751|NCT03555851|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92026752|NCT03029351|Exenatide|exenatide|mesh-list
92026753|NCT03029351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92026754|NCT03029351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026755|NCT03029351|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92026756|NCT03029351|Incretins|incretins|mesh-ancestor
92026757|NCT03029351|Hormones|hormones|mesh-ancestor
92026758|NCT03029351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026759|NCT02325219|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92026761|NCT02325219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026762|NCT02365233|Insulin|insulin|mesh-list
92026767|NCT02365233|Saxagliptin|saxagliptin|mesh-list
92026768|NCT02365233|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92026769|NCT02365233|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92026770|NCT02365233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026771|NCT02365233|Incretins|incretins|mesh-ancestor
92026772|NCT02365233|Hormones|hormones|mesh-ancestor
92026773|NCT02365233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92026774|NCT02365233|Protease Inhibitors|protease inhibitors|mesh-ancestor
92026775|NCT02365233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026776|NCT02365233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026777|NCT02364999|Paclitaxel|paclitaxel|mesh-list
92026778|NCT02364999|Bevacizumab|bevacizumab|mesh-list
92026779|NCT02364999|Carboplatin|carboplatin|mesh-list
92026780|NCT02364999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92026781|NCT02364999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026782|NCT02364999|Tubulin Modulators|tubulin modulators|mesh-ancestor
92026783|NCT02364999|Antimitotic Agents|antimitotic agents|mesh-ancestor
92026784|NCT02364999|Mitosis Modulators|mitosis modulators|mesh-ancestor
92026785|NCT02364999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026786|NCT02364999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026787|NCT02364999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92026788|NCT02364999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92026789|NCT02364999|Growth Substances|growth substances|mesh-ancestor
92026790|NCT02364999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026791|NCT02364999|Growth Inhibitors|growth inhibitors|mesh-ancestor
92026792|NCT02363283|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
92026794|NCT02363283|Immunotoxins|immunotoxins|mesh-list
92026795|NCT02363283|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92026796|NCT02363283|Immunologic Factors|immunologic factors|mesh-ancestor
92026797|NCT02363283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026798|NCT02363283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026799|NCT02363283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026800|NCT02321319|Hydromorphone|hydromorphone|mesh-list
92026801|NCT02321319|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92026802|NCT02321319|Narcotics|narcotics|mesh-ancestor
92026803|NCT02321319|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026804|NCT02321319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026805|NCT02321319|Analgesics|analgesics|mesh-ancestor
92026806|NCT02321319|Sensory System Agents|sensory system agents|mesh-ancestor
92026807|NCT02321319|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026808|NCT02088541|Cytarabine|cytarabine|mesh-list
92026809|NCT02088541|Hydroxyurea|hydroxyurea|mesh-list
92026810|NCT02088541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026811|NCT02088541|Antimetabolites|antimetabolites|mesh-ancestor
92026812|NCT02088541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026813|NCT02088541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026814|NCT02088541|Antiviral Agents|antiviral agents|mesh-ancestor
92026815|NCT02088541|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026816|NCT02088541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026817|NCT02088541|Immunologic Factors|immunologic factors|mesh-ancestor
92026818|NCT02088541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026819|NCT02088541|Antisickling Agents|antisickling agents|mesh-ancestor
92026820|NCT02088541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026821|NCT02088541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92026822|NCT02294019|Ibuprofen|ibuprofen|mesh-list
92026823|NCT02294019|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026824|NCT02294019|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026825|NCT02294019|Analgesics|analgesics|mesh-ancestor
92026826|NCT02294019|Sensory System Agents|sensory system agents|mesh-ancestor
92026827|NCT02294019|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026828|NCT02294019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026829|NCT02294019|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026830|NCT02294019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026831|NCT02294019|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026832|NCT02294019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026833|NCT02294019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026834|NCT02320149|Sarecycline|sarecycline|mesh-list
92026836|NCT02320149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026837|NCT02320149|Dermatologic Agents|dermatologic agents|mesh-ancestor
92026838|NCT05450965|Onvansertib|onvansertib|mesh-list
92026839|NCT05450965|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92026840|NCT05450965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026841|NCT05450965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026843|NCT05405725|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92026844|NCT05405725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026845|NCT02293863|Oseltamivir|oseltamivir|mesh-list
92026846|NCT02293863|Antiviral Agents|antiviral agents|mesh-ancestor
92026847|NCT02293863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026848|NCT02293863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026849|NCT02293863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026851|NCT02293395|Rivaroxaban|rivaroxaban|mesh-list
91985023|NCT04708067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985024|NCT04708067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026852|NCT02293395|Clopidogrel|clopidogrel|mesh-list
92026853|NCT02293395|Ticagrelor|ticagrelor|mesh-list
92026854|NCT02293395|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026855|NCT02293395|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026856|NCT02293395|Analgesics|analgesics|mesh-ancestor
92026857|NCT02293395|Sensory System Agents|sensory system agents|mesh-ancestor
92026858|NCT02293395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026859|NCT02293395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026860|NCT02293395|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026861|NCT02293395|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026862|NCT02293395|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92026863|NCT02293395|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92026864|NCT02293395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026865|NCT02293395|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92026866|NCT02293395|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026867|NCT02293395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026868|NCT02293395|Antipyretics|antipyretics|mesh-ancestor
92026869|NCT02293395|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92026870|NCT02293395|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92026871|NCT02293395|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92026872|NCT02293395|Purinergic Agents|purinergic agents|mesh-ancestor
92026873|NCT02293395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026874|NCT02293395|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92026875|NCT02293395|Antithrombins|antithrombins|mesh-ancestor
92026876|NCT02293395|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92026877|NCT02293395|Protease Inhibitors|protease inhibitors|mesh-ancestor
92026878|NCT02293395|Anticoagulants|anticoagulants|mesh-ancestor
92026879|NCT05447065|Vitamin D|vitamin d|mesh-list
92026880|NCT05447065|Vitamins|vitamins|mesh-ancestor
92026881|NCT05447065|Micronutrients|micronutrients|mesh-ancestor
92026882|NCT05447065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026883|NCT05447065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92026884|NCT01351909|Cyclophosphamide|cyclophosphamide|mesh-list
92026885|NCT01351909|Veliparib|veliparib|mesh-list
92026886|NCT01351909|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92026887|NCT01351909|Immunologic Factors|immunologic factors|mesh-ancestor
92026888|NCT01351909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026889|NCT01351909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026890|NCT01351909|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92026891|NCT01351909|Alkylating Agents|alkylating agents|mesh-ancestor
92026892|NCT01351909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026893|NCT01351909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026894|NCT01351909|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92026895|NCT01351909|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92026896|NCT01351909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026897|NCT05401357|Bimatoprost|bimatoprost|mesh-list
92026898|NCT05401357|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92026899|NCT05401357|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92026900|NCT05401357|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92026901|NCT05401279|Gemcitabine|gemcitabine|mesh-list
92026902|NCT05401279|Tislelizumab|tislelizumab|mesh-list
92026903|NCT05401279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026904|NCT05401279|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026905|NCT05401279|Antimetabolites|antimetabolites|mesh-ancestor
92026906|NCT05401279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026907|NCT05401279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92026908|NCT05451095|Ketamine|ketamine|mesh-list
92026912|NCT05451095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026913|NCT05451095|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92026914|NCT05451095|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92026915|NCT05451095|Anesthetics, General|anesthetics, general|mesh-ancestor
92026916|NCT05451095|Anesthetics|anesthetics|mesh-ancestor
92026917|NCT05451095|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026918|NCT05451095|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92026919|NCT05451095|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92026920|NCT05451095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026921|NCT05451095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985027|NCT03114215|Vitamins|vitamins|mesh-ancestor
92026923|NCT02954081|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026924|NCT02954081|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026925|NCT02954081|Analgesics|analgesics|mesh-ancestor
92026926|NCT02954081|Sensory System Agents|sensory system agents|mesh-ancestor
92026927|NCT02954081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026928|NCT02954081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026929|NCT02954081|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026930|NCT02954081|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026931|NCT02954081|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92026932|NCT02954081|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92026933|NCT02954081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026934|NCT02954081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026935|NCT02532283|Oseltamivir|oseltamivir|mesh-list
92026936|NCT02532283|Antiviral Agents|antiviral agents|mesh-ancestor
92026937|NCT02532283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026938|NCT02532283|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026939|NCT02532283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026940|NCT01349959|Azacitidine|azacitidine|mesh-list
92026941|NCT01349959|Entinostat|entinostat|mesh-list
92026942|NCT01349959|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92026943|NCT01349959|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92026944|NCT01349959|Antimetabolites|antimetabolites|mesh-ancestor
92026945|NCT01349959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026946|NCT01349959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026947|NCT01349959|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026948|NCT01349881|Eflornithine|eflornithine|mesh-list
92026949|NCT01349881|Sulindac|sulindac|mesh-list
92026950|NCT01349881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026951|NCT01349881|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92026952|NCT01349881|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92026953|NCT01349881|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92026954|NCT01349881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026955|NCT01349881|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92026956|NCT01349881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026957|NCT01349881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026958|NCT01349881|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026959|NCT01349881|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026960|NCT01349881|Analgesics|analgesics|mesh-ancestor
92026961|NCT01349881|Sensory System Agents|sensory system agents|mesh-ancestor
92026962|NCT01349881|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026963|NCT01349881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026964|NCT01349881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026965|NCT01349881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026966|NCT01349881|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92026967|NCT05417971|Fludarabine|fludarabine|mesh-list
92026968|NCT05417971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026969|NCT05398705|Cepharanthine|cepharanthine|mesh-list
92026970|NCT05398705|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92026971|NCT05398705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026972|NCT05398705|Analgesics|analgesics|mesh-ancestor
92026973|NCT05398705|Sensory System Agents|sensory system agents|mesh-ancestor
92026974|NCT05398705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026975|NCT05398705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026976|NCT05398705|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026977|NCT05398705|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92026978|NCT05398705|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92026979|NCT05398705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027002|NCT05415865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027003|NCT05415709|Paclitaxel|paclitaxel|mesh-list
92027004|NCT05415709|Cisplatin|cisplatin|mesh-list
92027005|NCT05415709|Carboplatin|carboplatin|mesh-list
92027006|NCT05415709|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92027007|NCT05415709|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92027008|NCT05415709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027009|NCT05415709|Tubulin Modulators|tubulin modulators|mesh-ancestor
92027010|NCT05415709|Antimitotic Agents|antimitotic agents|mesh-ancestor
92027011|NCT05415709|Mitosis Modulators|mitosis modulators|mesh-ancestor
92027012|NCT05415709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027013|NCT04262843|Vidarabine|vidarabine|mesh-list
92027014|NCT04262843|Mycophenolic Acid|mycophenolic acid|mesh-list
92027015|NCT04262843|Cyclophosphamide|cyclophosphamide|mesh-list
91985028|NCT03114215|Micronutrients|micronutrients|mesh-ancestor
91985029|NCT03114215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985030|NCT04722887|Protease Inhibitors|protease inhibitors|mesh-list
92027016|NCT04262843|Fludarabine|fludarabine|mesh-list
92027017|NCT04262843|Fludarabine phosphate|fludarabine phosphate|mesh-list
92027018|NCT04262843|Tacrolimus|tacrolimus|mesh-list
92027019|NCT04262843|Lenograstim|lenograstim|mesh-list
92027020|NCT04262843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027021|NCT04262843|Immunologic Factors|immunologic factors|mesh-ancestor
92027022|NCT04262843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027023|NCT04262843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027024|NCT04262843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92027025|NCT04262843|Alkylating Agents|alkylating agents|mesh-ancestor
92027026|NCT04262843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027027|NCT04262843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027028|NCT04262843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92027029|NCT04262843|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92027030|NCT04262843|Antimetabolites|antimetabolites|mesh-ancestor
92027031|NCT04262843|Antiviral Agents|antiviral agents|mesh-ancestor
92027032|NCT04262843|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027033|NCT04262843|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92027034|NCT04262843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027035|NCT04262843|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92027036|NCT04262843|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92027037|NCT04262843|Antitubercular Agents|antitubercular agents|mesh-ancestor
92027038|NCT04262843|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92027039|NCT04262843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92027040|NCT02552303|Modafinil|modafinil|mesh-list
92027041|NCT02552303|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92027042|NCT02552303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027043|NCT02552303|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92027044|NCT02552303|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92027045|NCT02552303|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92081691|NCT01402947|Mesalamine|mesalamine|mesh-list
92027046|NCT02552303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027047|NCT01660711|Leucovorin|leucovorin|mesh-list
92027048|NCT01660711|Fluorouracil|fluorouracil|mesh-list
92027049|NCT01660711|Oxaliplatin|oxaliplatin|mesh-list
92027061|NCT01660711|Antidotes|antidotes|mesh-ancestor
92027062|NCT01660711|Protective Agents|protective agents|mesh-ancestor
92027063|NCT01660711|Vitamin B Complex|vitamin b complex|mesh-ancestor
92027064|NCT01660711|Vitamins|vitamins|mesh-ancestor
92027065|NCT01660711|Micronutrients|micronutrients|mesh-ancestor
92027066|NCT05475665|Amlodipine|amlodipine|mesh-list
92027067|NCT05475665|Irbesartan|irbesartan|mesh-list
92027068|NCT05475665|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92027069|NCT05475665|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92027070|NCT05475665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027071|NCT05475665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027072|NCT05475665|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92027073|NCT05475665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027074|NCT05475665|Vasodilator Agents|vasodilator agents|mesh-ancestor
92027075|NCT05475665|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92027076|NCT05475665|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92027077|NCT02544113|Thymoglobulin|thymoglobulin|mesh-list
92027078|NCT02544113|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92027079|NCT02544113|Immunologic Factors|immunologic factors|mesh-ancestor
92027080|NCT02544113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027081|NCT02544113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027082|NCT02538965|Lenalidomide|lenalidomide|mesh-list
92027083|NCT02538965|Immunologic Factors|immunologic factors|mesh-ancestor
92027084|NCT02538965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027085|NCT02538965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92027086|NCT02538965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92027087|NCT02538965|Growth Substances|growth substances|mesh-ancestor
92027088|NCT02538965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92027089|NCT02538965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027090|NCT02543801|Ketorolac|ketorolac|mesh-list
92027091|NCT02543801|Clonidine|clonidine|mesh-list
92027092|NCT02543801|Epinephrine|epinephrine|mesh-list
92027093|NCT02543801|Bupivacaine|bupivacaine|mesh-list
92027094|NCT02543801|Ropivacaine|ropivacaine|mesh-list
92027095|NCT02543801|Anesthetics, Local|anesthetics, local|mesh-ancestor
92027096|NCT02543801|Anesthetics|anesthetics|mesh-ancestor
91985031|NCT04722887|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
91985032|NCT04722887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027097|NCT02543801|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027098|NCT02543801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027099|NCT02543801|Sensory System Agents|sensory system agents|mesh-ancestor
92027100|NCT02543801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027101|NCT02543801|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92027102|NCT02543801|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92027103|NCT02543801|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027104|NCT02543801|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027105|NCT02543801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027106|NCT02543801|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92027107|NCT02543801|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92027108|NCT02543801|Autonomic Agents|autonomic agents|mesh-ancestor
92027109|NCT02543801|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92027110|NCT02543801|Respiratory System Agents|respiratory system agents|mesh-ancestor
92027111|NCT02543801|Mydriatics|mydriatics|mesh-ancestor
92027112|NCT02543801|Sympathomimetics|sympathomimetics|mesh-ancestor
92027113|NCT02543801|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92027114|NCT02543801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027118|NCT02543801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027119|NCT02543801|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92027120|NCT02543801|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027121|NCT02543801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92027122|NCT02543801|Sympatholytics|sympatholytics|mesh-ancestor
92027123|NCT02543801|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92027125|NCT02481635|Gemcitabine|gemcitabine|mesh-list
92027126|NCT02481635|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92027127|NCT02481635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027128|NCT02481635|Tubulin Modulators|tubulin modulators|mesh-ancestor
92027129|NCT02481635|Antimitotic Agents|antimitotic agents|mesh-ancestor
92027130|NCT02481635|Mitosis Modulators|mitosis modulators|mesh-ancestor
92027131|NCT02481635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027132|NCT02481635|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92027133|NCT02481635|Antimetabolites|antimetabolites|mesh-ancestor
92027134|NCT02470091|Denosumab|denosumab|mesh-list
92027135|NCT02470091|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92027136|NCT02470091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027137|NCT02362503|Fostemsavir|fostemsavir|mesh-list
92027138|NCT02362503|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92027139|NCT02362503|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92027140|NCT02362503|Antiviral Agents|antiviral agents|mesh-ancestor
92027141|NCT02362503|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027142|NCT02362503|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92027143|NCT02362503|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92027144|NCT02362503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027145|NCT05411159|Analgesics, Opioid|analgesics, opioid|mesh-list
92027146|NCT05411159|Anesthetics|anesthetics|mesh-list
92027147|NCT05411159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027148|NCT05411159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027149|NCT05411159|Narcotics|narcotics|mesh-ancestor
92027150|NCT05411159|Analgesics|analgesics|mesh-ancestor
92027151|NCT05411159|Sensory System Agents|sensory system agents|mesh-ancestor
92027152|NCT05411159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027153|NCT02362425|Acetylcysteine|acetylcysteine|mesh-list
92027154|NCT02362425|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92027155|NCT02362425|Antiviral Agents|antiviral agents|mesh-ancestor
92027156|NCT02362425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027157|NCT02362425|Expectorants|expectorants|mesh-ancestor
92027158|NCT02362425|Respiratory System Agents|respiratory system agents|mesh-ancestor
92027159|NCT02362425|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92027160|NCT02362425|Antioxidants|antioxidants|mesh-ancestor
92027161|NCT02362425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027162|NCT02362425|Protective Agents|protective agents|mesh-ancestor
92027163|NCT02362425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027164|NCT02362425|Antidotes|antidotes|mesh-ancestor
92027165|NCT02362269|Vitamin D|vitamin d|mesh-list
92027166|NCT02362269|Vitamins|vitamins|mesh-ancestor
92027167|NCT02362269|Micronutrients|micronutrients|mesh-ancestor
92027168|NCT02362269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027169|NCT02362269|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92027170|NCT02529995|Osimertinib|osimertinib|mesh-list
92027171|NCT02529995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027172|NCT02529995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985033|NCT04722887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027173|NCT02529995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027174|NCT02529995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027175|NCT02319759|Ustekinumab|ustekinumab|mesh-list
92027176|NCT02319759|Dermatologic Agents|dermatologic agents|mesh-ancestor
92027177|NCT02318667|Golimumab|golimumab|mesh-list
92027178|NCT02318667|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92027179|NCT02318667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027180|NCT02318667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027181|NCT02318667|Immunologic Factors|immunologic factors|mesh-ancestor
92027182|NCT02318667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027183|NCT02292771|Vasotocin|vasotocin|mesh-list
92027184|NCT02292771|Atosiban|atosiban|mesh-list
92027185|NCT02292771|Hormone Antagonists|hormone antagonists|mesh-ancestor
92027186|NCT02292771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027187|NCT02292771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027188|NCT02292771|Tocolytic Agents|tocolytic agents|mesh-ancestor
92027195|NCT02291913|Fulvestrant|fulvestrant|mesh-list
92027196|NCT02291913|Anastrozole|anastrozole|mesh-list
92027197|NCT02291913|Exemestane|exemestane|mesh-list
92027198|NCT02291913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92027199|NCT02291913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027200|NCT02291913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027201|NCT02291913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027202|NCT02291913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027203|NCT02291913|Immunologic Factors|immunologic factors|mesh-ancestor
92027204|NCT02291913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027205|NCT02291913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027206|NCT02291913|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92027207|NCT02291913|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92027208|NCT02291913|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92027209|NCT02291913|Hormone Antagonists|hormone antagonists|mesh-ancestor
92027210|NCT02291913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027211|NCT02291913|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92027212|NCT02291913|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92027213|NCT02291913|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92027214|NCT02291913|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92027215|NCT02291913|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92027216|NCT02291679|Linaclotide|linaclotide|mesh-list
92027217|NCT02291679|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92027218|NCT02291679|Enzyme Activators|enzyme activators|mesh-ancestor
92027219|NCT02291679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027220|NCT02291679|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92027221|NCT02291601|Chlorhexidine|chlorhexidine|mesh-list
92027222|NCT02291601|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92027223|NCT02291601|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92027224|NCT02291601|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027225|NCT02291601|Disinfectants|disinfectants|mesh-ancestor
92027226|NCT02291601|Dermatologic Agents|dermatologic agents|mesh-ancestor
92027227|NCT02360475|Vaccines|vaccines|mesh-list
92027228|NCT02360475|Immunologic Factors|immunologic factors|mesh-ancestor
92027229|NCT02360475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027230|NCT02360397|Ranolazine|ranolazine|mesh-list
92027231|NCT02360397|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92027232|NCT02360397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027233|NCT02360397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027234|NCT02317809|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92027235|NCT02317809|Hormones|hormones|mesh-ancestor
92027236|NCT02317809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027237|NCT02317809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027238|NCT02359851|Pembrolizumab|pembrolizumab|mesh-list
92027239|NCT02359851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027240|NCT02359851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027241|NCT02359851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92027242|NCT02359851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027243|NCT01607905|Acetaminophen|acetaminophen|mesh-list
92027244|NCT01607905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027245|NCT01607905|Analgesics|analgesics|mesh-ancestor
92027246|NCT01607905|Sensory System Agents|sensory system agents|mesh-ancestor
92027247|NCT01607905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027248|NCT01607905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985034|NCT04722887|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
91985035|NCT04722887|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91985036|NCT05675813|Azacitidine|azacitidine|mesh-list
92027249|NCT01607905|Antipyretics|antipyretics|mesh-ancestor
92027250|NCT02389543|Dexamethasone|dexamethasone|mesh-list
92027251|NCT02389543|Lenalidomide|lenalidomide|mesh-list
92027252|NCT02389543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027253|NCT02389543|Antiemetics|antiemetics|mesh-ancestor
92027254|NCT02389543|Autonomic Agents|autonomic agents|mesh-ancestor
92027425|NCT05509933|Hormones|hormones|mesh-ancestor
92027255|NCT02389543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027256|NCT02389543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027257|NCT02389543|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92027258|NCT02389543|Glucocorticoids|glucocorticoids|mesh-ancestor
92027259|NCT02389543|Hormones|hormones|mesh-ancestor
92027261|NCT02389543|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92027263|NCT02389543|Immunologic Factors|immunologic factors|mesh-ancestor
92027264|NCT02389543|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92027265|NCT02389543|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92027266|NCT02389543|Growth Substances|growth substances|mesh-ancestor
92027267|NCT02389543|Growth Inhibitors|growth inhibitors|mesh-ancestor
92027268|NCT05441605|Chlorhexidine|chlorhexidine|mesh-list
92027269|NCT05441605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92027270|NCT05441605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027271|NCT05441605|Disinfectants|disinfectants|mesh-ancestor
92027272|NCT00843037|Sunitinib|sunitinib|mesh-list
92027273|NCT00843037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027274|NCT00843037|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92027275|NCT00843037|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92027276|NCT00843037|Growth Substances|growth substances|mesh-ancestor
92027277|NCT00843037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027278|NCT00843037|Growth Inhibitors|growth inhibitors|mesh-ancestor
92027279|NCT00843037|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027280|NCT00843037|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027281|NCT00843037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027282|NCT00602641|Thalidomide|thalidomide|mesh-list
92027283|NCT00602641|Prednisone|prednisone|mesh-list
92027284|NCT00602641|Cortisone|cortisone|mesh-list
92027285|NCT00602641|Lenalidomide|lenalidomide|mesh-list
92027286|NCT00602641|Melphalan|melphalan|mesh-list
92027287|NCT00602641|Mechlorethamine|mechlorethamine|mesh-list
92027288|NCT00602641|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92027289|NCT00602641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027290|NCT00602641|Glucocorticoids|glucocorticoids|mesh-ancestor
92027291|NCT00602641|Hormones|hormones|mesh-ancestor
92027292|NCT00602641|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027293|NCT00602641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027294|NCT00602641|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92027295|NCT00602641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027296|NCT00602641|Immunologic Factors|immunologic factors|mesh-ancestor
92027297|NCT00602641|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92027298|NCT00602641|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92027299|NCT00602641|Growth Substances|growth substances|mesh-ancestor
92027300|NCT00602641|Growth Inhibitors|growth inhibitors|mesh-ancestor
92027301|NCT00602641|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92027302|NCT00602641|Alkylating Agents|alkylating agents|mesh-ancestor
92027303|NCT00602641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027304|NCT00602641|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92027305|NCT00602641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027306|NCT00602641|Leprostatic Agents|leprostatic agents|mesh-ancestor
92027307|NCT00602641|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92027308|NCT00602641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027309|NCT05441527|Muramidase|muramidase|mesh-list
92027310|NCT05441527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027311|NCT02531035|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92027312|NCT02531035|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92027313|NCT02531035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027314|NCT02531035|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92027315|NCT02531035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027317|NCT05004805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027318|NCT05004805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027320|NCT04261387|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985037|NCT05675813|Tislelizumab|tislelizumab|mesh-list
91985038|NCT05675813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92027321|NCT04261387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027322|NCT04261387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027323|NCT05411965|Pioglitazone|pioglitazone|mesh-list
92027324|NCT05411965|Dapagliflozin|dapagliflozin|mesh-list
92027325|NCT05411965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92027326|NCT05411965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027327|NCT05411965|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92027328|NCT05411965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027329|NCT04261075|Durvalumab|durvalumab|mesh-list
92027330|NCT04261075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027344|NCT05378737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027345|NCT05378737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027346|NCT03929029|Nivolumab|nivolumab|mesh-list
92027348|NCT03929029|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92027349|NCT03929029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027350|NCT03929029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027351|NCT03929029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92027352|NCT03929029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027353|NCT03929029|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92027354|NCT03929029|Immunologic Factors|immunologic factors|mesh-ancestor
92027355|NCT03929029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027356|NCT01659853|Azelaic acid|azelaic acid|mesh-list
92027357|NCT01659853|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92027358|NCT01659853|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92027359|NCT01659853|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92027360|NCT01659853|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92027361|NCT01659853|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92027362|NCT01659853|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027363|NCT01659853|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027364|NCT01659853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027365|NCT01659853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027366|NCT01659853|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027367|NCT01659853|Dermatologic Agents|dermatologic agents|mesh-ancestor
92027368|NCT05376553|Docetaxel|docetaxel|mesh-list
92027369|NCT05376553|Cemiplimab|cemiplimab|mesh-list
92027370|NCT05376553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027371|NCT05376553|Tubulin Modulators|tubulin modulators|mesh-ancestor
92027372|NCT05376553|Antimitotic Agents|antimitotic agents|mesh-ancestor
92027373|NCT05376553|Mitosis Modulators|mitosis modulators|mesh-ancestor
92027374|NCT05376553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027375|NCT05376553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027376|NCT05385367|Anesthetics|anesthetics|mesh-list
92027377|NCT05385367|Anesthetics, General|anesthetics, general|mesh-list
92027378|NCT05385367|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027379|NCT05385367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027380|NCT05434351|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92027381|NCT05434351|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92027382|NCT05434351|Immunologic Factors|immunologic factors|mesh-ancestor
92027383|NCT05434351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027384|NCT05576389|Fluzoparib|fluzoparib|mesh-list
92027385|NCT05576389|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92027386|NCT05576389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027387|NCT05576389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027388|NCT05576389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027389|NCT05341609|Ritonavir|ritonavir|mesh-list
92027390|NCT05341609|Nirmatrelvir|nirmatrelvir|mesh-list
92027399|NCT05341609|Antiviral Agents|antiviral agents|mesh-ancestor
92027400|NCT05341609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027401|NCT05341609|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92027402|NCT05341609|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92027403|NCT05371015|Ropivacaine|ropivacaine|mesh-list
92027404|NCT05371015|Anesthetics, Local|anesthetics, local|mesh-ancestor
92027405|NCT05371015|Anesthetics|anesthetics|mesh-ancestor
92027406|NCT05371015|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027407|NCT05371015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027408|NCT05371015|Sensory System Agents|sensory system agents|mesh-ancestor
92027409|NCT05371015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985039|NCT05675813|Antimetabolites|antimetabolites|mesh-ancestor
92090424|NCT04416035|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92027411|NCT02531113|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92027412|NCT02531113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027413|NCT02531113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027414|NCT02531113|Immunologic Factors|immunologic factors|mesh-ancestor
92027415|NCT02531113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027416|NCT05509933|Budesonide|budesonide|mesh-list
92027417|NCT05509933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027418|NCT05509933|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92027419|NCT05509933|Autonomic Agents|autonomic agents|mesh-ancestor
92027420|NCT05509933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027421|NCT05509933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027422|NCT05509933|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92027423|NCT05509933|Respiratory System Agents|respiratory system agents|mesh-ancestor
92027426|NCT05509933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027427|NCT05369533|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92027428|NCT05369533|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92027429|NCT05369533|Immunologic Factors|immunologic factors|mesh-ancestor
92027430|NCT05369533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027431|NCT05369533|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92027432|NCT05369533|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92027433|NCT05369533|Dopamine Agonists|dopamine agonists|mesh-ancestor
92027434|NCT05369533|Dopamine Agents|dopamine agents|mesh-ancestor
92027435|NCT05369533|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027436|NCT05369533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027437|NCT04248595|Azacitidine|azacitidine|mesh-list
92027438|NCT04248595|Homoharringtonine|homoharringtonine|mesh-list
92027439|NCT04248595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92027440|NCT04248595|Antimetabolites|antimetabolites|mesh-ancestor
92027441|NCT04248595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027442|NCT04248595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027443|NCT04248595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027444|NCT04248595|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92027445|NCT04248595|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92027446|NCT05305105|Psilocybin|psilocybin|mesh-list
92027447|NCT05305105|Hallucinogens|hallucinogens|mesh-ancestor
92027448|NCT05305105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027449|NCT05305105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027450|NCT05334277|Bevacizumab|bevacizumab|mesh-list
92027451|NCT05334277|Carboplatin|carboplatin|mesh-list
92027452|NCT05334277|Pemetrexed|pemetrexed|mesh-list
92027453|NCT05334277|Aflutinib|aflutinib|mesh-list
92027454|NCT05334277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027455|NCT05334277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027456|NCT05334277|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92027463|NCT05334277|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92027464|NCT05334277|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92027465|NCT05334277|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027466|NCT05332717|Melatonin|melatonin|mesh-list
92027467|NCT05332717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027468|NCT05332717|Antioxidants|antioxidants|mesh-ancestor
92027469|NCT05332717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027470|NCT05332717|Protective Agents|protective agents|mesh-ancestor
92027471|NCT05332717|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027472|NCT05300269|Capecitabine|capecitabine|mesh-list
92027473|NCT05300269|Oxaliplatin|oxaliplatin|mesh-list
92027474|NCT05300269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92027475|NCT05300269|Antimetabolites|antimetabolites|mesh-ancestor
92027476|NCT05300269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027477|NCT05300269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027478|NCT05325853|Proxymetacaine|proxymetacaine|mesh-list
92027479|NCT05325853|Propoxycaine|propoxycaine|mesh-list
92027480|NCT05325853|Anesthetics, Local|anesthetics, local|mesh-ancestor
92027481|NCT05325853|Anesthetics|anesthetics|mesh-ancestor
92027482|NCT05325853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027483|NCT05325853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027485|NCT05325853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027486|NCT05353933|Pantoprazole|pantoprazole|mesh-list
92027487|NCT05353933|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91985040|NCT05675813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985041|NCT05675813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027488|NCT05353933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92027489|NCT05353933|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92027490|NCT05353933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027491|NCT05353933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027492|NCT05352685|Propofol|propofol|mesh-list
92027493|NCT05352685|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92027494|NCT05352685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027495|NCT05352685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027496|NCT05352685|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92027497|NCT05352685|Anesthetics, General|anesthetics, general|mesh-ancestor
92027498|NCT05352685|Anesthetics|anesthetics|mesh-ancestor
92027499|NCT05351593|Lenalidomide|lenalidomide|mesh-list
92027500|NCT05351593|Immunologic Factors|immunologic factors|mesh-ancestor
92027501|NCT05351593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027502|NCT05351593|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92027503|NCT05351593|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92027504|NCT05351593|Growth Substances|growth substances|mesh-ancestor
92027505|NCT05351593|Growth Inhibitors|growth inhibitors|mesh-ancestor
92027506|NCT05351593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027507|NCT05321875|Candesartan|candesartan|mesh-list
92027508|NCT05321875|Candesartan cilexetil|candesartan cilexetil|mesh-list
92027509|NCT05321875|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92027510|NCT05321875|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92027511|NCT05321875|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92027512|NCT05321875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027514|NCT05347069|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027515|NCT05347069|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027516|NCT05347069|Analgesics|analgesics|mesh-ancestor
92027517|NCT05347069|Sensory System Agents|sensory system agents|mesh-ancestor
92027518|NCT05347069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027519|NCT05347069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027520|NCT05347069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027521|NCT05347069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027522|NCT05347069|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92027523|NCT05347069|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92027524|NCT05347069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027525|NCT05347069|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92027527|NCT05347069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027528|NCT05347069|Antipyretics|antipyretics|mesh-ancestor
92027529|NCT05516953|Baclofen|baclofen|mesh-list
92027530|NCT05516953|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92027531|NCT05516953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027532|NCT05516953|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92027533|NCT05516953|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027534|NCT05516953|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92027535|NCT05516953|GABA Agonists|gaba agonists|mesh-ancestor
92027536|NCT05516953|GABA Agents|gaba agents|mesh-ancestor
92027537|NCT05516953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027538|NCT05516953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027539|NCT02522767|Mesalamine|mesalamine|mesh-list
92027540|NCT02522767|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027541|NCT02522767|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027542|NCT02522767|Analgesics|analgesics|mesh-ancestor
92027543|NCT02522767|Sensory System Agents|sensory system agents|mesh-ancestor
92027544|NCT02522767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027545|NCT02522767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027546|NCT02522767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027547|NCT02522767|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027548|NCT02522377|Midazolam|midazolam|mesh-list
92027549|NCT02522377|Ketamine|ketamine|mesh-list
92027550|NCT02522377|Analgesics|analgesics|mesh-ancestor
92027551|NCT02522377|Sensory System Agents|sensory system agents|mesh-ancestor
92027552|NCT02522377|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027553|NCT02522377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027554|NCT02522377|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92027555|NCT02522377|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92027556|NCT02522377|Anesthetics, General|anesthetics, general|mesh-ancestor
92027557|NCT02522377|Anesthetics|anesthetics|mesh-ancestor
92027558|NCT02522377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985042|NCT05675813|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985043|NCT05675813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985044|NCT02397083|Everolimus|everolimus|mesh-list
92027559|NCT02522377|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92027560|NCT02522377|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92027561|NCT02522377|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027562|NCT02522377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027563|NCT02522377|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92027564|NCT02522377|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92027565|NCT02522377|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92027566|NCT02522377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92027567|NCT02522377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027569|NCT02522377|GABA Agents|gaba agents|mesh-ancestor
92027570|NCT05345509|Donepezil|donepezil|mesh-list
92027571|NCT05345509|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92027572|NCT05345509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027573|NCT05345509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027574|NCT05345509|Cholinergic Agents|cholinergic agents|mesh-ancestor
92027575|NCT05345509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027576|NCT05345509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027577|NCT05345509|Nootropic Agents|nootropic agents|mesh-ancestor
92027578|NCT05318755|Testosterone|testosterone|mesh-list
92027579|NCT05318755|Androgens|androgens|mesh-ancestor
92027580|NCT05318755|Hormones|hormones|mesh-ancestor
92027581|NCT05318755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027582|NCT05318755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027583|NCT05267743|Lansoprazole|lansoprazole|mesh-list
92027584|NCT05267743|Dexlansoprazole|dexlansoprazole|mesh-list
92027585|NCT05267743|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92027586|NCT05267743|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92027587|NCT05267743|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92027588|NCT05267743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027589|NCT05267743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027590|NCT05291845|Vaccines|vaccines|mesh-list
92027591|NCT05291845|Immunologic Factors|immunologic factors|mesh-ancestor
92027592|NCT05291845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027593|NCT05314621|Fluticasone|fluticasone|mesh-list
92027594|NCT05314621|Xhance|xhance|mesh-list
92027595|NCT05314621|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92027596|NCT05314621|Dextrans|dextrans|mesh-list
92027597|NCT05314621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92027598|NCT05314621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92027599|NCT05314621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027600|NCT05314621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92027603|NCT05314621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027604|NCT05314621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92027605|NCT05314621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92027606|NCT05314621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92027607|NCT05314621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92027608|NCT05314621|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027609|NCT05314621|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027610|NCT05314621|Analgesics|analgesics|mesh-ancestor
92027611|NCT05314621|Sensory System Agents|sensory system agents|mesh-ancestor
92027612|NCT05314621|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027613|NCT05314621|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92027614|NCT05314621|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92027615|NCT05314621|Histamine Antagonists|histamine antagonists|mesh-ancestor
92027616|NCT05314621|Histamine Agents|histamine agents|mesh-ancestor
92027617|NCT05314621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027618|NCT05314621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027619|NCT05314621|Anticoagulants|anticoagulants|mesh-ancestor
92027620|NCT05314621|Plasma Substitutes|plasma substitutes|mesh-ancestor
92027621|NCT05314621|Blood Substitutes|blood substitutes|mesh-ancestor
92027622|NCT05266729|Polyene phosphatidylcholine|polyene phosphatidylcholine|mesh-list
92027623|NCT05266729|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92027624|NCT05266729|Antimetabolites|antimetabolites|mesh-ancestor
92027625|NCT05266729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027626|NCT05266729|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92027627|NCT05263609|Pembrolizumab|pembrolizumab|mesh-list
92027628|NCT05263609|Axitinib|axitinib|mesh-list
92027629|NCT05263609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985045|NCT02397083|Levonorgestrel|levonorgestrel|mesh-list
91985046|NCT02397083|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
91985047|NCT02397083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985048|NCT02397083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027630|NCT05263609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027631|NCT05263609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92027632|NCT05263609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027633|NCT05263609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027634|NCT05263609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027635|NCT05313997|Diclofenac|diclofenac|mesh-list
92027636|NCT05313997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027637|NCT05313997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027638|NCT05313997|Analgesics|analgesics|mesh-ancestor
92027639|NCT05313997|Sensory System Agents|sensory system agents|mesh-ancestor
92027640|NCT05313997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027641|NCT05313997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027642|NCT05313997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027643|NCT05313997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027644|NCT05313997|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92027645|NCT05313997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027646|NCT05313997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027647|NCT05259241|Thrombin|thrombin|mesh-list
92027648|NCT05259241|Hemostatics|hemostatics|mesh-ancestor
92027649|NCT05259241|Coagulants|coagulants|mesh-ancestor
92027650|NCT01657903|Listerine|listerine|mesh-list
92027651|NCT01657903|Fluorides|fluorides|mesh-list
92027652|NCT01657903|Sodium Fluoride|sodium fluoride|mesh-list
92027653|NCT01657903|Cariostatic Agents|cariostatic agents|mesh-ancestor
92027654|NCT01657903|Protective Agents|protective agents|mesh-ancestor
92027655|NCT01657903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027656|NCT01657903|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92027657|NCT01657903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027658|NCT05256823|Celecoxib|celecoxib|mesh-list
92027659|NCT05256823|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027660|NCT05256823|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027661|NCT05256823|Analgesics|analgesics|mesh-ancestor
92027662|NCT05256823|Sensory System Agents|sensory system agents|mesh-ancestor
92027663|NCT05256823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027664|NCT05256823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027665|NCT05256823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027666|NCT05256823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027667|NCT05256823|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92027668|NCT05256823|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92027669|NCT05256823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027670|NCT05256823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027671|NCT05284591|Daratumumab|daratumumab|mesh-list
92027672|NCT05284591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027673|NCT04243837|Pirfenidone|pirfenidone|mesh-list
92027676|NCT04243837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027677|NCT04243837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027678|NCT04243837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92027679|NCT04243837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027680|NCT04243837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027681|NCT04243837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92027682|NCT04243837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027683|NCT05253937|Epinephrine|epinephrine|mesh-list
92027684|NCT05253937|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92027685|NCT05253937|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92027686|NCT05253937|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027687|NCT05253937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027688|NCT05253937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027689|NCT05253937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027690|NCT05253937|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92027691|NCT05253937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92027692|NCT05253937|Autonomic Agents|autonomic agents|mesh-ancestor
92027693|NCT05253937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027694|NCT05253937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92027695|NCT05253937|Respiratory System Agents|respiratory system agents|mesh-ancestor
92027696|NCT05253937|Mydriatics|mydriatics|mesh-ancestor
92027697|NCT05253937|Sympathomimetics|sympathomimetics|mesh-ancestor
92027698|NCT05253937|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92027700|NCT05218603|Daratumumab|daratumumab|mesh-list
91985049|NCT02397083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985050|NCT02397083|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985051|NCT02397083|Immunologic Factors|immunologic factors|mesh-ancestor
92027701|NCT05218603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027702|NCT05214001|Almotriptan|almotriptan|mesh-list
92027703|NCT05214001|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92027704|NCT05214001|Serotonin Agents|serotonin agents|mesh-ancestor
92027705|NCT05214001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027706|NCT05214001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027707|NCT05214001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027708|NCT05280223|Dexmedetomidine|dexmedetomidine|mesh-list
92027709|NCT05280223|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92027710|NCT05280223|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027711|NCT05280223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027712|NCT05280223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027714|NCT05280223|Sensory System Agents|sensory system agents|mesh-ancestor
92027715|NCT05280223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027716|NCT05280223|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92027717|NCT05280223|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92027718|NCT05280223|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92027719|NCT05280223|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027721|NCT05280223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027722|NCT05277337|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92027723|NCT05277337|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92027724|NCT05277337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027725|NCT05277337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027726|NCT05277337|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92027727|NCT05277337|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027728|NCT05277337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027729|NCT05277337|Cholinergic Agents|cholinergic agents|mesh-ancestor
92027730|NCT05277337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027731|NCT05248945|Carbamazepine|carbamazepine|mesh-list
92027732|NCT05248945|Anticonvulsants|anticonvulsants|mesh-ancestor
92027733|NCT05248945|Antimanic Agents|antimanic agents|mesh-ancestor
92027734|NCT05248945|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92027735|NCT05248945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027736|NCT05248945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027737|NCT05248945|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027738|NCT05248945|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027739|NCT05248945|Analgesics|analgesics|mesh-ancestor
92027740|NCT05248945|Sensory System Agents|sensory system agents|mesh-ancestor
92027741|NCT05248945|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027742|NCT05248945|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92027743|NCT05248945|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027744|NCT05248945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027745|NCT05248945|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92027748|NCT04239313|Immunologic Factors|immunologic factors|mesh-ancestor
92027749|NCT04239313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027750|NCT05209867|Cannabidiol|cannabidiol|mesh-list
92027751|NCT05209867|Anticonvulsants|anticonvulsants|mesh-ancestor
92027752|NCT05273827|Paclitaxel|paclitaxel|mesh-list
92027753|NCT05273827|Pemetrexed|pemetrexed|mesh-list
92027754|NCT05273827|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92027755|NCT05273827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027756|NCT05273827|Tubulin Modulators|tubulin modulators|mesh-ancestor
92027757|NCT05273827|Antimitotic Agents|antimitotic agents|mesh-ancestor
92027758|NCT05273827|Mitosis Modulators|mitosis modulators|mesh-ancestor
92027759|NCT05273827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027760|NCT05273827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027761|NCT05273827|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92027762|NCT05273827|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92027763|NCT05209711|Lidocaine|lidocaine|mesh-list
92027764|NCT05209711|Anesthetics, Local|anesthetics, local|mesh-ancestor
92027765|NCT05209711|Anesthetics|anesthetics|mesh-ancestor
92027766|NCT05209711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027767|NCT05209711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985052|NCT02397083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985053|NCT02397083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027768|NCT05209711|Sensory System Agents|sensory system agents|mesh-ancestor
92027769|NCT05209711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027770|NCT05209711|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92027771|NCT05209711|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92027772|NCT05209711|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92027773|NCT05209711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027774|NCT05209711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027776|NCT05243563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027777|NCT05243563|Glucocorticoids|glucocorticoids|mesh-ancestor
92027778|NCT05243563|Hormones|hormones|mesh-ancestor
92027779|NCT05243563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027780|NCT05243563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027781|NCT05272969|Vitamin D|vitamin d|mesh-list
92027782|NCT05272969|Calcium|calcium|mesh-list
92027783|NCT05272969|Vitamins|vitamins|mesh-ancestor
92027784|NCT05272969|Micronutrients|micronutrients|mesh-ancestor
92027785|NCT05272969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027786|NCT05272969|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92027787|NCT05272969|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92027788|NCT05208619|Anesthetics|anesthetics|mesh-list
92027789|NCT05208619|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027790|NCT05208619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027791|NCT05206747|Methamphetamine|methamphetamine|mesh-list
92027792|NCT05206747|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92027794|NCT05206747|Sympathomimetics|sympathomimetics|mesh-ancestor
92027795|NCT05206747|Autonomic Agents|autonomic agents|mesh-ancestor
92027796|NCT05206747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027797|NCT05206747|Dopamine Agents|dopamine agents|mesh-ancestor
92027798|NCT05206747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027799|NCT05206747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027800|NCT05206747|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027801|NCT05206747|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92027802|NCT05206747|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92027803|NCT05206747|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027804|NCT05206747|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92027805|NCT05206435|Nicotine|nicotine|mesh-list
92027806|NCT05206435|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92027807|NCT05206435|Autonomic Agents|autonomic agents|mesh-ancestor
92027808|NCT05206435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027809|NCT05206435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027810|NCT05206435|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92027811|NCT05206435|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92027812|NCT05206435|Cholinergic Agents|cholinergic agents|mesh-ancestor
92027813|NCT05206435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027814|NCT05206435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027815|NCT05205811|Zonisamide|zonisamide|mesh-list
92027816|NCT05205811|Bupropion|bupropion|mesh-list
92027817|NCT05205811|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92027818|NCT05205811|Antidepressive Agents|antidepressive agents|mesh-ancestor
92027819|NCT05205811|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027829|NCT05205811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027830|NCT05205811|Anticonvulsants|anticonvulsants|mesh-ancestor
92027831|NCT05205811|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92027832|NCT05205811|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92027833|NCT05166967|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92027834|NCT05166967|Immunologic Factors|immunologic factors|mesh-ancestor
92027835|NCT05166967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027836|NCT05166967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027837|NCT05166343|Epinephrine|epinephrine|mesh-list
92027838|NCT05166343|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92027839|NCT05166343|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92027840|NCT05166343|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027841|NCT05166343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027842|NCT05166343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027843|NCT05166343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027844|NCT05166343|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92027845|NCT05166343|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92027846|NCT05166343|Autonomic Agents|autonomic agents|mesh-ancestor
91985054|NCT02397083|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
91985055|NCT02397083|Contraceptive Agents|contraceptive agents|mesh-ancestor
92027847|NCT05166343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027848|NCT05166343|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92027849|NCT05166343|Respiratory System Agents|respiratory system agents|mesh-ancestor
92027850|NCT05166343|Mydriatics|mydriatics|mesh-ancestor
92027851|NCT05166343|Sympathomimetics|sympathomimetics|mesh-ancestor
92027852|NCT05166343|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92027853|NCT05237947|Vaccines|vaccines|mesh-list
92027854|NCT05237947|Immunologic Factors|immunologic factors|mesh-ancestor
92027855|NCT05237947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027856|NCT01656733|Nicotine|nicotine|mesh-list
92027857|NCT01656733|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92027858|NCT01656733|Autonomic Agents|autonomic agents|mesh-ancestor
92027859|NCT01656733|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027860|NCT01656733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027861|NCT01656733|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92027862|NCT01656733|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92027863|NCT01656733|Cholinergic Agents|cholinergic agents|mesh-ancestor
92027864|NCT01656733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027865|NCT01656733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027866|NCT05236543|Itraconazole|itraconazole|mesh-list
92027867|NCT05236543|Antifungal Agents|antifungal agents|mesh-ancestor
92027868|NCT05236543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027869|NCT05236543|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92027870|NCT05236543|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92027871|NCT05236543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027872|NCT05236543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027873|NCT05236543|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92027874|NCT05236543|Hormone Antagonists|hormone antagonists|mesh-ancestor
92027875|NCT05236543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027876|NCT05236543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027877|NCT05236543|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92027878|NCT05159245|Trastuzumab|trastuzumab|mesh-list
92027879|NCT05159245|Atezolizumab|atezolizumab|mesh-list
92027880|NCT05159245|Pertuzumab|pertuzumab|mesh-list
92027881|NCT05159245|Trametinib|trametinib|mesh-list
92027882|NCT05159245|Vemurafenib|vemurafenib|mesh-list
92027892|NCT05157841|Bupivacaine|bupivacaine|mesh-list
92027893|NCT05157841|Anesthetics, Local|anesthetics, local|mesh-ancestor
92027894|NCT05157841|Anesthetics|anesthetics|mesh-ancestor
92027895|NCT05157841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028207|NCT05057767|GABA Modulators|gaba modulators|mesh-ancestor
92027896|NCT05157841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027897|NCT05157841|Sensory System Agents|sensory system agents|mesh-ancestor
92027898|NCT05157841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027899|NCT05154487|Fulvestrant|fulvestrant|mesh-list
92027900|NCT05154487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92027901|NCT05154487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027902|NCT05154487|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92027903|NCT05154487|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92027904|NCT05154487|Hormone Antagonists|hormone antagonists|mesh-ancestor
92027905|NCT05154487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027906|NCT05154487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027907|NCT05152927|Parathyroid Hormone|parathyroid hormone|mesh-list
92027908|NCT05152927|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92027909|NCT05152927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027910|NCT05225155|Enoxaparin|enoxaparin|mesh-list
92027911|NCT05225155|Anticoagulants|anticoagulants|mesh-ancestor
92027912|NCT05225155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92027913|NCT05225155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92027914|NCT05225155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027915|NCT05190445|Paclitaxel|paclitaxel|mesh-list
92027916|NCT05190445|Ramucirumab|ramucirumab|mesh-list
92027917|NCT05190445|Tucatinib|tucatinib|mesh-list
92027918|NCT05190445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92027919|NCT05190445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027920|NCT05190445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92027921|NCT05190445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92027922|NCT05190445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92027923|NCT05190445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027924|NCT05190445|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027925|NCT05190445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027926|NCT05189977|Propranolol|propranolol|mesh-list
91985056|NCT02397083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92027928|NCT05189977|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92027929|NCT05189977|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92027930|NCT05189977|Adrenergic Agents|adrenergic agents|mesh-ancestor
92027931|NCT05189977|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027932|NCT05189977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027933|NCT05189977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027934|NCT05189977|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92027935|NCT05189977|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92027936|NCT05189977|Vasodilator Agents|vasodilator agents|mesh-ancestor
92027937|NCT05189977|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92027938|NCT05189977|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92027940|NCT05148949|Immunologic Factors|immunologic factors|mesh-ancestor
92027941|NCT05148949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027943|NCT05107999|Antidepressive Agents|antidepressive agents|mesh-list
92027944|NCT05107999|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92027945|NCT05107999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027946|NCT05107999|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92027947|NCT05107999|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92027948|NCT05107999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027949|NCT05107999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027950|NCT05107999|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92027951|NCT05107999|Histamine Antagonists|histamine antagonists|mesh-ancestor
92027952|NCT05107999|Histamine Agents|histamine agents|mesh-ancestor
92027953|NCT05107999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027955|NCT05186545|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92027956|NCT05186545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027957|NCT05186545|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92027958|NCT05186545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92027959|NCT05186545|Hormone Antagonists|hormone antagonists|mesh-ancestor
92027960|NCT05186545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027961|NCT05186545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027962|NCT05107765|Pioglitazone|pioglitazone|mesh-list
92027963|NCT05107765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92027964|NCT05107765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027965|NCT05185999|Icodextrin|icodextrin|mesh-list
92027966|NCT05185999|Dialysis Solutions|dialysis solutions|mesh-ancestor
92027967|NCT05185999|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92027968|NCT05106127|Pembrolizumab|pembrolizumab|mesh-list
92027969|NCT05106127|Lenvatinib|lenvatinib|mesh-list
92027970|NCT05106127|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027971|NCT05106127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027972|NCT05106127|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92027973|NCT05106127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027974|NCT05106127|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027975|NCT05106127|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027976|NCT05183737|Propolis|propolis|mesh-list
92027977|NCT05183737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027978|NCT05177419|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92027979|NCT05177419|Hallucinogens|hallucinogens|mesh-ancestor
92027980|NCT05177419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027981|NCT05177419|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92027982|NCT05177419|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92027983|NCT05177419|Serotonin Agents|serotonin agents|mesh-ancestor
92027984|NCT05177419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027985|NCT05177419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027986|NCT05177419|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92027987|NCT05094427|Anesthetics|anesthetics|mesh-list
92027988|NCT05094427|Anesthetics, Local|anesthetics, local|mesh-list
92027989|NCT05094427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92027990|NCT05094427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027991|NCT05094427|Sensory System Agents|sensory system agents|mesh-ancestor
92027992|NCT05094427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027993|NCT05139043|Dexamethasone|dexamethasone|mesh-list
92027994|NCT05139043|Dexamethasone acetate|dexamethasone acetate|mesh-list
92027995|NCT05139043|Ichthammol|ichthammol|mesh-list
92027996|NCT05139043|BB 1101|bb 1101|mesh-list
92027997|NCT05139043|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027998|NCT05139043|Antiemetics|antiemetics|mesh-ancestor
92027999|NCT05139043|Autonomic Agents|autonomic agents|mesh-ancestor
91985057|NCT02397083|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92028000|NCT05139043|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028001|NCT05139043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028002|NCT05139043|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028003|NCT05139043|Glucocorticoids|glucocorticoids|mesh-ancestor
92028004|NCT05139043|Hormones|hormones|mesh-ancestor
92028005|NCT05139043|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028006|NCT05139043|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028007|NCT05139043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028008|NCT05139043|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028009|NCT05139043|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028010|NCT05139043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028011|NCT05139043|Dermatologic Agents|dermatologic agents|mesh-ancestor
92028012|NCT05175781|Dexmedetomidine|dexmedetomidine|mesh-list
92028013|NCT05175781|Ketamine|ketamine|mesh-list
92028014|NCT05175781|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92028015|NCT05175781|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028016|NCT05175781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028017|NCT05175781|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028018|NCT05175781|Analgesics|analgesics|mesh-ancestor
92028019|NCT05175781|Sensory System Agents|sensory system agents|mesh-ancestor
92028020|NCT05175781|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028021|NCT05175781|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92028022|NCT05175781|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92028032|NCT05175781|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92028033|NCT04421911|Diclofenac|diclofenac|mesh-list
92028034|NCT04421911|Ketoprofen|ketoprofen|mesh-list
92028035|NCT04421911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92028036|NCT04421911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028037|NCT04421911|Analgesics|analgesics|mesh-ancestor
92028038|NCT04421911|Sensory System Agents|sensory system agents|mesh-ancestor
92028039|NCT04421911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028040|NCT04421911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028041|NCT04421911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028042|NCT04421911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028043|NCT04421911|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92028044|NCT04421911|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028045|NCT04421911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028046|NCT05174611|Vitamin D|vitamin d|mesh-list
92028047|NCT05174611|Cholecalciferol|cholecalciferol|mesh-list
92028048|NCT05174611|Vitamins|vitamins|mesh-ancestor
92028049|NCT05174611|Micronutrients|micronutrients|mesh-ancestor
92028050|NCT05174611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028051|NCT05174611|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92028052|NCT05174611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92028053|NCT05133817|Norepinephrine|norepinephrine|mesh-list
92028054|NCT05133817|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92028055|NCT05133817|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92028056|NCT05133817|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92028057|NCT05133817|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028058|NCT05133817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028059|NCT05133817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028060|NCT05133817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028061|NCT05133817|Sympathomimetics|sympathomimetics|mesh-ancestor
92028062|NCT05133817|Autonomic Agents|autonomic agents|mesh-ancestor
92028063|NCT05133817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028064|NCT05171335|Lenvatinib|lenvatinib|mesh-list
92028065|NCT05171335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028066|NCT05171335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028067|NCT05171335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028068|NCT05171335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028069|NCT02522299|Nemiralisib|nemiralisib|mesh-list
92028070|NCT02522299|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028071|NCT02522299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028072|NCT02522299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028073|NCT01365091|Metformin|metformin|mesh-list
92028074|NCT01365091|Saxagliptin|saxagliptin|mesh-list
92028075|NCT01365091|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028076|NCT01365091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028077|NCT01365091|Incretins|incretins|mesh-ancestor
92028078|NCT01365091|Hormones|hormones|mesh-ancestor
92028079|NCT01365091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028080|NCT01365091|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
91985058|NCT02397083|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
91985059|NCT02397083|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
91985060|NCT02667275|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91985061|NCT01738139|Ipilimumab|ipilimumab|mesh-list
91985062|NCT01738139|Imatinib Mesylate|imatinib mesylate|mesh-list
91985063|NCT01738139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028081|NCT01365091|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028082|NCT01365091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028083|NCT01365091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028084|NCT05082025|Fulvestrant|fulvestrant|mesh-list
92028085|NCT05082025|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028086|NCT05082025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028087|NCT05082025|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92028097|NCT05081479|Respiratory System Agents|respiratory system agents|mesh-ancestor
92028098|NCT05081479|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92028099|NCT05081479|Antioxidants|antioxidants|mesh-ancestor
92028100|NCT05081479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028101|NCT05081479|Protective Agents|protective agents|mesh-ancestor
92028102|NCT05081479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028103|NCT05081479|Antidotes|antidotes|mesh-ancestor
92028104|NCT05079763|Monolaurin|monolaurin|mesh-list
92028105|NCT05079763|Cariostatic Agents|cariostatic agents|mesh-ancestor
92028106|NCT05079763|Protective Agents|protective agents|mesh-ancestor
92028107|NCT05079763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028108|NCT05050981|Hormones|hormones|mesh-list
92028109|NCT05050981|Serotonin|serotonin|mesh-list
92028110|NCT05050981|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92028111|NCT05050981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028112|NCT05050981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028113|NCT05050981|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92028114|NCT05050981|Serotonin Agents|serotonin agents|mesh-ancestor
92028115|NCT05050981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028116|NCT05050981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028117|NCT05050981|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92028118|NCT05050981|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92028120|NCT05073679|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92028121|NCT05073679|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92028122|NCT05073679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028123|NCT05073679|Sensory System Agents|sensory system agents|mesh-ancestor
92028124|NCT05073679|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028125|NCT05039281|Atezolizumab|atezolizumab|mesh-list
92028126|NCT05039281|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92028127|NCT05039281|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92028128|NCT05039281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028129|NCT05039281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028130|NCT05039281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028131|NCT05039281|Immunologic Factors|immunologic factors|mesh-ancestor
92028132|NCT05039281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028133|NCT05065645|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92028134|NCT05064631|Broncho-Vaxom|broncho-vaxom|mesh-list
92028135|NCT05064631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92028136|NCT05064631|Immunologic Factors|immunologic factors|mesh-ancestor
92028137|NCT05064631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028138|NCT01364467|Phenylpropanolamine|phenylpropanolamine|mesh-list
92028139|NCT01364467|Guaifenesin|guaifenesin|mesh-list
92028140|NCT01364467|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92028141|NCT01364467|Expectorants|expectorants|mesh-ancestor
92028142|NCT01364467|Respiratory System Agents|respiratory system agents|mesh-ancestor
92028143|NCT01364467|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92028144|NCT01364467|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92028145|NCT01364467|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028146|NCT01364467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028147|NCT01364467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028148|NCT01364467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985064|NCT01738139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028149|NCT01364467|Appetite Depressants|appetite depressants|mesh-ancestor
92028150|NCT01364467|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92028151|NCT01364467|Sympathomimetics|sympathomimetics|mesh-ancestor
92028152|NCT01364467|Autonomic Agents|autonomic agents|mesh-ancestor
92028154|NCT01364467|Nasal Decongestants|nasal decongestants|mesh-ancestor
92028155|NCT01364467|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92028157|NCT04226365|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92028158|NCT04226365|Antidepressive Agents|antidepressive agents|mesh-ancestor
92028159|NCT04226365|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92028160|NCT04226365|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92028161|NCT04226365|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92028162|NCT04226365|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92028163|NCT04226365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028164|NCT04226365|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028165|NCT04226365|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028166|NCT04226365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028167|NCT05062837|Apatinib|apatinib|mesh-list
92028168|NCT05062837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028169|NCT05062837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028170|NCT05062837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028171|NCT05062837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028172|NCT05110417|Bromides|bromides|mesh-list
92028173|NCT05110417|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92028174|NCT05110417|Anticonvulsants|anticonvulsants|mesh-ancestor
92028175|NCT05110417|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92028176|NCT05110417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028177|NCT05110417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028178|NCT05110417|Cholinergic Agents|cholinergic agents|mesh-ancestor
92028179|NCT05110417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028180|NCT05110417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028181|NCT05033665|Benzocaine|benzocaine|mesh-list
92028182|NCT05033665|Anesthetics, Local|anesthetics, local|mesh-ancestor
92028183|NCT05033665|Anesthetics|anesthetics|mesh-ancestor
92028184|NCT05033665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028185|NCT05033665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028186|NCT05033665|Sensory System Agents|sensory system agents|mesh-ancestor
92028187|NCT05033665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028188|NCT05031481|Butoconazole|butoconazole|mesh-list
92028189|NCT05031481|Antifungal Agents|antifungal agents|mesh-ancestor
92028190|NCT05031481|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028191|NCT05058859|Dapagliflozin|dapagliflozin|mesh-list
92028192|NCT05058859|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92028193|NCT05058859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028194|NCT05058859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028195|NCT05058859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028196|NCT05057767|Midazolam|midazolam|mesh-list
92028197|NCT05057767|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92028198|NCT05057767|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92028199|NCT05057767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028200|NCT05057767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028201|NCT05057767|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92028202|NCT05057767|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92028203|NCT05057767|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92028204|NCT05057767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92028205|NCT05057767|Anesthetics, General|anesthetics, general|mesh-ancestor
92028206|NCT05057767|Anesthetics|anesthetics|mesh-ancestor
92028208|NCT05057767|GABA Agents|gaba agents|mesh-ancestor
92028209|NCT05057767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028210|NCT05057767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028211|NCT04997317|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92028212|NCT04997317|Edotreotide lutetium LU-177|edotreotide lutetium lu-177|mesh-list
92028213|NCT04997317|Chelating Agents|chelating agents|mesh-ancestor
92028214|NCT04997317|Sequestering Agents|sequestering agents|mesh-ancestor
92028215|NCT04997317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028216|NCT04997317|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92028217|NCT04997239|Vaccines|vaccines|mesh-list
92028218|NCT04997239|Immunologic Factors|immunologic factors|mesh-ancestor
92028219|NCT04997239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028220|NCT04216693|Digoxin|digoxin|mesh-list
91985065|NCT01738139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91985066|NCT01738139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985067|NCT01738139|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028221|NCT04216693|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92028222|NCT04216693|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92028223|NCT04216693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028224|NCT04216693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028225|NCT04216693|Protective Agents|protective agents|mesh-ancestor
92028234|NCT01364389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028235|NCT05054881|Iodine|iodine|mesh-list
92028237|NCT05054881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028238|NCT05054881|Trace Elements|trace elements|mesh-ancestor
92028239|NCT05054881|Micronutrients|micronutrients|mesh-ancestor
92028240|NCT05054881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028241|NCT04949425|Adavosertib|adavosertib|mesh-list
92028242|NCT04949425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028243|NCT04949425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028244|NCT04203901|Nivolumab|nivolumab|mesh-list
92028245|NCT04203901|Ipilimumab|ipilimumab|mesh-list
92028246|NCT04203901|Everolimus|everolimus|mesh-list
92028247|NCT04203901|Lenvatinib|lenvatinib|mesh-list
92028248|NCT04203901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028249|NCT04203901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028250|NCT04203901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92028251|NCT04203901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028252|NCT04203901|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92028253|NCT04203901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028254|NCT04203901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028255|NCT04203901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028256|NCT04203901|Immunologic Factors|immunologic factors|mesh-ancestor
92028257|NCT04203901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028258|NCT04421209|Propranolol|propranolol|mesh-list
92028259|NCT04421209|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92028260|NCT04421209|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92028261|NCT04421209|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028262|NCT04421209|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028263|NCT04421209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028264|NCT04421209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028265|NCT04421209|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92028266|NCT04421209|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92028267|NCT04421209|Vasodilator Agents|vasodilator agents|mesh-ancestor
92028268|NCT04946305|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92028269|NCT04946305|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92028270|NCT04946305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028271|NCT04984993|Tadalafil|tadalafil|mesh-list
92028272|NCT04984993|Vasodilator Agents|vasodilator agents|mesh-ancestor
92028273|NCT04984993|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92028274|NCT04984993|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92028275|NCT04984993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028276|NCT04984993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028277|NCT04984993|Urological Agents|urological agents|mesh-ancestor
92028278|NCT04984837|Gemcitabine|gemcitabine|mesh-list
92028279|NCT04984837|Oxaliplatin|oxaliplatin|mesh-list
92028280|NCT04984837|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92028281|NCT04984837|Antimetabolites|antimetabolites|mesh-ancestor
92028282|NCT04984837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028283|NCT04984837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028284|NCT04983121|Antibodies|antibodies|mesh-list
92028285|NCT04983121|Mitogens|mitogens|mesh-list
92028286|NCT04983121|Immunoconjugates|immunoconjugates|mesh-list
92028287|NCT04983121|Immunologic Factors|immunologic factors|mesh-ancestor
92028288|NCT04983121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028289|NCT04983121|Mitosis Modulators|mitosis modulators|mesh-ancestor
92028290|NCT04983121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028291|NCT02291289|Bevacizumab|bevacizumab|mesh-list
92028292|NCT02291289|Trastuzumab|trastuzumab|mesh-list
92028298|NCT02291289|Vemurafenib|vemurafenib|mesh-list
92028299|NCT02291289|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028300|NCT02291289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028301|NCT02291289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91985068|NCT01738139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985069|NCT01729091|Lenalidomide|lenalidomide|mesh-list
91985070|NCT01729091|Melphalan|melphalan|mesh-list
91985071|NCT01729091|Mechlorethamine|mechlorethamine|mesh-list
91985072|NCT01729091|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92028302|NCT02291289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92028303|NCT02291289|Growth Substances|growth substances|mesh-ancestor
92028304|NCT02291289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028305|NCT02291289|Growth Inhibitors|growth inhibitors|mesh-ancestor
92028306|NCT02291289|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92028307|NCT02291289|Antimetabolites|antimetabolites|mesh-ancestor
92028308|NCT02291289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028309|NCT02291289|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028310|NCT02291289|Immunologic Factors|immunologic factors|mesh-ancestor
92028311|NCT02291289|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92028312|NCT02291289|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028313|NCT02291289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028314|NCT02317575|Insulin Lispro|insulin lispro|mesh-list
92028315|NCT02317575|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028316|NCT02317575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028317|NCT02289963|Alirocumab|alirocumab|mesh-list
92028318|NCT02289963|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92028319|NCT02289963|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92028320|NCT02289963|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92028321|NCT02289963|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92028322|NCT02289963|Antimetabolites|antimetabolites|mesh-ancestor
92028323|NCT02289963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028324|NCT02289963|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92028325|NCT02289963|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028326|NCT02289963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028327|NCT02289963|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92028328|NCT02289963|Immunologic Factors|immunologic factors|mesh-ancestor
92028329|NCT02289963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028330|NCT02358369|Timolol|timolol|mesh-list
92028331|NCT02358369|Bimatoprost|bimatoprost|mesh-list
92028332|NCT02358369|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92028333|NCT02358369|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92028334|NCT02358369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92028335|NCT02358369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92028336|NCT02358369|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028337|NCT02358369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028338|NCT02358369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028339|NCT02358369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028340|NCT02358369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92028341|NCT02358369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92028342|NCT02316171|Mitomycins|mitomycins|mesh-list
92028343|NCT02316171|Mitomycin|mitomycin|mesh-list
92028344|NCT02316171|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92028345|NCT02316171|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028346|NCT02316171|Alkylating Agents|alkylating agents|mesh-ancestor
92028347|NCT02316171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028348|NCT02316171|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92028349|NCT02316171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028350|NCT02315625|Everolimus|everolimus|mesh-list
92028351|NCT02315625|Sunitinib|sunitinib|mesh-list
92028352|NCT02315625|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92028353|NCT02315625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028354|NCT02315625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028355|NCT02315625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028356|NCT02315625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028357|NCT02315625|Immunologic Factors|immunologic factors|mesh-ancestor
92028358|NCT02315625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028359|NCT02315625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028360|NCT02315625|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92028361|NCT02315625|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92028362|NCT02315625|Growth Substances|growth substances|mesh-ancestor
92028363|NCT02315625|Growth Inhibitors|growth inhibitors|mesh-ancestor
92028364|NCT02357979|Fluorides|fluorides|mesh-list
92028365|NCT02357979|Cariostatic Agents|cariostatic agents|mesh-ancestor
92028372|NCT02357901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028373|NCT02357901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028374|NCT02357901|Analgesics|analgesics|mesh-ancestor
91985073|NCT01729091|Elotuzumab|elotuzumab|mesh-list
91985074|NCT01729091|Immunologic Factors|immunologic factors|mesh-ancestor
91985075|NCT01729091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028375|NCT02357901|Sensory System Agents|sensory system agents|mesh-ancestor
92028376|NCT02357901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028377|NCT02357901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92028378|NCT01601847|Vitamin D|vitamin d|mesh-list
92028379|NCT01601847|Cholecalciferol|cholecalciferol|mesh-list
92028380|NCT01601847|Vitamins|vitamins|mesh-ancestor
92028381|NCT01601847|Micronutrients|micronutrients|mesh-ancestor
92028382|NCT01601847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028383|NCT01601847|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92028384|NCT01601847|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92028386|NCT02515279|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92028387|NCT02515279|Antimetabolites|antimetabolites|mesh-ancestor
92081692|NCT01402947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028388|NCT02515279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028389|NCT02515279|Antiviral Agents|antiviral agents|mesh-ancestor
92028390|NCT02515279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028392|NCT02515045|Prednisolone|prednisolone|mesh-list
92028393|NCT02515045|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92028394|NCT02515045|Methylprednisolone|methylprednisolone|mesh-list
92028395|NCT02515045|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92028396|NCT02515045|Prednisolone acetate|prednisolone acetate|mesh-list
92028397|NCT02515045|Nepafenac|nepafenac|mesh-list
92028398|NCT02515045|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92028399|NCT02515045|Prednisolone phosphate|prednisolone phosphate|mesh-list
92028400|NCT02515045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028401|NCT02515045|Glucocorticoids|glucocorticoids|mesh-ancestor
92028402|NCT02515045|Hormones|hormones|mesh-ancestor
92028403|NCT02515045|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028404|NCT02515045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028405|NCT02515045|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028406|NCT02515045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028407|NCT02515045|Antiemetics|antiemetics|mesh-ancestor
92028408|NCT02515045|Autonomic Agents|autonomic agents|mesh-ancestor
92028409|NCT02515045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028410|NCT02515045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028411|NCT02515045|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92028412|NCT02515045|Protective Agents|protective agents|mesh-ancestor
92028413|NCT02515045|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028414|NCT02515045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028415|NCT02515045|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92028416|NCT02515045|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92028417|NCT02515045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028418|NCT02515045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028419|NCT02515045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92028420|NCT02515045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028421|NCT02515045|Analgesics|analgesics|mesh-ancestor
92028422|NCT02515045|Sensory System Agents|sensory system agents|mesh-ancestor
92028423|NCT02515045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028425|NCT02513485|Carbidopa|carbidopa|mesh-list
92028426|NCT02513485|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92028427|NCT02513485|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92028428|NCT02513485|Dopamine Agents|dopamine agents|mesh-ancestor
92028429|NCT02513485|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028430|NCT02513485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028431|NCT02513485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028432|NCT02513485|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92028433|NCT02513485|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028434|NCT02289417|Apremilast|apremilast|mesh-list
92028437|NCT02289417|Analgesics|analgesics|mesh-ancestor
92028438|NCT02289417|Sensory System Agents|sensory system agents|mesh-ancestor
92028439|NCT02289417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028440|NCT02289417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028441|NCT02289417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028442|NCT02289417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028443|NCT02289417|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92028444|NCT02289417|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92028445|NCT02289417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985076|NCT01729091|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91985077|NCT01729091|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91985078|NCT01729091|Growth Substances|growth substances|mesh-ancestor
91985079|NCT01729091|Growth Inhibitors|growth inhibitors|mesh-ancestor
91985080|NCT01729091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028446|NCT02289417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028448|NCT02512861|Anesthetics, Local|anesthetics, local|mesh-ancestor
92028449|NCT02512861|Anesthetics|anesthetics|mesh-ancestor
92028450|NCT02512861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028451|NCT02512861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028452|NCT02512861|Sensory System Agents|sensory system agents|mesh-ancestor
92028453|NCT02512861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028454|NCT04979611|Exenatide|exenatide|mesh-list
92028455|NCT04979611|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028456|NCT04979611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028457|NCT04979611|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92028458|NCT04979611|Incretins|incretins|mesh-ancestor
92028459|NCT04979611|Hormones|hormones|mesh-ancestor
92028460|NCT04979611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028461|NCT04979065|Vitamin D|vitamin d|mesh-list
92028462|NCT04979065|Vitamins|vitamins|mesh-ancestor
92028463|NCT04979065|Micronutrients|micronutrients|mesh-ancestor
92028464|NCT04979065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028465|NCT04979065|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92028466|NCT02288325|Milnacipran|milnacipran|mesh-list
92028467|NCT02288325|Levomilnacipran|levomilnacipran|mesh-list
92028468|NCT02288325|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92028469|NCT02288325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92028470|NCT02288325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92028471|NCT02288325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028472|NCT02288325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028473|NCT02288325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028474|NCT02288325|Antidepressive Agents|antidepressive agents|mesh-ancestor
92028475|NCT02288325|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92028476|NCT02288325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028477|NCT02288325|Analgesics|analgesics|mesh-ancestor
92028478|NCT02288325|Sensory System Agents|sensory system agents|mesh-ancestor
92028479|NCT02288325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028480|NCT04978051|Icatibant|icatibant|mesh-list
92028481|NCT04978051|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92028482|NCT04978051|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028483|NCT04978051|Analgesics|analgesics|mesh-ancestor
92028484|NCT04978051|Sensory System Agents|sensory system agents|mesh-ancestor
92028485|NCT04978051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028486|NCT04978051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028487|NCT04978051|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028488|NCT04978051|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028489|NCT04978051|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92028490|NCT04978051|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92028491|NCT04978051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028492|NCT04978051|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92028493|NCT04978051|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028494|NCT04978051|Immunologic Factors|immunologic factors|mesh-ancestor
92028495|NCT04214353|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92028496|NCT04214353|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92028497|NCT04214353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028498|NCT05010421|Clobetasol|clobetasol|mesh-list
92028499|NCT05010421|Emollients|emollients|mesh-list
92028500|NCT05010421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028501|NCT05010421|Glucocorticoids|glucocorticoids|mesh-ancestor
92028502|NCT05010421|Hormones|hormones|mesh-ancestor
92028503|NCT05010421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028504|NCT05010421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028505|NCT05010421|Dermatologic Agents|dermatologic agents|mesh-ancestor
92028507|NCT02504827|Avibactam|avibactam|mesh-list
92028508|NCT02504827|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
91985081|NCT01729091|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91985082|NCT01729091|Alkylating Agents|alkylating agents|mesh-ancestor
91985083|NCT01729091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985084|NCT01729091|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91985085|NCT01729091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985086|NCT04205903|Paclitaxel|paclitaxel|mesh-list
91985087|NCT04205903|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
91985088|NCT04205903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91985089|NCT04205903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985090|NCT04205903|Tubulin Modulators|tubulin modulators|mesh-ancestor
91985091|NCT04205903|Antimitotic Agents|antimitotic agents|mesh-ancestor
91985092|NCT04205903|Mitosis Modulators|mitosis modulators|mesh-ancestor
91985093|NCT04205903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985095|NCT01515527|Decitabine|decitabine|mesh-list
91985096|NCT01515527|Cladribine|cladribine|mesh-list
91985097|NCT01515527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91985098|NCT01515527|Antimetabolites|antimetabolites|mesh-ancestor
91985099|NCT01515527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985100|NCT01515527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985101|NCT01515527|Antiviral Agents|antiviral agents|mesh-ancestor
91985102|NCT01515527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985103|NCT01515527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985104|NCT01515527|Immunologic Factors|immunologic factors|mesh-ancestor
91985105|NCT01515527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985106|NCT01515527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985107|NCT02670551|Cariprazine|cariprazine|mesh-list
92028509|NCT02504827|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028510|NCT02504827|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028511|NCT02504827|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92028512|NCT02504827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028513|NCT02504827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028514|NCT02504671|Folic Acid|folic acid|mesh-list
92028515|NCT02504671|Hematinics|hematinics|mesh-ancestor
92028516|NCT02504671|Vitamin B Complex|vitamin b complex|mesh-ancestor
92028517|NCT02504671|Vitamins|vitamins|mesh-ancestor
92028518|NCT02504671|Micronutrients|micronutrients|mesh-ancestor
92028519|NCT02504671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028520|NCT02314143|Trametinib|trametinib|mesh-list
92028521|NCT02314143|Dabrafenib|dabrafenib|mesh-list
92028522|NCT02314143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028523|NCT02314143|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028524|NCT02314143|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028525|NCT02314143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028526|NCT02503501|Insulin glulisine|insulin glulisine|mesh-list
92028527|NCT02503501|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028528|NCT02503501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028529|NCT05007613|Atezolizumab|atezolizumab|mesh-list
92028530|NCT05007613|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91985108|NCT02670551|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91985109|NCT02670551|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91985110|NCT02670551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985111|NCT02670551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985112|NCT02670551|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91985113|NCT01430351|Metformin|metformin|mesh-list
91985114|NCT01430351|Mefloquine|mefloquine|mesh-list
91985115|NCT01430351|Temozolomide|temozolomide|mesh-list
91985116|NCT01430351|Memantine|memantine|mesh-list
91985117|NCT01430351|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91985118|NCT01430351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985119|NCT01430351|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91985120|NCT01430351|Alkylating Agents|alkylating agents|mesh-ancestor
91985121|NCT01430351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028531|NCT05007613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028532|NCT05007613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028533|NCT05007613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028534|NCT04970407|Botulinum Toxins|botulinum toxins|mesh-list
92028535|NCT04970407|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92028536|NCT04970407|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92028537|NCT04970407|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92028538|NCT04970407|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92028539|NCT04970407|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92028540|NCT04970407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028541|NCT04970407|Cholinergic Agents|cholinergic agents|mesh-ancestor
92028542|NCT04970407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028543|NCT04970407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028544|NCT04970407|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92028545|NCT04970407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028547|NCT02501629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92028548|NCT02501629|Respiratory System Agents|respiratory system agents|mesh-ancestor
92028549|NCT02501473|Rituximab|rituximab|mesh-list
92028550|NCT02501473|Pembrolizumab|pembrolizumab|mesh-list
92028551|NCT02501473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028552|NCT02501473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028553|NCT02501473|Immunologic Factors|immunologic factors|mesh-ancestor
92028554|NCT02501473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028555|NCT02501473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028556|NCT02501473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92028557|NCT02501473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028558|NCT02501161|Insulin|insulin|mesh-list
92028559|NCT02501161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92028561|NCT02501161|Liraglutide|liraglutide|mesh-list
92028562|NCT02501161|Xultophy|xultophy|mesh-list
92028563|NCT02501161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028564|NCT02501161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028565|NCT02501161|Incretins|incretins|mesh-ancestor
92028566|NCT02501161|Hormones|hormones|mesh-ancestor
92028567|NCT02501161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028568|NCT04966585|Posaconazole|posaconazole|mesh-list
92028569|NCT04966585|Antifungal Agents|antifungal agents|mesh-ancestor
92028570|NCT04966585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028571|NCT04966585|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92028572|NCT04966585|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92028573|NCT04966585|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92028574|NCT04966585|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92028575|NCT04966585|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92028576|NCT04966585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985122|NCT01430351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985123|NCT01430351|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91985124|NCT01430351|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91985125|NCT01430351|Dopamine Agents|dopamine agents|mesh-ancestor
91985126|NCT01430351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985127|NCT01430351|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91985128|NCT01430351|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91985129|NCT01430351|Antimalarials|antimalarials|mesh-ancestor
91985130|NCT01430351|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91985131|NCT01430351|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91985132|NCT01430351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985133|NCT00893399|Gemtuzumab|gemtuzumab|mesh-list
91985134|NCT00893399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028577|NCT04966585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028578|NCT04966585|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92028579|NCT04966585|Hormone Antagonists|hormone antagonists|mesh-ancestor
92028580|NCT04966585|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028593|NCT04205539|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028594|NCT04205539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028595|NCT04205539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028597|NCT02313909|Rivaroxaban|rivaroxaban|mesh-list
92028598|NCT02313909|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92028599|NCT02313909|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028600|NCT02313909|Analgesics|analgesics|mesh-ancestor
92028601|NCT02313909|Sensory System Agents|sensory system agents|mesh-ancestor
92028602|NCT02313909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028603|NCT02313909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028604|NCT02313909|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028605|NCT02313909|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028606|NCT02313909|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92028607|NCT02313909|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92028608|NCT02313909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028609|NCT02313909|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92028610|NCT02313909|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92028611|NCT02313909|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028612|NCT02313909|Antipyretics|antipyretics|mesh-ancestor
92028613|NCT02313909|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92028614|NCT02313909|Antithrombins|antithrombins|mesh-ancestor
92028615|NCT02313909|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92028616|NCT02313909|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028617|NCT02313909|Anticoagulants|anticoagulants|mesh-ancestor
92028618|NCT02287467|Immunoglobulins|immunoglobulins|mesh-list
92028619|NCT02287467|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92028620|NCT02287467|Antibodies|antibodies|mesh-list
92028621|NCT02287467|gamma-Globulins|gamma-globulins|mesh-list
92028622|NCT02287467|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92028623|NCT02287467|Immunologic Factors|immunologic factors|mesh-ancestor
92028624|NCT02287467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028625|NCT02287233|Cytarabine|cytarabine|mesh-list
92028626|NCT02287233|Venetoclax|venetoclax|mesh-list
92028627|NCT02287233|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92028628|NCT02287233|Antimetabolites|antimetabolites|mesh-ancestor
92028629|NCT02287233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028630|NCT02287233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028631|NCT02287233|Antiviral Agents|antiviral agents|mesh-ancestor
92028632|NCT02287233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028633|NCT02287233|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028634|NCT02287233|Immunologic Factors|immunologic factors|mesh-ancestor
92028635|NCT02287233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028636|NCT01646385|Etanercept|etanercept|mesh-list
92028637|NCT01646385|Antirheumatic Agents|antirheumatic agents|mesh-list
92028638|NCT01646385|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91985135|NCT00893399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985136|NCT00893399|Immunotoxins|immunotoxins|mesh-ancestor
91985137|NCT00893399|Immunoconjugates|immunoconjugates|mesh-ancestor
92028639|NCT01646385|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028640|NCT01646385|Analgesics|analgesics|mesh-ancestor
92028641|NCT01646385|Sensory System Agents|sensory system agents|mesh-ancestor
92028642|NCT01646385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028653|NCT02281773|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92028654|NCT02281773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028655|NCT02281773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028656|NCT02354235|Canagliflozin|canagliflozin|mesh-list
92028657|NCT02354235|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92028658|NCT02354235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028659|NCT02354235|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028660|NCT02354235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028661|NCT02284893|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92028662|NCT02284893|Dapagliflozin|dapagliflozin|mesh-list
92028663|NCT02284893|Saxagliptin|saxagliptin|mesh-list
92028664|NCT02284893|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92028665|NCT02284893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028666|NCT02284893|Incretins|incretins|mesh-ancestor
92028667|NCT02284893|Hormones|hormones|mesh-ancestor
92028668|NCT02284893|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028669|NCT02284893|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92028670|NCT02284893|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028671|NCT02284893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028672|NCT02284893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028673|NCT02284893|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92028674|NCT04965181|Nicotine|nicotine|mesh-list
92028675|NCT04965181|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92028676|NCT04965181|Autonomic Agents|autonomic agents|mesh-ancestor
92028677|NCT04965181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028678|NCT04965181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028679|NCT04965181|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92028680|NCT04965181|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92028681|NCT04965181|Cholinergic Agents|cholinergic agents|mesh-ancestor
92028682|NCT04965181|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028683|NCT04965181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028684|NCT02483611|Lidocaine|lidocaine|mesh-list
92028685|NCT02483611|Magnesium Sulfate|magnesium sulfate|mesh-list
92028686|NCT02483611|Cisatracurium|cisatracurium|mesh-list
92028687|NCT02483611|Anesthetics, Local|anesthetics, local|mesh-ancestor
92028688|NCT02483611|Anesthetics|anesthetics|mesh-ancestor
92028689|NCT02483611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028690|NCT02483611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028691|NCT02483611|Sensory System Agents|sensory system agents|mesh-ancestor
92028692|NCT02483611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028693|NCT02483611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92028694|NCT02483611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92028695|NCT02483611|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92028696|NCT02483611|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92028697|NCT02483611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028698|NCT02483611|Analgesics|analgesics|mesh-ancestor
92028699|NCT02483611|Anticonvulsants|anticonvulsants|mesh-ancestor
92028700|NCT02483611|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92028701|NCT02483611|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92028702|NCT02483611|Tocolytic Agents|tocolytic agents|mesh-ancestor
92028703|NCT02483611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92028704|NCT02483611|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92028705|NCT02483611|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92028708|NCT02482129|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92028709|NCT02482129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028710|NCT02482129|Antiemetics|antiemetics|mesh-ancestor
92028711|NCT02482129|Autonomic Agents|autonomic agents|mesh-ancestor
92028712|NCT02482129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028713|NCT02482129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028714|NCT02482129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028715|NCT02482129|Glucocorticoids|glucocorticoids|mesh-ancestor
92028716|NCT02482129|Hormones|hormones|mesh-ancestor
92028717|NCT02482129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985138|NCT00893399|Immunologic Factors|immunologic factors|mesh-ancestor
91985139|NCT00893399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985140|NCT05675033|Bevacizumab|bevacizumab|mesh-list
91985141|NCT05675033|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91985142|NCT05675033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028718|NCT02482129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028719|NCT02482129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028720|NCT02495857|Hyaluronic Acid|hyaluronic acid|mesh-list
92028721|NCT02495857|Viscosupplements|viscosupplements|mesh-list
92028722|NCT02495857|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92028723|NCT02495857|Immunologic Factors|immunologic factors|mesh-ancestor
92028724|NCT02495857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028725|NCT02495857|Protective Agents|protective agents|mesh-ancestor
92028726|NCT02495389|Mirabegron|mirabegron|mesh-list
92028727|NCT02495389|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92028728|NCT02495389|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92028729|NCT02495389|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92028730|NCT02495389|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028731|NCT02495389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028732|NCT02495389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028733|NCT02495389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028734|NCT02495389|Urological Agents|urological agents|mesh-ancestor
92028735|NCT02495233|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92028736|NCT02495233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028737|NCT02495233|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028738|NCT02495233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028739|NCT02495233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028740|NCT02495077|Acetaminophen|acetaminophen|mesh-list
92028741|NCT02495077|Diphenhydramine|diphenhydramine|mesh-list
92028742|NCT02495077|Promethazine|promethazine|mesh-list
92028743|NCT02495077|Loratadine|loratadine|mesh-list
92028744|NCT02495077|Mycophenolic Acid|mycophenolic acid|mesh-list
92028745|NCT02495077|Prednisone|prednisone|mesh-list
92028746|NCT02495077|Methylprednisolone|methylprednisolone|mesh-list
92028747|NCT02495077|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92028748|NCT02495077|Infliximab|infliximab|mesh-list
92028749|NCT02495077|Tacrolimus|tacrolimus|mesh-list
92028750|NCT02495077|Thymoglobulin|thymoglobulin|mesh-list
92028751|NCT02495077|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92028752|NCT02495077|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028753|NCT02495077|Glucocorticoids|glucocorticoids|mesh-ancestor
92028754|NCT02495077|Hormones|hormones|mesh-ancestor
92028755|NCT02495077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028756|NCT02495077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028757|NCT02495077|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028758|NCT02495077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028759|NCT02495077|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028760|NCT02495077|Immunologic Factors|immunologic factors|mesh-ancestor
92028761|NCT02495077|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92028762|NCT02495077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028763|NCT02495077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028764|NCT02495077|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028765|NCT02495077|Analgesics|analgesics|mesh-ancestor
92028766|NCT02495077|Sensory System Agents|sensory system agents|mesh-ancestor
92028767|NCT02495077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028768|NCT02495077|Antipyretics|antipyretics|mesh-ancestor
92028769|NCT02495077|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92028770|NCT02495077|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92028771|NCT02495077|Antitubercular Agents|antitubercular agents|mesh-ancestor
92028772|NCT02495077|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028773|NCT02495077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028774|NCT02495077|Antiemetics|antiemetics|mesh-ancestor
92028775|NCT02495077|Autonomic Agents|autonomic agents|mesh-ancestor
92028776|NCT02495077|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028777|NCT02495077|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92028778|NCT02495077|Protective Agents|protective agents|mesh-ancestor
92028779|NCT02495077|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92028780|NCT02495077|Dermatologic Agents|dermatologic agents|mesh-ancestor
92028781|NCT02495077|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028782|NCT02495077|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92028793|NCT02495077|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
91985143|NCT05675033|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91985144|NCT05675033|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91985145|NCT05675033|Growth Substances|growth substances|mesh-ancestor
92028794|NCT02278341|Epoetin Alfa|epoetin alfa|mesh-list
92028795|NCT02278341|Darbepoetin alfa|darbepoetin alfa|mesh-list
92028796|NCT02278341|Hematinics|hematinics|mesh-ancestor
92028797|NCT02278263|Tranexamic Acid|tranexamic acid|mesh-list
92028798|NCT02278263|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92028799|NCT02278263|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92028800|NCT02278263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028801|NCT02278263|Hemostatics|hemostatics|mesh-ancestor
92028802|NCT02278263|Coagulants|coagulants|mesh-ancestor
92028804|NCT02494921|Docetaxel|docetaxel|mesh-list
92028805|NCT02494921|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028806|NCT02494921|Tubulin Modulators|tubulin modulators|mesh-ancestor
92028807|NCT02494921|Antimitotic Agents|antimitotic agents|mesh-ancestor
92028808|NCT02494921|Mitosis Modulators|mitosis modulators|mesh-ancestor
92028809|NCT02494921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028810|NCT02494921|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028811|NCT02494921|Glucocorticoids|glucocorticoids|mesh-ancestor
92028812|NCT02494921|Hormones|hormones|mesh-ancestor
92028813|NCT02494921|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028814|NCT02494921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028815|NCT02494921|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028816|NCT01653847|Mycophenolic Acid|mycophenolic acid|mesh-list
92028817|NCT01653847|Everolimus|everolimus|mesh-list
92028818|NCT01653847|Tacrolimus|tacrolimus|mesh-list
92028819|NCT01653847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028820|NCT01653847|Immunologic Factors|immunologic factors|mesh-ancestor
92028821|NCT01653847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028822|NCT01653847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92028823|NCT01653847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028824|NCT01653847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028825|NCT01653847|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92028826|NCT01653847|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028827|NCT01653847|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028828|NCT01653847|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92028829|NCT01653847|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92028830|NCT01653847|Antitubercular Agents|antitubercular agents|mesh-ancestor
92028831|NCT01653847|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028832|NCT01653847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028834|NCT02493751|Axitinib|axitinib|mesh-list
92028835|NCT02493751|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028836|NCT02493751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028837|NCT02493751|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92028838|NCT02493751|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028839|NCT02493751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028840|NCT02493517|Lanreotide|lanreotide|mesh-list
92028841|NCT02493517|Somatostatin|somatostatin|mesh-list
92028842|NCT02493517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028843|NCT02493517|Hormones|hormones|mesh-ancestor
92028844|NCT02493517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028845|NCT02493517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028846|NCT02493361|Pembrolizumab|pembrolizumab|mesh-list
92028847|NCT02493361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028848|NCT02493361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028858|NCT04959331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028859|NCT04959331|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92028860|NCT02478463|Cabotegravir|cabotegravir|mesh-list
92028861|NCT02478463|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92028862|NCT02478463|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92028864|NCT02478463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028865|NCT02478463|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92028866|NCT02478463|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92028867|NCT02478463|Antiviral Agents|antiviral agents|mesh-ancestor
92028868|NCT02478463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028869|NCT02491411|Dexamethasone|dexamethasone|mesh-list
92028870|NCT02491411|Dexamethasone acetate|dexamethasone acetate|mesh-list
92028871|NCT02491411|Ichthammol|ichthammol|mesh-list
92028872|NCT02491411|BB 1101|bb 1101|mesh-list
92028873|NCT02491411|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028874|NCT02491411|Antiemetics|antiemetics|mesh-ancestor
91985146|NCT05675033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985147|NCT05675033|Growth Inhibitors|growth inhibitors|mesh-ancestor
91985149|NCT04103489|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92028875|NCT02491411|Autonomic Agents|autonomic agents|mesh-ancestor
92028876|NCT02491411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028877|NCT02491411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028878|NCT02491411|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028879|NCT02491411|Glucocorticoids|glucocorticoids|mesh-ancestor
92028880|NCT02491411|Hormones|hormones|mesh-ancestor
92028881|NCT02491411|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028882|NCT02491411|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028883|NCT02491411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028884|NCT02491411|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028885|NCT02491411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028886|NCT02491411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028887|NCT02491411|Dermatologic Agents|dermatologic agents|mesh-ancestor
92028888|NCT02517463|Ulipristal acetate|ulipristal acetate|mesh-list
92028889|NCT02517463|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92028890|NCT02517463|Contraceptive Agents|contraceptive agents|mesh-ancestor
92028891|NCT02517463|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92028892|NCT02517463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028893|NCT02517463|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92028894|NCT02490475|Docetaxel|docetaxel|mesh-list
92028895|NCT02490475|Pertuzumab|pertuzumab|mesh-list
92028896|NCT02490475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028897|NCT02490475|Tubulin Modulators|tubulin modulators|mesh-ancestor
92028898|NCT02490475|Antimitotic Agents|antimitotic agents|mesh-ancestor
92028899|NCT02490475|Mitosis Modulators|mitosis modulators|mesh-ancestor
92028900|NCT02490475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028901|NCT02490475|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028902|NCT02477839|Lacosamide|lacosamide|mesh-list
92028903|NCT02477839|Anticonvulsants|anticonvulsants|mesh-ancestor
92028904|NCT02477839|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92028905|NCT02477839|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92028906|NCT02477839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92028907|NCT02477839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028908|NCT04939987|Acetaminophen|acetaminophen|mesh-list
92028909|NCT04939987|Ketorolac|ketorolac|mesh-list
92028910|NCT04939987|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92028911|NCT04939987|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92028912|NCT04939987|Ketamine|ketamine|mesh-list
92028913|NCT04939987|Oxycodone|oxycodone|mesh-list
92028914|NCT04939987|Gabapentin|gabapentin|mesh-list
92028916|NCT04939987|Hydrocodone|hydrocodone|mesh-list
92028917|NCT04939987|Analgesics, Opioid|analgesics, opioid|mesh-list
92028927|NCT04939987|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92028928|NCT04939987|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92028929|NCT04939987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028930|NCT04939987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028931|NCT04939987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028932|NCT04939987|Antipyretics|antipyretics|mesh-ancestor
92028933|NCT04939987|Narcotics|narcotics|mesh-ancestor
92028934|NCT04939987|Anticonvulsants|anticonvulsants|mesh-ancestor
92028935|NCT04939987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92028936|NCT04939987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92028937|NCT04939987|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92028938|NCT04939987|Antimanic Agents|antimanic agents|mesh-ancestor
92028939|NCT04939987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92028940|NCT04939987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028941|NCT04939987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92028943|NCT04939987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028944|NCT04939987|Antitussive Agents|antitussive agents|mesh-ancestor
92028945|NCT04939987|Respiratory System Agents|respiratory system agents|mesh-ancestor
92028946|NCT02477527|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92028947|NCT02477527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92028948|NCT02477527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92028949|NCT02477527|Antiviral Agents|antiviral agents|mesh-ancestor
92028950|NCT02477527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028951|NCT02477215|Dexamethasone|dexamethasone|mesh-list
91985150|NCT04103489|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985151|NCT04103489|Immunologic Factors|immunologic factors|mesh-ancestor
91985152|NCT04103489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985153|NCT04479527|Apatinib|apatinib|mesh-list
91985154|NCT04479527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028952|NCT02477215|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92028953|NCT02477215|Ixazomib|ixazomib|mesh-list
92028954|NCT02477215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028955|NCT02477215|Antiemetics|antiemetics|mesh-ancestor
92028956|NCT02477215|Autonomic Agents|autonomic agents|mesh-ancestor
92029179|NCT02444533|Anesthetics|anesthetics|mesh-ancestor
92028957|NCT02477215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028958|NCT02477215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028959|NCT02477215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028960|NCT02477215|Glucocorticoids|glucocorticoids|mesh-ancestor
92028961|NCT02477215|Hormones|hormones|mesh-ancestor
92028962|NCT02477215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028963|NCT02477215|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028964|NCT02477215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028965|NCT02477215|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92028966|NCT02477215|Alkylating Agents|alkylating agents|mesh-ancestor
92028967|NCT02477215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028968|NCT02477215|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028969|NCT02477215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028970|NCT02487199|Ritonavir|ritonavir|mesh-list
92028971|NCT02487199|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92028972|NCT02487199|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92028973|NCT02487199|Protease Inhibitors|protease inhibitors|mesh-ancestor
92028974|NCT02487199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028975|NCT02487199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028976|NCT02487199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92028977|NCT02487199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92028978|NCT02487199|Antiviral Agents|antiviral agents|mesh-ancestor
92028979|NCT02487199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028980|NCT02487199|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92028981|NCT02487199|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92028982|NCT02475733|Metronidazole|metronidazole|mesh-list
92028987|NCT02475733|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028988|NCT02475733|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028989|NCT02475733|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92028990|NCT02475733|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92028991|NCT02475733|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92028992|NCT02475733|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92028993|NCT02475733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028994|NCT02486653|Tamsulosin|tamsulosin|mesh-list
92028995|NCT02486653|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92028996|NCT02486653|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92028997|NCT02486653|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92028998|NCT02486653|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028999|NCT02486653|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029000|NCT02486653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029001|NCT02486653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029002|NCT02486653|Urological Agents|urological agents|mesh-ancestor
92029003|NCT02475265|Levonorgestrel|levonorgestrel|mesh-list
92029004|NCT02475265|Estradiol|estradiol|mesh-list
92029005|NCT02475265|Estrogens|estrogens|mesh-ancestor
92029006|NCT02475265|Hormones|hormones|mesh-ancestor
92029007|NCT02475265|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029008|NCT02475265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029009|NCT02475265|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92029010|NCT02475265|Contraceptive Agents|contraceptive agents|mesh-ancestor
92029011|NCT02475265|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92029012|NCT02475265|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92029013|NCT02475265|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92029014|NCT02475265|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92029015|NCT02450539|Docetaxel|docetaxel|mesh-list
92029016|NCT02450539|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029017|NCT02450539|Tubulin Modulators|tubulin modulators|mesh-ancestor
92029018|NCT02450539|Antimitotic Agents|antimitotic agents|mesh-ancestor
91985155|NCT04479527|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985156|NCT04479527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985157|NCT04479527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985158|NCT02391077|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92029019|NCT02450539|Mitosis Modulators|mitosis modulators|mesh-ancestor
92029020|NCT02450539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029021|NCT02449915|Bupivacaine|bupivacaine|mesh-list
92029022|NCT02449915|Anesthetics, Local|anesthetics, local|mesh-ancestor
92029023|NCT02449915|Anesthetics|anesthetics|mesh-ancestor
92029024|NCT02449915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029025|NCT02449915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029026|NCT02449915|Sensory System Agents|sensory system agents|mesh-ancestor
92029027|NCT02449915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029028|NCT02472847|Dronabinol|dronabinol|mesh-list
92029029|NCT02472847|Hallucinogens|hallucinogens|mesh-ancestor
92029255|NCT05561361|Natriuretic Agents|natriuretic agents|mesh-ancestor
92029030|NCT02472847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029031|NCT02472847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029032|NCT02472847|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92029033|NCT02472847|Analgesics|analgesics|mesh-ancestor
92029034|NCT02472847|Sensory System Agents|sensory system agents|mesh-ancestor
92029035|NCT02472847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029036|NCT02472847|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92029037|NCT02472847|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92029038|NCT02472847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029039|NCT02472847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029040|NCT02472847|Hormones|hormones|mesh-ancestor
92029041|NCT02472847|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029042|NCT02472145|Decitabine|decitabine|mesh-list
92029043|NCT02472145|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029044|NCT02472145|Antimetabolites|antimetabolites|mesh-ancestor
92029045|NCT02472145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029046|NCT02472145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029047|NCT02472145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029048|NCT02418949|Cyproheptadine|cyproheptadine|mesh-list
92029049|NCT02418949|Antipruritics|antipruritics|mesh-ancestor
92029050|NCT02418949|Dermatologic Agents|dermatologic agents|mesh-ancestor
92029051|NCT02418949|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029052|NCT02418949|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92029053|NCT02418949|Histamine Antagonists|histamine antagonists|mesh-ancestor
92029057|NCT02418949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029058|NCT02418949|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92029059|NCT02418949|Serotonin Agents|serotonin agents|mesh-ancestor
92029060|NCT02418949|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92029061|NCT04912765|Nivolumab|nivolumab|mesh-list
92029062|NCT04912765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029063|NCT04912765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029064|NCT04912765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029065|NCT04912765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029067|NCT02448043|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92029068|NCT02447887|Interferon alpha-2|interferon alpha-2|mesh-list
92029069|NCT02447887|Ixazomib|ixazomib|mesh-list
92029070|NCT02447887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029071|NCT02447887|Protease Inhibitors|protease inhibitors|mesh-ancestor
92029072|NCT02447887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029073|NCT02447887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029074|NCT02447887|Antiviral Agents|antiviral agents|mesh-ancestor
92029075|NCT02447887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029076|NCT02470429|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92029077|NCT02470429|Lubricant Eye Drops|lubricant eye drops|mesh-list
92029078|NCT02470429|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92029079|NCT02417935|Pregabalin|pregabalin|mesh-list
92029080|NCT02417935|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92029081|NCT02417935|Analgesics|analgesics|mesh-ancestor
92029082|NCT02417935|Sensory System Agents|sensory system agents|mesh-ancestor
92029083|NCT02417935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029084|NCT02417935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029085|NCT02417935|Anticonvulsants|anticonvulsants|mesh-ancestor
92029086|NCT02417935|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92029087|NCT02417935|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985159|NCT02391077|Chlorhexidine|chlorhexidine|mesh-list
91985160|NCT02391077|Povidone-Iodine|povidone-iodine|mesh-list
91985162|NCT02391077|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985163|NCT02391077|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92029088|NCT02417935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029089|NCT02417935|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92029090|NCT02417935|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92029091|NCT02417935|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92029092|NCT02417935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029093|NCT02417935|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029094|NCT02417935|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92029095|NCT02417935|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92029096|NCT02417935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029097|NCT02417935|Antidepressive Agents|antidepressive agents|mesh-ancestor
92029098|NCT02417935|Dopamine Agents|dopamine agents|mesh-ancestor
92029099|NCT02447029|Lidocaine|lidocaine|mesh-list
92029100|NCT02447029|Anesthetics, Local|anesthetics, local|mesh-ancestor
92029101|NCT02447029|Anesthetics|anesthetics|mesh-ancestor
92029102|NCT02447029|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029103|NCT02447029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029104|NCT02447029|Sensory System Agents|sensory system agents|mesh-ancestor
92029105|NCT02447029|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029106|NCT02447029|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92029107|NCT02447029|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92029108|NCT02447029|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92029109|NCT02447029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029110|NCT02447029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029111|NCT02416453|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92029112|NCT02416453|Antiviral Agents|antiviral agents|mesh-ancestor
92029113|NCT02416453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029114|NCT02469961|Dexmedetomidine|dexmedetomidine|mesh-list
92029115|NCT02469961|Propofol|propofol|mesh-list
92029116|NCT02469961|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92029117|NCT02469961|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029118|NCT02469961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029119|NCT02469961|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92029120|NCT02469961|Analgesics|analgesics|mesh-ancestor
92029121|NCT02469961|Sensory System Agents|sensory system agents|mesh-ancestor
92029122|NCT02469961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029123|NCT02469961|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92029128|NCT02469961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029129|NCT02469961|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92029130|NCT02469961|Anesthetics, General|anesthetics, general|mesh-ancestor
92029131|NCT02469961|Anesthetics|anesthetics|mesh-ancestor
92029132|NCT02415595|BMS-955176|bms-955176|mesh-list
92029133|NCT02415595|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92029134|NCT02415595|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92029135|NCT02415595|Antiviral Agents|antiviral agents|mesh-ancestor
92029136|NCT02415595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029137|NCT02446717|Ribavirin|ribavirin|mesh-list
92029138|NCT02446717|Antimetabolites|antimetabolites|mesh-ancestor
92029139|NCT02446717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029140|NCT02446717|Antiviral Agents|antiviral agents|mesh-ancestor
92029141|NCT02446717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029142|NCT02469415|Azacitidine|azacitidine|mesh-list
92029143|NCT02469415|Decitabine|decitabine|mesh-list
92029144|NCT02469415|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029145|NCT02469415|Antimetabolites|antimetabolites|mesh-ancestor
92029146|NCT02469415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029147|NCT02469415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029148|NCT02469415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029149|NCT02446171|Naloxegol|naloxegol|mesh-list
92029150|NCT02446171|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92029151|NCT02446171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029152|NCT02446171|Sensory System Agents|sensory system agents|mesh-ancestor
92029153|NCT02446171|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029154|NCT02446015|Ophthalmic Solutions|ophthalmic solutions|mesh-list
91985165|NCT02391077|Plasma Substitutes|plasma substitutes|mesh-ancestor
91985166|NCT02391077|Blood Substitutes|blood substitutes|mesh-ancestor
91985167|NCT02390921|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
91985168|NCT02390921|Hematinics|hematinics|mesh-ancestor
91985169|NCT02390843|Cyclophosphamide|cyclophosphamide|mesh-list
91985170|NCT02390843|Topotecan|topotecan|mesh-list
92029155|NCT02446015|Lubricant Eye Drops|lubricant eye drops|mesh-list
92029156|NCT02446015|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92029157|NCT02415127|Interferons|interferons|mesh-list
92029158|NCT02415127|Interferon-gamma|interferon-gamma|mesh-list
92029159|NCT02415127|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029160|NCT02415127|Antiviral Agents|antiviral agents|mesh-ancestor
92029161|NCT02415127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029162|NCT02468557|Paclitaxel|paclitaxel|mesh-list
92029163|NCT02468557|Idelalisib|idelalisib|mesh-list
92029164|NCT02468557|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92029165|NCT02468557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029166|NCT02468557|Tubulin Modulators|tubulin modulators|mesh-ancestor
92029167|NCT02468557|Antimitotic Agents|antimitotic agents|mesh-ancestor
92029168|NCT02468557|Mitosis Modulators|mitosis modulators|mesh-ancestor
92029169|NCT02468557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029170|NCT02468557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029171|NCT02413489|Daratumumab|daratumumab|mesh-list
92029172|NCT02413489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029173|NCT02413333|Contact Lens Solutions|contact lens solutions|mesh-list
92029174|NCT02413333|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92029175|NCT02413333|Disinfectants|disinfectants|mesh-ancestor
92029176|NCT02413333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029177|NCT02444533|Bupivacaine|bupivacaine|mesh-list
92029178|NCT02444533|Anesthetics, Local|anesthetics, local|mesh-ancestor
92029180|NCT02444533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029181|NCT02444533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029182|NCT02444533|Sensory System Agents|sensory system agents|mesh-ancestor
92029183|NCT02444533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029184|NCT01651039|Dexamethasone|dexamethasone|mesh-list
92029185|NCT01651039|Lenalidomide|lenalidomide|mesh-list
92029186|NCT01651039|Panobinostat|panobinostat|mesh-list
92029187|NCT01651039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029188|NCT01651039|Antiemetics|antiemetics|mesh-ancestor
92029190|NCT01651039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029191|NCT01651039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029192|NCT01651039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029193|NCT01651039|Glucocorticoids|glucocorticoids|mesh-ancestor
92029194|NCT01651039|Hormones|hormones|mesh-ancestor
92029195|NCT01651039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029196|NCT01651039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92029199|NCT01651039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92029200|NCT01651039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92029201|NCT01651039|Growth Substances|growth substances|mesh-ancestor
92029202|NCT01651039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92029203|NCT01651039|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92029204|NCT01651039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029205|NCT01651039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029207|NCT02349633|Avelumab|avelumab|mesh-list
92029208|NCT02349633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029209|NCT02349633|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92029210|NCT02349633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029211|NCT02349633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029212|NCT02349633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029213|NCT02275611|Oxytocin|oxytocin|mesh-list
92029214|NCT02275611|Oxytocics|oxytocics|mesh-ancestor
92029215|NCT02275611|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92029216|NCT02275611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029217|NCT04875585|Pembrolizumab|pembrolizumab|mesh-list
92029218|NCT04875585|Lenvatinib|lenvatinib|mesh-list
92029219|NCT04875585|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029220|NCT04875585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029221|NCT04875585|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91985171|NCT02390843|Simvastatin|simvastatin|mesh-list
91985172|NCT02390843|Lenograstim|lenograstim|mesh-list
91985173|NCT02390843|Mitogens|mitogens|mesh-list
91985174|NCT02390843|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92029222|NCT04875585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029223|NCT04875585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92029224|NCT04875585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029225|NCT02273973|Letrozole|letrozole|mesh-list
92029227|NCT02273973|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92029228|NCT02273973|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92029229|NCT02273973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029230|NCT02273973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029231|NCT02273973|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92029232|NCT02273973|Hormone Antagonists|hormone antagonists|mesh-ancestor
92029233|NCT02273973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029234|NCT02273973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029235|NCT05649111|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92029236|NCT05649111|Difluprednate|difluprednate|mesh-list
92029237|NCT05649111|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92029238|NCT05649111|Glucocorticoids|glucocorticoids|mesh-ancestor
92029239|NCT05649111|Hormones|hormones|mesh-ancestor
92029240|NCT05649111|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029241|NCT05649111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029242|NCT02465515|rGLP-1 protein|rglp-1 protein|mesh-list
92029243|NCT02465515|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92029244|NCT02465515|Incretins|incretins|mesh-ancestor
92029245|NCT02465515|Hormones|hormones|mesh-ancestor
92029246|NCT02465515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029247|NCT02465515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029248|NCT05561361|Spironolactone|spironolactone|mesh-list
92029249|NCT05561361|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92029250|NCT05561361|Hormone Antagonists|hormone antagonists|mesh-ancestor
92029251|NCT05561361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029252|NCT05561361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029253|NCT05561361|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92029254|NCT05561361|Diuretics|diuretics|mesh-ancestor
92029256|NCT02412631|Varenicline|varenicline|mesh-list
92029257|NCT02412631|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92029258|NCT02412631|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92029259|NCT02412631|Cholinergic Agents|cholinergic agents|mesh-ancestor
92029260|NCT02412631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029261|NCT02412631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029262|NCT02412631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029263|NCT02272803|Dexamethasone|dexamethasone|mesh-list
92029264|NCT02272803|Lenalidomide|lenalidomide|mesh-list
92029265|NCT02272803|Elotuzumab|elotuzumab|mesh-list
92029266|NCT02272803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029267|NCT02272803|Antiemetics|antiemetics|mesh-ancestor
92029268|NCT02272803|Autonomic Agents|autonomic agents|mesh-ancestor
92029274|NCT02272803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029275|NCT02272803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92029276|NCT02272803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029277|NCT02272803|Immunologic Factors|immunologic factors|mesh-ancestor
92029278|NCT02272803|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92029279|NCT02272803|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92029280|NCT02272803|Growth Substances|growth substances|mesh-ancestor
92029281|NCT02272803|Growth Inhibitors|growth inhibitors|mesh-ancestor
92029282|NCT02272725|Ibuprofen|ibuprofen|mesh-list
92029283|NCT02272725|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92029284|NCT02272725|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92029285|NCT02272725|Analgesics|analgesics|mesh-ancestor
92029286|NCT02272725|Sensory System Agents|sensory system agents|mesh-ancestor
92029287|NCT02272725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029288|NCT02272725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029289|NCT02272725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029290|NCT02272725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029291|NCT02272725|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91985175|NCT02390843|Immunologic Factors|immunologic factors|mesh-ancestor
91985176|NCT02390843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029292|NCT02272725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029293|NCT02272725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029294|NCT01650805|Imatinib Mesylate|imatinib mesylate|mesh-list
92029295|NCT01650805|Ponatinib|ponatinib|mesh-list
92029296|NCT01650805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029297|NCT01650805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92029298|NCT01650805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029299|NCT01650805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029301|NCT02442349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029302|NCT02442349|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92029303|NCT02442349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029304|NCT02442349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029305|NCT02442271|Ritonavir|ritonavir|mesh-list
92029306|NCT02442271|Ribavirin|ribavirin|mesh-list
92029307|NCT02442271|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92029308|NCT02442271|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92029309|NCT02442271|Protease Inhibitors|protease inhibitors|mesh-ancestor
92029310|NCT02442271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029311|NCT02442271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029312|NCT02442271|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92029313|NCT02442271|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92029314|NCT02442271|Antiviral Agents|antiviral agents|mesh-ancestor
92029315|NCT02442271|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029316|NCT02442271|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92029317|NCT02442271|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92029318|NCT02442271|Antimetabolites|antimetabolites|mesh-ancestor
92029319|NCT02463409|Theophylline|theophylline|mesh-list
92029320|NCT02463409|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92029321|NCT02463409|Autonomic Agents|autonomic agents|mesh-ancestor
92029322|NCT02463409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029323|NCT02463409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029324|NCT02463409|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92029325|NCT02463409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92029326|NCT02463409|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92029327|NCT02463409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029328|NCT02463409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029329|NCT02463409|Vasodilator Agents|vasodilator agents|mesh-ancestor
92029330|NCT02463409|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92029331|NCT02463409|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92029332|NCT02463409|Purinergic Agents|purinergic agents|mesh-ancestor
92029333|NCT02463409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029334|NCT02528357|Pembrolizumab|pembrolizumab|mesh-list
92029335|NCT02528357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029336|NCT02528357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029338|NCT02528357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029340|NCT04910503|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92029341|NCT04910503|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029342|NCT04910503|Antiemetics|antiemetics|mesh-ancestor
92029343|NCT04910503|Autonomic Agents|autonomic agents|mesh-ancestor
92029344|NCT04910503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029345|NCT04910503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029346|NCT04910503|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029347|NCT04910503|Glucocorticoids|glucocorticoids|mesh-ancestor
92029348|NCT04910503|Hormones|hormones|mesh-ancestor
92029349|NCT04910503|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029350|NCT04910503|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92029351|NCT04910503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029352|NCT04910425|Fluorides|fluorides|mesh-list
92029353|NCT04910425|Cariostatic Agents|cariostatic agents|mesh-ancestor
92029354|NCT04910425|Protective Agents|protective agents|mesh-ancestor
92029355|NCT04910425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029356|NCT02463331|Chloroquine|chloroquine|mesh-list
92029357|NCT02463331|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92029358|NCT02463331|Prednisone|prednisone|mesh-list
92029359|NCT02463331|Azathioprine|azathioprine|mesh-list
92029360|NCT02463331|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029361|NCT02463331|Glucocorticoids|glucocorticoids|mesh-ancestor
92029363|NCT02463331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029364|NCT02463331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985177|NCT02390843|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985178|NCT02390843|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
91985179|NCT02390843|Alkylating Agents|alkylating agents|mesh-ancestor
92029365|NCT02463331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92029366|NCT02463331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029368|NCT02463331|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92029369|NCT02463331|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92029370|NCT02463331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029371|NCT02463331|Antimalarials|antimalarials|mesh-ancestor
92029372|NCT02463331|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029373|NCT02463331|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92029374|NCT02463331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92029375|NCT02463331|Analgesics|analgesics|mesh-ancestor
92029376|NCT02463331|Sensory System Agents|sensory system agents|mesh-ancestor
92029377|NCT02463331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029378|NCT02463331|Filaricides|filaricides|mesh-ancestor
92029379|NCT02463331|Antinematodal Agents|antinematodal agents|mesh-ancestor
92029380|NCT02463331|Anthelmintics|anthelmintics|mesh-ancestor
92029381|NCT02463331|Antimetabolites|antimetabolites|mesh-ancestor
92029382|NCT02463331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029383|NCT02463331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029384|NCT02463331|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92029385|NCT02463331|Immunologic Factors|immunologic factors|mesh-ancestor
92029386|NCT02463097|Insulin|insulin|mesh-list
92029387|NCT02463097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92029388|NCT02463097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029389|NCT05427149|Magnesium Sulfate|magnesium sulfate|mesh-list
92029390|NCT05427149|Analgesics|analgesics|mesh-ancestor
92029391|NCT05427149|Sensory System Agents|sensory system agents|mesh-ancestor
92029392|NCT05427149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029393|NCT05427149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029394|NCT05427149|Anesthetics|anesthetics|mesh-ancestor
92029395|NCT05427149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029396|NCT05427149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92029397|NCT05427149|Anticonvulsants|anticonvulsants|mesh-ancestor
92029398|NCT05427149|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92029399|NCT05427149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029400|NCT05427149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029401|NCT05427149|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92029402|NCT05427149|Tocolytic Agents|tocolytic agents|mesh-ancestor
92029403|NCT05427149|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92029404|NCT02462473|Olanzapine|olanzapine|mesh-list
92029405|NCT02462473|Risperidone|risperidone|mesh-list
92029406|NCT02462473|Aripiprazole|aripiprazole|mesh-list
92029407|NCT02462473|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92029408|NCT02462473|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92029409|NCT02462473|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92029410|NCT02462473|Serotonin Agents|serotonin agents|mesh-ancestor
92029411|NCT02462473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029412|NCT02462473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029414|NCT02462473|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92029415|NCT02462473|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92029416|NCT02462473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029417|NCT02462473|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029418|NCT02462473|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92029419|NCT02462473|Dopamine Agents|dopamine agents|mesh-ancestor
92029420|NCT02462473|Antiemetics|antiemetics|mesh-ancestor
92029421|NCT02462473|Autonomic Agents|autonomic agents|mesh-ancestor
92029422|NCT02462473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029423|NCT02462473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029424|NCT02462473|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92029425|NCT02462473|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92029426|NCT02462473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029427|NCT02462473|Antidepressive Agents|antidepressive agents|mesh-ancestor
92029428|NCT02462473|Dopamine Agonists|dopamine agonists|mesh-ancestor
92029429|NCT02462473|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92029430|NCT02462473|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92029431|NCT02462473|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92029432|NCT02462473|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92029433|NCT02440789|Sirolimus|sirolimus|mesh-list
91985180|NCT02390843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985181|NCT02390843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985182|NCT02390843|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91985183|NCT02390843|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91985184|NCT02390843|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92029434|NCT02440789|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92029435|NCT02440789|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029436|NCT02440789|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92029437|NCT02440789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029438|NCT02440789|Antifungal Agents|antifungal agents|mesh-ancestor
92029439|NCT02440789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92029440|NCT02440789|Immunologic Factors|immunologic factors|mesh-ancestor
92029441|NCT02440789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029443|NCT02538107|Hematinics|hematinics|mesh-ancestor
92029444|NCT02272413|Bevacizumab|bevacizumab|mesh-list
92029445|NCT02272413|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029446|NCT02272413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029447|NCT02272413|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92029448|NCT02272413|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92029449|NCT02272413|Growth Substances|growth substances|mesh-ancestor
92029450|NCT02272413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029451|NCT02272413|Growth Inhibitors|growth inhibitors|mesh-ancestor
92029452|NCT05648799|Molnupiravir|molnupiravir|mesh-list
92029453|NCT05648799|Antiviral Agents|antiviral agents|mesh-ancestor
92029454|NCT05648799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029455|NCT05400863|Metformin|metformin|mesh-list
92029456|NCT05400863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92029457|NCT05400863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029458|NCT02120807|Certolizumab Pegol|certolizumab pegol|mesh-list
92029459|NCT02120807|Pemetrexed|pemetrexed|mesh-list
92029460|NCT02120807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029461|NCT02120807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029462|NCT02120807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029463|NCT02120807|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92029464|NCT02120807|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92029465|NCT02120807|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92029466|NCT02120807|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029467|NCT02120807|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92029468|NCT02120807|Immunologic Factors|immunologic factors|mesh-ancestor
92029469|NCT02120807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029470|NCT02120807|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029471|NCT02532647|Midazolam|midazolam|mesh-list
92029472|NCT02532647|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92029473|NCT02532647|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92029474|NCT02532647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029475|NCT02532647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029476|NCT02532647|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92029477|NCT02532647|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92029478|NCT02532647|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029479|NCT02532647|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92029480|NCT02532647|Anesthetics, General|anesthetics, general|mesh-ancestor
92029481|NCT02532647|Anesthetics|anesthetics|mesh-ancestor
92029482|NCT02532647|GABA Modulators|gaba modulators|mesh-ancestor
92029483|NCT02532647|GABA Agents|gaba agents|mesh-ancestor
92029484|NCT02532647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029485|NCT02532647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029489|NCT02537015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92029490|NCT01660763|Sufentanil|sufentanil|mesh-list
92029491|NCT01660763|Dsuvia|dsuvia|mesh-list
92029492|NCT01660763|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92029493|NCT01660763|Narcotics|narcotics|mesh-ancestor
92029494|NCT01660763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029495|NCT01660763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029496|NCT01660763|Analgesics|analgesics|mesh-ancestor
92029497|NCT01660763|Sensory System Agents|sensory system agents|mesh-ancestor
92029498|NCT01660763|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029499|NCT01660763|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92029500|NCT01660763|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92029501|NCT01660763|Anesthetics, General|anesthetics, general|mesh-ancestor
92029502|NCT01660763|Anesthetics|anesthetics|mesh-ancestor
91985185|NCT02390843|Antimetabolites|antimetabolites|mesh-ancestor
91985186|NCT02390843|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91985187|NCT02390843|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92029503|NCT01937117|Trastuzumab|trastuzumab|mesh-list
92029504|NCT01937117|Pertuzumab|pertuzumab|mesh-list
92029505|NCT01937117|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029506|NCT01937117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029507|NCT04256213|Nivolumab|nivolumab|mesh-list
92029508|NCT04256213|Ipilimumab|ipilimumab|mesh-list
92029509|NCT04256213|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029510|NCT04256213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029511|NCT04256213|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029512|NCT04256213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029513|NCT02268045|Rituximab|rituximab|mesh-list
92029514|NCT02268045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029515|NCT02268045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029516|NCT02268045|Immunologic Factors|immunologic factors|mesh-ancestor
92029517|NCT02268045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029518|NCT02268045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029519|NCT02267187|Anesthetics|anesthetics|mesh-list
92029520|NCT02267187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029521|NCT02267187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029522|NCT05416229|Psilocybin|psilocybin|mesh-list
92029523|NCT05416229|Hallucinogens|hallucinogens|mesh-ancestor
92029524|NCT05416229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029525|NCT05416229|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029526|NCT01638533|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92029527|NCT01638533|Romidepsin|romidepsin|mesh-list
92029528|NCT01638533|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029529|NCT01638533|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92029530|NCT01638533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029531|NCT01638533|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92029532|NCT01638533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029533|NCT01638533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029534|NCT01641939|Trastuzumab|trastuzumab|mesh-list
92029535|NCT01641939|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92029536|NCT01641939|Maytansine|maytansine|mesh-list
92029538|NCT01641939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029539|NCT01641939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029540|NCT01641939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92029541|NCT01641939|Tubulin Modulators|tubulin modulators|mesh-ancestor
92029542|NCT01641939|Antimitotic Agents|antimitotic agents|mesh-ancestor
92029543|NCT01641939|Mitosis Modulators|mitosis modulators|mesh-ancestor
92029544|NCT01641939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029545|NCT01641939|Immunotoxins|immunotoxins|mesh-ancestor
92029546|NCT01641939|Immunoconjugates|immunoconjugates|mesh-ancestor
92029547|NCT01641939|Immunologic Factors|immunologic factors|mesh-ancestor
92029548|NCT01641939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029549|NCT02409355|Carboplatin|carboplatin|mesh-list
92029550|NCT02409355|Gemcitabine|gemcitabine|mesh-list
92029551|NCT02409355|Atezolizumab|atezolizumab|mesh-list
92029552|NCT02409355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029553|NCT02409355|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029554|NCT02409355|Antimetabolites|antimetabolites|mesh-ancestor
92029555|NCT02409355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029556|NCT02409355|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029557|NCT02409355|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029558|NCT02438371|Indomethacin|indomethacin|mesh-list
92029559|NCT02438371|Nifedipine|nifedipine|mesh-list
92029560|NCT02438371|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92029561|NCT02438371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029571|NCT02438371|Sensory System Agents|sensory system agents|mesh-ancestor
92029572|NCT02438371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029573|NCT02438371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029574|NCT02438371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029575|NCT02438371|Gout Suppressants|gout suppressants|mesh-ancestor
92029576|NCT02438371|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92029577|NCT02438371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029578|NCT02438137|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92029579|NCT02438137|Dermatologic Agents|dermatologic agents|mesh-ancestor
92029580|NCT02438137|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92029581|NCT02438137|Immunologic Factors|immunologic factors|mesh-ancestor
91985188|NCT02390843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985189|NCT02390843|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91985190|NCT02390843|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91985191|NCT02390843|Mitosis Modulators|mitosis modulators|mesh-ancestor
91985192|NCT02390843|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92029582|NCT02438137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029583|NCT04920565|Polymyxins|polymyxins|mesh-list
92029584|NCT04920565|Polymyxin B|polymyxin b|mesh-list
92029585|NCT04920565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92029586|NCT04920565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029587|NCT04934683|Propofol|propofol|mesh-list
92029588|NCT04934683|Etomidate|etomidate|mesh-list
92029589|NCT04934683|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92029590|NCT04934683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029591|NCT04934683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029592|NCT04934683|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92029593|NCT04934683|Anesthetics, General|anesthetics, general|mesh-ancestor
92029594|NCT04934683|Anesthetics|anesthetics|mesh-ancestor
92029603|NCT04909021|Vaccines|vaccines|mesh-list
92029604|NCT04909021|Immunologic Factors|immunologic factors|mesh-ancestor
92029605|NCT04909021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029607|NCT02460991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029608|NCT02460991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92029609|NCT02460991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029610|NCT02460991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029611|NCT02459899|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92029612|NCT02459899|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92029613|NCT02459899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029614|NCT02459899|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92029615|NCT02459899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029616|NCT02436889|Mirabegron|mirabegron|mesh-list
92029617|NCT02436889|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92029618|NCT02436889|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92029619|NCT02436889|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92029620|NCT02436889|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92029621|NCT02436889|Adrenergic Agents|adrenergic agents|mesh-ancestor
92029622|NCT02436889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029623|NCT02436889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029624|NCT02436889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029625|NCT02436889|Urological Agents|urological agents|mesh-ancestor
92029626|NCT02436889|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92029627|NCT02436889|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92029628|NCT02436889|Cholinergic Agents|cholinergic agents|mesh-ancestor
92029629|NCT02436577|Ticagrelor|ticagrelor|mesh-list
92029630|NCT02436577|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92029631|NCT02436577|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92029632|NCT02436577|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92029636|NCT02436577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029637|NCT02436577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029638|NCT02459665|Metronidazole|metronidazole|mesh-list
92029639|NCT02459665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029640|NCT02459665|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92029641|NCT02459665|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92029642|NCT02459665|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92029643|NCT02265237|Ritonavir|ritonavir|mesh-list
92029644|NCT02265237|Ribavirin|ribavirin|mesh-list
92029645|NCT02265237|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92029646|NCT02265237|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92029647|NCT02265237|Protease Inhibitors|protease inhibitors|mesh-ancestor
92029648|NCT02265237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029729|NCT02256969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029649|NCT02265237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029650|NCT02265237|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92029651|NCT02265237|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92029652|NCT02265237|Antiviral Agents|antiviral agents|mesh-ancestor
92029653|NCT02265237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029654|NCT02265237|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92029655|NCT02265237|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92029656|NCT02265237|Antimetabolites|antimetabolites|mesh-ancestor
92029657|NCT04874025|Palbociclib|palbociclib|mesh-list
92029658|NCT04874025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029659|NCT04874025|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92029660|NCT04874025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029661|NCT04874025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029662|NCT02263365|Loperamide|loperamide|mesh-list
92029663|NCT02263365|Antidiarrheals|antidiarrheals|mesh-list
92029664|NCT02263365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029665|NCT04858269|Paclitaxel|paclitaxel|mesh-list
92029666|NCT04858269|Carboplatin|carboplatin|mesh-list
92029667|NCT04858269|Pembrolizumab|pembrolizumab|mesh-list
92029668|NCT04858269|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92029669|NCT04858269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029670|NCT04858269|Tubulin Modulators|tubulin modulators|mesh-ancestor
92029671|NCT04858269|Antimitotic Agents|antimitotic agents|mesh-ancestor
92029672|NCT04858269|Mitosis Modulators|mitosis modulators|mesh-ancestor
92029673|NCT04858269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029674|NCT04858269|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029675|NCT04858269|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029676|NCT02261493|Botulinum Toxins|botulinum toxins|mesh-list
92029677|NCT02261493|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92029678|NCT02261493|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92029679|NCT02261493|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92029680|NCT02261493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029681|NCT02261493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029682|NCT02261493|Cholinergic Agents|cholinergic agents|mesh-ancestor
92029683|NCT02261493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029684|NCT02261493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029685|NCT02261493|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92029686|NCT02261493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029687|NCT02260791|Adalimumab|adalimumab|mesh-list
92029688|NCT02260791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92029689|NCT02260791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029690|NCT02260791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029691|NCT02260635|Evacetrapib|evacetrapib|mesh-list
92029692|NCT02260635|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92029693|NCT02260635|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92029694|NCT02260635|Antimetabolites|antimetabolites|mesh-ancestor
92029695|NCT02260635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029696|NCT02260635|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92029697|NCT05646459|Cannabidiol|cannabidiol|mesh-list
92029698|NCT05646459|Anticonvulsants|anticonvulsants|mesh-ancestor
92029699|NCT02259231|Nivolumab|nivolumab|mesh-list
92029700|NCT02259231|Ipilimumab|ipilimumab|mesh-list
92029701|NCT02259231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029702|NCT02259231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029703|NCT02259231|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029704|NCT02259231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029705|NCT02258529|Rituximab|rituximab|mesh-list
92029711|NCT02258529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029712|NCT02258529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029713|NCT02258529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029714|NCT02256969|Sulfacetamide|sulfacetamide|mesh-list
92029715|NCT02256969|Prednisolone|prednisolone|mesh-list
92029716|NCT02256969|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92029717|NCT02256969|Methylprednisolone|methylprednisolone|mesh-list
92029718|NCT02256969|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92029719|NCT02256969|Prednisolone acetate|prednisolone acetate|mesh-list
92029720|NCT02256969|Mineral Oil|mineral oil|mesh-list
92029721|NCT02256969|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92029722|NCT02256969|Prednisolone phosphate|prednisolone phosphate|mesh-list
92029723|NCT02256969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029724|NCT02256969|Glucocorticoids|glucocorticoids|mesh-ancestor
92029725|NCT02256969|Hormones|hormones|mesh-ancestor
92029726|NCT02256969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029727|NCT02256969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029728|NCT02256969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92029730|NCT02256969|Antiemetics|antiemetics|mesh-ancestor
92029731|NCT02256969|Autonomic Agents|autonomic agents|mesh-ancestor
92029732|NCT02256969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029733|NCT02256969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029734|NCT02256969|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92029735|NCT02256969|Protective Agents|protective agents|mesh-ancestor
91985193|NCT02390375|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92029736|NCT02256969|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92029737|NCT02256969|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029738|NCT02256969|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92029739|NCT02256969|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92029740|NCT02256969|Emollients|emollients|mesh-ancestor
92029741|NCT02256969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92029743|NCT02256267|Rifampin|rifampin|mesh-list
92029744|NCT02256267|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92029745|NCT02256267|Antitubercular Agents|antitubercular agents|mesh-ancestor
92029746|NCT02256267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92029747|NCT02256267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029748|NCT02256267|Leprostatic Agents|leprostatic agents|mesh-ancestor
92029749|NCT02256267|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92029750|NCT02256267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029751|NCT02256267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029752|NCT02256267|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92029753|NCT02256267|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92029754|NCT02256267|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92029755|NCT02256267|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92029756|NCT02256267|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92029757|NCT02256267|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92029758|NCT05429463|Paclitaxel|paclitaxel|mesh-list
92029759|NCT05429463|Carboplatin|carboplatin|mesh-list
92029760|NCT05429463|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92029761|NCT05429463|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92029762|NCT05429463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029763|NCT05429463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92029764|NCT05429463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92029765|NCT05429463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92029766|NCT05429463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029767|NCT02255565|Methylphenidate|methylphenidate|mesh-list
92029768|NCT02255565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92029769|NCT02255565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029770|NCT02255565|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92029771|NCT02255565|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92029772|NCT02255565|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029773|NCT02255565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029774|NCT02255565|Dopamine Agents|dopamine agents|mesh-ancestor
92029794|NCT01640301|Sensory System Agents|sensory system agents|mesh-ancestor
92029795|NCT01640301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029796|NCT01640301|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92029797|NCT01640301|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92029798|NCT01640301|Antiviral Agents|antiviral agents|mesh-ancestor
92029799|NCT01640301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029800|NCT01642407|Sildenafil Citrate|sildenafil citrate|mesh-list
92029801|NCT01642407|Vasodilator Agents|vasodilator agents|mesh-ancestor
92029802|NCT01642407|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92029803|NCT01642407|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92029804|NCT01642407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029805|NCT01642407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029806|NCT01642407|Urological Agents|urological agents|mesh-ancestor
92029807|NCT02255097|Pembrolizumab|pembrolizumab|mesh-list
92029808|NCT02255097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029809|NCT02255097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029810|NCT02255097|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029811|NCT02255097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029813|NCT02254551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029814|NCT05640375|Methylprednisolone|methylprednisolone|mesh-list
92029815|NCT05640375|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92029816|NCT05640375|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92029817|NCT05640375|Prednisolone|prednisolone|mesh-list
92029818|NCT05640375|Prednisolone acetate|prednisolone acetate|mesh-list
92029819|NCT05640375|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92029820|NCT05640375|Prednisolone phosphate|prednisolone phosphate|mesh-list
92029821|NCT05640375|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029822|NCT05640375|Antiemetics|antiemetics|mesh-ancestor
92029823|NCT05640375|Autonomic Agents|autonomic agents|mesh-ancestor
92029824|NCT05640375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029825|NCT05640375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985194|NCT02390375|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91985195|NCT02390375|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91985196|NCT02390375|Antimetabolites|antimetabolites|mesh-ancestor
91985197|NCT02390375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985198|NCT02390375|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92029826|NCT05640375|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029827|NCT05640375|Glucocorticoids|glucocorticoids|mesh-ancestor
92029828|NCT05640375|Hormones|hormones|mesh-ancestor
92029829|NCT05640375|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029830|NCT05640375|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92029839|NCT01641237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029840|NCT01641237|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92029841|NCT01641237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029842|NCT05650437|Vitamin D|vitamin d|mesh-list
92029843|NCT05650437|Vitamins|vitamins|mesh-ancestor
92029844|NCT05650437|Micronutrients|micronutrients|mesh-ancestor
92029845|NCT05650437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029846|NCT05650437|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92029847|NCT05617209|Thrombin|thrombin|mesh-list
92029848|NCT05617209|Hemostatics|hemostatics|mesh-ancestor
92029849|NCT05617209|Coagulants|coagulants|mesh-ancestor
92029850|NCT01639833|Hemostatics|hemostatics|mesh-list
92029851|NCT01639833|Coagulants|coagulants|mesh-ancestor
92029852|NCT01639131|Gemcitabine|gemcitabine|mesh-list
92029853|NCT01639131|Docetaxel|docetaxel|mesh-list
92029854|NCT01639131|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029855|NCT01639131|Antimetabolites|antimetabolites|mesh-ancestor
92029856|NCT01639131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029857|NCT01639131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029858|NCT01639131|Tubulin Modulators|tubulin modulators|mesh-ancestor
92029859|NCT01639131|Antimitotic Agents|antimitotic agents|mesh-ancestor
92029860|NCT01639131|Mitosis Modulators|mitosis modulators|mesh-ancestor
92029861|NCT01641159|Buspirone|buspirone|mesh-list
92029862|NCT01641159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92029863|NCT01641159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92029864|NCT01641159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029865|NCT01641159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029866|NCT01641159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029867|NCT01641159|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92029868|NCT01641159|Serotonin Agents|serotonin agents|mesh-ancestor
92029869|NCT01641159|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029870|NCT01641159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029871|NCT01641081|Formoterol Fumarate|formoterol fumarate|mesh-list
92029872|NCT01641081|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92029873|NCT01641081|Autonomic Agents|autonomic agents|mesh-ancestor
92029874|NCT01641081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029875|NCT01641081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029876|NCT01641081|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92029877|NCT01641081|Respiratory System Agents|respiratory system agents|mesh-ancestor
92029878|NCT01641081|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92029879|NCT01641081|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92029880|NCT01641081|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92029881|NCT01641081|Adrenergic Agents|adrenergic agents|mesh-ancestor
92029882|NCT01641081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029883|NCT01641081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029884|NCT01640925|Chlorhexidine|chlorhexidine|mesh-list
92029885|NCT01640925|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92029886|NCT01640925|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92029887|NCT01640925|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029888|NCT01640925|Disinfectants|disinfectants|mesh-ancestor
92029889|NCT01640925|Dermatologic Agents|dermatologic agents|mesh-ancestor
92029890|NCT05369481|Minoxidil|minoxidil|mesh-list
92029891|NCT05369481|Sildenafil Citrate|sildenafil citrate|mesh-list
92029892|NCT05369481|Vasodilator Agents|vasodilator agents|mesh-ancestor
92029893|NCT05369481|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92029894|NCT05369481|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92029895|NCT05369481|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029896|NCT05369481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029897|NCT05369481|Urological Agents|urological agents|mesh-ancestor
92029898|NCT05369481|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92029899|NCT04853589|Hyaluronic Acid|hyaluronic acid|mesh-list
91985199|NCT02390375|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91985200|NCT02390375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985201|NCT03806309|Leucovorin|leucovorin|mesh-list
91985202|NCT03806309|Fluorouracil|fluorouracil|mesh-list
91985203|NCT03806309|Irinotecan|irinotecan|mesh-list
91985204|NCT03806309|Antimetabolites|antimetabolites|mesh-ancestor
91985205|NCT03806309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985206|NCT03806309|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029900|NCT04853589|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92029906|NCT01638429|Neomycin|neomycin|mesh-list
92029907|NCT01638429|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92029908|NCT01638429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029909|NCT01638429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029910|NCT01638429|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92029911|NCT01638429|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029912|NCT01638429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029913|NCT04853511|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92029914|NCT04853511|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92029915|NCT04853511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029916|NCT04853355|Spironolactone|spironolactone|mesh-list
92029917|NCT04853355|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92029918|NCT04853355|Hormone Antagonists|hormone antagonists|mesh-ancestor
92029919|NCT04853355|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029920|NCT04853355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029921|NCT04853355|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92029922|NCT04853355|Diuretics|diuretics|mesh-ancestor
92029923|NCT04853355|Natriuretic Agents|natriuretic agents|mesh-ancestor
92029924|NCT05369091|Simvastatin|simvastatin|mesh-list
92029925|NCT05369091|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92029926|NCT05369091|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92029927|NCT05369091|Antimetabolites|antimetabolites|mesh-ancestor
92029928|NCT05369091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029929|NCT05369091|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92029930|NCT05369091|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92029931|NCT05369091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029932|NCT01601535|Irinotecan|irinotecan|mesh-list
92029933|NCT01601535|Temozolomide|temozolomide|mesh-list
92029934|NCT01601535|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92029935|NCT01601535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92029936|NCT01601535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92029937|NCT01601535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029938|NCT01601535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029939|NCT01601535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92029940|NCT01601535|Alkylating Agents|alkylating agents|mesh-ancestor
92029941|NCT05422365|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92029942|NCT05422365|Immunoglobulins|immunoglobulins|mesh-list
92029943|NCT05422365|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92029944|NCT05422365|Antibodies|antibodies|mesh-list
92029945|NCT05422365|gamma-Globulins|gamma-globulins|mesh-list
92029946|NCT05422365|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92029947|NCT05422365|Immunologic Factors|immunologic factors|mesh-ancestor
92029948|NCT05422365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029949|NCT04641273|Pregabalin|pregabalin|mesh-list
92029950|NCT04641273|Analgesics|analgesics|mesh-ancestor
92029951|NCT04641273|Sensory System Agents|sensory system agents|mesh-ancestor
92029952|NCT04641273|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029953|NCT04641273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029954|NCT04641273|Anticonvulsants|anticonvulsants|mesh-ancestor
92029955|NCT04641273|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92029956|NCT04641273|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92029957|NCT04641273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029958|NCT04641273|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92029959|NCT04641273|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92029960|NCT04641273|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91985207|NCT03806309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985208|NCT03806309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985209|NCT03806309|Immunologic Factors|immunologic factors|mesh-ancestor
92029961|NCT04641273|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029963|NCT04843917|Immunoglobulins|immunoglobulins|mesh-list
92029964|NCT04843917|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92029965|NCT04843917|Antibodies|antibodies|mesh-list
92029966|NCT04843917|Immunoglobulin G|immunoglobulin g|mesh-list
92029967|NCT04843917|Immunologic Factors|immunologic factors|mesh-ancestor
92029968|NCT04843917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029969|NCT04586985|Midazolam|midazolam|mesh-list
92029970|NCT04586985|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92029973|NCT04586985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029974|NCT04586985|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92029975|NCT04586985|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92029976|NCT04586985|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92029977|NCT04586985|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92029978|NCT04586985|Anesthetics, General|anesthetics, general|mesh-ancestor
92029980|NCT04586985|GABA Modulators|gaba modulators|mesh-ancestor
92029981|NCT04586985|GABA Agents|gaba agents|mesh-ancestor
92029982|NCT04586985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029983|NCT04586985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029984|NCT04841343|Triamcinolone|triamcinolone|mesh-list
92029985|NCT04841343|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92029986|NCT04841343|Glucocorticoids|glucocorticoids|mesh-ancestor
92029988|NCT04841343|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92029989|NCT04841343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029990|NCT05244057|Interferons|interferons|mesh-list
92029991|NCT05244057|Tenofovir|tenofovir|mesh-list
92029992|NCT05244057|Interferon-alpha|interferon-alpha|mesh-list
92029993|NCT05244057|Interferon alpha-2|interferon alpha-2|mesh-list
92029994|NCT05244057|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92029995|NCT05244057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029996|NCT05244057|Antiviral Agents|antiviral agents|mesh-ancestor
92029997|NCT05244057|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92029998|NCT05244057|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92029999|NCT05244057|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92030000|NCT05244057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030001|NCT05244057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030002|NCT05244057|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92030003|NCT05244057|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92030004|NCT05244057|Immunologic Factors|immunologic factors|mesh-ancestor
92030005|NCT05244057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030006|NCT05408403|Anesthetics|anesthetics|mesh-list
92030007|NCT05408403|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030008|NCT05408403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030009|NCT04830735|Dasatinib|dasatinib|mesh-list
92030010|NCT04830735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030011|NCT04830735|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030012|NCT04830735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030013|NCT04830735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030014|NCT05335317|Hormones|hormones|mesh-list
92030015|NCT05335317|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030016|NCT05335317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030017|NCT04419441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92030018|NCT04419441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030019|NCT04419441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030020|NCT04419441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030021|NCT05329779|Pregnanolone|pregnanolone|mesh-list
92030022|NCT05329779|Brexanolone|brexanolone|mesh-list
92030023|NCT05329779|Anesthetics|anesthetics|mesh-ancestor
92030024|NCT05329779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030025|NCT05329779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030026|NCT05329779|Neurosteroids|neurosteroids|mesh-ancestor
92030027|NCT05329779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030028|NCT05329779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030029|NCT05329779|GABA Modulators|gaba modulators|mesh-ancestor
92030030|NCT05329779|GABA Agents|gaba agents|mesh-ancestor
92030031|NCT04464759|Hydroxychloroquine|hydroxychloroquine|mesh-list
92030032|NCT04464759|Nivolumab|nivolumab|mesh-list
91985210|NCT03806309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985211|NCT03806309|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
91985212|NCT03806309|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91985213|NCT03806309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985214|NCT03806309|Antidotes|antidotes|mesh-ancestor
91985215|NCT03806309|Protective Agents|protective agents|mesh-ancestor
91985216|NCT03806309|Vitamin B Complex|vitamin b complex|mesh-ancestor
91985217|NCT03806309|Vitamins|vitamins|mesh-ancestor
92030033|NCT04464759|Ipilimumab|ipilimumab|mesh-list
92030034|NCT04464759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030035|NCT04464759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030036|NCT04464759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92030037|NCT04464759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030039|NCT04464759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92030040|NCT04464759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92030041|NCT04464759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030042|NCT04464759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030043|NCT04464759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030052|NCT04411329|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030053|NCT04411329|Antiemetics|antiemetics|mesh-ancestor
92030054|NCT04411329|Autonomic Agents|autonomic agents|mesh-ancestor
92030055|NCT04411329|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030056|NCT04411329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030057|NCT04411329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030058|NCT04411329|Glucocorticoids|glucocorticoids|mesh-ancestor
92030059|NCT04411329|Hormones|hormones|mesh-ancestor
92030060|NCT04411329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030061|NCT04411329|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92030062|NCT04411329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030063|NCT04411329|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030064|NCT04411329|Anesthetics|anesthetics|mesh-ancestor
92030065|NCT04411329|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030066|NCT04411329|Sensory System Agents|sensory system agents|mesh-ancestor
92030067|NCT04411329|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92030068|NCT04411329|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92030069|NCT04411329|Analgesics|analgesics|mesh-ancestor
92030070|NCT04411329|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92030071|NCT04411329|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92030072|NCT04411329|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92030073|NCT04411329|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030074|NCT04411329|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030075|NCT04411329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030076|NCT05171673|Diclofenac|diclofenac|mesh-list
92030077|NCT05171673|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92030078|NCT05171673|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92030079|NCT05171673|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92030080|NCT05171673|Analgesics|analgesics|mesh-ancestor
92030081|NCT05171673|Sensory System Agents|sensory system agents|mesh-ancestor
92030082|NCT05171673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030083|NCT05171673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030084|NCT05171673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030085|NCT05171673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030086|NCT05171673|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92030087|NCT05171673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030088|NCT05171673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030089|NCT05147415|Metoprolol|metoprolol|mesh-list
92030090|NCT05147415|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92030091|NCT05147415|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92030092|NCT05147415|Sympatholytics|sympatholytics|mesh-ancestor
92030093|NCT05147415|Autonomic Agents|autonomic agents|mesh-ancestor
92030094|NCT05147415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030095|NCT05147415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030096|NCT05147415|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92030097|NCT05147415|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92030098|NCT05147415|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92030099|NCT05147415|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030100|NCT05147415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985218|NCT03806309|Micronutrients|micronutrients|mesh-ancestor
91985220|NCT03489629|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91985221|NCT03489629|Minocycline|minocycline|mesh-list
91985222|NCT03489629|Trimethoprim|trimethoprim|mesh-list
91985223|NCT03489629|Sulfamethoxazole|sulfamethoxazole|mesh-list
92030101|NCT05147415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030102|NCT04390581|Lidocaine|lidocaine|mesh-list
92030103|NCT04390581|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030104|NCT04390581|Anesthetics|anesthetics|mesh-ancestor
92030105|NCT04390581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030106|NCT04390581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030107|NCT04390581|Sensory System Agents|sensory system agents|mesh-ancestor
92030108|NCT04390581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030109|NCT04390581|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92030110|NCT04390581|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92030135|NCT04820673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030136|NCT04820673|Dermatologic Agents|dermatologic agents|mesh-ancestor
92030137|NCT04114539|Ecopipam|ecopipam|mesh-list
92030138|NCT04114539|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92030139|NCT04114539|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92030140|NCT04114539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030141|NCT04114539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030142|NCT04114539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92030143|NCT04114539|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92030144|NCT04114539|Dopamine Agents|dopamine agents|mesh-ancestor
92030145|NCT04114539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030146|NCT04114539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030147|NCT03301857|Denosumab|denosumab|mesh-list
92030148|NCT03301857|Immunoglobulins|immunoglobulins|mesh-list
92030149|NCT03301857|Immunoglobulin G|immunoglobulin g|mesh-list
92030150|NCT03301857|Immunologic Factors|immunologic factors|mesh-ancestor
92030151|NCT03301857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030152|NCT03301857|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92030153|NCT03263559|Cyclophosphamide|cyclophosphamide|mesh-list
92030154|NCT03263559|Thiotepa|thiotepa|mesh-list
92030155|NCT03263559|Fludarabine|fludarabine|mesh-list
92030156|NCT03263559|Hydroxyurea|hydroxyurea|mesh-list
92030157|NCT03263559|Thymoglobulin|thymoglobulin|mesh-list
92030158|NCT03263559|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030159|NCT03263559|Immunologic Factors|immunologic factors|mesh-ancestor
92030160|NCT03263559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030161|NCT03263559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030162|NCT03263559|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92030163|NCT03263559|Alkylating Agents|alkylating agents|mesh-ancestor
92030164|NCT03263559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030165|NCT03263559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030166|NCT03263559|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92030167|NCT03263559|Antisickling Agents|antisickling agents|mesh-ancestor
92030168|NCT03263559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030169|NCT03263559|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92030177|NCT03256149|Glucocorticoids|glucocorticoids|mesh-ancestor
92030178|NCT03256149|Hormones|hormones|mesh-ancestor
92030179|NCT03256149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030180|NCT03256149|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92030181|NCT03256149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030182|NCT03253263|Mecasermin|mecasermin|mesh-list
92030183|NCT03253263|Growth Substances|growth substances|mesh-ancestor
92030184|NCT03253263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030185|NCT01636947|Dexamethasone|dexamethasone|mesh-list
92030186|NCT01636947|Dexamethasone acetate|dexamethasone acetate|mesh-list
92030187|NCT01636947|Ondansetron|ondansetron|mesh-list
92030188|NCT01636947|Aprepitant|aprepitant|mesh-list
92030189|NCT01636947|Fosaprepitant|fosaprepitant|mesh-list
92030190|NCT01636947|Metoclopramide|metoclopramide|mesh-list
92030191|NCT01636947|Granisetron|granisetron|mesh-list
92030192|NCT01636947|Tropisetron|tropisetron|mesh-list
92030193|NCT01636947|Dolasetron|dolasetron|mesh-list
92030194|NCT01636947|Alizapride|alizapride|mesh-list
92030195|NCT01636947|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92030196|NCT01636947|BB 1101|bb 1101|mesh-list
92030197|NCT01636947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030198|NCT01636947|Antiemetics|antiemetics|mesh-ancestor
92030199|NCT01636947|Autonomic Agents|autonomic agents|mesh-ancestor
91985224|NCT03489629|Mupirocin|mupirocin|mesh-list
91985225|NCT03489629|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
91985226|NCT03489629|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92030200|NCT01636947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030201|NCT01636947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030202|NCT01636947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030203|NCT01636947|Glucocorticoids|glucocorticoids|mesh-ancestor
92030204|NCT01636947|Hormones|hormones|mesh-ancestor
92030205|NCT01636947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030206|NCT01636947|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92030207|NCT01636947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030208|NCT01636947|Protease Inhibitors|protease inhibitors|mesh-ancestor
92030209|NCT01636947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030210|NCT01636947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030211|NCT01636947|Antipruritics|antipruritics|mesh-ancestor
92030212|NCT01636947|Dermatologic Agents|dermatologic agents|mesh-ancestor
92030213|NCT01636947|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92030214|NCT01636947|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92030215|NCT01636947|Serotonin Agents|serotonin agents|mesh-ancestor
92030216|NCT01636947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030217|NCT01636947|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92030218|NCT01636947|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92030219|NCT01636947|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92030220|NCT01636947|Dopamine Agents|dopamine agents|mesh-ancestor
92030221|NCT03052725|Reslizumab|reslizumab|mesh-list
92030222|NCT03052725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92030223|NCT03052725|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030224|NCT02980341|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92030225|NCT02980341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030226|NCT02980341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030227|NCT04793919|Tretinoin|tretinoin|mesh-list
92030228|NCT04793919|Arsenic Trioxide|arsenic trioxide|mesh-list
92030229|NCT04793919|Gemtuzumab|gemtuzumab|mesh-list
92030230|NCT04793919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030231|NCT04793919|Keratolytic Agents|keratolytic agents|mesh-ancestor
92030232|NCT04793919|Dermatologic Agents|dermatologic agents|mesh-ancestor
92030233|NCT04793919|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030234|NCT04793919|Immunotoxins|immunotoxins|mesh-ancestor
92030235|NCT04793919|Immunoconjugates|immunoconjugates|mesh-ancestor
92030236|NCT04793919|Immunologic Factors|immunologic factors|mesh-ancestor
92030237|NCT04793919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030238|NCT02817633|Carboplatin|carboplatin|mesh-list
92030239|NCT02817633|Docetaxel|docetaxel|mesh-list
92030240|NCT02817633|Nivolumab|nivolumab|mesh-list
92030241|NCT02817633|Pemetrexed|pemetrexed|mesh-list
92030242|NCT02817633|Dostarlimab|dostarlimab|mesh-list
92030257|NCT02775435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92030258|NCT02775435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030259|NCT02775435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92030260|NCT02775435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92030261|NCT02775435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92030262|NCT02775435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030263|NCT02775435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030264|NCT02775435|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92030265|NCT02774421|Trastuzumab|trastuzumab|mesh-list
92030266|NCT02774421|Molgramostim|molgramostim|mesh-list
92030267|NCT02774421|Sargramostim|sargramostim|mesh-list
92030268|NCT02774421|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030269|NCT02774421|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030270|NCT02774421|Immunologic Factors|immunologic factors|mesh-ancestor
92030271|NCT02774421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030272|NCT04791969|Naltrexone|naltrexone|mesh-list
92030273|NCT04791969|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92030274|NCT04791969|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92030275|NCT04791969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030276|NCT04791969|Sensory System Agents|sensory system agents|mesh-ancestor
92030277|NCT04791969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030278|NCT05651373|Hydroxychloroquine|hydroxychloroquine|mesh-list
92030279|NCT05651373|Prednisone|prednisone|mesh-list
92030280|NCT05651373|Certolizumab Pegol|certolizumab pegol|mesh-list
92030281|NCT05651373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030282|NCT05651373|Glucocorticoids|glucocorticoids|mesh-ancestor
92030283|NCT05651373|Hormones|hormones|mesh-ancestor
91985227|NCT03489629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985228|NCT03489629|Disinfectants|disinfectants|mesh-ancestor
91985229|NCT03489629|Dermatologic Agents|dermatologic agents|mesh-ancestor
91985230|NCT03489629|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92030284|NCT05651373|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030285|NCT05651373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030286|NCT05651373|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92030287|NCT05651373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030288|NCT05651373|Antimalarials|antimalarials|mesh-ancestor
92030289|NCT05651373|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92030290|NCT05651373|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92030291|NCT05651373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030292|NCT05651373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030293|NCT05651373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030294|NCT05651373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030295|NCT05651373|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92030296|NCT05651373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030297|NCT05651373|Immunologic Factors|immunologic factors|mesh-ancestor
92030299|NCT03905889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030300|NCT03905889|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92030301|NCT03905889|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92030302|NCT03905889|Growth Substances|growth substances|mesh-ancestor
92030303|NCT03905889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030315|NCT03846765|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030316|NCT03846765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030317|NCT03846765|Sympathomimetics|sympathomimetics|mesh-ancestor
92030318|NCT03846765|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92030319|NCT03846765|Nasal Decongestants|nasal decongestants|mesh-ancestor
92030320|NCT03846765|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030321|NCT03846765|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92030322|NCT03846765|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92030323|NCT03846765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92030324|NCT03846765|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030325|NCT03846765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030404|NCT04192773|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030326|NCT03846765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030327|NCT03846765|Protective Agents|protective agents|mesh-ancestor
92030328|NCT03846765|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92030329|NCT03846765|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92030330|NCT05163405|Bortezomib|bortezomib|mesh-list
92030331|NCT05163405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030332|NCT03822897|Cisplatin|cisplatin|mesh-list
92030333|NCT03822897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030334|NCT02311179|Cimetidine|cimetidine|mesh-list
92030335|NCT02311179|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92030336|NCT02311179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030337|NCT02311179|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92030338|NCT02311179|Histamine Antagonists|histamine antagonists|mesh-ancestor
92030339|NCT02311179|Histamine Agents|histamine agents|mesh-ancestor
92030340|NCT02311179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030341|NCT02311179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030342|NCT02311179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030343|NCT02311179|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92030344|NCT02311179|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92030345|NCT02311179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030346|NCT04801953|Nimodipine|nimodipine|mesh-list
92030347|NCT04801953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92030348|NCT04801953|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92030349|NCT04801953|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92030350|NCT04801953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030351|NCT04801953|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92030352|NCT04801953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030353|NCT04801953|Vasodilator Agents|vasodilator agents|mesh-ancestor
92030354|NCT01635153|Micronutrients|micronutrients|mesh-list
92030355|NCT01635153|Trace Elements|trace elements|mesh-list
92030356|NCT01635153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030357|NCT04446039|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92030358|NCT04446039|Vortioxetine|vortioxetine|mesh-list
92030359|NCT04446039|Mirtazapine|mirtazapine|mesh-list
92030360|NCT04446039|Bupropion|bupropion|mesh-list
92030361|NCT04446039|Fluoxetine|fluoxetine|mesh-list
92030362|NCT04446039|Paroxetine|paroxetine|mesh-list
92030363|NCT04446039|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92030365|NCT04446039|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92030366|NCT04446039|Tianeptine|tianeptine|mesh-list
92030367|NCT04446039|Escitalopram|escitalopram|mesh-list
92030368|NCT04446039|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92030369|NCT04446039|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92030371|NCT04446039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030373|NCT04446039|Serotonin Agents|serotonin agents|mesh-ancestor
92030374|NCT04446039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030375|NCT04446039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030376|NCT04446039|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92030377|NCT04446039|Antidepressive Agents|antidepressive agents|mesh-ancestor
92030378|NCT04446039|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92030379|NCT04446039|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92030380|NCT04446039|Dopamine Agents|dopamine agents|mesh-ancestor
92030381|NCT04446039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92030382|NCT04446039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92030383|NCT04446039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030384|NCT04446039|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92030385|NCT04446039|Analgesics|analgesics|mesh-ancestor
92030386|NCT04446039|Sensory System Agents|sensory system agents|mesh-ancestor
92030387|NCT04446039|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92030388|NCT04446039|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92030389|NCT04446039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030390|NCT04446039|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92030391|NCT04446039|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92030392|NCT04446039|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92030393|NCT04446039|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92030395|NCT04446039|Histamine Antagonists|histamine antagonists|mesh-ancestor
92030396|NCT04446039|Histamine Agents|histamine agents|mesh-ancestor
92030397|NCT04446039|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92030398|NCT04446039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92030399|NCT04446039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92030400|NCT04446039|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030401|NCT04446039|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92030402|NCT04446039|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92030403|NCT04192773|Lidocaine|lidocaine|mesh-list
92030405|NCT04192773|Anesthetics|anesthetics|mesh-ancestor
92030406|NCT04192773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030407|NCT04192773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030408|NCT04192773|Sensory System Agents|sensory system agents|mesh-ancestor
92030409|NCT04192773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030410|NCT04192773|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92030411|NCT04192773|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92030412|NCT04192773|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92030413|NCT04192773|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081693|NCT01402947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030414|NCT04192773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030416|NCT04784247|Lenvatinib|lenvatinib|mesh-list
92030417|NCT04784247|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030418|NCT04784247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030419|NCT04784247|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92030420|NCT04784247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030421|NCT04784247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030422|NCT04784247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030423|NCT05031897|Mycophenolic Acid|mycophenolic acid|mesh-list
92030424|NCT05031897|Cyclophosphamide|cyclophosphamide|mesh-list
92030425|NCT05031897|Melphalan|melphalan|mesh-list
92030426|NCT05031897|Fludarabine|fludarabine|mesh-list
92030427|NCT05031897|Tacrolimus|tacrolimus|mesh-list
92030428|NCT05031897|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030429|NCT05031897|Immunologic Factors|immunologic factors|mesh-ancestor
92030430|NCT05031897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030431|NCT05031897|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030432|NCT05031897|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92030433|NCT05031897|Alkylating Agents|alkylating agents|mesh-ancestor
92030434|NCT05031897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030435|NCT05031897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985231|NCT03489629|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
91985232|NCT03489629|Antimalarials|antimalarials|mesh-ancestor
91985233|NCT03489629|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91985234|NCT03489629|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91985235|NCT03489629|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92030436|NCT05031897|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92030437|NCT05031897|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92030438|NCT05031897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030439|NCT05031897|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92030442|NCT05031897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92030443|NCT05031897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030444|NCT04800471|Insulin|insulin|mesh-list
92030445|NCT04800471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92030446|NCT04800471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030447|NCT03591861|Carmustine|carmustine|mesh-list
92030448|NCT03591861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92030449|NCT03591861|Alkylating Agents|alkylating agents|mesh-ancestor
92030450|NCT03591861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030451|NCT03591861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030452|NCT01600053|Lenalidomide|lenalidomide|mesh-list
92030453|NCT01600053|Immunologic Factors|immunologic factors|mesh-ancestor
92030454|NCT01600053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030455|NCT01600053|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92030456|NCT01600053|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92030457|NCT01600053|Growth Substances|growth substances|mesh-ancestor
92030458|NCT01600053|Growth Inhibitors|growth inhibitors|mesh-ancestor
92030459|NCT01600053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030460|NCT03573297|Cariprazine|cariprazine|mesh-list
92030461|NCT03573297|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92030462|NCT03573297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92030463|NCT03573297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030464|NCT03573297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030465|NCT03573297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92030466|NCT03569241|Androgens|androgens|mesh-list
92030467|NCT03569241|Hormones|hormones|mesh-ancestor
92030468|NCT03569241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030469|NCT03569241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030470|NCT04716387|Milbemycin oxime|milbemycin oxime|mesh-list
92030471|NCT04716387|Anthelmintics|anthelmintics|mesh-ancestor
92030472|NCT04716387|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92030473|NCT04716387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030474|NCT01068249|Everolimus|everolimus|mesh-list
92030475|NCT01068249|Letrozole|letrozole|mesh-list
92030476|NCT01068249|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92030477|NCT01068249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030478|NCT01068249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030479|NCT01068249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030480|NCT01068249|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030481|NCT01068249|Immunologic Factors|immunologic factors|mesh-ancestor
92030482|NCT01068249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030483|NCT01068249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030484|NCT01068249|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92030485|NCT01068249|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92030486|NCT01068249|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92030487|NCT01068249|Hormone Antagonists|hormone antagonists|mesh-ancestor
92030488|NCT01068249|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030489|NCT01035099|Letrozole|letrozole|mesh-list
92030490|NCT01035099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030491|NCT01035099|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92030492|NCT01035099|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92030493|NCT01035099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030494|NCT01035099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030495|NCT01035099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92030496|NCT01035099|Hormone Antagonists|hormone antagonists|mesh-ancestor
92030497|NCT01035099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030498|NCT01035099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030499|NCT03560349|Lidocaine|lidocaine|mesh-list
92030500|NCT03560349|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030501|NCT03560349|Anesthetics|anesthetics|mesh-ancestor
91985236|NCT03489629|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985237|NCT03489629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030502|NCT03560349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030503|NCT03560349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030504|NCT03560349|Sensory System Agents|sensory system agents|mesh-ancestor
92030505|NCT03560349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030506|NCT03560349|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92030507|NCT03560349|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92030508|NCT03560349|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92030509|NCT03560349|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92030510|NCT03560349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030512|NCT04435431|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92030513|NCT04435431|Dopamine Agents|dopamine agents|mesh-ancestor
92030514|NCT04435431|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030515|NCT04435431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030516|NCT04435431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030517|NCT02246673|Febuxostat|febuxostat|mesh-list
92030518|NCT02246673|Verinurad|verinurad|mesh-list
92030519|NCT02246673|Gout Suppressants|gout suppressants|mesh-ancestor
92030520|NCT02246673|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030521|NCT03532425|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92030522|NCT03532425|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92030523|NCT03532425|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92030524|NCT03532425|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030525|NCT03532425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030526|NCT03532425|Antiviral Agents|antiviral agents|mesh-ancestor
92030527|NCT03532425|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030528|NCT03532425|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92030529|NCT03532425|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92030530|NCT04191447|Budesonide|budesonide|mesh-list
92030531|NCT04191447|Formoterol Fumarate|formoterol fumarate|mesh-list
92030532|NCT04191447|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92030533|NCT04191447|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030534|NCT04191447|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92030535|NCT04191447|Autonomic Agents|autonomic agents|mesh-ancestor
92030536|NCT04191447|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030537|NCT04191447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030538|NCT04191447|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92030539|NCT04191447|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030540|NCT04191447|Glucocorticoids|glucocorticoids|mesh-ancestor
92030541|NCT04191447|Hormones|hormones|mesh-ancestor
92030542|NCT04191447|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030543|NCT04191447|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92030544|NCT04191447|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92030545|NCT04191447|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92030546|NCT04191447|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030547|NCT04191447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030548|NCT04191447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030549|NCT04274361|Ketamine|ketamine|mesh-list
92030550|NCT04274361|Analgesics|analgesics|mesh-ancestor
92030551|NCT04274361|Sensory System Agents|sensory system agents|mesh-ancestor
92030552|NCT04274361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030553|NCT04274361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030554|NCT04274361|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92030555|NCT04274361|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92030556|NCT04274361|Anesthetics, General|anesthetics, general|mesh-ancestor
92030557|NCT04274361|Anesthetics|anesthetics|mesh-ancestor
92030558|NCT04274361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030559|NCT04274361|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92030560|NCT04274361|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92030561|NCT04274361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030562|NCT04274361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030563|NCT04251819|Baclofen|baclofen|mesh-list
92030564|NCT04251819|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92030565|NCT04251819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985238|NCT03489629|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91985239|NCT03489629|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
91985240|NCT03489629|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92030566|NCT04251819|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92030567|NCT04251819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030568|NCT04251819|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92030569|NCT04251819|GABA Agonists|gaba agonists|mesh-ancestor
92030571|NCT04251819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030572|NCT04251819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030573|NCT02243631|Probenecid|probenecid|mesh-list
92030574|NCT02243631|Uricosuric Agents|uricosuric agents|mesh-ancestor
92030575|NCT02243631|Gout Suppressants|gout suppressants|mesh-ancestor
92030576|NCT02243631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030577|NCT03401073|Immunoglobulins|immunoglobulins|mesh-list
92030578|NCT03401073|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92030579|NCT03401073|Antibodies|antibodies|mesh-list
92030580|NCT03401073|gamma-Globulins|gamma-globulins|mesh-list
92030581|NCT03401073|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92030585|NCT02242305|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92030586|NCT02242305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92030588|NCT02242305|Autonomic Agents|autonomic agents|mesh-ancestor
92030589|NCT02242305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030590|NCT02242305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030591|NCT02242305|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030592|NCT02242305|Mydriatics|mydriatics|mesh-ancestor
92030593|NCT02242305|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92030594|NCT02242305|Cholinergic Agents|cholinergic agents|mesh-ancestor
92030595|NCT02242305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030596|NCT02242305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030597|NCT02242305|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92030598|NCT02242305|Parasympatholytics|parasympatholytics|mesh-ancestor
92030599|NCT02240121|Rifaximin|rifaximin|mesh-list
92030600|NCT02240121|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92030601|NCT02240121|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030602|NCT02240121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030603|NCT04780269|Dinoprostone|dinoprostone|mesh-list
92030604|NCT04780269|Oxytocics|oxytocics|mesh-ancestor
92030605|NCT04780269|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92030606|NCT04780269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030607|NCT02238483|AZD7624|azd7624|mesh-list
92030609|NCT02238483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030610|NCT02238483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030611|NCT01632891|Ritonavir|ritonavir|mesh-list
92030612|NCT01632891|Lopinavir|lopinavir|mesh-list
92030613|NCT01632891|Tenofovir|tenofovir|mesh-list
92030614|NCT01632891|Emtricitabine|emtricitabine|mesh-list
92030615|NCT01632891|Nevirapine|nevirapine|mesh-list
92030616|NCT01632891|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92030618|NCT01632891|Trimethoprim|trimethoprim|mesh-list
92030619|NCT01632891|Sulfamethoxazole|sulfamethoxazole|mesh-list
92030620|NCT01632891|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92030621|NCT01632891|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92030622|NCT01632891|Protease Inhibitors|protease inhibitors|mesh-ancestor
92030624|NCT01632891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030625|NCT01632891|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92030626|NCT01632891|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92030627|NCT01632891|Antiviral Agents|antiviral agents|mesh-ancestor
92030628|NCT01632891|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030629|NCT01632891|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92030630|NCT01632891|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92030631|NCT01632891|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92030632|NCT01632891|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92030633|NCT01632891|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92030634|NCT01632891|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92030635|NCT01632891|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92030636|NCT01632891|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91985241|NCT03489629|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91985242|NCT02389751|Paclitaxel|paclitaxel|mesh-list
91985243|NCT02389751|Carboplatin|carboplatin|mesh-list
91985244|NCT02389751|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92030637|NCT01632891|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92030638|NCT01632891|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92030640|NCT01632891|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92030641|NCT01632891|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92030642|NCT01632891|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92030643|NCT01632891|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92030644|NCT01632891|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92030645|NCT02208843|Afatinib|afatinib|mesh-list
92030646|NCT02208843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030647|NCT02208843|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030648|NCT02208843|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030649|NCT02208843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030650|NCT02208063|Vancomycin|vancomycin|mesh-list
92030651|NCT02208063|Cefazolin|cefazolin|mesh-list
92030652|NCT02208063|Daptomycin|daptomycin|mesh-list
92030653|NCT02208063|Penicillins|penicillins|mesh-list
92030654|NCT02208063|Cloxacillin|cloxacillin|mesh-list
92030658|NCT02208063|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92030659|NCT02208063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030660|NCT03729609|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92030661|NCT03729609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030662|NCT03729609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030663|NCT03729609|Immunotoxins|immunotoxins|mesh-ancestor
92030664|NCT03729609|Immunoconjugates|immunoconjugates|mesh-ancestor
92030665|NCT03729609|Immunologic Factors|immunologic factors|mesh-ancestor
92030666|NCT03729609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030667|NCT02207907|Listerine|listerine|mesh-list
92030668|NCT02207907|Fluorides|fluorides|mesh-list
92030669|NCT02207907|Sodium Fluoride|sodium fluoride|mesh-list
92030670|NCT02207907|Cariostatic Agents|cariostatic agents|mesh-ancestor
92030671|NCT02207907|Protective Agents|protective agents|mesh-ancestor
92030672|NCT02207907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030673|NCT02207907|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92030674|NCT02207907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030675|NCT02207829|Tiotropium Bromide|tiotropium bromide|mesh-list
92030676|NCT02207829|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92030677|NCT02207829|Autonomic Agents|autonomic agents|mesh-ancestor
92030678|NCT02207829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030679|NCT02207829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030680|NCT02207829|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92030681|NCT02207829|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030682|NCT02207829|Parasympatholytics|parasympatholytics|mesh-ancestor
92030683|NCT02207829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92030684|NCT02207829|Cholinergic Agents|cholinergic agents|mesh-ancestor
92030685|NCT02207829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030686|NCT02207829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030687|NCT02237157|Gemcitabine|gemcitabine|mesh-list
92030688|NCT02237157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92030689|NCT02237157|Antimetabolites|antimetabolites|mesh-ancestor
92030690|NCT02237157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030691|NCT02237157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030692|NCT02236611|Glycopyrrolate|glycopyrrolate|mesh-list
92030693|NCT02236611|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92030694|NCT02236611|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92030695|NCT02236611|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92030696|NCT02236611|Cholinergic Agents|cholinergic agents|mesh-ancestor
92030697|NCT02236611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030698|NCT02236611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030699|NCT02236611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030700|NCT02233803|Budesonide|budesonide|mesh-list
92030701|NCT02233803|Albuterol|albuterol|mesh-list
92030702|NCT02233803|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92030703|NCT02233803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030704|NCT02233803|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92030706|NCT02233803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985245|NCT02389751|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91985246|NCT02389751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985247|NCT02389751|Tubulin Modulators|tubulin modulators|mesh-ancestor
91985248|NCT02389751|Antimitotic Agents|antimitotic agents|mesh-ancestor
91985249|NCT02389751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92030707|NCT02233803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030708|NCT02233803|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92030709|NCT02233803|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030711|NCT02233803|Hormones|hormones|mesh-ancestor
92030712|NCT02233803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030713|NCT02233803|Tocolytic Agents|tocolytic agents|mesh-ancestor
92030714|NCT02233803|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92030715|NCT02233803|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92030716|NCT02233803|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92030717|NCT02233803|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92030718|NCT02233803|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030719|NCT02233803|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030720|NCT02233803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030721|NCT02233647|Cocaine|cocaine|mesh-list
92030722|NCT02233647|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030723|NCT02233647|Anesthetics|anesthetics|mesh-ancestor
92030724|NCT02233647|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030725|NCT02233647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030726|NCT02233647|Sensory System Agents|sensory system agents|mesh-ancestor
92030727|NCT02233647|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030747|NCT01632579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030748|NCT01632345|Efavirenz|efavirenz|mesh-list
92030749|NCT01632345|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92030750|NCT01632345|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92030751|NCT01632345|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92030752|NCT01632345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030753|NCT01632345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030754|NCT01632345|Antiviral Agents|antiviral agents|mesh-ancestor
92030755|NCT01632345|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030756|NCT01632345|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92030757|NCT01632345|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92030758|NCT01632345|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92030759|NCT01632345|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92030760|NCT01632345|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92030761|NCT01632345|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92030762|NCT01632345|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92030763|NCT01632345|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92030764|NCT02232243|Hydroxychloroquine|hydroxychloroquine|mesh-list
92030765|NCT02232243|Antimalarials|antimalarials|mesh-ancestor
92030766|NCT02232243|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92030767|NCT02232243|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92030768|NCT02232243|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030769|NCT02232243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030770|NCT02232243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030771|NCT02232243|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030773|NCT02205333|Durvalumab|durvalumab|mesh-list
92030774|NCT02205333|Tremelimumab|tremelimumab|mesh-list
92030775|NCT02205333|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030776|NCT02205333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030777|NCT02205333|Immunologic Factors|immunologic factors|mesh-ancestor
92030778|NCT02205333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030779|NCT02205333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030794|NCT04776369|Anticonvulsants|anticonvulsants|mesh-ancestor
92030795|NCT04776369|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92030796|NCT04776369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92030797|NCT04776369|Tocolytic Agents|tocolytic agents|mesh-ancestor
92030798|NCT04776369|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92030799|NCT02230527|Clopidogrel|clopidogrel|mesh-list
92030800|NCT02230527|Ticagrelor|ticagrelor|mesh-list
92030801|NCT02230527|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92030802|NCT02230527|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
91985250|NCT02389751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985251|NCT02390063|Cyclophosphamide|cyclophosphamide|mesh-list
92030803|NCT02230527|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92030804|NCT02230527|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92030805|NCT02230527|Purinergic Agents|purinergic agents|mesh-ancestor
92030807|NCT02230527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030808|NCT02230527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030809|NCT03155061|Nivolumab|nivolumab|mesh-list
92030810|NCT03155061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030811|NCT03155061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030812|NCT03155061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92030813|NCT03155061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030814|NCT02227875|Insulin Glargine|insulin glargine|mesh-list
92030815|NCT02227875|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92030816|NCT02227875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030818|NCT02203149|Antiviral Agents|antiviral agents|mesh-ancestor
92030819|NCT02203149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030820|NCT02520063|Everolimus|everolimus|mesh-list
92030821|NCT02520063|Letrozole|letrozole|mesh-list
92030822|NCT02520063|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92030823|NCT02520063|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030824|NCT02520063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030825|NCT02520063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030826|NCT02520063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030827|NCT02520063|Immunologic Factors|immunologic factors|mesh-ancestor
92030828|NCT02520063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030829|NCT02520063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030830|NCT02520063|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92030831|NCT02520063|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92030832|NCT02520063|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92030833|NCT02520063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92030834|NCT02520063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030836|NCT02202837|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92030838|NCT02202837|Analgesics|analgesics|mesh-ancestor
92030839|NCT02202837|Sensory System Agents|sensory system agents|mesh-ancestor
92030840|NCT02202837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030841|NCT02202837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030842|NCT02202837|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030843|NCT02202837|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030844|NCT02202837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030845|NCT02202837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030846|NCT02202837|Immunologic Factors|immunologic factors|mesh-ancestor
92030848|NCT02226549|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92030849|NCT02226549|Ledipasvir|ledipasvir|mesh-list
92030850|NCT02226549|Antiviral Agents|antiviral agents|mesh-ancestor
92030851|NCT02226549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030852|NCT02226003|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92030853|NCT02226003|Glimepiride|glimepiride|mesh-list
92030854|NCT02226003|Ertugliflozin|ertugliflozin|mesh-list
92030855|NCT02226003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92030856|NCT02226003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030857|NCT02226003|Incretins|incretins|mesh-ancestor
92030858|NCT02226003|Hormones|hormones|mesh-ancestor
92030859|NCT02226003|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030860|NCT02226003|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92030861|NCT02226003|Protease Inhibitors|protease inhibitors|mesh-ancestor
92030862|NCT02226003|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030863|NCT02226003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030864|NCT02226003|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92030865|NCT02226003|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030866|NCT02226003|Immunologic Factors|immunologic factors|mesh-ancestor
92030867|NCT02226003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92030868|NCT02469519|Dexamethasone|dexamethasone|mesh-list
92030869|NCT02469519|Betamethasone|betamethasone|mesh-list
92030870|NCT02469519|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91985252|NCT02390063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91985253|NCT02390063|Immunologic Factors|immunologic factors|mesh-ancestor
91985254|NCT02390063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030871|NCT02469519|Antiemetics|antiemetics|mesh-ancestor
92030872|NCT02469519|Autonomic Agents|autonomic agents|mesh-ancestor
92030873|NCT02469519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030874|NCT02469519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030875|NCT02469519|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030876|NCT02469519|Glucocorticoids|glucocorticoids|mesh-ancestor
92030877|NCT02469519|Hormones|hormones|mesh-ancestor
92030878|NCT02469519|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92030879|NCT02469519|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92030880|NCT02469519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030881|NCT02469519|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92030882|NCT02469519|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030883|NCT01634139|Tiotropium Bromide|tiotropium bromide|mesh-list
92030884|NCT01634139|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92030885|NCT01634139|Autonomic Agents|autonomic agents|mesh-ancestor
92030886|NCT01634139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030887|NCT01634139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030888|NCT01634139|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92030889|NCT01634139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92030890|NCT01634139|Parasympatholytics|parasympatholytics|mesh-ancestor
92030891|NCT01634139|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92030892|NCT01634139|Cholinergic Agents|cholinergic agents|mesh-ancestor
92030893|NCT01634139|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030894|NCT01634139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030895|NCT02404441|Spartalizumab|spartalizumab|mesh-list
92030896|NCT02404441|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92030897|NCT02404441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030898|NCT02404441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030899|NCT02404441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030901|NCT02101281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92030902|NCT02101281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030903|NCT02224599|Cyclophosphamide|cyclophosphamide|mesh-list
92030904|NCT02224599|Imiquimod|imiquimod|mesh-list
92030905|NCT02224599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92030906|NCT02224599|Immunologic Factors|immunologic factors|mesh-ancestor
92030907|NCT02224599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030908|NCT02224599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030909|NCT02224599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92030918|NCT04763577|Vasodilator Agents|vasodilator agents|mesh-ancestor
92030919|NCT04763577|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92030920|NCT04763577|Protease Inhibitors|protease inhibitors|mesh-ancestor
92030922|NCT04763577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030924|NCT02201901|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92030926|NCT02201901|Antiviral Agents|antiviral agents|mesh-ancestor
92030927|NCT02201901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030928|NCT02224053|Osimertinib|osimertinib|mesh-list
92030929|NCT02224053|Omeprazole|omeprazole|mesh-list
92030930|NCT02224053|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92030931|NCT02224053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030932|NCT02224053|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92030933|NCT02224053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030934|NCT02224053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030935|NCT02224053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030936|NCT02224053|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030937|NCT04762875|Plerixafor|plerixafor|mesh-list
92030938|NCT04762875|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92030939|NCT04762875|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92030941|NCT04762875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030942|NCT04774107|Ribavirin|ribavirin|mesh-list
92030943|NCT04774107|Antimetabolites|antimetabolites|mesh-ancestor
92030944|NCT04774107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030945|NCT04774107|Antiviral Agents|antiviral agents|mesh-ancestor
92030946|NCT04774107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030947|NCT02457793|Ravoxertinib|ravoxertinib|mesh-list
92030948|NCT02457793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985255|NCT02390063|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030949|NCT02457793|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030950|NCT02457793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030951|NCT02457793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030952|NCT02434939|Ketamine|ketamine|mesh-list
92030953|NCT02434939|Morphine|morphine|mesh-list
92030954|NCT02434939|Analgesics|analgesics|mesh-ancestor
92030955|NCT02434939|Sensory System Agents|sensory system agents|mesh-ancestor
92030956|NCT02434939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030957|NCT02434939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030958|NCT02434939|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92030959|NCT02434939|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92030960|NCT02434939|Anesthetics, General|anesthetics, general|mesh-ancestor
92030961|NCT02434939|Anesthetics|anesthetics|mesh-ancestor
92030962|NCT02434939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030963|NCT02434939|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92030964|NCT02434939|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92030965|NCT02434939|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030966|NCT02434939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030967|NCT02434939|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92030968|NCT02434939|Narcotics|narcotics|mesh-ancestor
92030969|NCT02457325|Carticaine|carticaine|mesh-list
92030970|NCT02457325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030971|NCT02457325|Anesthetics|anesthetics|mesh-ancestor
92030972|NCT02457325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030973|NCT02457325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030974|NCT02457325|Sensory System Agents|sensory system agents|mesh-ancestor
92030975|NCT02457325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030976|NCT02434081|Nivolumab|nivolumab|mesh-list
92030977|NCT02434081|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030980|NCT02434081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030982|NCT02222493|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92030983|NCT02222493|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030984|NCT02222493|Dermatologic Agents|dermatologic agents|mesh-ancestor
92030985|NCT02222493|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030986|NCT02222493|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030987|NCT01439997|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92030988|NCT01439997|Hemostatics|hemostatics|mesh-ancestor
92030990|NCT01439997|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92030991|NCT01439997|Natriuretic Agents|natriuretic agents|mesh-ancestor
92030992|NCT01439997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030993|NCT02403271|Durvalumab|durvalumab|mesh-list
92030994|NCT02403271|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030995|NCT02403271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030996|NCT02219685|Sofosbuvir|sofosbuvir|mesh-list
92030997|NCT02219685|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92030998|NCT02219685|Ledipasvir|ledipasvir|mesh-list
92030999|NCT02219685|Antiviral Agents|antiviral agents|mesh-ancestor
92031000|NCT02219685|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031001|NCT02457247|Calcium Carbonate|calcium carbonate|mesh-list
92031003|NCT02457247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031004|NCT02457247|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031005|NCT04929535|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92031006|NCT04929535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92031007|NCT04929535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031009|NCT02198235|Buprenorphine|buprenorphine|mesh-list
92031010|NCT02198235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92031012|NCT02198235|Autonomic Agents|autonomic agents|mesh-ancestor
92031013|NCT02198235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031014|NCT02198235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031015|NCT02198235|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031016|NCT02198235|Glucocorticoids|glucocorticoids|mesh-ancestor
92031017|NCT02198235|Hormones|hormones|mesh-ancestor
92031018|NCT02198235|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031019|NCT02198235|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031020|NCT02198235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031021|NCT02198235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92031022|NCT02198235|Narcotics|narcotics|mesh-ancestor
92031023|NCT02198235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031024|NCT02198235|Analgesics|analgesics|mesh-ancestor
91985256|NCT02390063|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92031025|NCT02198235|Sensory System Agents|sensory system agents|mesh-ancestor
92031026|NCT02198235|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92031027|NCT00346125|Doxorubicin|doxorubicin|mesh-list
92031028|NCT00346125|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92031029|NCT00346125|Ifosfamide|ifosfamide|mesh-list
92031030|NCT00346125|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92031031|NCT00346125|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92031032|NCT00346125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031033|NCT00346125|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92031034|NCT00346125|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92031035|NCT00346125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031036|NCT00346125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031037|NCT00346125|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92031038|NCT00346125|Alkylating Agents|alkylating agents|mesh-ancestor
92031039|NCT00346125|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92031040|NCT04929379|Fenofibrate|fenofibrate|mesh-list
92031041|NCT04929379|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92031042|NCT04929379|Antimetabolites|antimetabolites|mesh-ancestor
92031043|NCT04929379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031044|NCT04929379|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92031045|NCT02217501|Aspirin|aspirin|mesh-list
92031046|NCT02217501|Clopidogrel|clopidogrel|mesh-list
92031134|NCT02396953|Somatostatin|somatostatin|mesh-list
92031047|NCT02217501|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92031048|NCT02217501|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92031049|NCT02217501|Analgesics|analgesics|mesh-ancestor
92031050|NCT02217501|Sensory System Agents|sensory system agents|mesh-ancestor
92031051|NCT02217501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031052|NCT02217501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031054|NCT02217501|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031057|NCT02217501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031059|NCT02217501|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92031060|NCT02217501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031061|NCT02217501|Antipyretics|antipyretics|mesh-ancestor
92031062|NCT02217501|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92031063|NCT02217501|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92031064|NCT02217501|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92031065|NCT02217501|Purinergic Agents|purinergic agents|mesh-ancestor
92031066|NCT02217501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031067|NCT01649869|Valganciclovir|valganciclovir|mesh-list
92031068|NCT01649869|Antiviral Agents|antiviral agents|mesh-ancestor
92031069|NCT01649869|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031070|NCT02197377|Chlorhexidine|chlorhexidine|mesh-list
92031071|NCT02197377|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92031072|NCT02197377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031073|NCT02197377|Disinfectants|disinfectants|mesh-ancestor
92031074|NCT02399449|Ferric gluconate|ferric gluconate|mesh-list
92031075|NCT02399449|Ferric Compounds|ferric compounds|mesh-list
92031076|NCT02399449|Hematinics|hematinics|mesh-ancestor
92031077|NCT02217345|Hormones|hormones|mesh-list
92031078|NCT02217345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031079|NCT02217345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031080|NCT02428855|Dasatinib|dasatinib|mesh-list
92031081|NCT02428855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031082|NCT02428855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92031083|NCT02428855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031084|NCT02428855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031085|NCT02428699|Cod Liver Oil|cod liver oil|mesh-list
92031086|NCT02428699|Liver Extracts|liver extracts|mesh-list
92031087|NCT02428699|Hematinics|hematinics|mesh-ancestor
92031089|NCT02428699|Micronutrients|micronutrients|mesh-ancestor
92031090|NCT02428699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031091|NCT02428231|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92031092|NCT02428231|Dermatologic Agents|dermatologic agents|mesh-ancestor
92031093|NCT02428231|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031094|NCT02428231|Immunologic Factors|immunologic factors|mesh-ancestor
92031095|NCT02428231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031096|NCT02427841|Paclitaxel|paclitaxel|mesh-list
92031097|NCT02427841|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92031098|NCT02427841|Gemcitabine|gemcitabine|mesh-list
92031099|NCT02427841|Fluorouracil|fluorouracil|mesh-list
92031100|NCT02427841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92031101|NCT02427841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031103|NCT02427841|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031104|NCT02427841|Mitosis Modulators|mitosis modulators|mesh-ancestor
92031105|NCT02427841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031106|NCT02427841|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031107|NCT02427841|Antimetabolites|antimetabolites|mesh-ancestor
92031108|NCT02427841|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031109|NCT02427841|Immunologic Factors|immunologic factors|mesh-ancestor
92031110|NCT02427841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031111|NCT02397889|Midazolam|midazolam|mesh-list
92031112|NCT02397889|Ketamine|ketamine|mesh-list
92031113|NCT02397889|Analgesics|analgesics|mesh-ancestor
92031114|NCT02397889|Sensory System Agents|sensory system agents|mesh-ancestor
92031115|NCT02397889|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031116|NCT02397889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031117|NCT02397889|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92031118|NCT02397889|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92031119|NCT02397889|Anesthetics, General|anesthetics, general|mesh-ancestor
92031120|NCT02397889|Anesthetics|anesthetics|mesh-ancestor
92031121|NCT02397889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031122|NCT02397889|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92031123|NCT02397889|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92031124|NCT02397889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031125|NCT02397889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031126|NCT02397889|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92031127|NCT02397889|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92031128|NCT02397889|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92031135|NCT02396953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031136|NCT02396953|Hormones|hormones|mesh-ancestor
92031137|NCT02396953|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031138|NCT02396953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031139|NCT02387983|Posaconazole|posaconazole|mesh-list
92031140|NCT02387983|Antifungal Agents|antifungal agents|mesh-ancestor
92031141|NCT02387983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031142|NCT02387983|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92031144|NCT02387983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92031145|NCT02387983|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92031146|NCT02387983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92031147|NCT02387983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031148|NCT02387983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031149|NCT02387983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92031150|NCT02387983|Hormone Antagonists|hormone antagonists|mesh-ancestor
92031151|NCT02387983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031152|NCT02387983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031153|NCT02395627|Tamoxifen|tamoxifen|mesh-list
92031154|NCT02395627|Pembrolizumab|pembrolizumab|mesh-list
92031156|NCT02395627|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92031157|NCT02395627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031158|NCT02395627|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92031159|NCT02395627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031160|NCT02395627|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92031161|NCT02395627|Hormone Antagonists|hormone antagonists|mesh-ancestor
92074274|NCT00074308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031162|NCT02395627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031163|NCT02395627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031164|NCT02395627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031165|NCT02395627|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92031166|NCT02395627|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92031167|NCT02395627|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92031168|NCT02395627|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92031169|NCT02395627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031170|NCT02395081|Vitamin D|vitamin d|mesh-list
92031171|NCT02395081|Ergocalciferols|ergocalciferols|mesh-list
92031172|NCT02395081|Cholecalciferol|cholecalciferol|mesh-list
92031173|NCT02395081|Vitamins|vitamins|mesh-list
92031174|NCT02395081|Micronutrients|micronutrients|mesh-ancestor
92031175|NCT02395081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985258|NCT02390063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985259|NCT02390063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031176|NCT02395081|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92031177|NCT02395081|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92031178|NCT04905277|Atenolol|atenolol|mesh-list
92031179|NCT04905277|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92031180|NCT04905277|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92031181|NCT04905277|Sympatholytics|sympatholytics|mesh-ancestor
92031182|NCT04905277|Autonomic Agents|autonomic agents|mesh-ancestor
92074275|NCT00166036|Atorvastatin|atorvastatin|mesh-list
92031183|NCT04905277|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031184|NCT04905277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074276|NCT00166036|Pravastatin|pravastatin|mesh-list
92031185|NCT04905277|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92031187|NCT04905277|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92031188|NCT04905277|Adrenergic Agents|adrenergic agents|mesh-ancestor
92031189|NCT04905277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031190|NCT04905277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031191|NCT02426125|Docetaxel|docetaxel|mesh-list
92031192|NCT02426125|Ramucirumab|ramucirumab|mesh-list
92031193|NCT02426125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031194|NCT02426125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92031195|NCT02426125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031196|NCT02426125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92031197|NCT02426125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031198|NCT02425111|Vedolizumab|vedolizumab|mesh-list
92031201|NCT02393755|Nintedanib|nintedanib|mesh-list
92031202|NCT02393755|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92031203|NCT02393755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031204|NCT02393755|Antimetabolites|antimetabolites|mesh-ancestor
92031205|NCT02393755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031206|NCT02393755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031207|NCT02393755|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92031208|NCT02393755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031209|NCT02393209|Docetaxel|docetaxel|mesh-list
92031210|NCT02393209|Serabelisib|serabelisib|mesh-list
92031211|NCT02393209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031212|NCT02393209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92031213|NCT02393209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031214|NCT02393209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92031215|NCT02393209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031216|NCT02393209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031218|NCT02424097|Fluorides|fluorides|mesh-list
92031219|NCT02424097|Sodium Fluoride|sodium fluoride|mesh-list
92031220|NCT02424097|Fluorides, Topical|fluorides, topical|mesh-list
92031221|NCT02424097|Cariostatic Agents|cariostatic agents|mesh-ancestor
92031222|NCT02424097|Protective Agents|protective agents|mesh-ancestor
92031223|NCT02424097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031224|NCT02424097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92031225|NCT02424097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031226|NCT02392507|Paclitaxel|paclitaxel|mesh-list
92031227|NCT02392507|Carboplatin|carboplatin|mesh-list
92031228|NCT02392507|Necitumumab|necitumumab|mesh-list
92031229|NCT02392507|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92031230|NCT02392507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031231|NCT02392507|Tubulin Modulators|tubulin modulators|mesh-ancestor
92031232|NCT02392507|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031233|NCT02392507|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081694|NCT01402947|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92031234|NCT02392507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031235|NCT02392507|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92031236|NCT04904341|Cerebrolysin|cerebrolysin|mesh-list
92031237|NCT04904341|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92031238|NCT04904341|Protective Agents|protective agents|mesh-ancestor
92031239|NCT04904341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031240|NCT04904341|Nootropic Agents|nootropic agents|mesh-ancestor
92031242|NCT02385799|Antidepressive Agents|antidepressive agents|mesh-ancestor
92031243|NCT02385799|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031244|NCT02385799|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92031245|NCT02385799|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92031246|NCT02385799|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985260|NCT02390063|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91985261|NCT02388035|Cefotaxime|cefotaxime|mesh-list
91985262|NCT02388035|Cefoxitin|cefoxitin|mesh-list
91985263|NCT02388035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92031247|NCT02385799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031248|NCT02385799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031249|NCT02385799|Serotonin Agents|serotonin agents|mesh-ancestor
92031250|NCT02385799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031252|NCT02422303|Analgesics|analgesics|mesh-ancestor
92031253|NCT02422303|Sensory System Agents|sensory system agents|mesh-ancestor
92031254|NCT02422303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031255|NCT02422303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031256|NCT02422303|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92031257|NCT02422303|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92031258|NCT02422303|Anesthetics, General|anesthetics, general|mesh-ancestor
92031259|NCT02422303|Anesthetics|anesthetics|mesh-ancestor
92031260|NCT02422303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031261|NCT02422303|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92031262|NCT02422303|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92031263|NCT02422303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031264|NCT02422303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031265|NCT02391961|4-Aminopyridine|4-aminopyridine|mesh-list
92031266|NCT02391961|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92031267|NCT02391961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92031268|NCT02391961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031269|NCT02384941|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|mesh-list
92031281|NCT02384395|Antiviral Agents|antiviral agents|mesh-ancestor
92031282|NCT02384395|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031283|NCT02384395|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92031284|NCT02384395|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92031285|NCT02384395|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92031286|NCT02384395|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92031287|NCT02391337|Digoxin|digoxin|mesh-list
92031288|NCT02391337|Bisoprolol|bisoprolol|mesh-list
92031289|NCT02391337|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92031290|NCT02391337|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92031291|NCT02391337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031292|NCT02391337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031293|NCT02391337|Protective Agents|protective agents|mesh-ancestor
92031294|NCT02391337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031295|NCT02391337|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92031296|NCT02391337|Sympatholytics|sympatholytics|mesh-ancestor
92031297|NCT02391337|Autonomic Agents|autonomic agents|mesh-ancestor
92031298|NCT02391337|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031299|NCT02391337|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92031300|NCT02391337|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92031301|NCT02391337|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92031302|NCT02391337|Adrenergic Agents|adrenergic agents|mesh-ancestor
92031303|NCT02391337|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031304|NCT01649791|Lenalidomide|lenalidomide|mesh-list
92031305|NCT01649791|Immunologic Factors|immunologic factors|mesh-ancestor
92031306|NCT01649791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031307|NCT01649791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92031308|NCT01649791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92031309|NCT01649791|Growth Substances|growth substances|mesh-ancestor
92031310|NCT01649791|Growth Inhibitors|growth inhibitors|mesh-ancestor
92031311|NCT01649791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031313|NCT02347657|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92031314|NCT02347657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92031315|NCT02347657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031316|NCT02346721|Sofosbuvir|sofosbuvir|mesh-list
92031317|NCT02346721|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92031318|NCT02346721|Velpatasvir|velpatasvir|mesh-list
92031319|NCT02346721|Antiviral Agents|antiviral agents|mesh-ancestor
92031320|NCT02346721|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031321|NCT02388997|Omalizumab|omalizumab|mesh-list
92031322|NCT02388997|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92031323|NCT02388997|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91985264|NCT02388035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985265|NCT02389439|Artesunate|artesunate|mesh-list
91985266|NCT02389439|Pyronaridine|pyronaridine|mesh-list
91985267|NCT02389439|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
91985268|NCT02389439|Antimalarials|antimalarials|mesh-ancestor
91985269|NCT02389439|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92031324|NCT02388997|Respiratory System Agents|respiratory system agents|mesh-ancestor
92031325|NCT02345161|Budesonide|budesonide|mesh-list
92031326|NCT02345161|Albuterol|albuterol|mesh-list
92031327|NCT02345161|Formoterol Fumarate|formoterol fumarate|mesh-list
92031328|NCT02345161|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92031329|NCT02345161|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92031330|NCT02345161|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92031331|NCT02345161|Autonomic Agents|autonomic agents|mesh-ancestor
92031332|NCT02345161|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031335|NCT02345161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92031336|NCT02345161|Glucocorticoids|glucocorticoids|mesh-ancestor
92031337|NCT02345161|Hormones|hormones|mesh-ancestor
92031338|NCT02345161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031339|NCT02345161|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92031340|NCT02345161|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92031341|NCT02345161|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92031342|NCT02345161|Adrenergic Agents|adrenergic agents|mesh-ancestor
92031343|NCT02345161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031344|NCT02345161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031345|NCT02345161|Tocolytic Agents|tocolytic agents|mesh-ancestor
92031346|NCT02345161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031347|NCT02251275|Tolvaptan|tolvaptan|mesh-list
92031348|NCT02251275|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92031349|NCT02251275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031350|NCT02251275|Natriuretic Agents|natriuretic agents|mesh-ancestor
92031351|NCT02251275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031352|NCT02379637|Acetylcysteine|acetylcysteine|mesh-list
92031353|NCT02379637|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92031354|NCT02379637|Antiviral Agents|antiviral agents|mesh-ancestor
92031355|NCT02379637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031356|NCT02379637|Expectorants|expectorants|mesh-ancestor
92031357|NCT02379637|Respiratory System Agents|respiratory system agents|mesh-ancestor
92031358|NCT02379637|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92031359|NCT02379637|Antioxidants|antioxidants|mesh-ancestor
92031360|NCT02379637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031361|NCT02379637|Protective Agents|protective agents|mesh-ancestor
92031362|NCT02379637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031363|NCT02379637|Antidotes|antidotes|mesh-ancestor
92031365|NCT02195583|Listerine|listerine|mesh-list
92031366|NCT02195583|Fluorides|fluorides|mesh-list
92031367|NCT02195583|Sodium Fluoride|sodium fluoride|mesh-list
92031368|NCT02195583|Cariostatic Agents|cariostatic agents|mesh-ancestor
92031369|NCT02195583|Protective Agents|protective agents|mesh-ancestor
92031370|NCT02195583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031371|NCT02195583|Trace Elements|trace elements|mesh-ancestor
92031372|NCT02195583|Micronutrients|micronutrients|mesh-ancestor
92031373|NCT02195583|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92031374|NCT02195583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031375|NCT02379091|Leucovorin|leucovorin|mesh-list
92031376|NCT02379091|Folic Acid|folic acid|mesh-list
92031377|NCT02379091|Methotrexate|methotrexate|mesh-list
92031378|NCT02379091|Levoleucovorin|levoleucovorin|mesh-list
92031379|NCT02379091|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92031380|NCT02379091|Abortifacient Agents|abortifacient agents|mesh-ancestor
92031381|NCT02379091|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031382|NCT02379091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031383|NCT02379091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031384|NCT02379091|Antimetabolites|antimetabolites|mesh-ancestor
92031385|NCT02379091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031386|NCT02379091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031387|NCT02379091|Dermatologic Agents|dermatologic agents|mesh-ancestor
92031388|NCT02379091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031389|NCT02379091|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92031390|NCT02379091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031391|NCT02379091|Immunologic Factors|immunologic factors|mesh-ancestor
92031392|NCT02379091|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031393|NCT02379091|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92031394|NCT02379091|Antidotes|antidotes|mesh-ancestor
92031395|NCT02379091|Protective Agents|protective agents|mesh-ancestor
92031396|NCT02379091|Vitamin B Complex|vitamin b complex|mesh-ancestor
92031397|NCT02379091|Vitamins|vitamins|mesh-ancestor
92031398|NCT02379091|Micronutrients|micronutrients|mesh-ancestor
92031399|NCT02379091|Hematinics|hematinics|mesh-ancestor
92031400|NCT02378935|Sofosbuvir|sofosbuvir|mesh-list
92031401|NCT02378935|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92031402|NCT02378935|Velpatasvir|velpatasvir|mesh-list
92031403|NCT02378935|Antiviral Agents|antiviral agents|mesh-ancestor
92031404|NCT02378935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031405|NCT02250651|Timolol|timolol|mesh-list
92031406|NCT02250651|Bimatoprost|bimatoprost|mesh-list
92031407|NCT02250651|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92031409|NCT02250651|Adrenergic Agents|adrenergic agents|mesh-ancestor
92031410|NCT02250651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031411|NCT02250651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031412|NCT02250651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031413|NCT02250651|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92031414|NCT02250651|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92031416|NCT02214225|Immunologic Factors|immunologic factors|mesh-ancestor
92031417|NCT02214225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031418|NCT02249949|Efatutazone|efatutazone|mesh-list
92031419|NCT02249949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031420|NCT02249091|Cytarabine|cytarabine|mesh-list
92031421|NCT02249091|Idarubicin|idarubicin|mesh-list
92031422|NCT02249091|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031423|NCT02249091|Antimetabolites|antimetabolites|mesh-ancestor
92031424|NCT02249091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031425|NCT02249091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031426|NCT02249091|Antiviral Agents|antiviral agents|mesh-ancestor
92031427|NCT02249091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031428|NCT02249091|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031429|NCT02249091|Immunologic Factors|immunologic factors|mesh-ancestor
92031430|NCT02249091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031431|NCT02249091|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92031432|NCT02249091|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92031433|NCT02249091|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92031434|NCT02249091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031436|NCT02213055|Malathion|malathion|mesh-list
92031437|NCT02213055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031438|NCT02213055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031439|NCT02213055|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92031440|NCT02213055|Cholinergic Agents|cholinergic agents|mesh-ancestor
92031441|NCT02213055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031442|NCT02213055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031443|NCT02309515|Lenalidomide|lenalidomide|mesh-list
92031444|NCT02309515|Vaccines|vaccines|mesh-list
92031445|NCT02309515|Immunologic Factors|immunologic factors|mesh-ancestor
92031446|NCT02309515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031447|NCT02309515|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92031448|NCT02309515|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92031449|NCT02309515|Growth Substances|growth substances|mesh-ancestor
92031450|NCT02309515|Growth Inhibitors|growth inhibitors|mesh-ancestor
92031451|NCT02309515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031452|NCT02309359|Methotrexate|methotrexate|mesh-list
92031453|NCT02309359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92031454|NCT02309359|Abortifacient Agents|abortifacient agents|mesh-ancestor
92031455|NCT02309359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031456|NCT02309359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031457|NCT02309359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031458|NCT02309359|Antimetabolites|antimetabolites|mesh-ancestor
92031459|NCT02309359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031460|NCT02309359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031461|NCT02309359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92031462|NCT02309359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031463|NCT02309359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92031464|NCT02309359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031465|NCT02309359|Immunologic Factors|immunologic factors|mesh-ancestor
92031466|NCT02309359|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985270|NCT02389439|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92031467|NCT02309359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92031468|NCT02375971|Ranibizumab|ranibizumab|mesh-list
92031469|NCT02375971|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92031470|NCT02375971|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92031471|NCT02375971|Growth Substances|growth substances|mesh-ancestor
92031472|NCT02375971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031474|NCT02375971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031475|NCT04886323|Itraconazole|itraconazole|mesh-list
92031476|NCT04886323|Antifungal Agents|antifungal agents|mesh-ancestor
92031477|NCT04886323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031478|NCT04886323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92031479|NCT04886323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92031480|NCT04886323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031481|NCT04886323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031484|NCT04886323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031486|NCT04886323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92031488|NCT02212197|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92031489|NCT02212197|Fertility Agents|fertility agents|mesh-ancestor
92031490|NCT02212197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031491|NCT02212197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031492|NCT02212197|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031493|NCT02212197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031494|NCT02193165|Triclosan|triclosan|mesh-list
92031495|NCT02193165|Cetylpyridinium|cetylpyridinium|mesh-list
92031496|NCT02193165|Fluorides|fluorides|mesh-list
92031497|NCT02193165|Tin Fluorides|tin fluorides|mesh-list
92031498|NCT02193165|Cariostatic Agents|cariostatic agents|mesh-ancestor
92031499|NCT02193165|Protective Agents|protective agents|mesh-ancestor
92031500|NCT02193165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031501|NCT02193165|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92031502|NCT02193165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031503|NCT02193165|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92031505|NCT02193165|Antimetabolites|antimetabolites|mesh-ancestor
92031506|NCT02193165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031507|NCT02193165|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92031508|NCT01617460|Aripiprazole|aripiprazole|mesh-list
92031509|NCT01617460|Antidepressive Agents|antidepressive agents|mesh-ancestor
92031510|NCT01617460|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031511|NCT01617460|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92031512|NCT01617460|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92031513|NCT01617460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031514|NCT01617460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031515|NCT01617460|Dopamine Agonists|dopamine agonists|mesh-ancestor
92031516|NCT01617460|Dopamine Agents|dopamine agents|mesh-ancestor
92031517|NCT01617460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031518|NCT01617460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031519|NCT01617460|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92031520|NCT01617460|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92031521|NCT01617460|Serotonin Agents|serotonin agents|mesh-ancestor
92031522|NCT01617460|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92031523|NCT01617460|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92031524|NCT01617460|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92031525|NCT01617460|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92031526|NCT01889602|Topiramate|topiramate|mesh-list
92031527|NCT01889602|Lorazepam|lorazepam|mesh-list
92031528|NCT01889602|Anticonvulsants|anticonvulsants|mesh-ancestor
92031529|NCT01889602|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92031530|NCT01889602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031531|NCT01889602|Antiemetics|antiemetics|mesh-ancestor
92031532|NCT01889602|Autonomic Agents|autonomic agents|mesh-ancestor
92031533|NCT01889602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031534|NCT01889602|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031535|NCT01889602|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92031536|NCT01889602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031537|NCT01889602|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92031538|NCT01889602|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92031539|NCT01889602|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031540|NCT01889602|GABA Modulators|gaba modulators|mesh-ancestor
92031541|NCT01889602|GABA Agents|gaba agents|mesh-ancestor
92031542|NCT01889602|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985271|NCT02389439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985272|NCT02389439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985273|NCT02389439|Antiviral Agents|antiviral agents|mesh-ancestor
91985274|NCT02389439|Schistosomicides|schistosomicides|mesh-ancestor
91985275|NCT02389439|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92031543|NCT01889602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031544|NCT01935700|Colchicine|colchicine|mesh-list
92031545|NCT01935700|Gout Suppressants|gout suppressants|mesh-ancestor
92031546|NCT01935700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031547|NCT01935700|Tubulin Modulators|tubulin modulators|mesh-ancestor
92031548|NCT01935700|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031549|NCT01935700|Mitosis Modulators|mitosis modulators|mesh-ancestor
92031550|NCT01935700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031551|NCT01935700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031552|NCT01618162|Liraglutide|liraglutide|mesh-list
92031553|NCT01618162|Xultophy|xultophy|mesh-list
92031555|NCT01618162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031556|NCT01618162|Incretins|incretins|mesh-ancestor
92031557|NCT01618162|Hormones|hormones|mesh-ancestor
92031558|NCT01618162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031559|NCT04771767|Ketamine|ketamine|mesh-list
92031560|NCT04771767|Analgesics|analgesics|mesh-ancestor
92031561|NCT04771767|Sensory System Agents|sensory system agents|mesh-ancestor
92031562|NCT04771767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031563|NCT04771767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031564|NCT04771767|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92031565|NCT04771767|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92031566|NCT04771767|Anesthetics, General|anesthetics, general|mesh-ancestor
92031567|NCT04771767|Anesthetics|anesthetics|mesh-ancestor
92031568|NCT04771767|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031569|NCT04771767|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92031570|NCT04771767|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92031571|NCT04771767|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031572|NCT04771767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031573|NCT02341417|Cinacalcet|cinacalcet|mesh-list
92031574|NCT02341417|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92031575|NCT02341417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031576|NCT02341417|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92031577|NCT02341417|Hormone Antagonists|hormone antagonists|mesh-ancestor
92031578|NCT02341417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031580|NCT02340949|Oxaliplatin|oxaliplatin|mesh-list
92031581|NCT02340949|Aflibercept|aflibercept|mesh-list
92031582|NCT02340949|Fluorouracil|fluorouracil|mesh-list
92031583|NCT02340949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031584|NCT02340949|Antidotes|antidotes|mesh-ancestor
92031585|NCT02340949|Protective Agents|protective agents|mesh-ancestor
92031586|NCT02340949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031587|NCT02340949|Vitamin B Complex|vitamin b complex|mesh-ancestor
92031588|NCT02340949|Vitamins|vitamins|mesh-ancestor
92031589|NCT02340949|Micronutrients|micronutrients|mesh-ancestor
92031590|NCT02340949|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92031591|NCT02340949|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92031592|NCT02340949|Growth Substances|growth substances|mesh-ancestor
92031593|NCT02340949|Growth Inhibitors|growth inhibitors|mesh-ancestor
92031594|NCT02340949|Antimetabolites|antimetabolites|mesh-ancestor
92031670|NCT02168439|Dexmedetomidine|dexmedetomidine|mesh-list
92031595|NCT02340949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031596|NCT02340949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031597|NCT02340949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031598|NCT02340949|Immunologic Factors|immunologic factors|mesh-ancestor
92031599|NCT02374957|Cilostazol|cilostazol|mesh-list
92031600|NCT02374957|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92031601|NCT02374957|Autonomic Agents|autonomic agents|mesh-ancestor
92031602|NCT02374957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031603|NCT02374957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031604|NCT02374957|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92031605|NCT02374957|Respiratory System Agents|respiratory system agents|mesh-ancestor
92031606|NCT02374957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92031607|NCT02374957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92081695|NCT01402947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91985276|NCT02389439|Anthelmintics|anthelmintics|mesh-ancestor
91985277|NCT02663687|Complement C1s|complement c1s|mesh-list
92031608|NCT02374957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031609|NCT02374957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92031610|NCT02374957|Vasodilator Agents|vasodilator agents|mesh-ancestor
92031611|NCT02374957|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92031612|NCT02374957|Protective Agents|protective agents|mesh-ancestor
92031613|NCT02374957|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92031614|NCT02374957|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92031615|NCT02374957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031617|NCT02308033|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031618|NCT02308033|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92031619|NCT02308033|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92031620|NCT02308033|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92031621|NCT02339155|Diphenhydramine|diphenhydramine|mesh-list
92031622|NCT02339155|Promethazine|promethazine|mesh-list
92031623|NCT02339155|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92031624|NCT02339155|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92031625|NCT02339155|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031626|NCT02339155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031629|NCT02339155|Sensory System Agents|sensory system agents|mesh-ancestor
92031630|NCT02339155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031631|NCT02339155|Antiemetics|antiemetics|mesh-ancestor
92031632|NCT02339155|Autonomic Agents|autonomic agents|mesh-ancestor
92031633|NCT02339155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031634|NCT02339155|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92031635|NCT02339155|Histamine Antagonists|histamine antagonists|mesh-ancestor
92031636|NCT02339155|Histamine Agents|histamine agents|mesh-ancestor
92031637|NCT02339155|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031638|NCT02339155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031639|NCT02339155|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92031640|NCT02339155|Antipruritics|antipruritics|mesh-ancestor
92031641|NCT02339155|Dermatologic Agents|dermatologic agents|mesh-ancestor
92031642|NCT02170077|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92031643|NCT02170077|Anticonvulsants|anticonvulsants|mesh-ancestor
92031644|NCT02170077|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92031645|NCT02170077|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92031646|NCT02170077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92031647|NCT02170077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031648|NCT02210091|Factor VIII|factor viii|mesh-list
92031649|NCT02210091|BAX 855|bax 855|mesh-list
92031650|NCT02210091|Coagulants|coagulants|mesh-ancestor
92031651|NCT02338999|Pioglitazone|pioglitazone|mesh-list
92031652|NCT02338999|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92031653|NCT02338999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031654|NCT02169219|Prednisone|prednisone|mesh-list
92031655|NCT02169219|Rituximab|rituximab|mesh-list
92031656|NCT02169219|Glucocorticoids|glucocorticoids|mesh-list
92031657|NCT02169219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92031658|NCT02169219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031659|NCT02169219|Immunologic Factors|immunologic factors|mesh-ancestor
92031660|NCT02169219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031661|NCT02169219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031662|NCT02169219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92031663|NCT02169219|Hormones|hormones|mesh-ancestor
92031664|NCT02169219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031665|NCT02169219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031666|NCT02191137|Riociguat|riociguat|mesh-list
92031667|NCT02191137|Enzyme Activators|enzyme activators|mesh-ancestor
92031668|NCT02191137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031669|NCT02168439|Midazolam|midazolam|mesh-list
92031671|NCT02168439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92031672|NCT02168439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031673|NCT02168439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031674|NCT02168439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92031675|NCT02168439|Analgesics|analgesics|mesh-ancestor
92031676|NCT02168439|Sensory System Agents|sensory system agents|mesh-ancestor
92031677|NCT02168439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031678|NCT02168439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92031679|NCT02168439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92031680|NCT02168439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92031681|NCT02168439|Adrenergic Agents|adrenergic agents|mesh-ancestor
91985278|NCT02663687|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
91985279|NCT02663687|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
91985280|NCT02663687|Immunologic Factors|immunologic factors|mesh-ancestor
92031682|NCT02168439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081696|NCT01402947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031683|NCT02168439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031684|NCT02168439|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92031685|NCT02168439|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92031686|NCT02168439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92031687|NCT02168439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031688|NCT02168439|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92031689|NCT02168439|Anesthetics, General|anesthetics, general|mesh-ancestor
92031690|NCT02168439|Anesthetics|anesthetics|mesh-ancestor
92031691|NCT02168439|GABA Modulators|gaba modulators|mesh-ancestor
92031692|NCT02168439|GABA Agents|gaba agents|mesh-ancestor
92031693|NCT02338843|Angiotensin II|angiotensin ii|mesh-list
92031694|NCT02338843|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92031695|NCT02135445|Relugolix|relugolix|mesh-list
92031696|NCT02135445|Androgen Antagonists|androgen antagonists|mesh-ancestor
92031697|NCT02135445|Hormone Antagonists|hormone antagonists|mesh-ancestor
92031698|NCT02135445|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031699|NCT02135445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031700|NCT02374099|Azacitidine|azacitidine|mesh-list
92031705|NCT02374099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031706|NCT02374099|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031707|NCT02374099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031708|NCT02374099|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031709|NCT02374099|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92031710|NCT02374099|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92031711|NCT02374099|Hormone Antagonists|hormone antagonists|mesh-ancestor
92031712|NCT02374099|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031713|NCT02374099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031715|NCT02134977|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92031716|NCT02134977|Fertility Agents|fertility agents|mesh-ancestor
92031717|NCT02134977|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031718|NCT02134977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031719|NCT02134977|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031720|NCT02134977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031721|NCT02374021|Hydroxychloroquine|hydroxychloroquine|mesh-list
92031722|NCT02374021|Sulfasalazine|sulfasalazine|mesh-list
92031723|NCT02374021|Adalimumab|adalimumab|mesh-list
92031724|NCT02374021|Etanercept|etanercept|mesh-list
92031725|NCT02374021|Methotrexate|methotrexate|mesh-list
92031726|NCT02374021|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92031727|NCT02374021|Abortifacient Agents|abortifacient agents|mesh-ancestor
92031728|NCT02374021|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031729|NCT02374021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031730|NCT02374021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031731|NCT02374021|Antimetabolites|antimetabolites|mesh-ancestor
92031732|NCT02374021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031733|NCT02374021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031734|NCT02374021|Dermatologic Agents|dermatologic agents|mesh-ancestor
92031735|NCT02374021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031736|NCT02374021|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92031737|NCT02374021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031738|NCT02374021|Immunologic Factors|immunologic factors|mesh-ancestor
92031739|NCT02374021|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031740|NCT02374021|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92031741|NCT02374021|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92031742|NCT02374021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92031743|NCT02374021|Antimalarials|antimalarials|mesh-ancestor
92031744|NCT02374021|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92031745|NCT02374021|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92031746|NCT02374021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031747|NCT02374021|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92031748|NCT02374021|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92031750|NCT02374021|Sensory System Agents|sensory system agents|mesh-ancestor
92031751|NCT02374021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031752|NCT02374021|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031753|NCT02372383|Azithromycin|azithromycin|mesh-list
92031754|NCT02372383|Rifampin|rifampin|mesh-list
91985281|NCT02663687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031755|NCT02372383|Ethambutol|ethambutol|mesh-list
92031756|NCT02372383|Pancrelipase|pancrelipase|mesh-list
92031757|NCT02372383|Pancreatin|pancreatin|mesh-list
92031758|NCT02372383|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92031759|NCT02372383|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92031760|NCT02372383|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92031761|NCT02372383|Antitubercular Agents|antitubercular agents|mesh-ancestor
92031762|NCT02372383|Leprostatic Agents|leprostatic agents|mesh-ancestor
92031763|NCT02372383|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92031764|NCT02372383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031765|NCT02372383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031766|NCT02372383|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92031767|NCT02372383|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92031768|NCT02372383|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92031769|NCT02372383|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92031770|NCT02372383|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92031771|NCT02372383|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92031775|NCT01648699|Narcotics|narcotics|mesh-ancestor
92031776|NCT01648699|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031777|NCT01648699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031778|NCT01648699|Analgesics|analgesics|mesh-ancestor
92031779|NCT01648699|Sensory System Agents|sensory system agents|mesh-ancestor
92031780|NCT01648699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031781|NCT02134353|Mannitol|mannitol|mesh-list
92031782|NCT02134353|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92031783|NCT02134353|Diuretics|diuretics|mesh-ancestor
92031784|NCT02134353|Natriuretic Agents|natriuretic agents|mesh-ancestor
92031785|NCT02134353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031786|NCT01646125|Docetaxel|docetaxel|mesh-list
92031787|NCT01646125|Pemetrexed|pemetrexed|mesh-list
92031788|NCT01646125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031789|NCT01646125|Tubulin Modulators|tubulin modulators|mesh-ancestor
92031790|NCT01646125|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031791|NCT01646125|Mitosis Modulators|mitosis modulators|mesh-ancestor
92031792|NCT01646125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031793|NCT01646125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031794|NCT01646125|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92031795|NCT01646125|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92031796|NCT01362790|Cyclophosphamide|cyclophosphamide|mesh-list
92031797|NCT01362790|Pentostatin|pentostatin|mesh-list
92031798|NCT01362790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92031799|NCT01362790|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031800|NCT01362790|Immunologic Factors|immunologic factors|mesh-ancestor
92031801|NCT01362790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031802|NCT01362790|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031803|NCT01362790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92031804|NCT01362790|Alkylating Agents|alkylating agents|mesh-ancestor
92031805|NCT01362790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031806|NCT01362790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031807|NCT01362790|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92031808|NCT01362790|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92031809|NCT01362790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031811|NCT02167893|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92031812|NCT02167893|Fertility Agents|fertility agents|mesh-ancestor
92031813|NCT02167893|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92031814|NCT02167893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031815|NCT02167893|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031816|NCT02167893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031817|NCT02167035|Brimonidine Tartrate, Timolol Maleate Drug Combination|brimonidine tartrate, timolol maleate drug combination|mesh-list
92031818|NCT02167035|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92031819|NCT02167035|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92031820|NCT02167035|Adrenergic Agents|adrenergic agents|mesh-ancestor
92031821|NCT02167035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031822|NCT02167035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985292|NCT04439825|Cholinergic Agents|cholinergic agents|mesh-ancestor
92031823|NCT02167035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031824|NCT02167035|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92031825|NCT02167035|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92031826|NCT02167035|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92031827|NCT01615198|Olmesartan|olmesartan|mesh-list
91985282|NCT02663687|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91985284|NCT02663453|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92031828|NCT01615198|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92031829|NCT01615198|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92031830|NCT01615198|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92031831|NCT01615198|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92031832|NCT01615198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031833|NCT02337907|Donepezil|donepezil|mesh-list
92031834|NCT02337907|BI 409306|bi 409306|mesh-list
92031835|NCT02337907|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92031836|NCT02337907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031837|NCT02337907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031838|NCT02337907|Cholinergic Agents|cholinergic agents|mesh-ancestor
92031839|NCT02337907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031840|NCT02337907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031841|NCT02337907|Nootropic Agents|nootropic agents|mesh-ancestor
92031842|NCT02337907|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92031843|NCT01913470|Losartan|losartan|mesh-list
92031846|NCT01913470|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92031847|NCT01913470|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92031848|NCT01913470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031850|NCT02166333|Ergocalciferols|ergocalciferols|mesh-list
92031851|NCT02166333|Cholecalciferol|cholecalciferol|mesh-list
92031852|NCT02166333|Vitamins|vitamins|mesh-list
92031853|NCT02166333|Micronutrients|micronutrients|mesh-ancestor
92031854|NCT02166333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031855|NCT02166333|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92031856|NCT02166333|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92031857|NCT02132949|Paclitaxel|paclitaxel|mesh-list
92031858|NCT02132949|Docetaxel|docetaxel|mesh-list
92031859|NCT02132949|Cyclophosphamide|cyclophosphamide|mesh-list
92031860|NCT02132949|Doxorubicin|doxorubicin|mesh-list
92031861|NCT02132949|Fluorouracil|fluorouracil|mesh-list
92031862|NCT02132949|Trastuzumab|trastuzumab|mesh-list
92031863|NCT02132949|Epirubicin|epirubicin|mesh-list
92031864|NCT02132949|Pertuzumab|pertuzumab|mesh-list
92031865|NCT02132949|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92031866|NCT02132949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031867|NCT02132949|Tubulin Modulators|tubulin modulators|mesh-ancestor
92031868|NCT02132949|Antimitotic Agents|antimitotic agents|mesh-ancestor
92031869|NCT02132949|Mitosis Modulators|mitosis modulators|mesh-ancestor
92031870|NCT02132949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031871|NCT02132949|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031872|NCT02132949|Immunologic Factors|immunologic factors|mesh-ancestor
92031873|NCT02132949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031874|NCT02132949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031875|NCT02132949|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92031876|NCT02132949|Alkylating Agents|alkylating agents|mesh-ancestor
92031877|NCT02132949|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92031878|NCT02132949|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92031879|NCT02132949|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92031880|NCT02132949|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92031881|NCT02132949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031882|NCT02132949|Antimetabolites|antimetabolites|mesh-ancestor
92031883|NCT02132949|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031884|NCT02132949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92031885|NCT02165397|Rituximab|rituximab|mesh-list
92031886|NCT02165397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92031887|NCT02165397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031888|NCT02165397|Immunologic Factors|immunologic factors|mesh-ancestor
92031889|NCT02165397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031890|NCT02165397|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92031891|NCT02132637|Insulin|insulin|mesh-list
92031892|NCT02132637|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92031893|NCT02132637|Insulin Glargine|insulin glargine|mesh-list
92031894|NCT02132637|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92031895|NCT02132637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031896|NCT02164929|Acetaminophen|acetaminophen|mesh-list
92031897|NCT02164929|Dexamethasone|dexamethasone|mesh-list
92031898|NCT02164929|Lidocaine|lidocaine|mesh-list
92031899|NCT02164929|Epinephrine|epinephrine|mesh-list
91985285|NCT02663453|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91985286|NCT02663453|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
91985287|NCT02663453|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91985288|NCT04439825|Botulinum Toxins|botulinum toxins|mesh-list
92031900|NCT02164929|Midazolam|midazolam|mesh-list
92031901|NCT02164929|Hydromorphone|hydromorphone|mesh-list
92031902|NCT02164929|Ropivacaine|ropivacaine|mesh-list
92031903|NCT02164929|Propofol|propofol|mesh-list
92031904|NCT02164929|Sevoflurane|sevoflurane|mesh-list
92031905|NCT02164929|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92031906|NCT02164929|Antiemetics|antiemetics|mesh-ancestor
92031907|NCT02164929|Autonomic Agents|autonomic agents|mesh-ancestor
92031908|NCT02164929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031909|NCT02164929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031910|NCT02164929|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031911|NCT02164929|Glucocorticoids|glucocorticoids|mesh-ancestor
92031912|NCT02164929|Hormones|hormones|mesh-ancestor
92031913|NCT02164929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031914|NCT02164929|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031915|NCT02164929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031916|NCT02164929|Anesthetics, Local|anesthetics, local|mesh-ancestor
92031917|NCT02164929|Anesthetics|anesthetics|mesh-ancestor
92031918|NCT02164929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92031919|NCT02164929|Sensory System Agents|sensory system agents|mesh-ancestor
92031924|NCT02164929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031925|NCT02164929|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92031926|NCT02164929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92031927|NCT02164929|Anesthetics, General|anesthetics, general|mesh-ancestor
92031928|NCT02164929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92031929|NCT02164929|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92031930|NCT02164929|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92031931|NCT02164929|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031932|NCT02164929|GABA Modulators|gaba modulators|mesh-ancestor
92031933|NCT02164929|GABA Agents|gaba agents|mesh-ancestor
92031934|NCT02164929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92031935|NCT02164929|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92031936|NCT02164929|Analgesics|analgesics|mesh-ancestor
92031937|NCT02164929|Antipyretics|antipyretics|mesh-ancestor
92031938|NCT02164929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92031939|NCT02164929|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92031940|NCT02164929|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92031941|NCT02164929|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92031942|NCT02164929|Adrenergic Agents|adrenergic agents|mesh-ancestor
92031943|NCT02164929|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92031944|NCT02164929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92031945|NCT02164929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92031946|NCT02164929|Respiratory System Agents|respiratory system agents|mesh-ancestor
92031947|NCT02164929|Mydriatics|mydriatics|mesh-ancestor
92031948|NCT02164929|Sympathomimetics|sympathomimetics|mesh-ancestor
92031949|NCT02164929|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92031950|NCT02164929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92031951|NCT02164929|Narcotics|narcotics|mesh-ancestor
92031952|NCT01888432|Everolimus|everolimus|mesh-list
92031953|NCT01888432|Tacrolimus|tacrolimus|mesh-list
92031954|NCT01888432|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031955|NCT01888432|Immunologic Factors|immunologic factors|mesh-ancestor
92031956|NCT01888432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031957|NCT01888432|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92031958|NCT01888432|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031959|NCT01888432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031960|NCT01888432|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92031961|NCT01888432|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92031962|NCT01888432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031963|NCT02188719|Acetaminophen|acetaminophen|mesh-list
92031964|NCT02188719|Diphenhydramine|diphenhydramine|mesh-list
92031965|NCT02188719|Promethazine|promethazine|mesh-list
92031966|NCT02188719|Mycophenolic Acid|mycophenolic acid|mesh-list
92031967|NCT02188719|Valganciclovir|valganciclovir|mesh-list
92031968|NCT02188719|Ganciclovir|ganciclovir|mesh-list
92031969|NCT02188719|Anti-Infective Agents|anti-infective agents|mesh-list
92031970|NCT02188719|Prednisone|prednisone|mesh-list
92031971|NCT02188719|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92031972|NCT02188719|Everolimus|everolimus|mesh-list
92031973|NCT02188719|Liver Extracts|liver extracts|mesh-list
92031974|NCT02188719|Tacrolimus|tacrolimus|mesh-list
92031975|NCT02188719|Thymoglobulin|thymoglobulin|mesh-list
91985289|NCT04439825|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91985290|NCT04439825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91985291|NCT04439825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985293|NCT04439825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985294|NCT04439825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031976|NCT02188719|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92031977|NCT02188719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92031978|NCT02188719|Glucocorticoids|glucocorticoids|mesh-ancestor
92031979|NCT02188719|Hormones|hormones|mesh-ancestor
92031980|NCT02188719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92031981|NCT02188719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031982|NCT02188719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92031983|NCT02188719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031984|NCT02188719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92031985|NCT02188719|Immunologic Factors|immunologic factors|mesh-ancestor
92031986|NCT02188719|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92031987|NCT02188719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031988|NCT02188719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031989|NCT02188719|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92031990|NCT02188719|Analgesics|analgesics|mesh-ancestor
92031991|NCT02188719|Sensory System Agents|sensory system agents|mesh-ancestor
92031992|NCT02188719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92031996|NCT02188719|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92031997|NCT02188719|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92031998|NCT02188719|Antitubercular Agents|antitubercular agents|mesh-ancestor
92031999|NCT02188719|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92032001|NCT02188719|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92032002|NCT02188719|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92032003|NCT02188719|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032004|NCT02188719|Anesthetics, Local|anesthetics, local|mesh-ancestor
92032005|NCT02188719|Anesthetics|anesthetics|mesh-ancestor
92032006|NCT02188719|Antiemetics|antiemetics|mesh-ancestor
92032007|NCT02188719|Autonomic Agents|autonomic agents|mesh-ancestor
92032008|NCT02188719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92032009|NCT02188719|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92032010|NCT02188719|Histamine Antagonists|histamine antagonists|mesh-ancestor
92032011|NCT02188719|Histamine Agents|histamine agents|mesh-ancestor
92032012|NCT02188719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032013|NCT02188719|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92032014|NCT02188719|Antipruritics|antipruritics|mesh-ancestor
92032015|NCT02188719|Dermatologic Agents|dermatologic agents|mesh-ancestor
92032016|NCT02188719|Antiviral Agents|antiviral agents|mesh-ancestor
92032017|NCT02188719|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92032018|NCT02188719|Protective Agents|protective agents|mesh-ancestor
92032019|NCT01933672|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92032020|NCT01933672|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92032021|NCT01933672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032022|NCT01933672|Incretins|incretins|mesh-ancestor
92032023|NCT01933672|Hormones|hormones|mesh-ancestor
92032024|NCT01933672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032025|NCT01933672|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92032026|NCT01933672|Protease Inhibitors|protease inhibitors|mesh-ancestor
92032027|NCT01933672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032028|NCT01933672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032029|NCT02132247|Diclofenac|diclofenac|mesh-list
92032030|NCT02132247|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92032031|NCT02132247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92032032|NCT02132247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92032033|NCT02132247|Analgesics|analgesics|mesh-ancestor
92032034|NCT02132247|Sensory System Agents|sensory system agents|mesh-ancestor
92032035|NCT02132247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032036|NCT02132247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032037|NCT02132247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032038|NCT02132247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032039|NCT02132247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91985296|NCT02388581|Metronidazole|metronidazole|mesh-list
91985297|NCT02388581|Clarithromycin|clarithromycin|mesh-list
91985298|NCT02388581|Lansoprazole|lansoprazole|mesh-list
91985299|NCT02388581|Dexlansoprazole|dexlansoprazole|mesh-list
91985300|NCT02388581|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91985301|NCT02388581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032040|NCT02132247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032041|NCT02132247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032042|NCT01629381|Rivaroxaban|rivaroxaban|mesh-list
92032043|NCT01629381|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92032044|NCT01629381|Antithrombins|antithrombins|mesh-ancestor
92032045|NCT01629381|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92032046|NCT01629381|Protease Inhibitors|protease inhibitors|mesh-ancestor
92032047|NCT01629381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032048|NCT01629381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032049|NCT01629381|Anticoagulants|anticoagulants|mesh-ancestor
92032050|NCT05269017|Vitamin D|vitamin d|mesh-list
92032051|NCT05269017|Cholecalciferol|cholecalciferol|mesh-list
92032052|NCT05269017|Budesonide|budesonide|mesh-list
92032053|NCT05269017|Vitamins|vitamins|mesh-ancestor
92032054|NCT05269017|Micronutrients|micronutrients|mesh-ancestor
92032055|NCT05269017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032056|NCT05269017|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92032057|NCT05269017|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032058|NCT05269017|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032059|NCT05269017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92032060|NCT05269017|Autonomic Agents|autonomic agents|mesh-ancestor
92032061|NCT05269017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032062|NCT05269017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92032063|NCT05269017|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032065|NCT05269017|Hormones|hormones|mesh-ancestor
92032069|NCT01628913|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92032070|NCT01628913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032071|NCT01628913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032072|NCT01628913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032073|NCT01628913|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032074|NCT01628913|Immunologic Factors|immunologic factors|mesh-ancestor
92032075|NCT01628913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032076|NCT01628913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032077|NCT02164383|Nicotine|nicotine|mesh-list
92032078|NCT02164383|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92032079|NCT02164383|Autonomic Agents|autonomic agents|mesh-ancestor
92032080|NCT02164383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032081|NCT02164383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032082|NCT02164383|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92032083|NCT02164383|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92032084|NCT02164383|Cholinergic Agents|cholinergic agents|mesh-ancestor
92032085|NCT02164383|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032086|NCT02164383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032087|NCT02131233|Raltegravir Potassium|raltegravir potassium|mesh-list
92032088|NCT02131233|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92032089|NCT02131233|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92032090|NCT02131233|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92032091|NCT02131233|Antiviral Agents|antiviral agents|mesh-ancestor
92032092|NCT02131233|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032093|NCT02131233|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92032094|NCT02131233|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92032095|NCT02131233|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032096|NCT02131233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032097|NCT02131233|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92032098|NCT02131233|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92032099|NCT02131155|Afatinib|afatinib|mesh-list
92032100|NCT02131155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032101|NCT02131155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032102|NCT02131155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032103|NCT02131155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032104|NCT01933594|Romidepsin|romidepsin|mesh-list
91985302|NCT02388581|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91985303|NCT02388581|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91985304|NCT02388581|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
91985305|NCT02388581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032105|NCT01933594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92032106|NCT01933594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032107|NCT01933594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92032108|NCT01933594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032109|NCT01933594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032110|NCT01912768|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92032111|NCT02305849|Methotrexate|methotrexate|mesh-list
92032112|NCT02305849|Peficitinib|peficitinib|mesh-list
92032113|NCT02305849|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92032114|NCT02305849|Abortifacient Agents|abortifacient agents|mesh-ancestor
92032115|NCT02305849|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92032116|NCT02305849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032117|NCT02305849|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92032118|NCT02305849|Antimetabolites|antimetabolites|mesh-ancestor
92032119|NCT02305849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032120|NCT02305849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032121|NCT02305849|Dermatologic Agents|dermatologic agents|mesh-ancestor
92032122|NCT02305849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032123|NCT02305849|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92032124|NCT02305849|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032125|NCT02305849|Immunologic Factors|immunologic factors|mesh-ancestor
92032126|NCT02305849|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032127|NCT02305849|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92032128|NCT02371759|Anesthetics|anesthetics|mesh-list
92032129|NCT02371759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032130|NCT02371759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032131|NCT02531633|Prednisone|prednisone|mesh-list
92032132|NCT02531633|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92032133|NCT02531633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032134|NCT02531633|Glucocorticoids|glucocorticoids|mesh-ancestor
92032135|NCT02531633|Hormones|hormones|mesh-ancestor
92032138|NCT02531633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92032139|NCT02531633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032140|NCT02531633|Immunologic Factors|immunologic factors|mesh-ancestor
92032141|NCT02536313|Sofosbuvir|sofosbuvir|mesh-list
92032142|NCT02536313|Velpatasvir|velpatasvir|mesh-list
92032143|NCT02536313|Antiviral Agents|antiviral agents|mesh-ancestor
92032144|NCT02536313|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032145|NCT05412875|Nicotine|nicotine|mesh-list
92032146|NCT05412875|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92032148|NCT05412875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032149|NCT05412875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032150|NCT05412875|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92032151|NCT05412875|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92032152|NCT05412875|Cholinergic Agents|cholinergic agents|mesh-ancestor
92032153|NCT05412875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032154|NCT05412875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032155|NCT02187861|Rituximab|rituximab|mesh-list
92032156|NCT02187861|Venetoclax|venetoclax|mesh-list
92032157|NCT02187861|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92032158|NCT02187861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032159|NCT02187861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032160|NCT02187861|Immunologic Factors|immunologic factors|mesh-ancestor
92032161|NCT02187861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032162|NCT02187861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032163|NCT02187861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92032164|NCT02187861|Alkylating Agents|alkylating agents|mesh-ancestor
92032165|NCT02187861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032166|NCT05379179|Fentanyl|fentanyl|mesh-list
92032167|NCT05379179|Ketamine|ketamine|mesh-list
92032168|NCT05379179|Analgesics|analgesics|mesh-ancestor
92032169|NCT05379179|Sensory System Agents|sensory system agents|mesh-ancestor
92032170|NCT05379179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032171|NCT05379179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032172|NCT05379179|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92032173|NCT05379179|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91985306|NCT02388581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985307|NCT02388581|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91985308|NCT02388581|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91985309|NCT02388581|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91985374|NCT04714372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985448|NCT02385617|Octreotide|octreotide|mesh-list
91985449|NCT02385617|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91985450|NCT02385617|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985451|NCT02385617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985521|NCT02384837|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91985522|NCT02384837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985593|NCT02383901|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91985596|NCT02383823|Hormones|hormones|mesh-ancestor
91985597|NCT02383823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985602|NCT02380001|Analgesics|analgesics|mesh-ancestor
91985663|NCT04688021|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
91985664|NCT04688021|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91985665|NCT04688021|Antimetabolites|antimetabolites|mesh-ancestor
91985666|NCT04688021|Antiviral Agents|antiviral agents|mesh-ancestor
91985667|NCT04688021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91985734|NCT02376413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985735|NCT02378441|Metformin|metformin|mesh-list
91985808|NCT04540133|Antiemetics|antiemetics|mesh-ancestor
91985809|NCT04540133|Autonomic Agents|autonomic agents|mesh-ancestor
91985810|NCT04540133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985877|NCT03672773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985878|NCT03625349|omega-N-Methylarginine|omega-n-methylarginine|mesh-list
91985879|NCT03625349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985880|NCT03625349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985882|NCT02371577|Immunologic Factors|immunologic factors|mesh-ancestor
91985883|NCT02371577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985884|NCT02371577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91985885|NCT02371577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91985886|NCT02371577|Growth Substances|growth substances|mesh-ancestor
91985887|NCT02371577|Growth Inhibitors|growth inhibitors|mesh-ancestor
91985888|NCT02371577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985889|NCT02373449|Ketamine|ketamine|mesh-list
91985890|NCT02373449|Analgesics|analgesics|mesh-ancestor
91985891|NCT02373449|Sensory System Agents|sensory system agents|mesh-ancestor
91985892|NCT02373449|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985893|NCT02373449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985894|NCT02373449|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
91985895|NCT02373449|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91985896|NCT02373449|Anesthetics, General|anesthetics, general|mesh-ancestor
91985897|NCT02373449|Anesthetics|anesthetics|mesh-ancestor
91985898|NCT02373449|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985899|NCT02373449|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91985900|NCT02373449|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91985901|NCT02373449|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985902|NCT02373449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985903|NCT02371421|Allopurinol|allopurinol|mesh-list
91985905|NCT02371421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985906|NCT02371421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985907|NCT02371421|Gout Suppressants|gout suppressants|mesh-ancestor
92032174|NCT05379179|Anesthetics, General|anesthetics, general|mesh-ancestor
92032175|NCT05379179|Anesthetics|anesthetics|mesh-ancestor
92032176|NCT05379179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032177|NCT05379179|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92032178|NCT05379179|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92032179|NCT05379179|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032180|NCT05379179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032182|NCT05379179|Narcotics|narcotics|mesh-ancestor
92032183|NCT05379179|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92032184|NCT05383001|Durvalumab|durvalumab|mesh-list
91985908|NCT02371421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91985909|NCT02371421|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91985910|NCT02371421|Antioxidants|antioxidants|mesh-ancestor
91985911|NCT02371421|Protective Agents|protective agents|mesh-ancestor
91985912|NCT02371421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985913|NCT02371031|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
91985914|NCT02371031|Dopamine Agents|dopamine agents|mesh-ancestor
91985915|NCT02371031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91985916|NCT02371031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985917|NCT02371031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985919|NCT03959891|Fulvestrant|fulvestrant|mesh-list
91985920|NCT03959891|Palbociclib|palbociclib|mesh-list
91985921|NCT03959891|Ipatasertib|ipatasertib|mesh-list
91985922|NCT03959891|Aromatase Inhibitors|aromatase inhibitors|mesh-list
91985923|NCT03959891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91985924|NCT03959891|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
91985925|NCT03959891|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91985926|NCT03959891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91985927|NCT03959891|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91985928|NCT03959891|Hormone Antagonists|hormone antagonists|mesh-ancestor
91985929|NCT03959891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91985930|NCT03959891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985931|NCT03959891|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91985932|NCT03959891|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91985933|NCT03959891|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91985934|NCT02373215|Nalbuphine|nalbuphine|mesh-list
91985935|NCT02373215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91985936|NCT02373215|Narcotics|narcotics|mesh-ancestor
91985937|NCT02373215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91985938|NCT02373215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91985939|NCT02373215|Analgesics|analgesics|mesh-ancestor
91985940|NCT02373215|Sensory System Agents|sensory system agents|mesh-ancestor
91985941|NCT02373215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91985942|NCT03785249|Pembrolizumab|pembrolizumab|mesh-list
91985947|NCT03785249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986096|NCT05653817|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986097|NCT05653817|Mitosis Modulators|mitosis modulators|mesh-ancestor
91986099|NCT05653817|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91986170|NCT03324113|Hormones|hormones|mesh-ancestor
91986171|NCT03324113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91986172|NCT03324113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91986173|NCT03324113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986174|NCT03324113|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
91986175|NCT03324113|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
91986176|NCT03324113|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91986177|NCT03324113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986178|NCT03324113|Anesthetics, Local|anesthetics, local|mesh-ancestor
91986179|NCT03324113|Anesthetics|anesthetics|mesh-ancestor
91986180|NCT03324113|Sensory System Agents|sensory system agents|mesh-ancestor
91986181|NCT03324113|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
91986230|NCT04479371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986231|NCT04479371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986232|NCT04479371|Sensory System Agents|sensory system agents|mesh-ancestor
91986233|NCT04479371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986234|NCT03112655|5-Hydroxytryptophan|5-hydroxytryptophan|mesh-list
91986236|NCT03112655|Antidepressive Agents|antidepressive agents|mesh-ancestor
91986237|NCT03112655|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91986238|NCT02366585|Cyclosporine|cyclosporine|mesh-list
91986239|NCT02366585|Cyclosporins|cyclosporins|mesh-list
91986240|NCT02366585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986241|NCT02366585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986242|NCT02366585|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91986243|NCT02366585|Immunologic Factors|immunologic factors|mesh-ancestor
91986291|NCT02794571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986292|NCT02794571|Tubulin Modulators|tubulin modulators|mesh-ancestor
91986293|NCT02794571|Antimitotic Agents|antimitotic agents|mesh-ancestor
91986294|NCT02794571|Mitosis Modulators|mitosis modulators|mesh-ancestor
91986295|NCT02794571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986296|NCT02794571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91986297|NCT02794571|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91986298|NCT02794571|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91986299|NCT02794571|Growth Substances|growth substances|mesh-ancestor
91986300|NCT02794571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986301|NCT02794571|Growth Inhibitors|growth inhibitors|mesh-ancestor
91986302|NCT02794571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91986350|NCT02365727|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91986351|NCT02365727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986352|NCT02365727|Sensory System Agents|sensory system agents|mesh-ancestor
91986353|NCT02365727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91986354|NCT02365727|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91986355|NCT02365727|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91986356|NCT02365727|Adrenergic Agents|adrenergic agents|mesh-ancestor
91986357|NCT02365727|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91986358|NCT02365727|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986359|NCT02365727|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91986371|NCT02365805|Paclitaxel|paclitaxel|mesh-list
91986415|NCT03112577|Dermatologic Agents|dermatologic agents|mesh-ancestor
91986416|NCT03112577|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91986489|NCT02357849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91986490|NCT02357849|Dopamine Agonists|dopamine agonists|mesh-ancestor
91986560|NCT02359643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91986561|NCT02359643|Antipyretics|antipyretics|mesh-ancestor
91986562|NCT02359721|Clarithromycin|clarithromycin|mesh-list
91986706|NCT02352311|Hormone Antagonists|hormone antagonists|mesh-ancestor
91986709|NCT02355431|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
91986781|NCT03159845|Fluconazole|fluconazole|mesh-list
91986850|NCT02350673|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91986851|NCT02350673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91986852|NCT02350673|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91986853|NCT02350673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91986854|NCT02350361|Endostatins|endostatins|mesh-list
91986861|NCT02353949|Flutemetamol|flutemetamol|mesh-list
91986918|NCT02349581|Bupivacaine|bupivacaine|mesh-list
91986919|NCT02349581|Anesthetics, Local|anesthetics, local|mesh-ancestor
91986933|NCT03112187|Iron|iron|mesh-list
91986996|NCT02348177|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91987063|NCT04478513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987064|NCT04478513|Serotonin Agents|serotonin agents|mesh-ancestor
91987065|NCT04478513|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
91987066|NCT04478513|Antidepressive Agents|antidepressive agents|mesh-ancestor
91987071|NCT02342093|Drospirenone|drospirenone|mesh-list
91987132|NCT02340455|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987133|NCT02340455|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987134|NCT02345837|Clomiphene|clomiphene|mesh-list
91987135|NCT02345837|Enclomiphene|enclomiphene|mesh-list
91987137|NCT02345837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91987138|NCT02345837|Hormone Antagonists|hormone antagonists|mesh-ancestor
91987139|NCT02345837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91987140|NCT02345837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987141|NCT02345837|Fertility Agents, Female|fertility agents, female|mesh-ancestor
91987142|NCT02345837|Fertility Agents|fertility agents|mesh-ancestor
91987143|NCT02345837|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91987144|NCT02345837|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
91987145|NCT02345837|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
91987147|NCT02345993|Formoterol Fumarate|formoterol fumarate|mesh-list
91987148|NCT02345993|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91987188|NCT02345213|Nootropic Agents|nootropic agents|mesh-ancestor
91987189|NCT02339753|Carboplatin|carboplatin|mesh-list
91987190|NCT02339753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987191|NCT02339441|Mycophenolic Acid|mycophenolic acid|mesh-list
91987192|NCT02339441|Cyclophosphamide|cyclophosphamide|mesh-list
91987193|NCT02339441|Methotrexate|methotrexate|mesh-list
91987194|NCT02339441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91987195|NCT02339441|Immunologic Factors|immunologic factors|mesh-ancestor
91987196|NCT02339441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987197|NCT02339441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91987253|NCT02338115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987327|NCT03111797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987474|NCT02436499|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987475|NCT02436499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987476|NCT02436499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987478|NCT02436499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987479|NCT02331563|Dexmedetomidine|dexmedetomidine|mesh-list
91987480|NCT02331563|Bupivacaine|bupivacaine|mesh-list
91987481|NCT02331563|Anesthetics, Local|anesthetics, local|mesh-ancestor
91987482|NCT02331563|Anesthetics|anesthetics|mesh-ancestor
91987483|NCT02331563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987484|NCT02331563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987540|NCT02331251|Tubulin Modulators|tubulin modulators|mesh-ancestor
91987617|NCT02709655|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
91987688|NCT04031729|Sensory System Agents|sensory system agents|mesh-ancestor
91987689|NCT04031729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987690|NCT04031729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987699|NCT04031729|Antipyretics|antipyretics|mesh-ancestor
91987759|NCT02434861|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91987760|NCT02434861|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91987761|NCT02434861|Analgesics|analgesics|mesh-ancestor
91987762|NCT02434861|Sensory System Agents|sensory system agents|mesh-ancestor
91987829|NCT02434549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987830|NCT02434549|Cholinergic Agents|cholinergic agents|mesh-ancestor
91987831|NCT02434549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91987832|NCT02434549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987833|NCT02328209|Ranibizumab|ranibizumab|mesh-list
91987834|NCT02328209|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91987835|NCT02328209|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91987836|NCT02328209|Growth Substances|growth substances|mesh-ancestor
91987837|NCT02328209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987838|NCT02328209|Growth Inhibitors|growth inhibitors|mesh-ancestor
91987839|NCT02328209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91987840|NCT02328443|Itraconazole|itraconazole|mesh-list
91987841|NCT02328443|Rifampin|rifampin|mesh-list
91987842|NCT02328443|Midazolam|midazolam|mesh-list
91987843|NCT02328443|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
91987844|NCT02328443|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91987845|NCT02328443|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91987846|NCT02328443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987847|NCT02328443|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91987848|NCT02328443|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91987849|NCT02328443|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91987881|NCT02039765|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91987882|NCT02039765|Adrenergic Agents|adrenergic agents|mesh-ancestor
91987883|NCT02039765|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074277|NCT00166036|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91987884|NCT02039765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91987885|NCT02039765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987886|NCT03191539|Apremilast|apremilast|mesh-list
91987887|NCT03191539|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91987888|NCT03191539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91987889|NCT03191539|Analgesics|analgesics|mesh-ancestor
91987890|NCT03191539|Sensory System Agents|sensory system agents|mesh-ancestor
91987891|NCT03191539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91987892|NCT03191539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91987893|NCT03191539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91987894|NCT03191539|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91987940|NCT02433457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91988014|NCT03142607|Metronidazole|metronidazole|mesh-list
91988015|NCT03142607|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91988016|NCT03142607|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988017|NCT03142607|Disinfectants|disinfectants|mesh-ancestor
91988018|NCT03142607|Dermatologic Agents|dermatologic agents|mesh-ancestor
91988019|NCT03142607|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91988020|NCT03142607|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91988021|NCT03142607|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91988022|NCT03186547|Botulinum Toxins|botulinum toxins|mesh-list
91988023|NCT03186547|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91988082|NCT03588767|Hormones|hormones|mesh-ancestor
91988083|NCT03588767|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988084|NCT03588767|Performance-Enhancing Substances|performance-enhancing substances|mesh-ancestor
91988086|NCT02440399|Diclofenac|diclofenac|mesh-list
91988088|NCT02440399|Oxycodone|oxycodone|mesh-list
91988089|NCT02440399|Tramadol|tramadol|mesh-list
91988090|NCT02440399|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91988091|NCT02440399|Narcotics|narcotics|mesh-ancestor
91988092|NCT02440399|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988093|NCT02440399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988094|NCT02440399|Analgesics|analgesics|mesh-ancestor
91988147|NCT03144245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988148|NCT04996199|Zileuton|zileuton|mesh-list
91988149|NCT04996199|Carbamazepine|carbamazepine|mesh-list
91988150|NCT04996199|Oxcarbazepine|oxcarbazepine|mesh-list
91988151|NCT04996199|Anticonvulsants|anticonvulsants|mesh-ancestor
91988152|NCT04996199|Antimanic Agents|antimanic agents|mesh-ancestor
91988153|NCT04996199|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91988154|NCT04996199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988155|NCT04996199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988156|NCT04996199|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91988157|NCT04996199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91988158|NCT04996199|Analgesics|analgesics|mesh-ancestor
91988159|NCT04996199|Sensory System Agents|sensory system agents|mesh-ancestor
91988160|NCT04996199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988161|NCT04996199|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91988162|NCT04996199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074278|NCT00166036|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91988163|NCT04996199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988175|NCT02432833|Tacrolimus|tacrolimus|mesh-list
91988200|NCT04984733|Temozolomide|temozolomide|mesh-list
91988276|NCT05076695|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91988277|NCT05076695|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
91988278|NCT05076695|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
91988279|NCT05076695|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988280|NCT05076695|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988281|NCT05076695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988282|NCT05076695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91988283|NCT05076695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988284|NCT05076695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988285|NCT03143933|Fentanyl|fentanyl|mesh-list
91988286|NCT03143933|Propofol|propofol|mesh-list
91988299|NCT02440243|Vaccines|vaccines|mesh-list
91988339|NCT02428777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074279|NCT00166036|Antimetabolites|antimetabolites|mesh-ancestor
91988411|NCT03143465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988412|NCT03143465|Urological Agents|urological agents|mesh-ancestor
91988413|NCT03143465|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91988414|NCT03143465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988415|NCT03143465|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91988416|NCT05034809|Melatonin|melatonin|mesh-list
91988417|NCT05034809|Antioxidants|antioxidants|mesh-ancestor
91988418|NCT05034809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988419|NCT05034809|Protective Agents|protective agents|mesh-ancestor
91988420|NCT05034809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988421|NCT05034809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988422|NCT02428543|Cytarabine|cytarabine|mesh-list
91988423|NCT02428543|Ponatinib|ponatinib|mesh-list
91988424|NCT02428543|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91988437|NCT02431663|Ketamine|ketamine|mesh-list
91988470|NCT03185611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988471|NCT03185611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91988472|NCT02431429|Miltefosine|miltefosine|mesh-list
91988473|NCT02431429|Antifungal Agents|antifungal agents|mesh-ancestor
91988478|NCT02027428|Paclitaxel|paclitaxel|mesh-list
91988541|NCT04438733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988542|NCT04438811|Anesthetics|anesthetics|mesh-list
91988543|NCT04438811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91988610|NCT02421289|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91988611|NCT02421289|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91988612|NCT02421289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91988613|NCT02421289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988677|NCT05080985|Sensory System Agents|sensory system agents|mesh-ancestor
91988678|NCT05080985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988752|NCT00157937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91988753|NCT00157937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91988754|NCT00157937|Autonomic Agents|autonomic agents|mesh-ancestor
91988755|NCT00157937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91988756|NCT00157937|Respiratory System Agents|respiratory system agents|mesh-ancestor
91988757|NCT00157937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91988758|NCT00157937|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
91988759|NCT00157937|Hormone Antagonists|hormone antagonists|mesh-ancestor
91988760|NCT00157937|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91988761|NCT00157937|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
91988762|NCT00157937|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
91988813|NCT04722809|Botulinum Toxins|botulinum toxins|mesh-list
91988820|NCT05083793|Pregabalin|pregabalin|mesh-list
91988887|NCT03194165|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91988888|NCT03194165|Antiviral Agents|antiviral agents|mesh-ancestor
91988889|NCT03194165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91988890|NCT03194165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91988891|NCT03194165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91988892|NCT03194165|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
91988893|NCT03194165|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
91988894|NCT03194165|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
91988895|NCT03194165|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91988903|NCT03116737|Benzocaine|benzocaine|mesh-list
91988951|NCT03106831|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91988952|NCT03106831|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91988953|NCT03106831|Adrenergic Agents|adrenergic agents|mesh-ancestor
91988954|NCT03106831|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91988956|NCT03106831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989020|NCT02423083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989021|NCT02423083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989022|NCT02423083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989092|NCT02420509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989093|NCT02420509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989095|NCT02420509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989096|NCT02420509|Antidotes|antidotes|mesh-ancestor
91989097|NCT02420509|Protective Agents|protective agents|mesh-ancestor
91989098|NCT02420509|Vitamin B Complex|vitamin b complex|mesh-ancestor
91989099|NCT02420509|Vitamins|vitamins|mesh-ancestor
91989100|NCT02420509|Micronutrients|micronutrients|mesh-ancestor
91989101|NCT02416531|Clobetasol|clobetasol|mesh-list
91989102|NCT02416531|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91989103|NCT02416531|Glucocorticoids|glucocorticoids|mesh-ancestor
91989104|NCT02416531|Hormones|hormones|mesh-ancestor
91989105|NCT02416531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91989106|NCT02416531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989107|NCT04483063|Chlorhexidine|chlorhexidine|mesh-list
91989108|NCT04483063|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
91989109|NCT04483063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91989110|NCT04483063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989111|NCT04483063|Disinfectants|disinfectants|mesh-ancestor
91989112|NCT04483063|Dermatologic Agents|dermatologic agents|mesh-ancestor
91989113|NCT02416141|Tramadol|tramadol|mesh-list
91989114|NCT02416141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91989115|NCT02416141|Narcotics|narcotics|mesh-ancestor
91989144|NCT01828697|Anticoagulants|anticoagulants|mesh-ancestor
91989145|NCT01828697|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
91989146|NCT01828697|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
91989147|NCT01828697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989148|NCT02415985|Lopinavir|lopinavir|mesh-list
91989149|NCT02415985|Rifabutin|rifabutin|mesh-list
91989150|NCT02415985|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
91989151|NCT02415985|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
91989152|NCT02415985|Protease Inhibitors|protease inhibitors|mesh-ancestor
91989153|NCT02415985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91989154|NCT02415985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989155|NCT02415985|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
91989156|NCT02415985|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
91989157|NCT02415985|Antiviral Agents|antiviral agents|mesh-ancestor
91989158|NCT02415985|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989159|NCT02415985|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
91989160|NCT02415985|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989161|NCT02415985|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91989162|NCT02415985|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91989163|NCT02415985|Antitubercular Agents|antitubercular agents|mesh-ancestor
91989164|NCT02415907|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
91989165|NCT02415907|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
91989166|NCT02415907|Serotonin Agents|serotonin agents|mesh-ancestor
91989167|NCT02415907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91989168|NCT02415907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989169|NCT02415907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989170|NCT02415829|Capecitabine|capecitabine|mesh-list
91989171|NCT02415829|Oxaliplatin|oxaliplatin|mesh-list
91989172|NCT02415829|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91989173|NCT02415829|Antimetabolites|antimetabolites|mesh-ancestor
91989174|NCT02415829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989175|NCT02415829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989176|NCT04631393|Alfentanil|alfentanil|mesh-list
91989177|NCT04631393|Propofol|propofol|mesh-list
92032185|NCT05383001|Tremelimumab|tremelimumab|mesh-list
92032186|NCT05383001|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032187|NCT05383001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032188|NCT02527421|Betamethasone|betamethasone|mesh-list
91989178|NCT04631393|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91989179|NCT04631393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989262|NCT05338931|Gossypol|gossypol|mesh-list
91989326|NCT05088083|Antimitotic Agents|antimitotic agents|mesh-ancestor
91989327|NCT05088083|Mitosis Modulators|mitosis modulators|mesh-ancestor
91989329|NCT03110159|Aminolevulinic Acid|aminolevulinic acid|mesh-list
91989400|NCT05088707|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91989401|NCT05088707|Abortifacient Agents|abortifacient agents|mesh-ancestor
91989471|NCT02414581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91989545|NCT02414425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989546|NCT02414425|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91989547|NCT02414425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91989548|NCT03116893|Itraconazole|itraconazole|mesh-list
91989620|NCT05737511|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
91989621|NCT05737511|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91989622|NCT05737511|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91989624|NCT05737511|Parasympatholytics|parasympatholytics|mesh-ancestor
91989689|NCT05736887|Respiratory System Agents|respiratory system agents|mesh-ancestor
91989690|NCT05736887|Free Radical Scavengers|free radical scavengers|mesh-ancestor
91989691|NCT05736887|Antioxidants|antioxidants|mesh-ancestor
91989692|NCT05736887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989693|NCT05736887|Protective Agents|protective agents|mesh-ancestor
91989694|NCT05736887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989695|NCT05736887|Antidotes|antidotes|mesh-ancestor
91989696|NCT02703337|Insulin Lispro|insulin lispro|mesh-list
91989697|NCT02703337|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91989698|NCT02703337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989699|NCT05735639|Enoxaparin|enoxaparin|mesh-list
91989700|NCT05735639|Dalteparin|dalteparin|mesh-list
91989701|NCT05735639|Tinzaparin|tinzaparin|mesh-list
91989702|NCT05735639|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
91989703|NCT05735639|Rivaroxaban|rivaroxaban|mesh-list
91989704|NCT05735639|Apixaban|apixaban|mesh-list
91989705|NCT05735639|Enoxaparin sodium|enoxaparin sodium|mesh-list
91989706|NCT05735639|Dabigatran|dabigatran|mesh-list
91989707|NCT05735639|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91989708|NCT05735639|Antithrombins|antithrombins|mesh-ancestor
91989709|NCT05735639|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
91989710|NCT05735639|Protease Inhibitors|protease inhibitors|mesh-ancestor
91989711|NCT05735639|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91990797|NCT02409199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989712|NCT05735639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989713|NCT05735639|Anticoagulants|anticoagulants|mesh-ancestor
91989744|NCT02423395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91989745|NCT02423395|Cytochrome P-450 CYP2B6 Inhibitors|cytochrome p-450 cyp2b6 inhibitors|mesh-ancestor
91989746|NCT02423395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
91989814|NCT02413021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91989815|NCT02413021|Antiviral Agents|antiviral agents|mesh-ancestor
91989816|NCT02413021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91989817|NCT02413021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91989818|NCT02413021|Immunologic Factors|immunologic factors|mesh-ancestor
91989819|NCT02413021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91989820|NCT02413021|Iron Chelating Agents|iron chelating agents|mesh-ancestor
91989821|NCT02413021|Chelating Agents|chelating agents|mesh-ancestor
91989822|NCT02413021|Sequestering Agents|sequestering agents|mesh-ancestor
91989824|NCT01680341|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
91989825|NCT01680341|Insulin Aspart|insulin aspart|mesh-list
91989826|NCT01680341|Insulin, Long-Acting|insulin, long-acting|mesh-list
91989827|NCT01680341|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
91989877|NCT02412475|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
91989878|NCT04543643|Carvedilol|carvedilol|mesh-list
91989879|NCT04543643|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
91989949|NCT02412085|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91989950|NCT02412085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91989951|NCT02412085|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91990021|NCT02416765|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91990022|NCT02703259|Acetaminophen|acetaminophen|mesh-list
91990093|NCT02411149|Sympathomimetics|sympathomimetics|mesh-ancestor
91990094|NCT02411149|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91990095|NCT04413227|Docetaxel|docetaxel|mesh-list
91990096|NCT04413227|Endostatins|endostatins|mesh-list
91990165|NCT02015104|Immunologic Factors|immunologic factors|mesh-ancestor
91990239|NCT01678313|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91990248|NCT03197207|Camphor|camphor|mesh-list
91990313|NCT03196817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990460|NCT05099081|Ethanolamine oleate|ethanolamine oleate|mesh-list
91990463|NCT04438577|Lidocaine|lidocaine|mesh-list
91990536|NCT03856619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990537|NCT03856619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990538|NCT03856619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990607|NCT01677377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990608|NCT01677377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990609|NCT01677377|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
91990610|NCT01677377|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91990611|NCT01677377|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990612|NCT01677377|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91990613|NCT01677377|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
91990614|NCT01677377|Dopamine Agents|dopamine agents|mesh-ancestor
91990615|NCT05097911|Bevacizumab|bevacizumab|mesh-list
91990616|NCT05097911|Atezolizumab|atezolizumab|mesh-list
91990617|NCT05097911|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91990618|NCT05097911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990669|NCT04999631|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91990670|NCT04999631|Immunologic Factors|immunologic factors|mesh-ancestor
91990671|NCT02718833|Dexamethasone|dexamethasone|mesh-list
91990672|NCT02718833|Bortezomib|bortezomib|mesh-list
91990673|NCT02718833|Pomalidomide|pomalidomide|mesh-list
91990674|NCT02718833|Elotuzumab|elotuzumab|mesh-list
91990675|NCT02718833|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91990676|NCT02718833|Antiemetics|antiemetics|mesh-ancestor
91990677|NCT02718833|Autonomic Agents|autonomic agents|mesh-ancestor
91990678|NCT02718833|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990679|NCT02718833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990680|NCT02718833|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91990681|NCT02718833|Glucocorticoids|glucocorticoids|mesh-ancestor
91990682|NCT02718833|Hormones|hormones|mesh-ancestor
91990683|NCT02718833|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91990684|NCT02718833|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
91990685|NCT02718833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91990686|NCT02718833|Immunologic Factors|immunologic factors|mesh-ancestor
91990687|NCT02718833|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91990688|NCT02718833|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91990689|NCT02718833|Growth Substances|growth substances|mesh-ancestor
91990690|NCT02718833|Growth Inhibitors|growth inhibitors|mesh-ancestor
91990691|NCT04908293|Listerine|listerine|mesh-list
91990721|NCT04414241|Hydroxychloroquine|hydroxychloroquine|mesh-list
91990722|NCT04414241|Antimalarials|antimalarials|mesh-ancestor
91990798|NCT02409199|Tubulin Modulators|tubulin modulators|mesh-ancestor
91990799|NCT02409199|Antimitotic Agents|antimitotic agents|mesh-ancestor
91990869|NCT03174067|Clonidine|clonidine|mesh-list
91990870|NCT03174067|Buprenorphine|buprenorphine|mesh-list
91990871|NCT03174067|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91990872|NCT03174067|Narcotics|narcotics|mesh-ancestor
91990873|NCT03174067|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91990874|NCT03174067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91990875|NCT03174067|Analgesics|analgesics|mesh-ancestor
91990876|NCT03174067|Sensory System Agents|sensory system agents|mesh-ancestor
91990877|NCT03174067|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91990878|NCT03174067|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
91990879|NCT03174067|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91990880|NCT03174067|Sympatholytics|sympatholytics|mesh-ancestor
91990881|NCT03174067|Autonomic Agents|autonomic agents|mesh-ancestor
91990882|NCT03174067|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
91990883|NCT03174067|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91990884|NCT03174067|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91990885|NCT03174067|Adrenergic Agents|adrenergic agents|mesh-ancestor
91990886|NCT03174067|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990887|NCT03174067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990925|NCT02405689|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91990926|NCT02405689|Anesthetics, General|anesthetics, general|mesh-ancestor
91990927|NCT02405689|Anesthetics|anesthetics|mesh-ancestor
91990929|NCT02400619|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91990930|NCT02400619|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91990931|NCT02400619|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91990932|NCT02400619|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91990933|NCT02400619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91990934|NCT02400619|Cholinergic Agents|cholinergic agents|mesh-ancestor
91990935|NCT02400619|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91990946|NCT02699125|Guanfacine|guanfacine|mesh-list
91990996|NCT05100719|Sodium Citrate|sodium citrate|mesh-list
91990997|NCT05100719|Alverine|alverine|mesh-list
91990998|NCT05100719|Anticoagulants|anticoagulants|mesh-ancestor
91990999|NCT05100719|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
91991000|NCT05100719|Chelating Agents|chelating agents|mesh-ancestor
91991001|NCT05100719|Sequestering Agents|sequestering agents|mesh-ancestor
91991067|NCT04351295|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91991068|NCT04351295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991144|NCT05106803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91991217|NCT02398123|Anesthetics|anesthetics|mesh-ancestor
91991222|NCT04486625|Aztreonam|aztreonam|mesh-list
91991292|NCT02658149|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91991362|NCT04832009|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
91991435|NCT05110469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991440|NCT05110469|Narcotics|narcotics|mesh-ancestor
91991508|NCT05108597|Abortifacient Agents|abortifacient agents|mesh-ancestor
91991509|NCT05108597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91991510|NCT05108597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991511|NCT05108597|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91991512|NCT05108597|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91991513|NCT05108597|Oxytocics|oxytocics|mesh-ancestor
91991514|NCT02396329|Chlorhexidine|chlorhexidine|mesh-list
91991515|NCT02396329|Povidone-Iodine|povidone-iodine|mesh-list
91991516|NCT02396329|Povidone|povidone|mesh-list
91991517|NCT02396329|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
91991518|NCT02396329|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991519|NCT02396329|Disinfectants|disinfectants|mesh-ancestor
91991570|NCT04309877|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
91991571|NCT04309877|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91991572|NCT04309877|Purinergic Agents|purinergic agents|mesh-ancestor
91991573|NCT04309877|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991575|NCT04367909|Docetaxel|docetaxel|mesh-list
91991576|NCT04367909|Nimotuzumab|nimotuzumab|mesh-list
91991577|NCT04367909|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991578|NCT04367909|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991579|NCT04367909|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991580|NCT04367909|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991581|NCT04367909|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991582|NCT04367909|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91991632|NCT03300479|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
91991633|NCT03300479|Vasodilator Agents|vasodilator agents|mesh-ancestor
91991634|NCT03300479|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
91991635|NCT03300479|Serotonin Agents|serotonin agents|mesh-ancestor
91991636|NCT03300479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91991637|NCT03300479|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92032244|NCT01887418|Anabolic Agents|anabolic agents|mesh-ancestor
91991638|NCT03300479|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
91991639|NCT03300479|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
91991640|NCT03300479|Adrenergic Agents|adrenergic agents|mesh-ancestor
91991641|NCT03012425|Hydrocortisone|hydrocortisone|mesh-list
91991642|NCT03012425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991643|NCT03540875|Remifentanil|remifentanil|mesh-list
91991644|NCT03540875|Propofol|propofol|mesh-list
91991645|NCT03540875|Anesthetics|anesthetics|mesh-ancestor
91991646|NCT03540875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91991647|NCT03540875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991648|NCT03540875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91991649|NCT03540875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91991650|NCT03540875|Anesthetics, General|anesthetics, general|mesh-ancestor
91991651|NCT03540875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91991652|NCT03540875|Narcotics|narcotics|mesh-ancestor
91991653|NCT03540875|Analgesics|analgesics|mesh-ancestor
91991654|NCT03540875|Sensory System Agents|sensory system agents|mesh-ancestor
91991655|NCT03540875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991656|NCT03536507|Acetazolamide|acetazolamide|mesh-list
91991657|NCT03536507|Anticonvulsants|anticonvulsants|mesh-ancestor
91991658|NCT03536507|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
91991659|NCT03536507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91991660|NCT03536507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991661|NCT03536507|Diuretics|diuretics|mesh-ancestor
91991662|NCT03536507|Natriuretic Agents|natriuretic agents|mesh-ancestor
91991678|NCT04765787|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91991679|NCT04765787|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91991680|NCT04765787|Cholinergic Agents|cholinergic agents|mesh-ancestor
91991750|NCT01986010|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91991751|NCT01986010|Immunologic Factors|immunologic factors|mesh-ancestor
91991752|NCT01986010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991754|NCT01986010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991755|NCT01986010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91991756|NCT04160117|Colchicine|colchicine|mesh-list
91991757|NCT04160117|Gout Suppressants|gout suppressants|mesh-ancestor
91991758|NCT04160117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991759|NCT04160117|Tubulin Modulators|tubulin modulators|mesh-ancestor
91991760|NCT04160117|Antimitotic Agents|antimitotic agents|mesh-ancestor
91991761|NCT04160117|Mitosis Modulators|mitosis modulators|mesh-ancestor
91991762|NCT04160117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91991763|NCT04160117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991764|NCT04414631|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
91991765|NCT04414631|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
91991766|NCT04414631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91991808|NCT04198961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991809|NCT01984684|Vancomycin|vancomycin|mesh-list
91991810|NCT01984684|Aztreonam|aztreonam|mesh-list
91991811|NCT01984684|Delafloxacin|delafloxacin|mesh-list
91991812|NCT01984684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91991813|NCT01984684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91991818|NCT02694523|Adalimumab|adalimumab|mesh-list
91991819|NCT02694523|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
91991820|NCT02694523|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91991821|NCT02694523|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91991822|NCT02694523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91991823|NCT02694523|Immunologic Factors|immunologic factors|mesh-ancestor
91991824|NCT02694523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991825|NCT05038475|Antibodies|antibodies|mesh-list
91991826|NCT05038475|Immunologic Factors|immunologic factors|mesh-ancestor
91991871|NCT01962298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91991872|NCT01962298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91991945|NCT03906617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91991946|NCT03906617|Anesthetics, Local|anesthetics, local|mesh-ancestor
91991947|NCT03906617|Anesthetics|anesthetics|mesh-ancestor
91991948|NCT03906617|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992016|NCT05120687|Dermatologic Agents|dermatologic agents|mesh-ancestor
91992017|NCT05120687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992018|NCT05120687|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91992019|NCT05120687|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91992020|NCT05120687|Antifungal Agents|antifungal agents|mesh-ancestor
91992021|NCT05120687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992022|NCT05120687|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
91992023|NCT05120687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
91992024|NCT05120687|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
91992025|NCT05120687|Antitubercular Agents|antitubercular agents|mesh-ancestor
91992026|NCT05120687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91992027|NCT05120687|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
91992028|NCT05120687|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992077|NCT02395237|Glimepiride|glimepiride|mesh-list
91992078|NCT02395237|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
91992079|NCT02395237|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91992080|NCT02395237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992081|NCT02395237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91992082|NCT02395237|Immunologic Factors|immunologic factors|mesh-ancestor
91992083|NCT02394847|Propofol|propofol|mesh-list
91992084|NCT02394847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
91992085|NCT02394847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992086|NCT02394847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992087|NCT02394847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91992088|NCT02394847|Anesthetics, General|anesthetics, general|mesh-ancestor
91992089|NCT02394847|Anesthetics|anesthetics|mesh-ancestor
91992090|NCT05021861|Cyproterone Acetate|cyproterone acetate|mesh-list
91992091|NCT05021861|Ethinyl Estradiol|ethinyl estradiol|mesh-list
91992092|NCT05021861|Estradiol|estradiol|mesh-list
91992093|NCT05021861|Cyproterone|cyproterone|mesh-list
91992094|NCT05021861|Cyproterone acetate, ethinyl estradiol drug combination|cyproterone acetate, ethinyl estradiol drug combination|mesh-list
91992095|NCT05021861|Estrogens|estrogens|mesh-ancestor
91992096|NCT05021861|Hormones|hormones|mesh-ancestor
91992133|NCT02653625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992134|NCT04480333|Antiviral Agents|antiviral agents|mesh-list
91992135|NCT04480333|Remdesivir|remdesivir|mesh-list
92032189|NCT02527421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032190|NCT02527421|Glucocorticoids|glucocorticoids|mesh-ancestor
92032191|NCT02527421|Hormones|hormones|mesh-ancestor
92032192|NCT02527421|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032193|NCT02527421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032194|NCT02527421|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92032195|NCT02527421|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032196|NCT05610371|Lidocaine|lidocaine|mesh-list
92032197|NCT05610371|Anesthetics, Local|anesthetics, local|mesh-ancestor
92032198|NCT05610371|Anesthetics|anesthetics|mesh-ancestor
92032199|NCT05610371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032200|NCT05610371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032201|NCT05610371|Sensory System Agents|sensory system agents|mesh-ancestor
92032202|NCT05610371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032203|NCT05610371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92032204|NCT05610371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92032205|NCT05610371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92032206|NCT05610371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032209|NCT02163759|Etrolizumab|etrolizumab|mesh-list
92032210|NCT02163759|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92032211|NCT02163759|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032212|NCT02163759|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032213|NCT02163759|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92032214|NCT02163759|Immunologic Factors|immunologic factors|mesh-ancestor
92032215|NCT02163759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032216|NCT02336737|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92032217|NCT02336737|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92032218|NCT02336737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032219|NCT02163447|Pyrimethamine|pyrimethamine|mesh-list
92032220|NCT02163447|Piperaquine|piperaquine|mesh-list
92032221|NCT02163447|Sulfadoxine|sulfadoxine|mesh-list
92032222|NCT02163447|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92032223|NCT02163447|Artenimol|artenimol|mesh-list
92032224|NCT02163447|Artemisinins|artemisinins|mesh-list
92032225|NCT02163447|Antimalarials|antimalarials|mesh-ancestor
92032226|NCT02163447|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92032227|NCT02163447|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92032228|NCT02163447|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032229|NCT02163447|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92032230|NCT02163447|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032231|NCT02163447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032232|NCT02163447|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92032233|NCT01887418|Methyltestosterone|methyltestosterone|mesh-list
92032235|NCT01887418|Testosterone undecanoate|testosterone undecanoate|mesh-list
92032236|NCT01887418|Testosterone enanthate|testosterone enanthate|mesh-list
92032237|NCT01887418|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92032238|NCT01887418|Androgens|androgens|mesh-ancestor
92032239|NCT01887418|Hormones|hormones|mesh-ancestor
92032240|NCT01887418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032241|NCT01887418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032242|NCT01887418|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92032243|NCT01887418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032245|NCT01912612|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92032246|NCT01912612|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92032247|NCT01912612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92032248|NCT01912612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032249|NCT01912612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032250|NCT01912612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032251|NCT01912612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032252|NCT01912612|Analgesics|analgesics|mesh-ancestor
92032253|NCT01912612|Sensory System Agents|sensory system agents|mesh-ancestor
92032254|NCT01912612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032255|NCT01912612|Antidepressive Agents|antidepressive agents|mesh-ancestor
92032256|NCT01912612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92032257|NCT01912612|Dopamine Agents|dopamine agents|mesh-ancestor
92032258|NCT02302807|Paclitaxel|paclitaxel|mesh-list
91992136|NCT04480333|Neuroprotective Agents|neuroprotective agents|mesh-list
91992137|NCT04480333|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992210|NCT03169777|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91992211|NCT03169777|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
91992212|NCT03169777|Growth Substances|growth substances|mesh-ancestor
91992213|NCT03169777|Growth Inhibitors|growth inhibitors|mesh-ancestor
91992281|NCT04255277|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
91992282|NCT04255277|Contraceptive Agents|contraceptive agents|mesh-list
91992284|NCT04255277|Charcoal|charcoal|mesh-list
91992355|NCT02004262|Pancrelipase|pancrelipase|mesh-list
91992356|NCT02004262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91992357|NCT02004262|Immunologic Factors|immunologic factors|mesh-ancestor
91992366|NCT02393599|Cocaine|cocaine|mesh-list
91992424|NCT02003638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91992497|NCT02392039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992498|NCT02392039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992499|NCT02392039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992569|NCT04809181|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91992570|NCT04809181|Antimetabolites|antimetabolites|mesh-ancestor
91992571|NCT04809181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992578|NCT05734807|Antiviral Agents|antiviral agents|mesh-ancestor
91992641|NCT03874091|Anesthetics, Local|anesthetics, local|mesh-ancestor
91992642|NCT03874091|Anesthetics|anesthetics|mesh-ancestor
91992643|NCT03874091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032259|NCT02302807|Docetaxel|docetaxel|mesh-list
92032260|NCT02302807|Atezolizumab|atezolizumab|mesh-list
92032261|NCT02302807|Antibodies|antibodies|mesh-list
92032262|NCT02302807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92032263|NCT02302807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032264|NCT02302807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032265|NCT02302807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92032266|NCT02302807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92032267|NCT02302807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032268|NCT02302807|Immunologic Factors|immunologic factors|mesh-ancestor
92032269|NCT02302807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032270|NCT02302807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032271|NCT02302807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032272|NCT05342519|Sirolimus|sirolimus|mesh-list
92032273|NCT05342519|Temsirolimus|temsirolimus|mesh-list
92032274|NCT05342519|MTOR Inhibitors|mtor inhibitors|mesh-list
92032275|NCT05342519|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92032276|NCT05342519|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032277|NCT05342519|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92032278|NCT05342519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032279|NCT05342519|Antifungal Agents|antifungal agents|mesh-ancestor
92032290|NCT05308901|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032291|NCT05308901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032292|NCT05308901|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032293|NCT05308901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032294|NCT01931566|Pioglitazone|pioglitazone|mesh-list
92032295|NCT01931566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92032296|NCT01931566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032298|NCT05372939|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92032299|NCT05372939|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032300|NCT05372939|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032301|NCT01912456|Complement C1s|complement c1s|mesh-list
92032302|NCT01912456|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92032303|NCT01912456|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92032304|NCT01912456|Immunologic Factors|immunologic factors|mesh-ancestor
92032305|NCT01912456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992684|NCT03560297|GABA Agents|gaba agents|mesh-ancestor
92032306|NCT01912456|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92032307|NCT01912456|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032308|NCT04251065|Daratumumab|daratumumab|mesh-list
92032309|NCT04251065|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032310|NCT01885936|Albuterol|albuterol|mesh-list
92032311|NCT01885936|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92032312|NCT01885936|Autonomic Agents|autonomic agents|mesh-ancestor
92032313|NCT01885936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032314|NCT01885936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032315|NCT01885936|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92032316|NCT01885936|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032317|NCT01885936|Tocolytic Agents|tocolytic agents|mesh-ancestor
92032318|NCT01885936|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92032319|NCT01885936|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92032320|NCT01885936|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92032321|NCT01885936|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92032322|NCT01885936|Adrenergic Agents|adrenergic agents|mesh-ancestor
92032323|NCT01885936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032324|NCT01885936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032325|NCT05305859|Azacitidine|azacitidine|mesh-list
92032326|NCT05305859|Venetoclax|venetoclax|mesh-list
92032327|NCT05305859|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92032328|NCT05305859|Antimetabolites|antimetabolites|mesh-ancestor
92032329|NCT05305859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032330|NCT05305859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032331|NCT05305859|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032332|NCT05368415|Norepinephrine|norepinephrine|mesh-list
92032333|NCT05368415|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92032334|NCT05368415|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92032335|NCT05368415|Adrenergic Agents|adrenergic agents|mesh-ancestor
92032336|NCT05368415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992644|NCT03874091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992645|NCT03874091|Sensory System Agents|sensory system agents|mesh-ancestor
91992646|NCT03874091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992647|NCT03874091|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
91992648|NCT03874091|Narcotics|narcotics|mesh-ancestor
91992649|NCT03874091|Analgesics|analgesics|mesh-ancestor
91992650|NCT03874091|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91992651|NCT03874091|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
91992652|NCT03874091|Adrenergic Agents|adrenergic agents|mesh-ancestor
91992653|NCT03874091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91992654|NCT03874091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992655|NCT03874091|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91992656|NCT03874091|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91992658|NCT03874091|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91992659|NCT03874091|Respiratory System Agents|respiratory system agents|mesh-ancestor
91992660|NCT03874091|Mydriatics|mydriatics|mesh-ancestor
91992661|NCT03874091|Sympathomimetics|sympathomimetics|mesh-ancestor
91992662|NCT03874091|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91992663|NCT01362491|Ibuprofen|ibuprofen|mesh-list
91992664|NCT01362491|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91992665|NCT01362491|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91992666|NCT01362491|Analgesics|analgesics|mesh-ancestor
91992667|NCT01362491|Sensory System Agents|sensory system agents|mesh-ancestor
91992668|NCT01362491|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91992669|NCT01362491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992670|NCT01362491|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91992671|NCT01362491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91992672|NCT01362491|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91992673|NCT01362491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992674|NCT01362491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91992675|NCT03560297|Nitrazepam|nitrazepam|mesh-list
91992676|NCT03560297|Anticonvulsants|anticonvulsants|mesh-ancestor
91992677|NCT03560297|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92032337|NCT05368415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032338|NCT05368415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032339|NCT05368415|Sympathomimetics|sympathomimetics|mesh-ancestor
92032340|NCT05368415|Autonomic Agents|autonomic agents|mesh-ancestor
92032341|NCT05368415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032342|NCT05368415|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
91992678|NCT03560297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91992679|NCT03560297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992680|NCT03560297|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91992681|NCT03560297|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91992682|NCT03560297|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91992746|NCT03115099|Protease Inhibitors|protease inhibitors|mesh-ancestor
91992747|NCT03115099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91992819|NCT03913247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
91992820|NCT03913247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91992821|NCT03805841|Bromides|bromides|mesh-list
91992891|NCT01976728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91992892|NCT02689219|Brentuximab Vedotin|brentuximab vedotin|mesh-list
91992893|NCT02689219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91992894|NCT02689219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91992962|NCT01999114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91992963|NCT01999114|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
91992964|NCT01999114|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
91992976|NCT01999114|Narcotics|narcotics|mesh-ancestor
91993034|NCT03161509|Acetaminophen|acetaminophen|mesh-list
91993109|NCT05128175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91993180|NCT04499495|Sensory System Agents|sensory system agents|mesh-ancestor
91993253|NCT05422027|Dexamethasone acetate|dexamethasone acetate|mesh-list
91993254|NCT05422027|Lenalidomide|lenalidomide|mesh-list
91993256|NCT05422027|BB 1101|bb 1101|mesh-list
91993324|NCT03163693|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91993329|NCT05030545|Eplerenone|eplerenone|mesh-list
91993398|NCT04439929|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91993399|NCT05131841|Vinorelbine|vinorelbine|mesh-list
91993400|NCT05131841|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91993468|NCT04941937|Dexamethasone|dexamethasone|mesh-list
91993469|NCT04941937|Lenalidomide|lenalidomide|mesh-list
91993470|NCT04941937|Pomalidomide|pomalidomide|mesh-list
91993541|NCT04955249|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91993542|NCT04955249|Analgesics|analgesics|mesh-ancestor
91993615|NCT02388373|Respiratory System Agents|respiratory system agents|mesh-ancestor
91993617|NCT02388373|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
91993688|NCT04556357|Respiratory System Agents|respiratory system agents|mesh-ancestor
91993690|NCT04556357|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91993762|NCT05900661|Vitamin B Complex|vitamin b complex|mesh-ancestor
91993835|NCT05900245|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91993909|NCT05899751|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
91993986|NCT05899049|Pembrolizumab|pembrolizumab|mesh-list
91993987|NCT05899049|Lenvatinib|lenvatinib|mesh-list
91993988|NCT05899049|Belzutifan|belzutifan|mesh-list
91994058|NCT05898321|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
91994059|NCT05898321|Hormone Antagonists|hormone antagonists|mesh-ancestor
91994060|NCT05898321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
91994130|NCT05890534|Protective Agents|protective agents|mesh-ancestor
91994131|NCT05890534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91994132|NCT05888896|Antihypertensive Agents|antihypertensive agents|mesh-list
91994134|NCT05888896|Sympatholytics|sympatholytics|mesh-ancestor
91994201|NCT05783219|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
91994202|NCT05783219|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
91994203|NCT05783219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91994204|NCT05783219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994205|NCT05765851|Trastuzumab|trastuzumab|mesh-list
91994206|NCT05765851|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
91994207|NCT05765851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91994208|NCT05765851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994209|NCT05765851|Immunoconjugates|immunoconjugates|mesh-ancestor
91994210|NCT05765851|Immunologic Factors|immunologic factors|mesh-ancestor
91994273|NCT05668585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994274|NCT05668585|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994275|NCT05668585|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994345|NCT05455697|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91994346|NCT05455697|Tubulin Modulators|tubulin modulators|mesh-ancestor
91994350|NCT05411679|Olaparib|olaparib|mesh-list
91994420|NCT05220046|Hallucinogens|hallucinogens|mesh-ancestor
91994421|NCT05220046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994492|NCT05020665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994493|NCT05020665|Immunologic Factors|immunologic factors|mesh-ancestor
91994495|NCT04996264|Varespladib methyl|varespladib methyl|mesh-list
91994565|NCT04776395|Antiemetics|antiemetics|mesh-ancestor
91994566|NCT04776395|Autonomic Agents|autonomic agents|mesh-ancestor
91994567|NCT04776395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994635|NCT04558281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994636|NCT04498468|Dexamethasone|dexamethasone|mesh-list
91994637|NCT04498468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91994638|NCT04498468|Antiemetics|antiemetics|mesh-ancestor
91994639|NCT04498468|Autonomic Agents|autonomic agents|mesh-ancestor
91994640|NCT04498468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91994710|NCT04230265|Cyclophosphamide|cyclophosphamide|mesh-list
91994711|NCT04230265|Fludarabine|fludarabine|mesh-list
91994712|NCT04230265|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994713|NCT04230265|Immunologic Factors|immunologic factors|mesh-ancestor
91994721|NCT04215978|Tislelizumab|tislelizumab|mesh-list
91994782|NCT04117945|Immunologic Factors|immunologic factors|mesh-ancestor
91994783|NCT04117945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994784|NCT04117945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91994853|NCT03828201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91994861|NCT03824704|Nivolumab|nivolumab|mesh-list
91994926|NCT03670966|Lenograstim|lenograstim|mesh-list
91994927|NCT03670966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91994928|NCT03670966|Immunologic Factors|immunologic factors|mesh-ancestor
91994929|NCT03670966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91994996|NCT03377361|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91994997|NCT03377361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91994998|NCT03330405|Avelumab|avelumab|mesh-list
91994999|NCT03330405|Talazoparib|talazoparib|mesh-list
91995008|NCT03284463|Glyburide|glyburide|mesh-list
91995068|NCT02953509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995069|NCT02953509|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91995070|NCT02953509|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995071|NCT02953509|Antimetabolites|antimetabolites|mesh-ancestor
91995214|NCT00632853|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
91995286|NCT04419389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91995287|NCT04419389|Immunologic Factors|immunologic factors|mesh-ancestor
91995288|NCT04419389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995435|NCT01228331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995436|NCT01228331|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
91995437|NCT01228331|Abortifacient Agents|abortifacient agents|mesh-ancestor
91995440|NCT01228331|Antimetabolites|antimetabolites|mesh-ancestor
91995506|NCT03189641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91995508|NCT00416351|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91995509|NCT00416351|Antimetabolites|antimetabolites|mesh-ancestor
91995579|NCT03103685|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
91995580|NCT03103685|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
91995581|NCT03103685|Purinergic Agents|purinergic agents|mesh-ancestor
91995582|NCT03103685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91995650|NCT03101735|Immunologic Factors|immunologic factors|mesh-ancestor
91995651|NCT03101735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995652|NCT04701593|Triamcinolone|triamcinolone|mesh-list
91995653|NCT04701593|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
91995654|NCT04701593|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
91995655|NCT04701593|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
91995656|NCT04701593|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91995718|NCT03101423|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91995719|NCT03101423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995720|NCT05073029|Vitamin D|vitamin d|mesh-list
91995721|NCT05073029|Cholecalciferol|cholecalciferol|mesh-list
91995722|NCT05073029|Vitamins|vitamins|mesh-ancestor
91995723|NCT05073029|Micronutrients|micronutrients|mesh-ancestor
91995791|NCT03882905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91995792|NCT03882905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
91995793|NCT03882905|Antimetabolites|antimetabolites|mesh-ancestor
91995863|NCT02382757|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
91995864|NCT02382757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91995865|NCT02382679|Vitamins|vitamins|mesh-list
91995934|NCT02386033|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
91995940|NCT02381275|Tenofovir|tenofovir|mesh-list
91996005|NCT02390089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91996006|NCT02390089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996007|NCT02379793|Mineral Oil|mineral oil|mesh-list
91996008|NCT02379793|Emollients|emollients|mesh-ancestor
91996075|NCT02383771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91996076|NCT02383771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
91996077|NCT02383771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996149|NCT02371603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91996221|NCT02376205|Bupivacaine|bupivacaine|mesh-list
91996222|NCT02376205|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
91996223|NCT02376205|Anesthetics, Local|anesthetics, local|mesh-ancestor
91996224|NCT02376205|Anesthetics|anesthetics|mesh-ancestor
91996229|NCT02370433|Glycopyrrolate|glycopyrrolate|mesh-list
91996294|NCT01971346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91996295|NCT01971346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91996296|NCT01971346|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91996365|NCT01953328|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
91996367|NCT01953328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996439|NCT00867191|Desloratadine|desloratadine|mesh-list
91996440|NCT00867191|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91996441|NCT00867191|Cholinergic Agents|cholinergic agents|mesh-ancestor
91996442|NCT00867191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91996453|NCT02299141|Nintedanib|nintedanib|mesh-list
91996511|NCT03100877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
91996512|NCT03100877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
91996514|NCT03100877|Growth Substances|growth substances|mesh-ancestor
91996583|NCT04439305|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
91996584|NCT04439305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91996585|NCT04439305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91996590|NCT02368795|Indomethacin|indomethacin|mesh-list
91996654|NCT05035277|Apixaban|apixaban|mesh-list
91996655|NCT05035277|Edoxaban|edoxaban|mesh-list
91996656|NCT05035277|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
91996682|NCT02368561|Hylan|hylan|mesh-list
91996735|NCT02374567|Olanzapine|olanzapine|mesh-list
91996736|NCT02374567|Zolpidem|zolpidem|mesh-list
91996737|NCT02374567|Alprazolam|alprazolam|mesh-list
91996738|NCT02374567|Zopiclone|zopiclone|mesh-list
91996739|NCT02374567|Agomelatine|agomelatine|mesh-list
91996740|NCT02374567|Chloral Hydrate|chloral hydrate|mesh-list
91996741|NCT02374567|Doxepin|doxepin|mesh-list
91996819|NCT02374567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91996820|NCT02374567|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
91996821|NCT02374567|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
91996822|NCT02374567|Antimanic Agents|antimanic agents|mesh-ancestor
91996887|NCT02374567|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
91996888|NCT02374567|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
91996889|NCT02374567|Vasodilator Agents|vasodilator agents|mesh-ancestor
91996961|NCT02367937|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
91996962|NCT02367937|Anesthetics, General|anesthetics, general|mesh-ancestor
91996963|NCT02367937|Anesthetics|anesthetics|mesh-ancestor
91996964|NCT02367937|GABA Modulators|gaba modulators|mesh-ancestor
91996965|NCT02367937|GABA Agents|gaba agents|mesh-ancestor
91997031|NCT05047055|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
91997104|NCT05058677|Anesthetics, Local|anesthetics, local|mesh-ancestor
91997105|NCT05058677|Anesthetics|anesthetics|mesh-ancestor
91997175|NCT05058209|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91997176|NCT05058209|Respiratory System Agents|respiratory system agents|mesh-ancestor
91997177|NCT05057663|Fluorouracil|fluorouracil|mesh-list
91997178|NCT05057663|Bleomycin|bleomycin|mesh-list
91997179|NCT05057663|Antimetabolites|antimetabolites|mesh-ancestor
91997245|NCT01951378|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997246|NCT01951378|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91997247|NCT01951378|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91997252|NCT05043233|Methimazole|methimazole|mesh-list
91997316|NCT02366299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
91997392|NCT02365675|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91997393|NCT02365675|Emollients|emollients|mesh-ancestor
91997465|NCT01969084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91997538|NCT05038007|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91997539|NCT02362165|Dexamethasone|dexamethasone|mesh-list
91997540|NCT02362165|Cyclophosphamide|cyclophosphamide|mesh-list
91997541|NCT02362165|Doxorubicin|doxorubicin|mesh-list
91997610|NCT05049473|Tubulin Modulators|tubulin modulators|mesh-ancestor
91997611|NCT05049473|Antimitotic Agents|antimitotic agents|mesh-ancestor
91997612|NCT05049473|Mitosis Modulators|mitosis modulators|mesh-ancestor
91997613|NCT02357797|Vortioxetine|vortioxetine|mesh-list
91997681|NCT02361619|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
91997682|NCT02361619|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91997753|NCT01950364|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
91997754|NCT01950364|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
91997827|NCT03160651|Prednisolone phosphate|prednisolone phosphate|mesh-list
91997828|NCT03160651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
91997829|NCT03160651|Antiemetics|antiemetics|mesh-ancestor
91997901|NCT03093467|Antipsychotic Agents|antipsychotic agents|mesh-list
91997902|NCT03093467|Antidepressive Agents|antidepressive agents|mesh-list
91997903|NCT03093467|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91997973|NCT01949116|Abortifacient Agents|abortifacient agents|mesh-ancestor
91997974|NCT01949116|Reproductive Control Agents|reproductive control agents|mesh-ancestor
91997975|NCT01949116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998043|NCT05023577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91998044|NCT05023577|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
91998045|NCT05023577|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91998046|NCT05023577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998122|NCT03149575|Lomustine|lomustine|mesh-list
91998185|NCT04638400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998186|NCT02349919|Procaterol|procaterol|mesh-list
91998187|NCT02349919|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
91998188|NCT02349919|Autonomic Agents|autonomic agents|mesh-ancestor
91998202|NCT02349763|BB 1101|bb 1101|mesh-list
91998257|NCT04438837|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
91998258|NCT04438837|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998259|NCT04438837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998260|NCT04438837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998327|NCT05019755|Phospholipase A2 Inhibitors|phospholipase a2 inhibitors|mesh-ancestor
91998328|NCT05019755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998398|NCT03112135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
91998399|NCT03112135|Respiratory System Agents|respiratory system agents|mesh-ancestor
91998400|NCT03112135|Mydriatics|mydriatics|mesh-ancestor
91998401|NCT03112135|Sympathomimetics|sympathomimetics|mesh-ancestor
91998418|NCT03090971|Diclofenac|diclofenac|mesh-list
91998469|NCT05026229|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91998470|NCT05026229|Immunologic Factors|immunologic factors|mesh-ancestor
91998471|NCT05026229|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91998472|NCT05026229|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
91998539|NCT03090503|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
91998540|NCT03090503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91998541|NCT03090503|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
91998611|NCT02342509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
91998612|NCT02342509|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
91998613|NCT02342509|Anesthetics, General|anesthetics, general|mesh-ancestor
91998682|NCT03079115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
91998755|NCT05917275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998756|NCT05917275|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
91998825|NCT05916742|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
91998826|NCT05916742|Anti-Infective Agents|anti-infective agents|mesh-ancestor
91998899|NCT05916352|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
91998900|NCT05916352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998901|NCT05916352|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
91998902|NCT05916352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998909|NCT05916339|Amphetamine|amphetamine|mesh-list
91998974|NCT05915676|Immunoglobulins|immunoglobulins|mesh-list
91998975|NCT05915676|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
91998976|NCT05915676|Antibodies|antibodies|mesh-list
91998977|NCT05915676|Immunologic Factors|immunologic factors|mesh-ancestor
91998978|NCT05915676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91998979|NCT05915520|Pantoprazole|pantoprazole|mesh-list
91998980|NCT05915520|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
91998981|NCT05915520|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
91998982|NCT05915520|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
91998983|NCT05915520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
91998984|NCT05915520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91998989|NCT05915286|Chlorthalidone|chlorthalidone|mesh-list
91999037|NCT05915169|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
91999038|NCT05915169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
91999111|NCT05914662|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999112|NCT05914662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999113|NCT05914662|Immunologic Factors|immunologic factors|mesh-ancestor
91999181|NCT05914285|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
91999182|NCT05914285|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
91999256|NCT05913427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999334|NCT05912712|Analgesics|analgesics|mesh-ancestor
91999405|NCT05911659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999406|NCT05911659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999407|NCT05911594|Solifenacin Succinate|solifenacin succinate|mesh-list
91999408|NCT05911594|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
91999409|NCT05911594|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
91999410|NCT05911594|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
91999411|NCT05911594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999412|NCT05911594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999413|NCT05911594|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
91999414|NCT05911594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
91999415|NCT05911594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999416|NCT05911594|Cholinergic Agents|cholinergic agents|mesh-ancestor
91999417|NCT05911594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999418|NCT05911594|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
91999419|NCT05911594|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
91999432|NCT05911347|Psyllium|psyllium|mesh-list
91999477|NCT05911022|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
91999478|NCT05911022|Tubulin Modulators|tubulin modulators|mesh-ancestor
91999479|NCT05911022|Antimitotic Agents|antimitotic agents|mesh-ancestor
91999480|NCT05911022|Mitosis Modulators|mitosis modulators|mesh-ancestor
91999481|NCT05911022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999482|NCT05911022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999483|NCT05910970|Lenvatinib|lenvatinib|mesh-list
91999484|NCT05910970|Tislelizumab|tislelizumab|mesh-list
91999490|NCT05910827|Docetaxel|docetaxel|mesh-list
91999551|NCT05906303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
91999552|NCT05906056|Zoledronic Acid|zoledronic acid|mesh-list
91999553|NCT05906056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
91999554|NCT05906056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999555|NCT05905770|Alemtuzumab|alemtuzumab|mesh-list
91999556|NCT05905770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999557|NCT05905770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
91999622|NCT05875857|Analgesics, Opioid|analgesics, opioid|mesh-list
91999623|NCT05875857|Narcotics|narcotics|mesh-ancestor
91999624|NCT05875857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
91999625|NCT05875857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999626|NCT05875857|Analgesics|analgesics|mesh-ancestor
91999694|NCT05856305|Protective Agents|protective agents|mesh-ancestor
91999695|NCT05848375|Levobupivacaine|levobupivacaine|mesh-list
91999697|NCT05848375|Anesthetics, Local|anesthetics, local|mesh-ancestor
91999768|NCT05813288|Pramipexole|pramipexole|mesh-list
91999769|NCT05813288|Antioxidants|antioxidants|mesh-ancestor
91999770|NCT05813288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999771|NCT05813288|Protective Agents|protective agents|mesh-ancestor
91999841|NCT05748600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
91999842|NCT05748600|Protective Agents|protective agents|mesh-ancestor
91999843|NCT05748600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
91999844|NCT05748600|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
91999845|NCT05748600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
91999846|NCT05748600|Dopamine Agonists|dopamine agonists|mesh-ancestor
91999847|NCT05748600|Dopamine Agents|dopamine agents|mesh-ancestor
91999848|NCT05748600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
91999860|NCT05722418|Cyclophosphamide|cyclophosphamide|mesh-list
91999861|NCT05722418|Fludarabine|fludarabine|mesh-list
91999862|NCT05722418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
91999863|NCT05722418|Immunologic Factors|immunologic factors|mesh-ancestor
91999913|NCT05714553|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
91999914|NCT05714553|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
91999915|NCT05714553|Antidotes|antidotes|mesh-ancestor
91999985|NCT05672459|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
91999986|NCT05672459|Antimetabolites|antimetabolites|mesh-ancestor
92000058|NCT05633615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000059|NCT05631626|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92000060|NCT05631626|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92000066|NCT05631626|Dopamine Agents|dopamine agents|mesh-ancestor
92000129|NCT05585398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000130|NCT05585398|Cholinergic Agents|cholinergic agents|mesh-ancestor
92000131|NCT05585398|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000274|NCT05507476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92000275|NCT05507476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92000346|NCT05442580|Alkylating Agents|alkylating agents|mesh-ancestor
92000347|NCT05442580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000348|NCT05442580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000349|NCT05442580|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92000415|NCT05408845|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92000416|NCT05408845|Antibodies|antibodies|mesh-list
92000417|NCT05408845|Immunoglobulins|immunoglobulins|mesh-list
92000489|NCT05371093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92000490|NCT05371093|Immunologic Factors|immunologic factors|mesh-ancestor
92000559|NCT05342844|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92000560|NCT05342844|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92000562|NCT05342844|Adrenergic Agents|adrenergic agents|mesh-ancestor
92000563|NCT05342844|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92000564|NCT05342844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000565|NCT05339087|Riociguat|riociguat|mesh-list
92000566|NCT05339087|Enzyme Activators|enzyme activators|mesh-ancestor
92000567|NCT05339087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000633|NCT05286762|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92000635|NCT05286762|Dopamine Agents|dopamine agents|mesh-ancestor
92000710|NCT05227391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92000711|NCT05227391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000712|NCT05227391|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92000713|NCT05227391|Contraceptive Agents|contraceptive agents|mesh-ancestor
92000714|NCT05227391|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92000715|NCT05227391|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92000716|NCT05227391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000717|NCT05227391|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92000718|NCT05227391|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92000783|NCT05201066|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92000784|NCT05192200|Interferons|interferons|mesh-list
92000785|NCT05192200|Interferon-beta|interferon-beta|mesh-list
92000786|NCT05192200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92000787|NCT05192200|Antiviral Agents|antiviral agents|mesh-ancestor
92000788|NCT05192200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92000789|NCT05192200|Immunologic Factors|immunologic factors|mesh-ancestor
92000790|NCT05192200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000791|NCT05175105|Mitapivat|mitapivat|mesh-list
92000792|NCT05175105|Enzyme Activators|enzyme activators|mesh-ancestor
92000793|NCT05175105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000855|NCT05151484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92000857|NCT05145010|Infigratinib|infigratinib|mesh-list
92000929|NCT05101551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92000930|NCT05101551|Antimetabolites|antimetabolites|mesh-ancestor
92000931|NCT05101551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92000932|NCT05101551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001002|NCT05050084|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92001004|NCT05050084|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92001005|NCT05050084|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92001006|NCT05050084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001073|NCT05029999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001074|NCT05029999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92001075|NCT05029999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92001076|NCT05029999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001077|NCT05029999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001078|NCT05023967|Metformin|metformin|mesh-list
92001079|NCT05023967|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92001080|NCT05023967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92001081|NCT05022004|Brinzolamide|brinzolamide|mesh-list
92001082|NCT05022004|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92001083|NCT05022004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92001084|NCT05022004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001085|NCT05012254|Paclitaxel|paclitaxel|mesh-list
92001086|NCT05012254|Cisplatin|cisplatin|mesh-list
92001087|NCT05012254|Carboplatin|carboplatin|mesh-list
92001088|NCT05012254|Nivolumab|nivolumab|mesh-list
92001089|NCT05012254|Pemetrexed|pemetrexed|mesh-list
92001090|NCT05012254|Ipilimumab|ipilimumab|mesh-list
92001091|NCT05012254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001147|NCT04958486|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92001148|NCT04958486|Antimetabolites|antimetabolites|mesh-ancestor
92001223|NCT04887259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92001295|NCT04830592|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001296|NCT04830592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92001367|NCT04736823|Carboplatin|carboplatin|mesh-list
92001368|NCT04736823|Pemetrexed|pemetrexed|mesh-list
92001369|NCT04736823|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92001370|NCT04736823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001513|NCT04590196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92001587|NCT04559139|Cisplatin|cisplatin|mesh-list
92001588|NCT04559139|Gemcitabine|gemcitabine|mesh-list
92001589|NCT04559139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001593|NCT04557449|Letrozole|letrozole|mesh-list
92001660|NCT04527991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92001661|NCT04527991|Tubulin Modulators|tubulin modulators|mesh-ancestor
92001736|NCT04484818|Androgen Antagonists|androgen antagonists|mesh-list
92001809|NCT04438382|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92001810|NCT04434040|Atezolizumab|atezolizumab|mesh-list
92001811|NCT04434040|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92001812|NCT04434040|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92001882|NCT04380545|Immunologic Factors|immunologic factors|mesh-ancestor
92001888|NCT04368559|Fluconazole|fluconazole|mesh-list
92001953|NCT04328727|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92002028|NCT04301076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92002029|NCT04301076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92002030|NCT04301076|Glucocorticoids|glucocorticoids|mesh-ancestor
92002031|NCT04301076|Hormones|hormones|mesh-ancestor
92002032|NCT04301076|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92002035|NCT04301076|Tubulin Modulators|tubulin modulators|mesh-ancestor
92002099|NCT04248452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92002100|NCT04248452|Antimetabolites|antimetabolites|mesh-ancestor
92002106|NCT04248452|Antidotes|antidotes|mesh-ancestor
92002175|NCT04217954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92002176|NCT04217954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92002247|NCT04191135|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92002248|NCT04191135|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92002321|NCT04145297|Hydroxychloroquine|hydroxychloroquine|mesh-list
92002322|NCT04145297|Antimalarials|antimalarials|mesh-ancestor
92002394|NCT04109482|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92002473|NCT04022239|Mycophenolic Acid|mycophenolic acid|mesh-list
92002544|NCT04002934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002546|NCT04001829|Paclitaxel|paclitaxel|mesh-list
92002617|NCT03887780|Rivaroxaban|rivaroxaban|mesh-list
92002618|NCT03887780|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92002619|NCT03887780|Antithrombins|antithrombins|mesh-ancestor
92002620|NCT03887780|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92002690|NCT03850691|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92002691|NCT03850691|Antiviral Agents|antiviral agents|mesh-ancestor
92002692|NCT03850691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92002764|NCT03785873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92002765|NCT03785873|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92002835|NCT03739112|Immunologic Factors|immunologic factors|mesh-ancestor
92002836|NCT03739112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92002837|NCT03734237|Vaccines|vaccines|mesh-list
92002907|NCT03644485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92002982|NCT03568383|Vitamin B 6|vitamin b 6|mesh-list
92002983|NCT03568383|Isoniazid|isoniazid|mesh-list
92002984|NCT03568383|Vitamins|vitamins|mesh-ancestor
92002996|NCT03558087|Gemcitabine|gemcitabine|mesh-list
92003057|NCT03505320|Oxaliplatin|oxaliplatin|mesh-list
92003058|NCT03505320|Levoleucovorin|levoleucovorin|mesh-list
92003059|NCT03505320|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003060|NCT03505320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003129|NCT03441113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003130|NCT03430219|Calcium|calcium|mesh-list
92003131|NCT03430219|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92003132|NCT03430219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003133|NCT03419234|Ascorbic Acid|ascorbic acid|mesh-list
92003134|NCT03419234|Prednisone|prednisone|mesh-list
92003200|NCT03337698|Gemcitabine|gemcitabine|mesh-list
92003348|NCT03133221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003350|NCT03113500|Prednisone|prednisone|mesh-list
92003498|NCT02924727|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92003499|NCT02924727|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92003504|NCT02905110|Methotrexate|methotrexate|mesh-list
92003569|NCT02720692|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92003570|NCT02720692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92003641|NCT02628626|Antimetabolites|antimetabolites|mesh-ancestor
92003642|NCT02628626|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92003715|NCT02352090|Estrogens|estrogens|mesh-ancestor
92003716|NCT02352090|Hormones|hormones|mesh-ancestor
92003717|NCT02352090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92003718|NCT02352090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003719|NCT02352090|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92003720|NCT02352090|Contraceptive Agents|contraceptive agents|mesh-ancestor
92003721|NCT02352090|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92003722|NCT02352090|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92003723|NCT02352090|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92003724|NCT02352090|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92003725|NCT02352090|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92003726|NCT02352090|Hormone Antagonists|hormone antagonists|mesh-ancestor
92003727|NCT02352090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003728|NCT02352090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003729|NCT02352090|Androgens|androgens|mesh-ancestor
92003730|NCT02352090|Anabolic Agents|anabolic agents|mesh-ancestor
92003787|NCT01938261|Sensory System Agents|sensory system agents|mesh-ancestor
92003788|NCT01938261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92003789|NCT01938261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003791|NCT01844986|Olaparib|olaparib|mesh-list
92003792|NCT01844986|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92003793|NCT01844986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003794|NCT01844986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003857|NCT01659151|Antiviral Agents|antiviral agents|mesh-ancestor
92003858|NCT01659151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92003859|NCT01659151|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003931|NCT01326312|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92003932|NCT01326312|Fertility Agents|fertility agents|mesh-ancestor
92003933|NCT01326312|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92003934|NCT01326312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003935|NCT01326312|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92003936|NCT01326312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003937|NCT01321554|Lenvatinib|lenvatinib|mesh-list
92003938|NCT01321554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003939|NCT01321554|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003940|NCT01321554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003941|NCT01321554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003942|NCT01308437|Insulin|insulin|mesh-list
92003943|NCT01308437|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92003944|NCT01308437|Isophane Insulin, Human|isophane insulin, human|mesh-list
92003945|NCT01308437|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92003946|NCT01308437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92003947|NCT01268293|Lenvatinib|lenvatinib|mesh-list
92003988|NCT01111461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003989|NCT01111461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003990|NCT01104155|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92003991|NCT01104155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003992|NCT01104155|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92003993|NCT01104155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92003994|NCT01104155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92003995|NCT01067287|Pidilizumab|pidilizumab|mesh-list
92003996|NCT01067287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92003997|NCT01067287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92003998|NCT01005745|Aldesleukin|aldesleukin|mesh-list
92003999|NCT01005745|Interleukin-2|interleukin-2|mesh-list
92004000|NCT01005745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004001|NCT01005745|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92004047|NCT00697684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004048|NCT00697684|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004049|NCT00675922|Silver Nitrate|silver nitrate|mesh-list
92004117|NCT00014508|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92004118|NCT00014508|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92004119|NCT00014508|Antimetabolites|antimetabolites|mesh-ancestor
92004191|NCT00005644|Paclitaxel|paclitaxel|mesh-list
92004192|NCT00005644|Gemcitabine|gemcitabine|mesh-list
92004266|NCT00003388|Vincristine|vincristine|mesh-list
92004267|NCT00003388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004268|NCT00003388|Immunologic Factors|immunologic factors|mesh-ancestor
92004269|NCT00003388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004336|NCT00003309|Cyclophosphamide|cyclophosphamide|mesh-list
92004338|NCT00003309|Vincristine|vincristine|mesh-list
92004339|NCT00003309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92004340|NCT00003309|Immunologic Factors|immunologic factors|mesh-ancestor
92004409|NCT00002868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92004410|NCT00002868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004411|NCT00002868|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92004415|NCT00002868|Antiviral Agents|antiviral agents|mesh-ancestor
92004481|NCT03111901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004482|NCT03111901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004487|NCT02341729|Ticagrelor|ticagrelor|mesh-list
92004552|NCT05005715|Analgesics|analgesics|mesh-ancestor
92004623|NCT04688203|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004696|NCT02039479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004697|NCT02039479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004769|NCT03105115|Fentanyl|fentanyl|mesh-list
92004844|NCT02334475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92004845|NCT02334631|Simethicone|simethicone|mesh-list
92004846|NCT02334631|Antifoaming Agents|antifoaming agents|mesh-ancestor
92004847|NCT02334631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004848|NCT02334631|Emollients|emollients|mesh-ancestor
92004849|NCT02334631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92004850|NCT02338687|Calcium|calcium|mesh-list
92004851|NCT02338687|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92004894|NCT02638259|GP2015|gp2015|mesh-list
92004912|NCT02334007|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92004913|NCT02334007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004914|NCT02637323|Triamcinolone|triamcinolone|mesh-list
92004915|NCT02637323|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92004916|NCT02637323|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92004917|NCT02637323|FX006|fx006|mesh-list
92004918|NCT02637323|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92004921|NCT02637323|Hormones|hormones|mesh-ancestor
92004979|NCT05004545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92004980|NCT05004545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92004981|NCT05004545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004982|NCT05004545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92004983|NCT05004545|Anesthetics, General|anesthetics, general|mesh-ancestor
92004984|NCT05004545|Anesthetics|anesthetics|mesh-ancestor
92004985|NCT03079895|Nicotine|nicotine|mesh-list
92005497|NCT04997291|Mitosis Modulators|mitosis modulators|mesh-ancestor
92004986|NCT03079895|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92004987|NCT03079895|Autonomic Agents|autonomic agents|mesh-ancestor
92004988|NCT03079895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92004989|NCT03079895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92004990|NCT03079895|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92004991|NCT03079895|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92004992|NCT03079895|Cholinergic Agents|cholinergic agents|mesh-ancestor
92004993|NCT03079895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92004994|NCT03079895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92004995|NCT04463615|Leflunomide|leflunomide|mesh-list
92004996|NCT04463615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92004997|NCT04463615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005023|NCT02337283|BI 425809|bi 425809|mesh-list
92005035|NCT02326987|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92005036|NCT02326987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005037|NCT02326987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005038|NCT02326987|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92005039|NCT02326987|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92005040|NCT02326987|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92005041|NCT02326987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005101|NCT03111511|Betadex|betadex|mesh-list
92005102|NCT03111511|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92005103|NCT03111511|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92005104|NCT03111511|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005105|NCT03111511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005106|NCT03111511|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92005107|NCT03111511|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92005108|NCT03111511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92005109|NCT03111511|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92005110|NCT03111511|Anesthetics, General|anesthetics, general|mesh-ancestor
92005111|NCT03111511|Anesthetics|anesthetics|mesh-ancestor
92005167|NCT02332447|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92005171|NCT05077813|Vitamin D|vitamin d|mesh-list
92005241|NCT03142165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005242|NCT03142165|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005243|NCT03142165|Anesthetics|anesthetics|mesh-ancestor
92005311|NCT05002517|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92005385|NCT04498741|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92005386|NCT04498741|Antithrombins|antithrombins|mesh-ancestor
92005387|NCT04498741|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92005388|NCT04498741|Protease Inhibitors|protease inhibitors|mesh-ancestor
92005389|NCT04498741|Anticoagulants|anticoagulants|mesh-ancestor
92005390|NCT03551743|Edoxaban|edoxaban|mesh-list
92005391|NCT03551743|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92005392|NCT03551743|Antithrombins|antithrombins|mesh-ancestor
92005393|NCT03551743|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92005394|NCT03551743|Protease Inhibitors|protease inhibitors|mesh-ancestor
92005395|NCT03551743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005396|NCT03551743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005397|NCT03551743|Anticoagulants|anticoagulants|mesh-ancestor
92005398|NCT04654429|Ondansetron|ondansetron|mesh-list
92005399|NCT04654429|Antiemetics|antiemetics|mesh-ancestor
92005400|NCT04654429|Autonomic Agents|autonomic agents|mesh-ancestor
92005401|NCT04654429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005402|NCT04654429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005403|NCT04654429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005404|NCT04654429|Antipruritics|antipruritics|mesh-ancestor
92005405|NCT04654429|Dermatologic Agents|dermatologic agents|mesh-ancestor
92005407|NCT04654429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92005439|NCT04998071|Sensory System Agents|sensory system agents|mesh-ancestor
92005440|NCT04998071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005441|NCT03734263|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92005442|NCT03734263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92005444|NCT03073343|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005445|NCT03073343|Lipotropic Agents|lipotropic agents|mesh-ancestor
92005446|NCT03073343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92005447|NCT03073343|Antimetabolites|antimetabolites|mesh-ancestor
92005448|NCT03073343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005449|NCT03073343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92005450|NCT03073265|Apixaban|apixaban|mesh-list
92005451|NCT03073265|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92005452|NCT03073265|Antithrombins|antithrombins|mesh-ancestor
92005453|NCT03073265|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92005454|NCT03073265|Protease Inhibitors|protease inhibitors|mesh-ancestor
92005455|NCT03073265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005457|NCT03073265|Anticoagulants|anticoagulants|mesh-ancestor
92005498|NCT02328079|Acyclovir|acyclovir|mesh-list
92005499|NCT02328079|Antiviral Agents|antiviral agents|mesh-list
92005500|NCT02328079|Prednisolone|prednisolone|mesh-list
92005501|NCT02328079|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92005502|NCT02328079|Methylprednisolone|methylprednisolone|mesh-list
92005503|NCT02328079|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92005504|NCT02328079|Prednisolone acetate|prednisolone acetate|mesh-list
92005505|NCT02328079|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92005506|NCT02328079|Prednisolone phosphate|prednisolone phosphate|mesh-list
92005508|NCT02328079|Glucocorticoids|glucocorticoids|mesh-ancestor
92005564|NCT03072485|Analgesics|analgesics|mesh-ancestor
92005565|NCT03072485|Sensory System Agents|sensory system agents|mesh-ancestor
92005566|NCT03072485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005567|NCT03072485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005568|NCT03072485|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92005569|NCT03072485|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92005570|NCT05080543|Terlipressin|terlipressin|mesh-list
92005571|NCT05080543|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92005572|NCT05080543|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92005573|NCT03074591|Ferric Compounds|ferric compounds|mesh-list
92005574|NCT03074591|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92005575|NCT03074591|Hematinics|hematinics|mesh-ancestor
92005576|NCT04996433|Antidepressive Agents|antidepressive agents|mesh-list
92005577|NCT04996433|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92005632|NCT02327923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005633|NCT02327923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005634|NCT02327923|Sensory System Agents|sensory system agents|mesh-ancestor
92005635|NCT02327923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92005636|NCT02327923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92005637|NCT02327923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92005638|NCT02327923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92005639|NCT02327923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92005640|NCT02327923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005641|NCT02327923|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92005642|NCT02327923|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92005643|NCT02327923|Anesthetics, General|anesthetics, general|mesh-ancestor
92005644|NCT02327923|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92005646|NCT02327923|Analgesics|analgesics|mesh-ancestor
92005647|NCT02327923|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92005648|NCT02327923|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92005649|NCT02327923|Antiemetics|antiemetics|mesh-ancestor
92005650|NCT02327923|Autonomic Agents|autonomic agents|mesh-ancestor
92005651|NCT02327923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005686|NCT04991207|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92005687|NCT04991207|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92005688|NCT04991207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005689|NCT04991207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005690|NCT03072173|Xylometazoline|xylometazoline|mesh-list
92005691|NCT03072173|Nasal Decongestants|nasal decongestants|mesh-ancestor
92005692|NCT03072173|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92005693|NCT03072173|Respiratory System Agents|respiratory system agents|mesh-ancestor
92005694|NCT03074123|Cosyntropin|cosyntropin|mesh-list
92005695|NCT03074123|Hormones|hormones|mesh-ancestor
92005748|NCT04994951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92005749|NCT04994951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005750|NCT03073889|Ropivacaine|ropivacaine|mesh-list
92005751|NCT03073889|Anesthetics, Local|anesthetics, local|mesh-ancestor
92005752|NCT03073889|Anesthetics|anesthetics|mesh-ancestor
92005753|NCT03073889|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92005754|NCT03073889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005816|NCT03139591|Dexamethasone|dexamethasone|mesh-list
92005817|NCT03139591|Lidocaine|lidocaine|mesh-list
92005818|NCT03139591|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92005819|NCT03139591|Antiemetics|antiemetics|mesh-ancestor
92005824|NCT03139591|Glucocorticoids|glucocorticoids|mesh-ancestor
92005884|NCT03069911|Cholinergic Agents|cholinergic agents|mesh-ancestor
92005885|NCT03069911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92005886|NCT03069911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92005959|NCT04988789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92005960|NCT04985669|Prucalopride|prucalopride|mesh-list
92005961|NCT04985669|Laxatives|laxatives|mesh-ancestor
92005962|NCT04985669|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92005964|NCT04985669|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92006045|NCT05088343|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92006046|NCT05088343|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92006047|NCT05088343|Antimetabolites|antimetabolites|mesh-ancestor
92006048|NCT05088343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006049|NCT05088343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92006050|NCT05088343|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92006051|NCT05088343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006052|NCT03068429|Sertraline|sertraline|mesh-list
92006053|NCT03068429|Antidepressive Agents|antidepressive agents|mesh-ancestor
92006054|NCT03068429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92006055|NCT03068429|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92006056|NCT03068429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92006057|NCT03068429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92006058|NCT03068429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006059|NCT03068429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006060|NCT03068429|Serotonin Agents|serotonin agents|mesh-ancestor
92006061|NCT03068429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006062|NCT03068351|Daratumumab|daratumumab|mesh-list
92006098|NCT05635955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006099|NCT05635955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92006100|NCT05635955|Anesthetics, General|anesthetics, general|mesh-ancestor
92006101|NCT05635955|Anesthetics|anesthetics|mesh-ancestor
92006102|NCT05635955|Antidepressive Agents|antidepressive agents|mesh-ancestor
92006103|NCT05635955|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92006104|NCT04452461|Leucovorin|leucovorin|mesh-list
92006105|NCT04452461|Paclitaxel|paclitaxel|mesh-list
92006106|NCT04452461|Gemcitabine|gemcitabine|mesh-list
92006107|NCT04452461|Oxaliplatin|oxaliplatin|mesh-list
92006168|NCT03013933|Vasodilator Agents|vasodilator agents|mesh-ancestor
92006169|NCT05635253|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92006170|NCT05635253|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92006171|NCT05635253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006172|NCT04262479|Vitamin D|vitamin d|mesh-list
92006173|NCT04262479|Vitamins|vitamins|mesh-ancestor
92006174|NCT04262479|Micronutrients|micronutrients|mesh-ancestor
92006175|NCT04262479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006176|NCT04262479|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92006177|NCT04133311|Latanoprost|latanoprost|mesh-list
92006178|NCT04133311|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92006179|NCT04133311|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92006180|NCT03217825|Losartan|losartan|mesh-list
92006231|NCT03867799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006243|NCT04873297|Antiemetics|antiemetics|mesh-ancestor
92006244|NCT04873297|Autonomic Agents|autonomic agents|mesh-ancestor
92006245|NCT04873297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006246|NCT04873297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006247|NCT04873297|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92006248|NCT04873297|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92006249|NCT04873297|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92006250|NCT04873297|Dopamine Agents|dopamine agents|mesh-ancestor
92006251|NCT04873297|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006252|NCT04873297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006253|NCT05634473|Methacholine Chloride|methacholine chloride|mesh-list
92006254|NCT05634473|Miotics|miotics|mesh-ancestor
92006255|NCT05634473|Autonomic Agents|autonomic agents|mesh-ancestor
92006256|NCT05634473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006257|NCT05634473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006258|NCT05634473|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92006297|NCT04858711|Adrenergic Agents|adrenergic agents|mesh-ancestor
92006298|NCT04858711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006299|NCT04858711|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92006300|NCT04858711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92006301|NCT04858711|Anesthetics, General|anesthetics, general|mesh-ancestor
92006302|NCT04858711|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92006303|NCT04858711|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92006304|NCT04858711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92006306|NCT04858711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92006307|NCT03068975|Alvimopan|alvimopan|mesh-list
92006308|NCT03068975|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92006309|NCT02034331|Acetylcholine|acetylcholine|mesh-list
92006310|NCT02034331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006311|NCT02034331|Vasodilator Agents|vasodilator agents|mesh-ancestor
92006312|NCT02034331|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92006313|NCT02034331|Cholinergic Agents|cholinergic agents|mesh-ancestor
92006314|NCT02034331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006315|NCT02034331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006316|NCT03067883|Ritonavir|ritonavir|mesh-list
92006317|NCT03067883|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92006318|NCT03067883|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92006319|NCT03067883|Protease Inhibitors|protease inhibitors|mesh-ancestor
92006320|NCT03067883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006321|NCT03067883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006322|NCT03067883|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92006323|NCT03067883|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92006324|NCT03067883|Antiviral Agents|antiviral agents|mesh-ancestor
92006325|NCT03067883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92006326|NCT03067883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92006328|NCT03285763|Atezolizumab|atezolizumab|mesh-list
92006364|NCT03085771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006366|NCT05619965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006435|NCT01884259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92006436|NCT01884259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92006437|NCT01884259|Immunologic Factors|immunologic factors|mesh-ancestor
92006440|NCT04930549|Dapagliflozin|dapagliflozin|mesh-list
92006506|NCT01305889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006507|NCT01305889|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006508|NCT01305889|Serotonin Agents|serotonin agents|mesh-ancestor
92006576|NCT04537897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92006577|NCT04537897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92006578|NCT04537897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92006579|NCT04537897|Anesthetics, General|anesthetics, general|mesh-ancestor
92006580|NCT04537897|Anesthetics|anesthetics|mesh-ancestor
92006581|NCT04537897|GABA Modulators|gaba modulators|mesh-ancestor
92006646|NCT04206059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92006647|NCT04206059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006648|NCT05431049|Anesthetics|anesthetics|mesh-list
92006649|NCT05431049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006651|NCT04132817|Paclitaxel|paclitaxel|mesh-list
92006716|NCT05729555|Promethazine|promethazine|mesh-list
92006717|NCT05729555|Ibuprofen|ibuprofen|mesh-list
92006718|NCT05729555|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92006719|NCT05729555|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92006720|NCT05729555|Analgesics|analgesics|mesh-ancestor
92006721|NCT05729555|Sensory System Agents|sensory system agents|mesh-ancestor
92006722|NCT05729555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92006723|NCT05729555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92006724|NCT05729555|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92006725|NCT05729555|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92006726|NCT05729555|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92006727|NCT05729555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92006728|NCT05729555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006729|NCT05729555|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92006730|NCT05729555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92006731|NCT05729555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92006732|NCT05729555|Anesthetics, Local|anesthetics, local|mesh-ancestor
92006787|NCT04750291|Cholinergic Agents|cholinergic agents|mesh-ancestor
92006858|NCT05188313|Mitosis Modulators|mitosis modulators|mesh-ancestor
92006859|NCT05188313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92006861|NCT02514655|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92006929|NCT04483739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92006930|NCT04483739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92006999|NCT05091151|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92007000|NCT05091151|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92007016|NCT04447235|Ivermectin|ivermectin|mesh-list
92007073|NCT02819479|Bevacizumab|bevacizumab|mesh-list
92007148|NCT02660359|Botulinum Toxins|botulinum toxins|mesh-list
92007149|NCT02660359|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92007223|NCT04884035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92007301|NCT01117441|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007302|NCT01117441|Glucocorticoids|glucocorticoids|mesh-ancestor
92007303|NCT01117441|Hormones|hormones|mesh-ancestor
92007308|NCT01117441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92007370|NCT03511625|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92007371|NCT03511625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92007372|NCT03493061|Oxaliplatin|oxaliplatin|mesh-list
92007373|NCT03493061|Irinotecan|irinotecan|mesh-list
92007374|NCT03493061|Floxuridine|floxuridine|mesh-list
92007378|NCT03493061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007442|NCT02630693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007515|NCT01915732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92007589|NCT04982549|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007590|NCT04982549|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92007592|NCT02621021|Cyclophosphamide|cyclophosphamide|mesh-list
92007659|NCT03062501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92007660|NCT02102789|Leucovorin|leucovorin|mesh-list
92007661|NCT02102789|Dexamethasone|dexamethasone|mesh-list
92007662|NCT02102789|Fluorouracil|fluorouracil|mesh-list
92007663|NCT02102789|Oxaliplatin|oxaliplatin|mesh-list
92007664|NCT02102789|Floxuridine|floxuridine|mesh-list
92007665|NCT02102789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92007666|NCT02102789|Antiemetics|antiemetics|mesh-ancestor
92007667|NCT02102789|Autonomic Agents|autonomic agents|mesh-ancestor
92007668|NCT02102789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92007669|NCT02102789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007670|NCT02102789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92007671|NCT02102789|Glucocorticoids|glucocorticoids|mesh-ancestor
92007672|NCT02102789|Hormones|hormones|mesh-ancestor
92007673|NCT02102789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92007722|NCT01670279|Dopamine Agonists|dopamine agonists|mesh-ancestor
92007723|NCT01670279|Dopamine Agents|dopamine agents|mesh-ancestor
92007797|NCT03063905|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92007799|NCT04432415|Fluorides, Topical|fluorides, topical|mesh-list
92007800|NCT04432415|Cariostatic Agents|cariostatic agents|mesh-ancestor
92007868|NCT02958709|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92007869|NCT02958709|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92007940|NCT04979273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92007941|NCT04979273|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92008013|NCT04794205|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008014|NCT04973033|Tofacitinib|tofacitinib|mesh-list
92008015|NCT04973033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92008016|NCT04973033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92008018|NCT04973033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008019|NCT03061565|Epoetin Alfa|epoetin alfa|mesh-list
92008020|NCT03061565|Hematinics|hematinics|mesh-ancestor
92008021|NCT02660281|Cyclophosphamide|cyclophosphamide|mesh-list
92008022|NCT02660281|Melphalan|melphalan|mesh-list
92008023|NCT02660281|Busulfan|busulfan|mesh-list
92008024|NCT02660281|Thiotepa|thiotepa|mesh-list
92008025|NCT02660281|Fludarabine|fludarabine|mesh-list
92008026|NCT02660281|Mesna|mesna|mesh-list
92008027|NCT02660281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92008087|NCT04437017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008088|NCT04437017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92008089|NCT04437017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92008090|NCT04437017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92008091|NCT04437017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92008156|NCT04971239|Immunologic Factors|immunologic factors|mesh-ancestor
92008157|NCT04971239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92008158|NCT04971239|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92008160|NCT04903093|Abrocitinib|abrocitinib|mesh-list
92008227|NCT04964219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92008230|NCT04964219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92008303|NCT02615119|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92008376|NCT02749513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92008377|NCT02684227|Paclitaxel|paclitaxel|mesh-list
92008452|NCT04632589|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92008453|NCT04632589|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92008454|NCT04632589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008524|NCT03059615|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92008525|NCT03059615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008526|NCT03059615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008598|NCT01675765|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92008599|NCT01675765|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92008600|NCT01675765|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92008669|NCT04942301|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92008670|NCT04942301|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92008745|NCT04948151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92008747|NCT02633293|Treprostinil|treprostinil|mesh-list
92008817|NCT03100045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92008818|NCT03100045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92008819|NCT03100045|Antiviral Agents|antiviral agents|mesh-ancestor
92008820|NCT03100045|Schistosomicides|schistosomicides|mesh-ancestor
92008889|NCT04526197|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92008891|NCT04526197|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92008961|NCT03890887|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92008962|NCT03890887|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92009033|NCT04931225|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92009034|NCT02195947|Hormones|hormones|mesh-list
92009035|NCT02195947|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92009106|NCT01675531|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92009107|NCT05406999|Prednisolone|prednisolone|mesh-list
92009108|NCT05406999|Abiraterone Acetate|abiraterone acetate|mesh-list
92009110|NCT05406999|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009176|NCT02807779|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92009177|NCT02807779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009179|NCT04912193|Antithrombin III|antithrombin iii|mesh-list
92009248|NCT05117125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009249|NCT05116345|Dexamethasone|dexamethasone|mesh-list
92009250|NCT05116345|Dexamethasone acetate|dexamethasone acetate|mesh-list
92009251|NCT05116345|BB 1101|bb 1101|mesh-list
92009252|NCT05116345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92009253|NCT05116345|Antiemetics|antiemetics|mesh-ancestor
92009254|NCT05116345|Autonomic Agents|autonomic agents|mesh-ancestor
92009255|NCT05116345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009256|NCT05116345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009257|NCT05116345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92009258|NCT05116345|Glucocorticoids|glucocorticoids|mesh-ancestor
92009259|NCT05116345|Hormones|hormones|mesh-ancestor
92009313|NCT01362439|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92009314|NCT01362439|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92009315|NCT01362439|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92009316|NCT01362439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92009317|NCT01362439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009318|NCT01362439|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92009319|NCT01362439|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92009321|NCT01362439|Serotonin Agents|serotonin agents|mesh-ancestor
92009380|NCT03906721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009381|NCT03906721|Analgesics|analgesics|mesh-ancestor
92009382|NCT03906721|Sensory System Agents|sensory system agents|mesh-ancestor
92009383|NCT03906721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009384|NCT04663711|Anesthetics|anesthetics|mesh-list
92009452|NCT03954613|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92009453|NCT03954613|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92009454|NCT03954613|Dopamine Agents|dopamine agents|mesh-ancestor
92009457|NCT03367819|Cemiplimab|cemiplimab|mesh-list
92009524|NCT04264663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009525|NCT04264663|Alkylating Agents|alkylating agents|mesh-ancestor
92009526|NCT04264663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92009595|NCT05123287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009596|NCT05123287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92009597|NCT05123287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009598|NCT04165993|Docetaxel|docetaxel|mesh-list
92009599|NCT04165993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92009600|NCT04165993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92009601|NCT04165993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92009602|NCT04165993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92009603|NCT04165993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92009604|NCT04911413|Tranexamic Acid|tranexamic acid|mesh-list
92009608|NCT04911413|Hemostatics|hemostatics|mesh-ancestor
92009611|NCT03889795|Digoxin|digoxin|mesh-list
92009612|NCT03889795|Simvastatin|simvastatin|mesh-list
92009684|NCT04929509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009685|NCT04929509|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92009759|NCT04101643|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92009832|NCT03055793|Respiratory System Agents|respiratory system agents|mesh-ancestor
92009833|NCT03055793|Glucocorticoids|glucocorticoids|mesh-ancestor
92009834|NCT03055793|Hormones|hormones|mesh-ancestor
92009901|NCT04075981|Cholinergic Agents|cholinergic agents|mesh-ancestor
92009902|NCT04075981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009903|NCT04075981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92009904|NCT04075981|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92009905|NCT04075981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92009973|NCT03052673|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92009974|NCT03052673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92009976|NCT03052673|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92010047|NCT02619617|Pasireotide|pasireotide|mesh-list
92010119|NCT02642809|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010120|NCT02642809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010121|NCT02642809|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92010123|NCT03052361|Ondansetron|ondansetron|mesh-list
92010190|NCT05134519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92010191|NCT05134519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010193|NCT04394663|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92010194|NCT04394663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92010261|NCT04400695|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92010262|NCT04400695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010264|NCT04400695|Antimitotic Agents|antimitotic agents|mesh-ancestor
92010268|NCT04400695|Antimetabolites|antimetabolites|mesh-ancestor
92010330|NCT01596335|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92010331|NCT01596335|Antibodies|antibodies|mesh-list
92010332|NCT01596335|Immunologic Factors|immunologic factors|mesh-ancestor
92010407|NCT04884503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010408|NCT04884503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010409|NCT04889651|Abiraterone Acetate|abiraterone acetate|mesh-list
92010474|NCT04887311|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92010475|NCT04887311|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92010549|NCT04882163|Antimetabolites|antimetabolites|mesh-ancestor
92010625|NCT04676399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92010626|NCT03047057|Lidocaine|lidocaine|mesh-list
92010627|NCT03047057|Anesthetics, Local|anesthetics, local|mesh-ancestor
92010697|NCT04870073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92010699|NCT02616029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92010700|NCT02616029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92010770|NCT04875611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010773|NCT04386317|Terazosin|terazosin|mesh-list
92010844|NCT02614703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92010845|NCT02614703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010846|NCT02614703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92010849|NCT02614703|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92010914|NCT01594931|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92010915|NCT01594931|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92010916|NCT01594931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92010987|NCT03044873|Dermatologic Agents|dermatologic agents|mesh-ancestor
92010988|NCT03044873|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92010990|NCT03044795|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92010991|NCT03044795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011055|NCT05304559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011056|NCT05304559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011057|NCT05304559|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92011058|NCT05304559|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92011127|NCT03472573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011128|NCT03472573|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92011200|NCT00136435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011201|NCT00136435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011202|NCT00136435|Antimetabolites|antimetabolites|mesh-ancestor
92011203|NCT00136435|Dermatologic Agents|dermatologic agents|mesh-ancestor
92011204|NCT00136435|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92011205|NCT00136435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011206|NCT00136435|Immunologic Factors|immunologic factors|mesh-ancestor
92011207|NCT00136435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011273|NCT02439385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011274|NCT02439385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011275|NCT02439385|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011344|NCT01371981|Antimetabolites|antimetabolites|mesh-ancestor
92011345|NCT01371981|Antiviral Agents|antiviral agents|mesh-ancestor
92011416|NCT03041207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011417|NCT03101995|Gemcitabine|gemcitabine|mesh-list
92011418|NCT03101995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92011419|NCT03101995|Antimetabolites|antimetabolites|mesh-ancestor
92011420|NCT03101995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011421|NCT03101995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011423|NCT04848467|Immunologic Factors|immunologic factors|mesh-ancestor
92011425|NCT03104335|Apatinib|apatinib|mesh-list
92011483|NCT04847687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011557|NCT05430217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011558|NCT03103555|Cyclophosphamide|cyclophosphamide|mesh-list
92011559|NCT03103555|Bortezomib|bortezomib|mesh-list
92011560|NCT03103555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92011627|NCT04853615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011630|NCT05573607|Chromium|chromium|mesh-list
92011698|NCT04851977|Immunologic Factors|immunologic factors|mesh-ancestor
92011699|NCT04851977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011700|NCT05370495|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92011701|NCT05370495|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92011771|NCT04850885|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92011772|NCT04850885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011773|NCT04850417|Aspirin|aspirin|mesh-list
92011774|NCT04850417|Clopidogrel|clopidogrel|mesh-list
92011775|NCT04850417|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92011776|NCT04850417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92011777|NCT04850417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011778|NCT04850417|Analgesics|analgesics|mesh-ancestor
92011837|NCT03040193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011838|NCT03040193|Sensory System Agents|sensory system agents|mesh-ancestor
92011839|NCT03040193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011840|NCT03040193|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92011841|NCT03040193|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92011842|NCT03040193|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92011843|NCT03040193|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92011844|NCT03040193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011846|NCT05373199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92011847|NCT05373199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011848|NCT03039101|Montelukast|montelukast|mesh-list
92011849|NCT03039101|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92011850|NCT03039101|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032343|NCT05529173|Povidone-Iodine|povidone-iodine|mesh-list
92032347|NCT05529173|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92032349|NCT05335109|Xenon|xenon|mesh-list
92032350|NCT05335109|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92032351|NCT05335109|Anesthetics, General|anesthetics, general|mesh-ancestor
92032352|NCT05335109|Anesthetics|anesthetics|mesh-ancestor
92032353|NCT05335109|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032354|NCT05335109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032355|NCT05300087|Albuterol|albuterol|mesh-list
92032356|NCT05300087|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92032357|NCT05300087|Autonomic Agents|autonomic agents|mesh-ancestor
92032358|NCT05300087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032359|NCT05300087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032360|NCT05300087|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92032361|NCT05300087|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032362|NCT05300087|Tocolytic Agents|tocolytic agents|mesh-ancestor
92032363|NCT05300087|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92032364|NCT05300087|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92032365|NCT05300087|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92032366|NCT05300087|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92032367|NCT05300087|Adrenergic Agents|adrenergic agents|mesh-ancestor
92032368|NCT05300087|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032369|NCT05300087|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032370|NCT05333237|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92032371|NCT01912222|Ixazomib|ixazomib|mesh-list
92032372|NCT01912222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032373|NCT01912222|Protease Inhibitors|protease inhibitors|mesh-ancestor
92032374|NCT01912222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032375|NCT01912222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032376|NCT05366933|Folic Acid|folic acid|mesh-list
92032377|NCT05366933|Vitamin B Complex|vitamin b complex|mesh-list
92032378|NCT05366933|Vitamins|vitamins|mesh-ancestor
92032379|NCT05366933|Micronutrients|micronutrients|mesh-ancestor
92032380|NCT05366933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032381|NCT05366933|Hematinics|hematinics|mesh-ancestor
92032382|NCT04250207|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92032383|NCT05500703|Dexmedetomidine|dexmedetomidine|mesh-list
92032384|NCT05500703|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92032385|NCT05500703|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032386|NCT05500703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032387|NCT05500703|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92032388|NCT05500703|Analgesics|analgesics|mesh-ancestor
92032389|NCT05500703|Sensory System Agents|sensory system agents|mesh-ancestor
92032390|NCT05500703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011851|NCT03039101|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92011852|NCT03039101|Hormone Antagonists|hormone antagonists|mesh-ancestor
92011853|NCT03039101|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92011854|NCT03039101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032391|NCT05500703|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92032392|NCT05500703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92032393|NCT05500703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92032394|NCT05500703|Adrenergic Agents|adrenergic agents|mesh-ancestor
92032395|NCT05500703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032396|NCT05500703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032397|NCT04246151|Vancomycin|vancomycin|mesh-list
92032398|NCT04246151|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92032399|NCT04246151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032400|NCT05331521|Vincristine|vincristine|mesh-list
92032401|NCT05331521|Temozolomide|temozolomide|mesh-list
92032402|NCT05331521|Lomustine|lomustine|mesh-list
92032403|NCT05331521|Procarbazine|procarbazine|mesh-list
92032404|NCT05331521|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92032405|NCT05331521|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032406|NCT05331521|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032407|NCT05331521|Antimitotic Agents|antimitotic agents|mesh-ancestor
92032408|NCT05331521|Mitosis Modulators|mitosis modulators|mesh-ancestor
92032409|NCT05331521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032410|NCT05331521|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92032411|NCT05331521|Alkylating Agents|alkylating agents|mesh-ancestor
92032412|NCT02525861|Protease Inhibitors|protease inhibitors|mesh-list
92032413|NCT02525861|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92032414|NCT02525861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032415|NCT02525861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032418|NCT02524847|Methoxsalen|methoxsalen|mesh-list
92032419|NCT02524847|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92032420|NCT02524847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92032421|NCT05363267|Curcumin|curcumin|mesh-list
92032422|NCT05363267|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92032423|NCT05363267|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92032424|NCT05363267|Analgesics|analgesics|mesh-ancestor
92032425|NCT05363267|Sensory System Agents|sensory system agents|mesh-ancestor
92032426|NCT05363267|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032427|NCT05363267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032428|NCT05363267|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032429|NCT05363267|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032430|NCT05363267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032431|NCT05363267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032432|NCT05363267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032433|NCT04422275|Budesonide|budesonide|mesh-list
92032434|NCT04422275|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032435|NCT04422275|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92032436|NCT04422275|Autonomic Agents|autonomic agents|mesh-ancestor
92032437|NCT04422275|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032438|NCT04422275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032439|NCT04422275|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92032440|NCT04422275|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032441|NCT04422275|Glucocorticoids|glucocorticoids|mesh-ancestor
92032442|NCT04422275|Hormones|hormones|mesh-ancestor
92032443|NCT04422275|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032444|NCT05361941|Tobramycin|tobramycin|mesh-list
92032445|NCT05361941|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92032446|NCT05361941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032447|NCT05290025|Nicotine|nicotine|mesh-list
92032448|NCT05290025|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92032449|NCT05290025|Autonomic Agents|autonomic agents|mesh-ancestor
92032450|NCT05290025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032451|NCT05290025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032452|NCT05290025|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92032453|NCT05290025|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92032454|NCT05290025|Cholinergic Agents|cholinergic agents|mesh-ancestor
92032455|NCT05290025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032456|NCT05290025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032457|NCT05324735|Pentoxifylline|pentoxifylline|mesh-list
92011855|NCT03039101|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92011856|NCT03039101|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92011857|NCT03039101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011858|NCT03594175|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92011860|NCT03594175|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92011861|NCT03594175|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92011862|NCT03594175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011863|NCT03103399|Levodopa|levodopa|mesh-list
92011864|NCT03103399|Carbidopa|carbidopa|mesh-list
92011865|NCT03103399|Entacapone|entacapone|mesh-list
92011866|NCT03103399|Benserazide|benserazide|mesh-list
92011867|NCT03103399|Dopa Decarboxylase|dopa decarboxylase|mesh-list
92011868|NCT03103399|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-list
92011869|NCT03103399|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92011870|NCT03103399|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92011871|NCT03103399|Dopamine Agents|dopamine agents|mesh-ancestor
92011872|NCT03103399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011873|NCT03103399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032458|NCT05324735|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92032459|NCT05324735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032460|NCT05324735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032461|NCT05324735|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92032462|NCT05324735|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92032463|NCT05324735|Protective Agents|protective agents|mesh-ancestor
92032464|NCT05324735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032465|NCT05324735|Vasodilator Agents|vasodilator agents|mesh-ancestor
92032466|NCT05324735|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92032467|NCT05324735|Antioxidants|antioxidants|mesh-ancestor
92032468|NCT05359055|Itraconazole|itraconazole|mesh-list
92032469|NCT05359055|Rifampin|rifampin|mesh-list
92032470|NCT05359055|Antifungal Agents|antifungal agents|mesh-ancestor
92032471|NCT05359055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032472|NCT05359055|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92032473|NCT05359055|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92032474|NCT05359055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032475|NCT05359055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032476|NCT05359055|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92032477|NCT05359055|Hormone Antagonists|hormone antagonists|mesh-ancestor
92032478|NCT05359055|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032479|NCT05359055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032480|NCT05359055|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92032481|NCT05359055|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92032482|NCT05359055|Antitubercular Agents|antitubercular agents|mesh-ancestor
92032483|NCT05359055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92032484|NCT05359055|Leprostatic Agents|leprostatic agents|mesh-ancestor
92032485|NCT05359055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92032486|NCT05359055|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92032489|NCT05359055|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92032490|NCT05359055|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92032491|NCT05359055|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92011874|NCT03103399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011875|NCT03103399|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011876|NCT03103399|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92011877|NCT05357833|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92011878|NCT05357833|Hematinics|hematinics|mesh-ancestor
92011879|NCT05357833|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92011880|NCT05357833|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92011881|NCT03043157|Rocuronium|rocuronium|mesh-list
92011882|NCT03043157|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92011883|NCT03043157|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92011884|NCT03043157|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92032492|NCT02524379|Glyburide|glyburide|mesh-list
92032493|NCT02524379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92032494|NCT02524379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032495|NCT02524145|Isoproterenol|isoproterenol|mesh-list
92032496|NCT02524145|Glycopyrrolate|glycopyrrolate|mesh-list
92032497|NCT02524145|Dexmedetomidine|dexmedetomidine|mesh-list
92032498|NCT02524145|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92032499|NCT02524145|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032500|NCT02524145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032501|NCT02524145|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92032502|NCT02524145|Analgesics|analgesics|mesh-ancestor
92032503|NCT02524145|Sensory System Agents|sensory system agents|mesh-ancestor
92032504|NCT02524145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032505|NCT02524145|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92032506|NCT02524145|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92032507|NCT02524145|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92032508|NCT02524145|Adrenergic Agents|adrenergic agents|mesh-ancestor
92032509|NCT02524145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032510|NCT02524145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032511|NCT02524145|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92032512|NCT02524145|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92032513|NCT02524145|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92032514|NCT02524145|Cholinergic Agents|cholinergic agents|mesh-ancestor
92032515|NCT02524145|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92032516|NCT02524145|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92032517|NCT02524145|Autonomic Agents|autonomic agents|mesh-ancestor
92032518|NCT02524145|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92032519|NCT02524145|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032520|NCT02524145|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92032521|NCT02524145|Sympathomimetics|sympathomimetics|mesh-ancestor
92032522|NCT02524145|Protective Agents|protective agents|mesh-ancestor
92032523|NCT05357417|Bevacizumab|bevacizumab|mesh-list
92032524|NCT05357417|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032525|NCT05357417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011996|NCT04860167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032526|NCT05357417|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92032527|NCT05357417|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92032528|NCT05357417|Growth Substances|growth substances|mesh-ancestor
92032529|NCT05357417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032530|NCT05357417|Growth Inhibitors|growth inhibitors|mesh-ancestor
92032531|NCT01658813|Interferons|interferons|mesh-list
92032532|NCT01658813|Fluorouracil|fluorouracil|mesh-list
92032533|NCT01658813|Antimetabolites|antimetabolites|mesh-ancestor
92032534|NCT01658813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032535|NCT01658813|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92032536|NCT01658813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032537|NCT01658813|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032538|NCT01658813|Immunologic Factors|immunologic factors|mesh-ancestor
92032539|NCT01658813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032540|NCT01658813|Antiviral Agents|antiviral agents|mesh-ancestor
92032541|NCT01658813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032542|NCT02187471|Pregabalin|pregabalin|mesh-list
92032543|NCT02187471|Analgesics|analgesics|mesh-ancestor
92011886|NCT03043157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011887|NCT05339113|FAPI-46|fapi-46|mesh-list
92011888|NCT05339113|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92011889|NCT05339113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011890|NCT05332795|Metformin|metformin|mesh-list
92011891|NCT05332795|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92011892|NCT05332795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011893|NCT03042923|Mannitol|mannitol|mesh-list
92011894|NCT03042923|Lactulose|lactulose|mesh-list
92011895|NCT03042923|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92011896|NCT03042923|Diuretics|diuretics|mesh-ancestor
92011897|NCT03042923|Natriuretic Agents|natriuretic agents|mesh-ancestor
92011898|NCT03042923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032544|NCT02187471|Sensory System Agents|sensory system agents|mesh-ancestor
92032545|NCT02187471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032546|NCT02187471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032547|NCT02187471|Anticonvulsants|anticonvulsants|mesh-ancestor
92032548|NCT02187471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92032549|NCT02187471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032550|NCT02187471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032551|NCT02187471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032552|NCT02187471|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92032553|NCT02187471|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92032554|NCT02187471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032555|NCT02187471|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92032558|NCT02525471|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92032559|NCT02525471|Analgesics|analgesics|mesh-ancestor
92032560|NCT02525471|Sensory System Agents|sensory system agents|mesh-ancestor
92032561|NCT02525471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032562|NCT02525471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032563|NCT02525471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032564|NCT02525471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032565|NCT02525471|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92032566|NCT05284409|Acetaminophen|acetaminophen|mesh-list
92032567|NCT05284409|Dexamethasone|dexamethasone|mesh-list
92032568|NCT05284409|Meperidine|meperidine|mesh-list
92032569|NCT05284409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032570|NCT05284409|Antiemetics|antiemetics|mesh-ancestor
92032571|NCT05284409|Autonomic Agents|autonomic agents|mesh-ancestor
92032572|NCT05284409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032573|NCT05284409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032574|NCT05284409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92032575|NCT05284409|Glucocorticoids|glucocorticoids|mesh-ancestor
92032576|NCT05284409|Hormones|hormones|mesh-ancestor
92032577|NCT05284409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032578|NCT05284409|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92032579|NCT05284409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032580|NCT05284409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92032581|NCT05284409|Analgesics|analgesics|mesh-ancestor
92032582|NCT05284409|Sensory System Agents|sensory system agents|mesh-ancestor
92032583|NCT05284409|Antipyretics|antipyretics|mesh-ancestor
92032584|NCT05284409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92032586|NCT05284409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032587|NCT05284409|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92032588|NCT02523599|Bupivacaine|bupivacaine|mesh-list
92032589|NCT02523599|Anesthetics, Local|anesthetics, local|mesh-ancestor
92032590|NCT02523599|Anesthetics|anesthetics|mesh-ancestor
92032591|NCT02523599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032817|NCT05276531|Progestins|progestins|mesh-ancestor
92032592|NCT02523599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032593|NCT02523599|Sensory System Agents|sensory system agents|mesh-ancestor
92011900|NCT04429295|Vaccines|vaccines|mesh-list
92011901|NCT04429295|Immunologic Factors|immunologic factors|mesh-ancestor
92011902|NCT04429295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011903|NCT05258851|Colistin|colistin|mesh-list
92011904|NCT05258851|Ceftazidime|ceftazidime|mesh-list
92011905|NCT05258851|Avibactam|avibactam|mesh-list
92011906|NCT05258851|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92011907|NCT05258851|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92011908|NCT05258851|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011909|NCT05258851|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92011910|NCT05258851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011911|NCT05258851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011912|NCT03043001|Memantine|memantine|mesh-list
92011913|NCT03043001|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92011914|NCT03043001|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92011915|NCT03043001|Dopamine Agents|dopamine agents|mesh-ancestor
92011916|NCT03043001|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92011917|NCT03043001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011918|NCT03043001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011919|NCT03043001|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92011920|NCT03043001|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92011921|NCT04843007|Pemetrexed|pemetrexed|mesh-list
92032594|NCT02523599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032595|NCT05296577|Vinorelbine|vinorelbine|mesh-list
92032596|NCT05296577|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92032597|NCT05296577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032598|NCT05296577|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032599|NCT05296577|Antimitotic Agents|antimitotic agents|mesh-ancestor
92032600|NCT05296577|Mitosis Modulators|mitosis modulators|mesh-ancestor
92032601|NCT05296577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032602|NCT05354999|Caffeine|caffeine|mesh-list
92032603|NCT05354999|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92032604|NCT05354999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032605|NCT05354999|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92032606|NCT05354999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032607|NCT05354999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032608|NCT05354999|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92032609|NCT05354999|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92032610|NCT05354999|Purinergic Agents|purinergic agents|mesh-ancestor
92032611|NCT05354999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032612|NCT02187159|Pregabalin|pregabalin|mesh-list
92032613|NCT02187159|Analgesics|analgesics|mesh-ancestor
92032614|NCT02187159|Sensory System Agents|sensory system agents|mesh-ancestor
92032615|NCT02187159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032616|NCT02187159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032617|NCT02187159|Anticonvulsants|anticonvulsants|mesh-ancestor
92032618|NCT02187159|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92032619|NCT02187159|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92011923|NCT04843007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011924|NCT04843007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011925|NCT04843007|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92011926|NCT04843007|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92011927|NCT04840745|Leuprolide|leuprolide|mesh-list
92011928|NCT04840745|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92011929|NCT04840745|Fertility Agents|fertility agents|mesh-ancestor
92011930|NCT04840745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92011931|NCT04840745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011932|NCT04840745|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92011933|NCT04840745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92011934|NCT05072899|Hyaluronic Acid|hyaluronic acid|mesh-list
92011935|NCT05072899|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92032620|NCT02187159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032621|NCT02187159|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032622|NCT02187159|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92032623|NCT02187159|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92032624|NCT02187159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032625|NCT02187159|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92032626|NCT02335411|Pembrolizumab|pembrolizumab|mesh-list
92032627|NCT02335411|Capecitabine|capecitabine|mesh-list
92032628|NCT02335411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032629|NCT02335411|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032818|NCT05276531|Hormones|hormones|mesh-ancestor
92032630|NCT02335411|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032632|NCT02335411|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92032633|NCT02335411|Antimetabolites|antimetabolites|mesh-ancestor
92032634|NCT02186301|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92032635|NCT02186301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032636|NCT02186301|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032637|NCT02186301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032638|NCT02186301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032640|NCT02161731|Evacetrapib|evacetrapib|mesh-list
92032641|NCT02161731|Anticoagulants|anticoagulants|mesh-ancestor
92032642|NCT02161731|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92032643|NCT02161731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92032644|NCT02161731|Antimetabolites|antimetabolites|mesh-ancestor
92032645|NCT02161731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032646|NCT02161731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92032647|NCT02124759|Sevelamer|sevelamer|mesh-list
92032648|NCT02124759|Chelating Agents|chelating agents|mesh-ancestor
92032649|NCT02124759|Sequestering Agents|sequestering agents|mesh-ancestor
92032650|NCT02124759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032651|NCT02302339|Pembrolizumab|pembrolizumab|mesh-list
92032652|NCT02302339|Nivolumab|nivolumab|mesh-list
92032653|NCT02302339|Glembatumumab vedotin|glembatumumab vedotin|mesh-list
92032654|NCT02302339|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92032655|NCT02302339|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032656|NCT02302339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032657|NCT02302339|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032658|NCT02302339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032660|NCT02302339|Immunologic Factors|immunologic factors|mesh-ancestor
92032661|NCT02302339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032662|NCT04895917|Daratumumab|daratumumab|mesh-list
92032663|NCT04895917|Pomalidomide|pomalidomide|mesh-list
92032664|NCT04895917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032665|NCT04895917|Immunologic Factors|immunologic factors|mesh-ancestor
92032666|NCT04895917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032667|NCT04895917|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92011937|NCT05072899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011938|NCT05072899|Viscosupplements|viscosupplements|mesh-ancestor
92011939|NCT05072899|Protective Agents|protective agents|mesh-ancestor
92011940|NCT04839653|Vancomycin|vancomycin|mesh-list
92011941|NCT04839653|Gentamicins|gentamicins|mesh-list
92011942|NCT04839653|Ceftriaxone|ceftriaxone|mesh-list
92011943|NCT04839653|Polymyxins|polymyxins|mesh-list
92032668|NCT04895917|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92032669|NCT04895917|Growth Substances|growth substances|mesh-ancestor
92032670|NCT04895917|Growth Inhibitors|growth inhibitors|mesh-ancestor
92032671|NCT02161575|Ranibizumab|ranibizumab|mesh-list
92032672|NCT02161575|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92032673|NCT02161575|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92032674|NCT02161575|Growth Substances|growth substances|mesh-ancestor
92032675|NCT02161575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032676|NCT02161575|Growth Inhibitors|growth inhibitors|mesh-ancestor
92032677|NCT02161575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032678|NCT02161185|Midazolam|midazolam|mesh-list
92032679|NCT02161185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92032680|NCT02161185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92032681|NCT02161185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032682|NCT02161185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032683|NCT02161185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92032684|NCT02161185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92032685|NCT02161185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92032686|NCT02161185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92032687|NCT02161185|Anesthetics, General|anesthetics, general|mesh-ancestor
92032688|NCT02161185|Anesthetics|anesthetics|mesh-ancestor
92032689|NCT02161185|GABA Modulators|gaba modulators|mesh-ancestor
92032691|NCT02161185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032692|NCT02161185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032693|NCT02159469|Methyltestosterone|methyltestosterone|mesh-list
92032694|NCT02159469|Testosterone|testosterone|mesh-list
92032695|NCT02159469|Testosterone undecanoate|testosterone undecanoate|mesh-list
92032696|NCT02159469|Testosterone enanthate|testosterone enanthate|mesh-list
92032697|NCT02159469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92032698|NCT02159469|Androgens|androgens|mesh-ancestor
92032699|NCT02159469|Hormones|hormones|mesh-ancestor
92032700|NCT02159469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032701|NCT02159469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032702|NCT02159469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92032703|NCT02159469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032704|NCT02159469|Anabolic Agents|anabolic agents|mesh-ancestor
92032705|NCT02123511|Acetylcysteine|acetylcysteine|mesh-list
92032710|NCT02123511|Respiratory System Agents|respiratory system agents|mesh-ancestor
92032711|NCT02123511|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92032712|NCT02123511|Antioxidants|antioxidants|mesh-ancestor
92032713|NCT02123511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032714|NCT02123511|Protective Agents|protective agents|mesh-ancestor
92032715|NCT02123511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032716|NCT02123511|Antidotes|antidotes|mesh-ancestor
92032717|NCT04746339|Apixaban|apixaban|mesh-list
92032718|NCT04746339|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92032719|NCT04746339|Antithrombins|antithrombins|mesh-ancestor
92032720|NCT04746339|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92032721|NCT04746339|Protease Inhibitors|protease inhibitors|mesh-ancestor
92032722|NCT04746339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032723|NCT04746339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032724|NCT04746339|Anticoagulants|anticoagulants|mesh-ancestor
92032725|NCT02301403|Nicotine|nicotine|mesh-list
92032726|NCT02301403|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92032727|NCT02301403|Autonomic Agents|autonomic agents|mesh-ancestor
92032728|NCT02301403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032729|NCT02301403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032730|NCT02301403|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92032731|NCT02301403|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92032732|NCT02301403|Cholinergic Agents|cholinergic agents|mesh-ancestor
92011944|NCT04839653|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92011945|NCT04839653|Cefotaxime|cefotaxime|mesh-list
92011947|NCT04839653|Polymyxin B|polymyxin b|mesh-list
92011948|NCT04839653|Amphotericin B|amphotericin b|mesh-list
92011949|NCT04839653|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92011950|NCT04839653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011951|NCT04839653|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92011952|NCT04839653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011953|NCT04839653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011954|NCT04839653|Amebicides|amebicides|mesh-ancestor
92011955|NCT04839653|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92011956|NCT04839653|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92011957|NCT04839653|Antifungal Agents|antifungal agents|mesh-ancestor
92011958|NCT04842383|Peppermint oil|peppermint oil|mesh-list
92011959|NCT04842383|Antiemetics|antiemetics|mesh-ancestor
92011960|NCT04842383|Autonomic Agents|autonomic agents|mesh-ancestor
92011961|NCT04842383|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011962|NCT04842383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032733|NCT02301403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032734|NCT02301403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032735|NCT02333383|Adalimumab|adalimumab|mesh-list
92032736|NCT02333383|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92032737|NCT02333383|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032738|NCT02333383|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032739|NCT02369341|Vaccines|vaccines|mesh-list
92032740|NCT02369341|Immunologic Factors|immunologic factors|mesh-ancestor
92032741|NCT02369341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032742|NCT02121795|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92032743|NCT02121795|Antiviral Agents|antiviral agents|mesh-ancestor
92032744|NCT02121795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032745|NCT02158533|Naltrexone|naltrexone|mesh-list
92032746|NCT02158533|Buprenorphine|buprenorphine|mesh-list
92032747|NCT02158533|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92032748|NCT02158533|Narcotics|narcotics|mesh-ancestor
92032749|NCT02158533|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032751|NCT02158533|Analgesics|analgesics|mesh-ancestor
92032752|NCT02158533|Sensory System Agents|sensory system agents|mesh-ancestor
92032753|NCT02158533|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032754|NCT02158533|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92032755|NCT02158533|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92032756|NCT02120469|Everolimus|everolimus|mesh-list
92032757|NCT02120469|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92032758|NCT02120469|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032759|NCT02120469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032760|NCT02120469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032761|NCT02120469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032762|NCT02120469|Immunologic Factors|immunologic factors|mesh-ancestor
92032763|NCT02120469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032764|NCT02120469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032765|NCT02180061|Pembrolizumab|pembrolizumab|mesh-list
92032766|NCT02180061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032767|NCT02180061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032768|NCT02180061|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032769|NCT02180061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032770|NCT02120157|Mycophenolic Acid|mycophenolic acid|mesh-list
92032771|NCT02120157|Cyclophosphamide|cyclophosphamide|mesh-list
92032772|NCT02120157|Busulfan|busulfan|mesh-list
92032773|NCT02120157|Tacrolimus|tacrolimus|mesh-list
92011964|NCT04842383|Parasympatholytics|parasympatholytics|mesh-ancestor
92011965|NCT04884139|Tenofovir|tenofovir|mesh-list
92011966|NCT04884139|Lamivudine|lamivudine|mesh-list
92011967|NCT04884139|Emtricitabine|emtricitabine|mesh-list
92011968|NCT04884139|Dolutegravir|dolutegravir|mesh-list
92011969|NCT04884139|Antiviral Agents|antiviral agents|mesh-ancestor
92011970|NCT04884139|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92011971|NCT04884139|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92011972|NCT04884139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92011973|NCT04884139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92011974|NCT04884139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011975|NCT04884139|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92011976|NCT04884139|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92011977|NCT04884139|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92011978|NCT04884139|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92011979|NCT04860167|Diclofenac|diclofenac|mesh-list
92011980|NCT04860167|Lidocaine|lidocaine|mesh-list
92011981|NCT04860167|Propofol|propofol|mesh-list
92032774|NCT02120157|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032775|NCT02120157|Immunologic Factors|immunologic factors|mesh-ancestor
92032776|NCT02120157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032777|NCT02120157|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032778|NCT02120157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92032783|NCT02120157|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92032785|NCT02120157|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92032786|NCT02120157|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92032787|NCT02120157|Antitubercular Agents|antitubercular agents|mesh-ancestor
92032788|NCT02120157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92032789|NCT02120157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032790|NCT01365455|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92032791|NCT01365455|Immunologic Factors|immunologic factors|mesh-ancestor
92032792|NCT01365455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032793|NCT02155881|Ciclesonide|ciclesonide|mesh-list
92032794|NCT02155881|Glucocorticoids|glucocorticoids|mesh-ancestor
92032795|NCT02155881|Hormones|hormones|mesh-ancestor
92032796|NCT02155881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032797|NCT02155881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032798|NCT02155881|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92032799|NCT05279807|Amlodipine|amlodipine|mesh-list
92032800|NCT05279807|Zofenopril|zofenopril|mesh-list
92032801|NCT05279807|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92032802|NCT05279807|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92032803|NCT05279807|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032804|NCT05279807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032805|NCT05279807|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032806|NCT05279807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032807|NCT05279807|Vasodilator Agents|vasodilator agents|mesh-ancestor
92032808|NCT05279807|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92032809|NCT05279807|Protease Inhibitors|protease inhibitors|mesh-ancestor
92032810|NCT05279807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032811|NCT05319431|Lenvatinib|lenvatinib|mesh-list
92032812|NCT05319431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032813|NCT05319431|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032814|NCT05319431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032815|NCT05319431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032816|NCT05276531|Progesterone|progesterone|mesh-list
92011982|NCT04860167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92011983|NCT04860167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011984|NCT04860167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92011985|NCT04860167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92011986|NCT04860167|Anesthetics, General|anesthetics, general|mesh-ancestor
92011987|NCT04860167|Anesthetics|anesthetics|mesh-ancestor
92011988|NCT04860167|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92011989|NCT04860167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92011990|NCT04860167|Analgesics|analgesics|mesh-ancestor
92011991|NCT04860167|Sensory System Agents|sensory system agents|mesh-ancestor
92011992|NCT04860167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92011993|NCT04860167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92011994|NCT04860167|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92011995|NCT04860167|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92032819|NCT05276531|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032820|NCT05276531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032821|NCT01658579|Insulin|insulin|mesh-list
92032822|NCT01658579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92032823|NCT01658579|Insulin Glargine|insulin glargine|mesh-list
92032824|NCT01658579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92032825|NCT01658579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032826|NCT05561309|Ropivacaine|ropivacaine|mesh-list
92032827|NCT05561309|Anesthetics, Local|anesthetics, local|mesh-ancestor
92032828|NCT05561309|Anesthetics|anesthetics|mesh-ancestor
92032829|NCT05561309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032830|NCT05561309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032831|NCT05561309|Sensory System Agents|sensory system agents|mesh-ancestor
92032832|NCT05561309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032833|NCT05268497|Antidepressive Agents|antidepressive agents|mesh-list
92032834|NCT05268497|Esketamine|esketamine|mesh-list
92032835|NCT05268497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92032836|NCT05266859|Calcium|calcium|mesh-list
92032837|NCT05266859|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032838|NCT05266859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032839|NCT05346731|Dexamethasone|dexamethasone|mesh-list
92032840|NCT05346731|Ondansetron|ondansetron|mesh-list
92032841|NCT05346731|Olanzapine|olanzapine|mesh-list
92032842|NCT05346731|Aprepitant|aprepitant|mesh-list
92032843|NCT05346731|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92032844|NCT05346731|Antiemetics|antiemetics|mesh-ancestor
92032845|NCT05346731|Autonomic Agents|autonomic agents|mesh-ancestor
92032846|NCT05346731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032847|NCT05346731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032848|NCT05346731|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92032849|NCT05346731|Glucocorticoids|glucocorticoids|mesh-ancestor
92032851|NCT05346731|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032853|NCT05346731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032854|NCT05346731|Antipruritics|antipruritics|mesh-ancestor
92032855|NCT05346731|Dermatologic Agents|dermatologic agents|mesh-ancestor
92032856|NCT05346731|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92032857|NCT05346731|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92032858|NCT05346731|Serotonin Agents|serotonin agents|mesh-ancestor
92032859|NCT05346731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032860|NCT05346731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032861|NCT05346731|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92032862|NCT05346731|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92032863|NCT05346731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92011997|NCT04860167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92011998|NCT04860167|Anesthetics, Local|anesthetics, local|mesh-ancestor
92011999|NCT04860167|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92012000|NCT04860167|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92012001|NCT04860167|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92032864|NCT05346731|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92032865|NCT05346731|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92032866|NCT05346731|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92032867|NCT05346731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032868|NCT05346731|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92032869|NCT02118597|Interferons|interferons|mesh-list
92032870|NCT02118597|Ribavirin|ribavirin|mesh-list
92032871|NCT02118597|Simeprevir|simeprevir|mesh-list
92032872|NCT02118597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032873|NCT02118597|Antiviral Agents|antiviral agents|mesh-ancestor
92032874|NCT02118597|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032875|NCT02118597|Antimetabolites|antimetabolites|mesh-ancestor
92032876|NCT02118597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032877|NCT02118597|Protease Inhibitors|protease inhibitors|mesh-ancestor
92032878|NCT02118597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032879|NCT05218889|Paclitaxel|paclitaxel|mesh-list
92032880|NCT05218889|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92032881|NCT05218889|Gemcitabine|gemcitabine|mesh-list
92032882|NCT05218889|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92032883|NCT05218889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032884|NCT05218889|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032885|NCT05218889|Antimitotic Agents|antimitotic agents|mesh-ancestor
92032887|NCT05218889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032888|NCT05218889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92032889|NCT05218889|Antimetabolites|antimetabolites|mesh-ancestor
92032890|NCT02117349|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92032891|NCT02117349|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92032892|NCT02117349|Hemostatics|hemostatics|mesh-ancestor
92032893|NCT02117349|Coagulants|coagulants|mesh-ancestor
92032894|NCT02177175|Carvedilol|carvedilol|mesh-list
92032895|NCT02177175|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92032896|NCT02177175|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92032897|NCT02177175|Adrenergic Agents|adrenergic agents|mesh-ancestor
92032898|NCT02177175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032899|NCT02177175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032900|NCT02177175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032901|NCT02177175|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92032902|NCT02177175|Antioxidants|antioxidants|mesh-ancestor
92032903|NCT02177175|Protective Agents|protective agents|mesh-ancestor
92032904|NCT02177175|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92032905|NCT02177175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032906|NCT02177175|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032907|NCT02177175|Vasodilator Agents|vasodilator agents|mesh-ancestor
92032908|NCT02177175|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92032909|NCT02177175|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92032910|NCT01657877|Calcium|calcium|mesh-list
92032911|NCT01657877|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92032912|NCT01657877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032913|NCT05254925|Sunscreening Agents|sunscreening agents|mesh-list
92032914|NCT05254925|Petrolatum|petrolatum|mesh-list
92032915|NCT05254925|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92032916|NCT05254925|Protective Agents|protective agents|mesh-ancestor
92032917|NCT05254925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032918|NCT05254925|Dermatologic Agents|dermatologic agents|mesh-ancestor
92032919|NCT05254925|Emollients|emollients|mesh-ancestor
92032920|NCT05205473|Lidocaine|lidocaine|mesh-list
92032921|NCT05205473|Anesthetics|anesthetics|mesh-list
92032922|NCT05205473|Anesthetics, Local|anesthetics, local|mesh-ancestor
92032923|NCT05205473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92032925|NCT05205473|Sensory System Agents|sensory system agents|mesh-ancestor
92032926|NCT05205473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032927|NCT05205473|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92012002|NCT04860167|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012003|NCT02514031|Beta-lapachone|beta-lapachone|mesh-list
92012004|NCT02514031|Paclitaxel|paclitaxel|mesh-list
92012005|NCT02514031|Gemcitabine|gemcitabine|mesh-list
92012006|NCT02514031|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92012007|NCT02514031|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012008|NCT02514031|Tubulin Modulators|tubulin modulators|mesh-ancestor
92012009|NCT02514031|Antimitotic Agents|antimitotic agents|mesh-ancestor
92012010|NCT02514031|Mitosis Modulators|mitosis modulators|mesh-ancestor
92012011|NCT02514031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012012|NCT02514031|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92012013|NCT02514031|Antimetabolites|antimetabolites|mesh-ancestor
92012014|NCT02514031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012015|NCT02514031|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92012016|NCT02514031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92012017|NCT02514031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012018|NCT02514031|Antiviral Agents|antiviral agents|mesh-ancestor
92012019|NCT04622917|Methylprednisolone|methylprednisolone|mesh-list
92012020|NCT04622917|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92032928|NCT05205473|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92032929|NCT05205473|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92032930|NCT05205473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92032931|NCT05205473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032933|NCT05253053|Atezolizumab|atezolizumab|mesh-list
92032934|NCT05253053|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92032935|NCT05253053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032936|NCT05253053|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032937|NCT05253053|Antimitotic Agents|antimitotic agents|mesh-ancestor
92032938|NCT05253053|Mitosis Modulators|mitosis modulators|mesh-ancestor
92032939|NCT05253053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032940|NCT05253053|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032941|NCT05253053|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032942|NCT04422197|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92032944|NCT04422197|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92032945|NCT04422197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92032946|NCT04422197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032947|NCT04422197|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92032948|NCT04422197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033086|NCT05196815|Sympathomimetics|sympathomimetics|mesh-ancestor
92032949|NCT04422197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032950|NCT04422197|Cholinergic Agents|cholinergic agents|mesh-ancestor
92032951|NCT04422197|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92032952|NCT05252429|Docetaxel|docetaxel|mesh-list
92032953|NCT05252429|Pembrolizumab|pembrolizumab|mesh-list
92032954|NCT05252429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032955|NCT05252429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032956|NCT05252429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92032957|NCT05252429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92032958|NCT05252429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032959|NCT05252429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032960|NCT05252429|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92032961|NCT05157971|Cytarabine|cytarabine|mesh-list
92032962|NCT05157971|Prednisone|prednisone|mesh-list
92012021|NCT04622917|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92012022|NCT04622917|Prednisolone|prednisolone|mesh-list
92012023|NCT04622917|Prednisolone acetate|prednisolone acetate|mesh-list
92012024|NCT04622917|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92012025|NCT04622917|Prednisolone phosphate|prednisolone phosphate|mesh-list
92012026|NCT04622917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012027|NCT04622917|Antiemetics|antiemetics|mesh-ancestor
92012028|NCT04622917|Autonomic Agents|autonomic agents|mesh-ancestor
92012029|NCT04622917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012030|NCT04622917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012031|NCT04622917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92032963|NCT05157971|Cortisone|cortisone|mesh-list
92032964|NCT05157971|Cyclophosphamide|cyclophosphamide|mesh-list
92032965|NCT05157971|Methotrexate|methotrexate|mesh-list
92032966|NCT05157971|Vincristine|vincristine|mesh-list
92032967|NCT05157971|Daunorubicin|daunorubicin|mesh-list
92032968|NCT05157971|Venetoclax|venetoclax|mesh-list
92032969|NCT05157971|Asparaginase|asparaginase|mesh-list
92032970|NCT05157971|Mercaptopurine|mercaptopurine|mesh-list
92032971|NCT05157971|Pegaspargase|pegaspargase|mesh-list
92032972|NCT05157971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032973|NCT05157971|Immunologic Factors|immunologic factors|mesh-ancestor
92032974|NCT05157971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032975|NCT05157971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92032976|NCT05157971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92032977|NCT05157971|Alkylating Agents|alkylating agents|mesh-ancestor
92032978|NCT05157971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032979|NCT05157971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032980|NCT05157971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92032982|NCT05157971|Glucocorticoids|glucocorticoids|mesh-ancestor
92032983|NCT05157971|Hormones|hormones|mesh-ancestor
92032984|NCT05157971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032985|NCT05157971|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92032986|NCT05157971|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92032987|NCT05157971|Abortifacient Agents|abortifacient agents|mesh-ancestor
92032988|NCT05157971|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92032989|NCT05157971|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92032990|NCT05157971|Antimetabolites|antimetabolites|mesh-ancestor
92032991|NCT05157971|Dermatologic Agents|dermatologic agents|mesh-ancestor
92032992|NCT05157971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032993|NCT05157971|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92032994|NCT05157971|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92032995|NCT05157971|Antiviral Agents|antiviral agents|mesh-ancestor
92033000|NCT05157971|Mitosis Modulators|mitosis modulators|mesh-ancestor
92033001|NCT05157971|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92033002|NCT05157971|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92033003|NCT05157971|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92033004|NCT02175771|Fluticasone|fluticasone|mesh-list
92033005|NCT02175771|Xhance|xhance|mesh-list
92033006|NCT02175771|Albuterol|albuterol|mesh-list
92033007|NCT02175771|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92033008|NCT02175771|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92033009|NCT02175771|Adrenergic Agonists|adrenergic agonists|mesh-list
92033010|NCT02175771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033011|NCT02175771|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92033012|NCT02175771|Autonomic Agents|autonomic agents|mesh-ancestor
92033013|NCT02175771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033014|NCT02175771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033015|NCT02175771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92033016|NCT02175771|Respiratory System Agents|respiratory system agents|mesh-ancestor
92033017|NCT02175771|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033018|NCT02175771|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92033019|NCT02175771|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92033020|NCT02175771|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92012033|NCT04622917|Hormones|hormones|mesh-ancestor
92012034|NCT04622917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012035|NCT04622917|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92012036|NCT04622917|Protective Agents|protective agents|mesh-ancestor
92012037|NCT04622917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012038|NCT04622917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012039|NCT03038477|Durvalumab|durvalumab|mesh-list
92012040|NCT03038477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012041|NCT03038477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012042|NCT03038243|Vaccines|vaccines|mesh-list
92012043|NCT03038243|Immunologic Factors|immunologic factors|mesh-ancestor
92033021|NCT02175771|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033022|NCT02175771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033023|NCT02175771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033024|NCT02175771|Tocolytic Agents|tocolytic agents|mesh-ancestor
92033025|NCT02175771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92033026|NCT02175771|Glucocorticoids|glucocorticoids|mesh-ancestor
92033027|NCT02175771|Hormones|hormones|mesh-ancestor
92033028|NCT02175771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033029|NCT02175771|Sympathomimetics|sympathomimetics|mesh-ancestor
92033030|NCT01657799|Veliparib|veliparib|mesh-list
92033031|NCT01657799|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92033032|NCT01657799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033033|NCT01657799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033034|NCT01657799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033036|NCT02116803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92033037|NCT02116803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033038|NCT02116803|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92033039|NCT02116803|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92033040|NCT02116803|Hormone Antagonists|hormone antagonists|mesh-ancestor
92033041|NCT02116803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033042|NCT02116803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033043|NCT02115321|Grazoprevir|grazoprevir|mesh-list
92033044|NCT02115321|Antiviral Agents|antiviral agents|mesh-ancestor
92033045|NCT02115321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033046|NCT05248841|Insulin Glargine|insulin glargine|mesh-list
92033047|NCT05248841|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033048|NCT05248841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033049|NCT05248139|Prednisolone|prednisolone|mesh-list
92033050|NCT05248139|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92033051|NCT05248139|Methylprednisolone|methylprednisolone|mesh-list
92033052|NCT05248139|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92033053|NCT05248139|Prednisolone acetate|prednisolone acetate|mesh-list
92033054|NCT05248139|Triamcinolone|triamcinolone|mesh-list
92033055|NCT05248139|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92033056|NCT05248139|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92033057|NCT05248139|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92033058|NCT05248139|Prednisolone phosphate|prednisolone phosphate|mesh-list
92033059|NCT05248139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033060|NCT05248139|Glucocorticoids|glucocorticoids|mesh-ancestor
92033061|NCT05248139|Hormones|hormones|mesh-ancestor
92033062|NCT05248139|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033063|NCT05248139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033064|NCT05248139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92033065|NCT05248139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033066|NCT05248139|Antiemetics|antiemetics|mesh-ancestor
92033067|NCT05248139|Autonomic Agents|autonomic agents|mesh-ancestor
92033071|NCT05248139|Protective Agents|protective agents|mesh-ancestor
92033072|NCT05248139|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033073|NCT05248139|Immunologic Factors|immunologic factors|mesh-ancestor
92012044|NCT03038243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012045|NCT03038321|Levofloxacin|levofloxacin|mesh-list
92012046|NCT03038321|Lornoxicam|lornoxicam|mesh-list
92033074|NCT05248139|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92033075|NCT05247125|Melatonin|melatonin|mesh-list
92033076|NCT05247125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033077|NCT05247125|Antioxidants|antioxidants|mesh-ancestor
92033078|NCT05247125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033079|NCT05247125|Protective Agents|protective agents|mesh-ancestor
92033080|NCT05247125|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033081|NCT05154383|Vaccines|vaccines|mesh-list
92033082|NCT05154383|Immunologic Factors|immunologic factors|mesh-ancestor
92033083|NCT05154383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033084|NCT05196815|Dobutamine|dobutamine|mesh-list
92033085|NCT05196815|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92033087|NCT05196815|Autonomic Agents|autonomic agents|mesh-ancestor
92033088|NCT05196815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033089|NCT05196815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033090|NCT05196815|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92033091|NCT05196815|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92033092|NCT05196815|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92033093|NCT05196815|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033094|NCT05196815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033095|NCT05196815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033096|NCT05196815|Protective Agents|protective agents|mesh-ancestor
92033097|NCT05245877|Enoxaparin|enoxaparin|mesh-list
92033098|NCT05245877|Dalteparin|dalteparin|mesh-list
92033099|NCT05245877|Tinzaparin|tinzaparin|mesh-list
92033100|NCT05245877|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92033101|NCT05245877|Anticoagulants|anticoagulants|mesh-ancestor
92033102|NCT05245877|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92033103|NCT05245877|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92033104|NCT05245877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033105|NCT05149781|Antihypertensive Agents|antihypertensive agents|mesh-list
92033106|NCT02367781|Paclitaxel|paclitaxel|mesh-list
92033107|NCT02367781|Carboplatin|carboplatin|mesh-list
92033108|NCT02367781|Pemetrexed|pemetrexed|mesh-list
92033109|NCT02367781|Atezolizumab|atezolizumab|mesh-list
92033110|NCT02367781|Antibodies|antibodies|mesh-list
92033111|NCT02367781|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92033112|NCT02367781|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92033113|NCT02367781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033114|NCT02367781|Tubulin Modulators|tubulin modulators|mesh-ancestor
92033115|NCT02367781|Antimitotic Agents|antimitotic agents|mesh-ancestor
92033116|NCT02367781|Mitosis Modulators|mitosis modulators|mesh-ancestor
92033117|NCT02367781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033118|NCT02367781|Immunologic Factors|immunologic factors|mesh-ancestor
92033119|NCT02367781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033120|NCT02367781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033121|NCT02367781|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92033122|NCT02367781|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92033123|NCT02367781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92033124|NCT02367781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033125|NCT05191277|Antidepressive Agents|antidepressive agents|mesh-list
92033126|NCT05191277|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92033127|NCT04242173|Cemiplimab|cemiplimab|mesh-list
92033128|NCT04242173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033129|NCT04242173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033130|NCT05189015|Olmesartan|olmesartan|mesh-list
92033131|NCT05189015|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92033132|NCT05189015|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92033133|NCT05189015|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92033134|NCT05189015|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92033135|NCT05189015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033136|NCT05239091|Lidocaine|lidocaine|mesh-list
92033137|NCT05239091|Anesthetics, Local|anesthetics, local|mesh-list
92033138|NCT05239091|Anesthetics|anesthetics|mesh-list
92033139|NCT05239091|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033140|NCT05239091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033155|NCT02332291|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92033156|NCT02332291|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92012047|NCT03038321|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92012048|NCT03038321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033157|NCT02332291|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033158|NCT02332291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033159|NCT02332291|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033160|NCT02332291|Serotonin Agents|serotonin agents|mesh-ancestor
92033161|NCT02332291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033162|NCT02332291|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92033163|NCT02332291|Antidepressive Agents|antidepressive agents|mesh-ancestor
92033164|NCT02332291|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92033165|NCT02332291|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92033166|NCT02332291|Dopamine Agents|dopamine agents|mesh-ancestor
92033167|NCT02332291|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92033168|NCT02332291|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92033169|NCT02332291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033170|NCT01656395|Montelukast|montelukast|mesh-list
92033171|NCT01656395|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92033172|NCT01656395|Respiratory System Agents|respiratory system agents|mesh-ancestor
92033173|NCT01656395|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92033174|NCT01656395|Hormone Antagonists|hormone antagonists|mesh-ancestor
92033175|NCT01656395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033176|NCT01656395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033177|NCT01656395|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92033178|NCT01656395|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92033179|NCT01656395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033180|NCT02114931|Adalimumab|adalimumab|mesh-list
92033181|NCT02114931|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92033182|NCT02114931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033183|NCT02114931|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033184|NCT05185739|Pembrolizumab|pembrolizumab|mesh-list
92033185|NCT05185739|Lenvatinib|lenvatinib|mesh-list
92033186|NCT05185739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033187|NCT05185739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033188|NCT05185739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92033189|NCT05185739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033190|NCT05185739|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92033191|NCT05185739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033192|NCT05237687|Sirolimus|sirolimus|mesh-list
92033193|NCT05237687|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92033194|NCT05237687|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033195|NCT05237687|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92033196|NCT05237687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033198|NCT05237687|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033204|NCT01657019|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92033205|NCT01657019|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92033206|NCT01657019|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033207|NCT01657019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033208|NCT01657019|Dopamine Agents|dopamine agents|mesh-ancestor
92033209|NCT01657019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033210|NCT05182151|Istradefylline|istradefylline|mesh-list
92033211|NCT05182151|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92033212|NCT05182151|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92033213|NCT05182151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92033214|NCT05182151|Purinergic Agents|purinergic agents|mesh-ancestor
92033215|NCT05182151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033216|NCT05182151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033217|NCT05182151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033218|NCT05181605|Folfirinox|folfirinox|mesh-list
92033219|NCT05181605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033220|NCT04883281|Paclitaxel|paclitaxel|mesh-list
92033221|NCT04883281|Carboplatin|carboplatin|mesh-list
92033223|NCT04883281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92033224|NCT04883281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033225|NCT04883281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92033226|NCT04883281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92033227|NCT04883281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92033228|NCT04883281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033229|NCT04883281|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012049|NCT03038321|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012050|NCT03038321|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92012051|NCT03038321|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92012052|NCT03038321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012053|NCT03038321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012054|NCT03038321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012055|NCT03038321|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92012056|NCT03038321|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92012057|NCT03038321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92012058|NCT03038321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012059|NCT03038321|Analgesics|analgesics|mesh-ancestor
92012060|NCT03038321|Sensory System Agents|sensory system agents|mesh-ancestor
92012061|NCT03038321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012062|NCT03038321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012063|NCT03038321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012064|NCT03038321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012065|NCT02531373|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92012066|NCT02531373|Immunologic Factors|immunologic factors|mesh-ancestor
92012067|NCT02531373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033230|NCT02300311|Nicotinic Acids|nicotinic acids|mesh-list
92033231|NCT02300311|Capsaicin|capsaicin|mesh-list
92033232|NCT02300311|Nonivamide|nonivamide|mesh-list
92033233|NCT02300311|Sensory System Agents|sensory system agents|mesh-ancestor
92033234|NCT02300311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033235|NCT02300311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033236|NCT02300311|Antipruritics|antipruritics|mesh-ancestor
92033237|NCT02300311|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033238|NCT02300311|Vitamin B Complex|vitamin b complex|mesh-ancestor
92033239|NCT02300311|Vitamins|vitamins|mesh-ancestor
92033240|NCT02300311|Micronutrients|micronutrients|mesh-ancestor
92033241|NCT05141903|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92033242|NCT05141903|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033243|NCT05140499|Bupivacaine|bupivacaine|mesh-list
92033244|NCT05140499|Anesthetics, Local|anesthetics, local|mesh-ancestor
92033245|NCT05140499|Anesthetics|anesthetics|mesh-ancestor
92033246|NCT05140499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033247|NCT05140499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033248|NCT05140499|Sensory System Agents|sensory system agents|mesh-ancestor
92033250|NCT04229381|Coal Tar|coal tar|mesh-list
92033251|NCT04229381|Keratolytic Agents|keratolytic agents|mesh-ancestor
92033252|NCT04229381|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033253|NCT05178485|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92033254|NCT05178485|Bupivacaine|bupivacaine|mesh-list
92033255|NCT05178485|Anesthetics, Local|anesthetics, local|mesh-ancestor
92033256|NCT05178485|Anesthetics|anesthetics|mesh-ancestor
92033257|NCT05178485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033258|NCT05178485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033259|NCT05178485|Sensory System Agents|sensory system agents|mesh-ancestor
92033260|NCT05178485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033261|NCT05178485|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033262|NCT05178485|Glucocorticoids|glucocorticoids|mesh-ancestor
92033263|NCT05178485|Hormones|hormones|mesh-ancestor
92033264|NCT05178485|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012068|NCT03042377|Calcium, Dietary|calcium, dietary|mesh-list
92012069|NCT03042377|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92012070|NCT03042377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92012072|NCT03042377|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92012073|NCT03042377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012074|NCT03042377|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92012075|NCT03042377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012076|NCT03042377|Antitubercular Agents|antitubercular agents|mesh-ancestor
92012077|NCT04859777|Pembrolizumab|pembrolizumab|mesh-list
92033265|NCT05178485|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033266|NCT05178485|Immunologic Factors|immunologic factors|mesh-ancestor
92033271|NCT05228951|Trastuzumab|trastuzumab|mesh-list
92033272|NCT05228951|Letrozole|letrozole|mesh-list
92033277|NCT05228951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033278|NCT05228951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033279|NCT05228951|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92033280|NCT05228951|Hormone Antagonists|hormone antagonists|mesh-ancestor
92033281|NCT05228951|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033282|NCT05228951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033284|NCT05227937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92033285|NCT05227937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033286|NCT05174039|Miglustat|miglustat|mesh-list
92033287|NCT05174039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033288|NCT05174039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033289|NCT05174039|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92033290|NCT05174039|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92033291|NCT05174039|Antiviral Agents|antiviral agents|mesh-ancestor
92033292|NCT05174039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033293|NCT05174039|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92033294|NCT05174039|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033295|NCT05174039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033296|NCT05138549|Beta Carotene|beta carotene|mesh-list
92033297|NCT05138549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033298|NCT05138549|Provitamins|provitamins|mesh-ancestor
92033299|NCT05138549|Vitamins|vitamins|mesh-ancestor
92033300|NCT05138549|Micronutrients|micronutrients|mesh-ancestor
92033301|NCT04241549|Azacitidine|azacitidine|mesh-list
92033302|NCT04241549|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92033303|NCT04241549|Antimetabolites|antimetabolites|mesh-ancestor
92033304|NCT04241549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033305|NCT04241549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033306|NCT04241549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033307|NCT02175225|Deferoxamine|deferoxamine|mesh-list
92033308|NCT02175225|Siderophores|siderophores|mesh-ancestor
92033309|NCT02175225|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92033310|NCT02175225|Chelating Agents|chelating agents|mesh-ancestor
92033311|NCT02175225|Sequestering Agents|sequestering agents|mesh-ancestor
92033312|NCT02175225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033313|NCT05170841|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92033314|NCT05170841|Tramadol|tramadol|mesh-list
92033315|NCT05170841|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92033316|NCT05170841|Narcotics|narcotics|mesh-ancestor
92033317|NCT05170841|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033318|NCT05170841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033319|NCT05170841|Analgesics|analgesics|mesh-ancestor
92033320|NCT05170841|Sensory System Agents|sensory system agents|mesh-ancestor
92033321|NCT05170841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033322|NCT05170841|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92033323|NCT05170841|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92033324|NCT05170841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033325|NCT05170841|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033327|NCT05135273|Immunologic Factors|immunologic factors|mesh-ancestor
92033328|NCT05135273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012078|NCT04859777|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012080|NCT04859777|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012081|NCT04859777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012082|NCT05562609|Tranexamic Acid|tranexamic acid|mesh-list
92012083|NCT05562609|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92012084|NCT05562609|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92012085|NCT05562609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012086|NCT05562609|Hemostatics|hemostatics|mesh-ancestor
92012087|NCT05562609|Coagulants|coagulants|mesh-ancestor
92012088|NCT05071339|Ganirelix|ganirelix|mesh-list
92012089|NCT05071339|Hormone Antagonists|hormone antagonists|mesh-ancestor
92012090|NCT05071339|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012091|NCT05071339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012092|NCT02606279|Valsartan|valsartan|mesh-list
92012093|NCT02606279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92033329|NCT02299375|Albuterol|albuterol|mesh-list
92033330|NCT02299375|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92033331|NCT02299375|Autonomic Agents|autonomic agents|mesh-ancestor
92033332|NCT02299375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033333|NCT02299375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033334|NCT02299375|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92033335|NCT02299375|Respiratory System Agents|respiratory system agents|mesh-ancestor
92033336|NCT02299375|Tocolytic Agents|tocolytic agents|mesh-ancestor
92033337|NCT02299375|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92033338|NCT02299375|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92033339|NCT02299375|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92033340|NCT02299375|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92033341|NCT02299375|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033342|NCT02299375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033343|NCT02299375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033345|NCT02151591|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92033346|NCT02151591|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92033347|NCT02151591|Cholinergic Agents|cholinergic agents|mesh-ancestor
92033348|NCT02151591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033349|NCT02151591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033350|NCT02151591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033351|NCT02174523|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92033352|NCT02174523|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92033353|NCT02174523|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92033354|NCT02174523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033355|NCT02174523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033356|NCT02174523|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92033357|NCT02174523|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92033358|NCT02174523|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92033359|NCT02174523|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92033360|NCT02174523|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033361|NCT02174523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033362|NCT02174523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033363|NCT02174523|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92033364|NCT02174523|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92033365|NCT02174523|Serotonin Agents|serotonin agents|mesh-ancestor
92033366|NCT02174523|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92033367|NCT02174523|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92033368|NCT02174523|Dopamine Agents|dopamine agents|mesh-ancestor
92033370|NCT04881799|Phentermine|phentermine|mesh-list
92033562|NCT02106975|Vitamins|vitamins|mesh-ancestor
92012094|NCT02606279|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92081678|NCT01392183|Anesthetics, Local|anesthetics, local|mesh-ancestor
92012095|NCT02606279|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92033372|NCT04881799|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033373|NCT04881799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033374|NCT04881799|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92033375|NCT04881799|Appetite Depressants|appetite depressants|mesh-ancestor
92033376|NCT04881799|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92033377|NCT04881799|Sympathomimetics|sympathomimetics|mesh-ancestor
92033378|NCT04881799|Autonomic Agents|autonomic agents|mesh-ancestor
92033379|NCT04881799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033380|NCT04881799|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033381|NCT04881799|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033382|NCT04881799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033383|NCT02297815|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92033384|NCT02297815|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92033385|NCT02297815|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033386|NCT02297815|Antitubercular Agents|antitubercular agents|mesh-ancestor
92033388|NCT02114385|Immunologic Factors|immunologic factors|mesh-ancestor
92033389|NCT02114385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033390|NCT05098457|Lidocaine|lidocaine|mesh-list
92033391|NCT05098457|Anesthetics, Local|anesthetics, local|mesh-ancestor
92033392|NCT05098457|Anesthetics|anesthetics|mesh-ancestor
92033393|NCT05098457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033394|NCT05098457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033395|NCT05098457|Sensory System Agents|sensory system agents|mesh-ancestor
92033396|NCT05098457|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033397|NCT05098457|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92033398|NCT05098457|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92033399|NCT05098457|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92033400|NCT05098457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033401|NCT05098457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033402|NCT02114151|Sofosbuvir|sofosbuvir|mesh-list
92033403|NCT02114151|Simeprevir|simeprevir|mesh-list
92033404|NCT02114151|Antiviral Agents|antiviral agents|mesh-ancestor
92033405|NCT02114151|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033406|NCT02114151|Protease Inhibitors|protease inhibitors|mesh-ancestor
92033407|NCT02114151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033408|NCT02114151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033409|NCT05220293|Betamethasone|betamethasone|mesh-list
92033410|NCT05220293|Betamethasone Valerate|betamethasone valerate|mesh-list
92033411|NCT05220293|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92033412|NCT05220293|Betamethasone benzoate|betamethasone benzoate|mesh-list
92033413|NCT05220293|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92033414|NCT05220293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033415|NCT05220293|Glucocorticoids|glucocorticoids|mesh-ancestor
92033417|NCT05220293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033432|NCT02297503|Viscosupplements|viscosupplements|mesh-ancestor
92033433|NCT02297503|Protective Agents|protective agents|mesh-ancestor
92033434|NCT02366767|Insulin|insulin|mesh-list
92033435|NCT02366767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033436|NCT02366767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033437|NCT02149875|Cerebrolysin|cerebrolysin|mesh-list
92033438|NCT02149875|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92033439|NCT02149875|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92033440|NCT02149875|Protective Agents|protective agents|mesh-ancestor
92033441|NCT02149875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033442|NCT02149875|Nootropic Agents|nootropic agents|mesh-ancestor
92033443|NCT02149875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92033444|NCT05095961|Prednisone|prednisone|mesh-list
92033445|NCT05095961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033446|NCT05095961|Glucocorticoids|glucocorticoids|mesh-ancestor
92033447|NCT05095961|Hormones|hormones|mesh-ancestor
92033448|NCT05095961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033449|NCT05095961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033450|NCT05095961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92033451|NCT05095961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033452|NCT05124899|Sunscreening Agents|sunscreening agents|mesh-list
92033455|NCT05124899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033456|NCT05124899|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033457|NCT05093621|Torsemide|torsemide|mesh-list
92033458|NCT05093621|Furosemide|furosemide|mesh-list
92033459|NCT05093621|Diuretics|diuretics|mesh-ancestor
92033460|NCT05093621|Natriuretic Agents|natriuretic agents|mesh-ancestor
92033461|NCT05093621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033462|NCT05093621|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92033463|NCT05093621|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033464|NCT05093621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033465|NCT05093621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92033466|NCT02112045|Melphalan|melphalan|mesh-list
92033467|NCT02112045|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92033468|NCT02112045|Alkylating Agents|alkylating agents|mesh-ancestor
92033469|NCT02112045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033470|NCT02112045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033471|NCT02112045|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92033472|NCT02112045|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033473|NCT02112045|Immunologic Factors|immunologic factors|mesh-ancestor
92033474|NCT02112045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033475|NCT02147691|Azelaic acid|azelaic acid|mesh-list
92033476|NCT02147691|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92033477|NCT02147691|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92033485|NCT02147691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033486|NCT02147691|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033487|NCT01655693|Doxorubicin|doxorubicin|mesh-list
92033488|NCT01655693|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92033489|NCT01655693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92033490|NCT01655693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033491|NCT01655693|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92033492|NCT01655693|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92033493|NCT01655693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033494|NCT01655693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033495|NCT05090657|Chlorhexidine|chlorhexidine|mesh-list
92033496|NCT05090657|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92033497|NCT05090657|Methylene Blue|methylene blue|mesh-list
92033498|NCT05090657|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92033499|NCT05090657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033500|NCT05090657|Disinfectants|disinfectants|mesh-ancestor
92033501|NCT05090657|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033502|NCT05090657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033503|NCT05090657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033504|NCT05048849|Somatomedin B|somatomedin b|mesh-list
92033505|NCT05048849|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92033506|NCT05048849|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92033507|NCT05048849|Protease Inhibitors|protease inhibitors|mesh-ancestor
92033508|NCT05048849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033509|NCT05048849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033510|NCT05116085|Tislelizumab|tislelizumab|mesh-list
92033511|NCT05116085|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033512|NCT05116085|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033513|NCT01656161|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92033514|NCT01656161|Luteolytic Agents|luteolytic agents|mesh-ancestor
92033515|NCT01656161|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92033516|NCT01656161|Contraceptive Agents|contraceptive agents|mesh-ancestor
92033517|NCT01656161|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92033518|NCT01656161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033519|NCT01656161|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92033520|NCT01656161|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92033521|NCT01656161|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033522|NCT05046431|Golimumab|golimumab|mesh-list
92033523|NCT05046431|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92033524|NCT05046431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033525|NCT05046431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033526|NCT05046431|Immunologic Factors|immunologic factors|mesh-ancestor
92033527|NCT05046431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033528|NCT04757883|Antibodies|antibodies|mesh-list
92033529|NCT04757883|Immunologic Factors|immunologic factors|mesh-ancestor
92033530|NCT04757883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033531|NCT04751877|Dexamethasone|dexamethasone|mesh-list
92033532|NCT04751877|Lenalidomide|lenalidomide|mesh-list
92033537|NCT04751877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033538|NCT04751877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033539|NCT04751877|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92033540|NCT04751877|Glucocorticoids|glucocorticoids|mesh-ancestor
92033541|NCT04751877|Hormones|hormones|mesh-ancestor
92033542|NCT04751877|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033543|NCT04751877|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92033559|NCT02107131|Growth Inhibitors|growth inhibitors|mesh-ancestor
92033560|NCT02107131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033561|NCT02106975|Ascorbic Acid|ascorbic acid|mesh-list
92033563|NCT02106975|Micronutrients|micronutrients|mesh-ancestor
92033564|NCT02106975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033565|NCT02106975|Antioxidants|antioxidants|mesh-ancestor
92033566|NCT02106975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033567|NCT02106975|Protective Agents|protective agents|mesh-ancestor
92033568|NCT05133765|Insulin|insulin|mesh-list
92033569|NCT05133765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033570|NCT05133765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033571|NCT02520011|Cytarabine|cytarabine|mesh-list
92033572|NCT02520011|Mitoxantrone|mitoxantrone|mesh-list
92033573|NCT02520011|Alvocidib|alvocidib|mesh-list
92033574|NCT02520011|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92033575|NCT02520011|Antimetabolites|antimetabolites|mesh-ancestor
92033576|NCT02520011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033577|NCT02520011|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033578|NCT02520011|Antiviral Agents|antiviral agents|mesh-ancestor
92033579|NCT02520011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033580|NCT02520011|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033581|NCT02520011|Immunologic Factors|immunologic factors|mesh-ancestor
92033582|NCT02520011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033583|NCT02520011|Analgesics|analgesics|mesh-ancestor
92033584|NCT02520011|Sensory System Agents|sensory system agents|mesh-ancestor
92033585|NCT02520011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033586|NCT02520011|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92033587|NCT02520011|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92033588|NCT02520011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033589|NCT02520011|Growth Inhibitors|growth inhibitors|mesh-ancestor
92033590|NCT02520011|Growth Substances|growth substances|mesh-ancestor
92033591|NCT02520011|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92033592|NCT05037539|Fentanyl|fentanyl|mesh-list
92033593|NCT05037539|Morphine|morphine|mesh-list
92033594|NCT05037539|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92033595|NCT05037539|Narcotics|narcotics|mesh-ancestor
92033596|NCT05037539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033597|NCT05037539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033598|NCT05037539|Analgesics|analgesics|mesh-ancestor
92033599|NCT05037539|Sensory System Agents|sensory system agents|mesh-ancestor
92033600|NCT05037539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033601|NCT05037539|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92033602|NCT05037539|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92033603|NCT05037539|Anesthetics, General|anesthetics, general|mesh-ancestor
92033604|NCT05037539|Anesthetics|anesthetics|mesh-ancestor
92033605|NCT02519231|Naproxen|naproxen|mesh-list
92033614|NCT02519231|Gout Suppressants|gout suppressants|mesh-ancestor
92033615|NCT02519231|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92033616|NCT02519231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033617|NCT02519231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033618|NCT02106351|Botulinum Toxins|botulinum toxins|mesh-list
92033619|NCT02106351|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92033620|NCT02106351|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92033621|NCT02106351|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92033622|NCT02106351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033623|NCT02106351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033624|NCT02106351|Cholinergic Agents|cholinergic agents|mesh-ancestor
92033625|NCT02106351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033626|NCT02106351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033627|NCT02106351|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92033628|NCT02106351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033629|NCT02075073|Trastuzumab|trastuzumab|mesh-list
92012096|NCT02606279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012098|NCT04859621|Ergocalciferols|ergocalciferols|mesh-list
92012099|NCT04859621|Cholecalciferol|cholecalciferol|mesh-list
92033630|NCT02075073|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033631|NCT02075073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033632|NCT01364597|Brivaracetam|brivaracetam|mesh-list
92033633|NCT01364597|Anticonvulsants|anticonvulsants|mesh-ancestor
92033634|NCT04738149|Bimatoprost|bimatoprost|mesh-list
92033635|NCT04738149|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92033636|NCT04995497|Lidocaine|lidocaine|mesh-list
92033637|NCT04995497|Anesthetics, Local|anesthetics, local|mesh-ancestor
92033638|NCT04995497|Anesthetics|anesthetics|mesh-ancestor
92033639|NCT04995497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033640|NCT04995497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033641|NCT04995497|Sensory System Agents|sensory system agents|mesh-ancestor
92033642|NCT04995497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033643|NCT04995497|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92033788|NCT04987463|GABA Agents|gaba agents|mesh-ancestor
92033644|NCT04995497|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92033645|NCT04995497|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92033646|NCT04995497|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033647|NCT04995497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033654|NCT05060627|Dexamethasone|dexamethasone|mesh-list
92033655|NCT05060627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033656|NCT05060627|Antiemetics|antiemetics|mesh-ancestor
92033657|NCT05060627|Autonomic Agents|autonomic agents|mesh-ancestor
92033658|NCT05060627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033659|NCT05060627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033660|NCT05060627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92033661|NCT05060627|Glucocorticoids|glucocorticoids|mesh-ancestor
92033662|NCT05060627|Hormones|hormones|mesh-ancestor
92033663|NCT05060627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033664|NCT05060627|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92033665|NCT05060627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033666|NCT05025605|Dexmedetomidine|dexmedetomidine|mesh-list
92033667|NCT05025605|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92033668|NCT05025605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033669|NCT05025605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033670|NCT05025605|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92033672|NCT05025605|Sensory System Agents|sensory system agents|mesh-ancestor
92033673|NCT05025605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033674|NCT05025605|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92033675|NCT05025605|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92033676|NCT05025605|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92033678|NCT05025605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033679|NCT05025605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033680|NCT04421105|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92033681|NCT04421105|Hallucinogens|hallucinogens|mesh-ancestor
92033682|NCT04421105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033683|NCT04421105|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92033684|NCT04421105|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92033685|NCT04421105|Serotonin Agents|serotonin agents|mesh-ancestor
92033686|NCT04421105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033687|NCT04421105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033688|NCT04421105|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92033689|NCT05024747|Nicotine|nicotine|mesh-list
92033690|NCT05024747|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92033691|NCT05024747|Autonomic Agents|autonomic agents|mesh-ancestor
92033692|NCT05024747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033693|NCT05024747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033694|NCT05024747|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92033695|NCT05024747|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92033696|NCT05024747|Cholinergic Agents|cholinergic agents|mesh-ancestor
92033697|NCT05024747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033698|NCT05024747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033699|NCT05056883|Ivermectin|ivermectin|mesh-list
92033700|NCT05056883|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92033701|NCT05056883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033702|NCT05055323|Pyrvinium|pyrvinium|mesh-list
92012101|NCT04859621|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92012102|NCT04859621|Micronutrients|micronutrients|mesh-ancestor
92012103|NCT04859621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012104|NCT04859621|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92033703|NCT05055323|Anthelmintics|anthelmintics|mesh-ancestor
92033704|NCT05055323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92033705|NCT05055323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033706|NCT04991597|Lidocaine|lidocaine|mesh-list
92033707|NCT04991597|Epinephrine|epinephrine|mesh-list
92033708|NCT04991597|Racepinephrine|racepinephrine|mesh-list
92033709|NCT04991597|Epinephryl borate|epinephryl borate|mesh-list
92033710|NCT04991597|Anesthetics, Local|anesthetics, local|mesh-ancestor
92033711|NCT04991597|Anesthetics|anesthetics|mesh-ancestor
92033712|NCT04991597|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033713|NCT04991597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033714|NCT04991597|Sensory System Agents|sensory system agents|mesh-ancestor
92033715|NCT04991597|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033716|NCT04991597|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92033717|NCT04991597|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92033718|NCT04991597|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92033719|NCT04991597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033720|NCT04991597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034081|NCT02480621|Bupivacaine|bupivacaine|mesh-list
92033721|NCT04991597|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92033722|NCT04991597|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92033723|NCT04991597|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033724|NCT04991597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033725|NCT04991597|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92033726|NCT04991597|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92033727|NCT04991597|Autonomic Agents|autonomic agents|mesh-ancestor
92033728|NCT04991597|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92033729|NCT04991597|Respiratory System Agents|respiratory system agents|mesh-ancestor
92033730|NCT04991597|Mydriatics|mydriatics|mesh-ancestor
92033731|NCT04991597|Sympathomimetics|sympathomimetics|mesh-ancestor
92033732|NCT04991597|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92033733|NCT04949867|Glucagon|glucagon|mesh-list
92033734|NCT04949867|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92033735|NCT04949867|Hormones|hormones|mesh-ancestor
92033736|NCT04949867|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033737|NCT04949867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033738|NCT04989491|Rituximab|rituximab|mesh-list
92033739|NCT04989491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033740|NCT04989491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033741|NCT04989491|Immunologic Factors|immunologic factors|mesh-ancestor
92033742|NCT04989491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033743|NCT04989491|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033744|NCT05018117|Nicotine|nicotine|mesh-list
92033745|NCT05018117|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92033746|NCT05018117|Autonomic Agents|autonomic agents|mesh-ancestor
92033747|NCT05018117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033748|NCT05018117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033749|NCT05018117|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92033750|NCT05018117|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92033751|NCT05018117|Cholinergic Agents|cholinergic agents|mesh-ancestor
92033756|NCT05016869|Antimetabolites|antimetabolites|mesh-ancestor
92033757|NCT05016869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033758|NCT05016869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033759|NCT02141997|Adalimumab|adalimumab|mesh-list
92033760|NCT02141997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92033761|NCT02141997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033762|NCT02141997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033763|NCT04411433|Azithromycin|azithromycin|mesh-list
92033764|NCT04411433|Hydroxychloroquine|hydroxychloroquine|mesh-list
92033765|NCT04411433|Favipiravir|favipiravir|mesh-list
92033766|NCT04411433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92033767|NCT04411433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033768|NCT04411433|Antimalarials|antimalarials|mesh-ancestor
92033769|NCT04411433|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92033770|NCT04411433|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92033771|NCT04411433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012105|NCT04859621|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92012106|NCT04859621|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012107|NCT03039491|Vaccines|vaccines|mesh-list
92012108|NCT03039491|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92012109|NCT03039491|Immunologic Factors|immunologic factors|mesh-ancestor
92012110|NCT03039491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012111|NCT03037775|Nicotine|nicotine|mesh-list
92012112|NCT03037775|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92012113|NCT03037775|Autonomic Agents|autonomic agents|mesh-ancestor
92012114|NCT03037775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012115|NCT03037775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012116|NCT03037775|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92012117|NCT03037775|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92012118|NCT03037775|Cholinergic Agents|cholinergic agents|mesh-ancestor
92012119|NCT03037775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033772|NCT04411433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033773|NCT04411433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033774|NCT04411433|Antiviral Agents|antiviral agents|mesh-ancestor
92033776|NCT04987463|Vigabatrin|vigabatrin|mesh-list
92033777|NCT04987463|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92033778|NCT04987463|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033779|NCT04987463|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92033780|NCT04987463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033781|NCT04987463|Antifungal Agents|antifungal agents|mesh-ancestor
92033782|NCT04987463|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92033783|NCT04987463|Immunologic Factors|immunologic factors|mesh-ancestor
92033784|NCT04987463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033785|NCT04987463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033786|NCT04987463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033787|NCT04987463|Anticonvulsants|anticonvulsants|mesh-ancestor
92033789|NCT04987463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033790|NCT05012735|Pantothenic Acid|pantothenic acid|mesh-list
92033791|NCT05012735|Provitamins|provitamins|mesh-list
92033792|NCT05012735|Vitamins|vitamins|mesh-ancestor
92033793|NCT05012735|Micronutrients|micronutrients|mesh-ancestor
92033794|NCT05012735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033795|NCT05012735|Vitamin B Complex|vitamin b complex|mesh-ancestor
92033796|NCT02519777|Dolutegravir|dolutegravir|mesh-list
92033797|NCT02519777|Maraviroc|maraviroc|mesh-list
92033798|NCT02519777|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92033799|NCT02519777|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92033800|NCT02519777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033801|NCT02519777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033802|NCT02519777|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92033803|NCT02519777|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92033804|NCT02519777|Antiviral Agents|antiviral agents|mesh-ancestor
92033805|NCT02519777|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033806|NCT02519777|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92033807|NCT02519777|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92033808|NCT02519777|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92033809|NCT05008913|Adavosertib|adavosertib|mesh-list
92033810|NCT05008913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033811|NCT05008913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033812|NCT04982705|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92033813|NCT04982705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033814|NCT04982705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033815|NCT04982705|Incretins|incretins|mesh-ancestor
92033816|NCT04982705|Hormones|hormones|mesh-ancestor
92033817|NCT04982705|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033818|NCT04982705|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92033819|NCT04982705|Protease Inhibitors|protease inhibitors|mesh-ancestor
92033820|NCT04982705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033821|NCT04982705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033822|NCT04944095|Antibodies|antibodies|mesh-list
92033823|NCT04944095|Immunologic Factors|immunologic factors|mesh-ancestor
92033831|NCT02141295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033832|NCT02141295|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92033833|NCT02141295|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92033835|NCT02141295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033836|NCT02141295|Growth Inhibitors|growth inhibitors|mesh-ancestor
92033837|NCT02141295|Antidotes|antidotes|mesh-ancestor
92033838|NCT02141295|Protective Agents|protective agents|mesh-ancestor
92033839|NCT02141295|Vitamin B Complex|vitamin b complex|mesh-ancestor
92033840|NCT02141295|Vitamins|vitamins|mesh-ancestor
92033841|NCT02141295|Micronutrients|micronutrients|mesh-ancestor
92033842|NCT02141295|Hematinics|hematinics|mesh-ancestor
92033843|NCT02514551|Paclitaxel|paclitaxel|mesh-list
92033844|NCT02514551|Ramucirumab|ramucirumab|mesh-list
92033845|NCT02514551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92033846|NCT02514551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033847|NCT02514551|Tubulin Modulators|tubulin modulators|mesh-ancestor
92033848|NCT02514551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92033849|NCT02514551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92033850|NCT02514551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033851|NCT02141217|Amoxicillin|amoxicillin|mesh-list
92033852|NCT02141217|Clindamycin|clindamycin|mesh-list
92033853|NCT02141217|Clindamycin palmitate|clindamycin palmitate|mesh-list
92033854|NCT02141217|Clindamycin phosphate|clindamycin phosphate|mesh-list
92033855|NCT02141217|Clavulanic Acid|clavulanic acid|mesh-list
92033856|NCT02141217|Clavulanic Acids|clavulanic acids|mesh-list
92033857|NCT02141217|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92033858|NCT02141217|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92033859|NCT02141217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033860|NCT02141217|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92033861|NCT02141217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033862|NCT02141217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033863|NCT02141217|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92033864|NCT02514473|Ivacaftor|ivacaftor|mesh-list
92033865|NCT02514473|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92033866|NCT02514473|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033867|NCT02514473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033868|NCT02513771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92033869|NCT02513771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033870|NCT02513771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033871|NCT02513771|Incretins|incretins|mesh-ancestor
92033872|NCT02513771|Hormones|hormones|mesh-ancestor
92034001|NCT02483975|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92033873|NCT02513771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033874|NCT02513771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92033875|NCT02513771|Protease Inhibitors|protease inhibitors|mesh-ancestor
92033876|NCT02513771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033877|NCT02513771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033878|NCT02513459|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92033879|NCT02513459|Immunologic Factors|immunologic factors|mesh-ancestor
92033880|NCT02513459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033887|NCT02069379|Metformin|metformin|mesh-list
92033888|NCT02069379|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033889|NCT02069379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033890|NCT02511431|Ritonavir|ritonavir|mesh-list
92033891|NCT02511431|Lonafarnib|lonafarnib|mesh-list
92033892|NCT02511431|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92033893|NCT02511431|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92033894|NCT02511431|Protease Inhibitors|protease inhibitors|mesh-ancestor
92033895|NCT02511431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033896|NCT02511431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033897|NCT02511431|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92033898|NCT02511431|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92033899|NCT02511431|Antiviral Agents|antiviral agents|mesh-ancestor
92033904|NCT02137785|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92033905|NCT02137785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92033906|NCT05003453|Palmidrol|palmidrol|mesh-list
92033907|NCT05003453|Analgesics|analgesics|mesh-ancestor
92033908|NCT05003453|Sensory System Agents|sensory system agents|mesh-ancestor
92033909|NCT05003453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012120|NCT03037775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012122|NCT03039257|Vitamins|vitamins|mesh-ancestor
92012123|NCT03039257|Micronutrients|micronutrients|mesh-ancestor
92012124|NCT03039257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033910|NCT05003453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033911|NCT05003453|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92033912|NCT05003453|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92033913|NCT05003453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033914|NCT05003453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033915|NCT05003453|Antiviral Agents|antiviral agents|mesh-ancestor
92033916|NCT05003453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033917|NCT05003453|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92033918|NCT05003453|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92033919|NCT05003453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033920|NCT05003453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033921|NCT05003453|Hormones|hormones|mesh-ancestor
92033922|NCT05003453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033923|NCT01655069|Solifenacin Succinate|solifenacin succinate|mesh-list
92033924|NCT01655069|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92033925|NCT01655069|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92033926|NCT01655069|Cholinergic Agents|cholinergic agents|mesh-ancestor
92033927|NCT01655069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033928|NCT01655069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033929|NCT01655069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033930|NCT01655069|Urological Agents|urological agents|mesh-ancestor
92033931|NCT01654601|Clozapine|clozapine|mesh-list
92033932|NCT01654601|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92033933|NCT01654601|Serotonin Agents|serotonin agents|mesh-ancestor
92033934|NCT01654601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033935|NCT01654601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033936|NCT01654601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033937|NCT01654601|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92033938|NCT01654601|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92033939|NCT01654601|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033940|NCT01654601|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92033941|NCT01654601|GABA Antagonists|gaba antagonists|mesh-ancestor
92033942|NCT01654601|GABA Agents|gaba agents|mesh-ancestor
92033943|NCT02068443|Metformin|metformin|mesh-list
92033944|NCT02068443|Alogliptin|alogliptin|mesh-list
92033945|NCT02068443|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033946|NCT02068443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033947|NCT02068443|Incretins|incretins|mesh-ancestor
92033948|NCT02068443|Hormones|hormones|mesh-ancestor
92033949|NCT02068443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92033950|NCT02068443|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92033951|NCT02068443|Protease Inhibitors|protease inhibitors|mesh-ancestor
92033952|NCT02068443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033953|NCT02068443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033954|NCT04978649|Amlodipine|amlodipine|mesh-list
92033955|NCT04978649|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92033956|NCT04978649|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92033957|NCT04978649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033958|NCT04978649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033959|NCT04978649|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92033960|NCT04978649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033961|NCT04978649|Vasodilator Agents|vasodilator agents|mesh-ancestor
92033962|NCT02508935|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92033963|NCT02508935|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92033964|NCT02508935|Narcotics|narcotics|mesh-ancestor
92033965|NCT02508935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033966|NCT02508935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033967|NCT02508935|Analgesics|analgesics|mesh-ancestor
92033969|NCT02508935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033970|NCT02508935|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92033971|NCT02508935|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92033972|NCT02508935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012127|NCT03038009|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012128|NCT03038009|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92012129|NCT03038009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012130|NCT03038009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012131|NCT03466801|Prednisone|prednisone|mesh-list
92012132|NCT03466801|Glucocorticoids|glucocorticoids|mesh-list
92012133|NCT03466801|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92012134|NCT03466801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012135|NCT03466801|Hormones|hormones|mesh-ancestor
92012136|NCT03466801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012137|NCT03466801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012138|NCT03466801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012139|NCT03466801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012140|NCT03466801|Immunologic Factors|immunologic factors|mesh-ancestor
92012141|NCT05069779|Diazepam|diazepam|mesh-list
92012142|NCT05069779|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92012143|NCT05069779|Anticonvulsants|anticonvulsants|mesh-ancestor
92012144|NCT05069779|Antiemetics|antiemetics|mesh-ancestor
92012145|NCT05069779|Autonomic Agents|autonomic agents|mesh-ancestor
92012146|NCT05069779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012147|NCT05069779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012148|NCT05069779|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012149|NCT05069779|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92012150|NCT05069779|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92033973|NCT02508935|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033974|NCT02507375|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92033976|NCT02507375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033977|NCT02507375|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92033978|NCT02507375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033979|NCT02507375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033980|NCT02507375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033982|NCT02507219|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92033983|NCT02507219|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92033984|NCT02507219|Analgesics|analgesics|mesh-ancestor
92033985|NCT02507219|Sensory System Agents|sensory system agents|mesh-ancestor
92033986|NCT02507219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033987|NCT02507219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033988|NCT02507219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033989|NCT02507219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033990|NCT02507219|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92033991|NCT02507219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92033992|NCT02507219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033993|NCT02483975|Albuterol|albuterol|mesh-list
92012151|NCT05069779|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92012152|NCT05069779|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92012153|NCT05069779|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92033994|NCT02483975|Montelukast|montelukast|mesh-list
92033995|NCT02483975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92033996|NCT02483975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92033997|NCT02483975|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92033998|NCT02483975|Hormone Antagonists|hormone antagonists|mesh-ancestor
92033999|NCT02483975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034000|NCT02483975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034002|NCT02483975|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92034003|NCT02483975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034004|NCT02483975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92034005|NCT02483975|Autonomic Agents|autonomic agents|mesh-ancestor
92034006|NCT02483975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034007|NCT02483975|Tocolytic Agents|tocolytic agents|mesh-ancestor
92034008|NCT02483975|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034009|NCT02483975|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92034010|NCT02483975|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92034011|NCT02483975|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92034012|NCT02483975|Adrenergic Agents|adrenergic agents|mesh-ancestor
92034013|NCT02483975|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034014|NCT02047227|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92034015|NCT02047227|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92034016|NCT02047227|Hormones|hormones|mesh-ancestor
92034017|NCT02047227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034018|NCT02047227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034019|NCT02047227|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034020|NCT02483585|Erenumab|erenumab|mesh-list
92034021|NCT02483585|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92034022|NCT02483585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034023|NCT02483585|Analgesics|analgesics|mesh-ancestor
92034024|NCT02483585|Sensory System Agents|sensory system agents|mesh-ancestor
92034025|NCT02483585|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034026|NCT02483585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034027|NCT02101983|Cytarabine|cytarabine|mesh-list
92034028|NCT02101983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92034029|NCT02101983|Antimetabolites|antimetabolites|mesh-ancestor
92034030|NCT02101983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034031|NCT02101983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034032|NCT02101983|Antiviral Agents|antiviral agents|mesh-ancestor
92034033|NCT02101983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034034|NCT02101983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92034035|NCT02101983|Immunologic Factors|immunologic factors|mesh-ancestor
92034036|NCT02101983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034037|NCT04974281|Lenvatinib|lenvatinib|mesh-list
92034041|NCT04974281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034043|NCT02503865|Diltiazem|diltiazem|mesh-list
92034045|NCT02503865|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92034046|NCT02503865|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92034047|NCT02503865|Antimetabolites|antimetabolites|mesh-ancestor
92034048|NCT02503865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034049|NCT02503865|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92034050|NCT02503865|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92034051|NCT02503865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034052|NCT02503865|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92034053|NCT02503865|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92034054|NCT02503865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034055|NCT02503865|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034056|NCT02503865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034057|NCT02503865|Vasodilator Agents|vasodilator agents|mesh-ancestor
92034058|NCT02503865|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92034059|NCT02481947|Laxatives|laxatives|mesh-list
92034060|NCT02481947|Lubiprostone|lubiprostone|mesh-list
92034061|NCT02481947|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92034062|NCT02481947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034064|NCT02481947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034065|NCT02503085|Ibuprofen|ibuprofen|mesh-list
92034066|NCT02503085|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92034067|NCT02503085|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92034068|NCT02503085|Analgesics|analgesics|mesh-ancestor
92034069|NCT02503085|Sensory System Agents|sensory system agents|mesh-ancestor
92034070|NCT02503085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034071|NCT02503085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034072|NCT02503085|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034073|NCT02503085|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034074|NCT02503085|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92034075|NCT02503085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034076|NCT02503085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034077|NCT02502149|Factor VIII|factor viii|mesh-list
92034078|NCT02502149|Coagulants|coagulants|mesh-ancestor
92034079|NCT04207619|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92034080|NCT04207619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034082|NCT02480621|Anesthetics, Local|anesthetics, local|mesh-ancestor
92034083|NCT02480621|Anesthetics|anesthetics|mesh-ancestor
92034084|NCT02480621|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034085|NCT02480621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034086|NCT02480621|Sensory System Agents|sensory system agents|mesh-ancestor
92034087|NCT02480621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034088|NCT02046603|Methotrexate|methotrexate|mesh-list
92034089|NCT02046603|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92034090|NCT02046603|Abortifacient Agents|abortifacient agents|mesh-ancestor
92034091|NCT02046603|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034092|NCT02046603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034093|NCT02046603|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92034094|NCT02046603|Antimetabolites|antimetabolites|mesh-ancestor
92034095|NCT02046603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034096|NCT02046603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034097|NCT02046603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92034098|NCT02046603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034099|NCT02046603|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92034100|NCT02046603|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92034101|NCT02046603|Immunologic Factors|immunologic factors|mesh-ancestor
92034102|NCT02046603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034103|NCT02046603|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92034104|NCT02046369|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92034105|NCT02046369|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92034106|NCT02046369|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92034107|NCT02046369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034110|NCT02046369|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92034111|NCT02046369|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92034112|NCT02046369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92034113|NCT02046369|Adrenergic Agents|adrenergic agents|mesh-ancestor
92034114|NCT02046369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034115|NCT02046369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034116|NCT02046369|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92034117|NCT02046369|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92034118|NCT02046369|Serotonin Agents|serotonin agents|mesh-ancestor
92034119|NCT02046369|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92034120|NCT02046369|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92034121|NCT02046369|Dopamine Agents|dopamine agents|mesh-ancestor
92034122|NCT02101359|Tetracaine|tetracaine|mesh-list
92034123|NCT02101359|Tropicamide|tropicamide|mesh-list
92034124|NCT02101359|Mydriatics|mydriatics|mesh-list
92034125|NCT02101359|Anesthetics, Local|anesthetics, local|mesh-ancestor
92034126|NCT02101359|Anesthetics|anesthetics|mesh-ancestor
92034127|NCT02101359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034128|NCT02101359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034129|NCT02101359|Sensory System Agents|sensory system agents|mesh-ancestor
92034130|NCT02101359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034131|NCT02101359|Autonomic Agents|autonomic agents|mesh-ancestor
92034132|NCT02101359|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92034133|NCT02101359|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92034134|NCT02101359|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034135|NCT02101359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034136|NCT02101359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012155|NCT05069779|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92012156|NCT05069779|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92012157|NCT05069779|Anesthetics, General|anesthetics, general|mesh-ancestor
92012158|NCT05069779|Anesthetics|anesthetics|mesh-ancestor
92012159|NCT05069779|GABA Modulators|gaba modulators|mesh-ancestor
92012160|NCT05069779|GABA Agents|gaba agents|mesh-ancestor
92012161|NCT05069779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012162|NCT05069779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012163|NCT03251911|Ivacaftor|ivacaftor|mesh-list
92012164|NCT03251911|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92012165|NCT03251911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012166|NCT03251911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012167|NCT02643355|Clonidine|clonidine|mesh-list
92012168|NCT02643355|Olanzapine|olanzapine|mesh-list
92012169|NCT02643355|Antiemetics|antiemetics|mesh-ancestor
92012170|NCT02643355|Autonomic Agents|autonomic agents|mesh-ancestor
92012171|NCT02643355|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012172|NCT02643355|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012173|NCT02643355|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012174|NCT02643355|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92034137|NCT02100969|Immunoglobulins|immunoglobulins|mesh-list
92034138|NCT02100969|gamma-Globulins|gamma-globulins|mesh-list
92034139|NCT02100969|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92034140|NCT02100969|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92034141|NCT02100969|Immunologic Factors|immunologic factors|mesh-ancestor
92034142|NCT02100969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034143|NCT01885000|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92034144|NCT01885000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92034145|NCT01885000|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92034146|NCT01885000|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92034147|NCT01885000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92034148|NCT01885000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92034149|NCT01885000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034150|NCT01885000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034151|NCT01885000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034152|NCT01883362|Midostaurin|midostaurin|mesh-list
92034153|NCT01883362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034154|NCT01883362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92034155|NCT01883362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034156|NCT01883362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034157|NCT04724967|Dimenhydrinate|dimenhydrinate|mesh-list
92034158|NCT04724967|Antiemetics|antiemetics|mesh-ancestor
92034159|NCT04724967|Autonomic Agents|autonomic agents|mesh-ancestor
92034160|NCT04724967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034161|NCT04724967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034162|NCT04724967|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034163|NCT04724967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92034164|NCT04724967|Histamine Antagonists|histamine antagonists|mesh-ancestor
92034165|NCT04724967|Histamine Agents|histamine agents|mesh-ancestor
92034166|NCT04724967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034167|NCT04724967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012176|NCT02643355|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012177|NCT02643355|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92012178|NCT02643355|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92012179|NCT02643355|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92012180|NCT02643355|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012181|NCT02643355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012182|NCT02643355|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012183|NCT02643355|Serotonin Agents|serotonin agents|mesh-ancestor
92012184|NCT02643355|Analgesics|analgesics|mesh-ancestor
92012185|NCT02643355|Sensory System Agents|sensory system agents|mesh-ancestor
92034169|NCT02045979|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034170|NCT02045979|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034171|NCT02045979|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034172|NCT04703751|Nitroglycerin|nitroglycerin|mesh-list
92034173|NCT04703751|Vasodilator Agents|vasodilator agents|mesh-ancestor
92034174|NCT04734405|Fluconazole|fluconazole|mesh-list
92034175|NCT04734405|Antifungal Agents|antifungal agents|mesh-ancestor
92034176|NCT04734405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034177|NCT04734405|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92034178|NCT04734405|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92034179|NCT04734405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034181|NCT04734405|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92034182|NCT04734405|Hormone Antagonists|hormone antagonists|mesh-ancestor
92034183|NCT04734405|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034184|NCT04734405|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034185|NCT04734405|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92034186|NCT04734405|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92034187|NCT01911442|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92034188|NCT01911442|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92034189|NCT01911442|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92034190|NCT01911442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034191|NCT01911442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034192|NCT01911442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034193|NCT01911442|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92034194|NCT01911442|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92034195|NCT01911442|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92034196|NCT01911442|Adrenergic Agents|adrenergic agents|mesh-ancestor
92034197|NCT01911442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034198|NCT01911442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034199|NCT01911442|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92034200|NCT01911442|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92034201|NCT01911442|Serotonin Agents|serotonin agents|mesh-ancestor
92034202|NCT01911442|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92034203|NCT01911442|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92034204|NCT01911442|Dopamine Agents|dopamine agents|mesh-ancestor
92034206|NCT01928758|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92034207|NCT01928758|Autonomic Agents|autonomic agents|mesh-ancestor
92034208|NCT01928758|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034209|NCT01928758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034210|NCT01928758|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92034211|NCT01928758|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92034212|NCT01928758|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034213|NCT01928758|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034214|NCT01928758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034215|NCT01614886|Rivastigmine|rivastigmine|mesh-list
92034216|NCT01614886|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92012187|NCT02643355|Sympatholytics|sympatholytics|mesh-ancestor
92012188|NCT02643355|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92012189|NCT02643355|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92012190|NCT02643355|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92012191|NCT02643355|Adrenergic Agents|adrenergic agents|mesh-ancestor
92012192|NCT03036605|Dexamethasone|dexamethasone|mesh-list
92012193|NCT03036605|Dexamethasone acetate|dexamethasone acetate|mesh-list
92012194|NCT03036605|Bupivacaine|bupivacaine|mesh-list
92012195|NCT03036605|BB 1101|bb 1101|mesh-list
92012196|NCT03036605|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012197|NCT03036605|Antiemetics|antiemetics|mesh-ancestor
92012198|NCT03036605|Autonomic Agents|autonomic agents|mesh-ancestor
92012199|NCT03036605|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012200|NCT03036605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012201|NCT03036605|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034217|NCT01614886|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034218|NCT01614886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034219|NCT01614886|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034220|NCT01614886|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034221|NCT01614886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034222|NCT01614886|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92034223|NCT01614886|Protective Agents|protective agents|mesh-ancestor
92034224|NCT04622254|Botulinum Toxins|botulinum toxins|mesh-list
92034225|NCT04622254|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92034226|NCT04622254|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92034227|NCT04622254|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92034228|NCT04622254|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92034229|NCT04622254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034230|NCT04622254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034231|NCT04622254|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034232|NCT04622254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034233|NCT04622254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034234|NCT04622254|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92034235|NCT04622254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034236|NCT04171726|Edoxaban|edoxaban|mesh-list
92034237|NCT04171726|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92034238|NCT04171726|Antithrombins|antithrombins|mesh-ancestor
92034239|NCT04171726|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92034240|NCT04171726|Protease Inhibitors|protease inhibitors|mesh-ancestor
92034241|NCT04171726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034242|NCT04171726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034243|NCT04171726|Anticoagulants|anticoagulants|mesh-ancestor
92034244|NCT02100657|Dexamethasone|dexamethasone|mesh-list
92034245|NCT02100657|Bortezomib|bortezomib|mesh-list
92034246|NCT02100657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034247|NCT02100657|Antiemetics|antiemetics|mesh-ancestor
92034248|NCT02100657|Autonomic Agents|autonomic agents|mesh-ancestor
92034249|NCT02100657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034250|NCT02100657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034265|NCT01909804|Ribavirin|ribavirin|mesh-list
92034266|NCT01909804|Antiviral Agents|antiviral agents|mesh-ancestor
92034267|NCT01909804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034268|NCT01909804|Antimetabolites|antimetabolites|mesh-ancestor
92034269|NCT01909804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034270|NCT01880086|Clomiphene|clomiphene|mesh-list
92034271|NCT01880086|Enclomiphene|enclomiphene|mesh-list
92034272|NCT01880086|Zuclomiphene|zuclomiphene|mesh-list
92034273|NCT01880086|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92034274|NCT01880086|Hormone Antagonists|hormone antagonists|mesh-ancestor
92012204|NCT03036605|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012205|NCT03036605|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012206|NCT03036605|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012207|NCT03036605|Protease Inhibitors|protease inhibitors|mesh-ancestor
92012208|NCT03036605|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012209|NCT03036605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012210|NCT03036605|Anesthetics, Local|anesthetics, local|mesh-ancestor
92012211|NCT03036605|Anesthetics|anesthetics|mesh-ancestor
92012212|NCT03036605|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012213|NCT03036605|Sensory System Agents|sensory system agents|mesh-ancestor
92012214|NCT03098875|Remifentanil|remifentanil|mesh-list
92012215|NCT03098875|Propofol|propofol|mesh-list
92012216|NCT03098875|Sevoflurane|sevoflurane|mesh-list
92034275|NCT01880086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034276|NCT01880086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034277|NCT01880086|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92034278|NCT01880086|Fertility Agents|fertility agents|mesh-ancestor
92034279|NCT01880086|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034280|NCT01880086|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92034281|NCT01880086|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92034282|NCT01879618|Dalteparin|dalteparin|mesh-list
92034283|NCT01879618|Anticoagulants|anticoagulants|mesh-ancestor
92034284|NCT01879618|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92034285|NCT01879618|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92034286|NCT01879618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034287|NCT01926886|Trastuzumab|trastuzumab|mesh-list
92034288|NCT01926886|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92034289|NCT01926886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034290|NCT01909336|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92034291|NCT01925950|Beclomethasone|beclomethasone|mesh-list
92034292|NCT01925950|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034293|NCT01925950|Glucocorticoids|glucocorticoids|mesh-ancestor
92034294|NCT01925950|Hormones|hormones|mesh-ancestor
92034295|NCT01925950|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034296|NCT01925950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034297|NCT01925950|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92034298|NCT01925950|Respiratory System Agents|respiratory system agents|mesh-ancestor
92034299|NCT04415320|Ensartinib|ensartinib|mesh-list
92034300|NCT04415320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034301|NCT04415320|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92034302|NCT04415320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034303|NCT04415320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034304|NCT01878292|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92034305|NCT01878292|Antidepressive Agents|antidepressive agents|mesh-ancestor
92034306|NCT01878292|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034307|NCT01878292|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92034308|NCT01878292|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92034311|NCT01878292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034312|NCT01878292|Serotonin Agents|serotonin agents|mesh-ancestor
92034313|NCT01878292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034314|NCT01878292|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92034315|NCT01878292|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92034316|NCT01907854|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92012217|NCT03098875|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92012218|NCT03098875|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012219|NCT03098875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012220|NCT03098875|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92012221|NCT03098875|Anesthetics, General|anesthetics, general|mesh-ancestor
92012222|NCT03098875|Anesthetics|anesthetics|mesh-ancestor
92012223|NCT03098875|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92012224|NCT03098875|Narcotics|narcotics|mesh-ancestor
92012225|NCT03098875|Analgesics|analgesics|mesh-ancestor
92012226|NCT03098875|Sensory System Agents|sensory system agents|mesh-ancestor
92012227|NCT03098875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034317|NCT01907854|Liraglutide|liraglutide|mesh-list
92034318|NCT01907854|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92034319|NCT01907854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034320|NCT01907854|Incretins|incretins|mesh-ancestor
92034321|NCT01907854|Hormones|hormones|mesh-ancestor
92034322|NCT01907854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034323|NCT01907854|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92034324|NCT01907854|Protease Inhibitors|protease inhibitors|mesh-ancestor
92034325|NCT01907854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034326|NCT01907854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034328|NCT02480153|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034329|NCT02480153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034330|NCT02480153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034331|NCT04972253|Infigratinib|infigratinib|mesh-list
92034332|NCT04972253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034333|NCT02500979|Insulin|insulin|mesh-list
92034334|NCT02500979|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92034335|NCT02500979|Insulin Lispro|insulin lispro|mesh-list
92034336|NCT02500979|Pramlintide|pramlintide|mesh-list
92034337|NCT02500979|Islet Amyloid Polypeptide|islet amyloid polypeptide|mesh-list
92034338|NCT02500979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92034339|NCT02500979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034340|NCT02500979|Appetite Depressants|appetite depressants|mesh-ancestor
92034341|NCT02500979|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92034342|NCT02500979|Amylin Receptor Agonists|amylin receptor agonists|mesh-ancestor
92034343|NCT02500979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034344|NCT02500901|Niraparib|niraparib|mesh-list
92034345|NCT02500901|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92034346|NCT02500901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034347|NCT02500901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034348|NCT02500901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034349|NCT01877668|Adalimumab|adalimumab|mesh-list
92034350|NCT01877668|Tofacitinib|tofacitinib|mesh-list
92034351|NCT01877668|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034352|NCT01877668|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034353|NCT01877668|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034354|NCT01877668|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92034355|NCT01877668|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92034356|NCT01877668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034357|NCT01877668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034358|NCT01906372|Hormones|hormones|mesh-list
92034359|NCT01906372|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92034360|NCT01906372|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92034361|NCT01906372|beta-Endorphin|beta-endorphin|mesh-list
92034362|NCT01906372|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034363|NCT01906372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034364|NCT01906372|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034365|NCT01906372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034366|NCT01925170|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92034367|NCT01925170|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92034368|NCT01925170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012228|NCT03098875|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92012229|NCT03098875|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92012230|NCT03099031|Tinzaparin|tinzaparin|mesh-list
92012231|NCT03099031|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92012232|NCT03099031|Dalteparin|dalteparin|mesh-list
92012233|NCT03099031|Anticoagulants|anticoagulants|mesh-ancestor
92012234|NCT03099031|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92012235|NCT03099031|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92012236|NCT03099031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012237|NCT04785287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92012239|NCT04785287|Antibodies|antibodies|mesh-list
92012240|NCT04785287|Immunoglobulins|immunoglobulins|mesh-list
92012241|NCT04785287|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92012242|NCT04785287|Immunologic Factors|immunologic factors|mesh-ancestor
92012243|NCT04785287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012244|NCT04785287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012245|NCT04785287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012246|NCT04785287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012247|NCT03101137|Dexamethasone|dexamethasone|mesh-list
92012248|NCT03101137|Bupivacaine|bupivacaine|mesh-list
92012249|NCT03101137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012250|NCT03101137|Antiemetics|antiemetics|mesh-ancestor
92012251|NCT03101137|Autonomic Agents|autonomic agents|mesh-ancestor
92012252|NCT03101137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012253|NCT03101137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012254|NCT03101137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012255|NCT03101137|Glucocorticoids|glucocorticoids|mesh-ancestor
92012256|NCT03101137|Hormones|hormones|mesh-ancestor
92012257|NCT03101137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012258|NCT03101137|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012259|NCT03101137|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012260|NCT03101137|Anesthetics, Local|anesthetics, local|mesh-ancestor
92012261|NCT03101137|Anesthetics|anesthetics|mesh-ancestor
92012262|NCT03101137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012263|NCT03101137|Sensory System Agents|sensory system agents|mesh-ancestor
92012264|NCT04833257|Tislelizumab|tislelizumab|mesh-list
92034369|NCT01876810|Gemfibrozil|gemfibrozil|mesh-list
92012265|NCT04833257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012266|NCT04833257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012267|NCT03098953|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92012268|NCT03098953|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92012269|NCT04833101|Vaccines|vaccines|mesh-list
92012270|NCT04833101|Immunologic Factors|immunologic factors|mesh-ancestor
92012271|NCT04833101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012272|NCT00794599|Cetirizine|cetirizine|mesh-list
92012273|NCT00794599|Desloratadine|desloratadine|mesh-list
92012274|NCT00794599|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92012275|NCT00794599|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92034370|NCT01876810|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92034371|NCT01876810|Antimetabolites|antimetabolites|mesh-ancestor
92034372|NCT01876810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034373|NCT01876810|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92034374|NCT01876810|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92034375|NCT01876810|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92034376|NCT01876810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034377|NCT01876732|Vitamin B 12|vitamin b 12|mesh-list
92034378|NCT01876732|Hydroxocobalamin|hydroxocobalamin|mesh-list
92034385|NCT01905592|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92034387|NCT01905592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034388|NCT01905592|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034389|NCT02500121|Pembrolizumab|pembrolizumab|mesh-list
92034390|NCT02500121|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92034391|NCT02500121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034392|NCT02500121|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92034393|NCT02500121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034394|NCT01875250|Metronidazole|metronidazole|mesh-list
92034395|NCT01875250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034396|NCT01875250|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92034397|NCT01875250|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92034398|NCT01875250|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92034399|NCT01904032|Vitamin D|vitamin d|mesh-list
92034400|NCT01904032|Ergocalciferols|ergocalciferols|mesh-list
92034401|NCT01904032|Cholecalciferol|cholecalciferol|mesh-list
92034402|NCT01904032|Vitamins|vitamins|mesh-list
92034403|NCT01904032|Micronutrients|micronutrients|mesh-ancestor
92034404|NCT01904032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034405|NCT01904032|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92034406|NCT01904032|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034407|NCT01921270|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92034408|NCT01921270|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92034409|NCT01921270|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92034410|NCT01921270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034411|NCT01921270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034412|NCT01921270|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034413|NCT01921270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034414|NCT01921270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034415|NCT01921270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92034416|NCT01921270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034417|NCT02325739|Spartalizumab|spartalizumab|mesh-list
92034418|NCT02325739|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92034419|NCT02325739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034420|NCT02325739|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92034421|NCT02325739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034422|NCT01903720|Dexamethasone|dexamethasone|mesh-list
92034423|NCT01903720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034424|NCT01903720|Antiemetics|antiemetics|mesh-ancestor
92034425|NCT01903720|Autonomic Agents|autonomic agents|mesh-ancestor
92034426|NCT01903720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034427|NCT01903720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012278|NCT00794599|Histamine Agents|histamine agents|mesh-ancestor
92012279|NCT00794599|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012280|NCT00794599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012281|NCT00794599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012282|NCT00794599|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92012283|NCT00794599|Cholinergic Agents|cholinergic agents|mesh-ancestor
92012285|NCT00783133|Desloratadine|desloratadine|mesh-list
92012286|NCT00783133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92012287|NCT00783133|Cholinergic Agents|cholinergic agents|mesh-ancestor
92012288|NCT00783133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034428|NCT01903720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034429|NCT01903720|Glucocorticoids|glucocorticoids|mesh-ancestor
92034430|NCT01903720|Hormones|hormones|mesh-ancestor
92034431|NCT01903720|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034432|NCT01903720|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92034433|NCT01903720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034434|NCT02366689|Triclosan|triclosan|mesh-list
92034435|NCT02366689|Cetylpyridinium|cetylpyridinium|mesh-list
92034436|NCT02366689|Fluorides|fluorides|mesh-list
92034437|NCT02366689|Tin Fluorides|tin fluorides|mesh-list
92034438|NCT02366689|Cariostatic Agents|cariostatic agents|mesh-ancestor
92034439|NCT02366689|Protective Agents|protective agents|mesh-ancestor
92034440|NCT02366689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034441|NCT02366689|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92034442|NCT02366689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034443|NCT02366689|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92034444|NCT02366689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92034445|NCT02366689|Antimetabolites|antimetabolites|mesh-ancestor
92034446|NCT02366689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034447|NCT02366689|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92034448|NCT01903252|Mesalamine|mesalamine|mesh-list
92034452|NCT01903252|Sensory System Agents|sensory system agents|mesh-ancestor
92034453|NCT01903252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034454|NCT01903252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034455|NCT01903252|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034456|NCT01903252|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034457|NCT01613716|Dexamethasone|dexamethasone|mesh-list
92034458|NCT01613716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034459|NCT01613716|Antiemetics|antiemetics|mesh-ancestor
92034460|NCT01613716|Autonomic Agents|autonomic agents|mesh-ancestor
92034461|NCT01613716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034462|NCT01613716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034463|NCT01613716|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034464|NCT01613716|Glucocorticoids|glucocorticoids|mesh-ancestor
92034465|NCT01613716|Hormones|hormones|mesh-ancestor
92034466|NCT01613716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034467|NCT01613716|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92034468|NCT01613716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034469|NCT05112952|Lazertinib|lazertinib|mesh-list
92034470|NCT05112952|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92034471|NCT05112952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034472|NCT05112952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034473|NCT01872910|Celecoxib|celecoxib|mesh-list
92034474|NCT01872910|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92034475|NCT01872910|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92034476|NCT01872910|Analgesics|analgesics|mesh-ancestor
92034477|NCT01872910|Sensory System Agents|sensory system agents|mesh-ancestor
92012289|NCT00783133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012290|NCT00783133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034478|NCT01872910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034479|NCT01872910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034480|NCT01872910|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034481|NCT01872910|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034482|NCT01872910|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92034483|NCT01872910|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92034484|NCT01872910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034485|NCT01872910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034487|NCT01920568|Zoledronic Acid|zoledronic acid|mesh-list
92034488|NCT01920568|Denosumab|denosumab|mesh-list
92034489|NCT01920568|Calcium|calcium|mesh-list
92034490|NCT01920568|Vitamins|vitamins|mesh-ancestor
92034491|NCT01920568|Micronutrients|micronutrients|mesh-ancestor
92034492|NCT01920568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034493|NCT01920568|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034494|NCT01920568|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92034495|NCT01901848|Bupropion|bupropion|mesh-list
92034496|NCT01901848|Nicotine|nicotine|mesh-list
92034497|NCT01901848|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92034498|NCT01901848|Autonomic Agents|autonomic agents|mesh-ancestor
92034499|NCT01901848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034500|NCT01901848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034501|NCT01901848|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92034502|NCT01901848|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92034503|NCT01901848|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034504|NCT01901848|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034505|NCT01901848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034506|NCT01901848|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92034507|NCT01901848|Antidepressive Agents|antidepressive agents|mesh-ancestor
92034508|NCT01901848|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034509|NCT01901848|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92034510|NCT01901848|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92034511|NCT01901848|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034512|NCT01901848|Dopamine Agents|dopamine agents|mesh-ancestor
92034513|NCT01901848|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92034514|NCT01901848|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92034515|NCT01901848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034516|NCT01901614|Anesthetics|anesthetics|mesh-list
92034517|NCT01901614|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034518|NCT01901614|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034519|NCT02499575|Bupivacaine|bupivacaine|mesh-list
92034520|NCT02499575|Ropivacaine|ropivacaine|mesh-list
92034523|NCT02499575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034524|NCT02499575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034526|NCT02499575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034527|NCT02065791|Canagliflozin|canagliflozin|mesh-list
92034528|NCT02065791|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92034529|NCT02065791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034530|NCT02065791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92034531|NCT02065791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034532|NCT02499029|Acetylcysteine|acetylcysteine|mesh-list
92034533|NCT02499029|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92034534|NCT02499029|Antiviral Agents|antiviral agents|mesh-ancestor
92034535|NCT02499029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034536|NCT02499029|Expectorants|expectorants|mesh-ancestor
92034537|NCT02499029|Respiratory System Agents|respiratory system agents|mesh-ancestor
92034538|NCT02499029|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92034539|NCT02499029|Antioxidants|antioxidants|mesh-ancestor
92034540|NCT02499029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034541|NCT02499029|Protective Agents|protective agents|mesh-ancestor
92034542|NCT02499029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034543|NCT02499029|Antidotes|antidotes|mesh-ancestor
92034544|NCT04939883|Carvedilol|carvedilol|mesh-list
92034545|NCT04939883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92034546|NCT04939883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92034547|NCT04939883|Adrenergic Agents|adrenergic agents|mesh-ancestor
92034548|NCT04939883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034549|NCT04939883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012291|NCT00783133|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92012292|NCT00783133|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92012293|NCT00783133|Histamine Antagonists|histamine antagonists|mesh-ancestor
92012294|NCT00783133|Histamine Agents|histamine agents|mesh-ancestor
92012295|NCT00783133|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92034550|NCT04939883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034551|NCT04939883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92034552|NCT04939883|Antioxidants|antioxidants|mesh-ancestor
92034553|NCT04939883|Protective Agents|protective agents|mesh-ancestor
92034554|NCT04939883|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92034555|NCT04939883|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034556|NCT04939883|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034557|NCT04939883|Vasodilator Agents|vasodilator agents|mesh-ancestor
92034558|NCT04939883|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92034559|NCT04939883|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92034560|NCT02065713|Golimumab|golimumab|mesh-list
92034561|NCT02065713|Methotrexate|methotrexate|mesh-list
92034562|NCT02065713|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92034563|NCT02065713|Abortifacient Agents|abortifacient agents|mesh-ancestor
92034564|NCT02065713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034565|NCT02065713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034566|NCT02065713|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92034567|NCT02065713|Antimetabolites|antimetabolites|mesh-ancestor
92034568|NCT02065713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034569|NCT02065713|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034570|NCT02065713|Dermatologic Agents|dermatologic agents|mesh-ancestor
92034571|NCT02065713|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034572|NCT02065713|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92034573|NCT02065713|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92034574|NCT02065713|Immunologic Factors|immunologic factors|mesh-ancestor
92034575|NCT02065713|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034576|NCT02065713|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92034577|NCT02065713|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034578|NCT02065713|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034579|NCT02497781|Ceftazidime|ceftazidime|mesh-list
92034580|NCT02497781|Cefepime|cefepime|mesh-list
92034581|NCT02497781|Avibactam|avibactam|mesh-list
92034582|NCT02497781|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92034583|NCT02497781|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92034584|NCT02497781|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034585|NCT02497781|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92034586|NCT02497781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034587|NCT02497781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034588|NCT02497469|Adalimumab|adalimumab|mesh-list
92034589|NCT02497469|Vedolizumab|vedolizumab|mesh-list
92034590|NCT02497469|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034591|NCT02497469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034592|NCT02497469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034593|NCT02497469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034594|NCT02497391|Evacetrapib|evacetrapib|mesh-list
92034607|NCT02476175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034608|NCT02476175|Urological Agents|urological agents|mesh-ancestor
92034609|NCT02065557|Adalimumab|adalimumab|mesh-list
92034610|NCT02065557|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034611|NCT02065557|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034612|NCT02065557|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034613|NCT02065245|Penicillins|penicillins|mesh-list
92034614|NCT02065245|Streptomycin|streptomycin|mesh-list
92034615|NCT02065245|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92034616|NCT02065245|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034617|NCT02065245|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92034618|NCT02065245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034619|NCT02065245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034620|NCT02063217|Sodium Oxybate|sodium oxybate|mesh-list
92034621|NCT02063217|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92034622|NCT02063217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92034623|NCT02063217|Anesthetics, General|anesthetics, general|mesh-ancestor
92034624|NCT02063217|Anesthetics|anesthetics|mesh-ancestor
92034625|NCT02063217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034626|NCT02063217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012296|NCT03098407|Buprenorphine|buprenorphine|mesh-list
92012297|NCT03098407|Methadone|methadone|mesh-list
92012298|NCT03098407|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92012299|NCT03098407|Narcotics|narcotics|mesh-ancestor
92012300|NCT03098407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012301|NCT03098407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012302|NCT03098407|Analgesics|analgesics|mesh-ancestor
92012303|NCT03098407|Sensory System Agents|sensory system agents|mesh-ancestor
92012304|NCT03098407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012305|NCT03098407|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92012306|NCT03098407|Antitussive Agents|antitussive agents|mesh-ancestor
92012307|NCT03098407|Respiratory System Agents|respiratory system agents|mesh-ancestor
92012308|NCT04836143|Mitogens|mitogens|mesh-list
92034627|NCT02497001|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92034628|NCT02497001|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92034629|NCT02497001|Respiratory System Agents|respiratory system agents|mesh-ancestor
92034630|NCT04182555|Bilirubin|bilirubin|mesh-list
92034631|NCT04182555|Antioxidants|antioxidants|mesh-ancestor
92034632|NCT04182555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034633|NCT04182555|Protective Agents|protective agents|mesh-ancestor
92034634|NCT04182555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034635|NCT02366143|Paclitaxel|paclitaxel|mesh-list
92034636|NCT02366143|Bevacizumab|bevacizumab|mesh-list
92034637|NCT02366143|Carboplatin|carboplatin|mesh-list
92034638|NCT02366143|Atezolizumab|atezolizumab|mesh-list
92034639|NCT02366143|Antibodies|antibodies|mesh-list
92034640|NCT02366143|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92034641|NCT02366143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92034642|NCT02366143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034643|NCT02366143|Tubulin Modulators|tubulin modulators|mesh-ancestor
92034644|NCT02366143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92034645|NCT02366143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92034646|NCT02366143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034647|NCT02366143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92034648|NCT02366143|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92034649|NCT02366143|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92034650|NCT02366143|Growth Substances|growth substances|mesh-ancestor
92034651|NCT02366143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034652|NCT02366143|Growth Inhibitors|growth inhibitors|mesh-ancestor
92034653|NCT02366143|Immunologic Factors|immunologic factors|mesh-ancestor
92034654|NCT02366143|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92034655|NCT02098395|Liraglutide|liraglutide|mesh-list
92034656|NCT02098395|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92034657|NCT02098395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034658|NCT02098395|Incretins|incretins|mesh-ancestor
92034659|NCT02098395|Hormones|hormones|mesh-ancestor
92034661|NCT02365519|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92034662|NCT02365519|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92034663|NCT02096835|Dexamethasone|dexamethasone|mesh-list
92034664|NCT02096835|Tropisetron|tropisetron|mesh-list
92034665|NCT02096835|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034666|NCT02096835|Antiemetics|antiemetics|mesh-ancestor
92034667|NCT02096835|Autonomic Agents|autonomic agents|mesh-ancestor
92034668|NCT02096835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034669|NCT02096835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034670|NCT02096835|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034671|NCT02096835|Glucocorticoids|glucocorticoids|mesh-ancestor
92034672|NCT02096835|Hormones|hormones|mesh-ancestor
92034673|NCT02096835|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034674|NCT02096835|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92034675|NCT02096835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034676|NCT02096835|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92034677|NCT02096835|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92034678|NCT02096835|Serotonin Agents|serotonin agents|mesh-ancestor
92034679|NCT02096835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012309|NCT04836143|Endothelial Growth Factors|endothelial growth factors|mesh-list
92012310|NCT04836143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92012311|NCT04836143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012312|NCT04836143|Growth Substances|growth substances|mesh-ancestor
92012314|NCT05068453|Antibodies|antibodies|mesh-list
92034680|NCT02096835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034681|NCT02294773|Letrozole|letrozole|mesh-list
92034682|NCT02294773|Clomiphene|clomiphene|mesh-list
92034683|NCT02294773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034684|NCT02294773|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92034685|NCT02294773|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92034686|NCT02294773|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034687|NCT02294773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034688|NCT02294773|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92034689|NCT02294773|Hormone Antagonists|hormone antagonists|mesh-ancestor
92034690|NCT02294773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034691|NCT02294773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034692|NCT02294773|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92034693|NCT02294773|Fertility Agents|fertility agents|mesh-ancestor
92034694|NCT02294773|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034695|NCT02294773|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92034696|NCT02294773|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92034697|NCT02365285|Heparin|heparin|mesh-list
92034698|NCT02365285|Galantamine|galantamine|mesh-list
92034699|NCT02365285|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92034700|NCT02365285|Anticoagulants|anticoagulants|mesh-ancestor
92034701|NCT02365285|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92034702|NCT02365285|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92034703|NCT02365285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034704|NCT02365285|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92034705|NCT02365285|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92034706|NCT02365285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92034707|NCT02365285|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92034708|NCT02365285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034709|NCT02365285|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034710|NCT02365285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034711|NCT02365285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034712|NCT02365285|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92034713|NCT02365285|Autonomic Agents|autonomic agents|mesh-ancestor
92034714|NCT02365285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034715|NCT02365285|Nootropic Agents|nootropic agents|mesh-ancestor
92034716|NCT02041299|Deferiprone|deferiprone|mesh-list
92034717|NCT02041299|Deferoxamine|deferoxamine|mesh-list
92034718|NCT02041299|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92034719|NCT02041299|Chelating Agents|chelating agents|mesh-ancestor
92034720|NCT02041299|Sequestering Agents|sequestering agents|mesh-ancestor
92034721|NCT02041299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034722|NCT02041299|Siderophores|siderophores|mesh-ancestor
92034723|NCT01645735|Vancomycin|vancomycin|mesh-list
92034724|NCT01645735|Ceftriaxone|ceftriaxone|mesh-list
92034725|NCT01645735|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92034726|NCT01645735|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92034727|NCT01645735|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034728|NCT01645111|Clevidipine|clevidipine|mesh-list
92034729|NCT01645111|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92034730|NCT01645111|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034731|NCT01645111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034733|NCT01645111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034735|NCT02364037|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034736|NCT02364037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034737|NCT01919164|Mitogens|mitogens|mesh-list
92034738|NCT01919164|Mitosis Modulators|mitosis modulators|mesh-ancestor
92034739|NCT01919164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034740|NCT01901224|Metformin|metformin|mesh-list
92034741|NCT01901224|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92034742|NCT01901224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034743|NCT01901146|Paclitaxel|paclitaxel|mesh-list
92012315|NCT05068453|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92012316|NCT05068453|Immunologic Factors|immunologic factors|mesh-ancestor
92012317|NCT05068453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034744|NCT01901146|Trastuzumab|trastuzumab|mesh-list
92034745|NCT01901146|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92034746|NCT01901146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034748|NCT01901146|Antimitotic Agents|antimitotic agents|mesh-ancestor
92034749|NCT01901146|Mitosis Modulators|mitosis modulators|mesh-ancestor
92034750|NCT01901146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034751|NCT01901146|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92034752|NCT01644643|Metronidazole|metronidazole|mesh-list
92034753|NCT01644643|Ceftazidime|ceftazidime|mesh-list
92034754|NCT01644643|Avibactam|avibactam|mesh-list
92034755|NCT01644643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034756|NCT01644643|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92034757|NCT01644643|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92034758|NCT01644643|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92034759|NCT01644643|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92034760|NCT01644643|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034761|NCT01644643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034763|NCT01864174|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92034764|NCT01864174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034765|NCT04420351|Aspirin|aspirin|mesh-list
92034766|NCT04420351|Clopidogrel|clopidogrel|mesh-list
92034767|NCT04420351|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92034768|NCT04420351|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92034769|NCT04420351|Analgesics|analgesics|mesh-ancestor
92034770|NCT04420351|Sensory System Agents|sensory system agents|mesh-ancestor
92034771|NCT04420351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034772|NCT04420351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034773|NCT04420351|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034774|NCT04420351|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034775|NCT04420351|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92034776|NCT04420351|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92034777|NCT04420351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034778|NCT04420351|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92034779|NCT04420351|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92034780|NCT04420351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034781|NCT04420351|Antipyretics|antipyretics|mesh-ancestor
92034782|NCT04420351|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92034783|NCT04420351|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92034784|NCT04420351|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92034785|NCT04420351|Purinergic Agents|purinergic agents|mesh-ancestor
92034786|NCT04420351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034787|NCT01900444|Vaccines|vaccines|mesh-list
92034788|NCT01900444|Immunologic Factors|immunologic factors|mesh-ancestor
92034789|NCT01900444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034790|NCT02496221|rGLP-1 protein|rglp-1 protein|mesh-list
92034791|NCT02496221|Incretins|incretins|mesh-ancestor
92034792|NCT02496221|Hormones|hormones|mesh-ancestor
92034793|NCT02496221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034794|NCT02496221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034795|NCT02475629|Ibalizumab|ibalizumab|mesh-list
92034796|NCT02475629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92034797|NCT02475629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92034798|NCT02475629|Antiviral Agents|antiviral agents|mesh-ancestor
92034799|NCT02475629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034800|NCT01653743|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92034801|NCT01653743|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92034802|NCT01653743|Hormones|hormones|mesh-ancestor
92034803|NCT01653743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034804|NCT01653743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034805|NCT01653743|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034808|NCT02322775|Benralizumab|benralizumab|mesh-list
92034809|NCT02322775|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92034810|NCT02322775|Respiratory System Agents|respiratory system agents|mesh-ancestor
92034811|NCT01646827|Aripiprazole|aripiprazole|mesh-list
92034812|NCT01646827|Antidepressive Agents|antidepressive agents|mesh-ancestor
92034813|NCT01646827|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034814|NCT01646827|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92012320|NCT00751075|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012321|NCT00751075|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012322|NCT00751075|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012323|NCT00751075|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012324|NCT00751075|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92012325|NCT00731185|Mometasone Furoate|mometasone furoate|mesh-list
92012326|NCT00731185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012327|NCT00731185|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012328|NCT00731185|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92012329|NCT04836299|Ivermectin|ivermectin|mesh-list
92012330|NCT04836299|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92034815|NCT01646827|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92034816|NCT01646827|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034817|NCT01646827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034818|NCT01646827|Dopamine Agonists|dopamine agonists|mesh-ancestor
92034819|NCT01646827|Dopamine Agents|dopamine agents|mesh-ancestor
92034820|NCT01646827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034821|NCT01646827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034822|NCT01646827|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92034823|NCT01646827|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92034824|NCT01646827|Serotonin Agents|serotonin agents|mesh-ancestor
92034825|NCT01646827|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92034826|NCT01646827|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92034827|NCT01646827|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92034828|NCT01646827|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92034829|NCT02360995|Triclosan|triclosan|mesh-list
92034830|NCT02360995|Cetylpyridinium|cetylpyridinium|mesh-list
92034831|NCT02360995|Fluorides|fluorides|mesh-list
92034832|NCT02360995|Tin Fluorides|tin fluorides|mesh-list
92034833|NCT02360995|Cariostatic Agents|cariostatic agents|mesh-ancestor
92034834|NCT02360995|Protective Agents|protective agents|mesh-ancestor
92034835|NCT02360995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034836|NCT02360995|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92034837|NCT02360995|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034838|NCT02360995|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92034839|NCT02360995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92034840|NCT02360995|Antimetabolites|antimetabolites|mesh-ancestor
92034841|NCT02360995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034842|NCT02360995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92034843|NCT02359903|Infliximab|infliximab|mesh-list
92034844|NCT02359903|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92034845|NCT02359903|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034846|NCT02359903|Dermatologic Agents|dermatologic agents|mesh-ancestor
92034847|NCT02359903|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034848|NCT02359903|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034849|NCT02291419|Aspirin|aspirin|mesh-list
92034850|NCT02291419|Ticagrelor|ticagrelor|mesh-list
92034851|NCT02291419|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92034852|NCT02291419|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92034853|NCT02291419|Analgesics|analgesics|mesh-ancestor
92034854|NCT02291419|Sensory System Agents|sensory system agents|mesh-ancestor
92034855|NCT02291419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034856|NCT02291419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034857|NCT02291419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034858|NCT02291419|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92034859|NCT02291419|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92034860|NCT02291419|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92034861|NCT02291419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034862|NCT02291419|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92034863|NCT02291419|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92012332|NCT00651391|Simvastatin|simvastatin|mesh-list
92012333|NCT00651391|Ezetimibe|ezetimibe|mesh-list
92012334|NCT00651391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92012335|NCT00651391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012336|NCT00651391|Antimetabolites|antimetabolites|mesh-ancestor
92012337|NCT00651391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012338|NCT00651391|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92012339|NCT00651391|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92012340|NCT00651391|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012341|NCT00650689|Atorvastatin|atorvastatin|mesh-list
92012342|NCT00650689|Ezetimibe|ezetimibe|mesh-list
92012343|NCT00650689|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92012344|NCT00650689|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012345|NCT00650689|Antimetabolites|antimetabolites|mesh-ancestor
92034864|NCT02291419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034866|NCT02291419|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92034867|NCT02291419|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92034868|NCT02291419|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92034869|NCT02291419|Purinergic Agents|purinergic agents|mesh-ancestor
92034870|NCT02291419|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034871|NCT02319031|Ribavirin|ribavirin|mesh-list
92034872|NCT02319031|Sofosbuvir|sofosbuvir|mesh-list
92034873|NCT02319031|Antimetabolites|antimetabolites|mesh-ancestor
92034874|NCT02319031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034875|NCT02319031|Antiviral Agents|antiviral agents|mesh-ancestor
92034876|NCT02319031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034877|NCT02359435|Amoxicillin|amoxicillin|mesh-list
92034878|NCT02359435|Metronidazole|metronidazole|mesh-list
92034879|NCT02359435|Clarithromycin|clarithromycin|mesh-list
92034880|NCT02359435|Pantoprazole|pantoprazole|mesh-list
92034883|NCT02359435|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92034884|NCT02359435|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92034885|NCT02359435|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92034886|NCT02359435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034887|NCT02359435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034888|NCT02359435|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92034889|NCT02359435|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92034890|NCT02359435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92034891|NCT02359435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034892|NCT02359435|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92034893|NCT04599868|Magnesium Sulfate|magnesium sulfate|mesh-list
92034894|NCT04599868|Analgesics|analgesics|mesh-ancestor
92034895|NCT04599868|Sensory System Agents|sensory system agents|mesh-ancestor
92034896|NCT04599868|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034897|NCT04599868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034898|NCT04599868|Anesthetics|anesthetics|mesh-ancestor
92034899|NCT04599868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034900|NCT04599868|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92034901|NCT04599868|Anticonvulsants|anticonvulsants|mesh-ancestor
92034902|NCT04599868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92034903|NCT04599868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034904|NCT04599868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034905|NCT04599868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034906|NCT04599868|Tocolytic Agents|tocolytic agents|mesh-ancestor
92034907|NCT04599868|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034908|NCT01900054|Bepotastine besilate|bepotastine besilate|mesh-list
92034909|NCT01900054|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92012346|NCT00650689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012348|NCT00650689|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92012349|NCT00650689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012350|NCT05067517|Nintedanib|nintedanib|mesh-list
92012351|NCT05067517|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012352|NCT05067517|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92012353|NCT05067517|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012354|NCT05067517|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012355|NCT03100513|Lactulose|lactulose|mesh-list
92012356|NCT03100513|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012357|NCT00552097|Simvastatin|simvastatin|mesh-list
92012358|NCT00552097|Ezetimibe|ezetimibe|mesh-list
92012359|NCT00552097|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92034910|NCT01612156|Lidocaine|lidocaine|mesh-list
92034911|NCT01612156|Anesthetics, Local|anesthetics, local|mesh-ancestor
92034912|NCT01612156|Anesthetics|anesthetics|mesh-ancestor
92034913|NCT01612156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034914|NCT01612156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034915|NCT01612156|Sensory System Agents|sensory system agents|mesh-ancestor
92034916|NCT01612156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034917|NCT01612156|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92034918|NCT01612156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92034919|NCT01612156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92034920|NCT01612156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034921|NCT01612156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034922|NCT01899742|Tiotropium Bromide|tiotropium bromide|mesh-list
92034923|NCT01899742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92034924|NCT01899742|Autonomic Agents|autonomic agents|mesh-ancestor
92034925|NCT01899742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034926|NCT01899742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034927|NCT01899742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92034928|NCT01899742|Respiratory System Agents|respiratory system agents|mesh-ancestor
92034929|NCT01899742|Parasympatholytics|parasympatholytics|mesh-ancestor
92034930|NCT01899742|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92034931|NCT01899742|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034932|NCT01899742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034933|NCT01899742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034934|NCT01615822|Artefenomel|artefenomel|mesh-list
92034935|NCT01615822|Antimalarials|antimalarials|mesh-ancestor
92034936|NCT01615822|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92034937|NCT01615822|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92034938|NCT01615822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034939|NCT01613326|Glycopyrrolate|glycopyrrolate|mesh-list
92034941|NCT01613326|Tiotropium Bromide|tiotropium bromide|mesh-list
92034942|NCT01613326|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92034943|NCT01613326|Autonomic Agents|autonomic agents|mesh-ancestor
92034944|NCT01613326|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92034945|NCT01613326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034946|NCT01613326|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92034947|NCT01613326|Respiratory System Agents|respiratory system agents|mesh-ancestor
92034948|NCT01613326|Parasympatholytics|parasympatholytics|mesh-ancestor
92034949|NCT01613326|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92034950|NCT01613326|Cholinergic Agents|cholinergic agents|mesh-ancestor
92034951|NCT01613326|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034954|NCT01613326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034955|NCT01613326|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92034956|NCT01613326|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92012360|NCT00552097|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012361|NCT00552097|Antimetabolites|antimetabolites|mesh-ancestor
92012362|NCT00552097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012363|NCT00552097|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92012364|NCT00552097|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92012365|NCT00552097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012367|NCT00396175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012368|NCT00396175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012369|NCT00396175|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92012370|NCT00396175|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92012371|NCT00396175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012372|NCT00396175|Hormone Antagonists|hormone antagonists|mesh-ancestor
92012373|NCT00396175|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012374|NCT00396175|Urological Agents|urological agents|mesh-ancestor
92012375|NCT02603393|Fluticasone|fluticasone|mesh-list
92034958|NCT01613326|Adrenergic Agents|adrenergic agents|mesh-ancestor
92034959|NCT01613326|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92034960|NCT01613326|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92034961|NCT01898806|Triamcinolone|triamcinolone|mesh-list
92034962|NCT01898806|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92034963|NCT01898806|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92034964|NCT01898806|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92034965|NCT01898806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92034966|NCT01898806|Glucocorticoids|glucocorticoids|mesh-ancestor
92034967|NCT01898806|Hormones|hormones|mesh-ancestor
92034968|NCT01898806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034969|NCT01898806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034970|NCT01898806|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92034971|NCT01898806|Immunologic Factors|immunologic factors|mesh-ancestor
92034972|NCT01898806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034973|NCT01898806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034974|NCT02291029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92034975|NCT02291029|Immunologic Factors|immunologic factors|mesh-ancestor
92034976|NCT02291029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034977|NCT02290873|Midazolam|midazolam|mesh-list
92034978|NCT02290873|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92034979|NCT02290873|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92034980|NCT02290873|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92034981|NCT02290873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034982|NCT02290873|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92034983|NCT02290873|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92034984|NCT02290873|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034985|NCT02290873|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92034986|NCT02290873|Anesthetics, General|anesthetics, general|mesh-ancestor
92034987|NCT02290873|Anesthetics|anesthetics|mesh-ancestor
92034988|NCT02290873|GABA Modulators|gaba modulators|mesh-ancestor
92034989|NCT02290873|GABA Agents|gaba agents|mesh-ancestor
92034990|NCT02290873|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034991|NCT02290873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034993|NCT02358343|Antidepressive Agents|antidepressive agents|mesh-list
92034994|NCT02358343|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034995|NCT02358343|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92034996|NCT02358343|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92034997|NCT02358343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012376|NCT02603393|Tiotropium Bromide|tiotropium bromide|mesh-list
92012377|NCT02603393|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92012378|NCT02603393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012379|NCT02603393|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92034998|NCT02358343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034999|NCT02358343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035000|NCT02358343|Serotonin Agents|serotonin agents|mesh-ancestor
92035001|NCT02358343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035002|NCT02318095|Paclitaxel|paclitaxel|mesh-list
92035003|NCT02318095|Gemcitabine|gemcitabine|mesh-list
92035004|NCT02318095|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035005|NCT02318095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035006|NCT02318095|Tubulin Modulators|tubulin modulators|mesh-ancestor
92035007|NCT02318095|Antimitotic Agents|antimitotic agents|mesh-ancestor
92035008|NCT02318095|Mitosis Modulators|mitosis modulators|mesh-ancestor
92035009|NCT02318095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035010|NCT02318095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035012|NCT02317627|Belumosudil|belumosudil|mesh-list
92035013|NCT02317627|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92035014|NCT02317627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035015|NCT02317627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035016|NCT02517905|Bupivacaine|bupivacaine|mesh-list
92035017|NCT02517905|Anesthetics, Local|anesthetics, local|mesh-ancestor
92035018|NCT02517905|Anesthetics|anesthetics|mesh-ancestor
92035019|NCT02517905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035020|NCT02517905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035021|NCT02517905|Sensory System Agents|sensory system agents|mesh-ancestor
92035022|NCT02517905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035027|NCT02473913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035028|NCT02316847|Diazepam|diazepam|mesh-list
92035029|NCT02316847|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92035030|NCT02316847|Anticonvulsants|anticonvulsants|mesh-ancestor
92035031|NCT02316847|Antiemetics|antiemetics|mesh-ancestor
92035032|NCT02316847|Autonomic Agents|autonomic agents|mesh-ancestor
92035033|NCT02316847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035034|NCT02316847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035035|NCT02316847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035036|NCT02316847|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92035037|NCT02316847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035038|NCT02316847|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92035039|NCT02316847|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92035040|NCT02316847|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92035041|NCT02316847|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92035042|NCT02316847|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035043|NCT02316847|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92035045|NCT02316847|Anesthetics|anesthetics|mesh-ancestor
92035046|NCT02316847|GABA Modulators|gaba modulators|mesh-ancestor
92035047|NCT02316847|GABA Agents|gaba agents|mesh-ancestor
92035048|NCT02316847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035049|NCT02316847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035051|NCT02473445|Cystine Depleting Agents|cystine depleting agents|mesh-ancestor
92035052|NCT02473445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035053|NCT02473367|Raltegravir Potassium|raltegravir potassium|mesh-list
92035054|NCT02473367|Antacids|antacids|mesh-list
92035055|NCT02473367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92035056|NCT02473367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92035057|NCT02473367|Antiviral Agents|antiviral agents|mesh-ancestor
92035058|NCT02473367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035059|NCT02473367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92035060|NCT02473367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92035061|NCT02473367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035062|NCT02473367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035063|NCT02473367|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035064|NCT04965701|Osimertinib|osimertinib|mesh-list
92035065|NCT04965701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035066|NCT04965701|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92035067|NCT04965701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035068|NCT04965701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035069|NCT02316613|Rituximab|rituximab|mesh-list
92012382|NCT02603393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012383|NCT02603393|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92012384|NCT02603393|Respiratory System Agents|respiratory system agents|mesh-ancestor
92012385|NCT02603393|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012386|NCT02603393|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92012387|NCT02603393|Parasympatholytics|parasympatholytics|mesh-ancestor
92012388|NCT02603393|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92012389|NCT02603393|Cholinergic Agents|cholinergic agents|mesh-ancestor
92012390|NCT02603393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035070|NCT02316613|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035071|NCT02316613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035072|NCT02316613|Immunologic Factors|immunologic factors|mesh-ancestor
92035073|NCT02316613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035074|NCT02316613|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035076|NCT02492165|Immunologic Factors|immunologic factors|mesh-ancestor
92035077|NCT02492165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035078|NCT02354599|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92035079|NCT02354599|Immunologic Factors|immunologic factors|mesh-ancestor
92035080|NCT02354599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035082|NCT02286895|Immunologic Factors|immunologic factors|mesh-ancestor
92035083|NCT02286895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035084|NCT02472977|Nivolumab|nivolumab|mesh-list
92035085|NCT02472977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035086|NCT02472977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035087|NCT02472977|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92035088|NCT02472977|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035089|NCT02060487|Sildenafil Citrate|sildenafil citrate|mesh-list
92035090|NCT02060487|Citric Acid|citric acid|mesh-list
92035091|NCT02060487|Sodium Citrate|sodium citrate|mesh-list
92035092|NCT02060487|Anticoagulants|anticoagulants|mesh-ancestor
92035093|NCT02060487|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92035094|NCT02060487|Chelating Agents|chelating agents|mesh-ancestor
92035095|NCT02060487|Sequestering Agents|sequestering agents|mesh-ancestor
92035097|NCT02060487|Vasodilator Agents|vasodilator agents|mesh-ancestor
92035098|NCT02060487|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92035099|NCT02060487|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92035100|NCT02060487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035101|NCT02060487|Urological Agents|urological agents|mesh-ancestor
92035103|NCT02059239|Rituximab|rituximab|mesh-list
92035104|NCT02059239|Alemtuzumab|alemtuzumab|mesh-list
92035105|NCT02059239|Etoposide|etoposide|mesh-list
92035106|NCT02059239|Melphalan|melphalan|mesh-list
92035107|NCT02059239|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92035108|NCT02059239|Carmustine|carmustine|mesh-list
92035109|NCT02059239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035110|NCT02059239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035111|NCT02059239|Immunologic Factors|immunologic factors|mesh-ancestor
92035112|NCT02059239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035113|NCT02059239|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035114|NCT02059239|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035115|NCT02059239|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92035116|NCT02059239|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92035117|NCT02059239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035118|NCT02059239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035119|NCT02059239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035120|NCT02059239|Antimetabolites|antimetabolites|mesh-ancestor
92035121|NCT02059239|Antiviral Agents|antiviral agents|mesh-ancestor
92035122|NCT02059239|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012391|NCT02603393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012392|NCT02603393|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92012393|NCT02603393|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92012394|NCT02603393|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92012395|NCT02603393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92012397|NCT04832945|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92012398|NCT04832945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012399|NCT02642653|Lovastatin|lovastatin|mesh-list
92012400|NCT02642653|L 647318|l 647318|mesh-list
92012401|NCT02642653|Dihydromevinolin|dihydromevinolin|mesh-list
92012402|NCT02642653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92012403|NCT02642653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012404|NCT02642653|Antimetabolites|antimetabolites|mesh-ancestor
92012405|NCT02642653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012406|NCT02642653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92012407|NCT02642653|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92012408|NCT02642653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012409|NCT01659567|Interferons|interferons|mesh-list
92012410|NCT01659567|Ribavirin|ribavirin|mesh-list
92012411|NCT01659567|Interferon-alpha|interferon-alpha|mesh-list
92012412|NCT01659567|Interferon alpha-2|interferon alpha-2|mesh-list
92035123|NCT02059239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035124|NCT02059239|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92035125|NCT02059239|Alkylating Agents|alkylating agents|mesh-ancestor
92035126|NCT02059239|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92035127|NCT02059161|Insulin|insulin|mesh-list
92035128|NCT02059161|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035129|NCT02059161|Insulin Glargine|insulin glargine|mesh-list
92035131|NCT02059161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035132|NCT02059161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035133|NCT02059161|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92035134|NCT02059161|Antimetabolites|antimetabolites|mesh-ancestor
92035135|NCT02059161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035136|NCT02059161|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92035137|NCT01897714|Dexamethasone|dexamethasone|mesh-list
92035138|NCT01897714|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035139|NCT01897714|Antiemetics|antiemetics|mesh-ancestor
92035140|NCT01897714|Autonomic Agents|autonomic agents|mesh-ancestor
92035141|NCT01897714|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035142|NCT01897714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035143|NCT01897714|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035144|NCT01897714|Glucocorticoids|glucocorticoids|mesh-ancestor
92035145|NCT01897714|Hormones|hormones|mesh-ancestor
92035146|NCT01897714|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035147|NCT01897714|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035148|NCT01897714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035149|NCT01861522|Bepotastine besilate|bepotastine besilate|mesh-list
92035150|NCT01861522|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92035151|NCT01860976|Abatacept|abatacept|mesh-list
92035152|NCT01860976|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92035153|NCT01860976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012414|NCT01659567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012415|NCT01659567|Antiviral Agents|antiviral agents|mesh-ancestor
92012416|NCT01659567|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012417|NCT01659567|Antimetabolites|antimetabolites|mesh-ancestor
92012418|NCT01659567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012419|NCT01659567|Immunologic Factors|immunologic factors|mesh-ancestor
92012420|NCT01659567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012421|NCT05363631|Selenium|selenium|mesh-list
92012422|NCT05363631|Pembrolizumab|pembrolizumab|mesh-list
92012423|NCT05363631|Axitinib|axitinib|mesh-list
92012424|NCT05363631|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012425|NCT05363631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012426|NCT05363631|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012427|NCT05363631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012428|NCT05363631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92012429|NCT05363631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012430|NCT05363631|Antioxidants|antioxidants|mesh-ancestor
92035154|NCT01860976|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035155|NCT01860976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035156|NCT01860976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035157|NCT01860976|Immunologic Factors|immunologic factors|mesh-ancestor
92035158|NCT01860976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035159|NCT01860976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035160|NCT01860040|Gemcitabine|gemcitabine|mesh-list
92035161|NCT01860040|Pemetrexed|pemetrexed|mesh-list
92035162|NCT01860040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035163|NCT01860040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035164|NCT01860040|Antimetabolites|antimetabolites|mesh-ancestor
92035165|NCT01860040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035166|NCT01860040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035167|NCT01860040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92035168|NCT01860040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92035169|NCT04618744|Insulin|insulin|mesh-list
92035564|NCT02282293|Artenimol|artenimol|mesh-list
92035172|NCT04618744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035173|NCT01896934|Sertraline|sertraline|mesh-list
92035174|NCT01896934|Antidepressive Agents|antidepressive agents|mesh-ancestor
92035175|NCT01896934|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035176|NCT01896934|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92035177|NCT01896934|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92035178|NCT01896934|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92035179|NCT01896934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035180|NCT01896934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035181|NCT01896934|Serotonin Agents|serotonin agents|mesh-ancestor
92035182|NCT01896934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035183|NCT02039505|Vedolizumab|vedolizumab|mesh-list
92035184|NCT02039505|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035185|NCT02095197|Triamcinolone|triamcinolone|mesh-list
92035186|NCT02095197|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035187|NCT02095197|Glucocorticoids|glucocorticoids|mesh-ancestor
92035188|NCT02095197|Hormones|hormones|mesh-ancestor
92035189|NCT02095197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035190|NCT02095197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035191|NCT02039427|Dexamethasone|dexamethasone|mesh-list
92035193|NCT02039427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035194|NCT02039427|Antiemetics|antiemetics|mesh-ancestor
92012431|NCT05363631|Protective Agents|protective agents|mesh-ancestor
92012432|NCT05363631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012433|NCT05363631|Trace Elements|trace elements|mesh-ancestor
92012434|NCT05363631|Micronutrients|micronutrients|mesh-ancestor
92012435|NCT03100435|Carbon Fiber|carbon fiber|mesh-list
92012436|NCT03100435|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92012437|NCT03100435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012438|NCT03036995|Apremilast|apremilast|mesh-list
92012439|NCT03036995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92012440|NCT03036995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012441|NCT03036995|Analgesics|analgesics|mesh-ancestor
92012442|NCT03036995|Sensory System Agents|sensory system agents|mesh-ancestor
92012443|NCT03036995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012444|NCT03036995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012445|NCT03036995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012446|NCT03036995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012447|NCT03036995|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92012448|NCT03036995|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92012449|NCT03036995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012450|NCT03036995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012451|NCT05066035|Neostigmine|neostigmine|mesh-list
92035195|NCT02039427|Autonomic Agents|autonomic agents|mesh-ancestor
92035196|NCT02039427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035197|NCT02039427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035198|NCT02039427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035199|NCT02039427|Glucocorticoids|glucocorticoids|mesh-ancestor
92035200|NCT02039427|Hormones|hormones|mesh-ancestor
92035201|NCT02039427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035202|NCT02039427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035203|NCT02039427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035204|NCT02039427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92035205|NCT02039427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92035206|NCT02039427|Analgesics|analgesics|mesh-ancestor
92035207|NCT02039427|Sensory System Agents|sensory system agents|mesh-ancestor
92035208|NCT02039427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035209|NCT02039427|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92035210|NCT02039427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035211|NCT02039427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035212|NCT02094885|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92035213|NCT02094885|Hemostatics|hemostatics|mesh-ancestor
92035214|NCT02094885|Coagulants|coagulants|mesh-ancestor
92035215|NCT01896856|Trifluridine|trifluridine|mesh-list
92035216|NCT01896856|Irinotecan|irinotecan|mesh-list
92035217|NCT01896856|Guadecitabine|guadecitabine|mesh-list
92035218|NCT01896856|Azacitidine|azacitidine|mesh-list
92035219|NCT01896856|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92035220|NCT01896856|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92035221|NCT01896856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035222|NCT01896856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035223|NCT01896856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035224|NCT01896856|Antimetabolites|antimetabolites|mesh-ancestor
92035225|NCT01896856|Antiviral Agents|antiviral agents|mesh-ancestor
92035226|NCT01896856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012452|NCT05066035|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92012453|NCT05066035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012454|NCT05066035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035227|NCT01896856|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035229|NCT01896700|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92035230|NCT01896700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035231|NCT01896700|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92035232|NCT01896700|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92035233|NCT01896700|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92035234|NCT01896700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035235|NCT01896700|Dopamine Agents|dopamine agents|mesh-ancestor
92035236|NCT01896700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035237|NCT01896232|Cinacalcet|cinacalcet|mesh-list
92035238|NCT01896232|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92035239|NCT01896232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035240|NCT01896232|Calcimimetic Agents|calcimimetic agents|mesh-ancestor
92035241|NCT01896232|Hormone Antagonists|hormone antagonists|mesh-ancestor
92035245|NCT02460224|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035246|NCT02460224|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035247|NCT02460224|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035249|NCT02058537|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92035250|NCT02058537|Autonomic Agents|autonomic agents|mesh-ancestor
92035251|NCT02058537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035252|NCT02058537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035253|NCT02058537|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92035254|NCT02058537|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92035255|NCT02058537|Cholinergic Agents|cholinergic agents|mesh-ancestor
92035256|NCT02058537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035257|NCT02058537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035258|NCT01612000|Hemagglutinins|hemagglutinins|mesh-list
92035259|NCT01612000|Agglutinins|agglutinins|mesh-ancestor
92035260|NCT01612000|Immunologic Factors|immunologic factors|mesh-ancestor
92035261|NCT01612000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035262|NCT01612000|Coagulants|coagulants|mesh-ancestor
92035263|NCT02409680|Aspirin|aspirin|mesh-list
92035264|NCT02409680|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92035266|NCT02409680|Analgesics|analgesics|mesh-ancestor
92035267|NCT02409680|Sensory System Agents|sensory system agents|mesh-ancestor
92035268|NCT02409680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035269|NCT02409680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035270|NCT02409680|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035271|NCT02409680|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035272|NCT02409680|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92035273|NCT02409680|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92035274|NCT02409680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035275|NCT02409680|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92035276|NCT02409680|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92035277|NCT02409680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035278|NCT02409680|Antipyretics|antipyretics|mesh-ancestor
92035279|NCT01894984|Risperidone|risperidone|mesh-list
92035280|NCT01894984|Antipsychotic Agents|antipsychotic agents|mesh-list
92035281|NCT01894984|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92035282|NCT01894984|Serotonin Agents|serotonin agents|mesh-ancestor
92035283|NCT01894984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035284|NCT01894984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035285|NCT01894984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035286|NCT01894984|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92035287|NCT01894984|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035288|NCT01894984|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035289|NCT01894984|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92035290|NCT01894984|Dopamine Agents|dopamine agents|mesh-ancestor
92035291|NCT02375672|Pembrolizumab|pembrolizumab|mesh-list
92035292|NCT02375672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035293|NCT02375672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035294|NCT02375672|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012455|NCT05066035|Cholinergic Agents|cholinergic agents|mesh-ancestor
92012456|NCT05066035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012457|NCT05066035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012458|NCT05066035|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92012459|NCT05066035|Autonomic Agents|autonomic agents|mesh-ancestor
92035295|NCT02375672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035297|NCT02491463|Immunologic Factors|immunologic factors|mesh-ancestor
92035565|NCT02282293|Sulfamethoxazole|sulfamethoxazole|mesh-list
92035298|NCT02491463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035299|NCT02038881|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92035300|NCT02038881|Antiviral Agents|antiviral agents|mesh-ancestor
92035301|NCT02038881|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035302|NCT01857622|Edoxaban|edoxaban|mesh-list
92035303|NCT01857622|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92035304|NCT01857622|Antithrombins|antithrombins|mesh-ancestor
92035305|NCT01857622|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92035306|NCT01857622|Protease Inhibitors|protease inhibitors|mesh-ancestor
92035307|NCT01857622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035308|NCT01857622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035309|NCT01857622|Anticoagulants|anticoagulants|mesh-ancestor
92035310|NCT01857310|Folic Acid|folic acid|mesh-list
92035311|NCT01857310|Hematinics|hematinics|mesh-ancestor
92035313|NCT01857310|Vitamins|vitamins|mesh-ancestor
92035314|NCT01857310|Micronutrients|micronutrients|mesh-ancestor
92035315|NCT01857310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035316|NCT02472353|Metformin|metformin|mesh-list
92035317|NCT02472353|Doxorubicin|doxorubicin|mesh-list
92035318|NCT02472353|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035319|NCT02472353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035320|NCT02472353|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92035321|NCT02472353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035322|NCT02472353|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92035323|NCT02472353|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92035324|NCT02472353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035325|NCT02472353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035326|NCT02314117|Fluorouracil|fluorouracil|mesh-list
92035327|NCT02314117|Capecitabine|capecitabine|mesh-list
92035328|NCT02314117|Ramucirumab|ramucirumab|mesh-list
92035329|NCT02314117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035330|NCT02314117|Antimetabolites|antimetabolites|mesh-ancestor
92035331|NCT02314117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035332|NCT02314117|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035333|NCT02314117|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035334|NCT02314117|Immunologic Factors|immunologic factors|mesh-ancestor
92035335|NCT02314117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035336|NCT02058147|Insulin|insulin|mesh-list
92035337|NCT02058147|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035338|NCT02058147|Metformin|metformin|mesh-list
92035339|NCT02058147|Insulin Glargine|insulin glargine|mesh-list
92035340|NCT02058147|Lixisenatide|lixisenatide|mesh-list
92035341|NCT02058147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035342|NCT02058147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035343|NCT02489981|Tiotropium Bromide|tiotropium bromide|mesh-list
92035344|NCT02489981|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92035345|NCT02489981|Autonomic Agents|autonomic agents|mesh-ancestor
92035346|NCT02489981|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035347|NCT02489981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035348|NCT02489981|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92035349|NCT02489981|Respiratory System Agents|respiratory system agents|mesh-ancestor
92035350|NCT02489981|Parasympatholytics|parasympatholytics|mesh-ancestor
92035351|NCT02489981|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92035352|NCT02489981|Cholinergic Agents|cholinergic agents|mesh-ancestor
92035353|NCT02489981|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035354|NCT02489981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035356|NCT02471183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92035357|NCT04964063|Listerine|listerine|mesh-list
92035358|NCT04964063|Fluorides|fluorides|mesh-list
92035359|NCT04964063|Sodium Fluoride|sodium fluoride|mesh-list
92035360|NCT04964063|Cariostatic Agents|cariostatic agents|mesh-ancestor
92035361|NCT04964063|Protective Agents|protective agents|mesh-ancestor
92012460|NCT05066035|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012461|NCT04822649|Adenosine|adenosine|mesh-list
92012462|NCT04822649|Analgesics|analgesics|mesh-ancestor
92012463|NCT04822649|Sensory System Agents|sensory system agents|mesh-ancestor
92035362|NCT04964063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035363|NCT04964063|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92035364|NCT04964063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035365|NCT04204967|Fentanyl|fentanyl|mesh-list
92035366|NCT04204967|Remifentanil|remifentanil|mesh-list
92035367|NCT04204967|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92035368|NCT04204967|Narcotics|narcotics|mesh-ancestor
92035369|NCT04204967|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035370|NCT04204967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035371|NCT04204967|Analgesics|analgesics|mesh-ancestor
92035372|NCT04204967|Sensory System Agents|sensory system agents|mesh-ancestor
92035373|NCT04204967|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035374|NCT04204967|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92035375|NCT04204967|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92035376|NCT04204967|Anesthetics, General|anesthetics, general|mesh-ancestor
92035377|NCT04204967|Anesthetics|anesthetics|mesh-ancestor
92035378|NCT01855828|Paclitaxel|paclitaxel|mesh-list
92035379|NCT01855828|Cyclophosphamide|cyclophosphamide|mesh-list
92035380|NCT01855828|Fluorouracil|fluorouracil|mesh-list
92035381|NCT01855828|Trastuzumab|trastuzumab|mesh-list
92035382|NCT01855828|Epirubicin|epirubicin|mesh-list
92035383|NCT01855828|Pertuzumab|pertuzumab|mesh-list
92035384|NCT01855828|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035385|NCT01855828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035386|NCT01855828|Tubulin Modulators|tubulin modulators|mesh-ancestor
92035387|NCT01855828|Antimitotic Agents|antimitotic agents|mesh-ancestor
92035388|NCT01855828|Mitosis Modulators|mitosis modulators|mesh-ancestor
92035389|NCT01855828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035391|NCT01855828|Immunologic Factors|immunologic factors|mesh-ancestor
92035392|NCT01855828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035393|NCT01855828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035394|NCT01855828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92035395|NCT01855828|Alkylating Agents|alkylating agents|mesh-ancestor
92035396|NCT01855828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92035397|NCT01855828|Antimetabolites|antimetabolites|mesh-ancestor
92035398|NCT01855828|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035399|NCT01855828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035400|NCT01855828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92035401|NCT01855828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92035402|NCT01855828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92035403|NCT01855828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035404|NCT04417335|BCG Vaccine|bcg vaccine|mesh-list
92035405|NCT04417335|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92035406|NCT04417335|Immunologic Factors|immunologic factors|mesh-ancestor
92035407|NCT04417335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035408|NCT02351167|Nicotine|nicotine|mesh-list
92035409|NCT02351167|Varenicline|varenicline|mesh-list
92035410|NCT02351167|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92035411|NCT02351167|Autonomic Agents|autonomic agents|mesh-ancestor
92035412|NCT02351167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035413|NCT02351167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035414|NCT02351167|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92035415|NCT02351167|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92035416|NCT02351167|Cholinergic Agents|cholinergic agents|mesh-ancestor
92035417|NCT02351167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035418|NCT02351167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035419|NCT02350309|Lemborexant|lemborexant|mesh-list
92035420|NCT02350309|Flurazepam|flurazepam|mesh-list
92035421|NCT02350309|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92035422|NCT02350309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035423|NCT02350309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035424|NCT02350309|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92035425|NCT02350309|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92035426|NCT02350309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035427|NCT02350309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035428|NCT02350309|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92035429|NCT02350309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92035430|NCT02350309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035431|NCT02350309|GABA Modulators|gaba modulators|mesh-ancestor
92012464|NCT04822649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012465|NCT04822649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012466|NCT04822649|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92012467|NCT04822649|Vasodilator Agents|vasodilator agents|mesh-ancestor
92012468|NCT04822649|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92012469|NCT04822649|Purinergic Agonists|purinergic agonists|mesh-ancestor
92012470|NCT04822649|Purinergic Agents|purinergic agents|mesh-ancestor
92012471|NCT04822649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012472|NCT04822649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012473|NCT04822415|Carticaine|carticaine|mesh-list
92012474|NCT04822415|Mepivacaine|mepivacaine|mesh-list
92012475|NCT04822415|Anesthetics, Local|anesthetics, local|mesh-ancestor
92012477|NCT04822415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012478|NCT04822415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012479|NCT04822415|Sensory System Agents|sensory system agents|mesh-ancestor
92012480|NCT04822415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012481|NCT05065177|Vaccines|vaccines|mesh-list
92012482|NCT05065177|Immunologic Factors|immunologic factors|mesh-ancestor
92035432|NCT02350309|GABA Agents|gaba agents|mesh-ancestor
92035434|NCT02038647|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035435|NCT02038647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035436|NCT02038647|Tubulin Modulators|tubulin modulators|mesh-ancestor
92035437|NCT02038647|Antimitotic Agents|antimitotic agents|mesh-ancestor
92035438|NCT02038647|Mitosis Modulators|mitosis modulators|mesh-ancestor
92035439|NCT02038647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035440|NCT02057757|Nitazoxanide|nitazoxanide|mesh-list
92035441|NCT02057757|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92035442|NCT02057757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035443|NCT02037477|Esomeprazole|esomeprazole|mesh-list
92035444|NCT02037477|Rabeprazole|rabeprazole|mesh-list
92035445|NCT02037477|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92035446|NCT02037477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035447|NCT02037477|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92035448|NCT02037477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035449|NCT02037477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035450|NCT02057523|Hormones|hormones|mesh-list
92035451|NCT02057523|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92035452|NCT02057523|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92035453|NCT02057523|beta-Endorphin|beta-endorphin|mesh-list
92035454|NCT02057523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035455|NCT02057523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035456|NCT02057523|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035457|NCT02057523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035459|NCT02037165|Pregabalin|pregabalin|mesh-list
92035460|NCT02037165|Analgesics|analgesics|mesh-ancestor
92035461|NCT02037165|Sensory System Agents|sensory system agents|mesh-ancestor
92035462|NCT02037165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035463|NCT02037165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035464|NCT02037165|Anticonvulsants|anticonvulsants|mesh-ancestor
92035468|NCT02037165|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92035469|NCT02037165|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92035470|NCT02037165|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92035471|NCT02037165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035472|NCT02037165|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92012483|NCT05065177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012485|NCT04821947|Anesthetics, Local|anesthetics, local|mesh-list
92012486|NCT04821947|Anesthetics|anesthetics|mesh-list
92012487|NCT04821947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012488|NCT04821947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012489|NCT04821947|Sensory System Agents|sensory system agents|mesh-ancestor
92012490|NCT04821947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012491|NCT03037073|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92012492|NCT03037073|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92012493|NCT03037073|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92012494|NCT03037073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012495|NCT03037073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035473|NCT02037165|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92035474|NCT02037165|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92035475|NCT02037165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035476|NCT02037165|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035477|NCT02037165|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92035478|NCT02037165|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92035479|NCT02037165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035480|NCT02470403|Licogliflozin|licogliflozin|mesh-list
92035481|NCT02470403|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92035482|NCT02470403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035483|NCT02470403|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035484|NCT02470403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035485|NCT01855750|Prednisone|prednisone|mesh-list
92035486|NCT01855750|Cyclophosphamide|cyclophosphamide|mesh-list
92035487|NCT01855750|Rituximab|rituximab|mesh-list
92035488|NCT01855750|Doxorubicin|doxorubicin|mesh-list
92035489|NCT01855750|Vincristine|vincristine|mesh-list
92035490|NCT01855750|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035491|NCT01855750|Immunologic Factors|immunologic factors|mesh-ancestor
92035492|NCT01855750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035493|NCT01855750|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035494|NCT01855750|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92035495|NCT01855750|Alkylating Agents|alkylating agents|mesh-ancestor
92035496|NCT01855750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035497|NCT01855750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035566|NCT02282293|Antimalarials|antimalarials|mesh-ancestor
92035498|NCT01855750|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92035499|NCT01855750|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035500|NCT01855750|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92035501|NCT01855750|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92035502|NCT01855750|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92035503|NCT01855750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035504|NCT01855750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035505|NCT01855750|Glucocorticoids|glucocorticoids|mesh-ancestor
92035506|NCT01855750|Hormones|hormones|mesh-ancestor
92035507|NCT01855750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035508|NCT01855750|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035509|NCT01855750|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035510|NCT01855750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92035511|NCT01855750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92035512|NCT01855750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92035513|NCT04963439|Macitentan|macitentan|mesh-list
92035514|NCT04963439|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92012496|NCT03037073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012497|NCT03037073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012498|NCT03037073|Analgesics|analgesics|mesh-ancestor
92012499|NCT03037073|Sensory System Agents|sensory system agents|mesh-ancestor
92012500|NCT03037073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012501|NCT03037073|Antidepressive Agents|antidepressive agents|mesh-ancestor
92012502|NCT03037073|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92012503|NCT03037073|Dopamine Agents|dopamine agents|mesh-ancestor
92012504|NCT04831541|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92012505|NCT04831541|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92012506|NCT04831541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035515|NCT04963439|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92035516|NCT04963439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035517|NCT04963439|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92035518|NCT01622673|Raltegravir Potassium|raltegravir potassium|mesh-list
92035519|NCT01622673|Calcium Carbonate|calcium carbonate|mesh-list
92035520|NCT01622673|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92035521|NCT01622673|Antacids|antacids|mesh-list
92035522|NCT01622673|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
92035523|NCT01622673|Aluminum hydroxide, magnesium hydroxide, simethicone drug combination|aluminum hydroxide, magnesium hydroxide, simethicone drug combination|mesh-list
92035524|NCT01622673|Anti-Ulcer Agents|anti-ulcer agents|mesh-list
92035525|NCT01622673|TEMPO|tempo|mesh-list
92035526|NCT01622673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035527|NCT01622673|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92035528|NCT01622673|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92035529|NCT01622673|Antiviral Agents|antiviral agents|mesh-ancestor
92035530|NCT01622673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035531|NCT01622673|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92035532|NCT01622673|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92035534|NCT01622673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035536|NCT01622673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92035537|NCT01622673|Immunologic Factors|immunologic factors|mesh-ancestor
92035538|NCT01622673|Antioxidants|antioxidants|mesh-ancestor
92035539|NCT01622673|Protective Agents|protective agents|mesh-ancestor
92035540|NCT02469077|Morphine|morphine|mesh-list
92035541|NCT02469077|Naloxone|naloxone|mesh-list
92035542|NCT02469077|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92035543|NCT02469077|Narcotics|narcotics|mesh-ancestor
92035544|NCT02469077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035545|NCT02469077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035546|NCT02469077|Analgesics|analgesics|mesh-ancestor
92035547|NCT02469077|Sensory System Agents|sensory system agents|mesh-ancestor
92035548|NCT02469077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035549|NCT02469077|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92035550|NCT02486627|Levofloxacin|levofloxacin|mesh-list
92035551|NCT02486627|Meropenem|meropenem|mesh-list
92035552|NCT02486627|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92035553|NCT02486627|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035554|NCT02486627|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92035555|NCT02486627|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92035556|NCT02486627|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92035557|NCT02486627|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035558|NCT02486627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035559|NCT02486627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035560|NCT02486627|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92035561|NCT02486627|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92035562|NCT02282293|Piperaquine|piperaquine|mesh-list
92035567|NCT02282293|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92035568|NCT02282293|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92012509|NCT04470973|Cefuroxime axetil|cefuroxime axetil|mesh-list
92012510|NCT04470973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012511|NCT04470973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012512|NCT05046457|Beta-Cryptoxanthin|beta-cryptoxanthin|mesh-list
92012513|NCT05046457|Provitamins|provitamins|mesh-ancestor
92012514|NCT05046457|Vitamins|vitamins|mesh-ancestor
92012515|NCT05046457|Micronutrients|micronutrients|mesh-ancestor
92012516|NCT05046457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012517|NCT05063071|Tenofovir|tenofovir|mesh-list
92012518|NCT05063071|Antiviral Agents|antiviral agents|mesh-ancestor
92012519|NCT05063071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012520|NCT05063071|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92035569|NCT02282293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035570|NCT02282293|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92035571|NCT02282293|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92035572|NCT02282293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035573|NCT02282293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035575|NCT02282293|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92035576|NCT02282293|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92035577|NCT01854658|Glycopyrrolate|glycopyrrolate|mesh-list
92035578|NCT01854658|Formoterol Fumarate|formoterol fumarate|mesh-list
92035579|NCT01854658|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92035580|NCT01854658|Autonomic Agents|autonomic agents|mesh-ancestor
92035581|NCT01854658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035582|NCT01854658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035583|NCT01854658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92035584|NCT01854658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92035585|NCT01854658|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92035586|NCT01854658|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92035587|NCT01854658|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92035588|NCT01854658|Adrenergic Agents|adrenergic agents|mesh-ancestor
92035589|NCT01854658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035590|NCT01854658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035591|NCT01854658|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92035592|NCT01854658|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92035593|NCT01854658|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92035594|NCT01854658|Cholinergic Agents|cholinergic agents|mesh-ancestor
92035595|NCT01892020|Insulin|insulin|mesh-list
92035596|NCT01892020|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035597|NCT01892020|Insulin Aspart|insulin aspart|mesh-list
92035598|NCT01892020|Biphasic Insulins|biphasic insulins|mesh-list
92035599|NCT01892020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035600|NCT01892020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035601|NCT02485691|Prednisone|prednisone|mesh-list
92035602|NCT02485691|Abiraterone Acetate|abiraterone acetate|mesh-list
92035603|NCT02485691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035604|NCT02485691|Glucocorticoids|glucocorticoids|mesh-ancestor
92035605|NCT02485691|Hormones|hormones|mesh-ancestor
92035606|NCT02485691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035607|NCT02485691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035609|NCT02485691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035610|NCT02485691|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92035611|NCT02485691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035612|NCT02485691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035613|NCT02485691|Hormone Antagonists|hormone antagonists|mesh-ancestor
92035614|NCT02485691|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92035615|NCT02517515|Ritonavir|ritonavir|mesh-list
92035616|NCT02517515|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92035617|NCT02517515|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92035618|NCT02517515|Protease Inhibitors|protease inhibitors|mesh-ancestor
92035619|NCT02517515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012521|NCT05063071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92012522|NCT05063071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012523|NCT05063071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012524|NCT05063071|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92012525|NCT05063071|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92012526|NCT05062681|Dexamethasone|dexamethasone|mesh-list
92012527|NCT05062681|Methylprednisolone|methylprednisolone|mesh-list
92012528|NCT05062681|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92035620|NCT02517515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035621|NCT02517515|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92035622|NCT02517515|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92035624|NCT02517515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035625|NCT02517515|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92035626|NCT02517515|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92035627|NCT01891864|Etanercept|etanercept|mesh-list
92035628|NCT01891864|GP2015|gp2015|mesh-list
92035629|NCT01891864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92035630|NCT01891864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92035631|NCT01891864|Analgesics|analgesics|mesh-ancestor
92035632|NCT01891864|Sensory System Agents|sensory system agents|mesh-ancestor
92035633|NCT01891864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035634|NCT01891864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035635|NCT01891864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035636|NCT01891864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035637|NCT01891864|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035638|NCT01891864|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035639|NCT01891864|Immunologic Factors|immunologic factors|mesh-ancestor
92035640|NCT01891864|Dermatologic Agents|dermatologic agents|mesh-ancestor
92035641|NCT02484911|Dexamethasone|dexamethasone|mesh-list
92035642|NCT02484911|Olanzapine|olanzapine|mesh-list
92035643|NCT02484911|Aprepitant|aprepitant|mesh-list
92035644|NCT02484911|Palonosetron|palonosetron|mesh-list
92035645|NCT02484911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035646|NCT02484911|Antiemetics|antiemetics|mesh-ancestor
92035647|NCT02484911|Autonomic Agents|autonomic agents|mesh-ancestor
92035648|NCT02484911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035649|NCT02484911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035650|NCT02484911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035651|NCT02484911|Glucocorticoids|glucocorticoids|mesh-ancestor
92035652|NCT02484911|Hormones|hormones|mesh-ancestor
92035653|NCT02484911|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035654|NCT02484911|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035655|NCT02484911|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035656|NCT02484911|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92035657|NCT02484911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92035658|NCT02484911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035659|NCT02484911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035660|NCT02484911|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92035661|NCT02484911|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92035662|NCT02484911|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92035663|NCT02484911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035664|NCT02484911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035665|NCT02484911|Serotonin Agents|serotonin agents|mesh-ancestor
92035666|NCT02484911|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92035667|NCT02484911|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92035668|NCT02484911|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92035669|NCT04306367|Pembrolizumab|pembrolizumab|mesh-list
92035670|NCT04306367|Olaparib|olaparib|mesh-list
92035671|NCT04306367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035672|NCT04306367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035673|NCT04306367|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92035674|NCT04306367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035675|NCT04306367|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92035676|NCT04306367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035677|NCT04616014|Insulin|insulin|mesh-list
92012529|NCT05062681|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92012530|NCT05062681|Prednisolone|prednisolone|mesh-list
92012531|NCT05062681|Prednisolone acetate|prednisolone acetate|mesh-list
92012532|NCT05062681|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92012533|NCT05062681|Prednisolone phosphate|prednisolone phosphate|mesh-list
92012534|NCT05062681|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012535|NCT05062681|Antiemetics|antiemetics|mesh-ancestor
92012536|NCT05062681|Autonomic Agents|autonomic agents|mesh-ancestor
92012537|NCT05062681|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012538|NCT05062681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012539|NCT05062681|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012540|NCT05062681|Glucocorticoids|glucocorticoids|mesh-ancestor
92012542|NCT05062681|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012543|NCT05062681|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012544|NCT05062681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012545|NCT05062681|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92012546|NCT05062681|Protective Agents|protective agents|mesh-ancestor
92035678|NCT04616014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035679|NCT04616014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035680|NCT04616014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035708|NCT04891484|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035709|NCT04891484|Antipruritics|antipruritics|mesh-ancestor
92035710|NCT04891484|Dermatologic Agents|dermatologic agents|mesh-ancestor
92035711|NCT04891484|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92035712|NCT04891484|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92035713|NCT04891484|Serotonin Agents|serotonin agents|mesh-ancestor
92035714|NCT04891484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035715|NCT04891484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035716|NCT02408120|Insulin|insulin|mesh-list
92035717|NCT02408120|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035718|NCT02408120|Insulin Glargine|insulin glargine|mesh-list
92035719|NCT02408120|Insulin Aspart|insulin aspart|mesh-list
92035720|NCT02408120|Insulin, Long-Acting|insulin, long-acting|mesh-list
92035721|NCT02408120|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92035722|NCT02408120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035723|NCT02408120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035724|NCT01853644|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92035725|NCT01853644|Tivozanib|tivozanib|mesh-list
92035726|NCT01853644|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92035727|NCT01853644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035755|NCT01852162|Antithrombins|antithrombins|mesh-ancestor
92035756|NCT01852162|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92035757|NCT01852162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92035758|NCT01852162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035759|NCT01852162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035760|NCT01852162|Anticoagulants|anticoagulants|mesh-ancestor
92035761|NCT01835470|Abatacept|abatacept|mesh-list
92035762|NCT01835470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92035763|NCT01835470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035764|NCT01835470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035765|NCT01835470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035766|NCT01835470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035767|NCT01835470|Immunologic Factors|immunologic factors|mesh-ancestor
92012548|NCT05056519|Immunologic Factors|immunologic factors|mesh-ancestor
92012549|NCT05056519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012550|NCT05045443|Curcumin|curcumin|mesh-list
92012551|NCT05045443|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92035768|NCT01835470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035769|NCT01835470|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035770|NCT02451137|Insulin|insulin|mesh-list
92035771|NCT02451137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035773|NCT02451137|Insulin Detemir|insulin detemir|mesh-list
92035774|NCT02451137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035775|NCT02451137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035776|NCT02372006|Afatinib|afatinib|mesh-list
92035777|NCT02372006|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035778|NCT02372006|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92035779|NCT02372006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035780|NCT02372006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035781|NCT02406248|Ticagrelor|ticagrelor|mesh-list
92035782|NCT02406248|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92035783|NCT02406248|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92035784|NCT02406248|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92035785|NCT02406248|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92035786|NCT02406248|Purinergic Agents|purinergic agents|mesh-ancestor
92035787|NCT02406248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035788|NCT02406248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035789|NCT02406248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035790|NCT02450903|Ceritinib|ceritinib|mesh-list
92035791|NCT02450903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035792|NCT02450903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92035793|NCT02450903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035794|NCT02450903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035795|NCT02371616|Listerine|listerine|mesh-list
92035796|NCT02371616|Calcium|calcium|mesh-list
92035797|NCT02371616|Fluorides|fluorides|mesh-list
92035798|NCT02371616|Sodium Fluoride|sodium fluoride|mesh-list
92035799|NCT02371616|Fluorophosphate|fluorophosphate|mesh-list
92035800|NCT02371616|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92035801|NCT02371616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035802|NCT02371616|Cariostatic Agents|cariostatic agents|mesh-ancestor
92035803|NCT02371616|Protective Agents|protective agents|mesh-ancestor
92035804|NCT02371616|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92035805|NCT02371616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035806|NCT01835158|Sunitinib|sunitinib|mesh-list
92035807|NCT01835158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035808|NCT01835158|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92035809|NCT01835158|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92035810|NCT01835158|Growth Substances|growth substances|mesh-ancestor
92035811|NCT01835158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035812|NCT01835158|Growth Inhibitors|growth inhibitors|mesh-ancestor
92035813|NCT01835158|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92035814|NCT01835158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035815|NCT01835158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035816|NCT01833832|Sodium thiosulfate|sodium thiosulfate|mesh-list
92035817|NCT01833832|Antidotes|antidotes|mesh-ancestor
92035818|NCT01833832|Protective Agents|protective agents|mesh-ancestor
92035819|NCT01833832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035820|NCT01833832|Antioxidants|antioxidants|mesh-ancestor
92035821|NCT01833832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035822|NCT01833832|Antitubercular Agents|antitubercular agents|mesh-ancestor
92035823|NCT01833832|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92035824|NCT01833832|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035825|NCT01833832|Chelating Agents|chelating agents|mesh-ancestor
92035826|NCT01833832|Sequestering Agents|sequestering agents|mesh-ancestor
92035827|NCT01850602|Sevelamer|sevelamer|mesh-list
92035828|NCT01850602|Chelating Agents|chelating agents|mesh-ancestor
92035829|NCT01850602|Sequestering Agents|sequestering agents|mesh-ancestor
92035830|NCT01850602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035831|NCT02405780|Adalimumab|adalimumab|mesh-list
92035832|NCT02405780|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92035833|NCT02405780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035834|NCT02405780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012552|NCT05045443|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012553|NCT05045443|Analgesics|analgesics|mesh-ancestor
92012554|NCT05045443|Sensory System Agents|sensory system agents|mesh-ancestor
92035835|NCT02369510|Epinephrine|epinephrine|mesh-list
92035836|NCT02369510|Racepinephrine|racepinephrine|mesh-list
92035837|NCT02369510|Epinephryl borate|epinephryl borate|mesh-list
92035838|NCT02369510|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92035839|NCT02369510|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92035840|NCT02369510|Adrenergic Agents|adrenergic agents|mesh-ancestor
92035841|NCT02369510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035842|NCT02369510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035843|NCT02369510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035844|NCT02369510|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92035845|NCT02369510|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92035846|NCT02369510|Autonomic Agents|autonomic agents|mesh-ancestor
92035852|NCT02369510|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92035854|NCT01650194|Abiraterone Acetate|abiraterone acetate|mesh-list
92035855|NCT01650194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035856|NCT01650194|Glucocorticoids|glucocorticoids|mesh-ancestor
92035857|NCT01650194|Hormones|hormones|mesh-ancestor
92035858|NCT01650194|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035859|NCT01650194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035860|NCT01650194|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035861|NCT01650194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035862|NCT01650194|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92035863|NCT01650194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035864|NCT01650194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035865|NCT01650194|Hormone Antagonists|hormone antagonists|mesh-ancestor
92035866|NCT01650194|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92035867|NCT02404220|Dexamethasone|dexamethasone|mesh-list
92035868|NCT02404220|Vincristine|vincristine|mesh-list
92035869|NCT02404220|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035870|NCT02404220|Antiemetics|antiemetics|mesh-ancestor
92035871|NCT02404220|Autonomic Agents|autonomic agents|mesh-ancestor
92035872|NCT02404220|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035873|NCT02404220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035874|NCT02404220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035875|NCT02404220|Glucocorticoids|glucocorticoids|mesh-ancestor
92035876|NCT02404220|Hormones|hormones|mesh-ancestor
92035877|NCT02404220|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035878|NCT02404220|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035879|NCT02404220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035880|NCT02404220|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92035881|NCT02404220|Tubulin Modulators|tubulin modulators|mesh-ancestor
92035882|NCT02404220|Antimitotic Agents|antimitotic agents|mesh-ancestor
92035883|NCT02404220|Mitosis Modulators|mitosis modulators|mesh-ancestor
92035884|NCT02404220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035885|NCT02366468|Ranibizumab|ranibizumab|mesh-list
92035886|NCT02366468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92035887|NCT02366468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92035888|NCT02366468|Growth Substances|growth substances|mesh-ancestor
92035889|NCT02366468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035890|NCT02366468|Growth Inhibitors|growth inhibitors|mesh-ancestor
92035891|NCT02366468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035892|NCT02335346|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92035893|NCT02335346|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92035894|NCT02335346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92035895|NCT02335346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92035896|NCT02335346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035897|NCT02335346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035898|NCT02335346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035899|NCT02335346|Analgesics|analgesics|mesh-ancestor
92035900|NCT02335346|Sensory System Agents|sensory system agents|mesh-ancestor
92035901|NCT02335346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035902|NCT02335346|Antidepressive Agents|antidepressive agents|mesh-ancestor
92035903|NCT02335346|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035904|NCT02335346|Dopamine Agents|dopamine agents|mesh-ancestor
92035905|NCT02403674|Tenofovir|tenofovir|mesh-list
92035906|NCT02403674|Lamivudine|lamivudine|mesh-list
92035907|NCT02403674|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92012555|NCT05045443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012556|NCT05045443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012558|NCT05045443|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012559|NCT05045443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012560|NCT05045443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012561|NCT05045443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012562|NCT05045053|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92012563|NCT05045053|Lifitegrast|lifitegrast|mesh-list
92012564|NCT05045053|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92012565|NCT05055895|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92012566|NCT05055895|Cholinergic Agents|cholinergic agents|mesh-ancestor
92012567|NCT05055895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012568|NCT05055895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012569|NCT05055895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012570|NCT05060809|Vitamin K|vitamin k|mesh-list
92012571|NCT05060809|Vitamin K 1|vitamin k 1|mesh-list
92012572|NCT05060809|Vitamins|vitamins|mesh-ancestor
92012573|NCT05060809|Micronutrients|micronutrients|mesh-ancestor
92012574|NCT05060809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012575|NCT05060809|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92012576|NCT05060809|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92035908|NCT02403674|Antiviral Agents|antiviral agents|mesh-ancestor
92035909|NCT02403674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035910|NCT02403674|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92035911|NCT02403674|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92035912|NCT02403674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035913|NCT02403674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035918|NCT02401256|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92035919|NCT02401256|Montelukast|montelukast|mesh-list
92035920|NCT02401256|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92035921|NCT02401256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92035922|NCT02401256|Antimetabolites|antimetabolites|mesh-ancestor
92035923|NCT02401256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035924|NCT02401256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92035925|NCT02401256|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92035926|NCT02401256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035927|NCT02401256|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92035928|NCT02401256|Antidepressive Agents|antidepressive agents|mesh-ancestor
92035929|NCT02401256|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92035930|NCT02401256|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92035931|NCT02401256|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92035932|NCT02401256|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92035933|NCT02401256|Dopamine Agents|dopamine agents|mesh-ancestor
92035934|NCT02401256|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035935|NCT02401256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035936|NCT02401256|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92035937|NCT02401256|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92035938|NCT02401256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92012577|NCT05060809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012578|NCT05060809|Hemostatics|hemostatics|mesh-ancestor
92012579|NCT05060809|Coagulants|coagulants|mesh-ancestor
92012580|NCT05060419|Meropenem|meropenem|mesh-list
92035939|NCT02401256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92035940|NCT02401256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92035941|NCT02401256|Hormone Antagonists|hormone antagonists|mesh-ancestor
92035942|NCT02401256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035943|NCT02401256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92035944|NCT02401256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92035945|NCT02401256|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92035946|NCT02401256|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92035947|NCT02401256|Antiviral Agents|antiviral agents|mesh-ancestor
92035948|NCT02401256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035949|NCT02401256|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92035950|NCT02401256|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92035951|NCT02401256|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92035952|NCT02401256|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92035953|NCT02349295|Ixekizumab|ixekizumab|mesh-list
92035954|NCT02349295|Dermatologic Agents|dermatologic agents|mesh-ancestor
92035955|NCT04877587|Gemcitabine|gemcitabine|mesh-list
92035956|NCT04877587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92035957|NCT04877587|Antimetabolites|antimetabolites|mesh-ancestor
92035958|NCT04877587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035959|NCT04877587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035960|NCT02284243|Dexmedetomidine|dexmedetomidine|mesh-list
92035961|NCT02284243|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92035962|NCT02284243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035963|NCT02284243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035964|NCT02284243|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92035965|NCT02284243|Analgesics|analgesics|mesh-ancestor
92035966|NCT02284243|Sensory System Agents|sensory system agents|mesh-ancestor
92035967|NCT02284243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035968|NCT02284243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92035969|NCT02284243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92035970|NCT02284243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92035971|NCT02284243|Adrenergic Agents|adrenergic agents|mesh-ancestor
92035972|NCT02284243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92035973|NCT02284243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035974|NCT02284009|rGLP-1 protein|rglp-1 protein|mesh-list
92035975|NCT02284009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035976|NCT02284009|Incretins|incretins|mesh-ancestor
92035978|NCT02284009|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035979|NCT02400476|Budesonide|budesonide|mesh-list
92035980|NCT02400476|Loperamide|loperamide|mesh-list
92035981|NCT02400476|Antidiarrheals|antidiarrheals|mesh-list
92035982|NCT02400476|Colestipol|colestipol|mesh-list
92035983|NCT02400476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035988|NCT02400476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92035989|NCT02400476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92035990|NCT02400476|Glucocorticoids|glucocorticoids|mesh-ancestor
92035991|NCT02400476|Hormones|hormones|mesh-ancestor
92035992|NCT02400476|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035993|NCT02400476|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035994|NCT02400476|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92035995|NCT02400476|Antimetabolites|antimetabolites|mesh-ancestor
92035996|NCT02400476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035997|NCT02400476|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92035998|NCT02400476|Sequestering Agents|sequestering agents|mesh-ancestor
92035999|NCT02363738|Infliximab|infliximab|mesh-list
92036000|NCT02363738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92036001|NCT02363738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036002|NCT02363738|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036003|NCT02363738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036004|NCT02363738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036005|NCT02331680|Tolvaptan|tolvaptan|mesh-list
92036006|NCT02331680|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92036007|NCT02331680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036008|NCT02331680|Natriuretic Agents|natriuretic agents|mesh-ancestor
92012582|NCT05060419|Piperacillin|piperacillin|mesh-list
92012583|NCT05060419|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92036009|NCT02331680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036010|NCT02349061|Ustekinumab|ustekinumab|mesh-list
92036011|NCT02349061|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036012|NCT02331368|Pembrolizumab|pembrolizumab|mesh-list
92036013|NCT02331368|Lenalidomide|lenalidomide|mesh-list
92036014|NCT02331368|Melphalan|melphalan|mesh-list
92036016|NCT02331368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036017|NCT02331368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92036018|NCT02331368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036019|NCT02331368|Immunologic Factors|immunologic factors|mesh-ancestor
92036020|NCT02331368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036021|NCT02331368|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92036022|NCT02331368|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92036023|NCT02331368|Growth Substances|growth substances|mesh-ancestor
92036024|NCT02331368|Growth Inhibitors|growth inhibitors|mesh-ancestor
92036025|NCT02331368|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92036026|NCT02331368|Alkylating Agents|alkylating agents|mesh-ancestor
92036027|NCT02331368|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92036028|NCT02331368|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036029|NCT02280421|Cyclosporine|cyclosporine|mesh-list
92036030|NCT02280421|Cyclosporins|cyclosporins|mesh-list
92036031|NCT02280421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036032|NCT02280421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036033|NCT02280421|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036034|NCT02280421|Immunologic Factors|immunologic factors|mesh-ancestor
92036035|NCT02280421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036036|NCT02280421|Antifungal Agents|antifungal agents|mesh-ancestor
92036037|NCT02280421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036038|NCT02280421|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036039|NCT02280421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036040|NCT02280421|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92036041|NCT04906382|Paclitaxel|paclitaxel|mesh-list
92036042|NCT04906382|Carboplatin|carboplatin|mesh-list
92036043|NCT04906382|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92036044|NCT04906382|Tislelizumab|tislelizumab|mesh-list
92036045|NCT04906382|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92036046|NCT04906382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036047|NCT04906382|Tubulin Modulators|tubulin modulators|mesh-ancestor
92036048|NCT04906382|Antimitotic Agents|antimitotic agents|mesh-ancestor
92036049|NCT04906382|Mitosis Modulators|mitosis modulators|mesh-ancestor
92036050|NCT04906382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036051|NCT04906382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036052|NCT02362412|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92036053|NCT02362412|Antidepressive Agents|antidepressive agents|mesh-ancestor
92036054|NCT02362412|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92036073|NCT04905446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036074|NCT04905446|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92036075|NCT04905446|Vasodilator Agents|vasodilator agents|mesh-ancestor
92036076|NCT02326298|Certolizumab Pegol|certolizumab pegol|mesh-list
92036077|NCT02326298|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92036078|NCT02326298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036079|NCT02326298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036080|NCT02326298|Immunologic Factors|immunologic factors|mesh-ancestor
92036081|NCT02326298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036082|NCT02326298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036083|NCT02279719|Sorafenib|sorafenib|mesh-list
92036084|NCT02279719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036085|NCT02279719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036086|NCT02279719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036087|NCT02279719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036088|NCT02279407|Dapagliflozin|dapagliflozin|mesh-list
92036089|NCT02279407|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92036090|NCT02279407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036092|NCT02279407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036093|NCT02326220|Alirocumab|alirocumab|mesh-list
92036094|NCT02326220|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92036095|NCT02326220|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92036096|NCT02326220|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92012584|NCT05060419|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012585|NCT05060419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012586|NCT05060419|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92012587|NCT05060419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012588|NCT05060419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012590|NCT03097003|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92012591|NCT03097003|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012592|NCT03097003|Analgesics|analgesics|mesh-ancestor
92036097|NCT02326220|Antimetabolites|antimetabolites|mesh-ancestor
92036098|NCT02326220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036099|NCT02326220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92036100|NCT02326220|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036101|NCT02326220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036102|NCT02326220|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92036104|NCT02358668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036105|NCT02358668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036107|NCT02282605|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92036108|NCT02282605|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92036109|NCT02282605|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036110|NCT02282605|Disinfectants|disinfectants|mesh-ancestor
92036111|NCT02282605|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036112|NCT02282527|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92036113|NCT02282527|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92036114|NCT02282527|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92036117|NCT02282527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036119|NCT05650099|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92036120|NCT05650099|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036121|NCT05650099|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92036122|NCT05650099|Histamine Antagonists|histamine antagonists|mesh-ancestor
92036123|NCT05650099|Histamine Agents|histamine agents|mesh-ancestor
92036124|NCT05650099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036125|NCT05650099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036126|NCT05650099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036127|NCT05650099|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92036128|NCT05650099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92036129|NCT05650099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036130|NCT02278471|Losartan|losartan|mesh-list
92036131|NCT02278471|Amlodipine|amlodipine|mesh-list
92036132|NCT02278471|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92036133|NCT02278471|Atorvastatin|atorvastatin|mesh-list
92036134|NCT02278471|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92036135|NCT02278471|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92036136|NCT02278471|Antimetabolites|antimetabolites|mesh-ancestor
92036137|NCT02278471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036138|NCT02278471|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92036139|NCT02278471|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92036140|NCT02278471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036141|NCT02278471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036142|NCT02278471|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92036143|NCT02278471|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036144|NCT02278471|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92036145|NCT02278471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036146|NCT02278471|Vasodilator Agents|vasodilator agents|mesh-ancestor
92036147|NCT02278471|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92036148|NCT02278471|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92036149|NCT02278471|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92036150|NCT02278471|Diuretics|diuretics|mesh-ancestor
92036151|NCT02278471|Natriuretic Agents|natriuretic agents|mesh-ancestor
92036152|NCT02278471|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92036153|NCT05565235|Nalbuphine|nalbuphine|mesh-list
92036154|NCT05565235|Bupivacaine|bupivacaine|mesh-list
92012593|NCT03097003|Sensory System Agents|sensory system agents|mesh-ancestor
92012594|NCT03097003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012595|NCT03097003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012596|NCT03097003|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012597|NCT03097003|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012598|NCT03097003|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92036155|NCT05565235|Anesthetics, Local|anesthetics, local|mesh-ancestor
92036156|NCT05565235|Anesthetics|anesthetics|mesh-ancestor
92036157|NCT05565235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036158|NCT05565235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036159|NCT05565235|Sensory System Agents|sensory system agents|mesh-ancestor
92036160|NCT05565235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036161|NCT05565235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92036162|NCT05565235|Narcotics|narcotics|mesh-ancestor
92036163|NCT05565235|Analgesics|analgesics|mesh-ancestor
92036164|NCT02278003|Propofol|propofol|mesh-list
92036165|NCT02278003|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92036166|NCT02278003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036167|NCT02278003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036168|NCT02278003|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92036169|NCT02278003|Anesthetics, General|anesthetics, general|mesh-ancestor
92036170|NCT02278003|Anesthetics|anesthetics|mesh-ancestor
92036171|NCT02277769|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92036172|NCT02277769|Immunologic Factors|immunologic factors|mesh-ancestor
92036173|NCT02277769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036174|NCT02277691|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92036175|NCT02277691|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92036176|NCT02277691|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92036177|NCT02277691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036179|NCT02395172|Avelumab|avelumab|mesh-list
92036180|NCT02395172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036181|NCT02395172|Tubulin Modulators|tubulin modulators|mesh-ancestor
92036182|NCT02395172|Antimitotic Agents|antimitotic agents|mesh-ancestor
92036183|NCT02395172|Mitosis Modulators|mitosis modulators|mesh-ancestor
92036184|NCT02395172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036185|NCT02395172|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036186|NCT04876027|Dulaglutide|dulaglutide|mesh-list
92036200|NCT05536219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036202|NCT05649241|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92036203|NCT05649241|Autonomic Agents|autonomic agents|mesh-ancestor
92036204|NCT05649241|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036205|NCT05649241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036206|NCT05649241|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92036207|NCT05649241|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92036208|NCT05649241|Cholinergic Agents|cholinergic agents|mesh-ancestor
92036209|NCT05649241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036210|NCT05649241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036211|NCT02272777|Imatinib Mesylate|imatinib mesylate|mesh-list
92036212|NCT02272777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036213|NCT02272777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036214|NCT02272777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036215|NCT02272777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036216|NCT02357810|Topotecan|topotecan|mesh-list
92036217|NCT02357810|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92036218|NCT02357810|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92036219|NCT02357810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036220|NCT02357810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036221|NCT02357810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036222|NCT02357576|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92036223|NCT02357576|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92036224|NCT02357576|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92036225|NCT02357576|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92036226|NCT01850446|Oseltamivir|oseltamivir|mesh-list
92036227|NCT01850446|Antiviral Agents|antiviral agents|mesh-ancestor
92036228|NCT01850446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012601|NCT03097003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012602|NCT02605967|Spartalizumab|spartalizumab|mesh-list
92012603|NCT02605967|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012604|NCT02605967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012605|NCT02605967|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012606|NCT02605967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012607|NCT03036059|Ivermectin|ivermectin|mesh-list
92012608|NCT03036059|Albendazole|albendazole|mesh-list
92012609|NCT03036059|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92012610|NCT03036059|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012611|NCT03036059|Anthelmintics|anthelmintics|mesh-ancestor
92036229|NCT01850446|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036230|NCT01850446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036231|NCT01644175|Alirocumab|alirocumab|mesh-list
92036232|NCT01644175|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92036233|NCT01644175|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92036234|NCT01644175|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92036235|NCT01644175|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92036236|NCT01644175|Antimetabolites|antimetabolites|mesh-ancestor
92036237|NCT01644175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036238|NCT01644175|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92036239|NCT01644175|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036240|NCT01644175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036241|NCT01644175|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92036242|NCT01644175|Immunologic Factors|immunologic factors|mesh-ancestor
92036243|NCT01644175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036244|NCT04856761|Capecitabine|capecitabine|mesh-list
92036245|NCT04856761|Tegafur|tegafur|mesh-list
92036246|NCT04856761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036247|NCT04856761|Antimetabolites|antimetabolites|mesh-ancestor
92036255|NCT01832038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036257|NCT01849588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036258|NCT01849588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036259|NCT01849588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036260|NCT01849588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036261|NCT02357342|Sirolimus|sirolimus|mesh-list
92036262|NCT02357342|Aflibercept|aflibercept|mesh-list
92036263|NCT02357342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036264|NCT02357342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92036265|NCT02357342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92036266|NCT02357342|Growth Substances|growth substances|mesh-ancestor
92036267|NCT02357342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036268|NCT02357342|Growth Inhibitors|growth inhibitors|mesh-ancestor
92036269|NCT02357342|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92036270|NCT02357342|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036271|NCT02357342|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92036272|NCT02357342|Antifungal Agents|antifungal agents|mesh-ancestor
92036273|NCT02357342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036274|NCT02357342|Immunologic Factors|immunologic factors|mesh-ancestor
92036275|NCT02325518|Timolol|timolol|mesh-list
92036276|NCT02325518|Dorzolamide|dorzolamide|mesh-list
92036277|NCT02325518|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92036278|NCT02325518|Maleic acid|maleic acid|mesh-list
92036279|NCT02325518|Brinzolamide|brinzolamide|mesh-list
92036280|NCT02325518|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92036281|NCT02325518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036282|NCT02325518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012612|NCT03036059|Anticestodal Agents|anticestodal agents|mesh-ancestor
92012613|NCT03036059|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92012614|NCT03036059|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92012615|NCT03036059|Tubulin Modulators|tubulin modulators|mesh-ancestor
92012616|NCT03036059|Antimitotic Agents|antimitotic agents|mesh-ancestor
92012617|NCT03036059|Mitosis Modulators|mitosis modulators|mesh-ancestor
92012618|NCT03036059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012619|NCT03036059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012620|NCT04834427|Ketamine|ketamine|mesh-list
92012621|NCT04834427|Esketamine|esketamine|mesh-list
92012622|NCT04834427|Analgesics|analgesics|mesh-ancestor
92012623|NCT04834427|Sensory System Agents|sensory system agents|mesh-ancestor
92012624|NCT04834427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012625|NCT04834427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012626|NCT04834427|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92036283|NCT02325518|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92036284|NCT02325518|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92036285|NCT02325518|Adrenergic Agents|adrenergic agents|mesh-ancestor
92036286|NCT02325518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036287|NCT02325518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036288|NCT02325518|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92036289|NCT02325518|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036290|NCT02325518|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92036291|NCT02270983|Linaclotide|linaclotide|mesh-list
92036292|NCT02270983|Guanylyl Cyclase C Agonists|guanylyl cyclase c agonists|mesh-ancestor
92036293|NCT02270983|Enzyme Activators|enzyme activators|mesh-ancestor
92036294|NCT02270983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036295|NCT02270983|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036296|NCT02449889|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92036297|NCT02449889|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92036298|NCT02449889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036299|NCT02324270|Diclofenac|diclofenac|mesh-list
92036300|NCT02324270|Diclofenac hydroxyethylpyrrolidine|diclofenac hydroxyethylpyrrolidine|mesh-list
92036301|NCT02324270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92036302|NCT02324270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036303|NCT02324270|Analgesics|analgesics|mesh-ancestor
92036304|NCT02324270|Sensory System Agents|sensory system agents|mesh-ancestor
92036305|NCT02324270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036306|NCT02324270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036307|NCT02324270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036308|NCT02324270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036309|NCT02324270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92036310|NCT02324270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036311|NCT02324270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036312|NCT05648071|Pemetrexed|pemetrexed|mesh-list
92036313|NCT05648071|Nedaplatin|nedaplatin|mesh-list
92036316|NCT05648071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036317|NCT05648071|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92036318|NCT05648071|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92036319|NCT03689699|Nivolumab|nivolumab|mesh-list
92036320|NCT03689699|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036321|NCT03689699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036322|NCT03689699|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92036323|NCT03689699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036324|NCT01849276|Metformin|metformin|mesh-list
92036325|NCT01849276|Cytarabine|cytarabine|mesh-list
92036326|NCT01849276|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036327|NCT01849276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036328|NCT01849276|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92012627|NCT04834427|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92012628|NCT04834427|Anesthetics, General|anesthetics, general|mesh-ancestor
92012629|NCT04834427|Anesthetics|anesthetics|mesh-ancestor
92012630|NCT04834427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012631|NCT04834427|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92012632|NCT04834427|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92012633|NCT04834427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012634|NCT04834427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012635|NCT04834427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92012636|NCT04834427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92012637|NCT05035849|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92012638|NCT05035849|Acarbose|acarbose|mesh-list
92012639|NCT05035849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92012640|NCT05035849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012641|NCT05035849|Incretins|incretins|mesh-ancestor
92012642|NCT05035849|Hormones|hormones|mesh-ancestor
92012643|NCT05035849|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012644|NCT05035849|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92012645|NCT05035849|Protease Inhibitors|protease inhibitors|mesh-ancestor
92012646|NCT05035849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012647|NCT05035849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012648|NCT05035849|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92012649|NCT04428437|Lenvatinib|lenvatinib|mesh-list
92012650|NCT04428437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012651|NCT04428437|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036329|NCT01849276|Antimetabolites|antimetabolites|mesh-ancestor
92036330|NCT01849276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036331|NCT01849276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036332|NCT01849276|Antiviral Agents|antiviral agents|mesh-ancestor
92036333|NCT01849276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036334|NCT01849276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036335|NCT01849276|Immunologic Factors|immunologic factors|mesh-ancestor
92036336|NCT02465489|Deferiprone|deferiprone|mesh-list
92036337|NCT02465489|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92036338|NCT02465489|Chelating Agents|chelating agents|mesh-ancestor
92036339|NCT02465489|Sequestering Agents|sequestering agents|mesh-ancestor
92036340|NCT02465489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036341|NCT04953923|Moxifloxacin|moxifloxacin|mesh-list
92036342|NCT04953923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92036343|NCT04953923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036344|NCT04953923|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92036345|NCT04953923|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92036346|NCT04953923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036347|NCT04953923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036348|NCT04953923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036349|NCT01601821|Sirolimus|sirolimus|mesh-list
92036350|NCT01601821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012652|NCT04428437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012653|NCT04428437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012654|NCT05035381|Leucovorin|leucovorin|mesh-list
92012655|NCT05035381|Bevacizumab|bevacizumab|mesh-list
92012656|NCT05035381|Pembrolizumab|pembrolizumab|mesh-list
92012657|NCT05035381|Fluorouracil|fluorouracil|mesh-list
92012658|NCT05035381|Irinotecan|irinotecan|mesh-list
92012659|NCT05035381|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92012660|NCT05035381|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012661|NCT05035381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012662|NCT05035381|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92012663|NCT05035381|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92012664|NCT05035381|Growth Substances|growth substances|mesh-ancestor
92012665|NCT05035381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012666|NCT05035381|Growth Inhibitors|growth inhibitors|mesh-ancestor
92012667|NCT05035381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012668|NCT05035381|Antimetabolites|antimetabolites|mesh-ancestor
92012669|NCT05035381|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92012670|NCT05035381|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92012671|NCT05035381|Immunologic Factors|immunologic factors|mesh-ancestor
92012672|NCT05035381|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92012673|NCT05035381|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92012674|NCT05035381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012675|NCT05035381|Antidotes|antidotes|mesh-ancestor
92012676|NCT05035381|Protective Agents|protective agents|mesh-ancestor
92012677|NCT05035381|Vitamin B Complex|vitamin b complex|mesh-ancestor
92012678|NCT05035381|Vitamins|vitamins|mesh-ancestor
92012679|NCT05035381|Micronutrients|micronutrients|mesh-ancestor
92012680|NCT04821323|Indomethacin|indomethacin|mesh-list
92012681|NCT04821323|Mannitol|mannitol|mesh-list
92012682|NCT04821323|Lactulose|lactulose|mesh-list
92012683|NCT04821323|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92012684|NCT04821323|Diuretics|diuretics|mesh-ancestor
92012685|NCT04821323|Natriuretic Agents|natriuretic agents|mesh-ancestor
92012686|NCT04821323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012687|NCT04821323|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92012688|NCT04821323|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036351|NCT01601821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036352|NCT01601821|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92036353|NCT01601821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012690|NCT04821323|Sensory System Agents|sensory system agents|mesh-ancestor
92012691|NCT04821323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012692|NCT04821323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012693|NCT04821323|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012694|NCT04821323|Gout Suppressants|gout suppressants|mesh-ancestor
92012695|NCT04821323|Tocolytic Agents|tocolytic agents|mesh-ancestor
92012696|NCT04821323|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92012697|NCT04821323|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92012698|NCT04821323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012699|NCT04821323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012700|NCT04821323|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012702|NCT05035069|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92012703|NCT05035069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012704|NCT05035069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012705|NCT05035069|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92012706|NCT05035069|Anesthetics, General|anesthetics, general|mesh-ancestor
92012707|NCT05035069|Anesthetics|anesthetics|mesh-ancestor
92012708|NCT05035147|Paclitaxel|paclitaxel|mesh-list
92012709|NCT05035147|Gemcitabine|gemcitabine|mesh-list
92012710|NCT05035147|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92012711|NCT05035147|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92012712|NCT05035147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012713|NCT05035147|Tubulin Modulators|tubulin modulators|mesh-ancestor
92012714|NCT05035147|Antimitotic Agents|antimitotic agents|mesh-ancestor
92036354|NCT01601821|Antifungal Agents|antifungal agents|mesh-ancestor
92036355|NCT01601821|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036356|NCT01601821|Immunologic Factors|immunologic factors|mesh-ancestor
92036357|NCT01601821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036358|NCT01846624|Decitabine|decitabine|mesh-list
92036359|NCT01846624|Azacitidine|azacitidine|mesh-list
92036360|NCT01846624|Midostaurin|midostaurin|mesh-list
92036361|NCT01846624|Staurosporine|staurosporine|mesh-list
92036362|NCT01846624|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036363|NCT01846624|Antimetabolites|antimetabolites|mesh-ancestor
92036364|NCT01846624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036365|NCT01846624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036366|NCT01846624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036367|NCT01846624|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036369|NCT01827670|Tin Fluorides|tin fluorides|mesh-list
92036370|NCT01827670|Fluorophosphate|fluorophosphate|mesh-list
92036371|NCT01827670|Cariostatic Agents|cariostatic agents|mesh-ancestor
92036372|NCT01827670|Protective Agents|protective agents|mesh-ancestor
92036373|NCT01827670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036374|NCT01844830|Phenylephrine|phenylephrine|mesh-list
92036375|NCT01844830|Oxymetazoline|oxymetazoline|mesh-list
92036376|NCT01844830|Tetracaine|tetracaine|mesh-list
92036377|NCT01844830|Anesthetics, Local|anesthetics, local|mesh-ancestor
92012715|NCT05035147|Mitosis Modulators|mitosis modulators|mesh-ancestor
92012716|NCT05035147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012717|NCT05035147|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92012718|NCT05035147|Antimetabolites|antimetabolites|mesh-ancestor
92012719|NCT04834115|Ivermectin|ivermectin|mesh-list
92012720|NCT04834115|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92012721|NCT04834115|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012722|NCT01505465|Melatonin|melatonin|mesh-list
92012723|NCT01505465|Antioxidants|antioxidants|mesh-ancestor
92012724|NCT01505465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012725|NCT01505465|Protective Agents|protective agents|mesh-ancestor
92012726|NCT01505465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012727|NCT01505465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012728|NCT04831229|Menthol|menthol|mesh-list
92012729|NCT04831229|Antipruritics|antipruritics|mesh-ancestor
92012730|NCT04831229|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012731|NCT04816253|Methylprednisolone|methylprednisolone|mesh-list
92012732|NCT04816253|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92012733|NCT04816253|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92012734|NCT04816253|Prednisolone|prednisolone|mesh-list
92012735|NCT04816253|Prednisolone acetate|prednisolone acetate|mesh-list
92012736|NCT04816253|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92012737|NCT04816253|Prednisolone phosphate|prednisolone phosphate|mesh-list
92012738|NCT04816253|Hyaluronic Acid|hyaluronic acid|mesh-list
92012739|NCT04816253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012740|NCT04816253|Antiemetics|antiemetics|mesh-ancestor
92012741|NCT04816253|Autonomic Agents|autonomic agents|mesh-ancestor
92012742|NCT04816253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012743|NCT04816253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012744|NCT04816253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012745|NCT04816253|Glucocorticoids|glucocorticoids|mesh-ancestor
92036378|NCT01844830|Anesthetics|anesthetics|mesh-ancestor
92036379|NCT01844830|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036380|NCT01844830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036381|NCT01844830|Sensory System Agents|sensory system agents|mesh-ancestor
92036382|NCT01844830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036383|NCT01844830|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92036384|NCT01844830|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92036385|NCT01844830|Adrenergic Agents|adrenergic agents|mesh-ancestor
92036386|NCT01844830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036387|NCT01844830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036391|NCT01844830|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92036392|NCT01844830|Respiratory System Agents|respiratory system agents|mesh-ancestor
92036393|NCT01844830|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92036394|NCT01844830|Mydriatics|mydriatics|mesh-ancestor
92012747|NCT04816253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012748|NCT04816253|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92012749|NCT04816253|Protective Agents|protective agents|mesh-ancestor
92012750|NCT04816253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012751|NCT04816253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012752|NCT04816253|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92012753|NCT04816253|Immunologic Factors|immunologic factors|mesh-ancestor
92012754|NCT04816253|Viscosupplements|viscosupplements|mesh-ancestor
92012755|NCT04816097|Dexamethasone|dexamethasone|mesh-list
92012756|NCT04816097|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92012757|NCT04816097|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012758|NCT04816097|Antiemetics|antiemetics|mesh-ancestor
92012759|NCT04816097|Autonomic Agents|autonomic agents|mesh-ancestor
92012760|NCT04816097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012761|NCT04816097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012762|NCT04816097|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012764|NCT04816097|Hormones|hormones|mesh-ancestor
92012765|NCT04816097|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012766|NCT04816097|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92036395|NCT01844830|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92036396|NCT01844830|Protective Agents|protective agents|mesh-ancestor
92036397|NCT02323334|Itraconazole|itraconazole|mesh-list
92036398|NCT02323334|Antifungal Agents|antifungal agents|mesh-ancestor
92036399|NCT02323334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036400|NCT02323334|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92036401|NCT02323334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92036402|NCT02323334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036403|NCT02323334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036404|NCT02323334|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92036405|NCT02323334|Hormone Antagonists|hormone antagonists|mesh-ancestor
92036406|NCT02323334|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036407|NCT02323334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036408|NCT02323334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92036409|NCT02322866|Sarecycline|sarecycline|mesh-list
92036410|NCT02322866|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92036411|NCT02322866|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036412|NCT02322866|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036413|NCT01827046|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92036414|NCT01827046|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92036415|NCT01827046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92036416|NCT01827046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036418|NCT02356562|Ribavirin|ribavirin|mesh-list
92036419|NCT02356562|Sofosbuvir|sofosbuvir|mesh-list
92036420|NCT02356562|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92036421|NCT02356562|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92036422|NCT02356562|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036423|NCT02356562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036424|NCT02356562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036425|NCT02356562|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92036426|NCT02356562|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92012768|NCT02600351|Sofosbuvir|sofosbuvir|mesh-list
92012769|NCT02600351|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92012770|NCT02600351|Ledipasvir|ledipasvir|mesh-list
92012771|NCT02600351|Antiviral Agents|antiviral agents|mesh-ancestor
92012772|NCT02600351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012773|NCT04829435|Rasburicase|rasburicase|mesh-list
92012774|NCT04829435|Gout Suppressants|gout suppressants|mesh-ancestor
92012775|NCT04829435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012777|NCT05042635|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012778|NCT04815395|Oxytocin|oxytocin|mesh-list
92012779|NCT04815395|Oxytocics|oxytocics|mesh-ancestor
92012780|NCT04815395|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92012781|NCT04815395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012782|NCT03096301|Salicylic Acid|salicylic acid|mesh-list
92012783|NCT03096301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036427|NCT02356562|Antiviral Agents|antiviral agents|mesh-ancestor
92036428|NCT02356562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036429|NCT02356562|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92036430|NCT02356562|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92036431|NCT02356562|Antimetabolites|antimetabolites|mesh-ancestor
92036432|NCT02354690|Cyclophosphamide|cyclophosphamide|mesh-list
92036433|NCT02354690|Fludarabine|fludarabine|mesh-list
92036434|NCT02354690|Interleukin-2|interleukin-2|mesh-list
92036435|NCT02354690|Vemurafenib|vemurafenib|mesh-list
92036436|NCT02354690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036437|NCT02354690|Immunologic Factors|immunologic factors|mesh-ancestor
92036438|NCT02354690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036439|NCT02354690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036440|NCT02354690|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92036441|NCT02354690|Alkylating Agents|alkylating agents|mesh-ancestor
92036442|NCT02354690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036443|NCT02354690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036444|NCT02354690|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92036445|NCT02354690|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036446|NCT02354690|Analgesics|analgesics|mesh-ancestor
92036447|NCT02354690|Sensory System Agents|sensory system agents|mesh-ancestor
92036448|NCT02354690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036449|NCT02354690|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036450|NCT02354690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036451|NCT02354222|Canagliflozin|canagliflozin|mesh-list
92036452|NCT02354222|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92036453|NCT02354222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036454|NCT02354222|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036455|NCT02354222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036456|NCT02351960|Dexlansoprazole|dexlansoprazole|mesh-list
92036457|NCT02351960|Lansoprazole|lansoprazole|mesh-list
92036458|NCT02351960|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92036459|NCT02351960|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036462|NCT02351960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036463|NCT02351180|Beclomethasone|beclomethasone|mesh-list
92036464|NCT02351180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036465|NCT02351180|Glucocorticoids|glucocorticoids|mesh-ancestor
92036466|NCT02351180|Hormones|hormones|mesh-ancestor
92036467|NCT02351180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036468|NCT02351180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036469|NCT02351180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92036470|NCT02351180|Respiratory System Agents|respiratory system agents|mesh-ancestor
92012784|NCT03096301|Antifungal Agents|antifungal agents|mesh-ancestor
92012785|NCT03096301|Keratolytic Agents|keratolytic agents|mesh-ancestor
92012786|NCT03096301|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012787|NCT05034055|Atezolizumab|atezolizumab|mesh-list
92012788|NCT05034055|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012789|NCT05034055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012790|NCT05034055|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012791|NCT05034055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012792|NCT05042245|Silymarin|silymarin|mesh-list
92012793|NCT05042245|N-Methylaspartate|n-methylaspartate|mesh-list
92012794|NCT05042245|Antioxidants|antioxidants|mesh-ancestor
92012795|NCT05042245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012796|NCT05042245|Protective Agents|protective agents|mesh-ancestor
92012797|NCT05042245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012798|NCT05042245|Excitatory Amino Acid Agonists|excitatory amino acid agonists|mesh-ancestor
92012799|NCT05042245|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92012800|NCT05042245|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012801|NCT03095209|Paclitaxel|paclitaxel|mesh-list
92012802|NCT03095209|Carboplatin|carboplatin|mesh-list
92012803|NCT03095209|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92012804|NCT03095209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012805|NCT03095209|Tubulin Modulators|tubulin modulators|mesh-ancestor
92012806|NCT03095209|Antimitotic Agents|antimitotic agents|mesh-ancestor
92012807|NCT03095209|Mitosis Modulators|mitosis modulators|mesh-ancestor
92012808|NCT03095209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012809|NCT05034133|Cisplatin|cisplatin|mesh-list
92012810|NCT05034133|Etoposide|etoposide|mesh-list
92012811|NCT05034133|Durvalumab|durvalumab|mesh-list
92012812|NCT05034133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012813|NCT05034133|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92012814|NCT05034133|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92036471|NCT02350478|Linagliptin|linagliptin|mesh-list
92036472|NCT02350478|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036473|NCT02350478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036474|NCT02350478|Incretins|incretins|mesh-ancestor
92036475|NCT02350478|Hormones|hormones|mesh-ancestor
92036476|NCT02350478|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036477|NCT02350478|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92036478|NCT02350478|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036479|NCT02350478|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036480|NCT02350478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036481|NCT02349542|Bupivacaine|bupivacaine|mesh-list
92036482|NCT02349542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92036483|NCT02349542|Anesthetics|anesthetics|mesh-ancestor
92012815|NCT05034133|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92012816|NCT05034133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012817|NCT05034133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012818|NCT05034133|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012819|NCT03096457|Paromomycin|paromomycin|mesh-list
92012820|NCT03096457|Pentamidine|pentamidine|mesh-list
92012821|NCT03096457|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012822|NCT03096457|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012823|NCT03096457|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92012824|NCT03096457|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92012825|NCT03096457|Antifungal Agents|antifungal agents|mesh-ancestor
92012826|NCT03096457|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92012827|NCT03096223|KHK4083|khk4083|mesh-list
92012828|NCT03096223|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012829|NCT04814303|Morphine|morphine|mesh-list
92012830|NCT04814303|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92012831|NCT04814303|Narcotics|narcotics|mesh-ancestor
92012832|NCT04814303|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012833|NCT04814303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012834|NCT04814303|Analgesics|analgesics|mesh-ancestor
92012835|NCT04814303|Sensory System Agents|sensory system agents|mesh-ancestor
92012836|NCT04814303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012837|NCT05053009|Ibuprofen|ibuprofen|mesh-list
92012838|NCT05053009|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92012839|NCT05053009|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012840|NCT05053009|Analgesics|analgesics|mesh-ancestor
92012841|NCT05053009|Sensory System Agents|sensory system agents|mesh-ancestor
92012842|NCT05053009|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012843|NCT05053009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012844|NCT05053009|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012845|NCT05053009|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012846|NCT05053009|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92012847|NCT05053009|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012848|NCT05053009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012849|NCT04813913|Bevacizumab|bevacizumab|mesh-list
92012850|NCT04813913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012851|NCT04813913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012853|NCT04813913|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92012854|NCT04813913|Growth Substances|growth substances|mesh-ancestor
92012855|NCT04813913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012856|NCT04813913|Growth Inhibitors|growth inhibitors|mesh-ancestor
92012857|NCT03094663|Cefazolin|cefazolin|mesh-list
92012858|NCT03094663|Dexamethasone|dexamethasone|mesh-list
92012859|NCT03094663|Dexamethasone acetate|dexamethasone acetate|mesh-list
92012860|NCT03094663|Methylprednisolone|methylprednisolone|mesh-list
92012861|NCT03094663|Epinephrine|epinephrine|mesh-list
92012862|NCT03094663|Bupivacaine|bupivacaine|mesh-list
92012863|NCT03094663|BB 1101|bb 1101|mesh-list
92012864|NCT03094663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012865|NCT03094663|Antiemetics|antiemetics|mesh-ancestor
92012866|NCT03094663|Autonomic Agents|autonomic agents|mesh-ancestor
92012867|NCT03094663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012868|NCT03094663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012869|NCT03094663|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012870|NCT03094663|Glucocorticoids|glucocorticoids|mesh-ancestor
92012871|NCT03094663|Hormones|hormones|mesh-ancestor
92012872|NCT03094663|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92012873|NCT03094663|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92012874|NCT03094663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012875|NCT03094663|Protease Inhibitors|protease inhibitors|mesh-ancestor
92012876|NCT03094663|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012877|NCT03094663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012878|NCT03094663|Anesthetics, Local|anesthetics, local|mesh-ancestor
92012879|NCT03094663|Anesthetics|anesthetics|mesh-ancestor
92012880|NCT03094663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012881|NCT03094663|Sensory System Agents|sensory system agents|mesh-ancestor
92012882|NCT03094663|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92012883|NCT03094663|Protective Agents|protective agents|mesh-ancestor
92012884|NCT03094663|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92012885|NCT03094663|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92012886|NCT03094663|Adrenergic Agents|adrenergic agents|mesh-ancestor
92012887|NCT03094663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012888|NCT03094663|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92012889|NCT03094663|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92012890|NCT03094663|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92012891|NCT03094663|Respiratory System Agents|respiratory system agents|mesh-ancestor
92012892|NCT03094663|Mydriatics|mydriatics|mesh-ancestor
92012893|NCT03094663|Sympathomimetics|sympathomimetics|mesh-ancestor
92012894|NCT03094663|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92012895|NCT03094663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92012896|NCT03094663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012897|NCT04814381|Magnesium Sulfate|magnesium sulfate|mesh-list
92012899|NCT04814381|Analgesics|analgesics|mesh-ancestor
92012900|NCT04814381|Sensory System Agents|sensory system agents|mesh-ancestor
92012901|NCT04814381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012902|NCT04814381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012903|NCT04814381|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92012904|NCT04814381|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92012905|NCT04814381|Anesthetics, General|anesthetics, general|mesh-ancestor
92012906|NCT04814381|Anesthetics|anesthetics|mesh-ancestor
92012907|NCT04814381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012908|NCT04814381|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92012909|NCT04814381|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92012910|NCT04814381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012911|NCT04814381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012912|NCT04814381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92012913|NCT04814381|Anticonvulsants|anticonvulsants|mesh-ancestor
92012914|NCT04814381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92012915|NCT04814381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92012916|NCT04814381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92012917|NCT04814381|Tocolytic Agents|tocolytic agents|mesh-ancestor
92012918|NCT04814381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92036484|NCT02349542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036485|NCT02349542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036486|NCT02349542|Sensory System Agents|sensory system agents|mesh-ancestor
92036487|NCT02349542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036488|NCT02321930|Tofacitinib|tofacitinib|mesh-list
92036489|NCT02321930|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92036490|NCT02321930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036491|NCT02321930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036492|NCT02321930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036493|NCT02264821|Morphine|morphine|mesh-list
92036494|NCT02264821|Ropivacaine|ropivacaine|mesh-list
92036495|NCT02264821|Anesthetics, Local|anesthetics, local|mesh-list
92036496|NCT02264821|Anesthetics|anesthetics|mesh-list
92036497|NCT02264821|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92012919|NCT04819217|Charcoal|charcoal|mesh-list
92012920|NCT04819217|Antidotes|antidotes|mesh-ancestor
92012921|NCT04819217|Protective Agents|protective agents|mesh-ancestor
92012922|NCT04819217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012923|NCT05052619|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92012924|NCT05052619|Cefmetazole|cefmetazole|mesh-list
92012925|NCT05052619|Sulperazone|sulperazone|mesh-list
92012926|NCT05052619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012927|NCT05052619|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92012928|NCT05052775|Chlorhexidine|chlorhexidine|mesh-list
92012929|NCT05052775|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92012930|NCT05052775|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012931|NCT05052775|Disinfectants|disinfectants|mesh-ancestor
92012932|NCT04813523|Cisplatin|cisplatin|mesh-list
92012933|NCT04813523|Pembrolizumab|pembrolizumab|mesh-list
92012934|NCT04813523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012935|NCT04813523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012936|NCT04813523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012937|NCT04813523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036498|NCT02264821|Narcotics|narcotics|mesh-ancestor
92036499|NCT02264821|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036500|NCT02264821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036501|NCT02264821|Analgesics|analgesics|mesh-ancestor
92036502|NCT02264821|Sensory System Agents|sensory system agents|mesh-ancestor
92036503|NCT02264821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036504|NCT04854889|Decitabine|decitabine|mesh-list
92036505|NCT04854889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036506|NCT04854889|Antimetabolites|antimetabolites|mesh-ancestor
92036507|NCT04854889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036508|NCT04854889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036509|NCT04854889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036510|NCT02261467|Botulinum Toxins|botulinum toxins|mesh-list
92036511|NCT02261467|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92036512|NCT02261467|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92036513|NCT02261467|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92036514|NCT02261467|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036515|NCT02261467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036516|NCT02261467|Cholinergic Agents|cholinergic agents|mesh-ancestor
92036517|NCT02261467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036518|NCT02261467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036519|NCT02261467|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92036520|NCT02261467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036521|NCT05341843|Sertraline|sertraline|mesh-list
92036522|NCT05341843|Antidepressive Agents|antidepressive agents|mesh-ancestor
92036523|NCT05341843|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92036524|NCT05341843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92036525|NCT05341843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92036526|NCT05341843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036527|NCT05341843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036528|NCT05341843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036529|NCT05341843|Serotonin Agents|serotonin agents|mesh-ancestor
92036530|NCT05341843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036544|NCT02258659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012939|NCT05032261|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92012940|NCT05032261|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92012941|NCT05032261|Adrenergic Agents|adrenergic agents|mesh-ancestor
92012942|NCT05032261|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012943|NCT05032261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012944|NCT05032261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012945|NCT05032261|Sympathomimetics|sympathomimetics|mesh-ancestor
92012946|NCT05032261|Autonomic Agents|autonomic agents|mesh-ancestor
92012947|NCT05032261|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012948|NCT05032261|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92012949|NCT05619341|Psyllium|psyllium|mesh-list
92012950|NCT05619341|Cathartics|cathartics|mesh-ancestor
92012951|NCT05619341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012952|NCT04814069|Tislelizumab|tislelizumab|mesh-list
92012953|NCT04814069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012954|NCT04814069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012955|NCT05051137|Hydroxychloroquine|hydroxychloroquine|mesh-list
92012956|NCT05051137|Sulfasalazine|sulfasalazine|mesh-list
92012958|NCT05051137|Antimalarials|antimalarials|mesh-ancestor
92012959|NCT05051137|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92012960|NCT05051137|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92012961|NCT05051137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92012962|NCT05051137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012963|NCT05051137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012964|NCT05051137|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92012965|NCT05051137|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92012966|NCT05051137|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92012967|NCT05051137|Dermatologic Agents|dermatologic agents|mesh-ancestor
92012968|NCT05051137|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036546|NCT02258659|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036547|NCT02258659|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036548|NCT02258659|Immunologic Factors|immunologic factors|mesh-ancestor
92036549|NCT02258659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036550|NCT02258659|Antisickling Agents|antisickling agents|mesh-ancestor
92036551|NCT02258659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036552|NCT02258659|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92036553|NCT02320058|Nivolumab|nivolumab|mesh-list
92036554|NCT02320058|Ipilimumab|ipilimumab|mesh-list
92036555|NCT02320058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036556|NCT02320058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036557|NCT02320058|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92036558|NCT02320058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036559|NCT02319668|Chlorhexidine|chlorhexidine|mesh-list
92012969|NCT05051137|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92012970|NCT05051137|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012971|NCT05051137|Analgesics|analgesics|mesh-ancestor
92012972|NCT05051137|Sensory System Agents|sensory system agents|mesh-ancestor
92012973|NCT05051137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012974|NCT05051137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012975|NCT05038969|Esomeprazole|esomeprazole|mesh-list
92012976|NCT05038969|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92012977|NCT05038969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92012978|NCT05038969|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92012979|NCT05038969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92012980|NCT05038969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012981|NCT05038657|Atezolizumab|atezolizumab|mesh-list
92012982|NCT05038657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92012983|NCT05038657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92012984|NCT05038657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92012985|NCT05038657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92012986|NCT05038111|Dexmedetomidine|dexmedetomidine|mesh-list
92012987|NCT05038111|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92012988|NCT05038111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92012989|NCT05038111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92012990|NCT05038111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92012991|NCT05038111|Analgesics|analgesics|mesh-ancestor
92012992|NCT05038111|Sensory System Agents|sensory system agents|mesh-ancestor
92012993|NCT05038111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92012994|NCT05038111|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92012995|NCT05038111|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92012996|NCT05038111|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92012997|NCT05038111|Adrenergic Agents|adrenergic agents|mesh-ancestor
92036560|NCT02319668|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92036562|NCT02319668|Fluorides|fluorides|mesh-list
92036563|NCT02319668|Sodium Fluoride|sodium fluoride|mesh-list
92036564|NCT02319668|Cariostatic Agents|cariostatic agents|mesh-ancestor
92036565|NCT02319668|Protective Agents|protective agents|mesh-ancestor
92036566|NCT02319668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036567|NCT02319668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92036568|NCT02319668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036569|NCT02319668|Disinfectants|disinfectants|mesh-ancestor
92036570|NCT02319668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036571|NCT02092467|Adalimumab|adalimumab|mesh-list
92036572|NCT02092467|Etanercept|etanercept|mesh-list
92036573|NCT02092467|Tofacitinib|tofacitinib|mesh-list
92036574|NCT02092467|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92012998|NCT05038111|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92012999|NCT05038111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013000|NCT05030077|Carboplatin|carboplatin|mesh-list
92013001|NCT05030077|Gemcitabine|gemcitabine|mesh-list
92013002|NCT05030077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013003|NCT05030077|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92081679|NCT01392183|Anesthetics|anesthetics|mesh-ancestor
92013005|NCT05030077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013006|NCT05029531|Immunomodulating Agents|immunomodulating agents|mesh-list
92013008|NCT05029531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013009|NCT05029453|Apatinib|apatinib|mesh-list
92013010|NCT05029453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013011|NCT05029453|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92013012|NCT05029453|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013013|NCT05029453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013014|NCT02640157|Sofosbuvir|sofosbuvir|mesh-list
92013015|NCT02640157|Antiviral Agents|antiviral agents|mesh-ancestor
92013016|NCT02640157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013017|NCT05037253|Vitamin D|vitamin d|mesh-list
92013018|NCT05037253|Vitamins|vitamins|mesh-ancestor
92013019|NCT05037253|Micronutrients|micronutrients|mesh-ancestor
92013020|NCT05037253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013021|NCT05037253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92013022|NCT05029297|Capsaicin|capsaicin|mesh-list
92013023|NCT05029297|Antipruritics|antipruritics|mesh-ancestor
92013024|NCT05029297|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013025|NCT05029297|Sensory System Agents|sensory system agents|mesh-ancestor
92013026|NCT05029297|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013027|NCT05029297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013028|NCT05028907|Tocopherols|tocopherols|mesh-list
92036575|NCT02092467|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036576|NCT02092467|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036577|NCT02092467|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92036578|NCT02092467|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036579|NCT02092467|Analgesics|analgesics|mesh-ancestor
92036580|NCT02092467|Sensory System Agents|sensory system agents|mesh-ancestor
92036581|NCT02092467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036582|NCT02092467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036583|NCT02092467|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036584|NCT02092467|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036585|NCT02092467|Immunologic Factors|immunologic factors|mesh-ancestor
92036586|NCT02092467|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92036587|NCT02092467|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92013030|NCT05028907|alpha-Tocopherol|alpha-tocopherol|mesh-list
92013031|NCT05028907|Chloramphenicol|chloramphenicol|mesh-list
92013032|NCT05028907|Dexamethasone|dexamethasone|mesh-list
92013033|NCT05028907|Dexamethasone acetate|dexamethasone acetate|mesh-list
92013034|NCT05028907|Tetrahydrozoline|tetrahydrozoline|mesh-list
92036588|NCT02092467|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036589|NCT02092467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036600|NCT04420871|Capecitabine|capecitabine|mesh-list
92036601|NCT04420871|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036602|NCT04420871|Antimetabolites|antimetabolites|mesh-ancestor
92036603|NCT04420871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036604|NCT04420871|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036605|NCT02349386|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92036609|NCT02349386|Estrogens|estrogens|mesh-ancestor
92036610|NCT02349386|Hormones|hormones|mesh-ancestor
92036611|NCT02349386|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036612|NCT02349386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036613|NCT02349386|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92036614|NCT02349386|Contraceptive Agents|contraceptive agents|mesh-ancestor
92036615|NCT02349386|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92036616|NCT02349386|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92036617|NCT04892888|Vaccines|vaccines|mesh-list
92036618|NCT04892888|Immunologic Factors|immunologic factors|mesh-ancestor
92036619|NCT04892888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036620|NCT02036775|Ambroxol|ambroxol|mesh-list
92036621|NCT02036775|Expectorants|expectorants|mesh-ancestor
92036622|NCT02036775|Respiratory System Agents|respiratory system agents|mesh-ancestor
92036623|NCT02034591|Apixaban|apixaban|mesh-list
92036624|NCT02034591|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92036625|NCT02034591|Antithrombins|antithrombins|mesh-ancestor
92036626|NCT02034591|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92036627|NCT02034591|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036628|NCT02034591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036629|NCT02034591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036630|NCT02034591|Anticoagulants|anticoagulants|mesh-ancestor
92036631|NCT02091921|Ticagrelor|ticagrelor|mesh-list
92036632|NCT02091921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92036633|NCT02091921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92036634|NCT02091921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92036635|NCT02091921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92036636|NCT02091921|Purinergic Agents|purinergic agents|mesh-ancestor
92036637|NCT02091921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036638|NCT02091921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036639|NCT02091921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036641|NCT04716933|Pembrolizumab|pembrolizumab|mesh-list
92036642|NCT04716933|Pemetrexed|pemetrexed|mesh-list
92036643|NCT04716933|Lenvatinib|lenvatinib|mesh-list
92036644|NCT04716933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036645|NCT04716933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036646|NCT04716933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92036647|NCT04716933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036648|NCT04716933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036649|NCT04716933|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92036650|NCT04716933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92036651|NCT04716933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92036652|NCT02034513|Insulin|insulin|mesh-list
92036653|NCT02034513|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92036654|NCT02034513|Insulin Glargine|insulin glargine|mesh-list
92036655|NCT02034513|Insulin Aspart|insulin aspart|mesh-list
92036656|NCT02034513|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036657|NCT02034513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036658|NCT02461745|Ribavirin|ribavirin|mesh-list
92036659|NCT02461745|Ritonavir|ritonavir|mesh-list
92036660|NCT02461745|Antimetabolites|antimetabolites|mesh-ancestor
92036661|NCT02461745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036662|NCT02461745|Antiviral Agents|antiviral agents|mesh-ancestor
92036663|NCT02461745|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036664|NCT02461745|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92036665|NCT02461745|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92013035|NCT05028907|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92013036|NCT05028907|Hyaluronic Acid|hyaluronic acid|mesh-list
92013037|NCT05028907|BB 1101|bb 1101|mesh-list
92013038|NCT05028907|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036666|NCT02461745|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036667|NCT02461745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036668|NCT02461745|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92036669|NCT02461745|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92036670|NCT02461745|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92036671|NCT02461745|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92036672|NCT02034435|Amlodipine|amlodipine|mesh-list
92036673|NCT02034435|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036674|NCT02034435|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92036675|NCT02034435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036676|NCT02034435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036677|NCT02034435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92036693|NCT02033889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036695|NCT02447003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036696|NCT02447003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036697|NCT02447003|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92036698|NCT02447003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036699|NCT04594018|Minoxidil|minoxidil|mesh-list
92036700|NCT04594018|Finasteride|finasteride|mesh-list
92036701|NCT04594018|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036702|NCT04594018|Vasodilator Agents|vasodilator agents|mesh-ancestor
92036703|NCT04594018|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92036704|NCT04594018|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92036705|NCT04594018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036706|NCT04594018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036707|NCT04594018|Hormone Antagonists|hormone antagonists|mesh-ancestor
92036708|NCT04594018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036709|NCT04594018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036710|NCT04594018|Urological Agents|urological agents|mesh-ancestor
92036711|NCT02054481|Ustekinumab|ustekinumab|mesh-list
92036712|NCT02054481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92036713|NCT02054481|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036714|NCT02054481|Immunologic Factors|immunologic factors|mesh-ancestor
92036715|NCT02054481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036716|NCT02054325|Polidocanol|polidocanol|mesh-list
92036717|NCT02054325|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92036718|NCT02054325|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92036719|NCT02091375|Cannabidiol|cannabidiol|mesh-list
92036720|NCT02091375|Anticonvulsants|anticonvulsants|mesh-ancestor
92036722|NCT02032875|Sofosbuvir|sofosbuvir|mesh-list
92036723|NCT02032875|Antimetabolites|antimetabolites|mesh-ancestor
92036724|NCT02032875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036725|NCT02032875|Antiviral Agents|antiviral agents|mesh-ancestor
92036726|NCT02032875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036727|NCT02032407|Dapsone|dapsone|mesh-list
92036728|NCT02032407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036729|NCT02032407|Antimalarials|antimalarials|mesh-ancestor
92036730|NCT02032407|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92036731|NCT02032407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92036732|NCT02032407|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92036733|NCT02032407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036734|NCT02032407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036735|NCT02032407|Leprostatic Agents|leprostatic agents|mesh-ancestor
92036736|NCT02032407|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92036737|NCT01843660|Acetaminophen|acetaminophen|mesh-list
92036738|NCT01843660|Tramadol|tramadol|mesh-list
92036739|NCT01843660|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036742|NCT01843660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036743|NCT01843660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036745|NCT01843660|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92036746|NCT01843660|Narcotics|narcotics|mesh-ancestor
92036747|NCT01843660|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036748|NCT02032173|Ranibizumab|ranibizumab|mesh-list
92036749|NCT02032173|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92036750|NCT02032173|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92036751|NCT02032173|Growth Substances|growth substances|mesh-ancestor
92013039|NCT05028907|Antiemetics|antiemetics|mesh-ancestor
92013040|NCT05028907|Autonomic Agents|autonomic agents|mesh-ancestor
92013041|NCT05028907|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013042|NCT05028907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036752|NCT02032173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036753|NCT02032173|Growth Inhibitors|growth inhibitors|mesh-ancestor
92036754|NCT02032173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036755|NCT02461589|Liraglutide|liraglutide|mesh-list
92036756|NCT02461589|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036757|NCT02461589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036758|NCT02461589|Incretins|incretins|mesh-ancestor
92036759|NCT02461589|Hormones|hormones|mesh-ancestor
92036760|NCT02461589|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036761|NCT02089737|Panitumumab|panitumumab|mesh-list
92036762|NCT02089737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036763|NCT02089737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036764|NCT02089347|Vaccines|vaccines|mesh-list
92036765|NCT02089347|Immunologic Factors|immunologic factors|mesh-ancestor
92036766|NCT02089347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036768|NCT02419469|Dexamethasone|dexamethasone|mesh-list
92036769|NCT02419469|Prednisone|prednisone|mesh-list
92036770|NCT02419469|Dexamethasone acetate|dexamethasone acetate|mesh-list
92036771|NCT02419469|Cyclophosphamide|cyclophosphamide|mesh-list
92036772|NCT02419469|Rituximab|rituximab|mesh-list
92036773|NCT02419469|Doxorubicin|doxorubicin|mesh-list
92036774|NCT02419469|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92036775|NCT02419469|Methotrexate|methotrexate|mesh-list
92036776|NCT02419469|Vincristine|vincristine|mesh-list
92036777|NCT02419469|Daunorubicin|daunorubicin|mesh-list
92036778|NCT02419469|Asparaginase|asparaginase|mesh-list
92036779|NCT02419469|Mercaptopurine|mercaptopurine|mesh-list
92036780|NCT02419469|Ofatumumab|ofatumumab|mesh-list
92036781|NCT02419469|Pegaspargase|pegaspargase|mesh-list
92036782|NCT02419469|Thioguanine|thioguanine|mesh-list
92036783|NCT02419469|BB 1101|bb 1101|mesh-list
92036784|NCT02419469|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036785|NCT02419469|Immunologic Factors|immunologic factors|mesh-ancestor
92036786|NCT02419469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036787|NCT02419469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036788|NCT02419469|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92036789|NCT02419469|Alkylating Agents|alkylating agents|mesh-ancestor
92036790|NCT02419469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036791|NCT02419469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036792|NCT02419469|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92036793|NCT02419469|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036794|NCT02419469|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036795|NCT02419469|Antiemetics|antiemetics|mesh-ancestor
92036796|NCT02419469|Autonomic Agents|autonomic agents|mesh-ancestor
92036797|NCT02419469|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036798|NCT02419469|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036799|NCT02419469|Glucocorticoids|glucocorticoids|mesh-ancestor
92036800|NCT02419469|Hormones|hormones|mesh-ancestor
92036801|NCT02419469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036802|NCT02419469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92036803|NCT02419469|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92036804|NCT02419469|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92036805|NCT02419469|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92036806|NCT02419469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036807|NCT02419469|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92036808|NCT02419469|Abortifacient Agents|abortifacient agents|mesh-ancestor
92036809|NCT02419469|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92036810|NCT02419469|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036811|NCT02419469|Antimetabolites|antimetabolites|mesh-ancestor
92036812|NCT02419469|Dermatologic Agents|dermatologic agents|mesh-ancestor
92036813|NCT02419469|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92036814|NCT02419469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92036815|NCT02419469|Antiviral Agents|antiviral agents|mesh-ancestor
92036817|NCT02419469|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92036819|NCT02419469|Antimitotic Agents|antimitotic agents|mesh-ancestor
92036820|NCT02419469|Mitosis Modulators|mitosis modulators|mesh-ancestor
92036821|NCT02419469|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036823|NCT04687761|Azacitidine|azacitidine|mesh-list
92036824|NCT04687761|Venetoclax|venetoclax|mesh-list
92013043|NCT05028907|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013045|NCT05028907|Hormones|hormones|mesh-ancestor
92013046|NCT05028907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013047|NCT05028907|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013048|NCT05028907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013049|NCT05028907|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92013050|NCT05028907|Immunologic Factors|immunologic factors|mesh-ancestor
92013051|NCT05028907|Viscosupplements|viscosupplements|mesh-ancestor
92013052|NCT05028907|Protective Agents|protective agents|mesh-ancestor
92013053|NCT05028907|Antioxidants|antioxidants|mesh-ancestor
92013054|NCT05028907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013055|NCT05028907|Vitamins|vitamins|mesh-ancestor
92013056|NCT05028907|Micronutrients|micronutrients|mesh-ancestor
92013057|NCT05028907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92013058|NCT05028907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013059|NCT05028907|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92013060|NCT05028907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036825|NCT04687761|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92036826|NCT04687761|Antimetabolites|antimetabolites|mesh-ancestor
92036827|NCT04687761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036828|NCT04687761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036829|NCT04687761|Antiviral Agents|antiviral agents|mesh-ancestor
92036830|NCT04687761|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036831|NCT04687761|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036832|NCT04687761|Immunologic Factors|immunologic factors|mesh-ancestor
92036833|NCT04687761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036834|NCT04687761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036835|NCT02419313|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92036836|NCT02419313|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92036837|NCT02419313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036838|NCT02419313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036839|NCT02419313|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92036840|NCT02419313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036841|NCT02419313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036842|NCT02419313|Cholinergic Agents|cholinergic agents|mesh-ancestor
92036843|NCT02419313|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036844|NCT04730583|Deoxycholic Acid|deoxycholic acid|mesh-list
92036845|NCT04730583|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92036846|NCT04730583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036847|NCT04730193|Caffeine|caffeine|mesh-list
92036848|NCT04730193|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92036849|NCT04730193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036850|NCT04730193|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92036851|NCT04730193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036852|NCT04730193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036853|NCT04730193|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92036854|NCT04730193|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92036855|NCT04730193|Purinergic Agents|purinergic agents|mesh-ancestor
92036856|NCT04730193|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036857|NCT02088957|Phenytoin|phenytoin|mesh-list
92036858|NCT02088957|Brivaracetam|brivaracetam|mesh-list
92036859|NCT02088957|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92036860|NCT02088957|Anticonvulsants|anticonvulsants|mesh-ancestor
92013061|NCT05028907|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92013062|NCT05028907|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92013063|NCT05028907|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92013064|NCT05028907|Sympathomimetics|sympathomimetics|mesh-ancestor
92013065|NCT05028907|Nasal Decongestants|nasal decongestants|mesh-ancestor
92013066|NCT05028907|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92013067|NCT05028907|Respiratory System Agents|respiratory system agents|mesh-ancestor
92013069|NCT05028049|Remifentanil|remifentanil|mesh-list
92013071|NCT05028049|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92013072|NCT05028049|Narcotics|narcotics|mesh-ancestor
92013073|NCT05028049|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013074|NCT05028049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013075|NCT05028049|Analgesics|analgesics|mesh-ancestor
92013076|NCT05028049|Sensory System Agents|sensory system agents|mesh-ancestor
92013077|NCT05028049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013078|NCT05028049|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92013079|NCT05028049|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013080|NCT05028049|Anesthetics, General|anesthetics, general|mesh-ancestor
92013081|NCT05028049|Anesthetics|anesthetics|mesh-ancestor
92013082|NCT05023915|Dexamethasone|dexamethasone|mesh-list
92013083|NCT05023915|Glycyrrhizic Acid|glycyrrhizic acid|mesh-list
92036861|NCT02088957|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92036862|NCT02088957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92036863|NCT02088957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036864|NCT02088957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036865|NCT02088957|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92036866|NCT02088957|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92036867|NCT02088177|Naltrexone|naltrexone|mesh-list
92036868|NCT02088177|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92036869|NCT02088177|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92036870|NCT02088177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036871|NCT02088177|Sensory System Agents|sensory system agents|mesh-ancestor
92036872|NCT02088177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036873|NCT02030535|Tiotropium Bromide|tiotropium bromide|mesh-list
92036874|NCT02030535|Olodaterol|olodaterol|mesh-list
92036875|NCT02030535|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92036876|NCT02030535|Autonomic Agents|autonomic agents|mesh-ancestor
92036877|NCT02030535|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036878|NCT02030535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036879|NCT02030535|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92036880|NCT02030535|Respiratory System Agents|respiratory system agents|mesh-ancestor
92036881|NCT02030535|Parasympatholytics|parasympatholytics|mesh-ancestor
92036882|NCT02030535|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92036883|NCT02030535|Cholinergic Agents|cholinergic agents|mesh-ancestor
92036884|NCT02030535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036885|NCT02030535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036886|NCT02029989|Chrysarobin|chrysarobin|mesh-list
92036887|NCT02029989|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92036888|NCT02029989|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036889|NCT02029989|Analgesics|analgesics|mesh-ancestor
92036890|NCT02029989|Sensory System Agents|sensory system agents|mesh-ancestor
92036891|NCT02029989|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013084|NCT05023915|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013085|NCT05023915|Antiemetics|antiemetics|mesh-ancestor
92013086|NCT05023915|Autonomic Agents|autonomic agents|mesh-ancestor
92013087|NCT05023915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013088|NCT05023915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013089|NCT05023915|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013090|NCT05023915|Glucocorticoids|glucocorticoids|mesh-ancestor
92013091|NCT05023915|Hormones|hormones|mesh-ancestor
92013092|NCT05023915|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92036892|NCT02029989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036893|NCT02029989|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036894|NCT02029989|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036896|NCT02048241|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036897|NCT02048241|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92036898|NCT02048241|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92036899|NCT02048241|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92036900|NCT02048241|Adrenergic Agents|adrenergic agents|mesh-ancestor
92036901|NCT02048241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036902|NCT02048241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036903|NCT02048241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036905|NCT02087943|Apremilast|apremilast|mesh-list
92036906|NCT02087943|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92036907|NCT02087943|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036909|NCT02087943|Sensory System Agents|sensory system agents|mesh-ancestor
92036910|NCT02087943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036911|NCT02087943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036912|NCT02087943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92036913|NCT02087943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92036914|NCT02087943|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92036915|NCT02087943|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92036916|NCT02087943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036917|NCT02087943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036918|NCT02087943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036919|NCT02087943|Immunologic Factors|immunologic factors|mesh-ancestor
92036920|NCT02087943|Leprostatic Agents|leprostatic agents|mesh-ancestor
92036921|NCT02087943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92036922|NCT02087943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036923|NCT02087943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92036924|NCT02087943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92036925|NCT02087943|Growth Substances|growth substances|mesh-ancestor
92036926|NCT02087943|Growth Inhibitors|growth inhibitors|mesh-ancestor
92036927|NCT02087943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036928|NCT04685811|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92036929|NCT04685811|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92036930|NCT04685811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036931|NCT04709211|Bupivacaine|bupivacaine|mesh-list
92036932|NCT04709211|Anesthetics, Local|anesthetics, local|mesh-ancestor
92036933|NCT04709211|Anesthetics|anesthetics|mesh-ancestor
92036934|NCT04709211|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036935|NCT04709211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036936|NCT04709211|Sensory System Agents|sensory system agents|mesh-ancestor
92036937|NCT04709211|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036938|NCT02443883|Ramucirumab|ramucirumab|mesh-list
92036939|NCT02443883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036940|NCT02087241|Carboplatin|carboplatin|mesh-list
92036941|NCT02087241|Pemetrexed|pemetrexed|mesh-list
92036942|NCT02087241|Adavosertib|adavosertib|mesh-list
92036943|NCT02087241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036944|NCT02087241|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036945|NCT02087241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036946|NCT02087241|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92036947|NCT02087241|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92036948|NCT02087085|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92013093|NCT05023915|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013094|NCT05023915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013096|NCT05027581|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92013097|NCT05027581|Immunologic Factors|immunologic factors|mesh-ancestor
92013098|NCT05027581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013099|NCT05027581|Viscosupplements|viscosupplements|mesh-ancestor
92013100|NCT05027581|Protective Agents|protective agents|mesh-ancestor
92013101|NCT05027191|Sevoflurane|sevoflurane|mesh-list
92013102|NCT05027191|Desflurane|desflurane|mesh-list
92013103|NCT05027191|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92013104|NCT05027191|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92013105|NCT05027191|Anesthetics, General|anesthetics, general|mesh-ancestor
92013106|NCT05027191|Anesthetics|anesthetics|mesh-ancestor
92013107|NCT05027191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013108|NCT05027191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013109|NCT03094507|Dolutegravir|dolutegravir|mesh-list
92013110|NCT03094507|Darunavir|darunavir|mesh-list
92013111|NCT03094507|Cobicistat|cobicistat|mesh-list
92013112|NCT03094507|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92013113|NCT03094507|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92013114|NCT03094507|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92013115|NCT03094507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036949|NCT02087085|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036950|NCT02087085|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92036951|NCT02087085|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92036952|NCT02087085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92036953|NCT02087085|Adrenergic Agents|adrenergic agents|mesh-ancestor
92036954|NCT02087085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036955|NCT02087085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036956|NCT02087085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036957|NCT04685577|Nefopam|nefopam|mesh-list
92036958|NCT04685577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92036959|NCT04685577|Analgesics|analgesics|mesh-ancestor
92036960|NCT04685577|Sensory System Agents|sensory system agents|mesh-ancestor
92036961|NCT04685577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92036964|NCT02443337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92036965|NCT02443337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036966|NCT02443103|Guanabenz|guanabenz|mesh-list
92036967|NCT02443103|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92036968|NCT02443103|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92036969|NCT02443103|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92036970|NCT02443103|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92036971|NCT02443103|Adrenergic Agents|adrenergic agents|mesh-ancestor
92036972|NCT02443103|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92036973|NCT02443103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036974|NCT02443103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036975|NCT02022657|Tenofovir|tenofovir|mesh-list
92036976|NCT02022657|Emtricitabine|emtricitabine|mesh-list
92036977|NCT02022657|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92036978|NCT02022657|Antiviral Agents|antiviral agents|mesh-ancestor
92013116|NCT03094507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013118|NCT03094507|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92013119|NCT03094507|Antiviral Agents|antiviral agents|mesh-ancestor
92013120|NCT03094507|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013121|NCT03094507|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92013122|NCT03094507|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92013123|NCT03094507|Protease Inhibitors|protease inhibitors|mesh-ancestor
92013124|NCT03094507|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92013125|NCT03094507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92013126|NCT02528253|Tramadol|tramadol|mesh-list
92013127|NCT02528253|Tanezumab|tanezumab|mesh-list
92013128|NCT02528253|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92013129|NCT02528253|Narcotics|narcotics|mesh-ancestor
92013130|NCT02528253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013131|NCT02528253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013132|NCT02528253|Analgesics|analgesics|mesh-ancestor
92013133|NCT02528253|Sensory System Agents|sensory system agents|mesh-ancestor
92013134|NCT02528253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013135|NCT03093103|Empagliflozin|empagliflozin|mesh-list
92036979|NCT02022657|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036980|NCT02022657|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92036981|NCT02022657|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92036982|NCT02022657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036983|NCT02022657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036984|NCT02022657|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92036985|NCT02022657|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92036986|NCT02021643|Sofosbuvir|sofosbuvir|mesh-list
92036987|NCT02021643|Ribavirin|ribavirin|mesh-list
92036988|NCT02021643|Antiviral Agents|antiviral agents|mesh-ancestor
92036989|NCT02021643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036990|NCT02021643|Antimetabolites|antimetabolites|mesh-ancestor
92036991|NCT02021643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036992|NCT02415959|Pancrelipase|pancrelipase|mesh-list
92036993|NCT02415959|Pancreatin|pancreatin|mesh-list
92036994|NCT02415959|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036995|NCT02021331|Cimetidine|cimetidine|mesh-list
92036996|NCT02021331|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92036997|NCT02021331|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92036998|NCT02021331|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92036999|NCT02021331|Histamine Antagonists|histamine antagonists|mesh-ancestor
92037000|NCT02021331|Histamine Agents|histamine agents|mesh-ancestor
92037001|NCT02021331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037002|NCT02021331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037003|NCT02021331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037004|NCT02021331|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92037005|NCT02021331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92037006|NCT02021331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037007|NCT04681833|Vaccines|vaccines|mesh-list
92037008|NCT04681833|Immunologic Factors|immunologic factors|mesh-ancestor
92037009|NCT04681833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037010|NCT02441309|Ifosfamide|ifosfamide|mesh-list
92037011|NCT02441309|Mifamurtide|mifamurtide|mesh-list
92013136|NCT03093103|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92013137|NCT03093103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013138|NCT03093103|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92013139|NCT03093103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013141|NCT03093805|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013142|NCT03093883|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92013143|NCT03093883|Hematinics|hematinics|mesh-ancestor
92013144|NCT05023759|Cannabidiol|cannabidiol|mesh-list
92013145|NCT05023759|Anticonvulsants|anticonvulsants|mesh-ancestor
92013146|NCT01672957|Mycophenolic Acid|mycophenolic acid|mesh-list
92037012|NCT02441309|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92037013|NCT02441309|Alkylating Agents|alkylating agents|mesh-ancestor
92037014|NCT02441309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037015|NCT02441309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037016|NCT02441309|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92037017|NCT02441309|Immunologic Factors|immunologic factors|mesh-ancestor
92037018|NCT02441309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037019|NCT01652729|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92037020|NCT01652729|Exenatide|exenatide|mesh-list
92037021|NCT01652729|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037022|NCT01652729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037023|NCT01652729|Incretins|incretins|mesh-ancestor
92037024|NCT01652729|Hormones|hormones|mesh-ancestor
92037025|NCT01652729|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037026|NCT01652729|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92037027|NCT01652729|Protease Inhibitors|protease inhibitors|mesh-ancestor
92037028|NCT01652729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037029|NCT01652729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037030|NCT01652729|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92037031|NCT02083965|Factor VIII|factor viii|mesh-list
92037032|NCT02083965|Coagulants|coagulants|mesh-ancestor
92037033|NCT04681287|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92037035|NCT04681287|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037037|NCT02438813|Deoxycholic Acid|deoxycholic acid|mesh-list
92037038|NCT02438813|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92037039|NCT02438813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037040|NCT02458469|Buspirone|buspirone|mesh-list
92037041|NCT02458469|Trazodone|trazodone|mesh-list
92037042|NCT02458469|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92037043|NCT02458469|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92037044|NCT02458469|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037045|NCT02458469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037046|NCT02458469|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037047|NCT02458469|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92037048|NCT02458469|Serotonin Agents|serotonin agents|mesh-ancestor
92037049|NCT02458469|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037050|NCT02458469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037051|NCT02458469|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92037052|NCT02458469|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92037053|NCT02458469|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037054|NCT02458469|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92037055|NCT02458469|Antidepressive Agents|antidepressive agents|mesh-ancestor
92037056|NCT01843348|Cyclosporine|cyclosporine|mesh-list
92037057|NCT01843348|Mycophenolic Acid|mycophenolic acid|mesh-list
92037058|NCT01843348|Everolimus|everolimus|mesh-list
92037059|NCT01843348|Tacrolimus|tacrolimus|mesh-list
92037060|NCT01843348|Cyclosporins|cyclosporins|mesh-list
92037061|NCT01843348|Basiliximab|basiliximab|mesh-list
92037062|NCT01843348|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92037063|NCT01843348|Immunologic Factors|immunologic factors|mesh-ancestor
92037064|NCT01843348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013148|NCT01672957|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92013149|NCT01672957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013150|NCT01672957|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92013151|NCT01672957|Antitubercular Agents|antitubercular agents|mesh-ancestor
92013152|NCT01672957|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92013153|NCT01672957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013154|NCT01672957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013155|NCT01672957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013156|NCT01672957|Immunologic Factors|immunologic factors|mesh-ancestor
92013157|NCT01672957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013158|NCT05047393|Vitamin D|vitamin d|mesh-list
92013159|NCT05047393|Vitamins|vitamins|mesh-ancestor
92013160|NCT05047393|Micronutrients|micronutrients|mesh-ancestor
92013161|NCT05047393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013162|NCT05047393|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92013163|NCT05017987|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92013164|NCT05017987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013165|NCT05017987|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92013166|NCT05017987|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92013167|NCT05017987|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92013168|NCT05021887|Fluticasone|fluticasone|mesh-list
92013169|NCT05021887|Xhance|xhance|mesh-list
92013170|NCT05021887|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037065|NCT01843348|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92037066|NCT01843348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037067|NCT01843348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037068|NCT01843348|Antifungal Agents|antifungal agents|mesh-ancestor
92037069|NCT01843348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037070|NCT01843348|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037071|NCT01843348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037072|NCT01843348|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92037073|NCT01843348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92037074|NCT01843348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037075|NCT01843348|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92037076|NCT01843348|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92037077|NCT01843348|Antitubercular Agents|antitubercular agents|mesh-ancestor
92037078|NCT01843348|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92037079|NCT01825876|Warfarin|warfarin|mesh-list
92037080|NCT01825876|Evacetrapib|evacetrapib|mesh-list
92037081|NCT01825876|Anticoagulants|anticoagulants|mesh-ancestor
92037082|NCT01825876|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92037083|NCT01825876|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92037084|NCT01825876|Antimetabolites|antimetabolites|mesh-ancestor
92037085|NCT01825876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037086|NCT01825876|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92037087|NCT01825798|Metformin|metformin|mesh-list
92037088|NCT01825798|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037089|NCT01825798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037090|NCT05370599|Losartan|losartan|mesh-list
92013172|NCT05021887|Autonomic Agents|autonomic agents|mesh-ancestor
92013173|NCT05021887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013174|NCT05021887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013175|NCT05021887|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92013176|NCT05021887|Respiratory System Agents|respiratory system agents|mesh-ancestor
92013177|NCT05021887|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013178|NCT05021887|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92013179|NCT05021731|Rifampin|rifampin|mesh-list
92013180|NCT05021731|Rifapentine|rifapentine|mesh-list
92013181|NCT05021731|Isoniazid|isoniazid|mesh-list
92013182|NCT05021731|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92013183|NCT05021731|Antitubercular Agents|antitubercular agents|mesh-ancestor
92013184|NCT05021731|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92013185|NCT05021731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037091|NCT05370599|Amlodipine|amlodipine|mesh-list
92037092|NCT05370599|Chlorthalidone|chlorthalidone|mesh-list
92037093|NCT05370599|Antihypertensive Agents|antihypertensive agents|mesh-list
92037094|NCT05370599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92037095|NCT05370599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037096|NCT05370599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037097|NCT05370599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92037098|NCT05370599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037099|NCT05370599|Vasodilator Agents|vasodilator agents|mesh-ancestor
92037100|NCT05370599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92037101|NCT05370599|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92037102|NCT05370599|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92037103|NCT05370599|Diuretics|diuretics|mesh-ancestor
92037104|NCT05370599|Natriuretic Agents|natriuretic agents|mesh-ancestor
92037105|NCT05370599|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92037106|NCT02412761|Amlodipine|amlodipine|mesh-list
92037110|NCT02412761|Diuretics|diuretics|mesh-list
92037111|NCT02412761|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-list
92037112|NCT02412761|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92037113|NCT02412761|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92037114|NCT02412761|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92037115|NCT02412761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037116|NCT02412761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92037117|NCT02412761|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037118|NCT02412761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037119|NCT02412761|Vasodilator Agents|vasodilator agents|mesh-ancestor
92037120|NCT02412761|Natriuretic Agents|natriuretic agents|mesh-ancestor
92037121|NCT02412761|Protease Inhibitors|protease inhibitors|mesh-ancestor
92037122|NCT02412761|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92037123|NCT02412761|Protective Agents|protective agents|mesh-ancestor
92037124|NCT01842334|Nicotine|nicotine|mesh-list
92037125|NCT01842334|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92037126|NCT01842334|Autonomic Agents|autonomic agents|mesh-ancestor
92037127|NCT01842334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037128|NCT01842334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037129|NCT01842334|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92037130|NCT01842334|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92037131|NCT01842334|Cholinergic Agents|cholinergic agents|mesh-ancestor
92037132|NCT01842334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037133|NCT01842334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037134|NCT02457611|Sofosbuvir|sofosbuvir|mesh-list
92037135|NCT02457611|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92037136|NCT02457611|Ledipasvir|ledipasvir|mesh-list
92013186|NCT05021731|Leprostatic Agents|leprostatic agents|mesh-ancestor
92013187|NCT05021731|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92013188|NCT05021731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013189|NCT05021731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013190|NCT05021731|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92013191|NCT05021731|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92013192|NCT05021731|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92013193|NCT05021731|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92013194|NCT05021731|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92013195|NCT05021731|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92013196|NCT05021731|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92013197|NCT05021731|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92013198|NCT05021731|Antimetabolites|antimetabolites|mesh-ancestor
92013199|NCT05021731|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92013201|NCT05009953|Fluorouracil|fluorouracil|mesh-list
92013202|NCT05009953|Irinotecan|irinotecan|mesh-list
92013203|NCT05009953|Antimetabolites|antimetabolites|mesh-ancestor
92013204|NCT05009953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013205|NCT05009953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92013206|NCT05009953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013207|NCT05009953|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92013208|NCT05009953|Immunologic Factors|immunologic factors|mesh-ancestor
92013209|NCT05009953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037137|NCT02457611|Antiviral Agents|antiviral agents|mesh-ancestor
92037138|NCT02457611|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037139|NCT02083653|Fluorouracil|fluorouracil|mesh-list
92037140|NCT02083653|Capecitabine|capecitabine|mesh-list
92037141|NCT02083653|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92037142|NCT02083653|Antimetabolites|antimetabolites|mesh-ancestor
92037143|NCT02083653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037144|NCT02083653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92037145|NCT02083653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037146|NCT02083653|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92037147|NCT02083653|Immunologic Factors|immunologic factors|mesh-ancestor
92037148|NCT02083653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037149|NCT02436239|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92037150|NCT02436239|Antidepressive Agents|antidepressive agents|mesh-ancestor
92037151|NCT02436239|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037152|NCT02436239|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92037153|NCT02436239|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92037154|NCT02436239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037155|NCT02436239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037156|NCT02436239|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037157|NCT02436239|Serotonin Agents|serotonin agents|mesh-ancestor
92013210|NCT05009953|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92013211|NCT05009953|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92013212|NCT05009953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013213|NCT05009953|Antidotes|antidotes|mesh-ancestor
92013214|NCT05009953|Protective Agents|protective agents|mesh-ancestor
92013215|NCT05009953|Vitamin B Complex|vitamin b complex|mesh-ancestor
92013217|NCT05009953|Micronutrients|micronutrients|mesh-ancestor
92013218|NCT03079453|Dexamethasone|dexamethasone|mesh-list
92013219|NCT03079453|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013220|NCT03079453|Antiemetics|antiemetics|mesh-ancestor
92013221|NCT03079453|Autonomic Agents|autonomic agents|mesh-ancestor
92013222|NCT03079453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013223|NCT03079453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037158|NCT02436239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037159|NCT02436239|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92037160|NCT02436239|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92037161|NCT02026011|Naltrexone|naltrexone|mesh-list
92037162|NCT02026011|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92037163|NCT02026011|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92037164|NCT02026011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037165|NCT02026011|Sensory System Agents|sensory system agents|mesh-ancestor
92037166|NCT02026011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037167|NCT02456909|Morphine|morphine|mesh-list
92037168|NCT02456909|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92037169|NCT02456909|Narcotics|narcotics|mesh-ancestor
92037170|NCT02456909|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037171|NCT02456909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037172|NCT02456909|Analgesics|analgesics|mesh-ancestor
92037173|NCT02456909|Sensory System Agents|sensory system agents|mesh-ancestor
92037174|NCT02456909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037175|NCT02025621|Simendan|simendan|mesh-list
92037176|NCT02025621|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92037177|NCT02025621|Vasodilator Agents|vasodilator agents|mesh-ancestor
92037178|NCT02025621|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92037187|NCT04729023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037188|NCT04729023|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92037189|NCT04729023|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92037190|NCT04729023|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037191|NCT04729023|GABA Modulators|gaba modulators|mesh-ancestor
92037192|NCT04729023|GABA Agents|gaba agents|mesh-ancestor
92037193|NCT04729023|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037194|NCT04729023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037195|NCT02020941|Dexamethasone|dexamethasone|mesh-list
92037196|NCT02020941|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037197|NCT02020941|Antiemetics|antiemetics|mesh-ancestor
92037198|NCT02020941|Autonomic Agents|autonomic agents|mesh-ancestor
92037199|NCT02020941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037200|NCT02020941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037201|NCT02020941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037202|NCT02020941|Glucocorticoids|glucocorticoids|mesh-ancestor
92037203|NCT02020941|Hormones|hormones|mesh-ancestor
92037204|NCT02020941|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037205|NCT02020941|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92037206|NCT02020941|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037207|NCT01823224|Acetaminophen|acetaminophen|mesh-list
92037208|NCT01823224|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037209|NCT01823224|Analgesics|analgesics|mesh-ancestor
92037210|NCT01823224|Sensory System Agents|sensory system agents|mesh-ancestor
92037211|NCT01823224|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037212|NCT01823224|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037213|NCT01823224|Antipyretics|antipyretics|mesh-ancestor
92037214|NCT01840228|Progesterone|progesterone|mesh-list
92037215|NCT01840228|Progestins|progestins|mesh-ancestor
92013225|NCT03079453|Glucocorticoids|glucocorticoids|mesh-ancestor
92013227|NCT03079453|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013228|NCT03079453|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013229|NCT03079453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013231|NCT05009017|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92013232|NCT05009017|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013233|NCT05009017|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92013234|NCT05009017|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92013235|NCT05009017|Growth Substances|growth substances|mesh-ancestor
92013236|NCT05009017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013237|NCT05009017|Growth Inhibitors|growth inhibitors|mesh-ancestor
92013238|NCT05008939|Sevoflurane|sevoflurane|mesh-list
92013239|NCT05008939|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92037216|NCT01840228|Hormones|hormones|mesh-ancestor
92037217|NCT01840228|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037218|NCT01840228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037220|NCT01823146|Oxytocics|oxytocics|mesh-ancestor
92037221|NCT01823146|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92037222|NCT01823146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037223|NCT02083185|Leuprolide|leuprolide|mesh-list
92037224|NCT02083185|Relugolix|relugolix|mesh-list
92037225|NCT02083185|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92037226|NCT02083185|Fertility Agents|fertility agents|mesh-ancestor
92037227|NCT02083185|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92037228|NCT02083185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037229|NCT02083185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92037230|NCT02083185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037231|NCT02083185|Androgen Antagonists|androgen antagonists|mesh-ancestor
92037232|NCT02083185|Hormone Antagonists|hormone antagonists|mesh-ancestor
92037233|NCT02083185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037234|NCT02412371|Paclitaxel|paclitaxel|mesh-list
92037235|NCT02412371|Carboplatin|carboplatin|mesh-list
92037236|NCT02412371|Veliparib|veliparib|mesh-list
92037237|NCT02412371|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92037238|NCT02412371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037239|NCT02412371|Tubulin Modulators|tubulin modulators|mesh-ancestor
92037240|NCT02412371|Antimitotic Agents|antimitotic agents|mesh-ancestor
92037241|NCT02412371|Mitosis Modulators|mitosis modulators|mesh-ancestor
92037242|NCT02412371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037243|NCT02412371|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92037244|NCT02412371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037245|NCT01822756|Paclitaxel|paclitaxel|mesh-list
92037246|NCT01822756|Gemcitabine|gemcitabine|mesh-list
92037250|NCT01822756|Antimitotic Agents|antimitotic agents|mesh-ancestor
92037251|NCT01822756|Mitosis Modulators|mitosis modulators|mesh-ancestor
92037252|NCT01822756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037253|NCT01822756|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92037254|NCT01822756|Antimetabolites|antimetabolites|mesh-ancestor
92037255|NCT01822678|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92037256|NCT01822678|Anticonvulsants|anticonvulsants|mesh-ancestor
92037257|NCT01822678|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92037258|NCT01822678|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92037259|NCT01822678|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92013240|NCT05008939|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92013241|NCT05008939|Anesthetics, General|anesthetics, general|mesh-ancestor
92013243|NCT05008939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013244|NCT05008939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013245|NCT05008861|Pembrolizumab|pembrolizumab|mesh-list
92013246|NCT05008861|Nivolumab|nivolumab|mesh-list
92013247|NCT05008861|Durvalumab|durvalumab|mesh-list
92013248|NCT05008861|Tislelizumab|tislelizumab|mesh-list
92013249|NCT05008861|Antibodies|antibodies|mesh-list
92013250|NCT05008861|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92013251|NCT05008861|Immunologic Factors|immunologic factors|mesh-ancestor
92037260|NCT01822678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037261|NCT01838590|Sofosbuvir|sofosbuvir|mesh-list
92037262|NCT01838590|Antiviral Agents|antiviral agents|mesh-ancestor
92037263|NCT01838590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037264|NCT01611298|Vaccines|vaccines|mesh-list
92037265|NCT01611298|Immunologic Factors|immunologic factors|mesh-ancestor
92037266|NCT01611298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037267|NCT01822132|Naltrexone|naltrexone|mesh-list
92037268|NCT01822132|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92037269|NCT01822132|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92037270|NCT01822132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037271|NCT01822132|Sensory System Agents|sensory system agents|mesh-ancestor
92037272|NCT01822132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037273|NCT01821898|Budesonide|budesonide|mesh-list
92037274|NCT01821898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037275|NCT01821898|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92037276|NCT01821898|Autonomic Agents|autonomic agents|mesh-ancestor
92037277|NCT01821898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037278|NCT01821898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037279|NCT01821898|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92037280|NCT01821898|Respiratory System Agents|respiratory system agents|mesh-ancestor
92037281|NCT01821898|Glucocorticoids|glucocorticoids|mesh-ancestor
92037282|NCT01821898|Hormones|hormones|mesh-ancestor
92037283|NCT01821898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037284|NCT02411591|Necitumumab|necitumumab|mesh-list
92037285|NCT02411591|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037286|NCT02411591|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037287|NCT02411201|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92037288|NCT02411201|Chelating Agents|chelating agents|mesh-ancestor
92037289|NCT02411201|Sequestering Agents|sequestering agents|mesh-ancestor
92037290|NCT02411201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037291|NCT01838044|Celecoxib|celecoxib|mesh-list
92037292|NCT01838044|Pregabalin|pregabalin|mesh-list
92037293|NCT01838044|Analgesics|analgesics|mesh-ancestor
92037294|NCT01838044|Sensory System Agents|sensory system agents|mesh-ancestor
92037295|NCT01838044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037296|NCT01838044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037297|NCT01838044|Anticonvulsants|anticonvulsants|mesh-ancestor
92037298|NCT01838044|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92037299|NCT01838044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037300|NCT01838044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037301|NCT01838044|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92037302|NCT01838044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92037303|NCT01838044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92037304|NCT01838044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037305|NCT01838044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037306|NCT01838044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92037307|NCT01838044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037308|NCT01838044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037309|NCT01838044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037310|NCT01838044|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92037311|NCT01838044|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92013252|NCT05008861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013253|NCT05008861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92013254|NCT05008861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013255|NCT05008861|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92013256|NCT05008861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013258|NCT05360277|Tislelizumab|tislelizumab|mesh-list
92013259|NCT05360277|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92013260|NCT05360277|Antimetabolites|antimetabolites|mesh-ancestor
92013261|NCT05360277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013262|NCT05360277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013263|NCT05360277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92013264|NCT05016973|Disitamab vedotin|disitamab vedotin|mesh-list
92013265|NCT05016973|Immunoconjugates|immunoconjugates|mesh-ancestor
92013266|NCT05016973|Immunologic Factors|immunologic factors|mesh-ancestor
92013267|NCT05016973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013268|NCT03091699|Nicotine|nicotine|mesh-list
92013269|NCT03091699|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92013270|NCT03091699|Autonomic Agents|autonomic agents|mesh-ancestor
92013271|NCT03091699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013272|NCT03091699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013273|NCT03091699|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92013274|NCT03091699|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92013275|NCT03091699|Cholinergic Agents|cholinergic agents|mesh-ancestor
92013276|NCT03091699|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037312|NCT01838044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037313|NCT02435147|Denosumab|denosumab|mesh-list
92037314|NCT02435147|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92037315|NCT02435147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037320|NCT02435069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037321|NCT04917731|Botulinum Toxins|botulinum toxins|mesh-list
92037322|NCT04917731|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92037323|NCT04917731|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92037324|NCT04917731|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92037325|NCT04917731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037326|NCT04917731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037327|NCT04917731|Cholinergic Agents|cholinergic agents|mesh-ancestor
92037328|NCT04917731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037329|NCT04917731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037330|NCT04917731|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92037331|NCT04917731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037332|NCT01820572|Cyclosporine|cyclosporine|mesh-list
92037333|NCT01820572|Abatacept|abatacept|mesh-list
92037334|NCT01820572|Tacrolimus|tacrolimus|mesh-list
92037335|NCT01820572|Cyclosporins|cyclosporins|mesh-list
92037336|NCT01820572|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92037337|NCT01820572|Immunologic Factors|immunologic factors|mesh-ancestor
92037338|NCT01820572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013277|NCT03091699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013278|NCT05344209|Sargramostim|sargramostim|mesh-list
92013279|NCT05344209|Immunologic Factors|immunologic factors|mesh-ancestor
92013280|NCT05344209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013281|NCT03091543|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92013282|NCT03091543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013283|NCT03091543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013284|NCT03091543|Dopamine Agents|dopamine agents|mesh-ancestor
92013285|NCT03091543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013286|NCT03091543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013287|NCT04253457|Triamcinolone|triamcinolone|mesh-list
92037339|NCT01820572|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92037340|NCT01820572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037341|NCT01820572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037343|NCT01820572|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037344|NCT01820572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037345|NCT01820572|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037346|NCT01820572|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92037347|NCT01820572|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037348|NCT01820572|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037349|NCT01610596|Halobetasol|halobetasol|mesh-list
92037350|NCT01610596|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92037351|NCT01818700|Buprenorphine|buprenorphine|mesh-list
92037352|NCT01818700|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92037353|NCT01818700|Narcotics|narcotics|mesh-ancestor
92037354|NCT01818700|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037355|NCT01818700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037356|NCT01818700|Analgesics|analgesics|mesh-ancestor
92037357|NCT01818700|Sensory System Agents|sensory system agents|mesh-ancestor
92037358|NCT01818700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037359|NCT01818700|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92037360|NCT01817764|Fluticasone|fluticasone|mesh-list
92037361|NCT01817764|Xhance|xhance|mesh-list
92037362|NCT01817764|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92037363|NCT01817764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037364|NCT01817764|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92037365|NCT01817764|Autonomic Agents|autonomic agents|mesh-ancestor
92037366|NCT01817764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037367|NCT01817764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037368|NCT01817764|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92037369|NCT01817764|Respiratory System Agents|respiratory system agents|mesh-ancestor
92037370|NCT01817764|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037371|NCT01817764|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92037372|NCT01817764|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92037373|NCT01817764|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92037374|NCT01817764|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92037375|NCT01817764|Adrenergic Agents|adrenergic agents|mesh-ancestor
92037376|NCT01817764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037377|NCT01817764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037378|NCT04726618|Xenon|xenon|mesh-list
92037379|NCT04726618|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92037380|NCT04726618|Anesthetics, General|anesthetics, general|mesh-ancestor
92037381|NCT04726618|Anesthetics|anesthetics|mesh-ancestor
92037382|NCT04726618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037383|NCT04726618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037384|NCT01817530|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92037385|NCT01817530|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92037386|NCT01817530|Norethindrone|norethindrone|mesh-list
92037387|NCT01817530|Norethindrone Acetate|norethindrone acetate|mesh-list
92037388|NCT01817530|Estradiol|estradiol|mesh-list
92037392|NCT01817530|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037393|NCT01817530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013288|NCT04253457|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013289|NCT04253457|Glucocorticoids|glucocorticoids|mesh-ancestor
92013290|NCT04253457|Hormones|hormones|mesh-ancestor
92013291|NCT04253457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013292|NCT04253457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013293|NCT05380947|Rabeprazole|rabeprazole|mesh-list
92013294|NCT05380947|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92013295|NCT05380947|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013296|NCT05380947|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92037394|NCT01817530|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92037395|NCT01817530|Contraceptive Agents|contraceptive agents|mesh-ancestor
92037396|NCT01817530|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92037397|NCT01817530|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92037398|NCT01817530|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92037399|NCT01817530|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92037400|NCT01817530|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92037401|NCT01816984|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92037402|NCT01816984|Cetuximab|cetuximab|mesh-list
92037403|NCT01816984|Antibodies|antibodies|mesh-list
92037404|NCT01816984|Immunoglobulins|immunoglobulins|mesh-list
92037405|NCT01816984|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92037406|NCT01816984|Immunologic Factors|immunologic factors|mesh-ancestor
92037407|NCT01816984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037408|NCT01816984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037409|NCT01816594|Paclitaxel|paclitaxel|mesh-list
92037410|NCT01816594|Trastuzumab|trastuzumab|mesh-list
92037411|NCT01816594|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92037412|NCT01816594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037413|NCT01816594|Tubulin Modulators|tubulin modulators|mesh-ancestor
92037414|NCT01816594|Antimitotic Agents|antimitotic agents|mesh-ancestor
92037415|NCT01816594|Mitosis Modulators|mitosis modulators|mesh-ancestor
92037416|NCT01816594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037417|NCT01816594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037418|NCT02453711|Liraglutide|liraglutide|mesh-list
92037419|NCT02453711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037420|NCT02453711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037421|NCT02453711|Incretins|incretins|mesh-ancestor
92037422|NCT02453711|Hormones|hormones|mesh-ancestor
92037458|NCT02452463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037423|NCT02453711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037424|NCT02453555|Empagliflozin|empagliflozin|mesh-list
92037425|NCT02453555|Linagliptin|linagliptin|mesh-list
92037426|NCT02453555|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92037427|NCT02453555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037428|NCT02453555|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037429|NCT02453555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037430|NCT02453555|Incretins|incretins|mesh-ancestor
92037431|NCT02453555|Hormones|hormones|mesh-ancestor
92037432|NCT02453555|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037433|NCT02453555|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92037434|NCT02453555|Protease Inhibitors|protease inhibitors|mesh-ancestor
92037435|NCT02453555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037436|NCT02453321|Bupivacaine|bupivacaine|mesh-list
92037437|NCT02453321|Anesthetics, Local|anesthetics, local|mesh-ancestor
92037438|NCT02453321|Anesthetics|anesthetics|mesh-ancestor
92037439|NCT02453321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037440|NCT02453321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037441|NCT02453321|Sensory System Agents|sensory system agents|mesh-ancestor
92037442|NCT02453321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037443|NCT01610284|Fulvestrant|fulvestrant|mesh-list
92037444|NCT01610284|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92037445|NCT01610284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037446|NCT01610284|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92037447|NCT01610284|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92037448|NCT01610284|Hormone Antagonists|hormone antagonists|mesh-ancestor
92037449|NCT01610284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013297|NCT05380947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013298|NCT05380947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013299|NCT02525133|Bupivacaine|bupivacaine|mesh-list
92013300|NCT02525133|Anesthetics, Local|anesthetics, local|mesh-ancestor
92013301|NCT02525133|Anesthetics|anesthetics|mesh-ancestor
92013302|NCT02525133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013303|NCT02525133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013304|NCT02525133|Sensory System Agents|sensory system agents|mesh-ancestor
92013305|NCT02525133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013306|NCT05602311|Anesthetics|anesthetics|mesh-list
92013307|NCT05602311|Anesthetics, General|anesthetics, general|mesh-list
92013308|NCT05602311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013309|NCT05602311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013310|NCT05016349|Tamoxifen|tamoxifen|mesh-list
92013311|NCT05016349|Tocopherols|tocopherols|mesh-list
92013312|NCT05016349|Tretinoin|tretinoin|mesh-list
92013313|NCT05016349|Alitretinoin|alitretinoin|mesh-list
92013314|NCT05016349|Cannabidiol|cannabidiol|mesh-list
92013315|NCT05016349|Isotretinoin|isotretinoin|mesh-list
92013316|NCT05016349|Mifepristone|mifepristone|mesh-list
92013317|NCT05016349|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92013318|NCT05016349|Hormone Antagonists|hormone antagonists|mesh-ancestor
92013319|NCT05016349|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013320|NCT05016349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013321|NCT05016349|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013322|NCT05016349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013323|NCT05016349|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92013324|NCT05016349|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92013325|NCT05016349|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92013326|NCT05016349|Anticonvulsants|anticonvulsants|mesh-ancestor
92013327|NCT05016349|Keratolytic Agents|keratolytic agents|mesh-ancestor
92013340|NCT05016349|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92013341|NCT05016349|Antioxidants|antioxidants|mesh-ancestor
92013342|NCT05016349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013343|NCT05016349|Protective Agents|protective agents|mesh-ancestor
92013344|NCT05016349|Vitamins|vitamins|mesh-ancestor
92013345|NCT05016349|Micronutrients|micronutrients|mesh-ancestor
92013346|NCT05380635|Hypericin|hypericin|mesh-list
92013347|NCT05380635|Antidepressive Agents|antidepressive agents|mesh-ancestor
92013348|NCT05380635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037450|NCT01610284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037451|NCT02452463|Durvalumab|durvalumab|mesh-list
92037452|NCT02452463|Nintedanib|nintedanib|mesh-list
92037453|NCT02452463|Immunoglobulins|immunoglobulins|mesh-list
92037454|NCT02452463|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92037455|NCT02452463|Immunoglobulin G|immunoglobulin g|mesh-list
92037456|NCT02452463|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92037457|NCT02452463|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037459|NCT02452463|Immunologic Factors|immunologic factors|mesh-ancestor
92037460|NCT02452463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037463|NCT02452463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037464|NCT04916327|Antioxidants|antioxidants|mesh-list
92037465|NCT04916327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037466|NCT04916327|Protective Agents|protective agents|mesh-ancestor
92037467|NCT04916327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037468|NCT03628391|Haloperidol|haloperidol|mesh-list
92037469|NCT03628391|Haloperidol decanoate|haloperidol decanoate|mesh-list
92037470|NCT03628391|Antiemetics|antiemetics|mesh-ancestor
92037471|NCT03628391|Autonomic Agents|autonomic agents|mesh-ancestor
92037472|NCT03628391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037473|NCT03628391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037474|NCT03628391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037475|NCT03628391|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92037476|NCT03628391|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92037477|NCT03628391|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037478|NCT03628391|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037479|NCT03628391|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92037480|NCT03628391|Dopamine Agents|dopamine agents|mesh-ancestor
92037481|NCT03628391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037482|NCT03628391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037483|NCT03628391|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92037484|NCT01610206|Gemcitabine|gemcitabine|mesh-list
92037485|NCT01610206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92037486|NCT01610206|Antimetabolites|antimetabolites|mesh-ancestor
92037487|NCT01610206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037488|NCT01610206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037489|NCT01816048|Listerine|listerine|mesh-list
92037490|NCT01816048|Fluorides|fluorides|mesh-list
92037491|NCT01816048|Sodium Fluoride|sodium fluoride|mesh-list
92037492|NCT01816048|Cariostatic Agents|cariostatic agents|mesh-ancestor
92037493|NCT01816048|Protective Agents|protective agents|mesh-ancestor
92037494|NCT01816048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037495|NCT01816048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92037496|NCT01816048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037497|NCT01612858|Metformin|metformin|mesh-list
92037498|NCT01612858|Pioglitazone|pioglitazone|mesh-list
92037499|NCT01612858|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037500|NCT01612858|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037501|NCT01612702|Dexamethasone|dexamethasone|mesh-list
92037502|NCT01612702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037503|NCT01612702|Antiemetics|antiemetics|mesh-ancestor
92037504|NCT01612702|Autonomic Agents|autonomic agents|mesh-ancestor
92037505|NCT01612702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037506|NCT01612702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037507|NCT01612702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037508|NCT01612702|Glucocorticoids|glucocorticoids|mesh-ancestor
92013349|NCT05380635|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013351|NCT05380635|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013352|NCT05380635|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013353|NCT05380635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013354|NCT05380635|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92013355|NCT05380635|Immunologic Factors|immunologic factors|mesh-ancestor
92013356|NCT05380635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013357|NCT05538819|Glimepiride|glimepiride|mesh-list
92013358|NCT05538819|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92013359|NCT05538819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92013360|NCT05538819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013361|NCT05538819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92013362|NCT05538819|Immunologic Factors|immunologic factors|mesh-ancestor
92013363|NCT03079219|Dexamethasone|dexamethasone|mesh-list
92013364|NCT03079219|Dexamethasone acetate|dexamethasone acetate|mesh-list
92013365|NCT03079219|Ondansetron|ondansetron|mesh-list
92013366|NCT03079219|Olanzapine|olanzapine|mesh-list
92013367|NCT03079219|Aprepitant|aprepitant|mesh-list
92013368|NCT03079219|Fosaprepitant|fosaprepitant|mesh-list
92013369|NCT03079219|BB 1101|bb 1101|mesh-list
92013370|NCT03079219|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013371|NCT03079219|Antiemetics|antiemetics|mesh-ancestor
92013372|NCT03079219|Autonomic Agents|autonomic agents|mesh-ancestor
92013373|NCT03079219|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037509|NCT01612702|Hormones|hormones|mesh-ancestor
92037510|NCT01612702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037511|NCT01612702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92037512|NCT01612702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037513|NCT02431559|Doxorubicin|doxorubicin|mesh-list
92037515|NCT02431559|Durvalumab|durvalumab|mesh-list
92037516|NCT02431559|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92037517|NCT02431559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037518|NCT02431559|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92037519|NCT02431559|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92037520|NCT02431559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037521|NCT02431559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037522|NCT02431559|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037523|NCT04926545|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92037524|NCT04926545|Fluorouracil|fluorouracil|mesh-list
92037525|NCT04926545|Irinotecan|irinotecan|mesh-list
92037526|NCT04926545|Antimetabolites|antimetabolites|mesh-ancestor
92037527|NCT04926545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037528|NCT04926545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92037529|NCT04926545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037530|NCT04926545|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92037531|NCT04926545|Immunologic Factors|immunologic factors|mesh-ancestor
92037532|NCT04926545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037535|NCT04926545|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013374|NCT03079219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013375|NCT03079219|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013376|NCT03079219|Glucocorticoids|glucocorticoids|mesh-ancestor
92013377|NCT03079219|Hormones|hormones|mesh-ancestor
92013378|NCT03079219|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013379|NCT03079219|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013380|NCT03079219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013381|NCT03079219|Protease Inhibitors|protease inhibitors|mesh-ancestor
92013382|NCT03079219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013383|NCT03079219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013384|NCT03079219|Antipruritics|antipruritics|mesh-ancestor
92013385|NCT03079219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013386|NCT03079219|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92013387|NCT03079219|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92037536|NCT04926545|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92037537|NCT04926545|Hormone Antagonists|hormone antagonists|mesh-ancestor
92037538|NCT04926545|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037539|NCT04926545|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92037540|NCT04926545|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92037541|NCT04926545|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92037542|NCT01652573|Calcitonin|calcitonin|mesh-list
92037543|NCT01652573|Salmon calcitonin|salmon calcitonin|mesh-list
92037544|NCT01652573|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92037545|NCT01652573|Katacalcin|katacalcin|mesh-list
92037546|NCT01652573|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92037547|NCT01652573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037548|NCT01652573|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92037549|NCT01652573|Vasodilator Agents|vasodilator agents|mesh-ancestor
92037550|NCT02388191|Naproxen|naproxen|mesh-list
92037551|NCT02388191|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92037552|NCT02388191|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037553|NCT02388191|Analgesics|analgesics|mesh-ancestor
92037554|NCT02388191|Sensory System Agents|sensory system agents|mesh-ancestor
92037555|NCT02388191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037556|NCT02388191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037557|NCT02388191|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037558|NCT02388191|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037559|NCT02388191|Gout Suppressants|gout suppressants|mesh-ancestor
92037560|NCT02388191|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92037561|NCT02388191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037562|NCT02388191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037563|NCT01815736|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92037564|NCT01815736|Antiviral Agents|antiviral agents|mesh-ancestor
92037565|NCT01815736|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037566|NCT01815736|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037567|NCT01815736|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037568|NCT02387957|Bevacizumab|bevacizumab|mesh-list
92037569|NCT02387957|Ranibizumab|ranibizumab|mesh-list
92037570|NCT02387957|Aflibercept|aflibercept|mesh-list
92037571|NCT02387957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037572|NCT02387957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037573|NCT02387957|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92037574|NCT02387957|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92037575|NCT02387957|Growth Substances|growth substances|mesh-ancestor
92037576|NCT02387957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037577|NCT02387957|Growth Inhibitors|growth inhibitors|mesh-ancestor
92013388|NCT03079219|Serotonin Agents|serotonin agents|mesh-ancestor
92013389|NCT03079219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013390|NCT03079219|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92013391|NCT03079219|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92013392|NCT03079219|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013393|NCT03079219|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92013394|NCT03079219|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92013395|NCT03079219|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92013396|NCT03079219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92013397|NCT03079219|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92013398|NCT03078829|Leuprolide|leuprolide|mesh-list
92013399|NCT03078829|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92013400|NCT03078829|Fertility Agents|fertility agents|mesh-ancestor
92013401|NCT03078829|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92013402|NCT03078829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013403|NCT03078829|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013404|NCT03078829|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013405|NCT05008237|Docetaxel|docetaxel|mesh-list
92013406|NCT05008237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013407|NCT05008237|Tubulin Modulators|tubulin modulators|mesh-ancestor
92013408|NCT05008237|Antimitotic Agents|antimitotic agents|mesh-ancestor
92013409|NCT05008237|Mitosis Modulators|mitosis modulators|mesh-ancestor
92037578|NCT01815580|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92037579|NCT01815580|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92037580|NCT01815580|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92037581|NCT01815580|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92037582|NCT01815580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037583|NCT01815580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037584|NCT01815580|Antiviral Agents|antiviral agents|mesh-ancestor
92037585|NCT01815580|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037586|NCT01815580|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037587|NCT01815580|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037589|NCT01651403|Antiviral Agents|antiviral agents|mesh-ancestor
92037590|NCT01651403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037591|NCT01651403|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92037592|NCT01651403|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92037593|NCT01651403|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037594|NCT01651403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037595|NCT01651403|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037596|NCT01651403|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037597|NCT01799590|Topiramate|topiramate|mesh-list
92037598|NCT01799590|Anticonvulsants|anticonvulsants|mesh-ancestor
92037599|NCT01799590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037600|NCT01799590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037601|NCT04902131|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92037603|NCT04902131|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92037604|NCT04902131|Fertility Agents|fertility agents|mesh-ancestor
92037605|NCT04902131|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92013410|NCT05008237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013412|NCT05014711|Remifentanil|remifentanil|mesh-list
92013413|NCT05014711|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92013414|NCT05014711|Narcotics|narcotics|mesh-ancestor
92013415|NCT05014711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013416|NCT05014711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013417|NCT05014711|Analgesics|analgesics|mesh-ancestor
92013418|NCT05014711|Sensory System Agents|sensory system agents|mesh-ancestor
92013419|NCT05014711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013420|NCT05014711|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92013421|NCT05014711|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013422|NCT05014711|Anesthetics, General|anesthetics, general|mesh-ancestor
92013423|NCT05014711|Anesthetics|anesthetics|mesh-ancestor
92013424|NCT05018923|Metronidazole|metronidazole|mesh-list
92013425|NCT05018923|Doxycycline|doxycycline|mesh-list
92037606|NCT04902131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037607|NCT01815424|Tofacitinib|tofacitinib|mesh-list
92037608|NCT01815424|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92037609|NCT01815424|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92037610|NCT01815424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037611|NCT01815424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037612|NCT02431247|Tenofovir|tenofovir|mesh-list
92037613|NCT02431247|Emtricitabine|emtricitabine|mesh-list
92037614|NCT02431247|Darunavir|darunavir|mesh-list
92037615|NCT02431247|Cobicistat|cobicistat|mesh-list
92037616|NCT02431247|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92037617|NCT02431247|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92037619|NCT02431247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037620|NCT02431247|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92037621|NCT02431247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92037622|NCT02431247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037623|NCT02431247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037624|NCT02431247|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037625|NCT02431247|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037626|NCT02431247|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92037627|NCT02431247|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92037628|NCT02431247|Protease Inhibitors|protease inhibitors|mesh-ancestor
92037629|NCT02431247|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92037630|NCT02431247|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92037631|NCT01814878|Acetaminophen|acetaminophen|mesh-list
92037632|NCT01814878|Tramadol|tramadol|mesh-list
92037633|NCT01814878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037634|NCT01814878|Analgesics|analgesics|mesh-ancestor
92037635|NCT01814878|Sensory System Agents|sensory system agents|mesh-ancestor
92037636|NCT01814878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037637|NCT01814878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037638|NCT01814878|Antipyretics|antipyretics|mesh-ancestor
92037639|NCT01814878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92037640|NCT01814878|Narcotics|narcotics|mesh-ancestor
92037641|NCT01814878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037642|NCT01814800|Immunoglobulins|immunoglobulins|mesh-list
92037643|NCT01814800|Immunologic Factors|immunologic factors|mesh-ancestor
92037644|NCT01814800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037645|NCT02407223|Ustekinumab|ustekinumab|mesh-list
92037646|NCT02407223|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037647|NCT04602754|Calcium, Dietary|calcium, dietary|mesh-list
92037648|NCT04602754|Empagliflozin|empagliflozin|mesh-list
92037649|NCT04602754|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92013427|NCT05018923|Potassium Citrate|potassium citrate|mesh-list
92013428|NCT05018923|Rabeprazole|rabeprazole|mesh-list
92013430|NCT05018923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013431|NCT05018923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013432|NCT05018923|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92013433|NCT05018923|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92013434|NCT05018923|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92013435|NCT05018923|Antimalarials|antimalarials|mesh-ancestor
92013436|NCT05018923|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92013437|NCT05018923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013438|NCT05018923|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92037651|NCT04602754|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92037652|NCT04602754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037653|NCT04602754|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92037654|NCT04602754|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92037655|NCT04602754|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92037656|NCT04602754|Antimetabolites|antimetabolites|mesh-ancestor
92037657|NCT04602754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037658|NCT04602754|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92037659|NCT04602754|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92037660|NCT04602754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037661|NCT04602754|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92037663|NCT01813474|Olaparib|olaparib|mesh-list
92037664|NCT01813474|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92037665|NCT01813474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037666|NCT01813474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037667|NCT01813474|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037668|NCT01868542|Insulin Detemir|insulin detemir|mesh-list
92037669|NCT01868542|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92037670|NCT01868542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037671|NCT01797094|Botulinum Toxins|botulinum toxins|mesh-list
92037672|NCT01797094|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92037673|NCT01797094|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92037674|NCT01797094|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92037675|NCT01797094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037676|NCT01797094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037691|NCT02383589|Antitubercular Agents|antitubercular agents|mesh-ancestor
92037692|NCT02383589|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92037693|NCT02383589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037695|NCT02383589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037696|NCT01810432|Evacetrapib|evacetrapib|mesh-list
92037697|NCT01810432|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92037698|NCT01810432|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92037699|NCT01810432|Antimetabolites|antimetabolites|mesh-ancestor
92037700|NCT01810432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037701|NCT01810432|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92037702|NCT02404805|Dolutegravir|dolutegravir|mesh-list
92037703|NCT02404805|Simeprevir|simeprevir|mesh-list
92037704|NCT02404805|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92037705|NCT02404805|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92037706|NCT02404805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037707|NCT02404805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037708|NCT02404805|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037709|NCT02404805|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037710|NCT02404805|Antiviral Agents|antiviral agents|mesh-ancestor
92037711|NCT02404805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037712|NCT02404805|Protease Inhibitors|protease inhibitors|mesh-ancestor
92037713|NCT02430311|Paclitaxel|paclitaxel|mesh-list
92013439|NCT05018923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013440|NCT05018923|Antacids|antacids|mesh-ancestor
92013441|NCT05018923|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92013442|NCT05018923|Diuretics|diuretics|mesh-ancestor
92013443|NCT05018923|Natriuretic Agents|natriuretic agents|mesh-ancestor
92013444|NCT05018923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013445|NCT05018923|Expectorants|expectorants|mesh-ancestor
92037714|NCT02430311|Olaparib|olaparib|mesh-list
92037715|NCT02430311|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92037716|NCT02430311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037717|NCT02430311|Tubulin Modulators|tubulin modulators|mesh-ancestor
92037718|NCT02430311|Antimitotic Agents|antimitotic agents|mesh-ancestor
92037719|NCT02430311|Mitosis Modulators|mitosis modulators|mesh-ancestor
92037720|NCT02430311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037721|NCT02430311|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92037722|NCT02430311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037723|NCT02383433|Gemcitabine|gemcitabine|mesh-list
92037724|NCT02383433|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92037725|NCT02383433|Antimetabolites|antimetabolites|mesh-ancestor
92037726|NCT02383433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037727|NCT02383433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037728|NCT02383355|Raltegravir Potassium|raltegravir potassium|mesh-list
92037729|NCT02383355|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037730|NCT02383355|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037731|NCT02383355|Antiviral Agents|antiviral agents|mesh-ancestor
92037732|NCT02383355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037733|NCT02383355|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92037734|NCT02383355|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92037735|NCT02383355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037736|NCT02383355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037749|NCT02379221|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92037750|NCT02379221|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92037751|NCT02379221|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92037752|NCT02379221|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037753|NCT02379221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037754|NCT02379221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92037755|NCT02379221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92037756|NCT02379221|Adrenergic Agents|adrenergic agents|mesh-ancestor
92037757|NCT02379221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037758|NCT02379221|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92037759|NCT02379221|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92037761|NCT02379221|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92037762|NCT02379221|Respiratory System Agents|respiratory system agents|mesh-ancestor
92037763|NCT02379221|Mydriatics|mydriatics|mesh-ancestor
92037764|NCT02379221|Sympathomimetics|sympathomimetics|mesh-ancestor
92037765|NCT02379221|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92037766|NCT02404103|Flunisolide|flunisolide|mesh-list
92037767|NCT02404103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037768|NCT02404103|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92037769|NCT02404103|Respiratory System Agents|respiratory system agents|mesh-ancestor
92037770|NCT02404025|Thymoglobulin|thymoglobulin|mesh-list
92037771|NCT02404025|Immunologic Factors|immunologic factors|mesh-ancestor
92037772|NCT02404025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037773|NCT02404025|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92037774|NCT02403635|Midazolam|midazolam|mesh-list
92037775|NCT02403635|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92037776|NCT02403635|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92037777|NCT02403635|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037778|NCT02403635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037779|NCT02403635|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92037780|NCT02403635|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92037781|NCT02403635|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92037782|NCT02403635|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92037783|NCT02403635|Anesthetics, General|anesthetics, general|mesh-ancestor
92037784|NCT02403635|Anesthetics|anesthetics|mesh-ancestor
92037785|NCT02403635|GABA Modulators|gaba modulators|mesh-ancestor
92037786|NCT02403635|GABA Agents|gaba agents|mesh-ancestor
92037787|NCT02403635|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013447|NCT03086473|Caffeine|caffeine|mesh-list
92013448|NCT03086473|Caffeine citrate|caffeine citrate|mesh-list
92013449|NCT03086473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013450|NCT03086473|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92013451|NCT03086473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013452|NCT03086473|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92013453|NCT03086473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013454|NCT03086473|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92013455|NCT03086473|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92013456|NCT03086473|Purinergic Agents|purinergic agents|mesh-ancestor
92013457|NCT03086473|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013459|NCT03086005|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92013460|NCT03086005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013461|NCT03079141|Eplerenone|eplerenone|mesh-list
92013462|NCT03079141|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92013463|NCT03079141|Hormone Antagonists|hormone antagonists|mesh-ancestor
92013464|NCT03079141|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013465|NCT03079141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013466|NCT03079141|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92013467|NCT03079141|Diuretics|diuretics|mesh-ancestor
92013468|NCT03079141|Natriuretic Agents|natriuretic agents|mesh-ancestor
92013469|NCT03079141|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92013470|NCT03085849|Durvalumab|durvalumab|mesh-list
92037788|NCT02403635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037789|NCT02402933|Glucagon|glucagon|mesh-list
92037790|NCT02402933|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92037791|NCT02402933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037792|NCT02402933|Hormones|hormones|mesh-ancestor
92037793|NCT02402933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037794|NCT02402933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037795|NCT02402933|Incretins|incretins|mesh-ancestor
92037796|NCT01796470|Idelalisib|idelalisib|mesh-list
92037797|NCT01796470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037798|NCT01796470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037799|NCT01796470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037800|NCT04414852|Apatinib|apatinib|mesh-list
92037804|NCT04414852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037805|NCT04415008|Cytarabine|cytarabine|mesh-list
92037806|NCT04415008|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92037807|NCT04415008|Antimetabolites|antimetabolites|mesh-ancestor
92037808|NCT04415008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037809|NCT04415008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013472|NCT03085849|Guadecitabine|guadecitabine|mesh-list
92013473|NCT03085849|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92013474|NCT03085849|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013475|NCT05001529|Antibodies|antibodies|mesh-list
92013476|NCT05001529|Immunologic Factors|immunologic factors|mesh-ancestor
92013477|NCT05001529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013478|NCT05001061|Misoprostol|misoprostol|mesh-list
92013479|NCT05001061|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92013480|NCT05001061|Abortifacient Agents|abortifacient agents|mesh-ancestor
92037810|NCT04415008|Antiviral Agents|antiviral agents|mesh-ancestor
92037812|NCT04415008|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92037813|NCT04415008|Immunologic Factors|immunologic factors|mesh-ancestor
92037814|NCT04415008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037815|NCT01810042|Ranibizumab|ranibizumab|mesh-list
92037816|NCT01810042|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92037817|NCT01810042|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92037818|NCT01810042|Growth Substances|growth substances|mesh-ancestor
92037819|NCT01810042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037820|NCT01810042|Growth Inhibitors|growth inhibitors|mesh-ancestor
92037821|NCT01810042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037822|NCT01808248|Sofosbuvir|sofosbuvir|mesh-list
92037823|NCT01808248|Antiviral Agents|antiviral agents|mesh-ancestor
92037824|NCT01808248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037825|NCT01867294|Doxycycline|doxycycline|mesh-list
92037826|NCT01867294|Hydrocortisone|hydrocortisone|mesh-list
92037827|NCT01867294|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92037828|NCT01867294|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92037829|NCT01867294|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92037830|NCT01867294|Spironolactone|spironolactone|mesh-list
92037831|NCT01867294|Sunscreening Agents|sunscreening agents|mesh-list
92037832|NCT01867294|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037833|NCT01867294|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92037834|NCT01867294|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037835|NCT01867294|Antimalarials|antimalarials|mesh-ancestor
92037836|NCT01867294|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92037837|NCT01867294|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92037838|NCT01867294|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92037839|NCT01867294|Hormone Antagonists|hormone antagonists|mesh-ancestor
92037840|NCT01867294|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037841|NCT01867294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037842|NCT01867294|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92037843|NCT01867294|Diuretics|diuretics|mesh-ancestor
92037844|NCT01867294|Natriuretic Agents|natriuretic agents|mesh-ancestor
92037845|NCT01867294|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92037846|NCT01867294|Protective Agents|protective agents|mesh-ancestor
92037847|NCT01867294|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037848|NCT02423291|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92037849|NCT02423291|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037850|NCT02423291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037851|NCT02423291|Immunotoxins|immunotoxins|mesh-ancestor
92037852|NCT02423291|Immunoconjugates|immunoconjugates|mesh-ancestor
92037853|NCT02423291|Immunologic Factors|immunologic factors|mesh-ancestor
92037854|NCT02423291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037855|NCT02401529|Acetaminophen|acetaminophen|mesh-list
92037856|NCT02401529|Dexamethasone|dexamethasone|mesh-list
92037858|NCT02401529|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037859|NCT02401529|Antiemetics|antiemetics|mesh-ancestor
92037860|NCT02401529|Autonomic Agents|autonomic agents|mesh-ancestor
92037861|NCT02401529|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037862|NCT02401529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037863|NCT02401529|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037864|NCT02401529|Glucocorticoids|glucocorticoids|mesh-ancestor
92037865|NCT02401529|Hormones|hormones|mesh-ancestor
92037866|NCT02401529|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037867|NCT02401529|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013482|NCT05001061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013483|NCT05001061|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92013484|NCT05001061|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013485|NCT05001061|Oxytocics|oxytocics|mesh-ancestor
92013486|NCT05531955|Pirfenidone|pirfenidone|mesh-list
92013487|NCT05531955|Analgesics|analgesics|mesh-ancestor
92013488|NCT05531955|Sensory System Agents|sensory system agents|mesh-ancestor
92013489|NCT05531955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013490|NCT05531955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013491|NCT05531955|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92013492|NCT05531955|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013493|NCT05531955|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013494|NCT05531955|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92013495|NCT05531955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013496|NCT05339529|Glycine|glycine|mesh-list
92013497|NCT05339529|Thymalfasin|thymalfasin|mesh-list
92013498|NCT05339529|Glycine Agents|glycine agents|mesh-ancestor
92013499|NCT05339529|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013500|NCT05339529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037868|NCT02401529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037869|NCT02401529|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037870|NCT02401529|Analgesics|analgesics|mesh-ancestor
92037871|NCT02401529|Sensory System Agents|sensory system agents|mesh-ancestor
92037872|NCT02401529|Antipyretics|antipyretics|mesh-ancestor
92037873|NCT01866826|Rifaximin|rifaximin|mesh-list
92037874|NCT01866826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92037875|NCT01866826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037879|NCT01865812|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037880|NCT01808092|Meropenem|meropenem|mesh-list
92037881|NCT01808092|Ceftazidime|ceftazidime|mesh-list
92037882|NCT01808092|Avibactam|avibactam|mesh-list
92037883|NCT01808092|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92037884|NCT01808092|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92037885|NCT01808092|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037886|NCT01808092|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92037887|NCT01808092|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037888|NCT01808092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037890|NCT01807234|Sumatriptan|sumatriptan|mesh-list
92037891|NCT01807234|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92037892|NCT01807234|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037893|NCT01807234|Analgesics|analgesics|mesh-ancestor
92037894|NCT01807234|Sensory System Agents|sensory system agents|mesh-ancestor
92037895|NCT01807234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037896|NCT01807234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037897|NCT01807234|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037898|NCT01807234|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037899|NCT01807234|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92037900|NCT01807234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037901|NCT01807234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037902|NCT01807234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92037903|NCT01807234|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92037904|NCT01807234|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92037905|NCT01807234|Serotonin Agents|serotonin agents|mesh-ancestor
92013501|NCT05339529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013502|NCT05339529|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92013503|NCT05339529|Immunologic Factors|immunologic factors|mesh-ancestor
92013504|NCT05006911|Bromfenac|bromfenac|mesh-list
92013505|NCT05006911|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92013506|NCT05006911|Phenylephrine|phenylephrine|mesh-list
92013507|NCT05006911|Oxymetazoline|oxymetazoline|mesh-list
92013508|NCT05006911|Hyaluronic Acid|hyaluronic acid|mesh-list
92013509|NCT05006911|Pilocarpine|pilocarpine|mesh-list
92013510|NCT05006911|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92013511|NCT05006911|Immunologic Factors|immunologic factors|mesh-ancestor
92013512|NCT05006911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037906|NCT01807234|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037907|NCT02421887|Antioxidants|antioxidants|mesh-list
92037908|NCT02421887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037909|NCT02421887|Protective Agents|protective agents|mesh-ancestor
92037910|NCT02421887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037911|NCT01789606|Ibuprofen|ibuprofen|mesh-list
92037912|NCT01789606|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92037913|NCT01789606|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92037914|NCT01789606|Analgesics|analgesics|mesh-ancestor
92037915|NCT01789606|Sensory System Agents|sensory system agents|mesh-ancestor
92037916|NCT01789606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037917|NCT01789606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037918|NCT01789606|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037919|NCT01789606|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037920|NCT01789606|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92037921|NCT01789606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037922|NCT01789606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037923|NCT01788358|Candesartan|candesartan|mesh-list
92037924|NCT01788358|Candesartan cilexetil|candesartan cilexetil|mesh-list
92037925|NCT01788358|Nifedipine|nifedipine|mesh-list
92037926|NCT01788358|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92037927|NCT01788358|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92037928|NCT01788358|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92037929|NCT01788358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037930|NCT01788358|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92037931|NCT01788358|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92037932|NCT01788358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92037933|NCT01788358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037934|NCT01788358|Vasodilator Agents|vasodilator agents|mesh-ancestor
92037935|NCT01788358|Tocolytic Agents|tocolytic agents|mesh-ancestor
92037936|NCT01788358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92037937|NCT01773070|Ritonavir|ritonavir|mesh-list
92037938|NCT01773070|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92037939|NCT01773070|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92037940|NCT01773070|Protease Inhibitors|protease inhibitors|mesh-ancestor
92037941|NCT01773070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037942|NCT01773070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037943|NCT01773070|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92037944|NCT01773070|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92037945|NCT01773070|Antiviral Agents|antiviral agents|mesh-ancestor
92037946|NCT01773070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037947|NCT01773070|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92037952|NCT01772368|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92037953|NCT01772368|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92037954|NCT01772368|Adrenergic Agonists|adrenergic agonists|mesh-list
92037955|NCT01772368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037956|NCT01772368|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92037957|NCT01772368|Autonomic Agents|autonomic agents|mesh-ancestor
92037958|NCT01772368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037959|NCT01772368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037960|NCT01772368|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92013513|NCT05006911|Viscosupplements|viscosupplements|mesh-ancestor
92013514|NCT05006911|Protective Agents|protective agents|mesh-ancestor
92013515|NCT05006911|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92013516|NCT05006911|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92013517|NCT05006911|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92013518|NCT05006911|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92013519|NCT05006911|Adrenergic Agents|adrenergic agents|mesh-ancestor
92013520|NCT05006911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037961|NCT01772368|Respiratory System Agents|respiratory system agents|mesh-ancestor
92037962|NCT01772368|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037963|NCT01772368|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92037964|NCT01772368|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92037965|NCT01772368|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92037966|NCT01772368|Adrenergic Agents|adrenergic agents|mesh-ancestor
92037967|NCT01772368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037968|NCT01772368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037969|NCT01772368|Tocolytic Agents|tocolytic agents|mesh-ancestor
92037970|NCT01772368|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92037971|NCT01772368|Glucocorticoids|glucocorticoids|mesh-ancestor
92037972|NCT01772368|Hormones|hormones|mesh-ancestor
92037973|NCT01772368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037974|NCT01772368|Sympathomimetics|sympathomimetics|mesh-ancestor
92037975|NCT01806298|Hormones|hormones|mesh-list
92037976|NCT01806298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92037977|NCT01806298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037978|NCT01772134|Fluticasone|fluticasone|mesh-list
92037979|NCT01772134|Xhance|xhance|mesh-list
92037980|NCT01772134|Bromides|bromides|mesh-list
92037981|NCT01772134|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92037982|NCT01772134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92037983|NCT01772134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92037984|NCT01772134|Autonomic Agents|autonomic agents|mesh-ancestor
92037985|NCT01772134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037986|NCT01772134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037987|NCT01772134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92037988|NCT01772134|Respiratory System Agents|respiratory system agents|mesh-ancestor
92037989|NCT01772134|Dermatologic Agents|dermatologic agents|mesh-ancestor
92037990|NCT01772134|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92037991|NCT01772134|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92037992|NCT01772134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92037993|NCT01772134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92037994|NCT01772134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92037995|NCT01772134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037996|NCT01772134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037998|NCT02017899|Vaccines|vaccines|mesh-list
92037999|NCT02017899|Immunologic Factors|immunologic factors|mesh-ancestor
92038000|NCT02017899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038001|NCT01993329|Mitomycin|mitomycin|mesh-list
92038002|NCT01993329|Cisplatin|cisplatin|mesh-list
92038003|NCT01993329|Ifosfamide|ifosfamide|mesh-list
92038004|NCT01993329|Mesna|mesna|mesh-list
92038005|NCT01993329|Protective Agents|protective agents|mesh-ancestor
92038006|NCT01993329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038007|NCT01993329|Alkylating Agents|alkylating agents|mesh-ancestor
92038008|NCT01993329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038009|NCT01993329|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92038010|NCT01993329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038011|NCT01993329|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92038012|NCT01993329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038013|NCT01993329|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038014|NCT02016183|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92038015|NCT02016183|Candesartan|candesartan|mesh-list
92038016|NCT02016183|Candesartan cilexetil|candesartan cilexetil|mesh-list
92038017|NCT02016183|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92038018|NCT02016183|Diuretics|diuretics|mesh-ancestor
92038019|NCT02016183|Natriuretic Agents|natriuretic agents|mesh-ancestor
92038020|NCT02016183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013612|NCT05000281|Ibuprofen|ibuprofen|mesh-list
92013521|NCT05006911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013523|NCT05006911|Autonomic Agents|autonomic agents|mesh-ancestor
92013524|NCT05006911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013525|NCT05006911|Nasal Decongestants|nasal decongestants|mesh-ancestor
92013526|NCT05006911|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92013527|NCT05006911|Respiratory System Agents|respiratory system agents|mesh-ancestor
92013528|NCT05006911|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92013530|NCT05006911|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92013531|NCT05006911|Miotics|miotics|mesh-ancestor
92013532|NCT05006911|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92013533|NCT05006911|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92013534|NCT05006911|Cholinergic Agents|cholinergic agents|mesh-ancestor
92013535|NCT05006911|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92013536|NCT05006911|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013537|NCT05006911|Analgesics|analgesics|mesh-ancestor
92013538|NCT05006911|Sensory System Agents|sensory system agents|mesh-ancestor
92013539|NCT05006911|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013540|NCT05006911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92013541|NCT05339295|Levofloxacin|levofloxacin|mesh-list
92013542|NCT05339295|Ofloxacin|ofloxacin|mesh-list
92013543|NCT05339295|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92013544|NCT05339295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013545|NCT05339295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92013546|NCT05339295|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92013547|NCT05339295|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92013548|NCT05339295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013549|NCT05339295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013550|NCT05339295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038024|NCT02016183|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92038025|NCT02016183|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92038027|NCT02421419|Dexamethasone acetate|dexamethasone acetate|mesh-list
92038028|NCT02421419|Lidocaine|lidocaine|mesh-list
92038029|NCT02421419|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92038030|NCT02421419|BB 1101|bb 1101|mesh-list
92038031|NCT02421419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038032|NCT02421419|Antiemetics|antiemetics|mesh-ancestor
92038033|NCT02421419|Autonomic Agents|autonomic agents|mesh-ancestor
92038034|NCT02421419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038035|NCT02421419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038036|NCT02421419|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038037|NCT02421419|Glucocorticoids|glucocorticoids|mesh-ancestor
92038038|NCT02421419|Hormones|hormones|mesh-ancestor
92038039|NCT02421419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013551|NCT05339295|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92013552|NCT05339295|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92013554|NCT02637037|Dapagliflozin|dapagliflozin|mesh-list
92013556|NCT02637037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013557|NCT02637037|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92013558|NCT02637037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013559|NCT05307081|Lubricant Eye Drops|lubricant eye drops|mesh-list
92013560|NCT05307081|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92013561|NCT05307081|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92013562|NCT05306535|Salicylic Acid|salicylic acid|mesh-list
92013563|NCT05306535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013564|NCT05306535|Antifungal Agents|antifungal agents|mesh-ancestor
92013565|NCT05306535|Keratolytic Agents|keratolytic agents|mesh-ancestor
92013566|NCT05306535|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013567|NCT02637895|Vortioxetine|vortioxetine|mesh-list
92013568|NCT02637895|Antidepressive Agents|antidepressive agents|mesh-ancestor
92013569|NCT02637895|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92013570|NCT02637895|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92013571|NCT02637895|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92013572|NCT02637895|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013573|NCT02637895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013574|NCT02637895|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92013575|NCT02637895|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92013576|NCT02637895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92013577|NCT02637895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013578|NCT02637895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013579|NCT02637895|Serotonin Agents|serotonin agents|mesh-ancestor
92013580|NCT02637895|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92013581|NCT02637895|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92013582|NCT02637895|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92013583|NCT02637895|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92013584|NCT05013697|Paclitaxel|paclitaxel|mesh-list
92013585|NCT05013697|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92013586|NCT05013697|Cisplatin|cisplatin|mesh-list
92038040|NCT02421419|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013588|NCT05013697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013589|NCT05013697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92013590|NCT05013697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92013591|NCT05013697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92013592|NCT05013697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013593|NCT05509647|Heparin|heparin|mesh-list
92013594|NCT05509647|Calcium heparin|calcium heparin|mesh-list
92013595|NCT05509647|Anticoagulants|anticoagulants|mesh-ancestor
92013596|NCT05509647|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92013597|NCT05509647|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92013598|NCT05509647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013599|NCT05305911|Dapagliflozin|dapagliflozin|mesh-list
92038041|NCT02421419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038042|NCT02421419|Anesthetics, Local|anesthetics, local|mesh-ancestor
92038043|NCT02421419|Anesthetics|anesthetics|mesh-ancestor
92038044|NCT02421419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038045|NCT02421419|Sensory System Agents|sensory system agents|mesh-ancestor
92038046|NCT02421419|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92038047|NCT02421419|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92038048|NCT02421419|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92038049|NCT02421419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038050|NCT02421419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038051|NCT02421419|Protease Inhibitors|protease inhibitors|mesh-ancestor
92038052|NCT02421419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038053|NCT02420717|Leucovorin|leucovorin|mesh-list
92038054|NCT02420717|Cytarabine|cytarabine|mesh-list
92038055|NCT02420717|Dexamethasone|dexamethasone|mesh-list
92038056|NCT02420717|Dexamethasone acetate|dexamethasone acetate|mesh-list
92038057|NCT02420717|Prednisone|prednisone|mesh-list
92038058|NCT02420717|Cortisone|cortisone|mesh-list
92038059|NCT02420717|Cyclophosphamide|cyclophosphamide|mesh-list
92038060|NCT02420717|Rituximab|rituximab|mesh-list
92038061|NCT02420717|Doxorubicin|doxorubicin|mesh-list
92038062|NCT02420717|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92038063|NCT02420717|Methotrexate|methotrexate|mesh-list
92038064|NCT02420717|Vincristine|vincristine|mesh-list
92038065|NCT02420717|Daunorubicin|daunorubicin|mesh-list
92038066|NCT02420717|Dasatinib|dasatinib|mesh-list
92038067|NCT02420717|Mercaptopurine|mercaptopurine|mesh-list
92038068|NCT02420717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92038069|NCT02420717|Antibodies|antibodies|mesh-list
92038070|NCT02420717|Immunoglobulins|immunoglobulins|mesh-list
92038071|NCT02420717|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92038072|NCT02420717|BB 1101|bb 1101|mesh-list
92038073|NCT02420717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038074|NCT02420717|Immunologic Factors|immunologic factors|mesh-ancestor
92038075|NCT02420717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038076|NCT02420717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038077|NCT02420717|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038078|NCT02420717|Alkylating Agents|alkylating agents|mesh-ancestor
92038079|NCT02420717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038080|NCT02420717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038081|NCT02420717|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92038082|NCT02420717|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038083|NCT02420717|Antiemetics|antiemetics|mesh-ancestor
92038084|NCT02420717|Autonomic Agents|autonomic agents|mesh-ancestor
92038085|NCT02420717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038086|NCT02420717|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038087|NCT02420717|Glucocorticoids|glucocorticoids|mesh-ancestor
92038088|NCT02420717|Hormones|hormones|mesh-ancestor
92038089|NCT02420717|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038090|NCT02420717|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013600|NCT05305911|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92013601|NCT05305911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013603|NCT05305911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013604|NCT05349435|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92013605|NCT05349435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013606|NCT05007223|Doxycycline|doxycycline|mesh-list
92013607|NCT05007223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92013608|NCT05007223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013609|NCT05007223|Antimalarials|antimalarials|mesh-ancestor
92013610|NCT05007223|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92013611|NCT05007223|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92013613|NCT05000281|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92013614|NCT05000281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013615|NCT05000281|Analgesics|analgesics|mesh-ancestor
92013616|NCT05000281|Sensory System Agents|sensory system agents|mesh-ancestor
92013617|NCT05000281|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038091|NCT02420717|Protease Inhibitors|protease inhibitors|mesh-ancestor
92038092|NCT02420717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038093|NCT02420717|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92038095|NCT02420717|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92038096|NCT02420717|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92038097|NCT02420717|Abortifacient Agents|abortifacient agents|mesh-ancestor
92038098|NCT02420717|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92038099|NCT02420717|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92038100|NCT02420717|Antimetabolites|antimetabolites|mesh-ancestor
92038101|NCT02420717|Dermatologic Agents|dermatologic agents|mesh-ancestor
92038102|NCT02420717|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92038103|NCT02420717|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92038104|NCT02420717|Antiviral Agents|antiviral agents|mesh-ancestor
92038105|NCT02420717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038106|NCT02420717|Antidotes|antidotes|mesh-ancestor
92038107|NCT02420717|Protective Agents|protective agents|mesh-ancestor
92038108|NCT02420717|Vitamin B Complex|vitamin b complex|mesh-ancestor
92038109|NCT02420717|Vitamins|vitamins|mesh-ancestor
92038110|NCT02420717|Micronutrients|micronutrients|mesh-ancestor
92038111|NCT02420717|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92038112|NCT02420717|Tubulin Modulators|tubulin modulators|mesh-ancestor
92038113|NCT02420717|Antimitotic Agents|antimitotic agents|mesh-ancestor
92038114|NCT02420717|Mitosis Modulators|mitosis modulators|mesh-ancestor
92038115|NCT02420717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038116|NCT02016105|Adalimumab|adalimumab|mesh-list
92038117|NCT02016105|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92038118|NCT02016105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038119|NCT02016105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038120|NCT02400749|Apremilast|apremilast|mesh-list
92038121|NCT02400749|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92038122|NCT02400749|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92038123|NCT02400749|Analgesics|analgesics|mesh-ancestor
92038124|NCT02400749|Sensory System Agents|sensory system agents|mesh-ancestor
92038125|NCT02400749|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038126|NCT02400749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038127|NCT02400749|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013618|NCT05000281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013620|NCT05000281|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92013621|NCT05000281|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92013622|NCT05000281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013623|NCT05000281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013624|NCT03081949|Selenium|selenium|mesh-list
92013625|NCT03081949|Selenious Acid|selenious acid|mesh-list
92013626|NCT03081949|Sodium Selenite|sodium selenite|mesh-list
92013627|NCT03081949|Antioxidants|antioxidants|mesh-ancestor
92013628|NCT03081949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013629|NCT03081949|Protective Agents|protective agents|mesh-ancestor
92013630|NCT03081949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013631|NCT03081949|Trace Elements|trace elements|mesh-ancestor
92013632|NCT03081949|Micronutrients|micronutrients|mesh-ancestor
92013633|NCT05347173|Dexmedetomidine|dexmedetomidine|mesh-list
92013634|NCT05347173|Nalbuphine|nalbuphine|mesh-list
92013635|NCT05347173|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013636|NCT05347173|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013637|NCT05347173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013638|NCT05347173|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013639|NCT05347173|Analgesics|analgesics|mesh-ancestor
92013640|NCT05347173|Sensory System Agents|sensory system agents|mesh-ancestor
92013641|NCT05347173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013642|NCT05347173|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92038128|NCT02400749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038129|NCT02400749|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92038130|NCT02400749|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92038131|NCT02400749|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038132|NCT02400749|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038133|NCT02420327|Galantamine|galantamine|mesh-list
92038134|NCT02420327|Nicotine|nicotine|mesh-list
92038135|NCT02420327|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92038136|NCT02420327|Autonomic Agents|autonomic agents|mesh-ancestor
92038137|NCT02420327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038138|NCT02420327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038139|NCT02420327|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92038140|NCT02420327|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92038141|NCT02420327|Cholinergic Agents|cholinergic agents|mesh-ancestor
92038142|NCT02420327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038143|NCT02420327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038144|NCT02420327|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92038145|NCT02420327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038146|NCT02420327|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92038147|NCT02420327|Nootropic Agents|nootropic agents|mesh-ancestor
92038148|NCT02374853|Vancomycin|vancomycin|mesh-list
92038149|NCT02374853|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92038150|NCT02374853|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038151|NCT02015793|Adalimumab|adalimumab|mesh-list
92038152|NCT02015793|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92013643|NCT05347173|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92013644|NCT05347173|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92013645|NCT05347173|Adrenergic Agents|adrenergic agents|mesh-ancestor
92013646|NCT05347173|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013647|NCT05347173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013648|NCT05347173|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92013649|NCT05347173|Narcotics|narcotics|mesh-ancestor
92013650|NCT05006287|Warfarin|warfarin|mesh-list
92013651|NCT05006287|Rivaroxaban|rivaroxaban|mesh-list
92013652|NCT05006287|Dabigatran|dabigatran|mesh-list
92013653|NCT05006287|Apixaban|apixaban|mesh-list
92013654|NCT05006287|Anticoagulants|anticoagulants|mesh-list
92013655|NCT05006287|Edoxaban|edoxaban|mesh-list
92013656|NCT05006287|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92013657|NCT05006287|Antithrombins|antithrombins|mesh-ancestor
92013658|NCT05006287|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92013659|NCT05006287|Protease Inhibitors|protease inhibitors|mesh-ancestor
92013660|NCT05006287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013661|NCT05006287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013662|NCT05013151|Castor Oil|castor oil|mesh-list
92038153|NCT02015793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038154|NCT02015793|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038155|NCT02347631|Dipivefrin|dipivefrin|mesh-list
92038156|NCT02347631|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92038157|NCT02347631|Adrenergic Agents|adrenergic agents|mesh-ancestor
92038158|NCT02347631|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038159|NCT02347631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038160|NCT02347631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038161|NCT02015637|Ceftriaxone|ceftriaxone|mesh-list
92038162|NCT02015637|Delafloxacin|delafloxacin|mesh-list
92038163|NCT02015637|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92038164|NCT02015637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038165|NCT02347085|Glycopyrrolate|glycopyrrolate|mesh-list
92038166|NCT02347085|Formoterol Fumarate|formoterol fumarate|mesh-list
92038167|NCT02347085|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92038168|NCT02347085|Autonomic Agents|autonomic agents|mesh-ancestor
92038169|NCT02347085|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038171|NCT02347085|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92038172|NCT02347085|Respiratory System Agents|respiratory system agents|mesh-ancestor
92038173|NCT02347085|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92038174|NCT02347085|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92038175|NCT02347085|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92038176|NCT02347085|Adrenergic Agents|adrenergic agents|mesh-ancestor
92038177|NCT02347085|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038178|NCT02347085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038179|NCT02347085|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92038180|NCT02347085|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92038181|NCT02347085|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92038182|NCT02347085|Cholinergic Agents|cholinergic agents|mesh-ancestor
92038183|NCT04898075|Nicotine|nicotine|mesh-list
92038184|NCT04898075|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92038185|NCT04898075|Autonomic Agents|autonomic agents|mesh-ancestor
92038186|NCT04898075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038187|NCT04898075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038188|NCT04898075|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92038189|NCT04898075|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92038190|NCT04898075|Cholinergic Agents|cholinergic agents|mesh-ancestor
92038191|NCT04898075|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013663|NCT05013151|Cathartics|cathartics|mesh-ancestor
92013664|NCT05013151|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013665|NCT05006209|Calcium|calcium|mesh-list
92013666|NCT05006209|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92013667|NCT05006209|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013668|NCT05335629|Dapagliflozin|dapagliflozin|mesh-list
92013669|NCT05335629|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92013670|NCT05335629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013671|NCT05335629|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92013672|NCT05335629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013673|NCT03076099|Dexmedetomidine|dexmedetomidine|mesh-list
92013674|NCT03076099|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013675|NCT03076099|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013676|NCT03076099|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013677|NCT03076099|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013678|NCT03076099|Analgesics|analgesics|mesh-ancestor
92013679|NCT03076099|Sensory System Agents|sensory system agents|mesh-ancestor
92013680|NCT03076099|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013681|NCT03076099|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92013682|NCT03076099|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92013683|NCT03076099|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92013684|NCT03076099|Adrenergic Agents|adrenergic agents|mesh-ancestor
92013685|NCT03076099|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013686|NCT03076099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013687|NCT05554965|Propofol|propofol|mesh-list
92013688|NCT05554965|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013689|NCT05554965|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013690|NCT05554965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013691|NCT05554965|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013692|NCT05554965|Anesthetics, General|anesthetics, general|mesh-ancestor
92013693|NCT05554965|Anesthetics|anesthetics|mesh-ancestor
92013695|NCT05554419|Azacitidine|azacitidine|mesh-list
92013696|NCT05554419|Daunorubicin|daunorubicin|mesh-list
92013703|NCT05554419|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013704|NCT05554419|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92013705|NCT05554419|Immunologic Factors|immunologic factors|mesh-ancestor
92013706|NCT05554419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013707|NCT05554419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013708|NCT05554419|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92013709|NCT05554419|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92013710|NCT05554419|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92013711|NCT05529147|Antihypertensive Agents|antihypertensive agents|mesh-list
92013712|NCT05331573|Apomorphine|apomorphine|mesh-list
92013713|NCT05331573|Emetics|emetics|mesh-ancestor
92013714|NCT05331573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013715|NCT05331573|Autonomic Agents|autonomic agents|mesh-ancestor
92013716|NCT05331573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013717|NCT05331573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013718|NCT05331573|Dopamine Agonists|dopamine agonists|mesh-ancestor
92013719|NCT05331573|Dopamine Agents|dopamine agents|mesh-ancestor
92013720|NCT05331573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013721|NCT05331573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013722|NCT05260359|Ethanol|ethanol|mesh-list
92013723|NCT05260359|Sunscreening Agents|sunscreening agents|mesh-list
92013724|NCT05260359|Petrolatum|petrolatum|mesh-list
92013725|NCT05260359|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92013726|NCT05260359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013727|NCT05260359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013728|NCT05260359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013729|NCT05260359|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92013730|NCT05260359|Protective Agents|protective agents|mesh-ancestor
92013731|NCT05260359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013732|NCT05260359|Emollients|emollients|mesh-ancestor
92013733|NCT05329155|Heparin|heparin|mesh-list
92013734|NCT05329155|Calcium heparin|calcium heparin|mesh-list
92013735|NCT05329155|Anticoagulants|anticoagulants|mesh-ancestor
92038192|NCT04898075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038193|NCT01621191|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92038194|NCT01621191|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92038195|NCT01621191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92038196|NCT01621191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038197|NCT01621191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038198|NCT01621191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013736|NCT05329155|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92013737|NCT05329155|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92013738|NCT05329155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013740|NCT05294835|Analgesics|analgesics|mesh-ancestor
92013741|NCT05294835|Sensory System Agents|sensory system agents|mesh-ancestor
92013742|NCT05294835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013743|NCT05294835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013744|NCT05294835|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92013745|NCT05294835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013746|NCT05294835|Anesthetics, General|anesthetics, general|mesh-ancestor
92013747|NCT05294835|Anesthetics|anesthetics|mesh-ancestor
92013748|NCT05294835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013749|NCT05294835|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92013750|NCT05294835|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92013751|NCT05294835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038199|NCT01621191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038200|NCT01621191|Analgesics|analgesics|mesh-ancestor
92038201|NCT01621191|Sensory System Agents|sensory system agents|mesh-ancestor
92038202|NCT01621191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038203|NCT01621191|Antidepressive Agents|antidepressive agents|mesh-ancestor
92038204|NCT01621191|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92038205|NCT01621191|Dopamine Agents|dopamine agents|mesh-ancestor
92038206|NCT02343263|Bupivacaine|bupivacaine|mesh-list
92038207|NCT02343263|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92038208|NCT02343263|Anesthetics, Local|anesthetics, local|mesh-ancestor
92038209|NCT02343263|Anesthetics|anesthetics|mesh-ancestor
92038210|NCT02343263|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038211|NCT02343263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038212|NCT02343263|Sensory System Agents|sensory system agents|mesh-ancestor
92038213|NCT02343263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038214|NCT02343263|Hemostatics|hemostatics|mesh-ancestor
92038215|NCT02343263|Coagulants|coagulants|mesh-ancestor
92038216|NCT02342639|Rifaximin|rifaximin|mesh-list
92038217|NCT02342639|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92038218|NCT02342639|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038219|NCT02342639|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038220|NCT01625091|Naltrexone|naltrexone|mesh-list
92038221|NCT01625091|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92038222|NCT01625091|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92038223|NCT01625091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038224|NCT01625091|Sensory System Agents|sensory system agents|mesh-ancestor
92038225|NCT01625091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038226|NCT02396537|Lidocaine|lidocaine|mesh-list
92038227|NCT02396537|Midazolam|midazolam|mesh-list
92038228|NCT02396537|Anesthetics, Local|anesthetics, local|mesh-ancestor
92038229|NCT02396537|Anesthetics|anesthetics|mesh-ancestor
92038230|NCT02396537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038231|NCT02396537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038232|NCT02396537|Sensory System Agents|sensory system agents|mesh-ancestor
92038233|NCT02396537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038234|NCT02396537|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92038235|NCT02396537|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92038236|NCT02396537|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92038237|NCT02396537|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038238|NCT02396537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013752|NCT05294835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013753|NCT02522325|Cocaine|cocaine|mesh-list
92013754|NCT02522325|Phendimetrazine|phendimetrazine|mesh-list
92013755|NCT02522325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92013756|NCT02522325|Anesthetics|anesthetics|mesh-ancestor
92013757|NCT02522325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013758|NCT02522325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013759|NCT02522325|Sensory System Agents|sensory system agents|mesh-ancestor
92013760|NCT02522325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013761|NCT02522325|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92013762|NCT02522325|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92013763|NCT02522325|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92013764|NCT02522325|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92013765|NCT02522325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013766|NCT02522325|Dopamine Agents|dopamine agents|mesh-ancestor
92013767|NCT02522325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013768|NCT02522325|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92013769|NCT05326347|Brexpiprazole|brexpiprazole|mesh-list
92013770|NCT05326347|Serotonin Agents|serotonin agents|mesh-ancestor
92013771|NCT05326347|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013772|NCT05326347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013773|NCT05326347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013774|NCT05326347|Dopamine Agonists|dopamine agonists|mesh-ancestor
92013775|NCT05326347|Dopamine Agents|dopamine agents|mesh-ancestor
92013776|NCT01659021|Ofatumumab|ofatumumab|mesh-list
92013777|NCT01659021|Idelalisib|idelalisib|mesh-list
92013778|NCT01659021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013779|NCT01659021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013780|NCT01659021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013781|NCT05012137|Ropivacaine|ropivacaine|mesh-list
92013782|NCT05012137|Anesthetics, Local|anesthetics, local|mesh-ancestor
92013783|NCT05012137|Anesthetics|anesthetics|mesh-ancestor
92013784|NCT05012137|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013785|NCT05012137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013786|NCT05012137|Sensory System Agents|sensory system agents|mesh-ancestor
92038239|NCT02396537|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92038240|NCT02396537|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013787|NCT05012137|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013788|NCT05325645|Brexpiprazole|brexpiprazole|mesh-list
92013789|NCT05325645|Serotonin Agents|serotonin agents|mesh-ancestor
92013790|NCT05325645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013791|NCT05325645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013792|NCT05325645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013793|NCT05325645|Dopamine Agonists|dopamine agonists|mesh-ancestor
92013794|NCT05325645|Dopamine Agents|dopamine agents|mesh-ancestor
92013795|NCT04925167|Heparin|heparin|mesh-list
92013796|NCT04925167|Calcium heparin|calcium heparin|mesh-list
92013797|NCT04925167|Argatroban|argatroban|mesh-list
92013798|NCT04925167|Anticoagulants|anticoagulants|mesh-ancestor
92013799|NCT04925167|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92013800|NCT04925167|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92013801|NCT04925167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013802|NCT04925167|Antithrombins|antithrombins|mesh-ancestor
92013803|NCT04925167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92013804|NCT04925167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92013805|NCT04925167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013806|NCT04925167|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92013807|NCT05011669|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92013808|NCT05011669|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92013809|NCT05011669|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92013810|NCT05011669|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013811|NCT05011669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013812|NCT05011669|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92013813|NCT05011669|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92013814|NCT05011669|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92013815|NCT05011669|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92013816|NCT05011669|Adrenergic Agents|adrenergic agents|mesh-ancestor
92013817|NCT05011669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013818|NCT05011669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038241|NCT02396537|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92038242|NCT02396537|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92038264|NCT01993017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038265|NCT01993017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038266|NCT01993017|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92038267|NCT01993017|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92038269|NCT01993017|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92038270|NCT01993017|Serotonin Agents|serotonin agents|mesh-ancestor
92038271|NCT01988493|Sorafenib|sorafenib|mesh-list
92013819|NCT05011669|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92013820|NCT05011669|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92013821|NCT05011669|Serotonin Agents|serotonin agents|mesh-ancestor
92013822|NCT05011669|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92013823|NCT05011669|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92013824|NCT05011669|Dopamine Agents|dopamine agents|mesh-ancestor
92013825|NCT02524665|Salicylic Acid|salicylic acid|mesh-list
92013826|NCT02524665|Salicylates|salicylates|mesh-list
92013827|NCT02524665|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92013828|NCT02524665|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013829|NCT02524665|Antifungal Agents|antifungal agents|mesh-ancestor
92013830|NCT02524665|Keratolytic Agents|keratolytic agents|mesh-ancestor
92038272|NCT01988493|Tepotinib|tepotinib|mesh-list
92038273|NCT01988493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038274|NCT01988493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038275|NCT01988493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038276|NCT01988493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038277|NCT02081079|Sofosbuvir|sofosbuvir|mesh-list
92038278|NCT02081079|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92038279|NCT02081079|Ledipasvir|ledipasvir|mesh-list
92038280|NCT02081079|Antiviral Agents|antiviral agents|mesh-ancestor
92038281|NCT02081079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038283|NCT02081001|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038284|NCT02081001|Hormones|hormones|mesh-ancestor
92038285|NCT02081001|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038286|NCT02081001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038287|NCT02080221|Leucovorin|leucovorin|mesh-list
92038288|NCT02080221|Oxaliplatin|oxaliplatin|mesh-list
92038289|NCT02080221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038290|NCT02080221|Antidotes|antidotes|mesh-ancestor
92038291|NCT02080221|Protective Agents|protective agents|mesh-ancestor
92038292|NCT02080221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038293|NCT02080221|Vitamin B Complex|vitamin b complex|mesh-ancestor
92038294|NCT02080221|Vitamins|vitamins|mesh-ancestor
92038295|NCT02080221|Micronutrients|micronutrients|mesh-ancestor
92038296|NCT02014467|Vitamin D|vitamin d|mesh-list
92038297|NCT02014467|Denosumab|denosumab|mesh-list
92038298|NCT02014467|Calcium|calcium|mesh-list
92038300|NCT02014467|Micronutrients|micronutrients|mesh-ancestor
92038301|NCT02014467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038302|NCT02014467|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92038303|NCT02014467|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92038304|NCT02013765|Trastuzumab|trastuzumab|mesh-list
92038305|NCT02013765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038306|NCT02013765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038307|NCT02013609|Brexpiprazole|brexpiprazole|mesh-list
92038308|NCT02013609|Serotonin Agents|serotonin agents|mesh-ancestor
92038309|NCT02013609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038310|NCT02013609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038311|NCT02013609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038312|NCT02013609|Dopamine Agonists|dopamine agonists|mesh-ancestor
92038313|NCT02013609|Dopamine Agents|dopamine agents|mesh-ancestor
92038314|NCT02013531|Brexpiprazole|brexpiprazole|mesh-list
92038315|NCT02013531|Serotonin Agents|serotonin agents|mesh-ancestor
92038316|NCT02013531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038317|NCT02013531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038318|NCT02013531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038319|NCT02013531|Dopamine Agonists|dopamine agonists|mesh-ancestor
92038320|NCT02013531|Dopamine Agents|dopamine agents|mesh-ancestor
92038321|NCT01988103|Thalidomide|thalidomide|mesh-list
92038323|NCT01988103|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92038324|NCT01988103|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92038325|NCT01988103|Analgesics|analgesics|mesh-ancestor
92038326|NCT01988103|Sensory System Agents|sensory system agents|mesh-ancestor
92038327|NCT01988103|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013831|NCT02524665|Dermatologic Agents|dermatologic agents|mesh-ancestor
92013832|NCT02524665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92013833|NCT02524665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013834|NCT02524665|Analgesics|analgesics|mesh-ancestor
92013835|NCT02524665|Sensory System Agents|sensory system agents|mesh-ancestor
92013836|NCT02524665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013837|NCT02524665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013838|NCT02524665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013839|NCT02524665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92013840|NCT02524665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92013841|NCT02524665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013842|NCT02524665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013843|NCT04998253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92013844|NCT04998253|Propofol|propofol|mesh-list
92013845|NCT04998253|Sevoflurane|sevoflurane|mesh-list
92013846|NCT04998253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013847|NCT04998253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013848|NCT04998253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013849|NCT04998253|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013850|NCT04998253|Anesthetics, General|anesthetics, general|mesh-ancestor
92013851|NCT04998253|Anesthetics|anesthetics|mesh-ancestor
92013852|NCT04998253|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92013854|NCT02638129|Naltrexone|naltrexone|mesh-list
92013880|NCT02524275|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92013881|NCT02524275|Antimetabolites|antimetabolites|mesh-ancestor
92013882|NCT03079687|Olaparib|olaparib|mesh-list
92013883|NCT03079687|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92013884|NCT03079687|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013885|NCT03079687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013886|NCT03079687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013888|NCT04997707|Sevoflurane|sevoflurane|mesh-list
92013889|NCT04997707|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013890|NCT04997707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013891|NCT04997707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038535|NCT01735396|Abiraterone Acetate|abiraterone acetate|mesh-list
92038328|NCT01988103|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038329|NCT01988103|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038330|NCT01988103|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038331|NCT01988103|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92038332|NCT01988103|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92038333|NCT01988103|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038334|NCT01988103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038335|NCT01988103|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038336|NCT01988103|Immunologic Factors|immunologic factors|mesh-ancestor
92038337|NCT01988103|Leprostatic Agents|leprostatic agents|mesh-ancestor
92038338|NCT01988103|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92038339|NCT01988103|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038340|NCT01988103|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038341|NCT01988103|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038342|NCT01988103|Growth Substances|growth substances|mesh-ancestor
92038343|NCT01988103|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038344|NCT01988103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038346|NCT02013375|Cyclophosphamide|cyclophosphamide|mesh-list
92038347|NCT02013375|Alemtuzumab|alemtuzumab|mesh-list
92038348|NCT02013375|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038349|NCT02013375|Immunologic Factors|immunologic factors|mesh-ancestor
92038350|NCT02013375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038351|NCT02013375|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038352|NCT02013375|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038353|NCT02013375|Alkylating Agents|alkylating agents|mesh-ancestor
92038354|NCT02013375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038355|NCT02013375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038356|NCT02013375|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92038358|NCT02013375|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038359|NCT02013375|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92038360|NCT02013375|Antifungal Agents|antifungal agents|mesh-ancestor
92038361|NCT02013375|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038362|NCT02079519|Bevacizumab|bevacizumab|mesh-list
92038363|NCT02079519|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038364|NCT02079519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038365|NCT02079519|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038366|NCT02079519|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038367|NCT02079519|Growth Substances|growth substances|mesh-ancestor
92038368|NCT02079519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038369|NCT02079519|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038370|NCT02078817|Ketamine|ketamine|mesh-list
92038371|NCT02078817|Analgesics|analgesics|mesh-ancestor
92038372|NCT02078817|Sensory System Agents|sensory system agents|mesh-ancestor
92038375|NCT02078817|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92038376|NCT02078817|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92038378|NCT02078817|Anesthetics|anesthetics|mesh-ancestor
92038379|NCT02078817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038380|NCT02078817|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92013892|NCT04997707|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013893|NCT04997707|Anesthetics, General|anesthetics, general|mesh-ancestor
92013894|NCT04997707|Anesthetics|anesthetics|mesh-ancestor
92038381|NCT02078817|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92038382|NCT02078817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038383|NCT02078817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038384|NCT02011113|Dexamethasone|dexamethasone|mesh-list
92038385|NCT02011113|Pomalidomide|pomalidomide|mesh-list
92038386|NCT02011113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038387|NCT02011113|Antiemetics|antiemetics|mesh-ancestor
92038388|NCT02011113|Autonomic Agents|autonomic agents|mesh-ancestor
92038389|NCT02011113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038390|NCT02011113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038391|NCT02011113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038392|NCT02011113|Glucocorticoids|glucocorticoids|mesh-ancestor
92038393|NCT02011113|Hormones|hormones|mesh-ancestor
92038394|NCT02011113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038395|NCT02011113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92038396|NCT02011113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038397|NCT02011113|Immunologic Factors|immunologic factors|mesh-ancestor
92038398|NCT02011113|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038399|NCT02011113|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038400|NCT02011113|Growth Substances|growth substances|mesh-ancestor
92038401|NCT02011113|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038402|NCT01807156|Tivozanib|tivozanib|mesh-list
92038403|NCT01807156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038404|NCT01807156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038405|NCT01807156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038406|NCT01987479|Methotrexate|methotrexate|mesh-list
92038407|NCT01987479|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92038408|NCT01987479|Abortifacient Agents|abortifacient agents|mesh-ancestor
92038409|NCT01987479|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92038410|NCT01987479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038411|NCT01987479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92038412|NCT01987479|Antimetabolites|antimetabolites|mesh-ancestor
92038413|NCT01987479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038414|NCT01987479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038415|NCT01987479|Dermatologic Agents|dermatologic agents|mesh-ancestor
92038416|NCT01987479|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038417|NCT01987479|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92038418|NCT01987479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038419|NCT01987479|Immunologic Factors|immunologic factors|mesh-ancestor
92038420|NCT01987479|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038421|NCT01987479|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92038422|NCT01620489|Liraglutide|liraglutide|mesh-list
92038423|NCT01620489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038424|NCT01620489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038425|NCT01620489|Incretins|incretins|mesh-ancestor
92038427|NCT01620489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038428|NCT02010567|Capecitabine|capecitabine|mesh-list
92038429|NCT02010567|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92038430|NCT02010567|Antimetabolites|antimetabolites|mesh-ancestor
92038431|NCT02010567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038432|NCT02010567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038433|NCT01806064|Axitinib|axitinib|mesh-list
92038434|NCT01806064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038435|NCT01806064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038436|NCT01806064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038437|NCT01806064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038438|NCT01787188|Meloxicam|meloxicam|mesh-list
92038439|NCT01787188|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92038440|NCT01787188|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92038441|NCT01787188|Analgesics|analgesics|mesh-ancestor
92038442|NCT01787188|Sensory System Agents|sensory system agents|mesh-ancestor
92038446|NCT01787188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038447|NCT01787188|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92038448|NCT01787188|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92038449|NCT01787188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013895|NCT04997707|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92013896|NCT04997707|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92013897|NCT05010499|Bupivacaine|bupivacaine|mesh-list
92038450|NCT01787188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038451|NCT01787032|Ketoconazole|ketoconazole|mesh-list
92038452|NCT01787032|Voriconazole|voriconazole|mesh-list
92038453|NCT01787032|Antifungal Agents|antifungal agents|mesh-ancestor
92038454|NCT01787032|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038455|NCT01787032|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92038456|NCT01787032|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92038457|NCT01787032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038458|NCT01787032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038459|NCT01787032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92038460|NCT01787032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038461|NCT01787032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038462|NCT01787032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038463|NCT01787032|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92038464|NCT01737268|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92038465|NCT01737268|Antidepressive Agents|antidepressive agents|mesh-ancestor
92038466|NCT01737268|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92038467|NCT01737268|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92038468|NCT01737268|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92038469|NCT01737268|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038470|NCT01737268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038471|NCT01769404|Insulin Glargine|insulin glargine|mesh-list
92038472|NCT01769404|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038473|NCT01769404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038474|NCT01786174|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92038475|NCT01786174|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92038476|NCT01786174|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038601|NCT02370095|Treprostinil|treprostinil|mesh-list
92038477|NCT01786174|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038478|NCT01786174|Immunologic Factors|immunologic factors|mesh-ancestor
92038479|NCT01786174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038481|NCT01768858|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92038482|NCT01768858|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038483|NCT01768858|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038484|NCT01736254|Gemfibrozil|gemfibrozil|mesh-list
92038485|NCT01736254|Evacetrapib|evacetrapib|mesh-list
92038486|NCT01736254|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92038487|NCT01736254|Antimetabolites|antimetabolites|mesh-ancestor
92038488|NCT01736254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038489|NCT01736254|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92038490|NCT01736254|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92038491|NCT01736254|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92038492|NCT01736254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038493|NCT01736254|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92038494|NCT01785472|Olmesartan|olmesartan|mesh-list
92038495|NCT01785472|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92038496|NCT01785472|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92038497|NCT01785472|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92038498|NCT01785472|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92038499|NCT01785472|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92038500|NCT01785472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038501|NCT01785160|Raltegravir Potassium|raltegravir potassium|mesh-list
92038502|NCT01785160|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92038503|NCT01785160|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92038504|NCT01785160|Antiviral Agents|antiviral agents|mesh-ancestor
92038505|NCT01785160|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038506|NCT01785160|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92038507|NCT01785160|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92038508|NCT01785160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038509|NCT01785160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038510|NCT01736176|Levodopa|levodopa|mesh-list
92038511|NCT01736176|Carbidopa|carbidopa|mesh-list
92038513|NCT01736176|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92038514|NCT01736176|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92038515|NCT01736176|Dopamine Agents|dopamine agents|mesh-ancestor
92038516|NCT01736176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013898|NCT05010499|Levobupivacaine|levobupivacaine|mesh-list
92013899|NCT05010499|Anesthetics, Local|anesthetics, local|mesh-ancestor
92013900|NCT05010499|Anesthetics|anesthetics|mesh-ancestor
92013901|NCT05010499|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013902|NCT05010499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013903|NCT05010499|Sensory System Agents|sensory system agents|mesh-ancestor
92013904|NCT05010499|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013905|NCT03075241|Zolpidem|zolpidem|mesh-list
92013906|NCT03075241|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92013907|NCT03075241|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013908|NCT03075241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013909|NCT03075241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013910|NCT03075241|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92013911|NCT03075241|GABA Agonists|gaba agonists|mesh-ancestor
92013912|NCT03075241|GABA Agents|gaba agents|mesh-ancestor
92013913|NCT03075241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92013914|NCT03075241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013915|NCT04994119|Warfarin|warfarin|mesh-list
92013916|NCT04994119|Zamicastat|zamicastat|mesh-list
92013917|NCT04994119|Anticoagulants|anticoagulants|mesh-ancestor
92038517|NCT01736176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038518|NCT01736176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038519|NCT01736176|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92038520|NCT01736176|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038521|NCT01736176|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92038522|NCT01736176|Immunologic Factors|immunologic factors|mesh-ancestor
92038523|NCT01736176|Dopamine Agonists|dopamine agonists|mesh-ancestor
92038525|NCT01735630|Vitamin B Complex|vitamin b complex|mesh-ancestor
92038526|NCT01735630|Vitamins|vitamins|mesh-ancestor
92038527|NCT01735630|Micronutrients|micronutrients|mesh-ancestor
92038528|NCT01735630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038529|NCT04575922|Nivolumab|nivolumab|mesh-list
92038530|NCT04575922|Ipilimumab|ipilimumab|mesh-list
92038531|NCT04575922|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038532|NCT04575922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038533|NCT04575922|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92038534|NCT04575922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038536|NCT01735396|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038537|NCT01735396|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92038538|NCT01735396|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038539|NCT01735396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038540|NCT01735396|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038541|NCT01735396|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038542|NCT01735396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038543|NCT01735396|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92038544|NCT01734850|Busulfan|busulfan|mesh-list
92038545|NCT01734850|Alkylating Agents|alkylating agents|mesh-ancestor
92038546|NCT01734850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038547|NCT01734850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038548|NCT01734850|Immunologic Factors|immunologic factors|mesh-ancestor
92038549|NCT01734850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013918|NCT04994119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013919|NCT04994119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013921|NCT01658943|Oxaliplatin|oxaliplatin|mesh-list
92013922|NCT01658943|Antimetabolites|antimetabolites|mesh-ancestor
92013923|NCT01658943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013924|NCT01658943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92013925|NCT01658943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013926|NCT01658943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92013927|NCT01658943|Immunologic Factors|immunologic factors|mesh-ancestor
92038550|NCT01734850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038551|NCT01734850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038552|NCT01734850|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92038553|NCT01766050|Abatacept|abatacept|mesh-list
92038554|NCT01766050|Losartan|losartan|mesh-list
92038555|NCT01766050|Midazolam|midazolam|mesh-list
92038556|NCT01766050|Dextromethorphan|dextromethorphan|mesh-list
92038557|NCT01766050|Caffeine|caffeine|mesh-list
92038558|NCT01766050|Omeprazole|omeprazole|mesh-list
92038559|NCT01766050|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92038560|NCT01766050|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92038561|NCT01766050|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038562|NCT01766050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038563|NCT01766050|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92038564|NCT01766050|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92038565|NCT01766050|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92038566|NCT01766050|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92038567|NCT01766050|Anesthetics, General|anesthetics, general|mesh-ancestor
92038568|NCT01766050|Anesthetics|anesthetics|mesh-ancestor
92038569|NCT01766050|GABA Modulators|gaba modulators|mesh-ancestor
92038570|NCT01766050|GABA Agents|gaba agents|mesh-ancestor
92038571|NCT01766050|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038572|NCT01766050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038573|NCT01766050|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92038574|NCT01766050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92038575|NCT01766050|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92038576|NCT01766050|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92038577|NCT01766050|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92038578|NCT01766050|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92038579|NCT01766050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038580|NCT01766050|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92038581|NCT01766050|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92038582|NCT01766050|Purinergic Agents|purinergic agents|mesh-ancestor
92038583|NCT01766050|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92038585|NCT01766050|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92038586|NCT01766050|Antitussive Agents|antitussive agents|mesh-ancestor
92038587|NCT01766050|Respiratory System Agents|respiratory system agents|mesh-ancestor
92038588|NCT01766050|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92038589|NCT01766050|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92038590|NCT01766050|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92038591|NCT01766050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038592|NCT01766050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038593|NCT01766050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038594|NCT01766050|Immunologic Factors|immunologic factors|mesh-ancestor
92038595|NCT01766050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038596|NCT02341625|Nivolumab|nivolumab|mesh-list
92038597|NCT02341625|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038598|NCT02341625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038599|NCT02341625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92038600|NCT02341625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038602|NCT02370095|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92038603|NCT02370095|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92038604|NCT01783678|Sofosbuvir|sofosbuvir|mesh-list
92013928|NCT01658943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013929|NCT02600819|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92013930|NCT02600819|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92013931|NCT02600819|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92013932|NCT02600819|Antiviral Agents|antiviral agents|mesh-ancestor
92013933|NCT02600819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92013934|NCT04433533|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92013935|NCT04433533|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92013936|NCT04433533|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92013937|NCT04433533|Antimetabolites|antimetabolites|mesh-ancestor
92013938|NCT04433533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013939|NCT04433533|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92013940|NCT04433533|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92013941|NCT04433533|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92013942|NCT04996459|Tislelizumab|tislelizumab|mesh-list
92013943|NCT04996459|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92013944|NCT04996459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013945|NCT03074773|Dexamethasone|dexamethasone|mesh-list
92013946|NCT03074773|Bupivacaine|bupivacaine|mesh-list
92013947|NCT03074773|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013948|NCT03074773|Antiemetics|antiemetics|mesh-ancestor
92013949|NCT03074773|Autonomic Agents|autonomic agents|mesh-ancestor
92013950|NCT03074773|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013951|NCT03074773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013952|NCT03074773|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92013953|NCT03074773|Glucocorticoids|glucocorticoids|mesh-ancestor
92013954|NCT03074773|Hormones|hormones|mesh-ancestor
92038605|NCT01783678|Antiviral Agents|antiviral agents|mesh-ancestor
92038606|NCT01783678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038607|NCT01734772|Dabigatran|dabigatran|mesh-list
92038608|NCT01734772|Ticagrelor|ticagrelor|mesh-list
92038609|NCT01734772|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92038610|NCT01734772|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92038611|NCT01734772|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92038612|NCT01734772|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92038613|NCT01734772|Purinergic Agents|purinergic agents|mesh-ancestor
92038614|NCT01734772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038615|NCT01734772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038616|NCT01734772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038617|NCT01734772|Antithrombins|antithrombins|mesh-ancestor
92038618|NCT01734772|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92038619|NCT01734772|Protease Inhibitors|protease inhibitors|mesh-ancestor
92038620|NCT01734772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038621|NCT01734772|Anticoagulants|anticoagulants|mesh-ancestor
92038623|NCT02340221|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92038624|NCT02340221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013955|NCT03074773|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92013956|NCT03074773|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92013957|NCT03074773|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92013958|NCT03074773|Anesthetics, Local|anesthetics, local|mesh-ancestor
92013959|NCT03074773|Anesthetics|anesthetics|mesh-ancestor
92013960|NCT03074773|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013961|NCT03074773|Sensory System Agents|sensory system agents|mesh-ancestor
92013962|NCT03077581|Anesthetics|anesthetics|mesh-list
92013963|NCT03077581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013964|NCT03077581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013965|NCT03077503|Fentanyl|fentanyl|mesh-list
92038625|NCT02340221|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92038626|NCT02340221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92038627|NCT02340221|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038628|NCT02340221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038629|NCT02340221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038630|NCT02395055|Adalimumab|adalimumab|mesh-list
92038631|NCT02395055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92038632|NCT02395055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038633|NCT02395055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038634|NCT02369159|Oseltamivir|oseltamivir|mesh-list
92038636|NCT02369159|Antiviral Agents|antiviral agents|mesh-ancestor
92038637|NCT02369159|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038638|NCT02369159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038639|NCT02369159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038640|NCT02394665|Temozolomide|temozolomide|mesh-list
92038641|NCT02394665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038642|NCT02394665|Alkylating Agents|alkylating agents|mesh-ancestor
92038643|NCT02394665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038644|NCT02394665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038645|NCT02367833|Contraceptive Agents|contraceptive agents|mesh-list
92038646|NCT02367833|NuvaRing|nuvaring|mesh-list
92038647|NCT02367833|Contraceptives, Oral|contraceptives, oral|mesh-list
92038648|NCT02367833|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92038649|NCT02367833|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92038650|NCT02367833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038651|NCT02367833|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92038652|NCT02367833|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92038653|NCT02338193|Metformin|metformin|mesh-list
92038654|NCT02338193|Dapagliflozin|dapagliflozin|mesh-list
92038655|NCT02338193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038656|NCT02338193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038657|NCT02338193|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92038661|NCT01783444|Exemestane|exemestane|mesh-list
92038662|NCT01783444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92038663|NCT01783444|Antimetabolites|antimetabolites|mesh-ancestor
92038664|NCT01783444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038665|NCT01783444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038666|NCT01783444|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92038667|NCT01783444|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038668|NCT01783444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038669|NCT01783444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038670|NCT01783444|Immunologic Factors|immunologic factors|mesh-ancestor
92038671|NCT01783444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038672|NCT01783444|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92038673|NCT01783444|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92038674|NCT01783444|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92038675|NCT01783444|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038676|NCT01783444|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038677|NCT02367131|Empagliflozin|empagliflozin|mesh-list
92038678|NCT02367131|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92013967|NCT03077503|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92013968|NCT03077503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92013969|NCT03077503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013970|NCT03077503|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92013971|NCT03077503|Analgesics|analgesics|mesh-ancestor
92013972|NCT03077503|Sensory System Agents|sensory system agents|mesh-ancestor
92013973|NCT03077503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92013974|NCT03077503|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92013975|NCT03077503|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92013976|NCT03077503|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92013977|NCT03077503|Adrenergic Agents|adrenergic agents|mesh-ancestor
92013978|NCT03077503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038679|NCT02367131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038680|NCT02367131|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038681|NCT02367131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038683|NCT01608724|Incretins|incretins|mesh-ancestor
92038684|NCT01608724|Hormones|hormones|mesh-ancestor
92038685|NCT01608724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038686|NCT01608724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038687|NCT01608724|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92038688|NCT01608724|Protease Inhibitors|protease inhibitors|mesh-ancestor
92038689|NCT01608724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038690|NCT01608724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038691|NCT01608724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038692|NCT02366195|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92038693|NCT02366195|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038694|NCT02366195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038696|NCT04905251|Mifepristone|mifepristone|mesh-list
92038697|NCT04905251|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92038698|NCT04905251|Abortifacient Agents|abortifacient agents|mesh-ancestor
92038699|NCT04905251|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92038700|NCT04905251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038701|NCT04905251|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92038702|NCT04905251|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038703|NCT04905251|Oxytocics|oxytocics|mesh-ancestor
92038704|NCT04905251|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92038705|NCT04905251|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92038706|NCT04905251|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92038707|NCT04905251|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92038709|NCT04905251|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92038710|NCT04905251|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92038711|NCT04905251|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038712|NCT04905251|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038713|NCT04905251|Luteolytic Agents|luteolytic agents|mesh-ancestor
92038714|NCT04905251|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92038715|NCT04905251|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92038716|NCT02364947|Nalmefene|nalmefene|mesh-list
92038717|NCT02364947|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92038718|NCT02364947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038719|NCT02364947|Sensory System Agents|sensory system agents|mesh-ancestor
92038720|NCT02364947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038721|NCT02337491|Bevacizumab|bevacizumab|mesh-list
92038722|NCT02337491|Pembrolizumab|pembrolizumab|mesh-list
92038723|NCT02337491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92013979|NCT03077503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92013981|NCT03077503|Narcotics|narcotics|mesh-ancestor
92013982|NCT03077503|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92013983|NCT03077503|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92013984|NCT03077503|Anesthetics, General|anesthetics, general|mesh-ancestor
92013985|NCT03077503|Anesthetics|anesthetics|mesh-ancestor
92013986|NCT05518695|Antibodies, Blocking|antibodies, blocking|mesh-list
92013987|NCT05518695|Immunologic Factors|immunologic factors|mesh-ancestor
92013988|NCT05518695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013990|NCT04136067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92013991|NCT04136067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92013992|NCT03073057|Budesonide|budesonide|mesh-list
92013993|NCT03073057|Formoterol Fumarate|formoterol fumarate|mesh-list
92013994|NCT03073057|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92013995|NCT03073057|Charcoal|charcoal|mesh-list
92013996|NCT03073057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92013997|NCT03073057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92013998|NCT03073057|Autonomic Agents|autonomic agents|mesh-ancestor
92013999|NCT03073057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014000|NCT03073057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014001|NCT03073057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92014002|NCT03073057|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014003|NCT03073057|Glucocorticoids|glucocorticoids|mesh-ancestor
92014004|NCT03073057|Hormones|hormones|mesh-ancestor
92038724|NCT02337491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038725|NCT02337491|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038726|NCT02337491|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038727|NCT02337491|Growth Substances|growth substances|mesh-ancestor
92038728|NCT02337491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038732|NCT01765582|Leucovorin|leucovorin|mesh-list
92038733|NCT01765582|Folic Acid|folic acid|mesh-list
92038734|NCT01765582|Bevacizumab|bevacizumab|mesh-list
92038735|NCT01765582|Fluorouracil|fluorouracil|mesh-list
92038736|NCT01765582|Capecitabine|capecitabine|mesh-list
92038737|NCT01765582|Oxaliplatin|oxaliplatin|mesh-list
92038738|NCT01765582|Irinotecan|irinotecan|mesh-list
92038739|NCT01765582|Levoleucovorin|levoleucovorin|mesh-list
92038740|NCT01765582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038741|NCT01765582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038742|NCT01765582|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038743|NCT01765582|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038744|NCT01765582|Growth Substances|growth substances|mesh-ancestor
92038745|NCT01765582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038746|NCT01765582|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038747|NCT01765582|Antimetabolites|antimetabolites|mesh-ancestor
92038748|NCT01765582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038749|NCT01765582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92014005|NCT03073057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014006|NCT03073057|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92014007|NCT03073057|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92014008|NCT03073057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92014009|NCT03073057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92014010|NCT03073057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014011|NCT03073057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014012|NCT03073057|Antidotes|antidotes|mesh-ancestor
92014013|NCT03073057|Protective Agents|protective agents|mesh-ancestor
92014014|NCT03073369|Ergocalciferols|ergocalciferols|mesh-list
92014015|NCT03073369|Vitamin D|vitamin d|mesh-list
92014016|NCT03073369|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92014017|NCT03073369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014018|NCT03073369|Vitamins|vitamins|mesh-ancestor
92014019|NCT03073369|Micronutrients|micronutrients|mesh-ancestor
92014020|NCT03073369|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92014021|NCT04433611|Lidocaine|lidocaine|mesh-list
92014022|NCT04433611|Anesthetics, Local|anesthetics, local|mesh-ancestor
92014023|NCT04433611|Anesthetics|anesthetics|mesh-ancestor
92014024|NCT04433611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014025|NCT04433611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014026|NCT04433611|Sensory System Agents|sensory system agents|mesh-ancestor
92014027|NCT04433611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014028|NCT04433611|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92014029|NCT04433611|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92038750|NCT01765582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038751|NCT01765582|Immunologic Factors|immunologic factors|mesh-ancestor
92038752|NCT01765582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92038753|NCT01765582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92038754|NCT01765582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038755|NCT01765582|Antidotes|antidotes|mesh-ancestor
92038756|NCT01765582|Protective Agents|protective agents|mesh-ancestor
92038757|NCT01765582|Vitamin B Complex|vitamin b complex|mesh-ancestor
92038758|NCT01765582|Vitamins|vitamins|mesh-ancestor
92038759|NCT01765582|Micronutrients|micronutrients|mesh-ancestor
92038760|NCT01765582|Hematinics|hematinics|mesh-ancestor
92038761|NCT04413838|Nivolumab|nivolumab|mesh-list
92038762|NCT04413838|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038763|NCT04413838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038764|NCT04413838|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92038765|NCT04413838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038766|NCT01649375|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92038767|NCT01649375|Immunologic Factors|immunologic factors|mesh-ancestor
92038768|NCT01649375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038769|NCT01648283|Methadone|methadone|mesh-list
92038770|NCT01648283|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92038771|NCT01648283|Narcotics|narcotics|mesh-ancestor
92038772|NCT01648283|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038773|NCT01648283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014032|NCT04433611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014033|NCT04992481|Fluorides|fluorides|mesh-list
92014034|NCT04992481|Fluorides, Topical|fluorides, topical|mesh-list
92014035|NCT04992481|Cariostatic Agents|cariostatic agents|mesh-ancestor
92014036|NCT04992481|Protective Agents|protective agents|mesh-ancestor
92038774|NCT01648283|Analgesics|analgesics|mesh-ancestor
92038775|NCT01648283|Sensory System Agents|sensory system agents|mesh-ancestor
92038776|NCT01648283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038777|NCT01648283|Antitussive Agents|antitussive agents|mesh-ancestor
92038778|NCT01648283|Respiratory System Agents|respiratory system agents|mesh-ancestor
92038779|NCT01649297|Empagliflozin|empagliflozin|mesh-list
92038780|NCT01649297|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92038781|NCT01649297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038782|NCT01649297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038783|NCT01649297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038785|NCT01648205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92038786|NCT01648205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038787|NCT01648205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038788|NCT02391545|Rituximab|rituximab|mesh-list
92038789|NCT02391545|Obinutuzumab|obinutuzumab|mesh-list
92038790|NCT02391545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038791|NCT02391545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038792|NCT02391545|Immunologic Factors|immunologic factors|mesh-ancestor
92038793|NCT02391545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038794|NCT02391545|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038795|NCT02362451|Vaccines|vaccines|mesh-list
92038796|NCT02362451|Immunologic Factors|immunologic factors|mesh-ancestor
92038797|NCT02362451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038798|NCT01765270|Saxagliptin|saxagliptin|mesh-list
92038799|NCT01765270|Incretins|incretins|mesh-ancestor
92038800|NCT01765270|Hormones|hormones|mesh-ancestor
92038801|NCT01765270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038802|NCT01765270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038803|NCT01765270|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92038805|NCT01765270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038806|NCT01765270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038807|NCT01765270|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038808|NCT01733758|Liraglutide|liraglutide|mesh-list
92038809|NCT01733758|rGLP-1 protein|rglp-1 protein|mesh-list
92038810|NCT01733758|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92038811|NCT01733758|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92038812|NCT01733758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038813|NCT01733758|Incretins|incretins|mesh-ancestor
92038814|NCT01733758|Hormones|hormones|mesh-ancestor
92038815|NCT01733758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038816|NCT01607554|Irinotecan|irinotecan|mesh-list
92038817|NCT01607554|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92038818|NCT01607554|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92038819|NCT01607554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038820|NCT01607554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038821|NCT01607554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038822|NCT01607476|Corticosterone|corticosterone|mesh-list
92038823|NCT01607476|Flutemetamol|flutemetamol|mesh-list
92038824|NCT01607476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038825|NCT01607476|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92038826|NCT01607476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038827|NCT01765192|Montelukast|montelukast|mesh-list
92038828|NCT01765192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92038829|NCT01765192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92038830|NCT01765192|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92038831|NCT01765192|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038832|NCT01765192|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014037|NCT04992481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014038|NCT02597933|Nintedanib|nintedanib|mesh-list
92014039|NCT02597933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014040|NCT02597933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92014041|NCT02597933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038833|NCT01765192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038834|NCT01765192|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92038835|NCT01765192|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92038836|NCT01765192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038837|NCT01733680|Amiloride|amiloride|mesh-list
92038838|NCT01733680|Diuretics|diuretics|mesh-ancestor
92038839|NCT01733680|Natriuretic Agents|natriuretic agents|mesh-ancestor
92038840|NCT01733680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038841|NCT01733680|Acid Sensing Ion Channel Blockers|acid sensing ion channel blockers|mesh-ancestor
92038842|NCT01733680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92038843|NCT01733680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038844|NCT01733680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038845|NCT01733680|Epithelial Sodium Channel Blockers|epithelial sodium channel blockers|mesh-ancestor
92038846|NCT01733680|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92038847|NCT02348216|Cyclophosphamide|cyclophosphamide|mesh-list
92038848|NCT02348216|Fludarabine|fludarabine|mesh-list
92038849|NCT02348216|Axicabtagene ciloleucel|axicabtagene ciloleucel|mesh-list
92038850|NCT02348216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038851|NCT02348216|Immunologic Factors|immunologic factors|mesh-ancestor
92038852|NCT02348216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038853|NCT02348216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038854|NCT02348216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038855|NCT02348216|Alkylating Agents|alkylating agents|mesh-ancestor
92038856|NCT02348216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038857|NCT02348216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038858|NCT02348216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92038859|NCT02348216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038860|NCT04892498|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92038861|NCT04892498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038862|NCT04892498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038863|NCT04892498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038865|NCT04887506|Abiraterone Acetate|abiraterone acetate|mesh-list
92038866|NCT04887506|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038867|NCT04887506|Glucocorticoids|glucocorticoids|mesh-ancestor
92038868|NCT04887506|Hormones|hormones|mesh-ancestor
92038869|NCT04887506|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92038870|NCT04887506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038871|NCT04887506|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92038872|NCT04887506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038873|NCT04887506|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92038874|NCT04887506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038887|NCT02360111|Cyclophosphamide|cyclophosphamide|mesh-list
92038888|NCT02360111|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92038889|NCT02360111|Immunologic Factors|immunologic factors|mesh-ancestor
92038890|NCT02360111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038891|NCT02360111|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92038892|NCT02360111|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92038893|NCT02360111|Alkylating Agents|alkylating agents|mesh-ancestor
92038894|NCT02360111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038895|NCT02360111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038896|NCT02360111|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92038897|NCT02319044|Durvalumab|durvalumab|mesh-list
92038898|NCT02319044|Tremelimumab|tremelimumab|mesh-list
92038899|NCT02319044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92038900|NCT02319044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038901|NCT02319044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038902|NCT02319044|Immunologic Factors|immunologic factors|mesh-ancestor
92038903|NCT02319044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038904|NCT01649765|Belimumab|belimumab|mesh-list
92038905|NCT01649765|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014042|NCT02597933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014043|NCT04911127|Cannabidiol|cannabidiol|mesh-list
92038906|NCT01649765|Immunologic Factors|immunologic factors|mesh-ancestor
92038907|NCT01649765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038908|NCT02317016|Osimertinib|osimertinib|mesh-list
92038909|NCT02317016|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92038910|NCT02317016|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92038911|NCT02317016|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92038912|NCT02317016|Antimetabolites|antimetabolites|mesh-ancestor
92038913|NCT02317016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038914|NCT02317016|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92038915|NCT02317016|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92038916|NCT02317016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038917|NCT02317016|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038918|NCT02317016|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038919|NCT02311478|Copper|copper|mesh-list
92038920|NCT02311478|Contraceptive Agents|contraceptive agents|mesh-list
92038921|NCT02311478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92038922|NCT02311478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038923|NCT02311478|Trace Elements|trace elements|mesh-ancestor
92038924|NCT02311478|Micronutrients|micronutrients|mesh-ancestor
92038925|NCT02281760|Trametinib|trametinib|mesh-list
92038926|NCT02281760|Dabrafenib|dabrafenib|mesh-list
92038927|NCT02281760|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92038928|NCT02281760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038929|NCT02281760|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92038930|NCT02281760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038931|NCT02281760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038932|NCT02281760|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92038933|NCT02281760|Protective Agents|protective agents|mesh-ancestor
92038934|NCT02281760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038935|NCT02281760|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92038938|NCT02390531|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038940|NCT02390531|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038941|NCT02390531|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038942|NCT02390531|Growth Substances|growth substances|mesh-ancestor
92038943|NCT02390531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038944|NCT02390531|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038946|NCT02390219|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92038947|NCT02390219|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038948|NCT02390219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038949|NCT02334215|Methadone|methadone|mesh-list
92038950|NCT02334215|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92038951|NCT02334215|Narcotics|narcotics|mesh-ancestor
92038952|NCT02334215|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038953|NCT02334215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038954|NCT02334215|Analgesics|analgesics|mesh-ancestor
92038955|NCT02334215|Sensory System Agents|sensory system agents|mesh-ancestor
92038956|NCT02334215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038957|NCT02334215|Antitussive Agents|antitussive agents|mesh-ancestor
92038958|NCT02334215|Respiratory System Agents|respiratory system agents|mesh-ancestor
92038959|NCT02359877|Interferons|interferons|mesh-list
92038960|NCT02359877|Interferon-beta|interferon-beta|mesh-list
92038961|NCT02359877|Interferon beta-1a|interferon beta-1a|mesh-list
92038962|NCT02359877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038963|NCT02359877|Antiviral Agents|antiviral agents|mesh-ancestor
92038964|NCT02359877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92038965|NCT02359877|Immunologic Factors|immunologic factors|mesh-ancestor
92038966|NCT02359877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038967|NCT02359877|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92038968|NCT02389829|Diphenhydramine|diphenhydramine|mesh-list
92038969|NCT02389829|Promethazine|promethazine|mesh-list
92038970|NCT02389829|Hydromorphone|hydromorphone|mesh-list
92038971|NCT02389829|Prochlorperazine|prochlorperazine|mesh-list
92038972|NCT02389829|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92038973|NCT02389829|Narcotics|narcotics|mesh-ancestor
92038974|NCT02389829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92038975|NCT02389829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038977|NCT02389829|Sensory System Agents|sensory system agents|mesh-ancestor
92038978|NCT02389829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038979|NCT02389829|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92014044|NCT04911127|Anticonvulsants|anticonvulsants|mesh-ancestor
92014045|NCT04995133|Colistin|colistin|mesh-list
92014046|NCT04995133|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92014047|NCT04995133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014048|NCT04362839|Nivolumab|nivolumab|mesh-list
92014049|NCT04362839|Ipilimumab|ipilimumab|mesh-list
92014050|NCT04362839|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038980|NCT02389829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92038981|NCT02389829|Anesthetics, Local|anesthetics, local|mesh-ancestor
92038982|NCT02389829|Anesthetics|anesthetics|mesh-ancestor
92038983|NCT02389829|Antiemetics|antiemetics|mesh-ancestor
92038984|NCT02389829|Autonomic Agents|autonomic agents|mesh-ancestor
92038985|NCT02389829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038986|NCT02389829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92038987|NCT02389829|Histamine Antagonists|histamine antagonists|mesh-ancestor
92038988|NCT02389829|Histamine Agents|histamine agents|mesh-ancestor
92038989|NCT02389829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038990|NCT02389829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038991|NCT02389829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92038992|NCT02389829|Antipruritics|antipruritics|mesh-ancestor
92038993|NCT02389829|Dermatologic Agents|dermatologic agents|mesh-ancestor
92038994|NCT02389829|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92038995|NCT02389829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92038996|NCT02389829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92038997|NCT02389829|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92038998|NCT02389829|Dopamine Agents|dopamine agents|mesh-ancestor
92038999|NCT02358863|Leucovorin|leucovorin|mesh-list
92039000|NCT02358863|Cisplatin|cisplatin|mesh-list
92039001|NCT02358863|Docetaxel|docetaxel|mesh-list
92039002|NCT02358863|Capecitabine|capecitabine|mesh-list
92039003|NCT02358863|Oxaliplatin|oxaliplatin|mesh-list
92039004|NCT02358863|Irinotecan|irinotecan|mesh-list
92039005|NCT02358863|Epirubicin|epirubicin|mesh-list
92039006|NCT02358863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039007|NCT02358863|Tubulin Modulators|tubulin modulators|mesh-ancestor
92039008|NCT02358863|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039009|NCT02358863|Mitosis Modulators|mitosis modulators|mesh-ancestor
92039010|NCT02358863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039011|NCT02358863|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039012|NCT02358863|Antimetabolites|antimetabolites|mesh-ancestor
92039016|NCT02358863|Antidotes|antidotes|mesh-ancestor
92039017|NCT02358863|Protective Agents|protective agents|mesh-ancestor
92039018|NCT02358863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039019|NCT02358863|Vitamin B Complex|vitamin b complex|mesh-ancestor
92039020|NCT02358863|Vitamins|vitamins|mesh-ancestor
92039021|NCT02358863|Micronutrients|micronutrients|mesh-ancestor
92039022|NCT02358863|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92039023|NCT02358863|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92039024|NCT02358473|Docetaxel|docetaxel|mesh-list
92039025|NCT02358473|Mogamulizumab|mogamulizumab|mesh-list
92039026|NCT02358473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039027|NCT02358473|Tubulin Modulators|tubulin modulators|mesh-ancestor
92039028|NCT02358473|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039029|NCT02358473|Mitosis Modulators|mitosis modulators|mesh-ancestor
92039030|NCT02358473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039031|NCT02357459|Triamcinolone|triamcinolone|mesh-list
92039032|NCT02357459|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92039033|NCT02357459|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92039034|NCT02357459|FX006|fx006|mesh-list
92039035|NCT02357459|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92039036|NCT02357459|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039037|NCT02357459|Glucocorticoids|glucocorticoids|mesh-ancestor
92039038|NCT02357459|Hormones|hormones|mesh-ancestor
92039039|NCT02357459|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039040|NCT02357459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039041|NCT02357459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039042|NCT02357459|Immunologic Factors|immunologic factors|mesh-ancestor
92039043|NCT02357459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039044|NCT02357459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039045|NCT02332889|Decitabine|decitabine|mesh-list
92039046|NCT02332889|Poly ICLC|poly iclc|mesh-list
92039047|NCT02332889|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92014051|NCT04362839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014052|NCT04362839|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92014053|NCT04362839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014054|NCT04360889|Tocopherols|tocopherols|mesh-list
92014055|NCT04360889|Vitamin E|vitamin e|mesh-list
92014056|NCT04360889|Tocotrienols|tocotrienols|mesh-list
92039048|NCT02332889|Antimetabolites|antimetabolites|mesh-ancestor
92039049|NCT02332889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039050|NCT02332889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039051|NCT02332889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039052|NCT02332889|Interferon Inducers|interferon inducers|mesh-ancestor
92039053|NCT02332889|Immunologic Factors|immunologic factors|mesh-ancestor
92039054|NCT02332889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039055|NCT02357147|Pemetrexed|pemetrexed|mesh-list
92039056|NCT02357147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039057|NCT02357147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039058|NCT02357147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039059|NCT02357147|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92039060|NCT02357147|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92039061|NCT02332655|Cannabidiol|cannabidiol|mesh-list
92039062|NCT02332655|Anticonvulsants|anticonvulsants|mesh-ancestor
92039063|NCT02388737|Lansoprazole|lansoprazole|mesh-list
92039064|NCT02388737|Dexlansoprazole|dexlansoprazole|mesh-list
92039065|NCT02388737|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92039066|NCT02388737|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039067|NCT02388737|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92039068|NCT02388737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039069|NCT02388737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039070|NCT02355665|Nicotine|nicotine|mesh-list
92039071|NCT02355665|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92039072|NCT02355665|Autonomic Agents|autonomic agents|mesh-ancestor
92039073|NCT02355665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039074|NCT02355665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039075|NCT02355665|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92039076|NCT02355665|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92039077|NCT02355665|Cholinergic Agents|cholinergic agents|mesh-ancestor
92039078|NCT02355665|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039079|NCT02355665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039080|NCT02010255|Sofosbuvir|sofosbuvir|mesh-list
92039081|NCT02010255|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92039083|NCT02010255|Antiviral Agents|antiviral agents|mesh-ancestor
92039084|NCT02010255|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039085|NCT04666701|Ketorolac|ketorolac|mesh-list
92039086|NCT04666701|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92039102|NCT04666701|Autonomic Agents|autonomic agents|mesh-ancestor
92039103|NCT04666701|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039104|NCT04666701|Mydriatics|mydriatics|mesh-ancestor
92039105|NCT04666701|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92039106|NCT04666701|Cholinergic Agents|cholinergic agents|mesh-ancestor
92039107|NCT04666701|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039108|NCT04666701|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92039109|NCT04666701|Parasympatholytics|parasympatholytics|mesh-ancestor
92039110|NCT02330549|Cenicriviroc|cenicriviroc|mesh-list
92039111|NCT02330549|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92039112|NCT02330549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039113|NCT02330549|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92039114|NCT02330549|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92039115|NCT02330549|Antiviral Agents|antiviral agents|mesh-ancestor
92039116|NCT02330549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039118|NCT01620177|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92039119|NCT01620177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039120|NCT01620177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039121|NCT01620177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039122|NCT01986855|Ertugliflozin|ertugliflozin|mesh-list
92039123|NCT01986855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92039124|NCT01986855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039125|NCT01986855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92039126|NCT01986855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014057|NCT04360889|alpha-Tocopherol|alpha-tocopherol|mesh-list
92014058|NCT04360889|Antioxidants|antioxidants|mesh-ancestor
92014059|NCT04360889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014060|NCT04360889|Protective Agents|protective agents|mesh-ancestor
92039127|NCT02353871|Botulinum Toxins|botulinum toxins|mesh-list
92039128|NCT02353871|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92039129|NCT02353871|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92039130|NCT02353871|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92039131|NCT02353871|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92039132|NCT02353871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039133|NCT02353871|Cholinergic Agents|cholinergic agents|mesh-ancestor
92039134|NCT02353871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039135|NCT02353871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039136|NCT02353871|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92039137|NCT02353871|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039138|NCT04673175|Tazobactam|tazobactam|mesh-list
92039139|NCT04673175|Ceftolozane|ceftolozane|mesh-list
92039140|NCT04673175|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92039141|NCT04673175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92039142|NCT04673175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039143|NCT04673175|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92039144|NCT04673175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039147|NCT02009397|Ipilimumab|ipilimumab|mesh-list
92039148|NCT02009397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039149|NCT02009397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039150|NCT02009397|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92039151|NCT02009397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039152|NCT02312219|Folic Acid|folic acid|mesh-list
92039153|NCT02312219|Methotrexate|methotrexate|mesh-list
92039154|NCT02312219|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92039155|NCT02312219|Abortifacient Agents|abortifacient agents|mesh-ancestor
92039156|NCT02312219|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92039157|NCT02312219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039158|NCT02312219|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039159|NCT02312219|Antimetabolites|antimetabolites|mesh-ancestor
92039160|NCT02312219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039161|NCT02312219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039162|NCT02312219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92039163|NCT02312219|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039164|NCT02312219|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92039165|NCT02312219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039166|NCT02312219|Immunologic Factors|immunologic factors|mesh-ancestor
92039167|NCT02312219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039168|NCT02312219|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92039169|NCT02312219|Hematinics|hematinics|mesh-ancestor
92039170|NCT02312219|Vitamin B Complex|vitamin b complex|mesh-ancestor
92039172|NCT02312219|Micronutrients|micronutrients|mesh-ancestor
92039173|NCT01986231|Glucagon|glucagon|mesh-list
92039174|NCT01986231|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039175|NCT01986231|Hormones|hormones|mesh-ancestor
92039176|NCT01986231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039177|NCT01986231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039178|NCT02312063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92039179|NCT02312063|Glimepiride|glimepiride|mesh-list
92039180|NCT02312063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92039181|NCT02312063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039182|NCT02312063|Incretins|incretins|mesh-ancestor
92039183|NCT02312063|Hormones|hormones|mesh-ancestor
92039184|NCT02312063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039185|NCT02312063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92039186|NCT02312063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92039187|NCT02312063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039188|NCT02312063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039189|NCT02312063|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92039190|NCT02312063|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039191|NCT02312063|Immunologic Factors|immunologic factors|mesh-ancestor
92039192|NCT02353169|Dexmedetomidine|dexmedetomidine|mesh-list
92039193|NCT02353169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92039194|NCT02353169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039195|NCT02353169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014061|NCT04360889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014062|NCT04360889|Vitamins|vitamins|mesh-ancestor
92014063|NCT04360889|Micronutrients|micronutrients|mesh-ancestor
92014064|NCT03072589|Regadenoson|regadenoson|mesh-list
92014065|NCT03072589|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92039196|NCT02353169|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92039197|NCT02353169|Analgesics|analgesics|mesh-ancestor
92039198|NCT02353169|Sensory System Agents|sensory system agents|mesh-ancestor
92039199|NCT02353169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039200|NCT02353169|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92039201|NCT02353169|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92039202|NCT02353169|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92039203|NCT02353169|Adrenergic Agents|adrenergic agents|mesh-ancestor
92039204|NCT02353169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039205|NCT02353169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039206|NCT02009163|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92039207|NCT02009163|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92039208|NCT02009163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039209|NCT02009163|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92039210|NCT02009163|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92039211|NCT02009163|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92039212|NCT02009163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039213|NCT02009163|Dopamine Agents|dopamine agents|mesh-ancestor
92039214|NCT02009163|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039215|NCT01983969|Pyridoxine|pyridoxine|mesh-list
92039221|NCT01983969|Busulfan|busulfan|mesh-list
92039222|NCT01983969|Vorinostat|vorinostat|mesh-list
92039223|NCT01983969|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039224|NCT01983969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039225|NCT01983969|Immunologic Factors|immunologic factors|mesh-ancestor
92039226|NCT01983969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039227|NCT01983969|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039228|NCT01983969|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039229|NCT01983969|Antiemetics|antiemetics|mesh-ancestor
92039230|NCT01983969|Autonomic Agents|autonomic agents|mesh-ancestor
92039231|NCT01983969|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039232|NCT01983969|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039233|NCT01983969|Glucocorticoids|glucocorticoids|mesh-ancestor
92039234|NCT01983969|Hormones|hormones|mesh-ancestor
92039235|NCT01983969|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039236|NCT01983969|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039237|NCT01983969|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039238|NCT01983969|Antimetabolites|antimetabolites|mesh-ancestor
92039239|NCT01983969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039240|NCT01983969|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039241|NCT01983969|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92039242|NCT01983969|Alkylating Agents|alkylating agents|mesh-ancestor
92039243|NCT01983969|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92039244|NCT01983969|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039245|NCT01983969|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92039246|NCT01983969|Vitamin B Complex|vitamin b complex|mesh-ancestor
92039247|NCT01983969|Vitamins|vitamins|mesh-ancestor
92039248|NCT01983969|Micronutrients|micronutrients|mesh-ancestor
92039249|NCT02008773|Valacyclovir|valacyclovir|mesh-list
92039250|NCT02008773|Antiviral Agents|antiviral agents|mesh-ancestor
92039251|NCT02008773|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039252|NCT02257567|Rituximab|rituximab|mesh-list
92039253|NCT02257567|Obinutuzumab|obinutuzumab|mesh-list
92039254|NCT02257567|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92039255|NCT02257567|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92039256|NCT02257567|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92039257|NCT02257567|Immunoconjugates|immunoconjugates|mesh-list
92039258|NCT02257567|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039259|NCT02257567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039260|NCT02257567|Immunologic Factors|immunologic factors|mesh-ancestor
92039261|NCT02257567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039262|NCT02257567|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039263|NCT02257567|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92039264|NCT02257567|Alkylating Agents|alkylating agents|mesh-ancestor
92039265|NCT02257567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014066|NCT03072589|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92014067|NCT03072589|Purinergic Agonists|purinergic agonists|mesh-ancestor
92014068|NCT03072589|Purinergic Agents|purinergic agents|mesh-ancestor
92014069|NCT03072589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039267|NCT01642615|Lansoprazole|lansoprazole|mesh-list
92039268|NCT01642615|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92039269|NCT01642615|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039270|NCT01642615|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92039271|NCT01642615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039428|NCT04672005|Gemcitabine|gemcitabine|mesh-list
92039272|NCT01642615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039273|NCT03571945|Anesthetics|anesthetics|mesh-list
92039274|NCT03571945|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039275|NCT03571945|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039276|NCT02311361|Durvalumab|durvalumab|mesh-list
92039277|NCT02311361|Tremelimumab|tremelimumab|mesh-list
92039278|NCT02311361|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039279|NCT02311361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039280|NCT02329223|Omalizumab|omalizumab|mesh-list
92039281|NCT02329223|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92039282|NCT02329223|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92039283|NCT02329223|Respiratory System Agents|respiratory system agents|mesh-ancestor
92039284|NCT05302297|Cemiplimab|cemiplimab|mesh-list
92039285|NCT05302297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039286|NCT05302297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039287|NCT02310581|Buprenorphine|buprenorphine|mesh-list
92039288|NCT02310581|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92039289|NCT02310581|Narcotics|narcotics|mesh-ancestor
92039297|NCT04892693|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92039299|NCT04892693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039300|NCT04892693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039301|NCT02309411|Rivaroxaban|rivaroxaban|mesh-list
92039302|NCT02309411|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92039303|NCT02309411|Antithrombins|antithrombins|mesh-ancestor
92039304|NCT02309411|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92039305|NCT02309411|Protease Inhibitors|protease inhibitors|mesh-ancestor
92039306|NCT02309411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039307|NCT02309411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039308|NCT02309411|Anticoagulants|anticoagulants|mesh-ancestor
92039309|NCT02008227|Docetaxel|docetaxel|mesh-list
92039310|NCT02008227|Atezolizumab|atezolizumab|mesh-list
92039311|NCT02008227|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039312|NCT02008227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92039313|NCT02008227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039314|NCT02008227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92039315|NCT02008227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039316|NCT02008227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92039317|NCT02008227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039318|NCT04198649|Azithromycin|azithromycin|mesh-list
92039319|NCT04198649|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92039320|NCT04198649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039321|NCT02348723|Warfarin|warfarin|mesh-list
92039322|NCT02348723|Dabigatran|dabigatran|mesh-list
92039323|NCT02348723|Anticoagulants|anticoagulants|mesh-ancestor
92039324|NCT02348723|Antithrombins|antithrombins|mesh-ancestor
92039325|NCT02348723|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92039326|NCT02348723|Protease Inhibitors|protease inhibitors|mesh-ancestor
92039327|NCT02348723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039328|NCT02348723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039329|NCT02006667|Gemcitabine|gemcitabine|mesh-list
92039330|NCT02006667|Trastuzumab|trastuzumab|mesh-list
92039331|NCT02006667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039332|NCT02006667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039333|NCT02006667|Antimetabolites|antimetabolites|mesh-ancestor
92039334|NCT02006667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039335|NCT02006667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039336|NCT01983111|Acetaminophen|acetaminophen|mesh-list
92039337|NCT01983111|Buprenorphine|buprenorphine|mesh-list
92039338|NCT01983111|Tramadol|tramadol|mesh-list
92039339|NCT01983111|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92014070|NCT03072589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014071|NCT03072589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014072|NCT04994743|Cortisone|cortisone|mesh-list
92014073|NCT04994743|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014074|NCT04994353|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92014075|NCT04807829|Nabilone|nabilone|mesh-list
92039340|NCT01983111|Analgesics|analgesics|mesh-ancestor
92039341|NCT01983111|Sensory System Agents|sensory system agents|mesh-ancestor
92039342|NCT01983111|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039343|NCT01983111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039344|NCT01983111|Antipyretics|antipyretics|mesh-ancestor
92039345|NCT01983111|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92039346|NCT01983111|Narcotics|narcotics|mesh-ancestor
92039347|NCT01983111|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039348|NCT01983111|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92039349|NCT04672941|Bromides|bromides|mesh-list
92039350|NCT04672941|Tiotropium Bromide|tiotropium bromide|mesh-list
92039351|NCT04672941|Olodaterol|olodaterol|mesh-list
92039352|NCT04672941|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92039353|NCT04672941|Autonomic Agents|autonomic agents|mesh-ancestor
92039354|NCT04672941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039355|NCT04672941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039356|NCT04672941|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92039360|NCT04672941|Cholinergic Agents|cholinergic agents|mesh-ancestor
92039361|NCT04672941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039362|NCT04672941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039363|NCT04672941|Anticonvulsants|anticonvulsants|mesh-ancestor
92039364|NCT02348489|Guadecitabine|guadecitabine|mesh-list
92039365|NCT02348489|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039366|NCT01966107|Bromides|bromides|mesh-list
92039367|NCT01966107|Anticonvulsants|anticonvulsants|mesh-ancestor
92039368|NCT01982331|Vaccines|vaccines|mesh-list
92039369|NCT01982331|Immunologic Factors|immunologic factors|mesh-ancestor
92039370|NCT01982331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039371|NCT02326025|Doxorubicin|doxorubicin|mesh-list
92039372|NCT02326025|Olaratumab|olaratumab|mesh-list
92039373|NCT02326025|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92039374|NCT02326025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039375|NCT02326025|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92039376|NCT02326025|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92039377|NCT02326025|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039378|NCT02326025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039380|NCT01619865|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92039381|NCT01619865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039382|NCT02006121|Apomorphine|apomorphine|mesh-list
92039383|NCT02006121|Emetics|emetics|mesh-ancestor
92039384|NCT02006121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039385|NCT02006121|Autonomic Agents|autonomic agents|mesh-ancestor
92039386|NCT02006121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039387|NCT02006121|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039388|NCT02006121|Dopamine Agonists|dopamine agonists|mesh-ancestor
92039389|NCT02006121|Dopamine Agents|dopamine agents|mesh-ancestor
92039390|NCT02006121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039391|NCT02006121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039392|NCT02005887|Letrozole|letrozole|mesh-list
92039393|NCT02005887|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92039394|NCT02005887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039395|NCT02005887|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92039396|NCT02005887|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92039397|NCT02005887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039398|NCT02005887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039399|NCT02005887|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92039400|NCT02005887|Hormone Antagonists|hormone antagonists|mesh-ancestor
92039401|NCT02005887|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039402|NCT02005887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039403|NCT02005887|Luteolytic Agents|luteolytic agents|mesh-ancestor
92039404|NCT02005887|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92039405|NCT02005887|Contraceptive Agents|contraceptive agents|mesh-ancestor
92014076|NCT04807829|Antiemetics|antiemetics|mesh-ancestor
92014077|NCT04807829|Autonomic Agents|autonomic agents|mesh-ancestor
92014078|NCT04807829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014079|NCT04807829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039406|NCT02005887|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92039407|NCT02005887|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92039408|NCT02005887|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039410|NCT01981473|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92039411|NCT01981473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039412|NCT01981473|Dermatologic Agents|dermatologic agents|mesh-ancestor
92039413|NCT01981473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039414|NCT01981473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039415|NCT02005029|Erythromycin|erythromycin|mesh-list
92039416|NCT02005029|Erythromycin Estolate|erythromycin estolate|mesh-list
92039417|NCT02005029|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92039418|NCT02005029|Erythromycin stearate|erythromycin stearate|mesh-list
92039419|NCT02005029|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92039420|NCT02005029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039421|NCT02005029|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039422|NCT02005029|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92039423|NCT02005029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039424|NCT02005029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039425|NCT04672005|Leucovorin|leucovorin|mesh-list
92039426|NCT04672005|Paclitaxel|paclitaxel|mesh-list
92039427|NCT04672005|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92039429|NCT04672005|Oxaliplatin|oxaliplatin|mesh-list
92039432|NCT04672005|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92039433|NCT04672005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039434|NCT04672005|Tubulin Modulators|tubulin modulators|mesh-ancestor
92039435|NCT04672005|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039436|NCT04672005|Mitosis Modulators|mitosis modulators|mesh-ancestor
92039437|NCT04672005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039438|NCT04672005|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039439|NCT04672005|Antimetabolites|antimetabolites|mesh-ancestor
92039440|NCT04672005|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92039441|NCT04672005|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92039442|NCT04672005|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039443|NCT04672005|Antidotes|antidotes|mesh-ancestor
92039444|NCT04672005|Protective Agents|protective agents|mesh-ancestor
92039445|NCT04672005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039446|NCT04672005|Vitamin B Complex|vitamin b complex|mesh-ancestor
92039448|NCT04672005|Micronutrients|micronutrients|mesh-ancestor
92039449|NCT04416399|Budesonide|budesonide|mesh-list
92039450|NCT04416399|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039451|NCT04416399|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92039452|NCT04416399|Autonomic Agents|autonomic agents|mesh-ancestor
92039453|NCT04416399|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039454|NCT04416399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039455|NCT04416399|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92039456|NCT04416399|Respiratory System Agents|respiratory system agents|mesh-ancestor
92039457|NCT04416399|Glucocorticoids|glucocorticoids|mesh-ancestor
92039458|NCT04416399|Hormones|hormones|mesh-ancestor
92039459|NCT04416399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039461|NCT02282345|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92039462|NCT02282345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039463|NCT02282345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039464|NCT02282345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039465|NCT01732822|Clopidogrel|clopidogrel|mesh-list
92039466|NCT01732822|Ticagrelor|ticagrelor|mesh-list
92039467|NCT01732822|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92039468|NCT01732822|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92039469|NCT01732822|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92039470|NCT01732822|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92039471|NCT01732822|Purinergic Agents|purinergic agents|mesh-ancestor
92039472|NCT01732822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039473|NCT01732822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014080|NCT04807829|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014081|NCT04807829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92014082|NCT04807829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92039474|NCT01732822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039475|NCT02004093|Paclitaxel|paclitaxel|mesh-list
92039476|NCT02004093|Carboplatin|carboplatin|mesh-list
92039477|NCT02004093|Gemcitabine|gemcitabine|mesh-list
92039478|NCT02004093|Pertuzumab|pertuzumab|mesh-list
92039479|NCT02004093|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92039480|NCT02004093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039481|NCT02004093|Tubulin Modulators|tubulin modulators|mesh-ancestor
92039482|NCT02004093|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039483|NCT02004093|Mitosis Modulators|mitosis modulators|mesh-ancestor
92039484|NCT02004093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039485|NCT02004093|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039486|NCT02004093|Antimetabolites|antimetabolites|mesh-ancestor
92039487|NCT02004093|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039488|NCT01641367|Tenofovir|tenofovir|mesh-list
92039489|NCT01641367|Emtricitabine|emtricitabine|mesh-list
92039490|NCT01641367|Raltegravir Potassium|raltegravir potassium|mesh-list
92039491|NCT01641367|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92039492|NCT01641367|Darunavir|darunavir|mesh-list
92039493|NCT01641367|Etravirine|etravirine|mesh-list
92039494|NCT01641367|HIV Protease Inhibitors|hiv protease inhibitors|mesh-list
92039495|NCT01641367|Protease Inhibitors|protease inhibitors|mesh-list
92039496|NCT01641367|Antiviral Agents|antiviral agents|mesh-ancestor
92039497|NCT01641367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039498|NCT01641367|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92039499|NCT01641367|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92039500|NCT01641367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039501|NCT01641367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039502|NCT01641367|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92039503|NCT01641367|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92039504|NCT01641367|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92039506|NCT01641367|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92039507|NCT02325713|Praziquantel|praziquantel|mesh-list
92039508|NCT02325713|Anthelmintics|anthelmintics|mesh-ancestor
92039509|NCT02325713|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92039510|NCT02325713|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039511|NCT04877639|Dexmedetomidine|dexmedetomidine|mesh-list
92039512|NCT04877639|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92039513|NCT04877639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039514|NCT04877639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039515|NCT04877639|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92039516|NCT04877639|Analgesics|analgesics|mesh-ancestor
92039517|NCT04877639|Sensory System Agents|sensory system agents|mesh-ancestor
92039518|NCT04877639|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039519|NCT04877639|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92039520|NCT04877639|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92039521|NCT04877639|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92039522|NCT04877639|Adrenergic Agents|adrenergic agents|mesh-ancestor
92039523|NCT04877639|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039524|NCT04877639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039525|NCT02325401|Metformin|metformin|mesh-list
92039526|NCT02325401|Cisplatin|cisplatin|mesh-list
92039527|NCT02325401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039528|NCT02325401|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92039529|NCT02325401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039530|NCT02324699|Prednisone|prednisone|mesh-list
92039531|NCT02324699|Vedolizumab|vedolizumab|mesh-list
92039532|NCT02324699|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039533|NCT02324699|Glucocorticoids|glucocorticoids|mesh-ancestor
92039534|NCT02324699|Hormones|hormones|mesh-ancestor
92039535|NCT02324699|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039536|NCT02324699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039537|NCT02324699|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039538|NCT02324699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039539|NCT02324699|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039541|NCT01979523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039542|NCT01979523|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92039543|NCT01979523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014083|NCT04807829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014084|NCT04807829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014085|NCT04811573|Thalidomide|thalidomide|mesh-list
92014086|NCT04811573|Apremilast|apremilast|mesh-list
92039544|NCT01979523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039545|NCT02255461|Palbociclib|palbociclib|mesh-list
92039546|NCT02255461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039547|NCT02255461|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92039548|NCT02255461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039549|NCT02255461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039550|NCT01764022|Paclitaxel|paclitaxel|mesh-list
92039551|NCT01764022|Trastuzumab|trastuzumab|mesh-list
92039552|NCT01764022|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92039553|NCT01764022|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039554|NCT01764022|Tubulin Modulators|tubulin modulators|mesh-ancestor
92039555|NCT01764022|Antimitotic Agents|antimitotic agents|mesh-ancestor
92039556|NCT01764022|Mitosis Modulators|mitosis modulators|mesh-ancestor
92039557|NCT01764022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039558|NCT01764022|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039559|NCT02003391|Timolol|timolol|mesh-list
92039560|NCT02003391|Travoprost|travoprost|mesh-list
92039561|NCT02003391|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92039562|NCT02003391|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92039563|NCT02003391|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92039564|NCT02003391|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92039565|NCT02003391|Adrenergic Agents|adrenergic agents|mesh-ancestor
92039566|NCT02003391|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039567|NCT02003391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039568|NCT02003391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039569|NCT02003391|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92039570|NCT02003391|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92039571|NCT02254681|Gemcitabine|gemcitabine|mesh-list
92039572|NCT02254681|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039573|NCT02254681|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039574|NCT02254681|Antimetabolites|antimetabolites|mesh-ancestor
92039575|NCT02254681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039576|NCT01965327|Interferons|interferons|mesh-list
92039577|NCT01965327|Interferon-gamma|interferon-gamma|mesh-list
92039578|NCT01965327|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039579|NCT01965327|Antiviral Agents|antiviral agents|mesh-ancestor
92039582|NCT04872595|Melphalan|melphalan|mesh-list
92039583|NCT04872595|Busulfan|busulfan|mesh-list
92039584|NCT04872595|Thiotepa|thiotepa|mesh-list
92039585|NCT04872595|Fludarabine|fludarabine|mesh-list
92039586|NCT04872595|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039587|NCT04872595|Immunologic Factors|immunologic factors|mesh-ancestor
92039588|NCT04872595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039589|NCT04872595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039590|NCT04872595|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92039591|NCT04872595|Alkylating Agents|alkylating agents|mesh-ancestor
92039592|NCT04872595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039593|NCT04872595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039594|NCT04872595|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92039596|NCT01639729|Dsuvia|dsuvia|mesh-list
92039597|NCT01639729|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92039598|NCT01639729|Narcotics|narcotics|mesh-ancestor
92039599|NCT01639729|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039600|NCT01639729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039601|NCT01639729|Analgesics|analgesics|mesh-ancestor
92039602|NCT01639729|Sensory System Agents|sensory system agents|mesh-ancestor
92039603|NCT01639729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039604|NCT01639729|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92039605|NCT01639729|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92039606|NCT01639729|Anesthetics, General|anesthetics, general|mesh-ancestor
92039607|NCT01639729|Anesthetics|anesthetics|mesh-ancestor
92039608|NCT02002221|Metformin|metformin|mesh-list
92039609|NCT02002221|Vildagliptin|vildagliptin|mesh-list
92039610|NCT02002221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92039611|NCT02002221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039612|NCT02002221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92039613|NCT02002221|Protease Inhibitors|protease inhibitors|mesh-ancestor
92039614|NCT02002221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014088|NCT04811573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92014089|NCT04811573|Analgesics|analgesics|mesh-ancestor
92014090|NCT04811573|Sensory System Agents|sensory system agents|mesh-ancestor
92014091|NCT04811573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039615|NCT02002221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039616|NCT05650723|Venetoclax|venetoclax|mesh-list
92039617|NCT05650723|Obinutuzumab|obinutuzumab|mesh-list
92039618|NCT05650723|Zanubrutinib|zanubrutinib|mesh-list
92039619|NCT05650723|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039620|NCT05650723|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039621|NCT05650723|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92039622|NCT05650723|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039623|NCT05650723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039624|NCT05247697|Mirtazapine|mirtazapine|mesh-list
92039625|NCT05247697|Antidepressive Agents|antidepressive agents|mesh-ancestor
92039626|NCT05247697|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92039627|NCT05247697|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92039628|NCT05247697|Histamine Antagonists|histamine antagonists|mesh-ancestor
92039629|NCT05247697|Histamine Agents|histamine agents|mesh-ancestor
92039630|NCT05247697|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039631|NCT05247697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039632|NCT05247697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039633|NCT05247697|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92039634|NCT05247697|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92039635|NCT05247697|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039636|NCT05247697|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92039637|NCT05247697|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92039638|NCT05247697|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92039639|NCT05247697|Adrenergic Agents|adrenergic agents|mesh-ancestor
92039640|NCT05247697|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92039641|NCT05247697|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92039642|NCT05247697|Serotonin Agents|serotonin agents|mesh-ancestor
92039643|NCT05247697|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92039644|NCT05100199|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92039645|NCT05100199|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92039646|NCT05100199|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92039647|NCT05100199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039648|NCT05100199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039649|NCT05100199|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92039650|NCT05100199|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92039651|NCT05100199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039652|NCT05100199|Cholinergic Agents|cholinergic agents|mesh-ancestor
92039656|NCT02001987|Abortifacient Agents|abortifacient agents|mesh-ancestor
92039657|NCT02001987|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92039658|NCT02001987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039659|NCT02001987|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92039660|NCT02001987|Antimetabolites|antimetabolites|mesh-ancestor
92039661|NCT02001987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039662|NCT02001987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039663|NCT02001987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92039664|NCT02001987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039665|NCT02001987|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92039666|NCT02001987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039667|NCT02001987|Immunologic Factors|immunologic factors|mesh-ancestor
92039668|NCT02001987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039669|NCT02001987|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92039671|NCT01763164|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92039672|NCT01763164|Alkylating Agents|alkylating agents|mesh-ancestor
92039673|NCT01763164|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039674|NCT01763164|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039675|NCT01782742|Bexarotene|bexarotene|mesh-list
92039676|NCT01782742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039677|NCT04561180|Dexamethasone|dexamethasone|mesh-list
92014092|NCT04811573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014093|NCT04811573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014094|NCT04811573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039678|NCT04561180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039680|NCT04561180|Autonomic Agents|autonomic agents|mesh-ancestor
92039681|NCT04561180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039682|NCT04561180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039683|NCT04561180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039685|NCT04561180|Hormones|hormones|mesh-ancestor
92039686|NCT04561180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039687|NCT04561180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039688|NCT04561180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039689|NCT01732588|Artefenomel|artefenomel|mesh-list
92039690|NCT01732588|Antimalarials|antimalarials|mesh-ancestor
92039691|NCT01732588|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92039692|NCT01732588|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92039693|NCT01732588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039694|NCT01639339|Belimumab|belimumab|mesh-list
92039695|NCT01639339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039696|NCT01639339|Immunologic Factors|immunologic factors|mesh-ancestor
92039697|NCT01639339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039698|NCT01641133|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92039699|NCT01641133|Immunologic Factors|immunologic factors|mesh-ancestor
92039700|NCT01641133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039701|NCT04836637|Calcium, Dietary|calcium, dietary|mesh-list
92039702|NCT04836637|Calcium Carbonate|calcium carbonate|mesh-list
92039703|NCT04836637|Calcium|calcium|mesh-list
92039704|NCT04836637|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92039705|NCT04836637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039706|NCT04836637|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92039707|NCT04836637|Antacids|antacids|mesh-ancestor
92039708|NCT04836637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039709|NCT04836637|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039710|NCT04419259|Erenumab|erenumab|mesh-list
92039711|NCT04419259|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92039712|NCT04419259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039713|NCT04419259|Analgesics|analgesics|mesh-ancestor
92039714|NCT04419259|Sensory System Agents|sensory system agents|mesh-ancestor
92039715|NCT04419259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039716|NCT04419259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039717|NCT02000427|Blinatumomab|blinatumomab|mesh-list
92039718|NCT02000427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039719|NCT04845217|Peppermint oil|peppermint oil|mesh-list
92039720|NCT04845217|Antiemetics|antiemetics|mesh-ancestor
92039721|NCT04845217|Autonomic Agents|autonomic agents|mesh-ancestor
92039722|NCT04845217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039723|NCT04845217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039724|NCT04845217|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039727|NCT05359393|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039728|NCT05359393|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039729|NCT01600885|Guanfacine|guanfacine|mesh-list
92039730|NCT01600885|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92039731|NCT01600885|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92039732|NCT01600885|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92039733|NCT01600885|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92039734|NCT01600885|Adrenergic Agents|adrenergic agents|mesh-ancestor
92039735|NCT01600885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039736|NCT01600885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039737|NCT01600885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039738|NCT04625257|Antibodies|antibodies|mesh-list
92039739|NCT04625257|Immunologic Factors|immunologic factors|mesh-ancestor
92039740|NCT04625257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039741|NCT05011513|Ritonavir|ritonavir|mesh-list
92039742|NCT05011513|Nirmatrelvir|nirmatrelvir|mesh-list
92039743|NCT05011513|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92039744|NCT05011513|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92039745|NCT05011513|Protease Inhibitors|protease inhibitors|mesh-ancestor
92039746|NCT05011513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014095|NCT04811573|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92014096|NCT04811573|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92014097|NCT04811573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014098|NCT04811573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039747|NCT05011513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039749|NCT05011513|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92039750|NCT05011513|Antiviral Agents|antiviral agents|mesh-ancestor
92039751|NCT05011513|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039752|NCT05011513|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92039753|NCT05011513|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92039754|NCT05369377|Zanubrutinib|zanubrutinib|mesh-list
92039755|NCT05369377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039756|NCT05369377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92039757|NCT05369377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039758|NCT05369377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039760|NCT04832269|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92039761|NCT04832269|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92039762|NCT04832269|Prednisolone|prednisolone|mesh-list
92039763|NCT04832269|Prednisolone acetate|prednisolone acetate|mesh-list
92039764|NCT04832269|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92039765|NCT04832269|Prednisolone phosphate|prednisolone phosphate|mesh-list
92039766|NCT04832269|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039767|NCT04832269|Antiemetics|antiemetics|mesh-ancestor
92039768|NCT04832269|Autonomic Agents|autonomic agents|mesh-ancestor
92039769|NCT04832269|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039770|NCT04832269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039771|NCT04832269|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039772|NCT04832269|Glucocorticoids|glucocorticoids|mesh-ancestor
92039773|NCT04832269|Hormones|hormones|mesh-ancestor
92039774|NCT04832269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039775|NCT04832269|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92039776|NCT04832269|Protective Agents|protective agents|mesh-ancestor
92039777|NCT04832269|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039778|NCT04832269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039779|NCT04608331|Dexmedetomidine|dexmedetomidine|mesh-list
92039780|NCT04608331|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92039781|NCT04608331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039782|NCT04608331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039783|NCT04608331|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92039784|NCT04608331|Analgesics|analgesics|mesh-ancestor
92039785|NCT04608331|Sensory System Agents|sensory system agents|mesh-ancestor
92039786|NCT04608331|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039787|NCT04608331|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92039788|NCT04608331|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92039789|NCT04608331|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92039790|NCT04608331|Adrenergic Agents|adrenergic agents|mesh-ancestor
92039791|NCT04608331|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039792|NCT04608331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039793|NCT01637077|Pregabalin|pregabalin|mesh-list
92039794|NCT01637077|Analgesics|analgesics|mesh-ancestor
92039795|NCT01637077|Sensory System Agents|sensory system agents|mesh-ancestor
92039796|NCT01637077|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039797|NCT01637077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039798|NCT01637077|Anticonvulsants|anticonvulsants|mesh-ancestor
92039802|NCT01637077|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92039803|NCT01637077|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92039804|NCT01637077|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92039805|NCT01637077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039806|NCT01637077|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92039807|NCT02308163|Etanercept|etanercept|mesh-list
92039808|NCT02308163|Peficitinib|peficitinib|mesh-list
92039809|NCT02308163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92039810|NCT02308163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92039811|NCT02308163|Analgesics|analgesics|mesh-ancestor
92039812|NCT02308163|Sensory System Agents|sensory system agents|mesh-ancestor
92039813|NCT02308163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039814|NCT02308163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014099|NCT04811573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014100|NCT04811573|Immunologic Factors|immunologic factors|mesh-ancestor
92039815|NCT02308163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039816|NCT02308163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039817|NCT02308163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039818|NCT02308163|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039819|NCT02308163|Immunologic Factors|immunologic factors|mesh-ancestor
92039820|NCT02308163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039821|NCT02308163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039822|NCT04001647|Ascorbic Acid|ascorbic acid|mesh-list
92039823|NCT04001647|Nitroprusside|nitroprusside|mesh-list
92039824|NCT04001647|Acetylcholine|acetylcholine|mesh-list
92039825|NCT04001647|Vitamins|vitamins|mesh-ancestor
92039826|NCT04001647|Micronutrients|micronutrients|mesh-ancestor
92039827|NCT04001647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039828|NCT04001647|Antioxidants|antioxidants|mesh-ancestor
92039829|NCT04001647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039830|NCT04001647|Protective Agents|protective agents|mesh-ancestor
92039831|NCT04001647|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92039832|NCT04001647|Vasodilator Agents|vasodilator agents|mesh-ancestor
92039833|NCT04001647|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92039834|NCT04001647|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92039835|NCT04001647|Cholinergic Agents|cholinergic agents|mesh-ancestor
92039836|NCT04001647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039837|NCT03939637|Immunoglobulins|immunoglobulins|mesh-list
92039838|NCT03939637|Antibodies|antibodies|mesh-list
92039839|NCT03939637|gamma-Globulins|gamma-globulins|mesh-list
92039840|NCT03939637|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92039841|NCT03939637|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92039842|NCT03939637|Immunologic Factors|immunologic factors|mesh-ancestor
92039843|NCT03939637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039844|NCT04479241|Pembrolizumab|pembrolizumab|mesh-list
92039845|NCT04479241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92039846|NCT04479241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039847|NCT04479241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92039848|NCT04479241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039849|NCT04880707|Anesthetics|anesthetics|mesh-list
92039850|NCT04880707|Anesthetics, Local|anesthetics, local|mesh-list
92039851|NCT04880707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039852|NCT04880707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039853|NCT04880707|Sensory System Agents|sensory system agents|mesh-ancestor
92039854|NCT04880707|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039855|NCT01999335|Dexamethasone|dexamethasone|mesh-list
92039856|NCT01999335|Pomalidomide|pomalidomide|mesh-list
92039857|NCT01999335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039858|NCT01999335|Antiemetics|antiemetics|mesh-ancestor
92039859|NCT01999335|Autonomic Agents|autonomic agents|mesh-ancestor
92039860|NCT01999335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039861|NCT01999335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039862|NCT01999335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039863|NCT01999335|Glucocorticoids|glucocorticoids|mesh-ancestor
92039864|NCT01999335|Hormones|hormones|mesh-ancestor
92039865|NCT01999335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039866|NCT01999335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039867|NCT01999335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039868|NCT01999335|Immunologic Factors|immunologic factors|mesh-ancestor
92039869|NCT01999335|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92039873|NCT01999179|Heparin|heparin|mesh-list
92039874|NCT01999179|Enoxaparin|enoxaparin|mesh-list
92039875|NCT01999179|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92039876|NCT01999179|Tinzaparin|tinzaparin|mesh-list
92039877|NCT01999179|Dalteparin|dalteparin|mesh-list
92039878|NCT01999179|Rivaroxaban|rivaroxaban|mesh-list
92039879|NCT01999179|Dabigatran|dabigatran|mesh-list
92039880|NCT01999179|Apixaban|apixaban|mesh-list
92039881|NCT01999179|Anticoagulants|anticoagulants|mesh-list
92039882|NCT01999179|Edoxaban|edoxaban|mesh-list
92039883|NCT01999179|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92039884|NCT01999179|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92039885|NCT01999179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039886|NCT01999179|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92039887|NCT01999179|Antithrombins|antithrombins|mesh-ancestor
92039888|NCT01999179|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92039889|NCT01999179|Protease Inhibitors|protease inhibitors|mesh-ancestor
92039890|NCT01999179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039891|NCT01977729|Sertraline|sertraline|mesh-list
92039892|NCT01977729|Antidepressive Agents|antidepressive agents|mesh-ancestor
92039893|NCT01977729|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92039894|NCT01977729|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92039895|NCT01977729|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92039896|NCT01977729|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92039897|NCT01977729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039898|NCT01977729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039899|NCT01977729|Serotonin Agents|serotonin agents|mesh-ancestor
92039900|NCT01977729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039901|NCT01998399|Ticagrelor|ticagrelor|mesh-list
92039902|NCT01998399|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92039903|NCT01998399|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92039904|NCT01998399|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92039905|NCT01998399|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92039906|NCT01998399|Purinergic Agents|purinergic agents|mesh-ancestor
92039907|NCT01998399|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039908|NCT01998399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039909|NCT01998399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039910|NCT01761292|Givinostat hydrochloride|givinostat hydrochloride|mesh-list
92039911|NCT01761292|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92039913|NCT01761292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039914|NCT01731886|Dexamethasone|dexamethasone|mesh-list
92039915|NCT01731886|Cyclophosphamide|cyclophosphamide|mesh-list
92039916|NCT01731886|Melphalan|melphalan|mesh-list
92039917|NCT01731886|Lenalidomide|lenalidomide|mesh-list
92039918|NCT01731886|Lenograstim|lenograstim|mesh-list
92039919|NCT01731886|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039920|NCT01731886|Immunologic Factors|immunologic factors|mesh-ancestor
92039921|NCT01731886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039922|NCT01731886|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039923|NCT01731886|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92039924|NCT01731886|Alkylating Agents|alkylating agents|mesh-ancestor
92039925|NCT01731886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039926|NCT01731886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039927|NCT01731886|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92039928|NCT01731886|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039929|NCT01731886|Antiemetics|antiemetics|mesh-ancestor
92039930|NCT01731886|Autonomic Agents|autonomic agents|mesh-ancestor
92039931|NCT01731886|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039932|NCT01731886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039933|NCT01731886|Glucocorticoids|glucocorticoids|mesh-ancestor
92039934|NCT01731886|Hormones|hormones|mesh-ancestor
92039935|NCT01731886|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039936|NCT01731886|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92039937|NCT01731886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92039938|NCT01731886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92039939|NCT01731886|Growth Substances|growth substances|mesh-ancestor
92039940|NCT01731886|Growth Inhibitors|growth inhibitors|mesh-ancestor
92039941|NCT01731886|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92039942|NCT01759420|Ondansetron|ondansetron|mesh-list
92039943|NCT01759420|Antiemetics|antiemetics|mesh-ancestor
92039944|NCT01759420|Autonomic Agents|autonomic agents|mesh-ancestor
92039945|NCT01759420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039946|NCT01759420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039947|NCT01759420|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92039948|NCT01759420|Antipruritics|antipruritics|mesh-ancestor
92039949|NCT01759420|Dermatologic Agents|dermatologic agents|mesh-ancestor
92039950|NCT01759420|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92039951|NCT01759420|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92039952|NCT01759420|Serotonin Agents|serotonin agents|mesh-ancestor
92039953|NCT01759420|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039954|NCT01759420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039955|NCT01781026|Vemurafenib|vemurafenib|mesh-list
92039956|NCT01781026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039957|NCT01781026|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92039958|NCT01781026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040031|NCT01995825|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92039959|NCT01781026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039960|NCT01729156|Metformin|metformin|mesh-list
92039961|NCT01729156|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92039962|NCT01729156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039963|NCT01779700|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92039964|NCT01779700|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92014101|NCT04811573|Leprostatic Agents|leprostatic agents|mesh-ancestor
92014102|NCT04811573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92014103|NCT04811573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039965|NCT01779700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039966|NCT01779700|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039967|NCT01779700|Immunologic Factors|immunologic factors|mesh-ancestor
92039968|NCT01779700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039969|NCT04572256|Montelukast|montelukast|mesh-list
92039970|NCT04572256|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92039971|NCT04572256|Respiratory System Agents|respiratory system agents|mesh-ancestor
92039972|NCT04572256|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92039973|NCT04572256|Hormone Antagonists|hormone antagonists|mesh-ancestor
92039974|NCT04572256|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92039975|NCT04572256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039976|NCT04572256|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92039977|NCT04572256|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92039978|NCT04572256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039979|NCT01963611|Glatiramer Acetate|glatiramer acetate|mesh-list
92039980|NCT01963611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92039981|NCT01963611|Immunologic Factors|immunologic factors|mesh-ancestor
92039982|NCT01963611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039983|NCT01963611|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92039984|NCT01963611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039985|NCT01975701|Infigratinib|infigratinib|mesh-list
92039986|NCT01975701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039987|NCT01962987|Diclofenac|diclofenac|mesh-list
92039988|NCT01962987|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92039989|NCT01962987|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92039990|NCT01962987|Analgesics|analgesics|mesh-ancestor
92039991|NCT01962987|Sensory System Agents|sensory system agents|mesh-ancestor
92039992|NCT01962987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039993|NCT01962987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039994|NCT01962987|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039995|NCT01962987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039996|NCT01962987|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92039997|NCT01962987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039998|NCT01962987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039999|NCT01962441|Sofosbuvir|sofosbuvir|mesh-list
92040000|NCT01962441|Antiviral Agents|antiviral agents|mesh-ancestor
92040001|NCT01962441|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040002|NCT01638013|Peficitinib|peficitinib|mesh-list
92040003|NCT01638013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040004|NCT01638013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040005|NCT01638013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040006|NCT01638013|Immunologic Factors|immunologic factors|mesh-ancestor
92040007|NCT01638013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040008|NCT01637623|Allopurinol|allopurinol|mesh-list
92040009|NCT01637623|Losartan|losartan|mesh-list
92040010|NCT01637623|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92040011|NCT01637623|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92040012|NCT01637623|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92040013|NCT01637623|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92040014|NCT01637623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040015|NCT01637623|Antimetabolites|antimetabolites|mesh-ancestor
92040016|NCT01637623|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040020|NCT01637623|Antioxidants|antioxidants|mesh-ancestor
92040021|NCT01637623|Protective Agents|protective agents|mesh-ancestor
92040022|NCT01637623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040023|NCT01995825|Lamotrigine|lamotrigine|mesh-list
92040024|NCT01995825|Anticonvulsants|anticonvulsants|mesh-list
92040025|NCT01995825|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92040026|NCT01995825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92040027|NCT01995825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040028|NCT01995825|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92040029|NCT01995825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040030|NCT01995825|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92040032|NCT01995825|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014104|NCT04811573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92014105|NCT04811573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92014106|NCT04811573|Growth Substances|growth substances|mesh-ancestor
92014107|NCT04811573|Growth Inhibitors|growth inhibitors|mesh-ancestor
92014108|NCT04811573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040033|NCT01995825|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92040034|NCT01995825|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92040035|NCT04267081|Venetoclax|venetoclax|mesh-list
92040036|NCT04267081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040037|NCT04792567|Siponimod|siponimod|mesh-list
92040038|NCT04792567|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92040039|NCT04792567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040040|NCT04792567|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040041|NCT04792567|Immunologic Factors|immunologic factors|mesh-ancestor
92040042|NCT04792567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040043|NCT04419025|Acetylcysteine|acetylcysteine|mesh-list
92040044|NCT04419025|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92040045|NCT04419025|Antiviral Agents|antiviral agents|mesh-ancestor
92040046|NCT04419025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040047|NCT04419025|Expectorants|expectorants|mesh-ancestor
92040048|NCT04419025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92040049|NCT04419025|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92040050|NCT04419025|Antioxidants|antioxidants|mesh-ancestor
92040051|NCT04419025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040052|NCT04419025|Protective Agents|protective agents|mesh-ancestor
92040053|NCT04419025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040054|NCT04419025|Antidotes|antidotes|mesh-ancestor
92040055|NCT04781647|Interferons|interferons|mesh-list
92040056|NCT04781647|Interferon-alpha|interferon-alpha|mesh-list
92040057|NCT04781647|Entecavir|entecavir|mesh-list
92040058|NCT04781647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040060|NCT04781647|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040061|NCT04781647|Immunologic Factors|immunologic factors|mesh-ancestor
92040062|NCT04781647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040063|NCT05259787|Propofol|propofol|mesh-list
92040064|NCT05259787|Etomidate|etomidate|mesh-list
92040065|NCT05259787|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92040066|NCT05259787|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040067|NCT05259787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040068|NCT05259787|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92040069|NCT05259787|Anesthetics, General|anesthetics, general|mesh-ancestor
92040070|NCT05259787|Anesthetics|anesthetics|mesh-ancestor
92040071|NCT04196413|Cyclophosphamide|cyclophosphamide|mesh-list
92040072|NCT04196413|Fludarabine|fludarabine|mesh-list
92040073|NCT04196413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040074|NCT04196413|Immunologic Factors|immunologic factors|mesh-ancestor
92040075|NCT04196413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040076|NCT04196413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040077|NCT04196413|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92040078|NCT04196413|Alkylating Agents|alkylating agents|mesh-ancestor
92040079|NCT04196413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040080|NCT04196413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040081|NCT04196413|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92040082|NCT03565159|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92040083|NCT03565159|Immunologic Factors|immunologic factors|mesh-ancestor
92040084|NCT03565159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040085|NCT01756456|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92040086|NCT01756456|Mitogens|mitogens|mesh-list
92040087|NCT01756456|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040088|NCT01756456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040089|NCT05226325|Dexmedetomidine|dexmedetomidine|mesh-list
92040092|NCT05226325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040093|NCT05226325|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92040095|NCT05226325|Sensory System Agents|sensory system agents|mesh-ancestor
92040096|NCT05226325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040097|NCT05226325|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92040098|NCT05226325|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92040099|NCT05226325|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92040100|NCT05226325|Adrenergic Agents|adrenergic agents|mesh-ancestor
92040101|NCT05226325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014109|NCT03072511|Nicotine|nicotine|mesh-list
92014110|NCT03072511|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92014111|NCT03072511|Autonomic Agents|autonomic agents|mesh-ancestor
92040102|NCT05226325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040103|NCT05221021|Mirabegron|mirabegron|mesh-list
92040104|NCT05221021|Estradiol|estradiol|mesh-list
92040105|NCT05221021|Estrogens|estrogens|mesh-list
92040106|NCT05221021|Hormones|hormones|mesh-ancestor
92040107|NCT05221021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040108|NCT05221021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040109|NCT05221021|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92040110|NCT05221021|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92040111|NCT05221021|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92040112|NCT05221021|Adrenergic Agents|adrenergic agents|mesh-ancestor
92040113|NCT05221021|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040114|NCT05221021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040115|NCT05221021|Urological Agents|urological agents|mesh-ancestor
92040116|NCT03167437|Vorinostat|vorinostat|mesh-list
92040117|NCT03167437|Ustekinumab|ustekinumab|mesh-list
92040118|NCT03167437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040119|NCT03167437|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92040120|NCT03167437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040121|NCT03167437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040122|NCT03167437|Dermatologic Agents|dermatologic agents|mesh-ancestor
92040123|NCT03164473|Rituximab|rituximab|mesh-list
92040124|NCT03164473|Azathioprine|azathioprine|mesh-list
92040125|NCT03164473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040126|NCT03164473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040127|NCT03164473|Immunologic Factors|immunologic factors|mesh-ancestor
92040128|NCT03164473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040129|NCT03164473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040130|NCT03164473|Antimetabolites|antimetabolites|mesh-ancestor
92040131|NCT03164473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040132|NCT03164473|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92040133|NCT03164473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040134|NCT05218915|Dulaglutide|dulaglutide|mesh-list
92040135|NCT05218915|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92040136|NCT05218915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040137|NCT01995201|Methotrexate|methotrexate|mesh-list
92040138|NCT01995201|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92040139|NCT01995201|Abortifacient Agents|abortifacient agents|mesh-ancestor
92040140|NCT01995201|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92040141|NCT01995201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040142|NCT01995201|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92040143|NCT01995201|Antimetabolites|antimetabolites|mesh-ancestor
92040144|NCT01995201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040145|NCT01995201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040146|NCT01995201|Dermatologic Agents|dermatologic agents|mesh-ancestor
92040147|NCT01995201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040148|NCT01995201|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92040149|NCT01995201|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040150|NCT01995201|Immunologic Factors|immunologic factors|mesh-ancestor
92040151|NCT01995201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040152|NCT01995201|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92040153|NCT01636687|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92040154|NCT01636687|Immunologic Factors|immunologic factors|mesh-ancestor
92040155|NCT01636687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040156|NCT05165641|Anesthetics|anesthetics|mesh-list
92040157|NCT05165641|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040158|NCT05165641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040162|NCT05814432|Amphotericin B|amphotericin b|mesh-list
92040163|NCT05814432|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92040164|NCT05814432|Amebicides|amebicides|mesh-ancestor
92040165|NCT05814432|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92040166|NCT05814432|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92040167|NCT05814432|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040168|NCT05814432|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92040169|NCT05814432|Antifungal Agents|antifungal agents|mesh-ancestor
92040171|NCT05814302|Ibuprofen|ibuprofen|mesh-list
92040172|NCT05814302|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92014112|NCT03072511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014113|NCT03072511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014114|NCT03072511|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92014115|NCT03072511|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92014116|NCT03072511|Cholinergic Agents|cholinergic agents|mesh-ancestor
92014117|NCT03072511|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040173|NCT05814302|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92040174|NCT05814302|Analgesics|analgesics|mesh-ancestor
92040175|NCT05814302|Sensory System Agents|sensory system agents|mesh-ancestor
92040176|NCT05814302|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040177|NCT05814302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040178|NCT05814302|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040179|NCT05814302|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040180|NCT05814302|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92040181|NCT05814302|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040182|NCT05814302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040183|NCT05814302|Antipyretics|antipyretics|mesh-ancestor
92040184|NCT05814159|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92040185|NCT05814159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040188|NCT05814068|Antihypertensive Agents|antihypertensive agents|mesh-list
92040189|NCT05813964|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92040190|NCT05813964|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92040191|NCT05813964|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92040192|NCT05813964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92040193|NCT05813964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040194|NCT05813964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040195|NCT05813964|Antiviral Agents|antiviral agents|mesh-ancestor
92040196|NCT05813964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040197|NCT05813964|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92040198|NCT05813964|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92040199|NCT05813951|Linezolid|linezolid|mesh-list
92040200|NCT05813951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92040201|NCT05813951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040202|NCT05813951|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92040203|NCT05813951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040204|NCT05813951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040205|NCT05813821|Anti-Infective Agents|anti-infective agents|mesh-list
92040206|NCT05813821|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92040207|NCT05813691|Antibodies|antibodies|mesh-list
92040208|NCT05813691|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92040209|NCT05813691|Immunologic Factors|immunologic factors|mesh-ancestor
92040210|NCT05813691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040211|NCT05813665|Denosumab|denosumab|mesh-list
92040212|NCT05813665|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92040213|NCT05813665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040214|NCT05813600|Ritonavir|ritonavir|mesh-list
92040215|NCT05813600|Nirmatrelvir|nirmatrelvir|mesh-list
92040216|NCT05813600|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92040217|NCT05813600|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92040218|NCT05813600|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92040219|NCT05813600|Protease Inhibitors|protease inhibitors|mesh-ancestor
92040220|NCT05813600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040221|NCT05813600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040222|NCT05813600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92040223|NCT05813600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92040224|NCT05813600|Antiviral Agents|antiviral agents|mesh-ancestor
92040225|NCT05813600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040226|NCT05813600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92040227|NCT05813600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92040228|NCT05813561|Fexuprazan|fexuprazan|mesh-list
92040229|NCT05813561|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92040230|NCT05813522|Aflutinib|aflutinib|mesh-list
92040231|NCT05813522|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92040236|NCT05813496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040238|NCT05813496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014118|NCT03072511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014120|NCT03072121|Metoprolol|metoprolol|mesh-list
92040239|NCT05813496|Vitamin B Complex|vitamin b complex|mesh-ancestor
92040240|NCT05813496|Vitamins|vitamins|mesh-ancestor
92040241|NCT05813496|Micronutrients|micronutrients|mesh-ancestor
92040242|NCT05813470|Omalizumab|omalizumab|mesh-list
92040243|NCT05813470|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92040244|NCT05813470|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92040245|NCT05813470|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92040246|NCT05813470|Respiratory System Agents|respiratory system agents|mesh-ancestor
92040247|NCT05813470|Immunologic Factors|immunologic factors|mesh-ancestor
92040248|NCT05813470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040249|NCT05813405|Antihypertensive Agents|antihypertensive agents|mesh-list
92040250|NCT05813366|Vitamin B 6|vitamin b 6|mesh-list
92040251|NCT05813366|Pyridoxal|pyridoxal|mesh-list
92040252|NCT05813366|Pyridoxine|pyridoxine|mesh-list
92040253|NCT05813366|Tryptophan|tryptophan|mesh-list
92040254|NCT05813366|Vitamins|vitamins|mesh-ancestor
92040255|NCT05813366|Micronutrients|micronutrients|mesh-ancestor
92040256|NCT05813366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040257|NCT05813366|Vitamin B Complex|vitamin b complex|mesh-ancestor
92040258|NCT05813366|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92040259|NCT05813366|Antidepressive Agents|antidepressive agents|mesh-ancestor
92040260|NCT05813366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92040261|NCT05813314|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
92040262|NCT05813314|Natriuretic Agents|natriuretic agents|mesh-ancestor
92040263|NCT05813314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040264|NCT05813249|Tocopherols|tocopherols|mesh-list
92040265|NCT05813249|Vitamin E|vitamin e|mesh-list
92040266|NCT05813249|Tocotrienols|tocotrienols|mesh-list
92040267|NCT05813249|alpha-Tocopherol|alpha-tocopherol|mesh-list
92040268|NCT05813249|Antioxidants|antioxidants|mesh-ancestor
92040269|NCT05813249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040270|NCT05813249|Protective Agents|protective agents|mesh-ancestor
92040271|NCT05813249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040272|NCT05813249|Vitamins|vitamins|mesh-ancestor
92040273|NCT05813249|Micronutrients|micronutrients|mesh-ancestor
92040274|NCT05813184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92040275|NCT05813184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040276|NCT05813145|Fenofibrate|fenofibrate|mesh-list
92040277|NCT05813145|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92040278|NCT05813145|Antimetabolites|antimetabolites|mesh-ancestor
92040279|NCT05813145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040280|NCT05813145|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92040282|NCT05813132|Carboplatin|carboplatin|mesh-list
92040284|NCT05813132|Etoposide phosphate|etoposide phosphate|mesh-list
92040285|NCT05813132|Melphalan|melphalan|mesh-list
92040286|NCT05813132|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92040287|NCT05813132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040288|NCT05813132|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92040289|NCT05813132|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92040290|NCT05813132|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92040291|NCT05813132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040292|NCT05813132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040293|NCT05813132|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92040294|NCT05813132|Antimetabolites|antimetabolites|mesh-ancestor
92040295|NCT05813132|Antiviral Agents|antiviral agents|mesh-ancestor
92040296|NCT05813132|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040297|NCT05813132|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040298|NCT05813132|Immunologic Factors|immunologic factors|mesh-ancestor
92040299|NCT05813132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040300|NCT05813132|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92040301|NCT05813132|Alkylating Agents|alkylating agents|mesh-ancestor
92040302|NCT05813132|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92040303|NCT05813106|Dexmedetomidine|dexmedetomidine|mesh-list
92040304|NCT05813106|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92040305|NCT05813106|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040308|NCT05813106|Analgesics|analgesics|mesh-ancestor
92040309|NCT05813106|Sensory System Agents|sensory system agents|mesh-ancestor
92040310|NCT05813106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040311|NCT05813106|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92040312|NCT05813106|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92040313|NCT05813106|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92014122|NCT03072121|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92014123|NCT03072121|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92014124|NCT03072121|Trimetazidine|trimetazidine|mesh-list
92014125|NCT03072121|Clopidogrel|clopidogrel|mesh-list
92014126|NCT03072121|Atorvastatin|atorvastatin|mesh-list
92014127|NCT03072121|Calcium|calcium|mesh-list
92014128|NCT03072121|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92014129|NCT03072121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014130|NCT03072121|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92014131|NCT03072121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92014132|NCT03072121|Analgesics|analgesics|mesh-ancestor
92014133|NCT03072121|Sensory System Agents|sensory system agents|mesh-ancestor
92014134|NCT03072121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014135|NCT03072121|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014136|NCT03072121|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040314|NCT05813106|Adrenergic Agents|adrenergic agents|mesh-ancestor
92040315|NCT05813106|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040316|NCT05813106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040317|NCT05813015|Docetaxel|docetaxel|mesh-list
92040318|NCT05813015|Tegafur|tegafur|mesh-list
92040319|NCT05813015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040320|NCT05813015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040321|NCT05813015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040322|NCT05813015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040323|NCT05813015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040324|NCT05813015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92040325|NCT05813015|Antimetabolites|antimetabolites|mesh-ancestor
92040326|NCT05812807|Pembrolizumab|pembrolizumab|mesh-list
92040327|NCT05812807|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040328|NCT05812807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040329|NCT05812807|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040330|NCT05812807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040331|NCT05811403|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92040332|NCT05811403|Eusol|eusol|mesh-list
92040333|NCT05811403|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92040334|NCT05811403|Disinfectants|disinfectants|mesh-ancestor
92040335|NCT05811403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040337|NCT05811403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040338|NCT05811403|Protective Agents|protective agents|mesh-ancestor
92040339|NCT05811403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040340|NCT05811403|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92040341|NCT05811403|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92040342|NCT05811403|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040343|NCT05811403|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92040344|NCT05808582|Fulvestrant|fulvestrant|mesh-list
92040345|NCT05808582|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040346|NCT05808582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040347|NCT05808582|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92040348|NCT05808582|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92040349|NCT05808582|Hormone Antagonists|hormone antagonists|mesh-ancestor
92040350|NCT05808582|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040351|NCT05808582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040352|NCT05796804|Anesthetics|anesthetics|mesh-list
92040353|NCT05796804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040354|NCT05796804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040355|NCT05788874|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92014137|NCT03072121|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92014138|NCT03072121|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92014139|NCT03072121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014140|NCT03072121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92014141|NCT03072121|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92014142|NCT03072121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014143|NCT03072121|Antipyretics|antipyretics|mesh-ancestor
92014144|NCT03072121|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92014145|NCT03072121|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92014146|NCT03072121|Antimetabolites|antimetabolites|mesh-ancestor
92014147|NCT03072121|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92014148|NCT03072121|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92014149|NCT03072121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92014150|NCT03072121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92014151|NCT03072121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92014152|NCT03072121|Purinergic Agents|purinergic agents|mesh-ancestor
92014153|NCT03072121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014154|NCT03072121|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92014155|NCT03072121|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92014156|NCT03072121|Sympatholytics|sympatholytics|mesh-ancestor
92014157|NCT03072121|Autonomic Agents|autonomic agents|mesh-ancestor
92014158|NCT03072121|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92014159|NCT03072121|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92014160|NCT03072121|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92014161|NCT03072121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92014162|NCT03072121|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92014164|NCT03072121|Natriuretic Agents|natriuretic agents|mesh-ancestor
92014165|NCT03072121|Vasodilator Agents|vasodilator agents|mesh-ancestor
92014166|NCT03072121|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92014167|NCT02597855|Aflibercept|aflibercept|mesh-list
92040356|NCT05788874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92040357|NCT05788874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040358|NCT05788289|Lenalidomide|lenalidomide|mesh-list
92040359|NCT05788289|Immunologic Factors|immunologic factors|mesh-ancestor
92040360|NCT05788289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040361|NCT05788289|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92040362|NCT05788289|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92040363|NCT05788289|Growth Substances|growth substances|mesh-ancestor
92014168|NCT02597855|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92014169|NCT02597855|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92014170|NCT02597855|Growth Substances|growth substances|mesh-ancestor
92014171|NCT02597855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014172|NCT02597855|Growth Inhibitors|growth inhibitors|mesh-ancestor
92040364|NCT05788289|Growth Inhibitors|growth inhibitors|mesh-ancestor
92040365|NCT05788289|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040366|NCT05787613|Paclitaxel|paclitaxel|mesh-list
92040367|NCT05787613|Carboplatin|carboplatin|mesh-list
92040368|NCT05787613|Pemetrexed|pemetrexed|mesh-list
92040369|NCT05787613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92040370|NCT05787613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040371|NCT05787613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040372|NCT05787613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040373|NCT05787613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040374|NCT05787613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040375|NCT05787613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040376|NCT05787613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92040381|NCT05767034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92040382|NCT05767034|Immunologic Factors|immunologic factors|mesh-ancestor
92040383|NCT05767034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040384|NCT05757388|Acetaminophen|acetaminophen|mesh-list
92040386|NCT05757388|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92040387|NCT05757388|Analgesics|analgesics|mesh-ancestor
92040388|NCT05757388|Sensory System Agents|sensory system agents|mesh-ancestor
92040389|NCT05757388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040390|NCT05757388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040391|NCT05757388|Antipyretics|antipyretics|mesh-ancestor
92040392|NCT05757388|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92040393|NCT05757388|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92040394|NCT05757388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040395|NCT05757388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040396|NCT05757388|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92040397|NCT05757388|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040398|NCT05757388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040399|NCT05755334|Ropivacaine|ropivacaine|mesh-list
92040400|NCT05755334|Anesthetics, Local|anesthetics, local|mesh-ancestor
92040401|NCT05755334|Anesthetics|anesthetics|mesh-ancestor
92040402|NCT05755334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040403|NCT05755334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040404|NCT05755334|Sensory System Agents|sensory system agents|mesh-ancestor
92040405|NCT05755334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040406|NCT05750459|Artesunate|artesunate|mesh-list
92040407|NCT05750459|Antimalarials|antimalarials|mesh-ancestor
92040408|NCT05750459|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92040409|NCT05750459|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92040410|NCT05750459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040411|NCT05750459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040412|NCT05750459|Antiviral Agents|antiviral agents|mesh-ancestor
92040413|NCT05750459|Schistosomicides|schistosomicides|mesh-ancestor
92040414|NCT05750459|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92040415|NCT05750459|Anthelmintics|anthelmintics|mesh-ancestor
92040416|NCT05749393|Heparin|heparin|mesh-list
92040417|NCT05749393|Calcium heparin|calcium heparin|mesh-list
92040418|NCT05749393|Anticoagulants|anticoagulants|mesh-ancestor
92040419|NCT05749393|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92040420|NCT05749393|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92040421|NCT05749393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040422|NCT05732883|Dexamethasone|dexamethasone|mesh-list
92040423|NCT05732883|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040424|NCT05732883|Antiemetics|antiemetics|mesh-ancestor
92040425|NCT05732883|Autonomic Agents|autonomic agents|mesh-ancestor
92040426|NCT05732883|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040427|NCT05732883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040428|NCT05732883|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92040429|NCT05732883|Glucocorticoids|glucocorticoids|mesh-ancestor
92040430|NCT05732883|Hormones|hormones|mesh-ancestor
92040431|NCT05732883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040432|NCT05732883|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92014173|NCT02597855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014174|NCT04987567|Antioxidants|antioxidants|mesh-list
92040433|NCT05732883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040434|NCT05720455|Fexofenadine|fexofenadine|mesh-list
92040435|NCT05720455|Pseudoephedrine|pseudoephedrine|mesh-list
92040437|NCT05720455|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92040438|NCT05720455|Autonomic Agents|autonomic agents|mesh-ancestor
92040439|NCT05720455|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040440|NCT05720455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040441|NCT05720455|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92040442|NCT05720455|Respiratory System Agents|respiratory system agents|mesh-ancestor
92040443|NCT05720455|Nasal Decongestants|nasal decongestants|mesh-ancestor
92040444|NCT05720455|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92040445|NCT05720455|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92040446|NCT05720455|Sympathomimetics|sympathomimetics|mesh-ancestor
92040447|NCT05720455|Adrenergic Agents|adrenergic agents|mesh-ancestor
92040448|NCT05720455|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040461|NCT05690204|Gout Suppressants|gout suppressants|mesh-ancestor
92040462|NCT05690204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040463|NCT05690204|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040464|NCT05690204|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040465|NCT05690204|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040466|NCT05690204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040467|NCT05690204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040468|NCT05688735|Isosorbide|isosorbide|mesh-list
92040469|NCT05688735|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92040470|NCT05688735|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92040471|NCT05688735|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92040472|NCT05688735|Diuretics|diuretics|mesh-ancestor
92040473|NCT05688735|Natriuretic Agents|natriuretic agents|mesh-ancestor
92040474|NCT05688735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040475|NCT05688735|Vasodilator Agents|vasodilator agents|mesh-ancestor
92040476|NCT05688735|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92040477|NCT05688735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040478|NCT05674994|Prednisone|prednisone|mesh-list
92040479|NCT05674994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040480|NCT05674994|Glucocorticoids|glucocorticoids|mesh-ancestor
92040481|NCT05674994|Hormones|hormones|mesh-ancestor
92040482|NCT05674994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040483|NCT05674994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040484|NCT05674994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040485|NCT05674994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040486|NCT05662397|Cemiplimab|cemiplimab|mesh-list
92040487|NCT05662397|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040488|NCT05662397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040489|NCT05627596|Nicotine|nicotine|mesh-list
92040490|NCT05627596|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92040491|NCT05627596|Autonomic Agents|autonomic agents|mesh-ancestor
92040492|NCT05627596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040493|NCT05627596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040494|NCT05627596|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92040495|NCT05627596|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92040496|NCT05627596|Cholinergic Agents|cholinergic agents|mesh-ancestor
92040497|NCT05627596|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040498|NCT05627596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040499|NCT05582798|Protease Inhibitors|protease inhibitors|mesh-list
92040500|NCT05582798|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92040501|NCT05582798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040502|NCT05582798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040503|NCT05582798|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92040504|NCT05582798|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92040507|NCT05552196|Anticonvulsants|anticonvulsants|mesh-ancestor
92040508|NCT05552196|Antimanic Agents|antimanic agents|mesh-ancestor
92040509|NCT05552196|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92040512|NCT05552196|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92040513|NCT05552196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92040514|NCT05552196|Analgesics|analgesics|mesh-ancestor
92040515|NCT05552196|Sensory System Agents|sensory system agents|mesh-ancestor
92040516|NCT05552196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014175|NCT04987567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040517|NCT05552196|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92040518|NCT05552196|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92040519|NCT05552196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040520|NCT05552196|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92040521|NCT05552196|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92040522|NCT05552196|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92040523|NCT05552196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040524|NCT05552196|Immunologic Factors|immunologic factors|mesh-ancestor
92040525|NCT05538247|Indomethacin|indomethacin|mesh-list
92040526|NCT05538247|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92040527|NCT05538247|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92040528|NCT05538247|Analgesics|analgesics|mesh-ancestor
92040529|NCT05538247|Sensory System Agents|sensory system agents|mesh-ancestor
92040530|NCT05538247|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040531|NCT05538247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040532|NCT05538247|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040533|NCT05538247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040534|NCT05538247|Gout Suppressants|gout suppressants|mesh-ancestor
92040535|NCT05538247|Tocolytic Agents|tocolytic agents|mesh-ancestor
92040536|NCT05538247|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92040537|NCT05538247|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92040538|NCT05538247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040539|NCT05538247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040540|NCT05536414|Escitalopram|escitalopram|mesh-list
92040541|NCT05536414|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92040542|NCT05536414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92040543|NCT05536414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92040544|NCT05536414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040545|NCT05536414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040546|NCT05536414|Serotonin Agents|serotonin agents|mesh-ancestor
92040547|NCT05536414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040548|NCT05496192|Nivolumab|nivolumab|mesh-list
92040549|NCT05496192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040550|NCT05496192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040551|NCT05496192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040552|NCT05496192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040553|NCT05472623|Nivolumab|nivolumab|mesh-list
92040554|NCT05472623|Adagrasib|adagrasib|mesh-list
92040555|NCT05472623|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040556|NCT05472623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040557|NCT05472623|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040558|NCT05472623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040559|NCT05438394|Melphalan|melphalan|mesh-list
92040560|NCT05438394|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92040561|NCT05438394|Alkylating Agents|alkylating agents|mesh-ancestor
92040562|NCT05438394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040563|NCT05438394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040564|NCT05438394|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92040565|NCT05438394|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040566|NCT05438394|Immunologic Factors|immunologic factors|mesh-ancestor
92040567|NCT05438394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040568|NCT05386030|Lidocaine|lidocaine|mesh-list
92040569|NCT05386030|Anesthetics, Local|anesthetics, local|mesh-ancestor
92040570|NCT05386030|Anesthetics|anesthetics|mesh-ancestor
92040571|NCT05386030|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040572|NCT05386030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040573|NCT05386030|Sensory System Agents|sensory system agents|mesh-ancestor
92040574|NCT05386030|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040575|NCT05386030|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92040576|NCT05386030|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92040577|NCT05386030|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92040578|NCT05386030|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92040581|NCT05324852|Loxapine|loxapine|mesh-list
92040582|NCT05324852|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92040583|NCT05324852|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92040584|NCT05324852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040585|NCT05324852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040586|NCT05324852|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92014176|NCT04987567|Protective Agents|protective agents|mesh-ancestor
92014177|NCT04987567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014178|NCT03072199|Rituximab|rituximab|mesh-list
92014179|NCT03072199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014180|NCT03072199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014181|NCT03072199|Immunologic Factors|immunologic factors|mesh-ancestor
92040587|NCT05324852|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92040588|NCT05324852|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92040589|NCT05324852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92040590|NCT05324852|Anesthetics, General|anesthetics, general|mesh-ancestor
92040591|NCT05324852|Anesthetics|anesthetics|mesh-ancestor
92040592|NCT05324852|GABA Modulators|gaba modulators|mesh-ancestor
92040593|NCT05324852|GABA Agents|gaba agents|mesh-ancestor
92040594|NCT05324852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040595|NCT05324852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040596|NCT05324852|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92040597|NCT05324852|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92040598|NCT05324852|Dopamine Agents|dopamine agents|mesh-ancestor
92040599|NCT05287568|Venetoclax|venetoclax|mesh-list
92040600|NCT05287568|Cc-486|cc-486|mesh-list
92040601|NCT05287568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040602|NCT05287191|Magnesium Sulfate|magnesium sulfate|mesh-list
92040603|NCT05287191|Digoxin|digoxin|mesh-list
92040604|NCT05287191|Amiodarone|amiodarone|mesh-list
92040605|NCT05287191|Analgesics|analgesics|mesh-ancestor
92040606|NCT05287191|Sensory System Agents|sensory system agents|mesh-ancestor
92040607|NCT05287191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040608|NCT05287191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040609|NCT05287191|Anesthetics|anesthetics|mesh-ancestor
92040610|NCT05287191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040611|NCT05287191|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92040612|NCT05287191|Anticonvulsants|anticonvulsants|mesh-ancestor
92040613|NCT05287191|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92040614|NCT05287191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92040615|NCT05287191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040616|NCT05287191|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92040617|NCT05287191|Tocolytic Agents|tocolytic agents|mesh-ancestor
92040618|NCT05287191|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92040619|NCT05287191|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92040620|NCT05287191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040621|NCT05287191|Protective Agents|protective agents|mesh-ancestor
92040622|NCT05287191|Vasodilator Agents|vasodilator agents|mesh-ancestor
92040623|NCT05287191|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92040624|NCT05287191|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92040625|NCT05287191|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92040626|NCT05287191|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92040627|NCT05287191|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92040628|NCT05287191|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92040629|NCT05287191|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92040630|NCT05259046|Vitamin K 2|vitamin k 2|mesh-list
92040631|NCT05259046|Vitamin K|vitamin k|mesh-list
92040632|NCT05259046|Menaquinone 7|menaquinone 7|mesh-list
92040633|NCT05259046|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92040634|NCT05259046|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92040635|NCT05259046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040636|NCT05259046|Hemostatics|hemostatics|mesh-ancestor
92040637|NCT05259046|Coagulants|coagulants|mesh-ancestor
92040638|NCT05259046|Vitamins|vitamins|mesh-ancestor
92040639|NCT05259046|Micronutrients|micronutrients|mesh-ancestor
92040640|NCT05259046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040641|NCT05206682|Leuprolide|leuprolide|mesh-list
92040642|NCT05206682|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92040643|NCT05206682|Fertility Agents|fertility agents|mesh-ancestor
92040644|NCT05206682|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92040645|NCT05206682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040646|NCT05206682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040647|NCT05206682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040648|NCT05197842|Prednisone|prednisone|mesh-list
92040649|NCT05197842|Cyclophosphamide|cyclophosphamide|mesh-list
92040650|NCT05197842|Glucocorticoids|glucocorticoids|mesh-list
92040651|NCT05197842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014182|NCT03072199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014183|NCT03072199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040652|NCT05197842|Immunologic Factors|immunologic factors|mesh-ancestor
92040653|NCT05197842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040656|NCT05197842|Alkylating Agents|alkylating agents|mesh-ancestor
92040657|NCT05197842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040658|NCT05197842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040659|NCT05197842|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92040660|NCT05197842|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040661|NCT05197842|Hormones|hormones|mesh-ancestor
92040662|NCT05197842|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040663|NCT05197842|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040664|NCT05189457|Docetaxel|docetaxel|mesh-list
92040665|NCT05189457|Tislelizumab|tislelizumab|mesh-list
92040666|NCT05189457|Leuprolide|leuprolide|mesh-list
92040667|NCT05189457|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92040668|NCT05189457|Hormones|hormones|mesh-list
92040669|NCT05189457|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92040670|NCT05189457|Relugolix|relugolix|mesh-list
92040671|NCT05189457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040672|NCT05189457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040673|NCT05189457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040674|NCT05189457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040675|NCT05189457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040751|NCT04933084|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040676|NCT05189457|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040677|NCT05189457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040678|NCT05189457|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040679|NCT05189457|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92040680|NCT05189457|Fertility Agents|fertility agents|mesh-ancestor
92040681|NCT05189457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92040682|NCT05189457|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040683|NCT05189457|Luteolytic Agents|luteolytic agents|mesh-ancestor
92040684|NCT05189457|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92040685|NCT05189457|Contraceptive Agents|contraceptive agents|mesh-ancestor
92040686|NCT05189457|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92040687|NCT05189457|Androgen Antagonists|androgen antagonists|mesh-ancestor
92040688|NCT05189457|Hormone Antagonists|hormone antagonists|mesh-ancestor
92040689|NCT05135910|Terbinafine|terbinafine|mesh-list
92040690|NCT05135910|Antifungal Agents|antifungal agents|mesh-ancestor
92040691|NCT05135910|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040692|NCT05135910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040693|NCT05135910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040694|NCT05129748|Sodium thiosulfate|sodium thiosulfate|mesh-list
92040695|NCT05129748|Mannitol|mannitol|mesh-list
92040696|NCT05129748|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92040697|NCT05129748|Diuretics|diuretics|mesh-ancestor
92040698|NCT05129748|Natriuretic Agents|natriuretic agents|mesh-ancestor
92040699|NCT05129748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040700|NCT05129748|Antidotes|antidotes|mesh-ancestor
92040701|NCT05129748|Protective Agents|protective agents|mesh-ancestor
92040702|NCT05129748|Antioxidants|antioxidants|mesh-ancestor
92040703|NCT05129748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040704|NCT05129748|Antitubercular Agents|antitubercular agents|mesh-ancestor
92040705|NCT05129748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92040706|NCT05129748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040707|NCT05129748|Chelating Agents|chelating agents|mesh-ancestor
92040708|NCT05129748|Sequestering Agents|sequestering agents|mesh-ancestor
92040709|NCT05127746|Donepezil|donepezil|mesh-list
92040710|NCT05127746|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92040711|NCT05127746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040712|NCT05127746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040713|NCT05127746|Cholinergic Agents|cholinergic agents|mesh-ancestor
92040714|NCT05127746|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040715|NCT05127746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040716|NCT05127746|Nootropic Agents|nootropic agents|mesh-ancestor
92040717|NCT05054998|Deoxyglucose|deoxyglucose|mesh-list
92040718|NCT05054998|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92040719|NCT05054998|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92040720|NCT05054998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040721|NCT05054998|Antimetabolites|antimetabolites|mesh-ancestor
92040722|NCT05054998|Antiviral Agents|antiviral agents|mesh-ancestor
92040723|NCT05054998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040725|NCT05024552|Daunorubicin|daunorubicin|mesh-list
92014184|NCT04806737|Teriflunomide|teriflunomide|mesh-list
92014185|NCT04806737|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92014186|NCT04806737|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92014187|NCT04806737|Analgesics|analgesics|mesh-ancestor
92040726|NCT05024552|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92040729|NCT05024552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040730|NCT05024552|Antiviral Agents|antiviral agents|mesh-ancestor
92040731|NCT05024552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040732|NCT05024552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040733|NCT05024552|Immunologic Factors|immunologic factors|mesh-ancestor
92040734|NCT05024552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040735|NCT05024552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92040736|NCT05024552|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92040737|NCT05024552|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92040738|NCT05024552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040740|NCT05004662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92040741|NCT05004662|Autonomic Agents|autonomic agents|mesh-ancestor
92040742|NCT05004662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040743|NCT05004662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040744|NCT05004662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92040745|NCT05004662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92040746|NCT05004662|Cholinergic Agents|cholinergic agents|mesh-ancestor
92040747|NCT05004662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040748|NCT05004662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040749|NCT04933084|Analgesics, Opioid|analgesics, opioid|mesh-list
92040750|NCT04933084|Narcotics|narcotics|mesh-ancestor
92040826|NCT04704505|Androgens|androgens|mesh-list
92040752|NCT04933084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040753|NCT04933084|Analgesics|analgesics|mesh-ancestor
92040754|NCT04933084|Sensory System Agents|sensory system agents|mesh-ancestor
92040755|NCT04933084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040756|NCT04930887|Bupivacaine|bupivacaine|mesh-list
92040757|NCT04930887|Anesthetics, Local|anesthetics, local|mesh-ancestor
92040758|NCT04930887|Anesthetics|anesthetics|mesh-ancestor
92040759|NCT04930887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040760|NCT04930887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040761|NCT04930887|Sensory System Agents|sensory system agents|mesh-ancestor
92040762|NCT04930887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040763|NCT04915612|Cytarabine|cytarabine|mesh-list
92040764|NCT04915612|Daunorubicin|daunorubicin|mesh-list
92040765|NCT04915612|Gemtuzumab|gemtuzumab|mesh-list
92040766|NCT04915612|Calicheamicins|calicheamicins|mesh-list
92040767|NCT04915612|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92040768|NCT04915612|Antimetabolites|antimetabolites|mesh-ancestor
92040769|NCT04915612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040770|NCT04915612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040771|NCT04915612|Antiviral Agents|antiviral agents|mesh-ancestor
92040772|NCT04915612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040773|NCT04915612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040774|NCT04915612|Immunologic Factors|immunologic factors|mesh-ancestor
92040775|NCT04915612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040776|NCT04915612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92040777|NCT04915612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92040778|NCT04915612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92040779|NCT04915612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040780|NCT04915612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040781|NCT04915612|Immunotoxins|immunotoxins|mesh-ancestor
92040782|NCT04915612|Immunoconjugates|immunoconjugates|mesh-ancestor
92040783|NCT04863248|Docetaxel|docetaxel|mesh-list
92040784|NCT04863248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040785|NCT04863248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040786|NCT04863248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040787|NCT04863248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040788|NCT04863248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040789|NCT04815902|Losartan|losartan|mesh-list
92040790|NCT04815902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92040791|NCT04815902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92040792|NCT04815902|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92040793|NCT04815902|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92040794|NCT04815902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014188|NCT04806737|Sensory System Agents|sensory system agents|mesh-ancestor
92014189|NCT04806737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014190|NCT04806737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014191|NCT04806737|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040795|NCT04807140|Paclitaxel|paclitaxel|mesh-list
92040796|NCT04807140|Carboplatin|carboplatin|mesh-list
92040797|NCT04807140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92040798|NCT04807140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040799|NCT04807140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040802|NCT04807140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040804|NCT04759248|Atezolizumab|atezolizumab|mesh-list
92040805|NCT04759248|Vinorelbine|vinorelbine|mesh-list
92040806|NCT04759248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040807|NCT04759248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040808|NCT04759248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040809|NCT04759248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040810|NCT04759248|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92040811|NCT04759248|Tubulin Modulators|tubulin modulators|mesh-ancestor
92040812|NCT04759248|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040813|NCT04759248|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040814|NCT04756726|Dexamethasone|dexamethasone|mesh-list
92040815|NCT04756726|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040816|NCT04756726|Antiemetics|antiemetics|mesh-ancestor
92040817|NCT04756726|Autonomic Agents|autonomic agents|mesh-ancestor
92040818|NCT04756726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040819|NCT04756726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040820|NCT04756726|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92040821|NCT04756726|Glucocorticoids|glucocorticoids|mesh-ancestor
92040822|NCT04756726|Hormones|hormones|mesh-ancestor
92040823|NCT04756726|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040824|NCT04756726|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040825|NCT04756726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040827|NCT04704505|Hormones|hormones|mesh-ancestor
92040828|NCT04704505|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040829|NCT04704505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040830|NCT04558918|Eculizumab|eculizumab|mesh-list
92040831|NCT04558918|Ravulizumab|ravulizumab|mesh-list
92040832|NCT04558918|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92040833|NCT04558918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92040834|NCT04558918|Immunologic Factors|immunologic factors|mesh-ancestor
92040835|NCT04558918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040836|NCT04529278|Liraglutide|liraglutide|mesh-list
92040837|NCT04529278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92040838|NCT04529278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040839|NCT04529278|Incretins|incretins|mesh-ancestor
92040840|NCT04529278|Hormones|hormones|mesh-ancestor
92040841|NCT04529278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040842|NCT04526730|Nivolumab|nivolumab|mesh-list
92040843|NCT04526730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040844|NCT04526730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040845|NCT04526730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040846|NCT04526730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040847|NCT04503148|Propofol|propofol|mesh-list
92040848|NCT04503148|Anesthetics|anesthetics|mesh-list
92040849|NCT04503148|Anesthetics, General|anesthetics, general|mesh-list
92040850|NCT04503148|Anesthetics, Inhalation|anesthetics, inhalation|mesh-list
92040851|NCT04503148|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92040852|NCT04503148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040853|NCT04503148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040854|NCT04503148|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92040855|NCT04498832|Vaccines|vaccines|mesh-list
92040856|NCT04498832|Immunologic Factors|immunologic factors|mesh-ancestor
92040858|NCT04493203|Nivolumab|nivolumab|mesh-list
92040859|NCT04493203|Axitinib|axitinib|mesh-list
92040860|NCT04493203|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040861|NCT04493203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040862|NCT04493203|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040863|NCT04493203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014192|NCT04806737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92014193|NCT04806737|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014194|NCT04806737|Immunologic Factors|immunologic factors|mesh-ancestor
92014196|NCT04991155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040864|NCT04493203|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92040865|NCT04493203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040866|NCT04458545|Heroin|heroin|mesh-list
92040867|NCT04458545|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92040868|NCT04458545|Narcotics|narcotics|mesh-ancestor
92040869|NCT04458545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040870|NCT04458545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040871|NCT04458545|Analgesics|analgesics|mesh-ancestor
92040872|NCT04458545|Sensory System Agents|sensory system agents|mesh-ancestor
92040895|NCT04412096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040896|NCT04412096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92040897|NCT04412096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92040898|NCT04405167|Dexamethasone|dexamethasone|mesh-list
92040899|NCT04405167|Lenalidomide|lenalidomide|mesh-list
92040900|NCT04405167|Ixazomib|ixazomib|mesh-list
92040901|NCT04405167|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92040902|NCT04405167|Antiemetics|antiemetics|mesh-ancestor
92040903|NCT04405167|Autonomic Agents|autonomic agents|mesh-ancestor
92040904|NCT04405167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040905|NCT04405167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040906|NCT04405167|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92040907|NCT04405167|Glucocorticoids|glucocorticoids|mesh-ancestor
92040908|NCT04405167|Hormones|hormones|mesh-ancestor
92040909|NCT04405167|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92040910|NCT04405167|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92040911|NCT04405167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040912|NCT04405167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92040913|NCT04405167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040914|NCT04405167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040915|NCT04405167|Immunologic Factors|immunologic factors|mesh-ancestor
92040916|NCT04405167|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92040917|NCT04405167|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92040918|NCT04405167|Growth Substances|growth substances|mesh-ancestor
92040919|NCT04405167|Growth Inhibitors|growth inhibitors|mesh-ancestor
92040920|NCT04388852|Ipilimumab|ipilimumab|mesh-list
92040921|NCT04388852|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92040922|NCT04388852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040923|NCT04388852|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92040924|NCT04388852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040955|NCT04357951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040958|NCT04282668|Tretinoin|tretinoin|mesh-list
92040959|NCT04282668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92040960|NCT04282668|Keratolytic Agents|keratolytic agents|mesh-ancestor
92040961|NCT04282668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92040962|NCT04259060|Hydroxocobalamin|hydroxocobalamin|mesh-list
92040963|NCT04259060|Vitamin B 12|vitamin b 12|mesh-list
92040964|NCT04259060|Hematinics|hematinics|mesh-ancestor
92040965|NCT04259060|Vitamin B Complex|vitamin b complex|mesh-ancestor
92040966|NCT04259060|Vitamins|vitamins|mesh-ancestor
92040967|NCT04259060|Micronutrients|micronutrients|mesh-ancestor
92040968|NCT04259060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040969|NCT04219904|Deoxyglucose|deoxyglucose|mesh-list
92040970|NCT04219904|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92040971|NCT04219904|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92040972|NCT04219904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040973|NCT04219904|Antimetabolites|antimetabolites|mesh-ancestor
92040974|NCT04219904|Antiviral Agents|antiviral agents|mesh-ancestor
92040975|NCT04219904|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040976|NCT04218240|Lofexidine|lofexidine|mesh-list
92040977|NCT04218240|Pregabalin|pregabalin|mesh-list
92040979|NCT04218240|Sensory System Agents|sensory system agents|mesh-ancestor
92040980|NCT04218240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040981|NCT04218240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040982|NCT04218240|Anticonvulsants|anticonvulsants|mesh-ancestor
92040983|NCT04218240|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92014197|NCT04991155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014199|NCT04462315|Chromium|chromium|mesh-list
92014200|NCT04462315|Everolimus|everolimus|mesh-list
92040984|NCT04218240|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92040985|NCT04218240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040986|NCT04218240|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92040987|NCT04218240|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92040988|NCT04218240|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92040989|NCT04218240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040990|NCT04218240|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92040991|NCT04218240|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92040992|NCT04218240|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92040993|NCT04218240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92040994|NCT04218240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92040995|NCT04218240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92040996|NCT04218240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92040997|NCT04218240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040998|NCT04212793|Bevacizumab|bevacizumab|mesh-list
92040999|NCT04212793|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041000|NCT04212793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041001|NCT04212793|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92041002|NCT04212793|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92041003|NCT04212793|Growth Substances|growth substances|mesh-ancestor
92041004|NCT04212793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041005|NCT04212793|Growth Inhibitors|growth inhibitors|mesh-ancestor
92041006|NCT04084951|Nivolumab|nivolumab|mesh-list
92041007|NCT04084951|Ipilimumab|ipilimumab|mesh-list
92041008|NCT04084951|Atezolizumab|atezolizumab|mesh-list
92041009|NCT04084951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041010|NCT04084951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041011|NCT04084951|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041012|NCT04084951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041013|NCT04083898|Prednisone|prednisone|mesh-list
92041014|NCT04083898|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92041015|NCT04083898|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041031|NCT04035837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041033|NCT04023227|Enalapril|enalapril|mesh-list
92041034|NCT04023227|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92041035|NCT04023227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92041036|NCT04023227|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92041037|NCT04023227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92041038|NCT04023227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041039|NCT04023227|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92041040|NCT04023227|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041041|NCT04023227|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041042|NCT04022135|Folic Acid|folic acid|mesh-list
92041044|NCT04022135|Vitamin B Complex|vitamin b complex|mesh-ancestor
92041045|NCT04022135|Vitamins|vitamins|mesh-ancestor
92041046|NCT04022135|Micronutrients|micronutrients|mesh-ancestor
92041047|NCT04022135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041048|NCT04001777|Osimertinib|osimertinib|mesh-list
92041049|NCT04001777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041050|NCT04001777|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92041051|NCT04001777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041052|NCT04001777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041053|NCT03987802|Insulin Aspart|insulin aspart|mesh-list
92041054|NCT03987802|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92041055|NCT03987802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041057|NCT03983668|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041058|NCT03983668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041059|NCT03983668|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041060|NCT03983668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041061|NCT03977012|Buprenorphine|buprenorphine|mesh-list
92041062|NCT03977012|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92041063|NCT03977012|Narcotics|narcotics|mesh-ancestor
92041064|NCT03977012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041065|NCT03977012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014201|NCT04462315|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92014202|NCT04462315|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92014203|NCT04462315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014204|NCT04462315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014205|NCT04462315|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014206|NCT04462315|Immunologic Factors|immunologic factors|mesh-ancestor
92014207|NCT04462315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014208|NCT04462315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014209|NCT04462315|Trace Elements|trace elements|mesh-ancestor
92014210|NCT04462315|Micronutrients|micronutrients|mesh-ancestor
92014211|NCT04806425|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92014212|NCT04806425|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92014213|NCT04806425|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92014214|NCT04806425|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92014215|NCT03071731|Bromides|bromides|mesh-list
92041066|NCT03977012|Analgesics|analgesics|mesh-ancestor
92041067|NCT03977012|Sensory System Agents|sensory system agents|mesh-ancestor
92041068|NCT03977012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041069|NCT03977012|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92041071|NCT03915964|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92041072|NCT03915964|Etanercept|etanercept|mesh-list
92041073|NCT03915964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041074|NCT03915964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041075|NCT03915964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92041080|NCT03915964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041081|NCT03915964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041082|NCT03915964|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041083|NCT03915964|Immunologic Factors|immunologic factors|mesh-ancestor
92041084|NCT03907423|Metformin|metformin|mesh-list
92041085|NCT03907423|Glimepiride|glimepiride|mesh-list
92041086|NCT03907423|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92041087|NCT03907423|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92041088|NCT03907423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041089|NCT03907423|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92041090|NCT03907423|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92041091|NCT03907423|Antimetabolites|antimetabolites|mesh-ancestor
92041092|NCT03907423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041093|NCT03907423|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92041094|NCT03907423|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92041095|NCT03907423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041096|NCT03907423|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92041097|NCT03907423|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041098|NCT03907423|Immunologic Factors|immunologic factors|mesh-ancestor
92041099|NCT03897621|Tranexamic Acid|tranexamic acid|mesh-list
92041100|NCT03897621|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92041101|NCT03897621|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92041102|NCT03897621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041103|NCT03897621|Hemostatics|hemostatics|mesh-ancestor
92041104|NCT03897621|Coagulants|coagulants|mesh-ancestor
92041105|NCT03896269|Cytarabine|cytarabine|mesh-list
92041106|NCT03896269|Daunorubicin|daunorubicin|mesh-list
92041107|NCT03896269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041108|NCT03896269|Antimetabolites|antimetabolites|mesh-ancestor
92041501|NCT01919086|Immunologic Factors|immunologic factors|mesh-ancestor
92041109|NCT03896269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041110|NCT03896269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041111|NCT03896269|Antiviral Agents|antiviral agents|mesh-ancestor
92041112|NCT03896269|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041113|NCT03896269|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041114|NCT03896269|Immunologic Factors|immunologic factors|mesh-ancestor
92041115|NCT03896269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041116|NCT03896269|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92041117|NCT03896269|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92041118|NCT03896269|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92041119|NCT03896269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041120|NCT03809884|Potassium Citrate|potassium citrate|mesh-list
92041121|NCT03809884|Diuretics|diuretics|mesh-ancestor
92041122|NCT03809884|Natriuretic Agents|natriuretic agents|mesh-ancestor
92041123|NCT03809884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041124|NCT03809884|Expectorants|expectorants|mesh-ancestor
92041125|NCT03809884|Respiratory System Agents|respiratory system agents|mesh-ancestor
92041126|NCT03805594|Pembrolizumab|pembrolizumab|mesh-list
92041127|NCT03805594|177Lu-PSMA-617|177lu-psma-617|mesh-list
92041128|NCT03805594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041129|NCT03805594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041130|NCT03805594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041131|NCT03805594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041132|NCT03805594|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92041133|NCT03768427|Atorvastatin|atorvastatin|mesh-list
92041134|NCT03768427|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92041135|NCT03768427|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92041136|NCT03768427|Antimetabolites|antimetabolites|mesh-ancestor
92041137|NCT03768427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041138|NCT03768427|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92041139|NCT03768427|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92041140|NCT03768427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041141|NCT03758781|Nivolumab|nivolumab|mesh-list
92041142|NCT03758781|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041143|NCT03758781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041144|NCT03758781|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041145|NCT03758781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041149|NCT03746080|Alkylating Agents|alkylating agents|mesh-ancestor
92041150|NCT03746080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041151|NCT03746080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041152|NCT03746080|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92041153|NCT03746080|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92041154|NCT03746080|Antiviral Agents|antiviral agents|mesh-ancestor
92041155|NCT03746080|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041157|NCT03737994|Carboplatin|carboplatin|mesh-list
92041158|NCT03737994|Pemetrexed|pemetrexed|mesh-list
92041159|NCT03737994|Crizotinib|crizotinib|mesh-list
92041160|NCT03737994|Ceritinib|ceritinib|mesh-list
92041161|NCT03737994|Ensartinib|ensartinib|mesh-list
92041162|NCT03737994|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92041163|NCT03737994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041164|NCT03737994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041165|NCT03737994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041166|NCT03737994|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92041167|NCT03737994|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92041168|NCT03737994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92041169|NCT03724149|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92041170|NCT03724149|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92041171|NCT03724149|Antiviral Agents|antiviral agents|mesh-ancestor
92041172|NCT03724149|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041173|NCT03598309|Curcumin|curcumin|mesh-list
92041174|NCT03598309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92041175|NCT03598309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92041176|NCT03598309|Analgesics|analgesics|mesh-ancestor
92041177|NCT03598309|Sensory System Agents|sensory system agents|mesh-ancestor
92041178|NCT03598309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041179|NCT03598309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041180|NCT03598309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041181|NCT03598309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041182|NCT03598309|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041183|NCT03598309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041184|NCT03598309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041185|NCT03572933|Pregnanolone|pregnanolone|mesh-list
92041186|NCT03572933|Ganaxolone|ganaxolone|mesh-list
92041187|NCT03572933|Neurosteroids|neurosteroids|mesh-ancestor
92041188|NCT03572933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041189|NCT03572933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041190|NCT03572933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014218|NCT03071731|Anticonvulsants|anticonvulsants|mesh-ancestor
92014219|NCT03071731|Autonomic Agents|autonomic agents|mesh-ancestor
92014220|NCT03071731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014221|NCT03071731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014222|NCT03071731|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92014223|NCT03071731|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014224|NCT03071731|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014225|NCT03071731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014226|NCT03071731|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92014227|NCT03071731|Cholinergic Agents|cholinergic agents|mesh-ancestor
92014229|NCT04809935|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92041191|NCT03572933|GABA Modulators|gaba modulators|mesh-ancestor
92041192|NCT03572933|GABA Agents|gaba agents|mesh-ancestor
92041193|NCT03572933|Anesthetics|anesthetics|mesh-ancestor
92041194|NCT03572933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041195|NCT03558152|Vedolizumab|vedolizumab|mesh-list
92041196|NCT03558152|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041197|NCT03511196|Prednisone|prednisone|mesh-list
92041198|NCT03511196|Glucocorticoids|glucocorticoids|mesh-list
92041199|NCT03511196|Androgens|androgens|mesh-list
92041200|NCT03511196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041201|NCT03511196|Hormones|hormones|mesh-ancestor
92041202|NCT03511196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041203|NCT03511196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041204|NCT03511196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041205|NCT03511196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041206|NCT03502668|Decitabine|decitabine|mesh-list
92041207|NCT03502668|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92041208|NCT03502668|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041209|NCT03502668|Antimetabolites|antimetabolites|mesh-ancestor
92041210|NCT03502668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041211|NCT03502668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041212|NCT03502668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041213|NCT03501368|Trametinib|trametinib|mesh-list
92041214|NCT03501368|Ceritinib|ceritinib|mesh-list
92041215|NCT03501368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041216|NCT03501368|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92041217|NCT03501368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041218|NCT03501368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041229|NCT03431974|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92041230|NCT03431974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041231|NCT03431974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041232|NCT03416335|Pembrolizumab|pembrolizumab|mesh-list
92041233|NCT03416335|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041234|NCT03416335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041235|NCT03416335|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041236|NCT03416335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041237|NCT03317496|Cisplatin|cisplatin|mesh-list
92041238|NCT03317496|Carboplatin|carboplatin|mesh-list
92041239|NCT03317496|Gemcitabine|gemcitabine|mesh-list
92041240|NCT03317496|Pemetrexed|pemetrexed|mesh-list
92041241|NCT03317496|Avelumab|avelumab|mesh-list
92041242|NCT03317496|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92041243|NCT03317496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041244|NCT03317496|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041245|NCT03317496|Antimetabolites|antimetabolites|mesh-ancestor
92041246|NCT03317496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014230|NCT04809935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014231|NCT04809935|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041248|NCT03317496|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92041249|NCT03317496|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92041250|NCT03317496|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041251|NCT03317496|Immunologic Factors|immunologic factors|mesh-ancestor
92041252|NCT03317496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041253|NCT03311308|Metformin|metformin|mesh-list
92041254|NCT03311308|Pembrolizumab|pembrolizumab|mesh-list
92041255|NCT03311308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92041256|NCT03311308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041257|NCT03311308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041258|NCT03311308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041259|NCT03311308|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041260|NCT03311308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041261|NCT03288545|Carboplatin|carboplatin|mesh-list
92041262|NCT03288545|Gemcitabine|gemcitabine|mesh-list
92041263|NCT03288545|Pembrolizumab|pembrolizumab|mesh-list
92041264|NCT03288545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041265|NCT03288545|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041266|NCT03288545|Antimetabolites|antimetabolites|mesh-ancestor
92041267|NCT03288545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041268|NCT03288545|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041269|NCT03288545|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041270|NCT03279393|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92041271|NCT03279393|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92041272|NCT03279393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041273|NCT03229499|Anastrozole|anastrozole|mesh-list
92041274|NCT03229499|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041275|NCT03229499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041276|NCT03229499|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92041277|NCT03229499|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92041278|NCT03229499|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041279|NCT03229499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041280|NCT03229499|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92041281|NCT03229499|Hormone Antagonists|hormone antagonists|mesh-ancestor
92041282|NCT03229499|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041299|NCT03132454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041301|NCT03132454|Glucocorticoids|glucocorticoids|mesh-ancestor
92041303|NCT03132454|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041304|NCT03132454|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041305|NCT03132454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041306|NCT03132454|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041307|NCT03132454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041308|NCT03132454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041309|NCT03132454|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92041310|NCT03132454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041312|NCT03132454|Dermatologic Agents|dermatologic agents|mesh-ancestor
92041313|NCT02964078|Aldesleukin|aldesleukin|mesh-list
92041314|NCT02964078|Pembrolizumab|pembrolizumab|mesh-list
92041315|NCT02964078|Interleukin-2|interleukin-2|mesh-list
92041316|NCT02964078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041317|NCT02964078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041318|NCT02964078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041319|NCT02964078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041320|NCT02964078|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92041321|NCT02964078|Analgesics|analgesics|mesh-ancestor
92041322|NCT02964078|Sensory System Agents|sensory system agents|mesh-ancestor
92041323|NCT02964078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041324|NCT02964078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041325|NCT02964078|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92041326|NCT02964078|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92041327|NCT02964078|Antiviral Agents|antiviral agents|mesh-ancestor
92041328|NCT02964078|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041329|NCT02960659|Metformin|metformin|mesh-list
92014232|NCT04809935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014233|NCT04255927|Triclosan|triclosan|mesh-list
92014234|NCT04255927|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92014235|NCT04255927|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014236|NCT04255927|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92014237|NCT04255927|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92014238|NCT04255927|Antimetabolites|antimetabolites|mesh-ancestor
92041330|NCT02960659|Liraglutide|liraglutide|mesh-list
92041331|NCT02960659|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92041332|NCT02960659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041333|NCT02960659|Incretins|incretins|mesh-ancestor
92041334|NCT02960659|Hormones|hormones|mesh-ancestor
92041335|NCT02960659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041336|NCT02915744|Paclitaxel|paclitaxel|mesh-list
92041337|NCT02915744|Vinorelbine|vinorelbine|mesh-list
92041338|NCT02915744|Docetaxel|docetaxel|mesh-list
92041339|NCT02915744|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92041340|NCT02915744|Gemcitabine|gemcitabine|mesh-list
92041341|NCT02915744|Etirinotecan pegol|etirinotecan pegol|mesh-list
92041342|NCT02915744|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92041343|NCT02915744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041344|NCT02915744|Tubulin Modulators|tubulin modulators|mesh-ancestor
92041348|NCT02915744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041350|NCT02915744|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92041351|NCT02915744|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92041352|NCT02915744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041353|NCT02782949|Curcumin|curcumin|mesh-list
92041354|NCT02782949|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92041355|NCT02782949|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92041356|NCT02782949|Analgesics|analgesics|mesh-ancestor
92041357|NCT02782949|Sensory System Agents|sensory system agents|mesh-ancestor
92041358|NCT02782949|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041359|NCT02782949|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041360|NCT02782949|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041361|NCT02782949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041362|NCT02782949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041363|NCT02782949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041364|NCT02782949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041365|NCT02736656|Viloxazine|viloxazine|mesh-list
92041366|NCT02736656|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92041367|NCT02736656|Antidepressive Agents|antidepressive agents|mesh-ancestor
92041368|NCT02736656|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92041369|NCT02736656|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92041370|NCT02736656|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92041371|NCT02736656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92041372|NCT02736656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041373|NCT02736656|Adrenergic Agents|adrenergic agents|mesh-ancestor
92041374|NCT02736656|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041375|NCT02736656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041376|NCT02506933|Vaccines|vaccines|mesh-list
92041377|NCT02506933|Immunologic Factors|immunologic factors|mesh-ancestor
92041378|NCT02506933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041379|NCT02491632|Dexamethasone|dexamethasone|mesh-list
92041380|NCT02491632|Dexamethasone acetate|dexamethasone acetate|mesh-list
92041382|NCT02491632|BB 1101|bb 1101|mesh-list
92041383|NCT02491632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041384|NCT02491632|Antiemetics|antiemetics|mesh-ancestor
92041385|NCT02491632|Autonomic Agents|autonomic agents|mesh-ancestor
92041386|NCT02491632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041387|NCT02491632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041388|NCT02491632|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041389|NCT02491632|Glucocorticoids|glucocorticoids|mesh-ancestor
92041390|NCT02491632|Hormones|hormones|mesh-ancestor
92041391|NCT02491632|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041392|NCT02491632|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041393|NCT02491632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041394|NCT02491632|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041395|NCT02491632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014239|NCT04255927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014240|NCT04255927|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92041396|NCT02491632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041397|NCT02491632|Dermatologic Agents|dermatologic agents|mesh-ancestor
92041399|NCT02409810|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92041400|NCT02409810|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041401|NCT02409810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041402|NCT02409810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92041403|NCT02409810|Analgesics|analgesics|mesh-ancestor
92041404|NCT02409810|Sensory System Agents|sensory system agents|mesh-ancestor
92041405|NCT02409810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041406|NCT02409810|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92041407|NCT02409810|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92041409|NCT02409810|Adrenergic Agents|adrenergic agents|mesh-ancestor
92041410|NCT02409810|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041411|NCT02409810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041412|NCT02324608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92041413|NCT02324608|Cetuximab|cetuximab|mesh-list
92041414|NCT02324608|Antibodies|antibodies|mesh-list
92041415|NCT02324608|Immunoglobulins|immunoglobulins|mesh-list
92041419|NCT02324608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041420|NCT02286726|Cytarabine|cytarabine|mesh-list
92041421|NCT02286726|Daunorubicin|daunorubicin|mesh-list
92041422|NCT02286726|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041423|NCT02286726|Antimetabolites|antimetabolites|mesh-ancestor
92041424|NCT02286726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041425|NCT02286726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041426|NCT02286726|Antiviral Agents|antiviral agents|mesh-ancestor
92041427|NCT02286726|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041428|NCT02286726|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041429|NCT02286726|Immunologic Factors|immunologic factors|mesh-ancestor
92041430|NCT02286726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041431|NCT02286726|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92041432|NCT02286726|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92041433|NCT02286726|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92041434|NCT02286726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041435|NCT02206815|Aspirin|aspirin|mesh-list
92041436|NCT02206815|Warfarin|warfarin|mesh-list
92041437|NCT02206815|Clopidogrel|clopidogrel|mesh-list
92041438|NCT02206815|Ticagrelor|ticagrelor|mesh-list
92041439|NCT02206815|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92041440|NCT02206815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92041441|NCT02206815|Analgesics|analgesics|mesh-ancestor
92041442|NCT02206815|Sensory System Agents|sensory system agents|mesh-ancestor
92041443|NCT02206815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041444|NCT02206815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041445|NCT02206815|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041446|NCT02206815|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041447|NCT02206815|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92041448|NCT02206815|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92041449|NCT02206815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041450|NCT02206815|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92041451|NCT02206815|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92041452|NCT02206815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041453|NCT02206815|Antipyretics|antipyretics|mesh-ancestor
92041454|NCT02206815|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92041455|NCT02206815|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92041456|NCT02206815|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92041457|NCT02206815|Purinergic Agents|purinergic agents|mesh-ancestor
92041458|NCT02206815|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041459|NCT02206815|Anticoagulants|anticoagulants|mesh-ancestor
92041460|NCT02175680|Leronlimab|leronlimab|mesh-list
92041461|NCT02175680|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92041462|NCT02175680|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92041463|NCT02175680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041464|NCT02175680|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92041465|NCT02175680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92041466|NCT02175680|Antiviral Agents|antiviral agents|mesh-ancestor
92041467|NCT02175680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041468|NCT01983462|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92041469|NCT01983462|Clonidine|clonidine|mesh-list
92014241|NCT03069781|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92014243|NCT03069781|Estradiol|estradiol|mesh-list
92014244|NCT03069781|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92014245|NCT03069781|Estrogens|estrogens|mesh-ancestor
92014246|NCT03069781|Hormones|hormones|mesh-ancestor
92014247|NCT03069781|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041470|NCT01983462|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92041471|NCT01983462|Diuretics|diuretics|mesh-ancestor
92041472|NCT01983462|Natriuretic Agents|natriuretic agents|mesh-ancestor
92041473|NCT01983462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041474|NCT01983462|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92041475|NCT01983462|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92041476|NCT01983462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041477|NCT01983462|Analgesics|analgesics|mesh-ancestor
92041478|NCT01983462|Sensory System Agents|sensory system agents|mesh-ancestor
92041479|NCT01983462|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041480|NCT01983462|Sympatholytics|sympatholytics|mesh-ancestor
92041481|NCT01983462|Autonomic Agents|autonomic agents|mesh-ancestor
92041482|NCT01983462|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92041483|NCT01983462|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92041484|NCT01983462|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92041485|NCT01983462|Adrenergic Agents|adrenergic agents|mesh-ancestor
92041486|NCT01983462|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041487|NCT01919086|Dexamethasone|dexamethasone|mesh-list
92041492|NCT01919086|Autonomic Agents|autonomic agents|mesh-ancestor
92041493|NCT01919086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041494|NCT01919086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041495|NCT01919086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041496|NCT01919086|Glucocorticoids|glucocorticoids|mesh-ancestor
92041497|NCT01919086|Hormones|hormones|mesh-ancestor
92041498|NCT01919086|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041499|NCT01919086|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041500|NCT01919086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041502|NCT01919086|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92041503|NCT01919086|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92041504|NCT01919086|Growth Substances|growth substances|mesh-ancestor
92041505|NCT01919086|Growth Inhibitors|growth inhibitors|mesh-ancestor
92041506|NCT01779375|Metformin|metformin|mesh-list
92041507|NCT01779375|Insulin Glargine|insulin glargine|mesh-list
92041508|NCT01779375|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92041509|NCT01779375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041510|NCT01559935|Clarithromycin|clarithromycin|mesh-list
92041511|NCT01559935|Dexamethasone|dexamethasone|mesh-list
92041512|NCT01559935|Dexamethasone acetate|dexamethasone acetate|mesh-list
92041513|NCT01559935|Lenalidomide|lenalidomide|mesh-list
92041514|NCT01559935|BB 1101|bb 1101|mesh-list
92041515|NCT01559935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041516|NCT01559935|Antiemetics|antiemetics|mesh-ancestor
92041517|NCT01559935|Autonomic Agents|autonomic agents|mesh-ancestor
92041518|NCT01559935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041519|NCT01559935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041520|NCT01559935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041521|NCT01559935|Glucocorticoids|glucocorticoids|mesh-ancestor
92041522|NCT01559935|Hormones|hormones|mesh-ancestor
92041523|NCT01559935|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041524|NCT01559935|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041525|NCT01559935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041526|NCT01559935|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041527|NCT01559935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041528|NCT01559935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041529|NCT01559935|Immunologic Factors|immunologic factors|mesh-ancestor
92041530|NCT01559935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92041531|NCT01559935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92041532|NCT01559935|Growth Substances|growth substances|mesh-ancestor
92041533|NCT01559935|Growth Inhibitors|growth inhibitors|mesh-ancestor
92041534|NCT01559935|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92014248|NCT03069781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014249|NCT03069781|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92014250|NCT03069781|Contraceptive Agents|contraceptive agents|mesh-ancestor
92041535|NCT01559935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041536|NCT01559935|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92041537|NCT01559935|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92041538|NCT01559935|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92041539|NCT00981058|Gemcitabine|gemcitabine|mesh-list
92041540|NCT00981058|Necitumumab|necitumumab|mesh-list
92041541|NCT00981058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041542|NCT00981058|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041543|NCT00981058|Antimetabolites|antimetabolites|mesh-ancestor
92041544|NCT00981058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041545|NCT00981058|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041546|NCT00667069|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92041547|NCT00667069|Luteolytic Agents|luteolytic agents|mesh-ancestor
92041548|NCT00667069|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92041549|NCT00667069|Contraceptive Agents|contraceptive agents|mesh-ancestor
92041550|NCT00667069|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92041551|NCT00667069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041552|NCT00667069|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92041553|NCT00667069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041554|NCT00667069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041557|NCT00565851|Bevacizumab|bevacizumab|mesh-list
92041558|NCT00565851|Carboplatin|carboplatin|mesh-list
92041559|NCT00565851|Gemcitabine|gemcitabine|mesh-list
92041560|NCT00565851|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92041561|NCT00565851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92041589|NCT04499677|Favipiravir|favipiravir|mesh-list
92041590|NCT04499677|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92041591|NCT04499677|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92041592|NCT04499677|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041593|NCT04499677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041594|NCT04499677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041595|NCT04499677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92041596|NCT04499677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92041597|NCT04499677|Antiviral Agents|antiviral agents|mesh-ancestor
92041598|NCT04499677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041599|NCT04499677|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92041600|NCT04499677|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92041601|NCT05652751|Mitogens|mitogens|mesh-list
92041602|NCT05652751|Mitosis Modulators|mitosis modulators|mesh-ancestor
92041603|NCT05652751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041604|NCT02915263|Immunoglobulins|immunoglobulins|mesh-list
92041605|NCT02915263|Immunologic Factors|immunologic factors|mesh-ancestor
92041606|NCT02915263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041607|NCT02909335|Mycophenolic Acid|mycophenolic acid|mesh-list
92041608|NCT02909335|Prednisone|prednisone|mesh-list
92041609|NCT02909335|Methylprednisolone|methylprednisolone|mesh-list
92041613|NCT02909335|Prednisolone acetate|prednisolone acetate|mesh-list
92041614|NCT02909335|Everolimus|everolimus|mesh-list
92041615|NCT02909335|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92041616|NCT02909335|Prednisolone phosphate|prednisolone phosphate|mesh-list
92041617|NCT02909335|Tacrolimus|tacrolimus|mesh-list
92041618|NCT02909335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041619|NCT02909335|Glucocorticoids|glucocorticoids|mesh-ancestor
92041620|NCT02909335|Hormones|hormones|mesh-ancestor
92041621|NCT02909335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041622|NCT02909335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041623|NCT02909335|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041624|NCT02909335|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041625|NCT02909335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041626|NCT02909335|Immunologic Factors|immunologic factors|mesh-ancestor
92041627|NCT02909335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92041628|NCT02909335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041629|NCT02909335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041630|NCT02909335|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92041631|NCT02909335|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92014251|NCT03069781|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92014252|NCT03069781|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92014253|NCT03071575|Vaccines|vaccines|mesh-list
92041632|NCT02909335|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92041633|NCT02909335|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92041634|NCT02909335|Antitubercular Agents|antitubercular agents|mesh-ancestor
92041635|NCT02909335|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92041636|NCT02909335|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041637|NCT02909335|Antiemetics|antiemetics|mesh-ancestor
92041638|NCT02909335|Autonomic Agents|autonomic agents|mesh-ancestor
92041639|NCT02909335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041640|NCT02909335|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041641|NCT02909335|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92041642|NCT02909335|Protective Agents|protective agents|mesh-ancestor
92041643|NCT04417699|Oxaliplatin|oxaliplatin|mesh-list
92041644|NCT04417699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041645|NCT05652517|Ethanol|ethanol|mesh-list
92041646|NCT05652517|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92041647|NCT05652517|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041648|NCT05652517|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041649|NCT05652517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041650|NCT04806373|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92041651|NCT04806373|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92041652|NCT04806373|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92041653|NCT04806373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041654|NCT03998293|Somatostatin|somatostatin|mesh-list
92041655|NCT03998293|Hormones|hormones|mesh-ancestor
92041656|NCT03998293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041657|NCT03998293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041658|NCT01606306|Fluticasone|fluticasone|mesh-list
92041659|NCT01606306|Xhance|xhance|mesh-list
92041660|NCT01606306|Montelukast|montelukast|mesh-list
92041661|NCT01606306|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041662|NCT01606306|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92041663|NCT01606306|Autonomic Agents|autonomic agents|mesh-ancestor
92041664|NCT01606306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041665|NCT01606306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041666|NCT01606306|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92041667|NCT01606306|Respiratory System Agents|respiratory system agents|mesh-ancestor
92041668|NCT01606306|Dermatologic Agents|dermatologic agents|mesh-ancestor
92041669|NCT01606306|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92041670|NCT01606306|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92041671|NCT01606306|Hormone Antagonists|hormone antagonists|mesh-ancestor
92041672|NCT01606306|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041673|NCT01606306|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92041674|NCT01606306|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92041675|NCT01606306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041676|NCT04567108|Benzocaine|benzocaine|mesh-list
92041677|NCT04567108|Anesthetics, Local|anesthetics, local|mesh-ancestor
92041678|NCT04567108|Anesthetics|anesthetics|mesh-ancestor
92041679|NCT04567108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041680|NCT04567108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041681|NCT04567108|Sensory System Agents|sensory system agents|mesh-ancestor
92041685|NCT01753570|Antiviral Agents|antiviral agents|mesh-ancestor
92041686|NCT01753570|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041687|NCT01753570|Immunologic Factors|immunologic factors|mesh-ancestor
92041688|NCT01753570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041689|NCT01753336|Botulinum Toxins|botulinum toxins|mesh-list
92041690|NCT01753336|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92041692|NCT01753336|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92041693|NCT01753336|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92041694|NCT01753336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041695|NCT01753336|Cholinergic Agents|cholinergic agents|mesh-ancestor
92041696|NCT01753336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041697|NCT01753336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041698|NCT01753336|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92041699|NCT01753336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041700|NCT01777282|Biguanides|biguanides|mesh-list
92041701|NCT01777282|2,4-thiazolidinedione|2,4-thiazolidinedione|mesh-list
92041702|NCT01777282|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-list
92041703|NCT01777282|rGLP-1 protein|rglp-1 protein|mesh-list
92014255|NCT03071575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014256|NCT04798391|Dexamethasone|dexamethasone|mesh-list
92014257|NCT04798391|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014258|NCT04798391|Antiemetics|antiemetics|mesh-ancestor
92014259|NCT04798391|Autonomic Agents|autonomic agents|mesh-ancestor
92014260|NCT04798391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014261|NCT04798391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014262|NCT04798391|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014263|NCT04798391|Glucocorticoids|glucocorticoids|mesh-ancestor
92014264|NCT04798391|Hormones|hormones|mesh-ancestor
92014265|NCT04798391|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014266|NCT04798391|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92014267|NCT04798391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014268|NCT03071497|Protoporphyrin IX|protoporphyrin ix|mesh-list
92014269|NCT03071497|Zinc protoporphyrin|zinc protoporphyrin|mesh-list
92014270|NCT03071497|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92014271|NCT03071497|Dermatologic Agents|dermatologic agents|mesh-ancestor
92014272|NCT03071497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014273|NCT03071497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014274|NCT05616455|Nitroglycerin|nitroglycerin|mesh-list
92014275|NCT05616455|Vasodilator Agents|vasodilator agents|mesh-ancestor
92014276|NCT04986319|Vitamin D|vitamin d|mesh-list
92014277|NCT04986319|Vitamins|vitamins|mesh-ancestor
92014278|NCT04986319|Micronutrients|micronutrients|mesh-ancestor
92041704|NCT01777282|Incretins|incretins|mesh-ancestor
92041706|NCT01777282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041707|NCT01777282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041708|NCT01777282|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92041709|NCT01777282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041710|NCT01777282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041711|NCT04571632|Pembrolizumab|pembrolizumab|mesh-list
92041712|NCT04571632|Ipilimumab|ipilimumab|mesh-list
92041713|NCT04571632|Avelumab|avelumab|mesh-list
92041714|NCT04571632|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041715|NCT04571632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041716|NCT04571632|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041717|NCT04571632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041718|NCT01975389|Bococizumab|bococizumab|mesh-list
92041719|NCT01975389|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92041720|NCT01975389|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92041721|NCT01975389|Antimetabolites|antimetabolites|mesh-ancestor
92041722|NCT01975389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041723|NCT01975389|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92041724|NCT01974141|Dapsone|dapsone|mesh-list
92041725|NCT01974141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041726|NCT01974141|Antimalarials|antimalarials|mesh-ancestor
92041727|NCT01974141|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92041728|NCT01974141|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92014280|NCT04986319|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92014281|NCT02593097|Metformin|metformin|mesh-list
92041729|NCT01974141|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92041730|NCT01974141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041731|NCT01974141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041732|NCT01974141|Leprostatic Agents|leprostatic agents|mesh-ancestor
92041733|NCT01974141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92041734|NCT01945593|Factor VIII|factor viii|mesh-list
92041735|NCT01945593|BAX 855|bax 855|mesh-list
92041736|NCT01945593|Coagulants|coagulants|mesh-ancestor
92041737|NCT01945281|Amphotericin B|amphotericin b|mesh-list
92041738|NCT01945281|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92041739|NCT01945281|Caspofungin|caspofungin|mesh-list
92041740|NCT01945281|Amphotericin B, deoxycholate drug combination|amphotericin b, deoxycholate drug combination|mesh-list
92041741|NCT01945281|Deoxycholic Acid|deoxycholic acid|mesh-list
92041742|NCT01945281|Amebicides|amebicides|mesh-ancestor
92041743|NCT01945281|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92041744|NCT01945281|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92041745|NCT01945281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041746|NCT01945281|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92041747|NCT01945281|Antifungal Agents|antifungal agents|mesh-ancestor
92041748|NCT01945281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041749|NCT01945281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041750|NCT01945281|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92041751|NCT01945281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041752|NCT01961349|Propofol|propofol|mesh-list
92041753|NCT01961349|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92041754|NCT01961349|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92041759|NCT01961349|Anesthetics|anesthetics|mesh-ancestor
92041760|NCT01961349|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92041761|NCT01961349|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92041762|NCT01961349|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92041763|NCT01944969|Brexpiprazole|brexpiprazole|mesh-list
92041764|NCT01944969|Serotonin Agents|serotonin agents|mesh-ancestor
92041765|NCT01944969|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041766|NCT01944969|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041767|NCT01944969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041768|NCT01944969|Dopamine Agonists|dopamine agonists|mesh-ancestor
92041769|NCT01944969|Dopamine Agents|dopamine agents|mesh-ancestor
92041770|NCT04661397|Tenofovir|tenofovir|mesh-list
92041771|NCT04661397|Emtricitabine|emtricitabine|mesh-list
92041772|NCT04661397|Darunavir|darunavir|mesh-list
92041773|NCT04661397|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92041774|NCT04661397|Cobicistat|cobicistat|mesh-list
92041775|NCT04661397|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92041776|NCT04661397|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92041777|NCT04661397|Antiviral Agents|antiviral agents|mesh-ancestor
92041778|NCT04661397|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041779|NCT04661397|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92041780|NCT04661397|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92041781|NCT04661397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041782|NCT04661397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041783|NCT04661397|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92041784|NCT04661397|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92041785|NCT04661397|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92041786|NCT04661397|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92041787|NCT04661397|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041788|NCT04661397|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92041789|NCT04661397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92041790|NCT01973439|Abacavir|abacavir|mesh-list
92041791|NCT01973439|Dideoxynucleosides|dideoxynucleosides|mesh-list
92041792|NCT01973439|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92041793|NCT01973439|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92041794|NCT01973439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041795|NCT01973439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041796|NCT01973439|Antiviral Agents|antiviral agents|mesh-ancestor
92041797|NCT01973439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041798|NCT01973439|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92041799|NCT01973439|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92041800|NCT01973439|Antimetabolites|antimetabolites|mesh-ancestor
92041801|NCT01973283|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92014282|NCT02593097|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014283|NCT02593097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014284|NCT04805801|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92014285|NCT04805801|Immunologic Factors|immunologic factors|mesh-ancestor
92014286|NCT04805801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014287|NCT01657461|Plasminogen|plasminogen|mesh-list
92014288|NCT01657461|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92014289|NCT01657461|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92014290|NCT01657461|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92081680|NCT01392183|Sensory System Agents|sensory system agents|mesh-ancestor
92014291|NCT01657461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041802|NCT01973283|Antidepressive Agents|antidepressive agents|mesh-list
92041803|NCT01973283|Escitalopram|escitalopram|mesh-list
92041804|NCT01973283|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92041805|NCT01973283|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92041806|NCT01973283|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92041807|NCT01973283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041808|NCT01973283|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041809|NCT01973283|Serotonin Agents|serotonin agents|mesh-ancestor
92041810|NCT01973283|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041811|NCT01973283|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041812|NCT01973283|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92041813|NCT01973283|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92041814|NCT01973283|Analgesics|analgesics|mesh-ancestor
92041815|NCT01973283|Sensory System Agents|sensory system agents|mesh-ancestor
92041816|NCT01973283|Dopamine Agents|dopamine agents|mesh-ancestor
92041817|NCT01972659|Magnesium Sulfate|magnesium sulfate|mesh-list
92041818|NCT01972659|Analgesics|analgesics|mesh-ancestor
92041819|NCT01972659|Sensory System Agents|sensory system agents|mesh-ancestor
92041820|NCT01972659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041821|NCT01972659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041822|NCT01972659|Anesthetics|anesthetics|mesh-ancestor
92041823|NCT01972659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041826|NCT01972659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92041827|NCT01972659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92041828|NCT01972659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041829|NCT01972659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92041830|NCT01972659|Tocolytic Agents|tocolytic agents|mesh-ancestor
92041831|NCT01972659|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92041832|NCT01942785|Brexpiprazole|brexpiprazole|mesh-list
92041833|NCT01942785|Serotonin Agents|serotonin agents|mesh-ancestor
92041834|NCT01942785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041835|NCT01942785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041836|NCT01942785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041837|NCT01942785|Dopamine Agonists|dopamine agonists|mesh-ancestor
92041838|NCT01942785|Dopamine Agents|dopamine agents|mesh-ancestor
92041839|NCT04416165|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92041840|NCT04416165|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92041841|NCT04416165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041842|NCT01774786|Fluorouracil|fluorouracil|mesh-list
92041843|NCT01774786|Capecitabine|capecitabine|mesh-list
92041844|NCT01774786|Trastuzumab|trastuzumab|mesh-list
92041845|NCT01774786|Pertuzumab|pertuzumab|mesh-list
92041846|NCT01774786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041847|NCT01774786|Antimetabolites|antimetabolites|mesh-ancestor
92041848|NCT01774786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041849|NCT01774786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041850|NCT01774786|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041851|NCT01774786|Immunologic Factors|immunologic factors|mesh-ancestor
92041852|NCT01774786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014293|NCT05001919|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014294|NCT05001919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014295|NCT05001763|Prucalopride|prucalopride|mesh-list
92014296|NCT05001763|Laxatives|laxatives|mesh-ancestor
92041853|NCT01774786|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041854|NCT01942161|Aripiprazole|aripiprazole|mesh-list
92041855|NCT01942161|Antidepressive Agents|antidepressive agents|mesh-ancestor
92041856|NCT01942161|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92041857|NCT01942161|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92041858|NCT01942161|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92041859|NCT01942161|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041860|NCT01942161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041861|NCT01942161|Dopamine Agonists|dopamine agonists|mesh-ancestor
92041862|NCT01942161|Dopamine Agents|dopamine agents|mesh-ancestor
92041863|NCT01942161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92041864|NCT01942161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041865|NCT01942161|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92041866|NCT01942161|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92041867|NCT01942161|Serotonin Agents|serotonin agents|mesh-ancestor
92041868|NCT01942161|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92041869|NCT01942161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92041870|NCT01942161|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92041871|NCT01942161|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92041872|NCT01971645|Dexamethasone|dexamethasone|mesh-list
92041873|NCT01971645|Ropivacaine|ropivacaine|mesh-list
92041874|NCT01971645|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041875|NCT01971645|Antiemetics|antiemetics|mesh-ancestor
92041876|NCT01971645|Autonomic Agents|autonomic agents|mesh-ancestor
92041877|NCT01971645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041878|NCT01971645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041879|NCT01971645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041880|NCT01971645|Glucocorticoids|glucocorticoids|mesh-ancestor
92041881|NCT01971645|Hormones|hormones|mesh-ancestor
92041882|NCT01971645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041883|NCT01971645|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041884|NCT01971645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041885|NCT01971645|Anesthetics, Local|anesthetics, local|mesh-ancestor
92041886|NCT01971645|Anesthetics|anesthetics|mesh-ancestor
92041887|NCT01971645|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041888|NCT01971645|Sensory System Agents|sensory system agents|mesh-ancestor
92041889|NCT01941537|Fezakinumab|fezakinumab|mesh-list
92041890|NCT01941537|Dermatologic Agents|dermatologic agents|mesh-ancestor
92041891|NCT01960413|Hydroxyurea|hydroxyurea|mesh-list
92041892|NCT01960413|Montelukast|montelukast|mesh-list
92041893|NCT01960413|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92041894|NCT01960413|Respiratory System Agents|respiratory system agents|mesh-ancestor
92041895|NCT01960413|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92041896|NCT01960413|Hormone Antagonists|hormone antagonists|mesh-ancestor
92041905|NCT01960413|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92041906|NCT01970475|Adalimumab|adalimumab|mesh-list
92041907|NCT01970475|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92041908|NCT01970475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041909|NCT01970475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041910|NCT01939977|Calcifediol|calcifediol|mesh-list
92041911|NCT01939977|Vitamins|vitamins|mesh-ancestor
92041912|NCT01939977|Micronutrients|micronutrients|mesh-ancestor
92041913|NCT01939977|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041914|NCT01939977|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92041915|NCT01939899|Ixazomib|ixazomib|mesh-list
92041916|NCT01939899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041917|NCT01939899|Protease Inhibitors|protease inhibitors|mesh-ancestor
92041918|NCT01939899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041919|NCT01939899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041920|NCT01970397|Hyaluronic Acid|hyaluronic acid|mesh-list
92041921|NCT01970397|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92041922|NCT01970397|Immunologic Factors|immunologic factors|mesh-ancestor
92041923|NCT01970397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041924|NCT01970397|Viscosupplements|viscosupplements|mesh-ancestor
92041925|NCT01970397|Protective Agents|protective agents|mesh-ancestor
92041926|NCT01970241|Insulin|insulin|mesh-list
92041927|NCT01970241|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92041928|NCT01970241|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014297|NCT05001763|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041929|NCT01970241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041930|NCT01728376|Daptomycin|daptomycin|mesh-list
92041931|NCT01728376|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92041932|NCT01728376|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92041933|NCT02488759|Nivolumab|nivolumab|mesh-list
92041934|NCT02488759|Ipilimumab|ipilimumab|mesh-list
92041935|NCT02488759|Relatlimab|relatlimab|mesh-list
92041936|NCT02488759|Daratumumab|daratumumab|mesh-list
92041937|NCT02488759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92041938|NCT02488759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041939|NCT02488759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92041940|NCT02488759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041941|NCT02217709|Phenelzine|phenelzine|mesh-list
92041942|NCT02217709|Antidepressive Agents|antidepressive agents|mesh-ancestor
92041943|NCT02217709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92041944|NCT02217709|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92041945|NCT02217709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041946|NCT02217709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041947|NCT02161783|Cyclophosphamide|cyclophosphamide|mesh-list
92041948|NCT02161783|Fludarabine|fludarabine|mesh-list
92041949|NCT02161783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041950|NCT02161783|Immunologic Factors|immunologic factors|mesh-ancestor
92041951|NCT02161783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041952|NCT02161783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041953|NCT02161783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92041954|NCT02161783|Alkylating Agents|alkylating agents|mesh-ancestor
92041955|NCT02161783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041956|NCT02161783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041957|NCT02161783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92041958|NCT02158507|Lapatinib|lapatinib|mesh-list
92041959|NCT02158507|Veliparib|veliparib|mesh-list
92041960|NCT02158507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041961|NCT02158507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92041962|NCT02158507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041964|NCT02158507|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92041965|NCT04791553|Cenobamate|cenobamate|mesh-list
92041966|NCT04791553|Anticonvulsants|anticonvulsants|mesh-ancestor
92041967|NCT05651347|Melatonin|melatonin|mesh-list
92041968|NCT05651347|Antioxidants|antioxidants|mesh-ancestor
92041969|NCT05651347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041970|NCT05651347|Protective Agents|protective agents|mesh-ancestor
92041971|NCT05651347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041972|NCT05651347|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041973|NCT05651269|Gemcitabine|gemcitabine|mesh-list
92041974|NCT05651269|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041975|NCT05651269|Antimetabolites|antimetabolites|mesh-ancestor
92041976|NCT05651269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041977|NCT05651269|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041978|NCT01707004|Vidarabine|vidarabine|mesh-list
92041979|NCT01707004|Mycophenolic Acid|mycophenolic acid|mesh-list
92041980|NCT01707004|Cyclophosphamide|cyclophosphamide|mesh-list
92041981|NCT01707004|Busulfan|busulfan|mesh-list
92041982|NCT01707004|Fludarabine|fludarabine|mesh-list
92041983|NCT01707004|Fludarabine phosphate|fludarabine phosphate|mesh-list
92041984|NCT01707004|Azacitidine|azacitidine|mesh-list
92041985|NCT01707004|Decitabine|decitabine|mesh-list
92041986|NCT01707004|Tacrolimus|tacrolimus|mesh-list
92041987|NCT01707004|Lenograstim|lenograstim|mesh-list
92041988|NCT01707004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92041989|NCT01707004|Immunologic Factors|immunologic factors|mesh-ancestor
92041990|NCT01707004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041991|NCT01707004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92041992|NCT01707004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92041993|NCT01707004|Alkylating Agents|alkylating agents|mesh-ancestor
92041994|NCT01707004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041995|NCT01707004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041996|NCT01707004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92041997|NCT01707004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041998|NCT01707004|Antimetabolites|antimetabolites|mesh-ancestor
92041999|NCT01707004|Antiviral Agents|antiviral agents|mesh-ancestor
92042000|NCT01707004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042001|NCT01707004|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92042002|NCT01707004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92042003|NCT01707004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042004|NCT01707004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92014298|NCT05001763|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92014299|NCT05001763|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92042005|NCT01707004|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92042006|NCT01707004|Antitubercular Agents|antitubercular agents|mesh-ancestor
92042007|NCT01707004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042008|NCT01939197|Ritonavir|ritonavir|mesh-list
92042009|NCT01939197|Ribavirin|ribavirin|mesh-list
92042010|NCT01939197|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92042011|NCT01939197|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92042012|NCT01939197|Protease Inhibitors|protease inhibitors|mesh-ancestor
92042013|NCT01939197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042014|NCT01939197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042015|NCT01939197|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92042016|NCT01939197|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92042017|NCT01939197|Antiviral Agents|antiviral agents|mesh-ancestor
92042018|NCT01939197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042019|NCT01939197|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92042020|NCT01939197|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92042021|NCT01939197|Antimetabolites|antimetabolites|mesh-ancestor
92042022|NCT01969851|Lacosamide|lacosamide|mesh-list
92042023|NCT01969851|Anticonvulsants|anticonvulsants|mesh-ancestor
92042024|NCT01969851|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92042025|NCT01969851|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92042026|NCT01969851|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042027|NCT01969851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042028|NCT01938573|Sirolimus|sirolimus|mesh-list
92042029|NCT01938573|Cisplatin|cisplatin|mesh-list
92042030|NCT01938573|Gemcitabine|gemcitabine|mesh-list
92042031|NCT01938573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042265|NCT00630565|Glucocorticoids|glucocorticoids|mesh-ancestor
92042032|NCT01938573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92042033|NCT01938573|Antimetabolites|antimetabolites|mesh-ancestor
92042034|NCT01938573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042035|NCT01938573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042036|NCT01938573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042039|NCT01938573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042040|NCT01938573|Immunologic Factors|immunologic factors|mesh-ancestor
92042041|NCT01938573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042042|NCT05546515|Suvorexant|suvorexant|mesh-list
92042043|NCT05546515|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-list
92042044|NCT05546515|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92042045|NCT05546515|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92042046|NCT05546515|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042047|NCT05546515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042048|NCT05546515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042049|NCT05546515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042050|NCT04789837|Cilostazol|cilostazol|mesh-list
92042051|NCT04789837|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92042052|NCT04789837|Autonomic Agents|autonomic agents|mesh-ancestor
92042053|NCT04789837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042054|NCT04789837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042055|NCT04789837|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042056|NCT04789837|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042057|NCT04789837|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92042058|NCT04789837|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92042059|NCT04789837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042060|NCT04789837|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92042061|NCT04789837|Vasodilator Agents|vasodilator agents|mesh-ancestor
92042062|NCT04789837|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92042063|NCT04789837|Protective Agents|protective agents|mesh-ancestor
92042064|NCT04789837|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92042065|NCT04789837|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92042066|NCT04789837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042067|NCT03522259|Rivaroxaban|rivaroxaban|mesh-list
92042068|NCT03522259|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92042069|NCT03522259|Antithrombins|antithrombins|mesh-ancestor
92042070|NCT03522259|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92042071|NCT03522259|Protease Inhibitors|protease inhibitors|mesh-ancestor
92042072|NCT03522259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042073|NCT03522259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014300|NCT05001763|Serotonin Agents|serotonin agents|mesh-ancestor
92042074|NCT03522259|Anticoagulants|anticoagulants|mesh-ancestor
92042075|NCT01937871|Tadalafil|tadalafil|mesh-list
92042076|NCT01937871|Tamsulosin|tamsulosin|mesh-list
92042077|NCT01937871|Vasodilator Agents|vasodilator agents|mesh-ancestor
92042078|NCT01937871|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92042079|NCT01937871|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92042080|NCT01937871|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042081|NCT01937871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042082|NCT01937871|Urological Agents|urological agents|mesh-ancestor
92042083|NCT01937871|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92042084|NCT01937871|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92042085|NCT01937871|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042086|NCT01937871|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042087|NCT01937871|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042088|NCT01937871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042089|NCT03220477|Pembrolizumab|pembrolizumab|mesh-list
92042090|NCT03220477|Guadecitabine|guadecitabine|mesh-list
92042091|NCT03220477|Mocetinostat|mocetinostat|mesh-list
92042092|NCT03220477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042093|NCT03220477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042094|NCT03220477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92042095|NCT03220477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042096|NCT03220477|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92042097|NCT03220477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042098|NCT01747447|Vitamin D|vitamin d|mesh-list
92042100|NCT01747447|Cholecalciferol|cholecalciferol|mesh-list
92042101|NCT01747447|Vitamins|vitamins|mesh-list
92042102|NCT01747447|Micronutrients|micronutrients|mesh-ancestor
92042103|NCT01747447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042104|NCT01747447|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92042105|NCT01747447|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92042107|NCT02740699|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92042108|NCT02740699|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92042111|NCT02740699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042112|NCT02740699|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92042113|NCT02740699|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92042114|NCT02740699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042115|NCT01287091|Rabeprazole|rabeprazole|mesh-list
92042116|NCT01287091|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92042117|NCT01287091|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042118|NCT01287091|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92042119|NCT01287091|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042120|NCT01287091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042121|NCT01269463|Methylphenidate|methylphenidate|mesh-list
92042122|NCT01269463|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92042123|NCT01269463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042124|NCT01269463|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92042125|NCT01269463|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92042126|NCT01269463|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042127|NCT01269463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042128|NCT01269463|Dopamine Agents|dopamine agents|mesh-ancestor
92042129|NCT01269463|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042130|NCT02539459|Everolimus|everolimus|mesh-list
92042131|NCT02539459|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92042132|NCT02539459|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92042133|NCT02539459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042134|NCT02539459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042135|NCT02539459|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042136|NCT02539459|Immunologic Factors|immunologic factors|mesh-ancestor
92042137|NCT02539459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042138|NCT02539459|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042139|NCT01706926|Mavrilimumab|mavrilimumab|mesh-list
92042140|NCT01706926|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92042141|NCT01706926|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042142|NCT01706926|Immunologic Factors|immunologic factors|mesh-ancestor
92042143|NCT01706926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042144|NCT01634113|Bromides|bromides|mesh-list
92042145|NCT01634113|Tiotropium Bromide|tiotropium bromide|mesh-list
92014301|NCT05001763|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042146|NCT01634113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92042147|NCT01634113|Autonomic Agents|autonomic agents|mesh-ancestor
92042148|NCT01634113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042149|NCT01634113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042150|NCT01634113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042151|NCT01634113|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042152|NCT01634113|Parasympatholytics|parasympatholytics|mesh-ancestor
92042153|NCT01634113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92042154|NCT01634113|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042155|NCT01634113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042156|NCT01634113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042157|NCT01634113|Anticonvulsants|anticonvulsants|mesh-ancestor
92042158|NCT01937715|Bevacizumab|bevacizumab|mesh-list
92042159|NCT01937715|Gedatolisib|gedatolisib|mesh-list
92042160|NCT01937715|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042161|NCT01937715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042162|NCT01937715|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92042163|NCT01937715|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92042164|NCT01937715|Growth Substances|growth substances|mesh-ancestor
92042165|NCT01937715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042166|NCT01937715|Growth Inhibitors|growth inhibitors|mesh-ancestor
92042167|NCT01937715|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92042168|NCT01937715|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042169|NCT01937715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042170|NCT01937559|Tranexamic Acid|tranexamic acid|mesh-list
92042171|NCT01937559|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92042172|NCT01937559|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92042173|NCT01937559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042174|NCT01937559|Hemostatics|hemostatics|mesh-ancestor
92042175|NCT01937559|Coagulants|coagulants|mesh-ancestor
92042176|NCT01918371|Ranibizumab|ranibizumab|mesh-list
92042177|NCT01918371|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92042178|NCT01918371|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92042179|NCT01918371|Growth Substances|growth substances|mesh-ancestor
92042184|NCT01916967|Desloratadine|desloratadine|mesh-list
92042185|NCT01916967|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92042186|NCT01916967|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042187|NCT01916967|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042188|NCT01916967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042189|NCT01916967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042190|NCT01916967|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92042191|NCT01916967|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92042192|NCT01916967|Histamine Antagonists|histamine antagonists|mesh-ancestor
92042193|NCT01916967|Histamine Agents|histamine agents|mesh-ancestor
92042194|NCT01959243|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92042195|NCT01959243|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92042196|NCT01959243|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92042197|NCT01959243|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92042198|NCT01959243|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92042199|NCT01959243|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92042200|NCT01959243|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92042201|NCT01959243|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042202|NCT01959243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042203|NCT01959243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042204|NCT01959243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042205|NCT01916109|Carboplatin|carboplatin|mesh-list
92042206|NCT01916109|Gemcitabine|gemcitabine|mesh-list
92042207|NCT01916109|Panitumumab|panitumumab|mesh-list
92042208|NCT01916109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042209|NCT01916109|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92042210|NCT01916109|Antimetabolites|antimetabolites|mesh-ancestor
92042211|NCT01916109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042212|NCT01916109|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042213|NCT01958619|Artefenomel|artefenomel|mesh-list
92042214|NCT01958619|Antimalarials|antimalarials|mesh-ancestor
92042215|NCT01958619|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92042216|NCT01958619|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92042217|NCT01958619|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042219|NCT01726270|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92014302|NCT05001763|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014303|NCT05001763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042220|NCT01726270|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92042221|NCT01726270|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042222|NCT01726270|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042223|NCT01726270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042224|NCT01726270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042225|NCT01726270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042227|NCT00942331|Bevacizumab|bevacizumab|mesh-list
92042228|NCT00942331|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92042229|NCT00942331|Cisplatin|cisplatin|mesh-list
92042230|NCT00942331|Gemcitabine|gemcitabine|mesh-list
92042231|NCT00942331|Endothelial Growth Factors|endothelial growth factors|mesh-list
92042232|NCT00942331|Antibodies|antibodies|mesh-list
92042233|NCT00942331|Immunoglobulins|immunoglobulins|mesh-list
92042234|NCT00942331|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92042235|NCT00942331|Immunoglobulin G|immunoglobulin g|mesh-list
92042236|NCT00942331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042237|NCT00942331|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92042238|NCT00942331|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92042239|NCT00942331|Growth Substances|growth substances|mesh-ancestor
92042240|NCT00942331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042241|NCT00942331|Growth Inhibitors|growth inhibitors|mesh-ancestor
92042242|NCT00942331|Immunologic Factors|immunologic factors|mesh-ancestor
92042243|NCT00942331|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92042244|NCT00942331|Antimetabolites|antimetabolites|mesh-ancestor
92042245|NCT00942331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042246|NCT00630565|Dexamethasone|dexamethasone|mesh-list
92042247|NCT00630565|Cyclophosphamide|cyclophosphamide|mesh-list
92042249|NCT00630565|Etoposide|etoposide|mesh-list
92042250|NCT00630565|Sargramostim|sargramostim|mesh-list
92042251|NCT00630565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042252|NCT00630565|Immunologic Factors|immunologic factors|mesh-ancestor
92042255|NCT00630565|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92042256|NCT00630565|Alkylating Agents|alkylating agents|mesh-ancestor
92042257|NCT00630565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042258|NCT00630565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042259|NCT00630565|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92042260|NCT00630565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92042261|NCT00630565|Antiemetics|antiemetics|mesh-ancestor
92042262|NCT00630565|Autonomic Agents|autonomic agents|mesh-ancestor
92042263|NCT00630565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042264|NCT00630565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042266|NCT00630565|Hormones|hormones|mesh-ancestor
92042267|NCT00630565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042268|NCT00630565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92042269|NCT00630565|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92042270|NCT00630565|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92042271|NCT00630565|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92042272|NCT00630565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042273|NCT01914393|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92042274|NCT01914393|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92042275|NCT01914393|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92042276|NCT01914393|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042277|NCT01914393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042278|NCT01914393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92042279|NCT01914393|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92042280|NCT01914393|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92042281|NCT01914393|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042282|NCT01914393|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042283|NCT01914393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042284|NCT01914393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042285|NCT01914393|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92042286|NCT01914393|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92042287|NCT01914393|Serotonin Agents|serotonin agents|mesh-ancestor
92042288|NCT01914393|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92042289|NCT01914393|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92042290|NCT01914393|Dopamine Agents|dopamine agents|mesh-ancestor
92042291|NCT01545271|Xenon|xenon|mesh-list
92042292|NCT01545271|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92042293|NCT01545271|Anesthetics, General|anesthetics, general|mesh-ancestor
92042295|NCT01545271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042296|NCT01545271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042297|NCT01931865|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92042298|NCT01931865|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92042299|NCT01931865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042300|NCT01931865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042301|NCT01931865|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92042302|NCT01931865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042303|NCT01931865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042305|NCT01931865|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042306|NCT01617447|Aripiprazole|aripiprazole|mesh-list
92042307|NCT01617447|Antidepressive Agents|antidepressive agents|mesh-ancestor
92042308|NCT01617447|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92042309|NCT01617447|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92042310|NCT01617447|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92042311|NCT01617447|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042312|NCT01617447|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042313|NCT01617447|Dopamine Agonists|dopamine agonists|mesh-ancestor
92042314|NCT01617447|Dopamine Agents|dopamine agents|mesh-ancestor
92042315|NCT01617447|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042316|NCT01617447|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042317|NCT01617447|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92042318|NCT01617447|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92042319|NCT01617447|Serotonin Agents|serotonin agents|mesh-ancestor
92042320|NCT01617447|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92042321|NCT01617447|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92042322|NCT01617447|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92042323|NCT01617447|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92042327|NCT04798027|Vaccines|vaccines|mesh-list
92042328|NCT04798027|Immunologic Factors|immunologic factors|mesh-ancestor
92042329|NCT04798027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042330|NCT05238025|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92042331|NCT05238025|Antiviral Agents|antiviral agents|mesh-ancestor
92042332|NCT05238025|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042333|NCT04797325|Prednisolone|prednisolone|mesh-list
92042334|NCT04797325|Infliximab|infliximab|mesh-list
92042335|NCT04797325|Vedolizumab|vedolizumab|mesh-list
92042336|NCT04797325|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92042337|NCT04797325|Glucocorticoids|glucocorticoids|mesh-ancestor
92042338|NCT04797325|Hormones|hormones|mesh-ancestor
92042339|NCT04797325|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042340|NCT04797325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042341|NCT04797325|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92042342|NCT04797325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042343|NCT04797325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042344|NCT04797325|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92042345|NCT04797325|Dermatologic Agents|dermatologic agents|mesh-ancestor
92042346|NCT04797325|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042347|NCT02246647|Mannitol|mannitol|mesh-list
92042348|NCT02246647|Lactulose|lactulose|mesh-list
92042349|NCT02246647|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92042350|NCT02246647|Diuretics|diuretics|mesh-ancestor
92042351|NCT02246647|Natriuretic Agents|natriuretic agents|mesh-ancestor
92042352|NCT02246647|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042353|NCT02246647|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042354|NCT02244619|Acetaminophen|acetaminophen|mesh-list
92042355|NCT02244619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92042356|NCT02244619|Analgesics|analgesics|mesh-ancestor
92042357|NCT02244619|Sensory System Agents|sensory system agents|mesh-ancestor
92042358|NCT02244619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042359|NCT02244619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042360|NCT02244619|Antipyretics|antipyretics|mesh-ancestor
92042361|NCT02243371|Cyclophosphamide|cyclophosphamide|mesh-list
92042362|NCT02243371|Nivolumab|nivolumab|mesh-list
92042363|NCT02243371|Immunologic Factors|immunologic factors|mesh-ancestor
92042364|NCT02243371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042365|NCT02243371|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042366|NCT02243371|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042367|NCT02243371|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92042368|NCT02243371|Alkylating Agents|alkylating agents|mesh-ancestor
92042369|NCT02243371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042370|NCT02243371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014304|NCT04989985|Oxaliplatin|oxaliplatin|mesh-list
92014305|NCT04989985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014306|NCT02592551|Durvalumab|durvalumab|mesh-list
92042371|NCT02243371|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92042372|NCT02243371|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042373|NCT02243371|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92042374|NCT01931475|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92042375|NCT01931475|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92042376|NCT01931475|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92042377|NCT01931475|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042378|NCT01931475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042379|NCT01931475|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042380|NCT01931475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042381|NCT01931475|Analgesics|analgesics|mesh-ancestor
92042382|NCT01931475|Sensory System Agents|sensory system agents|mesh-ancestor
92042383|NCT01931475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042384|NCT01931475|Antidepressive Agents|antidepressive agents|mesh-ancestor
92042385|NCT01931475|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92042386|NCT01931475|Dopamine Agents|dopamine agents|mesh-ancestor
92042387|NCT04630821|Sodium Hypochlorite|sodium hypochlorite|mesh-list
92042388|NCT04630821|Eusol|eusol|mesh-list
92042389|NCT04630821|Disinfectants|disinfectants|mesh-ancestor
92042390|NCT04630821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042391|NCT01646177|Etanercept|etanercept|mesh-list
92042392|NCT01646177|Ixekizumab|ixekizumab|mesh-list
92042393|NCT01646177|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92042394|NCT01646177|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92042395|NCT01646177|Analgesics|analgesics|mesh-ancestor
92042396|NCT01646177|Sensory System Agents|sensory system agents|mesh-ancestor
92042404|NCT01646177|Dermatologic Agents|dermatologic agents|mesh-ancestor
92042405|NCT01929135|Atorvastatin|atorvastatin|mesh-list
92042406|NCT01929135|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92042407|NCT01929135|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92042408|NCT01929135|Antimetabolites|antimetabolites|mesh-ancestor
92042409|NCT01929135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042410|NCT01929135|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92042411|NCT01929135|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92042412|NCT01929135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042413|NCT01911429|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92042414|NCT01911429|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92042415|NCT01911429|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92042416|NCT01911429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042417|NCT01911429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042418|NCT01911429|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92042419|NCT01911429|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92042420|NCT01911429|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92042421|NCT01911429|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042422|NCT01911429|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042423|NCT01911429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042424|NCT01911429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042425|NCT01911429|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92042426|NCT01911429|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92042427|NCT01911429|Serotonin Agents|serotonin agents|mesh-ancestor
92042428|NCT01911429|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92042429|NCT01911429|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92042430|NCT01911429|Dopamine Agents|dopamine agents|mesh-ancestor
92042431|NCT02324153|Riboflavin|riboflavin|mesh-list
92042432|NCT02324153|Vitamin B Complex|vitamin b complex|mesh-ancestor
92042433|NCT02324153|Vitamins|vitamins|mesh-ancestor
92042434|NCT02324153|Micronutrients|micronutrients|mesh-ancestor
92042435|NCT02324153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042436|NCT02324153|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92042437|NCT02324153|Dermatologic Agents|dermatologic agents|mesh-ancestor
92042438|NCT02280473|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92042439|NCT02280473|Laxatives|laxatives|mesh-ancestor
92042440|NCT02280473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042441|NCT02308007|Metronidazole|metronidazole|mesh-list
92042442|NCT02308007|Terconazole|terconazole|mesh-list
92042443|NCT02308007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042444|NCT02308007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042445|NCT02308007|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92042446|NCT02308007|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92014308|NCT02592551|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042447|NCT02308007|Antifungal Agents|antifungal agents|mesh-ancestor
92042448|NCT01910181|Vemurafenib|vemurafenib|mesh-list
92042449|NCT01910181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042450|NCT01910181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92042451|NCT01910181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042452|NCT01910181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042454|NCT04885907|Immunologic Factors|immunologic factors|mesh-ancestor
92042455|NCT04885907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042456|NCT01957215|Indomethacin|indomethacin|mesh-list
92042457|NCT01957215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92042458|NCT01957215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92042460|NCT01957215|Sensory System Agents|sensory system agents|mesh-ancestor
92042461|NCT01957215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042462|NCT01957215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042463|NCT01957215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92042464|NCT01957215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042465|NCT01957215|Gout Suppressants|gout suppressants|mesh-ancestor
92042470|NCT01957215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042472|NCT01928433|Finafloxacin|finafloxacin|mesh-list
92042473|NCT01928433|Fluoroquinolones|fluoroquinolones|mesh-list
92042474|NCT01928433|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042475|NCT01928433|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042476|NCT01928433|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92042477|NCT01928433|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92042478|NCT01928433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042479|NCT01928433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042480|NCT01928433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042481|NCT01928433|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92042482|NCT01928433|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92042483|NCT01928433|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92042484|NCT01928433|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92042485|NCT02322281|Paclitaxel|paclitaxel|mesh-list
92042486|NCT02322281|Docetaxel|docetaxel|mesh-list
92042487|NCT02322281|Gemcitabine|gemcitabine|mesh-list
92042488|NCT02322281|Pemetrexed|pemetrexed|mesh-list
92042489|NCT02322281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92042490|NCT02322281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042491|NCT02322281|Tubulin Modulators|tubulin modulators|mesh-ancestor
92042492|NCT02322281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92042493|NCT02322281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92042494|NCT02322281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042495|NCT02322281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92042496|NCT02322281|Antimetabolites|antimetabolites|mesh-ancestor
92042497|NCT02322281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042498|NCT02322281|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92042499|NCT02322281|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92042500|NCT02243293|Ribavirin|ribavirin|mesh-list
92042501|NCT02243293|Antimetabolites|antimetabolites|mesh-ancestor
92042502|NCT02243293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042503|NCT02243293|Antiviral Agents|antiviral agents|mesh-ancestor
92042504|NCT02243293|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042505|NCT02322047|Prazosin|prazosin|mesh-list
92042506|NCT02322047|Naltrexone|naltrexone|mesh-list
92042507|NCT02322047|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92042508|NCT02322047|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92042509|NCT02322047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042510|NCT02322047|Sensory System Agents|sensory system agents|mesh-ancestor
92042511|NCT02322047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042512|NCT02322047|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92042513|NCT02322047|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92042514|NCT02322047|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92042515|NCT02322047|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042516|NCT02322047|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042517|NCT02322047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042518|NCT02322047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042519|NCT02254291|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92042520|NCT02254291|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92042521|NCT02254291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042522|NCT02254291|Incretins|incretins|mesh-ancestor
92014309|NCT02592551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014310|NCT04989127|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92014311|NCT04989127|Penicillins|penicillins|mesh-list
92042523|NCT02254291|Hormones|hormones|mesh-ancestor
92042524|NCT02254291|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042525|NCT02254291|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92042526|NCT02254291|Protease Inhibitors|protease inhibitors|mesh-ancestor
92042527|NCT02254291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042528|NCT02254291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042529|NCT02277743|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92042530|NCT02277743|Immunologic Factors|immunologic factors|mesh-ancestor
92042531|NCT02277743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042532|NCT02320721|Insulin|insulin|mesh-list
92042533|NCT02320721|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92042534|NCT02320721|Insulin Glargine|insulin glargine|mesh-list
92042535|NCT02320721|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92042543|NCT02320487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042545|NCT04197089|Cholecalciferol|cholecalciferol|mesh-list
92042546|NCT04197089|Vitamins|vitamins|mesh-ancestor
92042547|NCT04197089|Micronutrients|micronutrients|mesh-ancestor
92042548|NCT04197089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042549|NCT04197089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92042550|NCT04197089|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92042551|NCT02252965|Metformin|metformin|mesh-list
92042552|NCT02252965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92042553|NCT02252965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042554|NCT02251717|Sofosbuvir|sofosbuvir|mesh-list
92042555|NCT02251717|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92042556|NCT02251717|Ledipasvir|ledipasvir|mesh-list
92042557|NCT02251717|Antiviral Agents|antiviral agents|mesh-ancestor
92042558|NCT02251717|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042559|NCT02242201|Ketorolac|ketorolac|mesh-list
92042560|NCT02242201|Epinephrine|epinephrine|mesh-list
92042561|NCT02242201|Bupivacaine|bupivacaine|mesh-list
92042562|NCT02242201|Ropivacaine|ropivacaine|mesh-list
92042563|NCT02242201|Anesthetics, Local|anesthetics, local|mesh-ancestor
92042564|NCT02242201|Anesthetics|anesthetics|mesh-ancestor
92042565|NCT02242201|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042566|NCT02242201|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042567|NCT02242201|Sensory System Agents|sensory system agents|mesh-ancestor
92042568|NCT02242201|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042569|NCT02242201|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92042570|NCT02242201|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92042571|NCT02242201|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042572|NCT02242201|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042573|NCT02242201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042574|NCT02242201|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92042575|NCT02242201|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92042576|NCT02242201|Autonomic Agents|autonomic agents|mesh-ancestor
92042577|NCT02242201|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042578|NCT02242201|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042579|NCT02242201|Mydriatics|mydriatics|mesh-ancestor
92042580|NCT02242201|Sympathomimetics|sympathomimetics|mesh-ancestor
92042581|NCT02242201|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92042582|NCT02242201|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92042583|NCT02242201|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92042584|NCT02242201|Analgesics|analgesics|mesh-ancestor
92042585|NCT02242201|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92042586|NCT02242201|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042587|NCT02242201|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92042588|NCT02242201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042589|NCT02242045|Idelalisib|idelalisib|mesh-list
92042590|NCT02242045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042591|NCT02242045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042592|NCT02242045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042593|NCT02241889|Pancrelipase|pancrelipase|mesh-list
92042594|NCT02241889|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042595|NCT02241187|Cetuximab|cetuximab|mesh-list
92042596|NCT02241187|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042597|NCT02241187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042598|NCT02249767|Tretinoin|tretinoin|mesh-list
92042599|NCT02249767|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042600|NCT02249767|Keratolytic Agents|keratolytic agents|mesh-ancestor
92014312|NCT04989127|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92014313|NCT04989127|Analgesics|analgesics|mesh-list
92014314|NCT04989127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014315|NCT04989127|Antitubercular Agents|antitubercular agents|mesh-ancestor
92042601|NCT02249767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92042602|NCT04892953|Paclitaxel|paclitaxel|mesh-list
92042603|NCT04892953|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92042604|NCT04892953|Carboplatin|carboplatin|mesh-list
92042612|NCT04892953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042613|NCT04892953|Tubulin Modulators|tubulin modulators|mesh-ancestor
92042614|NCT04892953|Antimitotic Agents|antimitotic agents|mesh-ancestor
92042615|NCT04892953|Mitosis Modulators|mitosis modulators|mesh-ancestor
92042616|NCT04892953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042617|NCT04892953|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92042619|NCT04892953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042620|NCT04892953|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92042621|NCT04892953|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92042622|NCT04892953|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042623|NCT04892953|Immunologic Factors|immunologic factors|mesh-ancestor
92042624|NCT04892953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042625|NCT02238379|Oxytocin|oxytocin|mesh-list
92042626|NCT02238379|Oxytocics|oxytocics|mesh-ancestor
92042627|NCT02238379|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92042628|NCT02238379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042629|NCT02207491|Timolol|timolol|mesh-list
92042630|NCT02207491|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92042631|NCT02207491|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92042632|NCT02207491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042633|NCT02207491|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92042634|NCT02207491|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042635|NCT02207491|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042636|NCT02207491|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042637|NCT02207491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042638|NCT02207491|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92042639|NCT02207491|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92042640|NCT02315066|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92042641|NCT02315066|Immunoglobulin G|immunoglobulin g|mesh-list
92042642|NCT02315066|Immunologic Factors|immunologic factors|mesh-ancestor
92042643|NCT02315066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042644|NCT02207413|Vaccines|vaccines|mesh-list
92042645|NCT02207413|Immunologic Factors|immunologic factors|mesh-ancestor
92042646|NCT02207413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042647|NCT02276027|Ceritinib|ceritinib|mesh-list
92042648|NCT02276027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042649|NCT02276027|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92042650|NCT02276027|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042651|NCT02276027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042652|NCT02233543|Glycopyrrolate|glycopyrrolate|mesh-list
92042653|NCT02233543|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92042654|NCT02233543|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92042655|NCT02233543|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92042656|NCT02233543|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042657|NCT02233543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042658|NCT02233543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042659|NCT02233543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042660|NCT04761133|Povidone-Iodine|povidone-iodine|mesh-list
92042661|NCT04761133|Povidone|povidone|mesh-list
92042662|NCT04761133|Plasma Substitutes|plasma substitutes|mesh-ancestor
92042663|NCT04761133|Blood Substitutes|blood substitutes|mesh-ancestor
92042664|NCT04761133|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92042665|NCT04761133|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042666|NCT02233309|Anesthetics|anesthetics|mesh-list
92042667|NCT02233309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042668|NCT02233309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042669|NCT02280044|Rifaximin|rifaximin|mesh-list
92042670|NCT02280044|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042671|NCT02280044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042672|NCT02280044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042673|NCT02308748|Moxifloxacin|moxifloxacin|mesh-list
92042674|NCT02308748|Lidocaine|lidocaine|mesh-list
92042694|NCT02308748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042695|NCT02308748|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92014316|NCT04989127|Sensory System Agents|sensory system agents|mesh-ancestor
92014317|NCT04989127|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014318|NCT04989127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014319|NCT04982809|Dexamethasone|dexamethasone|mesh-list
92042696|NCT02308748|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92042697|NCT02308748|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92042698|NCT02308748|Vasodilator Agents|vasodilator agents|mesh-ancestor
92042699|NCT02308748|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92042700|NCT04745689|Carboplatin|carboplatin|mesh-list
92042702|NCT04745689|Durvalumab|durvalumab|mesh-list
92042703|NCT04745689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042704|NCT04745689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92042705|NCT04745689|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92042706|NCT04745689|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92042707|NCT04745689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042708|NCT04745689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042709|NCT04745689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042711|NCT02308124|Bromides|bromides|mesh-list
92042712|NCT02308124|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92042713|NCT02308124|Anticonvulsants|anticonvulsants|mesh-ancestor
92042714|NCT02308124|Sympathomimetics|sympathomimetics|mesh-ancestor
92042715|NCT02308124|Autonomic Agents|autonomic agents|mesh-ancestor
92042716|NCT02308124|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042717|NCT02308124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042718|NCT02308124|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92042719|NCT02308124|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92042720|NCT02308124|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92042721|NCT02308124|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92042722|NCT02308124|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042723|NCT02308124|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042724|NCT02308124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042725|NCT02308124|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92042726|NCT02308124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042727|NCT02308124|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042728|NCT02232061|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92042729|NCT02232061|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92042730|NCT02232061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042731|NCT02232061|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042732|NCT02232061|Immunologic Factors|immunologic factors|mesh-ancestor
92042733|NCT02232061|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042735|NCT02275481|Formoterol Fumarate|formoterol fumarate|mesh-list
92042736|NCT02275481|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92042737|NCT02275481|Autonomic Agents|autonomic agents|mesh-ancestor
92042738|NCT02275481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042739|NCT02275481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042740|NCT02275481|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042741|NCT02275481|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042742|NCT02275481|Parasympatholytics|parasympatholytics|mesh-ancestor
92042743|NCT02275481|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92042744|NCT02275481|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042745|NCT02275481|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042746|NCT02275481|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042747|NCT02275481|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92042748|NCT02275481|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92042749|NCT02275481|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92042750|NCT02275481|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042751|NCT02308046|Terconazole|terconazole|mesh-list
92042752|NCT02308046|Antifungal Agents|antifungal agents|mesh-ancestor
92042753|NCT02308046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042754|NCT02318693|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92042755|NCT02318693|Glyburide|glyburide|mesh-list
92042756|NCT02318693|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92042757|NCT02318693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042758|NCT02318693|Incretins|incretins|mesh-ancestor
92042759|NCT02318693|Hormones|hormones|mesh-ancestor
92042760|NCT02318693|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042761|NCT02318693|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92042762|NCT02318693|Protease Inhibitors|protease inhibitors|mesh-ancestor
92014320|NCT04982809|Prednisolone|prednisolone|mesh-list
92014321|NCT04982809|Betamethasone|betamethasone|mesh-list
92014322|NCT04982809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014323|NCT04982809|Antiemetics|antiemetics|mesh-ancestor
92014324|NCT04982809|Autonomic Agents|autonomic agents|mesh-ancestor
92042763|NCT02318693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042764|NCT02318693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042765|NCT02230891|Carvedilol|carvedilol|mesh-list
92042766|NCT02230891|Spironolactone|spironolactone|mesh-list
92042767|NCT02230891|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92042768|NCT02230891|Hormone Antagonists|hormone antagonists|mesh-ancestor
92042769|NCT02230891|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042770|NCT02230891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042771|NCT02230891|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92042772|NCT02230891|Diuretics|diuretics|mesh-ancestor
92042773|NCT02230891|Natriuretic Agents|natriuretic agents|mesh-ancestor
92042774|NCT02230891|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92042775|NCT02230891|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92042776|NCT02230891|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042777|NCT02230891|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042778|NCT02230891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042779|NCT02230891|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92042780|NCT02230891|Antioxidants|antioxidants|mesh-ancestor
92042781|NCT02230891|Protective Agents|protective agents|mesh-ancestor
92042782|NCT02230891|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92042783|NCT02230891|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042784|NCT02230891|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92042785|NCT02230891|Vasodilator Agents|vasodilator agents|mesh-ancestor
92042786|NCT02230891|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92042787|NCT02230891|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92042788|NCT02302859|Nicotine|nicotine|mesh-list
92042789|NCT02302859|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92042790|NCT02302859|Autonomic Agents|autonomic agents|mesh-ancestor
92042791|NCT02302859|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042792|NCT02302859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042793|NCT02302859|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92042794|NCT02302859|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92042795|NCT02302859|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042796|NCT02302859|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042797|NCT02302859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042798|NCT02274311|Clomiphene|clomiphene|mesh-list
92042799|NCT02274311|Enclomiphene|enclomiphene|mesh-list
92042800|NCT02274311|Zuclomiphene|zuclomiphene|mesh-list
92042804|NCT02274311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042805|NCT02274311|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92042806|NCT02274311|Fertility Agents|fertility agents|mesh-ancestor
92042807|NCT02274311|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92042808|NCT02274311|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92042809|NCT02274311|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92042810|NCT02316353|Complement C1s|complement c1s|mesh-list
92042811|NCT02316353|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92042812|NCT02316353|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92042813|NCT02316353|Immunologic Factors|immunologic factors|mesh-ancestor
92042814|NCT02316353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042815|NCT02316353|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92042816|NCT02316353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042817|NCT02279732|Paclitaxel|paclitaxel|mesh-list
92042818|NCT02279732|Carboplatin|carboplatin|mesh-list
92042819|NCT02279732|Ipilimumab|ipilimumab|mesh-list
92042820|NCT02279732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92042821|NCT02279732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042822|NCT02279732|Tubulin Modulators|tubulin modulators|mesh-ancestor
92042823|NCT02279732|Antimitotic Agents|antimitotic agents|mesh-ancestor
92042824|NCT02279732|Mitosis Modulators|mitosis modulators|mesh-ancestor
92042825|NCT02279732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042826|NCT02279732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92042827|NCT02279732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92042828|NCT05649956|Letrozole|letrozole|mesh-list
92014325|NCT04982809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014326|NCT04982809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014327|NCT04982809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014328|NCT04982809|Glucocorticoids|glucocorticoids|mesh-ancestor
92014329|NCT04982809|Hormones|hormones|mesh-ancestor
92042829|NCT05649956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042830|NCT05649956|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92042831|NCT05649956|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92042832|NCT05649956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042833|NCT05649956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042834|NCT05649956|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92042835|NCT05649956|Hormone Antagonists|hormone antagonists|mesh-ancestor
92042836|NCT05649956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042837|NCT05649956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042838|NCT04876430|Meropenem|meropenem|mesh-list
92042839|NCT04876430|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042840|NCT04876430|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042841|NCT02305238|Aflibercept|aflibercept|mesh-list
92042842|NCT02305238|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92042843|NCT02305238|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92042844|NCT02305238|Growth Substances|growth substances|mesh-ancestor
92042845|NCT02305238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042846|NCT02305238|Growth Inhibitors|growth inhibitors|mesh-ancestor
92042847|NCT02305238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042849|NCT02304926|Ezetimibe|ezetimibe|mesh-list
92042850|NCT02304926|Ezetimibe, Simvastatin Drug Combination|ezetimibe, simvastatin drug combination|mesh-list
92042851|NCT02304926|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92042852|NCT02304926|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92042853|NCT02304926|Antimetabolites|antimetabolites|mesh-ancestor
92042854|NCT02304926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042855|NCT02304926|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92042856|NCT02304926|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92042857|NCT02304926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042858|NCT01646255|Levodopa|levodopa|mesh-list
92042859|NCT01646255|Rotigotine|rotigotine|mesh-list
92042860|NCT01646255|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92042861|NCT01646255|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92042862|NCT01646255|Dopamine Agents|dopamine agents|mesh-ancestor
92042863|NCT01646255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042864|NCT01646255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042865|NCT01646255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042866|NCT01646255|Dopamine Agonists|dopamine agonists|mesh-ancestor
92042867|NCT02203591|Ethanol|ethanol|mesh-list
92042868|NCT02203591|Chlorhexidine|chlorhexidine|mesh-list
92042869|NCT02203591|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92042870|NCT02203591|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92042873|NCT02203591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042874|NCT02203591|Disinfectants|disinfectants|mesh-ancestor
92042875|NCT02203591|Dermatologic Agents|dermatologic agents|mesh-ancestor
92042876|NCT01642277|Solifenacin Succinate|solifenacin succinate|mesh-list
92042877|NCT01642277|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92042878|NCT01642277|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92042879|NCT01642277|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042880|NCT01642277|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042881|NCT01642277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042882|NCT01642277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042883|NCT01642277|Urological Agents|urological agents|mesh-ancestor
92042884|NCT02230189|Methacholine Chloride|methacholine chloride|mesh-list
92042885|NCT02230189|Miotics|miotics|mesh-ancestor
92042886|NCT02230189|Autonomic Agents|autonomic agents|mesh-ancestor
92042887|NCT02230189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042888|NCT02230189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042889|NCT02230189|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92042890|NCT02230189|Bronchoconstrictor Agents|bronchoconstrictor agents|mesh-ancestor
92042891|NCT02230189|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042892|NCT02230189|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92042893|NCT02230189|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92014330|NCT04982809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014331|NCT04982809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92042894|NCT02230189|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042895|NCT02230189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042896|NCT02230189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042897|NCT02304302|Memantine|memantine|mesh-list
92042898|NCT02304302|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92042899|NCT02304302|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92042900|NCT02304302|Dopamine Agents|dopamine agents|mesh-ancestor
92042901|NCT02304302|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042902|NCT02304302|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042903|NCT02304302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042904|NCT02304302|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92042905|NCT02304302|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92042906|NCT02276612|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92042907|NCT02276612|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92042908|NCT02276612|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92042909|NCT02276612|Antiviral Agents|antiviral agents|mesh-ancestor
92042910|NCT02276612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042912|NCT02301143|Gemcitabine|gemcitabine|mesh-list
92042913|NCT02301143|Capecitabine|capecitabine|mesh-list
92042914|NCT02301143|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92042915|NCT02301143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042916|NCT02301143|Tubulin Modulators|tubulin modulators|mesh-ancestor
92042917|NCT02301143|Antimitotic Agents|antimitotic agents|mesh-ancestor
92042918|NCT02301143|Mitosis Modulators|mitosis modulators|mesh-ancestor
92042919|NCT02301143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042920|NCT02301143|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92042921|NCT02301143|Antimetabolites|antimetabolites|mesh-ancestor
92042922|NCT02276222|Glycopyrrolate|glycopyrrolate|mesh-list
92042923|NCT02276222|Tiotropium Bromide|tiotropium bromide|mesh-list
92042924|NCT02276222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92042925|NCT02276222|Autonomic Agents|autonomic agents|mesh-ancestor
92042926|NCT02276222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042927|NCT02276222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042928|NCT02276222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042929|NCT02276222|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042930|NCT02276222|Parasympatholytics|parasympatholytics|mesh-ancestor
92042931|NCT02276222|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92042932|NCT02276222|Cholinergic Agents|cholinergic agents|mesh-ancestor
92042933|NCT02276222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042934|NCT02276222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042935|NCT02276222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92042936|NCT02276222|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92042937|NCT02275052|Albuterol|albuterol|mesh-list
92042938|NCT02275052|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92042939|NCT02275052|Autonomic Agents|autonomic agents|mesh-ancestor
92042940|NCT02275052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042941|NCT02275052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042942|NCT02275052|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042947|NCT02275052|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92042948|NCT02275052|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92042949|NCT02275052|Adrenergic Agents|adrenergic agents|mesh-ancestor
92042950|NCT02275052|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92042951|NCT02275052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042953|NCT05649020|Anesthetics, Local|anesthetics, local|mesh-ancestor
92042954|NCT05649020|Anesthetics|anesthetics|mesh-ancestor
92042955|NCT05649020|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042956|NCT05649020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042957|NCT05649020|Sensory System Agents|sensory system agents|mesh-ancestor
92042958|NCT05649020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042959|NCT04869488|Prednisone|prednisone|mesh-list
92042960|NCT04869488|Apatinib|apatinib|mesh-list
92042961|NCT04869488|Abiraterone Acetate|abiraterone acetate|mesh-list
92042962|NCT04869488|Fluzoparib|fluzoparib|mesh-list
92042963|NCT04869488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92042964|NCT04869488|Glucocorticoids|glucocorticoids|mesh-ancestor
92042965|NCT04869488|Hormones|hormones|mesh-ancestor
92042966|NCT04869488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042967|NCT04869488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014332|NCT04982809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014333|NCT04982809|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92042968|NCT04869488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92042969|NCT04869488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042970|NCT04869488|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92042971|NCT04869488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042972|NCT04869488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042973|NCT04869488|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92042974|NCT04869488|Hormone Antagonists|hormone antagonists|mesh-ancestor
92042975|NCT04869488|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92042976|NCT04869488|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92042977|NCT02274038|Pemetrexed|pemetrexed|mesh-list
92042978|NCT02274038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042979|NCT02274038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042980|NCT02274038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042981|NCT02274038|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92042982|NCT02274038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92042983|NCT01646021|Sirolimus|sirolimus|mesh-list
92042984|NCT01646021|Temsirolimus|temsirolimus|mesh-list
92042985|NCT01646021|MTOR Inhibitors|mtor inhibitors|mesh-list
92042986|NCT01646021|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92042987|NCT01646021|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042988|NCT01646021|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042989|NCT01646021|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042990|NCT01646021|Immunologic Factors|immunologic factors|mesh-ancestor
92042991|NCT01646021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042992|NCT01646021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042993|NCT01646021|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042994|NCT01646021|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042995|NCT01646021|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92042996|NCT01646021|Antifungal Agents|antifungal agents|mesh-ancestor
92042997|NCT01750918|Fluorouracil|fluorouracil|mesh-list
92042998|NCT01750918|Panitumumab|panitumumab|mesh-list
92042999|NCT01750918|Trametinib|trametinib|mesh-list
92043000|NCT01750918|Dabrafenib|dabrafenib|mesh-list
92043001|NCT01750918|Antimetabolites|antimetabolites|mesh-ancestor
92043002|NCT01750918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043003|NCT01750918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043004|NCT01750918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043005|NCT01750918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043006|NCT01750918|Immunologic Factors|immunologic factors|mesh-ancestor
92043007|NCT01750918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043008|NCT01750918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043009|NCT01750918|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92043010|NCT01750918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043011|NCT01750840|Cimetidine|cimetidine|mesh-list
92043012|NCT01750840|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92043014|NCT01750840|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92043015|NCT01750840|Histamine Antagonists|histamine antagonists|mesh-ancestor
92043016|NCT01750840|Histamine Agents|histamine agents|mesh-ancestor
92043017|NCT01750840|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043018|NCT01750840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043019|NCT01750840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043020|NCT01750840|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92043021|NCT01750840|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92043022|NCT01750840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043023|NCT01606228|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92043024|NCT01606228|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92043025|NCT01606228|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92043026|NCT01606228|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043027|NCT01606228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043028|NCT01606228|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92043029|NCT01606228|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92043030|NCT01606228|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92043031|NCT01606228|Serotonin Agents|serotonin agents|mesh-ancestor
92043032|NCT01606228|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043033|NCT01606228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043034|NCT01606228|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92043035|NCT01606228|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92043036|NCT01606228|Dopamine Agents|dopamine agents|mesh-ancestor
92043037|NCT02269943|Azacitidine|azacitidine|mesh-list
92014334|NCT04982809|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014335|NCT03068533|Calcium Carbonate|calcium carbonate|mesh-list
92014336|NCT03068533|Calcium|calcium|mesh-list
92014337|NCT03068533|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92014338|NCT03068533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043039|NCT02269943|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043040|NCT02269943|Antimetabolites|antimetabolites|mesh-ancestor
92043041|NCT02269943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043042|NCT02269943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043043|NCT02269943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043044|NCT01605370|Metoprolol|metoprolol|mesh-list
92043045|NCT01605370|Nebivolol|nebivolol|mesh-list
92043046|NCT01605370|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92043047|NCT01605370|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92043048|NCT01605370|Sympatholytics|sympatholytics|mesh-ancestor
92043049|NCT01605370|Autonomic Agents|autonomic agents|mesh-ancestor
92043050|NCT01605370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043051|NCT01605370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043052|NCT01605370|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92043053|NCT01605370|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92043055|NCT01605370|Adrenergic Agents|adrenergic agents|mesh-ancestor
92043056|NCT01605370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043057|NCT01605370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043058|NCT01605370|Vasodilator Agents|vasodilator agents|mesh-ancestor
92043059|NCT01605370|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92043060|NCT01605370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92043061|NCT01605370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92043062|NCT01605136|Afamelanotide|afamelanotide|mesh-list
92043063|NCT01605136|Dermatologic Agents|dermatologic agents|mesh-ancestor
92043064|NCT01706146|Rivaroxaban|rivaroxaban|mesh-list
92043065|NCT01706146|Apixaban|apixaban|mesh-list
92043067|NCT01706146|Anticoagulants|anticoagulants|mesh-list
92043068|NCT01706146|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92043069|NCT01706146|Antithrombins|antithrombins|mesh-ancestor
92043070|NCT01706146|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92043071|NCT01706146|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043072|NCT01706146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043073|NCT01706146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043074|NCT02269241|Drospirenone|drospirenone|mesh-list
92043075|NCT02269241|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92043076|NCT02269241|Hormone Antagonists|hormone antagonists|mesh-ancestor
92043077|NCT02269241|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043078|NCT02269241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043079|NCT02269241|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92043080|NCT02269241|Diuretics|diuretics|mesh-ancestor
92043081|NCT02269241|Natriuretic Agents|natriuretic agents|mesh-ancestor
92043082|NCT01750294|Chlorthalidone|chlorthalidone|mesh-list
92043083|NCT01750294|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92043084|NCT01750294|Diuretics|diuretics|mesh-ancestor
92043085|NCT01750294|Natriuretic Agents|natriuretic agents|mesh-ancestor
92043088|NCT01750294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92043089|NCT01750294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043091|NCT01749982|Betaine|betaine|mesh-list
92043092|NCT01749982|Lipotropic Agents|lipotropic agents|mesh-ancestor
92043093|NCT01749982|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92043094|NCT01749982|Antimetabolites|antimetabolites|mesh-ancestor
92043095|NCT01749982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043096|NCT01749982|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043097|NCT01749982|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92043098|NCT01749982|Nootropic Agents|nootropic agents|mesh-ancestor
92043099|NCT02269163|Immunoglobulins|immunoglobulins|mesh-list
92043100|NCT02269163|Antibodies|antibodies|mesh-list
92043101|NCT02269163|gamma-Globulins|gamma-globulins|mesh-list
92043102|NCT02269163|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92043103|NCT02269163|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92043104|NCT02269163|Immunoglobulin G|immunoglobulin g|mesh-list
92043105|NCT02269163|Immunologic Factors|immunologic factors|mesh-ancestor
92043106|NCT02269163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014339|NCT03068533|Antacids|antacids|mesh-ancestor
92014340|NCT03068533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014341|NCT03068533|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043107|NCT01749826|Morphine|morphine|mesh-list
92043108|NCT01749826|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92043109|NCT01749826|Narcotics|narcotics|mesh-ancestor
92043110|NCT01749826|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043111|NCT01749826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043112|NCT01749826|Analgesics|analgesics|mesh-ancestor
92043113|NCT01749826|Sensory System Agents|sensory system agents|mesh-ancestor
92043114|NCT01749826|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043115|NCT01724866|Cyclophosphamide|cyclophosphamide|mesh-list
92043116|NCT01724866|Docetaxel|docetaxel|mesh-list
92043117|NCT01724866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043118|NCT01724866|Immunologic Factors|immunologic factors|mesh-ancestor
92043119|NCT01724866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043120|NCT01724866|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043121|NCT01724866|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92043122|NCT01724866|Alkylating Agents|alkylating agents|mesh-ancestor
92043123|NCT01724866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043124|NCT01724866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043125|NCT01724866|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92043126|NCT01724866|Tubulin Modulators|tubulin modulators|mesh-ancestor
92043127|NCT01724866|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043128|NCT01724866|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043129|NCT02266433|Dexamethasone|dexamethasone|mesh-list
92043130|NCT02266433|Ketorolac|ketorolac|mesh-list
92043131|NCT02266433|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043132|NCT02266433|Antiemetics|antiemetics|mesh-ancestor
92043133|NCT02266433|Autonomic Agents|autonomic agents|mesh-ancestor
92043134|NCT02266433|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043135|NCT02266433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043136|NCT02266433|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043137|NCT02266433|Glucocorticoids|glucocorticoids|mesh-ancestor
92043138|NCT02266433|Hormones|hormones|mesh-ancestor
92043139|NCT02266433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043140|NCT02266433|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92043141|NCT02266433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043142|NCT02266433|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92043143|NCT02266433|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92043144|NCT02266433|Analgesics|analgesics|mesh-ancestor
92043145|NCT02266433|Sensory System Agents|sensory system agents|mesh-ancestor
92043146|NCT02266433|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043147|NCT02266433|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92043148|NCT02266433|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043149|NCT02266433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043150|NCT02273726|Epoetin Alfa|epoetin alfa|mesh-list
92043151|NCT02273726|Hematinics|hematinics|mesh-ancestor
92043152|NCT01723228|Rasagiline|rasagiline|mesh-list
92043153|NCT01723228|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92043154|NCT01723228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043155|NCT01723228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043156|NCT01723228|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92043157|NCT01723228|Protective Agents|protective agents|mesh-ancestor
92043158|NCT01723228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043174|NCT01745380|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92043175|NCT01745380|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92043176|NCT01745380|Adrenergic Agents|adrenergic agents|mesh-ancestor
92043177|NCT01745380|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043178|NCT01745380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043179|NCT01745380|Sympathomimetics|sympathomimetics|mesh-ancestor
92043180|NCT01745380|Autonomic Agents|autonomic agents|mesh-ancestor
92043181|NCT01745380|Nasal Decongestants|nasal decongestants|mesh-ancestor
92043182|NCT01745380|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92043183|NCT01745380|Respiratory System Agents|respiratory system agents|mesh-ancestor
92043184|NCT01745380|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92043185|NCT01745380|Mydriatics|mydriatics|mesh-ancestor
92043186|NCT01745380|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92043187|NCT01745380|Protective Agents|protective agents|mesh-ancestor
92043188|NCT04550104|Olaparib|olaparib|mesh-list
92043189|NCT04550104|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92043190|NCT04550104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014342|NCT05281341|Hormones|hormones|mesh-list
92014343|NCT05281341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014344|NCT05281341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014345|NCT04808687|Paclitaxel|paclitaxel|mesh-list
92014346|NCT04808687|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92043191|NCT04550104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043192|NCT04550104|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043193|NCT05648318|Lactulose|lactulose|mesh-list
92043194|NCT05648318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043195|NCT02203513|Prexasertib|prexasertib|mesh-list
92043196|NCT02203513|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92043197|NCT02203513|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043198|NCT02203513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043199|NCT01703260|Pioglitazone|pioglitazone|mesh-list
92043200|NCT01703260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043201|NCT01703260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043203|NCT02299388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043204|NCT02299388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043205|NCT02299388|Incretins|incretins|mesh-ancestor
92043206|NCT02299388|Hormones|hormones|mesh-ancestor
92043207|NCT02299388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043208|NCT02202577|Chlorhexidine|chlorhexidine|mesh-list
92043209|NCT02202577|Povidone-Iodine|povidone-iodine|mesh-list
92043210|NCT02202577|Povidone|povidone|mesh-list
92043667|NCT04188223|Vaccines|vaccines|mesh-list
92043211|NCT02202577|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92043212|NCT02202577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043213|NCT02202577|Disinfectants|disinfectants|mesh-ancestor
92043214|NCT02202577|Plasma Substitutes|plasma substitutes|mesh-ancestor
92043215|NCT02202577|Blood Substitutes|blood substitutes|mesh-ancestor
92043216|NCT01723072|Omalizumab|omalizumab|mesh-list
92043217|NCT01723072|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92043218|NCT01723072|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92043219|NCT01723072|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92043220|NCT01723072|Respiratory System Agents|respiratory system agents|mesh-ancestor
92043221|NCT01723072|Immunologic Factors|immunologic factors|mesh-ancestor
92043222|NCT01723072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043223|NCT02169505|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92043224|NCT02169505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043225|NCT02169505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043227|NCT02169505|Immunoconjugates|immunoconjugates|mesh-ancestor
92043228|NCT02169505|Immunologic Factors|immunologic factors|mesh-ancestor
92043229|NCT02169505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043230|NCT01909791|Aflibercept|aflibercept|mesh-list
92043231|NCT01909791|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92043232|NCT01909791|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92043233|NCT01909791|Growth Substances|growth substances|mesh-ancestor
92043234|NCT01909791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043235|NCT01909791|Growth Inhibitors|growth inhibitors|mesh-ancestor
92043236|NCT01909791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043237|NCT02202499|Varenicline|varenicline|mesh-list
92043238|NCT02202499|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92043239|NCT02202499|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92043240|NCT02202499|Cholinergic Agents|cholinergic agents|mesh-ancestor
92043241|NCT02202499|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043242|NCT02202499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043243|NCT02202499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043244|NCT02227849|Canagliflozin|canagliflozin|mesh-list
92043245|NCT02227849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92043246|NCT02227849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043247|NCT02227849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043248|NCT02227849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043249|NCT02169271|Aspirin|aspirin|mesh-list
92043250|NCT02169271|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92043251|NCT02169271|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92043252|NCT02169271|Analgesics|analgesics|mesh-ancestor
92043253|NCT02169271|Sensory System Agents|sensory system agents|mesh-ancestor
92043254|NCT02169271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043255|NCT02169271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043256|NCT02169271|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014347|NCT04808687|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014348|NCT04808687|Tubulin Modulators|tubulin modulators|mesh-ancestor
92014349|NCT04808687|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043257|NCT02169271|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043258|NCT02169271|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92043259|NCT02169271|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92043260|NCT02169271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043261|NCT02169271|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92043262|NCT02169271|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92043263|NCT02169271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043264|NCT02169271|Antipyretics|antipyretics|mesh-ancestor
92043265|NCT01644188|Ezetimibe|ezetimibe|mesh-list
92043266|NCT01644188|Alirocumab|alirocumab|mesh-list
92043267|NCT01644188|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92043268|NCT01644188|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92043269|NCT01644188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92043270|NCT01644188|Antimetabolites|antimetabolites|mesh-ancestor
92043271|NCT01644188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043272|NCT01644188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92043273|NCT01644188|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92043274|NCT01644188|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92043275|NCT01644188|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043276|NCT01644188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043277|NCT01644188|Immunologic Factors|immunologic factors|mesh-ancestor
92043279|NCT02201953|Sofosbuvir|sofosbuvir|mesh-list
92043280|NCT02201953|Antiviral Agents|antiviral agents|mesh-ancestor
92043281|NCT02201953|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043282|NCT02271854|Diclofenac|diclofenac|mesh-list
92043283|NCT02271854|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92043284|NCT02271854|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92043285|NCT02271854|Analgesics|analgesics|mesh-ancestor
92043286|NCT02271854|Sensory System Agents|sensory system agents|mesh-ancestor
92043287|NCT02271854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043288|NCT02271854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043289|NCT02271854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043290|NCT02271854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043291|NCT02271854|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92043292|NCT02271854|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043293|NCT02271854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043295|NCT02296892|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92043296|NCT02296892|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92043297|NCT02296892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043301|NCT02296892|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92043302|NCT02296892|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92043303|NCT02296892|Anesthetics, General|anesthetics, general|mesh-ancestor
92043304|NCT02296892|Anesthetics|anesthetics|mesh-ancestor
92043305|NCT02296892|GABA Modulators|gaba modulators|mesh-ancestor
92043306|NCT02296892|GABA Agents|gaba agents|mesh-ancestor
92043307|NCT02296892|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043308|NCT02296892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043309|NCT02168803|Evacetrapib|evacetrapib|mesh-list
92043310|NCT02168803|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92043311|NCT02168803|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92043312|NCT02168803|Antimetabolites|antimetabolites|mesh-ancestor
92043313|NCT02168803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043314|NCT02168803|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92043315|NCT02201329|Azacitidine|azacitidine|mesh-list
92043316|NCT02201329|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043317|NCT02201329|Antimetabolites|antimetabolites|mesh-ancestor
92043318|NCT02201329|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043319|NCT02201329|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043320|NCT02201329|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043321|NCT01927419|Nivolumab|nivolumab|mesh-list
92043322|NCT01927419|Ipilimumab|ipilimumab|mesh-list
92043323|NCT01927419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043324|NCT01927419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043325|NCT01927419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92043326|NCT01927419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043327|NCT02168491|Insulin Glargine|insulin glargine|mesh-list
92043328|NCT02168491|Lixisenatide|lixisenatide|mesh-list
92043329|NCT02168491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043330|NCT02168491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014350|NCT04808687|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043331|NCT01721746|Paclitaxel|paclitaxel|mesh-list
92043332|NCT01721746|Carboplatin|carboplatin|mesh-list
92043333|NCT01721746|Nivolumab|nivolumab|mesh-list
92043334|NCT01721746|Dacarbazine|dacarbazine|mesh-list
92043335|NCT01721746|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92043336|NCT01721746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043337|NCT01721746|Tubulin Modulators|tubulin modulators|mesh-ancestor
92043338|NCT01721746|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043339|NCT01721746|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043340|NCT01721746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043341|NCT01721746|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043342|NCT01721746|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92043343|NCT01721746|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92043344|NCT01721746|Alkylating Agents|alkylating agents|mesh-ancestor
92043345|NCT02225665|Cyclophosphamide|cyclophosphamide|mesh-list
92043346|NCT02225665|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043347|NCT02225665|Immunologic Factors|immunologic factors|mesh-ancestor
92043348|NCT02225665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043349|NCT02225665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043350|NCT02225665|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92043351|NCT02225665|Alkylating Agents|alkylating agents|mesh-ancestor
92043352|NCT02225665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043353|NCT02225665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043354|NCT02225665|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92043355|NCT02225587|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92043356|NCT02225587|Immunologic Factors|immunologic factors|mesh-ancestor
92043357|NCT02225587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043358|NCT02296424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92043359|NCT02296424|Immunologic Factors|immunologic factors|mesh-ancestor
92043360|NCT02296424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043361|NCT02296190|Etripamil|etripamil|mesh-list
92043362|NCT02296190|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92043363|NCT02296190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92043364|NCT02296190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043365|NCT02296190|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92043366|NCT02296190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043367|NCT04875026|Fluorouracil|fluorouracil|mesh-list
92043368|NCT04875026|Antimetabolites|antimetabolites|mesh-ancestor
92043371|NCT04875026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043372|NCT04875026|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043373|NCT04875026|Immunologic Factors|immunologic factors|mesh-ancestor
92043374|NCT04875026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043376|NCT02296112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043377|NCT02296112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92043378|NCT02296112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043379|NCT02296112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043380|NCT02269670|Tamoxifen|tamoxifen|mesh-list
92043381|NCT02269670|Everolimus|everolimus|mesh-list
92043382|NCT02269670|Letrozole|letrozole|mesh-list
92043383|NCT02269670|Fulvestrant|fulvestrant|mesh-list
92043384|NCT02269670|Anastrozole|anastrozole|mesh-list
92043385|NCT02269670|Megestrol|megestrol|mesh-list
92043386|NCT02269670|Megestrol Acetate|megestrol acetate|mesh-list
92043387|NCT02269670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043388|NCT02269670|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92043389|NCT02269670|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92043390|NCT02269670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043391|NCT02269670|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043392|NCT02269670|Immunologic Factors|immunologic factors|mesh-ancestor
92043393|NCT02269670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043394|NCT02269670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043395|NCT02269670|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92043396|NCT02269670|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92043397|NCT02269670|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92043398|NCT02269670|Hormone Antagonists|hormone antagonists|mesh-ancestor
92043399|NCT02269670|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043400|NCT02269670|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92043401|NCT02269670|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92043402|NCT02269670|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92043403|NCT02269670|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92043404|NCT02269670|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92014351|NCT04808687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043405|NCT02269670|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92043406|NCT02269670|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92043407|NCT02269670|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92043408|NCT02269670|Contraceptive Agents|contraceptive agents|mesh-ancestor
92043409|NCT02269670|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92043410|NCT02269670|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92043411|NCT02269670|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92043412|NCT02269670|Appetite Stimulants|appetite stimulants|mesh-ancestor
92043413|NCT02269670|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92043414|NCT02225353|Progesterone|progesterone|mesh-list
92043415|NCT02225353|Progestins|progestins|mesh-ancestor
92043417|NCT02225353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043418|NCT02225353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043419|NCT01641926|Interferons|interferons|mesh-list
92043420|NCT01641926|Interferon-alpha|interferon-alpha|mesh-list
92043421|NCT01641926|Interferon alpha-2|interferon alpha-2|mesh-list
92043422|NCT01641926|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92043423|NCT01641926|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92043424|NCT01641926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043425|NCT01641926|Antiviral Agents|antiviral agents|mesh-ancestor
92043426|NCT01641926|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043428|NCT01641926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043429|NCT02294786|Capecitabine|capecitabine|mesh-list
92043430|NCT02294786|Lapatinib|lapatinib|mesh-list
92043431|NCT02294786|Octreotide|octreotide|mesh-list
92043432|NCT02294786|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043433|NCT02294786|Antimetabolites|antimetabolites|mesh-ancestor
92043434|NCT02294786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043435|NCT02294786|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043436|NCT02294786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92043437|NCT02294786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043438|NCT02294786|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043439|NCT02294786|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92043440|NCT04880876|Eluxadoline|eluxadoline|mesh-list
92043441|NCT04880876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043444|NCT01927341|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043445|NCT02294474|Insulin|insulin|mesh-list
92043446|NCT02294474|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92043447|NCT02294474|Insulin Glargine|insulin glargine|mesh-list
92043448|NCT02294474|Insulin Lispro|insulin lispro|mesh-list
92043449|NCT02294474|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043450|NCT02294474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043451|NCT02168101|Ixazomib|ixazomib|mesh-list
92043452|NCT02168101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043453|NCT02168101|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043454|NCT02168101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043455|NCT02168101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043456|NCT01956123|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92043457|NCT01956123|Hormones|hormones|mesh-ancestor
92043458|NCT01956123|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043459|NCT01956123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043460|NCT02298179|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92043461|NCT02298179|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92043462|NCT02298179|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92043463|NCT02298179|Immunologic Factors|immunologic factors|mesh-ancestor
92043464|NCT02298179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043465|NCT02298179|Antacids|antacids|mesh-ancestor
92043466|NCT02298179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043467|NCT02298179|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043468|NCT02298023|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92043469|NCT02298023|Hemostatics|hemostatics|mesh-ancestor
92043470|NCT02298023|Coagulants|coagulants|mesh-ancestor
92043471|NCT02296931|Magnesium Sulfate|magnesium sulfate|mesh-list
92043472|NCT02296931|Analgesics|analgesics|mesh-ancestor
92043473|NCT02296931|Sensory System Agents|sensory system agents|mesh-ancestor
92043474|NCT02296931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043475|NCT02296931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043476|NCT02296931|Anesthetics|anesthetics|mesh-ancestor
92043477|NCT02296931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043478|NCT02296931|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92043479|NCT02296931|Anticonvulsants|anticonvulsants|mesh-ancestor
92043480|NCT02296931|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92043481|NCT02296931|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014352|NCT05279703|Epinephrine|epinephrine|mesh-list
92014353|NCT05279703|Racepinephrine|racepinephrine|mesh-list
92014354|NCT05279703|Epinephryl borate|epinephryl borate|mesh-list
92014355|NCT05279703|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92014356|NCT05279703|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92014357|NCT05279703|Adrenergic Agents|adrenergic agents|mesh-ancestor
92043482|NCT02296931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043483|NCT02296931|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92043484|NCT02296931|Tocolytic Agents|tocolytic agents|mesh-ancestor
92043485|NCT02296931|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92043486|NCT02166697|Candesartan|candesartan|mesh-list
92043487|NCT02166697|Candesartan cilexetil|candesartan cilexetil|mesh-list
92043488|NCT02166697|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92043489|NCT02166697|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92043490|NCT02166697|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92043491|NCT02166697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043492|NCT04764721|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92043493|NCT04764721|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92043494|NCT04764721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043495|NCT02197897|Tamoxifen|tamoxifen|mesh-list
92043496|NCT02197897|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92043497|NCT02197897|Hormone Antagonists|hormone antagonists|mesh-ancestor
92043498|NCT02197897|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043499|NCT02197897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043500|NCT02197897|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92043501|NCT02197897|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043502|NCT02197897|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92043503|NCT02197897|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92043504|NCT02197897|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92043505|NCT02196259|Ketamine|ketamine|mesh-list
92043506|NCT02196259|Anesthetics, Dissociative|anesthetics, dissociative|mesh-list
92043507|NCT02196259|Anesthetics|anesthetics|mesh-list
92043508|NCT02196259|Analgesics|analgesics|mesh-ancestor
92043509|NCT02196259|Sensory System Agents|sensory system agents|mesh-ancestor
92043510|NCT02196259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043511|NCT02196259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043512|NCT02196259|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92043513|NCT02196259|Anesthetics, General|anesthetics, general|mesh-ancestor
92043517|NCT02196259|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043518|NCT02196259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043519|NCT02294396|Solifenacin Succinate|solifenacin succinate|mesh-list
92043520|NCT02294396|Mirabegron|mirabegron|mesh-list
92043521|NCT02294396|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92043522|NCT02294396|Propiverine|propiverine|mesh-list
92043523|NCT02294396|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92043524|NCT02294396|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92043525|NCT02294396|Cholinergic Agents|cholinergic agents|mesh-ancestor
92043526|NCT02294396|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043527|NCT02294396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043528|NCT02294396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043529|NCT02294396|Urological Agents|urological agents|mesh-ancestor
92043530|NCT02294396|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92043531|NCT02294396|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92043532|NCT02294396|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92043533|NCT02294396|Adrenergic Agents|adrenergic agents|mesh-ancestor
92043534|NCT02294396|Parasympatholytics|parasympatholytics|mesh-ancestor
92043535|NCT02294396|Autonomic Agents|autonomic agents|mesh-ancestor
92043536|NCT02294396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043537|NCT02164981|Nitroprusside|nitroprusside|mesh-list
92043538|NCT02164981|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92043539|NCT02164981|Vasodilator Agents|vasodilator agents|mesh-ancestor
92043540|NCT02164981|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92043541|NCT02164981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043542|NCT01908699|Beraprost|beraprost|mesh-list
92043543|NCT01908699|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92043544|NCT01908699|Vasodilator Agents|vasodilator agents|mesh-ancestor
92043545|NCT01363011|Darunavir|darunavir|mesh-list
92014358|NCT05279703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043546|NCT01363011|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92043547|NCT01363011|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92043548|NCT01363011|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92043549|NCT01363011|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043550|NCT01363011|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043551|NCT01363011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043552|NCT01363011|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92043553|NCT01363011|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92043554|NCT01363011|Antiviral Agents|antiviral agents|mesh-ancestor
92043555|NCT01363011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043556|NCT02263547|Teriflunomide|teriflunomide|mesh-list
92043557|NCT02263547|Colestipol|colestipol|mesh-list
92043558|NCT02263547|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92043559|NCT02263547|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92043560|NCT02263547|Analgesics|analgesics|mesh-ancestor
92043561|NCT02263547|Sensory System Agents|sensory system agents|mesh-ancestor
92043562|NCT02263547|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043563|NCT02263547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043564|NCT02263547|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043565|NCT02263547|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043566|NCT02263547|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043567|NCT02263547|Immunologic Factors|immunologic factors|mesh-ancestor
92043568|NCT02263547|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92043569|NCT02263547|Antimetabolites|antimetabolites|mesh-ancestor
92043570|NCT02263547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043571|NCT02263547|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92043572|NCT02263547|Sequestering Agents|sequestering agents|mesh-ancestor
92043573|NCT01925703|Ferric gluconate|ferric gluconate|mesh-list
92043575|NCT01617681|Valsartan|valsartan|mesh-list
92043576|NCT01617681|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92043577|NCT01617681|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92043578|NCT01617681|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92043579|NCT01617681|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043580|NCT02263079|Interferons|interferons|mesh-list
92043581|NCT02263079|Interferon-alpha|interferon-alpha|mesh-list
92043582|NCT02263079|Lamivudine|lamivudine|mesh-list
92043583|NCT02263079|Interferon alpha-2|interferon alpha-2|mesh-list
92043584|NCT02263079|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92043588|NCT02263079|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043589|NCT02263079|Immunologic Factors|immunologic factors|mesh-ancestor
92043590|NCT02263079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043591|NCT02263079|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92043668|NCT04188223|Immunologic Factors|immunologic factors|mesh-ancestor
92043592|NCT02263079|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92043593|NCT02263079|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043594|NCT02263079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043595|NCT02263079|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92043596|NCT02263079|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92043597|NCT02260817|Choline|choline|mesh-list
92043598|NCT02260817|Lipotropic Agents|lipotropic agents|mesh-ancestor
92043599|NCT02260817|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92043600|NCT02260817|Antimetabolites|antimetabolites|mesh-ancestor
92043601|NCT02260817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043602|NCT02260817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043603|NCT02260817|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92043604|NCT02260817|Nootropic Agents|nootropic agents|mesh-ancestor
92043605|NCT04873193|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92043606|NCT04873193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043607|NCT01642589|Vaccines|vaccines|mesh-list
92043608|NCT01642589|Immunologic Factors|immunologic factors|mesh-ancestor
92043609|NCT01642589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043610|NCT01954251|Vaccines|vaccines|mesh-list
92043611|NCT01954251|Immunologic Factors|immunologic factors|mesh-ancestor
92043612|NCT01954251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043613|NCT04643925|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92043614|NCT04643925|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92043615|NCT04643925|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043616|NCT04620603|Immunomodulating Agents|immunomodulating agents|mesh-list
92043617|NCT04620603|Immunologic Factors|immunologic factors|mesh-ancestor
92043618|NCT04620603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043619|NCT02257385|Albuterol|albuterol|mesh-list
92014359|NCT05279703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014360|NCT05279703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014361|NCT05279703|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92014362|NCT05279703|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92043620|NCT02257385|Tiotropium Bromide|tiotropium bromide|mesh-list
92043621|NCT02257385|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92043622|NCT02257385|Autonomic Agents|autonomic agents|mesh-ancestor
92043623|NCT02257385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043624|NCT02257385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043625|NCT02257385|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92043626|NCT02257385|Respiratory System Agents|respiratory system agents|mesh-ancestor
92043627|NCT02257385|Parasympatholytics|parasympatholytics|mesh-ancestor
92043628|NCT02257385|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92043629|NCT02257385|Cholinergic Agents|cholinergic agents|mesh-ancestor
92043630|NCT02257385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043631|NCT02257385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043632|NCT02257385|Tocolytic Agents|tocolytic agents|mesh-ancestor
92043633|NCT02257385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92043634|NCT02257385|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92043635|NCT02257385|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92043636|NCT02257385|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92043637|NCT02257385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92043638|NCT05647265|Nivolumab|nivolumab|mesh-list
92043639|NCT05647265|Ipilimumab|ipilimumab|mesh-list
92043640|NCT05647265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043641|NCT05647265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043642|NCT05647265|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92043643|NCT05647265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043644|NCT01629667|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92043645|NCT01629667|Immunologic Factors|immunologic factors|mesh-ancestor
92043646|NCT01629667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043647|NCT01645280|Methotrexate|methotrexate|mesh-list
92043648|NCT01645280|Ustekinumab|ustekinumab|mesh-list
92043649|NCT01645280|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92043650|NCT01645280|Abortifacient Agents|abortifacient agents|mesh-ancestor
92043651|NCT01645280|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92043652|NCT01645280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043653|NCT01645280|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043654|NCT01645280|Antimetabolites|antimetabolites|mesh-ancestor
92043655|NCT01645280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043656|NCT01645280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043657|NCT01645280|Dermatologic Agents|dermatologic agents|mesh-ancestor
92043663|NCT01645280|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92043664|NCT01629589|Vaccines|vaccines|mesh-list
92043665|NCT01629589|Immunologic Factors|immunologic factors|mesh-ancestor
92043666|NCT01629589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043669|NCT04188223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043670|NCT02220907|Canagliflozin|canagliflozin|mesh-list
92043671|NCT02220907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92043672|NCT02220907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043673|NCT02220907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043674|NCT02220907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043675|NCT01601873|Heparin|heparin|mesh-list
92043676|NCT01601873|Anticoagulants|anticoagulants|mesh-ancestor
92043677|NCT01601873|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92043678|NCT01601873|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92043679|NCT01601873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043680|NCT02194933|Brexpiprazole|brexpiprazole|mesh-list
92043681|NCT02194933|Serotonin Agents|serotonin agents|mesh-ancestor
92043682|NCT02194933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043683|NCT02194933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043684|NCT02194933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043685|NCT02194933|Dopamine Agonists|dopamine agonists|mesh-ancestor
92043686|NCT02194933|Dopamine Agents|dopamine agents|mesh-ancestor
92043687|NCT04420247|Hydroxychloroquine|hydroxychloroquine|mesh-list
92014363|NCT05279703|Autonomic Agents|autonomic agents|mesh-ancestor
92014364|NCT05279703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014365|NCT05279703|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92043688|NCT04420247|Chloroquine|chloroquine|mesh-list
92043689|NCT04420247|Antimalarials|antimalarials|mesh-ancestor
92043690|NCT04420247|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92043691|NCT04420247|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92043692|NCT04420247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043693|NCT04420247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043694|NCT04420247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043695|NCT04420247|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043696|NCT04420247|Amebicides|amebicides|mesh-ancestor
92043697|NCT01644890|Paclitaxel|paclitaxel|mesh-list
92043698|NCT01644890|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92043699|NCT01644890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043700|NCT01644890|Tubulin Modulators|tubulin modulators|mesh-ancestor
92043701|NCT01644890|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043702|NCT01644890|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043703|NCT01644890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043704|NCT04865237|Remdesivir|remdesivir|mesh-list
92043705|NCT04865237|Antimetabolites|antimetabolites|mesh-ancestor
92043706|NCT04865237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043707|NCT04865237|Antiviral Agents|antiviral agents|mesh-ancestor
92043708|NCT04865237|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043709|NCT01628965|Rotigotine|rotigotine|mesh-list
92043710|NCT01628965|Dopamine Agonists|dopamine agonists|mesh-ancestor
92043711|NCT01628965|Dopamine Agents|dopamine agents|mesh-ancestor
92043712|NCT01628965|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043713|NCT01628965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043714|NCT01628965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043715|NCT01644734|Tiotropium Bromide|tiotropium bromide|mesh-list
92043716|NCT01644734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92043717|NCT01644734|Autonomic Agents|autonomic agents|mesh-ancestor
92043718|NCT01644734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043719|NCT01644734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043720|NCT01644734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92043721|NCT01644734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92043722|NCT01644734|Parasympatholytics|parasympatholytics|mesh-ancestor
92043723|NCT01644734|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92043724|NCT01644734|Cholinergic Agents|cholinergic agents|mesh-ancestor
92043725|NCT01644734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043726|NCT01644734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043727|NCT02255279|Vaccines|vaccines|mesh-list
92043728|NCT02255279|Immunologic Factors|immunologic factors|mesh-ancestor
92043729|NCT02255279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043731|NCT04865159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043732|NCT02293538|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92043733|NCT02293538|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92043734|NCT02266706|Tazobactam|tazobactam|mesh-list
92043735|NCT02266706|Ceftolozane|ceftolozane|mesh-list
92043736|NCT02266706|Cephalosporins|cephalosporins|mesh-list
92043737|NCT02266706|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92043738|NCT02266706|Penicillanic Acid|penicillanic acid|mesh-list
92043739|NCT02266706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92043740|NCT02266706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043741|NCT02266706|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92043742|NCT02266706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043743|NCT02266706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043744|NCT02266706|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92043745|NCT02292719|Ritonavir|ritonavir|mesh-list
92043746|NCT02292719|Ribavirin|ribavirin|mesh-list
92043747|NCT02292719|Sofosbuvir|sofosbuvir|mesh-list
92043748|NCT02292719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92043749|NCT02292719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92043750|NCT02292719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043751|NCT02292719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043752|NCT02292719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043753|NCT02292719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92043754|NCT02292719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92043755|NCT02292719|Antiviral Agents|antiviral agents|mesh-ancestor
92043756|NCT02292719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043757|NCT02292719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92043758|NCT02292719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92014366|NCT05279703|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014367|NCT05279703|Mydriatics|mydriatics|mesh-ancestor
92014368|NCT05279703|Sympathomimetics|sympathomimetics|mesh-ancestor
92014369|NCT05279703|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92014370|NCT05392933|Lidocaine|lidocaine|mesh-list
92014371|NCT05392933|Anesthetics, Local|anesthetics, local|mesh-ancestor
92014372|NCT05392933|Anesthetics|anesthetics|mesh-ancestor
92043759|NCT02292719|Antimetabolites|antimetabolites|mesh-ancestor
92043760|NCT02291549|Mometasone Furoate|mometasone furoate|mesh-list
92043761|NCT02291549|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043762|NCT02291549|Dermatologic Agents|dermatologic agents|mesh-ancestor
92043763|NCT02291549|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92043764|NCT02264990|Paclitaxel|paclitaxel|mesh-list
92043765|NCT02264990|Carboplatin|carboplatin|mesh-list
92043766|NCT02264990|Pemetrexed|pemetrexed|mesh-list
92043767|NCT02264990|Veliparib|veliparib|mesh-list
92043768|NCT02264990|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92043769|NCT02264990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043770|NCT02264990|Tubulin Modulators|tubulin modulators|mesh-ancestor
92043771|NCT02264990|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043772|NCT02264990|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043773|NCT02264990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043774|NCT02264990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043775|NCT02264990|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92043776|NCT02264990|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92043777|NCT02264990|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92043778|NCT02289833|Trastuzumab|trastuzumab|mesh-list
92043779|NCT02289833|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92043780|NCT02289833|Maytansine|maytansine|mesh-list
92043781|NCT02289833|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043782|NCT02289833|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043783|NCT02289833|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92043784|NCT02289833|Tubulin Modulators|tubulin modulators|mesh-ancestor
92043785|NCT02289833|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043786|NCT02289833|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043787|NCT02289833|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043788|NCT02289833|Immunotoxins|immunotoxins|mesh-ancestor
92043789|NCT02289833|Immunoconjugates|immunoconjugates|mesh-ancestor
92043790|NCT02289833|Immunologic Factors|immunologic factors|mesh-ancestor
92043791|NCT02289833|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043792|NCT01702558|Capecitabine|capecitabine|mesh-list
92043793|NCT01702558|Trastuzumab|trastuzumab|mesh-list
92043794|NCT01702558|Maytansine|maytansine|mesh-list
92043795|NCT01702558|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92043796|NCT01702558|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043797|NCT01702558|Antimetabolites|antimetabolites|mesh-ancestor
92043798|NCT01702558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043799|NCT01702558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043800|NCT01702558|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043801|NCT01702558|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92043802|NCT01702558|Tubulin Modulators|tubulin modulators|mesh-ancestor
92043803|NCT01702558|Antimitotic Agents|antimitotic agents|mesh-ancestor
92043804|NCT01702558|Mitosis Modulators|mitosis modulators|mesh-ancestor
92043821|NCT02194465|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92043822|NCT02194465|Mineralocorticoids|mineralocorticoids|mesh-list
92043823|NCT02194465|Vasodilator Agents|vasodilator agents|mesh-ancestor
92043824|NCT02194465|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92043825|NCT02194465|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92043826|NCT02194465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043827|NCT02194465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043828|NCT02194465|Urological Agents|urological agents|mesh-ancestor
92043829|NCT02194465|Hormone Antagonists|hormone antagonists|mesh-ancestor
92043830|NCT02194465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043831|NCT02194465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043832|NCT02194465|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92043833|NCT02194465|Diuretics|diuretics|mesh-ancestor
92043834|NCT02194465|Natriuretic Agents|natriuretic agents|mesh-ancestor
92043836|NCT01720264|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92014373|NCT05392933|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043837|NCT01720264|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043838|NCT01720264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043839|NCT01720264|Incretins|incretins|mesh-ancestor
92043840|NCT01720264|Hormones|hormones|mesh-ancestor
92043841|NCT01720264|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043842|NCT01720264|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92043843|NCT01720264|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043844|NCT01720264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043845|NCT01720264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043846|NCT04564846|Insulin|insulin|mesh-list
92043847|NCT04564846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043848|NCT04564846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043849|NCT01702246|Simvastatin|simvastatin|mesh-list
92043850|NCT01702246|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92043851|NCT01702246|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92043852|NCT01702246|Antimetabolites|antimetabolites|mesh-ancestor
92043853|NCT01702246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043854|NCT01702246|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92043855|NCT01702246|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92043856|NCT01702246|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043857|NCT01631227|Eprosartan|eprosartan|mesh-list
92043858|NCT01631227|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92043859|NCT01631227|Angiotensin II Type 2 Receptor Blockers|angiotensin ii type 2 receptor blockers|mesh-ancestor
92043860|NCT01631227|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92043861|NCT01631227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043866|NCT05645861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043867|NCT05645861|Sensory System Agents|sensory system agents|mesh-ancestor
92043868|NCT05645861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043870|NCT01719172|Coagulants|coagulants|mesh-ancestor
92043871|NCT02285855|Metformin|metformin|mesh-list
92043872|NCT02285855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043873|NCT02285855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043874|NCT02285153|Aspirin|aspirin|mesh-list
92043875|NCT02285153|Acetylsalicylic acid lysinate|acetylsalicylic acid lysinate|mesh-list
92043876|NCT02285153|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92043877|NCT02285153|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92043878|NCT02285153|Analgesics|analgesics|mesh-ancestor
92043879|NCT02285153|Sensory System Agents|sensory system agents|mesh-ancestor
92043880|NCT02285153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043881|NCT02285153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043882|NCT02285153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043883|NCT02285153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043884|NCT02285153|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92043885|NCT02285153|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92043886|NCT02285153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043887|NCT02285153|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92043888|NCT02285153|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92043889|NCT02285153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043890|NCT02285153|Antipyretics|antipyretics|mesh-ancestor
92043892|NCT01632241|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043893|NCT01632241|Immunologic Factors|immunologic factors|mesh-ancestor
92043894|NCT01632241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043895|NCT02263508|Pembrolizumab|pembrolizumab|mesh-list
92043896|NCT02263508|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92043897|NCT02263508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043898|NCT02263508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043899|NCT02263508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92043900|NCT02263508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043901|NCT01741792|Blinatumomab|blinatumomab|mesh-list
92043902|NCT01741792|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043903|NCT02289950|Farletuzumab|farletuzumab|mesh-list
92043904|NCT02289950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043905|NCT02288312|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92043906|NCT02288312|Anticonvulsants|anticonvulsants|mesh-ancestor
92043907|NCT02288312|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92043908|NCT02288312|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92043909|NCT02288312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92043910|NCT02288312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043911|NCT01740388|Besifloxacin|besifloxacin|mesh-list
92014374|NCT05392933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014375|NCT05392933|Sensory System Agents|sensory system agents|mesh-ancestor
92043912|NCT01740388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92043913|NCT01740388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043914|NCT01740388|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92043915|NCT01740388|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92043916|NCT01740388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043917|NCT01740388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043918|NCT01740388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043919|NCT01740154|Sunitinib|sunitinib|mesh-list
92043920|NCT01740154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043921|NCT01740154|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92043922|NCT01740154|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92043923|NCT01740154|Growth Substances|growth substances|mesh-ancestor
92043924|NCT01740154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043925|NCT01740154|Growth Inhibitors|growth inhibitors|mesh-ancestor
92043926|NCT01740154|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92043927|NCT01740154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043928|NCT01740154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043929|NCT02287610|Prednisone|prednisone|mesh-list
92043930|NCT02287610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043931|NCT02287610|Glucocorticoids|glucocorticoids|mesh-ancestor
92043933|NCT02287610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043934|NCT02287610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043935|NCT02287610|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92043936|NCT02287610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043938|NCT02262728|Simeprevir|simeprevir|mesh-list
92043939|NCT02262728|Antiviral Agents|antiviral agents|mesh-ancestor
92043940|NCT02262728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92043941|NCT02262728|Protease Inhibitors|protease inhibitors|mesh-ancestor
92043942|NCT02262728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043943|NCT02262728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043944|NCT01717768|Testosterone|testosterone|mesh-list
92043945|NCT01717768|Androgens|androgens|mesh-ancestor
92043946|NCT01717768|Hormones|hormones|mesh-ancestor
92043947|NCT01717768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043948|NCT01717768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043949|NCT02260934|Acetaminophen|acetaminophen|mesh-list
92043950|NCT02260934|Diphenhydramine|diphenhydramine|mesh-list
92043951|NCT02260934|Promethazine|promethazine|mesh-list
92043952|NCT02260934|Prednisone|prednisone|mesh-list
92043953|NCT02260934|Methylprednisolone|methylprednisolone|mesh-list
92043954|NCT02260934|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92043955|NCT02260934|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92043956|NCT02260934|Prednisolone|prednisolone|mesh-list
92043957|NCT02260934|Prednisolone acetate|prednisolone acetate|mesh-list
92043958|NCT02260934|Cyclophosphamide|cyclophosphamide|mesh-list
92043959|NCT02260934|Rituximab|rituximab|mesh-list
92043960|NCT02260934|Belimumab|belimumab|mesh-list
92043961|NCT02260934|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92043962|NCT02260934|Prednisolone phosphate|prednisolone phosphate|mesh-list
92043963|NCT02260934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043964|NCT02260934|Immunologic Factors|immunologic factors|mesh-ancestor
92043965|NCT02260934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043966|NCT02260934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043967|NCT02260934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92043968|NCT02260934|Alkylating Agents|alkylating agents|mesh-ancestor
92043969|NCT02260934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043970|NCT02260934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043971|NCT02260934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92043972|NCT02260934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043973|NCT02260934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92043974|NCT02260934|Glucocorticoids|glucocorticoids|mesh-ancestor
92043975|NCT02260934|Hormones|hormones|mesh-ancestor
92043976|NCT02260934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92043977|NCT02260934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92043978|NCT02260934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92043979|NCT02260934|Analgesics|analgesics|mesh-ancestor
92043980|NCT02260934|Sensory System Agents|sensory system agents|mesh-ancestor
92043981|NCT02260934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043982|NCT02260934|Antipyretics|antipyretics|mesh-ancestor
92043983|NCT02260934|Antiemetics|antiemetics|mesh-ancestor
92014376|NCT05392933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014377|NCT05392933|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92043984|NCT02260934|Autonomic Agents|autonomic agents|mesh-ancestor
92043985|NCT02260934|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043986|NCT02260934|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92043987|NCT02260934|Protective Agents|protective agents|mesh-ancestor
92043988|NCT02260934|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92043989|NCT02260934|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92043990|NCT02260934|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043991|NCT02260934|Anesthetics, Local|anesthetics, local|mesh-ancestor
92043992|NCT02260934|Anesthetics|anesthetics|mesh-ancestor
92043993|NCT02260934|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92043994|NCT02260934|Histamine Antagonists|histamine antagonists|mesh-ancestor
92043995|NCT02260934|Histamine Agents|histamine agents|mesh-ancestor
92043996|NCT02260934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043997|NCT02260934|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92043998|NCT02260934|Antipruritics|antipruritics|mesh-ancestor
92043999|NCT02260934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92044000|NCT02260388|Mexiletine|mexiletine|mesh-list
92044001|NCT02260388|Pregabalin|pregabalin|mesh-list
92044002|NCT02260388|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92044003|NCT02260388|Nortriptyline|nortriptyline|mesh-list
92044004|NCT02260388|Analgesics|analgesics|mesh-ancestor
92044005|NCT02260388|Sensory System Agents|sensory system agents|mesh-ancestor
92044006|NCT02260388|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044007|NCT02260388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044008|NCT02260388|Anticonvulsants|anticonvulsants|mesh-ancestor
92044011|NCT02260388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044012|NCT02260388|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92044013|NCT02260388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92044014|NCT02260388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92044015|NCT02260388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044016|NCT02260388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92044017|NCT02260388|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92044018|NCT02260388|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92044019|NCT02260388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044020|NCT02260388|Antidepressive Agents|antidepressive agents|mesh-ancestor
92044021|NCT02260388|Dopamine Agents|dopamine agents|mesh-ancestor
92044022|NCT02260388|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92044023|NCT02260388|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92044024|NCT02260388|Adrenergic Agents|adrenergic agents|mesh-ancestor
92044025|NCT02260388|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92044026|NCT02260388|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92044027|NCT02260388|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92044028|NCT02260154|Mebeverine|mebeverine|mesh-list
92044029|NCT02260154|Alverine|alverine|mesh-list
92044030|NCT02260154|Anticonvulsants|anticonvulsants|mesh-ancestor
92044031|NCT02260154|Parasympatholytics|parasympatholytics|mesh-ancestor
92044032|NCT02260154|Autonomic Agents|autonomic agents|mesh-ancestor
92044033|NCT02260154|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044034|NCT02260154|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044035|NCT01643408|Asparaginase|asparaginase|mesh-list
92044036|NCT01643408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044037|NCT02283788|Moxifloxacin|moxifloxacin|mesh-list
92044038|NCT02283788|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92044039|NCT02283788|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92044040|NCT02283788|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044041|NCT02283788|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92044042|NCT02283788|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92044043|NCT02283788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044044|NCT02283788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044045|NCT02283788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044046|NCT02283788|Anticonvulsants|anticonvulsants|mesh-ancestor
92044047|NCT02283788|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92044048|NCT02283788|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92044049|NCT02283788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044050|NCT01739764|Vemurafenib|vemurafenib|mesh-list
92044051|NCT01739764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044052|NCT01739764|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92044053|NCT01739764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044054|NCT01739764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014378|NCT05392933|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92014379|NCT05392933|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92014380|NCT05392933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014381|NCT05392933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014382|NCT04796675|Cyclophosphamide|cyclophosphamide|mesh-list
92044055|NCT01700530|Simvastatin|simvastatin|mesh-list
92044056|NCT01700530|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92044057|NCT01700530|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92044058|NCT01700530|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92044059|NCT01700530|Antimetabolites|antimetabolites|mesh-ancestor
92044060|NCT01700530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044061|NCT01700530|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92044062|NCT01700530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044063|NCT01717456|Loperamide|loperamide|mesh-list
92044064|NCT01717456|Antidiarrheals|antidiarrheals|mesh-list
92044065|NCT01717456|Laxatives|laxatives|mesh-list
92044066|NCT01717456|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044067|NCT01716754|Omalizumab|omalizumab|mesh-list
92044068|NCT01716754|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92044069|NCT01716754|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044070|NCT01716754|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044071|NCT01698814|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92044072|NCT01698814|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92044073|NCT01698814|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92044074|NCT01698814|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044075|NCT01698814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044076|NCT01698814|Analgesics|analgesics|mesh-ancestor
92044077|NCT01698814|Sensory System Agents|sensory system agents|mesh-ancestor
92044078|NCT01698814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044079|NCT01698814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044081|NCT01698814|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044082|NCT01698814|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92044083|NCT01698814|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92044084|NCT01698814|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92044085|NCT01698814|Histamine Antagonists|histamine antagonists|mesh-ancestor
92044086|NCT01698814|Histamine Agents|histamine agents|mesh-ancestor
92044087|NCT01698814|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044088|NCT01698814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044090|NCT01738594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92044091|NCT01738594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044092|NCT01738594|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92044093|NCT01738594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044094|NCT01738594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044095|NCT01697956|Beclomethasone|beclomethasone|mesh-list
92044096|NCT01697956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044097|NCT01697956|Glucocorticoids|glucocorticoids|mesh-ancestor
92044098|NCT01697956|Hormones|hormones|mesh-ancestor
92044099|NCT01697956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044100|NCT01697956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044101|NCT01697956|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044102|NCT01697956|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044103|NCT01697800|Tadalafil|tadalafil|mesh-list
92044104|NCT01697800|Vasodilator Agents|vasodilator agents|mesh-ancestor
92044105|NCT01697800|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92044106|NCT01697800|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92044107|NCT01697800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044108|NCT01697800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044109|NCT01697800|Urological Agents|urological agents|mesh-ancestor
92044110|NCT04553770|Trastuzumab|trastuzumab|mesh-list
92044111|NCT04553770|Anastrozole|anastrozole|mesh-list
92044112|NCT04553770|Camptothecin|camptothecin|mesh-list
92044113|NCT04553770|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92044114|NCT04553770|Immunoconjugates|immunoconjugates|mesh-list
92044115|NCT04553770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044116|NCT04553770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044117|NCT04553770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044118|NCT04553770|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92044119|NCT04553770|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92014383|NCT04796675|Fludarabine|fludarabine|mesh-list
92014384|NCT04796675|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014385|NCT04796675|Immunologic Factors|immunologic factors|mesh-ancestor
92014386|NCT04796675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014387|NCT04796675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044120|NCT04553770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044121|NCT04553770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044122|NCT04553770|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92044123|NCT04553770|Hormone Antagonists|hormone antagonists|mesh-ancestor
92044124|NCT04553770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044125|NCT04553770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044126|NCT04553770|Immunologic Factors|immunologic factors|mesh-ancestor
92044127|NCT04553770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92044128|NCT04553770|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92044129|NCT04553770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92044130|NCT01644500|Glimepiride|glimepiride|mesh-list
92044131|NCT01644500|Dulaglutide|dulaglutide|mesh-list
92044132|NCT01644500|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92044133|NCT01644500|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92044134|NCT01644500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044135|NCT01644500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92044136|NCT01644500|Immunologic Factors|immunologic factors|mesh-ancestor
92044137|NCT04877834|Dexlansoprazole|dexlansoprazole|mesh-list
92044138|NCT04877834|Lansoprazole|lansoprazole|mesh-list
92044139|NCT04877834|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92044140|NCT04877834|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044141|NCT04877834|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92044142|NCT04877834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044143|NCT04877834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044144|NCT01604824|Alirocumab|alirocumab|mesh-list
92044145|NCT01604824|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92044146|NCT01604824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92044147|NCT01604824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92044148|NCT01604824|Antimetabolites|antimetabolites|mesh-ancestor
92044149|NCT01604824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044150|NCT01604824|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92044151|NCT01604824|Protease Inhibitors|protease inhibitors|mesh-ancestor
92044154|NCT01716052|Ibuprofen|ibuprofen|mesh-list
92044155|NCT01716052|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044156|NCT01716052|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044157|NCT01716052|Analgesics|analgesics|mesh-ancestor
92044158|NCT01716052|Sensory System Agents|sensory system agents|mesh-ancestor
92044159|NCT01716052|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044160|NCT01716052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044161|NCT01716052|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044162|NCT01716052|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044163|NCT01716052|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92044164|NCT01716052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044165|NCT01716052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044166|NCT01641692|Albuterol|albuterol|mesh-list
92044167|NCT01641692|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92044168|NCT01641692|Autonomic Agents|autonomic agents|mesh-ancestor
92044169|NCT01641692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044170|NCT01641692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044171|NCT01641692|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044172|NCT01641692|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044173|NCT01641692|Tocolytic Agents|tocolytic agents|mesh-ancestor
92044174|NCT01641692|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92044175|NCT01641692|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92044177|NCT01641692|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92044178|NCT01641692|Adrenergic Agents|adrenergic agents|mesh-ancestor
92044179|NCT01641692|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044180|NCT01641692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044182|NCT01682512|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044183|NCT01682512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044184|NCT01682512|Immunologic Factors|immunologic factors|mesh-ancestor
92044185|NCT01682512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014388|NCT04796675|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92014389|NCT04796675|Alkylating Agents|alkylating agents|mesh-ancestor
92014390|NCT04796675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014391|NCT04796675|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014392|NCT04796675|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92044186|NCT01682512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044187|NCT04863716|Fentanyl|fentanyl|mesh-list
92044188|NCT04863716|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92044189|NCT04863716|Narcotics|narcotics|mesh-ancestor
92044190|NCT04863716|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044191|NCT04863716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044192|NCT04863716|Analgesics|analgesics|mesh-ancestor
92044193|NCT04863716|Sensory System Agents|sensory system agents|mesh-ancestor
92044194|NCT04863716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044195|NCT04863716|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92044196|NCT04863716|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92044197|NCT04863716|Anesthetics, General|anesthetics, general|mesh-ancestor
92044198|NCT04863716|Anesthetics|anesthetics|mesh-ancestor
92044199|NCT04135352|Pembrolizumab|pembrolizumab|mesh-list
92044200|NCT04135352|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044201|NCT04135352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044202|NCT04135352|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044203|NCT04135352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044204|NCT01715896|Golimumab|golimumab|mesh-list
92044205|NCT01715896|Mavrilimumab|mavrilimumab|mesh-list
92044206|NCT01715896|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92044207|NCT01715896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044208|NCT01715896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92044209|NCT01715896|Immunologic Factors|immunologic factors|mesh-ancestor
92044210|NCT01715896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044211|NCT01715896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044212|NCT05642780|Pembrolizumab|pembrolizumab|mesh-list
92044213|NCT05642780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044214|NCT05642780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044215|NCT05642780|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044216|NCT05642780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044217|NCT05642702|Vitamins|vitamins|mesh-list
92044218|NCT05642702|Ascorbic Acid|ascorbic acid|mesh-list
92044219|NCT05642702|Niacinamide|niacinamide|mesh-list
92044221|NCT05642702|Nicotinic Acids|nicotinic acids|mesh-list
92044222|NCT05642702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92044223|NCT05642702|Micronutrients|micronutrients|mesh-ancestor
92044224|NCT05642702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044225|NCT05642702|Antioxidants|antioxidants|mesh-ancestor
92044238|NCT05544734|Sensory System Agents|sensory system agents|mesh-ancestor
92044239|NCT05544734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044240|NCT05544734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044241|NCT05544734|Antipyretics|antipyretics|mesh-ancestor
92044242|NCT05544734|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044243|NCT05544734|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044244|NCT05544734|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044245|NCT05544734|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92044246|NCT05544734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044247|NCT05544734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044248|NCT05544734|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92044249|NCT05544734|Narcotics|narcotics|mesh-ancestor
92044250|NCT05544734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044251|NCT05544734|Antitussive Agents|antitussive agents|mesh-ancestor
92044252|NCT05544734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044254|NCT02254772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044255|NCT02254772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044256|NCT02254772|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044257|NCT02254772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044259|NCT01682044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044260|NCT01682044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044261|NCT01682044|Immunologic Factors|immunologic factors|mesh-ancestor
92044262|NCT01682044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044263|NCT01682044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92014393|NCT05275725|Sildenafil Citrate|sildenafil citrate|mesh-list
92014394|NCT05275725|Vasodilator Agents|vasodilator agents|mesh-ancestor
92014395|NCT05275725|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92014396|NCT05275725|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92044264|NCT05640596|Betamethasone|betamethasone|mesh-list
92044265|NCT05640596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044266|NCT05640596|Glucocorticoids|glucocorticoids|mesh-ancestor
92044267|NCT05640596|Hormones|hormones|mesh-ancestor
92044268|NCT05640596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044269|NCT05640596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044270|NCT05640596|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044271|NCT05640596|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044272|NCT05651126|Psilocybin|psilocybin|mesh-list
92044273|NCT05651126|Hallucinogens|hallucinogens|mesh-ancestor
92044274|NCT05651126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044275|NCT05651126|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92044276|NCT01696942|Mesalamine|mesalamine|mesh-list
92044277|NCT01696942|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044278|NCT01696942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044279|NCT01696942|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044442|NCT04419662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92044280|NCT01696942|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044281|NCT01696942|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044282|NCT01696942|Analgesics|analgesics|mesh-ancestor
92044283|NCT01696942|Sensory System Agents|sensory system agents|mesh-ancestor
92044284|NCT01696942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044285|NCT05493566|Aldesleukin|aldesleukin|mesh-list
92044286|NCT05493566|Pembrolizumab|pembrolizumab|mesh-list
92044287|NCT05493566|Interleukin-2|interleukin-2|mesh-list
92044288|NCT05493566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044289|NCT05493566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044295|NCT05493566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044296|NCT05493566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044297|NCT05493566|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92044298|NCT05493566|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92044299|NCT05493566|Antiviral Agents|antiviral agents|mesh-ancestor
92044300|NCT05493566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044301|NCT04871204|Octreotide|octreotide|mesh-list
92044302|NCT04871204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044303|NCT04871204|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044304|NCT04871204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044305|NCT05650268|Vitamin D|vitamin d|mesh-list
92044306|NCT05650268|Ergocalciferols|ergocalciferols|mesh-list
92044307|NCT05650268|Cholecalciferol|cholecalciferol|mesh-list
92044308|NCT05650268|Vitamins|vitamins|mesh-list
92044309|NCT05650268|Micronutrients|micronutrients|mesh-ancestor
92044310|NCT05650268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044311|NCT05650268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92044312|NCT05650268|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92044313|NCT04835870|Prednisone|prednisone|mesh-list
92044314|NCT04835870|Cyclophosphamide|cyclophosphamide|mesh-list
92044315|NCT04835870|Rituximab|rituximab|mesh-list
92044316|NCT04835870|Doxorubicin|doxorubicin|mesh-list
92044317|NCT04835870|Vincristine|vincristine|mesh-list
92044318|NCT04835870|Zanubrutinib|zanubrutinib|mesh-list
92044319|NCT04835870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92044320|NCT04835870|Immunologic Factors|immunologic factors|mesh-ancestor
92044321|NCT04835870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044322|NCT04835870|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044323|NCT04835870|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92044324|NCT04835870|Alkylating Agents|alkylating agents|mesh-ancestor
92044325|NCT04835870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044326|NCT04835870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044327|NCT04835870|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92044328|NCT04835870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044329|NCT04835870|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92044330|NCT04835870|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92044331|NCT04835870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92044332|NCT04835870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044333|NCT04835870|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044336|NCT04835870|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014397|NCT05275725|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014398|NCT05275725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014399|NCT05275725|Urological Agents|urological agents|mesh-ancestor
92044337|NCT04835870|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044338|NCT04835870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92044339|NCT04835870|Tubulin Modulators|tubulin modulators|mesh-ancestor
92044340|NCT04835870|Antimitotic Agents|antimitotic agents|mesh-ancestor
92044341|NCT04835870|Mitosis Modulators|mitosis modulators|mesh-ancestor
92044342|NCT04835870|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92044343|NCT01639040|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92044344|NCT01639040|Immunologic Factors|immunologic factors|mesh-ancestor
92044345|NCT01639040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044346|NCT04834388|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92044347|NCT04834388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044349|NCT04834310|Clindamycin palmitate|clindamycin palmitate|mesh-list
92044350|NCT04834310|Clindamycin phosphate|clindamycin phosphate|mesh-list
92044351|NCT04834310|Cefazolin|cefazolin|mesh-list
92044352|NCT04834310|Cephalexin|cephalexin|mesh-list
92044353|NCT04834310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92044354|NCT04834310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044355|NCT04834310|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92044356|NCT04834310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044357|NCT04834310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044358|NCT04848116|Nivolumab|nivolumab|mesh-list
92044359|NCT04848116|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044360|NCT04848116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044365|NCT05372198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044366|NCT05359406|Tislelizumab|tislelizumab|mesh-list
92044367|NCT05359406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044368|NCT05359406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044369|NCT05038904|Acalabrutinib|acalabrutinib|mesh-list
92044370|NCT05038904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044371|NCT04654208|Palbociclib|palbociclib|mesh-list
92044372|NCT04654208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044373|NCT04654208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92044374|NCT04654208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044375|NCT04654208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044377|NCT04652960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044378|NCT04652960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044379|NCT04652960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044380|NCT04652960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044381|NCT05357846|Paclitaxel|paclitaxel|mesh-list
92044382|NCT05357846|Cisplatin|cisplatin|mesh-list
92044383|NCT05357846|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92044384|NCT05357846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044385|NCT05357846|Tubulin Modulators|tubulin modulators|mesh-ancestor
92044386|NCT05357846|Antimitotic Agents|antimitotic agents|mesh-ancestor
92044387|NCT05357846|Mitosis Modulators|mitosis modulators|mesh-ancestor
92044388|NCT05357846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044389|NCT05031494|Paclitaxel|paclitaxel|mesh-list
92044390|NCT05031494|Gemcitabine|gemcitabine|mesh-list
92044391|NCT05031494|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92044392|NCT05031494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044393|NCT05031494|Tubulin Modulators|tubulin modulators|mesh-ancestor
92044394|NCT05031494|Antimitotic Agents|antimitotic agents|mesh-ancestor
92044395|NCT05031494|Mitosis Modulators|mitosis modulators|mesh-ancestor
92044396|NCT05031494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044397|NCT05031494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92044398|NCT05031494|Antimetabolites|antimetabolites|mesh-ancestor
92044399|NCT04844216|Lidocaine|lidocaine|mesh-list
92044400|NCT04844216|Hyaluronic Acid|hyaluronic acid|mesh-list
92044401|NCT04844216|Anesthetics, Local|anesthetics, local|mesh-ancestor
92044402|NCT04844216|Anesthetics|anesthetics|mesh-ancestor
92044403|NCT04844216|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044404|NCT04844216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044405|NCT04844216|Sensory System Agents|sensory system agents|mesh-ancestor
92044406|NCT04844216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044407|NCT04844216|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92014400|NCT05315817|Dialysis Solutions|dialysis solutions|mesh-list
92014401|NCT05315817|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92014402|NCT04785755|Etilefrine|etilefrine|mesh-list
92044408|NCT04844216|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92044409|NCT04844216|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92044410|NCT04844216|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044411|NCT04844216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044412|NCT04844216|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92044413|NCT04844216|Immunologic Factors|immunologic factors|mesh-ancestor
92044414|NCT04844216|Viscosupplements|viscosupplements|mesh-ancestor
92044415|NCT04844216|Protective Agents|protective agents|mesh-ancestor
92044417|NCT05345678|Tremelimumab|tremelimumab|mesh-list
92044418|NCT05345678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044419|NCT05345678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044420|NCT05327738|Atezolizumab|atezolizumab|mesh-list
92044421|NCT05327738|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92044422|NCT05327738|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044423|NCT05327738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044424|NCT05327738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044425|NCT05327738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044426|NCT05327738|Immunologic Factors|immunologic factors|mesh-ancestor
92044427|NCT05327738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044428|NCT04419662|Phenylephrine|phenylephrine|mesh-list
92044429|NCT04419662|Oxymetazoline|oxymetazoline|mesh-list
92044430|NCT04419662|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92044434|NCT04419662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044436|NCT04419662|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92044437|NCT04419662|Nasal Decongestants|nasal decongestants|mesh-ancestor
92044438|NCT04419662|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044439|NCT04419662|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92044440|NCT04419662|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92044441|NCT04419662|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92044443|NCT04419662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044444|NCT04419662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044445|NCT04419662|Protective Agents|protective agents|mesh-ancestor
92044446|NCT04589546|Niacinamide|niacinamide|mesh-list
92044447|NCT04589546|Niacin|niacin|mesh-list
92044448|NCT04589546|Nicotinic Acids|nicotinic acids|mesh-list
92044449|NCT04589546|Vitamin B Complex|vitamin b complex|mesh-ancestor
92044450|NCT04589546|Vitamins|vitamins|mesh-ancestor
92044451|NCT04589546|Micronutrients|micronutrients|mesh-ancestor
92044452|NCT04589546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044453|NCT04589546|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92044454|NCT04589546|Antimetabolites|antimetabolites|mesh-ancestor
92044455|NCT04589546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044456|NCT04589546|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92044457|NCT04589546|Vasodilator Agents|vasodilator agents|mesh-ancestor
92044458|NCT05369468|Dexmedetomidine|dexmedetomidine|mesh-list
92044459|NCT05369468|Bupivacaine|bupivacaine|mesh-list
92044460|NCT05369468|Anesthetics, Local|anesthetics, local|mesh-ancestor
92044461|NCT05369468|Anesthetics|anesthetics|mesh-ancestor
92044462|NCT05369468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044463|NCT05369468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044464|NCT05369468|Sensory System Agents|sensory system agents|mesh-ancestor
92044465|NCT05369468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044466|NCT05369468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92044467|NCT05369468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044468|NCT05369468|Analgesics|analgesics|mesh-ancestor
92044469|NCT05369468|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92044470|NCT05369468|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92044471|NCT05369468|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92044472|NCT05369468|Adrenergic Agents|adrenergic agents|mesh-ancestor
92044473|NCT05369468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044474|NCT05369468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044475|NCT02164513|Fluticasone|fluticasone|mesh-list
92044476|NCT02164513|Xhance|xhance|mesh-list
92044477|NCT02164513|Bromides|bromides|mesh-list
92044478|NCT02164513|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044479|NCT02164513|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92044481|NCT02164513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044482|NCT02164513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014403|NCT04785755|Furosemide|furosemide|mesh-list
92014404|NCT04785755|Spironolactone|spironolactone|mesh-list
92014405|NCT04785755|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92014406|NCT04785755|Diuretics|diuretics|mesh-list
92014407|NCT04785755|Natriuretic Agents|natriuretic agents|mesh-ancestor
92044483|NCT02164513|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044484|NCT02164513|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044485|NCT02164513|Dermatologic Agents|dermatologic agents|mesh-ancestor
92044486|NCT02164513|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92044487|NCT02164513|Anticonvulsants|anticonvulsants|mesh-ancestor
92044488|NCT04532372|Leflunomide|leflunomide|mesh-list
92044489|NCT04532372|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044490|NCT04532372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044491|NCT04532372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92044492|NCT04532372|Immunologic Factors|immunologic factors|mesh-ancestor
92044493|NCT04532372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044494|NCT04513184|Dexamethasone|dexamethasone|mesh-list
92044495|NCT04513184|Dexamethasone acetate|dexamethasone acetate|mesh-list
92044496|NCT04513184|BB 1101|bb 1101|mesh-list
92044497|NCT04513184|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044498|NCT04513184|Antiemetics|antiemetics|mesh-ancestor
92044499|NCT04513184|Autonomic Agents|autonomic agents|mesh-ancestor
92044500|NCT04513184|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044501|NCT04513184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044502|NCT04513184|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044503|NCT04513184|Glucocorticoids|glucocorticoids|mesh-ancestor
92044504|NCT04513184|Hormones|hormones|mesh-ancestor
92044507|NCT04513184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044508|NCT04513184|Protease Inhibitors|protease inhibitors|mesh-ancestor
92044509|NCT04513184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044510|NCT04513184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044511|NCT04756531|Nirmatrelvir|nirmatrelvir|mesh-list
92044512|NCT04756531|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92044513|NCT04756531|Protease Inhibitors|protease inhibitors|mesh-ancestor
92044514|NCT04756531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044515|NCT04756531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044516|NCT04756531|Antiviral Agents|antiviral agents|mesh-ancestor
92044517|NCT04756531|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044518|NCT02218489|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92044519|NCT02218489|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92044520|NCT01713946|Everolimus|everolimus|mesh-list
92044521|NCT01713946|Anticonvulsants|anticonvulsants|mesh-list
92044522|NCT01713946|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92044523|NCT01713946|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92044524|NCT01713946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044525|NCT01713946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044526|NCT01713946|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92044527|NCT01713946|Immunologic Factors|immunologic factors|mesh-ancestor
92044528|NCT01713946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044529|NCT01713946|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044530|NCT04464512|Sufentanil|sufentanil|mesh-list
92044531|NCT04464512|Buprenorphine|buprenorphine|mesh-list
92044532|NCT04464512|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92044533|NCT04464512|Narcotics|narcotics|mesh-ancestor
92044534|NCT04464512|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044535|NCT04464512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044536|NCT04464512|Analgesics|analgesics|mesh-ancestor
92044537|NCT04464512|Sensory System Agents|sensory system agents|mesh-ancestor
92044538|NCT04464512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044539|NCT04464512|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92044540|NCT04464512|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92044541|NCT04464512|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92044542|NCT04464512|Anesthetics, General|anesthetics, general|mesh-ancestor
92044543|NCT04464512|Anesthetics|anesthetics|mesh-ancestor
92044544|NCT05369234|Sucralfate|sucralfate|mesh-list
92044545|NCT05369234|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92044546|NCT05369234|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044547|NCT04839692|Hyaluronic Acid|hyaluronic acid|mesh-list
92044548|NCT04839692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92044549|NCT04839692|Immunologic Factors|immunologic factors|mesh-ancestor
92044550|NCT04839692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044551|NCT04839692|Viscosupplements|viscosupplements|mesh-ancestor
92044552|NCT04839692|Protective Agents|protective agents|mesh-ancestor
92014408|NCT04785755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044553|NCT04827446|Methamphetamine|methamphetamine|mesh-list
92044554|NCT04827446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92044555|NCT04827446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044556|NCT04827446|Sympathomimetics|sympathomimetics|mesh-ancestor
92044557|NCT04827446|Autonomic Agents|autonomic agents|mesh-ancestor
92044558|NCT04827446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044559|NCT04827446|Dopamine Agents|dopamine agents|mesh-ancestor
92044560|NCT04827446|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044561|NCT04827446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044562|NCT04827446|Adrenergic Agents|adrenergic agents|mesh-ancestor
92044563|NCT04827446|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92044564|NCT04827446|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92044565|NCT04827446|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044566|NCT04827446|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92044567|NCT02191579|Topiramate|topiramate|mesh-list
92044568|NCT02191579|Botulinum Toxins|botulinum toxins|mesh-list
92044569|NCT02191579|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92044570|NCT02191579|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92044571|NCT02191579|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92044572|NCT02191579|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044573|NCT02191579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044574|NCT02191579|Cholinergic Agents|cholinergic agents|mesh-ancestor
92044575|NCT02191579|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044578|NCT02191579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044579|NCT02191579|Anticonvulsants|anticonvulsants|mesh-ancestor
92044580|NCT02191579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92044581|NCT05324462|Xultophy|xultophy|mesh-list
92044582|NCT05324462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92044583|NCT05324462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044584|NCT05324462|Incretins|incretins|mesh-ancestor
92044585|NCT05324462|Hormones|hormones|mesh-ancestor
92044586|NCT05324462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044587|NCT01363700|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92044588|NCT01363700|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92044589|NCT01363700|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92044590|NCT01363700|Epinastine|epinastine|mesh-list
92044591|NCT01363700|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044592|NCT01363700|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044593|NCT01363700|Analgesics|analgesics|mesh-ancestor
92044594|NCT01363700|Sensory System Agents|sensory system agents|mesh-ancestor
92044595|NCT01363700|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044596|NCT01363700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044597|NCT01363700|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044598|NCT01363700|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044599|NCT01363700|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92044600|NCT01363700|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92044601|NCT01363700|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92044602|NCT01363700|Histamine Antagonists|histamine antagonists|mesh-ancestor
92044603|NCT01363700|Histamine Agents|histamine agents|mesh-ancestor
92044604|NCT01363700|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044605|NCT01363700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044606|NCT04372706|Pembrolizumab|pembrolizumab|mesh-list
92044607|NCT04372706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044608|NCT04372706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044609|NCT04372706|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044610|NCT04372706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044611|NCT04178642|Idarubicin|idarubicin|mesh-list
92044612|NCT04178642|Ethiodized Oil|ethiodized oil|mesh-list
92044613|NCT04178642|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92044614|NCT04178642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044615|NCT04178642|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92044616|NCT04178642|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92044617|NCT04178642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044618|NCT04178642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044619|NCT04157894|Milbemycin oxime|milbemycin oxime|mesh-list
92044620|NCT04157894|Anthelmintics|anthelmintics|mesh-ancestor
92044621|NCT04157894|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92044622|NCT04157894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044623|NCT04838288|Tacrolimus|tacrolimus|mesh-list
92044624|NCT04838288|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014409|NCT04785755|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92014410|NCT04785755|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014411|NCT04785755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044625|NCT04838288|Immunologic Factors|immunologic factors|mesh-ancestor
92044626|NCT04838288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044628|NCT04838288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044629|NCT04838288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044630|NCT04327934|Methyltestosterone|methyltestosterone|mesh-list
92044631|NCT04327934|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92044632|NCT04327934|Testosterone|testosterone|mesh-list
92044633|NCT04327934|Testosterone undecanoate|testosterone undecanoate|mesh-list
92044634|NCT04327934|Testosterone enanthate|testosterone enanthate|mesh-list
92044635|NCT04327934|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92044636|NCT04327934|Hormones|hormones|mesh-ancestor
92044637|NCT04327934|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044638|NCT04327934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044639|NCT04327934|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044640|NCT04327934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044641|NCT04327934|Anabolic Agents|anabolic agents|mesh-ancestor
92044642|NCT04327934|Androgens|androgens|mesh-ancestor
92044643|NCT04791566|Dexamethasone|dexamethasone|mesh-list
92044644|NCT04791566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044645|NCT04791566|Antiemetics|antiemetics|mesh-ancestor
92044646|NCT04791566|Autonomic Agents|autonomic agents|mesh-ancestor
92044647|NCT04791566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044648|NCT04791566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044649|NCT04791566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044652|NCT04791566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044654|NCT04791566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044655|NCT04129736|Teriflunomide|teriflunomide|mesh-list
92044656|NCT04129736|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044657|NCT04129736|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044658|NCT04129736|Analgesics|analgesics|mesh-ancestor
92044659|NCT04129736|Sensory System Agents|sensory system agents|mesh-ancestor
92044660|NCT04129736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044661|NCT04129736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044662|NCT04129736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044663|NCT04129736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044664|NCT04129736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92044665|NCT04129736|Immunologic Factors|immunologic factors|mesh-ancestor
92044666|NCT01637402|Prednisone|prednisone|mesh-list
92044667|NCT01637402|Abiraterone Acetate|abiraterone acetate|mesh-list
92044668|NCT01637402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044669|NCT01637402|Glucocorticoids|glucocorticoids|mesh-ancestor
92044670|NCT01637402|Hormones|hormones|mesh-ancestor
92044671|NCT01637402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044672|NCT01637402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044673|NCT01637402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044674|NCT01637402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044675|NCT01637402|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92044676|NCT01637402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044677|NCT01637402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044678|NCT01637402|Hormone Antagonists|hormone antagonists|mesh-ancestor
92044679|NCT01637402|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92044680|NCT04419038|Mitomycins|mitomycins|mesh-list
92044681|NCT04419038|Mitomycin|mitomycin|mesh-list
92044682|NCT04419038|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92044683|NCT04419038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044684|NCT04419038|Alkylating Agents|alkylating agents|mesh-ancestor
92044685|NCT04419038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044686|NCT04419038|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92044687|NCT04419038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044688|NCT04824638|Vaccines|vaccines|mesh-list
92044689|NCT04824638|Immunologic Factors|immunologic factors|mesh-ancestor
92044690|NCT04824638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044692|NCT02217475|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92014412|NCT04785755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92014413|NCT04785755|Hormone Antagonists|hormone antagonists|mesh-ancestor
92044693|NCT02217475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044694|NCT02217475|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92044695|NCT02217475|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92044696|NCT02217475|Antiviral Agents|antiviral agents|mesh-ancestor
92044697|NCT02217475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044698|NCT04818944|Tirofiban|tirofiban|mesh-list
92044699|NCT04818944|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92044700|NCT04818944|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92044701|NCT04818944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044702|NCT04818944|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92044704|NCT04818866|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92044705|NCT04818866|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92044706|NCT04818866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044707|NCT04818866|Hemostatics|hemostatics|mesh-ancestor
92044708|NCT04818866|Coagulants|coagulants|mesh-ancestor
92044709|NCT02189941|Deferiprone|deferiprone|mesh-list
92044710|NCT02189941|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92044711|NCT02189941|Chelating Agents|chelating agents|mesh-ancestor
92044712|NCT02189941|Sequestering Agents|sequestering agents|mesh-ancestor
92044713|NCT02189941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044714|NCT01601132|Colchicine|colchicine|mesh-list
92044715|NCT01601132|Theophylline|theophylline|mesh-list
92044716|NCT01601132|Gout Suppressants|gout suppressants|mesh-ancestor
92044717|NCT01601132|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92044718|NCT01601132|Tubulin Modulators|tubulin modulators|mesh-ancestor
92044719|NCT01601132|Antimitotic Agents|antimitotic agents|mesh-ancestor
92044720|NCT01601132|Mitosis Modulators|mitosis modulators|mesh-ancestor
92044721|NCT01601132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044722|NCT01601132|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044736|NCT04836962|Dexamethasone|dexamethasone|mesh-list
92044737|NCT04836962|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044738|NCT04836962|Antiemetics|antiemetics|mesh-ancestor
92044739|NCT04836962|Autonomic Agents|autonomic agents|mesh-ancestor
92044740|NCT04836962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044741|NCT04836962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044742|NCT04836962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044743|NCT04836962|Glucocorticoids|glucocorticoids|mesh-ancestor
92044744|NCT04836962|Hormones|hormones|mesh-ancestor
92044745|NCT04836962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044746|NCT04836962|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044747|NCT04836962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044748|NCT05289440|Esketamine|esketamine|mesh-list
92044749|NCT05289440|Antidepressive Agents|antidepressive agents|mesh-ancestor
92044750|NCT05289440|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92044751|NCT04016090|Folic Acid|folic acid|mesh-list
92044752|NCT04016090|Hematinics|hematinics|mesh-ancestor
92044753|NCT04016090|Vitamin B Complex|vitamin b complex|mesh-ancestor
92044754|NCT04016090|Vitamins|vitamins|mesh-ancestor
92044755|NCT04016090|Micronutrients|micronutrients|mesh-ancestor
92044756|NCT04016090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044757|NCT04809974|Niacinamide|niacinamide|mesh-list
92044758|NCT04809974|Vitamins|vitamins|mesh-ancestor
92044759|NCT04809974|Micronutrients|micronutrients|mesh-ancestor
92044760|NCT04809974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044761|NCT04809974|Vitamin B Complex|vitamin b complex|mesh-ancestor
92044762|NCT04691960|Metformin|metformin|mesh-list
92044763|NCT04691960|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92044764|NCT04691960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044765|NCT04809038|Magnesium Sulfate|magnesium sulfate|mesh-list
92044766|NCT04809038|Analgesics|analgesics|mesh-ancestor
92044767|NCT04809038|Sensory System Agents|sensory system agents|mesh-ancestor
92044768|NCT04809038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044769|NCT04809038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044770|NCT04809038|Anesthetics|anesthetics|mesh-ancestor
92044771|NCT04809038|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044772|NCT04809038|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92044773|NCT04809038|Anticonvulsants|anticonvulsants|mesh-ancestor
92044774|NCT04809038|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92044775|NCT04809038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044776|NCT04809038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044777|NCT04809038|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92014414|NCT04785755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014415|NCT04785755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92014416|NCT04785755|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92014417|NCT04785755|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92044778|NCT04809038|Tocolytic Agents|tocolytic agents|mesh-ancestor
92044779|NCT04809038|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92044780|NCT05221190|Lidocaine|lidocaine|mesh-list
92044781|NCT05221190|Anesthetics, Local|anesthetics, local|mesh-ancestor
92044782|NCT05221190|Anesthetics|anesthetics|mesh-ancestor
92044783|NCT05221190|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044784|NCT05221190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044785|NCT05221190|Sensory System Agents|sensory system agents|mesh-ancestor
92044789|NCT05221190|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92044790|NCT05221190|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044791|NCT05221190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044792|NCT04816682|Silymarin|silymarin|mesh-list
92044793|NCT04816682|Antioxidants|antioxidants|mesh-ancestor
92044794|NCT04816682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044795|NCT04816682|Protective Agents|protective agents|mesh-ancestor
92044796|NCT04816682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044797|NCT02162719|Paclitaxel|paclitaxel|mesh-list
92044798|NCT02162719|Ipatasertib|ipatasertib|mesh-list
92044799|NCT02162719|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92044800|NCT02162719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044801|NCT02162719|Tubulin Modulators|tubulin modulators|mesh-ancestor
92044802|NCT02162719|Antimitotic Agents|antimitotic agents|mesh-ancestor
92044803|NCT02162719|Mitosis Modulators|mitosis modulators|mesh-ancestor
92044804|NCT02162719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044805|NCT02162719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92044806|NCT02162719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044807|NCT04808882|Tinzaparin|tinzaparin|mesh-list
92044808|NCT04808882|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92044809|NCT04808882|Dalteparin|dalteparin|mesh-list
92044810|NCT04808882|Anticoagulants|anticoagulants|mesh-ancestor
92044811|NCT04808882|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92044812|NCT04808882|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92044813|NCT04808882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044814|NCT05652374|Nitrofurantoin|nitrofurantoin|mesh-list
92044815|NCT05652374|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92044816|NCT05652374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044817|NCT05652374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92044818|NCT01636076|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92044819|NCT01636076|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92044820|NCT01636076|Autonomic Agents|autonomic agents|mesh-ancestor
92044821|NCT01636076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044822|NCT01636076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044823|NCT01636076|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044824|NCT01636076|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044825|NCT01636076|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92044826|NCT01636076|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92044827|NCT01636076|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92044828|NCT01636076|Adrenergic Agents|adrenergic agents|mesh-ancestor
92044829|NCT01636076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044830|NCT01636076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044831|NCT04794842|Phenol|phenol|mesh-list
92044832|NCT04794842|Tetracaine|tetracaine|mesh-list
92044833|NCT04794842|Anesthetics, Local|anesthetics, local|mesh-ancestor
92044834|NCT04794842|Anesthetics|anesthetics|mesh-ancestor
92044835|NCT04794842|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92044836|NCT04794842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044837|NCT04794842|Sensory System Agents|sensory system agents|mesh-ancestor
92044838|NCT04794842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044839|NCT04794842|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92044840|NCT04794842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044841|NCT04794842|Disinfectants|disinfectants|mesh-ancestor
92044842|NCT04794842|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92044843|NCT04794842|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92044844|NCT03029000|Lenograstim|lenograstim|mesh-list
92044845|NCT03029000|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92044846|NCT03029000|Immunologic Factors|immunologic factors|mesh-ancestor
92014418|NCT04785755|Adrenergic Agents|adrenergic agents|mesh-ancestor
92014419|NCT04785755|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014420|NCT04785755|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92014421|NCT04785755|Sympathomimetics|sympathomimetics|mesh-ancestor
92014422|NCT04785755|Autonomic Agents|autonomic agents|mesh-ancestor
92014423|NCT04785755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014424|NCT04785755|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92044847|NCT03029000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044848|NCT03783182|Betamethasone|betamethasone|mesh-list
92044849|NCT03783182|Betamethasone Valerate|betamethasone valerate|mesh-list
92044850|NCT03783182|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92044851|NCT03783182|Betamethasone benzoate|betamethasone benzoate|mesh-list
92044852|NCT03783182|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92044853|NCT03783182|Glucocorticoids|glucocorticoids|mesh-ancestor
92044854|NCT03783182|Hormones|hormones|mesh-ancestor
92044855|NCT03783182|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044856|NCT03783182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044868|NCT05651750|Autonomic Agents|autonomic agents|mesh-ancestor
92044869|NCT05651750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044870|NCT05651750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044871|NCT05651750|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044872|NCT05651750|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044873|NCT05651750|Dermatologic Agents|dermatologic agents|mesh-ancestor
92044874|NCT05651750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92044875|NCT05651750|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92044876|NCT05651750|Hormone Antagonists|hormone antagonists|mesh-ancestor
92044877|NCT05651750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044878|NCT05651750|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92044879|NCT05651750|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92044880|NCT05651750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044882|NCT02160145|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92044883|NCT02160145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044884|NCT02160145|Natriuretic Agents|natriuretic agents|mesh-ancestor
92044885|NCT02160145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044886|NCT02216071|Ciprofloxacin|ciprofloxacin|mesh-list
92044887|NCT02216071|Dexamethasone|dexamethasone|mesh-list
92044888|NCT02216071|Dexamethasone acetate|dexamethasone acetate|mesh-list
92044889|NCT02216071|BB 1101|bb 1101|mesh-list
92044890|NCT02216071|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044891|NCT02216071|Antiemetics|antiemetics|mesh-ancestor
92044892|NCT02216071|Autonomic Agents|autonomic agents|mesh-ancestor
92044893|NCT02216071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044894|NCT02216071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044895|NCT02216071|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044896|NCT02216071|Glucocorticoids|glucocorticoids|mesh-ancestor
92044897|NCT02216071|Hormones|hormones|mesh-ancestor
92044898|NCT02216071|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044899|NCT02216071|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044900|NCT02216071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044901|NCT02216071|Protease Inhibitors|protease inhibitors|mesh-ancestor
92044902|NCT02216071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044903|NCT02216071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044904|NCT02216071|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92044905|NCT02216071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044906|NCT02216071|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92044907|NCT02216071|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92044908|NCT02216071|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92044909|NCT02216071|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92044910|NCT01681576|Valsartan|valsartan|mesh-list
92044911|NCT01681576|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92044912|NCT01681576|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92044913|NCT01681576|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92044914|NCT01681576|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92044915|NCT01681576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044916|NCT02188459|Bupropion|bupropion|mesh-list
92014425|NCT04785755|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92014426|NCT04785755|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92014427|NCT04785755|Protective Agents|protective agents|mesh-ancestor
92014428|NCT04785911|Antiemetics|antiemetics|mesh-list
92014429|NCT04785911|Histamine|histamine|mesh-list
92014430|NCT04785911|Histamine Agonists|histamine agonists|mesh-ancestor
92044917|NCT02188459|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92044918|NCT02188459|Antidepressive Agents|antidepressive agents|mesh-ancestor
92044929|NCT02188459|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044930|NCT02743364|Simvastatin|simvastatin|mesh-list
92044931|NCT02743364|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92044932|NCT02743364|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92044933|NCT02743364|Antimetabolites|antimetabolites|mesh-ancestor
92044934|NCT02743364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044935|NCT02743364|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92044936|NCT02743364|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92044937|NCT02743364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044938|NCT04192136|Niacinamide|niacinamide|mesh-list
92044939|NCT04192136|Niacin|niacin|mesh-list
92044940|NCT04192136|Nicotinic Acids|nicotinic acids|mesh-list
92044941|NCT04192136|Vitamin B Complex|vitamin b complex|mesh-ancestor
92044942|NCT04192136|Vitamins|vitamins|mesh-ancestor
92044943|NCT04192136|Micronutrients|micronutrients|mesh-ancestor
92044944|NCT04192136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044945|NCT04192136|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92044946|NCT04192136|Antimetabolites|antimetabolites|mesh-ancestor
92044947|NCT04192136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044948|NCT04192136|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92044949|NCT04192136|Vasodilator Agents|vasodilator agents|mesh-ancestor
92044950|NCT02214121|Ticagrelor|ticagrelor|mesh-list
92044951|NCT02214121|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92044952|NCT02214121|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92044953|NCT02214121|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92044954|NCT02214121|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92044955|NCT02214121|Purinergic Agents|purinergic agents|mesh-ancestor
92044956|NCT02214121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044957|NCT02214121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044958|NCT02214121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044959|NCT01681186|Lansoprazole|lansoprazole|mesh-list
92044960|NCT01681186|Dexlansoprazole|dexlansoprazole|mesh-list
92044961|NCT01681186|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92044962|NCT01681186|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92044963|NCT01681186|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92044964|NCT01681186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044965|NCT01681186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044966|NCT01695772|Bevacizumab|bevacizumab|mesh-list
92044967|NCT01695772|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92044968|NCT01695772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92044969|NCT01695772|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92044970|NCT01695772|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92044971|NCT01695772|Growth Substances|growth substances|mesh-ancestor
92044972|NCT01695772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044973|NCT01695772|Growth Inhibitors|growth inhibitors|mesh-ancestor
92044974|NCT02159521|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92044975|NCT02159521|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92044976|NCT02159521|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92044977|NCT02159521|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044978|NCT01636934|Minocycline|minocycline|mesh-list
92044980|NCT01636934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044982|NCT01712854|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92044983|NCT01712854|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044984|NCT01712854|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92044985|NCT01712854|Autonomic Agents|autonomic agents|mesh-ancestor
92044986|NCT01712854|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044987|NCT01712854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044988|NCT01712854|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044989|NCT01712854|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014431|NCT04785911|Histamine Agents|histamine agents|mesh-ancestor
92014432|NCT04785911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044990|NCT01712854|Glucocorticoids|glucocorticoids|mesh-ancestor
92044991|NCT01712854|Hormones|hormones|mesh-ancestor
92044992|NCT01712854|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044993|NCT02986594|Aspirin|aspirin|mesh-list
92044994|NCT02986594|Heparin|heparin|mesh-list
92044995|NCT02986594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92044996|NCT02986594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044997|NCT02986594|Analgesics|analgesics|mesh-ancestor
92044998|NCT02986594|Sensory System Agents|sensory system agents|mesh-ancestor
92044999|NCT02986594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045000|NCT02986594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045001|NCT02986594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045002|NCT02986594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045003|NCT02986594|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92045004|NCT02986594|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92045005|NCT02986594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045006|NCT02986594|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92045007|NCT02986594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92045008|NCT02986594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045009|NCT02986594|Antipyretics|antipyretics|mesh-ancestor
92045010|NCT02986594|Anticoagulants|anticoagulants|mesh-ancestor
92045011|NCT02159365|Dexamethasone|dexamethasone|mesh-list
92045012|NCT02159365|Lenalidomide|lenalidomide|mesh-list
92045013|NCT02159365|Elotuzumab|elotuzumab|mesh-list
92045014|NCT02159365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045015|NCT02159365|Antiemetics|antiemetics|mesh-ancestor
92045016|NCT02159365|Autonomic Agents|autonomic agents|mesh-ancestor
92045017|NCT02159365|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045018|NCT02159365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045019|NCT02159365|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045020|NCT02159365|Glucocorticoids|glucocorticoids|mesh-ancestor
92045021|NCT02159365|Hormones|hormones|mesh-ancestor
92045022|NCT02159365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045023|NCT02159365|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045024|NCT02159365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045025|NCT02159365|Immunologic Factors|immunologic factors|mesh-ancestor
92045026|NCT02159365|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92045027|NCT02159365|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92045028|NCT02159365|Growth Substances|growth substances|mesh-ancestor
92045029|NCT02159365|Growth Inhibitors|growth inhibitors|mesh-ancestor
92045030|NCT02072200|Prednisone|prednisone|mesh-list
92045031|NCT02072200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045032|NCT02072200|Glucocorticoids|glucocorticoids|mesh-ancestor
92045033|NCT02072200|Hormones|hormones|mesh-ancestor
92045034|NCT02072200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045035|NCT02072200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045036|NCT02072200|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045037|NCT02072200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045038|NCT01691794|Ritonavir|ritonavir|mesh-list
92045039|NCT01691794|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92045040|NCT01691794|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92045041|NCT01691794|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92045042|NCT01691794|Protease Inhibitors|protease inhibitors|mesh-ancestor
92045043|NCT01691794|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045044|NCT01691794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045045|NCT01691794|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92045046|NCT01691794|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92045047|NCT01691794|Antiviral Agents|antiviral agents|mesh-ancestor
92045048|NCT01691794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045049|NCT01691794|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92045050|NCT01691794|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92045051|NCT02159053|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92045052|NCT02159053|Immunologic Factors|immunologic factors|mesh-ancestor
92045070|NCT02158039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92045071|NCT02158039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92045072|NCT02158039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92045073|NCT02158039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045074|NCT02158039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045075|NCT02158039|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92045079|NCT03563222|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92045080|NCT03563222|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92045081|NCT03563222|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92045083|NCT04803734|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92045084|NCT04803734|Autonomic Agents|autonomic agents|mesh-ancestor
92045085|NCT04803734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045086|NCT04803734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045087|NCT04803734|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92045088|NCT04803734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92045089|NCT04803734|Tocolytic Agents|tocolytic agents|mesh-ancestor
92045090|NCT04803734|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045091|NCT04803734|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92045092|NCT04803734|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92045093|NCT04803734|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92045094|NCT04803734|Adrenergic Agents|adrenergic agents|mesh-ancestor
92045095|NCT04803734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045096|NCT04803734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045097|NCT04802408|Listerine|listerine|mesh-list
92045098|NCT04802408|Sodium Fluoride|sodium fluoride|mesh-list
92045099|NCT04802408|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92045100|NCT04802408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045101|NCT04802408|Cariostatic Agents|cariostatic agents|mesh-ancestor
92045102|NCT04802408|Protective Agents|protective agents|mesh-ancestor
92045103|NCT04802408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045104|NCT02490800|Lisavanbulin|lisavanbulin|mesh-list
92045105|NCT02490800|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92045106|NCT02490800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045107|NCT02490800|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045108|NCT02490800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045135|NCT02158052|Immunologic Factors|immunologic factors|mesh-ancestor
92045136|NCT02158052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045137|NCT02158052|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92045138|NCT02158052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045139|NCT02158052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045140|NCT01635218|Fluoxetine|fluoxetine|mesh-list
92045141|NCT01635218|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92045142|NCT01635218|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92045143|NCT01635218|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045144|NCT01635218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045146|NCT01635218|Serotonin Agents|serotonin agents|mesh-ancestor
92045147|NCT01635218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045148|NCT01635218|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92045149|NCT01635218|Antidepressive Agents|antidepressive agents|mesh-ancestor
92045150|NCT01635218|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92045151|NCT01635218|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92045152|NCT01635218|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92045153|NCT01635218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045154|NCT05351684|Dolutegravir|dolutegravir|mesh-list
92045155|NCT05351684|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92045156|NCT05351684|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92045157|NCT05351684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045158|NCT05351684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045159|NCT05351684|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92045160|NCT05351684|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92045161|NCT05351684|Antiviral Agents|antiviral agents|mesh-ancestor
92045162|NCT05351684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045163|NCT02049866|Denosumab|denosumab|mesh-list
92045164|NCT02049866|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92045165|NCT02049866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045166|NCT04787744|Prednisone|prednisone|mesh-list
92045167|NCT04787744|Methylprednisolone|methylprednisolone|mesh-list
92045168|NCT04787744|Docetaxel|docetaxel|mesh-list
92045169|NCT04787744|Leuprolide|leuprolide|mesh-list
92045171|NCT04787744|Bicalutamide|bicalutamide|mesh-list
92045172|NCT04787744|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92045173|NCT04787744|Flutamide|flutamide|mesh-list
92045174|NCT04787744|Nilutamide|nilutamide|mesh-list
92045175|NCT04787744|Relugolix|relugolix|mesh-list
92014433|NCT04785911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014434|NCT04785911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014436|NCT04785911|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014437|NCT04785911|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014438|NCT04240821|Theophylline|theophylline|mesh-list
92014439|NCT04240821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92014440|NCT04240821|Autonomic Agents|autonomic agents|mesh-ancestor
92014441|NCT04240821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014442|NCT04240821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014443|NCT04240821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92045176|NCT04787744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045177|NCT04787744|Tubulin Modulators|tubulin modulators|mesh-ancestor
92045178|NCT04787744|Antimitotic Agents|antimitotic agents|mesh-ancestor
92045179|NCT04787744|Mitosis Modulators|mitosis modulators|mesh-ancestor
92045180|NCT04787744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045181|NCT04787744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045182|NCT04787744|Glucocorticoids|glucocorticoids|mesh-ancestor
92045183|NCT04787744|Hormones|hormones|mesh-ancestor
92045184|NCT04787744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045189|NCT04787744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045190|NCT04787744|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045191|NCT04787744|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92045192|NCT04787744|Protective Agents|protective agents|mesh-ancestor
92045193|NCT04787744|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92045194|NCT04787744|Fertility Agents|fertility agents|mesh-ancestor
92045195|NCT04787744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045196|NCT04787744|Androgen Antagonists|androgen antagonists|mesh-ancestor
92045197|NCT04787744|Hormone Antagonists|hormone antagonists|mesh-ancestor
92045198|NCT04787744|Luteolytic Agents|luteolytic agents|mesh-ancestor
92045199|NCT04787744|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92045200|NCT04787744|Contraceptive Agents|contraceptive agents|mesh-ancestor
92045201|NCT04787744|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92045203|NCT04274894|Androgens|androgens|mesh-ancestor
92045204|NCT04274894|Hormones|hormones|mesh-ancestor
92045205|NCT04274894|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045206|NCT04274894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045207|NCT04786964|Folic Acid|folic acid|mesh-list
92045208|NCT04786964|Vitamin B 12|vitamin b 12|mesh-list
92045209|NCT04786964|Dexamethasone|dexamethasone|mesh-list
92045210|NCT04786964|Carboplatin|carboplatin|mesh-list
92045211|NCT04786964|Pemetrexed|pemetrexed|mesh-list
92045212|NCT04786964|Vitamins|vitamins|mesh-ancestor
92045213|NCT04786964|Micronutrients|micronutrients|mesh-ancestor
92045214|NCT04786964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045215|NCT04786964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045216|NCT04786964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045217|NCT04786964|Antiemetics|antiemetics|mesh-ancestor
92045218|NCT04786964|Autonomic Agents|autonomic agents|mesh-ancestor
92045219|NCT04786964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045220|NCT04786964|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045221|NCT04786964|Glucocorticoids|glucocorticoids|mesh-ancestor
92045222|NCT04786964|Hormones|hormones|mesh-ancestor
92045223|NCT04786964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045224|NCT04786964|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045225|NCT04786964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045226|NCT04786964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045227|NCT04786964|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92045228|NCT04786964|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92045230|NCT04786964|Vitamin B Complex|vitamin b complex|mesh-ancestor
92045231|NCT04269200|Paclitaxel|paclitaxel|mesh-list
92045232|NCT04269200|Carboplatin|carboplatin|mesh-list
92014444|NCT04240821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014445|NCT04240821|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92014446|NCT04240821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014447|NCT04240821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014448|NCT04240821|Vasodilator Agents|vasodilator agents|mesh-ancestor
92014449|NCT04240821|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92014450|NCT04240821|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92014451|NCT04240821|Purinergic Agents|purinergic agents|mesh-ancestor
92014452|NCT04240821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014453|NCT04243941|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92014454|NCT04243941|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92014455|NCT04243941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014456|NCT05314101|Bevacizumab|bevacizumab|mesh-list
92014457|NCT05314101|Tislelizumab|tislelizumab|mesh-list
92014458|NCT05314101|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014459|NCT05314101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014460|NCT05314101|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92014461|NCT05314101|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92045233|NCT04269200|Durvalumab|durvalumab|mesh-list
92045234|NCT04269200|Olaparib|olaparib|mesh-list
92045235|NCT04269200|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92045236|NCT04269200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92045237|NCT04269200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045238|NCT04269200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92045239|NCT04269200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92045240|NCT04269200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92045241|NCT04269200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045242|NCT04269200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045243|NCT04269200|Immunologic Factors|immunologic factors|mesh-ancestor
92045244|NCT04269200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045245|NCT04269200|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92045246|NCT04269200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045247|NCT02213263|Rituximab|rituximab|mesh-list
92045248|NCT02213263|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045249|NCT02213263|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045250|NCT02213263|Immunologic Factors|immunologic factors|mesh-ancestor
92045251|NCT02213263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045252|NCT02213263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045253|NCT04781036|Chlorhexidine|chlorhexidine|mesh-list
92045254|NCT04781036|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92045255|NCT04781036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045256|NCT04781036|Disinfectants|disinfectants|mesh-ancestor
92045257|NCT04216784|Furosemide|furosemide|mesh-list
92045260|NCT04216784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045261|NCT04216784|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92045262|NCT04216784|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045263|NCT04216784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045265|NCT05173298|Atezolizumab|atezolizumab|mesh-list
92045266|NCT05173298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045267|NCT05173298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045268|NCT05173298|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92045269|NCT05173298|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92045270|NCT05173298|Growth Substances|growth substances|mesh-ancestor
92045271|NCT05173298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014462|NCT05314101|Growth Substances|growth substances|mesh-ancestor
92014463|NCT05314101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045272|NCT05173298|Growth Inhibitors|growth inhibitors|mesh-ancestor
92045273|NCT05173298|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92045274|NCT05173298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045275|NCT05168930|Venetoclax|venetoclax|mesh-list
92045276|NCT05168930|Zanubrutinib|zanubrutinib|mesh-list
92045277|NCT05168930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045278|NCT05168930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045279|NCT05168930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045280|NCT05168930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045281|NCT05170724|Remibrutinib|remibrutinib|mesh-list
92045282|NCT05170724|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045283|NCT05170724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045284|NCT05170724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045285|NCT01975064|Propofol|propofol|mesh-list
92045286|NCT01975064|Sevoflurane|sevoflurane|mesh-list
92045287|NCT01975064|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92045288|NCT01975064|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045289|NCT01975064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045290|NCT01975064|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92045291|NCT01975064|Anesthetics, General|anesthetics, general|mesh-ancestor
92045292|NCT01975064|Anesthetics|anesthetics|mesh-ancestor
92045293|NCT01975064|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92045294|NCT01975064|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92045295|NCT04062266|Azacitidine|azacitidine|mesh-list
92045296|NCT04062266|Venetoclax|venetoclax|mesh-list
92045297|NCT04062266|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045298|NCT04062266|Antimetabolites|antimetabolites|mesh-ancestor
92045299|NCT04062266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045300|NCT04062266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045301|NCT04062266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045302|NCT02210689|Clindamycin|clindamycin|mesh-list
92045303|NCT02210689|Clindamycin palmitate|clindamycin palmitate|mesh-list
92045304|NCT02210689|Clindamycin phosphate|clindamycin phosphate|mesh-list
92045305|NCT02210689|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045306|NCT02210689|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045307|NCT02210689|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92045308|NCT02210689|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045309|NCT02210689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045311|NCT02209597|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92045312|NCT02209597|Antidepressive Agents|antidepressive agents|mesh-ancestor
92045313|NCT02209597|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92045314|NCT02209597|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92045315|NCT02209597|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92045316|NCT02209597|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045317|NCT02209597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045318|NCT02209597|Dopamine Agents|dopamine agents|mesh-ancestor
92045319|NCT02209597|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045320|NCT02209597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045321|NCT02209597|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92045322|NCT02209597|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92045323|NCT02209597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045324|NCT03965468|Paclitaxel|paclitaxel|mesh-list
92045325|NCT03965468|Carboplatin|carboplatin|mesh-list
92045326|NCT03965468|Durvalumab|durvalumab|mesh-list
92045327|NCT03965468|Tremelimumab|tremelimumab|mesh-list
92045328|NCT03965468|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92045329|NCT03965468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045330|NCT03965468|Tubulin Modulators|tubulin modulators|mesh-ancestor
92045331|NCT03965468|Antimitotic Agents|antimitotic agents|mesh-ancestor
92045332|NCT03965468|Mitosis Modulators|mitosis modulators|mesh-ancestor
92045333|NCT03965468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045334|NCT03965468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045336|NCT01469156|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92045337|NCT01469156|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92045338|NCT01469156|Growth Substances|growth substances|mesh-ancestor
92045339|NCT01469156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045340|NCT01469156|Growth Inhibitors|growth inhibitors|mesh-ancestor
92045341|NCT01469156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045342|NCT04191434|Budesonide|budesonide|mesh-list
92045343|NCT04191434|Formoterol Fumarate|formoterol fumarate|mesh-list
92014464|NCT05314101|Growth Inhibitors|growth inhibitors|mesh-ancestor
92014466|NCT02595749|Oxytocics|oxytocics|mesh-ancestor
92045344|NCT04191434|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92045345|NCT04191434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045346|NCT04191434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92045347|NCT04191434|Autonomic Agents|autonomic agents|mesh-ancestor
92045348|NCT04191434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045349|NCT04191434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045350|NCT04191434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92045351|NCT04191434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92045352|NCT04191434|Glucocorticoids|glucocorticoids|mesh-ancestor
92045353|NCT04191434|Hormones|hormones|mesh-ancestor
92045354|NCT04191434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045355|NCT04191434|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92045356|NCT04191434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92045357|NCT04191434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92045358|NCT04191434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92045359|NCT04191434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045360|NCT04191434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045361|NCT03835676|Treprostinil|treprostinil|mesh-list
92045362|NCT03835676|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92045363|NCT03651128|Dexamethasone|dexamethasone|mesh-list
92045364|NCT03651128|Lenalidomide|lenalidomide|mesh-list
92045365|NCT03651128|Bortezomib|bortezomib|mesh-list
92045366|NCT03651128|Daratumumab|daratumumab|mesh-list
92045367|NCT03651128|Pomalidomide|pomalidomide|mesh-list
92045368|NCT03651128|Ixazomib|ixazomib|mesh-list
92045369|NCT03651128|Elotuzumab|elotuzumab|mesh-list
92045370|NCT03651128|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045371|NCT03651128|Antiemetics|antiemetics|mesh-ancestor
92045372|NCT03651128|Autonomic Agents|autonomic agents|mesh-ancestor
92045373|NCT03651128|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045374|NCT03651128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045375|NCT03651128|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045376|NCT03651128|Glucocorticoids|glucocorticoids|mesh-ancestor
92045377|NCT03651128|Hormones|hormones|mesh-ancestor
92045378|NCT03651128|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045379|NCT03651128|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045380|NCT03651128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045381|NCT03651128|Immunologic Factors|immunologic factors|mesh-ancestor
92045382|NCT03651128|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92045383|NCT03651128|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92045384|NCT03651128|Growth Substances|growth substances|mesh-ancestor
92045385|NCT03651128|Growth Inhibitors|growth inhibitors|mesh-ancestor
92045386|NCT03651128|Protease Inhibitors|protease inhibitors|mesh-ancestor
92045387|NCT03651128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045388|NCT03651128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045389|NCT00664898|Bortezomib|bortezomib|mesh-list
92045390|NCT00664898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045391|NCT04827992|Analgesics, Opioid|analgesics, opioid|mesh-list
92045392|NCT04827992|Narcotics|narcotics|mesh-ancestor
92045393|NCT04827992|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045394|NCT04827992|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045395|NCT04827992|Analgesics|analgesics|mesh-ancestor
92045396|NCT04827992|Sensory System Agents|sensory system agents|mesh-ancestor
92045397|NCT04827992|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045398|NCT04776980|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92045399|NCT04776980|Hematinics|hematinics|mesh-ancestor
92045400|NCT04776980|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92045401|NCT04776980|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92045403|NCT02187055|Methotrexate|methotrexate|mesh-list
92045404|NCT02187055|Tofacitinib|tofacitinib|mesh-list
92045405|NCT02187055|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92045408|NCT02187055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045409|NCT02187055|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045410|NCT02187055|Antimetabolites|antimetabolites|mesh-ancestor
92045411|NCT02187055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045412|NCT02187055|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045413|NCT02187055|Dermatologic Agents|dermatologic agents|mesh-ancestor
92045414|NCT02187055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045415|NCT02187055|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92045416|NCT02187055|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014467|NCT02595749|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92014468|NCT02595749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045417|NCT02187055|Immunologic Factors|immunologic factors|mesh-ancestor
92045418|NCT02187055|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045419|NCT02187055|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92045420|NCT02187055|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92045421|NCT02187055|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045422|NCT02187055|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92045423|NCT02187055|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045425|NCT00119366|Cyclosporine|cyclosporine|mesh-list
92045426|NCT00119366|Mycophenolic Acid|mycophenolic acid|mesh-list
92045427|NCT00119366|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92045428|NCT00119366|Fludarabine|fludarabine|mesh-list
92045429|NCT00119366|Fludarabine phosphate|fludarabine phosphate|mesh-list
92045430|NCT00119366|Antibodies|antibodies|mesh-list
92045431|NCT00119366|Immunoglobulins|immunoglobulins|mesh-list
92045432|NCT00119366|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92045433|NCT00119366|Cyclosporins|cyclosporins|mesh-list
92045434|NCT00119366|Immunologic Factors|immunologic factors|mesh-ancestor
92045435|NCT00119366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045436|NCT00119366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045437|NCT00119366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045438|NCT00119366|Antimetabolites|antimetabolites|mesh-ancestor
92045439|NCT00119366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045440|NCT00119366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045441|NCT00119366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045442|NCT00119366|Antifungal Agents|antifungal agents|mesh-ancestor
92045443|NCT00119366|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045444|NCT00119366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92045445|NCT00119366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045446|NCT00119366|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92045447|NCT00119366|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92045448|NCT00119366|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92045449|NCT00119366|Antitubercular Agents|antitubercular agents|mesh-ancestor
92045450|NCT00119366|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045451|NCT00119366|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92045452|NCT00119366|Trace Elements|trace elements|mesh-ancestor
92045453|NCT00119366|Micronutrients|micronutrients|mesh-ancestor
92045454|NCT02246660|Resveratrol|resveratrol|mesh-list
92045455|NCT02246660|Antioxidants|antioxidants|mesh-ancestor
92045456|NCT02246660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045457|NCT02246660|Protective Agents|protective agents|mesh-ancestor
92045458|NCT02246660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045459|NCT02246660|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045460|NCT02246660|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92045461|NCT03471260|Azacitidine|azacitidine|mesh-list
92045463|NCT03471260|Ivosidenib|ivosidenib|mesh-list
92045464|NCT03471260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045465|NCT03471260|Antimetabolites|antimetabolites|mesh-ancestor
92045466|NCT03471260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045467|NCT03471260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045468|NCT03471260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045469|NCT02246582|Insulin|insulin|mesh-list
92045470|NCT02246582|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92045471|NCT02246582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045472|NCT02137369|Dexetimide|dexetimide|mesh-list
92045473|NCT02137369|Citalopram|citalopram|mesh-list
92045474|NCT02137369|Sertraline|sertraline|mesh-list
92045475|NCT02137369|Antidepressive Agents|antidepressive agents|mesh-list
92045476|NCT02137369|Escitalopram|escitalopram|mesh-list
92045477|NCT02137369|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92045478|NCT02137369|Serotonin|serotonin|mesh-list
92045479|NCT02137369|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92045480|NCT02137369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045484|NCT02137369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045485|NCT02137369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92045486|NCT02137369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92045487|NCT02137369|Parasympatholytics|parasympatholytics|mesh-ancestor
92045488|NCT02137369|Autonomic Agents|autonomic agents|mesh-ancestor
92045489|NCT02137369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014471|NCT05221749|Protective Agents|protective agents|mesh-ancestor
92014472|NCT05221749|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014473|NCT04426721|Hyaluronic Acid|hyaluronic acid|mesh-list
92014474|NCT04426721|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92014475|NCT04426721|Immunologic Factors|immunologic factors|mesh-ancestor
92045490|NCT02137369|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92045491|NCT02137369|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92045492|NCT02137369|Cholinergic Agents|cholinergic agents|mesh-ancestor
92045493|NCT02137369|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92045494|NCT02137369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92045495|NCT02137369|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92045497|NCT02155309|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92045498|NCT02155309|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92045499|NCT02155309|Antiemetics|antiemetics|mesh-ancestor
92045500|NCT02155309|Autonomic Agents|autonomic agents|mesh-ancestor
92045501|NCT02155309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045502|NCT02155309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045503|NCT02155309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045504|NCT02155309|Mydriatics|mydriatics|mesh-ancestor
92045505|NCT02155309|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92045506|NCT02155309|Cholinergic Agents|cholinergic agents|mesh-ancestor
92045507|NCT02155309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045508|NCT02155309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045509|NCT02155309|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92045510|NCT02155309|Parasympatholytics|parasympatholytics|mesh-ancestor
92045511|NCT02186821|Ceritinib|ceritinib|mesh-list
92045512|NCT02186821|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045513|NCT02186821|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045514|NCT02186821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045515|NCT02186821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045516|NCT01710358|Adalimumab|adalimumab|mesh-list
92045517|NCT01710358|Methotrexate|methotrexate|mesh-list
92045518|NCT01710358|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92045519|NCT01710358|Abortifacient Agents|abortifacient agents|mesh-ancestor
92045520|NCT01710358|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045521|NCT01710358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045522|NCT01710358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045523|NCT01710358|Antimetabolites|antimetabolites|mesh-ancestor
92045524|NCT01710358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045525|NCT01710358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045526|NCT01710358|Dermatologic Agents|dermatologic agents|mesh-ancestor
92045527|NCT01710358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045528|NCT01710358|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92045529|NCT01710358|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045530|NCT01710358|Immunologic Factors|immunologic factors|mesh-ancestor
92045531|NCT01710358|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045532|NCT01710358|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92045533|NCT01710358|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92045534|NCT01710358|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045535|NCT01633112|Glatiramer Acetate|glatiramer acetate|mesh-list
92045536|NCT01633112|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92045538|NCT01633112|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92045539|NCT01633112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045540|NCT01633112|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045541|NCT01633112|Immunologic Factors|immunologic factors|mesh-ancestor
92045542|NCT01633112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045543|NCT01633112|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92045544|NCT01633112|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045545|NCT03455270|Palbociclib|palbociclib|mesh-list
92045546|NCT03455270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045547|NCT03455270|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045548|NCT03455270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045549|NCT03455270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045550|NCT01691482|Albuterol|albuterol|mesh-list
92045551|NCT01691482|Ipratropium|ipratropium|mesh-list
92014476|NCT04426721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014478|NCT04426721|Protective Agents|protective agents|mesh-ancestor
92014479|NCT05221359|Insulin Aspart|insulin aspart|mesh-list
92045565|NCT01691482|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045566|NCT01691482|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92045567|NCT01691482|Cholinergic Agents|cholinergic agents|mesh-ancestor
92045568|NCT01710046|Tofacitinib|tofacitinib|mesh-list
92045569|NCT01710046|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92045570|NCT01710046|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045571|NCT01710046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045572|NCT01710046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045573|NCT02154529|Trastuzumab|trastuzumab|mesh-list
92045574|NCT02154529|XL647|xl647|mesh-list
92045575|NCT02154529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045576|NCT02154529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045577|NCT02154529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045578|NCT02154529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045579|NCT02154529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045580|NCT02154139|Leuprolide|leuprolide|mesh-list
92045581|NCT02154139|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92045582|NCT02154139|Fertility Agents|fertility agents|mesh-ancestor
92045583|NCT02154139|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045584|NCT02154139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045585|NCT02154139|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045586|NCT02154139|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045587|NCT02154061|Metronidazole|metronidazole|mesh-list
92045588|NCT02154061|Vancomycin|vancomycin|mesh-list
92045589|NCT02154061|Neomycin|neomycin|mesh-list
92045590|NCT02154061|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045591|NCT02154061|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045592|NCT02154061|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92045593|NCT02154061|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92045594|NCT02154061|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92045595|NCT02154061|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045596|NCT02154061|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045597|NCT01907217|Methohexital|methohexital|mesh-list
92045598|NCT01907217|Succinylcholine|succinylcholine|mesh-list
92045599|NCT01907217|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92045600|NCT01907217|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92045601|NCT01907217|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92045602|NCT01907217|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045603|NCT01907217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045604|NCT01907217|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92045605|NCT01907217|Anesthetics, General|anesthetics, general|mesh-ancestor
92045607|NCT01907217|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045608|NCT01953783|Ixazomib|ixazomib|mesh-list
92045609|NCT01953783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045610|NCT01953783|Protease Inhibitors|protease inhibitors|mesh-ancestor
92045611|NCT01953783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045612|NCT01953783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045613|NCT02134015|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92045615|NCT02134015|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045616|NCT02134015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045617|NCT02134015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045618|NCT04619979|Anesthetics|anesthetics|mesh-list
92045619|NCT04619979|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045620|NCT04619979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045621|NCT01630135|Fluticasone|fluticasone|mesh-list
92045623|NCT01630135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045624|NCT01630135|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92045625|NCT01630135|Autonomic Agents|autonomic agents|mesh-ancestor
92045626|NCT01630135|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045627|NCT01630135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045628|NCT01630135|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92045629|NCT01630135|Respiratory System Agents|respiratory system agents|mesh-ancestor
92045630|NCT01630135|Dermatologic Agents|dermatologic agents|mesh-ancestor
92045631|NCT01630135|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92045632|NCT01691248|Fidaxomicin|fidaxomicin|mesh-list
92045633|NCT01691248|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045634|NCT01691248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014481|NCT05221359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014482|NCT04794413|Pimavanserin|pimavanserin|mesh-list
92014483|NCT04794413|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92045635|NCT01924767|Empagliflozin|empagliflozin|mesh-list
92045636|NCT01924767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92045637|NCT01924767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045638|NCT01924767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92045639|NCT01924767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045640|NCT01691092|Ketamine|ketamine|mesh-list
92045641|NCT01691092|Analgesics|analgesics|mesh-ancestor
92045642|NCT01691092|Sensory System Agents|sensory system agents|mesh-ancestor
92045643|NCT01691092|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045644|NCT01691092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045645|NCT01691092|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92045646|NCT01691092|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92045647|NCT01691092|Anesthetics, General|anesthetics, general|mesh-ancestor
92045648|NCT01691092|Anesthetics|anesthetics|mesh-ancestor
92045649|NCT01691092|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045650|NCT01691092|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92045651|NCT01691092|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92045652|NCT01691092|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045653|NCT01691092|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045654|NCT02133001|Esketamine|esketamine|mesh-list
92045655|NCT02133001|Antidepressive Agents|antidepressive agents|mesh-ancestor
92045656|NCT02133001|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92045657|NCT01709578|Hydroxychloroquine|hydroxychloroquine|mesh-list
92045658|NCT01709578|Sulfasalazine|sulfasalazine|mesh-list
92045659|NCT01709578|Methotrexate|methotrexate|mesh-list
92045660|NCT01709578|Leflunomide|leflunomide|mesh-list
92045661|NCT01709578|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92045662|NCT01709578|Abortifacient Agents|abortifacient agents|mesh-ancestor
92045663|NCT01709578|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045664|NCT01709578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045665|NCT01709578|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045666|NCT01709578|Antimetabolites|antimetabolites|mesh-ancestor
92045667|NCT01709578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045668|NCT01709578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045669|NCT01709578|Dermatologic Agents|dermatologic agents|mesh-ancestor
92045670|NCT01709578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045671|NCT01709578|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92045672|NCT01709578|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045673|NCT01709578|Immunologic Factors|immunologic factors|mesh-ancestor
92045674|NCT01709578|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045675|NCT01709578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92045676|NCT01709578|Antimalarials|antimalarials|mesh-ancestor
92045677|NCT01709578|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92045678|NCT01709578|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92045679|NCT01709578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045680|NCT01709578|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92045681|NCT01709578|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92045682|NCT01709578|Analgesics|analgesics|mesh-ancestor
92045683|NCT01709578|Sensory System Agents|sensory system agents|mesh-ancestor
92045684|NCT01709578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045685|NCT01709578|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045687|NCT02132767|Digoxin|digoxin|mesh-list
92045688|NCT02132767|Amiodarone|amiodarone|mesh-list
92045689|NCT02132767|Calcium Channel Blockers|calcium channel blockers|mesh-list
92045690|NCT02132767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92045691|NCT02132767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045692|NCT02132767|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92045693|NCT02132767|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92045694|NCT02132767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045695|NCT02132767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045696|NCT02132767|Protective Agents|protective agents|mesh-ancestor
92045697|NCT02132767|Vasodilator Agents|vasodilator agents|mesh-ancestor
92045698|NCT02132767|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92045699|NCT02132767|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045700|NCT02132767|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92014484|NCT04794413|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92014485|NCT04794413|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92045701|NCT02132767|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92045702|NCT02132767|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92045703|NCT02132767|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92045704|NCT02132767|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92045705|NCT02132767|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92045706|NCT02153905|Aldesleukin|aldesleukin|mesh-list
92045707|NCT02153905|Cyclophosphamide|cyclophosphamide|mesh-list
92045708|NCT02153905|Fludarabine|fludarabine|mesh-list
92045709|NCT02153905|Interleukin-2|interleukin-2|mesh-list
92045710|NCT02153905|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045711|NCT02153905|Immunologic Factors|immunologic factors|mesh-ancestor
92045712|NCT02153905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045713|NCT02153905|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045714|NCT02153905|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92045715|NCT02153905|Alkylating Agents|alkylating agents|mesh-ancestor
92045716|NCT02153905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045717|NCT02153905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045718|NCT02153905|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92045719|NCT02153905|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92045720|NCT02153905|Analgesics|analgesics|mesh-ancestor
92045721|NCT02153905|Sensory System Agents|sensory system agents|mesh-ancestor
92045722|NCT02153905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045724|NCT02153905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92045725|NCT02153905|Antiviral Agents|antiviral agents|mesh-ancestor
92045726|NCT02153905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045727|NCT04752631|Tenecteplase|tenecteplase|mesh-list
92045728|NCT04752631|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92045729|NCT04752631|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92045730|NCT04752631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045731|NCT04546672|Neostigmine|neostigmine|mesh-list
92045732|NCT04546672|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92045733|NCT04546672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045734|NCT04546672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045735|NCT04546672|Cholinergic Agents|cholinergic agents|mesh-ancestor
92045736|NCT04546672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045737|NCT04546672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045738|NCT04546672|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92045739|NCT04546672|Autonomic Agents|autonomic agents|mesh-ancestor
92045740|NCT04546672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045741|NCT02244944|Ezetimibe|ezetimibe|mesh-list
92045742|NCT02244944|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92045743|NCT02244944|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92045744|NCT02244944|Antimetabolites|antimetabolites|mesh-ancestor
92045745|NCT02244944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045747|NCT01689532|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92045748|NCT01689532|Immunologic Factors|immunologic factors|mesh-ancestor
92045749|NCT01689532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045750|NCT01591096|Plasminogen|plasminogen|mesh-list
92045751|NCT01591096|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92045752|NCT01591096|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92045753|NCT01591096|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92045754|NCT01591096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045755|NCT01953003|Capecitabine|capecitabine|mesh-list
92045756|NCT01953003|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045757|NCT01953003|Antimetabolites|antimetabolites|mesh-ancestor
92045758|NCT01953003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045759|NCT01953003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045777|NCT01599806|Doripenem|doripenem|mesh-list
92045778|NCT01599806|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92045779|NCT01599806|Trimethoprim|trimethoprim|mesh-list
92045780|NCT01599806|Sulfamethoxazole|sulfamethoxazole|mesh-list
92045781|NCT01599806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045782|NCT01599806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045783|NCT01599806|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92045784|NCT01599806|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92045785|NCT01599806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045786|NCT01599806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045787|NCT01599806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014486|NCT04794413|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92014487|NCT04794413|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014488|NCT04794413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045788|NCT01599806|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92045789|NCT01599806|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92045790|NCT01599806|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92045791|NCT01599806|Antimalarials|antimalarials|mesh-ancestor
92045792|NCT01599806|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92045793|NCT01599806|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92045794|NCT01599806|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92045795|NCT01599806|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92045796|NCT01599806|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92045797|NCT01599806|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92045798|NCT01599325|Azacitidine|azacitidine|mesh-list
92045799|NCT01599325|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92045800|NCT01599325|Antimetabolites|antimetabolites|mesh-ancestor
92045801|NCT01599325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045802|NCT01599325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045803|NCT01599325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045804|NCT01924299|Fluconazole|fluconazole|mesh-list
92045805|NCT01924299|Ketoconazole|ketoconazole|mesh-list
92045806|NCT01924299|Antifungal Agents|antifungal agents|mesh-ancestor
92045807|NCT01924299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045808|NCT01924299|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92045809|NCT01924299|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92045810|NCT01924299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045811|NCT01924299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045812|NCT01924299|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92045813|NCT01924299|Hormone Antagonists|hormone antagonists|mesh-ancestor
92045814|NCT01924299|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045815|NCT01924299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045816|NCT01924299|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92045817|NCT01924299|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92045819|NCT02182999|Ropivacaine|ropivacaine|mesh-list
92045820|NCT02182999|Anesthetics, Local|anesthetics, local|mesh-ancestor
92045821|NCT02182999|Anesthetics|anesthetics|mesh-ancestor
92045822|NCT02182999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045823|NCT02182999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045824|NCT02182999|Sensory System Agents|sensory system agents|mesh-ancestor
92045825|NCT02182999|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045826|NCT01598311|Vancomycin|vancomycin|mesh-list
92045827|NCT01598311|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045828|NCT01598311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045829|NCT02208050|4-Aminopyridine|4-aminopyridine|mesh-list
92045830|NCT02208050|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92045831|NCT02208050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045832|NCT02208050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045833|NCT02978222|Molgramostim|molgramostim|mesh-list
92045834|NCT02978222|Sargramostim|sargramostim|mesh-list
92045835|NCT02978222|Immunologic Factors|immunologic factors|mesh-ancestor
92045836|NCT02978222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045837|NCT02978222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045838|NCT02181673|Golimumab|golimumab|mesh-list
92045839|NCT02181673|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92045840|NCT02181673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045841|NCT02181673|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045842|NCT02181673|Immunologic Factors|immunologic factors|mesh-ancestor
92045843|NCT02181673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045844|NCT02152345|Methylprednisolone|methylprednisolone|mesh-list
92045845|NCT02152345|Abatacept|abatacept|mesh-list
92045846|NCT02152345|Tacrolimus|tacrolimus|mesh-list
92045847|NCT02152345|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92045848|NCT02152345|Thymoglobulin|thymoglobulin|mesh-list
92045849|NCT02152345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045850|NCT02152345|Immunologic Factors|immunologic factors|mesh-ancestor
92045851|NCT02152345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045852|NCT02152345|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92045853|NCT02152345|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045854|NCT02152345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045855|NCT02152345|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014489|NCT04794413|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014490|NCT04794413|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92014491|NCT04794413|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92014492|NCT04794413|Serotonin Agents|serotonin agents|mesh-ancestor
92014493|NCT04794413|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045856|NCT02152345|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045857|NCT02152345|Antiemetics|antiemetics|mesh-ancestor
92045858|NCT02152345|Autonomic Agents|autonomic agents|mesh-ancestor
92045859|NCT02152345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045860|NCT02152345|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045861|NCT02152345|Glucocorticoids|glucocorticoids|mesh-ancestor
92045862|NCT02152345|Hormones|hormones|mesh-ancestor
92045863|NCT02152345|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045864|NCT02152345|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92045865|NCT02152345|Protective Agents|protective agents|mesh-ancestor
92045866|NCT02152345|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92045867|NCT02152345|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045868|NCT02152345|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045869|NCT02180659|Buprenorphine|buprenorphine|mesh-list
92045870|NCT02180659|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92045871|NCT02180659|Narcotics|narcotics|mesh-ancestor
92045872|NCT02180659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045873|NCT02180659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045874|NCT02180659|Analgesics|analgesics|mesh-ancestor
92045875|NCT02180659|Sensory System Agents|sensory system agents|mesh-ancestor
92045876|NCT02180659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045877|NCT02180659|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92045878|NCT02207816|Vaccines|vaccines|mesh-list
92045879|NCT02207816|Immunologic Factors|immunologic factors|mesh-ancestor
92045880|NCT02207816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045881|NCT05156606|Testosterone|testosterone|mesh-list
92045882|NCT05156606|Androgens|androgens|mesh-ancestor
92045883|NCT05156606|Hormones|hormones|mesh-ancestor
92045884|NCT05156606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92045885|NCT05156606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045886|NCT02241512|Ibuprofen|ibuprofen|mesh-list
92045887|NCT02241512|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92045888|NCT02241512|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92045889|NCT02241512|Analgesics|analgesics|mesh-ancestor
92045890|NCT02241512|Sensory System Agents|sensory system agents|mesh-ancestor
92045904|NCT01709110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045905|NCT01709110|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92045906|NCT01709110|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92045907|NCT01709110|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92045908|NCT01709110|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92045909|NCT01709110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045911|NCT02240108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045912|NCT02240108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045913|NCT02240108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045914|NCT01590082|Doxycycline|doxycycline|mesh-list
92045915|NCT01590082|Temozolomide|temozolomide|mesh-list
92045916|NCT01590082|Ipilimumab|ipilimumab|mesh-list
92045917|NCT01590082|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92045918|NCT01590082|Alkylating Agents|alkylating agents|mesh-ancestor
92045919|NCT01590082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045920|NCT01590082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045921|NCT01590082|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045922|NCT01590082|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92045923|NCT01590082|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045924|NCT01590082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045925|NCT01590082|Antimalarials|antimalarials|mesh-ancestor
92045926|NCT01590082|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92045927|NCT01590082|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92045928|NCT02203916|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92045929|NCT02203916|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92045930|NCT02203916|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92014494|NCT04794413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014495|NCT05214573|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92045931|NCT02203916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045932|NCT02179177|Apixaban|apixaban|mesh-list
92045933|NCT02179177|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92045934|NCT02179177|Antithrombins|antithrombins|mesh-ancestor
92045935|NCT02179177|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92045936|NCT02179177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92045937|NCT02179177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045938|NCT02179177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045939|NCT02179177|Anticoagulants|anticoagulants|mesh-ancestor
92045940|NCT02239094|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92045941|NCT02239094|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92045942|NCT02239094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92045943|NCT02239094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045944|NCT02239094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045945|NCT02239094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92045946|NCT02239094|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92045947|NCT02239094|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92045948|NCT02239094|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92045949|NCT02239094|Adrenergic Agents|adrenergic agents|mesh-ancestor
92045950|NCT02239094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045951|NCT02239094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045954|NCT02239094|Serotonin Agents|serotonin agents|mesh-ancestor
92045955|NCT02239094|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92045956|NCT02239094|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92045957|NCT02239094|Dopamine Agents|dopamine agents|mesh-ancestor
92045958|NCT02129647|Axitinib|axitinib|mesh-list
92045959|NCT02129647|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045960|NCT02129647|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92045961|NCT02129647|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045962|NCT02129647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045963|NCT02238626|Ibudilast|ibudilast|mesh-list
92045964|NCT02238626|Riluzole|riluzole|mesh-list
92045965|NCT02238626|Anticonvulsants|anticonvulsants|mesh-ancestor
92045966|NCT02238626|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92045967|NCT02238626|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92045968|NCT02238626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045969|NCT02238626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045970|NCT02238626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045971|NCT02238626|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92045972|NCT02238626|Protective Agents|protective agents|mesh-ancestor
92045973|NCT02238626|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92045974|NCT02238626|Autonomic Agents|autonomic agents|mesh-ancestor
92045975|NCT02238626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045976|NCT02238626|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92045977|NCT02238626|Respiratory System Agents|respiratory system agents|mesh-ancestor
92045978|NCT02238626|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92045979|NCT02238626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045980|NCT02238626|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92045981|NCT02238626|Vasodilator Agents|vasodilator agents|mesh-ancestor
92045982|NCT02151643|Iron|iron|mesh-list
92045983|NCT02151643|Trace Elements|trace elements|mesh-ancestor
92045984|NCT02151643|Micronutrients|micronutrients|mesh-ancestor
92045985|NCT02151643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045986|NCT02203838|Risperidone|risperidone|mesh-list
92045987|NCT02203838|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92045988|NCT02203838|Serotonin Agents|serotonin agents|mesh-ancestor
92045989|NCT02203838|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045990|NCT02203838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045991|NCT02203838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045992|NCT02203838|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92045993|NCT02203838|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92045994|NCT02203838|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045995|NCT02203838|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92045996|NCT02203838|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92045997|NCT02203838|Dopamine Agents|dopamine agents|mesh-ancestor
92045998|NCT02178709|Leucovorin|leucovorin|mesh-list
92045999|NCT02178709|Oxaliplatin|oxaliplatin|mesh-list
92014496|NCT05214573|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92014497|NCT05214573|Glucagon|glucagon|mesh-list
92014498|NCT05214573|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92014499|NCT05214573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92046000|NCT02178709|Irinotecan|irinotecan|mesh-list
92046001|NCT02178709|Folfirinox|folfirinox|mesh-list
92046002|NCT02178709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046003|NCT02178709|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92046004|NCT02178709|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92046005|NCT02178709|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046006|NCT02178709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046007|NCT02178709|Antidotes|antidotes|mesh-ancestor
92046008|NCT02178709|Protective Agents|protective agents|mesh-ancestor
92046009|NCT02178709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046010|NCT02178709|Vitamin B Complex|vitamin b complex|mesh-ancestor
92046011|NCT02178709|Vitamins|vitamins|mesh-ancestor
92046012|NCT02178709|Micronutrients|micronutrients|mesh-ancestor
92046013|NCT02238080|Epoetin Alfa|epoetin alfa|mesh-list
92046014|NCT02238080|Hematinics|hematinics|mesh-ancestor
92046015|NCT02178553|Bupivacaine|bupivacaine|mesh-list
92046016|NCT02178553|Anesthetics, Local|anesthetics, local|mesh-ancestor
92046017|NCT02178553|Anesthetics|anesthetics|mesh-ancestor
92046018|NCT02178553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046019|NCT02178553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046020|NCT02178553|Sensory System Agents|sensory system agents|mesh-ancestor
92046021|NCT02178553|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046022|NCT01627327|Fluticasone|fluticasone|mesh-list
92046024|NCT01627327|Bromides|bromides|mesh-list
92046025|NCT01627327|Tiotropium Bromide|tiotropium bromide|mesh-list
92046026|NCT01627327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046029|NCT01627327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046030|NCT01627327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046032|NCT01627327|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046033|NCT01627327|Dermatologic Agents|dermatologic agents|mesh-ancestor
92046034|NCT01627327|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92046035|NCT01627327|Parasympatholytics|parasympatholytics|mesh-ancestor
92046036|NCT01627327|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92046037|NCT01627327|Cholinergic Agents|cholinergic agents|mesh-ancestor
92046038|NCT01627327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046039|NCT01627327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046040|NCT01627327|Anticonvulsants|anticonvulsants|mesh-ancestor
92046041|NCT01627249|Bevacizumab|bevacizumab|mesh-list
92046042|NCT01627249|Ranibizumab|ranibizumab|mesh-list
92046043|NCT01627249|Aflibercept|aflibercept|mesh-list
92046044|NCT01627249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046045|NCT01627249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046046|NCT01627249|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92046047|NCT01627249|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92046048|NCT01627249|Growth Substances|growth substances|mesh-ancestor
92046049|NCT01627249|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046050|NCT01627249|Growth Inhibitors|growth inhibitors|mesh-ancestor
92046052|NCT01688830|Antithrombins|antithrombins|mesh-ancestor
92046053|NCT01688830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92046054|NCT01688830|Protease Inhibitors|protease inhibitors|mesh-ancestor
92046055|NCT01688830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046056|NCT01688830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046057|NCT01688830|Anticoagulants|anticoagulants|mesh-ancestor
92046058|NCT01604278|Glycopyrrolate|glycopyrrolate|mesh-list
92046059|NCT01604278|Bromides|bromides|mesh-list
92046060|NCT01604278|Anticonvulsants|anticonvulsants|mesh-ancestor
92046061|NCT01604278|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92046062|NCT01604278|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92046063|NCT01604278|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92046064|NCT01604278|Cholinergic Agents|cholinergic agents|mesh-ancestor
92046065|NCT01604278|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046066|NCT01604278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046067|NCT01604278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046068|NCT01687270|Sofosbuvir|sofosbuvir|mesh-list
92046069|NCT01687270|Ribavirin|ribavirin|mesh-list
92046070|NCT01687270|Antiviral Agents|antiviral agents|mesh-ancestor
92046071|NCT01687270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046072|NCT01687270|Antimetabolites|antimetabolites|mesh-ancestor
92014501|NCT05214573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046073|NCT01687270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046074|NCT01588990|Leucovorin|leucovorin|mesh-list
92046075|NCT01588990|Bevacizumab|bevacizumab|mesh-list
92046076|NCT01588990|Capecitabine|capecitabine|mesh-list
92046077|NCT01588990|Oxaliplatin|oxaliplatin|mesh-list
92046078|NCT01588990|Irinotecan|irinotecan|mesh-list
92046079|NCT01588990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046080|NCT01588990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046081|NCT01588990|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92046082|NCT01588990|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92046083|NCT01588990|Growth Substances|growth substances|mesh-ancestor
92046084|NCT01588990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046085|NCT01588990|Growth Inhibitors|growth inhibitors|mesh-ancestor
92046086|NCT01588990|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92046087|NCT01588990|Antimetabolites|antimetabolites|mesh-ancestor
92046088|NCT01588990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046089|NCT01588990|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92046090|NCT01588990|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92046091|NCT01588990|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046092|NCT01588990|Antidotes|antidotes|mesh-ancestor
92046093|NCT01588990|Protective Agents|protective agents|mesh-ancestor
92046094|NCT01588990|Vitamin B Complex|vitamin b complex|mesh-ancestor
92046095|NCT01588990|Vitamins|vitamins|mesh-ancestor
92046096|NCT01588990|Micronutrients|micronutrients|mesh-ancestor
92046097|NCT02126839|Albuterol|albuterol|mesh-list
92046098|NCT02126839|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92046099|NCT02126839|Autonomic Agents|autonomic agents|mesh-ancestor
92046100|NCT02126839|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046101|NCT02126839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046104|NCT02126839|Tocolytic Agents|tocolytic agents|mesh-ancestor
92046105|NCT02126839|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92046106|NCT02126839|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92046107|NCT02126839|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92046108|NCT02126839|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92046109|NCT02126839|Adrenergic Agents|adrenergic agents|mesh-ancestor
92046110|NCT02126839|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046111|NCT02126839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046112|NCT04747795|Ascorbic Acid|ascorbic acid|mesh-list
92046113|NCT04747795|Vitamins|vitamins|mesh-ancestor
92046114|NCT04747795|Micronutrients|micronutrients|mesh-ancestor
92046115|NCT04747795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046116|NCT04747795|Antioxidants|antioxidants|mesh-ancestor
92046117|NCT04747795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046118|NCT04747795|Protective Agents|protective agents|mesh-ancestor
92046119|NCT02125279|Calcitriol|calcitriol|mesh-list
92046120|NCT02125279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92046121|NCT02125279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046122|NCT02125279|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92046123|NCT02125279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046124|NCT02125279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046125|NCT02125279|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92046126|NCT02125279|Vitamins|vitamins|mesh-ancestor
92046127|NCT02125279|Micronutrients|micronutrients|mesh-ancestor
92046128|NCT02125279|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046129|NCT02124811|Minocycline|minocycline|mesh-list
92046130|NCT02124811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92046131|NCT02124811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046132|NCT02148445|Nicotine|nicotine|mesh-list
92046133|NCT02148445|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92046134|NCT02148445|Autonomic Agents|autonomic agents|mesh-ancestor
92046135|NCT02148445|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046136|NCT02148445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046137|NCT02148445|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92046138|NCT02148445|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92046139|NCT02148445|Cholinergic Agents|cholinergic agents|mesh-ancestor
92046140|NCT02148445|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046141|NCT02148445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046142|NCT02147587|Tofacitinib|tofacitinib|mesh-list
92046143|NCT02147587|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92046144|NCT02147587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92046145|NCT02147587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014502|NCT05214573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014504|NCT05214573|Protease Inhibitors|protease inhibitors|mesh-ancestor
92014505|NCT05214573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014506|NCT05214573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046146|NCT02147587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046147|NCT02147197|Ulipristal acetate|ulipristal acetate|mesh-list
92046148|NCT02147197|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92046149|NCT02147197|Contraceptive Agents|contraceptive agents|mesh-ancestor
92046150|NCT02147197|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92046151|NCT02147197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046152|NCT02147197|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92046153|NCT04751929|Atezolizumab|atezolizumab|mesh-list
92046154|NCT04751929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92046155|NCT04751929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046156|NCT04751929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046157|NCT04751929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046158|NCT02176291|Buprenorphine|buprenorphine|mesh-list
92046159|NCT02176291|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046160|NCT02176291|Narcotics|narcotics|mesh-ancestor
92046161|NCT02176291|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046162|NCT02176291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046163|NCT02176291|Analgesics|analgesics|mesh-ancestor
92046164|NCT02176291|Sensory System Agents|sensory system agents|mesh-ancestor
92046165|NCT02176291|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046166|NCT02176291|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92046167|NCT02175745|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92046168|NCT02175745|Dopamine Agents|dopamine agents|mesh-ancestor
92046169|NCT02175745|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046170|NCT02175745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046171|NCT02175745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046172|NCT02175277|Darbepoetin alfa|darbepoetin alfa|mesh-list
92046173|NCT02175277|Hematinics|hematinics|mesh-ancestor
92046176|NCT01568866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046177|NCT01568866|Antiemetics|antiemetics|mesh-ancestor
92046178|NCT01568866|Autonomic Agents|autonomic agents|mesh-ancestor
92046179|NCT01568866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046180|NCT01568866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046181|NCT01568866|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92046182|NCT01568866|Glucocorticoids|glucocorticoids|mesh-ancestor
92046183|NCT01568866|Hormones|hormones|mesh-ancestor
92046184|NCT01568866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046185|NCT01568866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92046186|NCT01568866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046187|NCT01567852|Ketamine|ketamine|mesh-list
92046188|NCT01567852|Methohexital|methohexital|mesh-list
92046189|NCT01567852|Analgesics|analgesics|mesh-ancestor
92046190|NCT01567852|Sensory System Agents|sensory system agents|mesh-ancestor
92046191|NCT01567852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046192|NCT01567852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046193|NCT01567852|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92046194|NCT01567852|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92046195|NCT01567852|Anesthetics, General|anesthetics, general|mesh-ancestor
92046196|NCT01567852|Anesthetics|anesthetics|mesh-ancestor
92046197|NCT01567852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046198|NCT01567852|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92046199|NCT01567852|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92046200|NCT01567852|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046201|NCT01567852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046203|NCT01587274|Naproxen|naproxen|mesh-list
92046204|NCT01587274|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92046205|NCT01587274|Oxycodone|oxycodone|mesh-list
92046206|NCT01587274|Cyclobenzaprine|cyclobenzaprine|mesh-list
92046207|NCT01587274|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92046208|NCT01587274|Analgesics|analgesics|mesh-ancestor
92046209|NCT01587274|Sensory System Agents|sensory system agents|mesh-ancestor
92046210|NCT01587274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046211|NCT01587274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046212|NCT01587274|Antipyretics|antipyretics|mesh-ancestor
92014508|NCT04988191|Bevacizumab|bevacizumab|mesh-list
92014509|NCT04988191|Irinotecan|irinotecan|mesh-list
92014510|NCT04988191|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014511|NCT04988191|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014512|NCT04988191|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92014513|NCT04988191|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92014514|NCT04988191|Growth Substances|growth substances|mesh-ancestor
92014515|NCT04988191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014516|NCT04988191|Growth Inhibitors|growth inhibitors|mesh-ancestor
92014517|NCT04988191|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92014518|NCT04988191|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92014519|NCT04988191|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014520|NCT04988191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014522|NCT03069001|Sofosbuvir|sofosbuvir|mesh-list
92014523|NCT03069001|Simeprevir|simeprevir|mesh-list
92014524|NCT03069001|Antimetabolites|antimetabolites|mesh-ancestor
92014525|NCT03069001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046213|NCT01587274|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046214|NCT01587274|Narcotics|narcotics|mesh-ancestor
92046215|NCT01587274|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046216|NCT01587274|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92046217|NCT01587274|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046218|NCT01587274|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92046219|NCT01587274|Gout Suppressants|gout suppressants|mesh-ancestor
92046220|NCT01587274|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92046221|NCT01587274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046222|NCT01587274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046223|NCT01587274|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92046224|NCT01587274|Antidepressive Agents|antidepressive agents|mesh-ancestor
92046225|NCT01587274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92046226|NCT01587274|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92046227|NCT01587274|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92046228|NCT01587274|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92046229|NCT01587118|Asenapine|asenapine|mesh-list
92046230|NCT01587118|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92046231|NCT01587118|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92046232|NCT01587118|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046233|NCT01587118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046234|NCT01587118|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92046235|NCT01905657|Docetaxel|docetaxel|mesh-list
92046236|NCT01905657|Pembrolizumab|pembrolizumab|mesh-list
92046237|NCT01905657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046238|NCT01905657|Tubulin Modulators|tubulin modulators|mesh-ancestor
92046239|NCT01905657|Antimitotic Agents|antimitotic agents|mesh-ancestor
92046240|NCT01905657|Mitosis Modulators|mitosis modulators|mesh-ancestor
92046241|NCT01905657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046242|NCT01905657|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046243|NCT01905657|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92046244|NCT02202980|Sofosbuvir|sofosbuvir|mesh-list
92046245|NCT02202980|Antiviral Agents|antiviral agents|mesh-ancestor
92046246|NCT02202980|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046247|NCT01952145|Insulin|insulin|mesh-list
92046248|NCT01952145|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92014526|NCT03069001|Antiviral Agents|antiviral agents|mesh-ancestor
92014527|NCT03069001|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014528|NCT03069001|Protease Inhibitors|protease inhibitors|mesh-ancestor
92014529|NCT03069001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014530|NCT03070405|Tenofovir|tenofovir|mesh-list
92014531|NCT03070405|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92014532|NCT03070405|Antiviral Agents|antiviral agents|mesh-ancestor
92014533|NCT03070405|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046249|NCT01952145|Insulin Glargine|insulin glargine|mesh-list
92046255|NCT01952145|Hormones|hormones|mesh-ancestor
92046256|NCT01952145|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046257|NCT01923363|Tazobactam|tazobactam|mesh-list
92046258|NCT01923363|Piperacillin|piperacillin|mesh-list
92046259|NCT01923363|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92046260|NCT01923363|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92046261|NCT01923363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046262|NCT01923363|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92046263|NCT01923363|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046264|NCT01923363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046265|NCT01904721|Bimatoprost|bimatoprost|mesh-list
92046266|NCT01904721|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92046267|NCT01904721|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92046268|NCT01922739|Hydrocodone|hydrocodone|mesh-list
92046269|NCT01922739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046270|NCT01922739|Narcotics|narcotics|mesh-ancestor
92046271|NCT01922739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046272|NCT01922739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046273|NCT01922739|Analgesics|analgesics|mesh-ancestor
92046274|NCT01922739|Sensory System Agents|sensory system agents|mesh-ancestor
92046275|NCT01922739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046276|NCT01922739|Antitussive Agents|antitussive agents|mesh-ancestor
92046277|NCT01922739|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046278|NCT02236988|Thalidomide|thalidomide|mesh-list
92046280|NCT02236988|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92046281|NCT02236988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92046282|NCT02236988|Analgesics|analgesics|mesh-ancestor
92046283|NCT02236988|Sensory System Agents|sensory system agents|mesh-ancestor
92046284|NCT02236988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046285|NCT02236988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046286|NCT02236988|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046287|NCT02236988|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92046288|NCT02236988|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92046289|NCT02236988|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92046290|NCT02236988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046291|NCT02236988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046292|NCT02236988|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92046293|NCT02236988|Immunologic Factors|immunologic factors|mesh-ancestor
92046294|NCT02236988|Leprostatic Agents|leprostatic agents|mesh-ancestor
92046295|NCT02236988|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92046296|NCT02236988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046297|NCT02236988|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92046298|NCT02236988|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92046299|NCT02236988|Growth Substances|growth substances|mesh-ancestor
92046300|NCT02236988|Growth Inhibitors|growth inhibitors|mesh-ancestor
92046301|NCT02236988|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046302|NCT02236520|Chlorthalidone|chlorthalidone|mesh-list
92046303|NCT02236520|Spironolactone|spironolactone|mesh-list
92046304|NCT02236520|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92046305|NCT02236520|Hormone Antagonists|hormone antagonists|mesh-ancestor
92046306|NCT02236520|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046307|NCT02236520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046308|NCT02236520|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92046309|NCT02236520|Diuretics|diuretics|mesh-ancestor
92046310|NCT02236520|Natriuretic Agents|natriuretic agents|mesh-ancestor
92046311|NCT02236520|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92046312|NCT02236520|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92046313|NCT02236520|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046314|NCT02236520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046316|NCT04769414|Fluorouracil|fluorouracil|mesh-list
92046317|NCT04769414|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92046318|NCT04769414|Antimetabolites|antimetabolites|mesh-ancestor
92046319|NCT04769414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046320|NCT04769414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046322|NCT04769414|Immunologic Factors|immunologic factors|mesh-ancestor
92046323|NCT04769414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046326|NCT01922271|Tiotropium Bromide|tiotropium bromide|mesh-list
92046327|NCT01922271|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92046328|NCT01922271|Autonomic Agents|autonomic agents|mesh-ancestor
92046329|NCT01922271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046330|NCT01922271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046331|NCT01922271|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92046332|NCT01922271|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046333|NCT01922271|Parasympatholytics|parasympatholytics|mesh-ancestor
92046334|NCT01922271|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92046335|NCT01922271|Cholinergic Agents|cholinergic agents|mesh-ancestor
92046336|NCT01922271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046337|NCT01922271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046338|NCT01922271|Tocolytic Agents|tocolytic agents|mesh-ancestor
92046339|NCT01922271|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92046340|NCT01922271|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92046341|NCT01922271|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92046342|NCT01922271|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92046343|NCT01922271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92046344|NCT01922271|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92046345|NCT01922271|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92046346|NCT02236130|Acetaminophen|acetaminophen|mesh-list
92046347|NCT02236130|Morphine|morphine|mesh-list
92046349|NCT02236130|Analgesics|analgesics|mesh-list
92046350|NCT02236130|Anesthetics|anesthetics|mesh-list
92046351|NCT02236130|Ropivacaine|ropivacaine|mesh-list
92046352|NCT02236130|Anesthetics, Local|anesthetics, local|mesh-list
92046353|NCT02236130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046354|NCT02236130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046355|NCT02236130|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046356|NCT02236130|Narcotics|narcotics|mesh-ancestor
92046357|NCT02236130|Sensory System Agents|sensory system agents|mesh-ancestor
92046358|NCT02236130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046359|NCT02236130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92046360|NCT02236130|Antipyretics|antipyretics|mesh-ancestor
92046361|NCT02236130|Antitussive Agents|antitussive agents|mesh-ancestor
92046362|NCT02236130|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046363|NCT05153564|Ethinyl estradiol, levonorgestrel drug combination|ethinyl estradiol, levonorgestrel drug combination|mesh-list
92046364|NCT05153564|Ethinyl Estradiol-Norgestrel Combination|ethinyl estradiol-norgestrel combination|mesh-list
92046365|NCT05153564|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92046366|NCT05153564|Contraceptive Agents|contraceptive agents|mesh-ancestor
92046367|NCT05153564|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92046368|NCT05153564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046369|NCT05153564|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92046370|NCT05153564|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92046371|NCT05153564|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92046372|NCT05153564|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92046373|NCT05153564|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92046374|NCT05153564|Contraceptives, Postcoital, Hormonal|contraceptives, postcoital, hormonal|mesh-ancestor
92046375|NCT05153564|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92046376|NCT05153564|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92046377|NCT01641809|Tenofovir|tenofovir|mesh-list
92046378|NCT01641809|Lamivudine|lamivudine|mesh-list
92046379|NCT01641809|Emtricitabine|emtricitabine|mesh-list
92046380|NCT01641809|Efavirenz|efavirenz|mesh-list
92046381|NCT01641809|Abacavir|abacavir|mesh-list
92046382|NCT01641809|Rilpivirine|rilpivirine|mesh-list
92046383|NCT01641809|Cabotegravir|cabotegravir|mesh-list
92046384|NCT01641809|Antiviral Agents|antiviral agents|mesh-ancestor
92046385|NCT01641809|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046386|NCT01641809|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92046387|NCT01641809|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92046388|NCT01641809|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046472|NCT02121847|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92046389|NCT01641809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014534|NCT03070405|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92014535|NCT03070405|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92014536|NCT03070405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014537|NCT03070405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046390|NCT01641809|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92046391|NCT01641809|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92046392|NCT01641809|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92046393|NCT01641809|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92046394|NCT01641809|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92046407|NCT01632566|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92046408|NCT01632566|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92046409|NCT01632566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046410|NCT01632566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92046411|NCT01632566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92046412|NCT01632566|Analgesics|analgesics|mesh-ancestor
92046413|NCT01632566|Sensory System Agents|sensory system agents|mesh-ancestor
92046414|NCT01632566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046415|NCT01632566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046416|NCT01632566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046417|NCT01632566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92046418|NCT01632566|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92046419|NCT01632566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92046420|NCT01632566|Prostaglandin Antagonists|prostaglandin antagonists|mesh-ancestor
92046421|NCT01632566|Hormone Antagonists|hormone antagonists|mesh-ancestor
92046422|NCT01632566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046423|NCT02254304|Interferons|interferons|mesh-list
92046424|NCT02254304|Interferon-beta|interferon-beta|mesh-list
92046425|NCT02254304|Interferon beta-1a|interferon beta-1a|mesh-list
92046426|NCT02254304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046427|NCT02254304|Antiviral Agents|antiviral agents|mesh-ancestor
92046428|NCT02254304|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046429|NCT02254304|Immunologic Factors|immunologic factors|mesh-ancestor
92046430|NCT02254304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046431|NCT02254304|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92046433|NCT05650151|Vitamins|vitamins|mesh-ancestor
92046434|NCT05650151|Micronutrients|micronutrients|mesh-ancestor
92046435|NCT05650151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046436|NCT05650151|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046437|NCT02174731|Epoetin Alfa|epoetin alfa|mesh-list
92046438|NCT02174731|Hematinics|hematinics|mesh-ancestor
92046439|NCT01922037|Omalizumab|omalizumab|mesh-list
92046440|NCT01922037|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92046441|NCT01922037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92046442|NCT01922037|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046443|NCT02282813|Calcitriol|calcitriol|mesh-list
92046444|NCT02282813|Calcifediol|calcifediol|mesh-list
92046445|NCT02282813|1 alpha-hydroxyergocalciferol|1 alpha-hydroxyergocalciferol|mesh-list
92046446|NCT02282813|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92046447|NCT02282813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046448|NCT02282813|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92046449|NCT02282813|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046450|NCT02282813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046451|NCT02282813|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92046452|NCT02282813|Vitamins|vitamins|mesh-ancestor
92046453|NCT02282813|Micronutrients|micronutrients|mesh-ancestor
92046454|NCT02282813|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046455|NCT04878029|Immunoconjugates|immunoconjugates|mesh-list
92046456|NCT04878029|Immunologic Factors|immunologic factors|mesh-ancestor
92046457|NCT04878029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046460|NCT05638529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046462|NCT04859465|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92046463|NCT04859465|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92046464|NCT04859465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92046465|NCT04859465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046466|NCT04859465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92046467|NCT04859465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92046468|NCT04859465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014538|NCT03070405|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92014539|NCT03070405|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92046469|NCT04859465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046470|NCT02121847|Cyclosporine|cyclosporine|mesh-list
92046471|NCT02121847|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92046473|NCT02121847|Lubricant Eye Drops|lubricant eye drops|mesh-list
92046474|NCT02121847|Cyclosporins|cyclosporins|mesh-list
92046475|NCT02121847|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046476|NCT02121847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046477|NCT02121847|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92046478|NCT02121847|Immunologic Factors|immunologic factors|mesh-ancestor
92046479|NCT02121847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046480|NCT02121847|Antifungal Agents|antifungal agents|mesh-ancestor
92046481|NCT02121847|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046482|NCT02121847|Dermatologic Agents|dermatologic agents|mesh-ancestor
92046483|NCT02121847|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92046484|NCT02121847|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92046485|NCT02121847|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92046486|NCT02121847|Laxatives|laxatives|mesh-ancestor
92046487|NCT02121847|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92046488|NCT01586806|Dexamethasone|dexamethasone|mesh-list
92046489|NCT01586806|Dexamethasone acetate|dexamethasone acetate|mesh-list
92046490|NCT01586806|Bupivacaine|bupivacaine|mesh-list
92046491|NCT01586806|BB 1101|bb 1101|mesh-list
92046492|NCT01586806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046493|NCT01586806|Antiemetics|antiemetics|mesh-ancestor
92046494|NCT01586806|Autonomic Agents|autonomic agents|mesh-ancestor
92046495|NCT01586806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046496|NCT01586806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046497|NCT01586806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92046498|NCT01586806|Glucocorticoids|glucocorticoids|mesh-ancestor
92046499|NCT01586806|Hormones|hormones|mesh-ancestor
92046500|NCT01586806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046501|NCT01586806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92046502|NCT01586806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046503|NCT01586806|Protease Inhibitors|protease inhibitors|mesh-ancestor
92046504|NCT01586806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046505|NCT01586806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046506|NCT01586806|Anesthetics, Local|anesthetics, local|mesh-ancestor
92046507|NCT01586806|Anesthetics|anesthetics|mesh-ancestor
92046508|NCT01586806|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046509|NCT01586806|Sensory System Agents|sensory system agents|mesh-ancestor
92046510|NCT05631041|Silymarin|silymarin|mesh-list
92046511|NCT05631041|Antioxidants|antioxidants|mesh-ancestor
92046512|NCT05631041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046513|NCT05631041|Protective Agents|protective agents|mesh-ancestor
92046514|NCT05631041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046515|NCT02144077|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92046516|NCT02144077|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92046517|NCT02144077|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92046518|NCT02144077|Dermatologic Agents|dermatologic agents|mesh-ancestor
92046519|NCT05544071|Sertraline|sertraline|mesh-list
92046520|NCT05544071|Antidepressive Agents|antidepressive agents|mesh-ancestor
92046521|NCT05544071|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92046522|NCT05544071|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92046523|NCT05544071|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92046524|NCT05544071|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046525|NCT05544071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046526|NCT05544071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046527|NCT05544071|Serotonin Agents|serotonin agents|mesh-ancestor
92046528|NCT05544071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046529|NCT02143843|Bimatoprost|bimatoprost|mesh-list
92046538|NCT05598905|Anticonvulsants|anticonvulsants|mesh-ancestor
92046539|NCT05598905|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92046540|NCT05598905|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046541|NCT05598905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046542|NCT05598905|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92046543|NCT05598905|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92046544|NCT05598905|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92046545|NCT05598905|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046546|NCT05598905|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014540|NCT03070405|Antitubercular Agents|antitubercular agents|mesh-ancestor
92014541|NCT03070405|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92014542|NCT03068065|Metformin|metformin|mesh-list
92046547|NCT05598905|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046548|NCT05598905|Narcotics|narcotics|mesh-ancestor
92046549|NCT05598905|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92046550|NCT05598905|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92046551|NCT01586338|Hylan|hylan|mesh-list
92046552|NCT01586338|Viscosupplements|viscosupplements|mesh-ancestor
92046553|NCT01586338|Protective Agents|protective agents|mesh-ancestor
92046554|NCT01586338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046555|NCT02143141|Morphine|morphine|mesh-list
92046556|NCT02143141|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046557|NCT02143141|Narcotics|narcotics|mesh-ancestor
92046558|NCT02143141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046559|NCT02143141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046560|NCT02143141|Analgesics|analgesics|mesh-ancestor
92046561|NCT02143141|Sensory System Agents|sensory system agents|mesh-ancestor
92046562|NCT02143141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046563|NCT01566604|Glycopyrrolate|glycopyrrolate|mesh-list
92046564|NCT01566604|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92046565|NCT01566604|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92046566|NCT01566604|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92046567|NCT01566604|Cholinergic Agents|cholinergic agents|mesh-ancestor
92046568|NCT01566604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046569|NCT01566604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046570|NCT01566604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046572|NCT05497583|Coagulants|coagulants|mesh-ancestor
92046573|NCT02253992|Nivolumab|nivolumab|mesh-list
92046574|NCT02253992|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046575|NCT02253992|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046576|NCT02253992|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92046577|NCT02253992|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046579|NCT02252588|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92046580|NCT02252588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046581|NCT02252588|Disinfectants|disinfectants|mesh-ancestor
92046582|NCT01585558|Tamoxifen|tamoxifen|mesh-list
92046583|NCT01585558|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92046584|NCT01585558|Hormone Antagonists|hormone antagonists|mesh-ancestor
92046585|NCT01585558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046586|NCT01585558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046587|NCT01585558|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92046588|NCT01585558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046589|NCT01585558|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92046590|NCT01585558|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92046591|NCT01585558|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046592|NCT01585246|Saw palmetto extract|saw palmetto extract|mesh-list
92046593|NCT01585246|Urological Agents|urological agents|mesh-ancestor
92046594|NCT01585168|Memantine|memantine|mesh-list
92046595|NCT01585168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92046596|NCT01585168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92046597|NCT01585168|Dopamine Agents|dopamine agents|mesh-ancestor
92046598|NCT01585168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046600|NCT01585168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046601|NCT01585168|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92046602|NCT01585168|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92046603|NCT02231918|Pramipexole|pramipexole|mesh-list
92046604|NCT02231918|Antioxidants|antioxidants|mesh-ancestor
92046605|NCT02231918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046606|NCT02231918|Protective Agents|protective agents|mesh-ancestor
92046607|NCT02231918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046608|NCT02231918|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92046609|NCT02231918|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92046610|NCT02231918|Dopamine Agonists|dopamine agonists|mesh-ancestor
92046611|NCT02231918|Dopamine Agents|dopamine agents|mesh-ancestor
92046612|NCT02231918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046613|NCT02199314|Desflurane|desflurane|mesh-list
92046614|NCT02199314|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92046615|NCT02199314|Anesthetics, General|anesthetics, general|mesh-ancestor
92046616|NCT02199314|Anesthetics|anesthetics|mesh-ancestor
92046617|NCT02199314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046618|NCT02199314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014543|NCT03068065|Liraglutide|liraglutide|mesh-list
92014544|NCT03068065|Gliclazide|gliclazide|mesh-list
92014545|NCT03068065|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014546|NCT03068065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046619|NCT02199080|Fibrin fragment D|fibrin fragment d|mesh-list
92046620|NCT02199080|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92046621|NCT02199080|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92046622|NCT02199080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046623|NCT02199080|Hemostatics|hemostatics|mesh-ancestor
92046624|NCT02199080|Coagulants|coagulants|mesh-ancestor
92046625|NCT02197520|Insulin|insulin|mesh-list
92046626|NCT02197520|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92046627|NCT02197520|Insulin Glargine|insulin glargine|mesh-list
92046628|NCT02197520|Insulin Lispro|insulin lispro|mesh-list
92046629|NCT02197520|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046630|NCT02197520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046631|NCT02230904|Rotigotine|rotigotine|mesh-list
92046632|NCT02230904|Dopamine Agonists|dopamine agonists|mesh-ancestor
92046633|NCT02230904|Dopamine Agents|dopamine agents|mesh-ancestor
92046634|NCT02230904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046635|NCT02230904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046636|NCT02230904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046637|NCT02196506|Brexpiprazole|brexpiprazole|mesh-list
92046638|NCT02196506|Serotonin Agents|serotonin agents|mesh-ancestor
92046639|NCT02196506|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046640|NCT02196506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046641|NCT02196506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046642|NCT02196506|Dopamine Agonists|dopamine agonists|mesh-ancestor
92046643|NCT02196506|Dopamine Agents|dopamine agents|mesh-ancestor
92046644|NCT02228720|Mometasone Furoate|mometasone furoate|mesh-list
92046645|NCT02228720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046646|NCT02228720|Dermatologic Agents|dermatologic agents|mesh-ancestor
92046647|NCT02228720|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92046648|NCT01640951|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92046649|NCT01640951|Immunologic Factors|immunologic factors|mesh-ancestor
92046650|NCT01640951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046652|NCT02228096|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046653|NCT02228096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046654|NCT01683994|Prednisone|prednisone|mesh-list
92046655|NCT01683994|Docetaxel|docetaxel|mesh-list
92046656|NCT01683994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046657|NCT01683994|Tubulin Modulators|tubulin modulators|mesh-ancestor
92046658|NCT01683994|Antimitotic Agents|antimitotic agents|mesh-ancestor
92046659|NCT01683994|Mitosis Modulators|mitosis modulators|mesh-ancestor
92046660|NCT01683994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046661|NCT01683994|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92046662|NCT01683994|Glucocorticoids|glucocorticoids|mesh-ancestor
92046663|NCT01683994|Hormones|hormones|mesh-ancestor
92046664|NCT01683994|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046665|NCT01683994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046666|NCT01683994|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92046667|NCT02247440|Interferons|interferons|mesh-list
92046668|NCT02247440|Ribavirin|ribavirin|mesh-list
92046669|NCT02247440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046670|NCT02247440|Antiviral Agents|antiviral agents|mesh-ancestor
92046671|NCT02247440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046672|NCT02247440|Antimetabolites|antimetabolites|mesh-ancestor
92046673|NCT02247440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046674|NCT04844099|Piperaquine|piperaquine|mesh-list
92046679|NCT04844099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046681|NCT04857203|Vitamins|vitamins|mesh-ancestor
92046682|NCT04857203|Micronutrients|micronutrients|mesh-ancestor
92046683|NCT04857203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046684|NCT04857203|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046685|NCT05381597|Fluorouracil|fluorouracil|mesh-list
92046686|NCT05381597|Calcipotriene|calcipotriene|mesh-list
92046687|NCT05381597|Antimetabolites|antimetabolites|mesh-ancestor
92046688|NCT05381597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046689|NCT05381597|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92046690|NCT05381597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046691|NCT05381597|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92046692|NCT05381597|Immunologic Factors|immunologic factors|mesh-ancestor
92046693|NCT05381597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014547|NCT03068065|Incretins|incretins|mesh-ancestor
92014548|NCT03068065|Hormones|hormones|mesh-ancestor
92046694|NCT05381597|Dermatologic Agents|dermatologic agents|mesh-ancestor
92046695|NCT01683838|4-Aminopyridine|4-aminopyridine|mesh-list
92046696|NCT01683838|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92046697|NCT01683838|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046698|NCT01683838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046699|NCT05417165|Vaccines|vaccines|mesh-list
92046700|NCT05417165|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92046701|NCT05417165|Immunologic Factors|immunologic factors|mesh-ancestor
92046702|NCT05417165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046703|NCT04660643|Tirzepatide|tirzepatide|mesh-list
92046704|NCT04660643|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046705|NCT04660643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046706|NCT04660643|Incretins|incretins|mesh-ancestor
92046707|NCT04660643|Hormones|hormones|mesh-ancestor
92046708|NCT04660643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046709|NCT04659317|Oxycodone|oxycodone|mesh-list
92046710|NCT04659317|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92046711|NCT04659317|Narcotics|narcotics|mesh-ancestor
92046712|NCT04659317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046713|NCT04659317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046714|NCT04659317|Analgesics|analgesics|mesh-ancestor
92046715|NCT04659317|Sensory System Agents|sensory system agents|mesh-ancestor
92046716|NCT04659317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046717|NCT03602261|Calcifediol|calcifediol|mesh-list
92046718|NCT03602261|Vitamins|vitamins|mesh-ancestor
92046719|NCT03602261|Micronutrients|micronutrients|mesh-ancestor
92046720|NCT03602261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046721|NCT03602261|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046722|NCT02141659|Relugolix|relugolix|mesh-list
92046723|NCT02141659|Androgen Antagonists|androgen antagonists|mesh-ancestor
92046724|NCT02141659|Hormone Antagonists|hormone antagonists|mesh-ancestor
92046725|NCT02141659|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046726|NCT02141659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046727|NCT02121301|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92046728|NCT02121301|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92046729|NCT05422703|Analgesics|analgesics|mesh-list
92046730|NCT05422703|Sensory System Agents|sensory system agents|mesh-ancestor
92046731|NCT05422703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046732|NCT05422703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046733|NCT02227862|Insulin Glargine|insulin glargine|mesh-list
92046734|NCT02227862|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046735|NCT02227862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046736|NCT02120833|Decanoic acid|decanoic acid|mesh-list
92046737|NCT02120833|Antifungal Agents|antifungal agents|mesh-ancestor
92046738|NCT02120833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046739|NCT04615949|Cannabidiol|cannabidiol|mesh-list
92046740|NCT04615949|Anticonvulsants|anticonvulsants|mesh-ancestor
92046741|NCT02170207|Lansoprazole|lansoprazole|mesh-list
92046742|NCT02170207|Dexlansoprazole|dexlansoprazole|mesh-list
92046743|NCT02170207|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92046744|NCT02170207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92046745|NCT02170207|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92046746|NCT02170207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046747|NCT02170207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046760|NCT04577417|Adderall|adderall|mesh-list
92046761|NCT04577417|Dexmethylphenidate Hydrochloride|dexmethylphenidate hydrochloride|mesh-list
92046762|NCT04577417|Dextroamphetamine|dextroamphetamine|mesh-list
92046763|NCT04577417|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92046764|NCT04577417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046765|NCT04577417|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92046766|NCT04577417|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92046767|NCT04577417|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046768|NCT04577417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046769|NCT04577417|Dopamine Agents|dopamine agents|mesh-ancestor
92046770|NCT04577417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046771|NCT04577417|Sympathomimetics|sympathomimetics|mesh-ancestor
92046772|NCT04577417|Autonomic Agents|autonomic agents|mesh-ancestor
92046773|NCT04577417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046774|NCT04577417|Adrenergic Agents|adrenergic agents|mesh-ancestor
92046775|NCT04577417|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92046776|NCT01683058|Aripiprazole|aripiprazole|mesh-list
92046777|NCT01683058|Antidepressive Agents|antidepressive agents|mesh-ancestor
92046778|NCT01683058|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014549|NCT03068065|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014550|NCT05161611|Zinc Sulfate|zinc sulfate|mesh-list
92014551|NCT05161611|Astringents|astringents|mesh-ancestor
92046779|NCT01683058|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92046780|NCT01683058|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92046781|NCT01683058|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046782|NCT01683058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046783|NCT01683058|Dopamine Agonists|dopamine agonists|mesh-ancestor
92046784|NCT01683058|Dopamine Agents|dopamine agents|mesh-ancestor
92046785|NCT01683058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046786|NCT01683058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046787|NCT01683058|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92046788|NCT01683058|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92046789|NCT01683058|Serotonin Agents|serotonin agents|mesh-ancestor
92046790|NCT01683058|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92046791|NCT01683058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92046792|NCT01683058|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92046793|NCT01683058|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92046794|NCT02193776|Moxifloxacin|moxifloxacin|mesh-list
92046795|NCT02193776|Rifampin|rifampin|mesh-list
92046796|NCT02193776|Isoniazid|isoniazid|mesh-list
92046797|NCT02193776|Pyrazinamide|pyrazinamide|mesh-list
92046798|NCT02193776|Ethambutol|ethambutol|mesh-list
92046799|NCT02193776|Bedaquiline|bedaquiline|mesh-list
92046800|NCT02193776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92046801|NCT02193776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046802|NCT02193776|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92046803|NCT02193776|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92046804|NCT02193776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046805|NCT02193776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046806|NCT02193776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046807|NCT02193776|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92046808|NCT02193776|Antitubercular Agents|antitubercular agents|mesh-ancestor
92046809|NCT02193776|Leprostatic Agents|leprostatic agents|mesh-ancestor
92046833|NCT02170064|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92046834|NCT02170064|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92046835|NCT02170064|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046836|NCT02170064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046837|NCT05344625|Ketamine|ketamine|mesh-list
92046838|NCT05344625|Analgesics|analgesics|mesh-ancestor
92046839|NCT05344625|Sensory System Agents|sensory system agents|mesh-ancestor
92046840|NCT05344625|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046841|NCT05344625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046842|NCT05344625|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92046843|NCT05344625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92046844|NCT05344625|Anesthetics, General|anesthetics, general|mesh-ancestor
92046845|NCT05344625|Anesthetics|anesthetics|mesh-ancestor
92046846|NCT05344625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046847|NCT05344625|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92046848|NCT05344625|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92046849|NCT05344625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046850|NCT05344625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046851|NCT02169830|Topiramate|topiramate|mesh-list
92046852|NCT02169830|Nortriptyline|nortriptyline|mesh-list
92046853|NCT02169830|Anticonvulsants|anticonvulsants|mesh-ancestor
92046854|NCT02169830|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046855|NCT02169830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046856|NCT02169830|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92046857|NCT02169830|Antidepressive Agents|antidepressive agents|mesh-ancestor
92046861|NCT02169830|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92046862|NCT02169830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046863|NCT02169830|Adrenergic Agents|adrenergic agents|mesh-ancestor
92046864|NCT02169830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92046866|NCT04854551|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92046867|NCT04854551|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92046868|NCT04854551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046869|NCT04854551|Sensory System Agents|sensory system agents|mesh-ancestor
92046870|NCT04854551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046871|NCT04536467|Goserelin|goserelin|mesh-list
92014552|NCT05161611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014553|NCT05161611|Dermatologic Agents|dermatologic agents|mesh-ancestor
92014554|NCT03660475|Naltrexone|naltrexone|mesh-list
92014555|NCT03660475|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92046872|NCT04536467|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92046873|NCT04536467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046874|NCT05341349|Pembrolizumab|pembrolizumab|mesh-list
92046875|NCT05341349|Nivolumab|nivolumab|mesh-list
92046876|NCT05341349|Ipilimumab|ipilimumab|mesh-list
92046877|NCT05341349|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92046878|NCT05341349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046879|NCT05341349|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92046880|NCT05341349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046881|NCT04530149|Acetaminophen|acetaminophen|mesh-list
92046882|NCT04530149|Bupivacaine|bupivacaine|mesh-list
92046883|NCT04530149|Anesthetics, Local|anesthetics, local|mesh-ancestor
92046884|NCT04530149|Anesthetics|anesthetics|mesh-ancestor
92046885|NCT04530149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92046886|NCT04530149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046887|NCT04530149|Sensory System Agents|sensory system agents|mesh-ancestor
92046888|NCT04530149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046889|NCT04530149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92046890|NCT04530149|Analgesics|analgesics|mesh-ancestor
92046891|NCT04530149|Antipyretics|antipyretics|mesh-ancestor
92046892|NCT04525547|Nintedanib|nintedanib|mesh-list
92046893|NCT04525547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046894|NCT04525547|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92046895|NCT04525547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046896|NCT04525547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046897|NCT02169284|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92046898|NCT02169284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046899|NCT02169284|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92046900|NCT02169284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046901|NCT02169284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046902|NCT02119819|Metformin|metformin|mesh-list
92046903|NCT02119819|Exenatide|exenatide|mesh-list
92046904|NCT02119819|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046905|NCT02119819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046906|NCT02119819|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92046907|NCT02119819|Incretins|incretins|mesh-ancestor
92046908|NCT02119819|Hormones|hormones|mesh-ancestor
92046909|NCT02119819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046910|NCT04766450|Acetylcysteine|acetylcysteine|mesh-list
92046911|NCT04766450|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92046912|NCT04766450|Antiviral Agents|antiviral agents|mesh-ancestor
92046913|NCT04766450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046914|NCT04766450|Expectorants|expectorants|mesh-ancestor
92046915|NCT04766450|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046916|NCT04766450|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92046917|NCT04766450|Antioxidants|antioxidants|mesh-ancestor
92046918|NCT04766450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046919|NCT04766450|Protective Agents|protective agents|mesh-ancestor
92046920|NCT04766450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046921|NCT04766450|Antidotes|antidotes|mesh-ancestor
92046922|NCT02168816|Moxifloxacin|moxifloxacin|mesh-list
92046923|NCT02168816|Metronidazole|metronidazole|mesh-list
92046924|NCT02168816|Vancomycin|vancomycin|mesh-list
92046925|NCT02168816|Ciprofloxacin|ciprofloxacin|mesh-list
92046926|NCT02168816|Clindamycin|clindamycin|mesh-list
92046927|NCT02168816|Meropenem|meropenem|mesh-list
92046928|NCT02168816|Linezolid|linezolid|mesh-list
92046929|NCT02168816|Tazobactam|tazobactam|mesh-list
92046930|NCT02168816|Piperacillin|piperacillin|mesh-list
92046931|NCT02168816|Daptomycin|daptomycin|mesh-list
92046932|NCT02168816|Cefepime|cefepime|mesh-list
92046949|NCT02168816|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92046950|NCT02168816|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92046951|NCT02168816|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92046952|NCT02168816|Antimalarials|antimalarials|mesh-ancestor
92046953|NCT02168816|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92046954|NCT02168816|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92046955|NCT02168816|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92046956|NCT01584232|Insulin Glargine|insulin glargine|mesh-list
92046957|NCT01584232|Dulaglutide|dulaglutide|mesh-list
92014556|NCT03660475|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92014557|NCT03660475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046958|NCT01584232|Biguanides|biguanides|mesh-list
92046959|NCT01584232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046960|NCT01584232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046961|NCT02119663|Capecitabine|capecitabine|mesh-list
92046962|NCT02119663|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92046963|NCT02119663|Antimetabolites|antimetabolites|mesh-ancestor
92046964|NCT02119663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046965|NCT02119663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046966|NCT04481009|Paclitaxel|paclitaxel|mesh-list
92046967|NCT04481009|Gemcitabine|gemcitabine|mesh-list
92046968|NCT04481009|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92046969|NCT04481009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046970|NCT04481009|Tubulin Modulators|tubulin modulators|mesh-ancestor
92046971|NCT04481009|Antimitotic Agents|antimitotic agents|mesh-ancestor
92046972|NCT04481009|Mitosis Modulators|mitosis modulators|mesh-ancestor
92046973|NCT04481009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046974|NCT04481009|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92046975|NCT04481009|Antimetabolites|antimetabolites|mesh-ancestor
92046976|NCT05327231|Docetaxel|docetaxel|mesh-list
92046977|NCT05327231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046978|NCT05327231|Tubulin Modulators|tubulin modulators|mesh-ancestor
92046979|NCT05327231|Antimitotic Agents|antimitotic agents|mesh-ancestor
92046980|NCT05327231|Mitosis Modulators|mitosis modulators|mesh-ancestor
92046981|NCT05327231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046982|NCT04418102|Palmitic Acid|palmitic acid|mesh-list
92046983|NCT04418102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047086|NCT04791059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046984|NCT04418102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046985|NCT01628107|Epoetin Alfa|epoetin alfa|mesh-list
92046986|NCT01628107|Hematinics|hematinics|mesh-ancestor
92046987|NCT04745377|Antibodies|antibodies|mesh-list
92046988|NCT04745377|Immunologic Factors|immunologic factors|mesh-ancestor
92046992|NCT01583530|Immunologic Factors|immunologic factors|mesh-ancestor
92046993|NCT01583530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046994|NCT01639001|Carboplatin|carboplatin|mesh-list
92046995|NCT01639001|Pemetrexed|pemetrexed|mesh-list
92046996|NCT01639001|Crizotinib|crizotinib|mesh-list
92046997|NCT01639001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046998|NCT01639001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046999|NCT01639001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047000|NCT01639001|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92047001|NCT01639001|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92047002|NCT01639001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92047004|NCT02168270|Temozolomide|temozolomide|mesh-list
92047005|NCT02168270|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92047006|NCT02168270|Alkylating Agents|alkylating agents|mesh-ancestor
92047007|NCT02168270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047008|NCT02168270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047009|NCT02168270|Antioxidants|antioxidants|mesh-ancestor
92047010|NCT02168270|Protective Agents|protective agents|mesh-ancestor
92047011|NCT02168270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047012|NCT02168270|Vitamins|vitamins|mesh-ancestor
92047013|NCT02168270|Micronutrients|micronutrients|mesh-ancestor
92047014|NCT02167256|Saracatinib|saracatinib|mesh-list
92047015|NCT02167256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047016|NCT02167256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047017|NCT02167256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047018|NCT02166476|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92047019|NCT02166476|Levofloxacin|levofloxacin|mesh-list
92047020|NCT02166476|Meropenem|meropenem|mesh-list
92047021|NCT02166476|Tazobactam|tazobactam|mesh-list
92047022|NCT02166476|Piperacillin|piperacillin|mesh-list
92047023|NCT02166476|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92047024|NCT02166476|Vaborbactam|vaborbactam|mesh-list
92047025|NCT02166476|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92047026|NCT02166476|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047027|NCT02166476|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92047028|NCT02166476|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92047029|NCT02166476|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92047030|NCT02166476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047031|NCT02166476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014558|NCT03660475|Sensory System Agents|sensory system agents|mesh-ancestor
92014559|NCT03660475|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014561|NCT05211609|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92047032|NCT02166476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047033|NCT02166476|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92047034|NCT02166476|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92047035|NCT02224274|Clopidogrel|clopidogrel|mesh-list
92047036|NCT02224274|Ticagrelor|ticagrelor|mesh-list
92047037|NCT02224274|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92047038|NCT02224274|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92047039|NCT02224274|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92047040|NCT02224274|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92047041|NCT02224274|Purinergic Agents|purinergic agents|mesh-ancestor
92047042|NCT02224274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047043|NCT02224274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047044|NCT02224274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047045|NCT05219669|Nalmefene|nalmefene|mesh-list
92047046|NCT05219669|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92047047|NCT05219669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047048|NCT05219669|Sensory System Agents|sensory system agents|mesh-ancestor
92047049|NCT05219669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047050|NCT04837859|Tislelizumab|tislelizumab|mesh-list
92047051|NCT04837859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047052|NCT04837859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047053|NCT04763252|Coal Tar|coal tar|mesh-list
92047054|NCT04763252|Keratolytic Agents|keratolytic agents|mesh-ancestor
92047055|NCT04763252|Dermatologic Agents|dermatologic agents|mesh-ancestor
92047056|NCT05369039|Prednisolone|prednisolone|mesh-list
92047057|NCT05369039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047058|NCT05369039|Glucocorticoids|glucocorticoids|mesh-ancestor
92047059|NCT05369039|Hormones|hormones|mesh-ancestor
92047060|NCT05369039|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047088|NCT04791059|Analgesics|analgesics|mesh-ancestor
92047089|NCT04791059|Sensory System Agents|sensory system agents|mesh-ancestor
92047090|NCT04791059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047091|NCT04791059|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92047092|NCT04791059|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92047093|NCT04791059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92047094|NCT04791059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047095|NCT04791059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047096|NCT04791059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047097|NCT04791059|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92047098|NCT04791059|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92047099|NCT04791059|Anesthetics, General|anesthetics, general|mesh-ancestor
92047100|NCT04791059|Anesthetics|anesthetics|mesh-ancestor
92047101|NCT04791059|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92047102|NCT04791059|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92047103|NCT04791059|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047104|NCT04791059|Narcotics|narcotics|mesh-ancestor
92047105|NCT04791059|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92047106|NCT04791059|Antidepressive Agents|antidepressive agents|mesh-ancestor
92047107|NCT04791059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92047108|NCT05398913|Rimonabant|rimonabant|mesh-list
92047109|NCT05398913|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92047113|NCT05398913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047115|NCT05398913|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047116|NCT05398913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047117|NCT04260347|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92047118|NCT04260347|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92047119|NCT04260347|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92047120|NCT04260347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047121|NCT01583374|Thalidomide|thalidomide|mesh-list
92047122|NCT01583374|Apremilast|apremilast|mesh-list
92047123|NCT01583374|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92047124|NCT01583374|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047125|NCT01583374|Analgesics|analgesics|mesh-ancestor
92047126|NCT01583374|Sensory System Agents|sensory system agents|mesh-ancestor
92014562|NCT05211609|Sympatholytics|sympatholytics|mesh-ancestor
92014563|NCT05211609|Autonomic Agents|autonomic agents|mesh-ancestor
92014564|NCT05211609|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047127|NCT01583374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047128|NCT01583374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047129|NCT01583374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047130|NCT01583374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047131|NCT01583374|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92047132|NCT01583374|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92047133|NCT01583374|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047134|NCT01583374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047135|NCT01583374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047136|NCT01583374|Immunologic Factors|immunologic factors|mesh-ancestor
92047137|NCT01583374|Leprostatic Agents|leprostatic agents|mesh-ancestor
92047138|NCT01583374|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92047139|NCT01583374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047140|NCT01583374|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92047141|NCT01583374|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92047142|NCT01583374|Growth Substances|growth substances|mesh-ancestor
92047143|NCT01583374|Growth Inhibitors|growth inhibitors|mesh-ancestor
92047144|NCT01583374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047145|NCT04245215|Ustekinumab|ustekinumab|mesh-list
92047146|NCT04245215|Dermatologic Agents|dermatologic agents|mesh-ancestor
92047147|NCT05387759|Moxifloxacin|moxifloxacin|mesh-list
92047149|NCT05387759|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92047150|NCT05387759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047151|NCT05387759|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92047152|NCT05387759|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92047153|NCT05387759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047154|NCT05387759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047155|NCT05387759|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047156|NCT05387759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047157|NCT05387759|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92047158|NCT05387759|Sensory System Agents|sensory system agents|mesh-ancestor
92047159|NCT05387759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047160|NCT02222714|Protein C|protein c|mesh-list
92047161|NCT02222714|Anticoagulants|anticoagulants|mesh-ancestor
92047162|NCT02222714|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92047163|NCT02222714|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92047164|NCT02222714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047165|NCT04809311|Insulin|insulin|mesh-list
92047166|NCT04809311|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92047167|NCT04809311|Glucagon|glucagon|mesh-list
92047168|NCT04809311|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92047169|NCT04809311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92047170|NCT04809311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047171|NCT04809311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047172|NCT04809311|Hormones|hormones|mesh-ancestor
92047173|NCT04809311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047174|NCT04809311|Incretins|incretins|mesh-ancestor
92047175|NCT04145219|Immunomodulating Agents|immunomodulating agents|mesh-list
92047176|NCT04145219|Immunologic Factors|immunologic factors|mesh-ancestor
92047177|NCT04145219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047179|NCT03184571|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047180|NCT03184571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047182|NCT03184571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047183|NCT02164916|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92047184|NCT02164916|Cetuximab|cetuximab|mesh-list
92047185|NCT02164916|Irinotecan|irinotecan|mesh-list
92047186|NCT02164916|Camptothecin|camptothecin|mesh-list
92047187|NCT02164916|Vemurafenib|vemurafenib|mesh-list
92047188|NCT02164916|Antibodies|antibodies|mesh-list
92047189|NCT02164916|Immunoglobulins|immunoglobulins|mesh-list
92047190|NCT02164916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92047191|NCT02164916|Immunoglobulin G|immunoglobulin g|mesh-list
92047192|NCT02164916|Mitogens|mitogens|mesh-list
92047193|NCT02164916|Immunologic Factors|immunologic factors|mesh-ancestor
92047194|NCT02164916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047195|NCT02164916|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047196|NCT02164916|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92047197|NCT02164916|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92047198|NCT02164916|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014565|NCT05211609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014566|NCT05211609|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92047199|NCT02164916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047200|NCT02164916|Mitosis Modulators|mitosis modulators|mesh-ancestor
92047201|NCT02164916|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92047202|NCT02164916|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92047203|NCT04091867|Cetuximab|cetuximab|mesh-list
92047204|NCT04091867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047205|NCT04091867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047206|NCT04060277|Acetic Acid|acetic acid|mesh-list
92047207|NCT04060277|Letermovir|letermovir|mesh-list
92047208|NCT04060277|Vaccines|vaccines|mesh-list
92047209|NCT04060277|Immunologic Factors|immunologic factors|mesh-ancestor
92047210|NCT04060277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047211|NCT04060277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92047212|NCT04060277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047213|NCT04060277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047214|NCT04060277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047215|NCT04060277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047216|NCT04060277|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92047217|NCT04060277|Antiviral Agents|antiviral agents|mesh-ancestor
92047218|NCT05651789|Propranolol|propranolol|mesh-list
92047219|NCT05651789|Carvedilol|carvedilol|mesh-list
92047220|NCT05651789|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92047221|NCT05651789|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92047222|NCT05651789|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047223|NCT05651789|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047224|NCT05651789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047225|NCT05651789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047226|NCT05651789|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92047227|NCT05651789|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92047228|NCT05651789|Vasodilator Agents|vasodilator agents|mesh-ancestor
92047229|NCT05651789|Antioxidants|antioxidants|mesh-ancestor
92047230|NCT05651789|Protective Agents|protective agents|mesh-ancestor
92047231|NCT05651789|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92047232|NCT05651789|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047233|NCT05651789|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92047234|NCT05651789|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92047235|NCT05651789|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92047236|NCT02999477|Paclitaxel|paclitaxel|mesh-list
92047237|NCT02999477|Pembrolizumab|pembrolizumab|mesh-list
92047238|NCT02999477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92047239|NCT02999477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047240|NCT02999477|Tubulin Modulators|tubulin modulators|mesh-ancestor
92047241|NCT02999477|Antimitotic Agents|antimitotic agents|mesh-ancestor
92047242|NCT02999477|Mitosis Modulators|mitosis modulators|mesh-ancestor
92047243|NCT02999477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047244|NCT02999477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047245|NCT02999477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92047246|NCT02222558|Testosterone|testosterone|mesh-list
92047248|NCT02222558|Hormones|hormones|mesh-ancestor
92047249|NCT02222558|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047250|NCT02222558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047252|NCT02975999|Arginine Vasopressin|arginine vasopressin|mesh-list
92047253|NCT02975999|Hemostatics|hemostatics|mesh-ancestor
92047254|NCT02975999|Coagulants|coagulants|mesh-ancestor
92047255|NCT02975999|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92047257|NCT02975999|Natriuretic Agents|natriuretic agents|mesh-ancestor
92047258|NCT02975999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047260|NCT02188784|Trace Elements|trace elements|mesh-ancestor
92047261|NCT02188784|Micronutrients|micronutrients|mesh-ancestor
92047262|NCT02188784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047263|NCT02222246|Morphine|morphine|mesh-list
92047264|NCT02222246|Hydromorphone|hydromorphone|mesh-list
92047265|NCT02222246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047266|NCT02222246|Narcotics|narcotics|mesh-ancestor
92047267|NCT02222246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047268|NCT02222246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047269|NCT02222246|Analgesics|analgesics|mesh-ancestor
92047270|NCT02222246|Sensory System Agents|sensory system agents|mesh-ancestor
92047271|NCT02222246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014567|NCT05211609|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92014568|NCT05211609|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92014569|NCT05211609|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047272|NCT02188160|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92047273|NCT02188160|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92047274|NCT04013555|Acetylcysteine|acetylcysteine|mesh-list
92047275|NCT04013555|Tryptophan|tryptophan|mesh-list
92047276|NCT04013555|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92047277|NCT04013555|Antiviral Agents|antiviral agents|mesh-ancestor
92047278|NCT04013555|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047279|NCT04013555|Expectorants|expectorants|mesh-ancestor
92047280|NCT04013555|Respiratory System Agents|respiratory system agents|mesh-ancestor
92047281|NCT04013555|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92047282|NCT04013555|Antioxidants|antioxidants|mesh-ancestor
92047283|NCT04013555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047284|NCT04013555|Protective Agents|protective agents|mesh-ancestor
92047285|NCT04013555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047286|NCT04013555|Antidotes|antidotes|mesh-ancestor
92047287|NCT04013555|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92047288|NCT04013555|Antidepressive Agents|antidepressive agents|mesh-ancestor
92047289|NCT04013555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92047290|NCT02220998|Sofosbuvir|sofosbuvir|mesh-list
92047291|NCT02220998|Antiviral Agents|antiviral agents|mesh-ancestor
92047292|NCT02220998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047293|NCT02220920|Canagliflozin|canagliflozin|mesh-list
92047294|NCT02220920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92047295|NCT02220920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047296|NCT02220920|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92047297|NCT02220920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047298|NCT03966053|Trifluoperazine|trifluoperazine|mesh-list
92047299|NCT03966053|Antiemetics|antiemetics|mesh-ancestor
92047300|NCT03966053|Autonomic Agents|autonomic agents|mesh-ancestor
92047301|NCT03966053|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047302|NCT03966053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047303|NCT03966053|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047304|NCT03966053|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92047305|NCT03966053|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92047306|NCT03966053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047307|NCT03966053|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92047308|NCT03966053|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92047309|NCT03966053|Dopamine Agents|dopamine agents|mesh-ancestor
92047310|NCT03966053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047311|NCT03966053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047312|NCT03943901|Prednisone|prednisone|mesh-list
92047313|NCT03943901|Cyclophosphamide|cyclophosphamide|mesh-list
92047314|NCT03943901|Rituximab|rituximab|mesh-list
92047315|NCT03943901|Doxorubicin|doxorubicin|mesh-list
92047316|NCT03943901|Vincristine|vincristine|mesh-list
92047317|NCT03943901|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047318|NCT03943901|Immunologic Factors|immunologic factors|mesh-ancestor
92047319|NCT03943901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047320|NCT03943901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047321|NCT03943901|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92047322|NCT03943901|Alkylating Agents|alkylating agents|mesh-ancestor
92047323|NCT03943901|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047324|NCT03943901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047325|NCT03943901|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92047326|NCT03943901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047327|NCT03943901|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92047328|NCT03943901|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92047329|NCT03943901|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92047330|NCT03943901|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047333|NCT03943901|Hormones|hormones|mesh-ancestor
92047334|NCT03943901|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047335|NCT03943901|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92047336|NCT03943901|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92047337|NCT03943901|Tubulin Modulators|tubulin modulators|mesh-ancestor
92047338|NCT03943901|Antimitotic Agents|antimitotic agents|mesh-ancestor
92047339|NCT03943901|Mitosis Modulators|mitosis modulators|mesh-ancestor
92047340|NCT04790279|Amlodipine|amlodipine|mesh-list
92047341|NCT04790279|Nifedipine|nifedipine|mesh-list
92047342|NCT04790279|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92047344|NCT04790279|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047345|NCT04790279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047346|NCT04790279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92047347|NCT04790279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047349|NCT04790279|Tocolytic Agents|tocolytic agents|mesh-ancestor
92047350|NCT04790279|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92047351|NCT03877289|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92047352|NCT03877289|Oxybutynin|oxybutynin|mesh-list
92047353|NCT03877289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047354|NCT03877289|Parasympatholytics|parasympatholytics|mesh-ancestor
92047355|NCT03877289|Autonomic Agents|autonomic agents|mesh-ancestor
92047356|NCT03877289|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047357|NCT03877289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047358|NCT03877289|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92047359|NCT03877289|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92047360|NCT03877289|Cholinergic Agents|cholinergic agents|mesh-ancestor
92047361|NCT03877289|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047362|NCT03877289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047363|NCT03877289|Urological Agents|urological agents|mesh-ancestor
92047364|NCT05554679|Metformin|metformin|mesh-list
92047365|NCT05554679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92047366|NCT05554679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047367|NCT05494619|Immunoglobulins|immunoglobulins|mesh-list
92047368|NCT05494619|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92047369|NCT05494619|Antibodies|antibodies|mesh-list
92047370|NCT05494619|gamma-Globulins|gamma-globulins|mesh-list
92047371|NCT05494619|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92047372|NCT05494619|Immunologic Factors|immunologic factors|mesh-ancestor
92047373|NCT05494619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047374|NCT01583218|Enoxaparin|enoxaparin|mesh-list
92047375|NCT01583218|Betrixaban|betrixaban|mesh-list
92047376|NCT01583218|Anticoagulants|anticoagulants|mesh-ancestor
92047377|NCT01583218|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92047378|NCT01583218|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92047379|NCT01583218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047380|NCT01583218|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92047381|NCT01583218|Antithrombins|antithrombins|mesh-ancestor
92047382|NCT01583218|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92047383|NCT01583218|Protease Inhibitors|protease inhibitors|mesh-ancestor
92047384|NCT01583218|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047385|NCT01634555|Leucovorin|leucovorin|mesh-list
92047386|NCT01634555|Folic Acid|folic acid|mesh-list
92047387|NCT01634555|Fluorouracil|fluorouracil|mesh-list
92047388|NCT01634555|Irinotecan|irinotecan|mesh-list
92047389|NCT01634555|Ramucirumab|ramucirumab|mesh-list
92047390|NCT01634555|Levoleucovorin|levoleucovorin|mesh-list
92047391|NCT01634555|Antimetabolites|antimetabolites|mesh-ancestor
92047392|NCT01634555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047393|NCT01634555|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92047394|NCT01634555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047395|NCT01634555|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047396|NCT01634555|Immunologic Factors|immunologic factors|mesh-ancestor
92047397|NCT01634555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047398|NCT01634555|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92047399|NCT01634555|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92047400|NCT01634555|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047401|NCT01634555|Antidotes|antidotes|mesh-ancestor
92047402|NCT01634555|Protective Agents|protective agents|mesh-ancestor
92047403|NCT01634555|Vitamin B Complex|vitamin b complex|mesh-ancestor
92047404|NCT01634555|Vitamins|vitamins|mesh-ancestor
92047405|NCT01634555|Micronutrients|micronutrients|mesh-ancestor
92047406|NCT01634555|Hematinics|hematinics|mesh-ancestor
92047409|NCT05355155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047410|NCT05355155|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92047411|NCT05355155|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92047412|NCT05355155|Growth Substances|growth substances|mesh-ancestor
92047413|NCT05355155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047414|NCT05355155|Growth Inhibitors|growth inhibitors|mesh-ancestor
92047415|NCT01634243|Rotigotine|rotigotine|mesh-list
92047416|NCT01634243|Dopamine Agonists|dopamine agonists|mesh-ancestor
92047417|NCT01634243|Dopamine Agents|dopamine agents|mesh-ancestor
92047418|NCT01634243|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047419|NCT01634243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047420|NCT01634243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014570|NCT05211609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014571|NCT05211609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047421|NCT01542034|Deoxycholic Acid|deoxycholic acid|mesh-list
92047422|NCT01542034|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92047423|NCT01542034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047424|NCT04815083|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92047425|NCT04815083|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92047426|NCT04815083|Dermatologic Agents|dermatologic agents|mesh-ancestor
92047428|NCT04104646|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047429|NCT04104646|Narcotics|narcotics|mesh-ancestor
92047430|NCT04104646|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047431|NCT04104646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047432|NCT04104646|Analgesics|analgesics|mesh-ancestor
92047433|NCT04104646|Sensory System Agents|sensory system agents|mesh-ancestor
92047434|NCT04104646|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047435|NCT04814615|Daratumumab|daratumumab|mesh-list
92047436|NCT04814615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047437|NCT03800693|Leucovorin|leucovorin|mesh-list
92047438|NCT03800693|Fluorouracil|fluorouracil|mesh-list
92047439|NCT03800693|Oxaliplatin|oxaliplatin|mesh-list
92047440|NCT03800693|Antimetabolites|antimetabolites|mesh-ancestor
92047441|NCT03800693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047442|NCT03800693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92047443|NCT03800693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047444|NCT03800693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047445|NCT03800693|Immunologic Factors|immunologic factors|mesh-ancestor
92047446|NCT03800693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047447|NCT03800693|Antidotes|antidotes|mesh-ancestor
92047448|NCT03800693|Protective Agents|protective agents|mesh-ancestor
92047449|NCT03800693|Vitamin B Complex|vitamin b complex|mesh-ancestor
92047450|NCT03800693|Vitamins|vitamins|mesh-ancestor
92047451|NCT03800693|Micronutrients|micronutrients|mesh-ancestor
92047452|NCT04814537|Bupivacaine|bupivacaine|mesh-list
92047453|NCT04814537|Anesthetics, Local|anesthetics, local|mesh-ancestor
92047454|NCT04814537|Anesthetics|anesthetics|mesh-ancestor
92047455|NCT04814537|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047456|NCT04814537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047457|NCT04814537|Sensory System Agents|sensory system agents|mesh-ancestor
92047458|NCT04814537|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047459|NCT01582282|Psyllium|psyllium|mesh-list
92047460|NCT01582282|Calcium polycarbophil|calcium polycarbophil|mesh-list
92047461|NCT01582282|Cathartics|cathartics|mesh-ancestor
92047462|NCT01582282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047463|NCT01582282|Antidiarrheals|antidiarrheals|mesh-ancestor
92047465|NCT01599650|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92047466|NCT01599650|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92047467|NCT01599650|Growth Substances|growth substances|mesh-ancestor
92047468|NCT01599650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047469|NCT01599650|Growth Inhibitors|growth inhibitors|mesh-ancestor
92047470|NCT01599650|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047471|NCT03774875|Apremilast|apremilast|mesh-list
92047472|NCT03774875|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92047473|NCT03774875|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047474|NCT03774875|Analgesics|analgesics|mesh-ancestor
92047475|NCT03774875|Sensory System Agents|sensory system agents|mesh-ancestor
92047476|NCT03774875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047477|NCT03774875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047478|NCT03774875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047479|NCT03774875|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047480|NCT03774875|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92047481|NCT03774875|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92047482|NCT03774875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047499|NCT04755764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047500|NCT04755764|Vasodilator Agents|vasodilator agents|mesh-ancestor
92047501|NCT04755764|Tocolytic Agents|tocolytic agents|mesh-ancestor
92047502|NCT04755764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92047503|NCT04755764|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92047504|NCT04755764|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92047505|NCT04755764|Sympatholytics|sympatholytics|mesh-ancestor
92047506|NCT04755764|Autonomic Agents|autonomic agents|mesh-ancestor
92047507|NCT04755764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047508|NCT04755764|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92014572|NCT05615987|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92014574|NCT05615987|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92014575|NCT05615987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047509|NCT04755764|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92047510|NCT04755764|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92047511|NCT04755764|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047512|NCT04755764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047513|NCT04755764|Sympathomimetics|sympathomimetics|mesh-ancestor
92047514|NCT04755764|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92047515|NCT04755764|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92047516|NCT04113616|Cytarabine|cytarabine|mesh-list
92047517|NCT04113616|Decitabine|decitabine|mesh-list
92047518|NCT04113616|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92047519|NCT04113616|Antimetabolites|antimetabolites|mesh-ancestor
92047520|NCT04113616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047521|NCT04113616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047522|NCT04113616|Antiviral Agents|antiviral agents|mesh-ancestor
92047523|NCT04113616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047524|NCT04113616|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047525|NCT04113616|Immunologic Factors|immunologic factors|mesh-ancestor
92047526|NCT04113616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047527|NCT04113616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047528|NCT02161718|Olanzapine|olanzapine|mesh-list
92047529|NCT02161718|Antiemetics|antiemetics|mesh-ancestor
92047530|NCT02161718|Autonomic Agents|autonomic agents|mesh-ancestor
92047531|NCT02161718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047532|NCT02161718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047533|NCT02161718|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047534|NCT02161718|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92047535|NCT02161718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92047536|NCT02161718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047537|NCT02161718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92047538|NCT02161718|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92047539|NCT02161718|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92047540|NCT02161718|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047544|NCT02074631|Vitamin D|vitamin d|mesh-list
92047545|NCT02074631|Cholecalciferol|cholecalciferol|mesh-list
92047546|NCT02074631|Ergocalciferols|ergocalciferols|mesh-list
92047547|NCT02074631|Pamidronate|pamidronate|mesh-list
92047548|NCT02074631|Calcium|calcium|mesh-list
92047549|NCT02074631|Vitamins|vitamins|mesh-ancestor
92047550|NCT02074631|Micronutrients|micronutrients|mesh-ancestor
92047551|NCT02074631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047552|NCT02074631|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92047553|NCT02074631|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92047555|NCT04813991|Oxycodone|oxycodone|mesh-list
92047556|NCT04813991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92047557|NCT04813991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047558|NCT04813991|Analgesics|analgesics|mesh-ancestor
92047559|NCT04813991|Sensory System Agents|sensory system agents|mesh-ancestor
92047560|NCT04813991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047561|NCT04813991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047562|NCT04813991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047563|NCT04813991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047564|NCT04813991|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92047565|NCT04813991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047566|NCT04813991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047567|NCT04813991|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047568|NCT04813991|Narcotics|narcotics|mesh-ancestor
92047569|NCT04813991|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047570|NCT03624101|Ivacaftor|ivacaftor|mesh-list
92047571|NCT03624101|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92047572|NCT03624101|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047573|NCT03624101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047574|NCT02218736|Aticaprant|aticaprant|mesh-list
92047575|NCT02218736|Narcotic Antagonists|narcotic antagonists|mesh-list
92047576|NCT02218736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014576|NCT05615987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047577|NCT02218736|Sensory System Agents|sensory system agents|mesh-ancestor
92047578|NCT02218736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047580|NCT04801589|Dexmedetomidine|dexmedetomidine|mesh-list
92047581|NCT04801589|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92047582|NCT04801589|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047583|NCT04801589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047584|NCT04801589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047585|NCT04801589|Analgesics|analgesics|mesh-ancestor
92047586|NCT04801589|Sensory System Agents|sensory system agents|mesh-ancestor
92047587|NCT04801589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047588|NCT04801589|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92047589|NCT04801589|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92047590|NCT04801589|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92047591|NCT04801589|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047592|NCT04801589|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047593|NCT04801589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047594|NCT04801589|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92047595|NCT04801589|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92047596|NCT04801589|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92047597|NCT04801589|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92047598|NCT04801589|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92047599|NCT04801589|Anesthetics, General|anesthetics, general|mesh-ancestor
92047600|NCT04801589|Anesthetics|anesthetics|mesh-ancestor
92047601|NCT04801589|GABA Modulators|gaba modulators|mesh-ancestor
92047602|NCT04801589|GABA Agents|gaba agents|mesh-ancestor
92047603|NCT01580488|Calcitriol|calcitriol|mesh-list
92047604|NCT01580488|Calcipotriene|calcipotriene|mesh-list
92047605|NCT01580488|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92047606|NCT01580488|Dermatologic Agents|dermatologic agents|mesh-ancestor
92047607|NCT01580488|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92047608|NCT01580488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047609|NCT01580488|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92047610|NCT01580488|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047611|NCT01580488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047612|NCT01580488|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92047615|NCT01580488|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92047616|NCT01580020|Dexamethasone|dexamethasone|mesh-list
92047617|NCT01580020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047618|NCT01580020|Antiemetics|antiemetics|mesh-ancestor
92047619|NCT01580020|Autonomic Agents|autonomic agents|mesh-ancestor
92047620|NCT01580020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047621|NCT01580020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047622|NCT01580020|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047623|NCT01580020|Glucocorticoids|glucocorticoids|mesh-ancestor
92047625|NCT01580020|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047626|NCT01580020|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92047627|NCT01580020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047628|NCT01579318|Interleukin-12|interleukin-12|mesh-list
92047629|NCT01579318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92047630|NCT01579318|Immunologic Factors|immunologic factors|mesh-ancestor
92047631|NCT01579318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047632|NCT01579318|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92047633|NCT01579318|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92047634|NCT01579318|Growth Substances|growth substances|mesh-ancestor
92047635|NCT01579318|Growth Inhibitors|growth inhibitors|mesh-ancestor
92047636|NCT01579318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047637|NCT01578850|Etanercept|etanercept|mesh-list
92047638|NCT01578850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92047639|NCT01578850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047640|NCT01578850|Analgesics|analgesics|mesh-ancestor
92047641|NCT01578850|Sensory System Agents|sensory system agents|mesh-ancestor
92047642|NCT01578850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047643|NCT01578850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047644|NCT01578850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047645|NCT01578850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047646|NCT01578850|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047647|NCT01578850|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047648|NCT01578850|Immunologic Factors|immunologic factors|mesh-ancestor
92047649|NCT01539538|Sufentanil|sufentanil|mesh-list
92047650|NCT01539538|Morphine|morphine|mesh-list
92014577|NCT05615987|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92014578|NCT05615987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014579|NCT05615987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047651|NCT01539538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047652|NCT01539538|Narcotics|narcotics|mesh-ancestor
92047653|NCT01539538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047654|NCT01539538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047655|NCT01539538|Analgesics|analgesics|mesh-ancestor
92047656|NCT01539538|Sensory System Agents|sensory system agents|mesh-ancestor
92047657|NCT01539538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047658|NCT01539538|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92047659|NCT01539538|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92047660|NCT01539538|Anesthetics, General|anesthetics, general|mesh-ancestor
92047661|NCT01539538|Anesthetics|anesthetics|mesh-ancestor
92047662|NCT01562548|Phenylpropanolamine|phenylpropanolamine|mesh-list
92047663|NCT01562548|Guaifenesin|guaifenesin|mesh-list
92047664|NCT01562548|Chlorpheniramine, phenylpropanolamine drug combination|chlorpheniramine, phenylpropanolamine drug combination|mesh-list
92047665|NCT01562548|Expectorants|expectorants|mesh-ancestor
92047666|NCT01562548|Respiratory System Agents|respiratory system agents|mesh-ancestor
92047667|NCT01562548|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92047668|NCT01562548|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92047669|NCT01562548|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047670|NCT01562548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047671|NCT01562548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047672|NCT01562548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047673|NCT01562548|Appetite Depressants|appetite depressants|mesh-ancestor
92047674|NCT01562548|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92047675|NCT01562548|Sympathomimetics|sympathomimetics|mesh-ancestor
92047676|NCT01562548|Autonomic Agents|autonomic agents|mesh-ancestor
92047677|NCT01562548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047678|NCT01562548|Nasal Decongestants|nasal decongestants|mesh-ancestor
92047679|NCT01562548|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92047680|NCT03027934|Ticagrelor|ticagrelor|mesh-list
92047681|NCT03027934|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92047682|NCT03027934|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92047683|NCT03027934|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92047684|NCT03027934|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92047685|NCT03027934|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92047686|NCT03027934|Purinergic Agents|purinergic agents|mesh-ancestor
92047693|NCT01539226|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92047694|NCT01539226|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92047695|NCT01539226|Antiviral Agents|antiviral agents|mesh-ancestor
92047696|NCT01539226|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047697|NCT01537120|Vildagliptin|vildagliptin|mesh-list
92047698|NCT01537120|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92047699|NCT01537120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047700|NCT01537120|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92047701|NCT01537120|Protease Inhibitors|protease inhibitors|mesh-ancestor
92047702|NCT01537120|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047703|NCT01537120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047704|NCT01537042|Rotigotine|rotigotine|mesh-list
92047705|NCT01537042|Dopamine Agonists|dopamine agonists|mesh-ancestor
92047706|NCT01537042|Dopamine Agents|dopamine agents|mesh-ancestor
92047707|NCT01537042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047708|NCT01537042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047709|NCT01537042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047711|NCT01536574|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92047712|NCT01536574|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92047713|NCT01536574|Dopamine Agonists|dopamine agonists|mesh-ancestor
92047714|NCT01536574|Dopamine Agents|dopamine agents|mesh-ancestor
92047715|NCT01536574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047716|NCT01536574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047717|NCT01536574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047718|NCT04410094|Itraconazole|itraconazole|mesh-list
92047719|NCT04410094|Rifampin|rifampin|mesh-list
92047720|NCT04410094|Lazertinib|lazertinib|mesh-list
92047721|NCT04410094|Antifungal Agents|antifungal agents|mesh-ancestor
92047722|NCT04410094|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014580|NCT05615987|Cholinergic Agents|cholinergic agents|mesh-ancestor
92014581|NCT05615987|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047788|NCT04102618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014583|NCT02594735|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92014584|NCT02594735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014585|NCT02594735|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014586|NCT02594735|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014587|NCT02594735|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047723|NCT04410094|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92047724|NCT04410094|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92047725|NCT04410094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047726|NCT04410094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047727|NCT04410094|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92047728|NCT04410094|Hormone Antagonists|hormone antagonists|mesh-ancestor
92047729|NCT04410094|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047730|NCT04410094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047731|NCT04410094|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92047732|NCT04410094|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92047733|NCT04410094|Antitubercular Agents|antitubercular agents|mesh-ancestor
92047734|NCT04410094|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92047735|NCT04410094|Leprostatic Agents|leprostatic agents|mesh-ancestor
92047736|NCT04410094|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92047737|NCT04410094|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92047738|NCT04410094|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92047739|NCT04410094|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92047740|NCT04410094|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92047741|NCT04410094|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92047742|NCT04410094|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92047743|NCT04410094|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92047744|NCT01576042|Amiodarone|amiodarone|mesh-list
92047745|NCT01576042|Sotalol|sotalol|mesh-list
92047746|NCT01576042|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92047747|NCT01576042|Vasodilator Agents|vasodilator agents|mesh-ancestor
92047748|NCT01576042|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92047749|NCT01576042|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047750|NCT01576042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047751|NCT01576042|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92047752|NCT01576042|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92047753|NCT01576042|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92047755|NCT01576042|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92047756|NCT01576042|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92047757|NCT01576042|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92047758|NCT01576042|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92047759|NCT01576042|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92047760|NCT01576042|Adrenergic Agents|adrenergic agents|mesh-ancestor
92047761|NCT01576042|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047762|NCT01576042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047763|NCT01576042|Sympatholytics|sympatholytics|mesh-ancestor
92047764|NCT01576042|Autonomic Agents|autonomic agents|mesh-ancestor
92047765|NCT01576042|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047766|NCT01536262|Tiotropium Bromide|tiotropium bromide|mesh-list
92047767|NCT01536262|Olodaterol|olodaterol|mesh-list
92047768|NCT01536262|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92047769|NCT01536262|Autonomic Agents|autonomic agents|mesh-ancestor
92047770|NCT01536262|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047771|NCT01536262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047772|NCT01536262|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92047773|NCT01536262|Respiratory System Agents|respiratory system agents|mesh-ancestor
92047774|NCT01536262|Parasympatholytics|parasympatholytics|mesh-ancestor
92047775|NCT01536262|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92047776|NCT01536262|Cholinergic Agents|cholinergic agents|mesh-ancestor
92047777|NCT01536262|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014588|NCT02594735|Immunologic Factors|immunologic factors|mesh-ancestor
92047778|NCT01536262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047779|NCT04102618|Trastuzumab|trastuzumab|mesh-list
92047780|NCT04102618|Atezolizumab|atezolizumab|mesh-list
92047781|NCT04102618|Letrozole|letrozole|mesh-list
92047782|NCT04102618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047783|NCT04102618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047784|NCT04102618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92047785|NCT04102618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047786|NCT04102618|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92047787|NCT04102618|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92047789|NCT04102618|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92047790|NCT04102618|Hormone Antagonists|hormone antagonists|mesh-ancestor
92047791|NCT04102618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92047792|NCT04102618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047794|NCT01575028|Ropivacaine|ropivacaine|mesh-list
92047795|NCT01575028|Anesthetics, Local|anesthetics, local|mesh-ancestor
92047796|NCT01575028|Anesthetics|anesthetics|mesh-ancestor
92047797|NCT01575028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047798|NCT01575028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047799|NCT01575028|Sensory System Agents|sensory system agents|mesh-ancestor
92047800|NCT01575028|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047801|NCT04963283|Nivolumab|nivolumab|mesh-list
92047802|NCT04963283|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047803|NCT04963283|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047804|NCT04963283|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92047805|NCT04963283|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047806|NCT04443569|Lidocaine|lidocaine|mesh-list
92047807|NCT04443569|Anesthetics, Local|anesthetics, local|mesh-ancestor
92047808|NCT04443569|Anesthetics|anesthetics|mesh-ancestor
92047809|NCT04443569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047810|NCT04443569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047811|NCT04443569|Sensory System Agents|sensory system agents|mesh-ancestor
92047812|NCT04443569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047813|NCT04443569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92047814|NCT04443569|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92047815|NCT04443569|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92047816|NCT04443569|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047817|NCT04443569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047818|NCT01792583|Modafinil|modafinil|mesh-list
92047819|NCT01792583|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92047820|NCT01792583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047821|NCT01792583|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92047822|NCT01792583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92047823|NCT01792583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92047824|NCT01792583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047825|NCT03508895|Caseins|caseins|mesh-list
92047831|NCT03507491|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92047832|NCT03507491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047833|NCT03507491|Tubulin Modulators|tubulin modulators|mesh-ancestor
92047834|NCT03507491|Antimitotic Agents|antimitotic agents|mesh-ancestor
92047835|NCT03507491|Mitosis Modulators|mitosis modulators|mesh-ancestor
92047836|NCT03507491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047837|NCT03507491|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92047838|NCT03507491|Antimetabolites|antimetabolites|mesh-ancestor
92047839|NCT04566653|Calcium|calcium|mesh-list
92047840|NCT04566653|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
92047841|NCT04566653|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92047842|NCT04566653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047843|NCT04566653|Chelating Agents|chelating agents|mesh-ancestor
92047844|NCT04566653|Sequestering Agents|sequestering agents|mesh-ancestor
92047845|NCT04566653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047846|NCT04521569|Regadenoson|regadenoson|mesh-list
92047847|NCT04521569|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92047848|NCT04521569|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92047849|NCT04521569|Purinergic Agonists|purinergic agonists|mesh-ancestor
92047850|NCT04521569|Purinergic Agents|purinergic agents|mesh-ancestor
92047851|NCT04521569|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047852|NCT04521569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047853|NCT04521569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047854|NCT01574716|Gemcitabine|gemcitabine|mesh-list
92047855|NCT01574716|Docetaxel|docetaxel|mesh-list
92047856|NCT01574716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92047857|NCT01574716|Antimetabolites|antimetabolites|mesh-ancestor
92047858|NCT01574716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047859|NCT01574716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047860|NCT01574716|Tubulin Modulators|tubulin modulators|mesh-ancestor
92047861|NCT01574716|Antimitotic Agents|antimitotic agents|mesh-ancestor
92047862|NCT01574716|Mitosis Modulators|mitosis modulators|mesh-ancestor
92047863|NCT02161562|Omalizumab|omalizumab|mesh-list
92047864|NCT02161562|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92047865|NCT02161562|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92047866|NCT02161562|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92047867|NCT02161562|Respiratory System Agents|respiratory system agents|mesh-ancestor
92047868|NCT02161562|Immunologic Factors|immunologic factors|mesh-ancestor
92047869|NCT02161562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047870|NCT01559116|Tiotropium Bromide|tiotropium bromide|mesh-list
92047871|NCT01559116|Olodaterol|olodaterol|mesh-list
92047872|NCT01559116|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92047873|NCT01559116|Autonomic Agents|autonomic agents|mesh-ancestor
92047874|NCT01559116|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047875|NCT01559116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047876|NCT01559116|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92047877|NCT01559116|Respiratory System Agents|respiratory system agents|mesh-ancestor
92047878|NCT01559116|Parasympatholytics|parasympatholytics|mesh-ancestor
92047879|NCT01559116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92047880|NCT01559116|Cholinergic Agents|cholinergic agents|mesh-ancestor
92047881|NCT01559116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047882|NCT01559116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047883|NCT01574326|Sevelamer|sevelamer|mesh-list
92047884|NCT01574326|Chelating Agents|chelating agents|mesh-ancestor
92047885|NCT01574326|Sequestering Agents|sequestering agents|mesh-ancestor
92047886|NCT01574326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047887|NCT01574248|Icatibant|icatibant|mesh-list
92047888|NCT01574248|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92047889|NCT01574248|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047890|NCT01574248|Analgesics|analgesics|mesh-ancestor
92047891|NCT01574248|Sensory System Agents|sensory system agents|mesh-ancestor
92047892|NCT01574248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047893|NCT01574248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047894|NCT01574248|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047895|NCT01574248|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047908|NCT01557946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047909|NCT01557946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047912|NCT01557946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047913|NCT01557946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92047914|NCT01557946|Antidepressive Agents|antidepressive agents|mesh-ancestor
92047915|NCT01557946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92047916|NCT01534078|Doxorubicin|doxorubicin|mesh-list
92047917|NCT01534078|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92047918|NCT01534078|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92047919|NCT01534078|Dacarbazine|dacarbazine|mesh-list
92047920|NCT01534078|Vinblastine|vinblastine|mesh-list
92047921|NCT01534078|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92047922|NCT01534078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047923|NCT01534078|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92047924|NCT01534078|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92047925|NCT01534078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047926|NCT01534078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047927|NCT01534078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047928|NCT01534078|Immunotoxins|immunotoxins|mesh-ancestor
92047929|NCT01534078|Immunoconjugates|immunoconjugates|mesh-ancestor
92047930|NCT01534078|Immunologic Factors|immunologic factors|mesh-ancestor
92047931|NCT01534078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047932|NCT01534078|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92047933|NCT01534078|Alkylating Agents|alkylating agents|mesh-ancestor
92047934|NCT01534078|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92047935|NCT01534078|Tubulin Modulators|tubulin modulators|mesh-ancestor
92047936|NCT01534078|Antimitotic Agents|antimitotic agents|mesh-ancestor
92047937|NCT01534078|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014589|NCT02594735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014590|NCT02594735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92014591|NCT05209425|Vitamin D|vitamin d|mesh-list
92014592|NCT05209425|Cholecalciferol|cholecalciferol|mesh-list
92014593|NCT05209425|Vitamins|vitamins|mesh-ancestor
92047938|NCT03919942|Chlorhexidine|chlorhexidine|mesh-list
92047939|NCT03919942|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92047940|NCT03919942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047941|NCT03919942|Disinfectants|disinfectants|mesh-ancestor
92047942|NCT02161406|Abatacept|abatacept|mesh-list
92047943|NCT02161406|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92047944|NCT02161406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047945|NCT02161406|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047946|NCT02161406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047947|NCT02161406|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047948|NCT02161406|Immunologic Factors|immunologic factors|mesh-ancestor
92047949|NCT02161406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047950|NCT02161406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92047951|NCT01573000|Tositumomab I-131|tositumomab i-131|mesh-list
92047953|NCT01573000|Immunoglobulins|immunoglobulins|mesh-list
92047954|NCT01573000|Immunologic Factors|immunologic factors|mesh-ancestor
92047955|NCT01573000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047965|NCT01572844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047966|NCT01572844|Chelating Agents|chelating agents|mesh-ancestor
92047967|NCT01572844|Sequestering Agents|sequestering agents|mesh-ancestor
92047968|NCT01533922|Tiotropium Bromide|tiotropium bromide|mesh-list
92047969|NCT01533922|Olodaterol|olodaterol|mesh-list
92047970|NCT01533922|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92047971|NCT01533922|Autonomic Agents|autonomic agents|mesh-ancestor
92047972|NCT01533922|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047973|NCT01533922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047974|NCT01533922|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92047975|NCT01533922|Respiratory System Agents|respiratory system agents|mesh-ancestor
92047976|NCT01533922|Parasympatholytics|parasympatholytics|mesh-ancestor
92047977|NCT01533922|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92047978|NCT01533922|Cholinergic Agents|cholinergic agents|mesh-ancestor
92047979|NCT01533922|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047980|NCT01533922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047981|NCT01533688|Bisacodyl|bisacodyl|mesh-list
92047982|NCT01533688|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92047983|NCT01533688|Cathartics|cathartics|mesh-ancestor
92047984|NCT01533688|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92047985|NCT01533688|Laxatives|laxatives|mesh-ancestor
92047986|NCT01532908|Sofosbuvir|sofosbuvir|mesh-list
92047987|NCT01532908|Antiviral Agents|antiviral agents|mesh-ancestor
92047988|NCT01532908|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047989|NCT02160626|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92047990|NCT02217878|Morphine|morphine|mesh-list
92047991|NCT02217878|Ticagrelor|ticagrelor|mesh-list
92047992|NCT02217878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047993|NCT02217878|Narcotics|narcotics|mesh-ancestor
92047994|NCT02217878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047995|NCT02217878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047996|NCT02217878|Analgesics|analgesics|mesh-ancestor
92047997|NCT02217878|Sensory System Agents|sensory system agents|mesh-ancestor
92047998|NCT02217878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047999|NCT02217878|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92048000|NCT02217878|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92048001|NCT02217878|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92048002|NCT02217878|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92048003|NCT02217878|Purinergic Agents|purinergic agents|mesh-ancestor
92048004|NCT02217878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048005|NCT02217878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048007|NCT02217566|Abiraterone Acetate|abiraterone acetate|mesh-list
92048008|NCT02217566|Androgens|androgens|mesh-list
92048009|NCT02217566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048010|NCT02217566|Glucocorticoids|glucocorticoids|mesh-ancestor
92048011|NCT02217566|Hormones|hormones|mesh-ancestor
92048012|NCT02217566|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048013|NCT02217566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048014|NCT02217566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92048015|NCT02217566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014594|NCT05209425|Micronutrients|micronutrients|mesh-ancestor
92014595|NCT05209425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048016|NCT02217566|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92048017|NCT02217566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048018|NCT02217566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048019|NCT02217566|Hormone Antagonists|hormone antagonists|mesh-ancestor
92048020|NCT02217566|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92048021|NCT02217410|Mycophenolic Acid|mycophenolic acid|mesh-list
92048022|NCT02217410|Tacrolimus|tacrolimus|mesh-list
92048023|NCT02217410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048026|NCT02217410|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92048028|NCT02217410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048029|NCT02217410|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92048030|NCT02217410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048031|NCT02217410|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92048032|NCT02217410|Antitubercular Agents|antitubercular agents|mesh-ancestor
92048033|NCT02217410|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048034|NCT02217410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048035|NCT02217332|Pramipexole|pramipexole|mesh-list
92048036|NCT02217332|Antioxidants|antioxidants|mesh-ancestor
92048037|NCT02217332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048038|NCT02217332|Protective Agents|protective agents|mesh-ancestor
92048039|NCT02217332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048040|NCT02217332|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92048041|NCT02217332|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92048042|NCT02217332|Dopamine Agonists|dopamine agonists|mesh-ancestor
92048043|NCT02217332|Dopamine Agents|dopamine agents|mesh-ancestor
92048044|NCT02217332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048045|NCT02184572|Vaccines|vaccines|mesh-list
92048046|NCT02184572|Immunologic Factors|immunologic factors|mesh-ancestor
92048047|NCT02184572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048048|NCT04755218|Misoprostol|misoprostol|mesh-list
92048049|NCT04755218|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92048050|NCT04755218|Abortifacient Agents|abortifacient agents|mesh-ancestor
92048051|NCT04755218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92048052|NCT04755218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048053|NCT04755218|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92048054|NCT04755218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92048055|NCT04755218|Oxytocics|oxytocics|mesh-ancestor
92048056|NCT02181842|Pioglitazone|pioglitazone|mesh-list
92048057|NCT02181842|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048058|NCT02181842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048059|NCT01632020|Metformin|metformin|mesh-list
92048060|NCT01632020|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048061|NCT01632020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048062|NCT02181296|Ropivacaine|ropivacaine|mesh-list
92048063|NCT02181296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92048064|NCT02181296|Anesthetics|anesthetics|mesh-ancestor
92048065|NCT02181296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048066|NCT02181296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048067|NCT02181296|Sensory System Agents|sensory system agents|mesh-ancestor
92048068|NCT02181296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048069|NCT02158442|Clavulanic Acid|clavulanic acid|mesh-list
92048070|NCT02158442|Ticarcillin-clavulanic acid|ticarcillin-clavulanic acid|mesh-list
92048071|NCT02158442|Ticarcillin|ticarcillin|mesh-list
92048072|NCT02158442|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92048073|NCT02158442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048074|NCT02158442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048075|NCT02158442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048076|NCT02158442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048077|NCT02158364|Vaccines|vaccines|mesh-list
92048078|NCT02158364|Immunologic Factors|immunologic factors|mesh-ancestor
92048079|NCT02158364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048081|NCT02180672|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048082|NCT02180672|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92048083|NCT02180672|Autonomic Agents|autonomic agents|mesh-ancestor
92048084|NCT02180672|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048085|NCT02180672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048086|NCT02180672|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92048087|NCT02180672|Respiratory System Agents|respiratory system agents|mesh-ancestor
92048088|NCT02180672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048089|NCT02180672|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92048090|NCT01920711|Valsartan|valsartan|mesh-list
92014596|NCT05209425|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92014597|NCT05209425|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92014598|NCT04793243|Vitamin D|vitamin d|mesh-list
92014599|NCT04793243|Cholecalciferol|cholecalciferol|mesh-list
92014600|NCT04793243|Vitamins|vitamins|mesh-ancestor
92014601|NCT04793243|Micronutrients|micronutrients|mesh-ancestor
92048091|NCT01920711|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92048092|NCT01920711|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048093|NCT01920711|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92048094|NCT01920711|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92048095|NCT01920711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048096|NCT02180438|Tenofovir|tenofovir|mesh-list
92048110|NCT02180438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92048111|NCT02180438|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92048112|NCT02157116|Docetaxel|docetaxel|mesh-list
92048113|NCT02157116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048114|NCT02157116|Tubulin Modulators|tubulin modulators|mesh-ancestor
92048115|NCT02157116|Antimitotic Agents|antimitotic agents|mesh-ancestor
92048116|NCT02157116|Mitosis Modulators|mitosis modulators|mesh-ancestor
92048117|NCT02157116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048118|NCT01920555|Midazolam|midazolam|mesh-list
92048119|NCT01920555|Ketamine|ketamine|mesh-list
92048120|NCT01920555|Analgesics|analgesics|mesh-ancestor
92048121|NCT01920555|Sensory System Agents|sensory system agents|mesh-ancestor
92048122|NCT01920555|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048123|NCT01920555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048124|NCT01920555|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92048125|NCT01920555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92048126|NCT01920555|Anesthetics, General|anesthetics, general|mesh-ancestor
92048127|NCT01920555|Anesthetics|anesthetics|mesh-ancestor
92048128|NCT01920555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048129|NCT01920555|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92048130|NCT01920555|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92048131|NCT01920555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048132|NCT01920555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048133|NCT01920555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92048134|NCT01920555|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92048135|NCT01920555|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92048136|NCT01920555|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92048137|NCT01920555|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92048138|NCT01920555|GABA Modulators|gaba modulators|mesh-ancestor
92048139|NCT01920555|GABA Agents|gaba agents|mesh-ancestor
92048140|NCT02156804|Nivolumab|nivolumab|mesh-list
92048141|NCT02156804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048142|NCT02156804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048143|NCT02156804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92048144|NCT02156804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048145|NCT02156492|Atorvastatin|atorvastatin|mesh-list
92048146|NCT02156492|Simvastatin|simvastatin|mesh-list
92048147|NCT02156492|Evacetrapib|evacetrapib|mesh-list
92048148|NCT02156492|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92048149|NCT02156492|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92048150|NCT02156492|Antimetabolites|antimetabolites|mesh-ancestor
92048151|NCT02156492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048152|NCT02156492|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92048153|NCT02156492|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92048154|NCT02156492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048155|NCT01920477|Ofatumumab|ofatumumab|mesh-list
92048159|NCT04641195|Cholecalciferol|cholecalciferol|mesh-list
92048160|NCT04641195|Vitamins|vitamins|mesh-list
92048161|NCT04641195|Zinc|zinc|mesh-list
92048162|NCT04641195|Micronutrients|micronutrients|mesh-ancestor
92048163|NCT04641195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048164|NCT04641195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92048165|NCT04641195|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92048166|NCT04641195|Trace Elements|trace elements|mesh-ancestor
92048167|NCT02213042|Trastuzumab|trastuzumab|mesh-list
92048168|NCT02213042|Lapatinib|lapatinib|mesh-list
92048169|NCT02213042|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92014602|NCT04793243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048170|NCT02213042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048171|NCT02213042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048172|NCT02213042|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92048173|NCT02213042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048174|NCT02213042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048175|NCT02213042|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92048176|NCT02213042|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92048177|NCT02213042|Hormone Antagonists|hormone antagonists|mesh-ancestor
92048178|NCT02213042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048179|NCT02213042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048180|NCT04418180|Fenofibrate|fenofibrate|mesh-list
92048181|NCT04418180|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92048182|NCT04418180|Antimetabolites|antimetabolites|mesh-ancestor
92048183|NCT04418180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048184|NCT04418180|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92048185|NCT02212730|Pembrolizumab|pembrolizumab|mesh-list
92048186|NCT02212730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048187|NCT02212730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048188|NCT02212730|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92048189|NCT02212730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048190|NCT02178956|Paclitaxel|paclitaxel|mesh-list
92048191|NCT02178956|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92048192|NCT02178956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048193|NCT02178956|Tubulin Modulators|tubulin modulators|mesh-ancestor
92048194|NCT02178956|Antimitotic Agents|antimitotic agents|mesh-ancestor
92048195|NCT02178956|Mitosis Modulators|mitosis modulators|mesh-ancestor
92048196|NCT02178956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048198|NCT02211638|Candesartan cilexetil|candesartan cilexetil|mesh-list
92048199|NCT02211638|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048200|NCT02211638|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92048201|NCT02211638|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92048202|NCT02211638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048203|NCT02178566|Treprostinil|treprostinil|mesh-list
92048204|NCT02178566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048205|NCT02211014|Acalabrutinib|acalabrutinib|mesh-list
92048206|NCT02211014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048207|NCT01631864|Amlodipine|amlodipine|mesh-list
92048208|NCT01631864|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92048209|NCT01631864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048210|NCT01631864|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92048211|NCT01631864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92048212|NCT01631864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048213|NCT01631864|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92048214|NCT01631864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048215|NCT01631864|Vasodilator Agents|vasodilator agents|mesh-ancestor
92048216|NCT01631864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92048217|NCT01557244|Fesoterodine|fesoterodine|mesh-list
92048218|NCT01557244|Oxybutynin|oxybutynin|mesh-list
92048219|NCT01557244|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92048220|NCT01557244|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92048221|NCT01557244|Cholinergic Agents|cholinergic agents|mesh-ancestor
92048222|NCT01557244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048223|NCT01557244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048224|NCT01557244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048226|NCT01557244|Parasympatholytics|parasympatholytics|mesh-ancestor
92048227|NCT01557244|Autonomic Agents|autonomic agents|mesh-ancestor
92048228|NCT01557244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048229|NCT02177942|Micronutrients|micronutrients|mesh-list
92048230|NCT02177942|Trace Elements|trace elements|mesh-list
92048231|NCT02177942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048232|NCT02155322|Interferons|interferons|mesh-list
92048233|NCT02155322|Interferon-alpha|interferon-alpha|mesh-list
92048234|NCT02155322|Interferon alpha-2|interferon alpha-2|mesh-list
92048235|NCT02155322|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92048236|NCT02155322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048237|NCT02155322|Antiviral Agents|antiviral agents|mesh-ancestor
92048238|NCT02155322|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014604|NCT04793243|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92014605|NCT04793399|Atezolizumab|atezolizumab|mesh-list
92014606|NCT04793399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92014607|NCT04793399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014608|NCT04793399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014609|NCT04793399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014610|NCT05157711|Bismuth subgallate|bismuth subgallate|mesh-list
92014611|NCT05157711|Phenylephrine|phenylephrine|mesh-list
92014612|NCT05157711|Oxymetazoline|oxymetazoline|mesh-list
92014613|NCT05157711|Zinc Oxide|zinc oxide|mesh-list
92014614|NCT05157711|Bismuth|bismuth|mesh-list
92014615|NCT05157711|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92014616|NCT05157711|Mydriatics|mydriatics|mesh-ancestor
92014617|NCT05157711|Autonomic Agents|autonomic agents|mesh-ancestor
92014618|NCT05157711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014619|NCT05157711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014620|NCT05157711|Sympathomimetics|sympathomimetics|mesh-ancestor
92014621|NCT05157711|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92014622|NCT05157711|Nasal Decongestants|nasal decongestants|mesh-ancestor
92048239|NCT02155322|Immunologic Factors|immunologic factors|mesh-ancestor
92048240|NCT02155322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048241|NCT02209454|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92048242|NCT02209454|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92048243|NCT02209454|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048244|NCT02209454|Analgesics|analgesics|mesh-ancestor
92048245|NCT02209454|Sensory System Agents|sensory system agents|mesh-ancestor
92048246|NCT02209454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048247|NCT02209454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048248|NCT02209454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048249|NCT02209454|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048250|NCT01557166|Liraglutide|liraglutide|mesh-list
92048251|NCT01557166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048252|NCT01557166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048253|NCT01557166|Incretins|incretins|mesh-ancestor
92048255|NCT01557166|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048256|NCT01556932|Diphenhydramine|diphenhydramine|mesh-list
92048257|NCT01556932|Promethazine|promethazine|mesh-list
92048258|NCT01556932|Lorazepam|lorazepam|mesh-list
92048259|NCT01556932|Haloperidol|haloperidol|mesh-list
92048260|NCT01556932|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92048261|NCT01556932|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92048262|NCT01556932|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048263|NCT01556932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048264|NCT01556932|Anesthetics, Local|anesthetics, local|mesh-ancestor
92048265|NCT01556932|Anesthetics|anesthetics|mesh-ancestor
92048266|NCT01556932|Sensory System Agents|sensory system agents|mesh-ancestor
92048267|NCT01556932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048268|NCT01556932|Antiemetics|antiemetics|mesh-ancestor
92048269|NCT01556932|Autonomic Agents|autonomic agents|mesh-ancestor
92048270|NCT01556932|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92048271|NCT01556932|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92048272|NCT01556932|Histamine Antagonists|histamine antagonists|mesh-ancestor
92048273|NCT01556932|Histamine Agents|histamine agents|mesh-ancestor
92048274|NCT01556932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048275|NCT01556932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048276|NCT01556932|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92048277|NCT01556932|Antipruritics|antipruritics|mesh-ancestor
92048278|NCT01556932|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048279|NCT01556932|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92048280|NCT01556932|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92048281|NCT01556932|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92048282|NCT01556932|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92048283|NCT01556932|Dopamine Agents|dopamine agents|mesh-ancestor
92048284|NCT01556932|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92048285|NCT01556932|Anticonvulsants|anticonvulsants|mesh-ancestor
92048286|NCT01556932|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92048287|NCT01556932|GABA Modulators|gaba modulators|mesh-ancestor
92048288|NCT01556932|GABA Agents|gaba agents|mesh-ancestor
92048289|NCT02985736|Desoximetasone|desoximetasone|mesh-list
92048290|NCT02985736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048291|NCT02985736|Glucocorticoids|glucocorticoids|mesh-ancestor
92048292|NCT02985736|Hormones|hormones|mesh-ancestor
92048293|NCT02985736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048294|NCT02985736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048295|NCT02985658|Cisplatin|cisplatin|mesh-list
92048296|NCT02985658|Vinorelbine|vinorelbine|mesh-list
92048297|NCT02985658|Veliparib|veliparib|mesh-list
92048298|NCT02985658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048299|NCT02985658|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92048300|NCT02985658|Tubulin Modulators|tubulin modulators|mesh-ancestor
92048301|NCT02985658|Antimitotic Agents|antimitotic agents|mesh-ancestor
92048302|NCT02985658|Mitosis Modulators|mitosis modulators|mesh-ancestor
92048303|NCT02985658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048304|NCT02985658|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92048305|NCT02985658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048309|NCT02177786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048311|NCT02153918|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048312|NCT02153918|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048313|NCT02153918|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92048314|NCT02153918|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92048316|NCT04752566|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92048317|NCT04752566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048318|NCT04752566|Immunologic Factors|immunologic factors|mesh-ancestor
92048319|NCT04752566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048320|NCT01571362|Naltrexone|naltrexone|mesh-list
92048321|NCT01571362|Oxycodone|oxycodone|mesh-list
92048322|NCT01571362|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92048323|NCT01571362|Narcotics|narcotics|mesh-ancestor
92048324|NCT01571362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048325|NCT01571362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048326|NCT01571362|Analgesics|analgesics|mesh-ancestor
92048327|NCT01571362|Sensory System Agents|sensory system agents|mesh-ancestor
92048328|NCT01571362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048329|NCT01571362|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92048330|NCT01571362|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92048331|NCT01571284|Aflibercept|aflibercept|mesh-list
92048332|NCT01571284|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048333|NCT01571284|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048334|NCT01571284|Growth Substances|growth substances|mesh-ancestor
92048335|NCT01571284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048336|NCT01571284|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048337|NCT01571284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048339|NCT02137772|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92048340|NCT02137772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048341|NCT02137772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048342|NCT02137772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048343|NCT02137772|Antiviral Agents|antiviral agents|mesh-ancestor
92048344|NCT02137772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048345|NCT01555138|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92048346|NCT01555138|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92048347|NCT01555138|Autonomic Agents|autonomic agents|mesh-ancestor
92048348|NCT01555138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048349|NCT01555138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048350|NCT01555138|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92048351|NCT01555138|Respiratory System Agents|respiratory system agents|mesh-ancestor
92048352|NCT01555138|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92014624|NCT05157711|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92014625|NCT05157711|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92048353|NCT01555138|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92048354|NCT01555138|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92048355|NCT01555138|Adrenergic Agents|adrenergic agents|mesh-ancestor
92048356|NCT01555138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048357|NCT01555138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048358|NCT02137226|Adalimumab|adalimumab|mesh-list
92048359|NCT02137226|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92048360|NCT02137226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048361|NCT02137226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048362|NCT01530334|Gefitinib|gefitinib|mesh-list
92048363|NCT01530334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048364|NCT01530334|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92048365|NCT01530334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048366|NCT01530334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048367|NCT01570192|Vancomycin|vancomycin|mesh-list
92048368|NCT01570192|Gentamicins|gentamicins|mesh-list
92048369|NCT01570192|Meropenem|meropenem|mesh-list
92048370|NCT01570192|Linezolid|linezolid|mesh-list
92048371|NCT01570192|Tobramycin|tobramycin|mesh-list
92048372|NCT01570192|Amikacin|amikacin|mesh-list
92048373|NCT01570192|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048374|NCT01570192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048375|NCT01570192|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92048376|NCT01570192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048377|NCT01570192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048378|NCT02136914|Amantadine|amantadine|mesh-list
92048388|NCT02136914|Analgesics|analgesics|mesh-ancestor
92048389|NCT02136914|Sensory System Agents|sensory system agents|mesh-ancestor
92048390|NCT02136914|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048391|NCT01529632|Glycopyrrolate|glycopyrrolate|mesh-list
92048392|NCT01529632|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92048393|NCT01529632|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92048394|NCT01529632|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92048395|NCT01529632|Cholinergic Agents|cholinergic agents|mesh-ancestor
92048396|NCT01529632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048397|NCT01529632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048398|NCT01529632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048400|NCT01554514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048401|NCT01554514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048402|NCT01554514|Immunologic Factors|immunologic factors|mesh-ancestor
92048403|NCT01554514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048404|NCT01554514|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048405|NCT01553188|Prednisone|prednisone|mesh-list
92048406|NCT01553188|Trebananib|trebananib|mesh-list
92048407|NCT01553188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048408|NCT01553188|Glucocorticoids|glucocorticoids|mesh-ancestor
92048409|NCT01553188|Hormones|hormones|mesh-ancestor
92048410|NCT01553188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048411|NCT01553188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048412|NCT01553188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92048413|NCT01553188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048414|NCT01553188|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048415|NCT01553188|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048416|NCT01553188|Growth Substances|growth substances|mesh-ancestor
92048417|NCT01553188|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048419|NCT02175758|Sofosbuvir|sofosbuvir|mesh-list
92048420|NCT02175758|Antimetabolites|antimetabolites|mesh-ancestor
92048421|NCT02175758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048422|NCT02175758|Antiviral Agents|antiviral agents|mesh-ancestor
92048423|NCT02175758|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048424|NCT01599104|Olmesartan|olmesartan|mesh-list
92048588|NCT01919229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048425|NCT01599104|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92048426|NCT01599104|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048427|NCT01599104|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92048428|NCT01599104|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92048429|NCT01599104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048430|NCT01552954|Angiotensin II|angiotensin ii|mesh-list
92048431|NCT01552954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92048432|NCT01518244|Timolol|timolol|mesh-list
92014626|NCT05157711|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92014627|NCT05157711|Adrenergic Agents|adrenergic agents|mesh-ancestor
92048433|NCT01518244|Brinzolamide|brinzolamide|mesh-list
92048434|NCT01518244|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048435|NCT01518244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048436|NCT01518244|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92048437|NCT01518244|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92048438|NCT01518244|Adrenergic Agents|adrenergic agents|mesh-ancestor
92048439|NCT01518244|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048440|NCT01518244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048441|NCT01518244|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92048442|NCT01518244|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048443|NCT01518244|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92048444|NCT01552408|Ranibizumab|ranibizumab|mesh-list
92048445|NCT01552408|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048455|NCT04099888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048457|NCT02174276|Antiviral Agents|antiviral agents|mesh-ancestor
92048458|NCT02174276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048459|NCT02174276|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92048460|NCT02174276|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92048461|NCT02174276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048462|NCT02174276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048463|NCT02174276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92048464|NCT02174276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92048465|NCT01527682|Dorzolamide|dorzolamide|mesh-list
92048466|NCT01527682|Latanoprost|latanoprost|mesh-list
92048467|NCT01527682|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92048468|NCT01527682|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92048469|NCT01527682|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92048470|NCT01527682|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92048471|NCT01527682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048472|NCT01527682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048474|NCT01516216|Leucovorin|leucovorin|mesh-list
92048475|NCT01516216|Bevacizumab|bevacizumab|mesh-list
92048476|NCT01516216|Fluorouracil|fluorouracil|mesh-list
92048477|NCT01516216|Oxaliplatin|oxaliplatin|mesh-list
92048478|NCT01516216|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048479|NCT01516216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048480|NCT01516216|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048481|NCT01516216|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048482|NCT01516216|Growth Substances|growth substances|mesh-ancestor
92048483|NCT01516216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048484|NCT01516216|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048485|NCT01516216|Vitamins|vitamins|mesh-ancestor
92048486|NCT01516216|Micronutrients|micronutrients|mesh-ancestor
92048487|NCT01516216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92048488|NCT01516216|Antimetabolites|antimetabolites|mesh-ancestor
92048489|NCT01516216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048490|NCT01516216|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92048491|NCT01516216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048492|NCT01516216|Immunologic Factors|immunologic factors|mesh-ancestor
92048493|NCT01516216|Antidotes|antidotes|mesh-ancestor
92048494|NCT01516216|Protective Agents|protective agents|mesh-ancestor
92048495|NCT01516216|Vitamin B Complex|vitamin b complex|mesh-ancestor
92048496|NCT01950819|Cyclosporine|cyclosporine|mesh-list
92048497|NCT01950819|Prednisone|prednisone|mesh-list
92048498|NCT01950819|Methylprednisolone|methylprednisolone|mesh-list
92048499|NCT01950819|Tacrolimus|tacrolimus|mesh-list
92048500|NCT01950819|Thymoglobulin|thymoglobulin|mesh-list
92048501|NCT01950819|Cyclosporins|cyclosporins|mesh-list
92048502|NCT01950819|Basiliximab|basiliximab|mesh-list
92048503|NCT01950819|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048504|NCT01950819|Glucocorticoids|glucocorticoids|mesh-ancestor
92048505|NCT01950819|Hormones|hormones|mesh-ancestor
92048506|NCT01950819|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048507|NCT01950819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048508|NCT01950819|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92048509|NCT01950819|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048510|NCT01950819|Antiemetics|antiemetics|mesh-ancestor
92048511|NCT01950819|Autonomic Agents|autonomic agents|mesh-ancestor
92048512|NCT01950819|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048514|NCT01950819|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92048515|NCT01950819|Protective Agents|protective agents|mesh-ancestor
92048516|NCT01950819|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048517|NCT01950819|Immunologic Factors|immunologic factors|mesh-ancestor
92048519|NCT01950819|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048520|NCT01950819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048521|NCT01950819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048522|NCT01950819|Antifungal Agents|antifungal agents|mesh-ancestor
92048523|NCT01950819|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048524|NCT01950819|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048526|NCT01514422|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048527|NCT01514422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048528|NCT01524796|Pregabalin|pregabalin|mesh-list
92048529|NCT01524796|Analgesics|analgesics|mesh-ancestor
92048530|NCT01524796|Sensory System Agents|sensory system agents|mesh-ancestor
92048531|NCT01524796|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048532|NCT01524796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048533|NCT01524796|Anticonvulsants|anticonvulsants|mesh-ancestor
92048534|NCT01524796|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92048535|NCT01524796|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92048536|NCT01524796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048537|NCT01524796|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92048538|NCT01524796|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92048539|NCT01524796|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92048540|NCT01524796|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048541|NCT01524796|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92048542|NCT01547728|Antithrombins|antithrombins|mesh-list
92048543|NCT01547728|Antithrombin III|antithrombin iii|mesh-list
92048544|NCT01547728|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92048545|NCT01547728|Protease Inhibitors|protease inhibitors|mesh-ancestor
92048546|NCT01547728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048547|NCT01547728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048548|NCT01547728|Anticoagulants|anticoagulants|mesh-ancestor
92048549|NCT01523392|Clopidogrel|clopidogrel|mesh-list
92048550|NCT01523392|Ticagrelor|ticagrelor|mesh-list
92048551|NCT01523392|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92048552|NCT01523392|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92048553|NCT01523392|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92048554|NCT01523392|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92048555|NCT01523392|Purinergic Agents|purinergic agents|mesh-ancestor
92048556|NCT01523392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048557|NCT01523392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048558|NCT01523392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048559|NCT01512160|Ibuprofen|ibuprofen|mesh-list
92048560|NCT01512160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92048561|NCT01512160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048562|NCT01512160|Analgesics|analgesics|mesh-ancestor
92048563|NCT01512160|Sensory System Agents|sensory system agents|mesh-ancestor
92048564|NCT01512160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048565|NCT01512160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048566|NCT01512160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048567|NCT01512160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048568|NCT01512160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92048569|NCT01512160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048570|NCT01512160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048571|NCT01950741|Aflibercept|aflibercept|mesh-list
92048572|NCT01950741|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048573|NCT01950741|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048574|NCT01950741|Growth Substances|growth substances|mesh-ancestor
92048575|NCT01950741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048576|NCT01950741|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048577|NCT01950741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048578|NCT01950273|Rituximab|rituximab|mesh-list
92048579|NCT01950273|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048580|NCT01950273|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048581|NCT01950273|Immunologic Factors|immunologic factors|mesh-ancestor
92048582|NCT01950273|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048583|NCT01950273|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048584|NCT01919229|Letrozole|letrozole|mesh-list
92048587|NCT01919229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92048589|NCT01919229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048590|NCT01919229|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92048591|NCT01919229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92048592|NCT01919229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014628|NCT05157711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014629|NCT05157711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014630|NCT05157711|Protective Agents|protective agents|mesh-ancestor
92048593|NCT01919229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048594|NCT01511536|Prednisone|prednisone|mesh-list
92048595|NCT01511536|Abiraterone Acetate|abiraterone acetate|mesh-list
92048596|NCT01511536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048597|NCT01511536|Glucocorticoids|glucocorticoids|mesh-ancestor
92048598|NCT01511536|Hormones|hormones|mesh-ancestor
92048599|NCT01511536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048600|NCT01511536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048601|NCT01511536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92048602|NCT01511536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048603|NCT01511536|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92048605|NCT01511536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048606|NCT01511536|Hormone Antagonists|hormone antagonists|mesh-ancestor
92048607|NCT01511536|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92048608|NCT01510912|Diclofenac|diclofenac|mesh-list
92048609|NCT01510912|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92048610|NCT01510912|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048611|NCT01510912|Analgesics|analgesics|mesh-ancestor
92048612|NCT01510912|Sensory System Agents|sensory system agents|mesh-ancestor
92048613|NCT01510912|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048614|NCT01510912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048615|NCT01510912|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048616|NCT01510912|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048617|NCT01510912|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92048618|NCT01510912|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048619|NCT01510912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048620|NCT01510756|Sorafenib|sorafenib|mesh-list
92048621|NCT01510756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048622|NCT01510756|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92048623|NCT01510756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048624|NCT01510756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048625|NCT01522456|Tretinoin|tretinoin|mesh-list
92048626|NCT01522456|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048627|NCT01522456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048628|NCT01522456|Keratolytic Agents|keratolytic agents|mesh-ancestor
92048629|NCT01521364|Clarithromycin|clarithromycin|mesh-list
92048630|NCT01521364|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048631|NCT01521364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048632|NCT01521364|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92048633|NCT01521364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048634|NCT01521364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048635|NCT01521364|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92048636|NCT01521364|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92048637|NCT01545388|Metformin|metformin|mesh-list
92048638|NCT01545388|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92048639|NCT01545388|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048640|NCT01545388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048641|NCT01545388|Incretins|incretins|mesh-ancestor
92048642|NCT01545388|Hormones|hormones|mesh-ancestor
92048643|NCT01545388|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048644|NCT01545388|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92048645|NCT01545388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92048646|NCT01545388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048647|NCT01545388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048648|NCT01545076|Immunoglobulin G|immunoglobulin g|mesh-list
92048649|NCT01545076|Immunologic Factors|immunologic factors|mesh-ancestor
92048650|NCT01545076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048651|NCT01544920|Interferons|interferons|mesh-list
92048652|NCT01544920|Ribavirin|ribavirin|mesh-list
92048653|NCT01544920|Interferon-alpha|interferon-alpha|mesh-list
92048654|NCT01544920|Interferon alpha-2|interferon alpha-2|mesh-list
92048655|NCT01544920|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92048656|NCT01544920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048659|NCT01544920|Antimetabolites|antimetabolites|mesh-ancestor
92048660|NCT01544920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048661|NCT01544920|Immunologic Factors|immunologic factors|mesh-ancestor
92014631|NCT05157711|Antacids|antacids|mesh-ancestor
92014632|NCT05157711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014633|NCT05157711|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048662|NCT01544920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048663|NCT01519960|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92048664|NCT01519960|Interferon-alpha|interferon-alpha|mesh-list
92048665|NCT01519960|Antiviral Agents|antiviral agents|mesh-ancestor
92048666|NCT01519960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048667|NCT01519960|Immunologic Factors|immunologic factors|mesh-ancestor
92048668|NCT01519960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048669|NCT01543204|Etanercept|etanercept|mesh-list
92048670|NCT01543204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92048671|NCT01543204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048672|NCT01543204|Analgesics|analgesics|mesh-ancestor
92048673|NCT01543204|Sensory System Agents|sensory system agents|mesh-ancestor
92048674|NCT01543204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048675|NCT01543204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048676|NCT01543204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048677|NCT01543204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048678|NCT01543204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92048679|NCT01543204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048680|NCT01543204|Immunologic Factors|immunologic factors|mesh-ancestor
92048682|NCT01518946|Sympathomimetics|sympathomimetics|mesh-ancestor
92048683|NCT01518946|Autonomic Agents|autonomic agents|mesh-ancestor
92048684|NCT01518946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048685|NCT01518946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048686|NCT01518946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92048687|NCT01518946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92048688|NCT01518946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92048689|NCT01518946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92048690|NCT01518946|Adrenergic Agents|adrenergic agents|mesh-ancestor
92048691|NCT01518946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048692|NCT01518946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048693|NCT01507246|Morphine|morphine|mesh-list
92048694|NCT01507246|Bupivacaine|bupivacaine|mesh-list
92048695|NCT01507246|Anesthetics, Local|anesthetics, local|mesh-ancestor
92048696|NCT01507246|Anesthetics|anesthetics|mesh-ancestor
92048697|NCT01507246|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048698|NCT01507246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048699|NCT01507246|Sensory System Agents|sensory system agents|mesh-ancestor
92048700|NCT01507246|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048701|NCT01507246|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92048702|NCT01507246|Narcotics|narcotics|mesh-ancestor
92048703|NCT01507246|Analgesics|analgesics|mesh-ancestor
92048704|NCT03870022|Carbon Monoxide|carbon monoxide|mesh-list
92048705|NCT03870022|Antimetabolites|antimetabolites|mesh-ancestor
92048706|NCT03870022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048707|NCT03870022|Gasotransmitters|gasotransmitters|mesh-ancestor
92048708|NCT03870022|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048709|NCT03870022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048710|NCT02073448|Adapalene|adapalene|mesh-list
92048711|NCT02073448|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92048712|NCT02073448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048713|NCT02073448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92048714|NCT02073448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048715|NCT02073448|Analgesics|analgesics|mesh-ancestor
92048716|NCT02073448|Sensory System Agents|sensory system agents|mesh-ancestor
92048717|NCT02073448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048718|NCT02073448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048719|NCT02073448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048720|NCT02073448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048721|NCT01487200|Triamcinolone|triamcinolone|mesh-list
92048722|NCT01487200|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92048723|NCT01487200|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92048725|NCT01487200|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92048726|NCT01487200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048727|NCT01487200|Glucocorticoids|glucocorticoids|mesh-ancestor
92048728|NCT01487200|Hormones|hormones|mesh-ancestor
92048729|NCT01487200|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048730|NCT01487200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014634|NCT05157711|Sunscreening Agents|sunscreening agents|mesh-ancestor
92014635|NCT05157711|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92014636|NCT05157711|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048734|NCT01487200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048735|NCT01505608|Irinotecan|irinotecan|mesh-list
92048736|NCT01505608|Temozolomide|temozolomide|mesh-list
92048737|NCT01505608|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92048738|NCT01505608|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92048739|NCT01505608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048740|NCT01505608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048741|NCT01505608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048742|NCT01505608|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92048743|NCT01505608|Alkylating Agents|alkylating agents|mesh-ancestor
92048744|NCT01486966|Insulin|insulin|mesh-list
92048745|NCT01486966|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92048746|NCT01486966|Metformin|metformin|mesh-list
92048747|NCT01486966|Insulin Aspart|insulin aspart|mesh-list
92048748|NCT01486966|Insulin Detemir|insulin detemir|mesh-list
92048749|NCT01486966|Isophane Insulin, Human|isophane insulin, human|mesh-list
92048750|NCT01486966|Insulin, Isophane|insulin, isophane|mesh-list
92048751|NCT01486966|Isophane insulin, beef|isophane insulin, beef|mesh-list
92048752|NCT01486966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048753|NCT01486966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048755|NCT04080076|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048756|NCT04080076|Immunologic Factors|immunologic factors|mesh-ancestor
92048757|NCT04080076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048758|NCT04080076|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92048759|NCT04080076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048760|NCT04080076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048761|NCT01900431|Leucovorin|leucovorin|mesh-list
92048762|NCT01900431|Folic Acid|folic acid|mesh-list
92048763|NCT01900431|Prednisone|prednisone|mesh-list
92048764|NCT01900431|Methotrexate|methotrexate|mesh-list
92048765|NCT01900431|Levoleucovorin|levoleucovorin|mesh-list
92048766|NCT01900431|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048767|NCT01900431|Glucocorticoids|glucocorticoids|mesh-ancestor
92048768|NCT01900431|Hormones|hormones|mesh-ancestor
92048769|NCT01900431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048770|NCT01900431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048771|NCT01900431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92048772|NCT01900431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048773|NCT01900431|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92048774|NCT01900431|Abortifacient Agents|abortifacient agents|mesh-ancestor
92048775|NCT01900431|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92048776|NCT01900431|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92048777|NCT01900431|Antimetabolites|antimetabolites|mesh-ancestor
92048778|NCT01900431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048779|NCT01900431|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048780|NCT01900431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048781|NCT01900431|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92048782|NCT01900431|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048783|NCT01900431|Immunologic Factors|immunologic factors|mesh-ancestor
92048784|NCT01900431|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048785|NCT01900431|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92048786|NCT01900431|Antidotes|antidotes|mesh-ancestor
92048787|NCT01900431|Protective Agents|protective agents|mesh-ancestor
92048788|NCT01900431|Vitamin B Complex|vitamin b complex|mesh-ancestor
92048789|NCT01900431|Vitamins|vitamins|mesh-ancestor
92048790|NCT01900431|Micronutrients|micronutrients|mesh-ancestor
92048791|NCT01900431|Hematinics|hematinics|mesh-ancestor
92048792|NCT01948791|Rivastigmine|rivastigmine|mesh-list
92048793|NCT01948791|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92048794|NCT01948791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048795|NCT01948791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048796|NCT01948791|Cholinergic Agents|cholinergic agents|mesh-ancestor
92048797|NCT01948791|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048798|NCT01948791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048799|NCT01948791|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92048800|NCT01948791|Protective Agents|protective agents|mesh-ancestor
92048801|NCT01898091|Ascorbic Acid|ascorbic acid|mesh-list
92048802|NCT01898091|Glycerol|glycerol|mesh-list
92048803|NCT01898091|Antioxidants|antioxidants|mesh-ancestor
92014637|NCT05157711|Hemostatics|hemostatics|mesh-ancestor
92014638|NCT05157711|Coagulants|coagulants|mesh-ancestor
92014639|NCT05105997|Dexamethasone|dexamethasone|mesh-list
92014640|NCT05105997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014641|NCT05105997|Antiemetics|antiemetics|mesh-ancestor
92048804|NCT01898091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048805|NCT01898091|Protective Agents|protective agents|mesh-ancestor
92048808|NCT01898091|Micronutrients|micronutrients|mesh-ancestor
92048809|NCT01898091|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92048811|NCT01947855|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92048812|NCT01947855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048813|NCT01947855|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048814|NCT01947855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048815|NCT01888497|Diphenhydramine|diphenhydramine|mesh-list
92048816|NCT01888497|Promethazine|promethazine|mesh-list
92048817|NCT01888497|Triazolam|triazolam|mesh-list
92048818|NCT01888497|Gabapentin|gabapentin|mesh-list
92048819|NCT01888497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048820|NCT01888497|Analgesics|analgesics|mesh-ancestor
92048821|NCT01888497|Sensory System Agents|sensory system agents|mesh-ancestor
92048822|NCT01888497|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048823|NCT01888497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048824|NCT01888497|Anticonvulsants|anticonvulsants|mesh-ancestor
92048825|NCT01888497|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92048826|NCT01888497|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92048827|NCT01888497|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048828|NCT01888497|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92048829|NCT01888497|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92048830|NCT01888497|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92048831|NCT01888497|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048832|NCT01888497|Antimanic Agents|antimanic agents|mesh-ancestor
92048833|NCT01888497|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92048834|NCT01888497|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92048835|NCT01888497|Anesthetics, Local|anesthetics, local|mesh-ancestor
92048836|NCT01888497|Anesthetics|anesthetics|mesh-ancestor
92048837|NCT01888497|Antiemetics|antiemetics|mesh-ancestor
92048838|NCT01888497|Autonomic Agents|autonomic agents|mesh-ancestor
92048839|NCT01888497|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92048840|NCT01888497|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92048841|NCT01888497|Histamine Antagonists|histamine antagonists|mesh-ancestor
92048842|NCT01888497|Histamine Agents|histamine agents|mesh-ancestor
92048843|NCT01888497|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92048844|NCT01888497|Antipruritics|antipruritics|mesh-ancestor
92048845|NCT01888497|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048846|NCT01888497|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92048847|NCT01888497|GABA Modulators|gaba modulators|mesh-ancestor
92048848|NCT01888497|GABA Agents|gaba agents|mesh-ancestor
92048849|NCT01485796|Immunoglobulins|immunoglobulins|mesh-list
92048850|NCT01485796|Antibodies|antibodies|mesh-list
92048851|NCT01485796|gamma-Globulins|gamma-globulins|mesh-list
92048852|NCT01485796|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92048853|NCT01485796|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92048854|NCT01485796|Immunologic Factors|immunologic factors|mesh-ancestor
92048855|NCT01485796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048856|NCT01897233|Ivacaftor|ivacaftor|mesh-list
92048857|NCT01897233|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92048858|NCT01897233|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92048859|NCT01897233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048860|NCT01887717|Sorafenib|sorafenib|mesh-list
92048861|NCT01887717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048862|NCT01887717|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92048863|NCT01887717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048864|NCT01887717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048865|NCT01946529|Cyclophosphamide|cyclophosphamide|mesh-list
92048866|NCT01946529|Temozolomide|temozolomide|mesh-list
92048867|NCT01946529|Ifosfamide|ifosfamide|mesh-list
92048868|NCT01946529|Bevacizumab|bevacizumab|mesh-list
92048869|NCT01946529|Doxorubicin|doxorubicin|mesh-list
92048870|NCT01946529|Etoposide|etoposide|mesh-list
92048871|NCT01946529|Vincristine|vincristine|mesh-list
92048872|NCT01946529|Sorafenib|sorafenib|mesh-list
92048873|NCT01946529|Temsirolimus|temsirolimus|mesh-list
92014643|NCT05105997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014644|NCT05105997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014645|NCT05105997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014646|NCT05105997|Glucocorticoids|glucocorticoids|mesh-ancestor
92014647|NCT05105997|Hormones|hormones|mesh-ancestor
92014648|NCT05105997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048874|NCT01946529|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048875|NCT01946529|Immunologic Factors|immunologic factors|mesh-ancestor
92048876|NCT01946529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048877|NCT01946529|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048878|NCT01946529|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92048879|NCT01946529|Alkylating Agents|alkylating agents|mesh-ancestor
92048880|NCT01946529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048881|NCT01946529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048884|NCT01946529|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048885|NCT01946529|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048886|NCT01946529|Growth Substances|growth substances|mesh-ancestor
92048887|NCT01946529|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048888|NCT01946529|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92048889|NCT01946529|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92048890|NCT01946529|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92048891|NCT01946529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048892|NCT01946529|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92048893|NCT01946529|Tubulin Modulators|tubulin modulators|mesh-ancestor
92048894|NCT01946529|Antimitotic Agents|antimitotic agents|mesh-ancestor
92048895|NCT01946529|Mitosis Modulators|mitosis modulators|mesh-ancestor
92048896|NCT01946529|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92048897|NCT01946529|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92048898|NCT01463098|Zolpidem|zolpidem|mesh-list
92048899|NCT01463098|Lemborexant|lemborexant|mesh-list
92048900|NCT01463098|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92048901|NCT01463098|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92048902|NCT01463098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048903|NCT01463098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048904|NCT01463098|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92048905|NCT01463098|GABA Agonists|gaba agonists|mesh-ancestor
92048907|NCT01463098|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048908|NCT01463098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048909|NCT01463098|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92048910|NCT01462942|Bromides|bromides|mesh-list
92048911|NCT01462942|Formoterol Fumarate|formoterol fumarate|mesh-list
92048912|NCT01462942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92048913|NCT01462942|Autonomic Agents|autonomic agents|mesh-ancestor
92048914|NCT01462942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92048915|NCT01462942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048916|NCT01462942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92048917|NCT01462942|Respiratory System Agents|respiratory system agents|mesh-ancestor
92048918|NCT01462942|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92048919|NCT01462942|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92048920|NCT01462942|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92048921|NCT01462942|Adrenergic Agents|adrenergic agents|mesh-ancestor
92048922|NCT01462942|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048923|NCT01462942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048924|NCT01462942|Anticonvulsants|anticonvulsants|mesh-ancestor
92048925|NCT01462630|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92048926|NCT01462630|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92048927|NCT01462630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048928|NCT01504204|Adapalene|adapalene|mesh-list
92048929|NCT01504204|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92048930|NCT01504204|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92048931|NCT01504204|Dermatologic Agents|dermatologic agents|mesh-ancestor
92048932|NCT01504204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92048933|NCT01504204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048934|NCT01504204|Analgesics|analgesics|mesh-ancestor
92048935|NCT01504204|Sensory System Agents|sensory system agents|mesh-ancestor
92048936|NCT01504204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014649|NCT05105997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92014650|NCT05105997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048937|NCT01504204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048938|NCT01504204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92048939|NCT01504204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92048940|NCT01485640|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92048941|NCT01485640|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92048942|NCT01485640|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92048943|NCT01485640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92048944|NCT01485640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048945|NCT01485640|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92048946|NCT01485640|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92048947|NCT01485640|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92048948|NCT01485640|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92048949|NCT01485640|Adrenergic Agents|adrenergic agents|mesh-ancestor
92048950|NCT01485640|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048951|NCT01485640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048952|NCT01485640|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92048955|NCT01485640|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92048956|NCT01485640|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92048957|NCT01485640|Dopamine Agents|dopamine agents|mesh-ancestor
92048959|NCT02118961|Immunologic Factors|immunologic factors|mesh-ancestor
92048960|NCT02118961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048961|NCT02140645|Linagliptin|linagliptin|mesh-list
92048962|NCT02140645|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048963|NCT02140645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048964|NCT02140645|Incretins|incretins|mesh-ancestor
92048965|NCT02140645|Hormones|hormones|mesh-ancestor
92048966|NCT02140645|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92048967|NCT02140645|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92048968|NCT02140645|Protease Inhibitors|protease inhibitors|mesh-ancestor
92048969|NCT02140645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048970|NCT02140645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048971|NCT02140411|Ranibizumab|ranibizumab|mesh-list
92048972|NCT02140411|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92048973|NCT02140411|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048974|NCT02140411|Growth Substances|growth substances|mesh-ancestor
92048975|NCT02140411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048976|NCT02140411|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048977|NCT02140411|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048978|NCT02139943|Canagliflozin|canagliflozin|mesh-list
92048979|NCT02139943|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92048980|NCT02139943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048981|NCT02139943|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92048982|NCT02139943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048983|NCT01485172|Ropinirole|ropinirole|mesh-list
92048984|NCT01485172|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92048985|NCT01485172|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92048986|NCT01485172|Dopamine Agonists|dopamine agonists|mesh-ancestor
92048987|NCT01485172|Dopamine Agents|dopamine agents|mesh-ancestor
92048988|NCT01485172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048989|NCT01485172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048990|NCT01485172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048991|NCT02105701|Ribavirin|ribavirin|mesh-list
92048992|NCT02105701|Grazoprevir|grazoprevir|mesh-list
92048993|NCT02105701|Antimetabolites|antimetabolites|mesh-ancestor
92048994|NCT02105701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048995|NCT02105701|Antiviral Agents|antiviral agents|mesh-ancestor
92048996|NCT02105701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048997|NCT04411225|Cannabidiol|cannabidiol|mesh-list
92048998|NCT04411225|Anticonvulsants|anticonvulsants|mesh-ancestor
92048999|NCT01502956|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92049000|NCT01502956|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92049001|NCT01502956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049002|NCT01502956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049003|NCT01502956|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92049004|NCT01502956|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049005|NCT01502956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049006|NCT01502956|Cholinergic Agents|cholinergic agents|mesh-ancestor
92049007|NCT01502956|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014652|NCT03424525|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92014653|NCT03424525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014654|NCT03424525|Antimalarials|antimalarials|mesh-ancestor
92014655|NCT03424525|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92049008|NCT01502644|Morphine|morphine|mesh-list
92049009|NCT01502644|Oxycodone|oxycodone|mesh-list
92049010|NCT01502644|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92049011|NCT01502644|Narcotics|narcotics|mesh-ancestor
92049012|NCT01502644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049013|NCT01502644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049014|NCT01502644|Analgesics|analgesics|mesh-ancestor
92049015|NCT01502644|Sensory System Agents|sensory system agents|mesh-ancestor
92049016|NCT01502644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049017|NCT01462318|Vitamin K|vitamin k|mesh-list
92049019|NCT01462318|Dextromethorphan|dextromethorphan|mesh-list
92049020|NCT01462318|Caffeine|caffeine|mesh-list
92049021|NCT01462318|Omeprazole|omeprazole|mesh-list
92049022|NCT01462318|Warfarin|warfarin|mesh-list
92049023|NCT01462318|Daclizumab|daclizumab|mesh-list
92049024|NCT01462318|Vitamins|vitamins|mesh-ancestor
92049025|NCT01462318|Micronutrients|micronutrients|mesh-ancestor
92049026|NCT01462318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049027|NCT01462318|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92049031|NCT01462318|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049032|NCT01462318|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049033|NCT01462318|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92049034|NCT01462318|Anesthetics, General|anesthetics, general|mesh-ancestor
92049035|NCT01462318|Anesthetics|anesthetics|mesh-ancestor
92049036|NCT01462318|GABA Modulators|gaba modulators|mesh-ancestor
92049037|NCT01462318|GABA Agents|gaba agents|mesh-ancestor
92049038|NCT01462318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049039|NCT01462318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049040|NCT01462318|Anticoagulants|anticoagulants|mesh-ancestor
92049041|NCT01462318|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92049042|NCT01462318|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92049043|NCT01462318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049044|NCT01462318|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92049045|NCT01462318|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92049046|NCT01462318|Purinergic Agents|purinergic agents|mesh-ancestor
92049047|NCT01462318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92049048|NCT01462318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92049049|NCT01462318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92049050|NCT01462318|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92049051|NCT01462318|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92049052|NCT01462318|Hemostatics|hemostatics|mesh-ancestor
92049053|NCT01462318|Coagulants|coagulants|mesh-ancestor
92049054|NCT01462318|Antitussive Agents|antitussive agents|mesh-ancestor
92049055|NCT01462318|Respiratory System Agents|respiratory system agents|mesh-ancestor
92049056|NCT01462318|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92049057|NCT01462318|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92049058|NCT01462318|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049059|NCT01462318|Immunologic Factors|immunologic factors|mesh-ancestor
92049060|NCT01485094|Pregabalin|pregabalin|mesh-list
92049061|NCT01485094|Analgesics|analgesics|mesh-ancestor
92049062|NCT01485094|Sensory System Agents|sensory system agents|mesh-ancestor
92049063|NCT01485094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049064|NCT01485094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049065|NCT01485094|Anticonvulsants|anticonvulsants|mesh-ancestor
92049066|NCT01485094|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92049067|NCT01485094|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049068|NCT01485094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049069|NCT01485094|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92049070|NCT01485094|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92049071|NCT01485094|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049072|NCT01485094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049073|NCT01485094|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049074|NCT04079686|Cefazolin|cefazolin|mesh-list
92049075|NCT04079686|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92049076|NCT04079686|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049078|NCT01502410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014656|NCT03424525|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92014657|NCT03424525|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92014658|NCT03424525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014659|NCT03424525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049079|NCT01502410|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92049080|NCT01502410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049081|NCT01502410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049082|NCT04757636|Aflibercept|aflibercept|mesh-list
92049083|NCT04757636|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92049084|NCT04757636|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92049085|NCT04757636|Growth Substances|growth substances|mesh-ancestor
92049086|NCT04757636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049087|NCT04757636|Growth Inhibitors|growth inhibitors|mesh-ancestor
92049088|NCT04757636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049089|NCT02132312|Phenylephrine|phenylephrine|mesh-list
92049090|NCT02132312|Oxymetazoline|oxymetazoline|mesh-list
92049091|NCT02132312|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92049092|NCT02132312|Mydriatics|mydriatics|mesh-ancestor
92049093|NCT02132312|Autonomic Agents|autonomic agents|mesh-ancestor
92049094|NCT02132312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049095|NCT02132312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049096|NCT02132312|Sympathomimetics|sympathomimetics|mesh-ancestor
92049097|NCT02132312|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92049098|NCT02132312|Nasal Decongestants|nasal decongestants|mesh-ancestor
92049101|NCT02132312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92049102|NCT02132312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92049103|NCT02132312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92049104|NCT02132312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049105|NCT02132312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049106|NCT02132312|Protective Agents|protective agents|mesh-ancestor
92049108|NCT02150954|Oxytocics|oxytocics|mesh-ancestor
92049109|NCT02150954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92049110|NCT02150954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049111|NCT04188392|Pimavanserin|pimavanserin|mesh-list
92049112|NCT04188392|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92049113|NCT04188392|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92049114|NCT04188392|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92049115|NCT04188392|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049116|NCT04188392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049117|NCT04188392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049118|NCT04188392|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049119|NCT04188392|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92049120|NCT04188392|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92049121|NCT04188392|Serotonin Agents|serotonin agents|mesh-ancestor
92049122|NCT04188392|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049123|NCT04188392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049124|NCT02170298|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92049125|NCT02170298|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92049126|NCT02170298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049127|NCT02170298|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92049128|NCT02170298|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92049129|NCT02170298|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049130|NCT02170298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049131|NCT02170298|Dopamine Agents|dopamine agents|mesh-ancestor
92049132|NCT02170298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049133|NCT02131064|Carboplatin|carboplatin|mesh-list
92049134|NCT02131064|Docetaxel|docetaxel|mesh-list
92049135|NCT02131064|Trastuzumab|trastuzumab|mesh-list
92049136|NCT02131064|Pertuzumab|pertuzumab|mesh-list
92049137|NCT02131064|Maytansine|maytansine|mesh-list
92049138|NCT02131064|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92049139|NCT02131064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049140|NCT02131064|Tubulin Modulators|tubulin modulators|mesh-ancestor
92049141|NCT02131064|Antimitotic Agents|antimitotic agents|mesh-ancestor
92049142|NCT02131064|Mitosis Modulators|mitosis modulators|mesh-ancestor
92049143|NCT02131064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049144|NCT02131064|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014660|NCT03424525|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92014661|NCT03424525|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92049145|NCT02131064|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92049146|NCT02131064|Immunotoxins|immunotoxins|mesh-ancestor
92049147|NCT02131064|Immunoconjugates|immunoconjugates|mesh-ancestor
92049148|NCT02131064|Immunologic Factors|immunologic factors|mesh-ancestor
92049149|NCT02131064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049150|NCT02130284|Insulin|insulin|mesh-list
92049151|NCT02130284|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92049152|NCT02130284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92049153|NCT02130284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049154|NCT04749212|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92049155|NCT04749212|Natriuretic Agents|natriuretic agents|mesh-ancestor
92049156|NCT04749212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049157|NCT04748822|Ethanol|ethanol|mesh-list
92049158|NCT04748822|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92049159|NCT04748822|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049160|NCT04748822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049161|NCT04748822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049162|NCT04739150|Nintedanib|nintedanib|mesh-list
92049163|NCT04739150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049164|NCT04739150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92049165|NCT04739150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049166|NCT04739150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049167|NCT02147132|Nicotine|nicotine|mesh-list
92049168|NCT02147132|Varenicline|varenicline|mesh-list
92049169|NCT02147132|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92049172|NCT02147132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049174|NCT02147132|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92049175|NCT02147132|Cholinergic Agents|cholinergic agents|mesh-ancestor
92049176|NCT02147132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049177|NCT02147132|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049178|NCT02146430|Pregabalin|pregabalin|mesh-list
92049179|NCT02146430|Analgesics|analgesics|mesh-ancestor
92049180|NCT02146430|Sensory System Agents|sensory system agents|mesh-ancestor
92049181|NCT02146430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049182|NCT02146430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049183|NCT02146430|Anticonvulsants|anticonvulsants|mesh-ancestor
92049184|NCT02146430|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92049185|NCT02146430|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049186|NCT02146430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049187|NCT02146430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92049188|NCT02146430|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92049189|NCT02146430|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049190|NCT02146430|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049191|NCT02146430|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049192|NCT02129192|Amlodipine|amlodipine|mesh-list
92049193|NCT02129192|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92049194|NCT02129192|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92049195|NCT02129192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049196|NCT02129192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049197|NCT02129192|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92049198|NCT02129192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049199|NCT02129192|Vasodilator Agents|vasodilator agents|mesh-ancestor
92049200|NCT02128490|Naproxen|naproxen|mesh-list
92049201|NCT02128490|Colchicine|colchicine|mesh-list
92049202|NCT02128490|Febuxostat|febuxostat|mesh-list
92049203|NCT02128490|Lansoprazole|lansoprazole|mesh-list
92049204|NCT02128490|Dexlansoprazole|dexlansoprazole|mesh-list
92049205|NCT02128490|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92049206|NCT02128490|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049208|NCT02128490|Sensory System Agents|sensory system agents|mesh-ancestor
92049209|NCT02128490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049210|NCT02128490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049211|NCT02128490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049212|NCT02128490|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049213|NCT02128490|Gout Suppressants|gout suppressants|mesh-ancestor
92049214|NCT02128490|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92049215|NCT02128490|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049216|NCT02128490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049217|NCT02128490|Tubulin Modulators|tubulin modulators|mesh-ancestor
92014662|NCT03424525|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92049218|NCT02128490|Antimitotic Agents|antimitotic agents|mesh-ancestor
92049219|NCT02128490|Mitosis Modulators|mitosis modulators|mesh-ancestor
92049220|NCT02128490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049221|NCT02128490|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92049222|NCT02128490|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92049223|NCT02128490|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92049225|NCT02105636|Nivolumab|nivolumab|mesh-list
92049226|NCT02105636|Methotrexate|methotrexate|mesh-list
92049227|NCT02105636|Cetuximab|cetuximab|mesh-list
92049228|NCT02105636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049229|NCT02105636|Tubulin Modulators|tubulin modulators|mesh-ancestor
92049230|NCT02105636|Antimitotic Agents|antimitotic agents|mesh-ancestor
92049231|NCT02105636|Mitosis Modulators|mitosis modulators|mesh-ancestor
92049232|NCT02105636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049233|NCT02105636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049234|NCT02105636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92049235|NCT02105636|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92049236|NCT02105636|Abortifacient Agents|abortifacient agents|mesh-ancestor
92049237|NCT02105636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92049238|NCT02105636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049239|NCT02105636|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92049240|NCT02105636|Antimetabolites|antimetabolites|mesh-ancestor
92049241|NCT02105636|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049242|NCT02105636|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049246|NCT02105636|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049247|NCT02105636|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92049248|NCT04748042|Prednisone|prednisone|mesh-list
92049249|NCT04748042|Olaparib|olaparib|mesh-list
92049250|NCT04748042|Androgens|androgens|mesh-list
92049251|NCT04748042|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049252|NCT04748042|Glucocorticoids|glucocorticoids|mesh-ancestor
92049253|NCT04748042|Hormones|hormones|mesh-ancestor
92049254|NCT04748042|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049255|NCT04748042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049256|NCT04748042|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92049257|NCT04748042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049258|NCT04748042|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92049259|NCT04748042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049260|NCT04748042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049261|NCT01626872|Risperidone|risperidone|mesh-list
92049262|NCT01626872|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92049263|NCT01626872|Serotonin Agents|serotonin agents|mesh-ancestor
92049264|NCT01626872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049265|NCT01626872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049266|NCT01626872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049267|NCT01626872|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92049268|NCT01626872|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049269|NCT01626872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049270|NCT01626872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049271|NCT01626872|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92049272|NCT01626872|Dopamine Agents|dopamine agents|mesh-ancestor
92049273|NCT01598090|Ribavirin|ribavirin|mesh-list
92049274|NCT01598090|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92049275|NCT01598090|Antimetabolites|antimetabolites|mesh-ancestor
92049276|NCT01598090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049277|NCT01598090|Antiviral Agents|antiviral agents|mesh-ancestor
92049278|NCT01598090|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049279|NCT02145182|Eculizumab|eculizumab|mesh-list
92049281|NCT02145182|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049282|NCT02145182|Immunologic Factors|immunologic factors|mesh-ancestor
92049283|NCT02145182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049284|NCT02145026|Epoetin Alfa|epoetin alfa|mesh-list
92049285|NCT02145026|Hematinics|hematinics|mesh-ancestor
92049286|NCT02144012|Docetaxel|docetaxel|mesh-list
92049287|NCT02144012|Trastuzumab|trastuzumab|mesh-list
92049288|NCT02144012|Maytansine|maytansine|mesh-list
92049289|NCT02144012|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92049290|NCT02144012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049291|NCT02144012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92049292|NCT02144012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92049293|NCT02144012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92049294|NCT02144012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049295|NCT02144012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014664|NCT05104983|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92014666|NCT05104983|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92049296|NCT02144012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92049297|NCT02144012|Immunotoxins|immunotoxins|mesh-ancestor
92049298|NCT02144012|Immunoconjugates|immunoconjugates|mesh-ancestor
92049299|NCT02144012|Immunologic Factors|immunologic factors|mesh-ancestor
92049300|NCT02144012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049301|NCT02103062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92049302|NCT02103062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049303|NCT02141672|Cyclosporine|cyclosporine|mesh-list
92049304|NCT02141672|Antifungal Agents|antifungal agents|mesh-ancestor
92049305|NCT02141672|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049306|NCT02141672|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049307|NCT02141672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049308|NCT02141672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049309|NCT02141672|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049310|NCT02141672|Immunologic Factors|immunologic factors|mesh-ancestor
92049311|NCT02141672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049312|NCT02141672|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049313|NCT02141672|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92049314|NCT01628120|Epoetin Alfa|epoetin alfa|mesh-list
92049315|NCT01628120|Hematinics|hematinics|mesh-ancestor
92049316|NCT02125604|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92049317|NCT02125604|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049320|NCT02125604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049321|NCT02124746|N-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|n-(cyanomethyl)-4-(2-((4-(4-morpholinyl)phenyl)amino)-4-pyrimidinyl)benzamide|mesh-list
92049322|NCT02124746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92049323|NCT02124746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049324|NCT02124746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049325|NCT02123966|Sirolimus|sirolimus|mesh-list
92049326|NCT02123966|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92049327|NCT02123966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049328|NCT02123966|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92049329|NCT02123966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049330|NCT02123966|Antifungal Agents|antifungal agents|mesh-ancestor
92049331|NCT02123966|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049332|NCT02123966|Immunologic Factors|immunologic factors|mesh-ancestor
92049333|NCT02123966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049334|NCT02123576|Pentoxifylline|pentoxifylline|mesh-list
92049335|NCT02123576|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92049336|NCT02123576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049337|NCT02123576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049338|NCT02123576|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92049339|NCT02123576|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92049340|NCT02123576|Protective Agents|protective agents|mesh-ancestor
92049341|NCT02123576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049342|NCT02123576|Vasodilator Agents|vasodilator agents|mesh-ancestor
92049343|NCT02123576|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92049344|NCT02123576|Antioxidants|antioxidants|mesh-ancestor
92049345|NCT05235347|Sotrovimab|sotrovimab|mesh-list
92049346|NCT05235347|Antiviral Agents|antiviral agents|mesh-ancestor
92049347|NCT05235347|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049348|NCT03368729|Trastuzumab|trastuzumab|mesh-list
92049349|NCT03368729|Niraparib|niraparib|mesh-list
92049350|NCT03368729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049351|NCT03368729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049352|NCT03368729|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92049353|NCT03368729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049354|NCT03368729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049355|NCT02140970|Ibuprofen|ibuprofen|mesh-list
92049356|NCT02140970|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92049357|NCT02140970|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049358|NCT02140970|Analgesics|analgesics|mesh-ancestor
92049359|NCT02140970|Sensory System Agents|sensory system agents|mesh-ancestor
92049360|NCT02140970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049361|NCT02140970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049362|NCT02140970|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049363|NCT02140970|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049364|NCT02140970|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92049365|NCT02140970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014668|NCT05104983|Antifungal Agents|antifungal agents|mesh-ancestor
92014669|NCT05104983|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049366|NCT02140970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049367|NCT02101112|Apixaban|apixaban|mesh-list
92049368|NCT02101112|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92049369|NCT02101112|Antithrombins|antithrombins|mesh-ancestor
92049370|NCT02101112|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92049371|NCT02101112|Protease Inhibitors|protease inhibitors|mesh-ancestor
92049372|NCT02101112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049373|NCT02101112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049374|NCT02101112|Anticoagulants|anticoagulants|mesh-ancestor
92049375|NCT02139644|Fluticasone|fluticasone|mesh-list
92049376|NCT02139644|Xhance|xhance|mesh-list
92049377|NCT02139644|Beclomethasone|beclomethasone|mesh-list
92049378|NCT02139644|Albuterol|albuterol|mesh-list
92049379|NCT02139644|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92049380|NCT02139644|Adrenergic Agonists|adrenergic agonists|mesh-list
92049381|NCT02139644|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049382|NCT02139644|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92049383|NCT02139644|Autonomic Agents|autonomic agents|mesh-ancestor
92049384|NCT02139644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049385|NCT02139644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049386|NCT02139644|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92049387|NCT02139644|Respiratory System Agents|respiratory system agents|mesh-ancestor
92049388|NCT02139644|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049389|NCT02139644|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92049393|NCT02139644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049394|NCT02139644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049395|NCT02139644|Tocolytic Agents|tocolytic agents|mesh-ancestor
92049396|NCT02139644|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92049397|NCT02139644|Glucocorticoids|glucocorticoids|mesh-ancestor
92049398|NCT02139644|Hormones|hormones|mesh-ancestor
92049399|NCT02139644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049400|NCT02100644|Lamotrigine|lamotrigine|mesh-list
92049401|NCT02100644|Anticonvulsants|anticonvulsants|mesh-ancestor
92049402|NCT02100644|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92049403|NCT02100644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049404|NCT02100644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049405|NCT02100644|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92049406|NCT02100644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049407|NCT02100644|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92049408|NCT02100644|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049409|NCT02100644|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049410|NCT02100644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049411|NCT02100644|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92049412|NCT04798469|Methyltestosterone|methyltestosterone|mesh-list
92049413|NCT04798469|Testosterone|testosterone|mesh-list
92049414|NCT04798469|Testosterone undecanoate|testosterone undecanoate|mesh-list
92049415|NCT04798469|Testosterone enanthate|testosterone enanthate|mesh-list
92049416|NCT04798469|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92049417|NCT04798469|Androgens|androgens|mesh-ancestor
92049418|NCT04798469|Hormones|hormones|mesh-ancestor
92049419|NCT04798469|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049420|NCT04798469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049421|NCT04798469|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92049422|NCT04798469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049423|NCT04798469|Anabolic Agents|anabolic agents|mesh-ancestor
92049424|NCT02074982|Ustekinumab|ustekinumab|mesh-list
92049425|NCT02074982|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92049426|NCT02074982|Immunologic Factors|immunologic factors|mesh-ancestor
92049427|NCT02074982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049428|NCT02074982|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049430|NCT04150913|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92049431|NCT04150913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049432|NCT04150913|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049433|NCT04150913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049434|NCT04798001|Vaccines|vaccines|mesh-list
92049435|NCT04798001|Immunologic Factors|immunologic factors|mesh-ancestor
92049436|NCT04798001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049437|NCT02074514|Sofosbuvir|sofosbuvir|mesh-list
92049438|NCT02074514|Antiviral Agents|antiviral agents|mesh-ancestor
92049439|NCT02074514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014670|NCT05104983|Immunologic Factors|immunologic factors|mesh-ancestor
92014671|NCT05104983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014672|NCT04801511|Ascorbic Acid|ascorbic acid|mesh-list
92014673|NCT04801511|Vitamins|vitamins|mesh-ancestor
92014674|NCT04801511|Micronutrients|micronutrients|mesh-ancestor
92049440|NCT04073303|Botulinum Toxins|botulinum toxins|mesh-list
92049441|NCT04073303|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92049442|NCT04073303|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92049443|NCT04073303|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92049444|NCT04073303|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049445|NCT04073303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049446|NCT04073303|Cholinergic Agents|cholinergic agents|mesh-ancestor
92049447|NCT04073303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049448|NCT04073303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049449|NCT04073303|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92049450|NCT04073303|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049451|NCT04070573|Aspirin|aspirin|mesh-list
92049452|NCT04070573|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92049453|NCT04070573|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049454|NCT04070573|Analgesics|analgesics|mesh-ancestor
92049455|NCT04070573|Sensory System Agents|sensory system agents|mesh-ancestor
92049456|NCT04070573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049457|NCT04070573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049458|NCT04070573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049459|NCT04070573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049460|NCT04070573|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92049464|NCT04070573|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92049465|NCT04070573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049466|NCT04070573|Antipyretics|antipyretics|mesh-ancestor
92049467|NCT02099708|Lansoprazole|lansoprazole|mesh-list
92049468|NCT02099708|Dexlansoprazole|dexlansoprazole|mesh-list
92049469|NCT02099708|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92049470|NCT02099708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92049471|NCT02099708|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92049472|NCT02099708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049473|NCT02099708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049475|NCT02073656|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92049476|NCT02073656|Ledipasvir|ledipasvir|mesh-list
92049477|NCT02073656|Antiviral Agents|antiviral agents|mesh-ancestor
92049478|NCT02073656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049479|NCT04061213|Technetium Tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|technetium tc 99m 1,1-diphosphonopropane-2,3-dicarboxylic acid|mesh-list
92049480|NCT04061213|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92049481|NCT04061213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049482|NCT02209181|Acetaminophen|acetaminophen|mesh-list
92049483|NCT02209181|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049484|NCT02209181|Analgesics|analgesics|mesh-ancestor
92049485|NCT02209181|Sensory System Agents|sensory system agents|mesh-ancestor
92049486|NCT02209181|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049487|NCT02209181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049488|NCT02209181|Antipyretics|antipyretics|mesh-ancestor
92049489|NCT02242487|Levodopa|levodopa|mesh-list
92049490|NCT02242487|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92049491|NCT02242487|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92049492|NCT02242487|Dopamine Agents|dopamine agents|mesh-ancestor
92049493|NCT02242487|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049494|NCT02242487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049495|NCT02242487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049496|NCT02241785|Natalizumab|natalizumab|mesh-list
92049497|NCT02241785|Immunologic Factors|immunologic factors|mesh-ancestor
92049498|NCT02241785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049499|NCT02241551|Paclitaxel|paclitaxel|mesh-list
92049500|NCT02241551|Gemcitabine|gemcitabine|mesh-list
92049501|NCT02241551|Fluorouracil|fluorouracil|mesh-list
92049502|NCT02241551|Oxaliplatin|oxaliplatin|mesh-list
92049503|NCT02241551|Irinotecan|irinotecan|mesh-list
92049504|NCT02241551|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92049505|NCT02241551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049507|NCT02241551|Antimitotic Agents|antimitotic agents|mesh-ancestor
92049508|NCT02241551|Mitosis Modulators|mitosis modulators|mesh-ancestor
92049509|NCT02241551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014675|NCT04801511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014676|NCT04801511|Antioxidants|antioxidants|mesh-ancestor
92049510|NCT02241551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92049511|NCT02241551|Antimetabolites|antimetabolites|mesh-ancestor
92049512|NCT02241551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049513|NCT02241551|Immunologic Factors|immunologic factors|mesh-ancestor
92049514|NCT02241551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049515|NCT02241551|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92049516|NCT02241551|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92049517|NCT02241551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049518|NCT02207621|Timolol|timolol|mesh-list
92049519|NCT02207621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92049520|NCT02207621|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92049521|NCT02207621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049522|NCT02207621|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92049523|NCT02207621|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92049524|NCT02207621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92049525|NCT02207621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049526|NCT02207621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049527|NCT02207621|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92049528|NCT02207621|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92049529|NCT02240693|BI 409306|bi 409306|mesh-list
92049530|NCT02240693|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92049531|NCT02240693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049532|NCT02240693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049535|NCT02239679|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049537|NCT02072096|Insulin Glargine|insulin glargine|mesh-list
92049538|NCT02072096|Pioglitazone|pioglitazone|mesh-list
92049539|NCT02072096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92049540|NCT02072096|Liraglutide|liraglutide|mesh-list
92049541|NCT02072096|Exenatide|exenatide|mesh-list
92049542|NCT02072096|Glimepiride|glimepiride|mesh-list
92049543|NCT02072096|Linagliptin|linagliptin|mesh-list
92049544|NCT02072096|Acarbose|acarbose|mesh-list
92049545|NCT02072096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92049546|NCT02072096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049547|NCT02072096|Incretins|incretins|mesh-ancestor
92049548|NCT02072096|Hormones|hormones|mesh-ancestor
92049549|NCT02072096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049550|NCT02072096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92049551|NCT02072096|Protease Inhibitors|protease inhibitors|mesh-ancestor
92049552|NCT02072096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049553|NCT02072096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049554|NCT02072096|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92049555|NCT02072096|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92049556|NCT02072096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049557|NCT02072096|Immunologic Factors|immunologic factors|mesh-ancestor
92049558|NCT02072096|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92049559|NCT01631825|Rotigotine|rotigotine|mesh-list
92049560|NCT01631825|Dopamine Agonists|dopamine agonists|mesh-ancestor
92049561|NCT01631825|Dopamine Agents|dopamine agents|mesh-ancestor
92049562|NCT01631825|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049563|NCT01631825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049564|NCT01631825|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049565|NCT02071082|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92049566|NCT02071082|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92049567|NCT02071082|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92049568|NCT02071082|Antiviral Agents|antiviral agents|mesh-ancestor
92049569|NCT02071082|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049570|NCT03836105|Cemiplimab|cemiplimab|mesh-list
92049571|NCT03836105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049572|NCT03836105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049573|NCT02123108|Mycophenolic Acid|mycophenolic acid|mesh-list
92049574|NCT02123108|Tacrolimus|tacrolimus|mesh-list
92049575|NCT02123108|Basiliximab|basiliximab|mesh-list
92049576|NCT02123108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049577|NCT02123108|Immunologic Factors|immunologic factors|mesh-ancestor
92049578|NCT02123108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049579|NCT02123108|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92049580|NCT02123108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049581|NCT02123108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014677|NCT04801511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014678|NCT04801511|Protective Agents|protective agents|mesh-ancestor
92014679|NCT04230759|Fluorouracil|fluorouracil|mesh-list
92014680|NCT04230759|Durvalumab|durvalumab|mesh-list
92014681|NCT04230759|Mitomycins|mitomycins|mesh-list
92014682|NCT04230759|Mitomycin|mitomycin|mesh-list
92014683|NCT04230759|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92014684|NCT04230759|Antimetabolites|antimetabolites|mesh-ancestor
92014685|NCT04230759|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014686|NCT04230759|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92049582|NCT02123108|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92049583|NCT02123108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049584|NCT02123108|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92049585|NCT02123108|Antitubercular Agents|antitubercular agents|mesh-ancestor
92049586|NCT02123108|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92049587|NCT02123108|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049588|NCT02121392|Bupivacaine|bupivacaine|mesh-list
92049589|NCT02121392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92049590|NCT02121392|Anesthetics|anesthetics|mesh-ancestor
92049591|NCT02121392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049592|NCT02121392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049593|NCT02121392|Sensory System Agents|sensory system agents|mesh-ancestor
92049594|NCT02121392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049596|NCT02097056|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92049597|NCT02097056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049598|NCT02097056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049599|NCT02097056|Cholinergic Agents|cholinergic agents|mesh-ancestor
92049600|NCT02097056|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049601|NCT02097056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049602|NCT02097056|Nootropic Agents|nootropic agents|mesh-ancestor
92049603|NCT02121002|Diclofenac|diclofenac|mesh-list
92049604|NCT02121002|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92049605|NCT02121002|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049606|NCT02121002|Analgesics|analgesics|mesh-ancestor
92049607|NCT02121002|Sensory System Agents|sensory system agents|mesh-ancestor
92049609|NCT02121002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049611|NCT02121002|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049612|NCT02121002|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92049613|NCT02121002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049614|NCT02121002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049615|NCT02096900|Midazolam|midazolam|mesh-list
92049616|NCT02096900|Zolpidem|zolpidem|mesh-list
92049617|NCT02096900|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92049618|NCT02096900|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92049619|NCT02096900|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049620|NCT02096900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049621|NCT02096900|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92049622|NCT02096900|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92049623|NCT02096900|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049624|NCT02096900|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92049625|NCT02096900|Anesthetics, General|anesthetics, general|mesh-ancestor
92049626|NCT02096900|Anesthetics|anesthetics|mesh-ancestor
92049627|NCT02096900|GABA Modulators|gaba modulators|mesh-ancestor
92049628|NCT02096900|GABA Agents|gaba agents|mesh-ancestor
92049629|NCT02096900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049630|NCT02096900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049631|NCT02096900|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92049632|NCT02096900|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92049633|NCT02096900|GABA Agonists|gaba agonists|mesh-ancestor
92049634|NCT02120924|Azelaic acid|azelaic acid|mesh-list
92049635|NCT02120924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049636|NCT02120924|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049637|NCT02096744|Clonidine|clonidine|mesh-list
92049638|NCT02096744|Analgesics|analgesics|mesh-ancestor
92049639|NCT02096744|Sensory System Agents|sensory system agents|mesh-ancestor
92049640|NCT02096744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014688|NCT04230759|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92014689|NCT04230759|Immunologic Factors|immunologic factors|mesh-ancestor
92014690|NCT04230759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014691|NCT04230759|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014692|NCT04230759|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92049641|NCT02096744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049642|NCT02096744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92049643|NCT02096744|Sympatholytics|sympatholytics|mesh-ancestor
92049644|NCT02096744|Autonomic Agents|autonomic agents|mesh-ancestor
92049645|NCT02096744|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92049646|NCT02096744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92049647|NCT02096744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92049648|NCT02096744|Adrenergic Agents|adrenergic agents|mesh-ancestor
92049649|NCT02096744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049650|NCT02096744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049651|NCT02096042|Azacitidine|azacitidine|mesh-list
92049652|NCT02096042|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92049653|NCT02096042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92049654|NCT02096042|Antimetabolites|antimetabolites|mesh-ancestor
92049655|NCT02096042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049656|NCT02096042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049657|NCT02096042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049658|NCT02096042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049659|NCT02096042|Immunotoxins|immunotoxins|mesh-ancestor
92049660|NCT02096042|Immunoconjugates|immunoconjugates|mesh-ancestor
92049661|NCT02096042|Immunologic Factors|immunologic factors|mesh-ancestor
92049662|NCT02096042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049663|NCT02120300|Sofosbuvir|sofosbuvir|mesh-list
92049664|NCT02120300|Antiviral Agents|antiviral agents|mesh-ancestor
92049665|NCT02120300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049666|NCT02069366|Dronabinol|dronabinol|mesh-list
92049667|NCT02069366|Hallucinogens|hallucinogens|mesh-ancestor
92049668|NCT02069366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049669|NCT02069366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92049670|NCT02069366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049671|NCT02069366|Analgesics|analgesics|mesh-ancestor
92049672|NCT02069366|Sensory System Agents|sensory system agents|mesh-ancestor
92049673|NCT02069366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049674|NCT02069366|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92049675|NCT02069366|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92049676|NCT02069366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049677|NCT02069366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049678|NCT02069366|Hormones|hormones|mesh-ancestor
92049679|NCT02069366|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049680|NCT04732208|Mydriatics|mydriatics|mesh-list
92049681|NCT04732208|Autonomic Agents|autonomic agents|mesh-ancestor
92049688|NCT02207231|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92049689|NCT02207231|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92049690|NCT02207231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049691|NCT02207231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049692|NCT02207231|Immunologic Factors|immunologic factors|mesh-ancestor
92049693|NCT02207231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049695|NCT02206685|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92049696|NCT02206685|Narcotics|narcotics|mesh-ancestor
92049697|NCT02206685|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049698|NCT02206685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049699|NCT02206685|Analgesics|analgesics|mesh-ancestor
92049700|NCT02206685|Sensory System Agents|sensory system agents|mesh-ancestor
92049701|NCT02206685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049702|NCT02206685|Antitussive Agents|antitussive agents|mesh-ancestor
92049703|NCT02206685|Respiratory System Agents|respiratory system agents|mesh-ancestor
92049704|NCT02095106|Calpastatin|calpastatin|mesh-list
92049705|NCT02095106|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92049706|NCT02095106|Protease Inhibitors|protease inhibitors|mesh-ancestor
92049707|NCT02095106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014693|NCT04230759|Alkylating Agents|alkylating agents|mesh-ancestor
92014694|NCT04230759|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92014695|NCT04230759|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049708|NCT02095106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049712|NCT01634165|Insulin Glargine|insulin glargine|mesh-list
92049713|NCT01634165|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92049714|NCT01634165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049715|NCT02235311|Pantoprazole|pantoprazole|mesh-list
92049716|NCT02235311|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92049717|NCT02235311|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92049718|NCT02235311|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92049719|NCT02235311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049792|NCT01864005|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92049720|NCT02235311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049721|NCT02235077|Spironolactone|spironolactone|mesh-list
92049722|NCT02235077|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92049723|NCT02235077|Hormone Antagonists|hormone antagonists|mesh-ancestor
92049724|NCT02235077|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049725|NCT02235077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049726|NCT02235077|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92049727|NCT02235077|Diuretics|diuretics|mesh-ancestor
92049728|NCT02235077|Natriuretic Agents|natriuretic agents|mesh-ancestor
92049729|NCT02234141|Selonsertib|selonsertib|mesh-list
92049730|NCT02234141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92049731|NCT02234141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049732|NCT02234141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049733|NCT01896531|Leucovorin|leucovorin|mesh-list
92049734|NCT01896531|Fluorouracil|fluorouracil|mesh-list
92049735|NCT01896531|Oxaliplatin|oxaliplatin|mesh-list
92049736|NCT01896531|Ipatasertib|ipatasertib|mesh-list
92049737|NCT01896531|Antimetabolites|antimetabolites|mesh-ancestor
92049738|NCT01896531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049739|NCT01896531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92049740|NCT01896531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049741|NCT01896531|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049742|NCT01896531|Immunologic Factors|immunologic factors|mesh-ancestor
92049743|NCT01896531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049744|NCT01896531|Antidotes|antidotes|mesh-ancestor
92049745|NCT01896531|Protective Agents|protective agents|mesh-ancestor
92049746|NCT01896531|Vitamin B Complex|vitamin b complex|mesh-ancestor
92049747|NCT01896531|Vitamins|vitamins|mesh-ancestor
92049748|NCT01896531|Micronutrients|micronutrients|mesh-ancestor
92049749|NCT01896531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92049750|NCT01896531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049751|NCT01618305|Lamivudine|lamivudine|mesh-list
92049752|NCT01618305|Zidovudine|zidovudine|mesh-list
92049753|NCT01618305|Efavirenz|efavirenz|mesh-list
92049754|NCT01618305|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92049756|NCT01618305|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92049757|NCT01618305|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92049758|NCT01618305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049759|NCT01618305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049760|NCT01618305|Antiviral Agents|antiviral agents|mesh-ancestor
92049761|NCT01618305|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049762|NCT01618305|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92049763|NCT01618305|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92049764|NCT01618305|Antimetabolites|antimetabolites|mesh-ancestor
92049765|NCT01618305|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92049766|NCT01618305|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92049767|NCT01618305|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92049768|NCT01618305|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92049769|NCT01618305|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92049770|NCT01618305|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92049771|NCT01618305|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92049772|NCT01618305|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92049773|NCT01896297|Dabigatran|dabigatran|mesh-list
92049774|NCT01896297|Antithrombins|antithrombins|mesh-ancestor
92049775|NCT01896297|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92049776|NCT01896297|Protease Inhibitors|protease inhibitors|mesh-ancestor
92049777|NCT01896297|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049778|NCT01896297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014698|NCT05471687|Sensory System Agents|sensory system agents|mesh-ancestor
92014699|NCT05471687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014700|NCT05471687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014701|NCT05471687|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92049779|NCT01896297|Anticoagulants|anticoagulants|mesh-ancestor
92049780|NCT01884675|Ambrisentan|ambrisentan|mesh-list
92049781|NCT01884675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92049782|NCT01884597|Ranibizumab|ranibizumab|mesh-list
92049783|NCT01884597|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92049784|NCT01884597|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92049785|NCT01884597|Growth Substances|growth substances|mesh-ancestor
92049786|NCT01884597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049787|NCT01884597|Growth Inhibitors|growth inhibitors|mesh-ancestor
92049788|NCT01884597|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049789|NCT01864005|Clopidogrel|clopidogrel|mesh-list
92049790|NCT01864005|Ticagrelor|ticagrelor|mesh-list
92049791|NCT01864005|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92049793|NCT01864005|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92049794|NCT01864005|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92049795|NCT01864005|Purinergic Agents|purinergic agents|mesh-ancestor
92049796|NCT01864005|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049797|NCT01864005|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049798|NCT01864005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049799|NCT01863771|Golimumab|golimumab|mesh-list
92049800|NCT01863771|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92049801|NCT01863771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049802|NCT01863771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049803|NCT01863771|Immunologic Factors|immunologic factors|mesh-ancestor
92049804|NCT01863771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049805|NCT01894581|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92049806|NCT01894581|Hormones|hormones|mesh-ancestor
92049807|NCT01894581|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049808|NCT01894581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049809|NCT02203331|Anastrozole|anastrozole|mesh-list
92049810|NCT02203331|Leuprolide|leuprolide|mesh-list
92049811|NCT02203331|Levonorgestrel|levonorgestrel|mesh-list
92049812|NCT02203331|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92049813|NCT02203331|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049814|NCT02203331|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92049815|NCT02203331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92049816|NCT02203331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049817|NCT02203331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049818|NCT02203331|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92049819|NCT02203331|Hormone Antagonists|hormone antagonists|mesh-ancestor
92049820|NCT02203331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049821|NCT02203331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049822|NCT02203331|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92049823|NCT02203331|Fertility Agents|fertility agents|mesh-ancestor
92049824|NCT02203331|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92049825|NCT02203331|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92049826|NCT02203331|Contraceptive Agents|contraceptive agents|mesh-ancestor
92049839|NCT01893411|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049840|NCT01893411|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92049841|NCT01893411|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049842|NCT01862991|Digoxin|digoxin|mesh-list
92049843|NCT01862991|Misoprostol|misoprostol|mesh-list
92049844|NCT01862991|Mifepristone|mifepristone|mesh-list
92049845|NCT01862991|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92049846|NCT01862991|Abortifacient Agents|abortifacient agents|mesh-ancestor
92049847|NCT01862991|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92049848|NCT01862991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049849|NCT01862991|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92049850|NCT01862991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92049851|NCT01862991|Oxytocics|oxytocics|mesh-ancestor
92049852|NCT01862991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92049853|NCT01862991|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92049854|NCT01862991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014702|NCT05471687|Vasodilator Agents|vasodilator agents|mesh-ancestor
92014703|NCT05471687|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92014704|NCT05471687|Purinergic Agonists|purinergic agonists|mesh-ancestor
92014705|NCT05471687|Purinergic Agents|purinergic agents|mesh-ancestor
92049855|NCT01862991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049856|NCT01862991|Protective Agents|protective agents|mesh-ancestor
92049857|NCT01862991|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92049858|NCT01862991|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92049859|NCT01862991|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92049860|NCT01862991|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92049861|NCT01862991|Contraceptive Agents|contraceptive agents|mesh-ancestor
92049862|NCT01862991|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92049863|NCT01862991|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92049864|NCT01862991|Hormone Antagonists|hormone antagonists|mesh-ancestor
92049865|NCT01862991|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049866|NCT01862991|Luteolytic Agents|luteolytic agents|mesh-ancestor
92049867|NCT01862991|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92049868|NCT01862991|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92049870|NCT02202551|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92049871|NCT02202551|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92049872|NCT02202551|Antiviral Agents|antiviral agents|mesh-ancestor
92049873|NCT02202551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049874|NCT02202551|Dopamine Agents|dopamine agents|mesh-ancestor
92049875|NCT02202551|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049876|NCT02202551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049877|NCT02202551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049878|NCT02202551|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92049879|NCT02202551|Analgesics|analgesics|mesh-ancestor
92049880|NCT02202551|Sensory System Agents|sensory system agents|mesh-ancestor
92049881|NCT02202551|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049882|NCT02118337|Nivolumab|nivolumab|mesh-list
92049883|NCT02118337|Durvalumab|durvalumab|mesh-list
92049884|NCT02118337|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049885|NCT02118337|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049886|NCT02118337|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92049887|NCT02118337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049889|NCT05131555|Histamine H2 Antagonists|histamine h2 antagonists|mesh-list
92049890|NCT05131555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049891|NCT05131555|Histamine Antagonists|histamine antagonists|mesh-ancestor
92049892|NCT05131555|Histamine Agents|histamine agents|mesh-ancestor
92049893|NCT05131555|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049894|NCT05131555|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049895|NCT02105467|Grazoprevir|grazoprevir|mesh-list
92049896|NCT02105467|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92049897|NCT02105467|Antiviral Agents|antiviral agents|mesh-ancestor
92049898|NCT02105467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049900|NCT02202161|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92049901|NCT02202161|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92049902|NCT02202161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049903|NCT02202161|Incretins|incretins|mesh-ancestor
92049904|NCT02202161|Hormones|hormones|mesh-ancestor
92049905|NCT02202161|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049906|NCT02202161|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92049907|NCT02202161|Protease Inhibitors|protease inhibitors|mesh-ancestor
92049908|NCT02202161|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049909|NCT02202161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049910|NCT03109847|Metformin|metformin|mesh-list
92049911|NCT03109847|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92049912|NCT03109847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049913|NCT01461928|Rituximab|rituximab|mesh-list
92049914|NCT01461928|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92049915|NCT01461928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049916|NCT01461928|Immunologic Factors|immunologic factors|mesh-ancestor
92049917|NCT01461928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049918|NCT01461928|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049919|NCT02623205|Escitalopram|escitalopram|mesh-list
92049920|NCT02623205|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92014706|NCT05471687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014707|NCT05471687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014708|NCT05471609|Levodopa|levodopa|mesh-list
92014709|NCT05471609|Carbidopa|carbidopa|mesh-list
92014710|NCT05471609|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92014711|NCT05471609|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92014712|NCT05471609|Dopamine Agents|dopamine agents|mesh-ancestor
92014713|NCT05471609|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014714|NCT05471609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014715|NCT05471609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014716|NCT05471609|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92014717|NCT05471609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014718|NCT05370729|Acetylcysteine|acetylcysteine|mesh-list
92014719|NCT05370729|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92049921|NCT02623205|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92049922|NCT02623205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049923|NCT02623205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049924|NCT02623205|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049925|NCT02623205|Serotonin Agents|serotonin agents|mesh-ancestor
92049926|NCT02623205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049927|NCT01500694|Guanfacine|guanfacine|mesh-list
92049928|NCT01500694|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92049929|NCT01500694|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92049930|NCT01500694|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92049931|NCT01500694|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92049932|NCT01500694|Adrenergic Agents|adrenergic agents|mesh-ancestor
92049933|NCT01500694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049934|NCT01500694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050009|NCT01483144|Eflornithine|eflornithine|mesh-list
92049935|NCT01500694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049936|NCT01500382|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92049937|NCT01500382|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92049938|NCT01500382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92049939|NCT01500382|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92049940|NCT01500382|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92049941|NCT01500382|Cholinergic Agents|cholinergic agents|mesh-ancestor
92049942|NCT01500382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049943|NCT01500382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049944|NCT01500382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049945|NCT01500382|Urological Agents|urological agents|mesh-ancestor
92049946|NCT02137837|Everolimus|everolimus|mesh-list
92049947|NCT02137837|Fulvestrant|fulvestrant|mesh-list
92049948|NCT02137837|Anastrozole|anastrozole|mesh-list
92049949|NCT02137837|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92049950|NCT02137837|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92049951|NCT02137837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049952|NCT02137837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049953|NCT02137837|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049954|NCT02137837|Immunologic Factors|immunologic factors|mesh-ancestor
92049955|NCT02137837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049956|NCT02137837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049957|NCT02137837|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92049958|NCT02137837|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92049959|NCT02137837|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92049960|NCT02137837|Hormone Antagonists|hormone antagonists|mesh-ancestor
92049961|NCT02137837|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049962|NCT02137837|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92049963|NCT02137837|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92049965|NCT01483690|Dexamethasone acetate|dexamethasone acetate|mesh-list
92014720|NCT05370729|Antiviral Agents|antiviral agents|mesh-ancestor
92014721|NCT05370729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014722|NCT05370729|Expectorants|expectorants|mesh-ancestor
92014723|NCT05370729|Respiratory System Agents|respiratory system agents|mesh-ancestor
92049966|NCT01483690|Methotrexate|methotrexate|mesh-list
92049967|NCT01483690|Vincristine|vincristine|mesh-list
92049969|NCT01483690|Asparaginase|asparaginase|mesh-list
92049970|NCT01483690|Mitoxantrone|mitoxantrone|mesh-list
92049971|NCT01483690|Vorinostat|vorinostat|mesh-list
92049972|NCT01483690|Pegaspargase|pegaspargase|mesh-list
92049973|NCT01483690|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92049974|NCT01483690|BB 1101|bb 1101|mesh-list
92049975|NCT01483690|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049976|NCT01483690|Antiemetics|antiemetics|mesh-ancestor
92049977|NCT01483690|Autonomic Agents|autonomic agents|mesh-ancestor
92049978|NCT01483690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049979|NCT01483690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049980|NCT01483690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92049981|NCT01483690|Glucocorticoids|glucocorticoids|mesh-ancestor
92049982|NCT01483690|Hormones|hormones|mesh-ancestor
92049983|NCT01483690|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92049984|NCT01483690|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92049985|NCT01483690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92049986|NCT01483690|Protease Inhibitors|protease inhibitors|mesh-ancestor
92049987|NCT01483690|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92049988|NCT01483690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049989|NCT01483690|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92049990|NCT01483690|Abortifacient Agents|abortifacient agents|mesh-ancestor
92049991|NCT01483690|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92049992|NCT01483690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92049993|NCT01483690|Antimetabolites|antimetabolites|mesh-ancestor
92049994|NCT01483690|Dermatologic Agents|dermatologic agents|mesh-ancestor
92049995|NCT01483690|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92049996|NCT01483690|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049997|NCT01483690|Immunologic Factors|immunologic factors|mesh-ancestor
92049998|NCT01483690|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92049999|NCT01483690|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92050000|NCT01483690|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92050001|NCT01483690|Tubulin Modulators|tubulin modulators|mesh-ancestor
92050002|NCT01483690|Antimitotic Agents|antimitotic agents|mesh-ancestor
92050003|NCT01483690|Mitosis Modulators|mitosis modulators|mesh-ancestor
92050004|NCT01483690|Analgesics|analgesics|mesh-ancestor
92050005|NCT01483690|Sensory System Agents|sensory system agents|mesh-ancestor
92050006|NCT01483690|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92050007|NCT01483690|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92050008|NCT01483690|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92050010|NCT01483144|Sulindac|sulindac|mesh-list
92050011|NCT01483144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050012|NCT01483144|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92050013|NCT01483144|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92050014|NCT01483144|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92050015|NCT01483144|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050016|NCT01483144|Ornithine Decarboxylase Inhibitors|ornithine decarboxylase inhibitors|mesh-ancestor
92050017|NCT01483144|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050018|NCT01483144|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050019|NCT01483144|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92050020|NCT01483144|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92050021|NCT01483144|Analgesics|analgesics|mesh-ancestor
92050022|NCT01483144|Sensory System Agents|sensory system agents|mesh-ancestor
92050023|NCT01483144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050024|NCT01483144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050025|NCT01483144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050026|NCT01483144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050027|NCT01483144|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92050028|NCT01881789|Dexamethasone|dexamethasone|mesh-list
92050029|NCT01881789|Cyclophosphamide|cyclophosphamide|mesh-list
92050030|NCT01881789|Lenalidomide|lenalidomide|mesh-list
92050031|NCT01881789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050032|NCT01881789|Immunologic Factors|immunologic factors|mesh-ancestor
92050033|NCT01881789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050034|NCT01881789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050035|NCT01881789|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92014725|NCT05370729|Antioxidants|antioxidants|mesh-ancestor
92014726|NCT05370729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014727|NCT05370729|Protective Agents|protective agents|mesh-ancestor
92014728|NCT05370729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014729|NCT05370729|Antidotes|antidotes|mesh-ancestor
92014730|NCT05471531|Vaccines|vaccines|mesh-list
92014731|NCT05471531|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92014732|NCT05471531|Immunologic Factors|immunologic factors|mesh-ancestor
92014733|NCT05471531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050037|NCT01881789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050038|NCT01881789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050039|NCT01881789|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92050040|NCT01881789|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050042|NCT01881789|Autonomic Agents|autonomic agents|mesh-ancestor
92050043|NCT01881789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050044|NCT01881789|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050045|NCT01881789|Glucocorticoids|glucocorticoids|mesh-ancestor
92050046|NCT01881789|Hormones|hormones|mesh-ancestor
92050047|NCT01881789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050048|NCT01881789|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92050049|NCT01881789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92050050|NCT01881789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92050051|NCT01881789|Growth Substances|growth substances|mesh-ancestor
92050052|NCT01881789|Growth Inhibitors|growth inhibitors|mesh-ancestor
92050054|NCT02075203|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92050055|NCT02075203|Immunologic Factors|immunologic factors|mesh-ancestor
92050056|NCT02075203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050057|NCT01892163|Dexamethasone|dexamethasone|mesh-list
92050058|NCT01892163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050059|NCT01892163|Antiemetics|antiemetics|mesh-ancestor
92050060|NCT01892163|Autonomic Agents|autonomic agents|mesh-ancestor
92050061|NCT01892163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050062|NCT01892163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050063|NCT01892163|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050064|NCT01892163|Glucocorticoids|glucocorticoids|mesh-ancestor
92050065|NCT01892163|Hormones|hormones|mesh-ancestor
92050066|NCT01892163|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050067|NCT01892163|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92050068|NCT01892163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050069|NCT01500226|Dexamethasone|dexamethasone|mesh-list
92050070|NCT01500226|Granisetron|granisetron|mesh-list
92050071|NCT01500226|Rolapitant|rolapitant|mesh-list
92050072|NCT01500226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050073|NCT01500226|Antiemetics|antiemetics|mesh-ancestor
92050074|NCT01500226|Autonomic Agents|autonomic agents|mesh-ancestor
92050075|NCT01500226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050076|NCT01500226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050077|NCT01500226|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050078|NCT01500226|Glucocorticoids|glucocorticoids|mesh-ancestor
92050079|NCT01500226|Hormones|hormones|mesh-ancestor
92050080|NCT01500226|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050081|NCT01500226|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92050082|NCT01500226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050083|NCT01500226|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92050084|NCT01500226|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92050085|NCT01500226|Serotonin Agents|serotonin agents|mesh-ancestor
92050086|NCT01500226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050087|NCT01500226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050088|NCT01500226|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92050089|NCT02075047|Ziprasidone|ziprasidone|mesh-list
92050090|NCT02075047|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92014734|NCT05204667|Acetaminophen|acetaminophen|mesh-list
92014735|NCT05204667|Aspirin|aspirin|mesh-list
92014736|NCT05204667|Methocarbamol|methocarbamol|mesh-list
92050091|NCT02075047|Serotonin Agents|serotonin agents|mesh-ancestor
92050092|NCT02075047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050093|NCT02075047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050094|NCT02075047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050095|NCT02075047|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92050096|NCT02075047|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92050097|NCT02075047|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050098|NCT02075047|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050099|NCT02075047|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92050100|NCT02075047|Dopamine Agents|dopamine agents|mesh-ancestor
92050101|NCT01859793|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92050103|NCT01859793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050104|NCT01859793|Incretins|incretins|mesh-ancestor
92050105|NCT01859793|Hormones|hormones|mesh-ancestor
92050106|NCT01859793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050107|NCT01859793|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92050108|NCT01859793|Protease Inhibitors|protease inhibitors|mesh-ancestor
92050109|NCT01859793|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050111|NCT01859715|Oxycodone|oxycodone|mesh-list
92050112|NCT01859715|Hydrocodone|hydrocodone|mesh-list
92050113|NCT01859715|Ondansetron|ondansetron|mesh-list
92050114|NCT01859715|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92050115|NCT01859715|Narcotics|narcotics|mesh-ancestor
92050116|NCT01859715|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050117|NCT01859715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050118|NCT01859715|Analgesics|analgesics|mesh-ancestor
92050119|NCT01859715|Sensory System Agents|sensory system agents|mesh-ancestor
92050120|NCT01859715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050121|NCT01859715|Antiemetics|antiemetics|mesh-ancestor
92050122|NCT01859715|Autonomic Agents|autonomic agents|mesh-ancestor
92050123|NCT01859715|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050124|NCT01859715|Antipruritics|antipruritics|mesh-ancestor
92050125|NCT01859715|Dermatologic Agents|dermatologic agents|mesh-ancestor
92050126|NCT01859715|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92050127|NCT01859715|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92050128|NCT01859715|Serotonin Agents|serotonin agents|mesh-ancestor
92050129|NCT01859715|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050130|NCT01859715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050131|NCT01859715|Antitussive Agents|antitussive agents|mesh-ancestor
92050132|NCT01859715|Respiratory System Agents|respiratory system agents|mesh-ancestor
92050133|NCT04599465|Ivacaftor|ivacaftor|mesh-list
92050134|NCT04599465|Elexacaftor|elexacaftor|mesh-list
92050135|NCT04599465|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92050136|NCT04599465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050137|NCT04599465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050138|NCT04590495|Cannabidiol|cannabidiol|mesh-list
92050139|NCT04590495|Anticonvulsants|anticonvulsants|mesh-ancestor
92050140|NCT01461538|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92050141|NCT01461538|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92050142|NCT01461538|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92050143|NCT01461538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050144|NCT01461538|Immunotoxins|immunotoxins|mesh-ancestor
92050145|NCT01461538|Immunoconjugates|immunoconjugates|mesh-ancestor
92050146|NCT01461538|Immunologic Factors|immunologic factors|mesh-ancestor
92050147|NCT01461538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050148|NCT02117479|Capecitabine|capecitabine|mesh-list
92050149|NCT02117479|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92050150|NCT02117479|Antimetabolites|antimetabolites|mesh-ancestor
92050151|NCT02117479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050152|NCT02117479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050153|NCT01482910|Aflibercept|aflibercept|mesh-list
92050154|NCT01482910|Verteporfin|verteporfin|mesh-list
92050155|NCT01482910|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92050156|NCT01482910|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92050157|NCT01482910|Growth Substances|growth substances|mesh-ancestor
92050158|NCT01482910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050159|NCT01482910|Growth Inhibitors|growth inhibitors|mesh-ancestor
92050160|NCT01482910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050161|NCT01482910|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92050162|NCT01482910|Dermatologic Agents|dermatologic agents|mesh-ancestor
92014737|NCT05204667|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92014738|NCT05204667|Analgesics|analgesics|mesh-ancestor
92050163|NCT04077190|Cortisone|cortisone|mesh-list
92050164|NCT04077190|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050165|NCT02103439|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92050166|NCT02103439|Antiviral Agents|antiviral agents|mesh-ancestor
92050167|NCT02103439|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050168|NCT02229539|Diphenhydramine|diphenhydramine|mesh-list
92050169|NCT02229539|Promethazine|promethazine|mesh-list
92050170|NCT02229539|Lidocaine|lidocaine|mesh-list
92050171|NCT02229539|Doxepin|doxepin|mesh-list
92050172|NCT02229539|Antacids|antacids|mesh-list
92050173|NCT02229539|Anesthetics, Local|anesthetics, local|mesh-ancestor
92050174|NCT02229539|Anesthetics|anesthetics|mesh-ancestor
92050175|NCT02229539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050176|NCT02229539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050177|NCT02229539|Sensory System Agents|sensory system agents|mesh-ancestor
92050178|NCT02229539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050179|NCT02229539|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92050180|NCT02229539|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92050181|NCT02229539|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92050182|NCT02229539|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050183|NCT02229539|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050184|NCT02229539|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92050190|NCT02229539|Histamine Antagonists|histamine antagonists|mesh-ancestor
92050191|NCT02229539|Histamine Agents|histamine agents|mesh-ancestor
92050192|NCT02229539|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050193|NCT02229539|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92050194|NCT02229539|Antipruritics|antipruritics|mesh-ancestor
92050195|NCT02229539|Dermatologic Agents|dermatologic agents|mesh-ancestor
92050196|NCT02229539|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92050197|NCT02229539|Antidepressive Agents|antidepressive agents|mesh-ancestor
92050198|NCT02229539|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050200|NCT01835223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92050201|NCT01835223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050202|NCT01835223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050203|NCT02229383|Exenatide|exenatide|mesh-list
92050204|NCT02229383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92050205|NCT02229383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050206|NCT02229383|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92050207|NCT02229383|Incretins|incretins|mesh-ancestor
92050208|NCT02229383|Hormones|hormones|mesh-ancestor
92050209|NCT02229383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050210|NCT01499368|Omeprazole|omeprazole|mesh-list
92050211|NCT01499368|Famotidine|famotidine|mesh-list
92050212|NCT01499368|Lafutidine|lafutidine|mesh-list
92050213|NCT01499368|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92050214|NCT01499368|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050215|NCT01499368|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92050216|NCT01499368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050217|NCT01499368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050218|NCT01499368|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92050219|NCT01499368|Histamine Antagonists|histamine antagonists|mesh-ancestor
92050220|NCT01499368|Histamine Agents|histamine agents|mesh-ancestor
92050221|NCT01499368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050222|NCT01499368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050223|NCT01835145|Temozolomide|temozolomide|mesh-list
92050224|NCT01835145|Dacarbazine|dacarbazine|mesh-list
92050225|NCT01835145|Imidazole|imidazole|mesh-list
92050226|NCT01835145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92050227|NCT01835145|Alkylating Agents|alkylating agents|mesh-ancestor
92050228|NCT01835145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050229|NCT01835145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050230|NCT01835145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050231|NCT02229227|Insulin|insulin|mesh-list
92050232|NCT02229227|Insulin Glargine|insulin glargine|mesh-list
92050233|NCT02229227|Insulin Lispro|insulin lispro|mesh-list
92050234|NCT02229227|rGLP-1 protein|rglp-1 protein|mesh-list
92050235|NCT02229227|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92050236|NCT02229227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050237|NCT02229227|Incretins|incretins|mesh-ancestor
92050238|NCT02229227|Hormones|hormones|mesh-ancestor
92050239|NCT02229227|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050240|NCT01499290|Metronidazole|metronidazole|mesh-list
92050241|NCT01499290|Meropenem|meropenem|mesh-list
92050242|NCT01499290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014740|NCT05204667|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014741|NCT05204667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014743|NCT05204667|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92014744|NCT05204667|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92014745|NCT05204667|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92014746|NCT05204667|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014747|NCT05204667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92014748|NCT05204667|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92014749|NCT05204667|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92050243|NCT01499290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92050244|NCT01499290|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92050245|NCT01499290|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92050246|NCT01833897|Cycloserine|cycloserine|mesh-list
92050247|NCT01833897|Ketamine|ketamine|mesh-list
92050248|NCT01833897|Olanzapine|olanzapine|mesh-list
92050249|NCT01833897|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92050250|NCT01833897|Fluoxetine|fluoxetine|mesh-list
92050251|NCT01833897|Analgesics|analgesics|mesh-ancestor
92050252|NCT01833897|Sensory System Agents|sensory system agents|mesh-ancestor
92050253|NCT01833897|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050254|NCT01833897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050255|NCT01833897|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92050256|NCT01833897|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92050257|NCT01833897|Anesthetics, General|anesthetics, general|mesh-ancestor
92050258|NCT01833897|Anesthetics|anesthetics|mesh-ancestor
92050259|NCT01833897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050262|NCT01833897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050263|NCT01833897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050265|NCT01833897|Autonomic Agents|autonomic agents|mesh-ancestor
92050266|NCT01833897|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050267|NCT01833897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92050268|NCT01833897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92050269|NCT01833897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050270|NCT01833897|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92050271|NCT01833897|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92050272|NCT01833897|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050273|NCT01833897|Serotonin Agents|serotonin agents|mesh-ancestor
92050274|NCT01833897|Antidepressive Agents|antidepressive agents|mesh-ancestor
92050275|NCT01833897|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92050276|NCT01833897|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92050277|NCT01833897|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050278|NCT01833897|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050279|NCT01833897|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92050280|NCT01833897|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050281|NCT01833897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92050282|NCT01833897|Antitubercular Agents|antitubercular agents|mesh-ancestor
92050283|NCT01833897|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92050284|NCT01833897|Antimetabolites|antimetabolites|mesh-ancestor
92050285|NCT02226653|Evacetrapib|evacetrapib|mesh-list
92050286|NCT02226653|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92050287|NCT02226653|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92050288|NCT02226653|Antimetabolites|antimetabolites|mesh-ancestor
92050289|NCT02226653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050290|NCT02226653|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92050292|NCT02201771|Ticagrelor|ticagrelor|mesh-list
92050293|NCT02201771|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92050294|NCT02201771|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92050295|NCT02201771|Analgesics|analgesics|mesh-ancestor
92050296|NCT02201771|Sensory System Agents|sensory system agents|mesh-ancestor
92050297|NCT02201771|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014750|NCT05204667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050298|NCT02201771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050299|NCT02201771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050300|NCT02201771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050301|NCT02201771|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92050302|NCT02201771|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92050303|NCT02201771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050304|NCT02201771|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92050305|NCT02201771|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92050306|NCT02201771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050307|NCT02201771|Antipyretics|antipyretics|mesh-ancestor
92050308|NCT02201771|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92050309|NCT02201771|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92050310|NCT02201771|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92050311|NCT02201771|Purinergic Agents|purinergic agents|mesh-ancestor
92050312|NCT02201771|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050313|NCT01460368|Moxifloxacin|moxifloxacin|mesh-list
92050314|NCT01460368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92050315|NCT01460368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050316|NCT01460368|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92050317|NCT01460368|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92050318|NCT01460368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050319|NCT01460368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050320|NCT01460368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050321|NCT01460290|Asenapine|asenapine|mesh-list
92050322|NCT01460290|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92050323|NCT01460290|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92050324|NCT01460290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050325|NCT01460290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050326|NCT01460290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050327|NCT01459666|Hemagglutinins|hemagglutinins|mesh-list
92050328|NCT01459666|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92050329|NCT01459666|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92050330|NCT01459666|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92050331|NCT01459666|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050332|NCT01459666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050334|NCT01459666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050335|NCT01459666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050336|NCT01459666|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92050337|NCT01459666|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050338|NCT01459666|Agglutinins|agglutinins|mesh-ancestor
92050339|NCT01459666|Immunologic Factors|immunologic factors|mesh-ancestor
92050340|NCT01459666|Coagulants|coagulants|mesh-ancestor
92050341|NCT01645475|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92050342|NCT01645475|Hemostatics|hemostatics|mesh-ancestor
92050343|NCT01645475|Coagulants|coagulants|mesh-ancestor
92050344|NCT01645475|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92050345|NCT01645475|Natriuretic Agents|natriuretic agents|mesh-ancestor
92050346|NCT01645475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050347|NCT04767113|Heparin|heparin|mesh-list
92050348|NCT04767113|Calcium heparin|calcium heparin|mesh-list
92050349|NCT04767113|Anticoagulants|anticoagulants|mesh-ancestor
92050350|NCT04767113|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92050351|NCT04767113|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92050352|NCT04767113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050353|NCT04774991|Azithromycin|azithromycin|mesh-list
92050354|NCT04774991|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92050355|NCT04774991|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050356|NCT02199509|Levetiracetam|levetiracetam|mesh-list
92050357|NCT02199509|Anticonvulsants|anticonvulsants|mesh-ancestor
92050358|NCT02199509|Nootropic Agents|nootropic agents|mesh-ancestor
92050359|NCT01458574|Tofacitinib|tofacitinib|mesh-list
92050360|NCT01458574|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92050361|NCT01458574|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92050362|NCT01458574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050363|NCT01458574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050364|NCT02224703|Cannabidiol|cannabidiol|mesh-list
92050365|NCT02224703|Anticonvulsants|anticonvulsants|mesh-ancestor
92050366|NCT01458106|Factor VIII|factor viii|mesh-list
92050367|NCT01458106|Coagulants|coagulants|mesh-ancestor
92050368|NCT01457950|Denosumab|denosumab|mesh-list
92050369|NCT01457950|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92050370|NCT01457950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050371|NCT01499134|Metoprolol|metoprolol|mesh-list
92050373|NCT01499134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92050374|NCT01499134|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92050375|NCT01499134|Sympatholytics|sympatholytics|mesh-ancestor
92050376|NCT01499134|Autonomic Agents|autonomic agents|mesh-ancestor
92050377|NCT01499134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050378|NCT01499134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050379|NCT01499134|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92050380|NCT01499134|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92050381|NCT01499134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92050382|NCT01499134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92050383|NCT01499134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050384|NCT01499134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050385|NCT01499134|Vasodilator Agents|vasodilator agents|mesh-ancestor
92050386|NCT01499134|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92050387|NCT01499134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92050388|NCT01499134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92050389|NCT02198651|Adalimumab|adalimumab|mesh-list
92050390|NCT02198651|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92050391|NCT02198651|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050392|NCT02198651|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050393|NCT03026842|Cytarabine|cytarabine|mesh-list
92050394|NCT03026842|Decitabine|decitabine|mesh-list
92050395|NCT03026842|Daunorubicin|daunorubicin|mesh-list
92050396|NCT03026842|Mitoxantrone|mitoxantrone|mesh-list
92050397|NCT03026842|Aclacinomycins|aclacinomycins|mesh-list
92050398|NCT03026842|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92050399|NCT03026842|Antimetabolites|antimetabolites|mesh-ancestor
92050400|NCT03026842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050401|NCT03026842|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050402|NCT03026842|Antiviral Agents|antiviral agents|mesh-ancestor
92050403|NCT03026842|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050404|NCT03026842|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050405|NCT03026842|Immunologic Factors|immunologic factors|mesh-ancestor
92050408|NCT03026842|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92050409|NCT03026842|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92050411|NCT03026842|Analgesics|analgesics|mesh-ancestor
92050412|NCT03026842|Sensory System Agents|sensory system agents|mesh-ancestor
92050413|NCT03026842|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050414|NCT03026842|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92050415|NCT01498822|Oxcarbazepine|oxcarbazepine|mesh-list
92050416|NCT01498822|Levetiracetam|levetiracetam|mesh-list
92050417|NCT01498822|Anticonvulsants|anticonvulsants|mesh-ancestor
92050418|NCT01498822|Nootropic Agents|nootropic agents|mesh-ancestor
92050419|NCT01498822|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92050420|NCT01498822|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92050421|NCT01498822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050422|NCT01498822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050423|NCT01498822|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92050424|NCT01498822|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92050425|NCT01498120|Rotigotine|rotigotine|mesh-list
92050426|NCT01498120|Dopamine Agonists|dopamine agonists|mesh-ancestor
92050427|NCT01498120|Dopamine Agents|dopamine agents|mesh-ancestor
92050428|NCT01498120|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050429|NCT01498120|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050430|NCT01498120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050431|NCT01497262|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92050432|NCT01497262|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92050433|NCT01497262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050434|NCT01497262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050435|NCT01497262|Immunologic Factors|immunologic factors|mesh-ancestor
92050436|NCT01497262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050437|NCT02224625|Chlorhexidine|chlorhexidine|mesh-list
92050438|NCT02224625|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92050439|NCT02224625|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92050440|NCT02224625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050441|NCT02224625|Disinfectants|disinfectants|mesh-ancestor
92050442|NCT02224625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92050443|NCT01195493|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92050444|NCT02197247|Rifampin|rifampin|mesh-list
92050445|NCT02197247|Osimertinib|osimertinib|mesh-list
92050446|NCT02197247|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92050447|NCT02197247|Antitubercular Agents|antitubercular agents|mesh-ancestor
92050448|NCT02197247|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92050449|NCT02197247|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050450|NCT02197247|Leprostatic Agents|leprostatic agents|mesh-ancestor
92050451|NCT02197247|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92050452|NCT02197247|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050453|NCT02197247|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050454|NCT02197247|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92050455|NCT02197247|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92050456|NCT02197247|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92050457|NCT02197247|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92050458|NCT02197247|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92050459|NCT02197247|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92050460|NCT02197247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050461|NCT02197247|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92050462|NCT02224157|Budesonide|budesonide|mesh-list
92050463|NCT02224157|Terbutaline|terbutaline|mesh-list
92050464|NCT02224157|Formoterol Fumarate|formoterol fumarate|mesh-list
92050465|NCT02224157|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050466|NCT02224157|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92050467|NCT02224157|Autonomic Agents|autonomic agents|mesh-ancestor
92050468|NCT02224157|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050469|NCT02224157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050470|NCT02224157|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92050471|NCT02224157|Respiratory System Agents|respiratory system agents|mesh-ancestor
92050472|NCT02224157|Glucocorticoids|glucocorticoids|mesh-ancestor
92050474|NCT02224157|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050475|NCT02224157|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92050487|NCT02196701|Abortifacient Agents|abortifacient agents|mesh-ancestor
92050488|NCT02196701|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92050489|NCT02196701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050490|NCT02196701|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92050491|NCT02196701|Antimetabolites|antimetabolites|mesh-ancestor
92050492|NCT02196701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050493|NCT02196701|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050494|NCT02196701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92050495|NCT02196701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050496|NCT02196701|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92050497|NCT02196701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050498|NCT02196701|Immunologic Factors|immunologic factors|mesh-ancestor
92050499|NCT02196701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050500|NCT02196701|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92050501|NCT02196701|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92050502|NCT02196701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050503|NCT01481116|Glimepiride|glimepiride|mesh-list
92050504|NCT01481116|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92050505|NCT01481116|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92050506|NCT01481116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050507|NCT01481116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050508|NCT01481116|Immunologic Factors|immunologic factors|mesh-ancestor
92050509|NCT02222207|Ranibizumab|ranibizumab|mesh-list
92050510|NCT02222207|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92050511|NCT02222207|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92050512|NCT02222207|Growth Substances|growth substances|mesh-ancestor
92050513|NCT02222207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050514|NCT02222207|Growth Inhibitors|growth inhibitors|mesh-ancestor
92050515|NCT02222207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050516|NCT02195687|Botulinum Toxins|botulinum toxins|mesh-list
92050517|NCT02195687|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92050518|NCT02195687|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92050519|NCT02195687|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92050520|NCT02195687|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050521|NCT02195687|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050522|NCT02195687|Cholinergic Agents|cholinergic agents|mesh-ancestor
92050523|NCT02195687|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050524|NCT02195687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050525|NCT02195687|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92050526|NCT02195687|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050527|NCT02252081|Metformin|metformin|mesh-list
92050528|NCT02252081|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014753|NCT05204667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014754|NCT04801199|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92014755|NCT04801199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014756|NCT04801199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014757|NCT04801199|Incretins|incretins|mesh-ancestor
92014758|NCT04801199|Hormones|hormones|mesh-ancestor
92050529|NCT02252081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050530|NCT01623752|Etanercept|etanercept|mesh-list
92050531|NCT01623752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92050532|NCT01623752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92050533|NCT01623752|Analgesics|analgesics|mesh-ancestor
92050534|NCT01623752|Sensory System Agents|sensory system agents|mesh-ancestor
92050535|NCT01623752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050536|NCT01623752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050537|NCT01623752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050538|NCT01623752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050539|NCT01623752|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050540|NCT01623752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050543|NCT01623596|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92050544|NCT01623596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050545|NCT01623596|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050546|NCT01623596|Immunologic Factors|immunologic factors|mesh-ancestor
92050547|NCT01623596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050548|NCT02219477|Ritonavir|ritonavir|mesh-list
92050549|NCT02219477|Ribavirin|ribavirin|mesh-list
92050550|NCT02219477|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92050551|NCT02219477|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92050552|NCT02219477|Protease Inhibitors|protease inhibitors|mesh-ancestor
92050553|NCT02219477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050554|NCT02219477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050555|NCT02219477|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92050556|NCT02219477|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92050557|NCT02219477|Antiviral Agents|antiviral agents|mesh-ancestor
92050558|NCT02219477|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050559|NCT02219477|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92050560|NCT02219477|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050561|NCT02219477|Antimetabolites|antimetabolites|mesh-ancestor
92050562|NCT02093390|Fluconazole|fluconazole|mesh-list
92050563|NCT02093390|Atorvastatin|atorvastatin|mesh-list
92050564|NCT02093390|Relugolix|relugolix|mesh-list
92050565|NCT02093390|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92050566|NCT02093390|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92050567|NCT02093390|Antimetabolites|antimetabolites|mesh-ancestor
92050568|NCT02093390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050569|NCT02093390|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92050570|NCT02093390|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92050571|NCT02093390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050572|NCT02093390|Antifungal Agents|antifungal agents|mesh-ancestor
92050573|NCT02093390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050574|NCT02093390|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92050575|NCT02093390|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050576|NCT02093390|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92050577|NCT02093390|Hormone Antagonists|hormone antagonists|mesh-ancestor
92050578|NCT02093390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050579|NCT02093390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050580|NCT02093390|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92050581|NCT02093390|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92050582|NCT02093390|Androgen Antagonists|androgen antagonists|mesh-ancestor
92050583|NCT02219087|Bupivacaine|bupivacaine|mesh-list
92050584|NCT02219087|Anesthetics, Local|anesthetics, local|mesh-ancestor
92050585|NCT02219087|Anesthetics|anesthetics|mesh-ancestor
92050586|NCT02219087|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050587|NCT02219087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050588|NCT02219087|Sensory System Agents|sensory system agents|mesh-ancestor
92050589|NCT02219087|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050590|NCT02248961|Losartan|losartan|mesh-list
92050591|NCT02248961|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92014759|NCT04801199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014760|NCT04801199|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92050593|NCT02248961|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92050594|NCT02248961|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92050595|NCT02248961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050596|NCT02219009|Aripiprazole|aripiprazole|mesh-list
92050597|NCT02219009|Antidepressive Agents|antidepressive agents|mesh-ancestor
92050598|NCT02219009|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050599|NCT02219009|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92050600|NCT02219009|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92050601|NCT02219009|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050602|NCT02219009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050603|NCT02219009|Dopamine Agonists|dopamine agonists|mesh-ancestor
92050604|NCT02219009|Dopamine Agents|dopamine agents|mesh-ancestor
92050605|NCT02219009|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050606|NCT02219009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050607|NCT02219009|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92050608|NCT02219009|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92050609|NCT02219009|Serotonin Agents|serotonin agents|mesh-ancestor
92050621|NCT01456936|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92050622|NCT01456936|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92050623|NCT01456936|Cholinergic Agents|cholinergic agents|mesh-ancestor
92050624|NCT01456936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050625|NCT01456936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050626|NCT01456936|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92050627|NCT01456936|Antidepressive Agents|antidepressive agents|mesh-ancestor
92050628|NCT01456936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050629|NCT01456936|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92050630|NCT01456936|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92050631|NCT01456936|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050632|NCT01456936|Dopamine Agents|dopamine agents|mesh-ancestor
92050633|NCT01456936|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92050634|NCT01456936|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050635|NCT01456936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050636|NCT01456780|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92050637|NCT01456780|Tobramycin|tobramycin|mesh-list
92050638|NCT01456780|Lubricant Eye Drops|lubricant eye drops|mesh-list
92050639|NCT01456780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92050640|NCT01456780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050641|NCT01456780|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92050642|NCT01456780|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92050643|NCT01456780|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92050644|NCT01480258|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92050645|NCT01480258|Immunologic Factors|immunologic factors|mesh-ancestor
92050646|NCT01480258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050647|NCT01479868|Interferons|interferons|mesh-list
92050648|NCT01479868|Ribavirin|ribavirin|mesh-list
92050649|NCT01479868|Interferon-alpha|interferon-alpha|mesh-list
92050650|NCT01479868|Interferon alpha-2|interferon alpha-2|mesh-list
92050651|NCT01479868|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92050652|NCT01479868|Simeprevir|simeprevir|mesh-list
92050653|NCT01479868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050654|NCT01479868|Antiviral Agents|antiviral agents|mesh-ancestor
92050655|NCT01479868|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050656|NCT01479868|Antimetabolites|antimetabolites|mesh-ancestor
92050657|NCT01479868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050658|NCT01479868|Immunologic Factors|immunologic factors|mesh-ancestor
92050659|NCT01479868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050660|NCT01479868|Protease Inhibitors|protease inhibitors|mesh-ancestor
92050661|NCT01479868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050662|NCT01455220|Natalizumab|natalizumab|mesh-list
92050663|NCT01455220|Immunologic Factors|immunologic factors|mesh-ancestor
92050664|NCT01455220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050665|NCT01454596|Aldesleukin|aldesleukin|mesh-list
92050666|NCT01454596|Cyclophosphamide|cyclophosphamide|mesh-list
92050667|NCT01454596|Fludarabine|fludarabine|mesh-list
92050668|NCT01454596|Mitogens|mitogens|mesh-list
92050670|NCT01454596|Immunologic Factors|immunologic factors|mesh-ancestor
92050671|NCT01454596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050672|NCT01454596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050673|NCT01454596|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92050677|NCT01454596|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92050678|NCT01454596|Mitosis Modulators|mitosis modulators|mesh-ancestor
92050679|NCT01454596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92050680|NCT01454596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92050681|NCT01454596|Antiviral Agents|antiviral agents|mesh-ancestor
92050682|NCT01454596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050683|NCT01454284|Insulin Lispro|insulin lispro|mesh-list
92050684|NCT01454284|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92050685|NCT01454284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050687|NCT04541290|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050688|NCT04541290|Immunologic Factors|immunologic factors|mesh-ancestor
92050689|NCT04541290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050690|NCT04541290|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92050691|NCT04541290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050692|NCT04541290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050693|NCT01495702|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92050694|NCT01495702|Antiviral Agents|antiviral agents|mesh-ancestor
92050695|NCT01495702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050696|NCT01495702|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92050697|NCT01495702|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92050698|NCT01495000|Denosumab|denosumab|mesh-list
92050699|NCT01495000|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92050700|NCT01495000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050701|NCT01494610|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92050702|NCT01494610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92050703|NCT01494610|Autonomic Agents|autonomic agents|mesh-ancestor
92050704|NCT01494610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050705|NCT01494610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050706|NCT01494610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92050707|NCT01494610|Respiratory System Agents|respiratory system agents|mesh-ancestor
92050708|NCT01494610|Glucocorticoids|glucocorticoids|mesh-ancestor
92050709|NCT01494610|Hormones|hormones|mesh-ancestor
92050710|NCT01494610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050711|NCT01494610|Sympathomimetics|sympathomimetics|mesh-ancestor
92050712|NCT02116777|Temozolomide|temozolomide|mesh-list
92050713|NCT02116777|Talazoparib|talazoparib|mesh-list
92050714|NCT02116777|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92050715|NCT02116777|Alkylating Agents|alkylating agents|mesh-ancestor
92050716|NCT02116777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050717|NCT02116777|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050718|NCT02116777|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92050719|NCT02116777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050720|NCT01494532|Ropinirole|ropinirole|mesh-list
92050721|NCT01494532|Levodopa|levodopa|mesh-list
92050722|NCT01494532|Dihydroxyphenylalanine|dihydroxyphenylalanine|mesh-list
92050723|NCT01494532|Dopamine Agents|dopamine agents|mesh-ancestor
92050724|NCT01494532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050725|NCT01494532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050726|NCT01494532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050727|NCT01494532|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92050728|NCT01494532|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92050729|NCT01494532|Dopamine Agonists|dopamine agonists|mesh-ancestor
92050730|NCT02191397|Dexetimide|dexetimide|mesh-list
92050731|NCT02191397|Citalopram|citalopram|mesh-list
92050732|NCT02191397|Bupropion|bupropion|mesh-list
92050733|NCT02191397|Escitalopram|escitalopram|mesh-list
92050734|NCT02191397|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92050735|NCT02191397|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92050736|NCT02191397|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050737|NCT02191397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050738|NCT02191397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050739|NCT02191397|Serotonin Agents|serotonin agents|mesh-ancestor
92050740|NCT02191397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050741|NCT02191397|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92050742|NCT02191397|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92050743|NCT02191397|Parasympatholytics|parasympatholytics|mesh-ancestor
92014761|NCT04801199|Protease Inhibitors|protease inhibitors|mesh-ancestor
92014762|NCT04801199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014763|NCT04801199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050750|NCT02191397|Antidepressive Agents|antidepressive agents|mesh-ancestor
92050751|NCT02191397|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050752|NCT02191397|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92050753|NCT02191397|Dopamine Agents|dopamine agents|mesh-ancestor
92050754|NCT02191397|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92050755|NCT02191397|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050756|NCT02191397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050758|NCT01630811|Dextromethorphan|dextromethorphan|mesh-list
92050759|NCT01630811|Antitussive Agents|antitussive agents|mesh-ancestor
92050760|NCT01630811|Respiratory System Agents|respiratory system agents|mesh-ancestor
92050761|NCT01630811|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92050762|NCT01630811|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92050763|NCT01630811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050764|NCT01630811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050765|NCT01630811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050766|NCT01630811|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92050767|NCT01630811|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92050768|NCT01630811|Adrenergic Agents|adrenergic agents|mesh-ancestor
92050769|NCT01630811|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92050770|NCT01630811|Antimalarials|antimalarials|mesh-ancestor
92050771|NCT01630811|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92050772|NCT01630811|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92050773|NCT01630811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050774|NCT01630811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050775|NCT01630811|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92050776|NCT01630811|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92050777|NCT01630811|Cholinergic Agents|cholinergic agents|mesh-ancestor
92050778|NCT01630811|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92050779|NCT01630811|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92050780|NCT01630811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92050781|NCT01630811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92050867|NCT02168387|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92050782|NCT01630811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92050783|NCT02170025|Riociguat|riociguat|mesh-list
92050784|NCT02170025|Enzyme Activators|enzyme activators|mesh-ancestor
92050785|NCT02170025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050786|NCT02169791|Ixazomib|ixazomib|mesh-list
92050787|NCT02169791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050788|NCT02169791|Protease Inhibitors|protease inhibitors|mesh-ancestor
92050789|NCT02169791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050790|NCT02169791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050791|NCT02216357|Ifetroban|ifetroban|mesh-list
92050792|NCT02216357|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92050793|NCT01492426|Ribavirin|ribavirin|mesh-list
92050794|NCT01492426|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92050795|NCT01492426|Antimetabolites|antimetabolites|mesh-ancestor
92050796|NCT01492426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050797|NCT01492426|Antiviral Agents|antiviral agents|mesh-ancestor
92050798|NCT01492426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050799|NCT01453348|Vaccines|vaccines|mesh-list
92050800|NCT01453348|Immunologic Factors|immunologic factors|mesh-ancestor
92050801|NCT01453348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050802|NCT01475734|rGLP-1 protein|rglp-1 protein|mesh-list
92050803|NCT01475734|Incretins|incretins|mesh-ancestor
92050804|NCT01475734|Hormones|hormones|mesh-ancestor
92050805|NCT01475734|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92050806|NCT01475734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050807|NCT02189837|Atorvastatin|atorvastatin|mesh-list
92050808|NCT02189837|Evolocumab|evolocumab|mesh-list
92050809|NCT02189837|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92050810|NCT02189837|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92050811|NCT02189837|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92050812|NCT02189837|Antimetabolites|antimetabolites|mesh-ancestor
92050823|NCT02216123|Primaquine|primaquine|mesh-list
92050824|NCT02216123|Tafenoquine|tafenoquine|mesh-list
92050825|NCT02216123|Amebicides|amebicides|mesh-ancestor
92050826|NCT02216123|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92050827|NCT02216123|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92050828|NCT02216123|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050829|NCT02216123|Antimalarials|antimalarials|mesh-ancestor
92014765|NCT04340141|Fluorouracil|fluorouracil|mesh-list
92014766|NCT04340141|Oxaliplatin|oxaliplatin|mesh-list
92014767|NCT04340141|Irinotecan|irinotecan|mesh-list
92014768|NCT04340141|Calcium|calcium|mesh-list
92014769|NCT04340141|Levoleucovorin|levoleucovorin|mesh-list
92050830|NCT02216123|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050831|NCT01490866|Leucovorin|leucovorin|mesh-list
92050832|NCT01490866|Bevacizumab|bevacizumab|mesh-list
92050833|NCT01490866|Fluorouracil|fluorouracil|mesh-list
92050834|NCT01490866|Oxaliplatin|oxaliplatin|mesh-list
92050835|NCT01490866|Axitinib|axitinib|mesh-list
92050836|NCT01490866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92050837|NCT01490866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050838|NCT01490866|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92050839|NCT01490866|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92050840|NCT01490866|Growth Substances|growth substances|mesh-ancestor
92050841|NCT01490866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050842|NCT01490866|Growth Inhibitors|growth inhibitors|mesh-ancestor
92050843|NCT01490866|Antimetabolites|antimetabolites|mesh-ancestor
92050844|NCT01490866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050845|NCT01490866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92050846|NCT01490866|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050847|NCT01490866|Immunologic Factors|immunologic factors|mesh-ancestor
92050848|NCT01490866|Antidotes|antidotes|mesh-ancestor
92050849|NCT01490866|Protective Agents|protective agents|mesh-ancestor
92050850|NCT01490866|Vitamin B Complex|vitamin b complex|mesh-ancestor
92050851|NCT01490866|Vitamins|vitamins|mesh-ancestor
92050852|NCT01490866|Micronutrients|micronutrients|mesh-ancestor
92050853|NCT01490866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92050854|NCT01490866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050855|NCT02215967|Cyclophosphamide|cyclophosphamide|mesh-list
92050856|NCT02215967|Fludarabine|fludarabine|mesh-list
92050857|NCT02215967|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050858|NCT02215967|Immunologic Factors|immunologic factors|mesh-ancestor
92050859|NCT02215967|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050860|NCT02215967|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050861|NCT02215967|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92050862|NCT02215967|Alkylating Agents|alkylating agents|mesh-ancestor
92050863|NCT02215967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050864|NCT02215967|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050865|NCT02215967|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92050866|NCT02168387|Acetylcysteine|acetylcysteine|mesh-list
92050868|NCT02168387|Antiviral Agents|antiviral agents|mesh-ancestor
92050869|NCT02168387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050870|NCT02168387|Expectorants|expectorants|mesh-ancestor
92050871|NCT02168387|Respiratory System Agents|respiratory system agents|mesh-ancestor
92050872|NCT02168387|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92050873|NCT02168387|Antioxidants|antioxidants|mesh-ancestor
92050874|NCT02168387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050875|NCT02168387|Protective Agents|protective agents|mesh-ancestor
92050876|NCT02168387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050877|NCT02168387|Antidotes|antidotes|mesh-ancestor
92050878|NCT04418219|Interferons|interferons|mesh-list
92050879|NCT04418219|Interferon-alpha|interferon-alpha|mesh-list
92050883|NCT04418219|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92050884|NCT04418219|Immunologic Factors|immunologic factors|mesh-ancestor
92050885|NCT04418219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050886|NCT04418219|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050887|NCT04418219|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92050888|NCT04418219|Alkylating Agents|alkylating agents|mesh-ancestor
92050889|NCT04418219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050890|NCT04418219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050891|NCT04418219|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92050892|NCT04418219|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92050893|NCT04418219|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92050895|NCT04418219|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050896|NCT02167451|Maraviroc|maraviroc|mesh-list
92050897|NCT02167451|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92050898|NCT02167451|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92050899|NCT02167451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050900|NCT02167451|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92014770|NCT04340141|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92050901|NCT02167451|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92050902|NCT02167451|Antiviral Agents|antiviral agents|mesh-ancestor
92050903|NCT02167451|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92050904|NCT02167451|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92050905|NCT02167139|Adalimumab|adalimumab|mesh-list
92050906|NCT02167139|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92050907|NCT02167139|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050908|NCT02167139|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050909|NCT02116309|Indomethacin|indomethacin|mesh-list
92050910|NCT02116309|Epinephrine|epinephrine|mesh-list
92050911|NCT02116309|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92050912|NCT02116309|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92050913|NCT02116309|Adrenergic Agents|adrenergic agents|mesh-ancestor
92050914|NCT02116309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050915|NCT02116309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050916|NCT02116309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050917|NCT02116309|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92050918|NCT02116309|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92050919|NCT02116309|Autonomic Agents|autonomic agents|mesh-ancestor
92050920|NCT02116309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050921|NCT02116309|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92050922|NCT02116309|Respiratory System Agents|respiratory system agents|mesh-ancestor
92050923|NCT02116309|Mydriatics|mydriatics|mesh-ancestor
92050924|NCT02116309|Sympathomimetics|sympathomimetics|mesh-ancestor
92050925|NCT02116309|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92050926|NCT02116309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92050927|NCT02116309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92050928|NCT02116309|Analgesics|analgesics|mesh-ancestor
92050929|NCT02116309|Sensory System Agents|sensory system agents|mesh-ancestor
92050930|NCT02116309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92050931|NCT02116309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92050932|NCT02116309|Gout Suppressants|gout suppressants|mesh-ancestor
92050933|NCT02116309|Tocolytic Agents|tocolytic agents|mesh-ancestor
92050934|NCT02116309|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92050935|NCT02116309|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92050936|NCT02116309|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050937|NCT01474486|Ergocalciferols|ergocalciferols|mesh-list
92050938|NCT01474486|Thiamine|thiamine|mesh-list
92050939|NCT01474486|Micronutrients|micronutrients|mesh-list
92050940|NCT01474486|Trace Elements|trace elements|mesh-list
92050941|NCT01474486|Vitamins|vitamins|mesh-ancestor
92050942|NCT01474486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050943|NCT01474486|Vitamin B Complex|vitamin b complex|mesh-ancestor
92050944|NCT01474486|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92050945|NCT01474486|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92050946|NCT01451398|Insulin|insulin|mesh-list
92050947|NCT01451398|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92050948|NCT01451398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050949|NCT02073565|Everolimus|everolimus|mesh-list
92050950|NCT02073565|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92050951|NCT02073565|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92050952|NCT02073565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050955|NCT02073565|Immunologic Factors|immunologic factors|mesh-ancestor
92050956|NCT02073565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050957|NCT02073565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050958|NCT02071225|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92050959|NCT02071225|Obinutuzumab|obinutuzumab|mesh-list
92050960|NCT02071225|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92050961|NCT02071225|Alkylating Agents|alkylating agents|mesh-ancestor
92050962|NCT02071225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050963|NCT02071225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050964|NCT02071225|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92050965|NCT01450696|Capecitabine|capecitabine|mesh-list
92050966|NCT01450696|Trastuzumab|trastuzumab|mesh-list
92050967|NCT01450696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050968|NCT01450696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92050969|NCT01450696|Antimetabolites|antimetabolites|mesh-ancestor
92050970|NCT01450696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050971|NCT01450696|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92050972|NCT02070991|Macitentan|macitentan|mesh-list
92050973|NCT02070991|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92050974|NCT02070991|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92014771|NCT04340141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014772|NCT04340141|Antimetabolites|antimetabolites|mesh-ancestor
92050975|NCT02070991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050976|NCT02070991|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92050977|NCT01490086|Aripiprazole|aripiprazole|mesh-list
92050979|NCT01490086|Antidepressive Agents|antidepressive agents|mesh-ancestor
92050980|NCT01490086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92050981|NCT01490086|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92050982|NCT01490086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92050983|NCT01490086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92050984|NCT01490086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050985|NCT01490086|Dopamine Agonists|dopamine agonists|mesh-ancestor
92050986|NCT01490086|Dopamine Agents|dopamine agents|mesh-ancestor
92050987|NCT01490086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050988|NCT01490086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050989|NCT01490086|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92050990|NCT01490086|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92050991|NCT01490086|Serotonin Agents|serotonin agents|mesh-ancestor
92050992|NCT01490086|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92050993|NCT01490086|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92050994|NCT01490086|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92050995|NCT01490086|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92050996|NCT02113579|Fluorides|fluorides|mesh-list
92050997|NCT02113579|Cariostatic Agents|cariostatic agents|mesh-ancestor
92050998|NCT02113579|Protective Agents|protective agents|mesh-ancestor
92050999|NCT02113579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051000|NCT01474018|Bromocriptine|bromocriptine|mesh-list
92051001|NCT01474018|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92051002|NCT01474018|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92051003|NCT01474018|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081697|NCT01402947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051004|NCT01474018|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051005|NCT01474018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051006|NCT01474018|Dopamine Agonists|dopamine agonists|mesh-ancestor
92051007|NCT01474018|Dopamine Agents|dopamine agents|mesh-ancestor
92051008|NCT01474018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051009|NCT01474018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051010|NCT02100475|Insulin|insulin|mesh-list
92051011|NCT02100475|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92051012|NCT02100475|Insulin Aspart|insulin aspart|mesh-list
92051013|NCT02100475|Liraglutide|liraglutide|mesh-list
92051014|NCT02100475|Xultophy|xultophy|mesh-list
92051015|NCT02100475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051016|NCT02100475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051017|NCT02100475|Incretins|incretins|mesh-ancestor
92051018|NCT02100475|Hormones|hormones|mesh-ancestor
92051019|NCT02100475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051020|NCT04075240|Aspirin|aspirin|mesh-list
92051021|NCT04075240|Rivaroxaban|rivaroxaban|mesh-list
92051022|NCT04075240|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92051025|NCT04075240|Sensory System Agents|sensory system agents|mesh-ancestor
92051026|NCT04075240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051027|NCT04075240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051028|NCT04075240|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051029|NCT04075240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051030|NCT04075240|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92051031|NCT04075240|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92051032|NCT04075240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051033|NCT04075240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92051034|NCT04075240|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92051035|NCT04075240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051036|NCT04075240|Antipyretics|antipyretics|mesh-ancestor
92051037|NCT04075240|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92051038|NCT04075240|Antithrombins|antithrombins|mesh-ancestor
92051039|NCT04075240|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92051040|NCT04075240|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051041|NCT04075240|Anticoagulants|anticoagulants|mesh-ancestor
92051042|NCT02070757|Meropenem|meropenem|mesh-list
92051043|NCT02070757|Tazobactam|tazobactam|mesh-list
92051044|NCT02070757|Ceftolozane|ceftolozane|mesh-list
92014773|NCT04340141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014774|NCT04340141|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92014775|NCT04340141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051045|NCT02070757|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92051046|NCT02070757|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92051047|NCT02070757|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051048|NCT02070757|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92051049|NCT02070757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051050|NCT02070757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051051|NCT02070757|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92051052|NCT02100319|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92051053|NCT02100319|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92051054|NCT02100319|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92051055|NCT02100319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051056|NCT01625845|Pentoxifylline|pentoxifylline|mesh-list
92051057|NCT01625845|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92051058|NCT01625845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051059|NCT01625845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051060|NCT01625845|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92051061|NCT01625845|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92051062|NCT01625845|Protective Agents|protective agents|mesh-ancestor
92051063|NCT01625845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051064|NCT01625845|Vasodilator Agents|vasodilator agents|mesh-ancestor
92051065|NCT01625845|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92051066|NCT01625845|Antioxidants|antioxidants|mesh-ancestor
92051067|NCT01473940|Gemcitabine|gemcitabine|mesh-list
92051068|NCT01473940|Ipilimumab|ipilimumab|mesh-list
92051069|NCT01473940|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92051070|NCT01473940|Antibodies|antibodies|mesh-list
92051071|NCT01473940|Immunoglobulins|immunoglobulins|mesh-list
92051072|NCT01473940|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92051073|NCT01473940|Immunologic Factors|immunologic factors|mesh-ancestor
92051074|NCT01473940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051075|NCT01473940|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92051076|NCT01473940|Antimetabolites|antimetabolites|mesh-ancestor
92051077|NCT01473940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051078|NCT01473940|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051079|NCT01473940|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92051080|NCT01832727|Dexamethasone|dexamethasone|mesh-list
92051081|NCT01832727|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051082|NCT01832727|Antiemetics|antiemetics|mesh-ancestor
92051083|NCT01832727|Autonomic Agents|autonomic agents|mesh-ancestor
92051084|NCT01832727|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051085|NCT01832727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051086|NCT01832727|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051087|NCT01832727|Glucocorticoids|glucocorticoids|mesh-ancestor
92051088|NCT01832727|Hormones|hormones|mesh-ancestor
92051089|NCT01832727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051090|NCT01832727|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92051091|NCT01832727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051092|NCT01473394|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92051178|NCT02068495|Candesartan|candesartan|mesh-list
92051093|NCT01473394|Antidepressive Agents|antidepressive agents|mesh-ancestor
92051094|NCT01473394|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92051096|NCT01473394|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92051097|NCT01473394|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051098|NCT01473394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051099|NCT01473394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051100|NCT01473394|Serotonin Agents|serotonin agents|mesh-ancestor
92051101|NCT01473394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051102|NCT01473394|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92051103|NCT01473394|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92051104|NCT04408144|Dydrogesterone|dydrogesterone|mesh-list
92051105|NCT04408144|Progestins|progestins|mesh-ancestor
92051106|NCT04408144|Hormones|hormones|mesh-ancestor
92051107|NCT04408144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051108|NCT04408144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051109|NCT01449682|Dexamethasone|dexamethasone|mesh-list
92051110|NCT01449682|Dexamethasone acetate|dexamethasone acetate|mesh-list
92014776|NCT04340141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051111|NCT01449682|BB 1101|bb 1101|mesh-list
92051112|NCT01449682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051113|NCT01449682|Antiemetics|antiemetics|mesh-ancestor
92051114|NCT01449682|Autonomic Agents|autonomic agents|mesh-ancestor
92051115|NCT01449682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051116|NCT01449682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051117|NCT01449682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051118|NCT01449682|Glucocorticoids|glucocorticoids|mesh-ancestor
92051119|NCT01449682|Hormones|hormones|mesh-ancestor
92051120|NCT01449682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051121|NCT01449682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92051122|NCT01449682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051123|NCT01449682|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051124|NCT01449682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051125|NCT01449682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051126|NCT01831791|Dutasteride|dutasteride|mesh-list
92051127|NCT01831791|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92051128|NCT01831791|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92051129|NCT01831791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051130|NCT01831791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051131|NCT01831791|Hormone Antagonists|hormone antagonists|mesh-ancestor
92051132|NCT01831791|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051133|NCT01831791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051134|NCT01857531|Nicotine|nicotine|mesh-list
92051135|NCT01857531|Ganaxolone|ganaxolone|mesh-list
92051136|NCT01857531|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92051137|NCT01857531|Autonomic Agents|autonomic agents|mesh-ancestor
92051138|NCT01857531|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051139|NCT01857531|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051140|NCT01857531|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92051141|NCT01857531|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92051142|NCT01857531|Cholinergic Agents|cholinergic agents|mesh-ancestor
92051143|NCT01857531|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051144|NCT01857531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051145|NCT01857531|Neurosteroids|neurosteroids|mesh-ancestor
92051146|NCT01857531|GABA Modulators|gaba modulators|mesh-ancestor
92051147|NCT01857531|GABA Agents|gaba agents|mesh-ancestor
92051148|NCT02166047|Vesatolimod|vesatolimod|mesh-list
92051149|NCT02166047|Antiviral Agents|antiviral agents|mesh-ancestor
92051150|NCT02166047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051151|NCT01831089|Paclitaxel|paclitaxel|mesh-list
92051152|NCT01831089|Bevacizumab|bevacizumab|mesh-list
92051153|NCT01831089|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92051154|NCT01831089|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051155|NCT01831089|Tubulin Modulators|tubulin modulators|mesh-ancestor
92051156|NCT01831089|Antimitotic Agents|antimitotic agents|mesh-ancestor
92051157|NCT01831089|Mitosis Modulators|mitosis modulators|mesh-ancestor
92051158|NCT01831089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051159|NCT01831089|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92051160|NCT01831089|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92051161|NCT01831089|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92051162|NCT01831089|Growth Substances|growth substances|mesh-ancestor
92051163|NCT01831089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051164|NCT01831089|Growth Inhibitors|growth inhibitors|mesh-ancestor
92051165|NCT02111785|Dexamethasone|dexamethasone|mesh-list
92051166|NCT02111785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051179|NCT02068495|Candesartan cilexetil|candesartan cilexetil|mesh-list
92051180|NCT02068495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92051181|NCT02068495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92051182|NCT02068495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051183|NCT02068495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051184|NCT02068495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92051185|NCT02068495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051186|NCT02068495|Vasodilator Agents|vasodilator agents|mesh-ancestor
92051187|NCT02068495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92051188|NCT02068495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92051189|NCT02097823|Olanzapine|olanzapine|mesh-list
92051191|NCT02097823|Antiemetics|antiemetics|mesh-ancestor
92051192|NCT02097823|Autonomic Agents|autonomic agents|mesh-ancestor
92051193|NCT02097823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051194|NCT02097823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051195|NCT02097823|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051196|NCT02097823|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92051197|NCT02097823|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92051198|NCT02097823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051199|NCT02097823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92051200|NCT02097823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92051201|NCT02097823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92051202|NCT02097823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051203|NCT02097823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051204|NCT02097823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051205|NCT02097823|Serotonin Agents|serotonin agents|mesh-ancestor
92051206|NCT02097823|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92051207|NCT01857063|Montelukast|montelukast|mesh-list
92051208|NCT01857063|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92051209|NCT01857063|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051210|NCT01857063|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92051211|NCT01857063|Hormone Antagonists|hormone antagonists|mesh-ancestor
92051212|NCT01857063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051213|NCT01857063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051214|NCT01857063|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92051215|NCT01857063|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92051216|NCT01857063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051217|NCT01856907|Metformin|metformin|mesh-list
92051218|NCT01856907|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92051219|NCT01856907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051220|NCT01856907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051221|NCT01856907|Incretins|incretins|mesh-ancestor
92051222|NCT01856907|Hormones|hormones|mesh-ancestor
92081698|NCT01402947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051223|NCT01856907|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051224|NCT01856907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92051225|NCT01856907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051226|NCT01856907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051230|NCT02097745|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92051231|NCT02097745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051232|NCT02097745|Immunologic Factors|immunologic factors|mesh-ancestor
92051233|NCT02097745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051234|NCT02097745|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051235|NCT02097745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92051236|NCT02097745|Abortifacient Agents|abortifacient agents|mesh-ancestor
92051237|NCT02097745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92051238|NCT02097745|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92051239|NCT02097745|Antimetabolites|antimetabolites|mesh-ancestor
92051240|NCT02097745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051241|NCT02097745|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051242|NCT02097745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051243|NCT02097745|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92051244|NCT02097745|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051245|NCT02097745|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92051247|NCT02111083|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051248|NCT02111083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051249|NCT01629563|Ulipristal acetate|ulipristal acetate|mesh-list
92051250|NCT01629563|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92051251|NCT01629563|Contraceptive Agents|contraceptive agents|mesh-ancestor
92051252|NCT01629563|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92051253|NCT01629563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051254|NCT01629563|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92051255|NCT02212379|Raltegravir Potassium|raltegravir potassium|mesh-list
92051256|NCT02212379|Etravirine|etravirine|mesh-list
92051257|NCT02212379|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92051258|NCT02212379|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92051259|NCT02212379|Antiviral Agents|antiviral agents|mesh-ancestor
92051260|NCT02212379|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051261|NCT02212379|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92051262|NCT02212379|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92051263|NCT02212379|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051264|NCT02212379|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014778|NCT04340141|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92014779|NCT04340141|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92014780|NCT04340141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051265|NCT02212379|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92051266|NCT02212379|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92051268|NCT02187809|Anticonvulsants|anticonvulsants|mesh-ancestor
92051269|NCT02187809|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92051270|NCT02187809|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92051271|NCT02187809|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051272|NCT02187809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051273|NCT02187809|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92051274|NCT02187809|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92051275|NCT02187809|GABA Agonists|gaba agonists|mesh-ancestor
92051276|NCT02187809|GABA Agents|gaba agents|mesh-ancestor
92051277|NCT02187809|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051278|NCT02187809|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051279|NCT02110225|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92051280|NCT02110225|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92051281|NCT02110225|Mitogens|mitogens|mesh-list
92051282|NCT02110225|Mitosis Modulators|mitosis modulators|mesh-ancestor
92051283|NCT02110225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051284|NCT04756505|Interleukin-12|interleukin-12|mesh-list
92051285|NCT04756505|Immunoglobulin G|immunoglobulin g|mesh-list
92051286|NCT04756505|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92051287|NCT04756505|Immunologic Factors|immunologic factors|mesh-ancestor
92051288|NCT04756505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051289|NCT04756505|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92051290|NCT04756505|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92051291|NCT04756505|Growth Substances|growth substances|mesh-ancestor
92051292|NCT04756505|Growth Inhibitors|growth inhibitors|mesh-ancestor
92051293|NCT04756505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051294|NCT04750655|Moxifloxacin|moxifloxacin|mesh-list
92051295|NCT04750655|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92051296|NCT04750655|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051297|NCT04750655|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92051298|NCT04750655|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92051301|NCT04750655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051303|NCT02162771|Prednisolone|prednisolone|mesh-list
92051304|NCT02162771|Cyclophosphamide|cyclophosphamide|mesh-list
92051305|NCT02162771|Rituximab|rituximab|mesh-list
92051306|NCT02162771|Vincristine|vincristine|mesh-list
92051307|NCT02162771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051308|NCT02162771|Immunologic Factors|immunologic factors|mesh-ancestor
92051309|NCT02162771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051310|NCT02162771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051311|NCT02162771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92051312|NCT02162771|Alkylating Agents|alkylating agents|mesh-ancestor
92051313|NCT02162771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051314|NCT02162771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051315|NCT02162771|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92051316|NCT02162771|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92051317|NCT02162771|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051318|NCT02162771|Glucocorticoids|glucocorticoids|mesh-ancestor
92051319|NCT02162771|Hormones|hormones|mesh-ancestor
92051320|NCT02162771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051321|NCT02162771|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92051322|NCT02162771|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92051323|NCT02162771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92051324|NCT02162771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92051325|NCT02162771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92051326|NCT02160041|Infigratinib|infigratinib|mesh-list
92051327|NCT02160041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051328|NCT02186873|Golimumab|golimumab|mesh-list
92051329|NCT02186873|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92051330|NCT02186873|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051331|NCT02186873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051332|NCT02186873|Immunologic Factors|immunologic factors|mesh-ancestor
92051333|NCT02186873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051334|NCT02096263|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92051335|NCT02096263|Immunologic Factors|immunologic factors|mesh-ancestor
92014781|NCT04340141|Antidotes|antidotes|mesh-ancestor
92014782|NCT04340141|Protective Agents|protective agents|mesh-ancestor
92014783|NCT04340141|Vitamin B Complex|vitamin b complex|mesh-ancestor
92051336|NCT02096263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051337|NCT01830543|Aspirin|aspirin|mesh-list
92051338|NCT01830543|Vitamin K|vitamin k|mesh-list
92051339|NCT01830543|Rivaroxaban|rivaroxaban|mesh-list
92051340|NCT01830543|Clopidogrel|clopidogrel|mesh-list
92051341|NCT01830543|Ticagrelor|ticagrelor|mesh-list
92051342|NCT01830543|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92051343|NCT01830543|Vitamins|vitamins|mesh-ancestor
92051344|NCT01830543|Micronutrients|micronutrients|mesh-ancestor
92051345|NCT01830543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051346|NCT01830543|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92051347|NCT01830543|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92051348|NCT01830543|Analgesics|analgesics|mesh-ancestor
92051349|NCT01830543|Sensory System Agents|sensory system agents|mesh-ancestor
92051350|NCT01830543|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051351|NCT01830543|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051352|NCT01830543|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051353|NCT01830543|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92051354|NCT01830543|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92051355|NCT01830543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051356|NCT01830543|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92051357|NCT01830543|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92051358|NCT01830543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051359|NCT01830543|Antipyretics|antipyretics|mesh-ancestor
92051360|NCT01830543|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92051361|NCT01830543|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92051362|NCT01830543|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92051363|NCT01830543|Purinergic Agents|purinergic agents|mesh-ancestor
92051364|NCT01830543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051365|NCT01830543|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92051366|NCT01830543|Antithrombins|antithrombins|mesh-ancestor
92051367|NCT01830543|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92051368|NCT01830543|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051369|NCT01830543|Anticoagulants|anticoagulants|mesh-ancestor
92051370|NCT01830543|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92051371|NCT01830543|Hemostatics|hemostatics|mesh-ancestor
92051372|NCT01830543|Coagulants|coagulants|mesh-ancestor
92051377|NCT02109445|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92051378|NCT02109445|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051379|NCT02109445|Tubulin Modulators|tubulin modulators|mesh-ancestor
92051380|NCT02109445|Antimitotic Agents|antimitotic agents|mesh-ancestor
92051381|NCT02109445|Mitosis Modulators|mitosis modulators|mesh-ancestor
92051382|NCT02109445|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051383|NCT02109445|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92051384|NCT02109445|Antimetabolites|antimetabolites|mesh-ancestor
92051385|NCT02109445|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92051386|NCT02109445|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051387|NCT02109133|Rocuronium|rocuronium|mesh-list
92051388|NCT02109133|Atracurium|atracurium|mesh-list
92051389|NCT02109133|Neostigmine|neostigmine|mesh-list
92051390|NCT02109133|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92051391|NCT02109133|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92051392|NCT02109133|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92051393|NCT02109133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051394|NCT02109133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051395|NCT02109133|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92051396|NCT02109133|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051397|NCT02109133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051398|NCT02109133|Cholinergic Agents|cholinergic agents|mesh-ancestor
92051399|NCT02109133|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051400|NCT02109133|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92051401|NCT02109133|Autonomic Agents|autonomic agents|mesh-ancestor
92051402|NCT02109133|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92051403|NCT02109133|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92051404|NCT01623271|Gabapentin|gabapentin|mesh-list
92051405|NCT01623271|Analgesics|analgesics|mesh-ancestor
92051406|NCT01623271|Sensory System Agents|sensory system agents|mesh-ancestor
92051407|NCT01623271|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051408|NCT01623271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051409|NCT01623271|Anticonvulsants|anticonvulsants|mesh-ancestor
92014784|NCT04340141|Vitamins|vitamins|mesh-ancestor
92014785|NCT04340141|Micronutrients|micronutrients|mesh-ancestor
92014786|NCT05445791|Metformin|metformin|mesh-list
92051410|NCT01623271|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92051411|NCT01623271|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92051412|NCT01623271|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051413|NCT01623271|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92051414|NCT01623271|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92051415|NCT01623271|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92051416|NCT01623271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051417|NCT01623271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051418|NCT01623271|Antimanic Agents|antimanic agents|mesh-ancestor
92051419|NCT02095951|Ethanol|ethanol|mesh-list
92051420|NCT02095951|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92051421|NCT02095951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051422|NCT02095951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051423|NCT02095951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051424|NCT02095873|Resveratrol|resveratrol|mesh-list
92051425|NCT02095873|Antioxidants|antioxidants|mesh-ancestor
92051426|NCT02095873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051427|NCT02095873|Protective Agents|protective agents|mesh-ancestor
92051428|NCT02095873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051429|NCT02095873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051430|NCT02095873|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92051431|NCT02094937|Fluticasone|fluticasone|mesh-list
92051432|NCT02094937|Xhance|xhance|mesh-list
92051433|NCT02094937|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051434|NCT02094937|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92051435|NCT02094937|Autonomic Agents|autonomic agents|mesh-ancestor
92051436|NCT02094937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051437|NCT02094937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051438|NCT02094937|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92051439|NCT02094937|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051440|NCT02094937|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051441|NCT02094937|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92051442|NCT04724629|Aldesleukin|aldesleukin|mesh-list
92051443|NCT04724629|Colchicine|colchicine|mesh-list
92051444|NCT04724629|Ixekizumab|ixekizumab|mesh-list
92051445|NCT04724629|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051449|NCT04724629|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051450|NCT04724629|Gout Suppressants|gout suppressants|mesh-ancestor
92051451|NCT04724629|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051452|NCT04724629|Tubulin Modulators|tubulin modulators|mesh-ancestor
92051453|NCT04724629|Antimitotic Agents|antimitotic agents|mesh-ancestor
92051454|NCT04724629|Mitosis Modulators|mitosis modulators|mesh-ancestor
92051455|NCT04724629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051456|NCT04724629|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051458|NCT02186015|Ergocalciferols|ergocalciferols|mesh-list
92051459|NCT02186015|Cholecalciferol|cholecalciferol|mesh-list
92051460|NCT02186015|Vitamins|vitamins|mesh-list
92051461|NCT02186015|Micronutrients|micronutrients|mesh-ancestor
92051462|NCT02186015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051463|NCT02186015|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92051464|NCT02186015|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92051465|NCT02066389|Upadacitinib|upadacitinib|mesh-list
92051466|NCT02066389|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92051467|NCT02066389|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051468|NCT02066389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051469|NCT02066389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051470|NCT02066389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051471|NCT02106403|Disinfectants|disinfectants|mesh-list
92051472|NCT02106403|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051473|NCT02133131|Sofosbuvir|sofosbuvir|mesh-list
92051474|NCT02133131|Grazoprevir|grazoprevir|mesh-list
92051475|NCT02133131|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92051476|NCT02133131|Antiviral Agents|antiviral agents|mesh-ancestor
92051477|NCT02133131|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051479|NCT02106325|Promethazine|promethazine|mesh-list
92051480|NCT02106325|Ketamine|ketamine|mesh-list
92051481|NCT02106325|Analgesics|analgesics|mesh-ancestor
92051482|NCT02106325|Sensory System Agents|sensory system agents|mesh-ancestor
92051483|NCT02106325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051484|NCT02106325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051485|NCT02106325|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92051486|NCT02106325|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92051487|NCT02106325|Anesthetics, General|anesthetics, general|mesh-ancestor
92051488|NCT02106325|Anesthetics|anesthetics|mesh-ancestor
92051489|NCT02106325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051490|NCT02106325|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92051491|NCT02106325|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92051492|NCT02106325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051493|NCT02106325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051494|NCT02106325|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92051495|NCT02106325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92051496|NCT02106325|Anesthetics, Local|anesthetics, local|mesh-ancestor
92051497|NCT02106325|Antiemetics|antiemetics|mesh-ancestor
92051498|NCT02106325|Autonomic Agents|autonomic agents|mesh-ancestor
92051499|NCT02106325|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051500|NCT02106325|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92051501|NCT02106325|Histamine Antagonists|histamine antagonists|mesh-ancestor
92051502|NCT02106325|Histamine Agents|histamine agents|mesh-ancestor
92051503|NCT02106325|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92051504|NCT02106325|Antipruritics|antipruritics|mesh-ancestor
92051505|NCT02106325|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051506|NCT02184611|Bromides|bromides|mesh-list
92051507|NCT02184611|Anticonvulsants|anticonvulsants|mesh-ancestor
92051508|NCT02066311|Nelfinavir|nelfinavir|mesh-list
92051509|NCT02066311|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92051510|NCT02066311|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92051511|NCT02066311|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051512|NCT02066311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051513|NCT02066311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051514|NCT02066311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92051515|NCT02066311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92051516|NCT02066311|Antiviral Agents|antiviral agents|mesh-ancestor
92051517|NCT02066311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051518|NCT01625611|Naltrexone|naltrexone|mesh-list
92051519|NCT01625611|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92051520|NCT01625611|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92051522|NCT01625611|Sensory System Agents|sensory system agents|mesh-ancestor
92051523|NCT01625611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051524|NCT02159807|Fentanyl|fentanyl|mesh-list
92051525|NCT02159807|Bupivacaine|bupivacaine|mesh-list
92051526|NCT02159807|Anesthetics, Local|anesthetics, local|mesh-ancestor
92051527|NCT02159807|Anesthetics|anesthetics|mesh-ancestor
92051528|NCT02159807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051529|NCT02159807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051530|NCT02159807|Sensory System Agents|sensory system agents|mesh-ancestor
92051531|NCT02159807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051532|NCT02159807|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92051533|NCT02159807|Narcotics|narcotics|mesh-ancestor
92051534|NCT02159807|Analgesics|analgesics|mesh-ancestor
92051535|NCT02159807|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92051536|NCT02159807|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92051537|NCT02159807|Anesthetics, General|anesthetics, general|mesh-ancestor
92051538|NCT02183675|Amlodipine|amlodipine|mesh-list
92051539|NCT02183675|Telmisartan|telmisartan|mesh-list
92051540|NCT02183675|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92051541|NCT02183675|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92051542|NCT02183675|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92051543|NCT02183675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92051544|NCT02183675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051545|NCT02183675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051546|NCT02183675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92051547|NCT02183675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051548|NCT02183675|Vasodilator Agents|vasodilator agents|mesh-ancestor
92051549|NCT02183675|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92051550|NCT02183675|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92051551|NCT02183675|Diuretics|diuretics|mesh-ancestor
92051552|NCT02183675|Natriuretic Agents|natriuretic agents|mesh-ancestor
92051553|NCT02183675|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92051554|NCT02183519|Capsaicin|capsaicin|mesh-list
92051555|NCT02183519|Antipruritics|antipruritics|mesh-ancestor
92051556|NCT02183519|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051557|NCT02183519|Sensory System Agents|sensory system agents|mesh-ancestor
92051558|NCT02183519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051559|NCT02183519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051560|NCT02132195|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92051561|NCT02132195|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92051562|NCT02132195|beta-Endorphin|beta-endorphin|mesh-list
92051563|NCT02132195|Hormones|hormones|mesh-ancestor
92014787|NCT05445791|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014788|NCT05445791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051564|NCT02132195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051565|NCT02132195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051566|NCT02132195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051567|NCT02132195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051568|NCT02182895|Saxagliptin|saxagliptin|mesh-list
92051569|NCT02182895|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92051570|NCT02182895|Incretins|incretins|mesh-ancestor
92051571|NCT02182895|Hormones|hormones|mesh-ancestor
92051572|NCT02182895|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051573|NCT02182895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051574|NCT02182895|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051575|NCT02182895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051576|NCT02182895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051577|NCT02182895|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051578|NCT01625377|Mycophenolic Acid|mycophenolic acid|mesh-list
92051579|NCT01625377|Everolimus|everolimus|mesh-list
92051580|NCT01625377|Tacrolimus|tacrolimus|mesh-list
92051581|NCT01625377|Basiliximab|basiliximab|mesh-list
92051582|NCT01625377|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051583|NCT01625377|Immunologic Factors|immunologic factors|mesh-ancestor
92051584|NCT01625377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051585|NCT01625377|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92051586|NCT01625377|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051587|NCT01625377|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051588|NCT01625377|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92051589|NCT01625377|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051590|NCT01625377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051591|NCT01625377|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92051594|NCT01625377|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92051595|NCT01625377|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051596|NCT02132117|Phenylephrine|phenylephrine|mesh-list
92051597|NCT02132117|Oxymetazoline|oxymetazoline|mesh-list
92051598|NCT02132117|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92051599|NCT02132117|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92051600|NCT02132117|Adrenergic Agents|adrenergic agents|mesh-ancestor
92051601|NCT02132117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051602|NCT02132117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051603|NCT02132117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051605|NCT02132117|Autonomic Agents|autonomic agents|mesh-ancestor
92051606|NCT02132117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051607|NCT02132117|Nasal Decongestants|nasal decongestants|mesh-ancestor
92051608|NCT02132117|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92051609|NCT02132117|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051610|NCT02132117|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92051611|NCT02132117|Mydriatics|mydriatics|mesh-ancestor
92051612|NCT02132117|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92051613|NCT02132117|Protective Agents|protective agents|mesh-ancestor
92051614|NCT02047045|Prucalopride|prucalopride|mesh-list
92051615|NCT02047045|Serotonin|serotonin|mesh-list
92051616|NCT02047045|Laxatives|laxatives|mesh-ancestor
92051617|NCT02047045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051618|NCT02047045|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92051619|NCT02047045|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92051620|NCT02047045|Serotonin Agents|serotonin agents|mesh-ancestor
92051621|NCT02047045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051622|NCT02047045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051623|NCT02047045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051624|NCT02131259|Afatinib|afatinib|mesh-list
92051625|NCT02131259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051626|NCT02131259|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051627|NCT02131259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051628|NCT02131259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051629|NCT01829295|Mycophenolic Acid|mycophenolic acid|mesh-list
92051630|NCT01829295|Prednisone|prednisone|mesh-list
92051631|NCT01829295|Methotrexate|methotrexate|mesh-list
92051632|NCT01829295|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051633|NCT01829295|Glucocorticoids|glucocorticoids|mesh-ancestor
92051634|NCT01829295|Hormones|hormones|mesh-ancestor
92051635|NCT01829295|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92014789|NCT04799873|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92014790|NCT04799873|Protein C Inhibitor|protein c inhibitor|mesh-list
92014791|NCT04799873|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92051636|NCT01829295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051854|NCT02155829|Protective Agents|protective agents|mesh-ancestor
92051637|NCT01829295|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92051638|NCT01829295|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051639|NCT01829295|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92051640|NCT01829295|Abortifacient Agents|abortifacient agents|mesh-ancestor
92051641|NCT01829295|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92051642|NCT01829295|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92051643|NCT01829295|Antimetabolites|antimetabolites|mesh-ancestor
92051644|NCT01829295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051645|NCT01829295|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051646|NCT01829295|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051647|NCT01829295|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92051648|NCT01829295|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051649|NCT01829295|Immunologic Factors|immunologic factors|mesh-ancestor
92051650|NCT01829295|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051651|NCT01829295|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92051652|NCT01829295|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92051653|NCT01829295|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92051654|NCT01829295|Antitubercular Agents|antitubercular agents|mesh-ancestor
92051655|NCT01829295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92051656|NCT01829295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051657|NCT02157935|Formoterol Fumarate|formoterol fumarate|mesh-list
92051658|NCT02157935|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92051659|NCT02157935|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92051660|NCT02157935|Autonomic Agents|autonomic agents|mesh-ancestor
92051661|NCT02157935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051662|NCT02157935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051663|NCT02157935|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92051664|NCT02157935|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051666|NCT02157935|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92051667|NCT02157935|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92051668|NCT02157935|Adrenergic Agents|adrenergic agents|mesh-ancestor
92051669|NCT02157935|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051670|NCT02157935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051671|NCT02093221|Protease Inhibitors|protease inhibitors|mesh-list
92051672|NCT02093221|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92051673|NCT02093221|Protein C Inhibitor|protein c inhibitor|mesh-list
92051674|NCT02093221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051675|NCT02093221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051676|NCT02093221|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92051677|NCT02093221|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92051679|NCT01623115|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92051680|NCT01623115|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92051681|NCT01623115|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92051682|NCT01623115|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92051683|NCT01623115|Antimetabolites|antimetabolites|mesh-ancestor
92051684|NCT01623115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051685|NCT01623115|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92051686|NCT01623115|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051687|NCT01623115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051688|NCT01623115|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92051689|NCT01623115|Immunologic Factors|immunologic factors|mesh-ancestor
92051690|NCT01623115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051691|NCT02092285|Golimumab|golimumab|mesh-list
92051692|NCT02092285|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92051693|NCT02092285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051694|NCT02092285|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051695|NCT02092285|Immunologic Factors|immunologic factors|mesh-ancestor
92051696|NCT02092285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051697|NCT02091739|Botulinum Toxins|botulinum toxins|mesh-list
92051698|NCT02091739|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92051699|NCT02091739|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92051700|NCT02091739|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92051701|NCT02091739|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92051702|NCT02091739|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051703|NCT02091739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014792|NCT04799873|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92051704|NCT02091739|Cholinergic Agents|cholinergic agents|mesh-ancestor
92051705|NCT02091739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051706|NCT02091739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051707|NCT02091739|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92051708|NCT02091739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051709|NCT02045875|Mometasone Furoate|mometasone furoate|mesh-list
92051710|NCT02045875|Formoterol Fumarate|formoterol fumarate|mesh-list
92051711|NCT02045875|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92051712|NCT02045875|Autonomic Agents|autonomic agents|mesh-ancestor
92051713|NCT02045875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051714|NCT02045875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051715|NCT02045875|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92051716|NCT02045875|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051717|NCT02045875|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92051718|NCT02045875|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92051719|NCT02045875|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92051720|NCT02045875|Adrenergic Agents|adrenergic agents|mesh-ancestor
92051721|NCT02045875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051722|NCT02045875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051723|NCT02045875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051724|NCT02045875|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051725|NCT02045875|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92051726|NCT01827267|Sirolimus|sirolimus|mesh-list
92051727|NCT01827267|Temsirolimus|temsirolimus|mesh-list
92051728|NCT01827267|MTOR Inhibitors|mtor inhibitors|mesh-list
92051729|NCT01827267|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051730|NCT01827267|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051731|NCT01827267|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051732|NCT01827267|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051733|NCT01827267|Immunologic Factors|immunologic factors|mesh-ancestor
92051734|NCT01827267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051735|NCT01827267|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051737|NCT01827267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051738|NCT01827267|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92051739|NCT01827267|Antifungal Agents|antifungal agents|mesh-ancestor
92051741|NCT01827111|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92051742|NCT01827111|Ipilimumab|ipilimumab|mesh-list
92051743|NCT01827111|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92051744|NCT01827111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051745|NCT01827111|Tubulin Modulators|tubulin modulators|mesh-ancestor
92051746|NCT01827111|Antimitotic Agents|antimitotic agents|mesh-ancestor
92051747|NCT01827111|Mitosis Modulators|mitosis modulators|mesh-ancestor
92051748|NCT01827111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051749|NCT01827111|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92051750|NCT01827111|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92051751|NCT02064439|Rivaroxaban|rivaroxaban|mesh-list
92051752|NCT02064439|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92051753|NCT02064439|Antithrombins|antithrombins|mesh-ancestor
92051754|NCT02064439|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92051755|NCT02064439|Protease Inhibitors|protease inhibitors|mesh-ancestor
92051756|NCT02064439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051757|NCT02064439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051758|NCT02064439|Anticoagulants|anticoagulants|mesh-ancestor
92051759|NCT02130557|Imatinib Mesylate|imatinib mesylate|mesh-list
92051760|NCT02130557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051761|NCT02130557|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051762|NCT02130557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051763|NCT02130557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051764|NCT01854645|Bromides|bromides|mesh-list
92051765|NCT01854645|Tiotropium Bromide|tiotropium bromide|mesh-list
92051766|NCT01854645|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92051767|NCT01854645|Autonomic Agents|autonomic agents|mesh-ancestor
92051768|NCT01854645|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051769|NCT01854645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051770|NCT01854645|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92051771|NCT01854645|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051772|NCT01854645|Parasympatholytics|parasympatholytics|mesh-ancestor
92051773|NCT01854645|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92014794|NCT04799873|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014795|NCT04799873|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014796|NCT05201313|Lidocaine|lidocaine|mesh-list
92014797|NCT05201313|Mepivacaine|mepivacaine|mesh-list
92014798|NCT05201313|Anesthetics, Local|anesthetics, local|mesh-ancestor
92051774|NCT01854645|Cholinergic Agents|cholinergic agents|mesh-ancestor
92051775|NCT01854645|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051776|NCT01854645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051777|NCT01854645|Anticonvulsants|anticonvulsants|mesh-ancestor
92051778|NCT04418089|Simvastatin|simvastatin|mesh-list
92051779|NCT04418089|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92051780|NCT04418089|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92051781|NCT04418089|Antimetabolites|antimetabolites|mesh-ancestor
92051855|NCT02178995|Methylphenidate|methylphenidate|mesh-list
92051782|NCT04418089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051783|NCT04418089|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92051784|NCT04418089|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92051785|NCT04418089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051786|NCT01825941|Diphenhydramine|diphenhydramine|mesh-list
92051788|NCT01825941|Metoclopramide|metoclopramide|mesh-list
92051789|NCT01825941|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92051790|NCT01825941|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92051791|NCT01825941|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051792|NCT01825941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051793|NCT01825941|Anesthetics, Local|anesthetics, local|mesh-ancestor
92051794|NCT01825941|Anesthetics|anesthetics|mesh-ancestor
92051795|NCT01825941|Sensory System Agents|sensory system agents|mesh-ancestor
92051796|NCT01825941|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051797|NCT01825941|Antiemetics|antiemetics|mesh-ancestor
92051798|NCT01825941|Autonomic Agents|autonomic agents|mesh-ancestor
92051799|NCT01825941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051800|NCT01825941|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92051801|NCT01825941|Histamine Antagonists|histamine antagonists|mesh-ancestor
92051802|NCT01825941|Histamine Agents|histamine agents|mesh-ancestor
92051803|NCT01825941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051804|NCT01825941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051805|NCT01825941|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92051806|NCT01825941|Antipruritics|antipruritics|mesh-ancestor
92051807|NCT01825941|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051808|NCT01825941|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92051809|NCT01825941|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92051812|NCT02044159|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92051813|NCT02044159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051814|NCT02180165|Voriconazole|voriconazole|mesh-list
92051815|NCT02180165|Posaconazole|posaconazole|mesh-list
92051816|NCT02180165|Antifungal Agents|antifungal agents|mesh-ancestor
92051817|NCT02180165|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051818|NCT02180165|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92051819|NCT02180165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92051820|NCT02180165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051821|NCT02180165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051822|NCT02180165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92051823|NCT02180165|Hormone Antagonists|hormone antagonists|mesh-ancestor
92051824|NCT02180165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051825|NCT02180165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051826|NCT02180165|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92051827|NCT02180165|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92051828|NCT02180165|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92051829|NCT02180165|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92051831|NCT02155985|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92051832|NCT02155985|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92051833|NCT02155985|Analgesics|analgesics|mesh-ancestor
92051834|NCT02155985|Sensory System Agents|sensory system agents|mesh-ancestor
92051835|NCT02155985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051836|NCT02155985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051837|NCT02155985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051838|NCT02155985|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051839|NCT02155985|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92051840|NCT02155985|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92014799|NCT05201313|Anesthetics|anesthetics|mesh-ancestor
92014800|NCT05201313|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014801|NCT05201313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014802|NCT05201313|Sensory System Agents|sensory system agents|mesh-ancestor
92014803|NCT05201313|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051841|NCT02155985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051842|NCT02155985|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92051843|NCT02155985|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92051844|NCT02155985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051845|NCT02155985|Antipyretics|antipyretics|mesh-ancestor
92051847|NCT02155829|Anticonvulsants|anticonvulsants|mesh-ancestor
92051848|NCT02155829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92051849|NCT02155829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92051850|NCT02155829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051851|NCT02155829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051852|NCT02155829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051853|NCT02155829|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92051856|NCT02178995|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92051857|NCT02178995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051858|NCT02178995|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92051859|NCT02178995|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92051860|NCT02178995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051861|NCT02178995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051862|NCT02178995|Dopamine Agents|dopamine agents|mesh-ancestor
92051863|NCT02178995|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051864|NCT02154425|Certolizumab Pegol|certolizumab pegol|mesh-list
92051865|NCT02154425|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92051866|NCT02154425|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051867|NCT02154425|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051868|NCT02154425|Immunologic Factors|immunologic factors|mesh-ancestor
92051869|NCT02154425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051870|NCT02154425|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051871|NCT02154347|Mitiglinide|mitiglinide|mesh-list
92051872|NCT02154347|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051873|NCT02154347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051875|NCT01627067|Everolimus|everolimus|mesh-list
92051876|NCT01627067|Exemestane|exemestane|mesh-list
92051877|NCT01627067|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051878|NCT01627067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051879|NCT01627067|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92051880|NCT01627067|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051881|NCT01627067|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051885|NCT01627067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051886|NCT01627067|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92051887|NCT01627067|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92051888|NCT01627067|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92051889|NCT01627067|Hormone Antagonists|hormone antagonists|mesh-ancestor
92051890|NCT01627067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051892|NCT02178059|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92051894|NCT02178059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051895|NCT02178059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051896|NCT02178059|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92051897|NCT02178059|Respiratory System Agents|respiratory system agents|mesh-ancestor
92051898|NCT02178059|Sympathomimetics|sympathomimetics|mesh-ancestor
92051899|NCT02178059|Tocolytic Agents|tocolytic agents|mesh-ancestor
92051900|NCT02178059|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92051901|NCT02178059|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92051902|NCT02178059|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92051903|NCT02178059|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92051904|NCT02178059|Adrenergic Agents|adrenergic agents|mesh-ancestor
92051905|NCT02178059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051906|NCT02178059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051907|NCT02128217|Ribavirin|ribavirin|mesh-list
92014804|NCT05201313|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92014805|NCT05201313|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92014806|NCT05201313|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92014807|NCT05201313|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051908|NCT02128217|Sofosbuvir|sofosbuvir|mesh-list
92051909|NCT02128217|Ledipasvir|ledipasvir|mesh-list
92051910|NCT02128217|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92051911|NCT02128217|Antimetabolites|antimetabolites|mesh-ancestor
92051912|NCT02128217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051913|NCT02128217|Antiviral Agents|antiviral agents|mesh-ancestor
92051914|NCT02128217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051915|NCT01628549|Sarecycline|sarecycline|mesh-list
92051916|NCT01628549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92051917|NCT01628549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051918|NCT01628549|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051919|NCT02127125|Sevelamer|sevelamer|mesh-list
92051920|NCT02127125|Chelating Agents|chelating agents|mesh-ancestor
92051921|NCT02127125|Sequestering Agents|sequestering agents|mesh-ancestor
92051922|NCT02127125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051923|NCT02090413|Aspirin|aspirin|mesh-list
92051924|NCT02090413|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92051925|NCT02090413|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92051926|NCT02090413|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92051927|NCT02090413|Analgesics|analgesics|mesh-ancestor
92051928|NCT02090413|Sensory System Agents|sensory system agents|mesh-ancestor
92051929|NCT02090413|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051930|NCT02090413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051931|NCT02090413|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92051932|NCT02090413|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051933|NCT02090413|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92051934|NCT02090413|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92051935|NCT02090413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051936|NCT02090413|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92051937|NCT02090413|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92051938|NCT02090413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92051939|NCT02090413|Antipyretics|antipyretics|mesh-ancestor
92051940|NCT02090413|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051941|NCT02090413|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051942|NCT02090413|Immunologic Factors|immunologic factors|mesh-ancestor
92051943|NCT02125877|Deferasirox|deferasirox|mesh-list
92051944|NCT02125877|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92051945|NCT02125877|Chelating Agents|chelating agents|mesh-ancestor
92051946|NCT02125877|Sequestering Agents|sequestering agents|mesh-ancestor
92051947|NCT02125877|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051948|NCT01598987|Cyclosporine|cyclosporine|mesh-list
92051949|NCT01598987|Everolimus|everolimus|mesh-list
92051950|NCT01598987|Tacrolimus|tacrolimus|mesh-list
92051951|NCT01598987|Cyclosporins|cyclosporins|mesh-list
92051952|NCT01598987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051953|NCT01598987|Immunologic Factors|immunologic factors|mesh-ancestor
92051957|NCT01598987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051958|NCT01598987|Antifungal Agents|antifungal agents|mesh-ancestor
92051959|NCT01598987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92051960|NCT01598987|Dermatologic Agents|dermatologic agents|mesh-ancestor
92051961|NCT01598987|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92051962|NCT01598987|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92051963|NCT01598987|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92051964|NCT01598987|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051965|NCT02062879|Ketamine|ketamine|mesh-list
92051966|NCT02062879|Hydromorphone|hydromorphone|mesh-list
92051967|NCT02062879|Analgesics|analgesics|mesh-ancestor
92051968|NCT02062879|Sensory System Agents|sensory system agents|mesh-ancestor
92051969|NCT02062879|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051970|NCT02062879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051971|NCT02062879|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92051972|NCT02062879|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92051973|NCT02062879|Anesthetics, General|anesthetics, general|mesh-ancestor
92051974|NCT02062879|Anesthetics|anesthetics|mesh-ancestor
92051975|NCT02062879|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92051976|NCT02062879|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92051977|NCT02062879|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92051978|NCT02062879|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92051979|NCT02062879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051981|NCT02062879|Narcotics|narcotics|mesh-ancestor
92051982|NCT02062645|Amlodipine|amlodipine|mesh-list
92051983|NCT02062645|Valsartan|valsartan|mesh-list
92051984|NCT02062645|Amlodipine, Valsartan Drug Combination|amlodipine, valsartan drug combination|mesh-list
92051985|NCT02062645|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92051986|NCT02062645|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92051987|NCT02062645|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92051988|NCT02062645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051989|NCT02062645|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92051990|NCT02062645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051991|NCT02062645|Vasodilator Agents|vasodilator agents|mesh-ancestor
92051992|NCT02062645|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92051993|NCT02062645|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92051994|NCT04700839|Metformin|metformin|mesh-list
92051995|NCT04700839|Canagliflozin|canagliflozin|mesh-list
92051996|NCT04700839|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92051997|NCT04700839|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92051998|NCT04700839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051999|NCT04700839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052000|NCT02043301|Bococizumab|bococizumab|mesh-list
92052001|NCT02043301|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92052002|NCT02043301|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92052003|NCT02043301|Antimetabolites|antimetabolites|mesh-ancestor
92052004|NCT02043301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052005|NCT02043301|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92052006|NCT01598753|Tramadol|tramadol|mesh-list
92052007|NCT01598753|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92052008|NCT01598753|Narcotics|narcotics|mesh-ancestor
92052009|NCT01598753|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052010|NCT01598753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052011|NCT01598753|Analgesics|analgesics|mesh-ancestor
92052012|NCT01598753|Sensory System Agents|sensory system agents|mesh-ancestor
92052013|NCT01598753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052014|NCT01824693|Mycophenolic Acid|mycophenolic acid|mesh-list
92052015|NCT01824693|Cyclophosphamide|cyclophosphamide|mesh-list
92052016|NCT01824693|Melphalan|melphalan|mesh-list
92052017|NCT01824693|Busulfan|busulfan|mesh-list
92052018|NCT01824693|Mechlorethamine|mechlorethamine|mesh-list
92052019|NCT01824693|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92052020|NCT01824693|Fludarabine|fludarabine|mesh-list
92052021|NCT01824693|Fludarabine phosphate|fludarabine phosphate|mesh-list
92052022|NCT01824693|Tacrolimus|tacrolimus|mesh-list
92052023|NCT01824693|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052024|NCT01824693|Immunologic Factors|immunologic factors|mesh-ancestor
92052025|NCT01824693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052032|NCT01824693|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052033|NCT01824693|Antimetabolites|antimetabolites|mesh-ancestor
92052034|NCT01824693|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92052035|NCT01824693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052036|NCT01824693|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92052037|NCT01824693|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92052038|NCT01824693|Antitubercular Agents|antitubercular agents|mesh-ancestor
92052039|NCT01824693|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052040|NCT01824693|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052041|NCT02176655|Aspirin|aspirin|mesh-list
92052042|NCT02176655|Sumatriptan|sumatriptan|mesh-list
92052043|NCT02176655|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92052044|NCT02176655|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92052045|NCT02176655|Analgesics|analgesics|mesh-ancestor
92052046|NCT02176655|Sensory System Agents|sensory system agents|mesh-ancestor
92052047|NCT02176655|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052048|NCT02176655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052049|NCT02176655|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052050|NCT02176655|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052051|NCT02176655|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92052052|NCT02176655|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92052053|NCT02176655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052054|NCT02176655|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92014808|NCT05201313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014809|NCT05201001|Carboplatin|carboplatin|mesh-list
92052055|NCT02176655|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92052056|NCT02176655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052057|NCT02176655|Antipyretics|antipyretics|mesh-ancestor
92052058|NCT02176655|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92052059|NCT02176655|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92052060|NCT02176655|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92052061|NCT02176655|Serotonin Agents|serotonin agents|mesh-ancestor
92052062|NCT02176655|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052063|NCT01622569|Fluticasone|fluticasone|mesh-list
92052065|NCT01622569|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052066|NCT01622569|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92052067|NCT01622569|Autonomic Agents|autonomic agents|mesh-ancestor
92052068|NCT01622569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052069|NCT01622569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052070|NCT01622569|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92052071|NCT01622569|Respiratory System Agents|respiratory system agents|mesh-ancestor
92052072|NCT01622569|Dermatologic Agents|dermatologic agents|mesh-ancestor
92052073|NCT01622569|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92052074|NCT02152631|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92052075|NCT02152631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052076|NCT02152631|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92052077|NCT02152631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052078|NCT02152631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052079|NCT04747301|Dinoprostone|dinoprostone|mesh-list
92052080|NCT04747301|Oxytocics|oxytocics|mesh-ancestor
92052081|NCT04747301|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92052082|NCT04747301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052083|NCT02152163|Ibuprofen|ibuprofen|mesh-list
92052084|NCT02152163|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92052085|NCT02152163|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92052086|NCT02152163|Analgesics|analgesics|mesh-ancestor
92052087|NCT02152163|Sensory System Agents|sensory system agents|mesh-ancestor
92052088|NCT02152163|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052089|NCT02152163|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052090|NCT02152163|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052091|NCT02152163|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052092|NCT02152163|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92052094|NCT02152163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052096|NCT02152007|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052097|NCT02152007|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052098|NCT02152007|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92052099|NCT02152007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052100|NCT02152007|Antifungal Agents|antifungal agents|mesh-ancestor
92052101|NCT02152007|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052102|NCT02152007|Immunologic Factors|immunologic factors|mesh-ancestor
92052103|NCT02152007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052104|NCT02151851|Certolizumab Pegol|certolizumab pegol|mesh-list
92052105|NCT02151851|Methotrexate|methotrexate|mesh-list
92052106|NCT02151851|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92052107|NCT02151851|Abortifacient Agents|abortifacient agents|mesh-ancestor
92052108|NCT02151851|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92052109|NCT02151851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052110|NCT02151851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052111|NCT02151851|Antimetabolites|antimetabolites|mesh-ancestor
92052112|NCT02151851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052113|NCT02151851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052114|NCT02151851|Dermatologic Agents|dermatologic agents|mesh-ancestor
92052115|NCT02151851|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052116|NCT02151851|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92052117|NCT02151851|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052118|NCT02151851|Immunologic Factors|immunologic factors|mesh-ancestor
92052119|NCT02151851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052120|NCT02151851|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92052121|NCT02151851|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92052122|NCT02151851|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052124|NCT02176421|Anesthetics, Local|anesthetics, local|mesh-ancestor
92052126|NCT02176421|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052127|NCT02176421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014810|NCT05201001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014811|NCT04799639|Paclitaxel|paclitaxel|mesh-list
92014812|NCT04799639|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92014813|NCT04799639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052128|NCT02176421|Sensory System Agents|sensory system agents|mesh-ancestor
92052129|NCT02176421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052130|NCT02176421|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92052131|NCT02176421|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92052132|NCT02176421|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92052133|NCT02176421|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052134|NCT02176421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052135|NCT02042443|Calcium, Dietary|calcium, dietary|mesh-list
92052136|NCT02042443|Leucovorin|leucovorin|mesh-list
92052137|NCT02042443|Folic Acid|folic acid|mesh-list
92052138|NCT02042443|Fluorouracil|fluorouracil|mesh-list
92052139|NCT02042443|Capecitabine|capecitabine|mesh-list
92052140|NCT02042443|Trametinib|trametinib|mesh-list
92052141|NCT02042443|Calcium|calcium|mesh-list
92052142|NCT02042443|Levoleucovorin|levoleucovorin|mesh-list
92052143|NCT02042443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92052144|NCT02042443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052145|NCT02042443|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92052146|NCT02042443|Antimetabolites|antimetabolites|mesh-ancestor
92052147|NCT02042443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052148|NCT02042443|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052149|NCT02042443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052150|NCT02042443|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052151|NCT02042443|Immunologic Factors|immunologic factors|mesh-ancestor
92052152|NCT02042443|Antidotes|antidotes|mesh-ancestor
92052153|NCT02042443|Protective Agents|protective agents|mesh-ancestor
92052154|NCT02042443|Vitamin B Complex|vitamin b complex|mesh-ancestor
92052155|NCT02042443|Vitamins|vitamins|mesh-ancestor
92052156|NCT02042443|Micronutrients|micronutrients|mesh-ancestor
92052157|NCT02042443|Hematinics|hematinics|mesh-ancestor
92052158|NCT02042443|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92052159|NCT02042443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052160|NCT04747145|Temozolomide|temozolomide|mesh-list
92052161|NCT04747145|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92052162|NCT04747145|Alkylating Agents|alkylating agents|mesh-ancestor
92052163|NCT04747145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052164|NCT04747145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052165|NCT02118896|Tacrolimus|tacrolimus|mesh-list
92052166|NCT02118896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052167|NCT02118896|Immunologic Factors|immunologic factors|mesh-ancestor
92052177|NCT02124707|Tubulin Modulators|tubulin modulators|mesh-ancestor
92052178|NCT02124707|Antimitotic Agents|antimitotic agents|mesh-ancestor
92052179|NCT02124707|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052180|NCT02124707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052181|NCT02124707|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052182|NCT04723862|Spironolactone|spironolactone|mesh-list
92052183|NCT04723862|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92052184|NCT04723862|Hormone Antagonists|hormone antagonists|mesh-ancestor
92052185|NCT04723862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052186|NCT04723862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052187|NCT04723862|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92052188|NCT04723862|Diuretics|diuretics|mesh-ancestor
92052189|NCT04723862|Natriuretic Agents|natriuretic agents|mesh-ancestor
92052190|NCT02092220|Pancrelipase|pancrelipase|mesh-list
92052191|NCT02092220|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052192|NCT02066402|Linezolid|linezolid|mesh-list
92052193|NCT02066402|Tedizolid|tedizolid|mesh-list
92052194|NCT02066402|Oxazolidinones|oxazolidinones|mesh-list
92052195|NCT02066402|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052196|NCT02066402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052197|NCT02066402|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92052199|NCT02066402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052201|NCT02060383|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92052202|NCT02060383|Liraglutide|liraglutide|mesh-list
92052203|NCT02060383|Pasireotide|pasireotide|mesh-list
92052204|NCT02060383|Somatostatin|somatostatin|mesh-list
92014814|NCT04799639|Tubulin Modulators|tubulin modulators|mesh-ancestor
92014815|NCT04799639|Antimitotic Agents|antimitotic agents|mesh-ancestor
92014816|NCT04799639|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014817|NCT04799639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014818|NCT04798703|Paclitaxel|paclitaxel|mesh-list
92014819|NCT04798703|Hyaluronic Acid|hyaluronic acid|mesh-list
92014820|NCT04798703|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052205|NCT02060383|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92052206|NCT02060383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052207|NCT02060383|Incretins|incretins|mesh-ancestor
92052208|NCT02060383|Hormones|hormones|mesh-ancestor
92052209|NCT02060383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052210|NCT02060383|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92052211|NCT02060383|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052212|NCT02060383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052213|NCT02060383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052214|NCT02086591|Doxycycline|doxycycline|mesh-list
92052215|NCT02086591|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052216|NCT02086591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052217|NCT02086591|Antimalarials|antimalarials|mesh-ancestor
92052218|NCT02086591|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92052219|NCT02086591|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92052220|NCT02065622|Adalimumab|adalimumab|mesh-list
92052221|NCT02065622|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92052222|NCT02065622|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052223|NCT02065622|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052224|NCT02117648|Clarithromycin|clarithromycin|mesh-list
92052225|NCT02117648|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052226|NCT02117648|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052227|NCT02117648|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92052228|NCT02117648|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052229|NCT02117648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052230|NCT02117648|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92052231|NCT02117648|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92052232|NCT02124161|Vaccines|vaccines|mesh-list
92052235|NCT02124161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052236|NCT02117570|Vaccines|vaccines|mesh-list
92052237|NCT02117570|Immunologic Factors|immunologic factors|mesh-ancestor
92052238|NCT02117570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052239|NCT02123459|Cephalexin|cephalexin|mesh-list
92052240|NCT02123459|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052241|NCT02123459|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052242|NCT01853475|Artefenomel|artefenomel|mesh-list
92052243|NCT01853475|Antimalarials|antimalarials|mesh-ancestor
92052244|NCT01853475|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92052245|NCT01853475|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92052246|NCT01853475|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052247|NCT04411160|Nitric Oxide|nitric oxide|mesh-list
92052248|NCT04411160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052249|NCT04411160|Antioxidants|antioxidants|mesh-ancestor
92052250|NCT04411160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052251|NCT04411160|Protective Agents|protective agents|mesh-ancestor
92052252|NCT04411160|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92052253|NCT04411160|Autonomic Agents|autonomic agents|mesh-ancestor
92052254|NCT04411160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052255|NCT04411160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92052256|NCT04411160|Respiratory System Agents|respiratory system agents|mesh-ancestor
92052257|NCT04411160|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92052258|NCT04411160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052259|NCT04411160|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92052260|NCT04411160|Vasodilator Agents|vasodilator agents|mesh-ancestor
92052261|NCT04411160|Gasotransmitters|gasotransmitters|mesh-ancestor
92052262|NCT02151773|Vaccines|vaccines|mesh-list
92052263|NCT02151773|Immunologic Factors|immunologic factors|mesh-ancestor
92052264|NCT02151773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052265|NCT02151461|Metformin|metformin|mesh-list
92052266|NCT02151461|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92052267|NCT02151461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014823|NCT04798703|Antimitotic Agents|antimitotic agents|mesh-ancestor
92014824|NCT04798703|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014825|NCT04798703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014826|NCT04798703|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92014827|NCT04798703|Immunologic Factors|immunologic factors|mesh-ancestor
92052268|NCT02091986|Budesonide|budesonide|mesh-list
92052269|NCT02091986|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92052270|NCT02091986|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052271|NCT02091986|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92052272|NCT02091986|Autonomic Agents|autonomic agents|mesh-ancestor
92052273|NCT02091986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052274|NCT02091986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052275|NCT02091986|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92052276|NCT02091986|Respiratory System Agents|respiratory system agents|mesh-ancestor
92052277|NCT02091986|Glucocorticoids|glucocorticoids|mesh-ancestor
92052279|NCT02091986|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052280|NCT02117024|Paclitaxel|paclitaxel|mesh-list
92052281|NCT02117024|Vinorelbine|vinorelbine|mesh-list
92052283|NCT02117024|Cyclophosphamide|cyclophosphamide|mesh-list
92052284|NCT02117024|Gemcitabine|gemcitabine|mesh-list
92052285|NCT02117024|Pemetrexed|pemetrexed|mesh-list
92052286|NCT02117024|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92052287|NCT02117024|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052288|NCT02117024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052289|NCT02117024|Tubulin Modulators|tubulin modulators|mesh-ancestor
92052290|NCT02117024|Antimitotic Agents|antimitotic agents|mesh-ancestor
92052291|NCT02117024|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052292|NCT02117024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052293|NCT02117024|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052294|NCT02117024|Immunologic Factors|immunologic factors|mesh-ancestor
92052295|NCT02117024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052296|NCT02117024|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052297|NCT02117024|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92052298|NCT02117024|Alkylating Agents|alkylating agents|mesh-ancestor
92052299|NCT02117024|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92052300|NCT02117024|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052301|NCT02117024|Antimetabolites|antimetabolites|mesh-ancestor
92052302|NCT02117024|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052303|NCT02117024|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92052304|NCT02117024|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92052305|NCT02117024|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92052306|NCT02064920|Donepezil|donepezil|mesh-list
92052309|NCT02064920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052310|NCT02064920|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052311|NCT02064920|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052312|NCT02064920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052313|NCT02064920|Nootropic Agents|nootropic agents|mesh-ancestor
92052314|NCT02151149|Paclitaxel|paclitaxel|mesh-list
92052315|NCT02151149|Carboplatin|carboplatin|mesh-list
92052316|NCT02151149|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052317|NCT02151149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052318|NCT02151149|Tubulin Modulators|tubulin modulators|mesh-ancestor
92052319|NCT02151149|Antimitotic Agents|antimitotic agents|mesh-ancestor
92052320|NCT02151149|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052321|NCT02151149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052323|NCT02150213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052324|NCT02150213|Antiemetics|antiemetics|mesh-ancestor
92052325|NCT02150213|Autonomic Agents|autonomic agents|mesh-ancestor
92052326|NCT02150213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052327|NCT02150213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052328|NCT02150213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014828|NCT04798703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014829|NCT04798703|Viscosupplements|viscosupplements|mesh-ancestor
92014830|NCT04798703|Protective Agents|protective agents|mesh-ancestor
92014831|NCT04798313|Denosumab|denosumab|mesh-list
92052329|NCT02150213|Glucocorticoids|glucocorticoids|mesh-ancestor
92052331|NCT02150213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052332|NCT02150213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92052333|NCT02150213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052334|NCT02091362|Metformin|metformin|mesh-list
92052335|NCT02091362|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92052336|NCT02091362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052337|NCT02091206|Cannabidiol|cannabidiol|mesh-list
92052338|NCT02091206|Anticonvulsants|anticonvulsants|mesh-ancestor
92052340|NCT02062658|Analgesics|analgesics|mesh-ancestor
92052341|NCT02062658|Sensory System Agents|sensory system agents|mesh-ancestor
92052342|NCT02062658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052343|NCT02062658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052344|NCT02062658|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92052345|NCT02062658|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92052346|NCT02062658|Anesthetics, General|anesthetics, general|mesh-ancestor
92052348|NCT02062658|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052349|NCT02062658|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92052350|NCT02062658|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92052351|NCT02062658|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052352|NCT02062658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052353|NCT02115308|Regadenoson|regadenoson|mesh-list
92052354|NCT02115308|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92052355|NCT02115308|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92052356|NCT02115308|Purinergic Agonists|purinergic agonists|mesh-ancestor
92052357|NCT02115308|Purinergic Agents|purinergic agents|mesh-ancestor
92052358|NCT02115308|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052359|NCT02115308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052360|NCT02115308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052361|NCT02114684|Moxifloxacin|moxifloxacin|mesh-list
92052362|NCT02114684|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052363|NCT02114684|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052364|NCT02114684|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92052365|NCT02114684|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92052366|NCT02114684|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052367|NCT02114684|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052368|NCT02114684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052369|NCT02090114|Methyltestosterone|methyltestosterone|mesh-list
92052370|NCT02090114|Abiraterone Acetate|abiraterone acetate|mesh-list
92052371|NCT02090114|Testosterone|testosterone|mesh-list
92052372|NCT02090114|Testosterone undecanoate|testosterone undecanoate|mesh-list
92052373|NCT02090114|Testosterone enanthate|testosterone enanthate|mesh-list
92052374|NCT02090114|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92052375|NCT02090114|Androgens|androgens|mesh-ancestor
92052376|NCT02090114|Hormones|hormones|mesh-ancestor
92052377|NCT02090114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052378|NCT02090114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052379|NCT02090114|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92052388|NCT04742036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052389|NCT04742036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052390|NCT04742036|Tubulin Modulators|tubulin modulators|mesh-ancestor
92052391|NCT04742036|Antimitotic Agents|antimitotic agents|mesh-ancestor
92052392|NCT04742036|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052393|NCT04742036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052394|NCT02111564|Rivaroxaban|rivaroxaban|mesh-list
92052395|NCT02111564|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92052396|NCT02111564|Antithrombins|antithrombins|mesh-ancestor
92052397|NCT02111564|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92052398|NCT02111564|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052399|NCT02111564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052400|NCT02111564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052401|NCT02111564|Anticoagulants|anticoagulants|mesh-ancestor
92052403|NCT02111096|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92052404|NCT02111096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014832|NCT04798313|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92014833|NCT04798313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014834|NCT01655823|Tetrodotoxin|tetrodotoxin|mesh-list
92014835|NCT01655823|Anesthetics, Local|anesthetics, local|mesh-ancestor
92014836|NCT01655823|Anesthetics|anesthetics|mesh-ancestor
92052405|NCT02111096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052406|NCT02111096|Incretins|incretins|mesh-ancestor
92052407|NCT02111096|Hormones|hormones|mesh-ancestor
92052408|NCT02111096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052409|NCT02111096|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92052410|NCT02111096|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052411|NCT02111096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052412|NCT02111096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052413|NCT02110706|Rituximab|rituximab|mesh-list
92052414|NCT02110706|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052415|NCT02110706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052416|NCT02110706|Immunologic Factors|immunologic factors|mesh-ancestor
92052417|NCT02110706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052418|NCT02110706|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052419|NCT02110238|Hyaluronic Acid|hyaluronic acid|mesh-list
92052420|NCT02110238|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92052421|NCT02110238|Immunologic Factors|immunologic factors|mesh-ancestor
92052422|NCT02110238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052423|NCT02110238|Viscosupplements|viscosupplements|mesh-ancestor
92052424|NCT02110238|Protective Agents|protective agents|mesh-ancestor
92052425|NCT02107898|Alirocumab|alirocumab|mesh-list
92052426|NCT02107898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92052427|NCT02107898|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92052428|NCT02107898|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92052429|NCT02107898|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92052430|NCT02107898|Antimetabolites|antimetabolites|mesh-ancestor
92052431|NCT02107898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052432|NCT02107898|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92052433|NCT02107898|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052434|NCT02107898|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052435|NCT02107898|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92052436|NCT02107898|Immunologic Factors|immunologic factors|mesh-ancestor
92052437|NCT02107898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052438|NCT02058836|Botulinum Toxins|botulinum toxins|mesh-list
92052439|NCT02058836|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92052440|NCT02058836|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92052441|NCT02058836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052442|NCT02058836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052443|NCT02058836|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052444|NCT02058836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052445|NCT02058836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052455|NCT02173769|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052456|NCT02173769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052457|NCT02173769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92052458|NCT02173769|Respiratory System Agents|respiratory system agents|mesh-ancestor
92052459|NCT02173769|Parasympatholytics|parasympatholytics|mesh-ancestor
92052460|NCT02173769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92052461|NCT02173769|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052462|NCT02173769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052463|NCT02173769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052464|NCT02121509|Metformin|metformin|mesh-list
92052465|NCT02121509|Linagliptin|linagliptin|mesh-list
92052466|NCT02121509|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92052467|NCT02121509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052468|NCT02121509|Incretins|incretins|mesh-ancestor
92052469|NCT02121509|Hormones|hormones|mesh-ancestor
92052470|NCT02121509|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052471|NCT02121509|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92052472|NCT02121509|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052473|NCT02121509|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052474|NCT02121509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052475|NCT02149199|Budesonide|budesonide|mesh-list
92052476|NCT02149199|Terbutaline|terbutaline|mesh-list
92014837|NCT01655823|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014838|NCT01655823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052477|NCT02149199|Formoterol Fumarate|formoterol fumarate|mesh-list
92052478|NCT02149199|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052479|NCT02149199|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92052480|NCT02149199|Autonomic Agents|autonomic agents|mesh-ancestor
92052481|NCT02149199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052482|NCT02149199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052483|NCT02149199|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92052484|NCT02149199|Respiratory System Agents|respiratory system agents|mesh-ancestor
92052485|NCT02149199|Glucocorticoids|glucocorticoids|mesh-ancestor
92052486|NCT02149199|Hormones|hormones|mesh-ancestor
92052487|NCT02149199|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052488|NCT02149199|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92052489|NCT02149199|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92052490|NCT02149199|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92052491|NCT02149199|Adrenergic Agents|adrenergic agents|mesh-ancestor
92052492|NCT02149199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052493|NCT02149199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052494|NCT02149199|Sympathomimetics|sympathomimetics|mesh-ancestor
92052495|NCT02149199|Tocolytic Agents|tocolytic agents|mesh-ancestor
92052496|NCT02149199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92052497|NCT02120417|Capecitabine|capecitabine|mesh-list
92052498|NCT02120417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052499|NCT02120417|Antimetabolites|antimetabolites|mesh-ancestor
92052500|NCT02120417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052501|NCT02120417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052502|NCT02147561|Botulinum Toxins|botulinum toxins|mesh-list
92052503|NCT02147561|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92052504|NCT02147561|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92052505|NCT02147561|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92052506|NCT02147561|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052507|NCT02147561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052508|NCT02147561|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052509|NCT02147561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052510|NCT02147561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052511|NCT02147561|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92052515|NCT02058368|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92052516|NCT02058368|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92052517|NCT02058368|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92052519|NCT02058368|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052520|NCT02058368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052521|NCT02058368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052522|NCT02058368|Urological Agents|urological agents|mesh-ancestor
92052523|NCT02058368|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92052524|NCT02058368|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92052525|NCT02058368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052526|NCT02058368|Hormone Antagonists|hormone antagonists|mesh-ancestor
92052527|NCT02058368|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052528|NCT02058290|Morphine|morphine|mesh-list
92052529|NCT02058290|Bupivacaine|bupivacaine|mesh-list
92052530|NCT02058290|Anesthetics, Local|anesthetics, local|mesh-ancestor
92052531|NCT02058290|Anesthetics|anesthetics|mesh-ancestor
92052532|NCT02058290|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052533|NCT02058290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052534|NCT02058290|Sensory System Agents|sensory system agents|mesh-ancestor
92052535|NCT02058290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052536|NCT02058290|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92052537|NCT02058290|Narcotics|narcotics|mesh-ancestor
92052538|NCT02058290|Analgesics|analgesics|mesh-ancestor
92052539|NCT04718480|Fluvoxamine|fluvoxamine|mesh-list
92052540|NCT04718480|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92052541|NCT04718480|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92052542|NCT04718480|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052543|NCT04718480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052544|NCT04718480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92052545|NCT04718480|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92052546|NCT04718480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92052547|NCT04718480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014839|NCT01655823|Sensory System Agents|sensory system agents|mesh-ancestor
92014840|NCT01655823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014841|NCT01655823|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92014842|NCT01655823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052548|NCT04718480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052549|NCT04718480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052550|NCT04718480|Serotonin Agents|serotonin agents|mesh-ancestor
92052551|NCT04718480|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92052552|NCT04718480|Antidepressive Agents|antidepressive agents|mesh-ancestor
92053267|NCT05713994|Immunologic Factors|immunologic factors|mesh-ancestor
92052553|NCT04718480|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92052554|NCT04718480|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92052555|NCT04718480|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052556|NCT04718480|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92052557|NCT02106884|Paclitaxel|paclitaxel|mesh-list
92052558|NCT02106884|Gemcitabine|gemcitabine|mesh-list
92052559|NCT02106884|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052560|NCT02106884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052561|NCT02106884|Tubulin Modulators|tubulin modulators|mesh-ancestor
92052562|NCT02106884|Antimitotic Agents|antimitotic agents|mesh-ancestor
92052563|NCT02106884|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052564|NCT02106884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052565|NCT02106884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052566|NCT02106884|Antimetabolites|antimetabolites|mesh-ancestor
92052567|NCT02081690|Macitentan|macitentan|mesh-list
92052568|NCT02081690|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92052569|NCT02081690|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92052570|NCT02081690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052571|NCT02081690|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92052572|NCT01625000|Risperidone|risperidone|mesh-list
92052573|NCT01625000|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92052574|NCT01625000|Serotonin Agents|serotonin agents|mesh-ancestor
92052575|NCT01625000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052576|NCT01625000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052577|NCT01625000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052578|NCT01625000|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92052579|NCT01625000|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92052580|NCT01625000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052595|NCT02056340|Antimetabolites|antimetabolites|mesh-ancestor
92052596|NCT02056340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052597|NCT02056340|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92052598|NCT02056340|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92052599|NCT02056340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052600|NCT04726592|Ketoprofen|ketoprofen|mesh-list
92052601|NCT04726592|Clorazepate Dipotassium|clorazepate dipotassium|mesh-list
92052602|NCT04726592|Metoclopramide|metoclopramide|mesh-list
92052603|NCT04726592|Antiemetics|antiemetics|mesh-ancestor
92052604|NCT04726592|Autonomic Agents|autonomic agents|mesh-ancestor
92052605|NCT04726592|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052606|NCT04726592|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052608|NCT04726592|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92052609|NCT04726592|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92052610|NCT04726592|Dopamine Agents|dopamine agents|mesh-ancestor
92052611|NCT04726592|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052612|NCT04726592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052613|NCT04726592|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92052614|NCT04726592|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92052615|NCT04726592|Analgesics|analgesics|mesh-ancestor
92052616|NCT04726592|Sensory System Agents|sensory system agents|mesh-ancestor
92052617|NCT04726592|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052618|NCT04726592|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052619|NCT04726592|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92052620|NCT04726592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052621|NCT04726592|Anticonvulsants|anticonvulsants|mesh-ancestor
92052622|NCT04726592|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92052623|NCT04726592|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92052624|NCT04726592|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052625|NCT04726592|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014843|NCT01655823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014844|NCT05197257|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92014845|NCT05197257|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92052626|NCT04726592|GABA Modulators|gaba modulators|mesh-ancestor
92052627|NCT04726592|GABA Agents|gaba agents|mesh-ancestor
92052628|NCT02046122|Cytarabine|cytarabine|mesh-list
92052629|NCT02046122|Idarubicin|idarubicin|mesh-list
92052630|NCT02046122|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92052631|NCT02046122|Antimetabolites|antimetabolites|mesh-ancestor
92052632|NCT02046122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052633|NCT02046122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052634|NCT02046122|Antiviral Agents|antiviral agents|mesh-ancestor
92052635|NCT02046122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052636|NCT02046122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052637|NCT02046122|Immunologic Factors|immunologic factors|mesh-ancestor
92052638|NCT02046122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052639|NCT02046122|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92052640|NCT02046122|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92052641|NCT02046122|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92052642|NCT02046122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052643|NCT02080832|Dexetimide|dexetimide|mesh-list
92052644|NCT02080832|Citalopram|citalopram|mesh-list
92052645|NCT02080832|Escitalopram|escitalopram|mesh-list
92052661|NCT02080832|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92052662|NCT02080832|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92052663|NCT02080832|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052664|NCT02078960|Homoharringtonine|homoharringtonine|mesh-list
92052665|NCT02078960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052666|NCT02078960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052667|NCT02078960|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92052668|NCT02078960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052669|NCT02078960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052670|NCT02078102|Meloxicam|meloxicam|mesh-list
92052671|NCT02078102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052672|NCT02078102|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92052673|NCT02078102|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92052674|NCT02078102|Analgesics|analgesics|mesh-ancestor
92052675|NCT02078102|Sensory System Agents|sensory system agents|mesh-ancestor
92052676|NCT02078102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052677|NCT02078102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052678|NCT02078102|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052679|NCT02078102|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92052680|NCT02078102|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92052681|NCT02078102|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052682|NCT02078102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052683|NCT02054702|Aripiprazole|aripiprazole|mesh-list
92052684|NCT02054702|Brexpiprazole|brexpiprazole|mesh-list
92052685|NCT02054702|Antidepressive Agents|antidepressive agents|mesh-ancestor
92052686|NCT02054702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92052687|NCT02054702|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92052688|NCT02054702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92052689|NCT02054702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052690|NCT02054702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052691|NCT02054702|Dopamine Agonists|dopamine agonists|mesh-ancestor
92052693|NCT02054702|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052694|NCT02054702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052695|NCT02054702|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92052696|NCT02054702|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92052697|NCT02054702|Serotonin Agents|serotonin agents|mesh-ancestor
92052698|NCT02054702|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92052699|NCT02054702|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92052700|NCT02054702|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92052701|NCT02054702|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92052705|NCT02044094|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92052707|NCT02044094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052708|NCT02044094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052709|NCT02044094|Analgesics|analgesics|mesh-ancestor
92052710|NCT02044094|Sensory System Agents|sensory system agents|mesh-ancestor
92052711|NCT02044094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052712|NCT02044094|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92014846|NCT05197257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014847|NCT05092581|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92052714|NCT02053610|Obinutuzumab|obinutuzumab|mesh-list
92052715|NCT02053610|Chlorambucil|chlorambucil|mesh-list
92052716|NCT02053610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052717|NCT02053610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052718|NCT02053610|Immunologic Factors|immunologic factors|mesh-ancestor
92052719|NCT02053610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052720|NCT02053610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052721|NCT02053610|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92052722|NCT02053610|Alkylating Agents|alkylating agents|mesh-ancestor
92052723|NCT02053610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052724|NCT02075606|Lanreotide|lanreotide|mesh-list
92052725|NCT02075606|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052726|NCT04701008|Ketamine|ketamine|mesh-list
92052727|NCT04701008|Analgesics|analgesics|mesh-ancestor
92052728|NCT04701008|Sensory System Agents|sensory system agents|mesh-ancestor
92052729|NCT04701008|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052730|NCT04701008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052731|NCT04701008|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92052732|NCT04701008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92052733|NCT04701008|Anesthetics, General|anesthetics, general|mesh-ancestor
92052734|NCT04701008|Anesthetics|anesthetics|mesh-ancestor
92052735|NCT04701008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052736|NCT04701008|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92052737|NCT04701008|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92052738|NCT04701008|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052739|NCT04701008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052740|NCT04700696|Analgesics, Opioid|analgesics, opioid|mesh-list
92052741|NCT04700696|Narcotics|narcotics|mesh-ancestor
92052742|NCT04700696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92052743|NCT04700696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052744|NCT04700696|Analgesics|analgesics|mesh-ancestor
92052745|NCT04700696|Sensory System Agents|sensory system agents|mesh-ancestor
92052746|NCT04700696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052747|NCT02052440|Baclofen|baclofen|mesh-list
92052748|NCT02052440|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92052749|NCT02052440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052750|NCT02052440|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92052751|NCT02052440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052752|NCT02052440|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92052753|NCT02052440|GABA Agonists|gaba agonists|mesh-ancestor
92052754|NCT02052440|GABA Agents|gaba agents|mesh-ancestor
92052755|NCT02052440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052756|NCT02052440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052757|NCT02049944|Cefazolin|cefazolin|mesh-list
92052758|NCT02049944|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052759|NCT02049944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052761|NCT01621880|Bevacizumab|bevacizumab|mesh-list
92052762|NCT01621880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052763|NCT01621880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052764|NCT01621880|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92052765|NCT01621880|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92052766|NCT01621880|Growth Substances|growth substances|mesh-ancestor
92052767|NCT01621880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052768|NCT01621880|Growth Inhibitors|growth inhibitors|mesh-ancestor
92052769|NCT01621880|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052770|NCT01621880|Antiemetics|antiemetics|mesh-ancestor
92052771|NCT01621880|Autonomic Agents|autonomic agents|mesh-ancestor
92052772|NCT01621880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052773|NCT01621880|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052774|NCT01621880|Glucocorticoids|glucocorticoids|mesh-ancestor
92052813|NCT04720105|Dermatologic Agents|dermatologic agents|mesh-ancestor
92052814|NCT04720105|Keratolytic Agents|keratolytic agents|mesh-ancestor
92052815|NCT04720105|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92052816|NCT04695769|Ribavirin|ribavirin|mesh-list
92052817|NCT04695769|Sofosbuvir|sofosbuvir|mesh-list
92052818|NCT04695769|Velpatasvir|velpatasvir|mesh-list
92052819|NCT04695769|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92052820|NCT04695769|Antimetabolites|antimetabolites|mesh-ancestor
92014848|NCT05092581|Antiviral Agents|antiviral agents|mesh-ancestor
92014849|NCT05092581|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014850|NCT04848857|Colchicine|colchicine|mesh-list
92052821|NCT04695769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052822|NCT04695769|Antiviral Agents|antiviral agents|mesh-ancestor
92052823|NCT04695769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052824|NCT02038933|Nivolumab|nivolumab|mesh-list
92052825|NCT02038933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052826|NCT02038933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052827|NCT02038933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92052828|NCT02038933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052829|NCT02081599|Insulin|insulin|mesh-list
92052830|NCT02081599|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92052831|NCT02081599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052832|NCT02038153|Lenalidomide|lenalidomide|mesh-list
92052833|NCT02038153|Immunologic Factors|immunologic factors|mesh-ancestor
92052834|NCT02038153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052835|NCT02038153|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92052836|NCT02038153|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92052837|NCT02038153|Growth Substances|growth substances|mesh-ancestor
92052838|NCT02038153|Growth Inhibitors|growth inhibitors|mesh-ancestor
92052839|NCT02038153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052840|NCT02079805|Telmisartan|telmisartan|mesh-list
92052841|NCT02079805|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92052842|NCT02079805|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92052843|NCT02079805|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92052844|NCT02079805|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92052845|NCT02079805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052846|NCT02037295|Vancomycin|vancomycin|mesh-list
92052847|NCT02037295|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052848|NCT02037295|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052849|NCT02079649|Dexamethasone|dexamethasone|mesh-list
92052850|NCT02079649|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92052851|NCT02079649|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92052852|NCT02079649|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92052853|NCT02079649|Antiemetics|antiemetics|mesh-ancestor
92052854|NCT02079649|Autonomic Agents|autonomic agents|mesh-ancestor
92052855|NCT02079649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052856|NCT02079649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052857|NCT02079649|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052858|NCT02079649|Glucocorticoids|glucocorticoids|mesh-ancestor
92052860|NCT02079649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052861|NCT02079649|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92052862|NCT02079649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052863|NCT02036515|Metformin|metformin|mesh-list
92052864|NCT02036515|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92052865|NCT02036515|Glimepiride|glimepiride|mesh-list
92052866|NCT02036515|Ertugliflozin|ertugliflozin|mesh-list
92052867|NCT02036515|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92052868|NCT02036515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052869|NCT02036515|Incretins|incretins|mesh-ancestor
92052870|NCT02036515|Hormones|hormones|mesh-ancestor
92052871|NCT02036515|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052872|NCT02036515|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92052873|NCT02036515|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052874|NCT02036515|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052875|NCT02036515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052876|NCT02036515|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92052877|NCT02036515|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92052878|NCT02036515|Immunologic Factors|immunologic factors|mesh-ancestor
92052879|NCT02036515|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92052880|NCT02078713|Contraceptive Agents|contraceptive agents|mesh-list
92052881|NCT02078713|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92052882|NCT02078713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052883|NCT02035267|Deoxycholic Acid|deoxycholic acid|mesh-list
92052886|NCT05887479|Botulinum Toxins|botulinum toxins|mesh-list
92052887|NCT05887479|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92052888|NCT05887479|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92052889|NCT05887479|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92052890|NCT05887479|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052891|NCT05887479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014851|NCT04848857|Gout Suppressants|gout suppressants|mesh-ancestor
92052892|NCT05887479|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052893|NCT05887479|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052894|NCT05887479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052895|NCT05887479|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92052896|NCT05887479|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052897|NCT05887375|Glycopyrrolate|glycopyrrolate|mesh-list
92052898|NCT05887375|Bromides|bromides|mesh-list
92052899|NCT05887375|Rocuronium|rocuronium|mesh-list
92052900|NCT05887375|Neostigmine|neostigmine|mesh-list
92052901|NCT05887375|Anticonvulsants|anticonvulsants|mesh-ancestor
92052902|NCT05887375|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92052903|NCT05887375|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92052904|NCT05887375|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92052905|NCT05887375|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052906|NCT05887375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052907|NCT05887375|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92052908|NCT05887375|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052909|NCT05887375|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052910|NCT05887375|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052911|NCT05887375|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052912|NCT05887375|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92052913|NCT05887375|Autonomic Agents|autonomic agents|mesh-ancestor
92052914|NCT05887375|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92052915|NCT05887375|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92052916|NCT05887375|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92052917|NCT05887258|Analgesics, Opioid|analgesics, opioid|mesh-list
92052918|NCT05887258|Anesthetics|anesthetics|mesh-list
92052919|NCT05887258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053855|NCT04902443|Pomalidomide|pomalidomide|mesh-list
92052920|NCT05887258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052921|NCT05887258|Narcotics|narcotics|mesh-ancestor
92052922|NCT05887258|Analgesics|analgesics|mesh-ancestor
92052923|NCT05887258|Sensory System Agents|sensory system agents|mesh-ancestor
92052924|NCT05887258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052925|NCT05887219|Azelaic acid|azelaic acid|mesh-list
92052926|NCT05887219|Tranexamic Acid|tranexamic acid|mesh-list
92052927|NCT05887219|Hydroquinone|hydroquinone|mesh-list
92052928|NCT05887219|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92052929|NCT05887219|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92052930|NCT05887219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052931|NCT05887219|Hemostatics|hemostatics|mesh-ancestor
92052932|NCT05887219|Coagulants|coagulants|mesh-ancestor
92052933|NCT05887219|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052934|NCT05887219|Dermatologic Agents|dermatologic agents|mesh-ancestor
92052935|NCT05887219|Antioxidants|antioxidants|mesh-ancestor
92052936|NCT05887219|Protective Agents|protective agents|mesh-ancestor
92052937|NCT05887219|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052938|NCT05887219|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92052939|NCT05886998|Heparin|heparin|mesh-list
92052940|NCT05886998|Anticoagulants|anticoagulants|mesh-ancestor
92052941|NCT05886998|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92052942|NCT05886998|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92052943|NCT05886998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052945|NCT05886933|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052946|NCT05886829|Chlorpheniramine|chlorpheniramine|mesh-list
92052947|NCT05886829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052948|NCT05886829|Antipruritics|antipruritics|mesh-ancestor
92052949|NCT05886829|Dermatologic Agents|dermatologic agents|mesh-ancestor
92052950|NCT05886829|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92052951|NCT05886829|Histamine Antagonists|histamine antagonists|mesh-ancestor
92052952|NCT05886829|Histamine Agents|histamine agents|mesh-ancestor
92052953|NCT05886829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052954|NCT05886829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052955|NCT05886829|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92052956|NCT05886790|Vaccines|vaccines|mesh-list
92052957|NCT05886790|Immunologic Factors|immunologic factors|mesh-ancestor
92052958|NCT05886790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052961|NCT05886660|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92052962|NCT05886660|Antiemetics|antiemetics|mesh-ancestor
92052963|NCT05886660|Autonomic Agents|autonomic agents|mesh-ancestor
92052964|NCT05886660|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052965|NCT05886660|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052966|NCT05886660|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052967|NCT05886660|Mydriatics|mydriatics|mesh-ancestor
92052968|NCT05886660|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92014853|NCT04848857|Tubulin Modulators|tubulin modulators|mesh-ancestor
92014854|NCT04848857|Antimitotic Agents|antimitotic agents|mesh-ancestor
92014855|NCT04848857|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014856|NCT04848857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014857|NCT04848857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014859|NCT04338659|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92014860|NCT04338659|Immunologic Factors|immunologic factors|mesh-ancestor
92014861|NCT04338659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014862|NCT05189535|Paclitaxel|paclitaxel|mesh-list
92014863|NCT05189535|Pentoxifylline|pentoxifylline|mesh-list
92014864|NCT05189535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052969|NCT05886660|Cholinergic Agents|cholinergic agents|mesh-ancestor
92052970|NCT05886660|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052971|NCT05886660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052972|NCT05886660|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92052973|NCT05886660|Parasympatholytics|parasympatholytics|mesh-ancestor
92052974|NCT05886465|Bevacizumab|bevacizumab|mesh-list
92052975|NCT05886465|Atezolizumab|atezolizumab|mesh-list
92052976|NCT05886465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052977|NCT05886465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052978|NCT05886465|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92052979|NCT05886465|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92052980|NCT05886465|Growth Substances|growth substances|mesh-ancestor
92052981|NCT05886465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052982|NCT05886465|Growth Inhibitors|growth inhibitors|mesh-ancestor
92052983|NCT05886465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92052984|NCT05886465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052985|NCT05886439|Pembrolizumab|pembrolizumab|mesh-list
92052986|NCT05886439|Durvalumab|durvalumab|mesh-list
92052987|NCT05886439|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052988|NCT05886439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052989|NCT05886439|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92052990|NCT05886439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052991|NCT05886257|Bevacizumab|bevacizumab|mesh-list
92052992|NCT05886257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92052993|NCT05886257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052994|NCT05886257|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92052995|NCT05886257|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92052996|NCT05886257|Growth Substances|growth substances|mesh-ancestor
92052997|NCT05886257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052998|NCT05886257|Growth Inhibitors|growth inhibitors|mesh-ancestor
92052999|NCT05886192|Vasopressins|vasopressins|mesh-list
92053000|NCT05886192|Arginine Vasopressin|arginine vasopressin|mesh-list
92053001|NCT05886192|Norepinephrine|norepinephrine|mesh-list
92053002|NCT05886192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92053003|NCT05886192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92053004|NCT05886192|Adrenergic Agents|adrenergic agents|mesh-ancestor
92053005|NCT05886192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053006|NCT05886192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053007|NCT05886192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053008|NCT05886192|Sympathomimetics|sympathomimetics|mesh-ancestor
92053009|NCT05886192|Autonomic Agents|autonomic agents|mesh-ancestor
92053010|NCT05886192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053011|NCT05886192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92053012|NCT05886192|Hemostatics|hemostatics|mesh-ancestor
92053013|NCT05886192|Coagulants|coagulants|mesh-ancestor
92053014|NCT05886192|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92053015|NCT05886192|Natriuretic Agents|natriuretic agents|mesh-ancestor
92053016|NCT05886140|Paclitaxel|paclitaxel|mesh-list
92014865|NCT05189535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014866|NCT05189535|Tubulin Modulators|tubulin modulators|mesh-ancestor
92014867|NCT05189535|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053017|NCT05886140|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053018|NCT05886140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053019|NCT05886140|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053020|NCT05886140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053021|NCT05886140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053022|NCT05886140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053023|NCT05886127|Hemostatics|hemostatics|mesh-list
92053024|NCT05886127|Coagulants|coagulants|mesh-ancestor
92053025|NCT05886088|Dapagliflozin|dapagliflozin|mesh-list
92053026|NCT05886088|Linagliptin|linagliptin|mesh-list
92053027|NCT05886088|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92053028|NCT05886088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053029|NCT05886088|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92053030|NCT05886088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053032|NCT05886088|Hormones|hormones|mesh-ancestor
92053037|NCT05885932|Aspirin|aspirin|mesh-list
92053038|NCT05885932|Sirolimus|sirolimus|mesh-list
92053039|NCT05885932|Clopidogrel|clopidogrel|mesh-list
92053040|NCT05885932|Ticagrelor|ticagrelor|mesh-list
92053041|NCT05885932|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92053042|NCT05885932|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92053043|NCT05885932|Analgesics|analgesics|mesh-ancestor
92053044|NCT05885932|Sensory System Agents|sensory system agents|mesh-ancestor
92053045|NCT05885932|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053046|NCT05885932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053047|NCT05885932|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053048|NCT05885932|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053049|NCT05885932|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92053050|NCT05885932|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92053051|NCT05885932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053052|NCT05885932|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92053053|NCT05885932|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92053054|NCT05885932|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053055|NCT05885932|Antipyretics|antipyretics|mesh-ancestor
92053056|NCT05885932|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92053057|NCT05885932|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92053058|NCT05885932|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92053059|NCT05885932|Purinergic Agents|purinergic agents|mesh-ancestor
92053060|NCT05885932|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053061|NCT05885932|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92053062|NCT05885932|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053063|NCT05885932|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92053064|NCT05885932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053065|NCT05885932|Antifungal Agents|antifungal agents|mesh-ancestor
92053066|NCT05885932|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053067|NCT05885932|Immunologic Factors|immunologic factors|mesh-ancestor
92053068|NCT05885919|Edaravone|edaravone|mesh-list
92053069|NCT05885919|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92053070|NCT05885919|Antioxidants|antioxidants|mesh-ancestor
92053071|NCT05885919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053072|NCT05885919|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92053073|NCT05885919|Protective Agents|protective agents|mesh-ancestor
92053074|NCT05885919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053075|NCT05885802|Anesthetics|anesthetics|mesh-list
92053076|NCT05885802|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053077|NCT05885802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053078|NCT05885776|Trastuzumab|trastuzumab|mesh-list
92053079|NCT05885776|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053080|NCT05885776|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053082|NCT05885646|Anticonvulsants|anticonvulsants|mesh-ancestor
92053083|NCT05885542|Cannabidiol|cannabidiol|mesh-list
92053084|NCT05885542|Anticonvulsants|anticonvulsants|mesh-ancestor
92053085|NCT05885503|Aflibercept|aflibercept|mesh-list
92053086|NCT05885503|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053087|NCT05885503|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053088|NCT05885503|Growth Substances|growth substances|mesh-ancestor
92053089|NCT05885503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053090|NCT05885503|Growth Inhibitors|growth inhibitors|mesh-ancestor
92014868|NCT05189535|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014869|NCT05189535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014870|NCT05189535|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92014871|NCT05189535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014872|NCT05189535|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92014873|NCT05189535|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92014874|NCT05189535|Protective Agents|protective agents|mesh-ancestor
92014875|NCT05189535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014876|NCT05189535|Vasodilator Agents|vasodilator agents|mesh-ancestor
92014877|NCT05189535|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92053091|NCT05885503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053092|NCT05884372|Vitamin D|vitamin d|mesh-list
92053093|NCT05884372|Denosumab|denosumab|mesh-list
92053094|NCT05884372|Eldecalcitol|eldecalcitol|mesh-list
92053096|NCT05884372|Vitamins|vitamins|mesh-ancestor
92053097|NCT05884372|Micronutrients|micronutrients|mesh-ancestor
92053098|NCT05884372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053099|NCT05884372|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92053100|NCT05884372|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92053102|NCT05882643|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92053103|NCT05882643|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053104|NCT05882643|Trace Elements|trace elements|mesh-ancestor
92053105|NCT05882643|Micronutrients|micronutrients|mesh-ancestor
92053128|NCT05852691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053129|NCT05852691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053130|NCT05852691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053131|NCT05852691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053132|NCT05802056|Calcium, Dietary|calcium, dietary|mesh-list
92053133|NCT05802056|Leucovorin|leucovorin|mesh-list
92053134|NCT05802056|Folic Acid|folic acid|mesh-list
92053135|NCT05802056|Aldesleukin|aldesleukin|mesh-list
92053136|NCT05802056|Fluorouracil|fluorouracil|mesh-list
92053137|NCT05802056|Oxaliplatin|oxaliplatin|mesh-list
92053138|NCT05802056|Nivolumab|nivolumab|mesh-list
92053139|NCT05802056|Interleukin-2|interleukin-2|mesh-list
92053140|NCT05802056|Calcium|calcium|mesh-list
92053141|NCT05802056|Levoleucovorin|levoleucovorin|mesh-list
92053142|NCT05802056|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92053143|NCT05802056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053144|NCT05802056|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92053145|NCT05802056|Antimetabolites|antimetabolites|mesh-ancestor
92053146|NCT05802056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053147|NCT05802056|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92053148|NCT05802056|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053149|NCT05802056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053150|NCT05802056|Immunologic Factors|immunologic factors|mesh-ancestor
92053151|NCT05802056|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053152|NCT05802056|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053153|NCT05802056|Antidotes|antidotes|mesh-ancestor
92053154|NCT05802056|Protective Agents|protective agents|mesh-ancestor
92053155|NCT05802056|Vitamin B Complex|vitamin b complex|mesh-ancestor
92053156|NCT05802056|Vitamins|vitamins|mesh-ancestor
92053157|NCT05802056|Micronutrients|micronutrients|mesh-ancestor
92053158|NCT05802056|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92053159|NCT05802056|Analgesics|analgesics|mesh-ancestor
92053160|NCT05802056|Sensory System Agents|sensory system agents|mesh-ancestor
92053161|NCT05802056|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053162|NCT05802056|Hematinics|hematinics|mesh-ancestor
92053163|NCT05802056|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92053164|NCT05802056|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92053165|NCT05802056|Antiviral Agents|antiviral agents|mesh-ancestor
92053166|NCT05802056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053168|NCT05794477|Carboplatin|carboplatin|mesh-list
92053169|NCT05794477|Pemetrexed|pemetrexed|mesh-list
92053170|NCT05794477|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053171|NCT05794477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053172|NCT05794477|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053173|NCT05794477|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053174|NCT05794477|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053175|NCT05794477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053176|NCT05794477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053177|NCT05794477|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92053178|NCT05794477|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92053179|NCT05789381|Magnesium Sulfate|magnesium sulfate|mesh-list
92053180|NCT05789381|Analgesics|analgesics|mesh-ancestor
92053194|NCT05773989|Clopidogrel|clopidogrel|mesh-list
92053195|NCT05773989|Ticagrelor|ticagrelor|mesh-list
92053196|NCT05773989|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92053197|NCT05773989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053198|NCT05773989|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053199|NCT05773989|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92053200|NCT05773989|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92053201|NCT05773989|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92053202|NCT05773989|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92053203|NCT05773989|Purinergic Agents|purinergic agents|mesh-ancestor
92053204|NCT05773989|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053205|NCT05769478|Amifampridine|amifampridine|mesh-list
92053206|NCT05769478|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92053207|NCT05769478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053208|NCT05769478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053209|NCT05769478|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92053210|NCT05769478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92053211|NCT05769478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053212|NCT05745701|Cyclosporine|cyclosporine|mesh-list
92053213|NCT05745701|Itraconazole|itraconazole|mesh-list
92053214|NCT05745701|Cyclosporins|cyclosporins|mesh-list
92053215|NCT05745701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053216|NCT05745701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053217|NCT05745701|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053218|NCT05745701|Immunologic Factors|immunologic factors|mesh-ancestor
92053219|NCT05745701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053220|NCT05745701|Antifungal Agents|antifungal agents|mesh-ancestor
92053221|NCT05745701|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053222|NCT05745701|Dermatologic Agents|dermatologic agents|mesh-ancestor
92053223|NCT05745701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053224|NCT05745701|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92053225|NCT05745701|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92053226|NCT05745701|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92053227|NCT05745701|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92053228|NCT05745701|Hormone Antagonists|hormone antagonists|mesh-ancestor
92053229|NCT05745701|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053230|NCT05745701|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92053231|NCT05742594|Lazertinib|lazertinib|mesh-list
92053232|NCT05742594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053233|NCT05742594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053234|NCT05742594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053235|NCT05741086|Atorvastatin|atorvastatin|mesh-list
92053236|NCT05741086|Evolocumab|evolocumab|mesh-list
92053237|NCT05741086|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92053238|NCT05741086|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92053260|NCT05713994|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053261|NCT05713994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053262|NCT05713994|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053263|NCT05713994|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053264|NCT05713994|Growth Substances|growth substances|mesh-ancestor
92053265|NCT05713994|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053266|NCT05713994|Growth Inhibitors|growth inhibitors|mesh-ancestor
92053268|NCT05713994|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053269|NCT05713994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053270|NCT05713994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053272|NCT05710887|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92053273|NCT05710887|Anesthetics, General|anesthetics, general|mesh-ancestor
92053274|NCT05710887|Anesthetics|anesthetics|mesh-ancestor
92053275|NCT05710887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053276|NCT05710887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053277|NCT05710887|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92053278|NCT05710887|Analgesics|analgesics|mesh-ancestor
92053279|NCT05710887|Sensory System Agents|sensory system agents|mesh-ancestor
92014879|NCT05089461|Mitoxantrone|mitoxantrone|mesh-list
92014880|NCT05089461|Analgesics|analgesics|mesh-ancestor
92053280|NCT05710887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053281|NCT05707351|Factor VIII|factor viii|mesh-list
92053282|NCT05707351|BAX 855|bax 855|mesh-list
92053283|NCT05707351|Coagulants|coagulants|mesh-ancestor
92053303|NCT05657041|Clopidogrel|clopidogrel|mesh-list
92053304|NCT05657041|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92053305|NCT05657041|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92053306|NCT05657041|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92053307|NCT05657041|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92053310|NCT05657041|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053311|NCT05657041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053312|NCT05657041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053314|NCT05656599|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92053315|NCT05656599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053316|NCT05656599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053317|NCT05656599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053318|NCT05656599|Antiviral Agents|antiviral agents|mesh-ancestor
92053319|NCT05656599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053320|NCT05643573|Apixaban|apixaban|mesh-list
92053321|NCT05643573|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92053322|NCT05643573|Antithrombins|antithrombins|mesh-ancestor
92053323|NCT05643573|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92053324|NCT05643573|Protease Inhibitors|protease inhibitors|mesh-ancestor
92053325|NCT05643573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053326|NCT05643573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053327|NCT05643573|Anticoagulants|anticoagulants|mesh-ancestor
92053328|NCT05634707|Temozolomide|temozolomide|mesh-list
92053329|NCT05634707|Fluoxetine|fluoxetine|mesh-list
92053330|NCT05634707|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92053331|NCT05634707|Alkylating Agents|alkylating agents|mesh-ancestor
92053332|NCT05634707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053333|NCT05634707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053334|NCT05634707|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92053335|NCT05634707|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92053336|NCT05634707|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92053337|NCT05634707|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053338|NCT05634707|Serotonin Agents|serotonin agents|mesh-ancestor
92053339|NCT05634707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053340|NCT05634707|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92053341|NCT05634707|Antidepressive Agents|antidepressive agents|mesh-ancestor
92053342|NCT05634707|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92053343|NCT05634707|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92053344|NCT05634707|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92053345|NCT05634707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053346|NCT05747794|Paclitaxel|paclitaxel|mesh-list
92053347|NCT05747794|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053348|NCT05747794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053349|NCT05747794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053350|NCT05747794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053351|NCT05747794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053352|NCT05747794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053353|NCT05607420|Alemtuzumab|alemtuzumab|mesh-list
92053354|NCT05607420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053355|NCT05607420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053356|NCT05607316|Metformin|metformin|mesh-list
92053357|NCT05607316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92053358|NCT05607316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053359|NCT05605587|Leflunomide|leflunomide|mesh-list
92053360|NCT05605587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053361|NCT05605587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053362|NCT05605587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053363|NCT05605587|Immunologic Factors|immunologic factors|mesh-ancestor
92053364|NCT05605587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053365|NCT05597878|Acetaminophen|acetaminophen|mesh-list
92053366|NCT05597878|Ketorolac|ketorolac|mesh-list
92053367|NCT05597878|Ketamine|ketamine|mesh-list
92053368|NCT05597878|Oxycodone|oxycodone|mesh-list
92053369|NCT05597878|Analgesics|analgesics|mesh-ancestor
92053370|NCT05597878|Sensory System Agents|sensory system agents|mesh-ancestor
92014881|NCT05089461|Sensory System Agents|sensory system agents|mesh-ancestor
92014882|NCT05089461|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014883|NCT05089461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053371|NCT05597878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053372|NCT05597878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053373|NCT05597878|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92053374|NCT05597878|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92053375|NCT05597878|Anesthetics, General|anesthetics, general|mesh-ancestor
92053376|NCT05597878|Anesthetics|anesthetics|mesh-ancestor
92053377|NCT05597878|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053378|NCT05597878|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92053382|NCT05597878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92053383|NCT05597878|Antipyretics|antipyretics|mesh-ancestor
92053384|NCT05597878|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92053385|NCT05597878|Narcotics|narcotics|mesh-ancestor
92053386|NCT05597878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92053387|NCT05597878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053388|NCT05597878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053389|NCT05597878|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92053390|NCT05597878|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053391|NCT05586477|Diphenhydramine|diphenhydramine|mesh-list
92053392|NCT05586477|Promethazine|promethazine|mesh-list
92053393|NCT05586477|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92053394|NCT05586477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92053395|NCT05586477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053396|NCT05586477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053397|NCT05586477|Anesthetics, Local|anesthetics, local|mesh-ancestor
92053398|NCT05586477|Anesthetics|anesthetics|mesh-ancestor
92053399|NCT05586477|Sensory System Agents|sensory system agents|mesh-ancestor
92053400|NCT05586477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053401|NCT05586477|Antiemetics|antiemetics|mesh-ancestor
92053402|NCT05586477|Autonomic Agents|autonomic agents|mesh-ancestor
92053403|NCT05586477|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92053404|NCT05586477|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92053405|NCT05586477|Histamine Antagonists|histamine antagonists|mesh-ancestor
92053406|NCT05586477|Histamine Agents|histamine agents|mesh-ancestor
92053407|NCT05586477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053408|NCT05586477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053409|NCT05586477|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92053410|NCT05586477|Antipruritics|antipruritics|mesh-ancestor
92053411|NCT05586477|Dermatologic Agents|dermatologic agents|mesh-ancestor
92053412|NCT05582993|Factor VIII|factor viii|mesh-list
92053413|NCT05582993|Coagulants|coagulants|mesh-ancestor
92053415|NCT05581758|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053416|NCT05581758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053417|NCT05581758|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053418|NCT05581758|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053420|NCT05554146|Hallucinogens|hallucinogens|mesh-ancestor
92053421|NCT05554146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053422|NCT05554146|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92053423|NCT05554146|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92053424|NCT05554146|Analgesics|analgesics|mesh-ancestor
92053425|NCT05554146|Sensory System Agents|sensory system agents|mesh-ancestor
92053426|NCT05554146|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053427|NCT05554146|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92053428|NCT05554146|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92053429|NCT05554146|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053430|NCT05554146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053432|NCT05554146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053433|NCT05553301|Vaccines|vaccines|mesh-list
92053434|NCT05553301|Immunologic Factors|immunologic factors|mesh-ancestor
92053435|NCT05553301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053436|NCT05535738|Fluticasone|fluticasone|mesh-list
92053437|NCT05535738|Xhance|xhance|mesh-list
92053438|NCT05535738|Adalimumab|adalimumab|mesh-list
92053439|NCT05535738|Triamcinolone|triamcinolone|mesh-list
92053440|NCT05535738|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92053441|NCT05535738|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92053442|NCT05535738|Betamethasone|betamethasone|mesh-list
92053443|NCT05535738|Betamethasone Valerate|betamethasone valerate|mesh-list
92053445|NCT05535738|Betamethasone benzoate|betamethasone benzoate|mesh-list
92053446|NCT05535738|Ustekinumab|ustekinumab|mesh-list
92053447|NCT05535738|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92053448|NCT05535738|Squaric acid dibutyl ester|squaric acid dibutyl ester|mesh-list
92053449|NCT05535738|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92053450|NCT05535738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053451|NCT05535738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92053452|NCT05535738|Autonomic Agents|autonomic agents|mesh-ancestor
92053469|NCT05518110|Hydroxychloroquine|hydroxychloroquine|mesh-list
92053470|NCT05518110|Trametinib|trametinib|mesh-list
92053471|NCT05518110|Antimalarials|antimalarials|mesh-ancestor
92053472|NCT05518110|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92053473|NCT05518110|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92053474|NCT05518110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053475|NCT05518110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053476|NCT05518110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053477|NCT05518110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053478|NCT05518110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053479|NCT05518110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053480|NCT05508867|Gemcitabine|gemcitabine|mesh-list
92053481|NCT05508867|Pembrolizumab|pembrolizumab|mesh-list
92053482|NCT05508867|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92053483|NCT05508867|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92053484|NCT05508867|Antimetabolites|antimetabolites|mesh-ancestor
92053485|NCT05508867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053486|NCT05508867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053487|NCT05508867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053488|NCT05508867|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053489|NCT05508867|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92053490|NCT05508867|Alkylating Agents|alkylating agents|mesh-ancestor
92053491|NCT05486481|Dexamethasone|dexamethasone|mesh-list
92053492|NCT05486481|Venetoclax|venetoclax|mesh-list
92053493|NCT05486481|Daratumumab|daratumumab|mesh-list
92053494|NCT05486481|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92053495|NCT05486481|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053496|NCT05486481|Antiemetics|antiemetics|mesh-ancestor
92053497|NCT05486481|Autonomic Agents|autonomic agents|mesh-ancestor
92053498|NCT05486481|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053499|NCT05486481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053500|NCT05486481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92053501|NCT05486481|Glucocorticoids|glucocorticoids|mesh-ancestor
92053502|NCT05486481|Hormones|hormones|mesh-ancestor
92053503|NCT05486481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053504|NCT05486481|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92053505|NCT05486481|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053506|NCT05486481|Immunologic Factors|immunologic factors|mesh-ancestor
92053507|NCT05459129|Paclitaxel|paclitaxel|mesh-list
92053508|NCT05459129|Carboplatin|carboplatin|mesh-list
92053513|NCT05459129|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053514|NCT05459129|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053515|NCT05459129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053516|NCT05459129|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053517|NCT05459129|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053518|NCT05446870|Paclitaxel|paclitaxel|mesh-list
92053519|NCT05446870|Docetaxel|docetaxel|mesh-list
92053520|NCT05446870|Bevacizumab|bevacizumab|mesh-list
92053521|NCT05446870|Carboplatin|carboplatin|mesh-list
92053522|NCT05446870|Pembrolizumab|pembrolizumab|mesh-list
92053523|NCT05446870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053524|NCT05446870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053525|NCT05446870|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053526|NCT05446870|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053527|NCT05446870|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053528|NCT05446870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053529|NCT05446870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053530|NCT05446870|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053531|NCT05446870|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053532|NCT05446870|Growth Substances|growth substances|mesh-ancestor
92053533|NCT05446870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053534|NCT05446870|Growth Inhibitors|growth inhibitors|mesh-ancestor
92053535|NCT05446870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053536|NCT05441410|Artesunate|artesunate|mesh-list
92053537|NCT05441410|Pyronaridine|pyronaridine|mesh-list
92053538|NCT05441410|Pyronaridine tetraphosphate, artesunate drug combination|pyronaridine tetraphosphate, artesunate drug combination|mesh-list
92014884|NCT05089461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014885|NCT05089461|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92053539|NCT05441410|Antimalarials|antimalarials|mesh-ancestor
92053540|NCT05441410|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92053541|NCT05441410|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92053542|NCT05441410|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053543|NCT05441410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053544|NCT05441410|Antiviral Agents|antiviral agents|mesh-ancestor
92053545|NCT05441410|Schistosomicides|schistosomicides|mesh-ancestor
92053546|NCT05441410|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92053547|NCT05441410|Anthelmintics|anthelmintics|mesh-ancestor
92053548|NCT05431595|Valproic Acid|valproic acid|mesh-list
92053549|NCT05431595|Haloperidol|haloperidol|mesh-list
92053550|NCT05431595|Chlorpromazine|chlorpromazine|mesh-list
92053551|NCT05431595|Haloperidol decanoate|haloperidol decanoate|mesh-list
92053552|NCT05431595|Antiemetics|antiemetics|mesh-ancestor
92053553|NCT05431595|Autonomic Agents|autonomic agents|mesh-ancestor
92053554|NCT05431595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053555|NCT05431595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053556|NCT05431595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92053557|NCT05431595|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92053558|NCT05431595|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92053559|NCT05431595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053560|NCT05431595|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92053561|NCT05431595|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92053562|NCT05431595|Dopamine Agents|dopamine agents|mesh-ancestor
92053563|NCT05431595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053564|NCT05431595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053565|NCT05431595|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92053566|NCT05431595|Anticonvulsants|anticonvulsants|mesh-ancestor
92053567|NCT05431595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053568|NCT05431595|GABA Agents|gaba agents|mesh-ancestor
92053569|NCT05431595|Antimanic Agents|antimanic agents|mesh-ancestor
92053570|NCT05351489|Dexmedetomidine|dexmedetomidine|mesh-list
92053571|NCT05351489|Bupivacaine|bupivacaine|mesh-list
92053572|NCT05351489|Anesthetics, Local|anesthetics, local|mesh-ancestor
92053573|NCT05351489|Anesthetics|anesthetics|mesh-ancestor
92053574|NCT05351489|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053575|NCT05351489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053576|NCT05351489|Sensory System Agents|sensory system agents|mesh-ancestor
92053577|NCT05351489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053578|NCT05351489|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92053579|NCT05351489|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92053580|NCT05351489|Analgesics|analgesics|mesh-ancestor
92053581|NCT05351489|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92053585|NCT05351489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053586|NCT05351489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053588|NCT05345717|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92053589|NCT05345717|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053590|NCT05345717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053591|NCT05345717|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053592|NCT05345717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053593|NCT05345717|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053594|NCT05345717|Immunologic Factors|immunologic factors|mesh-ancestor
92053595|NCT05345717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053596|NCT05345717|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053597|NCT05345717|Protease Inhibitors|protease inhibitors|mesh-ancestor
92053598|NCT05345717|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053599|NCT05327127|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
92053600|NCT05327127|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92053601|NCT05327127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053602|NCT05327127|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92053603|NCT05327127|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053605|NCT05298423|Etoposide|etoposide|mesh-list
92053606|NCT05298423|Carboplatin|carboplatin|mesh-list
92053607|NCT05298423|Pembrolizumab|pembrolizumab|mesh-list
92053608|NCT05298423|Pemetrexed|pemetrexed|mesh-list
92053609|NCT05298423|Durvalumab|durvalumab|mesh-list
92053610|NCT05298423|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053611|NCT05298423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053612|NCT05298423|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053613|NCT05298423|Antimitotic Agents|antimitotic agents|mesh-ancestor
92014886|NCT05089461|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92014887|NCT05089461|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053698|NCT05100654|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92014888|NCT05089461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053614|NCT05298423|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053615|NCT05298423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053616|NCT05298423|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053617|NCT05298423|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053618|NCT05298423|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92053619|NCT05298423|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92053620|NCT05298423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053621|NCT05298423|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92053622|NCT05298423|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92053623|NCT05256537|Mycophenolic Acid|mycophenolic acid|mesh-list
92053624|NCT05256537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92053625|NCT05256537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053626|NCT05256537|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92053627|NCT05256537|Antitubercular Agents|antitubercular agents|mesh-ancestor
92053628|NCT05256537|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92053629|NCT05256537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053630|NCT05256537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053631|NCT05256537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053633|NCT05245968|Imatinib Mesylate|imatinib mesylate|mesh-list
92053634|NCT05245968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053635|NCT05245968|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053636|NCT05245968|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053637|NCT05245968|Growth Substances|growth substances|mesh-ancestor
92053638|NCT05245968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053639|NCT05245968|Growth Inhibitors|growth inhibitors|mesh-ancestor
92053640|NCT05245968|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053641|NCT05245968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053642|NCT05245968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053643|NCT05220514|PK 11195|pk 11195|mesh-list
92053644|NCT05220514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053645|NCT05194969|Petrolatum|petrolatum|mesh-list
92053646|NCT05194969|Emollients|emollients|mesh-ancestor
92053647|NCT05194969|Dermatologic Agents|dermatologic agents|mesh-ancestor
92053648|NCT05181735|Luspatercept|luspatercept|mesh-list
92053649|NCT05181735|Hematinics|hematinics|mesh-ancestor
92053650|NCT05169515|Obinutuzumab|obinutuzumab|mesh-list
92053651|NCT05169515|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053660|NCT05145296|Daratumumab|daratumumab|mesh-list
92053662|NCT05145296|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053663|NCT05145296|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053664|NCT05145296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053665|NCT05145296|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053666|NCT05145296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053667|NCT05145296|Immunologic Factors|immunologic factors|mesh-ancestor
92053668|NCT05145296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053669|NCT05145296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053670|NCT05122767|Dolutegravir|dolutegravir|mesh-list
92053671|NCT05122767|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92053672|NCT05122767|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92053673|NCT05122767|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053674|NCT05122767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053675|NCT05122767|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92053676|NCT05122767|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92053677|NCT05122767|Antiviral Agents|antiviral agents|mesh-ancestor
92053678|NCT05122767|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053684|NCT05100654|Doxycycline|doxycycline|mesh-list
92053685|NCT05100654|Ciprofloxacin|ciprofloxacin|mesh-list
92053686|NCT05100654|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92053687|NCT05100654|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92053688|NCT05100654|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92053689|NCT05100654|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053690|NCT05100654|Antimalarials|antimalarials|mesh-ancestor
92053691|NCT05100654|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92053692|NCT05100654|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92053693|NCT05100654|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92053694|NCT05100654|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92053695|NCT05100654|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014889|NCT05730439|Lobeline|lobeline|mesh-list
92014890|NCT05730439|Nicotine|nicotine|mesh-list
92014891|NCT05730439|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92014893|NCT05730439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053696|NCT05100654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053697|NCT05100654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053699|NCT05100654|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92053700|NCT05100654|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92053701|NCT05100654|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92053703|NCT05095922|Calcium Dobesilate|calcium dobesilate|mesh-list
92053704|NCT05095922|Calcium|calcium|mesh-list
92053705|NCT05095922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92053706|NCT05095922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053707|NCT05095922|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92053708|NCT05095922|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92053709|NCT05095922|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92053710|NCT05095922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053711|NCT05095922|Hemostatics|hemostatics|mesh-ancestor
92053712|NCT05095922|Coagulants|coagulants|mesh-ancestor
92053713|NCT05084222|Budesonide|budesonide|mesh-list
92053714|NCT05084222|Albuterol|albuterol|mesh-list
92053715|NCT05084222|Formoterol Fumarate|formoterol fumarate|mesh-list
92053716|NCT05084222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053717|NCT05084222|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92053718|NCT05084222|Autonomic Agents|autonomic agents|mesh-ancestor
92053719|NCT05084222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053720|NCT05084222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053721|NCT05084222|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92053723|NCT05084222|Glucocorticoids|glucocorticoids|mesh-ancestor
92053725|NCT05084222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053726|NCT05084222|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92053727|NCT05084222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92053728|NCT05084222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92053729|NCT05084222|Adrenergic Agents|adrenergic agents|mesh-ancestor
92053730|NCT05084222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053731|NCT05084222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053732|NCT05084222|Tocolytic Agents|tocolytic agents|mesh-ancestor
92053733|NCT05084222|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92053734|NCT05062980|Docetaxel|docetaxel|mesh-list
92053735|NCT05062980|Pembrolizumab|pembrolizumab|mesh-list
92053736|NCT05062980|Ramucirumab|ramucirumab|mesh-list
92053737|NCT05062980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053738|NCT05062980|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053739|NCT05062980|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053740|NCT05062980|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053741|NCT05062980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053742|NCT05062980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053743|NCT05062980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053744|NCT05014412|Dexamethasone|dexamethasone|mesh-list
92053745|NCT05014412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92053746|NCT05014412|Antiemetics|antiemetics|mesh-ancestor
92053747|NCT05014412|Autonomic Agents|autonomic agents|mesh-ancestor
92053748|NCT05014412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053749|NCT05014412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053750|NCT05014412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92053751|NCT05014412|Glucocorticoids|glucocorticoids|mesh-ancestor
92053752|NCT05014412|Hormones|hormones|mesh-ancestor
92053753|NCT05014412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053754|NCT05014412|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92053755|NCT05014412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053758|NCT05007106|Carboplatin|carboplatin|mesh-list
92053759|NCT05007106|Gemcitabine|gemcitabine|mesh-list
92053760|NCT05007106|Pembrolizumab|pembrolizumab|mesh-list
92053761|NCT05007106|Fluorouracil|fluorouracil|mesh-list
92053762|NCT05007106|Capecitabine|capecitabine|mesh-list
92053763|NCT05007106|Oxaliplatin|oxaliplatin|mesh-list
92014894|NCT05730439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014895|NCT05730439|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92014896|NCT05730439|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92014897|NCT05730439|Cholinergic Agents|cholinergic agents|mesh-ancestor
92014898|NCT05730439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053764|NCT05007106|Lenvatinib|lenvatinib|mesh-list
92053765|NCT05007106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053766|NCT05007106|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053767|NCT05007106|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053768|NCT05007106|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053769|NCT05007106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053770|NCT05007106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053771|NCT05007106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053772|NCT05007106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053773|NCT05007106|Growth Substances|growth substances|mesh-ancestor
92053774|NCT05007106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053775|NCT05007106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92053776|NCT05007106|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92053777|NCT05007106|Antimetabolites|antimetabolites|mesh-ancestor
92053778|NCT05007106|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053779|NCT05007106|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053780|NCT05007106|Immunologic Factors|immunologic factors|mesh-ancestor
92053781|NCT05007106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053782|NCT05007106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053783|NCT05006794|Gemcitabine|gemcitabine|mesh-list
92053784|NCT05006794|Docetaxel|docetaxel|mesh-list
92053785|NCT05006794|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92053786|NCT05006794|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92053787|NCT05006794|Antimetabolites|antimetabolites|mesh-ancestor
92053788|NCT05006794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053789|NCT05006794|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053790|NCT05006794|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053791|NCT05006794|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053792|NCT05006794|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053793|NCT05006794|Immunoconjugates|immunoconjugates|mesh-ancestor
92053794|NCT05006794|Immunologic Factors|immunologic factors|mesh-ancestor
92053795|NCT05006794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053796|NCT05005442|Pembrolizumab|pembrolizumab|mesh-list
92053797|NCT05005442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053810|NCT04931342|Ipatasertib|ipatasertib|mesh-list
92053812|NCT04931342|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92053813|NCT04931342|Inavolisib|inavolisib|mesh-list
92053814|NCT04931342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053815|NCT04931342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053816|NCT04931342|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053817|NCT04931342|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053818|NCT04931342|Mitosis Modulators|mitosis modulators|mesh-ancestor
92053819|NCT04931342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053820|NCT04931342|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053821|NCT04931342|Immunologic Factors|immunologic factors|mesh-ancestor
92053822|NCT04931342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053823|NCT04931342|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053824|NCT04931342|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92053825|NCT04931342|Alkylating Agents|alkylating agents|mesh-ancestor
92053826|NCT04931342|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92053827|NCT04931342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053828|NCT04931342|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053829|NCT04931342|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053830|NCT04931342|Growth Substances|growth substances|mesh-ancestor
92053831|NCT04931342|Growth Inhibitors|growth inhibitors|mesh-ancestor
92053832|NCT04931342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053833|NCT04931342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053834|NCT04931342|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92053835|NCT04931342|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92053836|NCT04931342|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053837|NCT04931342|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92014899|NCT05730439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014900|NCT05730439|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014901|NCT04224987|Azithromycin|azithromycin|mesh-list
92014902|NCT04224987|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92014903|NCT04224987|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014904|NCT04805515|Nicotine|nicotine|mesh-list
92014905|NCT04805515|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92053838|NCT04931342|Hormone Antagonists|hormone antagonists|mesh-ancestor
92053839|NCT04931342|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92053840|NCT04931342|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053841|NCT04931342|Immunotoxins|immunotoxins|mesh-ancestor
92053842|NCT04931342|Immunoconjugates|immunoconjugates|mesh-ancestor
92053843|NCT04931342|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-ancestor
92053844|NCT04924322|Enoxaparin|enoxaparin|mesh-list
92053845|NCT04924322|Anticoagulants|anticoagulants|mesh-ancestor
92053846|NCT04924322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92053847|NCT04924322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92053848|NCT04924322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053849|NCT04907253|Quercetin|quercetin|mesh-list
92053850|NCT04907253|Antioxidants|antioxidants|mesh-ancestor
92053851|NCT04907253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053852|NCT04907253|Protective Agents|protective agents|mesh-ancestor
92053853|NCT04907253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053854|NCT04902443|Nivolumab|nivolumab|mesh-list
92053856|NCT04902443|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053857|NCT04902443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053858|NCT04902443|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053859|NCT04902443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053860|NCT04902443|Immunologic Factors|immunologic factors|mesh-ancestor
92053861|NCT04902443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053862|NCT04902443|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92053875|NCT04882085|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92053876|NCT04882085|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92053877|NCT04882085|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053878|NCT04882085|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92053879|NCT04882085|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053880|NCT04882085|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053881|NCT04875715|Hydroquinone|hydroquinone|mesh-list
92053882|NCT04875715|Antioxidants|antioxidants|mesh-ancestor
92053883|NCT04875715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053884|NCT04875715|Protective Agents|protective agents|mesh-ancestor
92053885|NCT04875715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053886|NCT04875715|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92053887|NCT04875702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92053888|NCT04875702|Allopurinol|allopurinol|mesh-list
92053889|NCT04875702|Antimetabolites|antimetabolites|mesh-ancestor
92053890|NCT04875702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053891|NCT04875702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053892|NCT04875702|Gout Suppressants|gout suppressants|mesh-ancestor
92053893|NCT04875702|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053894|NCT04875702|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92053896|NCT04875702|Protective Agents|protective agents|mesh-ancestor
92053897|NCT04875702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053898|NCT04836429|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92053899|NCT04836429|Trioxsalen|trioxsalen|mesh-list
92053900|NCT04836429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053901|NCT04836429|Dermatologic Agents|dermatologic agents|mesh-ancestor
92053902|NCT04836429|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92053903|NCT04822467|Ethanol|ethanol|mesh-list
92053904|NCT04822467|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92053905|NCT04822467|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053906|NCT04822467|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053907|NCT04822467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053908|NCT04801368|Anesthetics|anesthetics|mesh-list
92053909|NCT04801368|Anesthetics, Local|anesthetics, local|mesh-list
92014906|NCT04805515|Autonomic Agents|autonomic agents|mesh-ancestor
92053910|NCT04801368|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053911|NCT04801368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053912|NCT04801368|Sensory System Agents|sensory system agents|mesh-ancestor
92053913|NCT04801368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053914|NCT04783935|Cladribine|cladribine|mesh-list
92053915|NCT04783935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053916|NCT04783935|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053917|NCT04783935|Immunologic Factors|immunologic factors|mesh-ancestor
92053918|NCT04783935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053919|NCT04769713|Ropivacaine|ropivacaine|mesh-list
92053920|NCT04769713|Anesthetics, Local|anesthetics, local|mesh-ancestor
92053921|NCT04769713|Anesthetics|anesthetics|mesh-ancestor
92053922|NCT04769713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053923|NCT04769713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053924|NCT04769713|Sensory System Agents|sensory system agents|mesh-ancestor
92053925|NCT04769713|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053926|NCT04751370|Nivolumab|nivolumab|mesh-list
92053927|NCT04751370|Ipilimumab|ipilimumab|mesh-list
92053935|NCT04746235|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92053936|NCT04746235|Antimetabolites|antimetabolites|mesh-ancestor
92053937|NCT04746235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053938|NCT04746235|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053939|NCT04746235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053940|NCT04738487|Pembrolizumab|pembrolizumab|mesh-list
92053941|NCT04738487|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053942|NCT04738487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053943|NCT04738487|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053944|NCT04738487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053945|NCT04728581|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92053946|NCT04728581|Mirtazapine|mirtazapine|mesh-list
92053947|NCT04728581|Antidepressive Agents|antidepressive agents|mesh-ancestor
92053948|NCT04728581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92053949|NCT04728581|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92053950|NCT04728581|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92053951|NCT04728581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053952|NCT04728581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053953|NCT04728581|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92053954|NCT04728581|Histamine Antagonists|histamine antagonists|mesh-ancestor
92053955|NCT04728581|Histamine Agents|histamine agents|mesh-ancestor
92053956|NCT04728581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053957|NCT04728581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053958|NCT04728581|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92053959|NCT04728581|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92053960|NCT04728581|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92053961|NCT04728581|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92053962|NCT04728581|Adrenergic Agents|adrenergic agents|mesh-ancestor
92053963|NCT04728581|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92053964|NCT04728581|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92053966|NCT04728581|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92053967|NCT04677543|Azithromycin|azithromycin|mesh-list
92053968|NCT04677543|Amikacin|amikacin|mesh-list
92053969|NCT04677543|Ethambutol|ethambutol|mesh-list
92053970|NCT04677543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92053971|NCT04677543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92053972|NCT04677543|Antitubercular Agents|antitubercular agents|mesh-ancestor
92053973|NCT04662840|Anesthetics|anesthetics|mesh-list
92053974|NCT04662840|Anesthetics, Local|anesthetics, local|mesh-list
92053975|NCT04662840|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053976|NCT04662840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053977|NCT04662840|Sensory System Agents|sensory system agents|mesh-ancestor
92053978|NCT04662840|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053986|NCT04544293|Molgramostim|molgramostim|mesh-list
92053987|NCT04544293|Sargramostim|sargramostim|mesh-list
92053988|NCT04544293|Immunologic Factors|immunologic factors|mesh-ancestor
92053989|NCT04544293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053990|NCT04544293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053991|NCT04413201|Osimertinib|osimertinib|mesh-list
92053992|NCT04413201|Afatinib|afatinib|mesh-list
92053993|NCT04413201|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053994|NCT04413201|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053995|NCT04413201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014907|NCT04805515|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053996|NCT04413201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053998|NCT04254627|Mifepristone|mifepristone|mesh-list
92053999|NCT04254627|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92054000|NCT04254627|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92054001|NCT04254627|Analgesics|analgesics|mesh-ancestor
92054009|NCT04254627|Immunologic Factors|immunologic factors|mesh-ancestor
92054010|NCT04254627|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92054011|NCT04254627|Abortifacient Agents|abortifacient agents|mesh-ancestor
92054012|NCT04254627|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92054013|NCT04254627|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92054014|NCT04254627|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92054015|NCT04254627|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92054016|NCT04254627|Contraceptive Agents|contraceptive agents|mesh-ancestor
92054017|NCT04254627|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92054018|NCT04254627|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92054019|NCT04254627|Hormone Antagonists|hormone antagonists|mesh-ancestor
92054020|NCT04254627|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054021|NCT04254627|Luteolytic Agents|luteolytic agents|mesh-ancestor
92054022|NCT04254627|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92054023|NCT04254627|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92054031|NCT04160052|Azacitidine|azacitidine|mesh-list
92054032|NCT04160052|Venetoclax|venetoclax|mesh-list
92054033|NCT04160052|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054034|NCT04160052|Antimetabolites|antimetabolites|mesh-ancestor
92054035|NCT04160052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054036|NCT04160052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054037|NCT04160052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054038|NCT04139902|Dostarlimab|dostarlimab|mesh-list
92054039|NCT04139902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054040|NCT04136366|Methotrexate|methotrexate|mesh-list
92054041|NCT04136366|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92054042|NCT04136366|Abortifacient Agents|abortifacient agents|mesh-ancestor
92054043|NCT04136366|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92054044|NCT04136366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054045|NCT04136366|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054046|NCT04136366|Antimetabolites|antimetabolites|mesh-ancestor
92054047|NCT04136366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054048|NCT04136366|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054049|NCT04136366|Dermatologic Agents|dermatologic agents|mesh-ancestor
92054050|NCT04136366|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054051|NCT04136366|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92054052|NCT04136366|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054053|NCT04136366|Immunologic Factors|immunologic factors|mesh-ancestor
92054054|NCT04136366|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054055|NCT04136366|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92054056|NCT04124432|Nicotine|nicotine|mesh-list
92054057|NCT04124432|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92054058|NCT04124432|Autonomic Agents|autonomic agents|mesh-ancestor
92054059|NCT04124432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054060|NCT04124432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054061|NCT04124432|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92054062|NCT04124432|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92054063|NCT04124432|Cholinergic Agents|cholinergic agents|mesh-ancestor
92054064|NCT04124432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054065|NCT04124432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054066|NCT04091217|Bevacizumab|bevacizumab|mesh-list
92054067|NCT04091217|Atezolizumab|atezolizumab|mesh-list
92054068|NCT04091217|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054069|NCT04091217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054070|NCT04091217|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92054071|NCT04091217|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92054072|NCT04091217|Growth Substances|growth substances|mesh-ancestor
92054073|NCT04091217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054074|NCT04091217|Growth Inhibitors|growth inhibitors|mesh-ancestor
92054076|NCT04091217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054078|NCT04081389|Interferon-alpha|interferon-alpha|mesh-list
92054079|NCT04081389|Interferon alpha-2|interferon alpha-2|mesh-list
92054080|NCT04081389|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92014908|NCT04805515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014909|NCT04805515|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92014910|NCT04805515|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92054083|NCT04081389|Cyclophosphamide|cyclophosphamide|mesh-list
92054084|NCT04081389|Doxorubicin|doxorubicin|mesh-list
92054085|NCT04081389|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92054086|NCT04081389|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92054087|NCT04081389|Daunorubicin|daunorubicin|mesh-list
92054088|NCT04081389|Benzenesulfonamide|benzenesulfonamide|mesh-list
92054089|NCT04081389|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054090|NCT04081389|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054091|NCT04081389|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054092|NCT04081389|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054093|NCT04081389|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054094|NCT04081389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054095|NCT04081389|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054096|NCT04081389|Immunologic Factors|immunologic factors|mesh-ancestor
92054097|NCT04081389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054098|NCT04081389|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054099|NCT04081389|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92054100|NCT04081389|Alkylating Agents|alkylating agents|mesh-ancestor
92054101|NCT04081389|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92054102|NCT04081389|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92054103|NCT04081389|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92054104|NCT04081389|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92054105|NCT04081389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054106|NCT04081389|Antiviral Agents|antiviral agents|mesh-ancestor
92054107|NCT04081389|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054108|NCT04081389|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92054109|NCT04081389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92054110|NCT04081389|Analgesics|analgesics|mesh-ancestor
92054111|NCT04081389|Sensory System Agents|sensory system agents|mesh-ancestor
92054112|NCT04081389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054113|NCT04081389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054114|NCT04081389|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92054115|NCT04081389|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92054116|NCT04081389|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92054117|NCT04060862|Fulvestrant|fulvestrant|mesh-list
92054118|NCT04060862|Palbociclib|palbociclib|mesh-list
92054119|NCT04060862|Ipatasertib|ipatasertib|mesh-list
92054120|NCT04060862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92054121|NCT04060862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054122|NCT04060862|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92054123|NCT04060862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92054124|NCT04060862|Hormone Antagonists|hormone antagonists|mesh-ancestor
92054125|NCT04060862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054126|NCT04060862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054127|NCT04060862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054128|NCT04060862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054129|NCT04060862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054130|NCT03856658|Floxuridine|floxuridine|mesh-list
92054131|NCT03856658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054132|NCT03856658|Antimetabolites|antimetabolites|mesh-ancestor
92054133|NCT03856658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054134|NCT03856658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054135|NCT03848845|Pembrolizumab|pembrolizumab|mesh-list
92054136|NCT03848845|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054137|NCT03848845|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054138|NCT03848845|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054139|NCT03848845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054140|NCT03811847|Methylphenidate|methylphenidate|mesh-list
92054141|NCT03811847|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92054142|NCT03811847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054143|NCT03811847|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92054144|NCT03811847|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92054145|NCT03811847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92054154|NCT03809000|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92054155|NCT03809000|Fertility Agents|fertility agents|mesh-ancestor
92054156|NCT03809000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92014911|NCT04805515|Cholinergic Agents|cholinergic agents|mesh-ancestor
92014912|NCT04805515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054157|NCT03809000|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92054158|NCT03809000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054159|NCT03809000|Androgen Antagonists|androgen antagonists|mesh-ancestor
92054160|NCT03809000|Hormone Antagonists|hormone antagonists|mesh-ancestor
92054161|NCT03698552|Epratuzumab|epratuzumab|mesh-list
92054162|NCT03698552|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054163|NCT03698552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054165|NCT03653364|Antiviral Agents|antiviral agents|mesh-ancestor
92054166|NCT03653364|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054167|NCT03653364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054168|NCT03653364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054169|NCT03600350|Nivolumab|nivolumab|mesh-list
92054170|NCT03600350|Sargramostim|sargramostim|mesh-list
92054171|NCT03600350|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054172|NCT03600350|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054173|NCT03600350|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054174|NCT03600350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054175|NCT03600350|Immunologic Factors|immunologic factors|mesh-ancestor
92054176|NCT03600350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054177|NCT03598608|Pembrolizumab|pembrolizumab|mesh-list
92054178|NCT03598608|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054179|NCT03598608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054180|NCT03598608|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054181|NCT03598608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054182|NCT03598595|Hydroxychloroquine|hydroxychloroquine|mesh-list
92054183|NCT03598595|Gemcitabine|gemcitabine|mesh-list
92054184|NCT03598595|Docetaxel|docetaxel|mesh-list
92054185|NCT03598595|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054186|NCT03598595|Antimetabolites|antimetabolites|mesh-ancestor
92054187|NCT03598595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054188|NCT03598595|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054189|NCT03598595|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054190|NCT03598595|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054191|NCT03598595|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054192|NCT03598595|Antimalarials|antimalarials|mesh-ancestor
92054193|NCT03598595|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92054194|NCT03598595|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92054195|NCT03598595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054196|NCT03598595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054197|NCT03598595|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054199|NCT03590054|Abexinostat|abexinostat|mesh-list
92054200|NCT03590054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054201|NCT03590054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054202|NCT03590054|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054203|NCT03590054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054204|NCT03590054|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92054205|NCT03590054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054206|NCT03568097|Avelumab|avelumab|mesh-list
92054207|NCT03568097|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054208|NCT03568097|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054214|NCT03564691|Paclitaxel|paclitaxel|mesh-list
92054215|NCT03564691|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92054216|NCT03564691|Cisplatin|cisplatin|mesh-list
92054217|NCT03564691|Carboplatin|carboplatin|mesh-list
92054221|NCT03564691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054222|NCT03564691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054223|NCT03564691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054224|NCT03564691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054225|NCT03564691|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054226|NCT03564691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054227|NCT03564691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054228|NCT03564691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054229|NCT03564691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054230|NCT03564691|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92054231|NCT03564691|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92054232|NCT03564691|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054233|NCT03546582|Pembrolizumab|pembrolizumab|mesh-list
92054234|NCT03546582|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014913|NCT04805515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054235|NCT03546582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054236|NCT03546582|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054237|NCT03546582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054238|NCT03398148|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92054239|NCT03398148|Immunologic Factors|immunologic factors|mesh-ancestor
92054240|NCT03398148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054241|NCT03384238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92054244|NCT03384238|Immunoglobulins|immunoglobulins|mesh-list
92054245|NCT03384238|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92054246|NCT03384238|Immunologic Factors|immunologic factors|mesh-ancestor
92054247|NCT03384238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054248|NCT03384238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054249|NCT03226249|Deoxyglucose|deoxyglucose|mesh-list
92054250|NCT03226249|Doxorubicin|doxorubicin|mesh-list
92054251|NCT03226249|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92054252|NCT03226249|Pembrolizumab|pembrolizumab|mesh-list
92054253|NCT03226249|Dacarbazine|dacarbazine|mesh-list
92054254|NCT03226249|Vinblastine|vinblastine|mesh-list
92054255|NCT03226249|Imidazole|imidazole|mesh-list
92054256|NCT03226249|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92054257|NCT03226249|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92054258|NCT03226249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054259|NCT03226249|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92054260|NCT03226249|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92054261|NCT03226249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054262|NCT03226249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054263|NCT03226249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054264|NCT03226249|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054265|NCT03226249|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92054266|NCT03226249|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92054267|NCT03226249|Alkylating Agents|alkylating agents|mesh-ancestor
92054268|NCT03226249|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054269|NCT03226249|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054270|NCT03226249|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054271|NCT03226249|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054272|NCT03226249|Antimetabolites|antimetabolites|mesh-ancestor
92054273|NCT03226249|Antiviral Agents|antiviral agents|mesh-ancestor
92054274|NCT03226249|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054275|NCT03184155|Nicardipine|nicardipine|mesh-list
92054276|NCT03184155|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92054277|NCT03184155|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92054278|NCT03184155|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92054279|NCT03184155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054280|NCT03184155|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92054281|NCT03184155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054282|NCT03184155|Vasodilator Agents|vasodilator agents|mesh-ancestor
92054283|NCT03172624|Nivolumab|nivolumab|mesh-list
92054284|NCT03172624|Ipilimumab|ipilimumab|mesh-list
92054285|NCT03172624|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054286|NCT03172624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054287|NCT03172624|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054288|NCT03172624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054289|NCT03101748|Paclitaxel|paclitaxel|mesh-list
92054290|NCT03101748|Cyclophosphamide|cyclophosphamide|mesh-list
92054316|NCT03101748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92054317|NCT03101748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92054318|NCT03101748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054319|NCT03085147|Olaparib|olaparib|mesh-list
92054320|NCT03085147|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92054321|NCT03085147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054322|NCT03085147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054323|NCT03085147|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054324|NCT03063944|Azacitidine|azacitidine|mesh-list
92054325|NCT03063944|Decitabine|decitabine|mesh-list
92054326|NCT03063944|Venetoclax|venetoclax|mesh-list
92054327|NCT03063944|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054328|NCT03063944|Antimetabolites|antimetabolites|mesh-ancestor
92054329|NCT03063944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054330|NCT03063944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054331|NCT03063944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054332|NCT03062631|Amifampridine|amifampridine|mesh-list
92054333|NCT03062631|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92014914|NCT05195177|Anesthetics|anesthetics|mesh-list
92014915|NCT05195177|Anesthetics, Local|anesthetics, local|mesh-list
92014916|NCT05195177|Histamine|histamine|mesh-list
92014917|NCT05195177|Histamine Antagonists|histamine antagonists|mesh-list
92054334|NCT03062631|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054335|NCT03062631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054336|NCT03062631|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92054337|NCT03062631|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92054338|NCT03062631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054339|NCT02979873|Sirolimus|sirolimus|mesh-list
92054340|NCT02979873|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92054344|NCT02979873|Antifungal Agents|antifungal agents|mesh-ancestor
92054345|NCT02979873|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054346|NCT02979873|Immunologic Factors|immunologic factors|mesh-ancestor
92054347|NCT02979873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054348|NCT02941926|Letrozole|letrozole|mesh-list
92054349|NCT02941926|Leuprolide|leuprolide|mesh-list
92054350|NCT02941926|Goserelin|goserelin|mesh-list
92054351|NCT02941926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054352|NCT02941926|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92054353|NCT02941926|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92054354|NCT02941926|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054355|NCT02941926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054356|NCT02941926|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92054357|NCT02941926|Hormone Antagonists|hormone antagonists|mesh-ancestor
92054358|NCT02941926|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054359|NCT02941926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054360|NCT02941926|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92054361|NCT02941926|Fertility Agents|fertility agents|mesh-ancestor
92054362|NCT02941926|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92054363|NCT02941926|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92054364|NCT02933255|Nivolumab|nivolumab|mesh-list
92054365|NCT02933255|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054366|NCT02933255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054367|NCT02933255|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054368|NCT02933255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054369|NCT02910700|Nivolumab|nivolumab|mesh-list
92054370|NCT02910700|Trametinib|trametinib|mesh-list
92054371|NCT02910700|Dabrafenib|dabrafenib|mesh-list
92054372|NCT02910700|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054373|NCT02910700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054374|NCT02910700|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054375|NCT02910700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054376|NCT02910700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054377|NCT02910700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054378|NCT02849548|Suvorexant|suvorexant|mesh-list
92054379|NCT02849548|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92054380|NCT02849548|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92054381|NCT02849548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92054382|NCT02849548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054383|NCT02849548|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92054384|NCT02849548|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054385|NCT02849548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054386|NCT02815995|Durvalumab|durvalumab|mesh-list
92054387|NCT02815995|Tremelimumab|tremelimumab|mesh-list
92054388|NCT02815995|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054389|NCT02815995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054390|NCT02780310|Lenvatinib|lenvatinib|mesh-list
92054391|NCT02780310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054392|NCT02780310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054393|NCT02780310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054394|NCT02780310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054395|NCT02758431|Methyltestosterone|methyltestosterone|mesh-list
92054396|NCT02758431|Anastrozole|anastrozole|mesh-list
92054397|NCT02758431|Testosterone|testosterone|mesh-list
92054398|NCT02758431|Testosterone undecanoate|testosterone undecanoate|mesh-list
92054399|NCT02758431|Testosterone enanthate|testosterone enanthate|mesh-list
92054400|NCT02758431|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92054401|NCT02758431|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92054402|NCT02758431|Acyline|acyline|mesh-list
92054403|NCT02758431|Hormone Antagonists|hormone antagonists|mesh-list
92014918|NCT05195177|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92054404|NCT02758431|Hormones|hormones|mesh-ancestor
92054405|NCT02758431|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054406|NCT02758431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054407|NCT02758431|Androgens|androgens|mesh-ancestor
92054408|NCT02758431|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92054409|NCT02758431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054410|NCT02758431|Anabolic Agents|anabolic agents|mesh-ancestor
92054411|NCT02758431|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92054412|NCT02758431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054413|NCT02758431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054414|NCT02758431|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92054416|NCT02756000|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92054417|NCT02756000|Sympathomimetics|sympathomimetics|mesh-ancestor
92054418|NCT02756000|Autonomic Agents|autonomic agents|mesh-ancestor
92054419|NCT02756000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054420|NCT02756000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054421|NCT02756000|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92054422|NCT02756000|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92054423|NCT02756000|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92054424|NCT02756000|Adrenergic Agents|adrenergic agents|mesh-ancestor
92054425|NCT02756000|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054426|NCT02756000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054427|NCT02756000|Protective Agents|protective agents|mesh-ancestor
92054428|NCT02688985|Ocrelizumab|ocrelizumab|mesh-list
92054429|NCT02688985|Histamine Antagonists|histamine antagonists|mesh-list
92054430|NCT02688985|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92054431|NCT02688985|Immunologic Factors|immunologic factors|mesh-ancestor
92054432|NCT02688985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054433|NCT02688985|Histamine Agents|histamine agents|mesh-ancestor
92054434|NCT02688985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054435|NCT02688985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054436|NCT02601365|Molgramostim|molgramostim|mesh-list
92054437|NCT02601365|Sargramostim|sargramostim|mesh-list
92054438|NCT02601365|Immunologic Factors|immunologic factors|mesh-ancestor
92054439|NCT02601365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054440|NCT02601365|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054441|NCT02583893|Cytarabine|cytarabine|mesh-list
92054442|NCT02583893|Sirolimus|sirolimus|mesh-list
92054443|NCT02583893|Etoposide|etoposide|mesh-list
92054444|NCT02583893|Mitoxantrone|mitoxantrone|mesh-list
92054445|NCT02583893|Etoposide phosphate|etoposide phosphate|mesh-list
92054446|NCT02583893|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054447|NCT02583893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054448|NCT02583893|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92054449|NCT02583893|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92054450|NCT02583893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054451|NCT02583893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054452|NCT02583893|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054453|NCT02583893|Antimetabolites|antimetabolites|mesh-ancestor
92054454|NCT02583893|Antiviral Agents|antiviral agents|mesh-ancestor
92054455|NCT02583893|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054456|NCT02583893|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054457|NCT02583893|Immunologic Factors|immunologic factors|mesh-ancestor
92054458|NCT02583893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054459|NCT02583893|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92054460|NCT02583893|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92054461|NCT02583893|Antifungal Agents|antifungal agents|mesh-ancestor
92054462|NCT02583893|Analgesics|analgesics|mesh-ancestor
92054463|NCT02583893|Sensory System Agents|sensory system agents|mesh-ancestor
92054464|NCT02583893|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054466|NCT02520154|Carboplatin|carboplatin|mesh-list
92054467|NCT02520154|Pembrolizumab|pembrolizumab|mesh-list
92054468|NCT02520154|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92054469|NCT02520154|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054470|NCT02520154|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054471|NCT02520154|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054472|NCT02520154|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054473|NCT02520154|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054474|NCT02520154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054475|NCT02520154|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054476|NCT02520154|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054477|NCT02411448|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92014919|NCT05195177|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92014920|NCT05195177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014921|NCT05195177|Sensory System Agents|sensory system agents|mesh-ancestor
92054479|NCT02411448|Osimertinib|osimertinib|mesh-list
92054480|NCT02411448|Ramucirumab|ramucirumab|mesh-list
92054481|NCT02411448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054482|NCT02411448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054483|NCT02411448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054484|NCT02411448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054485|NCT02107144|Trimetazidine|trimetazidine|mesh-list
92054486|NCT02107144|Vasodilator Agents|vasodilator agents|mesh-ancestor
92054487|NCT01860170|Cyclophosphamide|cyclophosphamide|mesh-list
92054488|NCT01860170|Bortezomib|bortezomib|mesh-list
92054546|NCT01330446|Modafinil|modafinil|mesh-list
92054547|NCT01330446|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92054548|NCT01330446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054549|NCT01330446|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92054550|NCT01330446|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92054551|NCT01330446|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92054552|NCT01330446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054553|NCT01258933|Ofatumumab|ofatumumab|mesh-list
92054554|NCT01258933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054555|NCT00866554|Tamoxifen|tamoxifen|mesh-list
92054556|NCT00866554|Bicalutamide|bicalutamide|mesh-list
92054557|NCT00866554|Dutasteride|dutasteride|mesh-list
92054558|NCT00866554|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92054559|NCT00866554|Hormone Antagonists|hormone antagonists|mesh-ancestor
92054560|NCT00866554|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054564|NCT00866554|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92054565|NCT00866554|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92054566|NCT00866554|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92054567|NCT00866554|Androgen Antagonists|androgen antagonists|mesh-ancestor
92054568|NCT00866554|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92054569|NCT00866554|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92054570|NCT00866554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054571|NCT00866554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054572|NCT00645931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92054573|NCT00645931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92054574|NCT00645931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054575|NCT00452023|Interferons|interferons|mesh-list
92054576|NCT00452023|Interferon-alpha|interferon-alpha|mesh-list
92054577|NCT00452023|Interferon alpha-2|interferon alpha-2|mesh-list
92054578|NCT00452023|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92054579|NCT00452023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054580|NCT00452023|Antiviral Agents|antiviral agents|mesh-ancestor
92054581|NCT00452023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054582|NCT00452023|Immunologic Factors|immunologic factors|mesh-ancestor
92054583|NCT00452023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054584|NCT00442104|Ganaxolone|ganaxolone|mesh-list
92054585|NCT00442104|Neurosteroids|neurosteroids|mesh-ancestor
92054586|NCT00442104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054587|NCT00442104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054588|NCT00442104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054589|NCT00442104|GABA Modulators|gaba modulators|mesh-ancestor
92054590|NCT00442104|GABA Agents|gaba agents|mesh-ancestor
92054591|NCT00441896|Ganaxolone|ganaxolone|mesh-list
92054592|NCT00441896|Neurosteroids|neurosteroids|mesh-ancestor
92054593|NCT00441896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081699|NCT01402947|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92054594|NCT00441896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054595|NCT00441896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054596|NCT00441896|GABA Modulators|gaba modulators|mesh-ancestor
92054597|NCT00441896|GABA Agents|gaba agents|mesh-ancestor
92054598|NCT00254423|Dasatinib|dasatinib|mesh-list
92054599|NCT00254423|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054600|NCT00254423|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054601|NCT00254423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054602|NCT00254423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054603|NCT00202800|Gemcitabine|gemcitabine|mesh-list
92054604|NCT00202800|Etoposide|etoposide|mesh-list
92054605|NCT00202800|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054606|NCT00202800|Antimetabolites|antimetabolites|mesh-ancestor
92054607|NCT00202800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054608|NCT00202800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054609|NCT00202800|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054610|NCT00202800|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92054611|NCT00202800|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92054612|NCT00202800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054613|NCT00194714|Vaccines|vaccines|mesh-list
92054614|NCT00194714|Immunologic Factors|immunologic factors|mesh-ancestor
92054615|NCT00194714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054616|NCT02034877|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92054617|NCT02034877|Immunologic Factors|immunologic factors|mesh-ancestor
92054618|NCT02034877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054619|NCT02034799|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92054620|NCT02034799|Hemostatics|hemostatics|mesh-ancestor
92054621|NCT02034799|Coagulants|coagulants|mesh-ancestor
92054622|NCT02057575|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92054623|NCT02057575|Latanoprost|latanoprost|mesh-list
92054624|NCT02057575|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92054625|NCT02077465|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92054626|NCT02077465|Immunologic Factors|immunologic factors|mesh-ancestor
92054627|NCT02077465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054628|NCT02034565|Apixaban|apixaban|mesh-list
92054629|NCT02034565|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92054630|NCT02034565|Antithrombins|antithrombins|mesh-ancestor
92054631|NCT02034565|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92054634|NCT02034565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054635|NCT02034565|Anticoagulants|anticoagulants|mesh-ancestor
92054636|NCT02075515|Vaccines|vaccines|mesh-list
92054637|NCT02075515|Immunologic Factors|immunologic factors|mesh-ancestor
92054638|NCT02075515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054639|NCT04682587|Pembrolizumab|pembrolizumab|mesh-list
92054640|NCT04682587|Avelumab|avelumab|mesh-list
92054641|NCT04682587|Axitinib|axitinib|mesh-list
92054642|NCT04682587|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054643|NCT04682587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054644|NCT04682587|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054645|NCT04682587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054646|NCT04682587|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054647|NCT04682587|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054648|NCT04417543|Memantine|memantine|mesh-list
92054649|NCT04417543|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92054650|NCT04417543|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92054651|NCT04417543|Dopamine Agents|dopamine agents|mesh-ancestor
92054652|NCT04417543|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054653|NCT04417543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054654|NCT04417543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054655|NCT04417543|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92054656|NCT04417543|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92054657|NCT02021318|Darbepoetin alfa|darbepoetin alfa|mesh-list
92054658|NCT02021318|Hematinics|hematinics|mesh-ancestor
92054659|NCT02020616|Metformin|metformin|mesh-list
92054660|NCT02020616|Exenatide|exenatide|mesh-list
92054661|NCT02020616|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92054662|NCT02020616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054663|NCT02020616|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92054664|NCT02020616|Incretins|incretins|mesh-ancestor
92054665|NCT02020616|Hormones|hormones|mesh-ancestor
92054666|NCT02020616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054667|NCT02048072|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92054668|NCT02048072|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92054669|NCT02048072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054670|NCT02048072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054671|NCT02048072|Immunologic Factors|immunologic factors|mesh-ancestor
92054672|NCT02048072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054673|NCT01622660|Gemcitabine|gemcitabine|mesh-list
92054674|NCT01622660|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054675|NCT01622660|Antimetabolites|antimetabolites|mesh-ancestor
92054676|NCT01622660|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054677|NCT01622660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054678|NCT04697498|Anesthetics|anesthetics|mesh-list
92054679|NCT04697498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92054680|NCT04697498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014922|NCT05195177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014923|NCT05195177|Histamine Agonists|histamine agonists|mesh-ancestor
92054681|NCT02019602|Certolizumab Pegol|certolizumab pegol|mesh-list
92054682|NCT02019602|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92054683|NCT02019602|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054684|NCT02019602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054685|NCT02019602|Immunologic Factors|immunologic factors|mesh-ancestor
92054686|NCT02019602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054687|NCT02019602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054688|NCT02040428|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92054690|NCT02040428|Coagulants|coagulants|mesh-ancestor
92054691|NCT02018822|Urethane|urethane|mesh-list
92054692|NCT02018822|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054693|NCT02018822|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92054694|NCT02018822|Anesthetics, General|anesthetics, general|mesh-ancestor
92054695|NCT02018822|Anesthetics|anesthetics|mesh-ancestor
92054696|NCT02018822|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92054697|NCT02018822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054698|NCT02055157|Natriuretic Peptide, C-Type|natriuretic peptide, c-type|mesh-list
92054699|NCT02055157|Natriuretic Agents|natriuretic agents|mesh-ancestor
92054700|NCT02055157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054701|NCT02022007|Metformin|metformin|mesh-list
92054702|NCT02022007|Saxagliptin|saxagliptin|mesh-list
92054703|NCT02022007|Biguanides|biguanides|mesh-list
92054704|NCT02022007|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92054705|NCT02022007|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92054708|NCT02022007|Hormones|hormones|mesh-ancestor
92054709|NCT02022007|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054710|NCT02022007|Protease Inhibitors|protease inhibitors|mesh-ancestor
92054711|NCT02022007|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054712|NCT02022007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054713|NCT04689919|Rivaroxaban|rivaroxaban|mesh-list
92054714|NCT04689919|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92054715|NCT04689919|Antithrombins|antithrombins|mesh-ancestor
92054716|NCT04689919|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92054717|NCT04689919|Protease Inhibitors|protease inhibitors|mesh-ancestor
92054718|NCT04689919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054719|NCT04689919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054720|NCT04689919|Anticoagulants|anticoagulants|mesh-ancestor
92054721|NCT04680949|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92054722|NCT04680949|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054723|NCT02053753|Denosumab|denosumab|mesh-list
92054724|NCT02053753|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92054725|NCT02053753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054726|NCT02019979|Metformin|metformin|mesh-list
92054727|NCT02019979|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92054728|NCT02019979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054729|NCT02019667|(3-aminopropyl)(n-butyl)phosphinic acid|(3-aminopropyl)(n-butyl)phosphinic acid|mesh-list
92054730|NCT02019667|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92054731|NCT02019667|Protective Agents|protective agents|mesh-ancestor
92054732|NCT02019667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054733|NCT02019667|GABA Antagonists|gaba antagonists|mesh-ancestor
92054734|NCT02019667|GABA Agents|gaba agents|mesh-ancestor
92054735|NCT02019667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054736|NCT02019667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054737|NCT02030821|Tranexamic Acid|tranexamic acid|mesh-list
92054738|NCT02030821|Aminocaproic Acid|aminocaproic acid|mesh-list
92054739|NCT02030821|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92054740|NCT02030821|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92054741|NCT02030821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054742|NCT02030821|Hemostatics|hemostatics|mesh-ancestor
92054743|NCT02030821|Coagulants|coagulants|mesh-ancestor
92054744|NCT02052739|Brexanolone|brexanolone|mesh-list
92054745|NCT02052739|Neurosteroids|neurosteroids|mesh-ancestor
92054746|NCT02052739|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054747|NCT02052739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054748|NCT02052739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054749|NCT02052739|GABA Modulators|gaba modulators|mesh-ancestor
92054750|NCT02052739|GABA Agents|gaba agents|mesh-ancestor
92054751|NCT02019277|Paclitaxel|paclitaxel|mesh-list
92054752|NCT02019277|Docetaxel|docetaxel|mesh-list
92054753|NCT02019277|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92054754|NCT02019277|Trastuzumab|trastuzumab|mesh-list
92014924|NCT05195177|Histamine Agents|histamine agents|mesh-ancestor
92014925|NCT05195177|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014926|NCT05195177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014928|NCT05170919|Mirtazapine|mirtazapine|mesh-list
92014929|NCT05170919|Antiemetics|antiemetics|mesh-ancestor
92054755|NCT02019277|Pertuzumab|pertuzumab|mesh-list
92054756|NCT02019277|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054757|NCT02019277|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054758|NCT02019277|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054759|NCT02019277|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054760|NCT02019277|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054761|NCT02019277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054762|NCT02019277|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92054763|NCT01823835|Palbociclib|palbociclib|mesh-list
92054764|NCT01823835|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054765|NCT01823835|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054766|NCT01823835|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054767|NCT01823835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054768|NCT01823679|Capecitabine|capecitabine|mesh-list
92054769|NCT01823679|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054770|NCT01823679|Antimetabolites|antimetabolites|mesh-ancestor
92054771|NCT01823679|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054772|NCT01823679|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054773|NCT01823289|Itraconazole|itraconazole|mesh-list
92054774|NCT01823289|Antifungal Agents|antifungal agents|mesh-ancestor
92054775|NCT01823289|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054776|NCT01823289|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92054777|NCT01823289|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92054779|NCT01823289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054780|NCT01823289|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92054781|NCT01823289|Hormone Antagonists|hormone antagonists|mesh-ancestor
92054782|NCT01823289|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054783|NCT01823289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054784|NCT01823289|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92054787|NCT01822899|Bromides|bromides|mesh-list
92054788|NCT01822899|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92054789|NCT01822899|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054790|NCT01822899|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92054791|NCT01822899|Autonomic Agents|autonomic agents|mesh-ancestor
92054792|NCT01822899|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054793|NCT01822899|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054794|NCT01822899|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92054795|NCT01822899|Respiratory System Agents|respiratory system agents|mesh-ancestor
92054796|NCT01822899|Dermatologic Agents|dermatologic agents|mesh-ancestor
92054797|NCT01822899|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92054798|NCT01822899|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92054799|NCT01822899|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92054800|NCT01822899|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92054801|NCT01822899|Adrenergic Agents|adrenergic agents|mesh-ancestor
92054802|NCT01822899|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054803|NCT01822899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054804|NCT01822899|Anticonvulsants|anticonvulsants|mesh-ancestor
92054805|NCT01822821|Acetaminophen|acetaminophen|mesh-list
92054806|NCT01822821|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92054807|NCT01822821|Analgesics|analgesics|mesh-ancestor
92054808|NCT01822821|Sensory System Agents|sensory system agents|mesh-ancestor
92054809|NCT01822821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054810|NCT01822821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054811|NCT01822821|Antipyretics|antipyretics|mesh-ancestor
92054812|NCT01822665|Acetaminophen|acetaminophen|mesh-list
92054813|NCT01822665|Ibuprofen|ibuprofen|mesh-list
92054814|NCT01822665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92054815|NCT01822665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92054816|NCT01822665|Analgesics|analgesics|mesh-ancestor
92054817|NCT01822665|Sensory System Agents|sensory system agents|mesh-ancestor
92054818|NCT01822665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014930|NCT05170919|Autonomic Agents|autonomic agents|mesh-ancestor
92054819|NCT01822665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054820|NCT01822665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054821|NCT01822665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054822|NCT01822665|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92054823|NCT01822665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054824|NCT01822665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054825|NCT01822665|Antipyretics|antipyretics|mesh-ancestor
92054826|NCT01822587|Propranolol|propranolol|mesh-list
92054827|NCT01822587|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92054828|NCT01822587|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92054829|NCT01822587|Adrenergic Agents|adrenergic agents|mesh-ancestor
92054830|NCT01822587|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054831|NCT01822587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054832|NCT01822587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054833|NCT01822587|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92054834|NCT01822587|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92054835|NCT01822587|Vasodilator Agents|vasodilator agents|mesh-ancestor
92054836|NCT01821963|Interferons|interferons|mesh-list
92054837|NCT01821963|Ribavirin|ribavirin|mesh-list
92054838|NCT01821963|Interferon-alpha|interferon-alpha|mesh-list
92054839|NCT01821963|Interferon alpha-2|interferon alpha-2|mesh-list
92054840|NCT01821963|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92054841|NCT01821963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054842|NCT01821963|Antiviral Agents|antiviral agents|mesh-ancestor
92054843|NCT01821963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054844|NCT01821963|Antimetabolites|antimetabolites|mesh-ancestor
92054845|NCT01821963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054846|NCT01821963|Immunologic Factors|immunologic factors|mesh-ancestor
92054847|NCT01821963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054848|NCT01821729|Leucovorin|leucovorin|mesh-list
92054849|NCT01821729|Fluorouracil|fluorouracil|mesh-list
92054850|NCT01821729|Oxaliplatin|oxaliplatin|mesh-list
92054851|NCT01821729|Folfirinox|folfirinox|mesh-list
92054854|NCT01821729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054855|NCT01821729|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054856|NCT01821729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054857|NCT01821729|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054858|NCT01821729|Immunologic Factors|immunologic factors|mesh-ancestor
92054859|NCT01821729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054860|NCT01821729|Antidotes|antidotes|mesh-ancestor
92054861|NCT01821729|Protective Agents|protective agents|mesh-ancestor
92054862|NCT01821729|Vitamin B Complex|vitamin b complex|mesh-ancestor
92054863|NCT01821729|Vitamins|vitamins|mesh-ancestor
92054864|NCT01821729|Micronutrients|micronutrients|mesh-ancestor
92054865|NCT01821729|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92054866|NCT01821729|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92054867|NCT01821729|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92054868|NCT01821729|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92054869|NCT01820637|Paclitaxel|paclitaxel|mesh-list
92054870|NCT01820637|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054871|NCT01820637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054872|NCT01820637|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054873|NCT01820637|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054874|NCT01820637|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054875|NCT01820637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054876|NCT01850823|Mometasone Furoate|mometasone furoate|mesh-list
92054877|NCT01850823|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054878|NCT01850823|Dermatologic Agents|dermatologic agents|mesh-ancestor
92054879|NCT01850823|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92054880|NCT01820559|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92054881|NCT01820559|Anticonvulsants|anticonvulsants|mesh-ancestor
92054882|NCT01820559|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92054883|NCT01820559|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92054884|NCT01820559|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92054885|NCT01820559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054887|NCT02171429|Etrolizumab|etrolizumab|mesh-list
92054888|NCT02171429|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92054889|NCT02171429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054890|NCT02171429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054891|NCT02171429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92054892|NCT02171429|Immunologic Factors|immunologic factors|mesh-ancestor
92014931|NCT05170919|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014932|NCT05170919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014933|NCT05170919|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92014934|NCT05170919|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92014935|NCT05170919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92054893|NCT02171429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054894|NCT01818141|Vancomycin|vancomycin|mesh-list
92054895|NCT01818141|Fidaxomicin|fidaxomicin|mesh-list
92054896|NCT01818141|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92054897|NCT01818141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054899|NCT01849497|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92054900|NCT01849497|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92054901|NCT01849497|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92054902|NCT01849497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92054903|NCT01849497|Antimetabolites|antimetabolites|mesh-ancestor
92054904|NCT01849497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054905|NCT01849497|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92054906|NCT01849497|Protease Inhibitors|protease inhibitors|mesh-ancestor
92054907|NCT01849497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054908|NCT01849497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92054909|NCT01849497|Immunologic Factors|immunologic factors|mesh-ancestor
92054910|NCT01849497|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054911|NCT04170465|Metformin|metformin|mesh-list
92054912|NCT04170465|Paclitaxel|paclitaxel|mesh-list
92054913|NCT04170465|Cyclophosphamide|cyclophosphamide|mesh-list
92054914|NCT04170465|Doxorubicin|doxorubicin|mesh-list
92054915|NCT04170465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054916|NCT04170465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054917|NCT04170465|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054918|NCT04170465|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054919|NCT04170465|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054920|NCT04170465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054921|NCT04170465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054922|NCT04170465|Immunologic Factors|immunologic factors|mesh-ancestor
92054923|NCT04170465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054924|NCT04170465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054925|NCT04170465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92054939|NCT01847313|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054941|NCT01847313|Hormones|hormones|mesh-ancestor
92054942|NCT01847313|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054943|NCT01847313|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92054944|NCT02117687|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92054945|NCT02117687|Hyaluronic Acid|hyaluronic acid|mesh-list
92054946|NCT02117687|Glycerol|glycerol|mesh-list
92054947|NCT02117687|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92054948|NCT02117687|Immunologic Factors|immunologic factors|mesh-ancestor
92054949|NCT02117687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054950|NCT02117687|Viscosupplements|viscosupplements|mesh-ancestor
92054951|NCT02117687|Protective Agents|protective agents|mesh-ancestor
92054952|NCT02117687|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92054953|NCT02117687|Laxatives|laxatives|mesh-ancestor
92054954|NCT02117687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92054955|NCT04740593|Methamphetamine|methamphetamine|mesh-list
92054956|NCT04740593|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92054957|NCT04740593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054958|NCT04740593|Sympathomimetics|sympathomimetics|mesh-ancestor
92054959|NCT04740593|Autonomic Agents|autonomic agents|mesh-ancestor
92054960|NCT04740593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054961|NCT04740593|Dopamine Agents|dopamine agents|mesh-ancestor
92054962|NCT04740593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054963|NCT04740593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054964|NCT04740593|Adrenergic Agents|adrenergic agents|mesh-ancestor
92054965|NCT04740593|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92054966|NCT04740593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92054967|NCT04740593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92054968|NCT04740593|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92054969|NCT02141633|Fluticasone|fluticasone|mesh-list
92014936|NCT05170919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92054971|NCT02141633|Albuterol|albuterol|mesh-list
92054972|NCT02141633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054973|NCT02141633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92054974|NCT02141633|Autonomic Agents|autonomic agents|mesh-ancestor
92054975|NCT02141633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054976|NCT02141633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054977|NCT02141633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92054978|NCT02141633|Respiratory System Agents|respiratory system agents|mesh-ancestor
92054979|NCT02141633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92054980|NCT02141633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92054981|NCT02141633|Tocolytic Agents|tocolytic agents|mesh-ancestor
92054982|NCT02141633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92054983|NCT02141633|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92054984|NCT02141633|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92054985|NCT02141633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92054986|NCT02141633|Adrenergic Agents|adrenergic agents|mesh-ancestor
92054987|NCT02141633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054988|NCT02141633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054990|NCT01846611|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92054991|NCT01846611|Doxorubicin|doxorubicin|mesh-list
92054992|NCT01846611|Trabectedin|trabectedin|mesh-list
92054993|NCT01846611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054994|NCT01846611|Antiemetics|antiemetics|mesh-ancestor
92054995|NCT01846611|Autonomic Agents|autonomic agents|mesh-ancestor
92054996|NCT01846611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054997|NCT01846611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054998|NCT01846611|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92054999|NCT01846611|Glucocorticoids|glucocorticoids|mesh-ancestor
92055000|NCT01846611|Hormones|hormones|mesh-ancestor
92055001|NCT01846611|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055002|NCT01846611|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92055003|NCT01846611|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055004|NCT01846611|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92055005|NCT01846611|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92055006|NCT01846611|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92055007|NCT01846611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055008|NCT01846611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055009|NCT01846611|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92055010|NCT01846611|Alkylating Agents|alkylating agents|mesh-ancestor
92055011|NCT01846299|Ranibizumab|ranibizumab|mesh-list
92055012|NCT01846299|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92055013|NCT01846299|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92055014|NCT01846299|Growth Substances|growth substances|mesh-ancestor
92055015|NCT01846299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055016|NCT01846299|Growth Inhibitors|growth inhibitors|mesh-ancestor
92055017|NCT01846299|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055018|NCT01628393|Ozanimod|ozanimod|mesh-list
92055019|NCT01628393|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92055020|NCT01628393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055021|NCT01628393|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055022|NCT01628393|Immunologic Factors|immunologic factors|mesh-ancestor
92055023|NCT01628393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055024|NCT01846221|Clonidine|clonidine|mesh-list
92055025|NCT01846221|Fentanyl|fentanyl|mesh-list
92055026|NCT01846221|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92055027|NCT01846221|Narcotics|narcotics|mesh-ancestor
92055028|NCT01846221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055029|NCT01846221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055030|NCT01846221|Analgesics|analgesics|mesh-ancestor
92055031|NCT01846221|Sensory System Agents|sensory system agents|mesh-ancestor
92055032|NCT01846221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055033|NCT01846221|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92055034|NCT01846221|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92055035|NCT01846221|Anesthetics, General|anesthetics, general|mesh-ancestor
92055036|NCT01846221|Anesthetics|anesthetics|mesh-ancestor
92055037|NCT01846221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92055038|NCT01846221|Sympatholytics|sympatholytics|mesh-ancestor
92055039|NCT01846221|Autonomic Agents|autonomic agents|mesh-ancestor
92055040|NCT01846221|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92014937|NCT05170919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014938|NCT05170919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92014939|NCT05170919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92014940|NCT05170919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92014941|NCT05170919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014942|NCT05170919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92014943|NCT05170919|Serotonin Agents|serotonin agents|mesh-ancestor
92014944|NCT05170919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92055041|NCT01846221|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92055042|NCT01846221|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92055043|NCT01846221|Adrenergic Agents|adrenergic agents|mesh-ancestor
92055044|NCT01846221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055045|NCT01846221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055046|NCT01845831|Metformin|metformin|mesh-list
92055047|NCT01845831|Insulin Glargine|insulin glargine|mesh-list
92055048|NCT01845831|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92055049|NCT01845831|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055050|NCT01845831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055051|NCT01845831|Incretins|incretins|mesh-ancestor
92055052|NCT01845831|Hormones|hormones|mesh-ancestor
92055053|NCT01845831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055054|NCT01845831|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92055055|NCT01845831|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055056|NCT01845831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055057|NCT01845831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055058|NCT01844895|Abatacept|abatacept|mesh-list
92055059|NCT01844895|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92055060|NCT01844895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055064|NCT01844895|Immunologic Factors|immunologic factors|mesh-ancestor
92055065|NCT01844895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055066|NCT01844895|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055067|NCT02116361|Botulinum Toxins|botulinum toxins|mesh-list
92055068|NCT02116361|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92055069|NCT02116361|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92055070|NCT02116361|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92055071|NCT02116361|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055072|NCT02116361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055073|NCT02116361|Cholinergic Agents|cholinergic agents|mesh-ancestor
92055074|NCT02116361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055075|NCT02116361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055076|NCT02116361|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92055077|NCT02116361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055078|NCT04594239|Lidocaine|lidocaine|mesh-list
92055079|NCT04594239|Hyaluronic Acid|hyaluronic acid|mesh-list
92055080|NCT04594239|Anesthetics, Local|anesthetics, local|mesh-ancestor
92055081|NCT04594239|Anesthetics|anesthetics|mesh-ancestor
92055082|NCT04594239|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055083|NCT04594239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055084|NCT04594239|Sensory System Agents|sensory system agents|mesh-ancestor
92055085|NCT04594239|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055086|NCT04594239|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92055087|NCT04594239|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92055088|NCT04594239|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92055089|NCT04594239|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055090|NCT04594239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055091|NCT04594239|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92055092|NCT04594239|Immunologic Factors|immunologic factors|mesh-ancestor
92055093|NCT04594239|Viscosupplements|viscosupplements|mesh-ancestor
92055094|NCT04594239|Protective Agents|protective agents|mesh-ancestor
92055095|NCT04585737|Tenofovir|tenofovir|mesh-list
92055096|NCT04585737|Lamivudine|lamivudine|mesh-list
92055097|NCT04585737|Emtricitabine|emtricitabine|mesh-list
92055098|NCT04585737|Dolutegravir|dolutegravir|mesh-list
92014945|NCT05170919|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92014946|NCT05170919|Histamine Antagonists|histamine antagonists|mesh-ancestor
92055099|NCT04585737|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92055100|NCT04585737|Antiviral Agents|antiviral agents|mesh-ancestor
92055101|NCT04585737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055102|NCT04585737|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92055103|NCT04585737|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92055104|NCT04585737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055105|NCT04585737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055106|NCT04585737|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92055107|NCT04585737|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92055108|NCT04585737|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92055109|NCT04585737|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92055110|NCT01814553|Afatinib|afatinib|mesh-list
92055111|NCT01814553|Loperamide|loperamide|mesh-list
92055112|NCT01814553|Antidiarrheals|antidiarrheals|mesh-list
92055113|NCT01814553|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055114|NCT01814553|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055115|NCT01814553|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055116|NCT01814553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055117|NCT01814553|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055118|NCT02116205|Vaccines|vaccines|mesh-list
92055119|NCT02116205|Immunologic Factors|immunologic factors|mesh-ancestor
92055120|NCT02116205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055121|NCT01844583|Rifampin|rifampin|mesh-list
92055122|NCT01844583|Esomeprazole|esomeprazole|mesh-list
92055123|NCT01844583|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92055124|NCT01844583|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055125|NCT01844583|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92055126|NCT01844583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055127|NCT01844583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055128|NCT01844583|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92055129|NCT01844583|Antitubercular Agents|antitubercular agents|mesh-ancestor
92055130|NCT01844583|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92055131|NCT01844583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055132|NCT01844583|Leprostatic Agents|leprostatic agents|mesh-ancestor
92055135|NCT01844583|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92055136|NCT01844583|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92055137|NCT01844583|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92055138|NCT01844583|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92055139|NCT01844583|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92055141|NCT04742075|Olaparib|olaparib|mesh-list
92055142|NCT04742075|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92055143|NCT04742075|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055144|NCT04742075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055145|NCT04742075|Immunologic Factors|immunologic factors|mesh-ancestor
92055146|NCT04742075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055147|NCT04742075|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92055148|NCT04742075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055149|NCT04742075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055150|NCT02115113|Everolimus|everolimus|mesh-list
92055151|NCT02115113|Tacrolimus|tacrolimus|mesh-list
92055152|NCT02115113|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055153|NCT02115113|Immunologic Factors|immunologic factors|mesh-ancestor
92055154|NCT02115113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055155|NCT02115113|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92055156|NCT02115113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055157|NCT02115113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055158|NCT02115113|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92055159|NCT02115113|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055160|NCT02115113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055161|NCT02114177|Sofosbuvir|sofosbuvir|mesh-list
92055162|NCT02114177|Simeprevir|simeprevir|mesh-list
92055163|NCT02114177|Antiviral Agents|antiviral agents|mesh-ancestor
92055164|NCT02114177|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055165|NCT02114177|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055166|NCT02114177|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055167|NCT02114177|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055168|NCT02138825|Riociguat|riociguat|mesh-list
92055169|NCT02138825|Enzyme Activators|enzyme activators|mesh-ancestor
92055170|NCT02138825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055171|NCT02138747|Mirabegron|mirabegron|mesh-list
92014947|NCT05170919|Histamine Agents|histamine agents|mesh-ancestor
92014948|NCT05170919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92014949|NCT05170919|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92014950|NCT05170919|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92055172|NCT02138747|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92055173|NCT02138747|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92055174|NCT02138747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92055175|NCT02138747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92055176|NCT02138747|Adrenergic Agents|adrenergic agents|mesh-ancestor
92055177|NCT02138747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055178|NCT02138747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055179|NCT02138747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055180|NCT02138747|Urological Agents|urological agents|mesh-ancestor
92055181|NCT02138747|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92055182|NCT02138747|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92055183|NCT02138747|Cholinergic Agents|cholinergic agents|mesh-ancestor
92055185|NCT02105285|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92055186|NCT02105285|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92055187|NCT02105285|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92055188|NCT02105285|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92055189|NCT02105285|Adrenergic Agents|adrenergic agents|mesh-ancestor
92055190|NCT02105285|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055191|NCT02105285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055192|NCT02105285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055193|NCT02105285|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92055194|NCT02105285|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92055195|NCT02105285|Sympatholytics|sympatholytics|mesh-ancestor
92055196|NCT02105285|Autonomic Agents|autonomic agents|mesh-ancestor
92055197|NCT02105285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055198|NCT01621490|Nivolumab|nivolumab|mesh-list
92055199|NCT01621490|Ipilimumab|ipilimumab|mesh-list
92055200|NCT01621490|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055201|NCT01621490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055202|NCT01621490|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92055203|NCT01621490|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055204|NCT02030041|Vitamin D|vitamin d|mesh-list
92055210|NCT02030041|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92055211|NCT02030041|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92055212|NCT02030041|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92055214|NCT02030041|Antimetabolites|antimetabolites|mesh-ancestor
92055215|NCT02030041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055216|NCT02030041|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92055217|NCT02030041|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92055218|NCT02030041|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055219|NCT01844505|Nivolumab|nivolumab|mesh-list
92055220|NCT01844505|Ipilimumab|ipilimumab|mesh-list
92055221|NCT01844505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055222|NCT01844505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055223|NCT01844505|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92055224|NCT01844505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055225|NCT01994720|Aspirin|aspirin|mesh-list
92055226|NCT01994720|Ticagrelor|ticagrelor|mesh-list
92055227|NCT01994720|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92055228|NCT01994720|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92055229|NCT01994720|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92055230|NCT01994720|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92055231|NCT01994720|Purinergic Agents|purinergic agents|mesh-ancestor
92055232|NCT01994720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055233|NCT01994720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055234|NCT01994720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055235|NCT01994720|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92055237|NCT01994720|Analgesics|analgesics|mesh-ancestor
92055238|NCT01994720|Sensory System Agents|sensory system agents|mesh-ancestor
92055239|NCT01994720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055240|NCT01994720|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055241|NCT01994720|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055242|NCT01994720|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92014951|NCT05170919|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92055243|NCT01994720|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92055244|NCT01994720|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92055245|NCT01994720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055246|NCT01994720|Antipyretics|antipyretics|mesh-ancestor
92055247|NCT01814397|Letrozole|letrozole|mesh-list
92055248|NCT01814397|Anastrozole|anastrozole|mesh-list
92055249|NCT01814397|Exemestane|exemestane|mesh-list
92055250|NCT01814397|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055251|NCT01814397|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92055252|NCT01814397|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92055253|NCT01814397|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055254|NCT01814397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055255|NCT01814397|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92055256|NCT01814397|Hormone Antagonists|hormone antagonists|mesh-ancestor
92055257|NCT01814397|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055258|NCT01814397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055259|NCT01814397|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92055260|NCT01844115|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92055261|NCT01844115|Antidepressive Agents|antidepressive agents|mesh-ancestor
92055262|NCT01844115|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92055263|NCT01844115|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92055264|NCT01844115|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92055265|NCT01844115|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055266|NCT01844115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055267|NCT01844115|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055268|NCT01844115|Serotonin Agents|serotonin agents|mesh-ancestor
92055269|NCT01844115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055270|NCT01844115|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92055271|NCT01844115|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92055272|NCT02018042|Abatacept|abatacept|mesh-list
92055283|NCT02017171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055285|NCT02017171|Gout Suppressants|gout suppressants|mesh-ancestor
92055286|NCT02017171|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055287|NCT02017171|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92055288|NCT02017171|Antioxidants|antioxidants|mesh-ancestor
92055289|NCT02017171|Protective Agents|protective agents|mesh-ancestor
92055290|NCT02017171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055291|NCT04686097|Sclerosing Solutions|sclerosing solutions|mesh-list
92055292|NCT04686097|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92055293|NCT02029417|Cytarabine|cytarabine|mesh-list
92055294|NCT02029417|Decitabine|decitabine|mesh-list
92055295|NCT02029417|Azacitidine|azacitidine|mesh-list
92055296|NCT02029417|Homoharringtonine|homoharringtonine|mesh-list
92055297|NCT02029417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92055298|NCT02029417|Antimetabolites|antimetabolites|mesh-ancestor
92055299|NCT02029417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055300|NCT02029417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055301|NCT02029417|Antiviral Agents|antiviral agents|mesh-ancestor
92055302|NCT02029417|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055303|NCT02029417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055304|NCT02029417|Immunologic Factors|immunologic factors|mesh-ancestor
92055305|NCT02029417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055306|NCT02029417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055307|NCT02029417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92055308|NCT02029417|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92055309|NCT02016716|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92055310|NCT02016716|Immunologic Factors|immunologic factors|mesh-ancestor
92055311|NCT02016716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055312|NCT04694846|Bupropion|bupropion|mesh-list
92055313|NCT04694846|Nicotine|nicotine|mesh-list
92055314|NCT04694846|Varenicline|varenicline|mesh-list
92055315|NCT04694846|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92055316|NCT04694846|Autonomic Agents|autonomic agents|mesh-ancestor
92055317|NCT04694846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055318|NCT04694846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055319|NCT04694846|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92055320|NCT04694846|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92055321|NCT04694846|Cholinergic Agents|cholinergic agents|mesh-ancestor
92055322|NCT04694846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055323|NCT04694846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055324|NCT04694846|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92055325|NCT04694846|Antidepressive Agents|antidepressive agents|mesh-ancestor
92055326|NCT04694846|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92014952|NCT05170919|Adrenergic Agents|adrenergic agents|mesh-ancestor
92014953|NCT05170919|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92055327|NCT04694846|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92055328|NCT04694846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92055329|NCT04694846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055330|NCT04694846|Dopamine Agents|dopamine agents|mesh-ancestor
92055331|NCT04694846|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92055332|NCT04694846|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92055333|NCT04694846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055334|NCT02050321|Vemurafenib|vemurafenib|mesh-list
92055335|NCT02050321|Acitretin|acitretin|mesh-list
92055339|NCT02050321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055341|NCT02050321|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055343|NCT02017015|Gemcitabine|gemcitabine|mesh-list
92055344|NCT02017015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92055345|NCT02017015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055346|NCT02017015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92055347|NCT02017015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92055348|NCT02017015|Mitosis Modulators|mitosis modulators|mesh-ancestor
92055349|NCT02017015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055350|NCT02017015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92055351|NCT02017015|Antimetabolites|antimetabolites|mesh-ancestor
92055352|NCT02016625|Cyclosporine|cyclosporine|mesh-list
92055353|NCT02016625|Tacrolimus|tacrolimus|mesh-list
92055354|NCT02016625|Cyclosporins|cyclosporins|mesh-list
92055355|NCT02016625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055356|NCT02016625|Immunologic Factors|immunologic factors|mesh-ancestor
92055357|NCT02016625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055358|NCT02016625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92055359|NCT02016625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055360|NCT02016625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055361|NCT02016625|Antifungal Agents|antifungal agents|mesh-ancestor
92055362|NCT02016625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055363|NCT02016625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055364|NCT02016625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055365|NCT02016482|Adalimumab|adalimumab|mesh-list
92055366|NCT02016482|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92055367|NCT02016482|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055368|NCT02016482|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055369|NCT02028871|Insulin|insulin|mesh-list
92055370|NCT02028871|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055371|NCT02028871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055372|NCT02028715|Acetaminophen|acetaminophen|mesh-list
92055373|NCT02028715|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92055374|NCT02028715|Analgesics|analgesics|mesh-ancestor
92055375|NCT02028715|Sensory System Agents|sensory system agents|mesh-ancestor
92055376|NCT02028715|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055377|NCT02028715|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055378|NCT02028715|Antipyretics|antipyretics|mesh-ancestor
92055379|NCT02016170|Ticagrelor|ticagrelor|mesh-list
92055380|NCT02016170|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92055381|NCT02016170|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92055382|NCT02016170|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92055383|NCT02016170|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92055384|NCT02016170|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92055385|NCT02016170|Purinergic Agents|purinergic agents|mesh-ancestor
92055386|NCT02016170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055387|NCT02016170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055388|NCT02016170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055389|NCT02015546|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92055390|NCT02015546|Antidepressive Agents|antidepressive agents|mesh-ancestor
92055391|NCT02015546|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92055392|NCT02015546|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92055393|NCT02015546|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92055394|NCT02015546|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055395|NCT02015546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055396|NCT02015546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055397|NCT02015546|Serotonin Agents|serotonin agents|mesh-ancestor
92055398|NCT02015546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055399|NCT02015546|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92014954|NCT05170919|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92014955|NCT05170919|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92055400|NCT02015546|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92055401|NCT02038790|Buprenorphine|buprenorphine|mesh-list
92055402|NCT02038790|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92055403|NCT02038790|Naloxone|naloxone|mesh-list
92055404|NCT02038790|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92055405|NCT02038790|Narcotics|narcotics|mesh-ancestor
92055406|NCT02038790|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055409|NCT02038790|Sensory System Agents|sensory system agents|mesh-ancestor
92055410|NCT02038790|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055411|NCT02038790|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92055412|NCT02027311|Midazolam|midazolam|mesh-list
92055413|NCT02027311|Meperidine|meperidine|mesh-list
92055414|NCT02027311|Etomidate|etomidate|mesh-list
92055415|NCT02027311|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92055416|NCT02027311|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92055417|NCT02027311|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055418|NCT02027311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055419|NCT02027311|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92055420|NCT02027311|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92055421|NCT02027311|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92055422|NCT02027311|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92055423|NCT02027311|Anesthetics, General|anesthetics, general|mesh-ancestor
92055424|NCT02027311|Anesthetics|anesthetics|mesh-ancestor
92055425|NCT02027311|GABA Modulators|gaba modulators|mesh-ancestor
92055426|NCT02027311|GABA Agents|gaba agents|mesh-ancestor
92055427|NCT02027311|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055428|NCT02027311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055429|NCT02027311|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92055430|NCT02027311|Narcotics|narcotics|mesh-ancestor
92055431|NCT02027311|Analgesics|analgesics|mesh-ancestor
92055432|NCT02027311|Sensory System Agents|sensory system agents|mesh-ancestor
92055433|NCT02027311|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055434|NCT02047903|Afatinib|afatinib|mesh-list
92055435|NCT02047903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055436|NCT02047903|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055437|NCT02047903|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055438|NCT02047903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055439|NCT02026141|Dexmedetomidine|dexmedetomidine|mesh-list
92055440|NCT02026141|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92055441|NCT02026141|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055442|NCT02026141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055443|NCT02026141|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92055444|NCT02026141|Analgesics|analgesics|mesh-ancestor
92055445|NCT02026141|Sensory System Agents|sensory system agents|mesh-ancestor
92055446|NCT02026141|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055447|NCT02026141|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92055448|NCT02026141|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92055449|NCT02026141|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92055450|NCT02026141|Adrenergic Agents|adrenergic agents|mesh-ancestor
92055451|NCT02026141|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055452|NCT02026141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055453|NCT02025907|Canagliflozin|canagliflozin|mesh-list
92055454|NCT02025907|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92055455|NCT02025907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055456|NCT02025907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055457|NCT02025907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055458|NCT02025751|Metoclopramide|metoclopramide|mesh-list
92055459|NCT02025751|Antiemetics|antiemetics|mesh-ancestor
92055460|NCT02025751|Autonomic Agents|autonomic agents|mesh-ancestor
92055461|NCT02025751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055462|NCT02025751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055463|NCT02025751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055464|NCT02025751|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92055465|NCT02025751|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92055466|NCT02025751|Dopamine Agents|dopamine agents|mesh-ancestor
92055467|NCT02025751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055468|NCT02025751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055469|NCT01812837|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92055470|NCT01812837|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92014957|NCT05613491|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92014958|NCT05613491|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92014959|NCT05613491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014960|NCT05151263|Salicylates|salicylates|mesh-list
92014961|NCT05151263|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92055471|NCT01812837|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055472|NCT02024971|Metformin|metformin|mesh-list
92055473|NCT02024971|Pioglitazone|pioglitazone|mesh-list
92055474|NCT02024971|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055475|NCT02024971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055476|NCT01843023|Naltrexone|naltrexone|mesh-list
92055477|NCT01843023|Buprenorphine|buprenorphine|mesh-list
92055478|NCT01843023|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92055479|NCT01843023|Narcotics|narcotics|mesh-ancestor
92055480|NCT01843023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055482|NCT01843023|Analgesics|analgesics|mesh-ancestor
92055483|NCT01843023|Sensory System Agents|sensory system agents|mesh-ancestor
92055484|NCT01843023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055485|NCT01843023|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92055486|NCT01843023|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92055487|NCT01812759|Fentanyl|fentanyl|mesh-list
92055488|NCT01812759|Hydromorphone|hydromorphone|mesh-list
92055489|NCT01812759|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92055490|NCT01812759|Narcotics|narcotics|mesh-ancestor
92055491|NCT01812759|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055492|NCT01812759|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055493|NCT01812759|Analgesics|analgesics|mesh-ancestor
92055494|NCT01812759|Sensory System Agents|sensory system agents|mesh-ancestor
92055495|NCT01812759|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055496|NCT01812759|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92055497|NCT01812759|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92055498|NCT01812759|Anesthetics, General|anesthetics, general|mesh-ancestor
92055499|NCT01812759|Anesthetics|anesthetics|mesh-ancestor
92055500|NCT01812057|Dexamethasone|dexamethasone|mesh-list
92055501|NCT01812057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055502|NCT01812057|Antiemetics|antiemetics|mesh-ancestor
92055503|NCT01812057|Autonomic Agents|autonomic agents|mesh-ancestor
92055504|NCT01812057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055505|NCT01812057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055506|NCT01812057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055507|NCT01812057|Glucocorticoids|glucocorticoids|mesh-ancestor
92055508|NCT01812057|Hormones|hormones|mesh-ancestor
92055509|NCT01812057|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055510|NCT01812057|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92055511|NCT01812057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055512|NCT01842633|Acetaminophen|acetaminophen|mesh-list
92055513|NCT01842633|Ibuprofen|ibuprofen|mesh-list
92055514|NCT01842633|Caffeine|caffeine|mesh-list
92055515|NCT01842633|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92055516|NCT01842633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92055517|NCT01842633|Analgesics|analgesics|mesh-ancestor
92055518|NCT01842633|Sensory System Agents|sensory system agents|mesh-ancestor
92055519|NCT01842633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055520|NCT01842633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055521|NCT01842633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055522|NCT01842633|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055523|NCT01842633|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92055524|NCT01842633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055525|NCT01842633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055526|NCT01842633|Antipyretics|antipyretics|mesh-ancestor
92055527|NCT01842633|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92055528|NCT01842633|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92055529|NCT01842633|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92055530|NCT01842633|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92055531|NCT01842633|Purinergic Agents|purinergic agents|mesh-ancestor
92055532|NCT01842633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055533|NCT01841697|Metformin|metformin|mesh-list
92055534|NCT01841697|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92055535|NCT01841697|Glimepiride|glimepiride|mesh-list
92055536|NCT01841697|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055537|NCT01841697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055538|NCT01841697|Incretins|incretins|mesh-ancestor
92055539|NCT01841697|Hormones|hormones|mesh-ancestor
92014962|NCT05151263|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92014963|NCT05151263|Analgesics|analgesics|mesh-ancestor
92055540|NCT01841697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055541|NCT01841697|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92055542|NCT01841697|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055543|NCT01841697|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055544|NCT01841697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055545|NCT01841697|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92055546|NCT01841697|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055547|NCT01841697|Immunologic Factors|immunologic factors|mesh-ancestor
92055548|NCT01809327|Metformin|metformin|mesh-list
92055549|NCT01809327|Canagliflozin|canagliflozin|mesh-list
92055550|NCT01809327|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055551|NCT01809327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055552|NCT01809327|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92055553|NCT01809327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055554|NCT03272139|Bupivacaine|bupivacaine|mesh-list
92055555|NCT03272139|Anesthetics, Local|anesthetics, local|mesh-ancestor
92055559|NCT03272139|Sensory System Agents|sensory system agents|mesh-ancestor
92055560|NCT03272139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055561|NCT01808313|Ambrisentan|ambrisentan|mesh-list
92055562|NCT01808313|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92055563|NCT01840605|Ketotifen|ketotifen|mesh-list
92055564|NCT01840605|Bepotastine besilate|bepotastine besilate|mesh-list
92055565|NCT01840605|Antipruritics|antipruritics|mesh-ancestor
92055566|NCT01840605|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055567|NCT01840605|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92055568|NCT01840605|Histamine Antagonists|histamine antagonists|mesh-ancestor
92055570|NCT01840605|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055571|NCT01840605|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055572|NCT01840605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055573|NCT01840605|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92055574|NCT02023879|Alirocumab|alirocumab|mesh-list
92055575|NCT02023879|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92055576|NCT02023879|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92055577|NCT02023879|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92055578|NCT02023879|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92055579|NCT02023879|Antimetabolites|antimetabolites|mesh-ancestor
92055580|NCT02023879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055581|NCT02023879|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92055582|NCT02023879|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055583|NCT02023879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055584|NCT02023879|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92055585|NCT02023879|Immunologic Factors|immunologic factors|mesh-ancestor
92055586|NCT02023879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055587|NCT02014441|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92055588|NCT02014441|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055589|NCT02014441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055590|NCT02013817|Cyclophosphamide|cyclophosphamide|mesh-list
92055591|NCT02013817|Rituximab|rituximab|mesh-list
92055592|NCT02013817|Fludarabine|fludarabine|mesh-list
92055593|NCT02013817|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055594|NCT02013817|Immunologic Factors|immunologic factors|mesh-ancestor
92055595|NCT02013817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055596|NCT02013817|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055597|NCT02013817|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92055598|NCT02013817|Alkylating Agents|alkylating agents|mesh-ancestor
92055599|NCT02013817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055600|NCT02013817|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055601|NCT02013817|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92055602|NCT02013817|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055604|NCT02023099|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92055605|NCT02023099|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92055606|NCT02023099|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055607|NCT02023099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055608|NCT02023099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055609|NCT02023099|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92055610|NCT02023099|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92055611|NCT02023099|Antiviral Agents|antiviral agents|mesh-ancestor
92055612|NCT02023099|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014964|NCT05151263|Sensory System Agents|sensory system agents|mesh-ancestor
92014965|NCT05151263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055613|NCT02023099|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92055614|NCT02023099|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92055615|NCT02013037|Eculizumab|eculizumab|mesh-list
92055616|NCT02013037|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92055617|NCT02013037|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055618|NCT02013037|Immunologic Factors|immunologic factors|mesh-ancestor
92055619|NCT02013037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055620|NCT04416607|Menotropins|menotropins|mesh-list
92055621|NCT04416607|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92055622|NCT04416607|Fertility Agents|fertility agents|mesh-ancestor
92055623|NCT04416607|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92055624|NCT04416607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055625|NCT01967173|Fluticasone|fluticasone|mesh-list
92055626|NCT01967173|Xhance|xhance|mesh-list
92055627|NCT01967173|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92055628|NCT01967173|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92055633|NCT01967173|Respiratory System Agents|respiratory system agents|mesh-ancestor
92055634|NCT01967173|Glucocorticoids|glucocorticoids|mesh-ancestor
92055635|NCT01967173|Hormones|hormones|mesh-ancestor
92055636|NCT01967173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055637|NCT01967173|Sympathomimetics|sympathomimetics|mesh-ancestor
92055638|NCT01967173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055639|NCT01967173|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055640|NCT01967173|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92055641|NCT01993927|Voglibose|voglibose|mesh-list
92055642|NCT01993927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055643|NCT01993927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055644|NCT01993927|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92055645|NCT01993927|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055646|NCT01993927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055647|NCT02012959|Tolvaptan|tolvaptan|mesh-list
92055648|NCT02012959|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92055649|NCT02012959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055650|NCT02012959|Natriuretic Agents|natriuretic agents|mesh-ancestor
92055651|NCT02012959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055652|NCT02012491|Misoprostol|misoprostol|mesh-list
92055653|NCT02012491|Mifepristone|mifepristone|mesh-list
92055654|NCT02012491|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92055655|NCT02012491|Abortifacient Agents|abortifacient agents|mesh-ancestor
92055656|NCT02012491|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92055657|NCT02012491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055658|NCT02012491|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92055659|NCT02012491|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055660|NCT02012491|Oxytocics|oxytocics|mesh-ancestor
92055661|NCT02012491|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92055662|NCT02012491|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92055663|NCT02012491|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92055664|NCT02012491|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92055665|NCT02012491|Contraceptive Agents|contraceptive agents|mesh-ancestor
92055666|NCT02012491|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92055667|NCT02012491|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92055668|NCT02012491|Hormone Antagonists|hormone antagonists|mesh-ancestor
92055669|NCT02012491|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055670|NCT02012491|Luteolytic Agents|luteolytic agents|mesh-ancestor
92055671|NCT02012491|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92055672|NCT02012491|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92055673|NCT02038010|Trastuzumab|trastuzumab|mesh-list
92055674|NCT02038010|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92055675|NCT02038010|Maytansine|maytansine|mesh-list
92055676|NCT02038010|Immunoconjugates|immunoconjugates|mesh-list
92055677|NCT02038010|Phosphoinositide-3 Kinase Inhibitors|phosphoinositide-3 kinase inhibitors|mesh-list
92055678|NCT02038010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055679|NCT02038010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055680|NCT02038010|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92055681|NCT02038010|Tubulin Modulators|tubulin modulators|mesh-ancestor
92055682|NCT02038010|Antimitotic Agents|antimitotic agents|mesh-ancestor
92055683|NCT02038010|Mitosis Modulators|mitosis modulators|mesh-ancestor
92014967|NCT05151263|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92014968|NCT05151263|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055684|NCT02038010|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055685|NCT02038010|Immunotoxins|immunotoxins|mesh-ancestor
92055686|NCT02038010|Immunologic Factors|immunologic factors|mesh-ancestor
92055687|NCT02038010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055688|NCT02038010|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055689|NCT04678154|Vancomycin|vancomycin|mesh-list
92055690|NCT04678154|Tobramycin|tobramycin|mesh-list
92055691|NCT04678154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92055692|NCT04678154|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055693|NCT04178798|Acalabrutinib|acalabrutinib|mesh-list
92055694|NCT04178798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055695|NCT01989572|Sargramostim|sargramostim|mesh-list
92055696|NCT01989572|Immunologic Factors|immunologic factors|mesh-ancestor
92055697|NCT01989572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055700|NCT01988402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055702|NCT01988402|Gout Suppressants|gout suppressants|mesh-ancestor
92055703|NCT01988402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055704|NCT01988402|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92055705|NCT01988402|Antioxidants|antioxidants|mesh-ancestor
92055706|NCT01988402|Protective Agents|protective agents|mesh-ancestor
92055707|NCT01988402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055708|NCT01988090|Vitamin D|vitamin d|mesh-list
92055709|NCT01988090|Ergocalciferols|ergocalciferols|mesh-list
92055710|NCT01988090|Cholecalciferol|cholecalciferol|mesh-list
92055711|NCT01988090|Vitamins|vitamins|mesh-list
92055712|NCT01988090|Micronutrients|micronutrients|mesh-ancestor
92055713|NCT01988090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055714|NCT01988090|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92055715|NCT01988090|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92055716|NCT02011945|Nivolumab|nivolumab|mesh-list
92055717|NCT02011945|Dasatinib|dasatinib|mesh-list
92055718|NCT02011945|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055719|NCT02011945|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055720|NCT02011945|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92055721|NCT02011945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055722|NCT02011945|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055723|NCT02011945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055724|NCT02013830|Bevacizumab|bevacizumab|mesh-list
92055725|NCT02013830|Capecitabine|capecitabine|mesh-list
92055726|NCT02013830|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055727|NCT02013830|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055728|NCT02013830|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92055729|NCT02013830|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92055730|NCT02013830|Growth Substances|growth substances|mesh-ancestor
92055731|NCT02013830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055732|NCT02013830|Growth Inhibitors|growth inhibitors|mesh-ancestor
92055733|NCT02013830|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92055734|NCT02013830|Antimetabolites|antimetabolites|mesh-ancestor
92055735|NCT02013830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055736|NCT02010775|Botulinum Toxins|botulinum toxins|mesh-list
92055737|NCT02010775|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92055738|NCT02010775|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92055739|NCT02010775|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92055740|NCT02010775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055741|NCT02010775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055742|NCT02010775|Cholinergic Agents|cholinergic agents|mesh-ancestor
92055743|NCT02010775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055744|NCT02010775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055745|NCT02010775|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92055746|NCT02010775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055747|NCT01619059|Metformin|metformin|mesh-list
92055748|NCT01619059|Dapagliflozin|dapagliflozin|mesh-list
92055749|NCT01619059|Saxagliptin|saxagliptin|mesh-list
92055750|NCT01619059|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055751|NCT01619059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055752|NCT01619059|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92014969|NCT05151263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014970|NCT05151263|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92014971|NCT05151263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014972|NCT04788407|Nitazoxanide|nitazoxanide|mesh-list
92014973|NCT04788407|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92055753|NCT01619059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055754|NCT01619059|Incretins|incretins|mesh-ancestor
92055755|NCT01619059|Hormones|hormones|mesh-ancestor
92055756|NCT01619059|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055757|NCT01619059|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92055758|NCT01619059|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055759|NCT01619059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055760|NCT04691804|Prednisone|prednisone|mesh-list
92055761|NCT04691804|Abiraterone Acetate|abiraterone acetate|mesh-list
92055762|NCT04691804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055763|NCT04691804|Glucocorticoids|glucocorticoids|mesh-ancestor
92055764|NCT04691804|Hormones|hormones|mesh-ancestor
92055765|NCT04691804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055766|NCT04691804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055767|NCT04691804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92055768|NCT04691804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055770|NCT04691804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055771|NCT04691804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055772|NCT04691804|Hormone Antagonists|hormone antagonists|mesh-ancestor
92055773|NCT04691804|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92055774|NCT02013206|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92055775|NCT02013206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055776|NCT02013206|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055777|NCT02013206|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055778|NCT02013206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055779|NCT01807923|Ivacaftor|ivacaftor|mesh-list
92055780|NCT01807923|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92055781|NCT01807923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92055782|NCT01807923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055783|NCT01966003|Paclitaxel|paclitaxel|mesh-list
92055784|NCT01966003|Bevacizumab|bevacizumab|mesh-list
92055785|NCT01966003|Carboplatin|carboplatin|mesh-list
92055786|NCT01966003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92055787|NCT01966003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055788|NCT01966003|Tubulin Modulators|tubulin modulators|mesh-ancestor
92055789|NCT01966003|Antimitotic Agents|antimitotic agents|mesh-ancestor
92055790|NCT01966003|Mitosis Modulators|mitosis modulators|mesh-ancestor
92055791|NCT01966003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055792|NCT01966003|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055793|NCT01966003|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92055794|NCT01966003|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92055795|NCT01966003|Growth Substances|growth substances|mesh-ancestor
92055796|NCT01966003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055797|NCT01966003|Growth Inhibitors|growth inhibitors|mesh-ancestor
92055798|NCT01839279|Moxifloxacin|moxifloxacin|mesh-list
92055800|NCT01839279|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92055801|NCT01839279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055802|NCT01839279|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92055803|NCT01839279|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92055804|NCT01839279|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055805|NCT01839279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055806|NCT01839279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055807|NCT01839279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055808|NCT01839279|Analgesics|analgesics|mesh-ancestor
92055809|NCT01839279|Sensory System Agents|sensory system agents|mesh-ancestor
92055810|NCT01839279|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055811|NCT01839279|Anticonvulsants|anticonvulsants|mesh-ancestor
92055812|NCT01839279|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92055813|NCT01839279|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92055814|NCT01839279|Parasympatholytics|parasympatholytics|mesh-ancestor
92055815|NCT01839279|Autonomic Agents|autonomic agents|mesh-ancestor
92055816|NCT01839279|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92014974|NCT04788407|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92014975|NCT03066427|Sunitinib|sunitinib|mesh-list
92055817|NCT01839279|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92055818|NCT01839279|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92055819|NCT01839279|Adrenergic Agents|adrenergic agents|mesh-ancestor
92055820|NCT01839279|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055821|NCT01965535|Sofosbuvir|sofosbuvir|mesh-list
92055822|NCT01965535|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92055823|NCT01965535|Ledipasvir|ledipasvir|mesh-list
92055824|NCT01965535|Antiviral Agents|antiviral agents|mesh-ancestor
92055825|NCT01965535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055826|NCT01964755|Leucovorin|leucovorin|mesh-list
92055827|NCT01964755|Tetrahydrofolates|tetrahydrofolates|mesh-list
92055828|NCT01964755|Formyltetrahydrofolates|formyltetrahydrofolates|mesh-list
92055829|NCT01964755|Zidovudine|zidovudine|mesh-list
92055830|NCT01964755|Rituximab|rituximab|mesh-list
92055831|NCT01964755|Doxorubicin|doxorubicin|mesh-list
92055832|NCT01964755|Methotrexate|methotrexate|mesh-list
92055833|NCT01964755|Hydroxyurea|hydroxyurea|mesh-list
92055834|NCT01964755|Levoleucovorin|levoleucovorin|mesh-list
92055835|NCT01964755|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055836|NCT01964755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055837|NCT01964755|Immunologic Factors|immunologic factors|mesh-ancestor
92055838|NCT01964755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055839|NCT01964755|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055840|NCT01964755|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92055841|NCT01964755|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92055842|NCT01964755|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92055843|NCT01964755|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055845|NCT01964755|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92055846|NCT01964755|Abortifacient Agents|abortifacient agents|mesh-ancestor
92055847|NCT01964755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92055848|NCT01964755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92055849|NCT01964755|Antimetabolites|antimetabolites|mesh-ancestor
92055850|NCT01964755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055851|NCT01964755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92055852|NCT01964755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055853|NCT01964755|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92055854|NCT01964755|Antidotes|antidotes|mesh-ancestor
92055855|NCT01964755|Protective Agents|protective agents|mesh-ancestor
92055856|NCT01964755|Vitamin B Complex|vitamin b complex|mesh-ancestor
92055857|NCT01964755|Vitamins|vitamins|mesh-ancestor
92055858|NCT01964755|Micronutrients|micronutrients|mesh-ancestor
92055859|NCT01964755|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92055860|NCT01964755|Antiviral Agents|antiviral agents|mesh-ancestor
92055861|NCT01964755|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055862|NCT01964755|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92055863|NCT01964755|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92055864|NCT01964755|Antisickling Agents|antisickling agents|mesh-ancestor
92055865|NCT01991743|Bupivacaine|bupivacaine|mesh-list
92055866|NCT01991743|Anesthetics, Local|anesthetics, local|mesh-ancestor
92055867|NCT01991743|Anesthetics|anesthetics|mesh-ancestor
92055868|NCT01991743|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055869|NCT01991743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055870|NCT01991743|Sensory System Agents|sensory system agents|mesh-ancestor
92055871|NCT01991743|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055872|NCT01991197|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92055874|NCT01991197|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92055875|NCT01991197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055876|NCT01991197|Incretins|incretins|mesh-ancestor
92055877|NCT01991197|Hormones|hormones|mesh-ancestor
92055878|NCT01991197|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92055879|NCT01991197|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92055880|NCT01991197|Protease Inhibitors|protease inhibitors|mesh-ancestor
92055881|NCT01991197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055882|NCT01991197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055883|NCT01990573|Methadone|methadone|mesh-list
92055884|NCT01990573|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92055885|NCT01990573|Narcotics|narcotics|mesh-ancestor
92055886|NCT01990573|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055887|NCT01990573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055888|NCT01990573|Analgesics|analgesics|mesh-ancestor
92055889|NCT01990573|Sensory System Agents|sensory system agents|mesh-ancestor
92055890|NCT01990573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055891|NCT01990573|Antitussive Agents|antitussive agents|mesh-ancestor
92055892|NCT01990573|Respiratory System Agents|respiratory system agents|mesh-ancestor
92014977|NCT03066427|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92014978|NCT03066427|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92055893|NCT01990339|Lansoprazole|lansoprazole|mesh-list
92055894|NCT01990339|Dexlansoprazole|dexlansoprazole|mesh-list
92055895|NCT01990339|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92055896|NCT01990339|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92055897|NCT01990339|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92055898|NCT01990339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055899|NCT01990339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055900|NCT02007577|Salicylsalicylic acid|salicylsalicylic acid|mesh-list
92055901|NCT02007577|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92055902|NCT02007577|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92055903|NCT02007577|Analgesics|analgesics|mesh-ancestor
92055904|NCT02007577|Sensory System Agents|sensory system agents|mesh-ancestor
92055905|NCT02007577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055906|NCT02007577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055907|NCT02007577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055908|NCT02007577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055909|NCT01990261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92055910|NCT01990261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055911|NCT01990261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055912|NCT01990261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055913|NCT01990261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055914|NCT01962493|Chlorhexidine|chlorhexidine|mesh-list
92055915|NCT01962493|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92055916|NCT01962493|Listerine|listerine|mesh-list
92055917|NCT01962493|Fluorides|fluorides|mesh-list
92055918|NCT01962493|Sodium Fluoride|sodium fluoride|mesh-list
92055921|NCT01962493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055923|NCT01962493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055924|NCT01962493|Disinfectants|disinfectants|mesh-ancestor
92055925|NCT01962493|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055926|NCT01989169|Midazolam|midazolam|mesh-list
92055927|NCT01989169|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92055928|NCT01989169|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92055929|NCT01989169|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055930|NCT01989169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055931|NCT01989169|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92055932|NCT01989169|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92055933|NCT01989169|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92055934|NCT01989169|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92055935|NCT01989169|Anesthetics, General|anesthetics, general|mesh-ancestor
92055936|NCT01989169|Anesthetics|anesthetics|mesh-ancestor
92055937|NCT01989169|GABA Modulators|gaba modulators|mesh-ancestor
92055938|NCT01989169|GABA Agents|gaba agents|mesh-ancestor
92055939|NCT01989169|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055940|NCT01989169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055941|NCT01988779|Levofloxacin|levofloxacin|mesh-list
92055942|NCT01988779|Ofloxacin|ofloxacin|mesh-list
92055943|NCT01988779|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92055944|NCT01988779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92055945|NCT01988779|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92055946|NCT01988779|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92055947|NCT01988779|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92055948|NCT01988779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055949|NCT01988779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055950|NCT01988779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055951|NCT01988779|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92055952|NCT01988779|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92055953|NCT01987765|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92055954|NCT01987765|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92055955|NCT01987232|Carboplatin|carboplatin|mesh-list
92055956|NCT01987232|Etoposide|etoposide|mesh-list
92055957|NCT01987232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055958|NCT01987232|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92055959|NCT01987232|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92055960|NCT01987232|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92055961|NCT01987232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055962|NCT01987232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055963|NCT04676204|Teriflunomide|teriflunomide|mesh-list
92055964|NCT04676204|Cladribine|cladribine|mesh-list
92055965|NCT04676204|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92055967|NCT04676204|Ozanimod|ozanimod|mesh-list
92055968|NCT04676204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055969|NCT04676204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055970|NCT04676204|Immunologic Factors|immunologic factors|mesh-ancestor
92055971|NCT04676204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055972|NCT04676204|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92055973|NCT04676204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055974|NCT04676204|Dermatologic Agents|dermatologic agents|mesh-ancestor
92055975|NCT04676204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92055976|NCT04676204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92055977|NCT04676204|Analgesics|analgesics|mesh-ancestor
92055978|NCT04676204|Sensory System Agents|sensory system agents|mesh-ancestor
92055979|NCT04676204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055980|NCT04676204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92055981|NCT04676204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055982|NCT02010632|Clopidogrel|clopidogrel|mesh-list
92055983|NCT02010632|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92055984|NCT02010632|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92055985|NCT02010632|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92055986|NCT02010632|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92055987|NCT02010632|Purinergic Agents|purinergic agents|mesh-ancestor
92055988|NCT02010632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055989|NCT02010632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055991|NCT01986062|Amphetamine|amphetamine|mesh-list
92055992|NCT01986062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92055993|NCT01986062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055994|NCT01986062|Sympathomimetics|sympathomimetics|mesh-ancestor
92055995|NCT01986062|Autonomic Agents|autonomic agents|mesh-ancestor
92055996|NCT01986062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055997|NCT01986062|Dopamine Agents|dopamine agents|mesh-ancestor
92055998|NCT01986062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92055999|NCT01986062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056000|NCT01986062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056001|NCT01986062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92056002|NCT01986062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92056003|NCT01986062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056004|NCT01986062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92056005|NCT01985126|Acetaminophen|acetaminophen|mesh-list
92056006|NCT01985126|Diphenhydramine|diphenhydramine|mesh-list
92056007|NCT01985126|Promethazine|promethazine|mesh-list
92056008|NCT01985126|Methylprednisolone|methylprednisolone|mesh-list
92056009|NCT01985126|Daratumumab|daratumumab|mesh-list
92056010|NCT01985126|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92056011|NCT01985126|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92056012|NCT01985126|Analgesics|analgesics|mesh-ancestor
92056013|NCT01985126|Sensory System Agents|sensory system agents|mesh-ancestor
92056014|NCT01985126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056015|NCT01985126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056016|NCT01985126|Antipyretics|antipyretics|mesh-ancestor
92056017|NCT01985126|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056018|NCT01985126|Antiemetics|antiemetics|mesh-ancestor
92056019|NCT01985126|Autonomic Agents|autonomic agents|mesh-ancestor
92056020|NCT01985126|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056021|NCT01985126|Glucocorticoids|glucocorticoids|mesh-ancestor
92056022|NCT01985126|Hormones|hormones|mesh-ancestor
92056023|NCT01985126|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056024|NCT01985126|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92056025|NCT01985126|Protective Agents|protective agents|mesh-ancestor
92056026|NCT01985126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056027|NCT01985126|Immunologic Factors|immunologic factors|mesh-ancestor
92056028|NCT01985126|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92056029|NCT01985126|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92056030|NCT01985126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056031|NCT01985126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92056032|NCT01985126|Anesthetics|anesthetics|mesh-ancestor
92056033|NCT01985126|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92056034|NCT01985126|Histamine Antagonists|histamine antagonists|mesh-ancestor
92056035|NCT01985126|Histamine Agents|histamine agents|mesh-ancestor
92056036|NCT01985126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056037|NCT01985126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056038|NCT01985126|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92056039|NCT01985126|Antipruritics|antipruritics|mesh-ancestor
92056040|NCT01985126|Dermatologic Agents|dermatologic agents|mesh-ancestor
92014980|NCT03066427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92014981|NCT03066427|Growth Inhibitors|growth inhibitors|mesh-ancestor
92014982|NCT03066427|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92014983|NCT03066427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056041|NCT01984892|Poly ICLC|poly iclc|mesh-list
92056042|NCT01984892|Interferon Inducers|interferon inducers|mesh-ancestor
92056043|NCT01984892|Immunologic Factors|immunologic factors|mesh-ancestor
92056044|NCT01984892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056045|NCT01807221|Eplerenone|eplerenone|mesh-list
92056046|NCT01807221|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92056047|NCT01807221|Hormone Antagonists|hormone antagonists|mesh-ancestor
92056048|NCT01807221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056049|NCT01807221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056050|NCT01807221|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92056051|NCT01807221|Diuretics|diuretics|mesh-ancestor
92056052|NCT01807221|Natriuretic Agents|natriuretic agents|mesh-ancestor
92056053|NCT01807221|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056054|NCT02031458|Atezolizumab|atezolizumab|mesh-list
92056055|NCT02031458|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92056056|NCT02031458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056057|NCT02031458|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056058|NCT02031458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056059|NCT01806597|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92056060|NCT01806597|Immunologic Factors|immunologic factors|mesh-ancestor
92056061|NCT01806597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056062|NCT01610037|Tiotropium Bromide|tiotropium bromide|mesh-list
92056063|NCT01610037|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056065|NCT01610037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056066|NCT01610037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056067|NCT01610037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056068|NCT01610037|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056069|NCT01610037|Parasympatholytics|parasympatholytics|mesh-ancestor
92056070|NCT01610037|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92056071|NCT01610037|Cholinergic Agents|cholinergic agents|mesh-ancestor
92056072|NCT01610037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056073|NCT01610037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056074|NCT04687514|Dulaglutide|dulaglutide|mesh-list
92056075|NCT04687514|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056076|NCT04687514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056077|NCT01837797|Brexpiprazole|brexpiprazole|mesh-list
92056078|NCT01837797|Serotonin Agents|serotonin agents|mesh-ancestor
92056079|NCT01837797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056080|NCT01837797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056081|NCT01837797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056082|NCT01837797|Dopamine Agonists|dopamine agonists|mesh-ancestor
92056083|NCT01837797|Dopamine Agents|dopamine agents|mesh-ancestor
92056084|NCT01984424|Atorvastatin|atorvastatin|mesh-list
92056085|NCT01984424|Ezetimibe|ezetimibe|mesh-list
92056086|NCT01984424|Evolocumab|evolocumab|mesh-list
92056087|NCT01984424|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92056088|NCT01984424|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92056089|NCT01984424|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92056090|NCT01984424|Antimetabolites|antimetabolites|mesh-ancestor
92081700|NCT01402947|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92056091|NCT01984424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056092|NCT01984424|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92056093|NCT01984424|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92056094|NCT01984424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056095|NCT01984424|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92056096|NCT01984424|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92056097|NCT01984424|Protease Inhibitors|protease inhibitors|mesh-ancestor
92056098|NCT01984424|Immunologic Factors|immunologic factors|mesh-ancestor
92056099|NCT01984424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056100|NCT01837719|Atazanavir Sulfate|atazanavir sulfate|mesh-list
92056101|NCT01837719|Cobicistat|cobicistat|mesh-list
92056102|NCT01837719|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92056103|NCT01837719|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92056104|NCT01837719|Protease Inhibitors|protease inhibitors|mesh-ancestor
92014984|NCT03066427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92014985|NCT05177133|Capecitabine|capecitabine|mesh-list
92014986|NCT05177133|Oxaliplatin|oxaliplatin|mesh-list
92014987|NCT05177133|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92056105|NCT01837719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056106|NCT01837719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056107|NCT01837719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92056108|NCT01837719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92056109|NCT01837719|Antiviral Agents|antiviral agents|mesh-ancestor
92056110|NCT01837719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056111|NCT01837719|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92056112|NCT01837719|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92056113|NCT01984268|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92056114|NCT01984268|Hormones|hormones|mesh-ancestor
92056115|NCT01984268|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056116|NCT01984268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056117|NCT02009384|Ipilimumab|ipilimumab|mesh-list
92056118|NCT02009384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056119|NCT02009384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056120|NCT02009384|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92056121|NCT02009384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056122|NCT01805037|Rituximab|rituximab|mesh-list
92056123|NCT01805037|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92056124|NCT01805037|Antibodies|antibodies|mesh-list
92056125|NCT01805037|Immunoglobulins|immunoglobulins|mesh-list
92056126|NCT01805037|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92056127|NCT01805037|Immunoconjugates|immunoconjugates|mesh-list
92056128|NCT01805037|Immunologic Factors|immunologic factors|mesh-ancestor
92056129|NCT01805037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056130|NCT01805037|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056131|NCT01805037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056132|NCT01805037|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056133|NCT01805037|Immunotoxins|immunotoxins|mesh-ancestor
92056134|NCT01803711|Desvenlafaxine Succinate|desvenlafaxine succinate|mesh-list
92056137|NCT01803711|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056138|NCT01803711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056140|NCT01803711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056141|NCT01803711|Antidepressive Agents|antidepressive agents|mesh-ancestor
92056142|NCT01803711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92056143|NCT01836549|Imetelstat|imetelstat|mesh-list
92056144|NCT01836549|Motesanib diphosphate|motesanib diphosphate|mesh-list
92056145|NCT01836549|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056146|NCT01836549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056147|NCT01836549|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92056148|NCT01836471|Fluticasone|fluticasone|mesh-list
92056150|NCT01836471|Indoleacetic Acids|indoleacetic acids|mesh-list
92056151|NCT01836471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056152|NCT01836471|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056153|NCT01836471|Autonomic Agents|autonomic agents|mesh-ancestor
92056154|NCT01836471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056155|NCT01836471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056156|NCT01836471|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056157|NCT01836471|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056158|NCT01836471|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056159|NCT01836471|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92056160|NCT01836471|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92056161|NCT01836471|Growth Substances|growth substances|mesh-ancestor
92056162|NCT02030600|Insulin|insulin|mesh-list
92056163|NCT02030600|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92056164|NCT02030600|Insulin Glargine|insulin glargine|mesh-list
92056165|NCT02030600|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056166|NCT02030600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056168|NCT01802775|Edoxaban|edoxaban|mesh-list
92056169|NCT01802775|Clopidogrel|clopidogrel|mesh-list
92056170|NCT01802775|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92056171|NCT01802775|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92056172|NCT01802775|Analgesics|analgesics|mesh-ancestor
92056173|NCT01802775|Sensory System Agents|sensory system agents|mesh-ancestor
92056174|NCT01802775|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014988|NCT05177133|Antimetabolites|antimetabolites|mesh-ancestor
92056175|NCT01802775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056176|NCT01802775|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056177|NCT01802775|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056178|NCT01802775|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92056179|NCT01802775|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92056180|NCT01802775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056181|NCT01802775|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92056182|NCT01802775|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92056183|NCT01802775|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056184|NCT01802775|Antipyretics|antipyretics|mesh-ancestor
92056185|NCT01802775|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92056186|NCT01802775|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92056187|NCT01802775|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92056188|NCT01802775|Purinergic Agents|purinergic agents|mesh-ancestor
92056189|NCT01802775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056190|NCT01802775|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92056191|NCT01802775|Antithrombins|antithrombins|mesh-ancestor
92056192|NCT01802775|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92056193|NCT01802775|Protease Inhibitors|protease inhibitors|mesh-ancestor
92056194|NCT01802775|Anticoagulants|anticoagulants|mesh-ancestor
92056195|NCT01802385|Sertraline|sertraline|mesh-list
92056196|NCT01802385|Antidepressive Agents|antidepressive agents|mesh-ancestor
92056197|NCT01802385|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92056198|NCT01802385|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92056199|NCT01802385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92056200|NCT01802385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056201|NCT01802385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056202|NCT01802385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056203|NCT01802385|Serotonin Agents|serotonin agents|mesh-ancestor
92056204|NCT01802385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056205|NCT01773993|Pregabalin|pregabalin|mesh-list
92056206|NCT01773993|Analgesics|analgesics|mesh-ancestor
92056209|NCT01773993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056210|NCT01773993|Anticonvulsants|anticonvulsants|mesh-ancestor
92056211|NCT01773993|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92056212|NCT01773993|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056213|NCT01773993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056214|NCT01773993|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92056215|NCT01773993|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92056216|NCT01773993|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92056217|NCT01773993|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056218|NCT01773993|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92056219|NCT01802073|Vancomycin|vancomycin|mesh-list
92056220|NCT01802073|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92056221|NCT01802073|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056222|NCT01607073|Verapamil|verapamil|mesh-list
92056223|NCT01607073|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92056224|NCT01607073|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92056225|NCT01607073|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056226|NCT01607073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056227|NCT01607073|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92056228|NCT01607073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056229|NCT01607073|Vasodilator Agents|vasodilator agents|mesh-ancestor
92056230|NCT01801917|Siponimod|siponimod|mesh-list
92056231|NCT01801917|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92056232|NCT01801917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056233|NCT01801917|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056234|NCT01801917|Immunologic Factors|immunologic factors|mesh-ancestor
92056235|NCT01801917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056236|NCT02008916|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92056237|NCT02008916|Immunologic Factors|immunologic factors|mesh-ancestor
92056238|NCT02008916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056240|NCT01772823|Emtricitabine|emtricitabine|mesh-list
92056241|NCT01772823|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92056242|NCT01772823|Antiviral Agents|antiviral agents|mesh-ancestor
92056243|NCT01772823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056244|NCT01772823|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92056245|NCT01772823|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92056246|NCT01772823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92014989|NCT05177133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056247|NCT01772823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056248|NCT01772823|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92056249|NCT01772823|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92056251|NCT04177082|Vitamin B Complex|vitamin b complex|mesh-ancestor
92056252|NCT04177082|Vitamins|vitamins|mesh-ancestor
92056253|NCT04177082|Micronutrients|micronutrients|mesh-ancestor
92056254|NCT04177082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056255|NCT04177082|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92056256|NCT04177082|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056257|NCT04177004|Sirolimus|sirolimus|mesh-list
92056258|NCT04177004|Cyclophosphamide|cyclophosphamide|mesh-list
92056259|NCT04177004|Etoposide|etoposide|mesh-list
92056260|NCT04177004|Etoposide phosphate|etoposide phosphate|mesh-list
92056261|NCT04177004|Podophyllotoxin|podophyllotoxin|mesh-list
92056262|NCT04177004|Tacrolimus|tacrolimus|mesh-list
92056263|NCT04177004|Mitogens|mitogens|mesh-list
92056264|NCT04177004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056265|NCT04177004|Immunologic Factors|immunologic factors|mesh-ancestor
92056266|NCT04177004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056267|NCT04177004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056268|NCT04177004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92056269|NCT04177004|Alkylating Agents|alkylating agents|mesh-ancestor
92056270|NCT04177004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056271|NCT04177004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056272|NCT04177004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92056273|NCT04177004|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92056274|NCT04177004|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92056275|NCT04177004|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92056276|NCT04177004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056277|NCT04177004|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92056278|NCT04177004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92056280|NCT04177004|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92056281|NCT04177004|Antifungal Agents|antifungal agents|mesh-ancestor
92056282|NCT04177004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92056283|NCT04177004|Keratolytic Agents|keratolytic agents|mesh-ancestor
92056284|NCT04177004|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056285|NCT04177004|Tubulin Modulators|tubulin modulators|mesh-ancestor
92056286|NCT04177004|Antimitotic Agents|antimitotic agents|mesh-ancestor
92056287|NCT01982942|Ibudilast|ibudilast|mesh-list
92056288|NCT01982942|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056289|NCT01982942|Autonomic Agents|autonomic agents|mesh-ancestor
92056290|NCT01982942|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056291|NCT01982942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056292|NCT01982942|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056293|NCT01982942|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056294|NCT01982942|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92056295|NCT01982942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056296|NCT01982942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056297|NCT01982942|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92056298|NCT01982942|Vasodilator Agents|vasodilator agents|mesh-ancestor
92056299|NCT01769469|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92056300|NCT01769469|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92056301|NCT01769469|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92056302|NCT01769469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056303|NCT01769469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056304|NCT01769469|Antiviral Agents|antiviral agents|mesh-ancestor
92056305|NCT01769469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056306|NCT01769469|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92056307|NCT01769469|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92056308|NCT01769391|Paclitaxel|paclitaxel|mesh-list
92056309|NCT01769391|Carboplatin|carboplatin|mesh-list
92056310|NCT01769391|Necitumumab|necitumumab|mesh-list
92056311|NCT01769391|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92056312|NCT01769391|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056313|NCT01769391|Tubulin Modulators|tubulin modulators|mesh-ancestor
92056314|NCT01769391|Antimitotic Agents|antimitotic agents|mesh-ancestor
92056315|NCT01769391|Mitosis Modulators|mitosis modulators|mesh-ancestor
92056316|NCT01769391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056317|NCT01769391|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92014990|NCT05177133|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92014991|NCT02866643|Contraceptive Agents|contraceptive agents|mesh-list
92014992|NCT02866643|Etonogestrel|etonogestrel|mesh-list
92014993|NCT02866643|Desogestrel|desogestrel|mesh-list
92014994|NCT02866643|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92056319|NCT01767987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92056320|NCT01767987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056321|NCT01767987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056322|NCT01767909|Insulin|insulin|mesh-list
92056323|NCT01767909|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92056324|NCT01767909|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056325|NCT01767909|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056327|NCT02029274|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92056328|NCT02029274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056329|NCT02029274|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056330|NCT02029274|Immunologic Factors|immunologic factors|mesh-ancestor
92056331|NCT02029274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056332|NCT02008370|Bupivacaine|bupivacaine|mesh-list
92056333|NCT02008370|Anesthetics, Local|anesthetics, local|mesh-ancestor
92056334|NCT02008370|Anesthetics|anesthetics|mesh-ancestor
92056335|NCT02008370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056336|NCT02008370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056337|NCT02008370|Sensory System Agents|sensory system agents|mesh-ancestor
92056338|NCT02008370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056339|NCT01981616|Vedolizumab|vedolizumab|mesh-list
92056340|NCT01981616|Vaccines|vaccines|mesh-list
92056341|NCT01981616|Immunologic Factors|immunologic factors|mesh-ancestor
92056342|NCT01981616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056343|NCT01981616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056344|NCT01962103|Paclitaxel|paclitaxel|mesh-list
92056345|NCT01962103|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92056346|NCT01962103|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92056347|NCT01962103|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056348|NCT01962103|Tubulin Modulators|tubulin modulators|mesh-ancestor
92056349|NCT01962103|Antimitotic Agents|antimitotic agents|mesh-ancestor
92056350|NCT01962103|Mitosis Modulators|mitosis modulators|mesh-ancestor
92056351|NCT01962103|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056352|NCT01961323|Nebivolol|nebivolol|mesh-list
92056354|NCT01961323|Vasodilator Agents|vasodilator agents|mesh-ancestor
92056355|NCT01961323|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92056356|NCT01961323|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92056357|NCT01961323|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92056358|NCT01961323|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056359|NCT01961323|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056360|NCT01961323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056361|NCT01961323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056362|NCT04186403|Brexpiprazole|brexpiprazole|mesh-list
92056363|NCT04186403|Serotonin Agents|serotonin agents|mesh-ancestor
92056364|NCT04186403|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056365|NCT04186403|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056366|NCT04186403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056367|NCT04186403|Dopamine Agonists|dopamine agonists|mesh-ancestor
92056368|NCT04186403|Dopamine Agents|dopamine agents|mesh-ancestor
92056369|NCT01960855|Upadacitinib|upadacitinib|mesh-list
92056370|NCT01960855|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92056371|NCT01960855|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92056372|NCT01960855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056373|NCT01960855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056374|NCT01960855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056375|NCT02007434|Loratadine|loratadine|mesh-list
92056376|NCT02007434|Ibuprofen|ibuprofen|mesh-list
92056377|NCT02007434|Lidocaine|lidocaine|mesh-list
92056378|NCT02007434|Epinephrine|epinephrine|mesh-list
92056379|NCT02007434|Deoxycholic Acid|deoxycholic acid|mesh-list
92056380|NCT02007434|Anesthetics, Local|anesthetics, local|mesh-ancestor
92056381|NCT02007434|Anesthetics|anesthetics|mesh-ancestor
92056382|NCT02007434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056383|NCT02007434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056384|NCT02007434|Sensory System Agents|sensory system agents|mesh-ancestor
92056385|NCT02007434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92014995|NCT02866643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056387|NCT02007434|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92056388|NCT02007434|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92056389|NCT02007434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056390|NCT02007434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056391|NCT02007434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92056392|NCT02007434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92056393|NCT02007434|Analgesics|analgesics|mesh-ancestor
92056394|NCT02007434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056395|NCT02007434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056396|NCT02007434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92056397|NCT02007434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056398|NCT02007434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92056399|NCT02007434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92056400|NCT02007434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056401|NCT02007434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056402|NCT02007434|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92056403|NCT02007434|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056404|NCT02007434|Autonomic Agents|autonomic agents|mesh-ancestor
92056405|NCT02007434|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056406|NCT02007434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056407|NCT02007434|Mydriatics|mydriatics|mesh-ancestor
92056408|NCT02007434|Sympathomimetics|sympathomimetics|mesh-ancestor
92056409|NCT02007434|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92056410|NCT02007434|Antipruritics|antipruritics|mesh-ancestor
92056411|NCT02007434|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056412|NCT02007434|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92056413|NCT02007434|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92056414|NCT02007434|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92056415|NCT02007434|Histamine Antagonists|histamine antagonists|mesh-ancestor
92056416|NCT02007434|Histamine Agents|histamine agents|mesh-ancestor
92056417|NCT02007434|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92056418|NCT02007434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056419|NCT01987453|Sofosbuvir|sofosbuvir|mesh-list
92056420|NCT01987453|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92056421|NCT01987453|Ledipasvir|ledipasvir|mesh-list
92056422|NCT01987453|Antiviral Agents|antiviral agents|mesh-ancestor
92056423|NCT01987453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056424|NCT02006641|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92056425|NCT02006641|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92056429|NCT02006641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056430|NCT01959919|Factor VIII|factor viii|mesh-list
92056431|NCT01959919|Coagulants|coagulants|mesh-ancestor
92056432|NCT01986907|Ranibizumab|ranibizumab|mesh-list
92056433|NCT01986907|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92056434|NCT01986907|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92056435|NCT01986907|Growth Substances|growth substances|mesh-ancestor
92056436|NCT01986907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056437|NCT01986907|Growth Inhibitors|growth inhibitors|mesh-ancestor
92056438|NCT01986907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056439|NCT01959841|Valacyclovir|valacyclovir|mesh-list
92056440|NCT01959841|Antiviral Agents|antiviral agents|mesh-ancestor
92056441|NCT01959841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056442|NCT02005627|Immunomodulating Agents|immunomodulating agents|mesh-list
92056443|NCT02005627|Immunologic Factors|immunologic factors|mesh-list
92056444|NCT02005627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056445|NCT02073929|Liraglutide|liraglutide|mesh-list
92056446|NCT02073929|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056447|NCT02073929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056448|NCT02073929|Incretins|incretins|mesh-ancestor
92056449|NCT02073929|Hormones|hormones|mesh-ancestor
92056450|NCT02073929|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056451|NCT02113007|Rituximab|rituximab|mesh-list
92056452|NCT02113007|Temozolomide|temozolomide|mesh-list
92056453|NCT02113007|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056454|NCT02113007|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056455|NCT02113007|Immunologic Factors|immunologic factors|mesh-ancestor
92056456|NCT02113007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056457|NCT02113007|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056458|NCT02113007|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92056459|NCT02113007|Alkylating Agents|alkylating agents|mesh-ancestor
92014996|NCT02866643|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92014997|NCT02866643|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92014998|NCT02866643|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92014999|NCT02866643|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92056460|NCT02113007|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056461|NCT02005471|Rituximab|rituximab|mesh-list
92056462|NCT02005471|Venetoclax|venetoclax|mesh-list
92056463|NCT02005471|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92056464|NCT02005471|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056465|NCT02005471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056466|NCT02005471|Immunologic Factors|immunologic factors|mesh-ancestor
92056467|NCT02005471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056468|NCT02005471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056469|NCT02005471|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92056470|NCT02005471|Alkylating Agents|alkylating agents|mesh-ancestor
92056471|NCT02005471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056472|NCT02104505|Tocopherols|tocopherols|mesh-list
92056473|NCT02104505|Vitamin E|vitamin e|mesh-list
92056474|NCT02104505|Tocotrienols|tocotrienols|mesh-list
92056475|NCT02104505|alpha-Tocopherol|alpha-tocopherol|mesh-list
92056476|NCT02104505|gamma-Tocopherol|gamma-tocopherol|mesh-list
92056477|NCT02104505|Antioxidants|antioxidants|mesh-ancestor
92056478|NCT02104505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056479|NCT02104505|Protective Agents|protective agents|mesh-ancestor
92056480|NCT02104505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056481|NCT02104505|Vitamins|vitamins|mesh-ancestor
92056482|NCT02104505|Micronutrients|micronutrients|mesh-ancestor
92056483|NCT02111603|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92056484|NCT02111603|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92056485|NCT02111603|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92056486|NCT02111603|Antimetabolites|antimetabolites|mesh-ancestor
92056487|NCT02111603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056488|NCT02111603|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92056489|NCT02111369|Propranolol|propranolol|mesh-list
92056490|NCT02111369|Botulinum Toxins|botulinum toxins|mesh-list
92056491|NCT02111369|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92056492|NCT02111369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056493|NCT02111369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056494|NCT02111369|Cholinergic Agents|cholinergic agents|mesh-ancestor
92056495|NCT02111369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056496|NCT02111369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056497|NCT02111369|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92056518|NCT02069093|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92056519|NCT02069093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056520|NCT02069093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056521|NCT02069093|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056522|NCT02069093|Immunologic Factors|immunologic factors|mesh-ancestor
92056523|NCT02069093|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92056524|NCT02069093|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92056525|NCT02069093|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92056526|NCT02069093|Hormone Antagonists|hormone antagonists|mesh-ancestor
92056528|NCT02109029|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92056529|NCT02109029|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056530|NCT02109029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056531|NCT02007278|Metformin|metformin|mesh-list
92056532|NCT02007278|Glimepiride|glimepiride|mesh-list
92056533|NCT02007278|Vildagliptin|vildagliptin|mesh-list
92056534|NCT02007278|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056535|NCT02007278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056536|NCT02007278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92056537|NCT02007278|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056538|NCT02007278|Immunologic Factors|immunologic factors|mesh-ancestor
92056539|NCT02007278|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92056540|NCT02007278|Protease Inhibitors|protease inhibitors|mesh-ancestor
92056541|NCT02007278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056542|NCT02007278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056543|NCT02028338|Dapivirine|dapivirine|mesh-list
92056544|NCT02028338|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92056545|NCT02028338|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92056546|NCT02028338|Antiviral Agents|antiviral agents|mesh-ancestor
92015000|NCT02866643|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92015001|NCT02866643|Progestins|progestins|mesh-ancestor
92015002|NCT02866643|Hormones|hormones|mesh-ancestor
92015003|NCT02866643|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015004|NCT05176821|Amoxicillin|amoxicillin|mesh-list
92056547|NCT02028338|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056548|NCT01625897|Risperidone|risperidone|mesh-list
92056549|NCT01625897|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92056550|NCT01625897|Serotonin Agents|serotonin agents|mesh-ancestor
92056551|NCT01625897|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056552|NCT01625897|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056553|NCT01625897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056554|NCT01625897|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92056564|NCT02106923|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92056565|NCT02106923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056567|NCT02006732|Olodaterol|olodaterol|mesh-list
92056568|NCT02006732|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056569|NCT02006732|Autonomic Agents|autonomic agents|mesh-ancestor
92056570|NCT02006732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056571|NCT02006732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056572|NCT02006732|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056573|NCT02006732|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056574|NCT02006732|Parasympatholytics|parasympatholytics|mesh-ancestor
92056575|NCT02006732|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92056576|NCT02006732|Cholinergic Agents|cholinergic agents|mesh-ancestor
92056577|NCT02006732|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056578|NCT02006732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056579|NCT02098733|Pioglitazone|pioglitazone|mesh-list
92056580|NCT02098733|Glimepiride|glimepiride|mesh-list
92056581|NCT02098733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056582|NCT02098733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056583|NCT02098733|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92056584|NCT02098733|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056585|NCT02098733|Immunologic Factors|immunologic factors|mesh-ancestor
92056586|NCT02098109|Plerixafor|plerixafor|mesh-list
92056587|NCT02098109|Lenograstim|lenograstim|mesh-list
92056588|NCT02098109|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92056589|NCT02098109|Immunologic Factors|immunologic factors|mesh-ancestor
92056590|NCT02098109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056591|NCT02098109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92056592|NCT02098109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92056593|NCT02098109|Antiviral Agents|antiviral agents|mesh-ancestor
92056594|NCT02098109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056595|NCT02097719|Timolol|timolol|mesh-list
92056596|NCT02097719|Bimatoprost|bimatoprost|mesh-list
92056597|NCT02097719|Travoprost|travoprost|mesh-list
92056598|NCT02097719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056599|NCT02097719|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92056600|NCT02097719|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92056601|NCT02097719|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056602|NCT02097719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056603|NCT02097719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056604|NCT02097719|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92056605|NCT02097719|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056607|NCT01449370|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056608|NCT01449370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056609|NCT02066129|Fluticasone|fluticasone|mesh-list
92056611|NCT02066129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056612|NCT02066129|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056613|NCT02066129|Autonomic Agents|autonomic agents|mesh-ancestor
92056614|NCT02066129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056615|NCT02066129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056616|NCT02066129|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056617|NCT02066129|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056618|NCT02066129|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056619|NCT02066129|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92056620|NCT04417985|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92056621|NCT04417985|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92015005|NCT05176821|Furazolidone|furazolidone|mesh-list
92015006|NCT05176821|Potassium Citrate|potassium citrate|mesh-list
92056626|NCT02106455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056627|NCT02106455|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92056628|NCT02106455|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056629|NCT02106455|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92056630|NCT02006654|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92056631|NCT02006654|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92056632|NCT02006654|Serotonin Agents|serotonin agents|mesh-ancestor
92056633|NCT02006654|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056634|NCT02006654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056635|NCT02006654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056636|NCT02006576|Ibuprofen|ibuprofen|mesh-list
92056637|NCT02006576|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92056638|NCT02006576|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92056639|NCT02006576|Analgesics|analgesics|mesh-ancestor
92056640|NCT02006576|Sensory System Agents|sensory system agents|mesh-ancestor
92056641|NCT02006576|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056642|NCT02006576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056643|NCT02006576|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056644|NCT02006576|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056645|NCT02006576|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92056646|NCT02006576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056647|NCT02006576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056648|NCT01448824|Ketoconazole|ketoconazole|mesh-list
92056649|NCT01448824|Evacetrapib|evacetrapib|mesh-list
92056650|NCT01448824|Antifungal Agents|antifungal agents|mesh-ancestor
92056651|NCT01448824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056652|NCT01448824|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92056653|NCT01448824|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92056654|NCT01448824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056655|NCT01448824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056656|NCT01448824|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92056657|NCT01448824|Hormone Antagonists|hormone antagonists|mesh-ancestor
92056658|NCT01448824|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056659|NCT01448824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056660|NCT01448824|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92056661|NCT01448824|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92056662|NCT01448824|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92056663|NCT01448824|Antimetabolites|antimetabolites|mesh-ancestor
92056664|NCT01448824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92056665|NCT02005562|Cyclosporine|cyclosporine|mesh-list
92056666|NCT02005562|Mycophenolic Acid|mycophenolic acid|mesh-list
92056667|NCT02005562|Methylprednisolone|methylprednisolone|mesh-list
92056668|NCT02005562|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92056669|NCT02005562|Cyclosporins|cyclosporins|mesh-list
92056670|NCT02005562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056671|NCT02005562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056672|NCT02005562|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056673|NCT02005562|Immunologic Factors|immunologic factors|mesh-ancestor
92056674|NCT02005562|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056675|NCT02005562|Antifungal Agents|antifungal agents|mesh-ancestor
92056676|NCT02005562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056677|NCT02005562|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056678|NCT02005562|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056679|NCT02005562|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92056680|NCT02005562|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92056681|NCT02005562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056682|NCT02005562|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92056683|NCT02005562|Antitubercular Agents|antitubercular agents|mesh-ancestor
92056684|NCT02005562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92056685|NCT02005562|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056686|NCT02005562|Antiemetics|antiemetics|mesh-ancestor
92056687|NCT02005562|Autonomic Agents|autonomic agents|mesh-ancestor
92056688|NCT02005562|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056694|NCT02005562|Protective Agents|protective agents|mesh-ancestor
92056695|NCT02005562|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92056696|NCT01448044|Interferons|interferons|mesh-list
92056698|NCT01448044|Interferon-alpha|interferon-alpha|mesh-list
92056699|NCT01448044|Interferon alpha-2|interferon alpha-2|mesh-list
92015008|NCT05176821|Bismuth|bismuth|mesh-list
92056700|NCT01448044|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92056701|NCT01448044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056702|NCT01448044|Antiviral Agents|antiviral agents|mesh-ancestor
92056703|NCT01448044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056704|NCT01448044|Antimetabolites|antimetabolites|mesh-ancestor
92056705|NCT01448044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056706|NCT01448044|Immunologic Factors|immunologic factors|mesh-ancestor
92056707|NCT01448044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056708|NCT01472380|Efavirenz|efavirenz|mesh-list
92056709|NCT01472380|Fenofibric acid|fenofibric acid|mesh-list
92056710|NCT01472380|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92056711|NCT01472380|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92056712|NCT01472380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056713|NCT01472380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056714|NCT01472380|Antiviral Agents|antiviral agents|mesh-ancestor
92056715|NCT01472380|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056716|NCT01472380|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92056717|NCT01472380|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92056718|NCT01472380|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92056719|NCT01472380|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92056720|NCT01472380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92056721|NCT01472380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92056722|NCT01472380|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92056723|NCT01472380|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92056724|NCT01472380|Antimetabolites|antimetabolites|mesh-ancestor
92056725|NCT01472380|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92056726|NCT01447576|Antidepressive Agents|antidepressive agents|mesh-list
92056727|NCT01447576|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92056728|NCT01447420|Ribavirin|ribavirin|mesh-list
92056729|NCT01447420|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92056730|NCT01447420|Antimetabolites|antimetabolites|mesh-ancestor
92056731|NCT01447420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056732|NCT01447420|Antiviral Agents|antiviral agents|mesh-ancestor
92056733|NCT01447420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056734|NCT01446874|Chlorhexidine|chlorhexidine|mesh-list
92056735|NCT01446874|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92056736|NCT01446874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056737|NCT01446874|Disinfectants|disinfectants|mesh-ancestor
92056738|NCT01439074|Sulfadiazine|sulfadiazine|mesh-list
92056739|NCT01439074|Silver Sulfadiazine|silver sulfadiazine|mesh-list
92056740|NCT01439074|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92056741|NCT01439074|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056742|NCT01439074|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92056743|NCT01439074|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92056744|NCT01439074|Coccidiostats|coccidiostats|mesh-ancestor
92056745|NCT01439074|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92056746|NCT01438840|Maleic acid|maleic acid|mesh-list
92056747|NCT01438840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056748|NCT01438840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056749|NCT01471054|Dexamethasone|dexamethasone|mesh-list
92056750|NCT01471054|Bevacizumab|bevacizumab|mesh-list
92056751|NCT01471054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056752|NCT01471054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056753|NCT01471054|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92056754|NCT01471054|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92056755|NCT01471054|Growth Substances|growth substances|mesh-ancestor
92056756|NCT01471054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056757|NCT01471054|Growth Inhibitors|growth inhibitors|mesh-ancestor
92056758|NCT01471054|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056759|NCT01471054|Antiemetics|antiemetics|mesh-ancestor
92056760|NCT01471054|Autonomic Agents|autonomic agents|mesh-ancestor
92056763|NCT01471054|Glucocorticoids|glucocorticoids|mesh-ancestor
92056765|NCT01471054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056766|NCT01471054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92056767|NCT01978184|Hydroxychloroquine|hydroxychloroquine|mesh-list
92056768|NCT01978184|Gemcitabine|gemcitabine|mesh-list
92056769|NCT01978184|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92056770|NCT01978184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92056771|NCT01978184|Antimetabolites|antimetabolites|mesh-ancestor
92056772|NCT01978184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056773|NCT01978184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056774|NCT01978184|Antimalarials|antimalarials|mesh-ancestor
92015009|NCT05176821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015010|NCT05176821|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92015011|NCT05176821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015012|NCT05176821|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92015013|NCT05176821|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056775|NCT01978184|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92056776|NCT01978184|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92056777|NCT01978184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056778|NCT01978184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056779|NCT01978184|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92056780|NCT01445548|Sirolimus|sirolimus|mesh-list
92056781|NCT01445548|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92056782|NCT01445548|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056783|NCT01445548|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92056784|NCT01445548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056785|NCT01445548|Antifungal Agents|antifungal agents|mesh-ancestor
92056786|NCT01445548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92056787|NCT01445548|Immunologic Factors|immunologic factors|mesh-ancestor
92056788|NCT01445548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056789|NCT01977794|Amlodipine|amlodipine|mesh-list
92056790|NCT01977794|Bisoprolol|bisoprolol|mesh-list
92056791|NCT01977794|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056792|NCT01977794|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92056793|NCT01977794|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056794|NCT01977794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056795|NCT01977794|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92056796|NCT01977794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056797|NCT01977794|Vasodilator Agents|vasodilator agents|mesh-ancestor
92056798|NCT01977794|Sympatholytics|sympatholytics|mesh-ancestor
92056799|NCT01977794|Autonomic Agents|autonomic agents|mesh-ancestor
92056800|NCT01977794|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056801|NCT01977794|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92056802|NCT01977794|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92056803|NCT01977794|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92056804|NCT01977794|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056805|NCT01977794|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056806|NCT02005484|Trastuzumab|trastuzumab|mesh-list
92056807|NCT02005484|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92056808|NCT02005484|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056809|NCT01597973|Meropenem|meropenem|mesh-list
92056810|NCT01597973|Colistin|colistin|mesh-list
92056811|NCT01597973|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92056812|NCT01597973|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056814|NCT02047253|Dexamethasone|dexamethasone|mesh-list
92056815|NCT02047253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056816|NCT02047253|Antiemetics|antiemetics|mesh-ancestor
92056817|NCT02047253|Autonomic Agents|autonomic agents|mesh-ancestor
92056818|NCT02047253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056819|NCT02047253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056820|NCT02047253|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056821|NCT02047253|Glucocorticoids|glucocorticoids|mesh-ancestor
92056822|NCT02047253|Hormones|hormones|mesh-ancestor
92056823|NCT02047253|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056824|NCT02047253|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92056825|NCT02047253|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056826|NCT02047253|Antiviral Agents|antiviral agents|mesh-ancestor
92056827|NCT02047253|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056828|NCT02096705|Dapagliflozin|dapagliflozin|mesh-list
92056829|NCT02096705|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92056830|NCT02096705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056831|NCT02096705|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056832|NCT02096705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056833|NCT02096003|Morphine|morphine|mesh-list
92056837|NCT02096003|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056838|NCT02096003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056839|NCT02096003|Analgesics|analgesics|mesh-ancestor
92056840|NCT02096003|Sensory System Agents|sensory system agents|mesh-ancestor
92056841|NCT02096003|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056842|NCT02095535|Chlorhexidine|chlorhexidine|mesh-list
92015014|NCT05176821|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92015015|NCT05176821|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015016|NCT05176821|Antacids|antacids|mesh-ancestor
92056843|NCT02095535|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92056844|NCT02095535|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92056845|NCT02095535|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056846|NCT02095535|Disinfectants|disinfectants|mesh-ancestor
92056847|NCT02095535|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056848|NCT02059187|Insulin|insulin|mesh-list
92056849|NCT02059187|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92056850|NCT02059187|Insulin Glargine|insulin glargine|mesh-list
92056851|NCT02059187|MK-1293|mk-1293|mesh-list
92056852|NCT02059187|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056853|NCT02059187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056854|NCT02059187|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92056855|NCT02059187|Antimetabolites|antimetabolites|mesh-ancestor
92056856|NCT02059187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056857|NCT02059187|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92056858|NCT02043899|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92056859|NCT02043899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056860|NCT02043899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056861|NCT02043899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056862|NCT02043899|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92056863|NCT01622231|Fluticasone|fluticasone|mesh-list
92056864|NCT01622231|Xhance|xhance|mesh-list
92056865|NCT01622231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056866|NCT01622231|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92056867|NCT01622231|Autonomic Agents|autonomic agents|mesh-ancestor
92056868|NCT01622231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056869|NCT01622231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056870|NCT01622231|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056871|NCT01622231|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056872|NCT01622231|Dermatologic Agents|dermatologic agents|mesh-ancestor
92056873|NCT01622231|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92056874|NCT02042183|Lubiprostone|lubiprostone|mesh-list
92056875|NCT02042183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92056876|NCT02042183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056877|NCT02042183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056878|NCT02058095|Tadalafil|tadalafil|mesh-list
92056879|NCT02058095|Vasodilator Agents|vasodilator agents|mesh-ancestor
92056880|NCT02058095|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92056881|NCT02058095|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92056882|NCT02058095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056883|NCT02058095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056884|NCT02058095|Urological Agents|urological agents|mesh-ancestor
92056885|NCT02023112|Ritonavir|ritonavir|mesh-list
92056886|NCT02023112|Ribavirin|ribavirin|mesh-list
92056887|NCT02023112|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92056888|NCT02023112|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92056889|NCT02023112|Protease Inhibitors|protease inhibitors|mesh-ancestor
92056890|NCT02023112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056891|NCT02023112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056892|NCT02023112|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92056893|NCT02023112|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92056894|NCT02023112|Antiviral Agents|antiviral agents|mesh-ancestor
92056895|NCT02023112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056896|NCT02023112|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92056897|NCT02023112|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92056898|NCT02023112|Antimetabolites|antimetabolites|mesh-ancestor
92056899|NCT04670666|Metformin|metformin|mesh-list
92056900|NCT04670666|Empagliflozin|empagliflozin|mesh-list
92056901|NCT04670666|Linagliptin|linagliptin|mesh-list
92056902|NCT04670666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056903|NCT04670666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056904|NCT04670666|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92056905|NCT04670666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056906|NCT04670666|Incretins|incretins|mesh-ancestor
92056907|NCT04670666|Hormones|hormones|mesh-ancestor
92056908|NCT04670666|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056910|NCT04670666|Protease Inhibitors|protease inhibitors|mesh-ancestor
92056911|NCT04670666|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056912|NCT01976624|Timolol|timolol|mesh-list
92015017|NCT05176821|Diuretics|diuretics|mesh-ancestor
92015018|NCT05176821|Natriuretic Agents|natriuretic agents|mesh-ancestor
92056914|NCT01976624|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92056915|NCT01976624|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92056916|NCT01976624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056917|NCT01976624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056918|NCT01976624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056919|NCT01976624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056920|NCT01976624|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92056921|NCT01976624|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056922|NCT02041091|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92056923|NCT02041091|Immunologic Factors|immunologic factors|mesh-ancestor
92056924|NCT02041091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056925|NCT04717973|Vitamin D|vitamin d|mesh-list
92056926|NCT04717973|Vitamins|vitamins|mesh-list
92056927|NCT04717973|Vitamin B 12|vitamin b 12|mesh-list
92056928|NCT04717973|Hydroxocobalamin|hydroxocobalamin|mesh-list
92056929|NCT04717973|Micronutrients|micronutrients|mesh-ancestor
92056930|NCT04717973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056931|NCT04717973|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92056932|NCT04717973|Vitamin B Complex|vitamin b complex|mesh-ancestor
92056933|NCT04717973|Hematinics|hematinics|mesh-ancestor
92056934|NCT02057549|Haloperidol|haloperidol|mesh-list
92056935|NCT02057549|Haloperidol decanoate|haloperidol decanoate|mesh-list
92056936|NCT02057549|Antiemetics|antiemetics|mesh-ancestor
92056937|NCT02057549|Autonomic Agents|autonomic agents|mesh-ancestor
92056938|NCT02057549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056939|NCT02057549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056940|NCT02057549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056941|NCT02057549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92056942|NCT02057549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92056943|NCT02057549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056944|NCT02057549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92056945|NCT02057549|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92056946|NCT02057549|Dopamine Agents|dopamine agents|mesh-ancestor
92056947|NCT02057549|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056948|NCT02057549|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056950|NCT02057393|Methylene Blue|methylene blue|mesh-list
92056951|NCT02057393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056952|NCT02057393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056953|NCT02040779|Beclomethasone|beclomethasone|mesh-list
92056955|NCT02040779|Bronchodilator Agents|bronchodilator agents|mesh-list
92056956|NCT02040779|Autonomic Agents|autonomic agents|mesh-ancestor
92056957|NCT02040779|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056958|NCT02040779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056959|NCT02040779|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92056960|NCT02040779|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056961|NCT02040779|Tocolytic Agents|tocolytic agents|mesh-ancestor
92056962|NCT02040779|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92056963|NCT02040779|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92056964|NCT02040779|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92056965|NCT02040779|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92056966|NCT02040779|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056967|NCT02040779|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056968|NCT02040779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056969|NCT02040779|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056970|NCT02040779|Glucocorticoids|glucocorticoids|mesh-ancestor
92056971|NCT02040779|Hormones|hormones|mesh-ancestor
92056972|NCT02040779|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056973|NCT02056301|Morphine|morphine|mesh-list
92056974|NCT02056301|Hydromorphone|hydromorphone|mesh-list
92056975|NCT02056301|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92056976|NCT02056301|Narcotics|narcotics|mesh-ancestor
92056977|NCT02056301|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056978|NCT02056301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056979|NCT02056301|Analgesics|analgesics|mesh-ancestor
92056980|NCT02056301|Sensory System Agents|sensory system agents|mesh-ancestor
92056981|NCT02056301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056982|NCT01967576|Axitinib|axitinib|mesh-list
92056983|NCT01967576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056987|NCT02003534|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92015019|NCT05176821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015020|NCT05176821|Expectorants|expectorants|mesh-ancestor
92015021|NCT05176821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92056988|NCT02003534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056989|NCT02003534|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92056990|NCT02003534|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92056991|NCT02003534|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92056992|NCT02003534|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056993|NCT02003534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056994|NCT02003534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056995|NCT02003534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056996|NCT01976312|Ranibizumab|ranibizumab|mesh-list
92056997|NCT01976312|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92056998|NCT01976312|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92056999|NCT01976312|Growth Substances|growth substances|mesh-ancestor
92057000|NCT01976312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057001|NCT01976312|Growth Inhibitors|growth inhibitors|mesh-ancestor
92057002|NCT01976312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057003|NCT02053493|Isosorbide|isosorbide|mesh-list
92057004|NCT02053493|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92057005|NCT02053493|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92057006|NCT02053493|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92057007|NCT02053493|Diuretics|diuretics|mesh-ancestor
92057008|NCT02053493|Natriuretic Agents|natriuretic agents|mesh-ancestor
92057009|NCT02053493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057010|NCT02053493|Vasodilator Agents|vasodilator agents|mesh-ancestor
92057011|NCT02053493|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92057012|NCT02053493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057013|NCT02003144|Eculizumab|eculizumab|mesh-list
92057014|NCT02003144|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92057015|NCT02003144|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057016|NCT02003144|Immunologic Factors|immunologic factors|mesh-ancestor
92057017|NCT02003144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057018|NCT02038907|Vaccines|vaccines|mesh-list
92057019|NCT02038907|Immunologic Factors|immunologic factors|mesh-ancestor
92057020|NCT02038907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057021|NCT02052011|Ranolazine|ranolazine|mesh-list
92057022|NCT02052011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92057023|NCT02052011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057024|NCT02052011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057025|NCT02051933|Botulinum Toxins|botulinum toxins|mesh-list
92057026|NCT02051933|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92057027|NCT02051933|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92057028|NCT02051933|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92057029|NCT02051933|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057030|NCT02051933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057031|NCT02051933|Cholinergic Agents|cholinergic agents|mesh-ancestor
92057032|NCT02051933|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057033|NCT02051933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057034|NCT02051933|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92057035|NCT02051933|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057036|NCT02035553|Pimavanserin|pimavanserin|mesh-list
92057037|NCT02035553|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92057038|NCT02035553|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92057039|NCT02035553|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92057040|NCT02035553|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92057041|NCT02035553|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057042|NCT02035553|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057043|NCT02035553|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057044|NCT02035553|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92057045|NCT02035553|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92057046|NCT02035553|Serotonin Agents|serotonin agents|mesh-ancestor
92057047|NCT02035553|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057048|NCT02035553|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057049|NCT01445080|Sorafenib|sorafenib|mesh-list
92057050|NCT01445080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057051|NCT01445080|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057052|NCT01445080|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057065|NCT01959529|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92057066|NCT01959529|Insulin Glargine|insulin glargine|mesh-list
92015022|NCT05176821|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92015023|NCT05176821|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92015024|NCT05176821|Antitrichomonal Agents|antitrichomonal agents|mesh-ancestor
92057067|NCT01959529|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057068|NCT01959529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057069|NCT02033369|Pramipexole|pramipexole|mesh-list
92057070|NCT02033369|Antioxidants|antioxidants|mesh-ancestor
92057071|NCT02033369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057072|NCT02033369|Protective Agents|protective agents|mesh-ancestor
92057073|NCT02033369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057074|NCT02033369|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92057075|NCT02033369|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92057076|NCT02033369|Dopamine Agonists|dopamine agonists|mesh-ancestor
92057077|NCT02033369|Dopamine Agents|dopamine agents|mesh-ancestor
92057078|NCT02033369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057079|NCT02032901|Sofosbuvir|sofosbuvir|mesh-list
92057080|NCT02032901|Antiviral Agents|antiviral agents|mesh-ancestor
92057081|NCT02032901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057082|NCT04681469|Niraparib|niraparib|mesh-list
92057083|NCT04681469|Dostarlimab|dostarlimab|mesh-list
92057084|NCT04681469|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92057085|NCT04681469|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057086|NCT04681469|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057087|NCT04681469|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057088|NCT01986751|Clonidine|clonidine|mesh-list
92057089|NCT01986751|Ropivacaine|ropivacaine|mesh-list
92057090|NCT01986751|Anesthetics, Local|anesthetics, local|mesh-ancestor
92057091|NCT01986751|Anesthetics|anesthetics|mesh-ancestor
92057092|NCT01986751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057093|NCT01986751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057094|NCT01986751|Sensory System Agents|sensory system agents|mesh-ancestor
92057095|NCT01986751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057096|NCT01986751|Analgesics|analgesics|mesh-ancestor
92057097|NCT01986751|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92057098|NCT01986751|Sympatholytics|sympatholytics|mesh-ancestor
92057099|NCT01986751|Autonomic Agents|autonomic agents|mesh-ancestor
92057100|NCT01986751|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92057101|NCT01986751|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92057102|NCT01986751|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92057103|NCT01986751|Adrenergic Agents|adrenergic agents|mesh-ancestor
92057104|NCT01986751|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057105|NCT01986751|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057106|NCT01438060|Aripiprazole|aripiprazole|mesh-list
92057107|NCT01438060|Antidepressive Agents|antidepressive agents|mesh-ancestor
92057108|NCT01438060|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057109|NCT01438060|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92057110|NCT01438060|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92057111|NCT01438060|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057112|NCT01438060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057113|NCT01438060|Dopamine Agonists|dopamine agonists|mesh-ancestor
92057114|NCT01438060|Dopamine Agents|dopamine agents|mesh-ancestor
92057115|NCT01438060|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057128|NCT01443364|Certolizumab Pegol|certolizumab pegol|mesh-list
92057129|NCT01443364|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92057130|NCT01443364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057131|NCT01443364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057132|NCT01443364|Immunologic Factors|immunologic factors|mesh-ancestor
92057133|NCT01443364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057134|NCT01443364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057135|NCT02020577|Cetuximab|cetuximab|mesh-list
92057136|NCT02020577|Afatinib|afatinib|mesh-list
92057137|NCT02020577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057138|NCT02020577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057139|NCT02020577|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057140|NCT02020577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057141|NCT02020577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057142|NCT02020031|Vancomycin|vancomycin|mesh-list
92057143|NCT02020031|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057144|NCT02020031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057145|NCT02030405|Ixazomib|ixazomib|mesh-list
92057146|NCT02030405|Proteasome Inhibitors|proteasome inhibitors|mesh-list
92057147|NCT02030405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015025|NCT05176821|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92015026|NCT05176821|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92057148|NCT02030405|Protease Inhibitors|protease inhibitors|mesh-ancestor
92057149|NCT02030405|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057379|NCT01442038|Ranolazine|ranolazine|mesh-list
92057150|NCT02030405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057151|NCT01975376|Bococizumab|bococizumab|mesh-list
92057152|NCT01975376|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92057153|NCT01975376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92057154|NCT01975376|Antimetabolites|antimetabolites|mesh-ancestor
92057155|NCT01975376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057156|NCT01975376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92057157|NCT01443130|Chloroquine|chloroquine|mesh-list
92057158|NCT01443130|Pyrimethamine|pyrimethamine|mesh-list
92057159|NCT01443130|Sulfadoxine|sulfadoxine|mesh-list
92057160|NCT01443130|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92057161|NCT01443130|Amebicides|amebicides|mesh-ancestor
92057162|NCT01443130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92057163|NCT01443130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92057164|NCT01443130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057165|NCT01443130|Antimalarials|antimalarials|mesh-ancestor
92057166|NCT01443130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057167|NCT01443130|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92057168|NCT01443130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057169|NCT01443130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057170|NCT01443130|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92057171|NCT01436500|Ifetroban|ifetroban|mesh-list
92057172|NCT01436500|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92057173|NCT01958827|Adalimumab|adalimumab|mesh-list
92057174|NCT01958827|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92057183|NCT01436110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057184|NCT01436110|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92057185|NCT01436110|Autonomic Agents|autonomic agents|mesh-ancestor
92057186|NCT01436110|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057187|NCT01436110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057188|NCT01436110|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92057189|NCT01436110|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057190|NCT01436110|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057191|NCT01436110|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92057193|NCT01619852|Anesthetics, Local|anesthetics, local|mesh-ancestor
92057194|NCT01619852|Anesthetics|anesthetics|mesh-ancestor
92057195|NCT01619852|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057196|NCT01619852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057197|NCT01619852|Sensory System Agents|sensory system agents|mesh-ancestor
92057198|NCT01619852|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057199|NCT01619852|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92057200|NCT01619852|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92057201|NCT01619852|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92057202|NCT01619852|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057203|NCT01619852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057205|NCT04069936|Tadalafil|tadalafil|mesh-list
92057206|NCT04069936|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057207|NCT04069936|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057208|NCT04069936|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92057209|NCT04069936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057210|NCT04069936|Vasodilator Agents|vasodilator agents|mesh-ancestor
92057211|NCT04069936|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92057212|NCT04069936|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92057213|NCT04069936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057214|NCT04069936|Urological Agents|urological agents|mesh-ancestor
92057215|NCT02000882|Capecitabine|capecitabine|mesh-list
92057216|NCT02000882|Trastuzumab|trastuzumab|mesh-list
92057217|NCT02000882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92057218|NCT02000882|Antimetabolites|antimetabolites|mesh-ancestor
92057219|NCT02000882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057220|NCT02000882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057221|NCT02000882|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057222|NCT04666129|Prednisone|prednisone|mesh-list
92057223|NCT04666129|Methylprednisolone|methylprednisolone|mesh-list
92057224|NCT04666129|Docetaxel|docetaxel|mesh-list
92057225|NCT04666129|Relugolix|relugolix|mesh-list
92057226|NCT04666129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057227|NCT04666129|Tubulin Modulators|tubulin modulators|mesh-ancestor
92015027|NCT05176821|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92015028|NCT05555641|Nafamostat|nafamostat|mesh-list
92015029|NCT05555641|Heparin|heparin|mesh-list
92015030|NCT05555641|Calcium heparin|calcium heparin|mesh-list
92015031|NCT05555641|Anticoagulants|anticoagulants|mesh-ancestor
92057228|NCT04666129|Antimitotic Agents|antimitotic agents|mesh-ancestor
92057229|NCT04666129|Mitosis Modulators|mitosis modulators|mesh-ancestor
92057530|NCT01946438|Vaccines|vaccines|mesh-list
92057230|NCT04666129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057231|NCT04666129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057232|NCT04666129|Glucocorticoids|glucocorticoids|mesh-ancestor
92057233|NCT04666129|Hormones|hormones|mesh-ancestor
92057234|NCT04666129|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92057235|NCT04666129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057236|NCT04666129|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92057237|NCT04666129|Antiemetics|antiemetics|mesh-ancestor
92057238|NCT04666129|Autonomic Agents|autonomic agents|mesh-ancestor
92057239|NCT04666129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057240|NCT04666129|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92057241|NCT04666129|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92057243|NCT04666129|Androgen Antagonists|androgen antagonists|mesh-ancestor
92057244|NCT04666129|Hormone Antagonists|hormone antagonists|mesh-ancestor
92057245|NCT04666051|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92057246|NCT04666051|Hemostatics|hemostatics|mesh-ancestor
92057247|NCT04666051|Coagulants|coagulants|mesh-ancestor
92057248|NCT01965704|Ondansetron|ondansetron|mesh-list
92057249|NCT01965704|Antiemetics|antiemetics|mesh-ancestor
92057250|NCT01965704|Autonomic Agents|autonomic agents|mesh-ancestor
92057251|NCT01965704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057252|NCT01965704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057253|NCT01965704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92057254|NCT01965704|Antipruritics|antipruritics|mesh-ancestor
92057255|NCT01965704|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057256|NCT01965704|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92057257|NCT01965704|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92057258|NCT01965704|Serotonin Agents|serotonin agents|mesh-ancestor
92057259|NCT01965704|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057260|NCT01965704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057261|NCT02003365|Triamcinolone|triamcinolone|mesh-list
92057262|NCT02003365|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92057263|NCT02003365|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92057264|NCT02003365|FX006|fx006|mesh-list
92057265|NCT02003365|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92057266|NCT02003365|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057267|NCT02003365|Glucocorticoids|glucocorticoids|mesh-ancestor
92057268|NCT02003365|Hormones|hormones|mesh-ancestor
92057269|NCT02003365|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92057270|NCT02003365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057271|NCT02003365|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057272|NCT02003365|Immunologic Factors|immunologic factors|mesh-ancestor
92057273|NCT02003365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057274|NCT02003365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057275|NCT01975220|Metformin|metformin|mesh-list
92057276|NCT01975220|Empagliflozin|empagliflozin|mesh-list
92057277|NCT01975220|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057278|NCT01975220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057279|NCT01975220|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92057280|NCT01975220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057281|NCT01974752|Dacarbazine|dacarbazine|mesh-list
92057282|NCT01974752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92057283|NCT01974752|Alkylating Agents|alkylating agents|mesh-ancestor
92057284|NCT01974752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057285|NCT01974752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057286|NCT01999946|Naltrexone|naltrexone|mesh-list
92057287|NCT01999946|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92057288|NCT01999946|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92057289|NCT01999946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057290|NCT01999946|Sensory System Agents|sensory system agents|mesh-ancestor
92057291|NCT01999946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057292|NCT01958281|Sofosbuvir|sofosbuvir|mesh-list
92057293|NCT01958281|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92057294|NCT01958281|Antiviral Agents|antiviral agents|mesh-ancestor
92015033|NCT05555641|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015034|NCT05555641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057295|NCT01958281|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057296|NCT02002975|Pioglitazone|pioglitazone|mesh-list
92057297|NCT02002975|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057298|NCT02002975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057299|NCT02001181|Tofacitinib|tofacitinib|mesh-list
92057300|NCT02001181|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92057301|NCT02001181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057302|NCT02001181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057531|NCT01946438|Immunologic Factors|immunologic factors|mesh-ancestor
92057303|NCT02001181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057304|NCT04176055|Haloperidol|haloperidol|mesh-list
92057305|NCT04176055|Haloperidol decanoate|haloperidol decanoate|mesh-list
92057306|NCT04176055|Antiemetics|antiemetics|mesh-ancestor
92057307|NCT04176055|Autonomic Agents|autonomic agents|mesh-ancestor
92057308|NCT04176055|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057309|NCT04176055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057310|NCT04176055|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92057311|NCT04176055|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92057312|NCT04176055|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92057313|NCT04176055|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057314|NCT04176055|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057315|NCT04176055|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92057316|NCT04176055|Dopamine Agents|dopamine agents|mesh-ancestor
92057318|NCT04176055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057320|NCT04659278|Peppermint oil|peppermint oil|mesh-list
92057321|NCT04659278|Antiemetics|antiemetics|mesh-ancestor
92057322|NCT04659278|Autonomic Agents|autonomic agents|mesh-ancestor
92057323|NCT04659278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057324|NCT04659278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057325|NCT04659278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92057326|NCT04659278|Parasympatholytics|parasympatholytics|mesh-ancestor
92057327|NCT04659044|Rituximab|rituximab|mesh-list
92057328|NCT04659044|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92057329|NCT04659044|Venetoclax|venetoclax|mesh-list
92057330|NCT04659044|Antibodies|antibodies|mesh-list
92057331|NCT04659044|Immunoglobulins|immunoglobulins|mesh-list
92057332|NCT04659044|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92057333|NCT04659044|Immunoconjugates|immunoconjugates|mesh-list
92057334|NCT04659044|Polatuzumab vedotin|polatuzumab vedotin|mesh-list
92057335|NCT04659044|Immunologic Factors|immunologic factors|mesh-ancestor
92057336|NCT04659044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057337|NCT04659044|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057338|NCT04659044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057339|NCT01999868|Abatacept|abatacept|mesh-list
92057340|NCT01999868|Ustekinumab|ustekinumab|mesh-list
92057341|NCT01999868|Immunoglobulins|immunoglobulins|mesh-list
92057342|NCT01999868|Immunologic Factors|immunologic factors|mesh-ancestor
92057343|NCT01999868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057344|NCT01999868|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92057345|NCT01999868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057346|NCT01999868|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057347|NCT01999868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057348|NCT01999868|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057349|NCT01999868|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057350|NCT01999868|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057351|NCT03511963|Bevacizumab|bevacizumab|mesh-list
92057352|NCT03511963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057353|NCT03511963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057354|NCT03511963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92057355|NCT03511963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92057356|NCT03511963|Growth Substances|growth substances|mesh-ancestor
92057357|NCT03511963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057358|NCT03511963|Growth Inhibitors|growth inhibitors|mesh-ancestor
92057359|NCT01999322|Insulin|insulin|mesh-list
92057360|NCT01999322|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92057361|NCT01999322|Insulin Aspart|insulin aspart|mesh-list
92057362|NCT01999322|Insulin, Long-Acting|insulin, long-acting|mesh-list
92057363|NCT01999322|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92057364|NCT01999322|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92015035|NCT05555641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92015036|NCT05555641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92015037|NCT05555641|Analgesics|analgesics|mesh-ancestor
92057365|NCT01999322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057367|NCT01964924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057368|NCT01964924|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057369|NCT01964924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057370|NCT01964924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057371|NCT01964378|Morphine|morphine|mesh-list
92057372|NCT01964378|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92057373|NCT01964378|Narcotics|narcotics|mesh-ancestor
92057374|NCT01964378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057375|NCT01964378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057376|NCT01964378|Analgesics|analgesics|mesh-ancestor
92057377|NCT01964378|Sensory System Agents|sensory system agents|mesh-ancestor
92057378|NCT01964378|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057380|NCT01442038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92057381|NCT01442038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057382|NCT01442038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057383|NCT01998919|Carboplatin|carboplatin|mesh-list
92057384|NCT01998919|Gemcitabine|gemcitabine|mesh-list
92057385|NCT01998919|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92057386|NCT01998919|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057387|NCT01998919|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92057388|NCT01998919|Antimetabolites|antimetabolites|mesh-ancestor
92057389|NCT01998919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057390|NCT01998919|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057391|NCT01998919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057395|NCT01972724|Metformin|metformin|mesh-list
92057396|NCT01972724|Pioglitazone|pioglitazone|mesh-list
92057397|NCT01972724|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057398|NCT01972724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057399|NCT01441960|Rocuronium|rocuronium|mesh-list
92057400|NCT01441960|Succinylcholine|succinylcholine|mesh-list
92057401|NCT01441960|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92057402|NCT01441960|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92057403|NCT01441960|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92057404|NCT01441960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057405|NCT01441960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057406|NCT01441960|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92057407|NCT01955707|Natalizumab|natalizumab|mesh-list
92057408|NCT01955707|Immunologic Factors|immunologic factors|mesh-ancestor
92057409|NCT01955707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057410|NCT01435798|Dextromethorphan|dextromethorphan|mesh-list
92057411|NCT01435798|Antitussive Agents|antitussive agents|mesh-ancestor
92057412|NCT01435798|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057413|NCT01435798|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92057414|NCT01435798|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92057415|NCT01435798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057416|NCT01435798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057417|NCT01435798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057418|NCT01955161|(2-(6-fluoro-1H-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|(2-(6-fluoro-1h-indol-3-yl)-ethyl)-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)amine|mesh-list
92057419|NCT01955161|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92057420|NCT01955161|Serotonin Agents|serotonin agents|mesh-ancestor
92057421|NCT01955161|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057422|NCT01955161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057423|NCT01955161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057424|NCT01441414|Axitinib|axitinib|mesh-list
92057425|NCT01441414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057426|NCT01441414|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057427|NCT01441414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057428|NCT01441414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057429|NCT01954927|Gabapentin|gabapentin|mesh-list
92057430|NCT01954927|Analgesics|analgesics|mesh-ancestor
92057431|NCT01954927|Sensory System Agents|sensory system agents|mesh-ancestor
92057432|NCT01954927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057433|NCT01954927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057434|NCT01954927|Anticonvulsants|anticonvulsants|mesh-ancestor
92057435|NCT01954927|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92015038|NCT05555641|Sensory System Agents|sensory system agents|mesh-ancestor
92015039|NCT05555641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015040|NCT05555641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057436|NCT01954927|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92057437|NCT01954927|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057439|NCT01954927|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92057440|NCT01954927|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92057441|NCT01954927|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057442|NCT01954927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057443|NCT01954927|Antimanic Agents|antimanic agents|mesh-ancestor
92057444|NCT01953913|Afatinib|afatinib|mesh-list
92057445|NCT01953913|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057446|NCT01953913|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057447|NCT01953913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057448|NCT01953913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057449|NCT01970540|Doxorubicin|doxorubicin|mesh-list
92057450|NCT01970540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92057451|NCT01970540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057452|NCT01970540|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92057453|NCT01970540|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92057454|NCT01970540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057455|NCT01970540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057456|NCT01996826|Bevacizumab|bevacizumab|mesh-list
92057457|NCT01996826|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92057458|NCT01996826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057459|NCT01996826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057460|NCT01996826|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92057461|NCT01996826|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92057462|NCT01996826|Growth Substances|growth substances|mesh-ancestor
92057468|NCT01621178|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92057469|NCT01621178|Insulin Glargine|insulin glargine|mesh-list
92057470|NCT01621178|Insulin Lispro|insulin lispro|mesh-list
92057471|NCT01621178|Dulaglutide|dulaglutide|mesh-list
92057472|NCT01621178|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057473|NCT01621178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057474|NCT01962974|Golimumab|golimumab|mesh-list
92057475|NCT01962974|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92057476|NCT01962974|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057477|NCT01962974|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057478|NCT01962974|Immunologic Factors|immunologic factors|mesh-ancestor
92057479|NCT01962974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057480|NCT01962896|Sirolimus|sirolimus|mesh-list
92057481|NCT01962896|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92057482|NCT01962896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057483|NCT01962896|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057484|NCT01962896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057485|NCT01962896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057486|NCT01962896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057487|NCT01962896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057488|NCT01962896|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92057489|NCT01962896|Antifungal Agents|antifungal agents|mesh-ancestor
92057490|NCT01962896|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057491|NCT01962896|Immunologic Factors|immunologic factors|mesh-ancestor
92057492|NCT01962896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057493|NCT01970462|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92057494|NCT01970462|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057495|NCT01970462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057496|NCT01970462|Incretins|incretins|mesh-ancestor
92057497|NCT01970462|Hormones|hormones|mesh-ancestor
92057498|NCT01970462|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92057499|NCT01970462|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92057500|NCT01970462|Protease Inhibitors|protease inhibitors|mesh-ancestor
92057501|NCT01970462|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057502|NCT01970462|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057503|NCT01958671|Metformin|metformin|mesh-list
92057504|NCT01958671|Glimepiride|glimepiride|mesh-list
92057505|NCT01958671|Ertugliflozin|ertugliflozin|mesh-list
92057506|NCT01958671|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057507|NCT01958671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057508|NCT01958671|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92015041|NCT05555641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015042|NCT05555641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015043|NCT05555641|Protease Inhibitors|protease inhibitors|mesh-ancestor
92015044|NCT05555641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057509|NCT01958671|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057510|NCT01958671|Immunologic Factors|immunologic factors|mesh-ancestor
92057511|NCT01958671|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92057512|NCT01958671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057514|NCT01995266|Protease Inhibitors|protease inhibitors|mesh-ancestor
92057515|NCT01995266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057516|NCT01995266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057517|NCT01969058|Isotretinoin|isotretinoin|mesh-list
92057518|NCT01969058|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057519|NCT01968980|Bococizumab|bococizumab|mesh-list
92057520|NCT01968980|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92057521|NCT01968980|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92057522|NCT01968980|Antimetabolites|antimetabolites|mesh-ancestor
92057523|NCT01968980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057524|NCT01968980|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92057525|NCT01968434|Carbocysteine|carbocysteine|mesh-list
92057526|NCT01968434|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92057527|NCT01968434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057528|NCT01968434|Expectorants|expectorants|mesh-ancestor
92057529|NCT01968434|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057532|NCT01946438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057533|NCT01618214|Insulin Aspart|insulin aspart|mesh-list
92057534|NCT01618214|Biphasic Insulins|biphasic insulins|mesh-list
92057537|NCT01618214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057539|NCT01917656|Liraglutide|liraglutide|mesh-list
92057540|NCT01917656|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057541|NCT01917656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057542|NCT01917656|Incretins|incretins|mesh-ancestor
92057543|NCT01917656|Hormones|hormones|mesh-ancestor
92057544|NCT01917656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92057545|NCT02018861|Rituximab|rituximab|mesh-list
92057546|NCT02018861|Carboplatin|carboplatin|mesh-list
92057547|NCT02018861|Etoposide|etoposide|mesh-list
92057548|NCT02018861|Ifosfamide|ifosfamide|mesh-list
92057549|NCT02018861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057550|NCT02018861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057551|NCT02018861|Immunologic Factors|immunologic factors|mesh-ancestor
92057552|NCT02018861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057553|NCT02018861|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057554|NCT02018861|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92057555|NCT02018861|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92057556|NCT02018861|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92057557|NCT02018861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057558|NCT02018861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057559|NCT02018861|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92057560|NCT02018861|Alkylating Agents|alkylating agents|mesh-ancestor
92057561|NCT02017535|Fluoxetine|fluoxetine|mesh-list
92057562|NCT02017535|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92057563|NCT02017535|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92057564|NCT02017535|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057565|NCT02017535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057566|NCT02017535|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057567|NCT02017535|Serotonin Agents|serotonin agents|mesh-ancestor
92057568|NCT02017535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057569|NCT02017535|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92057570|NCT02017535|Antidepressive Agents|antidepressive agents|mesh-ancestor
92057571|NCT02017535|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057572|NCT02017535|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92057573|NCT02017535|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92057574|NCT02017535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057575|NCT01944098|Lidocaine|lidocaine|mesh-list
92057576|NCT01944098|Anesthetics, Local|anesthetics, local|mesh-ancestor
92057577|NCT01944098|Anesthetics|anesthetics|mesh-ancestor
92015045|NCT05555641|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92015046|NCT05555641|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92015047|NCT05555641|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92015048|NCT05555641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015049|NCT05555641|Immunologic Factors|immunologic factors|mesh-ancestor
92015050|NCT05115513|Dronabinol|dronabinol|mesh-list
92057578|NCT01944098|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057579|NCT01944098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057580|NCT01944098|Sensory System Agents|sensory system agents|mesh-ancestor
92057581|NCT01944098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057582|NCT01944098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92057583|NCT01944098|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92057584|NCT01944098|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92057585|NCT01944098|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057586|NCT01944098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057587|NCT01943552|Bromides|bromides|mesh-list
92057588|NCT01943552|Ipratropium|ipratropium|mesh-list
92057589|NCT01943552|Anticonvulsants|anticonvulsants|mesh-ancestor
92057590|NCT01943552|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92057591|NCT01943552|Autonomic Agents|autonomic agents|mesh-ancestor
92057592|NCT01943552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057593|NCT01943552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057594|NCT01943552|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92057595|NCT01943552|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057596|NCT01943552|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92057597|NCT01943552|Cholinergic Agents|cholinergic agents|mesh-ancestor
92057598|NCT01943552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057599|NCT01943552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057600|NCT01915940|Timolol|timolol|mesh-list
92057601|NCT01915940|Bimatoprost|bimatoprost|mesh-list
92057602|NCT01915940|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92057603|NCT01915940|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92057604|NCT01915940|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92057606|NCT01915940|Adrenergic Agents|adrenergic agents|mesh-ancestor
92057607|NCT01915940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057608|NCT01915940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057609|NCT01915940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057610|NCT01915940|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92057611|NCT01915940|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92057613|NCT01914926|Diltiazem|diltiazem|mesh-list
92057614|NCT01914926|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92057615|NCT01914926|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92057616|NCT01914926|Sympatholytics|sympatholytics|mesh-ancestor
92057617|NCT01914926|Autonomic Agents|autonomic agents|mesh-ancestor
92057618|NCT01914926|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057619|NCT01914926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057620|NCT01914926|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92057621|NCT01914926|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92057622|NCT01914926|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92057623|NCT01914926|Adrenergic Agents|adrenergic agents|mesh-ancestor
92057624|NCT01914926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057625|NCT01914926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057626|NCT01914926|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92057627|NCT01914926|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057628|NCT01914926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92057629|NCT01914926|Vasodilator Agents|vasodilator agents|mesh-ancestor
92057630|NCT05119166|Niacinamide|niacinamide|mesh-list
92057632|NCT05119166|Nicotinic Acids|nicotinic acids|mesh-list
92057633|NCT05119166|Azithromycin|azithromycin|mesh-list
92057634|NCT05119166|Vitamins|vitamins|mesh-ancestor
92057635|NCT05119166|Micronutrients|micronutrients|mesh-ancestor
92057636|NCT05119166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057637|NCT05119166|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057638|NCT05119166|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057639|NCT05119166|Vitamin B Complex|vitamin b complex|mesh-ancestor
92057640|NCT05119166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92057641|NCT05119166|Antimetabolites|antimetabolites|mesh-ancestor
92015051|NCT05115513|Hallucinogens|hallucinogens|mesh-ancestor
92015052|NCT05115513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015053|NCT05115513|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015054|NCT05115513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92015055|NCT05115513|Analgesics|analgesics|mesh-ancestor
92015056|NCT05115513|Sensory System Agents|sensory system agents|mesh-ancestor
92015057|NCT05115513|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057642|NCT05119166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057643|NCT05119166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92057644|NCT05119166|Vasodilator Agents|vasodilator agents|mesh-ancestor
92057645|NCT01942148|Aripiprazole|aripiprazole|mesh-list
92057646|NCT01942148|Antidepressive Agents|antidepressive agents|mesh-ancestor
92057647|NCT01942148|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057648|NCT01942148|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92057649|NCT01942148|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92057650|NCT01942148|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057651|NCT01942148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057652|NCT01942148|Dopamine Agonists|dopamine agonists|mesh-ancestor
92057653|NCT01942148|Dopamine Agents|dopamine agents|mesh-ancestor
92057654|NCT01942148|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057655|NCT01942148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057656|NCT01942148|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92057657|NCT01942148|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92057658|NCT01942148|Serotonin Agents|serotonin agents|mesh-ancestor
92057659|NCT01942148|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92057660|NCT01942148|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92057661|NCT01942148|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92057662|NCT01942148|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92057663|NCT02030015|Miglustat|miglustat|mesh-list
92057664|NCT02030015|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057665|NCT02030015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057666|NCT02030015|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92057667|NCT02030015|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92057668|NCT02030015|Antiviral Agents|antiviral agents|mesh-ancestor
92057669|NCT02030015|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057670|NCT02030015|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92057671|NCT02030015|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057672|NCT02030015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057673|NCT02029235|Acetaminophen|acetaminophen|mesh-list
92057674|NCT02029235|Ibuprofen|ibuprofen|mesh-list
92057675|NCT02029235|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92057676|NCT02029235|Hydrocodone|hydrocodone|mesh-list
92057677|NCT02029235|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92057678|NCT02029235|Analgesics|analgesics|mesh-ancestor
92057689|NCT02029235|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92057690|NCT02029235|Narcotics|narcotics|mesh-ancestor
92057691|NCT02029235|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057692|NCT02029235|Antitussive Agents|antitussive agents|mesh-ancestor
92057693|NCT02029235|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057694|NCT01617434|Liraglutide|liraglutide|mesh-list
92057695|NCT01617434|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057696|NCT01617434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057697|NCT01617434|Incretins|incretins|mesh-ancestor
92057698|NCT01617434|Hormones|hormones|mesh-ancestor
92057699|NCT01617434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92057700|NCT01940900|Ranibizumab|ranibizumab|mesh-list
92057701|NCT01940900|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92057702|NCT01940900|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92057703|NCT01940900|Growth Substances|growth substances|mesh-ancestor
92057704|NCT01940900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057705|NCT01940900|Growth Inhibitors|growth inhibitors|mesh-ancestor
92057706|NCT01940900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057707|NCT01911260|Chelating Agents|chelating agents|mesh-list
92057708|NCT01911260|Sequestering Agents|sequestering agents|mesh-ancestor
92057709|NCT01911260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057710|NCT02015819|Leucovorin|leucovorin|mesh-list
92057711|NCT02015819|Flucytosine|flucytosine|mesh-list
92057712|NCT02015819|Calcium|calcium|mesh-list
92057713|NCT02015819|Levoleucovorin|levoleucovorin|mesh-list
92015058|NCT05115513|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92057714|NCT02015819|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92057715|NCT02015819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057716|NCT02015819|Antidotes|antidotes|mesh-ancestor
92057717|NCT02015819|Protective Agents|protective agents|mesh-ancestor
92057718|NCT02015819|Vitamin B Complex|vitamin b complex|mesh-ancestor
92057719|NCT02015819|Vitamins|vitamins|mesh-ancestor
92057720|NCT02015819|Micronutrients|micronutrients|mesh-ancestor
92057721|NCT02015819|Antifungal Agents|antifungal agents|mesh-ancestor
92057722|NCT02015819|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057723|NCT02015819|Antimetabolites|antimetabolites|mesh-ancestor
92057724|NCT02015819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057725|NCT01939496|Canagliflozin|canagliflozin|mesh-list
92057726|NCT01939496|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92057727|NCT01939496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057728|NCT01939496|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057729|NCT01939496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057730|NCT01939028|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92057731|NCT01938716|Gemcitabine|gemcitabine|mesh-list
92057732|NCT01938716|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92057733|NCT01938716|Antimetabolites|antimetabolites|mesh-ancestor
92057734|NCT01938716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057735|NCT01938716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057738|NCT01937390|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92057739|NCT01937390|Autonomic Agents|autonomic agents|mesh-ancestor
92057740|NCT01937390|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057741|NCT01937390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057742|NCT01937390|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92057744|NCT01937390|Parasympatholytics|parasympatholytics|mesh-ancestor
92057745|NCT01937390|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92057746|NCT01937390|Cholinergic Agents|cholinergic agents|mesh-ancestor
92057747|NCT01937390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057748|NCT01937390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057750|NCT02028767|Metformin|metformin|mesh-list
92057751|NCT02028767|Empagliflozin|empagliflozin|mesh-list
92057752|NCT02028767|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057753|NCT02028767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057754|NCT02028767|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92057755|NCT02028767|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057756|NCT04678895|Naltrexone|naltrexone|mesh-list
92057757|NCT04678895|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92057758|NCT04678895|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92057759|NCT04678895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057760|NCT04678895|Sensory System Agents|sensory system agents|mesh-ancestor
92058251|NCT01929044|Mydriatics|mydriatics|mesh-ancestor
92057761|NCT04678895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057762|NCT04683965|Bevacizumab|bevacizumab|mesh-list
92057763|NCT04683965|Pemetrexed|pemetrexed|mesh-list
92057764|NCT04683965|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057765|NCT04683965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057766|NCT04683965|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92057767|NCT04683965|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92057768|NCT04683965|Growth Substances|growth substances|mesh-ancestor
92057769|NCT04683965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057770|NCT04683965|Growth Inhibitors|growth inhibitors|mesh-ancestor
92057771|NCT04683965|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057772|NCT04683965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057773|NCT04683965|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92057774|NCT04683965|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92057775|NCT02015195|Ethanol|ethanol|mesh-list
92057776|NCT02015195|Acetic Acid|acetic acid|mesh-list
92057777|NCT02015195|Retinol acetate|retinol acetate|mesh-list
92057778|NCT02015195|Lidocaine|lidocaine|mesh-list
92057779|NCT02015195|Anesthetics, Local|anesthetics, local|mesh-ancestor
92057780|NCT02015195|Anesthetics|anesthetics|mesh-ancestor
92057781|NCT02015195|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057782|NCT02015195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057783|NCT02015195|Sensory System Agents|sensory system agents|mesh-ancestor
92057784|NCT02015195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057785|NCT02015195|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92057786|NCT02015195|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92057787|NCT02015195|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92057788|NCT02015195|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057789|NCT02015195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057790|NCT02015195|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92057791|NCT02015195|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057792|NCT02015195|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057793|NCT02015195|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92057794|NCT02015195|Immunologic Factors|immunologic factors|mesh-ancestor
92057795|NCT02015195|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92057796|NCT02015195|Protective Agents|protective agents|mesh-ancestor
92057797|NCT02015195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057798|NCT02025725|Metoclopramide|metoclopramide|mesh-list
92057799|NCT02025725|Antiemetics|antiemetics|mesh-ancestor
92057800|NCT02025725|Autonomic Agents|autonomic agents|mesh-ancestor
92057801|NCT02025725|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057802|NCT02025725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057803|NCT02025725|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92057804|NCT02025725|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92057805|NCT02025725|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92057806|NCT02025725|Dopamine Agents|dopamine agents|mesh-ancestor
92057807|NCT02025725|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057808|NCT02025725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057809|NCT02025179|Teriparatide|teriparatide|mesh-list
92057810|NCT02025179|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92057811|NCT02025179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057812|NCT02025179|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92057813|NCT02013791|Cyclosporine|cyclosporine|mesh-list
92057814|NCT02013791|Cyclosporins|cyclosporins|mesh-list
92057928|NCT01937312|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92057929|NCT01937312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057930|NCT01909934|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92057931|NCT01909934|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92057932|NCT01909934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057933|NCT01909934|Immunotoxins|immunotoxins|mesh-ancestor
92057934|NCT01909934|Immunoconjugates|immunoconjugates|mesh-ancestor
92057935|NCT01909934|Immunologic Factors|immunologic factors|mesh-ancestor
92057936|NCT01909934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057937|NCT01935128|Everolimus|everolimus|mesh-list
92057938|NCT01935128|Tacrolimus|tacrolimus|mesh-list
92057939|NCT01935128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057940|NCT01935128|Immunologic Factors|immunologic factors|mesh-ancestor
92057941|NCT01935128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057942|NCT01935128|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92057943|NCT01935128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057944|NCT01935128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057945|NCT01935128|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92057946|NCT01935128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92057947|NCT01935128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057948|NCT01934972|Cycloserine|cycloserine|mesh-list
92057949|NCT01934972|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92057950|NCT01934972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057951|NCT01934972|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92057952|NCT01934972|Antitubercular Agents|antitubercular agents|mesh-ancestor
92057953|NCT01934972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057954|NCT01934972|Antimetabolites|antimetabolites|mesh-ancestor
92057955|NCT01934972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057956|NCT01959230|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92057957|NCT01959230|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92057958|NCT01959230|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92057959|NCT01959230|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92057960|NCT01959230|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92057961|NCT01959230|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92057962|NCT01959230|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92057963|NCT01959230|Adrenergic Agents|adrenergic agents|mesh-ancestor
92057964|NCT01959230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057965|NCT01959230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057966|NCT01959230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057967|NCT01977937|Gabapentin|gabapentin|mesh-list
92057968|NCT01977937|Analgesics|analgesics|mesh-ancestor
92057969|NCT01977937|Sensory System Agents|sensory system agents|mesh-ancestor
92057970|NCT01977937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057971|NCT01977937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015059|NCT05115513|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92015060|NCT05115513|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015061|NCT05115513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015062|NCT05115513|Hormones|hormones|mesh-ancestor
92057972|NCT01977937|Anticonvulsants|anticonvulsants|mesh-ancestor
92057973|NCT01977937|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92057974|NCT01977937|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92057975|NCT01977937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92057976|NCT01977937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057977|NCT01977937|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92057978|NCT01977937|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92057980|NCT01977937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057982|NCT02015663|Tobramycin|tobramycin|mesh-list
92057983|NCT02015663|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057984|NCT02015663|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057985|NCT01978093|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92057986|NCT01978093|Immunologic Factors|immunologic factors|mesh-ancestor
92057987|NCT01978093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057988|NCT01951105|Naproxen|naproxen|mesh-list
92057989|NCT01951105|Levodopa|levodopa|mesh-list
92057990|NCT01951105|Carbidopa|carbidopa|mesh-list
92057991|NCT01951105|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92057992|NCT01951105|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92057993|NCT01951105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92057994|NCT01951105|Analgesics|analgesics|mesh-ancestor
92057995|NCT01951105|Sensory System Agents|sensory system agents|mesh-ancestor
92057996|NCT01951105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057997|NCT01951105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057998|NCT01951105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057999|NCT01951105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058000|NCT01951105|Gout Suppressants|gout suppressants|mesh-ancestor
92058001|NCT01951105|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92058002|NCT01951105|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058003|NCT01951105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058004|NCT01951105|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92058005|NCT01951105|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92058006|NCT01951105|Dopamine Agents|dopamine agents|mesh-ancestor
92058007|NCT01951105|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058008|NCT01951105|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92058009|NCT01951105|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92058010|NCT01951105|Immunologic Factors|immunologic factors|mesh-ancestor
92058011|NCT01951105|Dopamine Agonists|dopamine agonists|mesh-ancestor
92058012|NCT01958918|Ranibizumab|ranibizumab|mesh-list
92058013|NCT01958918|Aflibercept|aflibercept|mesh-list
92058014|NCT01958918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058015|NCT01958918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92058016|NCT01958918|Growth Substances|growth substances|mesh-ancestor
92058017|NCT01958918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058018|NCT01958918|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058019|NCT01958918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058020|NCT01945489|Botulinum Toxins|botulinum toxins|mesh-list
92058021|NCT01945489|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92058022|NCT01945489|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92058023|NCT01945489|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92058024|NCT01945489|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058025|NCT01945489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058026|NCT01945489|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058027|NCT01945489|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058028|NCT01945489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058029|NCT01945489|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92058030|NCT01945489|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058031|NCT01934894|Lapatinib|lapatinib|mesh-list
92058032|NCT01934894|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058033|NCT01934894|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92058034|NCT01934894|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058035|NCT01934894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015063|NCT05115513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015064|NCT01672801|Nimodipine|nimodipine|mesh-list
92058036|NCT01950169|Vitamin D|vitamin d|mesh-list
92058037|NCT01950169|Cholecalciferol|cholecalciferol|mesh-list
92058038|NCT01950169|Risedronic Acid|risedronic acid|mesh-list
92058039|NCT01950169|Diphosphonates|diphosphonates|mesh-list
92058040|NCT01950169|Calcium|calcium|mesh-list
92058041|NCT01950169|Vitamins|vitamins|mesh-ancestor
92058042|NCT01950169|Micronutrients|micronutrients|mesh-ancestor
92058043|NCT01950169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058044|NCT01950169|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92058045|NCT01950169|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92058046|NCT01950169|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92058047|NCT01950169|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058048|NCT01950169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058050|NCT01909466|Antidepressive Agents|antidepressive agents|mesh-ancestor
92058056|NCT01909466|Dopamine Agonists|dopamine agonists|mesh-ancestor
92058057|NCT01909466|Dopamine Agents|dopamine agents|mesh-ancestor
92058058|NCT01909466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058059|NCT01909466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058060|NCT01909466|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92058061|NCT01909466|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92058062|NCT01909466|Serotonin Agents|serotonin agents|mesh-ancestor
92058063|NCT01909466|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92058064|NCT01909466|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92058065|NCT01909466|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92058066|NCT01909466|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92058067|NCT01977625|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92058068|NCT01977625|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92058069|NCT01977625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058070|NCT01977625|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92058071|NCT01977625|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92058072|NCT01977625|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058073|NCT01977625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058074|NCT01977625|Dopamine Agents|dopamine agents|mesh-ancestor
92058075|NCT01977625|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058076|NCT01995071|Ribavirin|ribavirin|mesh-list
92058077|NCT01995071|Antimetabolites|antimetabolites|mesh-ancestor
92058078|NCT01995071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058079|NCT01995071|Antiviral Agents|antiviral agents|mesh-ancestor
92058080|NCT01995071|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058081|NCT01994837|Venetoclax|venetoclax|mesh-list
92058082|NCT01994837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058083|NCT02010593|Dapivirine|dapivirine|mesh-list
92058084|NCT02010593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92058085|NCT02010593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92058086|NCT02010593|Antiviral Agents|antiviral agents|mesh-ancestor
92058087|NCT02010593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058088|NCT01994291|Ranibizumab|ranibizumab|mesh-list
92058089|NCT01994291|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058090|NCT01994291|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92058091|NCT01994291|Growth Substances|growth substances|mesh-ancestor
92058092|NCT01994291|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058093|NCT01994291|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058094|NCT01994291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058095|NCT04667039|Ranibizumab|ranibizumab|mesh-list
92058096|NCT04667039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058097|NCT04667039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92058098|NCT04667039|Growth Substances|growth substances|mesh-ancestor
92058099|NCT04667039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058100|NCT04667039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058101|NCT04667039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058102|NCT01993823|Clotrimazole|clotrimazole|mesh-list
92058103|NCT01993823|Miconazole|miconazole|mesh-list
92058104|NCT01993823|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92058105|NCT01993823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058106|NCT01993823|Antifungal Agents|antifungal agents|mesh-ancestor
92058107|NCT01993823|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92058108|NCT01993823|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92058109|NCT01993823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058110|NCT01993823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015065|NCT01672801|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92015066|NCT01672801|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92015067|NCT01672801|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058111|NCT01993823|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92058112|NCT01993823|Hormone Antagonists|hormone antagonists|mesh-ancestor
92058113|NCT01993823|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92058114|NCT01993823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058115|NCT01993823|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92058116|NCT01993823|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92058117|NCT01993667|Acetazolamide|acetazolamide|mesh-list
92058118|NCT01993667|Anticonvulsants|anticonvulsants|mesh-ancestor
92058122|NCT01993667|Diuretics|diuretics|mesh-ancestor
92058123|NCT01993667|Natriuretic Agents|natriuretic agents|mesh-ancestor
92058124|NCT01993667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058125|NCT01934192|Metoclopramide|metoclopramide|mesh-list
92058126|NCT01934192|Antiemetics|antiemetics|mesh-ancestor
92058127|NCT01934192|Autonomic Agents|autonomic agents|mesh-ancestor
92058128|NCT01934192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058129|NCT01934192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058130|NCT01934192|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058131|NCT01934192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92058132|NCT01934192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92058133|NCT01934192|Dopamine Agents|dopamine agents|mesh-ancestor
92058134|NCT01934192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058135|NCT01934192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058136|NCT01933880|Methylphenidate|methylphenidate|mesh-list
92058137|NCT01933880|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92058138|NCT01933880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058139|NCT01933880|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92058140|NCT01933880|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92058141|NCT01933880|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058142|NCT01933880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058143|NCT01933880|Dopamine Agents|dopamine agents|mesh-ancestor
92058144|NCT01933880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058146|NCT02008877|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92058147|NCT02008877|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058148|NCT02008877|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92058149|NCT02008877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058150|NCT02008877|Antifungal Agents|antifungal agents|mesh-ancestor
92058151|NCT02008877|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058152|NCT02008877|Immunologic Factors|immunologic factors|mesh-ancestor
92058153|NCT02008877|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058154|NCT01933334|Pirfenidone|pirfenidone|mesh-list
92058155|NCT01933334|Analgesics|analgesics|mesh-ancestor
92058156|NCT01933334|Sensory System Agents|sensory system agents|mesh-ancestor
92058157|NCT01933334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058158|NCT01933334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058159|NCT01933334|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058160|NCT01933334|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058161|NCT01933334|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058162|NCT01933334|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058163|NCT01933334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058164|NCT01908140|Fluticasone|fluticasone|mesh-list
92058166|NCT01908140|Formoterol Fumarate|formoterol fumarate|mesh-list
92058167|NCT01908140|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92058168|NCT01908140|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058169|NCT01908140|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92058170|NCT01908140|Autonomic Agents|autonomic agents|mesh-ancestor
92058171|NCT01908140|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058172|NCT01908140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058173|NCT01908140|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92058174|NCT01908140|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058175|NCT01908140|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058176|NCT01908140|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92058177|NCT01908140|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92058178|NCT01908140|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92058179|NCT01908140|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92058180|NCT01908140|Adrenergic Agents|adrenergic agents|mesh-ancestor
92058181|NCT01908140|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015068|NCT01672801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015069|NCT01672801|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92015070|NCT01672801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058182|NCT01908140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058183|NCT01908140|Anticonvulsants|anticonvulsants|mesh-ancestor
92058185|NCT02008565|Antidiarrheals|antidiarrheals|mesh-list
92058186|NCT02008565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058187|NCT01931150|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92058188|NCT01931150|Dapsone|dapsone|mesh-list
92058189|NCT01931150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058190|NCT01931150|Antimalarials|antimalarials|mesh-ancestor
92058195|NCT01931150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058196|NCT01931150|Leprostatic Agents|leprostatic agents|mesh-ancestor
92058197|NCT01906346|Cocaine|cocaine|mesh-list
92058198|NCT01906346|Anesthetics, Local|anesthetics, local|mesh-ancestor
92058200|NCT01906346|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058201|NCT01906346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058202|NCT01906346|Sensory System Agents|sensory system agents|mesh-ancestor
92058203|NCT01906346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058204|NCT01906346|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92058205|NCT01906346|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92058206|NCT01906346|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92058207|NCT01906346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058208|NCT01906346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058209|NCT01906346|Dopamine Agents|dopamine agents|mesh-ancestor
92058210|NCT01906346|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058211|NCT04645004|Aspirin|aspirin|mesh-list
92058212|NCT04645004|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058213|NCT04645004|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058214|NCT04645004|Analgesics|analgesics|mesh-ancestor
92058215|NCT04645004|Sensory System Agents|sensory system agents|mesh-ancestor
92058216|NCT04645004|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058217|NCT04645004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058218|NCT04645004|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058219|NCT04645004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058220|NCT04645004|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92058221|NCT04645004|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92058222|NCT04645004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058223|NCT04645004|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92058224|NCT04645004|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92058225|NCT04645004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058226|NCT04645004|Antipyretics|antipyretics|mesh-ancestor
92058227|NCT01929980|Bortezomib|bortezomib|mesh-list
92058228|NCT01929980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058229|NCT01363076|Ketorolac|ketorolac|mesh-list
92058230|NCT01363076|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92058231|NCT01363076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058232|NCT01363076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058233|NCT01363076|Analgesics|analgesics|mesh-ancestor
92058234|NCT01363076|Sensory System Agents|sensory system agents|mesh-ancestor
92058235|NCT01363076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058236|NCT01363076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058237|NCT01363076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058238|NCT01363076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058239|NCT01363076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92058240|NCT01363076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058241|NCT01363076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058242|NCT01929044|Anisodamine|anisodamine|mesh-list
92058243|NCT01929044|Scopolamine|scopolamine|mesh-list
92058244|NCT01929044|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92058245|NCT01929044|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92058246|NCT01929044|Antiemetics|antiemetics|mesh-ancestor
92058247|NCT01929044|Autonomic Agents|autonomic agents|mesh-ancestor
92058248|NCT01929044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058249|NCT01929044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058250|NCT01929044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058252|NCT01929044|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92015071|NCT01672801|Vasodilator Agents|vasodilator agents|mesh-ancestor
92058253|NCT01929044|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058254|NCT01929044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058255|NCT01929044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058256|NCT01929044|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92058257|NCT01929044|Parasympatholytics|parasympatholytics|mesh-ancestor
92058258|NCT01929044|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92058259|NCT01929044|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92058260|NCT01929044|Adrenergic Agents|adrenergic agents|mesh-ancestor
92058261|NCT01929044|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92058264|NCT01929044|Analgesics|analgesics|mesh-ancestor
92058265|NCT01929044|Sensory System Agents|sensory system agents|mesh-ancestor
92058266|NCT01929044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058267|NCT01929044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058268|NCT01929044|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92058269|NCT01929044|Vasodilator Agents|vasodilator agents|mesh-ancestor
92058270|NCT01929044|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92058271|NCT01929044|Antioxidants|antioxidants|mesh-ancestor
92058272|NCT01929044|Protective Agents|protective agents|mesh-ancestor
92058273|NCT01957202|Levocabastine|levocabastine|mesh-list
92058274|NCT01957202|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92058275|NCT01957202|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92058276|NCT01957202|Histamine Antagonists|histamine antagonists|mesh-ancestor
92058277|NCT01957202|Histamine Agents|histamine agents|mesh-ancestor
92058278|NCT01957202|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058279|NCT01957202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058280|NCT01957202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058282|NCT01616654|Trifarotene|trifarotene|mesh-list
92058283|NCT01616654|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058284|NCT01616654|Keratolytic Agents|keratolytic agents|mesh-ancestor
92058285|NCT01902290|Brodalumab|brodalumab|mesh-list
92058286|NCT01902290|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058287|NCT01467466|Acetylcysteine|acetylcysteine|mesh-list
92058288|NCT01467466|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92058289|NCT01467466|Antiviral Agents|antiviral agents|mesh-ancestor
92058290|NCT01467466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058291|NCT01467466|Expectorants|expectorants|mesh-ancestor
92058292|NCT01467466|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058293|NCT01467466|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92058294|NCT01467466|Antioxidants|antioxidants|mesh-ancestor
92058295|NCT01467466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058296|NCT01467466|Protective Agents|protective agents|mesh-ancestor
92058297|NCT01467466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058298|NCT01467466|Antidotes|antidotes|mesh-ancestor
92058299|NCT01441180|Sofosbuvir|sofosbuvir|mesh-list
92058300|NCT01441180|Ribavirin|ribavirin|mesh-list
92058301|NCT01441180|Antiviral Agents|antiviral agents|mesh-ancestor
92058302|NCT01441180|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058303|NCT01441180|Antimetabolites|antimetabolites|mesh-ancestor
92058304|NCT01441180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058305|NCT01441102|Dextromethorphan|dextromethorphan|mesh-list
92058306|NCT01441102|Antitussive Agents|antitussive agents|mesh-ancestor
92058307|NCT01441102|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058308|NCT01441102|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92058309|NCT01441102|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92058310|NCT01441102|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058311|NCT01441102|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058312|NCT01441102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058313|NCT04061980|Nivolumab|nivolumab|mesh-list
92058314|NCT04061980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058315|NCT04061980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058316|NCT04061980|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92058317|NCT04061980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058318|NCT01467076|Alprostadil|alprostadil|mesh-list
92058319|NCT01467076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92058320|NCT01467076|Vasodilator Agents|vasodilator agents|mesh-ancestor
92058321|NCT01467076|Urological Agents|urological agents|mesh-ancestor
92058322|NCT01466062|Palivizumab|palivizumab|mesh-list
92058323|NCT01466062|Antiviral Agents|antiviral agents|mesh-ancestor
92058324|NCT01466062|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058325|NCT04504864|Aspirin|aspirin|mesh-list
92058326|NCT04504864|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058327|NCT04504864|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058328|NCT04504864|Analgesics|analgesics|mesh-ancestor
92015072|NCT05613335|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92015073|NCT05613335|Hemostatics|hemostatics|mesh-ancestor
92015074|NCT05613335|Coagulants|coagulants|mesh-ancestor
92058329|NCT04504864|Sensory System Agents|sensory system agents|mesh-ancestor
92058330|NCT04504864|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058331|NCT04504864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058332|NCT04504864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058333|NCT04504864|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058334|NCT04504864|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92058335|NCT04504864|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92058337|NCT04504864|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92058338|NCT04504864|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92058339|NCT04504864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058340|NCT04504864|Antipyretics|antipyretics|mesh-ancestor
92058342|NCT04060342|Gemcitabine|gemcitabine|mesh-list
92058343|NCT04060342|Pembrolizumab|pembrolizumab|mesh-list
92058344|NCT04060342|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92058345|NCT04060342|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058346|NCT04060342|Tubulin Modulators|tubulin modulators|mesh-ancestor
92058347|NCT04060342|Antimitotic Agents|antimitotic agents|mesh-ancestor
92058348|NCT04060342|Mitosis Modulators|mitosis modulators|mesh-ancestor
92058349|NCT04060342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058350|NCT04060342|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92058351|NCT04060342|Antimetabolites|antimetabolites|mesh-ancestor
92058352|NCT04060342|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058353|NCT04060342|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92058354|NCT01435018|Tenofovir|tenofovir|mesh-list
92058355|NCT01435018|Emtricitabine|emtricitabine|mesh-list
92058356|NCT01435018|Efavirenz|efavirenz|mesh-list
92058357|NCT01435018|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92058358|NCT01435018|Efavirenz, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|efavirenz, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92058359|NCT01435018|Paclitaxel|paclitaxel|mesh-list
92058360|NCT01435018|Etoposide|etoposide|mesh-list
92058361|NCT01435018|Vincristine|vincristine|mesh-list
92058362|NCT01435018|Bleomycin|bleomycin|mesh-list
92058363|NCT01435018|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92058364|NCT01435018|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058365|NCT01435018|Tubulin Modulators|tubulin modulators|mesh-ancestor
92058366|NCT01435018|Antimitotic Agents|antimitotic agents|mesh-ancestor
92058367|NCT01435018|Mitosis Modulators|mitosis modulators|mesh-ancestor
92058368|NCT01435018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058369|NCT01435018|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92058370|NCT01435018|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92058371|NCT01435018|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058372|NCT01435018|Antiviral Agents|antiviral agents|mesh-ancestor
92058373|NCT01435018|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058374|NCT01435018|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92058375|NCT01435018|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92058376|NCT01435018|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92058377|NCT01435018|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92058378|NCT01435018|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92058379|NCT01435018|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92058380|NCT01435018|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92058381|NCT01435018|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92058382|NCT01435018|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92058383|NCT01435018|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92058384|NCT01435018|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92058385|NCT01419184|Vancomycin|vancomycin|mesh-list
92058386|NCT01419184|Daptomycin|daptomycin|mesh-list
92058387|NCT01419184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92058389|NCT01417156|Nintedanib|nintedanib|mesh-list
92058390|NCT01417156|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058391|NCT01417156|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92058392|NCT01417156|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058393|NCT01417156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058394|NCT01417078|Diazepam|diazepam|mesh-list
92058395|NCT01417078|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92058396|NCT01417078|Anticonvulsants|anticonvulsants|mesh-ancestor
92058397|NCT01417078|Antiemetics|antiemetics|mesh-ancestor
92058398|NCT01417078|Autonomic Agents|autonomic agents|mesh-ancestor
92058399|NCT01417078|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015075|NCT05078463|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92015076|NCT05078463|Terephthalic acid|terephthalic acid|mesh-list
92015077|NCT05078463|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015078|NCT05078463|Anesthetics|anesthetics|mesh-ancestor
92015079|NCT05078463|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058400|NCT01417078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058401|NCT01417078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058402|NCT01417078|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92058403|NCT01417078|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058404|NCT01417078|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92058405|NCT01417078|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92058406|NCT01417078|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92058407|NCT01417078|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058409|NCT01417078|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92058410|NCT01417078|Anesthetics, General|anesthetics, general|mesh-ancestor
92058411|NCT01417078|Anesthetics|anesthetics|mesh-ancestor
92058412|NCT01417078|GABA Modulators|gaba modulators|mesh-ancestor
92058413|NCT01417078|GABA Agents|gaba agents|mesh-ancestor
92058414|NCT01417078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058415|NCT01417078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058416|NCT01954394|Alirocumab|alirocumab|mesh-list
92058417|NCT01954394|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92058418|NCT01954394|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92058419|NCT01954394|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92058420|NCT01954394|Antimetabolites|antimetabolites|mesh-ancestor
92058421|NCT01954394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058422|NCT01954394|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92058423|NCT01954394|Protease Inhibitors|protease inhibitors|mesh-ancestor
92058424|NCT01954394|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058425|NCT01954394|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92058426|NCT01464424|Bimatoprost|bimatoprost|mesh-list
92058427|NCT01464424|Travoprost|travoprost|mesh-list
92058428|NCT01464424|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92058429|NCT01464424|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92058430|NCT01464424|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92058431|NCT01902134|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92058432|NCT01902134|Tramadol|tramadol|mesh-list
92058433|NCT01902134|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92058434|NCT01902134|Narcotics|narcotics|mesh-ancestor
92058435|NCT01902134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058436|NCT01902134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058437|NCT01902134|Analgesics|analgesics|mesh-ancestor
92058438|NCT01902134|Sensory System Agents|sensory system agents|mesh-ancestor
92058439|NCT01902134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058440|NCT01902134|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058441|NCT01902134|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058442|NCT01902134|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058443|NCT01902134|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058444|NCT01954082|Inositol|inositol|mesh-list
92058445|NCT01954082|Vitamin B Complex|vitamin b complex|mesh-ancestor
92058446|NCT01954082|Vitamins|vitamins|mesh-ancestor
92058447|NCT01954082|Micronutrients|micronutrients|mesh-ancestor
92058448|NCT01954082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058449|NCT01417000|Cyclophosphamide|cyclophosphamide|mesh-list
92058450|NCT01417000|Pancrelipase|pancrelipase|mesh-list
92058451|NCT01417000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058452|NCT01417000|Immunologic Factors|immunologic factors|mesh-ancestor
92058453|NCT01417000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058454|NCT01417000|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058455|NCT01417000|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92058456|NCT01417000|Alkylating Agents|alkylating agents|mesh-ancestor
92058457|NCT01417000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058458|NCT01417000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058459|NCT01417000|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92058460|NCT01417000|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058461|NCT01415986|Temoporfin|temoporfin|mesh-list
92058462|NCT01415986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058463|NCT01415986|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92058464|NCT01415986|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058465|NCT01415518|Budesonide|budesonide|mesh-list
92058466|NCT01415518|Theophylline|theophylline|mesh-list
92058467|NCT01415518|Formoterol Fumarate|formoterol fumarate|mesh-list
92015080|NCT05078463|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015081|NCT05078463|Sensory System Agents|sensory system agents|mesh-ancestor
92015082|NCT05078463|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015083|NCT05078463|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92015084|NCT05078463|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92058468|NCT01415518|Ipratropium|ipratropium|mesh-list
92058469|NCT01415518|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92058470|NCT01415518|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058471|NCT01415518|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92058472|NCT01415518|Autonomic Agents|autonomic agents|mesh-ancestor
92058473|NCT01415518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058474|NCT01415518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058475|NCT01415518|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92058476|NCT01415518|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058477|NCT01415518|Glucocorticoids|glucocorticoids|mesh-ancestor
92058478|NCT01415518|Hormones|hormones|mesh-ancestor
92058479|NCT01415518|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92058480|NCT01415518|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92058481|NCT01415518|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92058482|NCT01415518|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92058483|NCT01415518|Adrenergic Agents|adrenergic agents|mesh-ancestor
92058489|NCT01415518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058490|NCT01415518|Vasodilator Agents|vasodilator agents|mesh-ancestor
92058491|NCT01415518|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92058492|NCT01415518|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92058493|NCT01415518|Purinergic Agents|purinergic agents|mesh-ancestor
92058494|NCT01393600|Tetrabenazine|tetrabenazine|mesh-list
92058495|NCT01393600|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92058496|NCT01393600|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92058497|NCT01393600|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058498|NCT01393600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058499|NCT01393600|Adrenergic Agents|adrenergic agents|mesh-ancestor
92058500|NCT01393600|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058501|NCT01393600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058502|NCT04767178|Acetaminophen|acetaminophen|mesh-list
92058503|NCT04767178|Ibuprofen|ibuprofen|mesh-list
92058504|NCT04767178|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058505|NCT04767178|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058506|NCT04767178|Analgesics|analgesics|mesh-ancestor
92058507|NCT04767178|Sensory System Agents|sensory system agents|mesh-ancestor
92058508|NCT04767178|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058509|NCT04767178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058510|NCT04767178|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058511|NCT04767178|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058512|NCT04767178|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92058513|NCT04767178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058514|NCT04767178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058515|NCT04767178|Antipyretics|antipyretics|mesh-ancestor
92058516|NCT01432600|Dexamethasone|dexamethasone|mesh-list
92058517|NCT01432600|Cyclophosphamide|cyclophosphamide|mesh-list
92058518|NCT01432600|Pomalidomide|pomalidomide|mesh-list
92058519|NCT01432600|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058520|NCT01432600|Immunologic Factors|immunologic factors|mesh-ancestor
92058521|NCT01432600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058522|NCT01432600|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058523|NCT01432600|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92058524|NCT01432600|Alkylating Agents|alkylating agents|mesh-ancestor
92058525|NCT01432600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058526|NCT01432600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058527|NCT01432600|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92058528|NCT01432600|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058529|NCT01432600|Antiemetics|antiemetics|mesh-ancestor
92058530|NCT01432600|Autonomic Agents|autonomic agents|mesh-ancestor
92058531|NCT01432600|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058532|NCT01432600|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058533|NCT01432600|Glucocorticoids|glucocorticoids|mesh-ancestor
92058534|NCT01432600|Hormones|hormones|mesh-ancestor
92058535|NCT01432600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015086|NCT05078463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015087|NCT05078463|Protective Agents|protective agents|mesh-ancestor
92058536|NCT01432600|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92058537|NCT01432600|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058538|NCT01432600|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92058539|NCT01432600|Growth Substances|growth substances|mesh-ancestor
92058540|NCT01432600|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058541|NCT01432444|Aripiprazole|aripiprazole|mesh-list
92058542|NCT01432444|Antidepressive Agents|antidepressive agents|mesh-ancestor
92058543|NCT01432444|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058544|NCT01432444|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92058545|NCT01432444|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058546|NCT01432444|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058547|NCT01432444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058548|NCT01432444|Dopamine Agonists|dopamine agonists|mesh-ancestor
92058549|NCT01432444|Dopamine Agents|dopamine agents|mesh-ancestor
92058550|NCT01432444|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058551|NCT01432444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058552|NCT01432444|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92058553|NCT01432444|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92058557|NCT01432444|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92058558|NCT01432444|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92058559|NCT01415440|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92058560|NCT01415440|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92058561|NCT01415440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058562|NCT01415440|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92058563|NCT01415440|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92058564|NCT01415440|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058565|NCT01415440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058566|NCT01415440|Dopamine Agents|dopamine agents|mesh-ancestor
92058567|NCT01415440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058569|NCT01932788|Cholecalciferol|cholecalciferol|mesh-list
92058570|NCT01932788|Vitamins|vitamins|mesh-list
92058571|NCT01932788|Micronutrients|micronutrients|mesh-ancestor
92058572|NCT01932788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058573|NCT01932788|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92058574|NCT01932788|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92058575|NCT01431976|Lamotrigine|lamotrigine|mesh-list
92058576|NCT01431976|Anticonvulsants|anticonvulsants|mesh-ancestor
92058577|NCT01431976|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92058578|NCT01431976|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058579|NCT01431976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058580|NCT01431976|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92058581|NCT01431976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058582|NCT01431976|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92058583|NCT01431976|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058584|NCT01431976|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058585|NCT01431976|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058586|NCT01431976|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92058587|NCT01413958|Loratadine|loratadine|mesh-list
92058588|NCT01413958|Phenylephrine|phenylephrine|mesh-list
92058589|NCT01413958|Oxymetazoline|oxymetazoline|mesh-list
92058590|NCT01413958|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92058591|NCT01413958|Mydriatics|mydriatics|mesh-ancestor
92058592|NCT01413958|Autonomic Agents|autonomic agents|mesh-ancestor
92058593|NCT01413958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058594|NCT01413958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058595|NCT01413958|Sympathomimetics|sympathomimetics|mesh-ancestor
92058596|NCT01413958|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92058597|NCT01413958|Nasal Decongestants|nasal decongestants|mesh-ancestor
92058598|NCT01413958|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058599|NCT01413958|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92058600|NCT01413958|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92058601|NCT01413958|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92058602|NCT01413958|Adrenergic Agents|adrenergic agents|mesh-ancestor
92058603|NCT01413958|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058604|NCT01413958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015088|NCT05170113|Caffeine|caffeine|mesh-list
92015089|NCT05170113|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92015090|NCT05170113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015091|NCT05170113|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92058605|NCT01413958|Protective Agents|protective agents|mesh-ancestor
92058606|NCT01413958|Antipruritics|antipruritics|mesh-ancestor
92058607|NCT01413958|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058608|NCT01413958|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92058609|NCT01413958|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92058610|NCT01413958|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92058611|NCT01413958|Histamine Antagonists|histamine antagonists|mesh-ancestor
92058612|NCT01413958|Histamine Agents|histamine agents|mesh-ancestor
92058613|NCT01413178|Melphalan|melphalan|mesh-list
92058614|NCT01413178|Busulfan|busulfan|mesh-list
92058615|NCT01413178|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92058616|NCT01413178|Alkylating Agents|alkylating agents|mesh-ancestor
92058617|NCT01413178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058618|NCT01413178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058619|NCT01413178|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92058620|NCT01413178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058621|NCT01413178|Immunologic Factors|immunologic factors|mesh-ancestor
92058622|NCT01413178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058623|NCT01412944|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92058644|NCT03025906|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92058645|NCT04053712|Glucagon|glucagon|mesh-list
92058646|NCT04053712|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058647|NCT04053712|Hormones|hormones|mesh-ancestor
92058648|NCT04053712|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92058649|NCT04053712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058650|NCT01798485|Docetaxel|docetaxel|mesh-list
92058651|NCT01798485|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058652|NCT01798485|Tubulin Modulators|tubulin modulators|mesh-ancestor
92058653|NCT01798485|Antimitotic Agents|antimitotic agents|mesh-ancestor
92058654|NCT01798485|Mitosis Modulators|mitosis modulators|mesh-ancestor
92058655|NCT01798485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058656|NCT01767519|Solifenacin Succinate|solifenacin succinate|mesh-list
92058657|NCT01767519|Botulinum Toxins|botulinum toxins|mesh-list
92058658|NCT01767519|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92058659|NCT01767519|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92058660|NCT01767519|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92058661|NCT01767519|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058662|NCT01767519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058663|NCT01767519|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058664|NCT01767519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058665|NCT01767519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058666|NCT01767519|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92058667|NCT01767519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058668|NCT01767519|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92058669|NCT01767519|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92058670|NCT01767519|Urological Agents|urological agents|mesh-ancestor
92058671|NCT01797081|Botulinum Toxins|botulinum toxins|mesh-list
92058672|NCT01797081|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92058673|NCT01797081|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92058674|NCT01797081|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92058675|NCT01797081|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92058676|NCT01797081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058720|NCT01793883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058721|NCT01953692|Pembrolizumab|pembrolizumab|mesh-list
92058722|NCT01953692|Lenalidomide|lenalidomide|mesh-list
92058723|NCT01953692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058724|NCT01953692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058725|NCT01953692|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92058726|NCT01953692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058727|NCT01953692|Immunologic Factors|immunologic factors|mesh-ancestor
92058728|NCT01953692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058729|NCT01953692|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058730|NCT01953692|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92058731|NCT01953692|Growth Substances|growth substances|mesh-ancestor
92015092|NCT05170113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015093|NCT05170113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015094|NCT05170113|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92015095|NCT05170113|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92015096|NCT05170113|Purinergic Agents|purinergic agents|mesh-ancestor
92015097|NCT05170113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015098|NCT05169957|Nivolumab|nivolumab|mesh-list
92015099|NCT05169957|Ipilimumab|ipilimumab|mesh-list
92015100|NCT05169957|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92015101|NCT05169957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058732|NCT01953692|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058733|NCT01791153|Prednisone|prednisone|mesh-list
92058734|NCT01791153|Methotrexate|methotrexate|mesh-list
92058735|NCT01791153|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058736|NCT01791153|Glucocorticoids|glucocorticoids|mesh-ancestor
92058737|NCT01791153|Hormones|hormones|mesh-ancestor
92058738|NCT01791153|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92058739|NCT01791153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058740|NCT01791153|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92058741|NCT01791153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058742|NCT01791153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92058743|NCT01791153|Abortifacient Agents|abortifacient agents|mesh-ancestor
92058744|NCT01791153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92058745|NCT01791153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92058746|NCT01791153|Antimetabolites|antimetabolites|mesh-ancestor
92058747|NCT01791153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058748|NCT01791153|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058749|NCT01791153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058750|NCT01791153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92058751|NCT01791153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058752|NCT01791153|Immunologic Factors|immunologic factors|mesh-ancestor
92058753|NCT01791153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058754|NCT01791153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92058755|NCT01926782|Alirocumab|alirocumab|mesh-list
92058756|NCT01926782|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92058757|NCT01926782|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92058758|NCT01926782|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92058759|NCT01926782|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92058760|NCT01926782|Antimetabolites|antimetabolites|mesh-ancestor
92058761|NCT01926782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058762|NCT01926782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92058763|NCT01926782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92058764|NCT01926782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058765|NCT01926782|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92058766|NCT01926782|Immunologic Factors|immunologic factors|mesh-ancestor
92058767|NCT01926782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058768|NCT01926626|Moclobemide|moclobemide|mesh-list
92058769|NCT01926626|Nicotine|nicotine|mesh-list
92058770|NCT01926626|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92058771|NCT01926626|Autonomic Agents|autonomic agents|mesh-ancestor
92058772|NCT01926626|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058773|NCT01926626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058774|NCT01926626|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92058775|NCT01926626|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92058776|NCT01926626|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058777|NCT01926626|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058778|NCT01926626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058779|NCT01926626|Antidepressive Agents|antidepressive agents|mesh-ancestor
92058780|NCT01926626|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058781|NCT01926626|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92058782|NCT01926626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058787|NCT01900730|GABA Agents|gaba agents|mesh-ancestor
92058788|NCT01900730|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058789|NCT01900730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015102|NCT05169957|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92058790|NCT01900730|Antimanic Agents|antimanic agents|mesh-ancestor
92058791|NCT01900730|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058792|NCT01900730|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058793|NCT01900730|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058794|NCT01952834|Vancomycin|vancomycin|mesh-list
92058795|NCT01952834|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92058796|NCT01952834|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058797|NCT01952054|Denosumab|denosumab|mesh-list
92058798|NCT01952054|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92058799|NCT01952054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058800|NCT01925768|Apremilast|apremilast|mesh-list
92058801|NCT01925768|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058802|NCT01925768|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058803|NCT01925768|Analgesics|analgesics|mesh-ancestor
92058804|NCT01925768|Sensory System Agents|sensory system agents|mesh-ancestor
92058805|NCT01925768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058806|NCT01925768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058807|NCT01925768|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058808|NCT01925768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058809|NCT01925768|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92058810|NCT01925768|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92058811|NCT01925768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058812|NCT01925768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058813|NCT01431274|Tiotropium Bromide|tiotropium bromide|mesh-list
92058814|NCT01431274|Olodaterol|olodaterol|mesh-list
92058815|NCT01431274|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92058816|NCT01431274|Autonomic Agents|autonomic agents|mesh-ancestor
92058817|NCT01431274|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058818|NCT01431274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058819|NCT01431274|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92058820|NCT01431274|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058821|NCT01431274|Parasympatholytics|parasympatholytics|mesh-ancestor
92058822|NCT01431274|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92058823|NCT01431274|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058824|NCT01431274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058825|NCT01431274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058826|NCT01991795|Ticagrelor|ticagrelor|mesh-list
92058827|NCT01991795|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92058988|NCT01925612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058828|NCT01991795|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92058829|NCT01991795|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92058830|NCT01991795|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92058831|NCT01991795|Purinergic Agents|purinergic agents|mesh-ancestor
92058832|NCT01991795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058833|NCT01991795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058834|NCT01991795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058835|NCT02076100|Ruzasvir|ruzasvir|mesh-list
92058836|NCT02076100|Antiviral Agents|antiviral agents|mesh-ancestor
92058837|NCT02076100|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058838|NCT01411774|Cycloserine|cycloserine|mesh-list
92058839|NCT01411774|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92058840|NCT01411774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058841|NCT01411774|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92058842|NCT01411774|Antitubercular Agents|antitubercular agents|mesh-ancestor
92058843|NCT01411774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92058844|NCT01411774|Antimetabolites|antimetabolites|mesh-ancestor
92058845|NCT01411774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058846|NCT01410604|Metformin|metformin|mesh-list
92058847|NCT01410604|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92058848|NCT01410604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058849|NCT01410448|Cyclosporine|cyclosporine|mesh-list
92058850|NCT01410448|Mycophenolic Acid|mycophenolic acid|mesh-list
92058851|NCT01410448|Everolimus|everolimus|mesh-list
92058852|NCT01410448|Cyclosporins|cyclosporins|mesh-list
92058853|NCT01410448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058854|NCT01410448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058855|NCT01410448|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058858|NCT01410448|Antifungal Agents|antifungal agents|mesh-ancestor
92058859|NCT01410448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058860|NCT01410448|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058861|NCT01410448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058862|NCT01410448|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92058863|NCT01410448|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92015103|NCT05169957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015104|NCT05611463|Docetaxel|docetaxel|mesh-list
92015105|NCT05611463|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015106|NCT05611463|Tubulin Modulators|tubulin modulators|mesh-ancestor
92058864|NCT01410448|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92058865|NCT01410448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058866|NCT01410448|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92058867|NCT01410448|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92058868|NCT01410448|Antitubercular Agents|antitubercular agents|mesh-ancestor
92058869|NCT01410448|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92058871|NCT04037176|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92058872|NCT04037176|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92058873|NCT04037176|Respiratory System Agents|respiratory system agents|mesh-ancestor
92058874|NCT01430104|Teriparatide|teriparatide|mesh-list
92058875|NCT01430104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92058876|NCT01430104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058877|NCT01430104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92058878|NCT01990859|Ipilimumab|ipilimumab|mesh-list
92058879|NCT01990859|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058880|NCT01990859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058881|NCT01990859|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92058882|NCT01990859|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058883|NCT02093897|Factor VIII|factor viii|mesh-list
92058884|NCT02093897|Coagulants|coagulants|mesh-ancestor
92058885|NCT01976845|Midazolam|midazolam|mesh-list
92058886|NCT01976845|Propofol|propofol|mesh-list
92058887|NCT01976845|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92058888|NCT01976845|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058889|NCT01976845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058890|NCT01976845|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92058891|NCT01976845|Anesthetics, General|anesthetics, general|mesh-ancestor
92058892|NCT01976845|Anesthetics|anesthetics|mesh-ancestor
92058893|NCT01976845|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92058894|NCT01976845|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92058895|NCT01976845|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058896|NCT01976845|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058897|NCT01976845|GABA Modulators|gaba modulators|mesh-ancestor
92058898|NCT01976845|GABA Agents|gaba agents|mesh-ancestor
92058899|NCT01976845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058900|NCT01976845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058901|NCT01989689|Etanercept|etanercept|mesh-list
92058993|NCT01925612|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92058902|NCT01989689|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058903|NCT01989689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058904|NCT01989689|Analgesics|analgesics|mesh-ancestor
92058905|NCT01989689|Sensory System Agents|sensory system agents|mesh-ancestor
92058906|NCT01989689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058907|NCT01989689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058908|NCT01989689|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058909|NCT01989689|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058910|NCT01989689|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92058911|NCT01989689|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058912|NCT01989689|Immunologic Factors|immunologic factors|mesh-ancestor
92058913|NCT01942993|Vemurafenib|vemurafenib|mesh-list
92058914|NCT01942993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058915|NCT01942993|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92058916|NCT01942993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058917|NCT01942993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058918|NCT01989455|Deferiprone|deferiprone|mesh-list
92058919|NCT01989455|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92058920|NCT01989455|Chelating Agents|chelating agents|mesh-ancestor
92058921|NCT01989455|Sequestering Agents|sequestering agents|mesh-ancestor
92058922|NCT01989455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058923|NCT01987895|Vancomycin|vancomycin|mesh-list
92058924|NCT01987895|Oxazolidinones|oxazolidinones|mesh-list
92058925|NCT01987895|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92058926|NCT01987895|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058927|NCT01987895|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92058928|NCT01987895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058943|NCT01390948|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92015107|NCT05611463|Antimitotic Agents|antimitotic agents|mesh-ancestor
92015108|NCT05611463|Mitosis Modulators|mitosis modulators|mesh-ancestor
92015109|NCT05611463|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058944|NCT01390948|Growth Substances|growth substances|mesh-ancestor
92058945|NCT01390948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058946|NCT01390948|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058947|NCT01390948|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92058948|NCT01390948|Alkylating Agents|alkylating agents|mesh-ancestor
92058949|NCT01390948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058950|NCT03842722|Protoporphyrin IX|protoporphyrin ix|mesh-list
92058951|NCT03842722|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92058952|NCT03842722|Dermatologic Agents|dermatologic agents|mesh-ancestor
92058953|NCT01429792|Ribavirin|ribavirin|mesh-list
92058954|NCT01429792|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92058955|NCT01429792|Antimetabolites|antimetabolites|mesh-ancestor
92058956|NCT01429792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058957|NCT01429792|Antiviral Agents|antiviral agents|mesh-ancestor
92058958|NCT01429792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058959|NCT01940887|Bevacizumab|bevacizumab|mesh-list
92058960|NCT01940887|Aflibercept|aflibercept|mesh-list
92058961|NCT01940887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058962|NCT01940887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058963|NCT01940887|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058964|NCT01940887|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92058965|NCT01940887|Growth Substances|growth substances|mesh-ancestor
92058966|NCT01940887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058967|NCT01940887|Growth Inhibitors|growth inhibitors|mesh-ancestor
92058968|NCT01925612|Prednisone|prednisone|mesh-list
92058969|NCT01925612|Cyclophosphamide|cyclophosphamide|mesh-list
92058970|NCT01925612|Rituximab|rituximab|mesh-list
92058971|NCT01925612|Doxorubicin|doxorubicin|mesh-list
92058972|NCT01925612|Vincristine|vincristine|mesh-list
92058973|NCT01925612|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92058974|NCT01925612|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92058975|NCT01925612|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92058976|NCT01925612|Immunologic Factors|immunologic factors|mesh-ancestor
92058977|NCT01925612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058978|NCT01925612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058979|NCT01925612|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92058980|NCT01925612|Alkylating Agents|alkylating agents|mesh-ancestor
92058981|NCT01925612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058982|NCT01925612|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058983|NCT01925612|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92058984|NCT01925612|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058985|NCT01925612|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92058986|NCT01925612|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92058987|NCT01925612|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92058994|NCT01925612|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92058995|NCT01925612|Tubulin Modulators|tubulin modulators|mesh-ancestor
92058996|NCT01925612|Antimitotic Agents|antimitotic agents|mesh-ancestor
92058997|NCT01925612|Mitosis Modulators|mitosis modulators|mesh-ancestor
92058998|NCT01925612|Immunotoxins|immunotoxins|mesh-ancestor
92058999|NCT01925612|Immunoconjugates|immunoconjugates|mesh-ancestor
92059000|NCT02093663|Mesalamine|mesalamine|mesh-list
92059001|NCT02093663|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92059002|NCT02093663|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059003|NCT02093663|Analgesics|analgesics|mesh-ancestor
92059004|NCT02093663|Sensory System Agents|sensory system agents|mesh-ancestor
92059005|NCT02093663|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059006|NCT02093663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059007|NCT02093663|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059008|NCT02093663|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059009|NCT01408888|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92059010|NCT01408888|Dulaglutide|dulaglutide|mesh-list
92059011|NCT01408888|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059012|NCT01408888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059013|NCT01408888|Incretins|incretins|mesh-ancestor
92059014|NCT01408888|Hormones|hormones|mesh-ancestor
92059015|NCT01408888|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059016|NCT01408888|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92015111|NCT05611385|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92015112|NCT05611385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015113|NCT05611385|Sympathomimetics|sympathomimetics|mesh-ancestor
92059017|NCT01408888|Protease Inhibitors|protease inhibitors|mesh-ancestor
92059018|NCT01408888|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059019|NCT01408888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059020|NCT01918033|Desloratadine|desloratadine|mesh-list
92059021|NCT01918033|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92059022|NCT01918033|Cholinergic Agents|cholinergic agents|mesh-ancestor
92059023|NCT01918033|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059024|NCT01918033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059025|NCT01918033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059026|NCT01918033|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92059027|NCT01918033|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92059028|NCT01918033|Histamine Antagonists|histamine antagonists|mesh-ancestor
92059029|NCT01918033|Histamine Agents|histamine agents|mesh-ancestor
92059030|NCT01408732|Sodium Tetradecyl Sulfate|sodium tetradecyl sulfate|mesh-list
92059031|NCT01408732|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92059032|NCT01408732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92059033|NCT01390402|Aldesleukin|aldesleukin|mesh-list
92059034|NCT01390402|Methotrexate|methotrexate|mesh-list
92059035|NCT01390402|Fludarabine phosphate|fludarabine phosphate|mesh-list
92059036|NCT01390402|Fludarabine|fludarabine|mesh-list
92059037|NCT01390402|Busulfan|busulfan|mesh-list
92059038|NCT01390402|Interleukin-2|interleukin-2|mesh-list
92059039|NCT01390402|Tacrolimus|tacrolimus|mesh-list
92059040|NCT01390402|Thymoglobulin|thymoglobulin|mesh-list
92059041|NCT01390402|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92059042|NCT01390402|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92059043|NCT01390402|Abortifacient Agents|abortifacient agents|mesh-ancestor
92059044|NCT01390402|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92059045|NCT01390402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059046|NCT01390402|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92059047|NCT01390402|Antimetabolites|antimetabolites|mesh-ancestor
92059048|NCT01390402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059049|NCT01390402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059050|NCT01390402|Dermatologic Agents|dermatologic agents|mesh-ancestor
92059051|NCT01390402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059052|NCT01390402|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92059053|NCT01390402|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92059054|NCT01390402|Immunologic Factors|immunologic factors|mesh-ancestor
92059055|NCT01390402|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059056|NCT01390402|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92059057|NCT01390402|Antiviral Agents|antiviral agents|mesh-ancestor
92059058|NCT01390402|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059059|NCT01390402|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92059060|NCT01390402|Alkylating Agents|alkylating agents|mesh-ancestor
92059074|NCT01428076|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92059075|NCT01428076|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92059076|NCT01900652|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92059077|NCT01900652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059078|NCT01900652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92059079|NCT01900652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059080|NCT01900652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059081|NCT02093351|Tamoxifen|tamoxifen|mesh-list
92059082|NCT02093351|Letrozole|letrozole|mesh-list
92059083|NCT02093351|Olaparib|olaparib|mesh-list
92059084|NCT02093351|Anastrozole|anastrozole|mesh-list
92059085|NCT02093351|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059086|NCT02093351|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92059087|NCT02093351|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92059088|NCT02093351|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059089|NCT02093351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059090|NCT02093351|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92059091|NCT02093351|Hormone Antagonists|hormone antagonists|mesh-ancestor
92059092|NCT02093351|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059093|NCT02093351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059094|NCT02093351|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92015114|NCT05611385|Autonomic Agents|autonomic agents|mesh-ancestor
92015115|NCT05611385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015116|NCT05611385|Dopamine Agents|dopamine agents|mesh-ancestor
92015117|NCT05611385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059095|NCT02093351|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92059096|NCT02093351|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92059097|NCT02093351|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92059098|NCT02093351|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92059099|NCT02078284|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92059100|NCT02078284|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92059101|NCT02078284|Protective Agents|protective agents|mesh-ancestor
92059102|NCT02078284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059103|NCT02078284|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92059104|NCT02078284|Antioxidants|antioxidants|mesh-ancestor
92059105|NCT02078284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059106|NCT02092961|Adalimumab|adalimumab|mesh-list
92059107|NCT02092961|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92059108|NCT02092961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059109|NCT02092961|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059110|NCT01940497|Paclitaxel|paclitaxel|mesh-list
92059111|NCT01940497|Docetaxel|docetaxel|mesh-list
92059112|NCT01940497|Doxorubicin|doxorubicin|mesh-list
92059113|NCT01940497|Trastuzumab|trastuzumab|mesh-list
92059114|NCT01940497|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92059115|NCT01940497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059116|NCT01940497|Tubulin Modulators|tubulin modulators|mesh-ancestor
92059117|NCT01940497|Antimitotic Agents|antimitotic agents|mesh-ancestor
92059118|NCT01940497|Mitosis Modulators|mitosis modulators|mesh-ancestor
92059119|NCT01940497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059120|NCT01940497|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92059121|NCT01940497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92059126|NCT01987505|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059127|NCT01987505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059128|NCT01987505|Immunologic Factors|immunologic factors|mesh-ancestor
92059129|NCT01987505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059130|NCT01987505|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059132|NCT01923896|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92059133|NCT01923896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059134|NCT01923896|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92059135|NCT01923896|Antitubercular Agents|antitubercular agents|mesh-ancestor
92059136|NCT01923896|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92059137|NCT01923896|Antimetabolites|antimetabolites|mesh-ancestor
92059138|NCT01923896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059139|NCT01938625|Cyclosporine|cyclosporine|mesh-list
92059140|NCT01938625|Ribavirin|ribavirin|mesh-list
92059141|NCT01938625|Simeprevir|simeprevir|mesh-list
92059142|NCT01938625|Tacrolimus|tacrolimus|mesh-list
92059143|NCT01938625|Cyclosporins|cyclosporins|mesh-list
92059144|NCT01938625|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92059145|NCT01938625|Immunologic Factors|immunologic factors|mesh-ancestor
92059146|NCT01938625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059147|NCT01938625|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92059148|NCT01938625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059149|NCT01938625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059150|NCT01938625|Antifungal Agents|antifungal agents|mesh-ancestor
92059151|NCT01938625|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059152|NCT01938625|Dermatologic Agents|dermatologic agents|mesh-ancestor
92059153|NCT01938625|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059154|NCT01938625|Antimetabolites|antimetabolites|mesh-ancestor
92059155|NCT01938625|Antiviral Agents|antiviral agents|mesh-ancestor
92059156|NCT01938625|Protease Inhibitors|protease inhibitors|mesh-ancestor
92059158|NCT01975675|Antiviral Agents|antiviral agents|mesh-ancestor
92059159|NCT01975675|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059160|NCT01975285|Dexamethasone|dexamethasone|mesh-list
92059161|NCT01975285|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059162|NCT01975285|Antiemetics|antiemetics|mesh-ancestor
92059163|NCT01975285|Autonomic Agents|autonomic agents|mesh-ancestor
92059164|NCT01975285|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059165|NCT01975285|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059166|NCT01975285|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015118|NCT05611385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015119|NCT05611385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92015120|NCT05611385|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92059167|NCT01975285|Glucocorticoids|glucocorticoids|mesh-ancestor
92059168|NCT01975285|Hormones|hormones|mesh-ancestor
92059169|NCT01975285|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059170|NCT01975285|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92059171|NCT01975285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059172|NCT01974817|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92059173|NCT01974817|Immunologic Factors|immunologic factors|mesh-ancestor
92059174|NCT01974817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059175|NCT04624399|Atezolizumab|atezolizumab|mesh-list
92059176|NCT04624399|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92059177|NCT04624399|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059178|NCT04624399|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059179|NCT04624399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059180|NCT01915849|Licogliflozin|licogliflozin|mesh-list
92059181|NCT01915849|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92059182|NCT01915849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059183|NCT01915849|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059184|NCT01915849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059185|NCT01915303|Cabergoline|cabergoline|mesh-list
92059186|NCT01915303|Pasireotide|pasireotide|mesh-list
92059187|NCT01915303|Hormones|hormones|mesh-ancestor
92059188|NCT01915303|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059189|NCT01915303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059190|NCT01915303|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92059191|NCT01915303|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92059205|NCT01987427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059206|NCT01987427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059207|NCT01937299|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92059208|NCT01937299|Travoprost|travoprost|mesh-list
92059209|NCT01937299|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92059210|NCT01937299|Brinzolamide|brinzolamide|mesh-list
92059211|NCT01937299|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92059212|NCT01937299|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92059213|NCT01937299|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92059214|NCT01937299|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92059215|NCT01937299|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92059216|NCT01937299|Adrenergic Agents|adrenergic agents|mesh-ancestor
92059217|NCT01937299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059218|NCT01937299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059219|NCT01937299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059220|NCT01937299|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92059221|NCT01937299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059222|NCT01606761|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92059223|NCT01606761|Immunologic Factors|immunologic factors|mesh-ancestor
92059224|NCT01606761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059225|NCT01597557|Magnesium Sulfate|magnesium sulfate|mesh-list
92059226|NCT01597557|Analgesics|analgesics|mesh-ancestor
92059227|NCT01597557|Sensory System Agents|sensory system agents|mesh-ancestor
92059228|NCT01597557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059229|NCT01597557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059230|NCT01597557|Anesthetics|anesthetics|mesh-ancestor
92059231|NCT01597557|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059232|NCT01597557|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92059233|NCT01597557|Anticonvulsants|anticonvulsants|mesh-ancestor
92059234|NCT01597557|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92059235|NCT01597557|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059236|NCT01597557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059237|NCT01597557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92059238|NCT01597557|Tocolytic Agents|tocolytic agents|mesh-ancestor
92059239|NCT01597557|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92059240|NCT01914757|Benralizumab|benralizumab|mesh-list
92059241|NCT01914757|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92059242|NCT01914757|Respiratory System Agents|respiratory system agents|mesh-ancestor
92059243|NCT02003573|Decitabine|decitabine|mesh-list
92059244|NCT02003573|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015121|NCT05611385|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92015122|NCT05611385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92015123|NCT05611385|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92059245|NCT02003573|Antimetabolites|antimetabolites|mesh-ancestor
92059246|NCT02003573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059247|NCT02003573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059248|NCT02003573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059250|NCT01789281|Octreotide|octreotide|mesh-list
92059251|NCT01789281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92059258|NCT01789281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059259|NCT01789281|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92059260|NCT01789281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92059261|NCT01789203|Ciprofloxacin|ciprofloxacin|mesh-list
92059262|NCT01789203|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92059263|NCT01789203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059264|NCT01789203|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92059265|NCT01789203|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92059266|NCT01789203|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059267|NCT01789203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059268|NCT01789203|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059269|NCT01789203|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92059270|NCT01789203|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92059271|NCT01789047|Topiramate|topiramate|mesh-list
92059272|NCT01789047|Amantadine|amantadine|mesh-list
92059273|NCT01789047|Anticonvulsants|anticonvulsants|mesh-ancestor
92059274|NCT01789047|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059275|NCT01789047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059276|NCT01789047|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92059277|NCT01789047|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92059278|NCT01789047|Antiviral Agents|antiviral agents|mesh-ancestor
92059279|NCT01789047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059280|NCT01789047|Dopamine Agents|dopamine agents|mesh-ancestor
92059281|NCT01789047|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059282|NCT01789047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059283|NCT01789047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059284|NCT01789047|Analgesics|analgesics|mesh-ancestor
92059285|NCT01789047|Sensory System Agents|sensory system agents|mesh-ancestor
92059286|NCT01789047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059287|NCT01617187|Olanzapine|olanzapine|mesh-list
92059288|NCT01617187|Asenapine|asenapine|mesh-list
92059289|NCT01617187|Antiemetics|antiemetics|mesh-ancestor
92059290|NCT01617187|Autonomic Agents|autonomic agents|mesh-ancestor
92059291|NCT01617187|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059292|NCT01617187|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059293|NCT01617187|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92059294|NCT01617187|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92059295|NCT01617187|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92059296|NCT01617187|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059297|NCT01617187|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92059298|NCT01617187|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92059299|NCT01617187|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92059300|NCT01617187|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059301|NCT01617187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059302|NCT01617187|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059303|NCT01617187|Serotonin Agents|serotonin agents|mesh-ancestor
92059304|NCT01759407|Epinephrine|epinephrine|mesh-list
92059306|NCT01759407|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92059307|NCT01759407|Adrenergic Agents|adrenergic agents|mesh-ancestor
92059308|NCT01759407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059309|NCT01759407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059310|NCT01759407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059311|NCT01759407|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92059312|NCT01759407|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92059313|NCT01759407|Autonomic Agents|autonomic agents|mesh-ancestor
92059314|NCT01759407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059315|NCT01759407|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92059316|NCT01759407|Respiratory System Agents|respiratory system agents|mesh-ancestor
92059317|NCT01759407|Mydriatics|mydriatics|mesh-ancestor
92059318|NCT01759407|Sympathomimetics|sympathomimetics|mesh-ancestor
92059319|NCT01759407|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92059320|NCT01787331|Itraconazole|itraconazole|mesh-list
92059337|NCT01787097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059339|NCT01787097|Respiratory System Agents|respiratory system agents|mesh-ancestor
92059340|NCT01787097|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92059341|NCT01787097|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92059342|NCT01787097|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92059343|NCT01787097|Adrenergic Agents|adrenergic agents|mesh-ancestor
92059344|NCT01787097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059345|NCT01787097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059346|NCT01757691|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92059347|NCT01757691|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92059348|NCT01757691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059349|NCT01757691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92059350|NCT01757691|Immunologic Factors|immunologic factors|mesh-ancestor
92059351|NCT01757691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059352|NCT01786707|Metformin|metformin|mesh-list
92059353|NCT01786707|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059354|NCT01786707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059355|NCT01786551|Eplerenone|eplerenone|mesh-list
92059356|NCT01786551|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92059357|NCT01786551|Hormone Antagonists|hormone antagonists|mesh-ancestor
92059358|NCT01786551|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059359|NCT01786551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059360|NCT01786551|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92059361|NCT01786551|Diuretics|diuretics|mesh-ancestor
92059362|NCT01786551|Natriuretic Agents|natriuretic agents|mesh-ancestor
92059363|NCT01786551|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92059364|NCT01973569|Denosumab|denosumab|mesh-list
92059365|NCT01973569|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92059366|NCT01973569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059367|NCT01951586|Zoledronic Acid|zoledronic acid|mesh-list
92059368|NCT01951586|Denosumab|denosumab|mesh-list
92059369|NCT01951586|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92059370|NCT01951586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059371|NCT04643678|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92059372|NCT04643678|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059379|NCT04641728|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92059380|NCT04641728|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059381|NCT01756833|Doxycycline|doxycycline|mesh-list
92059382|NCT01756833|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92059383|NCT01756833|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059384|NCT01756833|Antimalarials|antimalarials|mesh-ancestor
92059385|NCT01756833|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92059386|NCT01756833|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92059387|NCT01785615|Atorvastatin|atorvastatin|mesh-list
92059388|NCT01785615|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92059389|NCT01785615|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92059390|NCT01785615|Antimetabolites|antimetabolites|mesh-ancestor
92059391|NCT01785615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059393|NCT01785615|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92059394|NCT01785615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059395|NCT04172779|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92059396|NCT04172779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059397|NCT04172779|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92059398|NCT04172779|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059399|NCT04172779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059400|NCT01784523|Hydroxychloroquine|hydroxychloroquine|mesh-list
92059401|NCT01784523|Antimalarials|antimalarials|mesh-ancestor
92059402|NCT01784523|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92059403|NCT01784523|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92059404|NCT01784523|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059405|NCT01784523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059406|NCT01784523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059407|NCT01784523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059408|NCT01784211|Insulin Glargine|insulin glargine|mesh-list
92059409|NCT01784211|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059410|NCT01784211|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015127|NCT05611307|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015128|NCT05611307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015130|NCT02631577|Atezolizumab|atezolizumab|mesh-list
92015131|NCT02631577|Obinutuzumab|obinutuzumab|mesh-list
92015132|NCT02631577|Immunologic Factors|immunologic factors|mesh-ancestor
92059412|NCT01783821|Formoterol Fumarate|formoterol fumarate|mesh-list
92059413|NCT01783821|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059414|NCT01783821|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92059415|NCT01783821|Autonomic Agents|autonomic agents|mesh-ancestor
92059416|NCT01783821|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059417|NCT01783821|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059418|NCT01783821|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92059419|NCT01783821|Respiratory System Agents|respiratory system agents|mesh-ancestor
92059420|NCT01783821|Glucocorticoids|glucocorticoids|mesh-ancestor
92059421|NCT01783821|Hormones|hormones|mesh-ancestor
92059422|NCT01783821|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059423|NCT01783821|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92059424|NCT01783821|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92059425|NCT01783821|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92059426|NCT01783821|Adrenergic Agents|adrenergic agents|mesh-ancestor
92059427|NCT01783821|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059428|NCT01783821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059429|NCT01608087|Bevacizumab|bevacizumab|mesh-list
92059430|NCT01608087|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059431|NCT01608087|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059432|NCT01608087|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059433|NCT01608087|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92059434|NCT01608087|Growth Substances|growth substances|mesh-ancestor
92059435|NCT01608087|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059436|NCT01608087|Growth Inhibitors|growth inhibitors|mesh-ancestor
92059437|NCT01912963|Trastuzumab|trastuzumab|mesh-list
92059438|NCT01912963|Pertuzumab|pertuzumab|mesh-list
92059439|NCT01912963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059441|NCT01912807|Ondansetron|ondansetron|mesh-list
92059442|NCT01912807|Antiemetics|antiemetics|mesh-ancestor
92059443|NCT01912807|Autonomic Agents|autonomic agents|mesh-ancestor
92059444|NCT01912807|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059445|NCT01912807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059446|NCT01912807|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92059447|NCT01912807|Antipruritics|antipruritics|mesh-ancestor
92059448|NCT01912807|Dermatologic Agents|dermatologic agents|mesh-ancestor
92059449|NCT01912807|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92059450|NCT01912807|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92059451|NCT01912807|Serotonin Agents|serotonin agents|mesh-ancestor
92059452|NCT01912807|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059453|NCT01912807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059454|NCT01782885|Acetaminophen|acetaminophen|mesh-list
92059455|NCT01782885|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059456|NCT01782885|Analgesics|analgesics|mesh-ancestor
92059457|NCT01782885|Sensory System Agents|sensory system agents|mesh-ancestor
92059458|NCT01782885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059459|NCT01782885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059460|NCT01782885|Antipyretics|antipyretics|mesh-ancestor
92059461|NCT01754493|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92059462|NCT01754493|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92059463|NCT01754493|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92059464|NCT01754493|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059465|NCT01754493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059466|NCT01754493|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059467|NCT01754493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059468|NCT01754493|Analgesics|analgesics|mesh-ancestor
92059469|NCT01754493|Sensory System Agents|sensory system agents|mesh-ancestor
92059470|NCT01754493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059471|NCT01754493|Antidepressive Agents|antidepressive agents|mesh-ancestor
92015133|NCT02631577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015134|NCT02631577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059472|NCT01754493|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92059473|NCT01754493|Dopamine Agents|dopamine agents|mesh-ancestor
92059474|NCT01972789|Ranibizumab|ranibizumab|mesh-list
92059475|NCT01972789|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059476|NCT01972789|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92059477|NCT01972789|Growth Substances|growth substances|mesh-ancestor
92059478|NCT01972789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059479|NCT01972789|Growth Inhibitors|growth inhibitors|mesh-ancestor
92059480|NCT01972789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059481|NCT01910389|Tadalafil|tadalafil|mesh-list
92059482|NCT01910389|Vasodilator Agents|vasodilator agents|mesh-ancestor
92059483|NCT01910389|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92059484|NCT01910389|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92059485|NCT01910389|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059486|NCT01910389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059487|NCT01910389|Urological Agents|urological agents|mesh-ancestor
92059488|NCT01970995|Menthol|menthol|mesh-list
92059489|NCT01970995|Antipruritics|antipruritics|mesh-ancestor
92059490|NCT01970995|Dermatologic Agents|dermatologic agents|mesh-ancestor
92059491|NCT01932697|Docetaxel|docetaxel|mesh-list
92059492|NCT01932697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059493|NCT01932697|Tubulin Modulators|tubulin modulators|mesh-ancestor
92059494|NCT01932697|Antimitotic Agents|antimitotic agents|mesh-ancestor
92059495|NCT01932697|Mitosis Modulators|mitosis modulators|mesh-ancestor
92059496|NCT01932697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059497|NCT01970527|Ipilimumab|ipilimumab|mesh-list
92059498|NCT01970527|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059499|NCT01970527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059500|NCT01970527|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92059501|NCT01970527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059502|NCT01408576|Epratuzumab|epratuzumab|mesh-list
92059503|NCT01408576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059504|NCT01408576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059505|NCT01427920|Insulin Aspart|insulin aspart|mesh-list
92059506|NCT01427920|Biphasic Insulins|biphasic insulins|mesh-list
92059507|NCT01427920|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92059508|NCT01427920|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059509|NCT01427920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059510|NCT01427608|Olanzapine|olanzapine|mesh-list
92059511|NCT01427608|Sertraline|sertraline|mesh-list
92059512|NCT01427608|Antiemetics|antiemetics|mesh-ancestor
92059515|NCT01427608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059516|NCT01427608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92059518|NCT01427608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92059519|NCT01427608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059520|NCT01427608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92059521|NCT01427608|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92059522|NCT01427608|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92059523|NCT01427608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059524|NCT01427608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059525|NCT01427608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059526|NCT01427608|Serotonin Agents|serotonin agents|mesh-ancestor
92059527|NCT01427608|Antidepressive Agents|antidepressive agents|mesh-ancestor
92059528|NCT01408030|Bevacizumab|bevacizumab|mesh-list
92059529|NCT01408030|Tranexamic Acid|tranexamic acid|mesh-list
92059530|NCT01408030|Endothelial Growth Factors|endothelial growth factors|mesh-list
92059531|NCT01408030|Estrogens|estrogens|mesh-list
92059532|NCT01408030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059533|NCT01408030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059534|NCT01408030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059535|NCT01408030|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92059536|NCT01408030|Growth Substances|growth substances|mesh-ancestor
92059537|NCT01408030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059538|NCT01408030|Growth Inhibitors|growth inhibitors|mesh-ancestor
92059539|NCT01408030|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92059540|NCT01408030|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92059541|NCT01408030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059542|NCT01408030|Hemostatics|hemostatics|mesh-ancestor
92059543|NCT01408030|Coagulants|coagulants|mesh-ancestor
92059544|NCT01408030|Hormones|hormones|mesh-ancestor
92015136|NCT02631577|Growth Substances|growth substances|mesh-ancestor
92059545|NCT01408030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059546|NCT02985424|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92059547|NCT02985424|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92059548|NCT02985424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059549|NCT01897532|Linagliptin|linagliptin|mesh-list
92059550|NCT01897532|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059551|NCT01897532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059552|NCT01897532|Incretins|incretins|mesh-ancestor
92059553|NCT01897532|Hormones|hormones|mesh-ancestor
92059554|NCT01897532|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059555|NCT01897532|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92059556|NCT01897532|Protease Inhibitors|protease inhibitors|mesh-ancestor
92059557|NCT01897532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059558|NCT01897532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059559|NCT04641026|Deuterium Oxide|deuterium oxide|mesh-list
92059560|NCT04641026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059561|NCT04641026|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92059562|NCT04641026|Protective Agents|protective agents|mesh-ancestor
92059563|NCT04641026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059564|NCT04173416|Analgesics, Opioid|analgesics, opioid|mesh-list
92059565|NCT04173416|Narcotics|narcotics|mesh-ancestor
92059566|NCT04173416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059567|NCT04173416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059568|NCT04173416|Analgesics|analgesics|mesh-ancestor
92059569|NCT04173416|Sensory System Agents|sensory system agents|mesh-ancestor
92059570|NCT04173416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059571|NCT01896128|Modafinil|modafinil|mesh-list
92059572|NCT01896128|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92059573|NCT01896128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059574|NCT01896128|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92059575|NCT01896128|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92059576|NCT01896128|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92059577|NCT01896128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059579|NCT01949870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059580|NCT01949870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92059581|NCT01949870|Antimetabolites|antimetabolites|mesh-ancestor
92059591|NCT01406938|Immunologic Factors|immunologic factors|mesh-ancestor
92059592|NCT01406938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059594|NCT01405924|Fosaprepitant|fosaprepitant|mesh-list
92059595|NCT01405924|Aprepitant|aprepitant|mesh-list
92059596|NCT01405924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059597|NCT01405924|Antiemetics|antiemetics|mesh-ancestor
92059598|NCT01405924|Autonomic Agents|autonomic agents|mesh-ancestor
92059599|NCT01405924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059600|NCT01405924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059601|NCT01405924|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92059602|NCT01405924|Glucocorticoids|glucocorticoids|mesh-ancestor
92059603|NCT01405924|Hormones|hormones|mesh-ancestor
92059604|NCT01405924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059605|NCT01405924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92059606|NCT01405924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059607|NCT01405924|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92059608|NCT01405924|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059609|NCT01405924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059610|NCT01426438|Aspirin|aspirin|mesh-list
92059611|NCT01426438|Niacin|niacin|mesh-list
92059612|NCT01426438|Fenofibrate|fenofibrate|mesh-list
92059613|NCT01426438|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92059614|NCT01426438|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059615|NCT01426438|Analgesics|analgesics|mesh-ancestor
92059616|NCT01426438|Sensory System Agents|sensory system agents|mesh-ancestor
92059617|NCT01426438|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059618|NCT01426438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059619|NCT01426438|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059620|NCT01426438|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059621|NCT01426438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92059622|NCT01426438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015138|NCT02631577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015139|NCT02631577|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92059623|NCT01426438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059624|NCT01426438|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92059625|NCT01426438|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92059626|NCT01426438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059627|NCT01426438|Antipyretics|antipyretics|mesh-ancestor
92059628|NCT01426438|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92059629|NCT01426438|Antimetabolites|antimetabolites|mesh-ancestor
92059630|NCT01426438|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92059631|NCT01426438|Vasodilator Agents|vasodilator agents|mesh-ancestor
92059632|NCT01426438|Vitamin B Complex|vitamin b complex|mesh-ancestor
92059633|NCT01426438|Vitamins|vitamins|mesh-ancestor
92059634|NCT01426438|Micronutrients|micronutrients|mesh-ancestor
92059635|NCT01782495|Ritonavir|ritonavir|mesh-list
92059636|NCT01782495|Ribavirin|ribavirin|mesh-list
92059637|NCT01782495|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92059638|NCT01782495|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92059639|NCT01782495|Protease Inhibitors|protease inhibitors|mesh-ancestor
92059640|NCT01782495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059641|NCT01782495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059642|NCT01782495|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92059643|NCT01782495|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92059644|NCT01782495|Antiviral Agents|antiviral agents|mesh-ancestor
92059645|NCT01782495|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059646|NCT01782495|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92059652|NCT01922102|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92059653|NCT01922102|Growth Substances|growth substances|mesh-ancestor
92059654|NCT01922102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059655|NCT01922102|Growth Inhibitors|growth inhibitors|mesh-ancestor
92059656|NCT01922102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059657|NCT01922102|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92059658|NCT01922102|Dermatologic Agents|dermatologic agents|mesh-ancestor
92059659|NCT01405768|Lidocaine|lidocaine|mesh-list
92059660|NCT01405768|Anesthetics, Local|anesthetics, local|mesh-ancestor
92059661|NCT01405768|Anesthetics|anesthetics|mesh-ancestor
92059662|NCT01405768|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059663|NCT01405768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059664|NCT01405768|Sensory System Agents|sensory system agents|mesh-ancestor
92059665|NCT01405768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059666|NCT01405768|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92059667|NCT01405768|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92059668|NCT01405768|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92059669|NCT01405768|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059670|NCT01405768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081701|NCT01402947|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92059671|NCT01913353|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92059672|NCT01913353|Antiviral Agents|antiviral agents|mesh-ancestor
92059673|NCT01913353|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059674|NCT01754259|Ranolazine|ranolazine|mesh-list
92059675|NCT01754259|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92059676|NCT01754259|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059677|NCT01754259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059678|NCT01405456|Eplerenone|eplerenone|mesh-list
92059679|NCT01405456|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92059680|NCT01405456|Hormone Antagonists|hormone antagonists|mesh-ancestor
92059681|NCT01405456|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059682|NCT01405456|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059683|NCT01405456|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92059684|NCT01405456|Diuretics|diuretics|mesh-ancestor
92059685|NCT01405456|Natriuretic Agents|natriuretic agents|mesh-ancestor
92059686|NCT01405456|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92059687|NCT01404208|Cycloserine|cycloserine|mesh-list
92059688|NCT01404208|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92059689|NCT01404208|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059690|NCT01404208|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92059691|NCT01404208|Antitubercular Agents|antitubercular agents|mesh-ancestor
92059692|NCT01404208|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92059693|NCT01404208|Antimetabolites|antimetabolites|mesh-ancestor
92059694|NCT01404208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059695|NCT01617668|Paclitaxel|paclitaxel|mesh-list
92059696|NCT01617668|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92059697|NCT01617668|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059698|NCT01617668|Tubulin Modulators|tubulin modulators|mesh-ancestor
92059699|NCT01617668|Antimitotic Agents|antimitotic agents|mesh-ancestor
92059700|NCT01617668|Mitosis Modulators|mitosis modulators|mesh-ancestor
92059701|NCT01617668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059702|NCT01895270|Isradipine|isradipine|mesh-list
92059703|NCT01895270|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92059704|NCT01895270|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92059705|NCT01895270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059706|NCT01895270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059707|NCT01895270|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92059708|NCT01895270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059709|NCT01895270|Vasodilator Agents|vasodilator agents|mesh-ancestor
92059710|NCT01424644|Vaccines|vaccines|mesh-list
92059711|NCT01424644|Immunologic Factors|immunologic factors|mesh-ancestor
92059712|NCT01424644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059716|NCT01403116|Testosterone enanthate|testosterone enanthate|mesh-list
92059717|NCT01403116|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92059718|NCT01403116|Androgens|androgens|mesh-ancestor
92059719|NCT01403116|Hormones|hormones|mesh-ancestor
92059720|NCT01403116|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059721|NCT01403116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059722|NCT01403116|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92059723|NCT01403116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059724|NCT01403116|Anabolic Agents|anabolic agents|mesh-ancestor
92059725|NCT01753401|Prednisone|prednisone|mesh-list
92059726|NCT01753401|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92059727|NCT01753401|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059728|NCT01753401|Glucocorticoids|glucocorticoids|mesh-ancestor
92059729|NCT01753401|Hormones|hormones|mesh-ancestor
92059730|NCT01753401|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059731|NCT01753401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059732|NCT01753401|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92059733|NCT01753401|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059734|NCT01894568|Insulin|insulin|mesh-list
92059735|NCT01894568|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92059736|NCT01894568|Insulin Glargine|insulin glargine|mesh-list
92059737|NCT01894568|Pioglitazone|pioglitazone|mesh-list
92059738|NCT01894568|Biguanides|biguanides|mesh-list
92059739|NCT01894568|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92059740|NCT01894568|Meglitinide|meglitinide|mesh-list
92059741|NCT01894568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059742|NCT01920152|Hyaluronic Acid|hyaluronic acid|mesh-list
92059743|NCT01920152|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92059744|NCT01920152|Immunologic Factors|immunologic factors|mesh-ancestor
92059745|NCT01920152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059746|NCT01920152|Viscosupplements|viscosupplements|mesh-ancestor
92059747|NCT01920152|Protective Agents|protective agents|mesh-ancestor
92059749|NCT01752933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059750|NCT01752855|Adalimumab|adalimumab|mesh-list
92059751|NCT01752855|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92059752|NCT01752855|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059753|NCT01752855|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92059754|NCT01402492|Naltrexone|naltrexone|mesh-list
92059755|NCT01402492|Buprenorphine|buprenorphine|mesh-list
92059756|NCT01402492|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92059757|NCT01402492|Naloxone|naloxone|mesh-list
92059758|NCT01402492|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92059759|NCT01402492|Narcotics|narcotics|mesh-ancestor
92059760|NCT01402492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059761|NCT01402492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059762|NCT01402492|Analgesics|analgesics|mesh-ancestor
92059763|NCT01402492|Sensory System Agents|sensory system agents|mesh-ancestor
92059764|NCT01402492|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059765|NCT01402492|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92059766|NCT01402492|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92059767|NCT01894256|Olaparib|olaparib|mesh-list
92059768|NCT01894256|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92059769|NCT01894256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059770|NCT01894256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059771|NCT01894256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059772|NCT01780935|Ranibizumab|ranibizumab|mesh-list
92015140|NCT02631577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015141|NCT02631577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92015142|NCT01667081|Grazoprevir|grazoprevir|mesh-list
92059773|NCT01780935|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059774|NCT01780935|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92059775|NCT01780935|Growth Substances|growth substances|mesh-ancestor
92059776|NCT01780935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059777|NCT01780935|Growth Inhibitors|growth inhibitors|mesh-ancestor
92059778|NCT01780935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059779|NCT01422538|Mannitol|mannitol|mesh-list
92059780|NCT01422538|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92059781|NCT01422538|Diuretics|diuretics|mesh-ancestor
92059782|NCT01422538|Natriuretic Agents|natriuretic agents|mesh-ancestor
92059783|NCT01422538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059784|NCT04026256|Denosumab|denosumab|mesh-list
92059785|NCT04026256|Teriparatide|teriparatide|mesh-list
92059786|NCT04026256|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92059787|NCT04026256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059788|NCT04026256|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92059792|NCT01422382|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92059793|NCT01422382|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059794|NCT01422382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059795|NCT01422382|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92059796|NCT01422382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059797|NCT01422382|Vasodilator Agents|vasodilator agents|mesh-ancestor
92059798|NCT01422382|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92059799|NCT01422382|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92059800|NCT01422382|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92059801|NCT01422382|Antimetabolites|antimetabolites|mesh-ancestor
92059802|NCT01422382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059803|NCT01422382|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92059804|NCT01401322|Lenalidomide|lenalidomide|mesh-list
92059805|NCT01401322|Immunologic Factors|immunologic factors|mesh-ancestor
92059806|NCT01401322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059807|NCT01401322|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059808|NCT01401322|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92059809|NCT01401322|Growth Substances|growth substances|mesh-ancestor
92059810|NCT01401322|Growth Inhibitors|growth inhibitors|mesh-ancestor
92059811|NCT01401322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059812|NCT01401010|Doripenem|doripenem|mesh-list
92059813|NCT01401010|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92059814|NCT01401010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059815|NCT01400932|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92059816|NCT01400932|Dermatologic Agents|dermatologic agents|mesh-ancestor
92059817|NCT01890746|Cytarabine|cytarabine|mesh-list
92059818|NCT01890746|Daunorubicin|daunorubicin|mesh-list
92059819|NCT01890746|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92059820|NCT01890746|Antimetabolites|antimetabolites|mesh-ancestor
92059821|NCT01890746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059822|NCT01890746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059823|NCT01890746|Antiviral Agents|antiviral agents|mesh-ancestor
92059824|NCT01890746|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059825|NCT01890746|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92059826|NCT01890746|Immunologic Factors|immunologic factors|mesh-ancestor
92059827|NCT01890746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059828|NCT01890746|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92059829|NCT01890746|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92059830|NCT01890746|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92059831|NCT01890746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059832|NCT01422304|Atropine|atropine|mesh-list
92059833|NCT01422304|Glycopyrrolate|glycopyrrolate|mesh-list
92059834|NCT01422304|Neostigmine|neostigmine|mesh-list
92059835|NCT01422304|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92059836|NCT01422304|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92059837|NCT01422304|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92059838|NCT01422304|Autonomic Agents|autonomic agents|mesh-ancestor
92059839|NCT01422304|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059840|NCT01422304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059841|NCT01422304|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92059842|NCT01422304|Respiratory System Agents|respiratory system agents|mesh-ancestor
92059843|NCT01422304|Mydriatics|mydriatics|mesh-ancestor
92015144|NCT01667081|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059844|NCT01422304|Parasympatholytics|parasympatholytics|mesh-ancestor
92059845|NCT01422304|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92059846|NCT01422304|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92059847|NCT01422304|Cholinergic Agents|cholinergic agents|mesh-ancestor
92059848|NCT01422304|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059849|NCT01422304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059850|NCT01422304|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92059851|NCT01422304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059852|NCT01422304|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92059853|NCT01387516|Nicotine|nicotine|mesh-list
92059854|NCT01387516|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92059855|NCT01387516|Autonomic Agents|autonomic agents|mesh-ancestor
92059856|NCT01387516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059857|NCT01387516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059858|NCT01387516|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92059859|NCT01387516|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92059860|NCT01387516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92059874|NCT01421134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059876|NCT01421134|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92059877|NCT01421134|Serotonin Agents|serotonin agents|mesh-ancestor
92059878|NCT01421134|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92059879|NCT01421134|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92059881|NCT01894022|Ambrisentan|ambrisentan|mesh-list
92059882|NCT01894022|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92059884|NCT01386970|Zidovudine|zidovudine|mesh-list
92059885|NCT01386970|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92059886|NCT01386970|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92059887|NCT01386970|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92059888|NCT01386970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059889|NCT01386970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059890|NCT01386970|Antiviral Agents|antiviral agents|mesh-ancestor
92059891|NCT01386970|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059892|NCT01386970|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92059893|NCT01386970|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92059894|NCT01386970|Antimetabolites|antimetabolites|mesh-ancestor
92059895|NCT01385566|Vaccines|vaccines|mesh-list
92059897|NCT01385566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059898|NCT05365984|Carbon Monoxide|carbon monoxide|mesh-list
92059899|NCT05365984|Antimetabolites|antimetabolites|mesh-ancestor
92059900|NCT05365984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059901|NCT05365984|Gasotransmitters|gasotransmitters|mesh-ancestor
92059902|NCT05365984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059903|NCT05365984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059904|NCT01780545|Docetaxel|docetaxel|mesh-list
92059905|NCT01780545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059906|NCT01780545|Tubulin Modulators|tubulin modulators|mesh-ancestor
92059907|NCT01780545|Antimitotic Agents|antimitotic agents|mesh-ancestor
92059908|NCT01780545|Mitosis Modulators|mitosis modulators|mesh-ancestor
92059909|NCT01780545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059910|NCT01780389|Milnacipran|milnacipran|mesh-list
92059911|NCT01780389|Levomilnacipran|levomilnacipran|mesh-list
92059912|NCT01780389|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92059913|NCT01780389|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92059914|NCT01780389|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059915|NCT01780389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059916|NCT01780389|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059917|NCT01780389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059918|NCT01780389|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059919|NCT01780389|Analgesics|analgesics|mesh-ancestor
92059927|NCT01778985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059928|NCT01778985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059930|NCT01865084|Vasodilator Agents|vasodilator agents|mesh-ancestor
92059931|NCT01865084|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92059932|NCT01865084|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92059933|NCT01865084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059934|NCT01865084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059935|NCT01865084|Urological Agents|urological agents|mesh-ancestor
92015146|NCT03067753|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92015147|NCT03067753|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92015148|NCT03067753|Prednisolone|prednisolone|mesh-list
92059936|NCT01385098|Calcium, Dietary|calcium, dietary|mesh-list
92059937|NCT01385098|Vitamin D|vitamin d|mesh-list
92059938|NCT01385098|Ergocalciferols|ergocalciferols|mesh-list
92059939|NCT01385098|Cholecalciferol|cholecalciferol|mesh-list
92059940|NCT01385098|Vitamins|vitamins|mesh-list
92059941|NCT01385098|Calcium|calcium|mesh-list
92059942|NCT01385098|Micronutrients|micronutrients|mesh-ancestor
92059943|NCT01385098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059944|NCT01385098|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92059945|NCT01385098|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92059946|NCT01398514|Escitalopram|escitalopram|mesh-list
92059947|NCT01398514|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92059948|NCT01398514|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92059949|NCT01398514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059950|NCT01398514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059951|NCT01398514|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059952|NCT01398514|Serotonin Agents|serotonin agents|mesh-ancestor
92059953|NCT01398514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059954|NCT03025282|Betamethasone|betamethasone|mesh-list
92059955|NCT03025282|Betamethasone Valerate|betamethasone valerate|mesh-list
92059956|NCT03025282|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92059957|NCT03025282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92059958|NCT03025282|Glucocorticoids|glucocorticoids|mesh-ancestor
92059959|NCT03025282|Hormones|hormones|mesh-ancestor
92059960|NCT03025282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059961|NCT03025282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059962|NCT03025282|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92059963|NCT03025282|Respiratory System Agents|respiratory system agents|mesh-ancestor
92059964|NCT01778049|Empagliflozin|empagliflozin|mesh-list
92059965|NCT01778049|Linagliptin|linagliptin|mesh-list
92059966|NCT01778049|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92059967|NCT01778049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059968|NCT01778049|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92059969|NCT01778049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059970|NCT01778049|Incretins|incretins|mesh-ancestor
92059972|NCT01778049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059973|NCT01778049|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92059974|NCT01778049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92059975|NCT01778049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059976|NCT01777581|Milnacipran|milnacipran|mesh-list
92059977|NCT01777581|Levomilnacipran|levomilnacipran|mesh-list
92059978|NCT01777581|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92059979|NCT01777581|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92059980|NCT01777581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92059981|NCT01777581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059982|NCT01777581|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059983|NCT01777581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059984|NCT01777581|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059985|NCT01777581|Analgesics|analgesics|mesh-ancestor
92059989|NCT01777581|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92059990|NCT01864148|Interferons|interferons|mesh-list
92059991|NCT01864148|Interferon-beta|interferon-beta|mesh-list
92059992|NCT01864148|Interferon beta-1a|interferon beta-1a|mesh-list
92059993|NCT01864148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059994|NCT01864148|Antiviral Agents|antiviral agents|mesh-ancestor
92059995|NCT01864148|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059996|NCT01864148|Immunologic Factors|immunologic factors|mesh-ancestor
92059997|NCT01864148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059998|NCT01864148|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92059999|NCT01890122|Metformin|metformin|mesh-list
92060000|NCT01890122|Alogliptin|alogliptin|mesh-list
92060001|NCT01890122|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060002|NCT01890122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060003|NCT01890122|Incretins|incretins|mesh-ancestor
92060004|NCT01890122|Hormones|hormones|mesh-ancestor
92015149|NCT03067753|Prednisolone acetate|prednisolone acetate|mesh-list
92015150|NCT03067753|Hormones|hormones|mesh-list
92015151|NCT03067753|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92060005|NCT01890122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060006|NCT01890122|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92060007|NCT01890122|Protease Inhibitors|protease inhibitors|mesh-ancestor
92060008|NCT01890122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060009|NCT01890122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060010|NCT01397890|Budesonide|budesonide|mesh-list
92060011|NCT01397890|Formoterol Fumarate|formoterol fumarate|mesh-list
92060012|NCT01397890|Tiotropium Bromide|tiotropium bromide|mesh-list
92060013|NCT01397890|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92060014|NCT01397890|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060015|NCT01397890|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92060016|NCT01397890|Autonomic Agents|autonomic agents|mesh-ancestor
92060017|NCT01397890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060018|NCT01397890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060019|NCT01397890|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92060020|NCT01397890|Respiratory System Agents|respiratory system agents|mesh-ancestor
92060021|NCT01397890|Glucocorticoids|glucocorticoids|mesh-ancestor
92060022|NCT01397890|Hormones|hormones|mesh-ancestor
92060023|NCT01397890|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060024|NCT01397890|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92060025|NCT01397890|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92060026|NCT01397890|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92060027|NCT01397890|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060028|NCT01397890|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060029|NCT01397890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060030|NCT01397890|Parasympatholytics|parasympatholytics|mesh-ancestor
92060031|NCT01397890|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92060032|NCT01397890|Cholinergic Agents|cholinergic agents|mesh-ancestor
92060033|NCT01777269|Tamsulosin|tamsulosin|mesh-list
92060034|NCT01777269|Dutasteride|dutasteride|mesh-list
92060035|NCT01777269|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92060036|NCT01777269|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92060037|NCT01777269|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92060038|NCT01777269|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060039|NCT01777269|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060040|NCT01777269|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060041|NCT01777269|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060042|NCT01777269|Urological Agents|urological agents|mesh-ancestor
92060043|NCT01777269|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92060044|NCT01777269|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92060045|NCT01777269|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060046|NCT01777269|Hormone Antagonists|hormone antagonists|mesh-ancestor
92060047|NCT01777269|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060048|NCT04024696|Abexinostat|abexinostat|mesh-list
92060049|NCT04024696|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92060050|NCT04024696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060051|NCT04024696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060052|NCT01777191|Ixekizumab|ixekizumab|mesh-list
92060053|NCT01777191|Dermatologic Agents|dermatologic agents|mesh-ancestor
92060054|NCT01896050|Tamoxifen|tamoxifen|mesh-list
92060055|NCT01896050|Letrozole|letrozole|mesh-list
92060058|NCT01896050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060059|NCT01896050|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92060060|NCT01896050|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92060061|NCT01896050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060062|NCT01896050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060063|NCT01896050|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92060064|NCT01896050|Hormone Antagonists|hormone antagonists|mesh-ancestor
92060065|NCT01896050|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060066|NCT01896050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060067|NCT01896050|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060068|NCT01896050|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92060069|NCT01896050|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92060070|NCT01896050|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92060072|NCT01775787|Nicotine|nicotine|mesh-list
92015152|NCT03067753|Prednisolone phosphate|prednisolone phosphate|mesh-list
92015153|NCT03067753|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015154|NCT03067753|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015155|NCT03067753|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015156|NCT03067753|Antiemetics|antiemetics|mesh-ancestor
92015157|NCT03067753|Autonomic Agents|autonomic agents|mesh-ancestor
92060073|NCT01775787|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92060074|NCT01775787|Autonomic Agents|autonomic agents|mesh-ancestor
92060075|NCT01775787|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060076|NCT01775787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060077|NCT01775787|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92060078|NCT01775787|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92060079|NCT01775787|Cholinergic Agents|cholinergic agents|mesh-ancestor
92060080|NCT01775787|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060081|NCT01775787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060082|NCT01775787|Antipruritics|antipruritics|mesh-ancestor
92060083|NCT01775787|Dermatologic Agents|dermatologic agents|mesh-ancestor
92060084|NCT01775475|Prednisone|prednisone|mesh-list
92060085|NCT01775475|Cyclophosphamide|cyclophosphamide|mesh-list
92060086|NCT01775475|Lomustine|lomustine|mesh-list
92060087|NCT01775475|Doxorubicin|doxorubicin|mesh-list
92060088|NCT01775475|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92060089|NCT01775475|Etoposide|etoposide|mesh-list
92060090|NCT01775475|Vincristine|vincristine|mesh-list
92060091|NCT01775475|Etoposide phosphate|etoposide phosphate|mesh-list
92060092|NCT01775475|Procarbazine|procarbazine|mesh-list
92060093|NCT01775475|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060094|NCT01775475|Immunologic Factors|immunologic factors|mesh-ancestor
92060095|NCT01775475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060096|NCT01775475|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92060097|NCT01775475|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92060098|NCT01775475|Alkylating Agents|alkylating agents|mesh-ancestor
92060099|NCT01775475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060100|NCT01775475|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060101|NCT01775475|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92060102|NCT01775475|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92060103|NCT01775475|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92060104|NCT01775475|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92060105|NCT01775475|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060106|NCT01775475|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060107|NCT01775475|Glucocorticoids|glucocorticoids|mesh-ancestor
92060108|NCT01775475|Hormones|hormones|mesh-ancestor
92060109|NCT01775475|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060110|NCT01775475|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060111|NCT01775475|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92060112|NCT01775475|Tubulin Modulators|tubulin modulators|mesh-ancestor
92060113|NCT01775475|Antimitotic Agents|antimitotic agents|mesh-ancestor
92060114|NCT01775475|Mitosis Modulators|mitosis modulators|mesh-ancestor
92060115|NCT01774929|Fentanyl|fentanyl|mesh-list
92060116|NCT01774929|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92060117|NCT01774929|Narcotics|narcotics|mesh-ancestor
92060118|NCT01774929|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060119|NCT01774929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060120|NCT01774929|Analgesics|analgesics|mesh-ancestor
92060121|NCT01774929|Sensory System Agents|sensory system agents|mesh-ancestor
92060122|NCT01774929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060123|NCT01774929|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92060124|NCT01774929|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92060125|NCT01774929|Anesthetics, General|anesthetics, general|mesh-ancestor
92060126|NCT01774929|Anesthetics|anesthetics|mesh-ancestor
92060127|NCT01774305|Dexmedetomidine|dexmedetomidine|mesh-list
92060128|NCT01774305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92060129|NCT01774305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060133|NCT01774305|Sensory System Agents|sensory system agents|mesh-ancestor
92060134|NCT01774305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060135|NCT01774305|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92060136|NCT01774305|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92060137|NCT01774305|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92060138|NCT01774305|Adrenergic Agents|adrenergic agents|mesh-ancestor
92015158|NCT03067753|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015159|NCT03067753|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015160|NCT03067753|Glucocorticoids|glucocorticoids|mesh-ancestor
92015161|NCT03067753|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92060139|NCT01774305|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060140|NCT01774305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060142|NCT01397422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92060143|NCT01397422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92060145|NCT01397422|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060147|NCT01397422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060148|NCT01397422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060149|NCT01397422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060150|NCT01397422|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92060151|NCT01397422|Analgesics|analgesics|mesh-ancestor
92060152|NCT01397422|Sensory System Agents|sensory system agents|mesh-ancestor
92060153|NCT01397422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060154|NCT01736475|Factor VIII|factor viii|mesh-list
92060155|NCT01736475|BAX 855|bax 855|mesh-list
92060156|NCT01736475|Coagulants|coagulants|mesh-ancestor
92060157|NCT01863680|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92060158|NCT01863680|Hormones|hormones|mesh-list
92060159|NCT01863680|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92060160|NCT01863680|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060161|NCT01863680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060162|NCT01863680|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92060163|NCT01747629|Albuterol|albuterol|mesh-list
92060164|NCT01747629|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92060165|NCT01747629|Autonomic Agents|autonomic agents|mesh-ancestor
92060166|NCT01747629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060167|NCT01747629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060168|NCT01747629|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92060169|NCT01747629|Respiratory System Agents|respiratory system agents|mesh-ancestor
92060170|NCT01747629|Tocolytic Agents|tocolytic agents|mesh-ancestor
92060171|NCT01747629|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92060172|NCT01747629|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92060173|NCT01747629|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92060174|NCT01747629|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92060175|NCT01747629|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060176|NCT01747629|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060177|NCT01747629|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060178|NCT01863368|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92060179|NCT01863368|Lubricant Eye Drops|lubricant eye drops|mesh-list
92060180|NCT01863368|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92060181|NCT01886690|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92060182|NCT01886690|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92060183|NCT01886690|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92060184|NCT01886690|Laxatives|laxatives|mesh-ancestor
92060185|NCT01886690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060186|NCT04590404|Nicotine|nicotine|mesh-list
92060187|NCT04590404|Varenicline|varenicline|mesh-list
92060188|NCT04590404|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92060189|NCT04590404|Autonomic Agents|autonomic agents|mesh-ancestor
92060190|NCT04590404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060191|NCT04590404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060192|NCT04590404|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92060193|NCT04590404|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92060194|NCT04590404|Cholinergic Agents|cholinergic agents|mesh-ancestor
92060195|NCT04590404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060196|NCT04590404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060198|NCT01885208|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060199|NCT01885208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060200|NCT01885208|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92060201|NCT01885208|Incretins|incretins|mesh-ancestor
92060202|NCT01885208|Hormones|hormones|mesh-ancestor
92060204|NCT01859702|Moxifloxacin|moxifloxacin|mesh-list
92060205|NCT01859702|Dexamethasone|dexamethasone|mesh-list
92060206|NCT01859702|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92060207|NCT01859702|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060208|NCT01859702|Antiemetics|antiemetics|mesh-ancestor
92015162|NCT03067753|Protective Agents|protective agents|mesh-ancestor
92015163|NCT03067753|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92015164|NCT03067753|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015165|NCT04331639|Vitamin D|vitamin d|mesh-list
92015166|NCT04331639|Cholecalciferol|cholecalciferol|mesh-list
92015167|NCT04331639|Vitamins|vitamins|mesh-ancestor
92060209|NCT01859702|Autonomic Agents|autonomic agents|mesh-ancestor
92060210|NCT01859702|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060211|NCT01859702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060212|NCT01859702|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060213|NCT01859702|Glucocorticoids|glucocorticoids|mesh-ancestor
92060215|NCT01859702|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060216|NCT01859702|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060217|NCT01859702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060218|NCT01859702|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92060219|NCT01859702|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92060220|NCT01859702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060221|NCT01859702|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92060222|NCT01859702|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92060223|NCT01859702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060224|NCT01859702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060225|NCT01747551|Leucovorin|leucovorin|mesh-list
92060226|NCT01747551|Fluorouracil|fluorouracil|mesh-list
92060227|NCT01747551|Oxaliplatin|oxaliplatin|mesh-list
92060228|NCT01747551|Aflibercept|aflibercept|mesh-list
92060229|NCT01747551|Antimetabolites|antimetabolites|mesh-ancestor
92060230|NCT01747551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060231|NCT01747551|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92060232|NCT01747551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060233|NCT01747551|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060234|NCT01747551|Immunologic Factors|immunologic factors|mesh-ancestor
92060235|NCT01747551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060236|NCT01747551|Antidotes|antidotes|mesh-ancestor
92060237|NCT01747551|Protective Agents|protective agents|mesh-ancestor
92060238|NCT01747551|Vitamin B Complex|vitamin b complex|mesh-ancestor
92060239|NCT01747551|Vitamins|vitamins|mesh-ancestor
92060240|NCT01747551|Micronutrients|micronutrients|mesh-ancestor
92060241|NCT01747551|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92060242|NCT01747551|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92060243|NCT01747551|Growth Substances|growth substances|mesh-ancestor
92060244|NCT01747551|Growth Inhibitors|growth inhibitors|mesh-ancestor
92060245|NCT01859390|Antioxidants|antioxidants|mesh-list
92060246|NCT01859390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060247|NCT01859390|Protective Agents|protective agents|mesh-ancestor
92060248|NCT01859390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060249|NCT01858766|Ribavirin|ribavirin|mesh-list
92060250|NCT01858766|Antiviral Agents|antiviral agents|mesh-ancestor
92060251|NCT01858766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060252|NCT01858766|Antimetabolites|antimetabolites|mesh-ancestor
92060253|NCT01858766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060254|NCT01745367|Paclitaxel|paclitaxel|mesh-list
92060255|NCT01745367|Tivozanib|tivozanib|mesh-list
92060256|NCT01745367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92060257|NCT01745367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060258|NCT01745367|Tubulin Modulators|tubulin modulators|mesh-ancestor
92060259|NCT01745367|Antimitotic Agents|antimitotic agents|mesh-ancestor
92060260|NCT01745367|Mitosis Modulators|mitosis modulators|mesh-ancestor
92060261|NCT01745367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060262|NCT01745367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060263|NCT01745367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060264|NCT01733121|Tetrabenazine|tetrabenazine|mesh-list
92060265|NCT01733121|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92060266|NCT01733121|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92060267|NCT01733121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060268|NCT01733121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060269|NCT01733121|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060270|NCT01733121|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060271|NCT01733121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060272|NCT01383928|Dexamethasone|dexamethasone|mesh-list
92015168|NCT04331639|Micronutrients|micronutrients|mesh-ancestor
92015169|NCT04331639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015170|NCT04331639|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92015171|NCT04331639|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92015172|NCT03067597|Dinoprostone|dinoprostone|mesh-list
92060273|NCT01383928|Lenalidomide|lenalidomide|mesh-list
92060274|NCT01383928|Ixazomib|ixazomib|mesh-list
92060275|NCT01383928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060277|NCT01383928|Autonomic Agents|autonomic agents|mesh-ancestor
92060278|NCT01383928|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060279|NCT01383928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060280|NCT01383928|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060281|NCT01383928|Glucocorticoids|glucocorticoids|mesh-ancestor
92060282|NCT01383928|Hormones|hormones|mesh-ancestor
92060283|NCT01383928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060284|NCT01383928|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060285|NCT01383928|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060286|NCT01383928|Immunologic Factors|immunologic factors|mesh-ancestor
92060287|NCT01383928|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92060288|NCT01383928|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92060289|NCT01383928|Growth Substances|growth substances|mesh-ancestor
92060290|NCT01383928|Growth Inhibitors|growth inhibitors|mesh-ancestor
92060291|NCT01383928|Protease Inhibitors|protease inhibitors|mesh-ancestor
92060292|NCT01383928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060293|NCT01383928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060294|NCT04023604|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92060295|NCT04023604|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060296|NCT05368012|Dexamethasone|dexamethasone|mesh-list
92060297|NCT05368012|Bupivacaine|bupivacaine|mesh-list
92060298|NCT05368012|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060299|NCT05368012|Antiemetics|antiemetics|mesh-ancestor
92060300|NCT05368012|Autonomic Agents|autonomic agents|mesh-ancestor
92060301|NCT05368012|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060302|NCT05368012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060303|NCT05368012|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060304|NCT05368012|Glucocorticoids|glucocorticoids|mesh-ancestor
92060305|NCT05368012|Hormones|hormones|mesh-ancestor
92060306|NCT05368012|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060307|NCT05368012|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060308|NCT05368012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060309|NCT05368012|Anesthetics, Local|anesthetics, local|mesh-ancestor
92060310|NCT05368012|Anesthetics|anesthetics|mesh-ancestor
92060311|NCT05368012|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060312|NCT05368012|Sensory System Agents|sensory system agents|mesh-ancestor
92060313|NCT05893225|Metformin|metformin|mesh-list
92060314|NCT05893225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060315|NCT05893225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060316|NCT05893147|Lactams|lactams|mesh-list
92060317|NCT05893147|Cephalosporins|cephalosporins|mesh-list
92060318|NCT05893147|beta-Lactams|beta-lactams|mesh-list
92060319|NCT05893147|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92060320|NCT05893147|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060321|NCT05893108|Triamcinolone|triamcinolone|mesh-list
92060322|NCT05893108|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92060323|NCT05893108|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92060324|NCT05893108|Losartan|losartan|mesh-list
92060325|NCT05893108|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92060326|NCT05893108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060327|NCT05893108|Glucocorticoids|glucocorticoids|mesh-ancestor
92060328|NCT05893108|Hormones|hormones|mesh-ancestor
92060329|NCT05893108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060330|NCT05893108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060331|NCT05893108|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060332|NCT05893108|Immunologic Factors|immunologic factors|mesh-ancestor
92060333|NCT05893108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060334|NCT05893108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060335|NCT05893108|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92060336|NCT05893108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92060337|NCT05893108|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92060338|NCT05893108|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92015174|NCT03067597|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92015175|NCT03067597|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015176|NCT02518971|Tamsulosin|tamsulosin|mesh-list
92060339|NCT05892887|Bupivacaine|bupivacaine|mesh-list
92060340|NCT05892887|Anesthetics, Local|anesthetics, local|mesh-ancestor
92060341|NCT05892887|Anesthetics|anesthetics|mesh-ancestor
92060342|NCT05892887|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060343|NCT05892887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060344|NCT05892887|Sensory System Agents|sensory system agents|mesh-ancestor
92060345|NCT05892887|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060347|NCT05892770|Botulinum Toxins|botulinum toxins|mesh-list
92060348|NCT05892770|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92060349|NCT05892770|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92060350|NCT05892770|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92060351|NCT05892770|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060353|NCT05892770|Cholinergic Agents|cholinergic agents|mesh-ancestor
92060354|NCT05892770|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060355|NCT05892770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060356|NCT05892770|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92060357|NCT05892770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060358|NCT05892770|Trace Elements|trace elements|mesh-ancestor
92060359|NCT05892770|Micronutrients|micronutrients|mesh-ancestor
92060360|NCT05892744|Sertraline|sertraline|mesh-list
92060361|NCT05892744|Antidepressive Agents|antidepressive agents|mesh-ancestor
92060362|NCT05892744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92060363|NCT05892744|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92060364|NCT05892744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92060365|NCT05892744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060366|NCT05892744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060367|NCT05892744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060368|NCT05892744|Serotonin Agents|serotonin agents|mesh-ancestor
92060369|NCT05892744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060370|NCT05892705|Dexmedetomidine|dexmedetomidine|mesh-list
92060371|NCT05892705|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92060372|NCT05892705|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060373|NCT05892705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060374|NCT05892705|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92060375|NCT05892705|Analgesics|analgesics|mesh-ancestor
92060376|NCT05892705|Sensory System Agents|sensory system agents|mesh-ancestor
92060377|NCT05892705|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060378|NCT05892705|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92060379|NCT05892705|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92060380|NCT05892705|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92060381|NCT05892705|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060382|NCT05892705|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060383|NCT05892705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060384|NCT05892471|Propofol|propofol|mesh-list
92060385|NCT05892471|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92060386|NCT05892471|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060387|NCT05892471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060388|NCT05892471|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92060389|NCT05892471|Anesthetics, General|anesthetics, general|mesh-ancestor
92060390|NCT05892471|Anesthetics|anesthetics|mesh-ancestor
92060391|NCT05892341|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92060392|NCT05892341|Laxatives|laxatives|mesh-ancestor
92060393|NCT05892341|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060394|NCT05892237|Immunomodulating Agents|immunomodulating agents|mesh-list
92060395|NCT05892237|Immunologic Factors|immunologic factors|mesh-ancestor
92060396|NCT05892237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060397|NCT05892068|Tucatinib|tucatinib|mesh-list
92060398|NCT05892068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060399|NCT05892068|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060400|NCT05892068|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060401|NCT05892068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060402|NCT05892042|Rivaroxaban|rivaroxaban|mesh-list
92060403|NCT05892042|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92060404|NCT05892042|Antithrombins|antithrombins|mesh-ancestor
92060405|NCT05892042|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92015178|NCT02518971|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92015180|NCT02518971|Adrenergic Agents|adrenergic agents|mesh-ancestor
92015181|NCT02518971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015182|NCT02518971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015183|NCT02518971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015184|NCT02518971|Urological Agents|urological agents|mesh-ancestor
92060406|NCT05892042|Protease Inhibitors|protease inhibitors|mesh-ancestor
92060407|NCT05892042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060408|NCT05892042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060409|NCT05892042|Anticoagulants|anticoagulants|mesh-ancestor
92060410|NCT05891613|Bupivacaine|bupivacaine|mesh-list
92060411|NCT05891613|Anesthetics, Local|anesthetics, local|mesh-ancestor
92060412|NCT05891613|Anesthetics|anesthetics|mesh-ancestor
92060413|NCT05891613|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060414|NCT05891613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060415|NCT05891613|Sensory System Agents|sensory system agents|mesh-ancestor
92060416|NCT05891613|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060417|NCT05891561|Pertuzumab|pertuzumab|mesh-list
92060418|NCT05891561|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060419|NCT05891561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060420|NCT05890963|Ibalizumab|ibalizumab|mesh-list
92060421|NCT05890963|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92060422|NCT05890963|Antiviral Agents|antiviral agents|mesh-ancestor
92060423|NCT05890963|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060424|NCT05890963|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92060434|NCT05887804|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92060435|NCT05887804|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92060436|NCT05887804|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92060437|NCT05887804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060438|NCT05887804|Glucocorticoids|glucocorticoids|mesh-ancestor
92060439|NCT05887804|Hormones|hormones|mesh-ancestor
92060440|NCT05887804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060441|NCT05887804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060442|NCT05887804|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060443|NCT05887804|Immunologic Factors|immunologic factors|mesh-ancestor
92060444|NCT05887804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060445|NCT05887804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060446|NCT05875272|Hemostatics|hemostatics|mesh-list
92060447|NCT05875272|Coagulants|coagulants|mesh-ancestor
92060448|NCT05854966|Metformin|metformin|mesh-list
92060449|NCT05854966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060450|NCT05854966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060451|NCT05809700|Hyaluronic Acid|hyaluronic acid|mesh-list
92060452|NCT05809700|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92060453|NCT05809700|Immunologic Factors|immunologic factors|mesh-ancestor
92060454|NCT05809700|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060455|NCT05809700|Viscosupplements|viscosupplements|mesh-ancestor
92060456|NCT05809700|Protective Agents|protective agents|mesh-ancestor
92060457|NCT05808725|Amlodipine|amlodipine|mesh-list
92060458|NCT05808725|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92060459|NCT05808725|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92060460|NCT05808725|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92060461|NCT05808725|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060462|NCT05808725|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060463|NCT05808725|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92060464|NCT05808725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060465|NCT05808725|Vasodilator Agents|vasodilator agents|mesh-ancestor
92060466|NCT05792540|Dapagliflozin|dapagliflozin|mesh-list
92060467|NCT05792540|Fluoxetine|fluoxetine|mesh-list
92060468|NCT05792540|Atorvastatin|atorvastatin|mesh-list
92060469|NCT05792540|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92060470|NCT05792540|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92060471|NCT05792540|Antimetabolites|antimetabolites|mesh-ancestor
92015186|NCT04733963|Capecitabine|capecitabine|mesh-list
92015187|NCT04733963|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92015188|NCT04733963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060472|NCT05792540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060473|NCT05792540|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92060474|NCT05792540|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92060475|NCT05792540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060476|NCT05792540|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92060477|NCT05792540|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060478|NCT05792540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060479|NCT05792540|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92060480|NCT05792540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92060481|NCT05792540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060482|NCT05792540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060483|NCT05792540|Serotonin Agents|serotonin agents|mesh-ancestor
92060484|NCT05792540|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92060485|NCT05792540|Antidepressive Agents|antidepressive agents|mesh-ancestor
92060486|NCT05792540|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92060487|NCT05792540|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92060488|NCT05792540|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92060489|NCT05781711|Metformin|metformin|mesh-list
92060490|NCT05781711|Levodopa|levodopa|mesh-list
92060493|NCT05781711|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060494|NCT05781711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060495|NCT05781711|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92060496|NCT05781711|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92060498|NCT05781711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060499|NCT05781711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060500|NCT05781711|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92060501|NCT05781711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060502|NCT05781711|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92060503|NCT05781711|Immunologic Factors|immunologic factors|mesh-ancestor
92060504|NCT05781711|Dopamine Agonists|dopamine agonists|mesh-ancestor
92060505|NCT05780879|Venetoclax|venetoclax|mesh-list
92060506|NCT05780879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060507|NCT05780307|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92060508|NCT05780307|Immunologic Factors|immunologic factors|mesh-ancestor
92060509|NCT05780307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060510|NCT05776134|Brexucabtagene autoleucel|brexucabtagene autoleucel|mesh-list
92060511|NCT05776134|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060512|NCT05776134|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060513|NCT05746208|Pembrolizumab|pembrolizumab|mesh-list
92060514|NCT05746208|Lenvatinib|lenvatinib|mesh-list
92060515|NCT05746208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060516|NCT05746208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060517|NCT05746208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060518|NCT05746208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060519|NCT05746208|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060520|NCT05746208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060521|NCT05742958|Morphine|morphine|mesh-list
92060522|NCT05742958|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92060523|NCT05742958|Narcotics|narcotics|mesh-ancestor
92060524|NCT05742958|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060525|NCT05742958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060526|NCT05742958|Analgesics|analgesics|mesh-ancestor
92060527|NCT05742958|Sensory System Agents|sensory system agents|mesh-ancestor
92060528|NCT05742958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060529|NCT05718323|Niraparib|niraparib|mesh-list
92060530|NCT05718323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92060531|NCT05718323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060532|NCT05718323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060533|NCT05718323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060534|NCT05710666|Trastuzumab|trastuzumab|mesh-list
92060535|NCT05710666|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92060536|NCT05710666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060537|NCT05710666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060538|NCT05710666|Immunoconjugates|immunoconjugates|mesh-ancestor
92060539|NCT05710666|Immunologic Factors|immunologic factors|mesh-ancestor
92060540|NCT05710666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060541|NCT05701215|Venetoclax|venetoclax|mesh-list
92060542|NCT05701215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060543|NCT05700214|Lidocaine|lidocaine|mesh-list
92060544|NCT05700214|Ropivacaine|ropivacaine|mesh-list
92060545|NCT05700214|Anesthetics, Local|anesthetics, local|mesh-ancestor
92060546|NCT05700214|Anesthetics|anesthetics|mesh-ancestor
92060547|NCT05700214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060548|NCT05700214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060549|NCT05700214|Sensory System Agents|sensory system agents|mesh-ancestor
92060550|NCT05700214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060551|NCT05700214|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92060552|NCT05700214|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92060553|NCT05700214|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92060554|NCT05700214|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060555|NCT05700214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060557|NCT05700045|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92060558|NCT05700045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060559|NCT05700045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060560|NCT05700045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92060561|NCT05700045|Analgesics|analgesics|mesh-ancestor
92060562|NCT05700045|Sensory System Agents|sensory system agents|mesh-ancestor
92060564|NCT05700045|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92060566|NCT05700045|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92060567|NCT05700045|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060568|NCT05700045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060569|NCT05700045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060570|NCT05681039|Carboplatin|carboplatin|mesh-list
92060571|NCT05681039|Atezolizumab|atezolizumab|mesh-list
92060572|NCT05681039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060573|NCT05681039|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060574|NCT05681039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060575|NCT05681039|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060576|NCT05678348|Pyrimethamine|pyrimethamine|mesh-list
92060577|NCT05678348|Antimalarials|antimalarials|mesh-ancestor
92060578|NCT05678348|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92060579|NCT05678348|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92060580|NCT05678348|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060581|NCT05678348|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92060582|NCT05678348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060583|NCT05678348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060584|NCT05676294|Olanzapine|olanzapine|mesh-list
92060585|NCT05676294|Antiemetics|antiemetics|mesh-ancestor
92060586|NCT05676294|Autonomic Agents|autonomic agents|mesh-ancestor
92060587|NCT05676294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060588|NCT05676294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060589|NCT05676294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060590|NCT05676294|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92060591|NCT05676294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92060592|NCT05676294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060593|NCT05676294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92060594|NCT05676294|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92060595|NCT05676294|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92060596|NCT05676294|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060597|NCT05676294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060598|NCT05676294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060599|NCT05676294|Serotonin Agents|serotonin agents|mesh-ancestor
92060600|NCT05659576|Sucralfate|sucralfate|mesh-list
92060601|NCT05659576|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92060602|NCT05659576|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060603|NCT05638867|Aspirin|aspirin|mesh-list
92060604|NCT05638867|Rivaroxaban|rivaroxaban|mesh-list
92060605|NCT05638867|Clopidogrel|clopidogrel|mesh-list
92060606|NCT05638867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92060607|NCT05638867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92060608|NCT05638867|Analgesics|analgesics|mesh-ancestor
92060609|NCT05638867|Sensory System Agents|sensory system agents|mesh-ancestor
92060610|NCT05638867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060611|NCT05638867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060612|NCT05638867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060613|NCT05638867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015189|NCT04733963|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92015190|NCT04733963|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92060614|NCT05638867|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92060615|NCT05638867|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92060616|NCT05638867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060617|NCT05638867|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92060618|NCT05638867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92060619|NCT05638867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060620|NCT05638867|Antipyretics|antipyretics|mesh-ancestor
92060621|NCT05638867|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92060622|NCT05638867|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92060623|NCT05638867|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92060624|NCT05638867|Purinergic Agents|purinergic agents|mesh-ancestor
92060625|NCT05638867|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060626|NCT05638867|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92060627|NCT05638867|Antithrombins|antithrombins|mesh-ancestor
92060628|NCT05638867|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92060629|NCT05638867|Protease Inhibitors|protease inhibitors|mesh-ancestor
92060630|NCT05638867|Anticoagulants|anticoagulants|mesh-ancestor
92060631|NCT05607407|Methimazole|methimazole|mesh-list
92060632|NCT05607407|Antithyroid Agents|antithyroid agents|mesh-ancestor
92060633|NCT05607407|Hormone Antagonists|hormone antagonists|mesh-ancestor
92060634|NCT05607407|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060645|NCT05600686|Daunorubicin|daunorubicin|mesh-list
92060646|NCT05600686|Podophyllotoxin|podophyllotoxin|mesh-list
92060647|NCT05600686|Loncastuximab tesirine|loncastuximab tesirine|mesh-list
92060885|NCT05161195|Anastrozole|anastrozole|mesh-list
92060648|NCT05600686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92060649|NCT05600686|Antibodies|antibodies|mesh-list
92060650|NCT05600686|Immunoglobulins|immunoglobulins|mesh-list
92060651|NCT05600686|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92060652|NCT05600686|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060653|NCT05600686|Immunologic Factors|immunologic factors|mesh-ancestor
92060654|NCT05600686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060655|NCT05600686|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92060656|NCT05600686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92060657|NCT05600686|Alkylating Agents|alkylating agents|mesh-ancestor
92060658|NCT05600686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060659|NCT05600686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060660|NCT05600686|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92060661|NCT05600686|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92060662|NCT05600686|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92060663|NCT05600686|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92060664|NCT05600686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060665|NCT05600686|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060666|NCT05600686|Glucocorticoids|glucocorticoids|mesh-ancestor
92060667|NCT05600686|Hormones|hormones|mesh-ancestor
92060668|NCT05600686|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060669|NCT05600686|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060670|NCT05600686|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92060671|NCT05600686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92060672|NCT05600686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92060673|NCT05600686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92060674|NCT05600686|Keratolytic Agents|keratolytic agents|mesh-ancestor
92060675|NCT05600686|Dermatologic Agents|dermatologic agents|mesh-ancestor
92060676|NCT05585034|Pembrolizumab|pembrolizumab|mesh-list
92060677|NCT05585034|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060678|NCT05585034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060679|NCT05585034|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060680|NCT05585034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060681|NCT05565378|Pembrolizumab|pembrolizumab|mesh-list
92060682|NCT05565378|Dostarlimab|dostarlimab|mesh-list
92060683|NCT05565378|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060684|NCT05565378|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060685|NCT05565378|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060686|NCT05565378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060687|NCT05564338|Tislelizumab|tislelizumab|mesh-list
92060688|NCT05564338|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060689|NCT05564338|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060690|NCT05545384|Rituximab|rituximab|mesh-list
92060691|NCT05545384|Azathioprine|azathioprine|mesh-list
92015191|NCT04733963|Growth Substances|growth substances|mesh-ancestor
92015192|NCT04733963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060692|NCT05545384|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060693|NCT05545384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060694|NCT05545384|Immunologic Factors|immunologic factors|mesh-ancestor
92060695|NCT05545384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060696|NCT05545384|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92060697|NCT05545384|Antimetabolites|antimetabolites|mesh-ancestor
92060698|NCT05545384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060699|NCT05545384|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92060708|NCT05536284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92060709|NCT05536284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92060711|NCT05536284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060712|NCT05536284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060713|NCT05517668|Acetylcysteine|acetylcysteine|mesh-list
92060714|NCT05517668|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92060715|NCT05517668|Fomepizole|fomepizole|mesh-list
92060716|NCT05517668|Antiviral Agents|antiviral agents|mesh-ancestor
92060717|NCT05517668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060718|NCT05517668|Expectorants|expectorants|mesh-ancestor
92060719|NCT05517668|Respiratory System Agents|respiratory system agents|mesh-ancestor
92060720|NCT05517668|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92060721|NCT05517668|Antioxidants|antioxidants|mesh-ancestor
92060722|NCT05517668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060723|NCT05517668|Protective Agents|protective agents|mesh-ancestor
92060724|NCT05517668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060725|NCT05517668|Antidotes|antidotes|mesh-ancestor
92060726|NCT05517668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060727|NCT05503030|Nintedanib|nintedanib|mesh-list
92060728|NCT05503030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060729|NCT05503030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060730|NCT05503030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060731|NCT05503030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060732|NCT05468320|Prednisone|prednisone|mesh-list
92060733|NCT05468320|Prednisolone|prednisolone|mesh-list
92060734|NCT05468320|Antibodies|antibodies|mesh-list
92060735|NCT05468320|Immunologic Factors|immunologic factors|mesh-ancestor
92060736|NCT05468320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060737|NCT05468320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060738|NCT05468320|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060739|NCT05468320|Glucocorticoids|glucocorticoids|mesh-ancestor
92060740|NCT05468320|Hormones|hormones|mesh-ancestor
92060741|NCT05468320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060742|NCT05468320|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060743|NCT05456490|Bupivacaine|bupivacaine|mesh-list
92060744|NCT05456490|Anesthetics, Local|anesthetics, local|mesh-ancestor
92060745|NCT05456490|Anesthetics|anesthetics|mesh-ancestor
92060746|NCT05456490|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060747|NCT05456490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060748|NCT05456490|Sensory System Agents|sensory system agents|mesh-ancestor
92060749|NCT05456490|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060750|NCT05416333|Azelaic acid|azelaic acid|mesh-list
92060751|NCT05416333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060752|NCT05416333|Dermatologic Agents|dermatologic agents|mesh-ancestor
92060753|NCT05409391|Insulin|insulin|mesh-list
92060754|NCT05409391|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060755|NCT05409391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060756|NCT05401110|Osimertinib|osimertinib|mesh-list
92060757|NCT05401110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060758|NCT05401110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060759|NCT05401110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060760|NCT05401110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060761|NCT05394493|Avelumab|avelumab|mesh-list
92060762|NCT05394493|Axitinib|axitinib|mesh-list
92060763|NCT05394493|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060764|NCT05394493|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060765|NCT05394493|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060766|NCT05394493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060769|NCT05372354|Trametinib|trametinib|mesh-list
92060770|NCT05372354|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060771|NCT05372354|Antiemetics|antiemetics|mesh-ancestor
92060772|NCT05372354|Autonomic Agents|autonomic agents|mesh-ancestor
92060773|NCT05372354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015193|NCT04733963|Growth Inhibitors|growth inhibitors|mesh-ancestor
92015194|NCT04733963|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92060774|NCT05372354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060775|NCT05372354|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92060776|NCT05372354|Glucocorticoids|glucocorticoids|mesh-ancestor
92060777|NCT05372354|Hormones|hormones|mesh-ancestor
92060778|NCT05372354|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060779|NCT05372354|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060780|NCT05372354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060781|NCT05372354|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060783|NCT05372354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060784|NCT05367063|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92060785|NCT05367063|Canagliflozin|canagliflozin|mesh-list
92060786|NCT05367063|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92060787|NCT05367063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060788|NCT05367063|Incretins|incretins|mesh-ancestor
92060789|NCT05367063|Hormones|hormones|mesh-ancestor
92060790|NCT05367063|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060791|NCT05367063|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92060792|NCT05367063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92060793|NCT05367063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060794|NCT05367063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060795|NCT05367063|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92060796|NCT05358548|Paclitaxel|paclitaxel|mesh-list
92060797|NCT05358548|Carboplatin|carboplatin|mesh-list
92060798|NCT05358548|Pembrolizumab|pembrolizumab|mesh-list
92060799|NCT05358548|Fluorouracil|fluorouracil|mesh-list
92060800|NCT05358548|Pemetrexed|pemetrexed|mesh-list
92060801|NCT05358548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92060802|NCT05358548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060803|NCT05358548|Tubulin Modulators|tubulin modulators|mesh-ancestor
92060804|NCT05358548|Antimitotic Agents|antimitotic agents|mesh-ancestor
92060805|NCT05358548|Mitosis Modulators|mitosis modulators|mesh-ancestor
92060806|NCT05358548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060807|NCT05358548|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060808|NCT05358548|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060809|NCT05358548|Antimetabolites|antimetabolites|mesh-ancestor
92060810|NCT05358548|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92060811|NCT05358548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060812|NCT05358548|Immunologic Factors|immunologic factors|mesh-ancestor
92060813|NCT05358548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060814|NCT05358548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060815|NCT05358548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92060816|NCT05358548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92060817|NCT05358249|Cetuximab|cetuximab|mesh-list
92060818|NCT05358249|Trametinib|trametinib|mesh-list
92060819|NCT05358249|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060820|NCT05358249|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060821|NCT05358249|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060822|NCT05358249|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060823|NCT05358249|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060824|NCT05334004|Ritonavir|ritonavir|mesh-list
92060825|NCT05334004|Lopinavir|lopinavir|mesh-list
92060826|NCT05334004|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92060827|NCT05334004|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92060828|NCT05334004|Protease Inhibitors|protease inhibitors|mesh-ancestor
92060829|NCT05334004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060830|NCT05334004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060831|NCT05334004|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92060832|NCT05334004|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92060833|NCT05334004|Antiviral Agents|antiviral agents|mesh-ancestor
92060834|NCT05334004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060835|NCT05334004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92060836|NCT05334004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92060837|NCT05280548|Venglustat|venglustat|mesh-list
92060838|NCT05280548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060843|NCT05274477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060844|NCT05262556|Nivolumab|nivolumab|mesh-list
92060845|NCT05262556|Ipilimumab|ipilimumab|mesh-list
92060846|NCT05262556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060847|NCT05262556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060848|NCT05262556|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060849|NCT05262556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060850|NCT05244070|Cyclophosphamide|cyclophosphamide|mesh-list
92060851|NCT05244070|Fludarabine|fludarabine|mesh-list
92060852|NCT05244070|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060853|NCT05244070|Immunologic Factors|immunologic factors|mesh-ancestor
92060854|NCT05244070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060855|NCT05244070|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92060856|NCT05244070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92060857|NCT05244070|Alkylating Agents|alkylating agents|mesh-ancestor
92060858|NCT05244070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060859|NCT05244070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060860|NCT05244070|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92060861|NCT05236777|Natalizumab|natalizumab|mesh-list
92060862|NCT05236777|Immunologic Factors|immunologic factors|mesh-ancestor
92060863|NCT05236777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060864|NCT05222607|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92060865|NCT05222607|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92060866|NCT05222607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060867|NCT05222607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060868|NCT05222607|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92060869|NCT05222607|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060870|NCT05222607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060871|NCT05222607|Cholinergic Agents|cholinergic agents|mesh-ancestor
92060872|NCT05222607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060874|NCT05205486|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92060875|NCT05205486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060876|NCT05167409|Pembrolizumab|pembrolizumab|mesh-list
92060877|NCT05167409|Cetuximab|cetuximab|mesh-list
92060878|NCT05167409|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060879|NCT05167409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060880|NCT05167409|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060881|NCT05167409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060882|NCT05161195|Tamoxifen|tamoxifen|mesh-list
92060883|NCT05161195|Letrozole|letrozole|mesh-list
92060884|NCT05161195|Fulvestrant|fulvestrant|mesh-list
92060886|NCT05161195|Goserelin|goserelin|mesh-list
92060887|NCT05161195|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060888|NCT05161195|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92060889|NCT05161195|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92060890|NCT05161195|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060891|NCT05161195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060892|NCT05161195|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92060893|NCT05161195|Hormone Antagonists|hormone antagonists|mesh-ancestor
92060894|NCT05161195|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060895|NCT05161195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060896|NCT05161195|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060897|NCT05161195|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92060898|NCT05161195|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92060899|NCT05161195|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92060900|NCT05161195|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92060901|NCT05113940|Midazolam|midazolam|mesh-list
92060902|NCT05113940|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92060903|NCT05113940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92060904|NCT05113940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92060905|NCT05113940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060906|NCT05113940|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92060907|NCT05113940|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92060913|NCT05113940|GABA Agents|gaba agents|mesh-ancestor
92060914|NCT05113940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92060915|NCT05113940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060916|NCT05096117|ASP8062|asp8062|mesh-list
92060917|NCT05096117|Analgesics|analgesics|mesh-ancestor
92060918|NCT05096117|Sensory System Agents|sensory system agents|mesh-ancestor
92060919|NCT05096117|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060920|NCT05096117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060921|NCT05096117|GABA Modulators|gaba modulators|mesh-ancestor
92060922|NCT05096117|GABA Agents|gaba agents|mesh-ancestor
92060923|NCT05096117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015195|NCT04733963|Antimetabolites|antimetabolites|mesh-ancestor
92060924|NCT05096117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060925|NCT05072093|Tenofovir|tenofovir|mesh-list
92060926|NCT05072093|Emtricitabine|emtricitabine|mesh-list
92060927|NCT05072093|Cabotegravir|cabotegravir|mesh-list
92060928|NCT05072093|Doxycycline|doxycycline|mesh-list
92060929|NCT05072093|Antiviral Agents|antiviral agents|mesh-ancestor
92060930|NCT05072093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060931|NCT05072093|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92060932|NCT05072093|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92060933|NCT05072093|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060934|NCT05072093|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060935|NCT05072093|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92060936|NCT05072093|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92060937|NCT05072093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92060938|NCT05072093|Antimalarials|antimalarials|mesh-ancestor
92060939|NCT05072093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92060940|NCT05072093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92060941|NCT05072093|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92060942|NCT05072093|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92060944|NCT05047718|Immunologic Factors|immunologic factors|mesh-ancestor
92060945|NCT05047718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060946|NCT05027633|Carboplatin|carboplatin|mesh-list
92060947|NCT05027633|Docetaxel|docetaxel|mesh-list
92060948|NCT05027633|Pembrolizumab|pembrolizumab|mesh-list
92060949|NCT05027633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060950|NCT05027633|Tubulin Modulators|tubulin modulators|mesh-ancestor
92060951|NCT05027633|Antimitotic Agents|antimitotic agents|mesh-ancestor
92060952|NCT05027633|Mitosis Modulators|mitosis modulators|mesh-ancestor
92060953|NCT05027633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060954|NCT05027633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92060955|NCT05027633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92060956|NCT05011188|Antibodies|antibodies|mesh-list
92060957|NCT05011188|Immunoglobulins|immunoglobulins|mesh-list
92060958|NCT05011188|Immunoconjugates|immunoconjugates|mesh-list
92060959|NCT05011188|Immunologic Factors|immunologic factors|mesh-ancestor
92060960|NCT05011188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060961|NCT04979052|Interferons|interferons|mesh-list
92060962|NCT04979052|Interferon-gamma|interferon-gamma|mesh-list
92060963|NCT04979052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060964|NCT04979052|Antiviral Agents|antiviral agents|mesh-ancestor
92060965|NCT04979052|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92060966|NCT04978584|Prednisone|prednisone|mesh-list
92060967|NCT04978584|Cortisone|cortisone|mesh-list
92060968|NCT04978584|Cyclophosphamide|cyclophosphamide|mesh-list
92060969|NCT04978584|Rituximab|rituximab|mesh-list
92060970|NCT04978584|Doxorubicin|doxorubicin|mesh-list
92060971|NCT04978584|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92060972|NCT04978584|Vincristine|vincristine|mesh-list
92060973|NCT04978584|Lenalidomide|lenalidomide|mesh-list
92060974|NCT04978584|Acalabrutinib|acalabrutinib|mesh-list
92060975|NCT04978584|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92060976|NCT04978584|Antibodies|antibodies|mesh-list
92060977|NCT04978584|Immunoglobulins|immunoglobulins|mesh-list
92060978|NCT04978584|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92060979|NCT04978584|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92060980|NCT04978584|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060981|NCT04978584|Immunologic Factors|immunologic factors|mesh-ancestor
92060982|NCT04978584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060983|NCT04978584|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92060992|NCT04978584|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060993|NCT04978584|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92060994|NCT04978584|Glucocorticoids|glucocorticoids|mesh-ancestor
92060995|NCT04978584|Hormones|hormones|mesh-ancestor
92060996|NCT04978584|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060997|NCT04978584|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92060998|NCT04978584|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92060999|NCT04978584|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061000|NCT04978584|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061001|NCT04978584|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061002|NCT04978584|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92061003|NCT04978584|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061004|NCT04978584|Growth Substances|growth substances|mesh-ancestor
92061005|NCT04978584|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061006|NCT04978584|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015196|NCT04733963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015197|NCT04222023|Immunoglobulins|immunoglobulins|mesh-list
92015198|NCT04222023|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92061007|NCT04976634|Pembrolizumab|pembrolizumab|mesh-list
92061008|NCT04976634|Lenvatinib|lenvatinib|mesh-list
92061009|NCT04976634|Belzutifan|belzutifan|mesh-list
92061010|NCT04976634|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061011|NCT04976634|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061012|NCT04976634|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061013|NCT04976634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061014|NCT04976634|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061015|NCT04976634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061016|NCT04954820|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92061017|NCT04954820|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92061018|NCT04954820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061019|NCT04950608|Psilocybin|psilocybin|mesh-list
92061020|NCT04950608|Hallucinogens|hallucinogens|mesh-ancestor
92061021|NCT04950608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061022|NCT04950608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92061024|NCT04940052|Dabrafenib|dabrafenib|mesh-list
92061025|NCT04940052|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061026|NCT04940052|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061027|NCT04940052|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061028|NCT04940052|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061029|NCT04929028|Fluorouracil|fluorouracil|mesh-list
92061030|NCT04929028|Capecitabine|capecitabine|mesh-list
92061031|NCT04929028|Nivolumab|nivolumab|mesh-list
92061032|NCT04929028|Mitomycins|mitomycins|mesh-list
92061033|NCT04929028|Mitomycin|mitomycin|mesh-list
92061034|NCT04929028|Antimetabolites|antimetabolites|mesh-ancestor
92061035|NCT04929028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061036|NCT04929028|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061037|NCT04929028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061038|NCT04929028|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061039|NCT04929028|Immunologic Factors|immunologic factors|mesh-ancestor
92061040|NCT04929028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061041|NCT04929028|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061042|NCT04929028|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061043|NCT04929028|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92061044|NCT04929028|Alkylating Agents|alkylating agents|mesh-ancestor
92061045|NCT04929028|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92061046|NCT04929028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061047|NCT04924075|Belzutifan|belzutifan|mesh-list
92061048|NCT04924075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061049|NCT04898621|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92061050|NCT04892446|Dexamethasone|dexamethasone|mesh-list
92061054|NCT04892446|Magrolimab|magrolimab|mesh-list
92061055|NCT04892446|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061056|NCT04892446|Antiemetics|antiemetics|mesh-ancestor
92061057|NCT04892446|Autonomic Agents|autonomic agents|mesh-ancestor
92061058|NCT04892446|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061059|NCT04892446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061060|NCT04892446|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061061|NCT04892446|Glucocorticoids|glucocorticoids|mesh-ancestor
92061062|NCT04892446|Hormones|hormones|mesh-ancestor
92061063|NCT04892446|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061064|NCT04892446|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061065|NCT04892446|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061066|NCT04892446|Immunologic Factors|immunologic factors|mesh-ancestor
92061067|NCT04892446|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92061068|NCT04892446|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061069|NCT04892446|Growth Substances|growth substances|mesh-ancestor
92061070|NCT04892446|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061071|NCT04892446|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061072|NCT04862260|Atorvastatin|atorvastatin|mesh-list
92061073|NCT04862260|Ezetimibe|ezetimibe|mesh-list
92061074|NCT04862260|Evolocumab|evolocumab|mesh-list
92061075|NCT04862260|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92061076|NCT04862260|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92061077|NCT04862260|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92061078|NCT04862260|Antimetabolites|antimetabolites|mesh-ancestor
92015201|NCT04222023|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92015202|NCT04222023|Immunologic Factors|immunologic factors|mesh-ancestor
92015203|NCT04222023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015204|NCT03066115|Ascorbic Acid|ascorbic acid|mesh-list
92015205|NCT03066115|Ketorolac|ketorolac|mesh-list
92061079|NCT04862260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061080|NCT04862260|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92061081|NCT04862260|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92061082|NCT04862260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061083|NCT04862260|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92061084|NCT04862260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061085|NCT04851613|Fulvestrant|fulvestrant|mesh-list
92061086|NCT04851613|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061087|NCT04851613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061088|NCT04851613|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92061090|NCT04851613|Hormone Antagonists|hormone antagonists|mesh-ancestor
92061091|NCT04851613|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061092|NCT04851613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061093|NCT04843904|Rituximab|rituximab|mesh-list
92061094|NCT04843904|Obinutuzumab|obinutuzumab|mesh-list
92061095|NCT04843904|Venetoclax|venetoclax|mesh-list
92061096|NCT04843904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061097|NCT04843904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061098|NCT04843904|Immunologic Factors|immunologic factors|mesh-ancestor
92061099|NCT04843904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061100|NCT04843904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061101|NCT04820933|Tenofovir|tenofovir|mesh-list
92061102|NCT04820933|Emtricitabine|emtricitabine|mesh-list
92061103|NCT04820933|Antiviral Agents|antiviral agents|mesh-ancestor
92061104|NCT04820933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061105|NCT04820933|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92061106|NCT04820933|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92061107|NCT04820933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061108|NCT04820933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061109|NCT04820933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92061110|NCT04820933|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92061111|NCT04740931|Aflibercept|aflibercept|mesh-list
92061112|NCT04740931|Faricimab|faricimab|mesh-list
92061113|NCT04740931|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92061114|NCT04740931|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061115|NCT04740931|Growth Substances|growth substances|mesh-ancestor
92061116|NCT04740931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061117|NCT04740931|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061118|NCT04740931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061119|NCT04702880|Carboplatin|carboplatin|mesh-list
92061120|NCT04702880|Nivolumab|nivolumab|mesh-list
92061121|NCT04702880|Etoposide|etoposide|mesh-list
92061122|NCT04702880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061123|NCT04702880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061124|NCT04702880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061134|NCT04677816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061135|NCT04677816|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92061136|NCT04677816|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92061137|NCT04628026|Venetoclax|venetoclax|mesh-list
92061138|NCT04628026|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061139|NCT04605861|Liraglutide|liraglutide|mesh-list
92061140|NCT04605861|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92061141|NCT04605861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061142|NCT04605861|Incretins|incretins|mesh-ancestor
92061143|NCT04605861|Hormones|hormones|mesh-ancestor
92061144|NCT04605861|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061152|NCT04564443|Calcium|calcium|mesh-list
92061153|NCT04564443|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92061154|NCT04564443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061155|NCT04560595|Caffeine|caffeine|mesh-list
92061156|NCT04560595|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92015206|NCT03066115|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92015207|NCT03066115|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92061157|NCT04560595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061158|NCT04560595|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92061159|NCT04560595|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061160|NCT04560595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061161|NCT04560595|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92061162|NCT04560595|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92061163|NCT04560595|Purinergic Agents|purinergic agents|mesh-ancestor
92061164|NCT04560595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061165|NCT04550260|Cisplatin|cisplatin|mesh-list
92061166|NCT04550260|Fluorouracil|fluorouracil|mesh-list
92061167|NCT04550260|Capecitabine|capecitabine|mesh-list
92061168|NCT04550260|Durvalumab|durvalumab|mesh-list
92061169|NCT04550260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061170|NCT04550260|Antimetabolites|antimetabolites|mesh-ancestor
92061171|NCT04550260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061172|NCT04550260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061173|NCT04550260|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061174|NCT04550260|Immunologic Factors|immunologic factors|mesh-ancestor
92061175|NCT04550260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061176|NCT04550260|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061177|NCT04538742|Paclitaxel|paclitaxel|mesh-list
92061178|NCT04538742|Trastuzumab|trastuzumab|mesh-list
92061179|NCT04538742|Durvalumab|durvalumab|mesh-list
92061180|NCT04538742|Pertuzumab|pertuzumab|mesh-list
92061181|NCT04538742|Tucatinib|tucatinib|mesh-list
92061182|NCT04538742|Trastuzumab deruxtecan|trastuzumab deruxtecan|mesh-list
92061183|NCT04538742|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92061184|NCT04538742|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061185|NCT04538742|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061186|NCT04538742|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061187|NCT04538742|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061188|NCT04538742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061189|NCT04538742|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061191|NCT04538742|Immunologic Factors|immunologic factors|mesh-ancestor
92061192|NCT04538742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061193|NCT04538742|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061194|NCT04538742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061195|NCT04530630|Emtricitabine|emtricitabine|mesh-list
92061196|NCT04530630|Antiviral Agents|antiviral agents|mesh-ancestor
92061197|NCT04530630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061198|NCT04530630|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92061200|NCT04530630|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061201|NCT04530630|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061202|NCT04530630|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92061203|NCT04530630|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92061204|NCT04469764|Letrozole|letrozole|mesh-list
92061205|NCT04469764|Anastrozole|anastrozole|mesh-list
92061206|NCT04469764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061207|NCT04469764|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92061208|NCT04469764|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92061209|NCT04469764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061210|NCT04469764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061211|NCT04469764|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92061212|NCT04469764|Hormone Antagonists|hormone antagonists|mesh-ancestor
92061213|NCT04469764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061214|NCT04469764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061215|NCT04469764|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061216|NCT04450173|Venetoclax|venetoclax|mesh-list
92061217|NCT04450173|Obinutuzumab|obinutuzumab|mesh-list
92061218|NCT04450173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061219|NCT04450173|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061220|NCT04439292|Trametinib|trametinib|mesh-list
92061221|NCT04439292|Dabrafenib|dabrafenib|mesh-list
92061222|NCT04439292|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92061223|NCT04439292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061224|NCT04439292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061225|NCT04439292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061226|NCT04439292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015209|NCT03066115|Sensory System Agents|sensory system agents|mesh-ancestor
92015210|NCT03066115|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015211|NCT03066115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015212|NCT03066115|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015213|NCT03066115|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061227|NCT04439292|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92061228|NCT04439292|Protective Agents|protective agents|mesh-ancestor
92061229|NCT04439292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061230|NCT04439292|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92061231|NCT04439292|Antioxidants|antioxidants|mesh-ancestor
92061232|NCT04439188|GSK2636771|gsk2636771|mesh-list
92061233|NCT04439188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061234|NCT04439188|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061235|NCT04439188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061236|NCT04439188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061237|NCT04439149|GSK2636771|gsk2636771|mesh-list
92061238|NCT04439149|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061239|NCT04439149|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061240|NCT04439149|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061241|NCT04439149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061243|NCT04416737|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92061244|NCT04416737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061245|NCT04364607|Neostigmine|neostigmine|mesh-list
92061246|NCT04364607|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92061247|NCT04364607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081702|NCT01402947|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92061248|NCT04364607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061249|NCT04364607|Cholinergic Agents|cholinergic agents|mesh-ancestor
92061250|NCT04364607|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061251|NCT04364607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061252|NCT04364607|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92061253|NCT04364607|Autonomic Agents|autonomic agents|mesh-ancestor
92061254|NCT04364607|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061255|NCT04354012|Gentian Violet|gentian violet|mesh-list
92061256|NCT04354012|Methylene Blue|methylene blue|mesh-list
92061257|NCT04354012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061258|NCT04354012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061259|NCT04354012|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92061260|NCT04354012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061261|NCT04348383|Defibrotide|defibrotide|mesh-list
92061262|NCT04348383|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92061263|NCT04348383|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92061264|NCT04348383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061265|NCT04348383|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92061266|NCT04323202|Pembrolizumab|pembrolizumab|mesh-list
92061267|NCT04323202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061268|NCT04323202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061269|NCT04323202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061270|NCT04323202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061272|NCT04305691|Glycine|glycine|mesh-list
92061273|NCT04305691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061274|NCT04305691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061275|NCT04305691|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061276|NCT04305691|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061277|NCT04305691|Glycine Agents|glycine agents|mesh-ancestor
92061278|NCT04305691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061279|NCT04305691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061280|NCT04284787|Pembrolizumab|pembrolizumab|mesh-list
92061281|NCT04284787|Azacitidine|azacitidine|mesh-list
92061282|NCT04284787|Venetoclax|venetoclax|mesh-list
92061283|NCT04284787|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061284|NCT04284787|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061285|NCT04284787|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061286|NCT04284787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061287|NCT04284787|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015214|NCT03066115|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92061288|NCT04284787|Antimetabolites|antimetabolites|mesh-ancestor
92061289|NCT04284787|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061291|NCT04278781|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061292|NCT04278781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061293|NCT04278781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061294|NCT04263792|Trimethoprim|trimethoprim|mesh-list
92061295|NCT04263792|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92061296|NCT04263792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061297|NCT04263792|Antimalarials|antimalarials|mesh-ancestor
92061298|NCT04263792|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92061299|NCT04263792|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92061300|NCT04263792|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92061301|NCT04263792|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061302|NCT04263792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061303|NCT04263792|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92061304|NCT04263792|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92061305|NCT04263792|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92061307|NCT04230564|Venetoclax|venetoclax|mesh-list
92061308|NCT04230564|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061309|NCT04230564|Antimetabolites|antimetabolites|mesh-ancestor
92061310|NCT04230564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061311|NCT04230564|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061312|NCT04230564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061313|NCT04218409|Oxycodone|oxycodone|mesh-list
92061314|NCT04218409|Oxytocin|oxytocin|mesh-list
92061315|NCT04218409|Oxytocics|oxytocics|mesh-ancestor
92061316|NCT04218409|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92061317|NCT04218409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061318|NCT04218409|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92061319|NCT04218409|Narcotics|narcotics|mesh-ancestor
92061320|NCT04218409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061321|NCT04218409|Analgesics|analgesics|mesh-ancestor
92061322|NCT04218409|Sensory System Agents|sensory system agents|mesh-ancestor
92061323|NCT04218409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061325|NCT04085172|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92061326|NCT04085172|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92061327|NCT04085172|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92061328|NCT04085172|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92061329|NCT04085172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061330|NCT04085172|Adrenergic Agents|adrenergic agents|mesh-ancestor
92061331|NCT04085172|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061332|NCT04085172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061333|NCT04085172|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92061334|NCT04085172|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92061335|NCT04085172|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92061336|NCT04085172|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92061337|NCT04081545|Analgesics, Opioid|analgesics, opioid|mesh-list
92061339|NCT04081545|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92061340|NCT04081545|Anesthetics|anesthetics|mesh-list
92061341|NCT04081545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061342|NCT04081545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061343|NCT04081545|Narcotics|narcotics|mesh-ancestor
92061344|NCT04081545|Sensory System Agents|sensory system agents|mesh-ancestor
92061346|NCT04076527|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92061347|NCT04076527|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92061348|NCT04076527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061349|NCT04064697|Valganciclovir|valganciclovir|mesh-list
92061350|NCT04064697|Antiviral Agents|antiviral agents|mesh-ancestor
92061351|NCT04064697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061352|NCT03980561|Varenicline|varenicline|mesh-list
92061353|NCT03980561|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92061354|NCT03980561|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92061355|NCT03980561|Cholinergic Agents|cholinergic agents|mesh-ancestor
92061356|NCT03980561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061357|NCT03980561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061358|NCT03980561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061359|NCT03927157|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92061360|NCT03927157|Immunologic Factors|immunologic factors|mesh-ancestor
92015215|NCT03066115|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015216|NCT03066115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015217|NCT03066115|Antioxidants|antioxidants|mesh-ancestor
92015218|NCT03066115|Protective Agents|protective agents|mesh-ancestor
92061361|NCT03927157|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061362|NCT03921424|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92061363|NCT03921424|Immunologic Factors|immunologic factors|mesh-ancestor
92061364|NCT03921424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061366|NCT03896230|Analgesics|analgesics|mesh-ancestor
92061367|NCT03896230|Sensory System Agents|sensory system agents|mesh-ancestor
92061368|NCT03896230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061369|NCT03896230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061370|NCT03896230|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92061371|NCT03896230|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92061372|NCT03896230|Anesthetics, General|anesthetics, general|mesh-ancestor
92061373|NCT03896230|Anesthetics|anesthetics|mesh-ancestor
92061374|NCT03896230|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061375|NCT03896230|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92061376|NCT03896230|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92061378|NCT03896230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061379|NCT03878316|Oxytocin|oxytocin|mesh-list
92061380|NCT03878316|Oxytocics|oxytocics|mesh-ancestor
92061381|NCT03878316|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92061382|NCT03878316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061383|NCT03854929|Azithromycin|azithromycin|mesh-list
92061384|NCT03854929|Ciprofloxacin|ciprofloxacin|mesh-list
92061385|NCT03854929|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92061386|NCT03854929|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061387|NCT03854929|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92061388|NCT03854929|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92061389|NCT03854929|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061390|NCT03854929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061391|NCT03854929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061392|NCT03854929|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92061393|NCT03854929|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92061394|NCT03852628|Naltrexone|naltrexone|mesh-list
92061395|NCT03852628|Buprenorphine|buprenorphine|mesh-list
92061396|NCT03852628|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92061397|NCT03852628|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92061398|NCT03852628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061399|NCT03852628|Sensory System Agents|sensory system agents|mesh-ancestor
92061400|NCT03852628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061401|NCT03852628|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92061402|NCT03852628|Narcotics|narcotics|mesh-ancestor
92061403|NCT03852628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061404|NCT03852628|Analgesics|analgesics|mesh-ancestor
92061405|NCT03826524|Epinephrine|epinephrine|mesh-list
92061406|NCT03826524|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92061407|NCT03826524|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92061408|NCT03826524|Adrenergic Agents|adrenergic agents|mesh-ancestor
92061409|NCT03826524|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061410|NCT03826524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061411|NCT03826524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061412|NCT03826524|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92061413|NCT03826524|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92061414|NCT03826524|Autonomic Agents|autonomic agents|mesh-ancestor
92061415|NCT03826524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061416|NCT03826524|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92061417|NCT03826524|Respiratory System Agents|respiratory system agents|mesh-ancestor
92061422|NCT03798678|Dexamethasone acetate|dexamethasone acetate|mesh-list
92061424|NCT03798678|BB 1101|bb 1101|mesh-list
92061425|NCT03798678|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061426|NCT03798678|Antiemetics|antiemetics|mesh-ancestor
92061427|NCT03798678|Autonomic Agents|autonomic agents|mesh-ancestor
92061428|NCT03798678|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061429|NCT03798678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061430|NCT03798678|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061431|NCT03798678|Glucocorticoids|glucocorticoids|mesh-ancestor
92061432|NCT03798678|Hormones|hormones|mesh-ancestor
92015219|NCT03066115|Vitamins|vitamins|mesh-ancestor
92015220|NCT03066115|Micronutrients|micronutrients|mesh-ancestor
92015221|NCT04212039|Bupivacaine|bupivacaine|mesh-list
92015222|NCT04212039|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015223|NCT04212039|Anesthetics|anesthetics|mesh-ancestor
92015224|NCT04212039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061433|NCT03798678|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061434|NCT03798678|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061435|NCT03798678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061436|NCT03798678|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061437|NCT03798678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061438|NCT03798678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061439|NCT03798678|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061440|NCT03770260|Ixazomib|ixazomib|mesh-list
92061441|NCT03770260|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92061442|NCT03770260|Pevonedistat|pevonedistat|mesh-list
92061443|NCT03770260|Glycine|glycine|mesh-list
92061444|NCT03770260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061445|NCT03770260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061446|NCT03770260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061447|NCT03770260|Glycine Agents|glycine agents|mesh-ancestor
92061448|NCT03770260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061449|NCT03770260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061450|NCT03741426|Durvalumab|durvalumab|mesh-list
92061451|NCT03741426|Olaparib|olaparib|mesh-list
92061452|NCT03741426|Cediranib|cediranib|mesh-list
92061453|NCT03741426|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061454|NCT03741426|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061455|NCT03741426|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92061456|NCT03741426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061457|NCT03741426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061458|NCT03741426|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061459|NCT03727776|Hormones|hormones|mesh-list
92061460|NCT03727776|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92061461|NCT03727776|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92061462|NCT03727776|beta-Endorphin|beta-endorphin|mesh-list
92061463|NCT03727776|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061464|NCT03727776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061465|NCT03727776|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061466|NCT03727776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061467|NCT03698162|Bevacizumab|bevacizumab|mesh-list
92061468|NCT03698162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061469|NCT03698162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061470|NCT03698162|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92081703|NCT01402947|Analgesics|analgesics|mesh-ancestor
92061471|NCT03698162|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061472|NCT03698162|Growth Substances|growth substances|mesh-ancestor
92061473|NCT03698162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061474|NCT03698162|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061475|NCT03623633|Denosumab|denosumab|mesh-list
92061476|NCT03623633|Alendronate|alendronate|mesh-list
92061477|NCT03623633|Raloxifene Hydrochloride|raloxifene hydrochloride|mesh-list
92061478|NCT03623633|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92061479|NCT03623633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061480|NCT03623633|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92061481|NCT03623633|Hormone Antagonists|hormone antagonists|mesh-ancestor
92061482|NCT03623633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061483|NCT03623633|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92061484|NCT03623633|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92061485|NCT03602976|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92061486|NCT03602976|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92061487|NCT03602976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061491|NCT03554174|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92061492|NCT03508440|Prednisone|prednisone|mesh-list
92061493|NCT03508440|Prednisolone|prednisolone|mesh-list
92061494|NCT03508440|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061495|NCT03508440|Glucocorticoids|glucocorticoids|mesh-ancestor
92061496|NCT03508440|Hormones|hormones|mesh-ancestor
92015225|NCT04212039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015226|NCT04212039|Sensory System Agents|sensory system agents|mesh-ancestor
92015227|NCT04212039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015228|NCT05048589|Vaccines|vaccines|mesh-list
92061497|NCT03508440|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061498|NCT03508440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061499|NCT03508440|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061500|NCT03508440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061501|NCT03474107|Paclitaxel|paclitaxel|mesh-list
92061502|NCT03474107|Docetaxel|docetaxel|mesh-list
92061503|NCT03474107|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92061504|NCT03474107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061505|NCT03474107|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061506|NCT03474107|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061507|NCT03474107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061508|NCT03474107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061509|NCT03445845|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92061510|NCT03445845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061511|NCT03422861|Nabilone|nabilone|mesh-list
92061512|NCT03422861|Antiemetics|antiemetics|mesh-ancestor
92061513|NCT03422861|Autonomic Agents|autonomic agents|mesh-ancestor
92061514|NCT03422861|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061515|NCT03422861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061516|NCT03422861|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061517|NCT03422861|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92061518|NCT03422861|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92061519|NCT03422861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061520|NCT03422861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92061521|NCT03421496|Cannabidiol|cannabidiol|mesh-list
92061522|NCT03421496|Vigabatrin|vigabatrin|mesh-list
92061523|NCT03421496|Anticonvulsants|anticonvulsants|mesh-ancestor
92061524|NCT03421496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061525|NCT03421496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061526|NCT03421496|GABA Agents|gaba agents|mesh-ancestor
92061527|NCT03421496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061528|NCT03421496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061529|NCT03421353|Paclitaxel|paclitaxel|mesh-list
92061530|NCT03421353|Carboplatin|carboplatin|mesh-list
92061531|NCT03421353|Gemcitabine|gemcitabine|mesh-list
92061532|NCT03421353|Durvalumab|durvalumab|mesh-list
92061533|NCT03421353|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92061534|NCT03421353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061535|NCT03421353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061536|NCT03421353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061537|NCT03421353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061538|NCT03421353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061539|NCT03421353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061540|NCT03421353|Antimetabolites|antimetabolites|mesh-ancestor
92061541|NCT03421353|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061542|NCT03401320|Letrozole|letrozole|mesh-list
92061543|NCT03401320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061544|NCT03401320|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92061545|NCT03401320|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92061546|NCT03401320|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061547|NCT03401320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061548|NCT03401320|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92061549|NCT03401320|Hormone Antagonists|hormone antagonists|mesh-ancestor
92061550|NCT03401320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061551|NCT03401320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061552|NCT03278106|Trifluridine|trifluridine|mesh-list
92061553|NCT03278106|Antimetabolites|antimetabolites|mesh-ancestor
92061554|NCT03278106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061555|NCT03278106|Antiviral Agents|antiviral agents|mesh-ancestor
92061556|NCT03278106|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061557|NCT03255252|Cisplatin|cisplatin|mesh-list
92061558|NCT03255252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061559|NCT03203525|Leucovorin|leucovorin|mesh-list
92061560|NCT03203525|Sirolimus|sirolimus|mesh-list
92061561|NCT03203525|Bevacizumab|bevacizumab|mesh-list
92061579|NCT03203525|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061580|NCT03203525|Immunologic Factors|immunologic factors|mesh-ancestor
92015229|NCT05048589|Immunologic Factors|immunologic factors|mesh-ancestor
92015230|NCT05048589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015231|NCT05728333|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92061581|NCT03203525|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92061582|NCT03203525|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92061583|NCT03203525|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92061584|NCT03203525|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061585|NCT03203525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061586|NCT03203525|Antimetabolites|antimetabolites|mesh-ancestor
92061587|NCT03203525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061588|NCT03203525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061589|NCT03203525|Antidotes|antidotes|mesh-ancestor
92061590|NCT03203525|Protective Agents|protective agents|mesh-ancestor
92061591|NCT03203525|Vitamin B Complex|vitamin b complex|mesh-ancestor
92061592|NCT03203525|Vitamins|vitamins|mesh-ancestor
92061593|NCT03203525|Micronutrients|micronutrients|mesh-ancestor
92061594|NCT03203525|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92061595|NCT03203525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061596|NCT03203525|Antifungal Agents|antifungal agents|mesh-ancestor
92061597|NCT03203525|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061599|NCT03192215|Apixaban|apixaban|mesh-list
92061600|NCT03192215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92061601|NCT03192215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92061602|NCT03192215|Analgesics|analgesics|mesh-ancestor
92061603|NCT03192215|Sensory System Agents|sensory system agents|mesh-ancestor
92061604|NCT03192215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061605|NCT03192215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061606|NCT03192215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061607|NCT03192215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061608|NCT03192215|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92061609|NCT03192215|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92061610|NCT03192215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061611|NCT03192215|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92061612|NCT03192215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92061613|NCT03192215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061614|NCT03192215|Antipyretics|antipyretics|mesh-ancestor
92061615|NCT03192215|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92061616|NCT03192215|Antithrombins|antithrombins|mesh-ancestor
92061617|NCT03192215|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92061618|NCT03192215|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061619|NCT03192215|Anticoagulants|anticoagulants|mesh-ancestor
92061622|NCT03118986|Olanzapine|olanzapine|mesh-list
92061623|NCT03118986|Antiemetics|antiemetics|mesh-ancestor
92061626|NCT03118986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061627|NCT03118986|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061628|NCT03118986|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92061629|NCT03118986|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92061630|NCT03118986|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92061631|NCT03118986|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92061632|NCT03118986|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92061633|NCT03118986|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92061634|NCT03118986|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92061635|NCT03118986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061636|NCT03118986|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061637|NCT03118986|Serotonin Agents|serotonin agents|mesh-ancestor
92061638|NCT03052608|Crizotinib|crizotinib|mesh-list
92061639|NCT03052608|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061640|NCT03052608|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061641|NCT03052608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061642|NCT03052608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061643|NCT03031730|Dexamethasone|dexamethasone|mesh-list
92061644|NCT03031730|Dexamethasone acetate|dexamethasone acetate|mesh-list
92061645|NCT03031730|Lenalidomide|lenalidomide|mesh-list
92061646|NCT03031730|Ichthammol|ichthammol|mesh-list
92061647|NCT03031730|Dexamethasone 21-phosphate|dexamethasone 21-phosphate|mesh-list
92061649|NCT03031730|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061650|NCT03031730|Antiemetics|antiemetics|mesh-ancestor
92061651|NCT03031730|Autonomic Agents|autonomic agents|mesh-ancestor
92061652|NCT03031730|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061653|NCT03031730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061654|NCT03031730|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015232|NCT05728333|Tirofiban|tirofiban|mesh-list
92015233|NCT05728333|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92015234|NCT05728333|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015235|NCT05728333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015236|NCT05728333|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92061655|NCT03031730|Glucocorticoids|glucocorticoids|mesh-ancestor
92061656|NCT03031730|Hormones|hormones|mesh-ancestor
92061657|NCT03031730|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061658|NCT03031730|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061659|NCT03031730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061660|NCT03031730|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061661|NCT03031730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061662|NCT03031730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061663|NCT03031730|Immunologic Factors|immunologic factors|mesh-ancestor
92061664|NCT03031730|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92061665|NCT03031730|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061666|NCT03031730|Growth Substances|growth substances|mesh-ancestor
92061667|NCT03031730|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061668|NCT03031730|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061669|NCT02914639|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92061670|NCT02914639|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92061671|NCT02883049|Calcium, Dietary|calcium, dietary|mesh-list
92061672|NCT02883049|Leucovorin|leucovorin|mesh-list
92061673|NCT02883049|Folic Acid|folic acid|mesh-list
92061674|NCT02883049|Cytarabine|cytarabine|mesh-list
92061675|NCT02883049|Dexamethasone|dexamethasone|mesh-list
92061676|NCT02883049|Dexamethasone acetate|dexamethasone acetate|mesh-list
92061677|NCT02883049|Prednisone|prednisone|mesh-list
92061678|NCT02883049|Hydrocortisone|hydrocortisone|mesh-list
92061679|NCT02883049|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92061680|NCT02883049|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92061681|NCT02883049|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92061682|NCT02883049|Cortisone|cortisone|mesh-list
92061683|NCT02883049|Cyclophosphamide|cyclophosphamide|mesh-list
92061684|NCT02883049|Doxorubicin|doxorubicin|mesh-list
92061685|NCT02883049|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92061686|NCT02883049|Methotrexate|methotrexate|mesh-list
92061687|NCT02883049|Etoposide|etoposide|mesh-list
92061688|NCT02883049|Vincristine|vincristine|mesh-list
92061689|NCT02883049|Etoposide phosphate|etoposide phosphate|mesh-list
92061690|NCT02883049|Daunorubicin|daunorubicin|mesh-list
92061691|NCT02883049|Asparaginase|asparaginase|mesh-list
92061692|NCT02883049|Dasatinib|dasatinib|mesh-list
92061693|NCT02883049|Mercaptopurine|mercaptopurine|mesh-list
92061694|NCT02883049|Clofarabine|clofarabine|mesh-list
92061695|NCT02883049|Podophyllotoxin|podophyllotoxin|mesh-list
92061696|NCT02883049|Pegaspargase|pegaspargase|mesh-list
92061697|NCT02883049|Thioguanine|thioguanine|mesh-list
92061698|NCT02883049|BB 1101|bb 1101|mesh-list
92061699|NCT02883049|Calcium|calcium|mesh-list
92061700|NCT02883049|2-Aminopurine|2-aminopurine|mesh-list
92061701|NCT02883049|Levoleucovorin|levoleucovorin|mesh-list
92061705|NCT02883049|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061706|NCT02883049|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92061707|NCT02883049|Alkylating Agents|alkylating agents|mesh-ancestor
92061708|NCT02883049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061709|NCT02883049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061710|NCT02883049|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92061711|NCT02883049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061713|NCT02883049|Autonomic Agents|autonomic agents|mesh-ancestor
92061714|NCT02883049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061715|NCT02883049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061716|NCT02883049|Glucocorticoids|glucocorticoids|mesh-ancestor
92061717|NCT02883049|Hormones|hormones|mesh-ancestor
92061718|NCT02883049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061719|NCT02883049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061720|NCT02883049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061721|NCT02883049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061722|NCT02883049|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92061723|NCT02883049|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92061724|NCT02883049|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92061725|NCT02883049|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92061726|NCT02883049|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92015237|NCT04447651|Immunomodulating Agents|immunomodulating agents|mesh-list
92015238|NCT04447651|Immunologic Factors|immunologic factors|mesh-ancestor
92015239|NCT04447651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015240|NCT01364727|Amrubicin|amrubicin|mesh-list
92015241|NCT01364727|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061727|NCT02883049|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92061728|NCT02883049|Abortifacient Agents|abortifacient agents|mesh-ancestor
92061729|NCT02883049|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92061730|NCT02883049|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061731|NCT02883049|Antimetabolites|antimetabolites|mesh-ancestor
92061732|NCT02883049|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061733|NCT02883049|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92061734|NCT02883049|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92061735|NCT02883049|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92061736|NCT02883049|Antiviral Agents|antiviral agents|mesh-ancestor
92061737|NCT02883049|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061738|NCT02883049|Antidotes|antidotes|mesh-ancestor
92061739|NCT02883049|Protective Agents|protective agents|mesh-ancestor
92061740|NCT02883049|Vitamin B Complex|vitamin b complex|mesh-ancestor
92061741|NCT02883049|Vitamins|vitamins|mesh-ancestor
92061742|NCT02883049|Micronutrients|micronutrients|mesh-ancestor
92061743|NCT02883049|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061744|NCT02883049|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061745|NCT02883049|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061746|NCT02883049|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061747|NCT02883049|Hematinics|hematinics|mesh-ancestor
92061748|NCT02883049|Keratolytic Agents|keratolytic agents|mesh-ancestor
92061749|NCT02865018|Cetirizine|cetirizine|mesh-list
92061750|NCT02865018|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92061751|NCT02865018|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92061752|NCT02865018|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92061753|NCT02865018|Histamine Antagonists|histamine antagonists|mesh-ancestor
92061754|NCT02865018|Histamine Agents|histamine agents|mesh-ancestor
92061755|NCT02865018|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061756|NCT02865018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061757|NCT02865018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061758|NCT02795143|Isotretinoin|isotretinoin|mesh-list
92061759|NCT02795143|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061760|NCT02790736|Propranolol|propranolol|mesh-list
92061761|NCT02790736|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92061762|NCT02790736|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92061763|NCT02790736|Adrenergic Agents|adrenergic agents|mesh-ancestor
92061764|NCT02790736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061765|NCT02790736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061766|NCT02790736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061767|NCT02790736|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92061768|NCT02790736|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92061769|NCT02790736|Vasodilator Agents|vasodilator agents|mesh-ancestor
92061770|NCT02773238|Deoxyglucose|deoxyglucose|mesh-list
92061771|NCT02773238|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92061772|NCT02773238|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92061774|NCT02773238|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92061775|NCT02773238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061776|NCT02773238|Antimetabolites|antimetabolites|mesh-ancestor
92061777|NCT02773238|Antiviral Agents|antiviral agents|mesh-ancestor
92061778|NCT02773238|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061779|NCT02704208|Nicotine|nicotine|mesh-list
92061780|NCT02704208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92061781|NCT02704208|Autonomic Agents|autonomic agents|mesh-ancestor
92061782|NCT02704208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061783|NCT02704208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061784|NCT02704208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92061785|NCT02704208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92061786|NCT02704208|Cholinergic Agents|cholinergic agents|mesh-ancestor
92061787|NCT02704208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92061788|NCT02704208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061789|NCT02553460|Leucovorin|leucovorin|mesh-list
92061790|NCT02553460|Cytarabine|cytarabine|mesh-list
92061791|NCT02553460|Dexamethasone|dexamethasone|mesh-list
92061792|NCT02553460|Hydrocortisone|hydrocortisone|mesh-list
92061793|NCT02553460|Cyclophosphamide|cyclophosphamide|mesh-list
92061794|NCT02553460|Methotrexate|methotrexate|mesh-list
92015242|NCT04990869|Niacinamide|niacinamide|mesh-list
92015243|NCT04990869|Niacin|niacin|mesh-list
92015244|NCT04990869|Nicotinic Acids|nicotinic acids|mesh-list
92061795|NCT02553460|Etoposide|etoposide|mesh-list
92061796|NCT02553460|Vincristine|vincristine|mesh-list
92061797|NCT02553460|Bortezomib|bortezomib|mesh-list
92061798|NCT02553460|Asparaginase|asparaginase|mesh-list
92061799|NCT02553460|Mitoxantrone|mitoxantrone|mesh-list
92061800|NCT02553460|Mercaptopurine|mercaptopurine|mesh-list
92061801|NCT02553460|Vorinostat|vorinostat|mesh-list
92061802|NCT02553460|Pegaspargase|pegaspargase|mesh-list
92061803|NCT02553460|Levoleucovorin|levoleucovorin|mesh-list
92061804|NCT02553460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061805|NCT02553460|Immunologic Factors|immunologic factors|mesh-ancestor
92061806|NCT02553460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061807|NCT02553460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061808|NCT02553460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92061809|NCT02553460|Alkylating Agents|alkylating agents|mesh-ancestor
92061810|NCT02553460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061811|NCT02553460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061812|NCT02553460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92061813|NCT02553460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061814|NCT02553460|Antiemetics|antiemetics|mesh-ancestor
92061815|NCT02553460|Autonomic Agents|autonomic agents|mesh-ancestor
92061816|NCT02553460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061817|NCT02553460|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061818|NCT02553460|Glucocorticoids|glucocorticoids|mesh-ancestor
92061819|NCT02553460|Hormones|hormones|mesh-ancestor
92061820|NCT02553460|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061821|NCT02553460|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061822|NCT02553460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92061823|NCT02553460|Abortifacient Agents|abortifacient agents|mesh-ancestor
92061824|NCT02553460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92061825|NCT02553460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061826|NCT02553460|Antimetabolites|antimetabolites|mesh-ancestor
92061827|NCT02553460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061828|NCT02553460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061829|NCT02553460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92061830|NCT02553460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92061831|NCT02553460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92061832|NCT02553460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92061833|NCT02553460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92061834|NCT02553460|Antiviral Agents|antiviral agents|mesh-ancestor
92061835|NCT02553460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061836|NCT02553460|Antidotes|antidotes|mesh-ancestor
92061837|NCT02553460|Protective Agents|protective agents|mesh-ancestor
92061838|NCT02553460|Vitamin B Complex|vitamin b complex|mesh-ancestor
92061839|NCT02553460|Vitamins|vitamins|mesh-ancestor
92061840|NCT02553460|Micronutrients|micronutrients|mesh-ancestor
92061841|NCT02553460|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061842|NCT02553460|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061843|NCT02553460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061844|NCT02553460|Analgesics|analgesics|mesh-ancestor
92061845|NCT02553460|Sensory System Agents|sensory system agents|mesh-ancestor
92061846|NCT02553460|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92061847|NCT02530034|Antibodies|antibodies|mesh-list
92061848|NCT02530034|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92061850|NCT02530034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061851|NCT02516670|Vitamins|vitamins|mesh-list
92061852|NCT02516670|Ascorbic Acid|ascorbic acid|mesh-list
92061853|NCT02516670|Docetaxel|docetaxel|mesh-list
92061854|NCT02516670|Micronutrients|micronutrients|mesh-ancestor
92061855|NCT02516670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061856|NCT02516670|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061857|NCT02516670|Tubulin Modulators|tubulin modulators|mesh-ancestor
92061858|NCT02516670|Antimitotic Agents|antimitotic agents|mesh-ancestor
92061859|NCT02516670|Mitosis Modulators|mitosis modulators|mesh-ancestor
92061860|NCT02516670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061861|NCT02516670|Antioxidants|antioxidants|mesh-ancestor
92061862|NCT02516670|Protective Agents|protective agents|mesh-ancestor
92061863|NCT02315898|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92061864|NCT02315898|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92061865|NCT02315898|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92061866|NCT02315898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061867|NCT02315326|Rituximab|rituximab|mesh-list
92061868|NCT02315326|Methotrexate|methotrexate|mesh-list
92061869|NCT02315326|Procarbazine|procarbazine|mesh-list
92061870|NCT02315326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061871|NCT02315326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061872|NCT02315326|Immunologic Factors|immunologic factors|mesh-ancestor
92061873|NCT02315326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061874|NCT02315326|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061875|NCT02315326|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92061876|NCT02315326|Abortifacient Agents|abortifacient agents|mesh-ancestor
92061877|NCT02315326|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92061878|NCT02315326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061880|NCT02315326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061881|NCT02315326|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061882|NCT02315326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061883|NCT02315326|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92061884|NCT02315326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061885|NCT02315326|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92061886|NCT02280525|Cytarabine|cytarabine|mesh-list
92061887|NCT02280525|Cyclophosphamide|cyclophosphamide|mesh-list
92061888|NCT02280525|Rituximab|rituximab|mesh-list
92061889|NCT02280525|Fludarabine|fludarabine|mesh-list
92061890|NCT02280525|Fludarabine phosphate|fludarabine phosphate|mesh-list
92061891|NCT02280525|Lenalidomide|lenalidomide|mesh-list
92061892|NCT02280525|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061893|NCT02280525|Immunologic Factors|immunologic factors|mesh-ancestor
92061894|NCT02280525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061895|NCT02280525|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92061896|NCT02280525|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92061897|NCT02280525|Alkylating Agents|alkylating agents|mesh-ancestor
92061898|NCT02280525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061899|NCT02280525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061900|NCT02280525|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92061901|NCT02280525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061902|NCT02280525|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061903|NCT02280525|Antimetabolites|antimetabolites|mesh-ancestor
92061904|NCT02280525|Antiviral Agents|antiviral agents|mesh-ancestor
92061905|NCT02280525|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061906|NCT02280525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92061907|NCT02280525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061908|NCT02280525|Growth Substances|growth substances|mesh-ancestor
92061909|NCT02280525|Growth Inhibitors|growth inhibitors|mesh-ancestor
92061910|NCT02157883|Itraconazole|itraconazole|mesh-list
92061911|NCT02157883|Osimertinib|osimertinib|mesh-list
92061912|NCT02157883|Antifungal Agents|antifungal agents|mesh-ancestor
92061913|NCT02157883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061914|NCT02157883|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92061915|NCT02157883|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92061916|NCT02157883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061917|NCT02157883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061918|NCT02157883|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92061919|NCT02157883|Hormone Antagonists|hormone antagonists|mesh-ancestor
92061920|NCT02157883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061921|NCT02157883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061922|NCT02157883|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92061925|NCT02101944|Dexamethasone|dexamethasone|mesh-list
92061926|NCT02101944|Dexamethasone acetate|dexamethasone acetate|mesh-list
92061927|NCT02101944|Ichthammol|ichthammol|mesh-list
92061928|NCT02101944|BB 1101|bb 1101|mesh-list
92061929|NCT02101944|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061930|NCT02101944|Antiemetics|antiemetics|mesh-ancestor
92061931|NCT02101944|Autonomic Agents|autonomic agents|mesh-ancestor
92061932|NCT02101944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061933|NCT02101944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061934|NCT02101944|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92061935|NCT02101944|Glucocorticoids|glucocorticoids|mesh-ancestor
92061936|NCT02101944|Hormones|hormones|mesh-ancestor
92061937|NCT02101944|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061938|NCT02101944|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061939|NCT02101944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061940|NCT02101944|Protease Inhibitors|protease inhibitors|mesh-ancestor
92061941|NCT02101944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061942|NCT02101944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061943|NCT02101944|Dermatologic Agents|dermatologic agents|mesh-ancestor
92061944|NCT02091141|Trastuzumab|trastuzumab|mesh-list
92061945|NCT02091141|Atezolizumab|atezolizumab|mesh-list
92061946|NCT02091141|Pertuzumab|pertuzumab|mesh-list
92015245|NCT04990869|Vitamin B Complex|vitamin b complex|mesh-ancestor
92015246|NCT04990869|Vitamins|vitamins|mesh-ancestor
92015247|NCT04990869|Micronutrients|micronutrients|mesh-ancestor
92015248|NCT04990869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015249|NCT04990869|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92015250|NCT04990869|Antimetabolites|antimetabolites|mesh-ancestor
92061947|NCT02091141|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92061948|NCT02091141|Vemurafenib|vemurafenib|mesh-list
92061949|NCT02091141|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061950|NCT02091141|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061951|NCT02091141|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061952|NCT02091141|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061953|NCT02091141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061954|NCT02091141|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061955|NCT02066181|Sorafenib|sorafenib|mesh-list
92061956|NCT02066181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061957|NCT02066181|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061958|NCT02066181|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061959|NCT02066181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061960|NCT01972217|Prednisone|prednisone|mesh-list
92061961|NCT01972217|Prednisolone|prednisolone|mesh-list
92061962|NCT01972217|Olaparib|olaparib|mesh-list
92061963|NCT01972217|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92061964|NCT01972217|Glucocorticoids|glucocorticoids|mesh-ancestor
92061965|NCT01972217|Hormones|hormones|mesh-ancestor
92061966|NCT01972217|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92061967|NCT01972217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061968|NCT01972217|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92061969|NCT01972217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061970|NCT01972217|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92061971|NCT01972217|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061972|NCT01972217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061973|NCT01970865|Crizotinib|crizotinib|mesh-list
92061974|NCT01970865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061975|NCT01970865|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061976|NCT01970865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061977|NCT01970865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061978|NCT01928576|Nivolumab|nivolumab|mesh-list
92061979|NCT01928576|Azacitidine|azacitidine|mesh-list
92061980|NCT01928576|Entinostat|entinostat|mesh-list
92061981|NCT01928576|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92061982|NCT01928576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061983|NCT01928576|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92061984|NCT01928576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061985|NCT01928576|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061986|NCT01928576|Antimetabolites|antimetabolites|mesh-ancestor
92061987|NCT01928576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061988|NCT01928576|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92061989|NCT01869114|Sirolimus|sirolimus|mesh-list
92061990|NCT01869114|Azacitidine|azacitidine|mesh-list
92061991|NCT01869114|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92061992|NCT01869114|Antimetabolites|antimetabolites|mesh-ancestor
92061993|NCT01869114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061994|NCT01869114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061995|NCT01869114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062003|NCT01843751|Buprenorphine|buprenorphine|mesh-list
92062004|NCT01843751|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92062005|NCT01843751|Naloxone|naloxone|mesh-list
92062006|NCT01843751|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92062007|NCT01843751|Narcotics|narcotics|mesh-ancestor
92062008|NCT01843751|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062009|NCT01843751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062010|NCT01843751|Analgesics|analgesics|mesh-ancestor
92062011|NCT01843751|Sensory System Agents|sensory system agents|mesh-ancestor
92062012|NCT01843751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062013|NCT01843751|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92062014|NCT01756248|Aflibercept|aflibercept|mesh-list
92062015|NCT01756248|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92062016|NCT01756248|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92062017|NCT01756248|Growth Substances|growth substances|mesh-ancestor
92015251|NCT04990869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015252|NCT04990869|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92015253|NCT04990869|Vasodilator Agents|vasodilator agents|mesh-ancestor
92015254|NCT04401553|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92015255|NCT04401553|Vancomycin|vancomycin|mesh-list
92015256|NCT04401553|Cephalosporins|cephalosporins|mesh-list
92015257|NCT04401553|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062018|NCT01756248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062019|NCT01756248|Growth Inhibitors|growth inhibitors|mesh-ancestor
92062020|NCT01756248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062021|NCT01744652|Dasatinib|dasatinib|mesh-list
92062022|NCT01744652|Crizotinib|crizotinib|mesh-list
92062023|NCT01744652|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062024|NCT01744652|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062025|NCT01744652|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062026|NCT01744652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062027|NCT01711541|Paclitaxel|paclitaxel|mesh-list
92062028|NCT01711541|Cisplatin|cisplatin|mesh-list
92062029|NCT01711541|Carboplatin|carboplatin|mesh-list
92062030|NCT01711541|Fluorouracil|fluorouracil|mesh-list
92062031|NCT01711541|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92062032|NCT01711541|Hydroxyurea|hydroxyurea|mesh-list
92062033|NCT01711541|Veliparib|veliparib|mesh-list
92062034|NCT01711541|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062035|NCT01711541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062036|NCT01711541|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062037|NCT01711541|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062038|NCT01711541|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062039|NCT01711541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062040|NCT01711541|Antimetabolites|antimetabolites|mesh-ancestor
92062041|NCT01711541|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062042|NCT01711541|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062043|NCT01711541|Immunologic Factors|immunologic factors|mesh-ancestor
92062044|NCT01711541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062045|NCT01711541|Antisickling Agents|antisickling agents|mesh-ancestor
92062046|NCT01711541|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062047|NCT01711541|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92062048|NCT01711541|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92062049|NCT01500551|Tofacitinib|tofacitinib|mesh-list
92062050|NCT01500551|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92062051|NCT01500551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062052|NCT01500551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062053|NCT01500551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062054|NCT01370512|Droxidopa|droxidopa|mesh-list
92062055|NCT01370512|Pyridostigmine Bromide|pyridostigmine bromide|mesh-list
92062056|NCT01370512|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92062057|NCT01370512|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92062058|NCT01370512|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92062059|NCT01370512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062060|NCT01370512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062061|NCT01370512|Cholinergic Agents|cholinergic agents|mesh-ancestor
92062062|NCT01370512|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062063|NCT01370512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062064|NCT00215813|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92062067|NCT00215813|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062068|NCT00215813|Interferon Inducers|interferon inducers|mesh-ancestor
92062069|NCT00215813|Immunologic Factors|immunologic factors|mesh-ancestor
92062070|NCT00215813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062071|NCT00179465|Tiagabine|tiagabine|mesh-list
92062072|NCT00179465|Antipsychotic Agents|antipsychotic agents|mesh-list
92062073|NCT00179465|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92062074|NCT00179465|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062075|NCT00179465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062076|NCT00179465|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062077|NCT00179465|Anticonvulsants|anticonvulsants|mesh-ancestor
92062078|NCT00179465|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92062079|NCT00179465|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92062080|NCT00179465|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062081|NCT00179465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062083|NCT00179465|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062084|NCT00134030|Interferons|interferons|mesh-list
92062086|NCT00134030|Interferon alpha-2|interferon alpha-2|mesh-list
92062087|NCT00134030|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92062088|NCT00134030|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92062089|NCT00134030|Cisplatin|cisplatin|mesh-list
92062090|NCT00134030|Doxorubicin|doxorubicin|mesh-list
92062091|NCT00134030|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92062092|NCT00134030|Methotrexate|methotrexate|mesh-list
92062093|NCT00134030|Etoposide|etoposide|mesh-list
92062094|NCT00134030|Etoposide phosphate|etoposide phosphate|mesh-list
92062095|NCT00134030|Ifosfamide|ifosfamide|mesh-list
92062096|NCT00134030|Isophosphamide mustard|isophosphamide mustard|mesh-list
92062097|NCT00134030|Podophyllotoxin|podophyllotoxin|mesh-list
92062098|NCT00134030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062099|NCT00134030|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92062100|NCT00134030|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92062101|NCT00134030|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92062102|NCT00134030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062103|NCT00134030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062104|NCT00134030|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92062105|NCT00134030|Abortifacient Agents|abortifacient agents|mesh-ancestor
92062106|NCT00134030|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062107|NCT00134030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062108|NCT00134030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062110|NCT00134030|Dermatologic Agents|dermatologic agents|mesh-ancestor
92062111|NCT00134030|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92062112|NCT00134030|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062113|NCT00134030|Immunologic Factors|immunologic factors|mesh-ancestor
92062114|NCT00134030|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92062115|NCT00134030|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92062116|NCT00134030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062117|NCT00134030|Antiviral Agents|antiviral agents|mesh-ancestor
92062118|NCT00134030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062119|NCT00134030|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92062120|NCT00134030|Alkylating Agents|alkylating agents|mesh-ancestor
92062121|NCT00134030|Keratolytic Agents|keratolytic agents|mesh-ancestor
92062122|NCT00134030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062123|NCT00134030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062124|NCT00134030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062125|NCT01382446|Chlorhexidine|chlorhexidine|mesh-list
92062126|NCT01382446|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92062127|NCT01382446|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92062128|NCT01382446|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062129|NCT01382446|Disinfectants|disinfectants|mesh-ancestor
92062130|NCT01382446|Dermatologic Agents|dermatologic agents|mesh-ancestor
92062131|NCT01381900|Metformin|metformin|mesh-list
92062132|NCT01381900|Canagliflozin|canagliflozin|mesh-list
92062133|NCT01381900|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92062134|NCT01381900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062135|NCT01381900|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92062136|NCT01381900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062137|NCT01744197|Lidocaine|lidocaine|mesh-list
92062138|NCT01744197|Tetracaine|tetracaine|mesh-list
92062139|NCT01744197|Anesthetics, Local|anesthetics, local|mesh-ancestor
92062140|NCT01744197|Anesthetics|anesthetics|mesh-ancestor
92062141|NCT01744197|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062144|NCT01744197|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062145|NCT01744197|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92062146|NCT01744197|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92062147|NCT01744197|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92062148|NCT01744197|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062149|NCT01744197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062150|NCT04565301|Dexamethasone|dexamethasone|mesh-list
92062151|NCT04565301|Neostigmine|neostigmine|mesh-list
92062152|NCT04565301|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92062153|NCT04565301|Antiemetics|antiemetics|mesh-ancestor
92062154|NCT04565301|Autonomic Agents|autonomic agents|mesh-ancestor
92062155|NCT04565301|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062156|NCT04565301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062157|NCT04565301|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062158|NCT04565301|Glucocorticoids|glucocorticoids|mesh-ancestor
92062159|NCT04565301|Hormones|hormones|mesh-ancestor
92062160|NCT04565301|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062161|NCT04565301|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92062162|NCT04565301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062163|NCT04565301|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92062164|NCT04565301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062165|NCT04565301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062166|NCT04565301|Cholinergic Agents|cholinergic agents|mesh-ancestor
92062167|NCT04565301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062168|NCT04565301|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92062169|NCT01743027|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92062170|NCT01743027|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92062171|NCT01743027|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92062172|NCT01743027|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92062173|NCT01743027|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92062174|NCT01743027|Analgesics|analgesics|mesh-ancestor
92062175|NCT01743027|Sensory System Agents|sensory system agents|mesh-ancestor
92062176|NCT01743027|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062177|NCT01743027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062178|NCT01743027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92062179|NCT01743027|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92062180|NCT01743027|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92062181|NCT01743027|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92062182|NCT01743027|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92062183|NCT01743027|Histamine Antagonists|histamine antagonists|mesh-ancestor
92062184|NCT01743027|Histamine Agents|histamine agents|mesh-ancestor
92062185|NCT01743027|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062186|NCT01743027|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062188|NCT01380730|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92062189|NCT01380730|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92062190|NCT01380730|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92062191|NCT01380730|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92062192|NCT01380730|Antimetabolites|antimetabolites|mesh-ancestor
92062193|NCT01380730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062194|NCT01380730|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92062195|NCT01380730|Protease Inhibitors|protease inhibitors|mesh-ancestor
92062196|NCT01380730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062197|NCT01380730|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92062198|NCT01380730|Immunologic Factors|immunologic factors|mesh-ancestor
92062199|NCT01380730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062200|NCT04010968|Venetoclax|venetoclax|mesh-list
92062201|NCT04010968|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062202|NCT01395784|Pioglitazone|pioglitazone|mesh-list
92062203|NCT01395784|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92062204|NCT01395784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062205|NCT01380184|Sirolimus|sirolimus|mesh-list
92062206|NCT01380184|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92062207|NCT01380184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062208|NCT01380184|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92062209|NCT01380184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062210|NCT01380184|Antifungal Agents|antifungal agents|mesh-ancestor
92062211|NCT01380184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062212|NCT01380184|Immunologic Factors|immunologic factors|mesh-ancestor
92062213|NCT01380184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062214|NCT00002826|Paclitaxel|paclitaxel|mesh-list
92062217|NCT00002826|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062218|NCT00002826|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062219|NCT00002826|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062220|NCT00002826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062221|NCT01395316|Alemtuzumab|alemtuzumab|mesh-list
92062222|NCT01395316|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92062223|NCT01395316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062224|NCT04331938|Anesthetics|anesthetics|mesh-list
92062225|NCT04331938|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062226|NCT04331938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062227|NCT01731951|Imetelstat|imetelstat|mesh-list
92062228|NCT01731951|Motesanib diphosphate|motesanib diphosphate|mesh-list
92062229|NCT01731951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062230|NCT01731951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062231|NCT01731951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062232|NCT01741545|Interferons|interferons|mesh-list
92062233|NCT01741545|Ribavirin|ribavirin|mesh-list
92062234|NCT01741545|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062235|NCT01741545|Antiviral Agents|antiviral agents|mesh-ancestor
92015259|NCT01364649|Escitalopram|escitalopram|mesh-list
92015260|NCT01364649|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92015261|NCT01364649|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92062236|NCT01741545|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062237|NCT01741545|Antimetabolites|antimetabolites|mesh-ancestor
92062238|NCT01741545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062239|NCT01884350|Apixaban|apixaban|mesh-list
92062240|NCT01884350|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92062241|NCT01884350|Antithrombins|antithrombins|mesh-ancestor
92062242|NCT01884350|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92062243|NCT01884350|Protease Inhibitors|protease inhibitors|mesh-ancestor
92062244|NCT01884350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062245|NCT01884350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062246|NCT01884350|Anticoagulants|anticoagulants|mesh-ancestor
92062247|NCT01614795|Sirolimus|sirolimus|mesh-list
92062248|NCT01614795|Temsirolimus|temsirolimus|mesh-list
92062249|NCT01614795|MTOR Inhibitors|mtor inhibitors|mesh-list
92062250|NCT01614795|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92062251|NCT01614795|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92062252|NCT01614795|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062253|NCT01614795|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92062254|NCT01614795|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062255|NCT01614795|Antifungal Agents|antifungal agents|mesh-ancestor
92062256|NCT01614795|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062257|NCT01614795|Immunologic Factors|immunologic factors|mesh-ancestor
92062258|NCT01614795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062259|NCT01614795|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062260|NCT01614795|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062261|NCT01614795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062262|NCT01834586|Anesthetics|anesthetics|mesh-list
92062263|NCT01834586|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062264|NCT01834586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062265|NCT01614093|Oxytocin|oxytocin|mesh-list
92062266|NCT01614093|Oxytocics|oxytocics|mesh-ancestor
92062267|NCT01614093|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062268|NCT01614093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062269|NCT04559607|Apatinib|apatinib|mesh-list
92062270|NCT04559607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062271|NCT04559607|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062272|NCT04559607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062273|NCT04559607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062274|NCT01834274|Metformin|metformin|mesh-list
92062275|NCT01834274|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92062276|NCT01834274|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92062277|NCT01834274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062278|NCT01834274|Incretins|incretins|mesh-ancestor
92062279|NCT01834274|Hormones|hormones|mesh-ancestor
92062280|NCT01834274|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062281|NCT01834274|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92062282|NCT01834274|Protease Inhibitors|protease inhibitors|mesh-ancestor
92062283|NCT01834274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062284|NCT01834274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062285|NCT01739595|Enclomiphene|enclomiphene|mesh-list
92062286|NCT01739595|Clomiphene|clomiphene|mesh-list
92062287|NCT01739595|Zuclomiphene|zuclomiphene|mesh-list
92062288|NCT01739595|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92062296|NCT01739595|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92062298|NCT01738971|Hormones|hormones|mesh-ancestor
92062299|NCT01738971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062300|NCT01738971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062301|NCT01738503|Buprenorphine|buprenorphine|mesh-list
92062302|NCT01738503|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92062303|NCT01738503|Narcotics|narcotics|mesh-ancestor
92062304|NCT01738503|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062305|NCT01738503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062307|NCT01738503|Sensory System Agents|sensory system agents|mesh-ancestor
92062308|NCT01738503|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062309|NCT01738503|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92015262|NCT01364649|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92015263|NCT01364649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015264|NCT01364649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062310|NCT01738191|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92062311|NCT01738191|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92062312|NCT01738191|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92062313|NCT01738191|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062314|NCT01738191|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062315|NCT01738191|Adrenergic Agents|adrenergic agents|mesh-ancestor
92062316|NCT01738191|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062317|NCT01738191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062318|NCT01737879|Epoetin Alfa|epoetin alfa|mesh-list
92062319|NCT01737879|Hematinics|hematinics|mesh-ancestor
92062320|NCT01605825|4-Aminopyridine|4-aminopyridine|mesh-list
92062321|NCT01605825|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92062322|NCT01605825|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062323|NCT01605825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062324|NCT01726335|Risperidone|risperidone|mesh-list
92062325|NCT01726335|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92062326|NCT01726335|Serotonin Agents|serotonin agents|mesh-ancestor
92062327|NCT01726335|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062328|NCT01726335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062329|NCT01726335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062330|NCT01726335|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92062331|NCT01726335|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92062332|NCT01726335|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062333|NCT01726335|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062334|NCT01726335|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92062335|NCT01726335|Dopamine Agents|dopamine agents|mesh-ancestor
92062336|NCT01726023|Metronidazole|metronidazole|mesh-list
92062337|NCT01726023|Meropenem|meropenem|mesh-list
92062338|NCT01726023|Ceftazidime|ceftazidime|mesh-list
92062339|NCT01726023|Avibactam|avibactam|mesh-list
92062340|NCT01726023|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92062341|NCT01726023|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062342|NCT01726023|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92062343|NCT01726023|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92062344|NCT01726023|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92062345|NCT01726023|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92062346|NCT01726023|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062347|NCT01726023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062348|NCT01877187|Ethiodized Oil|ethiodized oil|mesh-list
92062349|NCT01877187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062350|NCT04609761|Immunoglobulins|immunoglobulins|mesh-list
92062351|NCT04609761|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92062352|NCT04609761|Antibodies|antibodies|mesh-list
92062353|NCT04609761|gamma-Globulins|gamma-globulins|mesh-list
92062356|NCT04609761|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062357|NCT01858532|Atrasentan|atrasentan|mesh-list
92062358|NCT01858532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062359|NCT01858532|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92062360|NCT01858532|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92062361|NCT01858532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062362|NCT04613960|Magnesium Sulfate|magnesium sulfate|mesh-list
92062363|NCT04613960|Analgesics|analgesics|mesh-ancestor
92062364|NCT04613960|Sensory System Agents|sensory system agents|mesh-ancestor
92062365|NCT04613960|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062366|NCT04613960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062367|NCT04613960|Anesthetics|anesthetics|mesh-ancestor
92062368|NCT04613960|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062369|NCT04613960|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92062370|NCT04613960|Anticonvulsants|anticonvulsants|mesh-ancestor
92062371|NCT04613960|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92062372|NCT04613960|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062373|NCT04613960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062374|NCT04613960|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92062376|NCT04613960|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062377|NCT04599140|Nivolumab|nivolumab|mesh-list
92015266|NCT01364649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015267|NCT01364649|Antidepressive Agents|antidepressive agents|mesh-ancestor
92015268|NCT01364649|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015269|NCT01364649|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92062378|NCT04599140|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92062379|NCT04599140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062380|NCT04599140|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92062381|NCT04599140|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062382|NCT01857206|Vaccines|vaccines|mesh-list
92062383|NCT01857206|Immunologic Factors|immunologic factors|mesh-ancestor
92062384|NCT01857206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062386|NCT01882088|Cathartics|cathartics|mesh-ancestor
92062387|NCT01882088|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062388|NCT01722669|Quercetin|quercetin|mesh-list
92062389|NCT01722669|Antioxidants|antioxidants|mesh-ancestor
92062390|NCT01722669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062391|NCT01722669|Protective Agents|protective agents|mesh-ancestor
92062392|NCT01722669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062393|NCT01707147|Linagliptin|linagliptin|mesh-list
92062394|NCT01707147|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92062395|NCT01707147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062396|NCT01707147|Incretins|incretins|mesh-ancestor
92062397|NCT01707147|Hormones|hormones|mesh-ancestor
92062398|NCT01707147|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062399|NCT01707147|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92062400|NCT01707147|Protease Inhibitors|protease inhibitors|mesh-ancestor
92062401|NCT01707147|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062402|NCT01707147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062403|NCT01876251|Docetaxel|docetaxel|mesh-list
92062404|NCT01876251|Nirogacestat|nirogacestat|mesh-list
92062405|NCT01876251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062406|NCT01876251|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062407|NCT01876251|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062408|NCT01876251|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062409|NCT01876251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062410|NCT01876251|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92062411|NCT01876251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062412|NCT01875237|Methylprednisolone|methylprednisolone|mesh-list
92062413|NCT01875237|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92062414|NCT01875237|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92062415|NCT01875237|Prednisolone|prednisolone|mesh-list
92062416|NCT01875237|Prednisolone acetate|prednisolone acetate|mesh-list
92062417|NCT01875237|Methotrexate|methotrexate|mesh-list
92062418|NCT01875237|Fludarabine phosphate|fludarabine phosphate|mesh-list
92062419|NCT01875237|Fludarabine|fludarabine|mesh-list
92062420|NCT01875237|Melphalan|melphalan|mesh-list
92062421|NCT01875237|Alemtuzumab|alemtuzumab|mesh-list
92062422|NCT01875237|Tacrolimus|tacrolimus|mesh-list
92062423|NCT01875237|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92062424|NCT01875237|Prednisolone phosphate|prednisolone phosphate|mesh-list
92062425|NCT01875237|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92062426|NCT01875237|Abortifacient Agents|abortifacient agents|mesh-ancestor
92062427|NCT01875237|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062431|NCT01875237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062432|NCT01875237|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062433|NCT01875237|Dermatologic Agents|dermatologic agents|mesh-ancestor
92062434|NCT01875237|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062435|NCT01875237|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92062436|NCT01875237|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062437|NCT01875237|Immunologic Factors|immunologic factors|mesh-ancestor
92062438|NCT01875237|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92062439|NCT01875237|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92062440|NCT01875237|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92062441|NCT01875237|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92062442|NCT01875237|Antiemetics|antiemetics|mesh-ancestor
92062443|NCT01875237|Autonomic Agents|autonomic agents|mesh-ancestor
92062444|NCT01875237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062445|NCT01875237|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062446|NCT01875237|Glucocorticoids|glucocorticoids|mesh-ancestor
92062447|NCT01875237|Hormones|hormones|mesh-ancestor
92062448|NCT01875237|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015271|NCT01364649|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062449|NCT01875237|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92062450|NCT01875237|Protective Agents|protective agents|mesh-ancestor
92062451|NCT01875237|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92062452|NCT01875237|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92062453|NCT01875237|Alkylating Agents|alkylating agents|mesh-ancestor
92062454|NCT01875237|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92062455|NCT01875237|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92062456|NCT01874535|Esomeprazole|esomeprazole|mesh-list
92062457|NCT01874535|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92062458|NCT01874535|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062459|NCT01874535|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92062460|NCT01874535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062461|NCT01874535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062462|NCT01722045|Aflibercept|aflibercept|mesh-list
92062463|NCT01722045|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92062464|NCT01722045|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92062465|NCT01722045|Growth Substances|growth substances|mesh-ancestor
92062466|NCT01722045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062467|NCT01722045|Growth Inhibitors|growth inhibitors|mesh-ancestor
92062468|NCT01722045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062469|NCT01721109|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92062470|NCT01721109|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92062471|NCT01721109|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92062472|NCT01721109|Antiviral Agents|antiviral agents|mesh-ancestor
92062473|NCT01721109|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062474|NCT01874145|Glatiramer Acetate|glatiramer acetate|mesh-list
92062475|NCT01874145|(T,G)-A-L|(t,g)-a-l|mesh-list
92062476|NCT01874145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92062477|NCT01874145|Immunologic Factors|immunologic factors|mesh-ancestor
92062478|NCT01874145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062479|NCT01874145|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062480|NCT01874145|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92062481|NCT04415385|Apatinib|apatinib|mesh-list
92062482|NCT04415385|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062483|NCT04415385|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062484|NCT04415385|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062485|NCT04415385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062486|NCT01720797|Chlorhexidine|chlorhexidine|mesh-list
92062487|NCT01720797|Anesthetics|anesthetics|mesh-list
92062488|NCT01720797|Anesthetics, Local|anesthetics, local|mesh-list
92062489|NCT01720797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062490|NCT01720797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062491|NCT01720797|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92062492|NCT01720797|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062493|NCT01720797|Disinfectants|disinfectants|mesh-ancestor
92062494|NCT01720797|Sensory System Agents|sensory system agents|mesh-ancestor
92062495|NCT01720797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062496|NCT01831466|Tofacitinib|tofacitinib|mesh-list
92062497|NCT01831466|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92062500|NCT01831466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062501|NCT01881230|Paclitaxel|paclitaxel|mesh-list
92062502|NCT01881230|Carboplatin|carboplatin|mesh-list
92062503|NCT01881230|Gemcitabine|gemcitabine|mesh-list
92062504|NCT01881230|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062505|NCT01881230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062506|NCT01881230|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062507|NCT01881230|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062508|NCT01881230|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062509|NCT01881230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062510|NCT01881230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062511|NCT01881230|Antimetabolites|antimetabolites|mesh-ancestor
92062512|NCT01856114|Fentanyl|fentanyl|mesh-list
92062513|NCT01856114|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92062514|NCT01856114|Narcotics|narcotics|mesh-ancestor
92062515|NCT01856114|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062516|NCT01856114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062517|NCT01856114|Analgesics|analgesics|mesh-ancestor
92062518|NCT01856114|Sensory System Agents|sensory system agents|mesh-ancestor
92015272|NCT01364649|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92062519|NCT01856114|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062520|NCT01856114|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92062521|NCT01856114|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92062522|NCT01856114|Anesthetics, General|anesthetics, general|mesh-ancestor
92062523|NCT01856114|Anesthetics|anesthetics|mesh-ancestor
92062524|NCT01614470|Ivacaftor|ivacaftor|mesh-list
92062525|NCT01614470|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92062526|NCT01614470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062527|NCT01614470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062528|NCT01880528|Lisinopril|lisinopril|mesh-list
92062529|NCT01880528|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92062530|NCT01880528|Protease Inhibitors|protease inhibitors|mesh-ancestor
92062531|NCT01880528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062532|NCT01880528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062533|NCT01880528|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92062534|NCT01880528|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92062535|NCT01880528|Protective Agents|protective agents|mesh-ancestor
92062536|NCT01880528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062537|NCT01854944|Brexpiprazole|brexpiprazole|mesh-list
92062538|NCT01854944|Serotonin Agents|serotonin agents|mesh-ancestor
92062539|NCT01854944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062540|NCT01854944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062541|NCT01854944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062542|NCT01854944|Dopamine Agonists|dopamine agonists|mesh-ancestor
92062543|NCT01854944|Dopamine Agents|dopamine agents|mesh-ancestor
92062544|NCT01854710|Moxifloxacin|moxifloxacin|mesh-list
92062545|NCT01854710|Loxapine|loxapine|mesh-list
92062546|NCT01854710|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92062547|NCT01854710|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062548|NCT01854710|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92062549|NCT01854710|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92062550|NCT01854710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062551|NCT01854710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062552|NCT01854710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062553|NCT01854710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062554|NCT01854710|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92062555|NCT01854710|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92062556|NCT01854710|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062557|NCT01854710|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062558|NCT01854710|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92062559|NCT01854710|Dopamine Agents|dopamine agents|mesh-ancestor
92062560|NCT01854710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062561|NCT01828034|Gemcitabine|gemcitabine|mesh-list
92062562|NCT01828034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062563|NCT01828034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062564|NCT01828034|Antimetabolites|antimetabolites|mesh-ancestor
92062565|NCT01828034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062566|NCT01853696|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92062567|NCT01853696|Prednisolone|prednisolone|mesh-list
92062568|NCT01853696|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92062569|NCT01853696|Methylprednisolone|methylprednisolone|mesh-list
92062573|NCT01853696|Prednisolone phosphate|prednisolone phosphate|mesh-list
92062574|NCT01853696|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92062575|NCT01853696|Glucocorticoids|glucocorticoids|mesh-ancestor
92062576|NCT01853696|Hormones|hormones|mesh-ancestor
92062577|NCT01853696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062578|NCT01853696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062579|NCT01853696|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92062580|NCT01853696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062581|NCT01853696|Antiemetics|antiemetics|mesh-ancestor
92062582|NCT01853696|Autonomic Agents|autonomic agents|mesh-ancestor
92062583|NCT01853696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062584|NCT01853696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062585|NCT01853696|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92062586|NCT01853696|Protective Agents|protective agents|mesh-ancestor
92062587|NCT01853696|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92062588|NCT01719861|Desipramine|desipramine|mesh-list
92062589|NCT01719861|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92062590|NCT01719861|Antidepressive Agents|antidepressive agents|mesh-ancestor
92062591|NCT01719861|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015273|NCT01364649|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92015274|NCT01364649|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92015275|NCT01364649|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92015276|NCT03065569|Bupivacaine|bupivacaine|mesh-list
92062592|NCT01719861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062593|NCT01719861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062594|NCT01719861|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92062595|NCT01719861|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92062596|NCT01719861|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062597|NCT01719861|Adrenergic Agents|adrenergic agents|mesh-ancestor
92062598|NCT01719861|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062599|NCT01719861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062600|NCT01853618|Tremelimumab|tremelimumab|mesh-list
92062601|NCT01853618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062602|NCT01719783|Vaccines|vaccines|mesh-list
92062603|NCT01719783|Immunologic Factors|immunologic factors|mesh-ancestor
92062604|NCT01719783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062605|NCT01878890|Efavirenz|efavirenz|mesh-list
92062606|NCT01878890|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92062607|NCT01878890|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92062608|NCT01878890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062609|NCT01878890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062610|NCT01878890|Antiviral Agents|antiviral agents|mesh-ancestor
92062611|NCT01878890|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062612|NCT01878890|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92062613|NCT01878890|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92062614|NCT01878890|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92062615|NCT01878890|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92062616|NCT01878890|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92062617|NCT01878890|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92062618|NCT01827332|Oxytocin|oxytocin|mesh-list
92062619|NCT01827332|Oxytocics|oxytocics|mesh-ancestor
92062620|NCT01827332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062621|NCT01827332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062622|NCT01719003|Metformin|metformin|mesh-list
92062623|NCT01719003|Empagliflozin|empagliflozin|mesh-list
92062624|NCT01719003|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92062625|NCT01719003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062626|NCT01719003|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92062627|NCT01719003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062628|NCT01853228|Cytarabine|cytarabine|mesh-list
92062629|NCT01853228|Decitabine|decitabine|mesh-list
92062630|NCT01853228|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062631|NCT01853228|Antimetabolites|antimetabolites|mesh-ancestor
92062632|NCT01853228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062633|NCT01853228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062634|NCT01853228|Antiviral Agents|antiviral agents|mesh-ancestor
92062635|NCT01853228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062636|NCT01853228|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062637|NCT01853228|Immunologic Factors|immunologic factors|mesh-ancestor
92062638|NCT01853228|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062639|NCT01853228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062640|NCT01705587|Teriparatide|teriparatide|mesh-list
92062659|NCT01853072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062660|NCT01853072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062661|NCT01853072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92062663|NCT01853072|Antiemetics|antiemetics|mesh-ancestor
92062664|NCT01853072|Autonomic Agents|autonomic agents|mesh-ancestor
92062665|NCT01853072|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062666|NCT01853072|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062667|NCT01853072|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92062668|NCT01853072|Protective Agents|protective agents|mesh-ancestor
92062669|NCT01853072|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92062670|NCT01853072|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92062671|NCT01853072|Analgesics|analgesics|mesh-ancestor
92062672|NCT01853072|Sensory System Agents|sensory system agents|mesh-ancestor
92062673|NCT01853072|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92062674|NCT01717287|Raltegravir Potassium|raltegravir potassium|mesh-list
92062675|NCT01717287|Anti-Retroviral Agents|anti-retroviral agents|mesh-list
92015277|NCT03065569|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015279|NCT03065569|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015280|NCT03065569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015281|NCT03065569|Sensory System Agents|sensory system agents|mesh-ancestor
92015282|NCT03065569|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015283|NCT05723419|Anesthetics|anesthetics|mesh-list
92015284|NCT05723419|Anesthetics, Local|anesthetics, local|mesh-list
92062676|NCT01717287|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92062677|NCT01717287|Antiviral Agents|antiviral agents|mesh-ancestor
92062678|NCT01717287|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062679|NCT01717287|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92062680|NCT01717287|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92062681|NCT01717287|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062682|NCT01717287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062683|NCT04605393|Dronabinol|dronabinol|mesh-list
92062684|NCT04605393|Cannabidiol|cannabidiol|mesh-list
92062685|NCT04605393|Anticonvulsants|anticonvulsants|mesh-ancestor
92062686|NCT04605393|Hallucinogens|hallucinogens|mesh-ancestor
92062687|NCT04605393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062688|NCT04605393|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062689|NCT04605393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92062690|NCT04605393|Analgesics|analgesics|mesh-ancestor
92062691|NCT04605393|Sensory System Agents|sensory system agents|mesh-ancestor
92062692|NCT04605393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062693|NCT04605393|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92062694|NCT04605393|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92062695|NCT04605393|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062696|NCT04605393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062701|NCT01827254|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92062702|NCT01827254|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92062703|NCT01827254|Growth Substances|growth substances|mesh-ancestor
92062704|NCT01827254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062705|NCT01827254|Growth Inhibitors|growth inhibitors|mesh-ancestor
92062706|NCT01827254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062707|NCT01827254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062708|NCT01827254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062709|NCT01824602|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92062710|NCT01824602|Anticonvulsants|anticonvulsants|mesh-ancestor
92062711|NCT01824602|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92062712|NCT01824602|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92062713|NCT01824602|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062714|NCT01824602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062715|NCT01704651|Alvimopan|alvimopan|mesh-list
92062716|NCT01704651|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062717|NCT04609592|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92062718|NCT04609592|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062719|NCT04609592|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92062720|NCT01876082|Methotrexate|methotrexate|mesh-list
92062721|NCT01876082|Vinblastine|vinblastine|mesh-list
92062722|NCT01876082|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92062723|NCT01876082|Abortifacient Agents|abortifacient agents|mesh-ancestor
92062724|NCT01876082|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062725|NCT01876082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062726|NCT01876082|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062727|NCT01876082|Antimetabolites|antimetabolites|mesh-ancestor
92062728|NCT01876082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062729|NCT01876082|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062730|NCT01876082|Dermatologic Agents|dermatologic agents|mesh-ancestor
92062731|NCT01876082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062732|NCT01876082|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92062733|NCT01876082|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062734|NCT01876082|Immunologic Factors|immunologic factors|mesh-ancestor
92062735|NCT01876082|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92062736|NCT01876082|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92015285|NCT05723419|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015286|NCT05723419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015287|NCT05723419|Sensory System Agents|sensory system agents|mesh-ancestor
92015288|NCT05723419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062737|NCT01876082|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062738|NCT01876082|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062739|NCT01876082|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062740|NCT01876082|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062741|NCT01716585|Ribavirin|ribavirin|mesh-list
92062742|NCT01716585|Antimetabolites|antimetabolites|mesh-ancestor
92062743|NCT01716585|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062744|NCT01716585|Antiviral Agents|antiviral agents|mesh-ancestor
92062745|NCT01716585|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062746|NCT01852292|Paclitaxel|paclitaxel|mesh-list
92062747|NCT01852292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062748|NCT01852292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062749|NCT01852292|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062750|NCT01852292|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062751|NCT01852292|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062752|NCT01852292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062753|NCT01715805|Cariprazine|cariprazine|mesh-list
92062754|NCT01715805|Antidepressive Agents|antidepressive agents|mesh-list
92062755|NCT01715805|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062756|NCT01715805|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92062757|NCT01715805|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92062758|NCT01715805|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062759|NCT01715805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062760|NCT01852214|Ticagrelor|ticagrelor|mesh-list
92062761|NCT01852214|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92062762|NCT01852214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92062763|NCT01852214|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92062764|NCT01852214|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92062765|NCT01852214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92062769|NCT01852214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062770|NCT04594772|Paclitaxel|paclitaxel|mesh-list
92062771|NCT04594772|Gemcitabine|gemcitabine|mesh-list
92062772|NCT04594772|Fluorouracil|fluorouracil|mesh-list
92062773|NCT04594772|Oxaliplatin|oxaliplatin|mesh-list
92062774|NCT04594772|Irinotecan|irinotecan|mesh-list
92062775|NCT04594772|Folfirinox|folfirinox|mesh-list
92062776|NCT04594772|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062777|NCT04594772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062778|NCT04594772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92062779|NCT04594772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92062780|NCT04594772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92062781|NCT04594772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062782|NCT04594772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062783|NCT04594772|Antimetabolites|antimetabolites|mesh-ancestor
92062784|NCT04594772|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062785|NCT04594772|Immunologic Factors|immunologic factors|mesh-ancestor
92062786|NCT04594772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062787|NCT04594772|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92062788|NCT04594772|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92062789|NCT04594772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062790|NCT01393990|Tamoxifen|tamoxifen|mesh-list
92062791|NCT01393990|Midazolam|midazolam|mesh-list
92062792|NCT01393990|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92062793|NCT01393990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92062794|NCT01393990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062795|NCT01393990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062796|NCT01393990|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92062797|NCT01393990|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92062798|NCT01393990|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062799|NCT01393990|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92062800|NCT01393990|Anesthetics, General|anesthetics, general|mesh-ancestor
92062801|NCT01393990|Anesthetics|anesthetics|mesh-ancestor
92062802|NCT01393990|GABA Modulators|gaba modulators|mesh-ancestor
92062803|NCT01393990|GABA Agents|gaba agents|mesh-ancestor
92062804|NCT01393990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062805|NCT01393990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015289|NCT02588261|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92015291|NCT02588261|Naquotinib|naquotinib|mesh-list
92062806|NCT01393990|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92062807|NCT01393990|Hormone Antagonists|hormone antagonists|mesh-ancestor
92062808|NCT01393990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062809|NCT01393990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92062810|NCT01393990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062811|NCT01393990|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92062812|NCT01393990|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92062813|NCT01393990|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92062815|NCT00210184|Fluorouracil|fluorouracil|mesh-list
92062816|NCT00210184|Irinotecan|irinotecan|mesh-list
92062817|NCT00210184|Antimetabolites|antimetabolites|mesh-ancestor
92062818|NCT00210184|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062819|NCT00210184|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062820|NCT00210184|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062821|NCT00210184|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062822|NCT00210184|Immunologic Factors|immunologic factors|mesh-ancestor
92062823|NCT00210184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062824|NCT00210184|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92062825|NCT00210184|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92062826|NCT00210184|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062827|NCT00210184|Antidotes|antidotes|mesh-ancestor
92062828|NCT00210184|Protective Agents|protective agents|mesh-ancestor
92062829|NCT00210184|Vitamin B Complex|vitamin b complex|mesh-ancestor
92062830|NCT00210184|Vitamins|vitamins|mesh-ancestor
92062831|NCT00210184|Micronutrients|micronutrients|mesh-ancestor
92062832|NCT05364190|Empagliflozin|empagliflozin|mesh-list
92062833|NCT05364190|Canagliflozin|canagliflozin|mesh-list
92062834|NCT05364190|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92062835|NCT05364190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062836|NCT05364190|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92062837|NCT05364190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062840|NCT00210964|Ceftobiprole|ceftobiprole|mesh-list
92062841|NCT00210964|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92062842|NCT00210964|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92062843|NCT00210964|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062844|NCT00210964|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92062845|NCT00210964|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062846|NCT00210964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062847|NCT05630638|Dolutegravir|dolutegravir|mesh-list
92062848|NCT05630638|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92062849|NCT05630638|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92062850|NCT05630638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062851|NCT05630638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062852|NCT05630638|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92062853|NCT05630638|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92062854|NCT05630638|Antiviral Agents|antiviral agents|mesh-ancestor
92062855|NCT05630638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062857|NCT03593434|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92062858|NCT03593434|Anesthetics, General|anesthetics, general|mesh-ancestor
92062859|NCT03593434|Anesthetics|anesthetics|mesh-ancestor
92062860|NCT03593434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92062861|NCT03593434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062862|NCT03792958|Vorolanib|vorolanib|mesh-list
92062863|NCT03792958|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062864|NCT03792958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062865|NCT03792958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062866|NCT03989362|Ipilimumab|ipilimumab|mesh-list
92062867|NCT03989362|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92062868|NCT03989362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062869|NCT03989362|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92062870|NCT03989362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062871|NCT03599596|Pyrimethamine|pyrimethamine|mesh-list
92062872|NCT03599596|Sulfadoxine|sulfadoxine|mesh-list
92062873|NCT03599596|Fanasil, pyrimethamine drug combination|fanasil, pyrimethamine drug combination|mesh-list
92062874|NCT03599596|Antimalarials|antimalarials|mesh-ancestor
92062875|NCT03599596|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92062876|NCT03599596|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92015292|NCT02588261|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015293|NCT02588261|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015294|NCT02588261|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062877|NCT03599596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062878|NCT03599596|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92062879|NCT03599596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062880|NCT03599596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062881|NCT03599596|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92062883|NCT04407130|Ivermectin|ivermectin|mesh-list
92062884|NCT04407130|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92062885|NCT04407130|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062886|NCT04407130|Antimalarials|antimalarials|mesh-ancestor
92062887|NCT04407130|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92062888|NCT04407130|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92062889|NCT03599284|Clopidogrel|clopidogrel|mesh-list
92062890|NCT03599284|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92062891|NCT03599284|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92062892|NCT03599284|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92062893|NCT03599284|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92062894|NCT03599284|Purinergic Agents|purinergic agents|mesh-ancestor
92062895|NCT03599284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062896|NCT03599284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062897|NCT03599284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062898|NCT03024814|Acetaminophen|acetaminophen|mesh-list
92062899|NCT03024814|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92062900|NCT03024814|Analgesics|analgesics|mesh-ancestor
92062901|NCT03024814|Sensory System Agents|sensory system agents|mesh-ancestor
92062902|NCT03024814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92062903|NCT03024814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062904|NCT03024814|Antipyretics|antipyretics|mesh-ancestor
92062905|NCT03024502|Clotrimazole|clotrimazole|mesh-list
92062906|NCT03024502|Miconazole|miconazole|mesh-list
92062907|NCT03024502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92062908|NCT03024502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062909|NCT03024502|Antifungal Agents|antifungal agents|mesh-ancestor
92062910|NCT03024502|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92062911|NCT03024502|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92062920|NCT03024580|Tamoxifen|tamoxifen|mesh-list
92062921|NCT03024580|Letrozole|letrozole|mesh-list
92062922|NCT03024580|Fulvestrant|fulvestrant|mesh-list
92062923|NCT03024580|Anastrozole|anastrozole|mesh-list
92062924|NCT03024580|Exemestane|exemestane|mesh-list
92062925|NCT03024580|Megestrol|megestrol|mesh-list
92062926|NCT03024580|Megestrol Acetate|megestrol acetate|mesh-list
92062927|NCT03024580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062928|NCT03024580|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92062929|NCT03024580|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92062930|NCT03024580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062931|NCT03024580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062932|NCT03024580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92062933|NCT03024580|Hormone Antagonists|hormone antagonists|mesh-ancestor
92062934|NCT03024580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062935|NCT03024580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062936|NCT03024580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92062937|NCT03024580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92062938|NCT03024580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92062939|NCT03024580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92062940|NCT03024580|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92062941|NCT03024580|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92062942|NCT03024580|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92062943|NCT03024580|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92062944|NCT03024580|Contraceptive Agents|contraceptive agents|mesh-ancestor
92062945|NCT03024580|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062946|NCT03024580|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92062947|NCT03024580|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92062948|NCT03024580|Appetite Stimulants|appetite stimulants|mesh-ancestor
92062949|NCT03024580|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92062951|NCT01851590|Amorolfine|amorolfine|mesh-list
92062952|NCT01851590|Antifungal Agents|antifungal agents|mesh-ancestor
92062953|NCT01851590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92062954|NCT01851590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062955|NCT01851590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062956|NCT03598816|Durvalumab|durvalumab|mesh-list
92062957|NCT03598816|Tremelimumab|tremelimumab|mesh-list
92062958|NCT03598816|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92062959|NCT03598816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062960|NCT05633758|Metolazone|metolazone|mesh-list
92062961|NCT05633758|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92062962|NCT05633758|Diuretics|diuretics|mesh-ancestor
92062963|NCT05633758|Natriuretic Agents|natriuretic agents|mesh-ancestor
92062964|NCT05633758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062965|NCT05633758|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92062966|NCT05633758|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062967|NCT05633758|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062968|NCT03978442|Bupropion|bupropion|mesh-list
92062969|NCT03978442|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92062970|NCT03978442|Antidepressive Agents|antidepressive agents|mesh-ancestor
92062971|NCT03978442|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92062972|NCT03978442|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92062973|NCT03978442|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92062976|NCT03978442|Dopamine Agents|dopamine agents|mesh-ancestor
92062977|NCT03978442|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062978|NCT03978442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062979|NCT03978442|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92062980|NCT03978442|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92062981|NCT03978442|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062982|NCT03598738|Esomeprazole|esomeprazole|mesh-list
92062983|NCT03598738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92062984|NCT03598738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92062985|NCT03598738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92062986|NCT03598738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062987|NCT03598738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062988|NCT03594214|Vitamin D|vitamin d|mesh-list
92062989|NCT03594214|Vitamins|vitamins|mesh-ancestor
92062990|NCT03594214|Micronutrients|micronutrients|mesh-ancestor
92062991|NCT03594214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062992|NCT03594214|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92062993|NCT04003948|Ibogaine|ibogaine|mesh-list
92062994|NCT04003948|Hallucinogens|hallucinogens|mesh-ancestor
92062995|NCT04003948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062996|NCT04003948|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92063075|NCT00217672|Bevacizumab|bevacizumab|mesh-list
92062997|NCT04003948|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92062998|NCT04003948|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92062999|NCT04003948|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063000|NCT04003948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063001|NCT03598582|Epoetin Alfa|epoetin alfa|mesh-list
92063002|NCT03598582|Hematinics|hematinics|mesh-ancestor
92063003|NCT01852058|Botulinum Toxins|botulinum toxins|mesh-list
92063004|NCT01852058|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92063005|NCT01852058|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92063006|NCT01852058|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92063007|NCT01852058|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063008|NCT01852058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063009|NCT01852058|Cholinergic Agents|cholinergic agents|mesh-ancestor
92063010|NCT01852058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063011|NCT01852058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063012|NCT01852058|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92063013|NCT01852058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063014|NCT03593668|Metformin|metformin|mesh-list
92063015|NCT03593668|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92063016|NCT03593668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063017|NCT03598348|Capecitabine|capecitabine|mesh-list
92063018|NCT03598348|Apatinib|apatinib|mesh-list
92063019|NCT03598348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92063020|NCT03598348|Antimetabolites|antimetabolites|mesh-ancestor
92063021|NCT03598348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063022|NCT03598348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063023|NCT03598348|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92063024|NCT03598348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063025|NCT03976258|Naltrexone|naltrexone|mesh-list
92063026|NCT03976258|Buprenorphine|buprenorphine|mesh-list
92063027|NCT03976258|Methadone|methadone|mesh-list
92015295|NCT02588261|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063028|NCT03976258|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92063029|NCT03976258|Heroin|heroin|mesh-list
92063030|NCT03976258|Naloxone|naloxone|mesh-list
92063031|NCT03976258|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063032|NCT03976258|Narcotics|narcotics|mesh-ancestor
92063033|NCT03976258|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063034|NCT03976258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063035|NCT03976258|Analgesics|analgesics|mesh-ancestor
92063036|NCT03976258|Sensory System Agents|sensory system agents|mesh-ancestor
92063037|NCT03976258|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063038|NCT03976258|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92063039|NCT03976258|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92063040|NCT03976258|Antitussive Agents|antitussive agents|mesh-ancestor
92063041|NCT03976258|Respiratory System Agents|respiratory system agents|mesh-ancestor
92063042|NCT03598192|Sufentanil|sufentanil|mesh-list
92063043|NCT03598192|Dsuvia|dsuvia|mesh-list
92063044|NCT03598192|Ropivacaine|ropivacaine|mesh-list
92063045|NCT03598192|Anesthetics, Local|anesthetics, local|mesh-ancestor
92063046|NCT03598192|Anesthetics|anesthetics|mesh-ancestor
92063047|NCT03598192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063049|NCT03598192|Sensory System Agents|sensory system agents|mesh-ancestor
92063050|NCT03598192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063051|NCT03598192|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063052|NCT03598192|Narcotics|narcotics|mesh-ancestor
92063053|NCT03598192|Analgesics|analgesics|mesh-ancestor
92063054|NCT03598192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92063055|NCT03598192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92063056|NCT03598192|Anesthetics, General|anesthetics, general|mesh-ancestor
92063058|NCT04003246|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92063059|NCT04003246|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063060|NCT04003246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063061|NCT04003246|Immunologic Factors|immunologic factors|mesh-ancestor
92063062|NCT04003246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063063|NCT00218296|Lobeline|lobeline|mesh-list
92063064|NCT00218296|Nicotine|nicotine|mesh-list
92063065|NCT00218296|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92063066|NCT00218296|Autonomic Agents|autonomic agents|mesh-ancestor
92063067|NCT00218296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063068|NCT00218296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063069|NCT00218296|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92063070|NCT00218296|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92063071|NCT00218296|Cholinergic Agents|cholinergic agents|mesh-ancestor
92063072|NCT00218296|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063073|NCT00218296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063074|NCT00218296|Respiratory System Agents|respiratory system agents|mesh-ancestor
92063076|NCT00217672|Docetaxel|docetaxel|mesh-list
92063077|NCT00217672|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063078|NCT00217672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063079|NCT00217672|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92063080|NCT00217672|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92063081|NCT00217672|Growth Substances|growth substances|mesh-ancestor
92063082|NCT00217672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063083|NCT00217672|Growth Inhibitors|growth inhibitors|mesh-ancestor
92063084|NCT00217672|Tubulin Modulators|tubulin modulators|mesh-ancestor
92063085|NCT00217672|Antimitotic Agents|antimitotic agents|mesh-ancestor
92063086|NCT00217672|Mitosis Modulators|mitosis modulators|mesh-ancestor
92063087|NCT00217672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063088|NCT00216736|Dexamethasone|dexamethasone|mesh-list
92063089|NCT00216736|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063090|NCT00216736|Antiemetics|antiemetics|mesh-ancestor
92063091|NCT00216736|Autonomic Agents|autonomic agents|mesh-ancestor
92063092|NCT00216736|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063093|NCT00216736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063094|NCT00216736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063095|NCT00216736|Glucocorticoids|glucocorticoids|mesh-ancestor
92063096|NCT00216736|Hormones|hormones|mesh-ancestor
92063097|NCT00216736|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063098|NCT00216736|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063099|NCT00216736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063100|NCT01850030|Progesterone|progesterone|mesh-list
92063101|NCT01850030|Dydrogesterone|dydrogesterone|mesh-list
92063102|NCT01850030|Progestins|progestins|mesh-ancestor
92015297|NCT04989699|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92015298|NCT04989699|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92015299|NCT04989699|Growth Substances|growth substances|mesh-ancestor
92063103|NCT01850030|Hormones|hormones|mesh-ancestor
92063104|NCT01850030|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063105|NCT01850030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063106|NCT00215644|Capecitabine|capecitabine|mesh-list
92063107|NCT00215644|Epirubicin|epirubicin|mesh-list
92063108|NCT00215644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063109|NCT00215644|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92063110|NCT00215644|Antimetabolites|antimetabolites|mesh-ancestor
92063111|NCT00215644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063112|NCT00215644|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92063113|NCT00215644|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92063114|NCT00215644|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92063115|NCT00215644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063116|NCT00213148|Anastrozole|anastrozole|mesh-list
92063117|NCT00213148|Citric Acid|citric acid|mesh-list
92063118|NCT00213148|Sodium Citrate|sodium citrate|mesh-list
92063119|NCT00213148|Clomiphene|clomiphene|mesh-list
92063120|NCT00213148|Enclomiphene|enclomiphene|mesh-list
92063121|NCT00213148|Zuclomiphene|zuclomiphene|mesh-list
92063122|NCT00213148|Anticoagulants|anticoagulants|mesh-ancestor
92063125|NCT00213148|Sequestering Agents|sequestering agents|mesh-ancestor
92063126|NCT00213148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063127|NCT00213148|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063128|NCT00213148|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063129|NCT00213148|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92063130|NCT00213148|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92063131|NCT00213148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063132|NCT00213148|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92063133|NCT00213148|Hormone Antagonists|hormone antagonists|mesh-ancestor
92063134|NCT00213148|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063135|NCT00213148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063136|NCT00213148|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92063137|NCT00213148|Fertility Agents|fertility agents|mesh-ancestor
92063138|NCT00213148|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92063139|NCT00213148|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92063140|NCT00213148|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92063141|NCT01704261|Metformin|metformin|mesh-list
92063142|NCT01704261|Glimepiride|glimepiride|mesh-list
92063143|NCT01704261|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92063144|NCT01704261|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063145|NCT01704261|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92063146|NCT01704261|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92063147|NCT01704261|Immunologic Factors|immunologic factors|mesh-ancestor
92063148|NCT00212758|Hormones|hormones|mesh-list
92063149|NCT00212758|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063230|NCT03595930|Xhance|xhance|mesh-list
92063150|NCT00212758|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063151|NCT01824290|Tadalafil|tadalafil|mesh-list
92063152|NCT01824290|Vasodilator Agents|vasodilator agents|mesh-ancestor
92063153|NCT01824290|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92063154|NCT01824290|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92063155|NCT01824290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063156|NCT01824290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063157|NCT01824290|Urological Agents|urological agents|mesh-ancestor
92063158|NCT03592342|Clobetasol|clobetasol|mesh-list
92063159|NCT03592342|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063160|NCT03592342|Glucocorticoids|glucocorticoids|mesh-ancestor
92063161|NCT03592342|Hormones|hormones|mesh-ancestor
92063162|NCT03592342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063163|NCT03592342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063164|NCT01715415|Ribavirin|ribavirin|mesh-list
92063165|NCT01715415|Antimetabolites|antimetabolites|mesh-ancestor
92063166|NCT01715415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063167|NCT01715415|Antiviral Agents|antiviral agents|mesh-ancestor
92063168|NCT01715415|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063169|NCT00211510|Insulin|insulin|mesh-list
92063170|NCT00211510|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92063171|NCT00211510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063172|NCT04198636|Denosumab|denosumab|mesh-list
92063173|NCT04198636|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92063174|NCT04198636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063176|NCT04414995|Ibuprofen|ibuprofen|mesh-list
92063177|NCT04414995|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92063178|NCT04414995|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92063179|NCT04414995|Analgesics|analgesics|mesh-ancestor
92063180|NCT04414995|Sensory System Agents|sensory system agents|mesh-ancestor
92063181|NCT04414995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063182|NCT04414995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063183|NCT04414995|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063184|NCT04414995|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92063185|NCT04414995|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92063186|NCT04414995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063187|NCT04414995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063188|NCT04414995|Antipyretics|antipyretics|mesh-ancestor
92063189|NCT01869699|Acetaminophen|acetaminophen|mesh-list
92063190|NCT01869699|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92063191|NCT01869699|Analgesics|analgesics|mesh-ancestor
92063192|NCT01869699|Sensory System Agents|sensory system agents|mesh-ancestor
92063193|NCT01869699|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063194|NCT01869699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063199|NCT03981796|Dostarlimab|dostarlimab|mesh-list
92063200|NCT03981796|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92063201|NCT03981796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063202|NCT03981796|Tubulin Modulators|tubulin modulators|mesh-ancestor
92063203|NCT03981796|Antimitotic Agents|antimitotic agents|mesh-ancestor
92063204|NCT03981796|Mitosis Modulators|mitosis modulators|mesh-ancestor
92063205|NCT03981796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063206|NCT03981796|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92063207|NCT03981796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063208|NCT01875848|Buprenorphine|buprenorphine|mesh-list
92063209|NCT01875848|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92063210|NCT01875848|Naloxone|naloxone|mesh-list
92063211|NCT01875848|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063212|NCT01875848|Narcotics|narcotics|mesh-ancestor
92063213|NCT01875848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063214|NCT01875848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063215|NCT01875848|Analgesics|analgesics|mesh-ancestor
92063216|NCT01875848|Sensory System Agents|sensory system agents|mesh-ancestor
92063217|NCT01875848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063218|NCT01875848|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92063219|NCT03591172|Propolis|propolis|mesh-list
92063220|NCT03591172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063221|NCT04197622|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92063222|NCT04197622|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92063223|NCT04197622|Diuretics|diuretics|mesh-ancestor
92063224|NCT04197622|Natriuretic Agents|natriuretic agents|mesh-ancestor
92063225|NCT04197622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063226|NCT04197622|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92063227|NCT04197622|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063228|NCT04197622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063229|NCT03595930|Fluticasone|fluticasone|mesh-list
92063231|NCT03595930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063232|NCT03595930|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92063233|NCT03595930|Autonomic Agents|autonomic agents|mesh-ancestor
92063234|NCT03595930|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063235|NCT03595930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063236|NCT03595930|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92063237|NCT03595930|Respiratory System Agents|respiratory system agents|mesh-ancestor
92063238|NCT03595930|Dermatologic Agents|dermatologic agents|mesh-ancestor
92063239|NCT03595930|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92063240|NCT03595852|Cefazolin|cefazolin|mesh-list
92063241|NCT03595852|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92063242|NCT03595852|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063243|NCT04191382|Letrozole|letrozole|mesh-list
92063244|NCT04191382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063245|NCT04191382|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92063246|NCT04191382|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92063247|NCT04191382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063248|NCT04191382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063249|NCT04191382|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92015300|NCT04989699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015301|NCT04989699|Growth Inhibitors|growth inhibitors|mesh-ancestor
92063250|NCT04191382|Hormone Antagonists|hormone antagonists|mesh-ancestor
92063251|NCT04191382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063252|NCT04191382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063255|NCT01703091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063256|NCT01703091|Tubulin Modulators|tubulin modulators|mesh-ancestor
92063257|NCT01703091|Antimitotic Agents|antimitotic agents|mesh-ancestor
92063258|NCT01703091|Mitosis Modulators|mitosis modulators|mesh-ancestor
92063259|NCT01703091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063260|NCT04196998|Tenofovir|tenofovir|mesh-list
92063261|NCT04196998|Entecavir|entecavir|mesh-list
92063262|NCT04196998|Antiviral Agents|antiviral agents|mesh-ancestor
92063263|NCT04196998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063264|NCT04196998|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92063265|NCT04196998|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92063266|NCT04196998|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063268|NCT04196998|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92063269|NCT04196998|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92063270|NCT04196452|Ipilimumab|ipilimumab|mesh-list
92063271|NCT04196452|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063272|NCT04196452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063273|NCT04196452|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92063274|NCT04196452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063275|NCT01867671|Immunomodulating Agents|immunomodulating agents|mesh-list
92063276|NCT01867671|Immunologic Factors|immunologic factors|mesh-list
92063277|NCT01867671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063278|NCT03967054|Ivermectin|ivermectin|mesh-list
92063279|NCT03967054|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92063280|NCT03967054|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063281|NCT01702311|Insulin Aspart|insulin aspart|mesh-list
92063282|NCT01702311|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92063283|NCT01702311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063285|NCT04196608|Imipenem|imipenem|mesh-list
92063286|NCT04196608|Ceftolozane|ceftolozane|mesh-list
92063287|NCT04196608|Ceftolozane, tazobactam drug combination|ceftolozane, tazobactam drug combination|mesh-list
92063288|NCT04196608|Relebactam|relebactam|mesh-list
92063289|NCT04196608|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92063290|NCT04196608|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063291|NCT04196608|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92063292|NCT04196608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063293|NCT04196608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063294|NCT04196608|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92063295|NCT04022200|Paclitaxel|paclitaxel|mesh-list
92063296|NCT04022200|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92063297|NCT04022200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063298|NCT04022200|Tubulin Modulators|tubulin modulators|mesh-ancestor
92063299|NCT04022200|Antimitotic Agents|antimitotic agents|mesh-ancestor
92063300|NCT04022200|Mitosis Modulators|mitosis modulators|mesh-ancestor
92063301|NCT04022200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063302|NCT04552743|Plerixafor|plerixafor|mesh-list
92063303|NCT04552743|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92063304|NCT04552743|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92063305|NCT04552743|Antiviral Agents|antiviral agents|mesh-ancestor
92063306|NCT04552743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063307|NCT03590080|Methylprednisolone|methylprednisolone|mesh-list
92063308|NCT03590080|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92063309|NCT03590080|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92063310|NCT03590080|Prednisolone|prednisolone|mesh-list
92063311|NCT03590080|Prednisolone acetate|prednisolone acetate|mesh-list
92063312|NCT03590080|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92063313|NCT03590080|Prednisolone phosphate|prednisolone phosphate|mesh-list
92063314|NCT03590080|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063315|NCT03590080|Antiemetics|antiemetics|mesh-ancestor
92063316|NCT03590080|Autonomic Agents|autonomic agents|mesh-ancestor
92063317|NCT03590080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063318|NCT03590080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063319|NCT03590080|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063320|NCT03590080|Glucocorticoids|glucocorticoids|mesh-ancestor
92063321|NCT03590080|Hormones|hormones|mesh-ancestor
92015302|NCT04989699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015303|NCT05279131|Tirbanibulin|tirbanibulin|mesh-list
92015304|NCT05279131|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015305|NCT05279131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015306|NCT04426487|Progesterone|progesterone|mesh-list
92063322|NCT03590080|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063323|NCT03590080|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92063324|NCT03590080|Protective Agents|protective agents|mesh-ancestor
92063325|NCT03590080|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063326|NCT03590080|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063327|NCT04028362|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92063328|NCT04028362|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92063329|NCT04028362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063330|NCT04028362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063332|NCT03594058|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92063333|NCT03594058|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92063334|NCT03594058|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92063335|NCT03594058|Adrenergic Agents|adrenergic agents|mesh-ancestor
92063336|NCT03594058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063337|NCT03594058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063338|NCT03594058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063339|NCT03970720|Metoclopramide|metoclopramide|mesh-list
92063340|NCT03970720|Antiemetics|antiemetics|mesh-ancestor
92063342|NCT03970720|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063343|NCT03970720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063344|NCT03970720|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063345|NCT03970720|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92063346|NCT03970720|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92063347|NCT03970720|Dopamine Agents|dopamine agents|mesh-ancestor
92063348|NCT03970720|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063349|NCT03970720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063350|NCT04028830|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92063351|NCT04028830|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92063352|NCT04028830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063353|NCT04028830|Antitubercular Agents|antitubercular agents|mesh-ancestor
92063354|NCT04194658|Letrozole|letrozole|mesh-list
92063355|NCT04194658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063356|NCT04194658|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92063357|NCT04194658|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92063358|NCT04194658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063359|NCT04194658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063360|NCT04194658|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92063361|NCT04194658|Hormone Antagonists|hormone antagonists|mesh-ancestor
92063362|NCT04194658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063363|NCT04194658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063364|NCT04028518|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92063366|NCT04028518|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92063367|NCT04028518|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92063368|NCT04028518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063369|NCT04747678|Ivermectin|ivermectin|mesh-list
92063370|NCT04747678|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92063371|NCT04747678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063372|NCT04027972|Glycopyrrolate|glycopyrrolate|mesh-list
92063373|NCT04027972|Neostigmine|neostigmine|mesh-list
92063374|NCT04027972|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92063375|NCT04027972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063376|NCT04027972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063377|NCT04027972|Cholinergic Agents|cholinergic agents|mesh-ancestor
92063378|NCT04027972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063379|NCT04027972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063380|NCT04027972|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92063381|NCT04027972|Autonomic Agents|autonomic agents|mesh-ancestor
92063382|NCT04027972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063383|NCT04027972|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92063384|NCT04027972|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92063385|NCT04027972|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92063386|NCT04191928|Apixaban|apixaban|mesh-list
92015308|NCT04426487|Hormones|hormones|mesh-ancestor
92015309|NCT04426487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015310|NCT04426487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015311|NCT04988217|Interferons|interferons|mesh-list
92015312|NCT04988217|Interferon-alpha|interferon-alpha|mesh-list
92015313|NCT04988217|Interferon alpha-2|interferon alpha-2|mesh-list
92015314|NCT04988217|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015315|NCT04988217|Antiviral Agents|antiviral agents|mesh-ancestor
92015316|NCT04988217|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015317|NCT04988217|Immunologic Factors|immunologic factors|mesh-ancestor
92015318|NCT04988217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063387|NCT04191928|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92063388|NCT04191928|Antithrombins|antithrombins|mesh-ancestor
92063389|NCT04191928|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92063390|NCT04191928|Protease Inhibitors|protease inhibitors|mesh-ancestor
92063391|NCT04191928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063392|NCT04191928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063393|NCT04191928|Anticoagulants|anticoagulants|mesh-ancestor
92063394|NCT04199494|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92063395|NCT04199494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063397|NCT04027192|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92063398|NCT04027192|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92063399|NCT04027192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063400|NCT04027192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063401|NCT04027192|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92063402|NCT04027192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92063403|NCT04027192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92063404|NCT04027192|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92063405|NCT04027192|Anesthetics, General|anesthetics, general|mesh-ancestor
92063406|NCT04027192|Anesthetics|anesthetics|mesh-ancestor
92063407|NCT04027192|GABA Modulators|gaba modulators|mesh-ancestor
92063408|NCT04027192|GABA Agents|gaba agents|mesh-ancestor
92063409|NCT04027192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063410|NCT04027192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063411|NCT04406506|Erythromycin|erythromycin|mesh-list
92063412|NCT04406506|Erythromycin Estolate|erythromycin estolate|mesh-list
92063413|NCT04406506|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92063414|NCT04406506|Erythromycin stearate|erythromycin stearate|mesh-list
92063415|NCT04406506|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92063417|NCT04406506|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063418|NCT04406506|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92063419|NCT04406506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063420|NCT04406506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063422|NCT03828292|Bortezomib|bortezomib|mesh-list
92063423|NCT03828292|Pomalidomide|pomalidomide|mesh-list
92063424|NCT03828292|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063425|NCT03828292|Antiemetics|antiemetics|mesh-ancestor
92063426|NCT03828292|Autonomic Agents|autonomic agents|mesh-ancestor
92063427|NCT03828292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063428|NCT03828292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063429|NCT03828292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063430|NCT03828292|Glucocorticoids|glucocorticoids|mesh-ancestor
92063431|NCT03828292|Hormones|hormones|mesh-ancestor
92063432|NCT03828292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063433|NCT03828292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063434|NCT03828292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063435|NCT03828292|Immunologic Factors|immunologic factors|mesh-ancestor
92063436|NCT03828292|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92063437|NCT03828292|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92063438|NCT03828292|Growth Substances|growth substances|mesh-ancestor
92063439|NCT03828292|Growth Inhibitors|growth inhibitors|mesh-ancestor
92063440|NCT04191694|Ondansetron|ondansetron|mesh-list
92063441|NCT04191694|Antiemetics|antiemetics|mesh-ancestor
92015319|NCT05038839|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92015320|NCT05038839|Pamiparib|pamiparib|mesh-list
92015321|NCT05038839|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015322|NCT05038839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015323|NCT05038839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015324|NCT01672723|Naltrexone|naltrexone|mesh-list
92015325|NCT01672723|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92063442|NCT04191694|Autonomic Agents|autonomic agents|mesh-ancestor
92063443|NCT04191694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063444|NCT04191694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063445|NCT04191694|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063446|NCT04191694|Antipruritics|antipruritics|mesh-ancestor
92063447|NCT04191694|Dermatologic Agents|dermatologic agents|mesh-ancestor
92063448|NCT04191694|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92063449|NCT04191694|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92063450|NCT04191694|Serotonin Agents|serotonin agents|mesh-ancestor
92063451|NCT04191694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063452|NCT04191694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063453|NCT04026022|Fentanyl|fentanyl|mesh-list
92063454|NCT04026022|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063455|NCT04026022|Narcotics|narcotics|mesh-ancestor
92063456|NCT04026022|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063457|NCT04026022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063458|NCT04026022|Analgesics|analgesics|mesh-ancestor
92063459|NCT04026022|Sensory System Agents|sensory system agents|mesh-ancestor
92063460|NCT04026022|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063461|NCT04026022|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92063462|NCT04026022|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92063463|NCT04026022|Anesthetics, General|anesthetics, general|mesh-ancestor
92063464|NCT04026022|Anesthetics|anesthetics|mesh-ancestor
92063465|NCT04020406|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92063466|NCT04020406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063467|NCT04020328|Prednisone|prednisone|mesh-list
92063468|NCT04020328|Leflunomide|leflunomide|mesh-list
92063469|NCT04020328|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063470|NCT04020328|Glucocorticoids|glucocorticoids|mesh-ancestor
92063471|NCT04020328|Hormones|hormones|mesh-ancestor
92063472|NCT04020328|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063473|NCT04020328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063474|NCT04020328|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063475|NCT04020328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063476|NCT04020328|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063477|NCT04020328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063478|NCT04020328|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92063479|NCT04020328|Immunologic Factors|immunologic factors|mesh-ancestor
92063480|NCT04020094|Atezolizumab|atezolizumab|mesh-list
92063481|NCT04020094|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92063482|NCT04020094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063483|NCT04020094|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063484|NCT04020094|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063485|NCT02080468|Norgestimate|norgestimate|mesh-list
92063486|NCT02080468|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92063487|NCT02080468|Contraceptive Agents|contraceptive agents|mesh-ancestor
92063488|NCT02080468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92063492|NCT02080468|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92063493|NCT04020016|Nalbuphine|nalbuphine|mesh-list
92063494|NCT04020016|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063495|NCT04020016|Narcotics|narcotics|mesh-ancestor
92063496|NCT04020016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063497|NCT04020016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063498|NCT04020016|Analgesics|analgesics|mesh-ancestor
92063499|NCT04020016|Sensory System Agents|sensory system agents|mesh-ancestor
92063500|NCT04020016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063501|NCT01874054|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92063502|NCT01874054|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92063503|NCT01874054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92063504|NCT01874054|Alkylating Agents|alkylating agents|mesh-ancestor
92015327|NCT01672723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015328|NCT01672723|Sensory System Agents|sensory system agents|mesh-ancestor
92015329|NCT01672723|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015330|NCT04443673|Glycine|glycine|mesh-list
92015331|NCT04443673|Glycine Agents|glycine agents|mesh-ancestor
92015332|NCT04443673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015333|NCT04443673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063505|NCT01874054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063506|NCT01874054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063507|NCT01874054|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063508|NCT01874054|Immunotoxins|immunotoxins|mesh-ancestor
92063509|NCT01874054|Immunoconjugates|immunoconjugates|mesh-ancestor
92063510|NCT01874054|Immunologic Factors|immunologic factors|mesh-ancestor
92063511|NCT01874054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063512|NCT04029610|Lidocaine|lidocaine|mesh-list
92063513|NCT04029610|Epinephrine|epinephrine|mesh-list
92063514|NCT04029610|Racepinephrine|racepinephrine|mesh-list
92063515|NCT04029610|Epinephryl borate|epinephryl borate|mesh-list
92063516|NCT04029610|Anesthetics, Local|anesthetics, local|mesh-ancestor
92063517|NCT04029610|Anesthetics|anesthetics|mesh-ancestor
92063518|NCT04029610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063519|NCT04029610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063520|NCT04029610|Sensory System Agents|sensory system agents|mesh-ancestor
92063521|NCT04029610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063522|NCT04029610|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92063523|NCT04029610|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92063524|NCT04029610|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92063525|NCT04029610|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063526|NCT04029610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063527|NCT04029610|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92063528|NCT04029610|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92063529|NCT04029610|Adrenergic Agents|adrenergic agents|mesh-ancestor
92063530|NCT04029610|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063531|NCT04029610|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92063532|NCT04029610|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92063533|NCT04029610|Autonomic Agents|autonomic agents|mesh-ancestor
92063534|NCT04029610|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92063535|NCT04029610|Respiratory System Agents|respiratory system agents|mesh-ancestor
92063536|NCT04029610|Mydriatics|mydriatics|mesh-ancestor
92063537|NCT04029610|Sympathomimetics|sympathomimetics|mesh-ancestor
92063538|NCT04029610|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92063539|NCT04026880|Methyltestosterone|methyltestosterone|mesh-list
92063540|NCT04026880|Testosterone|testosterone|mesh-list
92063541|NCT04026880|Testosterone undecanoate|testosterone undecanoate|mesh-list
92063542|NCT04026880|Testosterone enanthate|testosterone enanthate|mesh-list
92063543|NCT04026880|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92063544|NCT04026880|Androgens|androgens|mesh-ancestor
92063545|NCT04026880|Hormones|hormones|mesh-ancestor
92063546|NCT04026880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063547|NCT04026880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063548|NCT04026880|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063549|NCT04026880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063550|NCT04026880|Anabolic Agents|anabolic agents|mesh-ancestor
92063551|NCT04024384|Daratumumab|daratumumab|mesh-list
92063552|NCT04024384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063553|NCT01849562|Ribavirin|ribavirin|mesh-list
92063554|NCT01849562|Odalasvir|odalasvir|mesh-list
92063555|NCT01849562|Antimetabolites|antimetabolites|mesh-ancestor
92063556|NCT01849562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063557|NCT01849562|Antiviral Agents|antiviral agents|mesh-ancestor
92063558|NCT01849562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063559|NCT04023760|Apixaban|apixaban|mesh-list
92063560|NCT04023760|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92063561|NCT04023760|Antithrombins|antithrombins|mesh-ancestor
92063564|NCT04023760|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015334|NCT04443673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015335|NCT05036577|Dexamethasone|dexamethasone|mesh-list
92015336|NCT05036577|Rituximab|rituximab|mesh-list
92015337|NCT05036577|Methotrexate|methotrexate|mesh-list
92015338|NCT05036577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92015339|NCT05036577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063565|NCT04023760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063567|NCT04020718|Nicotine|nicotine|mesh-list
92063568|NCT04020718|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92063569|NCT04020718|Autonomic Agents|autonomic agents|mesh-ancestor
92063570|NCT04020718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063571|NCT04020718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063572|NCT04020718|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92063573|NCT04020718|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92063574|NCT04020718|Cholinergic Agents|cholinergic agents|mesh-ancestor
92063575|NCT04020718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063576|NCT04020718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063577|NCT04027348|Dexamethasone|dexamethasone|mesh-list
92063578|NCT04027348|Octreotide|octreotide|mesh-list
92063579|NCT04027348|Metoclopramide|metoclopramide|mesh-list
92063580|NCT04027348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063581|NCT04027348|Antiemetics|antiemetics|mesh-ancestor
92063582|NCT04027348|Autonomic Agents|autonomic agents|mesh-ancestor
92063583|NCT04027348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063584|NCT04027348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063585|NCT04027348|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063586|NCT04027348|Glucocorticoids|glucocorticoids|mesh-ancestor
92063588|NCT04027348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063589|NCT04027348|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063590|NCT04027348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063591|NCT04027348|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92063592|NCT04027348|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92063593|NCT04027348|Dopamine Agents|dopamine agents|mesh-ancestor
92063594|NCT04027348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063595|NCT04027348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063596|NCT04195204|Tropisetron|tropisetron|mesh-list
92063597|NCT04195204|Antiemetics|antiemetics|mesh-ancestor
92063598|NCT04195204|Autonomic Agents|autonomic agents|mesh-ancestor
92063599|NCT04195204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063600|NCT04195204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063601|NCT04195204|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063602|NCT04195204|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92063603|NCT04195204|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92063604|NCT04195204|Serotonin Agents|serotonin agents|mesh-ancestor
92063605|NCT04195204|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063606|NCT04195204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063607|NCT04023292|Tamoxifen|tamoxifen|mesh-list
92063608|NCT04023292|Letrozole|letrozole|mesh-list
92063609|NCT04023292|Exemestane|exemestane|mesh-list
92063610|NCT04023292|Anastrozole|anastrozole|mesh-list
92063611|NCT04023292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063612|NCT04023292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92063613|NCT04023292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92063614|NCT04023292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063615|NCT04023292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063616|NCT04023292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92063617|NCT04023292|Hormone Antagonists|hormone antagonists|mesh-ancestor
92063618|NCT04023292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063619|NCT04023292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063620|NCT04023292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063621|NCT04023292|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92063622|NCT04023292|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92063623|NCT04023292|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92063624|NCT03022240|Ondansetron|ondansetron|mesh-list
92063625|NCT03022240|Propofol|propofol|mesh-list
92063626|NCT03022240|Sevoflurane|sevoflurane|mesh-list
92063627|NCT03022240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92063628|NCT03022240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063629|NCT03022240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015340|NCT05036577|Immunologic Factors|immunologic factors|mesh-ancestor
92015341|NCT05036577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015342|NCT05036577|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015343|NCT05036577|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015344|NCT05036577|Antiemetics|antiemetics|mesh-ancestor
92015345|NCT05036577|Autonomic Agents|autonomic agents|mesh-ancestor
92015346|NCT05036577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015347|NCT05036577|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015348|NCT05036577|Glucocorticoids|glucocorticoids|mesh-ancestor
92063630|NCT03022240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92063631|NCT03022240|Anesthetics, General|anesthetics, general|mesh-ancestor
92063632|NCT03022240|Anesthetics|anesthetics|mesh-ancestor
92063633|NCT03022240|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92063634|NCT03022240|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92063638|NCT03022240|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063639|NCT03022240|Antipruritics|antipruritics|mesh-ancestor
92063640|NCT03022240|Dermatologic Agents|dermatologic agents|mesh-ancestor
92063641|NCT03022240|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92063642|NCT03022240|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92063643|NCT03022240|Serotonin Agents|serotonin agents|mesh-ancestor
92063644|NCT03022240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063645|NCT03022240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063646|NCT02704390|Methylphenidate|methylphenidate|mesh-list
92063647|NCT02704390|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92063648|NCT02704390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063649|NCT02704390|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92063650|NCT02704390|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92063651|NCT02704390|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063652|NCT02704390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063653|NCT02704390|Dopamine Agents|dopamine agents|mesh-ancestor
92063654|NCT02704390|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063655|NCT04147390|Mycophenolic Acid|mycophenolic acid|mesh-list
92063656|NCT04147390|Tacrolimus|tacrolimus|mesh-list
92063657|NCT04147390|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92063658|NCT04147390|Immunologic Factors|immunologic factors|mesh-ancestor
92063659|NCT04147390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063660|NCT04147390|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92063661|NCT04147390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063662|NCT04147390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063663|NCT04147390|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92063664|NCT04147390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063665|NCT04147390|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92063666|NCT04147390|Antitubercular Agents|antitubercular agents|mesh-ancestor
92063667|NCT04147390|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92063668|NCT04147390|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063669|NCT02708680|Atezolizumab|atezolizumab|mesh-list
92063670|NCT02708680|Entinostat|entinostat|mesh-list
92063671|NCT02708680|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92063672|NCT02708680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063673|NCT02708680|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063674|NCT02708680|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063675|NCT02708680|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92063676|NCT02708680|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063677|NCT03932656|Psychotropic Drugs|psychotropic drugs|mesh-list
92063678|NCT03931642|Blinatumomab|blinatumomab|mesh-list
92063679|NCT03931642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063680|NCT04021420|Nivolumab|nivolumab|mesh-list
92063681|NCT04021420|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063682|NCT04021420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063683|NCT04021420|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92063684|NCT04021420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063685|NCT04144582|Docetaxel|docetaxel|mesh-list
92063686|NCT04144582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063687|NCT04144582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92063688|NCT04144582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92015349|NCT05036577|Hormones|hormones|mesh-ancestor
92015350|NCT05036577|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015351|NCT05036577|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92015352|NCT05036577|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92015353|NCT05036577|Abortifacient Agents|abortifacient agents|mesh-ancestor
92063689|NCT04144582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92063690|NCT04144582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063691|NCT01611974|Maribavir|maribavir|mesh-list
92063692|NCT01611974|Antiviral Agents|antiviral agents|mesh-ancestor
92063693|NCT01611974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063694|NCT01871870|Pancrelipase|pancrelipase|mesh-list
92063695|NCT01871870|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063696|NCT02080780|Clarithromycin|clarithromycin|mesh-list
92063697|NCT02080780|Diltiazem|diltiazem|mesh-list
92063698|NCT02080780|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92063699|NCT02080780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063700|NCT02080780|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92063701|NCT02080780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063702|NCT02080780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063703|NCT02080780|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92063704|NCT02080780|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92063705|NCT02080780|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92063717|NCT01871558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063718|NCT01871558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063719|NCT01711359|Folic Acid|folic acid|mesh-list
92063721|NCT01711359|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92063722|NCT01711359|Abortifacient Agents|abortifacient agents|mesh-ancestor
92063723|NCT01711359|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92063724|NCT01711359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063725|NCT01711359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92063726|NCT01711359|Antimetabolites|antimetabolites|mesh-ancestor
92063727|NCT01711359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063728|NCT01711359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063729|NCT01711359|Dermatologic Agents|dermatologic agents|mesh-ancestor
92063730|NCT01711359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063731|NCT01711359|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92063732|NCT01711359|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92063733|NCT01711359|Immunologic Factors|immunologic factors|mesh-ancestor
92063735|NCT01711359|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92063736|NCT01711359|Hematinics|hematinics|mesh-ancestor
92063737|NCT01711359|Vitamin B Complex|vitamin b complex|mesh-ancestor
92063738|NCT01711359|Vitamins|vitamins|mesh-ancestor
92063739|NCT01711359|Micronutrients|micronutrients|mesh-ancestor
92063740|NCT04149964|Acetaminophen|acetaminophen|mesh-list
92063741|NCT04149964|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92063742|NCT04149964|Oxycodone|oxycodone|mesh-list
92063743|NCT04149964|Hydrocodone|hydrocodone|mesh-list
92063744|NCT04149964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92063745|NCT04149964|Analgesics|analgesics|mesh-ancestor
92063746|NCT04149964|Sensory System Agents|sensory system agents|mesh-ancestor
92063747|NCT04149964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063748|NCT04149964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063749|NCT04149964|Antipyretics|antipyretics|mesh-ancestor
92063750|NCT04149964|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063751|NCT04149964|Narcotics|narcotics|mesh-ancestor
92063752|NCT04149964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063753|NCT04149964|Antitussive Agents|antitussive agents|mesh-ancestor
92063754|NCT04149964|Respiratory System Agents|respiratory system agents|mesh-ancestor
92063755|NCT04149964|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92063756|NCT04149964|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063757|NCT04149964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92063758|NCT04140136|Tocotrienols|tocotrienols|mesh-list
92063759|NCT04140136|Vitamin E|vitamin e|mesh-list
92063760|NCT04140136|Tocopherols|tocopherols|mesh-list
92063761|NCT04140136|Antioxidants|antioxidants|mesh-ancestor
92063762|NCT04140136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063763|NCT04140136|Protective Agents|protective agents|mesh-ancestor
92015354|NCT05036577|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92015355|NCT05036577|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015356|NCT05036577|Antimetabolites|antimetabolites|mesh-ancestor
92015357|NCT05036577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015358|NCT05036577|Dermatologic Agents|dermatologic agents|mesh-ancestor
92015359|NCT05036577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015360|NCT05036577|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92015361|NCT05036577|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92063764|NCT04140136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063765|NCT04140136|Vitamins|vitamins|mesh-ancestor
92063766|NCT04140136|Micronutrients|micronutrients|mesh-ancestor
92063767|NCT04146532|Aspirin|aspirin|mesh-list
92063768|NCT04146532|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92063769|NCT04146532|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92063770|NCT04146532|Analgesics|analgesics|mesh-ancestor
92063771|NCT04146532|Sensory System Agents|sensory system agents|mesh-ancestor
92063774|NCT04146532|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063775|NCT04146532|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92063776|NCT04146532|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92063777|NCT04146532|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92063778|NCT04146532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063779|NCT04146532|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92063780|NCT04146532|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92063781|NCT04146532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063782|NCT04146532|Antipyretics|antipyretics|mesh-ancestor
92063783|NCT03929224|Bacitracin|bacitracin|mesh-list
92063784|NCT03929224|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92063785|NCT03929224|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063786|NCT03929224|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92063787|NCT03928288|Cabergoline|cabergoline|mesh-list
92063788|NCT03928288|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92063789|NCT03928288|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92063790|NCT03928288|Dopamine Agonists|dopamine agonists|mesh-ancestor
92063791|NCT03928288|Dopamine Agents|dopamine agents|mesh-ancestor
92063792|NCT03928288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063793|NCT03928288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063794|NCT03928288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063795|NCT04146610|Antibodies|antibodies|mesh-list
92063796|NCT04146610|Immunoconjugates|immunoconjugates|mesh-list
92063797|NCT04146610|Immunologic Factors|immunologic factors|mesh-ancestor
92063798|NCT04146610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063799|NCT04146376|Tranexamic Acid|tranexamic acid|mesh-list
92063800|NCT04146376|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92063801|NCT04146376|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92063802|NCT04146376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063803|NCT04146376|Hemostatics|hemostatics|mesh-ancestor
92063804|NCT04146376|Coagulants|coagulants|mesh-ancestor
92063805|NCT01710657|Lacosamide|lacosamide|mesh-list
92063806|NCT01710657|Anticonvulsants|anticonvulsants|mesh-ancestor
92063807|NCT01710657|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92063808|NCT01710657|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92063809|NCT01710657|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063810|NCT01710657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063811|NCT03021772|Dexamethasone|dexamethasone|mesh-list
92063812|NCT03021772|Neostigmine|neostigmine|mesh-list
92063813|NCT03021772|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92063814|NCT03021772|Antiemetics|antiemetics|mesh-ancestor
92063815|NCT03021772|Autonomic Agents|autonomic agents|mesh-ancestor
92063816|NCT03021772|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063817|NCT03021772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063818|NCT03021772|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063819|NCT03021772|Glucocorticoids|glucocorticoids|mesh-ancestor
92063821|NCT03021772|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063822|NCT03021772|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063823|NCT03021772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063824|NCT03021772|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92015362|NCT05036577|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92015365|NCT04982367|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92015366|NCT04982367|Temsirolimus|temsirolimus|mesh-list
92015367|NCT04982367|MTOR Inhibitors|mtor inhibitors|mesh-list
92015368|NCT04982367|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92015369|NCT04982367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015370|NCT04982367|Tubulin Modulators|tubulin modulators|mesh-ancestor
92015371|NCT04982367|Antimitotic Agents|antimitotic agents|mesh-ancestor
92063825|NCT03021772|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063826|NCT03021772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063827|NCT03021772|Cholinergic Agents|cholinergic agents|mesh-ancestor
92063828|NCT03021772|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063829|NCT03021772|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92063830|NCT04149262|Insulin Aspart|insulin aspart|mesh-list
92063831|NCT04149262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92063832|NCT04149262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063833|NCT05581420|Ferrous fumarate|ferrous fumarate|mesh-list
92063834|NCT05581420|Trace Elements|trace elements|mesh-ancestor
92063835|NCT05581420|Micronutrients|micronutrients|mesh-ancestor
92063836|NCT05581420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063837|NCT03904498|Tolcapone|tolcapone|mesh-list
92063838|NCT03904498|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92063839|NCT03904498|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92063840|NCT03904498|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92063841|NCT03904498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063842|NCT03904498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063843|NCT04405960|Alfacalcidol|alfacalcidol|mesh-list
92063844|NCT04405960|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92063875|NCT03944434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063877|NCT03944356|Dabrafenib|dabrafenib|mesh-list
92063878|NCT03944356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063879|NCT03944356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92063880|NCT03944356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063881|NCT03944356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063882|NCT01701063|Ribavirin|ribavirin|mesh-list
92063883|NCT01701063|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92063884|NCT01701063|Antimetabolites|antimetabolites|mesh-ancestor
92063885|NCT01701063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063886|NCT01701063|Antiviral Agents|antiviral agents|mesh-ancestor
92063887|NCT01701063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063888|NCT03920722|Rituximab|rituximab|mesh-list
92063890|NCT03920722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063891|NCT03920722|Immunologic Factors|immunologic factors|mesh-ancestor
92063892|NCT03920722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063893|NCT03920722|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92063895|NCT05580094|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063896|NCT05580094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063897|NCT05589766|Niacinamide|niacinamide|mesh-list
92063898|NCT05589766|Niacin|niacin|mesh-list
92063899|NCT05589766|Nicotinic Acids|nicotinic acids|mesh-list
92063900|NCT05589766|Vitamin B Complex|vitamin b complex|mesh-ancestor
92063901|NCT05589766|Vitamins|vitamins|mesh-ancestor
92063902|NCT05589766|Micronutrients|micronutrients|mesh-ancestor
92063903|NCT05589766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063904|NCT05589766|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92063905|NCT05589766|Antimetabolites|antimetabolites|mesh-ancestor
92063906|NCT05589766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063907|NCT05589766|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92063908|NCT05589766|Vasodilator Agents|vasodilator agents|mesh-ancestor
92063909|NCT05586100|Cetuximab|cetuximab|mesh-list
92063910|NCT05586100|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063911|NCT05586100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063912|NCT05585086|Peppermint oil|peppermint oil|mesh-list
92063913|NCT05585086|Antiemetics|antiemetics|mesh-ancestor
92063914|NCT05585086|Autonomic Agents|autonomic agents|mesh-ancestor
92015373|NCT04982367|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015374|NCT04982367|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92015375|NCT04982367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015376|NCT04982367|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92015377|NCT04982367|Antifungal Agents|antifungal agents|mesh-ancestor
92015378|NCT04982367|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015379|NCT04982367|Immunologic Factors|immunologic factors|mesh-ancestor
92063915|NCT05585086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063916|NCT05585086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063917|NCT05585086|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92063918|NCT05585086|Parasympatholytics|parasympatholytics|mesh-ancestor
92063920|NCT01710501|Ribavirin|ribavirin|mesh-list
92063921|NCT01710501|Interferon-alpha|interferon-alpha|mesh-list
92063922|NCT01710501|Interferon alpha-2|interferon alpha-2|mesh-list
92063923|NCT01710501|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92063924|NCT01710501|Grazoprevir|grazoprevir|mesh-list
92063925|NCT01710501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063926|NCT01710501|Antiviral Agents|antiviral agents|mesh-ancestor
92063927|NCT01710501|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063928|NCT01710501|Antimetabolites|antimetabolites|mesh-ancestor
92063929|NCT01710501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063930|NCT01710501|Immunologic Factors|immunologic factors|mesh-ancestor
92063931|NCT01710501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063932|NCT05583058|Hormones|hormones|mesh-list
92063933|NCT05583058|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063934|NCT05583058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063935|NCT01700829|Midazolam|midazolam|mesh-list
92063936|NCT01700829|Ketamine|ketamine|mesh-list
92063937|NCT01700829|Analgesics|analgesics|mesh-ancestor
92063938|NCT01700829|Sensory System Agents|sensory system agents|mesh-ancestor
92063939|NCT01700829|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063940|NCT01700829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063941|NCT01700829|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92063942|NCT01700829|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92063943|NCT01700829|Anesthetics, General|anesthetics, general|mesh-ancestor
92063944|NCT01700829|Anesthetics|anesthetics|mesh-ancestor
92063945|NCT01700829|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063946|NCT01700829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92063947|NCT01700829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92063948|NCT01700829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92063949|NCT01700829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063950|NCT01700829|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92063951|NCT01700829|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92063952|NCT01700829|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92063953|NCT01700829|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92063954|NCT01700829|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92063955|NCT01700829|GABA Modulators|gaba modulators|mesh-ancestor
92063956|NCT01700829|GABA Agents|gaba agents|mesh-ancestor
92063957|NCT04143880|Progesterone|progesterone|mesh-list
92063958|NCT04143880|Progestins|progestins|mesh-ancestor
92063959|NCT04143880|Hormones|hormones|mesh-ancestor
92063960|NCT04143880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92063961|NCT04143880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063962|NCT04144192|Lidocaine|lidocaine|mesh-list
92063963|NCT04144192|Anesthetics, Local|anesthetics, local|mesh-ancestor
92063964|NCT04144192|Anesthetics|anesthetics|mesh-ancestor
92063966|NCT04144192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063967|NCT04144192|Sensory System Agents|sensory system agents|mesh-ancestor
92063968|NCT04144192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063969|NCT04144192|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92063970|NCT04144192|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92063971|NCT04144192|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92063972|NCT04144192|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92015380|NCT04982367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015381|NCT04982367|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015382|NCT04982367|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015383|NCT05034627|Asparaginase|asparaginase|mesh-list
92015384|NCT05034627|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015385|NCT05031975|Irinotecan|irinotecan|mesh-list
92015386|NCT05031975|Temozolomide|temozolomide|mesh-list
92015387|NCT05031975|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92015388|NCT05031975|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92063973|NCT04144192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063974|NCT01710345|Sufentanil|sufentanil|mesh-list
92063976|NCT01710345|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92063977|NCT01710345|Narcotics|narcotics|mesh-ancestor
92063978|NCT01710345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92063979|NCT01710345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063980|NCT01710345|Analgesics|analgesics|mesh-ancestor
92063981|NCT01710345|Sensory System Agents|sensory system agents|mesh-ancestor
92063982|NCT01710345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063983|NCT01710345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92063984|NCT01710345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92063985|NCT01710345|Anesthetics, General|anesthetics, general|mesh-ancestor
92063986|NCT01710345|Anesthetics|anesthetics|mesh-ancestor
92063987|NCT03022006|Grazoprevir|grazoprevir|mesh-list
92063988|NCT03022006|Antiviral Agents|antiviral agents|mesh-ancestor
92063989|NCT03022006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063990|NCT04143256|Menthol|menthol|mesh-list
92063991|NCT04143256|Antipruritics|antipruritics|mesh-ancestor
92063992|NCT04143256|Dermatologic Agents|dermatologic agents|mesh-ancestor
92063993|NCT04143412|Ramipril|ramipril|mesh-list
92063994|NCT04143412|Eplerenone|eplerenone|mesh-list
92063995|NCT04143412|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92063996|NCT04143412|Protease Inhibitors|protease inhibitors|mesh-ancestor
92063997|NCT04143412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063998|NCT04143412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063999|NCT04143412|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92064000|NCT04143412|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92064001|NCT04143412|Hormone Antagonists|hormone antagonists|mesh-ancestor
92064002|NCT04143412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064003|NCT04143412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064004|NCT04143412|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92064005|NCT04143412|Diuretics|diuretics|mesh-ancestor
92064006|NCT04143412|Natriuretic Agents|natriuretic agents|mesh-ancestor
92064007|NCT05582278|Lenvatinib|lenvatinib|mesh-list
92064008|NCT05582278|Tislelizumab|tislelizumab|mesh-list
92064009|NCT05582278|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92064010|NCT05582278|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064011|NCT05582278|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92064012|NCT05582278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064013|NCT05582278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064014|NCT05582278|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064015|NCT01710033|Tofacitinib|tofacitinib|mesh-list
92064016|NCT01710033|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92064017|NCT01710033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92064018|NCT01710033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064019|NCT01710033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064020|NCT01822496|Paclitaxel|paclitaxel|mesh-list
92064021|NCT01822496|Etoposide|etoposide|mesh-list
92064022|NCT01822496|Podophyllotoxin|podophyllotoxin|mesh-list
92064023|NCT01822496|Cisplatin|cisplatin|mesh-list
92064024|NCT01822496|Carboplatin|carboplatin|mesh-list
92064025|NCT01822496|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92064026|NCT01822496|Etoposide phosphate|etoposide phosphate|mesh-list
92064027|NCT01822496|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92064028|NCT01822496|Crizotinib|crizotinib|mesh-list
92064029|NCT01822496|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92064030|NCT01822496|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92064031|NCT01822496|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064032|NCT01822496|Tubulin Modulators|tubulin modulators|mesh-ancestor
92015390|NCT05031975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015391|NCT05031975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015392|NCT05031975|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92015393|NCT05031975|Alkylating Agents|alkylating agents|mesh-ancestor
92015394|NCT02632747|Empagliflozin|empagliflozin|mesh-list
92015395|NCT02632747|Ramipril|ramipril|mesh-list
92064033|NCT01822496|Antimitotic Agents|antimitotic agents|mesh-ancestor
92064034|NCT01822496|Mitosis Modulators|mitosis modulators|mesh-ancestor
92064035|NCT01822496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064036|NCT01822496|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92064037|NCT01822496|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92064038|NCT01822496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064049|NCT03588988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064050|NCT03588988|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064051|NCT03588988|Analgesics|analgesics|mesh-ancestor
92064052|NCT03588988|Sensory System Agents|sensory system agents|mesh-ancestor
92064053|NCT03588988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064054|NCT03588988|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92064055|NCT03588988|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92064056|NCT03588988|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92064057|NCT03588988|Adrenergic Agents|adrenergic agents|mesh-ancestor
92064058|NCT03588988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064059|NCT03588988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064060|NCT04414137|Daptomycin|daptomycin|mesh-list
92064061|NCT04414137|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92064062|NCT04414137|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064063|NCT01821560|Baclofen|baclofen|mesh-list
92064064|NCT01821560|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92064065|NCT01821560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064066|NCT01821560|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92064067|NCT01821560|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064068|NCT01821560|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92064069|NCT01821560|GABA Agonists|gaba agonists|mesh-ancestor
92064070|NCT01821560|GABA Agents|gaba agents|mesh-ancestor
92064071|NCT01821560|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064072|NCT01821560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064073|NCT05580328|Hematoporphyrins|hematoporphyrins|mesh-list
92064074|NCT05580328|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92064075|NCT05580328|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064076|NCT03588676|Melatonin|melatonin|mesh-list
92064077|NCT03588676|Antioxidants|antioxidants|mesh-ancestor
92064078|NCT03588676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064079|NCT03588676|Protective Agents|protective agents|mesh-ancestor
92064080|NCT03588676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064081|NCT03588676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064082|NCT01846442|Dehydroepiandrosterone|dehydroepiandrosterone|mesh-list
92064083|NCT01846442|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92064084|NCT01846442|Immunologic Factors|immunologic factors|mesh-ancestor
92064085|NCT01846442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064086|NCT01709721|Hydromorphone|hydromorphone|mesh-list
92064087|NCT01709721|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92064088|NCT01709721|Narcotics|narcotics|mesh-ancestor
92064089|NCT01709721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064090|NCT01709721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064091|NCT01709721|Analgesics|analgesics|mesh-ancestor
92064092|NCT01709721|Sensory System Agents|sensory system agents|mesh-ancestor
92064093|NCT01709721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064094|NCT01866657|Phenylephrine|phenylephrine|mesh-list
92064095|NCT01866657|Dopamine|dopamine|mesh-list
92064096|NCT01866657|Ephedrine|ephedrine|mesh-list
92064097|NCT01866657|Vasoconstrictor Agents|vasoconstrictor agents|mesh-list
92064098|NCT01866657|Propofol|propofol|mesh-list
92064099|NCT01866657|Sevoflurane|sevoflurane|mesh-list
92064100|NCT01866657|Anesthetics|anesthetics|mesh-ancestor
92064101|NCT01866657|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064102|NCT01866657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015396|NCT02632747|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92015397|NCT02632747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015398|NCT02632747|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92015399|NCT02632747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064103|NCT01866657|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92064105|NCT01866657|Anesthetics, General|anesthetics, general|mesh-ancestor
92064106|NCT01866657|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92064107|NCT01866657|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92064108|NCT01866657|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92064110|NCT01866657|Autonomic Agents|autonomic agents|mesh-ancestor
92064111|NCT01866657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064112|NCT01866657|Sympathomimetics|sympathomimetics|mesh-ancestor
92064113|NCT01866657|Nasal Decongestants|nasal decongestants|mesh-ancestor
92064114|NCT01866657|Respiratory System Agents|respiratory system agents|mesh-ancestor
92064115|NCT01866657|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92064116|NCT01866657|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92064118|NCT01866657|Adrenergic Agents|adrenergic agents|mesh-ancestor
92064119|NCT01866657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064120|NCT01866657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064121|NCT01866657|Protective Agents|protective agents|mesh-ancestor
92064122|NCT01866657|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92064123|NCT01866657|Dopamine Agents|dopamine agents|mesh-ancestor
92064124|NCT03584152|Acetaminophen|acetaminophen|mesh-list
92064125|NCT03584152|Ibuprofen|ibuprofen|mesh-list
92064126|NCT03584152|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064127|NCT03584152|Analgesics|analgesics|mesh-ancestor
92064128|NCT03584152|Sensory System Agents|sensory system agents|mesh-ancestor
92064129|NCT03584152|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064130|NCT03584152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064131|NCT03584152|Antipyretics|antipyretics|mesh-ancestor
92064132|NCT03584152|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064133|NCT03584152|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064134|NCT03584152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064135|NCT03584152|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064136|NCT03584152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064137|NCT03584152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064138|NCT03589690|Thioctic Acid|thioctic acid|mesh-list
92064139|NCT03589690|Antioxidants|antioxidants|mesh-ancestor
92064140|NCT03589690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064141|NCT03589690|Protective Agents|protective agents|mesh-ancestor
92064142|NCT03589690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064143|NCT03589690|Vitamin B Complex|vitamin b complex|mesh-ancestor
92064144|NCT03589690|Vitamins|vitamins|mesh-ancestor
92064145|NCT03589690|Micronutrients|micronutrients|mesh-ancestor
92064146|NCT03587194|Apremilast|apremilast|mesh-list
92064147|NCT03587194|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064148|NCT03587194|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064149|NCT03587194|Analgesics|analgesics|mesh-ancestor
92064150|NCT03587194|Sensory System Agents|sensory system agents|mesh-ancestor
92064151|NCT03587194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064152|NCT03587194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064153|NCT03587194|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064154|NCT03587194|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064155|NCT03587194|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92064156|NCT03587194|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92064157|NCT03587194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064158|NCT03587194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064159|NCT01699815|Acetaminophen|acetaminophen|mesh-list
92064160|NCT01699815|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064161|NCT01699815|Analgesics|analgesics|mesh-ancestor
92064162|NCT01699815|Sensory System Agents|sensory system agents|mesh-ancestor
92064163|NCT01699815|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064164|NCT01699815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064165|NCT01699815|Antipyretics|antipyretics|mesh-ancestor
92064166|NCT03589222|Dexamethasone|dexamethasone|mesh-list
92064167|NCT03589222|Bortezomib|bortezomib|mesh-list
92064168|NCT03589222|Daratumumab|daratumumab|mesh-list
92064169|NCT03589222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064170|NCT03589222|Antiemetics|antiemetics|mesh-ancestor
92015400|NCT02632747|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92015401|NCT02632747|Protease Inhibitors|protease inhibitors|mesh-ancestor
92015402|NCT02632747|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015403|NCT02632747|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92015404|NCT04218825|Mechlorethamine|mechlorethamine|mesh-list
92015405|NCT04218825|Alkylating Agents|alkylating agents|mesh-ancestor
92015406|NCT04218825|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015407|NCT04218825|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92015408|NCT04218825|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015409|NCT04216797|Diazepam|diazepam|mesh-list
92064171|NCT03589222|Autonomic Agents|autonomic agents|mesh-ancestor
92064172|NCT03589222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064173|NCT03589222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064174|NCT03589222|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064175|NCT03589222|Glucocorticoids|glucocorticoids|mesh-ancestor
92064176|NCT03589222|Hormones|hormones|mesh-ancestor
92064177|NCT03589222|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064178|NCT03589222|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064179|NCT03589222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064183|NCT03589066|Rotigotine|rotigotine|mesh-list
92064184|NCT03589066|Dopamine Agonists|dopamine agonists|mesh-ancestor
92064185|NCT03589066|Dopamine Agents|dopamine agents|mesh-ancestor
92064186|NCT03589066|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064187|NCT03589066|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064188|NCT03589066|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064189|NCT03020368|Diclofenac|diclofenac|mesh-list
92064190|NCT03020368|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064191|NCT03020368|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064192|NCT03020368|Analgesics|analgesics|mesh-ancestor
92064193|NCT03020368|Sensory System Agents|sensory system agents|mesh-ancestor
92064194|NCT03020368|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064195|NCT03020368|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064196|NCT03020368|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064197|NCT03020368|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064198|NCT03020368|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064199|NCT03020368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064200|NCT03020368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064201|NCT03891706|Interleukin-2|interleukin-2|mesh-list
92064202|NCT03891706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064203|NCT03891706|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064204|NCT03891706|Analgesics|analgesics|mesh-ancestor
92064205|NCT03891706|Sensory System Agents|sensory system agents|mesh-ancestor
92064206|NCT03891706|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064207|NCT03891706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064208|NCT03581422|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92064209|NCT03581422|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92064210|NCT03581422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064211|NCT05702944|Phenoxybenzamine|phenoxybenzamine|mesh-list
92064212|NCT05702944|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92064213|NCT05702944|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92064214|NCT05702944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92064215|NCT05702944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064216|NCT05702944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064217|NCT05702944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064218|NCT05702944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92064219|NCT05702944|Vasodilator Agents|vasodilator agents|mesh-ancestor
92064220|NCT03580876|Azathioprine|azathioprine|mesh-list
92064221|NCT03580876|Antimetabolites|antimetabolites|mesh-ancestor
92064222|NCT03580876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064223|NCT03580876|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92064224|NCT03580876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064225|NCT03580876|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015410|NCT04216797|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92015411|NCT04216797|Anticonvulsants|anticonvulsants|mesh-ancestor
92015412|NCT04216797|Antiemetics|antiemetics|mesh-ancestor
92015413|NCT04216797|Autonomic Agents|autonomic agents|mesh-ancestor
92015414|NCT04216797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015415|NCT04216797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015416|NCT04216797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015417|NCT04216797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92015418|NCT04216797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015419|NCT04216797|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92015420|NCT04216797|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92064226|NCT03580876|Immunologic Factors|immunologic factors|mesh-ancestor
92064227|NCT03580876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064228|NCT03580876|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064229|NCT03586024|Pembrolizumab|pembrolizumab|mesh-list
92064230|NCT03586024|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064231|NCT03586024|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064232|NCT03586024|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064233|NCT03586024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064234|NCT03585556|Prednisolone|prednisolone|mesh-list
92064235|NCT03585556|Ranibizumab|ranibizumab|mesh-list
92064236|NCT03585556|Aflibercept|aflibercept|mesh-list
92064237|NCT03585556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064238|NCT03585556|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92064239|NCT03585556|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92064240|NCT03585556|Growth Substances|growth substances|mesh-ancestor
92064241|NCT03585556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064242|NCT03585556|Growth Inhibitors|growth inhibitors|mesh-ancestor
92064243|NCT03585556|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064244|NCT03585556|Glucocorticoids|glucocorticoids|mesh-ancestor
92064245|NCT03585556|Hormones|hormones|mesh-ancestor
92064246|NCT03585556|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064247|NCT03585556|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064248|NCT05702398|Vitamins|vitamins|mesh-list
92064249|NCT05702398|Vitamin A|vitamin a|mesh-list
92064251|NCT05702398|Niacinamide|niacinamide|mesh-list
92064254|NCT05702398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064255|NCT05702398|Vitamin B Complex|vitamin b complex|mesh-ancestor
92064256|NCT05702398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064257|NCT05702398|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92064258|NCT05702398|Antimetabolites|antimetabolites|mesh-ancestor
92064259|NCT05702398|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92064260|NCT05702398|Vasodilator Agents|vasodilator agents|mesh-ancestor
92064261|NCT01709409|Poractant alfa|poractant alfa|mesh-list
92064262|NCT01709409|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92064263|NCT01709409|Respiratory System Agents|respiratory system agents|mesh-ancestor
92064264|NCT01698879|Gemtuzumab|gemtuzumab|mesh-list
92064265|NCT01698879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064266|NCT01698879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064267|NCT01698879|Immunotoxins|immunotoxins|mesh-ancestor
92064268|NCT01698879|Immunoconjugates|immunoconjugates|mesh-ancestor
92064269|NCT01698879|Immunologic Factors|immunologic factors|mesh-ancestor
92064270|NCT01698879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064271|NCT02335294|Morphine|morphine|mesh-list
92064272|NCT02335294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92064273|NCT02335294|Narcotics|narcotics|mesh-ancestor
92064274|NCT02335294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064275|NCT02335294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064276|NCT02335294|Analgesics|analgesics|mesh-ancestor
92064277|NCT02335294|Sensory System Agents|sensory system agents|mesh-ancestor
92064278|NCT02335294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064279|NCT01698801|Dexamethasone|dexamethasone|mesh-list
92064280|NCT01698801|Lenalidomide|lenalidomide|mesh-list
92064281|NCT01698801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064282|NCT01698801|Antiemetics|antiemetics|mesh-ancestor
92064283|NCT01698801|Autonomic Agents|autonomic agents|mesh-ancestor
92015421|NCT04216797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92015422|NCT04216797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92015423|NCT04216797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015424|NCT04216797|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92015425|NCT04216797|Anesthetics, General|anesthetics, general|mesh-ancestor
92015426|NCT04216797|Anesthetics|anesthetics|mesh-ancestor
92064284|NCT01698801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064285|NCT01698801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064286|NCT01698801|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064287|NCT01698801|Glucocorticoids|glucocorticoids|mesh-ancestor
92064288|NCT01698801|Hormones|hormones|mesh-ancestor
92064289|NCT01698801|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064290|NCT01698801|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064291|NCT01698801|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064292|NCT01698801|Immunologic Factors|immunologic factors|mesh-ancestor
92064293|NCT01698801|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92064294|NCT01698801|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92064295|NCT01698801|Growth Substances|growth substances|mesh-ancestor
92064296|NCT01698801|Growth Inhibitors|growth inhibitors|mesh-ancestor
92064297|NCT03735628|Nivolumab|nivolumab|mesh-list
92064298|NCT03735628|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064299|NCT03735628|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064300|NCT03735628|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064301|NCT03735628|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064302|NCT01682811|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92064303|NCT01682811|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92064304|NCT01682811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064305|NCT03580018|Tranexamic Acid|tranexamic acid|mesh-list
92064306|NCT03580018|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92064307|NCT03580018|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92064308|NCT03580018|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064309|NCT03580018|Hemostatics|hemostatics|mesh-ancestor
92064310|NCT03580018|Coagulants|coagulants|mesh-ancestor
92064311|NCT03584854|Carboprost|carboprost|mesh-list
92064312|NCT03584854|Dinoprost|dinoprost|mesh-list
92064313|NCT03584854|Dinoprost tromethamine|dinoprost tromethamine|mesh-list
92064314|NCT03584854|Methylergonovine|methylergonovine|mesh-list
92064315|NCT03584854|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92064316|NCT03584854|Abortifacient Agents|abortifacient agents|mesh-ancestor
92064317|NCT03584854|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92064318|NCT03584854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064319|NCT03584854|Oxytocics|oxytocics|mesh-ancestor
92064320|NCT03584698|Evening primrose oil|evening primrose oil|mesh-list
92064321|NCT03584698|Misoprostol|misoprostol|mesh-list
92064322|NCT03584698|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92064323|NCT03584698|Abortifacient Agents|abortifacient agents|mesh-ancestor
92064324|NCT03584698|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92064325|NCT03584698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064326|NCT03584698|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92064330|NCT03584698|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064331|NCT03584698|Analgesics|analgesics|mesh-ancestor
92064332|NCT03584698|Sensory System Agents|sensory system agents|mesh-ancestor
92064333|NCT03584698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064392|NCT03584074|Anticonvulsants|anticonvulsants|mesh-ancestor
92064334|NCT03584698|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064335|NCT03584698|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064336|NCT03584698|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92064337|NCT03584698|Antimetabolites|antimetabolites|mesh-ancestor
92064338|NCT03584698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064339|NCT03584698|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92064340|NCT03584698|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064341|NCT03587038|Temozolomide|temozolomide|mesh-list
92064342|NCT03587038|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92064343|NCT03587038|Alkylating Agents|alkylating agents|mesh-ancestor
92064344|NCT03587038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064345|NCT03587038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064346|NCT03582124|Panitumumab|panitumumab|mesh-list
92064347|NCT03582124|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064348|NCT03582124|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064349|NCT01682031|Selenium|selenium|mesh-list
92064350|NCT01682031|Antioxidants|antioxidants|mesh-ancestor
92015428|NCT04216797|GABA Agents|gaba agents|mesh-ancestor
92015429|NCT04216797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015430|NCT04216797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015431|NCT05029401|Ibogaine|ibogaine|mesh-list
92015432|NCT05029401|Hallucinogens|hallucinogens|mesh-ancestor
92015433|NCT05029401|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015434|NCT05029401|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015435|NCT05029401|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92015436|NCT05029401|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92015437|NCT05029401|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015438|NCT05029401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015439|NCT05025813|Pembrolizumab|pembrolizumab|mesh-list
92015440|NCT05025813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92015441|NCT05025813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015442|NCT05025813|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064351|NCT01682031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064352|NCT01682031|Protective Agents|protective agents|mesh-ancestor
92064353|NCT01682031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064354|NCT01682031|Trace Elements|trace elements|mesh-ancestor
92064355|NCT01682031|Micronutrients|micronutrients|mesh-ancestor
92064356|NCT03020134|Ritonavir|ritonavir|mesh-list
92064357|NCT03020134|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92064358|NCT03020134|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92064359|NCT03020134|Protease Inhibitors|protease inhibitors|mesh-ancestor
92064360|NCT03020134|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064361|NCT03020134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064362|NCT03020134|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92064363|NCT03020134|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92064364|NCT03020134|Antiviral Agents|antiviral agents|mesh-ancestor
92064365|NCT03020134|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064366|NCT03020134|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92064367|NCT03020134|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92064368|NCT03020056|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92064369|NCT03020056|Antioxidants|antioxidants|mesh-list
92064370|NCT03020056|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92064371|NCT03020056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064372|NCT03020056|Protective Agents|protective agents|mesh-ancestor
92064373|NCT03020056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064374|NCT03026062|Durvalumab|durvalumab|mesh-list
92064375|NCT03026062|Ipilimumab|ipilimumab|mesh-list
92064376|NCT03026062|Tremelimumab|tremelimumab|mesh-list
92064377|NCT03026062|Immunoglobulins|immunoglobulins|mesh-list
92064378|NCT03026062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92064379|NCT03026062|Immunoglobulin G|immunoglobulin g|mesh-list
92064380|NCT03026062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064381|NCT03026062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064382|NCT03026062|Immunologic Factors|immunologic factors|mesh-ancestor
92064383|NCT03026062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064384|NCT03026062|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064385|NCT03026062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064386|NCT03584074|Celecoxib|celecoxib|mesh-list
92064387|NCT03584074|Pregabalin|pregabalin|mesh-list
92064388|NCT03584074|Analgesics|analgesics|mesh-ancestor
92064389|NCT03584074|Sensory System Agents|sensory system agents|mesh-ancestor
92064390|NCT03584074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015443|NCT05025813|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064391|NCT03584074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064393|NCT03584074|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92064394|NCT03584074|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92064395|NCT03584074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064396|NCT03584074|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92064407|NCT03584074|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064408|NCT03583138|Buprenorphine|buprenorphine|mesh-list
92064409|NCT03583138|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92064410|NCT03583138|Narcotics|narcotics|mesh-ancestor
92064411|NCT03583138|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064412|NCT03583138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064414|NCT03583138|Sensory System Agents|sensory system agents|mesh-ancestor
92064415|NCT03583138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064416|NCT03583138|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92064417|NCT03153514|Obinutuzumab|obinutuzumab|mesh-list
92064418|NCT03153514|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064419|NCT03153514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064420|NCT03020602|Ubiquinone|ubiquinone|mesh-list
92064421|NCT03020602|Coenzyme Q10|coenzyme q10|mesh-list
92064422|NCT03020602|Micronutrients|micronutrients|mesh-ancestor
92064423|NCT03020602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064424|NCT03020602|Vitamins|vitamins|mesh-ancestor
92064425|NCT01567527|Aripiprazole|aripiprazole|mesh-list
92064426|NCT01567527|Antidepressive Agents|antidepressive agents|mesh-ancestor
92064427|NCT01567527|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92064428|NCT01567527|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92064429|NCT01567527|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92064430|NCT01567527|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064431|NCT01567527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064432|NCT01567527|Dopamine Agonists|dopamine agonists|mesh-ancestor
92064433|NCT01567527|Dopamine Agents|dopamine agents|mesh-ancestor
92064434|NCT01567527|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064435|NCT01567527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064436|NCT01567527|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92064437|NCT01567527|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92064438|NCT01567527|Serotonin Agents|serotonin agents|mesh-ancestor
92064439|NCT01567527|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92064440|NCT01567527|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92064441|NCT01567527|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92064442|NCT01567527|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92064443|NCT03159988|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92064444|NCT03159988|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92064445|NCT03159988|Vasodilator Agents|vasodilator agents|mesh-ancestor
92064446|NCT05701540|Esomeprazole|esomeprazole|mesh-list
92064447|NCT05701540|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92064448|NCT05701540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064449|NCT05701540|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92064450|NCT05701540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064451|NCT05701540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064452|NCT03159598|Urethane|urethane|mesh-list
92064453|NCT03159598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064454|NCT03159598|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92064455|NCT03159598|Anesthetics, General|anesthetics, general|mesh-ancestor
92064456|NCT03159598|Anesthetics|anesthetics|mesh-ancestor
92064457|NCT03159598|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064458|NCT03159598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064459|NCT01818752|Prednisone|prednisone|mesh-list
92064460|NCT01818752|Bortezomib|bortezomib|mesh-list
92064461|NCT01818752|Melphalan|melphalan|mesh-list
92064462|NCT01818752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064465|NCT01818752|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064467|NCT01818752|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064468|NCT01818752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064469|NCT01818752|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92064470|NCT01818752|Alkylating Agents|alkylating agents|mesh-ancestor
92064471|NCT01818752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064472|NCT01818752|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92015446|NCT04033237|Autonomic Agents|autonomic agents|mesh-ancestor
92015447|NCT04033237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015448|NCT04033237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064473|NCT01818752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92064474|NCT01818752|Immunologic Factors|immunologic factors|mesh-ancestor
92064475|NCT03582280|Calcium Carbonate|calcium carbonate|mesh-list
92064477|NCT03582280|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92064478|NCT03582280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064479|NCT03582280|Antacids|antacids|mesh-ancestor
92064480|NCT03582280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064481|NCT03582280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064482|NCT03159754|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92064483|NCT03159754|Metronidazole|metronidazole|mesh-list
92064484|NCT03159754|Ciprofloxacin|ciprofloxacin|mesh-list
92064485|NCT03159754|Tazobactam|tazobactam|mesh-list
92064486|NCT03159754|Piperacillin|piperacillin|mesh-list
92064487|NCT03159754|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92064488|NCT03159754|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064489|NCT03159754|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92064490|NCT03159754|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92064491|NCT03159754|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92064492|NCT03159754|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92064493|NCT03159754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064494|NCT03159754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064495|NCT03159754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064496|NCT03159754|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92064497|NCT03159754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92064498|NCT03159754|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92064499|NCT05701384|Lazertinib|lazertinib|mesh-list
92064500|NCT05701384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92064501|NCT05701384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064502|NCT05701384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064503|NCT01362608|Triamcinolone|triamcinolone|mesh-list
92064504|NCT01362608|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92064505|NCT01362608|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92064506|NCT01362608|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92064507|NCT01362608|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064508|NCT01362608|Glucocorticoids|glucocorticoids|mesh-ancestor
92064509|NCT01362608|Hormones|hormones|mesh-ancestor
92064510|NCT01362608|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064511|NCT01362608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064512|NCT01362608|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92064513|NCT01362608|Immunologic Factors|immunologic factors|mesh-ancestor
92064514|NCT01362608|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064515|NCT01362608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064516|NCT03581968|Pancrelipase|pancrelipase|mesh-list
92064517|NCT03581968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064518|NCT03158584|Morphine|morphine|mesh-list
92064519|NCT03158584|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92064520|NCT03158584|Narcotics|narcotics|mesh-ancestor
92064521|NCT03158584|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064522|NCT03158584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064523|NCT03158584|Analgesics|analgesics|mesh-ancestor
92064524|NCT03158584|Sensory System Agents|sensory system agents|mesh-ancestor
92064525|NCT03158584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064526|NCT04765228|Doxorubicin|doxorubicin|mesh-list
92064527|NCT04765228|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92064528|NCT04765228|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92064529|NCT04765228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064530|NCT04765228|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92064531|NCT04765228|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92064532|NCT04765228|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064533|NCT04765228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064535|NCT05696626|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064537|NCT05696626|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92064538|NCT05696626|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92064539|NCT05696626|Hormone Antagonists|hormone antagonists|mesh-ancestor
92015449|NCT04033237|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92015450|NCT04033237|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92064540|NCT05696626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064541|NCT05696626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064542|NCT01818596|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92064543|NCT01818596|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92064544|NCT01818596|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92064545|NCT01818596|Antiviral Agents|antiviral agents|mesh-ancestor
92064546|NCT01818596|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064548|NCT04140448|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92064549|NCT04140448|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92064550|NCT04140448|Growth Substances|growth substances|mesh-ancestor
92064551|NCT04140448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064552|NCT04140448|Growth Inhibitors|growth inhibitors|mesh-ancestor
92064553|NCT04140448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064554|NCT03156322|Fentanyl|fentanyl|mesh-list
92064555|NCT03156322|Bupivacaine|bupivacaine|mesh-list
92064556|NCT03156322|Anesthetics, Local|anesthetics, local|mesh-ancestor
92064557|NCT03156322|Anesthetics|anesthetics|mesh-ancestor
92064558|NCT03156322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064559|NCT03156322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064560|NCT03156322|Sensory System Agents|sensory system agents|mesh-ancestor
92064561|NCT03156322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064562|NCT03156322|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92064563|NCT03156322|Narcotics|narcotics|mesh-ancestor
92064564|NCT03156322|Analgesics|analgesics|mesh-ancestor
92064565|NCT03156322|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92064566|NCT03156322|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92064567|NCT03156322|Anesthetics, General|anesthetics, general|mesh-ancestor
92064568|NCT03156088|Neurotransmitter Agents|neurotransmitter agents|mesh-list
92064569|NCT03156088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064570|NCT03156088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064571|NCT04140058|Ondansetron|ondansetron|mesh-list
92064572|NCT04140058|Antiemetics|antiemetics|mesh-ancestor
92064573|NCT04140058|Autonomic Agents|autonomic agents|mesh-ancestor
92064574|NCT04140058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064575|NCT04140058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064576|NCT04140058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064577|NCT04140058|Antipruritics|antipruritics|mesh-ancestor
92064578|NCT04140058|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064579|NCT04140058|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92064580|NCT04140058|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92064581|NCT04140058|Serotonin Agents|serotonin agents|mesh-ancestor
92064582|NCT04140058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064583|NCT04140058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064584|NCT04146298|Cyclophosphamide|cyclophosphamide|mesh-list
92064585|NCT04146298|Fludarabine|fludarabine|mesh-list
92064586|NCT04146298|Antibodies|antibodies|mesh-list
92064587|NCT04146298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92064588|NCT04146298|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92064589|NCT04146298|Immunologic Factors|immunologic factors|mesh-ancestor
92064590|NCT04146298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064591|NCT04146298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064592|NCT04146298|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92064593|NCT04146298|Alkylating Agents|alkylating agents|mesh-ancestor
92064594|NCT04146298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064595|NCT04146298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064596|NCT04146298|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92064597|NCT02899078|Nivolumab|nivolumab|mesh-list
92064598|NCT02899078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064599|NCT02899078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064600|NCT02899078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064601|NCT02899078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064602|NCT01670734|Alirocumab|alirocumab|mesh-list
92064603|NCT01670734|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92064604|NCT01670734|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92064605|NCT01670734|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92064606|NCT01670734|Antimetabolites|antimetabolites|mesh-ancestor
92064610|NCT01670734|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064611|NCT01670734|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92064613|NCT01670890|Temozolomide|temozolomide|mesh-list
92064614|NCT01670890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015451|NCT04033237|Cholinergic Agents|cholinergic agents|mesh-ancestor
92015452|NCT04033237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064615|NCT01670890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92064616|NCT01670890|Alkylating Agents|alkylating agents|mesh-ancestor
92064617|NCT01670890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064618|NCT04551196|Acetaminophen|acetaminophen|mesh-list
92064619|NCT04551196|Ibuprofen|ibuprofen|mesh-list
92064620|NCT04551196|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064621|NCT04551196|Analgesics|analgesics|mesh-ancestor
92064622|NCT04551196|Sensory System Agents|sensory system agents|mesh-ancestor
92064623|NCT04551196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064624|NCT04551196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064625|NCT04551196|Antipyretics|antipyretics|mesh-ancestor
92064626|NCT04551196|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064627|NCT04551196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064628|NCT04551196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064629|NCT04551196|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064630|NCT04551196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064631|NCT04551196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064632|NCT01923298|Estradiol|estradiol|mesh-list
92064633|NCT01923298|Estrogens|estrogens|mesh-ancestor
92064634|NCT01923298|Hormones|hormones|mesh-ancestor
92064635|NCT01923298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064636|NCT01923298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064637|NCT05212246|Imiquimod|imiquimod|mesh-list
92064638|NCT05212246|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92064639|NCT05212246|Immunologic Factors|immunologic factors|mesh-ancestor
92064640|NCT05212246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064641|NCT05212246|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064642|NCT05212246|Interferon Inducers|interferon inducers|mesh-ancestor
92064643|NCT04297618|Lifitegrast|lifitegrast|mesh-list
92064644|NCT04297618|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92064645|NCT04297618|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92064646|NCT03154918|Dexamethasone|dexamethasone|mesh-list
92064647|NCT03154918|Gemcitabine|gemcitabine|mesh-list
92064648|NCT03154918|Etoposide|etoposide|mesh-list
92064649|NCT03154918|Ifosfamide|ifosfamide|mesh-list
92064650|NCT03154918|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064651|NCT03154918|Antiemetics|antiemetics|mesh-ancestor
92064652|NCT03154918|Autonomic Agents|autonomic agents|mesh-ancestor
92064653|NCT03154918|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064654|NCT03154918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064655|NCT03154918|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064656|NCT03154918|Glucocorticoids|glucocorticoids|mesh-ancestor
92064657|NCT03154918|Hormones|hormones|mesh-ancestor
92064658|NCT03154918|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064659|NCT03154918|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064660|NCT03154918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064661|NCT03154918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064662|NCT03154918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064663|NCT03154918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92064664|NCT03154918|Antimetabolites|antimetabolites|mesh-ancestor
92064665|NCT03154918|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92064666|NCT03154918|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92064667|NCT03154918|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92064668|NCT03154918|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92064669|NCT03154918|Alkylating Agents|alkylating agents|mesh-ancestor
92064670|NCT01671904|Rituximab|rituximab|mesh-list
92064671|NCT01671904|Obinutuzumab|obinutuzumab|mesh-list
92064672|NCT01671904|Venetoclax|venetoclax|mesh-list
92064673|NCT01671904|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92064674|NCT01671904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064675|NCT01671904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064676|NCT01671904|Immunologic Factors|immunologic factors|mesh-ancestor
92064677|NCT01671904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064678|NCT01671904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064680|NCT01671904|Alkylating Agents|alkylating agents|mesh-ancestor
92064681|NCT01671904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064682|NCT01671982|Tenofovir|tenofovir|mesh-list
92064683|NCT01671982|Antiviral Agents|antiviral agents|mesh-ancestor
92064684|NCT01671982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064685|NCT01671982|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92064686|NCT01671982|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92064687|NCT01671982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064688|NCT01671982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064689|NCT01671982|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92064690|NCT01671982|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92064691|NCT04040452|Ketorolac|ketorolac|mesh-list
92064692|NCT04040452|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064693|NCT04040452|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064694|NCT04040452|Analgesics|analgesics|mesh-ancestor
92064695|NCT04040452|Sensory System Agents|sensory system agents|mesh-ancestor
92064696|NCT04040452|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064697|NCT04040452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064698|NCT04040452|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064699|NCT04040452|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064700|NCT04040452|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064701|NCT04040452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064702|NCT04040452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064703|NCT04027894|Rifamycins|rifamycins|mesh-list
92064704|NCT04027894|Rifamycin SV|rifamycin sv|mesh-list
92064705|NCT04027894|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92064706|NCT04027894|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064707|NCT04027894|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064708|NCT02564068|Oxytocin|oxytocin|mesh-list
92064709|NCT02564068|Oxytocics|oxytocics|mesh-ancestor
92064710|NCT02564068|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92064711|NCT02564068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064712|NCT03154528|Vitamin D|vitamin d|mesh-list
92064713|NCT03154528|Vitamins|vitamins|mesh-ancestor
92064714|NCT03154528|Micronutrients|micronutrients|mesh-ancestor
92064715|NCT03154528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064716|NCT03154528|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92064717|NCT03154372|Metronidazole|metronidazole|mesh-list
92064718|NCT03154372|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064719|NCT03154372|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92064720|NCT03154372|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92064721|NCT03154372|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92064722|NCT01676506|Ranibizumab|ranibizumab|mesh-list
92064723|NCT01676506|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92064724|NCT01676506|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92064725|NCT01676506|Growth Substances|growth substances|mesh-ancestor
92064726|NCT01676506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064727|NCT01676506|Growth Inhibitors|growth inhibitors|mesh-ancestor
92064728|NCT01676506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064729|NCT03154294|Paclitaxel|paclitaxel|mesh-list
92064730|NCT03154294|Serabelisib|serabelisib|mesh-list
92064731|NCT03154294|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92064732|NCT03154294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064733|NCT03154294|Tubulin Modulators|tubulin modulators|mesh-ancestor
92064734|NCT03154294|Antimitotic Agents|antimitotic agents|mesh-ancestor
92064735|NCT03154294|Mitosis Modulators|mitosis modulators|mesh-ancestor
92064736|NCT03154294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064737|NCT03154294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064738|NCT03154606|Calcium|calcium|mesh-list
92064739|NCT03154606|Caseins|caseins|mesh-list
92064740|NCT03154606|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92064741|NCT03154606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064742|NCT03154606|Chelating Agents|chelating agents|mesh-ancestor
92064743|NCT03154606|Sequestering Agents|sequestering agents|mesh-ancestor
92064744|NCT03154606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064745|NCT01672450|Ipilimumab|ipilimumab|mesh-list
92064746|NCT01672450|Interleukin-2|interleukin-2|mesh-list
92064747|NCT01672450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064748|NCT01672450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064749|NCT01672450|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064750|NCT01672450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064751|NCT01672450|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064752|NCT01672450|Analgesics|analgesics|mesh-ancestor
92064753|NCT01672450|Sensory System Agents|sensory system agents|mesh-ancestor
92064755|NCT01672450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064757|NCT01854268|Antipruritics|antipruritics|mesh-ancestor
92064758|NCT01854268|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064759|NCT01854268|Sensory System Agents|sensory system agents|mesh-ancestor
92064760|NCT01854268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064761|NCT01854268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015453|NCT04033237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015454|NCT04421547|Letrozole|letrozole|mesh-list
92015455|NCT04421547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015456|NCT04421547|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92015457|NCT04421547|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92064762|NCT01672606|Rocuronium|rocuronium|mesh-list
92064763|NCT01672606|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92064764|NCT01672606|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92064765|NCT01672606|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92064766|NCT01672606|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064767|NCT01672606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064768|NCT01594281|Ranibizumab|ranibizumab|mesh-list
92064769|NCT01594281|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92064770|NCT01594281|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92064771|NCT01594281|Growth Substances|growth substances|mesh-ancestor
92064772|NCT01594281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064773|NCT01594281|Growth Inhibitors|growth inhibitors|mesh-ancestor
92064774|NCT01594281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064775|NCT04964050|Captopril, hydrochlorothiazide drug combination|captopril, hydrochlorothiazide drug combination|mesh-list
92064776|NCT04964050|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92064777|NCT04964050|Protease Inhibitors|protease inhibitors|mesh-ancestor
92064778|NCT04964050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064779|NCT04964050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064780|NCT04964050|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92064781|NCT04964050|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92064782|NCT04964050|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92064783|NCT04964050|Diuretics|diuretics|mesh-ancestor
92064784|NCT04964050|Natriuretic Agents|natriuretic agents|mesh-ancestor
92064785|NCT04964050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064786|NCT03526900|Atezolizumab|atezolizumab|mesh-list
92064787|NCT03526900|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92064788|NCT03526900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064789|NCT03526900|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92064790|NCT03526900|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064791|NCT03420742|Midazolam|midazolam|mesh-list
92064792|NCT03420742|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92064793|NCT03420742|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92064794|NCT03420742|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064795|NCT03420742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064796|NCT03420742|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92064797|NCT03420742|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92064798|NCT03420742|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92064799|NCT03420742|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92064800|NCT03420742|Anesthetics, General|anesthetics, general|mesh-ancestor
92064801|NCT03420742|Anesthetics|anesthetics|mesh-ancestor
92064802|NCT03420742|GABA Modulators|gaba modulators|mesh-ancestor
92064803|NCT03420742|GABA Agents|gaba agents|mesh-ancestor
92064804|NCT03420742|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064805|NCT03420742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064806|NCT01818284|Plerixafor|plerixafor|mesh-list
92064807|NCT01818284|Lenograstim|lenograstim|mesh-list
92064808|NCT01818284|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92064809|NCT01818284|Immunologic Factors|immunologic factors|mesh-ancestor
92064810|NCT01818284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064811|NCT01818284|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92064812|NCT01818284|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92064813|NCT01818284|Antiviral Agents|antiviral agents|mesh-ancestor
92064814|NCT01818284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064815|NCT02081014|Glucagon|glucagon|mesh-list
92064816|NCT02081014|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92064817|NCT02081014|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064818|NCT02081014|Hormones|hormones|mesh-ancestor
92064819|NCT02081014|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064821|NCT02081014|Incretins|incretins|mesh-ancestor
92064822|NCT03025594|Ketorolac|ketorolac|mesh-list
92064823|NCT03025594|Epinephrine|epinephrine|mesh-list
92064824|NCT03025594|Levobupivacaine|levobupivacaine|mesh-list
92064825|NCT03025594|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92015458|NCT04421547|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015459|NCT04421547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064826|NCT03025594|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92064827|NCT03025594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92064830|NCT03025594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064831|NCT03025594|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92064832|NCT03025594|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92064833|NCT03025594|Autonomic Agents|autonomic agents|mesh-ancestor
92064834|NCT03025594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064835|NCT03025594|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92064836|NCT03025594|Respiratory System Agents|respiratory system agents|mesh-ancestor
92064838|NCT03025594|Sympathomimetics|sympathomimetics|mesh-ancestor
92064839|NCT03025594|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92064840|NCT03025594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064841|NCT03025594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064842|NCT03025594|Analgesics|analgesics|mesh-ancestor
92064843|NCT03025594|Sensory System Agents|sensory system agents|mesh-ancestor
92064844|NCT03025594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064845|NCT03025594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064846|NCT03025594|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064847|NCT03025594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064848|NCT03025594|Anesthetics, Local|anesthetics, local|mesh-ancestor
92064849|NCT03025594|Anesthetics|anesthetics|mesh-ancestor
92064850|NCT03025594|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064851|NCT04404946|Phenylephrine|phenylephrine|mesh-list
92064852|NCT04404946|Oxymetazoline|oxymetazoline|mesh-list
92064853|NCT04404946|Norepinephrine|norepinephrine|mesh-list
92064854|NCT04404946|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92064855|NCT04404946|Mydriatics|mydriatics|mesh-ancestor
92064856|NCT04404946|Autonomic Agents|autonomic agents|mesh-ancestor
92064857|NCT04404946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064858|NCT04404946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064859|NCT04404946|Sympathomimetics|sympathomimetics|mesh-ancestor
92064860|NCT04404946|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92064861|NCT04404946|Nasal Decongestants|nasal decongestants|mesh-ancestor
92064862|NCT04404946|Respiratory System Agents|respiratory system agents|mesh-ancestor
92064863|NCT04404946|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92064864|NCT04404946|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92064865|NCT04404946|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92064866|NCT04404946|Adrenergic Agents|adrenergic agents|mesh-ancestor
92064867|NCT04404946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064868|NCT04404946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064869|NCT04404946|Protective Agents|protective agents|mesh-ancestor
92064870|NCT01673542|Lidocaine|lidocaine|mesh-list
92064871|NCT01673542|Prilocaine|prilocaine|mesh-list
92064872|NCT01673542|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92064873|NCT01673542|Anesthetics, Local|anesthetics, local|mesh-ancestor
92064874|NCT01673542|Anesthetics|anesthetics|mesh-ancestor
92064875|NCT01673542|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064876|NCT01673542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064877|NCT01673542|Sensory System Agents|sensory system agents|mesh-ancestor
92064878|NCT01673542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064879|NCT01673542|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92064880|NCT01673542|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92064881|NCT01673542|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92064882|NCT01673542|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92064883|NCT01673542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064884|NCT01673542|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92064885|NCT04804540|Vedolizumab|vedolizumab|mesh-list
92064886|NCT04804540|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064887|NCT01610492|Belimumab|belimumab|mesh-list
92064888|NCT01610492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92064889|NCT01610492|Immunologic Factors|immunologic factors|mesh-ancestor
92064890|NCT01610492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064891|NCT02738866|Fulvestrant|fulvestrant|mesh-list
92064892|NCT02738866|Palbociclib|palbociclib|mesh-list
92064893|NCT02738866|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92064894|NCT02738866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064895|NCT02738866|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92064896|NCT02738866|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92064897|NCT02738866|Hormone Antagonists|hormone antagonists|mesh-ancestor
92015461|NCT04421547|Hormone Antagonists|hormone antagonists|mesh-ancestor
92015462|NCT04421547|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015463|NCT04421547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015464|NCT03066817|Ergocalciferols|ergocalciferols|mesh-list
92090429|NCT04416035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064899|NCT02738866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064900|NCT02738866|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92064901|NCT02738866|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064902|NCT02738866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064903|NCT01817582|Loteprednol Etabonate|loteprednol etabonate|mesh-list
92064905|NCT01817582|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92064906|NCT01817582|Lubricant Eye Drops|lubricant eye drops|mesh-list
92064907|NCT01817582|Cyclosporins|cyclosporins|mesh-list
92064908|NCT01817582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064909|NCT01817582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064910|NCT01817582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92064911|NCT01817582|Immunologic Factors|immunologic factors|mesh-ancestor
92064912|NCT01817582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064913|NCT01817582|Antifungal Agents|antifungal agents|mesh-ancestor
92064914|NCT01817582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92064915|NCT01817582|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064916|NCT01817582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064917|NCT01817582|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92064918|NCT01817582|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92064919|NCT01817582|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92064920|NCT01594125|Nintedanib|nintedanib|mesh-list
92064921|NCT01594125|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064922|NCT01594125|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92064923|NCT01594125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064924|NCT01594125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064925|NCT01592409|Dronabinol|dronabinol|mesh-list
92064926|NCT01592409|Hallucinogens|hallucinogens|mesh-ancestor
92064927|NCT01592409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064928|NCT01592409|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92064929|NCT01592409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064930|NCT01592409|Analgesics|analgesics|mesh-ancestor
92064931|NCT01592409|Sensory System Agents|sensory system agents|mesh-ancestor
92064932|NCT01592409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064933|NCT01592409|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92064934|NCT01592409|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92064935|NCT01592409|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064936|NCT01592409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064937|NCT01592409|Hormones|hormones|mesh-ancestor
92064938|NCT01592409|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064939|NCT02081638|Aspirin|aspirin|mesh-list
92064940|NCT02081638|Atorvastatin|atorvastatin|mesh-list
92064941|NCT02081638|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064942|NCT02081638|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064943|NCT02081638|Analgesics|analgesics|mesh-ancestor
92064944|NCT02081638|Sensory System Agents|sensory system agents|mesh-ancestor
92064945|NCT02081638|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064946|NCT02081638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064947|NCT02081638|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064948|NCT02081638|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064949|NCT02081638|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92064950|NCT02081638|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92064951|NCT02081638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064952|NCT02081638|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92064953|NCT02081638|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064954|NCT02081638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064955|NCT02081638|Antipyretics|antipyretics|mesh-ancestor
92064956|NCT02081638|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92064957|NCT02081638|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92064958|NCT02081638|Antimetabolites|antimetabolites|mesh-ancestor
92064959|NCT02081638|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92015465|NCT03066817|Vitamin D|vitamin d|mesh-list
92015466|NCT03066817|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92015467|NCT03066817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015468|NCT03066817|Vitamins|vitamins|mesh-ancestor
92064960|NCT02081638|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92064961|NCT04603508|Calcium, Dietary|calcium, dietary|mesh-list
92064962|NCT04603508|Empagliflozin|empagliflozin|mesh-list
92064963|NCT04603508|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92064964|NCT04603508|Calcium|calcium|mesh-list
92064965|NCT04603508|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92064966|NCT04603508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064967|NCT04603508|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92064968|NCT04603508|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92064969|NCT04603508|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92064971|NCT04603508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064973|NCT04603508|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92064974|NCT04603508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064975|NCT04603508|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92064976|NCT04603508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92064977|NCT01674166|Prucalopride|prucalopride|mesh-list
92064978|NCT01674166|Laxatives|laxatives|mesh-ancestor
92064979|NCT01674166|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064980|NCT01674166|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92064981|NCT01674166|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92064982|NCT01674166|Serotonin Agents|serotonin agents|mesh-ancestor
92064983|NCT01674166|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064984|NCT01674166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064985|NCT01674166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064986|NCT02235688|Gemcitabine|gemcitabine|mesh-list
92064987|NCT02235688|Doxorubicin|doxorubicin|mesh-list
92064988|NCT02235688|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92064989|NCT02235688|Antimetabolites|antimetabolites|mesh-ancestor
92064990|NCT02235688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064991|NCT02235688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064992|NCT02235688|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92064993|NCT02235688|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92064994|NCT02235688|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92064995|NCT02235688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064996|NCT03152578|Capsaicin|capsaicin|mesh-list
92064997|NCT03152578|Antipruritics|antipruritics|mesh-ancestor
92064998|NCT03152578|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064999|NCT03152578|Sensory System Agents|sensory system agents|mesh-ancestor
92065000|NCT03152578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065001|NCT03152578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065003|NCT01065532|Everolimus|everolimus|mesh-list
92065004|NCT01065532|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92065005|NCT01065532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065006|NCT01065532|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065007|NCT01065532|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065008|NCT01065532|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065009|NCT01065532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065010|NCT01065532|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92065011|NCT01065532|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92065012|NCT01065532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065013|NCT01065532|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065014|NCT01065532|Immunologic Factors|immunologic factors|mesh-ancestor
92065015|NCT01065532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065017|NCT04764916|Anesthetics, Local|anesthetics, local|mesh-ancestor
92065018|NCT04764916|Anesthetics|anesthetics|mesh-ancestor
92065019|NCT04764916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065020|NCT04764916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065021|NCT04764916|Sensory System Agents|sensory system agents|mesh-ancestor
92065022|NCT04764916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065023|NCT01674868|Fluoxetine|fluoxetine|mesh-list
92065024|NCT01674868|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92065025|NCT01674868|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92065026|NCT01674868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065027|NCT01674868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065028|NCT01674868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065029|NCT01674868|Serotonin Agents|serotonin agents|mesh-ancestor
92065030|NCT01674868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065031|NCT01674868|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92065032|NCT01674868|Antidepressive Agents|antidepressive agents|mesh-ancestor
92065033|NCT01674868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065034|NCT01674868|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92065035|NCT01674868|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92065036|NCT01674868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065037|NCT01674946|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92065038|NCT01674946|Bile Acids and Salts|bile acids and salts|mesh-list
92065039|NCT01674946|Cathartics|cathartics|mesh-ancestor
92065040|NCT01674946|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065041|NCT01675024|Rotigotine|rotigotine|mesh-list
92065046|NCT01675024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065047|NCT03883828|Chlorhexidine|chlorhexidine|mesh-list
92065048|NCT03883828|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92065049|NCT03883828|Mupirocin|mupirocin|mesh-list
92065050|NCT03883828|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92065051|NCT03883828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065052|NCT03883828|Disinfectants|disinfectants|mesh-ancestor
92065053|NCT03883828|Dermatologic Agents|dermatologic agents|mesh-ancestor
92065054|NCT03883828|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92065055|NCT03883828|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92065056|NCT03883828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065057|NCT03883828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065058|NCT02081950|Enoxaparin|enoxaparin|mesh-list
92065059|NCT02081950|Enoxaparin sodium|enoxaparin sodium|mesh-list
92065060|NCT02081950|Anticoagulants|anticoagulants|mesh-ancestor
92065061|NCT02081950|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92065062|NCT02081950|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92065063|NCT02081950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065064|NCT01675648|Lofexidine|lofexidine|mesh-list
92065065|NCT01675648|Clonidine|clonidine|mesh-list
92065066|NCT01675648|Diazepam|diazepam|mesh-list
92065067|NCT01675648|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92065068|NCT01675648|Anticonvulsants|anticonvulsants|mesh-ancestor
92065069|NCT01675648|Antiemetics|antiemetics|mesh-ancestor
92065070|NCT01675648|Autonomic Agents|autonomic agents|mesh-ancestor
92065071|NCT01675648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065072|NCT01675648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065073|NCT01675648|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065074|NCT01675648|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92065075|NCT01675648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065076|NCT01675648|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92065077|NCT01675648|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92065078|NCT01675648|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92065079|NCT01675648|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92065080|NCT01675648|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065081|NCT01675648|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92065082|NCT01675648|Anesthetics, General|anesthetics, general|mesh-ancestor
92065083|NCT01675648|Anesthetics|anesthetics|mesh-ancestor
92065084|NCT01675648|GABA Modulators|gaba modulators|mesh-ancestor
92065085|NCT01675648|GABA Agents|gaba agents|mesh-ancestor
92065086|NCT01675648|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065087|NCT01675648|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065088|NCT01675648|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92065089|NCT01675648|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92065090|NCT01675648|Sensory System Agents|sensory system agents|mesh-ancestor
92065091|NCT01675648|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92065092|NCT01675648|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92065093|NCT01675648|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92065094|NCT01675648|Adrenergic Agents|adrenergic agents|mesh-ancestor
92065095|NCT01675648|Analgesics|analgesics|mesh-ancestor
92065096|NCT01675648|Sympatholytics|sympatholytics|mesh-ancestor
92065097|NCT01566435|Paclitaxel|paclitaxel|mesh-list
92065098|NCT01566435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92065099|NCT01566435|Fluorouracil|fluorouracil|mesh-list
92065100|NCT01566435|Cetuximab|cetuximab|mesh-list
92065101|NCT01566435|Antibodies|antibodies|mesh-list
92065102|NCT01566435|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92065103|NCT01566435|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92065104|NCT01566435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065105|NCT01566435|Tubulin Modulators|tubulin modulators|mesh-ancestor
92015470|NCT03066817|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92015471|NCT05060913|Lidocaine|lidocaine|mesh-list
92015472|NCT05060913|Prilocaine|prilocaine|mesh-list
92015473|NCT05060913|Benzocaine|benzocaine|mesh-list
92065106|NCT01566435|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065107|NCT01566435|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065108|NCT01566435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065109|NCT01566435|Immunologic Factors|immunologic factors|mesh-ancestor
92065110|NCT01566435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065111|NCT01566435|Antimetabolites|antimetabolites|mesh-ancestor
92065112|NCT01566435|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065113|NCT01566435|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065114|NCT01566435|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065117|NCT01675804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065118|NCT01675804|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92065119|NCT01675804|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92065120|NCT01675804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065121|NCT01675804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065123|NCT01675804|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065124|NCT01696695|Capecitabine|capecitabine|mesh-list
92065125|NCT01696695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065126|NCT01696695|Antimetabolites|antimetabolites|mesh-ancestor
92065127|NCT01696695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065128|NCT01696695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065129|NCT05261386|Betadex|betadex|mesh-list
92065130|NCT05261386|Sequestering Agents|sequestering agents|mesh-ancestor
92065131|NCT05261386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065132|NCT03899805|Pembrolizumab|pembrolizumab|mesh-list
92065133|NCT03899805|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065134|NCT03899805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065135|NCT03899805|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065136|NCT03899805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065137|NCT03861988|Ketamine|ketamine|mesh-list
92065138|NCT03861988|Analgesics|analgesics|mesh-ancestor
92065139|NCT03861988|Sensory System Agents|sensory system agents|mesh-ancestor
92065140|NCT03861988|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065141|NCT03861988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065142|NCT03861988|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92065143|NCT03861988|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92065144|NCT03861988|Anesthetics, General|anesthetics, general|mesh-ancestor
92065145|NCT03861988|Anesthetics|anesthetics|mesh-ancestor
92065146|NCT03861988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065147|NCT03861988|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92065148|NCT03861988|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92065149|NCT03861988|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065150|NCT03861988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065151|NCT03755440|Antibodies|antibodies|mesh-list
92065152|NCT03755440|Immunologic Factors|immunologic factors|mesh-ancestor
92065153|NCT03755440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065154|NCT03749902|Misoprostol|misoprostol|mesh-list
92065155|NCT03749902|Oxytocin|oxytocin|mesh-list
92065156|NCT03749902|Oxytocics|oxytocics|mesh-ancestor
92065157|NCT03749902|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92065158|NCT03749902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065159|NCT03749902|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92065160|NCT03749902|Abortifacient Agents|abortifacient agents|mesh-ancestor
92065161|NCT03749902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92065162|NCT03749902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065163|NCT01565889|Ritonavir|ritonavir|mesh-list
92065164|NCT01565889|Ribavirin|ribavirin|mesh-list
92065165|NCT01565889|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92065166|NCT01565889|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92065167|NCT01565889|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065168|NCT01565889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065169|NCT01565889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065170|NCT01565889|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92065171|NCT01565889|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92065172|NCT01565889|Antiviral Agents|antiviral agents|mesh-ancestor
92065173|NCT01565889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065174|NCT01565889|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92015474|NCT05060913|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92065175|NCT01565889|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92065176|NCT01565889|Antimetabolites|antimetabolites|mesh-ancestor
92065177|NCT01696071|Tiotropium Bromide|tiotropium bromide|mesh-list
92065178|NCT01696071|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92065179|NCT01696071|Autonomic Agents|autonomic agents|mesh-ancestor
92065180|NCT01696071|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065181|NCT01696071|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065182|NCT01696071|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92065183|NCT01696071|Respiratory System Agents|respiratory system agents|mesh-ancestor
92065184|NCT01696071|Parasympatholytics|parasympatholytics|mesh-ancestor
92065185|NCT01696071|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92065188|NCT01696071|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065189|NCT01591863|Fidaxomicin|fidaxomicin|mesh-list
92065190|NCT01591863|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92065191|NCT01591863|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065192|NCT01591785|Retapamulin|retapamulin|mesh-list
92065193|NCT01591785|Petrolatum|petrolatum|mesh-list
92065194|NCT01591785|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92065195|NCT01591785|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065196|NCT01591785|Emollients|emollients|mesh-ancestor
92065197|NCT01591785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92065198|NCT03660046|Medroxyprogesterone Acetate|medroxyprogesterone acetate|mesh-list
92065199|NCT03660046|Levonorgestrel|levonorgestrel|mesh-list
92065200|NCT03660046|Medroxyprogesterone|medroxyprogesterone|mesh-list
92065201|NCT03660046|Etonogestrel|etonogestrel|mesh-list
92065202|NCT03660046|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92065203|NCT03660046|Contraceptive Agents|contraceptive agents|mesh-ancestor
92065204|NCT03660046|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92065205|NCT03660046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065206|NCT03660046|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92065207|NCT03660046|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92065208|NCT03660046|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92065209|NCT03660046|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92065210|NCT03660046|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92065211|NCT03660046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92065212|NCT03660046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065213|NCT03654040|Cyclophosphamide|cyclophosphamide|mesh-list
92065214|NCT03654040|Everolimus|everolimus|mesh-list
92065215|NCT03654040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065216|NCT03654040|Immunologic Factors|immunologic factors|mesh-ancestor
92065217|NCT03654040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065218|NCT03654040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065219|NCT03654040|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92065220|NCT03654040|Alkylating Agents|alkylating agents|mesh-ancestor
92065221|NCT03654040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065222|NCT03654040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065223|NCT03654040|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92065224|NCT03654040|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92065225|NCT03654040|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92065226|NCT03654040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065227|NCT03844048|Venetoclax|venetoclax|mesh-list
92065228|NCT03844048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065229|NCT03833440|Docetaxel|docetaxel|mesh-list
92065230|NCT03833440|Durvalumab|durvalumab|mesh-list
92065231|NCT03833440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065232|NCT03833440|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065233|NCT03833440|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065234|NCT03833440|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065235|NCT03833440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065236|NCT03833440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065237|NCT01677442|Anesthetics|anesthetics|mesh-list
92065238|NCT01677442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065239|NCT01677442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065240|NCT01695135|Prednisone|prednisone|mesh-list
92065241|NCT01695135|Abiraterone Acetate|abiraterone acetate|mesh-list
92065242|NCT01695135|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92065244|NCT01695135|Hormones|hormones|mesh-ancestor
92065245|NCT01695135|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065246|NCT01695135|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065247|NCT01695135|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92015476|NCT05060913|Anesthetics|anesthetics|mesh-ancestor
92065248|NCT01695135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065249|NCT01695135|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92065250|NCT01695135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065251|NCT01695135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065252|NCT01695135|Hormone Antagonists|hormone antagonists|mesh-ancestor
92065253|NCT01695135|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92065254|NCT01590771|Metformin|metformin|mesh-list
92065255|NCT01590771|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92065256|NCT01590771|Glimepiride|glimepiride|mesh-list
92065257|NCT01590771|Gliclazide|gliclazide|mesh-list
92065258|NCT01590771|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92065259|NCT01590771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065270|NCT04764058|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92065271|NCT04764058|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92065272|NCT04764058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065273|NCT04764058|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065274|NCT04764058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065275|NCT04764058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065276|NCT03735316|Vitamin B 12|vitamin b 12|mesh-list
92065277|NCT03735316|Hydroxocobalamin|hydroxocobalamin|mesh-list
92065278|NCT03735316|Vitamins|vitamins|mesh-ancestor
92065279|NCT03735316|Micronutrients|micronutrients|mesh-ancestor
92065280|NCT03735316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065281|NCT03735316|Vitamin B Complex|vitamin b complex|mesh-ancestor
92065282|NCT03735316|Hematinics|hematinics|mesh-ancestor
92065283|NCT01694433|Vitamin D|vitamin d|mesh-list
92065284|NCT01694433|Calcitriol|calcitriol|mesh-list
92065285|NCT01694433|Calcipotriene|calcipotriene|mesh-list
92065286|NCT01694433|Vitamins|vitamins|mesh-ancestor
92065287|NCT01694433|Micronutrients|micronutrients|mesh-ancestor
92065288|NCT01694433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065289|NCT01694433|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92065290|NCT01694433|Dermatologic Agents|dermatologic agents|mesh-ancestor
92065291|NCT01694433|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92065292|NCT01694433|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92065293|NCT01694433|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065294|NCT01694433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065295|NCT01694433|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92065296|NCT01693185|Midazolam|midazolam|mesh-list
92065297|NCT01693185|Meperidine|meperidine|mesh-list
92065298|NCT01693185|Remifentanil|remifentanil|mesh-list
92065299|NCT01693185|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92065300|NCT01693185|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92065301|NCT01693185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065302|NCT01693185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065303|NCT01693185|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92065304|NCT01693185|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92065305|NCT01693185|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065306|NCT01693185|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92065307|NCT01693185|Anesthetics, General|anesthetics, general|mesh-ancestor
92065308|NCT01693185|Anesthetics|anesthetics|mesh-ancestor
92065309|NCT01693185|GABA Modulators|gaba modulators|mesh-ancestor
92065310|NCT01693185|GABA Agents|gaba agents|mesh-ancestor
92065311|NCT01693185|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081704|NCT01402947|Sensory System Agents|sensory system agents|mesh-ancestor
92065312|NCT01693185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065313|NCT01693185|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92065314|NCT01693185|Narcotics|narcotics|mesh-ancestor
92065315|NCT01693185|Analgesics|analgesics|mesh-ancestor
92065316|NCT01693185|Sensory System Agents|sensory system agents|mesh-ancestor
92065317|NCT01693185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065318|NCT03824938|Aspirin|aspirin|mesh-list
92065319|NCT03824938|Acetaminophen|acetaminophen|mesh-list
92065320|NCT03824938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92065321|NCT03824938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92065322|NCT03824938|Analgesics|analgesics|mesh-ancestor
92065323|NCT03824938|Sensory System Agents|sensory system agents|mesh-ancestor
92065327|NCT03824938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065328|NCT03824938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92065329|NCT03824938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92065330|NCT03824938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065331|NCT03824938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92065332|NCT03824938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92015477|NCT05060913|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015478|NCT05060913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065333|NCT03824938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065334|NCT03824938|Antipyretics|antipyretics|mesh-ancestor
92065335|NCT03630640|Nivolumab|nivolumab|mesh-list
92065336|NCT03630640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065337|NCT03630640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065338|NCT03630640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065339|NCT03630640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065340|NCT03820726|Nintedanib|nintedanib|mesh-list
92065341|NCT03820726|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065342|NCT03820726|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92065343|NCT03820726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065344|NCT03820726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065345|NCT03625726|Thrombin|thrombin|mesh-list
92065346|NCT03625726|Hemostatics|hemostatics|mesh-ancestor
92065347|NCT03625726|Coagulants|coagulants|mesh-ancestor
92065348|NCT03814954|Epinephrine|epinephrine|mesh-list
92065349|NCT03814954|Albuterol|albuterol|mesh-list
92065350|NCT03814954|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92065351|NCT03814954|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92065352|NCT03814954|Adrenergic Agents|adrenergic agents|mesh-ancestor
92065353|NCT03814954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065354|NCT03814954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065355|NCT03814954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065356|NCT03814954|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92065357|NCT03814954|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92065358|NCT03814954|Autonomic Agents|autonomic agents|mesh-ancestor
92065359|NCT03814954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065360|NCT03814954|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92065361|NCT03814954|Respiratory System Agents|respiratory system agents|mesh-ancestor
92065362|NCT03814954|Mydriatics|mydriatics|mesh-ancestor
92065363|NCT03814954|Sympathomimetics|sympathomimetics|mesh-ancestor
92065364|NCT03814954|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92065365|NCT03814954|Tocolytic Agents|tocolytic agents|mesh-ancestor
92065366|NCT03814954|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92065367|NCT03814954|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92065368|NCT03813160|Dronabinol|dronabinol|mesh-list
92065369|NCT03813160|Lenabasum|lenabasum|mesh-list
92065370|NCT03813160|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92065371|NCT03813160|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92065372|NCT03813160|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065373|NCT03813160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065374|NCT03813160|Hormones|hormones|mesh-ancestor
92065375|NCT03813160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065376|NCT03813160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065377|NCT03813160|Hallucinogens|hallucinogens|mesh-ancestor
92065378|NCT03813160|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065379|NCT03813160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92065380|NCT03813160|Analgesics|analgesics|mesh-ancestor
92065381|NCT03813160|Sensory System Agents|sensory system agents|mesh-ancestor
92065382|NCT03813160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065383|NCT03619252|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92065384|NCT03619252|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92065385|NCT03619252|Immunologic Factors|immunologic factors|mesh-ancestor
92065386|NCT03619252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065387|NCT03619252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065389|NCT03807856|Antithrombins|antithrombins|mesh-ancestor
92065390|NCT03807856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92065391|NCT03807856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065392|NCT03807856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065393|NCT03807856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065394|NCT03807856|Anticoagulants|anticoagulants|mesh-ancestor
92065398|NCT03806530|Sensory System Agents|sensory system agents|mesh-ancestor
92065399|NCT03806530|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065400|NCT03806530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065401|NCT03806530|Anticonvulsants|anticonvulsants|mesh-ancestor
92065402|NCT03806530|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92065403|NCT03806530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92065404|NCT03806530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015479|NCT05060913|Sensory System Agents|sensory system agents|mesh-ancestor
92015480|NCT05060913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015481|NCT05060913|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92065405|NCT03806530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065406|NCT03806530|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92065407|NCT03806530|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92065408|NCT03806530|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065409|NCT03806530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065410|NCT03806530|Antimanic Agents|antimanic agents|mesh-ancestor
92065411|NCT03806530|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92065412|NCT03806530|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92065413|NCT03806530|Dopamine Agonists|dopamine agonists|mesh-ancestor
92065414|NCT03806530|Dopamine Agents|dopamine agents|mesh-ancestor
92065415|NCT00003820|Rituximab|rituximab|mesh-list
92065416|NCT00003820|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065417|NCT00003820|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065418|NCT00003820|Immunologic Factors|immunologic factors|mesh-ancestor
92065419|NCT00003820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065420|NCT00003820|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065421|NCT01693029|Epoetin Alfa|epoetin alfa|mesh-list
92065422|NCT01693029|Hematinics|hematinics|mesh-ancestor
92065423|NCT01589445|Metformin|metformin|mesh-list
92065424|NCT01589445|Pioglitazone|pioglitazone|mesh-list
92065425|NCT01589445|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92065426|NCT01589445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065427|NCT01561989|Vitamin D|vitamin d|mesh-list
92065428|NCT01561989|Cholecalciferol|cholecalciferol|mesh-list
92065429|NCT01561989|Vaccines|vaccines|mesh-list
92065430|NCT01561989|Immunologic Factors|immunologic factors|mesh-ancestor
92065431|NCT01561989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065432|NCT01561989|Vitamins|vitamins|mesh-ancestor
92065433|NCT01561989|Micronutrients|micronutrients|mesh-ancestor
92065434|NCT01561989|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92065435|NCT01561989|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92065436|NCT00004054|Paclitaxel|paclitaxel|mesh-list
92065437|NCT00004054|Etoposide|etoposide|mesh-list
92065438|NCT00004054|Bicalutamide|bicalutamide|mesh-list
92065439|NCT00004054|Flutamide|flutamide|mesh-list
92065440|NCT00004054|Estramustine|estramustine|mesh-list
92065441|NCT00004054|Warfarin|warfarin|mesh-list
92065442|NCT00004054|Hormones|hormones|mesh-list
92065443|NCT00004054|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92065444|NCT00004054|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92065445|NCT00004054|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065446|NCT00004054|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065447|NCT00004054|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065448|NCT00004054|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065449|NCT00004054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065450|NCT00004054|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92065451|NCT00004054|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92065452|NCT00004054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065453|NCT00004054|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065454|NCT00004054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065455|NCT00004054|Anticoagulants|anticoagulants|mesh-ancestor
92065456|NCT00004054|Androgen Antagonists|androgen antagonists|mesh-ancestor
92065457|NCT00004054|Hormone Antagonists|hormone antagonists|mesh-ancestor
92065458|NCT00004054|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92065459|NCT00004054|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92065460|NCT00004054|Alkylating Agents|alkylating agents|mesh-ancestor
92065461|NCT01587885|Omeprazole|omeprazole|mesh-list
92065462|NCT01587885|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92065463|NCT01587885|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065464|NCT01587885|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92065465|NCT01587885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065466|NCT01587885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065467|NCT03802240|Pemetrexed|pemetrexed|mesh-list
92065468|NCT03802240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065469|NCT03802240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065470|NCT03802240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065817|NCT03563248|Folfirinox|folfirinox|mesh-list
92065472|NCT03802240|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92065473|NCT03710122|Vancomycin|vancomycin|mesh-list
92065474|NCT03710122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92065475|NCT03710122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015482|NCT05060913|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92015483|NCT05060913|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92015484|NCT05060913|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92015485|NCT05060913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015486|NCT05060913|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92065476|NCT01587651|Ticagrelor|ticagrelor|mesh-list
92065477|NCT01587651|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92065478|NCT01587651|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92065479|NCT01587651|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92065480|NCT01587651|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92065481|NCT01587651|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92065482|NCT01587651|Purinergic Agents|purinergic agents|mesh-ancestor
92065483|NCT01587651|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065484|NCT01587651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065485|NCT01587651|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065486|NCT04763434|Dexamethasone|dexamethasone|mesh-list
92065487|NCT04763434|Dexmedetomidine|dexmedetomidine|mesh-list
92065488|NCT04763434|Ropivacaine|ropivacaine|mesh-list
92065489|NCT04763434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92065490|NCT04763434|Antiemetics|antiemetics|mesh-ancestor
92065491|NCT04763434|Autonomic Agents|autonomic agents|mesh-ancestor
92065492|NCT04763434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065493|NCT04763434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065494|NCT04763434|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065495|NCT04763434|Glucocorticoids|glucocorticoids|mesh-ancestor
92065496|NCT04763434|Hormones|hormones|mesh-ancestor
92065497|NCT04763434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065498|NCT04763434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92065499|NCT04763434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065500|NCT04763434|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92065501|NCT04763434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065502|NCT04763434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92065503|NCT04763434|Analgesics|analgesics|mesh-ancestor
92065504|NCT04763434|Sensory System Agents|sensory system agents|mesh-ancestor
92065505|NCT04763434|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92065506|NCT04763434|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92065507|NCT04763434|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92065508|NCT04763434|Adrenergic Agents|adrenergic agents|mesh-ancestor
92065509|NCT04763434|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065510|NCT04763434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065511|NCT04763434|Anesthetics, Local|anesthetics, local|mesh-ancestor
92065512|NCT04763434|Anesthetics|anesthetics|mesh-ancestor
92065513|NCT03606538|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92065514|NCT03606538|Hallucinogens|hallucinogens|mesh-ancestor
92065515|NCT03606538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065516|NCT03606538|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065517|NCT03606538|Serotonin Agents|serotonin agents|mesh-ancestor
92065518|NCT03606538|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065519|NCT03606538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065520|NCT03606538|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92065521|NCT03606538|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92065522|NCT03606538|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065523|NCT03606538|Adrenergic Agents|adrenergic agents|mesh-ancestor
92065524|NCT04762966|Metformin|metformin|mesh-list
92065525|NCT04762966|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92065526|NCT04762966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065527|NCT03602560|Seladelpar|seladelpar|mesh-list
92065528|NCT03602560|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92065529|NCT03602560|Antimetabolites|antimetabolites|mesh-ancestor
92065530|NCT03602560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065531|NCT03602560|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92065532|NCT03797326|Pembrolizumab|pembrolizumab|mesh-list
92065533|NCT03797326|Lenvatinib|lenvatinib|mesh-list
92065534|NCT03797326|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065535|NCT03797326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065536|NCT03797326|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92081681|NCT01392183|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015488|NCT05165251|Amlodipine, atorvastatin drug combination|amlodipine, atorvastatin drug combination|mesh-list
92015489|NCT05165251|Atorvastatin|atorvastatin|mesh-list
92015490|NCT05165251|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92015491|NCT05165251|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92081705|NCT01402947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065537|NCT03797326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065538|NCT03797326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92065539|NCT03797326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065541|NCT00779116|Desloratadine|desloratadine|mesh-list
92065542|NCT00779116|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92065545|NCT00779116|Histamine Antagonists|histamine antagonists|mesh-ancestor
92065546|NCT00779116|Histamine Agents|histamine agents|mesh-ancestor
92065547|NCT00779116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065548|NCT00779116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065549|NCT00779116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065550|NCT00779116|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92065551|NCT00779116|Cholinergic Agents|cholinergic agents|mesh-ancestor
92065553|NCT01691781|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92065554|NCT01691781|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065555|NCT01691781|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065556|NCT01691781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065557|NCT01691781|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92065558|NCT01691781|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92065559|NCT01691781|Protective Agents|protective agents|mesh-ancestor
92065560|NCT01691781|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065561|NCT01561755|Immunoglobulins|immunoglobulins|mesh-list
92065562|NCT01561755|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92065563|NCT01561755|Antibodies|antibodies|mesh-list
92065564|NCT01561755|gamma-Globulins|gamma-globulins|mesh-list
92065565|NCT01561755|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92065566|NCT01561755|Immunologic Factors|immunologic factors|mesh-ancestor
92065567|NCT01561755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065568|NCT03789214|Suvorexant|suvorexant|mesh-list
92065569|NCT03789214|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92065570|NCT03789214|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92065571|NCT03789214|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065572|NCT03789214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065573|NCT03789214|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92065574|NCT03789214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065575|NCT03789214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065576|NCT04124367|Cerebrolysin|cerebrolysin|mesh-list
92065577|NCT04124367|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92065578|NCT04124367|Protective Agents|protective agents|mesh-ancestor
92065579|NCT04124367|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065580|NCT04124367|Nootropic Agents|nootropic agents|mesh-ancestor
92065581|NCT01560507|Bupropion|bupropion|mesh-list
92065582|NCT01560507|Nicotine|nicotine|mesh-list
92065583|NCT01560507|Varenicline|varenicline|mesh-list
92065584|NCT01560507|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92065585|NCT01560507|Autonomic Agents|autonomic agents|mesh-ancestor
92065586|NCT01560507|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065587|NCT01560507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065588|NCT01560507|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92065589|NCT01560507|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92065590|NCT01560507|Cholinergic Agents|cholinergic agents|mesh-ancestor
92065591|NCT01560507|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065592|NCT01560507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065593|NCT01560507|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92065594|NCT01560507|Antidepressive Agents|antidepressive agents|mesh-ancestor
92065595|NCT01560507|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065596|NCT01560507|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92065597|NCT01560507|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92065598|NCT01560507|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065599|NCT01560507|Dopamine Agents|dopamine agents|mesh-ancestor
92065600|NCT01560507|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92065601|NCT01560507|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92015492|NCT05165251|Antimetabolites|antimetabolites|mesh-ancestor
92015493|NCT05165251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015494|NCT05165251|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92065602|NCT01560507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065603|NCT03694834|Pembrolizumab|pembrolizumab|mesh-list
92065604|NCT03694834|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065605|NCT03694834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065606|NCT03694834|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065607|NCT03694834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065608|NCT03587740|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92065609|NCT03587740|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065610|NCT03587740|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065611|NCT03587740|Immunotoxins|immunotoxins|mesh-ancestor
92065612|NCT03587740|Immunoconjugates|immunoconjugates|mesh-ancestor
92065613|NCT03587740|Immunologic Factors|immunologic factors|mesh-ancestor
92065616|NCT03587740|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065617|NCT03587740|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065618|NCT03587740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065619|NCT03586414|Ubiquinone|ubiquinone|mesh-list
92065620|NCT03586414|Micronutrients|micronutrients|mesh-ancestor
92065621|NCT03586414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065622|NCT03684538|Zinc|zinc|mesh-list
92065623|NCT03684538|Trace Elements|trace elements|mesh-ancestor
92065624|NCT03684538|Micronutrients|micronutrients|mesh-ancestor
92065625|NCT03684538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065626|NCT03682978|Baclofen|baclofen|mesh-list
92065627|NCT03682978|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92065628|NCT03682978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065629|NCT03682978|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92065630|NCT03682978|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065631|NCT03682978|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92065632|NCT03682978|GABA Agonists|gaba agonists|mesh-ancestor
92065633|NCT03682978|GABA Agents|gaba agents|mesh-ancestor
92065634|NCT03682978|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065635|NCT03682978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065636|NCT03676192|Bevacizumab|bevacizumab|mesh-list
92065637|NCT03676192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065638|NCT03676192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065639|NCT03676192|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92065640|NCT03676192|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92065641|NCT03676192|Growth Substances|growth substances|mesh-ancestor
92065642|NCT03676192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065643|NCT03676192|Growth Inhibitors|growth inhibitors|mesh-ancestor
92065644|NCT01584843|Botulinum Toxins|botulinum toxins|mesh-list
92065645|NCT01584843|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92065646|NCT01584843|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92065647|NCT01584843|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92065648|NCT01584843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065649|NCT01584843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065650|NCT01584843|Cholinergic Agents|cholinergic agents|mesh-ancestor
92065651|NCT01584843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065652|NCT01584843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065653|NCT01584843|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92065654|NCT01584843|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065655|NCT03580408|Nivolumab|nivolumab|mesh-list
92065656|NCT03580408|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065657|NCT03580408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065658|NCT03580408|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065659|NCT03580408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065660|NCT03775096|Carvedilol|carvedilol|mesh-list
92065661|NCT03775096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92065662|NCT03775096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92065663|NCT03775096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92065664|NCT03775096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065665|NCT03775096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065666|NCT03775096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065667|NCT03775096|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92065668|NCT03775096|Antioxidants|antioxidants|mesh-ancestor
92065669|NCT03775096|Protective Agents|protective agents|mesh-ancestor
92065670|NCT03775096|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92015495|NCT05165251|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92065671|NCT03775096|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065672|NCT03775096|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92065673|NCT03775096|Vasodilator Agents|vasodilator agents|mesh-ancestor
92065674|NCT03775096|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92065675|NCT03775096|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92065677|NCT03774394|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92065678|NCT03774394|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92065679|NCT03774394|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92065680|NCT03774394|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92065681|NCT03774394|Purinergic Agents|purinergic agents|mesh-ancestor
92065682|NCT03774394|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081706|NCT01402947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065683|NCT03774394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065686|NCT03772834|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92065687|NCT03772834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065688|NCT03772834|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92065689|NCT03772834|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92065690|NCT03772834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065691|NCT03772834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065692|NCT03772834|Dopamine Agents|dopamine agents|mesh-ancestor
92065693|NCT03772834|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065695|NCT03675256|Immunologic Factors|immunologic factors|mesh-ancestor
92065696|NCT03675256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065697|NCT03766750|Dapagliflozin|dapagliflozin|mesh-list
92065698|NCT03766750|Linagliptin|linagliptin|mesh-list
92065699|NCT03766750|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92065700|NCT03766750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065701|NCT03766750|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92065702|NCT03766750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065703|NCT03766750|Incretins|incretins|mesh-ancestor
92065705|NCT03766750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065706|NCT03766750|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92065707|NCT03766750|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065708|NCT03766750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065709|NCT04762810|Cyclophosphamide|cyclophosphamide|mesh-list
92065710|NCT04762810|Glucocorticoids|glucocorticoids|mesh-list
92065711|NCT04762810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065712|NCT04762810|Immunologic Factors|immunologic factors|mesh-ancestor
92065713|NCT04762810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065714|NCT04762810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065715|NCT04762810|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92065716|NCT04762810|Alkylating Agents|alkylating agents|mesh-ancestor
92065717|NCT04762810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065718|NCT04762810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065719|NCT04762810|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92065720|NCT04762810|Hormones|hormones|mesh-ancestor
92065721|NCT04762810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065722|NCT03674242|Carboplatin|carboplatin|mesh-list
92065723|NCT03674242|Gemcitabine|gemcitabine|mesh-list
92065724|NCT03674242|Asparaginase|asparaginase|mesh-list
92065725|NCT03674242|Eryaspase|eryaspase|mesh-list
92065726|NCT03674242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065727|NCT03674242|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065728|NCT03674242|Antimetabolites|antimetabolites|mesh-ancestor
92065729|NCT03674242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065730|NCT04761952|Infliximab|infliximab|mesh-list
92065731|NCT04761952|Azathioprine|azathioprine|mesh-list
92065732|NCT04761952|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92065733|NCT04761952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92065734|NCT04761952|Dermatologic Agents|dermatologic agents|mesh-ancestor
92065735|NCT04761952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065736|NCT04761952|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065737|NCT04761952|Antimetabolites|antimetabolites|mesh-ancestor
92065738|NCT04761952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065739|NCT04761952|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065740|NCT04761952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065741|NCT04761952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015496|NCT05165251|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015497|NCT05165251|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92015498|NCT05165251|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92015499|NCT05165251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92015500|NCT05165251|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92015501|NCT05165251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015502|NCT05165251|Vasodilator Agents|vasodilator agents|mesh-ancestor
92015503|NCT04209075|Metformin|metformin|mesh-list
92015504|NCT04209075|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92015505|NCT04209075|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015506|NCT05023473|Morphine|morphine|mesh-list
92015507|NCT05023473|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92015508|NCT05023473|Narcotics|narcotics|mesh-ancestor
92015509|NCT05023473|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015510|NCT05023473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065742|NCT04761952|Immunologic Factors|immunologic factors|mesh-ancestor
92065818|NCT03563248|Losartan|losartan|mesh-list
92065743|NCT04761952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065744|NCT03673072|Gemcitabine|gemcitabine|mesh-list
92065745|NCT03673072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065746|NCT03673072|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065747|NCT03673072|Antimetabolites|antimetabolites|mesh-ancestor
92065748|NCT03673072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065749|NCT01690299|Etanercept|etanercept|mesh-list
92065750|NCT01690299|Apremilast|apremilast|mesh-list
92065751|NCT01690299|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92065752|NCT01690299|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92065753|NCT01690299|Analgesics|analgesics|mesh-ancestor
92065754|NCT01690299|Sensory System Agents|sensory system agents|mesh-ancestor
92065755|NCT01690299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065756|NCT01690299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065760|NCT01690299|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065761|NCT01690299|Immunologic Factors|immunologic factors|mesh-ancestor
92065762|NCT01690299|Phosphodiesterase 4 Inhibitors|phosphodiesterase 4 inhibitors|mesh-ancestor
92065763|NCT01690299|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92065764|NCT01690299|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065765|NCT01690299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065766|NCT03570814|Azithromycin|azithromycin|mesh-list
92065767|NCT03570814|Ivermectin|ivermectin|mesh-list
92065768|NCT03570814|Albendazole|albendazole|mesh-list
92065769|NCT03570814|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92065770|NCT03570814|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92065771|NCT03570814|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92065772|NCT03570814|Anthelmintics|anthelmintics|mesh-ancestor
92065773|NCT03570814|Anticestodal Agents|anticestodal agents|mesh-ancestor
92065774|NCT03570814|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92065775|NCT03570814|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92065776|NCT03570814|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065777|NCT03570814|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065778|NCT03570814|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065779|NCT03570814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065780|NCT03570814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065781|NCT00723736|Desloratadine|desloratadine|mesh-list
92065782|NCT00723736|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92065783|NCT00723736|Cholinergic Agents|cholinergic agents|mesh-ancestor
92065784|NCT00723736|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065785|NCT00723736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065786|NCT00723736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065787|NCT00723736|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92065788|NCT00723736|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92015512|NCT05023473|Sensory System Agents|sensory system agents|mesh-ancestor
92015513|NCT05023473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015514|NCT03066661|Entrectinib|entrectinib|mesh-list
92015515|NCT03066661|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015516|NCT03066661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065789|NCT00723736|Histamine Antagonists|histamine antagonists|mesh-ancestor
92065790|NCT00723736|Histamine Agents|histamine agents|mesh-ancestor
92065791|NCT00305344|Vaccines|vaccines|mesh-list
92065792|NCT00305344|Immunologic Factors|immunologic factors|mesh-ancestor
92065793|NCT00305344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065794|NCT01690143|Melphalan|melphalan|mesh-list
92065795|NCT01690143|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92065796|NCT01690143|Alkylating Agents|alkylating agents|mesh-ancestor
92065797|NCT01690143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065798|NCT01690143|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065799|NCT01690143|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92065800|NCT01690143|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065801|NCT01690143|Immunologic Factors|immunologic factors|mesh-ancestor
92065802|NCT01690143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065803|NCT05347498|Febuxostat|febuxostat|mesh-list
92065804|NCT05347498|Gout Suppressants|gout suppressants|mesh-ancestor
92065805|NCT05347498|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065806|NCT03553186|Tranexamic Acid|tranexamic acid|mesh-list
92065807|NCT03553186|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92065808|NCT03553186|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92065809|NCT03553186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065810|NCT03553186|Hemostatics|hemostatics|mesh-ancestor
92065811|NCT03553186|Coagulants|coagulants|mesh-ancestor
92065812|NCT01677364|Oxytocin|oxytocin|mesh-list
92065813|NCT01677364|Oxytocics|oxytocics|mesh-ancestor
92065814|NCT01677364|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92065815|NCT01677364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065816|NCT03563248|Nivolumab|nivolumab|mesh-list
92065819|NCT03563248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065820|NCT03563248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065821|NCT03563248|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065822|NCT03563248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065823|NCT03563248|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92065824|NCT03563248|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92065825|NCT03563248|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92065826|NCT03563248|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92065827|NCT04403776|Tofacitinib|tofacitinib|mesh-list
92065828|NCT04403776|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92065829|NCT04403776|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92065831|NCT04403776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065833|NCT03662074|Nivolumab|nivolumab|mesh-list
92065834|NCT03662074|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065835|NCT03662074|Antimetabolites|antimetabolites|mesh-ancestor
92065836|NCT03662074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065837|NCT03662074|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065838|NCT03662074|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065839|NCT03662074|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065840|NCT03559348|Leucovorin|leucovorin|mesh-list
92065841|NCT03559348|Gemcitabine|gemcitabine|mesh-list
92065842|NCT03559348|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92065843|NCT03559348|Antimetabolites|antimetabolites|mesh-ancestor
92065844|NCT03559348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065845|NCT03559348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065846|NCT03559348|Antidotes|antidotes|mesh-ancestor
92065847|NCT03559348|Protective Agents|protective agents|mesh-ancestor
92065848|NCT03559348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065849|NCT03559348|Vitamin B Complex|vitamin b complex|mesh-ancestor
92065850|NCT03559348|Vitamins|vitamins|mesh-ancestor
92065851|NCT03559348|Micronutrients|micronutrients|mesh-ancestor
92065852|NCT04762030|Paclitaxel|paclitaxel|mesh-list
92015517|NCT03066661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015518|NCT05022147|Dopamine|dopamine|mesh-list
92015519|NCT05022147|Dopamine Agonists|dopamine agonists|mesh-list
92015520|NCT05022147|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92015521|NCT05022147|Sympathomimetics|sympathomimetics|mesh-ancestor
92015522|NCT05022147|Autonomic Agents|autonomic agents|mesh-ancestor
92015523|NCT05022147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015524|NCT05022147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015526|NCT05022147|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015527|NCT05022147|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015528|NCT05022147|Protective Agents|protective agents|mesh-ancestor
92015529|NCT03775629|Tramadol|tramadol|mesh-list
92015530|NCT03775629|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92015531|NCT03775629|Narcotics|narcotics|mesh-ancestor
92015532|NCT03775629|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015533|NCT03775629|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015534|NCT03775629|Analgesics|analgesics|mesh-ancestor
92015535|NCT03775629|Sensory System Agents|sensory system agents|mesh-ancestor
92015536|NCT03775629|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065853|NCT04762030|Carboplatin|carboplatin|mesh-list
92065854|NCT04762030|Durvalumab|durvalumab|mesh-list
92065855|NCT04762030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92065856|NCT04762030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065857|NCT04762030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065858|NCT04762030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065859|NCT04762030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065860|NCT04762030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065861|NCT04762030|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065862|NCT01559259|Acetaminophen|acetaminophen|mesh-list
92065863|NCT01559259|Ibuprofen|ibuprofen|mesh-list
92065864|NCT01559259|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92065865|NCT01559259|Analgesics|analgesics|mesh-ancestor
92065866|NCT01559259|Sensory System Agents|sensory system agents|mesh-ancestor
92065867|NCT01559259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065868|NCT01559259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065869|NCT01559259|Antipyretics|antipyretics|mesh-ancestor
92065870|NCT01559259|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92065871|NCT01559259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92065872|NCT01559259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065873|NCT01559259|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92065874|NCT01559259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065875|NCT01559259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065876|NCT03088306|Acetaminophen|acetaminophen|mesh-list
92065877|NCT03088306|Fentanyl|fentanyl|mesh-list
92065878|NCT03088306|Ketamine|ketamine|mesh-list
92065879|NCT03088306|Gabapentin|gabapentin|mesh-list
92065880|NCT03088306|Hydromorphone|hydromorphone|mesh-list
92065881|NCT03088306|Anesthetics|anesthetics|mesh-ancestor
92065882|NCT03088306|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065883|NCT03088306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065884|NCT03088306|Analgesics|analgesics|mesh-ancestor
92065885|NCT03088306|Sensory System Agents|sensory system agents|mesh-ancestor
92065886|NCT03088306|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065887|NCT03088306|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92065888|NCT03088306|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92015538|NCT01671319|Docetaxel|docetaxel|mesh-list
92065889|NCT03088306|Anesthetics, General|anesthetics, general|mesh-ancestor
92065890|NCT03088306|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92065891|NCT03088306|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92065892|NCT03088306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065893|NCT03088306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065894|NCT03088306|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92065895|NCT03088306|Narcotics|narcotics|mesh-ancestor
92065896|NCT03088306|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92065897|NCT03088306|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92065898|NCT03088306|Antipyretics|antipyretics|mesh-ancestor
92065899|NCT03088306|Anticonvulsants|anticonvulsants|mesh-ancestor
92065900|NCT03088306|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92065901|NCT03088306|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92065902|NCT03088306|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92065903|NCT03088306|Antimanic Agents|antimanic agents|mesh-ancestor
92065904|NCT01672762|Ipragliflozin|ipragliflozin|mesh-list
92065905|NCT01672762|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92065915|NCT03088384|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92065916|NCT03088384|Anesthetics, General|anesthetics, general|mesh-ancestor
92065917|NCT03088384|Anesthetics|anesthetics|mesh-ancestor
92065918|NCT03088384|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92065919|NCT03088384|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92065920|NCT03088384|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92065921|NCT03088384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065922|NCT03088384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065923|NCT01677598|Ustekinumab|ustekinumab|mesh-list
92065924|NCT01677598|Dermatologic Agents|dermatologic agents|mesh-ancestor
92065925|NCT01677754|Memantine|memantine|mesh-list
92065926|NCT01677754|Rivastigmine|rivastigmine|mesh-list
92065927|NCT01677754|Donepezil|donepezil|mesh-list
92065928|NCT01677754|Galantamine|galantamine|mesh-list
92065929|NCT01677754|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92065930|NCT01677754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065931|NCT01677754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065932|NCT01677754|Cholinergic Agents|cholinergic agents|mesh-ancestor
92065933|NCT01677754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065934|NCT01677754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065935|NCT01677754|Nootropic Agents|nootropic agents|mesh-ancestor
92065936|NCT01677754|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92065937|NCT01677754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92065938|NCT01677754|Dopamine Agents|dopamine agents|mesh-ancestor
92065939|NCT01677754|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92065940|NCT01677754|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92065941|NCT01677754|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92065942|NCT01677754|Autonomic Agents|autonomic agents|mesh-ancestor
92065943|NCT01677754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065944|NCT01677754|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92065945|NCT01677754|Protective Agents|protective agents|mesh-ancestor
92065946|NCT01670500|Cyclophosphamide|cyclophosphamide|mesh-list
92065947|NCT01670500|Cisplatin|cisplatin|mesh-list
92065948|NCT01670500|Doxorubicin|doxorubicin|mesh-list
92065949|NCT01670500|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065950|NCT01670500|Immunologic Factors|immunologic factors|mesh-ancestor
92065951|NCT01670500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065952|NCT01670500|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065953|NCT01670500|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92065954|NCT01670500|Alkylating Agents|alkylating agents|mesh-ancestor
92065955|NCT01670500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065956|NCT01670500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065957|NCT01670500|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92065958|NCT01670500|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92065959|NCT01670500|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92065960|NCT01670500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92065961|NCT01670500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065963|NCT01678612|Trace Elements|trace elements|mesh-ancestor
92065964|NCT01678612|Micronutrients|micronutrients|mesh-ancestor
92065965|NCT01678612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065966|NCT03525574|Ivacaftor|ivacaftor|mesh-list
92065967|NCT03525574|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92065968|NCT03525574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92065969|NCT03525574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065970|NCT02402920|Cisplatin|cisplatin|mesh-list
92015539|NCT01671319|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015540|NCT01671319|Immunologic Factors|immunologic factors|mesh-ancestor
92015541|NCT01671319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065971|NCT02402920|Carboplatin|carboplatin|mesh-list
92065976|NCT02402920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92065977|NCT02402920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92065978|NCT02402920|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92065979|NCT02402920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065980|NCT02402920|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92065981|NCT02402920|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92065982|NCT02402920|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92065983|NCT02402920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065984|NCT02402920|Keratolytic Agents|keratolytic agents|mesh-ancestor
92065985|NCT02402920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92065986|NCT02402920|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065987|NCT02402920|Antimitotic Agents|antimitotic agents|mesh-ancestor
92065988|NCT02402920|Mitosis Modulators|mitosis modulators|mesh-ancestor
92065989|NCT02405260|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92065990|NCT02405260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92065991|NCT02405260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065992|NCT02405260|Incretins|incretins|mesh-ancestor
92065994|NCT02405260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065995|NCT02405260|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92065996|NCT02405260|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065997|NCT02405260|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065998|NCT02405260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065999|NCT03519646|Eliglustat|eliglustat|mesh-list
92066000|NCT03519646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066001|NCT03519646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066002|NCT02984722|Metformin|metformin|mesh-list
92066003|NCT02984722|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92066004|NCT02984722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066005|NCT02401750|Naltrexone|naltrexone|mesh-list
92066006|NCT02401750|Oxycodone|oxycodone|mesh-list
92066007|NCT02401750|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92066008|NCT02401750|Narcotics|narcotics|mesh-ancestor
92066009|NCT02401750|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066010|NCT02401750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066011|NCT02401750|Analgesics|analgesics|mesh-ancestor
92066012|NCT02401750|Sensory System Agents|sensory system agents|mesh-ancestor
92066013|NCT02401750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066014|NCT02401750|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92066015|NCT02401750|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92066016|NCT03087136|polysaccharide-K|polysaccharide-k|mesh-list
92066017|NCT03087136|Antibodies|antibodies|mesh-list
92066018|NCT03087136|Immunologic Factors|immunologic factors|mesh-ancestor
92066019|NCT03087136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066020|NCT03087136|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92066021|NCT03087136|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92066022|NCT03087136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066023|NCT03087136|Antiviral Agents|antiviral agents|mesh-ancestor
92066024|NCT03087136|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066025|NCT03087136|Interferon Inducers|interferon inducers|mesh-ancestor
92066026|NCT03087136|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92066027|NCT03087136|Protective Agents|protective agents|mesh-ancestor
92066028|NCT01689519|Vemurafenib|vemurafenib|mesh-list
92066029|NCT01689519|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066030|NCT01689519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066031|NCT01689519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066032|NCT01689519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066033|NCT01689363|Histamine|histamine|mesh-list
92066034|NCT01689363|Histamine Agonists|histamine agonists|mesh-ancestor
92066035|NCT01689363|Histamine Agents|histamine agents|mesh-ancestor
92066036|NCT01689363|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066037|NCT01689363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066038|NCT01689363|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066039|NCT03455140|BCT-100|bct-100|mesh-list
92066040|NCT03455140|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066041|NCT03502018|Bupivacaine|bupivacaine|mesh-list
92066042|NCT03502018|Anesthetics, Local|anesthetics, local|mesh-ancestor
92066043|NCT03502018|Anesthetics|anesthetics|mesh-ancestor
92066044|NCT03502018|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015542|NCT01671319|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015543|NCT01671319|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92015544|NCT01671319|Alkylating Agents|alkylating agents|mesh-ancestor
92015545|NCT01671319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015546|NCT01671319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015547|NCT01671319|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92066046|NCT03502018|Sensory System Agents|sensory system agents|mesh-ancestor
92066047|NCT03502018|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066049|NCT01689207|Avibactam|avibactam|mesh-list
92066050|NCT01689207|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92066051|NCT01689207|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066052|NCT01689207|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92066053|NCT01689207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066054|NCT01689207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066055|NCT00089284|Rituximab|rituximab|mesh-list
92066056|NCT00089284|Motexafin gadolinium|motexafin gadolinium|mesh-list
92066057|NCT00089284|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066058|NCT00089284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066059|NCT00089284|Immunologic Factors|immunologic factors|mesh-ancestor
92066060|NCT00089284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066061|NCT00089284|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066062|NCT00089284|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92066063|NCT00089284|Dermatologic Agents|dermatologic agents|mesh-ancestor
92066064|NCT01688973|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92066065|NCT01688973|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066066|NCT01688973|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066067|NCT01688973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066068|NCT01688973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066070|NCT00087646|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92066072|NCT00087646|Antimetabolites|antimetabolites|mesh-ancestor
92066073|NCT00087646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066074|NCT00087646|Antiviral Agents|antiviral agents|mesh-ancestor
92066075|NCT00087646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066076|NCT00087646|Immunologic Factors|immunologic factors|mesh-ancestor
92066077|NCT00087646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066078|NCT03492658|Methotrexate|methotrexate|mesh-list
92066079|NCT03492658|Abatacept|abatacept|mesh-list
92066080|NCT03492658|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92066081|NCT03492658|Abortifacient Agents|abortifacient agents|mesh-ancestor
92066082|NCT03492658|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066083|NCT03492658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066084|NCT03492658|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066085|NCT03492658|Antimetabolites|antimetabolites|mesh-ancestor
92066086|NCT03492658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066087|NCT03492658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066088|NCT03492658|Dermatologic Agents|dermatologic agents|mesh-ancestor
92066089|NCT03492658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066090|NCT03492658|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92066091|NCT03492658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066092|NCT03492658|Immunologic Factors|immunologic factors|mesh-ancestor
92066093|NCT03492658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066094|NCT03492658|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92066095|NCT03492658|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92066096|NCT03492658|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066097|NCT03085654|Oxytocin|oxytocin|mesh-list
92066098|NCT03085654|Oxytocics|oxytocics|mesh-ancestor
92066099|NCT03085654|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066100|NCT03085654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066101|NCT00087568|Ribavirin|ribavirin|mesh-list
92066102|NCT00087568|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92066103|NCT00087568|Antimetabolites|antimetabolites|mesh-ancestor
92066104|NCT00087568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066105|NCT00087568|Antiviral Agents|antiviral agents|mesh-ancestor
92066106|NCT00087568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066107|NCT04402762|Enoxaparin|enoxaparin|mesh-list
92066108|NCT04402762|Enoxaparin sodium|enoxaparin sodium|mesh-list
92066109|NCT04402762|Anticoagulants|anticoagulants|mesh-ancestor
92015548|NCT01671319|Tubulin Modulators|tubulin modulators|mesh-ancestor
92015549|NCT01671319|Antimitotic Agents|antimitotic agents|mesh-ancestor
92015550|NCT01671319|Mitosis Modulators|mitosis modulators|mesh-ancestor
92066110|NCT04402762|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92066111|NCT04402762|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92066112|NCT04402762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066113|NCT00085540|Romidepsin|romidepsin|mesh-list
92066114|NCT00085540|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92066115|NCT00085540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066116|NCT00085540|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92066117|NCT00085540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066118|NCT00085540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066121|NCT01688739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066122|NCT01688739|Analgesics|analgesics|mesh-ancestor
92066123|NCT01688739|Sensory System Agents|sensory system agents|mesh-ancestor
92066124|NCT01688739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066125|NCT01688739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066126|NCT00084838|Calcium, Dietary|calcium, dietary|mesh-list
92066127|NCT00084838|Leucovorin|leucovorin|mesh-list
92066128|NCT00084838|Cytarabine|cytarabine|mesh-list
92066129|NCT00084838|Dactinomycin|dactinomycin|mesh-list
92066130|NCT00084838|Hydrocortisone|hydrocortisone|mesh-list
92066131|NCT00084838|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92066132|NCT00084838|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92066133|NCT00084838|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92066134|NCT00084838|Cyclophosphamide|cyclophosphamide|mesh-list
92066135|NCT00084838|Temozolomide|temozolomide|mesh-list
92066137|NCT00084838|Doxorubicin|doxorubicin|mesh-list
92066138|NCT00084838|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92066139|NCT00084838|Methotrexate|methotrexate|mesh-list
92066140|NCT00084838|Etoposide|etoposide|mesh-list
92066141|NCT00084838|Vincristine|vincristine|mesh-list
92066142|NCT00084838|Dexrazoxane|dexrazoxane|mesh-list
92066143|NCT00084838|Razoxane|razoxane|mesh-list
92066144|NCT00084838|Lenograstim|lenograstim|mesh-list
92066145|NCT00084838|Calcium|calcium|mesh-list
92066146|NCT00084838|Levoleucovorin|levoleucovorin|mesh-list
92066147|NCT00084838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066148|NCT00084838|Immunologic Factors|immunologic factors|mesh-ancestor
92066149|NCT00084838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066150|NCT00084838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066151|NCT00084838|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92066152|NCT00084838|Alkylating Agents|alkylating agents|mesh-ancestor
92066153|NCT00084838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066154|NCT00084838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066155|NCT00084838|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92066156|NCT00084838|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92066157|NCT00084838|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92066158|NCT00084838|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92066159|NCT00084838|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066160|NCT00084838|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92066161|NCT00084838|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92066162|NCT00084838|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92066163|NCT00084838|Abortifacient Agents|abortifacient agents|mesh-ancestor
92066164|NCT00084838|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066165|NCT00084838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066166|NCT00084838|Antimetabolites|antimetabolites|mesh-ancestor
92066167|NCT00084838|Dermatologic Agents|dermatologic agents|mesh-ancestor
92066168|NCT00084838|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92066169|NCT00084838|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92066170|NCT00084838|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92066171|NCT00084838|Antiviral Agents|antiviral agents|mesh-ancestor
92066172|NCT00084838|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066173|NCT00084838|Antidotes|antidotes|mesh-ancestor
92066174|NCT00084838|Protective Agents|protective agents|mesh-ancestor
92066175|NCT00084838|Vitamin B Complex|vitamin b complex|mesh-ancestor
92066176|NCT00084838|Vitamins|vitamins|mesh-ancestor
92066177|NCT00084838|Micronutrients|micronutrients|mesh-ancestor
92066178|NCT00084838|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92066179|NCT00084838|Tubulin Modulators|tubulin modulators|mesh-ancestor
92066180|NCT00084838|Antimitotic Agents|antimitotic agents|mesh-ancestor
92066181|NCT00084838|Mitosis Modulators|mitosis modulators|mesh-ancestor
92066182|NCT00084838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066183|NCT00084838|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92015553|NCT05019885|Sensory System Agents|sensory system agents|mesh-ancestor
92015554|NCT05019885|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015555|NCT05019885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015556|NCT05019885|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92015557|NCT05019885|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92066184|NCT00084838|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92066185|NCT00084838|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92066186|NCT01558089|Etanercept|etanercept|mesh-list
92066187|NCT01558089|Methotrexate|methotrexate|mesh-list
92066188|NCT01558089|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92066189|NCT01558089|Abortifacient Agents|abortifacient agents|mesh-ancestor
92066190|NCT01558089|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066191|NCT01558089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066192|NCT01558089|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066193|NCT01558089|Antimetabolites|antimetabolites|mesh-ancestor
92090430|NCT04416035|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066197|NCT01558089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066198|NCT01558089|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92066199|NCT01558089|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066200|NCT01558089|Immunologic Factors|immunologic factors|mesh-ancestor
92066201|NCT01558089|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066202|NCT01558089|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92066203|NCT01558089|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92066204|NCT01558089|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92066206|NCT01558089|Sensory System Agents|sensory system agents|mesh-ancestor
92066207|NCT01558089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066208|NCT01558089|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066209|NCT01558089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92066210|NCT00084682|Romidepsin|romidepsin|mesh-list
92066211|NCT00084682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92066212|NCT00084682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066213|NCT00084682|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92066214|NCT00084682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066215|NCT00084682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066216|NCT01556997|Amlodipine|amlodipine|mesh-list
92066217|NCT01556997|Perindopril|perindopril|mesh-list
92066218|NCT01556997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92066219|NCT01556997|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92066220|NCT01556997|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92066221|NCT01556997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066222|NCT01556997|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92066223|NCT01556997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066224|NCT01556997|Vasodilator Agents|vasodilator agents|mesh-ancestor
92066225|NCT01556997|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92066226|NCT01556997|Protease Inhibitors|protease inhibitors|mesh-ancestor
92066227|NCT01556997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066228|NCT00082888|Tipifarnib|tipifarnib|mesh-list
92066229|NCT00082888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066230|NCT03409588|Riociguat|riociguat|mesh-list
92066231|NCT03409588|Enzyme Activators|enzyme activators|mesh-ancestor
92066232|NCT03409588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066233|NCT03085186|Crizotinib|crizotinib|mesh-list
92066234|NCT03085186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066235|NCT03085186|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066236|NCT03085186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066237|NCT03085186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066238|NCT03084952|Meglumine Antimoniate|meglumine antimoniate|mesh-list
92066239|NCT03084952|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92066240|NCT03084952|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92066241|NCT03084952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066242|NCT00082810|Fulvestrant|fulvestrant|mesh-list
92066243|NCT00082810|Tipifarnib|tipifarnib|mesh-list
92066244|NCT00082810|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92066245|NCT00082810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015558|NCT05019885|Anesthetics, General|anesthetics, general|mesh-ancestor
92015559|NCT05019885|Anesthetics|anesthetics|mesh-ancestor
92015560|NCT05019885|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066246|NCT00082810|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92066247|NCT00082810|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92066248|NCT00082810|Hormone Antagonists|hormone antagonists|mesh-ancestor
92066249|NCT00082810|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066250|NCT00082810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066251|NCT03480334|Nivolumab|nivolumab|mesh-list
92066252|NCT03480334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066253|NCT03480334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066254|NCT03480334|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92066255|NCT03480334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066256|NCT03085030|Antioxidants|antioxidants|mesh-list
92066416|NCT03466294|Antimetabolites|antimetabolites|mesh-ancestor
92066257|NCT03085030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066258|NCT03085030|Protective Agents|protective agents|mesh-ancestor
92066259|NCT03085030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066260|NCT03443128|Vinorelbine|vinorelbine|mesh-list
92066261|NCT03443128|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92066262|NCT03443128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066266|NCT03443128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066267|NCT03437746|Methylprednisolone|methylprednisolone|mesh-list
92066268|NCT03437746|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92066269|NCT03437746|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92066270|NCT03437746|Prednisolone|prednisolone|mesh-list
92066271|NCT03437746|Prednisolone acetate|prednisolone acetate|mesh-list
92066272|NCT03437746|Anesthetics|anesthetics|mesh-list
92066273|NCT03437746|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92066274|NCT03437746|Prednisolone phosphate|prednisolone phosphate|mesh-list
92066275|NCT03437746|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066276|NCT03437746|Antiemetics|antiemetics|mesh-ancestor
92066277|NCT03437746|Autonomic Agents|autonomic agents|mesh-ancestor
92066278|NCT03437746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066279|NCT03437746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066280|NCT03437746|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92066281|NCT03437746|Glucocorticoids|glucocorticoids|mesh-ancestor
92066282|NCT03437746|Hormones|hormones|mesh-ancestor
92066283|NCT03437746|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066284|NCT03437746|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92066285|NCT03437746|Protective Agents|protective agents|mesh-ancestor
92066286|NCT03437746|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92066287|NCT03437746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066288|NCT03437746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066289|NCT03084250|Tenofovir|tenofovir|mesh-list
92066290|NCT03084250|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92066291|NCT03084250|Entecavir|entecavir|mesh-list
92066292|NCT03084250|Adefovir|adefovir|mesh-list
92066293|NCT03084250|Antiviral Agents|antiviral agents|mesh-ancestor
92066294|NCT03084250|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066295|NCT03084250|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92066296|NCT03084250|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92066297|NCT03084250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066298|NCT03084250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066299|NCT03084250|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92066300|NCT03084250|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92066301|NCT01688037|Tetrabenazine|tetrabenazine|mesh-list
92066302|NCT01688037|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92066303|NCT01688037|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92066304|NCT01688037|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92066305|NCT01688037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066306|NCT01688037|Adrenergic Agents|adrenergic agents|mesh-ancestor
92066307|NCT01688037|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066308|NCT01688037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066309|NCT03084328|Vitamin D|vitamin d|mesh-list
92066310|NCT03084328|Vitamins|vitamins|mesh-ancestor
92066311|NCT03084328|Micronutrients|micronutrients|mesh-ancestor
92066312|NCT03084328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066313|NCT03084328|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92066314|NCT03435718|Albendazole|albendazole|mesh-list
92066315|NCT03435718|Oxfendazole|oxfendazole|mesh-list
92066316|NCT03435718|Anthelmintics|anthelmintics|mesh-ancestor
92066317|NCT03435718|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92066318|NCT03435718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066319|NCT03435718|Anticestodal Agents|anticestodal agents|mesh-ancestor
92066320|NCT03435718|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92066321|NCT03435718|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92066322|NCT03435718|Tubulin Modulators|tubulin modulators|mesh-ancestor
92066323|NCT03435718|Antimitotic Agents|antimitotic agents|mesh-ancestor
92066324|NCT03435718|Mitosis Modulators|mitosis modulators|mesh-ancestor
92066325|NCT03435718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066326|NCT03435718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066327|NCT03435718|Antinematodal Agents|antinematodal agents|mesh-ancestor
92066328|NCT01678690|Gemcitabine|gemcitabine|mesh-list
92066329|NCT01678690|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066330|NCT01678690|Antimetabolites|antimetabolites|mesh-ancestor
92066331|NCT01678690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066332|NCT01678690|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066333|NCT01679080|Zoledronic Acid|zoledronic acid|mesh-list
92066334|NCT01679080|Teriparatide|teriparatide|mesh-list
92066335|NCT01679080|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92066337|NCT01679080|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92066339|NCT03083782|Apixaban|apixaban|mesh-list
92066340|NCT03083782|Tacrolimus|tacrolimus|mesh-list
92066341|NCT03083782|Cyclosporins|cyclosporins|mesh-list
92066342|NCT03083782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066343|NCT03083782|Immunologic Factors|immunologic factors|mesh-ancestor
92066344|NCT03083782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066345|NCT03083782|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92066346|NCT03083782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066347|NCT03083782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066348|NCT03083782|Antifungal Agents|antifungal agents|mesh-ancestor
92066349|NCT03083782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066350|NCT03083782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92066351|NCT03083782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066352|NCT03083782|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92066353|NCT03083782|Antithrombins|antithrombins|mesh-ancestor
92066354|NCT03083782|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92066355|NCT03083782|Protease Inhibitors|protease inhibitors|mesh-ancestor
92066356|NCT03083782|Anticoagulants|anticoagulants|mesh-ancestor
92066358|NCT03083704|Rivaroxaban|rivaroxaban|mesh-list
92066359|NCT03083704|Apixaban|apixaban|mesh-list
92066360|NCT03083704|Edoxaban|edoxaban|mesh-list
92066361|NCT03083704|Enoxaparin sodium|enoxaparin sodium|mesh-list
92066362|NCT03083704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92066364|NCT03083704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92066365|NCT03083704|Protease Inhibitors|protease inhibitors|mesh-ancestor
92066366|NCT03083704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066367|NCT03083704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066368|NCT03083704|Anticoagulants|anticoagulants|mesh-ancestor
92066369|NCT03083704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92066370|NCT03083704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92066371|NCT03471442|Bupivacaine|bupivacaine|mesh-list
92066372|NCT03471442|Ropivacaine|ropivacaine|mesh-list
92066373|NCT03471442|Anesthetics, Local|anesthetics, local|mesh-list
92066374|NCT03471442|Anesthetics|anesthetics|mesh-list
92066375|NCT03471442|Anesthetics, General|anesthetics, general|mesh-list
92066376|NCT03471442|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066377|NCT03471442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066378|NCT03471442|Sensory System Agents|sensory system agents|mesh-ancestor
92066379|NCT03471442|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066380|NCT01679392|Ropivacaine|ropivacaine|mesh-list
92066381|NCT01679392|Anesthetics, Local|anesthetics, local|mesh-ancestor
92066382|NCT01679392|Anesthetics|anesthetics|mesh-ancestor
92066383|NCT01679392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066384|NCT01679392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066385|NCT01679392|Sensory System Agents|sensory system agents|mesh-ancestor
92066386|NCT01679392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066387|NCT03083080|Epinephrine|epinephrine|mesh-list
92066388|NCT03083080|Ropivacaine|ropivacaine|mesh-list
92066389|NCT03083080|Anesthetics, Local|anesthetics, local|mesh-ancestor
92066390|NCT03083080|Anesthetics|anesthetics|mesh-ancestor
92066391|NCT03083080|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066392|NCT03083080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066393|NCT03083080|Sensory System Agents|sensory system agents|mesh-ancestor
92066394|NCT03083080|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066395|NCT03083080|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92066396|NCT03083080|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92015562|NCT05019885|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92015563|NCT05019885|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066397|NCT03083080|Adrenergic Agents|adrenergic agents|mesh-ancestor
92066398|NCT03083080|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066399|NCT03083080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066400|NCT03083080|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92066401|NCT03083080|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92066402|NCT03083080|Autonomic Agents|autonomic agents|mesh-ancestor
92066403|NCT03083080|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92066404|NCT03083080|Respiratory System Agents|respiratory system agents|mesh-ancestor
92066405|NCT03083080|Mydriatics|mydriatics|mesh-ancestor
92066406|NCT03083080|Sympathomimetics|sympathomimetics|mesh-ancestor
92066407|NCT03083080|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92066408|NCT03087760|Pembrolizumab|pembrolizumab|mesh-list
92066409|NCT03087760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066410|NCT03087760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066411|NCT03087760|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92066414|NCT03466294|Venetoclax|venetoclax|mesh-list
92066415|NCT03466294|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066417|NCT03466294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066418|NCT03466294|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066419|NCT03466294|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066420|NCT03082300|Naquotinib|naquotinib|mesh-list
92066421|NCT03082300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066422|NCT03082300|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066423|NCT03082300|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066424|NCT03082300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066425|NCT01679860|Alemtuzumab|alemtuzumab|mesh-list
92066426|NCT01679860|Immunomodulating Agents|immunomodulating agents|mesh-list
92066427|NCT01679860|Immunologic Factors|immunologic factors|mesh-list
92066428|NCT01679860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066429|NCT01679860|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066430|NCT01679860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066431|NCT05346952|Carboplatin|carboplatin|mesh-list
92066432|NCT05346952|Pemetrexed|pemetrexed|mesh-list
92066433|NCT05346952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066434|NCT05346952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066435|NCT05346952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066436|NCT05346952|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92066437|NCT05346952|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92066439|NCT03081442|Contraceptive Agents|contraceptive agents|mesh-list
92066440|NCT03081442|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92066441|NCT03081442|Abortifacient Agents|abortifacient agents|mesh-ancestor
92066442|NCT03081442|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066443|NCT03081442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066444|NCT03081442|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92066445|NCT03081442|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92066446|NCT03081442|Oxytocics|oxytocics|mesh-ancestor
92066447|NCT03431194|Midodrine|midodrine|mesh-list
92066448|NCT03431194|Sympathomimetics|sympathomimetics|mesh-ancestor
92066449|NCT03431194|Autonomic Agents|autonomic agents|mesh-ancestor
92066450|NCT03431194|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066451|NCT03431194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066452|NCT03431194|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92066453|NCT03431194|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92066454|NCT03431194|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92066455|NCT03431194|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92066456|NCT03431194|Adrenergic Agents|adrenergic agents|mesh-ancestor
92066457|NCT03431194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066458|NCT03431194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066459|NCT03080740|Metronidazole|metronidazole|mesh-list
92066460|NCT03080740|Clindamycin|clindamycin|mesh-list
92066461|NCT03080740|Clindamycin palmitate|clindamycin palmitate|mesh-list
92066462|NCT03080740|Clindamycin phosphate|clindamycin phosphate|mesh-list
92066463|NCT03080740|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066464|NCT03080740|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92066465|NCT03080740|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92015564|NCT05019885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015565|NCT05016609|Sofosbuvir|sofosbuvir|mesh-list
92015566|NCT05016609|Velpatasvir|velpatasvir|mesh-list
92066466|NCT03080740|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92066467|NCT03080740|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92066468|NCT03080740|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066469|NCT03080740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066470|NCT03081832|Oxytocin|oxytocin|mesh-list
92066471|NCT03081832|Oxytocics|oxytocics|mesh-ancestor
92066472|NCT03081832|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066473|NCT03081832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066474|NCT05345938|Mitoxantrone|mitoxantrone|mesh-list
92066475|NCT05345938|Analgesics|analgesics|mesh-ancestor
92066476|NCT05345938|Sensory System Agents|sensory system agents|mesh-ancestor
92066477|NCT05345938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066478|NCT05345938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066479|NCT05345938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066480|NCT05345938|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92066481|NCT05345938|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92066482|NCT05345938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066483|NCT05345938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066487|NCT03080350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066488|NCT03080350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066490|NCT03080350|Sensory System Agents|sensory system agents|mesh-ancestor
92066491|NCT03080350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066492|NCT03080350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92066493|NCT03080350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92066494|NCT03080350|Anesthetics, General|anesthetics, general|mesh-ancestor
92066495|NCT03080350|Anesthetics|anesthetics|mesh-ancestor
92066496|NCT03080194|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92066497|NCT03080194|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92066498|NCT03080194|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92066499|NCT03080194|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066500|NCT03080194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066501|NCT03080194|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92066502|NCT03080194|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92066503|NCT03080194|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92066504|NCT03080194|Serotonin Agents|serotonin agents|mesh-ancestor
92066505|NCT03080194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066506|NCT03080194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066507|NCT03080194|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92066508|NCT03080194|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92066509|NCT03080194|Dopamine Agents|dopamine agents|mesh-ancestor
92066510|NCT01610336|Gefitinib|gefitinib|mesh-list
92066511|NCT01610336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066512|NCT01610336|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066513|NCT01610336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066514|NCT01610336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066515|NCT03323866|Mometasone Furoate|mometasone furoate|mesh-list
92066516|NCT03323866|Budesonide|budesonide|mesh-list
92066517|NCT03323866|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066518|NCT03323866|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92066519|NCT03323866|Autonomic Agents|autonomic agents|mesh-ancestor
92066520|NCT03323866|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066521|NCT03323866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066522|NCT03323866|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92066523|NCT03323866|Respiratory System Agents|respiratory system agents|mesh-ancestor
92066524|NCT03323866|Glucocorticoids|glucocorticoids|mesh-ancestor
92066525|NCT03323866|Hormones|hormones|mesh-ancestor
92066526|NCT03323866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066527|NCT03323866|Dermatologic Agents|dermatologic agents|mesh-ancestor
92066528|NCT03323866|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92066529|NCT05688670|Ropivacaine|ropivacaine|mesh-list
92066530|NCT05688670|Anesthetics|anesthetics|mesh-ancestor
92066531|NCT05688670|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066532|NCT05688670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066533|NCT05688670|Anesthetics, Local|anesthetics, local|mesh-ancestor
92066534|NCT05688670|Sensory System Agents|sensory system agents|mesh-ancestor
92015567|NCT05016609|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92066535|NCT05688670|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066537|NCT05684848|Antioxidants|antioxidants|mesh-ancestor
92066538|NCT05684848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066539|NCT05684848|Protective Agents|protective agents|mesh-ancestor
92066540|NCT05684848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066541|NCT05684848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066542|NCT05684848|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92066543|NCT03366298|Epinephrine|epinephrine|mesh-list
92066544|NCT03366298|Racepinephrine|racepinephrine|mesh-list
92066545|NCT03366298|Epinephryl borate|epinephryl borate|mesh-list
92066546|NCT03366298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92066547|NCT03366298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92066548|NCT03366298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92066549|NCT03366298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066550|NCT03366298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066551|NCT03366298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066552|NCT03366298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92066553|NCT03366298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92066554|NCT03366298|Autonomic Agents|autonomic agents|mesh-ancestor
92066555|NCT03366298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066556|NCT03366298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92066557|NCT03366298|Respiratory System Agents|respiratory system agents|mesh-ancestor
92066562|NCT05688436|Interferon-beta|interferon-beta|mesh-list
92066563|NCT05688436|Alemtuzumab|alemtuzumab|mesh-list
92066564|NCT05688436|Glatiramer Acetate|glatiramer acetate|mesh-list
92066565|NCT05688436|Ocrelizumab|ocrelizumab|mesh-list
92066566|NCT05688436|Natalizumab|natalizumab|mesh-list
92066567|NCT05688436|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92066568|NCT05688436|(T,G)-A-L|(t,g)-a-l|mesh-list
92066569|NCT05688436|Siponimod|siponimod|mesh-list
92066570|NCT05688436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066571|NCT05688436|Antiviral Agents|antiviral agents|mesh-ancestor
92066572|NCT05688436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066573|NCT05688436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066574|NCT05688436|Immunologic Factors|immunologic factors|mesh-ancestor
92066575|NCT05688436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066576|NCT05688436|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92066577|NCT05688436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066578|NCT05688436|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066579|NCT05688436|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92066580|NCT05688436|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066581|NCT03386578|Tenofovir|tenofovir|mesh-list
92066582|NCT03386578|Emtricitabine|emtricitabine|mesh-list
92066583|NCT03386578|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92066584|NCT03386578|Antiviral Agents|antiviral agents|mesh-ancestor
92066585|NCT03386578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066586|NCT03386578|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92066587|NCT03386578|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92066588|NCT03386578|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066589|NCT03386578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066590|NCT03386578|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92066591|NCT03386578|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92066592|NCT05688202|Acetaminophen|acetaminophen|mesh-list
92066594|NCT05688202|Prilocaine|prilocaine|mesh-list
92066595|NCT05688202|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92066596|NCT05688202|Anesthetics, Local|anesthetics, local|mesh-ancestor
92066597|NCT05688202|Anesthetics|anesthetics|mesh-ancestor
92066598|NCT05688202|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066599|NCT05688202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066600|NCT05688202|Sensory System Agents|sensory system agents|mesh-ancestor
92066601|NCT05688202|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066602|NCT05688202|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92066603|NCT05688202|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92066604|NCT05688202|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92066605|NCT05688202|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92066606|NCT05688202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066607|NCT05688202|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92066608|NCT05688202|Analgesics|analgesics|mesh-ancestor
92066609|NCT05688202|Antipyretics|antipyretics|mesh-ancestor
92066610|NCT05688202|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92066611|NCT05688124|Esomeprazole|esomeprazole|mesh-list
92015569|NCT05016609|Hepatitis C Antibodies|hepatitis c antibodies|mesh-list
92066612|NCT05688124|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92066613|NCT05688124|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92066614|NCT05688124|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92066615|NCT05688124|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066616|NCT05688124|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066617|NCT01842620|Metformin|metformin|mesh-list
92066618|NCT01842620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92066619|NCT01842620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066620|NCT05687344|Nifedipine|nifedipine|mesh-list
92066621|NCT05687344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92066622|NCT05687344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92066623|NCT05687344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066624|NCT05687344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92066625|NCT05687344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066626|NCT05687344|Vasodilator Agents|vasodilator agents|mesh-ancestor
92066627|NCT05687344|Tocolytic Agents|tocolytic agents|mesh-ancestor
92066628|NCT05687344|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92066629|NCT04760704|Antibodies|antibodies|mesh-list
92066630|NCT04760704|Immunologic Factors|immunologic factors|mesh-ancestor
92066640|NCT01842308|Alkylating Agents|alkylating agents|mesh-ancestor
92066641|NCT01842308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066642|NCT01842308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066643|NCT01842308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92066644|NCT01842308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066645|NCT01842308|Immunologic Factors|immunologic factors|mesh-ancestor
92066646|NCT01842308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066647|NCT01931059|Risperidone|risperidone|mesh-list
92066648|NCT01931059|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92066649|NCT01931059|Serotonin Agents|serotonin agents|mesh-ancestor
92066650|NCT01931059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066651|NCT01931059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066652|NCT01931059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066653|NCT01931059|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92066654|NCT01931059|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92066655|NCT01931059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066656|NCT01931059|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92066657|NCT01931059|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92066658|NCT01931059|Dopamine Agents|dopamine agents|mesh-ancestor
92066659|NCT01841762|Macitentan|macitentan|mesh-list
92066660|NCT01841762|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92066661|NCT01841762|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92066662|NCT01841762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066663|NCT01841762|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92066664|NCT03301636|Pembrolizumab|pembrolizumab|mesh-list
92066666|NCT03301636|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066667|NCT03301636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066668|NCT03301636|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92066669|NCT03301636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066670|NCT04602494|Varenicline|varenicline|mesh-list
92066671|NCT04602494|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92066672|NCT04602494|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92066673|NCT04602494|Cholinergic Agents|cholinergic agents|mesh-ancestor
92066674|NCT04602494|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066675|NCT04602494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066676|NCT04602494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066677|NCT05640232|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92066678|NCT05640232|Parasympatholytics|parasympatholytics|mesh-ancestor
92066679|NCT05640232|Autonomic Agents|autonomic agents|mesh-ancestor
92066680|NCT05640232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066681|NCT05640232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066682|NCT05640232|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92066683|NCT05640232|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92066684|NCT05640232|Cholinergic Agents|cholinergic agents|mesh-ancestor
92066685|NCT05640232|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066686|NCT05640232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066687|NCT01970371|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92066688|NCT01970371|Meropenem|meropenem|mesh-list
92066689|NCT01970371|Colistin|colistin|mesh-list
92066690|NCT01970371|Tigecycline|tigecycline|mesh-list
92015570|NCT05016609|Immunologic Factors|immunologic factors|mesh-ancestor
92015571|NCT05016609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015572|NCT05016609|Antiviral Agents|antiviral agents|mesh-ancestor
92015573|NCT05016609|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015574|NCT03763305|Fentanyl|fentanyl|mesh-list
92066691|NCT01970371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066692|NCT01970371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92066693|NCT01970371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066694|NCT01970371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066699|NCT04171700|Rucaparib|rucaparib|mesh-list
92066700|NCT04171700|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92066701|NCT04171700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066702|NCT04171700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066703|NCT04171700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066704|NCT05604742|Belimumab|belimumab|mesh-list
92066705|NCT05604742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066706|NCT05604742|Immunologic Factors|immunologic factors|mesh-ancestor
92066707|NCT05604742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066708|NCT03350386|Oxaprozin|oxaprozin|mesh-list
92066709|NCT03350386|Dotinurad|dotinurad|mesh-list
92066710|NCT03350386|Uricosuric Agents|uricosuric agents|mesh-ancestor
92066711|NCT03350386|Gout Suppressants|gout suppressants|mesh-ancestor
92066712|NCT03350386|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066713|NCT03350386|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92066714|NCT03350386|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92066715|NCT03350386|Analgesics|analgesics|mesh-ancestor
92066716|NCT03350386|Sensory System Agents|sensory system agents|mesh-ancestor
92066717|NCT03350386|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066718|NCT03350386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066719|NCT03350386|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066720|NCT03350386|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92066721|NCT03350386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066722|NCT03350386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066723|NCT05567458|Luspatercept|luspatercept|mesh-list
92066724|NCT05567458|Hematinics|hematinics|mesh-ancestor
92066726|NCT03344692|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92066727|NCT03344692|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92066728|NCT03344692|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92066729|NCT03344692|Antimetabolites|antimetabolites|mesh-ancestor
92066804|NCT05181046|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92066730|NCT03344692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066731|NCT03344692|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92066732|NCT03344692|Protease Inhibitors|protease inhibitors|mesh-ancestor
92066733|NCT03344692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066734|NCT03344692|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92066735|NCT05305924|Fulvestrant|fulvestrant|mesh-list
92066736|NCT05305924|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92066737|NCT05305924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066738|NCT05305924|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92066739|NCT05305924|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92066740|NCT05305924|Hormone Antagonists|hormone antagonists|mesh-ancestor
92066741|NCT05305924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066742|NCT05305924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066743|NCT05548582|Acetaminophen|acetaminophen|mesh-list
92066744|NCT05548582|Ibuprofen|ibuprofen|mesh-list
92066745|NCT05548582|Oxycodone|oxycodone|mesh-list
92066746|NCT05548582|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92066747|NCT05548582|Analgesics|analgesics|mesh-ancestor
92066748|NCT05548582|Sensory System Agents|sensory system agents|mesh-ancestor
92066749|NCT05548582|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066750|NCT05548582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066751|NCT05548582|Antipyretics|antipyretics|mesh-ancestor
92066752|NCT05548582|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92066753|NCT05548582|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066754|NCT05548582|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066755|NCT05548582|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92066756|NCT05548582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066757|NCT05548582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066758|NCT05548582|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92066759|NCT05548582|Narcotics|narcotics|mesh-ancestor
92066760|NCT05548582|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015575|NCT03763305|Remifentanil|remifentanil|mesh-list
92015576|NCT03763305|Propofol|propofol|mesh-list
92015577|NCT03763305|Sevoflurane|sevoflurane|mesh-list
92015578|NCT03763305|Desflurane|desflurane|mesh-list
92015579|NCT03763305|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92066761|NCT01839188|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92066762|NCT01839188|Immunologic Factors|immunologic factors|mesh-ancestor
92066763|NCT01839188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066764|NCT05223088|Oxaliplatin|oxaliplatin|mesh-list
92066765|NCT05223088|Apatinib|apatinib|mesh-list
92066766|NCT05223088|Tislelizumab|tislelizumab|mesh-list
92066767|NCT05223088|Tegafur|tegafur|mesh-list
92066772|NCT05223088|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066773|NCT05223088|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066774|NCT05223088|Antimetabolites|antimetabolites|mesh-ancestor
92066775|NCT01838876|Cariprazine|cariprazine|mesh-list
92066776|NCT01838876|Antidepressive Agents|antidepressive agents|mesh-list
92066777|NCT01838876|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92066778|NCT01838876|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92066779|NCT01838876|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92066780|NCT01838876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066781|NCT01838876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066782|NCT03279250|Prednisone|prednisone|mesh-list
92066783|NCT03279250|Cortisone|cortisone|mesh-list
92066784|NCT03279250|Abiraterone Acetate|abiraterone acetate|mesh-list
92066785|NCT03279250|Hormones|hormones|mesh-list
92066786|NCT03279250|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92066787|NCT03279250|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066788|NCT03279250|Glucocorticoids|glucocorticoids|mesh-ancestor
92066789|NCT03279250|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066790|NCT03279250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066791|NCT03279250|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92066792|NCT03279250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066793|NCT03279250|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92066794|NCT03279250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066795|NCT03279250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066796|NCT03279250|Hormone Antagonists|hormone antagonists|mesh-ancestor
92066797|NCT03279250|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92066798|NCT01838642|Ponatinib|ponatinib|mesh-list
92066799|NCT01838642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066800|NCT01838642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066801|NCT01838642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066802|NCT01838642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066803|NCT05181046|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92066805|NCT01813058|Tranexamic Acid|tranexamic acid|mesh-list
92066806|NCT01813058|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92066807|NCT01813058|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92066808|NCT01813058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066809|NCT01813058|Hemostatics|hemostatics|mesh-ancestor
92066810|NCT01813058|Coagulants|coagulants|mesh-ancestor
92066811|NCT05491330|Ritonavir|ritonavir|mesh-list
92066812|NCT05491330|Nirmatrelvir|nirmatrelvir|mesh-list
92066813|NCT05491330|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92066814|NCT05491330|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92066815|NCT05491330|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92066816|NCT05491330|Protease Inhibitors|protease inhibitors|mesh-ancestor
92066817|NCT05491330|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066818|NCT05491330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066819|NCT05491330|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92066820|NCT05491330|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92066821|NCT05491330|Antiviral Agents|antiviral agents|mesh-ancestor
92066822|NCT05491330|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066823|NCT05491330|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92066824|NCT05491330|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92066825|NCT04601402|Avelumab|avelumab|mesh-list
92066826|NCT04601402|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066827|NCT04601402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066828|NCT01811732|Vancomycin|vancomycin|mesh-list
92066829|NCT01811732|Aztreonam|aztreonam|mesh-list
92066830|NCT01811732|Delafloxacin|delafloxacin|mesh-list
92066831|NCT01811732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92066832|NCT01811732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015580|NCT03763305|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92015581|NCT03763305|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015582|NCT03763305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015583|NCT03763305|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92066833|NCT05139004|Fludarabine|fludarabine|mesh-list
92066834|NCT05139004|Fludarabine phosphate|fludarabine phosphate|mesh-list
92066835|NCT05139004|Melphalan|melphalan|mesh-list
92066836|NCT05139004|Mechlorethamine|mechlorethamine|mesh-list
92066837|NCT05139004|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92066838|NCT05139004|Basiliximab|basiliximab|mesh-list
92066841|NCT05139004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066842|NCT05139004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066843|NCT05139004|Antimetabolites|antimetabolites|mesh-ancestor
92066844|NCT05139004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066845|NCT05139004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066846|NCT05139004|Immunologic Factors|immunologic factors|mesh-ancestor
92066847|NCT05139004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066848|NCT05139004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92066849|NCT05139004|Alkylating Agents|alkylating agents|mesh-ancestor
92066850|NCT05139004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92066851|NCT05139004|Mitosis Modulators|mitosis modulators|mesh-ancestor
92066853|NCT05139004|Sequestering Agents|sequestering agents|mesh-ancestor
92066855|NCT01811186|Naloxone|naloxone|mesh-list
92066856|NCT01811186|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92066857|NCT01811186|Narcotics|narcotics|mesh-ancestor
92066858|NCT01811186|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066859|NCT01811186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066860|NCT01811186|Analgesics|analgesics|mesh-ancestor
92066861|NCT01811186|Sensory System Agents|sensory system agents|mesh-ancestor
92066862|NCT01811186|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066863|NCT01811186|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92066864|NCT04630756|Acalabrutinib|acalabrutinib|mesh-list
92066865|NCT04630756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066866|NCT01866098|Naltrexone|naltrexone|mesh-list
92066867|NCT01866098|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92066868|NCT01866098|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92066869|NCT01866098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066870|NCT01866098|Sensory System Agents|sensory system agents|mesh-ancestor
92066871|NCT01866098|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066872|NCT04885972|Triamcinolone|triamcinolone|mesh-list
92066873|NCT04885972|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92066874|NCT04885972|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92066875|NCT04885972|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92066876|NCT04885972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066877|NCT04885972|Glucocorticoids|glucocorticoids|mesh-ancestor
92066878|NCT04885972|Hormones|hormones|mesh-ancestor
92066879|NCT04885972|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066880|NCT04885972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066881|NCT04885972|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066882|NCT04885972|Immunologic Factors|immunologic factors|mesh-ancestor
92066883|NCT04885972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066884|NCT04885972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066885|NCT04039750|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92066886|NCT04039750|Clindamycin|clindamycin|mesh-list
92066887|NCT04039750|Gentamicins|gentamicins|mesh-list
92066888|NCT04039750|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066889|NCT04039750|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92066890|NCT04039750|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066891|NCT04039750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066892|NCT03236428|Daratumumab|daratumumab|mesh-list
92066893|NCT03236428|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066894|NCT03985540|Methamphetamine|methamphetamine|mesh-list
92066895|NCT03985540|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92066896|NCT03985540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066897|NCT03985540|Sympathomimetics|sympathomimetics|mesh-ancestor
92066898|NCT03985540|Autonomic Agents|autonomic agents|mesh-ancestor
92066899|NCT03985540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066900|NCT03985540|Dopamine Agents|dopamine agents|mesh-ancestor
92066901|NCT03985540|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066902|NCT03985540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015584|NCT03763305|Anesthetics, General|anesthetics, general|mesh-ancestor
92015585|NCT03763305|Anesthetics|anesthetics|mesh-ancestor
92015586|NCT03763305|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92066903|NCT03985540|Adrenergic Agents|adrenergic agents|mesh-ancestor
92066904|NCT03985540|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92066905|NCT03985540|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92066906|NCT03985540|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92066907|NCT03985540|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92066908|NCT04858360|Lidocaine, Prilocaine Drug Combination|lidocaine, prilocaine drug combination|mesh-list
92066909|NCT04858360|Anesthetics, Local|anesthetics, local|mesh-ancestor
92066910|NCT04858360|Anesthetics|anesthetics|mesh-ancestor
92066913|NCT04858360|Sensory System Agents|sensory system agents|mesh-ancestor
92066914|NCT04858360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066915|NCT04858360|Anesthetics, Combined|anesthetics, combined|mesh-ancestor
92066916|NCT01865552|Etanercept|etanercept|mesh-list
92066917|NCT01865552|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92066918|NCT01865552|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92066919|NCT01865552|Analgesics|analgesics|mesh-ancestor
92066920|NCT01865552|Sensory System Agents|sensory system agents|mesh-ancestor
92066921|NCT01865552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066922|NCT01865552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066923|NCT01865552|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066924|NCT01865552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066925|NCT01865552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92066926|NCT01865552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066927|NCT01865552|Immunologic Factors|immunologic factors|mesh-ancestor
92066928|NCT01809314|Epoetin Alfa|epoetin alfa|mesh-list
92066929|NCT01809314|Hematinics|hematinics|mesh-ancestor
92066930|NCT03943498|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92066931|NCT03943498|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92066932|NCT03943498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066933|NCT03943498|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92066934|NCT03943498|Immunologic Factors|immunologic factors|mesh-ancestor
92066935|NCT03943498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066936|NCT05185024|Iron|iron|mesh-list
92066937|NCT05185024|Trace Elements|trace elements|mesh-ancestor
92066938|NCT05185024|Micronutrients|micronutrients|mesh-ancestor
92066939|NCT05185024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066940|NCT01808690|Metformin|metformin|mesh-list
92066941|NCT01808690|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92066942|NCT01808690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066943|NCT04583618|Vaccines|vaccines|mesh-list
92066944|NCT04583618|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92066945|NCT04583618|Immunologic Factors|immunologic factors|mesh-ancestor
92066946|NCT04583618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066947|NCT04413734|Cisplatin|cisplatin|mesh-list
92066948|NCT04413734|Gemcitabine|gemcitabine|mesh-list
92066949|NCT04413734|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066950|NCT04413734|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92066951|NCT04413734|Antimetabolites|antimetabolites|mesh-ancestor
92066952|NCT04413734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066953|NCT03229798|Sumatriptan|sumatriptan|mesh-list
92066954|NCT03229798|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92066955|NCT03229798|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92066956|NCT03229798|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92066957|NCT03229798|Serotonin Agents|serotonin agents|mesh-ancestor
92066958|NCT03229798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92066959|NCT03229798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066960|NCT03229798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066962|NCT04805944|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92066963|NCT04805944|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92066964|NCT04805944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066965|NCT04805944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066966|NCT04805944|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92066967|NCT04805944|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92066968|NCT04805944|Antiviral Agents|antiviral agents|mesh-ancestor
92066969|NCT04805944|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92066970|NCT03906292|Niacinamide|niacinamide|mesh-list
92066971|NCT03906292|Imatinib Mesylate|imatinib mesylate|mesh-list
92066972|NCT03906292|Dasatinib|dasatinib|mesh-list
92066973|NCT03906292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015587|NCT03763305|Narcotics|narcotics|mesh-ancestor
92015588|NCT03763305|Analgesics|analgesics|mesh-ancestor
92015589|NCT03763305|Sensory System Agents|sensory system agents|mesh-ancestor
92066974|NCT03906292|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066975|NCT03906292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066976|NCT03906292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066977|NCT03906292|Vitamin B Complex|vitamin b complex|mesh-ancestor
92066978|NCT03906292|Vitamins|vitamins|mesh-ancestor
92066979|NCT03906292|Micronutrients|micronutrients|mesh-ancestor
92066980|NCT03906292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066981|NCT03229174|Droxidopa|droxidopa|mesh-list
92066982|NCT03229174|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92066983|NCT03229174|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92066984|NCT03227926|Panitumumab|panitumumab|mesh-list
92066987|NCT03615742|Budesonide|budesonide|mesh-list
92066988|NCT03615742|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92066989|NCT03615742|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92066990|NCT03615742|Autonomic Agents|autonomic agents|mesh-ancestor
92066991|NCT03615742|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92066992|NCT03615742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066993|NCT03615742|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92066994|NCT03615742|Respiratory System Agents|respiratory system agents|mesh-ancestor
92066995|NCT03615742|Glucocorticoids|glucocorticoids|mesh-ancestor
92066996|NCT03615742|Hormones|hormones|mesh-ancestor
92066997|NCT03615742|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92066998|NCT01363297|Inotuzumab Ozogamicin|inotuzumab ozogamicin|mesh-list
92066999|NCT01363297|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067000|NCT01363297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067001|NCT01363297|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92067002|NCT01363297|Immunotoxins|immunotoxins|mesh-ancestor
92067003|NCT01363297|Immunoconjugates|immunoconjugates|mesh-ancestor
92067004|NCT01363297|Immunologic Factors|immunologic factors|mesh-ancestor
92067005|NCT01363297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067006|NCT04756804|Ethanol|ethanol|mesh-list
92067007|NCT04756804|Chlorhexidine|chlorhexidine|mesh-list
92067008|NCT04756804|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92067009|NCT04756804|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92067010|NCT04756804|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067011|NCT04756804|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067012|NCT04756804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067013|NCT04756804|Disinfectants|disinfectants|mesh-ancestor
92067014|NCT04756804|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067015|NCT03199924|Diclofenac|diclofenac|mesh-list
92067016|NCT03199924|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92067017|NCT03199924|Lidocaine|lidocaine|mesh-list
92067018|NCT03199924|Magnesium Sulfate|magnesium sulfate|mesh-list
92067019|NCT03199924|Anesthetics, Local|anesthetics, local|mesh-ancestor
92067020|NCT03199924|Anesthetics|anesthetics|mesh-ancestor
92067021|NCT03199924|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067022|NCT03199924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067023|NCT03199924|Sensory System Agents|sensory system agents|mesh-ancestor
92067024|NCT03199924|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067025|NCT03199924|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92067026|NCT03199924|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92067027|NCT03199924|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92067028|NCT03199924|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92067029|NCT03199924|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067030|NCT03199924|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92067031|NCT03199924|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92067032|NCT03199924|Analgesics|analgesics|mesh-ancestor
92067033|NCT03199924|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067034|NCT03199924|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92067035|NCT03199924|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067036|NCT03199924|Anticonvulsants|anticonvulsants|mesh-ancestor
92067037|NCT03199924|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92067038|NCT03199924|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92067039|NCT03199924|Tocolytic Agents|tocolytic agents|mesh-ancestor
92067040|NCT03199924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067041|NCT03199300|Trastuzumab|trastuzumab|mesh-list
92067042|NCT03199300|Bleomycin|bleomycin|mesh-list
92067043|NCT03199300|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015590|NCT03763305|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015591|NCT03763305|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92067044|NCT03199300|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067045|NCT03199300|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92067046|NCT04746430|Dexamethasone|dexamethasone|mesh-list
92067047|NCT04746430|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067048|NCT04746430|Antiemetics|antiemetics|mesh-ancestor
92067049|NCT04746430|Autonomic Agents|autonomic agents|mesh-ancestor
92067050|NCT04746430|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067051|NCT04746430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067052|NCT04746430|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067053|NCT04746430|Glucocorticoids|glucocorticoids|mesh-ancestor
92067054|NCT04746430|Hormones|hormones|mesh-ancestor
92067055|NCT04746430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067056|NCT04746430|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92067057|NCT04746430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067062|NCT03642028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067063|NCT03642028|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92067064|NCT03642028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067065|NCT03642028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067066|NCT04402138|Acalabrutinib|acalabrutinib|mesh-list
92067067|NCT04402138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067068|NCT03197662|Oxytocin|oxytocin|mesh-list
92067069|NCT03197662|Oxytocics|oxytocics|mesh-ancestor
92067070|NCT03197662|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067071|NCT03197662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067072|NCT03194542|Luspatercept|luspatercept|mesh-list
92067073|NCT03194542|Hematinics|hematinics|mesh-ancestor
92067074|NCT03247582|Edoxaban|edoxaban|mesh-list
92067075|NCT03247582|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92067076|NCT03247582|Antithrombins|antithrombins|mesh-ancestor
92067077|NCT03247582|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92067078|NCT03247582|Protease Inhibitors|protease inhibitors|mesh-ancestor
92067079|NCT03247582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067080|NCT03247582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067081|NCT03247582|Anticoagulants|anticoagulants|mesh-ancestor
92067082|NCT01808612|Fluoxetine|fluoxetine|mesh-list
92067083|NCT01808612|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92067084|NCT01808612|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92067085|NCT01808612|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92067086|NCT01808612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067087|NCT01808612|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067088|NCT01808612|Serotonin Agents|serotonin agents|mesh-ancestor
92067089|NCT01808612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067090|NCT01808612|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92067091|NCT01808612|Antidepressive Agents|antidepressive agents|mesh-ancestor
92067092|NCT01808612|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92067093|NCT01808612|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92067094|NCT01808612|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92067095|NCT01808612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067096|NCT01908829|Solifenacin Succinate|solifenacin succinate|mesh-list
92067097|NCT01908829|Mirabegron|mirabegron|mesh-list
92067098|NCT01908829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92067099|NCT01908829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92067100|NCT01908829|Cholinergic Agents|cholinergic agents|mesh-ancestor
92067101|NCT01908829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067102|NCT01908829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067103|NCT01908829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067104|NCT01908829|Urological Agents|urological agents|mesh-ancestor
92067105|NCT01908829|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92067106|NCT01908829|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92067107|NCT01908829|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92067108|NCT01908829|Adrenergic Agents|adrenergic agents|mesh-ancestor
92067109|NCT01773122|Dapsone|dapsone|mesh-list
92067110|NCT01773122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067111|NCT01773122|Antimalarials|antimalarials|mesh-ancestor
92067112|NCT01773122|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92067113|NCT01773122|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92067114|NCT01773122|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92067115|NCT01773122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067116|NCT01773122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067117|NCT01773122|Leprostatic Agents|leprostatic agents|mesh-ancestor
92015592|NCT03763305|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92067118|NCT01773122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067119|NCT01808534|Isophosphamide mustard|isophosphamide mustard|mesh-list
92067120|NCT01808534|Ifosfamide|ifosfamide|mesh-list
92067121|NCT01808534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92067122|NCT01808534|Alkylating Agents|alkylating agents|mesh-ancestor
92067123|NCT01808534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067124|NCT01808534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067125|NCT03221140|Anti-Infective Agents|anti-infective agents|mesh-list
92067126|NCT03221140|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92067127|NCT03218800|Ertapenem|ertapenem|mesh-list
92067128|NCT03218800|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067132|NCT01802216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067133|NCT03621904|Tamoxifen|tamoxifen|mesh-list
92067134|NCT03621904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-list
92067135|NCT03621904|Antineoplastic Agents|antineoplastic agents|mesh-list
92067137|NCT03621904|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92067138|NCT03621904|Progestins|progestins|mesh-ancestor
92067139|NCT03621904|Hormones|hormones|mesh-ancestor
92067140|NCT03621904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067141|NCT03621904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067142|NCT03621904|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92067143|NCT03621904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92067144|NCT03621904|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92067145|NCT03621904|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92067146|NCT03621904|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92067147|NCT03621904|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92067148|NCT03621904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067149|NCT03621904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067150|NCT01808144|Febuxostat|febuxostat|mesh-list
92067151|NCT01808144|Lesinurad|lesinurad|mesh-list
92067152|NCT01808144|Gout Suppressants|gout suppressants|mesh-ancestor
92067153|NCT01808144|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067154|NCT01808144|Uricosuric Agents|uricosuric agents|mesh-ancestor
92067155|NCT02085070|Pembrolizumab|pembrolizumab|mesh-list
92067156|NCT02085070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067157|NCT02085070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067158|NCT02085070|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92067159|NCT02085070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067160|NCT01604343|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92067161|NCT01604343|Immunologic Factors|immunologic factors|mesh-ancestor
92067162|NCT01604343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067163|NCT01801436|Bortezomib|bortezomib|mesh-list
92067164|NCT01801436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067165|NCT01771250|Insulin|insulin|mesh-list
92067166|NCT01771250|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92067167|NCT01771250|Insulin Glargine|insulin glargine|mesh-list
92067168|NCT01771250|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92067169|NCT01771250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067170|NCT03568708|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92067171|NCT03568708|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92067172|NCT03568708|Estradiol|estradiol|mesh-list
92067173|NCT03568708|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92067174|NCT03568708|Estrogens|estrogens|mesh-list
92067175|NCT03568708|Hormones|hormones|mesh-ancestor
92067176|NCT03568708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067177|NCT03568708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067178|NCT03568708|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92067179|NCT03568708|Contraceptive Agents|contraceptive agents|mesh-ancestor
92067180|NCT03568708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067181|NCT03568708|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92067182|NCT04305106|Bevacizumab|bevacizumab|mesh-list
92067183|NCT04305106|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067184|NCT04305106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067185|NCT04305106|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92067186|NCT04305106|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92067187|NCT04305106|Growth Substances|growth substances|mesh-ancestor
92067188|NCT04305106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067189|NCT04305106|Growth Inhibitors|growth inhibitors|mesh-ancestor
92067190|NCT01770392|Rifampin|rifampin|mesh-list
92067191|NCT01770392|Nintedanib|nintedanib|mesh-list
92067192|NCT01770392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92015593|NCT03763305|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92015594|NCT05054361|Mannitol|mannitol|mesh-list
92015595|NCT05054361|Lactulose|lactulose|mesh-list
92015596|NCT05054361|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92015597|NCT05054361|Diuretics|diuretics|mesh-ancestor
92067193|NCT01770392|Antitubercular Agents|antitubercular agents|mesh-ancestor
92067194|NCT01770392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067195|NCT01770392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067196|NCT01770392|Leprostatic Agents|leprostatic agents|mesh-ancestor
92067197|NCT01770392|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92067198|NCT01770392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067199|NCT01770392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067200|NCT01770392|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92067201|NCT01770392|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92067204|NCT01770392|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92067205|NCT01770392|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92067206|NCT01770392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067207|NCT01770392|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92067208|NCT01603641|Botulinum Toxins|botulinum toxins|mesh-list
92067209|NCT01603641|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92067210|NCT01603641|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92067211|NCT01603641|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92067212|NCT01603641|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92067213|NCT01603641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067214|NCT01603641|Cholinergic Agents|cholinergic agents|mesh-ancestor
92067215|NCT01603641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067216|NCT01603641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067217|NCT01603641|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92067218|NCT01603641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067219|NCT03492112|Sofosbuvir|sofosbuvir|mesh-list
92067220|NCT03492112|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92067221|NCT03492112|Velpatasvir|velpatasvir|mesh-list
92067222|NCT03492112|Antiviral Agents|antiviral agents|mesh-ancestor
92067223|NCT03492112|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067224|NCT01556763|Antipsychotic Agents|antipsychotic agents|mesh-list
92067225|NCT01556763|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92067226|NCT01556763|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067227|NCT01556763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067228|NCT01556763|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92067229|NCT04397458|Dexamethasone|dexamethasone|mesh-list
92067230|NCT04397458|Bupivacaine|bupivacaine|mesh-list
92067231|NCT04397458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067232|NCT04397458|Antiemetics|antiemetics|mesh-ancestor
92067233|NCT04397458|Autonomic Agents|autonomic agents|mesh-ancestor
92067234|NCT04397458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067235|NCT04397458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067236|NCT04397458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067237|NCT04397458|Glucocorticoids|glucocorticoids|mesh-ancestor
92067238|NCT04397458|Hormones|hormones|mesh-ancestor
92067239|NCT04397458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067240|NCT04397458|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92067241|NCT04397458|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067242|NCT04397458|Anesthetics, Local|anesthetics, local|mesh-ancestor
92067243|NCT04397458|Anesthetics|anesthetics|mesh-ancestor
92067244|NCT04397458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067245|NCT04397458|Sensory System Agents|sensory system agents|mesh-ancestor
92067246|NCT04398316|Lidocaine|lidocaine|mesh-list
92067247|NCT04398316|Hydromorphone|hydromorphone|mesh-list
92067248|NCT04398316|Anesthetics, Local|anesthetics, local|mesh-ancestor
92067249|NCT04398316|Anesthetics|anesthetics|mesh-ancestor
92067250|NCT04398316|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067251|NCT04398316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067252|NCT04398316|Sensory System Agents|sensory system agents|mesh-ancestor
92067253|NCT04398316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067254|NCT04398316|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92067255|NCT04398316|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92067256|NCT04398316|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92067257|NCT04398316|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92067258|NCT04398316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067259|NCT04398316|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92015598|NCT05054361|Natriuretic Agents|natriuretic agents|mesh-ancestor
92015599|NCT05054361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015600|NCT05054361|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015601|NCT04906213|Empagliflozin|empagliflozin|mesh-list
92067260|NCT04398316|Narcotics|narcotics|mesh-ancestor
92067261|NCT04398316|Analgesics|analgesics|mesh-ancestor
92067262|NCT01576575|Rifampin|rifampin|mesh-list
92067263|NCT01576575|Ketoconazole|ketoconazole|mesh-list
92067264|NCT01576575|Buprenorphine|buprenorphine|mesh-list
92067265|NCT01576575|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92067266|NCT01576575|Narcotics|narcotics|mesh-ancestor
92067267|NCT01576575|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067268|NCT01576575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067270|NCT01576575|Sensory System Agents|sensory system agents|mesh-ancestor
92067271|NCT01576575|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067272|NCT01576575|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92067273|NCT01576575|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92067274|NCT01576575|Antitubercular Agents|antitubercular agents|mesh-ancestor
92067279|NCT01576575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067280|NCT01576575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067281|NCT01576575|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92067282|NCT01576575|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92067283|NCT01576575|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92067284|NCT01576575|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92067285|NCT01576575|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92067286|NCT01576575|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92067287|NCT01576575|Antifungal Agents|antifungal agents|mesh-ancestor
92067288|NCT01576575|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92067289|NCT01576575|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92067290|NCT01576575|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92067291|NCT01576575|Hormone Antagonists|hormone antagonists|mesh-ancestor
92067292|NCT01576575|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067293|NCT01576575|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92067294|NCT05051566|Esomeprazole|esomeprazole|mesh-list
92067295|NCT05051566|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92067296|NCT05051566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067297|NCT05051566|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92067298|NCT05051566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067299|NCT05051566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067300|NCT01576341|Epoetin Alfa|epoetin alfa|mesh-list
92067301|NCT01576341|Hematinics|hematinics|mesh-ancestor
92067302|NCT04226248|Rivastigmine|rivastigmine|mesh-list
92067303|NCT04226248|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92067304|NCT04226248|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067305|NCT04226248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067306|NCT04226248|Cholinergic Agents|cholinergic agents|mesh-ancestor
92067307|NCT04226248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067308|NCT04226248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067309|NCT04226248|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92067310|NCT04226248|Protective Agents|protective agents|mesh-ancestor
92067311|NCT01892722|Interferons|interferons|mesh-list
92067312|NCT01892722|Interferon-beta|interferon-beta|mesh-list
92067313|NCT01892722|Interferon beta-1a|interferon beta-1a|mesh-list
92067314|NCT01892722|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92067315|NCT01892722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067316|NCT01892722|Antiviral Agents|antiviral agents|mesh-ancestor
92067317|NCT01892722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067318|NCT01892722|Immunologic Factors|immunologic factors|mesh-ancestor
92067319|NCT01892722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067320|NCT01892722|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92067321|NCT01892722|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92067322|NCT01892722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067323|NCT01892722|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92067324|NCT04398004|Clarithromycin|clarithromycin|mesh-list
92067325|NCT04398004|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067326|NCT04398004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067327|NCT04398004|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92067328|NCT04398004|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067329|NCT04398004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015602|NCT04906213|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92067330|NCT04398004|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92067331|NCT04398004|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92067332|NCT01687413|Cisplatin|cisplatin|mesh-list
92067333|NCT01687413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067334|NCT01555671|Meperidine|meperidine|mesh-list
92067335|NCT01555671|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92067336|NCT01555671|Narcotics|narcotics|mesh-ancestor
92067337|NCT01555671|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067338|NCT01555671|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067339|NCT01555671|Analgesics|analgesics|mesh-ancestor
92067340|NCT01555671|Sensory System Agents|sensory system agents|mesh-ancestor
92067341|NCT01555671|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067342|NCT01555671|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92067343|NCT03226756|Nivolumab|nivolumab|mesh-list
92067347|NCT03226756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067348|NCT01807598|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92067349|NCT01807598|Immunoconjugates|immunoconjugates|mesh-list
92067350|NCT01807598|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067351|NCT01807598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067353|NCT01807598|Immunologic Factors|immunologic factors|mesh-ancestor
92067354|NCT01807598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067355|NCT01801280|Mycophenolic Acid|mycophenolic acid|mesh-list
92067356|NCT01801280|Pantoprazole|pantoprazole|mesh-list
92067357|NCT01801280|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92067358|NCT01801280|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067359|NCT01801280|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92067360|NCT01801280|Antitubercular Agents|antitubercular agents|mesh-ancestor
92067361|NCT01801280|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067362|NCT01801280|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067363|NCT01801280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067364|NCT01801280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067365|NCT01801280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92067366|NCT01801280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067367|NCT01801280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92067368|NCT01769456|Tenofovir|tenofovir|mesh-list
92067369|NCT01769456|Emtricitabine|emtricitabine|mesh-list
92067370|NCT01769456|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92067371|NCT01769456|Antiviral Agents|antiviral agents|mesh-ancestor
92067372|NCT01769456|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067373|NCT01769456|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92067374|NCT01769456|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92067375|NCT01769456|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067376|NCT01769456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067377|NCT01769456|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92067378|NCT01769456|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92067379|NCT01769378|Glimepiride|glimepiride|mesh-list
92067380|NCT01769378|Dulaglutide|dulaglutide|mesh-list
92067381|NCT01769378|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92067382|NCT01769378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92067383|NCT01769378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067384|NCT01769378|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92067385|NCT01769378|Immunologic Factors|immunologic factors|mesh-ancestor
92067386|NCT01807520|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92067387|NCT01807520|Immunologic Factors|immunologic factors|mesh-ancestor
92067388|NCT01807520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067389|NCT01555125|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92067390|NCT01555125|Immunologic Factors|immunologic factors|mesh-ancestor
92067391|NCT01555125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067392|NCT01768286|Ledipasvir, sofosbuvir drug combination|ledipasvir, sofosbuvir drug combination|mesh-list
92067393|NCT01768286|Ledipasvir|ledipasvir|mesh-list
92067394|NCT01768286|Antiviral Agents|antiviral agents|mesh-ancestor
92067395|NCT01768286|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067396|NCT01800968|Liraglutide|liraglutide|mesh-list
92067397|NCT01800968|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92067398|NCT01800968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067399|NCT01800968|Incretins|incretins|mesh-ancestor
92067400|NCT01800968|Hormones|hormones|mesh-ancestor
92067401|NCT01800968|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067402|NCT01687257|Sofosbuvir|sofosbuvir|mesh-list
92067403|NCT01687257|Antiviral Agents|antiviral agents|mesh-ancestor
92067404|NCT01687257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015603|NCT04906213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015604|NCT04906213|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92015605|NCT04906213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067405|NCT01806740|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92067406|NCT01806740|Chelating Agents|chelating agents|mesh-ancestor
92067407|NCT01806740|Sequestering Agents|sequestering agents|mesh-ancestor
92067408|NCT01806740|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067409|NCT01687101|Menthol|menthol|mesh-list
92067410|NCT01687101|Antipruritics|antipruritics|mesh-ancestor
92067411|NCT01687101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067412|NCT01968967|Bococizumab|bococizumab|mesh-list
92067413|NCT01968967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92067414|NCT01968967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92067416|NCT01968967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067417|NCT01968967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92067419|NCT01806662|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067420|NCT01930045|Raltegravir Potassium|raltegravir potassium|mesh-list
92067421|NCT01930045|Aluminum hydroxide, magnesium hydroxide, drug combination|aluminum hydroxide, magnesium hydroxide, drug combination|mesh-list
92067422|NCT01930045|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92067423|NCT01930045|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92067424|NCT01930045|Antiviral Agents|antiviral agents|mesh-ancestor
92067425|NCT01930045|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067426|NCT01930045|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92067427|NCT01930045|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92067428|NCT01930045|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067429|NCT01930045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067431|NCT01930045|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067432|NCT04631263|Hyaluronic Acid|hyaluronic acid|mesh-list
92067433|NCT04631263|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92067434|NCT04631263|Immunologic Factors|immunologic factors|mesh-ancestor
92067435|NCT04631263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067436|NCT04631263|Viscosupplements|viscosupplements|mesh-ancestor
92067437|NCT04631263|Protective Agents|protective agents|mesh-ancestor
92067438|NCT01929343|Lidocaine|lidocaine|mesh-list
92067439|NCT01929343|Anesthetics, Local|anesthetics, local|mesh-ancestor
92067440|NCT01929343|Anesthetics|anesthetics|mesh-ancestor
92067441|NCT01929343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067442|NCT01929343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067443|NCT01929343|Sensory System Agents|sensory system agents|mesh-ancestor
92067444|NCT01929343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067445|NCT01929343|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92067446|NCT01929343|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92067447|NCT01929343|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92067448|NCT01929343|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92067449|NCT01929343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067450|NCT01806584|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92067451|NCT01806584|Hemostatics|hemostatics|mesh-ancestor
92067452|NCT01806584|Coagulants|coagulants|mesh-ancestor
92067453|NCT01798706|Lixisenatide|lixisenatide|mesh-list
92067454|NCT01798706|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92067455|NCT01798706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067456|NCT01767194|Sirolimus|sirolimus|mesh-list
92067457|NCT01767194|Irinotecan|irinotecan|mesh-list
92067458|NCT01767194|Camptothecin|camptothecin|mesh-list
92067459|NCT01767194|Temozolomide|temozolomide|mesh-list
92067460|NCT01767194|Temsirolimus|temsirolimus|mesh-list
92067461|NCT01767194|Dinutuximab|dinutuximab|mesh-list
92067462|NCT01767194|MTOR Inhibitors|mtor inhibitors|mesh-list
92067463|NCT01767194|Sargramostim|sargramostim|mesh-list
92067464|NCT01767194|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92067465|NCT01767194|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92067466|NCT01767194|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067467|NCT01767194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067468|NCT01767194|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067469|NCT01767194|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92067470|NCT01767194|Alkylating Agents|alkylating agents|mesh-ancestor
92067471|NCT01767194|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067472|NCT01767194|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067473|NCT01767194|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92067474|NCT01767194|Antifungal Agents|antifungal agents|mesh-ancestor
92067475|NCT01767194|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015606|NCT01670539|Triamcinolone|triamcinolone|mesh-list
92015607|NCT01670539|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015608|NCT01670539|Glucocorticoids|glucocorticoids|mesh-ancestor
92067476|NCT01767194|Immunologic Factors|immunologic factors|mesh-ancestor
92067477|NCT01767194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067478|NCT01767194|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92067479|NCT01767194|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92067480|NCT01575873|Denosumab|denosumab|mesh-list
92067481|NCT01575873|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92067482|NCT01575873|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067483|NCT04276636|Calcium Carbonate|calcium carbonate|mesh-list
92067484|NCT04276636|Antacids|antacids|mesh-ancestor
92067485|NCT04276636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067486|NCT04276636|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067488|NCT00002644|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92067489|NCT00002644|Hormone Antagonists|hormone antagonists|mesh-ancestor
92067490|NCT00002644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067492|NCT00002644|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92067493|NCT00002644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067494|NCT00002644|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92067495|NCT00002644|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92067496|NCT00002644|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92067497|NCT01575561|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92067498|NCT01575561|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92067499|NCT01575561|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92067500|NCT01575561|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067501|NCT01575561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067502|NCT01575561|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92067503|NCT01575561|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92067504|NCT01575561|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92067505|NCT01575561|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92067506|NCT01575561|Adrenergic Agents|adrenergic agents|mesh-ancestor
92067507|NCT01575561|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067508|NCT01575561|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067509|NCT01575561|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92067510|NCT01575561|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92067511|NCT01575561|Serotonin Agents|serotonin agents|mesh-ancestor
92067512|NCT01575561|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92067513|NCT01575561|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92067514|NCT01575561|Dopamine Agents|dopamine agents|mesh-ancestor
92067515|NCT03021460|Pembrolizumab|pembrolizumab|mesh-list
92067516|NCT03021460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067517|NCT03021460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067518|NCT03021460|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92067519|NCT03021460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067520|NCT04397770|Temozolomide|temozolomide|mesh-list
92067521|NCT04397770|Apatinib|apatinib|mesh-list
92067522|NCT04397770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92067523|NCT04397770|Alkylating Agents|alkylating agents|mesh-ancestor
92067524|NCT04397770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067525|NCT04397770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067526|NCT04397770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92067527|NCT04397770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067528|NCT03082846|Temozolomide|temozolomide|mesh-list
92067529|NCT03082846|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92067530|NCT03082846|Alkylating Agents|alkylating agents|mesh-ancestor
92067531|NCT03082846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067532|NCT03082846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067533|NCT05249920|Edaravone|edaravone|mesh-list
92067534|NCT05249920|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92067535|NCT05249920|Antioxidants|antioxidants|mesh-ancestor
92067536|NCT05249920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067537|NCT05249920|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92067538|NCT05249920|Protective Agents|protective agents|mesh-ancestor
92067539|NCT05249920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067540|NCT01609790|Bevacizumab|bevacizumab|mesh-list
92067541|NCT01609790|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92067542|NCT01609790|Trebananib|trebananib|mesh-list
92067543|NCT01609790|Endothelial Growth Factors|endothelial growth factors|mesh-list
92015610|NCT01670539|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067544|NCT01609790|Antibodies|antibodies|mesh-list
92067545|NCT01609790|Immunoglobulins|immunoglobulins|mesh-list
92067546|NCT01609790|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92067547|NCT01609790|Immunoglobulin G|immunoglobulin g|mesh-list
92067548|NCT01609790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067549|NCT01609790|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92067550|NCT01609790|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92067551|NCT01609790|Growth Substances|growth substances|mesh-ancestor
92067552|NCT01609790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067553|NCT01609790|Growth Inhibitors|growth inhibitors|mesh-ancestor
92067554|NCT01609790|Immunologic Factors|immunologic factors|mesh-ancestor
92067556|NCT01767116|Antimetabolites|antimetabolites|mesh-ancestor
92067557|NCT01767116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067558|NCT01767116|Antiviral Agents|antiviral agents|mesh-ancestor
92067559|NCT01767116|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067560|NCT01574703|Bupropion|bupropion|mesh-list
92067561|NCT01574703|Nicotine|nicotine|mesh-list
92067562|NCT01574703|Varenicline|varenicline|mesh-list
92067570|NCT01574703|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067571|NCT01574703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067572|NCT01574703|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92067573|NCT01574703|Antidepressive Agents|antidepressive agents|mesh-ancestor
92067574|NCT01574703|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92067575|NCT01574703|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92067576|NCT01574703|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92067577|NCT01574703|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92067579|NCT01574703|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92067580|NCT01574703|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92067581|NCT01574703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067582|NCT01686633|Fluticasone|fluticasone|mesh-list
92067584|NCT01686633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067585|NCT01686633|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92067586|NCT01686633|Autonomic Agents|autonomic agents|mesh-ancestor
92067587|NCT01686633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067588|NCT01686633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067589|NCT01686633|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92067590|NCT01686633|Respiratory System Agents|respiratory system agents|mesh-ancestor
92067591|NCT01686633|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067592|NCT01686633|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92067598|NCT03180034|Vaccines|vaccines|mesh-list
92067599|NCT03180034|Immunologic Factors|immunologic factors|mesh-ancestor
92067600|NCT03180034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067601|NCT03141424|Fluticasone|fluticasone|mesh-list
92067602|NCT03141424|Mometasone Furoate|mometasone furoate|mesh-list
92067603|NCT03141424|Ciclesonide|ciclesonide|mesh-list
92067604|NCT03141424|Budesonide|budesonide|mesh-list
92067605|NCT03141424|Beclomethasone|beclomethasone|mesh-list
92067606|NCT03141424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067607|NCT03141424|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92067608|NCT03141424|Autonomic Agents|autonomic agents|mesh-ancestor
92067609|NCT03141424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067610|NCT03141424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067611|NCT03141424|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92067612|NCT03141424|Respiratory System Agents|respiratory system agents|mesh-ancestor
92067613|NCT03141424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067614|NCT03141424|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92067615|NCT03141424|Glucocorticoids|glucocorticoids|mesh-ancestor
92067616|NCT03141424|Hormones|hormones|mesh-ancestor
92067617|NCT03141424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067618|NCT03614494|Piroxicam|piroxicam|mesh-list
92067619|NCT03614494|Levonorgestrel|levonorgestrel|mesh-list
92067620|NCT03614494|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92067621|NCT03614494|Contraceptive Agents|contraceptive agents|mesh-ancestor
92067622|NCT03614494|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067623|NCT03614494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067624|NCT03614494|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92067625|NCT03614494|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92067626|NCT03614494|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92067627|NCT03614494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92067628|NCT03614494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92015611|NCT01670539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067630|NCT03614494|Sensory System Agents|sensory system agents|mesh-ancestor
92067631|NCT03614494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067632|NCT03614494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067633|NCT03614494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067638|NCT03028155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067639|NCT05245708|Oxytocin|oxytocin|mesh-list
92067640|NCT05245708|Oxytocics|oxytocics|mesh-ancestor
92067641|NCT05245708|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067642|NCT05245708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067643|NCT01922596|Ropivacaine|ropivacaine|mesh-list
92067644|NCT01922596|Anesthetics, Local|anesthetics, local|mesh-ancestor
92067645|NCT01922596|Anesthetics|anesthetics|mesh-ancestor
92067646|NCT01922596|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067647|NCT01922596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067648|NCT01922596|Sensory System Agents|sensory system agents|mesh-ancestor
92067649|NCT01922596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067650|NCT01573767|Fluticasone|fluticasone|mesh-list
92067651|NCT01573767|Xhance|xhance|mesh-list
92067652|NCT01573767|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067653|NCT01573767|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92067654|NCT01573767|Autonomic Agents|autonomic agents|mesh-ancestor
92067655|NCT01573767|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067656|NCT01573767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067657|NCT01573767|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92067658|NCT01573767|Respiratory System Agents|respiratory system agents|mesh-ancestor
92067659|NCT01573767|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067660|NCT01573767|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92067661|NCT04396990|Prednisolone|prednisolone|mesh-list
92067662|NCT04396990|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067663|NCT04396990|Glucocorticoids|glucocorticoids|mesh-ancestor
92067664|NCT04396990|Hormones|hormones|mesh-ancestor
92067665|NCT04396990|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067666|NCT04396990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067667|NCT04396990|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92067668|NCT04396990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067669|NCT03133546|Bevacizumab|bevacizumab|mesh-list
92067670|NCT03133546|Osimertinib|osimertinib|mesh-list
92067671|NCT03133546|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067672|NCT03133546|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067673|NCT03133546|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92067674|NCT03133546|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92067675|NCT03133546|Growth Substances|growth substances|mesh-ancestor
92067676|NCT03133546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067677|NCT03133546|Growth Inhibitors|growth inhibitors|mesh-ancestor
92067678|NCT03133546|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92067679|NCT03133546|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067680|NCT03133546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067681|NCT01551303|Oxytocin|oxytocin|mesh-list
92067682|NCT01551303|Oxytocics|oxytocics|mesh-ancestor
92067683|NCT01551303|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067684|NCT01551303|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067685|NCT01685073|Zolpidem|zolpidem|mesh-list
92067686|NCT01685073|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92067687|NCT01685073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92067688|NCT01685073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067689|NCT01685073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067690|NCT01685073|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92067691|NCT01685073|GABA Agonists|gaba agonists|mesh-ancestor
92067692|NCT01685073|GABA Agents|gaba agents|mesh-ancestor
92067693|NCT01685073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067694|NCT01685073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067695|NCT05241028|Ensartinib|ensartinib|mesh-list
92067696|NCT05241028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067697|NCT05241028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92067698|NCT05241028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067699|NCT05241028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067700|NCT01572675|Celecoxib|celecoxib|mesh-list
92067701|NCT01572675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92067702|NCT01572675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92067703|NCT01572675|Analgesics|analgesics|mesh-ancestor
92015612|NCT02252887|Gemcitabine|gemcitabine|mesh-list
92067704|NCT01572675|Sensory System Agents|sensory system agents|mesh-ancestor
92067706|NCT01572675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067707|NCT01572675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067708|NCT01572675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067709|NCT01572675|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92067710|NCT01572675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92067711|NCT01572675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067712|NCT01572675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067714|NCT05929937|Narcotics|narcotics|mesh-ancestor
92067715|NCT05929937|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067716|NCT05929937|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067717|NCT05929937|Analgesics|analgesics|mesh-ancestor
92067718|NCT05929937|Sensory System Agents|sensory system agents|mesh-ancestor
92067719|NCT05929937|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067720|NCT05929898|Dopamine|dopamine|mesh-list
92067721|NCT05929898|Dopamine Agonists|dopamine agonists|mesh-list
92067722|NCT05929898|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92067723|NCT05929898|Sympathomimetics|sympathomimetics|mesh-ancestor
92067724|NCT05929898|Autonomic Agents|autonomic agents|mesh-ancestor
92067725|NCT05929898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067726|NCT05929898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067727|NCT05929898|Dopamine Agents|dopamine agents|mesh-ancestor
92067728|NCT05929898|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067729|NCT05929898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067730|NCT05929898|Protective Agents|protective agents|mesh-ancestor
92067731|NCT05929794|Metronidazole|metronidazole|mesh-list
92067732|NCT05929794|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067733|NCT05929794|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067734|NCT05929794|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92067735|NCT05929794|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92067736|NCT05929768|Paclitaxel|paclitaxel|mesh-list
92067737|NCT05929768|Docetaxel|docetaxel|mesh-list
92067738|NCT05929768|Cyclophosphamide|cyclophosphamide|mesh-list
92067739|NCT05929768|Carboplatin|carboplatin|mesh-list
92067740|NCT05929768|Doxorubicin|doxorubicin|mesh-list
92067741|NCT05929768|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92067742|NCT05929768|Pembrolizumab|pembrolizumab|mesh-list
92067743|NCT05929768|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92067744|NCT05929768|Daunorubicin|daunorubicin|mesh-list
92067745|NCT05929768|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92067746|NCT05929768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067747|NCT05929768|Tubulin Modulators|tubulin modulators|mesh-ancestor
92067748|NCT05929768|Antimitotic Agents|antimitotic agents|mesh-ancestor
92067749|NCT05929768|Mitosis Modulators|mitosis modulators|mesh-ancestor
92067750|NCT05929768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067751|NCT05929768|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92067752|NCT05929768|Immunologic Factors|immunologic factors|mesh-ancestor
92067753|NCT05929768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067754|NCT05929768|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067755|NCT05929768|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92067756|NCT05929768|Alkylating Agents|alkylating agents|mesh-ancestor
92067757|NCT05929768|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92067758|NCT05929768|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92067759|NCT05929768|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92067760|NCT05929768|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92067761|NCT05929768|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067762|NCT05929768|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067763|NCT05929768|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92067764|NCT05929755|Methylprednisolone|methylprednisolone|mesh-list
92067765|NCT05929755|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92067766|NCT05929755|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92067767|NCT05929755|Prednisolone|prednisolone|mesh-list
92067768|NCT05929755|Prednisolone acetate|prednisolone acetate|mesh-list
92067769|NCT05929755|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92067770|NCT05929755|Prednisolone phosphate|prednisolone phosphate|mesh-list
92067771|NCT05929755|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067772|NCT05929755|Antiemetics|antiemetics|mesh-ancestor
92067773|NCT05929755|Autonomic Agents|autonomic agents|mesh-ancestor
92067774|NCT05929755|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067775|NCT05929755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067776|NCT05929755|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067777|NCT05929755|Glucocorticoids|glucocorticoids|mesh-ancestor
92067778|NCT05929755|Hormones|hormones|mesh-ancestor
92067781|NCT05929755|Protective Agents|protective agents|mesh-ancestor
92015613|NCT02252887|Trastuzumab|trastuzumab|mesh-list
92015614|NCT02252887|Pertuzumab|pertuzumab|mesh-list
92015615|NCT02252887|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015616|NCT02252887|Antimetabolites|antimetabolites|mesh-ancestor
92067782|NCT05929755|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92067783|NCT05929755|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067784|NCT05929716|Rituximab|rituximab|mesh-list
92067786|NCT05929716|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067787|NCT05929716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067788|NCT05929716|Immunologic Factors|immunologic factors|mesh-ancestor
92067789|NCT05929716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067790|NCT05929716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067792|NCT05929664|Immunoglobulins|immunoglobulins|mesh-list
92067793|NCT05929664|Immunoglobulin G|immunoglobulin g|mesh-list
92067794|NCT05929664|Immunologic Factors|immunologic factors|mesh-ancestor
92067795|NCT05929664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067796|NCT05929664|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067797|NCT05929664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067798|NCT05929456|Cetuximab|cetuximab|mesh-list
92067799|NCT05929456|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067800|NCT05929456|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067801|NCT05929339|Oxytocin|oxytocin|mesh-list
92067802|NCT05929339|Oxytocics|oxytocics|mesh-ancestor
92067803|NCT05929339|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067804|NCT05929339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067805|NCT05928988|Itraconazole|itraconazole|mesh-list
92067806|NCT05928988|Antifungal Agents|antifungal agents|mesh-ancestor
92067807|NCT05928988|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067808|NCT05928988|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92067809|NCT05928988|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92067810|NCT05928988|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067811|NCT05928988|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067812|NCT05928988|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92067813|NCT05928988|Hormone Antagonists|hormone antagonists|mesh-ancestor
92067814|NCT05928988|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067815|NCT05928988|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067816|NCT05928988|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92067817|NCT05928871|Misoprostol|misoprostol|mesh-list
92067818|NCT05928871|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92067819|NCT05928871|Abortifacient Agents|abortifacient agents|mesh-ancestor
92067820|NCT05928871|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92067821|NCT05928871|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067822|NCT05928871|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92067823|NCT05928871|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067824|NCT05928871|Oxytocics|oxytocics|mesh-ancestor
92067825|NCT05928780|Fluzoparib|fluzoparib|mesh-list
92067826|NCT05928780|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92067827|NCT05928780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067828|NCT05928780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067829|NCT05928780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067830|NCT05928741|Vitamin D|vitamin d|mesh-list
92067831|NCT05928741|Cholecalciferol|cholecalciferol|mesh-list
92067832|NCT05928741|Vitamins|vitamins|mesh-ancestor
92067833|NCT05928741|Micronutrients|micronutrients|mesh-ancestor
92067834|NCT05928741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067835|NCT05928741|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92067836|NCT05928741|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92067837|NCT05928728|Colchicine|colchicine|mesh-list
92067838|NCT05928728|Gout Suppressants|gout suppressants|mesh-ancestor
92067839|NCT05928728|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067840|NCT05928728|Tubulin Modulators|tubulin modulators|mesh-ancestor
92067841|NCT05928728|Antimitotic Agents|antimitotic agents|mesh-ancestor
92067842|NCT05928728|Mitosis Modulators|mitosis modulators|mesh-ancestor
92067843|NCT05928728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067844|NCT05928728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067845|NCT05928689|Propranolol|propranolol|mesh-list
92067846|NCT05928689|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92067847|NCT05928689|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92015617|NCT02252887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015618|NCT02252887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015619|NCT02252887|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067848|NCT05928689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92067849|NCT05928689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067850|NCT05928689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067853|NCT05928689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92067854|NCT05928689|Vasodilator Agents|vasodilator agents|mesh-ancestor
92067856|NCT05928546|Antioxidants|antioxidants|mesh-ancestor
92067857|NCT05928546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067858|NCT05928546|Protective Agents|protective agents|mesh-ancestor
92067859|NCT05928546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067860|NCT05928039|Adalimumab|adalimumab|mesh-list
92067861|NCT05928039|Infliximab|infliximab|mesh-list
92067862|NCT05928039|Interleukin-12|interleukin-12|mesh-list
92067863|NCT05928039|Interleukin-23|interleukin-23|mesh-list
92067864|NCT05928039|Ustekinumab|ustekinumab|mesh-list
92067865|NCT05928039|Vedolizumab|vedolizumab|mesh-list
92067866|NCT05928039|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92067867|NCT05928039|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067868|NCT05928039|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92067869|NCT05928039|Dermatologic Agents|dermatologic agents|mesh-ancestor
92067870|NCT05928039|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067871|NCT05928039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92067872|NCT05928039|Immunologic Factors|immunologic factors|mesh-ancestor
92067873|NCT05928039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067874|NCT05928039|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92067875|NCT05928039|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92067876|NCT05928039|Growth Substances|growth substances|mesh-ancestor
92067877|NCT05928039|Growth Inhibitors|growth inhibitors|mesh-ancestor
92067878|NCT05928039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067879|NCT05928000|Tenofovir|tenofovir|mesh-list
92067880|NCT05928000|Entecavir|entecavir|mesh-list
92067881|NCT05928000|Antiviral Agents|antiviral agents|mesh-ancestor
92067882|NCT05928000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067883|NCT05928000|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92067884|NCT05928000|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92067885|NCT05928000|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067886|NCT05928000|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067887|NCT05928000|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92067888|NCT05928000|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92067889|NCT05927714|Hemostatics|hemostatics|mesh-list
92067890|NCT05927714|Coagulants|coagulants|mesh-ancestor
92067891|NCT05927233|Methylprednisolone|methylprednisolone|mesh-list
92067892|NCT05927233|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92067893|NCT05927233|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92067894|NCT05927233|Prednisolone|prednisolone|mesh-list
92067895|NCT05927233|Prednisolone acetate|prednisolone acetate|mesh-list
92067896|NCT05927233|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92067897|NCT05927233|Prednisolone phosphate|prednisolone phosphate|mesh-list
92067898|NCT05927233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92067899|NCT05927233|Antiemetics|antiemetics|mesh-ancestor
92067900|NCT05927233|Autonomic Agents|autonomic agents|mesh-ancestor
92067901|NCT05927233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067902|NCT05927233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067903|NCT05927233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92067904|NCT05927233|Glucocorticoids|glucocorticoids|mesh-ancestor
92067905|NCT05927233|Hormones|hormones|mesh-ancestor
92067906|NCT05927233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067907|NCT05927233|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92067908|NCT05927233|Protective Agents|protective agents|mesh-ancestor
92067909|NCT05927233|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92067910|NCT05927233|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067911|NCT05919823|Xanomeline|xanomeline|mesh-list
92067912|NCT05919823|Trospium chloride|trospium chloride|mesh-list
92067913|NCT05919823|Parasympatholytics|parasympatholytics|mesh-ancestor
92067914|NCT05919823|Autonomic Agents|autonomic agents|mesh-ancestor
92067915|NCT05919823|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067916|NCT05919823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067917|NCT05919823|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92067918|NCT05919823|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92067919|NCT05919823|Cholinergic Agents|cholinergic agents|mesh-ancestor
92067920|NCT05919823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015620|NCT04431895|Tofacitinib|tofacitinib|mesh-list
92015621|NCT04431895|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92015622|NCT04431895|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015623|NCT04431895|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067921|NCT05919823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067922|NCT05919823|Urological Agents|urological agents|mesh-ancestor
92067923|NCT05919823|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92067924|NCT05919823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92067925|NCT05919823|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92067931|NCT05907213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067932|NCT05907213|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92067933|NCT05907213|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92067934|NCT05907213|Anesthetics, General|anesthetics, general|mesh-ancestor
92067935|NCT05907213|Anesthetics|anesthetics|mesh-ancestor
92067936|NCT05907213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067937|NCT05907213|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92067938|NCT05907213|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92067939|NCT05907213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067940|NCT05907213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067943|NCT05887609|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92067944|NCT05887609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92067945|NCT05887609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067946|NCT05887609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067947|NCT05887609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067948|NCT05887609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92067949|NCT05887609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92067950|NCT05887609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92067951|NCT05887609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92067952|NCT05887609|Immunoconjugates|immunoconjugates|mesh-ancestor
92067953|NCT05887609|Immunologic Factors|immunologic factors|mesh-ancestor
92067954|NCT05887609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067955|NCT05873218|Ephedrine|ephedrine|mesh-list
92067956|NCT05873218|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92067957|NCT05873218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067958|NCT05873218|Sympathomimetics|sympathomimetics|mesh-ancestor
92067959|NCT05873218|Autonomic Agents|autonomic agents|mesh-ancestor
92067960|NCT05873218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067961|NCT05873218|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92067962|NCT05873218|Adrenergic Agents|adrenergic agents|mesh-ancestor
92067963|NCT05873218|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92067964|NCT05873218|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067965|NCT05872204|Letrozole|letrozole|mesh-list
92067966|NCT05872204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067967|NCT05872204|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92067968|NCT05872204|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92067969|NCT05872204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067970|NCT05872204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067971|NCT05872204|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92067972|NCT05872204|Hormone Antagonists|hormone antagonists|mesh-ancestor
92067973|NCT05872204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067974|NCT05872204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067975|NCT05864625|Propofol|propofol|mesh-list
92067976|NCT05864625|Sevoflurane|sevoflurane|mesh-list
92067977|NCT05864625|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92067978|NCT05864625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067979|NCT05864625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067980|NCT05864625|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92067981|NCT05864625|Anesthetics, General|anesthetics, general|mesh-ancestor
92067982|NCT05864625|Anesthetics|anesthetics|mesh-ancestor
92067983|NCT05864625|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92067984|NCT05864625|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92067985|NCT05862285|Ipatasertib|ipatasertib|mesh-list
92067986|NCT05862285|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067987|NCT05862285|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92067988|NCT05862285|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067989|NCT05862285|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067990|NCT05846646|Pembrolizumab|pembrolizumab|mesh-list
92067991|NCT05846646|Nivolumab|nivolumab|mesh-list
92067992|NCT05846646|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92015624|NCT04431895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015625|NCT03064633|Dexamethasone|dexamethasone|mesh-list
92015626|NCT03064633|Dexamethasone acetate|dexamethasone acetate|mesh-list
92015627|NCT03064633|Dexmedetomidine|dexmedetomidine|mesh-list
92067993|NCT05846646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067994|NCT05846646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067995|NCT05846646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068016|NCT05839158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068017|NCT05839158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068019|NCT05827549|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068020|NCT05820685|Dronabinol|dronabinol|mesh-list
92068021|NCT05820685|Hallucinogens|hallucinogens|mesh-ancestor
92068022|NCT05820685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068023|NCT05820685|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92068024|NCT05820685|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92068025|NCT05820685|Analgesics|analgesics|mesh-ancestor
92068026|NCT05820685|Sensory System Agents|sensory system agents|mesh-ancestor
92068027|NCT05820685|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068028|NCT05820685|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92068029|NCT05820685|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92068030|NCT05820685|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068031|NCT05820685|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068032|NCT05820685|Hormones|hormones|mesh-ancestor
92068033|NCT05820685|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068050|NCT05754710|Tofacitinib|tofacitinib|mesh-list
92068051|NCT05754710|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92068052|NCT05754710|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068053|NCT05754710|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068054|NCT05754710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068055|NCT05742841|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92068056|NCT05742841|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92068057|NCT05742841|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92068058|NCT05742841|Antimetabolites|antimetabolites|mesh-ancestor
92068059|NCT05742841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068060|NCT05742841|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92068061|NCT05742841|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92068062|NCT05742841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068063|NCT05742607|Paclitaxel|paclitaxel|mesh-list
92068064|NCT05742607|Cisplatin|cisplatin|mesh-list
92068065|NCT05742607|Carboplatin|carboplatin|mesh-list
92068066|NCT05742607|Pemetrexed|pemetrexed|mesh-list
92068067|NCT05742607|Durvalumab|durvalumab|mesh-list
92068068|NCT05742607|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068071|NCT05742607|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068072|NCT05742607|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068073|NCT05742607|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068074|NCT05742607|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068075|NCT05742607|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068076|NCT05742607|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92068077|NCT05742607|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068078|NCT05742607|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068079|NCT05742607|Immunologic Factors|immunologic factors|mesh-ancestor
92068080|NCT05742607|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068081|NCT05704933|Nivolumab|nivolumab|mesh-list
92068082|NCT05704933|Ipilimumab|ipilimumab|mesh-list
92068083|NCT05704933|Relatlimab|relatlimab|mesh-list
92068084|NCT05704933|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068085|NCT05704933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068086|NCT05704933|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068087|NCT05704933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068088|NCT05694364|Cyclophosphamide|cyclophosphamide|mesh-list
92068089|NCT05694364|Fludarabine|fludarabine|mesh-list
92068090|NCT05694364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068091|NCT05694364|Immunologic Factors|immunologic factors|mesh-ancestor
92068092|NCT05694364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068093|NCT05694364|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068094|NCT05694364|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92068095|NCT05694364|Alkylating Agents|alkylating agents|mesh-ancestor
92068096|NCT05694364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015628|NCT03064633|Bupivacaine|bupivacaine|mesh-list
92015629|NCT03064633|BB 1101|bb 1101|mesh-list
92015630|NCT03064633|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015631|NCT03064633|Antiemetics|antiemetics|mesh-ancestor
92015632|NCT03064633|Autonomic Agents|autonomic agents|mesh-ancestor
92068097|NCT05694364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068098|NCT05694364|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92068099|NCT05686408|Tianeptine|tianeptine|mesh-list
92068100|NCT05686408|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92068101|NCT05686408|Antidepressive Agents|antidepressive agents|mesh-ancestor
92068102|NCT05686408|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92068103|NCT05683977|Durvalumab|durvalumab|mesh-list
92068104|NCT05683977|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068105|NCT05683977|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068106|NCT05676476|Antihypertensive Agents|antihypertensive agents|mesh-list
92068107|NCT05660525|Nicotine|nicotine|mesh-list
92068108|NCT05660525|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92068109|NCT05660525|Autonomic Agents|autonomic agents|mesh-ancestor
92068110|NCT05660525|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068111|NCT05660525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068112|NCT05660525|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92068113|NCT05660525|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92068114|NCT05660525|Cholinergic Agents|cholinergic agents|mesh-ancestor
92068115|NCT05660525|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068116|NCT05660525|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068117|NCT05648110|Cilgavimab and tixagevimab drug combination|cilgavimab and tixagevimab drug combination|mesh-list
92068118|NCT05648110|Antiviral Agents|antiviral agents|mesh-ancestor
92068119|NCT05648110|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068120|NCT05647564|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92068121|NCT05647564|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92068122|NCT05647564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068123|NCT05640245|Adalimumab|adalimumab|mesh-list
92068124|NCT05640245|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92068125|NCT05640245|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068126|NCT05640245|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068127|NCT05601752|Nivolumab|nivolumab|mesh-list
92068128|NCT05601752|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068129|NCT05601752|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068130|NCT05601752|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068131|NCT05601752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068132|NCT05595642|Astegolimab|astegolimab|mesh-list
92068133|NCT05595642|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92068134|NCT05595642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068135|NCT05595642|Antiviral Agents|antiviral agents|mesh-ancestor
92068136|NCT05595642|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068137|NCT05576662|Ritonavir|ritonavir|mesh-list
92068138|NCT05576662|Nirmatrelvir|nirmatrelvir|mesh-list
92068139|NCT05576662|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92068140|NCT05576662|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92068154|NCT05553366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068155|NCT05553366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068156|NCT05553366|Antipyretics|antipyretics|mesh-ancestor
92068171|NCT05497804|Dexamethasone acetate|dexamethasone acetate|mesh-list
92068172|NCT05497804|Lenalidomide|lenalidomide|mesh-list
92068173|NCT05497804|Daratumumab|daratumumab|mesh-list
92068175|NCT05497804|BB 1101|bb 1101|mesh-list
92068176|NCT05497804|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068177|NCT05497804|Antiemetics|antiemetics|mesh-ancestor
92068178|NCT05497804|Autonomic Agents|autonomic agents|mesh-ancestor
92068179|NCT05497804|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068180|NCT05497804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068181|NCT05497804|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068182|NCT05497804|Glucocorticoids|glucocorticoids|mesh-ancestor
92068183|NCT05497804|Hormones|hormones|mesh-ancestor
92068184|NCT05497804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068185|NCT05497804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92068186|NCT05497804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068187|NCT05497804|Protease Inhibitors|protease inhibitors|mesh-ancestor
92068188|NCT05497804|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068189|NCT05497804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068190|NCT05497804|Immunologic Factors|immunologic factors|mesh-ancestor
92068191|NCT05497804|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92015634|NCT03064633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015635|NCT03064633|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015636|NCT03064633|Glucocorticoids|glucocorticoids|mesh-ancestor
92068192|NCT05497804|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92068193|NCT05497804|Growth Substances|growth substances|mesh-ancestor
92068194|NCT05497804|Growth Inhibitors|growth inhibitors|mesh-ancestor
92068195|NCT05497804|Dermatologic Agents|dermatologic agents|mesh-ancestor
92068196|NCT05490511|Cannabidiol|cannabidiol|mesh-list
92068197|NCT05490511|Tacrolimus|tacrolimus|mesh-list
92068198|NCT05490511|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068199|NCT05490511|Immunologic Factors|immunologic factors|mesh-ancestor
92068200|NCT05490511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068201|NCT05490511|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92068202|NCT05490511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068203|NCT05490511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068204|NCT05490511|Anticonvulsants|anticonvulsants|mesh-ancestor
92068205|NCT05450692|Docetaxel|docetaxel|mesh-list
92068206|NCT05450692|Durvalumab|durvalumab|mesh-list
92068207|NCT05450692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068208|NCT05450692|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068209|NCT05450692|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068210|NCT05450692|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068211|NCT05450692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068212|NCT05450692|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068213|NCT05441280|Pimavanserin|pimavanserin|mesh-list
92068214|NCT05441280|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92068215|NCT05441280|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92068216|NCT05441280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92068220|NCT05441280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92068221|NCT05441280|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92068222|NCT05441280|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92068223|NCT05441280|Serotonin Agents|serotonin agents|mesh-ancestor
92068224|NCT05441280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068225|NCT05441280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068226|NCT05429502|Temozolomide|temozolomide|mesh-list
92068227|NCT05429502|Topotecan|topotecan|mesh-list
92068228|NCT05429502|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92068229|NCT05429502|Alkylating Agents|alkylating agents|mesh-ancestor
92068230|NCT05429502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068231|NCT05429502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068232|NCT05429502|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92068233|NCT05429502|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92068235|NCT05413161|Omalizumab|omalizumab|mesh-list
92068236|NCT05413161|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068237|NCT05413161|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92068238|NCT05413161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92068239|NCT05413161|Respiratory System Agents|respiratory system agents|mesh-ancestor
92068240|NCT05413161|Immunologic Factors|immunologic factors|mesh-ancestor
92068241|NCT05413161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068242|NCT05413122|Nicotine|nicotine|mesh-list
92068243|NCT05413122|Varenicline|varenicline|mesh-list
92068244|NCT05413122|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92068245|NCT05413122|Autonomic Agents|autonomic agents|mesh-ancestor
92068246|NCT05413122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068247|NCT05413122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068248|NCT05413122|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92068249|NCT05413122|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92068250|NCT05413122|Cholinergic Agents|cholinergic agents|mesh-ancestor
92068251|NCT05413122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068252|NCT05413122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068253|NCT05378750|Diuretics|diuretics|mesh-list
92068254|NCT05378750|Natriuretic Agents|natriuretic agents|mesh-ancestor
92068255|NCT05378750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068256|NCT05370885|Vancomycin|vancomycin|mesh-list
92068257|NCT05370885|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92068258|NCT05370885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068259|NCT05366816|Sunitinib|sunitinib|mesh-list
92068260|NCT05366816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068261|NCT05366816|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92068262|NCT05366816|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92015637|NCT03064633|Hormones|hormones|mesh-ancestor
92015638|NCT03064633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068263|NCT05366816|Growth Substances|growth substances|mesh-ancestor
92068264|NCT05366816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068265|NCT05366816|Growth Inhibitors|growth inhibitors|mesh-ancestor
92068266|NCT05366816|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068267|NCT05366816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068268|NCT05366816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068269|NCT05362955|Fluorouracil|fluorouracil|mesh-list
92068270|NCT05362955|Antimetabolites|antimetabolites|mesh-ancestor
92068271|NCT05362955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068272|NCT05362955|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068273|NCT05362955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068274|NCT05362955|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068275|NCT05362955|Immunologic Factors|immunologic factors|mesh-ancestor
92068276|NCT05362955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068277|NCT05343169|Naloxone|naloxone|mesh-list
92068278|NCT05343169|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92068279|NCT05343169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068280|NCT05343169|Sensory System Agents|sensory system agents|mesh-ancestor
92068281|NCT05343169|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068282|NCT05331183|Ivacaftor|ivacaftor|mesh-list
92068283|NCT05331183|Elexacaftor|elexacaftor|mesh-list
92068284|NCT05331183|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92068285|NCT05331183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92068286|NCT05331183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068287|NCT05319587|Cytarabine|cytarabine|mesh-list
92068288|NCT05319587|Annamycin|annamycin|mesh-list
92068291|NCT05319587|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068292|NCT05319587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068294|NCT05319587|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068295|NCT05319587|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068296|NCT05319587|Immunologic Factors|immunologic factors|mesh-ancestor
92068297|NCT05319587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068298|NCT05319587|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92068299|NCT05316116|Siltuximab|siltuximab|mesh-list
92068300|NCT05316116|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068301|NCT05269706|Cannabidiol|cannabidiol|mesh-list
92068302|NCT05269706|Anticonvulsants|anticonvulsants|mesh-ancestor
92068303|NCT05257824|Aspirin|aspirin|mesh-list
92068304|NCT05257824|Clopidogrel|clopidogrel|mesh-list
92068305|NCT05257824|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92068306|NCT05257824|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92068307|NCT05257824|Analgesics|analgesics|mesh-ancestor
92068308|NCT05257824|Sensory System Agents|sensory system agents|mesh-ancestor
92068309|NCT05257824|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068310|NCT05257824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068312|NCT05257824|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068313|NCT05257824|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92068314|NCT05257824|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92068315|NCT05257824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068316|NCT05257824|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92068317|NCT05257824|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92068318|NCT05257824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068319|NCT05257824|Antipyretics|antipyretics|mesh-ancestor
92068320|NCT05257824|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92068321|NCT05257824|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92068322|NCT05257824|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92068323|NCT05257824|Purinergic Agents|purinergic agents|mesh-ancestor
92068324|NCT05257824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068325|NCT05228314|Aluminum Hydroxide|aluminum hydroxide|mesh-list
92068326|NCT05228314|Vaccines|vaccines|mesh-list
92068327|NCT05228314|Aluminum sulfate|aluminum sulfate|mesh-list
92068328|NCT05228314|Immunologic Factors|immunologic factors|mesh-ancestor
92068329|NCT05228314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068330|NCT05228314|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92068331|NCT05228314|Antacids|antacids|mesh-ancestor
92068332|NCT05228314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068333|NCT05228314|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068334|NCT05216328|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92068335|NCT05216328|Antacids|antacids|mesh-ancestor
92068336|NCT05216328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015639|NCT03064633|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92015640|NCT03064633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068337|NCT05216328|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068338|NCT05183854|Vaccines|vaccines|mesh-list
92068339|NCT05183854|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92068340|NCT05183854|Immunologic Factors|immunologic factors|mesh-ancestor
92068341|NCT05183854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068342|NCT05167760|Apraclonidine|apraclonidine|mesh-list
92068343|NCT05167760|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92068344|NCT05167760|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92068345|NCT05167760|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92068346|NCT05167760|Adrenergic Agents|adrenergic agents|mesh-ancestor
92068347|NCT05167760|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068348|NCT05167760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068349|NCT05167760|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068351|NCT05127590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068352|NCT05127590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068353|NCT05127590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068354|NCT05127590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068355|NCT05116891|Leucovorin|leucovorin|mesh-list
92068356|NCT05116891|Cisplatin|cisplatin|mesh-list
92068357|NCT05116891|Gemcitabine|gemcitabine|mesh-list
92068358|NCT05116891|Docetaxel|docetaxel|mesh-list
92068359|NCT05116891|Fluorouracil|fluorouracil|mesh-list
92068360|NCT05116891|Oxaliplatin|oxaliplatin|mesh-list
92068361|NCT05116891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068362|NCT05116891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068365|NCT05116891|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068366|NCT05116891|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068367|NCT05116891|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068368|NCT05116891|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068369|NCT05116891|Immunologic Factors|immunologic factors|mesh-ancestor
92068370|NCT05116891|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068371|NCT05116891|Antidotes|antidotes|mesh-ancestor
92068372|NCT05116891|Protective Agents|protective agents|mesh-ancestor
92068373|NCT05116891|Vitamin B Complex|vitamin b complex|mesh-ancestor
92068374|NCT05116891|Vitamins|vitamins|mesh-ancestor
92068375|NCT05116891|Micronutrients|micronutrients|mesh-ancestor
92068376|NCT05069038|Palbociclib|palbociclib|mesh-list
92068377|NCT05069038|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068378|NCT05069038|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068379|NCT05069038|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068380|NCT05069038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068381|NCT05060549|Cariprazine|cariprazine|mesh-list
92068382|NCT05060549|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92068383|NCT05060549|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92068384|NCT05060549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068385|NCT05060549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068386|NCT05060549|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92068387|NCT05020912|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92068388|NCT05020912|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92068389|NCT05020912|Dermatologic Agents|dermatologic agents|mesh-ancestor
92068390|NCT05017012|Paclitaxel|paclitaxel|mesh-list
92068391|NCT05017012|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92068392|NCT05017012|Carboplatin|carboplatin|mesh-list
92068393|NCT05017012|Pembrolizumab|pembrolizumab|mesh-list
92068394|NCT05017012|Pemetrexed|pemetrexed|mesh-list
92068395|NCT05017012|Axitinib|axitinib|mesh-list
92068396|NCT05017012|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068397|NCT05017012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068398|NCT05017012|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068399|NCT05017012|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068400|NCT05017012|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068401|NCT05017012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068402|NCT05017012|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068403|NCT05017012|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068404|NCT05017012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068405|NCT05017012|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92068406|NCT05017012|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068407|NCT05017012|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068408|NCT04983030|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92015641|NCT03064633|Protease Inhibitors|protease inhibitors|mesh-ancestor
92015642|NCT03064633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068409|NCT04983030|Antiviral Agents|antiviral agents|mesh-ancestor
92068410|NCT04983030|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068411|NCT04973566|Hydroxychloroquine|hydroxychloroquine|mesh-list
92068412|NCT04973566|Etanercept|etanercept|mesh-list
92068413|NCT04973566|Antimalarials|antimalarials|mesh-ancestor
92068414|NCT04973566|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92068415|NCT04973566|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92068416|NCT04973566|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068417|NCT04973566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068418|NCT04973566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068419|NCT04973566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068420|NCT04973566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92068421|NCT04973566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92068422|NCT04973566|Analgesics|analgesics|mesh-ancestor
92068423|NCT04973566|Sensory System Agents|sensory system agents|mesh-ancestor
92068424|NCT04973566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068425|NCT04973566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068426|NCT04973566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068427|NCT04973566|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068428|NCT04973566|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068429|NCT04973566|Immunologic Factors|immunologic factors|mesh-ancestor
92068431|NCT04965155|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068432|NCT04965155|Antiemetics|antiemetics|mesh-ancestor
92068433|NCT04965155|Autonomic Agents|autonomic agents|mesh-ancestor
92068434|NCT04965155|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068435|NCT04965155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068438|NCT04965155|Hormones|hormones|mesh-ancestor
92068439|NCT04965155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068440|NCT04965155|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92068441|NCT04965155|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068442|NCT04948333|Niacinamide|niacinamide|mesh-list
92068443|NCT04948333|Vitamin B Complex|vitamin b complex|mesh-ancestor
92068444|NCT04948333|Vitamins|vitamins|mesh-ancestor
92068445|NCT04948333|Micronutrients|micronutrients|mesh-ancestor
92068446|NCT04948333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068447|NCT04935359|Paclitaxel|paclitaxel|mesh-list
92068448|NCT04935359|Gemcitabine|gemcitabine|mesh-list
92068449|NCT04935359|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068450|NCT04935359|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068451|NCT04935359|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068452|NCT04935359|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068453|NCT04935359|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068454|NCT04935359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068455|NCT04935359|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068456|NCT04935359|Antimetabolites|antimetabolites|mesh-ancestor
92068457|NCT04903197|Lenalidomide|lenalidomide|mesh-list
92068458|NCT04903197|Immunologic Factors|immunologic factors|mesh-ancestor
92068459|NCT04903197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068460|NCT04903197|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92068461|NCT04903197|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92068462|NCT04903197|Growth Substances|growth substances|mesh-ancestor
92068463|NCT04903197|Growth Inhibitors|growth inhibitors|mesh-ancestor
92068464|NCT04903197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068465|NCT04902378|Insulin|insulin|mesh-list
92068466|NCT04902378|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92068467|NCT04902378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068468|NCT04863885|Nivolumab|nivolumab|mesh-list
92068469|NCT04863885|Ipilimumab|ipilimumab|mesh-list
92068470|NCT04863885|Sacituzumab govitecan|sacituzumab govitecan|mesh-list
92068471|NCT04863885|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068472|NCT04863885|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068473|NCT04863885|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068474|NCT04863885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068475|NCT04863885|Immunoconjugates|immunoconjugates|mesh-ancestor
92068476|NCT04863885|Immunologic Factors|immunologic factors|mesh-ancestor
92068477|NCT04863885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068478|NCT04856189|Pembrolizumab|pembrolizumab|mesh-list
92068479|NCT04856189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068480|NCT04856189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068481|NCT04856189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068482|NCT04856189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068483|NCT04855929|Ipilimumab|ipilimumab|mesh-list
92068484|NCT04855929|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068485|NCT04855929|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068486|NCT04855929|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068487|NCT04855929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068488|NCT04810078|Nivolumab|nivolumab|mesh-list
92068489|NCT04810078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068490|NCT04810078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068491|NCT04810078|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068492|NCT04810078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068493|NCT04779242|Moxifloxacin|moxifloxacin|mesh-list
92068494|NCT04779242|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92068495|NCT04779242|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068496|NCT04779242|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92068497|NCT04779242|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92068498|NCT04779242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068499|NCT04779242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068500|NCT04779242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068501|NCT04760496|Oxytocin|oxytocin|mesh-list
92068502|NCT04760496|Oxytocics|oxytocics|mesh-ancestor
92068503|NCT04760496|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92068504|NCT04760496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068505|NCT04724837|Dapagliflozin|dapagliflozin|mesh-list
92068506|NCT04724837|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92068507|NCT04724837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068519|NCT04690192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068520|NCT04690192|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92068521|NCT04690192|Alkylating Agents|alkylating agents|mesh-ancestor
92068522|NCT04690192|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92068523|NCT04690192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068524|NCT04690192|Immunologic Factors|immunologic factors|mesh-ancestor
92068525|NCT04690192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068526|NCT04682431|Pembrolizumab|pembrolizumab|mesh-list
92068527|NCT04682431|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068528|NCT04682431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068529|NCT04682431|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068530|NCT04682431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068532|NCT04675788|Testosterone|testosterone|mesh-list
92068533|NCT04675788|Progesterone|progesterone|mesh-list
92068534|NCT04675788|Androgens|androgens|mesh-ancestor
92068535|NCT04675788|Hormones|hormones|mesh-ancestor
92068536|NCT04675788|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068537|NCT04675788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068538|NCT04675788|Progestins|progestins|mesh-ancestor
92068539|NCT04675788|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92068548|NCT04631029|Carboplatin|carboplatin|mesh-list
92068549|NCT04631029|Etoposide|etoposide|mesh-list
92068550|NCT04631029|Etoposide phosphate|etoposide phosphate|mesh-list
92068551|NCT04631029|Atezolizumab|atezolizumab|mesh-list
92068552|NCT04631029|Podophyllotoxin|podophyllotoxin|mesh-list
92068553|NCT04631029|Entinostat|entinostat|mesh-list
92068554|NCT04631029|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068555|NCT04631029|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92068556|NCT04631029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068557|NCT04631029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068558|NCT04631029|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92068559|NCT04631029|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92068560|NCT04631029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068561|NCT04631029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068562|NCT04631029|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068563|NCT04631029|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068564|NCT04631029|Immunologic Factors|immunologic factors|mesh-ancestor
92068565|NCT04631029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068566|NCT04631029|Keratolytic Agents|keratolytic agents|mesh-ancestor
92068567|NCT04631029|Dermatologic Agents|dermatologic agents|mesh-ancestor
92068568|NCT04631029|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068569|NCT04631029|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068570|NCT04631029|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068571|NCT04626518|Pembrolizumab|pembrolizumab|mesh-list
92068572|NCT04626518|Lenvatinib|lenvatinib|mesh-list
92068573|NCT04626518|Belzutifan|belzutifan|mesh-list
92068574|NCT04626518|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068575|NCT04626518|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015643|NCT03064633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015644|NCT03064633|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015646|NCT03064633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068576|NCT04626518|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068577|NCT04626518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068578|NCT04626518|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068579|NCT04626518|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068580|NCT04567784|Cannabidiol|cannabidiol|mesh-list
92068581|NCT04567784|Anticonvulsants|anticonvulsants|mesh-ancestor
92068592|NCT04563507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068593|NCT04563507|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068594|NCT04515641|Islatravir|islatravir|mesh-list
92068595|NCT04515641|Antiviral Agents|antiviral agents|mesh-ancestor
92068596|NCT04515641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068597|NCT04515641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068598|NCT04515641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068599|NCT04515641|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92068600|NCT04515641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068601|NCT04515641|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92068602|NCT04474366|Ropivacaine|ropivacaine|mesh-list
92068603|NCT04474366|Anesthetics, Local|anesthetics, local|mesh-ancestor
92068604|NCT04474366|Anesthetics|anesthetics|mesh-ancestor
92068605|NCT04474366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068606|NCT04474366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068607|NCT04474366|Sensory System Agents|sensory system agents|mesh-ancestor
92068608|NCT04474366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068610|NCT04465643|Ipilimumab|ipilimumab|mesh-list
92068611|NCT04465643|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068612|NCT04465643|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068613|NCT04465643|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068614|NCT04465643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068615|NCT04431453|Remdesivir|remdesivir|mesh-list
92068616|NCT04431453|Antimetabolites|antimetabolites|mesh-ancestor
92068617|NCT04431453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068618|NCT04431453|Antiviral Agents|antiviral agents|mesh-ancestor
92068619|NCT04431453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068621|NCT04424303|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92068622|NCT04424303|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068623|NCT04424303|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068624|NCT04424303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068625|NCT04422431|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92068626|NCT04422431|Choline|choline|mesh-list
92068627|NCT04422431|Lipotropic Agents|lipotropic agents|mesh-ancestor
92068628|NCT04422431|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92068629|NCT04422431|Antimetabolites|antimetabolites|mesh-ancestor
92068630|NCT04422431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068631|NCT04422431|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068632|NCT04422431|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92068633|NCT04422431|Nootropic Agents|nootropic agents|mesh-ancestor
92068634|NCT04422431|Chelating Agents|chelating agents|mesh-ancestor
92068635|NCT04422431|Sequestering Agents|sequestering agents|mesh-ancestor
92068636|NCT04422431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068637|NCT04422431|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92068638|NCT04422431|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92068639|NCT04422431|Growth Substances|growth substances|mesh-ancestor
92068640|NCT04422431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068641|NCT04422431|Growth Inhibitors|growth inhibitors|mesh-ancestor
92068642|NCT04422431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068643|NCT04416451|Rituximab|rituximab|mesh-list
92068644|NCT04416451|Venetoclax|venetoclax|mesh-list
92068645|NCT04416451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068655|NCT04406649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068657|NCT04406649|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92068658|NCT04406649|Analgesics|analgesics|mesh-ancestor
92068659|NCT04406649|Sensory System Agents|sensory system agents|mesh-ancestor
92068660|NCT04406649|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015647|NCT03064633|Sensory System Agents|sensory system agents|mesh-ancestor
92015648|NCT03064633|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92015649|NCT03064633|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92068661|NCT04316390|Vitamins|vitamins|mesh-list
92068662|NCT04316390|Ascorbic Acid|ascorbic acid|mesh-list
92068663|NCT04316390|Micronutrients|micronutrients|mesh-ancestor
92068664|NCT04316390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068665|NCT04316390|Antioxidants|antioxidants|mesh-ancestor
92068666|NCT04316390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068667|NCT04316390|Protective Agents|protective agents|mesh-ancestor
92068668|NCT04251533|Paclitaxel|paclitaxel|mesh-list
92068669|NCT04251533|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068670|NCT04251533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068671|NCT04251533|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068672|NCT04251533|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068673|NCT04251533|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068674|NCT04251533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068675|NCT04241185|Gemcitabine|gemcitabine|mesh-list
92068676|NCT04241185|Pembrolizumab|pembrolizumab|mesh-list
92068677|NCT04241185|Fluorouracil|fluorouracil|mesh-list
92068678|NCT04241185|Mitomycins|mitomycins|mesh-list
92068679|NCT04241185|Mitomycin|mitomycin|mesh-list
92068680|NCT04241185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068681|NCT04241185|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068682|NCT04241185|Antimetabolites|antimetabolites|mesh-ancestor
92068683|NCT04241185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068684|NCT04241185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068685|NCT04241185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068686|NCT04241185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068687|NCT04241185|Immunologic Factors|immunologic factors|mesh-ancestor
92068688|NCT04241185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068689|NCT04241185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92068690|NCT04241185|Alkylating Agents|alkylating agents|mesh-ancestor
92068691|NCT04241185|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068692|NCT04241185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068694|NCT04236414|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92068695|NCT04236414|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068696|NCT04236414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068697|NCT04236414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068698|NCT04228042|Infigratinib|infigratinib|mesh-list
92068699|NCT04228042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068701|NCT04214067|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068702|NCT04214067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068703|NCT04214067|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068704|NCT04214067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068705|NCT04208178|Trastuzumab|trastuzumab|mesh-list
92068706|NCT04208178|Pertuzumab|pertuzumab|mesh-list
92068707|NCT04208178|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068708|NCT04208178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068709|NCT04206319|Listerine|listerine|mesh-list
92068710|NCT04206319|Fluorides|fluorides|mesh-list
92068711|NCT04206319|Sodium Fluoride|sodium fluoride|mesh-list
92068712|NCT04206319|Cariostatic Agents|cariostatic agents|mesh-ancestor
92068715|NCT04206319|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92068716|NCT04206319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068717|NCT04171817|Chlorhexidine|chlorhexidine|mesh-list
92068718|NCT04171817|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92068719|NCT04171817|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068720|NCT04171817|Disinfectants|disinfectants|mesh-ancestor
92068721|NCT04163952|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92068722|NCT04163952|Panitumumab|panitumumab|mesh-list
92068723|NCT04163952|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92068724|NCT04163952|Antibodies|antibodies|mesh-list
92068725|NCT04163952|Immunoglobulins|immunoglobulins|mesh-list
92068726|NCT04163952|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068727|NCT04163952|Immunologic Factors|immunologic factors|mesh-ancestor
92068728|NCT04163952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068729|NCT04163952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068730|NCT04152863|Pembrolizumab|pembrolizumab|mesh-list
92068731|NCT04152863|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068732|NCT04152863|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015651|NCT03064633|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92068733|NCT04152863|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068734|NCT04152863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068735|NCT04129554|Tenofovir|tenofovir|mesh-list
92068736|NCT04129554|Entecavir|entecavir|mesh-list
92068737|NCT04129554|JNJ-56136379|jnj-56136379|mesh-list
92068738|NCT04129554|Antiviral Agents|antiviral agents|mesh-ancestor
92068739|NCT04129554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068740|NCT04129554|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92068741|NCT04129554|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068742|NCT04129554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068743|NCT04129554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068744|NCT04129554|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92068745|NCT04129554|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92068746|NCT04109729|Nivolumab|nivolumab|mesh-list
92068747|NCT04109729|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068748|NCT04109729|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068749|NCT04109729|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068750|NCT04109729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068751|NCT04106856|Losartan|losartan|mesh-list
92068752|NCT04106856|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92068753|NCT04106856|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92068755|NCT04106856|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92068756|NCT04106856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068757|NCT04098666|Metformin|metformin|mesh-list
92068758|NCT04098666|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92068759|NCT04098666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068760|NCT04094311|Tisagenlecleucel|tisagenlecleucel|mesh-list
92068761|NCT04094311|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068762|NCT04094311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068763|NCT04049513|Cyclophosphamide|cyclophosphamide|mesh-list
92068764|NCT04049513|Fludarabine|fludarabine|mesh-list
92068765|NCT04049513|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068766|NCT04049513|Immunologic Factors|immunologic factors|mesh-ancestor
92068767|NCT04049513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068768|NCT04049513|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068769|NCT04049513|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92068770|NCT04049513|Alkylating Agents|alkylating agents|mesh-ancestor
92068771|NCT04049513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068772|NCT04049513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068773|NCT04049513|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92068774|NCT04002180|Vedolizumab|vedolizumab|mesh-list
92068775|NCT04002180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068776|NCT03997123|Paclitaxel|paclitaxel|mesh-list
92068777|NCT03997123|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068778|NCT03997123|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068779|NCT03997123|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068780|NCT03997123|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068781|NCT03997123|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068782|NCT03997123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068783|NCT03968419|Pembrolizumab|pembrolizumab|mesh-list
92068784|NCT03968419|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068792|NCT03924986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068793|NCT03924986|Antimetabolites|antimetabolites|mesh-ancestor
92068794|NCT03924986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068795|NCT03910244|Pomalidomide|pomalidomide|mesh-list
92068796|NCT03910244|Immunologic Factors|immunologic factors|mesh-ancestor
92068797|NCT03910244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068798|NCT03910244|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92068799|NCT03910244|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92068800|NCT03910244|Growth Substances|growth substances|mesh-ancestor
92068801|NCT03910244|Growth Inhibitors|growth inhibitors|mesh-ancestor
92068802|NCT03910244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068803|NCT03904550|Rocuronium|rocuronium|mesh-list
92068804|NCT03904550|Cisatracurium|cisatracurium|mesh-list
92068805|NCT03904550|Neostigmine|neostigmine|mesh-list
92068806|NCT03904550|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92068807|NCT03904550|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92068808|NCT03904550|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92015652|NCT03064633|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92015653|NCT03064633|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92015654|NCT03064633|Adrenergic Agents|adrenergic agents|mesh-ancestor
92015655|NCT03064633|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068809|NCT03904550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068810|NCT03904550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068811|NCT03904550|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92068812|NCT03904550|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068813|NCT03904550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068814|NCT03904550|Cholinergic Agents|cholinergic agents|mesh-ancestor
92068815|NCT03904550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068816|NCT03904550|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92068817|NCT03904550|Autonomic Agents|autonomic agents|mesh-ancestor
92068818|NCT03866577|Immunoglobulins|immunoglobulins|mesh-list
92068819|NCT03866577|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92068820|NCT03866577|Antibodies|antibodies|mesh-list
92068821|NCT03866577|gamma-Globulins|gamma-globulins|mesh-list
92068822|NCT03866577|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92068823|NCT03866577|Immunologic Factors|immunologic factors|mesh-ancestor
92068824|NCT03866577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068825|NCT03834883|Ibutilide|ibutilide|mesh-list
92068826|NCT03834883|Progesterone|progesterone|mesh-list
92068827|NCT03834883|Progestins|progestins|mesh-ancestor
92068828|NCT03834883|Hormones|hormones|mesh-ancestor
92068829|NCT03834883|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068830|NCT03834883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068831|NCT03834883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92068832|NCT03822468|Letrozole|letrozole|mesh-list
92068833|NCT03822468|Anastrozole|anastrozole|mesh-list
92068834|NCT03822468|Goserelin|goserelin|mesh-list
92068835|NCT03822468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068836|NCT03822468|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92068837|NCT03822468|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92068838|NCT03822468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068839|NCT03822468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068840|NCT03822468|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92068841|NCT03822468|Hormone Antagonists|hormone antagonists|mesh-ancestor
92068842|NCT03822468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068843|NCT03822468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068844|NCT03822468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92068845|NCT03816332|Prednisone|prednisone|mesh-list
92068846|NCT03816332|Cortisone|cortisone|mesh-list
92068847|NCT03816332|Nivolumab|nivolumab|mesh-list
92068848|NCT03816332|Ipilimumab|ipilimumab|mesh-list
92068849|NCT03816332|Tacrolimus|tacrolimus|mesh-list
92068850|NCT03816332|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068851|NCT03816332|Glucocorticoids|glucocorticoids|mesh-ancestor
92068852|NCT03816332|Hormones|hormones|mesh-ancestor
92068853|NCT03816332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068855|NCT03816332|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92068857|NCT03816332|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068858|NCT03816332|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068859|NCT03816332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068860|NCT03816332|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068861|NCT03816332|Immunologic Factors|immunologic factors|mesh-ancestor
92068862|NCT03816332|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92068863|NCT03816332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068865|NCT03810807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068866|NCT03810807|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068867|NCT03810807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068868|NCT03810807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068869|NCT03801902|Durvalumab|durvalumab|mesh-list
92068870|NCT03801902|Immunoglobulins|immunoglobulins|mesh-list
92068871|NCT03801902|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068872|NCT03801902|Immunoglobulin G|immunoglobulin g|mesh-list
92068873|NCT03801902|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068874|NCT03801902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068875|NCT03801902|Immunologic Factors|immunologic factors|mesh-ancestor
92068876|NCT03801902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068877|NCT03765918|Cisplatin|cisplatin|mesh-list
92068878|NCT03765918|Pembrolizumab|pembrolizumab|mesh-list
92068879|NCT03765918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015656|NCT04950465|Fluorides|fluorides|mesh-list
92015657|NCT04950465|Cariostatic Agents|cariostatic agents|mesh-ancestor
92068880|NCT03765918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068881|NCT03765918|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068882|NCT03765918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068883|NCT03759288|Adalimumab|adalimumab|mesh-list
92068884|NCT03759288|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92068885|NCT03759288|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92068886|NCT03759288|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068887|NCT03711032|Pembrolizumab|pembrolizumab|mesh-list
92068888|NCT03711032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068889|NCT03711032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068890|NCT03711032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068891|NCT03711032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068892|NCT03693014|Pembrolizumab|pembrolizumab|mesh-list
92068893|NCT03693014|Nivolumab|nivolumab|mesh-list
92068894|NCT03693014|Ipilimumab|ipilimumab|mesh-list
92068895|NCT03693014|Atezolizumab|atezolizumab|mesh-list
92068896|NCT03693014|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068897|NCT03693014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068898|NCT03693014|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068899|NCT03693014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068900|NCT03684980|Leucovorin|leucovorin|mesh-list
92068901|NCT03684980|Rituximab|rituximab|mesh-list
92068902|NCT03684980|Methotrexate|methotrexate|mesh-list
92068903|NCT03684980|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068904|NCT03684980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068905|NCT03684980|Immunologic Factors|immunologic factors|mesh-ancestor
92068906|NCT03684980|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068907|NCT03684980|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068908|NCT03684980|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92068909|NCT03684980|Abortifacient Agents|abortifacient agents|mesh-ancestor
92068910|NCT03684980|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92068911|NCT03684980|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068912|NCT03684980|Antimetabolites|antimetabolites|mesh-ancestor
92068913|NCT03684980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068914|NCT03684980|Dermatologic Agents|dermatologic agents|mesh-ancestor
92068915|NCT03684980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068916|NCT03684980|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92068917|NCT03684980|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068918|NCT03684980|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068919|NCT03684980|Antidotes|antidotes|mesh-ancestor
92068920|NCT03684980|Protective Agents|protective agents|mesh-ancestor
92068921|NCT03684980|Vitamin B Complex|vitamin b complex|mesh-ancestor
92068922|NCT03684980|Vitamins|vitamins|mesh-ancestor
92068923|NCT03684980|Micronutrients|micronutrients|mesh-ancestor
92068924|NCT03682068|Carboplatin|carboplatin|mesh-list
92068925|NCT03682068|Gemcitabine|gemcitabine|mesh-list
92068926|NCT03682068|Durvalumab|durvalumab|mesh-list
92068927|NCT03682068|Tremelimumab|tremelimumab|mesh-list
92068929|NCT03682068|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068930|NCT03682068|Antimetabolites|antimetabolites|mesh-ancestor
92068931|NCT03682068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068932|NCT03682068|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068933|NCT03672487|Benzonidazole|benzonidazole|mesh-list
92068934|NCT03672487|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92068935|NCT03672487|Immunologic Factors|immunologic factors|mesh-ancestor
92068936|NCT03672487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068937|NCT03672487|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92068938|NCT03672487|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92068939|NCT03672487|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92068940|NCT03672487|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068941|NCT03666559|Azacitidine|azacitidine|mesh-list
92068942|NCT03666559|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068943|NCT03666559|Antimetabolites|antimetabolites|mesh-ancestor
92068944|NCT03666559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068945|NCT03666559|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068946|NCT03666559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068947|NCT03662022|Rifampin|rifampin|mesh-list
92068948|NCT03662022|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92068949|NCT03662022|Antitubercular Agents|antitubercular agents|mesh-ancestor
92068950|NCT03662022|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92068951|NCT03662022|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068952|NCT03662022|Leprostatic Agents|leprostatic agents|mesh-ancestor
92015658|NCT04950465|Protective Agents|protective agents|mesh-ancestor
92068953|NCT03662022|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92068954|NCT03662022|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068955|NCT03662022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068956|NCT03662022|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92068957|NCT03662022|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92068958|NCT03662022|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92068959|NCT03662022|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92068960|NCT03662022|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92068961|NCT03662022|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92068962|NCT03660826|Durvalumab|durvalumab|mesh-list
92068963|NCT03660826|Olaparib|olaparib|mesh-list
92068964|NCT03660826|Cediranib|cediranib|mesh-list
92068965|NCT03660826|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92068966|NCT03660826|Immunoglobulins|immunoglobulins|mesh-list
92068967|NCT03660826|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068968|NCT03660826|Immunoglobulin G|immunoglobulin g|mesh-list
92068969|NCT03660826|Maleic acid|maleic acid|mesh-list
92068970|NCT03660826|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068971|NCT03660826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068972|NCT03660826|Immunologic Factors|immunologic factors|mesh-ancestor
92068973|NCT03660826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068974|NCT03660826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068975|NCT03660826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068976|NCT03660826|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92068978|NCT03648996|Antimetabolites|antimetabolites|mesh-ancestor
92068979|NCT03648996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068980|NCT03648996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068981|NCT03648996|Gout Suppressants|gout suppressants|mesh-ancestor
92068982|NCT03648996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068983|NCT03648996|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92068984|NCT03648996|Antioxidants|antioxidants|mesh-ancestor
92068985|NCT03648996|Protective Agents|protective agents|mesh-ancestor
92068986|NCT03648996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068987|NCT03631199|Paclitaxel|paclitaxel|mesh-list
92068988|NCT03631199|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92068989|NCT03631199|Carboplatin|carboplatin|mesh-list
92068990|NCT03631199|Pembrolizumab|pembrolizumab|mesh-list
92068991|NCT03631199|Pemetrexed|pemetrexed|mesh-list
92068992|NCT03631199|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92068993|NCT03631199|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068994|NCT03631199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068995|NCT03631199|Tubulin Modulators|tubulin modulators|mesh-ancestor
92068996|NCT03631199|Antimitotic Agents|antimitotic agents|mesh-ancestor
92068997|NCT03631199|Mitosis Modulators|mitosis modulators|mesh-ancestor
92068998|NCT03631199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068999|NCT03631199|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069000|NCT03631199|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069001|NCT03631199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069003|NCT03631199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069004|NCT03631199|Immunologic Factors|immunologic factors|mesh-ancestor
92069005|NCT03631199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069006|NCT03611738|Docetaxel|docetaxel|mesh-list
92069008|NCT03611738|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92069009|NCT03611738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069010|NCT03611738|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069011|NCT03611738|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069012|NCT03611738|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069013|NCT03611738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069014|NCT03611738|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069015|NCT03611738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069016|NCT03585465|Cyclophosphamide|cyclophosphamide|mesh-list
92069017|NCT03585465|Capecitabine|capecitabine|mesh-list
92069018|NCT03585465|Nivolumab|nivolumab|mesh-list
92069019|NCT03585465|Vinblastine|vinblastine|mesh-list
92069020|NCT03585465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069021|NCT03585465|Immunologic Factors|immunologic factors|mesh-ancestor
92069022|NCT03585465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069023|NCT03585465|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069024|NCT03585465|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069025|NCT03585465|Alkylating Agents|alkylating agents|mesh-ancestor
92069026|NCT03585465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015659|NCT04950465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015660|NCT02589665|Mirikizumab|mirikizumab|mesh-list
92015661|NCT02589665|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92015662|NCT02589665|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92069027|NCT03585465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069028|NCT03585465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069029|NCT03585465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069030|NCT03585465|Antimetabolites|antimetabolites|mesh-ancestor
92069031|NCT03585465|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069032|NCT03585465|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069033|NCT03585465|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069034|NCT03585465|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069035|NCT03585465|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069036|NCT03585465|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069037|NCT03523312|Capecitabine|capecitabine|mesh-list
92069038|NCT03523312|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069039|NCT03523312|Antimetabolites|antimetabolites|mesh-ancestor
92069040|NCT03523312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069129|NCT03239210|Serotonin Agents|serotonin agents|mesh-ancestor
92069041|NCT03523312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069042|NCT03471624|Tenofovir|tenofovir|mesh-list
92069043|NCT03471624|Antiviral Agents|antiviral agents|mesh-ancestor
92069045|NCT03471624|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92069046|NCT03471624|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069047|NCT03471624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069048|NCT03471624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069049|NCT03471624|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92069050|NCT03471624|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92069051|NCT03471143|Betadex|betadex|mesh-list
92069052|NCT03471143|Sequestering Agents|sequestering agents|mesh-ancestor
92069053|NCT03471143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069054|NCT03459807|Antihypertensive Agents|antihypertensive agents|mesh-list
92069055|NCT03449238|Pembrolizumab|pembrolizumab|mesh-list
92069056|NCT03449238|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069057|NCT03449238|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069058|NCT03449238|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069059|NCT03449238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069060|NCT03439293|Dexamethasone|dexamethasone|mesh-list
92069061|NCT03439293|Daratumumab|daratumumab|mesh-list
92069062|NCT03439293|Ixazomib|ixazomib|mesh-list
92069063|NCT03439293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92069064|NCT03439293|Antiemetics|antiemetics|mesh-ancestor
92069065|NCT03439293|Autonomic Agents|autonomic agents|mesh-ancestor
92069066|NCT03439293|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069067|NCT03439293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069068|NCT03439293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069069|NCT03439293|Glucocorticoids|glucocorticoids|mesh-ancestor
92069070|NCT03439293|Hormones|hormones|mesh-ancestor
92069071|NCT03439293|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069072|NCT03439293|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069073|NCT03439293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069074|NCT03439293|Protease Inhibitors|protease inhibitors|mesh-ancestor
92069075|NCT03439293|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069088|NCT03439046|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069089|NCT03439046|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92069091|NCT03423979|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069092|NCT03423979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069093|NCT03423979|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069094|NCT03423979|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069095|NCT03423979|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069096|NCT03423979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069097|NCT03404778|Cimetidine|cimetidine|mesh-list
92069098|NCT03404778|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92069099|NCT03404778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069100|NCT03404778|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92069101|NCT03404778|Histamine Antagonists|histamine antagonists|mesh-ancestor
92069102|NCT03404778|Histamine Agents|histamine agents|mesh-ancestor
92069103|NCT03404778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015664|NCT02589665|Sensory System Agents|sensory system agents|mesh-ancestor
92069104|NCT03404778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069105|NCT03404778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069106|NCT03404778|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92069107|NCT03404778|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92069108|NCT03404778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069109|NCT03258554|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92069110|NCT03258554|Cetuximab|cetuximab|mesh-list
92069111|NCT03258554|Durvalumab|durvalumab|mesh-list
92069112|NCT03258554|Antibodies|antibodies|mesh-list
92069113|NCT03258554|Immunoglobulins|immunoglobulins|mesh-list
92069114|NCT03258554|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92069115|NCT03258554|Immunoglobulin G|immunoglobulin g|mesh-list
92069116|NCT03258554|Immunologic Factors|immunologic factors|mesh-ancestor
92069117|NCT03258554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069118|NCT03258554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069119|NCT03239210|Ondansetron|ondansetron|mesh-list
92069120|NCT03239210|Antiemetics|antiemetics|mesh-ancestor
92069121|NCT03239210|Autonomic Agents|autonomic agents|mesh-ancestor
92069122|NCT03239210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069123|NCT03239210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069124|NCT03239210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069125|NCT03239210|Antipruritics|antipruritics|mesh-ancestor
92069126|NCT03239210|Dermatologic Agents|dermatologic agents|mesh-ancestor
92069127|NCT03239210|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92069128|NCT03239210|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92069130|NCT03239210|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069131|NCT03239210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069132|NCT03196466|Topiramate|topiramate|mesh-list
92069133|NCT03196466|Pregabalin|pregabalin|mesh-list
92069134|NCT03196466|Lamotrigine|lamotrigine|mesh-list
92069135|NCT03196466|Zonisamide|zonisamide|mesh-list
92069136|NCT03196466|Lacosamide|lacosamide|mesh-list
92069137|NCT03196466|Carbamazepine|carbamazepine|mesh-list
92069140|NCT03196466|Rufinamide|rufinamide|mesh-list
92069141|NCT03196466|Cannabidiol|cannabidiol|mesh-list
92069142|NCT03196466|Levetiracetam|levetiracetam|mesh-list
92069143|NCT03196466|Valproic Acid|valproic acid|mesh-list
92069144|NCT03196466|Brivaracetam|brivaracetam|mesh-list
92069145|NCT03196466|Phenobarbital|phenobarbital|mesh-list
92069146|NCT03196466|Clobazam|clobazam|mesh-list
92069147|NCT03196466|Ethosuximide|ethosuximide|mesh-list
92069148|NCT03196466|Stiripentol|stiripentol|mesh-list
92069149|NCT03196466|Tiagabine|tiagabine|mesh-list
92069150|NCT03196466|Primidone|primidone|mesh-list
92069151|NCT03196466|Felbamate|felbamate|mesh-list
92069152|NCT03196466|Analgesics|analgesics|mesh-ancestor
92069153|NCT03196466|Sensory System Agents|sensory system agents|mesh-ancestor
92069154|NCT03196466|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069155|NCT03196466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069156|NCT03196466|Anticonvulsants|anticonvulsants|mesh-ancestor
92069157|NCT03196466|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92069158|NCT03196466|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92069159|NCT03196466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069160|NCT03196466|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92069161|NCT03196466|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92069162|NCT03196466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92069163|NCT03196466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069164|NCT03196466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92069165|NCT03196466|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92069166|NCT03196466|Nootropic Agents|nootropic agents|mesh-ancestor
92069167|NCT03196466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92069168|NCT03196466|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92069169|NCT03196466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069170|NCT03196466|GABA Agents|gaba agents|mesh-ancestor
92069171|NCT03196466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069172|NCT03196466|Antimanic Agents|antimanic agents|mesh-ancestor
92069173|NCT03196466|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92069174|NCT03196466|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92069175|NCT03196466|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92069176|NCT03196466|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92069177|NCT03196466|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92069178|NCT03196466|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92015665|NCT02589665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069179|NCT03196466|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92069180|NCT03196466|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92069181|NCT03196466|GABA Modulators|gaba modulators|mesh-ancestor
92069182|NCT03196466|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92069183|NCT03196466|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92069184|NCT03196466|GABA Agonists|gaba agonists|mesh-ancestor
92069185|NCT03196466|GABA Uptake Inhibitors|gaba uptake inhibitors|mesh-ancestor
92069186|NCT03196466|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92069187|NCT03184870|Leucovorin|leucovorin|mesh-list
92069188|NCT03184870|Paclitaxel|paclitaxel|mesh-list
92069189|NCT03184870|Gemcitabine|gemcitabine|mesh-list
92069190|NCT03184870|Fluorouracil|fluorouracil|mesh-list
92069191|NCT03184870|Nivolumab|nivolumab|mesh-list
92069192|NCT03184870|Irinotecan|irinotecan|mesh-list
92069193|NCT03184870|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069194|NCT03184870|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069195|NCT03184870|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069196|NCT03184870|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069197|NCT03184870|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069198|NCT03184870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069199|NCT03184870|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069200|NCT03184870|Antimetabolites|antimetabolites|mesh-ancestor
92069201|NCT03184870|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069202|NCT03184870|Immunologic Factors|immunologic factors|mesh-ancestor
92069203|NCT03184870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069204|NCT03184870|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069205|NCT03184870|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069206|NCT03184870|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92069207|NCT03184870|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92069208|NCT03184870|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069210|NCT03184870|Protective Agents|protective agents|mesh-ancestor
92069211|NCT03184870|Vitamin B Complex|vitamin b complex|mesh-ancestor
92069212|NCT03184870|Vitamins|vitamins|mesh-ancestor
92069213|NCT03184870|Micronutrients|micronutrients|mesh-ancestor
92069214|NCT03122522|Nivolumab|nivolumab|mesh-list
92069215|NCT03122522|Ipilimumab|ipilimumab|mesh-list
92069230|NCT03108846|Escitalopram|escitalopram|mesh-list
92069231|NCT03108846|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92069232|NCT03108846|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92069233|NCT03108846|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92069234|NCT03108846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069235|NCT03108846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069236|NCT03108846|Serotonin Agents|serotonin agents|mesh-ancestor
92069237|NCT03108846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069238|NCT03103971|Cyclophosphamide|cyclophosphamide|mesh-list
92069239|NCT03103971|Fludarabine|fludarabine|mesh-list
92069240|NCT03103971|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069241|NCT03103971|Immunologic Factors|immunologic factors|mesh-ancestor
92069242|NCT03103971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069243|NCT03103971|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069244|NCT03103971|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069245|NCT03103971|Alkylating Agents|alkylating agents|mesh-ancestor
92069246|NCT03103971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069247|NCT03103971|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069248|NCT03103971|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069249|NCT03086343|Abatacept|abatacept|mesh-list
92069250|NCT03086343|Upadacitinib|upadacitinib|mesh-list
92069251|NCT03086343|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069252|NCT03086343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069253|NCT03086343|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069254|NCT03086343|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069255|NCT03086343|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069256|NCT03086343|Immunologic Factors|immunologic factors|mesh-ancestor
92069257|NCT03086343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069258|NCT03086343|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069259|NCT03086343|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92069260|NCT03086343|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069261|NCT03086343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069262|NCT02904226|Pembrolizumab|pembrolizumab|mesh-list
92069263|NCT02904226|Nivolumab|nivolumab|mesh-list
92069264|NCT02904226|Ipilimumab|ipilimumab|mesh-list
92069265|NCT02904226|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92015666|NCT02589665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015667|NCT02589665|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015668|NCT02589665|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015669|NCT02589665|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92069266|NCT02904226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069267|NCT02904226|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069268|NCT02904226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069282|NCT02775851|Pembrolizumab|pembrolizumab|mesh-list
92069283|NCT02775851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069284|NCT02775851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069285|NCT02775851|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069286|NCT02775851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069287|NCT02775695|Doxycycline|doxycycline|mesh-list
92069289|NCT02775695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069290|NCT02775695|Antimalarials|antimalarials|mesh-ancestor
92069291|NCT02775695|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92069292|NCT02775695|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92069293|NCT02679040|Trastuzumab|trastuzumab|mesh-list
92069294|NCT02679040|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069295|NCT02679040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069296|NCT02610075|Adavosertib|adavosertib|mesh-list
92069297|NCT02610075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069298|NCT02610075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069299|NCT02599454|Atezolizumab|atezolizumab|mesh-list
92069300|NCT02599454|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069301|NCT02599454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069302|NCT02599454|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069303|NCT02599454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069304|NCT02595879|Deoxyglucose|deoxyglucose|mesh-list
92069305|NCT02595879|Cisplatin|cisplatin|mesh-list
92069306|NCT02595879|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92069307|NCT02595879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069308|NCT02595879|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92069309|NCT02595879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069310|NCT02595879|Antimetabolites|antimetabolites|mesh-ancestor
92069311|NCT02595879|Antiviral Agents|antiviral agents|mesh-ancestor
92069312|NCT02595879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069313|NCT02584933|Ceritinib|ceritinib|mesh-list
92069314|NCT02584933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069315|NCT02584933|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069316|NCT02584933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069317|NCT02584933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069318|NCT02559856|Rivaroxaban|rivaroxaban|mesh-list
92069319|NCT02559856|Apixaban|apixaban|mesh-list
92069320|NCT02559856|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92069321|NCT02559856|Antithrombins|antithrombins|mesh-ancestor
92069322|NCT02559856|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92069323|NCT02559856|Protease Inhibitors|protease inhibitors|mesh-ancestor
92069324|NCT02559856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069325|NCT02559856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069326|NCT02559856|Anticoagulants|anticoagulants|mesh-ancestor
92069327|NCT02482311|Adavosertib|adavosertib|mesh-list
92069328|NCT02482311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069329|NCT02482311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069330|NCT02453282|Paclitaxel|paclitaxel|mesh-list
92069331|NCT02453282|Cisplatin|cisplatin|mesh-list
92069332|NCT02453282|Carboplatin|carboplatin|mesh-list
92069333|NCT02453282|Gemcitabine|gemcitabine|mesh-list
92069334|NCT02453282|Pemetrexed|pemetrexed|mesh-list
92069335|NCT02453282|Durvalumab|durvalumab|mesh-list
92069336|NCT02453282|Tremelimumab|tremelimumab|mesh-list
92069337|NCT02453282|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92069338|NCT02453282|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069339|NCT02453282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069340|NCT02453282|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069341|NCT02453282|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069342|NCT02453282|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069343|NCT02453282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069344|NCT02453282|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069345|NCT02453282|Antimetabolites|antimetabolites|mesh-ancestor
92069346|NCT02453282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015670|NCT02589665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015671|NCT05011383|Testosterone|testosterone|mesh-list
92069347|NCT02453282|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92069348|NCT02453282|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069349|NCT02453282|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069350|NCT02453282|Immunologic Factors|immunologic factors|mesh-ancestor
92069351|NCT02453282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069352|NCT02437318|Fulvestrant|fulvestrant|mesh-list
92069353|NCT02437318|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069354|NCT02437318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069355|NCT02437318|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92069356|NCT02437318|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92069357|NCT02437318|Hormone Antagonists|hormone antagonists|mesh-ancestor
92069358|NCT02437318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069359|NCT02437318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069360|NCT02344680|Anti-HIV Agents|anti-hiv agents|mesh-list
92069361|NCT02344680|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92069362|NCT02344680|Antiviral Agents|antiviral agents|mesh-ancestor
92069365|NCT02338609|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92069366|NCT02338609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069367|NCT02338609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069368|NCT02338609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069369|NCT02338609|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069370|NCT02338609|Immunologic Factors|immunologic factors|mesh-ancestor
92069371|NCT02338609|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069372|NCT02338609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069374|NCT02125461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069375|NCT02125461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069376|NCT01933932|Docetaxel|docetaxel|mesh-list
92069377|NCT01933932|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069378|NCT01933932|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069379|NCT01933932|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069380|NCT01933932|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069381|NCT01933932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069382|NCT01828112|Docetaxel|docetaxel|mesh-list
92069383|NCT01828112|Pemetrexed|pemetrexed|mesh-list
92069384|NCT01828112|Ceritinib|ceritinib|mesh-list
92069385|NCT01828112|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069386|NCT01828112|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069387|NCT01828112|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069388|NCT01828112|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069389|NCT01828112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069390|NCT01828112|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069391|NCT01828112|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92069392|NCT01828112|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069393|NCT01828112|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069394|NCT01466686|Temozolomide|temozolomide|mesh-list
92069395|NCT01466686|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069396|NCT01466686|Alkylating Agents|alkylating agents|mesh-ancestor
92069397|NCT01466686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069398|NCT01466686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069399|NCT01093196|Dexamethasone|dexamethasone|mesh-list
92069400|NCT01093196|Prednisone|prednisone|mesh-list
92069401|NCT01093196|Cyclophosphamide|cyclophosphamide|mesh-list
92069402|NCT01093196|Melphalan|melphalan|mesh-list
92069403|NCT01093196|Lenalidomide|lenalidomide|mesh-list
92069404|NCT01093196|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069405|NCT01093196|Immunologic Factors|immunologic factors|mesh-ancestor
92069406|NCT01093196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069407|NCT01093196|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069408|NCT01093196|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069409|NCT01093196|Alkylating Agents|alkylating agents|mesh-ancestor
92069410|NCT01093196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069411|NCT01093196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069412|NCT01093196|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069413|NCT01093196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92069414|NCT01093196|Antiemetics|antiemetics|mesh-ancestor
92069415|NCT01093196|Autonomic Agents|autonomic agents|mesh-ancestor
92069416|NCT01093196|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069417|NCT01093196|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069418|NCT01093196|Glucocorticoids|glucocorticoids|mesh-ancestor
92069419|NCT01093196|Hormones|hormones|mesh-ancestor
92015672|NCT05011383|Androgens|androgens|mesh-list
92015673|NCT05011383|Hormones|hormones|mesh-ancestor
92015674|NCT05011383|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015675|NCT05011383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015676|NCT01697527|Aldesleukin|aldesleukin|mesh-list
92015677|NCT01697527|Cyclophosphamide|cyclophosphamide|mesh-list
92015678|NCT01697527|Fludarabine|fludarabine|mesh-list
92015679|NCT01697527|Fludarabine phosphate|fludarabine phosphate|mesh-list
92015680|NCT01697527|Interleukin-2|interleukin-2|mesh-list
92015681|NCT01697527|Vaccines|vaccines|mesh-list
92015682|NCT01697527|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92015683|NCT01697527|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015684|NCT01697527|Immunologic Factors|immunologic factors|mesh-ancestor
92069420|NCT01093196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069421|NCT01093196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069422|NCT01093196|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92069423|NCT01093196|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92069424|NCT01093196|Growth Substances|growth substances|mesh-ancestor
92069425|NCT01093196|Growth Inhibitors|growth inhibitors|mesh-ancestor
92069426|NCT01091831|Dexamethasone|dexamethasone|mesh-list
92069427|NCT01091831|Cyclophosphamide|cyclophosphamide|mesh-list
92069428|NCT01091831|Melphalan|melphalan|mesh-list
92069429|NCT01091831|Lenalidomide|lenalidomide|mesh-list
92069430|NCT01091831|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069431|NCT01091831|Immunologic Factors|immunologic factors|mesh-ancestor
92069432|NCT01091831|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069433|NCT01091831|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069434|NCT01091831|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069435|NCT01091831|Alkylating Agents|alkylating agents|mesh-ancestor
92069436|NCT01091831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069441|NCT01091831|Autonomic Agents|autonomic agents|mesh-ancestor
92069442|NCT01091831|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069443|NCT01091831|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069444|NCT01091831|Glucocorticoids|glucocorticoids|mesh-ancestor
92069446|NCT01091831|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069447|NCT01091831|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069448|NCT01091831|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92069449|NCT01091831|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92069450|NCT01091831|Growth Substances|growth substances|mesh-ancestor
92069451|NCT01091831|Growth Inhibitors|growth inhibitors|mesh-ancestor
92069452|NCT00093834|Cyclophosphamide|cyclophosphamide|mesh-list
92069453|NCT00093834|Doxorubicin|doxorubicin|mesh-list
92069454|NCT00093834|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92069455|NCT00093834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069456|NCT00093834|Immunologic Factors|immunologic factors|mesh-ancestor
92069457|NCT00093834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069458|NCT00093834|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069459|NCT00093834|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069460|NCT00093834|Alkylating Agents|alkylating agents|mesh-ancestor
92069461|NCT00093834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069462|NCT00093834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069463|NCT00093834|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069464|NCT00093834|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92069465|NCT00093834|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92069466|NCT00093834|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92069467|NCT00093834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069468|NCT01550289|Vaccines|vaccines|mesh-list
92069469|NCT01550289|Immunologic Factors|immunologic factors|mesh-ancestor
92069470|NCT01550289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069471|NCT01968031|Istradefylline|istradefylline|mesh-list
92069472|NCT01968031|Adenosine A2 Receptor Antagonists|adenosine a2 receptor antagonists|mesh-ancestor
92069473|NCT01968031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92069474|NCT01968031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92015685|NCT01697527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015686|NCT01697527|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015687|NCT01697527|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92015688|NCT01697527|Alkylating Agents|alkylating agents|mesh-ancestor
92015689|NCT01697527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015690|NCT01697527|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015691|NCT01697527|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069475|NCT01968031|Purinergic Agents|purinergic agents|mesh-ancestor
92069476|NCT01968031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069477|NCT01968031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069478|NCT01968031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069479|NCT01684215|Letrozole|letrozole|mesh-list
92069480|NCT01684215|Palbociclib|palbociclib|mesh-list
92069481|NCT01684215|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069482|NCT01684215|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92069483|NCT01684215|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92069484|NCT01684215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069485|NCT01684215|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069486|NCT01684215|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92069487|NCT01684215|Hormone Antagonists|hormone antagonists|mesh-ancestor
92069488|NCT01684215|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069489|NCT01684215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069490|NCT01684215|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069491|NCT01908205|Oxytocin|oxytocin|mesh-list
92069492|NCT01908205|Oxytocics|oxytocics|mesh-ancestor
92069493|NCT01908205|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92069494|NCT01908205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069495|NCT03911739|Buprenorphine|buprenorphine|mesh-list
92069496|NCT03911739|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92069497|NCT03911739|Narcotics|narcotics|mesh-ancestor
92069498|NCT03911739|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069499|NCT03911739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069500|NCT03911739|Analgesics|analgesics|mesh-ancestor
92069501|NCT03911739|Sensory System Agents|sensory system agents|mesh-ancestor
92069502|NCT03911739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069503|NCT03911739|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92069504|NCT01549041|Asenapine|asenapine|mesh-list
92069505|NCT01549041|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92069506|NCT01549041|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92069507|NCT01549041|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069518|NCT01907815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069519|NCT01907815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069520|NCT01907815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069521|NCT01907815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069522|NCT01548573|Thalidomide|thalidomide|mesh-list
92069523|NCT01548573|Dexamethasone|dexamethasone|mesh-list
92069524|NCT01548573|Cyclophosphamide|cyclophosphamide|mesh-list
92069525|NCT01548573|Melphalan|melphalan|mesh-list
92069526|NCT01548573|Doxorubicin|doxorubicin|mesh-list
92069527|NCT01548573|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92069528|NCT01548573|Etoposide|etoposide|mesh-list
92069529|NCT01548573|Etoposide phosphate|etoposide phosphate|mesh-list
92069530|NCT01548573|Bortezomib|bortezomib|mesh-list
92069531|NCT01548573|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069532|NCT01548573|Immunologic Factors|immunologic factors|mesh-ancestor
92069533|NCT01548573|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069534|NCT01548573|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069535|NCT01548573|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069536|NCT01548573|Alkylating Agents|alkylating agents|mesh-ancestor
92069537|NCT01548573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069538|NCT01548573|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069539|NCT01548573|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069540|NCT01548573|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92069541|NCT01548573|Antiemetics|antiemetics|mesh-ancestor
92069542|NCT01548573|Autonomic Agents|autonomic agents|mesh-ancestor
92069543|NCT01548573|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069544|NCT01548573|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069545|NCT01548573|Glucocorticoids|glucocorticoids|mesh-ancestor
92069546|NCT01548573|Hormones|hormones|mesh-ancestor
92069547|NCT01548573|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069548|NCT01548573|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069549|NCT01548573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92069550|NCT01548573|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92069551|NCT01548573|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92069552|NCT01548573|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069553|NCT01548573|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069554|NCT01548573|Leprostatic Agents|leprostatic agents|mesh-ancestor
92069555|NCT01548573|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92069556|NCT01548573|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069557|NCT01548573|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92069558|NCT01548573|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92069559|NCT01548573|Growth Substances|growth substances|mesh-ancestor
92069560|NCT01548573|Growth Inhibitors|growth inhibitors|mesh-ancestor
92069561|NCT01570491|Anesthetics|anesthetics|mesh-list
92069562|NCT01570491|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069563|NCT01570491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069564|NCT01518153|Methotrexate|methotrexate|mesh-list
92069565|NCT01518153|Fludarabine phosphate|fludarabine phosphate|mesh-list
92069566|NCT01518153|Fludarabine|fludarabine|mesh-list
92069567|NCT01518153|Melphalan|melphalan|mesh-list
92069568|NCT01518153|Alemtuzumab|alemtuzumab|mesh-list
92069569|NCT01518153|Tacrolimus|tacrolimus|mesh-list
92069570|NCT01518153|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92069571|NCT01518153|Abortifacient Agents|abortifacient agents|mesh-ancestor
92069572|NCT01518153|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92069576|NCT01518153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069578|NCT01518153|Dermatologic Agents|dermatologic agents|mesh-ancestor
92069579|NCT01518153|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069580|NCT01518153|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92069581|NCT01518153|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069582|NCT01518153|Immunologic Factors|immunologic factors|mesh-ancestor
92069583|NCT01518153|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069584|NCT01518153|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069585|NCT01518153|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92069586|NCT01518153|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069587|NCT01518153|Alkylating Agents|alkylating agents|mesh-ancestor
92069588|NCT01518153|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069589|NCT01518153|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069590|NCT04620343|Anesthetics|anesthetics|mesh-list
92069591|NCT04620343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069592|NCT04620343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069593|NCT01517373|Glimepiride|glimepiride|mesh-list
92069594|NCT01517373|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92069595|NCT01517373|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92069596|NCT01517373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069597|NCT01517373|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069598|NCT01517373|Immunologic Factors|immunologic factors|mesh-ancestor
92069599|NCT01517295|Hydrocodone|hydrocodone|mesh-list
92069600|NCT01517295|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92069601|NCT01517295|Narcotics|narcotics|mesh-ancestor
92069602|NCT01517295|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069603|NCT01517295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069604|NCT01517295|Analgesics|analgesics|mesh-ancestor
92069605|NCT01517295|Sensory System Agents|sensory system agents|mesh-ancestor
92069606|NCT01517295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069607|NCT01517295|Antitussive Agents|antitussive agents|mesh-ancestor
92069608|NCT01517295|Respiratory System Agents|respiratory system agents|mesh-ancestor
92069609|NCT01548417|Mifepristone|mifepristone|mesh-list
92069610|NCT01548417|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92069611|NCT01548417|Abortifacient Agents|abortifacient agents|mesh-ancestor
92069612|NCT01548417|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92069613|NCT01548417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069614|NCT01548417|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92069615|NCT01548417|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92069616|NCT01548417|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92069617|NCT01548417|Contraceptive Agents|contraceptive agents|mesh-ancestor
92069618|NCT01548417|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92069619|NCT01548417|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92069620|NCT01548417|Hormone Antagonists|hormone antagonists|mesh-ancestor
92069621|NCT01548417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015692|NCT01697527|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015693|NCT01697527|Antimetabolites|antimetabolites|mesh-ancestor
92015694|NCT01697527|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92015695|NCT01697527|Analgesics|analgesics|mesh-ancestor
92015696|NCT01697527|Sensory System Agents|sensory system agents|mesh-ancestor
92069622|NCT01548417|Luteolytic Agents|luteolytic agents|mesh-ancestor
92069623|NCT01548417|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92069624|NCT01548417|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92069625|NCT01546857|Gabapentin|gabapentin|mesh-list
92069626|NCT01546857|Analgesics|analgesics|mesh-ancestor
92069627|NCT01546857|Sensory System Agents|sensory system agents|mesh-ancestor
92069628|NCT01546857|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069629|NCT01546857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069630|NCT01546857|Anticonvulsants|anticonvulsants|mesh-ancestor
92069631|NCT01546857|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92069632|NCT01546857|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92069633|NCT01546857|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069634|NCT01546857|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92069635|NCT01546857|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92069636|NCT01546857|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92069637|NCT01546857|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069638|NCT01546857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069640|NCT01516749|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92069649|NCT00637000|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92069651|NCT00637000|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069652|NCT00637000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069653|NCT00637000|Analgesics|analgesics|mesh-ancestor
92069654|NCT00637000|Sensory System Agents|sensory system agents|mesh-ancestor
92069655|NCT00637000|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069656|NCT00637000|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92069657|NCT01515189|Ipilimumab|ipilimumab|mesh-list
92069658|NCT01515189|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069659|NCT01515189|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069660|NCT01515189|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069661|NCT01515189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069662|NCT01546623|Leuprolide|leuprolide|mesh-list
92069663|NCT01546623|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92069664|NCT01546623|Fertility Agents|fertility agents|mesh-ancestor
92069665|NCT01546623|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92069666|NCT01546623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069667|NCT01546623|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92069668|NCT01546623|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069669|NCT00636610|Bevacizumab|bevacizumab|mesh-list
92069670|NCT00636610|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069671|NCT00636610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069672|NCT00636610|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92069673|NCT00636610|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92069674|NCT00636610|Growth Substances|growth substances|mesh-ancestor
92069675|NCT00636610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069676|NCT00636610|Growth Inhibitors|growth inhibitors|mesh-ancestor
92069677|NCT00635050|Paclitaxel|paclitaxel|mesh-list
92069678|NCT00635050|Cyclophosphamide|cyclophosphamide|mesh-list
92069679|NCT00635050|Bevacizumab|bevacizumab|mesh-list
92069680|NCT00635050|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069681|NCT00635050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069682|NCT00635050|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069683|NCT00635050|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069684|NCT00635050|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069685|NCT00635050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069686|NCT00635050|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069687|NCT00635050|Immunologic Factors|immunologic factors|mesh-ancestor
92069688|NCT00635050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069689|NCT00635050|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069690|NCT00635050|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069691|NCT00635050|Alkylating Agents|alkylating agents|mesh-ancestor
92069692|NCT00635050|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92015697|NCT01697527|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015698|NCT01697527|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92015699|NCT01697527|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92015700|NCT01697527|Antiviral Agents|antiviral agents|mesh-ancestor
92069693|NCT00635050|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069694|NCT00635050|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92069695|NCT00635050|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92069696|NCT00635050|Growth Substances|growth substances|mesh-ancestor
92069697|NCT00635050|Growth Inhibitors|growth inhibitors|mesh-ancestor
92069698|NCT05240404|Immunomodulating Agents|immunomodulating agents|mesh-list
92069699|NCT05240404|Immunologic Factors|immunologic factors|mesh-ancestor
92069700|NCT05240404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069701|NCT01923376|Lactulose|lactulose|mesh-list
92069702|NCT01923376|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92069703|NCT01923376|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069704|NCT01923376|Laxatives|laxatives|mesh-ancestor
92069705|NCT05245786|Copper|copper|mesh-list
92069706|NCT05245786|Antibodies|antibodies|mesh-list
92069707|NCT05245786|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92069721|NCT00634504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069722|NCT00634504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069723|NCT00634504|Dermatologic Agents|dermatologic agents|mesh-ancestor
92069724|NCT00634504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069725|NCT00634504|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92069726|NCT00634504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069727|NCT00634504|Immunologic Factors|immunologic factors|mesh-ancestor
92069728|NCT00634504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069729|NCT00634504|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069730|NCT00634504|Antidotes|antidotes|mesh-ancestor
92069731|NCT00634504|Protective Agents|protective agents|mesh-ancestor
92069732|NCT00634504|Vitamin B Complex|vitamin b complex|mesh-ancestor
92069733|NCT00634504|Vitamins|vitamins|mesh-ancestor
92069734|NCT00634504|Micronutrients|micronutrients|mesh-ancestor
92069735|NCT03101254|Vemurafenib|vemurafenib|mesh-list
92069736|NCT03101254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069737|NCT03101254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069738|NCT03101254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069739|NCT03101254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069740|NCT00634114|Esomeprazole|esomeprazole|mesh-list
92069741|NCT00634114|Omeprazole|omeprazole|mesh-list
92069742|NCT00634114|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92069743|NCT00634114|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069744|NCT00634114|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92069745|NCT00634114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069746|NCT00634114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069747|NCT00634036|Pioglitazone|pioglitazone|mesh-list
92069748|NCT00634036|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92069749|NCT00634036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069750|NCT05241496|Lidocaine|lidocaine|mesh-list
92069751|NCT05241496|Anesthetics, Local|anesthetics, local|mesh-ancestor
92069752|NCT05241496|Anesthetics|anesthetics|mesh-ancestor
92069753|NCT05241496|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069754|NCT05241496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069755|NCT05241496|Sensory System Agents|sensory system agents|mesh-ancestor
92069756|NCT05241496|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069757|NCT05241496|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92069758|NCT05241496|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92069759|NCT05241496|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92069760|NCT05241496|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92069761|NCT05241496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069762|NCT01545375|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92069763|NCT01545375|Immunologic Factors|immunologic factors|mesh-ancestor
92069764|NCT01545375|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069765|NCT01539837|Deferiprone|deferiprone|mesh-list
92069766|NCT01539837|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92069767|NCT01539837|Chelating Agents|chelating agents|mesh-ancestor
92069768|NCT01539837|Sequestering Agents|sequestering agents|mesh-ancestor
92069769|NCT01539837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015701|NCT01697527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069771|NCT03156790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069772|NCT03153202|Pembrolizumab|pembrolizumab|mesh-list
92069773|NCT03153202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069774|NCT03153202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069775|NCT03153202|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069776|NCT03153202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069778|NCT04410081|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92069779|NCT04410081|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069780|NCT04410081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069781|NCT01923844|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92069782|NCT01923844|Beractant|beractant|mesh-list
92069783|NCT01923844|Respiratory System Agents|respiratory system agents|mesh-ancestor
92069784|NCT01924000|Minoxidil|minoxidil|mesh-list
92069785|NCT01924000|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92069786|NCT01924000|Vasodilator Agents|vasodilator agents|mesh-ancestor
92069787|NCT01924078|Capecitabine|capecitabine|mesh-list
92069788|NCT01924078|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92069789|NCT01924078|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069790|NCT01924078|Antimetabolites|antimetabolites|mesh-ancestor
92069791|NCT01924078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069792|NCT01924078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069793|NCT01924078|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92069794|NCT01924078|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069795|NCT01924078|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92069796|NCT01924078|Hormone Antagonists|hormone antagonists|mesh-ancestor
92069797|NCT01924078|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069798|NCT01924078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069799|NCT00630994|Decitabine|decitabine|mesh-list
92069800|NCT00630994|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069801|NCT00630994|Antimetabolites|antimetabolites|mesh-ancestor
92069802|NCT00630994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069803|NCT00630994|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069804|NCT00630994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069805|NCT03126214|Warfarin|warfarin|mesh-list
92069806|NCT03126214|Anticoagulants|anticoagulants|mesh-list
92069808|NCT01924234|Remifentanil|remifentanil|mesh-list
92069809|NCT01924234|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92069810|NCT01924234|Narcotics|narcotics|mesh-ancestor
92069811|NCT01924234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069812|NCT01924234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069813|NCT01924234|Analgesics|analgesics|mesh-ancestor
92069814|NCT01924234|Sensory System Agents|sensory system agents|mesh-ancestor
92069815|NCT01924234|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069816|NCT00630058|Interferon-alpha|interferon-alpha|mesh-list
92069817|NCT00630058|Interferon alpha-2|interferon alpha-2|mesh-list
92069818|NCT00630058|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92069819|NCT00630058|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92069820|NCT00630058|Antiviral Agents|antiviral agents|mesh-ancestor
92069821|NCT00630058|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069822|NCT00630058|Immunologic Factors|immunologic factors|mesh-ancestor
92069823|NCT00630058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069824|NCT00630058|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069825|NCT01927198|Verinurad|verinurad|mesh-list
92069826|NCT01927198|Gout Suppressants|gout suppressants|mesh-ancestor
92069827|NCT01927198|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069828|NCT01924468|Haloperidol|haloperidol|mesh-list
92069829|NCT01924468|Haloperidol decanoate|haloperidol decanoate|mesh-list
92069830|NCT01924468|Methylphenidate|methylphenidate|mesh-list
92069831|NCT01924468|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92069832|NCT01924468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069833|NCT01924468|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92069834|NCT01924468|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92069835|NCT01924468|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92069836|NCT01924468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069837|NCT01924468|Dopamine Agents|dopamine agents|mesh-ancestor
92069838|NCT01924468|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069839|NCT01924468|Antiemetics|antiemetics|mesh-ancestor
92069840|NCT01924468|Autonomic Agents|autonomic agents|mesh-ancestor
92069841|NCT01924468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069842|NCT01924468|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92069843|NCT01924468|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92069846|NCT01924468|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015702|NCT01697527|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92015703|NCT04426409|Ofloxacin|ofloxacin|mesh-list
92015704|NCT04426409|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92015705|NCT04426409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015706|NCT04426409|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92015707|NCT04426409|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92015708|NCT04426409|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92015709|NCT04426409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069934|NCT00989092|Hematinics|hematinics|mesh-ancestor
92015710|NCT04426409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069847|NCT01924468|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92069848|NCT01924468|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92069849|NCT01923064|Ethiodized Oil|ethiodized oil|mesh-list
92069850|NCT01923064|Polidocanol|polidocanol|mesh-list
92069851|NCT01923064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069852|NCT01923064|Sclerosing Solutions|sclerosing solutions|mesh-ancestor
92069853|NCT01923064|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92069854|NCT01924624|Thalidomide|thalidomide|mesh-list
92069855|NCT01924624|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069856|NCT01924624|Immunologic Factors|immunologic factors|mesh-ancestor
92069857|NCT01924624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069858|NCT01924624|Leprostatic Agents|leprostatic agents|mesh-ancestor
92069859|NCT01924624|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92069860|NCT01924624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069861|NCT01924624|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92069862|NCT01924624|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92069863|NCT01924624|Growth Substances|growth substances|mesh-ancestor
92069864|NCT01924624|Growth Inhibitors|growth inhibitors|mesh-ancestor
92069865|NCT01924624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069866|NCT01929382|Interferons|interferons|mesh-list
92069867|NCT01929382|Interferon-gamma|interferon-gamma|mesh-list
92069868|NCT01929382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069869|NCT01929382|Antiviral Agents|antiviral agents|mesh-ancestor
92069870|NCT01929382|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069871|NCT00989950|Methylphenidate|methylphenidate|mesh-list
92069872|NCT00989950|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92069873|NCT00989950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069874|NCT00989950|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92069875|NCT00989950|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92069876|NCT00989950|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92069877|NCT00989950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069878|NCT00989950|Dopamine Agents|dopamine agents|mesh-ancestor
92069879|NCT00989950|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069880|NCT03121456|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92069881|NCT03121456|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92069882|NCT03121456|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069883|NCT01925092|Mifepristone|mifepristone|mesh-list
92069884|NCT01925092|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92069885|NCT01925092|Abortifacient Agents|abortifacient agents|mesh-ancestor
92069886|NCT01925092|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92069887|NCT01925092|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069888|NCT01925092|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92069889|NCT01925092|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92069890|NCT01925092|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92069891|NCT01925092|Contraceptive Agents|contraceptive agents|mesh-ancestor
92069892|NCT01925092|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92069893|NCT01925092|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92069895|NCT01925092|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069896|NCT01925092|Luteolytic Agents|luteolytic agents|mesh-ancestor
92069897|NCT01925092|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92069898|NCT01925092|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92069899|NCT01905943|Cyclophosphamide|cyclophosphamide|mesh-list
92069900|NCT01905943|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92069901|NCT01905943|Chlorambucil|chlorambucil|mesh-list
92069902|NCT01905943|Fludarabine|fludarabine|mesh-list
92069903|NCT01905943|Obinutuzumab|obinutuzumab|mesh-list
92015711|NCT04426409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015712|NCT04426409|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92015713|NCT04426409|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92069904|NCT01905943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92069905|NCT01905943|Immunologic Factors|immunologic factors|mesh-ancestor
92069906|NCT01905943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069907|NCT01905943|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069908|NCT01905943|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92069909|NCT01905943|Alkylating Agents|alkylating agents|mesh-ancestor
92069910|NCT01905943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069911|NCT01905943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069912|NCT01905943|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069913|NCT01905943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069914|NCT01929031|Ibuprofen|ibuprofen|mesh-list
92069915|NCT01929031|Caffeine|caffeine|mesh-list
92069916|NCT01929031|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92069933|NCT00989092|Darbepoetin alfa|darbepoetin alfa|mesh-list
92069936|NCT00988858|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069937|NCT00988858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069938|NCT00988858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069939|NCT00988858|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92069940|NCT00988858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92069941|NCT01920334|Zolpidem|zolpidem|mesh-list
92069942|NCT01920334|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92069943|NCT01920334|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92069944|NCT01920334|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069945|NCT01920334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069946|NCT01920334|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92069947|NCT01920334|GABA Agonists|gaba agonists|mesh-ancestor
92069948|NCT01920334|GABA Agents|gaba agents|mesh-ancestor
92069949|NCT01920334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069950|NCT01920334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069951|NCT03096418|Paclitaxel|paclitaxel|mesh-list
92069952|NCT03096418|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069953|NCT03096418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069954|NCT03096418|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069955|NCT03096418|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069956|NCT03096418|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069957|NCT03096418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069958|NCT00986986|Niacin|niacin|mesh-list
92069959|NCT00986986|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92069960|NCT00986986|Antimetabolites|antimetabolites|mesh-ancestor
92069961|NCT00986986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069962|NCT00986986|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92069963|NCT00986986|Vasodilator Agents|vasodilator agents|mesh-ancestor
92069964|NCT00986986|Vitamin B Complex|vitamin b complex|mesh-ancestor
92069965|NCT00986986|Vitamins|vitamins|mesh-ancestor
92069966|NCT00986986|Micronutrients|micronutrients|mesh-ancestor
92069967|NCT00986986|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069969|NCT01928719|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92069970|NCT01928719|Autonomic Agents|autonomic agents|mesh-ancestor
92069971|NCT01928719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069972|NCT01928719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069973|NCT01928719|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92069991|NCT00986674|Immunologic Factors|immunologic factors|mesh-ancestor
92069992|NCT00986674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069994|NCT00986440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069995|NCT03118492|Mycophenolic Acid|mycophenolic acid|mesh-list
92069996|NCT03118492|Cyclophosphamide|cyclophosphamide|mesh-list
92069997|NCT03118492|Melphalan|melphalan|mesh-list
92069998|NCT03118492|Mechlorethamine|mechlorethamine|mesh-list
92069999|NCT03118492|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92070000|NCT03118492|Fludarabine|fludarabine|mesh-list
92070001|NCT03118492|Tacrolimus|tacrolimus|mesh-list
92070002|NCT03118492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070003|NCT03118492|Immunologic Factors|immunologic factors|mesh-ancestor
92070004|NCT03118492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015715|NCT04426097|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92015716|NCT04426097|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070005|NCT03118492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070006|NCT03118492|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92070007|NCT03118492|Alkylating Agents|alkylating agents|mesh-ancestor
92070008|NCT03118492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070009|NCT03118492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070010|NCT03118492|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92070011|NCT03118492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92070012|NCT03118492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070013|NCT03118492|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92070014|NCT03118492|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92070015|NCT03118492|Antitubercular Agents|antitubercular agents|mesh-ancestor
92070016|NCT03118492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070017|NCT03118492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070018|NCT01904149|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92070019|NCT01904149|Tramadol|tramadol|mesh-list
92070020|NCT01904149|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92070021|NCT01904149|Narcotics|narcotics|mesh-ancestor
92070022|NCT01904149|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070023|NCT01904149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070024|NCT01904149|Analgesics|analgesics|mesh-ancestor
92070025|NCT01904149|Sensory System Agents|sensory system agents|mesh-ancestor
92070026|NCT01904149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070027|NCT01904149|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070028|NCT01904149|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070029|NCT01904149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070030|NCT01904149|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070032|NCT01925638|Antifungal Agents|antifungal agents|mesh-ancestor
92070035|NCT01925638|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92070037|NCT01925638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070038|NCT01925638|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92070039|NCT01925638|Hormone Antagonists|hormone antagonists|mesh-ancestor
92070040|NCT01925638|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070041|NCT01925638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070042|NCT01925638|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92070044|NCT00985738|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92070045|NCT00985738|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92070046|NCT00985738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070047|NCT00985738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070048|NCT00985738|Hormone Antagonists|hormone antagonists|mesh-ancestor
92070049|NCT00985738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070050|NCT00985738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070051|NCT00985504|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92070052|NCT00985504|Escitalopram|escitalopram|mesh-list
92070053|NCT00985504|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92070054|NCT00985504|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92070055|NCT00985504|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070056|NCT00985504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070057|NCT00985504|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070058|NCT00985504|Serotonin Agents|serotonin agents|mesh-ancestor
92070059|NCT00985504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070060|NCT00985504|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070061|NCT00985504|Antidepressive Agents|antidepressive agents|mesh-ancestor
92070062|NCT00985504|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070063|NCT00985504|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92070064|NCT00985504|Analgesics|analgesics|mesh-ancestor
92070065|NCT00985504|Sensory System Agents|sensory system agents|mesh-ancestor
92070066|NCT00985504|Dopamine Agents|dopamine agents|mesh-ancestor
92070067|NCT01921192|Folic Acid|folic acid|mesh-list
92070068|NCT01921192|Hematinics|hematinics|mesh-ancestor
92070069|NCT01921192|Vitamin B Complex|vitamin b complex|mesh-ancestor
92070070|NCT01921192|Vitamins|vitamins|mesh-ancestor
92070071|NCT01921192|Micronutrients|micronutrients|mesh-ancestor
92070072|NCT01921192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070073|NCT04275388|Interferons|interferons|mesh-list
92070074|NCT04275388|Ritonavir|ritonavir|mesh-list
92070075|NCT04275388|Lopinavir|lopinavir|mesh-list
92070076|NCT04275388|Interferon-alpha|interferon-alpha|mesh-list
92070077|NCT04275388|Interferon-alfa-1b|interferon-alfa-1b|mesh-list
92015718|NCT04426097|Micronutrients|micronutrients|mesh-ancestor
92015719|NCT04426097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015720|NCT05556083|Sildenafil Citrate|sildenafil citrate|mesh-list
92015721|NCT05556083|Vasodilator Agents|vasodilator agents|mesh-ancestor
92015722|NCT05556083|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92015723|NCT05556083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92015724|NCT05556083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015725|NCT05556083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015726|NCT05556083|Urological Agents|urological agents|mesh-ancestor
92015727|NCT05556005|Trimetazidine|trimetazidine|mesh-list
92015728|NCT05556005|Vasodilator Agents|vasodilator agents|mesh-ancestor
92015729|NCT04373603|Tranexamic Acid|tranexamic acid|mesh-list
92015730|NCT04373603|Hyaluronic Acid|hyaluronic acid|mesh-list
92015731|NCT04373603|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92015732|NCT04373603|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015733|NCT04373603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070078|NCT04275388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070079|NCT04275388|Antiviral Agents|antiviral agents|mesh-ancestor
92070080|NCT04275388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070081|NCT04275388|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92070082|NCT04275388|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92070083|NCT04275388|Protease Inhibitors|protease inhibitors|mesh-ancestor
92070084|NCT04275388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070085|NCT04275388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070086|NCT04275388|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92070087|NCT04275388|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92070088|NCT04275388|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92070089|NCT04275388|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92070090|NCT04275388|Immunologic Factors|immunologic factors|mesh-ancestor
92070091|NCT04275388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070092|NCT01921426|Avasopasem manganese|avasopasem manganese|mesh-list
92070093|NCT01921426|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92070094|NCT01921426|Antioxidants|antioxidants|mesh-ancestor
92070095|NCT01921426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070096|NCT01921426|Protective Agents|protective agents|mesh-ancestor
92070097|NCT01921426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070098|NCT01921582|Methylphenidate|methylphenidate|mesh-list
92070099|NCT01921582|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92070100|NCT01921582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070101|NCT01921582|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92070102|NCT01921582|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92070106|NCT01921582|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070108|NCT00985426|Immunologic Factors|immunologic factors|mesh-ancestor
92070109|NCT00985426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070111|NCT00985192|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92070112|NCT00985192|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92070113|NCT00985192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070114|NCT00985192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070115|NCT00985192|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070116|NCT00985192|Immunologic Factors|immunologic factors|mesh-ancestor
92070117|NCT00985192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070118|NCT00985192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070119|NCT03390010|Misoprostol|misoprostol|mesh-list
92070120|NCT03390010|Carboprost|carboprost|mesh-list
92070121|NCT03390010|Oxytocin|oxytocin|mesh-list
92070122|NCT03390010|Carboprost tromethamine|carboprost tromethamine|mesh-list
92070123|NCT03390010|Methylergonovine|methylergonovine|mesh-list
92015735|NCT04373603|Coagulants|coagulants|mesh-ancestor
92015736|NCT04373603|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92015737|NCT04373603|Immunologic Factors|immunologic factors|mesh-ancestor
92015738|NCT04373603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015739|NCT04373603|Viscosupplements|viscosupplements|mesh-ancestor
92070124|NCT03390010|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92070125|NCT03390010|Abortifacient Agents|abortifacient agents|mesh-ancestor
92070126|NCT03390010|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92070127|NCT03390010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070128|NCT03390010|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92070129|NCT03390010|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070130|NCT03390010|Oxytocics|oxytocics|mesh-ancestor
92070131|NCT00984568|Aminosalicylic Acid|aminosalicylic acid|mesh-list
92070132|NCT00984568|Prednisolone|prednisolone|mesh-list
92070133|NCT00984568|Infliximab|infliximab|mesh-list
92070134|NCT00984568|Mesalamine|mesalamine|mesh-list
92070135|NCT00984568|Azathioprine|azathioprine|mesh-list
92070136|NCT00984568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070137|NCT00984568|Glucocorticoids|glucocorticoids|mesh-ancestor
92070138|NCT00984568|Hormones|hormones|mesh-ancestor
92070139|NCT00984568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070140|NCT00984568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070141|NCT00984568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070142|NCT00984568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070143|NCT00984568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070144|NCT00984568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070145|NCT00984568|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92070146|NCT00984568|Dermatologic Agents|dermatologic agents|mesh-ancestor
92070147|NCT00984568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070148|NCT00984568|Antimetabolites|antimetabolites|mesh-ancestor
92070149|NCT00984568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070150|NCT00984568|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92070151|NCT00984568|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070152|NCT00984568|Immunologic Factors|immunologic factors|mesh-ancestor
92070153|NCT00984568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070154|NCT00984568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070155|NCT00984568|Analgesics|analgesics|mesh-ancestor
92070156|NCT00984568|Sensory System Agents|sensory system agents|mesh-ancestor
92070157|NCT00984568|Antitubercular Agents|antitubercular agents|mesh-ancestor
92070158|NCT00984568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070159|NCT00984568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070160|NCT02984176|Simethicone|simethicone|mesh-list
92070161|NCT02984176|Antifoaming Agents|antifoaming agents|mesh-ancestor
92070162|NCT02984176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070163|NCT02984176|Emollients|emollients|mesh-ancestor
92070164|NCT02984176|Dermatologic Agents|dermatologic agents|mesh-ancestor
92070165|NCT01921738|Azithromycin|azithromycin|mesh-list
92070166|NCT01921738|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070167|NCT01921738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070168|NCT01921816|Dialysis Solutions|dialysis solutions|mesh-list
92070169|NCT01921816|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92070170|NCT00984256|Atovaquone|atovaquone|mesh-list
92070171|NCT00984256|Proguanil|proguanil|mesh-list
92070172|NCT00984256|Atovaquone, proguanil drug combination|atovaquone, proguanil drug combination|mesh-list
92070173|NCT00984256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070174|NCT00984256|Antimalarials|antimalarials|mesh-ancestor
92070175|NCT00984256|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92070178|NCT00984256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070179|NCT00984256|Antimetabolites|antimetabolites|mesh-ancestor
92070180|NCT00984022|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92070182|NCT00984022|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070183|NCT01890265|Pirfenidone|pirfenidone|mesh-list
92070184|NCT01890265|Nintedanib|nintedanib|mesh-list
92070185|NCT01890265|Immunoglobulins|immunoglobulins|mesh-list
92070186|NCT01890265|Antibodies|antibodies|mesh-list
92070187|NCT01890265|Immunoglobulin G|immunoglobulin g|mesh-list
92070188|NCT01890265|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92070189|NCT01890265|Immunologic Factors|immunologic factors|mesh-ancestor
92070190|NCT01890265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070191|NCT01890265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070192|NCT01890265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015740|NCT04373603|Protective Agents|protective agents|mesh-ancestor
92070193|NCT01890265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070194|NCT01890265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070195|NCT01890265|Analgesics|analgesics|mesh-ancestor
92070196|NCT01890265|Sensory System Agents|sensory system agents|mesh-ancestor
92070197|NCT01890265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070198|NCT01890265|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070199|NCT01890265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070200|NCT01890265|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070201|NCT01890265|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070202|NCT01926652|Amlodipine|amlodipine|mesh-list
92070203|NCT01926652|Candesartan|candesartan|mesh-list
92070204|NCT01926652|Candesartan cilexetil|candesartan cilexetil|mesh-list
92070205|NCT01926652|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92070206|NCT01926652|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92070207|NCT01926652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070208|NCT01926652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070209|NCT01926652|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92070210|NCT01926652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070211|NCT01926652|Vasodilator Agents|vasodilator agents|mesh-ancestor
92070212|NCT01926652|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92070213|NCT01926652|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92070214|NCT03110926|Leucovorin|leucovorin|mesh-list
92070215|NCT03110926|Paclitaxel|paclitaxel|mesh-list
92070216|NCT03110926|Carboplatin|carboplatin|mesh-list
92070217|NCT03110926|Oxaliplatin|oxaliplatin|mesh-list
92070218|NCT03110926|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92070219|NCT03110926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070220|NCT03110926|Tubulin Modulators|tubulin modulators|mesh-ancestor
92070221|NCT03110926|Antimitotic Agents|antimitotic agents|mesh-ancestor
92070222|NCT03110926|Mitosis Modulators|mitosis modulators|mesh-ancestor
92070223|NCT03110926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070224|NCT03110926|Antidotes|antidotes|mesh-ancestor
92070225|NCT03110926|Protective Agents|protective agents|mesh-ancestor
92070226|NCT03110926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070227|NCT03110926|Vitamin B Complex|vitamin b complex|mesh-ancestor
92070228|NCT03110926|Vitamins|vitamins|mesh-ancestor
92070229|NCT03110926|Micronutrients|micronutrients|mesh-ancestor
92070230|NCT01928329|Exenatide|exenatide|mesh-list
92070231|NCT01928329|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92070232|NCT01928329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070233|NCT01928329|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92070234|NCT01928329|Incretins|incretins|mesh-ancestor
92070235|NCT01928329|Hormones|hormones|mesh-ancestor
92070236|NCT01928329|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070237|NCT01890109|Erenumab|erenumab|mesh-list
92070238|NCT01890109|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92070239|NCT01890109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070240|NCT01890109|Analgesics|analgesics|mesh-ancestor
92070241|NCT01890109|Sensory System Agents|sensory system agents|mesh-ancestor
92070242|NCT01890109|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070243|NCT01890109|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070244|NCT03069976|Metronidazole|metronidazole|mesh-list
92070245|NCT03069976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070246|NCT03069976|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070247|NCT03069976|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92070248|NCT03069976|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92070249|NCT00982930|Tobramycin|tobramycin|mesh-list
92070251|NCT00982930|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070252|NCT03088540|Paclitaxel|paclitaxel|mesh-list
92070253|NCT03088540|Carboplatin|carboplatin|mesh-list
92070254|NCT03088540|Gemcitabine|gemcitabine|mesh-list
92070255|NCT03088540|Pemetrexed|pemetrexed|mesh-list
92070256|NCT03088540|Cemiplimab|cemiplimab|mesh-list
92070257|NCT03088540|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92070258|NCT03088540|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070259|NCT03088540|Tubulin Modulators|tubulin modulators|mesh-ancestor
92070260|NCT03088540|Antimitotic Agents|antimitotic agents|mesh-ancestor
92070261|NCT03088540|Mitosis Modulators|mitosis modulators|mesh-ancestor
92070262|NCT03088540|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070263|NCT03088540|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92070264|NCT03088540|Antimetabolites|antimetabolites|mesh-ancestor
92070265|NCT03088540|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070266|NCT03088540|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92070267|NCT03088540|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92070268|NCT03088540|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92070269|NCT01903993|Docetaxel|docetaxel|mesh-list
92070270|NCT01903993|Atezolizumab|atezolizumab|mesh-list
92070271|NCT01903993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070272|NCT01903993|Tubulin Modulators|tubulin modulators|mesh-ancestor
92070273|NCT01903993|Antimitotic Agents|antimitotic agents|mesh-ancestor
92070274|NCT01903993|Mitosis Modulators|mitosis modulators|mesh-ancestor
92070275|NCT01903993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070276|NCT01903993|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92070277|NCT01903993|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92070279|NCT00980044|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92070280|NCT00980044|Narcotics|narcotics|mesh-ancestor
92070281|NCT00980044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070282|NCT00980044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070283|NCT00980044|Analgesics|analgesics|mesh-ancestor
92070284|NCT00980044|Sensory System Agents|sensory system agents|mesh-ancestor
92070285|NCT00980044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070286|NCT03049306|Propranolol|propranolol|mesh-list
92070287|NCT03049306|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92070288|NCT03049306|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92070289|NCT03049306|Adrenergic Agents|adrenergic agents|mesh-ancestor
92070290|NCT03049306|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070291|NCT03049306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070292|NCT03049306|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070293|NCT03049306|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92070294|NCT03049306|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92070295|NCT03049306|Vasodilator Agents|vasodilator agents|mesh-ancestor
92070296|NCT01927588|Prednisone|prednisone|mesh-list
92070297|NCT01927588|Everolimus|everolimus|mesh-list
92070298|NCT01927588|Tacrolimus|tacrolimus|mesh-list
92070299|NCT01927588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070300|NCT01927588|Glucocorticoids|glucocorticoids|mesh-ancestor
92070301|NCT01927588|Hormones|hormones|mesh-ancestor
92070302|NCT01927588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070303|NCT01927588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070304|NCT01927588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070305|NCT01927588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070306|NCT01927588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070307|NCT01927588|Immunologic Factors|immunologic factors|mesh-ancestor
92070308|NCT01927588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92070309|NCT01927588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070310|NCT01927588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070311|NCT01927588|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92070312|NCT01927588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92070313|NCT05601466|Cytarabine|cytarabine|mesh-list
92070314|NCT05601466|Cyclophosphamide|cyclophosphamide|mesh-list
92070315|NCT05601466|Fludarabine|fludarabine|mesh-list
92070316|NCT05601466|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070317|NCT05601466|Immunologic Factors|immunologic factors|mesh-ancestor
92070318|NCT05601466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070319|NCT05601466|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070320|NCT05601466|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92070321|NCT05601466|Alkylating Agents|alkylating agents|mesh-ancestor
92070396|NCT04274608|Cholinergic Agents|cholinergic agents|mesh-ancestor
92070322|NCT05601466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070323|NCT05601466|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070324|NCT05601466|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92070326|NCT05601466|Antimetabolites|antimetabolites|mesh-ancestor
92070327|NCT05601466|Antiviral Agents|antiviral agents|mesh-ancestor
92070328|NCT05601466|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070329|NCT01903837|Naltrexone|naltrexone|mesh-list
92070330|NCT01903837|Olanzapine|olanzapine|mesh-list
92070331|NCT01903837|ALKS-33|alks-33|mesh-list
92070332|NCT01903837|Antiemetics|antiemetics|mesh-ancestor
92070333|NCT01903837|Autonomic Agents|autonomic agents|mesh-ancestor
92070334|NCT01903837|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070335|NCT01903837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070336|NCT01903837|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070337|NCT01903837|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92070338|NCT01903837|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92070339|NCT01903837|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070340|NCT01903837|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070341|NCT01903837|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92070342|NCT01903837|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92015742|NCT02519595|Analgesics|analgesics|mesh-ancestor
92070343|NCT01903837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081707|NCT01402947|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070344|NCT01903837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070345|NCT01903837|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070346|NCT01903837|Serotonin Agents|serotonin agents|mesh-ancestor
92070347|NCT01903837|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92070348|NCT01903837|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92070349|NCT01903837|Sensory System Agents|sensory system agents|mesh-ancestor
92070350|NCT00982696|Analgesics, Opioid|analgesics, opioid|mesh-list
92070351|NCT00982696|Mitogens|mitogens|mesh-list
92070352|NCT00982696|Enkephalins|enkephalins|mesh-list
92070353|NCT00982696|Opioid Peptides|opioid peptides|mesh-list
92070354|NCT00982696|Narcotics|narcotics|mesh-ancestor
92070355|NCT00982696|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070356|NCT00982696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070357|NCT00982696|Analgesics|analgesics|mesh-ancestor
92070358|NCT00982696|Sensory System Agents|sensory system agents|mesh-ancestor
92070359|NCT00982696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070360|NCT00982696|Mitosis Modulators|mitosis modulators|mesh-ancestor
92070361|NCT00982696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070362|NCT00982696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070363|NCT00981526|Telmisartan|telmisartan|mesh-list
92070364|NCT00981526|Olanzapine|olanzapine|mesh-list
92070365|NCT00981526|Clozapine|clozapine|mesh-list
92070366|NCT00981526|Antiemetics|antiemetics|mesh-ancestor
92070367|NCT00981526|Autonomic Agents|autonomic agents|mesh-ancestor
92070368|NCT00981526|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070369|NCT00981526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070370|NCT00981526|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070371|NCT00981526|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92070372|NCT00981526|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92070373|NCT00981526|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070374|NCT00981526|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070375|NCT00981526|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92070376|NCT00981526|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92070377|NCT00981526|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070378|NCT00981526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070379|NCT00981526|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070380|NCT00981526|Serotonin Agents|serotonin agents|mesh-ancestor
92070381|NCT00981526|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92070382|NCT00981526|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92070383|NCT00981526|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92070384|NCT00981526|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92070385|NCT00981526|GABA Antagonists|gaba antagonists|mesh-ancestor
92070386|NCT00981526|GABA Agents|gaba agents|mesh-ancestor
92070387|NCT04274920|Calcium|calcium|mesh-list
92070388|NCT04274920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92070389|NCT04274920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070390|NCT04274608|Botulinum Toxins|botulinum toxins|mesh-list
92070391|NCT04274608|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92070392|NCT04274608|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92070393|NCT04274608|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92070394|NCT04274608|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070395|NCT04274608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070397|NCT04274608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070408|NCT05607940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070409|NCT05607940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070410|NCT04394728|Trabectedin|trabectedin|mesh-list
92070411|NCT04394728|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92070412|NCT04394728|Alkylating Agents|alkylating agents|mesh-ancestor
92070413|NCT04394728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070414|NCT04394728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070415|NCT05600608|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92070416|NCT05600608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070417|NCT01616173|Dexamethasone|dexamethasone|mesh-list
92070418|NCT01616173|Dexamethasone acetate|dexamethasone acetate|mesh-list
92070419|NCT01616173|BB 1101|bb 1101|mesh-list
92070420|NCT01616173|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070421|NCT01616173|Antiemetics|antiemetics|mesh-ancestor
92070422|NCT01616173|Autonomic Agents|autonomic agents|mesh-ancestor
92070423|NCT01616173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015743|NCT02519595|Sensory System Agents|sensory system agents|mesh-ancestor
92015744|NCT02519595|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070424|NCT01616173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070425|NCT01616173|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070426|NCT01616173|Glucocorticoids|glucocorticoids|mesh-ancestor
92070427|NCT01616173|Hormones|hormones|mesh-ancestor
92070428|NCT01616173|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070429|NCT01616173|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070430|NCT01616173|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070431|NCT01616173|Protease Inhibitors|protease inhibitors|mesh-ancestor
92070432|NCT01616173|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070433|NCT01616173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070435|NCT05609500|Anticoagulants|anticoagulants|mesh-ancestor
92070436|NCT03044314|Nitric Oxide|nitric oxide|mesh-list
92070437|NCT03044314|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92070438|NCT03044314|Autonomic Agents|autonomic agents|mesh-ancestor
92070439|NCT03044314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070440|NCT03044314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070441|NCT03044314|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92070442|NCT03044314|Respiratory System Agents|respiratory system agents|mesh-ancestor
92070443|NCT03044314|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92070444|NCT03044314|Antioxidants|antioxidants|mesh-ancestor
92070445|NCT03044314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070446|NCT03044314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070447|NCT03044314|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92070448|NCT03044314|Vasodilator Agents|vasodilator agents|mesh-ancestor
92070450|NCT03044314|Protective Agents|protective agents|mesh-ancestor
92070451|NCT05608642|Prednisolone|prednisolone|mesh-list
92070452|NCT05608642|Lidocaine|lidocaine|mesh-list
92070453|NCT05608642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92070454|NCT05608642|Anesthetics|anesthetics|mesh-ancestor
92070455|NCT05608642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070456|NCT05608642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070457|NCT05608642|Sensory System Agents|sensory system agents|mesh-ancestor
92070458|NCT05608642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070459|NCT05608642|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92070460|NCT05608642|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92070463|NCT05608642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070465|NCT05608642|Glucocorticoids|glucocorticoids|mesh-ancestor
92070466|NCT05608642|Hormones|hormones|mesh-ancestor
92070467|NCT05608642|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070468|NCT05608642|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070469|NCT05608642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070470|NCT05608564|Amoxicillin|amoxicillin|mesh-list
92070471|NCT05608564|Metronidazole|metronidazole|mesh-list
92070472|NCT05608564|Tazobactam|tazobactam|mesh-list
92070473|NCT05608564|Piperacillin|piperacillin|mesh-list
92070474|NCT05608564|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070475|NCT05608564|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070476|NCT05608564|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92070477|NCT05608564|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92070478|NCT05608564|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92070479|NCT05608564|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070480|NCT05608564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070481|NCT03036904|Prednisone|prednisone|mesh-list
92070482|NCT03036904|Cyclophosphamide|cyclophosphamide|mesh-list
92070483|NCT03036904|Rituximab|rituximab|mesh-list
92070484|NCT03036904|Doxorubicin|doxorubicin|mesh-list
92070485|NCT03036904|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92070486|NCT03036904|Etoposide|etoposide|mesh-list
92070487|NCT03036904|Vincristine|vincristine|mesh-list
92070488|NCT03036904|Venetoclax|venetoclax|mesh-list
92070489|NCT03036904|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070490|NCT03036904|Immunologic Factors|immunologic factors|mesh-ancestor
92070491|NCT03036904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070492|NCT03036904|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070493|NCT03036904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92070494|NCT03036904|Alkylating Agents|alkylating agents|mesh-ancestor
92070495|NCT03036904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070496|NCT03036904|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070497|NCT03036904|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92015745|NCT02519595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070498|NCT03036904|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92070499|NCT03036904|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92070500|NCT03036904|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92070501|NCT03036904|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92070502|NCT03036904|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070503|NCT03036904|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070504|NCT03036904|Glucocorticoids|glucocorticoids|mesh-ancestor
92070505|NCT03036904|Hormones|hormones|mesh-ancestor
92070506|NCT03036904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070507|NCT03036904|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070508|NCT03036904|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92070509|NCT03036904|Tubulin Modulators|tubulin modulators|mesh-ancestor
92070510|NCT03036904|Antimitotic Agents|antimitotic agents|mesh-ancestor
92070511|NCT03036904|Mitosis Modulators|mitosis modulators|mesh-ancestor
92070512|NCT05604898|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92070514|NCT05604898|Immunoglobulins|immunoglobulins|mesh-list
92070515|NCT05604898|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92070516|NCT05604898|Immunologic Factors|immunologic factors|mesh-ancestor
92070517|NCT05604898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070518|NCT05604898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070519|NCT04392700|Tenofovir|tenofovir|mesh-list
92070520|NCT04392700|Entecavir|entecavir|mesh-list
92070521|NCT04392700|Antiviral Agents|antiviral agents|mesh-ancestor
92070522|NCT04392700|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070523|NCT04392700|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92070524|NCT04392700|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92070525|NCT04392700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070526|NCT04392700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070527|NCT04392700|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92070528|NCT04392700|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92070529|NCT03828058|Tacrolimus|tacrolimus|mesh-list
92070530|NCT03828058|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070531|NCT03828058|Immunologic Factors|immunologic factors|mesh-ancestor
92070532|NCT03828058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070533|NCT03828058|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92070536|NCT01513551|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92070538|NCT01513551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070539|NCT03827122|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92070540|NCT03827122|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92070541|NCT03827122|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92070542|NCT03827122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070543|NCT03827122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070544|NCT03827122|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92070545|NCT03827122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070546|NCT03827122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070547|NCT03827122|Cholinergic Agents|cholinergic agents|mesh-ancestor
92070548|NCT03827122|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070549|NCT03827200|Ambrisentan|ambrisentan|mesh-list
92070550|NCT03827200|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92070551|NCT02983630|Penicillins|penicillins|mesh-list
92070552|NCT02983630|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070553|NCT02983630|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070554|NCT03827278|Itraconazole|itraconazole|mesh-list
92070555|NCT03827278|Voriconazole|voriconazole|mesh-list
92070556|NCT03827278|Amphotericin B|amphotericin b|mesh-list
92070557|NCT03827278|Antifungal Agents|antifungal agents|mesh-ancestor
92070558|NCT03827278|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070559|NCT03827278|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92070560|NCT03827278|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92070561|NCT03827278|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071168|NCT02735122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070562|NCT03827278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070563|NCT03827278|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92070564|NCT03827278|Hormone Antagonists|hormone antagonists|mesh-ancestor
92070565|NCT03827278|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070566|NCT03827278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070567|NCT03827278|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92070569|NCT03827278|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92070570|NCT03827278|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92070571|NCT03827278|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070572|NCT01513473|Insulin|insulin|mesh-list
92070573|NCT01513473|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92015746|NCT02519595|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92015747|NCT02519595|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92015748|NCT02519595|Anesthetics, General|anesthetics, general|mesh-ancestor
92015749|NCT02519595|Anesthetics|anesthetics|mesh-ancestor
92015750|NCT02519595|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015751|NCT02519595|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92015752|NCT02519595|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92015753|NCT02519595|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015754|NCT02519595|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070574|NCT01513473|Insulin Aspart|insulin aspart|mesh-list
92070575|NCT01513473|Insulin Detemir|insulin detemir|mesh-list
92070576|NCT01513473|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92070577|NCT01513473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070578|NCT03109990|Dexmedetomidine|dexmedetomidine|mesh-list
92070579|NCT03109990|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92070580|NCT03109990|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070581|NCT03109990|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070582|NCT03109990|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070583|NCT03109990|Analgesics|analgesics|mesh-ancestor
92070584|NCT03109990|Sensory System Agents|sensory system agents|mesh-ancestor
92070585|NCT03109990|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070586|NCT03109990|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92070587|NCT03109990|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92070588|NCT03109990|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92070589|NCT03109990|Adrenergic Agents|adrenergic agents|mesh-ancestor
92070590|NCT03109990|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070591|NCT03109990|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070592|NCT03071536|Furosemide|furosemide|mesh-list
92070593|NCT03071536|Diuretics|diuretics|mesh-ancestor
92070594|NCT03071536|Natriuretic Agents|natriuretic agents|mesh-ancestor
92070595|NCT03071536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070596|NCT03071536|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92070597|NCT03071536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070598|NCT03071536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070599|NCT01513317|Siltuximab|siltuximab|mesh-list
92070600|NCT01513317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070601|NCT03825250|Valproic Acid|valproic acid|mesh-list
92070602|NCT03825250|Anticonvulsants|anticonvulsants|mesh-ancestor
92070603|NCT03825250|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070604|NCT03825250|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070607|NCT03825250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070608|NCT03825250|Antimanic Agents|antimanic agents|mesh-ancestor
92070609|NCT03825250|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92070610|NCT03825250|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070611|NCT03825250|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070612|NCT03825328|Paclitaxel|paclitaxel|mesh-list
92070613|NCT03825328|Gemcitabine|gemcitabine|mesh-list
92070614|NCT03825328|Oxaliplatin|oxaliplatin|mesh-list
92070615|NCT03825328|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92070616|NCT03825328|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92070617|NCT03825328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070618|NCT03825328|Tubulin Modulators|tubulin modulators|mesh-ancestor
92070619|NCT03825328|Antimitotic Agents|antimitotic agents|mesh-ancestor
92070620|NCT03825328|Mitosis Modulators|mitosis modulators|mesh-ancestor
92070621|NCT03825328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070622|NCT03825328|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92070623|NCT03825328|Antimetabolites|antimetabolites|mesh-ancestor
92070624|NCT03825016|Diclofenac|diclofenac|mesh-list
92070625|NCT03825016|Lidocaine|lidocaine|mesh-list
92070626|NCT03825016|Anesthetics, Local|anesthetics, local|mesh-ancestor
92070627|NCT03825016|Anesthetics|anesthetics|mesh-ancestor
92070628|NCT03825016|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070629|NCT03825016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070630|NCT03825016|Sensory System Agents|sensory system agents|mesh-ancestor
92015756|NCT04278755|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92015757|NCT04278755|Drospirenone and ethinyl estradiol combination|drospirenone and ethinyl estradiol combination|mesh-list
92015758|NCT04278755|Estradiol|estradiol|mesh-list
92015759|NCT04278755|Estrogens|estrogens|mesh-ancestor
92015760|NCT04278755|Hormones|hormones|mesh-ancestor
92015761|NCT04278755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070631|NCT03825016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070632|NCT03825016|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92070633|NCT03825016|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92070634|NCT03825016|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92070635|NCT03825016|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070636|NCT03825016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070637|NCT03825016|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070638|NCT03825016|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070639|NCT03825016|Analgesics|analgesics|mesh-ancestor
92070640|NCT03825016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070641|NCT03825016|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070642|NCT03825016|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92070643|NCT03825016|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070644|NCT03043924|Cyproterone Acetate|cyproterone acetate|mesh-list
92070645|NCT03043924|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92070646|NCT03043924|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92070647|NCT03043924|Levonorgestrel|levonorgestrel|mesh-list
92070648|NCT03043924|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92070650|NCT03043924|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92070651|NCT03043924|Cyproterone|cyproterone|mesh-list
92070652|NCT03043924|Estrogens|estrogens|mesh-ancestor
92070653|NCT03043924|Hormones|hormones|mesh-ancestor
92070654|NCT03043924|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070655|NCT03043924|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070656|NCT03043924|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92070657|NCT03043924|Contraceptive Agents|contraceptive agents|mesh-ancestor
92070658|NCT03043924|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92070659|NCT03043924|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92070660|NCT03043924|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92070661|NCT03043924|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92070662|NCT03043924|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92070663|NCT03043924|Androgen Antagonists|androgen antagonists|mesh-ancestor
92070664|NCT03043924|Hormone Antagonists|hormone antagonists|mesh-ancestor
92070665|NCT03043924|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070666|NCT03043924|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92070667|NCT03824314|Fentanyl|fentanyl|mesh-list
92070668|NCT03824314|Midazolam|midazolam|mesh-list
92070669|NCT03824314|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92070670|NCT03824314|Narcotics|narcotics|mesh-ancestor
92070671|NCT03824314|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070672|NCT03824314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070673|NCT03824314|Analgesics|analgesics|mesh-ancestor
92070674|NCT03824314|Sensory System Agents|sensory system agents|mesh-ancestor
92070675|NCT03824314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070676|NCT03824314|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92070677|NCT03824314|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92070678|NCT03824314|Anesthetics, General|anesthetics, general|mesh-ancestor
92070679|NCT03824314|Anesthetics|anesthetics|mesh-ancestor
92070698|NCT03824002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070700|NCT03823846|Flurbiprofen axetil|flurbiprofen axetil|mesh-list
92070701|NCT03823846|Parecoxib|parecoxib|mesh-list
92070702|NCT03823846|Dezocine|dezocine|mesh-list
92070703|NCT03823846|Analgesics|analgesics|mesh-ancestor
92070704|NCT03823846|Sensory System Agents|sensory system agents|mesh-ancestor
92070705|NCT03823846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070706|NCT03823846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070707|NCT03823846|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070708|NCT03823846|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070709|NCT03823846|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92015762|NCT04278755|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015763|NCT04278755|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92015764|NCT04278755|Contraceptive Agents|contraceptive agents|mesh-ancestor
92015765|NCT04278755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92070710|NCT03823846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070711|NCT03823846|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92070712|NCT03823846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070713|NCT03823846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071905|NCT01450774|Autonomic Agents|autonomic agents|mesh-ancestor
92070714|NCT03823846|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92070715|NCT03823846|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92070716|NCT03823846|Narcotics|narcotics|mesh-ancestor
92070717|NCT03823846|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070718|NCT02908750|Fexofenadine|fexofenadine|mesh-list
92070719|NCT02908750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070720|NCT02908750|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92070721|NCT02908750|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92070722|NCT02908750|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92070723|NCT02908750|Histamine Antagonists|histamine antagonists|mesh-ancestor
92070724|NCT02908750|Histamine Agents|histamine agents|mesh-ancestor
92070725|NCT02908750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070726|NCT02908750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070727|NCT03823612|Calcium|calcium|mesh-list
92070728|NCT03823612|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92070729|NCT03823612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070730|NCT02810704|Aspirin|aspirin|mesh-list
92070731|NCT02810704|Warfarin|warfarin|mesh-list
92070732|NCT02810704|Rivaroxaban|rivaroxaban|mesh-list
92070733|NCT02810704|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070734|NCT02810704|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070735|NCT02810704|Analgesics|analgesics|mesh-ancestor
92070736|NCT02810704|Sensory System Agents|sensory system agents|mesh-ancestor
92070737|NCT02810704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070752|NCT02810704|Protease Inhibitors|protease inhibitors|mesh-ancestor
92070754|NCT02735902|Vitamin K|vitamin k|mesh-list
92070755|NCT02735902|Anticoagulants|anticoagulants|mesh-list
92070756|NCT02735902|Vitamins|vitamins|mesh-ancestor
92070757|NCT02735902|Micronutrients|micronutrients|mesh-ancestor
92070758|NCT02735902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070759|NCT02735902|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070760|NCT02735902|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070761|NCT02735902|Analgesics|analgesics|mesh-ancestor
92070762|NCT02735902|Sensory System Agents|sensory system agents|mesh-ancestor
92070763|NCT02735902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070764|NCT02735902|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070765|NCT02735902|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070766|NCT02735902|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92070767|NCT02735902|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92070768|NCT02735902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070769|NCT02735902|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92070770|NCT02735902|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92070771|NCT02735902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070772|NCT02735902|Antipyretics|antipyretics|mesh-ancestor
92070773|NCT02735902|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92070774|NCT02735902|Hemostatics|hemostatics|mesh-ancestor
92070775|NCT02735902|Coagulants|coagulants|mesh-ancestor
92070776|NCT02926222|Lomustine|lomustine|mesh-list
92070777|NCT02926222|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92070778|NCT02926222|Alkylating Agents|alkylating agents|mesh-ancestor
92070779|NCT02926222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070780|NCT02926222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070781|NCT04273282|Moxifloxacin|moxifloxacin|mesh-list
92070782|NCT04273282|Dexamethasone|dexamethasone|mesh-list
92070783|NCT04273282|Prednisolone|prednisolone|mesh-list
92070784|NCT04273282|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92070785|NCT04273282|Methylprednisolone|methylprednisolone|mesh-list
92070786|NCT04273282|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92070787|NCT04273282|Prednisolone acetate|prednisolone acetate|mesh-list
92070788|NCT04273282|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92070789|NCT04273282|Prednisolone phosphate|prednisolone phosphate|mesh-list
92070790|NCT04273282|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070791|NCT04273282|Antiemetics|antiemetics|mesh-ancestor
92015766|NCT04278755|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92015767|NCT04278755|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92015768|NCT04278755|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92070792|NCT04273282|Autonomic Agents|autonomic agents|mesh-ancestor
92070793|NCT04273282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070794|NCT04273282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070795|NCT04273282|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070796|NCT04273282|Glucocorticoids|glucocorticoids|mesh-ancestor
92070797|NCT04273282|Hormones|hormones|mesh-ancestor
92070798|NCT04273282|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070801|NCT04273282|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92070803|NCT04273282|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070804|NCT04273282|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070805|NCT04273282|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92070806|NCT04273282|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92070807|NCT04273282|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070808|NCT04273282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070809|NCT01454440|Eptifibatide|eptifibatide|mesh-list
92070810|NCT01454440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92070811|NCT01454518|Anesthetics|anesthetics|mesh-list
92070812|NCT01454518|Anesthetics, Local|anesthetics, local|mesh-list
92070813|NCT01454518|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070814|NCT01454518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070815|NCT01454518|Sensory System Agents|sensory system agents|mesh-ancestor
92070816|NCT01454518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070817|NCT02983084|Copper|copper|mesh-list
92070818|NCT02983084|Nickel|nickel|mesh-list
92070819|NCT02983084|Trace Elements|trace elements|mesh-ancestor
92070820|NCT02983084|Micronutrients|micronutrients|mesh-ancestor
92070821|NCT02983084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070822|NCT01455142|Insulin|insulin|mesh-list
92070823|NCT01455142|Insulin Aspart|insulin aspart|mesh-list
92070824|NCT01455142|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92070825|NCT01455142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070826|NCT01455532|Carboplatin|carboplatin|mesh-list
92070827|NCT01455532|Gemcitabine|gemcitabine|mesh-list
92070828|NCT01455532|Doxorubicin|doxorubicin|mesh-list
92070829|NCT01455532|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92070830|NCT01455532|Iniparib|iniparib|mesh-list
92070831|NCT01455532|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070832|NCT01455532|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92070833|NCT01455532|Antimetabolites|antimetabolites|mesh-ancestor
92070834|NCT01455532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070835|NCT01455532|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92070836|NCT01455532|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92070838|NCT01455532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070839|NCT01455532|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92070840|NCT01455922|Glimepiride|glimepiride|mesh-list
92070841|NCT01455922|Exenatide|exenatide|mesh-list
92070842|NCT01455922|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92070843|NCT01455922|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92070844|NCT01455922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070845|NCT01455922|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92070846|NCT01455922|Immunologic Factors|immunologic factors|mesh-ancestor
92070847|NCT01455922|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92070848|NCT01455922|Incretins|incretins|mesh-ancestor
92070849|NCT01455922|Hormones|hormones|mesh-ancestor
92070850|NCT01455922|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070851|NCT01456234|Oseltamivir|oseltamivir|mesh-list
92070852|NCT01456234|Antiviral Agents|antiviral agents|mesh-ancestor
92070853|NCT01456234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070854|NCT01456234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070855|NCT01456234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070856|NCT01456312|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92070857|NCT01456312|Entecavir|entecavir|mesh-list
92070858|NCT01456312|Antiviral Agents|antiviral agents|mesh-ancestor
92070859|NCT01456312|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070860|NCT02542696|Apomorphine|apomorphine|mesh-list
92070861|NCT02542696|Emetics|emetics|mesh-ancestor
92070862|NCT02542696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070863|NCT02542696|Autonomic Agents|autonomic agents|mesh-ancestor
92070864|NCT02542696|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015769|NCT04278755|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92015770|NCT04278755|Hormone Antagonists|hormone antagonists|mesh-ancestor
92015771|NCT04278755|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92015772|NCT04278755|Diuretics|diuretics|mesh-ancestor
92015773|NCT04278755|Natriuretic Agents|natriuretic agents|mesh-ancestor
92015774|NCT04277975|Analgesics, Opioid|analgesics, opioid|mesh-list
92015775|NCT04277975|Narcotics|narcotics|mesh-ancestor
92070865|NCT02542696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070866|NCT02542696|Dopamine Agonists|dopamine agonists|mesh-ancestor
92070867|NCT02542696|Dopamine Agents|dopamine agents|mesh-ancestor
92070868|NCT02542696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070869|NCT02542696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070870|NCT01456468|Tretinoin|tretinoin|mesh-list
92070871|NCT01456468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070872|NCT01456468|Keratolytic Agents|keratolytic agents|mesh-ancestor
92070876|NCT01456546|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92070877|NCT01456546|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92070878|NCT01456546|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92070880|NCT01456546|Purinergic Agents|purinergic agents|mesh-ancestor
92070881|NCT01456546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070882|NCT01456546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070883|NCT01456546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070884|NCT01456546|Antimalarials|antimalarials|mesh-ancestor
92070885|NCT01456546|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92070886|NCT01456546|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92070887|NCT01456546|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070888|NCT01456546|Antimetabolites|antimetabolites|mesh-ancestor
92070889|NCT01456624|Megestrol Acetate|megestrol acetate|mesh-list
92070890|NCT01456624|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070891|NCT01456624|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070892|NCT01456624|Appetite Stimulants|appetite stimulants|mesh-ancestor
92070893|NCT01456624|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92070894|NCT01456624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070895|NCT01457716|Budesonide|budesonide|mesh-list
92070896|NCT01457716|Formoterol Fumarate|formoterol fumarate|mesh-list
92070897|NCT01457716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070898|NCT01457716|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92070899|NCT01457716|Autonomic Agents|autonomic agents|mesh-ancestor
92070900|NCT01457716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070901|NCT01457716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070902|NCT01457716|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92070903|NCT01457716|Respiratory System Agents|respiratory system agents|mesh-ancestor
92070904|NCT01457716|Glucocorticoids|glucocorticoids|mesh-ancestor
92070906|NCT01457716|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070907|NCT01457716|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92070908|NCT01457716|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92070909|NCT01457716|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92070910|NCT01457716|Adrenergic Agents|adrenergic agents|mesh-ancestor
92070911|NCT01457716|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070912|NCT01457716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070913|NCT02880982|Vitamin D|vitamin d|mesh-list
92070914|NCT02880982|Cholecalciferol|cholecalciferol|mesh-list
92070915|NCT02880982|Vitamins|vitamins|mesh-ancestor
92070916|NCT02880982|Micronutrients|micronutrients|mesh-ancestor
92070917|NCT02880982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070918|NCT02880982|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92070919|NCT02880982|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92070920|NCT01458964|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92070921|NCT01458964|Antidepressive Agents|antidepressive agents|mesh-ancestor
92070922|NCT01458964|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070923|NCT01458964|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92070924|NCT01458964|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92070925|NCT01458964|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92070926|NCT01458964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070927|NCT01459198|Vaccines|vaccines|mesh-list
92070928|NCT01459198|Immunologic Factors|immunologic factors|mesh-ancestor
92015776|NCT04277975|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015777|NCT04277975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070929|NCT01459198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070930|NCT02490904|Eplerenone|eplerenone|mesh-list
92070931|NCT02490904|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92070932|NCT02490904|Hormone Antagonists|hormone antagonists|mesh-ancestor
92070933|NCT02490904|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070934|NCT02490904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070935|NCT02490904|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92070936|NCT02490904|Diuretics|diuretics|mesh-ancestor
92070937|NCT02490904|Natriuretic Agents|natriuretic agents|mesh-ancestor
92070938|NCT02490904|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92070939|NCT04390984|Apatinib|apatinib|mesh-list
92070940|NCT04390984|Gefitinib|gefitinib|mesh-list
92070941|NCT04390984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070942|NCT04390984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92070943|NCT04390984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070944|NCT04390984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070945|NCT02873806|Tobramycin|tobramycin|mesh-list
92070948|NCT02873806|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070950|NCT02873806|Autonomic Agents|autonomic agents|mesh-ancestor
92070951|NCT02873806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070952|NCT02873806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070953|NCT02873806|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92070954|NCT02873806|Glucocorticoids|glucocorticoids|mesh-ancestor
92070955|NCT02873806|Hormones|hormones|mesh-ancestor
92070956|NCT02873806|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92070957|NCT02873806|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070958|NCT02873806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070959|NCT02873806|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92070960|NCT02873806|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070961|NCT02873806|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070962|NCT01890772|Vitamin D|vitamin d|mesh-list
92070963|NCT01890772|Ribavirin|ribavirin|mesh-list
92070964|NCT01890772|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92070965|NCT01890772|Vitamins|vitamins|mesh-ancestor
92070966|NCT01890772|Micronutrients|micronutrients|mesh-ancestor
92070967|NCT01890772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070968|NCT01890772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92070969|NCT01890772|Antimetabolites|antimetabolites|mesh-ancestor
92070970|NCT01890772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070971|NCT01890772|Antiviral Agents|antiviral agents|mesh-ancestor
92070972|NCT01890772|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070974|NCT01891084|Ibuprofen|ibuprofen|mesh-list
92070975|NCT01891084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070976|NCT01891084|Analgesics|analgesics|mesh-ancestor
92070977|NCT01891084|Sensory System Agents|sensory system agents|mesh-ancestor
92070978|NCT01891084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070979|NCT01891084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070980|NCT01891084|Antipyretics|antipyretics|mesh-ancestor
92070981|NCT01891084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070982|NCT01891084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070983|NCT01891084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070984|NCT01891084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92070985|NCT01891084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070986|NCT01891084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070987|NCT01891708|Bevacizumab|bevacizumab|mesh-list
92070988|NCT01891708|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92070989|NCT01891708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070990|NCT01891708|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92070991|NCT01891708|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92070992|NCT01891708|Growth Substances|growth substances|mesh-ancestor
92070993|NCT01891708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070994|NCT01891708|Growth Inhibitors|growth inhibitors|mesh-ancestor
92070995|NCT01892098|Zinc Sulfate|zinc sulfate|mesh-list
92070996|NCT01892098|Astringents|astringents|mesh-ancestor
92070997|NCT01892098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070998|NCT01892098|Dermatologic Agents|dermatologic agents|mesh-ancestor
92070999|NCT01892176|Ubiquinone|ubiquinone|mesh-list
92071000|NCT01892176|Coenzyme Q10|coenzyme q10|mesh-list
92071001|NCT01892176|Micronutrients|micronutrients|mesh-ancestor
92015779|NCT04277975|Sensory System Agents|sensory system agents|mesh-ancestor
92015780|NCT04277975|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015781|NCT04062695|Tofacitinib|tofacitinib|mesh-list
92015782|NCT04062695|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92015783|NCT04062695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92015784|NCT04062695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071002|NCT01892176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071003|NCT01892176|Vitamins|vitamins|mesh-ancestor
92071004|NCT01892254|Metformin|metformin|mesh-list
92071005|NCT01892254|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92071006|NCT01892254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071007|NCT01892332|Lidocaine|lidocaine|mesh-list
92071008|NCT01892332|Fentanyl|fentanyl|mesh-list
92071009|NCT01892332|Anesthetics, Local|anesthetics, local|mesh-ancestor
92071010|NCT01892332|Anesthetics|anesthetics|mesh-ancestor
92071011|NCT01892332|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071012|NCT01892332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071013|NCT01892332|Sensory System Agents|sensory system agents|mesh-ancestor
92071014|NCT01892332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071015|NCT01892332|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92071016|NCT01892332|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92071017|NCT01892332|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92071018|NCT01892332|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92071019|NCT01892332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071023|NCT01892332|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92071024|NCT01892332|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92071025|NCT01892332|Anesthetics, General|anesthetics, general|mesh-ancestor
92071026|NCT01892488|Sultamicillin|sultamicillin|mesh-list
92071027|NCT01892488|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-list
92071028|NCT01892488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071029|NCT01892488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071030|NCT01892488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072032|NCT01453426|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92071031|NCT01892488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071032|NCT02809690|Clevudine|clevudine|mesh-list
92071033|NCT02809690|Antiviral Agents|antiviral agents|mesh-ancestor
92071034|NCT02809690|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071035|NCT01892644|Deferasirox|deferasirox|mesh-list
92071036|NCT01892644|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92071037|NCT01892644|Chelating Agents|chelating agents|mesh-ancestor
92071038|NCT01892644|Sequestering Agents|sequestering agents|mesh-ancestor
92071039|NCT01892644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071040|NCT01901653|Rovalpituzumab tesirine|rovalpituzumab tesirine|mesh-list
92071041|NCT01901653|Immunoconjugates|immunoconjugates|mesh-ancestor
92071042|NCT01901653|Immunologic Factors|immunologic factors|mesh-ancestor
92071043|NCT01901653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071044|NCT01925989|Insulin Glargine|insulin glargine|mesh-list
92071045|NCT01925989|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92071046|NCT01925989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071047|NCT01901419|Nitroglycerin|nitroglycerin|mesh-list
92071048|NCT01901419|Vasodilator Agents|vasodilator agents|mesh-ancestor
92071049|NCT02798536|Paclitaxel|paclitaxel|mesh-list
92071050|NCT02798536|LMB-100|lmb-100|mesh-list
92071051|NCT02798536|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071052|NCT02798536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071053|NCT02798536|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071054|NCT02798536|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071055|NCT02798536|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071056|NCT02798536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071057|NCT02798536|Immunoconjugates|immunoconjugates|mesh-ancestor
92071058|NCT02798536|Immunologic Factors|immunologic factors|mesh-ancestor
92071059|NCT02798536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071060|NCT04758286|Anesthetics|anesthetics|mesh-list
92071061|NCT04758286|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071062|NCT04758286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071063|NCT01453660|Cisplatin|cisplatin|mesh-list
92071064|NCT01453660|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071065|NCT01615939|Bupivacaine|bupivacaine|mesh-list
92071066|NCT01615939|Ropivacaine|ropivacaine|mesh-list
92015785|NCT04062695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015786|NCT04330079|Dapagliflozin|dapagliflozin|mesh-list
92015787|NCT04330079|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92015788|NCT04330079|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015789|NCT04330079|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92015790|NCT04330079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015791|NCT00660673|Levodopa|levodopa|mesh-list
92015792|NCT00660673|Carbidopa|carbidopa|mesh-list
92015793|NCT00660673|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92015794|NCT00660673|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92015795|NCT00660673|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92015796|NCT00660673|Dopamine Agents|dopamine agents|mesh-ancestor
92015797|NCT00660673|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015798|NCT00660673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015799|NCT00660673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071067|NCT01615939|Anesthetics, Local|anesthetics, local|mesh-ancestor
92071068|NCT01615939|Anesthetics|anesthetics|mesh-ancestor
92071069|NCT01615939|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071070|NCT01615939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071071|NCT01615939|Sensory System Agents|sensory system agents|mesh-ancestor
92071072|NCT01615939|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071073|NCT02789878|Prednisone|prednisone|mesh-list
92071074|NCT02789878|Goserelin|goserelin|mesh-list
92071075|NCT02789878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071076|NCT02789878|Glucocorticoids|glucocorticoids|mesh-ancestor
92071077|NCT02789878|Hormones|hormones|mesh-ancestor
92071078|NCT02789878|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071079|NCT02789878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071080|NCT02789878|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071081|NCT02789878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071082|NCT01901185|Etanercept|etanercept|mesh-list
92071083|NCT01901185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071084|NCT01901185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071085|NCT01901185|Analgesics|analgesics|mesh-ancestor
92071086|NCT01901185|Sensory System Agents|sensory system agents|mesh-ancestor
92071087|NCT01901185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071088|NCT01901185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071089|NCT01901185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071090|NCT01901185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071091|NCT01901185|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071092|NCT01901185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071093|NCT01901185|Immunologic Factors|immunologic factors|mesh-ancestor
92071094|NCT01893424|Dronabinol|dronabinol|mesh-list
92071100|NCT01893424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071101|NCT01893424|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92071102|NCT01893424|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071103|NCT01893424|Analgesics|analgesics|mesh-ancestor
92071104|NCT01893424|Sensory System Agents|sensory system agents|mesh-ancestor
92071105|NCT01893424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071106|NCT01893424|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92071107|NCT01893424|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92071108|NCT01893424|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071109|NCT01893424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071111|NCT01893424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071112|NCT01893424|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92071113|NCT01893424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015800|NCT00660673|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92015801|NCT00660673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015802|NCT00660673|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92015803|NCT00660673|Immunologic Factors|immunologic factors|mesh-ancestor
92071114|NCT02788708|Paclitaxel|paclitaxel|mesh-list
92071115|NCT02788708|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92071116|NCT02788708|Lenvatinib|lenvatinib|mesh-list
92071117|NCT02788708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071118|NCT02788708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071119|NCT02788708|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071120|NCT02788708|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071121|NCT02788708|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071122|NCT02788708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071123|NCT02788708|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92071124|NCT02788708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071125|NCT01888003|Epoetin Alfa|epoetin alfa|mesh-list
92071126|NCT01888003|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92071127|NCT01888003|Hematinics|hematinics|mesh-ancestor
92071128|NCT02784496|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92071129|NCT02784496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92071130|NCT02784496|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071131|NCT02784496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071132|NCT02780128|Ceritinib|ceritinib|mesh-list
92071133|NCT02780128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071134|NCT02780128|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92071135|NCT02780128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071136|NCT02780128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071137|NCT02773732|Ciprofloxacin|ciprofloxacin|mesh-list
92071138|NCT02773732|Etoposide|etoposide|mesh-list
92071139|NCT02773732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071140|NCT02773732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071141|NCT02773732|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92071142|NCT02773732|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92071143|NCT02773732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071144|NCT02773732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071145|NCT02773732|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071146|NCT02773732|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071147|NCT02773732|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92071148|NCT02773732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92071149|NCT02769520|Pembrolizumab|pembrolizumab|mesh-list
92071150|NCT02769520|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071151|NCT02769520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071152|NCT02769520|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92071153|NCT02769520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071154|NCT02762266|Ethiodized Oil|ethiodized oil|mesh-list
92071155|NCT02762266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071156|NCT02735122|Acetaminophen|acetaminophen|mesh-list
92071157|NCT02735122|Ibuprofen|ibuprofen|mesh-list
92071158|NCT02735122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071159|NCT02735122|Analgesics|analgesics|mesh-ancestor
92071160|NCT02735122|Sensory System Agents|sensory system agents|mesh-ancestor
92071161|NCT02735122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071162|NCT02735122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071163|NCT02735122|Antipyretics|antipyretics|mesh-ancestor
92071164|NCT02735122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071165|NCT02735122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071169|NCT02735122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071170|NCT02718118|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92071171|NCT02718118|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92071172|NCT02718118|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92071173|NCT02718118|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92071174|NCT02718118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071175|NCT02718118|Cholinergic Agents|cholinergic agents|mesh-ancestor
92071176|NCT02718118|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071177|NCT02718118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071178|NCT02718118|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92071179|NCT02718118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071180|NCT02717962|Dianhydrogalactitol|dianhydrogalactitol|mesh-list
92015804|NCT00660673|Dopamine Agonists|dopamine agonists|mesh-ancestor
92015805|NCT03644381|Immunomodulating Agents|immunomodulating agents|mesh-list
92015806|NCT03644381|Immunologic Factors|immunologic factors|mesh-ancestor
92015807|NCT03644381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015808|NCT05612711|Dronabinol|dronabinol|mesh-list
92071181|NCT02717962|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92071182|NCT02717962|Alkylating Agents|alkylating agents|mesh-ancestor
92071183|NCT02717962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071184|NCT02717962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071185|NCT01893658|Omalizumab|omalizumab|mesh-list
92071186|NCT01893658|Prednisone|prednisone|mesh-list
92071187|NCT01893658|Prednisolone|prednisolone|mesh-list
92071188|NCT01893658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071189|NCT01893658|Glucocorticoids|glucocorticoids|mesh-ancestor
92071190|NCT01893658|Hormones|hormones|mesh-ancestor
92071191|NCT01893658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071192|NCT01893658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071193|NCT01893658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071194|NCT01893658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071195|NCT01893658|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92071196|NCT01893658|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92071197|NCT01893658|Respiratory System Agents|respiratory system agents|mesh-ancestor
92071198|NCT02703610|Acetaminophen|acetaminophen|mesh-list
92071199|NCT02703610|Ibuprofen|ibuprofen|mesh-list
92071200|NCT02703610|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92071201|NCT02703610|Oxycodone|oxycodone|mesh-list
92071202|NCT02703610|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071203|NCT02703610|Analgesics|analgesics|mesh-ancestor
92071204|NCT02703610|Sensory System Agents|sensory system agents|mesh-ancestor
92071205|NCT02703610|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071206|NCT02703610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071207|NCT02703610|Antipyretics|antipyretics|mesh-ancestor
92071208|NCT02703610|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071209|NCT02703610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071210|NCT02703610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071211|NCT02703610|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92071212|NCT02703610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071213|NCT02703610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071214|NCT02703610|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92071215|NCT02703610|Narcotics|narcotics|mesh-ancestor
92071216|NCT02703610|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071217|NCT02688556|Cyclosporine|cyclosporine|mesh-list
92071218|NCT02688556|Cyclosporins|cyclosporins|mesh-list
92071219|NCT02688556|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071220|NCT02688556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071221|NCT02688556|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071222|NCT02688556|Immunologic Factors|immunologic factors|mesh-ancestor
92071223|NCT02688556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071224|NCT02688556|Antifungal Agents|antifungal agents|mesh-ancestor
92071225|NCT02688556|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071226|NCT02688556|Dermatologic Agents|dermatologic agents|mesh-ancestor
92071227|NCT02688556|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071228|NCT02688556|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92071229|NCT02684032|Letrozole|letrozole|mesh-list
92071230|NCT02684032|Fulvestrant|fulvestrant|mesh-list
92071231|NCT02684032|Palbociclib|palbociclib|mesh-list
92071232|NCT02684032|Gedatolisib|gedatolisib|mesh-list
92071233|NCT02684032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071234|NCT02684032|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92071235|NCT02684032|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92071236|NCT02684032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071237|NCT02684032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071238|NCT02684032|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92071240|NCT02684032|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071241|NCT02684032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071242|NCT02684032|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071243|NCT02684032|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92071244|NCT02684032|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92071246|NCT02388178|Cariostatic Agents|cariostatic agents|mesh-ancestor
92071247|NCT02388178|Protective Agents|protective agents|mesh-ancestor
92015809|NCT05612711|Hallucinogens|hallucinogens|mesh-ancestor
92015810|NCT05612711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015811|NCT05612711|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92071248|NCT02388178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071249|NCT02384668|Vitamin D|vitamin d|mesh-list
92071250|NCT02384668|Cholecalciferol|cholecalciferol|mesh-list
92071251|NCT02384668|Vitamins|vitamins|mesh-ancestor
92071252|NCT02384668|Micronutrients|micronutrients|mesh-ancestor
92071253|NCT02384668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071254|NCT02384668|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92071255|NCT02384668|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92071256|NCT01898923|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92071257|NCT01898923|Laxatives|laxatives|mesh-ancestor
92071258|NCT01898923|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071259|NCT01924429|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92071260|NCT01924429|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92071261|NCT01924429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071262|NCT01924429|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92071263|NCT01924429|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92071264|NCT01924429|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92071265|NCT01924429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071266|NCT01924429|Dopamine Agents|dopamine agents|mesh-ancestor
92071267|NCT01924429|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071268|NCT01886287|Octreotide|octreotide|mesh-list
92071269|NCT01886287|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071270|NCT01886287|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071271|NCT01886287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071272|NCT02707588|Pembrolizumab|pembrolizumab|mesh-list
92071273|NCT02707588|Cetuximab|cetuximab|mesh-list
92071274|NCT02707588|Antibodies|antibodies|mesh-list
92071275|NCT02707588|Immunoglobulins|immunoglobulins|mesh-list
92071276|NCT02707588|Immunologic Factors|immunologic factors|mesh-ancestor
92071277|NCT02707588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071278|NCT02707588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071279|NCT02707588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071280|NCT02707588|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92071281|NCT02707588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071282|NCT05602480|Vaccines|vaccines|mesh-list
92071283|NCT05602480|Immunologic Factors|immunologic factors|mesh-ancestor
92071284|NCT05602480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071285|NCT05600296|Levobupivacaine|levobupivacaine|mesh-list
92071286|NCT05600296|Anesthetics, Local|anesthetics, local|mesh-ancestor
92071287|NCT05600296|Anesthetics|anesthetics|mesh-ancestor
92071288|NCT05600296|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071289|NCT05600296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071290|NCT05600296|Sensory System Agents|sensory system agents|mesh-ancestor
92071291|NCT05600296|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071292|NCT05604586|Acetylcysteine|acetylcysteine|mesh-list
92071293|NCT05604586|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92071294|NCT05604586|Antiviral Agents|antiviral agents|mesh-ancestor
92071295|NCT05604586|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071296|NCT05604586|Expectorants|expectorants|mesh-ancestor
92071297|NCT05604586|Respiratory System Agents|respiratory system agents|mesh-ancestor
92071298|NCT05604586|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92071299|NCT05604586|Antioxidants|antioxidants|mesh-ancestor
92071300|NCT05604586|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071301|NCT05604586|Protective Agents|protective agents|mesh-ancestor
92071302|NCT05604586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071303|NCT05604586|Antidotes|antidotes|mesh-ancestor
92071304|NCT05604118|Aspirin|aspirin|mesh-list
92071305|NCT05604118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071306|NCT05604118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071307|NCT05604118|Analgesics|analgesics|mesh-ancestor
92071308|NCT05604118|Sensory System Agents|sensory system agents|mesh-ancestor
92071309|NCT05604118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071310|NCT05604118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071311|NCT05604118|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071326|NCT05603884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071327|NCT05603884|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015812|NCT05612711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92015813|NCT05612711|Analgesics|analgesics|mesh-ancestor
92015814|NCT05612711|Sensory System Agents|sensory system agents|mesh-ancestor
92015815|NCT05612711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015816|NCT05612711|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92015817|NCT05612711|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92015818|NCT05612711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015819|NCT05612711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015820|NCT05612711|Hormones|hormones|mesh-ancestor
92015821|NCT05612711|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015822|NCT04807309|Danazol|danazol|mesh-list
92015823|NCT04807309|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92015824|NCT04807309|Hormone Antagonists|hormone antagonists|mesh-ancestor
92015825|NCT04807309|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015826|NCT04807309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015827|NCT04744649|Fluorouracil|fluorouracil|mesh-list
92015828|NCT04744649|Antimetabolites|antimetabolites|mesh-ancestor
92015829|NCT04744649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015830|NCT04744649|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92015831|NCT04744649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015832|NCT04744649|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015833|NCT04744649|Immunologic Factors|immunologic factors|mesh-ancestor
92015834|NCT04744649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015835|NCT04426955|Paclitaxel|paclitaxel|mesh-list
92071328|NCT05603884|Antiviral Agents|antiviral agents|mesh-ancestor
92071329|NCT05603884|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071330|NCT05603884|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071331|NCT05603884|Immunologic Factors|immunologic factors|mesh-ancestor
92071332|NCT05603884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071333|NCT05603884|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071334|NCT05603884|Analgesics|analgesics|mesh-ancestor
92071335|NCT05603884|Sensory System Agents|sensory system agents|mesh-ancestor
92071336|NCT05603884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071337|NCT05603884|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92071338|NCT05603884|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92071339|NCT05603650|Listerine|listerine|mesh-list
92071340|NCT05603650|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92071341|NCT05603650|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071342|NCT03337594|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92071343|NCT03337594|Chelating Agents|chelating agents|mesh-ancestor
92071344|NCT03337594|Sequestering Agents|sequestering agents|mesh-ancestor
92071345|NCT03337594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071346|NCT03313804|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92071347|NCT03313804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071348|NCT03313804|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071349|NCT03313804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015836|NCT04426955|Cisplatin|cisplatin|mesh-list
92015837|NCT04426955|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071350|NCT04393792|Povidone-Iodine|povidone-iodine|mesh-list
92071351|NCT04393792|Povidone|povidone|mesh-list
92071352|NCT04393792|Plasma Substitutes|plasma substitutes|mesh-ancestor
92071353|NCT04393792|Blood Substitutes|blood substitutes|mesh-ancestor
92071354|NCT04393792|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92071355|NCT04393792|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071356|NCT01896895|Botulinum Toxins|botulinum toxins|mesh-list
92071357|NCT01896895|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92071358|NCT01896895|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92071359|NCT01896895|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92071360|NCT01896895|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92071361|NCT01896895|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92071362|NCT01896895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071363|NCT01896895|Cholinergic Agents|cholinergic agents|mesh-ancestor
92071364|NCT01896895|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071365|NCT01896895|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071366|NCT01896895|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92071367|NCT01896895|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071368|NCT02315872|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92071369|NCT02315872|Hormones|hormones|mesh-ancestor
92071370|NCT02315872|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071371|NCT02315872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071374|NCT04127500|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071375|NCT04127500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071376|NCT04127500|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071377|NCT04127500|Analgesics|analgesics|mesh-ancestor
92071378|NCT04127500|Sensory System Agents|sensory system agents|mesh-ancestor
92071379|NCT04127500|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071380|NCT04127500|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92071381|NCT04127500|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92071382|NCT04127500|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92071383|NCT04127500|Adrenergic Agents|adrenergic agents|mesh-ancestor
92071384|NCT04127500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071385|NCT04127500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071386|NCT03017326|Carboplatin|carboplatin|mesh-list
92071387|NCT03017326|Gemcitabine|gemcitabine|mesh-list
92071388|NCT03017326|Doxorubicin|doxorubicin|mesh-list
92071389|NCT03017326|Fluorouracil|fluorouracil|mesh-list
92071390|NCT03017326|Oxaliplatin|oxaliplatin|mesh-list
92071391|NCT03017326|Irinotecan|irinotecan|mesh-list
92071392|NCT03017326|Etoposide|etoposide|mesh-list
92071393|NCT03017326|Vincristine|vincristine|mesh-list
92071394|NCT03017326|Sorafenib|sorafenib|mesh-list
92071395|NCT03017326|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071396|NCT03017326|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92071397|NCT03017326|Antimetabolites|antimetabolites|mesh-ancestor
92071398|NCT03017326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071399|NCT03017326|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92071400|NCT03017326|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92071401|NCT03017326|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92071402|NCT03017326|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071403|NCT03017326|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071404|NCT03017326|Immunologic Factors|immunologic factors|mesh-ancestor
92071405|NCT03017326|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071406|NCT03017326|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92071407|NCT03017326|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071408|NCT03017326|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071409|NCT03017326|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071410|NCT03017326|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071411|NCT03017326|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92071412|NCT04126330|Vitamin D|vitamin d|mesh-list
92071413|NCT04126330|Vitamins|vitamins|mesh-ancestor
92071414|NCT04126330|Micronutrients|micronutrients|mesh-ancestor
92071415|NCT04126330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071416|NCT04126330|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92071417|NCT04126720|Vitamin E|vitamin e|mesh-list
92071418|NCT04126720|Vitamins|vitamins|mesh-ancestor
92071419|NCT04126720|Micronutrients|micronutrients|mesh-ancestor
92071420|NCT04126720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071421|NCT04126720|Antioxidants|antioxidants|mesh-ancestor
92071422|NCT04126720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071423|NCT04126720|Protective Agents|protective agents|mesh-ancestor
92015838|NCT04426955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015840|NCT04426955|Antimitotic Agents|antimitotic agents|mesh-ancestor
92015841|NCT04426955|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071424|NCT04126252|Sildenafil Citrate|sildenafil citrate|mesh-list
92071425|NCT04126252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071426|NCT04126252|Vasodilator Agents|vasodilator agents|mesh-ancestor
92071428|NCT04126252|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92071429|NCT04126252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071430|NCT04126252|Urological Agents|urological agents|mesh-ancestor
92071431|NCT04125862|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92071432|NCT04125862|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92071433|NCT04125862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071434|NCT03007732|Ascorbic Acid|ascorbic acid|mesh-list
92071435|NCT03007732|Prednisone|prednisone|mesh-list
92071436|NCT03007732|Pembrolizumab|pembrolizumab|mesh-list
92071437|NCT03007732|Leuprolide|leuprolide|mesh-list
92071438|NCT03007732|Abiraterone Acetate|abiraterone acetate|mesh-list
92071439|NCT03007732|Methyltestosterone|methyltestosterone|mesh-list
92071440|NCT03007732|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92071441|NCT03007732|Androgens|androgens|mesh-list
92071442|NCT03007732|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071443|NCT03007732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071444|NCT03007732|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92071445|NCT03007732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071446|NCT03007732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071449|NCT03007732|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072033|NCT01453426|Dermatologic Agents|dermatologic agents|mesh-ancestor
92071450|NCT03007732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071451|NCT03007732|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071452|NCT03007732|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92071453|NCT03007732|Fertility Agents|fertility agents|mesh-ancestor
92071454|NCT03007732|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92071455|NCT03007732|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92071456|NCT03007732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071457|NCT03007732|Hormone Antagonists|hormone antagonists|mesh-ancestor
92071458|NCT03007732|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92071459|NCT03007732|Antioxidants|antioxidants|mesh-ancestor
92071460|NCT03007732|Protective Agents|protective agents|mesh-ancestor
92071462|NCT03007732|Micronutrients|micronutrients|mesh-ancestor
92071463|NCT03007732|Estrogens|estrogens|mesh-ancestor
92071464|NCT03007732|Anabolic Agents|anabolic agents|mesh-ancestor
92071466|NCT03007420|Anesthetics, Local|anesthetics, local|mesh-ancestor
92071467|NCT03007420|Anesthetics|anesthetics|mesh-ancestor
92071468|NCT03007420|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071469|NCT03007420|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071470|NCT03007420|Sensory System Agents|sensory system agents|mesh-ancestor
92071471|NCT03007420|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071472|NCT03007420|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92071473|NCT03007420|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92071474|NCT03007420|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92071475|NCT03007420|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92071476|NCT03007420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071477|NCT04125706|Metronidazole|metronidazole|mesh-list
92071478|NCT04125706|Minocycline|minocycline|mesh-list
92071479|NCT04125706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071480|NCT04125706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071481|NCT04125706|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92071482|NCT04125706|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92071483|NCT03005782|Cemiplimab|cemiplimab|mesh-list
92071484|NCT03005782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071485|NCT03005782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071486|NCT04125394|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92071487|NCT04125394|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92071488|NCT04125082|Insulin|insulin|mesh-list
92071489|NCT04125082|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92071490|NCT04125082|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92071491|NCT04125082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071492|NCT04393246|Dapagliflozin|dapagliflozin|mesh-list
92015842|NCT04426955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015843|NCT02630563|Cyclosporine|cyclosporine|mesh-list
92015844|NCT02630563|Mycophenolic Acid|mycophenolic acid|mesh-list
92015845|NCT02630563|Cyclosporins|cyclosporins|mesh-list
92071493|NCT04393246|Ambrisentan|ambrisentan|mesh-list
92071494|NCT04393246|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92071495|NCT04393246|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071496|NCT04393246|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92071497|NCT04393246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071498|NCT04393246|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92071499|NCT04124302|Insulin|insulin|mesh-list
92071500|NCT04124302|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92071502|NCT04124302|Insulin Lispro|insulin lispro|mesh-list
92071503|NCT04124302|Insulin glulisine|insulin glulisine|mesh-list
92071504|NCT04124302|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92071505|NCT04124302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071506|NCT04124068|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92071507|NCT04124068|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92071508|NCT04124068|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071509|NCT04411069|Droperidol|droperidol|mesh-list
92071510|NCT04411069|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92071511|NCT04411069|Antiemetics|antiemetics|mesh-ancestor
92071512|NCT04411069|Autonomic Agents|autonomic agents|mesh-ancestor
92071513|NCT04411069|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071514|NCT04411069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071515|NCT04411069|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071516|NCT04411069|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92071517|NCT04411069|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92071518|NCT04411069|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071519|NCT04411069|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92071520|NCT04411069|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92071521|NCT04411069|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92071525|NCT03003130|Hyaluronic Acid|hyaluronic acid|mesh-list
92071526|NCT03003130|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92071527|NCT03003130|Immunologic Factors|immunologic factors|mesh-ancestor
92072107|NCT02864914|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92071528|NCT03003130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071529|NCT03003130|Viscosupplements|viscosupplements|mesh-ancestor
92071530|NCT03003130|Protective Agents|protective agents|mesh-ancestor
92071531|NCT01884571|Mycophenolic Acid|mycophenolic acid|mesh-list
92071532|NCT01884571|Prednisone|prednisone|mesh-list
92071533|NCT01884571|Methylprednisolone|methylprednisolone|mesh-list
92071534|NCT01884571|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92071535|NCT01884571|Tacrolimus|tacrolimus|mesh-list
92071536|NCT01884571|Basiliximab|basiliximab|mesh-list
92071537|NCT01884571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071538|NCT01884571|Glucocorticoids|glucocorticoids|mesh-ancestor
92071539|NCT01884571|Hormones|hormones|mesh-ancestor
92071540|NCT01884571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071541|NCT01884571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071542|NCT01884571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071543|NCT01884571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071544|NCT01884571|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071545|NCT01884571|Immunologic Factors|immunologic factors|mesh-ancestor
92071546|NCT01884571|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92071547|NCT01884571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071548|NCT01884571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071549|NCT01884571|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92071550|NCT01884571|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92071551|NCT01884571|Antitubercular Agents|antitubercular agents|mesh-ancestor
92071552|NCT01884571|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071553|NCT01884571|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071554|NCT01884571|Antiemetics|antiemetics|mesh-ancestor
92071555|NCT01884571|Autonomic Agents|autonomic agents|mesh-ancestor
92071556|NCT01884571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071557|NCT01884571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071558|NCT01884571|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92071559|NCT01884571|Protective Agents|protective agents|mesh-ancestor
92071560|NCT01884337|Apixaban|apixaban|mesh-list
92071561|NCT01884337|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92071562|NCT01884337|Antithrombins|antithrombins|mesh-ancestor
92071563|NCT01884337|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92015846|NCT02630563|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015847|NCT02630563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015848|NCT02630563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015849|NCT02630563|Immunologic Factors|immunologic factors|mesh-ancestor
92015850|NCT02630563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071564|NCT01884337|Protease Inhibitors|protease inhibitors|mesh-ancestor
92071565|NCT01884337|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071566|NCT01884337|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071567|NCT01884337|Anticoagulants|anticoagulants|mesh-ancestor
92071568|NCT04123288|ACT-709478|act-709478|mesh-list
92071569|NCT04123288|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92071570|NCT04123288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92071571|NCT04123288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071572|NCT04123288|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92071573|NCT04123288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071574|NCT04123210|Vitamin A|vitamin a|mesh-list
92071575|NCT04123210|Vitamins|vitamins|mesh-ancestor
92071576|NCT04123210|Micronutrients|micronutrients|mesh-ancestor
92071577|NCT04123210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071578|NCT01922089|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92071579|NCT01922089|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92071580|NCT01922089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071581|NCT04121416|Sufentanil|sufentanil|mesh-list
92071582|NCT04121416|Oxycodone|oxycodone|mesh-list
92071583|NCT04121416|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92071584|NCT04121416|Narcotics|narcotics|mesh-ancestor
92071585|NCT04121416|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071586|NCT04121416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071587|NCT04121416|Analgesics|analgesics|mesh-ancestor
92071588|NCT04121416|Sensory System Agents|sensory system agents|mesh-ancestor
92071589|NCT04121416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071590|NCT04121416|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92071591|NCT04121416|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92071592|NCT04121416|Anesthetics, General|anesthetics, general|mesh-ancestor
92071593|NCT04121416|Anesthetics|anesthetics|mesh-ancestor
92071594|NCT04121338|Bupivacaine|bupivacaine|mesh-list
92071595|NCT04121338|Anesthetics, Local|anesthetics, local|mesh-ancestor
92071596|NCT04121338|Anesthetics|anesthetics|mesh-ancestor
92071597|NCT04121338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92071598|NCT04121338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071599|NCT04121338|Sensory System Agents|sensory system agents|mesh-ancestor
92071600|NCT04121338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071602|NCT01896193|Antiviral Agents|antiviral agents|mesh-ancestor
92071603|NCT01896193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071604|NCT01922011|Vancomycin|vancomycin|mesh-list
92071605|NCT01922011|Daptomycin|daptomycin|mesh-list
92071606|NCT01922011|Nafcillin|nafcillin|mesh-list
92071607|NCT01922011|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071608|NCT01922011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071609|NCT04127968|Vitamin A|vitamin a|mesh-list
92071610|NCT04127968|Vitamins|vitamins|mesh-ancestor
92071611|NCT04127968|Micronutrients|micronutrients|mesh-ancestor
92071612|NCT04127968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071613|NCT01921387|Cytarabine|cytarabine|mesh-list
92071614|NCT01921387|Etoposide|etoposide|mesh-list
92071615|NCT01921387|Podophyllotoxin|podophyllotoxin|mesh-list
92071616|NCT01921387|Etoposide phosphate|etoposide phosphate|mesh-list
92071617|NCT01921387|Melphalan|melphalan|mesh-list
92071618|NCT01921387|Mechlorethamine|mechlorethamine|mesh-list
92071619|NCT01921387|Carmustine|carmustine|mesh-list
92071620|NCT01921387|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92071621|NCT01921387|Antibodies|antibodies|mesh-list
92071622|NCT01921387|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92071623|NCT01921387|Immunologic Factors|immunologic factors|mesh-ancestor
92071624|NCT01921387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071625|NCT01921387|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071626|NCT01921387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071627|NCT01921387|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92071628|NCT01921387|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92071629|NCT01921387|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015851|NCT02630563|Antifungal Agents|antifungal agents|mesh-ancestor
92015852|NCT02630563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071630|NCT01921387|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071631|NCT01921387|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92071632|NCT01921387|Antimetabolites|antimetabolites|mesh-ancestor
92071633|NCT01921387|Antiviral Agents|antiviral agents|mesh-ancestor
92071634|NCT01921387|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071635|NCT01921387|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071636|NCT01921387|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92071637|NCT01921387|Alkylating Agents|alkylating agents|mesh-ancestor
92071638|NCT01921387|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92071639|NCT01921387|Keratolytic Agents|keratolytic agents|mesh-ancestor
92071640|NCT01921387|Dermatologic Agents|dermatologic agents|mesh-ancestor
92071641|NCT01921387|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071642|NCT01921387|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071643|NCT01921387|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071644|NCT04129996|Paclitaxel|paclitaxel|mesh-list
92071645|NCT04129996|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92071646|NCT04129996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071647|NCT04129996|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071648|NCT04129996|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071649|NCT04129996|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071650|NCT04129996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071652|NCT04129216|Letrozole|letrozole|mesh-list
92071653|NCT04129216|Exemestane|exemestane|mesh-list
92071654|NCT04129216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071655|NCT04129216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071656|NCT04129216|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92071657|NCT04129216|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92071658|NCT04129216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071659|NCT04129216|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92071660|NCT04129216|Hormone Antagonists|hormone antagonists|mesh-ancestor
92071661|NCT04129216|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071662|NCT04129216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071663|NCT04129216|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071664|NCT04129216|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92071665|NCT04129216|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92071666|NCT04129216|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92071667|NCT01895335|Teriflunomide|teriflunomide|mesh-list
92071668|NCT01895335|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071670|NCT01895335|Analgesics|analgesics|mesh-ancestor
92071671|NCT01895335|Sensory System Agents|sensory system agents|mesh-ancestor
92071672|NCT01895335|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071673|NCT01895335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071674|NCT01895335|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071675|NCT01895335|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071676|NCT01895335|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071677|NCT01895335|Immunologic Factors|immunologic factors|mesh-ancestor
92071678|NCT02980510|Leucovorin|leucovorin|mesh-list
92071679|NCT02980510|Folic Acid|folic acid|mesh-list
92071680|NCT02980510|Oxaliplatin|oxaliplatin|mesh-list
92071681|NCT02980510|Irinotecan|irinotecan|mesh-list
92071682|NCT02980510|Panitumumab|panitumumab|mesh-list
92071683|NCT02980510|Fluorouracil|fluorouracil|mesh-list
92071684|NCT02980510|Levoleucovorin|levoleucovorin|mesh-list
92071685|NCT02980510|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071686|NCT02980510|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92071687|NCT02980510|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92071688|NCT02980510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071689|NCT02980510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071690|NCT02980510|Antidotes|antidotes|mesh-ancestor
92071691|NCT02980510|Protective Agents|protective agents|mesh-ancestor
92071692|NCT02980510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071693|NCT02980510|Vitamin B Complex|vitamin b complex|mesh-ancestor
92071694|NCT02980510|Vitamins|vitamins|mesh-ancestor
92071695|NCT02980510|Micronutrients|micronutrients|mesh-ancestor
92071696|NCT02980510|Hematinics|hematinics|mesh-ancestor
92071697|NCT02980510|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071698|NCT02980510|Antimetabolites|antimetabolites|mesh-ancestor
92071699|NCT02980510|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92071700|NCT02980510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071701|NCT02980510|Immunologic Factors|immunologic factors|mesh-ancestor
92071702|NCT03829696|Misoprostol|misoprostol|mesh-list
92015853|NCT02630563|Dermatologic Agents|dermatologic agents|mesh-ancestor
92015854|NCT02630563|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92015855|NCT02630563|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92071703|NCT03829696|Mifepristone|mifepristone|mesh-list
92071704|NCT03829696|Ulipristal acetate|ulipristal acetate|mesh-list
92071705|NCT03829696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92071706|NCT03829696|Abortifacient Agents|abortifacient agents|mesh-ancestor
92071707|NCT03829696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92071708|NCT03829696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071709|NCT03829696|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92071710|NCT03829696|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071711|NCT03829696|Oxytocics|oxytocics|mesh-ancestor
92071712|NCT03829696|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92071713|NCT03829696|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92071714|NCT03829696|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92071715|NCT03829696|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92071716|NCT03829696|Contraceptive Agents|contraceptive agents|mesh-ancestor
92071717|NCT03829696|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92071718|NCT03829696|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92071719|NCT03829696|Hormone Antagonists|hormone antagonists|mesh-ancestor
92071720|NCT03829696|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071721|NCT03829696|Luteolytic Agents|luteolytic agents|mesh-ancestor
92071722|NCT03829696|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92071723|NCT03829696|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92071724|NCT03829774|Acetaminophen|acetaminophen|mesh-list
92071725|NCT03829774|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071726|NCT03829774|Analgesics|analgesics|mesh-ancestor
92071727|NCT03829774|Sensory System Agents|sensory system agents|mesh-ancestor
92071728|NCT03829774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071729|NCT03829774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071730|NCT03829774|Antipyretics|antipyretics|mesh-ancestor
92071731|NCT02977780|Temozolomide|temozolomide|mesh-list
92071732|NCT02977780|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92071733|NCT02977780|Alkylating Agents|alkylating agents|mesh-ancestor
92071734|NCT02977780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071735|NCT02977780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071736|NCT02974738|Belzutifan|belzutifan|mesh-list
92071737|NCT02974738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071738|NCT02972398|Acetylcysteine|acetylcysteine|mesh-list
92071739|NCT02972398|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92071740|NCT02972398|Antiviral Agents|antiviral agents|mesh-ancestor
92071741|NCT02972398|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071742|NCT02972398|Expectorants|expectorants|mesh-ancestor
92071743|NCT02972398|Respiratory System Agents|respiratory system agents|mesh-ancestor
92071744|NCT02972398|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92071745|NCT02972398|Antioxidants|antioxidants|mesh-ancestor
92071750|NCT01617655|Alirocumab|alirocumab|mesh-list
92071751|NCT01617655|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92071752|NCT01617655|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92071753|NCT01617655|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92071754|NCT01617655|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92071755|NCT01617655|Antimetabolites|antimetabolites|mesh-ancestor
92071756|NCT01617655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071757|NCT01617655|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92071758|NCT01617655|Protease Inhibitors|protease inhibitors|mesh-ancestor
92071759|NCT01617655|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071760|NCT01617655|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92071761|NCT01617655|Immunologic Factors|immunologic factors|mesh-ancestor
92071762|NCT01617655|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071763|NCT02965768|Naltrexone|naltrexone|mesh-list
92071764|NCT02965768|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92071765|NCT02965768|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92071766|NCT02965768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071767|NCT02965768|Sensory System Agents|sensory system agents|mesh-ancestor
92071768|NCT02965768|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071769|NCT01895101|Tranexamic Acid|tranexamic acid|mesh-list
92071770|NCT01895101|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92071771|NCT01895101|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92071772|NCT01895101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071773|NCT01895101|Hemostatics|hemostatics|mesh-ancestor
92071774|NCT01895101|Coagulants|coagulants|mesh-ancestor
92071775|NCT03828682|Mycophenolic Acid|mycophenolic acid|mesh-list
92071776|NCT03828682|Prednisone|prednisone|mesh-list
92071777|NCT03828682|Methylprednisolone|methylprednisolone|mesh-list
92015856|NCT02630563|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92015857|NCT02630563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071778|NCT03828682|Tacrolimus|tacrolimus|mesh-list
92071779|NCT03828682|Thymoglobulin|thymoglobulin|mesh-list
92071780|NCT03828682|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92071781|NCT03828682|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071782|NCT03828682|Glucocorticoids|glucocorticoids|mesh-ancestor
92071783|NCT03828682|Hormones|hormones|mesh-ancestor
92071784|NCT03828682|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071785|NCT03828682|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071786|NCT03828682|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071787|NCT03828682|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071788|NCT03828682|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071789|NCT03828682|Immunologic Factors|immunologic factors|mesh-ancestor
92071790|NCT03828682|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92071791|NCT03828682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071792|NCT03828682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071793|NCT03828682|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92071794|NCT03828682|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92071795|NCT03828682|Antitubercular Agents|antitubercular agents|mesh-ancestor
92071796|NCT03828682|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071797|NCT03828682|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071798|NCT03828682|Antiemetics|antiemetics|mesh-ancestor
92071799|NCT03828682|Autonomic Agents|autonomic agents|mesh-ancestor
92071800|NCT03828682|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071801|NCT03828682|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071802|NCT03828682|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92071803|NCT03828682|Protective Agents|protective agents|mesh-ancestor
92071804|NCT03483649|Bevacizumab|bevacizumab|mesh-list
92071805|NCT03483649|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071806|NCT03483649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071807|NCT03483649|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92071808|NCT03483649|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92071809|NCT03483649|Growth Substances|growth substances|mesh-ancestor
92071810|NCT03483649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071811|NCT03483649|Growth Inhibitors|growth inhibitors|mesh-ancestor
92071812|NCT03822520|Moxifloxacin|moxifloxacin|mesh-list
92071813|NCT03822520|Celecoxib|celecoxib|mesh-list
92071814|NCT03822520|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071815|NCT03822520|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071816|NCT03822520|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92071818|NCT03822520|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071819|NCT03822520|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071820|NCT03822520|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071821|NCT03822520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071822|NCT03822520|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071823|NCT03822520|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071824|NCT03822520|Analgesics|analgesics|mesh-ancestor
92071825|NCT03822520|Sensory System Agents|sensory system agents|mesh-ancestor
92071826|NCT03822520|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071827|NCT03822520|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071828|NCT03822520|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071829|NCT03822520|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92071830|NCT03822520|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92071831|NCT01894477|Fludarabine|fludarabine|mesh-list
92071832|NCT01894477|Fludarabine phosphate|fludarabine phosphate|mesh-list
92071833|NCT01894477|Treosulfan|treosulfan|mesh-list
92071834|NCT01894477|Busulfan|busulfan|mesh-list
92071835|NCT01894477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071836|NCT01894477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92071837|NCT01894477|Antimetabolites|antimetabolites|mesh-ancestor
92071838|NCT01894477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071839|NCT01894477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92071840|NCT01894477|Immunologic Factors|immunologic factors|mesh-ancestor
92071841|NCT01894477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071842|NCT01894477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92071843|NCT01894477|Alkylating Agents|alkylating agents|mesh-ancestor
92071844|NCT01894477|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92071845|NCT04391998|Metronidazole|metronidazole|mesh-list
92071846|NCT04391998|Albendazole|albendazole|mesh-list
92071847|NCT04391998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92071848|NCT04391998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92015858|NCT02630563|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92015859|NCT02630563|Antitubercular Agents|antitubercular agents|mesh-ancestor
92015860|NCT02630563|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92071849|NCT04391998|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92071850|NCT04391998|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92071851|NCT04391998|Anthelmintics|anthelmintics|mesh-ancestor
92071852|NCT04391998|Anticestodal Agents|anticestodal agents|mesh-ancestor
92071853|NCT04391998|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92071854|NCT04391998|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071855|NCT04391998|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071856|NCT04391998|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071857|NCT04391998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071858|NCT04391998|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071859|NCT03820180|Fluticasone|fluticasone|mesh-list
92071861|NCT03820180|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92071862|NCT03820180|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92071863|NCT03820180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071864|NCT03820180|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92071865|NCT03820180|Autonomic Agents|autonomic agents|mesh-ancestor
92071866|NCT03820180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071867|NCT03820180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071868|NCT03820180|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92071869|NCT03820180|Respiratory System Agents|respiratory system agents|mesh-ancestor
92071870|NCT03820180|Dermatologic Agents|dermatologic agents|mesh-ancestor
92071871|NCT03820180|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92071872|NCT03820180|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92071873|NCT03820180|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92071874|NCT03820180|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92071875|NCT03820180|Adrenergic Agents|adrenergic agents|mesh-ancestor
92071876|NCT03820180|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071877|NCT03820180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071878|NCT03820180|Glucocorticoids|glucocorticoids|mesh-ancestor
92071879|NCT03820180|Hormones|hormones|mesh-ancestor
92071880|NCT03820180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071881|NCT03820180|Sympathomimetics|sympathomimetics|mesh-ancestor
92071882|NCT01894243|Olaparib|olaparib|mesh-list
92071883|NCT01894243|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92071884|NCT01894243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071885|NCT01894243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071886|NCT01894243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071887|NCT01450384|Pemetrexed|pemetrexed|mesh-list
92071888|NCT01450384|Sorafenib|sorafenib|mesh-list
92071889|NCT01450384|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071890|NCT01450384|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071892|NCT01450384|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92071893|NCT01450384|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92071894|NCT01450384|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92071895|NCT01450462|Vitamin D|vitamin d|mesh-list
92071896|NCT01450462|Cholecalciferol|cholecalciferol|mesh-list
92071897|NCT01450462|Vitamins|vitamins|mesh-ancestor
92071898|NCT01450462|Micronutrients|micronutrients|mesh-ancestor
92071899|NCT01450462|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071900|NCT01450462|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92071901|NCT01450462|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92071902|NCT01450774|Beclomethasone|beclomethasone|mesh-list
92071903|NCT01450774|Formoterol Fumarate|formoterol fumarate|mesh-list
92071904|NCT01450774|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92071906|NCT01450774|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071907|NCT01450774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071908|NCT01450774|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92071909|NCT01450774|Respiratory System Agents|respiratory system agents|mesh-ancestor
92071910|NCT01450774|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92071911|NCT01450774|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92071912|NCT01450774|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92071913|NCT01450774|Adrenergic Agents|adrenergic agents|mesh-ancestor
92071914|NCT01450774|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071915|NCT01450774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071916|NCT01450774|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071917|NCT01450774|Glucocorticoids|glucocorticoids|mesh-ancestor
92071918|NCT01450774|Hormones|hormones|mesh-ancestor
92015861|NCT05700695|Lactulose|lactulose|mesh-list
92015862|NCT05700695|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92015863|NCT05555147|Ropivacaine|ropivacaine|mesh-list
92015864|NCT05555147|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015865|NCT05555147|Anesthetics|anesthetics|mesh-ancestor
92071919|NCT01450774|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071920|NCT01450930|Hydrocortisone|hydrocortisone|mesh-list
92071921|NCT01450930|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92071922|NCT01450930|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92071923|NCT01450930|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92071924|NCT01450930|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071925|NCT02913196|Prednisone|prednisone|mesh-list
92071926|NCT02913196|Docetaxel|docetaxel|mesh-list
92071927|NCT02913196|Abiraterone Acetate|abiraterone acetate|mesh-list
92071928|NCT02913196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071929|NCT02913196|Tubulin Modulators|tubulin modulators|mesh-ancestor
92071930|NCT02913196|Antimitotic Agents|antimitotic agents|mesh-ancestor
92071931|NCT02913196|Mitosis Modulators|mitosis modulators|mesh-ancestor
92071932|NCT02913196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071933|NCT02913196|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071934|NCT02913196|Glucocorticoids|glucocorticoids|mesh-ancestor
92071936|NCT02913196|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071937|NCT02913196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071938|NCT02913196|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071939|NCT02913196|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92071940|NCT02913196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071941|NCT02913196|Hormone Antagonists|hormone antagonists|mesh-ancestor
92071942|NCT02913196|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92071943|NCT01451086|Vaccines|vaccines|mesh-list
92071944|NCT01451086|Immunologic Factors|immunologic factors|mesh-ancestor
92071945|NCT01451086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071946|NCT01451710|Prednisone|prednisone|mesh-list
92071947|NCT01451710|Prednisolone|prednisolone|mesh-list
92071948|NCT01451710|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92071949|NCT01451710|Methylprednisolone|methylprednisolone|mesh-list
92071950|NCT01451710|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92071951|NCT01451710|Prednisolone acetate|prednisolone acetate|mesh-list
92071952|NCT01451710|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92071953|NCT01451710|Prednisolone phosphate|prednisolone phosphate|mesh-list
92071954|NCT01451710|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071955|NCT01451710|Glucocorticoids|glucocorticoids|mesh-ancestor
92071956|NCT01451710|Hormones|hormones|mesh-ancestor
92071957|NCT01451710|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071958|NCT01451710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071959|NCT01451710|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071960|NCT01451710|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071961|NCT01451710|Antiemetics|antiemetics|mesh-ancestor
92071962|NCT01451710|Autonomic Agents|autonomic agents|mesh-ancestor
92071963|NCT01451710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071964|NCT01451710|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92071966|NCT01451710|Protective Agents|protective agents|mesh-ancestor
92071967|NCT01451788|Thrombin|thrombin|mesh-list
92071968|NCT01451788|Hemostatics|hemostatics|mesh-ancestor
92071969|NCT01451788|Coagulants|coagulants|mesh-ancestor
92071970|NCT01452100|Prednisone|prednisone|mesh-list
92071971|NCT01452100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071972|NCT01452100|Glucocorticoids|glucocorticoids|mesh-ancestor
92071973|NCT01452100|Hormones|hormones|mesh-ancestor
92071974|NCT01452100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92071975|NCT01452100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071976|NCT01452100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92071977|NCT01452100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071978|NCT01452334|BMS-936559|bms-936559|mesh-list
92071979|NCT01452334|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92071980|NCT01452334|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92071981|NCT01452568|Aspirin|aspirin|mesh-list
92071982|NCT01452568|Salicylic Acid|salicylic acid|mesh-list
92071983|NCT01452568|Salicylates|salicylates|mesh-list
92071984|NCT01452568|Warfarin|warfarin|mesh-list
92071985|NCT01452568|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92071986|NCT01452568|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071987|NCT01452568|Analgesics|analgesics|mesh-ancestor
92015866|NCT05555147|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015867|NCT05555147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015868|NCT05555147|Sensory System Agents|sensory system agents|mesh-ancestor
92015869|NCT05555147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015870|NCT02587247|Antibodies|antibodies|mesh-list
92015871|NCT02587247|Immunologic Factors|immunologic factors|mesh-ancestor
92015872|NCT02587247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015873|NCT02555111|Rivaroxaban|rivaroxaban|mesh-list
92015874|NCT02555111|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92015875|NCT02555111|Antithrombins|antithrombins|mesh-ancestor
92015876|NCT02555111|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92015877|NCT02555111|Protease Inhibitors|protease inhibitors|mesh-ancestor
92015878|NCT02555111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015879|NCT02555111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015880|NCT02555111|Anticoagulants|anticoagulants|mesh-ancestor
92015881|NCT02521415|Acetaminophen|acetaminophen|mesh-list
92015882|NCT02521415|Ibuprofen|ibuprofen|mesh-list
92015883|NCT02521415|Fentanyl|fentanyl|mesh-list
92015884|NCT02521415|Ketamine|ketamine|mesh-list
92071988|NCT01452568|Sensory System Agents|sensory system agents|mesh-ancestor
92071989|NCT01452568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92071990|NCT01452568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071991|NCT01452568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92071992|NCT01452568|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071993|NCT01452568|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92071994|NCT01452568|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92071995|NCT01452568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071996|NCT01452568|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92071997|NCT01452568|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92071998|NCT01452568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071999|NCT01452568|Antipyretics|antipyretics|mesh-ancestor
92072000|NCT01452568|Anticoagulants|anticoagulants|mesh-ancestor
92072001|NCT01452568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072002|NCT01452568|Antifungal Agents|antifungal agents|mesh-ancestor
92072003|NCT01452568|Keratolytic Agents|keratolytic agents|mesh-ancestor
92072004|NCT01452568|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072005|NCT01452724|Lansoprazole|lansoprazole|mesh-list
92072006|NCT01452724|Dexlansoprazole|dexlansoprazole|mesh-list
92072007|NCT01452724|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92072008|NCT01452724|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072009|NCT01452724|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92072010|NCT01452724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072011|NCT01452724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072013|NCT02620072|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92072014|NCT02620072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072015|NCT01452880|Remifentanil|remifentanil|mesh-list
92072016|NCT01452880|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92072017|NCT01452880|Narcotics|narcotics|mesh-ancestor
92072018|NCT01452880|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92072019|NCT01452880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072020|NCT01452880|Analgesics|analgesics|mesh-ancestor
92072021|NCT01452880|Sensory System Agents|sensory system agents|mesh-ancestor
92072022|NCT01452880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072023|NCT01453192|Raltegravir Potassium|raltegravir potassium|mesh-list
92072024|NCT01453192|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92072025|NCT01453192|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92072026|NCT01453192|Antiviral Agents|antiviral agents|mesh-ancestor
92072027|NCT01453192|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015885|NCT02521415|Analgesics|analgesics|mesh-list
92015886|NCT02521415|Sensory System Agents|sensory system agents|mesh-ancestor
92015887|NCT02521415|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015888|NCT02521415|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015889|NCT02521415|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92015890|NCT02521415|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92072028|NCT01453192|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92072029|NCT01453192|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92072030|NCT01453192|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072031|NCT01453192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072034|NCT01453426|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072035|NCT01453426|Immunologic Factors|immunologic factors|mesh-ancestor
92072036|NCT01453426|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072037|NCT01453504|Everolimus|everolimus|mesh-list
92072038|NCT01453504|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92072039|NCT01453504|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92072040|NCT01453504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072041|NCT01453504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072044|NCT01453504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072045|NCT01453504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072046|NCT01453582|Propolis|propolis|mesh-list
92072047|NCT01453582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072048|NCT01453738|Plasma-lyte 148|plasma-lyte 148|mesh-list
92072049|NCT01453738|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92072050|NCT01453738|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92072051|NCT04847752|Aspirin|aspirin|mesh-list
92072052|NCT04847752|Warfarin|warfarin|mesh-list
92072053|NCT04847752|Rivaroxaban|rivaroxaban|mesh-list
92072054|NCT04847752|Dabigatran|dabigatran|mesh-list
92072055|NCT04847752|Anticoagulants|anticoagulants|mesh-list
92072056|NCT04847752|Clopidogrel|clopidogrel|mesh-list
92072057|NCT04847752|Atorvastatin|atorvastatin|mesh-list
92072058|NCT04847752|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92072059|NCT04847752|Evolocumab|evolocumab|mesh-list
92072060|NCT04847752|Alirocumab|alirocumab|mesh-list
92072061|NCT04847752|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92072062|NCT04847752|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92072063|NCT04847752|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92072064|NCT04847752|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92072065|NCT04847752|Analgesics|analgesics|mesh-ancestor
92072066|NCT04847752|Sensory System Agents|sensory system agents|mesh-ancestor
92072067|NCT04847752|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072068|NCT04847752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072069|NCT04847752|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072070|NCT04847752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072071|NCT04847752|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92072072|NCT04847752|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92072073|NCT04847752|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072074|NCT04847752|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92072075|NCT04847752|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92072076|NCT04847752|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072077|NCT04847752|Antipyretics|antipyretics|mesh-ancestor
92072078|NCT04847752|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92072079|NCT04847752|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92072080|NCT04847752|Antimetabolites|antimetabolites|mesh-ancestor
92072081|NCT04847752|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92072082|NCT04847752|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92072083|NCT04847752|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92072084|NCT04847752|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92072085|NCT04847752|Purinergic Agents|purinergic agents|mesh-ancestor
92072086|NCT04847752|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072087|NCT04847752|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92072088|NCT04847752|Antithrombins|antithrombins|mesh-ancestor
92072089|NCT04847752|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92072090|NCT04847752|Protease Inhibitors|protease inhibitors|mesh-ancestor
92072091|NCT04847206|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92072092|NCT04847206|3,4-Methylenedioxyamphetamine|3,4-methylenedioxyamphetamine|mesh-list
92072093|NCT04847206|Hallucinogens|hallucinogens|mesh-ancestor
92015892|NCT02521415|Anesthetics|anesthetics|mesh-ancestor
92015893|NCT02521415|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015894|NCT02521415|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92015895|NCT02521415|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92072094|NCT04847206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072095|NCT04847206|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92072096|NCT04847206|Serotonin Agents|serotonin agents|mesh-ancestor
92072097|NCT04847206|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072098|NCT04847206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072099|NCT04847206|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92072100|NCT04847206|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92072101|NCT04847206|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072102|NCT04847206|Adrenergic Agents|adrenergic agents|mesh-ancestor
92072103|NCT02864914|Empagliflozin|empagliflozin|mesh-list
92072104|NCT02864914|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92072105|NCT02864914|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92072106|NCT02864914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072108|NCT02864914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072109|NCT02864914|Protease Inhibitors|protease inhibitors|mesh-ancestor
92072110|NCT02864914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072111|NCT04840264|Docetaxel|docetaxel|mesh-list
92072112|NCT04840264|Fluorouracil|fluorouracil|mesh-list
92072113|NCT04840264|Oxaliplatin|oxaliplatin|mesh-list
92072114|NCT04840264|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072115|NCT04840264|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072116|NCT04840264|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072118|NCT04840264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072120|NCT04840264|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92072121|NCT04840264|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072122|NCT04840264|Immunologic Factors|immunologic factors|mesh-ancestor
92072123|NCT04840264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072124|NCT04841434|Methotrexate|methotrexate|mesh-list
92072125|NCT04841434|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92072126|NCT04841434|Abortifacient Agents|abortifacient agents|mesh-ancestor
92072127|NCT04841434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92072128|NCT04841434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072129|NCT04841434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92072130|NCT04841434|Antimetabolites|antimetabolites|mesh-ancestor
92072131|NCT04841434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072132|NCT04841434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072133|NCT04841434|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072134|NCT04841434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072135|NCT04841434|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92072136|NCT04841434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072137|NCT04841434|Immunologic Factors|immunologic factors|mesh-ancestor
92072138|NCT04841434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072139|NCT04841434|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92072140|NCT04840342|Amlodipine|amlodipine|mesh-list
92072141|NCT04840342|Eplerenone|eplerenone|mesh-list
92072142|NCT04840342|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92072143|NCT04840342|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92072144|NCT04840342|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072145|NCT04840342|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072146|NCT04840342|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92072147|NCT04840342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072148|NCT04840342|Vasodilator Agents|vasodilator agents|mesh-ancestor
92072149|NCT04840342|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92072150|NCT04840342|Hormone Antagonists|hormone antagonists|mesh-ancestor
92072151|NCT04840342|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072152|NCT04840342|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92072153|NCT04840342|Diuretics|diuretics|mesh-ancestor
92072154|NCT04840342|Natriuretic Agents|natriuretic agents|mesh-ancestor
92072155|NCT02849470|Complement Factor H|complement factor h|mesh-list
92072156|NCT02849470|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92072157|NCT02849470|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92015896|NCT02521415|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015897|NCT02521415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072158|NCT02849470|Immunologic Factors|immunologic factors|mesh-ancestor
92072159|NCT02849470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072160|NCT05024188|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92072161|NCT05024188|Metronidazole|metronidazole|mesh-list
92072162|NCT05024188|Ciprofloxacin|ciprofloxacin|mesh-list
92072163|NCT05024188|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072164|NCT05024188|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92072165|NCT05024188|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92072166|NCT05024188|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072167|NCT05024188|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072168|NCT05024188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072169|NCT05024188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072170|NCT05024188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072171|NCT05024188|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92072172|NCT05024188|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92072173|NCT04390594|Nafamostat|nafamostat|mesh-list
92072174|NCT04390594|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92072175|NCT04390594|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92072176|NCT04390594|Analgesics|analgesics|mesh-ancestor
92072177|NCT04390594|Sensory System Agents|sensory system agents|mesh-ancestor
92072178|NCT04390594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072179|NCT04390594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072180|NCT04390594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072181|NCT04390594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072182|NCT04390594|Anticoagulants|anticoagulants|mesh-ancestor
92072183|NCT04390594|Protease Inhibitors|protease inhibitors|mesh-ancestor
92072184|NCT04390594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072185|NCT04390594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072186|NCT04390594|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92072187|NCT04390594|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92072188|NCT04390594|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92072189|NCT04390594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072191|NCT05024422|Pyridoxine|pyridoxine|mesh-list
92072192|NCT05024422|Vitamin B 6|vitamin b 6|mesh-list
92072193|NCT05024422|Cabergoline|cabergoline|mesh-list
92072194|NCT05024422|Vitamins|vitamins|mesh-ancestor
92072195|NCT05024422|Micronutrients|micronutrients|mesh-ancestor
92072196|NCT05024422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072197|NCT05024422|Vitamin B Complex|vitamin b complex|mesh-ancestor
92072198|NCT05024422|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92072199|NCT05024422|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92072200|NCT05024422|Dopamine Agonists|dopamine agonists|mesh-ancestor
92072201|NCT05024422|Dopamine Agents|dopamine agents|mesh-ancestor
92072202|NCT05024422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072203|NCT05024422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072204|NCT02819596|Durvalumab|durvalumab|mesh-list
92072205|NCT02819596|Tremelimumab|tremelimumab|mesh-list
92072206|NCT02819596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072207|NCT02819596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072208|NCT02818894|Lidocaine|lidocaine|mesh-list
92072209|NCT02818894|Bupivacaine|bupivacaine|mesh-list
92072210|NCT02818894|Anesthetics, Local|anesthetics, local|mesh-ancestor
92072211|NCT02818894|Anesthetics|anesthetics|mesh-ancestor
92072212|NCT02818894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92072213|NCT02818894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072214|NCT02818894|Sensory System Agents|sensory system agents|mesh-ancestor
92072215|NCT02818894|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072216|NCT02818894|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92072217|NCT02818894|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92072218|NCT02818894|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92072219|NCT02818894|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072220|NCT02818894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072221|NCT05586568|Itraconazole|itraconazole|mesh-list
92072222|NCT05586568|Rifampin|rifampin|mesh-list
92072223|NCT05586568|Esomeprazole|esomeprazole|mesh-list
92072224|NCT05586568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92072225|NCT05586568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072226|NCT05586568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92072227|NCT05586568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015898|NCT02521415|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92015900|NCT02521415|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92015901|NCT02521415|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92072228|NCT05586568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072229|NCT05586568|Antifungal Agents|antifungal agents|mesh-ancestor
92072230|NCT05586568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072231|NCT05586568|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92072232|NCT05586568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92072233|NCT05586568|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92072234|NCT05586568|Hormone Antagonists|hormone antagonists|mesh-ancestor
92072235|NCT05586568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072236|NCT05586568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072237|NCT05586568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92072238|NCT05586568|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92072239|NCT05586568|Antitubercular Agents|antitubercular agents|mesh-ancestor
92072240|NCT05586568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072241|NCT05586568|Leprostatic Agents|leprostatic agents|mesh-ancestor
92072242|NCT05586568|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92072243|NCT05586568|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92072244|NCT05586568|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92072245|NCT05586568|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92072246|NCT05586568|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92072247|NCT05586568|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92072248|NCT05586568|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92072250|NCT02632708|Etoposide|etoposide|mesh-list
92072251|NCT02632708|Daunorubicin|daunorubicin|mesh-list
92072252|NCT02632708|Mitoxantrone|mitoxantrone|mesh-list
92072253|NCT02632708|Idarubicin|idarubicin|mesh-list
92072720|NCT04756492|Immunologic Factors|immunologic factors|mesh-ancestor
92072254|NCT02632708|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072255|NCT02632708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072256|NCT02632708|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072257|NCT02632708|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072258|NCT02632708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072259|NCT02632708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072260|NCT02632708|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92072265|NCT02632708|Immunologic Factors|immunologic factors|mesh-ancestor
92072266|NCT02632708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072267|NCT02632708|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072268|NCT02632708|Analgesics|analgesics|mesh-ancestor
92072269|NCT02632708|Sensory System Agents|sensory system agents|mesh-ancestor
92072270|NCT02632708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072271|NCT02624908|Canagliflozin|canagliflozin|mesh-list
92072272|NCT02624908|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92072273|NCT02624908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072274|NCT02624908|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92072275|NCT02624908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072276|NCT02614534|Mitomycins|mitomycins|mesh-list
92072277|NCT02614534|Mitomycin|mitomycin|mesh-list
92072278|NCT02614534|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072279|NCT02614534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072280|NCT02614534|Alkylating Agents|alkylating agents|mesh-ancestor
92072281|NCT02614534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072282|NCT02614534|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92072283|NCT02614534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072284|NCT02608216|Paclitaxel|paclitaxel|mesh-list
92072285|NCT02608216|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072286|NCT02608216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072287|NCT02608216|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072288|NCT02608216|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072289|NCT02608216|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072290|NCT02608216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072291|NCT02587000|Ulipristal acetate|ulipristal acetate|mesh-list
92072292|NCT02587000|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92072293|NCT02587000|Contraceptive Agents|contraceptive agents|mesh-ancestor
92072294|NCT02587000|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92015902|NCT02521415|Antipyretics|antipyretics|mesh-ancestor
92015903|NCT02521415|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92015904|NCT02521415|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072295|NCT02587000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072296|NCT02587000|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92072297|NCT04757818|Cetylpyridinium|cetylpyridinium|mesh-list
92072298|NCT04757818|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92072299|NCT04757818|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072300|NCT02556424|Dexamethasone|dexamethasone|mesh-list
92072301|NCT02556424|Triamcinolone|triamcinolone|mesh-list
92072302|NCT02556424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072303|NCT02556424|Antiemetics|antiemetics|mesh-ancestor
92072304|NCT02556424|Autonomic Agents|autonomic agents|mesh-ancestor
92072305|NCT02556424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072306|NCT02556424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072307|NCT02556424|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072308|NCT02556424|Glucocorticoids|glucocorticoids|mesh-ancestor
92072309|NCT02556424|Hormones|hormones|mesh-ancestor
92072310|NCT02556424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072311|NCT02556424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072312|NCT02556424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072313|NCT02543944|Clonidine|clonidine|mesh-list
92072314|NCT02543944|Naltrexone|naltrexone|mesh-list
92072315|NCT02543944|Buprenorphine|buprenorphine|mesh-list
92072316|NCT02543944|Gabapentin|gabapentin|mesh-list
92072317|NCT02543944|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92072318|NCT02543944|Narcotics|narcotics|mesh-ancestor
92072319|NCT02543944|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92072320|NCT02543944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072321|NCT02543944|Analgesics|analgesics|mesh-ancestor
92072322|NCT02543944|Sensory System Agents|sensory system agents|mesh-ancestor
92072323|NCT02543944|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072324|NCT02543944|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92072325|NCT02543944|Anticonvulsants|anticonvulsants|mesh-ancestor
92072326|NCT02543944|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92072327|NCT02543944|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92072328|NCT02543944|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92072329|NCT02543944|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92072330|NCT02543944|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92072331|NCT02543944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072332|NCT02543944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072335|NCT02543944|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92072336|NCT02543944|Sympatholytics|sympatholytics|mesh-ancestor
92072337|NCT02543944|Autonomic Agents|autonomic agents|mesh-ancestor
92072338|NCT02543944|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92072339|NCT02543944|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92072340|NCT02543944|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92072341|NCT02543944|Adrenergic Agents|adrenergic agents|mesh-ancestor
92072342|NCT02531308|Metformin|metformin|mesh-list
92072343|NCT02531308|Prednisone|prednisone|mesh-list
92072344|NCT02531308|Cyclophosphamide|cyclophosphamide|mesh-list
92072345|NCT02531308|Rituximab|rituximab|mesh-list
92072346|NCT02531308|Doxorubicin|doxorubicin|mesh-list
92072347|NCT02531308|Vincristine|vincristine|mesh-list
92072348|NCT02531308|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072349|NCT02531308|Immunologic Factors|immunologic factors|mesh-ancestor
92072350|NCT02531308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072351|NCT02531308|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072352|NCT02531308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92072353|NCT02531308|Alkylating Agents|alkylating agents|mesh-ancestor
92072354|NCT02531308|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072355|NCT02531308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072356|NCT02531308|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92072357|NCT02531308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072358|NCT02531308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92072359|NCT02531308|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072360|NCT02531308|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072361|NCT02531308|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072362|NCT02531308|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072363|NCT02531308|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072364|NCT02531308|Glucocorticoids|glucocorticoids|mesh-ancestor
92072365|NCT02531308|Hormones|hormones|mesh-ancestor
92072366|NCT02531308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015906|NCT02521415|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92015907|NCT02521415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072367|NCT02531308|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072368|NCT02531308|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072369|NCT02531308|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072370|NCT02531308|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072371|NCT02531308|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072372|NCT02523976|Cytarabine|cytarabine|mesh-list
92072373|NCT02523976|Dexamethasone|dexamethasone|mesh-list
92072374|NCT02523976|Prednisone|prednisone|mesh-list
92072375|NCT02523976|Cyclophosphamide|cyclophosphamide|mesh-list
92072376|NCT02523976|Methotrexate|methotrexate|mesh-list
92072377|NCT02523976|Etoposide|etoposide|mesh-list
92072378|NCT02523976|Vincristine|vincristine|mesh-list
92072379|NCT02523976|Daunorubicin|daunorubicin|mesh-list
92072380|NCT02523976|Dasatinib|dasatinib|mesh-list
92072381|NCT02523976|Mitoxantrone|mitoxantrone|mesh-list
92072382|NCT02523976|Mercaptopurine|mercaptopurine|mesh-list
92072383|NCT02523976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072384|NCT02523976|Immunologic Factors|immunologic factors|mesh-ancestor
92072385|NCT02523976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072386|NCT02523976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072387|NCT02523976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92072388|NCT02523976|Alkylating Agents|alkylating agents|mesh-ancestor
92072389|NCT02523976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072390|NCT02523976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072391|NCT02523976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92072392|NCT02523976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072393|NCT02523976|Antiemetics|antiemetics|mesh-ancestor
92072394|NCT02523976|Autonomic Agents|autonomic agents|mesh-ancestor
92072395|NCT02523976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072396|NCT02523976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072397|NCT02523976|Glucocorticoids|glucocorticoids|mesh-ancestor
92072399|NCT02523976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072400|NCT02523976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072401|NCT02523976|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92072402|NCT02523976|Abortifacient Agents|abortifacient agents|mesh-ancestor
92072403|NCT02523976|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92072404|NCT02523976|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92072405|NCT02523976|Antimetabolites|antimetabolites|mesh-ancestor
92072406|NCT02523976|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072407|NCT02523976|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072411|NCT02523976|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072412|NCT02523976|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072413|NCT02523976|Antiviral Agents|antiviral agents|mesh-ancestor
92072414|NCT02523976|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072415|NCT02523976|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072416|NCT02523976|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072417|NCT02523976|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072418|NCT02523976|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072419|NCT02523976|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92072420|NCT02523976|Analgesics|analgesics|mesh-ancestor
92072421|NCT02523976|Sensory System Agents|sensory system agents|mesh-ancestor
92072422|NCT02514382|Dexamethasone|dexamethasone|mesh-list
92072423|NCT02514382|Dexamethasone acetate|dexamethasone acetate|mesh-list
92072424|NCT02514382|Bortezomib|bortezomib|mesh-list
92072425|NCT02514382|Ichthammol|ichthammol|mesh-list
92072426|NCT02514382|BB 1101|bb 1101|mesh-list
92072427|NCT02514382|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072428|NCT02514382|Antiemetics|antiemetics|mesh-ancestor
92072429|NCT02514382|Autonomic Agents|autonomic agents|mesh-ancestor
92072430|NCT02514382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072431|NCT02514382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072432|NCT02514382|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072433|NCT02514382|Glucocorticoids|glucocorticoids|mesh-ancestor
92072434|NCT02514382|Hormones|hormones|mesh-ancestor
92072435|NCT02514382|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072436|NCT02514382|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072437|NCT02514382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072438|NCT02514382|Protease Inhibitors|protease inhibitors|mesh-ancestor
92072439|NCT02514382|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072440|NCT02514382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015908|NCT02078141|Deoxyglucose|deoxyglucose|mesh-list
92015909|NCT02078141|Antimetabolites|antimetabolites|mesh-ancestor
92015910|NCT02078141|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072441|NCT02514382|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072442|NCT02495896|Paclitaxel|paclitaxel|mesh-list
92072443|NCT02495896|Docetaxel|docetaxel|mesh-list
92072444|NCT02495896|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92072445|NCT02495896|Cisplatin|cisplatin|mesh-list
92072446|NCT02495896|Gemcitabine|gemcitabine|mesh-list
92072447|NCT02495896|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072448|NCT02495896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072449|NCT02495896|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072450|NCT02495896|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072451|NCT02495896|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072452|NCT02495896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072453|NCT02495896|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92072454|NCT02495896|Antimetabolites|antimetabolites|mesh-ancestor
92072455|NCT02493322|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92072456|NCT02493322|Olmesartan|olmesartan|mesh-list
92072457|NCT02493322|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92072458|NCT02493322|Chlorthalidone|chlorthalidone|mesh-list
92072459|NCT02493322|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92072460|NCT02493322|Diuretics|diuretics|mesh-ancestor
92072461|NCT02493322|Natriuretic Agents|natriuretic agents|mesh-ancestor
92072462|NCT02493322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072463|NCT02493322|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92072464|NCT02493322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072465|NCT02493322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072466|NCT02493322|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92072467|NCT02493322|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92072468|NCT04757974|Fostemsavir|fostemsavir|mesh-list
92072469|NCT04757974|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92072470|NCT04757974|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92072471|NCT04757974|Antiviral Agents|antiviral agents|mesh-ancestor
92072472|NCT04757974|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072473|NCT04757974|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92072474|NCT04757974|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92072475|NCT04757974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072476|NCT04757506|Naltrexone|naltrexone|mesh-list
92072477|NCT04757506|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92072478|NCT04757506|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92072479|NCT04757506|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072481|NCT04757506|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072483|NCT02477644|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92072484|NCT02477644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072485|NCT02477644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072486|NCT02477644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072487|NCT02466334|Calcitonin|calcitonin|mesh-list
92072488|NCT02466334|Salmon calcitonin|salmon calcitonin|mesh-list
92072489|NCT02466334|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92072490|NCT02466334|Katacalcin|katacalcin|mesh-list
92072491|NCT02466334|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92072492|NCT02466334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072493|NCT02466334|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92072494|NCT02466334|Vasodilator Agents|vasodilator agents|mesh-ancestor
92072495|NCT02460874|Glyburide|glyburide|mesh-list
92072496|NCT02460874|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92072497|NCT02460874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072498|NCT02443324|Pembrolizumab|pembrolizumab|mesh-list
92072499|NCT02443324|Ramucirumab|ramucirumab|mesh-list
92072500|NCT02443324|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072501|NCT02443324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072502|NCT02443324|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92072503|NCT02443324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072504|NCT01894048|Beclomethasone|beclomethasone|mesh-list
92072505|NCT01894048|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072506|NCT01894048|Glucocorticoids|glucocorticoids|mesh-ancestor
92072507|NCT01894048|Hormones|hormones|mesh-ancestor
92072508|NCT01894048|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072509|NCT01894048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072510|NCT01894048|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92015911|NCT02078141|Antiviral Agents|antiviral agents|mesh-ancestor
92015912|NCT02078141|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015913|NCT02588339|Sirolimus|sirolimus|mesh-list
92015914|NCT02588339|Panobinostat|panobinostat|mesh-list
92015915|NCT02588339|Tacrolimus|tacrolimus|mesh-list
92072511|NCT01894048|Respiratory System Agents|respiratory system agents|mesh-ancestor
92072512|NCT02420860|Lenalidomide|lenalidomide|mesh-list
92072513|NCT02420860|Elotuzumab|elotuzumab|mesh-list
92072514|NCT02420860|Immunologic Factors|immunologic factors|mesh-ancestor
92072515|NCT02420860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072516|NCT02420860|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92072517|NCT02420860|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92072518|NCT02420860|Growth Substances|growth substances|mesh-ancestor
92072519|NCT02420860|Growth Inhibitors|growth inhibitors|mesh-ancestor
92072520|NCT02420860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072521|NCT02420314|Ascorbic Acid|ascorbic acid|mesh-list
92072522|NCT02420314|Paclitaxel|paclitaxel|mesh-list
92072523|NCT02420314|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92072524|NCT02420314|Carboplatin|carboplatin|mesh-list
92072525|NCT02420314|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072526|NCT02420314|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072527|NCT02420314|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072528|NCT02420314|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072529|NCT02420314|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072530|NCT02420314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072531|NCT02420314|Vitamins|vitamins|mesh-ancestor
92072532|NCT02420314|Micronutrients|micronutrients|mesh-ancestor
92072533|NCT02420314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072534|NCT02420314|Antioxidants|antioxidants|mesh-ancestor
92072535|NCT02420314|Protective Agents|protective agents|mesh-ancestor
92072536|NCT02403778|Ipilimumab|ipilimumab|mesh-list
92072537|NCT02403778|Tretinoin|tretinoin|mesh-list
92081708|NCT01402947|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072538|NCT02403778|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072539|NCT02403778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072540|NCT02403778|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92072541|NCT02403778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072542|NCT02403778|Keratolytic Agents|keratolytic agents|mesh-ancestor
92072543|NCT02403778|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072544|NCT01539291|Idelalisib|idelalisib|mesh-list
92072545|NCT01539291|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072546|NCT01539291|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072547|NCT01539291|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072548|NCT04746040|Fluticasone|fluticasone|mesh-list
92072549|NCT04746040|Xhance|xhance|mesh-list
92072550|NCT04746040|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92072551|NCT04746040|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92072563|NCT04746040|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92072564|NCT04746040|Adrenergic Agents|adrenergic agents|mesh-ancestor
92072565|NCT04746040|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072566|NCT04746040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072567|NCT04746040|Glucocorticoids|glucocorticoids|mesh-ancestor
92072568|NCT04746040|Hormones|hormones|mesh-ancestor
92072569|NCT04746040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072570|NCT04746040|Sympathomimetics|sympathomimetics|mesh-ancestor
92072571|NCT02400814|Atezolizumab|atezolizumab|mesh-list
92072572|NCT02400814|Antibodies|antibodies|mesh-list
92072573|NCT02400814|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92072574|NCT02400814|Immunologic Factors|immunologic factors|mesh-ancestor
92072575|NCT02400814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072576|NCT02400814|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92072577|NCT02400814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072578|NCT02400814|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072579|NCT02400814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072580|NCT02398240|Rituximab|rituximab|mesh-list
92072581|NCT02398240|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92072582|NCT02398240|Doxorubicin|doxorubicin|mesh-list
92072583|NCT02398240|Vincristine|vincristine|mesh-list
92072584|NCT02398240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072585|NCT02398240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015916|NCT02588339|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072586|NCT02398240|Immunologic Factors|immunologic factors|mesh-ancestor
92072587|NCT02398240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072588|NCT02398240|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072589|NCT02398240|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072590|NCT02398240|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072591|NCT02398240|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072592|NCT02398240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072593|NCT02398240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072594|NCT02398240|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072595|NCT02398240|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072596|NCT02398240|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072597|NCT02398240|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072598|NCT02398240|Immunotoxins|immunotoxins|mesh-ancestor
92072599|NCT02398240|Immunoconjugates|immunoconjugates|mesh-ancestor
92072600|NCT02022280|Lansoprazole|lansoprazole|mesh-list
92072601|NCT02022280|Dexlansoprazole|dexlansoprazole|mesh-list
92072602|NCT02022280|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92072603|NCT02022280|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072604|NCT02022280|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92072605|NCT02022280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072606|NCT02022280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072607|NCT02363374|Leucovorin|leucovorin|mesh-list
92072608|NCT02363374|Folic Acid|folic acid|mesh-list
92072609|NCT02363374|Fluorouracil|fluorouracil|mesh-list
92072610|NCT02363374|Oxaliplatin|oxaliplatin|mesh-list
92072611|NCT02363374|Levoleucovorin|levoleucovorin|mesh-list
92072612|NCT02363374|Antimetabolites|antimetabolites|mesh-ancestor
92072613|NCT02363374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072614|NCT02363374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92072615|NCT02363374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072618|NCT02363374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072620|NCT02363374|Protective Agents|protective agents|mesh-ancestor
92072621|NCT02363374|Vitamin B Complex|vitamin b complex|mesh-ancestor
92072622|NCT02363374|Vitamins|vitamins|mesh-ancestor
92072623|NCT02363374|Micronutrients|micronutrients|mesh-ancestor
92072624|NCT02363374|Hematinics|hematinics|mesh-ancestor
92072625|NCT01511445|Silicon|silicon|mesh-list
92072626|NCT01511445|Trace Elements|trace elements|mesh-ancestor
92072627|NCT01511445|Micronutrients|micronutrients|mesh-ancestor
92072628|NCT01511445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072629|NCT02362594|Pembrolizumab|pembrolizumab|mesh-list
92072630|NCT02362594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072631|NCT02362594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072632|NCT02362594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92072633|NCT02362594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072634|NCT02344186|Liraglutide|liraglutide|mesh-list
92072635|NCT02344186|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92072636|NCT02344186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072637|NCT02344186|Incretins|incretins|mesh-ancestor
92072639|NCT02344186|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072640|NCT01537887|Moxifloxacin|moxifloxacin|mesh-list
92072641|NCT01537887|Evacetrapib|evacetrapib|mesh-list
92072642|NCT01537887|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072643|NCT01537887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072644|NCT01537887|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072645|NCT01537887|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072646|NCT01537887|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072647|NCT01537887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072648|NCT01537887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072649|NCT01537887|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92072650|NCT01537887|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92072651|NCT01537887|Antimetabolites|antimetabolites|mesh-ancestor
92072652|NCT01537887|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92072653|NCT02305264|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92072654|NCT02305264|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92072655|NCT02305264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072656|NCT02297698|Trastuzumab|trastuzumab|mesh-list
92072657|NCT02297698|Sargramostim|sargramostim|mesh-list
92072658|NCT02297698|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072659|NCT02297698|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072660|NCT02297698|Immunologic Factors|immunologic factors|mesh-ancestor
92072661|NCT02297698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072662|NCT01487577|Mycophenolic Acid|mycophenolic acid|mesh-list
92072663|NCT01487577|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92015917|NCT02588339|Immunologic Factors|immunologic factors|mesh-ancestor
92015918|NCT02588339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015919|NCT02588339|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92015920|NCT02588339|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072664|NCT01487577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072665|NCT01487577|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92072666|NCT01487577|Antitubercular Agents|antitubercular agents|mesh-ancestor
92072667|NCT01487577|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072668|NCT01487577|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072669|NCT01487577|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072670|NCT01487577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072671|NCT01928056|Montelukast|montelukast|mesh-list
92072672|NCT01928056|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92072673|NCT01928056|Respiratory System Agents|respiratory system agents|mesh-ancestor
92072674|NCT01928056|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92072675|NCT01928056|Hormone Antagonists|hormone antagonists|mesh-ancestor
92074280|NCT00166036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072676|NCT01928056|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072677|NCT01928056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072678|NCT01928056|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92072679|NCT01928056|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92072680|NCT01928056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072681|NCT05585866|Anesthetics|anesthetics|mesh-list
92072682|NCT05585866|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92072683|NCT05585866|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072684|NCT01992952|Fulvestrant|fulvestrant|mesh-list
92072685|NCT01992952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072686|NCT01992952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072687|NCT01992952|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92072692|NCT01928134|Calcium Carbonate|calcium carbonate|mesh-list
92072694|NCT01928134|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92072695|NCT01928134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072696|NCT01928134|Antacids|antacids|mesh-ancestor
92072697|NCT01928134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072698|NCT01928134|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072699|NCT02285140|Vancomycin|vancomycin|mesh-list
92072700|NCT02285140|Cefazolin|cefazolin|mesh-list
92072701|NCT02285140|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072702|NCT02285140|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072703|NCT04756882|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92072704|NCT04756882|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92072705|NCT04756882|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92072706|NCT04756882|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072707|NCT04756882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072708|NCT04756882|Cholinergic Agents|cholinergic agents|mesh-ancestor
92072709|NCT04756882|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072710|NCT04756882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072711|NCT04756882|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92072712|NCT04756882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072713|NCT04756492|Cyclosporine|cyclosporine|mesh-list
92072714|NCT04756492|Antifungal Agents|antifungal agents|mesh-ancestor
92072715|NCT04756492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072716|NCT04756492|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072717|NCT04756492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072718|NCT04756492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072719|NCT04756492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072721|NCT04756492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072722|NCT04756492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072723|NCT04756492|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92072724|NCT01536951|Moxifloxacin|moxifloxacin|mesh-list
92072725|NCT01536951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072726|NCT01536951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072727|NCT01536951|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072728|NCT01536951|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072729|NCT01536951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015921|NCT02588339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015922|NCT02588339|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92015923|NCT02588339|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072730|NCT01536951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072731|NCT01536951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072732|NCT04767633|Magnesium Sulfate|magnesium sulfate|mesh-list
92072733|NCT04767633|Analgesics|analgesics|mesh-ancestor
92072734|NCT04767633|Sensory System Agents|sensory system agents|mesh-ancestor
92072735|NCT04767633|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072736|NCT04767633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072737|NCT04767633|Anesthetics|anesthetics|mesh-ancestor
92072738|NCT04767633|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92072739|NCT04767633|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92072740|NCT04767633|Anticonvulsants|anticonvulsants|mesh-ancestor
92072741|NCT04767633|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92072742|NCT04767633|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072743|NCT04767633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072744|NCT04767633|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92072745|NCT04767633|Tocolytic Agents|tocolytic agents|mesh-ancestor
92072746|NCT04767633|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92072747|NCT01928914|Moxifloxacin|moxifloxacin|mesh-list
92072748|NCT01928914|Tafenoquine|tafenoquine|mesh-list
92072749|NCT01928914|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072750|NCT01928914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072751|NCT01928914|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072752|NCT01928914|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072753|NCT01928914|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072754|NCT01928914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072755|NCT01928914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072756|NCT01928914|Antimalarials|antimalarials|mesh-ancestor
92072759|NCT02249104|Adapalene|adapalene|mesh-list
92072760|NCT02249104|Adapalene, Benzoyl Peroxide Drug Combination|adapalene, benzoyl peroxide drug combination|mesh-list
92072761|NCT02249104|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92072762|NCT02249104|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072763|NCT02249104|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92072764|NCT02249104|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92072765|NCT02249104|Analgesics|analgesics|mesh-ancestor
92072766|NCT02249104|Sensory System Agents|sensory system agents|mesh-ancestor
92072767|NCT02249104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072768|NCT02249104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072769|NCT02249104|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072770|NCT02249104|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072771|NCT01929070|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92072772|NCT01929070|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92072773|NCT01929070|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92072774|NCT01929070|Antimetabolites|antimetabolites|mesh-ancestor
92072775|NCT01929070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072776|NCT01929070|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92072777|NCT01929070|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92072778|NCT01929070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072779|NCT01536561|Tositumomab I-131|tositumomab i-131|mesh-list
92072780|NCT01536561|Antibodies|antibodies|mesh-list
92072781|NCT01536561|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92072782|NCT01536561|Antibodies, Anti-Idiotypic|antibodies, anti-idiotypic|mesh-list
92072783|NCT01536561|Immunologic Factors|immunologic factors|mesh-ancestor
92072784|NCT01536561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072785|NCT01536561|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072786|NCT02236312|Botulinum Toxins|botulinum toxins|mesh-list
92072787|NCT02236312|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92072788|NCT02236312|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92072789|NCT02236312|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92072790|NCT02236312|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072791|NCT02236312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072792|NCT02236312|Cholinergic Agents|cholinergic agents|mesh-ancestor
92072793|NCT02236312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072794|NCT02236312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072795|NCT02236312|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92072796|NCT02236312|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072797|NCT01916278|Lidocaine|lidocaine|mesh-list
92072798|NCT01916278|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015924|NCT02588339|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92015925|NCT02588339|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015926|NCT02588339|Antifungal Agents|antifungal agents|mesh-ancestor
92015927|NCT02588339|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92015928|NCT01752491|Ascorbic Acid|ascorbic acid|mesh-list
92015929|NCT01752491|Temozolomide|temozolomide|mesh-list
92015930|NCT01752491|Vitamins|vitamins|mesh-ancestor
92072799|NCT01916278|Anesthetics|anesthetics|mesh-ancestor
92072800|NCT01916278|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92072801|NCT01916278|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072802|NCT01916278|Sensory System Agents|sensory system agents|mesh-ancestor
92072803|NCT01916278|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072804|NCT01916278|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92072805|NCT01916278|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92072806|NCT01916278|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92072807|NCT01916278|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92072808|NCT01916278|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072809|NCT03084640|Pembrolizumab|pembrolizumab|mesh-list
92072810|NCT03084640|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072811|NCT03084640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072812|NCT03084640|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92074281|NCT00166036|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92072813|NCT03084640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072815|NCT04409691|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072816|NCT04409691|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072817|NCT04409691|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072818|NCT04409691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072819|NCT04409691|Antifungal Agents|antifungal agents|mesh-ancestor
92072820|NCT04409691|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072821|NCT04409691|Immunologic Factors|immunologic factors|mesh-ancestor
92072822|NCT04409691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072823|NCT02223208|Prednisone|prednisone|mesh-list
92072824|NCT02223208|Cyclophosphamide|cyclophosphamide|mesh-list
92072825|NCT02223208|Doxorubicin|doxorubicin|mesh-list
92072826|NCT02223208|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92072827|NCT02223208|Etoposide|etoposide|mesh-list
92072828|NCT02223208|Etoposide phosphate|etoposide phosphate|mesh-list
92072829|NCT02223208|Romidepsin|romidepsin|mesh-list
92072834|NCT02223208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072835|NCT02223208|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92072836|NCT02223208|Alkylating Agents|alkylating agents|mesh-ancestor
92072837|NCT02223208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072838|NCT02223208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072839|NCT02223208|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92072840|NCT02223208|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072841|NCT02223208|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072842|NCT02223208|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072843|NCT02223208|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072844|NCT02223208|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072845|NCT02223208|Glucocorticoids|glucocorticoids|mesh-ancestor
92072846|NCT02223208|Hormones|hormones|mesh-ancestor
92072847|NCT02223208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072848|NCT02223208|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072849|NCT02223208|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072850|NCT02223208|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92072851|NCT02223208|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072852|NCT02223208|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072853|NCT02223208|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072854|NCT02219776|Chlorhexidine|chlorhexidine|mesh-list
92072855|NCT02219776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92072856|NCT02219776|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92072857|NCT02219776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92072858|NCT02219776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072859|NCT02219776|Disinfectants|disinfectants|mesh-ancestor
92072860|NCT02219776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072861|NCT01487265|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92015931|NCT01752491|Micronutrients|micronutrients|mesh-ancestor
92015932|NCT01752491|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015933|NCT01752491|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92072862|NCT01487265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072863|NCT01487265|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92072864|NCT01487265|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072865|NCT01487265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072866|NCT01516606|Clarithromycin|clarithromycin|mesh-list
92072867|NCT01516606|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92072868|NCT01516606|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072869|NCT01516606|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92072870|NCT01516606|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072871|NCT01516606|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072872|NCT01516606|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92072873|NCT01516606|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92072874|NCT02209636|Ascorbic Acid|ascorbic acid|mesh-list
92072875|NCT02209636|Nitroglycerin|nitroglycerin|mesh-list
92072876|NCT02209636|Vitamins|vitamins|mesh-ancestor
92072877|NCT02209636|Micronutrients|micronutrients|mesh-ancestor
92072878|NCT02209636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072879|NCT02209636|Antioxidants|antioxidants|mesh-ancestor
92072880|NCT02209636|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072881|NCT02209636|Protective Agents|protective agents|mesh-ancestor
92072882|NCT02209636|Vasodilator Agents|vasodilator agents|mesh-ancestor
92072883|NCT01508325|Metoprolol|metoprolol|mesh-list
92072884|NCT01508325|Bisoprolol|bisoprolol|mesh-list
92072885|NCT01508325|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92072886|NCT01508325|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92072887|NCT01508325|Sympatholytics|sympatholytics|mesh-ancestor
92072888|NCT01508325|Autonomic Agents|autonomic agents|mesh-ancestor
92072889|NCT01508325|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072890|NCT01508325|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072891|NCT01508325|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92072892|NCT01508325|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92072893|NCT01508325|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92072894|NCT01508325|Adrenergic Agents|adrenergic agents|mesh-ancestor
92072895|NCT01508325|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072896|NCT01508325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072897|NCT01514344|Rituximab|rituximab|mesh-list
92072898|NCT01514344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072899|NCT01514344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072903|NCT01506856|Paclitaxel|paclitaxel|mesh-list
92072904|NCT01506856|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92072905|NCT01506856|Carboplatin|carboplatin|mesh-list
92072906|NCT01506856|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072907|NCT01506856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072908|NCT01506856|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072909|NCT01506856|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072910|NCT01506856|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072911|NCT01506856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072912|NCT02191930|Cyclophosphamide|cyclophosphamide|mesh-list
92072913|NCT02191930|Doxorubicin|doxorubicin|mesh-list
92072914|NCT02191930|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92072915|NCT02191930|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92072916|NCT02191930|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072917|NCT02191930|Immunologic Factors|immunologic factors|mesh-ancestor
92072918|NCT02191930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072919|NCT02191930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072920|NCT02191930|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92072921|NCT02191930|Alkylating Agents|alkylating agents|mesh-ancestor
92072922|NCT02191930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072923|NCT02191930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072924|NCT02191930|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92072925|NCT02191930|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072926|NCT02191930|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072927|NCT02191930|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072928|NCT02191930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072929|NCT02191930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072930|NCT02191930|Immunotoxins|immunotoxins|mesh-ancestor
92072931|NCT02191930|Immunoconjugates|immunoconjugates|mesh-ancestor
92015934|NCT01752491|Alkylating Agents|alkylating agents|mesh-ancestor
92015935|NCT01752491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015936|NCT01752491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92015937|NCT01752491|Antioxidants|antioxidants|mesh-ancestor
92072932|NCT01536015|Rotigotine|rotigotine|mesh-list
92072933|NCT01536015|Dopamine Agonists|dopamine agonists|mesh-ancestor
92072934|NCT01536015|Dopamine Agents|dopamine agents|mesh-ancestor
92072935|NCT01536015|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92072936|NCT01536015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072937|NCT01536015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072938|NCT01865110|Prednisone|prednisone|mesh-list
92072939|NCT01865110|Rituximab|rituximab|mesh-list
92072940|NCT01865110|Lenalidomide|lenalidomide|mesh-list
92072941|NCT01865110|Cyclophosphamide|cyclophosphamide|mesh-list
92072942|NCT01865110|Vincristine|vincristine|mesh-list
92072943|NCT01865110|Doxorubicin|doxorubicin|mesh-list
92072944|NCT01865110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92072945|NCT01865110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072946|NCT01865110|Immunologic Factors|immunologic factors|mesh-ancestor
92072947|NCT01865110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072948|NCT01865110|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072949|NCT01865110|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92072950|NCT01865110|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92072951|NCT01865110|Growth Substances|growth substances|mesh-ancestor
92072952|NCT01865110|Growth Inhibitors|growth inhibitors|mesh-ancestor
92072953|NCT01865110|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072954|NCT01865110|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92072955|NCT01865110|Alkylating Agents|alkylating agents|mesh-ancestor
92072956|NCT01865110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92072957|NCT01865110|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92072958|NCT01865110|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072959|NCT01865110|Glucocorticoids|glucocorticoids|mesh-ancestor
92072960|NCT01865110|Hormones|hormones|mesh-ancestor
92072961|NCT01865110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072962|NCT01865110|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072963|NCT01865110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072964|NCT01865110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92072965|NCT01865110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92072966|NCT01865110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072967|NCT01865110|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92072968|NCT01865110|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92072969|NCT01865110|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92072970|NCT01865110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92072971|NCT01484691|Budesonide|budesonide|mesh-list
92072972|NCT01484691|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072976|NCT01484691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072977|NCT01484691|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92072978|NCT01484691|Respiratory System Agents|respiratory system agents|mesh-ancestor
92072979|NCT01484691|Glucocorticoids|glucocorticoids|mesh-ancestor
92072980|NCT01484691|Hormones|hormones|mesh-ancestor
92072981|NCT01484691|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072982|NCT01464034|Dexamethasone|dexamethasone|mesh-list
92072983|NCT01464034|Pomalidomide|pomalidomide|mesh-list
92072984|NCT01464034|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072985|NCT01464034|Antiemetics|antiemetics|mesh-ancestor
92072986|NCT01464034|Autonomic Agents|autonomic agents|mesh-ancestor
92072987|NCT01464034|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072988|NCT01464034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072989|NCT01464034|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92072990|NCT01464034|Glucocorticoids|glucocorticoids|mesh-ancestor
92072992|NCT01464034|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072993|NCT01464034|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92072994|NCT01464034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92072995|NCT01464034|Immunologic Factors|immunologic factors|mesh-ancestor
92072996|NCT01464034|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92072997|NCT01464034|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92072998|NCT01464034|Growth Substances|growth substances|mesh-ancestor
92072999|NCT01464034|Growth Inhibitors|growth inhibitors|mesh-ancestor
92073000|NCT01535235|Lisinopril|lisinopril|mesh-list
92015938|NCT01752491|Protective Agents|protective agents|mesh-ancestor
92015939|NCT05554211|Tranexamic Acid|tranexamic acid|mesh-list
92015940|NCT05554211|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92015941|NCT05554211|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015942|NCT05554211|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015943|NCT05554211|Hemostatics|hemostatics|mesh-ancestor
92073001|NCT01535235|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92073002|NCT01535235|Protease Inhibitors|protease inhibitors|mesh-ancestor
92073003|NCT01535235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073004|NCT01535235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073005|NCT01535235|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92073006|NCT01535235|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92073007|NCT01535235|Protective Agents|protective agents|mesh-ancestor
92073487|NCT03027219|Vasodilator Agents|vasodilator agents|mesh-ancestor
92073008|NCT01535235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073009|NCT02317744|Naltrexone|naltrexone|mesh-list
92073010|NCT02317744|Bupropion|bupropion|mesh-list
92073011|NCT02317744|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92073012|NCT02317744|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92073013|NCT02317744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073014|NCT02317744|Sensory System Agents|sensory system agents|mesh-ancestor
92073015|NCT02317744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073016|NCT02317744|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92073017|NCT02317744|Antidepressive Agents|antidepressive agents|mesh-ancestor
92073018|NCT02317744|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073019|NCT02317744|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92073020|NCT02317744|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073021|NCT02317744|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073022|NCT02317744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073023|NCT02317744|Dopamine Agents|dopamine agents|mesh-ancestor
92073024|NCT02317744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073025|NCT02317744|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92073026|NCT02317744|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92073027|NCT02317744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073029|NCT01810588|Rituximab|rituximab|mesh-list
92073030|NCT01810588|Fludarabine|fludarabine|mesh-list
92073031|NCT01810588|Fludarabine phosphate|fludarabine phosphate|mesh-list
92073032|NCT01810588|Melphalan|melphalan|mesh-list
92073033|NCT01810588|Tacrolimus|tacrolimus|mesh-list
92073034|NCT01810588|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92073035|NCT01810588|Thymoglobulin|thymoglobulin|mesh-list
92073036|NCT01810588|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073037|NCT01810588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073038|NCT01810588|Immunologic Factors|immunologic factors|mesh-ancestor
92073039|NCT01810588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073040|NCT01810588|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073041|NCT01810588|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073042|NCT01810588|Antimetabolites|antimetabolites|mesh-ancestor
92073043|NCT01810588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073044|NCT01810588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073052|NCT01810588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92073053|NCT01810588|Alkylating Agents|alkylating agents|mesh-ancestor
92073054|NCT01810588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92073056|NCT02144584|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92073057|NCT02144584|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92073058|NCT02144584|Dopamine Agents|dopamine agents|mesh-ancestor
92073059|NCT02144584|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073060|NCT02144584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073061|NCT02144584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073062|NCT02144584|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92073063|NCT02144584|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92073064|NCT05577442|Trastuzumab|trastuzumab|mesh-list
92073065|NCT05577442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073066|NCT05577442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073067|NCT01895764|Adalimumab|adalimumab|mesh-list
92073068|NCT01895764|Methotrexate|methotrexate|mesh-list
92073069|NCT01895764|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92015945|NCT05554055|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92015946|NCT05554055|Dalteparin|dalteparin|mesh-list
92073070|NCT01895764|Abortifacient Agents|abortifacient agents|mesh-ancestor
92073071|NCT01895764|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92073072|NCT01895764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073073|NCT01895764|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073074|NCT01895764|Antimetabolites|antimetabolites|mesh-ancestor
92073075|NCT01895764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073076|NCT01895764|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073077|NCT01895764|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073078|NCT01895764|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073079|NCT01895764|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92073080|NCT01895764|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073081|NCT01895764|Immunologic Factors|immunologic factors|mesh-ancestor
92073082|NCT01895764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073083|NCT01895764|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92073084|NCT01895764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92073085|NCT01895764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073086|NCT01894360|Belimumab|belimumab|mesh-list
92073087|NCT01894360|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073088|NCT01894360|Immunologic Factors|immunologic factors|mesh-ancestor
92073089|NCT01894360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073090|NCT01483599|Adalimumab|adalimumab|mesh-list
92073091|NCT01483599|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92073092|NCT01483599|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073093|NCT01483599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073094|NCT01407562|Paclitaxel|paclitaxel|mesh-list
92073095|NCT01407562|Carboplatin|carboplatin|mesh-list
92073096|NCT01407562|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92073097|NCT01407562|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073098|NCT01407562|Tubulin Modulators|tubulin modulators|mesh-ancestor
92073099|NCT01407562|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073100|NCT01407562|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073101|NCT01407562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073102|NCT01406548|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92073103|NCT01406548|Immunologic Factors|immunologic factors|mesh-ancestor
92073104|NCT01406548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073106|NCT01393522|Levomilnacipran|levomilnacipran|mesh-list
92073107|NCT01393522|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92073108|NCT01393522|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073109|NCT01393522|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073110|NCT01393522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073123|NCT02086786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073124|NCT02086786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073125|NCT02086786|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92073126|NCT02086786|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92073127|NCT02086786|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073128|NCT02086786|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073129|NCT02086786|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92073130|NCT02086786|Dopamine Agents|dopamine agents|mesh-ancestor
92073131|NCT01787500|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92073132|NCT01787500|Cetuximab|cetuximab|mesh-list
92073133|NCT01787500|Irinotecan|irinotecan|mesh-list
92073134|NCT01787500|Camptothecin|camptothecin|mesh-list
92073135|NCT01787500|Vemurafenib|vemurafenib|mesh-list
92073136|NCT01787500|Antibodies|antibodies|mesh-list
92073137|NCT01787500|Immunoglobulins|immunoglobulins|mesh-list
92073138|NCT01787500|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92073139|NCT01787500|Immunologic Factors|immunologic factors|mesh-ancestor
92073140|NCT01787500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073141|NCT01787500|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073142|NCT01787500|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92073143|NCT01787500|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92073144|NCT01787500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073145|NCT01787500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073146|NCT01787500|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92073147|NCT01787500|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92073148|NCT01782352|Vitamin D|vitamin d|mesh-list
92073149|NCT01782352|Ergocalciferols|ergocalciferols|mesh-list
92073150|NCT01782352|Cholecalciferol|cholecalciferol|mesh-list
92073151|NCT01782352|Vitamins|vitamins|mesh-list
92015947|NCT05554055|Anticoagulants|anticoagulants|mesh-ancestor
92015948|NCT05554055|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92015949|NCT05554055|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92015950|NCT05554055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073152|NCT01782352|Micronutrients|micronutrients|mesh-ancestor
92073153|NCT01782352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073154|NCT01782352|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92073155|NCT01782352|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92073156|NCT02108158|Botulinum Toxins|botulinum toxins|mesh-list
92073157|NCT02108158|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92073158|NCT02108158|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92073159|NCT02108158|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92073160|NCT02108158|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073161|NCT02108158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073162|NCT02108158|Cholinergic Agents|cholinergic agents|mesh-ancestor
92073163|NCT02108158|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073164|NCT02108158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073165|NCT02108158|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92073166|NCT02108158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073167|NCT01895218|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92073168|NCT01895218|Hematinics|hematinics|mesh-ancestor
92073170|NCT01895998|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92073171|NCT01895998|Autonomic Agents|autonomic agents|mesh-ancestor
92073172|NCT01895998|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073173|NCT01895998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073174|NCT01895998|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92073176|NCT01895998|Tocolytic Agents|tocolytic agents|mesh-ancestor
92073177|NCT01895998|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92073178|NCT01895998|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92073179|NCT01895998|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92073180|NCT01895998|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92073181|NCT01895998|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073182|NCT01895998|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073183|NCT01895998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073185|NCT01895296|Hormones|hormones|mesh-ancestor
92073186|NCT01895296|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073187|NCT01895296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073188|NCT01276600|Tenofovir|tenofovir|mesh-list
92073189|NCT01276600|Emtricitabine|emtricitabine|mesh-list
92073190|NCT01276600|Antiviral Agents|antiviral agents|mesh-ancestor
92073191|NCT01276600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073192|NCT01276600|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92073193|NCT01276600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92073194|NCT01276600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073195|NCT01276600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073196|NCT01276600|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92073197|NCT01276600|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92073198|NCT02040376|Metformin|metformin|mesh-list
92073199|NCT02040376|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92073200|NCT02040376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073201|NCT04755868|Talazoparib|talazoparib|mesh-list
92073202|NCT04755868|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92073203|NCT04755868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073204|NCT04755868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073205|NCT04755868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073206|NCT01659658|Thalidomide|thalidomide|mesh-list
92073207|NCT01659658|Dexamethasone|dexamethasone|mesh-list
92073208|NCT01659658|Cyclophosphamide|cyclophosphamide|mesh-list
92073209|NCT01659658|Melphalan|melphalan|mesh-list
92073210|NCT01659658|Lenalidomide|lenalidomide|mesh-list
92073211|NCT01659658|Ixazomib|ixazomib|mesh-list
92073212|NCT01659658|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073213|NCT01659658|Immunologic Factors|immunologic factors|mesh-ancestor
92073214|NCT01659658|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073215|NCT01659658|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073216|NCT01659658|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92073217|NCT01659658|Alkylating Agents|alkylating agents|mesh-ancestor
92073218|NCT01659658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015951|NCT05700617|Dobutamine|dobutamine|mesh-list
92015952|NCT05700617|Milrinone|milrinone|mesh-list
92015953|NCT05700617|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92015954|NCT05700617|Sympathomimetics|sympathomimetics|mesh-ancestor
92073219|NCT01659658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073220|NCT01659658|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92073221|NCT01659658|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073222|NCT01659658|Antiemetics|antiemetics|mesh-ancestor
92073223|NCT01659658|Autonomic Agents|autonomic agents|mesh-ancestor
92073224|NCT01659658|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073225|NCT01659658|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073226|NCT01659658|Glucocorticoids|glucocorticoids|mesh-ancestor
92073227|NCT01659658|Hormones|hormones|mesh-ancestor
92073228|NCT01659658|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073229|NCT01659658|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073230|NCT01659658|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92073231|NCT01659658|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92073232|NCT01659658|Growth Substances|growth substances|mesh-ancestor
92073233|NCT01659658|Growth Inhibitors|growth inhibitors|mesh-ancestor
92073234|NCT01659658|Leprostatic Agents|leprostatic agents|mesh-ancestor
92073235|NCT01659658|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92073236|NCT01659658|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073237|NCT01659658|Protease Inhibitors|protease inhibitors|mesh-ancestor
92073238|NCT01659658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073239|NCT01621906|Alovudine|alovudine|mesh-list
92073240|NCT01621906|Antiviral Agents|antiviral agents|mesh-ancestor
92073241|NCT01621906|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073242|NCT01615510|Tapentadol|tapentadol|mesh-list
92073243|NCT01615510|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92073244|NCT01615510|Narcotics|narcotics|mesh-ancestor
92073245|NCT01615510|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073246|NCT01615510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073247|NCT01615510|Analgesics|analgesics|mesh-ancestor
92073248|NCT01615510|Sensory System Agents|sensory system agents|mesh-ancestor
92073250|NCT01615510|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92073251|NCT01615510|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073252|NCT01615510|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073253|NCT01615510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073254|NCT01615510|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073255|NCT01615510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073256|NCT00530062|Albuterol|albuterol|mesh-list
92073257|NCT00530062|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92073258|NCT00530062|Autonomic Agents|autonomic agents|mesh-ancestor
92073259|NCT00530062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073260|NCT00530062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073261|NCT00530062|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92073262|NCT00530062|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073263|NCT00530062|Tocolytic Agents|tocolytic agents|mesh-ancestor
92073264|NCT00530062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92073265|NCT00530062|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92073266|NCT00530062|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92073267|NCT00530062|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92073268|NCT00530062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073269|NCT00530062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073270|NCT00530062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073271|NCT01209364|Methylprednisolone|methylprednisolone|mesh-list
92073272|NCT01209364|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92073273|NCT01209364|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92073274|NCT01209364|Prednisolone|prednisolone|mesh-list
92073275|NCT01209364|Prednisolone acetate|prednisolone acetate|mesh-list
92073276|NCT01209364|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92073277|NCT01209364|Prednisolone phosphate|prednisolone phosphate|mesh-list
92073278|NCT01209364|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073279|NCT01209364|Antiemetics|antiemetics|mesh-ancestor
92073280|NCT01209364|Autonomic Agents|autonomic agents|mesh-ancestor
92073281|NCT01209364|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073282|NCT01209364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073283|NCT01209364|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073284|NCT01209364|Glucocorticoids|glucocorticoids|mesh-ancestor
92073285|NCT01209364|Hormones|hormones|mesh-ancestor
92081709|NCT03025893|Sunitinib|sunitinib|mesh-list
92073286|NCT01209364|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073287|NCT01209364|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92015955|NCT05700617|Autonomic Agents|autonomic agents|mesh-ancestor
92015956|NCT05700617|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92015957|NCT05700617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015958|NCT05700617|Adrenergic beta-1 Receptor Agonists|adrenergic beta-1 receptor agonists|mesh-ancestor
92015959|NCT05700617|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92073288|NCT01209364|Protective Agents|protective agents|mesh-ancestor
92073289|NCT01209364|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073290|NCT01209364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073291|NCT05080192|Fenofibrate|fenofibrate|mesh-list
92073292|NCT05080192|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92073293|NCT05080192|Antimetabolites|antimetabolites|mesh-ancestor
92073294|NCT05080192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073295|NCT05080192|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92073296|NCT00479128|Gemcitabine|gemcitabine|mesh-list
92073297|NCT00479128|Doxorubicin|doxorubicin|mesh-list
92073298|NCT00479128|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92073299|NCT00479128|Bortezomib|bortezomib|mesh-list
92073300|NCT00479128|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073301|NCT00479128|Antimetabolites|antimetabolites|mesh-ancestor
92073302|NCT00479128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073303|NCT00479128|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073304|NCT00479128|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92073305|NCT00479128|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92073306|NCT00479128|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92073307|NCT00479128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073308|NCT00472966|Fluocinolone Acetonide|fluocinolone acetonide|mesh-list
92073309|NCT00472966|Tretinoin|tretinoin|mesh-list
92073310|NCT00472966|Glycolic acid|glycolic acid|mesh-list
92073311|NCT00472966|Hydroquinone|hydroquinone|mesh-list
92073312|NCT00472966|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073313|NCT00472966|Keratolytic Agents|keratolytic agents|mesh-ancestor
92073314|NCT00472966|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073315|NCT00472966|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073316|NCT00472966|Glucocorticoids|glucocorticoids|mesh-ancestor
92073317|NCT00472966|Hormones|hormones|mesh-ancestor
92073486|NCT03027219|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92073318|NCT00472966|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073319|NCT00472966|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073320|NCT00472966|Antioxidants|antioxidants|mesh-ancestor
92073322|NCT00472966|Protective Agents|protective agents|mesh-ancestor
92073323|NCT00472966|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92073324|NCT01573780|Gemcitabine|gemcitabine|mesh-list
92073325|NCT01573780|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073326|NCT01573780|Antimetabolites|antimetabolites|mesh-ancestor
92073327|NCT01573780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073328|NCT01573780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073329|NCT01547260|Gemcitabine|gemcitabine|mesh-list
92073330|NCT01547260|Lenalidomide|lenalidomide|mesh-list
92073331|NCT01547260|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073332|NCT01547260|Antimetabolites|antimetabolites|mesh-ancestor
92073333|NCT01547260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073334|NCT01547260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073335|NCT01547260|Immunologic Factors|immunologic factors|mesh-ancestor
92073336|NCT01547260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073337|NCT01547260|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92073338|NCT01547260|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92073339|NCT01547260|Growth Substances|growth substances|mesh-ancestor
92073340|NCT01547260|Growth Inhibitors|growth inhibitors|mesh-ancestor
92073341|NCT04205266|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92073342|NCT04205266|Hematinics|hematinics|mesh-ancestor
92073343|NCT04205266|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92073344|NCT04205266|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92073345|NCT01896388|Ifenprodil|ifenprodil|mesh-list
92073346|NCT01896388|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92073347|NCT01896388|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92073348|NCT01896388|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073349|NCT01896388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073350|NCT01896388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073351|NCT01896388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073352|NCT01896388|Vasodilator Agents|vasodilator agents|mesh-ancestor
92015960|NCT05700617|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92015961|NCT05700617|Adrenergic Agents|adrenergic agents|mesh-ancestor
92015962|NCT05700617|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92015963|NCT05700617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073353|NCT01896388|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92073354|NCT01896388|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92073355|NCT01125436|Vitamin D|vitamin d|mesh-list
92073356|NCT01125436|Cholecalciferol|cholecalciferol|mesh-list
92073357|NCT01125436|Vitamins|vitamins|mesh-ancestor
92073358|NCT01125436|Micronutrients|micronutrients|mesh-ancestor
92073359|NCT01125436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073360|NCT01125436|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92073361|NCT01125436|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92073362|NCT04755322|Aspirin|aspirin|mesh-list
92073363|NCT04755322|Folic Acid|folic acid|mesh-list
92073364|NCT04755322|Hydroxychloroquine|hydroxychloroquine|mesh-list
92073365|NCT04755322|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92073366|NCT04755322|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92073367|NCT04755322|Analgesics|analgesics|mesh-ancestor
92073368|NCT04755322|Sensory System Agents|sensory system agents|mesh-ancestor
92073369|NCT04755322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073370|NCT04755322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073371|NCT04755322|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073372|NCT04755322|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073373|NCT04755322|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92073374|NCT04755322|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92073375|NCT04755322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073376|NCT04755322|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92073377|NCT04755322|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92073378|NCT04755322|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073379|NCT04755322|Antipyretics|antipyretics|mesh-ancestor
92073380|NCT04755322|Antimalarials|antimalarials|mesh-ancestor
92073381|NCT04755322|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92073382|NCT04755322|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92073384|NCT04755322|Hematinics|hematinics|mesh-ancestor
92073385|NCT04755322|Vitamin B Complex|vitamin b complex|mesh-ancestor
92073386|NCT04755322|Vitamins|vitamins|mesh-ancestor
92073387|NCT04755322|Micronutrients|micronutrients|mesh-ancestor
92073388|NCT00436540|Clobetasol|clobetasol|mesh-list
92073389|NCT00436540|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073390|NCT00436540|Glucocorticoids|glucocorticoids|mesh-ancestor
92073391|NCT00436540|Hormones|hormones|mesh-ancestor
92073392|NCT00436540|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073393|NCT00436540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073394|NCT00425230|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92073398|NCT00425230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073400|NCT00425230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073401|NCT00425230|Analgesics|analgesics|mesh-ancestor
92073402|NCT00425230|Sensory System Agents|sensory system agents|mesh-ancestor
92073403|NCT00425230|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073404|NCT00425230|Antidepressive Agents|antidepressive agents|mesh-ancestor
92073405|NCT00425230|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073406|NCT00425230|Dopamine Agents|dopamine agents|mesh-ancestor
92073407|NCT00410956|Dexamethasone|dexamethasone|mesh-list
92073408|NCT00410956|Bevacizumab|bevacizumab|mesh-list
92073409|NCT00410956|Floxuridine|floxuridine|mesh-list
92073410|NCT00410956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073411|NCT00410956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073412|NCT00410956|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92073413|NCT00410956|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92073414|NCT00410956|Growth Substances|growth substances|mesh-ancestor
92073415|NCT00410956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073416|NCT00410956|Growth Inhibitors|growth inhibitors|mesh-ancestor
92073417|NCT00410956|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073418|NCT00410956|Antiemetics|antiemetics|mesh-ancestor
92073419|NCT00410956|Autonomic Agents|autonomic agents|mesh-ancestor
92073420|NCT00410956|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073421|NCT00410956|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073422|NCT00410956|Glucocorticoids|glucocorticoids|mesh-ancestor
92073423|NCT00410956|Hormones|hormones|mesh-ancestor
92073424|NCT00410956|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015964|NCT05700617|Protective Agents|protective agents|mesh-ancestor
92015965|NCT05700617|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92073425|NCT00410956|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073426|NCT00410956|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073427|NCT00410956|Antimetabolites|antimetabolites|mesh-ancestor
92073428|NCT00410956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073429|NCT04634578|Bevacizumab|bevacizumab|mesh-list
92073430|NCT04634578|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073431|NCT04634578|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073432|NCT04634578|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92073433|NCT04634578|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92073434|NCT04634578|Growth Substances|growth substances|mesh-ancestor
92081710|NCT03025893|Lomustine|lomustine|mesh-list
92073435|NCT04634578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073436|NCT04634578|Growth Inhibitors|growth inhibitors|mesh-ancestor
92073437|NCT01066858|Tenofovir|tenofovir|mesh-list
92073438|NCT01066858|Antiviral Agents|antiviral agents|mesh-ancestor
92073439|NCT01066858|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073440|NCT01066858|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92073441|NCT01066858|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92073442|NCT01066858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073443|NCT01066858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073444|NCT01066858|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92073445|NCT01066858|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92073446|NCT04777552|Diazepam|diazepam|mesh-list
92073447|NCT04777552|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92073448|NCT04777552|Anticonvulsants|anticonvulsants|mesh-ancestor
92073449|NCT04777552|Antiemetics|antiemetics|mesh-ancestor
92073450|NCT04777552|Autonomic Agents|autonomic agents|mesh-ancestor
92073451|NCT04777552|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073452|NCT04777552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073453|NCT04777552|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073454|NCT04777552|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92073455|NCT04777552|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073456|NCT04777552|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92073457|NCT04777552|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92073458|NCT04777552|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92073459|NCT04777552|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92073460|NCT04777552|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073461|NCT04777552|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92073462|NCT04777552|Anesthetics, General|anesthetics, general|mesh-ancestor
92073463|NCT04777552|Anesthetics|anesthetics|mesh-ancestor
92073482|NCT04777162|Tislelizumab|tislelizumab|mesh-list
92073483|NCT04777162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073484|NCT04777162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073485|NCT03027219|Alprostadil|alprostadil|mesh-list
92073488|NCT03027219|Urological Agents|urological agents|mesh-ancestor
92073489|NCT04776772|Complement System Proteins|complement system proteins|mesh-list
92073490|NCT04776772|Immunologic Factors|immunologic factors|mesh-ancestor
92073491|NCT04776772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073492|NCT01506453|Gabapentin|gabapentin|mesh-list
92073493|NCT01506453|Analgesics|analgesics|mesh-ancestor
92073494|NCT01506453|Sensory System Agents|sensory system agents|mesh-ancestor
92073495|NCT01506453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073496|NCT01506453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073497|NCT01506453|Anticonvulsants|anticonvulsants|mesh-ancestor
92073498|NCT01506453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92073499|NCT01506453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92073500|NCT01506453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073501|NCT01506453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073502|NCT01506453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92073503|NCT01506453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92073504|NCT01506453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073505|NCT01506453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073506|NCT01506453|Antimanic Agents|antimanic agents|mesh-ancestor
92073507|NCT04389580|Tamoxifen|tamoxifen|mesh-list
92073508|NCT04389580|Isotretinoin|isotretinoin|mesh-list
92073509|NCT04389580|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92073510|NCT04389580|Hormone Antagonists|hormone antagonists|mesh-ancestor
92073511|NCT04389580|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92015966|NCT05700617|Vasodilator Agents|vasodilator agents|mesh-ancestor
92015967|NCT05700617|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92015968|NCT05700617|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92015969|NCT05700617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073512|NCT04389580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073513|NCT04389580|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073514|NCT04389580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073515|NCT04389580|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92073516|NCT04389580|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92073517|NCT04389580|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92073519|NCT00199108|Dexamethasone|dexamethasone|mesh-list
92073522|NCT00199108|Autonomic Agents|autonomic agents|mesh-ancestor
92073523|NCT00199108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073524|NCT00199108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073525|NCT00199108|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073526|NCT00199108|Glucocorticoids|glucocorticoids|mesh-ancestor
92073527|NCT00199108|Hormones|hormones|mesh-ancestor
92073528|NCT00199108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073529|NCT00199108|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073530|NCT00199108|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073531|NCT01504971|Rabeprazole|rabeprazole|mesh-list
92073532|NCT01504971|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92073533|NCT01504971|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073534|NCT01504971|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92073535|NCT01504971|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073536|NCT01504971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073537|NCT00954226|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92073538|NCT00954226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073539|NCT00954226|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92073540|NCT00954226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073541|NCT00954226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073542|NCT04753918|Ethiodized Oil|ethiodized oil|mesh-list
92073543|NCT04753918|Dihematoporphyrin Ether|dihematoporphyrin ether|mesh-list
92073544|NCT04753918|Trioxsalen|trioxsalen|mesh-list
92073545|NCT04753918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073546|NCT04753918|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073547|NCT04753918|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92073548|NCT04161664|Paclitaxel|paclitaxel|mesh-list
92073549|NCT04161664|Carboplatin|carboplatin|mesh-list
92073550|NCT04161664|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92073551|NCT04161664|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073552|NCT04161664|Tubulin Modulators|tubulin modulators|mesh-ancestor
92073553|NCT04161664|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073554|NCT04161664|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073555|NCT04161664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073556|NCT00936832|Leucovorin|leucovorin|mesh-list
92073557|NCT00936832|Fluorouracil|fluorouracil|mesh-list
92073558|NCT00936832|Irinotecan|irinotecan|mesh-list
92073559|NCT00936832|Sunitinib|sunitinib|mesh-list
92073560|NCT00936832|Calcium|calcium|mesh-list
92073561|NCT00936832|Levoleucovorin|levoleucovorin|mesh-list
92073637|NCT00885664|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073562|NCT00936832|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92073563|NCT00936832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073564|NCT00936832|Antimetabolites|antimetabolites|mesh-ancestor
92073565|NCT00936832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073566|NCT00936832|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073567|NCT00936832|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073568|NCT00936832|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073569|NCT00936832|Immunologic Factors|immunologic factors|mesh-ancestor
92073570|NCT00936832|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92073571|NCT00936832|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92073572|NCT00936832|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073573|NCT00936832|Antidotes|antidotes|mesh-ancestor
92073574|NCT00936832|Protective Agents|protective agents|mesh-ancestor
92073575|NCT00936832|Vitamin B Complex|vitamin b complex|mesh-ancestor
92073576|NCT00936832|Vitamins|vitamins|mesh-ancestor
92073577|NCT00936832|Micronutrients|micronutrients|mesh-ancestor
92073578|NCT00936832|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92073579|NCT00936832|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92073580|NCT00936832|Growth Substances|growth substances|mesh-ancestor
92073581|NCT00936832|Growth Inhibitors|growth inhibitors|mesh-ancestor
92015970|NCT05553743|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92015971|NCT05553743|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92015972|NCT05553665|Lidocaine|lidocaine|mesh-list
92015973|NCT05553665|Fentanyl|fentanyl|mesh-list
92073582|NCT00936832|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92073583|NCT01479621|Fluticasone|fluticasone|mesh-list
92073585|NCT01479621|Albuterol|albuterol|mesh-list
92073586|NCT01479621|Adrenergic Agonists|adrenergic agonists|mesh-list
92073587|NCT01479621|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073588|NCT01479621|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92073589|NCT01479621|Autonomic Agents|autonomic agents|mesh-ancestor
92073590|NCT01479621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073591|NCT01479621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073592|NCT01479621|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92073593|NCT01479621|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073594|NCT01479621|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073595|NCT01479621|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92073598|NCT01479621|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92073599|NCT01479621|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92073600|NCT01479621|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073601|NCT01479621|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073602|NCT01479621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073603|NCT04776226|Citalopram|citalopram|mesh-list
92073604|NCT04776226|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92073605|NCT04776226|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073606|NCT04776226|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073607|NCT04776226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073608|NCT04776226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073609|NCT04776226|Serotonin Agents|serotonin agents|mesh-ancestor
92073610|NCT04776226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073611|NCT04776226|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92073612|NCT04776226|Antidepressive Agents|antidepressive agents|mesh-ancestor
92073613|NCT04776226|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073614|NCT02319304|Leucovorin|leucovorin|mesh-list
92073615|NCT02319304|Fluorouracil|fluorouracil|mesh-list
92073616|NCT02319304|Oxaliplatin|oxaliplatin|mesh-list
92073617|NCT02319304|Antimetabolites|antimetabolites|mesh-ancestor
92073618|NCT02319304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073619|NCT02319304|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073620|NCT02319304|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073621|NCT02319304|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073622|NCT02319304|Immunologic Factors|immunologic factors|mesh-ancestor
92073623|NCT02319304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073624|NCT02319304|Antidotes|antidotes|mesh-ancestor
92073625|NCT02319304|Protective Agents|protective agents|mesh-ancestor
92073626|NCT02319304|Vitamin B Complex|vitamin b complex|mesh-ancestor
92073627|NCT02319304|Vitamins|vitamins|mesh-ancestor
92073628|NCT02319304|Micronutrients|micronutrients|mesh-ancestor
92073629|NCT00885664|Ritonavir|ritonavir|mesh-list
92073630|NCT00885664|Lopinavir|lopinavir|mesh-list
92073631|NCT00885664|Tenofovir|tenofovir|mesh-list
92073632|NCT00885664|Emtricitabine|emtricitabine|mesh-list
92073633|NCT00885664|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92073634|NCT00885664|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92073635|NCT00885664|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92073636|NCT00885664|Protease Inhibitors|protease inhibitors|mesh-ancestor
92073638|NCT00885664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073639|NCT00885664|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92073640|NCT00885664|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92073641|NCT00885664|Antiviral Agents|antiviral agents|mesh-ancestor
92073642|NCT00885664|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073643|NCT00885664|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92073644|NCT00885664|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92073645|NCT00885664|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92073646|NCT00885664|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92073647|NCT04784104|Epinephrine|epinephrine|mesh-list
92073648|NCT04784104|Racepinephrine|racepinephrine|mesh-list
92073649|NCT04784104|Bupivacaine|bupivacaine|mesh-list
92073650|NCT04784104|Prilocaine|prilocaine|mesh-list
92073651|NCT04784104|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92073652|NCT04784104|Epinephryl borate|epinephryl borate|mesh-list
92015974|NCT05553665|Midazolam|midazolam|mesh-list
92015975|NCT05553665|Complement System Proteins|complement system proteins|mesh-list
92015976|NCT05553665|Complement C4|complement c4|mesh-list
92015977|NCT05553665|Anesthetics, Local|anesthetics, local|mesh-ancestor
92015978|NCT05553665|Anesthetics|anesthetics|mesh-ancestor
92073653|NCT04784104|Anesthetics, Local|anesthetics, local|mesh-ancestor
92073654|NCT04784104|Anesthetics|anesthetics|mesh-ancestor
92073655|NCT04784104|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073656|NCT04784104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073657|NCT04784104|Sensory System Agents|sensory system agents|mesh-ancestor
92073658|NCT04784104|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073659|NCT04784104|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92073660|NCT04784104|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92073661|NCT04784104|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073662|NCT04784104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073663|NCT04784104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073664|NCT04784104|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92073665|NCT04784104|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92073666|NCT04784104|Autonomic Agents|autonomic agents|mesh-ancestor
92073667|NCT04784104|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92073670|NCT04784104|Sympathomimetics|sympathomimetics|mesh-ancestor
92073671|NCT04784104|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92073672|NCT00880594|Desipramine|desipramine|mesh-list
92073673|NCT00880594|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92073674|NCT00880594|Antidepressive Agents|antidepressive agents|mesh-ancestor
92073675|NCT00880594|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073676|NCT00880594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073677|NCT00880594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073678|NCT00880594|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92073679|NCT00880594|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073680|NCT00880594|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073681|NCT00880594|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073682|NCT00880594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073683|NCT00880594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073685|NCT04783870|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92073686|NCT04783870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073687|NCT04783870|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92073688|NCT04783870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073689|NCT00878254|Leucovorin|leucovorin|mesh-list
92073690|NCT00878254|Cytarabine|cytarabine|mesh-list
92073691|NCT00878254|Cyclophosphamide|cyclophosphamide|mesh-list
92073692|NCT00878254|Ifosfamide|ifosfamide|mesh-list
92073693|NCT00878254|Rituximab|rituximab|mesh-list
92073694|NCT00878254|Doxorubicin|doxorubicin|mesh-list
92073695|NCT00878254|Methotrexate|methotrexate|mesh-list
92073696|NCT00878254|Etoposide|etoposide|mesh-list
92073697|NCT00878254|Vincristine|vincristine|mesh-list
92073698|NCT00878254|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073699|NCT00878254|Immunologic Factors|immunologic factors|mesh-ancestor
92073700|NCT00878254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073701|NCT00878254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073702|NCT00878254|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92073703|NCT00878254|Alkylating Agents|alkylating agents|mesh-ancestor
92073704|NCT00878254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073705|NCT00878254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073706|NCT00878254|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92073707|NCT00878254|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073708|NCT00878254|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92073709|NCT00878254|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92073710|NCT00878254|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92073711|NCT00878254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073712|NCT00878254|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92073713|NCT00878254|Abortifacient Agents|abortifacient agents|mesh-ancestor
92073714|NCT00878254|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92073715|NCT00878254|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073716|NCT00878254|Antimetabolites|antimetabolites|mesh-ancestor
92073717|NCT00878254|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073718|NCT00878254|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92015979|NCT05553665|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92015980|NCT05553665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92015981|NCT05553665|Sensory System Agents|sensory system agents|mesh-ancestor
92015982|NCT05553665|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073719|NCT00878254|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92073720|NCT00878254|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92073721|NCT00878254|Antiviral Agents|antiviral agents|mesh-ancestor
92073722|NCT00878254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073723|NCT00878254|Antidotes|antidotes|mesh-ancestor
92073724|NCT00878254|Protective Agents|protective agents|mesh-ancestor
92073725|NCT00878254|Vitamin B Complex|vitamin b complex|mesh-ancestor
92073726|NCT00878254|Vitamins|vitamins|mesh-ancestor
92073727|NCT00878254|Micronutrients|micronutrients|mesh-ancestor
92073728|NCT00878254|Tubulin Modulators|tubulin modulators|mesh-ancestor
92073729|NCT00878254|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073730|NCT00878254|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073731|NCT04783636|Leuprolide|leuprolide|mesh-list
92073732|NCT04783636|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92073733|NCT04783636|Fertility Agents|fertility agents|mesh-ancestor
92073734|NCT04783636|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92073735|NCT04783636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073736|NCT04783636|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073737|NCT04783636|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073738|NCT00820846|Vaccines|vaccines|mesh-list
92073739|NCT00820846|Immunologic Factors|immunologic factors|mesh-ancestor
92073740|NCT00820846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073741|NCT03364348|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92073742|NCT03364348|Trastuzumab|trastuzumab|mesh-list
92073749|NCT03364348|Immunoconjugates|immunoconjugates|mesh-list
92073750|NCT03364348|Immunologic Factors|immunologic factors|mesh-ancestor
92073751|NCT03364348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073752|NCT03364348|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073753|NCT03364348|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92073755|NCT03364348|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073756|NCT03364348|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073757|NCT03364348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073758|NCT03364348|Immunotoxins|immunotoxins|mesh-ancestor
92073759|NCT04782622|Apatinib|apatinib|mesh-list
92073760|NCT04782622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073761|NCT04782622|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92073762|NCT04782622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073763|NCT04782622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073764|NCT04775212|Sevoflurane|sevoflurane|mesh-list
92073765|NCT04775212|Desflurane|desflurane|mesh-list
92073766|NCT04775212|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92073767|NCT04775212|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92073768|NCT04775212|Anesthetics, General|anesthetics, general|mesh-ancestor
92073769|NCT04775212|Anesthetics|anesthetics|mesh-ancestor
92073770|NCT04775212|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073771|NCT04775212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073772|NCT04774822|Mydriatics|mydriatics|mesh-list
92073773|NCT04774822|Autonomic Agents|autonomic agents|mesh-ancestor
92073774|NCT04774822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073775|NCT04774822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073776|NCT04782388|Alprazolam|alprazolam|mesh-list
92073777|NCT04782388|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92073778|NCT04782388|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073779|NCT04782388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073780|NCT04782388|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92073781|NCT04782388|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92073782|NCT04782388|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073783|NCT04782388|GABA Modulators|gaba modulators|mesh-ancestor
92073784|NCT04782388|GABA Agents|gaba agents|mesh-ancestor
92073785|NCT04782388|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073786|NCT04782388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073787|NCT04782076|Dabigatran|dabigatran|mesh-list
92073788|NCT04782076|Antithrombins|antithrombins|mesh-ancestor
92073789|NCT04782076|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92073790|NCT04782076|Protease Inhibitors|protease inhibitors|mesh-ancestor
92073791|NCT04782076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92015983|NCT05553665|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92015984|NCT05553665|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92073792|NCT04782076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073793|NCT04782076|Anticoagulants|anticoagulants|mesh-ancestor
92073794|NCT04782310|Pregabalin|pregabalin|mesh-list
92073795|NCT04782310|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92073796|NCT04782310|Analgesics|analgesics|mesh-ancestor
92073797|NCT04782310|Sensory System Agents|sensory system agents|mesh-ancestor
92073798|NCT04782310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073799|NCT04782310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073800|NCT04782310|Anticonvulsants|anticonvulsants|mesh-ancestor
92073801|NCT04782310|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92073802|NCT04782310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073803|NCT04782310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073804|NCT04782310|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92073805|NCT04782310|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92073806|NCT04782310|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92073807|NCT04782310|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073808|NCT04782310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073809|NCT04782310|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92073810|NCT04782310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073811|NCT04782310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073812|NCT04782310|Antidepressive Agents|antidepressive agents|mesh-ancestor
92073843|NCT03249844|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92073845|NCT03249844|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073846|NCT03249844|Antiemetics|antiemetics|mesh-ancestor
92073847|NCT03249844|Autonomic Agents|autonomic agents|mesh-ancestor
92073848|NCT03249844|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073849|NCT03249844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073850|NCT03249844|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073851|NCT03249844|Glucocorticoids|glucocorticoids|mesh-ancestor
92073852|NCT03249844|Hormones|hormones|mesh-ancestor
92073853|NCT03249844|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073854|NCT03249844|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92073855|NCT03249844|Protective Agents|protective agents|mesh-ancestor
92073856|NCT03249844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073857|NCT03249844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073858|NCT00637624|Acetylcysteine|acetylcysteine|mesh-list
92073859|NCT00637624|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92073861|NCT00637624|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073862|NCT00637624|Expectorants|expectorants|mesh-ancestor
92073863|NCT00637624|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073864|NCT00637624|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92073865|NCT00637624|Antioxidants|antioxidants|mesh-ancestor
92073866|NCT00637624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073867|NCT00637624|Protective Agents|protective agents|mesh-ancestor
92073868|NCT00637624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073869|NCT00637624|Antidotes|antidotes|mesh-ancestor
92073870|NCT01479465|Leucovorin|leucovorin|mesh-list
92073871|NCT01479465|Fluorouracil|fluorouracil|mesh-list
92073872|NCT01479465|Irinotecan|irinotecan|mesh-list
92073873|NCT01479465|Antimetabolites|antimetabolites|mesh-ancestor
92073874|NCT01479465|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073875|NCT01479465|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073876|NCT01479465|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073877|NCT01479465|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073878|NCT01479465|Immunologic Factors|immunologic factors|mesh-ancestor
92073879|NCT01479465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073880|NCT01479465|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92073881|NCT01479465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92073882|NCT01479465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073883|NCT01479465|Antidotes|antidotes|mesh-ancestor
92073884|NCT01479465|Protective Agents|protective agents|mesh-ancestor
92073885|NCT01479465|Vitamin B Complex|vitamin b complex|mesh-ancestor
92073886|NCT01479465|Vitamins|vitamins|mesh-ancestor
92073887|NCT01479465|Micronutrients|micronutrients|mesh-ancestor
92073888|NCT02428192|Nivolumab|nivolumab|mesh-list
92073889|NCT02428192|Ipilimumab|ipilimumab|mesh-list
92073890|NCT02428192|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073891|NCT02428192|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073892|NCT02428192|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92015985|NCT05553665|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92015986|NCT05553665|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073985|NCT04389424|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92073893|NCT02428192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073894|NCT04781686|Docetaxel|docetaxel|mesh-list
92073895|NCT04781686|Apatinib|apatinib|mesh-list
92073896|NCT04781686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073897|NCT04781686|Tubulin Modulators|tubulin modulators|mesh-ancestor
92073898|NCT04781686|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073899|NCT04781686|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073900|NCT04781686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073901|NCT04781686|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92073902|NCT04781686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073903|NCT02390284|Timolol|timolol|mesh-list
92073904|NCT02390284|Bimatoprost|bimatoprost|mesh-list
92073905|NCT02390284|Travoprost|travoprost|mesh-list
92073906|NCT02390284|Dorzolamide|dorzolamide|mesh-list
92073907|NCT02390284|Acetazolamide|acetazolamide|mesh-list
92073908|NCT02390284|Methazolamide|methazolamide|mesh-list
92073909|NCT02390284|Latanoprost|latanoprost|mesh-list
92073910|NCT02390284|Brinzolamide|brinzolamide|mesh-list
92073911|NCT02390284|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92073912|NCT02390284|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92073913|NCT02390284|Adrenergic Agents|adrenergic agents|mesh-ancestor
92073914|NCT02390284|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073915|NCT02390284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073916|NCT02390284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073917|NCT02390284|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92073918|NCT02390284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92073919|NCT02390284|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92073920|NCT02390284|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92073921|NCT02390284|Anticonvulsants|anticonvulsants|mesh-ancestor
92073922|NCT02390284|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92073923|NCT02390284|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073924|NCT02390284|Diuretics|diuretics|mesh-ancestor
92073925|NCT02390284|Natriuretic Agents|natriuretic agents|mesh-ancestor
92073926|NCT04780750|Docetaxel|docetaxel|mesh-list
92073927|NCT04780750|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073928|NCT04780750|Tubulin Modulators|tubulin modulators|mesh-ancestor
92073929|NCT04780750|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073930|NCT04780750|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073931|NCT04780750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073933|NCT04780984|Tiotropium Bromide|tiotropium bromide|mesh-list
92073934|NCT04780984|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92073935|NCT04780984|Autonomic Agents|autonomic agents|mesh-ancestor
92073936|NCT04780984|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073937|NCT04780984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073952|NCT02090374|Interferon Inducers|interferon inducers|mesh-ancestor
92073953|NCT02090374|Immunologic Factors|immunologic factors|mesh-ancestor
92073954|NCT02222740|Hydrocodone|hydrocodone|mesh-list
92073955|NCT02222740|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92073956|NCT02222740|Narcotics|narcotics|mesh-ancestor
92073957|NCT02222740|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92073958|NCT02222740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073959|NCT02222740|Analgesics|analgesics|mesh-ancestor
92073960|NCT02222740|Sensory System Agents|sensory system agents|mesh-ancestor
92073961|NCT02222740|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073962|NCT02222740|Antitussive Agents|antitussive agents|mesh-ancestor
92073963|NCT02222740|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073964|NCT04780438|Dapagliflozin|dapagliflozin|mesh-list
92073965|NCT04780438|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92073966|NCT04780438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073967|NCT04780438|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92073968|NCT04780438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073970|NCT04779892|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92073971|NCT04779892|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073972|NCT04779892|Dermatologic Agents|dermatologic agents|mesh-ancestor
92073973|NCT04779892|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92073974|NCT04779892|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92073975|NCT04389424|Tamoxifen|tamoxifen|mesh-list
92073976|NCT04389424|Anastrozole|anastrozole|mesh-list
92073977|NCT04389424|Exemestane|exemestane|mesh-list
92073978|NCT04389424|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92073979|NCT04389424|Hormone Antagonists|hormone antagonists|mesh-ancestor
92073980|NCT04389424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073981|NCT04389424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073982|NCT04389424|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92073983|NCT04389424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073984|NCT04389424|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92074058|NCT00058240|Growth Inhibitors|growth inhibitors|mesh-ancestor
92073986|NCT04389424|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92073987|NCT04389424|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92073988|NCT04389424|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92073989|NCT04389424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073990|NCT04389424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073991|NCT04771390|Selitrectinib|selitrectinib|mesh-list
92073992|NCT04771390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073993|NCT04771390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073994|NCT04779502|Chlorhexidine|chlorhexidine|mesh-list
92073995|NCT04779502|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92073996|NCT04779502|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92073997|NCT04779502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073998|NCT04779502|Disinfectants|disinfectants|mesh-ancestor
92074000|NCT05411380|Capecitabine|capecitabine|mesh-list
92074002|NCT05411380|Fulvestrant|fulvestrant|mesh-list
92074003|NCT05411380|Anastrozole|anastrozole|mesh-list
92074004|NCT05411380|Exemestane|exemestane|mesh-list
92074005|NCT05411380|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074006|NCT05411380|Antimetabolites|antimetabolites|mesh-ancestor
92074007|NCT05411380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074008|NCT05411380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074009|NCT05411380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92074010|NCT05411380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92074011|NCT05411380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074012|NCT05411380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92074013|NCT05411380|Hormone Antagonists|hormone antagonists|mesh-ancestor
92074014|NCT05411380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92074015|NCT05411380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074016|NCT05411380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92074017|NCT05411380|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92074019|NCT04779580|Anesthetics, Local|anesthetics, local|mesh-list
92074020|NCT04779580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074021|NCT04779580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074022|NCT04779580|Sensory System Agents|sensory system agents|mesh-ancestor
92074023|NCT04779580|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074024|NCT04770688|Osimertinib|osimertinib|mesh-list
92074025|NCT04770688|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074026|NCT04770688|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074027|NCT04770688|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074028|NCT04770688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074029|NCT05390476|Capecitabine|capecitabine|mesh-list
92074030|NCT05390476|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074031|NCT05390476|Antimetabolites|antimetabolites|mesh-ancestor
92074032|NCT05390476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074033|NCT05390476|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074034|NCT05324332|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92074035|NCT05324332|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92074036|NCT05324332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074037|NCT04769908|Lenvatinib|lenvatinib|mesh-list
92074038|NCT04769908|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074039|NCT04769908|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074040|NCT04769908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074041|NCT04769908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074042|NCT00054028|Suramin|suramin|mesh-list
92074043|NCT00054028|Paclitaxel|paclitaxel|mesh-list
92074044|NCT00054028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92074045|NCT00054028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074046|NCT00054028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92074047|NCT00054028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92074048|NCT00054028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074049|NCT00054028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074050|NCT00054028|Antinematodal Agents|antinematodal agents|mesh-ancestor
92074051|NCT00054028|Anthelmintics|anthelmintics|mesh-ancestor
92074052|NCT00054028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92015987|NCT05553665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92015988|NCT05553665|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92015989|NCT05553665|Narcotics|narcotics|mesh-ancestor
92015990|NCT05553665|Analgesics|analgesics|mesh-ancestor
92015991|NCT05553665|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92074053|NCT00054028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074054|NCT00054028|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92074055|NCT00054028|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92074056|NCT00058240|Alvocidib|alvocidib|mesh-list
92074057|NCT00058240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074059|NCT00058240|Growth Substances|growth substances|mesh-ancestor
92074060|NCT00058240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074061|NCT00058240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074062|NCT00058240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074063|NCT00058240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074064|NCT03026907|Azathioprine|azathioprine|mesh-list
92074065|NCT03026907|Alitretinoin|alitretinoin|mesh-list
92074066|NCT03026907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074067|NCT03026907|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074068|NCT03026907|Antimetabolites|antimetabolites|mesh-ancestor
92074069|NCT03026907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074070|NCT03026907|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074073|NCT03026907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074074|NCT03026907|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074075|NCT00060424|Cyclosporine|cyclosporine|mesh-list
92074076|NCT00060424|Mycophenolic Acid|mycophenolic acid|mesh-list
92074077|NCT00060424|Fludarabine|fludarabine|mesh-list
92074078|NCT00060424|Fludarabine phosphate|fludarabine phosphate|mesh-list
92074079|NCT00060424|Cyclosporins|cyclosporins|mesh-list
92074080|NCT00060424|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074081|NCT00060424|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074082|NCT00060424|Antimetabolites|antimetabolites|mesh-ancestor
92074083|NCT00060424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074084|NCT00060424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074085|NCT00060424|Immunologic Factors|immunologic factors|mesh-ancestor
92074086|NCT00060424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074087|NCT00060424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074088|NCT00060424|Antifungal Agents|antifungal agents|mesh-ancestor
92074089|NCT00060424|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074090|NCT00060424|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074091|NCT00060424|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074092|NCT00060424|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92074093|NCT00060424|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92074094|NCT00060424|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92074095|NCT00060424|Antitubercular Agents|antitubercular agents|mesh-ancestor
92074096|NCT00060424|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074097|NCT00062764|Pioglitazone|pioglitazone|mesh-list
92074098|NCT00062764|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074099|NCT00062764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074101|NCT00063232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074102|NCT00063232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074103|NCT00063622|Vitamin E|vitamin e|mesh-list
92074104|NCT00063622|Pioglitazone|pioglitazone|mesh-list
92074105|NCT00063622|Vitamins|vitamins|mesh-ancestor
92074106|NCT00063622|Micronutrients|micronutrients|mesh-ancestor
92074107|NCT00063622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074108|NCT00063622|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074109|NCT00063622|Antioxidants|antioxidants|mesh-ancestor
92074110|NCT00063622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074111|NCT00063622|Protective Agents|protective agents|mesh-ancestor
92074112|NCT05605756|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92074113|NCT05605756|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92074114|NCT05605756|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92074115|NCT05605756|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074116|NCT05605756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074117|NCT05605756|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92074118|NCT05605756|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074119|NCT05605756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074120|NCT05605756|Cholinergic Agents|cholinergic agents|mesh-ancestor
92015992|NCT05553665|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92015993|NCT05553665|Anesthetics, General|anesthetics, general|mesh-ancestor
92015994|NCT05553665|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92074121|NCT05605756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074122|NCT00153166|Pioglitazone|pioglitazone|mesh-list
92074123|NCT00153166|Atorvastatin|atorvastatin|mesh-list
92074124|NCT00153166|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92074125|NCT00153166|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92074126|NCT00153166|Antimetabolites|antimetabolites|mesh-ancestor
92074127|NCT00153166|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074128|NCT00153166|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92074129|NCT00153166|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92074130|NCT00153166|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074131|NCT00153166|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074132|NCT00153166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074133|NCT00156910|Botulinum Toxins|botulinum toxins|mesh-list
92074134|NCT00156910|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92074135|NCT00156910|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92074136|NCT00156910|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92074137|NCT00156910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074138|NCT00156910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074139|NCT00156910|Cholinergic Agents|cholinergic agents|mesh-ancestor
92074140|NCT00156910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074141|NCT00156910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074142|NCT00156910|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92074143|NCT00156910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074146|NCT01475721|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92074147|NCT01475721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92074148|NCT01475721|Autonomic Agents|autonomic agents|mesh-ancestor
92074149|NCT01475721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074150|NCT01475721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074151|NCT01475721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92074152|NCT01475721|Respiratory System Agents|respiratory system agents|mesh-ancestor
92074153|NCT01475721|Glucocorticoids|glucocorticoids|mesh-ancestor
92074154|NCT01475721|Hormones|hormones|mesh-ancestor
92074155|NCT01475721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92074156|NCT01475721|Sympathomimetics|sympathomimetics|mesh-ancestor
92074157|NCT01475721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074158|NCT01475721|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074159|NCT01475721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92074160|NCT00065806|Atorvastatin|atorvastatin|mesh-list
92074161|NCT00065806|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92074162|NCT00065806|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92074163|NCT00065806|Antimetabolites|antimetabolites|mesh-ancestor
92074164|NCT00065806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074165|NCT00065806|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92074166|NCT00065806|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92074167|NCT00065806|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074168|NCT00068770|Celecoxib|celecoxib|mesh-list
92074169|NCT00068770|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92074170|NCT00068770|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074171|NCT00068770|Analgesics|analgesics|mesh-ancestor
92074172|NCT00068770|Sensory System Agents|sensory system agents|mesh-ancestor
92074173|NCT00068770|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074174|NCT00068770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074175|NCT00068770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074176|NCT00068770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074177|NCT00068770|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92074178|NCT00068770|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92074179|NCT00068770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074180|NCT00068770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074181|NCT01475331|Ethanol|ethanol|mesh-list
92074182|NCT01475331|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92074183|NCT01475331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074184|NCT01475331|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074185|NCT01475331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074186|NCT01500213|Dexamethasone|dexamethasone|mesh-list
92074187|NCT01500213|Granisetron|granisetron|mesh-list
92074188|NCT01500213|Rolapitant|rolapitant|mesh-list
92074189|NCT01500213|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074190|NCT01500213|Antiemetics|antiemetics|mesh-ancestor
92015995|NCT05553665|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92015996|NCT05553665|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92015997|NCT05553665|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92015998|NCT05553665|GABA Modulators|gaba modulators|mesh-ancestor
92015999|NCT05553665|GABA Agents|gaba agents|mesh-ancestor
92074191|NCT01500213|Autonomic Agents|autonomic agents|mesh-ancestor
92074192|NCT01500213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074193|NCT01500213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074194|NCT01500213|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92074195|NCT01500213|Glucocorticoids|glucocorticoids|mesh-ancestor
92074196|NCT01500213|Hormones|hormones|mesh-ancestor
92074197|NCT01500213|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92074198|NCT01500213|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92074199|NCT01500213|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074200|NCT01500213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92074201|NCT01500213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92074202|NCT01500213|Serotonin Agents|serotonin agents|mesh-ancestor
92074203|NCT01500213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074204|NCT01500213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074205|NCT01500213|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92074206|NCT00069160|Docetaxel|docetaxel|mesh-list
92074207|NCT00069160|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92074208|NCT00069160|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074209|NCT00069160|Tubulin Modulators|tubulin modulators|mesh-ancestor
92074210|NCT00069160|Antimitotic Agents|antimitotic agents|mesh-ancestor
92074211|NCT00069160|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074212|NCT00069160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074213|NCT00069160|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92074214|NCT00071890|Aldesleukin|aldesleukin|mesh-list
92074215|NCT00071890|Interleukin-2|interleukin-2|mesh-list
92074216|NCT00071890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074219|NCT00071890|Sensory System Agents|sensory system agents|mesh-ancestor
92074220|NCT00071890|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074221|NCT00071890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074223|NCT00071890|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92074282|NCT00166036|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92074283|NCT00166036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074284|NCT00167206|Cyclophosphamide|cyclophosphamide|mesh-list
92074285|NCT00167206|Fludarabine|fludarabine|mesh-list
92074286|NCT00167206|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074287|NCT00167206|Immunologic Factors|immunologic factors|mesh-ancestor
92074288|NCT00167206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074291|NCT00167206|Alkylating Agents|alkylating agents|mesh-ancestor
92074292|NCT00167206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074293|NCT00167206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074294|NCT00167206|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92074295|NCT01474551|Vemurafenib|vemurafenib|mesh-list
92074296|NCT01474551|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074297|NCT01474551|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074298|NCT01474551|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074299|NCT01474551|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074300|NCT01499667|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92074301|NCT01499667|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92074302|NCT01499667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074303|NCT01499667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074304|NCT01499667|Immunologic Factors|immunologic factors|mesh-ancestor
92074305|NCT01499667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074306|NCT00168298|Dexamethasone|dexamethasone|mesh-list
92074307|NCT00168298|Dexamethasone acetate|dexamethasone acetate|mesh-list
92074308|NCT00168298|BB 1101|bb 1101|mesh-list
92074309|NCT00168298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074310|NCT00168298|Antiemetics|antiemetics|mesh-ancestor
92074311|NCT00168298|Autonomic Agents|autonomic agents|mesh-ancestor
92074312|NCT00168298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074313|NCT00168298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074314|NCT00168298|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92074315|NCT00168298|Glucocorticoids|glucocorticoids|mesh-ancestor
92074316|NCT00168298|Hormones|hormones|mesh-ancestor
92074317|NCT00168298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92074318|NCT00168298|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92074319|NCT00168298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074320|NCT00168298|Protease Inhibitors|protease inhibitors|mesh-ancestor
92074321|NCT00168298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074322|NCT00168298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074323|NCT00076258|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-list
92074324|NCT00076258|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92074325|NCT00076258|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074326|NCT00076258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074327|NCT00076258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074328|NCT00076258|Serotonin Agents|serotonin agents|mesh-ancestor
92016003|NCT02629159|Upadacitinib|upadacitinib|mesh-list
92016004|NCT02629159|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92016005|NCT02629159|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016006|NCT02629159|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016007|NCT02629159|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92016008|NCT02629159|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92016009|NCT02629159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016010|NCT02629159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074329|NCT00076258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074330|NCT00078286|Sertraline|sertraline|mesh-list
92074331|NCT00078286|Antidepressive Agents|antidepressive agents|mesh-ancestor
92074332|NCT00078286|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074333|NCT00078286|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92074334|NCT00078286|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92074335|NCT00078286|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074336|NCT00078286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074337|NCT00078286|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074338|NCT00078286|Serotonin Agents|serotonin agents|mesh-ancestor
92074339|NCT00078286|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074340|NCT00078754|Valproic Acid|valproic acid|mesh-list
92074341|NCT00078754|Fluoxetine|fluoxetine|mesh-list
92074342|NCT00078754|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92074343|NCT00078754|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92074344|NCT00078754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074345|NCT00078754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074346|NCT00078754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074348|NCT00078754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074349|NCT00078754|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92074350|NCT00078754|Antidepressive Agents|antidepressive agents|mesh-ancestor
92074351|NCT00078754|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074352|NCT00078754|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92074353|NCT00078754|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92074354|NCT00078754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074355|NCT00078754|Anticonvulsants|anticonvulsants|mesh-ancestor
92074356|NCT00078754|GABA Agents|gaba agents|mesh-ancestor
92074362|NCT00081328|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074363|NCT00081328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074364|NCT01499355|Mycophenolic Acid|mycophenolic acid|mesh-list
92074365|NCT01499355|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92074366|NCT01499355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074367|NCT01499355|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92074368|NCT01499355|Antitubercular Agents|antitubercular agents|mesh-ancestor
92074369|NCT01499355|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074370|NCT01499355|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074371|NCT01499355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074372|NCT01499355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074373|NCT00083122|Cisplatin|cisplatin|mesh-list
92074374|NCT00083122|Alvocidib|alvocidib|mesh-list
92074375|NCT00083122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074376|NCT00083122|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074377|NCT00083122|Growth Substances|growth substances|mesh-ancestor
92074378|NCT00083122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074379|NCT00083122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074380|NCT00083122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074381|NCT00083122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074382|NCT01474239|Bevacizumab|bevacizumab|mesh-list
92074383|NCT01474239|Fotemustine|fotemustine|mesh-list
92074384|NCT01474239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074385|NCT01474239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074386|NCT01474239|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92074387|NCT01474239|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016012|NCT05548985|Metoclopramide|metoclopramide|mesh-list
92016013|NCT05548985|Antiemetics|antiemetics|mesh-ancestor
92016014|NCT05548985|Autonomic Agents|autonomic agents|mesh-ancestor
92016015|NCT05548985|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016016|NCT05548985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016017|NCT05548985|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016018|NCT05548985|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92016019|NCT05548985|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92016020|NCT05548985|Dopamine Agents|dopamine agents|mesh-ancestor
92016021|NCT05548985|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016022|NCT05548985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016023|NCT05548985|Sympathomimetics|sympathomimetics|mesh-ancestor
92016024|NCT05548985|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92016025|NCT05548985|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92016026|NCT05548985|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92016027|NCT05548985|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92016028|NCT05548985|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016029|NCT05548361|Chlorhexidine|chlorhexidine|mesh-list
92016030|NCT05548361|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92016031|NCT05548361|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92016032|NCT05548361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016033|NCT05548361|Disinfectants|disinfectants|mesh-ancestor
92016034|NCT05548361|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016035|NCT02628769|Solithromycin|solithromycin|mesh-list
92016036|NCT02628769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016037|NCT02628769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016040|NCT05552807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92074388|NCT01474239|Growth Substances|growth substances|mesh-ancestor
92074389|NCT01474239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074390|NCT01474239|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074391|NCT01473381|Dexetimide|dexetimide|mesh-list
92074392|NCT01473381|Citalopram|citalopram|mesh-list
92074393|NCT01473381|Vilazodone Hydrochloride|vilazodone hydrochloride|mesh-list
92074394|NCT01473381|Escitalopram|escitalopram|mesh-list
92074395|NCT01473381|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92074396|NCT01473381|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92074397|NCT01473381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074398|NCT01473381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074399|NCT01473381|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074400|NCT01473381|Serotonin Agents|serotonin agents|mesh-ancestor
92074401|NCT01473381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016041|NCT05552807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016042|NCT05552807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92016043|NCT05552807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92016044|NCT05552807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074402|NCT01473381|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92074403|NCT01473381|Antidepressive Agents|antidepressive agents|mesh-ancestor
92074404|NCT01473381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074405|NCT01473381|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92074406|NCT01473381|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92074407|NCT01473381|Parasympatholytics|parasympatholytics|mesh-ancestor
92074408|NCT01473381|Autonomic Agents|autonomic agents|mesh-ancestor
92074409|NCT01473381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074410|NCT01473381|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92074411|NCT01473381|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92074412|NCT01473381|Cholinergic Agents|cholinergic agents|mesh-ancestor
92074413|NCT01473381|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92074415|NCT00168454|Botulinum Toxins|botulinum toxins|mesh-list
92074416|NCT00168454|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92074417|NCT00168454|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92074418|NCT00168454|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92074419|NCT00168454|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074420|NCT00168454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074421|NCT00168454|Cholinergic Agents|cholinergic agents|mesh-ancestor
92074422|NCT00168454|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074423|NCT00168454|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074424|NCT00168454|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92074425|NCT00168454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074426|NCT01499277|Vancomycin|vancomycin|mesh-list
92074427|NCT01499277|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92074430|NCT01499277|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074432|NCT00176800|Chelating Agents|chelating agents|mesh-ancestor
92074433|NCT00176800|Sequestering Agents|sequestering agents|mesh-ancestor
92074434|NCT00176800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074435|NCT00176800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074436|NCT00176800|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92074437|NCT00176800|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92074438|NCT00176800|Growth Substances|growth substances|mesh-ancestor
92074439|NCT00176800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074440|NCT00176800|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074441|NCT00176800|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074442|NCT00176878|Fludarabine|fludarabine|mesh-list
92074443|NCT00176878|Fludarabine phosphate|fludarabine phosphate|mesh-list
92074444|NCT00176878|Busulfan|busulfan|mesh-list
92074445|NCT00176878|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92074446|NCT00176878|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074447|NCT00176878|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074448|NCT00176878|Antimetabolites|antimetabolites|mesh-ancestor
92074449|NCT00176878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074450|NCT00176878|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074451|NCT00176878|Immunologic Factors|immunologic factors|mesh-ancestor
92074452|NCT00176878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074453|NCT00176878|Alkylating Agents|alkylating agents|mesh-ancestor
92074454|NCT00176878|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92074455|NCT00176878|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92074456|NCT01898182|Kinetin|kinetin|mesh-list
92074457|NCT01898182|Plant Growth Regulators|plant growth regulators|mesh-ancestor
92074458|NCT01898182|Growth Substances|growth substances|mesh-ancestor
92074713|NCT00189436|Tocolytic Agents|tocolytic agents|mesh-ancestor
92074459|NCT01898182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074460|NCT01499199|Dolutegravir|dolutegravir|mesh-list
92074461|NCT01499199|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92074462|NCT01499199|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92074463|NCT01499199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074464|NCT01499199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074465|NCT01499199|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92074466|NCT01499199|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92074467|NCT01499199|Antiviral Agents|antiviral agents|mesh-ancestor
92074468|NCT01499199|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074469|NCT00090844|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92074470|NCT00090844|Luteolytic Agents|luteolytic agents|mesh-ancestor
92016045|NCT05552807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016046|NCT05552729|Vitamin D|vitamin d|mesh-list
92074471|NCT00090844|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92074472|NCT00090844|Contraceptive Agents|contraceptive agents|mesh-ancestor
92074473|NCT00090844|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92074474|NCT00090844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074475|NCT00090844|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92074476|NCT00090844|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92074477|NCT00090844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074478|NCT01897012|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92074479|NCT01897012|Romidepsin|romidepsin|mesh-list
92074480|NCT01897012|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074481|NCT01897012|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92074482|NCT01897012|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074483|NCT01897012|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92074484|NCT01897012|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074485|NCT01897012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074486|NCT01498887|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92074487|NCT01498887|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92074488|NCT01498887|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074489|NCT01498887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074490|NCT01498887|Immunologic Factors|immunologic factors|mesh-ancestor
92074491|NCT01498887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074492|NCT01498185|Dapagliflozin|dapagliflozin|mesh-list
92074493|NCT01498185|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92074494|NCT01498185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074495|NCT01498185|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074496|NCT01498185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074497|NCT01527357|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92074498|NCT01527357|Fibrin Foam|fibrin foam|mesh-list
92074499|NCT01527357|Hemostatics|hemostatics|mesh-ancestor
92074503|NCT00181714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074504|NCT00181714|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92074505|NCT00181714|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92074506|NCT00181714|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074507|NCT00181714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074509|NCT00181714|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074511|NCT01472835|Midazolam|midazolam|mesh-list
92074512|NCT01472835|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92074513|NCT01472835|Narcotics|narcotics|mesh-ancestor
92074514|NCT01472835|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074515|NCT01472835|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074516|NCT01472835|Analgesics|analgesics|mesh-ancestor
92074517|NCT01472835|Sensory System Agents|sensory system agents|mesh-ancestor
92074518|NCT01472835|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074519|NCT01472835|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92074520|NCT01472835|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92074521|NCT01472835|Anesthetics, General|anesthetics, general|mesh-ancestor
92074522|NCT01472835|Anesthetics|anesthetics|mesh-ancestor
92074523|NCT01472835|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92074524|NCT01472835|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92074525|NCT01472835|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92074526|NCT01472835|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074527|NCT01472835|GABA Modulators|gaba modulators|mesh-ancestor
92074528|NCT01472835|GABA Agents|gaba agents|mesh-ancestor
92074529|NCT01472835|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074530|NCT01472835|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074531|NCT00185692|Acetaminophen|acetaminophen|mesh-list
92074532|NCT00185692|Cyclosporine|cyclosporine|mesh-list
92074533|NCT00185692|Mycophenolic Acid|mycophenolic acid|mesh-list
92074534|NCT00185692|Methylprednisolone|methylprednisolone|mesh-list
92074535|NCT00185692|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92074536|NCT00185692|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92074537|NCT00185692|Prednisolone|prednisolone|mesh-list
92074538|NCT00185692|Prednisolone acetate|prednisolone acetate|mesh-list
92074539|NCT00185692|Hydrocortisone|hydrocortisone|mesh-list
92074540|NCT00185692|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92074541|NCT00185692|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92074542|NCT00185692|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92074543|NCT00185692|Cyclosporins|cyclosporins|mesh-list
92074544|NCT00185692|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92016048|NCT05552729|Cholecalciferol|cholecalciferol|mesh-list
92016049|NCT05552729|Vitamins|vitamins|mesh-list
92074545|NCT00185692|Lenograstim|lenograstim|mesh-list
92074546|NCT00185692|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92074547|NCT00185692|Prednisolone phosphate|prednisolone phosphate|mesh-list
92074548|NCT00185692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074549|NCT00185692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074550|NCT00185692|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074551|NCT00185692|Immunologic Factors|immunologic factors|mesh-ancestor
92074552|NCT00185692|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074553|NCT00185692|Antifungal Agents|antifungal agents|mesh-ancestor
92074554|NCT00185692|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074555|NCT00185692|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074556|NCT00185692|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074557|NCT00185692|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92074558|NCT00185692|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074559|NCT00185692|Analgesics|analgesics|mesh-ancestor
92074560|NCT00185692|Sensory System Agents|sensory system agents|mesh-ancestor
92074561|NCT00185692|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074562|NCT00185692|Antipyretics|antipyretics|mesh-ancestor
92074563|NCT00185692|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92074564|NCT00185692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074565|NCT00185692|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92074566|NCT00185692|Antitubercular Agents|antitubercular agents|mesh-ancestor
92074567|NCT00185692|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074568|NCT00185692|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074569|NCT00185692|Antiemetics|antiemetics|mesh-ancestor
92074570|NCT00185692|Autonomic Agents|autonomic agents|mesh-ancestor
92074571|NCT00185692|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92074572|NCT00185692|Glucocorticoids|glucocorticoids|mesh-ancestor
92074573|NCT00185692|Hormones|hormones|mesh-ancestor
92074583|NCT01526733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074584|NCT01526733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074585|NCT00094900|Rilonacept|rilonacept|mesh-list
92074586|NCT00094900|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074587|NCT00096460|Cyclophosphamide|cyclophosphamide|mesh-list
92074588|NCT00096460|Carmustine|carmustine|mesh-list
92074589|NCT00096460|Rituximab|rituximab|mesh-list
92074590|NCT00096460|Methotrexate|methotrexate|mesh-list
92074591|NCT00096460|Fludarabine|fludarabine|mesh-list
92074592|NCT00096460|Etoposide|etoposide|mesh-list
92074593|NCT00096460|Tacrolimus|tacrolimus|mesh-list
92074594|NCT00096460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074595|NCT00096460|Immunologic Factors|immunologic factors|mesh-ancestor
92074596|NCT00096460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074597|NCT00096460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074598|NCT00096460|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92074599|NCT00096460|Alkylating Agents|alkylating agents|mesh-ancestor
92074600|NCT00096460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074601|NCT00096460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074602|NCT00096460|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92074603|NCT00096460|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074604|NCT00096460|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92074605|NCT00096460|Abortifacient Agents|abortifacient agents|mesh-ancestor
92074606|NCT00096460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92074607|NCT00096460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074608|NCT00096460|Antimetabolites|antimetabolites|mesh-ancestor
92074609|NCT00096460|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074610|NCT00096460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074611|NCT00096460|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92074612|NCT00096460|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92074613|NCT00096460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92074614|NCT00096460|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92074615|NCT00096460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92074616|NCT00096460|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92074617|NCT00006178|Sirolimus|sirolimus|mesh-list
92074618|NCT00006178|Thymoglobulin|thymoglobulin|mesh-list
92074619|NCT00006178|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074620|NCT00006178|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074621|NCT00006178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92074622|NCT00006178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074623|NCT00006178|Antifungal Agents|antifungal agents|mesh-ancestor
92074624|NCT00006178|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074625|NCT00006178|Immunologic Factors|immunologic factors|mesh-ancestor
92016050|NCT05552729|Micronutrients|micronutrients|mesh-ancestor
92016051|NCT05552729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016052|NCT05552729|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92074626|NCT00006178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074627|NCT00097708|Anti-Anxiety Agents|anti-anxiety agents|mesh-list
92074628|NCT00097708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92074629|NCT00097708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074630|NCT00097708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074631|NCT00097708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074632|NCT00098956|Topotecan|topotecan|mesh-list
92074633|NCT00098956|7-hydroxystaurosporine|7-hydroxystaurosporine|mesh-list
92074634|NCT00098956|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92074635|NCT00098956|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92074636|NCT00098956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074637|NCT00098956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074638|NCT00098956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074639|NCT00098956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074656|NCT00006244|Interferons|interferons|mesh-list
92074657|NCT00006244|Interferon-alpha|interferon-alpha|mesh-list
92074658|NCT00006244|Aldesleukin|aldesleukin|mesh-list
92074659|NCT00006244|Interferon alpha-2|interferon alpha-2|mesh-list
92074660|NCT00006244|Melphalan|melphalan|mesh-list
92074661|NCT00006244|Interleukin-2|interleukin-2|mesh-list
92074662|NCT00006244|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074663|NCT00006244|Antiviral Agents|antiviral agents|mesh-ancestor
92074664|NCT00006244|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074665|NCT00006244|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92074666|NCT00006244|Alkylating Agents|alkylating agents|mesh-ancestor
92074667|NCT00006244|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074668|NCT00006244|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92074669|NCT00006244|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074670|NCT00006244|Immunologic Factors|immunologic factors|mesh-ancestor
92074671|NCT00006244|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074672|NCT00006244|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074673|NCT00006244|Analgesics|analgesics|mesh-ancestor
92074674|NCT00006244|Sensory System Agents|sensory system agents|mesh-ancestor
92074675|NCT00006244|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074676|NCT00006244|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92074677|NCT00006244|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92074678|NCT01525875|Magnesium Oxide|magnesium oxide|mesh-list
92074679|NCT01525875|Antacids|antacids|mesh-ancestor
92074680|NCT01525875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074681|NCT01525875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92074682|NCT01525641|Pramipexole|pramipexole|mesh-list
92074683|NCT01525641|Antioxidants|antioxidants|mesh-ancestor
92074684|NCT01525641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074685|NCT01525641|Protective Agents|protective agents|mesh-ancestor
92074686|NCT01525641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074687|NCT01525641|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92074688|NCT01525641|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92074689|NCT01525641|Dopamine Agonists|dopamine agonists|mesh-ancestor
92074690|NCT01525641|Dopamine Agents|dopamine agents|mesh-ancestor
92074691|NCT01525641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074692|NCT00006400|Hydroxyurea|hydroxyurea|mesh-list
92074693|NCT00006400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074694|NCT00006400|Antisickling Agents|antisickling agents|mesh-ancestor
92074695|NCT00006400|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074696|NCT00006400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074697|NCT00006400|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92074698|NCT01496469|Febuxostat|febuxostat|mesh-list
92074699|NCT01496469|Gout Suppressants|gout suppressants|mesh-ancestor
92074700|NCT01496469|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074701|NCT00189436|Budesonide|budesonide|mesh-list
92074702|NCT00189436|Albuterol|albuterol|mesh-list
92074703|NCT00189436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074706|NCT00189436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074707|NCT00189436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074708|NCT00189436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92074709|NCT00189436|Respiratory System Agents|respiratory system agents|mesh-ancestor
92074710|NCT00189436|Glucocorticoids|glucocorticoids|mesh-ancestor
92074712|NCT00189436|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016053|NCT05552729|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92074714|NCT00189436|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92074715|NCT00189436|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92074716|NCT00189436|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92074718|NCT00189436|Adrenergic Agents|adrenergic agents|mesh-ancestor
92074719|NCT00189436|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074720|NCT00189436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074721|NCT01471353|Capecitabine|capecitabine|mesh-list
92074722|NCT01471353|Sorafenib|sorafenib|mesh-list
92074723|NCT01471353|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074724|NCT01471353|Antimetabolites|antimetabolites|mesh-ancestor
92074725|NCT01471353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074726|NCT01471353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074727|NCT01471353|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074728|NCT01471353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074729|NCT01525407|Atorvastatin|atorvastatin|mesh-list
92074730|NCT01525407|Calcium|calcium|mesh-list
92074731|NCT01525407|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92074732|NCT01525407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074733|NCT01525407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92074734|NCT01525407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92074735|NCT01525407|Antimetabolites|antimetabolites|mesh-ancestor
92074736|NCT01525407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074737|NCT01525407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92074738|NCT01525407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92074739|NCT01525407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074740|NCT01471197|Pemetrexed|pemetrexed|mesh-list
92074741|NCT01471197|Ipilimumab|ipilimumab|mesh-list
92074742|NCT01471197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074743|NCT01471197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074744|NCT01471197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074745|NCT01471197|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92074746|NCT01471197|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92074747|NCT01471197|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074748|NCT01471197|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92074749|NCT04408989|Bevacizumab|bevacizumab|mesh-list
92074750|NCT04408989|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074751|NCT04408989|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074752|NCT04408989|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92074753|NCT04408989|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92074754|NCT04408989|Growth Substances|growth substances|mesh-ancestor
92074755|NCT04408989|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074756|NCT04408989|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074757|NCT00011986|Paclitaxel|paclitaxel|mesh-list
92074758|NCT00011986|Carboplatin|carboplatin|mesh-list
92074759|NCT00011986|Gemcitabine|gemcitabine|mesh-list
92074760|NCT00011986|Doxorubicin|doxorubicin|mesh-list
92074761|NCT00011986|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92074762|NCT00011986|Topotecan|topotecan|mesh-list
92074763|NCT00011986|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92074764|NCT00011986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074765|NCT00011986|Tubulin Modulators|tubulin modulators|mesh-ancestor
92074766|NCT00011986|Antimitotic Agents|antimitotic agents|mesh-ancestor
92074767|NCT00011986|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074768|NCT00011986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074769|NCT00011986|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074770|NCT00011986|Antimetabolites|antimetabolites|mesh-ancestor
92074771|NCT00011986|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92074772|NCT00011986|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92074773|NCT00011986|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92074774|NCT00011986|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074775|NCT00011986|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92074776|NCT01898416|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92074786|NCT01524783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074787|NCT01524783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074788|NCT01494987|Glimepiride|glimepiride|mesh-list
92074789|NCT01494987|Ranolazine|ranolazine|mesh-list
92074790|NCT01494987|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92074791|NCT01494987|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074792|NCT01494987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074793|NCT01494987|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074794|NCT01494987|Immunologic Factors|immunologic factors|mesh-ancestor
92016055|NCT05699993|Dextromethorphan|dextromethorphan|mesh-list
92016056|NCT05699993|Antifungal Agents|antifungal agents|mesh-ancestor
92074795|NCT01494987|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92074796|NCT01494987|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074797|NCT01494987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074798|NCT04409769|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92074799|NCT04409769|Ceftobiprole|ceftobiprole|mesh-list
92074800|NCT04409769|Ceftobiprole medocaril|ceftobiprole medocaril|mesh-list
92074801|NCT04409769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074802|NCT04409769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074803|NCT01470417|Gemcitabine|gemcitabine|mesh-list
92074804|NCT01470417|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92074805|NCT01470417|Paclitaxel|paclitaxel|mesh-list
92074806|NCT01470417|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074807|NCT01470417|Antimetabolites|antimetabolites|mesh-ancestor
92074808|NCT01470417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074809|NCT01470417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074810|NCT01470417|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92074811|NCT01470417|Tubulin Modulators|tubulin modulators|mesh-ancestor
92074812|NCT01470417|Antimitotic Agents|antimitotic agents|mesh-ancestor
92074813|NCT01470417|Mitosis Modulators|mitosis modulators|mesh-ancestor
92074814|NCT01524627|Varenicline|varenicline|mesh-list
92074815|NCT01524627|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92074816|NCT01524627|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92074817|NCT01524627|Cholinergic Agents|cholinergic agents|mesh-ancestor
92074818|NCT01524627|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074819|NCT01524627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074820|NCT01524627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074821|NCT01469637|Sulfamethoxazole|sulfamethoxazole|mesh-list
92074822|NCT01469637|Mesalamine|mesalamine|mesh-list
92074823|NCT01469637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074824|NCT01469637|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92074825|NCT01469637|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074826|NCT01469637|Analgesics|analgesics|mesh-ancestor
92074827|NCT01469637|Sensory System Agents|sensory system agents|mesh-ancestor
92074828|NCT01469637|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074829|NCT01469637|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074830|NCT01469637|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074831|NCT01469637|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074832|NCT04409223|Sunitinib|sunitinib|mesh-list
92074833|NCT04409223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074834|NCT04409223|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92074835|NCT04409223|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92074836|NCT04409223|Growth Substances|growth substances|mesh-ancestor
92074837|NCT04409223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074838|NCT04409223|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074839|NCT04409223|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074840|NCT04409223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074841|NCT04409223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074852|NCT00193258|Imatinib Mesylate|imatinib mesylate|mesh-list
92074853|NCT00193258|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074854|NCT00193258|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074855|NCT00193258|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92074856|NCT00193258|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92074857|NCT00193258|Growth Substances|growth substances|mesh-ancestor
92074858|NCT00193258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074859|NCT00193258|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074860|NCT00193258|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074861|NCT00193258|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074862|NCT00193258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074863|NCT00029536|Progesterone|progesterone|mesh-list
92074864|NCT00029536|Progestins|progestins|mesh-ancestor
92074865|NCT00029536|Hormones|hormones|mesh-ancestor
92074866|NCT00029536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92074867|NCT00029536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074868|NCT00193492|Bevacizumab|bevacizumab|mesh-list
92074869|NCT00193492|Rituximab|rituximab|mesh-list
92074870|NCT00193492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074871|NCT00193492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074872|NCT00193492|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92074873|NCT00193492|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016057|NCT05699993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074874|NCT00193492|Growth Substances|growth substances|mesh-ancestor
92074875|NCT00193492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074876|NCT00193492|Growth Inhibitors|growth inhibitors|mesh-ancestor
92074877|NCT00193492|Immunologic Factors|immunologic factors|mesh-ancestor
92074878|NCT00193492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074879|NCT00194116|Valproic Acid|valproic acid|mesh-list
92074880|NCT00194116|Anticonvulsants|anticonvulsants|mesh-ancestor
92074881|NCT00194116|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074882|NCT00194116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074883|NCT00194116|GABA Agents|gaba agents|mesh-ancestor
92074884|NCT00194116|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074885|NCT00194116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074886|NCT00194116|Antimanic Agents|antimanic agents|mesh-ancestor
92074887|NCT00194116|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92074888|NCT00194116|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074889|NCT00194116|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074890|NCT02096458|Dexlansoprazole|dexlansoprazole|mesh-list
92074891|NCT02096458|Lansoprazole|lansoprazole|mesh-list
92074892|NCT02096458|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92074893|NCT02096458|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92074894|NCT02096458|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92074895|NCT02096458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074896|NCT02096458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074897|NCT00194896|Rosiglitazone|rosiglitazone|mesh-list
92074898|NCT00194896|Glyburide|glyburide|mesh-list
92074899|NCT00194896|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074900|NCT00194896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074901|NCT04348474|Azithromycin|azithromycin|mesh-list
92074902|NCT04348474|Hydroxychloroquine|hydroxychloroquine|mesh-list
92074903|NCT04348474|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074904|NCT04348474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92074905|NCT04348474|Antimalarials|antimalarials|mesh-ancestor
92074906|NCT04348474|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92074907|NCT04348474|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92074908|NCT04348474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074913|NCT00107536|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074915|NCT00107536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074916|NCT00108550|Gabapentin|gabapentin|mesh-list
92074917|NCT00108550|Analgesics|analgesics|mesh-ancestor
92074918|NCT00108550|Sensory System Agents|sensory system agents|mesh-ancestor
92074919|NCT00108550|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074920|NCT00108550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074921|NCT00108550|Anticonvulsants|anticonvulsants|mesh-ancestor
92074922|NCT00108550|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92074923|NCT00108550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92074924|NCT00108550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074925|NCT00108550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074926|NCT00108550|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92074927|NCT00108550|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92074928|NCT00108550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074929|NCT00108550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074930|NCT00108550|Antimanic Agents|antimanic agents|mesh-ancestor
92074931|NCT02093962|Pemetrexed|pemetrexed|mesh-list
92074932|NCT02093962|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074933|NCT02093962|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074934|NCT02093962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074935|NCT02093962|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92074936|NCT02093962|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92074937|NCT00200902|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92074938|NCT00200902|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92074939|NCT00200902|Escitalopram|escitalopram|mesh-list
92074940|NCT00200902|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92074941|NCT00200902|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92074942|NCT00200902|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92074943|NCT00200902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074944|NCT00200902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92074945|NCT00200902|Serotonin Agents|serotonin agents|mesh-ancestor
92074946|NCT00200902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074947|NCT00200902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074948|NCT00200902|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92016058|NCT05699993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92016059|NCT05699993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92074949|NCT00200902|Antidepressive Agents|antidepressive agents|mesh-ancestor
92074950|NCT00200902|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92074951|NCT00200902|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92074952|NCT00200902|Analgesics|analgesics|mesh-ancestor
92074953|NCT00200902|Sensory System Agents|sensory system agents|mesh-ancestor
92074954|NCT00200902|Dopamine Agents|dopamine agents|mesh-ancestor
92074955|NCT00201448|Vaccines|vaccines|mesh-list
92074956|NCT00201448|Immunologic Factors|immunologic factors|mesh-ancestor
92074957|NCT00201448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074958|NCT00201760|Gemcitabine|gemcitabine|mesh-list
92074959|NCT00201760|Trastuzumab|trastuzumab|mesh-list
92074960|NCT00201760|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074961|NCT00201760|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074962|NCT00201760|Antimetabolites|antimetabolites|mesh-ancestor
92074963|NCT00201760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074964|NCT00201760|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074965|NCT00201838|Etanercept|etanercept|mesh-list
92074966|NCT00201838|Gemcitabine|gemcitabine|mesh-list
92074967|NCT00201838|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074968|NCT00201838|Antimetabolites|antimetabolites|mesh-ancestor
92074969|NCT00201838|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074970|NCT00201838|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074971|NCT00201838|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92074972|NCT00201838|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074973|NCT00201838|Analgesics|analgesics|mesh-ancestor
92074974|NCT00201838|Sensory System Agents|sensory system agents|mesh-ancestor
92074975|NCT00201838|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074978|NCT00201838|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074979|NCT00201838|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92074980|NCT00201838|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074981|NCT00201838|Immunologic Factors|immunologic factors|mesh-ancestor
92074982|NCT00040846|Cyclosporine|cyclosporine|mesh-list
92074983|NCT00040846|Mycophenolic Acid|mycophenolic acid|mesh-list
92074984|NCT00040846|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92074985|NCT00040846|Alemtuzumab|alemtuzumab|mesh-list
92074986|NCT00040846|Fludarabine|fludarabine|mesh-list
92074987|NCT00040846|Fludarabine phosphate|fludarabine phosphate|mesh-list
92074989|NCT00040846|Immunoglobulins|immunoglobulins|mesh-list
92074990|NCT00040846|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92074991|NCT00040846|Cyclosporins|cyclosporins|mesh-list
92074992|NCT00040846|Immunologic Factors|immunologic factors|mesh-ancestor
92074993|NCT00040846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074994|NCT00040846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074995|NCT00040846|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92074996|NCT00040846|Antimetabolites|antimetabolites|mesh-ancestor
92074997|NCT00040846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074998|NCT00040846|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074999|NCT00040846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075000|NCT00040846|Antifungal Agents|antifungal agents|mesh-ancestor
92075001|NCT00040846|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075002|NCT00040846|Dermatologic Agents|dermatologic agents|mesh-ancestor
92075003|NCT00040846|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075004|NCT00040846|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92075005|NCT00040846|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92075006|NCT00040846|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92075007|NCT00040846|Antitubercular Agents|antitubercular agents|mesh-ancestor
92075008|NCT00040846|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075009|NCT00041938|Aspirin|aspirin|mesh-list
92075010|NCT00041938|Warfarin|warfarin|mesh-list
92075011|NCT00041938|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92075012|NCT00041938|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92075013|NCT00041938|Analgesics|analgesics|mesh-ancestor
92075014|NCT00041938|Sensory System Agents|sensory system agents|mesh-ancestor
92075015|NCT00041938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075016|NCT00041938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075017|NCT00041938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92075018|NCT00041938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075019|NCT00041938|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92075020|NCT00041938|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92075021|NCT00041938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075022|NCT00041938|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92016060|NCT05699993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016061|NCT05699993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016062|NCT05699993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92016063|NCT05699993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92075023|NCT00041938|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92075024|NCT00041938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075025|NCT00041938|Antipyretics|antipyretics|mesh-ancestor
92075026|NCT00041938|Anticoagulants|anticoagulants|mesh-ancestor
92075027|NCT00202930|Rituximab|rituximab|mesh-list
92075028|NCT00202930|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075029|NCT00202930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075030|NCT00202930|Immunologic Factors|immunologic factors|mesh-ancestor
92075181|NCT00118378|Modafinil|modafinil|mesh-list
92075031|NCT00202930|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075032|NCT00202930|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075033|NCT00044044|Haloperidol|haloperidol|mesh-list
92075034|NCT00044044|Haloperidol decanoate|haloperidol decanoate|mesh-list
92075035|NCT00044044|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92075036|NCT00044044|Antiemetics|antiemetics|mesh-ancestor
92075037|NCT00044044|Autonomic Agents|autonomic agents|mesh-ancestor
92075038|NCT00044044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075039|NCT00044044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075040|NCT00044044|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92075041|NCT00044044|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92075042|NCT00044044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92075043|NCT00044044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075044|NCT00044044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92075045|NCT00044044|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92075046|NCT00044044|Dopamine Agents|dopamine agents|mesh-ancestor
92075047|NCT00044044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075048|NCT00044044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075049|NCT00044044|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92075052|NCT00044044|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92075053|NCT00044044|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075054|NCT00044044|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92075055|NCT00044044|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92075056|NCT00044044|Serotonin Agents|serotonin agents|mesh-ancestor
92075057|NCT00044044|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92075058|NCT00112918|Leucovorin|leucovorin|mesh-list
92075059|NCT00112918|Bevacizumab|bevacizumab|mesh-list
92075060|NCT00112918|Fluorouracil|fluorouracil|mesh-list
92075061|NCT00112918|Capecitabine|capecitabine|mesh-list
92075062|NCT00112918|Oxaliplatin|oxaliplatin|mesh-list
92075063|NCT00112918|Calcium|calcium|mesh-list
92075064|NCT00112918|Levoleucovorin|levoleucovorin|mesh-list
92075065|NCT00112918|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075066|NCT00112918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075067|NCT00112918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92075068|NCT00112918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92075069|NCT00112918|Growth Substances|growth substances|mesh-ancestor
92075070|NCT00112918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075071|NCT00112918|Growth Inhibitors|growth inhibitors|mesh-ancestor
92075072|NCT00112918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92075073|NCT00112918|Antimetabolites|antimetabolites|mesh-ancestor
92075074|NCT00112918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075075|NCT00112918|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075076|NCT00112918|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92075077|NCT00112918|Immunologic Factors|immunologic factors|mesh-ancestor
92075078|NCT00112918|Antidotes|antidotes|mesh-ancestor
92075079|NCT00112918|Protective Agents|protective agents|mesh-ancestor
92075080|NCT00112918|Vitamin B Complex|vitamin b complex|mesh-ancestor
92075081|NCT00112918|Vitamins|vitamins|mesh-ancestor
92075082|NCT00112918|Micronutrients|micronutrients|mesh-ancestor
92075083|NCT00046228|Reteplase|reteplase|mesh-list
92075084|NCT00046228|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92075085|NCT00046228|Abciximab|abciximab|mesh-list
92075086|NCT00046228|Anticoagulants|anticoagulants|mesh-ancestor
92075087|NCT00046228|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92075088|NCT00046228|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92075089|NCT00046228|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92075090|NCT00046228|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016064|NCT05699993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016065|NCT05699993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075091|NCT00205504|Moxifloxacin|moxifloxacin|mesh-list
92075092|NCT00205504|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92075093|NCT00205504|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92075094|NCT00205504|Contraceptive Agents|contraceptive agents|mesh-ancestor
92075095|NCT00205504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92075096|NCT00205504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075097|NCT00205504|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92075098|NCT00205504|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92075099|NCT00205504|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92075100|NCT00205504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075101|NCT00205504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075102|NCT00205504|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92075103|NCT00205504|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92075104|NCT00205504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075105|NCT00205504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075106|NCT00205504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075107|NCT00113230|Bevacizumab|bevacizumab|mesh-list
92075108|NCT00113230|Capecitabine|capecitabine|mesh-list
92075109|NCT00113230|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075110|NCT00113230|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075111|NCT00113230|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92075112|NCT00113230|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92075113|NCT00113230|Growth Substances|growth substances|mesh-ancestor
92075114|NCT00113230|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075115|NCT00113230|Growth Inhibitors|growth inhibitors|mesh-ancestor
92075116|NCT00113230|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075117|NCT00113230|Antimetabolites|antimetabolites|mesh-ancestor
92075118|NCT00113230|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075120|NCT00049036|Cyclophosphamide|cyclophosphamide|mesh-list
92075121|NCT00049036|Rituximab|rituximab|mesh-list
92075122|NCT00049036|Doxorubicin|doxorubicin|mesh-list
92075123|NCT00049036|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92075126|NCT00049036|Etoposide phosphate|etoposide phosphate|mesh-list
92075127|NCT00049036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92075128|NCT00049036|Immunologic Factors|immunologic factors|mesh-ancestor
92075129|NCT00049036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075130|NCT00049036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075131|NCT00049036|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075132|NCT00049036|Alkylating Agents|alkylating agents|mesh-ancestor
92075133|NCT00049036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075134|NCT00049036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075135|NCT00049036|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92075136|NCT00049036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075137|NCT00049036|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92075138|NCT00049036|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92075139|NCT00049036|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92075140|NCT00049036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075141|NCT00049036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92075142|NCT00049036|Glucocorticoids|glucocorticoids|mesh-ancestor
92075143|NCT00049036|Hormones|hormones|mesh-ancestor
92075144|NCT00049036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075145|NCT00049036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92075146|NCT00049036|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92075147|NCT00049036|Tubulin Modulators|tubulin modulators|mesh-ancestor
92075148|NCT00049036|Antimitotic Agents|antimitotic agents|mesh-ancestor
92075149|NCT00049036|Mitosis Modulators|mitosis modulators|mesh-ancestor
92075150|NCT00049504|Mycophenolic Acid|mycophenolic acid|mesh-list
92075151|NCT00049504|Cyclophosphamide|cyclophosphamide|mesh-list
92075152|NCT00049504|Fludarabine|fludarabine|mesh-list
92075153|NCT00049504|Fludarabine phosphate|fludarabine phosphate|mesh-list
92075154|NCT00049504|Tacrolimus|tacrolimus|mesh-list
92075155|NCT00049504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92075156|NCT00049504|Immunologic Factors|immunologic factors|mesh-ancestor
92075157|NCT00049504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075158|NCT00049504|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075159|NCT00049504|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075160|NCT00049504|Alkylating Agents|alkylating agents|mesh-ancestor
92016066|NCT05699993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92016067|NCT05699993|Antitussive Agents|antitussive agents|mesh-ancestor
92016068|NCT05699993|Respiratory System Agents|respiratory system agents|mesh-ancestor
92075161|NCT00049504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075162|NCT00049504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075163|NCT00049504|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92075164|NCT00049504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075165|NCT00049504|Antimetabolites|antimetabolites|mesh-ancestor
92075166|NCT00049504|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92075167|NCT00049504|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075168|NCT00049504|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92075169|NCT00049504|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92075170|NCT00049504|Antitubercular Agents|antitubercular agents|mesh-ancestor
92075171|NCT00049504|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075172|NCT00049504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075173|NCT00050986|Temozolomide|temozolomide|mesh-list
92075174|NCT00050986|Tipifarnib|tipifarnib|mesh-list
92075175|NCT00050986|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075176|NCT00050986|Alkylating Agents|alkylating agents|mesh-ancestor
92075177|NCT00050986|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075178|NCT00050986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075179|NCT00118144|Bortezomib|bortezomib|mesh-list
92075180|NCT00118144|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075182|NCT00118378|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92075183|NCT00118378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075184|NCT00118378|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92075185|NCT00118378|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92075186|NCT00118378|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92075187|NCT00118378|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075188|NCT00217438|Melphalan|melphalan|mesh-list
92075189|NCT00217438|Amifostine|amifostine|mesh-list
92075190|NCT00217438|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075191|NCT00217438|Alkylating Agents|alkylating agents|mesh-ancestor
92075192|NCT00217438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075193|NCT00217438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075194|NCT00217438|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92075195|NCT00217438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92075226|NCT05820347|Neuromuscular Depolarizing Agents|neuromuscular depolarizing agents|mesh-ancestor
92075227|NCT05820256|Caseins|caseins|mesh-list
92075228|NCT05820256|Chelating Agents|chelating agents|mesh-ancestor
92075229|NCT05820256|Sequestering Agents|sequestering agents|mesh-ancestor
92075230|NCT05820256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075231|NCT05820048|Lansoprazole|lansoprazole|mesh-list
92075232|NCT05820048|Dexlansoprazole|dexlansoprazole|mesh-list
92075233|NCT05820048|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92075234|NCT05820048|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92075235|NCT05820048|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92075236|NCT05820048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075237|NCT05820048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075239|NCT05819983|Permethrin|permethrin|mesh-list
92075240|NCT05819983|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92075241|NCT05819983|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075242|NCT05819983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075243|NCT05819983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075244|NCT05819970|Allyl sulfide|allyl sulfide|mesh-list
92075245|NCT05819970|Antioxidants|antioxidants|mesh-ancestor
92075246|NCT05819970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075247|NCT05819970|Protective Agents|protective agents|mesh-ancestor
92075248|NCT05819970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075249|NCT05819970|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92075250|NCT05819970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075251|NCT05819970|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92075252|NCT05819970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075253|NCT05819632|Curcumin|curcumin|mesh-list
92075254|NCT05819632|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92075255|NCT05819632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92075257|NCT05819632|Sensory System Agents|sensory system agents|mesh-ancestor
92016069|NCT05699993|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92075258|NCT05819632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075259|NCT05819632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075260|NCT05819632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92075261|NCT05819632|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075262|NCT05819632|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075263|NCT05819632|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075264|NCT05819632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075265|NCT05819541|Albuterol|albuterol|mesh-list
92075266|NCT05819541|Montelukast|montelukast|mesh-list
92075267|NCT05819541|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92075268|NCT05819541|Respiratory System Agents|respiratory system agents|mesh-ancestor
92075269|NCT05819541|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92075270|NCT05819541|Hormone Antagonists|hormone antagonists|mesh-ancestor
92075271|NCT05819541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075272|NCT05819541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075273|NCT05819541|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92075274|NCT05819541|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92075275|NCT05819541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075276|NCT05819541|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92075277|NCT05819541|Autonomic Agents|autonomic agents|mesh-ancestor
92075278|NCT05819541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075279|NCT05819541|Tocolytic Agents|tocolytic agents|mesh-ancestor
92075280|NCT05819541|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92075281|NCT05819541|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92075282|NCT05819541|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92075283|NCT05819541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92075284|NCT05819541|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075285|NCT05819541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075286|NCT05819229|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92075287|NCT05819229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075288|NCT05819060|Bevacizumab|bevacizumab|mesh-list
92075289|NCT05819060|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075290|NCT05819060|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075291|NCT05819060|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92075292|NCT05819060|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92075293|NCT05819060|Growth Substances|growth substances|mesh-ancestor
92075294|NCT05819060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075295|NCT05819060|Growth Inhibitors|growth inhibitors|mesh-ancestor
92075296|NCT05818995|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-list
92075297|NCT05818995|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92075298|NCT05818995|Calcium Channel Blockers|calcium channel blockers|mesh-list
92075299|NCT05818995|Angiotensin II|angiotensin ii|mesh-list
92075300|NCT05818995|Giapreza|giapreza|mesh-list
92075301|NCT05818995|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92075302|NCT05818995|Angiotensinogen|angiotensinogen|mesh-list
92075303|NCT05818995|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92075304|NCT05818995|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-list
92075305|NCT05818995|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92075306|NCT05818995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075307|NCT05818995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075308|NCT05818995|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92075309|NCT05818995|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92075311|NCT05818995|Protease Inhibitors|protease inhibitors|mesh-ancestor
92075312|NCT05818995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92075314|NCT05818982|Afatinib|afatinib|mesh-list
92075315|NCT05818982|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92075316|NCT05818982|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92075317|NCT05818982|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075318|NCT05818982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075319|NCT05818982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075320|NCT05818982|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92075321|NCT05818670|Tadalafil|tadalafil|mesh-list
92075322|NCT05818670|Tamsulosin|tamsulosin|mesh-list
92075323|NCT05818670|Vasodilator Agents|vasodilator agents|mesh-ancestor
92075324|NCT05818670|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92075325|NCT05818670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92075326|NCT05818670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075327|NCT05818670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016070|NCT05699993|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92016071|NCT05699993|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016073|NCT05552651|Carboplatin|carboplatin|mesh-list
92016074|NCT05552651|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92075328|NCT05818670|Urological Agents|urological agents|mesh-ancestor
92075329|NCT05818670|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92075330|NCT05818670|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92075331|NCT05818670|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92075332|NCT05818670|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075333|NCT05818670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075334|NCT05818670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075335|NCT05816512|Chlorhexidine|chlorhexidine|mesh-list
92075336|NCT05816512|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92075337|NCT05816512|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92075338|NCT05816512|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075339|NCT05816512|Disinfectants|disinfectants|mesh-ancestor
92075340|NCT05816512|Dermatologic Agents|dermatologic agents|mesh-ancestor
92075341|NCT05816499|Docetaxel|docetaxel|mesh-list
92075342|NCT05816499|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075343|NCT05816499|Tubulin Modulators|tubulin modulators|mesh-ancestor
92075344|NCT05816499|Antimitotic Agents|antimitotic agents|mesh-ancestor
92075345|NCT05816499|Mitosis Modulators|mitosis modulators|mesh-ancestor
92075346|NCT05816499|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075347|NCT05816343|Orlistat|orlistat|mesh-list
92075348|NCT05816343|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075349|NCT05816343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075350|NCT05816343|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92075351|NCT05816343|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92075352|NCT05816226|Hydrocortisone|hydrocortisone|mesh-list
92075353|NCT05816226|Diclofenac|diclofenac|mesh-list
92075354|NCT05816226|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92075355|NCT05816226|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92075356|NCT05816226|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92075357|NCT05816226|Analgesics|analgesics|mesh-ancestor
92075358|NCT05816226|Sensory System Agents|sensory system agents|mesh-ancestor
92075359|NCT05816226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075360|NCT05816226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075361|NCT05816226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075362|NCT05816226|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92075363|NCT05816226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075364|NCT05816226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075365|NCT05816070|Ofloxacin|ofloxacin|mesh-list
92075366|NCT05816070|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92075367|NCT05816070|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92075368|NCT05816070|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92075369|NCT05816070|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075370|NCT05816070|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075371|NCT05816070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92075372|NCT05816070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92075373|NCT05816070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075374|NCT05816070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075375|NCT05816070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075376|NCT05816070|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92075377|NCT05816070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92075378|NCT05815927|Pembrolizumab|pembrolizumab|mesh-list
92075379|NCT05815927|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075380|NCT05815927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075381|NCT05815927|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075382|NCT05815927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075405|NCT05815719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075407|NCT05815654|Sensory System Agents|sensory system agents|mesh-ancestor
92075408|NCT05815654|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075409|NCT05815654|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075410|NCT05815303|Capecitabine|capecitabine|mesh-list
92075411|NCT05815303|Oxaliplatin|oxaliplatin|mesh-list
92075412|NCT05815303|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075413|NCT05815303|Antimetabolites|antimetabolites|mesh-ancestor
92075414|NCT05815303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016075|NCT05552651|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016076|NCT05552651|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016077|NCT05552651|Tubulin Modulators|tubulin modulators|mesh-ancestor
92075415|NCT05815303|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075416|NCT05815264|Vaccines|vaccines|mesh-list
92075417|NCT05815264|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92075418|NCT05815264|Immunologic Factors|immunologic factors|mesh-ancestor
92075419|NCT05815264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075420|NCT05815199|Nicotine|nicotine|mesh-list
92075421|NCT05815199|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92075422|NCT05815199|Autonomic Agents|autonomic agents|mesh-ancestor
92075423|NCT05815199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075424|NCT05815199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075425|NCT05815199|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92075426|NCT05815199|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92075427|NCT05815199|Cholinergic Agents|cholinergic agents|mesh-ancestor
92075428|NCT05815199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075429|NCT05815199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075430|NCT05815186|Sotorasib|sotorasib|mesh-list
92075431|NCT05815186|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075432|NCT05815186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075435|NCT05814939|Tofacitinib|tofacitinib|mesh-list
92075436|NCT05814939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075437|NCT05814939|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92075438|NCT05814939|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92075439|NCT05814939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075440|NCT05814874|Selenium|selenium|mesh-list
92075441|NCT05814874|Antioxidants|antioxidants|mesh-ancestor
92075442|NCT05814874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075443|NCT05814874|Protective Agents|protective agents|mesh-ancestor
92075444|NCT05814874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075445|NCT05814874|Trace Elements|trace elements|mesh-ancestor
92075446|NCT05814874|Micronutrients|micronutrients|mesh-ancestor
92075447|NCT05814770|Spironolactone|spironolactone|mesh-list
92075448|NCT05814770|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92075449|NCT05814770|Hormone Antagonists|hormone antagonists|mesh-ancestor
92075450|NCT05814770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075451|NCT05814770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075452|NCT05814770|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92075453|NCT05814770|Diuretics|diuretics|mesh-ancestor
92075454|NCT05814770|Natriuretic Agents|natriuretic agents|mesh-ancestor
92075455|NCT05814731|Cytarabine|cytarabine|mesh-list
92075456|NCT05814731|Cyclophosphamide|cyclophosphamide|mesh-list
92075457|NCT05814731|Busulfan|busulfan|mesh-list
92075458|NCT05814731|Semustine|semustine|mesh-list
92075459|NCT05814731|Mitoxantrone|mitoxantrone|mesh-list
92075460|NCT05814731|Thymoglobulin|thymoglobulin|mesh-list
92075461|NCT05814731|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92075462|NCT05814731|Immunoglobulins|immunoglobulins|mesh-list
92075463|NCT05814731|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92075464|NCT05814731|Antibodies|antibodies|mesh-list
92075465|NCT05814731|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92075466|NCT05814731|Immunologic Factors|immunologic factors|mesh-ancestor
92075467|NCT05814731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075468|NCT05814731|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075469|NCT05814731|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075470|NCT05814731|Alkylating Agents|alkylating agents|mesh-ancestor
92075471|NCT05814731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075472|NCT05814731|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075473|NCT05814731|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92075474|NCT05814731|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075475|NCT05814731|Antimetabolites|antimetabolites|mesh-ancestor
92075476|NCT05814731|Antiviral Agents|antiviral agents|mesh-ancestor
92075477|NCT05814731|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075478|NCT05814731|Analgesics|analgesics|mesh-ancestor
92075479|NCT05814731|Sensory System Agents|sensory system agents|mesh-ancestor
92075480|NCT05814731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075481|NCT05814731|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92075482|NCT05814731|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92075483|NCT05814731|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075484|NCT05814718|Cytarabine|cytarabine|mesh-list
92075485|NCT05814718|Etoposide|etoposide|mesh-list
92016078|NCT05552651|Antimitotic Agents|antimitotic agents|mesh-ancestor
92016079|NCT05552651|Mitosis Modulators|mitosis modulators|mesh-ancestor
92016080|NCT05552651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016081|NCT04981327|Apixaban|apixaban|mesh-list
92016082|NCT04981327|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92075486|NCT05814718|Mitoxantrone|mitoxantrone|mesh-list
92075487|NCT05814718|Etoposide phosphate|etoposide phosphate|mesh-list
92075488|NCT05814718|Melphalan|melphalan|mesh-list
92075489|NCT05814718|Carmustine|carmustine|mesh-list
92075490|NCT05814718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92075491|NCT05814718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075492|NCT05814718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92075493|NCT05814718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92075494|NCT05814718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075495|NCT05814718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075496|NCT05814718|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075497|NCT05814718|Antimetabolites|antimetabolites|mesh-ancestor
92075498|NCT05814718|Antiviral Agents|antiviral agents|mesh-ancestor
92075499|NCT05814718|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075500|NCT05814718|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92075501|NCT05814718|Immunologic Factors|immunologic factors|mesh-ancestor
92075502|NCT05814718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075503|NCT05814718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075504|NCT05814718|Alkylating Agents|alkylating agents|mesh-ancestor
92075505|NCT05814718|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92075506|NCT05814718|Analgesics|analgesics|mesh-ancestor
92075510|NCT05814666|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075511|NCT05814666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075512|NCT05814666|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075513|NCT05814666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075514|NCT05814601|Norepinephrine|norepinephrine|mesh-list
92075515|NCT05814601|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92075516|NCT05814601|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92075517|NCT05814601|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075518|NCT05814601|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075519|NCT05814601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075520|NCT05814601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075521|NCT05814601|Sympathomimetics|sympathomimetics|mesh-ancestor
92075522|NCT05814601|Autonomic Agents|autonomic agents|mesh-ancestor
92075523|NCT05814601|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075524|NCT05814601|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92075525|NCT05797662|Propranolol|propranolol|mesh-list
92075526|NCT05797662|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92075527|NCT05797662|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92075528|NCT05797662|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075529|NCT05797662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075530|NCT05797662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075531|NCT05797662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075532|NCT05797662|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92075533|NCT05797662|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92075534|NCT05797662|Vasodilator Agents|vasodilator agents|mesh-ancestor
92075535|NCT05795257|Dimercaprol|dimercaprol|mesh-list
92075536|NCT05795257|Chelating Agents|chelating agents|mesh-ancestor
92075537|NCT05795257|Sequestering Agents|sequestering agents|mesh-ancestor
92075538|NCT05795257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075539|NCT05786378|Anesthetics|anesthetics|mesh-list
92075540|NCT05786378|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075541|NCT05786378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075542|NCT05779241|Risperidone|risperidone|mesh-list
92075543|NCT05779241|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92075544|NCT05779241|Serotonin Agents|serotonin agents|mesh-ancestor
92075545|NCT05779241|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075546|NCT05779241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075547|NCT05779241|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075548|NCT05779241|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92075549|NCT05779241|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92075550|NCT05779241|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075551|NCT05779241|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92016083|NCT04981327|Antithrombins|antithrombins|mesh-ancestor
92016084|NCT04981327|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92016085|NCT04981327|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016086|NCT04981327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075552|NCT05779241|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92075553|NCT05779241|Dopamine Agents|dopamine agents|mesh-ancestor
92075555|NCT05766358|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92075556|NCT05766358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075557|NCT05766358|Incretins|incretins|mesh-ancestor
92075558|NCT05766358|Hormones|hormones|mesh-ancestor
92075559|NCT05766358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075560|NCT05757557|Nitric Oxide|nitric oxide|mesh-list
92075561|NCT05757557|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92075562|NCT05757557|Autonomic Agents|autonomic agents|mesh-ancestor
92075563|NCT05757557|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075564|NCT05757557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075565|NCT05757557|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92075566|NCT05757557|Respiratory System Agents|respiratory system agents|mesh-ancestor
92075567|NCT05757557|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92075568|NCT05757557|Antioxidants|antioxidants|mesh-ancestor
92075569|NCT05757557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075570|NCT05757557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075571|NCT05757557|Endothelium-Dependent Relaxing Factors|endothelium-dependent relaxing factors|mesh-ancestor
92075572|NCT05757557|Vasodilator Agents|vasodilator agents|mesh-ancestor
92075573|NCT05757557|Gasotransmitters|gasotransmitters|mesh-ancestor
92075574|NCT05757557|Protective Agents|protective agents|mesh-ancestor
92075575|NCT05751317|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92075576|NCT05751317|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075586|NCT05688904|Imipramine|imipramine|mesh-list
92075587|NCT05688904|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92075588|NCT05688904|Antidepressive Agents|antidepressive agents|mesh-ancestor
92075589|NCT05688904|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92075590|NCT05688904|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92075591|NCT05688904|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92075592|NCT05688904|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92075593|NCT05688904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075594|NCT05688904|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075595|NCT05688904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075596|NCT05688904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075597|NCT05687357|Paclitaxel|paclitaxel|mesh-list
92075598|NCT05687357|Oxaliplatin|oxaliplatin|mesh-list
92075599|NCT05687357|Tislelizumab|tislelizumab|mesh-list
92075600|NCT05687357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92075601|NCT05687357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075602|NCT05687357|Tubulin Modulators|tubulin modulators|mesh-ancestor
92075603|NCT05687357|Antimitotic Agents|antimitotic agents|mesh-ancestor
92075604|NCT05687357|Mitosis Modulators|mitosis modulators|mesh-ancestor
92075605|NCT05687357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075606|NCT05687357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075607|NCT05679492|Meplazumab|meplazumab|mesh-list
92075608|NCT05679492|Antiviral Agents|antiviral agents|mesh-ancestor
92075609|NCT05679492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075610|NCT05675943|Antibodies|antibodies|mesh-list
92075611|NCT05675943|Immunologic Factors|immunologic factors|mesh-ancestor
92075612|NCT05675943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075613|NCT05632133|Lacosamide|lacosamide|mesh-list
92075614|NCT05632133|Anticonvulsants|anticonvulsants|mesh-ancestor
92075615|NCT05632133|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92075616|NCT05632133|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92075617|NCT05632133|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92075618|NCT05632133|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075619|NCT05626803|Vaccines|vaccines|mesh-list
92075620|NCT05626803|Immunologic Factors|immunologic factors|mesh-ancestor
92075621|NCT05626803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075623|NCT05619289|Ergocalciferols|ergocalciferols|mesh-list
92075624|NCT05619289|Vitamins|vitamins|mesh-ancestor
92075625|NCT05619289|Micronutrients|micronutrients|mesh-ancestor
92075626|NCT05619289|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075627|NCT05619289|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92075628|NCT05619289|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92016087|NCT04981327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016088|NCT04981327|Anticoagulants|anticoagulants|mesh-ancestor
92075629|NCT05618002|Clonidine|clonidine|mesh-list
92075630|NCT05618002|Lemborexant|lemborexant|mesh-list
92075631|NCT05618002|Zopiclone|zopiclone|mesh-list
92075632|NCT05618002|Analgesics|analgesics|mesh-ancestor
92075633|NCT05618002|Sensory System Agents|sensory system agents|mesh-ancestor
92075634|NCT05618002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075635|NCT05618002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075636|NCT05618002|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92075637|NCT05618002|Sympatholytics|sympatholytics|mesh-ancestor
92075638|NCT05618002|Autonomic Agents|autonomic agents|mesh-ancestor
92075639|NCT05618002|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92075640|NCT05618002|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92075641|NCT05618002|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92075642|NCT05618002|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075643|NCT05618002|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075644|NCT05618002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075645|NCT05618002|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92075646|NCT05618002|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92075647|NCT05618002|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92075648|NCT05618002|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075650|NCT05615844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075652|NCT05608005|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92075653|NCT05608005|Immunologic Factors|immunologic factors|mesh-ancestor
92075654|NCT05608005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075656|NCT05605470|Immunologic Factors|immunologic factors|mesh-ancestor
92075657|NCT05605470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075658|NCT05604222|Mirabegron|mirabegron|mesh-list
92075659|NCT05604222|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92075660|NCT05604222|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92075661|NCT05604222|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92075662|NCT05604222|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075663|NCT05604222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075664|NCT05604222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075665|NCT05604222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075666|NCT05604222|Urological Agents|urological agents|mesh-ancestor
92075667|NCT05603910|Pembrolizumab|pembrolizumab|mesh-list
92075668|NCT05603910|Lenvatinib|lenvatinib|mesh-list
92075669|NCT05603910|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075670|NCT05603910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075671|NCT05603910|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075672|NCT05603910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075673|NCT05603910|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92075674|NCT05603910|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075675|NCT05586776|Chlorhexidine|chlorhexidine|mesh-list
92075676|NCT05586776|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92075677|NCT05586776|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92075678|NCT05586776|Mupirocin|mupirocin|mesh-list
92075679|NCT05586776|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075680|NCT05586776|Disinfectants|disinfectants|mesh-ancestor
92075681|NCT05586776|Dermatologic Agents|dermatologic agents|mesh-ancestor
92075682|NCT05586776|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075683|NCT05586776|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92075684|NCT05586776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075685|NCT05586776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075687|NCT05565222|Tazobactam|tazobactam|mesh-list
92075688|NCT05565222|Piperacillin|piperacillin|mesh-list
92075689|NCT05565222|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92075690|NCT05565222|Temocillin|temocillin|mesh-list
92075691|NCT05565222|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075692|NCT05565222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075693|NCT05565222|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92075694|NCT05565222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075695|NCT05565222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075696|NCT05563766|Itraconazole|itraconazole|mesh-list
92075697|NCT05563766|Antifungal Agents|antifungal agents|mesh-ancestor
92075698|NCT05563766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075699|NCT05563766|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92075700|NCT05563766|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92075701|NCT05563766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016089|NCT05547659|Acetaminophen|acetaminophen|mesh-list
92016091|NCT05547659|Pregabalin|pregabalin|mesh-list
92016092|NCT05547659|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016093|NCT05547659|Analgesics|analgesics|mesh-ancestor
92016094|NCT05547659|Sensory System Agents|sensory system agents|mesh-ancestor
92075702|NCT05563766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075703|NCT05563766|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92075704|NCT05563766|Hormone Antagonists|hormone antagonists|mesh-ancestor
92075705|NCT05563766|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075706|NCT05563766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075707|NCT05563766|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92075708|NCT05562492|Insulin|insulin|mesh-list
92075709|NCT05562492|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92075710|NCT05562492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075711|NCT05497778|Paclitaxel|paclitaxel|mesh-list
92075712|NCT05497778|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92075713|NCT05497778|Gemcitabine|gemcitabine|mesh-list
92075714|NCT05497778|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92075715|NCT05497778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075716|NCT05497778|Tubulin Modulators|tubulin modulators|mesh-ancestor
92075717|NCT05497778|Antimitotic Agents|antimitotic agents|mesh-ancestor
92075718|NCT05497778|Mitosis Modulators|mitosis modulators|mesh-ancestor
92075719|NCT05497778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075720|NCT05497778|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075721|NCT05497778|Antimetabolites|antimetabolites|mesh-ancestor
92075722|NCT05493501|Paclitaxel|paclitaxel|mesh-list
92075726|NCT05493501|Pemetrexed|pemetrexed|mesh-list
92075727|NCT05493501|Osimertinib|osimertinib|mesh-list
92075728|NCT05493501|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92075729|NCT05493501|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075730|NCT05493501|Tubulin Modulators|tubulin modulators|mesh-ancestor
92075731|NCT05493501|Antimitotic Agents|antimitotic agents|mesh-ancestor
92075732|NCT05493501|Mitosis Modulators|mitosis modulators|mesh-ancestor
92075733|NCT05493501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075734|NCT05493501|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92075735|NCT05493501|Antimetabolites|antimetabolites|mesh-ancestor
92075736|NCT05493501|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075737|NCT05493501|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92075738|NCT05493501|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92075739|NCT05493501|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92075740|NCT05483491|Aldesleukin|aldesleukin|mesh-list
92075741|NCT05483491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075742|NCT05483491|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92075743|NCT05483491|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92075744|NCT05483491|Antiviral Agents|antiviral agents|mesh-ancestor
92075745|NCT05483491|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075746|NCT05482789|Exenatide|exenatide|mesh-list
92075747|NCT05482789|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92075748|NCT05482789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075749|NCT05482789|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92075750|NCT05482789|Incretins|incretins|mesh-ancestor
92075751|NCT05482789|Hormones|hormones|mesh-ancestor
92075752|NCT05482789|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075753|NCT05474950|Minocycline|minocycline|mesh-list
92075754|NCT05474950|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075755|NCT05474950|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075756|NCT05664386|Propofol|propofol|mesh-list
92075757|NCT05664386|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92075758|NCT05664386|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075759|NCT05664386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075760|NCT05664386|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92075761|NCT05664386|Anesthetics, General|anesthetics, general|mesh-ancestor
92075762|NCT05664386|Anesthetics|anesthetics|mesh-ancestor
92075763|NCT05461404|Emollients|emollients|mesh-list
92075764|NCT05461404|Dermatologic Agents|dermatologic agents|mesh-ancestor
92075765|NCT05449392|Bacitracin zinc, neomycin sulfate, polymyxin B, drug combination|bacitracin zinc, neomycin sulfate, polymyxin b, drug combination|mesh-list
92075766|NCT05449392|Petrolatum|petrolatum|mesh-list
92075767|NCT05449392|Emollients|emollients|mesh-ancestor
92075768|NCT05449392|Dermatologic Agents|dermatologic agents|mesh-ancestor
92075769|NCT05449392|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92075770|NCT05449392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075771|NCT05449392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075772|NCT05445076|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92075773|NCT05445076|Antibodies|antibodies|mesh-list
92075774|NCT05445076|Immunoglobulins|immunoglobulins|mesh-list
92075775|NCT05445076|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92075776|NCT05445076|Immunologic Factors|immunologic factors|mesh-ancestor
92075777|NCT05445076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075778|NCT05445076|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075779|NCT05405439|Prednisone|prednisone|mesh-list
92075780|NCT05405439|Abiraterone Acetate|abiraterone acetate|mesh-list
92075781|NCT05405439|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92075782|NCT05405439|Glucocorticoids|glucocorticoids|mesh-ancestor
92075783|NCT05405439|Hormones|hormones|mesh-ancestor
92075784|NCT05405439|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075785|NCT05405439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075786|NCT05405439|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92075787|NCT05405439|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075788|NCT05405439|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92075789|NCT05405439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075790|NCT05405439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075791|NCT05405439|Hormone Antagonists|hormone antagonists|mesh-ancestor
92075792|NCT05405439|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92075793|NCT05389722|Itraconazole|itraconazole|mesh-list
92075794|NCT05389722|Rifampin|rifampin|mesh-list
92075795|NCT05389722|Digoxin|digoxin|mesh-list
92075796|NCT05389722|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92075797|NCT05389722|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92075817|NCT05389722|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92075818|NCT05389722|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92075819|NCT05389722|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92075820|NCT05389722|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92075821|NCT05389722|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92075822|NCT05389722|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92075823|NCT05389722|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92075824|NCT05389722|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92075825|NCT05389722|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92075826|NCT05389722|Protective Agents|protective agents|mesh-ancestor
92075828|NCT05383170|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075829|NCT05383170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075830|NCT05383170|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075831|NCT05383170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075832|NCT05378464|Trastuzumab|trastuzumab|mesh-list
92075833|NCT05378464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075834|NCT05378464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075835|NCT05373680|Metformin|metformin|mesh-list
92075836|NCT05373680|Empagliflozin|empagliflozin|mesh-list
92075837|NCT05373680|Biguanides|biguanides|mesh-list
92075838|NCT05373680|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92075839|NCT05373680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075840|NCT05373680|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92075841|NCT05373680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075842|NCT05353348|Iron|iron|mesh-list
92075843|NCT05353348|Ascorbic Acid|ascorbic acid|mesh-list
92075844|NCT05353348|Epoetin Alfa|epoetin alfa|mesh-list
92075845|NCT05353348|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92075846|NCT05353348|Trace Elements|trace elements|mesh-ancestor
92075847|NCT05353348|Micronutrients|micronutrients|mesh-ancestor
92075850|NCT05353348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075851|NCT05353348|Protective Agents|protective agents|mesh-ancestor
92075852|NCT05353348|Vitamins|vitamins|mesh-ancestor
92075853|NCT05353348|Hematinics|hematinics|mesh-ancestor
92075854|NCT05304520|Natalizumab|natalizumab|mesh-list
92075855|NCT05304520|Immunologic Factors|immunologic factors|mesh-ancestor
92075856|NCT05304520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075857|NCT05300152|Antibodies|antibodies|mesh-list
92075858|NCT05300152|Immunoglobulins|immunoglobulins|mesh-list
92075859|NCT05300152|Immunologic Factors|immunologic factors|mesh-ancestor
92075860|NCT05300152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075861|NCT05295173|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92075862|NCT05295173|Plasminogen|plasminogen|mesh-list
92075863|NCT05295173|Reteplase|reteplase|mesh-list
92075864|NCT05295173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92075865|NCT05295173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92075866|NCT05295173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016095|NCT05547659|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016096|NCT05547659|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016098|NCT05547659|Anticonvulsants|anticonvulsants|mesh-ancestor
92075867|NCT05294263|Varenicline|varenicline|mesh-list
92075868|NCT05294263|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92075869|NCT05294263|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92075870|NCT05294263|Cholinergic Agents|cholinergic agents|mesh-ancestor
92075871|NCT05294263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075872|NCT05294263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075873|NCT05294263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075874|NCT05265728|Natalizumab|natalizumab|mesh-list
92075875|NCT05265728|Immunologic Factors|immunologic factors|mesh-ancestor
92075876|NCT05265728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075877|NCT05261594|Caffeine|caffeine|mesh-list
92075878|NCT05261594|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92075879|NCT05261594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075880|NCT05261594|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92075881|NCT05261594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075882|NCT05261594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075883|NCT05261594|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92075884|NCT05261594|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92075885|NCT05261594|Purinergic Agents|purinergic agents|mesh-ancestor
92075886|NCT05261594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075887|NCT05256290|Temozolomide|temozolomide|mesh-list
92075888|NCT05256290|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92075889|NCT05256290|Alkylating Agents|alkylating agents|mesh-ancestor
92075890|NCT05256290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075891|NCT05256290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075892|NCT05242965|Vaccines|vaccines|mesh-list
92075893|NCT05242965|Sargramostim|sargramostim|mesh-list
92075894|NCT05242965|Immunologic Factors|immunologic factors|mesh-ancestor
92075895|NCT05242965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075896|NCT05241288|Albuterol|albuterol|mesh-list
92075897|NCT05241288|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92075898|NCT05241288|Autonomic Agents|autonomic agents|mesh-ancestor
92075899|NCT05241288|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075900|NCT05241288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075901|NCT05241288|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92075902|NCT05241288|Respiratory System Agents|respiratory system agents|mesh-ancestor
92075903|NCT05241288|Tocolytic Agents|tocolytic agents|mesh-ancestor
92075904|NCT05241288|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92075905|NCT05241288|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92075906|NCT05241288|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92075907|NCT05241288|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92075908|NCT05241288|Adrenergic Agents|adrenergic agents|mesh-ancestor
92075909|NCT05241288|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075910|NCT05241288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075911|NCT05220748|Pembrolizumab|pembrolizumab|mesh-list
92075912|NCT05220748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075913|NCT05220748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075914|NCT05220748|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075915|NCT05220748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075916|NCT05180357|Benralizumab|benralizumab|mesh-list
92075917|NCT05180357|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92075918|NCT05180357|Respiratory System Agents|respiratory system agents|mesh-ancestor
92075919|NCT05144542|Nicotine|nicotine|mesh-list
92075927|NCT05144542|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075928|NCT05144542|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075930|NCT05141708|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92075931|NCT05141708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075932|NCT05141708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075933|NCT05141708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075934|NCT05137119|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92075935|NCT05137119|Vancomycin|vancomycin|mesh-list
92075936|NCT05137119|Clindamycin|clindamycin|mesh-list
92075937|NCT05137119|Cefazolin|cefazolin|mesh-list
92075938|NCT05137119|Daptomycin|daptomycin|mesh-list
92075939|NCT05137119|Penicillins|penicillins|mesh-list
92016099|NCT05547659|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92016100|NCT05547659|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92075941|NCT05137119|Lincomycin|lincomycin|mesh-list
92075942|NCT05137119|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075943|NCT05137119|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92075944|NCT05137119|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075945|NCT05137119|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075946|NCT05117489|Cortisone|cortisone|mesh-list
92075947|NCT05117489|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92075948|NCT05085808|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92075949|NCT05085808|Trazodone|trazodone|mesh-list
92075950|NCT05085808|Antidepressive Agents|antidepressive agents|mesh-ancestor
92075951|NCT05085808|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92075952|NCT05085808|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92075953|NCT05085808|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92075954|NCT05085808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92075955|NCT05085808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075956|NCT05085808|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92075957|NCT05085808|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92075958|NCT05085808|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92075959|NCT05085808|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92075960|NCT05085808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075961|NCT05085808|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075962|NCT05085808|Serotonin Agents|serotonin agents|mesh-ancestor
92075963|NCT05085808|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92075964|NCT05081609|Pembrolizumab|pembrolizumab|mesh-list
92075965|NCT05081609|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075966|NCT05081609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075967|NCT05081609|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92075968|NCT05081609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075969|NCT05078944|Donepezil|donepezil|mesh-list
92075970|NCT05078944|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92075971|NCT05078944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075972|NCT05078944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075973|NCT05078944|Cholinergic Agents|cholinergic agents|mesh-ancestor
92075974|NCT05078944|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075975|NCT05078944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075976|NCT05078944|Nootropic Agents|nootropic agents|mesh-ancestor
92075977|NCT05076019|Atorvastatin|atorvastatin|mesh-list
92075978|NCT05076019|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92075979|NCT05076019|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92075980|NCT05076019|Antimetabolites|antimetabolites|mesh-ancestor
92075981|NCT05076019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075982|NCT05076019|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92075983|NCT05076019|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92075984|NCT05076019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075985|NCT05071937|Talazoparib|talazoparib|mesh-list
92076004|NCT05033769|Paclitaxel|paclitaxel|mesh-list
92076005|NCT05033769|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92076006|NCT05033769|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076007|NCT05033769|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076008|NCT05033769|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076009|NCT05033769|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076010|NCT05033769|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076011|NCT05033769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076012|NCT05019846|Bicalutamide|bicalutamide|mesh-list
92076013|NCT05019846|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92076014|NCT05019846|Androgen Antagonists|androgen antagonists|mesh-ancestor
92076015|NCT05019846|Hormone Antagonists|hormone antagonists|mesh-ancestor
92076016|NCT05019846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076017|NCT05019846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076018|NCT05019846|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076019|NCT05019846|Luteolytic Agents|luteolytic agents|mesh-ancestor
92076020|NCT05019846|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92076021|NCT05019846|Contraceptive Agents|contraceptive agents|mesh-ancestor
92076022|NCT05019846|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92076023|NCT05019846|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92076024|NCT05019846|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92076025|NCT05004025|Nivolumab|nivolumab|mesh-list
92076026|NCT05004025|Ipilimumab|ipilimumab|mesh-list
92016101|NCT05547659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016102|NCT05547659|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92076027|NCT05004025|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076028|NCT05004025|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076029|NCT05004025|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076030|NCT05004025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076031|NCT04998240|Myeloma Proteins|myeloma proteins|mesh-list
92076032|NCT04998240|Paraproteins|paraproteins|mesh-list
92076033|NCT04998240|Immunologic Factors|immunologic factors|mesh-ancestor
92076034|NCT04998240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076035|NCT04996823|Ipilimumab|ipilimumab|mesh-list
92076036|NCT04996823|Axitinib|axitinib|mesh-list
92076037|NCT04996823|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076038|NCT04996823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076039|NCT04996823|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076042|NCT04996823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076043|NCT04984759|Primaquine|primaquine|mesh-list
92076044|NCT04984759|Tafenoquine|tafenoquine|mesh-list
92076045|NCT04984759|Antimalarials|antimalarials|mesh-ancestor
92076046|NCT04984759|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92076047|NCT04984759|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92076048|NCT04984759|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076049|NCT04975152|Cemiplimab|cemiplimab|mesh-list
92076050|NCT04975152|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076051|NCT04975152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076052|NCT04960618|Gemcitabine|gemcitabine|mesh-list
92076053|NCT04960618|Pembrolizumab|pembrolizumab|mesh-list
92076054|NCT04960618|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076055|NCT04960618|Antimetabolites|antimetabolites|mesh-ancestor
92076056|NCT04960618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076057|NCT04960618|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076058|NCT04960618|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076059|NCT04960618|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076060|NCT04955743|Pembrolizumab|pembrolizumab|mesh-list
92076061|NCT04955743|Lenvatinib|lenvatinib|mesh-list
92076062|NCT04955743|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076063|NCT04955743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076064|NCT04955743|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076065|NCT04955743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076066|NCT04955743|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076067|NCT04955743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076068|NCT04952324|Folic Acid|folic acid|mesh-list
92076069|NCT04952324|Vitamin B 12|vitamin b 12|mesh-list
92076070|NCT04952324|Hydroxocobalamin|hydroxocobalamin|mesh-list
92076071|NCT04952324|Vitamins|vitamins|mesh-ancestor
92076072|NCT04952324|Micronutrients|micronutrients|mesh-ancestor
92076073|NCT04952324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076074|NCT04952324|Hematinics|hematinics|mesh-ancestor
92076075|NCT04952324|Vitamin B Complex|vitamin b complex|mesh-ancestor
92076076|NCT04951726|Neostigmine|neostigmine|mesh-list
92076077|NCT04951726|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92076078|NCT04951726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076079|NCT04951726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076080|NCT04951726|Cholinergic Agents|cholinergic agents|mesh-ancestor
92076081|NCT04951726|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076082|NCT04951726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076083|NCT04951726|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92076084|NCT04951726|Autonomic Agents|autonomic agents|mesh-ancestor
92076085|NCT04951726|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076086|NCT04950764|Seladelpar|seladelpar|mesh-list
92076087|NCT04950764|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92076088|NCT04950764|Antimetabolites|antimetabolites|mesh-ancestor
92076089|NCT04950764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076090|NCT04950764|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92076091|NCT04948892|Anesthetics|anesthetics|mesh-list
92076092|NCT04948892|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076093|NCT04948892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076094|NCT04943341|Triamcinolone|triamcinolone|mesh-list
92076095|NCT04943341|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92076096|NCT04943341|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92076097|NCT04943341|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92076098|NCT04943341|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016103|NCT05547659|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92016104|NCT05547659|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92016105|NCT05547659|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076099|NCT04943341|Glucocorticoids|glucocorticoids|mesh-ancestor
92076100|NCT04943341|Hormones|hormones|mesh-ancestor
92076101|NCT04943341|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076102|NCT04943341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076103|NCT04943341|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076104|NCT04943341|Immunologic Factors|immunologic factors|mesh-ancestor
92076105|NCT04943341|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076106|NCT04943341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076107|NCT04941664|Levobupivacaine|levobupivacaine|mesh-list
92076108|NCT04941664|Anesthetics, Local|anesthetics, local|mesh-ancestor
92076109|NCT04941664|Anesthetics|anesthetics|mesh-ancestor
92076110|NCT04941664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076111|NCT04941664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076112|NCT04941664|Sensory System Agents|sensory system agents|mesh-ancestor
92076115|NCT04933266|Anesthetics, Local|anesthetics, local|mesh-ancestor
92076116|NCT04933266|Anesthetics|anesthetics|mesh-ancestor
92076117|NCT04933266|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076118|NCT04933266|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076119|NCT04933266|Sensory System Agents|sensory system agents|mesh-ancestor
92076120|NCT04933266|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076121|NCT04930562|Belumosudil|belumosudil|mesh-list
92076122|NCT04930562|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076123|NCT04930562|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076124|NCT04930562|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076125|NCT04926571|Dexamethasone|dexamethasone|mesh-list
92076126|NCT04926571|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076127|NCT04926571|Antiemetics|antiemetics|mesh-ancestor
92076128|NCT04926571|Autonomic Agents|autonomic agents|mesh-ancestor
92076129|NCT04926571|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076130|NCT04926571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076131|NCT04926571|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92076132|NCT04926571|Glucocorticoids|glucocorticoids|mesh-ancestor
92076134|NCT04926571|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076135|NCT04926571|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92076136|NCT04926571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076137|NCT04919382|Temozolomide|temozolomide|mesh-list
92076138|NCT04919382|Atezolizumab|atezolizumab|mesh-list
92076139|NCT04919382|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92076140|NCT04919382|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076141|NCT04919382|Alkylating Agents|alkylating agents|mesh-ancestor
92076142|NCT04919382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076143|NCT04919382|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076144|NCT04919382|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076145|NCT04919382|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076146|NCT04919382|Immunologic Factors|immunologic factors|mesh-ancestor
92076147|NCT04919382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076148|NCT04918823|Cyclosporine|cyclosporine|mesh-list
92076149|NCT04918823|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92076150|NCT04918823|Cyclosporins|cyclosporins|mesh-list
92076151|NCT04918823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076152|NCT04918823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076153|NCT04918823|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076154|NCT04918823|Immunologic Factors|immunologic factors|mesh-ancestor
92076155|NCT04918823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076156|NCT04918823|Antifungal Agents|antifungal agents|mesh-ancestor
92076157|NCT04918823|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076158|NCT04918823|Dermatologic Agents|dermatologic agents|mesh-ancestor
92076159|NCT04918823|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076160|NCT04918823|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92076161|NCT04918823|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92076162|NCT04912492|Ethanol|ethanol|mesh-list
92076163|NCT04912492|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92076164|NCT04912492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076165|NCT04912492|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076166|NCT04912492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076167|NCT04909073|Afatinib|afatinib|mesh-list
92076168|NCT04909073|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076169|NCT04909073|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92016106|NCT05547659|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92016107|NCT05547659|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92016108|NCT05547659|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016109|NCT05547659|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076170|NCT04909073|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076171|NCT04909073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076172|NCT04833855|Omalizumab|omalizumab|mesh-list
92076173|NCT04833855|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92076174|NCT04833855|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92076175|NCT04833855|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92076176|NCT04833855|Respiratory System Agents|respiratory system agents|mesh-ancestor
92076177|NCT04833855|Immunologic Factors|immunologic factors|mesh-ancestor
92076178|NCT04833855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076179|NCT04792385|Drospirenone|drospirenone|mesh-list
92076180|NCT04792385|Contraceptive Agents|contraceptive agents|mesh-list
92076181|NCT04792385|Contraceptives, Oral|contraceptives, oral|mesh-list
92076182|NCT04792385|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92076183|NCT04792385|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92076184|NCT04792385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076185|NCT04792385|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92076194|NCT04785651|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92076195|NCT04785651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076196|NCT04785651|Hemostatics|hemostatics|mesh-ancestor
92076197|NCT04785651|Coagulants|coagulants|mesh-ancestor
92076198|NCT04780204|Tenofovir|tenofovir|mesh-list
92076199|NCT04780204|Antiviral Agents|antiviral agents|mesh-ancestor
92076200|NCT04780204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076201|NCT04780204|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92076202|NCT04780204|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92076203|NCT04780204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076204|NCT04780204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076205|NCT04780204|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92076206|NCT04780204|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92076207|NCT04763564|Liraglutide|liraglutide|mesh-list
92076208|NCT04763564|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92076209|NCT04763564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076210|NCT04763564|Incretins|incretins|mesh-ancestor
92076211|NCT04763564|Hormones|hormones|mesh-ancestor
92076212|NCT04763564|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076213|NCT04748588|Sotrovimab|sotrovimab|mesh-list
92076214|NCT04748588|Bamlanivimab|bamlanivimab|mesh-list
92076215|NCT04748588|Antiviral Agents|antiviral agents|mesh-ancestor
92076216|NCT04748588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076217|NCT04741997|Nivolumab|nivolumab|mesh-list
92076218|NCT04741997|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076219|NCT04741997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076220|NCT04741997|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076221|NCT04741997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076222|NCT04735510|Cyclosporine|cyclosporine|mesh-list
92076223|NCT04735510|Cyclosporins|cyclosporins|mesh-list
92076224|NCT04735510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076225|NCT04735510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076226|NCT04735510|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076227|NCT04735510|Immunologic Factors|immunologic factors|mesh-ancestor
92076228|NCT04735510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076229|NCT04735510|Antifungal Agents|antifungal agents|mesh-ancestor
92076230|NCT04735510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076231|NCT04735510|Dermatologic Agents|dermatologic agents|mesh-ancestor
92076232|NCT04735510|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076233|NCT04735510|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92076235|NCT04696523|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92076236|NCT04696523|Anesthetics, General|anesthetics, general|mesh-ancestor
92076237|NCT04696523|Anesthetics|anesthetics|mesh-ancestor
92076238|NCT04696523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076239|NCT04696523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076240|NCT04669197|Hydroxychloroquine|hydroxychloroquine|mesh-list
92076241|NCT04669197|Paclitaxel|paclitaxel|mesh-list
92076242|NCT04669197|Gemcitabine|gemcitabine|mesh-list
92076243|NCT04669197|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92076244|NCT04669197|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016110|NCT05547659|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92016111|NCT05547659|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92016112|NCT05547659|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016113|NCT05541419|Budesonide|budesonide|mesh-list
92016114|NCT05541419|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076245|NCT04669197|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076246|NCT04669197|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076247|NCT04669197|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076248|NCT04669197|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076249|NCT04669197|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076250|NCT04669197|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076251|NCT04669197|Antimetabolites|antimetabolites|mesh-ancestor
92076272|NCT04655222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076273|NCT04652440|Tislelizumab|tislelizumab|mesh-list
92076274|NCT04652440|Antibodies|antibodies|mesh-list
92076275|NCT04652440|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92076276|NCT04652440|Immunologic Factors|immunologic factors|mesh-ancestor
92076277|NCT04652440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076278|NCT04652440|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076279|NCT04652440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076280|NCT04615013|Leucovorin|leucovorin|mesh-list
92076281|NCT04615013|Paclitaxel|paclitaxel|mesh-list
92076282|NCT04615013|Docetaxel|docetaxel|mesh-list
92076283|NCT04615013|Carboplatin|carboplatin|mesh-list
92076284|NCT04615013|Fluorouracil|fluorouracil|mesh-list
92076285|NCT04615013|Capecitabine|capecitabine|mesh-list
92076286|NCT04615013|Oxaliplatin|oxaliplatin|mesh-list
92076287|NCT04615013|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92076288|NCT04615013|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076289|NCT04615013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076290|NCT04615013|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076291|NCT04615013|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076292|NCT04615013|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076293|NCT04615013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076294|NCT04615013|Antimetabolites|antimetabolites|mesh-ancestor
92076295|NCT04615013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076296|NCT04615013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076297|NCT04615013|Immunologic Factors|immunologic factors|mesh-ancestor
92076298|NCT04615013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076299|NCT04615013|Antidotes|antidotes|mesh-ancestor
92076300|NCT04615013|Protective Agents|protective agents|mesh-ancestor
92076301|NCT04615013|Vitamin B Complex|vitamin b complex|mesh-ancestor
92076302|NCT04615013|Vitamins|vitamins|mesh-ancestor
92076303|NCT04615013|Micronutrients|micronutrients|mesh-ancestor
92076304|NCT04612725|Benralizumab|benralizumab|mesh-list
92076305|NCT04612725|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92076306|NCT04612725|Respiratory System Agents|respiratory system agents|mesh-ancestor
92076308|NCT04604067|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076309|NCT04592744|Vasopressins|vasopressins|mesh-list
92076310|NCT04592744|Epinephrine|epinephrine|mesh-list
92076311|NCT04592744|Norepinephrine|norepinephrine|mesh-list
92076312|NCT04592744|Angiotensin II|angiotensin ii|mesh-list
92076313|NCT04592744|Giapreza|giapreza|mesh-list
92076314|NCT04592744|Angiotensinogen|angiotensinogen|mesh-list
92076315|NCT04592744|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92076316|NCT04592744|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92076317|NCT04592744|Adrenergic Agents|adrenergic agents|mesh-ancestor
92076318|NCT04592744|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076319|NCT04592744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076320|NCT04592744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076321|NCT04592744|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92076322|NCT04592744|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92076323|NCT04592744|Autonomic Agents|autonomic agents|mesh-ancestor
92076324|NCT04592744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076325|NCT04592744|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92076326|NCT04592744|Respiratory System Agents|respiratory system agents|mesh-ancestor
92076327|NCT04592744|Mydriatics|mydriatics|mesh-ancestor
92076330|NCT04592744|Hemostatics|hemostatics|mesh-ancestor
92076331|NCT04592744|Coagulants|coagulants|mesh-ancestor
92076332|NCT04592744|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92076333|NCT04592744|Natriuretic Agents|natriuretic agents|mesh-ancestor
92016115|NCT05541419|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92076334|NCT04592744|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92076335|NCT04592744|Protease Inhibitors|protease inhibitors|mesh-ancestor
92076336|NCT04592744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076337|NCT04585711|Etanercept|etanercept|mesh-list
92076338|NCT04585711|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92076339|NCT04585711|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92076340|NCT04585711|Analgesics|analgesics|mesh-ancestor
92076341|NCT04585711|Sensory System Agents|sensory system agents|mesh-ancestor
92076342|NCT04585711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076343|NCT04585711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076344|NCT04585711|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076345|NCT04585711|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076346|NCT04585711|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92076347|NCT04585711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076348|NCT04585711|Immunologic Factors|immunologic factors|mesh-ancestor
92076349|NCT04581824|Pembrolizumab|pembrolizumab|mesh-list
92076350|NCT04581824|Dostarlimab|dostarlimab|mesh-list
92076351|NCT04581824|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076352|NCT04581824|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076494|NCT04217317|Alkylating Agents|alkylating agents|mesh-ancestor
92076353|NCT04581824|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076354|NCT04581824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076355|NCT04559334|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92076356|NCT04551495|Letrozole|letrozole|mesh-list
92076357|NCT04551495|Goserelin|goserelin|mesh-list
92076358|NCT04551495|Entrectinib|entrectinib|mesh-list
92076359|NCT04551495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076360|NCT04551495|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92076361|NCT04551495|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92076362|NCT04551495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076363|NCT04551495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076364|NCT04551495|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92076365|NCT04551495|Hormone Antagonists|hormone antagonists|mesh-ancestor
92076366|NCT04551495|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076367|NCT04551495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076368|NCT04551495|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92076369|NCT04551495|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076370|NCT04545424|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-list
92076371|NCT04545424|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92076372|NCT04545424|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076373|NCT04545424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076374|NCT04501718|Etoposide|etoposide|mesh-list
92076375|NCT04501718|Temozolomide|temozolomide|mesh-list
92076376|NCT04501718|Apatinib|apatinib|mesh-list
92076377|NCT04501718|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076378|NCT04501718|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076379|NCT04501718|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92076380|NCT04501718|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92076381|NCT04501718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076382|NCT04501718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076383|NCT04501718|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076384|NCT04501718|Alkylating Agents|alkylating agents|mesh-ancestor
92076385|NCT04501718|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076386|NCT04501705|Apatinib|apatinib|mesh-list
92076387|NCT04501705|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076388|NCT04501705|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076389|NCT04501705|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076390|NCT04501705|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076391|NCT04463394|Vasopressins|vasopressins|mesh-list
92076392|NCT04463394|Arginine Vasopressin|arginine vasopressin|mesh-list
92076393|NCT04463394|Hemostatics|hemostatics|mesh-ancestor
92076394|NCT04463394|Coagulants|coagulants|mesh-ancestor
92076395|NCT04463394|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92076396|NCT04463394|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92076397|NCT04463394|Natriuretic Agents|natriuretic agents|mesh-ancestor
92076398|NCT04463394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076399|NCT04454905|Apatinib|apatinib|mesh-list
92076400|NCT04454905|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076401|NCT04454905|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076404|NCT04436601|Lactulose|lactulose|mesh-list
92076405|NCT04436601|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92076406|NCT04397484|Lidocaine|lidocaine|mesh-list
92076407|NCT04397484|Epinephrine|epinephrine|mesh-list
92076408|NCT04397484|Racepinephrine|racepinephrine|mesh-list
92016116|NCT05541419|Autonomic Agents|autonomic agents|mesh-ancestor
92016117|NCT05541419|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016118|NCT05541419|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016119|NCT05541419|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92016120|NCT05541419|Respiratory System Agents|respiratory system agents|mesh-ancestor
92016121|NCT05541419|Glucocorticoids|glucocorticoids|mesh-ancestor
92016123|NCT05541419|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016124|NCT05546879|Bevacizumab|bevacizumab|mesh-list
92016125|NCT05546879|Atezolizumab|atezolizumab|mesh-list
92016126|NCT05546879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016127|NCT05546879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016128|NCT05546879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92076409|NCT04397484|Levobupivacaine|levobupivacaine|mesh-list
92076410|NCT04397484|Epinephryl borate|epinephryl borate|mesh-list
92076411|NCT04397484|Anesthetics, Local|anesthetics, local|mesh-ancestor
92076412|NCT04397484|Anesthetics|anesthetics|mesh-ancestor
92076413|NCT04397484|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076414|NCT04397484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076415|NCT04397484|Sensory System Agents|sensory system agents|mesh-ancestor
92076416|NCT04397484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076417|NCT04397484|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92076418|NCT04397484|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92076419|NCT04397484|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92076420|NCT04397484|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076421|NCT04397484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076422|NCT04397484|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92076423|NCT04397484|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92076424|NCT04397484|Adrenergic Agents|adrenergic agents|mesh-ancestor
92076425|NCT04397484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076426|NCT04397484|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92076427|NCT04397484|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92076428|NCT04397484|Autonomic Agents|autonomic agents|mesh-ancestor
92076429|NCT04397484|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92076430|NCT04397484|Respiratory System Agents|respiratory system agents|mesh-ancestor
92076431|NCT04397484|Mydriatics|mydriatics|mesh-ancestor
92076432|NCT04397484|Sympathomimetics|sympathomimetics|mesh-ancestor
92076433|NCT04397484|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92076434|NCT04373785|Temozolomide|temozolomide|mesh-list
92076435|NCT04373785|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076436|NCT04373785|Alkylating Agents|alkylating agents|mesh-ancestor
92076437|NCT04373785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076438|NCT04373785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076440|NCT04313712|Hallucinogens|hallucinogens|mesh-ancestor
92076441|NCT04313712|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076442|NCT04313712|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92076443|NCT04313712|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92076444|NCT04313712|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92076445|NCT04313712|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076446|NCT04313712|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076447|NCT04312997|Pam2CSK4 acetate and ODN M362 combination|pam2csk4 acetate and odn m362 combination|mesh-list
92076448|NCT04312997|Respiratory System Agents|respiratory system agents|mesh-ancestor
92076450|NCT04309552|Antiviral Agents|antiviral agents|mesh-ancestor
92076451|NCT04309552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076452|NCT04275180|Argatroban|argatroban|mesh-list
92076453|NCT04275180|Antithrombins|antithrombins|mesh-ancestor
92076454|NCT04275180|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92076455|NCT04275180|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016129|NCT05546879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016130|NCT05546879|Growth Substances|growth substances|mesh-ancestor
92016131|NCT05546879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016132|NCT05546879|Growth Inhibitors|growth inhibitors|mesh-ancestor
92076456|NCT04275180|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076457|NCT04275180|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076458|NCT04275180|Anticoagulants|anticoagulants|mesh-ancestor
92076459|NCT04275180|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92076461|NCT04271332|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92076462|NCT04271332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076463|NCT04271332|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92076464|NCT04271332|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076465|NCT04271332|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92076466|NCT04271332|GABA Agonists|gaba agonists|mesh-ancestor
92076467|NCT04271332|GABA Agents|gaba agents|mesh-ancestor
92076468|NCT04271332|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076469|NCT04271332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076470|NCT04267978|Irinotecan|irinotecan|mesh-list
92076471|NCT04267978|Temozolomide|temozolomide|mesh-list
92076472|NCT04267978|Endostatins|endostatins|mesh-list
92076473|NCT04267978|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92076474|NCT04267978|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92076475|NCT04267978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076479|NCT04267978|Alkylating Agents|alkylating agents|mesh-ancestor
92076480|NCT04267978|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92076481|NCT04267978|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92076482|NCT04267978|Growth Substances|growth substances|mesh-ancestor
92076483|NCT04267978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076484|NCT04267978|Growth Inhibitors|growth inhibitors|mesh-ancestor
92076485|NCT04230252|Acetaminophen|acetaminophen|mesh-list
92076486|NCT04230252|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92076487|NCT04230252|Analgesics|analgesics|mesh-ancestor
92076488|NCT04230252|Sensory System Agents|sensory system agents|mesh-ancestor
92076489|NCT04230252|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076490|NCT04230252|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076491|NCT04230252|Antipyretics|antipyretics|mesh-ancestor
92076492|NCT04217317|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92076493|NCT04217317|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076495|NCT04217317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076496|NCT04217317|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076497|NCT04189263|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92076498|NCT04189263|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92076499|NCT04189263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076500|NCT04189263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076501|NCT04189263|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92076502|NCT04189263|Hormone Antagonists|hormone antagonists|mesh-ancestor
92076503|NCT04189263|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076504|NCT04189263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076505|NCT04140396|Lidocaine|lidocaine|mesh-list
92076506|NCT04140396|Anesthetics, Local|anesthetics, local|mesh-ancestor
92076507|NCT04140396|Anesthetics|anesthetics|mesh-ancestor
92076508|NCT04140396|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076509|NCT04140396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076510|NCT04140396|Sensory System Agents|sensory system agents|mesh-ancestor
92076511|NCT04140396|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076512|NCT04140396|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92076513|NCT04140396|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92076514|NCT04140396|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92076515|NCT04140396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076516|NCT04140396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076517|NCT04117178|Memantine|memantine|mesh-list
92076518|NCT04117178|Donepezil|donepezil|mesh-list
92076519|NCT04117178|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92076520|NCT04117178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076521|NCT04117178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076522|NCT04117178|Cholinergic Agents|cholinergic agents|mesh-ancestor
92076523|NCT04117178|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016133|NCT05546879|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92016134|NCT05546879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016136|NCT05541185|Lidocaine|lidocaine|mesh-list
92016137|NCT05541185|Anesthetics, Local|anesthetics, local|mesh-ancestor
92016138|NCT05541185|Anesthetics|anesthetics|mesh-ancestor
92076524|NCT04117178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076526|NCT04117178|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92076527|NCT04117178|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92076528|NCT04117178|Dopamine Agents|dopamine agents|mesh-ancestor
92076529|NCT04117178|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92076530|NCT04117178|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92076531|NCT04099836|Bevacizumab|bevacizumab|mesh-list
92076532|NCT04099836|Atezolizumab|atezolizumab|mesh-list
92076533|NCT04099836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076534|NCT04099836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076535|NCT04099836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92076536|NCT04099836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92076537|NCT04099836|Growth Substances|growth substances|mesh-ancestor
92076538|NCT04099836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076539|NCT04099836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92076540|NCT04099836|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076541|NCT04099836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076542|NCT04094961|Dexamethasone|dexamethasone|mesh-list
92076543|NCT04094961|Dexamethasone acetate|dexamethasone acetate|mesh-list
92076544|NCT04094961|Pomalidomide|pomalidomide|mesh-list
92076548|NCT04094961|Antiemetics|antiemetics|mesh-ancestor
92076549|NCT04094961|Autonomic Agents|autonomic agents|mesh-ancestor
92076550|NCT04094961|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076551|NCT04094961|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076552|NCT04094961|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92076553|NCT04094961|Glucocorticoids|glucocorticoids|mesh-ancestor
92076554|NCT04094961|Hormones|hormones|mesh-ancestor
92076555|NCT04094961|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076556|NCT04094961|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92076557|NCT04094961|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076558|NCT04094961|Protease Inhibitors|protease inhibitors|mesh-ancestor
92076559|NCT04094961|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076560|NCT04094961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076561|NCT04094961|Immunologic Factors|immunologic factors|mesh-ancestor
92076562|NCT04094961|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92076563|NCT04094961|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92076564|NCT04094961|Growth Substances|growth substances|mesh-ancestor
92076565|NCT04094961|Growth Inhibitors|growth inhibitors|mesh-ancestor
92076566|NCT04025216|Cyclophosphamide|cyclophosphamide|mesh-list
92076567|NCT04025216|Fludarabine|fludarabine|mesh-list
92076568|NCT04025216|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076569|NCT04025216|Immunologic Factors|immunologic factors|mesh-ancestor
92076570|NCT04025216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076571|NCT04025216|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076572|NCT04025216|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076573|NCT04025216|Alkylating Agents|alkylating agents|mesh-ancestor
92076574|NCT04025216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076575|NCT04025216|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076576|NCT04025216|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92076577|NCT04020185|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92076578|NCT04020185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076579|NCT04020185|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076580|NCT04020185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076581|NCT03991936|Triamcinolone|triamcinolone|mesh-list
92076582|NCT03991936|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92076583|NCT03991936|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92076584|NCT03991936|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92076585|NCT03991936|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076586|NCT03991936|Glucocorticoids|glucocorticoids|mesh-ancestor
92076587|NCT03991936|Hormones|hormones|mesh-ancestor
92076588|NCT03991936|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016139|NCT05541185|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016140|NCT05541185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016141|NCT05541185|Sensory System Agents|sensory system agents|mesh-ancestor
92076589|NCT03991936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076590|NCT03991936|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076591|NCT03991936|Immunologic Factors|immunologic factors|mesh-ancestor
92076592|NCT03991936|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076593|NCT03991936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076594|NCT03982082|Coal Tar|coal tar|mesh-list
92076595|NCT03982082|Keratolytic Agents|keratolytic agents|mesh-ancestor
92076596|NCT03982082|Dermatologic Agents|dermatologic agents|mesh-ancestor
92076597|NCT03979599|Magnesium Sulfate|magnesium sulfate|mesh-list
92076598|NCT03979599|Levobupivacaine|levobupivacaine|mesh-list
92076599|NCT03979599|Analgesics|analgesics|mesh-ancestor
92076600|NCT03979599|Sensory System Agents|sensory system agents|mesh-ancestor
92076601|NCT03979599|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076602|NCT03979599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076603|NCT03979599|Anesthetics|anesthetics|mesh-ancestor
92076604|NCT03979599|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92076605|NCT03979599|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92076606|NCT03979599|Anticonvulsants|anticonvulsants|mesh-ancestor
92076607|NCT03979599|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92076608|NCT03979599|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076609|NCT03979599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076610|NCT03979599|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92076611|NCT03979599|Tocolytic Agents|tocolytic agents|mesh-ancestor
92076612|NCT03979599|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92076613|NCT03979599|Anesthetics, Local|anesthetics, local|mesh-ancestor
92076614|NCT03966651|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92076615|NCT03966651|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92076619|NCT03946514|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92076620|NCT03946514|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92076621|NCT03946514|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92076622|NCT03946514|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076623|NCT03946514|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076624|NCT03946514|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92076625|NCT03946514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076626|NCT03946514|Vasodilator Agents|vasodilator agents|mesh-ancestor
92076627|NCT03946514|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92076628|NCT03946514|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92076629|NCT03946514|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92076630|NCT03946514|Diuretics|diuretics|mesh-ancestor
92076631|NCT03946514|Natriuretic Agents|natriuretic agents|mesh-ancestor
92076632|NCT03946514|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92076633|NCT03935958|Curcumin|curcumin|mesh-list
92076634|NCT03935958|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92076635|NCT03935958|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92076636|NCT03935958|Analgesics|analgesics|mesh-ancestor
92076637|NCT03935958|Sensory System Agents|sensory system agents|mesh-ancestor
92076638|NCT03935958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076639|NCT03935958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076640|NCT03935958|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076641|NCT03935958|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076642|NCT03935958|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076643|NCT03935958|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076644|NCT03935958|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076645|NCT03935295|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92076646|NCT03935295|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92076647|NCT03935295|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92076648|NCT03935295|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076649|NCT03935295|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076650|NCT03935295|Cholinergic Agents|cholinergic agents|mesh-ancestor
92076651|NCT03935295|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076652|NCT03935295|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076653|NCT03935295|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92076654|NCT03935295|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016142|NCT05541185|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076656|NCT03915444|Gemcitabine|gemcitabine|mesh-list
92076657|NCT03915444|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076658|NCT03915444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076659|NCT03915444|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076660|NCT03915444|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076661|NCT03915444|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076662|NCT03915444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076663|NCT03915444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076664|NCT03915444|Antimetabolites|antimetabolites|mesh-ancestor
92076665|NCT03892785|Prednisone|prednisone|mesh-list
92076666|NCT03892785|Methotrexate|methotrexate|mesh-list
92076667|NCT03892785|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076668|NCT03892785|Glucocorticoids|glucocorticoids|mesh-ancestor
92076669|NCT03892785|Hormones|hormones|mesh-ancestor
92076670|NCT03892785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076671|NCT03892785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076672|NCT03892785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92076673|NCT03892785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076674|NCT03892785|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92076675|NCT03892785|Abortifacient Agents|abortifacient agents|mesh-ancestor
92076676|NCT03892785|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92076677|NCT03892785|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076678|NCT03892785|Antimetabolites|antimetabolites|mesh-ancestor
92076679|NCT03892785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076680|NCT03892785|Dermatologic Agents|dermatologic agents|mesh-ancestor
92076681|NCT03892785|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076682|NCT03892785|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92076683|NCT03892785|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076684|NCT03892785|Immunologic Factors|immunologic factors|mesh-ancestor
92076685|NCT03892785|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076689|NCT03869034|Oxaliplatin|oxaliplatin|mesh-list
92076690|NCT03869034|Antimetabolites|antimetabolites|mesh-ancestor
92076691|NCT03869034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076692|NCT03869034|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076693|NCT03869034|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076694|NCT03869034|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076695|NCT03869034|Immunologic Factors|immunologic factors|mesh-ancestor
92076696|NCT03869034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076697|NCT03869034|Antidotes|antidotes|mesh-ancestor
92076698|NCT03869034|Protective Agents|protective agents|mesh-ancestor
92076699|NCT03869034|Vitamin B Complex|vitamin b complex|mesh-ancestor
92076701|NCT03869034|Micronutrients|micronutrients|mesh-ancestor
92076702|NCT03841097|Tacrolimus|tacrolimus|mesh-list
92076703|NCT03841097|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076704|NCT03841097|Immunologic Factors|immunologic factors|mesh-ancestor
92076705|NCT03841097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076706|NCT03841097|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92076707|NCT03841097|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076708|NCT03841097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076709|NCT03831425|Ubiquinone|ubiquinone|mesh-list
92076710|NCT03831425|Coenzyme Q10|coenzyme q10|mesh-list
92076711|NCT03831425|Micronutrients|micronutrients|mesh-ancestor
92076712|NCT03831425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076713|NCT03831425|Vitamins|vitamins|mesh-ancestor
92076714|NCT03830866|Carboplatin|carboplatin|mesh-list
92076715|NCT03830866|Durvalumab|durvalumab|mesh-list
92076716|NCT03830866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077091|NCT02923115|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92076717|NCT03830866|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076718|NCT03807765|Nivolumab|nivolumab|mesh-list
92076719|NCT03807765|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076720|NCT03807765|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076721|NCT03807765|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076722|NCT03807765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076723|NCT03804944|Pembrolizumab|pembrolizumab|mesh-list
92076724|NCT03804944|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076725|NCT03804944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076726|NCT03804944|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076727|NCT03804944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076728|NCT03790111|Cisplatin|cisplatin|mesh-list
92076729|NCT03790111|Gemcitabine|gemcitabine|mesh-list
92076730|NCT03790111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016143|NCT05541185|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92016144|NCT05541185|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92016145|NCT05541185|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92076731|NCT03790111|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076732|NCT03790111|Antimetabolites|antimetabolites|mesh-ancestor
92076733|NCT03790111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076735|NCT03780543|Entecavir|entecavir|mesh-list
92076736|NCT03780543|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-list
92076737|NCT03780543|Antiviral Agents|antiviral agents|mesh-ancestor
92076738|NCT03780543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076739|NCT03780543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92076740|NCT03780543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076741|NCT03780543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076742|NCT03780543|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92076743|NCT03780543|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92076744|NCT03772314|Modafinil|modafinil|mesh-list
92076745|NCT03772314|Amphetamine|amphetamine|mesh-list
92076746|NCT03772314|Adderall|adderall|mesh-list
92076747|NCT03772314|Dextroamphetamine|dextroamphetamine|mesh-list
92076748|NCT03772314|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92076749|NCT03772314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076750|NCT03772314|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92076751|NCT03772314|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92076752|NCT03772314|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92076753|NCT03772314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076754|NCT03772314|Sympathomimetics|sympathomimetics|mesh-ancestor
92076755|NCT03772314|Autonomic Agents|autonomic agents|mesh-ancestor
92076756|NCT03772314|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076757|NCT03772314|Dopamine Agents|dopamine agents|mesh-ancestor
92076758|NCT03772314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076759|NCT03772314|Adrenergic Agents|adrenergic agents|mesh-ancestor
92076760|NCT03772314|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92076761|NCT03772314|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92076762|NCT03772314|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076763|NCT03772314|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92076765|NCT03760575|Pemetrexed|pemetrexed|mesh-list
92076766|NCT03760575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076767|NCT03760575|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076768|NCT03760575|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076769|NCT03760575|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076770|NCT03760575|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076771|NCT03760575|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92076772|NCT03760575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92076773|NCT03738579|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92076774|NCT03738579|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076775|NCT03720522|Adenosine|adenosine|mesh-list
92076776|NCT03720522|Analgesics|analgesics|mesh-ancestor
92076777|NCT03720522|Sensory System Agents|sensory system agents|mesh-ancestor
92076778|NCT03720522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076779|NCT03720522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076780|NCT03720522|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92076781|NCT03720522|Vasodilator Agents|vasodilator agents|mesh-ancestor
92076782|NCT03720522|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92076783|NCT03720522|Purinergic Agonists|purinergic agonists|mesh-ancestor
92076784|NCT03720522|Purinergic Agents|purinergic agents|mesh-ancestor
92076785|NCT03720522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076786|NCT03720522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076787|NCT03699631|Methotrexate|methotrexate|mesh-list
92076788|NCT03699631|Tacrolimus|tacrolimus|mesh-list
92076789|NCT03699631|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92076790|NCT03699631|Abortifacient Agents|abortifacient agents|mesh-ancestor
92076791|NCT03699631|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92076792|NCT03699631|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076793|NCT03699631|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076794|NCT03699631|Antimetabolites|antimetabolites|mesh-ancestor
92076795|NCT03699631|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076796|NCT03699631|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076797|NCT03699631|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016146|NCT05541185|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016147|NCT05541185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076798|NCT03699631|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076799|NCT03699631|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92076800|NCT03699631|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076801|NCT03699631|Immunologic Factors|immunologic factors|mesh-ancestor
92076802|NCT03699631|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076803|NCT03699631|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92076804|NCT03699631|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92076805|NCT03686488|Ramucirumab|ramucirumab|mesh-list
92076806|NCT03686488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076807|NCT03686150|Vitamin D|vitamin d|mesh-list
92076808|NCT03686150|Cholecalciferol|cholecalciferol|mesh-list
92076809|NCT03686150|Vitamins|vitamins|mesh-ancestor
92076810|NCT03686150|Micronutrients|micronutrients|mesh-ancestor
92076811|NCT03686150|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076812|NCT03686150|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92076813|NCT03686150|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92076814|NCT03678233|Testosterone|testosterone|mesh-list
92076815|NCT03678233|Androgens|androgens|mesh-ancestor
92076816|NCT03678233|Hormones|hormones|mesh-ancestor
92076817|NCT03678233|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076818|NCT03678233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076819|NCT03629327|Aspirin|aspirin|mesh-list
92076820|NCT03629327|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92076821|NCT03629327|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92076822|NCT03629327|Analgesics|analgesics|mesh-ancestor
92076823|NCT03629327|Sensory System Agents|sensory system agents|mesh-ancestor
92076824|NCT03629327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076825|NCT03629327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076826|NCT03629327|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076827|NCT03629327|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076828|NCT03629327|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92076829|NCT03629327|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92076830|NCT03629327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076831|NCT03629327|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92076834|NCT03629327|Antipyretics|antipyretics|mesh-ancestor
92076836|NCT03628209|Azacitidine|azacitidine|mesh-list
92076837|NCT03628209|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076838|NCT03628209|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076839|NCT03628209|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076840|NCT03628209|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076841|NCT03628209|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076842|NCT03628209|Antimetabolites|antimetabolites|mesh-ancestor
92076843|NCT03628209|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076844|NCT03618641|Nivolumab|nivolumab|mesh-list
92076845|NCT03618641|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076846|NCT03618641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076847|NCT03618641|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076848|NCT03618641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076849|NCT03617718|Glycine|glycine|mesh-list
92076850|NCT03617718|Glycine Agents|glycine agents|mesh-ancestor
92076851|NCT03617718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076852|NCT03617718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076853|NCT03617718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076854|NCT03610061|Durvalumab|durvalumab|mesh-list
92076855|NCT03610061|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076856|NCT03610061|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076857|NCT03606642|Clopidogrel|clopidogrel|mesh-list
92076858|NCT03606642|Ticagrelor|ticagrelor|mesh-list
92076859|NCT03606642|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92076860|NCT03606642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076861|NCT03606642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076862|NCT03606642|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92076863|NCT03606642|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92076864|NCT03606642|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92076865|NCT03606642|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92016148|NCT05541185|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92016149|NCT05541185|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92076866|NCT03606642|Purinergic Agents|purinergic agents|mesh-ancestor
92076867|NCT03606642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076868|NCT03530124|Vaccines|vaccines|mesh-list
92076869|NCT03530124|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92076870|NCT03530124|Immunologic Factors|immunologic factors|mesh-ancestor
92076871|NCT03530124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076872|NCT03527043|Escitalopram|escitalopram|mesh-list
92076873|NCT03527043|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92076874|NCT03527043|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92076875|NCT03527043|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92076876|NCT03527043|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076877|NCT03527043|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92076878|NCT03527043|Serotonin Agents|serotonin agents|mesh-ancestor
92076879|NCT03527043|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076880|NCT03505723|Tranexamic Acid|tranexamic acid|mesh-list
92076881|NCT03505723|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92076882|NCT03505723|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92076883|NCT03505723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076884|NCT03505723|Hemostatics|hemostatics|mesh-ancestor
92076885|NCT03505723|Coagulants|coagulants|mesh-ancestor
92076886|NCT03458221|Itraconazole|itraconazole|mesh-list
92076888|NCT03458221|Letrozole|letrozole|mesh-list
92076890|NCT03458221|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92076891|NCT03458221|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076892|NCT03458221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076893|NCT03458221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076894|NCT03458221|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076895|NCT03458221|Immunologic Factors|immunologic factors|mesh-ancestor
92076896|NCT03458221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076897|NCT03458221|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076898|NCT03458221|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92076899|NCT03458221|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92076900|NCT03458221|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92076901|NCT03458221|Hormone Antagonists|hormone antagonists|mesh-ancestor
92076902|NCT03458221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076903|NCT03458221|Antifungal Agents|antifungal agents|mesh-ancestor
92076905|NCT03458221|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92076906|NCT03458221|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92076907|NCT03458221|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92076908|NCT03458221|Androgen Antagonists|androgen antagonists|mesh-ancestor
92076909|NCT03451487|Acetaminophen|acetaminophen|mesh-list
92076910|NCT03451487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92076911|NCT03451487|Analgesics|analgesics|mesh-ancestor
92076912|NCT03451487|Sensory System Agents|sensory system agents|mesh-ancestor
92076913|NCT03451487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076914|NCT03451487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076915|NCT03451487|Antipyretics|antipyretics|mesh-ancestor
92076916|NCT03410030|Ascorbic Acid|ascorbic acid|mesh-list
92076917|NCT03410030|Paclitaxel|paclitaxel|mesh-list
92076918|NCT03410030|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92076919|NCT03410030|Cisplatin|cisplatin|mesh-list
92076920|NCT03410030|Gemcitabine|gemcitabine|mesh-list
92076921|NCT03410030|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076922|NCT03410030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076923|NCT03410030|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076924|NCT03410030|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076925|NCT03410030|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076926|NCT03410030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076927|NCT03410030|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076928|NCT03410030|Antimetabolites|antimetabolites|mesh-ancestor
92076929|NCT03410030|Antioxidants|antioxidants|mesh-ancestor
92076930|NCT03410030|Protective Agents|protective agents|mesh-ancestor
92076931|NCT03410030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076932|NCT03410030|Vitamins|vitamins|mesh-ancestor
92076933|NCT03410030|Micronutrients|micronutrients|mesh-ancestor
92076934|NCT03382301|Cyclosporine|cyclosporine|mesh-list
92076935|NCT03382301|Cyclosporins|cyclosporins|mesh-list
92016151|NCT05541185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016152|NCT05541185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016153|NCT05541185|Gout Suppressants|gout suppressants|mesh-ancestor
92016154|NCT05541185|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92016155|NCT05541185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016156|NCT02518113|Dexamethasone|dexamethasone|mesh-list
92076936|NCT03382301|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076937|NCT03382301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076938|NCT03382301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92076939|NCT03382301|Immunologic Factors|immunologic factors|mesh-ancestor
92076940|NCT03382301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076941|NCT03382301|Antifungal Agents|antifungal agents|mesh-ancestor
92076942|NCT03382301|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076943|NCT03382301|Dermatologic Agents|dermatologic agents|mesh-ancestor
92076944|NCT03382301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076945|NCT03382301|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92076947|NCT03301506|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92076948|NCT03301506|Antimetabolites|antimetabolites|mesh-ancestor
92076949|NCT03301506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076950|NCT03301506|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92076951|NCT03290391|Naltrexone|naltrexone|mesh-list
92076952|NCT03290391|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92076953|NCT03290391|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92076954|NCT03290391|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076955|NCT03290391|Sensory System Agents|sensory system agents|mesh-ancestor
92076956|NCT03290391|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076957|NCT03280030|Midostaurin|midostaurin|mesh-list
92076958|NCT03280030|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076959|NCT03280030|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076960|NCT03280030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076961|NCT03280030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076962|NCT03263481|Secretin|secretin|mesh-list
92076963|NCT03263481|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92076964|NCT03263481|Hormones|hormones|mesh-ancestor
92076965|NCT03263481|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076966|NCT03263481|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92076967|NCT03245892|Paclitaxel|paclitaxel|mesh-list
92076968|NCT03245892|Carboplatin|carboplatin|mesh-list
92076969|NCT03245892|Nivolumab|nivolumab|mesh-list
92076970|NCT03245892|Ipilimumab|ipilimumab|mesh-list
92076971|NCT03245892|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076972|NCT03245892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076973|NCT03245892|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076974|NCT03245892|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076975|NCT03245892|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076976|NCT03245892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076977|NCT03245892|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076978|NCT03245892|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076979|NCT03204188|Pembrolizumab|pembrolizumab|mesh-list
92076987|NCT03194867|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076989|NCT03138720|Cisplatin|cisplatin|mesh-list
92076990|NCT03138720|Gemcitabine|gemcitabine|mesh-list
92076991|NCT03138720|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92076992|NCT03138720|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92076993|NCT03138720|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076994|NCT03138720|Tubulin Modulators|tubulin modulators|mesh-ancestor
92076995|NCT03138720|Antimitotic Agents|antimitotic agents|mesh-ancestor
92076996|NCT03138720|Mitosis Modulators|mitosis modulators|mesh-ancestor
92076997|NCT03138720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076998|NCT03138720|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92076999|NCT03138720|Antimetabolites|antimetabolites|mesh-ancestor
92077000|NCT03131726|Simvastatin|simvastatin|mesh-list
92077001|NCT03131726|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92077002|NCT03131726|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92077003|NCT03131726|Antimetabolites|antimetabolites|mesh-ancestor
92077004|NCT03131726|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077005|NCT03131726|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92077006|NCT03131726|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92016157|NCT02518113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016158|NCT02518113|Antiemetics|antiemetics|mesh-ancestor
92016159|NCT02518113|Autonomic Agents|autonomic agents|mesh-ancestor
92016160|NCT02518113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016161|NCT02518113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077007|NCT03131726|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077008|NCT03112590|Interferons|interferons|mesh-list
92077009|NCT03112590|Interferon-gamma|interferon-gamma|mesh-list
92077011|NCT03112590|Trastuzumab|trastuzumab|mesh-list
92077012|NCT03112590|Pertuzumab|pertuzumab|mesh-list
92077013|NCT03112590|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077014|NCT03112590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077015|NCT03112590|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077016|NCT03112590|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077017|NCT03112590|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077018|NCT03112590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077019|NCT03112590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077020|NCT03112590|Antiviral Agents|antiviral agents|mesh-ancestor
92077021|NCT03112590|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077022|NCT03085394|Tranexamic Acid|tranexamic acid|mesh-list
92077023|NCT03085394|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92077024|NCT03085394|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92077025|NCT03085394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077026|NCT03085394|Hemostatics|hemostatics|mesh-ancestor
92077027|NCT03085394|Coagulants|coagulants|mesh-ancestor
92077028|NCT03065621|Palbociclib|palbociclib|mesh-list
92077029|NCT03065621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077030|NCT03065621|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92077031|NCT03065621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077032|NCT03065621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077034|NCT03060434|Ibuprofen|ibuprofen|mesh-list
92077035|NCT03060434|Pregabalin|pregabalin|mesh-list
92077036|NCT03060434|Pentoxifylline|pentoxifylline|mesh-list
92077037|NCT03060434|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92077038|NCT03060434|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92077039|NCT03060434|Analgesics|analgesics|mesh-ancestor
92077040|NCT03060434|Sensory System Agents|sensory system agents|mesh-ancestor
92077041|NCT03060434|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077042|NCT03060434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077043|NCT03060434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077044|NCT03060434|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077045|NCT03060434|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92077046|NCT03060434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077047|NCT03060434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077051|NCT03060434|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92077052|NCT03060434|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92077053|NCT03060434|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92077054|NCT03060434|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077055|NCT03060434|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92077056|NCT03060434|Antipyretics|antipyretics|mesh-ancestor
92077057|NCT03060434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92077058|NCT03060434|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92077059|NCT03060434|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92077060|NCT03060434|Protective Agents|protective agents|mesh-ancestor
92077061|NCT03060434|Vasodilator Agents|vasodilator agents|mesh-ancestor
92077062|NCT03060434|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92077063|NCT03060434|Antioxidants|antioxidants|mesh-ancestor
92077064|NCT03021486|Haloperidol|haloperidol|mesh-list
92077065|NCT03021486|Chlorpromazine|chlorpromazine|mesh-list
92077066|NCT03021486|Haloperidol decanoate|haloperidol decanoate|mesh-list
92077067|NCT03021486|Antiemetics|antiemetics|mesh-ancestor
92077068|NCT03021486|Autonomic Agents|autonomic agents|mesh-ancestor
92077069|NCT03021486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077070|NCT03021486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077071|NCT03021486|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92077072|NCT03021486|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92077073|NCT03021486|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92077074|NCT03021486|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016162|NCT02518113|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016163|NCT02518113|Glucocorticoids|glucocorticoids|mesh-ancestor
92016164|NCT02518113|Hormones|hormones|mesh-ancestor
92077075|NCT03021486|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92077076|NCT03021486|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92077077|NCT03021486|Dopamine Agents|dopamine agents|mesh-ancestor
92077078|NCT03021486|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077079|NCT03021486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077080|NCT03021486|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92077081|NCT02949128|Ravulizumab|ravulizumab|mesh-list
92077082|NCT02949128|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92077083|NCT02949128|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077084|NCT02949128|Immunologic Factors|immunologic factors|mesh-ancestor
92077085|NCT02949128|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077086|NCT02944617|Micronutrients|micronutrients|mesh-list
92077087|NCT02944617|Trace Elements|trace elements|mesh-list
92077088|NCT02944617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077089|NCT02923115|Enoxaparin|enoxaparin|mesh-list
92077090|NCT02923115|Anticoagulants|anticoagulants|mesh-ancestor
92077092|NCT02923115|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92077093|NCT02923115|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077094|NCT02910583|Venetoclax|venetoclax|mesh-list
92077095|NCT02910583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077096|NCT02820857|Bevacizumab|bevacizumab|mesh-list
92077097|NCT02820857|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077098|NCT02820857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077099|NCT02820857|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92077100|NCT02820857|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92077101|NCT02820857|Growth Substances|growth substances|mesh-ancestor
92077102|NCT02820857|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077103|NCT02820857|Growth Inhibitors|growth inhibitors|mesh-ancestor
92077104|NCT02790710|Propranolol|propranolol|mesh-list
92077105|NCT02790710|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92077106|NCT02790710|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92077107|NCT02790710|Adrenergic Agents|adrenergic agents|mesh-ancestor
92077108|NCT02790710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077109|NCT02790710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077110|NCT02790710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077111|NCT02790710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92077112|NCT02790710|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92077113|NCT02790710|Vasodilator Agents|vasodilator agents|mesh-ancestor
92077114|NCT02779855|Paclitaxel|paclitaxel|mesh-list
92077115|NCT02779855|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92077116|NCT02779855|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077117|NCT02779855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077118|NCT02779855|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077119|NCT02779855|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077123|NCT02661035|Mycophenolic Acid|mycophenolic acid|mesh-list
92077124|NCT02661035|Cyclophosphamide|cyclophosphamide|mesh-list
92077125|NCT02661035|Fludarabine|fludarabine|mesh-list
92077126|NCT02661035|Allopurinol|allopurinol|mesh-list
92077127|NCT02661035|Tacrolimus|tacrolimus|mesh-list
92077128|NCT02661035|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92077129|NCT02661035|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077130|NCT02661035|Immunologic Factors|immunologic factors|mesh-ancestor
92077131|NCT02661035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077132|NCT02661035|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077133|NCT02661035|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077134|NCT02661035|Alkylating Agents|alkylating agents|mesh-ancestor
92077135|NCT02661035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077136|NCT02661035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077137|NCT02661035|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077138|NCT02661035|Antimetabolites|antimetabolites|mesh-ancestor
92077139|NCT02661035|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92077140|NCT02661035|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077141|NCT02661035|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077142|NCT02661035|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92077143|NCT02661035|Antitubercular Agents|antitubercular agents|mesh-ancestor
92077144|NCT02661035|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077145|NCT02661035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077146|NCT02661035|Gout Suppressants|gout suppressants|mesh-ancestor
92077147|NCT02661035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92016165|NCT02518113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016166|NCT02518113|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016167|NCT02518113|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016168|NCT05541107|Amphotericin B|amphotericin b|mesh-list
92016169|NCT05541107|Liposomal amphotericin B|liposomal amphotericin b|mesh-list
92077148|NCT02661035|Antioxidants|antioxidants|mesh-ancestor
92077149|NCT02661035|Protective Agents|protective agents|mesh-ancestor
92077150|NCT02648477|Doxorubicin|doxorubicin|mesh-list
92077151|NCT02648477|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92077152|NCT02648477|Pembrolizumab|pembrolizumab|mesh-list
92077153|NCT02648477|Letrozole|letrozole|mesh-list
92077154|NCT02648477|Anastrozole|anastrozole|mesh-list
92077155|NCT02648477|Exemestane|exemestane|mesh-list
92077156|NCT02648477|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077157|NCT02648477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077158|NCT02648477|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92077159|NCT02648477|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92077160|NCT02648477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077161|NCT02648477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077162|NCT02648477|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077163|NCT02648477|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92077164|NCT02648477|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92077165|NCT02648477|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92077166|NCT02648477|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92077167|NCT02648477|Hormone Antagonists|hormone antagonists|mesh-ancestor
92077168|NCT02648477|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077169|NCT02648477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077170|NCT02648477|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92077171|NCT02604732|Aspirin|aspirin|mesh-list
92077172|NCT02604732|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92077173|NCT02604732|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92077174|NCT02604732|Analgesics|analgesics|mesh-ancestor
92077175|NCT02604732|Sensory System Agents|sensory system agents|mesh-ancestor
92077176|NCT02604732|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077177|NCT02604732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077178|NCT02604732|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077179|NCT02604732|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077180|NCT02604732|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92077181|NCT02604732|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92077182|NCT02604732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077183|NCT02604732|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92077184|NCT02604732|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92077185|NCT02604732|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077186|NCT02604732|Antipyretics|antipyretics|mesh-ancestor
92077187|NCT02444429|Methylprednisolone|methylprednisolone|mesh-list
92077188|NCT02444429|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92077189|NCT02444429|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92077190|NCT02444429|Prednisolone|prednisolone|mesh-list
92077191|NCT02444429|Prednisolone acetate|prednisolone acetate|mesh-list
92077194|NCT02444429|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077195|NCT02444429|Antiemetics|antiemetics|mesh-ancestor
92077196|NCT02444429|Autonomic Agents|autonomic agents|mesh-ancestor
92077197|NCT02444429|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077198|NCT02444429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077199|NCT02444429|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92077200|NCT02444429|Glucocorticoids|glucocorticoids|mesh-ancestor
92077201|NCT02444429|Hormones|hormones|mesh-ancestor
92077202|NCT02444429|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077203|NCT02444429|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92077204|NCT02444429|Protective Agents|protective agents|mesh-ancestor
92077205|NCT02444429|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92077206|NCT02444429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077207|NCT02318342|Warfarin|warfarin|mesh-list
92077208|NCT02318342|Anticoagulants|anticoagulants|mesh-ancestor
92077209|NCT02134184|Vaccines|vaccines|mesh-list
92077210|NCT02134184|Immunologic Factors|immunologic factors|mesh-ancestor
92077211|NCT02134184|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016170|NCT05541107|Amebicides|amebicides|mesh-ancestor
92016171|NCT05541107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92016172|NCT05541107|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92016173|NCT05541107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016174|NCT05541107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016175|NCT05541107|Antifungal Agents|antifungal agents|mesh-ancestor
92077212|NCT02029846|Metformin|metformin|mesh-list
92077213|NCT02029846|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-list
92077214|NCT02029846|Incretins|incretins|mesh-list
92077215|NCT02029846|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92077216|NCT02029846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077217|NCT02029846|Protease Inhibitors|protease inhibitors|mesh-ancestor
92077218|NCT02029846|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077219|NCT02029846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077220|NCT02029846|Hormones|hormones|mesh-ancestor
92077221|NCT02029846|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077222|NCT02020694|Vitamin D|vitamin d|mesh-list
92077223|NCT02020694|Ergocalciferols|ergocalciferols|mesh-list
92077224|NCT02020694|Cholecalciferol|cholecalciferol|mesh-list
92077225|NCT02020694|Vitamins|vitamins|mesh-list
92077226|NCT02020694|Micronutrients|micronutrients|mesh-ancestor
92077227|NCT02020694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077228|NCT02020694|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92077229|NCT02020694|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92077230|NCT02019875|Clarithromycin|clarithromycin|mesh-list
92077231|NCT02019875|Rifampin|rifampin|mesh-list
92077232|NCT02019875|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077233|NCT02019875|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077234|NCT02019875|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92077235|NCT02019875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077236|NCT02019875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077466|NCT00119392|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077237|NCT02019875|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92077238|NCT02019875|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92077239|NCT02019875|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92077240|NCT02019875|Antitubercular Agents|antitubercular agents|mesh-ancestor
92077241|NCT02019875|Leprostatic Agents|leprostatic agents|mesh-ancestor
92077242|NCT02019875|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92077243|NCT02019875|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92077244|NCT02019875|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92077245|NCT02019875|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92077246|NCT02019875|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92077247|NCT02019875|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92077248|NCT02019875|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92077249|NCT01907009|Melphalan|melphalan|mesh-list
92077250|NCT01907009|Lenograstim|lenograstim|mesh-list
92077251|NCT01907009|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077252|NCT01907009|Alkylating Agents|alkylating agents|mesh-ancestor
92077253|NCT01907009|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077254|NCT01907009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077255|NCT01907009|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077256|NCT01907009|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077257|NCT01907009|Immunologic Factors|immunologic factors|mesh-ancestor
92077258|NCT01907009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077259|NCT01907009|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92077261|NCT01882933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077262|NCT01726582|Leucovorin|leucovorin|mesh-list
92077263|NCT01726582|Paclitaxel|paclitaxel|mesh-list
92077265|NCT01726582|Gemcitabine|gemcitabine|mesh-list
92077266|NCT01726582|Fluorouracil|fluorouracil|mesh-list
92077267|NCT01726582|Capecitabine|capecitabine|mesh-list
92077268|NCT01726582|Oxaliplatin|oxaliplatin|mesh-list
92077269|NCT01726582|Irinotecan|irinotecan|mesh-list
92077270|NCT01726582|Cisplatin|cisplatin|mesh-list
92077271|NCT01726582|Folfirinox|folfirinox|mesh-list
92077272|NCT01726582|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077273|NCT01726582|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077274|NCT01726582|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077275|NCT01726582|Antimitotic Agents|antimitotic agents|mesh-ancestor
92016176|NCT03062839|Melatonin|melatonin|mesh-list
92016177|NCT03062839|Antioxidants|antioxidants|mesh-ancestor
92016178|NCT03062839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016179|NCT03062839|Protective Agents|protective agents|mesh-ancestor
92016180|NCT03062839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077276|NCT01726582|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077277|NCT01726582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077278|NCT01726582|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077279|NCT01726582|Antimetabolites|antimetabolites|mesh-ancestor
92077280|NCT01726582|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077281|NCT01726582|Immunologic Factors|immunologic factors|mesh-ancestor
92077282|NCT01726582|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077283|NCT01726582|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92077284|NCT01726582|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92077285|NCT01726582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077286|NCT01726582|Antidotes|antidotes|mesh-ancestor
92077287|NCT01726582|Protective Agents|protective agents|mesh-ancestor
92077288|NCT01726582|Vitamin B Complex|vitamin b complex|mesh-ancestor
92077289|NCT01726582|Vitamins|vitamins|mesh-ancestor
92077290|NCT01726582|Micronutrients|micronutrients|mesh-ancestor
92077291|NCT01718743|Lenalidomide|lenalidomide|mesh-list
92077293|NCT01718743|Glycine|glycine|mesh-list
92077294|NCT01718743|Immunologic Factors|immunologic factors|mesh-ancestor
92077295|NCT01718743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077296|NCT01718743|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92077297|NCT01718743|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92077298|NCT01718743|Growth Substances|growth substances|mesh-ancestor
92077299|NCT01718743|Growth Inhibitors|growth inhibitors|mesh-ancestor
92077300|NCT01718743|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077301|NCT01718743|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077302|NCT01718743|Protease Inhibitors|protease inhibitors|mesh-ancestor
92077303|NCT01718743|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077304|NCT01718743|Glycine Agents|glycine agents|mesh-ancestor
92077305|NCT01718743|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077306|NCT01701674|Aldesleukin|aldesleukin|mesh-list
92077307|NCT01701674|Cyclophosphamide|cyclophosphamide|mesh-list
92077308|NCT01701674|Fludarabine|fludarabine|mesh-list
92077309|NCT01701674|Ipilimumab|ipilimumab|mesh-list
92077310|NCT01701674|Interleukin-2|interleukin-2|mesh-list
92077311|NCT01701674|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077312|NCT01701674|Immunologic Factors|immunologic factors|mesh-ancestor
92077313|NCT01701674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077314|NCT01701674|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077315|NCT01701674|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077316|NCT01701674|Alkylating Agents|alkylating agents|mesh-ancestor
92077317|NCT01701674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077318|NCT01701674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077319|NCT01701674|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077320|NCT01701674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077321|NCT01701674|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92077322|NCT01701674|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92077323|NCT01701674|Analgesics|analgesics|mesh-ancestor
92077324|NCT01701674|Sensory System Agents|sensory system agents|mesh-ancestor
92077325|NCT01701674|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077326|NCT01701674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92077327|NCT01701674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92077328|NCT01701674|Antiviral Agents|antiviral agents|mesh-ancestor
92077329|NCT01701674|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077330|NCT01686126|Metformin|metformin|mesh-list
92077331|NCT01686126|Levonorgestrel|levonorgestrel|mesh-list
92077332|NCT01686126|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92077333|NCT01686126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077334|NCT01686126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92077335|NCT01686126|Contraceptive Agents|contraceptive agents|mesh-ancestor
92077336|NCT01686126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92077337|NCT01686126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92077338|NCT01686126|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92077339|NCT01686126|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92077341|NCT01531582|Tetracycline|tetracycline|mesh-list
92016181|NCT03062839|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016182|NCT05540951|Bevacizumab|bevacizumab|mesh-list
92016183|NCT05540951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016184|NCT05540951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077344|NCT01531582|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92077346|NCT01531582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077347|NCT01512888|Busulfan|busulfan|mesh-list
92077348|NCT01512888|Alkylating Agents|alkylating agents|mesh-ancestor
92077349|NCT01512888|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077350|NCT01512888|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077351|NCT01512888|Immunologic Factors|immunologic factors|mesh-ancestor
92077352|NCT01512888|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077353|NCT01512888|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077354|NCT01512888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077355|NCT01512888|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077356|NCT01493453|Cyclophosphamide|cyclophosphamide|mesh-list
92077357|NCT01493453|Fludarabine|fludarabine|mesh-list
92077358|NCT01493453|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077359|NCT01493453|Immunologic Factors|immunologic factors|mesh-ancestor
92077360|NCT01493453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077361|NCT01493453|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077362|NCT01493453|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077363|NCT01493453|Alkylating Agents|alkylating agents|mesh-ancestor
92077364|NCT01493453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077365|NCT01493453|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077366|NCT01493453|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077367|NCT01208662|Dexamethasone|dexamethasone|mesh-list
92077368|NCT01208662|Lenalidomide|lenalidomide|mesh-list
92077369|NCT01208662|Bortezomib|bortezomib|mesh-list
92077370|NCT01208662|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077371|NCT01208662|Antiemetics|antiemetics|mesh-ancestor
92077372|NCT01208662|Autonomic Agents|autonomic agents|mesh-ancestor
92077373|NCT01208662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077374|NCT01208662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077375|NCT01208662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92077376|NCT01208662|Glucocorticoids|glucocorticoids|mesh-ancestor
92077377|NCT01208662|Hormones|hormones|mesh-ancestor
92077378|NCT01208662|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077379|NCT01208662|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92077380|NCT01208662|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077381|NCT01208662|Immunologic Factors|immunologic factors|mesh-ancestor
92077382|NCT01208662|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92077383|NCT01208662|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92077384|NCT01208662|Growth Substances|growth substances|mesh-ancestor
92077385|NCT01208662|Growth Inhibitors|growth inhibitors|mesh-ancestor
92077386|NCT00667199|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92077387|NCT00667199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077388|NCT00460486|Formaldehyde|formaldehyde|mesh-list
92077389|NCT00460486|Disinfectants|disinfectants|mesh-ancestor
92077390|NCT00460486|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077391|NCT00378105|Dexamethasone|dexamethasone|mesh-list
92077392|NCT00378105|Lenalidomide|lenalidomide|mesh-list
92077393|NCT00378105|Bortezomib|bortezomib|mesh-list
92077394|NCT00378105|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077395|NCT00378105|Antiemetics|antiemetics|mesh-ancestor
92077396|NCT00378105|Autonomic Agents|autonomic agents|mesh-ancestor
92077397|NCT00378105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077398|NCT00378105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077399|NCT00378105|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92077400|NCT00378105|Glucocorticoids|glucocorticoids|mesh-ancestor
92077401|NCT00378105|Hormones|hormones|mesh-ancestor
92077402|NCT00378105|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077403|NCT00378105|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92077404|NCT00378105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077405|NCT00378105|Immunologic Factors|immunologic factors|mesh-ancestor
92077406|NCT00378105|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92077407|NCT00378105|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92077408|NCT00378105|Growth Substances|growth substances|mesh-ancestor
92077409|NCT00378105|Growth Inhibitors|growth inhibitors|mesh-ancestor
92077411|NCT00139477|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92016185|NCT05540951|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92016186|NCT05540951|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016187|NCT05540951|Growth Substances|growth substances|mesh-ancestor
92077412|NCT00139477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077414|NCT00082706|Cisplatin|cisplatin|mesh-list
92077415|NCT00082706|Gemcitabine|gemcitabine|mesh-list
92077416|NCT00082706|Fluorouracil|fluorouracil|mesh-list
92077418|NCT00082706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077419|NCT00082706|Antimetabolites|antimetabolites|mesh-ancestor
92077420|NCT00082706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077421|NCT00082706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077422|NCT00082706|Immunologic Factors|immunologic factors|mesh-ancestor
92077423|NCT00082706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077424|NCT00082706|Antidotes|antidotes|mesh-ancestor
92077425|NCT00082706|Protective Agents|protective agents|mesh-ancestor
92077426|NCT00082706|Vitamin B Complex|vitamin b complex|mesh-ancestor
92077427|NCT00082706|Vitamins|vitamins|mesh-ancestor
92077428|NCT00082706|Micronutrients|micronutrients|mesh-ancestor
92077429|NCT00004935|Trastuzumab|trastuzumab|mesh-list
92077430|NCT00004935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077431|NCT00004935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077432|NCT00119158|Fluticasone|fluticasone|mesh-list
92077433|NCT00119158|Xhance|xhance|mesh-list
92077434|NCT00119158|Pimecrolimus|pimecrolimus|mesh-list
92077435|NCT00119158|Tacrolimus|tacrolimus|mesh-list
92077436|NCT00119158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077437|NCT00119158|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92077438|NCT00119158|Autonomic Agents|autonomic agents|mesh-ancestor
92077439|NCT00119158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077440|NCT00119158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077441|NCT00119158|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92077442|NCT00119158|Respiratory System Agents|respiratory system agents|mesh-ancestor
92077443|NCT00119158|Dermatologic Agents|dermatologic agents|mesh-ancestor
92077444|NCT00119158|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92077445|NCT00119158|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92077446|NCT00119158|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92077447|NCT00119158|Analgesics|analgesics|mesh-ancestor
92077448|NCT00119158|Sensory System Agents|sensory system agents|mesh-ancestor
92077449|NCT00119158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077450|NCT00119158|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077451|NCT00119158|Immunologic Factors|immunologic factors|mesh-ancestor
92077452|NCT00119158|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92077453|NCT00119158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077454|NCT00119158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077455|NCT00119392|Cyclosporine|cyclosporine|mesh-list
92077456|NCT00119392|Mycophenolic Acid|mycophenolic acid|mesh-list
92077457|NCT00119392|Rituximab|rituximab|mesh-list
92077458|NCT00119392|Fludarabine|fludarabine|mesh-list
92077459|NCT00119392|Fludarabine phosphate|fludarabine phosphate|mesh-list
92077460|NCT00119392|Cyclosporins|cyclosporins|mesh-list
92077461|NCT00119392|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92077462|NCT00119392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077463|NCT00119392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077464|NCT00119392|Immunologic Factors|immunologic factors|mesh-ancestor
92077465|NCT00119392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077467|NCT00119392|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077468|NCT00119392|Antimetabolites|antimetabolites|mesh-ancestor
92077469|NCT00119392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077470|NCT00119392|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077471|NCT00119392|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077472|NCT00119392|Antifungal Agents|antifungal agents|mesh-ancestor
92077473|NCT00119392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077474|NCT00119392|Dermatologic Agents|dermatologic agents|mesh-ancestor
92077475|NCT00119392|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92077476|NCT00119392|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077477|NCT00119392|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92077478|NCT00119392|Antitubercular Agents|antitubercular agents|mesh-ancestor
92077479|NCT00119392|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077480|NCT00218062|Modafinil|modafinil|mesh-list
92077481|NCT00218062|Amphetamine|amphetamine|mesh-list
92077482|NCT00218062|Dextroamphetamine|dextroamphetamine|mesh-list
92077483|NCT00218062|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92016188|NCT05540951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077484|NCT00218062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077485|NCT00218062|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92077486|NCT00218062|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92077487|NCT00218062|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92077488|NCT00218062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077489|NCT00218062|Sympathomimetics|sympathomimetics|mesh-ancestor
92077490|NCT00218062|Autonomic Agents|autonomic agents|mesh-ancestor
92077491|NCT00218062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077493|NCT00218062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077495|NCT00218062|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92077496|NCT00218062|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92077497|NCT00218062|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92077498|NCT00218062|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92077499|NCT00121186|Methotrexate|methotrexate|mesh-list
92077500|NCT00121186|Fludarabine phosphate|fludarabine phosphate|mesh-list
92077501|NCT00121186|Fludarabine|fludarabine|mesh-list
92077503|NCT00121186|Tacrolimus|tacrolimus|mesh-list
92077504|NCT00121186|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92077505|NCT00121186|Abortifacient Agents|abortifacient agents|mesh-ancestor
92077506|NCT00121186|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92077507|NCT00121186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077508|NCT00121186|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077509|NCT00121186|Antimetabolites|antimetabolites|mesh-ancestor
92077510|NCT00121186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077511|NCT00121186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077512|NCT00121186|Dermatologic Agents|dermatologic agents|mesh-ancestor
92077513|NCT00121186|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077514|NCT00121186|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92077515|NCT00121186|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077516|NCT00121186|Immunologic Factors|immunologic factors|mesh-ancestor
92077517|NCT00121186|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077518|NCT00121186|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92077519|NCT00121186|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92077520|NCT00121186|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077521|NCT00121186|Alkylating Agents|alkylating agents|mesh-ancestor
92077522|NCT00121186|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077523|NCT00121810|Mycophenolic Acid|mycophenolic acid|mesh-list
92077524|NCT00121810|Sirolimus|sirolimus|mesh-list
92077525|NCT00121810|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92077526|NCT00121810|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077527|NCT00121810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077528|NCT00121810|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92077529|NCT00121810|Antitubercular Agents|antitubercular agents|mesh-ancestor
92077530|NCT00121810|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077531|NCT00121810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077532|NCT00121810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077533|NCT00121810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077534|NCT00121810|Antifungal Agents|antifungal agents|mesh-ancestor
92077535|NCT00121810|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077536|NCT00121810|Immunologic Factors|immunologic factors|mesh-ancestor
92077537|NCT00121810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077538|NCT00053014|Cyclosporine|cyclosporine|mesh-list
92077539|NCT00053014|Mycophenolic Acid|mycophenolic acid|mesh-list
92077540|NCT00053014|Fludarabine|fludarabine|mesh-list
92077541|NCT00053014|Cyclosporins|cyclosporins|mesh-list
92077542|NCT00053014|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016222|NCT05698511|Hallucinogens|hallucinogens|mesh-ancestor
92077543|NCT00053014|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077544|NCT00053014|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077545|NCT00053014|Immunologic Factors|immunologic factors|mesh-ancestor
92077546|NCT00053014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077547|NCT00053014|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077548|NCT00053014|Antifungal Agents|antifungal agents|mesh-ancestor
92077549|NCT00053014|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077550|NCT00053014|Dermatologic Agents|dermatologic agents|mesh-ancestor
92077551|NCT00053014|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077552|NCT00053014|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92077553|NCT00053014|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077554|NCT00053014|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92077555|NCT00053014|Antitubercular Agents|antitubercular agents|mesh-ancestor
92077556|NCT00053014|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077557|NCT00123604|Metoprolol|metoprolol|mesh-list
92016189|NCT05540951|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016190|NCT04964505|Azacitidine|azacitidine|mesh-list
92016191|NCT04964505|Venetoclax|venetoclax|mesh-list
92077558|NCT00123604|Carvedilol|carvedilol|mesh-list
92077559|NCT00123604|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92077560|NCT00123604|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92077561|NCT00123604|Sympatholytics|sympatholytics|mesh-ancestor
92077562|NCT00123604|Autonomic Agents|autonomic agents|mesh-ancestor
92077563|NCT00123604|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077564|NCT00123604|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077570|NCT00123604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077571|NCT00123604|Antioxidants|antioxidants|mesh-ancestor
92077572|NCT00123604|Protective Agents|protective agents|mesh-ancestor
92077573|NCT00123604|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92077574|NCT00123604|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92077575|NCT00123604|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92077576|NCT00123604|Vasodilator Agents|vasodilator agents|mesh-ancestor
92077577|NCT00123604|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92077578|NCT00123604|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92077579|NCT00221338|Gabapentin|gabapentin|mesh-list
92077580|NCT00221338|Analgesics|analgesics|mesh-ancestor
92077581|NCT00221338|Sensory System Agents|sensory system agents|mesh-ancestor
92077582|NCT00221338|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077583|NCT00221338|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077584|NCT00221338|Anticonvulsants|anticonvulsants|mesh-ancestor
92077585|NCT00221338|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92077586|NCT00221338|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92077587|NCT00221338|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077588|NCT00221338|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92077589|NCT00221338|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92077590|NCT00221338|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92077591|NCT00221338|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077592|NCT00221338|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077593|NCT00221338|Antimanic Agents|antimanic agents|mesh-ancestor
92077594|NCT00223678|Sirolimus|sirolimus|mesh-list
92077595|NCT00223678|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077596|NCT00223678|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077597|NCT00223678|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077598|NCT00223678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077599|NCT00223678|Antifungal Agents|antifungal agents|mesh-ancestor
92077600|NCT00223678|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077601|NCT00223678|Immunologic Factors|immunologic factors|mesh-ancestor
92077602|NCT00223678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077603|NCT00053482|Vaccines|vaccines|mesh-list
92077604|NCT00053482|Immunologic Factors|immunologic factors|mesh-ancestor
92077605|NCT00053482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077606|NCT00130780|Bevacizumab|bevacizumab|mesh-list
92077607|NCT00130780|Docetaxel|docetaxel|mesh-list
92077608|NCT00130780|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077609|NCT00130780|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077610|NCT00130780|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92077611|NCT00130780|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92077612|NCT00130780|Growth Substances|growth substances|mesh-ancestor
92077613|NCT00130780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077614|NCT00130780|Growth Inhibitors|growth inhibitors|mesh-ancestor
92077615|NCT00130780|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077616|NCT00130780|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077617|NCT00130780|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077618|NCT00130780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077619|NCT00225784|Gemcitabine|gemcitabine|mesh-list
92077620|NCT00225784|Cetuximab|cetuximab|mesh-list
92077621|NCT00225784|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077622|NCT00225784|Antimetabolites|antimetabolites|mesh-ancestor
92077623|NCT00225784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077624|NCT00225784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077625|NCT00225784|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077626|NCT02092168|Opicapone|opicapone|mesh-list
92077627|NCT02092168|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92077628|NCT02092168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077629|NCT02092168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077630|NCT02092168|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92016192|NCT04964505|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016194|NCT04964505|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077631|NCT02092168|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92077632|NCT00133978|Selenium|selenium|mesh-list
92077633|NCT00133978|Antioxidants|antioxidants|mesh-list
92077636|NCT00133978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077637|NCT00133978|Trace Elements|trace elements|mesh-ancestor
92077638|NCT00133978|Micronutrients|micronutrients|mesh-ancestor
92077639|NCT01897324|Hormones|hormones|mesh-list
92077640|NCT01897324|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077641|NCT01897324|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077642|NCT00254410|Cyclophosphamide|cyclophosphamide|mesh-list
92077643|NCT00254410|Rituximab|rituximab|mesh-list
92077644|NCT00254410|Fludarabine|fludarabine|mesh-list
92077645|NCT00254410|Mitoxantrone|mitoxantrone|mesh-list
92077646|NCT00254410|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077647|NCT00254410|Immunologic Factors|immunologic factors|mesh-ancestor
92077648|NCT00254410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077649|NCT00254410|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077650|NCT00254410|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92077651|NCT00254410|Alkylating Agents|alkylating agents|mesh-ancestor
92077652|NCT00254410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077653|NCT00254410|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077654|NCT00254410|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92077655|NCT00254410|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077656|NCT00254410|Analgesics|analgesics|mesh-ancestor
92077657|NCT00254410|Sensory System Agents|sensory system agents|mesh-ancestor
92077658|NCT00254410|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077659|NCT00254410|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92077660|NCT00254410|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92077661|NCT00254410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077662|NCT00254488|Valproic Acid|valproic acid|mesh-list
92077663|NCT00254488|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92077664|NCT00254488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077665|NCT00254488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077666|NCT00254488|Antimanic Agents|antimanic agents|mesh-ancestor
92077667|NCT00254488|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92077668|NCT00254488|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077669|NCT00254488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077670|NCT00254488|Anticonvulsants|anticonvulsants|mesh-ancestor
92077671|NCT00254488|GABA Agents|gaba agents|mesh-ancestor
92077672|NCT00254488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077673|NCT01899118|Capecitabine|capecitabine|mesh-list
92077674|NCT01899118|Oxaliplatin|oxaliplatin|mesh-list
92077675|NCT01899118|Nimotuzumab|nimotuzumab|mesh-list
92077676|NCT01899118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077677|NCT01899118|Antimetabolites|antimetabolites|mesh-ancestor
92077678|NCT01899118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077679|NCT01899118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077680|NCT01899118|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077681|NCT00231868|Paclitaxel|paclitaxel|mesh-list
92077682|NCT00231868|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92077683|NCT00231868|Carboplatin|carboplatin|mesh-list
92077684|NCT00231868|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077685|NCT00231868|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077686|NCT00231868|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077687|NCT00231868|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077688|NCT00231868|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077689|NCT00231868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077690|NCT00257686|Pravastatin|pravastatin|mesh-list
92077691|NCT00257686|Pitavastatin|pitavastatin|mesh-list
92077692|NCT00257686|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92077693|NCT00257686|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92077694|NCT00257686|Antimetabolites|antimetabolites|mesh-ancestor
92077790|NCT01606748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077695|NCT00257686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077696|NCT00257686|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92077697|NCT00257686|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92077698|NCT00257686|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077699|NCT01469013|Methotrexate|methotrexate|mesh-list
92077700|NCT01469013|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92077701|NCT01469013|Abortifacient Agents|abortifacient agents|mesh-ancestor
92016195|NCT04964505|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016196|NCT04964505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016198|NCT04981093|Dexamethasone acetate|dexamethasone acetate|mesh-list
92016199|NCT04981093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016200|NCT04981093|Antiemetics|antiemetics|mesh-ancestor
92077702|NCT01469013|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92077703|NCT01469013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077704|NCT01469013|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077705|NCT01469013|Antimetabolites|antimetabolites|mesh-ancestor
92077729|NCT01766336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077731|NCT01797302|Cholecalciferol|cholecalciferol|mesh-list
92077732|NCT01797302|Vitamins|vitamins|mesh-ancestor
92077733|NCT01797302|Micronutrients|micronutrients|mesh-ancestor
92077734|NCT01797302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077735|NCT01797302|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92077736|NCT01797302|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92077737|NCT01804946|Oseltamivir|oseltamivir|mesh-list
92077738|NCT01804946|Antiviral Agents|antiviral agents|mesh-ancestor
92077739|NCT01804946|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077740|NCT01804946|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077741|NCT01804946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077742|NCT01795898|Fentanyl|fentanyl|mesh-list
92077743|NCT01795898|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92077744|NCT01795898|Narcotics|narcotics|mesh-ancestor
92077745|NCT01795898|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077746|NCT01795898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077747|NCT01795898|Analgesics|analgesics|mesh-ancestor
92077748|NCT01795898|Sensory System Agents|sensory system agents|mesh-ancestor
92077749|NCT01795898|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077750|NCT01795898|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92077751|NCT01795898|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92077752|NCT01795898|Anesthetics, General|anesthetics, general|mesh-ancestor
92077753|NCT01795898|Anesthetics|anesthetics|mesh-ancestor
92077754|NCT01736696|Tofacitinib|tofacitinib|mesh-list
92077755|NCT01736696|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92077756|NCT01736696|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92077757|NCT01736696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077758|NCT01736696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077760|NCT01609478|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077761|NCT01609478|Dermatologic Agents|dermatologic agents|mesh-ancestor
92077762|NCT01609478|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92077763|NCT01764464|Gabapentin|gabapentin|mesh-list
92077764|NCT01764464|Analgesics|analgesics|mesh-ancestor
92077765|NCT01764464|Sensory System Agents|sensory system agents|mesh-ancestor
92077766|NCT01764464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077767|NCT01764464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077768|NCT01764464|Anticonvulsants|anticonvulsants|mesh-ancestor
92077769|NCT01764464|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92077770|NCT01764464|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92077771|NCT01764464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077772|NCT01764464|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92077773|NCT01764464|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92077774|NCT01764464|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92077775|NCT01764464|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077776|NCT01764464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077777|NCT01764464|Antimanic Agents|antimanic agents|mesh-ancestor
92077778|NCT01763918|Evolocumab|evolocumab|mesh-list
92077779|NCT01763918|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92077780|NCT01763918|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92077781|NCT01763918|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92077782|NCT01763918|Antimetabolites|antimetabolites|mesh-ancestor
92077783|NCT01763918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077784|NCT01763918|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92077785|NCT01763918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92077786|NCT01763918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077787|NCT01763918|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92077788|NCT01606748|Gemcitabine|gemcitabine|mesh-list
92077789|NCT01606748|Necitumumab|necitumumab|mesh-list
92016221|NCT05698511|Psilocybin|psilocybin|mesh-list
92077791|NCT01606748|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016201|NCT04981093|Autonomic Agents|autonomic agents|mesh-ancestor
92016202|NCT04981093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016203|NCT04981093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016204|NCT04981093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016205|NCT04981093|Glucocorticoids|glucocorticoids|mesh-ancestor
92016206|NCT04981093|Hormones|hormones|mesh-ancestor
92016207|NCT04981093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016208|NCT04981093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016209|NCT04981093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077792|NCT01606748|Antimetabolites|antimetabolites|mesh-ancestor
92077793|NCT01606748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077794|NCT01606748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077795|NCT01597622|Belimumab|belimumab|mesh-list
92077796|NCT01597622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077797|NCT01597622|Immunologic Factors|immunologic factors|mesh-ancestor
92077798|NCT01597622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077799|NCT01761266|Sorafenib|sorafenib|mesh-list
92077800|NCT01761266|Lenvatinib|lenvatinib|mesh-list
92077801|NCT01761266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077802|NCT01761266|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92077803|NCT01761266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077804|NCT01761266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077805|NCT01759862|Aminophylline|aminophylline|mesh-list
92077806|NCT01759862|Theophylline|theophylline|mesh-list
92077807|NCT01759862|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92077808|NCT01759862|Autonomic Agents|autonomic agents|mesh-ancestor
92077809|NCT01759862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077810|NCT01759862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077811|NCT01759862|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92077812|NCT01759862|Respiratory System Agents|respiratory system agents|mesh-ancestor
92077813|NCT01759862|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92077814|NCT01759862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077815|NCT01759862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077816|NCT01759862|Vasodilator Agents|vasodilator agents|mesh-ancestor
92077817|NCT01759862|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92077818|NCT01759862|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92077819|NCT01759862|Purinergic Agents|purinergic agents|mesh-ancestor
92077820|NCT01759862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077821|NCT01759862|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92077822|NCT01759862|Protective Agents|protective agents|mesh-ancestor
92077824|NCT01790828|Coagulants|coagulants|mesh-ancestor
92077825|NCT01790594|Mycophenolic Acid|mycophenolic acid|mesh-list
92077826|NCT01790594|Methylprednisolone|methylprednisolone|mesh-list
92077827|NCT01790594|Abatacept|abatacept|mesh-list
92077828|NCT01790594|Tacrolimus|tacrolimus|mesh-list
92077829|NCT01790594|Thymoglobulin|thymoglobulin|mesh-list
92077830|NCT01790594|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92077831|NCT01790594|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077832|NCT01790594|Immunologic Factors|immunologic factors|mesh-ancestor
92077833|NCT01790594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077834|NCT01790594|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92077837|NCT01790594|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92077838|NCT01790594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077839|NCT01790594|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92077840|NCT01790594|Antitubercular Agents|antitubercular agents|mesh-ancestor
92077841|NCT01790594|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077842|NCT01790594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077843|NCT01790594|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92077844|NCT01790594|Antiemetics|antiemetics|mesh-ancestor
92077845|NCT01790594|Autonomic Agents|autonomic agents|mesh-ancestor
92077846|NCT01790594|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077847|NCT01790594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92077848|NCT01790594|Glucocorticoids|glucocorticoids|mesh-ancestor
92077849|NCT01790594|Hormones|hormones|mesh-ancestor
92077850|NCT01790594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016211|NCT05551247|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016212|NCT05551247|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92016213|NCT05551247|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016214|NCT05551247|Growth Substances|growth substances|mesh-ancestor
92016215|NCT05551247|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016216|NCT05551247|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016217|NCT05540483|Disitamab vedotin|disitamab vedotin|mesh-list
92016218|NCT05540483|Immunoconjugates|immunoconjugates|mesh-ancestor
92016219|NCT05540483|Immunologic Factors|immunologic factors|mesh-ancestor
92016220|NCT05540483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016223|NCT05698511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016224|NCT05698511|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92016225|NCT02629861|Calcitonin|calcitonin|mesh-list
92016226|NCT02629861|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92016227|NCT02629861|Katacalcin|katacalcin|mesh-list
92016228|NCT02629861|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92077851|NCT01790594|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92077852|NCT01790594|Protective Agents|protective agents|mesh-ancestor
92077853|NCT01790594|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92077854|NCT01790594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077855|NCT01790594|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077856|NCT01790516|Cetuximab|cetuximab|mesh-list
92077857|NCT01790516|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077858|NCT01790516|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077859|NCT01790438|Insulin|insulin|mesh-list
92077860|NCT01790438|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92077861|NCT01790438|Isophane Insulin, Human|isophane insulin, human|mesh-list
92077862|NCT01790438|Insulin, Isophane|insulin, isophane|mesh-list
92077863|NCT01790438|Isophane insulin, beef|isophane insulin, beef|mesh-list
92077864|NCT01790438|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92077865|NCT01790438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077866|NCT01790126|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92077867|NCT01790126|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92077868|NCT01790126|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077869|NCT01790126|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92077870|NCT01790126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077871|NCT01790126|Luteolytic Agents|luteolytic agents|mesh-ancestor
92077872|NCT01790126|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92077873|NCT01790126|Contraceptive Agents|contraceptive agents|mesh-ancestor
92077874|NCT01790126|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92077875|NCT01734902|Scopolamine|scopolamine|mesh-list
92077876|NCT01734902|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92077877|NCT01734902|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92077878|NCT01734902|Antiemetics|antiemetics|mesh-ancestor
92077879|NCT01734902|Autonomic Agents|autonomic agents|mesh-ancestor
92077880|NCT01734902|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077881|NCT01734902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077882|NCT01734902|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92077883|NCT01734902|Mydriatics|mydriatics|mesh-ancestor
92077884|NCT01734902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92077885|NCT01734902|Cholinergic Agents|cholinergic agents|mesh-ancestor
92077886|NCT01734902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016229|NCT02629861|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016230|NCT02629861|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92016231|NCT02629861|Vasodilator Agents|vasodilator agents|mesh-ancestor
92016233|NCT02513823|Cholecalciferol|cholecalciferol|mesh-list
92016234|NCT02513823|Vitamins|vitamins|mesh-ancestor
92016235|NCT02513823|Micronutrients|micronutrients|mesh-ancestor
92016236|NCT02513823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016237|NCT02513823|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92016238|NCT02513823|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92077887|NCT01734902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077888|NCT01734902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92077889|NCT01734902|Parasympatholytics|parasympatholytics|mesh-ancestor
92077890|NCT01789970|Hydrocodone|hydrocodone|mesh-list
92077891|NCT01789970|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92077892|NCT01789970|Narcotics|narcotics|mesh-ancestor
92077893|NCT01789970|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077894|NCT01789970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077895|NCT01789970|Analgesics|analgesics|mesh-ancestor
92077896|NCT01789970|Sensory System Agents|sensory system agents|mesh-ancestor
92077897|NCT01789970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92077898|NCT01789970|Antitussive Agents|antitussive agents|mesh-ancestor
92077899|NCT01789970|Respiratory System Agents|respiratory system agents|mesh-ancestor
92077900|NCT01788566|Gemcitabine|gemcitabine|mesh-list
92077901|NCT01788566|Necitumumab|necitumumab|mesh-list
92077902|NCT01788566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077903|NCT01788566|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92077904|NCT01788566|Antimetabolites|antimetabolites|mesh-ancestor
92077905|NCT01788566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077906|NCT01788566|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077912|NCT01732796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077913|NCT01732796|Antiviral Agents|antiviral agents|mesh-ancestor
92077914|NCT01732796|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077915|NCT01732640|Paclitaxel|paclitaxel|mesh-list
92077916|NCT01732640|Cisplatin|cisplatin|mesh-list
92077917|NCT01732640|Carboplatin|carboplatin|mesh-list
92077918|NCT01732640|Afatinib|afatinib|mesh-list
92077919|NCT01732640|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077920|NCT01732640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077921|NCT01732640|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077922|NCT01732640|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077923|NCT01732640|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077924|NCT01732640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077925|NCT01732640|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92077926|NCT01732640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077927|NCT04560686|Atezolizumab|atezolizumab|mesh-list
92077928|NCT04560686|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92077929|NCT04560686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077930|NCT04560686|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077931|NCT04560686|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077932|NCT01757288|Paclitaxel|paclitaxel|mesh-list
92077933|NCT01757288|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92077934|NCT01757288|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077935|NCT01757288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077936|NCT01757288|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077937|NCT01757288|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077938|NCT01757288|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077939|NCT01757288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077940|NCT01731938|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92077941|NCT01731938|Hemostatics|hemostatics|mesh-ancestor
92077942|NCT01731938|Coagulants|coagulants|mesh-ancestor
92077943|NCT01731002|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92077944|NCT01731002|Latanoprost|latanoprost|mesh-list
92077945|NCT01731002|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92016239|NCT05545475|Heparin|heparin|mesh-list
92016240|NCT05545475|Enoxaparin|enoxaparin|mesh-list
92016241|NCT05545475|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92016242|NCT05545475|Tinzaparin|tinzaparin|mesh-list
92016243|NCT05545475|Dalteparin|dalteparin|mesh-list
92016244|NCT05545475|Nadroparin|nadroparin|mesh-list
92016246|NCT05545475|Anticoagulants|anticoagulants|mesh-ancestor
92016247|NCT05545475|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92016248|NCT05545475|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92016249|NCT05545475|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016250|NCT05545397|Propofol|propofol|mesh-list
92016251|NCT05545397|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92016252|NCT05545397|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016253|NCT05545397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016254|NCT05545397|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92016255|NCT05545397|Anesthetics, General|anesthetics, general|mesh-ancestor
92016256|NCT05545397|Anesthetics|anesthetics|mesh-ancestor
92016257|NCT04952727|Vaccines|vaccines|mesh-list
92077946|NCT01783886|Aflibercept|aflibercept|mesh-list
92077947|NCT01783886|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92077948|NCT01783886|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92077949|NCT01783886|Growth Substances|growth substances|mesh-ancestor
92077950|NCT01783886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077951|NCT01783886|Growth Inhibitors|growth inhibitors|mesh-ancestor
92077952|NCT01783886|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077953|NCT01609556|Maytansine|maytansine|mesh-list
92077954|NCT01609556|Mirvetuximab soravtansine|mirvetuximab soravtansine|mesh-list
92077955|NCT01609556|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92077956|NCT01609556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077957|NCT01609556|Tubulin Modulators|tubulin modulators|mesh-ancestor
92077958|NCT01609556|Antimitotic Agents|antimitotic agents|mesh-ancestor
92077959|NCT01609556|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077960|NCT01609556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077961|NCT01609556|Immunoconjugates|immunoconjugates|mesh-ancestor
92077962|NCT01609556|Immunologic Factors|immunologic factors|mesh-ancestor
92077963|NCT01609556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077964|NCT00234832|Sibutramine|sibutramine|mesh-list
92077965|NCT00234832|Antidepressive Agents|antidepressive agents|mesh-ancestor
92077966|NCT00234832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92077967|NCT00234832|Appetite Depressants|appetite depressants|mesh-ancestor
92077968|NCT00234832|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92077969|NCT00259090|Fulvestrant|fulvestrant|mesh-list
92077970|NCT00259090|Anastrozole|anastrozole|mesh-list
92077971|NCT00259090|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92077972|NCT00259090|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077973|NCT00259090|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92077974|NCT00259090|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92077975|NCT00259090|Hormone Antagonists|hormone antagonists|mesh-ancestor
92016284|NCT03063073|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92077976|NCT00259090|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92077977|NCT00259090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077981|NCT00259090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077983|NCT00236938|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92077984|NCT00236938|Hematinics|hematinics|mesh-ancestor
92077986|NCT01898728|Cadexomer iodine|cadexomer iodine|mesh-list
92077987|NCT01898728|Povidone-Iodine|povidone-iodine|mesh-list
92077989|NCT01898728|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92077990|NCT01898728|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92077991|NCT01898728|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92077992|NCT01898728|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016258|NCT04952727|Immunologic Factors|immunologic factors|mesh-ancestor
92016259|NCT04952727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016260|NCT04433143|Minocycline|minocycline|mesh-list
92016261|NCT04433143|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016262|NCT04433143|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016263|NCT01665911|Listerine|listerine|mesh-list
92016264|NCT01665911|Fluorides|fluorides|mesh-list
92016265|NCT01665911|Sodium Fluoride|sodium fluoride|mesh-list
92016266|NCT01665911|Cariostatic Agents|cariostatic agents|mesh-ancestor
92016267|NCT01665911|Protective Agents|protective agents|mesh-ancestor
92016268|NCT01665911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016269|NCT01665911|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92016270|NCT01665911|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016271|NCT03063073|Dexmedetomidine|dexmedetomidine|mesh-list
92016272|NCT03063073|Bupivacaine|bupivacaine|mesh-list
92016273|NCT03063073|Anesthetics, Local|anesthetics, local|mesh-ancestor
92016274|NCT03063073|Anesthetics|anesthetics|mesh-ancestor
92016275|NCT03063073|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92077993|NCT01898728|Trace Elements|trace elements|mesh-ancestor
92077994|NCT01898728|Micronutrients|micronutrients|mesh-ancestor
92077995|NCT01898728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077996|NCT01898728|Plasma Substitutes|plasma substitutes|mesh-ancestor
92077997|NCT01898728|Blood Substitutes|blood substitutes|mesh-ancestor
92077998|NCT00260962|Olanzapine|olanzapine|mesh-list
92077999|NCT00260962|Antiemetics|antiemetics|mesh-ancestor
92078000|NCT00260962|Autonomic Agents|autonomic agents|mesh-ancestor
92078001|NCT00260962|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078002|NCT00260962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078003|NCT00260962|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078004|NCT00260962|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92078005|NCT00260962|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92078006|NCT00260962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078007|NCT00260962|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078008|NCT00260962|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92078009|NCT00260962|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92078010|NCT00260962|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078011|NCT00260962|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078012|NCT00260962|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078013|NCT00260962|Serotonin Agents|serotonin agents|mesh-ancestor
92078015|NCT00237718|Tocopherols|tocopherols|mesh-list
92078016|NCT00237718|Tocotrienols|tocotrienols|mesh-list
92078017|NCT00237718|alpha-Tocopherol|alpha-tocopherol|mesh-list
92078018|NCT00237718|Thioctic Acid|thioctic acid|mesh-list
92078019|NCT00237718|Vitamins|vitamins|mesh-ancestor
92078020|NCT00237718|Micronutrients|micronutrients|mesh-ancestor
92078021|NCT00237718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078022|NCT00237718|Antioxidants|antioxidants|mesh-ancestor
92078023|NCT00237718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078024|NCT00237718|Protective Agents|protective agents|mesh-ancestor
92078025|NCT00237718|Vitamin B Complex|vitamin b complex|mesh-ancestor
92078026|NCT00238108|Melatonin|melatonin|mesh-list
92078027|NCT00238108|Antioxidants|antioxidants|mesh-ancestor
92078028|NCT00238108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078029|NCT00238108|Protective Agents|protective agents|mesh-ancestor
92078030|NCT00238108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078031|NCT00238108|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078032|NCT00266110|Trastuzumab|trastuzumab|mesh-list
92078033|NCT00266110|Vinorelbine|vinorelbine|mesh-list
92016276|NCT03063073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016277|NCT03063073|Sensory System Agents|sensory system agents|mesh-ancestor
92016278|NCT03063073|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016279|NCT03063073|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92016280|NCT03063073|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016282|NCT03063073|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92016283|NCT03063073|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92016285|NCT03063073|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016286|NCT03063073|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016287|NCT03063073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016288|NCT04620733|Seladelpar|seladelpar|mesh-list
92016289|NCT04620733|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92016290|NCT04620733|Antimetabolites|antimetabolites|mesh-ancestor
92016291|NCT04620733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016292|NCT04620733|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92078034|NCT00266110|Sargramostim|sargramostim|mesh-list
92078035|NCT00266110|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078036|NCT00266110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078037|NCT00266110|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92078038|NCT00266110|Tubulin Modulators|tubulin modulators|mesh-ancestor
92078039|NCT00266110|Antimitotic Agents|antimitotic agents|mesh-ancestor
92078040|NCT00266110|Mitosis Modulators|mitosis modulators|mesh-ancestor
92078041|NCT00266110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078042|NCT00266110|Immunologic Factors|immunologic factors|mesh-ancestor
92078043|NCT00266110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078044|NCT00240526|Immunoglobulins|immunoglobulins|mesh-list
92078045|NCT00240526|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92078046|NCT00240526|Antibodies|antibodies|mesh-list
92078047|NCT00240526|Immunologic Factors|immunologic factors|mesh-ancestor
92078048|NCT00240526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078049|NCT00242632|Memantine|memantine|mesh-list
92078050|NCT00242632|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92078051|NCT00242632|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92078055|NCT00242632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078056|NCT00242632|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92078057|NCT00242632|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92078058|NCT01899430|Metformin|metformin|mesh-list
92078059|NCT01899430|Liraglutide|liraglutide|mesh-list
92078060|NCT01899430|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078061|NCT01899430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078062|NCT01899430|Incretins|incretins|mesh-ancestor
92078063|NCT01899430|Hormones|hormones|mesh-ancestor
92078064|NCT01899430|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078065|NCT00267670|Pentoxifylline|pentoxifylline|mesh-list
92078066|NCT00267670|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92078067|NCT00267670|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078068|NCT00267670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078069|NCT00267670|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92078070|NCT00267670|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92078071|NCT00267670|Protective Agents|protective agents|mesh-ancestor
92078072|NCT00267670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078073|NCT00267670|Vasodilator Agents|vasodilator agents|mesh-ancestor
92078074|NCT00267670|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92078075|NCT00267670|Antioxidants|antioxidants|mesh-ancestor
92078076|NCT00247624|Eszopiclone|eszopiclone|mesh-list
92016293|NCT02476617|Ritonavir|ritonavir|mesh-list
92016294|NCT02476617|Ribavirin|ribavirin|mesh-list
92016295|NCT02476617|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92016296|NCT02476617|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92016297|NCT02476617|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016298|NCT02476617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016299|NCT02476617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078077|NCT00247624|Fluoxetine|fluoxetine|mesh-list
92078078|NCT00247624|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92078079|NCT00247624|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92078080|NCT00247624|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078081|NCT00247624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078082|NCT00247624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078083|NCT00247624|Serotonin Agents|serotonin agents|mesh-ancestor
92078084|NCT00247624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078085|NCT00247624|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92078086|NCT00247624|Antidepressive Agents|antidepressive agents|mesh-ancestor
92078087|NCT00247624|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078088|NCT00247624|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92078089|NCT00247624|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92078090|NCT00247624|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078091|NCT00247624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92078092|NCT00247624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078093|NCT00248560|Gemcitabine|gemcitabine|mesh-list
92078094|NCT00248560|Docetaxel|docetaxel|mesh-list
92078095|NCT00248560|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92078096|NCT00248560|Antimetabolites|antimetabolites|mesh-ancestor
92078097|NCT00248560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078098|NCT00248560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078099|NCT00248560|Tubulin Modulators|tubulin modulators|mesh-ancestor
92078100|NCT00248560|Antimitotic Agents|antimitotic agents|mesh-ancestor
92078101|NCT00248560|Mitosis Modulators|mitosis modulators|mesh-ancestor
92078102|NCT00268762|Argatroban|argatroban|mesh-list
92078103|NCT00268762|Antithrombins|antithrombins|mesh-ancestor
92078104|NCT00268762|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92078105|NCT00268762|Protease Inhibitors|protease inhibitors|mesh-ancestor
92078106|NCT00268762|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078107|NCT00268762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078108|NCT00268762|Anticoagulants|anticoagulants|mesh-ancestor
92078109|NCT00268762|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92078110|NCT00270634|Tacrolimus|tacrolimus|mesh-list
92078111|NCT00270634|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078112|NCT00270634|Immunologic Factors|immunologic factors|mesh-ancestor
92078113|NCT00270634|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078114|NCT00270634|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92078115|NCT00270634|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078116|NCT00270634|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078117|NCT04110340|Ciprofloxacin|ciprofloxacin|mesh-list
92078118|NCT04110340|Gentamicins|gentamicins|mesh-list
92078119|NCT04110340|Streptomycin|streptomycin|mesh-list
92078120|NCT04110340|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078121|NCT04110340|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078122|NCT04110340|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92078125|NCT04110340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078126|NCT04110340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078127|NCT04110340|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92078128|NCT04110340|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92078129|NCT04110340|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92078130|NCT00270790|Carboplatin|carboplatin|mesh-list
92078131|NCT00270790|Amifostine|amifostine|mesh-list
92078132|NCT00270790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078133|NCT00270790|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92078134|NCT00270790|Protective Agents|protective agents|mesh-ancestor
92078135|NCT00270790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078136|NCT00271570|Infliximab|infliximab|mesh-list
92078137|NCT00271570|Immunoglobulins|immunoglobulins|mesh-list
92078138|NCT00271570|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92078139|NCT00271570|Antibodies|antibodies|mesh-list
92016301|NCT02476617|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92016302|NCT02476617|Antiviral Agents|antiviral agents|mesh-ancestor
92016303|NCT02476617|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016304|NCT02476617|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92016305|NCT02476617|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92016306|NCT02476617|Antimetabolites|antimetabolites|mesh-ancestor
92016307|NCT04428307|Artemisinins|artemisinins|mesh-list
92016308|NCT04428307|Artemisinin|artemisinin|mesh-list
92016309|NCT04428307|Antimalarials|antimalarials|mesh-ancestor
92016310|NCT04428307|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92078140|NCT00271570|gamma-Globulins|gamma-globulins|mesh-list
92078141|NCT00271570|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92078142|NCT00271570|Immunologic Factors|immunologic factors|mesh-ancestor
92078143|NCT00271570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078144|NCT00271570|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92078145|NCT00271570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078146|NCT00271570|Dermatologic Agents|dermatologic agents|mesh-ancestor
92078147|NCT00271570|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078148|NCT00271570|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078149|NCT05237596|Acetaminophen|acetaminophen|mesh-list
92078150|NCT05237596|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92078151|NCT05237596|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92078152|NCT05237596|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92078153|NCT05237596|Analgesics|analgesics|mesh-ancestor
92078154|NCT05237596|Sensory System Agents|sensory system agents|mesh-ancestor
92078155|NCT05237596|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078156|NCT05237596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078158|NCT05237596|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078159|NCT02102932|Metformin|metformin|mesh-list
92078160|NCT02102932|Empagliflozin|empagliflozin|mesh-list
92078161|NCT02102932|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078162|NCT02102932|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078163|NCT02102932|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92078164|NCT02102932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078166|NCT00273754|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92078167|NCT00273754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078168|NCT00273754|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92078169|NCT00273754|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078170|NCT00273754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078171|NCT00273754|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92078172|NCT00273754|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92078173|NCT00273754|Purinergic Agents|purinergic agents|mesh-ancestor
92078174|NCT00273754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078175|NCT04751344|Bupivacaine|bupivacaine|mesh-list
92078176|NCT04751344|Anesthetics, Local|anesthetics, local|mesh-ancestor
92078177|NCT04751344|Anesthetics|anesthetics|mesh-ancestor
92078178|NCT04751344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078179|NCT04751344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078180|NCT04751344|Sensory System Agents|sensory system agents|mesh-ancestor
92078181|NCT04751344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078182|NCT05211232|Tislelizumab|tislelizumab|mesh-list
92078183|NCT05211232|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078184|NCT05211232|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078185|NCT00273910|Imiquimod|imiquimod|mesh-list
92078186|NCT00273910|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92078187|NCT00273910|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92078188|NCT00273910|Immunologic Factors|immunologic factors|mesh-ancestor
92078189|NCT00273910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078190|NCT00273910|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078191|NCT00273910|Interferon Inducers|interferon inducers|mesh-ancestor
92078192|NCT00274768|Capecitabine|capecitabine|mesh-list
92078193|NCT00274768|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92078194|NCT00274768|Antimetabolites|antimetabolites|mesh-ancestor
92016311|NCT04428307|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92016312|NCT04428307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016313|NCT05535725|Vancomycin|vancomycin|mesh-list
92016314|NCT05535725|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016315|NCT05535725|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016316|NCT05535569|Paclitaxel|paclitaxel|mesh-list
92016317|NCT05535569|Nivolumab|nivolumab|mesh-list
92016318|NCT05535569|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016319|NCT05535569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016320|NCT05535569|Tubulin Modulators|tubulin modulators|mesh-ancestor
92016321|NCT05535569|Antimitotic Agents|antimitotic agents|mesh-ancestor
92016322|NCT05535569|Mitosis Modulators|mitosis modulators|mesh-ancestor
92016323|NCT05535569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016324|NCT05535569|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078195|NCT00274768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078196|NCT00274768|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078200|NCT00280384|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92078201|NCT00280384|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92078202|NCT00280384|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078203|NCT00280384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078204|NCT00280384|Cholinergic Agents|cholinergic agents|mesh-ancestor
92078205|NCT00280384|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078206|NCT00280384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078207|NCT00280384|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92078208|NCT00280384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078209|NCT00280384|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92078210|NCT01763996|Febuxostat|febuxostat|mesh-list
92078211|NCT01763996|Gout Suppressants|gout suppressants|mesh-ancestor
92078212|NCT01763996|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078213|NCT01790464|Lidocaine|lidocaine|mesh-list
92078214|NCT01790464|Anesthetics, Local|anesthetics, local|mesh-ancestor
92078215|NCT01790464|Anesthetics|anesthetics|mesh-ancestor
92078216|NCT01790464|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078217|NCT01790464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078218|NCT01790464|Sensory System Agents|sensory system agents|mesh-ancestor
92078219|NCT01790464|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078220|NCT01790464|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92078221|NCT01790464|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92078222|NCT01790464|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92078223|NCT01790464|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078224|NCT01790464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078225|NCT01790542|Iron|iron|mesh-list
92078226|NCT01790542|Trace Elements|trace elements|mesh-ancestor
92078227|NCT01790542|Micronutrients|micronutrients|mesh-ancestor
92078228|NCT01790542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078229|NCT01899820|Lumefantrine|lumefantrine|mesh-list
92078230|NCT01899820|Artemether|artemether|mesh-list
92078231|NCT01899820|Piperaquine|piperaquine|mesh-list
92078232|NCT01899820|Artemether, Lumefantrine Drug Combination|artemether, lumefantrine drug combination|mesh-list
92078233|NCT01899820|Artenimol|artenimol|mesh-list
92078234|NCT01899820|Antimalarials|antimalarials|mesh-ancestor
92078235|NCT01899820|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92078236|NCT01899820|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92078237|NCT01899820|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078238|NCT02100748|Morphine|morphine|mesh-list
92078239|NCT02100748|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92078240|NCT02100748|Narcotics|narcotics|mesh-ancestor
92078241|NCT02100748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078242|NCT02100748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078243|NCT02100748|Analgesics|analgesics|mesh-ancestor
92078244|NCT02100748|Sensory System Agents|sensory system agents|mesh-ancestor
92016325|NCT05535569|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92016326|NCT03822871|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92016327|NCT03822871|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92016328|NCT03822871|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078245|NCT02100748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078246|NCT00283504|Omalizumab|omalizumab|mesh-list
92078247|NCT00283504|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92078248|NCT00283504|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92078249|NCT00283504|Respiratory System Agents|respiratory system agents|mesh-ancestor
92078250|NCT00283816|Metformin|metformin|mesh-list
92078251|NCT00283816|Contraceptive Agents|contraceptive agents|mesh-list
92078252|NCT00283816|Contraceptives, Oral|contraceptives, oral|mesh-list
92078253|NCT00283816|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-list
92078254|NCT00283816|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078255|NCT00283816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078256|NCT00283816|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078257|NCT00283816|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92078258|NCT00284518|Botulinum Toxins|botulinum toxins|mesh-list
92078259|NCT00284518|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92078260|NCT00284518|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92078261|NCT00284518|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92078262|NCT00284518|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078263|NCT00284518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078264|NCT00284518|Cholinergic Agents|cholinergic agents|mesh-ancestor
92078265|NCT00284518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078266|NCT00284518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078267|NCT00284518|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92078268|NCT00284518|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078271|NCT04339426|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078272|NCT04339426|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078273|NCT04339426|Antimalarials|antimalarials|mesh-ancestor
92078274|NCT04339426|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92078275|NCT04339426|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92078276|NCT04339426|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078277|NCT04339426|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078278|NCT01899898|Anticonvulsants|anticonvulsants|mesh-list
92078279|NCT00287716|Pirfenidone|pirfenidone|mesh-list
92078280|NCT00287716|Analgesics|analgesics|mesh-ancestor
92078281|NCT00287716|Sensory System Agents|sensory system agents|mesh-ancestor
92078282|NCT00287716|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078283|NCT00287716|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078284|NCT00287716|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92078285|NCT00287716|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92078286|NCT00287716|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078287|NCT00287716|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078288|NCT00287716|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078289|NCT00287872|Thalidomide|thalidomide|mesh-list
92078290|NCT00287872|Bortezomib|bortezomib|mesh-list
92078291|NCT00287872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078292|NCT00287872|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078293|NCT00287872|Immunologic Factors|immunologic factors|mesh-ancestor
92078294|NCT00287872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078295|NCT00287872|Leprostatic Agents|leprostatic agents|mesh-ancestor
92078296|NCT00287872|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078297|NCT00287872|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078298|NCT00287872|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92078299|NCT00287872|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92078300|NCT00287872|Growth Substances|growth substances|mesh-ancestor
92078301|NCT00287872|Growth Inhibitors|growth inhibitors|mesh-ancestor
92078302|NCT00288574|Fluoxetine|fluoxetine|mesh-list
92078303|NCT00288574|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92078304|NCT00288574|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92078305|NCT00288574|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078306|NCT00288574|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078307|NCT00288574|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078308|NCT00288574|Serotonin Agents|serotonin agents|mesh-ancestor
92078309|NCT00288574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078310|NCT00288574|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92016331|NCT03064165|Anesthetics, Local|anesthetics, local|mesh-ancestor
92016333|NCT03064165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016334|NCT03064165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016335|NCT03064165|Sensory System Agents|sensory system agents|mesh-ancestor
92016336|NCT03064165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078311|NCT00288574|Antidepressive Agents|antidepressive agents|mesh-ancestor
92078312|NCT00288574|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078313|NCT00288574|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92078314|NCT00288574|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92078315|NCT00288574|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078316|NCT04079218|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92078317|NCT04079218|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92078319|NCT04079218|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92078320|NCT04079218|Estrogens|estrogens|mesh-ancestor
92078321|NCT04079218|Hormones|hormones|mesh-ancestor
92078322|NCT04079218|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078323|NCT04079218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078324|NCT04079218|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92078325|NCT04079218|Contraceptive Agents|contraceptive agents|mesh-ancestor
92078326|NCT04079218|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078327|NCT04079218|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92078328|NCT04061590|Cisplatin|cisplatin|mesh-list
92078329|NCT04061590|Pembrolizumab|pembrolizumab|mesh-list
92078330|NCT04061590|Pemetrexed|pemetrexed|mesh-list
92078331|NCT04061590|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078332|NCT04061590|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078333|NCT04061590|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92078334|NCT04061590|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078335|NCT04061590|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078336|NCT04061590|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92078337|NCT04061590|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92078338|NCT01791088|Sirolimus|sirolimus|mesh-list
92078339|NCT01791088|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078340|NCT01791088|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078341|NCT01791088|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92078342|NCT01791088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078346|NCT01791088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078347|NCT00291226|Glycine|glycine|mesh-list
92078348|NCT00291226|Glycine Agents|glycine agents|mesh-ancestor
92078349|NCT00291226|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078350|NCT00291226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078351|NCT00291226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078352|NCT01791166|Antibodies|antibodies|mesh-list
92078353|NCT01791166|Immunologic Factors|immunologic factors|mesh-ancestor
92078354|NCT01791166|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078355|NCT00291694|Celecoxib|celecoxib|mesh-list
92078356|NCT00291694|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92078357|NCT00291694|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92078358|NCT00291694|Analgesics|analgesics|mesh-ancestor
92078359|NCT00291694|Sensory System Agents|sensory system agents|mesh-ancestor
92078360|NCT00291694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078361|NCT00291694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078362|NCT00291694|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078363|NCT00291694|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078364|NCT00291694|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92078365|NCT00291694|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92078366|NCT00291694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078367|NCT00291694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078368|NCT00292162|Metoprolol|metoprolol|mesh-list
92078369|NCT00292162|Carvedilol|carvedilol|mesh-list
92078370|NCT00292162|Ramipril|ramipril|mesh-list
92078371|NCT00292162|Enalapril|enalapril|mesh-list
92078372|NCT00292162|Lisinopril|lisinopril|mesh-list
92078373|NCT00292162|Bisoprolol|bisoprolol|mesh-list
92078374|NCT00292162|Perindopril|perindopril|mesh-list
92016337|NCT03064165|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92016338|NCT03064165|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92016339|NCT03064165|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016340|NCT03064165|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016341|NCT03064165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016342|NCT03064165|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92016343|NCT03064165|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92016344|NCT03064165|Autonomic Agents|autonomic agents|mesh-ancestor
92078376|NCT00292162|Spironolactone|spironolactone|mesh-list
92078377|NCT00292162|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92078378|NCT00292162|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92078379|NCT00292162|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92078380|NCT00292162|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92078381|NCT00292162|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92078382|NCT00292162|Sympatholytics|sympatholytics|mesh-ancestor
92078383|NCT00292162|Autonomic Agents|autonomic agents|mesh-ancestor
92078384|NCT00292162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078385|NCT00292162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078386|NCT00292162|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92078387|NCT00292162|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92078388|NCT00292162|Adrenergic Agents|adrenergic agents|mesh-ancestor
92078389|NCT00292162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078390|NCT00292162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078391|NCT00292162|Hormone Antagonists|hormone antagonists|mesh-ancestor
92078392|NCT00292162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078393|NCT00292162|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92078394|NCT00292162|Diuretics|diuretics|mesh-ancestor
92078395|NCT00292162|Natriuretic Agents|natriuretic agents|mesh-ancestor
92078396|NCT00292162|Antioxidants|antioxidants|mesh-ancestor
92078397|NCT00292162|Protective Agents|protective agents|mesh-ancestor
92078398|NCT00292162|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92078399|NCT00292162|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078400|NCT00292162|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92078401|NCT00292162|Vasodilator Agents|vasodilator agents|mesh-ancestor
92078402|NCT00292162|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92078403|NCT00292162|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92078404|NCT00292162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92078405|NCT00292162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078406|NCT00292162|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92078407|NCT00296296|Cyclosporine|cyclosporine|mesh-list
92078408|NCT00296296|Tacrolimus|tacrolimus|mesh-list
92078409|NCT00296296|Cyclosporins|cyclosporins|mesh-list
92078410|NCT00296296|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078411|NCT00296296|Immunologic Factors|immunologic factors|mesh-ancestor
92078412|NCT00296296|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078413|NCT00296296|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92078414|NCT00296296|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078415|NCT00296296|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078418|NCT00296296|Dermatologic Agents|dermatologic agents|mesh-ancestor
92078419|NCT00296296|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078421|NCT01791400|Metoclopramide|metoclopramide|mesh-list
92078422|NCT01791400|Antiemetics|antiemetics|mesh-ancestor
92078423|NCT01791400|Autonomic Agents|autonomic agents|mesh-ancestor
92078424|NCT01791400|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078425|NCT01791400|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078426|NCT01791400|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078427|NCT01791400|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92078428|NCT01791400|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92078429|NCT01791400|Dopamine Agents|dopamine agents|mesh-ancestor
92078430|NCT01791400|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078431|NCT01791400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078432|NCT01791400|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92078433|NCT01791400|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92078434|NCT01791400|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92016345|NCT03064165|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92016346|NCT03064165|Respiratory System Agents|respiratory system agents|mesh-ancestor
92078435|NCT01791400|Serotonin Agents|serotonin agents|mesh-ancestor
92078436|NCT00300430|Calcium, Dietary|calcium, dietary|mesh-list
92078437|NCT00300430|Atorvastatin|atorvastatin|mesh-list
92078438|NCT00300430|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92078439|NCT00300430|Simvastatin|simvastatin|mesh-list
92078440|NCT00300430|Fenofibrate|fenofibrate|mesh-list
92078441|NCT00300430|Calcium|calcium|mesh-list
92078442|NCT00300430|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92078443|NCT00300430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078444|NCT00300430|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92078445|NCT00300430|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92078446|NCT00300430|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92078447|NCT00300430|Antimetabolites|antimetabolites|mesh-ancestor
92078448|NCT00300430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078449|NCT00300430|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92078450|NCT00300430|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92078451|NCT00300430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078453|NCT02104414|Bupivacaine|bupivacaine|mesh-list
92078454|NCT02104414|Anesthetics, Local|anesthetics, local|mesh-ancestor
92078455|NCT02104414|Anesthetics|anesthetics|mesh-ancestor
92078456|NCT02104414|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078457|NCT02104414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078458|NCT02104414|Sensory System Agents|sensory system agents|mesh-ancestor
92078459|NCT02104414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078460|NCT02104414|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92078461|NCT02104414|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92078462|NCT02104414|Adrenergic Agents|adrenergic agents|mesh-ancestor
92078463|NCT02104414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078464|NCT02104414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078465|NCT02104414|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92078466|NCT02104414|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92078467|NCT02104414|Autonomic Agents|autonomic agents|mesh-ancestor
92078468|NCT02104414|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92078469|NCT02104414|Respiratory System Agents|respiratory system agents|mesh-ancestor
92078470|NCT02104414|Mydriatics|mydriatics|mesh-ancestor
92078471|NCT02104414|Sympathomimetics|sympathomimetics|mesh-ancestor
92078472|NCT02104414|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92078473|NCT02100826|Cephalexin|cephalexin|mesh-list
92078474|NCT02100826|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078475|NCT02100826|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078476|NCT03587272|Sirolimus|sirolimus|mesh-list
92078477|NCT03587272|Alemtuzumab|alemtuzumab|mesh-list
92078478|NCT03587272|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078479|NCT03587272|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078480|NCT03587272|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92078481|NCT03587272|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078482|NCT03587272|Antifungal Agents|antifungal agents|mesh-ancestor
92078483|NCT03587272|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078484|NCT03587272|Immunologic Factors|immunologic factors|mesh-ancestor
92078485|NCT03587272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078486|NCT03587272|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078487|NCT02101918|Aflibercept|aflibercept|mesh-list
92078488|NCT02101918|Endothelial Growth Factors|endothelial growth factors|mesh-list
92078489|NCT02101918|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92078493|NCT02101918|Growth Inhibitors|growth inhibitors|mesh-ancestor
92078494|NCT02101918|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078497|NCT00300742|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078498|NCT00300742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078499|NCT00301756|Belinostat|belinostat|mesh-list
92078500|NCT00301756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078501|NCT00301756|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92078502|NCT00301756|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078503|NCT00301756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078504|NCT00302068|Sertraline|sertraline|mesh-list
92078505|NCT00302068|Antidepressive Agents|antidepressive agents|mesh-ancestor
92078506|NCT00302068|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078507|NCT00302068|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92078508|NCT00302068|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92016347|NCT03064165|Mydriatics|mydriatics|mesh-ancestor
92016348|NCT03064165|Sympathomimetics|sympathomimetics|mesh-ancestor
92078509|NCT00302068|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078510|NCT00302068|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078511|NCT00302068|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078512|NCT00302068|Serotonin Agents|serotonin agents|mesh-ancestor
92078513|NCT00302068|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078514|NCT00302848|Drospirenone|drospirenone|mesh-list
92078515|NCT00302848|Levonorgestrel|levonorgestrel|mesh-list
92078516|NCT00302848|Contraceptive Agents|contraceptive agents|mesh-list
92078517|NCT00302848|Contraceptives, Oral|contraceptives, oral|mesh-list
92078518|NCT00302848|Progestins|progestins|mesh-list
92078519|NCT00302848|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92078520|NCT00302848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078521|NCT00302848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078522|NCT00302848|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92078523|NCT00302848|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92078524|NCT00302848|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92078525|NCT00302848|Hormone Antagonists|hormone antagonists|mesh-ancestor
92078526|NCT00302848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078527|NCT00302848|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92078528|NCT00302848|Diuretics|diuretics|mesh-ancestor
92078529|NCT00302848|Natriuretic Agents|natriuretic agents|mesh-ancestor
92078530|NCT00302848|Hormones|hormones|mesh-ancestor
92078531|NCT00303862|Cediranib|cediranib|mesh-list
92078532|NCT00303862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078533|NCT00303862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078534|NCT00303862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078535|NCT00303862|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92078536|NCT00304096|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92078537|NCT00304096|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92078538|NCT00304096|Immunologic Factors|immunologic factors|mesh-ancestor
92078539|NCT00304096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078541|NCT05267392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078542|NCT05267392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078543|NCT00142168|Rituximab|rituximab|mesh-list
92078544|NCT00142168|Lenalidomide|lenalidomide|mesh-list
92078545|NCT00142168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078546|NCT00142168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078547|NCT00142168|Immunologic Factors|immunologic factors|mesh-ancestor
92078548|NCT00142168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078549|NCT00142168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078550|NCT00142168|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92078551|NCT00142168|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92078552|NCT00142168|Growth Substances|growth substances|mesh-ancestor
92078553|NCT00142168|Growth Inhibitors|growth inhibitors|mesh-ancestor
92078554|NCT02501434|Heparin|heparin|mesh-list
92078555|NCT02501434|Calcium heparin|calcium heparin|mesh-list
92078556|NCT02501434|Anticoagulants|anticoagulants|mesh-ancestor
92078557|NCT02501434|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92078558|NCT02501434|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92078559|NCT02501434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078560|NCT00147316|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92078563|NCT00147316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078564|NCT00148798|Cisplatin|cisplatin|mesh-list
92078565|NCT00148798|Cetuximab|cetuximab|mesh-list
92078566|NCT00148798|Vinorelbine|vinorelbine|mesh-list
92078567|NCT00148798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078568|NCT00148798|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078569|NCT00148798|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92078570|NCT00148798|Tubulin Modulators|tubulin modulators|mesh-ancestor
92078571|NCT00148798|Antimitotic Agents|antimitotic agents|mesh-ancestor
92078572|NCT00148798|Mitosis Modulators|mitosis modulators|mesh-ancestor
92078573|NCT00148798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078574|NCT00149734|Ondansetron|ondansetron|mesh-list
92078575|NCT00149734|Antiemetics|antiemetics|mesh-ancestor
92078576|NCT00149734|Autonomic Agents|autonomic agents|mesh-ancestor
92078577|NCT00149734|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078578|NCT00149734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078579|NCT00149734|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078580|NCT00149734|Antipruritics|antipruritics|mesh-ancestor
92016349|NCT03064165|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92016350|NCT05535413|Capecitabine|capecitabine|mesh-list
92016351|NCT05535413|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92078581|NCT00149734|Dermatologic Agents|dermatologic agents|mesh-ancestor
92078582|NCT00149734|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92078583|NCT00149734|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92078584|NCT00149734|Serotonin Agents|serotonin agents|mesh-ancestor
92078585|NCT00149734|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078586|NCT00149734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078587|NCT00198328|Bleomycin|bleomycin|mesh-list
92078588|NCT00198328|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92078589|NCT00198328|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078590|NCT00305578|Memantine|memantine|mesh-list
92078591|NCT00305578|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92078592|NCT00305578|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92078593|NCT00305578|Dopamine Agents|dopamine agents|mesh-ancestor
92078594|NCT00305578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078595|NCT00305578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078596|NCT00305578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078597|NCT00305578|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92078598|NCT00305578|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92078599|NCT01492101|Etirinotecan pegol|etirinotecan pegol|mesh-list
92078600|NCT01492101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078601|NCT01492101|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92078602|NCT01492101|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92078603|NCT01492101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078604|NCT01492101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078605|NCT01468311|Daclizumab|daclizumab|mesh-list
92078606|NCT01468311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078607|NCT01468311|Immunologic Factors|immunologic factors|mesh-ancestor
92078608|NCT01468311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078609|NCT00306202|Dasatinib|dasatinib|mesh-list
92078610|NCT00306202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078611|NCT00306202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92078612|NCT00306202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078613|NCT00306202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078614|NCT00325078|Infliximab|infliximab|mesh-list
92078615|NCT00325078|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92078616|NCT00325078|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078617|NCT00325078|Dermatologic Agents|dermatologic agents|mesh-ancestor
92078618|NCT00325078|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078619|NCT00325078|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078620|NCT00325780|Pitavastatin|pitavastatin|mesh-list
92078621|NCT00325780|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92078622|NCT00325780|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92078623|NCT00325780|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92078624|NCT00325780|Antimetabolites|antimetabolites|mesh-ancestor
92078625|NCT00325780|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078626|NCT00325780|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078627|NCT00325780|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92078628|NCT00326170|Azacitidine|azacitidine|mesh-list
92078629|NCT00326170|Tretinoin|tretinoin|mesh-list
92078630|NCT00326170|Valproic Acid|valproic acid|mesh-list
92078631|NCT00326170|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92078632|NCT00326170|Antimetabolites|antimetabolites|mesh-ancestor
92078633|NCT00326170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078646|NCT00326872|Cediranib|cediranib|mesh-list
92078647|NCT00326872|Maleic acid|maleic acid|mesh-list
92078648|NCT00326872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078649|NCT00326872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078650|NCT00326872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078651|NCT00326872|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92078652|NCT05266690|Dextrans|dextrans|mesh-list
92078653|NCT05266690|Anticoagulants|anticoagulants|mesh-ancestor
92078654|NCT05266690|Plasma Substitutes|plasma substitutes|mesh-ancestor
92078655|NCT05266690|Blood Substitutes|blood substitutes|mesh-ancestor
92078656|NCT01730534|Dapagliflozin|dapagliflozin|mesh-list
92078657|NCT01730534|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92078658|NCT01730534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078659|NCT01730534|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078660|NCT01730534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078661|NCT05266534|Terlipressin|terlipressin|mesh-list
92016352|NCT05535413|Antimetabolites|antimetabolites|mesh-ancestor
92016353|NCT05535413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016354|NCT05535413|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016355|NCT03813199|Methotrexate|methotrexate|mesh-list
92078662|NCT05266534|Carbetocin|carbetocin|mesh-list
92078663|NCT05266534|Oxytocics|oxytocics|mesh-ancestor
92078664|NCT05266534|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078665|NCT05266534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078666|NCT05266534|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92078667|NCT05266534|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92078668|NCT01730378|Vaccines|vaccines|mesh-list
92078669|NCT01730378|Immunologic Factors|immunologic factors|mesh-ancestor
92078670|NCT01730378|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078671|NCT00331162|Alemtuzumab|alemtuzumab|mesh-list
92078672|NCT00331162|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92078673|NCT00331162|Immunologic Factors|immunologic factors|mesh-ancestor
92078674|NCT00331162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078675|NCT00331162|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078676|NCT00331162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078677|NCT00331162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078678|NCT01790308|Liraglutide|liraglutide|mesh-list
92078679|NCT01790308|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078680|NCT01790308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078681|NCT01790308|Incretins|incretins|mesh-ancestor
92078682|NCT01790308|Hormones|hormones|mesh-ancestor
92078981|NCT01462929|Tiotropium Bromide|tiotropium bromide|mesh-list
92078683|NCT01790308|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078684|NCT01609010|Interferons|interferons|mesh-list
92078685|NCT01609010|Interferon alpha-2|interferon alpha-2|mesh-list
92078686|NCT01609010|Rituximab|rituximab|mesh-list
92078687|NCT01609010|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92078688|NCT01609010|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078689|NCT01609010|Immunologic Factors|immunologic factors|mesh-ancestor
92078690|NCT01609010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078691|NCT01609010|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078692|NCT01609010|Antiviral Agents|antiviral agents|mesh-ancestor
92078693|NCT01609010|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078694|NCT01608308|Acetaminophen|acetaminophen|mesh-list
92078695|NCT01608308|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92078696|NCT01608308|Analgesics|analgesics|mesh-ancestor
92078697|NCT01608308|Sensory System Agents|sensory system agents|mesh-ancestor
92078698|NCT01608308|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078703|NCT00332644|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92078704|NCT00332644|Autonomic Agents|autonomic agents|mesh-ancestor
92078705|NCT00332644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078706|NCT00332644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078707|NCT00332644|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92078708|NCT00332644|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92078709|NCT00332644|Cholinergic Agents|cholinergic agents|mesh-ancestor
92078710|NCT00332644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078711|NCT00332644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078712|NCT00332644|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92078713|NCT00332644|Antidepressive Agents|antidepressive agents|mesh-ancestor
92078714|NCT00332644|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078715|NCT00332644|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92078716|NCT00332644|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92078717|NCT00332644|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078718|NCT00332644|Dopamine Agents|dopamine agents|mesh-ancestor
92078719|NCT00332644|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92078720|NCT00332644|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92078721|NCT00332644|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078722|NCT01755416|Insulin|insulin|mesh-list
92078723|NCT01755416|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92078724|NCT01755416|Liraglutide|liraglutide|mesh-list
92078725|NCT01755416|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92078726|NCT01755416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078727|NCT01755416|Incretins|incretins|mesh-ancestor
92078728|NCT01755416|Hormones|hormones|mesh-ancestor
92078729|NCT01755416|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078730|NCT01755026|Cefazolin|cefazolin|mesh-list
92078731|NCT01755026|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016357|NCT03813199|Abortifacient Agents|abortifacient agents|mesh-ancestor
92016358|NCT03813199|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92016359|NCT03813199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016360|NCT03813199|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016361|NCT03813199|Antimetabolites|antimetabolites|mesh-ancestor
92078732|NCT01755026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078733|NCT00333814|Dexamethasone|dexamethasone|mesh-list
92078734|NCT00333814|Dexamethasone acetate|dexamethasone acetate|mesh-list
92078736|NCT00333814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078737|NCT00333814|Antiemetics|antiemetics|mesh-ancestor
92078738|NCT00333814|Autonomic Agents|autonomic agents|mesh-ancestor
92078739|NCT00333814|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078740|NCT00333814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078741|NCT00333814|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078742|NCT00333814|Glucocorticoids|glucocorticoids|mesh-ancestor
92078743|NCT00333814|Hormones|hormones|mesh-ancestor
92078744|NCT00333814|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078745|NCT00333814|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92078746|NCT00333814|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078747|NCT00333814|Protease Inhibitors|protease inhibitors|mesh-ancestor
92078748|NCT00333814|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078749|NCT00333814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078750|NCT01728584|Bromides|bromides|mesh-list
92078751|NCT01728584|Rocuronium|rocuronium|mesh-list
92078752|NCT01728584|Anticonvulsants|anticonvulsants|mesh-ancestor
92078753|NCT01728584|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92078754|NCT01728584|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92078755|NCT01728584|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92078756|NCT01728584|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078757|NCT01728584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078759|NCT00315328|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92078760|NCT00315328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92078761|NCT00315328|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92078762|NCT00315328|Autonomic Agents|autonomic agents|mesh-ancestor
92078763|NCT00315328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078764|NCT00315328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078765|NCT00315328|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92078766|NCT00315328|Respiratory System Agents|respiratory system agents|mesh-ancestor
92078767|NCT00315328|Mydriatics|mydriatics|mesh-ancestor
92078768|NCT00315328|Parasympatholytics|parasympatholytics|mesh-ancestor
92078769|NCT00315328|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92078770|NCT00315328|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92078771|NCT00315328|Cholinergic Agents|cholinergic agents|mesh-ancestor
92078772|NCT00315328|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078779|NCT01522443|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078780|NCT01522443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078781|NCT01522443|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92078782|NCT01522443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078783|NCT01522443|Analgesics|analgesics|mesh-ancestor
92078784|NCT01522443|Sensory System Agents|sensory system agents|mesh-ancestor
92078785|NCT01522443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078786|NCT01522443|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92078787|NCT01522443|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92078788|NCT01522443|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078789|NCT01522443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078790|NCT00336232|Vitamin K|vitamin k|mesh-list
92078791|NCT00336232|Vitamin K 1|vitamin k 1|mesh-list
92078792|NCT00336232|Vitamins|vitamins|mesh-ancestor
92078793|NCT00336232|Micronutrients|micronutrients|mesh-ancestor
92078794|NCT00336232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078795|NCT00336232|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92078796|NCT00336232|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92016362|NCT03813199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016363|NCT03813199|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016364|NCT03813199|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016365|NCT03813199|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016366|NCT03813199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92078797|NCT00336232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078798|NCT00336232|Hemostatics|hemostatics|mesh-ancestor
92078799|NCT00336232|Coagulants|coagulants|mesh-ancestor
92078800|NCT00336700|Gemcitabine|gemcitabine|mesh-list
92078801|NCT00336700|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92078802|NCT00336700|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92078803|NCT00336700|Antimetabolites|antimetabolites|mesh-ancestor
92078804|NCT00336700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078805|NCT00336700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078806|NCT00336700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92078807|NCT00336700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078808|NCT01468233|Adalimumab|adalimumab|mesh-list
92078809|NCT01468233|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92078810|NCT01468233|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078811|NCT01468233|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078812|NCT01754402|Dexamethasone|dexamethasone|mesh-list
92078813|NCT01754402|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92078814|NCT01754402|Pomalidomide|pomalidomide|mesh-list
92078815|NCT01754402|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078816|NCT01754402|Antiemetics|antiemetics|mesh-ancestor
92078817|NCT01754402|Autonomic Agents|autonomic agents|mesh-ancestor
92078818|NCT01754402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078819|NCT01754402|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078820|NCT01754402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078821|NCT01754402|Glucocorticoids|glucocorticoids|mesh-ancestor
92078822|NCT01754402|Hormones|hormones|mesh-ancestor
92078823|NCT01754402|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078824|NCT01754402|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92078825|NCT01754402|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078826|NCT01754402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92078827|NCT01754402|Alkylating Agents|alkylating agents|mesh-ancestor
92078828|NCT01754402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078829|NCT01754402|Immunologic Factors|immunologic factors|mesh-ancestor
92078830|NCT01754402|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92078831|NCT01754402|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92078832|NCT01754402|Growth Substances|growth substances|mesh-ancestor
92078833|NCT01754402|Growth Inhibitors|growth inhibitors|mesh-ancestor
92078834|NCT01521897|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92078835|NCT01521897|Immunologic Factors|immunologic factors|mesh-ancestor
92078836|NCT01521897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078837|NCT01782872|Ropivacaine|ropivacaine|mesh-list
92078838|NCT01782872|Anesthetics, Local|anesthetics, local|mesh-ancestor
92078839|NCT01782872|Anesthetics|anesthetics|mesh-ancestor
92078840|NCT01782872|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078841|NCT01782872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078845|NCT01490697|Mifepristone|mifepristone|mesh-list
92078846|NCT01490697|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92078847|NCT01490697|Abortifacient Agents|abortifacient agents|mesh-ancestor
92078848|NCT01490697|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078849|NCT01490697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078850|NCT01490697|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92078851|NCT01490697|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92078852|NCT01490697|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92078853|NCT01490697|Contraceptive Agents|contraceptive agents|mesh-ancestor
92078854|NCT01490697|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92078855|NCT01490697|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92078856|NCT01490697|Hormone Antagonists|hormone antagonists|mesh-ancestor
92078857|NCT01490697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078858|NCT01490697|Luteolytic Agents|luteolytic agents|mesh-ancestor
92078859|NCT01490697|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92078860|NCT01490697|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92078861|NCT01490697|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92016367|NCT03813199|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016368|NCT03813199|Immunologic Factors|immunologic factors|mesh-ancestor
92016369|NCT03813199|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92078862|NCT01490697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078863|NCT01490697|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92078864|NCT01490697|Antitubercular Agents|antitubercular agents|mesh-ancestor
92078865|NCT01490697|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078867|NCT01490697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078868|NCT01728194|Escitalopram|escitalopram|mesh-list
92078869|NCT01728194|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92078870|NCT01728194|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92078871|NCT01728194|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078872|NCT01728194|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078873|NCT01728194|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078874|NCT01728194|Serotonin Agents|serotonin agents|mesh-ancestor
92078875|NCT01728194|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078876|NCT04408911|Midazolam|midazolam|mesh-list
92078877|NCT04408911|Lormetazepam|lormetazepam|mesh-list
92078878|NCT04408911|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92078879|NCT04408911|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92078880|NCT04408911|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078881|NCT04408911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078882|NCT04408911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92078883|NCT04408911|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92078884|NCT04408911|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078885|NCT04408911|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92078886|NCT04408911|Anesthetics, General|anesthetics, general|mesh-ancestor
92078887|NCT04408911|Anesthetics|anesthetics|mesh-ancestor
92078888|NCT04408911|GABA Modulators|gaba modulators|mesh-ancestor
92078889|NCT04408911|GABA Agents|gaba agents|mesh-ancestor
92078890|NCT04408911|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078891|NCT04408911|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078892|NCT01466673|Moxifloxacin|moxifloxacin|mesh-list
92078893|NCT01466673|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92078894|NCT01466673|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92078895|NCT01466673|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92078896|NCT01466673|Desogestrel|desogestrel|mesh-list
92078897|NCT01466673|Norgestimate|norgestimate|mesh-list
92078898|NCT01466673|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92078899|NCT01466673|Estradiol|estradiol|mesh-list
92078900|NCT01466673|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92078901|NCT01466673|Estrogens|estrogens|mesh-ancestor
92078902|NCT01466673|Hormones|hormones|mesh-ancestor
92078903|NCT01466673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92078904|NCT01466673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078905|NCT01466673|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92078907|NCT01466673|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078908|NCT01466673|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92078909|NCT01466673|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92078910|NCT01466673|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92078911|NCT01466673|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92078912|NCT01466673|Progestins|progestins|mesh-ancestor
92078913|NCT01466673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078915|NCT01466673|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92078916|NCT01466673|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92078917|NCT01466673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078918|NCT01466673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078919|NCT01466673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078920|NCT01466673|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92078921|NCT01753856|Vitamin D|vitamin d|mesh-list
92078922|NCT01753856|Denosumab|denosumab|mesh-list
92078923|NCT01753856|Teriparatide|teriparatide|mesh-list
92078924|NCT01753856|Tetracycline|tetracycline|mesh-list
92078925|NCT01753856|Demeclocycline|demeclocycline|mesh-list
92078926|NCT01753856|Calcium|calcium|mesh-list
92078927|NCT01753856|Vitamins|vitamins|mesh-ancestor
92078928|NCT01753856|Micronutrients|micronutrients|mesh-ancestor
92078929|NCT01753856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078930|NCT01753856|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92078931|NCT01753856|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92078932|NCT01753856|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016370|NCT03813199|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92016371|NCT05699135|Avelumab|avelumab|mesh-list
92016372|NCT05699135|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016373|NCT05699135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078933|NCT01753856|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078934|NCT01753856|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92078935|NCT01753856|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078936|NCT01753856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078937|NCT01753310|Botulinum Toxins|botulinum toxins|mesh-list
92078938|NCT01753310|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92078939|NCT01753310|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92078940|NCT01753310|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92078941|NCT01753310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92078942|NCT01753310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078943|NCT01753310|Cholinergic Agents|cholinergic agents|mesh-ancestor
92078944|NCT01753310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078945|NCT01753310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078946|NCT01753310|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92078947|NCT01753310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078948|NCT01521117|Donepezil|donepezil|mesh-list
92078949|NCT01521117|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92078950|NCT01521117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078951|NCT01521117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078952|NCT01521117|Cholinergic Agents|cholinergic agents|mesh-ancestor
92078953|NCT01521117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078954|NCT01521117|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078955|NCT01521117|Nootropic Agents|nootropic agents|mesh-ancestor
92078956|NCT01466595|Rifaximin|rifaximin|mesh-list
92078957|NCT01466595|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92078958|NCT01466595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078959|NCT01466595|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92078960|NCT02073747|Albuterol|albuterol|mesh-list
92078961|NCT02073747|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92078962|NCT02073747|Autonomic Agents|autonomic agents|mesh-ancestor
92078963|NCT02073747|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078964|NCT02073747|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078965|NCT02073747|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92078966|NCT02073747|Respiratory System Agents|respiratory system agents|mesh-ancestor
92078967|NCT02073747|Tocolytic Agents|tocolytic agents|mesh-ancestor
92078968|NCT02073747|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92078969|NCT02073747|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92078970|NCT02073747|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92078971|NCT02073747|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92078972|NCT02073747|Adrenergic Agents|adrenergic agents|mesh-ancestor
92078973|NCT02073747|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078974|NCT02073747|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078976|NCT01465659|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92078977|NCT01465659|Alkylating Agents|alkylating agents|mesh-ancestor
92078978|NCT01465659|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078979|NCT01465659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078980|NCT01462929|Bromides|bromides|mesh-list
92078982|NCT01462929|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92078983|NCT01462929|Autonomic Agents|autonomic agents|mesh-ancestor
92078984|NCT01462929|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92078985|NCT01462929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078986|NCT01462929|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92078987|NCT01462929|Respiratory System Agents|respiratory system agents|mesh-ancestor
92078991|NCT01462929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078992|NCT01462929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078993|NCT01462929|Anticonvulsants|anticonvulsants|mesh-ancestor
92078994|NCT01462695|Sunitinib|sunitinib|mesh-list
92078995|NCT01462695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078996|NCT01462695|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92078997|NCT01462695|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92078998|NCT01462695|Growth Substances|growth substances|mesh-ancestor
92078999|NCT01462695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079000|NCT01462695|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016374|NCT03791593|Evolocumab|evolocumab|mesh-list
92016375|NCT03791593|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92016376|NCT03791593|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92079001|NCT01462695|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079002|NCT01462695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079003|NCT01462695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079004|NCT01465347|Trans-sodium crocetinate|trans-sodium crocetinate|mesh-list
92079005|NCT01465347|Antioxidants|antioxidants|mesh-ancestor
92079006|NCT01465347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079007|NCT01465347|Protective Agents|protective agents|mesh-ancestor
92079008|NCT01465347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079009|NCT01465347|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92079010|NCT01465347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079011|NCT01465191|Morphine|morphine|mesh-list
92079012|NCT01465191|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92079013|NCT01465191|Narcotics|narcotics|mesh-ancestor
92079014|NCT01465191|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079015|NCT01465191|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079016|NCT01465191|Analgesics|analgesics|mesh-ancestor
92079017|NCT01465191|Sensory System Agents|sensory system agents|mesh-ancestor
92079018|NCT01465191|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079019|NCT01519947|Epoetin Alfa|epoetin alfa|mesh-list
92079020|NCT01519947|Hematinics|hematinics|mesh-ancestor
92079021|NCT01462227|Naltrexone|naltrexone|mesh-list
92079022|NCT01462227|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92079023|NCT01462227|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92079024|NCT01462227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079025|NCT01462227|Sensory System Agents|sensory system agents|mesh-ancestor
92079026|NCT01462227|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079027|NCT01464879|Testosterone|testosterone|mesh-list
92079028|NCT01464879|Androgens|androgens|mesh-ancestor
92079029|NCT01464879|Hormones|hormones|mesh-ancestor
92079030|NCT01464879|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079031|NCT01464879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079032|NCT03026205|Cetylpyridinium|cetylpyridinium|mesh-list
92079033|NCT03026205|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92079034|NCT03026205|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079035|NCT01519791|Certolizumab Pegol|certolizumab pegol|mesh-list
92079037|NCT01519791|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92079038|NCT01519791|Abortifacient Agents|abortifacient agents|mesh-ancestor
92079039|NCT01519791|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92079040|NCT01519791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079041|NCT01519791|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079042|NCT01519791|Antimetabolites|antimetabolites|mesh-ancestor
92079043|NCT01519791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079044|NCT01519791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079045|NCT01519791|Dermatologic Agents|dermatologic agents|mesh-ancestor
92079046|NCT01519791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079047|NCT01519791|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92079048|NCT01519791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079049|NCT01519791|Immunologic Factors|immunologic factors|mesh-ancestor
92079050|NCT01519791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079051|NCT01519791|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92079052|NCT01519791|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92079053|NCT01519791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079055|NCT01439373|Ribavirin|ribavirin|mesh-list
92079056|NCT01439373|Interferon-alpha|interferon-alpha|mesh-list
92079057|NCT01439373|Interferon alpha-2|interferon alpha-2|mesh-list
92079058|NCT01439373|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92079059|NCT01439373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079060|NCT01439373|Antiviral Agents|antiviral agents|mesh-ancestor
92079061|NCT01439373|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079062|NCT01439373|Antimetabolites|antimetabolites|mesh-ancestor
92079064|NCT01439373|Immunologic Factors|immunologic factors|mesh-ancestor
92079065|NCT01439373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079066|NCT01461369|Diclofenac|diclofenac|mesh-list
92079067|NCT01461369|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92079068|NCT01461369|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92079069|NCT01461369|Analgesics|analgesics|mesh-ancestor
92079070|NCT01461369|Sensory System Agents|sensory system agents|mesh-ancestor
92016378|NCT03791593|Antimetabolites|antimetabolites|mesh-ancestor
92016379|NCT03791593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079071|NCT01461369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079072|NCT01461369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079073|NCT01461369|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079074|NCT01461369|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079075|NCT01461369|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92079076|NCT01461369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079077|NCT01461369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079078|NCT01727258|Fluorides|fluorides|mesh-list
92079079|NCT01727258|Cariostatic Agents|cariostatic agents|mesh-ancestor
92079080|NCT01727258|Protective Agents|protective agents|mesh-ancestor
92079081|NCT01727258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079082|NCT01781234|Insulin|insulin|mesh-list
92079083|NCT01781234|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92079084|NCT01781234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079085|NCT01752842|Fenofibrate|fenofibrate|mesh-list
92079086|NCT01752842|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92079087|NCT01752842|Antimetabolites|antimetabolites|mesh-ancestor
92079088|NCT01752842|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079089|NCT01752842|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92079090|NCT01461057|Capecitabine|capecitabine|mesh-list
92079091|NCT01461057|Trastuzumab|trastuzumab|mesh-list
92079092|NCT01461057|Pertuzumab|pertuzumab|mesh-list
92079093|NCT01461057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079094|NCT01461057|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079095|NCT01461057|Antimetabolites|antimetabolites|mesh-ancestor
92079096|NCT01461057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079097|NCT01461057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079098|NCT04567407|Ropivacaine|ropivacaine|mesh-list
92079099|NCT04567407|Anesthetics, Local|anesthetics, local|mesh-ancestor
92079100|NCT04567407|Anesthetics|anesthetics|mesh-ancestor
92079101|NCT04567407|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079102|NCT04567407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079103|NCT04567407|Sensory System Agents|sensory system agents|mesh-ancestor
92079104|NCT04567407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079105|NCT01519635|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92079106|NCT01519635|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92079107|NCT01519635|Diuretics|diuretics|mesh-ancestor
92079108|NCT01519635|Natriuretic Agents|natriuretic agents|mesh-ancestor
92079109|NCT01519635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079110|NCT01519635|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92079111|NCT01519635|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92079112|NCT01519635|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079113|NCT01519323|Vemurafenib|vemurafenib|mesh-list
92079114|NCT01519323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079115|NCT01519323|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079116|NCT01519323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079117|NCT01519323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079118|NCT01519245|Tranexamic Acid|tranexamic acid|mesh-list
92079119|NCT01519245|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92079120|NCT01519245|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92079121|NCT01519245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079122|NCT01519245|Hemostatics|hemostatics|mesh-ancestor
92079123|NCT01519245|Coagulants|coagulants|mesh-ancestor
92079124|NCT01519167|Fentanyl|fentanyl|mesh-list
92079125|NCT01519167|Midazolam|midazolam|mesh-list
92079126|NCT01519167|Dexmedetomidine|dexmedetomidine|mesh-list
92079127|NCT01519167|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92079128|NCT01519167|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079129|NCT01519167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079130|NCT01519167|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92079131|NCT01519167|Analgesics|analgesics|mesh-ancestor
92079132|NCT01519167|Sensory System Agents|sensory system agents|mesh-ancestor
92079133|NCT01519167|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079134|NCT01519167|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92079136|NCT01519167|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92079137|NCT01519167|Adrenergic Agents|adrenergic agents|mesh-ancestor
92079138|NCT01519167|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081711|NCT03025893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079139|NCT01519167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079140|NCT01519167|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92079142|NCT01519167|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92079143|NCT01519167|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92079144|NCT01519167|Anesthetics, General|anesthetics, general|mesh-ancestor
92079145|NCT01519167|Anesthetics|anesthetics|mesh-ancestor
92079146|NCT01519167|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92079147|NCT01519167|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92079148|NCT01519167|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079149|NCT01519167|GABA Modulators|gaba modulators|mesh-ancestor
92079150|NCT01519167|GABA Agents|gaba agents|mesh-ancestor
92079151|NCT00318136|Paclitaxel|paclitaxel|mesh-list
92079152|NCT00318136|Bevacizumab|bevacizumab|mesh-list
92079153|NCT00318136|Carboplatin|carboplatin|mesh-list
92079154|NCT00318136|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079155|NCT00318136|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079156|NCT00318136|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079157|NCT00318136|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079158|NCT00318136|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079159|NCT00318136|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079160|NCT00318136|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079161|NCT00318136|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079162|NCT00318136|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079163|NCT00318136|Growth Substances|growth substances|mesh-ancestor
92079164|NCT00318136|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079165|NCT00318136|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079166|NCT00318292|Epinephrine|epinephrine|mesh-list
92079167|NCT00318292|Bupivacaine|bupivacaine|mesh-list
92079168|NCT00318292|Anesthetics, Local|anesthetics, local|mesh-ancestor
92079169|NCT00318292|Anesthetics|anesthetics|mesh-ancestor
92079170|NCT00318292|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079171|NCT00318292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079172|NCT00318292|Sensory System Agents|sensory system agents|mesh-ancestor
92079173|NCT00318292|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079174|NCT00318292|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92079175|NCT00318292|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92079176|NCT00318292|Adrenergic Agents|adrenergic agents|mesh-ancestor
92079177|NCT00318292|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079178|NCT00318292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079179|NCT00318292|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92079180|NCT00318292|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92079181|NCT00318292|Autonomic Agents|autonomic agents|mesh-ancestor
92079182|NCT00318292|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92079183|NCT00318292|Respiratory System Agents|respiratory system agents|mesh-ancestor
92079184|NCT00318292|Mydriatics|mydriatics|mesh-ancestor
92079185|NCT00318292|Sympathomimetics|sympathomimetics|mesh-ancestor
92079186|NCT00318292|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92079187|NCT01791868|Valproic Acid|valproic acid|mesh-list
92079188|NCT01791868|Anticonvulsants|anticonvulsants|mesh-ancestor
92079189|NCT01791868|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079190|NCT01791868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079191|NCT01791868|GABA Agents|gaba agents|mesh-ancestor
92079192|NCT01791868|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079193|NCT01791868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079194|NCT01791868|Antimanic Agents|antimanic agents|mesh-ancestor
92079195|NCT01791868|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92079196|NCT01791868|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079197|NCT01791868|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079198|NCT03793114|Cosyntropin|cosyntropin|mesh-list
92079199|NCT03793114|Hormones|hormones|mesh-ancestor
92079200|NCT03793114|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079201|NCT03793114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079202|NCT00348946|Androgens|androgens|mesh-list
92079203|NCT00348946|Oxandrolone|oxandrolone|mesh-list
92079204|NCT00348946|Hormones|hormones|mesh-ancestor
92079205|NCT00348946|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079206|NCT00348946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079207|NCT00348946|Anabolic Agents|anabolic agents|mesh-ancestor
92079208|NCT00349336|Bevacizumab|bevacizumab|mesh-list
92079211|NCT00349336|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079212|NCT00349336|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079213|NCT00349336|Growth Substances|growth substances|mesh-ancestor
92079214|NCT00349336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079215|NCT00349336|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016381|NCT03791593|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016382|NCT03791593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016383|NCT03791593|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92016385|NCT03064243|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016386|NCT03064243|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079216|NCT04751188|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92079217|NCT04751188|Bezafibrate|bezafibrate|mesh-list
92079218|NCT04751188|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92079219|NCT04751188|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92079220|NCT04751188|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92079221|NCT04751188|Antimetabolites|antimetabolites|mesh-ancestor
92079222|NCT04751188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079223|NCT04751188|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92079224|NCT00352612|Clindamycin|clindamycin|mesh-list
92079225|NCT00352612|Clindamycin palmitate|clindamycin palmitate|mesh-list
92079226|NCT00352612|Clindamycin phosphate|clindamycin phosphate|mesh-list
92079228|NCT00352612|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92079229|NCT00352612|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079230|NCT00352612|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92079231|NCT00352612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079232|NCT00352612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079233|NCT00323362|Gemcitabine|gemcitabine|mesh-list
92079234|NCT00323362|Imatinib Mesylate|imatinib mesylate|mesh-list
92079235|NCT00323362|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079236|NCT00323362|Antimetabolites|antimetabolites|mesh-ancestor
92079237|NCT00323362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079238|NCT00323362|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079239|NCT00323362|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079240|NCT00323362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079242|NCT00390364|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92079243|NCT00390364|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92079244|NCT00390364|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079245|NCT00390364|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079246|NCT00390364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079247|NCT00390364|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079248|NCT00390364|Immunologic Factors|immunologic factors|mesh-ancestor
92079249|NCT00390364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079250|NCT00390364|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079251|NCT00354640|Anastrozole|anastrozole|mesh-list
92079252|NCT00354640|Simvastatin|simvastatin|mesh-list
92079253|NCT00354640|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92079254|NCT00354640|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92079255|NCT00354640|Antimetabolites|antimetabolites|mesh-ancestor
92079256|NCT00354640|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079257|NCT00354640|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92079258|NCT00354640|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92079259|NCT00354640|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079260|NCT00354640|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92079261|NCT00354640|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079262|NCT00354640|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92079263|NCT00354640|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92079264|NCT00354640|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92079265|NCT00354640|Hormone Antagonists|hormone antagonists|mesh-ancestor
92079266|NCT00354640|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079267|NCT00354640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079268|NCT00392392|Paclitaxel|paclitaxel|mesh-list
92079269|NCT00392392|Bevacizumab|bevacizumab|mesh-list
92079270|NCT00392392|Trastuzumab|trastuzumab|mesh-list
92079271|NCT00392392|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079272|NCT00392392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079273|NCT00392392|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079274|NCT00392392|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079275|NCT00392392|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079276|NCT00392392|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079277|NCT00392392|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079278|NCT00392392|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079279|NCT00392392|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016387|NCT03064243|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079280|NCT00392392|Growth Substances|growth substances|mesh-ancestor
92079282|NCT00392392|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079283|NCT01519089|Tofacitinib|tofacitinib|mesh-list
92079284|NCT01519089|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92079285|NCT01519089|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079286|NCT01519089|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079287|NCT01519089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079288|NCT00392704|Paclitaxel|paclitaxel|mesh-list
92079289|NCT00392704|Bevacizumab|bevacizumab|mesh-list
92079290|NCT00392704|Fluorouracil|fluorouracil|mesh-list
92079291|NCT00392704|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92079292|NCT00392704|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079293|NCT00392704|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079294|NCT00392704|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079295|NCT00392704|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079296|NCT00392704|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079297|NCT00392704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079298|NCT00392704|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079299|NCT00392704|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079300|NCT00392704|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079301|NCT00392704|Growth Substances|growth substances|mesh-ancestor
92079302|NCT00392704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079303|NCT00392704|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079304|NCT00392704|Antimetabolites|antimetabolites|mesh-ancestor
92079305|NCT00392704|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079306|NCT00392704|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079307|NCT00392704|Immunologic Factors|immunologic factors|mesh-ancestor
92079308|NCT00392704|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079309|NCT00392704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079310|NCT00392782|Fludarabine|fludarabine|mesh-list
92079311|NCT00392782|Fludarabine phosphate|fludarabine phosphate|mesh-list
92079312|NCT00392782|Thiotepa|thiotepa|mesh-list
92079313|NCT00392782|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92079314|NCT00392782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079315|NCT00392782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079316|NCT00392782|Antimetabolites|antimetabolites|mesh-ancestor
92079317|NCT00392782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079318|NCT00392782|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079319|NCT00392782|Immunologic Factors|immunologic factors|mesh-ancestor
92079320|NCT00392782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079321|NCT00392782|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92079322|NCT00392782|Alkylating Agents|alkylating agents|mesh-ancestor
92079323|NCT00392782|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92079324|NCT01518699|Moxifloxacin|moxifloxacin|mesh-list
92079325|NCT01518699|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92079326|NCT01518699|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92079327|NCT01518699|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079328|NCT01518699|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92079329|NCT01518699|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92079330|NCT01518699|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079331|NCT01518699|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079332|NCT01518699|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079333|NCT01518699|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92079334|NCT01518699|Contraceptive Agents|contraceptive agents|mesh-ancestor
92079335|NCT01518699|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92079336|NCT01518699|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079337|NCT01518699|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92079338|NCT01518699|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92079339|NCT01518699|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92079340|NCT01518309|Pimavanserin|pimavanserin|mesh-list
92079341|NCT01518309|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92079342|NCT01518309|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92079343|NCT01518309|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92079344|NCT01518309|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92079345|NCT01518309|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079346|NCT01518309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079347|NCT01518309|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079348|NCT01518309|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92079349|NCT01518309|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92079350|NCT01518309|Serotonin Agents|serotonin agents|mesh-ancestor
92016388|NCT03064243|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016390|NCT03765619|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92016391|NCT03765619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016392|NCT03765619|Analgesics|analgesics|mesh-ancestor
92079351|NCT01518309|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079352|NCT01518309|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079353|NCT01419717|Denosumab|denosumab|mesh-list
92079357|NCT01458951|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92079358|NCT01458951|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079359|NCT01458951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079360|NCT01458951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079361|NCT01458639|Xenon|xenon|mesh-list
92079362|NCT01458639|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92079363|NCT01458639|Anesthetics, General|anesthetics, general|mesh-ancestor
92079364|NCT01458639|Anesthetics|anesthetics|mesh-ancestor
92079365|NCT01458639|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079366|NCT01458639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079367|NCT00393796|Sunitinib|sunitinib|mesh-list
92079368|NCT00393796|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079369|NCT00393796|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079370|NCT00393796|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079371|NCT00393796|Growth Substances|growth substances|mesh-ancestor
92079372|NCT00393796|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079373|NCT00393796|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079374|NCT00393796|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079375|NCT00393796|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079376|NCT00393796|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079377|NCT00393874|Prazosin|prazosin|mesh-list
92079378|NCT00393874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92079379|NCT00393874|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92079380|NCT00393874|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92079381|NCT00393874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92079382|NCT00393874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92079383|NCT00393874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079384|NCT00393874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079385|NCT00393874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079386|NCT00394888|Dermatologic Agents|dermatologic agents|mesh-list
92079387|NCT01458171|Immunoglobulins|immunoglobulins|mesh-list
92079388|NCT01458171|Antibodies|antibodies|mesh-list
92079389|NCT01458171|gamma-Globulins|gamma-globulins|mesh-list
92079390|NCT01458171|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92079391|NCT01458171|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92079392|NCT01458171|Immunologic Factors|immunologic factors|mesh-ancestor
92079393|NCT01458171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079394|NCT00395044|Gabapentin|gabapentin|mesh-list
92079395|NCT00395044|Analgesics|analgesics|mesh-ancestor
92079396|NCT00395044|Sensory System Agents|sensory system agents|mesh-ancestor
92079397|NCT00395044|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079398|NCT00395044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079399|NCT00395044|Anticonvulsants|anticonvulsants|mesh-ancestor
92079400|NCT00395044|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92079401|NCT00395044|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92079402|NCT00395044|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079403|NCT00395044|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079404|NCT00395044|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92079405|NCT00395044|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92079406|NCT00395044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079407|NCT00395044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079408|NCT00395044|Antimanic Agents|antimanic agents|mesh-ancestor
92079409|NCT01457703|Letrozole|letrozole|mesh-list
92079410|NCT01457703|Cetrorelix|cetrorelix|mesh-list
92079411|NCT01457703|Prolactin Release-Inhibiting Factors|prolactin release-inhibiting factors|mesh-list
92079412|NCT01457703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079413|NCT01457703|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92079414|NCT01457703|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92079415|NCT01457703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079416|NCT01457703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079417|NCT01457703|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92016393|NCT03765619|Sensory System Agents|sensory system agents|mesh-ancestor
92016394|NCT03765619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016395|NCT03765619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016396|NCT03765619|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079418|NCT01457703|Hormone Antagonists|hormone antagonists|mesh-ancestor
92079419|NCT01457703|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079420|NCT01457703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079421|NCT01457703|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92079422|NCT01457703|Fertility Agents|fertility agents|mesh-ancestor
92079423|NCT01457703|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92079424|NCT01457703|Hormones|hormones|mesh-ancestor
92079431|NCT02076321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079433|NCT02076321|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92079434|NCT02076321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079435|NCT02076321|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079436|NCT02076321|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92079437|NCT02076321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079438|NCT02076321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079439|NCT00358462|Azithromycin|azithromycin|mesh-list
92079440|NCT00358462|Doxycycline|doxycycline|mesh-list
92079441|NCT00358462|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92079442|NCT00358462|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079443|NCT00358462|Antimalarials|antimalarials|mesh-ancestor
92079444|NCT00358462|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92079445|NCT00358462|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92079446|NCT01437267|Vaccines|vaccines|mesh-list
92079447|NCT01437267|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92079448|NCT01437267|Immunologic Factors|immunologic factors|mesh-ancestor
92079449|NCT01437267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079450|NCT01437111|Vitamin D|vitamin d|mesh-list
92079451|NCT01437111|Cholecalciferol|cholecalciferol|mesh-list
92079452|NCT01437111|Alendronate|alendronate|mesh-list
92079453|NCT01437111|Vitamins|vitamins|mesh-ancestor
92079454|NCT01437111|Micronutrients|micronutrients|mesh-ancestor
92079455|NCT01437111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079456|NCT01437111|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92079457|NCT01437111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92079458|NCT04065555|Cetuximab|cetuximab|mesh-list
92079459|NCT04065555|Avelumab|avelumab|mesh-list
92079460|NCT04065555|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92079461|NCT04065555|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079462|NCT04065555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079463|NCT04065555|Immunologic Factors|immunologic factors|mesh-ancestor
92079464|NCT04065555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079465|NCT00360724|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92079466|NCT00360724|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92079467|NCT00360724|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92079468|NCT00360724|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92079469|NCT00360724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079470|NCT00360724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079471|NCT00360724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079472|NCT00360724|Analgesics|analgesics|mesh-ancestor
92079473|NCT00360724|Sensory System Agents|sensory system agents|mesh-ancestor
92079474|NCT00360724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079475|NCT00360724|Antidepressive Agents|antidepressive agents|mesh-ancestor
92079476|NCT00360724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079477|NCT00360724|Dopamine Agents|dopamine agents|mesh-ancestor
92079478|NCT00398398|Capecitabine|capecitabine|mesh-list
92079479|NCT00398398|Oxaliplatin|oxaliplatin|mesh-list
92079480|NCT00398398|Cetuximab|cetuximab|mesh-list
92079481|NCT00398398|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079482|NCT00398398|Antimetabolites|antimetabolites|mesh-ancestor
92079483|NCT00398398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079484|NCT00398398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079485|NCT00398398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079486|NCT00398476|Fluticasone|fluticasone|mesh-list
92079488|NCT00398476|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079489|NCT00398476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92016397|NCT03765619|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079490|NCT00398476|Autonomic Agents|autonomic agents|mesh-ancestor
92079491|NCT00398476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079492|NCT00398476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079493|NCT00398476|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92079494|NCT00398476|Respiratory System Agents|respiratory system agents|mesh-ancestor
92079502|NCT01436643|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92079503|NCT01436643|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92079504|NCT01436643|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079505|NCT01436643|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079506|NCT01436643|Serotonin Agents|serotonin agents|mesh-ancestor
92079507|NCT01436643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079508|NCT01436643|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92079509|NCT01436643|Antidepressive Agents|antidepressive agents|mesh-ancestor
92079510|NCT01436643|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079511|NCT01436643|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92079587|NCT00369226|Dermatologic Agents|dermatologic agents|mesh-ancestor
92079512|NCT01436643|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92079514|NCT01436643|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92079515|NCT01436643|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92079516|NCT01436643|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079517|NCT01436643|Immunologic Factors|immunologic factors|mesh-ancestor
92079518|NCT04316494|Hydroxychloroquine|hydroxychloroquine|mesh-list
92079519|NCT04316494|Antimalarials|antimalarials|mesh-ancestor
92079520|NCT04316494|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92079521|NCT04316494|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92079522|NCT04316494|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079523|NCT04316494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079524|NCT04316494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079525|NCT04316494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079526|NCT00361972|Lansoprazole|lansoprazole|mesh-list
92079527|NCT00361972|Dexlansoprazole|dexlansoprazole|mesh-list
92079528|NCT00361972|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92079529|NCT00361972|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92079530|NCT00361972|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92079531|NCT00361972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079532|NCT00361972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079533|NCT00362440|Metformin|metformin|mesh-list
92079534|NCT00362440|Pioglitazone|pioglitazone|mesh-list
92079535|NCT00362440|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92079536|NCT00362440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079537|NCT02109640|Oxycodone|oxycodone|mesh-list
92079538|NCT02109640|Naloxone|naloxone|mesh-list
92079539|NCT02109640|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92079540|NCT02109640|Narcotics|narcotics|mesh-ancestor
92079541|NCT02109640|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079542|NCT02109640|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079543|NCT02109640|Analgesics|analgesics|mesh-ancestor
92079544|NCT02109640|Sensory System Agents|sensory system agents|mesh-ancestor
92079545|NCT02109640|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079546|NCT02109640|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92079547|NCT01454739|Factor VIII|factor viii|mesh-list
92079548|NCT01454739|Coagulants|coagulants|mesh-ancestor
92079549|NCT00366106|Dexamethasone|dexamethasone|mesh-list
92079550|NCT00366106|Doxorubicin|doxorubicin|mesh-list
92079551|NCT00366106|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92079552|NCT00366106|Bortezomib|bortezomib|mesh-list
92079553|NCT00366106|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079554|NCT00366106|Antiemetics|antiemetics|mesh-ancestor
92079555|NCT00366106|Autonomic Agents|autonomic agents|mesh-ancestor
92079556|NCT00366106|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079557|NCT00366106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079558|NCT00366106|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92079559|NCT00366106|Glucocorticoids|glucocorticoids|mesh-ancestor
92079560|NCT00366106|Hormones|hormones|mesh-ancestor
92079561|NCT00366106|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079562|NCT00366106|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92079563|NCT00366106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079567|NCT00366106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079568|NCT00366106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079569|NCT00368290|Modafinil|modafinil|mesh-list
92079570|NCT00368290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92016398|NCT03765619|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92016399|NCT03765619|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92016400|NCT03765619|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016401|NCT03765619|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92079571|NCT00368290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079572|NCT00368290|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92079573|NCT00368290|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92079574|NCT00368290|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92079575|NCT00368290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079576|NCT00369226|Methotrexate|methotrexate|mesh-list
92079577|NCT00369226|Bortezomib|bortezomib|mesh-list
92079578|NCT00369226|Tacrolimus|tacrolimus|mesh-list
92079579|NCT00369226|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92079580|NCT00369226|Abortifacient Agents|abortifacient agents|mesh-ancestor
92079581|NCT00369226|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92079582|NCT00369226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079583|NCT00369226|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079584|NCT00369226|Antimetabolites|antimetabolites|mesh-ancestor
92079585|NCT00369226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079586|NCT00369226|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079588|NCT00369226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079589|NCT00369226|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92079590|NCT00369226|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079591|NCT00369226|Immunologic Factors|immunologic factors|mesh-ancestor
92079592|NCT00369226|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079593|NCT00369226|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92079594|NCT00369226|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92079595|NCT01416441|Aripiprazole|aripiprazole|mesh-list
92079596|NCT01416441|Antidepressive Agents|antidepressive agents|mesh-ancestor
92079597|NCT01416441|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92079598|NCT01416441|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92079599|NCT01416441|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92079600|NCT01416441|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079601|NCT01416441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079602|NCT01416441|Dopamine Agonists|dopamine agonists|mesh-ancestor
92079603|NCT01416441|Dopamine Agents|dopamine agents|mesh-ancestor
92079604|NCT01416441|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079605|NCT01416441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079606|NCT01416441|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92079607|NCT01416441|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92079608|NCT01416441|Serotonin Agents|serotonin agents|mesh-ancestor
92079609|NCT01416441|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92079610|NCT01416441|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92079611|NCT01416441|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92079612|NCT01416441|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92079613|NCT00406276|Docetaxel|docetaxel|mesh-list
92079614|NCT00406276|Everolimus|everolimus|mesh-list
92079615|NCT00406276|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079616|NCT00406276|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079617|NCT00406276|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079618|NCT00406276|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079619|NCT00406276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079620|NCT00406276|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92079621|NCT00406276|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079622|NCT00406276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079623|NCT00406276|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079624|NCT00406276|Immunologic Factors|immunologic factors|mesh-ancestor
92079625|NCT00406276|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079626|NCT00408070|Paclitaxel|paclitaxel|mesh-list
92079627|NCT00408070|Bevacizumab|bevacizumab|mesh-list
92079628|NCT00408070|Carboplatin|carboplatin|mesh-list
92079629|NCT00408070|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079630|NCT00408070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079631|NCT00408070|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079632|NCT00408070|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079633|NCT00408070|Mitosis Modulators|mitosis modulators|mesh-ancestor
92016402|NCT03765619|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92016403|NCT03765619|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016404|NCT03765619|Antipyretics|antipyretics|mesh-ancestor
92016405|NCT05543603|Chlorhexidine|chlorhexidine|mesh-list
92016406|NCT05543603|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92079644|NCT00408460|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079645|NCT00408460|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079646|NCT00408460|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079647|NCT00408460|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079648|NCT00408460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079649|NCT00408460|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079650|NCT00408460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079651|NCT02111200|Sodium Benzoate|sodium benzoate|mesh-list
92079652|NCT02111200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92079653|NCT02111200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079654|NCT02111200|Antifungal Agents|antifungal agents|mesh-ancestor
92079655|NCT02111200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079656|NCT02111746|Bupivacaine|bupivacaine|mesh-list
92079657|NCT02111746|Anesthetics, Local|anesthetics, local|mesh-ancestor
92079658|NCT02111746|Anesthetics|anesthetics|mesh-ancestor
92079659|NCT02111746|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079660|NCT02111746|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079661|NCT02111746|Sensory System Agents|sensory system agents|mesh-ancestor
92079662|NCT02111746|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079664|NCT01793272|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92079665|NCT01793272|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079666|NCT01793272|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079667|NCT01793272|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92079668|NCT01793272|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92079669|NCT01793272|Protective Agents|protective agents|mesh-ancestor
92079670|NCT01793272|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079671|NCT01793272|Vasodilator Agents|vasodilator agents|mesh-ancestor
92079672|NCT01793272|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92079673|NCT01793272|Antioxidants|antioxidants|mesh-ancestor
92079674|NCT00410488|Dexamethasone|dexamethasone|mesh-list
92079675|NCT00410488|Dexamethasone acetate|dexamethasone acetate|mesh-list
92079676|NCT00410488|Doxorubicin|doxorubicin|mesh-list
92079677|NCT00410488|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92079678|NCT00410488|Vincristine|vincristine|mesh-list
92079680|NCT00410488|Dexrazoxane|dexrazoxane|mesh-list
92079681|NCT00410488|Palonosetron|palonosetron|mesh-list
92079682|NCT00410488|BB 1101|bb 1101|mesh-list
92079683|NCT00410488|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079684|NCT00410488|Antiemetics|antiemetics|mesh-ancestor
92079685|NCT00410488|Autonomic Agents|autonomic agents|mesh-ancestor
92079686|NCT00410488|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079687|NCT00410488|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079688|NCT00410488|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92079689|NCT00410488|Glucocorticoids|glucocorticoids|mesh-ancestor
92079690|NCT00410488|Hormones|hormones|mesh-ancestor
92079691|NCT00410488|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079692|NCT00410488|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92079693|NCT00410488|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079694|NCT00410488|Protease Inhibitors|protease inhibitors|mesh-ancestor
92079695|NCT00410488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079696|NCT00410488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079697|NCT00410488|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92079698|NCT00410488|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92079702|NCT00410488|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079703|NCT00410488|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079704|NCT00410488|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92079705|NCT00410488|Alkylating Agents|alkylating agents|mesh-ancestor
92079706|NCT00410488|Protective Agents|protective agents|mesh-ancestor
92079707|NCT00410488|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92079708|NCT00410488|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92079709|NCT00410488|Serotonin Agents|serotonin agents|mesh-ancestor
92079710|NCT00410488|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079711|NCT00410488|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92079712|NCT01793350|Benphothiamine|benphothiamine|mesh-list
92079713|NCT01793350|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92079714|NCT01793350|Immunologic Factors|immunologic factors|mesh-ancestor
92016407|NCT05543603|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92016408|NCT05543603|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016409|NCT05543603|Disinfectants|disinfectants|mesh-ancestor
92079715|NCT01793350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079716|NCT01793350|Chelating Agents|chelating agents|mesh-ancestor
92079717|NCT01793350|Sequestering Agents|sequestering agents|mesh-ancestor
92079718|NCT01793350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079719|NCT03127774|Sodium thiosulfate|sodium thiosulfate|mesh-list
92079720|NCT03127774|Antidotes|antidotes|mesh-ancestor
92079721|NCT03127774|Protective Agents|protective agents|mesh-ancestor
92079722|NCT03127774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079723|NCT03127774|Antioxidants|antioxidants|mesh-ancestor
92079724|NCT03127774|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079725|NCT03127774|Antitubercular Agents|antitubercular agents|mesh-ancestor
92079726|NCT03127774|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92079727|NCT03127774|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079728|NCT03127774|Chelating Agents|chelating agents|mesh-ancestor
92079729|NCT03127774|Sequestering Agents|sequestering agents|mesh-ancestor
92079730|NCT00416494|Bevacizumab|bevacizumab|mesh-list
92079731|NCT00416494|Capecitabine|capecitabine|mesh-list
92079732|NCT00416494|Oxaliplatin|oxaliplatin|mesh-list
92079733|NCT00416494|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079734|NCT00416494|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079735|NCT00416494|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079736|NCT00416494|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079738|NCT00416494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079739|NCT00416494|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079740|NCT00416494|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079741|NCT00416494|Antimetabolites|antimetabolites|mesh-ancestor
92079742|NCT00416494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079743|NCT02845882|Cytarabine|cytarabine|mesh-list
92079744|NCT02845882|Dexamethasone|dexamethasone|mesh-list
92079745|NCT02845882|Dexamethasone acetate|dexamethasone acetate|mesh-list
92079746|NCT02845882|Prednisone|prednisone|mesh-list
92079747|NCT02845882|Cyclophosphamide|cyclophosphamide|mesh-list
92079748|NCT02845882|Ifosfamide|ifosfamide|mesh-list
92079749|NCT02845882|Doxorubicin|doxorubicin|mesh-list
92079750|NCT02845882|Methotrexate|methotrexate|mesh-list
92079751|NCT02845882|Etoposide|etoposide|mesh-list
92079752|NCT02845882|Vincristine|vincristine|mesh-list
92079753|NCT02845882|Daunorubicin|daunorubicin|mesh-list
92079754|NCT02845882|Asparaginase|asparaginase|mesh-list
92079755|NCT02845882|Mercaptopurine|mercaptopurine|mesh-list
92079756|NCT02845882|Vindesine|vindesine|mesh-list
92079757|NCT02845882|Pegaspargase|pegaspargase|mesh-list
92079758|NCT02845882|BB 1101|bb 1101|mesh-list
92079759|NCT02845882|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079760|NCT02845882|Immunologic Factors|immunologic factors|mesh-ancestor
92079761|NCT02845882|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079762|NCT02845882|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079763|NCT02845882|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92079764|NCT02845882|Alkylating Agents|alkylating agents|mesh-ancestor
92079765|NCT02845882|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079766|NCT02845882|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079767|NCT02845882|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92079768|NCT02845882|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92079769|NCT02845882|Antiemetics|antiemetics|mesh-ancestor
92079770|NCT02845882|Autonomic Agents|autonomic agents|mesh-ancestor
92079771|NCT02845882|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079772|NCT02845882|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92079773|NCT02845882|Glucocorticoids|glucocorticoids|mesh-ancestor
92079774|NCT02845882|Hormones|hormones|mesh-ancestor
92079797|NCT00417274|Anticestodal Agents|anticestodal agents|mesh-ancestor
92079798|NCT00417274|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92079799|NCT00417274|Anthelmintics|anthelmintics|mesh-ancestor
92079800|NCT00417274|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92079801|NCT00417274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079802|NCT00417274|Antimalarials|antimalarials|mesh-ancestor
92079803|NCT00417274|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92079804|NCT00417274|Antinematodal Agents|antinematodal agents|mesh-ancestor
92079805|NCT00417274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079806|NCT00417274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079807|NCT00417274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079808|NCT04749940|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92079809|NCT04749940|Laxatives|laxatives|mesh-ancestor
92016410|NCT05543603|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016411|NCT04979923|Lidocaine|lidocaine|mesh-list
92079810|NCT04749940|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92079811|NCT05286346|Tenofovir|tenofovir|mesh-list
92079812|NCT05286346|Antiviral Agents|antiviral agents|mesh-ancestor
92079813|NCT05286346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079814|NCT05286346|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92079815|NCT05286346|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92079816|NCT05286346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079817|NCT05286346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079818|NCT05286346|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92079819|NCT05286346|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92079820|NCT05286268|Plasminogen|plasminogen|mesh-list
92079821|NCT05286268|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92079822|NCT05286268|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92079823|NCT05286268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079824|NCT00422032|Clofarabine|clofarabine|mesh-list
92079825|NCT00422032|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079826|NCT00422032|Antimetabolites|antimetabolites|mesh-ancestor
92079827|NCT00422032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079828|NCT00422032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079830|NCT01388920|Growth Substances|growth substances|mesh-ancestor
92079831|NCT01388920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079832|NCT00423358|Vitamin D|vitamin d|mesh-list
92079833|NCT00423358|Ergocalciferols|ergocalciferols|mesh-list
92079834|NCT00423358|Vitamins|vitamins|mesh-ancestor
92079835|NCT00423358|Micronutrients|micronutrients|mesh-ancestor
92079836|NCT00423358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079837|NCT00423358|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92079838|NCT00423358|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92079839|NCT00424840|Bevacizumab|bevacizumab|mesh-list
92079840|NCT00424840|Carboplatin|carboplatin|mesh-list
92079841|NCT00424840|Bortezomib|bortezomib|mesh-list
92079842|NCT00424840|Docetaxel|docetaxel|mesh-list
92079843|NCT00424840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079844|NCT00424840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079845|NCT00424840|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079846|NCT00424840|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079847|NCT00424840|Growth Substances|growth substances|mesh-ancestor
92079848|NCT00424840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079849|NCT00424840|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079850|NCT00424840|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079851|NCT00424840|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079852|NCT00424840|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079853|NCT00424840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079855|NCT00425386|Sunitinib|sunitinib|mesh-list
92079856|NCT00425386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079857|NCT00425386|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079858|NCT00425386|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079859|NCT00425386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079860|NCT00425386|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079861|NCT00425386|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079862|NCT00425386|Growth Substances|growth substances|mesh-ancestor
92079863|NCT00425386|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079864|NCT00425386|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079865|NCT01164202|Sunitinib|sunitinib|mesh-list
92079866|NCT01164202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079867|NCT01164202|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079868|NCT01164202|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079869|NCT01164202|Growth Substances|growth substances|mesh-ancestor
92079870|NCT01164202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079871|NCT01164202|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079872|NCT01164202|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079873|NCT01164202|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079874|NCT01164202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079875|NCT02112370|Epinephrine|epinephrine|mesh-list
92079876|NCT02112370|Racepinephrine|racepinephrine|mesh-list
92079877|NCT02112370|Ropivacaine|ropivacaine|mesh-list
92079878|NCT02112370|Epinephryl borate|epinephryl borate|mesh-list
92079879|NCT02112370|Anesthetics, Local|anesthetics, local|mesh-ancestor
92079880|NCT02112370|Anesthetics|anesthetics|mesh-ancestor
92079881|NCT02112370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92079882|NCT02112370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016412|NCT04979923|Anesthetics, Local|anesthetics, local|mesh-ancestor
92016413|NCT04979923|Anesthetics|anesthetics|mesh-ancestor
92079883|NCT02112370|Sensory System Agents|sensory system agents|mesh-ancestor
92079884|NCT02112370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079885|NCT02112370|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92079886|NCT02112370|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92079887|NCT02112370|Adrenergic Agents|adrenergic agents|mesh-ancestor
92079888|NCT02112370|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079889|NCT02112370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079890|NCT02112370|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92079891|NCT02112370|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92079892|NCT02112370|Autonomic Agents|autonomic agents|mesh-ancestor
92079893|NCT02112370|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92079894|NCT02112370|Respiratory System Agents|respiratory system agents|mesh-ancestor
92079895|NCT02112370|Mydriatics|mydriatics|mesh-ancestor
92079896|NCT02112370|Sympathomimetics|sympathomimetics|mesh-ancestor
92079897|NCT02112370|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92079898|NCT00427336|Cyclophosphamide|cyclophosphamide|mesh-list
92079899|NCT00427336|Fludarabine|fludarabine|mesh-list
92079909|NCT00427336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079910|NCT00427336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079911|NCT00427336|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92079912|NCT00427336|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079913|NCT00427336|Antimetabolites|antimetabolites|mesh-ancestor
92079914|NCT00371176|Cycloserine|cycloserine|mesh-list
92079915|NCT00371176|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92079916|NCT00371176|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079917|NCT00371176|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92079918|NCT00371176|Antitubercular Agents|antitubercular agents|mesh-ancestor
92079919|NCT00371176|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92079920|NCT00371176|Antimetabolites|antimetabolites|mesh-ancestor
92079921|NCT00371176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079922|NCT00428584|Interferons|interferons|mesh-list
92079923|NCT00428584|Interferon-beta|interferon-beta|mesh-list
92079924|NCT00428584|Interferon beta-1a|interferon beta-1a|mesh-list
92079925|NCT00428584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079926|NCT00428584|Antiviral Agents|antiviral agents|mesh-ancestor
92079927|NCT00428584|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079928|NCT00428584|Immunologic Factors|immunologic factors|mesh-ancestor
92079929|NCT00428584|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079930|NCT00428584|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92079931|NCT05187286|Apixaban|apixaban|mesh-list
92079932|NCT05187286|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92079933|NCT05187286|Antithrombins|antithrombins|mesh-ancestor
92079934|NCT05187286|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92079935|NCT05187286|Protease Inhibitors|protease inhibitors|mesh-ancestor
92079936|NCT05187286|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079937|NCT05187286|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079938|NCT05187286|Anticoagulants|anticoagulants|mesh-ancestor
92079939|NCT00372970|Botulinum Toxins|botulinum toxins|mesh-list
92079940|NCT00372970|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92079941|NCT00372970|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92079942|NCT00372970|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92079943|NCT00372970|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92079944|NCT00372970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079945|NCT00372970|Cholinergic Agents|cholinergic agents|mesh-ancestor
92079946|NCT00372970|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079947|NCT00372970|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079948|NCT00372970|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92079949|NCT00372970|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079950|NCT00373360|Treprostinil|treprostinil|mesh-list
92079951|NCT00373360|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92079952|NCT00455650|Mecamylamine|mecamylamine|mesh-list
92079953|NCT00455650|Varenicline|varenicline|mesh-list
92079954|NCT00455650|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92079955|NCT00455650|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92079956|NCT00455650|Cholinergic Agents|cholinergic agents|mesh-ancestor
92079957|NCT00455650|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92079958|NCT00455650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079959|NCT00455650|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079960|NCT00455650|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92079961|NCT00455650|Ganglionic Blockers|ganglionic blockers|mesh-ancestor
92016414|NCT04979923|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016415|NCT04979923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016416|NCT04979923|Sensory System Agents|sensory system agents|mesh-ancestor
92079962|NCT00455650|Autonomic Agents|autonomic agents|mesh-ancestor
92079963|NCT00455650|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079964|NCT00455650|Nicotinic Antagonists|nicotinic antagonists|mesh-ancestor
92079965|NCT00455650|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92079968|NCT00431626|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92079969|NCT00431626|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079970|NCT00431626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079971|NCT00431626|Hormone Antagonists|hormone antagonists|mesh-ancestor
92079972|NCT00431626|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079973|NCT00431626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079975|NCT00455962|Progesterone|progesterone|mesh-list
92079976|NCT00455962|Estrogens|estrogens|mesh-ancestor
92079977|NCT00455962|Hormones|hormones|mesh-ancestor
92079978|NCT00455962|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079979|NCT00455962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079980|NCT00455962|Progestins|progestins|mesh-ancestor
92079981|NCT00434356|Paclitaxel|paclitaxel|mesh-list
92079983|NCT00434356|Sunitinib|sunitinib|mesh-list
92079984|NCT00434356|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079985|NCT00434356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079986|NCT00434356|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079987|NCT00434356|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079988|NCT00434356|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079989|NCT00434356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079990|NCT00434356|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079991|NCT00434356|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079992|NCT00434356|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079993|NCT00434356|Growth Substances|growth substances|mesh-ancestor
92079994|NCT00434356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079995|NCT00434356|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079996|NCT00434356|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92079997|NCT00434356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079998|NCT00376948|Gemcitabine|gemcitabine|mesh-list
92080000|NCT00376948|Genistein|genistein|mesh-list
92080001|NCT00376948|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080002|NCT00376948|Antimetabolites|antimetabolites|mesh-ancestor
92080003|NCT00376948|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080004|NCT00376948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080005|NCT00376948|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080006|NCT00376948|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080007|NCT00376948|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92080008|NCT00376948|Protective Agents|protective agents|mesh-ancestor
92080009|NCT00376948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080010|NCT00376948|Phytoestrogens|phytoestrogens|mesh-ancestor
92080011|NCT00376948|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92080012|NCT00376948|Estrogens|estrogens|mesh-ancestor
92080013|NCT00376948|Hormones|hormones|mesh-ancestor
92080014|NCT00376948|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080015|NCT03396874|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92080016|NCT03396874|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92080017|NCT03396874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080018|NCT00438100|Capecitabine|capecitabine|mesh-list
92080019|NCT00438100|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080020|NCT00438100|Antimetabolites|antimetabolites|mesh-ancestor
92080021|NCT00438100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080022|NCT00438100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080023|NCT00456508|Ecallantide|ecallantide|mesh-list
92080024|NCT00456508|Analgesics|analgesics|mesh-ancestor
92080025|NCT00456508|Sensory System Agents|sensory system agents|mesh-ancestor
92080026|NCT00456508|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080027|NCT00456508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080028|NCT00456508|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92080029|NCT00456508|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016417|NCT04979923|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016418|NCT04979923|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92016419|NCT04979923|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92016420|NCT04979923|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92080030|NCT00456508|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080031|NCT00456508|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080033|NCT00457366|Haloperidol|haloperidol|mesh-list
92080034|NCT00457366|Benztropine|benztropine|mesh-list
92080035|NCT00457366|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92080036|NCT00457366|Haloperidol decanoate|haloperidol decanoate|mesh-list
92080037|NCT00457366|Antidepressive Agents|antidepressive agents|mesh-ancestor
92080038|NCT00457366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080039|NCT00457366|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92080043|NCT00457366|Antiemetics|antiemetics|mesh-ancestor
92080044|NCT00457366|Autonomic Agents|autonomic agents|mesh-ancestor
92080045|NCT00457366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080046|NCT00457366|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080047|NCT00457366|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92080048|NCT00457366|Dopamine Agents|dopamine agents|mesh-ancestor
92080049|NCT00457366|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080050|NCT00457366|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080051|NCT00457366|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92080052|NCT00457366|Anticonvulsants|anticonvulsants|mesh-ancestor
92080053|NCT00457366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92080054|NCT00457366|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92080055|NCT00457366|GABA Modulators|gaba modulators|mesh-ancestor
92080056|NCT00457366|GABA Agents|gaba agents|mesh-ancestor
92080057|NCT00457366|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92080058|NCT00457366|Parasympatholytics|parasympatholytics|mesh-ancestor
92080059|NCT00457366|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92080060|NCT00457366|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92080061|NCT00457366|Cholinergic Agents|cholinergic agents|mesh-ancestor
92080062|NCT00457366|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92080063|NCT00457366|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92080064|NCT00457366|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080065|NCT00458848|Prednisone|prednisone|mesh-list
92080066|NCT00458848|Methylprednisolone|methylprednisolone|mesh-list
92080067|NCT00458848|Methotrexate|methotrexate|mesh-list
92080068|NCT00458848|Etoposide|etoposide|mesh-list
92080069|NCT00458848|Vincristine|vincristine|mesh-list
92080070|NCT00458848|Imatinib Mesylate|imatinib mesylate|mesh-list
92080071|NCT00458848|Daunorubicin|daunorubicin|mesh-list
92080072|NCT00458848|Asparaginase|asparaginase|mesh-list
92080073|NCT00458848|Mitoxantrone|mitoxantrone|mesh-list
92080074|NCT00458848|Mercaptopurine|mercaptopurine|mesh-list
92080075|NCT00458848|Idarubicin|idarubicin|mesh-list
92080076|NCT00458848|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080077|NCT00458848|Glucocorticoids|glucocorticoids|mesh-ancestor
92080078|NCT00458848|Hormones|hormones|mesh-ancestor
92080079|NCT00458848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080080|NCT00458848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080081|NCT00458848|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080082|NCT00458848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080083|NCT00458848|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92080084|NCT00458848|Abortifacient Agents|abortifacient agents|mesh-ancestor
92080085|NCT00458848|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92080086|NCT00458848|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080087|NCT00458848|Antimetabolites|antimetabolites|mesh-ancestor
92080088|NCT00458848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080089|NCT00458848|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080090|NCT00458848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080091|NCT00458848|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92080092|NCT00458848|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080093|NCT00458848|Immunologic Factors|immunologic factors|mesh-ancestor
92080094|NCT00458848|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080095|NCT00458848|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92080096|NCT00458848|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080097|NCT00458848|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92080098|NCT00458848|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92080099|NCT00458848|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080100|NCT00458848|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080101|NCT00458848|Mitosis Modulators|mitosis modulators|mesh-ancestor
92016421|NCT04979923|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016422|NCT04979923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016423|NCT03706885|Efavirenz|efavirenz|mesh-list
92016424|NCT03706885|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92016425|NCT03706885|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92016426|NCT03706885|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080102|NCT00458848|Antiemetics|antiemetics|mesh-ancestor
92080103|NCT00458848|Autonomic Agents|autonomic agents|mesh-ancestor
92080104|NCT00458848|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080105|NCT00458848|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080106|NCT00458848|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92080107|NCT00458848|Protective Agents|protective agents|mesh-ancestor
92080108|NCT00458848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080109|NCT00458848|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92080110|NCT00458848|Analgesics|analgesics|mesh-ancestor
92080111|NCT00458848|Sensory System Agents|sensory system agents|mesh-ancestor
92080112|NCT00438802|Alefacept|alefacept|mesh-list
92080113|NCT00438802|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080124|NCT00438880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92080125|NCT00438880|Antibodies|antibodies|mesh-list
92080126|NCT00438880|Immunoglobulins|immunoglobulins|mesh-list
92080127|NCT00438880|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92080128|NCT00438880|Immunologic Factors|immunologic factors|mesh-ancestor
92080129|NCT00438880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080130|NCT00438880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080131|NCT00438880|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080132|NCT00378352|Epoetin Alfa|epoetin alfa|mesh-list
92080133|NCT00378352|Hematinics|hematinics|mesh-ancestor
92080134|NCT00462280|Lovastatin|lovastatin|mesh-list
92080135|NCT00462280|L 647318|l 647318|mesh-list
92080136|NCT00462280|Dihydromevinolin|dihydromevinolin|mesh-list
92080137|NCT00462280|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92080138|NCT00462280|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92080139|NCT00462280|Antimetabolites|antimetabolites|mesh-ancestor
92080140|NCT00462280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080141|NCT00462280|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92080142|NCT00462280|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92080143|NCT00462280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080144|NCT00381004|Cyclophosphamide|cyclophosphamide|mesh-list
92080145|NCT00381004|Rituximab|rituximab|mesh-list
92080146|NCT00381004|Fludarabine|fludarabine|mesh-list
92080147|NCT00381004|Fludarabine phosphate|fludarabine phosphate|mesh-list
92080148|NCT00381004|Sargramostim|sargramostim|mesh-list
92080149|NCT00381004|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080150|NCT00381004|Immunologic Factors|immunologic factors|mesh-ancestor
92080151|NCT00381004|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080152|NCT00381004|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080153|NCT00381004|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92080154|NCT00381004|Alkylating Agents|alkylating agents|mesh-ancestor
92080155|NCT00381004|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080156|NCT00381004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080157|NCT00381004|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92080158|NCT00381004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080159|NCT00381004|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080160|NCT00381004|Antimetabolites|antimetabolites|mesh-ancestor
92080161|NCT00381550|Fludarabine|fludarabine|mesh-list
92080162|NCT00381550|Fludarabine phosphate|fludarabine phosphate|mesh-list
92080163|NCT00381550|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080164|NCT00381550|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080165|NCT00381550|Antimetabolites|antimetabolites|mesh-ancestor
92080166|NCT00381550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080167|NCT00381550|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080168|NCT00381550|Immunologic Factors|immunologic factors|mesh-ancestor
92080169|NCT00381550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080170|NCT00440830|Nicotine|nicotine|mesh-list
92080171|NCT00440830|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92080172|NCT00440830|Autonomic Agents|autonomic agents|mesh-ancestor
92080173|NCT00440830|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080174|NCT00440830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080175|NCT00440830|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92016427|NCT03706885|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016428|NCT03706885|Antiviral Agents|antiviral agents|mesh-ancestor
92016429|NCT03706885|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016430|NCT03706885|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92080176|NCT00440830|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92080177|NCT00440830|Cholinergic Agents|cholinergic agents|mesh-ancestor
92080178|NCT00440830|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080179|NCT00440830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080182|NCT00427804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080183|NCT00427804|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92080184|NCT00427804|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080185|NCT00427804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080186|NCT00427804|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92080187|NCT00427804|Vitamins|vitamins|mesh-ancestor
92080188|NCT00427804|Micronutrients|micronutrients|mesh-ancestor
92080189|NCT00427804|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92080190|NCT00381862|Leucovorin|leucovorin|mesh-list
92080191|NCT00381862|Dexamethasone|dexamethasone|mesh-list
92080192|NCT00381862|Fluorouracil|fluorouracil|mesh-list
92080194|NCT00381862|Irinotecan|irinotecan|mesh-list
92080195|NCT00381862|Camptothecin|camptothecin|mesh-list
92080196|NCT00381862|Aprepitant|aprepitant|mesh-list
92080197|NCT00381862|Palonosetron|palonosetron|mesh-list
92080198|NCT00381862|Levoleucovorin|levoleucovorin|mesh-list
92080199|NCT00381862|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080200|NCT00381862|Antiemetics|antiemetics|mesh-ancestor
92080201|NCT00381862|Autonomic Agents|autonomic agents|mesh-ancestor
92080202|NCT00381862|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080203|NCT00381862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080204|NCT00381862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080205|NCT00381862|Glucocorticoids|glucocorticoids|mesh-ancestor
92080206|NCT00381862|Hormones|hormones|mesh-ancestor
92080207|NCT00381862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080208|NCT00381862|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080209|NCT00381862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080210|NCT00381862|Antimetabolites|antimetabolites|mesh-ancestor
92080211|NCT00381862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080212|NCT00381862|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080213|NCT00381862|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080214|NCT00381862|Immunologic Factors|immunologic factors|mesh-ancestor
92080215|NCT00381862|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92080216|NCT00381862|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92080217|NCT00381862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080218|NCT00381862|Antidotes|antidotes|mesh-ancestor
92080219|NCT00381862|Protective Agents|protective agents|mesh-ancestor
92080220|NCT00381862|Vitamin B Complex|vitamin b complex|mesh-ancestor
92080221|NCT00381862|Vitamins|vitamins|mesh-ancestor
92080222|NCT00381862|Micronutrients|micronutrients|mesh-ancestor
92080223|NCT00381862|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92080224|NCT00381862|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080225|NCT00381862|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92080226|NCT00381862|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92080227|NCT00381862|Serotonin Agents|serotonin agents|mesh-ancestor
92080228|NCT00381862|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080229|NCT00464698|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92080230|NCT00464698|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92080231|NCT00464698|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92080232|NCT00464698|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080233|NCT00464698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080234|NCT00464698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080235|NCT00464698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080236|NCT00464698|Analgesics|analgesics|mesh-ancestor
92080237|NCT00464698|Sensory System Agents|sensory system agents|mesh-ancestor
92080238|NCT00464698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080239|NCT00464698|Antidepressive Agents|antidepressive agents|mesh-ancestor
92080240|NCT00464698|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080241|NCT00464698|Dopamine Agents|dopamine agents|mesh-ancestor
92080243|NCT00465088|Niacinamide|niacinamide|mesh-list
92016431|NCT03706885|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92016432|NCT03706885|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92080244|NCT00465088|Nicotinic Acids|nicotinic acids|mesh-list
92080245|NCT00465088|Atorvastatin|atorvastatin|mesh-list
92080246|NCT00465088|Simvastatin|simvastatin|mesh-list
92080247|NCT00465088|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92080248|NCT00465088|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92080249|NCT00465088|Antimetabolites|antimetabolites|mesh-ancestor
92080250|NCT00465088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080251|NCT00465088|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92080252|NCT00465088|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92080253|NCT00465088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080257|NCT00465088|Micronutrients|micronutrients|mesh-ancestor
92080258|NCT00465088|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080259|NCT01796782|Capecitabine|capecitabine|mesh-list
92080260|NCT01796782|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080261|NCT01796782|Antimetabolites|antimetabolites|mesh-ancestor
92080262|NCT01796782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080263|NCT01796782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080264|NCT00466960|Paclitaxel|paclitaxel|mesh-list
92080265|NCT00466960|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92080266|NCT00466960|Sargramostim|sargramostim|mesh-list
92080267|NCT00466960|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080268|NCT00466960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080269|NCT00466960|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080270|NCT00466960|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080271|NCT00466960|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080272|NCT00466960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080273|NCT00466960|Immunologic Factors|immunologic factors|mesh-ancestor
92080274|NCT00466960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080276|NCT00383266|Pemetrexed|pemetrexed|mesh-list
92080277|NCT00383266|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080278|NCT00383266|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080279|NCT00383266|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080280|NCT00383266|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92080281|NCT00383266|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92080282|NCT00384670|Vaccines|vaccines|mesh-list
92080283|NCT00384670|Immunologic Factors|immunologic factors|mesh-ancestor
92080284|NCT00384670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080285|NCT00467350|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92080286|NCT00467350|Laxatives|laxatives|mesh-ancestor
92080287|NCT00467350|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080288|NCT00444028|Loxapine|loxapine|mesh-list
92080289|NCT00444028|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92080290|NCT00444028|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92080291|NCT00444028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080292|NCT00444028|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080293|NCT00444028|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080294|NCT00444028|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92080296|NCT00444028|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080297|NCT00444028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080298|NCT00444964|Hormones|hormones|mesh-list
92080299|NCT00444964|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080300|NCT00444964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080301|NCT00445588|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92080302|NCT00445588|Sorafenib|sorafenib|mesh-list
92080303|NCT00445588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080304|NCT00445588|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080305|NCT00445588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080306|NCT00445588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080307|NCT00445744|Cyclophosphamide|cyclophosphamide|mesh-list
92080308|NCT00445744|Busulfan|busulfan|mesh-list
92080309|NCT00445744|Methotrexate|methotrexate|mesh-list
92080310|NCT00445744|Tacrolimus|tacrolimus|mesh-list
92080311|NCT00445744|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080312|NCT00445744|Immunologic Factors|immunologic factors|mesh-ancestor
92080313|NCT00445744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080314|NCT00445744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080315|NCT00445744|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92016433|NCT03706885|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92016434|NCT03706885|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92016435|NCT03706885|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92080316|NCT00445744|Alkylating Agents|alkylating agents|mesh-ancestor
92080317|NCT00445744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080318|NCT00445744|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080319|NCT00445744|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92080320|NCT00445744|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92080321|NCT00445744|Abortifacient Agents|abortifacient agents|mesh-ancestor
92080322|NCT00445744|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92080323|NCT00445744|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080324|NCT00445744|Antimetabolites|antimetabolites|mesh-ancestor
92080325|NCT00445744|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080326|NCT00445744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080330|NCT00468208|Abatacept|abatacept|mesh-list
92080331|NCT00468208|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92080332|NCT00468208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080333|NCT00468208|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080334|NCT00468208|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080335|NCT00468208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080336|NCT00468208|Immunologic Factors|immunologic factors|mesh-ancestor
92080337|NCT00468208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080338|NCT00468208|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080339|NCT00385138|Clopidogrel|clopidogrel|mesh-list
92080340|NCT00385138|Cangrelor|cangrelor|mesh-list
92080341|NCT00385138|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92080342|NCT00385138|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92080343|NCT00385138|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92080344|NCT00385138|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92080345|NCT00385138|Purinergic Agents|purinergic agents|mesh-ancestor
92080346|NCT00385138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080347|NCT00385138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080348|NCT00385138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080349|NCT00446290|Docetaxel|docetaxel|mesh-list
92080350|NCT00446290|Capecitabine|capecitabine|mesh-list
92080351|NCT00446290|Oxaliplatin|oxaliplatin|mesh-list
92080352|NCT00446290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080353|NCT00446290|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080354|NCT00446290|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080355|NCT00446290|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080356|NCT00446290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080357|NCT00446290|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080358|NCT00446290|Antimetabolites|antimetabolites|mesh-ancestor
92080359|NCT00385216|Nicotine|nicotine|mesh-list
92080360|NCT00385216|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92080361|NCT00385216|Autonomic Agents|autonomic agents|mesh-ancestor
92080362|NCT00385216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080363|NCT00385216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080364|NCT00385216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92080365|NCT00385216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92080366|NCT00385216|Cholinergic Agents|cholinergic agents|mesh-ancestor
92080367|NCT00385216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080368|NCT00385216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080369|NCT00385996|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92080370|NCT00385996|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080371|NCT00385996|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080372|NCT00385996|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080373|NCT00385996|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080374|NCT00470392|Clobetasol|clobetasol|mesh-list
92080375|NCT00470392|Imiquimod|imiquimod|mesh-list
92080376|NCT00470392|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92080377|NCT00470392|Immunologic Factors|immunologic factors|mesh-ancestor
92080378|NCT00470392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080379|NCT00470392|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080380|NCT00470392|Interferon Inducers|interferon inducers|mesh-ancestor
92080381|NCT00470392|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080382|NCT00470392|Glucocorticoids|glucocorticoids|mesh-ancestor
92080383|NCT00470392|Hormones|hormones|mesh-ancestor
92080384|NCT00470392|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016436|NCT01665599|Testosterone|testosterone|mesh-list
92016437|NCT01665599|Androgens|androgens|mesh-ancestor
92016438|NCT01665599|Hormones|hormones|mesh-ancestor
92016439|NCT01665599|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016440|NCT01665599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016441|NCT04979221|Cyproheptadine|cyproheptadine|mesh-list
92080385|NCT00470548|Paclitaxel|paclitaxel|mesh-list
92080386|NCT00470548|Pemetrexed|pemetrexed|mesh-list
92080387|NCT00470548|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92080388|NCT00470548|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080389|NCT00470548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080390|NCT00470548|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080391|NCT00470548|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080392|NCT00470548|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080393|NCT00470548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080394|NCT00470548|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080395|NCT00470548|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92080396|NCT00470548|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92080400|NCT00388414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080401|NCT00388414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080403|NCT00388414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080404|NCT00388414|Analgesics|analgesics|mesh-ancestor
92080405|NCT00388414|Sensory System Agents|sensory system agents|mesh-ancestor
92080406|NCT00388414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080407|NCT00388414|Antidepressive Agents|antidepressive agents|mesh-ancestor
92080408|NCT00388414|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080409|NCT00388414|Dopamine Agents|dopamine agents|mesh-ancestor
92080410|NCT00475150|Cediranib|cediranib|mesh-list
92080411|NCT00475150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080412|NCT00475150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080413|NCT00475150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080414|NCT00475150|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080415|NCT00451048|Sunitinib|sunitinib|mesh-list
92080416|NCT00451048|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080417|NCT00451048|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92080418|NCT00451048|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92080419|NCT00451048|Growth Substances|growth substances|mesh-ancestor
92080420|NCT00451048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080421|NCT00451048|Growth Inhibitors|growth inhibitors|mesh-ancestor
92080422|NCT00451048|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080423|NCT00451048|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080424|NCT00451048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080425|NCT00388804|Leuprolide|leuprolide|mesh-list
92080426|NCT00388804|Goserelin|goserelin|mesh-list
92080427|NCT00388804|Flutamide|flutamide|mesh-list
92080428|NCT00388804|Bicalutamide|bicalutamide|mesh-list
92080429|NCT00388804|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92080430|NCT00388804|Fertility Agents|fertility agents|mesh-ancestor
92080431|NCT00388804|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92080432|NCT00388804|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080433|NCT00388804|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080434|NCT00388804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080435|NCT00388804|Androgen Antagonists|androgen antagonists|mesh-ancestor
92080436|NCT00388804|Hormone Antagonists|hormone antagonists|mesh-ancestor
92080437|NCT00388804|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080438|NCT00389818|Prednisone|prednisone|mesh-list
92080439|NCT00389818|Cyclophosphamide|cyclophosphamide|mesh-list
92080440|NCT00389818|Rituximab|rituximab|mesh-list
92080441|NCT00389818|Doxorubicin|doxorubicin|mesh-list
92080442|NCT00389818|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92080443|NCT00389818|Vincristine|vincristine|mesh-list
92080444|NCT00389818|Sargramostim|sargramostim|mesh-list
92080445|NCT00389818|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080446|NCT00389818|Immunologic Factors|immunologic factors|mesh-ancestor
92080447|NCT00389818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080448|NCT00389818|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080449|NCT00389818|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92080450|NCT00389818|Alkylating Agents|alkylating agents|mesh-ancestor
92016442|NCT04979221|Antipruritics|antipruritics|mesh-ancestor
92016443|NCT04979221|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016444|NCT04979221|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080451|NCT00389818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080452|NCT00389818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080453|NCT00389818|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92080454|NCT00389818|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080455|NCT00389818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92080456|NCT00389818|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92080457|NCT00389818|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92080458|NCT00389818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080459|NCT00389818|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080460|NCT00389818|Glucocorticoids|glucocorticoids|mesh-ancestor
92080461|NCT00389818|Hormones|hormones|mesh-ancestor
92080462|NCT00389818|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080463|NCT00389818|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080464|NCT00389818|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080465|NCT00389818|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080474|NCT00452374|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080475|NCT00452374|Immunologic Factors|immunologic factors|mesh-ancestor
92080476|NCT00452374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080477|NCT00452374|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080478|NCT00452374|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080480|NCT00452374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080481|NCT00452374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080482|NCT00452374|Antiviral Agents|antiviral agents|mesh-ancestor
92080483|NCT00452374|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080484|NCT03286114|Pembrolizumab|pembrolizumab|mesh-list
92080485|NCT03286114|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080486|NCT03286114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080487|NCT03286114|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92080488|NCT03286114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080489|NCT00476242|Naltrexone|naltrexone|mesh-list
92080490|NCT00476242|Memantine|memantine|mesh-list
92080491|NCT00476242|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92080492|NCT00476242|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92080493|NCT00476242|Dopamine Agents|dopamine agents|mesh-ancestor
92080494|NCT00476242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080495|NCT00476242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080496|NCT00476242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080497|NCT00476242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92080498|NCT00476242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92080499|NCT00476242|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92080500|NCT00476242|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92080501|NCT00476242|Sensory System Agents|sensory system agents|mesh-ancestor
92080502|NCT00476242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080503|NCT00476788|Insulin|insulin|mesh-list
92080504|NCT00476788|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92080505|NCT00476788|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92080506|NCT00476788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080507|NCT01795144|Glucagon|glucagon|mesh-list
92080508|NCT01795144|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92080509|NCT01795144|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080510|NCT01795144|Hormones|hormones|mesh-ancestor
92080511|NCT01795144|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080512|NCT01795144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080513|NCT01795144|Incretins|incretins|mesh-ancestor
92080514|NCT01436175|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92080515|NCT01436175|Antidepressive Agents|antidepressive agents|mesh-list
92080516|NCT01436175|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080517|NCT01436175|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92080518|NCT01436175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080519|NCT01436175|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92080520|NCT01436175|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92080521|NCT01436175|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080522|NCT01436175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080523|NCT01436175|Dopamine Agents|dopamine agents|mesh-ancestor
92080524|NCT01436175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080525|NCT00453388|Cyclosporine|cyclosporine|mesh-list
92080526|NCT00453388|Mycophenolic Acid|mycophenolic acid|mesh-list
92080527|NCT00453388|Cyclophosphamide|cyclophosphamide|mesh-list
92080528|NCT00453388|Fludarabine|fludarabine|mesh-list
92080529|NCT00453388|Fludarabine phosphate|fludarabine phosphate|mesh-list
92080530|NCT00453388|Cyclosporins|cyclosporins|mesh-list
92080531|NCT00453388|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080532|NCT00453388|Immunologic Factors|immunologic factors|mesh-ancestor
92080533|NCT00453388|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080537|NCT00453388|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080538|NCT00453388|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080539|NCT00453388|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92080540|NCT00453388|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080541|NCT00453388|Antimetabolites|antimetabolites|mesh-ancestor
92080542|NCT00453388|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080543|NCT00453388|Antifungal Agents|antifungal agents|mesh-ancestor
92080544|NCT00453388|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080545|NCT00453388|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080546|NCT00453388|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92080547|NCT00453388|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92080548|NCT00453388|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92080549|NCT00453388|Antitubercular Agents|antitubercular agents|mesh-ancestor
92080550|NCT00453388|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92080551|NCT00389974|Sunitinib|sunitinib|mesh-list
92080552|NCT00389974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080553|NCT00389974|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92080554|NCT00389974|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92080555|NCT00389974|Growth Substances|growth substances|mesh-ancestor
92080556|NCT00389974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080557|NCT00389974|Growth Inhibitors|growth inhibitors|mesh-ancestor
92080558|NCT00389974|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080559|NCT00389974|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080560|NCT00389974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080561|NCT01453725|Golimumab|golimumab|mesh-list
92080562|NCT01453725|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92080563|NCT01453725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080564|NCT01453725|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080565|NCT01453725|Immunologic Factors|immunologic factors|mesh-ancestor
92080566|NCT01453725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080567|NCT00454324|Paclitaxel|paclitaxel|mesh-list
92080568|NCT00454324|Carboplatin|carboplatin|mesh-list
92080569|NCT00454324|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92080570|NCT00454324|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080571|NCT00454324|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080572|NCT00454324|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080573|NCT00454324|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080574|NCT00454324|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080575|NCT00454324|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080576|NCT02110264|Naltrexone|naltrexone|mesh-list
92080577|NCT02110264|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92080578|NCT02110264|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92080579|NCT02110264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080580|NCT02110264|Sensory System Agents|sensory system agents|mesh-ancestor
92080581|NCT02110264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080582|NCT01795222|Midazolam|midazolam|mesh-list
92080583|NCT01795222|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92080584|NCT01795222|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92080585|NCT01795222|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080586|NCT01795222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080587|NCT01795222|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92080588|NCT01795222|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92080589|NCT01795222|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080590|NCT01795222|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92080591|NCT01795222|Anesthetics, General|anesthetics, general|mesh-ancestor
92080592|NCT01795222|Anesthetics|anesthetics|mesh-ancestor
92080593|NCT01795222|GABA Modulators|gaba modulators|mesh-ancestor
92080594|NCT01795222|GABA Agents|gaba agents|mesh-ancestor
92080595|NCT01795222|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080596|NCT01795222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080597|NCT01415349|Omeprazole|omeprazole|mesh-list
92080598|NCT01415349|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92080599|NCT01415349|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080600|NCT01415349|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92080601|NCT01415349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016445|NCT04979221|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92016446|NCT04979221|Histamine Antagonists|histamine antagonists|mesh-ancestor
92016447|NCT04979221|Histamine Agents|histamine agents|mesh-ancestor
92016448|NCT04979221|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080602|NCT01415349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080603|NCT00528190|Itraconazole|itraconazole|mesh-list
92080604|NCT00528190|Antifungal Agents|antifungal agents|mesh-ancestor
92080605|NCT00528190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080608|NCT00528190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080609|NCT00528190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080610|NCT00528190|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92080611|NCT00528190|Hormone Antagonists|hormone antagonists|mesh-ancestor
92080612|NCT00528190|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080613|NCT00528190|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080614|NCT00528190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92080615|NCT02334813|Dexamethasone|dexamethasone|mesh-list
92080616|NCT02334813|Prednisone|prednisone|mesh-list
92080617|NCT02334813|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080618|NCT02334813|Antiemetics|antiemetics|mesh-ancestor
92080619|NCT02334813|Autonomic Agents|autonomic agents|mesh-ancestor
92080620|NCT02334813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080621|NCT02334813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080622|NCT02334813|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080623|NCT02334813|Glucocorticoids|glucocorticoids|mesh-ancestor
92080624|NCT02334813|Hormones|hormones|mesh-ancestor
92080625|NCT02334813|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080626|NCT02334813|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080627|NCT02334813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080628|NCT00478036|Prednisolone|prednisolone|mesh-list
92080629|NCT00478036|Prednisolone acetate|prednisolone acetate|mesh-list
92080630|NCT00478036|Ketorolac|ketorolac|mesh-list
92080631|NCT00478036|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92080632|NCT00478036|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92080633|NCT00478036|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080634|NCT00478036|Glucocorticoids|glucocorticoids|mesh-ancestor
92080635|NCT00478036|Hormones|hormones|mesh-ancestor
92080636|NCT00478036|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080637|NCT00478036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080638|NCT00478036|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92080639|NCT00478036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080640|NCT00478036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080641|NCT00478036|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080642|NCT00478036|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92080643|NCT00478036|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92080644|NCT00478036|Analgesics|analgesics|mesh-ancestor
92080645|NCT00478036|Sensory System Agents|sensory system agents|mesh-ancestor
92080646|NCT00478036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080647|NCT00478036|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92080648|NCT00478036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080649|NCT00478036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080650|NCT00478036|Laxatives|laxatives|mesh-ancestor
92080651|NCT04048863|Imidacloprid|imidacloprid|mesh-list
92080652|NCT04048863|Cholinergic Agents|cholinergic agents|mesh-ancestor
92080653|NCT04048863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080654|NCT04048863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080655|NCT04048863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080656|NCT04522557|Interferon alpha-2|interferon alpha-2|mesh-list
92080657|NCT04522557|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080658|NCT04522557|Antiviral Agents|antiviral agents|mesh-ancestor
92080659|NCT04522557|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080660|NCT01453023|Fluticasone|fluticasone|mesh-list
92080662|NCT01453023|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080663|NCT01453023|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92080664|NCT01453023|Autonomic Agents|autonomic agents|mesh-ancestor
92080665|NCT01453023|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080666|NCT01453023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080667|NCT01453023|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92080668|NCT01453023|Respiratory System Agents|respiratory system agents|mesh-ancestor
92080669|NCT01453023|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080670|NCT01453023|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92080672|NCT01452789|Buprenorphine|buprenorphine|mesh-list
92080673|NCT01452789|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92080674|NCT01452789|Narcotics|narcotics|mesh-ancestor
92080675|NCT01452789|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080676|NCT01452789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080677|NCT01452789|Analgesics|analgesics|mesh-ancestor
92080693|NCT01414257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080694|NCT01414257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080695|NCT01414257|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080696|NCT01414257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080697|NCT01414257|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92080698|NCT01414257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080699|NCT01414257|Immunologic Factors|immunologic factors|mesh-ancestor
92080700|NCT01414257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080701|NCT01414257|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92080702|NCT00528268|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92080703|NCT00528268|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080704|NCT00528580|Simvastatin|simvastatin|mesh-list
92080705|NCT00528580|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92080706|NCT00528580|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92080707|NCT00528580|Antimetabolites|antimetabolites|mesh-ancestor
92080708|NCT00528580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080709|NCT00528580|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92080710|NCT00528580|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92080711|NCT00528580|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080712|NCT00529126|Epinephrine|epinephrine|mesh-list
92080713|NCT00529126|Bupivacaine|bupivacaine|mesh-list
92080714|NCT00529126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92080716|NCT00529126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080717|NCT00529126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080718|NCT00529126|Sensory System Agents|sensory system agents|mesh-ancestor
92080719|NCT00529126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080720|NCT00529126|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92080721|NCT00529126|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92080722|NCT00529126|Adrenergic Agents|adrenergic agents|mesh-ancestor
92080723|NCT00529126|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080724|NCT00529126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080725|NCT00529126|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92080726|NCT00529126|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92080727|NCT00529126|Autonomic Agents|autonomic agents|mesh-ancestor
92080728|NCT00529126|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92080729|NCT00529126|Respiratory System Agents|respiratory system agents|mesh-ancestor
92080730|NCT00529126|Mydriatics|mydriatics|mesh-ancestor
92080731|NCT00529126|Sympathomimetics|sympathomimetics|mesh-ancestor
92080732|NCT00529126|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92080733|NCT00529204|Exenatide|exenatide|mesh-list
92080734|NCT00529204|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92080735|NCT00529204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080757|NCT00530764|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92080758|NCT00530764|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92080759|NCT00530764|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080760|NCT00530764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080761|NCT00530764|Hormones|hormones|mesh-ancestor
92080762|NCT00530764|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080763|NCT00532480|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92080764|NCT00532480|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92080765|NCT00532480|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92080766|NCT00532480|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080767|NCT00532480|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080768|NCT00532480|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080769|NCT00532480|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080770|NCT00532480|Analgesics|analgesics|mesh-ancestor
92080771|NCT00532480|Sensory System Agents|sensory system agents|mesh-ancestor
92080772|NCT00532480|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080773|NCT00532480|Antidepressive Agents|antidepressive agents|mesh-ancestor
92080774|NCT00532480|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080775|NCT00532480|Dopamine Agents|dopamine agents|mesh-ancestor
92080776|NCT00483262|Bortezomib|bortezomib|mesh-list
92080777|NCT00483262|Temsirolimus|temsirolimus|mesh-list
92016449|NCT04979221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016450|NCT04979221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080778|NCT00483262|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080779|NCT00483262|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92080780|NCT00483262|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080781|NCT00483262|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080782|NCT00483262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080783|NCT00483262|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080784|NCT00483262|Immunologic Factors|immunologic factors|mesh-ancestor
92080785|NCT00483262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080786|NCT00483496|Titanium dioxide|titanium dioxide|mesh-list
92080787|NCT00483496|Sunscreening Agents|sunscreening agents|mesh-ancestor
92080788|NCT00483496|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92080791|NCT00483496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080792|NCT00483496|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92080794|NCT00485836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92080795|NCT00485836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92080796|NCT00485836|Growth Substances|growth substances|mesh-ancestor
92080797|NCT00485836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080798|NCT00485836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92080799|NCT00485836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080800|NCT00488488|Tigecycline|tigecycline|mesh-list
92080801|NCT00488488|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92080802|NCT00488488|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080803|NCT00488488|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92080804|NCT00488488|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080805|NCT00488488|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080806|NCT01450761|Carboplatin|carboplatin|mesh-list
92080807|NCT01450761|Etoposide|etoposide|mesh-list
92080808|NCT01450761|Ipilimumab|ipilimumab|mesh-list
92080809|NCT01450761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080810|NCT01450761|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080811|NCT01450761|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92080812|NCT01450761|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92080813|NCT01450761|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080814|NCT01450761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080815|NCT01450761|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080816|NCT01450761|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92080817|NCT00491374|Mometasone Furoate|mometasone furoate|mesh-list
92080818|NCT00491374|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080819|NCT00491374|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080820|NCT00491374|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92080821|NCT00538642|Ziprasidone|ziprasidone|mesh-list
92080822|NCT00538642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92080823|NCT00538642|Serotonin Agents|serotonin agents|mesh-ancestor
92080824|NCT00538642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080825|NCT00538642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080826|NCT00538642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080827|NCT00538642|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92080828|NCT00538642|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92080829|NCT00538642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080830|NCT00538642|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080831|NCT00538642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92080832|NCT00538642|Dopamine Agents|dopamine agents|mesh-ancestor
92080833|NCT01433991|Lenvatinib|lenvatinib|mesh-list
92080834|NCT01433991|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080835|NCT01433991|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92080836|NCT01433991|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080837|NCT01433991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080838|NCT01450683|Itraconazole|itraconazole|mesh-list
92080839|NCT01450683|Antifungal Agents|antifungal agents|mesh-ancestor
92080840|NCT01450683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080841|NCT01450683|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92080842|NCT01450683|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92080843|NCT01450683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080844|NCT01450683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080845|NCT01450683|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92080846|NCT01450683|Hormone Antagonists|hormone antagonists|mesh-ancestor
92080847|NCT01450683|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080848|NCT01450683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016451|NCT04979221|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92080849|NCT01450683|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92080850|NCT01433055|Minocycline|minocycline|mesh-list
92080851|NCT01433055|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92080852|NCT01433055|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92080853|NCT01450137|Glucocorticoids|glucocorticoids|mesh-list
92080854|NCT01450137|Hormones|hormones|mesh-ancestor
92080855|NCT01450137|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080856|NCT01450137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080857|NCT04075149|Spironolactone|spironolactone|mesh-list
92080858|NCT04075149|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92080859|NCT04075149|Hormone Antagonists|hormone antagonists|mesh-ancestor
92080862|NCT04075149|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92080864|NCT04075149|Natriuretic Agents|natriuretic agents|mesh-ancestor
92080865|NCT01412229|Paclitaxel|paclitaxel|mesh-list
92080866|NCT01412229|Carboplatin|carboplatin|mesh-list
92080867|NCT01412229|Cetuximab|cetuximab|mesh-list
92080868|NCT01412229|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080869|NCT01412229|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080870|NCT01412229|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080871|NCT01412229|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080872|NCT01412229|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080873|NCT01412229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080874|NCT01412229|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080875|NCT01432275|Insulin|insulin|mesh-list
92080876|NCT01432275|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92080877|NCT01432275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080878|NCT01411995|Lidocaine|lidocaine|mesh-list
92080879|NCT01411995|Anesthetics, Local|anesthetics, local|mesh-ancestor
92080880|NCT01411995|Anesthetics|anesthetics|mesh-ancestor
92080881|NCT01411995|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080882|NCT01411995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080883|NCT01411995|Sensory System Agents|sensory system agents|mesh-ancestor
92080884|NCT01411995|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080885|NCT01411995|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92080886|NCT01411995|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92080887|NCT01411995|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92080888|NCT01411995|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080889|NCT01411995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080891|NCT01411215|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92080892|NCT01411215|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92080893|NCT01411215|Analgesics|analgesics|mesh-ancestor
92080894|NCT01411215|Sensory System Agents|sensory system agents|mesh-ancestor
92080895|NCT01411215|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080896|NCT01411215|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080897|NCT01411215|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080898|NCT01411215|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080899|NCT01411215|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080900|NCT01411215|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92080901|NCT01411215|Immunologic Factors|immunologic factors|mesh-ancestor
92080902|NCT01449279|Ipilimumab|ipilimumab|mesh-list
92080903|NCT01449279|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080904|NCT01449279|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080905|NCT01449279|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92080906|NCT01449279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080907|NCT01431963|Lamotrigine|lamotrigine|mesh-list
92080908|NCT01431963|Anticonvulsants|anticonvulsants|mesh-ancestor
92080909|NCT01431963|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92080910|NCT01431963|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080911|NCT01431963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080912|NCT01431963|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92080913|NCT01431963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080914|NCT01431963|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92080915|NCT01431963|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92080916|NCT01431963|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080917|NCT01431963|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080918|NCT01431963|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92080919|NCT01447407|Vaccines|vaccines|mesh-list
92080920|NCT01447407|Aluminum sulfate|aluminum sulfate|mesh-list
92080921|NCT01447407|Immunologic Factors|immunologic factors|mesh-ancestor
92016452|NCT04979221|Serotonin Agents|serotonin agents|mesh-ancestor
92016453|NCT04979221|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92016454|NCT05697809|Dexamethasone|dexamethasone|mesh-list
92016455|NCT05697809|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016456|NCT05697809|Antiemetics|antiemetics|mesh-ancestor
92080922|NCT01447407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080923|NCT01447407|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92080924|NCT01446237|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92080925|NCT01446237|Dermatologic Agents|dermatologic agents|mesh-ancestor
92080926|NCT00540982|Vinorelbine|vinorelbine|mesh-list
92080927|NCT00540982|Lidocaine|lidocaine|mesh-list
92080928|NCT00540982|Anesthetics, Local|anesthetics, local|mesh-ancestor
92080929|NCT00540982|Anesthetics|anesthetics|mesh-ancestor
92080930|NCT00540982|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080931|NCT00540982|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080935|NCT00540982|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92080936|NCT00540982|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92080937|NCT00540982|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080938|NCT00540982|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080939|NCT00540982|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92080940|NCT00540982|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080941|NCT00540982|Tubulin Modulators|tubulin modulators|mesh-ancestor
92080942|NCT00540982|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080943|NCT00540982|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080945|NCT00542308|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080946|NCT00542308|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080947|NCT00542620|Insulin|insulin|mesh-list
92080948|NCT00542620|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92080949|NCT00542620|Insulin Aspart|insulin aspart|mesh-list
92080950|NCT00542620|Insulin, Long-Acting|insulin, long-acting|mesh-list
92080951|NCT00542620|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92080952|NCT00542620|Insulin Detemir|insulin detemir|mesh-list
92080953|NCT00542620|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92080954|NCT00542620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080955|NCT00543400|Heparin|heparin|mesh-list
92080956|NCT00543400|Calcium heparin|calcium heparin|mesh-list
92080957|NCT00543400|Anticoagulants|anticoagulants|mesh-ancestor
92080958|NCT00543400|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92081038|NCT03019666|Micronutrients|micronutrients|mesh-ancestor
92080959|NCT00543400|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92080960|NCT00543400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080961|NCT01796938|Lacosamide|lacosamide|mesh-list
92080962|NCT01796938|Anticonvulsants|anticonvulsants|mesh-ancestor
92080963|NCT01796938|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92080964|NCT01796938|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92080965|NCT01796938|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92080966|NCT01796938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080967|NCT00492544|Vaccines|vaccines|mesh-list
92080968|NCT00492544|Immunologic Factors|immunologic factors|mesh-ancestor
92080969|NCT00492544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080970|NCT00492622|Omeprazole|omeprazole|mesh-list
92080971|NCT00492622|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92080972|NCT00492622|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92080973|NCT00492622|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92080974|NCT00492622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080975|NCT00492622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080976|NCT00494494|Nepafenac|nepafenac|mesh-list
92080977|NCT00494494|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92080978|NCT00494494|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92080979|NCT00494494|Analgesics|analgesics|mesh-ancestor
92080980|NCT00494494|Sensory System Agents|sensory system agents|mesh-ancestor
92080981|NCT00494494|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080982|NCT00494494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080983|NCT00494494|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92080984|NCT00494494|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080985|NCT03145558|Doxorubicin|doxorubicin|mesh-list
92080986|NCT03145558|Tirapazamine|tirapazamine|mesh-list
92080987|NCT03145558|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92080988|NCT03145558|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080989|NCT03145558|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92080990|NCT03145558|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92016457|NCT05697809|Autonomic Agents|autonomic agents|mesh-ancestor
92016458|NCT05697809|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016459|NCT05697809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016460|NCT05697809|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016461|NCT05697809|Glucocorticoids|glucocorticoids|mesh-ancestor
92080991|NCT03145558|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080992|NCT03145558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080994|NCT00497770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92080995|NCT00497770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92080996|NCT00497770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080997|NCT00497770|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92080998|NCT00497770|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92080999|NCT00498550|Clozapine|clozapine|mesh-list
92081000|NCT00498550|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92081001|NCT00498550|Serotonin Agents|serotonin agents|mesh-ancestor
92081002|NCT00498550|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081003|NCT00498550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081012|NCT00498628|Antidepressive Agents|antidepressive agents|mesh-ancestor
92081013|NCT00498628|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92081014|NCT00498628|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92081015|NCT00498628|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92081016|NCT00498628|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081017|NCT00498628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081018|NCT01446159|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92081019|NCT01446159|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92081020|NCT01446159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081021|NCT01446159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081022|NCT01446159|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92081023|NCT01446159|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081024|NCT01446159|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081025|NCT01446159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081027|NCT00499408|Cholecalciferol|cholecalciferol|mesh-list
92081028|NCT00499408|Vitamins|vitamins|mesh-ancestor
92081029|NCT00499408|Micronutrients|micronutrients|mesh-ancestor
92081030|NCT00499408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081031|NCT00499408|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92081032|NCT00499408|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92081033|NCT03019666|Niacinamide|niacinamide|mesh-list
92081034|NCT03019666|Niacin|niacin|mesh-list
92081035|NCT03019666|Nicotinic Acids|nicotinic acids|mesh-list
92081036|NCT03019666|Vitamin B Complex|vitamin b complex|mesh-ancestor
92081037|NCT03019666|Vitamins|vitamins|mesh-ancestor
92081039|NCT03019666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081040|NCT03019666|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92081041|NCT03019666|Antimetabolites|antimetabolites|mesh-ancestor
92081042|NCT03019666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081043|NCT03019666|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92081044|NCT03019666|Vasodilator Agents|vasodilator agents|mesh-ancestor
92081045|NCT00500578|Ribavirin|ribavirin|mesh-list
92081046|NCT00500578|Antimetabolites|antimetabolites|mesh-ancestor
92081047|NCT00500578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081048|NCT00500578|Antiviral Agents|antiviral agents|mesh-ancestor
92081049|NCT00500578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081050|NCT01430559|Meloxicam|meloxicam|mesh-list
92081051|NCT01430559|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92081052|NCT01430559|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92081053|NCT01430559|Analgesics|analgesics|mesh-ancestor
92081054|NCT01430559|Sensory System Agents|sensory system agents|mesh-ancestor
92081055|NCT01430559|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081056|NCT01430559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081057|NCT01430559|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081058|NCT01430559|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081059|NCT01430559|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92081060|NCT01430559|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92081061|NCT01430559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081062|NCT01430559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081063|NCT00500656|Icatibant|icatibant|mesh-list
92016462|NCT05697809|Hormones|hormones|mesh-ancestor
92016463|NCT05697809|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081064|NCT00500656|Tranexamic Acid|tranexamic acid|mesh-list
92081065|NCT00500656|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92081066|NCT00500656|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92081067|NCT00500656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081068|NCT00500656|Hemostatics|hemostatics|mesh-ancestor
92081069|NCT00500656|Coagulants|coagulants|mesh-ancestor
92081072|NCT00500656|Analgesics|analgesics|mesh-ancestor
92081073|NCT00500656|Sensory System Agents|sensory system agents|mesh-ancestor
92081074|NCT00500656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081075|NCT00500656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081076|NCT00500656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081077|NCT00500656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081078|NCT00500656|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92081079|NCT00500656|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92081080|NCT00500656|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92081081|NCT00500656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081082|NCT00500656|Immunologic Factors|immunologic factors|mesh-ancestor
92081083|NCT01409811|Zoledronic Acid|zoledronic acid|mesh-list
92081084|NCT01409811|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92081085|NCT01409811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081086|NCT01445847|Lidocaine|lidocaine|mesh-list
92081087|NCT01445847|Anesthetics, Local|anesthetics, local|mesh-ancestor
92081088|NCT01445847|Anesthetics|anesthetics|mesh-ancestor
92081089|NCT01445847|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081090|NCT01445847|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081091|NCT01445847|Sensory System Agents|sensory system agents|mesh-ancestor
92081092|NCT01445847|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081093|NCT01445847|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081094|NCT01445847|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92081095|NCT01445847|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92081096|NCT01445847|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081097|NCT01445847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081098|NCT00502216|Naltrexone|naltrexone|mesh-list
92081099|NCT00502216|Varenicline|varenicline|mesh-list
92081100|NCT00502216|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92081101|NCT00502216|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92081102|NCT00502216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081103|NCT00502216|Sensory System Agents|sensory system agents|mesh-ancestor
92081104|NCT00502216|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081105|NCT00502216|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92081106|NCT00502216|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92081107|NCT00502216|Cholinergic Agents|cholinergic agents|mesh-ancestor
92081108|NCT00502216|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081109|NCT00502216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081110|NCT00545662|Choline|choline|mesh-list
92081111|NCT00545662|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92081112|NCT00545662|Lipotropic Agents|lipotropic agents|mesh-ancestor
92081113|NCT00545662|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92081114|NCT00545662|Antimetabolites|antimetabolites|mesh-ancestor
92081115|NCT00545662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081116|NCT00545662|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92081117|NCT00545662|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92081118|NCT00545662|Nootropic Agents|nootropic agents|mesh-ancestor
92081119|NCT00545974|Memantine|memantine|mesh-list
92081120|NCT00545974|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92081121|NCT00545974|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92081122|NCT00545974|Dopamine Agents|dopamine agents|mesh-ancestor
92081123|NCT00545974|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081124|NCT00545974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081125|NCT00545974|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081126|NCT00545974|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92081127|NCT00545974|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92081128|NCT00548470|Varenicline|varenicline|mesh-list
92081129|NCT00548470|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92081130|NCT00548470|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92081131|NCT00548470|Cholinergic Agents|cholinergic agents|mesh-ancestor
92081132|NCT00548470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081133|NCT00548470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016464|NCT05697809|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016465|NCT05697809|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016466|NCT03980483|Methotrexate|methotrexate|mesh-list
92016467|NCT03980483|Tofacitinib|tofacitinib|mesh-list
92081134|NCT00548470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081135|NCT02675452|Itraconazole|itraconazole|mesh-list
92081136|NCT02675452|Azacitidine|azacitidine|mesh-list
92081137|NCT02675452|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92081138|NCT02675452|Antimetabolites|antimetabolites|mesh-ancestor
92081139|NCT02675452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081140|NCT02675452|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081152|NCT00509002|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081153|NCT00509002|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081154|NCT00509002|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081155|NCT00509002|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081156|NCT00887380|Anastrozole|anastrozole|mesh-list
92081157|NCT00887380|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92081158|NCT00887380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081159|NCT00887380|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92081160|NCT00887380|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92081161|NCT00887380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081162|NCT00887380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081163|NCT00887380|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92081164|NCT00887380|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081165|NCT00887380|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081166|NCT00887380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081167|NCT00551200|4-phenylbutyric acid|4-phenylbutyric acid|mesh-list
92081168|NCT00551200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081169|NCT00557284|Montelukast|montelukast|mesh-list
92081170|NCT00557284|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92081171|NCT00557284|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081172|NCT00557284|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92081173|NCT00557284|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081174|NCT00557284|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081175|NCT00557284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081176|NCT00557284|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92081177|NCT00557284|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92081178|NCT00557284|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081179|NCT00557362|Voriconazole|voriconazole|mesh-list
92081181|NCT00557362|Antifungal Agents|antifungal agents|mesh-ancestor
92081182|NCT00557362|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081183|NCT00557362|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92081184|NCT00557362|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92081185|NCT00557362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081186|NCT00557362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081187|NCT00557362|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92081188|NCT00557362|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081189|NCT00557362|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081190|NCT00557362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081191|NCT00557362|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92081192|NCT00557362|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92081193|NCT00557362|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92081194|NCT00512278|Infliximab|infliximab|mesh-list
92081195|NCT00512278|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92081196|NCT00512278|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081197|NCT00512278|Dermatologic Agents|dermatologic agents|mesh-ancestor
92081198|NCT00512278|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92081199|NCT00512278|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081203|NCT01445535|Doxorubicin|doxorubicin|mesh-list
92081204|NCT01445535|Etoposide|etoposide|mesh-list
92081205|NCT01445535|Vincristine|vincristine|mesh-list
92081206|NCT01445535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081207|NCT01445535|Immunologic Factors|immunologic factors|mesh-ancestor
92081208|NCT01445535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081209|NCT01445535|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081210|NCT01445535|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081211|NCT01445535|Alkylating Agents|alkylating agents|mesh-ancestor
92081212|NCT01445535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016468|NCT03980483|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92016469|NCT03980483|Abortifacient Agents|abortifacient agents|mesh-ancestor
92016470|NCT03980483|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92081213|NCT01445535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081214|NCT01445535|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92081215|NCT01445535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92081216|NCT01445535|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92081217|NCT01445535|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92081218|NCT01445535|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92081219|NCT01445535|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081220|NCT01445535|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081221|NCT01445535|Glucocorticoids|glucocorticoids|mesh-ancestor
92081222|NCT01445535|Hormones|hormones|mesh-ancestor
92081223|NCT01445535|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081224|NCT01445535|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92081225|NCT01445535|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92081226|NCT01445535|Tubulin Modulators|tubulin modulators|mesh-ancestor
92081227|NCT01445535|Antimitotic Agents|antimitotic agents|mesh-ancestor
92081228|NCT01445535|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081229|NCT01409031|Sildenafil Citrate|sildenafil citrate|mesh-list
92081230|NCT01409031|Vasodilator Agents|vasodilator agents|mesh-ancestor
92081231|NCT01409031|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92081232|NCT01409031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92081233|NCT01409031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081234|NCT01409031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081235|NCT01409031|Urological Agents|urological agents|mesh-ancestor
92081236|NCT01430403|Fluticasone|fluticasone|mesh-list
92081238|NCT01430403|Omalizumab|omalizumab|mesh-list
92081239|NCT01430403|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92081240|NCT01430403|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081241|NCT01430403|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92081242|NCT01430403|Autonomic Agents|autonomic agents|mesh-ancestor
92081243|NCT01430403|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081244|NCT01430403|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081245|NCT01430403|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92081246|NCT01430403|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081247|NCT01430403|Dermatologic Agents|dermatologic agents|mesh-ancestor
92081248|NCT01430403|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92081249|NCT01430403|Immunologic Factors|immunologic factors|mesh-ancestor
92081250|NCT01408641|Topiramate|topiramate|mesh-list
92081251|NCT01408641|Anticonvulsants|anticonvulsants|mesh-ancestor
92081252|NCT01408641|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92081253|NCT01408641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081254|NCT01429077|Levodopa|levodopa|mesh-list
92081255|NCT01429077|Carbidopa|carbidopa|mesh-list
92081256|NCT01429077|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92081257|NCT01429077|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92081258|NCT01429077|Dopamine Agents|dopamine agents|mesh-ancestor
92081259|NCT01429077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081260|NCT01429077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081261|NCT01429077|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081262|NCT01429077|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92081263|NCT01429077|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081264|NCT01408563|Fludarabine|fludarabine|mesh-list
92081265|NCT01408563|Melphalan|melphalan|mesh-list
92081266|NCT01408563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081267|NCT01408563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081268|NCT01408563|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081269|NCT01408563|Immunologic Factors|immunologic factors|mesh-ancestor
92081270|NCT01408563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081271|NCT01408563|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081272|NCT01408563|Alkylating Agents|alkylating agents|mesh-ancestor
92081282|NCT01442493|Antitussive Agents|antitussive agents|mesh-ancestor
92081283|NCT01442493|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081284|NCT04407975|Betamethasone|betamethasone|mesh-list
92081285|NCT04407975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081286|NCT04407975|Glucocorticoids|glucocorticoids|mesh-ancestor
92081288|NCT04407975|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016471|NCT03980483|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016472|NCT03980483|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016473|NCT03980483|Antimetabolites|antimetabolites|mesh-ancestor
92081289|NCT04407975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081290|NCT04407975|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92081291|NCT04407975|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081292|NCT01428063|Interferons|interferons|mesh-list
92081293|NCT01428063|Ribavirin|ribavirin|mesh-list
92081294|NCT01428063|Interferon-alpha|interferon-alpha|mesh-list
92081295|NCT01428063|Interferon alpha-2|interferon alpha-2|mesh-list
92081296|NCT01428063|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92081297|NCT01428063|Asunaprevir|asunaprevir|mesh-list
92081298|NCT01428063|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081299|NCT01428063|Antiviral Agents|antiviral agents|mesh-ancestor
92081300|NCT01428063|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081301|NCT01428063|Antimetabolites|antimetabolites|mesh-ancestor
92081302|NCT01428063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081303|NCT01428063|Immunologic Factors|immunologic factors|mesh-ancestor
92081304|NCT01428063|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081305|NCT01428063|Protease Inhibitors|protease inhibitors|mesh-ancestor
92081306|NCT01428063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081308|NCT00513292|Cyclophosphamide|cyclophosphamide|mesh-list
92081309|NCT00513292|Trastuzumab|trastuzumab|mesh-list
92081310|NCT00513292|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92081311|NCT00513292|Epirubicin|epirubicin|mesh-list
92081312|NCT00513292|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92081313|NCT00513292|Antibodies|antibodies|mesh-list
92081314|NCT00513292|Immunoglobulins|immunoglobulins|mesh-list
92081315|NCT00513292|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92081316|NCT00513292|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92081317|NCT00513292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081318|NCT00513292|Tubulin Modulators|tubulin modulators|mesh-ancestor
92081319|NCT00513292|Antimitotic Agents|antimitotic agents|mesh-ancestor
92081320|NCT00513292|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081321|NCT00513292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081322|NCT00513292|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081323|NCT00513292|Immunologic Factors|immunologic factors|mesh-ancestor
92081324|NCT00513292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081325|NCT00513292|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081326|NCT00513292|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081327|NCT00513292|Alkylating Agents|alkylating agents|mesh-ancestor
92081328|NCT00513292|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92081329|NCT00513292|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92081330|NCT00513292|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92081331|NCT00513292|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92081332|NCT00513292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081333|NCT00513370|Adalimumab|adalimumab|mesh-list
92081334|NCT00513370|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92081335|NCT00513370|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081336|NCT00513370|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081337|NCT00559468|Bromides|bromides|mesh-list
92081338|NCT00559468|Propofol|propofol|mesh-list
92081339|NCT00559468|Sevoflurane|sevoflurane|mesh-list
92081340|NCT00559468|Rocuronium|rocuronium|mesh-list
92081353|NCT00559468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081354|NCT00513526|Vaccines|vaccines|mesh-list
92081355|NCT00513526|Immunologic Factors|immunologic factors|mesh-ancestor
92081356|NCT00513526|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081357|NCT00561418|Vorinostat|vorinostat|mesh-list
92081358|NCT00561418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081359|NCT00561418|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92081360|NCT00561418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081361|NCT00561418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081362|NCT00514852|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92081363|NCT00514852|Lubricant Eye Drops|lubricant eye drops|mesh-list
92081364|NCT00514852|Glycerol|glycerol|mesh-list
92081365|NCT00514852|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92081366|NCT00514852|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92081367|NCT00514852|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92081368|NCT00514852|Protective Agents|protective agents|mesh-ancestor
92081369|NCT00514852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016474|NCT03980483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016475|NCT03980483|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016476|NCT03980483|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016477|NCT03980483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081370|NCT00514852|Laxatives|laxatives|mesh-ancestor
92081371|NCT00514852|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92081373|NCT00555880|Sympathomimetics|sympathomimetics|mesh-ancestor
92081374|NCT00555880|Autonomic Agents|autonomic agents|mesh-ancestor
92081375|NCT00555880|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081376|NCT00555880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081377|NCT00555880|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92081378|NCT00555880|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92081379|NCT00555880|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92081380|NCT00555880|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92081381|NCT00555880|Adrenergic Agents|adrenergic agents|mesh-ancestor
92081382|NCT00555880|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081383|NCT00555880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081384|NCT00563290|Dasatinib|dasatinib|mesh-list
92081385|NCT00563290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081386|NCT00563290|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081387|NCT00563290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081388|NCT00563290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081389|NCT00556504|Ribavirin|ribavirin|mesh-list
92081390|NCT00556504|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92081391|NCT00556504|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92081392|NCT00556504|Antimetabolites|antimetabolites|mesh-ancestor
92081393|NCT00556504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081394|NCT00556504|Antiviral Agents|antiviral agents|mesh-ancestor
92081395|NCT00556504|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081396|NCT02128828|Cenicriviroc|cenicriviroc|mesh-list
92081397|NCT02128828|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92081398|NCT02128828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081399|NCT02128828|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92081400|NCT02128828|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92081401|NCT02128828|Antiviral Agents|antiviral agents|mesh-ancestor
92081402|NCT02128828|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081405|NCT00520234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081406|NCT00520234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081407|NCT00520234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081408|NCT00520468|Cyclosporine|cyclosporine|mesh-list
92081409|NCT00520468|Prednisone|prednisone|mesh-list
92081410|NCT00520468|Epoetin Alfa|epoetin alfa|mesh-list
92081411|NCT00520468|Darbepoetin alfa|darbepoetin alfa|mesh-list
92081412|NCT00520468|Cyclosporins|cyclosporins|mesh-list
92081413|NCT00520468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081414|NCT00520468|Glucocorticoids|glucocorticoids|mesh-ancestor
92081415|NCT00520468|Hormones|hormones|mesh-ancestor
92081416|NCT00520468|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081417|NCT00520468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081418|NCT00520468|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92081419|NCT00520468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081420|NCT00520468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081421|NCT00520468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081422|NCT00520468|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081423|NCT00520468|Immunologic Factors|immunologic factors|mesh-ancestor
92081424|NCT00520468|Antifungal Agents|antifungal agents|mesh-ancestor
92081425|NCT00520468|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081426|NCT00520468|Dermatologic Agents|dermatologic agents|mesh-ancestor
92081427|NCT00520468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081428|NCT00520468|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92081429|NCT00520468|Hematinics|hematinics|mesh-ancestor
92081430|NCT05560516|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92081431|NCT05560516|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92081432|NCT05560516|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92081433|NCT05560516|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081434|NCT05560516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081435|NCT05560516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081436|NCT05560516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081437|NCT05560516|Analgesics|analgesics|mesh-ancestor
92016478|NCT03980483|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92016479|NCT03980483|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016480|NCT03980483|Immunologic Factors|immunologic factors|mesh-ancestor
92081438|NCT05560516|Sensory System Agents|sensory system agents|mesh-ancestor
92081439|NCT05560516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081440|NCT05560516|Antidepressive Agents|antidepressive agents|mesh-ancestor
92081441|NCT05560516|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92081442|NCT05560516|Dopamine Agents|dopamine agents|mesh-ancestor
92081444|NCT05559268|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92081445|NCT05559268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081446|NCT02121418|Cytarabine|cytarabine|mesh-list
92081447|NCT02121418|Decitabine|decitabine|mesh-list
92081448|NCT02121418|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92081449|NCT02121418|Antimetabolites|antimetabolites|mesh-ancestor
92081450|NCT02121418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081451|NCT02121418|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081452|NCT02121418|Antiviral Agents|antiviral agents|mesh-ancestor
92081453|NCT02121418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081454|NCT02121418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081455|NCT02121418|Immunologic Factors|immunologic factors|mesh-ancestor
92081456|NCT02121418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081457|NCT02121418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081458|NCT01441635|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92081459|NCT01441635|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92081460|NCT01441635|Norethindrone|norethindrone|mesh-list
92081461|NCT01441635|Norethindrone Acetate|norethindrone acetate|mesh-list
92081462|NCT01441635|Estradiol|estradiol|mesh-list
92081463|NCT01441635|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92081464|NCT01441635|Progesterone|progesterone|mesh-list
92081465|NCT01441635|Estrogens|estrogens|mesh-ancestor
92081466|NCT01441635|Hormones|hormones|mesh-ancestor
92081467|NCT01441635|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081468|NCT01441635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081469|NCT01441635|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92081470|NCT01441635|Contraceptive Agents|contraceptive agents|mesh-ancestor
92081471|NCT01441635|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92081472|NCT01441635|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92081473|NCT01441635|Progestins|progestins|mesh-ancestor
92081474|NCT01441635|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92081475|NCT01441635|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92081477|NCT01427907|Calcium|calcium|mesh-list
92081478|NCT01427907|Sevelamer|sevelamer|mesh-list
92081479|NCT01427907|Calcium acetate|calcium acetate|mesh-list
92081480|NCT01427907|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92081481|NCT01427907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081482|NCT01427907|Chelating Agents|chelating agents|mesh-ancestor
92081483|NCT01427907|Sequestering Agents|sequestering agents|mesh-ancestor
92081484|NCT01427907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081485|NCT02985333|Dexamethasone|dexamethasone|mesh-list
92081486|NCT02985333|Paclitaxel|paclitaxel|mesh-list
92081487|NCT02985333|Cyclophosphamide|cyclophosphamide|mesh-list
92081488|NCT02985333|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92081489|NCT02985333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081490|NCT02985333|Tubulin Modulators|tubulin modulators|mesh-ancestor
92081491|NCT02985333|Antimitotic Agents|antimitotic agents|mesh-ancestor
92081492|NCT02985333|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081493|NCT02985333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081494|NCT02985333|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081495|NCT02985333|Immunologic Factors|immunologic factors|mesh-ancestor
92081496|NCT02985333|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081497|NCT02985333|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081498|NCT02985333|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081499|NCT02985333|Alkylating Agents|alkylating agents|mesh-ancestor
92081500|NCT02985333|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92081501|NCT02985333|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081502|NCT02985333|Antiemetics|antiemetics|mesh-ancestor
92081503|NCT02985333|Autonomic Agents|autonomic agents|mesh-ancestor
92081504|NCT02985333|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081505|NCT02985333|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92081506|NCT02985333|Glucocorticoids|glucocorticoids|mesh-ancestor
92081507|NCT02985333|Hormones|hormones|mesh-ancestor
92081508|NCT02985333|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016481|NCT03980483|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016482|NCT03980483|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92016483|NCT03980483|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92081509|NCT02985333|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92081510|NCT01427751|Dexamethasone|dexamethasone|mesh-list
92081511|NCT01427751|Ranibizumab|ranibizumab|mesh-list
92081512|NCT01427751|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081513|NCT01427751|Antiemetics|antiemetics|mesh-ancestor
92081514|NCT01427751|Autonomic Agents|autonomic agents|mesh-ancestor
92081515|NCT01427751|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081516|NCT01427751|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081517|NCT01427751|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92081518|NCT01427751|Glucocorticoids|glucocorticoids|mesh-ancestor
92081519|NCT01427751|Hormones|hormones|mesh-ancestor
92081520|NCT01427751|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081521|NCT01427751|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92081522|NCT01427751|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081523|NCT01427751|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92081524|NCT01427751|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92081525|NCT01427751|Growth Substances|growth substances|mesh-ancestor
92081526|NCT01427751|Growth Inhibitors|growth inhibitors|mesh-ancestor
92081712|NCT03025893|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92081713|NCT03025893|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92081714|NCT03025893|Growth Substances|growth substances|mesh-ancestor
92081715|NCT03025893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081716|NCT03025893|Growth Inhibitors|growth inhibitors|mesh-ancestor
92081717|NCT03025893|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081718|NCT03025893|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081719|NCT03025893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081720|NCT03025893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081721|NCT03025893|Alkylating Agents|alkylating agents|mesh-ancestor
92081722|NCT01402869|Lidocaine|lidocaine|mesh-list
92081723|NCT01402869|Epinephrine|epinephrine|mesh-list
92081724|NCT01402869|Prilocaine|prilocaine|mesh-list
92081725|NCT01402869|Anesthetics, Local|anesthetics, local|mesh-ancestor
92081726|NCT01402869|Anesthetics|anesthetics|mesh-ancestor
92081727|NCT01402869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081728|NCT01402869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081729|NCT01402869|Sensory System Agents|sensory system agents|mesh-ancestor
92081730|NCT01402869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081731|NCT01402869|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081732|NCT01402869|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92081735|NCT01402869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081737|NCT01402869|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92081738|NCT01402869|Adrenergic Agents|adrenergic agents|mesh-ancestor
92081739|NCT01402869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081740|NCT01402869|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92081741|NCT01402869|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92081742|NCT01402869|Autonomic Agents|autonomic agents|mesh-ancestor
92081743|NCT01402869|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92081744|NCT01402869|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081745|NCT01402869|Mydriatics|mydriatics|mesh-ancestor
92081746|NCT01402869|Sympathomimetics|sympathomimetics|mesh-ancestor
92081747|NCT01402869|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92081748|NCT01391793|Dexamethasone|dexamethasone|mesh-list
92081749|NCT01391793|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081750|NCT01391793|Antiemetics|antiemetics|mesh-ancestor
92081751|NCT01391793|Autonomic Agents|autonomic agents|mesh-ancestor
92081752|NCT01391793|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081753|NCT01391793|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081754|NCT01391793|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92081755|NCT01391793|Glucocorticoids|glucocorticoids|mesh-ancestor
92081756|NCT01391793|Hormones|hormones|mesh-ancestor
92081757|NCT01391793|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081758|NCT01391793|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92081759|NCT01391793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081760|NCT01422915|Colestipol|colestipol|mesh-list
92081761|NCT01422915|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92081762|NCT01422915|Antimetabolites|antimetabolites|mesh-ancestor
92016484|NCT03980483|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92016485|NCT03063775|Fibrin Foam|fibrin foam|mesh-list
92016486|NCT03063775|Hemostatics|hemostatics|mesh-ancestor
92016487|NCT03063775|Coagulants|coagulants|mesh-ancestor
92016488|NCT03063541|Aspirin|aspirin|mesh-list
92016489|NCT03063541|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92016490|NCT03063541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92081763|NCT01422915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081764|NCT01422915|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92081765|NCT01422915|Sequestering Agents|sequestering agents|mesh-ancestor
92081766|NCT01727024|Tiotropium Bromide|tiotropium bromide|mesh-list
92081767|NCT01727024|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92081768|NCT01727024|Autonomic Agents|autonomic agents|mesh-ancestor
92081769|NCT01727024|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081770|NCT01727024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081771|NCT01727024|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92081772|NCT01727024|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081773|NCT01727024|Parasympatholytics|parasympatholytics|mesh-ancestor
92081774|NCT01727024|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92081775|NCT01727024|Cholinergic Agents|cholinergic agents|mesh-ancestor
92081776|NCT01727024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081777|NCT01727024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081778|NCT04558736|Cyclophosphamide|cyclophosphamide|mesh-list
92081779|NCT04558736|Fludarabine|fludarabine|mesh-list
92081780|NCT04558736|Thymoglobulin|thymoglobulin|mesh-list
92081781|NCT04558736|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92081782|NCT04558736|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081783|NCT04558736|Immunologic Factors|immunologic factors|mesh-ancestor
92081784|NCT04558736|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081785|NCT04558736|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081786|NCT04558736|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081787|NCT04558736|Alkylating Agents|alkylating agents|mesh-ancestor
92081788|NCT04558736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081789|NCT04558736|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081790|NCT04558736|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92081791|NCT01422213|Vortioxetine|vortioxetine|mesh-list
92081792|NCT01422213|Antidepressive Agents|antidepressive agents|mesh-ancestor
92081793|NCT01422213|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92081794|NCT01422213|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92081795|NCT01422213|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92081796|NCT01422213|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081797|NCT01422213|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081798|NCT01422213|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92081799|NCT01422213|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92081800|NCT01422213|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081801|NCT01422213|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081802|NCT01422213|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081803|NCT01422213|Serotonin Agents|serotonin agents|mesh-ancestor
92081806|NCT01422213|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92081807|NCT01422213|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92081808|NCT01390857|Valacyclovir|valacyclovir|mesh-list
92081809|NCT01390857|Antiviral Agents|antiviral agents|mesh-ancestor
92081810|NCT01390857|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081811|NCT01725386|Capecitabine|capecitabine|mesh-list
92081812|NCT01725386|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92081813|NCT01725386|Antimetabolites|antimetabolites|mesh-ancestor
92081814|NCT01725386|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081815|NCT01725386|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081816|NCT01402011|Lidocaine|lidocaine|mesh-list
92081817|NCT01402011|Anesthetics, Local|anesthetics, local|mesh-ancestor
92081818|NCT01402011|Anesthetics|anesthetics|mesh-ancestor
92081819|NCT01402011|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081820|NCT01402011|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081821|NCT01402011|Sensory System Agents|sensory system agents|mesh-ancestor
92081822|NCT01402011|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081823|NCT01402011|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081824|NCT01402011|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92016492|NCT03063541|Sensory System Agents|sensory system agents|mesh-ancestor
92016493|NCT03063541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016494|NCT03063541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081825|NCT01402011|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92081826|NCT01402011|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081827|NCT01402011|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081828|NCT01421667|Rituximab|rituximab|mesh-list
92081829|NCT01421667|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92081830|NCT01421667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92081831|NCT01421667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081832|NCT01421667|Immunologic Factors|immunologic factors|mesh-ancestor
92081833|NCT01421667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081834|NCT01421667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081835|NCT01421667|Immunotoxins|immunotoxins|mesh-ancestor
92081836|NCT01421667|Immunoconjugates|immunoconjugates|mesh-ancestor
92081837|NCT01891669|PF-06263507|pf-06263507|mesh-list
92081838|NCT01891669|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92081839|NCT01891669|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081840|NCT01891669|Antimitotic Agents|antimitotic agents|mesh-ancestor
92081841|NCT01891669|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081842|NCT01891669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081843|NCT01421511|Linezolid|linezolid|mesh-list
92081844|NCT01421511|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92081845|NCT01421511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081846|NCT01421511|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92081847|NCT01421511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081848|NCT01421511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081849|NCT01891357|Paclitaxel|paclitaxel|mesh-list
92081850|NCT01891357|Trastuzumab|trastuzumab|mesh-list
92081851|NCT01891357|Lapatinib|lapatinib|mesh-list
92081852|NCT01891357|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92081853|NCT01891357|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081854|NCT01891357|Tubulin Modulators|tubulin modulators|mesh-ancestor
92081855|NCT01891357|Antimitotic Agents|antimitotic agents|mesh-ancestor
92081856|NCT01891357|Mitosis Modulators|mitosis modulators|mesh-ancestor
92081857|NCT01891357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081858|NCT01891357|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92081859|NCT01891357|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081860|NCT01891357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081861|NCT01420965|Cyclophosphamide|cyclophosphamide|mesh-list
92081862|NCT01420965|Antibodies|antibodies|mesh-list
92081863|NCT01420965|Immunoglobulins|immunoglobulins|mesh-list
92081864|NCT01420965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081865|NCT01420965|Immunologic Factors|immunologic factors|mesh-ancestor
92081866|NCT01420965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081867|NCT01420965|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92081868|NCT01420965|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92081869|NCT01420965|Alkylating Agents|alkylating agents|mesh-ancestor
92081870|NCT01420965|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081871|NCT01420965|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081872|NCT01420965|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92081875|NCT04033575|Sodium Fluoride|sodium fluoride|mesh-list
92081876|NCT04033575|Tin Fluorides|tin fluorides|mesh-list
92081880|NCT04033575|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92081881|NCT04033575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081882|NCT03842085|Antibodies|antibodies|mesh-list
92081883|NCT03842085|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92081884|NCT03842085|Antibodies, Bispecific|antibodies, bispecific|mesh-list
92081885|NCT03842085|Immunologic Factors|immunologic factors|mesh-ancestor
92081886|NCT03842085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081887|NCT01390389|Ubiquinone|ubiquinone|mesh-list
92081888|NCT01390389|Coenzyme Q10|coenzyme q10|mesh-list
92081889|NCT01390389|Micronutrients|micronutrients|mesh-ancestor
92081890|NCT01390389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081891|NCT01390389|Vitamins|vitamins|mesh-ancestor
92081892|NCT03835533|Nivolumab|nivolumab|mesh-list
92081893|NCT03835533|Poly ICLC|poly iclc|mesh-list
92081894|NCT03835533|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016495|NCT03063541|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016496|NCT03063541|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016497|NCT03063541|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92016498|NCT03063541|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92016499|NCT03063541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016500|NCT03063541|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92016501|NCT03063541|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92081895|NCT03835533|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081896|NCT03835533|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92081897|NCT03835533|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081898|NCT03835533|Interferon Inducers|interferon inducers|mesh-ancestor
92081899|NCT03835533|Immunologic Factors|immunologic factors|mesh-ancestor
92081900|NCT03835533|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081901|NCT01401465|Mometasone Furoate|mometasone furoate|mesh-list
92081902|NCT01401465|Ciclesonide|ciclesonide|mesh-list
92081903|NCT01401465|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92081904|NCT01401465|Dermatologic Agents|dermatologic agents|mesh-ancestor
92081905|NCT01401465|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92081906|NCT01401465|Glucocorticoids|glucocorticoids|mesh-ancestor
92081907|NCT01401465|Hormones|hormones|mesh-ancestor
92081908|NCT01401465|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081909|NCT01401465|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081910|NCT01890967|Atorvastatin|atorvastatin|mesh-list
92081911|NCT01890967|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92081912|NCT01890967|Simvastatin|simvastatin|mesh-list
92081913|NCT01890967|Ezetimibe|ezetimibe|mesh-list
92081914|NCT01890967|Pravastatin|pravastatin|mesh-list
92081915|NCT01890967|Pitavastatin|pitavastatin|mesh-list
92081916|NCT01890967|Lovastatin|lovastatin|mesh-list
92081917|NCT01890967|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92081918|NCT01890967|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92081919|NCT01890967|Antimetabolites|antimetabolites|mesh-ancestor
92081920|NCT01890967|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081921|NCT01890967|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92081922|NCT01890967|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92081923|NCT01890967|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081924|NCT01863667|Glimepiride|glimepiride|mesh-list
92081925|NCT01863667|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081926|NCT01863667|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92081927|NCT01863667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081928|NCT01863667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081929|NCT01863667|Immunologic Factors|immunologic factors|mesh-ancestor
92081930|NCT01614769|Glimepiride|glimepiride|mesh-list
92081931|NCT01614769|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92081932|NCT01614769|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081933|NCT01614769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081934|NCT01614769|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92081935|NCT01614769|Immunologic Factors|immunologic factors|mesh-ancestor
92081936|NCT01614457|Ivacaftor|ivacaftor|mesh-list
92081937|NCT01614457|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92081938|NCT01614457|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081939|NCT01614457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081940|NCT01835431|Insulin|insulin|mesh-list
92081941|NCT01835431|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92081942|NCT01835431|Insulin Aspart|insulin aspart|mesh-list
92081943|NCT01835431|Insulin, Long-Acting|insulin, long-acting|mesh-list
92081944|NCT01835431|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92081945|NCT01835431|Insulin Detemir|insulin detemir|mesh-list
92081946|NCT01835431|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92081947|NCT01835431|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081948|NCT01880593|Ketamine|ketamine|mesh-list
92081949|NCT01880593|Lithium Carbonate|lithium carbonate|mesh-list
92081950|NCT01880593|Analgesics|analgesics|mesh-ancestor
92081951|NCT01880593|Sensory System Agents|sensory system agents|mesh-ancestor
92081954|NCT01880593|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92081956|NCT01880593|Anesthetics, General|anesthetics, general|mesh-ancestor
92081957|NCT01880593|Anesthetics|anesthetics|mesh-ancestor
92081958|NCT01880593|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016503|NCT03063541|Antipyretics|antipyretics|mesh-ancestor
92016504|NCT04978597|Opicapone|opicapone|mesh-list
92081959|NCT01880593|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92081960|NCT01880593|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92081961|NCT01880593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081962|NCT01880593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081963|NCT01880593|Antidepressive Agents|antidepressive agents|mesh-ancestor
92081964|NCT01880593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92081965|NCT01880593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081966|NCT01880593|Antimanic Agents|antimanic agents|mesh-ancestor
92081967|NCT01880593|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92081968|NCT01400451|Ipilimumab|ipilimumab|mesh-list
92081969|NCT01400451|Vemurafenib|vemurafenib|mesh-list
92081970|NCT01400451|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92081971|NCT01400451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92081972|NCT01400451|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92081973|NCT01400451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081974|NCT01400451|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92081975|NCT01400451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081976|NCT01400139|Hydrocodone|hydrocodone|mesh-list
92081977|NCT01400139|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92081978|NCT01400139|Narcotics|narcotics|mesh-ancestor
92081979|NCT01400139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081980|NCT01400139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081981|NCT01400139|Analgesics|analgesics|mesh-ancestor
92081982|NCT01400139|Sensory System Agents|sensory system agents|mesh-ancestor
92081983|NCT01400139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081984|NCT01400139|Antitussive Agents|antitussive agents|mesh-ancestor
92081985|NCT01400139|Respiratory System Agents|respiratory system agents|mesh-ancestor
92081986|NCT01399905|Carbidopa|carbidopa|mesh-list
92081987|NCT01399905|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92081988|NCT01399905|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92081989|NCT01399905|Dopamine Agents|dopamine agents|mesh-ancestor
92081990|NCT01399905|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081991|NCT01399905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92081992|NCT01399905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081993|NCT01399905|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92081994|NCT01399905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081995|NCT01725308|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92081996|NCT01725308|Antidepressive Agents|antidepressive agents|mesh-ancestor
92081997|NCT01725308|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92081998|NCT01725308|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92081999|NCT01725308|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92082000|NCT01725308|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082001|NCT01725308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082002|NCT01724528|Allopurinol|allopurinol|mesh-list
92082003|NCT01724528|Febuxostat|febuxostat|mesh-list
92082004|NCT01724528|Antimetabolites|antimetabolites|mesh-ancestor
92082005|NCT01724528|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082006|NCT01724528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082007|NCT01724528|Gout Suppressants|gout suppressants|mesh-ancestor
92082008|NCT01724528|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082009|NCT01724528|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92082010|NCT01724528|Antioxidants|antioxidants|mesh-ancestor
92082011|NCT01724528|Protective Agents|protective agents|mesh-ancestor
92082012|NCT01724528|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082013|NCT01750268|Topiramate|topiramate|mesh-list
92082014|NCT01750268|Anticonvulsants|anticonvulsants|mesh-ancestor
92082015|NCT01750268|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082016|NCT01750268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082017|NCT01880437|Cytarabine|cytarabine|mesh-list
92082018|NCT01880437|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92082019|NCT01880437|Antimetabolites|antimetabolites|mesh-ancestor
92082020|NCT01880437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082021|NCT01880437|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082022|NCT01880437|Antiviral Agents|antiviral agents|mesh-ancestor
92082023|NCT01880437|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082060|NCT01388361|Insulin Aspart|insulin aspart|mesh-list
92082061|NCT01388361|Liraglutide|liraglutide|mesh-list
92082062|NCT01388361|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082063|NCT01388361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082064|NCT01388361|Incretins|incretins|mesh-ancestor
92082065|NCT01388361|Hormones|hormones|mesh-ancestor
92016505|NCT04978597|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92016506|NCT04978597|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082066|NCT01388361|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082067|NCT05368935|Nitazoxanide|nitazoxanide|mesh-list
92082068|NCT05368935|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92082069|NCT05368935|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082070|NCT01399125|Rivastigmine|rivastigmine|mesh-list
92082071|NCT01399125|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92082072|NCT01399125|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082073|NCT01399125|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082074|NCT01399125|Cholinergic Agents|cholinergic agents|mesh-ancestor
92082075|NCT01399125|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082076|NCT01399125|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082077|NCT01399125|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92082078|NCT01399125|Protective Agents|protective agents|mesh-ancestor
92082079|NCT01399047|Mycophenolic Acid|mycophenolic acid|mesh-list
92082080|NCT01399047|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92082081|NCT01399047|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082082|NCT01399047|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92082083|NCT01399047|Antitubercular Agents|antitubercular agents|mesh-ancestor
92082084|NCT01399047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082085|NCT01399047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082086|NCT01399047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082087|NCT01399047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082088|NCT01387347|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92082089|NCT01387347|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92082090|NCT04040439|Dexmedetomidine|dexmedetomidine|mesh-list
92082091|NCT04040439|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92082092|NCT04040439|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082093|NCT04040439|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082094|NCT04040439|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082095|NCT04040439|Analgesics|analgesics|mesh-ancestor
92082096|NCT04040439|Sensory System Agents|sensory system agents|mesh-ancestor
92082097|NCT04040439|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082098|NCT04040439|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92082099|NCT04040439|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92082100|NCT04040439|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92082101|NCT04040439|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082102|NCT04040439|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082103|NCT04040439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082104|NCT04012827|Doxorubicin|doxorubicin|mesh-list
92082106|NCT04012827|Ifosfamide|ifosfamide|mesh-list
92082107|NCT04012827|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92082108|NCT04012827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082109|NCT04012827|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92082110|NCT04012827|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92082111|NCT04012827|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082112|NCT04012827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082113|NCT04012827|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082114|NCT04012827|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92082115|NCT04012827|Alkylating Agents|alkylating agents|mesh-ancestor
92082116|NCT01879579|Insulin|insulin|mesh-list
92082117|NCT01879579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082118|NCT01879579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082119|NCT01386645|Acetylcysteine|acetylcysteine|mesh-list
92082120|NCT01386645|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92082121|NCT01386645|Antiviral Agents|antiviral agents|mesh-ancestor
92082122|NCT01386645|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082123|NCT01386645|Expectorants|expectorants|mesh-ancestor
92082124|NCT01386645|Respiratory System Agents|respiratory system agents|mesh-ancestor
92082125|NCT01386645|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92082126|NCT01386645|Antioxidants|antioxidants|mesh-ancestor
92082127|NCT01386645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082128|NCT01386645|Protective Agents|protective agents|mesh-ancestor
92082129|NCT01386645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082130|NCT01386645|Antidotes|antidotes|mesh-ancestor
92082131|NCT01831765|Insulin|insulin|mesh-list
92082132|NCT01831765|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92082135|NCT01831765|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92082137|NCT01831765|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082138|NCT01831765|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082139|NCT01830595|Lactoferrin|lactoferrin|mesh-list
92016507|NCT04978597|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016508|NCT04978597|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92082140|NCT01830595|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082141|NCT01748162|Fluticasone|fluticasone|mesh-list
92082142|NCT01748162|Prednisolone|prednisolone|mesh-list
92082143|NCT01748162|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082144|NCT01748162|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92082145|NCT01748162|Autonomic Agents|autonomic agents|mesh-ancestor
92082146|NCT01748162|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082147|NCT01748162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082148|NCT01748162|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92082149|NCT01748162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92082150|NCT01748162|Dermatologic Agents|dermatologic agents|mesh-ancestor
92082151|NCT01748162|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92082152|NCT01748162|Glucocorticoids|glucocorticoids|mesh-ancestor
92082153|NCT01748162|Hormones|hormones|mesh-ancestor
92082154|NCT01748162|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082155|NCT01748162|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082156|NCT01748162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082157|NCT01723904|Rotigotine|rotigotine|mesh-list
92082158|NCT01723904|Dopamine Agonists|dopamine agonists|mesh-ancestor
92082159|NCT01723904|Dopamine Agents|dopamine agents|mesh-ancestor
92082160|NCT01723904|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082161|NCT01723904|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082162|NCT01723904|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082163|NCT01830127|Ribavirin|ribavirin|mesh-list
92082164|NCT01830127|Antimetabolites|antimetabolites|mesh-ancestor
92082165|NCT01830127|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082166|NCT01830127|Antiviral Agents|antiviral agents|mesh-ancestor
92082167|NCT01830127|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082168|NCT01614067|Ganirelix|ganirelix|mesh-list
92082169|NCT01614067|Hormone Antagonists|hormone antagonists|mesh-ancestor
92082170|NCT01614067|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082171|NCT01614067|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082172|NCT01397409|Ranibizumab|ranibizumab|mesh-list
92082173|NCT01397409|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92082174|NCT01397409|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92082175|NCT01397409|Growth Substances|growth substances|mesh-ancestor
92082176|NCT01397409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082177|NCT01397409|Growth Inhibitors|growth inhibitors|mesh-ancestor
92082178|NCT01397409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082179|NCT04766775|Fluorides|fluorides|mesh-list
92082180|NCT04766775|Cariostatic Agents|cariostatic agents|mesh-ancestor
92082181|NCT04766775|Protective Agents|protective agents|mesh-ancestor
92082182|NCT04766775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082183|NCT01777334|Tiotropium Bromide|tiotropium bromide|mesh-list
92082184|NCT01777334|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92082185|NCT01777334|Autonomic Agents|autonomic agents|mesh-ancestor
92082186|NCT01777334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082187|NCT01777334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082188|NCT01777334|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92082189|NCT01777334|Respiratory System Agents|respiratory system agents|mesh-ancestor
92082190|NCT01777334|Parasympatholytics|parasympatholytics|mesh-ancestor
92082191|NCT01777334|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92082192|NCT01777334|Cholinergic Agents|cholinergic agents|mesh-ancestor
92082193|NCT01777334|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082194|NCT01777334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082195|NCT03024879|Erythromycin|erythromycin|mesh-list
92082196|NCT03024879|Erythromycin Estolate|erythromycin estolate|mesh-list
92082197|NCT03024879|Erythromycin Ethylsuccinate|erythromycin ethylsuccinate|mesh-list
92082198|NCT03024879|Erythromycin stearate|erythromycin stearate|mesh-list
92082199|NCT03024879|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082200|NCT03024879|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082201|NCT03024879|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082202|NCT03024879|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92082203|NCT03024879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082204|NCT03024879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082214|NCT01383993|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082215|NCT01383993|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082216|NCT01383993|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92016509|NCT04978597|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92016511|NCT03490513|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082218|NCT01396395|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92082219|NCT01396395|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92082220|NCT01396395|Vasodilator Agents|vasodilator agents|mesh-ancestor
92082221|NCT01396395|Vitamin B Complex|vitamin b complex|mesh-ancestor
92082222|NCT01396395|Vitamins|vitamins|mesh-ancestor
92082223|NCT01396395|Micronutrients|micronutrients|mesh-ancestor
92082224|NCT01396395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082225|NCT01396083|Dexamethasone|dexamethasone|mesh-list
92082226|NCT01396083|Ranibizumab|ranibizumab|mesh-list
92082227|NCT01396083|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082228|NCT01396083|Antiemetics|antiemetics|mesh-ancestor
92082229|NCT01396083|Autonomic Agents|autonomic agents|mesh-ancestor
92082230|NCT01396083|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082231|NCT01396083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082232|NCT01396083|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082233|NCT01396083|Glucocorticoids|glucocorticoids|mesh-ancestor
92082234|NCT01396083|Hormones|hormones|mesh-ancestor
92082235|NCT01396083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082236|NCT01396083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082237|NCT01396083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082238|NCT01396083|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92082239|NCT01396083|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92082240|NCT01396083|Growth Substances|growth substances|mesh-ancestor
92082241|NCT01396083|Growth Inhibitors|growth inhibitors|mesh-ancestor
92082242|NCT01776008|Anastrozole|anastrozole|mesh-list
92082243|NCT01776008|Goserelin|goserelin|mesh-list
92082244|NCT01776008|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082245|NCT01776008|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082246|NCT01776008|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92082247|NCT01776008|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92082248|NCT01776008|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082249|NCT01776008|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082250|NCT01776008|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92082251|NCT01776008|Hormone Antagonists|hormone antagonists|mesh-ancestor
92082252|NCT01776008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082253|NCT01776008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082254|NCT01858363|Paclitaxel|paclitaxel|mesh-list
92082255|NCT01858363|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92082256|NCT01858363|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082257|NCT01858363|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082258|NCT01858363|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082259|NCT01858363|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082260|NCT01858363|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082261|NCT01877551|Ursodoxicoltaurine|ursodoxicoltaurine|mesh-list
92082262|NCT01877551|Antiviral Agents|antiviral agents|mesh-ancestor
92082263|NCT01877551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082264|NCT01877551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92082265|NCT01877551|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082266|NCT01396005|Buprenorphine|buprenorphine|mesh-list
92082267|NCT01396005|Methadone|methadone|mesh-list
92082268|NCT01396005|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92082269|NCT01396005|Naloxone|naloxone|mesh-list
92082270|NCT01396005|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92082274|NCT01396005|Analgesics|analgesics|mesh-ancestor
92082275|NCT01396005|Sensory System Agents|sensory system agents|mesh-ancestor
92082276|NCT01396005|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082277|NCT01396005|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92082278|NCT01396005|Antitussive Agents|antitussive agents|mesh-ancestor
92082279|NCT01396005|Respiratory System Agents|respiratory system agents|mesh-ancestor
92082280|NCT03024957|Dexmedetomidine|dexmedetomidine|mesh-list
92082281|NCT03024957|Morphine|morphine|mesh-list
92082282|NCT03024957|Bupivacaine|bupivacaine|mesh-list
92082283|NCT03024957|Anesthetics, Local|anesthetics, local|mesh-ancestor
92082284|NCT03024957|Anesthetics|anesthetics|mesh-ancestor
92082285|NCT03024957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082286|NCT03024957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082287|NCT03024957|Sensory System Agents|sensory system agents|mesh-ancestor
92082288|NCT03024957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082289|NCT03024957|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92082290|NCT03024957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082291|NCT03024957|Analgesics|analgesics|mesh-ancestor
92016512|NCT03490513|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016513|NCT03490513|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92082292|NCT03024957|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92082293|NCT03024957|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92082294|NCT03024957|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92082295|NCT03024957|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082296|NCT03024957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082297|NCT03024957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082298|NCT03024957|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92082299|NCT03024957|Narcotics|narcotics|mesh-ancestor
92082300|NCT03025113|Ketoprofen|ketoprofen|mesh-list
92082301|NCT03025113|Amitriptyline|amitriptyline|mesh-list
92082302|NCT03025113|Cyclobenzaprine|cyclobenzaprine|mesh-list
92082303|NCT03025113|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92082304|NCT03025113|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082305|NCT03025113|Analgesics|analgesics|mesh-ancestor
92082306|NCT03025113|Sensory System Agents|sensory system agents|mesh-ancestor
92082307|NCT03025113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082308|NCT03025113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082309|NCT03025113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082310|NCT03025113|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082311|NCT03025113|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92082312|NCT03025113|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082313|NCT03025113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082314|NCT03025113|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92082315|NCT03025113|Antidepressive Agents|antidepressive agents|mesh-ancestor
92082316|NCT03025113|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92082317|NCT03025113|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92082318|NCT03025113|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92082319|NCT03025113|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92082320|NCT03025113|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082321|NCT03025113|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92082322|NCT03025113|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92082323|NCT03025113|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92082324|NCT03025113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082325|NCT03025113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082326|NCT01877083|Lenvatinib|lenvatinib|mesh-list
92082327|NCT01877083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082328|NCT01877083|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082329|NCT01877083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082330|NCT01877083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082331|NCT01380327|Immunomodulating Agents|immunomodulating agents|mesh-list
92082332|NCT01380327|Immunologic Factors|immunologic factors|mesh-list
92082333|NCT01380327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082334|NCT01829425|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92082335|NCT01829425|Oxybutynin|oxybutynin|mesh-list
92082336|NCT01829425|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92082337|NCT01829425|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92082338|NCT01829425|Cholinergic Agents|cholinergic agents|mesh-ancestor
92082339|NCT01829425|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082340|NCT01829425|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082341|NCT01829425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082345|NCT01829425|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082348|NCT01394523|Bupivacaine|bupivacaine|mesh-list
92082349|NCT01394523|Anesthetics, Local|anesthetics, local|mesh-ancestor
92082350|NCT01394523|Anesthetics|anesthetics|mesh-ancestor
92082351|NCT01394523|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082352|NCT01394523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082353|NCT01394523|Sensory System Agents|sensory system agents|mesh-ancestor
92082354|NCT01394523|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082355|NCT01857583|PENTA|penta|mesh-list
92082356|NCT01857583|Edoxaban|edoxaban|mesh-list
92082357|NCT01857583|Fondaparinux|fondaparinux|mesh-list
92082358|NCT01857583|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92082359|NCT01857583|Antithrombins|antithrombins|mesh-ancestor
92082360|NCT01857583|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92082361|NCT01857583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92082362|NCT01857583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082363|NCT01857583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082364|NCT01857583|Anticoagulants|anticoagulants|mesh-ancestor
92016514|NCT03490513|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92082365|NCT01857583|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92082366|NCT01857583|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92082367|NCT04000347|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92082368|NCT04000347|Dermatologic Agents|dermatologic agents|mesh-ancestor
92082369|NCT00211185|Prednisone|prednisone|mesh-list
92082370|NCT00211185|Cyclophosphamide|cyclophosphamide|mesh-list
92082371|NCT00211185|Doxorubicin|doxorubicin|mesh-list
92082372|NCT00211185|Vincristine|vincristine|mesh-list
92082373|NCT00211185|Denileukin diftitox|denileukin diftitox|mesh-list
92082374|NCT00211185|Lenograstim|lenograstim|mesh-list
92082375|NCT00211185|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082376|NCT00211185|Immunologic Factors|immunologic factors|mesh-ancestor
92082377|NCT00211185|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082378|NCT00211185|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082379|NCT00211185|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92082380|NCT00211185|Alkylating Agents|alkylating agents|mesh-ancestor
92082381|NCT00211185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082382|NCT00211185|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082383|NCT00211185|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92082384|NCT00211185|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92082385|NCT00211185|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92082386|NCT00211185|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92082387|NCT00211185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082388|NCT00211185|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082389|NCT00211185|Glucocorticoids|glucocorticoids|mesh-ancestor
92082390|NCT00211185|Hormones|hormones|mesh-ancestor
92082391|NCT00211185|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082392|NCT00211185|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082393|NCT00211185|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92082395|NCT00211185|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082396|NCT00211185|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082397|NCT00211185|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92082398|NCT00219297|Epothilone B|epothilone b|mesh-list
92082399|NCT00219297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082400|NCT00219297|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082401|NCT00219297|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082402|NCT00219297|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082403|NCT00219297|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082404|NCT01857271|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92082405|NCT01857271|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082406|NCT01857271|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082407|NCT01857271|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082408|NCT01857271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082409|NCT01721486|Acetaminophen|acetaminophen|mesh-list
92082410|NCT01721486|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082411|NCT01721486|Analgesics|analgesics|mesh-ancestor
92082412|NCT01721486|Sensory System Agents|sensory system agents|mesh-ancestor
92082413|NCT01721486|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082414|NCT01721486|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082415|NCT01721486|Antipyretics|antipyretics|mesh-ancestor
92082416|NCT01721408|Imipenem|imipenem|mesh-list
92082420|NCT01721408|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082421|NCT01721408|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92082422|NCT01721408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082423|NCT01721408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082424|NCT01721408|Protease Inhibitors|protease inhibitors|mesh-ancestor
92082425|NCT03998709|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92082426|NCT03998709|Somatostatin|somatostatin|mesh-list
92082427|NCT03998709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082428|NCT03998709|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92082429|NCT03998709|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92082430|NCT03998709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92082431|NCT03998709|Hormones|hormones|mesh-ancestor
92082432|NCT03998709|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082433|NCT01744496|Rotigotine|rotigotine|mesh-list
92082434|NCT01744496|Dopamine Agonists|dopamine agonists|mesh-ancestor
92082435|NCT01744496|Dopamine Agents|dopamine agents|mesh-ancestor
92082436|NCT01744496|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082437|NCT01744496|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016516|NCT03490513|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016517|NCT03490513|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92016518|NCT03490513|Hormone Antagonists|hormone antagonists|mesh-ancestor
92082438|NCT01744496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082439|NCT04007055|Ticagrelor|ticagrelor|mesh-list
92082440|NCT04007055|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92082441|NCT04007055|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92082442|NCT04007055|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92082443|NCT04007055|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92082444|NCT04007055|Purinergic Agents|purinergic agents|mesh-ancestor
92082445|NCT04007055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082446|NCT04007055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082447|NCT04007055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082448|NCT01721330|Naltrexone|naltrexone|mesh-list
92082449|NCT01721330|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92082450|NCT01721330|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92082451|NCT01721330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082452|NCT01721330|Sensory System Agents|sensory system agents|mesh-ancestor
92082453|NCT01721330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082454|NCT03592407|Pembrolizumab|pembrolizumab|mesh-list
92082455|NCT03592407|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082456|NCT03592407|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082457|NCT03592407|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92082458|NCT03592407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082459|NCT03595371|Dapansutrile|dapansutrile|mesh-list
92082460|NCT03595371|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082461|NCT05634057|Anisodamine|anisodamine|mesh-list
92082462|NCT05634057|Heparin|heparin|mesh-list
92082463|NCT05634057|Calcium heparin|calcium heparin|mesh-list
92082464|NCT05634057|Anticoagulants|anticoagulants|mesh-ancestor
92082465|NCT05634057|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92082466|NCT05634057|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92082467|NCT05634057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082468|NCT05634057|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92082469|NCT05634057|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92082470|NCT05634057|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082471|NCT05634057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082472|NCT05634057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082473|NCT05634057|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92082474|NCT05634057|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92082475|NCT05634057|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082476|NCT05634057|Analgesics|analgesics|mesh-ancestor
92082477|NCT05634057|Sensory System Agents|sensory system agents|mesh-ancestor
92082478|NCT05634057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082479|NCT05634057|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082480|NCT05634057|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082481|NCT05634057|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92082482|NCT05634057|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082483|NCT05634057|Parasympatholytics|parasympatholytics|mesh-ancestor
92082484|NCT05634057|Autonomic Agents|autonomic agents|mesh-ancestor
92082485|NCT05634057|Vasodilator Agents|vasodilator agents|mesh-ancestor
92082486|NCT05634057|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92082487|NCT05634057|Antioxidants|antioxidants|mesh-ancestor
92082488|NCT05634057|Protective Agents|protective agents|mesh-ancestor
92082493|NCT03596385|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92082494|NCT03596385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92082495|NCT03596385|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92082496|NCT03596385|Sympatholytics|sympatholytics|mesh-ancestor
92082497|NCT03596385|Autonomic Agents|autonomic agents|mesh-ancestor
92082498|NCT03596385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082499|NCT03596385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082500|NCT03596385|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92082501|NCT03596385|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92082502|NCT03596385|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082503|NCT03596385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082504|NCT03596385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082505|NCT03596385|Antioxidants|antioxidants|mesh-ancestor
92082506|NCT03596385|Protective Agents|protective agents|mesh-ancestor
92082507|NCT03596385|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92082508|NCT03596385|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016519|NCT03490513|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082509|NCT03596385|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92082510|NCT03596385|Vasodilator Agents|vasodilator agents|mesh-ancestor
92082511|NCT03596385|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92082512|NCT03596385|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92082513|NCT01828021|Margetuximab|margetuximab|mesh-list
92082514|NCT01828021|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082515|NCT03784599|Trastuzumab|trastuzumab|mesh-list
92082516|NCT03784599|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92082517|NCT03784599|Osimertinib|osimertinib|mesh-list
92082518|NCT03784599|Maytansine|maytansine|mesh-list
92082519|NCT03784599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082520|NCT03784599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082521|NCT03784599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082522|NCT03784599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082523|NCT03784599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082524|NCT03784599|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92082525|NCT03784599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082526|NCT03784599|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082527|NCT03784599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082528|NCT03784599|Immunotoxins|immunotoxins|mesh-ancestor
92082529|NCT03784599|Immunoconjugates|immunoconjugates|mesh-ancestor
92082530|NCT03784599|Immunologic Factors|immunologic factors|mesh-ancestor
92082531|NCT03784599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082532|NCT01827943|Sirolimus|sirolimus|mesh-list
92082533|NCT01827943|Temsirolimus|temsirolimus|mesh-list
92082534|NCT01827943|MTOR Inhibitors|mtor inhibitors|mesh-list
92082535|NCT01827943|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082536|NCT01827943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082537|NCT01827943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082538|NCT01827943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082539|NCT01827943|Immunologic Factors|immunologic factors|mesh-ancestor
92082540|NCT01827943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082541|NCT01827943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082542|NCT01827943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082543|NCT01827943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082544|NCT01827943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92082545|NCT01827943|Antifungal Agents|antifungal agents|mesh-ancestor
92082546|NCT02985255|Docetaxel|docetaxel|mesh-list
92082547|NCT02985255|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082548|NCT02985255|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082549|NCT02985255|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082550|NCT02985255|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082551|NCT02985255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082552|NCT00214851|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92082553|NCT00214851|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082554|NCT00217971|Dronabinol|dronabinol|mesh-list
92082555|NCT00217971|Hallucinogens|hallucinogens|mesh-ancestor
92082556|NCT00217971|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082557|NCT00217971|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92082558|NCT00217971|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082559|NCT00217971|Analgesics|analgesics|mesh-ancestor
92082560|NCT00217971|Sensory System Agents|sensory system agents|mesh-ancestor
92082561|NCT00217971|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082563|NCT00217971|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92082564|NCT00217971|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082565|NCT00217971|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082566|NCT00217971|Hormones|hormones|mesh-ancestor
92082567|NCT00217971|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082568|NCT03976323|Cisplatin|cisplatin|mesh-list
92082569|NCT03976323|Carboplatin|carboplatin|mesh-list
92082570|NCT03976323|Pembrolizumab|pembrolizumab|mesh-list
92082571|NCT03976323|Pemetrexed|pemetrexed|mesh-list
92082572|NCT03976323|Olaparib|olaparib|mesh-list
92082573|NCT03976323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082574|NCT03976323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082575|NCT03976323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92082576|NCT03976323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082577|NCT03976323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082578|NCT03976323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92082579|NCT03976323|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92016520|NCT03490513|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016521|NCT03439345|Fenofibrate|fenofibrate|mesh-list
92016522|NCT03439345|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92016523|NCT03439345|Antimetabolites|antimetabolites|mesh-ancestor
92082580|NCT03976323|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92082581|NCT00217581|Bevacizumab|bevacizumab|mesh-list
92082582|NCT00217581|Docetaxel|docetaxel|mesh-list
92082583|NCT00217581|Oxaliplatin|oxaliplatin|mesh-list
92082584|NCT00217581|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082585|NCT00217581|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082586|NCT00217581|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92082587|NCT00217581|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92082588|NCT00217581|Growth Substances|growth substances|mesh-ancestor
92082589|NCT00217581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082590|NCT00217581|Growth Inhibitors|growth inhibitors|mesh-ancestor
92082591|NCT00217581|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082592|NCT00217581|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082593|NCT00217581|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082594|NCT00217581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082595|NCT01856257|Mycophenolic Acid|mycophenolic acid|mesh-list
92082596|NCT01856257|Methylprednisolone|methylprednisolone|mesh-list
92082597|NCT01856257|Abatacept|abatacept|mesh-list
92082598|NCT01856257|Tacrolimus|tacrolimus|mesh-list
92082599|NCT01856257|Thymoglobulin|thymoglobulin|mesh-list
92082600|NCT01856257|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92082601|NCT01856257|Basiliximab|basiliximab|mesh-list
92082602|NCT01856257|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082603|NCT01856257|Immunologic Factors|immunologic factors|mesh-ancestor
92082604|NCT01856257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082605|NCT01856257|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92082606|NCT01856257|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082607|NCT01856257|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082608|NCT01856257|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92082609|NCT01856257|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082610|NCT01856257|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92082611|NCT01856257|Antitubercular Agents|antitubercular agents|mesh-ancestor
92082612|NCT01856257|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082613|NCT01856257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082614|NCT01856257|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082615|NCT01856257|Antiemetics|antiemetics|mesh-ancestor
92082616|NCT01856257|Autonomic Agents|autonomic agents|mesh-ancestor
92082617|NCT01856257|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082618|NCT01856257|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082619|NCT01856257|Glucocorticoids|glucocorticoids|mesh-ancestor
92082620|NCT01856257|Hormones|hormones|mesh-ancestor
92082621|NCT01856257|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082622|NCT01856257|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92082623|NCT01856257|Protective Agents|protective agents|mesh-ancestor
92082624|NCT01856257|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92082625|NCT01856257|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082626|NCT01856257|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082627|NCT00215943|Zoledronic Acid|zoledronic acid|mesh-list
92082628|NCT00215943|Thalidomide|thalidomide|mesh-list
92082629|NCT00215943|Dexamethasone|dexamethasone|mesh-list
92082630|NCT00215943|Doxorubicin|doxorubicin|mesh-list
92082631|NCT00215943|Vincristine|vincristine|mesh-list
92082632|NCT00215943|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92082633|NCT00215943|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082634|NCT00215943|Antiemetics|antiemetics|mesh-ancestor
92082635|NCT00215943|Autonomic Agents|autonomic agents|mesh-ancestor
92082636|NCT00215943|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082639|NCT00215943|Glucocorticoids|glucocorticoids|mesh-ancestor
92082640|NCT00215943|Hormones|hormones|mesh-ancestor
92082641|NCT00215943|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082642|NCT00215943|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082643|NCT00215943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082644|NCT00215943|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92082645|NCT00215943|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92082646|NCT00215943|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92082647|NCT00215943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016524|NCT03439345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016525|NCT03439345|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92016526|NCT04977661|Vitamin E|vitamin e|mesh-list
92016527|NCT04977661|Tocopherols|tocopherols|mesh-list
92082648|NCT00215943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082649|NCT00215943|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92082650|NCT00215943|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082651|NCT00215943|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082652|NCT00215943|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082653|NCT00215943|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082654|NCT00215943|Immunologic Factors|immunologic factors|mesh-ancestor
92082655|NCT00215943|Leprostatic Agents|leprostatic agents|mesh-ancestor
92082656|NCT00215943|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082657|NCT00215943|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082658|NCT00215943|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92082659|NCT00215943|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92082660|NCT00215943|Growth Substances|growth substances|mesh-ancestor
92082661|NCT00215943|Growth Inhibitors|growth inhibitors|mesh-ancestor
92082662|NCT00215943|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92082663|NCT01827163|Paclitaxel|paclitaxel|mesh-list
92082664|NCT01827163|Trastuzumab|trastuzumab|mesh-list
92082665|NCT01827163|Lapatinib|lapatinib|mesh-list
92082666|NCT01827163|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92082667|NCT01827163|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082668|NCT01827163|Tubulin Modulators|tubulin modulators|mesh-ancestor
92082669|NCT01827163|Antimitotic Agents|antimitotic agents|mesh-ancestor
92082670|NCT01827163|Mitosis Modulators|mitosis modulators|mesh-ancestor
92082671|NCT01827163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082672|NCT01827163|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082673|NCT01827163|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082674|NCT01827163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082675|NCT00215553|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92082676|NCT00215553|Respiratory System Agents|respiratory system agents|mesh-ancestor
92082677|NCT00214461|Vaccines|vaccines|mesh-list
92082678|NCT00214461|Immunologic Factors|immunologic factors|mesh-ancestor
92082679|NCT00214461|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082680|NCT03599973|Plasma-lyte 148|plasma-lyte 148|mesh-list
92082681|NCT03599973|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92082682|NCT03599973|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92082683|NCT00211887|Interferons|interferons|mesh-list
92082684|NCT00211887|Interferon-beta|interferon-beta|mesh-list
92082685|NCT00211887|Interferon beta-1a|interferon beta-1a|mesh-list
92082686|NCT00211887|Glatiramer Acetate|glatiramer acetate|mesh-list
92082687|NCT00211887|(T,G)-A-L|(t,g)-a-l|mesh-list
92082688|NCT00211887|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082689|NCT00211887|Antiviral Agents|antiviral agents|mesh-ancestor
92082690|NCT00211887|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082691|NCT00211887|Immunologic Factors|immunologic factors|mesh-ancestor
92082692|NCT00211887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082693|NCT00211887|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92082694|NCT00211887|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082695|NCT00211887|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082696|NCT04002453|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92082697|NCT04002453|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082698|NCT03592485|Acetaminophen|acetaminophen|mesh-list
92082699|NCT03592485|Oxycodone|oxycodone|mesh-list
92082700|NCT03592485|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082701|NCT03592485|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082702|NCT03592485|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082703|NCT03592485|Analgesics|analgesics|mesh-ancestor
92082704|NCT03592485|Sensory System Agents|sensory system agents|mesh-ancestor
92082705|NCT03592485|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082706|NCT03592485|Antipyretics|antipyretics|mesh-ancestor
92082707|NCT03592485|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92082708|NCT03592485|Narcotics|narcotics|mesh-ancestor
92082709|NCT04199013|Fentanyl|fentanyl|mesh-list
92082710|NCT04199013|Ropivacaine|ropivacaine|mesh-list
92082711|NCT04199013|Anesthetics, Local|anesthetics, local|mesh-ancestor
92082715|NCT04199013|Sensory System Agents|sensory system agents|mesh-ancestor
92082716|NCT04199013|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082717|NCT04199013|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92082718|NCT04199013|Narcotics|narcotics|mesh-ancestor
92082719|NCT04199013|Analgesics|analgesics|mesh-ancestor
92082720|NCT04199013|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92016528|NCT04977661|alpha-Tocopherol|alpha-tocopherol|mesh-list
92016529|NCT04977661|Pentoxifylline|pentoxifylline|mesh-list
92016530|NCT04977661|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92016531|NCT04977661|Vitamins|vitamins|mesh-ancestor
92082721|NCT04199013|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92082722|NCT04199013|Anesthetics, General|anesthetics, general|mesh-ancestor
92082723|NCT04198467|Hyaluronic Acid|hyaluronic acid|mesh-list
92082724|NCT04198467|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92082725|NCT04198467|Immunologic Factors|immunologic factors|mesh-ancestor
92082726|NCT04198467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082727|NCT04198467|Viscosupplements|viscosupplements|mesh-ancestor
92082728|NCT04198467|Protective Agents|protective agents|mesh-ancestor
92082729|NCT03599427|Lidocaine|lidocaine|mesh-list
92082730|NCT03599427|Anesthetics, Local|anesthetics, local|mesh-ancestor
92082731|NCT03599427|Anesthetics|anesthetics|mesh-ancestor
92082732|NCT03599427|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082733|NCT03599427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082734|NCT03599427|Sensory System Agents|sensory system agents|mesh-ancestor
92082735|NCT03599427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082736|NCT03599427|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92082737|NCT03599427|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92082738|NCT03599427|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92082739|NCT03599427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92082740|NCT03599427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082741|NCT01855789|Methotrexate|methotrexate|mesh-list
92082742|NCT01855789|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92082743|NCT01855789|Abortifacient Agents|abortifacient agents|mesh-ancestor
92082744|NCT01855789|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92082745|NCT01855789|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082746|NCT01855789|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92082747|NCT01855789|Antimetabolites|antimetabolites|mesh-ancestor
92082748|NCT01855789|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082749|NCT01855789|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082750|NCT01855789|Dermatologic Agents|dermatologic agents|mesh-ancestor
92082751|NCT01855789|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082752|NCT01855789|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92082753|NCT01855789|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082754|NCT01855789|Immunologic Factors|immunologic factors|mesh-ancestor
92082755|NCT01855789|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082756|NCT01855789|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92082757|NCT04198233|Diazepam|diazepam|mesh-list
92082758|NCT04198233|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92082759|NCT04198233|Anticonvulsants|anticonvulsants|mesh-ancestor
92082760|NCT04198233|Antiemetics|antiemetics|mesh-ancestor
92082761|NCT04198233|Autonomic Agents|autonomic agents|mesh-ancestor
92082762|NCT04198233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082763|NCT04198233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082764|NCT04198233|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082765|NCT04198233|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92082766|NCT04198233|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082767|NCT04198233|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92082768|NCT04198233|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92082769|NCT04198233|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92082770|NCT04198233|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92082771|NCT04198233|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92082773|NCT04198233|Anesthetics, General|anesthetics, general|mesh-ancestor
92082774|NCT04198233|Anesthetics|anesthetics|mesh-ancestor
92082775|NCT04198233|GABA Modulators|gaba modulators|mesh-ancestor
92082776|NCT04198233|GABA Agents|gaba agents|mesh-ancestor
92082777|NCT04198233|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082778|NCT04198233|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082779|NCT03591471|Prednisone|prednisone|mesh-list
92082780|NCT03591471|Benazepril|benazepril|mesh-list
92082781|NCT03591471|Heparin|heparin|mesh-list
92082782|NCT03591471|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92082783|NCT03591471|Tinzaparin|tinzaparin|mesh-list
92082784|NCT03591471|Dalteparin|dalteparin|mesh-list
92082785|NCT03591471|Calcium heparin|calcium heparin|mesh-list
92082800|NCT03591471|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92082801|NCT03591471|Vasodilator Agents|vasodilator agents|mesh-ancestor
92082802|NCT03591471|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92082803|NCT03591471|Protease Inhibitors|protease inhibitors|mesh-ancestor
92082804|NCT03591471|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92016532|NCT04977661|Micronutrients|micronutrients|mesh-ancestor
92082805|NCT04406805|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92082806|NCT04406805|Natriuretic Agents|natriuretic agents|mesh-ancestor
92082807|NCT04406805|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082809|NCT01876381|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92082810|NCT01876381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082811|NCT01876381|Natriuretic Agents|natriuretic agents|mesh-ancestor
92082812|NCT01876381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082813|NCT03591003|Antibodies|antibodies|mesh-list
92082814|NCT03591003|Antibodies, Blocking|antibodies, blocking|mesh-list
92082815|NCT03591003|Immunologic Factors|immunologic factors|mesh-ancestor
92082816|NCT03591003|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082817|NCT01875991|Etanercept|etanercept|mesh-list
92082818|NCT01875991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92082819|NCT01875991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082820|NCT01875991|Analgesics|analgesics|mesh-ancestor
92082821|NCT01875991|Sensory System Agents|sensory system agents|mesh-ancestor
92082822|NCT01875991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082823|NCT01875991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082824|NCT01875991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082825|NCT01875991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082826|NCT01875991|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082827|NCT01875991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082828|NCT01875991|Immunologic Factors|immunologic factors|mesh-ancestor
92082829|NCT04203927|Empagliflozin|empagliflozin|mesh-list
92082830|NCT04203927|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92082831|NCT04203927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082832|NCT04203927|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082833|NCT04203927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082834|NCT01855243|Insulin|insulin|mesh-list
92082835|NCT01855243|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92082836|NCT01855243|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92082837|NCT01855243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082838|NCT04196829|Fluorides|fluorides|mesh-list
92082839|NCT04196829|Cariostatic Agents|cariostatic agents|mesh-ancestor
92082840|NCT04196829|Protective Agents|protective agents|mesh-ancestor
92082841|NCT04196829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082842|NCT01825837|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92082843|NCT01825837|Anticonvulsants|anticonvulsants|mesh-ancestor
92082844|NCT01825837|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92082847|NCT01825837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082849|NCT01854697|Ribavirin|ribavirin|mesh-list
92082850|NCT01854697|Interferon-alpha|interferon-alpha|mesh-list
92082851|NCT01854697|Interferon alpha-2|interferon alpha-2|mesh-list
92082852|NCT01854697|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92082853|NCT01854697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082854|NCT01854697|Antiviral Agents|antiviral agents|mesh-ancestor
92082855|NCT01854697|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082856|NCT01854697|Antimetabolites|antimetabolites|mesh-ancestor
92082857|NCT01854697|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082858|NCT01854697|Immunologic Factors|immunologic factors|mesh-ancestor
92082859|NCT01854697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082860|NCT03594123|Brexpiprazole|brexpiprazole|mesh-list
92082861|NCT03594123|Serotonin Agents|serotonin agents|mesh-ancestor
92082862|NCT03594123|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082863|NCT03594123|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082864|NCT03594123|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082865|NCT03594123|Dopamine Agonists|dopamine agonists|mesh-ancestor
92082866|NCT03594123|Dopamine Agents|dopamine agents|mesh-ancestor
92082867|NCT01824823|Afatinib|afatinib|mesh-list
92082868|NCT01824823|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082869|NCT01824823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92082870|NCT01824823|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082871|NCT01824823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082872|NCT03598725|Prednisone|prednisone|mesh-list
92082873|NCT03598725|Rituximab|rituximab|mesh-list
92082874|NCT03598725|Factor VIII|factor viii|mesh-list
92082875|NCT03598725|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082876|NCT03598725|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082877|NCT03598725|Immunologic Factors|immunologic factors|mesh-ancestor
92082878|NCT03598725|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082879|NCT03598725|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016533|NCT04977661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082880|NCT03598725|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082881|NCT03598725|Glucocorticoids|glucocorticoids|mesh-ancestor
92082882|NCT03598725|Hormones|hormones|mesh-ancestor
92082883|NCT03598725|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082884|NCT03598725|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082885|NCT03598725|Coagulants|coagulants|mesh-ancestor
92082886|NCT04766307|Interleukin-2|interleukin-2|mesh-list
92082887|NCT04766307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082888|NCT04766307|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082889|NCT04766307|Analgesics|analgesics|mesh-ancestor
92082890|NCT04766307|Sensory System Agents|sensory system agents|mesh-ancestor
92082891|NCT04766307|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082892|NCT04766307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082893|NCT01875367|Trastuzumab|trastuzumab|mesh-list
92082894|NCT01875367|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92082895|NCT01875367|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082896|NCT04194957|Fluorouracil|fluorouracil|mesh-list
92082897|NCT04194957|Capecitabine|capecitabine|mesh-list
92082898|NCT04194957|Antimetabolites|antimetabolites|mesh-ancestor
92082899|NCT04194957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082900|NCT04194957|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92082901|NCT04194957|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082902|NCT04194957|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082903|NCT04194957|Immunologic Factors|immunologic factors|mesh-ancestor
92082904|NCT04194957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082905|NCT04194255|Ferrous fumarate|ferrous fumarate|mesh-list
92082906|NCT04194255|Trace Elements|trace elements|mesh-ancestor
92082907|NCT04194255|Micronutrients|micronutrients|mesh-ancestor
92082908|NCT04194255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082909|NCT04406883|Simvastatin|simvastatin|mesh-list
92082910|NCT04406883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92082911|NCT04406883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92082912|NCT04406883|Antimetabolites|antimetabolites|mesh-ancestor
92082913|NCT04406883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082914|NCT04406883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92082915|NCT04406883|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92082916|NCT04406883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082917|NCT03952299|Mandelic Acids|mandelic acids|mesh-list
92082920|NCT03952299|Autonomic Agents|autonomic agents|mesh-ancestor
92082921|NCT03952299|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082922|NCT03952299|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082923|NCT03952299|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92082924|NCT03952299|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92082925|NCT03952299|Cholinergic Agents|cholinergic agents|mesh-ancestor
92082926|NCT03952299|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082927|NCT03952299|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082928|NCT03952299|Urological Agents|urological agents|mesh-ancestor
92082929|NCT03952299|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92082930|NCT03952299|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082931|NCT03597867|Diclofenac|diclofenac|mesh-list
92082932|NCT03597867|Indomethacin|indomethacin|mesh-list
92082933|NCT03597867|Nepafenac|nepafenac|mesh-list
92082934|NCT03597867|Bromfenac|bromfenac|mesh-list
92082935|NCT03597867|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92082936|NCT03597867|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92082937|NCT03597867|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92082938|NCT03597867|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082939|NCT03597867|Analgesics|analgesics|mesh-ancestor
92082940|NCT03597867|Sensory System Agents|sensory system agents|mesh-ancestor
92082941|NCT03597867|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082942|NCT03597867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082943|NCT03597867|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082944|NCT03597867|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92082945|NCT03597867|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92082946|NCT03597867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082947|NCT03597867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082948|NCT03597867|Gout Suppressants|gout suppressants|mesh-ancestor
92082949|NCT03597867|Tocolytic Agents|tocolytic agents|mesh-ancestor
92082950|NCT03597867|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92082951|NCT03597555|Sodium Oxybate|sodium oxybate|mesh-list
92082952|NCT03597555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92082953|NCT03597555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92016535|NCT04977661|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016536|NCT04977661|Protective Agents|protective agents|mesh-ancestor
92016537|NCT04977661|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92016538|NCT04977661|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016539|NCT04977661|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92082954|NCT03597555|Anesthetics, General|anesthetics, general|mesh-ancestor
92082956|NCT03597555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082957|NCT03597555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082958|NCT03597477|Dexmedetomidine|dexmedetomidine|mesh-list
92082959|NCT03597477|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92082960|NCT03597477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082961|NCT03597477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082962|NCT03597477|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92082963|NCT03597477|Analgesics|analgesics|mesh-ancestor
92082964|NCT03597477|Sensory System Agents|sensory system agents|mesh-ancestor
92082965|NCT03597477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92082966|NCT03597477|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92082967|NCT03597477|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92082968|NCT03597477|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92082969|NCT03597477|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082970|NCT03597477|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082971|NCT03597477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082972|NCT04193319|Fluconazole|fluconazole|mesh-list
92082973|NCT04193319|Fluzoparib|fluzoparib|mesh-list
92082974|NCT04193319|Antifungal Agents|antifungal agents|mesh-ancestor
92082975|NCT04193319|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082976|NCT04193319|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92082977|NCT04193319|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92082978|NCT04193319|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082979|NCT04193319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082980|NCT04193319|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92082981|NCT04193319|Hormone Antagonists|hormone antagonists|mesh-ancestor
92082982|NCT04193319|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082983|NCT04193319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082984|NCT04193319|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92082985|NCT04193319|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92082986|NCT04193319|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92082987|NCT04193319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082988|NCT04192617|Methotrexate|methotrexate|mesh-list
92083002|NCT04192617|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083003|NCT04192617|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92083004|NCT04026009|Vaccines|vaccines|mesh-list
92083005|NCT04026009|Immunologic Factors|immunologic factors|mesh-ancestor
92083006|NCT04026009|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083007|NCT01874665|Ponatinib|ponatinib|mesh-list
92083008|NCT01874665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083009|NCT01874665|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92083010|NCT01874665|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083011|NCT01874665|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083012|NCT04766151|Nitroglycerin|nitroglycerin|mesh-list
92083013|NCT04766151|Vasodilator Agents|vasodilator agents|mesh-ancestor
92083014|NCT04028739|Curcumin|curcumin|mesh-list
92083015|NCT04028739|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92083016|NCT04028739|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083017|NCT04028739|Analgesics|analgesics|mesh-ancestor
92083018|NCT04028739|Sensory System Agents|sensory system agents|mesh-ancestor
92083019|NCT04028739|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083020|NCT04028739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083021|NCT04028739|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083022|NCT04028739|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083023|NCT04028739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083024|NCT04028739|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083025|NCT04028739|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083026|NCT04028505|Terlipressin|terlipressin|mesh-list
92083027|NCT04028505|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92016540|NCT04977661|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92016541|NCT04977661|Vasodilator Agents|vasodilator agents|mesh-ancestor
92016542|NCT04977661|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92016543|NCT04977661|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92083028|NCT04028505|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92083029|NCT04190745|Paclitaxel|paclitaxel|mesh-list
92083030|NCT04190745|Apatinib|apatinib|mesh-list
92083031|NCT04190745|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92083032|NCT04190745|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083033|NCT04190745|Tubulin Modulators|tubulin modulators|mesh-ancestor
92083034|NCT04190745|Antimitotic Agents|antimitotic agents|mesh-ancestor
92083035|NCT04190745|Mitosis Modulators|mitosis modulators|mesh-ancestor
92083036|NCT04190745|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083037|NCT04190745|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92083038|NCT04190745|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083039|NCT04028349|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92083040|NCT04028349|Antiviral Agents|antiviral agents|mesh-ancestor
92083041|NCT04028349|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083042|NCT04198623|Montelukast|montelukast|mesh-list
92083043|NCT04198623|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92083044|NCT04198623|Respiratory System Agents|respiratory system agents|mesh-ancestor
92083045|NCT04198623|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92083046|NCT04198623|Hormone Antagonists|hormone antagonists|mesh-ancestor
92083054|NCT01873729|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92083055|NCT01873729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083056|NCT01873729|Sensory System Agents|sensory system agents|mesh-ancestor
92083057|NCT01873729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083058|NCT01873495|Homoharringtonine|homoharringtonine|mesh-list
92083059|NCT01873495|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92083060|NCT01873495|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083061|NCT01873495|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92083062|NCT01873495|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083063|NCT01873495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083064|NCT04027959|Vitamin B 12|vitamin b 12|mesh-list
92083065|NCT04027959|Hydroxocobalamin|hydroxocobalamin|mesh-list
92083066|NCT04027959|Vitamins|vitamins|mesh-ancestor
92083067|NCT04027959|Micronutrients|micronutrients|mesh-ancestor
92083068|NCT04027959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083069|NCT04027959|Vitamin B Complex|vitamin b complex|mesh-ancestor
92083070|NCT04027959|Hematinics|hematinics|mesh-ancestor
92083071|NCT04344951|Chloroquine|chloroquine|mesh-list
92083072|NCT04344951|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92083073|NCT04344951|Amebicides|amebicides|mesh-ancestor
92083074|NCT04344951|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92083075|NCT04344951|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92083076|NCT04344951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083077|NCT04344951|Antimalarials|antimalarials|mesh-ancestor
92083078|NCT04344951|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083079|NCT04344951|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92083080|NCT04344951|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083081|NCT04344951|Analgesics|analgesics|mesh-ancestor
92083082|NCT04344951|Sensory System Agents|sensory system agents|mesh-ancestor
92083083|NCT04344951|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083084|NCT04344951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083085|NCT04344951|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083086|NCT04344951|Filaricides|filaricides|mesh-ancestor
92083087|NCT04344951|Antinematodal Agents|antinematodal agents|mesh-ancestor
92083088|NCT04344951|Anthelmintics|anthelmintics|mesh-ancestor
92083090|NCT01822561|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92083091|NCT01822561|Hormone Antagonists|hormone antagonists|mesh-ancestor
92083092|NCT01822561|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083093|NCT01822561|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083094|NCT01822561|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92083095|NCT01822561|Diuretics|diuretics|mesh-ancestor
92083096|NCT01822561|Natriuretic Agents|natriuretic agents|mesh-ancestor
92083097|NCT01822561|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92083098|NCT02080455|Atorvastatin|atorvastatin|mesh-list
92083099|NCT02080455|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92016545|NCT04977427|Prednisolone|prednisolone|mesh-list
92083100|NCT02080455|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92083101|NCT02080455|Antimetabolites|antimetabolites|mesh-ancestor
92083102|NCT02080455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083103|NCT02080455|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92083104|NCT02080455|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92083105|NCT02080455|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083106|NCT01852591|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92083107|NCT01852591|Immunologic Factors|immunologic factors|mesh-ancestor
92083108|NCT01852591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083109|NCT04021173|Fibrinolysin|fibrinolysin|mesh-list
92083110|NCT04021173|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92083111|NCT04021173|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92083114|NCT01852045|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92083116|NCT01852045|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92083117|NCT01852045|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083118|NCT01852045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083119|NCT01852045|Cholinergic Agents|cholinergic agents|mesh-ancestor
92083120|NCT01852045|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083121|NCT01852045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083122|NCT01852045|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92083123|NCT01852045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083124|NCT03960957|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92083125|NCT03960957|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92083126|NCT03960957|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92083127|NCT03960957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083128|NCT03960957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083129|NCT03960957|Cholinergic Agents|cholinergic agents|mesh-ancestor
92083130|NCT03960957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083131|NCT03960957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083132|NCT03960957|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92083133|NCT03960957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083134|NCT04027179|Chlorhexidine|chlorhexidine|mesh-list
92083135|NCT04027179|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92083136|NCT04027179|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92083137|NCT04027179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083138|NCT04027179|Disinfectants|disinfectants|mesh-ancestor
92083139|NCT04027179|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083141|NCT04199169|Immunologic Factors|immunologic factors|mesh-ancestor
92083142|NCT04199169|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083143|NCT03022929|Anti-Infective Agents|anti-infective agents|mesh-list
92083144|NCT03022929|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92083145|NCT01821391|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92083146|NCT01821391|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92083147|NCT01821391|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083148|NCT04020705|Cytidine Diphosphate Choline|cytidine diphosphate choline|mesh-list
92083149|NCT04020705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92083150|NCT04020705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92083151|NCT04020705|Nootropic Agents|nootropic agents|mesh-ancestor
92083152|NCT01873417|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92083153|NCT01873417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083154|NCT01873417|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083155|NCT01873417|Immunologic Factors|immunologic factors|mesh-ancestor
92083156|NCT01873417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083157|NCT03950427|Bupropion|bupropion|mesh-list
92083158|NCT03950427|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92083159|NCT03950427|Antidepressive Agents|antidepressive agents|mesh-ancestor
92083160|NCT03950427|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92083161|NCT03950427|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92083162|NCT03950427|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92083163|NCT03950427|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083164|NCT03950427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083165|NCT03950427|Dopamine Agents|dopamine agents|mesh-ancestor
92083166|NCT03950427|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083167|NCT03950427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083168|NCT03950427|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92083169|NCT03950427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92016546|NCT04977427|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92016547|NCT04977427|Methylprednisolone|methylprednisolone|mesh-list
92016548|NCT04977427|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92083170|NCT03950427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083171|NCT01872715|Doxycycline|doxycycline|mesh-list
92083172|NCT01872715|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083173|NCT01872715|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083174|NCT01872715|Antimalarials|antimalarials|mesh-ancestor
92083175|NCT01872715|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92083176|NCT01872715|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92083177|NCT01613599|Rituximab|rituximab|mesh-list
92083178|NCT01613599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92083179|NCT01613599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083180|NCT01613599|Immunologic Factors|immunologic factors|mesh-ancestor
92083181|NCT01613599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083182|NCT01613599|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083187|NCT03930771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083188|NCT03930771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083189|NCT03930771|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92083190|NCT03930771|Alkylating Agents|alkylating agents|mesh-ancestor
92083191|NCT04024683|Ropivacaine|ropivacaine|mesh-list
92083192|NCT04024683|Anesthetics, Local|anesthetics, local|mesh-ancestor
92083193|NCT04024683|Anesthetics|anesthetics|mesh-ancestor
92083194|NCT04024683|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083195|NCT04024683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083196|NCT04024683|Sensory System Agents|sensory system agents|mesh-ancestor
92083197|NCT04024683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083198|NCT04024527|Amoxicillin|amoxicillin|mesh-list
92083199|NCT04024527|Metronidazole|metronidazole|mesh-list
92083200|NCT04024527|Esomeprazole|esomeprazole|mesh-list
92083201|NCT04024527|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083202|NCT04024527|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083203|NCT04024527|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92083204|NCT04024527|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92083205|NCT04024527|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92083206|NCT04024527|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083207|NCT04024527|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92083208|NCT04024527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083209|NCT04024527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083210|NCT01819129|Insulin|insulin|mesh-list
92083211|NCT01819129|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92083212|NCT01819129|Insulin Glargine|insulin glargine|mesh-list
92083213|NCT01819129|Insulin Aspart|insulin aspart|mesh-list
92083214|NCT01819129|Insulin, Long-Acting|insulin, long-acting|mesh-list
92083215|NCT01819129|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92083216|NCT01819129|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92083217|NCT01819129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083219|NCT04025775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92083220|NCT04025775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083221|NCT04022811|Tobramycin|tobramycin|mesh-list
92083222|NCT04022811|Dexamethasone|dexamethasone|mesh-list
92083223|NCT04022811|Bromfenac|bromfenac|mesh-list
92083224|NCT04022811|Hyaluronic Acid|hyaluronic acid|mesh-list
92083225|NCT04022811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083226|NCT04022811|Antiemetics|antiemetics|mesh-ancestor
92083227|NCT04022811|Autonomic Agents|autonomic agents|mesh-ancestor
92083228|NCT04022811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083229|NCT04022811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083230|NCT04022811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083231|NCT04022811|Glucocorticoids|glucocorticoids|mesh-ancestor
92083232|NCT04022811|Hormones|hormones|mesh-ancestor
92083233|NCT04022811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083234|NCT04022811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92083235|NCT04022811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083236|NCT04022811|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083237|NCT04022811|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083238|NCT04022811|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92083239|NCT04022811|Immunologic Factors|immunologic factors|mesh-ancestor
92083240|NCT04022811|Viscosupplements|viscosupplements|mesh-ancestor
92083241|NCT04022811|Protective Agents|protective agents|mesh-ancestor
92083242|NCT04022811|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92083243|NCT04022811|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083244|NCT04022811|Analgesics|analgesics|mesh-ancestor
92083245|NCT04022811|Sensory System Agents|sensory system agents|mesh-ancestor
92016549|NCT04977427|Prednisolone acetate|prednisolone acetate|mesh-list
92016550|NCT04977427|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92016551|NCT04977427|Prednisolone phosphate|prednisolone phosphate|mesh-list
92083246|NCT04022811|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083247|NCT04145583|Voriconazole|voriconazole|mesh-list
92083248|NCT04145583|Antifungal Agents|antifungal agents|mesh-ancestor
92083249|NCT04145583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083250|NCT04145583|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92083251|NCT04145583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92083252|NCT04145583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083253|NCT04145583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083254|NCT04145583|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92083255|NCT04145583|Hormone Antagonists|hormone antagonists|mesh-ancestor
92083272|NCT04145193|Antimetabolites|antimetabolites|mesh-ancestor
92083273|NCT04145193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083274|NCT04145193|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083275|NCT04145193|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083276|NCT04145193|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083277|NCT04145193|Immunologic Factors|immunologic factors|mesh-ancestor
92083278|NCT04145193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083279|NCT04145193|Antidotes|antidotes|mesh-ancestor
92083280|NCT04145193|Protective Agents|protective agents|mesh-ancestor
92083281|NCT04145193|Vitamin B Complex|vitamin b complex|mesh-ancestor
92083282|NCT04145193|Vitamins|vitamins|mesh-ancestor
92083283|NCT04145193|Micronutrients|micronutrients|mesh-ancestor
92083284|NCT04145193|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92083285|NCT04147845|Triamcinolone|triamcinolone|mesh-list
92083286|NCT04147845|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92083287|NCT04147845|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92083288|NCT04147845|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92083289|NCT04147845|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083290|NCT04147845|Glucocorticoids|glucocorticoids|mesh-ancestor
92083291|NCT04147845|Hormones|hormones|mesh-ancestor
92083292|NCT04147845|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083293|NCT04147845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083294|NCT04147845|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083295|NCT04147845|Immunologic Factors|immunologic factors|mesh-ancestor
92083296|NCT04147845|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083297|NCT04147845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083298|NCT01849783|Thalidomide|thalidomide|mesh-list
92083299|NCT01849783|Dexamethasone|dexamethasone|mesh-list
92083300|NCT01849783|Cyclophosphamide|cyclophosphamide|mesh-list
92083301|NCT01849783|Melphalan|melphalan|mesh-list
92083302|NCT01849783|Doxorubicin|doxorubicin|mesh-list
92083303|NCT01849783|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92083304|NCT01849783|Etoposide|etoposide|mesh-list
92083305|NCT01849783|Etoposide phosphate|etoposide phosphate|mesh-list
92083306|NCT01849783|Bortezomib|bortezomib|mesh-list
92083307|NCT01849783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083308|NCT01849783|Immunologic Factors|immunologic factors|mesh-ancestor
92083309|NCT01849783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083310|NCT01849783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083311|NCT01849783|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92083312|NCT01849783|Alkylating Agents|alkylating agents|mesh-ancestor
92083313|NCT01849783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083314|NCT01849783|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083315|NCT01849783|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92083319|NCT01849783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083320|NCT01849783|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083321|NCT01849783|Glucocorticoids|glucocorticoids|mesh-ancestor
92083322|NCT01849783|Hormones|hormones|mesh-ancestor
92083323|NCT01849783|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083324|NCT01849783|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92083325|NCT01849783|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92083326|NCT01849783|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92083327|NCT01849783|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92083328|NCT01849783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083329|NCT01849783|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92083330|NCT01849783|Leprostatic Agents|leprostatic agents|mesh-ancestor
92083331|NCT01849783|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016552|NCT04977427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016553|NCT04977427|Glucocorticoids|glucocorticoids|mesh-ancestor
92016555|NCT04977427|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083332|NCT01849783|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083333|NCT01849783|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92083334|NCT01849783|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92083335|NCT01849783|Growth Substances|growth substances|mesh-ancestor
92083336|NCT01849783|Growth Inhibitors|growth inhibitors|mesh-ancestor
92083337|NCT01611883|Ezetimibe|ezetimibe|mesh-list
92083338|NCT01611883|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92083339|NCT01611883|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92083340|NCT01611883|Antimetabolites|antimetabolites|mesh-ancestor
92083341|NCT01611883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083342|NCT01611883|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92083343|NCT04170517|Progesterone|progesterone|mesh-list
92083344|NCT04170517|Progestins|progestins|mesh-ancestor
92083345|NCT04170517|Hormones|hormones|mesh-ancestor
92083346|NCT04170517|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083347|NCT04170517|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083348|NCT01848457|Methotrexate|methotrexate|mesh-list
92083349|NCT01848457|Pantoprazole|pantoprazole|mesh-list
92083350|NCT01848457|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92083351|NCT01848457|Abortifacient Agents|abortifacient agents|mesh-ancestor
92083352|NCT01848457|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92083353|NCT01848457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083354|NCT01848457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083355|NCT01848457|Antimetabolites|antimetabolites|mesh-ancestor
92083356|NCT01848457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083357|NCT01848457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083358|NCT01848457|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083359|NCT01848457|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083360|NCT01848457|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92083361|NCT01848457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083362|NCT01848457|Immunologic Factors|immunologic factors|mesh-ancestor
92083363|NCT01848457|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083364|NCT01848457|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92083365|NCT01848457|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92083366|NCT01848457|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083367|NCT01848457|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92083368|NCT01870999|Aripiprazole|aripiprazole|mesh-list
92083369|NCT01870999|Antidepressive Agents|antidepressive agents|mesh-ancestor
92083370|NCT01870999|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92083371|NCT01870999|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92083372|NCT01870999|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92083373|NCT01870999|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083374|NCT01870999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083375|NCT01870999|Dopamine Agonists|dopamine agonists|mesh-ancestor
92083376|NCT01870999|Dopamine Agents|dopamine agents|mesh-ancestor
92083377|NCT01870999|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083378|NCT01870999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083379|NCT01870999|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92083380|NCT01870999|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92083381|NCT01870999|Serotonin Agents|serotonin agents|mesh-ancestor
92083382|NCT01870999|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92083383|NCT01870999|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92083384|NCT01870999|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92083385|NCT01870999|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92083389|NCT01870921|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92083390|NCT01870921|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92083391|NCT01870921|Purinergic Agents|purinergic agents|mesh-ancestor
92083392|NCT01870921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083393|NCT01870921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083394|NCT01870921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083395|NCT00526474|Vorapaxar|vorapaxar|mesh-list
92083396|NCT00526474|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92083397|NCT01848145|Ofatumumab|ofatumumab|mesh-list
92083398|NCT01848145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016556|NCT04977427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016557|NCT04977427|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016558|NCT04977427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016559|NCT04977427|Antiemetics|antiemetics|mesh-ancestor
92016560|NCT04977427|Autonomic Agents|autonomic agents|mesh-ancestor
92016561|NCT04977427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016562|NCT04977427|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083399|NCT00527644|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92083400|NCT00527644|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92083401|NCT00527644|beta-Endorphin|beta-endorphin|mesh-list
92083402|NCT00527644|Hormones|hormones|mesh-ancestor
92083403|NCT00527644|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083404|NCT00527644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083405|NCT00527644|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083406|NCT00527644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083407|NCT01847443|Nicotine|nicotine|mesh-list
92083408|NCT01847443|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92083409|NCT01847443|Autonomic Agents|autonomic agents|mesh-ancestor
92083410|NCT01847443|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083411|NCT01847443|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083412|NCT01847443|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92083413|NCT01847443|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92083414|NCT01847443|Cholinergic Agents|cholinergic agents|mesh-ancestor
92083415|NCT01847443|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083416|NCT01847443|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083417|NCT00527878|Ranitidine|ranitidine|mesh-list
92083418|NCT00527878|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92083419|NCT00527878|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92083420|NCT00527878|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083421|NCT00527878|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92083422|NCT00527878|Histamine Antagonists|histamine antagonists|mesh-ancestor
92083423|NCT00527878|Histamine Agents|histamine agents|mesh-ancestor
92083424|NCT00527878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083425|NCT00527878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083426|NCT00527878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083427|NCT05558878|Ambroxol|ambroxol|mesh-list
92083428|NCT05558878|Expectorants|expectorants|mesh-ancestor
92083429|NCT05558878|Respiratory System Agents|respiratory system agents|mesh-ancestor
92083430|NCT05621434|Maleic acid|maleic acid|mesh-list
92083431|NCT05621434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083432|NCT05621434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083433|NCT01870843|Escitalopram|escitalopram|mesh-list
92083434|NCT01870843|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92083435|NCT01870843|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92083436|NCT01870843|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083437|NCT01870843|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083438|NCT01870843|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083439|NCT01870843|Serotonin Agents|serotonin agents|mesh-ancestor
92083440|NCT01870843|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083441|NCT01816477|Ropivacaine|ropivacaine|mesh-list
92083442|NCT01816477|Anesthetics, Local|anesthetics, local|mesh-ancestor
92083443|NCT01816477|Anesthetics|anesthetics|mesh-ancestor
92083444|NCT01816477|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083445|NCT01816477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083446|NCT01816477|Sensory System Agents|sensory system agents|mesh-ancestor
92083447|NCT01816477|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083448|NCT01846507|Tranexamic Acid|tranexamic acid|mesh-list
92083449|NCT01846507|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92083450|NCT01846507|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92083451|NCT01846507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083452|NCT01846507|Hemostatics|hemostatics|mesh-ancestor
92083453|NCT01846507|Coagulants|coagulants|mesh-ancestor
92083454|NCT01846039|Hyaluronic Acid|hyaluronic acid|mesh-list
92083455|NCT01846039|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92083456|NCT01846039|Immunologic Factors|immunologic factors|mesh-ancestor
92083457|NCT01846039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083461|NCT01610167|Fluorides|fluorides|mesh-list
92016564|NCT04977427|Protective Agents|protective agents|mesh-ancestor
92016565|NCT03327805|Choline|choline|mesh-list
92016566|NCT03327805|Lipotropic Agents|lipotropic agents|mesh-ancestor
92016567|NCT03327805|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92016568|NCT03327805|Antimetabolites|antimetabolites|mesh-ancestor
92083462|NCT01610167|Sodium Fluoride|sodium fluoride|mesh-list
92083463|NCT01610167|Cariostatic Agents|cariostatic agents|mesh-ancestor
92083464|NCT01610167|Protective Agents|protective agents|mesh-ancestor
92083465|NCT01610167|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083466|NCT01610167|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92083467|NCT01610167|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083468|NCT04478500|Minocycline|minocycline|mesh-list
92083469|NCT04478500|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083470|NCT04478500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083471|NCT01816243|Fentanyl|fentanyl|mesh-list
92083472|NCT01816243|Morphine|morphine|mesh-list
92083473|NCT01816243|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92083474|NCT01816243|Narcotics|narcotics|mesh-ancestor
92083475|NCT01816243|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083476|NCT01816243|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083477|NCT01816243|Analgesics|analgesics|mesh-ancestor
92083478|NCT01816243|Sensory System Agents|sensory system agents|mesh-ancestor
92083479|NCT01816243|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083480|NCT01816243|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92083481|NCT01816243|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92083482|NCT01816243|Anesthetics, General|anesthetics, general|mesh-ancestor
92083483|NCT01816243|Anesthetics|anesthetics|mesh-ancestor
92083484|NCT05576896|Hydroxychloroquine|hydroxychloroquine|mesh-list
92083485|NCT05576896|Cetuximab|cetuximab|mesh-list
92083486|NCT05576896|Panitumumab|panitumumab|mesh-list
92083487|NCT05576896|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92083488|NCT05576896|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083489|NCT05576896|Antimalarials|antimalarials|mesh-ancestor
92083490|NCT05576896|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92083491|NCT05576896|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92083492|NCT05576896|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083493|NCT05576896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083494|NCT05576896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083495|NCT05576896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083496|NCT01845805|Azacitidine|azacitidine|mesh-list
92083497|NCT01845805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083498|NCT01845805|Antimetabolites|antimetabolites|mesh-ancestor
92083499|NCT01845805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083500|NCT01845805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083501|NCT01845805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083502|NCT05575804|Capecitabine|capecitabine|mesh-list
92083503|NCT05575804|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083504|NCT05575804|Antimetabolites|antimetabolites|mesh-ancestor
92083505|NCT05575804|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083506|NCT05575804|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083507|NCT01845025|Fluticasone|fluticasone|mesh-list
92083509|NCT01845025|Formoterol Fumarate|formoterol fumarate|mesh-list
92083510|NCT01845025|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083511|NCT01845025|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92083512|NCT01845025|Autonomic Agents|autonomic agents|mesh-ancestor
92083593|NCT04616248|Protective Agents|protective agents|mesh-ancestor
92083513|NCT01845025|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083514|NCT01845025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083515|NCT01845025|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92083516|NCT01845025|Respiratory System Agents|respiratory system agents|mesh-ancestor
92083517|NCT01845025|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083518|NCT01845025|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92083519|NCT01845025|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92083520|NCT01845025|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92083521|NCT01845025|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92083522|NCT01845025|Adrenergic Agents|adrenergic agents|mesh-ancestor
92083523|NCT01845025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083524|NCT01845025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083525|NCT04148872|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92016569|NCT03327805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016570|NCT03327805|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083527|NCT04148872|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083528|NCT04148872|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083529|NCT04148872|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92083530|NCT04148872|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083531|NCT04148872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083536|NCT05072236|Anesthetics|anesthetics|mesh-ancestor
92083537|NCT05072236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083538|NCT05072236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083539|NCT05072236|Sensory System Agents|sensory system agents|mesh-ancestor
92083540|NCT05072236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083541|NCT05072236|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92083542|NCT05072236|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92083543|NCT05072236|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92083544|NCT05072236|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083545|NCT05072236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083547|NCT04847440|Antiviral Agents|antiviral agents|mesh-ancestor
92083548|NCT04847440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083549|NCT04847440|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92083550|NCT04847440|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92083551|NCT04847440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083552|NCT04847440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083553|NCT04847440|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92083554|NCT04847440|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92083559|NCT03519412|Pembrolizumab|pembrolizumab|mesh-list
92083560|NCT03519412|Temozolomide|temozolomide|mesh-list
92083561|NCT03519412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92083562|NCT03519412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083563|NCT03519412|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92083564|NCT03519412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083565|NCT03519412|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92083566|NCT03519412|Alkylating Agents|alkylating agents|mesh-ancestor
92083567|NCT01870297|Liraglutide|liraglutide|mesh-list
92083568|NCT01870297|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92083569|NCT01870297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083570|NCT01870297|Incretins|incretins|mesh-ancestor
92083571|NCT01870297|Hormones|hormones|mesh-ancestor
92083572|NCT01870297|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083573|NCT01814761|Bimatoprost|bimatoprost|mesh-list
92083574|NCT01814761|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92083575|NCT04616248|Poly I-C|poly i-c|mesh-list
92083576|NCT04616248|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92083577|NCT04616248|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92083578|NCT04616248|Antibodies|antibodies|mesh-list
92083579|NCT04616248|Immunoglobulins|immunoglobulins|mesh-list
92083580|NCT04616248|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92083581|NCT04616248|Poly ICLC|poly iclc|mesh-list
92083582|NCT04616248|Flt3 ligand protein|flt3 ligand protein|mesh-list
92083583|NCT04616248|Immunologic Factors|immunologic factors|mesh-ancestor
92083584|NCT04616248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083585|NCT04616248|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083586|NCT04616248|Interferon Inducers|interferon inducers|mesh-ancestor
92083587|NCT04616248|Laxatives|laxatives|mesh-ancestor
92083588|NCT04616248|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083589|NCT04616248|Antiviral Agents|antiviral agents|mesh-ancestor
92083590|NCT04616248|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083591|NCT04616248|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92083592|NCT04616248|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92083595|NCT01798030|Vitamins|vitamins|mesh-ancestor
92083596|NCT01798030|Micronutrients|micronutrients|mesh-ancestor
92083597|NCT01798030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083598|NCT01798030|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92083599|NCT03329950|Pembrolizumab|pembrolizumab|mesh-list
92083600|NCT03329950|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016571|NCT03327805|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92083601|NCT03329950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083602|NCT03329950|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92083603|NCT03329950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083605|NCT01814371|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083606|NCT01814371|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083607|NCT01814371|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92083609|NCT01814371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083610|NCT03232138|Sulforaphane|sulforaphane|mesh-list
92083611|NCT03232138|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92083612|NCT03232138|Protective Agents|protective agents|mesh-ancestor
92083613|NCT03232138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083614|NCT03232138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083615|NCT01814137|Insulin|insulin|mesh-list
92083616|NCT01814137|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92083617|NCT01814137|Insulin Aspart|insulin aspart|mesh-list
92083618|NCT01814137|Insulin, Long-Acting|insulin, long-acting|mesh-list
92083619|NCT01814137|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92083620|NCT01814137|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92083621|NCT01814137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083622|NCT01813435|Aspirin|aspirin|mesh-list
92083623|NCT01813435|Clopidogrel|clopidogrel|mesh-list
92083624|NCT01813435|Ticagrelor|ticagrelor|mesh-list
92083625|NCT01813435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92083626|NCT01813435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083627|NCT01813435|Analgesics|analgesics|mesh-ancestor
92083628|NCT01813435|Sensory System Agents|sensory system agents|mesh-ancestor
92083629|NCT01813435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083630|NCT01813435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083631|NCT01813435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083632|NCT01813435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083633|NCT01813435|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92083634|NCT01813435|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92083635|NCT01813435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083636|NCT01813435|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92083637|NCT01813435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92083638|NCT01813435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083639|NCT01813435|Antipyretics|antipyretics|mesh-ancestor
92083640|NCT01813435|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92083641|NCT01813435|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92083642|NCT01813435|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92083643|NCT01813435|Purinergic Agents|purinergic agents|mesh-ancestor
92083644|NCT01813435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083645|NCT01798498|Hyaluronic Acid|hyaluronic acid|mesh-list
92083646|NCT01798498|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92083647|NCT01798498|Immunologic Factors|immunologic factors|mesh-ancestor
92083648|NCT01798498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083649|NCT01798498|Viscosupplements|viscosupplements|mesh-ancestor
92083650|NCT01798498|Protective Agents|protective agents|mesh-ancestor
92083651|NCT01813357|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92083652|NCT01813357|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92083653|NCT01813357|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92083654|NCT01813357|Antimetabolites|antimetabolites|mesh-ancestor
92083655|NCT01813357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083656|NCT01813357|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92083657|NCT01813357|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92083658|NCT01813357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083659|NCT02346526|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92083660|NCT02346526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083661|NCT03944902|Niraparib|niraparib|mesh-list
92083662|NCT03944902|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92083663|NCT03944902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083664|NCT03944902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083665|NCT03944902|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083666|NCT01811953|Metformin|metformin|mesh-list
92083667|NCT01811953|Empagliflozin|empagliflozin|mesh-list
92083668|NCT01811953|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92083669|NCT01811953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083670|NCT01811953|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92016572|NCT03327805|Nootropic Agents|nootropic agents|mesh-ancestor
92016574|NCT04261855|Lutetium Lu 177 dotatate|lutetium lu 177 dotatate|mesh-list
92016575|NCT04261855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016576|NCT04261855|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016577|NCT04261855|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92016578|NCT04261855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016579|NCT04224415|Irinotecan|irinotecan|mesh-list
92016580|NCT04224415|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92016581|NCT04224415|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92016582|NCT04224415|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083671|NCT01811953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083672|NCT03895762|Fentanyl|fentanyl|mesh-list
92083673|NCT03895762|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92083674|NCT03895762|Narcotics|narcotics|mesh-ancestor
92083675|NCT03895762|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083676|NCT03895762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083677|NCT03895762|Analgesics|analgesics|mesh-ancestor
92083678|NCT03895762|Sensory System Agents|sensory system agents|mesh-ancestor
92083679|NCT03895762|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083680|NCT03895762|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92083682|NCT03895762|Anesthetics, General|anesthetics, general|mesh-ancestor
92083683|NCT03895762|Anesthetics|anesthetics|mesh-ancestor
92083684|NCT01033552|Cyclosporine|cyclosporine|mesh-list
92083685|NCT01033552|Mycophenolic Acid|mycophenolic acid|mesh-list
92083686|NCT01033552|Cyclophosphamide|cyclophosphamide|mesh-list
92083687|NCT01033552|Fludarabine|fludarabine|mesh-list
92083688|NCT01033552|Cyclosporins|cyclosporins|mesh-list
92083689|NCT01033552|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92083690|NCT01033552|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083691|NCT01033552|Immunologic Factors|immunologic factors|mesh-ancestor
92083692|NCT01033552|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083693|NCT01033552|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083694|NCT01033552|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92083695|NCT01033552|Alkylating Agents|alkylating agents|mesh-ancestor
92083696|NCT01033552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083697|NCT01033552|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083698|NCT01033552|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92083699|NCT01033552|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083700|NCT01033552|Antifungal Agents|antifungal agents|mesh-ancestor
92083701|NCT01033552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083702|NCT01033552|Dermatologic Agents|dermatologic agents|mesh-ancestor
92083703|NCT01033552|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92083704|NCT01033552|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92083705|NCT01033552|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92083706|NCT01033552|Antitubercular Agents|antitubercular agents|mesh-ancestor
92083707|NCT01033552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083708|NCT00997906|Paclitaxel|paclitaxel|mesh-list
92083709|NCT00997906|Carboplatin|carboplatin|mesh-list
92083710|NCT00997906|Gemcitabine|gemcitabine|mesh-list
92083711|NCT00997906|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92083712|NCT00997906|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083713|NCT00997906|Tubulin Modulators|tubulin modulators|mesh-ancestor
92083714|NCT00997906|Antimitotic Agents|antimitotic agents|mesh-ancestor
92083715|NCT00997906|Mitosis Modulators|mitosis modulators|mesh-ancestor
92083716|NCT00997906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083717|NCT00997906|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083718|NCT00997906|Antimetabolites|antimetabolites|mesh-ancestor
92083719|NCT05246644|Acetaminophen|acetaminophen|mesh-list
92083720|NCT05246644|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083721|NCT05246644|Analgesics|analgesics|mesh-ancestor
92083722|NCT05246644|Sensory System Agents|sensory system agents|mesh-ancestor
92083723|NCT05246644|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083724|NCT05246644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083725|NCT05246644|Antipyretics|antipyretics|mesh-ancestor
92083726|NCT01798576|Interferons|interferons|mesh-list
92083727|NCT01798576|Ribavirin|ribavirin|mesh-list
92083728|NCT01798576|Interferon-alpha|interferon-alpha|mesh-list
92083729|NCT01798576|Interferon alpha-2|interferon alpha-2|mesh-list
92083730|NCT01798576|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92083731|NCT01798576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083732|NCT01798576|Antiviral Agents|antiviral agents|mesh-ancestor
92083733|NCT01798576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083734|NCT01798576|Antimetabolites|antimetabolites|mesh-ancestor
92083735|NCT01798576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083736|NCT01798576|Immunologic Factors|immunologic factors|mesh-ancestor
92083737|NCT01798576|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083738|NCT00565084|Ibuprofen|ibuprofen|mesh-list
92083739|NCT00565084|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92083740|NCT00565084|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083741|NCT00565084|Analgesics|analgesics|mesh-ancestor
92083742|NCT00565084|Sensory System Agents|sensory system agents|mesh-ancestor
92083743|NCT00565084|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083744|NCT00565084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083745|NCT00565084|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083746|NCT00565084|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083747|NCT00565084|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92083748|NCT00565084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083749|NCT00565084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083750|NCT01810783|Brexpiprazole|brexpiprazole|mesh-list
92083751|NCT01810783|Serotonin Agents|serotonin agents|mesh-ancestor
92083752|NCT01810783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083753|NCT01810783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083754|NCT01810783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083755|NCT01810783|Dopamine Agonists|dopamine agonists|mesh-ancestor
92083758|NCT01807117|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92083759|NCT01807117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083761|NCT01613131|Estrogens|estrogens|mesh-ancestor
92083762|NCT01613131|Hormones|hormones|mesh-ancestor
92083763|NCT01613131|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083764|NCT01613131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083765|NCT05362942|Cytarabine|cytarabine|mesh-list
92083766|NCT05362942|Azacitidine|azacitidine|mesh-list
92083767|NCT05362942|Decitabine|decitabine|mesh-list
92083768|NCT05362942|Venetoclax|venetoclax|mesh-list
92083769|NCT05362942|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083770|NCT05362942|Antimetabolites|antimetabolites|mesh-ancestor
92083771|NCT05362942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083772|NCT05362942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083773|NCT05362942|Antiviral Agents|antiviral agents|mesh-ancestor
92083774|NCT05362942|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083775|NCT05362942|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083776|NCT05362942|Immunologic Factors|immunologic factors|mesh-ancestor
92083777|NCT05362942|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083778|NCT05362942|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083779|NCT01868893|Obinutuzumab|obinutuzumab|mesh-list
92083780|NCT01868893|Chlorambucil|chlorambucil|mesh-list
92083781|NCT01868893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92083782|NCT01868893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083783|NCT01868893|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92083784|NCT01868893|Alkylating Agents|alkylating agents|mesh-ancestor
92083785|NCT01868893|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083786|NCT01868503|Lapatinib|lapatinib|mesh-list
92083787|NCT01868503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083788|NCT01868503|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92083789|NCT01868503|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083790|NCT01868503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083791|NCT05204368|Meropenem|meropenem|mesh-list
92083792|NCT05204368|Imipenem|imipenem|mesh-list
92083793|NCT05204368|Cilastatin|cilastatin|mesh-list
92083794|NCT05204368|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083795|NCT05204368|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083796|NCT05204368|Protease Inhibitors|protease inhibitors|mesh-ancestor
92083797|NCT05204368|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083798|NCT05204368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083799|NCT01868035|Tositumomab I-131|tositumomab i-131|mesh-list
92083800|NCT01868035|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083801|NCT04414969|Asparaginase|asparaginase|mesh-list
92083802|NCT04414969|Pegaspargase|pegaspargase|mesh-list
92083803|NCT04414969|Antibodies|antibodies|mesh-list
92083804|NCT04414969|Immunoglobulins|immunoglobulins|mesh-list
92083805|NCT04414969|Immunologic Factors|immunologic factors|mesh-ancestor
92016583|NCT04224415|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016584|NCT04224415|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016586|NCT03239899|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92083806|NCT04414969|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083807|NCT04414969|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083808|NCT01609933|Interferons|interferons|mesh-list
92083809|NCT01609933|Ritonavir|ritonavir|mesh-list
92083810|NCT01609933|Ribavirin|ribavirin|mesh-list
92083811|NCT01609933|Interferon-alpha|interferon-alpha|mesh-list
92083812|NCT01609933|Interferon alpha-2|interferon alpha-2|mesh-list
92083813|NCT01609933|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92083814|NCT01609933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083815|NCT01609933|Antiviral Agents|antiviral agents|mesh-ancestor
92083816|NCT01609933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083817|NCT01609933|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92083818|NCT01609933|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92083819|NCT01609933|Protease Inhibitors|protease inhibitors|mesh-ancestor
92083820|NCT01609933|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083821|NCT01609933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083822|NCT01609933|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92083824|NCT01609933|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92083825|NCT01609933|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92083826|NCT01609933|Antimetabolites|antimetabolites|mesh-ancestor
92083827|NCT01609933|Immunologic Factors|immunologic factors|mesh-ancestor
92083828|NCT01609933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083829|NCT05361772|Colchicine|colchicine|mesh-list
92083830|NCT05361772|Gout Suppressants|gout suppressants|mesh-ancestor
92083831|NCT05361772|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083832|NCT05361772|Tubulin Modulators|tubulin modulators|mesh-ancestor
92083849|NCT02958514|Hormones|hormones|mesh-ancestor
92083850|NCT02958514|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083851|NCT02958514|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92083852|NCT02958514|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083853|NCT02958514|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083854|NCT02958514|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083855|NCT01867021|Vaccines|vaccines|mesh-list
92083856|NCT01867021|Immunologic Factors|immunologic factors|mesh-ancestor
92083857|NCT01867021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083858|NCT01866709|Polystyrene sulfonic acid|polystyrene sulfonic acid|mesh-list
92083859|NCT01866709|Chelating Agents|chelating agents|mesh-ancestor
92083860|NCT01866709|Sequestering Agents|sequestering agents|mesh-ancestor
92083861|NCT01866709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083862|NCT01841593|Raltegravir Potassium|raltegravir potassium|mesh-list
92083863|NCT01841593|Amlodipine|amlodipine|mesh-list
92083864|NCT01841593|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92083865|NCT01841593|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92083866|NCT01841593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083867|NCT01841593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083868|NCT01841593|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92083869|NCT01841593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083870|NCT01841593|Vasodilator Agents|vasodilator agents|mesh-ancestor
92083871|NCT01841593|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92083872|NCT01841593|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92083873|NCT01841593|Antiviral Agents|antiviral agents|mesh-ancestor
92083874|NCT01841593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083875|NCT01841593|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92083876|NCT01841593|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92083877|NCT01841593|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083887|NCT02454322|Magnesium Sulfate|magnesium sulfate|mesh-list
92083888|NCT02454322|Analgesics|analgesics|mesh-ancestor
92083889|NCT02454322|Sensory System Agents|sensory system agents|mesh-ancestor
92083890|NCT02454322|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083891|NCT02454322|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083892|NCT02454322|Anesthetics|anesthetics|mesh-ancestor
92083893|NCT02454322|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92083894|NCT02454322|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92083895|NCT02454322|Anticonvulsants|anticonvulsants|mesh-ancestor
92083896|NCT02454322|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92083897|NCT02454322|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016587|NCT03239899|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016588|NCT03239899|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92016589|NCT03239899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016591|NCT03061981|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92083898|NCT02454322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083899|NCT02454322|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92083901|NCT02454322|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92083905|NCT04505566|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92083906|NCT04505566|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92083907|NCT04505566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92083908|NCT04505566|Analgesics|analgesics|mesh-ancestor
92083909|NCT04505566|Sensory System Agents|sensory system agents|mesh-ancestor
92083910|NCT04505566|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083911|NCT04505566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083912|NCT04505566|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083913|NCT04505566|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083914|NCT04505566|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92083915|NCT04505566|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083916|NCT04505566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083918|NCT05076292|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083919|NCT05076292|Hormones|hormones|mesh-ancestor
92083920|NCT05076292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083921|NCT05076292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083922|NCT04789330|Phenylephrine|phenylephrine|mesh-list
92083923|NCT04789330|Oxymetazoline|oxymetazoline|mesh-list
92083924|NCT04789330|Norepinephrine|norepinephrine|mesh-list
92083925|NCT04789330|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92083926|NCT04789330|Mydriatics|mydriatics|mesh-ancestor
92083927|NCT04789330|Autonomic Agents|autonomic agents|mesh-ancestor
92083928|NCT04789330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083929|NCT04789330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083930|NCT04789330|Sympathomimetics|sympathomimetics|mesh-ancestor
92083931|NCT04789330|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92083932|NCT04789330|Nasal Decongestants|nasal decongestants|mesh-ancestor
92083933|NCT04789330|Respiratory System Agents|respiratory system agents|mesh-ancestor
92083934|NCT04789330|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92083935|NCT04789330|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92083936|NCT04789330|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92083937|NCT04789330|Adrenergic Agents|adrenergic agents|mesh-ancestor
92083938|NCT04789330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083939|NCT04789330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083940|NCT04789330|Protective Agents|protective agents|mesh-ancestor
92083941|NCT02339038|Sofosbuvir|sofosbuvir|mesh-list
92083942|NCT02339038|Ledipasvir|ledipasvir|mesh-list
92083943|NCT02339038|Antiviral Agents|antiviral agents|mesh-ancestor
92083944|NCT02339038|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083945|NCT04497298|Vaccines|vaccines|mesh-list
92083946|NCT04497298|Immunologic Factors|immunologic factors|mesh-ancestor
92083947|NCT04497298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083948|NCT04387786|Albuterol|albuterol|mesh-list
92083949|NCT04387786|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92083950|NCT04387786|Autonomic Agents|autonomic agents|mesh-ancestor
92083951|NCT04387786|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083952|NCT04387786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083953|NCT04387786|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92083954|NCT04387786|Respiratory System Agents|respiratory system agents|mesh-ancestor
92083955|NCT04387786|Tocolytic Agents|tocolytic agents|mesh-ancestor
92083956|NCT04387786|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92083957|NCT04387786|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92083958|NCT04387786|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92083959|NCT04387786|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92083960|NCT04387786|Adrenergic Agents|adrenergic agents|mesh-ancestor
92083961|NCT04387786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083962|NCT04387786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083963|NCT00569530|Calfactant|calfactant|mesh-list
92083964|NCT00569530|Pulmonary Surfactants|pulmonary surfactants|mesh-ancestor
92016592|NCT03061981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016594|NCT02510001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016595|NCT02510001|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92016596|NCT02510001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016597|NCT02510001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016598|NCT02452047|Imipenem|imipenem|mesh-list
92016599|NCT02452047|Relebactam|relebactam|mesh-list
92016600|NCT02452047|Cilastatin, Imipenem Drug Combination|cilastatin, imipenem drug combination|mesh-list
92016601|NCT02452047|Cilastatin|cilastatin|mesh-list
92016602|NCT02452047|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016603|NCT02452047|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016604|NCT02452047|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016605|NCT02452047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016606|NCT02452047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016607|NCT02452047|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92016608|NCT04925505|Anesthetics|anesthetics|mesh-list
92016609|NCT04925505|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016610|NCT04925505|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016611|NCT02475369|Pancrelipase|pancrelipase|mesh-list
92016612|NCT02475369|Pancreatin|pancreatin|mesh-list
92016613|NCT02475369|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016614|NCT02474589|Tecovirimat|tecovirimat|mesh-list
92016615|NCT02474589|Antiviral Agents|antiviral agents|mesh-ancestor
92016616|NCT02474589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016617|NCT03862157|Azacitidine|azacitidine|mesh-list
92016618|NCT03862157|Venetoclax|venetoclax|mesh-list
92016619|NCT03862157|Enzyme Inhibitors|enzyme inhibitors|mesh-list
92016620|NCT03862157|Pevonedistat|pevonedistat|mesh-list
92016621|NCT03862157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016622|NCT03862157|Antimetabolites|antimetabolites|mesh-ancestor
92016623|NCT03862157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016624|NCT03862157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016625|NCT02474355|Osimertinib|osimertinib|mesh-list
92016626|NCT02474355|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016627|NCT02474355|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92016628|NCT02474355|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083965|NCT00569530|Respiratory System Agents|respiratory system agents|mesh-ancestor
92083966|NCT04509622|Cytarabine|cytarabine|mesh-list
92083967|NCT04509622|Venetoclax|venetoclax|mesh-list
92016629|NCT02474355|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016631|NCT02474199|Diphenhydramine|diphenhydramine|mesh-list
92016632|NCT02474199|Promethazine|promethazine|mesh-list
92016633|NCT02474199|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016634|NCT02474199|Analgesics|analgesics|mesh-ancestor
92016635|NCT02474199|Sensory System Agents|sensory system agents|mesh-ancestor
92016636|NCT02474199|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016637|NCT02474199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083968|NCT04509622|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083969|NCT04509622|Antimetabolites|antimetabolites|mesh-ancestor
92083970|NCT04509622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083971|NCT04509622|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083972|NCT04509622|Antiviral Agents|antiviral agents|mesh-ancestor
92083973|NCT04509622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083976|NCT04509622|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083978|NCT00570700|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083979|NCT00570700|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92083980|NCT00570700|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083981|NCT00570700|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083982|NCT00573508|Solifenacin Succinate|solifenacin succinate|mesh-list
92083983|NCT00573508|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92083984|NCT00573508|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92083985|NCT00573508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92083986|NCT00573508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083987|NCT00573508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083988|NCT00573508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083989|NCT00573508|Urological Agents|urological agents|mesh-ancestor
92083990|NCT00574834|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92083991|NCT00574834|Ramipril|ramipril|mesh-list
92083992|NCT00574834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92083993|NCT00574834|Diuretics|diuretics|mesh-ancestor
92083994|NCT00574834|Natriuretic Agents|natriuretic agents|mesh-ancestor
92083995|NCT00574834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083996|NCT00574834|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92083997|NCT00574834|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92083998|NCT00574834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083999|NCT00574834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92084000|NCT00574834|Protease Inhibitors|protease inhibitors|mesh-ancestor
92084001|NCT00574834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084002|NCT04259398|Propofol|propofol|mesh-list
92084003|NCT04259398|Sevoflurane|sevoflurane|mesh-list
92084004|NCT04259398|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92084005|NCT04259398|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084006|NCT04259398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084007|NCT04259398|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92084008|NCT04259398|Anesthetics, General|anesthetics, general|mesh-ancestor
92084009|NCT04259398|Anesthetics|anesthetics|mesh-ancestor
92084010|NCT04259398|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92084011|NCT04259398|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92084012|NCT01592110|Risperidone|risperidone|mesh-list
92084013|NCT01592110|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92084014|NCT01592110|Serotonin Agents|serotonin agents|mesh-ancestor
92084015|NCT01592110|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084016|NCT01592110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084017|NCT01592110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084018|NCT01592110|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92084019|NCT01592110|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92084020|NCT01592110|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084021|NCT01592110|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084022|NCT01592110|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92084023|NCT01592110|Dopamine Agents|dopamine agents|mesh-ancestor
92084024|NCT00578734|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92016638|NCT02474199|Antipyretics|antipyretics|mesh-ancestor
92016639|NCT02474199|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92016640|NCT02474199|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92016641|NCT02474199|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016642|NCT02474199|Anesthetics, Local|anesthetics, local|mesh-ancestor
92016643|NCT02474199|Anesthetics|anesthetics|mesh-ancestor
92016644|NCT02474199|Antiemetics|antiemetics|mesh-ancestor
92016645|NCT02474199|Autonomic Agents|autonomic agents|mesh-ancestor
92016646|NCT02474199|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016647|NCT02474199|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92016648|NCT02474199|Histamine Antagonists|histamine antagonists|mesh-ancestor
92016649|NCT02474199|Histamine Agents|histamine agents|mesh-ancestor
92016650|NCT02474199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016651|NCT02474199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084025|NCT00578734|Respiratory System Agents|respiratory system agents|mesh-ancestor
92084026|NCT00578968|Tiotropium Bromide|tiotropium bromide|mesh-list
92084027|NCT00578968|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92084028|NCT00578968|Autonomic Agents|autonomic agents|mesh-ancestor
92084029|NCT00578968|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084030|NCT00578968|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084031|NCT00578968|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92084032|NCT00578968|Respiratory System Agents|respiratory system agents|mesh-ancestor
92084033|NCT00578968|Parasympatholytics|parasympatholytics|mesh-ancestor
92084034|NCT00578968|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92084035|NCT00578968|Cholinergic Agents|cholinergic agents|mesh-ancestor
92084036|NCT00578968|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084037|NCT00578968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084038|NCT00579280|Valproic Acid|valproic acid|mesh-list
92084039|NCT00579280|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92084040|NCT00579280|Antidepressive Agents|antidepressive agents|mesh-ancestor
92084041|NCT00579280|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084042|NCT00579280|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92084043|NCT00579280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92084044|NCT00579280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084048|NCT00579280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084049|NCT00579280|GABA Agents|gaba agents|mesh-ancestor
92084050|NCT00579280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084051|NCT00579280|Antimanic Agents|antimanic agents|mesh-ancestor
92084052|NCT00580294|Oxymorphone|oxymorphone|mesh-list
92084053|NCT00580294|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92084054|NCT00580294|Narcotics|narcotics|mesh-ancestor
92084055|NCT00580294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084056|NCT00580294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084057|NCT00580294|Analgesics|analgesics|mesh-ancestor
92084058|NCT00580294|Sensory System Agents|sensory system agents|mesh-ancestor
92084059|NCT00580294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084060|NCT00580294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92084061|NCT00580372|Cyclophosphamide|cyclophosphamide|mesh-list
92084062|NCT00580372|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084063|NCT00580372|Immunologic Factors|immunologic factors|mesh-ancestor
92084064|NCT00580372|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084065|NCT00580372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084066|NCT00580372|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92084067|NCT00580372|Alkylating Agents|alkylating agents|mesh-ancestor
92084068|NCT00580372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084069|NCT00580372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084070|NCT00580372|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92084071|NCT02134210|Etanercept|etanercept|mesh-list
92084072|NCT02134210|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92084073|NCT02134210|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016652|NCT02474199|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92016653|NCT02474199|Antipruritics|antipruritics|mesh-ancestor
92016654|NCT02474199|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016656|NCT02450487|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92016657|NCT02450487|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016658|NCT02450487|Analgesics|analgesics|mesh-ancestor
92016659|NCT02450487|Sensory System Agents|sensory system agents|mesh-ancestor
92016660|NCT02450487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016661|NCT02450487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016662|NCT02450487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016663|NCT02450487|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084074|NCT02134210|Analgesics|analgesics|mesh-ancestor
92084075|NCT02134210|Sensory System Agents|sensory system agents|mesh-ancestor
92084076|NCT02134210|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084077|NCT02134210|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084078|NCT02134210|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084079|NCT02134210|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084080|NCT02134210|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084081|NCT02134210|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084082|NCT02134210|Immunologic Factors|immunologic factors|mesh-ancestor
92084083|NCT00607594|Saracatinib|saracatinib|mesh-list
92084084|NCT00607594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084085|NCT00607594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084086|NCT00607594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084087|NCT01866319|Pembrolizumab|pembrolizumab|mesh-list
92084088|NCT01866319|Ipilimumab|ipilimumab|mesh-list
92084089|NCT01866319|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084090|NCT01866319|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084091|NCT01866319|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92084092|NCT01866319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084093|NCT00607672|Candesartan|candesartan|mesh-list
92084094|NCT00607672|Candesartan cilexetil|candesartan cilexetil|mesh-list
92084095|NCT00607672|Ramipril|ramipril|mesh-list
92084096|NCT00607672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92084097|NCT00607672|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92084098|NCT00607672|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92084099|NCT00607672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084100|NCT00607672|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92084101|NCT00607672|Protease Inhibitors|protease inhibitors|mesh-ancestor
92084102|NCT00607672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084103|NCT01802515|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92084104|NCT01802515|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92084105|NCT01802515|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92084106|NCT01802515|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084107|NCT01802515|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084108|NCT01802515|Adrenergic Agents|adrenergic agents|mesh-ancestor
92084109|NCT01802515|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084110|NCT01802515|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084111|NCT01802437|Fluoxetine|fluoxetine|mesh-list
92084112|NCT01802437|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92084113|NCT01802437|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92084114|NCT01802437|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084116|NCT01802437|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084118|NCT01802437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084119|NCT01802437|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92084120|NCT01802437|Antidepressive Agents|antidepressive agents|mesh-ancestor
92084121|NCT01802437|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084122|NCT01802437|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92084123|NCT01802437|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92084124|NCT01802437|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016665|NCT02450487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084126|NCT00608062|Ganirelix|ganirelix|mesh-list
92084127|NCT00608062|Estrogens|estrogens|mesh-ancestor
92084128|NCT00608062|Hormones|hormones|mesh-ancestor
92084129|NCT00608062|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084130|NCT00608062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084131|NCT00608062|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084132|NCT02135146|Plasma-lyte 148|plasma-lyte 148|mesh-list
92084133|NCT02135146|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92084134|NCT02135146|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92084135|NCT02829268|Dantrolene|dantrolene|mesh-list
92084136|NCT02829268|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92084137|NCT02829268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084138|NCT02829268|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92084139|NCT02829268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084140|NCT02202772|Cisplatin|cisplatin|mesh-list
92084141|NCT02202772|Gemcitabine|gemcitabine|mesh-list
92084142|NCT02202772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084143|NCT02202772|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084144|NCT02202772|Antimetabolites|antimetabolites|mesh-ancestor
92084145|NCT02202772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084146|NCT00582400|Arsenic Trioxide|arsenic trioxide|mesh-list
92084147|NCT00582400|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084148|NCT01801735|Meloxicam|meloxicam|mesh-list
92084149|NCT01801735|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92084150|NCT01801735|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92084151|NCT01801735|Analgesics|analgesics|mesh-ancestor
92084152|NCT01801735|Sensory System Agents|sensory system agents|mesh-ancestor
92084153|NCT01801735|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084154|NCT01801735|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084155|NCT01801735|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084156|NCT01801735|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084157|NCT01801735|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92084158|NCT01801735|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92084159|NCT01801735|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084160|NCT01801735|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084161|NCT00612430|Bevacizumab|bevacizumab|mesh-list
92084162|NCT00612430|Etoposide|etoposide|mesh-list
92084163|NCT00612430|Etoposide phosphate|etoposide phosphate|mesh-list
92084164|NCT00612430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084165|NCT00612430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084166|NCT00612430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084167|NCT00612430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92084168|NCT00612430|Growth Substances|growth substances|mesh-ancestor
92084169|NCT00612430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084170|NCT00612430|Growth Inhibitors|growth inhibitors|mesh-ancestor
92084171|NCT00612430|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92084172|NCT00612430|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92084173|NCT00612430|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92084174|NCT00612430|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084175|NCT00612430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084176|NCT01571128|Tenofovir|tenofovir|mesh-list
92084177|NCT01571128|Emtricitabine|emtricitabine|mesh-list
92084178|NCT01571128|Antiviral Agents|antiviral agents|mesh-ancestor
92084179|NCT01571128|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084180|NCT01571128|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92084181|NCT01571128|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92084182|NCT01571128|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084183|NCT01571128|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084184|NCT01571128|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92084185|NCT01571128|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92084186|NCT00614458|Raltegravir Potassium|raltegravir potassium|mesh-list
92084187|NCT00614458|Valproic Acid|valproic acid|mesh-list
92084188|NCT00614458|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92084191|NCT00614458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084192|NCT00614458|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92084193|NCT00614458|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92084194|NCT00614458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084195|NCT00614458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084196|NCT00614458|Anticonvulsants|anticonvulsants|mesh-ancestor
92084197|NCT00614458|GABA Agents|gaba agents|mesh-ancestor
92084198|NCT00614458|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016666|NCT02450487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016667|NCT02506881|Darbepoetin alfa|darbepoetin alfa|mesh-list
92016668|NCT02506881|Hematinics|hematinics|mesh-ancestor
92084199|NCT00614458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084200|NCT00614458|Antimanic Agents|antimanic agents|mesh-ancestor
92084201|NCT00614458|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92084202|NCT00614458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084203|NCT00614458|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084204|NCT01429168|Etoricoxib|etoricoxib|mesh-list
92084205|NCT01429168|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92084206|NCT01429168|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92084207|NCT01429168|Analgesics|analgesics|mesh-ancestor
92084208|NCT01429168|Sensory System Agents|sensory system agents|mesh-ancestor
92084209|NCT01429168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084210|NCT01429168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084211|NCT01429168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084212|NCT01429168|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084213|NCT01429168|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92084214|NCT01429168|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92084215|NCT01429168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084216|NCT01429168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084217|NCT00771160|Montelukast|montelukast|mesh-list
92084218|NCT00771160|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92084219|NCT00771160|Respiratory System Agents|respiratory system agents|mesh-ancestor
92084220|NCT00771160|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92084221|NCT00771160|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084222|NCT00771160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084223|NCT00771160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084224|NCT00771160|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92084225|NCT00771160|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92084226|NCT00771160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084227|NCT00756418|Theophylline|theophylline|mesh-list
92084228|NCT00756418|Montelukast|montelukast|mesh-list
92084229|NCT00756418|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92084230|NCT00756418|Respiratory System Agents|respiratory system agents|mesh-ancestor
92084231|NCT00756418|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92084232|NCT00756418|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084233|NCT00756418|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084234|NCT00756418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084235|NCT00756418|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92084236|NCT00756418|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92084237|NCT00756418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084238|NCT00756418|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92084239|NCT00756418|Autonomic Agents|autonomic agents|mesh-ancestor
92084240|NCT00756418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084241|NCT00756418|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92084242|NCT00756418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084243|NCT00756418|Vasodilator Agents|vasodilator agents|mesh-ancestor
92084244|NCT00756418|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92084245|NCT00756418|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92084246|NCT00756418|Purinergic Agents|purinergic agents|mesh-ancestor
92084247|NCT00756418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084248|NCT00615472|Remifentanil|remifentanil|mesh-list
92084249|NCT00615472|Propofol|propofol|mesh-list
92084250|NCT00615472|Isoflurane|isoflurane|mesh-list
92084251|NCT00615472|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92084252|NCT00615472|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084253|NCT00615472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084254|NCT00615472|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92084255|NCT00615472|Anesthetics, General|anesthetics, general|mesh-ancestor
92084256|NCT00615472|Anesthetics|anesthetics|mesh-ancestor
92084257|NCT00615472|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92084258|NCT00615472|Narcotics|narcotics|mesh-ancestor
92084259|NCT00615472|Analgesics|analgesics|mesh-ancestor
92084262|NCT00615472|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92084263|NCT00615784|Bexarotene|bexarotene|mesh-list
92084264|NCT00615784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084265|NCT00755794|Montelukast|montelukast|mesh-list
92084266|NCT00755794|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92084267|NCT00755794|Respiratory System Agents|respiratory system agents|mesh-ancestor
92016669|NCT02506257|Biguanides|biguanides|mesh-list
92016670|NCT02506257|Polihexanide|polihexanide|mesh-list
92016671|NCT02506257|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92016672|NCT02506257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016673|NCT02506257|Disinfectants|disinfectants|mesh-ancestor
92084268|NCT00755794|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92084269|NCT00755794|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084270|NCT00755794|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084271|NCT00755794|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084272|NCT00755794|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92084273|NCT00755794|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92084274|NCT00755794|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084275|NCT00652444|Simvastatin|simvastatin|mesh-list
92084276|NCT00652444|Ezetimibe|ezetimibe|mesh-list
92084277|NCT00652444|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92084278|NCT00652444|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92084279|NCT00652444|Antimetabolites|antimetabolites|mesh-ancestor
92084280|NCT00652444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084281|NCT00652444|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92084282|NCT00652444|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92084283|NCT00652444|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084284|NCT00585910|Methylphenidate|methylphenidate|mesh-list
92084285|NCT00585910|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92084286|NCT00585910|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92084287|NCT00585910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084288|NCT00585910|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92084289|NCT00585910|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92084290|NCT00585910|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084291|NCT00585910|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084292|NCT00585910|Dopamine Agents|dopamine agents|mesh-ancestor
92084293|NCT00585910|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084294|NCT00585910|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92084295|NCT00585910|Adrenergic Agents|adrenergic agents|mesh-ancestor
92084296|NCT00489346|Fluticasone|fluticasone|mesh-list
92084297|NCT00489346|Xhance|xhance|mesh-list
92084298|NCT00489346|Montelukast|montelukast|mesh-list
92084299|NCT00489346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084300|NCT00489346|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92084301|NCT00489346|Autonomic Agents|autonomic agents|mesh-ancestor
92084302|NCT00489346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084303|NCT00489346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084304|NCT00489346|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92084305|NCT00489346|Respiratory System Agents|respiratory system agents|mesh-ancestor
92084306|NCT00489346|Dermatologic Agents|dermatologic agents|mesh-ancestor
92084307|NCT00489346|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92084308|NCT00489346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084309|NCT00489346|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92084310|NCT00489346|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084311|NCT00489346|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084312|NCT00489346|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92084313|NCT00489346|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92084314|NCT00617188|Fulvestrant|fulvestrant|mesh-list
92084315|NCT00617188|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92084316|NCT00617188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084317|NCT00617188|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92084318|NCT00617188|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92084319|NCT00617188|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084320|NCT00617188|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084321|NCT00617188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084322|NCT00618436|Phenytoin|phenytoin|mesh-list
92084323|NCT00618436|Levetiracetam|levetiracetam|mesh-list
92084324|NCT00618436|Anticonvulsants|anticonvulsants|mesh-ancestor
92084325|NCT00618436|Nootropic Agents|nootropic agents|mesh-ancestor
92084326|NCT00618436|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92084327|NCT00618436|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92084328|NCT00618436|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084329|NCT00618436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016674|NCT02506257|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016675|NCT02505945|Omeprazole|omeprazole|mesh-list
92016676|NCT02505945|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92016677|NCT02505945|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016678|NCT02505945|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92016679|NCT02505945|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016680|NCT02505945|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016681|NCT04213885|Riboflavin|riboflavin|mesh-list
92016682|NCT04213885|Vitamin B Complex|vitamin b complex|mesh-ancestor
92016683|NCT04213885|Vitamins|vitamins|mesh-ancestor
92016684|NCT04213885|Micronutrients|micronutrients|mesh-ancestor
92016685|NCT04213885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016686|NCT04213885|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92016687|NCT04213885|Dermatologic Agents|dermatologic agents|mesh-ancestor
92016688|NCT02448771|Bazedoxifene|bazedoxifene|mesh-list
92016689|NCT02448771|Palbociclib|palbociclib|mesh-list
92016690|NCT02448771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016691|NCT02448771|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92084330|NCT00618436|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92084331|NCT00618436|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92084333|NCT00619060|Nicotinic Acids|nicotinic acids|mesh-list
92084334|NCT00619060|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92084335|NCT00619060|Antimetabolites|antimetabolites|mesh-ancestor
92084336|NCT00619060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084337|NCT00619060|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92084338|NCT00619060|Vasodilator Agents|vasodilator agents|mesh-ancestor
92084339|NCT00619060|Vitamin B Complex|vitamin b complex|mesh-ancestor
92084340|NCT00619060|Vitamins|vitamins|mesh-ancestor
92084341|NCT00619060|Micronutrients|micronutrients|mesh-ancestor
92084342|NCT00619060|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084343|NCT05247424|Heparin|heparin|mesh-list
92084344|NCT05247424|Calcium heparin|calcium heparin|mesh-list
92084345|NCT05247424|Anticoagulants|anticoagulants|mesh-ancestor
92084346|NCT05247424|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92084347|NCT05247424|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92084348|NCT05247424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084349|NCT00092716|Atorvastatin|atorvastatin|mesh-list
92084350|NCT00092716|Ezetimibe|ezetimibe|mesh-list
92084351|NCT00092716|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92084352|NCT00092716|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92084353|NCT00092716|Antimetabolites|antimetabolites|mesh-ancestor
92084354|NCT00092716|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084355|NCT00092716|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92084356|NCT00092716|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92084357|NCT00092716|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084358|NCT00619684|Lenalidomide|lenalidomide|mesh-list
92084359|NCT00619684|Immunologic Factors|immunologic factors|mesh-ancestor
92084360|NCT00619684|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084361|NCT00619684|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084362|NCT00619684|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92084363|NCT00619684|Growth Substances|growth substances|mesh-ancestor
92084364|NCT00619684|Growth Inhibitors|growth inhibitors|mesh-ancestor
92084365|NCT00619684|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084366|NCT00588406|Prednisone|prednisone|mesh-list
92084367|NCT00588406|Budesonide|budesonide|mesh-list
92084368|NCT00588406|Bromides|bromides|mesh-list
92084369|NCT00588406|Albuterol|albuterol|mesh-list
92084370|NCT00588406|Ipratropium|ipratropium|mesh-list
92084371|NCT00588406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084372|NCT00588406|Glucocorticoids|glucocorticoids|mesh-ancestor
92084373|NCT00588406|Hormones|hormones|mesh-ancestor
92016692|NCT02448771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016693|NCT02448771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016694|NCT02448771|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92016695|NCT02448771|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92016696|NCT02448771|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081682|NCT01392183|Antiemetics|antiemetics|mesh-ancestor
92016697|NCT02448771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084374|NCT00588406|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084375|NCT00588406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084376|NCT00588406|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92084377|NCT00588406|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084378|NCT00588406|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92084379|NCT00588406|Autonomic Agents|autonomic agents|mesh-ancestor
92084380|NCT00588406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084381|NCT00588406|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92084382|NCT00588406|Respiratory System Agents|respiratory system agents|mesh-ancestor
92084383|NCT00588406|Anticonvulsants|anticonvulsants|mesh-ancestor
92084384|NCT00588406|Tocolytic Agents|tocolytic agents|mesh-ancestor
92084385|NCT00588406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92084386|NCT00588406|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92084387|NCT00588406|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92084388|NCT00588406|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92084389|NCT00588406|Adrenergic Agents|adrenergic agents|mesh-ancestor
92084390|NCT00588406|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084391|NCT00588406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084392|NCT00588406|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92084393|NCT00588406|Cholinergic Agents|cholinergic agents|mesh-ancestor
92084394|NCT00668434|Prednisone|prednisone|mesh-list
92084395|NCT00668434|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084396|NCT00668434|Glucocorticoids|glucocorticoids|mesh-ancestor
92084397|NCT00668434|Hormones|hormones|mesh-ancestor
92084398|NCT00668434|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084399|NCT00668434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084400|NCT00668434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92084401|NCT00668434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084402|NCT00668902|Pantoprazole|pantoprazole|mesh-list
92084403|NCT00668902|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92084405|NCT00668902|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92084406|NCT00668902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084407|NCT00668902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084408|NCT00589888|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92084409|NCT00589888|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92084410|NCT00589888|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92084411|NCT00589888|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92084412|NCT00621946|Dexetimide|dexetimide|mesh-list
92084413|NCT00621946|Citalopram|citalopram|mesh-list
92084414|NCT00621946|Escitalopram|escitalopram|mesh-list
92084415|NCT00621946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92084416|NCT00621946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92084417|NCT00621946|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084418|NCT00621946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084419|NCT00621946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084420|NCT00621946|Serotonin Agents|serotonin agents|mesh-ancestor
92084421|NCT00621946|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084422|NCT00621946|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92084423|NCT00621946|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92084424|NCT00621946|Parasympatholytics|parasympatholytics|mesh-ancestor
92084425|NCT00621946|Autonomic Agents|autonomic agents|mesh-ancestor
92084426|NCT00621946|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084427|NCT00621946|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92084428|NCT00621946|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92016698|NCT02448771|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016699|NCT02448771|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92016700|NCT02504541|Methyltestosterone|methyltestosterone|mesh-list
92016702|NCT02504541|Testosterone undecanoate|testosterone undecanoate|mesh-list
92084429|NCT00621946|Cholinergic Agents|cholinergic agents|mesh-ancestor
92084430|NCT00621946|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92084431|NCT00621946|Antidepressive Agents|antidepressive agents|mesh-ancestor
92084432|NCT00621946|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084433|NCT02139358|Gemcitabine|gemcitabine|mesh-list
92084434|NCT02139358|Trastuzumab|trastuzumab|mesh-list
92084435|NCT02139358|Pertuzumab|pertuzumab|mesh-list
92084436|NCT02139358|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084437|NCT02139358|Antimetabolites|antimetabolites|mesh-ancestor
92084438|NCT02139358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084439|NCT02139358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084440|NCT02139358|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084441|NCT02140372|Colchicine|colchicine|mesh-list
92084442|NCT02140372|Gout Suppressants|gout suppressants|mesh-ancestor
92084443|NCT02140372|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084444|NCT02140372|Tubulin Modulators|tubulin modulators|mesh-ancestor
92084445|NCT02140372|Antimitotic Agents|antimitotic agents|mesh-ancestor
92084446|NCT02140372|Mitosis Modulators|mitosis modulators|mesh-ancestor
92084447|NCT02140372|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084448|NCT02140372|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084449|NCT00670774|Eculizumab|eculizumab|mesh-list
92084450|NCT00670774|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92084451|NCT00670774|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084452|NCT00670774|Immunologic Factors|immunologic factors|mesh-ancestor
92084453|NCT00670774|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084454|NCT00672100|Ropivacaine|ropivacaine|mesh-list
92084455|NCT00672100|Anesthetics, Local|anesthetics, local|mesh-ancestor
92084456|NCT00672100|Anesthetics|anesthetics|mesh-ancestor
92084457|NCT00672100|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084458|NCT00672100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084459|NCT00672100|Sensory System Agents|sensory system agents|mesh-ancestor
92084460|NCT00672100|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084461|NCT00593866|Gemcitabine|gemcitabine|mesh-list
92084462|NCT00593866|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084463|NCT00593866|Antimetabolites|antimetabolites|mesh-ancestor
92084464|NCT00593866|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084465|NCT00593866|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084466|NCT00624910|Bupivacaine|bupivacaine|mesh-list
92084467|NCT00624910|Anesthetics, Local|anesthetics, local|mesh-ancestor
92084468|NCT00624910|Anesthetics|anesthetics|mesh-ancestor
92084469|NCT00624910|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084470|NCT00624910|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084471|NCT00624910|Sensory System Agents|sensory system agents|mesh-ancestor
92084472|NCT00624910|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084473|NCT00626626|Alemtuzumab|alemtuzumab|mesh-list
92084474|NCT00626626|Clofarabine|clofarabine|mesh-list
92084475|NCT00626626|Cyclophosphamide|cyclophosphamide|mesh-list
92084476|NCT00626626|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084478|NCT00626626|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084479|NCT00626626|Antimetabolites|antimetabolites|mesh-ancestor
92084480|NCT00626626|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084481|NCT00626626|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084482|NCT00626626|Immunologic Factors|immunologic factors|mesh-ancestor
92084483|NCT00626626|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084484|NCT00626626|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084485|NCT00626626|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92084486|NCT00626626|Alkylating Agents|alkylating agents|mesh-ancestor
92084487|NCT00626626|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92084488|NCT00626782|Ranibizumab|ranibizumab|mesh-list
92084489|NCT00626782|Mitomycins|mitomycins|mesh-list
92084490|NCT00626782|Mitomycin|mitomycin|mesh-list
92084491|NCT00626782|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084492|NCT00626782|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92016703|NCT02504541|Testosterone enanthate|testosterone enanthate|mesh-list
92016704|NCT02504541|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92016706|NCT02504541|Hormones|hormones|mesh-ancestor
92016707|NCT02504541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084493|NCT00626782|Growth Substances|growth substances|mesh-ancestor
92084494|NCT00626782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084495|NCT00626782|Growth Inhibitors|growth inhibitors|mesh-ancestor
92084496|NCT00626782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084497|NCT00626782|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92084498|NCT00626782|Alkylating Agents|alkylating agents|mesh-ancestor
92084499|NCT00626782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084500|NCT00626782|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92084501|NCT00626782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084502|NCT00594256|Sodium Oxybate|sodium oxybate|mesh-list
92084503|NCT00594256|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92084504|NCT00594256|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92084505|NCT00594256|Anesthetics, General|anesthetics, general|mesh-ancestor
92084506|NCT00594256|Anesthetics|anesthetics|mesh-ancestor
92084507|NCT00594256|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084508|NCT00594256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084509|NCT00627406|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92084510|NCT00627406|Buserelin|buserelin|mesh-list
92084511|NCT00627406|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92084512|NCT00627406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084513|NCT00627406|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92084514|NCT00627406|Fertility Agents|fertility agents|mesh-ancestor
92084515|NCT00673738|Docetaxel|docetaxel|mesh-list
92084516|NCT00673738|Cetuximab|cetuximab|mesh-list
92084517|NCT00673738|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084518|NCT00673738|Tubulin Modulators|tubulin modulators|mesh-ancestor
92084519|NCT00673738|Antimitotic Agents|antimitotic agents|mesh-ancestor
92084520|NCT00673738|Mitosis Modulators|mitosis modulators|mesh-ancestor
92084521|NCT00673738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084522|NCT00673738|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084523|NCT00674206|Gemcitabine|gemcitabine|mesh-list
92084524|NCT00674206|Oxaliplatin|oxaliplatin|mesh-list
92084525|NCT00674206|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084526|NCT00674206|Antimetabolites|antimetabolites|mesh-ancestor
92084527|NCT00674206|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084528|NCT00674206|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084529|NCT00595270|Vaccines|vaccines|mesh-list
92084530|NCT00595270|Immunologic Factors|immunologic factors|mesh-ancestor
92084531|NCT00595270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084532|NCT00628498|Defibrotide|defibrotide|mesh-list
92084533|NCT00628498|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92084534|NCT00628498|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92084535|NCT00628498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084536|NCT00628498|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92084537|NCT00629122|Clotrimazole|clotrimazole|mesh-list
92084538|NCT00629122|Miconazole|miconazole|mesh-list
92084539|NCT00629122|Nystatin|nystatin|mesh-list
92084540|NCT00629122|Tacrolimus|tacrolimus|mesh-list
92084541|NCT00629122|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084542|NCT00629122|Immunologic Factors|immunologic factors|mesh-ancestor
92084543|NCT00629122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084544|NCT00629122|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92084545|NCT00629122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084546|NCT00629122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084547|NCT00629122|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92084548|NCT00629122|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084549|NCT00629122|Antifungal Agents|antifungal agents|mesh-ancestor
92084550|NCT00629122|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92084552|NCT00629122|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92084553|NCT00629122|Hormone Antagonists|hormone antagonists|mesh-ancestor
92084554|NCT00629122|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084555|NCT00629122|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92084556|NCT00629122|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92016708|NCT02504541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084557|NCT00629122|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92084559|NCT00629122|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084560|NCT00596440|Nicotine|nicotine|mesh-list
92084561|NCT00596440|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92084562|NCT00596440|Autonomic Agents|autonomic agents|mesh-ancestor
92084563|NCT00596440|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084564|NCT00596440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084565|NCT00596440|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92084566|NCT00596440|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92084567|NCT00596440|Cholinergic Agents|cholinergic agents|mesh-ancestor
92084568|NCT00596440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084569|NCT00596440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084570|NCT00632632|Cycloserine|cycloserine|mesh-list
92084571|NCT00632632|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92084572|NCT00632632|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084573|NCT00632632|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92084574|NCT00632632|Antitubercular Agents|antitubercular agents|mesh-ancestor
92084575|NCT00632632|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92084576|NCT00632632|Antimetabolites|antimetabolites|mesh-ancestor
92084577|NCT00632632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084578|NCT00633256|Isoniazid|isoniazid|mesh-list
92084579|NCT00633256|Cycloserine|cycloserine|mesh-list
92084580|NCT00633256|Antitubercular Agents|antitubercular agents|mesh-ancestor
92084581|NCT00633256|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92084582|NCT00633256|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084583|NCT00633256|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92084584|NCT00633256|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92084585|NCT00633256|Antimetabolites|antimetabolites|mesh-ancestor
92084586|NCT00633256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084587|NCT00633256|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92084588|NCT00633256|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92084589|NCT00633256|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92084590|NCT00634270|Sirolimus|sirolimus|mesh-list
92084591|NCT00634270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92084592|NCT00634270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084593|NCT00634270|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92084594|NCT00634270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084595|NCT00634270|Antifungal Agents|antifungal agents|mesh-ancestor
92084596|NCT00634270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084597|NCT00634270|Immunologic Factors|immunologic factors|mesh-ancestor
92084598|NCT00634270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084599|NCT00678418|Naltrexone|naltrexone|mesh-list
92084600|NCT00678418|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92084601|NCT00678418|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92084602|NCT00678418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084603|NCT00678418|Sensory System Agents|sensory system agents|mesh-ancestor
92084604|NCT00678418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084605|NCT00600340|Paclitaxel|paclitaxel|mesh-list
92084606|NCT00600340|Bevacizumab|bevacizumab|mesh-list
92084607|NCT00600340|Capecitabine|capecitabine|mesh-list
92084608|NCT00600340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92084609|NCT00600340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084610|NCT00600340|Tubulin Modulators|tubulin modulators|mesh-ancestor
92084611|NCT00600340|Antimitotic Agents|antimitotic agents|mesh-ancestor
92084612|NCT00600340|Mitosis Modulators|mitosis modulators|mesh-ancestor
92084613|NCT00600340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084614|NCT00600340|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084615|NCT00600340|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084616|NCT00600340|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92084617|NCT00600340|Growth Substances|growth substances|mesh-ancestor
92084618|NCT00600340|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084619|NCT00600340|Growth Inhibitors|growth inhibitors|mesh-ancestor
92084620|NCT00600340|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084621|NCT00600340|Antimetabolites|antimetabolites|mesh-ancestor
92084622|NCT01799356|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92084623|NCT01799356|Moxifloxacin|moxifloxacin|mesh-list
92084634|NCT01799356|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92084635|NCT01799356|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92084636|NCT01799356|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92084637|NCT01799356|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92084638|NCT01799356|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92016709|NCT02504541|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016710|NCT02504541|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016711|NCT02504541|Anabolic Agents|anabolic agents|mesh-ancestor
92016712|NCT04924257|Esketamine|esketamine|mesh-list
92016713|NCT04924257|Antidepressive Agents|antidepressive agents|mesh-ancestor
92016714|NCT04924257|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92016715|NCT04924179|Tislelizumab|tislelizumab|mesh-list
92016716|NCT04924179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016717|NCT04924179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016718|NCT04975945|Ceftriaxone|ceftriaxone|mesh-list
92084639|NCT00602290|Methylphenidate|methylphenidate|mesh-list
92084640|NCT00602290|Citalopram|citalopram|mesh-list
92084641|NCT00602290|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92084642|NCT00602290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084643|NCT00602290|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92084644|NCT00602290|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92084645|NCT00602290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084646|NCT00602290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084647|NCT00602290|Dopamine Agents|dopamine agents|mesh-ancestor
92084648|NCT00602290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084649|NCT00602290|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92084650|NCT00602290|Serotonin Agents|serotonin agents|mesh-ancestor
92084651|NCT00602290|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92084652|NCT00602290|Antidepressive Agents|antidepressive agents|mesh-ancestor
92084653|NCT00602290|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084654|NCT00637780|Sulfasalazine|sulfasalazine|mesh-list
92084655|NCT00637780|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084656|NCT00637780|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92084657|NCT00637780|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92084658|NCT00637780|Analgesics|analgesics|mesh-ancestor
92084659|NCT00637780|Sensory System Agents|sensory system agents|mesh-ancestor
92084660|NCT00637780|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084661|NCT00637780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084662|NCT00637780|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084663|NCT00637780|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084664|NCT00637780|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084665|NCT01799902|Solifenacin Succinate|solifenacin succinate|mesh-list
92084666|NCT01799902|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92084667|NCT01799902|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92084668|NCT01799902|Cholinergic Agents|cholinergic agents|mesh-ancestor
92084669|NCT01799902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084670|NCT01799902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084671|NCT01799902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084672|NCT01799902|Urological Agents|urological agents|mesh-ancestor
92084673|NCT00602446|Deferasirox|deferasirox|mesh-list
92084674|NCT00602446|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92084675|NCT00602446|Chelating Agents|chelating agents|mesh-ancestor
92084676|NCT00602446|Sequestering Agents|sequestering agents|mesh-ancestor
92084677|NCT00602446|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084678|NCT00602836|Cyclophosphamide|cyclophosphamide|mesh-list
92084679|NCT00602836|Rituximab|rituximab|mesh-list
92084680|NCT00602836|Lenalidomide|lenalidomide|mesh-list
92084681|NCT00602836|Pentostatin|pentostatin|mesh-list
92084682|NCT00602836|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084683|NCT00602836|Immunologic Factors|immunologic factors|mesh-ancestor
92084684|NCT00602836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084685|NCT00602836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084688|NCT00602836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084690|NCT00602836|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92084691|NCT00602836|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084692|NCT00602836|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084693|NCT00602836|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92084694|NCT00602836|Growth Substances|growth substances|mesh-ancestor
92084695|NCT00602836|Growth Inhibitors|growth inhibitors|mesh-ancestor
92016719|NCT04975945|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92084696|NCT00602836|Adenosine Deaminase Inhibitors|adenosine deaminase inhibitors|mesh-ancestor
92084697|NCT00602836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084698|NCT00683332|Tigecycline|tigecycline|mesh-list
92084699|NCT00683332|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92084700|NCT00683332|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084701|NCT00683332|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92084702|NCT00683332|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084703|NCT00683332|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084704|NCT00683410|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92084705|NCT00683410|Immunologic Factors|immunologic factors|mesh-ancestor
92084706|NCT00683410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084707|NCT00640822|Calcitriol|calcitriol|mesh-list
92084708|NCT00640822|Hydrocortisone|hydrocortisone|mesh-list
92084709|NCT00640822|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92084711|NCT00640822|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92084712|NCT00640822|1 alpha,24-dihydroxyvitamin D3|1 alpha,24-dihydroxyvitamin d3|mesh-list
92084713|NCT00640822|Calcipotriene|calcipotriene|mesh-list
92084714|NCT00640822|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084715|NCT00640822|Dermatologic Agents|dermatologic agents|mesh-ancestor
92084716|NCT00640822|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92084717|NCT00640822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084718|NCT00640822|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92084719|NCT00640822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084720|NCT00640822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084721|NCT00640822|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92084722|NCT00640822|Vitamins|vitamins|mesh-ancestor
92084723|NCT00640822|Micronutrients|micronutrients|mesh-ancestor
92084724|NCT00640822|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92084725|NCT00640978|Everolimus|everolimus|mesh-list
92084726|NCT00640978|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92084727|NCT00640978|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92084728|NCT00640978|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92084729|NCT00640978|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084730|NCT00640978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084731|NCT00640978|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084732|NCT00640978|Immunologic Factors|immunologic factors|mesh-ancestor
92084733|NCT00640978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084734|NCT00640978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084735|NCT00642694|Dexetimide|dexetimide|mesh-list
92084736|NCT00642694|Citalopram|citalopram|mesh-list
92084737|NCT00642694|Escitalopram|escitalopram|mesh-list
92084738|NCT00642694|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92084739|NCT00642694|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92084740|NCT00642694|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084741|NCT00642694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084742|NCT00642694|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084743|NCT00642694|Serotonin Agents|serotonin agents|mesh-ancestor
92084744|NCT00642694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084745|NCT00642694|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92084746|NCT00642694|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92084747|NCT00642694|Parasympatholytics|parasympatholytics|mesh-ancestor
92084748|NCT00642694|Autonomic Agents|autonomic agents|mesh-ancestor
92084749|NCT00642694|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084750|NCT00642694|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92084751|NCT00642694|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92084752|NCT00642694|Cholinergic Agents|cholinergic agents|mesh-ancestor
92084753|NCT00642694|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92084754|NCT00642694|Antidepressive Agents|antidepressive agents|mesh-ancestor
92084755|NCT00642694|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92084756|NCT00705874|Leucovorin|leucovorin|mesh-list
92084760|NCT00705874|Docetaxel|docetaxel|mesh-list
92084761|NCT00705874|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92084762|NCT00705874|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084763|NCT00705874|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084764|NCT00705874|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92084765|NCT00705874|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92084766|NCT00705874|Growth Substances|growth substances|mesh-ancestor
92084767|NCT00705874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084768|NCT00705874|Growth Inhibitors|growth inhibitors|mesh-ancestor
92084769|NCT00705874|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016720|NCT04975945|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016721|NCT03063307|Fluorides|fluorides|mesh-list
92016722|NCT03063307|Cariostatic Agents|cariostatic agents|mesh-ancestor
92016723|NCT03063307|Protective Agents|protective agents|mesh-ancestor
92016724|NCT03063307|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016725|NCT04874935|Lansoprazole|lansoprazole|mesh-list
92084770|NCT00705874|Antimetabolites|antimetabolites|mesh-ancestor
92084771|NCT00705874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084772|NCT00705874|Tubulin Modulators|tubulin modulators|mesh-ancestor
92084773|NCT00705874|Antimitotic Agents|antimitotic agents|mesh-ancestor
92084774|NCT00705874|Mitosis Modulators|mitosis modulators|mesh-ancestor
92084775|NCT00705874|Antidotes|antidotes|mesh-ancestor
92084776|NCT00705874|Protective Agents|protective agents|mesh-ancestor
92084777|NCT00705874|Vitamin B Complex|vitamin b complex|mesh-ancestor
92084778|NCT00705874|Vitamins|vitamins|mesh-ancestor
92084779|NCT00705874|Micronutrients|micronutrients|mesh-ancestor
92084780|NCT00705874|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92084781|NCT00705874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084782|NCT00647998|Darbepoetin alfa|darbepoetin alfa|mesh-list
92084783|NCT00647998|Hematinics|hematinics|mesh-ancestor
92084784|NCT00649792|4-Aminopyridine|4-aminopyridine|mesh-list
92084785|NCT00649792|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92084786|NCT00649792|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92084787|NCT00649792|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084788|NCT00687076|Aspirin|aspirin|mesh-list
92084790|NCT00687076|Nicotinic Acids|nicotinic acids|mesh-list
92084791|NCT00687076|Clopidogrel|clopidogrel|mesh-list
92084792|NCT00687076|Ezetimibe|ezetimibe|mesh-list
92084793|NCT00687076|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92084794|NCT00687076|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92084795|NCT00687076|Analgesics|analgesics|mesh-ancestor
92084796|NCT00687076|Sensory System Agents|sensory system agents|mesh-ancestor
92084797|NCT00687076|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084798|NCT00687076|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084799|NCT00687076|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084800|NCT00687076|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084801|NCT00687076|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92084802|NCT00687076|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92084803|NCT00687076|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084804|NCT00687076|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92084805|NCT00687076|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92084806|NCT00687076|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084807|NCT00687076|Antipyretics|antipyretics|mesh-ancestor
92084808|NCT00687076|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92084809|NCT00687076|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92084810|NCT00687076|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92084811|NCT00687076|Purinergic Agents|purinergic agents|mesh-ancestor
92084812|NCT00687076|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084813|NCT00687076|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92084814|NCT00687076|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92084815|NCT00687076|Antimetabolites|antimetabolites|mesh-ancestor
92084816|NCT00687076|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92084817|NCT00687076|Vasodilator Agents|vasodilator agents|mesh-ancestor
92084818|NCT00687076|Vitamin B Complex|vitamin b complex|mesh-ancestor
92084819|NCT00687076|Vitamins|vitamins|mesh-ancestor
92084820|NCT00687076|Micronutrients|micronutrients|mesh-ancestor
92084821|NCT00687544|Ribavirin|ribavirin|mesh-list
92084822|NCT00687544|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92084823|NCT00687544|Antimetabolites|antimetabolites|mesh-ancestor
92084824|NCT00687544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084825|NCT00687544|Antiviral Agents|antiviral agents|mesh-ancestor
92084826|NCT00687544|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084827|NCT02143648|Nalbuphine|nalbuphine|mesh-list
92084828|NCT02143648|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92084829|NCT02143648|Narcotics|narcotics|mesh-ancestor
92084830|NCT02143648|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084831|NCT02143648|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084832|NCT02143648|Analgesics|analgesics|mesh-ancestor
92084836|NCT02997982|Antiviral Agents|antiviral agents|mesh-ancestor
92084837|NCT02997982|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084838|NCT00689572|Ondansetron|ondansetron|mesh-list
92084839|NCT00689572|Antiemetics|antiemetics|mesh-ancestor
92016726|NCT04874935|Dexlansoprazole|dexlansoprazole|mesh-list
92016727|NCT04874935|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92016728|NCT04874935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084840|NCT00689572|Autonomic Agents|autonomic agents|mesh-ancestor
92084841|NCT00689572|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084842|NCT00689572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084843|NCT00689572|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084844|NCT00689572|Antipruritics|antipruritics|mesh-ancestor
92084845|NCT00689572|Dermatologic Agents|dermatologic agents|mesh-ancestor
92084846|NCT00689572|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92084847|NCT00689572|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92084848|NCT00689572|Serotonin Agents|serotonin agents|mesh-ancestor
92084849|NCT00689572|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084850|NCT00689572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084851|NCT01840579|Paclitaxel|paclitaxel|mesh-list
92084852|NCT01840579|Etoposide|etoposide|mesh-list
92084853|NCT01840579|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92084854|NCT01840579|Carboplatin|carboplatin|mesh-list
92084855|NCT01840579|Pembrolizumab|pembrolizumab|mesh-list
92084856|NCT01840579|Pemetrexed|pemetrexed|mesh-list
92084857|NCT01840579|Ipilimumab|ipilimumab|mesh-list
92084858|NCT01840579|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92084859|NCT01840579|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084860|NCT01840579|Tubulin Modulators|tubulin modulators|mesh-ancestor
92084861|NCT01840579|Antimitotic Agents|antimitotic agents|mesh-ancestor
92084862|NCT01840579|Mitosis Modulators|mitosis modulators|mesh-ancestor
92084863|NCT01840579|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084864|NCT01840579|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084865|NCT01840579|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92084866|NCT01840579|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92084867|NCT01840579|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92084868|NCT01840579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084869|NCT01840579|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92084870|NCT01840579|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92084871|NCT00651040|Prednisone|prednisone|mesh-list
92084872|NCT00651040|Prednisolone|prednisolone|mesh-list
92084873|NCT00651040|Methotrexate|methotrexate|mesh-list
92084874|NCT00651040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084875|NCT00651040|Glucocorticoids|glucocorticoids|mesh-ancestor
92084876|NCT00651040|Hormones|hormones|mesh-ancestor
92084877|NCT00651040|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084878|NCT00651040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084879|NCT00651040|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92084880|NCT00651040|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084881|NCT00651040|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92084882|NCT00651040|Abortifacient Agents|abortifacient agents|mesh-ancestor
92084883|NCT00651040|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92084884|NCT00651040|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084885|NCT00651040|Antimetabolites|antimetabolites|mesh-ancestor
92084886|NCT00651040|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084887|NCT00651040|Dermatologic Agents|dermatologic agents|mesh-ancestor
92084888|NCT00651040|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084889|NCT00651040|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92084890|NCT00651040|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084891|NCT00651040|Immunologic Factors|immunologic factors|mesh-ancestor
92084892|NCT00651040|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084893|NCT00651040|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92084894|NCT00654784|Idebenone|idebenone|mesh-list
92084895|NCT00654784|Antioxidants|antioxidants|mesh-ancestor
92084896|NCT00654784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084897|NCT00654784|Protective Agents|protective agents|mesh-ancestor
92084898|NCT00654784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084899|NCT02997514|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92084900|NCT01801111|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92084901|NCT01801111|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084902|NCT01801111|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92084903|NCT01801111|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084904|NCT01801111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084909|NCT00691600|Antimalarials|antimalarials|mesh-ancestor
92084910|NCT00691600|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92084911|NCT00691600|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92084912|NCT00691600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92016729|NCT04874935|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92084913|NCT00691600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084914|NCT00691600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084915|NCT00691600|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92084916|NCT00691600|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92084917|NCT00691600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92084919|NCT00655642|Diphenhydramine|diphenhydramine|mesh-list
92084920|NCT00655642|Ondansetron|ondansetron|mesh-list
92084921|NCT00655642|Metoclopramide|metoclopramide|mesh-list
92084922|NCT00655642|Antiemetics|antiemetics|mesh-ancestor
92084923|NCT00655642|Autonomic Agents|autonomic agents|mesh-ancestor
92084924|NCT00655642|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084925|NCT00655642|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084926|NCT00655642|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084927|NCT00655642|Antipruritics|antipruritics|mesh-ancestor
92084928|NCT00655642|Dermatologic Agents|dermatologic agents|mesh-ancestor
92084929|NCT00655642|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92084930|NCT00655642|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92084932|NCT00655642|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92084933|NCT00655642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084934|NCT00655642|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92084935|NCT00655642|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92084936|NCT00655642|Dopamine Agents|dopamine agents|mesh-ancestor
92084937|NCT00655642|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92084938|NCT00655642|Histamine Antagonists|histamine antagonists|mesh-ancestor
92084939|NCT00655642|Histamine Agents|histamine agents|mesh-ancestor
92084940|NCT00655642|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92084941|NCT00655642|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92084942|NCT00655642|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92084943|NCT00655642|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084944|NCT00655642|Anesthetics, Local|anesthetics, local|mesh-ancestor
92084945|NCT00655642|Anesthetics|anesthetics|mesh-ancestor
92084946|NCT00655642|Sensory System Agents|sensory system agents|mesh-ancestor
92084947|NCT00656656|Dexamethasone|dexamethasone|mesh-list
92084948|NCT00656656|Rituximab|rituximab|mesh-list
92084949|NCT00656656|Azathioprine|azathioprine|mesh-list
92084950|NCT00656656|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92084951|NCT00656656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084952|NCT00656656|Immunologic Factors|immunologic factors|mesh-ancestor
92084953|NCT00656656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084954|NCT00656656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92084955|NCT00656656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92084956|NCT00656656|Antiemetics|antiemetics|mesh-ancestor
92084957|NCT00656656|Autonomic Agents|autonomic agents|mesh-ancestor
92084958|NCT00656656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084959|NCT00656656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084960|NCT00656656|Glucocorticoids|glucocorticoids|mesh-ancestor
92084961|NCT00656656|Hormones|hormones|mesh-ancestor
92084962|NCT00656656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084963|NCT00656656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92084964|NCT00656656|Antimetabolites|antimetabolites|mesh-ancestor
92084965|NCT00656656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084966|NCT00656656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92084967|NCT00656656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92084968|NCT01773889|Interferon alpha-2|interferon alpha-2|mesh-list
92084969|NCT01773889|Denileukin diftitox|denileukin diftitox|mesh-list
92084970|NCT01773889|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084971|NCT01773889|Antiviral Agents|antiviral agents|mesh-ancestor
92084972|NCT01773889|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084973|NCT00656968|Esomeprazole|esomeprazole|mesh-list
92084974|NCT00656968|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92084975|NCT00656968|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92084976|NCT00656968|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92084977|NCT00656968|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084979|NCT00657280|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92084980|NCT00657280|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92084981|NCT00657280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084982|NCT00657280|Incretins|incretins|mesh-ancestor
92084984|NCT00657280|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92084985|NCT00657280|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92084986|NCT00657280|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016730|NCT04874935|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084987|NCT00657280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084988|NCT00657280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084990|NCT00693160|Remifentanil|remifentanil|mesh-list
92084991|NCT00693160|Capsaicin|capsaicin|mesh-list
92084992|NCT00693160|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92084993|NCT00693160|Narcotics|narcotics|mesh-ancestor
92084994|NCT00693160|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92084995|NCT00693160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084996|NCT00693160|Analgesics|analgesics|mesh-ancestor
92084997|NCT00693160|Sensory System Agents|sensory system agents|mesh-ancestor
92084998|NCT00693160|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084999|NCT00693160|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92085000|NCT00693160|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085001|NCT00693160|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085002|NCT00693160|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085003|NCT00693160|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92085004|NCT00693160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085005|NCT00693160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085006|NCT00693160|Antipruritics|antipruritics|mesh-ancestor
92085007|NCT00693160|Dermatologic Agents|dermatologic agents|mesh-ancestor
92085008|NCT00695188|Methotrexate|methotrexate|mesh-list
92085009|NCT00695188|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92085010|NCT00695188|Abortifacient Agents|abortifacient agents|mesh-ancestor
92085011|NCT00695188|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92085012|NCT00695188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085013|NCT00695188|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92085014|NCT00695188|Antimetabolites|antimetabolites|mesh-ancestor
92085015|NCT00695188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085016|NCT00695188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085017|NCT00695188|Dermatologic Agents|dermatologic agents|mesh-ancestor
92085018|NCT00695188|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085019|NCT00695188|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92085020|NCT00695188|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085021|NCT00695188|Immunologic Factors|immunologic factors|mesh-ancestor
92085022|NCT00695188|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085023|NCT00695188|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085024|NCT00706264|Silicon|silicon|mesh-list
92085025|NCT00706264|Trace Elements|trace elements|mesh-ancestor
92085026|NCT00706264|Micronutrients|micronutrients|mesh-ancestor
92085027|NCT00706264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085028|NCT00695500|Varenicline|varenicline|mesh-list
92085029|NCT00695500|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92085030|NCT00695500|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92085031|NCT00695500|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085032|NCT00695500|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085033|NCT00695500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085034|NCT00695500|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085035|NCT00695578|Bacitracin|bacitracin|mesh-list
92085036|NCT00695578|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92085037|NCT00695578|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085038|NCT00695578|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085039|NCT01792102|Dexamethasone|dexamethasone|mesh-list
92085040|NCT01792102|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085041|NCT01792102|Antiemetics|antiemetics|mesh-ancestor
92085042|NCT01792102|Autonomic Agents|autonomic agents|mesh-ancestor
92085043|NCT01792102|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085044|NCT01792102|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085045|NCT01792102|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92085046|NCT01792102|Glucocorticoids|glucocorticoids|mesh-ancestor
92085047|NCT01792102|Hormones|hormones|mesh-ancestor
92085048|NCT01792102|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92085049|NCT01792102|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92085053|NCT02996734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085054|NCT00699010|Oxycodone|oxycodone|mesh-list
92085055|NCT00699010|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92085056|NCT00699010|Narcotics|narcotics|mesh-ancestor
92085057|NCT00699010|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085058|NCT00699010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085059|NCT00699010|Analgesics|analgesics|mesh-ancestor
92085060|NCT00699010|Sensory System Agents|sensory system agents|mesh-ancestor
92085061|NCT00699010|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085062|NCT00706810|Hydroxyurea|hydroxyurea|mesh-list
92016731|NCT04874935|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016732|NCT02961361|Dexmedetomidine|dexmedetomidine|mesh-list
92016734|NCT02961361|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92085063|NCT00706810|Verapamil|verapamil|mesh-list
92085064|NCT00706810|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085065|NCT00706810|Antisickling Agents|antisickling agents|mesh-ancestor
92085066|NCT00706810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085067|NCT00706810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085068|NCT00706810|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085069|NCT00706810|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92085070|NCT00706810|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92085071|NCT00706810|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085072|NCT00706810|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92085073|NCT00706810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085074|NCT00706810|Vasodilator Agents|vasodilator agents|mesh-ancestor
92085075|NCT00661960|Efavirenz|efavirenz|mesh-list
92085076|NCT00661960|Raltegravir Potassium|raltegravir potassium|mesh-list
92085077|NCT00661960|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92085078|NCT00661960|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085079|NCT00661960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085080|NCT00661960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085081|NCT00661960|Antiviral Agents|antiviral agents|mesh-ancestor
92085082|NCT00661960|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085083|NCT00661960|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92085084|NCT00661960|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92085085|NCT00661960|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92085086|NCT00661960|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92085087|NCT00661960|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92085088|NCT00661960|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92085089|NCT00661960|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92085090|NCT00661960|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92085091|NCT00661960|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92085092|NCT00661960|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92085093|NCT00662818|Acetaminophen|acetaminophen|mesh-list
92085094|NCT00662818|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085095|NCT00662818|Analgesics|analgesics|mesh-ancestor
92085096|NCT00662818|Sensory System Agents|sensory system agents|mesh-ancestor
92085097|NCT00662818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085098|NCT00662818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085099|NCT00662818|Antipyretics|antipyretics|mesh-ancestor
92085100|NCT00699556|Nicotine|nicotine|mesh-list
92085101|NCT00699556|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92085102|NCT00699556|Autonomic Agents|autonomic agents|mesh-ancestor
92085103|NCT00699556|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085104|NCT00699556|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085105|NCT00699556|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92085106|NCT00699556|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92085107|NCT00699556|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085108|NCT00699556|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085109|NCT00699556|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085110|NCT00700336|Cisplatin|cisplatin|mesh-list
92085111|NCT00700336|Pemetrexed|pemetrexed|mesh-list
92085112|NCT00700336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085113|NCT00700336|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085114|NCT00700336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085115|NCT00700336|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92085116|NCT00700336|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085117|NCT01795846|Immunomodulating Agents|immunomodulating agents|mesh-list
92085118|NCT01795846|Immunologic Factors|immunologic factors|mesh-ancestor
92085119|NCT01795846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085120|NCT00701896|Nicotine|nicotine|mesh-list
92085121|NCT00701896|Varenicline|varenicline|mesh-list
92085125|NCT00701896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085126|NCT00701896|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92085127|NCT00701896|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92085128|NCT00701896|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085129|NCT00701896|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085130|NCT00701896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016735|NCT02961361|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016736|NCT02961361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016737|NCT02961361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085132|NCT01839487|Paclitaxel|paclitaxel|mesh-list
92085133|NCT01839487|Gemcitabine|gemcitabine|mesh-list
92085134|NCT01839487|Enoxaparin|enoxaparin|mesh-list
92085135|NCT01839487|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92085136|NCT01839487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085137|NCT01839487|Tubulin Modulators|tubulin modulators|mesh-ancestor
92085138|NCT01839487|Antimitotic Agents|antimitotic agents|mesh-ancestor
92085139|NCT01839487|Mitosis Modulators|mitosis modulators|mesh-ancestor
92085140|NCT01839487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085141|NCT01839487|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085142|NCT01839487|Antiemetics|antiemetics|mesh-ancestor
92085143|NCT01839487|Autonomic Agents|autonomic agents|mesh-ancestor
92085144|NCT01839487|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085145|NCT01839487|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085146|NCT01839487|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92085147|NCT01839487|Glucocorticoids|glucocorticoids|mesh-ancestor
92085148|NCT01839487|Hormones|hormones|mesh-ancestor
92085149|NCT01839487|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92085150|NCT01839487|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92085151|NCT01839487|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92085152|NCT01839487|Antimetabolites|antimetabolites|mesh-ancestor
92085153|NCT01839487|Anticoagulants|anticoagulants|mesh-ancestor
92085154|NCT01839487|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92085155|NCT01839487|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92085156|NCT00665470|Aldesleukin|aldesleukin|mesh-list
92085157|NCT00665470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085158|NCT00665470|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92085159|NCT00665470|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92085160|NCT00665470|Antiviral Agents|antiviral agents|mesh-ancestor
92085161|NCT00665470|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085162|NCT00666406|Factor VIII|factor viii|mesh-list
92085163|NCT00666406|Coagulants|coagulants|mesh-ancestor
92085164|NCT02995954|Amlodipine|amlodipine|mesh-list
92085165|NCT02995954|Perindopril|perindopril|mesh-list
92085166|NCT02995954|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92085167|NCT02995954|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92085168|NCT02995954|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085169|NCT02995954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085170|NCT02995954|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92085171|NCT02995954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085172|NCT02995954|Vasodilator Agents|vasodilator agents|mesh-ancestor
92085173|NCT02995954|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92085174|NCT02995954|Protease Inhibitors|protease inhibitors|mesh-ancestor
92085175|NCT02995954|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085176|NCT01799941|Quinidine|quinidine|mesh-list
92085177|NCT01799941|Dextromethorphan|dextromethorphan|mesh-list
92085178|NCT01799941|Antitussive Agents|antitussive agents|mesh-ancestor
92085179|NCT01799941|Respiratory System Agents|respiratory system agents|mesh-ancestor
92085180|NCT01799941|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92085181|NCT01799941|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92085182|NCT01799941|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085183|NCT01799941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085184|NCT01799941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085185|NCT01799941|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92085186|NCT01799941|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92085187|NCT01799941|Adrenergic Agents|adrenergic agents|mesh-ancestor
92085188|NCT01799941|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92085189|NCT01799941|Antimalarials|antimalarials|mesh-ancestor
92085190|NCT01799941|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92085191|NCT01799941|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92085192|NCT01799941|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085193|NCT01799941|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085194|NCT01799941|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92085220|NCT00702754|Botulinum Toxins|botulinum toxins|mesh-list
92085221|NCT00702754|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92085222|NCT00702754|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92085223|NCT00702754|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92085224|NCT00702754|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085225|NCT00702754|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016738|NCT02961361|Analgesics|analgesics|mesh-ancestor
92016739|NCT02961361|Sensory System Agents|sensory system agents|mesh-ancestor
92016740|NCT02961361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085226|NCT00702754|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085227|NCT00702754|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085228|NCT00702754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085229|NCT00702754|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92085230|NCT00702754|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085231|NCT00702754|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92085232|NCT02995720|Amlodipine|amlodipine|mesh-list
92085233|NCT02995720|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92085234|NCT02995720|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92085235|NCT02995720|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92085236|NCT02995720|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085237|NCT02995720|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085238|NCT02995720|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92085241|NCT02995720|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92085242|NCT02995720|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92085243|NCT02995720|Antimetabolites|antimetabolites|mesh-ancestor
92085244|NCT02995720|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92085245|NCT02995720|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92085246|NCT02995720|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085247|NCT02990728|Metformin|metformin|mesh-list
92085248|NCT02990728|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085249|NCT02990728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085250|NCT02995330|Cyclophosphamide|cyclophosphamide|mesh-list
92085251|NCT02995330|Methyltestosterone|methyltestosterone|mesh-list
92085252|NCT02995330|Testosterone|testosterone|mesh-list
92085253|NCT02995330|Testosterone undecanoate|testosterone undecanoate|mesh-list
92085254|NCT02995330|Testosterone enanthate|testosterone enanthate|mesh-list
92085255|NCT02995330|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92085256|NCT02995330|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085257|NCT02995330|Immunologic Factors|immunologic factors|mesh-ancestor
92085258|NCT02995330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085259|NCT02995330|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085260|NCT02995330|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92085261|NCT02995330|Alkylating Agents|alkylating agents|mesh-ancestor
92085262|NCT02995330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085263|NCT02995330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085264|NCT02995330|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92085265|NCT02995330|Androgens|androgens|mesh-ancestor
92085266|NCT02995330|Hormones|hormones|mesh-ancestor
92085267|NCT02995330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92085268|NCT02995330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92085269|NCT02995330|Anabolic Agents|anabolic agents|mesh-ancestor
92085270|NCT02990884|Ketamine|ketamine|mesh-list
92085271|NCT02990884|Analgesics|analgesics|mesh-ancestor
92085272|NCT02990884|Sensory System Agents|sensory system agents|mesh-ancestor
92085948|NCT04143477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085273|NCT02990884|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085274|NCT02990884|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085275|NCT02990884|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92085276|NCT02990884|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92085277|NCT02990884|Anesthetics, General|anesthetics, general|mesh-ancestor
92085278|NCT02990884|Anesthetics|anesthetics|mesh-ancestor
92085279|NCT02990884|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085280|NCT02990884|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92085281|NCT02990884|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92085282|NCT02990884|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085283|NCT02990884|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085284|NCT02990416|Pembrolizumab|pembrolizumab|mesh-list
92085285|NCT02990416|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085286|NCT02990416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085287|NCT02990416|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085288|NCT02990416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085290|NCT02999776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92085291|NCT02999776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085292|NCT02999776|Analgesics|analgesics|mesh-ancestor
92016741|NCT02961361|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92085293|NCT02999776|Sensory System Agents|sensory system agents|mesh-ancestor
92085294|NCT02999776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085295|NCT02999776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085296|NCT02999776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085297|NCT02999776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085298|NCT02999776|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92085299|NCT02999776|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085300|NCT02999776|Immunologic Factors|immunologic factors|mesh-ancestor
92085301|NCT02996656|Cefazolin|cefazolin|mesh-list
92085302|NCT02996656|Ceftriaxone|ceftriaxone|mesh-list
92085303|NCT02996656|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085304|NCT02996656|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085305|NCT04387630|Metformin|metformin|mesh-list
92085306|NCT04387630|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085307|NCT04387630|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085308|NCT04270318|Pemetrexed|pemetrexed|mesh-list
92085309|NCT04270318|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085310|NCT04270318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085311|NCT04270318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085315|NCT02999854|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085316|NCT02999854|Immunologic Factors|immunologic factors|mesh-ancestor
92085317|NCT02999854|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085318|NCT02999854|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085319|NCT02999854|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92085320|NCT02999854|Alkylating Agents|alkylating agents|mesh-ancestor
92085321|NCT02999854|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085322|NCT02999854|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085323|NCT02999854|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92085324|NCT04270708|Dexmedetomidine|dexmedetomidine|mesh-list
92085325|NCT04270708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92085326|NCT04270708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085327|NCT04270708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085328|NCT04270708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085329|NCT04270708|Analgesics|analgesics|mesh-ancestor
92085330|NCT04270708|Sensory System Agents|sensory system agents|mesh-ancestor
92085331|NCT04270708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085332|NCT04270708|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92085333|NCT04270708|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92085334|NCT04270708|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92085335|NCT04270708|Adrenergic Agents|adrenergic agents|mesh-ancestor
92085336|NCT04270708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085337|NCT04270708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085338|NCT00704938|Aldesleukin|aldesleukin|mesh-list
92085339|NCT00704938|Cyclophosphamide|cyclophosphamide|mesh-list
92085340|NCT00704938|Fludarabine|fludarabine|mesh-list
92085341|NCT00704938|Fludarabine phosphate|fludarabine phosphate|mesh-list
92085342|NCT00704938|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085343|NCT00704938|Immunologic Factors|immunologic factors|mesh-ancestor
92085344|NCT00704938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085345|NCT00704938|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085346|NCT00704938|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92085347|NCT00704938|Alkylating Agents|alkylating agents|mesh-ancestor
92085348|NCT00704938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085349|NCT00704938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085350|NCT00704938|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92085351|NCT00704938|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92085352|NCT00704938|Antimetabolites|antimetabolites|mesh-ancestor
92085353|NCT00704938|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92085354|NCT00704938|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92085355|NCT00704938|Antiviral Agents|antiviral agents|mesh-ancestor
92085356|NCT00704938|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085357|NCT02994082|Bupropion|bupropion|mesh-list
92085359|NCT02994082|Varenicline|varenicline|mesh-list
92085360|NCT02994082|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92085361|NCT02994082|Autonomic Agents|autonomic agents|mesh-ancestor
92085362|NCT02994082|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085363|NCT02994082|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085364|NCT02994082|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92085365|NCT02994082|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92085366|NCT02994082|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085367|NCT02994082|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016742|NCT02961361|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92085368|NCT02994082|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085369|NCT02994082|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92085370|NCT02994082|Antidepressive Agents|antidepressive agents|mesh-ancestor
92085371|NCT02994082|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92085372|NCT02994082|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92085373|NCT02994082|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92085374|NCT02994082|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085375|NCT02994082|Dopamine Agents|dopamine agents|mesh-ancestor
92085376|NCT02994082|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92085377|NCT02994082|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92085378|NCT02994082|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085379|NCT02995096|Sirolimus|sirolimus|mesh-list
92085380|NCT02995096|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085381|NCT02995096|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085382|NCT02995096|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92085384|NCT02995096|Antifungal Agents|antifungal agents|mesh-ancestor
92085385|NCT02995096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085386|NCT02995096|Immunologic Factors|immunologic factors|mesh-ancestor
92085387|NCT02995096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085388|NCT01275976|Complement C1s|complement c1s|mesh-list
92085389|NCT01275976|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92085390|NCT01275976|Complement C1 Inactivator Proteins|complement c1 inactivator proteins|mesh-list
92085391|NCT01275976|Immunologic Factors|immunologic factors|mesh-ancestor
92085392|NCT01275976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085393|NCT01275976|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92085394|NCT01275976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085395|NCT01270438|Leucovorin|leucovorin|mesh-list
92085396|NCT01270438|Bevacizumab|bevacizumab|mesh-list
92085397|NCT01270438|Fluorouracil|fluorouracil|mesh-list
92085398|NCT01270438|Oxaliplatin|oxaliplatin|mesh-list
92085399|NCT01270438|Calcium|calcium|mesh-list
92085400|NCT01270438|Levoleucovorin|levoleucovorin|mesh-list
92085401|NCT01270438|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92085402|NCT01270438|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085403|NCT01270438|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085404|NCT01270438|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92085405|NCT01270438|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92085406|NCT01270438|Growth Substances|growth substances|mesh-ancestor
92085407|NCT01270438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085408|NCT01270438|Growth Inhibitors|growth inhibitors|mesh-ancestor
92085409|NCT01270438|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92085410|NCT01270438|Antimetabolites|antimetabolites|mesh-ancestor
92085411|NCT01270438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085412|NCT01270438|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92085413|NCT01270438|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085414|NCT01270438|Immunologic Factors|immunologic factors|mesh-ancestor
92085415|NCT01270438|Antidotes|antidotes|mesh-ancestor
92085416|NCT01270438|Protective Agents|protective agents|mesh-ancestor
92085417|NCT01270438|Vitamin B Complex|vitamin b complex|mesh-ancestor
92085418|NCT01270438|Vitamins|vitamins|mesh-ancestor
92085419|NCT01270438|Micronutrients|micronutrients|mesh-ancestor
92085420|NCT01270438|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92085421|NCT01270438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085422|NCT01270672|Carvedilol|carvedilol|mesh-list
92085423|NCT01270672|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92085424|NCT01270672|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92085425|NCT01270672|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92085426|NCT01270672|Adrenergic Agents|adrenergic agents|mesh-ancestor
92085427|NCT01270672|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085428|NCT01270672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085429|NCT01270672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085430|NCT01270672|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92085431|NCT01270672|Antioxidants|antioxidants|mesh-ancestor
92085432|NCT01270672|Protective Agents|protective agents|mesh-ancestor
92085433|NCT01270672|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92085434|NCT01270672|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085435|NCT01270672|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92085436|NCT01270672|Vasodilator Agents|vasodilator agents|mesh-ancestor
92016744|NCT02961361|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016745|NCT02961361|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016746|NCT02961361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085437|NCT01270672|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92085438|NCT01270672|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92085439|NCT01270672|Hallucinogens|hallucinogens|mesh-ancestor
92085440|NCT01270672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92085441|NCT01270672|Serotonin Agents|serotonin agents|mesh-ancestor
92085442|NCT01270672|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92085443|NCT01270672|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92085444|NCT01276210|Sorafenib|sorafenib|mesh-list
92085445|NCT01276210|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085446|NCT01276210|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92085447|NCT01276210|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085448|NCT01276210|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085449|NCT00727636|Vaccines|vaccines|mesh-list
92085450|NCT00727636|Immunologic Factors|immunologic factors|mesh-ancestor
92085451|NCT00727636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085452|NCT01270750|Bosentan|bosentan|mesh-list
92085453|NCT01270750|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92085454|NCT01270750|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92090431|NCT04416035|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92085456|NCT00709696|Varenicline|varenicline|mesh-list
92085457|NCT00709696|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92085458|NCT00709696|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92085459|NCT00709696|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085460|NCT00709696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085461|NCT00709696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085462|NCT00709696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085463|NCT01270984|Imatinib Mesylate|imatinib mesylate|mesh-list
92085464|NCT01270984|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085465|NCT01270984|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92085466|NCT01270984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085467|NCT01270984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085468|NCT02992678|Pentoxifylline|pentoxifylline|mesh-list
92085469|NCT02992678|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92085470|NCT02992678|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085471|NCT02992678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085472|NCT02992678|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92085473|NCT02992678|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92085474|NCT02992678|Protective Agents|protective agents|mesh-ancestor
92085475|NCT02992678|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085476|NCT02992678|Vasodilator Agents|vasodilator agents|mesh-ancestor
92085477|NCT02992678|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92085478|NCT02992678|Antioxidants|antioxidants|mesh-ancestor
92085479|NCT02992912|Atezolizumab|atezolizumab|mesh-list
92085481|NCT02992912|Immunologic Factors|immunologic factors|mesh-ancestor
92085482|NCT02992912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085483|NCT02992912|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085484|NCT02992912|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085485|NCT02992912|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085486|NCT02992912|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085487|NCT01271140|Insulin|insulin|mesh-list
92085488|NCT01271140|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085489|NCT01271140|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085490|NCT01271374|Losartan|losartan|mesh-list
92085491|NCT01271374|Amlodipine|amlodipine|mesh-list
92085492|NCT01271374|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92085493|NCT01271374|Olmesartan|olmesartan|mesh-list
92085494|NCT01271374|Amlodipine Besylate, Olmesartan Medoxomil Drug Combination|amlodipine besylate, olmesartan medoxomil drug combination|mesh-list
92085495|NCT01271374|Spironolactone|spironolactone|mesh-list
92085496|NCT01271374|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92085497|NCT01271374|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92085498|NCT01271374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085499|NCT01271374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085500|NCT01271374|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92085501|NCT01271374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085502|NCT01271374|Vasodilator Agents|vasodilator agents|mesh-ancestor
92085503|NCT01271374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92016747|NCT02961361|Anesthetics, Local|anesthetics, local|mesh-ancestor
92016748|NCT02961361|Anesthetics|anesthetics|mesh-ancestor
92085504|NCT01271374|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92085505|NCT01271374|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92085506|NCT01271374|Diuretics|diuretics|mesh-ancestor
92085507|NCT01271374|Natriuretic Agents|natriuretic agents|mesh-ancestor
92085508|NCT01271374|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92085509|NCT01271374|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92085510|NCT01271374|Hormone Antagonists|hormone antagonists|mesh-ancestor
92085511|NCT01271374|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92085512|NCT01271374|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92085513|NCT01276834|Everolimus|everolimus|mesh-list
92085514|NCT01276834|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92085515|NCT01276834|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92085516|NCT01276834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085517|NCT01276834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085518|NCT01276834|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085519|NCT01276834|Immunologic Factors|immunologic factors|mesh-ancestor
92085520|NCT01276834|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085521|NCT01276834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085522|NCT01276912|Insulin Glargine|insulin glargine|mesh-list
92085523|NCT01276912|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085524|NCT01276912|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085528|NCT00711490|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92085529|NCT00711490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085530|NCT00711490|Antifungal Agents|antifungal agents|mesh-ancestor
92085531|NCT00711490|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085532|NCT00711490|Immunologic Factors|immunologic factors|mesh-ancestor
92085533|NCT00711490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085534|NCT01271998|Tedizolid phosphate|tedizolid phosphate|mesh-list
92085535|NCT01271998|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085536|NCT01271998|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085537|NCT00717418|Cyclosporine|cyclosporine|mesh-list
92085538|NCT00717418|Lubricant Eye Drops|lubricant eye drops|mesh-list
92085539|NCT00717418|Cyclosporins|cyclosporins|mesh-list
92085540|NCT00717418|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085541|NCT00717418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085542|NCT00717418|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085543|NCT00717418|Immunologic Factors|immunologic factors|mesh-ancestor
92085544|NCT00717418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085545|NCT00717418|Antifungal Agents|antifungal agents|mesh-ancestor
92085546|NCT00717418|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085547|NCT00717418|Dermatologic Agents|dermatologic agents|mesh-ancestor
92085548|NCT00717418|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085549|NCT00717418|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92085550|NCT00717418|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92085551|NCT00717418|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92085553|NCT00717574|Propofol|propofol|mesh-list
92085554|NCT00717574|Sevoflurane|sevoflurane|mesh-list
92085555|NCT00717574|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92085556|NCT00717574|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085557|NCT00717574|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085558|NCT00717574|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92085559|NCT00717574|Anesthetics, General|anesthetics, general|mesh-ancestor
92085560|NCT00717574|Anesthetics|anesthetics|mesh-ancestor
92085561|NCT00717574|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92085562|NCT00717574|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92085563|NCT00717574|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085564|NCT00717574|Analgesics|analgesics|mesh-ancestor
92085565|NCT00717574|Sensory System Agents|sensory system agents|mesh-ancestor
92085566|NCT00717574|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085567|NCT00719134|Rizatriptan|rizatriptan|mesh-list
92085568|NCT00719134|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92085569|NCT00719134|Serotonin Agents|serotonin agents|mesh-ancestor
92085570|NCT00719134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085571|NCT00719134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085572|NCT00719134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085573|NCT01277770|Thymoglobulin|thymoglobulin|mesh-list
92085574|NCT01277770|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92085575|NCT01277770|Immunologic Factors|immunologic factors|mesh-ancestor
92085576|NCT01277770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085577|NCT01277770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085579|NCT00721162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085581|NCT01838941|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92085582|NCT01838941|Lipotropic Agents|lipotropic agents|mesh-ancestor
92085583|NCT01838941|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92085584|NCT01838941|Antimetabolites|antimetabolites|mesh-ancestor
92085585|NCT01838941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085586|NCT01838941|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92085587|NCT01773109|Irinotecan|irinotecan|mesh-list
92085588|NCT01773109|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-list
92085589|NCT01773109|Etirinotecan pegol|etirinotecan pegol|mesh-list
92085590|NCT01773109|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92085591|NCT01773109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085592|NCT01773109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085593|NCT01773109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085594|NCT01773109|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92085595|NCT01772719|Zoledronic Acid|zoledronic acid|mesh-list
92085596|NCT01772719|Simvastatin|simvastatin|mesh-list
92085597|NCT01772719|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92085600|NCT01772719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085601|NCT01772719|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92085602|NCT01772719|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92085603|NCT01772719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085604|NCT01772719|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92085605|NCT01772719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085606|NCT05582265|Paclitaxel|paclitaxel|mesh-list
92085607|NCT05582265|Cisplatin|cisplatin|mesh-list
92085608|NCT05582265|Tislelizumab|tislelizumab|mesh-list
92085609|NCT05582265|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92085610|NCT05582265|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085611|NCT05582265|Tubulin Modulators|tubulin modulators|mesh-ancestor
92085612|NCT05582265|Antimitotic Agents|antimitotic agents|mesh-ancestor
92085613|NCT05582265|Mitosis Modulators|mitosis modulators|mesh-ancestor
92085614|NCT05582265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085615|NCT05582265|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085616|NCT04144101|Etoricoxib|etoricoxib|mesh-list
92085617|NCT04144101|Aceclofenac|aceclofenac|mesh-list
92085618|NCT04144101|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92085619|NCT04144101|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085620|NCT04144101|Analgesics|analgesics|mesh-ancestor
92085621|NCT04144101|Sensory System Agents|sensory system agents|mesh-ancestor
92085622|NCT04144101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085623|NCT04144101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085624|NCT04144101|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085625|NCT04144101|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085626|NCT04144101|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92085627|NCT04144101|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92085628|NCT04144101|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085629|NCT04144101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085630|NCT01278004|Ethosuximide|ethosuximide|mesh-list
92085631|NCT01278004|Anticonvulsants|anticonvulsants|mesh-ancestor
92085632|NCT01278238|Phenylephrine|phenylephrine|mesh-list
92085633|NCT01278238|Oxymetazoline|oxymetazoline|mesh-list
92085634|NCT01278238|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92085635|NCT01278238|Mydriatics|mydriatics|mesh-ancestor
92085636|NCT01278238|Autonomic Agents|autonomic agents|mesh-ancestor
92085637|NCT01278238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085638|NCT01278238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085639|NCT01278238|Sympathomimetics|sympathomimetics|mesh-ancestor
92085640|NCT01278238|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92085641|NCT01278238|Nasal Decongestants|nasal decongestants|mesh-ancestor
92085642|NCT01278238|Respiratory System Agents|respiratory system agents|mesh-ancestor
92085643|NCT01278238|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92085644|NCT01278238|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92085645|NCT01278238|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92085646|NCT01278238|Adrenergic Agents|adrenergic agents|mesh-ancestor
92085647|NCT01278238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085648|NCT01278238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085649|NCT01278238|Protective Agents|protective agents|mesh-ancestor
92085650|NCT02706795|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92016749|NCT04974853|Complement System Proteins|complement system proteins|mesh-list
92016750|NCT04974853|Immunologic Factors|immunologic factors|mesh-ancestor
92016751|NCT04974853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085651|NCT02706795|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92085652|NCT02706795|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92085653|NCT02706795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085654|NCT02706795|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085655|NCT02706795|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92085656|NCT02706795|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085657|NCT02706795|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085658|NCT02706795|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085659|NCT02706795|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085660|NCT01272310|Interferons|interferons|mesh-list
92085661|NCT01272310|Ribavirin|ribavirin|mesh-list
92085662|NCT01272310|Interferon-alpha|interferon-alpha|mesh-list
92085663|NCT01272310|Interferon alpha-2|interferon alpha-2|mesh-list
92085664|NCT01272310|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92085665|NCT01272310|Hydroxychloroquine|hydroxychloroquine|mesh-list
92085666|NCT01272310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085667|NCT01272310|Antiviral Agents|antiviral agents|mesh-ancestor
92085668|NCT01272310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085669|NCT01272310|Antimetabolites|antimetabolites|mesh-ancestor
92085679|NCT04386850|Calcifediol|calcifediol|mesh-list
92085680|NCT04386850|Vitamins|vitamins|mesh-ancestor
92085681|NCT04386850|Micronutrients|micronutrients|mesh-ancestor
92085682|NCT04386850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085683|NCT04386850|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92085684|NCT01272778|Lorazepam|lorazepam|mesh-list
92085685|NCT01272778|Anticonvulsants|anticonvulsants|mesh-ancestor
92085686|NCT01272778|Antiemetics|antiemetics|mesh-ancestor
92085687|NCT01272778|Autonomic Agents|autonomic agents|mesh-ancestor
92085688|NCT01272778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085689|NCT01272778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085690|NCT01272778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92085691|NCT01272778|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92085692|NCT01272778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085693|NCT01272778|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92085694|NCT01272778|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92085695|NCT01272778|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92085696|NCT01272778|GABA Modulators|gaba modulators|mesh-ancestor
92085697|NCT01272778|GABA Agents|gaba agents|mesh-ancestor
92085698|NCT01272778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085699|NCT01272778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085700|NCT01272856|Abatacept|abatacept|mesh-list
92085701|NCT01272856|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085702|NCT01272856|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085703|NCT01272856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085704|NCT01272856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085705|NCT01272856|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085706|NCT01272856|Immunologic Factors|immunologic factors|mesh-ancestor
92085707|NCT01272856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085708|NCT01272856|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085709|NCT01273090|Imetelstat|imetelstat|mesh-list
92085710|NCT01273090|Motesanib diphosphate|motesanib diphosphate|mesh-list
92085711|NCT01273090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085712|NCT01273090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085713|NCT01273090|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92085714|NCT01273246|Vaccines|vaccines|mesh-list
92085715|NCT01273246|Immunologic Factors|immunologic factors|mesh-ancestor
92085716|NCT01273246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085717|NCT00730522|Vigabatrin|vigabatrin|mesh-list
92085718|NCT00730522|Anticonvulsants|anticonvulsants|mesh-ancestor
92085719|NCT00730522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085720|NCT00730522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085721|NCT00730522|GABA Agents|gaba agents|mesh-ancestor
92085722|NCT00730522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085723|NCT00730522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085724|NCT04345276|Ritonavir|ritonavir|mesh-list
92085725|NCT04345276|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92085726|NCT04345276|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92085727|NCT04345276|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016752|NCT02725177|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92016753|NCT02725177|Hormones|hormones|mesh-ancestor
92016754|NCT02725177|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016755|NCT02725177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016756|NCT02426281|Paclitaxel|paclitaxel|mesh-list
92016757|NCT02426281|Gemcitabine|gemcitabine|mesh-list
92016758|NCT02426281|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016759|NCT02426281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085728|NCT04345276|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085729|NCT04345276|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085730|NCT04345276|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92085731|NCT04345276|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92085732|NCT04345276|Antiviral Agents|antiviral agents|mesh-ancestor
92085733|NCT04345276|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085734|NCT04345276|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92085735|NCT04345276|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92085738|NCT01273558|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085739|NCT01273558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085740|NCT01273558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085741|NCT00733096|Methylprednisolone|methylprednisolone|mesh-list
92085742|NCT00733096|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92085743|NCT00733096|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92085745|NCT00733096|Prednisolone acetate|prednisolone acetate|mesh-list
92085746|NCT00733096|Etanercept|etanercept|mesh-list
92085747|NCT00733096|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92085748|NCT00733096|Prednisolone phosphate|prednisolone phosphate|mesh-list
92085749|NCT00733096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085750|NCT00733096|Antiemetics|antiemetics|mesh-ancestor
92085751|NCT00733096|Autonomic Agents|autonomic agents|mesh-ancestor
92085752|NCT00733096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085753|NCT00733096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085754|NCT00733096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92085755|NCT00733096|Glucocorticoids|glucocorticoids|mesh-ancestor
92085756|NCT00733096|Hormones|hormones|mesh-ancestor
92085757|NCT00733096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92085758|NCT00733096|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92085759|NCT00733096|Protective Agents|protective agents|mesh-ancestor
92085760|NCT00733096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92085761|NCT00733096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085762|NCT00733096|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92085763|NCT00733096|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085764|NCT00733096|Analgesics|analgesics|mesh-ancestor
92085765|NCT00733096|Sensory System Agents|sensory system agents|mesh-ancestor
92085766|NCT00733096|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085767|NCT00733096|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085768|NCT00733096|Immunologic Factors|immunologic factors|mesh-ancestor
92085769|NCT02991196|Nivolumab|nivolumab|mesh-list
92085770|NCT02991196|DS-8273a|ds-8273a|mesh-list
92085771|NCT02991196|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085772|NCT02991196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085773|NCT02991196|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085774|NCT02991196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085775|NCT01278784|Acetylcysteine|acetylcysteine|mesh-list
92085776|NCT01278784|Chitosan|chitosan|mesh-list
92085777|NCT01278784|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92085778|NCT01278784|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92085779|NCT01278784|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92085780|NCT01278784|Antiviral Agents|antiviral agents|mesh-ancestor
92085781|NCT01278784|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085782|NCT01278784|Expectorants|expectorants|mesh-ancestor
92085783|NCT01278784|Respiratory System Agents|respiratory system agents|mesh-ancestor
92085784|NCT01278784|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92085785|NCT01278784|Antioxidants|antioxidants|mesh-ancestor
92085786|NCT01278784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085787|NCT01278784|Protective Agents|protective agents|mesh-ancestor
92085788|NCT01278784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085789|NCT01278784|Antidotes|antidotes|mesh-ancestor
92085790|NCT01278784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92085791|NCT01278784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92085792|NCT01278784|Antimetabolites|antimetabolites|mesh-ancestor
92085793|NCT01278784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92085794|NCT01278784|Chelating Agents|chelating agents|mesh-ancestor
92085795|NCT01278784|Sequestering Agents|sequestering agents|mesh-ancestor
92085796|NCT01278784|Hemostatics|hemostatics|mesh-ancestor
92085797|NCT01278784|Coagulants|coagulants|mesh-ancestor
92085798|NCT01276288|Empagliflozin|empagliflozin|mesh-list
92085799|NCT01276288|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92085800|NCT01276288|Torsemide|torsemide|mesh-list
92085801|NCT01276288|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92085802|NCT01276288|Diuretics|diuretics|mesh-ancestor
92085803|NCT01276288|Natriuretic Agents|natriuretic agents|mesh-ancestor
92085804|NCT01276288|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086031|NCT04149171|Hemostatics|hemostatics|mesh-ancestor
92085805|NCT01276288|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92085806|NCT01276288|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085807|NCT01276288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085808|NCT01276288|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92085809|NCT01276288|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085813|NCT00722722|Bortezomib|bortezomib|mesh-list
92085814|NCT00722722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085815|NCT00723580|Risperidone|risperidone|mesh-list
92085816|NCT00723580|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92085817|NCT00723580|Serotonin Agents|serotonin agents|mesh-ancestor
92085818|NCT00723580|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085819|NCT00723580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085820|NCT00723580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085821|NCT00723580|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92085822|NCT00723580|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92085823|NCT00723580|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085824|NCT00723580|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92085825|NCT00723580|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92085826|NCT00723580|Dopamine Agents|dopamine agents|mesh-ancestor
92085827|NCT01273948|Interferons|interferons|mesh-list
92085828|NCT01273948|Bavituximab|bavituximab|mesh-list
92085829|NCT01273948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085830|NCT01273948|Antiviral Agents|antiviral agents|mesh-ancestor
92085831|NCT01273948|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085832|NCT01273948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085833|NCT00734344|Tenofovir|tenofovir|mesh-list
92085834|NCT00734344|Efavirenz|efavirenz|mesh-list
92085835|NCT00734344|Raltegravir Potassium|raltegravir potassium|mesh-list
92085836|NCT00734344|Antiviral Agents|antiviral agents|mesh-ancestor
92085837|NCT00734344|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085838|NCT00734344|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92085839|NCT00734344|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085840|NCT00734344|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085841|NCT00734344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085842|NCT00734344|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92085843|NCT00734344|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92085844|NCT00734344|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92085845|NCT00734344|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92085846|NCT00734344|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92085847|NCT00734344|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92085848|NCT00734344|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92085849|NCT00734344|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92085850|NCT00734344|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92085851|NCT00734344|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92085852|NCT04148937|Pembrolizumab|pembrolizumab|mesh-list
92085853|NCT04148937|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085854|NCT04148937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085855|NCT04148937|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085856|NCT04148937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085857|NCT03021057|Pembrolizumab|pembrolizumab|mesh-list
92085858|NCT03021057|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085859|NCT03021057|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085860|NCT03021057|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085861|NCT03021057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085862|NCT00734500|Anidulafungin|anidulafungin|mesh-list
92085863|NCT00734500|Antifungal Agents|antifungal agents|mesh-ancestor
92085864|NCT00734500|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085865|NCT04143321|Empagliflozin|empagliflozin|mesh-list
92016761|NCT02426281|Antimitotic Agents|antimitotic agents|mesh-ancestor
92016762|NCT02426281|Mitosis Modulators|mitosis modulators|mesh-ancestor
92016763|NCT02426281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085866|NCT04143321|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92085867|NCT04143321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085868|NCT04143321|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92085869|NCT04143321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085870|NCT00734968|Nitrofurantoin|nitrofurantoin|mesh-list
92085871|NCT00734968|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92085872|NCT00734968|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085873|NCT00734968|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085874|NCT00735436|Bevacizumab|bevacizumab|mesh-list
92085875|NCT00735436|Irinotecan|irinotecan|mesh-list
92085876|NCT00735436|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085877|NCT00735436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085878|NCT00735436|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92085879|NCT00735436|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92085880|NCT00735436|Growth Substances|growth substances|mesh-ancestor
92085883|NCT00735436|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92085884|NCT00735436|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92085886|NCT00735436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085887|NCT04143165|Lidocaine|lidocaine|mesh-list
92085888|NCT04143165|Anesthetics, Local|anesthetics, local|mesh-ancestor
92085889|NCT04143165|Anesthetics|anesthetics|mesh-ancestor
92085890|NCT04143165|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92085891|NCT04143165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085892|NCT04143165|Sensory System Agents|sensory system agents|mesh-ancestor
92085893|NCT04143165|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085894|NCT04143165|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92085895|NCT04143165|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92085896|NCT04143165|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92085897|NCT04143165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085898|NCT04143165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085899|NCT00735670|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92085900|NCT00735670|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92085901|NCT00735670|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92085902|NCT00735670|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085903|NCT00735670|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085904|NCT00735670|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085905|NCT00735670|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085906|NCT00735670|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92085907|NCT00735670|Antidepressive Agents|antidepressive agents|mesh-ancestor
92085908|NCT00735670|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92085909|NCT00735826|Vorinostat|vorinostat|mesh-list
92085910|NCT00735826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085911|NCT00735826|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92085912|NCT00735826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085913|NCT00735826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085914|NCT03916341|Nicotine|nicotine|mesh-list
92085915|NCT03916341|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92085916|NCT03916341|Autonomic Agents|autonomic agents|mesh-ancestor
92085917|NCT03916341|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085918|NCT03916341|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085919|NCT03916341|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92085920|NCT03916341|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92085921|NCT03916341|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085922|NCT03916341|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085923|NCT03916341|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085924|NCT01276054|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92085925|NCT01276054|Methylene Blue|methylene blue|mesh-list
92085926|NCT01276054|Technetium Tc 99m Sulfur Colloid|technetium tc 99m sulfur colloid|mesh-list
92085927|NCT01276054|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085928|NCT01276054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085929|NCT01276054|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92085930|NCT00724594|Acetylcysteine|acetylcysteine|mesh-list
92085931|NCT00724594|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92016764|NCT02426281|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016765|NCT02426281|Antimetabolites|antimetabolites|mesh-ancestor
92016766|NCT02448537|Gemcitabine|gemcitabine|mesh-list
92016767|NCT02448537|Doxorubicin|doxorubicin|mesh-list
92016768|NCT02448537|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92085932|NCT00724594|Antiviral Agents|antiviral agents|mesh-ancestor
92085933|NCT00724594|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085934|NCT00724594|Expectorants|expectorants|mesh-ancestor
92085935|NCT00724594|Respiratory System Agents|respiratory system agents|mesh-ancestor
92085936|NCT00724594|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92085937|NCT00724594|Antioxidants|antioxidants|mesh-ancestor
92085938|NCT00724594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085939|NCT00724594|Protective Agents|protective agents|mesh-ancestor
92085940|NCT00724594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085941|NCT00724594|Antidotes|antidotes|mesh-ancestor
92085942|NCT04142931|Nivolumab|nivolumab|mesh-list
92085943|NCT04142931|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92085944|NCT04142931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085945|NCT04142931|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92085946|NCT04142931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085947|NCT04143477|Peficitinib|peficitinib|mesh-list
92085949|NCT04143477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085956|NCT03020979|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085957|NCT03020979|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92085958|NCT03020979|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085959|NCT03020979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085960|NCT04142151|Aspirin|aspirin|mesh-list
92085961|NCT04142151|Clopidogrel|clopidogrel|mesh-list
92085962|NCT04142151|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92085963|NCT04142151|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92085964|NCT04142151|Analgesics|analgesics|mesh-ancestor
92085965|NCT04142151|Sensory System Agents|sensory system agents|mesh-ancestor
92085966|NCT04142151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085967|NCT04142151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085968|NCT04142151|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92085969|NCT04142151|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085970|NCT04142151|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92085971|NCT04142151|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92085972|NCT04142151|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085973|NCT04142151|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92085974|NCT04142151|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92085975|NCT04142151|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085976|NCT04142151|Antipyretics|antipyretics|mesh-ancestor
92085977|NCT04142151|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92085978|NCT04142151|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92085979|NCT04142151|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92085980|NCT04142151|Purinergic Agents|purinergic agents|mesh-ancestor
92085981|NCT04142151|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085982|NCT02985099|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92085983|NCT02985099|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92085984|NCT02985099|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92085985|NCT02985099|Antimetabolites|antimetabolites|mesh-ancestor
92085986|NCT02985099|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085987|NCT02985099|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92085988|NCT02985099|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92085989|NCT02985099|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085990|NCT03904329|Anticoagulants|anticoagulants|mesh-list
92085991|NCT04149483|Atorvastatin|atorvastatin|mesh-list
92085992|NCT04149483|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92085993|NCT04149483|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92085994|NCT04149483|Antimetabolites|antimetabolites|mesh-ancestor
92085995|NCT04149483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085996|NCT04149483|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92085997|NCT04149483|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92085998|NCT04149483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085999|NCT04149327|Amoxicillin|amoxicillin|mesh-list
92086000|NCT04149327|Metronidazole|metronidazole|mesh-list
92016769|NCT02448537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086001|NCT04149327|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086002|NCT04149327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086003|NCT04149327|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92086004|NCT04149327|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92086005|NCT05582577|Bevacizumab|bevacizumab|mesh-list
92086006|NCT05582577|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086007|NCT05582577|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086008|NCT05582577|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92086009|NCT05582577|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92086010|NCT05582577|Growth Substances|growth substances|mesh-ancestor
92086011|NCT05582577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086012|NCT05582577|Growth Inhibitors|growth inhibitors|mesh-ancestor
92086013|NCT04149015|Paclitaxel|paclitaxel|mesh-list
92086014|NCT04149015|Fluorouracil|fluorouracil|mesh-list
92086015|NCT04149015|Oxaliplatin|oxaliplatin|mesh-list
92086016|NCT04149015|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92086017|NCT04149015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086018|NCT04149015|Tubulin Modulators|tubulin modulators|mesh-ancestor
92086019|NCT04149015|Antimitotic Agents|antimitotic agents|mesh-ancestor
92086023|NCT04149015|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086024|NCT04149015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92086025|NCT04149015|Immunologic Factors|immunologic factors|mesh-ancestor
92086026|NCT04149015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086027|NCT04149171|Tranexamic Acid|tranexamic acid|mesh-list
92086028|NCT04149171|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92086029|NCT04149171|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92086030|NCT04149171|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086032|NCT04149171|Coagulants|coagulants|mesh-ancestor
92086033|NCT04140591|Propranolol|propranolol|mesh-list
92086034|NCT04140591|Proton Pump Inhibitors|proton pump inhibitors|mesh-list
92086035|NCT04140591|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92086036|NCT04140591|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92086037|NCT04140591|Adrenergic Agents|adrenergic agents|mesh-ancestor
92086038|NCT04140591|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086039|NCT04140591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086040|NCT04140591|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086041|NCT04140591|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92086042|NCT04140591|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92086043|NCT04140591|Vasodilator Agents|vasodilator agents|mesh-ancestor
92086044|NCT04140591|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086045|NCT05582109|Lenvatinib|lenvatinib|mesh-list
92086046|NCT05582109|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086047|NCT05582109|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086048|NCT05582109|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086049|NCT05582109|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086050|NCT03020901|Teicoplanin|teicoplanin|mesh-list
92086051|NCT03020901|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086052|NCT03020901|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086053|NCT04140201|Simvastatin|simvastatin|mesh-list
92086054|NCT04140201|Fenofibrate|fenofibrate|mesh-list
92086055|NCT04140201|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92086056|NCT04140201|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92086057|NCT04140201|Antimetabolites|antimetabolites|mesh-ancestor
92086058|NCT04140201|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086059|NCT04140201|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92086060|NCT04140201|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92086061|NCT04140201|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086062|NCT05581875|Dexamethasone|dexamethasone|mesh-list
92086063|NCT05581875|Daratumumab|daratumumab|mesh-list
92086064|NCT05581875|Pomalidomide|pomalidomide|mesh-list
92086065|NCT05581875|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086066|NCT05581875|Antiemetics|antiemetics|mesh-ancestor
92086067|NCT05581875|Autonomic Agents|autonomic agents|mesh-ancestor
92086068|NCT05581875|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086069|NCT05581875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086070|NCT05581875|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086071|NCT05581875|Glucocorticoids|glucocorticoids|mesh-ancestor
92086072|NCT05581875|Hormones|hormones|mesh-ancestor
92086073|NCT05581875|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086074|NCT05581875|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086075|NCT05581875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086076|NCT05581875|Immunologic Factors|immunologic factors|mesh-ancestor
92086077|NCT05581875|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92016770|NCT02448537|Antimetabolites|antimetabolites|mesh-ancestor
92086078|NCT05581875|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92086079|NCT05581875|Growth Substances|growth substances|mesh-ancestor
92086080|NCT05581875|Growth Inhibitors|growth inhibitors|mesh-ancestor
92086081|NCT04406025|Anesthetics|anesthetics|mesh-list
92086082|NCT04406025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086083|NCT04406025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086084|NCT05587881|Vaccines|vaccines|mesh-list
92086085|NCT05587881|Immunologic Factors|immunologic factors|mesh-ancestor
92086086|NCT05587881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086087|NCT05582421|Diclofenac|diclofenac|mesh-list
92086088|NCT05582421|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92086089|NCT05582421|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92086090|NCT05582421|Analgesics|analgesics|mesh-ancestor
92086091|NCT05582421|Sensory System Agents|sensory system agents|mesh-ancestor
92086096|NCT05582421|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92086097|NCT05582421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086098|NCT05582421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086099|NCT03580473|Moxifloxacin|moxifloxacin|mesh-list
92086100|NCT03580473|Dexamethasone|dexamethasone|mesh-list
92086101|NCT03580473|Norgestimate, ethinyl estradiol drug combination|norgestimate, ethinyl estradiol drug combination|mesh-list
92086102|NCT03580473|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086103|NCT03580473|Antiemetics|antiemetics|mesh-ancestor
92086104|NCT03580473|Autonomic Agents|autonomic agents|mesh-ancestor
92086105|NCT03580473|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086106|NCT03580473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086107|NCT03580473|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086108|NCT03580473|Glucocorticoids|glucocorticoids|mesh-ancestor
92086109|NCT03580473|Hormones|hormones|mesh-ancestor
92086110|NCT03580473|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086111|NCT03580473|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086112|NCT03580473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086113|NCT03580473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086114|NCT03580473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086115|NCT03580473|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086116|NCT03580473|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086117|NCT03580473|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92086118|NCT03580473|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92086119|NCT03580473|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92086120|NCT03580473|Contraceptive Agents|contraceptive agents|mesh-ancestor
92086121|NCT03580473|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92086122|NCT03580473|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92086123|NCT03580473|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92086124|NCT03580473|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92086125|NCT03897309|Vaccines|vaccines|mesh-list
92086126|NCT03897309|Immunologic Factors|immunologic factors|mesh-ancestor
92086127|NCT03897309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086128|NCT03588429|Sevoflurane|sevoflurane|mesh-list
92086130|NCT03588429|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92086131|NCT03588429|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92086132|NCT03588429|Anesthetics, General|anesthetics, general|mesh-ancestor
92086133|NCT03588429|Anesthetics|anesthetics|mesh-ancestor
92086134|NCT03588429|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086135|NCT03588429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086136|NCT03580161|Sodium Pertechnetate Tc 99m|sodium pertechnetate tc 99m|mesh-list
92086137|NCT03580161|Technetium Tc 99m Medronate|technetium tc 99m medronate|mesh-list
92086138|NCT03580161|Technetium Tc 99m Dimercaptosuccinic Acid|technetium tc 99m dimercaptosuccinic acid|mesh-list
92086139|NCT03580161|Technetium Tc 99m Mertiatide|technetium tc 99m mertiatide|mesh-list
92086140|NCT03580161|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92086141|NCT03580161|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086142|NCT03588351|Chlorhexidine|chlorhexidine|mesh-list
92086143|NCT03588351|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92086144|NCT03588351|Chitosan|chitosan|mesh-list
92086145|NCT03588351|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92086146|NCT03588351|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086147|NCT03588351|Disinfectants|disinfectants|mesh-ancestor
92086148|NCT03588351|Dermatologic Agents|dermatologic agents|mesh-ancestor
92086149|NCT03588351|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92086150|NCT03588351|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92086151|NCT03588351|Antimetabolites|antimetabolites|mesh-ancestor
92086152|NCT03588351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086153|NCT03588351|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92086154|NCT03588351|Chelating Agents|chelating agents|mesh-ancestor
92016771|NCT02448537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016772|NCT02448537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016773|NCT02448537|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92016774|NCT02448537|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92016775|NCT02448537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92016776|NCT02448537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086155|NCT03588351|Sequestering Agents|sequestering agents|mesh-ancestor
92086156|NCT03588351|Hemostatics|hemostatics|mesh-ancestor
92086157|NCT03588351|Coagulants|coagulants|mesh-ancestor
92086158|NCT03588273|Amoxicillin|amoxicillin|mesh-list
92086159|NCT03588273|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086160|NCT03588273|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086161|NCT02984865|Flurbiprofen|flurbiprofen|mesh-list
92086162|NCT02984865|Sufentanil|sufentanil|mesh-list
92086163|NCT02984865|Nalbuphine|nalbuphine|mesh-list
92086166|NCT02984865|Narcotics|narcotics|mesh-ancestor
92086167|NCT02984865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086168|NCT02984865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086169|NCT02984865|Analgesics|analgesics|mesh-ancestor
92086170|NCT02984865|Sensory System Agents|sensory system agents|mesh-ancestor
92086171|NCT02984865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086172|NCT02984865|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92086173|NCT02984865|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92086174|NCT02984865|Anesthetics, General|anesthetics, general|mesh-ancestor
92086175|NCT02984865|Anesthetics|anesthetics|mesh-ancestor
92086176|NCT02984865|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92086177|NCT02984865|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92086178|NCT02984865|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086179|NCT02984865|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086180|NCT02984865|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92086181|NCT02984865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086182|NCT02984865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086183|NCT01797445|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92086184|NCT01797445|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92086185|NCT01797445|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92086186|NCT01797445|Antiviral Agents|antiviral agents|mesh-ancestor
92086187|NCT01797445|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086188|NCT03935451|Apixaban|apixaban|mesh-list
92086189|NCT03935451|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92086190|NCT03935451|Antithrombins|antithrombins|mesh-ancestor
92086191|NCT03935451|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92086192|NCT03935451|Protease Inhibitors|protease inhibitors|mesh-ancestor
92086193|NCT03935451|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086194|NCT03935451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086195|NCT03935451|Anticoagulants|anticoagulants|mesh-ancestor
92086196|NCT01611259|Rituximab|rituximab|mesh-list
92086197|NCT01611259|Lenalidomide|lenalidomide|mesh-list
92086198|NCT01611259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086199|NCT01611259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086200|NCT01611259|Immunologic Factors|immunologic factors|mesh-ancestor
92086201|NCT01611259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086202|NCT01611259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086203|NCT01611259|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92086204|NCT01611259|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92086205|NCT01611259|Growth Substances|growth substances|mesh-ancestor
92086206|NCT01611259|Growth Inhibitors|growth inhibitors|mesh-ancestor
92086208|NCT03586869|Paclitaxel|paclitaxel|mesh-list
92086209|NCT03586869|Cyclophosphamide|cyclophosphamide|mesh-list
92086210|NCT03586869|Bevacizumab|bevacizumab|mesh-list
92086211|NCT03586869|Fluorouracil|fluorouracil|mesh-list
92086212|NCT03586869|Capecitabine|capecitabine|mesh-list
92086213|NCT03586869|Oxaliplatin|oxaliplatin|mesh-list
92086214|NCT03586869|Avelumab|avelumab|mesh-list
92086215|NCT03586869|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92086216|NCT03586869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086217|NCT03586869|Tubulin Modulators|tubulin modulators|mesh-ancestor
92086218|NCT03586869|Antimitotic Agents|antimitotic agents|mesh-ancestor
92086219|NCT03586869|Mitosis Modulators|mitosis modulators|mesh-ancestor
92086220|NCT03586869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086221|NCT03586869|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016778|NCT04838743|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92016779|NCT04838743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016780|NCT04838743|Incretins|incretins|mesh-ancestor
92016781|NCT04838743|Hormones|hormones|mesh-ancestor
92016782|NCT04838743|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016783|NCT03060265|Acetaminophen|acetaminophen|mesh-list
92016784|NCT03060265|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92086222|NCT03586869|Immunologic Factors|immunologic factors|mesh-ancestor
92086223|NCT03586869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086224|NCT03586869|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086225|NCT03586869|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92086226|NCT03586869|Alkylating Agents|alkylating agents|mesh-ancestor
92086227|NCT03586869|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92086228|NCT03586869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086229|NCT03586869|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92086230|NCT03586869|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92086231|NCT03586869|Growth Substances|growth substances|mesh-ancestor
92086232|NCT03586869|Growth Inhibitors|growth inhibitors|mesh-ancestor
92086233|NCT03586869|Antimetabolites|antimetabolites|mesh-ancestor
92086234|NCT03586869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086235|NCT03586869|Antidotes|antidotes|mesh-ancestor
92086236|NCT03586869|Protective Agents|protective agents|mesh-ancestor
92086237|NCT03586869|Vitamin B Complex|vitamin b complex|mesh-ancestor
92086238|NCT03586869|Vitamins|vitamins|mesh-ancestor
92086239|NCT03586869|Micronutrients|micronutrients|mesh-ancestor
92086242|NCT03586791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086244|NCT01795495|Remifentanil|remifentanil|mesh-list
92086245|NCT01795495|Methadone|methadone|mesh-list
92086246|NCT01795495|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92086247|NCT01795495|Narcotics|narcotics|mesh-ancestor
92086248|NCT01795495|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086249|NCT01795495|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086250|NCT01795495|Analgesics|analgesics|mesh-ancestor
92086251|NCT01795495|Sensory System Agents|sensory system agents|mesh-ancestor
92086252|NCT01795495|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086253|NCT01795495|Anesthetics|anesthetics|mesh-ancestor
92086254|NCT01795495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92086255|NCT01795495|Anticonvulsants|anticonvulsants|mesh-ancestor
92086256|NCT01795495|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92086257|NCT01795495|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92086258|NCT01795495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086259|NCT01795495|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92086260|NCT01795495|Tocolytic Agents|tocolytic agents|mesh-ancestor
92086261|NCT01795495|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92086262|NCT01795495|Antitussive Agents|antitussive agents|mesh-ancestor
92086263|NCT01795495|Respiratory System Agents|respiratory system agents|mesh-ancestor
92086264|NCT04765527|Turmeric extract|turmeric extract|mesh-list
92086265|NCT04765527|Antioxidants|antioxidants|mesh-ancestor
92086266|NCT04765527|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086267|NCT04765527|Protective Agents|protective agents|mesh-ancestor
92086268|NCT04765527|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086269|NCT02947503|Metformin|metformin|mesh-list
92086271|NCT02947503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086272|NCT03586323|Lidocaine|lidocaine|mesh-list
92086273|NCT03586323|Anesthetics, Local|anesthetics, local|mesh-ancestor
92086274|NCT03586323|Anesthetics|anesthetics|mesh-ancestor
92086275|NCT03586323|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086276|NCT03586323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086277|NCT03586323|Sensory System Agents|sensory system agents|mesh-ancestor
92086278|NCT03586323|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086279|NCT03586323|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92086280|NCT03586323|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92086281|NCT03586323|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92086282|NCT03586323|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92086283|NCT03586323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086284|NCT03586089|Diazepam|diazepam|mesh-list
92016785|NCT03060265|Analgesics|analgesics|mesh-ancestor
92016786|NCT03060265|Sensory System Agents|sensory system agents|mesh-ancestor
92016787|NCT03060265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016788|NCT03060265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016789|NCT03060265|Antipyretics|antipyretics|mesh-ancestor
92016790|NCT02504151|Cannabidiol|cannabidiol|mesh-list
92016791|NCT02504151|Anticonvulsants|anticonvulsants|mesh-ancestor
92086285|NCT03586089|Phenobarbital|phenobarbital|mesh-list
92086286|NCT03586089|Anticonvulsants|anticonvulsants|mesh-ancestor
92086287|NCT03586089|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92086288|NCT03586089|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086289|NCT03586089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086290|NCT03586089|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92086291|NCT03586089|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92086292|NCT03586089|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086293|NCT03586089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086294|NCT03586089|GABA Modulators|gaba modulators|mesh-ancestor
92086295|NCT03586089|GABA Agents|gaba agents|mesh-ancestor
92086296|NCT03586089|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92086297|NCT03586089|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92086298|NCT03586089|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92086299|NCT03586089|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92086300|NCT03586089|Antiemetics|antiemetics|mesh-ancestor
92086301|NCT03586089|Autonomic Agents|autonomic agents|mesh-ancestor
92086302|NCT03586089|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086303|NCT03586089|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086304|NCT03586089|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92086305|NCT03586089|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92086306|NCT03586089|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92086307|NCT03586089|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92086308|NCT03586089|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92086309|NCT03586089|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92086310|NCT03586089|Anesthetics, General|anesthetics, general|mesh-ancestor
92086311|NCT03586089|Anesthetics|anesthetics|mesh-ancestor
92086313|NCT01986881|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92086314|NCT01986881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086316|NCT01986881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086317|NCT03580395|Paclitaxel|paclitaxel|mesh-list
92086318|NCT03580395|Apatinib|apatinib|mesh-list
92086319|NCT03580395|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92086320|NCT03580395|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086321|NCT03580395|Tubulin Modulators|tubulin modulators|mesh-ancestor
92086322|NCT03580395|Antimitotic Agents|antimitotic agents|mesh-ancestor
92086323|NCT03580395|Mitosis Modulators|mitosis modulators|mesh-ancestor
92086324|NCT03580395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086325|NCT03580395|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086326|NCT03580395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086327|NCT01770145|Levodopa|levodopa|mesh-list
92086328|NCT01770145|Carbidopa|carbidopa|mesh-list
92086329|NCT01770145|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92086330|NCT01770145|Trimethobenzamide|trimethobenzamide|mesh-list
92086331|NCT01770145|Apomorphine|apomorphine|mesh-list
92086332|NCT01770145|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92086333|NCT01770145|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92086334|NCT01770145|Dopamine Agents|dopamine agents|mesh-ancestor
92086335|NCT01770145|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086336|NCT01770145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086337|NCT01770145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086338|NCT01770145|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92086339|NCT01770145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086340|NCT01770145|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92086341|NCT01770145|Immunologic Factors|immunologic factors|mesh-ancestor
92086342|NCT01770145|Dopamine Agonists|dopamine agonists|mesh-ancestor
92086343|NCT01770145|Emetics|emetics|mesh-ancestor
92086344|NCT01770145|Autonomic Agents|autonomic agents|mesh-ancestor
92086345|NCT01770145|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086346|NCT01770145|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086347|NCT01770145|Antiemetics|antiemetics|mesh-ancestor
92086348|NCT01609543|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92016793|NCT02448381|Antidepressive Agents|antidepressive agents|mesh-ancestor
92016794|NCT02448381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92016795|NCT02448381|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016796|NCT02448381|Antiviral Agents|antiviral agents|mesh-ancestor
92016797|NCT02448381|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016798|NCT02448381|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086349|NCT01609543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086350|NCT01609543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086351|NCT01609543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086352|NCT01609543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086353|NCT03580239|Everolimus|everolimus|mesh-list
92086354|NCT03580239|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92086355|NCT03580239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086356|NCT03580239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086357|NCT03580239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086358|NCT03580239|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92086359|NCT03580239|Immunologic Factors|immunologic factors|mesh-ancestor
92086360|NCT03580239|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086361|NCT03580239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086363|NCT03156153|Diuretics|diuretics|mesh-ancestor
92086364|NCT03156153|Natriuretic Agents|natriuretic agents|mesh-ancestor
92086365|NCT03156153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086366|NCT03156153|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92086367|NCT03156153|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92086368|NCT03156153|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086369|NCT03156231|Acetazolamide|acetazolamide|mesh-list
92086370|NCT03156231|Anticonvulsants|anticonvulsants|mesh-ancestor
92086371|NCT03156231|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92086372|NCT03156231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086373|NCT03156231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086374|NCT03156231|Diuretics|diuretics|mesh-ancestor
92086375|NCT03156231|Natriuretic Agents|natriuretic agents|mesh-ancestor
92086376|NCT03156231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086377|NCT05702151|Morphine|morphine|mesh-list
92086378|NCT05702151|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92086379|NCT05702151|Narcotics|narcotics|mesh-ancestor
92086380|NCT05702151|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086381|NCT05702151|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086382|NCT05702151|Analgesics|analgesics|mesh-ancestor
92086383|NCT05702151|Sensory System Agents|sensory system agents|mesh-ancestor
92086384|NCT05702151|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086385|NCT05701995|Deucravacitinib|deucravacitinib|mesh-list
92086387|NCT05701995|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086388|NCT05701995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086389|NCT05701995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086390|NCT01985321|Ethanol|ethanol|mesh-list
92086391|NCT01985321|Glycolic acid|glycolic acid|mesh-list
92086392|NCT01985321|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92086393|NCT01985321|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086394|NCT01985321|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086395|NCT01985321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086396|NCT01985321|Keratolytic Agents|keratolytic agents|mesh-ancestor
92086397|NCT01985321|Dermatologic Agents|dermatologic agents|mesh-ancestor
92086398|NCT03584919|Doxycycline|doxycycline|mesh-list
92086399|NCT03584919|Cefuroxime|cefuroxime|mesh-list
92086400|NCT03584919|Cefuroxime axetil|cefuroxime axetil|mesh-list
92086401|NCT03584919|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086402|NCT03584919|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086403|NCT03584919|Antimalarials|antimalarials|mesh-ancestor
92086404|NCT03584919|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92086405|NCT03584919|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92086406|NCT03584841|Pilocarpine|pilocarpine|mesh-list
92086407|NCT03584841|Miotics|miotics|mesh-ancestor
92086408|NCT03584841|Autonomic Agents|autonomic agents|mesh-ancestor
92086409|NCT03584841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086410|NCT03584841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086411|NCT03584841|Muscarinic Agonists|muscarinic agonists|mesh-ancestor
92086412|NCT03584841|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92016799|NCT02448381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016801|NCT02448381|Immunologic Factors|immunologic factors|mesh-ancestor
92016802|NCT02448381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016803|NCT02448225|Deoxyglucose|deoxyglucose|mesh-list
92016804|NCT02448225|Fluorides|fluorides|mesh-list
92016805|NCT02448225|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92016806|NCT02448225|Cariostatic Agents|cariostatic agents|mesh-ancestor
92016807|NCT02448225|Protective Agents|protective agents|mesh-ancestor
92086413|NCT03584841|Cholinergic Agents|cholinergic agents|mesh-ancestor
92086414|NCT03584841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086415|NCT03584841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086416|NCT02000921|Nicotine|nicotine|mesh-list
92086417|NCT02000921|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92086418|NCT02000921|Autonomic Agents|autonomic agents|mesh-ancestor
92086419|NCT02000921|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086420|NCT02000921|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086421|NCT02000921|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92086422|NCT02000921|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92086423|NCT02000921|Cholinergic Agents|cholinergic agents|mesh-ancestor
92086424|NCT02000921|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086425|NCT02000921|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086426|NCT03586947|Vitamin D|vitamin d|mesh-list
92086427|NCT03586947|Ergocalciferols|ergocalciferols|mesh-list
92086428|NCT03586947|Cholecalciferol|cholecalciferol|mesh-list
92086429|NCT03586947|Vitamins|vitamins|mesh-list
92086430|NCT03586947|Micronutrients|micronutrients|mesh-ancestor
92086432|NCT03586947|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92086433|NCT03586947|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92086434|NCT03584529|Vitamin D|vitamin d|mesh-list
92086435|NCT03584529|Cholecalciferol|cholecalciferol|mesh-list
92086436|NCT03584529|Vitamins|vitamins|mesh-ancestor
92086437|NCT03584529|Micronutrients|micronutrients|mesh-ancestor
92086438|NCT03584529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086439|NCT03584529|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92086440|NCT03584529|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92086441|NCT00724984|Abexinostat|abexinostat|mesh-list
92086442|NCT00724984|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92086443|NCT00724984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086444|NCT00724984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086445|NCT03113253|Tranexamic Acid|tranexamic acid|mesh-list
92086446|NCT03113253|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92086447|NCT03113253|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92086448|NCT03113253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086449|NCT03113253|Hemostatics|hemostatics|mesh-ancestor
92086450|NCT03113253|Coagulants|coagulants|mesh-ancestor
92086451|NCT01836523|Liraglutide|liraglutide|mesh-list
92086452|NCT01836523|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92086453|NCT01836523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086454|NCT01836523|Incretins|incretins|mesh-ancestor
92086455|NCT01836523|Hormones|hormones|mesh-ancestor
92086456|NCT01836523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086457|NCT01275196|Imatinib Mesylate|imatinib mesylate|mesh-list
92086458|NCT01275196|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086459|NCT01275196|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086460|NCT01275196|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086461|NCT01275196|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086462|NCT03583749|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92086466|NCT02000531|Cisplatin|cisplatin|mesh-list
92086467|NCT02000531|Gemcitabine|gemcitabine|mesh-list
92086468|NCT02000531|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92086469|NCT02000531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086470|NCT02000531|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086471|NCT02000531|Antimetabolites|antimetabolites|mesh-ancestor
92086472|NCT02000531|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086473|NCT02000531|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086474|NCT02000531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016808|NCT02448225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086475|NCT01609231|Irinotecan|irinotecan|mesh-list
92086476|NCT01609231|Cetuximab|cetuximab|mesh-list
92086477|NCT01609231|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92086478|NCT01609231|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92086479|NCT01609231|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086480|NCT01609231|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086481|NCT01609231|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086482|NCT01609231|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086483|NCT04438187|Anti-Infective Agents|anti-infective agents|mesh-list
92086484|NCT04438187|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92086485|NCT02092025|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92086486|NCT02092025|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92086487|NCT02092025|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92086488|NCT02092025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086489|NCT04405011|Entecavir|entecavir|mesh-list
92086490|NCT04405011|Antiviral Agents|antiviral agents|mesh-ancestor
92086491|NCT04405011|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086492|NCT01769443|Bortezomib|bortezomib|mesh-list
92086493|NCT01769443|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086494|NCT03154827|Atezolizumab|atezolizumab|mesh-list
92086495|NCT03154827|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92086496|NCT03154827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086497|NCT03154827|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086498|NCT03154827|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095878|NCT01001806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095879|NCT04021264|Sufentanil|sufentanil|mesh-list
92095880|NCT04021264|Ropivacaine|ropivacaine|mesh-list
92095881|NCT04021264|Anesthetics, Local|anesthetics, local|mesh-ancestor
92095882|NCT04021264|Anesthetics|anesthetics|mesh-ancestor
92086499|NCT01274182|Rituximab|rituximab|mesh-list
92086500|NCT01274182|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086501|NCT01274182|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086502|NCT01274182|Immunologic Factors|immunologic factors|mesh-ancestor
92086503|NCT01274182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086504|NCT01274182|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086505|NCT01984229|Posaconazole|posaconazole|mesh-list
92086506|NCT01984229|Antifungal Agents|antifungal agents|mesh-ancestor
92086507|NCT01984229|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086508|NCT01984229|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92086509|NCT01984229|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92086510|NCT01984229|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92086511|NCT01984229|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92086512|NCT01984229|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92086513|NCT01984229|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086514|NCT01984229|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086515|NCT01984229|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92086516|NCT01984229|Hormone Antagonists|hormone antagonists|mesh-ancestor
92086517|NCT01984229|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086518|NCT01984229|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086519|NCT01274026|Verapamil|verapamil|mesh-list
92086520|NCT01274026|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92086521|NCT01274026|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92086522|NCT01274026|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92086523|NCT01274026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086524|NCT01274026|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92086525|NCT01274026|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086526|NCT01274026|Vasodilator Agents|vasodilator agents|mesh-ancestor
92086527|NCT01274104|Vitamin D|vitamin d|mesh-list
92086532|NCT01274104|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92086533|NCT01274104|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92086534|NCT01279096|Dexamethasone|dexamethasone|mesh-list
92086535|NCT01279096|Etoposide|etoposide|mesh-list
92086536|NCT01279096|Asparaginase|asparaginase|mesh-list
92086537|NCT01279096|Mitoxantrone|mitoxantrone|mesh-list
92086538|NCT01279096|Clofarabine|clofarabine|mesh-list
92086539|NCT01279096|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086540|NCT01279096|Antiemetics|antiemetics|mesh-ancestor
92086541|NCT01279096|Autonomic Agents|autonomic agents|mesh-ancestor
92086542|NCT01279096|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086543|NCT01279096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016809|NCT02448225|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92016810|NCT02448225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016811|NCT02448225|Antimetabolites|antimetabolites|mesh-ancestor
92016812|NCT02448225|Antiviral Agents|antiviral agents|mesh-ancestor
92016813|NCT02448225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016814|NCT02447991|Rizatriptan|rizatriptan|mesh-list
92016815|NCT02447991|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92016816|NCT02447991|Serotonin Agents|serotonin agents|mesh-ancestor
92016817|NCT02447991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016818|NCT02447991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016819|NCT02447991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016820|NCT02586155|Atorvastatin|atorvastatin|mesh-list
92016821|NCT02586155|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92016822|NCT02586155|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92016823|NCT02586155|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92016824|NCT02586155|Antimetabolites|antimetabolites|mesh-ancestor
92016825|NCT02586155|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016826|NCT02586155|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92016827|NCT02586155|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92016828|NCT02586155|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016829|NCT05696093|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92016830|NCT05696093|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92016831|NCT05696093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086544|NCT01279096|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086545|NCT01279096|Glucocorticoids|glucocorticoids|mesh-ancestor
92086546|NCT01279096|Hormones|hormones|mesh-ancestor
92086547|NCT01279096|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086548|NCT01279096|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086549|NCT01279096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086550|NCT01279096|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086551|NCT01279096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086552|NCT01279096|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92086553|NCT01279096|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92086554|NCT01279096|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92086555|NCT01279096|Analgesics|analgesics|mesh-ancestor
92086556|NCT01279096|Sensory System Agents|sensory system agents|mesh-ancestor
92086557|NCT01279096|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086558|NCT01279096|Antimetabolites|antimetabolites|mesh-ancestor
92086560|NCT01272934|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92086561|NCT01272934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92086562|NCT01272934|Analgesics|analgesics|mesh-ancestor
92086564|NCT01272934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086565|NCT01272934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086566|NCT01272934|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086567|NCT01272934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086568|NCT01272934|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92016832|NCT05696093|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92016833|NCT05696093|Antimalarials|antimalarials|mesh-ancestor
92016834|NCT05696093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92016835|NCT05696093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92016836|NCT05536661|Lubricant Eye Drops|lubricant eye drops|mesh-list
92016837|NCT05536661|Hyaluronic Acid|hyaluronic acid|mesh-list
92016838|NCT05536661|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92016839|NCT05536661|Immunologic Factors|immunologic factors|mesh-ancestor
92016840|NCT05536661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016841|NCT05536661|Viscosupplements|viscosupplements|mesh-ancestor
92086569|NCT01272934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086570|NCT01272934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086571|NCT01279252|Metronidazole|metronidazole|mesh-list
92086572|NCT01279252|Clarithromycin|clarithromycin|mesh-list
92086573|NCT01279252|Ciprofloxacin|ciprofloxacin|mesh-list
92086574|NCT01279252|Lansoprazole|lansoprazole|mesh-list
92086575|NCT01279252|Dexlansoprazole|dexlansoprazole|mesh-list
92086576|NCT01279252|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086577|NCT01279252|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086578|NCT01279252|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92086579|NCT01279252|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92086580|NCT01279252|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92086581|NCT01279252|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086582|NCT01279252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086583|NCT01279252|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92086584|NCT01279252|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92086585|NCT01279252|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92086586|NCT01279252|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92086587|NCT01279252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086588|NCT01279252|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92086589|NCT01279252|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92086590|NCT01279252|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086591|NCT01279252|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92086592|NCT04385836|Alpha 1-Antitrypsin|alpha 1-antitrypsin|mesh-list
92086593|NCT04385836|Protein C Inhibitor|protein c inhibitor|mesh-list
92086594|NCT04385836|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92086595|NCT04385836|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92086596|NCT04385836|Protease Inhibitors|protease inhibitors|mesh-ancestor
92086597|NCT04385836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086598|NCT04385836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086628|NCT03154983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086629|NCT03154983|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086630|NCT03154983|Antimetabolites|antimetabolites|mesh-ancestor
92086631|NCT01983683|Vancomycin|vancomycin|mesh-list
92086632|NCT01983683|Oxazolidinones|oxazolidinones|mesh-list
92086633|NCT01983683|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086634|NCT01983683|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086635|NCT01983683|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92086636|NCT01983683|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086637|NCT01983683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086638|NCT03154515|Pentanedioic acid imidazolyl ethanamide|pentanedioic acid imidazolyl ethanamide|mesh-list
92086639|NCT03154515|Antiviral Agents|antiviral agents|mesh-ancestor
92086640|NCT03154515|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086641|NCT03158025|Zolpidem|zolpidem|mesh-list
92086642|NCT03158025|Suvorexant|suvorexant|mesh-list
92086643|NCT03158025|Lemborexant|lemborexant|mesh-list
92086644|NCT03158025|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92086645|NCT03158025|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92086647|NCT03158025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086648|NCT03158025|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92086649|NCT03158025|GABA Agonists|gaba agonists|mesh-ancestor
92086650|NCT03158025|GABA Agents|gaba agents|mesh-ancestor
92086651|NCT03158025|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086652|NCT03158025|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086653|NCT03158025|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92016842|NCT05536661|Protective Agents|protective agents|mesh-ancestor
92016843|NCT05536661|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92016844|NCT05536661|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92016846|NCT05536271|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92016847|NCT05536271|Sympatholytics|sympatholytics|mesh-ancestor
92086655|NCT01998893|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086656|NCT01998893|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086657|NCT01998893|Immunologic Factors|immunologic factors|mesh-ancestor
92086658|NCT01998893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086659|NCT01998893|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086660|NCT01791985|Letrozole|letrozole|mesh-list
92086661|NCT01791985|Anastrozole|anastrozole|mesh-list
92086662|NCT01791985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086663|NCT01791985|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92086664|NCT01791985|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92086665|NCT01791985|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086666|NCT01791985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086667|NCT01791985|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92086668|NCT01791985|Hormone Antagonists|hormone antagonists|mesh-ancestor
92086669|NCT01791985|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086670|NCT01791985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086671|NCT01791985|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086672|NCT04176497|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92086673|NCT04176497|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92086674|NCT04176497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086675|NCT01791517|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92086676|NCT03154281|Everolimus|everolimus|mesh-list
92086677|NCT03154281|Niraparib|niraparib|mesh-list
92086678|NCT03154281|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92086679|NCT03154281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086680|NCT03154281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086681|NCT03154281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086682|NCT03154281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92086683|NCT03154281|Immunologic Factors|immunologic factors|mesh-ancestor
92086684|NCT03154281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086685|NCT03154281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086763|NCT03153657|Analgesics|analgesics|mesh-ancestor
92086686|NCT03154281|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92086687|NCT03157791|Simethicone|simethicone|mesh-list
92086688|NCT03157791|Antifoaming Agents|antifoaming agents|mesh-ancestor
92086689|NCT03157791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086690|NCT03157791|Emollients|emollients|mesh-ancestor
92086691|NCT03157791|Dermatologic Agents|dermatologic agents|mesh-ancestor
92086692|NCT05701059|Meloxicam|meloxicam|mesh-list
92086693|NCT05701059|Cimetidine|cimetidine|mesh-list
92086694|NCT05701059|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92086695|NCT05701059|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086696|NCT05701059|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92086697|NCT05701059|Histamine Antagonists|histamine antagonists|mesh-ancestor
92086698|NCT05701059|Histamine Agents|histamine agents|mesh-ancestor
92086699|NCT05701059|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086700|NCT05701059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086701|NCT05701059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086702|NCT05701059|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92086703|NCT05701059|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92086704|NCT05701059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086705|NCT05701059|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92086706|NCT05701059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92086707|NCT05701059|Analgesics|analgesics|mesh-ancestor
92086708|NCT05701059|Sensory System Agents|sensory system agents|mesh-ancestor
92086709|NCT05701059|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086710|NCT05701059|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086711|NCT05701059|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086712|NCT05701059|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92086713|NCT05701059|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92086714|NCT03157479|Anesthetics|anesthetics|mesh-list
92086715|NCT03157479|Anesthetics, Intravenous|anesthetics, intravenous|mesh-list
92086716|NCT03157479|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016848|NCT05536271|Autonomic Agents|autonomic agents|mesh-ancestor
92086719|NCT03013491|Ipilimumab|ipilimumab|mesh-list
92086720|NCT03013491|Vemurafenib|vemurafenib|mesh-list
92086721|NCT03013491|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086722|NCT03013491|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086723|NCT03013491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92086724|NCT03013491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086725|NCT03013491|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086726|NCT03013491|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086728|NCT01272232|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92086729|NCT01272232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086730|NCT01272232|Incretins|incretins|mesh-ancestor
92086731|NCT01272232|Hormones|hormones|mesh-ancestor
92086732|NCT01272232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086733|NCT03157401|Tranexamic Acid|tranexamic acid|mesh-list
92086734|NCT03157401|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92086735|NCT03157401|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92086736|NCT03157401|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086737|NCT03157401|Hemostatics|hemostatics|mesh-ancestor
92086738|NCT03157401|Coagulants|coagulants|mesh-ancestor
92086739|NCT03153813|Capsaicin|capsaicin|mesh-list
92086740|NCT03153813|Antipruritics|antipruritics|mesh-ancestor
92086741|NCT03153813|Dermatologic Agents|dermatologic agents|mesh-ancestor
92086742|NCT03153813|Sensory System Agents|sensory system agents|mesh-ancestor
92086743|NCT03153813|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086744|NCT03153813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086745|NCT03156855|Bismuth|bismuth|mesh-list
92086746|NCT03156855|Antacids|antacids|mesh-ancestor
92086747|NCT03156855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086748|NCT03156855|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086749|NCT00739960|Abatacept|abatacept|mesh-list
92086750|NCT00739960|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92086751|NCT00739960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086752|NCT00739960|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086753|NCT00739960|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086754|NCT00739960|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92086755|NCT00739960|Immunologic Factors|immunologic factors|mesh-ancestor
92086756|NCT00739960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086757|NCT00739960|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086758|NCT03153657|Piroxicam|piroxicam|mesh-list
92086759|NCT03153657|Piroxicam-beta-cyclodextrin|piroxicam-beta-cyclodextrin|mesh-list
92086760|NCT03153657|Betadex|betadex|mesh-list
92086761|NCT03153657|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92086762|NCT03153657|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92086764|NCT03153657|Sensory System Agents|sensory system agents|mesh-ancestor
92086765|NCT03153657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086766|NCT03153657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086767|NCT03153657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086768|NCT03153657|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086769|NCT03153657|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92086770|NCT03153657|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086771|NCT03153657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086772|NCT03153657|Sequestering Agents|sequestering agents|mesh-ancestor
92086773|NCT01670955|Folic Acid|folic acid|mesh-list
92086774|NCT01670955|Hematinics|hematinics|mesh-ancestor
92086775|NCT01670955|Vitamin B Complex|vitamin b complex|mesh-ancestor
92086776|NCT01670955|Vitamins|vitamins|mesh-ancestor
92086777|NCT01670955|Micronutrients|micronutrients|mesh-ancestor
92086778|NCT01670955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086779|NCT01275274|Tretinoin|tretinoin|mesh-list
92086780|NCT01275274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086781|NCT01275274|Keratolytic Agents|keratolytic agents|mesh-ancestor
92086782|NCT01275274|Dermatologic Agents|dermatologic agents|mesh-ancestor
92086783|NCT01997333|Capecitabine|capecitabine|mesh-list
92086784|NCT01997333|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086785|NCT01997333|Antimetabolites|antimetabolites|mesh-ancestor
92086786|NCT01997333|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086787|NCT01997333|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086788|NCT01271920|Trastuzumab|trastuzumab|mesh-list
92086789|NCT01271920|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086790|NCT01271920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016850|NCT05536271|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016851|NCT05536271|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92016852|NCT05536271|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92086791|NCT01275352|Eplerenone|eplerenone|mesh-list
92086794|NCT01275352|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086795|NCT01275352|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086796|NCT01275352|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92086797|NCT01275352|Diuretics|diuretics|mesh-ancestor
92086799|NCT01275352|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92086800|NCT01676259|Paclitaxel|paclitaxel|mesh-list
92086801|NCT01676259|Gemcitabine|gemcitabine|mesh-list
92086802|NCT01676259|Folfirinox|folfirinox|mesh-list
92086803|NCT01676259|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92086804|NCT01676259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086805|NCT01676259|Tubulin Modulators|tubulin modulators|mesh-ancestor
92086806|NCT01676259|Antimitotic Agents|antimitotic agents|mesh-ancestor
92086807|NCT01676259|Mitosis Modulators|mitosis modulators|mesh-ancestor
92086808|NCT01676259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086809|NCT01676259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92086810|NCT01676259|Antimetabolites|antimetabolites|mesh-ancestor
92086811|NCT02662257|Propofol|propofol|mesh-list
92086812|NCT02662257|Sevoflurane|sevoflurane|mesh-list
92086813|NCT02662257|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92086814|NCT02662257|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086815|NCT02662257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086816|NCT02662257|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92086817|NCT02662257|Anesthetics, General|anesthetics, general|mesh-ancestor
92086818|NCT02662257|Anesthetics|anesthetics|mesh-ancestor
92086819|NCT02662257|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92086820|NCT02662257|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92086821|NCT03153267|Doxycycline|doxycycline|mesh-list
92086822|NCT03153267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086823|NCT03153267|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086824|NCT03153267|Antimalarials|antimalarials|mesh-ancestor
92086825|NCT03153267|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92086826|NCT03153267|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92086827|NCT00746512|Prednisone|prednisone|mesh-list
92086828|NCT00746512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086829|NCT00746512|Glucocorticoids|glucocorticoids|mesh-ancestor
92086830|NCT00746512|Hormones|hormones|mesh-ancestor
92086831|NCT00746512|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086832|NCT00746512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086833|NCT00746512|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086834|NCT00746512|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086835|NCT05409027|Cortisone|cortisone|mesh-list
92086836|NCT05409027|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92086837|NCT05409027|Glucocorticoids|glucocorticoids|mesh-list
92086838|NCT05409027|Hormones|hormones|mesh-ancestor
92086839|NCT05409027|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086840|NCT05409027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086841|NCT01982435|Ranibizumab|ranibizumab|mesh-list
92086842|NCT01982435|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92086843|NCT01982435|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92086844|NCT01982435|Growth Substances|growth substances|mesh-ancestor
92086845|NCT01982435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086846|NCT01982435|Growth Inhibitors|growth inhibitors|mesh-ancestor
92086847|NCT01982435|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086848|NCT00747214|Prednisolone|prednisolone|mesh-list
92086849|NCT00747214|Antirheumatic Agents|antirheumatic agents|mesh-list
92086850|NCT00747214|Dipyridamole|dipyridamole|mesh-list
92086851|NCT00747214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086852|NCT00747214|Glucocorticoids|glucocorticoids|mesh-ancestor
92086853|NCT00747214|Hormones|hormones|mesh-ancestor
92086854|NCT00747214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086855|NCT00747214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086856|NCT00747214|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086857|NCT00747214|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086858|NCT00747214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92086859|NCT00747214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016853|NCT05536271|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92016854|NCT05536271|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016855|NCT05536271|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016856|NCT05536271|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086860|NCT00747214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086861|NCT00747214|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92086862|NCT00747214|Vasodilator Agents|vasodilator agents|mesh-ancestor
92086863|NCT00753142|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92086864|NCT00753142|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92086868|NCT01279876|Antioxidants|antioxidants|mesh-ancestor
92086869|NCT01279876|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086870|NCT01279876|Protective Agents|protective agents|mesh-ancestor
92086871|NCT01279876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086872|NCT01279876|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086873|NCT01996709|Hydrogen Peroxide|hydrogen peroxide|mesh-list
92086874|NCT01996709|Contact Lens Solutions|contact lens solutions|mesh-list
92086875|NCT01996709|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92086876|NCT01996709|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92086877|NCT01996709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086878|NCT01996709|Disinfectants|disinfectants|mesh-ancestor
92086879|NCT00753220|Cyclophosphamide|cyclophosphamide|mesh-list
92086880|NCT00753220|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92086881|NCT00753220|Immunologic Factors|immunologic factors|mesh-ancestor
92086882|NCT00753220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086883|NCT00753220|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086884|NCT00753220|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92086885|NCT00753220|Alkylating Agents|alkylating agents|mesh-ancestor
92086886|NCT00753220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086887|NCT00753220|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086888|NCT00753220|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92086889|NCT01279954|Abatacept|abatacept|mesh-list
92086890|NCT01279954|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92086891|NCT01279954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086892|NCT01279954|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086893|NCT01279954|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086894|NCT01279954|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92086895|NCT01279954|Immunologic Factors|immunologic factors|mesh-ancestor
92086896|NCT01279954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086897|NCT01279954|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086898|NCT00763048|Triclosan|triclosan|mesh-list
92086899|NCT00763048|Fluorides|fluorides|mesh-list
92086900|NCT00763048|Cariostatic Agents|cariostatic agents|mesh-ancestor
92086901|NCT00763048|Protective Agents|protective agents|mesh-ancestor
92086902|NCT00763048|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086903|NCT00763048|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92086904|NCT00763048|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086905|NCT00763048|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92086906|NCT00763048|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92086907|NCT00763048|Antimetabolites|antimetabolites|mesh-ancestor
92086908|NCT00763048|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086909|NCT00763048|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92086910|NCT01278394|Tavaborole|tavaborole|mesh-list
92086911|NCT01278394|Antifungal Agents|antifungal agents|mesh-ancestor
92087063|NCT00246376|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92086912|NCT01278394|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086913|NCT00240916|Vaccines|vaccines|mesh-list
92086914|NCT00240916|Immunologic Factors|immunologic factors|mesh-ancestor
92086915|NCT00240916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086916|NCT01278160|Insulin|insulin|mesh-list
92086917|NCT01278160|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92086918|NCT01278160|Metformin|metformin|mesh-list
92086919|NCT01278160|Insulin Aspart|insulin aspart|mesh-list
92086920|NCT01278160|Insulin, Long-Acting|insulin, long-acting|mesh-list
92086921|NCT01278160|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92086922|NCT01278160|Biphasic Insulins|biphasic insulins|mesh-list
92086923|NCT01278160|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92086924|NCT01278160|Insulin, Isophane|insulin, isophane|mesh-list
92086925|NCT01278160|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92016857|NCT05536193|Metformin|metformin|mesh-list
92016858|NCT05536193|Salicylic Acid|salicylic acid|mesh-list
92016859|NCT05536193|Salicylates|salicylates|mesh-list
92016860|NCT05536193|Mitogens|mitogens|mesh-list
92016861|NCT05536193|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92086926|NCT01278160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086927|NCT00748072|Vasopressins|vasopressins|mesh-list
92086928|NCT00748072|Hemostatics|hemostatics|mesh-ancestor
92086929|NCT00748072|Coagulants|coagulants|mesh-ancestor
92086930|NCT00748072|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92086931|NCT00748072|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92086932|NCT00748072|Natriuretic Agents|natriuretic agents|mesh-ancestor
92086933|NCT00748072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086934|NCT01835587|Cc-486|cc-486|mesh-list
92086935|NCT01835587|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086936|NCT01736917|Dexamethasone|dexamethasone|mesh-list
92086937|NCT01736917|Fosaprepitant|fosaprepitant|mesh-list
92086940|NCT01736917|Antiemetics|antiemetics|mesh-ancestor
92086941|NCT01736917|Autonomic Agents|autonomic agents|mesh-ancestor
92086942|NCT01736917|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086943|NCT01736917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086944|NCT01736917|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086945|NCT01736917|Glucocorticoids|glucocorticoids|mesh-ancestor
92086946|NCT01736917|Hormones|hormones|mesh-ancestor
92086947|NCT01736917|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086948|NCT01736917|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086949|NCT01736917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086950|NCT01736917|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92086951|NCT01736917|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92086952|NCT01736917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086953|NCT01277302|Ranibizumab|ranibizumab|mesh-list
92086954|NCT01277302|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92086955|NCT01277302|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92086956|NCT01277302|Growth Substances|growth substances|mesh-ancestor
92086957|NCT01277302|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086958|NCT01277302|Growth Inhibitors|growth inhibitors|mesh-ancestor
92086959|NCT01277302|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086960|NCT04414579|Insulin|insulin|mesh-list
92086961|NCT04414579|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92086962|NCT04414579|Insulin Aspart|insulin aspart|mesh-list
92086963|NCT04414579|Insulin, Long-Acting|insulin, long-acting|mesh-list
92086964|NCT04414579|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92086965|NCT04414579|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92086966|NCT04414579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086967|NCT01980875|Obinutuzumab|obinutuzumab|mesh-list
92086968|NCT01980875|Idelalisib|idelalisib|mesh-list
92086969|NCT01980875|Chlorambucil|chlorambucil|mesh-list
92086970|NCT01980875|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92086971|NCT01980875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086972|NCT01980875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086973|NCT01980875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086974|NCT01980875|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92086975|NCT01980875|Alkylating Agents|alkylating agents|mesh-ancestor
92086976|NCT01967225|Linezolid|linezolid|mesh-list
92086977|NCT01967225|Tedizolid|tedizolid|mesh-list
92086978|NCT01967225|Tedizolid phosphate|tedizolid phosphate|mesh-list
92086979|NCT01967225|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92086980|NCT01967225|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086981|NCT01967225|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92086982|NCT01967225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92086983|NCT01967225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086984|NCT01967147|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92086985|NCT01967147|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92086986|NCT01790503|Temozolomide|temozolomide|mesh-list
92086987|NCT01790503|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92086988|NCT01790503|Alkylating Agents|alkylating agents|mesh-ancestor
92086989|NCT01790503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086990|NCT01790503|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086991|NCT01765543|Rifampin|rifampin|mesh-list
92086992|NCT01765543|Vemurafenib|vemurafenib|mesh-list
92086993|NCT01765543|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92086994|NCT01765543|Antitubercular Agents|antitubercular agents|mesh-ancestor
92086995|NCT01765543|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92016862|NCT05536193|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086996|NCT01765543|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086997|NCT01765543|Leprostatic Agents|leprostatic agents|mesh-ancestor
92086998|NCT01765543|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92086999|NCT01765543|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087000|NCT01765543|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087001|NCT01765543|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92087002|NCT01765543|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92087003|NCT01765543|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92087004|NCT01765543|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92087005|NCT01765543|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92087006|NCT01765543|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92087007|NCT01765543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087008|NCT01765543|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087009|NCT00248170|Letrozole|letrozole|mesh-list
92087013|NCT00248170|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92087014|NCT00248170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087015|NCT00248170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087016|NCT00248170|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92087017|NCT00248170|Hormone Antagonists|hormone antagonists|mesh-ancestor
92087018|NCT00248170|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087019|NCT00248170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087020|NCT00248170|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92087022|NCT01764997|Etanercept|etanercept|mesh-list
92087023|NCT01764997|Methotrexate|methotrexate|mesh-list
92087024|NCT01764997|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92087025|NCT01764997|Abortifacient Agents|abortifacient agents|mesh-ancestor
92087026|NCT01764997|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92087027|NCT01764997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087028|NCT01764997|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92087029|NCT01764997|Antimetabolites|antimetabolites|mesh-ancestor
92087030|NCT01764997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087031|NCT01764997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087032|NCT01764997|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087033|NCT01764997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087034|NCT01764997|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92087035|NCT01764997|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92087036|NCT01764997|Immunologic Factors|immunologic factors|mesh-ancestor
92087037|NCT01764997|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087038|NCT01764997|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92087039|NCT01764997|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92087040|NCT01764997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087041|NCT01764997|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087042|NCT01764997|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087043|NCT01764997|Analgesics|analgesics|mesh-ancestor
92087044|NCT01764997|Sensory System Agents|sensory system agents|mesh-ancestor
92087045|NCT01764997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087046|NCT01764997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087047|NCT01276756|Interferons|interferons|mesh-list
92087048|NCT01276756|Ribavirin|ribavirin|mesh-list
92087049|NCT01276756|Interferon-alpha|interferon-alpha|mesh-list
92087050|NCT01276756|Interferon alpha-2|interferon alpha-2|mesh-list
92087051|NCT01276756|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92087052|NCT01276756|Nitazoxanide|nitazoxanide|mesh-list
92087053|NCT01276756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087054|NCT01276756|Antiviral Agents|antiviral agents|mesh-ancestor
92087055|NCT01276756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087056|NCT01276756|Antimetabolites|antimetabolites|mesh-ancestor
92087057|NCT01276756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087058|NCT01276756|Immunologic Factors|immunologic factors|mesh-ancestor
92087059|NCT01276756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087060|NCT01276756|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92087061|NCT00246376|Niacin|niacin|mesh-list
92087062|NCT00246376|Fenofibrate|fenofibrate|mesh-list
92087064|NCT00246376|Antimetabolites|antimetabolites|mesh-ancestor
92087065|NCT00246376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087066|NCT00246376|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92087067|NCT00246376|Vasodilator Agents|vasodilator agents|mesh-ancestor
92087068|NCT00246376|Vitamin B Complex|vitamin b complex|mesh-ancestor
92087069|NCT00246376|Vitamins|vitamins|mesh-ancestor
92087070|NCT00246376|Micronutrients|micronutrients|mesh-ancestor
92016863|NCT05536193|Mitosis Modulators|mitosis modulators|mesh-ancestor
92016864|NCT05536193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087071|NCT00246376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087072|NCT03806062|Domperidone|domperidone|mesh-list
92087073|NCT03806062|Antiemetics|antiemetics|mesh-ancestor
92087074|NCT03806062|Autonomic Agents|autonomic agents|mesh-ancestor
92087075|NCT03806062|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087076|NCT03806062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087077|NCT03806062|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087078|NCT03806062|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92087079|NCT03806062|Dopamine Agents|dopamine agents|mesh-ancestor
92087080|NCT03806062|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087081|NCT03806062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087082|NCT00754546|Formoterol Fumarate|formoterol fumarate|mesh-list
92087084|NCT00754546|Autonomic Agents|autonomic agents|mesh-ancestor
92087085|NCT00754546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087086|NCT00754546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087087|NCT00754546|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92087088|NCT00754546|Respiratory System Agents|respiratory system agents|mesh-ancestor
92087089|NCT00754546|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92087090|NCT00754546|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92087091|NCT00754546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92087092|NCT00754546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92087093|NCT00754546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087094|NCT00754546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087095|NCT01764841|Ciprofloxacin|ciprofloxacin|mesh-list
92087096|NCT01764841|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087097|NCT01764841|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087098|NCT01764841|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92087099|NCT01764841|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92087100|NCT01764841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087101|NCT01764841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087102|NCT01764841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087103|NCT01764841|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92087104|NCT01764841|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92087105|NCT00245050|Pyridoxine|pyridoxine|mesh-list
92087106|NCT00245050|Vitamin B 6|vitamin b 6|mesh-list
92087107|NCT00245050|Doxorubicin|doxorubicin|mesh-list
92087108|NCT00245050|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92087109|NCT00245050|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92087110|NCT00245050|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087111|NCT00245050|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92087112|NCT00245050|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92087113|NCT00245050|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087114|NCT00245050|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087115|NCT00245050|Vitamin B Complex|vitamin b complex|mesh-ancestor
92087116|NCT00245050|Vitamins|vitamins|mesh-ancestor
92087117|NCT00245050|Micronutrients|micronutrients|mesh-ancestor
92087118|NCT00245050|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087119|NCT04345588|Dexamethasone|dexamethasone|mesh-list
92087120|NCT04345588|Dexamethasone acetate|dexamethasone acetate|mesh-list
92087121|NCT04345588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087122|NCT04345588|Antiemetics|antiemetics|mesh-ancestor
92087123|NCT04345588|Autonomic Agents|autonomic agents|mesh-ancestor
92087124|NCT04345588|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087125|NCT04345588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087126|NCT04345588|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087127|NCT04345588|Glucocorticoids|glucocorticoids|mesh-ancestor
92087128|NCT04345588|Hormones|hormones|mesh-ancestor
92087129|NCT04345588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087130|NCT04345588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92087131|NCT04345588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087132|NCT03806374|Lidocaine|lidocaine|mesh-list
92087133|NCT03806374|Fentanyl|fentanyl|mesh-list
92087134|NCT03806374|Ketamine|ketamine|mesh-list
92087135|NCT03806374|Propofol|propofol|mesh-list
92087136|NCT03806374|Cisatracurium|cisatracurium|mesh-list
92087137|NCT03806374|Anesthetics, Local|anesthetics, local|mesh-ancestor
92087138|NCT03806374|Anesthetics|anesthetics|mesh-ancestor
92087139|NCT03806374|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087140|NCT03806374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087141|NCT03806374|Sensory System Agents|sensory system agents|mesh-ancestor
92087142|NCT03806374|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016865|NCT05536193|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016866|NCT05536193|Antifungal Agents|antifungal agents|mesh-ancestor
92016867|NCT05536193|Keratolytic Agents|keratolytic agents|mesh-ancestor
92016868|NCT05536193|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087143|NCT03806374|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92087144|NCT03806374|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92087145|NCT03806374|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92087146|NCT03806374|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087147|NCT03806374|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087148|NCT03806374|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92087149|NCT03806374|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92087150|NCT03806374|Anesthetics, General|anesthetics, general|mesh-ancestor
92087151|NCT03806374|Analgesics|analgesics|mesh-ancestor
92087152|NCT03806374|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92087153|NCT03806374|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92087154|NCT03806374|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92087155|NCT03806374|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087156|NCT03806374|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92087162|NCT00763360|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92087163|NCT00763360|Immunologic Factors|immunologic factors|mesh-ancestor
92087164|NCT00763360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087165|NCT00763360|Viscosupplements|viscosupplements|mesh-ancestor
92087166|NCT00763360|Protective Agents|protective agents|mesh-ancestor
92087167|NCT00756106|Temozolomide|temozolomide|mesh-list
92087168|NCT00756106|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92087169|NCT00756106|Alkylating Agents|alkylating agents|mesh-ancestor
92087170|NCT00756106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087171|NCT00756106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087172|NCT00243412|Methylprednisolone|methylprednisolone|mesh-list
92087173|NCT00243412|Rituximab|rituximab|mesh-list
92087174|NCT00243412|Methotrexate|methotrexate|mesh-list
92087175|NCT00243412|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92087176|NCT00243412|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087177|NCT00243412|Immunologic Factors|immunologic factors|mesh-ancestor
92087178|NCT00243412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087179|NCT00243412|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087180|NCT00243412|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92087181|NCT00243412|Abortifacient Agents|abortifacient agents|mesh-ancestor
92087182|NCT00243412|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92087183|NCT00243412|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92087184|NCT00243412|Antimetabolites|antimetabolites|mesh-ancestor
92087185|NCT00243412|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087186|NCT00243412|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087187|NCT00243412|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087188|NCT00243412|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92087189|NCT00243412|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92087190|NCT00243412|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92087191|NCT00243412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087192|NCT00243412|Antiemetics|antiemetics|mesh-ancestor
92087193|NCT00243412|Autonomic Agents|autonomic agents|mesh-ancestor
92087194|NCT00243412|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087195|NCT00243412|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087196|NCT00243412|Glucocorticoids|glucocorticoids|mesh-ancestor
92087197|NCT00243412|Hormones|hormones|mesh-ancestor
92087198|NCT00243412|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087199|NCT00243412|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92087200|NCT00243412|Protective Agents|protective agents|mesh-ancestor
92087201|NCT00765232|Ketorolac|ketorolac|mesh-list
92087202|NCT00765232|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087203|NCT00765232|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087204|NCT00765232|Analgesics|analgesics|mesh-ancestor
92087205|NCT00765232|Sensory System Agents|sensory system agents|mesh-ancestor
92087206|NCT00765232|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087207|NCT00765232|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087208|NCT00765232|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087209|NCT00765232|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087210|NCT00765232|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92087211|NCT00765232|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087212|NCT00765232|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016869|NCT05536193|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92016870|NCT05536193|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016871|NCT05536193|Analgesics|analgesics|mesh-ancestor
92016872|NCT05536193|Sensory System Agents|sensory system agents|mesh-ancestor
92087213|NCT03805282|Lidocaine|lidocaine|mesh-list
92087214|NCT03805282|Anesthetics, Local|anesthetics, local|mesh-ancestor
92087215|NCT03805282|Anesthetics|anesthetics|mesh-ancestor
92087216|NCT03805282|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087217|NCT03805282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087218|NCT03805282|Sensory System Agents|sensory system agents|mesh-ancestor
92087219|NCT03805282|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087220|NCT03805282|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92087221|NCT03805282|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92087222|NCT03805282|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92087223|NCT03805282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087224|NCT03805282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087225|NCT03805750|Dronabinol|dronabinol|mesh-list
92087226|NCT03805750|Cannabidiol|cannabidiol|mesh-list
92087227|NCT03805750|Anticonvulsants|anticonvulsants|mesh-ancestor
92087229|NCT03805750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087230|NCT03805750|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087231|NCT03805750|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087232|NCT03805750|Analgesics|analgesics|mesh-ancestor
92087233|NCT03805750|Sensory System Agents|sensory system agents|mesh-ancestor
92087234|NCT03805750|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087235|NCT03805750|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92087236|NCT03805750|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92087237|NCT03805750|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087238|NCT03805750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087239|NCT03805750|Hormones|hormones|mesh-ancestor
92087240|NCT03805750|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087241|NCT03804268|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92087242|NCT03804268|Pilocarpine|pilocarpine|mesh-list
92087243|NCT03804268|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92087245|NCT03804268|Autonomic Agents|autonomic agents|mesh-ancestor
92087246|NCT03804268|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087247|NCT03804268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087249|NCT03804268|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92087250|NCT03804268|Cholinergic Agents|cholinergic agents|mesh-ancestor
92087251|NCT03804268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087252|NCT03804268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087253|NCT00765856|Oxymorphone|oxymorphone|mesh-list
92087254|NCT00765856|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92087255|NCT00765856|Narcotics|narcotics|mesh-ancestor
92087256|NCT00765856|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087257|NCT00765856|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087258|NCT00765856|Analgesics|analgesics|mesh-ancestor
92087259|NCT00765856|Sensory System Agents|sensory system agents|mesh-ancestor
92087260|NCT00765856|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087261|NCT00765856|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92087262|NCT00780208|Methylphenidate|methylphenidate|mesh-list
92087263|NCT00780208|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92087264|NCT00780208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087265|NCT00780208|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92087266|NCT00780208|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92087267|NCT00780208|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087268|NCT00780208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087269|NCT00780208|Dopamine Agents|dopamine agents|mesh-ancestor
92087270|NCT00780208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087271|NCT00243022|Vitamin B 12|vitamin b 12|mesh-list
92087272|NCT00243022|Hydroxocobalamin|hydroxocobalamin|mesh-list
92087273|NCT00243022|Vitamins|vitamins|mesh-ancestor
92087274|NCT00243022|Micronutrients|micronutrients|mesh-ancestor
92087275|NCT00243022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087276|NCT00243022|Vitamin B Complex|vitamin b complex|mesh-ancestor
92087277|NCT00243022|Hematinics|hematinics|mesh-ancestor
92087278|NCT03805360|Ropivacaine|ropivacaine|mesh-list
92016873|NCT05536193|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087279|NCT03805360|Anesthetics, Local|anesthetics, local|mesh-list
92087280|NCT03805360|Anesthetics|anesthetics|mesh-list
92087281|NCT03805360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087282|NCT03805360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087283|NCT03805360|Sensory System Agents|sensory system agents|mesh-ancestor
92087284|NCT03805360|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087285|NCT00756964|Rasburicase|rasburicase|mesh-list
92087286|NCT00756964|Gout Suppressants|gout suppressants|mesh-ancestor
92087287|NCT00756964|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087288|NCT00780442|Cycloserine|cycloserine|mesh-list
92087289|NCT00780442|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92087290|NCT00780442|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087291|NCT00780442|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92087292|NCT00780442|Antitubercular Agents|antitubercular agents|mesh-ancestor
92087293|NCT00780442|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087294|NCT00780442|Antimetabolites|antimetabolites|mesh-ancestor
92087295|NCT00780442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087296|NCT04384666|Rotigotine|rotigotine|mesh-list
92087297|NCT04384666|Dopamine Agonists|dopamine agonists|mesh-ancestor
92087298|NCT04384666|Dopamine Agents|dopamine agents|mesh-ancestor
92087299|NCT04384666|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087300|NCT04384666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087301|NCT04384666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087302|NCT00767572|Atorvastatin|atorvastatin|mesh-list
92087306|NCT00767572|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087307|NCT00767572|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92087308|NCT00767572|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92087309|NCT00767572|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087311|NCT00780676|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087312|NCT00780676|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087313|NCT00780676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087314|NCT00780676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087315|NCT00768118|Curcumin|curcumin|mesh-list
92087316|NCT00768118|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087317|NCT00768118|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087318|NCT00768118|Analgesics|analgesics|mesh-ancestor
92087319|NCT00768118|Sensory System Agents|sensory system agents|mesh-ancestor
92087320|NCT00768118|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087321|NCT00768118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087323|NCT00768118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087324|NCT00768118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087325|NCT00768118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087326|NCT00768118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087327|NCT04345432|Gabapentin|gabapentin|mesh-list
92087328|NCT04345432|Analgesics|analgesics|mesh-ancestor
92087329|NCT04345432|Sensory System Agents|sensory system agents|mesh-ancestor
92087330|NCT04345432|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087331|NCT04345432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087332|NCT04345432|Anticonvulsants|anticonvulsants|mesh-ancestor
92087333|NCT04345432|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92087334|NCT04345432|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92087335|NCT04345432|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087336|NCT04345432|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087337|NCT04345432|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92087338|NCT04345432|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92087339|NCT04345432|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087340|NCT04345432|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087341|NCT04345432|Antimanic Agents|antimanic agents|mesh-ancestor
92087342|NCT00757822|Dronabinol|dronabinol|mesh-list
92087343|NCT00757822|Ondansetron|ondansetron|mesh-list
92087344|NCT00757822|Antiemetics|antiemetics|mesh-ancestor
92087345|NCT00757822|Autonomic Agents|autonomic agents|mesh-ancestor
92087346|NCT00757822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087347|NCT00757822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087348|NCT00757822|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087349|NCT00757822|Antipruritics|antipruritics|mesh-ancestor
92087350|NCT00757822|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087351|NCT00757822|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92087352|NCT00757822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92087353|NCT00757822|Serotonin Agents|serotonin agents|mesh-ancestor
92087354|NCT00757822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016874|NCT05536193|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016875|NCT05536193|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016876|NCT05536193|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92087355|NCT00757822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087356|NCT00757822|Hallucinogens|hallucinogens|mesh-ancestor
92087357|NCT00757822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087358|NCT00757822|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087359|NCT00757822|Analgesics|analgesics|mesh-ancestor
92087360|NCT00757822|Sensory System Agents|sensory system agents|mesh-ancestor
92087361|NCT00757822|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92087362|NCT00757822|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92087364|NCT00757822|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087365|NCT00758836|Acetaminophen|acetaminophen|mesh-list
92087366|NCT00758836|Ibuprofen|ibuprofen|mesh-list
92087367|NCT00758836|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087368|NCT00758836|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087369|NCT00758836|Analgesics|analgesics|mesh-ancestor
92087370|NCT00758836|Sensory System Agents|sensory system agents|mesh-ancestor
92087371|NCT00758836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087372|NCT00758836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087373|NCT00758836|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087374|NCT00758836|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087377|NCT00758836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087378|NCT00758836|Antipyretics|antipyretics|mesh-ancestor
92087379|NCT00769600|Itraconazole|itraconazole|mesh-list
92087380|NCT00769600|Pemetrexed|pemetrexed|mesh-list
92087381|NCT00769600|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087382|NCT00769600|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087383|NCT00769600|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087384|NCT00769600|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92087385|NCT00769600|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92087386|NCT00769600|Antifungal Agents|antifungal agents|mesh-ancestor
92087387|NCT00769600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087388|NCT00769600|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92087389|NCT00769600|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92087390|NCT00769600|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92087391|NCT00769600|Hormone Antagonists|hormone antagonists|mesh-ancestor
92087392|NCT00769600|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087393|NCT00769600|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087394|NCT00769600|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92087396|NCT03809650|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92087397|NCT03809650|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92087398|NCT03809650|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087399|NCT03809650|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92087400|NCT03809260|Metformin|metformin|mesh-list
92087401|NCT03809260|Vancomycin|vancomycin|mesh-list
92087402|NCT03809260|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92087403|NCT03809260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087404|NCT03809260|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087405|NCT03809260|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087406|NCT01763905|Ezetimibe|ezetimibe|mesh-list
92087407|NCT01763905|Evolocumab|evolocumab|mesh-list
92087408|NCT01763905|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92087409|NCT01763905|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92087410|NCT01763905|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92087411|NCT01763905|Antimetabolites|antimetabolites|mesh-ancestor
92087412|NCT01763905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087413|NCT01763905|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92087414|NCT01763905|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92087415|NCT01763905|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92087416|NCT01763905|Protease Inhibitors|protease inhibitors|mesh-ancestor
92087417|NCT01763905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087418|NCT01763905|Immunologic Factors|immunologic factors|mesh-ancestor
92087419|NCT01763905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087420|NCT05743504|Paclitaxel|paclitaxel|mesh-list
92087421|NCT05743504|Cisplatin|cisplatin|mesh-list
92087422|NCT05743504|Atezolizumab|atezolizumab|mesh-list
92087423|NCT05743504|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016877|NCT05536193|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016878|NCT04425707|Hydroxychloroquine|hydroxychloroquine|mesh-list
92016879|NCT04425707|Ivermectin|ivermectin|mesh-list
92016880|NCT04425707|Antimalarials|antimalarials|mesh-ancestor
92016881|NCT04425707|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92087424|NCT05743504|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087425|NCT05743504|Tubulin Modulators|tubulin modulators|mesh-ancestor
92087426|NCT05743504|Antimitotic Agents|antimitotic agents|mesh-ancestor
92087427|NCT05743504|Mitosis Modulators|mitosis modulators|mesh-ancestor
92087428|NCT05743504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087429|NCT05743504|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92087430|NCT05743504|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92087431|NCT03803254|Lenvatinib|lenvatinib|mesh-list
92087432|NCT03803254|Antibodies|antibodies|mesh-list
92087433|NCT03803254|Immunologic Factors|immunologic factors|mesh-ancestor
92087504|NCT01619423|Sequestering Agents|sequestering agents|mesh-ancestor
92087434|NCT03803254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087435|NCT03803254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087436|NCT03803254|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087437|NCT03803254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087438|NCT03803254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087439|NCT04730999|Bevacizumab|bevacizumab|mesh-list
92087440|NCT04730999|Atezolizumab|atezolizumab|mesh-list
92087441|NCT04730999|Carboplatin|carboplatin|mesh-list
92087442|NCT04730999|Etoposide|etoposide|mesh-list
92087443|NCT04730999|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92087444|NCT04730999|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087445|NCT04730999|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92087446|NCT04730999|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92087447|NCT04730999|Growth Substances|growth substances|mesh-ancestor
92087455|NCT04730999|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92087456|NCT00759772|Teriparatide|teriparatide|mesh-list
92087457|NCT00759772|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92087458|NCT00759772|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087459|NCT00759772|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92087461|NCT01977677|Temozolomide|temozolomide|mesh-list
92087462|NCT01977677|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92087463|NCT01977677|Alkylating Agents|alkylating agents|mesh-ancestor
92087464|NCT01977677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087465|NCT01977677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087466|NCT01977677|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92087467|NCT01977677|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92087468|NCT01977677|Antiviral Agents|antiviral agents|mesh-ancestor
92087469|NCT01977677|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087471|NCT04384744|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087472|NCT04384744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087473|NCT01736215|Epoetin Alfa|epoetin alfa|mesh-list
92087474|NCT01736215|Hematinics|hematinics|mesh-ancestor
92087475|NCT01786603|Rasagiline|rasagiline|mesh-list
92087476|NCT01786603|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92087477|NCT01786603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087478|NCT01786603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087479|NCT01786603|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92087480|NCT01786603|Protective Agents|protective agents|mesh-ancestor
92087481|NCT01786603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087482|NCT00786916|Lidocaine|lidocaine|mesh-list
92087483|NCT00786916|Anesthetics, Local|anesthetics, local|mesh-ancestor
92087484|NCT00786916|Anesthetics|anesthetics|mesh-ancestor
92087485|NCT00786916|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087486|NCT00786916|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087487|NCT00786916|Sensory System Agents|sensory system agents|mesh-ancestor
92087488|NCT00786916|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087489|NCT00786916|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92087490|NCT00786916|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92087491|NCT00786916|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92087492|NCT00786916|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087493|NCT00786916|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087494|NCT04414267|Vaccines|vaccines|mesh-list
92087495|NCT04414267|BCG Vaccine|bcg vaccine|mesh-list
92087496|NCT04414267|Immunologic Factors|immunologic factors|mesh-ancestor
92087497|NCT04414267|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016882|NCT04425707|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92016883|NCT04425707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016884|NCT04425707|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016885|NCT04425707|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016886|NCT04425707|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016887|NCT05697185|Evolocumab|evolocumab|mesh-list
92016888|NCT05697185|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92016889|NCT05697185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92016890|NCT05697185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92016891|NCT05697185|Antimetabolites|antimetabolites|mesh-ancestor
92016892|NCT05697185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016893|NCT05697185|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92016894|NCT05697185|Protease Inhibitors|protease inhibitors|mesh-ancestor
92087498|NCT04414267|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92087499|NCT01619423|Pyridoxal Phosphate|pyridoxal phosphate|mesh-list
92087500|NCT01619423|Edetic Acid|edetic acid|mesh-list
92087501|NCT01619423|Anticoagulants|anticoagulants|mesh-ancestor
92087502|NCT01619423|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92087503|NCT01619423|Chelating Agents|chelating agents|mesh-ancestor
92087505|NCT01619423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087506|NCT01619423|Vitamin B Complex|vitamin b complex|mesh-ancestor
92087507|NCT01619423|Vitamins|vitamins|mesh-ancestor
92087508|NCT01619423|Micronutrients|micronutrients|mesh-ancestor
92087509|NCT01619423|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087510|NCT03802552|Cephalexin|cephalexin|mesh-list
92087511|NCT03802552|Cefadroxil|cefadroxil|mesh-list
92087512|NCT03802552|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087513|NCT03802552|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087514|NCT01735279|Mineral Oil|mineral oil|mesh-list
92087515|NCT01735279|Emollients|emollients|mesh-ancestor
92087522|NCT03802318|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087523|NCT03802318|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92087524|NCT03802318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087525|NCT03802318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087526|NCT01758523|Dutasteride|dutasteride|mesh-list
92087527|NCT01758523|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92087528|NCT01758523|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92087529|NCT01758523|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087530|NCT01758523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087531|NCT01758523|Hormone Antagonists|hormone antagonists|mesh-ancestor
92087532|NCT01758523|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087533|NCT01758523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087534|NCT00773422|Naltrexone|naltrexone|mesh-list
92087535|NCT00773422|Varenicline|varenicline|mesh-list
92087536|NCT00773422|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92087537|NCT00773422|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92087538|NCT00773422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087539|NCT00773422|Sensory System Agents|sensory system agents|mesh-ancestor
92087540|NCT00773422|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087541|NCT00773422|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92087542|NCT00773422|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92087543|NCT00773422|Cholinergic Agents|cholinergic agents|mesh-ancestor
92087544|NCT00773422|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087545|NCT00773422|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087546|NCT00786994|Petrolatum|petrolatum|mesh-list
92087547|NCT00786994|Emollients|emollients|mesh-ancestor
92087548|NCT00786994|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087549|NCT00774202|Prednisone|prednisone|mesh-list
92087550|NCT00774202|Cyclophosphamide|cyclophosphamide|mesh-list
92087551|NCT00774202|Rituximab|rituximab|mesh-list
92087552|NCT00774202|Vincristine|vincristine|mesh-list
92087553|NCT00774202|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016895|NCT05697185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016896|NCT05697185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92016897|NCT05695781|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92016898|NCT05695781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92016899|NCT02581163|Ritonavir|ritonavir|mesh-list
92087554|NCT00774202|Immunologic Factors|immunologic factors|mesh-ancestor
92087555|NCT00774202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087556|NCT00774202|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087557|NCT00774202|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92087558|NCT00774202|Alkylating Agents|alkylating agents|mesh-ancestor
92087559|NCT00774202|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087560|NCT00774202|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087561|NCT00774202|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92087562|NCT00774202|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92087563|NCT00774202|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087564|NCT00774202|Glucocorticoids|glucocorticoids|mesh-ancestor
92087565|NCT00774202|Hormones|hormones|mesh-ancestor
92087566|NCT00774202|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087567|NCT00774202|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92087568|NCT00774202|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92087569|NCT00774202|Tubulin Modulators|tubulin modulators|mesh-ancestor
92087570|NCT00774202|Antimitotic Agents|antimitotic agents|mesh-ancestor
92087571|NCT00774202|Mitosis Modulators|mitosis modulators|mesh-ancestor
92087572|NCT03808168|Nivolumab|nivolumab|mesh-list
92087573|NCT03808168|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92087574|NCT03808168|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087575|NCT03808168|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92087576|NCT03808168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087577|NCT03802162|Memantine|memantine|mesh-list
92087578|NCT03802162|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92087579|NCT03802162|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92087580|NCT03802162|Dopamine Agents|dopamine agents|mesh-ancestor
92087581|NCT03802162|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087582|NCT03802162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087583|NCT03802162|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087586|NCT01757275|Esomeprazole|esomeprazole|mesh-list
92087588|NCT01757275|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92087589|NCT01757275|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087590|NCT01757275|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92087591|NCT01757275|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087592|NCT01757275|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087593|NCT01757275|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92087594|NCT01757275|Histamine Antagonists|histamine antagonists|mesh-ancestor
92087595|NCT01757275|Histamine Agents|histamine agents|mesh-ancestor
92087596|NCT01757275|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087597|NCT01757275|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087598|NCT01757275|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92087599|NCT01757275|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92087600|NCT00787852|Paclitaxel|paclitaxel|mesh-list
92087601|NCT00787852|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92087602|NCT00787852|Dasatinib|dasatinib|mesh-list
92087603|NCT00787852|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92087604|NCT00787852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087605|NCT00787852|Tubulin Modulators|tubulin modulators|mesh-ancestor
92087606|NCT00787852|Antimitotic Agents|antimitotic agents|mesh-ancestor
92087607|NCT00787852|Mitosis Modulators|mitosis modulators|mesh-ancestor
92087608|NCT00787852|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087609|NCT00787852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087610|NCT00787852|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087611|NCT00788008|Propofol|propofol|mesh-list
92087612|NCT00788008|Isoflurane|isoflurane|mesh-list
92087613|NCT00788008|Anesthetics|anesthetics|mesh-ancestor
92087614|NCT00788008|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087615|NCT00788008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087616|NCT00788008|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92087617|NCT00788008|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92087618|NCT00788008|Anesthetics, General|anesthetics, general|mesh-ancestor
92087619|NCT00788008|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92087620|NCT00760006|Ampicillin|ampicillin|mesh-list
92087621|NCT00760006|Sulbactam|sulbactam|mesh-list
92016901|NCT02581163|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92016902|NCT02581163|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92087622|NCT00760006|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92087623|NCT00760006|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087624|NCT00760006|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087625|NCT00760006|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92087626|NCT00760006|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087627|NCT00760006|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087628|NCT01784965|Liraglutide|liraglutide|mesh-list
92087629|NCT01784965|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92087630|NCT01784965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087631|NCT01784965|Incretins|incretins|mesh-ancestor
92087632|NCT01784965|Hormones|hormones|mesh-ancestor
92087633|NCT01784965|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087634|NCT05742724|Dronabinol|dronabinol|mesh-list
92087635|NCT05742724|Nabiximols|nabiximols|mesh-list
92087636|NCT05742724|Cannabidiol|cannabidiol|mesh-list
92087637|NCT05742724|Anticonvulsants|anticonvulsants|mesh-ancestor
92087638|NCT05742724|Hallucinogens|hallucinogens|mesh-ancestor
92087639|NCT05742724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087640|NCT05742724|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087641|NCT05742724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087642|NCT05742724|Analgesics|analgesics|mesh-ancestor
92087643|NCT05742724|Sensory System Agents|sensory system agents|mesh-ancestor
92087644|NCT05742724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087645|NCT05742724|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92087646|NCT05742724|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92087647|NCT05742724|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087648|NCT05742724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087649|NCT05742724|Hormones|hormones|mesh-ancestor
92087650|NCT05742724|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087651|NCT01784419|Ivacaftor|ivacaftor|mesh-list
92087652|NCT01784419|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92087653|NCT01784419|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087654|NCT01784419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087655|NCT01784029|Vitamin D|vitamin d|mesh-list
92087656|NCT01784029|Cholecalciferol|cholecalciferol|mesh-list
92087659|NCT01784029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087660|NCT01784029|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92087661|NCT01784029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92087662|NCT00789256|Bortezomib|bortezomib|mesh-list
92087663|NCT00789256|Melphalan|melphalan|mesh-list
92087664|NCT00789256|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087665|NCT00789256|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92087666|NCT00789256|Alkylating Agents|alkylating agents|mesh-ancestor
92087667|NCT00789256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087668|NCT00789256|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92087669|NCT00789256|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92087670|NCT00789256|Immunologic Factors|immunologic factors|mesh-ancestor
92087671|NCT00789256|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087672|NCT01733329|Folic Acid|folic acid|mesh-list
92087673|NCT01733329|Misoprostol|misoprostol|mesh-list
92087674|NCT01733329|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92087675|NCT01733329|Abortifacient Agents|abortifacient agents|mesh-ancestor
92087676|NCT01733329|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92087677|NCT01733329|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087678|NCT01733329|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92087679|NCT01733329|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087680|NCT01733329|Oxytocics|oxytocics|mesh-ancestor
92087681|NCT01733329|Hematinics|hematinics|mesh-ancestor
92087682|NCT01733329|Vitamin B Complex|vitamin b complex|mesh-ancestor
92087683|NCT01733329|Vitamins|vitamins|mesh-ancestor
92087684|NCT01733329|Micronutrients|micronutrients|mesh-ancestor
92087685|NCT02145676|Botulinum Toxins|botulinum toxins|mesh-list
92087686|NCT02145676|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92087687|NCT02145676|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92087688|NCT02145676|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92087689|NCT02145676|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087690|NCT02145676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087691|NCT02145676|Cholinergic Agents|cholinergic agents|mesh-ancestor
92087692|NCT02145676|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016903|NCT02581163|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016904|NCT02581163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016905|NCT02581163|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016906|NCT02581163|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92087693|NCT02145676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087694|NCT02145676|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92087695|NCT02145676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087697|NCT05742568|Clarithromycin|clarithromycin|mesh-list
92087698|NCT05742568|Esomeprazole|esomeprazole|mesh-list
92087699|NCT05742568|Bismuth|bismuth|mesh-list
92087700|NCT05742568|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087701|NCT05742568|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087702|NCT05742568|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92087703|NCT05742568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087704|NCT05742568|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92087705|NCT05742568|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087706|NCT05742568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087707|NCT05742568|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92087708|NCT05742568|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92087709|NCT05742568|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92087710|NCT05742568|Antacids|antacids|mesh-ancestor
92087711|NCT01607593|Sertraline|sertraline|mesh-list
92087712|NCT01607593|Antidepressive Agents|antidepressive agents|mesh-ancestor
92087713|NCT01607593|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087714|NCT01607593|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92087715|NCT01607593|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92087716|NCT01607593|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087717|NCT01607593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087718|NCT01607593|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087719|NCT01607593|Serotonin Agents|serotonin agents|mesh-ancestor
92087720|NCT01607593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087721|NCT00789724|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92087722|NCT00789724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087723|NCT01755637|Albendazole|albendazole|mesh-list
92087724|NCT01755637|Anthelmintics|anthelmintics|mesh-ancestor
92087725|NCT01755637|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92087726|NCT01755637|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087727|NCT01755637|Anticestodal Agents|anticestodal agents|mesh-ancestor
92087728|NCT01755637|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92087729|NCT01755637|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92087730|NCT01755637|Tubulin Modulators|tubulin modulators|mesh-ancestor
92087731|NCT01755637|Antimitotic Agents|antimitotic agents|mesh-ancestor
92087734|NCT01755637|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087735|NCT03801226|Calcium|calcium|mesh-list
92087736|NCT03801226|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92087737|NCT03801226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087738|NCT03837808|Nimotuzumab|nimotuzumab|mesh-list
92087739|NCT03837808|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087740|NCT03837808|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92087741|NCT02148874|Vaccines|vaccines|mesh-list
92087742|NCT02148874|Immunologic Factors|immunologic factors|mesh-ancestor
92087743|NCT02148874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087744|NCT01755091|Dronabinol|dronabinol|mesh-list
92087745|NCT01755091|Hallucinogens|hallucinogens|mesh-ancestor
92087746|NCT01755091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087747|NCT01755091|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087748|NCT01755091|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087749|NCT01755091|Analgesics|analgesics|mesh-ancestor
92087750|NCT01755091|Sensory System Agents|sensory system agents|mesh-ancestor
92087751|NCT01755091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087752|NCT01755091|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92087753|NCT01755091|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92087754|NCT01755091|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087755|NCT01755091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087756|NCT01755091|Hormones|hormones|mesh-ancestor
92087757|NCT01755091|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087758|NCT00789802|Naproxen|naproxen|mesh-list
92087759|NCT00789802|Estradiol|estradiol|mesh-list
92087760|NCT00789802|Estrogens|estrogens|mesh-ancestor
92087761|NCT00789802|Hormones|hormones|mesh-ancestor
92087762|NCT00789802|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016907|NCT02581163|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92016908|NCT02581163|Antiviral Agents|antiviral agents|mesh-ancestor
92016909|NCT02581163|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92016910|NCT02581163|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92016911|NCT02581163|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92016912|NCT02581163|Antimetabolites|antimetabolites|mesh-ancestor
92016913|NCT05591417|Dexamethasone|dexamethasone|mesh-list
92087763|NCT00789802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087764|NCT00789802|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087765|NCT00789802|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087766|NCT00789802|Analgesics|analgesics|mesh-ancestor
92087767|NCT00789802|Sensory System Agents|sensory system agents|mesh-ancestor
92087768|NCT00789802|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087769|NCT00789802|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087770|NCT00789802|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087771|NCT00789802|Gout Suppressants|gout suppressants|mesh-ancestor
92087772|NCT00789802|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92087773|NCT00789802|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087774|NCT00789802|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087775|NCT04567225|Insulin Glargine|insulin glargine|mesh-list
92087776|NCT04567225|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92087777|NCT04567225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087778|NCT02149342|Methyl 5-aminolevulinate|methyl 5-aminolevulinate|mesh-list
92087779|NCT02149342|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92087780|NCT02149342|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92087781|NCT02149342|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087782|NCT01783015|Etanercept|etanercept|mesh-list
92087783|NCT01783015|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087784|NCT01783015|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087785|NCT01783015|Analgesics|analgesics|mesh-ancestor
92087786|NCT01783015|Sensory System Agents|sensory system agents|mesh-ancestor
92087787|NCT01783015|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087788|NCT01783015|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087789|NCT01783015|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087790|NCT01783015|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087791|NCT01783015|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92087792|NCT01783015|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92087793|NCT01783015|Immunologic Factors|immunologic factors|mesh-ancestor
92087794|NCT05567770|Androgens|androgens|mesh-list
92087795|NCT05567770|Hormones|hormones|mesh-ancestor
92087796|NCT05567770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087797|NCT05567770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087798|NCT01782859|Prednisone|prednisone|mesh-list
92087799|NCT01782859|Hydrocortisone|hydrocortisone|mesh-list
92087800|NCT01782859|Hydrocortisone 17-butyrate 21-propionate|hydrocortisone 17-butyrate 21-propionate|mesh-list
92087801|NCT01782859|Hydrocortisone acetate|hydrocortisone acetate|mesh-list
92087802|NCT01782859|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92087803|NCT01782859|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087806|NCT01782859|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087807|NCT01782859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087808|NCT01782859|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92087809|NCT01782859|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087810|NCT01782313|Tyrosine Protein Kinase Inhibitors|tyrosine protein kinase inhibitors|mesh-list
92087812|NCT01782313|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087813|NCT01782313|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087814|NCT01782313|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087815|NCT04574947|Lidocaine|lidocaine|mesh-list
92087816|NCT04574947|Anesthetics, Local|anesthetics, local|mesh-ancestor
92087817|NCT04574947|Anesthetics|anesthetics|mesh-ancestor
92087818|NCT04574947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087819|NCT04574947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087820|NCT04574947|Sensory System Agents|sensory system agents|mesh-ancestor
92087821|NCT04574947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087822|NCT04574947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92087823|NCT04574947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92087824|NCT04574947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92016914|NCT05591417|Dexamethasone acetate|dexamethasone acetate|mesh-list
92016915|NCT05591417|Dexmedetomidine|dexmedetomidine|mesh-list
92016916|NCT05591417|Morphine|morphine|mesh-list
92087825|NCT04574947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087826|NCT04574947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087827|NCT00790192|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92087828|NCT00790192|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92087829|NCT00790192|Antidepressive Agents|antidepressive agents|mesh-ancestor
92087830|NCT00790192|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087831|NCT00790192|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92087832|NCT00790192|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92087833|NCT00790192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087834|NCT00790192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087835|NCT00790192|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92087836|NCT00790192|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92087837|NCT00790192|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92087838|NCT00790192|Adrenergic Agents|adrenergic agents|mesh-ancestor
92087839|NCT00790192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087840|NCT00790192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087841|NCT00790192|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92087843|NCT00790192|Serotonin Agents|serotonin agents|mesh-ancestor
92087844|NCT00790192|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92087845|NCT00790192|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92087846|NCT00790192|Dopamine Agents|dopamine agents|mesh-ancestor
92087847|NCT01781611|Aspirin|aspirin|mesh-list
92087848|NCT01781611|Dipyridamole|dipyridamole|mesh-list
92087849|NCT01781611|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087850|NCT01781611|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087851|NCT01781611|Analgesics|analgesics|mesh-ancestor
92087852|NCT01781611|Sensory System Agents|sensory system agents|mesh-ancestor
92087853|NCT01781611|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087854|NCT01781611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087855|NCT01781611|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087856|NCT01781611|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087857|NCT01781611|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92087858|NCT01781611|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92087859|NCT01781611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087860|NCT01781611|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92087861|NCT01781611|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92087862|NCT01781611|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087863|NCT01781611|Antipyretics|antipyretics|mesh-ancestor
92087864|NCT01781611|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92087865|NCT01781611|Vasodilator Agents|vasodilator agents|mesh-ancestor
92087866|NCT03802084|Imatinib Mesylate|imatinib mesylate|mesh-list
92087867|NCT03802084|Vactosertib|vactosertib|mesh-list
92087868|NCT03802084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087869|NCT03802084|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087870|NCT03802084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087871|NCT03802084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087872|NCT00790270|Ibuprofen|ibuprofen|mesh-list
92087873|NCT00790270|Amitriptyline|amitriptyline|mesh-list
92087874|NCT00790270|Cyclobenzaprine|cyclobenzaprine|mesh-list
92087875|NCT00790270|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92087879|NCT00790270|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087880|NCT00790270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087881|NCT00790270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087882|NCT00790270|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92087883|NCT00790270|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92087884|NCT00790270|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087885|NCT00790270|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087886|NCT00790270|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92087887|NCT00790270|Antidepressive Agents|antidepressive agents|mesh-ancestor
92087888|NCT00790270|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92087889|NCT00790270|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92087890|NCT00790270|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92087891|NCT00790270|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92087892|NCT00790270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087893|NCT00790270|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92087894|NCT00790270|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92087895|NCT00790270|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92087896|NCT00790270|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016918|NCT05591417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016919|NCT05591417|Antiemetics|antiemetics|mesh-ancestor
92087897|NCT00790270|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087898|NCT01780987|Heparin|heparin|mesh-list
92087899|NCT01780987|Calcium heparin|calcium heparin|mesh-list
92087900|NCT01780987|Warfarin|warfarin|mesh-list
92087901|NCT01780987|Apixaban|apixaban|mesh-list
92087902|NCT01780987|Anticoagulants|anticoagulants|mesh-ancestor
92087903|NCT01780987|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92087904|NCT01780987|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92087905|NCT01780987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087906|NCT01780987|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92087907|NCT01780987|Antithrombins|antithrombins|mesh-ancestor
92087908|NCT01780987|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92087909|NCT01780987|Protease Inhibitors|protease inhibitors|mesh-ancestor
92087910|NCT01780987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087911|NCT03800290|Clenbuterol|clenbuterol|mesh-list
92087912|NCT03800290|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92087913|NCT03800290|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92087914|NCT03800290|Adrenergic Agents|adrenergic agents|mesh-ancestor
92087915|NCT03800290|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087916|NCT03800290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087917|NCT03800290|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087918|NCT03800290|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92087919|NCT03800290|Autonomic Agents|autonomic agents|mesh-ancestor
92087920|NCT03800290|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087921|NCT03800290|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92087922|NCT03800290|Respiratory System Agents|respiratory system agents|mesh-ancestor
92087923|NCT03800290|Sympathomimetics|sympathomimetics|mesh-ancestor
92087924|NCT05709184|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92087926|NCT05709184|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087927|NCT03831334|Minoxidil|minoxidil|mesh-list
92087928|NCT03831334|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92087929|NCT03831334|Vasodilator Agents|vasodilator agents|mesh-ancestor
92087930|NCT04795336|Melatonin|melatonin|mesh-list
92087931|NCT04795336|Antioxidants|antioxidants|mesh-ancestor
92087932|NCT04795336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087933|NCT04795336|Protective Agents|protective agents|mesh-ancestor
92087934|NCT04795336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087935|NCT04795336|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92087936|NCT00809848|Bimatoprost|bimatoprost|mesh-list
92087937|NCT00809848|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92087938|NCT00809848|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92087939|NCT00809848|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92087940|NCT01730053|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92087941|NCT01730053|Ezetimibe|ezetimibe|mesh-list
92087942|NCT01730053|Alirocumab|alirocumab|mesh-list
92087943|NCT01730053|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92087944|NCT01730053|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92087945|NCT01730053|Antimetabolites|antimetabolites|mesh-ancestor
92087946|NCT01730053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087947|NCT01730053|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92087948|NCT01730053|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92087949|NCT01730053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087951|NCT01730053|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92087952|NCT01730053|Protease Inhibitors|protease inhibitors|mesh-ancestor
92087953|NCT01751113|Fluticasone|fluticasone|mesh-list
92087955|NCT01751113|Bromides|bromides|mesh-list
92087956|NCT01751113|Tiotropium Bromide|tiotropium bromide|mesh-list
92087957|NCT01751113|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92087958|NCT01751113|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92087959|NCT01751113|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087960|NCT01751113|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92087961|NCT01751113|Autonomic Agents|autonomic agents|mesh-ancestor
92087962|NCT01751113|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087963|NCT01751113|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087964|NCT01751113|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92087965|NCT01751113|Respiratory System Agents|respiratory system agents|mesh-ancestor
92087966|NCT01751113|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087967|NCT01751113|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92087968|NCT01751113|Parasympatholytics|parasympatholytics|mesh-ancestor
92087969|NCT01751113|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92087970|NCT01751113|Cholinergic Agents|cholinergic agents|mesh-ancestor
92087971|NCT01751113|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92087972|NCT01751113|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087973|NCT01751113|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92087975|NCT01751113|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92087976|NCT01751113|Adrenergic Agents|adrenergic agents|mesh-ancestor
92087977|NCT01751113|Anticonvulsants|anticonvulsants|mesh-ancestor
92087978|NCT01751113|Glucocorticoids|glucocorticoids|mesh-ancestor
92087979|NCT01751113|Hormones|hormones|mesh-ancestor
92087980|NCT01751113|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92087981|NCT01751113|Sympathomimetics|sympathomimetics|mesh-ancestor
92087982|NCT00795340|Paclitaxel|paclitaxel|mesh-list
92087983|NCT00795340|Carboplatin|carboplatin|mesh-list
92087984|NCT00795340|Cediranib|cediranib|mesh-list
92087985|NCT00795340|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92087986|NCT00795340|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087987|NCT00795340|Tubulin Modulators|tubulin modulators|mesh-ancestor
92087988|NCT00795340|Antimitotic Agents|antimitotic agents|mesh-ancestor
92087989|NCT00795340|Mitosis Modulators|mitosis modulators|mesh-ancestor
92087990|NCT00795340|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087991|NCT00795340|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087992|NCT00795340|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92087993|NCT04753294|Diazepam|diazepam|mesh-list
92087994|NCT04753294|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92087995|NCT04753294|Anticonvulsants|anticonvulsants|mesh-ancestor
92087996|NCT04753294|Antiemetics|antiemetics|mesh-ancestor
92087997|NCT04753294|Autonomic Agents|autonomic agents|mesh-ancestor
92087998|NCT04753294|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92087999|NCT04753294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088000|NCT04753294|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088001|NCT04753294|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92088002|NCT04753294|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088003|NCT04753294|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92088004|NCT04753294|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92088005|NCT04753294|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92088006|NCT04753294|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088007|NCT04753294|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088008|NCT04753294|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92088009|NCT04753294|Anesthetics, General|anesthetics, general|mesh-ancestor
92088010|NCT04753294|Anesthetics|anesthetics|mesh-ancestor
92088011|NCT04753294|GABA Modulators|gaba modulators|mesh-ancestor
92088012|NCT04753294|GABA Agents|gaba agents|mesh-ancestor
92088013|NCT04753294|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088014|NCT04753294|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088015|NCT01719380|Cetuximab|cetuximab|mesh-list
92088016|NCT01719380|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92088017|NCT01719380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088018|NCT00792142|Thalidomide|thalidomide|mesh-list
92088019|NCT00792142|Dexamethasone|dexamethasone|mesh-list
92088020|NCT00792142|Bortezomib|bortezomib|mesh-list
92088021|NCT00792142|Melphalan|melphalan|mesh-list
92088022|NCT00792142|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088023|NCT00792142|Antiemetics|antiemetics|mesh-ancestor
92088024|NCT00792142|Autonomic Agents|autonomic agents|mesh-ancestor
92088025|NCT00792142|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088026|NCT00792142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088030|NCT00792142|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088031|NCT00792142|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088032|NCT00792142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088033|NCT00792142|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92088034|NCT00792142|Alkylating Agents|alkylating agents|mesh-ancestor
92088035|NCT00792142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088036|NCT00792142|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92088037|NCT00792142|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92088038|NCT00792142|Immunologic Factors|immunologic factors|mesh-ancestor
92088039|NCT00792142|Leprostatic Agents|leprostatic agents|mesh-ancestor
92088040|NCT00792142|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92088041|NCT00792142|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088042|NCT00792142|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92088043|NCT00792142|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92088044|NCT00792142|Growth Substances|growth substances|mesh-ancestor
92088045|NCT00792142|Growth Inhibitors|growth inhibitors|mesh-ancestor
92088046|NCT05640778|Cyclophosphamide|cyclophosphamide|mesh-list
92088048|NCT05640778|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92088049|NCT05640778|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92088050|NCT05640778|Immunologic Factors|immunologic factors|mesh-ancestor
92016920|NCT05591417|Autonomic Agents|autonomic agents|mesh-ancestor
92016921|NCT05591417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016922|NCT05591417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016923|NCT05591417|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92016924|NCT05591417|Glucocorticoids|glucocorticoids|mesh-ancestor
92088051|NCT05640778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088052|NCT05640778|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92088053|NCT05640778|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92088054|NCT05640778|Alkylating Agents|alkylating agents|mesh-ancestor
92088055|NCT05640778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088056|NCT05640778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088057|NCT05640778|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92088058|NCT05640778|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92088059|NCT05640778|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088060|NCT05640778|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92088061|NCT05640778|Hormone Antagonists|hormone antagonists|mesh-ancestor
92088062|NCT05640778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088063|NCT01743560|Everolimus|everolimus|mesh-list
92088064|NCT01743560|Exemestane|exemestane|mesh-list
92088065|NCT01743560|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92088066|NCT01743560|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92088067|NCT01743560|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088068|NCT01743560|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088069|NCT01743560|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92088070|NCT01743560|Immunologic Factors|immunologic factors|mesh-ancestor
92088071|NCT01743560|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088072|NCT01743560|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088073|NCT01743560|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92088074|NCT01743560|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92088075|NCT01743560|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92088076|NCT01743560|Hormone Antagonists|hormone antagonists|mesh-ancestor
92088077|NCT01743560|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088078|NCT00796744|Angiotensin I (1-7)|angiotensin i (1-7)|mesh-list
92088079|NCT00796744|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92088080|NCT00796744|Vasodilator Agents|vasodilator agents|mesh-ancestor
92088081|NCT00792922|Azithromycin|azithromycin|mesh-list
92088082|NCT00792922|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92088083|NCT00792922|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088084|NCT01780831|Raltegravir Potassium|raltegravir potassium|mesh-list
92088085|NCT01780831|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92088086|NCT01780831|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92088087|NCT01780831|Antiviral Agents|antiviral agents|mesh-ancestor
92088088|NCT01780831|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088089|NCT01780831|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92088090|NCT01780831|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92088091|NCT01780831|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088092|NCT01780831|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088093|NCT04382170|Dexmedetomidine|dexmedetomidine|mesh-list
92088094|NCT04382170|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92088095|NCT04382170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088096|NCT04382170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088097|NCT04382170|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92088098|NCT04382170|Analgesics|analgesics|mesh-ancestor
92088100|NCT04382170|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088101|NCT04382170|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92088102|NCT04382170|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92088103|NCT04382170|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088104|NCT04382170|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088105|NCT04382170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088106|NCT04382170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088107|NCT01753297|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92088108|NCT01753297|Luteolytic Agents|luteolytic agents|mesh-ancestor
92088109|NCT01753297|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92088110|NCT01753297|Contraceptive Agents|contraceptive agents|mesh-ancestor
92088111|NCT01753297|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92088112|NCT01753297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088113|NCT01753297|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92088114|NCT01753297|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088115|NCT01753297|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088116|NCT04718350|Simendan|simendan|mesh-list
92088117|NCT04718350|Milrinone|milrinone|mesh-list
92088118|NCT04718350|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92088119|NCT04718350|Vasodilator Agents|vasodilator agents|mesh-ancestor
92088120|NCT04718350|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92088121|NCT04718350|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92088122|NCT04718350|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088123|NCT04718350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088124|NCT04718350|Protective Agents|protective agents|mesh-ancestor
92088125|NCT04718350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088126|NCT04718350|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92088127|NCT01729819|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92088128|NCT01729819|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92088129|NCT01729819|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92088130|NCT01729819|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92088131|NCT01729819|Cholinergic Agents|cholinergic agents|mesh-ancestor
92088132|NCT01729819|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088133|NCT01729819|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088134|NCT01729819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088135|NCT01729819|Urological Agents|urological agents|mesh-ancestor
92088136|NCT01729819|Hemostatics|hemostatics|mesh-ancestor
92088137|NCT01729819|Coagulants|coagulants|mesh-ancestor
92088138|NCT01729819|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92088139|NCT01729819|Natriuretic Agents|natriuretic agents|mesh-ancestor
92088140|NCT00811564|Timolol|timolol|mesh-list
92088141|NCT00811564|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92088142|NCT00811564|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92088143|NCT00811564|Latanoprost|latanoprost|mesh-list
92088144|NCT00811564|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92088145|NCT00811564|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088146|NCT00811564|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92088147|NCT00811564|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92088148|NCT00811564|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088149|NCT00811564|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088150|NCT00811564|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088151|NCT00811564|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92088152|NCT00811564|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92088153|NCT00811564|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92088154|NCT00811564|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92088155|NCT00811564|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088156|NCT04520776|Meloxicam|meloxicam|mesh-list
92088157|NCT04520776|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92088158|NCT04520776|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92088159|NCT04520776|Analgesics|analgesics|mesh-ancestor
92088160|NCT04520776|Sensory System Agents|sensory system agents|mesh-ancestor
92088161|NCT04520776|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088162|NCT04520776|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088163|NCT04520776|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088164|NCT04520776|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92088165|NCT04520776|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92088166|NCT04520776|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92088167|NCT04520776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088168|NCT04520776|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088169|NCT01709084|Tenofovir|tenofovir|mesh-list
92088170|NCT01709084|Emtricitabine|emtricitabine|mesh-list
92088174|NCT01709084|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088175|NCT01709084|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92088176|NCT01709084|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92088177|NCT01709084|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088178|NCT01709084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088179|NCT01709084|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92088180|NCT01709084|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92088181|NCT01709084|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92088182|NCT01709084|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92088259|NCT01974323|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92088183|NCT01709084|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92088184|NCT01709084|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92088185|NCT01709084|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92088186|NCT01709084|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92088187|NCT01776307|Capecitabine|capecitabine|mesh-list
92088188|NCT01776307|Cetuximab|cetuximab|mesh-list
92088189|NCT01776307|Panitumumab|panitumumab|mesh-list
92016925|NCT05591417|Hormones|hormones|mesh-ancestor
92016926|NCT05591417|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088190|NCT01776307|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92088191|NCT01776307|Antimetabolites|antimetabolites|mesh-ancestor
92088192|NCT01776307|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088193|NCT01776307|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088194|NCT01776307|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92088195|NCT01741532|Deferiprone|deferiprone|mesh-list
92088196|NCT01741532|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92088197|NCT01741532|Chelating Agents|chelating agents|mesh-ancestor
92088198|NCT01741532|Sequestering Agents|sequestering agents|mesh-ancestor
92088199|NCT01741532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088200|NCT01727713|Aripiprazole|aripiprazole|mesh-list
92088201|NCT01727713|Antidepressive Agents|antidepressive agents|mesh-ancestor
92088202|NCT01727713|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088203|NCT01727713|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92088204|NCT01727713|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088205|NCT01727713|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088206|NCT01727713|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088207|NCT01727713|Dopamine Agonists|dopamine agonists|mesh-ancestor
92088208|NCT01727713|Dopamine Agents|dopamine agents|mesh-ancestor
92088209|NCT01727713|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088210|NCT01727713|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088211|NCT01727713|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92088212|NCT01727713|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92088214|NCT01727713|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92088215|NCT01727713|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92088216|NCT01727713|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92088217|NCT01727713|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92088218|NCT04658927|Dexamethasone|dexamethasone|mesh-list
92088219|NCT04658927|Prednisone|prednisone|mesh-list
92088220|NCT04658927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088221|NCT04658927|Antiemetics|antiemetics|mesh-ancestor
92088222|NCT04658927|Autonomic Agents|autonomic agents|mesh-ancestor
92088223|NCT04658927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088224|NCT04658927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088225|NCT04658927|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088226|NCT04658927|Glucocorticoids|glucocorticoids|mesh-ancestor
92088227|NCT04658927|Hormones|hormones|mesh-ancestor
92088228|NCT04658927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088229|NCT04658927|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088230|NCT04658927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088231|NCT01965431|Moxifloxacin|moxifloxacin|mesh-list
92088232|NCT01965431|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92088233|NCT01965431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088234|NCT01965431|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92088235|NCT01965431|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92088236|NCT01965431|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088237|NCT01965431|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088238|NCT01965431|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088239|NCT01976507|Dabigatran|dabigatran|mesh-list
92088240|NCT01976507|Antithrombins|antithrombins|mesh-ancestor
92088241|NCT01976507|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92088242|NCT01976507|Protease Inhibitors|protease inhibitors|mesh-ancestor
92088246|NCT01964963|Alogliptin|alogliptin|mesh-list
92088247|NCT01964963|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92088248|NCT01964963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088249|NCT01964963|Incretins|incretins|mesh-ancestor
92088250|NCT01964963|Hormones|hormones|mesh-ancestor
92088251|NCT01964963|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088252|NCT01964963|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92088253|NCT01964963|Protease Inhibitors|protease inhibitors|mesh-ancestor
92088254|NCT01964963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088255|NCT01964963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088256|NCT01974323|Dapsone|dapsone|mesh-list
92088257|NCT01974323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088258|NCT01974323|Antimalarials|antimalarials|mesh-ancestor
92088260|NCT01974323|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92016927|NCT05591417|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016928|NCT05591417|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016929|NCT05591417|Protease Inhibitors|protease inhibitors|mesh-ancestor
92016930|NCT05591417|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016931|NCT05591417|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016932|NCT05591417|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92016933|NCT05591417|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016934|NCT05591417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92016936|NCT05591417|Sensory System Agents|sensory system agents|mesh-ancestor
92088261|NCT01974323|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92088262|NCT01974323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088263|NCT01974323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088264|NCT01974323|Leprostatic Agents|leprostatic agents|mesh-ancestor
92088265|NCT01974323|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92088266|NCT01973387|Rituximab|rituximab|mesh-list
92088267|NCT01973387|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92088268|NCT01973387|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088269|NCT01973387|Immunologic Factors|immunologic factors|mesh-ancestor
92088270|NCT01973387|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088271|NCT01973387|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92088273|NCT01973231|Lixisenatide|lixisenatide|mesh-list
92088274|NCT01973231|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92088275|NCT01973231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088276|NCT01973231|Incretins|incretins|mesh-ancestor
92088277|NCT01973231|Hormones|hormones|mesh-ancestor
92088278|NCT01973231|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088279|NCT02151994|Zamicastat|zamicastat|mesh-list
92088280|NCT02151994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088281|NCT02151994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088282|NCT04382950|Tretinoin|tretinoin|mesh-list
92088283|NCT04382950|Isotretinoin|isotretinoin|mesh-list
92088284|NCT04382950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088285|NCT04382950|Keratolytic Agents|keratolytic agents|mesh-ancestor
92088286|NCT04382950|Dermatologic Agents|dermatologic agents|mesh-ancestor
92088287|NCT04383418|Dexmedetomidine|dexmedetomidine|mesh-list
92088288|NCT04383418|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92088289|NCT04383418|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088290|NCT04383418|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088291|NCT04383418|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92088292|NCT04383418|Analgesics|analgesics|mesh-ancestor
92088293|NCT04383418|Sensory System Agents|sensory system agents|mesh-ancestor
92088294|NCT04383418|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088295|NCT04383418|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92088296|NCT04383418|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92088297|NCT04383418|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088298|NCT04383418|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088299|NCT04383418|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088300|NCT04383418|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088301|NCT03414112|Oxytocin|oxytocin|mesh-list
92088302|NCT03414112|Oxytocics|oxytocics|mesh-ancestor
92088303|NCT03414112|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92088304|NCT03414112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088305|NCT03839134|Lidocaine|lidocaine|mesh-list
92088306|NCT03839134|Epinephrine|epinephrine|mesh-list
92088307|NCT03839134|Racepinephrine|racepinephrine|mesh-list
92088308|NCT03839134|Epinephryl borate|epinephryl borate|mesh-list
92088309|NCT03839134|Anesthetics, Local|anesthetics, local|mesh-ancestor
92088310|NCT03839134|Anesthetics|anesthetics|mesh-ancestor
92088311|NCT03839134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088312|NCT03839134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088313|NCT03839134|Sensory System Agents|sensory system agents|mesh-ancestor
92088314|NCT03839134|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088317|NCT03839134|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92016937|NCT05591417|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92016938|NCT05591417|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92016939|NCT05591417|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92016940|NCT05591417|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016941|NCT05591417|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088318|NCT03839134|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088319|NCT03839134|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088320|NCT03839134|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92088321|NCT03839134|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088322|NCT03839134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088323|NCT03839134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088324|NCT03839134|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92088325|NCT03839134|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92088326|NCT03839134|Autonomic Agents|autonomic agents|mesh-ancestor
92088327|NCT03839134|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92088328|NCT03839134|Respiratory System Agents|respiratory system agents|mesh-ancestor
92088329|NCT03839134|Mydriatics|mydriatics|mesh-ancestor
92088330|NCT03839134|Sympathomimetics|sympathomimetics|mesh-ancestor
92088331|NCT03839134|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92088333|NCT03906526|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92088334|NCT03906526|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088335|NCT03906526|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92088336|NCT03906526|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088337|NCT03088930|Crizotinib|crizotinib|mesh-list
92088338|NCT03088930|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088339|NCT03088930|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92088340|NCT03088930|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088341|NCT03088930|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088342|NCT02152696|Methotrexate|methotrexate|mesh-list
92088343|NCT02152696|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92088344|NCT02152696|Abortifacient Agents|abortifacient agents|mesh-ancestor
92088345|NCT02152696|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92088346|NCT02152696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088347|NCT02152696|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92088348|NCT02152696|Antimetabolites|antimetabolites|mesh-ancestor
92088349|NCT02152696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088350|NCT02152696|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088351|NCT02152696|Dermatologic Agents|dermatologic agents|mesh-ancestor
92088352|NCT02152696|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088353|NCT02152696|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92088354|NCT02152696|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92088355|NCT02152696|Immunologic Factors|immunologic factors|mesh-ancestor
92088356|NCT02152696|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92088357|NCT02152696|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92088358|NCT01905436|Ivermectin|ivermectin|mesh-list
92088359|NCT01905436|Albendazole|albendazole|mesh-list
92088360|NCT01905436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92088361|NCT01905436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088362|NCT01905436|Anthelmintics|anthelmintics|mesh-ancestor
92088363|NCT01905436|Anticestodal Agents|anticestodal agents|mesh-ancestor
92088364|NCT01905436|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92088365|NCT01905436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92088366|NCT01905436|Tubulin Modulators|tubulin modulators|mesh-ancestor
92088367|NCT01905436|Antimitotic Agents|antimitotic agents|mesh-ancestor
92088368|NCT01905436|Mitosis Modulators|mitosis modulators|mesh-ancestor
92088369|NCT01905436|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088370|NCT01905436|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088371|NCT01256086|Formoterol Fumarate|formoterol fumarate|mesh-list
92088372|NCT01256086|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92088373|NCT01256086|Autonomic Agents|autonomic agents|mesh-ancestor
92088374|NCT01256086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088375|NCT01256086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088376|NCT01256086|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92088377|NCT01256086|Respiratory System Agents|respiratory system agents|mesh-ancestor
92088378|NCT01256086|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92088379|NCT01256086|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92088380|NCT01256086|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088381|NCT01256086|Adrenergic Agents|adrenergic agents|mesh-ancestor
92016942|NCT05591417|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92016943|NCT05591417|Narcotics|narcotics|mesh-ancestor
92016944|NCT01938547|Clevidipine|clevidipine|mesh-list
92016945|NCT01938547|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92016946|NCT01938547|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088382|NCT01256086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088383|NCT01256086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088385|NCT01149850|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92088391|NCT01149850|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92088392|NCT01149850|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92088393|NCT01149850|Growth Substances|growth substances|mesh-ancestor
92088394|NCT01149850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088395|NCT01149850|Growth Inhibitors|growth inhibitors|mesh-ancestor
92088396|NCT01149850|Immunologic Factors|immunologic factors|mesh-ancestor
92088397|NCT01149850|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92088398|NCT01149850|Alkylating Agents|alkylating agents|mesh-ancestor
92088399|NCT01149850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088400|NCT01972841|Solifenacin Succinate|solifenacin succinate|mesh-list
92088401|NCT01972841|Mirabegron|mirabegron|mesh-list
92088402|NCT01972841|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92088403|NCT01972841|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92088404|NCT01972841|Cholinergic Agents|cholinergic agents|mesh-ancestor
92088405|NCT01972841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088406|NCT01972841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088407|NCT01972841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088408|NCT01972841|Urological Agents|urological agents|mesh-ancestor
92088409|NCT01972841|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92088410|NCT01972841|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92088411|NCT01972841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088412|NCT01972841|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088414|NCT01774903|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92088415|NCT01774903|Narcotics|narcotics|mesh-ancestor
92088416|NCT01774903|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088417|NCT01774903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088418|NCT01774903|Analgesics|analgesics|mesh-ancestor
92088419|NCT01774903|Sensory System Agents|sensory system agents|mesh-ancestor
92088420|NCT01774903|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088421|NCT01774903|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92088422|NCT01774903|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92088423|NCT01774903|Anesthetics, General|anesthetics, general|mesh-ancestor
92088424|NCT01774903|Anesthetics|anesthetics|mesh-ancestor
92088425|NCT01774591|Azilsartan medoxomil|azilsartan medoxomil|mesh-list
92088426|NCT01774591|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92088427|NCT01774591|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92088428|NCT01774591|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088429|NCT01708915|Nicotinic Acids|nicotinic acids|mesh-list
92088430|NCT01708915|Capsaicin|capsaicin|mesh-list
92088431|NCT01708915|Nonivamide|nonivamide|mesh-list
92088432|NCT01708915|Sensory System Agents|sensory system agents|mesh-ancestor
92088433|NCT01708915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088434|NCT01708915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088435|NCT01708915|Antipruritics|antipruritics|mesh-ancestor
92088436|NCT01708915|Dermatologic Agents|dermatologic agents|mesh-ancestor
92088437|NCT01708915|Vitamin B Complex|vitamin b complex|mesh-ancestor
92088438|NCT01708915|Vitamins|vitamins|mesh-ancestor
92088439|NCT01708915|Micronutrients|micronutrients|mesh-ancestor
92088440|NCT01708057|Tiotropium Bromide|tiotropium bromide|mesh-list
92088441|NCT01708057|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92088442|NCT01708057|Autonomic Agents|autonomic agents|mesh-ancestor
92088443|NCT01708057|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088444|NCT01708057|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088445|NCT01708057|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92088446|NCT01708057|Respiratory System Agents|respiratory system agents|mesh-ancestor
92088447|NCT01708057|Parasympatholytics|parasympatholytics|mesh-ancestor
92088448|NCT01708057|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92088449|NCT01708057|Cholinergic Agents|cholinergic agents|mesh-ancestor
92088450|NCT01708057|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088451|NCT01708057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088452|NCT01747915|Pregabalin|pregabalin|mesh-list
92016947|NCT01938547|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088454|NCT01747915|Sensory System Agents|sensory system agents|mesh-ancestor
92088455|NCT01747915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088456|NCT01747915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088457|NCT01747915|Anticonvulsants|anticonvulsants|mesh-ancestor
92088460|NCT01747915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088461|NCT01747915|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92088462|NCT01747915|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92088463|NCT01747915|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088464|NCT01747915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088465|NCT01747915|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088466|NCT01961297|Sodium Oxybate|sodium oxybate|mesh-list
92088467|NCT01961297|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92088468|NCT01961297|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92088469|NCT01961297|Anesthetics, General|anesthetics, general|mesh-ancestor
92088470|NCT01961297|Anesthetics|anesthetics|mesh-ancestor
92088471|NCT01961297|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088472|NCT01961297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088473|NCT04656041|Paclitaxel|paclitaxel|mesh-list
92088474|NCT04656041|Carboplatin|carboplatin|mesh-list
92088475|NCT04656041|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92088476|NCT04656041|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088477|NCT04656041|Tubulin Modulators|tubulin modulators|mesh-ancestor
92088478|NCT04656041|Antimitotic Agents|antimitotic agents|mesh-ancestor
92088479|NCT04656041|Mitosis Modulators|mitosis modulators|mesh-ancestor
92088480|NCT04656041|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088481|NCT01971203|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92088482|NCT01971203|Antidepressive Agents|antidepressive agents|mesh-ancestor
92088483|NCT01971203|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088484|NCT01971203|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92088485|NCT01971203|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088486|NCT01971203|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088487|NCT01971203|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088488|NCT01970501|Metoprolol|metoprolol|mesh-list
92088489|NCT01970501|Bucindolol|bucindolol|mesh-list
92088490|NCT01970501|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92088491|NCT01970501|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92088492|NCT01970501|Sympatholytics|sympatholytics|mesh-ancestor
92088493|NCT01970501|Autonomic Agents|autonomic agents|mesh-ancestor
92088494|NCT01970501|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088495|NCT01970501|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088496|NCT01970501|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92088497|NCT01970501|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92088498|NCT01970501|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92088499|NCT01970501|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088500|NCT01970501|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088501|NCT01970501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088502|NCT01970501|Sympathomimetics|sympathomimetics|mesh-ancestor
92088503|NCT01970501|Vasodilator Agents|vasodilator agents|mesh-ancestor
92088504|NCT01970501|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92088505|NCT01970501|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92088506|NCT01969799|Amikacin|amikacin|mesh-list
92088507|NCT01969799|Fosfomycin|fosfomycin|mesh-list
92088508|NCT01969799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92088509|NCT01969799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088510|NCT01969721|Fluticasone|fluticasone|mesh-list
92088511|NCT01969721|Xhance|xhance|mesh-list
92088512|NCT01969721|Tiotropium Bromide|tiotropium bromide|mesh-list
92088513|NCT01969721|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92088514|NCT01969721|Olodaterol|olodaterol|mesh-list
92088515|NCT01969721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088516|NCT01969721|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92088518|NCT01969721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088519|NCT01969721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088520|NCT01969721|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92088521|NCT01969721|Respiratory System Agents|respiratory system agents|mesh-ancestor
92088522|NCT01969721|Dermatologic Agents|dermatologic agents|mesh-ancestor
92088523|NCT01969721|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92088524|NCT01969721|Parasympatholytics|parasympatholytics|mesh-ancestor
92088525|NCT01969721|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92088526|NCT01969721|Cholinergic Agents|cholinergic agents|mesh-ancestor
92088527|NCT01969721|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92016948|NCT01938547|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92016949|NCT01938547|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016950|NCT05695625|Anesthetics|anesthetics|mesh-list
92088528|NCT01969721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088529|NCT01969721|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92088530|NCT01969721|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92088531|NCT01969721|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088535|NCT01969565|Antiemetics|antiemetics|mesh-ancestor
92088536|NCT01969565|Autonomic Agents|autonomic agents|mesh-ancestor
92088537|NCT01969565|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088538|NCT01969565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088539|NCT01969565|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088540|NCT01969565|Glucocorticoids|glucocorticoids|mesh-ancestor
92088541|NCT01969565|Hormones|hormones|mesh-ancestor
92088542|NCT01969565|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088543|NCT01969565|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088544|NCT01969565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088545|NCT01968707|Ethanol|ethanol|mesh-list
92088546|NCT01968707|Chlorhexidine|chlorhexidine|mesh-list
92088547|NCT01968707|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92088548|NCT01968707|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92088549|NCT01968707|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088550|NCT01968707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088551|NCT01968707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088552|NCT01968707|Disinfectants|disinfectants|mesh-ancestor
92088553|NCT01968707|Dermatologic Agents|dermatologic agents|mesh-ancestor
92088554|NCT01746901|Naltrexone|naltrexone|mesh-list
92088555|NCT01746901|Oxycodone|oxycodone|mesh-list
92088556|NCT01746901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92088557|NCT01746901|Narcotics|narcotics|mesh-ancestor
92088558|NCT01746901|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088559|NCT01746901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088560|NCT01746901|Analgesics|analgesics|mesh-ancestor
92088561|NCT01746901|Sensory System Agents|sensory system agents|mesh-ancestor
92088562|NCT01746901|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088563|NCT01746901|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92088564|NCT01746901|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92088565|NCT01968551|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92088566|NCT01968551|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92088567|NCT01968551|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92088568|NCT01968551|Antiviral Agents|antiviral agents|mesh-ancestor
92088569|NCT01968551|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088570|NCT01946165|Prednisone|prednisone|mesh-list
92088571|NCT01946165|Abiraterone Acetate|abiraterone acetate|mesh-list
92088572|NCT01946165|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088573|NCT01946165|Glucocorticoids|glucocorticoids|mesh-ancestor
92088574|NCT01946165|Hormones|hormones|mesh-ancestor
92088575|NCT01946165|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088576|NCT01946165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088577|NCT01946165|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088578|NCT01946165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088579|NCT01946165|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92088580|NCT01946165|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088581|NCT01946165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088582|NCT01946165|Hormone Antagonists|hormone antagonists|mesh-ancestor
92088583|NCT01946165|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92088584|NCT01707667|Prucalopride|prucalopride|mesh-list
92088585|NCT01707667|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92088586|NCT01707667|Laxatives|laxatives|mesh-ancestor
92088587|NCT01707667|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088588|NCT01707667|Serotonin 5-HT4 Receptor Agonists|serotonin 5-ht4 receptor agonists|mesh-ancestor
92088589|NCT01707667|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92088590|NCT01707667|Serotonin Agents|serotonin agents|mesh-ancestor
92088591|NCT01707667|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088592|NCT01707667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088593|NCT01707667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088594|NCT01959503|Gelatin Sponge, Absorbable|gelatin sponge, absorbable|mesh-list
92088596|NCT01959503|Coagulants|coagulants|mesh-ancestor
92088597|NCT01706575|Interferons|interferons|mesh-list
92016951|NCT05695625|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92016952|NCT05695625|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016953|NCT05586737|Rituximab|rituximab|mesh-list
92016954|NCT05586737|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92016955|NCT05586737|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016956|NCT05586737|Immunologic Factors|immunologic factors|mesh-ancestor
92088598|NCT01706575|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088599|NCT01706575|Antiviral Agents|antiviral agents|mesh-ancestor
92088600|NCT01706575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088601|NCT01725529|Ribavirin|ribavirin|mesh-list
92088602|NCT01725529|Simeprevir|simeprevir|mesh-list
92088603|NCT01725529|Antimetabolites|antimetabolites|mesh-ancestor
92088604|NCT01725529|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088605|NCT01725529|Antiviral Agents|antiviral agents|mesh-ancestor
92088607|NCT01725529|Protease Inhibitors|protease inhibitors|mesh-ancestor
92088608|NCT01725529|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088609|NCT01744093|Doxycycline|doxycycline|mesh-list
92088610|NCT01744093|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92088611|NCT01744093|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088612|NCT01744093|Antimalarials|antimalarials|mesh-ancestor
92088613|NCT01744093|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92088614|NCT01744093|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92088615|NCT01725451|Testosterone|testosterone|mesh-list
92088616|NCT01725451|Androgens|androgens|mesh-ancestor
92088617|NCT01725451|Hormones|hormones|mesh-ancestor
92088618|NCT01725451|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088619|NCT01725451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088620|NCT01707290|Ivacaftor|ivacaftor|mesh-list
92088621|NCT01707290|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92088622|NCT01707290|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088623|NCT01707290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088624|NCT01717040|Pioglitazone|pioglitazone|mesh-list
92088625|NCT01717040|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92088626|NCT01717040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088627|NCT00803062|Paclitaxel|paclitaxel|mesh-list
92088628|NCT00803062|Bevacizumab|bevacizumab|mesh-list
92088629|NCT00803062|Cisplatin|cisplatin|mesh-list
92088630|NCT00803062|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92088631|NCT00803062|Topotecan|topotecan|mesh-list
92088632|NCT00803062|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92088633|NCT00803062|Endothelial Growth Factors|endothelial growth factors|mesh-list
92088634|NCT00803062|Antibodies|antibodies|mesh-list
92088635|NCT00803062|Immunoglobulins|immunoglobulins|mesh-list
92088636|NCT00803062|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92088637|NCT00803062|Immunoglobulin G|immunoglobulin g|mesh-list
92088638|NCT00803062|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92088639|NCT00803062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088640|NCT00803062|Tubulin Modulators|tubulin modulators|mesh-ancestor
92088641|NCT00803062|Antimitotic Agents|antimitotic agents|mesh-ancestor
92088642|NCT00803062|Mitosis Modulators|mitosis modulators|mesh-ancestor
92088643|NCT00803062|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088644|NCT00803062|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92088645|NCT00803062|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92088646|NCT00803062|Growth Substances|growth substances|mesh-ancestor
92088647|NCT00803062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088648|NCT00803062|Growth Inhibitors|growth inhibitors|mesh-ancestor
92088649|NCT00803062|Immunologic Factors|immunologic factors|mesh-ancestor
92088650|NCT00803062|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92088651|NCT00803062|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92088652|NCT00803062|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088653|NCT01743001|Macitentan|macitentan|mesh-list
92088654|NCT01743001|Endothelin A Receptor Antagonists|endothelin a receptor antagonists|mesh-ancestor
92088655|NCT01743001|Endothelin Receptor Antagonists|endothelin receptor antagonists|mesh-ancestor
92088656|NCT01743001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088657|NCT01743001|Endothelin B Receptor Antagonists|endothelin b receptor antagonists|mesh-ancestor
92088658|NCT01704079|Calcifediol|calcifediol|mesh-list
92088659|NCT01704079|Vitamins|vitamins|mesh-ancestor
92088660|NCT01704079|Micronutrients|micronutrients|mesh-ancestor
92088661|NCT01704079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088662|NCT01704079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92016957|NCT05586737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016958|NCT05586737|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92016959|NCT05678933|Prednisone|prednisone|mesh-list
92016960|NCT05678933|Cyclophosphamide|cyclophosphamide|mesh-list
92016961|NCT05678933|Vincristine|vincristine|mesh-list
92016962|NCT05678933|Azacitidine|azacitidine|mesh-list
92016963|NCT05678933|Epirubicin|epirubicin|mesh-list
92088663|NCT01703845|Tiotropium Bromide|tiotropium bromide|mesh-list
92088664|NCT01703845|Olodaterol|olodaterol|mesh-list
92088665|NCT01703845|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92088666|NCT01703845|Autonomic Agents|autonomic agents|mesh-ancestor
92088667|NCT01703845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088668|NCT01703845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088669|NCT01703845|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92088670|NCT01703845|Respiratory System Agents|respiratory system agents|mesh-ancestor
92088671|NCT01703845|Parasympatholytics|parasympatholytics|mesh-ancestor
92088672|NCT01703845|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92088673|NCT01703845|Cholinergic Agents|cholinergic agents|mesh-ancestor
92088674|NCT01703845|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088675|NCT01703845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088676|NCT01724359|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92088677|NCT01724359|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92088678|NCT01724359|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088679|NCT01724359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088680|NCT01724359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088682|NCT01724359|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92088683|NCT01724359|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92088684|NCT01724359|Serotonin Agents|serotonin agents|mesh-ancestor
92088685|NCT01724359|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088686|NCT01724359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088687|NCT01724359|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92088688|NCT01724359|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92088689|NCT01724359|Dopamine Agents|dopamine agents|mesh-ancestor
92088690|NCT01703221|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92088691|NCT01703221|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92088692|NCT01703221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088694|NCT01703221|Hormones|hormones|mesh-ancestor
92088695|NCT01703221|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088696|NCT01703221|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92088697|NCT01703221|Protease Inhibitors|protease inhibitors|mesh-ancestor
92088698|NCT01703221|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088699|NCT01703221|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088700|NCT00803686|Salmon calcitonin|salmon calcitonin|mesh-list
92088701|NCT00803686|Calcitonin|calcitonin|mesh-list
92088702|NCT00803686|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92088703|NCT00803686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088704|NCT00803686|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92088705|NCT00823966|Delavirdine|delavirdine|mesh-list
92088706|NCT00823966|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92088707|NCT00823966|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92088708|NCT00823966|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088709|NCT00823966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088710|NCT00823966|Antiviral Agents|antiviral agents|mesh-ancestor
92088711|NCT00823966|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088712|NCT00823966|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92088713|NCT00823966|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92088714|NCT01702987|Coenzyme Q10|coenzyme q10|mesh-list
92088715|NCT01702987|Atorvastatin|atorvastatin|mesh-list
92088716|NCT01702987|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92088717|NCT01702987|Simvastatin|simvastatin|mesh-list
92088718|NCT01702987|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92088719|NCT01702987|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92088720|NCT01702987|Antimetabolites|antimetabolites|mesh-ancestor
92088721|NCT01702987|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088722|NCT01702987|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92088723|NCT01702987|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92088724|NCT01702987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088725|NCT01702987|Micronutrients|micronutrients|mesh-ancestor
92016964|NCT05678933|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92016965|NCT05678933|Immunologic Factors|immunologic factors|mesh-ancestor
92016966|NCT05678933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088726|NCT01702987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088728|NCT00824044|Escitalopram|escitalopram|mesh-list
92088729|NCT00824044|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92088730|NCT00824044|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92088731|NCT00824044|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088732|NCT00824044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088733|NCT00824044|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088734|NCT00824044|Serotonin Agents|serotonin agents|mesh-ancestor
92088735|NCT00824044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088736|NCT01702519|Nicotine|nicotine|mesh-list
92088737|NCT01702519|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92088738|NCT01702519|Autonomic Agents|autonomic agents|mesh-ancestor
92088739|NCT01702519|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088740|NCT01702519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088741|NCT01702519|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92088742|NCT01702519|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92088743|NCT01702519|Cholinergic Agents|cholinergic agents|mesh-ancestor
92088744|NCT01702519|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088745|NCT01702519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088746|NCT01739335|Mifepristone|mifepristone|mesh-list
92088747|NCT01739335|Abortifacient Agents, Steroidal|abortifacient agents, steroidal|mesh-ancestor
92088748|NCT01739335|Abortifacient Agents|abortifacient agents|mesh-ancestor
92088749|NCT01739335|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92088750|NCT01739335|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088751|NCT01739335|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92088753|NCT01739335|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92088754|NCT01739335|Contraceptive Agents|contraceptive agents|mesh-ancestor
92088755|NCT01739335|Contraceptives, Postcoital, Synthetic|contraceptives, postcoital, synthetic|mesh-ancestor
92088756|NCT01739335|Contraceptives, Postcoital|contraceptives, postcoital|mesh-ancestor
92088757|NCT01739335|Hormone Antagonists|hormone antagonists|mesh-ancestor
92088758|NCT01739335|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088759|NCT01739335|Luteolytic Agents|luteolytic agents|mesh-ancestor
92088760|NCT01739335|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92088761|NCT01739335|Menstruation-Inducing Agents|menstruation-inducing agents|mesh-ancestor
92088762|NCT00824746|Gefitinib|gefitinib|mesh-list
92088763|NCT00824746|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088764|NCT00824746|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92088765|NCT00824746|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088766|NCT00824746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088767|NCT01722097|Rocuronium|rocuronium|mesh-list
92088934|NCT01943435|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92088768|NCT01722097|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92088769|NCT01722097|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92088770|NCT01722097|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92088771|NCT01722097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088772|NCT01722097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088773|NCT00824824|Timolol|timolol|mesh-list
92088774|NCT00824824|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92088775|NCT00824824|Dorzolamide|dorzolamide|mesh-list
92088776|NCT00824824|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92088777|NCT00824824|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92088778|NCT00824824|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088779|NCT00824824|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088780|NCT00824824|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088781|NCT00824824|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088782|NCT00824824|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92088783|NCT00824824|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92088784|NCT00824824|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92088785|NCT00824824|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92088786|NCT00824824|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92088787|NCT00824824|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92088788|NCT00824824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088789|NCT01701973|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92088790|NCT01701973|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92088791|NCT01701973|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92016968|NCT05678933|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92016969|NCT05678933|Alkylating Agents|alkylating agents|mesh-ancestor
92016970|NCT05678933|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92016971|NCT05678933|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92016972|NCT05678933|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92088792|NCT01701973|Incretins|incretins|mesh-ancestor
92088794|NCT01701973|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088795|NCT01701973|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92088796|NCT01701973|Protease Inhibitors|protease inhibitors|mesh-ancestor
92088797|NCT01701973|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088798|NCT01701973|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088799|NCT00825370|Hydromorphone|hydromorphone|mesh-list
92088800|NCT00825370|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92088801|NCT00825370|Narcotics|narcotics|mesh-ancestor
92088802|NCT00825370|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088803|NCT00825370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088804|NCT00825370|Analgesics|analgesics|mesh-ancestor
92088805|NCT00825370|Sensory System Agents|sensory system agents|mesh-ancestor
92088806|NCT00825370|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088807|NCT01721317|Ezogabine|ezogabine|mesh-list
92088808|NCT01721317|Anticonvulsants|anticonvulsants|mesh-ancestor
92088809|NCT01721317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088810|NCT01721317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088811|NCT05014438|Branebrutinib|branebrutinib|mesh-list
92088812|NCT05014438|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92088813|NCT05014438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088814|NCT05014438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088815|NCT00828412|Desonide|desonide|mesh-list
92088816|NCT00828412|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088817|NCT01959035|Aripiprazole|aripiprazole|mesh-list
92088818|NCT01959035|Antidepressive Agents|antidepressive agents|mesh-ancestor
92088819|NCT01959035|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088820|NCT01959035|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92088821|NCT01959035|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088822|NCT01959035|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088823|NCT01959035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088827|NCT01959035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088828|NCT01959035|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92088829|NCT01959035|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92088830|NCT01959035|Serotonin Agents|serotonin agents|mesh-ancestor
92088831|NCT01959035|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92088832|NCT01959035|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92088833|NCT01959035|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92088834|NCT01959035|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92088835|NCT01700959|Melatonin|melatonin|mesh-list
92088836|NCT01700959|Antioxidants|antioxidants|mesh-ancestor
92088837|NCT01700959|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088838|NCT01700959|Protective Agents|protective agents|mesh-ancestor
92088839|NCT01700959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088840|NCT01700959|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088841|NCT00829738|Pantoprazole|pantoprazole|mesh-list
92088842|NCT00829738|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92088843|NCT00829738|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088844|NCT00829738|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92088845|NCT00829738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088846|NCT00829738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088847|NCT01737931|Diphenhydramine|diphenhydramine|mesh-list
92088848|NCT01737931|Promethazine|promethazine|mesh-list
92088849|NCT01737931|Dexamethasone|dexamethasone|mesh-list
92088850|NCT01737931|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92088851|NCT01737931|Histamine Antagonists|histamine antagonists|mesh-list
92088852|NCT01737931|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088853|NCT01737931|Antiemetics|antiemetics|mesh-ancestor
92088854|NCT01737931|Autonomic Agents|autonomic agents|mesh-ancestor
92088855|NCT01737931|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92016973|NCT05678933|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92016974|NCT05678933|Glucocorticoids|glucocorticoids|mesh-ancestor
92088856|NCT01737931|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088857|NCT01737931|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088858|NCT01737931|Glucocorticoids|glucocorticoids|mesh-ancestor
92088860|NCT01737931|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088861|NCT01737931|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088862|NCT01737931|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088863|NCT01737931|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92088864|NCT01737931|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92088865|NCT01737931|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088866|NCT01737931|Anesthetics, Local|anesthetics, local|mesh-ancestor
92088867|NCT01737931|Anesthetics|anesthetics|mesh-ancestor
92088868|NCT01737931|Sensory System Agents|sensory system agents|mesh-ancestor
92088869|NCT01737931|Histamine Agents|histamine agents|mesh-ancestor
92088870|NCT01737931|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088871|NCT01737931|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088872|NCT01737931|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92088873|NCT01737931|Antipruritics|antipruritics|mesh-ancestor
92088874|NCT01737931|Dermatologic Agents|dermatologic agents|mesh-ancestor
92088875|NCT01958489|Pravastatin|pravastatin|mesh-list
92088876|NCT01958489|Evacetrapib|evacetrapib|mesh-list
92088877|NCT01958489|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92088878|NCT01958489|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92088879|NCT01958489|Antimetabolites|antimetabolites|mesh-ancestor
92088880|NCT01958489|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088881|NCT01958489|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92088882|NCT01958489|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92088883|NCT01958489|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088884|NCT01700179|Ribavirin|ribavirin|mesh-list
92088885|NCT01700179|Antimetabolites|antimetabolites|mesh-ancestor
92088886|NCT01700179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088887|NCT01700179|Antiviral Agents|antiviral agents|mesh-ancestor
92088888|NCT01700179|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088890|NCT00830362|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92088891|NCT00830362|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92088892|NCT00830362|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088893|NCT00830362|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088894|NCT00830362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088895|NCT00830362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088914|NCT01943435|Ibuprofen|ibuprofen|mesh-list
92088915|NCT01943435|Celecoxib|celecoxib|mesh-list
92088916|NCT01943435|Diclofenac|diclofenac|mesh-list
92088917|NCT01943435|Gabapentin|gabapentin|mesh-list
92088918|NCT01943435|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92088919|NCT01943435|Tramadol|tramadol|mesh-list
92088920|NCT01943435|Analgesics|analgesics|mesh-list
92088921|NCT01943435|Mirtazapine|mirtazapine|mesh-list
92088922|NCT01943435|Trazodone|trazodone|mesh-list
92088923|NCT01943435|Sertraline|sertraline|mesh-list
92088924|NCT01943435|Nortriptyline|nortriptyline|mesh-list
92088925|NCT01943435|Antidepressive Agents|antidepressive agents|mesh-list
92088926|NCT01943435|Misoprostol|misoprostol|mesh-list
92088927|NCT01943435|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92088928|NCT01943435|Sensory System Agents|sensory system agents|mesh-ancestor
92088929|NCT01943435|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92088930|NCT01943435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088931|NCT01943435|Antipyretics|antipyretics|mesh-ancestor
92088932|NCT01943435|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92088933|NCT01943435|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088935|NCT01943435|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92088936|NCT01943435|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088937|NCT01943435|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088938|NCT01943435|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92088939|NCT01943435|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92088940|NCT01943435|Abortifacient Agents|abortifacient agents|mesh-ancestor
92088941|NCT01943435|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92088942|NCT01943435|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92088943|NCT01943435|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088944|NCT01943435|Oxytocics|oxytocics|mesh-ancestor
92088945|NCT01943435|Anticonvulsants|anticonvulsants|mesh-ancestor
92088946|NCT01943435|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92016975|NCT05678933|Hormones|hormones|mesh-ancestor
92016976|NCT05678933|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016977|NCT05678933|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92016978|NCT05678933|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92016979|NCT05678933|Tubulin Modulators|tubulin modulators|mesh-ancestor
92016980|NCT05678933|Antimitotic Agents|antimitotic agents|mesh-ancestor
92016981|NCT05678933|Mitosis Modulators|mitosis modulators|mesh-ancestor
92088947|NCT01943435|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92088948|NCT01943435|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92088949|NCT01943435|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088950|NCT01943435|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92088951|NCT01943435|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92088952|NCT01943435|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088953|NCT01943435|Antimanic Agents|antimanic agents|mesh-ancestor
92088954|NCT01943435|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92088969|NCT01943435|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92088970|NCT01943435|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92088971|NCT01943435|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92088972|NCT01943435|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92088973|NCT01943435|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92088974|NCT01943435|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92088975|NCT01942733|Brexpiprazole|brexpiprazole|mesh-list
92088976|NCT01942733|Serotonin Agents|serotonin agents|mesh-ancestor
92088977|NCT01942733|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088978|NCT01942733|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088979|NCT01942733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088980|NCT01942733|Dopamine Agonists|dopamine agonists|mesh-ancestor
92088981|NCT01942733|Dopamine Agents|dopamine agents|mesh-ancestor
92088982|NCT00807586|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92088983|NCT00807586|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92088984|NCT00807586|Methylprednisolone|methylprednisolone|mesh-list
92088985|NCT00807586|Prednisolone|prednisolone|mesh-list
92088986|NCT00807586|Prednisolone acetate|prednisolone acetate|mesh-list
92088987|NCT00807586|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92088988|NCT00807586|Prednisolone phosphate|prednisolone phosphate|mesh-list
92088989|NCT00807586|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088990|NCT00807586|Glucocorticoids|glucocorticoids|mesh-ancestor
92088992|NCT00807586|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92088993|NCT00807586|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088994|NCT00807586|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92088995|NCT00807586|Protective Agents|protective agents|mesh-ancestor
92088996|NCT00807586|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92088997|NCT00807586|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088998|NCT00807586|Antiemetics|antiemetics|mesh-ancestor
92088999|NCT00807586|Autonomic Agents|autonomic agents|mesh-ancestor
92089000|NCT00807586|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089001|NCT00807586|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089002|NCT01698775|Glipizide|glipizide|mesh-list
92089003|NCT01698775|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089004|NCT01698775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089005|NCT01941095|Hydroxychloroquine|hydroxychloroquine|mesh-list
92089006|NCT01941095|Chloroquine|chloroquine|mesh-list
92089007|NCT01941095|Sulfasalazine|sulfasalazine|mesh-list
92089008|NCT01941095|Methotrexate|methotrexate|mesh-list
92089009|NCT01941095|Azathioprine|azathioprine|mesh-list
92089010|NCT01941095|Leflunomide|leflunomide|mesh-list
92089011|NCT01941095|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92089012|NCT01941095|Abortifacient Agents|abortifacient agents|mesh-ancestor
92089014|NCT01941095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089015|NCT01941095|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089016|NCT01941095|Antimetabolites|antimetabolites|mesh-ancestor
92089017|NCT01941095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089018|NCT01941095|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089019|NCT01941095|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089020|NCT01941095|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92016982|NCT05678933|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92016983|NCT05678933|Antimetabolites|antimetabolites|mesh-ancestor
92089021|NCT01941095|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089022|NCT01941095|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089023|NCT01941095|Immunologic Factors|immunologic factors|mesh-ancestor
92089024|NCT01941095|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089025|NCT01941095|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92089026|NCT01941095|Antimalarials|antimalarials|mesh-ancestor
92089027|NCT01941095|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92089028|NCT01941095|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92089029|NCT01941095|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089031|NCT01941095|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92089032|NCT01941095|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089033|NCT01941095|Analgesics|analgesics|mesh-ancestor
92089034|NCT01941095|Sensory System Agents|sensory system agents|mesh-ancestor
92089035|NCT01941095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089036|NCT01941095|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089037|NCT01941095|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089038|NCT00831766|Cytarabine|cytarabine|mesh-list
92089039|NCT00831766|Lenalidomide|lenalidomide|mesh-list
92089040|NCT00831766|Idarubicin|idarubicin|mesh-list
92089041|NCT00831766|Antineoplastic Agents|antineoplastic agents|mesh-list
92089042|NCT00831766|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089043|NCT00831766|Antimetabolites|antimetabolites|mesh-ancestor
92089044|NCT00831766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089045|NCT00831766|Antiviral Agents|antiviral agents|mesh-ancestor
92089046|NCT00831766|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089047|NCT00831766|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089048|NCT00831766|Immunologic Factors|immunologic factors|mesh-ancestor
92089049|NCT00831766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089050|NCT00831766|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92089051|NCT00831766|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92089052|NCT00831766|Growth Substances|growth substances|mesh-ancestor
92089053|NCT00831766|Growth Inhibitors|growth inhibitors|mesh-ancestor
92089054|NCT00831766|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92089055|NCT00831766|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92089056|NCT00831766|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92089057|NCT00831766|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089058|NCT01957709|Interferons|interferons|mesh-list
92089059|NCT01957709|Interferon-gamma|interferon-gamma|mesh-list
92089060|NCT01957709|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089061|NCT01957709|Antiviral Agents|antiviral agents|mesh-ancestor
92089062|NCT01957709|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089063|NCT00832390|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92089064|NCT00832390|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089065|NCT00832390|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089066|NCT00832390|Incretins|incretins|mesh-ancestor
92089067|NCT00832390|Hormones|hormones|mesh-ancestor
92089068|NCT00832390|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089069|NCT00832390|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92089070|NCT00832390|Protease Inhibitors|protease inhibitors|mesh-ancestor
92089071|NCT00832390|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089072|NCT00832390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089073|NCT00844090|Methylphenidate|methylphenidate|mesh-list
92089074|NCT00844090|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92089075|NCT00844090|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089076|NCT00844090|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92089077|NCT00844090|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089078|NCT00844090|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089079|NCT00844090|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089080|NCT00844090|Dopamine Agents|dopamine agents|mesh-ancestor
92089081|NCT00844090|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089082|NCT00844714|Rituximab|rituximab|mesh-list
92089083|NCT00844714|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92089084|NCT00844714|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089085|NCT00844714|Immunologic Factors|immunologic factors|mesh-ancestor
92089088|NCT00834652|Metformin|metformin|mesh-list
92089089|NCT00834652|Sertraline|sertraline|mesh-list
92089090|NCT00834652|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089091|NCT00834652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089092|NCT00834652|Antidepressive Agents|antidepressive agents|mesh-ancestor
92089093|NCT00834652|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92016989|NCT05678621|Ciprofloxacin|ciprofloxacin|mesh-list
92089094|NCT00834652|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92016985|NCT05678933|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92089095|NCT00834652|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089096|NCT00834652|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089097|NCT00834652|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089098|NCT00834652|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089099|NCT00834652|Serotonin Agents|serotonin agents|mesh-ancestor
92089100|NCT00834808|Tramadol|tramadol|mesh-list
92089101|NCT00834808|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92089102|NCT00834808|Narcotics|narcotics|mesh-ancestor
92089103|NCT00834808|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089104|NCT00834808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089105|NCT00834808|Analgesics|analgesics|mesh-ancestor
92089106|NCT00834808|Sensory System Agents|sensory system agents|mesh-ancestor
92089107|NCT00834808|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089108|NCT00850096|Insulin|insulin|mesh-list
92089109|NCT00850096|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089110|NCT00850096|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089111|NCT00834886|Melatonin|melatonin|mesh-list
92089112|NCT00834886|Antioxidants|antioxidants|mesh-ancestor
92089113|NCT00834886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089114|NCT00834886|Protective Agents|protective agents|mesh-ancestor
92089115|NCT00834886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089116|NCT00834886|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089117|NCT00835198|Dapsone|dapsone|mesh-list
92089118|NCT00835198|Tretinoin|tretinoin|mesh-list
92089119|NCT00835198|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089120|NCT00835198|Keratolytic Agents|keratolytic agents|mesh-ancestor
92089121|NCT00835198|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089122|NCT00835198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089123|NCT00835198|Antimalarials|antimalarials|mesh-ancestor
92089124|NCT00835198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92089125|NCT00835198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92089126|NCT00835198|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089127|NCT00835198|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089128|NCT00835198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089129|NCT00835198|Leprostatic Agents|leprostatic agents|mesh-ancestor
92089130|NCT00835198|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92089131|NCT00835510|Butenafine|butenafine|mesh-list
92089132|NCT00835510|Clotrimazole|clotrimazole|mesh-list
92089133|NCT00835510|Antifungal Agents|antifungal agents|mesh-ancestor
92089134|NCT00835510|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089135|NCT00835510|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92089136|NCT00835510|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92089137|NCT00835510|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089138|NCT00835510|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089139|NCT00835510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089140|NCT00835510|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92089141|NCT00835510|Hormone Antagonists|hormone antagonists|mesh-ancestor
92089142|NCT00835510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089143|NCT00835510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089144|NCT00835900|Varenicline|varenicline|mesh-list
92089145|NCT00835900|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92089146|NCT00835900|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92089147|NCT00835900|Cholinergic Agents|cholinergic agents|mesh-ancestor
92089148|NCT00835900|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089149|NCT00835900|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089150|NCT00835900|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089151|NCT01954121|Carbamazepine|carbamazepine|mesh-list
92089152|NCT01954121|Levetiracetam|levetiracetam|mesh-list
92089153|NCT01954121|Anticonvulsants|anticonvulsants|mesh-ancestor
92089154|NCT01954121|Nootropic Agents|nootropic agents|mesh-ancestor
92089155|NCT01954121|Antimanic Agents|antimanic agents|mesh-ancestor
92089156|NCT01954121|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92089157|NCT01954121|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089158|NCT01954121|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089160|NCT01954121|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089161|NCT01954121|Analgesics|analgesics|mesh-ancestor
92089162|NCT01954121|Sensory System Agents|sensory system agents|mesh-ancestor
92089163|NCT01954121|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089164|NCT01954121|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92089165|NCT01954121|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92016986|NCT05678933|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92016987|NCT05678933|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92016988|NCT05678621|Amoxicillin|amoxicillin|mesh-list
92016990|NCT05678621|Clavulanic Acids|clavulanic acids|mesh-list
92016991|NCT05678621|Clavulanic Acid|clavulanic acid|mesh-list
92089166|NCT01954121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089167|NCT01954121|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92089168|NCT01954121|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92089170|NCT03643744|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92089171|NCT03643744|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089172|NCT03643744|Analgesics|analgesics|mesh-ancestor
92089173|NCT03643744|Sensory System Agents|sensory system agents|mesh-ancestor
92089174|NCT03643744|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089175|NCT03643744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089176|NCT03643744|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089177|NCT03643744|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089178|NCT03643744|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92089179|NCT03643744|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92089180|NCT03643744|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089181|NCT03643744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089182|NCT00838162|Ritonavir|ritonavir|mesh-list
92089183|NCT00838162|TMC-310911|tmc-310911|mesh-list
92089184|NCT00838162|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92089185|NCT00838162|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92089186|NCT00838162|Protease Inhibitors|protease inhibitors|mesh-ancestor
92089187|NCT00838162|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089188|NCT00838162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089189|NCT00838162|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92089190|NCT00838162|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92089191|NCT00838162|Antiviral Agents|antiviral agents|mesh-ancestor
92089192|NCT00838162|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089193|NCT00838162|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92089194|NCT00838162|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089195|NCT00841204|Sulindac|sulindac|mesh-list
92089196|NCT00841204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92089197|NCT00841204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089198|NCT00841204|Analgesics|analgesics|mesh-ancestor
92089199|NCT00841204|Sensory System Agents|sensory system agents|mesh-ancestor
92089200|NCT00841204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089201|NCT00841204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089202|NCT00841204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089203|NCT00841204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089204|NCT00841204|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089205|NCT00841204|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92089206|NCT00841204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089207|NCT00841204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089208|NCT00853840|Maraviroc|maraviroc|mesh-list
92089209|NCT00853840|Vardenafil Dihydrochloride|vardenafil dihydrochloride|mesh-list
92089210|NCT00853840|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92089211|NCT00853840|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92089212|NCT00853840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089213|NCT00853840|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92089214|NCT00853840|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92089215|NCT00853840|Antiviral Agents|antiviral agents|mesh-ancestor
92089216|NCT00853840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089217|NCT00853840|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92089218|NCT00853840|Vasodilator Agents|vasodilator agents|mesh-ancestor
92089219|NCT00853840|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92089220|NCT00853840|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92089221|NCT00853840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089222|NCT00853840|Urological Agents|urological agents|mesh-ancestor
92089223|NCT00841828|Cyclophosphamide|cyclophosphamide|mesh-list
92089224|NCT00841828|Docetaxel|docetaxel|mesh-list
92089225|NCT00841828|Trastuzumab|trastuzumab|mesh-list
92089226|NCT00841828|Epirubicin|epirubicin|mesh-list
92089227|NCT00841828|Lapatinib|lapatinib|mesh-list
92016992|NCT05678621|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92016993|NCT05678621|Trimethoprim|trimethoprim|mesh-list
92016994|NCT05678621|Sulfamethoxazole|sulfamethoxazole|mesh-list
92016995|NCT05678621|Immunoglobulins|immunoglobulins|mesh-list
92089228|NCT00841828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089229|NCT00841828|Immunologic Factors|immunologic factors|mesh-ancestor
92089230|NCT00841828|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089231|NCT00841828|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089234|NCT00841828|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089236|NCT00841828|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92089237|NCT00841828|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089238|NCT00841828|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089239|NCT00841828|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089240|NCT00841828|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92089241|NCT00841828|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92089242|NCT00841828|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92089243|NCT00841828|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92089244|NCT00841828|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089245|NCT00841828|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92089246|NCT00855010|Pioglitazone|pioglitazone|mesh-list
92089247|NCT00855010|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089248|NCT00855010|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089249|NCT00842608|Haloperidol|haloperidol|mesh-list
92089250|NCT00842608|Haloperidol decanoate|haloperidol decanoate|mesh-list
92089251|NCT00842608|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92089252|NCT00842608|Antiemetics|antiemetics|mesh-ancestor
92089253|NCT00842608|Autonomic Agents|autonomic agents|mesh-ancestor
92089254|NCT00842608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089255|NCT00842608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089256|NCT00842608|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089257|NCT00842608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92089258|NCT00842608|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92089259|NCT00842608|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089260|NCT00842608|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089261|NCT00842608|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92089262|NCT00842608|Dopamine Agents|dopamine agents|mesh-ancestor
92089263|NCT00842608|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095883|NCT04021264|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089264|NCT00842608|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089265|NCT00842608|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92089266|NCT00842608|Cholinergic Agents|cholinergic agents|mesh-ancestor
92089268|NCT00856024|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92089269|NCT00856024|Antimetabolites|antimetabolites|mesh-ancestor
92089270|NCT00856024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089271|NCT00856024|Antiviral Agents|antiviral agents|mesh-ancestor
92089272|NCT00856024|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089273|NCT00856414|Botulinum Toxins|botulinum toxins|mesh-list
92089274|NCT00856414|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92089275|NCT00856414|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92089276|NCT00856414|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92089277|NCT00856414|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089278|NCT00856414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089279|NCT00856414|Cholinergic Agents|cholinergic agents|mesh-ancestor
92089280|NCT00856414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089281|NCT00856414|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089282|NCT00856414|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92089283|NCT00856414|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089284|NCT00856726|Parathyroid Hormone|parathyroid hormone|mesh-list
92089285|NCT00856726|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92089286|NCT00856726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089287|NCT00857272|Bisacodyl|bisacodyl|mesh-list
92089288|NCT00857272|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92089289|NCT00857272|Cathartics|cathartics|mesh-ancestor
92089290|NCT00857272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089291|NCT00857272|Laxatives|laxatives|mesh-ancestor
92089292|NCT03696784|Cyclophosphamide|cyclophosphamide|mesh-list
92089293|NCT03696784|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92089294|NCT03696784|Fludarabine|fludarabine|mesh-list
92089295|NCT03696784|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089296|NCT03696784|Immunologic Factors|immunologic factors|mesh-ancestor
92089297|NCT03696784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089298|NCT03696784|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089299|NCT03696784|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92089300|NCT03696784|Alkylating Agents|alkylating agents|mesh-ancestor
92089301|NCT03696784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089302|NCT03696784|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089306|NCT01682863|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92089307|NCT01682863|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92089308|NCT01682863|Cholinergic Agents|cholinergic agents|mesh-ancestor
92089309|NCT01682863|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089310|NCT01682863|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089311|NCT01682863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089312|NCT02453620|Nivolumab|nivolumab|mesh-list
92089313|NCT02453620|Ipilimumab|ipilimumab|mesh-list
92089314|NCT02453620|Entinostat|entinostat|mesh-list
92089315|NCT02453620|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92089316|NCT02453620|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92089317|NCT02453620|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089318|NCT02453620|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92089319|NCT02453620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089320|NCT02453620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089321|NCT04400890|Vitamin D|vitamin d|mesh-list
92089322|NCT04400890|Cholecalciferol|cholecalciferol|mesh-list
92089323|NCT04400890|Resveratrol|resveratrol|mesh-list
92089324|NCT04400890|Vitamins|vitamins|mesh-ancestor
92089325|NCT04400890|Micronutrients|micronutrients|mesh-ancestor
92089326|NCT04400890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089327|NCT04400890|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92089328|NCT04400890|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92089329|NCT04400890|Antioxidants|antioxidants|mesh-ancestor
92089330|NCT04400890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089331|NCT04400890|Protective Agents|protective agents|mesh-ancestor
92089332|NCT04400890|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089333|NCT04400890|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92089334|NCT01936649|3-Iodobenzylguanidine|3-iodobenzylguanidine|mesh-list
92089335|NCT01936649|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089336|NCT01936649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089337|NCT01936649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089338|NCT01936649|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92089339|NCT04351438|Heparin|heparin|mesh-list
92089340|NCT04351438|Citric Acid|citric acid|mesh-list
92089341|NCT04351438|Sodium Citrate|sodium citrate|mesh-list
92089342|NCT04351438|Anticoagulants|anticoagulants|mesh-ancestor
92089343|NCT04351438|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92089344|NCT04351438|Chelating Agents|chelating agents|mesh-ancestor
92089345|NCT04351438|Sequestering Agents|sequestering agents|mesh-ancestor
92089346|NCT04351438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089347|NCT04351438|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92089348|NCT04351438|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92089349|NCT00890656|Dexamethasone|dexamethasone|mesh-list
92089350|NCT00890656|Cyclophosphamide|cyclophosphamide|mesh-list
92089351|NCT00890656|Doxorubicin|doxorubicin|mesh-list
92089352|NCT00890656|Methotrexate|methotrexate|mesh-list
92089353|NCT00890656|Vincristine|vincristine|mesh-list
92089354|NCT00890656|Asparaginase|asparaginase|mesh-list
92089355|NCT00890656|Pegaspargase|pegaspargase|mesh-list
92089356|NCT00890656|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089357|NCT00890656|Immunologic Factors|immunologic factors|mesh-ancestor
92089358|NCT00890656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089359|NCT00890656|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089360|NCT00890656|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92089361|NCT00890656|Alkylating Agents|alkylating agents|mesh-ancestor
92089362|NCT00890656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089363|NCT00890656|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089364|NCT00890656|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92089365|NCT00890656|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089366|NCT00890656|Antiemetics|antiemetics|mesh-ancestor
92089367|NCT00890656|Autonomic Agents|autonomic agents|mesh-ancestor
92089368|NCT00890656|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089369|NCT00890656|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089370|NCT00890656|Glucocorticoids|glucocorticoids|mesh-ancestor
92089371|NCT00890656|Hormones|hormones|mesh-ancestor
92089372|NCT00890656|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92016998|NCT05678621|Immunologic Factors|immunologic factors|mesh-ancestor
92016999|NCT05678621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089373|NCT00890656|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92089374|NCT00890656|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089375|NCT00890656|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92089376|NCT00890656|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92089379|NCT00890656|Abortifacient Agents|abortifacient agents|mesh-ancestor
92089380|NCT00890656|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92089381|NCT00890656|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089382|NCT00890656|Antimetabolites|antimetabolites|mesh-ancestor
92089383|NCT00890656|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089384|NCT00890656|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089385|NCT00890656|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92089386|NCT00890656|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92089387|NCT00890656|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089388|NCT00890656|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089389|NCT00890656|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089390|NCT00814138|Methotrexate|methotrexate|mesh-list
92089391|NCT00814138|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92089392|NCT00814138|Abortifacient Agents|abortifacient agents|mesh-ancestor
92089393|NCT00814138|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92089394|NCT00814138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089395|NCT00814138|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089396|NCT00814138|Antimetabolites|antimetabolites|mesh-ancestor
92089397|NCT00814138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089398|NCT00814138|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089399|NCT00814138|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089400|NCT00814138|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089401|NCT00814138|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089402|NCT00814138|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089403|NCT00814138|Immunologic Factors|immunologic factors|mesh-ancestor
92089404|NCT00814138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089405|NCT00814138|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92089406|NCT00860938|Budesonide|budesonide|mesh-list
92089407|NCT00860938|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089408|NCT00860938|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92089409|NCT00860938|Autonomic Agents|autonomic agents|mesh-ancestor
92089410|NCT00860938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089411|NCT00860938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089412|NCT00860938|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92089413|NCT00860938|Respiratory System Agents|respiratory system agents|mesh-ancestor
92089415|NCT00860938|Hormones|hormones|mesh-ancestor
92089416|NCT00860938|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089417|NCT01719757|Oxycodone|oxycodone|mesh-list
92089418|NCT01719757|Naloxone|naloxone|mesh-list
92089419|NCT01719757|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92089420|NCT01719757|Narcotics|narcotics|mesh-ancestor
92089421|NCT01719757|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089422|NCT01719757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089423|NCT01719757|Analgesics|analgesics|mesh-ancestor
92089424|NCT01719757|Sensory System Agents|sensory system agents|mesh-ancestor
92089425|NCT01719757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089426|NCT01719757|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92089427|NCT01718509|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92089428|NCT01718509|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92089429|NCT01718509|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089430|NCT01718509|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92089431|NCT01718509|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089432|NCT01718509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089433|NCT01718509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089434|NCT01718509|Dopamine Agents|dopamine agents|mesh-ancestor
92089435|NCT01718509|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089436|NCT01857934|Aldesleukin|aldesleukin|mesh-list
92089437|NCT01857934|Cyclophosphamide|cyclophosphamide|mesh-list
92089438|NCT01857934|Melphalan|melphalan|mesh-list
92089439|NCT01857934|Busulfan|busulfan|mesh-list
92089440|NCT01857934|Mechlorethamine|mechlorethamine|mesh-list
92089441|NCT01857934|Doxorubicin|doxorubicin|mesh-list
92089442|NCT01857934|Etoposide|etoposide|mesh-list
92089443|NCT01857934|Vincristine|vincristine|mesh-list
92089444|NCT01857934|Topotecan|topotecan|mesh-list
92017000|NCT05678621|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92017001|NCT05678621|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92017002|NCT05678621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017003|NCT05678621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017004|NCT05678621|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089445|NCT01857934|Interleukin-2|interleukin-2|mesh-list
92089446|NCT01857934|Molgramostim|molgramostim|mesh-list
92089447|NCT01857934|Dinutuximab|dinutuximab|mesh-list
92089448|NCT01857934|Levetiracetam|levetiracetam|mesh-list
92089449|NCT01857934|Isotretinoin|isotretinoin|mesh-list
92089450|NCT01857934|Antibodies|antibodies|mesh-list
92089451|NCT01857934|Immunoglobulins|immunoglobulins|mesh-list
92089454|NCT01857934|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089455|NCT01857934|Immunologic Factors|immunologic factors|mesh-ancestor
92089456|NCT01857934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089457|NCT01857934|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089458|NCT01857934|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92089459|NCT01857934|Alkylating Agents|alkylating agents|mesh-ancestor
92089460|NCT01857934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089461|NCT01857934|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089462|NCT01857934|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92089463|NCT01857934|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92089464|NCT01857934|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92089465|NCT01857934|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92089466|NCT01857934|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089467|NCT01857934|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92089468|NCT01857934|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089469|NCT01857934|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089470|NCT01857934|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089471|NCT01857934|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92089472|NCT01857934|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089473|NCT01857934|Analgesics|analgesics|mesh-ancestor
92089474|NCT01857934|Sensory System Agents|sensory system agents|mesh-ancestor
92089475|NCT01857934|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089476|NCT01857934|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92089477|NCT01857934|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92089478|NCT01857934|Antiviral Agents|antiviral agents|mesh-ancestor
92089479|NCT01857934|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089480|NCT01857934|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92089481|NCT01857934|Anticonvulsants|anticonvulsants|mesh-ancestor
92089482|NCT01857934|Nootropic Agents|nootropic agents|mesh-ancestor
92089483|NCT01857934|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089485|NCT00862810|Immunologic Factors|immunologic factors|mesh-ancestor
92089486|NCT00862810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089487|NCT00863122|Lapatinib|lapatinib|mesh-list
92089488|NCT00863122|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089489|NCT00863122|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92089490|NCT00863122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089491|NCT00863122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089492|NCT01604785|Dopamine|dopamine|mesh-list
92089493|NCT01604785|Propofol|propofol|mesh-list
92089494|NCT01604785|Dopamine Antagonists|dopamine antagonists|mesh-list
92089495|NCT01604785|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92089496|NCT01604785|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089497|NCT01604785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089498|NCT01604785|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92089499|NCT01604785|Anesthetics, General|anesthetics, general|mesh-ancestor
92089500|NCT01604785|Anesthetics|anesthetics|mesh-ancestor
92089501|NCT01604785|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92089502|NCT01604785|Sympathomimetics|sympathomimetics|mesh-ancestor
92089503|NCT01604785|Autonomic Agents|autonomic agents|mesh-ancestor
92089504|NCT01604785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089505|NCT01604785|Dopamine Agents|dopamine agents|mesh-ancestor
92089506|NCT01604785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089507|NCT01604785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089508|NCT01604785|Protective Agents|protective agents|mesh-ancestor
92089509|NCT01681849|Paroxetine|paroxetine|mesh-list
92089510|NCT01681849|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92089511|NCT01681849|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089512|NCT01681849|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017005|NCT05678621|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92017006|NCT05678621|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92017007|NCT05678621|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92017008|NCT05678621|Antimalarials|antimalarials|mesh-ancestor
92089513|NCT01681849|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089514|NCT01681849|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089515|NCT01681849|Serotonin Agents|serotonin agents|mesh-ancestor
92089516|NCT01681849|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089517|NCT01681849|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92089518|NCT01681849|Antidepressive Agents|antidepressive agents|mesh-ancestor
92089519|NCT01681849|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089520|NCT01681849|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92089521|NCT01681849|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089522|NCT01681849|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089523|NCT00863356|Hemostatics|hemostatics|mesh-list
92089524|NCT00863356|Chitosan|chitosan|mesh-list
92089525|NCT00863356|Coagulants|coagulants|mesh-ancestor
92089529|NCT00863356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089531|NCT00863356|Chelating Agents|chelating agents|mesh-ancestor
92089532|NCT00863356|Sequestering Agents|sequestering agents|mesh-ancestor
92089533|NCT00863434|Cytarabine|cytarabine|mesh-list
92089534|NCT00863434|Clofarabine|clofarabine|mesh-list
92089535|NCT00863434|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089536|NCT00863434|Antimetabolites|antimetabolites|mesh-ancestor
92089537|NCT00863434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089538|NCT00863434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089539|NCT00863434|Antiviral Agents|antiviral agents|mesh-ancestor
92089540|NCT00863434|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089541|NCT00863434|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089542|NCT00863434|Immunologic Factors|immunologic factors|mesh-ancestor
92089543|NCT00863434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089544|NCT04209790|Temozolomide|temozolomide|mesh-list
92089545|NCT04209790|Benzolamide|benzolamide|mesh-list
92089546|NCT04209790|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92089547|NCT04209790|Alkylating Agents|alkylating agents|mesh-ancestor
92089548|NCT04209790|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089549|NCT04209790|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089550|NCT04209790|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92089551|NCT04209790|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089552|NCT01718353|Prednisone|prednisone|mesh-list
92089553|NCT01718353|Docetaxel|docetaxel|mesh-list
92089554|NCT01718353|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089555|NCT01718353|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089556|NCT01718353|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089557|NCT01718353|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089558|NCT01718353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089559|NCT01718353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089560|NCT01718353|Glucocorticoids|glucocorticoids|mesh-ancestor
92089561|NCT01718353|Hormones|hormones|mesh-ancestor
92089562|NCT01718353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089563|NCT01718353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089564|NCT01718353|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92089565|NCT01716715|Paclitaxel|paclitaxel|mesh-list
92089566|NCT01716715|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92089567|NCT01716715|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92089568|NCT01716715|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089569|NCT01716715|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089570|NCT01716715|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089571|NCT01716715|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089572|NCT01716715|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089573|NCT01696279|Calcium Carbonate|calcium carbonate|mesh-list
92089574|NCT01696279|Calcium|calcium|mesh-list
92089575|NCT01696279|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92089576|NCT01696279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089577|NCT01696279|Antacids|antacids|mesh-ancestor
92089578|NCT01696279|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017009|NCT05678621|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92017010|NCT05678621|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92017011|NCT05678621|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089579|NCT01696279|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089580|NCT01936181|Infliximab|infliximab|mesh-list
92089581|NCT01936181|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92089582|NCT01936181|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089583|NCT01936181|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089584|NCT01936181|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089585|NCT01936181|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089586|NCT01696045|Ipilimumab|ipilimumab|mesh-list
92089587|NCT01696045|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92089588|NCT01696045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089589|NCT01696045|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92089590|NCT01696045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089592|NCT01935947|Azacitidine|azacitidine|mesh-list
92089593|NCT01935947|Docetaxel|docetaxel|mesh-list
92089594|NCT01935947|Irinotecan|irinotecan|mesh-list
92089595|NCT01935947|Pemetrexed|pemetrexed|mesh-list
92089596|NCT01935947|Camptothecin|camptothecin|mesh-list
92089597|NCT01935947|Entinostat|entinostat|mesh-list
92089598|NCT01935947|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-list
92089599|NCT01935947|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089619|NCT02986321|Respiratory System Agents|respiratory system agents|mesh-ancestor
92089620|NCT02986321|Glucocorticoids|glucocorticoids|mesh-ancestor
92089621|NCT02986321|Hormones|hormones|mesh-ancestor
92089622|NCT02986321|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089623|NCT01593787|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92089624|NCT01593787|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92089625|NCT01593787|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089626|NCT01951157|Gemcitabine|gemcitabine|mesh-list
92089627|NCT01951157|Docetaxel|docetaxel|mesh-list
92089628|NCT01951157|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92089629|NCT01951157|Antimetabolites|antimetabolites|mesh-ancestor
92089630|NCT01951157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089631|NCT01951157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089632|NCT01951157|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089633|NCT01951157|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089634|NCT01951157|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089635|NCT01363349|Risperidone|risperidone|mesh-list
92089636|NCT01363349|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92089637|NCT01363349|Serotonin Agents|serotonin agents|mesh-ancestor
92089638|NCT01363349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089639|NCT01363349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089640|NCT01363349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089641|NCT01363349|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92089643|NCT01363349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089644|NCT01363349|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089645|NCT01363349|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92089646|NCT01363349|Dopamine Agents|dopamine agents|mesh-ancestor
92089647|NCT00818272|Infliximab|infliximab|mesh-list
92089648|NCT00818272|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92089649|NCT00818272|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089650|NCT00818272|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089651|NCT00818272|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089652|NCT00818272|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089653|NCT00868348|Ketorolac|ketorolac|mesh-list
92089655|NCT00868348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089656|NCT00868348|Analgesics|analgesics|mesh-ancestor
92089657|NCT00868348|Sensory System Agents|sensory system agents|mesh-ancestor
92089658|NCT00868348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089659|NCT00868348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089660|NCT00868348|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089661|NCT00868348|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089662|NCT00868348|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92089663|NCT00868348|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089664|NCT00868348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089665|NCT01933919|Fluvoxamine|fluvoxamine|mesh-list
92089666|NCT01933919|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017012|NCT05678621|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92017013|NCT05678621|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92089667|NCT01933919|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089668|NCT01933919|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92089669|NCT01933919|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92089670|NCT01933919|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089671|NCT01933919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089672|NCT01933919|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089673|NCT01933919|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92089674|NCT01933919|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089675|NCT01933919|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089676|NCT01933919|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089677|NCT01933919|Serotonin Agents|serotonin agents|mesh-ancestor
92089678|NCT01933919|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92089679|NCT01933919|Antidepressive Agents|antidepressive agents|mesh-ancestor
92089680|NCT01933919|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92089681|NCT01933919|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089682|NCT01933919|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92089683|NCT05317468|Contraceptive Agents|contraceptive agents|mesh-list
92089684|NCT05317468|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92089685|NCT05317468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089686|NCT01933217|Methylphenidate|methylphenidate|mesh-list
92089687|NCT01933217|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92089688|NCT01933217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089689|NCT01933217|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92089690|NCT01933217|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089691|NCT01933217|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089692|NCT01933217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089693|NCT01933217|Dopamine Agents|dopamine agents|mesh-ancestor
92089694|NCT01933217|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089695|NCT01949051|Levocabastine|levocabastine|mesh-list
92089696|NCT01949051|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92089697|NCT01949051|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92089698|NCT01949051|Histamine Antagonists|histamine antagonists|mesh-ancestor
92089699|NCT01949051|Histamine Agents|histamine agents|mesh-ancestor
92089700|NCT01949051|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089701|NCT01949051|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089702|NCT01949051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089703|NCT01692301|Amlodipine|amlodipine|mesh-list
92089704|NCT01692301|Valsartan|valsartan|mesh-list
92089705|NCT01692301|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92089706|NCT01692301|Olmesartan|olmesartan|mesh-list
92089707|NCT01692301|Olmesartan Medoxomil|olmesartan medoxomil|mesh-list
92089708|NCT01692301|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92089709|NCT01692301|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92089710|NCT01692301|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92089711|NCT01692301|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089712|NCT01692301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089713|NCT01692301|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92089714|NCT01692301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089716|NCT01692301|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92089717|NCT01692301|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92089718|NCT01692301|Diuretics|diuretics|mesh-ancestor
92089719|NCT01692301|Natriuretic Agents|natriuretic agents|mesh-ancestor
92089720|NCT01692301|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92089721|NCT01592773|Memantine|memantine|mesh-list
92089722|NCT01592773|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92089723|NCT01592773|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92089740|NCT01592695|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089741|NCT01592695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089743|NCT01592695|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92089744|NCT01592695|Cholinergic Agents|cholinergic agents|mesh-ancestor
92089745|NCT01592695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089746|NCT01592695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089747|NCT01592695|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92089748|NCT01592695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089749|NCT01592695|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017014|NCT05678621|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92017016|NCT05697029|Antimalarials|antimalarials|mesh-ancestor
92017017|NCT05697029|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92017018|NCT05697029|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92089750|NCT01592695|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92089751|NCT01592695|Antidepressive Agents|antidepressive agents|mesh-ancestor
92089752|NCT01592695|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089753|NCT01592695|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92089754|NCT01592695|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089755|NCT01592695|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089756|NCT01592695|Dopamine Agents|dopamine agents|mesh-ancestor
92089757|NCT01592695|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92089758|NCT01592695|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089759|NCT01592695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089760|NCT01929863|Metformin|metformin|mesh-list
92089761|NCT01929863|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089762|NCT01929863|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089763|NCT01714609|Sorafenib|sorafenib|mesh-list
92089764|NCT01714609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089765|NCT01714609|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92089766|NCT01714609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089767|NCT01714609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089768|NCT04553263|Bupropion hydrochloride, naltrexone hydrochoride drug combination|bupropion hydrochloride, naltrexone hydrochoride drug combination|mesh-list
92089769|NCT04553263|Naltrexone|naltrexone|mesh-list
92089770|NCT04553263|Bupropion|bupropion|mesh-list
92089771|NCT04553263|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92089772|NCT04553263|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92089773|NCT04553263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089774|NCT04553263|Sensory System Agents|sensory system agents|mesh-ancestor
92089775|NCT04553263|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089776|NCT04553263|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92089777|NCT04553263|Antidepressive Agents|antidepressive agents|mesh-ancestor
92089778|NCT04553263|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089779|NCT04553263|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92089782|NCT04553263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089783|NCT04553263|Dopamine Agents|dopamine agents|mesh-ancestor
92089784|NCT04553263|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089785|NCT04553263|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92089786|NCT04553263|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92089787|NCT04553263|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089788|NCT04553263|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92089789|NCT01713283|Sofosbuvir|sofosbuvir|mesh-list
92089790|NCT01713283|Antiviral Agents|antiviral agents|mesh-ancestor
92089791|NCT01713283|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089792|NCT04768075|Paclitaxel|paclitaxel|mesh-list
92089793|NCT04768075|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92089794|NCT04768075|Carboplatin|carboplatin|mesh-list
92089795|NCT04768075|Pemetrexed|pemetrexed|mesh-list
92089796|NCT04768075|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92089797|NCT04768075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089798|NCT04768075|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089799|NCT04768075|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089800|NCT04768075|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089801|NCT04768075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089802|NCT04768075|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089803|NCT04768075|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089804|NCT04768075|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92089805|NCT01592383|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92089806|NCT01592383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089807|NCT01592383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92089808|NCT01592383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089809|NCT01592383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089810|NCT01929317|Ropinirole|ropinirole|mesh-list
92089811|NCT01929317|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92089812|NCT01929317|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92089813|NCT01929317|Dopamine Agonists|dopamine agonists|mesh-ancestor
92089814|NCT01929317|Dopamine Agents|dopamine agents|mesh-ancestor
92089815|NCT01929317|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017019|NCT05697029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017020|NCT05697029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017021|NCT05697029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017022|NCT05697029|Antiviral Agents|antiviral agents|mesh-ancestor
92017023|NCT05697029|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92089816|NCT01929317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089817|NCT01929317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089818|NCT01711879|Aflibercept|aflibercept|mesh-list
92089819|NCT01711879|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92089820|NCT01711879|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92089821|NCT01711879|Growth Substances|growth substances|mesh-ancestor
92089822|NCT01711879|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089823|NCT01711879|Growth Inhibitors|growth inhibitors|mesh-ancestor
92089824|NCT01711879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089825|NCT00869206|Zoledronic Acid|zoledronic acid|mesh-list
92089826|NCT00869206|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92089827|NCT00869206|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089828|NCT01689649|Topiramate|topiramate|mesh-list
92089829|NCT01689649|Anticonvulsants|anticonvulsants|mesh-ancestor
92089830|NCT01689649|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089831|NCT01689649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089832|NCT01929083|Ibutilide|ibutilide|mesh-list
92089833|NCT01929083|Progesterone|progesterone|mesh-list
92089834|NCT01929083|Progestins|progestins|mesh-ancestor
92089835|NCT01929083|Hormones|hormones|mesh-ancestor
92089836|NCT01929083|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089837|NCT01929083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089838|NCT01929083|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92089839|NCT01688635|Insulin Glargine|insulin glargine|mesh-list
92089840|NCT01688635|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089841|NCT01688635|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089842|NCT00891436|Fluticasone|fluticasone|mesh-list
92089843|NCT00891436|Xhance|xhance|mesh-list
92089844|NCT00891436|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089845|NCT00891436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92089846|NCT00891436|Autonomic Agents|autonomic agents|mesh-ancestor
92089847|NCT00891436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089848|NCT00891436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089849|NCT00891436|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92089850|NCT00891436|Respiratory System Agents|respiratory system agents|mesh-ancestor
92089851|NCT00891436|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089852|NCT00891436|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92089866|NCT01590433|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92089868|NCT01590433|Hormones|hormones|mesh-ancestor
92089869|NCT01590433|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089870|NCT00820612|Indomethacin|indomethacin|mesh-list
92089871|NCT00820612|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92089872|NCT00820612|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089873|NCT00820612|Analgesics|analgesics|mesh-ancestor
92089874|NCT00820612|Sensory System Agents|sensory system agents|mesh-ancestor
92089875|NCT00820612|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089876|NCT00820612|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089877|NCT00820612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089878|NCT00820612|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089879|NCT00820612|Gout Suppressants|gout suppressants|mesh-ancestor
92089880|NCT00820612|Tocolytic Agents|tocolytic agents|mesh-ancestor
92089881|NCT00820612|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92089882|NCT00820612|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92089883|NCT00820612|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089884|NCT00820612|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089885|NCT01928927|Telmisartan|telmisartan|mesh-list
92089886|NCT01928927|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92089887|NCT01928927|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92089888|NCT01928927|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92089889|NCT01928927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089890|NCT00871624|Dexmedetomidine|dexmedetomidine|mesh-list
92089891|NCT00871624|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92089892|NCT00871624|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089893|NCT00871624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017024|NCT05697029|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017025|NCT05697029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017026|NCT05697029|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92017027|NCT05697029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017028|NCT05697029|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92017029|NCT05697029|Immunologic Factors|immunologic factors|mesh-ancestor
92017030|NCT04708613|Corticosterone|corticosterone|mesh-list
92089894|NCT00871624|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089895|NCT00871624|Analgesics|analgesics|mesh-ancestor
92089896|NCT00871624|Sensory System Agents|sensory system agents|mesh-ancestor
92089897|NCT00871624|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089898|NCT00871624|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92089899|NCT00871624|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92089900|NCT00871624|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92089901|NCT00871624|Adrenergic Agents|adrenergic agents|mesh-ancestor
92089902|NCT00871624|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089903|NCT00871624|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089904|NCT01710709|Aripiprazole|aripiprazole|mesh-list
92089905|NCT01710709|Antidepressive Agents|antidepressive agents|mesh-ancestor
92089906|NCT01710709|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089907|NCT01710709|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92089908|NCT01710709|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92089909|NCT01710709|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089910|NCT01710709|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089911|NCT01710709|Dopamine Agonists|dopamine agonists|mesh-ancestor
92089912|NCT01710709|Dopamine Agents|dopamine agents|mesh-ancestor
92089913|NCT01710709|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089916|NCT01710709|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92089917|NCT01710709|Serotonin Agents|serotonin agents|mesh-ancestor
92089918|NCT01710709|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92089919|NCT01710709|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92089920|NCT01710709|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92089921|NCT01710709|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92089922|NCT05317546|Cannabidiol|cannabidiol|mesh-list
92089923|NCT05317546|Anticonvulsants|anticonvulsants|mesh-ancestor
92089924|NCT01709695|Guanfacine|guanfacine|mesh-list
92089925|NCT01709695|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92089926|NCT01709695|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92089927|NCT01709695|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92089928|NCT01709695|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92089929|NCT01709695|Adrenergic Agents|adrenergic agents|mesh-ancestor
92089930|NCT01709695|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089931|NCT01709695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089932|NCT01709695|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089933|NCT05236504|Melatonin|melatonin|mesh-list
92089934|NCT05236504|Antioxidants|antioxidants|mesh-ancestor
92089935|NCT05236504|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089936|NCT05236504|Protective Agents|protective agents|mesh-ancestor
92089937|NCT05236504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089938|NCT05236504|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089939|NCT01685983|Prednisolone|prednisolone|mesh-list
92089940|NCT01685983|Abiraterone Acetate|abiraterone acetate|mesh-list
92089941|NCT01685983|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089942|NCT01685983|Glucocorticoids|glucocorticoids|mesh-ancestor
92089943|NCT01685983|Hormones|hormones|mesh-ancestor
92089944|NCT01685983|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92089945|NCT01685983|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090341|NCT04088890|Cyclophosphamide|cyclophosphamide|mesh-list
92089946|NCT01685983|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92089947|NCT01685983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089948|NCT01685983|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92089949|NCT01685983|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089950|NCT01685983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089951|NCT01685983|Hormone Antagonists|hormone antagonists|mesh-ancestor
92089952|NCT01685983|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92017031|NCT04708613|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089954|NCT02151448|Interferon-alpha|interferon-alpha|mesh-list
92089955|NCT02151448|Interferon alpha-2|interferon alpha-2|mesh-list
92089956|NCT02151448|poly(I).poly(c12,U)|poly(i).poly(c12,u)|mesh-list
92089958|NCT02151448|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089959|NCT02151448|Antiviral Agents|antiviral agents|mesh-ancestor
92089960|NCT02151448|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089961|NCT02151448|Immunologic Factors|immunologic factors|mesh-ancestor
92089962|NCT02151448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089963|NCT02151448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92089964|NCT02151448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92089965|NCT02151448|Analgesics|analgesics|mesh-ancestor
92089966|NCT02151448|Sensory System Agents|sensory system agents|mesh-ancestor
92089967|NCT02151448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089968|NCT02151448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089969|NCT02151448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089970|NCT02151448|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92089971|NCT02151448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92089972|NCT02151448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089973|NCT02151448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089974|NCT00875212|Calcium|calcium|mesh-list
92089975|NCT00875212|Fluorides|fluorides|mesh-list
92089976|NCT00875212|Sodium Fluoride|sodium fluoride|mesh-list
92089977|NCT00875212|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92089978|NCT00875212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089979|NCT00875212|Cariostatic Agents|cariostatic agents|mesh-ancestor
92089980|NCT00875212|Protective Agents|protective agents|mesh-ancestor
92089981|NCT00875836|Buspirone|buspirone|mesh-list
92089982|NCT00875836|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92089983|NCT00875836|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92089984|NCT00875836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92089996|NCT05312398|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92089997|NCT05312398|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089998|NCT05312398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089999|NCT05312398|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090000|NCT05312398|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090001|NCT01685203|Ribavirin|ribavirin|mesh-list
92090002|NCT01685203|Antimetabolites|antimetabolites|mesh-ancestor
92090003|NCT01685203|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090004|NCT01685203|Antiviral Agents|antiviral agents|mesh-ancestor
92090005|NCT01685203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090006|NCT01928771|Benralizumab|benralizumab|mesh-list
92090007|NCT01928771|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92090008|NCT01928771|Respiratory System Agents|respiratory system agents|mesh-ancestor
92090009|NCT01589653|Insulin|insulin|mesh-list
92090010|NCT01589653|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92090011|NCT01589653|Insulin Aspart|insulin aspart|mesh-list
92090012|NCT01589653|Insulin, Long-Acting|insulin, long-acting|mesh-list
92090013|NCT01589653|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92090014|NCT01589653|Biphasic Insulins|biphasic insulins|mesh-list
92090015|NCT01589653|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92090016|NCT01589653|Insulin, Isophane|insulin, isophane|mesh-list
92090017|NCT01589653|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92090018|NCT01589653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090019|NCT01928615|Trastuzumab|trastuzumab|mesh-list
92090020|NCT01928615|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92090021|NCT01928615|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090022|NCT01928615|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090023|NCT01589497|Moxifloxacin|moxifloxacin|mesh-list
92090024|NCT01589497|Rifampin|rifampin|mesh-list
92090025|NCT01589497|Isoniazid|isoniazid|mesh-list
92090026|NCT01589497|Pyrazinamide|pyrazinamide|mesh-list
92090027|NCT01589497|Ethambutol|ethambutol|mesh-list
92090028|NCT01589497|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090029|NCT01589497|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090030|NCT01589497|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92090031|NCT01589497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92090032|NCT01589497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090342|NCT04088890|Fludarabine|fludarabine|mesh-list
92090033|NCT01589497|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090034|NCT01589497|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090035|NCT01589497|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92090036|NCT01589497|Antitubercular Agents|antitubercular agents|mesh-ancestor
92090037|NCT01589497|Leprostatic Agents|leprostatic agents|mesh-ancestor
92017033|NCT02627677|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090038|NCT01589497|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92090039|NCT01589497|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92090040|NCT01589497|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92090041|NCT01589497|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92090042|NCT01589497|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92090043|NCT01589497|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92090044|NCT01589497|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92090045|NCT01589497|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92090046|NCT01589497|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92090047|NCT01589497|Antimetabolites|antimetabolites|mesh-ancestor
92090068|NCT01927757|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92090069|NCT01927757|Abortifacient Agents|abortifacient agents|mesh-ancestor
92090070|NCT01927757|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92090071|NCT01927757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090072|NCT01927757|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92090074|NCT01927757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090075|NCT01927757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090076|NCT01927757|Dermatologic Agents|dermatologic agents|mesh-ancestor
92090077|NCT01927757|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090078|NCT01927757|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92090079|NCT01927757|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090080|NCT01927757|Immunologic Factors|immunologic factors|mesh-ancestor
92090081|NCT01927757|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090082|NCT01927757|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92090083|NCT01927757|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090084|NCT01927757|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090085|NCT01927757|Analgesics|analgesics|mesh-ancestor
92090086|NCT01927757|Sensory System Agents|sensory system agents|mesh-ancestor
92090087|NCT01927757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090088|NCT01927757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090089|NCT01927757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090090|NCT01913639|Leucovorin|leucovorin|mesh-list
92090091|NCT01913639|Fluorouracil|fluorouracil|mesh-list
92090092|NCT01913639|Oxaliplatin|oxaliplatin|mesh-list
92090093|NCT01913639|Antimetabolites|antimetabolites|mesh-ancestor
92090094|NCT01913639|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090095|NCT01913639|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92090096|NCT01913639|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090097|NCT01913639|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090098|NCT01913639|Immunologic Factors|immunologic factors|mesh-ancestor
92090099|NCT01913639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090100|NCT01913639|Antidotes|antidotes|mesh-ancestor
92090101|NCT01913639|Protective Agents|protective agents|mesh-ancestor
92090104|NCT01913639|Micronutrients|micronutrients|mesh-ancestor
92090106|NCT01913483|Calcium heparin|calcium heparin|mesh-list
92090107|NCT01913483|Bivalirudin|bivalirudin|mesh-list
92090108|NCT01913483|Anticoagulants|anticoagulants|mesh-ancestor
92090109|NCT01913483|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92090110|NCT01913483|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92090111|NCT01913483|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090112|NCT01913483|Antithrombins|antithrombins|mesh-ancestor
92090113|NCT01913483|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92090114|NCT01913483|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090115|NCT01913483|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090116|NCT01913405|Factor VIII|factor viii|mesh-list
92090117|NCT01913405|BAX 855|bax 855|mesh-list
92090118|NCT01913405|Coagulants|coagulants|mesh-ancestor
92090119|NCT01927055|Mannitol|mannitol|mesh-list
92090120|NCT01927055|Droxidopa|droxidopa|mesh-list
92090121|NCT01927055|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92090122|NCT01927055|Diuretics|diuretics|mesh-ancestor
92090123|NCT01927055|Natriuretic Agents|natriuretic agents|mesh-ancestor
92090124|NCT01927055|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090125|NCT01927055|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92090126|NCT01927055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92090127|NCT01913327|Risperidone|risperidone|mesh-list
92090128|NCT01913327|Aripiprazole|aripiprazole|mesh-list
92090129|NCT01913327|Modafinil|modafinil|mesh-list
92090130|NCT01913327|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92090131|NCT01913327|Serotonin Agents|serotonin agents|mesh-ancestor
92090132|NCT01913327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090133|NCT01913327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017034|NCT02627677|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017035|NCT02627677|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017036|NCT02627677|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017037|NCT04964479|Pembrolizumab|pembrolizumab|mesh-list
92017038|NCT04964479|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017039|NCT04964479|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090134|NCT01913327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090135|NCT01913327|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92090136|NCT01913327|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92090137|NCT01913327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090138|NCT01913327|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92090139|NCT01913327|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92090140|NCT01913327|Dopamine Agents|dopamine agents|mesh-ancestor
92090141|NCT01913327|Antidepressive Agents|antidepressive agents|mesh-ancestor
92090142|NCT01913327|Dopamine Agonists|dopamine agonists|mesh-ancestor
92090143|NCT01913327|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92090144|NCT01913327|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92090145|NCT01913327|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92090146|NCT01913327|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92090147|NCT01913327|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92090148|NCT01913327|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92090149|NCT01913327|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92090150|NCT01913327|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92090151|NCT01912781|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92090152|NCT01911845|Ribavirin|ribavirin|mesh-list
92090153|NCT01911845|Antimetabolites|antimetabolites|mesh-ancestor
92090154|NCT01911845|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090155|NCT01911845|Antiviral Agents|antiviral agents|mesh-ancestor
92090156|NCT01911845|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090157|NCT01925183|Interferons|interferons|mesh-list
92090158|NCT01925183|Ribavirin|ribavirin|mesh-list
92090159|NCT01925183|Interferon-alpha|interferon-alpha|mesh-list
92090160|NCT01925183|Interferon alpha-2|interferon alpha-2|mesh-list
92090161|NCT01925183|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92090162|NCT01925183|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090163|NCT01925183|Antiviral Agents|antiviral agents|mesh-ancestor
92090164|NCT01925183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090165|NCT01925183|Antimetabolites|antimetabolites|mesh-ancestor
92090166|NCT01925183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090167|NCT01925183|Immunologic Factors|immunologic factors|mesh-ancestor
92090168|NCT01925183|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090170|NCT01910519|Immunologic Factors|immunologic factors|mesh-ancestor
92090171|NCT01910519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090172|NCT01910441|Metformin|metformin|mesh-list
92090173|NCT01910441|Glimepiride|glimepiride|mesh-list
92090174|NCT01910441|Vildagliptin|vildagliptin|mesh-list
92090175|NCT01910441|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92090176|NCT01910441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090177|NCT01910441|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92090178|NCT01910441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090180|NCT01910441|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92090181|NCT01910441|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090182|NCT01910441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090183|NCT01910441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090184|NCT01923467|Nicotine|nicotine|mesh-list
92090185|NCT01923467|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92090186|NCT01923467|Autonomic Agents|autonomic agents|mesh-ancestor
92090187|NCT01923467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090188|NCT01923467|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090189|NCT01923467|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92090190|NCT01923467|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92090191|NCT01923467|Cholinergic Agents|cholinergic agents|mesh-ancestor
92090192|NCT01923467|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090193|NCT01923467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090194|NCT01908803|Ciprofloxacin|ciprofloxacin|mesh-list
92090195|NCT01908803|Dexamethasone|dexamethasone|mesh-list
92090196|NCT01908803|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090197|NCT01908803|Antiemetics|antiemetics|mesh-ancestor
92017040|NCT04964479|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92017041|NCT04964479|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017042|NCT02501811|Plasma-lyte 148|plasma-lyte 148|mesh-list
92090198|NCT01908803|Autonomic Agents|autonomic agents|mesh-ancestor
92090199|NCT01908803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090200|NCT01908803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090201|NCT01908803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090202|NCT01908803|Glucocorticoids|glucocorticoids|mesh-ancestor
92090204|NCT01908803|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090205|NCT01908803|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92090206|NCT01908803|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090207|NCT01908803|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090208|NCT01908803|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090209|NCT01908803|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92090210|NCT01908803|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92090211|NCT01908803|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090212|NCT01908803|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090213|NCT01908803|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92090214|NCT01908803|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92090215|NCT01908101|Halichondrin B|halichondrin b|mesh-list
92090216|NCT01908101|Tubulin Modulators|tubulin modulators|mesh-ancestor
92090217|NCT01908101|Antimitotic Agents|antimitotic agents|mesh-ancestor
92090218|NCT01908101|Mitosis Modulators|mitosis modulators|mesh-ancestor
92090219|NCT01908101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090220|NCT01908101|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090221|NCT01588951|Cytarabine|cytarabine|mesh-list
92090222|NCT01588951|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92090223|NCT01588951|Antimetabolites|antimetabolites|mesh-ancestor
92090224|NCT01588951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090225|NCT01588951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090226|NCT01588951|Antiviral Agents|antiviral agents|mesh-ancestor
92090227|NCT01588951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090228|NCT01588951|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090229|NCT01588951|Immunologic Factors|immunologic factors|mesh-ancestor
92090230|NCT01588951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090231|NCT01588405|Treprostinil|treprostinil|mesh-list
92090232|NCT01588405|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92090233|NCT01923311|Elvitegravir|elvitegravir|mesh-list
92090234|NCT01923311|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92090235|NCT01923311|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92090236|NCT01923311|Antiviral Agents|antiviral agents|mesh-ancestor
92090237|NCT01923311|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090238|NCT01923311|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92090239|NCT01923311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090240|NCT01923311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090241|NCT01603615|Botulinum Toxins|botulinum toxins|mesh-list
92090242|NCT01603615|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92090243|NCT01603615|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92090244|NCT01603615|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92090245|NCT01603615|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090246|NCT01603615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090247|NCT01603615|Cholinergic Agents|cholinergic agents|mesh-ancestor
92090248|NCT01603615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090249|NCT01603615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090250|NCT01603615|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92090251|NCT01603615|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090253|NCT01905683|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92090254|NCT01905683|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92090255|NCT01905683|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92090256|NCT01905683|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92090257|NCT01905683|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090258|NCT01905683|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090259|NCT01905683|Cholinergic Agents|cholinergic agents|mesh-ancestor
92090260|NCT01905683|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090261|NCT01905683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090262|NCT01905683|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92017043|NCT02501811|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92017044|NCT02501811|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92017045|NCT02585999|Contraceptive Agents|contraceptive agents|mesh-list
92090263|NCT01905683|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090264|NCT01921829|Diuretics|diuretics|mesh-list
92090265|NCT01921829|Natriuretic Agents|natriuretic agents|mesh-ancestor
92090266|NCT01921829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090267|NCT01904903|Trastuzumab|trastuzumab|mesh-list
92090268|NCT01904903|Pertuzumab|pertuzumab|mesh-list
92090269|NCT01904903|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92090270|NCT01904903|Maytansine|maytansine|mesh-list
92090556|NCT03216538|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090271|NCT01904903|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090272|NCT01904903|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090273|NCT01904903|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92090274|NCT01904903|Tubulin Modulators|tubulin modulators|mesh-ancestor
92090275|NCT01904903|Antimitotic Agents|antimitotic agents|mesh-ancestor
92090276|NCT01904903|Mitosis Modulators|mitosis modulators|mesh-ancestor
92090277|NCT01904903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090278|NCT01904903|Immunotoxins|immunotoxins|mesh-ancestor
92090279|NCT01904903|Immunoconjugates|immunoconjugates|mesh-ancestor
92090280|NCT01904903|Immunologic Factors|immunologic factors|mesh-ancestor
92090281|NCT01904903|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090282|NCT01921205|Lacosamide|lacosamide|mesh-list
92090283|NCT01921205|Anticonvulsants|anticonvulsants|mesh-ancestor
92090284|NCT01921205|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92090285|NCT01921205|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92090286|NCT01921205|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090287|NCT01921205|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090288|NCT01920893|Mometasone Furoate|mometasone furoate|mesh-list
92090289|NCT01920893|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92090290|NCT01920893|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090291|NCT01920893|Dermatologic Agents|dermatologic agents|mesh-ancestor
92090292|NCT01920893|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92090293|NCT01920893|Immunologic Factors|immunologic factors|mesh-ancestor
92090294|NCT01920893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090295|NCT01709305|Metformin|metformin|mesh-list
92090296|NCT01709305|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92090297|NCT01709305|Glimepiride|glimepiride|mesh-list
92090298|NCT01709305|Acarbose|acarbose|mesh-list
92090299|NCT01709305|Repaglinide|repaglinide|mesh-list
92090300|NCT01709305|Gliclazide|gliclazide|mesh-list
92090301|NCT01709305|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92090302|NCT01709305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090303|NCT01709305|Incretins|incretins|mesh-ancestor
92090304|NCT01709305|Hormones|hormones|mesh-ancestor
92090305|NCT01709305|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090306|NCT01709305|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92090307|NCT01709305|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090308|NCT01709305|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090309|NCT01709305|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090310|NCT01709305|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92090311|NCT01709305|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090312|NCT01709305|Immunologic Factors|immunologic factors|mesh-ancestor
92090313|NCT01709305|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92090314|NCT01684423|Rivaroxaban|rivaroxaban|mesh-list
92090315|NCT01684423|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92090316|NCT01684423|Antithrombins|antithrombins|mesh-ancestor
92090317|NCT01684423|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92090318|NCT01684423|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090319|NCT01684423|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090320|NCT01684423|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090321|NCT01684423|Anticoagulants|anticoagulants|mesh-ancestor
92090322|NCT01709227|Furosemide|furosemide|mesh-list
92090323|NCT01709227|Diuretics|diuretics|mesh-ancestor
92090324|NCT01709227|Natriuretic Agents|natriuretic agents|mesh-ancestor
92090325|NCT01709227|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090326|NCT01709227|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92090328|NCT01709227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090329|NCT00879034|Zoledronic Acid|zoledronic acid|mesh-list
92090330|NCT00879034|Pravastatin|pravastatin|mesh-list
92090331|NCT00879034|Lonafarnib|lonafarnib|mesh-list
92017047|NCT02585999|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92017048|NCT02585999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017049|NCT02585999|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92017050|NCT05696951|Tranylcypromine|tranylcypromine|mesh-list
92017051|NCT05696951|Antidepressive Agents|antidepressive agents|mesh-ancestor
92017052|NCT05696951|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92090332|NCT00879034|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92090333|NCT00879034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090334|NCT00879034|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92090335|NCT00879034|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92090336|NCT00879034|Antimetabolites|antimetabolites|mesh-ancestor
92090337|NCT00879034|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090338|NCT00879034|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92090339|NCT00879034|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92090340|NCT00879034|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090343|NCT04088890|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090344|NCT04088890|Immunologic Factors|immunologic factors|mesh-ancestor
92090345|NCT04088890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090346|NCT04088890|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090347|NCT04088890|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92090348|NCT04088890|Alkylating Agents|alkylating agents|mesh-ancestor
92090349|NCT04088890|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090350|NCT04088890|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090351|NCT04088890|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92090352|NCT00879190|Gentamicins|gentamicins|mesh-list
92090353|NCT00879190|Ampicillin|ampicillin|mesh-list
92090354|NCT00879190|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090355|NCT00879190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090356|NCT00879190|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92090357|NCT00879190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090358|NCT00879190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090359|NCT01903811|Dexamethasone|dexamethasone|mesh-list
92090360|NCT01903811|Dexamethasone acetate|dexamethasone acetate|mesh-list
92090361|NCT01903811|Ichthammol|ichthammol|mesh-list
92090362|NCT01903811|BB 1101|bb 1101|mesh-list
92090363|NCT01903811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090364|NCT01903811|Antiemetics|antiemetics|mesh-ancestor
92090365|NCT01903811|Autonomic Agents|autonomic agents|mesh-ancestor
92090366|NCT01903811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090367|NCT01903811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090368|NCT01903811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090369|NCT01903811|Glucocorticoids|glucocorticoids|mesh-ancestor
92090370|NCT01903811|Hormones|hormones|mesh-ancestor
92090371|NCT01903811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090372|NCT01903811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92090373|NCT01903811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090374|NCT01903811|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090375|NCT01903811|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090376|NCT01903811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090377|NCT01903811|Dermatologic Agents|dermatologic agents|mesh-ancestor
92090378|NCT00880360|Denileukin diftitox|denileukin diftitox|mesh-list
92090379|NCT00880360|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090380|NCT01709149|Riluzole|riluzole|mesh-list
92090381|NCT01709149|Anticonvulsants|anticonvulsants|mesh-ancestor
92090382|NCT01709149|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92090383|NCT01709149|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92090384|NCT01709149|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090385|NCT01709149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090386|NCT01709149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090387|NCT01709149|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92090388|NCT01709149|Protective Agents|protective agents|mesh-ancestor
92090389|NCT05214196|Povidone-Iodine|povidone-iodine|mesh-list
92090390|NCT05214196|Povidone|povidone|mesh-list
92090391|NCT05214196|Plasma Substitutes|plasma substitutes|mesh-ancestor
92017053|NCT05696951|Monoamine Oxidase Inhibitors|monoamine oxidase inhibitors|mesh-ancestor
92017054|NCT05696951|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017055|NCT05696951|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017056|NCT05696951|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92017057|NCT05696951|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92090392|NCT05214196|Blood Substitutes|blood substitutes|mesh-ancestor
92090393|NCT05214196|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92090394|NCT05214196|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090396|NCT05311228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090397|NCT05311228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090398|NCT04382014|Curcumin|curcumin|mesh-list
92090399|NCT04382014|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090466|NCT01903031|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92090467|NCT01903031|Contraceptive Agents|contraceptive agents|mesh-ancestor
92090468|NCT01903031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92090469|NCT01903031|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92090470|NCT01903031|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92090471|NCT01903031|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92090472|NCT01903031|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92090473|NCT01903031|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92090474|NCT01903031|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92090475|NCT01903031|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92090476|NCT01903031|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92090477|NCT00883168|Fluticasone|fluticasone|mesh-list
92090478|NCT00883168|Xhance|xhance|mesh-list
92090479|NCT00883168|Azelastine|azelastine|mesh-list
92090480|NCT00883168|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090481|NCT00883168|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92090482|NCT00883168|Autonomic Agents|autonomic agents|mesh-ancestor
92090483|NCT00883168|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090484|NCT00883168|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090485|NCT00883168|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92090486|NCT00883168|Respiratory System Agents|respiratory system agents|mesh-ancestor
92090487|NCT00883168|Dermatologic Agents|dermatologic agents|mesh-ancestor
92090488|NCT00883168|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92090489|NCT00883168|Lipoxygenase Inhibitors|lipoxygenase inhibitors|mesh-ancestor
92090490|NCT00883168|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090491|NCT00883168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090492|NCT00883168|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92090493|NCT00883168|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92090494|NCT00883168|Histamine Antagonists|histamine antagonists|mesh-ancestor
92090495|NCT00883168|Histamine Agents|histamine agents|mesh-ancestor
92090496|NCT00883168|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090497|NCT01616693|Zinc|zinc|mesh-list
92090498|NCT01616693|Vaccines|vaccines|mesh-list
92090499|NCT01616693|Immunologic Factors|immunologic factors|mesh-ancestor
92090500|NCT01616693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090501|NCT01616693|Trace Elements|trace elements|mesh-ancestor
92090502|NCT01616693|Micronutrients|micronutrients|mesh-ancestor
92090503|NCT00893074|Dronabinol|dronabinol|mesh-list
92090504|NCT00893074|Hallucinogens|hallucinogens|mesh-ancestor
92090505|NCT00893074|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090506|NCT00893074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92090507|NCT00893074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090509|NCT00893074|Sensory System Agents|sensory system agents|mesh-ancestor
92090510|NCT00893074|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090511|NCT00893074|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92090512|NCT00893074|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92090513|NCT00893074|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090519|NCT00885742|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92090520|NCT00885742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090522|NCT00887458|Hydroxyitraconazole|hydroxyitraconazole|mesh-list
92090523|NCT00887458|Antifungal Agents|antifungal agents|mesh-ancestor
92090524|NCT00887458|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090525|NCT00887458|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92017058|NCT05696951|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017059|NCT05696951|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017060|NCT05677373|Trametinib|trametinib|mesh-list
92017061|NCT05677373|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090526|NCT00887458|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92090527|NCT00887458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090528|NCT00887458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090529|NCT00887458|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92090530|NCT00887458|Hormone Antagonists|hormone antagonists|mesh-ancestor
92090531|NCT00887458|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090532|NCT00887458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090533|NCT00887458|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92090534|NCT03216304|Calcium, Dietary|calcium, dietary|mesh-list
92090535|NCT03216304|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92090536|NCT03216304|Calcium|calcium|mesh-list
92090537|NCT03216304|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92090538|NCT03216304|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090539|NCT03216304|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92090540|NCT03216304|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92090541|NCT03216304|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92090543|NCT03216304|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090544|NCT03216304|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92090545|NCT03216304|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92090546|NCT03216304|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090547|NCT03216538|Ammonium trichloro(dioxoethylene-O,O'-)tellurate|ammonium trichloro(dioxoethylene-o,o'-)tellurate|mesh-list
92090548|NCT03216538|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92090549|NCT03216538|Immunologic Factors|immunologic factors|mesh-ancestor
92090550|NCT03216538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090551|NCT03216538|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090552|NCT03216538|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92090553|NCT03216538|Protective Agents|protective agents|mesh-ancestor
92090554|NCT03216538|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92090555|NCT03216538|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92090557|NCT03216538|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090558|NCT03216538|Antiviral Agents|antiviral agents|mesh-ancestor
92090559|NCT03216538|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090560|NCT03218722|Thrombin|thrombin|mesh-list
92090561|NCT03218722|Hemostatics|hemostatics|mesh-ancestor
92090562|NCT03218722|Coagulants|coagulants|mesh-ancestor
92090563|NCT00888628|Etanercept|etanercept|mesh-list
92090564|NCT00888628|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090565|NCT00888628|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090566|NCT00888628|Analgesics|analgesics|mesh-ancestor
92090567|NCT00888628|Sensory System Agents|sensory system agents|mesh-ancestor
92090568|NCT00888628|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090569|NCT00888628|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090570|NCT00888628|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090571|NCT00888628|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090572|NCT00888628|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090573|NCT00888628|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090574|NCT00888628|Immunologic Factors|immunologic factors|mesh-ancestor
92090575|NCT03837886|Calcium Carbonate|calcium carbonate|mesh-list
92090576|NCT03837886|Calcium|calcium|mesh-list
92090577|NCT03837886|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92090578|NCT03837886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090579|NCT03837886|Antacids|antacids|mesh-ancestor
92090592|NCT00889330|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090593|NCT00889330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090595|NCT03219580|Antimetabolites|antimetabolites|mesh-ancestor
92090596|NCT03219580|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090597|NCT03219580|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92090598|NCT03219580|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090599|NCT03219580|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090600|NCT03219580|Immunologic Factors|immunologic factors|mesh-ancestor
92090601|NCT03219580|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090602|NCT03215446|Anesthetics|anesthetics|mesh-list
92017062|NCT05677373|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017063|NCT05677373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017064|NCT05677373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090603|NCT03215446|Propofol|propofol|mesh-list
92090604|NCT03215446|Sevoflurane|sevoflurane|mesh-list
92090605|NCT03215446|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090606|NCT03215446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090607|NCT03215446|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92090608|NCT03215446|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92090609|NCT03215446|Anesthetics, General|anesthetics, general|mesh-ancestor
92090610|NCT03215446|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92090611|NCT03215446|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92090612|NCT00896038|Aprepitant|aprepitant|mesh-list
92090613|NCT00896038|Antiemetics|antiemetics|mesh-ancestor
92090614|NCT00896038|Autonomic Agents|autonomic agents|mesh-ancestor
92090615|NCT00896038|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090616|NCT00896038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090617|NCT00896038|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090618|NCT00896038|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92090619|NCT00896038|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090620|NCT00896038|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090621|NCT02804074|Antihypertensive Agents|antihypertensive agents|mesh-list
92090623|NCT04381234|Sodium Citrate|sodium citrate|mesh-list
92090624|NCT04381234|Dialysis Solutions|dialysis solutions|mesh-list
92090625|NCT04381234|Anticoagulants|anticoagulants|mesh-ancestor
92090626|NCT04381234|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92090627|NCT04381234|Chelating Agents|chelating agents|mesh-ancestor
92090628|NCT04381234|Sequestering Agents|sequestering agents|mesh-ancestor
92090629|NCT04381234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090630|NCT04381234|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92090631|NCT01616459|Vaccines|vaccines|mesh-list
92090632|NCT01616459|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92090633|NCT01616459|Immunologic Factors|immunologic factors|mesh-ancestor
92090634|NCT01616459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090635|NCT03218254|Methylphenidate|methylphenidate|mesh-list
92090636|NCT03218254|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92090637|NCT03218254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090638|NCT03218254|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92090639|NCT03218254|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92090657|NCT01919801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090658|NCT01919801|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090659|NCT01919801|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92090660|NCT01919801|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92090661|NCT01919801|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090662|NCT01919801|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92090663|NCT01919801|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090664|NCT01919801|Immunologic Factors|immunologic factors|mesh-ancestor
92090665|NCT01919723|Ticagrelor|ticagrelor|mesh-list
92090666|NCT01919723|Eptifibatide|eptifibatide|mesh-list
92090667|NCT01919723|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92090668|NCT01919723|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92090669|NCT01919723|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92090670|NCT01919723|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92090671|NCT01919723|Purinergic Agents|purinergic agents|mesh-ancestor
92090672|NCT01919723|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090673|NCT01919723|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090674|NCT01919723|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090675|NCT01919489|Insulin Glargine|insulin glargine|mesh-list
92090676|NCT01919489|Liraglutide|liraglutide|mesh-list
92090677|NCT01919489|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92090678|NCT01919489|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090679|NCT01919489|Incretins|incretins|mesh-ancestor
92090680|NCT01919489|Hormones|hormones|mesh-ancestor
92090681|NCT01919489|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090682|NCT01919411|Amoxicillin|amoxicillin|mesh-list
92090683|NCT01919411|Clavulanic Acid|clavulanic acid|mesh-list
92090684|NCT01919411|Clavulanic Acids|clavulanic acids|mesh-list
92090685|NCT01919411|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92090686|NCT01919411|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090687|NCT01919411|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090688|NCT01919411|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92090689|NCT01919411|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090690|NCT01919411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090692|NCT01901393|Ketorolac|ketorolac|mesh-list
92090693|NCT01901393|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92090694|NCT01901393|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090695|NCT01901393|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090696|NCT01901393|Analgesics|analgesics|mesh-ancestor
92090698|NCT01901393|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090699|NCT01901393|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090700|NCT01901393|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090701|NCT01901393|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090702|NCT01901393|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92090703|NCT01901393|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090704|NCT01901393|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090705|NCT01890707|Anesthetics|anesthetics|mesh-list
92090706|NCT01890707|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090707|NCT01890707|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090708|NCT01890473|Abatacept|abatacept|mesh-list
92090709|NCT01890473|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92090710|NCT01890473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090711|NCT01890473|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090712|NCT01890473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090713|NCT01890473|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090714|NCT01890473|Immunologic Factors|immunologic factors|mesh-ancestor
92090715|NCT01890473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090716|NCT01890473|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090717|NCT01889069|Prednisone|prednisone|mesh-list
92090718|NCT01889069|Cyclophosphamide|cyclophosphamide|mesh-list
92090719|NCT01889069|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92090720|NCT01889069|Rituximab|rituximab|mesh-list
92090721|NCT01889069|Doxorubicin|doxorubicin|mesh-list
92090722|NCT01889069|Vincristine|vincristine|mesh-list
92090723|NCT01889069|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090724|NCT01889069|Immunologic Factors|immunologic factors|mesh-ancestor
92090725|NCT01889069|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090726|NCT01889069|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090727|NCT01889069|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92090728|NCT01889069|Alkylating Agents|alkylating agents|mesh-ancestor
92090729|NCT01889069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090730|NCT01889069|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090731|NCT01889069|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92090732|NCT01889069|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090733|NCT01889069|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92090734|NCT01889069|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92090735|NCT01889069|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92090736|NCT01889069|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090737|NCT01889069|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090738|NCT01889069|Glucocorticoids|glucocorticoids|mesh-ancestor
92090740|NCT01889069|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090741|NCT01889069|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92090742|NCT01889069|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92090743|NCT01889069|Tubulin Modulators|tubulin modulators|mesh-ancestor
92090744|NCT01889069|Antimitotic Agents|antimitotic agents|mesh-ancestor
92090745|NCT01889069|Mitosis Modulators|mitosis modulators|mesh-ancestor
92090746|NCT00898222|Aspirin|aspirin|mesh-list
92090747|NCT00898222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090748|NCT00898222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090749|NCT00898222|Analgesics|analgesics|mesh-ancestor
92090750|NCT00898222|Sensory System Agents|sensory system agents|mesh-ancestor
92090751|NCT00898222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090752|NCT00898222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090753|NCT00898222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090754|NCT00898222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090755|NCT00898222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92090756|NCT00898222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92090757|NCT00898222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090758|NCT00898222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92090759|NCT00898222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92017066|NCT05041907|Ivermectin|ivermectin|mesh-list
92090760|NCT00898222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090761|NCT00898222|Antipyretics|antipyretics|mesh-ancestor
92090762|NCT01830556|Cetuximab|cetuximab|mesh-list
92090763|NCT01830556|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090764|NCT01830556|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090765|NCT03214354|Sirolimus|sirolimus|mesh-list
92090766|NCT03214354|Alemtuzumab|alemtuzumab|mesh-list
92090767|NCT03214354|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090768|NCT03214354|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090769|NCT03214354|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92090774|NCT03214354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090775|NCT03214354|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090776|NCT03217942|Mitogens|mitogens|mesh-list
92090777|NCT03217942|Mitosis Modulators|mitosis modulators|mesh-ancestor
92090778|NCT03217942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090779|NCT00903448|Omeprazole|omeprazole|mesh-list
92090780|NCT00903448|Lansoprazole|lansoprazole|mesh-list
92090781|NCT00903448|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92090782|NCT00903448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090783|NCT00903448|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92090784|NCT00903448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090785|NCT00903448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090786|NCT00895180|Ramucirumab|ramucirumab|mesh-list
92090787|NCT00895180|Olaratumab|olaratumab|mesh-list
92090788|NCT00895180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090789|NCT01830868|Zonisamide|zonisamide|mesh-list
92090790|NCT01830868|Anticonvulsants|anticonvulsants|mesh-ancestor
92090791|NCT01830868|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92090792|NCT01830868|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090793|NCT01830868|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090794|NCT01830868|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92090795|NCT01830868|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090796|NCT03213964|Interleukin-2|interleukin-2|mesh-list
92090797|NCT03213964|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090798|NCT03213964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090799|NCT03213964|Analgesics|analgesics|mesh-ancestor
92090800|NCT03213964|Sensory System Agents|sensory system agents|mesh-ancestor
92090801|NCT03213964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090802|NCT03213964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090803|NCT03217474|Ganciclovir|ganciclovir|mesh-list
92090804|NCT03217474|Ganciclovir triphosphate|ganciclovir triphosphate|mesh-list
92090805|NCT03217474|Antiviral Agents|antiviral agents|mesh-ancestor
92090806|NCT03217474|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090807|NCT03217474|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92090808|NCT03217474|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090809|NCT03217474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090810|NCT01830946|Caseins|caseins|mesh-list
92090811|NCT01830946|Chelating Agents|chelating agents|mesh-ancestor
92090812|NCT01830946|Sequestering Agents|sequestering agents|mesh-ancestor
92090813|NCT01830946|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090814|NCT03213886|Vitamin D|vitamin d|mesh-list
92090815|NCT03213886|Calcifediol|calcifediol|mesh-list
92090816|NCT03213886|Vitamins|vitamins|mesh-ancestor
92090817|NCT03213886|Micronutrients|micronutrients|mesh-ancestor
92090818|NCT03213886|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090819|NCT03213886|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92090820|NCT03217084|Fluorides|fluorides|mesh-list
92090821|NCT03217084|Fluorides, Topical|fluorides, topical|mesh-list
92090822|NCT03217084|Cariostatic Agents|cariostatic agents|mesh-ancestor
92090823|NCT03217084|Protective Agents|protective agents|mesh-ancestor
92090824|NCT03217084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090825|NCT00899470|Metformin|metformin|mesh-list
92090826|NCT00899470|Saxagliptin|saxagliptin|mesh-list
92090827|NCT00899470|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92090828|NCT00899470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090829|NCT00899470|Incretins|incretins|mesh-ancestor
92090830|NCT00899470|Hormones|hormones|mesh-ancestor
92090831|NCT00899470|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090832|NCT00899470|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92090833|NCT00899470|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090834|NCT00899470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090835|NCT00899470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017068|NCT05041907|Remdesivir|remdesivir|mesh-list
92017069|NCT05041907|Favipiravir|favipiravir|mesh-list
92017070|NCT05041907|Nirmatrelvir|nirmatrelvir|mesh-list
92017071|NCT05041907|Sotrovimab|sotrovimab|mesh-list
92017072|NCT05041907|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92017073|NCT05041907|Molnupiravir|molnupiravir|mesh-list
92017074|NCT05041907|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92017075|NCT05041907|Fluoxetine|fluoxetine|mesh-list
92017076|NCT05041907|Antibodies|antibodies|mesh-list
92017077|NCT05041907|Immunoglobulins|immunoglobulins|mesh-list
92017078|NCT05041907|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92017079|NCT05041907|Immunologic Factors|immunologic factors|mesh-ancestor
92017080|NCT05041907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017081|NCT05041907|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017082|NCT05041907|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92017083|NCT05041907|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92090837|NCT01738646|Vorinostat|vorinostat|mesh-list
92090838|NCT01738646|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090839|NCT01738646|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090840|NCT01738646|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92090841|NCT01738646|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92090848|NCT00904618|Lidocaine|lidocaine|mesh-list
92090849|NCT00904618|Anesthetics, Local|anesthetics, local|mesh-ancestor
92090850|NCT00904618|Anesthetics|anesthetics|mesh-ancestor
92090851|NCT00904618|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090852|NCT00904618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090853|NCT00904618|Sensory System Agents|sensory system agents|mesh-ancestor
92090854|NCT00904618|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090855|NCT00904618|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92090856|NCT00904618|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92090857|NCT00904618|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92090858|NCT00904618|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090859|NCT00904618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090860|NCT01839370|Pramlintide|pramlintide|mesh-list
92090861|NCT01839370|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92090862|NCT01839370|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090863|NCT00907426|Bimatoprost|bimatoprost|mesh-list
92090864|NCT00907426|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92090865|NCT00907426|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92090866|NCT01832662|Caffeine|caffeine|mesh-list
92090867|NCT01832662|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92090868|NCT01832662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090869|NCT01832662|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92090870|NCT01832662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090871|NCT01832662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090872|NCT01832662|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92090873|NCT01832662|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92090874|NCT01832662|Purinergic Agents|purinergic agents|mesh-ancestor
92090875|NCT01832662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090876|NCT00909064|PENTA|penta|mesh-list
92090877|NCT00909064|Fondaparinux|fondaparinux|mesh-list
92090878|NCT00909064|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92090879|NCT00909064|Antithrombins|antithrombins|mesh-ancestor
92090880|NCT00909064|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92090881|NCT00909064|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090882|NCT00909064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017084|NCT05041907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92017085|NCT05041907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017086|NCT05041907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017088|NCT05041907|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92017089|NCT05041907|Antiviral Agents|antiviral agents|mesh-ancestor
92017090|NCT05041907|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017091|NCT05041907|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92017092|NCT05041907|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92017093|NCT05041907|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92017094|NCT05041907|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92090883|NCT00909064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090884|NCT00909064|Anticoagulants|anticoagulants|mesh-ancestor
92090885|NCT00909064|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92090886|NCT00909064|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92090887|NCT01832896|Ecallantide|ecallantide|mesh-list
92090888|NCT01832896|Analgesics|analgesics|mesh-ancestor
92090889|NCT01832896|Sensory System Agents|sensory system agents|mesh-ancestor
92090890|NCT01832896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090891|NCT01832896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090892|NCT01832896|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090893|NCT01832896|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090894|NCT01832896|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92090895|NCT01832896|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090896|NCT01830400|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92090897|NCT01830400|Anticonvulsants|anticonvulsants|mesh-ancestor
92090898|NCT01830400|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92090899|NCT01830400|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92090900|NCT01830400|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090901|NCT01830400|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090902|NCT01830478|Rituximab|rituximab|mesh-list
92090903|NCT01830478|Lenalidomide|lenalidomide|mesh-list
92090904|NCT01830478|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090905|NCT01830478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090906|NCT01830478|Immunologic Factors|immunologic factors|mesh-ancestor
92090907|NCT01830478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090913|NCT04426695|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92090915|NCT04426695|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090916|NCT01838200|Isoniazid|isoniazid|mesh-list
92090917|NCT01838200|Ipilimumab|ipilimumab|mesh-list
92090918|NCT01838200|BCG Vaccine|bcg vaccine|mesh-list
92090919|NCT01838200|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090920|NCT01838200|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090921|NCT01838200|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92090922|NCT01838200|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090923|NCT01838200|Antitubercular Agents|antitubercular agents|mesh-ancestor
92090924|NCT01838200|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92090925|NCT01838200|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090926|NCT01838200|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92090927|NCT01838200|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92090929|NCT01838200|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92090930|NCT01838200|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92090931|NCT01838200|Immunologic Factors|immunologic factors|mesh-ancestor
92090932|NCT01838200|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090933|NCT01720030|Simendan|simendan|mesh-list
92090934|NCT01720030|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92090935|NCT01720030|Vasodilator Agents|vasodilator agents|mesh-ancestor
92090936|NCT01720030|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92017095|NCT05041907|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017096|NCT05041907|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017097|NCT05041907|Serotonin Agents|serotonin agents|mesh-ancestor
92017098|NCT05041907|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92017099|NCT05041907|Antidepressive Agents|antidepressive agents|mesh-ancestor
92090937|NCT01720030|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92090938|NCT01720030|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090939|NCT01720030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090940|NCT01720030|Protective Agents|protective agents|mesh-ancestor
92090941|NCT01720030|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090942|NCT01720108|Rivaroxaban|rivaroxaban|mesh-list
92090943|NCT01720108|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92090944|NCT01720108|Antithrombins|antithrombins|mesh-ancestor
92090945|NCT01720108|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92090946|NCT01720108|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090947|NCT01720108|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090948|NCT01720108|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090949|NCT01720108|Anticoagulants|anticoagulants|mesh-ancestor
92090951|NCT04380220|Antithrombins|antithrombins|mesh-list
92090952|NCT04380220|Protein S|protein s|mesh-list
92090953|NCT04380220|Factor VIII|factor viii|mesh-list
92090954|NCT04380220|Complement C3|complement c3|mesh-list
92090955|NCT04380220|Coagulants|coagulants|mesh-ancestor
92090956|NCT04380220|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92090957|NCT04380220|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090958|NCT04380220|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92090959|NCT04380220|Protease Inhibitors|protease inhibitors|mesh-ancestor
92090960|NCT04380220|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090961|NCT04380220|Anticoagulants|anticoagulants|mesh-ancestor
92090962|NCT04380220|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92090963|NCT04380220|Immunologic Factors|immunologic factors|mesh-ancestor
92090964|NCT04380220|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090965|NCT01832974|Pseudomonas aeruginosa exotoxin A|pseudomonas aeruginosa exotoxin a|mesh-list
92090966|NCT01832974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090967|NCT01671813|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92090968|NCT01671813|Immunoconjugates|immunoconjugates|mesh-list
92090969|NCT01671813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92090970|NCT01671813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090971|NCT01671813|Immunotoxins|immunotoxins|mesh-ancestor
92090972|NCT01671813|Immunologic Factors|immunologic factors|mesh-ancestor
92090973|NCT01671813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090974|NCT03830398|Acetaminophen|acetaminophen|mesh-list
92090975|NCT03830398|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090976|NCT03830398|Analgesics|analgesics|mesh-ancestor
92090977|NCT03830398|Sensory System Agents|sensory system agents|mesh-ancestor
92090978|NCT03830398|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091009|NCT00911326|Technetium Tc 99m Pentetate|technetium tc 99m pentetate|mesh-list
92091011|NCT00911326|Plasma Substitutes|plasma substitutes|mesh-ancestor
92091012|NCT00911326|Blood Substitutes|blood substitutes|mesh-ancestor
92091013|NCT00911326|Chelating Agents|chelating agents|mesh-ancestor
92091014|NCT00911326|Sequestering Agents|sequestering agents|mesh-ancestor
92091015|NCT00911326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091016|NCT00911326|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92091018|NCT01833676|Desflurane|desflurane|mesh-list
92091019|NCT01833676|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92091020|NCT01833676|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92091021|NCT01833676|Anesthetics, General|anesthetics, general|mesh-ancestor
92091049|NCT04380298|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92091050|NCT04380298|Autonomic Agents|autonomic agents|mesh-ancestor
92091051|NCT04380298|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92091052|NCT04380298|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091053|NCT04380298|Mydriatics|mydriatics|mesh-ancestor
92091054|NCT04380298|Sympathomimetics|sympathomimetics|mesh-ancestor
92091055|NCT04380298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92091056|NCT04380298|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92091057|NCT04380298|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091058|NCT04380298|Analgesics|analgesics|mesh-ancestor
92091059|NCT04380298|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091060|NCT04380298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017101|NCT05041907|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92017102|NCT05041907|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92017103|NCT05041907|Antimetabolites|antimetabolites|mesh-ancestor
92017104|NCT05674253|Hydrocortisone|hydrocortisone|mesh-list
92017105|NCT05674253|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92091061|NCT04380298|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92091062|NCT04380298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091063|NCT04164849|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92091064|NCT04164849|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92091065|NCT04164849|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091066|NCT05384691|Luspatercept|luspatercept|mesh-list
92091067|NCT05384691|Hematinics|hematinics|mesh-ancestor
92091068|NCT03210610|Colchicine|colchicine|mesh-list
92091069|NCT03210610|Gout Suppressants|gout suppressants|mesh-ancestor
92091077|NCT03152955|Ketamine|ketamine|mesh-list
92091078|NCT03152955|Ondansetron|ondansetron|mesh-list
92091079|NCT03152955|Analgesics|analgesics|mesh-ancestor
92091080|NCT03152955|Sensory System Agents|sensory system agents|mesh-ancestor
92091081|NCT03152955|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091082|NCT03152955|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091083|NCT03152955|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92091084|NCT03152955|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92091085|NCT03152955|Anesthetics, General|anesthetics, general|mesh-ancestor
92091086|NCT03152955|Anesthetics|anesthetics|mesh-ancestor
92091087|NCT03152955|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091088|NCT03152955|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92091089|NCT03152955|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92091090|NCT03152955|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091091|NCT03152955|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091092|NCT03152955|Antiemetics|antiemetics|mesh-ancestor
92091093|NCT03152955|Autonomic Agents|autonomic agents|mesh-ancestor
92091094|NCT03152955|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92091095|NCT03152955|Antipruritics|antipruritics|mesh-ancestor
92091096|NCT03152955|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091097|NCT03152955|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92091098|NCT03152955|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92091099|NCT03152955|Serotonin Agents|serotonin agents|mesh-ancestor
92091100|NCT03152955|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091101|NCT03152955|Narcotics|narcotics|mesh-ancestor
92091102|NCT03152955|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92091103|NCT01676493|Codeine|codeine|mesh-list
92091104|NCT01676493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091105|NCT01676493|Narcotics|narcotics|mesh-ancestor
92091106|NCT01676493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091107|NCT01676493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091108|NCT01676493|Analgesics|analgesics|mesh-ancestor
92091109|NCT01676493|Sensory System Agents|sensory system agents|mesh-ancestor
92091110|NCT01676493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091111|NCT01676493|Antitussive Agents|antitussive agents|mesh-ancestor
92091112|NCT01676493|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091113|NCT01721434|Simendan|simendan|mesh-list
92091114|NCT01721434|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92091115|NCT01721434|Vasodilator Agents|vasodilator agents|mesh-ancestor
92091116|NCT01721434|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92091117|NCT01721434|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92091118|NCT01721434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091119|NCT01721434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091120|NCT01721434|Protective Agents|protective agents|mesh-ancestor
92091121|NCT01721434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091123|NCT03210532|Telmisartan|telmisartan|mesh-list
92091124|NCT03210532|Telmisartan amlodipine combination|telmisartan amlodipine combination|mesh-list
92091125|NCT03210532|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92091126|NCT03210532|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92091127|NCT03210532|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92091128|NCT03210532|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92091129|NCT03210532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091130|NCT03210532|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92091131|NCT03210532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017106|NCT05674253|Dexmedetomidine|dexmedetomidine|mesh-list
92017107|NCT05674253|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92017108|NCT05674253|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017109|NCT05674253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017110|NCT05674253|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091132|NCT03210532|Vasodilator Agents|vasodilator agents|mesh-ancestor
92091133|NCT03210532|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92091134|NCT03210532|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92091135|NCT03210532|Antimetabolites|antimetabolites|mesh-ancestor
92091136|NCT03210532|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92091142|NCT03152565|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92091143|NCT03152565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091144|NCT03210064|Fluorouracil|fluorouracil|mesh-list
92091145|NCT03210064|Apatinib|apatinib|mesh-list
92091146|NCT03210064|Antimetabolites|antimetabolites|mesh-ancestor
92091147|NCT03210064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091148|NCT03210064|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92091149|NCT03210064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091150|NCT03210064|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091151|NCT03210064|Immunologic Factors|immunologic factors|mesh-ancestor
92091152|NCT03210064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091153|NCT03210064|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92091154|NCT03210064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091155|NCT03215524|Thalidomide|thalidomide|mesh-list
92091156|NCT03215524|Dexamethasone|dexamethasone|mesh-list
92091157|NCT03215524|Dexamethasone acetate|dexamethasone acetate|mesh-list
92091158|NCT03215524|Cyclophosphamide|cyclophosphamide|mesh-list
92091159|NCT03215524|Daratumumab|daratumumab|mesh-list
92091160|NCT03215524|Pomalidomide|pomalidomide|mesh-list
92091161|NCT03215524|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92091162|NCT03215524|BB 1101|bb 1101|mesh-list
92091163|NCT03215524|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091164|NCT03215524|Immunologic Factors|immunologic factors|mesh-ancestor
92091165|NCT03215524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091166|NCT03215524|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091167|NCT03215524|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92091168|NCT03215524|Alkylating Agents|alkylating agents|mesh-ancestor
92091169|NCT03215524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091170|NCT03215524|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091171|NCT03215524|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92091172|NCT03215524|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091173|NCT03215524|Antiemetics|antiemetics|mesh-ancestor
92091174|NCT03215524|Autonomic Agents|autonomic agents|mesh-ancestor
92091175|NCT03215524|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091176|NCT03215524|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92091177|NCT03215524|Glucocorticoids|glucocorticoids|mesh-ancestor
92091178|NCT03215524|Hormones|hormones|mesh-ancestor
92091179|NCT03215524|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091180|NCT03215524|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92091181|NCT03215524|Protease Inhibitors|protease inhibitors|mesh-ancestor
92091182|NCT03215524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091183|NCT03215524|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92091184|NCT03215524|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92091185|NCT03215524|Growth Substances|growth substances|mesh-ancestor
92091186|NCT03215524|Growth Inhibitors|growth inhibitors|mesh-ancestor
92091187|NCT03215524|Leprostatic Agents|leprostatic agents|mesh-ancestor
92091188|NCT03215524|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92091189|NCT03215524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091190|NCT05372991|Atropine|atropine|mesh-list
92091191|NCT05372991|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92091192|NCT05372991|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92091193|NCT05372991|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92091194|NCT05372991|Autonomic Agents|autonomic agents|mesh-ancestor
92091195|NCT05372991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091196|NCT05372991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091197|NCT05372991|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92091198|NCT05372991|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091199|NCT05372991|Mydriatics|mydriatics|mesh-ancestor
92091200|NCT05372991|Parasympatholytics|parasympatholytics|mesh-ancestor
92017112|NCT05674253|Sensory System Agents|sensory system agents|mesh-ancestor
92017113|NCT05674253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091201|NCT05372991|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92091202|NCT05372991|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92091203|NCT05372991|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091204|NCT05372991|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091205|NCT05372991|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091206|NCT01672593|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92091210|NCT01722448|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92091211|NCT01722448|Antimetabolites|antimetabolites|mesh-ancestor
92091212|NCT01722448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091213|NCT01722448|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92091214|NCT01722448|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92091216|NCT01834768|Eplerenone|eplerenone|mesh-list
92091217|NCT01834768|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92091218|NCT01834768|Hormone Antagonists|hormone antagonists|mesh-ancestor
92091219|NCT01834768|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091220|NCT01834768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091221|NCT01834768|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92091222|NCT01834768|Diuretics|diuretics|mesh-ancestor
92091223|NCT01834768|Natriuretic Agents|natriuretic agents|mesh-ancestor
92091224|NCT01834768|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92091225|NCT01672671|Paclitaxel|paclitaxel|mesh-list
92091226|NCT01672671|Doxorubicin|doxorubicin|mesh-list
92091227|NCT01672671|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92091228|NCT01672671|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091229|NCT01672671|Tubulin Modulators|tubulin modulators|mesh-ancestor
92091230|NCT01672671|Antimitotic Agents|antimitotic agents|mesh-ancestor
92091231|NCT01672671|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091232|NCT01672671|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091233|NCT01672671|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92091234|NCT01672671|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92091235|NCT01672671|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92091236|NCT01672671|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091237|NCT02459457|Paclitaxel|paclitaxel|mesh-list
92091238|NCT02459457|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92091239|NCT02459457|Carboplatin|carboplatin|mesh-list
92091240|NCT02459457|Fluorouracil|fluorouracil|mesh-list
92091241|NCT02459457|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92091242|NCT02459457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091243|NCT02459457|Tubulin Modulators|tubulin modulators|mesh-ancestor
92091244|NCT02459457|Antimitotic Agents|antimitotic agents|mesh-ancestor
92091245|NCT02459457|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091246|NCT02459457|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091247|NCT02459457|Antimetabolites|antimetabolites|mesh-ancestor
92091248|NCT02459457|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92091249|NCT02459457|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091250|NCT02459457|Immunologic Factors|immunologic factors|mesh-ancestor
92091251|NCT02459457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091252|NCT01835236|Paclitaxel|paclitaxel|mesh-list
92091253|NCT01835236|Vinorelbine|vinorelbine|mesh-list
92091254|NCT01835236|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92091255|NCT01835236|Trastuzumab|trastuzumab|mesh-list
92091256|NCT01835236|Pertuzumab|pertuzumab|mesh-list
92091257|NCT01835236|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92091258|NCT01835236|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091259|NCT01835236|Tubulin Modulators|tubulin modulators|mesh-ancestor
92091260|NCT01835236|Antimitotic Agents|antimitotic agents|mesh-ancestor
92091261|NCT01835236|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091262|NCT01835236|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091263|NCT01835236|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92091264|NCT01835236|Immunotoxins|immunotoxins|mesh-ancestor
92091265|NCT01835236|Immunoconjugates|immunoconjugates|mesh-ancestor
92091266|NCT01835236|Immunologic Factors|immunologic factors|mesh-ancestor
92091267|NCT01835236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091268|NCT01671891|Capecitabine|capecitabine|mesh-list
92091269|NCT01671891|Oxaliplatin|oxaliplatin|mesh-list
92091270|NCT01671891|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92091271|NCT01671891|Antimetabolites|antimetabolites|mesh-ancestor
92091272|NCT01671891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017114|NCT05674253|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92017115|NCT05674253|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92017116|NCT05674253|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92091273|NCT01671891|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091274|NCT03152409|Aspirin|aspirin|mesh-list
92091275|NCT03152409|Salicylic Acid|salicylic acid|mesh-list
92091276|NCT03152409|Salicylates|salicylates|mesh-list
92091277|NCT03152409|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92091278|NCT03152409|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091279|NCT03152409|Analgesics|analgesics|mesh-ancestor
92091280|NCT03152409|Sensory System Agents|sensory system agents|mesh-ancestor
92091283|NCT03152409|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091284|NCT03152409|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091285|NCT03152409|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92091286|NCT03152409|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92091287|NCT03152409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091288|NCT03152409|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92091289|NCT03152409|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92091290|NCT03152409|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091292|NCT03152409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091293|NCT03152409|Antifungal Agents|antifungal agents|mesh-ancestor
92091294|NCT03152409|Keratolytic Agents|keratolytic agents|mesh-ancestor
92091295|NCT03152409|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091296|NCT01830322|Gemcitabine|gemcitabine|mesh-list
92091297|NCT01830322|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92091298|NCT01830322|Antimetabolites|antimetabolites|mesh-ancestor
92091299|NCT01830322|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091300|NCT01830322|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091301|NCT01835314|Stiripentol|stiripentol|mesh-list
92091302|NCT01835314|Anticonvulsants|anticonvulsants|mesh-ancestor
92091303|NCT01706198|Fluticasone|fluticasone|mesh-list
92091304|NCT01706198|Xhance|xhance|mesh-list
92091305|NCT01706198|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091306|NCT01706198|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92091307|NCT01706198|Autonomic Agents|autonomic agents|mesh-ancestor
92091308|NCT01706198|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091309|NCT01706198|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091310|NCT01706198|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92091311|NCT01706198|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091312|NCT01706198|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091313|NCT01706198|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92091314|NCT04378972|Vitamin D|vitamin d|mesh-list
92091315|NCT04378972|Cholecalciferol|cholecalciferol|mesh-list
92091316|NCT04378972|Curcumin|curcumin|mesh-list
92091317|NCT04378972|Tramiprosate|tramiprosate|mesh-list
92091318|NCT04378972|Vitamins|vitamins|mesh-ancestor
92091319|NCT04378972|Micronutrients|micronutrients|mesh-ancestor
92091320|NCT04378972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091321|NCT04378972|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92091322|NCT04378972|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92091323|NCT04378972|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92091324|NCT04378972|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091325|NCT04378972|Analgesics|analgesics|mesh-ancestor
92091326|NCT04378972|Sensory System Agents|sensory system agents|mesh-ancestor
92091327|NCT04378972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091328|NCT04378972|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091329|NCT04378972|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091330|NCT04378972|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091331|NCT04378972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091332|NCT04378972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091333|NCT04378972|Anticonvulsants|anticonvulsants|mesh-ancestor
92091334|NCT04378972|GABA Agonists|gaba agonists|mesh-ancestor
92091335|NCT04378972|GABA Agents|gaba agents|mesh-ancestor
92091336|NCT04378972|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091337|NCT01723150|Ciprofloxacin|ciprofloxacin|mesh-list
92091338|NCT01723150|Ceftriaxone|ceftriaxone|mesh-list
92091339|NCT01723150|Ertapenem|ertapenem|mesh-list
92091340|NCT01723150|Trimethoprim|trimethoprim|mesh-list
92091341|NCT01723150|Sulfamethoxazole|sulfamethoxazole|mesh-list
92091342|NCT01723150|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92091343|NCT01723150|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091344|NCT01723150|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92091345|NCT01723150|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92017117|NCT05674253|Adrenergic Agents|adrenergic agents|mesh-ancestor
92017118|NCT05674253|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091346|NCT01723150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091347|NCT01723150|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091348|NCT01723150|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091349|NCT01723150|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92091350|NCT01723150|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92091351|NCT01723150|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92091352|NCT01723150|Antimalarials|antimalarials|mesh-ancestor
92091353|NCT01723150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92091357|NCT01723150|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92091358|NCT01835938|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92091359|NCT01835938|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091360|NCT01835938|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92091361|NCT01835938|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091362|NCT01835938|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091363|NCT01836016|Fluticasone|fluticasone|mesh-list
92091365|NCT01836016|Albuterol|albuterol|mesh-list
92091366|NCT01836016|Formoterol Fumarate|formoterol fumarate|mesh-list
92091367|NCT01836016|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92091368|NCT01836016|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92091369|NCT01836016|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091370|NCT01836016|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92091371|NCT01836016|Autonomic Agents|autonomic agents|mesh-ancestor
92091372|NCT01836016|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091373|NCT01836016|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091374|NCT01836016|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92091375|NCT01836016|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091376|NCT01836016|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091377|NCT01836016|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92091378|NCT01836016|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92091379|NCT01836016|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92091380|NCT01836016|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92091381|NCT01836016|Adrenergic Agents|adrenergic agents|mesh-ancestor
92091382|NCT01836016|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091383|NCT01836016|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091384|NCT01836016|Tocolytic Agents|tocolytic agents|mesh-ancestor
92091385|NCT01836016|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92091386|NCT01836016|Glucocorticoids|glucocorticoids|mesh-ancestor
92091387|NCT01836016|Hormones|hormones|mesh-ancestor
92091388|NCT01836016|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091389|NCT01836016|Sympathomimetics|sympathomimetics|mesh-ancestor
92091390|NCT01836094|Methylene Blue|methylene blue|mesh-list
92091391|NCT01836094|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091392|NCT01836094|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091393|NCT01726192|Ropivacaine|ropivacaine|mesh-list
92091394|NCT01726192|Anesthetics, Local|anesthetics, local|mesh-ancestor
92091395|NCT01726192|Anesthetics|anesthetics|mesh-ancestor
92091396|NCT01726192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091397|NCT01726192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091398|NCT01726192|Sensory System Agents|sensory system agents|mesh-ancestor
92091399|NCT01726192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091400|NCT01836328|Methadone|methadone|mesh-list
92091401|NCT01836328|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92091402|NCT01836328|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091403|NCT01836328|Narcotics|narcotics|mesh-ancestor
92091404|NCT01836328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091405|NCT01836328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091406|NCT01836328|Analgesics|analgesics|mesh-ancestor
92091407|NCT01836328|Sensory System Agents|sensory system agents|mesh-ancestor
92091408|NCT01836328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091409|NCT01836328|Antitussive Agents|antitussive agents|mesh-ancestor
92091410|NCT01836328|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091411|NCT01836406|Ketorolac|ketorolac|mesh-list
92091412|NCT01836406|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92091413|NCT01836406|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92091414|NCT01836406|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091415|NCT01836406|Analgesics|analgesics|mesh-ancestor
92091416|NCT01836406|Sensory System Agents|sensory system agents|mesh-ancestor
92017119|NCT05674253|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017120|NCT05674253|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017121|NCT02500641|Naproxen|naproxen|mesh-list
92017122|NCT02500641|Colchicine|colchicine|mesh-list
92091417|NCT01836406|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091418|NCT01836406|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091419|NCT01836406|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091420|NCT01836406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091421|NCT01836406|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92091422|NCT01836406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091423|NCT01836406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091424|NCT01836484|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92091425|NCT01836484|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92091439|NCT00915538|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92091440|NCT00915538|Autonomic Agents|autonomic agents|mesh-ancestor
92091441|NCT00915538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091442|NCT00915538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091443|NCT00915538|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92091444|NCT00915538|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091445|NCT00915538|Glucocorticoids|glucocorticoids|mesh-ancestor
92091447|NCT00915538|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091448|NCT01724086|Interferons|interferons|mesh-list
92091449|NCT01724086|Ritonavir|ritonavir|mesh-list
92091450|NCT01724086|Ribavirin|ribavirin|mesh-list
92091451|NCT01724086|Interferon-alpha|interferon-alpha|mesh-list
92091452|NCT01724086|Interferon alpha-2|interferon alpha-2|mesh-list
92091453|NCT01724086|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92091454|NCT01724086|Simeprevir|simeprevir|mesh-list
92091455|NCT01724086|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091456|NCT01724086|Antiviral Agents|antiviral agents|mesh-ancestor
92091457|NCT01724086|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091458|NCT01724086|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92091459|NCT01724086|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92091460|NCT01724086|Protease Inhibitors|protease inhibitors|mesh-ancestor
92091461|NCT01724086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091462|NCT01724086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091463|NCT01724086|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92091464|NCT01724086|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92091465|NCT01724086|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92091466|NCT01724086|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92091467|NCT01724086|Antimetabolites|antimetabolites|mesh-ancestor
92091468|NCT01724086|Immunologic Factors|immunologic factors|mesh-ancestor
92091469|NCT01724086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091470|NCT00913510|Cholinergic Antagonists|cholinergic antagonists|mesh-list
92091471|NCT00913510|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091472|NCT00913510|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091473|NCT00913510|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091474|NCT00913510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091475|NCT01727050|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92091476|NCT01727050|Hemostatics|hemostatics|mesh-ancestor
92091477|NCT01727050|Coagulants|coagulants|mesh-ancestor
92091478|NCT03836638|Botulinum Toxins|botulinum toxins|mesh-list
92091479|NCT03836638|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92091651|NCT03409432|Immunotoxins|immunotoxins|mesh-ancestor
92091480|NCT03836638|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92091481|NCT03836638|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091482|NCT03836638|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091483|NCT03836638|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091484|NCT03836638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091485|NCT01837108|Eplerenone|eplerenone|mesh-list
92091488|NCT01837108|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091489|NCT01837108|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091490|NCT01837108|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92091491|NCT01837108|Diuretics|diuretics|mesh-ancestor
92091492|NCT01837108|Natriuretic Agents|natriuretic agents|mesh-ancestor
92091493|NCT01837108|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92091494|NCT01724554|Aflibercept|aflibercept|mesh-list
92091495|NCT01724554|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92091496|NCT01724554|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92017123|NCT02500641|Allopurinol|allopurinol|mesh-list
92017124|NCT02500641|Febuxostat|febuxostat|mesh-list
92017125|NCT02500641|Omeprazole|omeprazole|mesh-list
92017126|NCT02500641|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92017127|NCT02500641|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92091497|NCT01724554|Growth Substances|growth substances|mesh-ancestor
92091498|NCT01724554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091499|NCT01724554|Growth Inhibitors|growth inhibitors|mesh-ancestor
92091500|NCT01724554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091501|NCT01724788|Furosemide|furosemide|mesh-list
92091502|NCT01724788|Diuretics|diuretics|mesh-ancestor
92091503|NCT01724788|Natriuretic Agents|natriuretic agents|mesh-ancestor
92091504|NCT01724788|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091505|NCT01724788|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92091506|NCT01724788|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92091507|NCT01724788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091508|NCT01837498|Neostigmine|neostigmine|mesh-list
92091509|NCT01837498|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92091510|NCT01837498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091511|NCT01837498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091512|NCT01837498|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091513|NCT01837498|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091514|NCT01837498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091515|NCT01837498|Parasympathomimetics|parasympathomimetics|mesh-ancestor
92091516|NCT01837498|Autonomic Agents|autonomic agents|mesh-ancestor
92091517|NCT01837498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091518|NCT01705574|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92091519|NCT01705574|Antiviral Agents|antiviral agents|mesh-ancestor
92091520|NCT01705574|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091521|NCT01705574|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92091522|NCT01705574|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92091524|NCT01837576|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091525|NCT01728298|Immunomodulating Agents|immunomodulating agents|mesh-list
92091526|NCT01728298|Immunologic Factors|immunologic factors|mesh-ancestor
92091527|NCT01728298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091528|NCT01737710|Vaccines|vaccines|mesh-list
92091529|NCT01737710|Immunologic Factors|immunologic factors|mesh-ancestor
92091530|NCT01737710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091531|NCT01837810|Ibuprofen|ibuprofen|mesh-list
92091532|NCT01837810|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92091533|NCT01837810|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091534|NCT01837810|Analgesics|analgesics|mesh-ancestor
92091535|NCT01837810|Sensory System Agents|sensory system agents|mesh-ancestor
92091536|NCT01837810|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091537|NCT01837810|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091538|NCT01837810|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091539|NCT01837810|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091540|NCT01837810|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92091541|NCT01837810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091542|NCT01837810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091543|NCT01725100|Trametinib|trametinib|mesh-list
92091544|NCT01725100|Dimethyl Sulfoxide|dimethyl sulfoxide|mesh-list
92091545|NCT01725100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091546|NCT01725100|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92091547|NCT01725100|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091548|NCT01725100|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091549|NCT01725100|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92091550|NCT01725100|Protective Agents|protective agents|mesh-ancestor
92091551|NCT01725100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091552|NCT01725100|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92091553|NCT01725100|Antioxidants|antioxidants|mesh-ancestor
92091554|NCT01725412|Thiamine|thiamine|mesh-list
92091555|NCT01725412|Vitamin B Complex|vitamin b complex|mesh-ancestor
92091556|NCT01725412|Vitamins|vitamins|mesh-ancestor
92091564|NCT04553666|Epigallocatechin gallate|epigallocatechin gallate|mesh-list
92091566|NCT04553666|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091567|NCT04553666|Antioxidants|antioxidants|mesh-ancestor
92017129|NCT02500641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017130|NCT02500641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017131|NCT02500641|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92017132|NCT02500641|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017134|NCT02500641|Sensory System Agents|sensory system agents|mesh-ancestor
92091568|NCT04553666|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091569|NCT04553666|Protective Agents|protective agents|mesh-ancestor
92091570|NCT04553666|Antimutagenic Agents|antimutagenic agents|mesh-ancestor
92091571|NCT04553666|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92091572|NCT04553666|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091573|NCT04553666|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92091574|NCT03834766|Amphetamine|amphetamine|mesh-list
92091575|NCT03834766|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92091576|NCT03834766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091577|NCT03834766|Sympathomimetics|sympathomimetics|mesh-ancestor
92091578|NCT03834766|Autonomic Agents|autonomic agents|mesh-ancestor
92091579|NCT03834766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091580|NCT03834766|Dopamine Agents|dopamine agents|mesh-ancestor
92091581|NCT03834766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091582|NCT03834766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091583|NCT03834766|Adrenergic Agents|adrenergic agents|mesh-ancestor
92091584|NCT03834766|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92091585|NCT03834766|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92091586|NCT03834766|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92091587|NCT03834766|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92091588|NCT01838434|Lenalidomide|lenalidomide|mesh-list
92091589|NCT01838434|Idelalisib|idelalisib|mesh-list
92091590|NCT01838434|Immunologic Factors|immunologic factors|mesh-ancestor
92091591|NCT01838434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091592|NCT01838434|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92091593|NCT01838434|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92091594|NCT01838434|Growth Substances|growth substances|mesh-ancestor
92091595|NCT01838434|Growth Inhibitors|growth inhibitors|mesh-ancestor
92091596|NCT01838434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091597|NCT01838434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091598|NCT01838434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091599|NCT01838668|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92091600|NCT01838668|Dermatologic Agents|dermatologic agents|mesh-ancestor
92091601|NCT01838668|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091602|NCT01838668|Immunologic Factors|immunologic factors|mesh-ancestor
92091603|NCT01838668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091605|NCT04377646|Hydroxychloroquine|hydroxychloroquine|mesh-list
92091606|NCT04377646|Antimalarials|antimalarials|mesh-ancestor
92091607|NCT04377646|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92091608|NCT04377646|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92091609|NCT04377646|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091610|NCT04377646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091611|NCT04377646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091612|NCT04377646|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091613|NCT04377646|Trace Elements|trace elements|mesh-ancestor
92091614|NCT04377646|Micronutrients|micronutrients|mesh-ancestor
92091615|NCT04377646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091616|NCT01728922|Vitamin D|vitamin d|mesh-list
92091617|NCT01728922|Ergocalciferols|ergocalciferols|mesh-list
92091618|NCT01728922|Cholecalciferol|cholecalciferol|mesh-list
92091619|NCT01728922|Vitamins|vitamins|mesh-list
92091620|NCT01728922|Micronutrients|micronutrients|mesh-ancestor
92091621|NCT01728922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091622|NCT01728922|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92091623|NCT01728922|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92091624|NCT01682720|Sofosbuvir|sofosbuvir|mesh-list
92091625|NCT01682720|Antiviral Agents|antiviral agents|mesh-ancestor
92017135|NCT02500641|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017136|NCT02500641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017137|NCT02500641|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017138|NCT02500641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017139|NCT02500641|Gout Suppressants|gout suppressants|mesh-ancestor
92091652|NCT01703858|Pantoprazole|pantoprazole|mesh-list
92091653|NCT01703858|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92091654|NCT01703858|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92091655|NCT01703858|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92091656|NCT01703858|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091657|NCT01703858|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091658|NCT01729468|Aspirin|aspirin|mesh-list
92091659|NCT01729468|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92091660|NCT01729468|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091661|NCT01729468|Analgesics|analgesics|mesh-ancestor
92091662|NCT01729468|Sensory System Agents|sensory system agents|mesh-ancestor
92091663|NCT01729468|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091664|NCT01729468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091665|NCT01729468|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091666|NCT01729468|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091667|NCT01729468|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92091668|NCT01729468|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92091669|NCT01729468|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091670|NCT01729468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92091671|NCT01729468|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92091672|NCT01729468|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091674|NCT04376788|Methylene Blue|methylene blue|mesh-list
92091675|NCT04376788|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091676|NCT04376788|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091682|NCT01714310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091683|NCT01714310|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091684|NCT01714310|Serotonin Agents|serotonin agents|mesh-ancestor
92091685|NCT01714310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091686|NCT01714310|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92091687|NCT01714310|Antidepressive Agents|antidepressive agents|mesh-ancestor
92091688|NCT01714310|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92091689|NCT01714310|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92091690|NCT01714310|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92091691|NCT01714310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091692|NCT01714310|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92091693|NCT01714310|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92091694|NCT01714310|Dopamine Agents|dopamine agents|mesh-ancestor
92091695|NCT03401788|Belzutifan|belzutifan|mesh-list
92091696|NCT03401788|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091697|NCT01728064|Ubiquinone|ubiquinone|mesh-list
92091698|NCT01728064|Micronutrients|micronutrients|mesh-ancestor
92091699|NCT01728064|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091700|NCT03405142|Panitumumab|panitumumab|mesh-list
92091701|NCT03405142|Diethylenetriamine|diethylenetriamine|mesh-list
92091702|NCT03405142|Dextrans|dextrans|mesh-list
92091703|NCT03405142|Edetic Acid|edetic acid|mesh-list
92091704|NCT03405142|Pentetic Acid|pentetic acid|mesh-list
92091705|NCT03405142|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92091706|NCT03405142|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091707|NCT03405142|Anticoagulants|anticoagulants|mesh-ancestor
92091708|NCT03405142|Plasma Substitutes|plasma substitutes|mesh-ancestor
92091709|NCT03405142|Blood Substitutes|blood substitutes|mesh-ancestor
92091710|NCT03405142|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92091711|NCT03405142|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091712|NCT03405142|Antidotes|antidotes|mesh-ancestor
92091713|NCT03405142|Protective Agents|protective agents|mesh-ancestor
92091714|NCT03405142|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091715|NCT03405142|Chelating Agents|chelating agents|mesh-ancestor
92091716|NCT03405142|Sequestering Agents|sequestering agents|mesh-ancestor
92091717|NCT03405142|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92091718|NCT03405142|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92091719|NCT03407872|Esketamine|esketamine|mesh-list
92017140|NCT02500641|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92017141|NCT02500641|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017142|NCT02500641|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017143|NCT02500641|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091720|NCT03407872|Antidepressive Agents|antidepressive agents|mesh-ancestor
92091721|NCT03407872|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92091722|NCT03834610|Tadalafil|tadalafil|mesh-list
92091723|NCT03834610|Testosterone|testosterone|mesh-list
92091724|NCT03834610|Androgens|androgens|mesh-ancestor
92091725|NCT03834610|Hormones|hormones|mesh-ancestor
92091726|NCT03834610|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091727|NCT03834610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091728|NCT03834610|Vasodilator Agents|vasodilator agents|mesh-ancestor
92091729|NCT03834610|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92091730|NCT03834610|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92091731|NCT03834610|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091732|NCT03834610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091733|NCT03834610|Urological Agents|urological agents|mesh-ancestor
92091734|NCT01681472|Leucovorin|leucovorin|mesh-list
92091735|NCT01681472|Tetrahydrofolates|tetrahydrofolates|mesh-list
92091736|NCT01681472|Levoleucovorin|levoleucovorin|mesh-list
92091737|NCT01681472|Antidotes|antidotes|mesh-ancestor
92091738|NCT01681472|Protective Agents|protective agents|mesh-ancestor
92091739|NCT01681472|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091740|NCT01681472|Vitamin B Complex|vitamin b complex|mesh-ancestor
92091741|NCT01681472|Vitamins|vitamins|mesh-ancestor
92091742|NCT01681472|Micronutrients|micronutrients|mesh-ancestor
92091743|NCT00915928|Perindopril|perindopril|mesh-list
92091744|NCT00915928|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92091745|NCT00915928|Protease Inhibitors|protease inhibitors|mesh-ancestor
92091746|NCT00915928|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091747|NCT00915928|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091752|NCT03407404|Analgesics|analgesics|mesh-ancestor
92091753|NCT03407404|Sensory System Agents|sensory system agents|mesh-ancestor
92091754|NCT03407404|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091755|NCT03407404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091756|NCT03407404|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92091757|NCT03407404|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92091758|NCT03407404|Anesthetics, General|anesthetics, general|mesh-ancestor
92091759|NCT03407404|Anesthetics|anesthetics|mesh-ancestor
92091760|NCT03407404|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091761|NCT03407404|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92091762|NCT03407404|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92091763|NCT03407404|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091764|NCT03407404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091765|NCT03407404|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091766|NCT03407404|Narcotics|narcotics|mesh-ancestor
92091767|NCT03407404|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92091768|NCT03407404|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92091769|NCT03407404|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92091770|NCT03407404|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92091771|NCT03407404|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92091772|NCT03407404|GABA Modulators|gaba modulators|mesh-ancestor
92091773|NCT03407404|GABA Agents|gaba agents|mesh-ancestor
92091774|NCT03830086|Midazolam|midazolam|mesh-list
92091775|NCT03830086|Sufentanil|sufentanil|mesh-list
92091776|NCT03830086|Bupivacaine|bupivacaine|mesh-list
92091777|NCT03830086|Propofol|propofol|mesh-list
92091779|NCT03830086|Rocuronium|rocuronium|mesh-list
92091780|NCT03830086|Anesthetics, Local|anesthetics, local|mesh-ancestor
92091781|NCT03830086|Anesthetics|anesthetics|mesh-ancestor
92091782|NCT03830086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091783|NCT03830086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091784|NCT03830086|Sensory System Agents|sensory system agents|mesh-ancestor
92091785|NCT03830086|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091786|NCT03830086|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92091787|NCT03830086|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92091788|NCT03830086|Anesthetics, General|anesthetics, general|mesh-ancestor
92091789|NCT03830086|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92091790|NCT03830086|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92091791|NCT03830086|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92091792|NCT03830086|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92091793|NCT03830086|GABA Modulators|gaba modulators|mesh-ancestor
92017144|NCT02500641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017145|NCT02500641|Antimetabolites|antimetabolites|mesh-ancestor
92017146|NCT02500641|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92017147|NCT02500641|Antioxidants|antioxidants|mesh-ancestor
92017148|NCT02500641|Protective Agents|protective agents|mesh-ancestor
92091794|NCT03830086|GABA Agents|gaba agents|mesh-ancestor
92091795|NCT03830086|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091796|NCT03830086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091797|NCT03830086|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92091798|NCT03830086|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92091799|NCT03830086|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92091800|NCT03830086|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92091801|NCT03830086|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92091802|NCT03830086|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091803|NCT03830086|Narcotics|narcotics|mesh-ancestor
92091804|NCT03830086|Analgesics|analgesics|mesh-ancestor
92091805|NCT02240212|Paclitaxel|paclitaxel|mesh-list
92091806|NCT02240212|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92091807|NCT02240212|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091808|NCT02240212|Tubulin Modulators|tubulin modulators|mesh-ancestor
92091809|NCT02240212|Antimitotic Agents|antimitotic agents|mesh-ancestor
92091810|NCT02240212|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091811|NCT02240212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091812|NCT01047436|Artemether|artemether|mesh-list
92091813|NCT01047436|Quinine|quinine|mesh-list
92091814|NCT01047436|Antimalarials|antimalarials|mesh-ancestor
92091815|NCT01047436|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92091816|NCT01047436|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92091817|NCT01047436|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091818|NCT01047436|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92091819|NCT01047436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091820|NCT01047436|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92091821|NCT01047436|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091822|NCT01047436|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091824|NCT01047436|Sensory System Agents|sensory system agents|mesh-ancestor
92091826|NCT03406936|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92091827|NCT03406936|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92091828|NCT03406936|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091829|NCT03406936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091830|NCT03406936|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92091831|NCT03406936|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92091832|NCT03406936|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92091833|NCT03406936|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92091834|NCT03406936|Anesthetics, General|anesthetics, general|mesh-ancestor
92091835|NCT03406936|Anesthetics|anesthetics|mesh-ancestor
92091836|NCT03406936|GABA Modulators|gaba modulators|mesh-ancestor
92091837|NCT03406936|GABA Agents|gaba agents|mesh-ancestor
92091838|NCT03406936|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091839|NCT03406936|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091840|NCT02240602|Oxycodone|oxycodone|mesh-list
92091841|NCT02240602|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091842|NCT02240602|Narcotics|narcotics|mesh-ancestor
92091843|NCT02240602|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091844|NCT02240602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091845|NCT02240602|Analgesics|analgesics|mesh-ancestor
92091846|NCT02240602|Sensory System Agents|sensory system agents|mesh-ancestor
92091847|NCT02240602|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091848|NCT03406546|Dexmedetomidine|dexmedetomidine|mesh-list
92091849|NCT03406546|Remifentanil|remifentanil|mesh-list
92091850|NCT03406546|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92091851|NCT03406546|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091852|NCT03406546|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091853|NCT03406546|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091854|NCT03406546|Analgesics|analgesics|mesh-ancestor
92091855|NCT03406546|Sensory System Agents|sensory system agents|mesh-ancestor
92091856|NCT03406546|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091857|NCT03406546|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92091858|NCT03406546|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92091859|NCT03406546|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92091860|NCT03406546|Adrenergic Agents|adrenergic agents|mesh-ancestor
92017149|NCT04973293|Bevacizumab|bevacizumab|mesh-list
92017150|NCT04973293|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017151|NCT04973293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017152|NCT04973293|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92017153|NCT04973293|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92091861|NCT03406546|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091862|NCT03406546|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091863|NCT03406546|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92091864|NCT03406546|Narcotics|narcotics|mesh-ancestor
92091865|NCT01046110|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92091866|NCT01046110|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92091867|NCT01046110|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091868|NCT01046110|Incretins|incretins|mesh-ancestor
92091870|NCT01046110|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091871|NCT01046110|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92091872|NCT01046110|Protease Inhibitors|protease inhibitors|mesh-ancestor
92091873|NCT01046110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091874|NCT01046110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091875|NCT01713530|Insulin|insulin|mesh-list
92091876|NCT01713530|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92091877|NCT01713530|Insulin Aspart|insulin aspart|mesh-list
92091878|NCT01713530|Insulin, Long-Acting|insulin, long-acting|mesh-list
92091879|NCT01713530|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92091880|NCT01713530|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92091881|NCT01713530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091882|NCT01045798|Caspofungin|caspofungin|mesh-list
92091883|NCT01045798|Antifungal Agents|antifungal agents|mesh-ancestor
92091884|NCT01045798|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091885|NCT01045798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091886|NCT01045798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091887|NCT02982694|Bevacizumab|bevacizumab|mesh-list
92091888|NCT02982694|Atezolizumab|atezolizumab|mesh-list
92091889|NCT02982694|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92091890|NCT02982694|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091891|NCT02982694|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92091892|NCT02982694|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92091893|NCT02982694|Growth Substances|growth substances|mesh-ancestor
92091894|NCT02982694|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091895|NCT02982694|Growth Inhibitors|growth inhibitors|mesh-ancestor
92091896|NCT02982694|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92091904|NCT01712984|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92091905|NCT01712984|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92091906|NCT01712984|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091907|NCT01712984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091908|NCT01712984|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92091909|NCT01712984|Hormone Antagonists|hormone antagonists|mesh-ancestor
92091910|NCT01712984|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091911|NCT01712984|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92091912|NCT01712984|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92091913|NCT00921310|Sirolimus|sirolimus|mesh-list
92091914|NCT00921310|Pemetrexed|pemetrexed|mesh-list
92091915|NCT00921310|Temsirolimus|temsirolimus|mesh-list
92091916|NCT00921310|MTOR Inhibitors|mtor inhibitors|mesh-list
92091917|NCT00921310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091918|NCT00921310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091919|NCT00921310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091920|NCT00921310|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92091921|NCT00921310|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92091922|NCT00921310|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92091923|NCT00921310|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091924|NCT00921310|Immunologic Factors|immunologic factors|mesh-ancestor
92091925|NCT00921310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091926|NCT00921310|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92091927|NCT00921310|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091928|NCT00921310|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92091929|NCT00921310|Antifungal Agents|antifungal agents|mesh-ancestor
92091930|NCT02241148|Acetaminophen|acetaminophen|mesh-list
92017155|NCT04973293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017156|NCT04973293|Growth Inhibitors|growth inhibitors|mesh-ancestor
92091931|NCT02241148|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92091932|NCT02241148|Analgesics|analgesics|mesh-ancestor
92091933|NCT02241148|Sensory System Agents|sensory system agents|mesh-ancestor
92091934|NCT02241148|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091935|NCT02241148|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091936|NCT02241148|Antipyretics|antipyretics|mesh-ancestor
92091937|NCT01712516|Glycopyrrolate|glycopyrrolate|mesh-list
92091938|NCT01712516|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92091939|NCT01712516|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92091940|NCT01712516|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92091941|NCT01712516|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091942|NCT01712516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091943|NCT01712516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091944|NCT01712516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091945|NCT01040728|Tiotropium Bromide|tiotropium bromide|mesh-list
92091946|NCT01040728|Olodaterol|olodaterol|mesh-list
92091947|NCT01040728|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92091948|NCT01040728|Autonomic Agents|autonomic agents|mesh-ancestor
92091949|NCT01040728|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091950|NCT01040728|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091951|NCT01040728|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92091952|NCT01040728|Respiratory System Agents|respiratory system agents|mesh-ancestor
92091953|NCT01040728|Parasympatholytics|parasympatholytics|mesh-ancestor
92091954|NCT01040728|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92091955|NCT01040728|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091956|NCT01040728|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091957|NCT01040728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091958|NCT01593020|Paclitaxel|paclitaxel|mesh-list
92091959|NCT01593020|Cyclophosphamide|cyclophosphamide|mesh-list
92091960|NCT01593020|Doxorubicin|doxorubicin|mesh-list
92091961|NCT01593020|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92091962|NCT01593020|Fluorouracil|fluorouracil|mesh-list
92091963|NCT01593020|Epirubicin|epirubicin|mesh-list
92091965|NCT01593020|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091966|NCT01593020|Tubulin Modulators|tubulin modulators|mesh-ancestor
92091967|NCT01593020|Antimitotic Agents|antimitotic agents|mesh-ancestor
92091968|NCT01593020|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091969|NCT01593020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091970|NCT01593020|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091971|NCT01593020|Immunologic Factors|immunologic factors|mesh-ancestor
92091972|NCT01593020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091973|NCT01593020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091974|NCT01593020|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92091975|NCT01593020|Alkylating Agents|alkylating agents|mesh-ancestor
92091976|NCT01593020|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92091977|NCT01593020|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92091978|NCT01593020|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92091979|NCT01593020|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92091980|NCT01593020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091981|NCT01593020|Antimetabolites|antimetabolites|mesh-ancestor
92091982|NCT01593020|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92091983|NCT01040260|Nicotine|nicotine|mesh-list
92091984|NCT01040260|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92091985|NCT01040260|Autonomic Agents|autonomic agents|mesh-ancestor
92091986|NCT01040260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091987|NCT01040260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091988|NCT01040260|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92091989|NCT01040260|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92091990|NCT01040260|Cholinergic Agents|cholinergic agents|mesh-ancestor
92091991|NCT01040260|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091992|NCT01040260|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091993|NCT01046422|Metformin|metformin|mesh-list
92091994|NCT01046422|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92091995|NCT01046422|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091996|NCT03405376|Aflibercept|aflibercept|mesh-list
92091997|NCT03405376|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92091998|NCT03405376|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92091999|NCT03405376|Growth Substances|growth substances|mesh-ancestor
92092000|NCT03405376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017158|NCT04962451|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92092001|NCT03405376|Growth Inhibitors|growth inhibitors|mesh-ancestor
92092002|NCT03405376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092003|NCT02241460|Lidocaine|lidocaine|mesh-list
92092004|NCT02241460|Anesthetics, Local|anesthetics, local|mesh-ancestor
92092005|NCT02241460|Anesthetics|anesthetics|mesh-ancestor
92092006|NCT02241460|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092007|NCT02241460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092008|NCT02241460|Sensory System Agents|sensory system agents|mesh-ancestor
92092009|NCT02241460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092010|NCT02241460|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92092011|NCT02241460|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92092012|NCT02241460|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92092013|NCT02241460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092014|NCT02241460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092015|NCT01712204|Febuxostat|febuxostat|mesh-list
92092016|NCT01712204|Gout Suppressants|gout suppressants|mesh-ancestor
92092017|NCT01712204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092018|NCT01592864|Fluorides|fluorides|mesh-list
92092019|NCT01592864|Tin Fluorides|tin fluorides|mesh-list
92092020|NCT01592864|Fluorophosphate|fluorophosphate|mesh-list
92092021|NCT01592864|Cariostatic Agents|cariostatic agents|mesh-ancestor
92092022|NCT01592864|Protective Agents|protective agents|mesh-ancestor
92092023|NCT01592864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092024|NCT01592786|Memantine|memantine|mesh-list
92092025|NCT01592786|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92092026|NCT01592786|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92092027|NCT01592786|Dopamine Agents|dopamine agents|mesh-ancestor
92092028|NCT01592786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092029|NCT01592786|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092030|NCT01592786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092031|NCT01592786|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92092032|NCT01592786|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92092033|NCT01592708|Erythromycin|erythromycin|mesh-list
92092034|NCT01592708|Ibuprofen|ibuprofen|mesh-list
92092035|NCT01592708|Ketorolac|ketorolac|mesh-list
92092036|NCT01592708|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92092037|NCT01592708|Fentanyl|fentanyl|mesh-list
92092038|NCT01592708|Scopolamine|scopolamine|mesh-list
92092049|NCT01592708|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92092051|NCT01592708|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92092052|NCT01592708|Narcotics|narcotics|mesh-ancestor
92092053|NCT01592708|Analgesics|analgesics|mesh-ancestor
92092054|NCT01592708|Sensory System Agents|sensory system agents|mesh-ancestor
92092055|NCT01592708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092056|NCT01592708|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92092057|NCT01592708|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092058|NCT01592708|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092059|NCT01592708|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092060|NCT01592708|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092061|NCT01592708|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92092062|NCT01592708|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092063|NCT01592708|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092064|NCT01592708|Autonomic Agents|autonomic agents|mesh-ancestor
92092065|NCT01592708|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92092066|NCT01592708|Antipruritics|antipruritics|mesh-ancestor
92092067|NCT01592708|Dermatologic Agents|dermatologic agents|mesh-ancestor
92092068|NCT01592708|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92092069|NCT01592708|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92092070|NCT01592708|Serotonin Agents|serotonin agents|mesh-ancestor
92092071|NCT01592708|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092072|NCT01592708|Antitussive Agents|antitussive agents|mesh-ancestor
92092073|NCT01592708|Respiratory System Agents|respiratory system agents|mesh-ancestor
92092074|NCT01592708|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092075|NCT01592708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092076|NCT01592708|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92092077|NCT01592708|Mydriatics|mydriatics|mesh-ancestor
92092078|NCT01592708|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92092079|NCT01592708|Cholinergic Agents|cholinergic agents|mesh-ancestor
92092080|NCT01592708|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92092081|NCT01592708|Glucocorticoids|glucocorticoids|mesh-ancestor
92092083|NCT01592708|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92092084|NCT01592708|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92017159|NCT04962451|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92017160|NCT04962451|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92092085|NCT01592708|Protective Agents|protective agents|mesh-ancestor
92092086|NCT01592708|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92092087|NCT01592708|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092088|NCT01592708|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92092089|NCT01592708|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92092090|NCT01592708|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92092091|NCT01592708|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92092092|NCT01592708|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92092093|NCT01592708|Dopamine Agents|dopamine agents|mesh-ancestor
92092094|NCT01042522|Paclitaxel|paclitaxel|mesh-list
92092095|NCT01042522|Etoposide|etoposide|mesh-list
92092096|NCT01042522|Cisplatin|cisplatin|mesh-list
92092097|NCT01042522|Carboplatin|carboplatin|mesh-list
92092098|NCT01042522|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92092099|NCT01042522|Bleomycin|bleomycin|mesh-list
92092100|NCT01042522|Etoposide phosphate|etoposide phosphate|mesh-list
92092101|NCT01042522|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92092102|NCT01042522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092103|NCT01042522|Tubulin Modulators|tubulin modulators|mesh-ancestor
92092104|NCT01042522|Antimitotic Agents|antimitotic agents|mesh-ancestor
92092105|NCT01042522|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092106|NCT01042522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092107|NCT01042522|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92092113|NCT01702844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092114|NCT01702844|Tubulin Modulators|tubulin modulators|mesh-ancestor
92092115|NCT01702844|Antimitotic Agents|antimitotic agents|mesh-ancestor
92092116|NCT01702844|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092117|NCT01702844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092119|NCT01702532|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92092120|NCT01702532|Autonomic Agents|autonomic agents|mesh-ancestor
92092121|NCT01702532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092122|NCT01702532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092123|NCT01702532|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92092124|NCT01702532|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92092125|NCT01702532|Cholinergic Agents|cholinergic agents|mesh-ancestor
92092126|NCT01702532|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092239|NCT02982850|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092127|NCT01702532|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092128|NCT02241616|Entecavir|entecavir|mesh-list
92092129|NCT02241616|Antiviral Agents|antiviral agents|mesh-ancestor
92092130|NCT02241616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092131|NCT03400306|Paclitaxel|paclitaxel|mesh-list
92092132|NCT03400306|Carboplatin|carboplatin|mesh-list
92092133|NCT03400306|Veliparib|veliparib|mesh-list
92092134|NCT03400306|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92092135|NCT03400306|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092136|NCT03400306|Tubulin Modulators|tubulin modulators|mesh-ancestor
92092137|NCT03400306|Antimitotic Agents|antimitotic agents|mesh-ancestor
92092138|NCT03400306|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092139|NCT03400306|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092140|NCT03400306|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92092141|NCT03400306|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092142|NCT03405064|Linezolid|linezolid|mesh-list
92092143|NCT03405064|Levonadifloxacin|levonadifloxacin|mesh-list
92092144|NCT03405064|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092145|NCT03405064|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092146|NCT03405064|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92092147|NCT03405064|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092148|NCT03405064|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092149|NCT03405064|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92092150|NCT03404908|Acetaminophen|acetaminophen|mesh-list
92092151|NCT03404908|Dipyrone|dipyrone|mesh-list
92092152|NCT03404908|Ketoprofen|ketoprofen|mesh-list
92092153|NCT03404908|Morphine|morphine|mesh-list
92092154|NCT03404908|Ropivacaine|ropivacaine|mesh-list
92092155|NCT03404908|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92092157|NCT03404908|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092158|NCT03404908|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092159|NCT03404908|Analgesics|analgesics|mesh-ancestor
92092160|NCT03404908|Sensory System Agents|sensory system agents|mesh-ancestor
92092161|NCT03404908|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017161|NCT04962451|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92017162|NCT04962451|Purinergic Agents|purinergic agents|mesh-ancestor
92017163|NCT04962451|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092162|NCT03404908|Anesthetics, Local|anesthetics, local|mesh-ancestor
92092164|NCT03404908|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092165|NCT03404908|Antipyretics|antipyretics|mesh-ancestor
92092166|NCT03404908|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092167|NCT03404908|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092168|NCT03404908|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092169|NCT03404908|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92092170|NCT03404908|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092171|NCT03404908|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092172|NCT01702298|Metformin|metformin|mesh-list
92092173|NCT01702298|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92092174|NCT01702298|Simvastatin|simvastatin|mesh-list
92092175|NCT01702298|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92092176|NCT01702298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092177|NCT01702298|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92092178|NCT01702298|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92092179|NCT01702298|Antimetabolites|antimetabolites|mesh-ancestor
92092204|NCT01701362|Anticonvulsants|anticonvulsants|mesh-ancestor
92092205|NCT01701362|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92092206|NCT01701362|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092207|NCT01701362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092208|NCT01701362|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92092209|NCT01701362|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92092210|NCT01701362|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92092211|NCT01701362|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092212|NCT01701362|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92092214|NCT00919126|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92092215|NCT00919126|Anesthetics, General|anesthetics, general|mesh-ancestor
92092216|NCT00919126|Anesthetics|anesthetics|mesh-ancestor
92092217|NCT00919126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092218|NCT00919126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092219|NCT01710800|Esomeprazole|esomeprazole|mesh-list
92092220|NCT01710800|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92092221|NCT01710800|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92092222|NCT01710800|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92092223|NCT01710800|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092224|NCT01710800|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092225|NCT01710020|Tofacitinib|tofacitinib|mesh-list
92092238|NCT02982850|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092240|NCT02982850|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092241|NCT02982850|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92092242|NCT02982850|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92092243|NCT02982850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092244|NCT02982850|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92092245|NCT02982850|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92092246|NCT02982850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092247|NCT02982850|Antipyretics|antipyretics|mesh-ancestor
92092248|NCT02982850|Anticoagulants|anticoagulants|mesh-ancestor
92092249|NCT02982850|Antithrombins|antithrombins|mesh-ancestor
92092250|NCT02982850|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92092251|NCT02982850|Protease Inhibitors|protease inhibitors|mesh-ancestor
92092252|NCT02242240|Formoterol Fumarate|formoterol fumarate|mesh-list
92092253|NCT02242240|Tiotropium Bromide|tiotropium bromide|mesh-list
92092254|NCT02242240|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92092255|NCT02242240|Autonomic Agents|autonomic agents|mesh-ancestor
92092256|NCT02242240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092257|NCT02242240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092258|NCT02242240|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92092259|NCT02242240|Respiratory System Agents|respiratory system agents|mesh-ancestor
92092260|NCT02242240|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92092261|NCT02242240|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92092262|NCT02242240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92092263|NCT02242240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92092264|NCT02242240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092265|NCT02242240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092266|NCT02242240|Parasympatholytics|parasympatholytics|mesh-ancestor
92092267|NCT02242240|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92017164|NCT04962451|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092268|NCT02242240|Cholinergic Agents|cholinergic agents|mesh-ancestor
92092269|NCT03403972|Vancomycin|vancomycin|mesh-list
92092270|NCT03403972|Simvastatin|simvastatin|mesh-list
92092271|NCT03403972|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92092272|NCT03403972|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92092273|NCT03403972|Antimetabolites|antimetabolites|mesh-ancestor
92092274|NCT03403972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092275|NCT03403972|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92092276|NCT03403972|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92092277|NCT03403972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092278|NCT03403972|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092279|NCT03403972|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092280|NCT02242318|Valsartan|valsartan|mesh-list
92092281|NCT02242318|Telmisartan|telmisartan|mesh-list
92092282|NCT02242318|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092283|NCT02242318|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92092284|NCT02242318|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92092285|NCT02242318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092286|NCT01700192|Mometasone Furoate|mometasone furoate|mesh-list
92092287|NCT01700192|Loratadine|loratadine|mesh-list
92092291|NCT01700192|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92092292|NCT01700192|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92092293|NCT01700192|Adrenergic Agents|adrenergic agents|mesh-ancestor
92092294|NCT01700192|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092295|NCT01700192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092296|NCT01700192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092297|NCT01700192|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92092298|NCT01700192|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92092299|NCT01700192|Autonomic Agents|autonomic agents|mesh-ancestor
92092300|NCT01700192|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092301|NCT01700192|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92092302|NCT01700192|Respiratory System Agents|respiratory system agents|mesh-ancestor
92092303|NCT01700192|Mydriatics|mydriatics|mesh-ancestor
92092304|NCT01700192|Sympathomimetics|sympathomimetics|mesh-ancestor
92092305|NCT01700192|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92092306|NCT01700192|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092307|NCT01700192|Dermatologic Agents|dermatologic agents|mesh-ancestor
92092308|NCT01700192|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92092309|NCT01700192|Antipruritics|antipruritics|mesh-ancestor
92092310|NCT01700192|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92092311|NCT01700192|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92092312|NCT01700192|Histamine Antagonists|histamine antagonists|mesh-ancestor
92092313|NCT01700192|Histamine Agents|histamine agents|mesh-ancestor
92092314|NCT01700192|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092315|NCT01700192|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092316|NCT01700192|Analgesics|analgesics|mesh-ancestor
92092317|NCT01700192|Sensory System Agents|sensory system agents|mesh-ancestor
92092318|NCT01700192|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092319|NCT01700192|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92092320|NCT02242396|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92092321|NCT02242396|Telmisartan|telmisartan|mesh-list
92092322|NCT02242396|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92092323|NCT02242396|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092324|NCT02242396|Diuretics|diuretics|mesh-ancestor
92092325|NCT02242396|Natriuretic Agents|natriuretic agents|mesh-ancestor
92092326|NCT02242396|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092327|NCT02242396|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92092328|NCT02242396|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092329|NCT02242396|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092330|NCT02242396|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92092331|NCT02242396|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92092333|NCT02242474|Infliximab|infliximab|mesh-list
92092334|NCT02242474|Golimumab|golimumab|mesh-list
92092335|NCT02242474|Certolizumab Pegol|certolizumab pegol|mesh-list
92092336|NCT02242474|Etanercept|etanercept|mesh-list
92092337|NCT02242474|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92092338|NCT02242474|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92092339|NCT02242474|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092340|NCT02242474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092341|NCT02242474|Dermatologic Agents|dermatologic agents|mesh-ancestor
92092342|NCT02242474|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017165|NCT04962451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017166|NCT04953871|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-list
92092343|NCT02242474|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092344|NCT02242474|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092345|NCT02242474|Analgesics|analgesics|mesh-ancestor
92092346|NCT02242474|Sensory System Agents|sensory system agents|mesh-ancestor
92092347|NCT02242474|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092348|NCT02242474|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092349|NCT02242474|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92092350|NCT02242474|Immunologic Factors|immunologic factors|mesh-ancestor
92092351|NCT01709864|Glycopyrrolate|glycopyrrolate|mesh-list
92092352|NCT01709864|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92092353|NCT01709864|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92092354|NCT01709864|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92092355|NCT01709864|Cholinergic Agents|cholinergic agents|mesh-ancestor
92092356|NCT01709864|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092357|NCT01709864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092358|NCT01709864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092359|NCT04878315|Captopril|captopril|mesh-list
92092367|NCT04374604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092368|NCT02242864|Telmisartan|telmisartan|mesh-list
92092369|NCT02242864|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92092370|NCT02242864|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092371|NCT02242864|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92092372|NCT02242864|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92092373|NCT02242864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092374|NCT02242864|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92092375|NCT02242864|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092376|NCT02242864|Diuretics|diuretics|mesh-ancestor
92092377|NCT02242864|Natriuretic Agents|natriuretic agents|mesh-ancestor
92092378|NCT02242864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092379|NCT01709708|Bupivacaine|bupivacaine|mesh-list
92092380|NCT01709708|Anesthetics, Local|anesthetics, local|mesh-ancestor
92092381|NCT01709708|Anesthetics|anesthetics|mesh-ancestor
92092382|NCT01709708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092383|NCT01709708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092384|NCT01709708|Sensory System Agents|sensory system agents|mesh-ancestor
92092385|NCT01709708|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092386|NCT02243098|Digoxin|digoxin|mesh-list
92092387|NCT02243098|Atorvastatin|atorvastatin|mesh-list
92092388|NCT02243098|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92092389|NCT02243098|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92092390|NCT02243098|Antimetabolites|antimetabolites|mesh-ancestor
92092391|NCT02243098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092392|NCT02243098|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92092393|NCT02243098|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92092394|NCT02243098|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092395|NCT02243098|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92092396|NCT02243098|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92092397|NCT02243098|Protective Agents|protective agents|mesh-ancestor
92092398|NCT02243098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092399|NCT02845323|Nivolumab|nivolumab|mesh-list
92092400|NCT02845323|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092401|NCT02845323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092402|NCT02845323|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92092403|NCT02845323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092404|NCT05289063|Atorvastatin|atorvastatin|mesh-list
92092405|NCT05289063|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92092406|NCT05289063|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92092407|NCT05289063|Antimetabolites|antimetabolites|mesh-ancestor
92092408|NCT05289063|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092409|NCT05289063|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92092410|NCT05289063|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92092411|NCT05289063|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092412|NCT01709318|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92092413|NCT01709318|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92092414|NCT01709318|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92092415|NCT01709318|Etonogestrel|etonogestrel|mesh-list
92017167|NCT04953871|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017168|NCT03059719|Exenatide|exenatide|mesh-list
92017169|NCT03059719|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92017170|NCT03059719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017171|NCT03059719|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92092416|NCT01709318|Estradiol|estradiol|mesh-list
92092417|NCT01709318|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92092418|NCT01709318|Estrogens|estrogens|mesh-ancestor
92092419|NCT01709318|Hormones|hormones|mesh-ancestor
92092420|NCT01709318|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92092421|NCT01709318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092422|NCT01709318|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92092423|NCT01709318|Contraceptive Agents|contraceptive agents|mesh-ancestor
92092424|NCT01709318|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092430|NCT02243254|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092431|NCT02243254|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092432|NCT02243254|Analgesics|analgesics|mesh-ancestor
92092433|NCT02243254|Sensory System Agents|sensory system agents|mesh-ancestor
92092434|NCT02243254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092435|NCT02243254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092436|NCT02243254|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092437|NCT02243254|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092438|NCT02243254|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92092439|NCT02243254|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092440|NCT02243254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092441|NCT02243254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92092442|NCT02243254|Narcotics|narcotics|mesh-ancestor
92092443|NCT02243254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092444|NCT03402880|Pembrolizumab|pembrolizumab|mesh-list
92092445|NCT03402880|Immunoglobulins|immunoglobulins|mesh-list
92092446|NCT03402880|Immunoglobulin G|immunoglobulin g|mesh-list
92092447|NCT03402880|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092448|NCT03402880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092449|NCT03402880|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92092450|NCT03402880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092451|NCT03402880|Immunologic Factors|immunologic factors|mesh-ancestor
92092452|NCT03402880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092453|NCT01673997|Metoprolol|metoprolol|mesh-list
92092454|NCT01673997|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92092455|NCT01673997|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092456|NCT01673997|Sympatholytics|sympatholytics|mesh-ancestor
92092457|NCT01673997|Autonomic Agents|autonomic agents|mesh-ancestor
92092458|NCT01673997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092459|NCT01673997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092460|NCT01673997|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92092461|NCT01673997|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92092462|NCT01673997|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92092463|NCT01673997|Adrenergic Agents|adrenergic agents|mesh-ancestor
92092464|NCT01673997|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092465|NCT01673997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092466|NCT04373824|Ivermectin|ivermectin|mesh-list
92092467|NCT04373824|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92092468|NCT04373824|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092469|NCT01676571|Vortioxetine|vortioxetine|mesh-list
92092470|NCT01676571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92092471|NCT01676571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92092472|NCT01676571|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92092473|NCT01676571|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92092474|NCT01676571|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092475|NCT01676571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092476|NCT01676571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92092477|NCT01676571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92092478|NCT01676571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092479|NCT01676571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092480|NCT01676571|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092481|NCT01676571|Serotonin Agents|serotonin agents|mesh-ancestor
92092482|NCT01676571|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92092483|NCT01676571|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92017172|NCT03059719|Incretins|incretins|mesh-ancestor
92017173|NCT03059719|Hormones|hormones|mesh-ancestor
92017174|NCT03059719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017175|NCT03060031|Oxytocin|oxytocin|mesh-list
92017176|NCT03060031|Oxytocics|oxytocics|mesh-ancestor
92092484|NCT01676571|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92092485|NCT01676571|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92092486|NCT01699178|Methyltestosterone|methyltestosterone|mesh-list
92092487|NCT01699178|Testosterone|testosterone|mesh-list
92092488|NCT01699178|Testosterone undecanoate|testosterone undecanoate|mesh-list
92092489|NCT01699178|Testosterone enanthate|testosterone enanthate|mesh-list
92092490|NCT01699178|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92092491|NCT01699178|Androgens|androgens|mesh-ancestor
92092492|NCT01699178|Hormones|hormones|mesh-ancestor
92092501|NCT02077959|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092502|NCT02077959|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92092503|NCT02077959|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92092504|NCT02077959|Growth Substances|growth substances|mesh-ancestor
92092505|NCT02077959|Growth Inhibitors|growth inhibitors|mesh-ancestor
92092506|NCT02077959|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092507|NCT02077959|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092509|NCT04548518|Immunologic Factors|immunologic factors|mesh-ancestor
92092510|NCT04548518|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092511|NCT01699022|CycloProvera|cycloprovera|mesh-list
92092512|NCT01699022|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92092513|NCT01699022|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92092514|NCT01699022|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92092515|NCT01699022|Contraceptive Agents|contraceptive agents|mesh-ancestor
92092516|NCT01699022|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092517|NCT01699022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092518|NCT01699022|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92092519|NCT01699022|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92092520|NCT01670175|Sirolimus|sirolimus|mesh-list
92092521|NCT01670175|Cyclophosphamide|cyclophosphamide|mesh-list
92092522|NCT01670175|Topotecan|topotecan|mesh-list
92092523|NCT01670175|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92092524|NCT01670175|Immunologic Factors|immunologic factors|mesh-ancestor
92092525|NCT01670175|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092526|NCT01670175|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092527|NCT01670175|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92092528|NCT01670175|Alkylating Agents|alkylating agents|mesh-ancestor
92092529|NCT01670175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092530|NCT01670175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092531|NCT01670175|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92092532|NCT01670175|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092533|NCT01670175|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092534|NCT01670175|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92092535|NCT01670175|Antifungal Agents|antifungal agents|mesh-ancestor
92092536|NCT01670175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092537|NCT01670175|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92092538|NCT01670175|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92092539|NCT02243566|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92092540|NCT02243566|Telmisartan|telmisartan|mesh-list
92092541|NCT02243566|Telmisartan, hydrochlorothiazide drug combination|telmisartan, hydrochlorothiazide drug combination|mesh-list
92092542|NCT02243566|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092543|NCT02243566|Diuretics|diuretics|mesh-ancestor
92092544|NCT02243566|Natriuretic Agents|natriuretic agents|mesh-ancestor
92092545|NCT02243566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092546|NCT02243566|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92092547|NCT02243566|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092548|NCT02243566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092549|NCT02243566|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92092550|NCT02243566|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92092551|NCT02243644|Albendazole|albendazole|mesh-list
92092552|NCT02243644|Anthelmintics|anthelmintics|mesh-ancestor
92092553|NCT02243644|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92092554|NCT02243644|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092555|NCT02243644|Anticestodal Agents|anticestodal agents|mesh-ancestor
92092556|NCT02243644|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92017177|NCT03060031|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092557|NCT02243644|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92092567|NCT01988883|Adrenergic Agents|adrenergic agents|mesh-ancestor
92092568|NCT01988883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092569|NCT01988883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092570|NCT01988883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092571|NCT01988883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92092572|NCT01988883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092573|NCT01988883|Vasodilator Agents|vasodilator agents|mesh-ancestor
92092574|NCT01988883|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92092575|NCT01988883|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92092576|NCT01988883|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92092577|NCT01988883|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92092578|NCT04373356|Listerine|listerine|mesh-list
92092579|NCT04373356|Fluorides|fluorides|mesh-list
92092580|NCT04373356|Sodium Fluoride|sodium fluoride|mesh-list
92092581|NCT04373356|Fluorides, Topical|fluorides, topical|mesh-list
92092582|NCT04373356|Cariostatic Agents|cariostatic agents|mesh-ancestor
92092583|NCT04373356|Protective Agents|protective agents|mesh-ancestor
92092584|NCT04373356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092585|NCT04373356|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92092586|NCT04373356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092587|NCT01745757|Paclitaxel|paclitaxel|mesh-list
92092588|NCT01745757|Bevacizumab|bevacizumab|mesh-list
92092589|NCT01745757|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92092590|NCT01745757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092591|NCT01745757|Tubulin Modulators|tubulin modulators|mesh-ancestor
92092592|NCT01745757|Antimitotic Agents|antimitotic agents|mesh-ancestor
92092593|NCT01745757|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092594|NCT01745757|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092595|NCT01745757|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092596|NCT01745757|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92092597|NCT01745757|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92092598|NCT01745757|Growth Substances|growth substances|mesh-ancestor
92092599|NCT01745757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092600|NCT01745757|Growth Inhibitors|growth inhibitors|mesh-ancestor
92092601|NCT01709162|Ipilimumab|ipilimumab|mesh-list
92092602|NCT01709162|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092603|NCT01709162|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092604|NCT01709162|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92092605|NCT01709162|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092606|NCT02243800|Cholecalciferol|cholecalciferol|mesh-list
92092607|NCT02243800|Vitamin D|vitamin d|mesh-list
92092608|NCT02243800|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92092609|NCT02243800|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092610|NCT02243800|Vitamins|vitamins|mesh-ancestor
92092611|NCT02243800|Micronutrients|micronutrients|mesh-ancestor
92092612|NCT02243800|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92092613|NCT03402100|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92092614|NCT03402100|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92092615|NCT04764045|Ropivacaine|ropivacaine|mesh-list
92092616|NCT04764045|Anesthetics, Local|anesthetics, local|mesh-ancestor
92092617|NCT04764045|Anesthetics|anesthetics|mesh-ancestor
92092618|NCT04764045|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092619|NCT04764045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092620|NCT04764045|Sensory System Agents|sensory system agents|mesh-ancestor
92092621|NCT04764045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092622|NCT01698554|Bimatoprost|bimatoprost|mesh-list
92092623|NCT01698554|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92092637|NCT01698320|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92092638|NCT01698320|Respiratory System Agents|respiratory system agents|mesh-ancestor
92092639|NCT01698320|Tocolytic Agents|tocolytic agents|mesh-ancestor
92092640|NCT01698320|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092641|NCT01698320|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92092642|NCT01698320|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92092643|NCT01698320|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92092644|NCT01698320|Adrenergic Agents|adrenergic agents|mesh-ancestor
92092645|NCT01698320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092646|NCT01698320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092647|NCT03401476|Morphine|morphine|mesh-list
92092648|NCT03401476|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92092649|NCT03401476|Narcotics|narcotics|mesh-ancestor
92092650|NCT03401476|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017178|NCT03060031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017179|NCT02499783|Adalimumab|adalimumab|mesh-list
92092651|NCT03401476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092652|NCT03401476|Analgesics|analgesics|mesh-ancestor
92092653|NCT03401476|Sensory System Agents|sensory system agents|mesh-ancestor
92092654|NCT03401476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092655|NCT01674777|Ipragliflozin|ipragliflozin|mesh-list
92092656|NCT01674777|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92092657|NCT01674777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092658|NCT01674777|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92092659|NCT01674777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092660|NCT03876717|Colesevelam Hydrochloride|colesevelam hydrochloride|mesh-list
92092661|NCT03876717|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92092662|NCT03876717|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92092663|NCT03876717|Antimetabolites|antimetabolites|mesh-ancestor
92092664|NCT03876717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092665|NCT03876717|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92092666|NCT01674855|Lenograstim|lenograstim|mesh-list
92092667|NCT01674855|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92092668|NCT01674855|Immunologic Factors|immunologic factors|mesh-ancestor
92092669|NCT01674855|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092670|NCT03854799|Capecitabine|capecitabine|mesh-list
92092671|NCT03854799|Avelumab|avelumab|mesh-list
92092672|NCT03854799|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92092673|NCT03854799|Antimetabolites|antimetabolites|mesh-ancestor
92092674|NCT03854799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092675|NCT03854799|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092676|NCT03854799|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092677|NCT00924352|Dasatinib|dasatinib|mesh-list
92092678|NCT00924352|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092679|NCT00924352|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92092680|NCT00924352|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092681|NCT00924352|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092682|NCT01674933|Listerine|listerine|mesh-list
92092683|NCT01674933|Fluorides|fluorides|mesh-list
92092684|NCT01674933|Fluorides, Topical|fluorides, topical|mesh-list
92092685|NCT01674933|Sodium fluoride topical preparation|sodium fluoride topical preparation|mesh-list
92092693|NCT04373044|Antimalarials|antimalarials|mesh-ancestor
92092694|NCT04373044|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92092695|NCT04373044|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92092696|NCT04373044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092697|NCT04373044|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092698|NCT04373044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092699|NCT04373044|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092700|NCT01675089|Zoledronic Acid|zoledronic acid|mesh-list
92092701|NCT01675089|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92092702|NCT01675089|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092703|NCT01697696|Glycopyrrolate|glycopyrrolate|mesh-list
92092704|NCT01697696|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92092705|NCT01697696|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92092706|NCT01697696|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92092707|NCT01697696|Cholinergic Agents|cholinergic agents|mesh-ancestor
92092708|NCT01697696|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092709|NCT01697696|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092710|NCT01697696|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092711|NCT01569152|Methotrexate|methotrexate|mesh-list
92092712|NCT01569152|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92092713|NCT01569152|Abortifacient Agents|abortifacient agents|mesh-ancestor
92092714|NCT01569152|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092715|NCT01569152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092716|NCT01569152|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92092717|NCT01569152|Antimetabolites|antimetabolites|mesh-ancestor
92092718|NCT01569152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092719|NCT01569152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092720|NCT01569152|Dermatologic Agents|dermatologic agents|mesh-ancestor
92092721|NCT01569152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092722|NCT01569152|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92092723|NCT01569152|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92092724|NCT01569152|Immunologic Factors|immunologic factors|mesh-ancestor
92017180|NCT02499783|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92017181|NCT02499783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017182|NCT02499783|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092725|NCT01569152|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092726|NCT01569152|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92092727|NCT01675557|Vitamin D|vitamin d|mesh-list
92092728|NCT01675557|Ergocalciferols|ergocalciferols|mesh-list
92092729|NCT01675557|Cholecalciferol|cholecalciferol|mesh-list
92092730|NCT01675557|Vitamins|vitamins|mesh-list
92092731|NCT01675557|Micronutrients|micronutrients|mesh-ancestor
92092732|NCT01675557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092733|NCT01675557|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92092734|NCT01675557|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92092735|NCT01675947|Sirolimus|sirolimus|mesh-list
92092736|NCT01675947|Lidocaine|lidocaine|mesh-list
92092737|NCT01675947|Anesthetics, Local|anesthetics, local|mesh-ancestor
92092738|NCT01675947|Anesthetics|anesthetics|mesh-ancestor
92092739|NCT01675947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092740|NCT01675947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092741|NCT01675947|Sensory System Agents|sensory system agents|mesh-ancestor
92092742|NCT01675947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092743|NCT01675947|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92092744|NCT01675947|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92092745|NCT01675947|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92092746|NCT01675947|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092747|NCT01675947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092748|NCT01675947|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092749|NCT01675947|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092750|NCT01675947|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92092751|NCT01675947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092775|NCT03748953|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092776|NCT03748953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092777|NCT01567826|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92092778|NCT01567826|Atorvastatin|atorvastatin|mesh-list
92092779|NCT01567826|Simvastatin|simvastatin|mesh-list
92092780|NCT01567826|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92092781|NCT01567826|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92092782|NCT01567826|Antimetabolites|antimetabolites|mesh-ancestor
92092783|NCT01567826|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092784|NCT01567826|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92092785|NCT01567826|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92092786|NCT01567826|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092787|NCT03744975|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92092788|NCT03744975|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92092789|NCT03744975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092790|NCT03743025|Dulaglutide|dulaglutide|mesh-list
92092791|NCT03743025|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92092792|NCT03743025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092795|NCT03742245|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92092796|NCT03742245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092797|NCT03742245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092798|NCT03742245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092799|NCT03742245|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92092800|NCT02083107|Misoprostol|misoprostol|mesh-list
92092801|NCT02083107|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92092802|NCT02083107|Abortifacient Agents|abortifacient agents|mesh-ancestor
92092803|NCT02083107|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092804|NCT02083107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092805|NCT02083107|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92092821|NCT04372732|Immunologic Factors|immunologic factors|mesh-ancestor
92092822|NCT04372732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092823|NCT02245126|Lidocaine|lidocaine|mesh-list
92092824|NCT02245126|Bupivacaine|bupivacaine|mesh-list
92092825|NCT02245126|Anesthetics, Local|anesthetics, local|mesh-ancestor
92092826|NCT02245126|Anesthetics|anesthetics|mesh-ancestor
92092827|NCT02245126|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017184|NCT04972045|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92017185|NCT04972045|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092828|NCT02245126|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092829|NCT02245126|Sensory System Agents|sensory system agents|mesh-ancestor
92092830|NCT02245126|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092831|NCT02245126|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92092832|NCT02245126|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92092833|NCT02245126|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92092834|NCT02245126|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092835|NCT02245126|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092836|NCT04372342|Remifentanil|remifentanil|mesh-list
92092837|NCT04372342|Nalbuphine|nalbuphine|mesh-list
92092838|NCT04372342|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92092839|NCT04372342|Narcotics|narcotics|mesh-ancestor
92092840|NCT04372342|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092841|NCT04372342|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092842|NCT04372342|Analgesics|analgesics|mesh-ancestor
92092843|NCT04372342|Sensory System Agents|sensory system agents|mesh-ancestor
92092844|NCT04372342|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092845|NCT04372264|Acetaminophen|acetaminophen|mesh-list
92092846|NCT04372264|Ibuprofen|ibuprofen|mesh-list
92092847|NCT04372264|Dexketoprofen trometamol|dexketoprofen trometamol|mesh-list
92092848|NCT04372264|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092849|NCT04372264|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092851|NCT04372264|Sensory System Agents|sensory system agents|mesh-ancestor
92092852|NCT04372264|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092853|NCT04372264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092854|NCT04372264|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092855|NCT04372264|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092856|NCT04372264|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92092857|NCT04372264|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092858|NCT04372264|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092859|NCT04372264|Antipyretics|antipyretics|mesh-ancestor
92092860|NCT02083809|Oxytocin|oxytocin|mesh-list
92092861|NCT02083809|Oxytocics|oxytocics|mesh-ancestor
92092862|NCT02083809|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92092863|NCT02083809|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092864|NCT02244112|Midazolam|midazolam|mesh-list
92092865|NCT02244112|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92092866|NCT02244112|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92092872|NCT02244112|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92092873|NCT02244112|Anesthetics, General|anesthetics, general|mesh-ancestor
92092874|NCT02244112|Anesthetics|anesthetics|mesh-ancestor
92092875|NCT02244112|GABA Modulators|gaba modulators|mesh-ancestor
92092876|NCT02244112|GABA Agents|gaba agents|mesh-ancestor
92092877|NCT02244112|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092878|NCT02244112|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092879|NCT02244190|Ritonavir|ritonavir|mesh-list
92092880|NCT02244190|Tipranavir|tipranavir|mesh-list
92092881|NCT02244190|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92092882|NCT02244190|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92092883|NCT02244190|Protease Inhibitors|protease inhibitors|mesh-ancestor
92092884|NCT02244190|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092885|NCT02244190|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092886|NCT02244190|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92092887|NCT02244190|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92092888|NCT02244190|Antiviral Agents|antiviral agents|mesh-ancestor
92092889|NCT02244190|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092890|NCT02244190|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92092891|NCT02244190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92092892|NCT00926380|Denosumab|denosumab|mesh-list
92092893|NCT00926380|Teriparatide|teriparatide|mesh-list
92092894|NCT00926380|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92092895|NCT00926380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092896|NCT00926380|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92092897|NCT02244268|Tamsulosin|tamsulosin|mesh-list
92092898|NCT02244268|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92092899|NCT02244268|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92092900|NCT02244268|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92092901|NCT02244268|Adrenergic Agents|adrenergic agents|mesh-ancestor
92017188|NCT04972045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092902|NCT02244268|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092903|NCT02244268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092904|NCT02244268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092905|NCT02244268|Urological Agents|urological agents|mesh-ancestor
92092906|NCT03630315|Bevacizumab|bevacizumab|mesh-list
92092907|NCT03630315|Ranibizumab|ranibizumab|mesh-list
92092908|NCT03630315|Aflibercept|aflibercept|mesh-list
92092909|NCT03630315|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092910|NCT03630315|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092911|NCT03630315|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92092912|NCT03630315|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92092913|NCT03630315|Growth Substances|growth substances|mesh-ancestor
92092914|NCT03630315|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092915|NCT03630315|Growth Inhibitors|growth inhibitors|mesh-ancestor
92092916|NCT00929344|Pregabalin|pregabalin|mesh-list
92092917|NCT00929344|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92092918|NCT00929344|Analgesics|analgesics|mesh-ancestor
92092919|NCT00929344|Sensory System Agents|sensory system agents|mesh-ancestor
92092920|NCT00929344|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092921|NCT00929344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092922|NCT00929344|Anticonvulsants|anticonvulsants|mesh-ancestor
92092923|NCT00929344|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92092924|NCT00929344|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092925|NCT00929344|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092926|NCT00929344|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92092927|NCT00929344|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92092928|NCT00929344|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92092929|NCT00929344|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092930|NCT00929344|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92092931|NCT00929344|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92092932|NCT00929344|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92092933|NCT00929344|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092934|NCT00929344|Antidepressive Agents|antidepressive agents|mesh-ancestor
92092935|NCT00929344|Dopamine Agents|dopamine agents|mesh-ancestor
92092938|NCT03630159|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92092940|NCT03630159|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92092941|NCT03630159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092942|NCT04371874|Aspirin|aspirin|mesh-list
92092943|NCT04371874|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92092944|NCT04371874|Captopril|captopril|mesh-list
92092945|NCT04371874|Nitrendipine|nitrendipine|mesh-list
92092946|NCT04371874|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092947|NCT04371874|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092948|NCT04371874|Analgesics|analgesics|mesh-ancestor
92092949|NCT04371874|Sensory System Agents|sensory system agents|mesh-ancestor
92092950|NCT04371874|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092951|NCT04371874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092952|NCT04371874|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092953|NCT04371874|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092954|NCT04371874|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92092955|NCT04371874|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92092956|NCT04371874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092957|NCT04371874|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92092958|NCT04371874|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92092959|NCT04371874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092960|NCT04371874|Antipyretics|antipyretics|mesh-ancestor
92092961|NCT04371874|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092962|NCT04371874|Diuretics|diuretics|mesh-ancestor
92092963|NCT04371874|Natriuretic Agents|natriuretic agents|mesh-ancestor
92092964|NCT04371874|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92092965|NCT04371874|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92092966|NCT04371874|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92092967|NCT04371874|Protease Inhibitors|protease inhibitors|mesh-ancestor
92092968|NCT04371874|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92092969|NCT04371874|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92092970|NCT04371874|Vasodilator Agents|vasodilator agents|mesh-ancestor
92092971|NCT03629613|Antioxidants|antioxidants|mesh-list
92092972|NCT03629613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017189|NCT04972045|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017190|NCT04972045|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017191|NCT04972045|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92092973|NCT03629613|Protective Agents|protective agents|mesh-ancestor
92092974|NCT03629613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092975|NCT03629223|Tepotinib|tepotinib|mesh-list
92092976|NCT03629223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092977|NCT03720717|Baclofen|baclofen|mesh-list
92092978|NCT03720717|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92092979|NCT03720717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092980|NCT03720717|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92092981|NCT03720717|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092982|NCT03720717|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92092983|NCT03720717|GABA Agonists|gaba agonists|mesh-ancestor
92092984|NCT03720717|GABA Agents|gaba agents|mesh-ancestor
92092985|NCT03720717|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92092986|NCT03720717|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092987|NCT04376554|Amoxicillin|amoxicillin|mesh-list
92092988|NCT04376554|Clavulanic Acid|clavulanic acid|mesh-list
92092989|NCT04376554|Clavulanic Acids|clavulanic acids|mesh-list
92092990|NCT04376554|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92092991|NCT04376554|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092992|NCT04376554|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092993|NCT04376554|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92092994|NCT04376554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092995|NCT04376554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092996|NCT03627741|Triamcinolone|triamcinolone|mesh-list
92092997|NCT03627741|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92092998|NCT03627741|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92092999|NCT03627741|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92093000|NCT03627741|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093001|NCT03627741|Glucocorticoids|glucocorticoids|mesh-ancestor
92093002|NCT03627741|Hormones|hormones|mesh-ancestor
92093003|NCT03627741|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093004|NCT03627741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093005|NCT03627741|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093006|NCT03627741|Immunologic Factors|immunologic factors|mesh-ancestor
92093007|NCT03627741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093010|NCT03626337|Vitamin B Complex|vitamin b complex|mesh-ancestor
92093012|NCT03626337|Micronutrients|micronutrients|mesh-ancestor
92093013|NCT03626337|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093014|NCT00929578|Fluphenazine|fluphenazine|mesh-list
92093015|NCT00929578|Fluphenazine depot|fluphenazine depot|mesh-list
92093016|NCT00929578|Fluphenazine enanthate|fluphenazine enanthate|mesh-list
92093017|NCT00929578|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92093018|NCT00929578|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92093019|NCT00929578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093020|NCT00929578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093021|NCT00929578|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92093022|NCT00929578|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92093023|NCT00929578|Dopamine Agents|dopamine agents|mesh-ancestor
92093024|NCT00929578|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093025|NCT00929578|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093026|NCT03615105|Cyclophosphamide|cyclophosphamide|mesh-list
92093027|NCT03615105|Melphalan|melphalan|mesh-list
92093028|NCT03615105|Busulfan|busulfan|mesh-list
92093029|NCT03615105|Thiotepa|thiotepa|mesh-list
92093030|NCT03615105|Rituximab|rituximab|mesh-list
92093031|NCT03615105|Fludarabine|fludarabine|mesh-list
92093032|NCT03615105|Clofarabine|clofarabine|mesh-list
92093033|NCT03615105|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92093034|NCT03615105|Thymoglobulin|thymoglobulin|mesh-list
92093035|NCT03615105|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093036|NCT03615105|Immunologic Factors|immunologic factors|mesh-ancestor
92093037|NCT03615105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093038|NCT03615105|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093039|NCT03615105|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92093040|NCT03615105|Alkylating Agents|alkylating agents|mesh-ancestor
92093041|NCT03615105|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093042|NCT03615105|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093043|NCT03615105|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92093044|NCT03615105|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017192|NCT04972045|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017194|NCT04972045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017195|NCT03059017|Albuterol|albuterol|mesh-list
92093045|NCT03615105|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92093046|NCT03615105|Antimetabolites|antimetabolites|mesh-ancestor
92093047|NCT04371406|Azithromycin|azithromycin|mesh-list
92093048|NCT04371406|Hydroxychloroquine|hydroxychloroquine|mesh-list
92093049|NCT04371406|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92093050|NCT04371406|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093051|NCT04371406|Antimalarials|antimalarials|mesh-ancestor
92093052|NCT04371406|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92093053|NCT04371406|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92093054|NCT04371406|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093055|NCT04371406|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093056|NCT04371406|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093057|NCT03716739|Methyltestosterone|methyltestosterone|mesh-list
92093058|NCT03716739|Testosterone|testosterone|mesh-list
92093059|NCT03716739|Testosterone undecanoate|testosterone undecanoate|mesh-list
92093060|NCT03716739|Testosterone enanthate|testosterone enanthate|mesh-list
92093061|NCT03716739|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92093062|NCT03716739|Androgens|androgens|mesh-ancestor
92093063|NCT03716739|Hormones|hormones|mesh-ancestor
92093064|NCT03716739|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093065|NCT03716739|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093066|NCT03716739|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92093067|NCT03716739|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093068|NCT03716739|Anabolic Agents|anabolic agents|mesh-ancestor
92093069|NCT04763265|Botulinum Toxins|botulinum toxins|mesh-list
92093070|NCT04763265|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92093071|NCT04763265|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92093072|NCT04763265|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92093073|NCT04763265|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093074|NCT04763265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093075|NCT04763265|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093076|NCT04763265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093077|NCT04763265|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093078|NCT04763265|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92093079|NCT04763265|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093080|NCT00004143|Alemtuzumab|alemtuzumab|mesh-list
92093081|NCT00004143|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093087|NCT03705429|Trastuzumab|trastuzumab|mesh-list
92093088|NCT03705429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92093089|NCT03705429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093090|NCT03705429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92093091|NCT03705429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92093092|NCT03705429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92093093|NCT03705429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093094|NCT03705429|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093095|NCT03705429|Immunologic Factors|immunologic factors|mesh-ancestor
92093096|NCT03705429|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093097|NCT03705429|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093098|NCT03705429|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92093099|NCT03705429|Alkylating Agents|alkylating agents|mesh-ancestor
92093100|NCT03705429|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92093101|NCT03705429|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093102|NCT04370782|Azithromycin|azithromycin|mesh-list
92093103|NCT04370782|Doxycycline|doxycycline|mesh-list
92093104|NCT04370782|Hydroxychloroquine|hydroxychloroquine|mesh-list
92093105|NCT04370782|Zinc Sulfate|zinc sulfate|mesh-list
92093106|NCT04370782|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92093107|NCT04370782|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093108|NCT04370782|Antimalarials|antimalarials|mesh-ancestor
92093109|NCT04370782|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92093110|NCT04370782|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92093111|NCT04370782|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093112|NCT04370782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093113|NCT04370782|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093114|NCT04370782|Astringents|astringents|mesh-ancestor
92093115|NCT04370782|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093116|NCT04370782|Dermatologic Agents|dermatologic agents|mesh-ancestor
92017196|NCT03059017|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92017197|NCT03059017|Autonomic Agents|autonomic agents|mesh-ancestor
92017198|NCT03059017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093118|NCT03604653|Doxorubicin|doxorubicin|mesh-list
92093119|NCT03604653|Mitomycins|mitomycins|mesh-list
92093121|NCT03604653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093122|NCT03604653|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92093123|NCT03604653|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92093124|NCT03604653|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92093125|NCT03604653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093126|NCT03604653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093127|NCT03604653|Alkylating Agents|alkylating agents|mesh-ancestor
92093128|NCT03604653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92093129|NCT04376086|Anesthetics|anesthetics|mesh-list
92093130|NCT04376086|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093131|NCT04376086|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093132|NCT04375852|Autoantibodies|autoantibodies|mesh-list
92093133|NCT04375852|Immunologic Factors|immunologic factors|mesh-ancestor
92093134|NCT04375852|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093135|NCT04364464|Riociguat|riociguat|mesh-list
92093136|NCT04364464|Enzyme Activators|enzyme activators|mesh-ancestor
92093208|NCT01591616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093137|NCT04364464|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093138|NCT03600441|Abexinostat|abexinostat|mesh-list
92093139|NCT03600441|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92093140|NCT03600441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093141|NCT03600441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093142|NCT01592240|Bococizumab|bococizumab|mesh-list
92093143|NCT01592240|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92093144|NCT01592240|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92093145|NCT01592240|Antimetabolites|antimetabolites|mesh-ancestor
92093146|NCT01592240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093147|NCT01592240|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92093148|NCT05620654|Paclitaxel|paclitaxel|mesh-list
92093149|NCT05620654|Cisplatin|cisplatin|mesh-list
92093150|NCT05620654|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92093151|NCT05620654|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093152|NCT05620654|Tubulin Modulators|tubulin modulators|mesh-ancestor
92093153|NCT05620654|Antimitotic Agents|antimitotic agents|mesh-ancestor
92093154|NCT05620654|Mitosis Modulators|mitosis modulators|mesh-ancestor
92093156|NCT03692325|Nivolumab|nivolumab|mesh-list
92093157|NCT03692325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093158|NCT03692325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093159|NCT03692325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92093160|NCT03692325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093161|NCT04357522|Vaccines|vaccines|mesh-list
92093162|NCT04357522|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92093163|NCT04357522|Immunologic Factors|immunologic factors|mesh-ancestor
92093164|NCT04357522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093165|NCT00005901|Pamidronate|pamidronate|mesh-list
92093166|NCT00005901|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92093167|NCT00005901|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093168|NCT04369534|Clopidogrel|clopidogrel|mesh-list
92093169|NCT04369534|Ticagrelor|ticagrelor|mesh-list
92093170|NCT04369534|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92093171|NCT04369534|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92093172|NCT04369534|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92093173|NCT04369534|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92093174|NCT04369534|Purinergic Agents|purinergic agents|mesh-ancestor
92093175|NCT04369534|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093176|NCT04369534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093177|NCT04369534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093179|NCT04363762|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093180|NCT04363762|Antifungal Agents|antifungal agents|mesh-ancestor
92093181|NCT04363762|Keratolytic Agents|keratolytic agents|mesh-ancestor
92093182|NCT04363762|Dermatologic Agents|dermatologic agents|mesh-ancestor
92093183|NCT04363450|Hydroxychloroquine|hydroxychloroquine|mesh-list
92093184|NCT04363450|Antimalarials|antimalarials|mesh-ancestor
92093185|NCT04363450|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92093186|NCT04363450|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92093187|NCT04363450|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017199|NCT03059017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017200|NCT03059017|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92017201|NCT03059017|Respiratory System Agents|respiratory system agents|mesh-ancestor
92017202|NCT03059017|Tocolytic Agents|tocolytic agents|mesh-ancestor
92017203|NCT03059017|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92093188|NCT04363450|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093189|NCT04363450|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093190|NCT04363450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093191|NCT03685149|Flecainide|flecainide|mesh-list
92093192|NCT03685149|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92093193|NCT03685149|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92093194|NCT03685149|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92093195|NCT03685149|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093196|NCT03685149|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093197|NCT04370080|Fluorides|fluorides|mesh-list
92093198|NCT04370080|Cariostatic Agents|cariostatic agents|mesh-ancestor
92093199|NCT04370080|Protective Agents|protective agents|mesh-ancestor
92093200|NCT04370080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093201|NCT01591616|Lidocaine|lidocaine|mesh-list
92093202|NCT01591616|Prilocaine|prilocaine|mesh-list
92093203|NCT01591616|Anesthetics, Local|anesthetics, local|mesh-ancestor
92093204|NCT01591616|Anesthetics|anesthetics|mesh-ancestor
92093205|NCT01591616|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093206|NCT01591616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093207|NCT01591616|Sensory System Agents|sensory system agents|mesh-ancestor
92093209|NCT01591616|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92093210|NCT01591616|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92093211|NCT01591616|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92093212|NCT01591616|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093213|NCT01591616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093214|NCT00938314|Epoetin Alfa|epoetin alfa|mesh-list
92093215|NCT00938314|Chorionic Gonadotropin|chorionic gonadotropin|mesh-list
92093216|NCT00938314|Hematinics|hematinics|mesh-ancestor
92093217|NCT00938314|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92093218|NCT00938314|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093219|NCT03587961|Ivacaftor|ivacaftor|mesh-list
92093220|NCT03587961|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92093221|NCT03587961|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093222|NCT03587961|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093223|NCT04370392|Anesthetics|anesthetics|mesh-list
92093224|NCT04370392|Anesthetics, Local|anesthetics, local|mesh-list
92093225|NCT04370392|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093227|NCT04370392|Sensory System Agents|sensory system agents|mesh-ancestor
92093228|NCT04370392|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093230|NCT04369222|Aspirin|aspirin|mesh-list
92093231|NCT04369222|Salicylic Acid|salicylic acid|mesh-list
92093232|NCT04369222|Salicylates|salicylates|mesh-list
92093233|NCT04369222|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-list
92093234|NCT04369222|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92093235|NCT04369222|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093236|NCT04369222|Analgesics|analgesics|mesh-ancestor
92093237|NCT04369222|Sensory System Agents|sensory system agents|mesh-ancestor
92093238|NCT04369222|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093239|NCT04369222|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093240|NCT04369222|Antipyretics|antipyretics|mesh-ancestor
92093241|NCT04369222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093242|NCT04369222|Antifungal Agents|antifungal agents|mesh-ancestor
92093243|NCT04369222|Keratolytic Agents|keratolytic agents|mesh-ancestor
92093244|NCT04369222|Dermatologic Agents|dermatologic agents|mesh-ancestor
92093245|NCT04369222|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093246|NCT04369222|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92093247|NCT04369222|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093248|NCT04369222|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093249|NCT04369222|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92093250|NCT04369222|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92093251|NCT04369222|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92093252|NCT03584373|Acetaminophen|acetaminophen|mesh-list
92017204|NCT03059017|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92017205|NCT03059017|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92017206|NCT03059017|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92017207|NCT03059017|Adrenergic Agents|adrenergic agents|mesh-ancestor
92093254|NCT03584373|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92093255|NCT03584373|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92093256|NCT03584373|Oxycodone|oxycodone|mesh-list
92093257|NCT03584373|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093258|NCT03584373|Analgesics|analgesics|mesh-ancestor
92093259|NCT03584373|Sensory System Agents|sensory system agents|mesh-ancestor
92093260|NCT03584373|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093261|NCT03584373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093262|NCT03584373|Antipyretics|antipyretics|mesh-ancestor
92093263|NCT03584373|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92093264|NCT03584373|Narcotics|narcotics|mesh-ancestor
92093265|NCT03584373|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093266|NCT03584373|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92093267|NCT03584373|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093268|NCT03584373|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093269|NCT03584373|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92093270|NCT03584373|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093271|NCT03584373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093272|NCT01591460|Ribavirin|ribavirin|mesh-list
92093273|NCT01591460|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92093274|NCT01591460|Interferon-alpha|interferon-alpha|mesh-list
92093275|NCT01591460|Antimetabolites|antimetabolites|mesh-ancestor
92093276|NCT01591460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093277|NCT01591460|Antiviral Agents|antiviral agents|mesh-ancestor
92093278|NCT01591460|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093279|NCT01591460|Immunologic Factors|immunologic factors|mesh-ancestor
92093280|NCT01591460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093281|NCT04363216|Ascorbic Acid|ascorbic acid|mesh-list
92093282|NCT04363216|Vitamins|vitamins|mesh-ancestor
92093283|NCT04363216|Micronutrients|micronutrients|mesh-ancestor
92093284|NCT04363216|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093285|NCT04363216|Antioxidants|antioxidants|mesh-ancestor
92093286|NCT04363216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093287|NCT04363216|Protective Agents|protective agents|mesh-ancestor
92093288|NCT03678675|Ketorolac|ketorolac|mesh-list
92093289|NCT03678675|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92093290|NCT03678675|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093291|NCT03678675|Analgesics|analgesics|mesh-ancestor
92093292|NCT03678675|Sensory System Agents|sensory system agents|mesh-ancestor
92093293|NCT03678675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093294|NCT03678675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093295|NCT03678675|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093296|NCT03678675|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093297|NCT03678675|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92093298|NCT03678675|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093299|NCT03678675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093302|NCT04363060|Clavulanic Acid|clavulanic acid|mesh-list
92093303|NCT04363060|Clavulanic Acids|clavulanic acids|mesh-list
92093304|NCT04363060|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92093305|NCT04363060|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92093306|NCT04363060|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093307|NCT04363060|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92093308|NCT04363060|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093309|NCT04363060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093310|NCT01591382|Ketamine|ketamine|mesh-list
92093311|NCT01591382|Hydromorphone|hydromorphone|mesh-list
92093312|NCT01591382|Analgesics|analgesics|mesh-ancestor
92093313|NCT01591382|Sensory System Agents|sensory system agents|mesh-ancestor
92093314|NCT01591382|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093315|NCT01591382|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093316|NCT01591382|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92093317|NCT01591382|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92093319|NCT01591382|Anesthetics|anesthetics|mesh-ancestor
92093320|NCT01591382|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017208|NCT03059017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017209|NCT03059017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093321|NCT01591382|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92093322|NCT01591382|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92093323|NCT01591382|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093324|NCT01591382|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093325|NCT01591382|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92093326|NCT01591382|Narcotics|narcotics|mesh-ancestor
92093327|NCT03677817|Lidocaine|lidocaine|mesh-list
92093328|NCT03677817|Anesthetics, Local|anesthetics, local|mesh-ancestor
92093329|NCT03677817|Anesthetics|anesthetics|mesh-ancestor
92093330|NCT03677817|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093331|NCT03677817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093332|NCT03677817|Sensory System Agents|sensory system agents|mesh-ancestor
92093333|NCT03677817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093334|NCT03677817|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92093335|NCT03677817|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92093336|NCT03677817|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92093337|NCT03677817|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093338|NCT03677817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093339|NCT00931996|Antipsychotic Agents|antipsychotic agents|mesh-list
92093340|NCT00931996|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92093341|NCT00931996|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093342|NCT00931996|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093343|NCT00931996|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92093344|NCT04348305|Hydrocortisone|hydrocortisone|mesh-list
92093345|NCT04348305|Hydrocortisone hemisuccinate|hydrocortisone hemisuccinate|mesh-list
92093346|NCT04348305|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093347|NCT00928174|Fluorides|fluorides|mesh-list
92093348|NCT00928174|Cariostatic Agents|cariostatic agents|mesh-ancestor
92093349|NCT00928174|Protective Agents|protective agents|mesh-ancestor
92093350|NCT00928174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093351|NCT01696214|Fluticasone|fluticasone|mesh-list
92093353|NCT01696214|Theophylline|theophylline|mesh-list
92093354|NCT01696214|Salmeterol Xinafoate|salmeterol xinafoate|mesh-list
92093355|NCT01696214|Ipratropium|ipratropium|mesh-list
92093356|NCT01696214|Fluticasone-Salmeterol Drug Combination|fluticasone-salmeterol drug combination|mesh-list
92093357|NCT01696214|Montelukast|montelukast|mesh-list
92093358|NCT01696214|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093359|NCT01696214|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92093360|NCT01696214|Autonomic Agents|autonomic agents|mesh-ancestor
92093361|NCT01696214|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093362|NCT01696214|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093363|NCT01696214|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92093364|NCT01696214|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093365|NCT01696214|Dermatologic Agents|dermatologic agents|mesh-ancestor
92093366|NCT01696214|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92093367|NCT01696214|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92093368|NCT01696214|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92093369|NCT01696214|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92093370|NCT01696214|Adrenergic Agents|adrenergic agents|mesh-ancestor
92093371|NCT01696214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093372|NCT01696214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093385|NCT01696214|Purinergic Agents|purinergic agents|mesh-ancestor
92093386|NCT01696214|Glucocorticoids|glucocorticoids|mesh-ancestor
92093387|NCT01696214|Hormones|hormones|mesh-ancestor
92093388|NCT01696214|Sympathomimetics|sympathomimetics|mesh-ancestor
92093389|NCT03794037|Montelukast|montelukast|mesh-list
92093390|NCT03794037|Progesterone|progesterone|mesh-list
92093391|NCT03794037|Progestins|progestins|mesh-ancestor
92093392|NCT03794037|Hormones|hormones|mesh-ancestor
92093393|NCT03794037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093394|NCT03794037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093395|NCT03794037|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92093396|NCT03794037|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093397|NCT03794037|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92093398|NCT03794037|Hormone Antagonists|hormone antagonists|mesh-ancestor
92093399|NCT03794037|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92093400|NCT03794037|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92017212|NCT04971577|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92017213|NCT04971577|Antimetabolites|antimetabolites|mesh-ancestor
92093401|NCT03794037|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093403|NCT04356508|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093404|NCT04356508|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093405|NCT04356508|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92093406|NCT04356508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093407|NCT04368598|Acetylcysteine|acetylcysteine|mesh-list
92093408|NCT04368598|Dexamethasone|dexamethasone|mesh-list
92093409|NCT04368598|Dexamethasone acetate|dexamethasone acetate|mesh-list
92093410|NCT04368598|BB 1101|bb 1101|mesh-list
92093411|NCT04368598|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92093412|NCT04368598|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093413|NCT04368598|Antiemetics|antiemetics|mesh-ancestor
92093414|NCT04368598|Autonomic Agents|autonomic agents|mesh-ancestor
92093415|NCT04368598|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093416|NCT04368598|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093417|NCT04368598|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92093418|NCT04368598|Glucocorticoids|glucocorticoids|mesh-ancestor
92093419|NCT04368598|Hormones|hormones|mesh-ancestor
92093420|NCT04368598|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093421|NCT04368598|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92093422|NCT04368598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093423|NCT04368598|Protease Inhibitors|protease inhibitors|mesh-ancestor
92093424|NCT04368598|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093425|NCT04368598|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093426|NCT04368598|Antiviral Agents|antiviral agents|mesh-ancestor
92093427|NCT04368598|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093428|NCT04368598|Expectorants|expectorants|mesh-ancestor
92093429|NCT04368598|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093430|NCT04368598|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92093431|NCT04368598|Antioxidants|antioxidants|mesh-ancestor
92093432|NCT04368598|Protective Agents|protective agents|mesh-ancestor
92093433|NCT04368598|Antidotes|antidotes|mesh-ancestor
92093434|NCT05347641|Cytarabine|cytarabine|mesh-list
92093446|NCT05347641|Dermatologic Agents|dermatologic agents|mesh-ancestor
92093447|NCT05347641|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093448|NCT05347641|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92093449|NCT05347641|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093450|NCT05347641|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92093451|NCT05347641|Antiviral Agents|antiviral agents|mesh-ancestor
92093452|NCT05347641|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093453|NCT01696058|Tiotropium Bromide|tiotropium bromide|mesh-list
92093454|NCT01696058|Olodaterol|olodaterol|mesh-list
92093455|NCT01696058|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92093456|NCT01696058|Autonomic Agents|autonomic agents|mesh-ancestor
92093457|NCT01696058|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093458|NCT01696058|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093459|NCT01696058|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92093460|NCT01696058|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093461|NCT01696058|Parasympatholytics|parasympatholytics|mesh-ancestor
92093462|NCT01696058|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92093463|NCT01696058|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093464|NCT01696058|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093465|NCT01696058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093466|NCT04368520|Vitamin D|vitamin d|mesh-list
92093467|NCT04368520|Ergocalciferols|ergocalciferols|mesh-list
92093468|NCT04368520|Cholecalciferol|cholecalciferol|mesh-list
92093469|NCT04368520|Vitamins|vitamins|mesh-list
92093470|NCT04368520|Micronutrients|micronutrients|mesh-ancestor
92093471|NCT04368520|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093472|NCT04368520|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92093473|NCT04368520|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92093474|NCT03790137|Fenfluramine|fenfluramine|mesh-list
92093475|NCT03790137|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92093476|NCT03790137|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92093477|NCT03790137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093478|NCT03790137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093479|NCT03790137|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093480|NCT03790137|Serotonin Agents|serotonin agents|mesh-ancestor
92093481|NCT03790137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017214|NCT04971577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017215|NCT04971577|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92017216|NCT04971577|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92093482|NCT01694420|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92093483|NCT01694420|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92093484|NCT01694420|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92093485|NCT01694420|Antiviral Agents|antiviral agents|mesh-ancestor
92093486|NCT01694420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093487|NCT03580317|Carbamazepine|carbamazepine|mesh-list
92093488|NCT03580317|Anticonvulsants|anticonvulsants|mesh-ancestor
92093489|NCT03580317|Antimanic Agents|antimanic agents|mesh-ancestor
92093490|NCT03580317|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92093491|NCT03580317|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093492|NCT03580317|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093493|NCT03580317|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92093494|NCT03580317|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093495|NCT03580317|Analgesics|analgesics|mesh-ancestor
92093499|NCT03580317|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093500|NCT03580317|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093501|NCT03580317|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92093502|NCT03580317|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92093503|NCT04362124|BCG Vaccine|bcg vaccine|mesh-list
92093504|NCT04362124|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92093505|NCT04362124|Immunologic Factors|immunologic factors|mesh-ancestor
92093506|NCT04362124|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093507|NCT04356118|Methotrexate|methotrexate|mesh-list
92093508|NCT04356118|Endostatins|endostatins|mesh-list
92093509|NCT04356118|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92093510|NCT04356118|Abortifacient Agents|abortifacient agents|mesh-ancestor
92093511|NCT04356118|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92093512|NCT04356118|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093513|NCT04356118|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92093514|NCT04356118|Antimetabolites|antimetabolites|mesh-ancestor
92093515|NCT04356118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093516|NCT04356118|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093517|NCT04356118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92093518|NCT04356118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093519|NCT04356118|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92093520|NCT04356118|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093521|NCT04356118|Immunologic Factors|immunologic factors|mesh-ancestor
92093522|NCT04356118|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093523|NCT04356118|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92093524|NCT04356118|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92093525|NCT04356118|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92093526|NCT04356118|Growth Substances|growth substances|mesh-ancestor
92093527|NCT04356118|Growth Inhibitors|growth inhibitors|mesh-ancestor
92093528|NCT04361734|Nitroglycerin|nitroglycerin|mesh-list
92093529|NCT04361734|Vasodilator Agents|vasodilator agents|mesh-ancestor
92093530|NCT04361812|Omalizumab|omalizumab|mesh-list
92093531|NCT04361812|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92093532|NCT04361812|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92093533|NCT04361812|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92093534|NCT04361812|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093535|NCT04361812|Immunologic Factors|immunologic factors|mesh-ancestor
92093536|NCT04361812|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093537|NCT04355962|Sevoflurane|sevoflurane|mesh-list
92093538|NCT04355962|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92093539|NCT04355962|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92093540|NCT04355962|Anesthetics, General|anesthetics, general|mesh-ancestor
92093541|NCT04355962|Anesthetics|anesthetics|mesh-ancestor
92093542|NCT04355962|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093543|NCT04355962|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093544|NCT00705081|Ezetimibe|ezetimibe|mesh-list
92093545|NCT00705081|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92093546|NCT00705081|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92093547|NCT00705081|Antimetabolites|antimetabolites|mesh-ancestor
92017218|NCT04425655|Fludarabine|fludarabine|mesh-list
92017219|NCT04425655|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017220|NCT04970719|Remdesivir|remdesivir|mesh-list
92093548|NCT00705081|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093549|NCT00705081|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92093550|NCT00704769|Desloratadine|desloratadine|mesh-list
92093551|NCT00704769|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92093552|NCT00704769|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093553|NCT00704769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093554|NCT00704769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093555|NCT00704769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093556|NCT00704769|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92093557|NCT00704769|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92093558|NCT00704769|Histamine Antagonists|histamine antagonists|mesh-ancestor
92093559|NCT00704769|Histamine Agents|histamine agents|mesh-ancestor
92093560|NCT00938548|Pregabalin|pregabalin|mesh-list
92093561|NCT00938548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093562|NCT00938548|Analgesics|analgesics|mesh-ancestor
92093563|NCT00938548|Sensory System Agents|sensory system agents|mesh-ancestor
92093564|NCT00938548|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093565|NCT00938548|Anticonvulsants|anticonvulsants|mesh-ancestor
92093566|NCT00938548|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92093579|NCT00932620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093580|NCT00932620|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92093581|NCT00932620|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92093582|NCT00932620|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093583|NCT04361188|Anesthetics|anesthetics|mesh-list
92093584|NCT04361188|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093585|NCT04361188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093586|NCT04367818|Anesthetics|anesthetics|mesh-list
92093587|NCT04367818|Anesthetics, Local|anesthetics, local|mesh-list
92093588|NCT04367818|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093589|NCT04367818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093590|NCT04367818|Sensory System Agents|sensory system agents|mesh-ancestor
92093591|NCT04367818|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093592|NCT01677273|Caseins|caseins|mesh-list
92093593|NCT01677273|Chelating Agents|chelating agents|mesh-ancestor
92093594|NCT01677273|Sequestering Agents|sequestering agents|mesh-ancestor
92093595|NCT01677273|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093596|NCT04355806|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92093597|NCT04355806|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92093598|NCT04355806|Vaccines|vaccines|mesh-list
92093599|NCT04355806|Antibodies|antibodies|mesh-list
92093600|NCT04355806|Immunoglobulins|immunoglobulins|mesh-list
92093601|NCT04355806|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92093602|NCT04355806|Immunologic Factors|immunologic factors|mesh-ancestor
92093603|NCT04355806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093604|NCT04355806|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093605|NCT04355806|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093606|NCT01677351|Clonidine|clonidine|mesh-list
92093607|NCT01677351|Analgesics|analgesics|mesh-ancestor
92093608|NCT01677351|Sensory System Agents|sensory system agents|mesh-ancestor
92093609|NCT01677351|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093610|NCT01677351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093611|NCT01677351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92093612|NCT01677351|Sympatholytics|sympatholytics|mesh-ancestor
92093613|NCT01677351|Autonomic Agents|autonomic agents|mesh-ancestor
92093614|NCT01677351|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92093615|NCT01677351|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92093617|NCT01677351|Adrenergic Agents|adrenergic agents|mesh-ancestor
92093618|NCT01677351|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093619|NCT01677351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093620|NCT00938704|Carboxymethylcellulose Sodium|carboxymethylcellulose sodium|mesh-list
92093621|NCT00938704|Hyaluronic Acid|hyaluronic acid|mesh-list
92093622|NCT00938704|Glycerol|glycerol|mesh-list
92093623|NCT00938704|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92093624|NCT00938704|Immunologic Factors|immunologic factors|mesh-ancestor
92093625|NCT00938704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093626|NCT00938704|Viscosupplements|viscosupplements|mesh-ancestor
92093627|NCT00938704|Protective Agents|protective agents|mesh-ancestor
92017221|NCT04970719|Dexamethasone|dexamethasone|mesh-list
92017222|NCT04970719|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-list
92017223|NCT04970719|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017224|NCT04970719|Antiemetics|antiemetics|mesh-ancestor
92017225|NCT04970719|Autonomic Agents|autonomic agents|mesh-ancestor
92093635|NCT03666351|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92093636|NCT03666351|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093637|NCT03666351|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093638|NCT03666351|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92093639|NCT03666351|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093640|NCT03666351|Vasodilator Agents|vasodilator agents|mesh-ancestor
92093641|NCT03666351|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92093642|NCT03666351|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92093643|NCT03666351|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92093644|NCT03666351|Diuretics|diuretics|mesh-ancestor
92093645|NCT03666351|Natriuretic Agents|natriuretic agents|mesh-ancestor
92093646|NCT03666351|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92093647|NCT00928642|Gemcitabine|gemcitabine|mesh-list
92093648|NCT00928642|Imatinib Mesylate|imatinib mesylate|mesh-list
92093649|NCT00928642|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92093650|NCT00928642|Antimetabolites|antimetabolites|mesh-ancestor
92093651|NCT00928642|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093652|NCT00928642|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093653|NCT00928642|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92093654|NCT00928642|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093655|NCT03663543|Estrogens|estrogens|mesh-list
92093656|NCT03663543|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92093657|NCT03663543|Hormones|hormones|mesh-ancestor
92093658|NCT03663543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093659|NCT03663543|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093660|NCT04361422|Isotretinoin|isotretinoin|mesh-list
92093661|NCT04361422|Dermatologic Agents|dermatologic agents|mesh-ancestor
92093662|NCT03579615|Insulin|insulin|mesh-list
92093663|NCT03579615|Insulin Aspart|insulin aspart|mesh-list
92093664|NCT03579615|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92093665|NCT03579615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093666|NCT03553875|Memantine|memantine|mesh-list
92093667|NCT03553875|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92093668|NCT03553875|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92093669|NCT03553875|Dopamine Agents|dopamine agents|mesh-ancestor
92093670|NCT03553875|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093671|NCT03553875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093672|NCT03553875|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093673|NCT03553875|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92093674|NCT03553875|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92093676|NCT04355416|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92093677|NCT04355416|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093678|NCT04355416|Analgesics|analgesics|mesh-ancestor
92093679|NCT04355416|Sensory System Agents|sensory system agents|mesh-ancestor
92093680|NCT04355416|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093681|NCT04355416|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093682|NCT04355416|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093683|NCT04355416|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093684|NCT04355416|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093685|NCT04355416|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093686|NCT04355416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093687|NCT03777813|Leucovorin|leucovorin|mesh-list
92093688|NCT03777813|Oxaliplatin|oxaliplatin|mesh-list
92093689|NCT03777813|Durvalumab|durvalumab|mesh-list
92093690|NCT03777813|Levoleucovorin|levoleucovorin|mesh-list
92093691|NCT03777813|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093692|NCT03777813|Antidotes|antidotes|mesh-ancestor
92093693|NCT03777813|Protective Agents|protective agents|mesh-ancestor
92093694|NCT03777813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093695|NCT03777813|Vitamin B Complex|vitamin b complex|mesh-ancestor
92093696|NCT03777813|Vitamins|vitamins|mesh-ancestor
92093697|NCT03777813|Micronutrients|micronutrients|mesh-ancestor
92093699|NCT04355494|Eculizumab|eculizumab|mesh-list
92093700|NCT04355494|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92093701|NCT04355494|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093702|NCT04355494|Immunologic Factors|immunologic factors|mesh-ancestor
92093703|NCT04355494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093704|NCT00934024|Varenicline|varenicline|mesh-list
92093705|NCT00934024|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92093706|NCT00934024|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92093707|NCT00934024|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093708|NCT00934024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093709|NCT00934024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093710|NCT00934024|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093711|NCT04361032|Deferoxamine|deferoxamine|mesh-list
92093712|NCT04361032|Siderophores|siderophores|mesh-ancestor
92093713|NCT04361032|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92093714|NCT04361032|Chelating Agents|chelating agents|mesh-ancestor
92093715|NCT04361032|Sequestering Agents|sequestering agents|mesh-ancestor
92093716|NCT04361032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093717|NCT00928954|Gabapentin|gabapentin|mesh-list
92093718|NCT00928954|Memantine|memantine|mesh-list
92093719|NCT00928954|Analgesics|analgesics|mesh-ancestor
92093720|NCT00928954|Sensory System Agents|sensory system agents|mesh-ancestor
92093721|NCT00928954|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093722|NCT00928954|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093723|NCT00928954|Anticonvulsants|anticonvulsants|mesh-ancestor
92093724|NCT00928954|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92093725|NCT00928954|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92093726|NCT00928954|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093727|NCT00928954|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92093728|NCT00928954|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92093729|NCT00928954|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92093730|NCT00928954|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093731|NCT00928954|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093732|NCT00928954|Antimanic Agents|antimanic agents|mesh-ancestor
92093733|NCT00928954|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92093734|NCT00928954|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92093735|NCT00928954|Dopamine Agents|dopamine agents|mesh-ancestor
92093736|NCT04355026|Hydroxychloroquine|hydroxychloroquine|mesh-list
92093737|NCT04355026|Bromhexine|bromhexine|mesh-list
92093738|NCT04355026|Antimalarials|antimalarials|mesh-ancestor
92093739|NCT04355026|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92093740|NCT04355026|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92093741|NCT04355026|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093742|NCT04355026|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093743|NCT04355026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093744|NCT04355026|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093745|NCT04355026|Expectorants|expectorants|mesh-ancestor
92093746|NCT04355026|Respiratory System Agents|respiratory system agents|mesh-ancestor
92093747|NCT03548571|Temozolomide|temozolomide|mesh-list
92093748|NCT03548571|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92093749|NCT03548571|Alkylating Agents|alkylating agents|mesh-ancestor
92093750|NCT03548571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093751|NCT03548571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093752|NCT00939562|Doxycycline|doxycycline|mesh-list
92093753|NCT00939562|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92093754|NCT00939562|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093755|NCT00939562|Antimalarials|antimalarials|mesh-ancestor
92093756|NCT00939562|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92093757|NCT00939562|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92093759|NCT04359862|Sevoflurane|sevoflurane|mesh-list
92093760|NCT04359862|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92093761|NCT04359862|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093762|NCT04359862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093763|NCT04359862|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92093764|NCT04359862|Anesthetics, General|anesthetics, general|mesh-ancestor
92093765|NCT04359862|Anesthetics|anesthetics|mesh-ancestor
92093766|NCT04359862|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92093767|NCT04359862|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92093768|NCT04366726|Abaloparatide|abaloparatide|mesh-list
92093769|NCT04366726|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92093770|NCT04366726|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093771|NCT04366960|Enoxaparin|enoxaparin|mesh-list
92093772|NCT04366960|Anticoagulants|anticoagulants|mesh-ancestor
92093773|NCT04366960|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92093791|NCT04360876|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017226|NCT04970719|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017227|NCT04970719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017228|NCT04970719|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017229|NCT04970719|Glucocorticoids|glucocorticoids|mesh-ancestor
92017230|NCT04970719|Hormones|hormones|mesh-ancestor
92093792|NCT04360876|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92093793|NCT04360876|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093794|NCT04359550|Antibodies|antibodies|mesh-list
92093795|NCT04359550|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92093796|NCT04359550|Immunologic Factors|immunologic factors|mesh-ancestor
92093797|NCT04359550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093798|NCT02084511|Celecoxib|celecoxib|mesh-list
92093799|NCT02084511|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92093800|NCT02084511|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093801|NCT02084511|Analgesics|analgesics|mesh-ancestor
92093802|NCT02084511|Sensory System Agents|sensory system agents|mesh-ancestor
92093803|NCT02084511|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093804|NCT02084511|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093805|NCT02084511|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093806|NCT02084511|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093807|NCT02084511|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92093808|NCT02084511|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92093809|NCT02084511|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093810|NCT02084511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093811|NCT00942448|Diclofenac|diclofenac|mesh-list
92093812|NCT00942448|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92093813|NCT00942448|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093814|NCT00942448|Analgesics|analgesics|mesh-ancestor
92093815|NCT00942448|Sensory System Agents|sensory system agents|mesh-ancestor
92093816|NCT00942448|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093817|NCT00942448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093818|NCT00942448|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093819|NCT00942448|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093820|NCT00942448|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92093821|NCT00942448|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093822|NCT00942448|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093823|NCT03532581|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92093824|NCT02982148|Methylene Blue|methylene blue|mesh-list
92093825|NCT02982148|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093826|NCT02982148|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093827|NCT04359316|Azithromycin|azithromycin|mesh-list
92093828|NCT04359316|Hydroxychloroquine|hydroxychloroquine|mesh-list
92093829|NCT04359316|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92093830|NCT04359316|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093852|NCT03557385|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093853|NCT03557385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093854|NCT03557385|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92093855|NCT03557385|Vasodilator Agents|vasodilator agents|mesh-ancestor
92093856|NCT03557385|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92093857|NCT03557385|Purinergic Agonists|purinergic agonists|mesh-ancestor
92093858|NCT03557385|Purinergic Agents|purinergic agents|mesh-ancestor
92093859|NCT03557385|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093860|NCT03557385|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093861|NCT04601350|Midazolam|midazolam|mesh-list
92093862|NCT04601350|Anesthetics|anesthetics|mesh-list
92093863|NCT04601350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093864|NCT04601350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093865|NCT04601350|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92093866|NCT04601350|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92093867|NCT04601350|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92093868|NCT04601350|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92093869|NCT04601350|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92093870|NCT04601350|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92093871|NCT04601350|Anesthetics, General|anesthetics, general|mesh-ancestor
92093872|NCT04601350|GABA Modulators|gaba modulators|mesh-ancestor
92093873|NCT04601350|GABA Agents|gaba agents|mesh-ancestor
92093874|NCT04601350|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017231|NCT04970719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017232|NCT04970719|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92093875|NCT04601350|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093876|NCT05346861|Trastuzumab|trastuzumab|mesh-list
92093877|NCT05346861|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093878|NCT05346861|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093879|NCT04358614|Ritonavir|ritonavir|mesh-list
92093880|NCT04358614|Lopinavir|lopinavir|mesh-list
92093881|NCT04358614|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92093882|NCT04358614|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92093883|NCT04358614|Protease Inhibitors|protease inhibitors|mesh-ancestor
92093884|NCT04358614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093885|NCT04358614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093899|NCT01670409|Immunologic Factors|immunologic factors|mesh-ancestor
92093900|NCT01670409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093901|NCT04761705|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92093902|NCT04761705|Latanoprost|latanoprost|mesh-list
92093903|NCT04761705|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92093904|NCT04358770|Clocortolone|clocortolone|mesh-list
92093905|NCT04358770|Fluocortolone|fluocortolone|mesh-list
92093906|NCT04358770|Clocortolone pivalate|clocortolone pivalate|mesh-list
92093907|NCT04358770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093908|NCT04358770|Glucocorticoids|glucocorticoids|mesh-ancestor
92093909|NCT04358770|Hormones|hormones|mesh-ancestor
92093910|NCT04358770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093911|NCT04358770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093912|NCT03516981|Pembrolizumab|pembrolizumab|mesh-list
92093913|NCT03516981|Lenvatinib|lenvatinib|mesh-list
92093914|NCT03516981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093915|NCT03516981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093916|NCT03516981|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92093917|NCT03516981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093918|NCT03516981|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92093919|NCT03516981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093920|NCT05618470|Botulinum Toxins|botulinum toxins|mesh-list
92093921|NCT05618470|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92093922|NCT05618470|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92093923|NCT05618470|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92093924|NCT05618470|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093925|NCT05618470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093926|NCT05618470|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093927|NCT05618470|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093928|NCT05618470|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093929|NCT05618470|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92093930|NCT05618470|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093931|NCT04358146|Locust bean gum|locust bean gum|mesh-list
92093932|NCT04358146|Antidiarrheals|antidiarrheals|mesh-ancestor
92093933|NCT04358146|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92093935|NCT05620498|Tislelizumab|tislelizumab|mesh-list
92093936|NCT05620498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093937|NCT05620498|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92093938|NCT05620498|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093939|NCT05620498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093940|NCT05620498|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093941|NCT01670565|Mycophenolic Acid|mycophenolic acid|mesh-list
92093942|NCT01670565|Belimumab|belimumab|mesh-list
92093943|NCT01670565|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92093944|NCT01670565|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093945|NCT01670565|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92093946|NCT01670565|Antitubercular Agents|antitubercular agents|mesh-ancestor
92093976|NCT04320940|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92093977|NCT04320940|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92093978|NCT04320940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093979|NCT04320940|GABA Modulators|gaba modulators|mesh-ancestor
92093980|NCT04320940|GABA Agents|gaba agents|mesh-ancestor
92093981|NCT04320940|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92093982|NCT04320940|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92093983|NCT04320940|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92093984|NCT03422523|Rituximab|rituximab|mesh-list
92093985|NCT03422523|Atezolizumab|atezolizumab|mesh-list
92017233|NCT04970719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017234|NCT04970719|Antimetabolites|antimetabolites|mesh-ancestor
92017235|NCT04970719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093986|NCT03422523|Gemcitabine|gemcitabine|mesh-list
92093987|NCT03422523|Oxaliplatin|oxaliplatin|mesh-list
92093988|NCT03422523|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093989|NCT03422523|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093996|NCT03422523|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92093998|NCT03032536|Entecavir|entecavir|mesh-list
92093999|NCT03032536|Antiviral Agents|antiviral agents|mesh-ancestor
92094000|NCT03032536|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094001|NCT03032536|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92094002|NCT03032536|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92094003|NCT03032536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094004|NCT03032536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094005|NCT03032536|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92094006|NCT03032536|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92094007|NCT03420963|Cyclophosphamide|cyclophosphamide|mesh-list
92094008|NCT03420963|Etoposide|etoposide|mesh-list
92094009|NCT03420963|Etoposide phosphate|etoposide phosphate|mesh-list
92094010|NCT03420963|Podophyllotoxin|podophyllotoxin|mesh-list
92094011|NCT03420963|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094012|NCT03420963|Immunologic Factors|immunologic factors|mesh-ancestor
92094013|NCT03420963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094014|NCT03420963|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094015|NCT03420963|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92094016|NCT03420963|Alkylating Agents|alkylating agents|mesh-ancestor
92094017|NCT03420963|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094018|NCT03420963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094019|NCT03420963|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92094020|NCT03420963|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92094021|NCT03420963|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92094022|NCT03420963|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92094023|NCT03420963|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094024|NCT03420963|Keratolytic Agents|keratolytic agents|mesh-ancestor
92094025|NCT03420963|Dermatologic Agents|dermatologic agents|mesh-ancestor
92094026|NCT03420963|Tubulin Modulators|tubulin modulators|mesh-ancestor
92094027|NCT03420963|Antimitotic Agents|antimitotic agents|mesh-ancestor
92094028|NCT03420963|Mitosis Modulators|mitosis modulators|mesh-ancestor
92094029|NCT03032614|Carboplatin|carboplatin|mesh-list
92094030|NCT03032614|Veliparib|veliparib|mesh-list
92094031|NCT03032614|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094032|NCT03032614|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92094033|NCT03032614|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094034|NCT03032614|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094035|NCT03032458|Ketorolac|ketorolac|mesh-list
92094036|NCT03032458|Lidocaine|lidocaine|mesh-list
92094037|NCT03032458|Meperidine|meperidine|mesh-list
92094038|NCT03032458|Anesthetics, Local|anesthetics, local|mesh-ancestor
92094039|NCT03032458|Anesthetics|anesthetics|mesh-ancestor
92094040|NCT03032458|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094041|NCT03032458|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094042|NCT03032458|Sensory System Agents|sensory system agents|mesh-ancestor
92094043|NCT03032458|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094044|NCT03032458|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92094045|NCT03032458|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92094046|NCT03032458|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92094047|NCT03032458|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094048|NCT03032458|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094049|NCT03032458|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92094050|NCT03032458|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92094051|NCT03032458|Analgesics|analgesics|mesh-ancestor
92094052|NCT03032458|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094053|NCT03032458|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094054|NCT03032458|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92094055|NCT03032458|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094058|NCT03032458|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92094060|NCT02245438|Tipranavir|tipranavir|mesh-list
92094061|NCT02245438|Ethinyl Estradiol|ethinyl estradiol|mesh-list
92094062|NCT02245438|Norethindrone|norethindrone|mesh-list
92094063|NCT02245438|Norethindrone Acetate|norethindrone acetate|mesh-list
92094064|NCT02245438|Norinyl|norinyl|mesh-list
92017236|NCT04970719|Antiviral Agents|antiviral agents|mesh-ancestor
92017237|NCT04970719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017238|NCT04970719|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017239|NCT04970719|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017240|NCT02466399|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92017241|NCT02466399|Latanoprost|latanoprost|mesh-list
92094065|NCT02245438|Estradiol|estradiol|mesh-list
92094066|NCT02245438|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92094067|NCT02245438|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92094068|NCT02245438|Protease Inhibitors|protease inhibitors|mesh-ancestor
92094069|NCT02245438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094070|NCT02245438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094072|NCT02245438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92094073|NCT02245438|Antiviral Agents|antiviral agents|mesh-ancestor
92094074|NCT02245438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094075|NCT02245438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92094076|NCT02245438|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92094077|NCT02245438|Estrogens|estrogens|mesh-ancestor
92094078|NCT02245438|Hormones|hormones|mesh-ancestor
92094079|NCT02245438|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094080|NCT02245438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094081|NCT02245438|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92094082|NCT02245438|Contraceptive Agents|contraceptive agents|mesh-ancestor
92094083|NCT02245438|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92094084|NCT02245438|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92094085|NCT02245438|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92094086|NCT02245438|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92094087|NCT02245438|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92094088|NCT02245438|Contraceptives, Oral, Combined|contraceptives, oral, combined|mesh-ancestor
92094089|NCT03087669|Norepinephrine|norepinephrine|mesh-list
92094090|NCT03087669|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92094091|NCT03087669|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92094092|NCT03087669|Adrenergic Agents|adrenergic agents|mesh-ancestor
92094093|NCT03087669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094094|NCT03087669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094095|NCT03087669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094096|NCT03087669|Sympathomimetics|sympathomimetics|mesh-ancestor
92094097|NCT03087669|Autonomic Agents|autonomic agents|mesh-ancestor
92094098|NCT03087669|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094099|NCT03087669|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92094100|NCT00939952|Ertapenem|ertapenem|mesh-list
92094101|NCT00939952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094102|NCT00939952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094103|NCT02401815|Sunitinib|sunitinib|mesh-list
92094104|NCT02401815|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094105|NCT02401815|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92094106|NCT02401815|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92094107|NCT02401815|Growth Substances|growth substances|mesh-ancestor
92094108|NCT02401815|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094109|NCT02401815|Growth Inhibitors|growth inhibitors|mesh-ancestor
92094110|NCT02401815|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92094111|NCT02401815|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094112|NCT02401815|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094113|NCT00947752|Glatiramer Acetate|glatiramer acetate|mesh-list
92094114|NCT00947752|(T,G)-A-L|(t,g)-a-l|mesh-list
92094115|NCT00947752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92094116|NCT00947752|Immunologic Factors|immunologic factors|mesh-ancestor
92094117|NCT00947752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094118|NCT00947752|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094119|NCT00947752|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094120|NCT03456687|Exenatide|exenatide|mesh-list
92094121|NCT03456687|Glucagon|glucagon|mesh-list
92094122|NCT03456687|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92094123|NCT03456687|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92094124|NCT03456687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094125|NCT03456687|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92094126|NCT03456687|Incretins|incretins|mesh-ancestor
92094127|NCT03456687|Hormones|hormones|mesh-ancestor
92094128|NCT03456687|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017242|NCT02466399|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92017243|NCT03059251|Obinutuzumab|obinutuzumab|mesh-list
92017244|NCT03059251|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017245|NCT03059251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017246|NCT04970251|Aflibercept|aflibercept|mesh-list
92094129|NCT03456687|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094131|NCT00948298|Vitamins|vitamins|mesh-ancestor
92094161|NCT00944710|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92094162|NCT00944710|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92094164|NCT00944710|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094165|NCT00944710|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094166|NCT00944710|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92094167|NCT00944710|Respiratory System Agents|respiratory system agents|mesh-ancestor
92094168|NCT00944710|Mydriatics|mydriatics|mesh-ancestor
92094169|NCT00944710|Parasympatholytics|parasympatholytics|mesh-ancestor
92094170|NCT00944710|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92094171|NCT00944710|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92094172|NCT00944710|Cholinergic Agents|cholinergic agents|mesh-ancestor
92094173|NCT00944710|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094174|NCT00944710|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094175|NCT00949078|Omalizumab|omalizumab|mesh-list
92094176|NCT00949078|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92094177|NCT00949078|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92094203|NCT03031444|Antidotes|antidotes|mesh-ancestor
92094204|NCT03031444|Protective Agents|protective agents|mesh-ancestor
92094205|NCT03031444|Vitamin B Complex|vitamin b complex|mesh-ancestor
92094206|NCT03031444|Vitamins|vitamins|mesh-ancestor
92094207|NCT03031444|Micronutrients|micronutrients|mesh-ancestor
92094208|NCT03031054|Hyaluronic Acid|hyaluronic acid|mesh-list
92094209|NCT03031054|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92094210|NCT03031054|Immunologic Factors|immunologic factors|mesh-ancestor
92094211|NCT03031054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094212|NCT03031054|Viscosupplements|viscosupplements|mesh-ancestor
92094213|NCT03031054|Protective Agents|protective agents|mesh-ancestor
92094214|NCT00945334|Rifaximin|rifaximin|mesh-list
92094215|NCT00945334|Neomycin|neomycin|mesh-list
92094216|NCT00945334|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094217|NCT00945334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094218|NCT00945334|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094219|NCT00945334|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92094220|NCT00945334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094221|NCT00945334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094222|NCT03559114|Dalteparin|dalteparin|mesh-list
92094223|NCT03559114|Tinzaparin|tinzaparin|mesh-list
92094224|NCT03559114|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92094225|NCT03559114|Anticoagulants|anticoagulants|mesh-ancestor
92094226|NCT03559114|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92094227|NCT03559114|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92094228|NCT03559114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094236|NCT03490864|Antioxidants|antioxidants|mesh-ancestor
92094237|NCT03490864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094238|NCT03490864|Protective Agents|protective agents|mesh-ancestor
92094239|NCT03490864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094240|NCT03490864|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094241|NCT04402203|Favipiravir|favipiravir|mesh-list
92094242|NCT04402203|Antiviral Agents|antiviral agents|mesh-ancestor
92094243|NCT04402203|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094244|NCT03030976|Cyclophosphamide|cyclophosphamide|mesh-list
92094245|NCT03030976|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094246|NCT03030976|Immunologic Factors|immunologic factors|mesh-ancestor
92094247|NCT03030976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094248|NCT03030976|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094249|NCT03030976|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92094250|NCT03030976|Alkylating Agents|alkylating agents|mesh-ancestor
92094251|NCT03030976|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094252|NCT03030976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094253|NCT03030976|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92094254|NCT00949234|Ritonavir|ritonavir|mesh-list
92094255|NCT00949234|Lopinavir|lopinavir|mesh-list
92094256|NCT00949234|Tenofovir|tenofovir|mesh-list
92094257|NCT00949234|Emtricitabine|emtricitabine|mesh-list
92094258|NCT00949234|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92017247|NCT04970251|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92017248|NCT04970251|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92094259|NCT00949234|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92094260|NCT00949234|Protease Inhibitors|protease inhibitors|mesh-ancestor
92094261|NCT00949234|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094262|NCT00949234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094263|NCT00949234|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92094264|NCT00949234|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92094265|NCT00949234|Antiviral Agents|antiviral agents|mesh-ancestor
92094266|NCT00949234|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094267|NCT00949234|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92094268|NCT00949234|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92094269|NCT00949234|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92094270|NCT00949234|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92094272|NCT03090880|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92094273|NCT03090880|Dalteparin|dalteparin|mesh-list
92094274|NCT03090880|Anticoagulants|anticoagulants|mesh-ancestor
92094275|NCT03090880|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92094276|NCT03090880|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92094277|NCT03090880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094278|NCT05097976|Methylprednisolone|methylprednisolone|mesh-list
92094279|NCT05097976|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92094280|NCT05097976|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92094281|NCT05097976|Prednisolone|prednisolone|mesh-list
92094282|NCT05097976|Prednisolone acetate|prednisolone acetate|mesh-list
92094283|NCT05097976|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92094284|NCT05097976|Prednisolone phosphate|prednisolone phosphate|mesh-list
92094285|NCT05097976|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094286|NCT05097976|Antiemetics|antiemetics|mesh-ancestor
92094287|NCT05097976|Autonomic Agents|autonomic agents|mesh-ancestor
92094288|NCT05097976|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094289|NCT05097976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094290|NCT05097976|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094291|NCT05097976|Glucocorticoids|glucocorticoids|mesh-ancestor
92094292|NCT05097976|Hormones|hormones|mesh-ancestor
92094293|NCT05097976|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094294|NCT05097976|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92094295|NCT05097976|Protective Agents|protective agents|mesh-ancestor
92094296|NCT05097976|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92094297|NCT05097976|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094332|NCT04984330|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094333|NCT04984330|Glucocorticoids|glucocorticoids|mesh-ancestor
92094335|NCT04984330|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094336|NCT04984330|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92094337|NCT04984330|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094338|NCT03030196|Denosumab|denosumab|mesh-list
92094342|NCT00265798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094343|NCT00265798|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92094344|NCT00265798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094345|NCT00265798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094346|NCT03035578|Morphine|morphine|mesh-list
92094347|NCT03035578|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92094348|NCT03035578|Narcotics|narcotics|mesh-ancestor
92094349|NCT03035578|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094350|NCT03035578|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094351|NCT03035578|Analgesics|analgesics|mesh-ancestor
92094352|NCT03035578|Sensory System Agents|sensory system agents|mesh-ancestor
92094353|NCT03035578|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094354|NCT04933942|Lomustine|lomustine|mesh-list
92094355|NCT04933942|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92094356|NCT04933942|Alkylating Agents|alkylating agents|mesh-ancestor
92094357|NCT04933942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094358|NCT04933942|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094359|NCT00089583|Ritonavir|ritonavir|mesh-list
92094360|NCT00089583|Fosamprenavir|fosamprenavir|mesh-list
92094361|NCT00089583|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92094362|NCT00089583|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92094363|NCT00089583|Protease Inhibitors|protease inhibitors|mesh-ancestor
92094364|NCT00089583|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017249|NCT04970251|Growth Substances|growth substances|mesh-ancestor
92017250|NCT04970251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017251|NCT04970251|Growth Inhibitors|growth inhibitors|mesh-ancestor
92017252|NCT04970251|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017253|NCT04970329|Dextrans|dextrans|mesh-list
92094365|NCT00089583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094366|NCT00089583|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92094367|NCT00089583|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92094368|NCT00089583|Antiviral Agents|antiviral agents|mesh-ancestor
92094369|NCT00089583|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094370|NCT00089583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92094371|NCT00089583|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92094372|NCT03029494|Ascorbic Acid|ascorbic acid|mesh-list
92094373|NCT03029494|Vitamins|vitamins|mesh-ancestor
92094374|NCT03029494|Micronutrients|micronutrients|mesh-ancestor
92094375|NCT03029494|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094376|NCT03029494|Antioxidants|antioxidants|mesh-ancestor
92094377|NCT03029494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094378|NCT03029494|Protective Agents|protective agents|mesh-ancestor
92094379|NCT04402047|Diclofenac|diclofenac|mesh-list
92094380|NCT04402047|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92094381|NCT04402047|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92094382|NCT04402047|Analgesics|analgesics|mesh-ancestor
92094383|NCT04402047|Sensory System Agents|sensory system agents|mesh-ancestor
92094384|NCT04402047|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094385|NCT04402047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094386|NCT04402047|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094387|NCT04402047|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094388|NCT04402047|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92094389|NCT04402047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094390|NCT04402047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094391|NCT03017248|Ketamine|ketamine|mesh-list
92094392|NCT03017248|Morphine|morphine|mesh-list
92094393|NCT03017248|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92094394|NCT03017248|Analgesics|analgesics|mesh-ancestor
92094395|NCT03017248|Sensory System Agents|sensory system agents|mesh-ancestor
92094396|NCT03017248|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094397|NCT03017248|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094398|NCT03017248|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92094399|NCT03017248|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92094400|NCT03017248|Anesthetics, General|anesthetics, general|mesh-ancestor
92094401|NCT03017248|Anesthetics|anesthetics|mesh-ancestor
92094402|NCT03017248|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094403|NCT03017248|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92094404|NCT03017248|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92094405|NCT03017248|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094406|NCT03017248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094407|NCT03017248|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92094408|NCT03017248|Narcotics|narcotics|mesh-ancestor
92094409|NCT00088881|Prednisone|prednisone|mesh-list
92094410|NCT00088881|Cyclophosphamide|cyclophosphamide|mesh-list
92094413|NCT00088881|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92094414|NCT00088881|Vincristine|vincristine|mesh-list
92094415|NCT00088881|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094416|NCT00088881|Immunologic Factors|immunologic factors|mesh-ancestor
92094417|NCT00088881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094418|NCT00088881|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094419|NCT00088881|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92094420|NCT00088881|Alkylating Agents|alkylating agents|mesh-ancestor
92094421|NCT00088881|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094422|NCT00088881|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094423|NCT00088881|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92094424|NCT00088881|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094425|NCT00088881|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92094426|NCT00088881|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92094427|NCT00088881|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92094428|NCT00088881|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094429|NCT00088881|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094430|NCT00088881|Glucocorticoids|glucocorticoids|mesh-ancestor
92094431|NCT00088881|Hormones|hormones|mesh-ancestor
92017254|NCT04970329|Anticoagulants|anticoagulants|mesh-ancestor
92017255|NCT04970329|Plasma Substitutes|plasma substitutes|mesh-ancestor
92017256|NCT04970329|Blood Substitutes|blood substitutes|mesh-ancestor
92017257|NCT04960657|Glyburide|glyburide|mesh-list
92094432|NCT00088881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094433|NCT00088881|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92094434|NCT00088881|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92094435|NCT00088881|Tubulin Modulators|tubulin modulators|mesh-ancestor
92094436|NCT00088881|Antimitotic Agents|antimitotic agents|mesh-ancestor
92094437|NCT00088881|Mitosis Modulators|mitosis modulators|mesh-ancestor
92094438|NCT02981914|Pembrolizumab|pembrolizumab|mesh-list
92094439|NCT02981914|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094440|NCT02981914|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094441|NCT02981914|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92094442|NCT02981914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094443|NCT03025750|Vaccines|vaccines|mesh-list
92094444|NCT03025750|Immunologic Factors|immunologic factors|mesh-ancestor
92094445|NCT03025750|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094446|NCT03017404|Cyclophosphamide|cyclophosphamide|mesh-list
92094447|NCT03017404|Docetaxel|docetaxel|mesh-list
92094448|NCT03017404|Doxorubicin|doxorubicin|mesh-list
92094449|NCT03017404|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92094450|NCT03017404|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094451|NCT03017404|Immunologic Factors|immunologic factors|mesh-ancestor
92094452|NCT03017404|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094453|NCT03017404|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094454|NCT03017404|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92094455|NCT03017404|Alkylating Agents|alkylating agents|mesh-ancestor
92094456|NCT03017404|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094457|NCT03017404|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094458|NCT03017404|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92094459|NCT03017404|Tubulin Modulators|tubulin modulators|mesh-ancestor
92094460|NCT03017404|Antimitotic Agents|antimitotic agents|mesh-ancestor
92094461|NCT03017404|Mitosis Modulators|mitosis modulators|mesh-ancestor
92094462|NCT03017404|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92094463|NCT03017404|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92094464|NCT03017404|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92094465|NCT03017404|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094466|NCT00953212|Ascorbic Acid|ascorbic acid|mesh-list
92094467|NCT00953212|Amiodarone|amiodarone|mesh-list
92094468|NCT00953212|Metoprolol|metoprolol|mesh-list
92094469|NCT00953212|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-list
92094470|NCT00953212|Vitamins|vitamins|mesh-ancestor
92094471|NCT00953212|Micronutrients|micronutrients|mesh-ancestor
92094472|NCT00953212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094473|NCT00953212|Antioxidants|antioxidants|mesh-ancestor
92094474|NCT00953212|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094475|NCT00953212|Protective Agents|protective agents|mesh-ancestor
92094476|NCT00953212|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92094477|NCT00953212|Adrenergic Agents|adrenergic agents|mesh-ancestor
92094478|NCT00953212|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094479|NCT00953212|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92094480|NCT00953212|Vasodilator Agents|vasodilator agents|mesh-ancestor
92094481|NCT00953212|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92094482|NCT00953212|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094483|NCT00953212|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92094492|NCT00953212|Autonomic Agents|autonomic agents|mesh-ancestor
92094493|NCT00953212|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094494|NCT00953212|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92094497|NCT03034408|Nalmefene|nalmefene|mesh-list
92094498|NCT03034408|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92094499|NCT03034408|Diuretics|diuretics|mesh-ancestor
92094500|NCT03034408|Natriuretic Agents|natriuretic agents|mesh-ancestor
92094501|NCT03034408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094502|NCT03034408|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92094503|NCT03034408|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92094504|NCT03034408|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094505|NCT03034408|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92094506|NCT03034408|GABA Agonists|gaba agonists|mesh-ancestor
92094507|NCT03034408|GABA Agents|gaba agents|mesh-ancestor
92094508|NCT03034408|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017258|NCT04960657|Pituitary Adenylate Cyclase-Activating Polypeptide|pituitary adenylate cyclase-activating polypeptide|mesh-list
92017259|NCT04960657|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92017260|NCT04960657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017261|NCT04960657|Growth Substances|growth substances|mesh-ancestor
92017262|NCT04960657|Vasodilator Agents|vasodilator agents|mesh-ancestor
92017263|NCT04960657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017264|NCT04960657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017265|NCT02464059|Vitamin D|vitamin d|mesh-list
92017266|NCT02464059|Cholecalciferol|cholecalciferol|mesh-list
92017267|NCT02464059|Vitamins|vitamins|mesh-ancestor
92017268|NCT02464059|Micronutrients|micronutrients|mesh-ancestor
92017269|NCT02464059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017270|NCT02464059|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92017271|NCT02464059|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92017272|NCT02463357|Metformin|metformin|mesh-list
92094509|NCT03034408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094510|NCT03034408|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92094511|NCT03034408|Sensory System Agents|sensory system agents|mesh-ancestor
92094512|NCT03023020|Aspirin|aspirin|mesh-list
92094513|NCT03023020|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92094514|NCT03023020|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92094515|NCT03023020|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92094516|NCT03023020|Analgesics|analgesics|mesh-ancestor
92094517|NCT03023020|Sensory System Agents|sensory system agents|mesh-ancestor
92094518|NCT03023020|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094519|NCT03023020|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094520|NCT03023020|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094521|NCT03023020|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094522|NCT03023020|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92094523|NCT03023020|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92094524|NCT03023020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094525|NCT03023020|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92094526|NCT03023020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094528|NCT00087555|Sodium Oxybate|sodium oxybate|mesh-list
92094529|NCT00087555|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92094530|NCT00087555|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92094531|NCT00087555|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92094532|NCT00087555|Anesthetics, General|anesthetics, general|mesh-ancestor
92094533|NCT00087555|Anesthetics|anesthetics|mesh-ancestor
92094534|NCT00087555|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094535|NCT00087555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094536|NCT03022318|Levodopa|levodopa|mesh-list
92094537|NCT03022318|Carbidopa|carbidopa|mesh-list
92094538|NCT03022318|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92094539|NCT03022318|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92094540|NCT03022318|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92094541|NCT03022318|Dopamine Agents|dopamine agents|mesh-ancestor
92094542|NCT03022318|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094543|NCT03022318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094544|NCT03022318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094545|NCT03022318|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92094546|NCT03022318|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094547|NCT03022318|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92094548|NCT03022318|Immunologic Factors|immunologic factors|mesh-ancestor
92094563|NCT00086619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094564|NCT00086619|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92094565|NCT00085917|Interferons|interferons|mesh-list
92017274|NCT02463357|Methazolamide|methazolamide|mesh-list
92017275|NCT02463357|Quercetin|quercetin|mesh-list
92094566|NCT00085917|Ribavirin|ribavirin|mesh-list
92094567|NCT00085917|Interferon-alpha|interferon-alpha|mesh-list
92094568|NCT00085917|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92094569|NCT00085917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094570|NCT00085917|Antiviral Agents|antiviral agents|mesh-ancestor
92094571|NCT00085917|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094572|NCT00085917|Antimetabolites|antimetabolites|mesh-ancestor
92094573|NCT00085917|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094574|NCT00085917|Immunologic Factors|immunologic factors|mesh-ancestor
92094575|NCT00085917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094576|NCT00084747|Bortezomib|bortezomib|mesh-list
92094577|NCT00084747|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094578|NCT04402671|Glutaral|glutaral|mesh-list
92094579|NCT04402671|Disinfectants|disinfectants|mesh-ancestor
92094580|NCT04402671|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094581|NCT01678287|Ipragliflozin|ipragliflozin|mesh-list
92094582|NCT01678287|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92094583|NCT01678287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094584|NCT01678287|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92094585|NCT01678287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094586|NCT01678365|Metronidazole|metronidazole|mesh-list
92094587|NCT01678365|Gentamicins|gentamicins|mesh-list
92094588|NCT01678365|Ceftriaxone|ceftriaxone|mesh-list
92094589|NCT01678365|Ampicillin|ampicillin|mesh-list
92094590|NCT01678365|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094591|NCT01678365|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094592|NCT01678365|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92094593|NCT01678365|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92094594|NCT01678365|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92094595|NCT01678365|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094596|NCT01678365|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094597|NCT00946270|Thalidomide|thalidomide|mesh-list
92094598|NCT00946270|Prednisone|prednisone|mesh-list
92094599|NCT00946270|Pomalidomide|pomalidomide|mesh-list
92094600|NCT00946270|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094601|NCT00946270|Glucocorticoids|glucocorticoids|mesh-ancestor
92094602|NCT00946270|Hormones|hormones|mesh-ancestor
92094603|NCT00946270|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094604|NCT00946270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094605|NCT00946270|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92094606|NCT00946270|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094607|NCT00946270|Immunologic Factors|immunologic factors|mesh-ancestor
92094608|NCT00946270|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92094609|NCT00946270|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92094610|NCT00946270|Growth Substances|growth substances|mesh-ancestor
92094611|NCT00946270|Growth Inhibitors|growth inhibitors|mesh-ancestor
92094614|NCT00946270|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094615|NCT00946270|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094616|NCT03021616|Moxifloxacin|moxifloxacin|mesh-list
92094617|NCT03021616|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094618|NCT03021616|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094619|NCT03021616|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92094620|NCT03021616|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92094621|NCT03021616|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094622|NCT03021616|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094623|NCT03021616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094624|NCT03021694|Caseins|caseins|mesh-list
92094625|NCT03021694|Chelating Agents|chelating agents|mesh-ancestor
92094626|NCT03021694|Sequestering Agents|sequestering agents|mesh-ancestor
92094627|NCT03021694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094628|NCT00956254|Fentanyl|fentanyl|mesh-list
92094629|NCT00956254|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92094630|NCT00956254|Narcotics|narcotics|mesh-ancestor
92094631|NCT00956254|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094632|NCT00956254|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094633|NCT00956254|Analgesics|analgesics|mesh-ancestor
92094634|NCT00956254|Sensory System Agents|sensory system agents|mesh-ancestor
92094635|NCT00956254|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094636|NCT00956254|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92094637|NCT00956254|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92094638|NCT00956254|Anesthetics, General|anesthetics, general|mesh-ancestor
92094639|NCT00956254|Anesthetics|anesthetics|mesh-ancestor
92017276|NCT02463357|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92017277|NCT02463357|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017278|NCT02463357|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92017279|NCT02463357|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017280|NCT02463357|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017281|NCT02463357|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92094641|NCT03020680|Coenzyme Q10|coenzyme q10|mesh-list
92094642|NCT03020680|Micronutrients|micronutrients|mesh-ancestor
92094643|NCT03020680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094644|NCT03020680|Vitamins|vitamins|mesh-ancestor
92094645|NCT01678599|Benzonidazole|benzonidazole|mesh-list
92094646|NCT01678599|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094647|NCT01678599|Immunologic Factors|immunologic factors|mesh-ancestor
92094648|NCT01678599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094649|NCT01678599|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92094650|NCT01678599|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92094651|NCT01678599|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92094652|NCT01678599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094653|NCT03019822|Amphetamine|amphetamine|mesh-list
92094654|NCT03019822|Dextroamphetamine|dextroamphetamine|mesh-list
92094655|NCT03019822|N-Methyl-3,4-methylenedioxyamphetamine|n-methyl-3,4-methylenedioxyamphetamine|mesh-list
92094656|NCT03019822|Lysergic Acid Diethylamide|lysergic acid diethylamide|mesh-list
92094657|NCT03019822|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92094658|NCT03019822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094659|NCT03019822|Sympathomimetics|sympathomimetics|mesh-ancestor
92094660|NCT03019822|Autonomic Agents|autonomic agents|mesh-ancestor
92094661|NCT03019822|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094662|NCT03019822|Dopamine Agents|dopamine agents|mesh-ancestor
92094663|NCT03019822|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094664|NCT03019822|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094665|NCT03019822|Adrenergic Agents|adrenergic agents|mesh-ancestor
92094666|NCT03019822|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92094667|NCT03019822|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92094668|NCT03019822|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094669|NCT03019822|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92094670|NCT03019822|Hallucinogens|hallucinogens|mesh-ancestor
92094671|NCT03019822|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92094672|NCT03019822|Serotonin Agents|serotonin agents|mesh-ancestor
92094673|NCT03019822|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92094674|NCT03019822|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92094675|NCT01678677|Vaccines|vaccines|mesh-list
92094676|NCT01678677|Immunologic Factors|immunologic factors|mesh-ancestor
92094677|NCT01678677|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094678|NCT00946348|Dronabinol|dronabinol|mesh-list
92094679|NCT00946348|Hallucinogens|hallucinogens|mesh-ancestor
92094680|NCT00946348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094681|NCT00946348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92094682|NCT00946348|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92094683|NCT00946348|Analgesics|analgesics|mesh-ancestor
92094684|NCT00946348|Sensory System Agents|sensory system agents|mesh-ancestor
92094685|NCT00946348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094687|NCT00946348|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92094688|NCT00946348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094689|NCT00946348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094690|NCT00946348|Hormones|hormones|mesh-ancestor
92094691|NCT00946348|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094692|NCT00081159|Zoledronic Acid|zoledronic acid|mesh-list
92094693|NCT00081159|Doxorubicin|doxorubicin|mesh-list
92094694|NCT00081159|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92094695|NCT00081159|Leuprolide|leuprolide|mesh-list
92094696|NCT00081159|Goserelin|goserelin|mesh-list
92094697|NCT00081159|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92094698|NCT00081159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094699|NCT00081159|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92094700|NCT00081159|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92094701|NCT00081159|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017282|NCT02463357|Vasodilator Agents|vasodilator agents|mesh-ancestor
92017283|NCT02463357|Tocolytic Agents|tocolytic agents|mesh-ancestor
92017284|NCT02463357|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92017285|NCT02463357|Antioxidants|antioxidants|mesh-ancestor
92094702|NCT00081159|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094703|NCT00081159|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92094704|NCT00081159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094705|NCT00081159|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92094706|NCT00081159|Fertility Agents|fertility agents|mesh-ancestor
92094707|NCT00081159|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92094708|NCT00081159|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92094709|NCT03033472|Clindamycin|clindamycin|mesh-list
92094710|NCT03033472|Clindamycin palmitate|clindamycin palmitate|mesh-list
92094711|NCT03033472|Clindamycin phosphate|clindamycin phosphate|mesh-list
92094712|NCT03033472|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094713|NCT03033472|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094714|NCT03033472|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92094715|NCT03033472|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094716|NCT03033472|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094717|NCT02981836|Vaccines|vaccines|mesh-list
92094718|NCT02981836|Immunologic Factors|immunologic factors|mesh-ancestor
92094719|NCT02981836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094720|NCT03033160|Estradiol|estradiol|mesh-list
92094721|NCT03033160|Estrogens|estrogens|mesh-ancestor
92094722|NCT03033160|Hormones|hormones|mesh-ancestor
92094723|NCT03033160|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094724|NCT03033160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094725|NCT00958282|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92094726|NCT00958282|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92094727|NCT00958282|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094728|NCT00958282|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92094729|NCT00958282|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92094730|NCT00958282|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094731|NCT00958282|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094732|NCT00958282|Dopamine Agents|dopamine agents|mesh-ancestor
92094733|NCT00958282|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094734|NCT03033316|Dexamethasone|dexamethasone|mesh-list
92094735|NCT03033316|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094736|NCT03033316|Antiemetics|antiemetics|mesh-ancestor
92094737|NCT03033316|Autonomic Agents|autonomic agents|mesh-ancestor
92094738|NCT03033316|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094739|NCT03033316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094740|NCT03033316|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094741|NCT03033316|Glucocorticoids|glucocorticoids|mesh-ancestor
92094742|NCT03033316|Hormones|hormones|mesh-ancestor
92094743|NCT03033316|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094744|NCT03033316|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92094745|NCT03033316|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094746|NCT03032848|Estrogens|estrogens|mesh-list
92094747|NCT03032848|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92094748|NCT03032848|Hormones|hormones|mesh-ancestor
92094749|NCT03032848|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094750|NCT03032848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094751|NCT00080223|Pirfenidone|pirfenidone|mesh-list
92094752|NCT00080223|Analgesics|analgesics|mesh-ancestor
92094753|NCT00080223|Sensory System Agents|sensory system agents|mesh-ancestor
92094754|NCT00080223|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094755|NCT00080223|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094756|NCT00080223|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92094790|NCT01005706|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92094791|NCT01005706|Antitubercular Agents|antitubercular agents|mesh-ancestor
92094792|NCT01005706|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094793|NCT01005706|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094794|NCT01005706|Antifungal Agents|antifungal agents|mesh-ancestor
92094795|NCT01005706|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92094796|NCT03085485|Ivacaftor|ivacaftor|mesh-list
92094797|NCT03085485|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92017286|NCT02463357|Protective Agents|protective agents|mesh-ancestor
92094798|NCT03085485|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094799|NCT03085485|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094802|NCT01679691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094803|NCT03470805|Olaparib|olaparib|mesh-list
92094804|NCT03470805|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92094805|NCT03470805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094806|NCT03470805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094807|NCT03470805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094809|NCT03088059|Palbociclib|palbociclib|mesh-list
92094810|NCT03088059|Niraparib|niraparib|mesh-list
92094811|NCT03088059|Afatinib|afatinib|mesh-list
92094812|NCT03088059|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094813|NCT03088059|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094814|NCT03088059|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92094815|NCT03088059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094816|NCT03088059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094817|NCT03088059|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92094818|NCT03084549|Ropivacaine|ropivacaine|mesh-list
92094819|NCT03084549|Anesthetics, Local|anesthetics, local|mesh-ancestor
92094820|NCT03084549|Anesthetics|anesthetics|mesh-ancestor
92094821|NCT03084549|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094822|NCT03084549|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094823|NCT03084549|Sensory System Agents|sensory system agents|mesh-ancestor
92094824|NCT03084549|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094825|NCT03082521|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92094826|NCT03082521|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094827|NCT03085719|Pembrolizumab|pembrolizumab|mesh-list
92094828|NCT03085719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094829|NCT03085719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094830|NCT03085719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92094831|NCT03085719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094832|NCT03080259|Central Nervous System Stimulants|central nervous system stimulants|mesh-list
92094833|NCT03080259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094834|NCT03084861|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92094835|NCT03084861|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92094836|NCT01006252|Paclitaxel|paclitaxel|mesh-list
92094837|NCT01006252|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92094838|NCT01006252|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094839|NCT01006252|Tubulin Modulators|tubulin modulators|mesh-ancestor
92094840|NCT01006252|Antimitotic Agents|antimitotic agents|mesh-ancestor
92094841|NCT01006252|Mitosis Modulators|mitosis modulators|mesh-ancestor
92094842|NCT01006252|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094843|NCT03080805|Capecitabine|capecitabine|mesh-list
92094844|NCT03080805|Lapatinib|lapatinib|mesh-list
92094845|NCT03080805|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92094846|NCT03080805|Antimetabolites|antimetabolites|mesh-ancestor
92094847|NCT03080805|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094848|NCT03080805|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094849|NCT03080805|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92094850|NCT03080805|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094851|NCT03019120|Vitamin D|vitamin d|mesh-list
92094852|NCT03019120|Vitamins|vitamins|mesh-ancestor
92094853|NCT03019120|Micronutrients|micronutrients|mesh-ancestor
92094854|NCT03019120|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094855|NCT03019120|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92094856|NCT00960622|Tenofovir|tenofovir|mesh-list
92094857|NCT00960622|Lamivudine|lamivudine|mesh-list
92094858|NCT00960622|Emtricitabine|emtricitabine|mesh-list
92094859|NCT00960622|Zidovudine|zidovudine|mesh-list
92094860|NCT00960622|Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92094861|NCT00960622|Abacavir|abacavir|mesh-list
92094862|NCT00960622|Dideoxynucleosides|dideoxynucleosides|mesh-list
92094863|NCT00960622|Lamivudine, zidovudine drug combination|lamivudine, zidovudine drug combination|mesh-list
92094864|NCT00960622|Antiviral Agents|antiviral agents|mesh-ancestor
92094865|NCT00960622|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094866|NCT00960622|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92094867|NCT00960622|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92094868|NCT00960622|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094869|NCT00960622|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094870|NCT00960622|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92094871|NCT00960622|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92017287|NCT02463357|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92017288|NCT02463357|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017289|NCT02463357|Diuretics|diuretics|mesh-ancestor
92017290|NCT02463357|Natriuretic Agents|natriuretic agents|mesh-ancestor
92094872|NCT00960622|Antimetabolites|antimetabolites|mesh-ancestor
92094894|NCT03088293|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094895|NCT03088293|Immunologic Factors|immunologic factors|mesh-ancestor
92094896|NCT03088293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094897|NCT03088293|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094898|NCT03088293|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92094899|NCT03088293|Alkylating Agents|alkylating agents|mesh-ancestor
92094900|NCT03088293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094901|NCT03088293|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094902|NCT03088293|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92094903|NCT03088293|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92094904|NCT03088293|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094905|NCT03088293|Dermatologic Agents|dermatologic agents|mesh-ancestor
92094906|NCT03088293|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094907|NCT01008280|Baclofen|baclofen|mesh-list
92094908|NCT01008280|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92094909|NCT01008280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094910|NCT01008280|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92094911|NCT01008280|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094912|NCT01008280|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92094913|NCT01008280|GABA Agonists|gaba agonists|mesh-ancestor
92094914|NCT01008280|GABA Agents|gaba agents|mesh-ancestor
92094915|NCT01008280|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094916|NCT01008280|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094917|NCT03089073|Deamino Arginine Vasopressin|deamino arginine vasopressin|mesh-list
92094918|NCT03089073|Hemostatics|hemostatics|mesh-ancestor
92094919|NCT03089073|Coagulants|coagulants|mesh-ancestor
92094920|NCT03089073|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92094921|NCT03089073|Natriuretic Agents|natriuretic agents|mesh-ancestor
92094922|NCT03089073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094923|NCT05688813|Anesthetics|anesthetics|mesh-list
92094924|NCT05688813|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094956|NCT04401657|Purinergic Agents|purinergic agents|mesh-ancestor
92094957|NCT04401657|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094958|NCT04401657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094959|NCT03019198|Tranexamic Acid|tranexamic acid|mesh-list
92094960|NCT03019198|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92094961|NCT03019198|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92094962|NCT03019198|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094963|NCT03019198|Hemostatics|hemostatics|mesh-ancestor
92094964|NCT03019198|Coagulants|coagulants|mesh-ancestor
92094965|NCT03083613|Paclitaxel|paclitaxel|mesh-list
92094966|NCT03083613|Raltitrexed|raltitrexed|mesh-list
92094967|NCT03083613|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92094969|NCT03083613|Tubulin Modulators|tubulin modulators|mesh-ancestor
92094970|NCT03083613|Antimitotic Agents|antimitotic agents|mesh-ancestor
92094971|NCT03083613|Mitosis Modulators|mitosis modulators|mesh-ancestor
92094972|NCT03083613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094973|NCT03083613|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92094974|NCT03083613|Antimetabolites|antimetabolites|mesh-ancestor
92094975|NCT03083613|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92094976|NCT03083613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094977|NCT00963508|Permethrin|permethrin|mesh-list
92094978|NCT00963508|Malathion|malathion|mesh-list
92094979|NCT00963508|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094980|NCT00963508|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094981|NCT00963508|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92094982|NCT00963508|Cholinergic Agents|cholinergic agents|mesh-ancestor
92094983|NCT00963508|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094984|NCT00963508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094985|NCT03088371|Lidocaine|lidocaine|mesh-list
92094986|NCT03088371|Bupivacaine|bupivacaine|mesh-list
92094987|NCT03088371|Anesthetics, Local|anesthetics, local|mesh-ancestor
92094988|NCT03088371|Anesthetics|anesthetics|mesh-ancestor
92017294|NCT04959721|Triamcinolone|triamcinolone|mesh-list
92017295|NCT04959721|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92017296|NCT04959721|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92017297|NCT04959721|Bupivacaine|bupivacaine|mesh-list
92017298|NCT04959721|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92094989|NCT03088371|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094990|NCT03088371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094991|NCT03088371|Sensory System Agents|sensory system agents|mesh-ancestor
92094992|NCT03088371|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094993|NCT03088371|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92095072|NCT05688345|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92094994|NCT03088371|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92094995|NCT03088371|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92094996|NCT03088371|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094997|NCT03088371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094999|NCT03083691|Ipilimumab|ipilimumab|mesh-list
92095000|NCT03083691|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095001|NCT03083691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095002|NCT03083691|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095003|NCT03083691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095004|NCT05685537|Simendan|simendan|mesh-list
92095005|NCT05685537|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92095006|NCT05685537|Vasodilator Agents|vasodilator agents|mesh-ancestor
92095007|NCT05685537|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92095008|NCT05685537|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92095009|NCT05685537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095010|NCT05685537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095011|NCT05685537|Protective Agents|protective agents|mesh-ancestor
92095012|NCT05685537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095013|NCT04400721|Ropivacaine|ropivacaine|mesh-list
92095014|NCT04400721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92095015|NCT04400721|Anesthetics|anesthetics|mesh-ancestor
92095016|NCT04400721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095017|NCT04400721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095018|NCT04400721|Sensory System Agents|sensory system agents|mesh-ancestor
92095019|NCT04400721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095020|NCT01010932|Gadolinium 1,4,7,10-tetraazacyclododecane-N,N',N'',N'''-tetraacetate|gadolinium 1,4,7,10-tetraazacyclododecane-n,n',n'',n'''-tetraacetate|mesh-list
92095021|NCT01010932|Chelating Agents|chelating agents|mesh-ancestor
92095022|NCT01010932|Sequestering Agents|sequestering agents|mesh-ancestor
92095023|NCT01010932|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095024|NCT03018652|Immunoglobulins|immunoglobulins|mesh-list
92095025|NCT03018652|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92095026|NCT03018652|Antibodies|antibodies|mesh-list
92095027|NCT03018652|gamma-Globulins|gamma-globulins|mesh-list
92095028|NCT03018652|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92095029|NCT03018652|Immunologic Factors|immunologic factors|mesh-ancestor
92095030|NCT03018652|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095031|NCT01012336|Dexamethasone|dexamethasone|mesh-list
92095032|NCT01012336|Aprepitant|aprepitant|mesh-list
92095033|NCT01012336|Ramosetron|ramosetron|mesh-list
92095034|NCT01012336|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095035|NCT01012336|Antiemetics|antiemetics|mesh-ancestor
92095036|NCT01012336|Autonomic Agents|autonomic agents|mesh-ancestor
92095037|NCT01012336|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095038|NCT01012336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095045|NCT01012336|Neurokinin-1 Receptor Antagonists|neurokinin-1 receptor antagonists|mesh-ancestor
92095046|NCT01012336|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095047|NCT01012336|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095048|NCT01012336|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92095049|NCT01012336|Serotonin Agents|serotonin agents|mesh-ancestor
92095050|NCT03387501|Mitogens|mitogens|mesh-list
92095051|NCT03387501|Mitosis Modulators|mitosis modulators|mesh-ancestor
92095052|NCT03387501|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095053|NCT01012492|Abatacept|abatacept|mesh-list
92095054|NCT01012492|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095055|NCT01012492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017299|NCT04959721|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017301|NCT04959721|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095056|NCT01012492|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095057|NCT01012492|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095058|NCT01012492|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095059|NCT01012492|Immunologic Factors|immunologic factors|mesh-ancestor
92095060|NCT01012492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095061|NCT01012492|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095062|NCT05688345|Dexmedetomidine|dexmedetomidine|mesh-list
92095064|NCT05688345|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92095065|NCT05688345|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095066|NCT05688345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095067|NCT05688345|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92095068|NCT05688345|Analgesics|analgesics|mesh-ancestor
92095069|NCT05688345|Sensory System Agents|sensory system agents|mesh-ancestor
92095070|NCT05688345|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095071|NCT05688345|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92095073|NCT05688345|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92095074|NCT05688345|Adrenergic Agents|adrenergic agents|mesh-ancestor
92095075|NCT05688345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095076|NCT05688345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095077|NCT05688345|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92095078|NCT05688345|Anesthetics, General|anesthetics, general|mesh-ancestor
92095079|NCT05688345|Anesthetics|anesthetics|mesh-ancestor
92095080|NCT03083457|Anesthetics|anesthetics|mesh-list
92095081|NCT03083457|Anesthetics, General|anesthetics, general|mesh-list
92095082|NCT03083457|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095083|NCT03083457|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095084|NCT04401345|Glycopyrrolate|glycopyrrolate|mesh-list
92095085|NCT04401345|Bromides|bromides|mesh-list
92095086|NCT04401345|Anticonvulsants|anticonvulsants|mesh-ancestor
92095087|NCT04401345|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92095088|NCT04401345|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92095089|NCT04401345|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92095090|NCT04401345|Cholinergic Agents|cholinergic agents|mesh-ancestor
92095091|NCT04401345|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095092|NCT04401345|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095093|NCT04401345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095094|NCT01015534|Temozolomide|temozolomide|mesh-list
92095095|NCT01015534|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92095096|NCT01015534|Alkylating Agents|alkylating agents|mesh-ancestor
92095097|NCT01015534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095098|NCT01015534|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095099|NCT00968890|Vaccines|vaccines|mesh-list
92095100|NCT00968890|Immunologic Factors|immunologic factors|mesh-ancestor
92095101|NCT00968890|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095102|NCT00970216|Telbivudine|telbivudine|mesh-list
92095103|NCT00970216|Antiviral Agents|antiviral agents|mesh-ancestor
92095104|NCT00970216|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095105|NCT00970216|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92095106|NCT00970216|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095107|NCT00970216|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095112|NCT00971620|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095113|NCT00971620|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095114|NCT00971620|Cholinergic Agents|cholinergic agents|mesh-ancestor
92095115|NCT00971620|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095116|NCT00971620|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095117|NCT00971620|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92095118|NCT00971620|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095121|NCT03384537|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92095122|NCT03384537|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095123|NCT03384537|Disinfectants|disinfectants|mesh-ancestor
92095124|NCT01884922|Vinblastine|vinblastine|mesh-list
92095125|NCT01884922|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92095126|NCT01884922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095127|NCT01884922|Tubulin Modulators|tubulin modulators|mesh-ancestor
92095128|NCT01884922|Antimitotic Agents|antimitotic agents|mesh-ancestor
92095129|NCT01884922|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017302|NCT04959721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017303|NCT04959721|Sensory System Agents|sensory system agents|mesh-ancestor
92017304|NCT04959721|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095130|NCT01884922|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095131|NCT05687409|Entecavir|entecavir|mesh-list
92095132|NCT05687409|Lactulose|lactulose|mesh-list
92095133|NCT05687409|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92095134|NCT05687409|Antiviral Agents|antiviral agents|mesh-ancestor
92095135|NCT05687409|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095136|NCT05687409|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095137|NCT02162680|Lidocaine|lidocaine|mesh-list
92095138|NCT02162680|Anesthetics, Local|anesthetics, local|mesh-ancestor
92095139|NCT02162680|Anesthetics|anesthetics|mesh-ancestor
92095140|NCT02162680|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095141|NCT02162680|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095142|NCT02162680|Sensory System Agents|sensory system agents|mesh-ancestor
92095143|NCT02162680|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095144|NCT02162680|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92095145|NCT02162680|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92095146|NCT02162680|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92095147|NCT02162680|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095148|NCT02162680|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095149|NCT01017250|Bevacizumab|bevacizumab|mesh-list
92095150|NCT01017250|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095151|NCT01017250|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095152|NCT01017250|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92095153|NCT01017250|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92095154|NCT01017250|Growth Substances|growth substances|mesh-ancestor
92095155|NCT01017250|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095156|NCT01017250|Growth Inhibitors|growth inhibitors|mesh-ancestor
92095157|NCT00812032|Aspirin|aspirin|mesh-list
92095158|NCT00812032|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92095159|NCT00812032|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92095160|NCT00812032|Analgesics|analgesics|mesh-ancestor
92095161|NCT00812032|Sensory System Agents|sensory system agents|mesh-ancestor
92095162|NCT00812032|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095163|NCT00812032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095164|NCT00812032|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095165|NCT00812032|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095166|NCT00812032|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92095167|NCT00812032|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92095168|NCT00812032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095169|NCT00812032|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92095170|NCT00812032|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92095171|NCT00812032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095172|NCT00812032|Antipyretics|antipyretics|mesh-ancestor
92095173|NCT05687253|Bromides|bromides|mesh-list
92095174|NCT05687253|Rocuronium|rocuronium|mesh-list
92095175|NCT05687253|Anticonvulsants|anticonvulsants|mesh-ancestor
92095176|NCT05687253|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92095188|NCT00417664|Dexmedetomidine|dexmedetomidine|mesh-list
92095189|NCT00417664|Propofol|propofol|mesh-list
92095190|NCT00417664|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92095191|NCT00417664|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095192|NCT00417664|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095193|NCT00417664|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92095194|NCT00417664|Analgesics|analgesics|mesh-ancestor
92095195|NCT00417664|Sensory System Agents|sensory system agents|mesh-ancestor
92095196|NCT00417664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095197|NCT00417664|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92095198|NCT00417664|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92095199|NCT00417664|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92095200|NCT00417664|Adrenergic Agents|adrenergic agents|mesh-ancestor
92095201|NCT00417664|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095202|NCT00417664|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095203|NCT00417664|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92095204|NCT00417664|Anesthetics, General|anesthetics, general|mesh-ancestor
92095205|NCT00417664|Anesthetics|anesthetics|mesh-ancestor
92095206|NCT00417664|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92095207|NCT00417664|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92017305|NCT04959721|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017306|NCT04959721|Glucocorticoids|glucocorticoids|mesh-ancestor
92017307|NCT04959721|Hormones|hormones|mesh-ancestor
92017308|NCT04959721|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095208|NCT00417664|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92095209|NCT00417664|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92095210|NCT00417664|GABA Modulators|gaba modulators|mesh-ancestor
92095211|NCT00417664|GABA Agents|gaba agents|mesh-ancestor
92095212|NCT01021618|Dipyridamole|dipyridamole|mesh-list
92095213|NCT01021618|Regadenoson|regadenoson|mesh-list
92095214|NCT01021618|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92095215|NCT01021618|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92095216|NCT01021618|Purinergic Agonists|purinergic agonists|mesh-ancestor
92095217|NCT01021618|Purinergic Agents|purinergic agents|mesh-ancestor
92095218|NCT01021618|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095219|NCT01021618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095220|NCT01021618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095221|NCT01021618|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92095222|NCT01021618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095223|NCT01021618|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92095224|NCT01021618|Vasodilator Agents|vasodilator agents|mesh-ancestor
92095225|NCT03082053|Capecitabine|capecitabine|mesh-list
92095226|NCT03082053|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095227|NCT03082053|Antimetabolites|antimetabolites|mesh-ancestor
92095228|NCT03082053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095229|NCT03082053|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095230|NCT03358563|Docetaxel|docetaxel|mesh-list
92095231|NCT03358563|Bicalutamide|bicalutamide|mesh-list
92095232|NCT03358563|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92095233|NCT03358563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095234|NCT03358563|Tubulin Modulators|tubulin modulators|mesh-ancestor
92095235|NCT03358563|Antimitotic Agents|antimitotic agents|mesh-ancestor
92095236|NCT03358563|Mitosis Modulators|mitosis modulators|mesh-ancestor
92095237|NCT03358563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095238|NCT03358563|Androgen Antagonists|androgen antagonists|mesh-ancestor
92095239|NCT03358563|Hormone Antagonists|hormone antagonists|mesh-ancestor
92095243|NCT03358563|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92095244|NCT03358563|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92095245|NCT01018420|Moxifloxacin|moxifloxacin|mesh-list
92095246|NCT01018420|Colchicine|colchicine|mesh-list
92095247|NCT01018420|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92095248|NCT01018420|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095249|NCT01018420|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92095250|NCT01018420|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92095251|NCT01018420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095252|NCT01018420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095253|NCT01018420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095254|NCT01018420|Gout Suppressants|gout suppressants|mesh-ancestor
92095255|NCT01018420|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095256|NCT01018420|Tubulin Modulators|tubulin modulators|mesh-ancestor
92095257|NCT01018420|Antimitotic Agents|antimitotic agents|mesh-ancestor
92095258|NCT01018420|Mitosis Modulators|mitosis modulators|mesh-ancestor
92095259|NCT00974350|Bupivacaine|bupivacaine|mesh-list
92095260|NCT00974350|Anesthetics, Local|anesthetics, local|mesh-ancestor
92095261|NCT00974350|Anesthetics|anesthetics|mesh-ancestor
92095262|NCT00974350|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095263|NCT00974350|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095264|NCT00974350|Sensory System Agents|sensory system agents|mesh-ancestor
92095265|NCT00974350|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095266|NCT05395702|Interferons|interferons|mesh-list
92095267|NCT05395702|Interferon-gamma|interferon-gamma|mesh-list
92095268|NCT05395702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095269|NCT05395702|Antiviral Agents|antiviral agents|mesh-ancestor
92095270|NCT05395702|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095271|NCT01023178|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92095272|NCT01023178|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92095273|NCT01023178|Estradiol|estradiol|mesh-list
92095274|NCT01023178|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92095275|NCT01023178|Estrogens|estrogens|mesh-list
92095276|NCT01023178|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92095277|NCT01023178|Progesterone|progesterone|mesh-list
92095278|NCT01023178|Hormones|hormones|mesh-ancestor
92017309|NCT04959721|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92017310|NCT04959721|Immunologic Factors|immunologic factors|mesh-ancestor
92017311|NCT04959721|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017312|NCT04959721|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095279|NCT01023178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095280|NCT01023178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095281|NCT01023178|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92095282|NCT01023178|Contraceptive Agents|contraceptive agents|mesh-ancestor
92095283|NCT01023178|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92095284|NCT01023178|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92095285|NCT01023178|Progestins|progestins|mesh-ancestor
92095286|NCT03373851|Sufentanil|sufentanil|mesh-list
92095287|NCT03373851|Dsuvia|dsuvia|mesh-list
92095288|NCT03373851|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92095289|NCT03373851|Narcotics|narcotics|mesh-ancestor
92095290|NCT03373851|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095291|NCT03373851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095292|NCT03373851|Analgesics|analgesics|mesh-ancestor
92095293|NCT03373851|Sensory System Agents|sensory system agents|mesh-ancestor
92095294|NCT03373851|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095295|NCT03373851|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92095296|NCT03373851|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92095297|NCT03373851|Anesthetics, General|anesthetics, general|mesh-ancestor
92095298|NCT03373851|Anesthetics|anesthetics|mesh-ancestor
92095299|NCT05623995|Evolocumab|evolocumab|mesh-list
92095300|NCT05623995|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-list
92095301|NCT05623995|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92095302|NCT05623995|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92095303|NCT05623995|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92095304|NCT05623995|Antimetabolites|antimetabolites|mesh-ancestor
92095305|NCT05623995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095306|NCT05623995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92095307|NCT05623995|Protease Inhibitors|protease inhibitors|mesh-ancestor
92095308|NCT05623995|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095309|NCT05623995|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92095310|NCT01023724|Ketorolac|ketorolac|mesh-list
92095311|NCT01023724|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92095317|NCT01023724|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095318|NCT01023724|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095319|NCT01023724|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095320|NCT01023724|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095321|NCT01023724|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92095322|NCT01023724|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095323|NCT01023724|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095324|NCT00974818|Mitomycins|mitomycins|mesh-list
92095325|NCT00974818|Mitomycin|mitomycin|mesh-list
92095326|NCT00974818|BCG Vaccine|bcg vaccine|mesh-list
92095327|NCT00974818|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92095328|NCT00974818|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095329|NCT00974818|Alkylating Agents|alkylating agents|mesh-ancestor
92095330|NCT00974818|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095331|NCT00974818|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92095332|NCT00974818|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095333|NCT00974818|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92095334|NCT00974818|Immunologic Factors|immunologic factors|mesh-ancestor
92095335|NCT00974818|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095336|NCT03371667|Methotrexate|methotrexate|mesh-list
92095337|NCT03371667|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92095338|NCT03371667|Abortifacient Agents|abortifacient agents|mesh-ancestor
92095339|NCT03371667|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92095340|NCT03371667|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095341|NCT03371667|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095342|NCT03371667|Antimetabolites|antimetabolites|mesh-ancestor
92095343|NCT03371667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095344|NCT03371667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095345|NCT03371667|Dermatologic Agents|dermatologic agents|mesh-ancestor
92095346|NCT03371667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095347|NCT03371667|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92017313|NCT04968613|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92017314|NCT04968613|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095348|NCT03371667|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095349|NCT03371667|Immunologic Factors|immunologic factors|mesh-ancestor
92095350|NCT03371667|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095351|NCT03371667|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92095352|NCT01024738|Chlorhexidine|chlorhexidine|mesh-list
92095353|NCT01024738|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92095354|NCT01024738|Triclosan|triclosan|mesh-list
92095355|NCT01024738|Fluorides|fluorides|mesh-list
92095356|NCT01024738|Cariostatic Agents|cariostatic agents|mesh-ancestor
92095357|NCT01024738|Protective Agents|protective agents|mesh-ancestor
92095358|NCT01024738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095359|NCT01024738|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92095360|NCT01024738|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095361|NCT01024738|Disinfectants|disinfectants|mesh-ancestor
92095362|NCT01024738|Dermatologic Agents|dermatologic agents|mesh-ancestor
92095363|NCT01024738|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92095364|NCT01024738|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92095365|NCT01024738|Antimetabolites|antimetabolites|mesh-ancestor
92095366|NCT01024738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095367|NCT01024738|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92095368|NCT05613153|Peppermint oil|peppermint oil|mesh-list
92095369|NCT05613153|Antiemetics|antiemetics|mesh-ancestor
92095370|NCT05613153|Autonomic Agents|autonomic agents|mesh-ancestor
92095371|NCT05613153|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095372|NCT05613153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095373|NCT05613153|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095374|NCT05613153|Parasympatholytics|parasympatholytics|mesh-ancestor
92095375|NCT01024972|Mannitol|mannitol|mesh-list
92095376|NCT01024972|Dantrolene|dantrolene|mesh-list
92095377|NCT01024972|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92095378|NCT01024972|Diuretics|diuretics|mesh-ancestor
92095379|NCT01024972|Natriuretic Agents|natriuretic agents|mesh-ancestor
92095380|NCT01024972|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095381|NCT01024972|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92095382|NCT01024972|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92095383|NCT01024972|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095384|NCT05686395|Bupivacaine|bupivacaine|mesh-list
92095394|NCT01025830|Stavudine, lamivudine, nevirapine drug combination|stavudine, lamivudine, nevirapine drug combination|mesh-list
92095395|NCT01025830|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92095396|NCT01025830|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92095397|NCT01025830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095398|NCT01025830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095400|NCT01025830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095401|NCT01025830|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92095402|NCT01025830|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92095403|NCT01025830|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92095404|NCT01025830|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92095405|NCT01025830|Antimetabolites|antimetabolites|mesh-ancestor
92095407|NCT03081039|Gemcitabine|gemcitabine|mesh-list
92095408|NCT03081039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095409|NCT03081039|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095410|NCT03081039|Antimetabolites|antimetabolites|mesh-ancestor
92095411|NCT03081039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095412|NCT01026844|Hydroxychloroquine|hydroxychloroquine|mesh-list
92095413|NCT01026844|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92095414|NCT01026844|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095415|NCT01026844|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92095416|NCT01026844|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095417|NCT01026844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095418|NCT01026844|Antimalarials|antimalarials|mesh-ancestor
92095419|NCT01026844|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92095420|NCT01026844|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92095421|NCT01026844|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095422|NCT01026844|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095423|NCT00979732|Grape Seed Extract|grape seed extract|mesh-list
92095424|NCT00979732|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92095425|NCT00979732|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095426|NCT00979732|Antioxidants|antioxidants|mesh-ancestor
92095427|NCT00979732|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095428|NCT00979732|Protective Agents|protective agents|mesh-ancestor
92095429|NCT00979732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095430|NCT03322995|Fluorouracil|fluorouracil|mesh-list
92095431|NCT03322995|Antimetabolites|antimetabolites|mesh-ancestor
92095432|NCT03322995|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095433|NCT03322995|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095434|NCT03322995|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095435|NCT03322995|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095436|NCT03322995|Immunologic Factors|immunologic factors|mesh-ancestor
92095437|NCT03322995|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095438|NCT03321981|Trastuzumab|trastuzumab|mesh-list
92095439|NCT03321981|Letrozole|letrozole|mesh-list
92095440|NCT03321981|Vinorelbine|vinorelbine|mesh-list
92095441|NCT03321981|Fulvestrant|fulvestrant|mesh-list
92095442|NCT03321981|Exemestane|exemestane|mesh-list
92095443|NCT03321981|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095444|NCT03321981|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095445|NCT03321981|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92095446|NCT03321981|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92095447|NCT03321981|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095448|NCT03321981|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095449|NCT03321981|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92095450|NCT03321981|Hormone Antagonists|hormone antagonists|mesh-ancestor
92095460|NCT01027468|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095461|NCT01027468|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095462|NCT01027468|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92095463|NCT01027468|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92095464|NCT01027468|Growth Substances|growth substances|mesh-ancestor
92095465|NCT01027468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095466|NCT01027468|Growth Inhibitors|growth inhibitors|mesh-ancestor
92095468|NCT05237349|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095469|NCT04278807|Anesthetics|anesthetics|mesh-list
92095470|NCT04278807|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095471|NCT04278807|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095472|NCT03344211|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92095473|NCT03344211|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095474|NCT03274401|Anticoagulants|anticoagulants|mesh-list
92095475|NCT05086107|Rifabutin|rifabutin|mesh-list
92095476|NCT05086107|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92095477|NCT05086107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095478|NCT05086107|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92095479|NCT05086107|Antitubercular Agents|antitubercular agents|mesh-ancestor
92095480|NCT01029730|Rituximab|rituximab|mesh-list
92095481|NCT01029730|Bortezomib|bortezomib|mesh-list
92095482|NCT01029730|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92095483|NCT01029730|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095484|NCT01029730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095485|NCT01029730|Immunologic Factors|immunologic factors|mesh-ancestor
92095486|NCT01029730|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095487|NCT01029730|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095488|NCT01029730|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92095489|NCT01029730|Alkylating Agents|alkylating agents|mesh-ancestor
92095490|NCT01029730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095492|NCT05066997|Dexamethasone acetate|dexamethasone acetate|mesh-list
92095493|NCT05066997|BB 1101|bb 1101|mesh-list
92095494|NCT05066997|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095495|NCT05066997|Antiemetics|antiemetics|mesh-ancestor
92095496|NCT05066997|Autonomic Agents|autonomic agents|mesh-ancestor
92095497|NCT05066997|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095498|NCT05066997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095499|NCT05066997|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095500|NCT05066997|Glucocorticoids|glucocorticoids|mesh-ancestor
92095501|NCT05066997|Hormones|hormones|mesh-ancestor
92095502|NCT05066997|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095503|NCT05066997|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92095504|NCT05066997|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095505|NCT05066997|Protease Inhibitors|protease inhibitors|mesh-ancestor
92095506|NCT05066997|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095507|NCT05066997|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095508|NCT05025033|Paclitaxel|paclitaxel|mesh-list
92095509|NCT05025033|Irinotecan|irinotecan|mesh-list
92095510|NCT05025033|Apatinib|apatinib|mesh-list
92095511|NCT05025033|Antibodies|antibodies|mesh-list
92017315|NCT04968613|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095512|NCT05025033|Immunoglobulins|immunoglobulins|mesh-list
92095513|NCT05025033|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92095514|NCT05025033|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095527|NCT00980746|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92095528|NCT00980746|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92095529|NCT00980746|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095530|NCT00980746|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095532|NCT00981214|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095533|NCT05415657|Denosumab|denosumab|mesh-list
92095534|NCT05415657|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92095535|NCT05415657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095536|NCT03016234|Propofol|propofol|mesh-list
92095537|NCT03016234|Desflurane|desflurane|mesh-list
92095538|NCT03016234|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92095539|NCT03016234|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095540|NCT03016234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095541|NCT03016234|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92095542|NCT03016234|Anesthetics, General|anesthetics, general|mesh-ancestor
92095543|NCT03016234|Anesthetics|anesthetics|mesh-ancestor
92095544|NCT03016234|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92095545|NCT02167204|Alovudine|alovudine|mesh-list
92095546|NCT02167204|Antiviral Agents|antiviral agents|mesh-ancestor
92095547|NCT02167204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095548|NCT00982072|Prednisolone|prednisolone|mesh-list
92095549|NCT00982072|Tacrolimus|tacrolimus|mesh-list
92095550|NCT00982072|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095551|NCT00982072|Immunologic Factors|immunologic factors|mesh-ancestor
92095552|NCT00982072|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095553|NCT00982072|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92095554|NCT00982072|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095555|NCT00982072|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095556|NCT00982072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095557|NCT00982072|Glucocorticoids|glucocorticoids|mesh-ancestor
92095558|NCT00982072|Hormones|hormones|mesh-ancestor
92095559|NCT00982072|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095560|NCT00982072|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92095561|NCT00982072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095562|NCT01899053|Serabelisib|serabelisib|mesh-list
92095563|NCT01899053|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095564|NCT01899053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095565|NCT01032694|Azithromycin|azithromycin|mesh-list
92095566|NCT01032694|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92095567|NCT01032694|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095568|NCT04957095|Levodopa|levodopa|mesh-list
92095569|NCT04957095|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92095570|NCT04957095|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92095571|NCT04957095|Dopamine Agents|dopamine agents|mesh-ancestor
92095572|NCT04957095|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095573|NCT04957095|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095574|NCT04957095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095575|NCT01032850|Capecitabine|capecitabine|mesh-list
92095577|NCT01032850|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095580|NCT01032850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095581|NCT01032850|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92095582|NCT01032850|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095583|NCT00983242|Colchicine|colchicine|mesh-list
92095584|NCT00983242|Verapamil|verapamil|mesh-list
92095585|NCT00983242|Gout Suppressants|gout suppressants|mesh-ancestor
92095586|NCT00983242|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095587|NCT00983242|Tubulin Modulators|tubulin modulators|mesh-ancestor
92095588|NCT00983242|Antimitotic Agents|antimitotic agents|mesh-ancestor
92095589|NCT00983242|Mitosis Modulators|mitosis modulators|mesh-ancestor
92095590|NCT00983242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095591|NCT00983242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095592|NCT00983242|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92095593|NCT00983242|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92095594|NCT00983242|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095595|NCT00983242|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92095596|NCT00983242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095597|NCT00983242|Vasodilator Agents|vasodilator agents|mesh-ancestor
92095598|NCT00984334|Naloxone|naloxone|mesh-list
92095599|NCT00984334|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92017316|NCT04968613|Dopamine Agents|dopamine agents|mesh-ancestor
92017317|NCT04968613|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017318|NCT04968613|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017319|NCT04676555|Ofatumumab|ofatumumab|mesh-list
92017320|NCT04676555|Ocrelizumab|ocrelizumab|mesh-list
92095600|NCT00984334|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095601|NCT00984334|Sensory System Agents|sensory system agents|mesh-ancestor
92095602|NCT00984334|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095603|NCT02168062|Leuprolide|leuprolide|mesh-list
92095604|NCT02168062|Goserelin|goserelin|mesh-list
92095605|NCT02168062|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92095606|NCT02168062|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92095607|NCT02168062|Fertility Agents|fertility agents|mesh-ancestor
92095608|NCT02168062|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92095609|NCT02168062|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095610|NCT02168062|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92095611|NCT02168062|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095612|NCT02168062|Luteolytic Agents|luteolytic agents|mesh-ancestor
92095613|NCT02168062|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92095614|NCT02168062|Contraceptive Agents|contraceptive agents|mesh-ancestor
92095615|NCT02168062|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92095616|NCT01888367|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92095617|NCT01888367|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095618|NCT05343117|Palbociclib|palbociclib|mesh-list
92095619|NCT05343117|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095620|NCT05343117|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92095621|NCT05343117|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095622|NCT05343117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095623|NCT01898195|Varenicline|varenicline|mesh-list
92095624|NCT01898195|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92095625|NCT01898195|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92095626|NCT01898195|Cholinergic Agents|cholinergic agents|mesh-ancestor
92095627|NCT01898195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095628|NCT01898195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095629|NCT01898195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095630|NCT01897727|Spironolactone|spironolactone|mesh-list
92095631|NCT01897727|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92095632|NCT01897727|Hormone Antagonists|hormone antagonists|mesh-ancestor
92095633|NCT01897727|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095634|NCT01897727|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095635|NCT01897727|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92095636|NCT01897727|Diuretics|diuretics|mesh-ancestor
92095637|NCT01897727|Natriuretic Agents|natriuretic agents|mesh-ancestor
92095638|NCT01897493|Digoxin|digoxin|mesh-list
92095639|NCT01897493|Evacetrapib|evacetrapib|mesh-list
92095640|NCT01897493|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92095641|NCT01897493|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92095642|NCT01897493|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095643|NCT01897493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095644|NCT01897493|Protective Agents|protective agents|mesh-ancestor
92095645|NCT01897493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095646|NCT01897493|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92095647|NCT01897493|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92095648|NCT01897493|Antimetabolites|antimetabolites|mesh-ancestor
92095649|NCT01897493|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92095651|NCT01887353|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92095652|NCT01887353|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095653|NCT01887353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095654|NCT00988156|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92095655|NCT00988156|Anticonvulsants|anticonvulsants|mesh-ancestor
92095656|NCT00988156|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92095657|NCT00988156|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92095658|NCT00988156|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095659|NCT00988156|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095660|NCT02160730|Roscovitine|roscovitine|mesh-list
92095661|NCT02160730|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095662|NCT02160730|Antiviral Agents|antiviral agents|mesh-ancestor
92095663|NCT02160730|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095664|NCT02160730|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017321|NCT04676555|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017322|NCT04676555|Immunologic Factors|immunologic factors|mesh-ancestor
92017323|NCT04676555|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017325|NCT04314167|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92017326|NCT04314167|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92017327|NCT04314167|Antimetabolites|antimetabolites|mesh-ancestor
92017328|NCT04314167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017329|NCT04314167|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92017330|NCT04314167|Protease Inhibitors|protease inhibitors|mesh-ancestor
92017331|NCT04314167|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017332|NCT04314167|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92017333|NCT05575427|Levofloxacin|levofloxacin|mesh-list
92095665|NCT02160730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095666|NCT02160730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095667|NCT03329313|Dialysis Solutions|dialysis solutions|mesh-list
92095668|NCT03329313|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92095669|NCT01896869|Ipilimumab|ipilimumab|mesh-list
92095670|NCT01896869|Folfirinox|folfirinox|mesh-list
92095671|NCT01896869|Vaccines|vaccines|mesh-list
92095672|NCT01896869|Immunologic Factors|immunologic factors|mesh-ancestor
92095673|NCT01896869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095674|NCT01896869|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095675|NCT01896869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095676|NCT01896869|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095677|NCT01896869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095678|NCT03329001|Niraparib|niraparib|mesh-list
92095679|NCT03329001|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92095680|NCT03329001|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095681|NCT03329001|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095682|NCT03329001|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095683|NCT01896557|Omeprazole|omeprazole|mesh-list
92095684|NCT01896557|Ranitidine|ranitidine|mesh-list
92095685|NCT01896557|Ranitidine bismuth citrate|ranitidine bismuth citrate|mesh-list
92095686|NCT01896557|Clopidogrel|clopidogrel|mesh-list
92095687|NCT01896557|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
92095688|NCT01896557|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92095689|NCT01896557|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92095690|NCT01896557|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92095691|NCT01896557|Purinergic Agents|purinergic agents|mesh-ancestor
92095692|NCT01896557|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095693|NCT01896557|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095694|NCT01896557|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095695|NCT01896557|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92095696|NCT01896557|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095697|NCT01896557|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92095698|NCT01896557|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095699|NCT01896557|Histamine H2 Antagonists|histamine h2 antagonists|mesh-ancestor
92095700|NCT01896557|Histamine Antagonists|histamine antagonists|mesh-ancestor
92095701|NCT01896557|Histamine Agents|histamine agents|mesh-ancestor
92095702|NCT02160808|Secretin|secretin|mesh-list
92095703|NCT02160808|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095704|NCT02160808|Hormones|hormones|mesh-ancestor
92095705|NCT02160808|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095706|NCT02160808|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095707|NCT01886105|Samarium Sm-153 lexidronam|samarium sm-153 lexidronam|mesh-list
92095708|NCT01886105|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92095709|NCT01886105|Analgesics|analgesics|mesh-ancestor
92095710|NCT01886105|Sensory System Agents|sensory system agents|mesh-ancestor
92095711|NCT01886105|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017334|NCT05575427|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92017335|NCT05575427|Minocycline|minocycline|mesh-list
92017336|NCT05575427|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92017337|NCT05575427|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017338|NCT05575427|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92017339|NCT05575427|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92095712|NCT01886105|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095713|NCT03262779|Nivolumab|nivolumab|mesh-list
92095714|NCT03262779|Ipilimumab|ipilimumab|mesh-list
92095715|NCT03262779|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095716|NCT03262779|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095717|NCT03262779|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095718|NCT03262779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095719|NCT05022394|Nivolumab|nivolumab|mesh-list
92095720|NCT05022394|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095721|NCT05022394|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095722|NCT05022394|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095743|NCT00992602|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92095744|NCT00992602|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095745|NCT00992602|Immunologic Factors|immunologic factors|mesh-ancestor
92095746|NCT00992602|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095747|NCT00992602|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92095748|NCT00992602|Antiviral Agents|antiviral agents|mesh-ancestor
92095749|NCT00992602|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095750|NCT00993226|Bupivacaine|bupivacaine|mesh-list
92095751|NCT00993226|Anesthetics, Local|anesthetics, local|mesh-ancestor
92095752|NCT00993226|Anesthetics|anesthetics|mesh-ancestor
92095753|NCT00993226|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095754|NCT00993226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095755|NCT00993226|Sensory System Agents|sensory system agents|mesh-ancestor
92095756|NCT00993226|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095757|NCT01885559|Telmisartan|telmisartan|mesh-list
92095758|NCT01885559|Lisinopril|lisinopril|mesh-list
92095759|NCT01885559|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92095760|NCT01885559|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92095761|NCT01885559|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92095762|NCT01885559|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92095763|NCT01885559|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095764|NCT01885559|Protease Inhibitors|protease inhibitors|mesh-ancestor
92095765|NCT01885559|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095766|NCT01885559|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92095767|NCT01885559|Protective Agents|protective agents|mesh-ancestor
92095768|NCT01885559|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095769|NCT00994318|Ferric Compounds|ferric compounds|mesh-list
92095770|NCT00994318|Hematinics|hematinics|mesh-ancestor
92095771|NCT00995722|Prednisone|prednisone|mesh-list
92095772|NCT00995722|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095773|NCT00995722|Glucocorticoids|glucocorticoids|mesh-ancestor
92095774|NCT00995722|Hormones|hormones|mesh-ancestor
92095775|NCT00995722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095776|NCT00995722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095789|NCT00996346|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92095790|NCT00996346|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095791|NCT00996346|Immunologic Factors|immunologic factors|mesh-ancestor
92095792|NCT00996346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095793|NCT00996346|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92095794|NCT00996346|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095795|NCT00996346|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92095796|NCT00996346|Antifungal Agents|antifungal agents|mesh-ancestor
92095797|NCT00996346|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92095798|NCT03016468|Treprostinil|treprostinil|mesh-list
92095799|NCT03016468|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92095800|NCT00997204|Icatibant|icatibant|mesh-list
92095801|NCT00997204|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92095802|NCT00997204|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017340|NCT05575427|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92095803|NCT00997204|Analgesics|analgesics|mesh-ancestor
92095804|NCT00997204|Sensory System Agents|sensory system agents|mesh-ancestor
92095805|NCT00997204|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095806|NCT00997204|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095807|NCT00997204|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095808|NCT00997204|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095809|NCT00997204|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92095810|NCT00997204|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92095811|NCT00997204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095812|NCT00997204|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92095813|NCT00997204|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095814|NCT00997204|Immunologic Factors|immunologic factors|mesh-ancestor
92095815|NCT04263610|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92095816|NCT04263610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92095817|NCT04263610|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095818|NCT04263610|Immunologic Factors|immunologic factors|mesh-ancestor
92095819|NCT04263610|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095820|NCT04225390|Dacarbazine|dacarbazine|mesh-list
92095821|NCT04225390|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92095822|NCT04225390|Alkylating Agents|alkylating agents|mesh-ancestor
92095823|NCT04225390|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095824|NCT04225390|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095825|NCT00997672|Lithium Carbonate|lithium carbonate|mesh-list
92095826|NCT00997672|Antidepressive Agents|antidepressive agents|mesh-ancestor
92095827|NCT00997672|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92095828|NCT00997672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095829|NCT00997672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095830|NCT00997672|Antimanic Agents|antimanic agents|mesh-ancestor
92095831|NCT00997672|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92095832|NCT00997672|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095833|NCT00997672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095834|NCT04606797|Nicotine|nicotine|mesh-list
92095835|NCT04606797|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92095836|NCT04606797|Autonomic Agents|autonomic agents|mesh-ancestor
92095837|NCT04606797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095838|NCT04606797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095850|NCT02164240|Growth Inhibitors|growth inhibitors|mesh-ancestor
92095851|NCT02164240|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92095852|NCT02164240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095853|NCT02164240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095854|NCT02169466|Opicapone|opicapone|mesh-list
92095855|NCT02169466|Benserazide, levodopa drug combination|benserazide, levodopa drug combination|mesh-list
92095856|NCT02169466|Catechol O-Methyltransferase Inhibitors|catechol o-methyltransferase inhibitors|mesh-ancestor
92095857|NCT02169466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095858|NCT02169466|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095859|NCT02169466|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92095860|NCT02169466|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92095861|NCT02169466|Dopamine Agents|dopamine agents|mesh-ancestor
92095862|NCT02169466|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095863|NCT02169466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095864|NCT01001806|Ketorolac|ketorolac|mesh-list
92095865|NCT01001806|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92095866|NCT01001806|Nepafenac|nepafenac|mesh-list
92095867|NCT01001806|Bromfenac|bromfenac|mesh-list
92095868|NCT01001806|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92095869|NCT01001806|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017341|NCT05575427|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017342|NCT05575427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017343|NCT05575427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017344|NCT05575427|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92017345|NCT05575427|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92017346|NCT05575427|Antimalarials|antimalarials|mesh-ancestor
92017347|NCT05575427|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92017348|NCT05575427|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92017349|NCT04959253|Psilocybin|psilocybin|mesh-list
92017350|NCT04959253|Hallucinogens|hallucinogens|mesh-ancestor
92017351|NCT04959253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017352|NCT04959253|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92017353|NCT02499159|Bupivacaine|bupivacaine|mesh-list
92017354|NCT02499159|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017355|NCT02499159|Anesthetics|anesthetics|mesh-ancestor
92017356|NCT02499159|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017357|NCT02499159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017358|NCT02499159|Sensory System Agents|sensory system agents|mesh-ancestor
92017359|NCT02499159|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017360|NCT01664039|Bimatoprost|bimatoprost|mesh-list
92017361|NCT01664039|Travoprost|travoprost|mesh-list
92017362|NCT01664039|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92017363|NCT01664039|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92017364|NCT01664039|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92017365|NCT05645705|Listerine|listerine|mesh-list
92017366|NCT05645705|Anti-Infective Agents, Local|anti-infective agents, local|mesh-list
92017367|NCT05645705|Sodium Fluoride|sodium fluoride|mesh-list
92017368|NCT05645705|Cariostatic Agents|cariostatic agents|mesh-ancestor
92017369|NCT05645705|Protective Agents|protective agents|mesh-ancestor
92017370|NCT05645705|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095870|NCT01001806|Analgesics|analgesics|mesh-ancestor
92017373|NCT02445339|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92017374|NCT02445339|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92017375|NCT02445339|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017376|NCT02445339|Sensory System Agents|sensory system agents|mesh-ancestor
92017377|NCT02445339|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017378|NCT04959409|Tetracaine|tetracaine|mesh-list
92017379|NCT04959409|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017380|NCT04959409|Anesthetics|anesthetics|mesh-ancestor
92017381|NCT04959409|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017382|NCT04959409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017383|NCT04959409|Sensory System Agents|sensory system agents|mesh-ancestor
92017384|NCT04959409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017385|NCT03058939|Tamoxifen|tamoxifen|mesh-list
92017386|NCT03058939|Paclitaxel|paclitaxel|mesh-list
92017387|NCT03058939|Carboplatin|carboplatin|mesh-list
92017388|NCT03058939|Trastuzumab|trastuzumab|mesh-list
92017389|NCT03058939|Letrozole|letrozole|mesh-list
92017390|NCT03058939|Pertuzumab|pertuzumab|mesh-list
92017391|NCT03058939|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017392|NCT03058939|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017393|NCT03058939|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017394|NCT03058939|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017395|NCT03058939|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017396|NCT03058939|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017397|NCT03058939|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017398|NCT03058939|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92017399|NCT03058939|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92017400|NCT03058939|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017401|NCT03058939|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92017402|NCT03058939|Hormone Antagonists|hormone antagonists|mesh-ancestor
92017403|NCT03058939|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017404|NCT03058939|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017405|NCT03058939|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92017406|NCT03058939|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92017407|NCT03058939|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92017408|NCT03058939|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92017409|NCT03058471|Methotrexate|methotrexate|mesh-list
92017410|NCT03058471|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92017411|NCT03058471|Abortifacient Agents|abortifacient agents|mesh-ancestor
92017412|NCT03058471|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92017413|NCT03058471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017414|NCT03058471|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92017415|NCT03058471|Antimetabolites|antimetabolites|mesh-ancestor
92017416|NCT03058471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017417|NCT03058471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017418|NCT03058471|Dermatologic Agents|dermatologic agents|mesh-ancestor
92017419|NCT03058471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017420|NCT03058471|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92017421|NCT03058471|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92017422|NCT03058471|Immunologic Factors|immunologic factors|mesh-ancestor
92017423|NCT03058471|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017424|NCT03058471|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92017425|NCT02579603|Pirfenidone|pirfenidone|mesh-list
92017426|NCT02579603|Nintedanib|nintedanib|mesh-list
92017427|NCT02579603|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017428|NCT02579603|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017429|NCT02579603|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017430|NCT02579603|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017431|NCT02579603|Analgesics|analgesics|mesh-ancestor
92017432|NCT02579603|Sensory System Agents|sensory system agents|mesh-ancestor
92017433|NCT02579603|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017434|NCT02579603|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017435|NCT02579603|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92017436|NCT02579603|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017437|NCT02579603|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017438|NCT02579603|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017439|NCT04291079|Antibodies|antibodies|mesh-list
92017440|NCT04291079|Immunologic Factors|immunologic factors|mesh-ancestor
92017441|NCT04291079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017442|NCT03060889|Tranexamic Acid|tranexamic acid|mesh-list
92017443|NCT03060889|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92017444|NCT03060889|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92017445|NCT03060889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017447|NCT03060889|Coagulants|coagulants|mesh-ancestor
92017448|NCT05546957|Aspirin|aspirin|mesh-list
92017449|NCT05546957|Rivaroxaban|rivaroxaban|mesh-list
92017450|NCT05546957|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92017451|NCT05546957|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017452|NCT05546957|Analgesics|analgesics|mesh-ancestor
92017453|NCT05546957|Sensory System Agents|sensory system agents|mesh-ancestor
92017454|NCT05546957|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017455|NCT05546957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017456|NCT05546957|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017457|NCT05546957|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017458|NCT05546957|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92017459|NCT05546957|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92017460|NCT05546957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017461|NCT05546957|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92017462|NCT05546957|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92017463|NCT05546957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017464|NCT05546957|Antipyretics|antipyretics|mesh-ancestor
92017465|NCT05546957|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92017466|NCT05546957|Antithrombins|antithrombins|mesh-ancestor
92017467|NCT05546957|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92017468|NCT05546957|Protease Inhibitors|protease inhibitors|mesh-ancestor
92017469|NCT05546957|Anticoagulants|anticoagulants|mesh-ancestor
92017470|NCT04950205|Sevoflurane|sevoflurane|mesh-list
92017471|NCT04950205|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92017472|NCT04950205|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92017473|NCT04950205|Anesthetics, General|anesthetics, general|mesh-ancestor
92017474|NCT04950205|Anesthetics|anesthetics|mesh-ancestor
92017475|NCT04950205|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017476|NCT04950205|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017477|NCT02625259|Lansoprazole|lansoprazole|mesh-list
92017478|NCT02625259|Dexlansoprazole|dexlansoprazole|mesh-list
92017479|NCT02625259|Serabelisib|serabelisib|mesh-list
92017481|NCT02625259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017482|NCT02625259|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92017483|NCT02625259|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017484|NCT02625259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017485|NCT02577107|Ranibizumab|ranibizumab|mesh-list
92017486|NCT02577107|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92017487|NCT02577107|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92017488|NCT02577107|Growth Substances|growth substances|mesh-ancestor
92017489|NCT02577107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017491|NCT02577107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017492|NCT04958473|Axitinib|axitinib|mesh-list
92017493|NCT04958473|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017494|NCT04958473|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017495|NCT04958473|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017496|NCT04958473|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017497|NCT04957927|Fluticasone|fluticasone|mesh-list
92017498|NCT04957927|Xhance|xhance|mesh-list
92017499|NCT04957927|Montelukast|montelukast|mesh-list
92017500|NCT04957927|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017501|NCT04957927|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92017502|NCT04957927|Autonomic Agents|autonomic agents|mesh-ancestor
92017503|NCT04957927|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017504|NCT04957927|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017505|NCT04957927|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92017506|NCT04957927|Respiratory System Agents|respiratory system agents|mesh-ancestor
92017507|NCT04957927|Dermatologic Agents|dermatologic agents|mesh-ancestor
92017509|NCT04957927|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92017510|NCT04957927|Hormone Antagonists|hormone antagonists|mesh-ancestor
92017511|NCT04957927|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017512|NCT04957927|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92017513|NCT04957927|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92017514|NCT04957927|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017515|NCT04688801|Antineoplastic Agents|antineoplastic agents|mesh-list
92017516|NCT04950049|Dexamethasone|dexamethasone|mesh-list
92017517|NCT04950049|Dexamethasone acetate|dexamethasone acetate|mesh-list
92017518|NCT04950049|BB 1101|bb 1101|mesh-list
92017519|NCT04950049|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017520|NCT04950049|Antiemetics|antiemetics|mesh-ancestor
92017521|NCT04950049|Autonomic Agents|autonomic agents|mesh-ancestor
92017522|NCT04950049|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017523|NCT04950049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017524|NCT04950049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017525|NCT04950049|Glucocorticoids|glucocorticoids|mesh-ancestor
92017526|NCT04950049|Hormones|hormones|mesh-ancestor
92017527|NCT04950049|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017528|NCT04950049|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92017529|NCT04950049|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017530|NCT04950049|Protease Inhibitors|protease inhibitors|mesh-ancestor
92017531|NCT04950049|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017532|NCT04950049|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017533|NCT05587673|Methylprednisolone|methylprednisolone|mesh-list
92017534|NCT05587673|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92017535|NCT05587673|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92017536|NCT05587673|Prednisolone|prednisolone|mesh-list
92017537|NCT05587673|Prednisolone acetate|prednisolone acetate|mesh-list
92017538|NCT05587673|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92017539|NCT05587673|Prednisolone phosphate|prednisolone phosphate|mesh-list
92017540|NCT05587673|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017541|NCT05587673|Antiemetics|antiemetics|mesh-ancestor
92017542|NCT05587673|Autonomic Agents|autonomic agents|mesh-ancestor
92017543|NCT05587673|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017544|NCT05587673|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017545|NCT05587673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017547|NCT05587673|Hormones|hormones|mesh-ancestor
92017548|NCT05587673|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017550|NCT05587673|Protective Agents|protective agents|mesh-ancestor
92017551|NCT05587673|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92017552|NCT05587673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017553|NCT02444793|Mogamulizumab|mogamulizumab|mesh-list
92017554|NCT02444793|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017555|NCT04966429|Maraviroc|maraviroc|mesh-list
92017556|NCT04966429|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92017557|NCT04966429|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92017558|NCT04966429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017559|NCT04966429|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92017560|NCT04966429|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92017561|NCT04966429|Antiviral Agents|antiviral agents|mesh-ancestor
92017562|NCT04966429|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017563|NCT04966429|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92017564|NCT04949347|Glycerol|glycerol|mesh-list
92017565|NCT04949347|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92017566|NCT04949347|Protective Agents|protective agents|mesh-ancestor
92017567|NCT04949347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017568|NCT04948957|Nitroglycerin|nitroglycerin|mesh-list
92017569|NCT04948957|Esmolol|esmolol|mesh-list
92017570|NCT04948957|Vasodilator Agents|vasodilator agents|mesh-ancestor
92017571|NCT04948957|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92017572|NCT04948957|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92017573|NCT04948957|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92017574|NCT04948957|Adrenergic Agents|adrenergic agents|mesh-ancestor
92017575|NCT04948957|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017576|NCT04948957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017577|NCT04948957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017578|NCT04948801|Sofosbuvir|sofosbuvir|mesh-list
92017579|NCT04948801|Sofosbuvir-velpatasvir drug combination|sofosbuvir-velpatasvir drug combination|mesh-list
92017580|NCT04948801|Velpatasvir|velpatasvir|mesh-list
92017581|NCT04948801|Antiviral Agents|antiviral agents|mesh-ancestor
92017582|NCT04948801|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017583|NCT04948567|Magnesium Sulfate|magnesium sulfate|mesh-list
92017585|NCT04948567|Sensory System Agents|sensory system agents|mesh-ancestor
92017586|NCT04948567|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017587|NCT04948567|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017588|NCT04948567|Anesthetics|anesthetics|mesh-ancestor
92017589|NCT04948567|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017590|NCT04948567|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92017591|NCT04948567|Anticonvulsants|anticonvulsants|mesh-ancestor
92017592|NCT04948567|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92017593|NCT04948567|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017594|NCT04948567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017595|NCT04948567|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92017597|NCT04948567|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92017598|NCT04419181|Carboplatin|carboplatin|mesh-list
92017600|NCT04419181|Trastuzumab|trastuzumab|mesh-list
92017601|NCT04419181|Pertuzumab|pertuzumab|mesh-list
92017602|NCT04419181|Maytansine|maytansine|mesh-list
92017603|NCT04419181|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92017604|NCT04419181|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017605|NCT04419181|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017606|NCT04419181|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017607|NCT04419181|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017608|NCT04419181|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017609|NCT04419181|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017610|NCT04419181|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017612|NCT04419181|Immunoconjugates|immunoconjugates|mesh-ancestor
92017613|NCT04419181|Immunologic Factors|immunologic factors|mesh-ancestor
92017614|NCT04419181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017615|NCT04430179|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92017616|NCT04430179|Immunologic Factors|immunologic factors|mesh-ancestor
92017617|NCT04430179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017618|NCT04946929|Heparin|heparin|mesh-list
92095871|NCT01001806|Sensory System Agents|sensory system agents|mesh-ancestor
92017621|NCT04946929|Dalteparin|dalteparin|mesh-list
92017622|NCT04946929|Ticagrelor|ticagrelor|mesh-list
92017623|NCT04946929|Anticoagulants|anticoagulants|mesh-ancestor
92017624|NCT04946929|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92017625|NCT04946929|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92017626|NCT04946929|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017627|NCT04946929|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92017628|NCT04946929|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92017629|NCT04946929|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92017630|NCT04946929|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92017631|NCT04946929|Purinergic Agents|purinergic agents|mesh-ancestor
92017632|NCT04946929|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017633|NCT04946929|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017634|NCT03058237|Arbaclofen placarbil|arbaclofen placarbil|mesh-list
92017636|NCT03058237|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92017637|NCT03058237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017639|NCT03058237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017640|NCT03058237|GABA-B Receptor Agonists|gaba-b receptor agonists|mesh-ancestor
92017641|NCT03058237|GABA Agonists|gaba agonists|mesh-ancestor
92017642|NCT03058237|GABA Agents|gaba agents|mesh-ancestor
92017643|NCT03058237|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017644|NCT03058237|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017645|NCT04947241|Gemcitabine|gemcitabine|mesh-list
92017646|NCT04947241|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92017647|NCT04947241|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017648|NCT04947241|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92017649|NCT04947241|Antimetabolites|antimetabolites|mesh-ancestor
92017650|NCT04947241|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017651|NCT04947241|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017653|NCT04410991|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92017654|NCT04410991|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017655|NCT04410991|Analgesics|analgesics|mesh-ancestor
92017656|NCT04410991|Sensory System Agents|sensory system agents|mesh-ancestor
92017657|NCT04410991|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017658|NCT04410991|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017659|NCT04410991|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017660|NCT04410991|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017661|NCT04410991|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92017662|NCT04410991|Immunologic Factors|immunologic factors|mesh-ancestor
92017664|NCT04933279|Cadexomer iodine|cadexomer iodine|mesh-list
92017665|NCT04933279|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92017666|NCT04933279|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017667|NCT04933279|Trace Elements|trace elements|mesh-ancestor
92017668|NCT04933279|Micronutrients|micronutrients|mesh-ancestor
92017669|NCT04933279|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017670|NCT02577029|Interferons|interferons|mesh-list
92017671|NCT02577029|Tenofovir|tenofovir|mesh-list
92017672|NCT02577029|Interferon-alpha|interferon-alpha|mesh-list
92017674|NCT02577029|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92017675|NCT02577029|Entecavir|entecavir|mesh-list
92017676|NCT02577029|Histamine Antagonists|histamine antagonists|mesh-list
92017677|NCT02577029|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92017678|NCT02577029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017679|NCT02577029|Antiviral Agents|antiviral agents|mesh-ancestor
92017680|NCT02577029|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017681|NCT02577029|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92017682|NCT02577029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92017683|NCT02577029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017684|NCT02577029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017685|NCT02577029|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92017686|NCT02577029|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92017687|NCT02577029|Immunologic Factors|immunologic factors|mesh-ancestor
92017688|NCT02577029|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017690|NCT02577029|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017692|NCT04946383|Quercetin|quercetin|mesh-list
92017693|NCT04946383|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017694|NCT04946383|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017695|NCT04946383|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017696|NCT04946383|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017697|NCT04946383|Antioxidants|antioxidants|mesh-ancestor
92017698|NCT04946383|Protective Agents|protective agents|mesh-ancestor
92017699|NCT04946383|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017701|NCT04943653|Capecitabine|capecitabine|mesh-list
92017702|NCT04943653|Oxaliplatin|oxaliplatin|mesh-list
92017703|NCT04943653|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017704|NCT04943653|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017705|NCT04943653|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017706|NCT04943653|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017707|NCT04943653|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017708|NCT04943653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017709|NCT04943653|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92017710|NCT04943653|Antimetabolites|antimetabolites|mesh-ancestor
92017711|NCT04943029|Paclitaxel|paclitaxel|mesh-list
92017712|NCT04943029|Carboplatin|carboplatin|mesh-list
92017713|NCT04943029|Pemetrexed|pemetrexed|mesh-list
92017714|NCT04943029|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017715|NCT04943029|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017716|NCT04943029|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017717|NCT04943029|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017718|NCT04943029|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017719|NCT04943029|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017720|NCT04943029|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017721|NCT04943029|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92017722|NCT04943029|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92017723|NCT03660059|Antirheumatic Agents|antirheumatic agents|mesh-list
92017724|NCT03660059|Peficitinib|peficitinib|mesh-list
92017725|NCT03660059|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017726|NCT03660059|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017727|NCT03660059|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92017728|NCT03660059|Immunologic Factors|immunologic factors|mesh-ancestor
92017729|NCT03660059|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017730|NCT04946227|Paclitaxel|paclitaxel|mesh-list
92017731|NCT04946227|Pembrolizumab|pembrolizumab|mesh-list
92017732|NCT04946227|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017734|NCT04946227|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017735|NCT04946227|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017736|NCT04946227|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017737|NCT04946227|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017738|NCT04946227|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017739|NCT04946227|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92017740|NCT04932187|Capecitabine|capecitabine|mesh-list
92017741|NCT04932187|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92017742|NCT04932187|Antimetabolites|antimetabolites|mesh-ancestor
92017743|NCT04932187|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017744|NCT04932187|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017745|NCT04945681|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92017746|NCT04945681|Immunologic Factors|immunologic factors|mesh-ancestor
92017747|NCT04945681|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017748|NCT03597347|Molgramostim|molgramostim|mesh-list
92017749|NCT03597347|Sargramostim|sargramostim|mesh-list
92017750|NCT03597347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017751|NCT03597347|Immunologic Factors|immunologic factors|mesh-ancestor
92017752|NCT03597347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017753|NCT04930627|Empagliflozin|empagliflozin|mesh-list
92017754|NCT04930627|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92017755|NCT04930627|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017756|NCT04930627|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92017757|NCT04930627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017925|NCT04938583|Oregovomab|oregovomab|mesh-list
92017760|NCT03057769|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92017761|NCT03057769|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92017762|NCT03057769|Adrenergic Agents|adrenergic agents|mesh-ancestor
92017763|NCT03057769|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017764|NCT03057769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017765|NCT03057769|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017766|NCT03057769|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92017767|NCT03057769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92017768|NCT03057769|Autonomic Agents|autonomic agents|mesh-ancestor
92017770|NCT03057769|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92017771|NCT03057769|Respiratory System Agents|respiratory system agents|mesh-ancestor
92017772|NCT03057769|Mydriatics|mydriatics|mesh-ancestor
92017773|NCT03057769|Sympathomimetics|sympathomimetics|mesh-ancestor
92017774|NCT03057769|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92017775|NCT03057769|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92017776|NCT03057769|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017778|NCT03057769|Sensory System Agents|sensory system agents|mesh-ancestor
92017779|NCT03057769|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017780|NCT03057769|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92017781|NCT03057769|Gout Suppressants|gout suppressants|mesh-ancestor
92017782|NCT03057769|Tocolytic Agents|tocolytic agents|mesh-ancestor
92017783|NCT03057769|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92017784|NCT03057769|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92017785|NCT03057769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017787|NCT04633577|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017788|NCT04633577|Anesthetics|anesthetics|mesh-ancestor
92017789|NCT04633577|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017790|NCT04633577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017792|NCT04633577|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017793|NCT04633577|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92017794|NCT04633577|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92017795|NCT04633577|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92017796|NCT04633577|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017797|NCT04633577|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017799|NCT04941625|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92017800|NCT04941625|Protease Inhibitors|protease inhibitors|mesh-ancestor
92017801|NCT04941625|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017802|NCT04941625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017803|NCT03534323|Venetoclax|venetoclax|mesh-list
92017804|NCT03534323|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017805|NCT04922047|Tislelizumab|tislelizumab|mesh-list
92017806|NCT04922047|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017808|NCT04406389|Heparin|heparin|mesh-list
92017809|NCT04406389|Calcium heparin|calcium heparin|mesh-list
92017810|NCT04406389|Enoxaparin|enoxaparin|mesh-list
92017811|NCT04406389|Enoxaparin sodium|enoxaparin sodium|mesh-list
92017812|NCT04406389|Argatroban|argatroban|mesh-list
92017813|NCT04406389|Anticoagulants|anticoagulants|mesh-ancestor
92017814|NCT04406389|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92017815|NCT04406389|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92017816|NCT04406389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017817|NCT04406389|Antithrombins|antithrombins|mesh-ancestor
92017818|NCT04406389|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92017819|NCT04406389|Protease Inhibitors|protease inhibitors|mesh-ancestor
92017821|NCT04406389|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92017822|NCT04921657|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92017823|NCT04921657|Simvastatin|simvastatin|mesh-list
92017824|NCT04921657|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92017825|NCT04921657|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92017826|NCT04921657|Antimetabolites|antimetabolites|mesh-ancestor
92017827|NCT04921657|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017828|NCT04921657|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92017829|NCT04921657|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92017832|NCT04930471|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92017833|NCT04930471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017834|NCT04940689|Lidocaine|lidocaine|mesh-list
92017835|NCT04940689|Dexmedetomidine|dexmedetomidine|mesh-list
92017836|NCT04940689|Remifentanil|remifentanil|mesh-list
92017837|NCT04940689|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017838|NCT04940689|Anesthetics|anesthetics|mesh-ancestor
92017839|NCT04940689|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017840|NCT04940689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017841|NCT04940689|Sensory System Agents|sensory system agents|mesh-ancestor
92017842|NCT04940689|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017843|NCT04940689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92017844|NCT04940689|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92017845|NCT04940689|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92017846|NCT04940689|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017847|NCT04940689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017848|NCT04940689|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92017849|NCT04940689|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92017851|NCT04940689|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92017852|NCT04940689|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92017853|NCT04940689|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92017854|NCT04940689|Adrenergic Agents|adrenergic agents|mesh-ancestor
92017855|NCT04940689|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017856|NCT04940689|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92017857|NCT04940689|Narcotics|narcotics|mesh-ancestor
92017858|NCT05530811|Dexamethasone|dexamethasone|mesh-list
92017859|NCT05530811|Bupivacaine|bupivacaine|mesh-list
92017860|NCT05530811|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92017861|NCT05530811|Antiemetics|antiemetics|mesh-ancestor
92017862|NCT05530811|Autonomic Agents|autonomic agents|mesh-ancestor
92017863|NCT05530811|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017864|NCT05530811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017865|NCT05530811|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017866|NCT05530811|Glucocorticoids|glucocorticoids|mesh-ancestor
92017867|NCT05530811|Hormones|hormones|mesh-ancestor
92095872|NCT01001806|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017868|NCT05530811|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017869|NCT05530811|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92017870|NCT05530811|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017871|NCT05530811|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017872|NCT05530811|Anesthetics|anesthetics|mesh-ancestor
92017873|NCT05530811|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017874|NCT05530811|Sensory System Agents|sensory system agents|mesh-ancestor
92017876|NCT04940845|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92017877|NCT04940845|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017879|NCT04921111|Vaccines|vaccines|mesh-list
92017880|NCT04921111|Immunologic Factors|immunologic factors|mesh-ancestor
92017881|NCT04921111|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017882|NCT04921111|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92017883|NCT04921111|Antacids|antacids|mesh-ancestor
92017884|NCT04921111|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017885|NCT04921111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017886|NCT03387917|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92017887|NCT03387917|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92017888|NCT03387917|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017890|NCT03057145|Prexasertib|prexasertib|mesh-list
92017891|NCT03057145|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92017892|NCT03057145|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92017893|NCT03057145|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017894|NCT03057145|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017895|NCT03057145|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92017897|NCT04940143|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92017898|NCT04940143|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92017899|NCT04940143|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92017900|NCT04940143|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017901|NCT04940143|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017902|NCT04940143|Cholinergic Agents|cholinergic agents|mesh-ancestor
92017903|NCT04940143|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017904|NCT04940143|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017905|NCT04940143|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92017906|NCT04940143|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017910|NCT04939675|Anticonvulsants|anticonvulsants|mesh-ancestor
92017911|NCT04939675|Nootropic Agents|nootropic agents|mesh-ancestor
92017912|NCT04939675|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92017913|NCT04939675|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92017914|NCT04939675|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017915|NCT04939675|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92017916|NCT04939675|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017918|NCT04939675|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92017919|NCT04939675|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017920|NCT04939675|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92017921|NCT04939675|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92017922|NCT04938583|Paclitaxel|paclitaxel|mesh-list
92017923|NCT04938583|Bevacizumab|bevacizumab|mesh-list
92017924|NCT04938583|Carboplatin|carboplatin|mesh-list
92017926|NCT04938583|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92017927|NCT04938583|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017928|NCT04938583|Tubulin Modulators|tubulin modulators|mesh-ancestor
92017929|NCT04938583|Antimitotic Agents|antimitotic agents|mesh-ancestor
92017930|NCT04938583|Mitosis Modulators|mitosis modulators|mesh-ancestor
92017931|NCT04938583|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017932|NCT04938583|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92017933|NCT04938583|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92017934|NCT04938583|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92017935|NCT04938583|Growth Substances|growth substances|mesh-ancestor
92017936|NCT04938583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017937|NCT04938583|Growth Inhibitors|growth inhibitors|mesh-ancestor
92017938|NCT03055663|Midazolam|midazolam|mesh-list
92017939|NCT03055663|Hypnotics and Sedatives|hypnotics and sedatives|mesh-list
92017940|NCT03055663|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92017941|NCT03055663|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017942|NCT03055663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017943|NCT03055663|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92017944|NCT03055663|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92017945|NCT03055663|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92017946|NCT03055663|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92017947|NCT03055663|Anesthetics, General|anesthetics, general|mesh-ancestor
92017948|NCT03055663|Anesthetics|anesthetics|mesh-ancestor
92017949|NCT03055663|GABA Modulators|gaba modulators|mesh-ancestor
92017950|NCT03055663|GABA Agents|gaba agents|mesh-ancestor
92017951|NCT03055663|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92017952|NCT03055663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92017953|NCT03057691|Antidepressive Agents|antidepressive agents|mesh-list
92017954|NCT03057691|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92017955|NCT04928365|Antibodies|antibodies|mesh-list
92017956|NCT04928365|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92017957|NCT04928365|Immunologic Factors|immunologic factors|mesh-ancestor
92017958|NCT04928365|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017959|NCT04938037|Methylprednisolone|methylprednisolone|mesh-list
92017960|NCT04938037|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92017961|NCT04938037|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92017963|NCT04938037|Prednisolone acetate|prednisolone acetate|mesh-list
92017965|NCT04938037|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92017966|NCT04938037|Prednisolone phosphate|prednisolone phosphate|mesh-list
92017967|NCT04938037|Anesthetics, Local|anesthetics, local|mesh-ancestor
92017968|NCT04938037|Anesthetics|anesthetics|mesh-ancestor
92017969|NCT04938037|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017970|NCT04938037|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017971|NCT04938037|Sensory System Agents|sensory system agents|mesh-ancestor
92017972|NCT04938037|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017974|NCT04938037|Antiemetics|antiemetics|mesh-ancestor
92017975|NCT04938037|Autonomic Agents|autonomic agents|mesh-ancestor
92017976|NCT04938037|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92017977|NCT04938037|Glucocorticoids|glucocorticoids|mesh-ancestor
92017978|NCT04938037|Hormones|hormones|mesh-ancestor
92017979|NCT04938037|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92017980|NCT04938037|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92017981|NCT04938037|Protective Agents|protective agents|mesh-ancestor
92017982|NCT04938037|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92017983|NCT04938037|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92017984|NCT04937569|Ivermectin|ivermectin|mesh-list
92017985|NCT04937569|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92017986|NCT04937569|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92017987|NCT04937101|Chlorpheniramine|chlorpheniramine|mesh-list
92017988|NCT04937101|Codeine|codeine|mesh-list
92017989|NCT04937101|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92017990|NCT04937101|Narcotics|narcotics|mesh-ancestor
92017991|NCT04937101|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92017992|NCT04937101|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92017993|NCT04937101|Analgesics|analgesics|mesh-ancestor
92017994|NCT04937101|Sensory System Agents|sensory system agents|mesh-ancestor
92017995|NCT04937101|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92017996|NCT04937101|Antitussive Agents|antitussive agents|mesh-ancestor
92017997|NCT04937101|Respiratory System Agents|respiratory system agents|mesh-ancestor
92017998|NCT04937101|Antipruritics|antipruritics|mesh-ancestor
92017999|NCT04937101|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018000|NCT04937101|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92018001|NCT04937101|Histamine Antagonists|histamine antagonists|mesh-ancestor
92018002|NCT04937101|Histamine Agents|histamine agents|mesh-ancestor
92018003|NCT04937101|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018004|NCT04937101|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018005|NCT04937101|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92018006|NCT04937023|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92018007|NCT04937023|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92018008|NCT04937023|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018010|NCT04936711|Anesthetics, Local|anesthetics, local|mesh-ancestor
92018012|NCT04936711|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018013|NCT04936711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018014|NCT04936711|Sensory System Agents|sensory system agents|mesh-ancestor
92018015|NCT04936711|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018016|NCT04431349|Clopidogrel|clopidogrel|mesh-list
92018017|NCT04431349|Ticagrelor|ticagrelor|mesh-list
92018018|NCT04431349|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92018019|NCT04431349|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92018020|NCT04431349|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92018021|NCT04431349|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92018022|NCT04431349|Purinergic Agents|purinergic agents|mesh-ancestor
92018023|NCT04431349|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018024|NCT04431349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018025|NCT04431349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018026|NCT03055741|Donepezil|donepezil|mesh-list
92018027|NCT03055741|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92018028|NCT03055741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018029|NCT03055741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018030|NCT03055741|Cholinergic Agents|cholinergic agents|mesh-ancestor
92018031|NCT03055741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018032|NCT03055741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018033|NCT03055741|Nootropic Agents|nootropic agents|mesh-ancestor
92018035|NCT04927039|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92018036|NCT04927039|Vasodilator Agents|vasodilator agents|mesh-ancestor
92018037|NCT04917679|Diacerein|diacerein|mesh-list
92018038|NCT04917679|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018039|NCT02443155|Liraglutide|liraglutide|mesh-list
92018040|NCT02443155|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92018041|NCT02443155|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018042|NCT02443155|Incretins|incretins|mesh-ancestor
92018043|NCT02443155|Hormones|hormones|mesh-ancestor
92018044|NCT02443155|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018045|NCT04935541|Dexmedetomidine|dexmedetomidine|mesh-list
92018046|NCT04935541|Remifentanil|remifentanil|mesh-list
92018047|NCT04935541|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92018048|NCT04935541|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018049|NCT04935541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018050|NCT04935541|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92018051|NCT04935541|Analgesics|analgesics|mesh-ancestor
92018052|NCT04935541|Sensory System Agents|sensory system agents|mesh-ancestor
92018053|NCT04935541|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018054|NCT04935541|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92018055|NCT04935541|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92018056|NCT04935541|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92018057|NCT04935541|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018058|NCT04935541|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018059|NCT04935541|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018060|NCT04935541|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92018062|NCT04935073|Cetrorelix|cetrorelix|mesh-list
92018063|NCT04935073|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92018064|NCT04935073|Hormones|hormones|mesh-ancestor
92018065|NCT04935073|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018066|NCT04935073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018067|NCT04935073|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92018068|NCT04935073|Fertility Agents|fertility agents|mesh-ancestor
92018069|NCT04935073|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018070|NCT04935073|Hormone Antagonists|hormone antagonists|mesh-ancestor
92018071|NCT04917757|Dexamethasone|dexamethasone|mesh-list
92018072|NCT04917757|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018073|NCT04917757|Antiemetics|antiemetics|mesh-ancestor
92018074|NCT04917757|Autonomic Agents|autonomic agents|mesh-ancestor
92018075|NCT04917757|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018076|NCT04917757|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018077|NCT04917757|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018078|NCT04917757|Glucocorticoids|glucocorticoids|mesh-ancestor
92018079|NCT04917757|Hormones|hormones|mesh-ancestor
92018080|NCT04917757|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018081|NCT04917757|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92018082|NCT04917757|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018083|NCT04916899|Rifampin|rifampin|mesh-list
92018085|NCT04916899|Pyrazinamide|pyrazinamide|mesh-list
92018086|NCT04916899|Ethambutol|ethambutol|mesh-list
92018087|NCT04916899|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92018088|NCT04916899|Antitubercular Agents|antitubercular agents|mesh-ancestor
92018089|NCT04916899|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92018090|NCT04916899|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018091|NCT04916899|Leprostatic Agents|leprostatic agents|mesh-ancestor
92018092|NCT04916899|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92018093|NCT04916899|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018094|NCT04916899|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018095|NCT04916899|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92018096|NCT04916899|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92018097|NCT04916899|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92018098|NCT04916899|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92018099|NCT04916899|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92018100|NCT04916899|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92018101|NCT04916899|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92018102|NCT04916899|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92018103|NCT04916899|Antimetabolites|antimetabolites|mesh-ancestor
92018104|NCT04916899|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92018105|NCT04916821|Propolis|propolis|mesh-list
92018106|NCT04916821|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018107|NCT04916665|Teduglutide|teduglutide|mesh-list
92018108|NCT04916665|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018109|NCT04916665|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92018110|NCT04916665|Protective Agents|protective agents|mesh-ancestor
92018111|NCT04916665|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018112|NCT04916353|Triamcinolone|triamcinolone|mesh-list
92018113|NCT04916353|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92018114|NCT04916353|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92018115|NCT04916353|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92018116|NCT04916353|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018117|NCT04916353|Glucocorticoids|glucocorticoids|mesh-ancestor
92018118|NCT04916353|Hormones|hormones|mesh-ancestor
92018119|NCT04916353|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018120|NCT04916353|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018121|NCT04916353|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018122|NCT04916353|Immunologic Factors|immunologic factors|mesh-ancestor
92018123|NCT04916353|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018124|NCT04916353|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018125|NCT03056599|Interferons|interferons|mesh-list
92018126|NCT03056599|Interferon-alpha|interferon-alpha|mesh-list
92018127|NCT03056599|Interferon alpha-2|interferon alpha-2|mesh-list
92018128|NCT03056599|Aldesleukin|aldesleukin|mesh-list
92018129|NCT03056599|Interferon-gamma|interferon-gamma|mesh-list
92018130|NCT03056599|Gemcitabine|gemcitabine|mesh-list
92018131|NCT03056599|Docetaxel|docetaxel|mesh-list
92018132|NCT03056599|Doxorubicin|doxorubicin|mesh-list
92018133|NCT03056599|Pembrolizumab|pembrolizumab|mesh-list
92018134|NCT03056599|Nivolumab|nivolumab|mesh-list
92018135|NCT03056599|Bortezomib|bortezomib|mesh-list
92018136|NCT03056599|Ipilimumab|ipilimumab|mesh-list
92018137|NCT03056599|Atezolizumab|atezolizumab|mesh-list
92018138|NCT03056599|Durvalumab|durvalumab|mesh-list
92018139|NCT03056599|Avelumab|avelumab|mesh-list
92018140|NCT03056599|Trabectedin|trabectedin|mesh-list
92018141|NCT03056599|Olaratumab|olaratumab|mesh-list
92018142|NCT03056599|Entrectinib|entrectinib|mesh-list
92018143|NCT03056599|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018144|NCT03056599|Antimetabolites|antimetabolites|mesh-ancestor
92018145|NCT03056599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018146|NCT03056599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018147|NCT03056599|Tubulin Modulators|tubulin modulators|mesh-ancestor
92018148|NCT03056599|Antimitotic Agents|antimitotic agents|mesh-ancestor
92018149|NCT03056599|Mitosis Modulators|mitosis modulators|mesh-ancestor
92018150|NCT03056599|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92018151|NCT03056599|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92018152|NCT03056599|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92018153|NCT03056599|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018154|NCT03056599|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018155|NCT03056599|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92018157|NCT03056599|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018158|NCT03056599|Immunologic Factors|immunologic factors|mesh-ancestor
92018159|NCT03056599|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018160|NCT03056599|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92018161|NCT03056599|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92018162|NCT03056599|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92018163|NCT03056599|Alkylating Agents|alkylating agents|mesh-ancestor
92018164|NCT03056599|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92018165|NCT04915885|Contraceptive Agents|contraceptive agents|mesh-list
92018166|NCT04915885|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018167|NCT04915885|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018168|NCT04915963|Vitamin D|vitamin d|mesh-list
92018169|NCT04915963|Vitamins|vitamins|mesh-ancestor
92018170|NCT04915963|Micronutrients|micronutrients|mesh-ancestor
92018171|NCT04915963|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018172|NCT04915963|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92018173|NCT04915807|Paclitaxel|paclitaxel|mesh-list
92018174|NCT04915807|Irinotecan|irinotecan|mesh-list
92018175|NCT04915807|Ramucirumab|ramucirumab|mesh-list
92018177|NCT04915807|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92018178|NCT04915807|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018179|NCT04915807|Tubulin Modulators|tubulin modulators|mesh-ancestor
92018180|NCT04915807|Antimitotic Agents|antimitotic agents|mesh-ancestor
92018181|NCT04915807|Mitosis Modulators|mitosis modulators|mesh-ancestor
92018182|NCT04915807|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018183|NCT04915807|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92018184|NCT04915807|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92018185|NCT04915807|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018187|NCT01360021|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92018188|NCT01360021|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018189|NCT01360021|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92018190|NCT01360021|Autonomic Agents|autonomic agents|mesh-ancestor
92018191|NCT01360021|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018192|NCT01360021|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018193|NCT01360021|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92018194|NCT01360021|Respiratory System Agents|respiratory system agents|mesh-ancestor
92018196|NCT01360021|Hormones|hormones|mesh-ancestor
92018197|NCT01360021|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018198|NCT04912297|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92018199|NCT04912297|Immunologic Factors|immunologic factors|mesh-ancestor
92018200|NCT04912297|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018201|NCT02497287|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92018202|NCT02497287|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92018203|NCT02497287|Sertraline|sertraline|mesh-list
92018204|NCT02497287|Antidepressive Agents|antidepressive agents|mesh-list
92018205|NCT02497287|Esketamine|esketamine|mesh-list
92018206|NCT02497287|Escitalopram|escitalopram|mesh-list
92018207|NCT02497287|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92018208|NCT02497287|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92018209|NCT02497287|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018210|NCT02497287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018211|NCT02497287|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018212|NCT02497287|Serotonin Agents|serotonin agents|mesh-ancestor
92018213|NCT02497287|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018214|NCT02497287|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018215|NCT02497287|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92018216|NCT02497287|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92018217|NCT02497287|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92018218|NCT02497287|Analgesics|analgesics|mesh-ancestor
92018219|NCT02497287|Sensory System Agents|sensory system agents|mesh-ancestor
92018220|NCT02497287|Dopamine Agents|dopamine agents|mesh-ancestor
92018221|NCT04912141|Complement C1 Inhibitor Protein|complement c1 inhibitor protein|mesh-list
92018222|NCT04912141|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92018223|NCT04912141|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018224|NCT04912141|Immunologic Factors|immunologic factors|mesh-ancestor
92018225|NCT04912141|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018226|NCT02458287|Bococizumab|bococizumab|mesh-list
92018227|NCT02458287|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92018229|NCT02458287|Antimetabolites|antimetabolites|mesh-ancestor
92018230|NCT02458287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018231|NCT02458287|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92018232|NCT03056053|Zolpidem|zolpidem|mesh-list
92018233|NCT03056053|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92018234|NCT03056053|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92018235|NCT03056053|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018236|NCT03056053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018237|NCT03056053|GABA-A Receptor Agonists|gaba-a receptor agonists|mesh-ancestor
92018238|NCT03056053|GABA Agonists|gaba agonists|mesh-ancestor
92018239|NCT03056053|GABA Agents|gaba agents|mesh-ancestor
92018240|NCT03056053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018241|NCT03056053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018242|NCT02496039|Quinidine|quinidine|mesh-list
92018243|NCT02496039|Dextromethorphan|dextromethorphan|mesh-list
92018244|NCT02496039|Antitussive Agents|antitussive agents|mesh-ancestor
92018245|NCT02496039|Respiratory System Agents|respiratory system agents|mesh-ancestor
92018246|NCT02496039|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92018247|NCT02496039|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92018248|NCT02496039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018249|NCT02496039|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018250|NCT02496039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018251|NCT02496039|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92018252|NCT02496039|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92018253|NCT02496039|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018254|NCT02496039|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92018255|NCT02496039|Antimalarials|antimalarials|mesh-ancestor
92018256|NCT02496039|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92018257|NCT02496039|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92018258|NCT02496039|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018259|NCT02496039|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018260|NCT02496039|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92018261|NCT02496039|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92018262|NCT02496039|Cholinergic Agents|cholinergic agents|mesh-ancestor
92018263|NCT02496039|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92018264|NCT02496039|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92018265|NCT02496039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018266|NCT02496039|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92018267|NCT02496039|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92018268|NCT04922359|Lidocaine|lidocaine|mesh-list
92018269|NCT04922359|Anesthetics, Local|anesthetics, local|mesh-ancestor
92018271|NCT04922359|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018272|NCT04922359|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018273|NCT04922359|Sensory System Agents|sensory system agents|mesh-ancestor
92018274|NCT04922359|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018275|NCT04922359|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92018276|NCT04922359|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92018277|NCT04922359|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92018278|NCT04922359|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018279|NCT04922359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018281|NCT02495883|Propranolol|propranolol|mesh-list
92018282|NCT02495883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92018283|NCT02495883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92018284|NCT02495883|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018285|NCT02495883|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018286|NCT02495883|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018287|NCT02495883|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018288|NCT02495883|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92018289|NCT02495883|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92018291|NCT02495883|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92018292|NCT02495883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018293|NCT02495883|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018295|NCT04910347|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018296|NCT04910347|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018297|NCT04910347|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92018298|NCT04910347|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018299|NCT02439957|Valganciclovir|valganciclovir|mesh-list
92018300|NCT02439957|Brincidofovir|brincidofovir|mesh-list
92018301|NCT02439957|Antiviral Agents|antiviral agents|mesh-ancestor
92018302|NCT02439957|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018303|NCT02457195|Granisetron|granisetron|mesh-list
92018304|NCT02457195|Antiemetics|antiemetics|mesh-ancestor
92018305|NCT02457195|Autonomic Agents|autonomic agents|mesh-ancestor
92018306|NCT02457195|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018307|NCT02457195|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018308|NCT02457195|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018309|NCT02457195|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92018310|NCT02457195|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92018311|NCT02457195|Serotonin Agents|serotonin agents|mesh-ancestor
92018312|NCT02457195|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018313|NCT02457195|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018314|NCT04913779|Immunomodulating Agents|immunomodulating agents|mesh-list
92018315|NCT04913779|Immunologic Factors|immunologic factors|mesh-ancestor
92018317|NCT03054259|Methylprednisolone|methylprednisolone|mesh-list
92018318|NCT03054259|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92018319|NCT03054259|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92018320|NCT03054259|Prednisolone|prednisolone|mesh-list
92018321|NCT03054259|Prednisolone acetate|prednisolone acetate|mesh-list
92018323|NCT03054259|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92018324|NCT03054259|Prednisolone phosphate|prednisolone phosphate|mesh-list
92018325|NCT03054259|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018326|NCT03054259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018327|NCT03054259|Immunologic Factors|immunologic factors|mesh-ancestor
92018328|NCT03054259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018329|NCT03054259|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92018330|NCT03054259|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018331|NCT03054259|Antiemetics|antiemetics|mesh-ancestor
92018333|NCT03054259|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018334|NCT03054259|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018335|NCT03054259|Glucocorticoids|glucocorticoids|mesh-ancestor
92018336|NCT03054259|Hormones|hormones|mesh-ancestor
92018337|NCT03054259|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018338|NCT03054259|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92018339|NCT03054259|Protective Agents|protective agents|mesh-ancestor
92018340|NCT03054259|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92018341|NCT01653327|Ketamine|ketamine|mesh-list
92018343|NCT01653327|Sensory System Agents|sensory system agents|mesh-ancestor
92018344|NCT01653327|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018345|NCT01653327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018346|NCT01653327|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92018347|NCT01653327|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92018348|NCT01653327|Anesthetics, General|anesthetics, general|mesh-ancestor
92018349|NCT01653327|Anesthetics|anesthetics|mesh-ancestor
92018350|NCT01653327|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018351|NCT01653327|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92018352|NCT01653327|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92018353|NCT01653327|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018354|NCT01653327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018356|NCT03053869|Lorazepam|lorazepam|mesh-list
92018357|NCT03053869|Alprazolam|alprazolam|mesh-list
92018358|NCT03053869|Anticonvulsants|anticonvulsants|mesh-ancestor
92018359|NCT03053869|Antiemetics|antiemetics|mesh-ancestor
92018360|NCT03053869|Autonomic Agents|autonomic agents|mesh-ancestor
92018361|NCT03053869|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018362|NCT03053869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018363|NCT03053869|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018364|NCT03053869|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92018365|NCT03053869|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018366|NCT03053869|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92018367|NCT03053869|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92018368|NCT03053869|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92018369|NCT03053869|GABA Modulators|gaba modulators|mesh-ancestor
92018370|NCT03053869|GABA Agents|gaba agents|mesh-ancestor
92018371|NCT03053869|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018372|NCT03053869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018373|NCT03053869|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92018374|NCT03053869|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92018375|NCT03053869|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92018376|NCT03053869|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92018377|NCT03053869|Anesthetics, General|anesthetics, general|mesh-ancestor
92018378|NCT03053869|Anesthetics|anesthetics|mesh-ancestor
92018379|NCT03053947|Ketamine|ketamine|mesh-list
92095903|NCT03233139|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095904|NCT03233139|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095905|NCT03233139|Antimetabolites|antimetabolites|mesh-ancestor
92095906|NCT03233139|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095907|NCT03233139|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92095908|NCT03233139|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92095909|NCT03233139|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095910|NCT03233139|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095911|NCT04763343|Ketamine|ketamine|mesh-list
92095912|NCT04763343|Analgesics|analgesics|mesh-ancestor
92095913|NCT04763343|Sensory System Agents|sensory system agents|mesh-ancestor
92095914|NCT04763343|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095915|NCT04763343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018380|NCT03053947|Analgesics|analgesics|mesh-ancestor
92018381|NCT03053947|Sensory System Agents|sensory system agents|mesh-ancestor
92018382|NCT03053947|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018383|NCT03053947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095916|NCT04763343|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92095917|NCT04763343|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92095918|NCT04763343|Anesthetics, General|anesthetics, general|mesh-ancestor
92095919|NCT04763343|Anesthetics|anesthetics|mesh-ancestor
92095920|NCT04763343|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095921|NCT04763343|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92095922|NCT04763343|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92095923|NCT04763343|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095924|NCT04763343|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095925|NCT04757571|Paroxetine|paroxetine|mesh-list
92095926|NCT04757571|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92095927|NCT04757571|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92095928|NCT04757571|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92095929|NCT04757571|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095940|NCT03232593|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095941|NCT03232593|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095942|NCT03232593|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92095943|NCT03232593|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095944|NCT04746183|Ritonavir|ritonavir|mesh-list
92095945|NCT04746183|Nitazoxanide|nitazoxanide|mesh-list
92095946|NCT04746183|Favipiravir|favipiravir|mesh-list
92095947|NCT04746183|Nirmatrelvir|nirmatrelvir|mesh-list
92095948|NCT04746183|Sotrovimab|sotrovimab|mesh-list
92095949|NCT04746183|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92095950|NCT04746183|Molnupiravir|molnupiravir|mesh-list
92095951|NCT04746183|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92095952|NCT04746183|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92095953|NCT04746183|Protease Inhibitors|protease inhibitors|mesh-ancestor
92095954|NCT04746183|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095955|NCT04746183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095956|NCT04746183|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92095957|NCT04746183|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92095958|NCT04746183|Antiviral Agents|antiviral agents|mesh-ancestor
92095959|NCT04746183|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92095960|NCT04746183|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92095961|NCT04746183|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92095962|NCT04746183|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92095963|NCT01895309|Etanercept|etanercept|mesh-list
92095964|NCT01895309|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92095965|NCT01895309|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92095966|NCT01895309|Analgesics|analgesics|mesh-ancestor
92095967|NCT01895309|Sensory System Agents|sensory system agents|mesh-ancestor
92095968|NCT01895309|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095969|NCT01895309|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095970|NCT01895309|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095971|NCT01895309|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92095972|NCT01895309|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92095973|NCT01895309|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095974|NCT01895309|Immunologic Factors|immunologic factors|mesh-ancestor
92095975|NCT04614311|Triamcinolone|triamcinolone|mesh-list
92095976|NCT04614311|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92095977|NCT04614311|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92095978|NCT04614311|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92095979|NCT04614311|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92095982|NCT04614311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095983|NCT04614311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095984|NCT04614311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92095985|NCT04614311|Immunologic Factors|immunologic factors|mesh-ancestor
92095986|NCT04614311|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095987|NCT04614311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095988|NCT03681639|Cobalt|cobalt|mesh-list
92095989|NCT03681639|Chromium|chromium|mesh-list
92095990|NCT03681639|Trace Elements|trace elements|mesh-ancestor
92095991|NCT03681639|Micronutrients|micronutrients|mesh-ancestor
92018384|NCT03053947|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92018385|NCT03053947|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92018386|NCT03053947|Anesthetics, General|anesthetics, general|mesh-ancestor
92018387|NCT03053947|Anesthetics|anesthetics|mesh-ancestor
92018388|NCT03053947|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018389|NCT03053947|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92018390|NCT03053947|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92018391|NCT03053947|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018392|NCT03053947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095992|NCT03681639|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095993|NCT03285321|Nivolumab|nivolumab|mesh-list
92095994|NCT03285321|Ipilimumab|ipilimumab|mesh-list
92095995|NCT03285321|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096014|NCT05320731|Anesthetics|anesthetics|mesh-ancestor
92096015|NCT05320731|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096016|NCT05320731|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096017|NCT05320731|Sensory System Agents|sensory system agents|mesh-ancestor
92096018|NCT05320731|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096019|NCT05320731|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92096020|NCT05320731|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92096021|NCT05320731|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92096022|NCT05320731|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096023|NCT05320731|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096024|NCT02808364|Vaccines|vaccines|mesh-list
92096025|NCT02808364|Immunologic Factors|immunologic factors|mesh-ancestor
92096026|NCT02808364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096027|NCT02709616|Vaccines|vaccines|mesh-list
92096028|NCT02709616|Immunologic Factors|immunologic factors|mesh-ancestor
92096029|NCT02709616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096030|NCT04534881|Progesterone|progesterone|mesh-list
92096031|NCT04534881|Progestins|progestins|mesh-ancestor
92096032|NCT04534881|Hormones|hormones|mesh-ancestor
92096033|NCT04534881|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096034|NCT04534881|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096035|NCT04817956|Trastuzumab|trastuzumab|mesh-list
92096036|NCT04817956|Atezolizumab|atezolizumab|mesh-list
92096037|NCT04817956|Pertuzumab|pertuzumab|mesh-list
92096038|NCT04817956|Vemurafenib|vemurafenib|mesh-list
92096039|NCT04817956|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92096040|NCT04817956|Entrectinib|entrectinib|mesh-list
92096041|NCT04817956|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096042|NCT04817956|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096043|NCT04817956|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096044|NCT04817956|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096045|NCT04817956|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096046|NCT04817956|Immunologic Factors|immunologic factors|mesh-ancestor
92096047|NCT04817956|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92096048|NCT04817956|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096049|NCT01894919|Vaccines|vaccines|mesh-list
92096051|NCT01894919|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096070|NCT05306223|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096071|NCT05306223|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92096072|NCT05306223|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92096073|NCT05306223|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92096075|NCT05306223|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096076|NCT05306223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096077|NCT05306223|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92096078|NCT05306223|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92096079|NCT05306223|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92096080|NCT05306223|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92096081|NCT05306223|Antitubercular Agents|antitubercular agents|mesh-ancestor
92096082|NCT05306223|Antimetabolites|antimetabolites|mesh-ancestor
92018393|NCT04893733|Folic Acid|folic acid|mesh-list
92018394|NCT04893733|Vitamin B Complex|vitamin b complex|mesh-list
92018395|NCT04893733|Vitamins|vitamins|mesh-ancestor
92018396|NCT04893733|Micronutrients|micronutrients|mesh-ancestor
92096083|NCT05306223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096084|NCT05306223|Leprostatic Agents|leprostatic agents|mesh-ancestor
92096085|NCT03016000|Thalidomide|thalidomide|mesh-list
92096086|NCT03016000|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096087|NCT03016000|Immunologic Factors|immunologic factors|mesh-ancestor
92096088|NCT03016000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096089|NCT03016000|Leprostatic Agents|leprostatic agents|mesh-ancestor
92096090|NCT03016000|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92096091|NCT03016000|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096092|NCT03016000|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92096093|NCT03016000|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92096094|NCT03016000|Growth Substances|growth substances|mesh-ancestor
92096095|NCT03016000|Growth Inhibitors|growth inhibitors|mesh-ancestor
92096096|NCT03016000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096097|NCT04130152|Letrozole|letrozole|mesh-list
92096098|NCT04130152|Palbociclib|palbociclib|mesh-list
92096099|NCT04130152|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096100|NCT04130152|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92096101|NCT04130152|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92096102|NCT04130152|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096103|NCT04130152|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096104|NCT04130152|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92096105|NCT04130152|Hormone Antagonists|hormone antagonists|mesh-ancestor
92096106|NCT04130152|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096107|NCT04130152|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096108|NCT04130152|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92096109|NCT03254589|Sulfasalazine|sulfasalazine|mesh-list
92096125|NCT03254589|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92096126|NCT03254589|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096127|NCT03254589|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92096128|NCT03254589|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92096129|NCT03254589|Analgesics|analgesics|mesh-ancestor
92096130|NCT03254589|Sensory System Agents|sensory system agents|mesh-ancestor
92096131|NCT03254589|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096132|NCT03254589|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096133|NCT03254589|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92096134|NCT04399395|Naltrexone|naltrexone|mesh-list
92096135|NCT04399395|Bupropion|bupropion|mesh-list
92096136|NCT04399395|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92096137|NCT04399395|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92096138|NCT04399395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096139|NCT04399395|Sensory System Agents|sensory system agents|mesh-ancestor
92096140|NCT04399395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096141|NCT04399395|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92096142|NCT04399395|Antidepressive Agents|antidepressive agents|mesh-ancestor
92096143|NCT04399395|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096144|NCT04399395|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92096145|NCT04399395|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92096146|NCT04399395|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096147|NCT04399395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096148|NCT04399395|Dopamine Agents|dopamine agents|mesh-ancestor
92096149|NCT04399395|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096150|NCT04399395|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92096151|NCT04399395|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92096152|NCT04399395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096153|NCT04613453|Midazolam|midazolam|mesh-list
92096154|NCT04613453|Ketamine|ketamine|mesh-list
92096155|NCT04613453|Analgesics|analgesics|mesh-ancestor
92096156|NCT04613453|Sensory System Agents|sensory system agents|mesh-ancestor
92096157|NCT04613453|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096158|NCT04613453|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096159|NCT04613453|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92096160|NCT04613453|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92096161|NCT04613453|Anesthetics, General|anesthetics, general|mesh-ancestor
92096162|NCT04613453|Anesthetics|anesthetics|mesh-ancestor
92096163|NCT04613453|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096164|NCT04613453|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92096165|NCT04613453|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92096166|NCT04613453|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096176|NCT02000596|Pertuzumab|pertuzumab|mesh-list
92096177|NCT02000596|Fulvestrant|fulvestrant|mesh-list
92096178|NCT02000596|Anastrozole|anastrozole|mesh-list
92096179|NCT02000596|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096180|NCT02000596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096181|NCT02000596|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92096182|NCT02000596|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92096183|NCT02000596|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92096184|NCT02000596|Hormone Antagonists|hormone antagonists|mesh-ancestor
92096185|NCT02000596|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096186|NCT02000596|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096187|NCT02000596|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92096188|NCT02000596|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92096189|NCT02000596|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096190|NCT02000596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096191|NCT03223779|Trifluridine|trifluridine|mesh-list
92096192|NCT03223779|Antimetabolites|antimetabolites|mesh-ancestor
92096193|NCT03223779|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096194|NCT03223779|Antiviral Agents|antiviral agents|mesh-ancestor
92096195|NCT03223779|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096196|NCT05168865|Letrozole|letrozole|mesh-list
92096197|NCT05168865|Estradiol|estradiol|mesh-list
92096198|NCT05168865|Progesterone|progesterone|mesh-list
92096199|NCT05168865|Estrogens|estrogens|mesh-ancestor
92096200|NCT05168865|Hormones|hormones|mesh-ancestor
92096201|NCT05168865|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096202|NCT05168865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096203|NCT05168865|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096204|NCT05168865|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92096205|NCT05168865|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92096206|NCT05168865|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096207|NCT05168865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096208|NCT05168865|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92096209|NCT05168865|Hormone Antagonists|hormone antagonists|mesh-ancestor
92096210|NCT05168865|Progestins|progestins|mesh-ancestor
92096211|NCT01882985|Lycopene|lycopene|mesh-list
92096212|NCT01882985|Docetaxel|docetaxel|mesh-list
92096213|NCT01882985|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096214|NCT01882985|Tubulin Modulators|tubulin modulators|mesh-ancestor
92096215|NCT01882985|Antimitotic Agents|antimitotic agents|mesh-ancestor
92096216|NCT01882985|Mitosis Modulators|mitosis modulators|mesh-ancestor
92096217|NCT01882985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096218|NCT01882985|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096219|NCT01882985|Antioxidants|antioxidants|mesh-ancestor
92096220|NCT01882985|Protective Agents|protective agents|mesh-ancestor
92096221|NCT01882985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096222|NCT01882985|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92096223|NCT01882985|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92096224|NCT02166346|4-Aminopyridine|4-aminopyridine|mesh-list
92096225|NCT02166346|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92096226|NCT02166346|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096227|NCT02166346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096228|NCT04460235|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92096229|NCT04460235|Immunologic Factors|immunologic factors|mesh-ancestor
92096230|NCT04460235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096231|NCT03015922|Lenalidomide|lenalidomide|mesh-list
92096232|NCT03015922|Pomalidomide|pomalidomide|mesh-list
92096245|NCT01893827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096247|NCT01882907|Vildagliptin|vildagliptin|mesh-list
92096248|NCT01882907|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92096249|NCT01882907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096250|NCT01882907|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92096251|NCT01882907|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096252|NCT01882907|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096253|NCT01882907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096254|NCT01051570|Prednisone|prednisone|mesh-list
92096255|NCT01051570|Carboplatin|carboplatin|mesh-list
92096256|NCT01051570|Everolimus|everolimus|mesh-list
92096257|NCT01051570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096258|NCT01051570|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096259|NCT01051570|Glucocorticoids|glucocorticoids|mesh-ancestor
92096260|NCT01051570|Hormones|hormones|mesh-ancestor
92096261|NCT01051570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018397|NCT04893733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018398|NCT04893733|Hematinics|hematinics|mesh-ancestor
92018399|NCT02493855|Ritonavir|ritonavir|mesh-list
92096262|NCT01051570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096263|NCT01051570|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92096264|NCT01051570|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92096265|NCT01051570|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92096266|NCT01051570|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096267|NCT01051570|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096268|NCT01051570|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096269|NCT01051570|Immunologic Factors|immunologic factors|mesh-ancestor
92096270|NCT01893281|Methyltestosterone|methyltestosterone|mesh-list
92096271|NCT01893281|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92096272|NCT01893281|Testosterone|testosterone|mesh-list
92096273|NCT01893281|Testosterone undecanoate|testosterone undecanoate|mesh-list
92096274|NCT01893281|Testosterone enanthate|testosterone enanthate|mesh-list
92096275|NCT01893281|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92096276|NCT01893281|Androgens|androgens|mesh-ancestor
92096277|NCT01893281|Hormones|hormones|mesh-ancestor
92096278|NCT01893281|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096279|NCT01893281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096280|NCT01893281|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92096281|NCT01893281|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096282|NCT01893281|Anabolic Agents|anabolic agents|mesh-ancestor
92096283|NCT02981446|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92096284|NCT02981446|Latanoprost|latanoprost|mesh-list
92096285|NCT02981446|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92096286|NCT01893203|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92096287|NCT01893203|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92096288|NCT01893203|Dermatologic Agents|dermatologic agents|mesh-ancestor
92096289|NCT05263947|Bevacizumab|bevacizumab|mesh-list
92096290|NCT05263947|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096291|NCT05263947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096292|NCT05263947|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92096293|NCT05263947|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92096294|NCT05263947|Growth Substances|growth substances|mesh-ancestor
92096305|NCT03280251|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92096306|NCT03280251|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92096307|NCT03280251|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096308|NCT03280251|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096309|NCT03280251|Dopamine Agents|dopamine agents|mesh-ancestor
92096310|NCT03280251|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096311|NCT01882829|Quinidine|quinidine|mesh-list
92096312|NCT01882829|Dextromethorphan|dextromethorphan|mesh-list
92096313|NCT01882829|Antitussive Agents|antitussive agents|mesh-ancestor
92096314|NCT01882829|Respiratory System Agents|respiratory system agents|mesh-ancestor
92096315|NCT01882829|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92096316|NCT01882829|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92096317|NCT01882829|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096318|NCT01882829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096319|NCT01882829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096320|NCT01882829|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92096321|NCT01882829|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92096322|NCT01882829|Adrenergic Agents|adrenergic agents|mesh-ancestor
92096323|NCT01882829|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92096324|NCT01882829|Antimalarials|antimalarials|mesh-ancestor
92096325|NCT01882829|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92096326|NCT01882829|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92096327|NCT01882829|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096328|NCT01882829|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096329|NCT01882829|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92096330|NCT01882829|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92096331|NCT01882829|Cholinergic Agents|cholinergic agents|mesh-ancestor
92096332|NCT01882829|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92096333|NCT01882829|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92096334|NCT01882829|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096335|NCT01882829|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92096336|NCT01882829|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92096337|NCT04760301|Tranexamic Acid|tranexamic acid|mesh-list
92096338|NCT04760301|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92096339|NCT04760301|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92096340|NCT04760301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096341|NCT04760301|Hemostatics|hemostatics|mesh-ancestor
92096342|NCT04760301|Coagulants|coagulants|mesh-ancestor
92096343|NCT01054768|Thioctic Acid|thioctic acid|mesh-list
92096344|NCT01054768|Acetylcarnitine|acetylcarnitine|mesh-list
92096345|NCT01054768|Antioxidants|antioxidants|mesh-ancestor
92096346|NCT01054768|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096347|NCT01054768|Protective Agents|protective agents|mesh-ancestor
92096348|NCT01054768|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096349|NCT01054768|Vitamin B Complex|vitamin b complex|mesh-ancestor
92096350|NCT01054768|Vitamins|vitamins|mesh-ancestor
92096351|NCT01054768|Micronutrients|micronutrients|mesh-ancestor
92096352|NCT01054768|Nootropic Agents|nootropic agents|mesh-ancestor
92096353|NCT04387617|Cannabidiol|cannabidiol|mesh-list
92096354|NCT04387617|Anticonvulsants|anticonvulsants|mesh-ancestor
92096355|NCT03014830|Alirocumab|alirocumab|mesh-list
92096356|NCT03014830|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92096357|NCT03014830|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92096358|NCT03014830|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92096372|NCT01055704|Analgesics|analgesics|mesh-ancestor
92096373|NCT01055704|Sensory System Agents|sensory system agents|mesh-ancestor
92096374|NCT01055704|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096375|NCT01055704|Antitussive Agents|antitussive agents|mesh-ancestor
92096376|NCT01055704|Respiratory System Agents|respiratory system agents|mesh-ancestor
92096377|NCT01055704|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92096378|NCT01055704|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92096379|NCT03280017|Ketamine|ketamine|mesh-list
92096380|NCT03280017|Analgesics|analgesics|mesh-ancestor
92096381|NCT03280017|Sensory System Agents|sensory system agents|mesh-ancestor
92096382|NCT03280017|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096383|NCT03280017|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096384|NCT03280017|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92096385|NCT03280017|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92096386|NCT03280017|Anesthetics, General|anesthetics, general|mesh-ancestor
92096387|NCT03280017|Anesthetics|anesthetics|mesh-ancestor
92096388|NCT03280017|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096389|NCT03280017|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92096390|NCT03280017|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92096391|NCT03280017|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096392|NCT03280017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096393|NCT01882439|Tofacitinib|tofacitinib|mesh-list
92096394|NCT01882439|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92096395|NCT01882439|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92096396|NCT01882439|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096397|NCT01882439|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096398|NCT04400019|Hydroxychloroquine|hydroxychloroquine|mesh-list
92096399|NCT04400019|Antimalarials|antimalarials|mesh-ancestor
92096400|NCT04400019|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92096401|NCT04400019|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92096402|NCT04400019|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096403|NCT04400019|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096404|NCT04400019|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096405|NCT04400019|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096406|NCT05225805|Lefamulin|lefamulin|mesh-list
92096407|NCT05225805|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92096408|NCT05225805|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096409|NCT03915405|Avelumab|avelumab|mesh-list
92096410|NCT03915405|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096411|NCT03915405|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096412|NCT04351581|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92096413|NCT04351581|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096414|NCT04351581|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096415|NCT04351581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096416|NCT01109056|Cyclosporine|cyclosporine|mesh-list
92096417|NCT01109056|Cyclosporins|cyclosporins|mesh-list
92096418|NCT01109056|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096419|NCT01109056|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096420|NCT01109056|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096433|NCT03870399|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92096434|NCT03870399|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096435|NCT03870399|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92096436|NCT03870399|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92096437|NCT03870399|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92018401|NCT02493855|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92018402|NCT02493855|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92018403|NCT02493855|Protease Inhibitors|protease inhibitors|mesh-ancestor
92018404|NCT02493855|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096439|NCT04333407|Omeprazole|omeprazole|mesh-list
92096440|NCT04333407|Rivaroxaban|rivaroxaban|mesh-list
92096441|NCT04333407|Clopidogrel|clopidogrel|mesh-list
92096442|NCT04333407|Atorvastatin|atorvastatin|mesh-list
92096443|NCT04333407|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92096444|NCT04333407|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92096445|NCT04333407|Analgesics|analgesics|mesh-ancestor
92096446|NCT04333407|Sensory System Agents|sensory system agents|mesh-ancestor
92096447|NCT04333407|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096448|NCT04333407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096449|NCT04333407|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096450|NCT04333407|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096451|NCT04333407|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92096452|NCT04333407|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92096453|NCT04333407|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096454|NCT04333407|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92096455|NCT04333407|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92096456|NCT04333407|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096457|NCT04333407|Antipyretics|antipyretics|mesh-ancestor
92096458|NCT04333407|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92096459|NCT04333407|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92096460|NCT04333407|Antimetabolites|antimetabolites|mesh-ancestor
92096461|NCT04333407|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92096462|NCT04333407|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92096463|NCT04333407|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92096464|NCT04333407|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92096465|NCT04333407|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92096466|NCT04333407|Purinergic Agents|purinergic agents|mesh-ancestor
92096467|NCT04333407|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096468|NCT04333407|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92096469|NCT04333407|Antithrombins|antithrombins|mesh-ancestor
92096470|NCT04333407|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92096471|NCT04333407|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096472|NCT04333407|Anticoagulants|anticoagulants|mesh-ancestor
92096473|NCT04333407|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92096474|NCT04333407|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92096475|NCT04333407|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92096476|NCT04398927|Folfirinox|folfirinox|mesh-list
92096477|NCT04398927|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096478|NCT01059682|Dalcetrapib|dalcetrapib|mesh-list
92096479|NCT01059682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92096480|NCT01059682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92096481|NCT01059682|Antimetabolites|antimetabolites|mesh-ancestor
92096482|NCT01059682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096500|NCT01059994|Vasodilator Agents|vasodilator agents|mesh-ancestor
92096501|NCT01059994|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92096502|NCT01059994|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92096503|NCT01059994|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096504|NCT01059994|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096505|NCT01059994|Urological Agents|urological agents|mesh-ancestor
92096506|NCT01111318|Empagliflozin|empagliflozin|mesh-list
92096507|NCT01111318|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92096508|NCT01111318|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096509|NCT01111318|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92096510|NCT01111318|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096511|NCT05165433|Pembrolizumab|pembrolizumab|mesh-list
92096512|NCT05165433|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096513|NCT05165433|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096514|NCT05165433|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096515|NCT05165433|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096517|NCT01892189|Analgesics|analgesics|mesh-ancestor
92096518|NCT01892189|Sensory System Agents|sensory system agents|mesh-ancestor
92096519|NCT01892189|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018405|NCT02493855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018406|NCT02493855|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92018407|NCT02493855|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92018408|NCT02493855|Antiviral Agents|antiviral agents|mesh-ancestor
92096520|NCT01892189|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096521|NCT01892189|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92096522|NCT01892189|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92096523|NCT01892189|Anesthetics, General|anesthetics, general|mesh-ancestor
92096524|NCT01892189|Anesthetics|anesthetics|mesh-ancestor
92096525|NCT01892189|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096526|NCT01892189|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92096527|NCT01892189|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92096528|NCT01892189|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096529|NCT01892189|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096530|NCT01062568|Dexamethasone|dexamethasone|mesh-list
92096531|NCT01062568|Cosyntropin|cosyntropin|mesh-list
92096532|NCT01062568|Adrenocorticotropic Hormone|adrenocorticotropic hormone|mesh-list
92096533|NCT01062568|Melanocyte-Stimulating Hormones|melanocyte-stimulating hormones|mesh-list
92096534|NCT01062568|beta-Endorphin|beta-endorphin|mesh-list
92096535|NCT01062568|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096536|NCT01062568|Antiemetics|antiemetics|mesh-ancestor
92096553|NCT05155137|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096554|NCT05155137|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096555|NCT05155137|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92096556|NCT05155137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096557|NCT05155137|Vasodilator Agents|vasodilator agents|mesh-ancestor
92096558|NCT05155137|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92096559|NCT05155137|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92096560|NCT05155137|Antimetabolites|antimetabolites|mesh-ancestor
92096561|NCT05155137|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92096562|NCT05155137|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92096563|NCT05155137|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096564|NCT05155137|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92096565|NCT05155137|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92096567|NCT01064284|Coagulants|coagulants|mesh-ancestor
92096568|NCT01064362|Heparin|heparin|mesh-list
92096569|NCT01064362|Heparin, Low-Molecular-Weight|heparin, low-molecular-weight|mesh-list
92096570|NCT01064362|Tinzaparin|tinzaparin|mesh-list
92096571|NCT01064362|Dalteparin|dalteparin|mesh-list
92096572|NCT01064362|PENTA|penta|mesh-list
92096573|NCT01064362|Fondaparinux|fondaparinux|mesh-list
92096575|NCT01064362|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92096576|NCT01064362|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92096577|NCT01064362|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096578|NCT01064362|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92096579|NCT01064362|Antithrombins|antithrombins|mesh-ancestor
92096580|NCT01064362|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92096581|NCT01064362|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096582|NCT01064362|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096583|NCT03646461|Nivolumab|nivolumab|mesh-list
92096584|NCT03646461|Cetuximab|cetuximab|mesh-list
92096585|NCT03646461|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096586|NCT03646461|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096587|NCT03646461|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096588|NCT03646461|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096589|NCT01880957|Lamotrigine|lamotrigine|mesh-list
92096590|NCT01880957|Lithium Carbonate|lithium carbonate|mesh-list
92096591|NCT01880957|Antidepressive Agents|antidepressive agents|mesh-ancestor
92096592|NCT01880957|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096593|NCT01880957|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096594|NCT01880957|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096609|NCT01064830|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096610|NCT01064830|Immunologic Factors|immunologic factors|mesh-ancestor
92096611|NCT01064830|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096612|NCT01064830|Antifungal Agents|antifungal agents|mesh-ancestor
92096613|NCT01064830|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096614|NCT01064830|Dermatologic Agents|dermatologic agents|mesh-ancestor
92096615|NCT01064830|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096616|NCT01064830|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92096617|NCT01890785|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92018409|NCT02493855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018410|NCT02493855|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92018411|NCT02493855|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92018413|NCT04892563|Morphine|morphine|mesh-list
92018414|NCT04892563|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92018415|NCT04892563|Narcotics|narcotics|mesh-ancestor
92096618|NCT01890785|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92096619|NCT01890785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096620|NCT01890785|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92096621|NCT01890785|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92096622|NCT01890785|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096623|NCT01890785|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096624|NCT01890785|Dopamine Agents|dopamine agents|mesh-ancestor
92096625|NCT01890785|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096626|NCT01066624|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92096627|NCT01066624|Calcium|calcium|mesh-list
92096628|NCT01066624|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92096629|NCT01066624|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096630|NCT04398771|Valsartan|valsartan|mesh-list
92096631|NCT04398771|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92096632|NCT04398771|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92096633|NCT04398771|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92096634|NCT04398771|Antimetabolites|antimetabolites|mesh-ancestor
92096635|NCT04398771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096636|NCT04398771|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92096637|NCT04398771|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92096638|NCT04398771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096639|NCT04398771|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92096640|NCT04398771|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92096641|NCT04398771|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92096642|NCT01863953|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92096643|NCT01863953|Bimatoprost|bimatoprost|mesh-list
92096644|NCT01863953|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92096645|NCT01863953|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92096646|NCT01863953|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92096647|NCT01863953|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92096648|NCT01863953|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92096649|NCT01863953|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92096650|NCT01863953|Adrenergic Agents|adrenergic agents|mesh-ancestor
92096651|NCT01863953|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096652|NCT01863953|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096670|NCT02984475|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096671|NCT01069354|Lidocaine|lidocaine|mesh-list
92096672|NCT01069354|Anesthetics, Local|anesthetics, local|mesh-ancestor
92096673|NCT01069354|Anesthetics|anesthetics|mesh-ancestor
92096674|NCT01069354|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096675|NCT01069354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096676|NCT01069354|Sensory System Agents|sensory system agents|mesh-ancestor
92096677|NCT01069354|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096678|NCT01069354|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92096679|NCT01069354|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92096680|NCT01069354|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92096681|NCT01069354|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096682|NCT01069354|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096683|NCT03080974|Nivolumab|nivolumab|mesh-list
92096684|NCT03080974|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096685|NCT03080974|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096686|NCT03080974|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096687|NCT03080974|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096688|NCT01069510|Spironolactone|spironolactone|mesh-list
92096689|NCT01069510|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92096690|NCT01069510|Hormone Antagonists|hormone antagonists|mesh-ancestor
92018416|NCT04892563|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096691|NCT01069510|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096692|NCT01069510|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096693|NCT01069510|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92096694|NCT01069510|Diuretics|diuretics|mesh-ancestor
92096695|NCT01069510|Natriuretic Agents|natriuretic agents|mesh-ancestor
92096696|NCT04278495|Losartan|losartan|mesh-list
92096697|NCT04278495|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92096698|NCT04278495|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92096699|NCT04278495|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92096700|NCT04278495|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92096701|NCT04278495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096702|NCT04276545|Midazolam|midazolam|mesh-list
92096703|NCT04276545|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92096704|NCT04276545|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92096705|NCT04276545|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096706|NCT04276545|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096707|NCT04276545|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92096708|NCT04276545|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92096730|NCT03602157|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92096731|NCT03602157|Alkylating Agents|alkylating agents|mesh-ancestor
92096733|NCT03014440|Anticonvulsants|anticonvulsants|mesh-ancestor
92096734|NCT03013036|Fentanyl|fentanyl|mesh-list
92096735|NCT03013036|Midazolam|midazolam|mesh-list
92096736|NCT03013036|Propofol|propofol|mesh-list
92096737|NCT03013036|Sevoflurane|sevoflurane|mesh-list
92096738|NCT03013036|Rocuronium|rocuronium|mesh-list
92096739|NCT03013036|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92096740|NCT03013036|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096741|NCT03013036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096742|NCT03013036|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92096743|NCT03013036|Anesthetics, General|anesthetics, general|mesh-ancestor
92096744|NCT03013036|Anesthetics|anesthetics|mesh-ancestor
92096745|NCT03013036|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92096746|NCT03013036|Narcotics|narcotics|mesh-ancestor
92096747|NCT03013036|Analgesics|analgesics|mesh-ancestor
92096748|NCT03013036|Sensory System Agents|sensory system agents|mesh-ancestor
92096749|NCT03013036|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096750|NCT03013036|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92096751|NCT03013036|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92096752|NCT03013036|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92096753|NCT03013036|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096754|NCT03013036|GABA Modulators|gaba modulators|mesh-ancestor
92096755|NCT03013036|GABA Agents|gaba agents|mesh-ancestor
92096756|NCT03013036|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096757|NCT03013036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096758|NCT03013036|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92096759|NCT03013036|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92096760|NCT03013036|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92096761|NCT03013036|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92096762|NCT03013036|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92096763|NCT01071538|Buprenorphine|buprenorphine|mesh-list
92096781|NCT04352686|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096782|NCT03146091|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92096783|NCT03146091|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096784|NCT02287311|Cyclophosphamide|cyclophosphamide|mesh-list
92096785|NCT02287311|Fludarabine|fludarabine|mesh-list
92096786|NCT02287311|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096787|NCT02287311|Immunologic Factors|immunologic factors|mesh-ancestor
92096788|NCT02287311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096789|NCT02287311|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096790|NCT02287311|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92096791|NCT02287311|Alkylating Agents|alkylating agents|mesh-ancestor
92096792|NCT02287311|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096793|NCT02287311|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096794|NCT02287311|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92096796|NCT02172742|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92096797|NCT02172742|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92096798|NCT02172742|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92096799|NCT02172742|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096800|NCT02172742|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096801|NCT02172742|Protective Agents|protective agents|mesh-ancestor
92096802|NCT02172742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096803|NCT02172742|Anticonvulsants|anticonvulsants|mesh-ancestor
92096804|NCT02172742|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92096805|NCT02172742|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92096806|NCT02172742|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096807|NCT01075204|Clarithromycin|clarithromycin|mesh-list
92096808|NCT01075204|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92096809|NCT01075204|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096810|NCT01075204|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92096811|NCT01075204|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096812|NCT01075204|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096813|NCT01075204|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92096814|NCT01075204|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92096815|NCT01120834|Azacitidine|azacitidine|mesh-list
92096816|NCT01120834|Vorinostat|vorinostat|mesh-list
92096817|NCT01120834|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92096818|NCT01120834|Antimetabolites|antimetabolites|mesh-ancestor
92096819|NCT01120834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096820|NCT01120834|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096831|NCT02623816|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92096832|NCT02623816|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92096833|NCT02623816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096834|NCT02623816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096836|NCT01122238|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92096837|NCT01122238|Autonomic Agents|autonomic agents|mesh-ancestor
92096838|NCT01122238|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096839|NCT01122238|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096840|NCT01122238|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92096841|NCT01122238|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92096842|NCT01122238|Cholinergic Agents|cholinergic agents|mesh-ancestor
92096843|NCT01122238|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096844|NCT01122238|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096845|NCT01122316|Metformin|metformin|mesh-list
92096846|NCT01122316|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92096847|NCT01122316|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096848|NCT03049449|Cyclophosphamide|cyclophosphamide|mesh-list
92096849|NCT03049449|Fludarabine|fludarabine|mesh-list
92096850|NCT03049449|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096851|NCT03049449|Immunologic Factors|immunologic factors|mesh-ancestor
92096852|NCT03049449|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096853|NCT03049449|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096854|NCT03049449|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92096855|NCT03049449|Alkylating Agents|alkylating agents|mesh-ancestor
92096856|NCT03049449|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096857|NCT03049449|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096858|NCT03049449|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92096859|NCT03186729|Fibrinolytic Agents|fibrinolytic agents|mesh-list
92096860|NCT03186729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92096861|NCT03186729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096862|NCT02399943|Panitumumab|panitumumab|mesh-list
92096863|NCT02399943|Trametinib|trametinib|mesh-list
92096864|NCT02399943|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096865|NCT02399943|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096867|NCT02399943|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096868|NCT02399943|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096869|NCT03186027|Coenzyme Q10|coenzyme q10|mesh-list
92096870|NCT03186027|Ubiquinone|ubiquinone|mesh-list
92096872|NCT03186027|Micronutrients|micronutrients|mesh-ancestor
92096873|NCT03186027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096874|NCT02595892|Gemcitabine|gemcitabine|mesh-list
92096875|NCT02595892|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92096876|NCT02595892|Antimetabolites|antimetabolites|mesh-ancestor
92096877|NCT02595892|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096878|NCT02595892|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096879|NCT04397913|Acetaminophen|acetaminophen|mesh-list
92096880|NCT04397913|Ibuprofen|ibuprofen|mesh-list
92096881|NCT04397913|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92096882|NCT04397913|Analgesics|analgesics|mesh-ancestor
92096883|NCT04397913|Sensory System Agents|sensory system agents|mesh-ancestor
92096884|NCT04397913|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096885|NCT04397913|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096886|NCT04397913|Antipyretics|antipyretics|mesh-ancestor
92018417|NCT04892563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018418|NCT04892563|Analgesics|analgesics|mesh-ancestor
92018419|NCT04892563|Sensory System Agents|sensory system agents|mesh-ancestor
92018420|NCT04892563|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096900|NCT01124188|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92096901|NCT01124188|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096902|NCT01124188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096903|NCT01124188|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096904|NCT01124188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096905|NCT01124188|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92096906|NCT01124188|Antidepressive Agents|antidepressive agents|mesh-ancestor
92096907|NCT01124188|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096908|NCT03013114|Bortezomib|bortezomib|mesh-list
92096909|NCT03013114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096910|NCT01077310|Naltrexone|naltrexone|mesh-list
92096911|NCT01077310|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92096912|NCT01077310|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92096913|NCT01077310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096914|NCT01077310|Sensory System Agents|sensory system agents|mesh-ancestor
92096915|NCT01077310|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096916|NCT02989857|Ivosidenib|ivosidenib|mesh-list
92096917|NCT02989857|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096918|NCT02989857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096919|NCT02989857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096920|NCT02393937|Metronidazole|metronidazole|mesh-list
92096921|NCT02393937|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096922|NCT02393937|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92096923|NCT02393937|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92096924|NCT02393937|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92096925|NCT01877915|Rivaroxaban|rivaroxaban|mesh-list
92096926|NCT01877915|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92096927|NCT01877915|Antithrombins|antithrombins|mesh-ancestor
92096928|NCT01877915|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92096929|NCT01877915|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096930|NCT01877915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096931|NCT01877915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096932|NCT01877915|Anticoagulants|anticoagulants|mesh-ancestor
92096933|NCT04397601|Bevacizumab|bevacizumab|mesh-list
92096934|NCT04397601|Aflibercept|aflibercept|mesh-list
92096935|NCT04397601|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096936|NCT04397601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096937|NCT04397601|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92096938|NCT04397601|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92096939|NCT04397601|Growth Substances|growth substances|mesh-ancestor
92096940|NCT04397601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096941|NCT04397601|Growth Inhibitors|growth inhibitors|mesh-ancestor
92096942|NCT02870829|Vitamin K 2|vitamin k 2|mesh-list
92096943|NCT02870829|Vitamin K|vitamin k|mesh-list
92096944|NCT02870829|Menaquinone 7|menaquinone 7|mesh-list
92096945|NCT02870829|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92096946|NCT02870829|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92096959|NCT01876823|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096960|NCT01876823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096961|NCT01876823|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096962|NCT01876823|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92096963|NCT01876823|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92096964|NCT01876823|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92096965|NCT01876823|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92096966|NCT01876823|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096967|NCT01876823|Serotonin Agents|serotonin agents|mesh-ancestor
92096968|NCT01876823|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92096969|NCT01876823|Antidepressive Agents|antidepressive agents|mesh-ancestor
92096970|NCT01876823|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096971|NCT01876511|Pembrolizumab|pembrolizumab|mesh-list
92096972|NCT01876511|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096973|NCT01876511|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096974|NCT01876511|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096975|NCT01876511|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096976|NCT01993719|Vidarabine|vidarabine|mesh-list
92096977|NCT01993719|Aldesleukin|aldesleukin|mesh-list
92018421|NCT04909255|Solifenacin Succinate|solifenacin succinate|mesh-list
92018422|NCT04909255|Mirabegron|mirabegron|mesh-list
92096978|NCT01993719|Cyclophosphamide|cyclophosphamide|mesh-list
92096979|NCT01993719|Pembrolizumab|pembrolizumab|mesh-list
92096980|NCT01993719|Fludarabine|fludarabine|mesh-list
92096981|NCT01993719|Fludarabine phosphate|fludarabine phosphate|mesh-list
92096982|NCT01993719|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096983|NCT01993719|Immunologic Factors|immunologic factors|mesh-ancestor
92096984|NCT01993719|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096985|NCT01993719|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096986|NCT01993719|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92096987|NCT01993719|Alkylating Agents|alkylating agents|mesh-ancestor
92096988|NCT01993719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096989|NCT01993719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096990|NCT01993719|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92096991|NCT01993719|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096992|NCT01993719|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096993|NCT01993719|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92096994|NCT01993719|Antimetabolites|antimetabolites|mesh-ancestor
92096995|NCT01993719|Antiviral Agents|antiviral agents|mesh-ancestor
92096996|NCT01993719|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096997|NCT01993719|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92096998|NCT01993719|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92096999|NCT02758665|Venetoclax|venetoclax|mesh-list
92097000|NCT02758665|Obinutuzumab|obinutuzumab|mesh-list
92097001|NCT02758665|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097002|NCT02758665|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097003|NCT03182673|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-list
92097004|NCT03182673|Fluzoparib|fluzoparib|mesh-list
92097005|NCT03182673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097006|NCT03182673|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097007|NCT03182673|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097008|NCT00638157|Gentamicins|gentamicins|mesh-list
92097009|NCT00638157|Daptomycin|daptomycin|mesh-list
92097010|NCT00638157|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92097011|NCT00638157|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097038|NCT05307718|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92097039|NCT05307718|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92097040|NCT05307718|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92097041|NCT05307718|Purinergic Agents|purinergic agents|mesh-ancestor
92097042|NCT05307718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097043|NCT05307718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097044|NCT05307718|Antithrombins|antithrombins|mesh-ancestor
92097045|NCT05307718|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92097046|NCT05307718|Protease Inhibitors|protease inhibitors|mesh-ancestor
92097047|NCT01033864|Mycophenolic Acid|mycophenolic acid|mesh-list
92097048|NCT01033864|Prednisone|prednisone|mesh-list
92097049|NCT01033864|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097050|NCT01033864|Glucocorticoids|glucocorticoids|mesh-ancestor
92097051|NCT01033864|Hormones|hormones|mesh-ancestor
92097052|NCT01033864|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097053|NCT01033864|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097054|NCT01033864|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097055|NCT01033864|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097056|NCT01033864|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92097057|NCT01033864|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92097070|NCT01083706|Antimetabolites|antimetabolites|mesh-ancestor
92097071|NCT01083706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097072|NCT01083706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097073|NCT01083706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097074|NCT01035346|Ibuprofen|ibuprofen|mesh-list
92097075|NCT01035346|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097076|NCT01035346|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097077|NCT01035346|Analgesics|analgesics|mesh-ancestor
92097078|NCT01035346|Sensory System Agents|sensory system agents|mesh-ancestor
92097079|NCT01035346|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097080|NCT01035346|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097081|NCT01035346|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097082|NCT01035346|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097083|NCT01035346|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92097084|NCT01035346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097085|NCT01035346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097086|NCT01085344|Factor VIII|factor viii|mesh-list
92018423|NCT04909255|Tolterodine Tartrate|tolterodine tartrate|mesh-list
92018424|NCT04909255|Oxybutynin|oxybutynin|mesh-list
92018425|NCT04909255|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92097087|NCT01085344|Coagulants|coagulants|mesh-ancestor
92097088|NCT01035658|Doxorubicin|doxorubicin|mesh-list
92097089|NCT01035658|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92097090|NCT01035658|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92097091|NCT01035658|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097092|NCT01035658|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92097093|NCT01035658|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92097094|NCT01035658|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097095|NCT01035658|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097096|NCT01037452|Calcium, Dietary|calcium, dietary|mesh-list
92097097|NCT01037452|Lansoprazole|lansoprazole|mesh-list
92097098|NCT01037452|Dexlansoprazole|dexlansoprazole|mesh-list
92097099|NCT01037452|Calcium Carbonate|calcium carbonate|mesh-list
92097100|NCT01037452|Magnesium Hydroxide|magnesium hydroxide|mesh-list
92097101|NCT01037452|Calcium|calcium|mesh-list
92097102|NCT01037452|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92097103|NCT01037452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097104|NCT01037452|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92097105|NCT01037452|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92097106|NCT01037452|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097107|NCT01037452|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92097108|NCT01037452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097109|NCT01037452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097110|NCT01037452|Antacids|antacids|mesh-ancestor
92097111|NCT03012646|Treprostinil|treprostinil|mesh-list
92097112|NCT03012646|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92097113|NCT05289856|Avelumab|avelumab|mesh-list
92097114|NCT05289856|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097115|NCT05289856|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097116|NCT00636441|Cyclophosphamide|cyclophosphamide|mesh-list
92097117|NCT00636441|Docetaxel|docetaxel|mesh-list
92097118|NCT00636441|Doxorubicin|doxorubicin|mesh-list
92097119|NCT00636441|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92097120|NCT00636441|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097131|NCT00636441|Mitosis Modulators|mitosis modulators|mesh-ancestor
92097132|NCT00636441|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92097133|NCT00636441|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92097134|NCT00636441|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92097135|NCT00636441|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097136|NCT00636363|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92097137|NCT02984397|Ketotifen|ketotifen|mesh-list
92097138|NCT02984397|Antipruritics|antipruritics|mesh-ancestor
92097139|NCT02984397|Dermatologic Agents|dermatologic agents|mesh-ancestor
92097140|NCT02984397|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92097141|NCT02984397|Histamine Antagonists|histamine antagonists|mesh-ancestor
92097142|NCT02984397|Histamine Agents|histamine agents|mesh-ancestor
92097143|NCT02984397|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097144|NCT02984397|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097145|NCT02984397|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097146|NCT02984397|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92097147|NCT01922427|RNS60|rns60|mesh-list
92097148|NCT01922427|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097149|NCT01922427|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097150|NCT01922427|Analgesics|analgesics|mesh-ancestor
92097151|NCT01922427|Sensory System Agents|sensory system agents|mesh-ancestor
92097152|NCT01922427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097153|NCT01922427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097154|NCT01922427|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097155|NCT01922427|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097156|NCT01922427|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92097157|NCT01088464|Necitumumab|necitumumab|mesh-list
92097158|NCT01088464|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92097159|NCT01088464|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097160|NCT01088464|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097161|NCT01088464|Immunologic Factors|immunologic factors|mesh-ancestor
92097162|NCT01088464|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097163|NCT01090180|Dexamethasone|dexamethasone|mesh-list
92097164|NCT01090180|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097165|NCT01090180|Antiemetics|antiemetics|mesh-ancestor
92097166|NCT01090180|Autonomic Agents|autonomic agents|mesh-ancestor
92097167|NCT01090180|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097168|NCT01090180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018426|NCT04909255|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92018427|NCT04909255|Cholinergic Agents|cholinergic agents|mesh-ancestor
92018428|NCT04909255|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097169|NCT01090180|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097170|NCT01090180|Glucocorticoids|glucocorticoids|mesh-ancestor
92097171|NCT01090180|Hormones|hormones|mesh-ancestor
92097172|NCT01090180|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097173|NCT01090180|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097174|NCT01090180|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097175|NCT00636207|Montelukast|montelukast|mesh-list
92097176|NCT00636207|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92097177|NCT00636207|Respiratory System Agents|respiratory system agents|mesh-ancestor
92097178|NCT00636207|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92097179|NCT00636207|Hormone Antagonists|hormone antagonists|mesh-ancestor
92097180|NCT00636207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097181|NCT00636207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097182|NCT00636207|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92097196|NCT01092676|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097198|NCT01092676|Analgesics|analgesics|mesh-ancestor
92097199|NCT01092676|Sensory System Agents|sensory system agents|mesh-ancestor
92097200|NCT01092676|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097201|NCT01092676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097202|NCT01092676|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097203|NCT01092676|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097204|NCT01092676|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92097205|NCT01092676|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097206|NCT01092676|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097207|NCT05273320|Dronabinol|dronabinol|mesh-list
92097208|NCT05273320|Nabilone|nabilone|mesh-list
92097209|NCT05273320|Antiemetics|antiemetics|mesh-ancestor
92097210|NCT05273320|Autonomic Agents|autonomic agents|mesh-ancestor
92097211|NCT05273320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097212|NCT05273320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097213|NCT05273320|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097214|NCT05273320|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92097215|NCT05273320|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92097216|NCT05273320|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097217|NCT05273320|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92097218|NCT05273320|Hallucinogens|hallucinogens|mesh-ancestor
92097219|NCT05273320|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097220|NCT05273320|Analgesics|analgesics|mesh-ancestor
92097221|NCT05273320|Sensory System Agents|sensory system agents|mesh-ancestor
92097222|NCT05273320|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92097223|NCT05273320|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92097224|NCT05273320|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097225|NCT05273320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097227|NCT05273320|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097228|NCT01039792|Vitamin B 12|vitamin b 12|mesh-list
92097229|NCT01039792|Vitamins|vitamins|mesh-ancestor
92097230|NCT01039792|Micronutrients|micronutrients|mesh-ancestor
92097231|NCT01039792|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097232|NCT01039792|Vitamin B Complex|vitamin b complex|mesh-ancestor
92097233|NCT01041274|Citalopram|citalopram|mesh-list
92097234|NCT01041274|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92097235|NCT01041274|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92097264|NCT00634803|Buprenorphine|buprenorphine|mesh-list
92097265|NCT00634803|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92097266|NCT00634803|Narcotics|narcotics|mesh-ancestor
92097267|NCT00634803|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097268|NCT00634803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097269|NCT00634803|Analgesics|analgesics|mesh-ancestor
92097270|NCT00634803|Sensory System Agents|sensory system agents|mesh-ancestor
92097271|NCT00634803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097272|NCT00634803|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92097273|NCT01042288|Carboplatin|carboplatin|mesh-list
92097274|NCT01042288|Pemetrexed|pemetrexed|mesh-list
92097275|NCT01042288|Panitumumab|panitumumab|mesh-list
92097276|NCT01042288|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018429|NCT04909255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018430|NCT04909255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018431|NCT04909255|Urological Agents|urological agents|mesh-ancestor
92018432|NCT04909255|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92018433|NCT04909255|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92097277|NCT01042288|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097278|NCT01042288|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097279|NCT01042288|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92097280|NCT01042288|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92097295|NCT01044706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097296|NCT04447534|Hydroxychloroquine|hydroxychloroquine|mesh-list
92097297|NCT04447534|Chloroquine|chloroquine|mesh-list
92097298|NCT04447534|Chloroquine diphosphate|chloroquine diphosphate|mesh-list
92097299|NCT04447534|Antimalarials|antimalarials|mesh-ancestor
92097300|NCT04447534|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92097301|NCT04447534|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92097302|NCT04447534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097303|NCT04447534|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097304|NCT04447534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097305|NCT04447534|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097306|NCT04447534|Amebicides|amebicides|mesh-ancestor
92097307|NCT04447534|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097308|NCT04447534|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097309|NCT04447534|Analgesics|analgesics|mesh-ancestor
92097310|NCT04447534|Sensory System Agents|sensory system agents|mesh-ancestor
92097311|NCT04447534|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097312|NCT04447534|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097313|NCT04447534|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097314|NCT04447534|Filaricides|filaricides|mesh-ancestor
92097315|NCT04447534|Antinematodal Agents|antinematodal agents|mesh-ancestor
92097316|NCT04447534|Anthelmintics|anthelmintics|mesh-ancestor
92097317|NCT01044862|Letrozole|letrozole|mesh-list
92097318|NCT01044862|Clomiphene|clomiphene|mesh-list
92097319|NCT01044862|Enclomiphene|enclomiphene|mesh-list
92097320|NCT01044862|Zuclomiphene|zuclomiphene|mesh-list
92097321|NCT01044862|Hormones|hormones|mesh-list
92097322|NCT01044862|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92097323|NCT01044862|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92097324|NCT01044862|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097325|NCT01044862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097326|NCT01044862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097327|NCT01044862|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097328|NCT01044862|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92097329|NCT01044862|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097330|NCT01044862|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92097331|NCT01044862|Hormone Antagonists|hormone antagonists|mesh-ancestor
92097332|NCT01044862|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92097333|NCT01044862|Fertility Agents|fertility agents|mesh-ancestor
92097334|NCT01044862|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92097335|NCT01044862|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92097336|NCT01044862|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92097337|NCT04361656|Lubiprostone|lubiprostone|mesh-list
92097338|NCT04361656|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92097347|NCT01047358|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92097348|NCT01047358|Hormone Antagonists|hormone antagonists|mesh-ancestor
92097349|NCT01047358|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097350|NCT01047358|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097351|NCT01048606|Phytoestrogens|phytoestrogens|mesh-list
92097352|NCT01048606|Estrogens, Non-Steroidal|estrogens, non-steroidal|mesh-ancestor
92097353|NCT01048606|Estrogens|estrogens|mesh-ancestor
92097354|NCT01048606|Hormones|hormones|mesh-ancestor
92097355|NCT01048606|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097356|NCT01048606|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097357|NCT04224766|Bupivacaine|bupivacaine|mesh-list
92097358|NCT04224766|Anesthetics, Local|anesthetics, local|mesh-ancestor
92097359|NCT04224766|Anesthetics|anesthetics|mesh-ancestor
92097360|NCT04224766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018435|NCT04909255|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018436|NCT04909255|Parasympatholytics|parasympatholytics|mesh-ancestor
92018437|NCT04909255|Autonomic Agents|autonomic agents|mesh-ancestor
92018438|NCT04909255|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097361|NCT04224766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097362|NCT04224766|Sensory System Agents|sensory system agents|mesh-ancestor
92097363|NCT04224766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097364|NCT01772004|Avelumab|avelumab|mesh-list
92097365|NCT01772004|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097366|NCT01772004|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097367|NCT02930044|Insulin|insulin|mesh-list
92097368|NCT02930044|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92097369|NCT02930044|Insulin Glargine|insulin glargine|mesh-list
92097370|NCT02930044|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92097371|NCT02930044|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097372|NCT03683524|Dolutegravir|dolutegravir|mesh-list
92097373|NCT03683524|Darunavir|darunavir|mesh-list
92097374|NCT03683524|Cobicistat|cobicistat|mesh-list
92097375|NCT03683524|Cobicistat mixture with darunavir|cobicistat mixture with darunavir|mesh-list
92097376|NCT03683524|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92097377|NCT03683524|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92097378|NCT03683524|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097379|NCT03683524|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097380|NCT03683524|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92097381|NCT03683524|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92097382|NCT03683524|Antiviral Agents|antiviral agents|mesh-ancestor
92097383|NCT03683524|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097384|NCT03683524|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92097385|NCT03683524|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92097386|NCT03683524|Protease Inhibitors|protease inhibitors|mesh-ancestor
92097387|NCT03683524|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92097388|NCT03683524|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92097389|NCT02246842|Immunoglobulins|immunoglobulins|mesh-list
92097390|NCT02246842|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92097391|NCT02246842|Antibodies|antibodies|mesh-list
92097392|NCT02246842|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92097393|NCT02246842|gamma-Globulins|gamma-globulins|mesh-list
92097394|NCT02246842|Immunologic Factors|immunologic factors|mesh-ancestor
92097395|NCT02246842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097396|NCT02182492|Clarithromycin|clarithromycin|mesh-list
92097397|NCT02182492|Glucocorticoids|glucocorticoids|mesh-list
92097398|NCT02182492|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92097399|NCT02182492|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097400|NCT02182492|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92097401|NCT02182492|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097402|NCT02182492|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097403|NCT02182492|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92097409|NCT01163656|Trace Elements|trace elements|mesh-ancestor
92097410|NCT01163656|Micronutrients|micronutrients|mesh-ancestor
92097411|NCT01163656|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097412|NCT01165840|Dapsone|dapsone|mesh-list
92097413|NCT01165840|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097414|NCT01165840|Antimalarials|antimalarials|mesh-ancestor
92097415|NCT01165840|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92097416|NCT01165840|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92097417|NCT01165840|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92097418|NCT01165840|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097419|NCT01165840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097420|NCT01165840|Leprostatic Agents|leprostatic agents|mesh-ancestor
92097421|NCT01165840|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92097422|NCT00952692|Lapatinib|lapatinib|mesh-list
92097423|NCT00952692|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097424|NCT00952692|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097425|NCT00952692|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097426|NCT00952692|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097427|NCT03535506|Palbociclib|palbociclib|mesh-list
92097428|NCT03535506|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097429|NCT03535506|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097430|NCT03535506|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097431|NCT03535506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018441|NCT04891861|Edoxaban|edoxaban|mesh-list
92018442|NCT04891861|Dabigatran|dabigatran|mesh-list
92018443|NCT04891861|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92018444|NCT04891861|Antithrombins|antithrombins|mesh-ancestor
92097432|NCT01170754|Polyethylene glycol 3350|polyethylene glycol 3350|mesh-list
92097433|NCT01170754|Laxatives|laxatives|mesh-ancestor
92097434|NCT01170754|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097435|NCT01378104|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92097436|NCT01378104|Interferon-alpha|interferon-alpha|mesh-list
92097437|NCT01378104|Antiviral Agents|antiviral agents|mesh-ancestor
92097438|NCT01378104|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097439|NCT01378104|Immunologic Factors|immunologic factors|mesh-ancestor
92097440|NCT01378104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097441|NCT01131052|Insulin|insulin|mesh-list
92097442|NCT01131052|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92097443|NCT01131052|Insulin Glargine|insulin glargine|mesh-list
92097444|NCT01131052|Insulin glulisine|insulin glulisine|mesh-list
92097445|NCT01131052|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92097446|NCT01131052|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097447|NCT01379274|Lenalidomide|lenalidomide|mesh-list
92097448|NCT01379274|Azacitidine|azacitidine|mesh-list
92097449|NCT01379274|Immunologic Factors|immunologic factors|mesh-ancestor
92097450|NCT01379274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097451|NCT01379274|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92097452|NCT01379274|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92097453|NCT01379274|Growth Substances|growth substances|mesh-ancestor
92097454|NCT01379274|Growth Inhibitors|growth inhibitors|mesh-ancestor
92097455|NCT01379274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097456|NCT01379274|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92097457|NCT01379274|Antimetabolites|antimetabolites|mesh-ancestor
92097458|NCT01379274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097459|NCT01379274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097460|NCT01171690|Teriparatide|teriparatide|mesh-list
92097461|NCT01171690|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92097462|NCT01171690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097463|NCT01171690|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92097464|NCT05396742|Ravulizumab|ravulizumab|mesh-list
92097465|NCT05396742|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92097466|NCT05396742|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097467|NCT05396742|Immunologic Factors|immunologic factors|mesh-ancestor
92097468|NCT05396742|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097469|NCT05389176|Esmolol|esmolol|mesh-list
92097470|NCT05389176|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92097471|NCT05389176|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92097472|NCT05389176|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92097473|NCT05389176|Adrenergic Agents|adrenergic agents|mesh-ancestor
92097486|NCT01132846|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097487|NCT01132846|Protective Agents|protective agents|mesh-ancestor
92097488|NCT01132846|Natriuretic Agents|natriuretic agents|mesh-ancestor
92097489|NCT01133158|Dexamethasone|dexamethasone|mesh-list
92097490|NCT01133158|Rituximab|rituximab|mesh-list
92097491|NCT01133158|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92097492|NCT01133158|Mitoxantrone|mitoxantrone|mesh-list
92097493|NCT01133158|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097494|NCT01133158|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097495|NCT01133158|Immunologic Factors|immunologic factors|mesh-ancestor
92097496|NCT01133158|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097497|NCT01133158|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097498|NCT01133158|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097499|NCT01133158|Antiemetics|antiemetics|mesh-ancestor
92097500|NCT01133158|Autonomic Agents|autonomic agents|mesh-ancestor
92097501|NCT01133158|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097502|NCT01133158|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097503|NCT01133158|Glucocorticoids|glucocorticoids|mesh-ancestor
92097505|NCT01133158|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097506|NCT01133158|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097507|NCT01133158|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92097508|NCT01133158|Alkylating Agents|alkylating agents|mesh-ancestor
92097509|NCT01133158|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097510|NCT01133158|Analgesics|analgesics|mesh-ancestor
92097511|NCT01133158|Sensory System Agents|sensory system agents|mesh-ancestor
92097512|NCT01133158|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92097513|NCT01133158|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92097514|NCT01133158|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097515|NCT05396118|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92097516|NCT05396118|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92097517|NCT05396118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097518|NCT04092894|Suvorexant|suvorexant|mesh-list
92097519|NCT04092894|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92097520|NCT04092894|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92097521|NCT04092894|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097522|NCT04092894|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097523|NCT04092894|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92097524|NCT04092894|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097525|NCT04092894|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097526|NCT01134952|Mycophenolic Acid|mycophenolic acid|mesh-list
92097527|NCT01134952|Sirolimus|sirolimus|mesh-list
92097528|NCT01134952|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92097529|NCT01134952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097530|NCT01134952|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92097531|NCT01134952|Antitubercular Agents|antitubercular agents|mesh-ancestor
92097532|NCT01134952|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92097533|NCT01134952|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097534|NCT01134952|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097553|NCT01175902|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92097554|NCT01175902|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097556|NCT01135186|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92097557|NCT01135186|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92097558|NCT01135186|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92097559|NCT01135186|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097560|NCT01135186|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92097561|NCT01135186|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097562|NCT01135186|Vasodilator Agents|vasodilator agents|mesh-ancestor
92097563|NCT05376228|Vancomycin|vancomycin|mesh-list
92097564|NCT05376228|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92097565|NCT05376228|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097566|NCT05164848|Afatinib|afatinib|mesh-list
92097567|NCT05164848|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097568|NCT05164848|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097569|NCT05164848|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097570|NCT05164848|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097571|NCT05164770|Prednisone|prednisone|mesh-list
92097572|NCT05164770|Zanubrutinib|zanubrutinib|mesh-list
92097573|NCT05164770|Cyclophosphamide|cyclophosphamide|mesh-list
92097574|NCT05164770|Vincristine|vincristine|mesh-list
92097575|NCT05164770|Rituximab|rituximab|mesh-list
92097576|NCT05164770|Doxorubicin|doxorubicin|mesh-list
92097577|NCT05164770|Etoposide|etoposide|mesh-list
92097578|NCT05164770|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097579|NCT05164770|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097580|NCT05164770|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097581|NCT05164770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097582|NCT05164770|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097583|NCT05164770|Immunologic Factors|immunologic factors|mesh-ancestor
92097584|NCT05164770|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097585|NCT05164770|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097586|NCT05164770|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92097587|NCT05164770|Alkylating Agents|alkylating agents|mesh-ancestor
92097588|NCT05164770|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92097589|NCT05164770|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097590|NCT05164770|Glucocorticoids|glucocorticoids|mesh-ancestor
92097591|NCT05164770|Hormones|hormones|mesh-ancestor
92097600|NCT05164770|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92097601|NCT05164770|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92097602|NCT00634569|gamma-Globulins|gamma-globulins|mesh-list
92097603|NCT00634569|Immunoglobulins, Intravenous|immunoglobulins, intravenous|mesh-list
92097604|NCT00634569|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92097605|NCT00634569|Immunologic Factors|immunologic factors|mesh-ancestor
92097606|NCT00634569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097607|NCT01175980|Vorinostat|vorinostat|mesh-list
92097608|NCT01175980|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097609|NCT01175980|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92018445|NCT04891861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92018446|NCT04891861|Protease Inhibitors|protease inhibitors|mesh-ancestor
92018447|NCT04891861|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018448|NCT04891861|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018449|NCT04891861|Anticoagulants|anticoagulants|mesh-ancestor
92018450|NCT03053167|Irinotecan|irinotecan|mesh-list
92018451|NCT03053167|Raltitrexed|raltitrexed|mesh-list
92018452|NCT03053167|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92018453|NCT03053167|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92097610|NCT01175980|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097611|NCT01175980|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097612|NCT04246554|Acetaminophen|acetaminophen|mesh-list
92097613|NCT04246554|Ketorolac|ketorolac|mesh-list
92097614|NCT04246554|Acetaminophen, hydrocodone drug combination|acetaminophen, hydrocodone drug combination|mesh-list
92097615|NCT04246554|Oxycodone|oxycodone|mesh-list
92097616|NCT04246554|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097617|NCT04246554|Analgesics|analgesics|mesh-ancestor
92097618|NCT04246554|Sensory System Agents|sensory system agents|mesh-ancestor
92097619|NCT04246554|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097620|NCT04246554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097621|NCT04246554|Antipyretics|antipyretics|mesh-ancestor
92097622|NCT04246554|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92097623|NCT04246554|Narcotics|narcotics|mesh-ancestor
92097624|NCT04246554|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097625|NCT04246554|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097626|NCT04246554|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097627|NCT04246554|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097628|NCT04246554|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92097629|NCT04246554|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097630|NCT04246554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097631|NCT01922817|Saxagliptin|saxagliptin|mesh-list
92097632|NCT01922817|Incretins|incretins|mesh-ancestor
92097633|NCT01922817|Hormones|hormones|mesh-ancestor
92097634|NCT01922817|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097635|NCT01922817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097636|NCT01922817|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92097637|NCT01922817|Protease Inhibitors|protease inhibitors|mesh-ancestor
92097638|NCT01922817|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097639|NCT01922817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097640|NCT01922817|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92097641|NCT04397289|Heparin|heparin|mesh-list
92097642|NCT04397289|Rivaroxaban|rivaroxaban|mesh-list
92097643|NCT04397289|Anticoagulants|anticoagulants|mesh-ancestor
92097644|NCT04397289|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92097645|NCT04397289|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92097646|NCT04397289|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097647|NCT04397289|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92097648|NCT04397289|Antithrombins|antithrombins|mesh-ancestor
92097649|NCT04397289|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92097650|NCT04397289|Protease Inhibitors|protease inhibitors|mesh-ancestor
92097651|NCT04397289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097652|NCT00634179|Prednisone|prednisone|mesh-list
92097653|NCT00634179|Cyclophosphamide|cyclophosphamide|mesh-list
92097654|NCT00634179|Rituximab|rituximab|mesh-list
92097655|NCT00634179|Doxorubicin|doxorubicin|mesh-list
92097656|NCT00634179|Vincristine|vincristine|mesh-list
92097657|NCT00634179|Bortezomib|bortezomib|mesh-list
92097666|NCT00634179|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92097667|NCT00634179|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097668|NCT00634179|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92097669|NCT00634179|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92097670|NCT00634179|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92097671|NCT00634179|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097672|NCT00634179|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097674|NCT00634179|Hormones|hormones|mesh-ancestor
92097675|NCT00634179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018455|NCT03053167|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018456|NCT03053167|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018457|NCT03053167|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018458|NCT03053167|Antimetabolites|antimetabolites|mesh-ancestor
92018459|NCT03053167|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92018460|NCT04901923|Itraconazole|itraconazole|mesh-list
92018461|NCT04901923|Acalabrutinib|acalabrutinib|mesh-list
92018462|NCT04901923|Antifungal Agents|antifungal agents|mesh-ancestor
92097676|NCT00634179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097677|NCT00634179|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92097678|NCT00634179|Tubulin Modulators|tubulin modulators|mesh-ancestor
92097679|NCT00634179|Antimitotic Agents|antimitotic agents|mesh-ancestor
92097680|NCT00634179|Mitosis Modulators|mitosis modulators|mesh-ancestor
92097681|NCT01178944|Oxaliplatin|oxaliplatin|mesh-list
92097682|NCT01178944|10-deazaaminopterin|10-deazaaminopterin|mesh-list
92097683|NCT01178944|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097684|NCT01178944|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92097685|NCT01178944|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097686|NCT01178944|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097687|NCT01179490|Prednisolone|prednisolone|mesh-list
92097688|NCT01179490|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097689|NCT01179490|Glucocorticoids|glucocorticoids|mesh-ancestor
92097690|NCT01179490|Hormones|hormones|mesh-ancestor
92097691|NCT01179490|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097692|NCT01179490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097693|NCT01179490|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097694|NCT01179490|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097695|NCT01179568|Citalopram|citalopram|mesh-list
92097696|NCT01179568|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92097697|NCT01179568|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92097698|NCT01179568|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92097804|NCT05439798|Antiemetics|antiemetics|mesh-ancestor
92097699|NCT01179568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097700|NCT01179568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097701|NCT01179568|Serotonin Agents|serotonin agents|mesh-ancestor
92097702|NCT01179568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097703|NCT01179568|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92097704|NCT01179568|Antidepressive Agents|antidepressive agents|mesh-ancestor
92097705|NCT01179568|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92097706|NCT01180036|Cyclosporine|cyclosporine|mesh-list
92097707|NCT01180036|Rituximab|rituximab|mesh-list
92097708|NCT01180036|Cyclosporins|cyclosporins|mesh-list
92097709|NCT01180036|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097710|NCT01180036|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097711|NCT01180036|Immunologic Factors|immunologic factors|mesh-ancestor
92097712|NCT01180036|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097713|NCT01180036|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097714|NCT01180036|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097715|NCT01180036|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097716|NCT01180036|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097717|NCT01180036|Antifungal Agents|antifungal agents|mesh-ancestor
92097718|NCT01180036|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097719|NCT01180036|Dermatologic Agents|dermatologic agents|mesh-ancestor
92097720|NCT01180036|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92097721|NCT01180894|Ferric Oxide, Saccharated|ferric oxide, saccharated|mesh-list
92097742|NCT01183312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097743|NCT03188172|Dexamethasone|dexamethasone|mesh-list
92097744|NCT03188172|Cyclophosphamide|cyclophosphamide|mesh-list
92097745|NCT03188172|Melphalan|melphalan|mesh-list
92097746|NCT03188172|Lenalidomide|lenalidomide|mesh-list
92097747|NCT03188172|Bortezomib|bortezomib|mesh-list
92097748|NCT03188172|Daratumumab|daratumumab|mesh-list
92097749|NCT03188172|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097750|NCT03188172|Immunologic Factors|immunologic factors|mesh-ancestor
92097751|NCT03188172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018463|NCT04901923|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018464|NCT04901923|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92018465|NCT04901923|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92097752|NCT03188172|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097753|NCT03188172|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92097754|NCT03188172|Alkylating Agents|alkylating agents|mesh-ancestor
92097755|NCT03188172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097756|NCT03188172|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097757|NCT03188172|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92097758|NCT03188172|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097759|NCT03188172|Antiemetics|antiemetics|mesh-ancestor
92097760|NCT03188172|Autonomic Agents|autonomic agents|mesh-ancestor
92097761|NCT03188172|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097762|NCT03188172|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097763|NCT03188172|Glucocorticoids|glucocorticoids|mesh-ancestor
92097764|NCT03188172|Hormones|hormones|mesh-ancestor
92097765|NCT03188172|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097766|NCT03188172|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097767|NCT03188172|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92097768|NCT03188172|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92097769|NCT03188172|Growth Substances|growth substances|mesh-ancestor
92097770|NCT03188172|Growth Inhibitors|growth inhibitors|mesh-ancestor
92097772|NCT01184014|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92097773|NCT01184014|Insulin Glargine|insulin glargine|mesh-list
92097774|NCT01184014|Insulin Lispro|insulin lispro|mesh-list
92097775|NCT01184014|Insulin, Isophane|insulin, isophane|mesh-list
92097776|NCT01184014|Isophane Insulin, Human|isophane insulin, human|mesh-list
92097777|NCT01184014|Isophane insulin, beef|isophane insulin, beef|mesh-list
92097778|NCT01184014|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92097779|NCT01184014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097780|NCT05672550|Enoxaparin|enoxaparin|mesh-list
92097781|NCT05672550|Enoxaparin sodium|enoxaparin sodium|mesh-list
92097782|NCT05672550|Anticoagulants|anticoagulants|mesh-ancestor
92097793|NCT01185028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097794|NCT01185028|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92097795|NCT02187016|Listerine|listerine|mesh-list
92097796|NCT02187016|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92097797|NCT02187016|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097798|NCT05439798|Dexamethasone|dexamethasone|mesh-list
92097799|NCT05439798|Dexamethasone acetate|dexamethasone acetate|mesh-list
92097800|NCT05439798|Ondansetron|ondansetron|mesh-list
92097801|NCT05439798|Palonosetron|palonosetron|mesh-list
92097802|NCT05439798|BB 1101|bb 1101|mesh-list
92097803|NCT05439798|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097805|NCT05439798|Autonomic Agents|autonomic agents|mesh-ancestor
92097806|NCT05439798|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097807|NCT05439798|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097808|NCT05439798|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097809|NCT05439798|Glucocorticoids|glucocorticoids|mesh-ancestor
92097810|NCT05439798|Hormones|hormones|mesh-ancestor
92097811|NCT05439798|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097812|NCT05439798|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097813|NCT05439798|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097814|NCT05439798|Protease Inhibitors|protease inhibitors|mesh-ancestor
92097815|NCT05439798|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097816|NCT05439798|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097817|NCT05439798|Antipruritics|antipruritics|mesh-ancestor
92097818|NCT05439798|Dermatologic Agents|dermatologic agents|mesh-ancestor
92097819|NCT05439798|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92097820|NCT05439798|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92097821|NCT05439798|Serotonin Agents|serotonin agents|mesh-ancestor
92097822|NCT05439798|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097823|NCT02188576|Tranexamic Acid|tranexamic acid|mesh-list
92097824|NCT02188576|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92097825|NCT02188576|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92097826|NCT02188576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097827|NCT02188576|Hemostatics|hemostatics|mesh-ancestor
92097828|NCT02188576|Coagulants|coagulants|mesh-ancestor
92097829|NCT02189122|Aspirin|aspirin|mesh-list
92097830|NCT02189122|Bradykinin|bradykinin|mesh-list
92097831|NCT02189122|Kininogens|kininogens|mesh-list
92018466|NCT04901923|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097832|NCT02189122|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097833|NCT02189122|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097834|NCT02189122|Analgesics|analgesics|mesh-ancestor
92097835|NCT02189122|Sensory System Agents|sensory system agents|mesh-ancestor
92097836|NCT02189122|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097837|NCT02189122|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097838|NCT02189122|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097839|NCT02189122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097840|NCT02189122|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92097841|NCT02189122|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92097842|NCT02189122|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097843|NCT02189122|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92097844|NCT02189122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92097845|NCT02189122|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097847|NCT02189122|Vasodilator Agents|vasodilator agents|mesh-ancestor
92097848|NCT02189122|Cysteine Proteinase Inhibitors|cysteine proteinase inhibitors|mesh-ancestor
92097849|NCT02189122|Protease Inhibitors|protease inhibitors|mesh-ancestor
92097866|NCT05309460|Autonomic Agents|autonomic agents|mesh-ancestor
92097867|NCT05309460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097868|NCT05309460|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92097869|NCT05309460|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92097870|NCT01093690|Metoclopramide|metoclopramide|mesh-list
92097871|NCT01093690|Antiemetics|antiemetics|mesh-ancestor
92097872|NCT01093690|Autonomic Agents|autonomic agents|mesh-ancestor
92097873|NCT01093690|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097874|NCT01093690|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097875|NCT01093690|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92097876|NCT01093690|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92097877|NCT01093690|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92097878|NCT01093690|Dopamine Agents|dopamine agents|mesh-ancestor
92097879|NCT01093690|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097880|NCT01093690|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097881|NCT01143688|Albuterol|albuterol|mesh-list
92097882|NCT01143688|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92097883|NCT01143688|Autonomic Agents|autonomic agents|mesh-ancestor
92097884|NCT01143688|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097885|NCT01143688|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097886|NCT01143688|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92097887|NCT01143688|Respiratory System Agents|respiratory system agents|mesh-ancestor
92097888|NCT01143688|Tocolytic Agents|tocolytic agents|mesh-ancestor
92097889|NCT01143688|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92097890|NCT01143688|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92097891|NCT01143688|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92097892|NCT01143688|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92097893|NCT01143688|Adrenergic Agents|adrenergic agents|mesh-ancestor
92097894|NCT01143688|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098298|NCT04978038|Immunologic Factors|immunologic factors|mesh-ancestor
92097895|NCT01143688|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097896|NCT04455594|Carboplatin|carboplatin|mesh-list
92097897|NCT04455594|Pemetrexed|pemetrexed|mesh-list
92097898|NCT04455594|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92097899|NCT04455594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097900|NCT04455594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097901|NCT04455594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097902|NCT04455594|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92097903|NCT04455594|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92097904|NCT04455594|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097905|NCT01143766|Gabapentin|gabapentin|mesh-list
92097906|NCT01143766|Analgesics|analgesics|mesh-ancestor
92097907|NCT01143766|Sensory System Agents|sensory system agents|mesh-ancestor
92097921|NCT05439408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097922|NCT05439408|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097923|NCT05439408|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097924|NCT05439408|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097926|NCT03011476|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92097927|NCT03011476|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097928|NCT03011476|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097929|NCT03011476|Cholinergic Agents|cholinergic agents|mesh-ancestor
92097930|NCT03011476|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097931|NCT03011476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097932|NCT03011476|Nootropic Agents|nootropic agents|mesh-ancestor
92097933|NCT02522754|Vaccines|vaccines|mesh-list
92018467|NCT04901923|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018468|NCT04901923|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92097934|NCT02522754|Immunologic Factors|immunologic factors|mesh-ancestor
92097935|NCT02522754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097936|NCT01188694|Methylene Blue|methylene blue|mesh-list
92097937|NCT01188694|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097938|NCT01188694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097939|NCT01188928|Betamethasone|betamethasone|mesh-list
92097940|NCT01188928|Betamethasone Valerate|betamethasone valerate|mesh-list
92097941|NCT01188928|Betamethasone-17,21-dipropionate|betamethasone-17,21-dipropionate|mesh-list
92097942|NCT01188928|Betamethasone benzoate|betamethasone benzoate|mesh-list
92097943|NCT01188928|Calcipotriene|calcipotriene|mesh-list
92097944|NCT01188928|Betamethasone sodium phosphate|betamethasone sodium phosphate|mesh-list
92097945|NCT01188928|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097946|NCT01188928|Glucocorticoids|glucocorticoids|mesh-ancestor
92097947|NCT01188928|Hormones|hormones|mesh-ancestor
92097948|NCT01188928|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097949|NCT01188928|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097950|NCT01188928|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92097951|NCT01188928|Respiratory System Agents|respiratory system agents|mesh-ancestor
92097952|NCT01188928|Dermatologic Agents|dermatologic agents|mesh-ancestor
92097953|NCT05438706|Carboplatin|carboplatin|mesh-list
92097954|NCT05438706|Capecitabine|capecitabine|mesh-list
92097955|NCT05438706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097956|NCT05438706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92097957|NCT05438706|Antimetabolites|antimetabolites|mesh-ancestor
92097958|NCT05438706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097959|NCT01189240|Bevacizumab|bevacizumab|mesh-list
92097960|NCT01189240|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92097961|NCT01189240|Antibodies|antibodies|mesh-list
92097962|NCT01189240|Immunoglobulins|immunoglobulins|mesh-list
92097963|NCT01189240|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92097964|NCT01189240|2,2-dimethyl-N-(6-oxo-6,7-dihydro-5H-dibenzo(b,d)azepin-7-yl)-N'-(2,2,3,3,3-pentafluoropropyl)malonamide|2,2-dimethyl-n-(6-oxo-6,7-dihydro-5h-dibenzo(b,d)azepin-7-yl)-n'-(2,2,3,3,3-pentafluoropropyl)malonamide|mesh-list
92097965|NCT01189240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097966|NCT01189240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92097974|NCT01189240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097976|NCT03467334|Antifoaming Agents|antifoaming agents|mesh-ancestor
92097977|NCT03467334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097978|NCT03467334|Emollients|emollients|mesh-ancestor
92097979|NCT03467334|Dermatologic Agents|dermatologic agents|mesh-ancestor
92097980|NCT02874144|Mometasone Furoate|mometasone furoate|mesh-list
92097981|NCT02874144|Fluticasone|fluticasone|mesh-list
92097982|NCT02874144|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097983|NCT02874144|Dermatologic Agents|dermatologic agents|mesh-ancestor
92097984|NCT02874144|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92097985|NCT02874144|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92097986|NCT02874144|Autonomic Agents|autonomic agents|mesh-ancestor
92097987|NCT02874144|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097988|NCT02874144|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097989|NCT02874144|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92097990|NCT02874144|Respiratory System Agents|respiratory system agents|mesh-ancestor
92097992|NCT03467178|Carboplatin|carboplatin|mesh-list
92097993|NCT03467178|Gemcitabine|gemcitabine|mesh-list
92097994|NCT03467178|Doxorubicin|doxorubicin|mesh-list
92097995|NCT03467178|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92097996|NCT03467178|Decitabine|decitabine|mesh-list
92097997|NCT03467178|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92097998|NCT03467178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097999|NCT03467178|Tubulin Modulators|tubulin modulators|mesh-ancestor
92098000|NCT03467178|Antimitotic Agents|antimitotic agents|mesh-ancestor
92098001|NCT03467178|Mitosis Modulators|mitosis modulators|mesh-ancestor
92098002|NCT03467178|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098003|NCT03467178|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92098004|NCT03467178|Antimetabolites|antimetabolites|mesh-ancestor
92098005|NCT03467178|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92098006|NCT03467178|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92098007|NCT03467178|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92098008|NCT03467178|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098009|NCT02835534|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92098010|NCT02835534|Plasminogen|plasminogen|mesh-list
92098011|NCT02835534|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92018469|NCT04901923|Hormone Antagonists|hormone antagonists|mesh-ancestor
92098012|NCT02835534|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92098013|NCT02835534|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098014|NCT02722200|Hydrocortisone|hydrocortisone|mesh-list
92098015|NCT02722200|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098016|NCT01094548|Cyclophosphamide|cyclophosphamide|mesh-list
92098017|NCT01094548|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098018|NCT01094548|Immunologic Factors|immunologic factors|mesh-ancestor
92098019|NCT01094548|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098020|NCT01094548|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098021|NCT01094548|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098022|NCT01094548|Alkylating Agents|alkylating agents|mesh-ancestor
92098023|NCT01094548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098024|NCT01094548|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098025|NCT01094548|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92098026|NCT02611830|Vedolizumab|vedolizumab|mesh-list
92098027|NCT02611830|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098028|NCT03461718|Fentanyl|fentanyl|mesh-list
92098029|NCT03461718|Midazolam|midazolam|mesh-list
92098030|NCT03461718|Ketamine|ketamine|mesh-list
92098031|NCT03461718|Analgesics|analgesics|mesh-ancestor
92098032|NCT03461718|Sensory System Agents|sensory system agents|mesh-ancestor
92098033|NCT03461718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098034|NCT03461718|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098065|NCT03467022|Micronutrients|micronutrients|mesh-ancestor
92098066|NCT03467022|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098068|NCT03467022|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098069|NCT03467022|Protective Agents|protective agents|mesh-ancestor
92098071|NCT03129594|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92098072|NCT03129594|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098073|NCT03129594|Hormones|hormones|mesh-ancestor
92098074|NCT03129594|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098075|NCT03129594|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098076|NCT03129594|Incretins|incretins|mesh-ancestor
92098077|NCT03466632|Dexmedetomidine|dexmedetomidine|mesh-list
92098078|NCT03466632|Propofol|propofol|mesh-list
92098079|NCT03466632|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92098080|NCT03466632|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098097|NCT05339334|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92098098|NCT05339334|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92098099|NCT05339334|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098100|NCT05339334|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098101|NCT05339334|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098102|NCT05339334|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92098103|NCT05339334|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92098104|NCT05339334|Antiviral Agents|antiviral agents|mesh-ancestor
92098105|NCT05339334|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098106|NCT05339334|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92098107|NCT05339334|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92098108|NCT03461328|Magnesium Sulfate|magnesium sulfate|mesh-list
92098110|NCT03461328|Sensory System Agents|sensory system agents|mesh-ancestor
92098111|NCT03461328|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098112|NCT03461328|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098113|NCT03461328|Anesthetics|anesthetics|mesh-ancestor
92098114|NCT03461328|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098115|NCT03461328|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92098116|NCT03461328|Anticonvulsants|anticonvulsants|mesh-ancestor
92098117|NCT03461328|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92098118|NCT03461328|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098119|NCT03461328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098120|NCT03461328|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92098121|NCT03461328|Tocolytic Agents|tocolytic agents|mesh-ancestor
92098122|NCT03461328|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92098123|NCT01145638|Iron|iron|mesh-list
92098124|NCT01145638|Iron isomaltoside 1000|iron isomaltoside 1000|mesh-list
92098125|NCT01145638|Trace Elements|trace elements|mesh-ancestor
92098126|NCT01145638|Micronutrients|micronutrients|mesh-ancestor
92098127|NCT01145638|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098128|NCT01145638|Hematinics|hematinics|mesh-ancestor
92098129|NCT03466320|Cyclophosphamide|cyclophosphamide|mesh-list
92098130|NCT03466320|Fludarabine|fludarabine|mesh-list
92098131|NCT03466320|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098132|NCT03466320|Immunologic Factors|immunologic factors|mesh-ancestor
92018470|NCT04901923|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018471|NCT04901923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018472|NCT04901923|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92098133|NCT03466320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098134|NCT03466320|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098135|NCT03466320|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098136|NCT03466320|Alkylating Agents|alkylating agents|mesh-ancestor
92098137|NCT03466320|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098138|NCT03466320|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098148|NCT03466242|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098149|NCT03466242|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92098150|NCT03466242|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92098152|NCT03466242|Adrenergic Agents|adrenergic agents|mesh-ancestor
92098153|NCT03466242|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098154|NCT03466242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098155|NCT03466242|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92098156|NCT03466242|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92098157|NCT03466242|Anesthetics, General|anesthetics, general|mesh-ancestor
92098158|NCT03466242|Anesthetics|anesthetics|mesh-ancestor
92098159|NCT03466242|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92098160|NCT03466242|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92098161|NCT01190878|Bromfenac|bromfenac|mesh-list
92098162|NCT01190878|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92098163|NCT01190878|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098164|NCT01190878|Analgesics|analgesics|mesh-ancestor
92098165|NCT01190878|Sensory System Agents|sensory system agents|mesh-ancestor
92098166|NCT01190878|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098167|NCT01190878|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098168|NCT01190878|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098169|NCT01190878|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098170|NCT01146808|Adefovir|adefovir|mesh-list
92098171|NCT01146808|Adefovir dipivoxil|adefovir dipivoxil|mesh-list
92098172|NCT01146808|Antiviral Agents|antiviral agents|mesh-ancestor
92098173|NCT01146808|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098174|NCT01146808|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92098175|NCT01146808|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92098176|NCT01146808|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098177|NCT01146808|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098178|NCT02522130|Naproxen|naproxen|mesh-list
92098179|NCT02522130|Lidocaine|lidocaine|mesh-list
92098180|NCT02522130|Misoprostol|misoprostol|mesh-list
92098181|NCT02522130|Anesthetics, Local|anesthetics, local|mesh-ancestor
92098182|NCT02522130|Anesthetics|anesthetics|mesh-ancestor
92098183|NCT02522130|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098184|NCT02522130|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098185|NCT02522130|Sensory System Agents|sensory system agents|mesh-ancestor
92098186|NCT02522130|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098187|NCT02522130|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92098188|NCT02522130|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92098189|NCT02522130|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92098190|NCT02522130|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098191|NCT02522130|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098192|NCT02522130|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92098193|NCT02522130|Abortifacient Agents|abortifacient agents|mesh-ancestor
92098194|NCT02522130|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92098195|NCT02522130|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92098196|NCT02522130|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098198|NCT02522130|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92098199|NCT02522130|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098200|NCT02522130|Analgesics|analgesics|mesh-ancestor
92098201|NCT02522130|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098224|NCT05215236|Opiate Alkaloids|opiate alkaloids|mesh-list
92098225|NCT05215236|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92098226|NCT05215236|Narcotics|narcotics|mesh-ancestor
92098227|NCT05215236|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098228|NCT05215236|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018473|NCT04901923|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018474|NCT03050905|Ritonavir|ritonavir|mesh-list
92018475|NCT03050905|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92018476|NCT03050905|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92018477|NCT03050905|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098229|NCT05215236|Analgesics|analgesics|mesh-ancestor
92098230|NCT05215236|Sensory System Agents|sensory system agents|mesh-ancestor
92098231|NCT05215236|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098232|NCT03460782|Ipilimumab|ipilimumab|mesh-list
92098233|NCT03460782|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92098234|NCT03460782|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098235|NCT03460782|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92098236|NCT03460782|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098237|NCT01099618|Metformin|metformin|mesh-list
92098238|NCT01099618|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92098239|NCT01099618|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92098240|NCT01099618|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098241|NCT01099618|Incretins|incretins|mesh-ancestor
92098242|NCT01099618|Hormones|hormones|mesh-ancestor
92098243|NCT01099618|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098244|NCT01099618|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92098245|NCT01099618|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098246|NCT01099618|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098247|NCT01099618|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098248|NCT01099774|Bimatoprost|bimatoprost|mesh-list
92098249|NCT01099774|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92098250|NCT01099774|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92098251|NCT01099774|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92098252|NCT01100242|Bortezomib|bortezomib|mesh-list
92098253|NCT01100242|Sorafenib|sorafenib|mesh-list
92098254|NCT01100242|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098255|NCT01100242|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92098256|NCT01100242|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098257|NCT01100242|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098271|NCT01149616|Hormones|hormones|mesh-ancestor
92098272|NCT01149616|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098273|NCT01149616|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098274|NCT01149616|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098275|NCT03460470|Sildenafil Citrate|sildenafil citrate|mesh-list
92098276|NCT03460470|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098277|NCT03460470|Phosphodiesterase 5 Inhibitors|phosphodiesterase 5 inhibitors|mesh-ancestor
92098278|NCT03460470|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92098279|NCT03460470|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098280|NCT03460470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098281|NCT03460470|Urological Agents|urological agents|mesh-ancestor
92098282|NCT01101100|Brodalumab|brodalumab|mesh-list
92098283|NCT01101100|Dermatologic Agents|dermatologic agents|mesh-ancestor
92098284|NCT03460392|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92098285|NCT03460392|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098286|NCT01101880|Cytarabine|cytarabine|mesh-list
92098287|NCT01101880|Clofarabine|clofarabine|mesh-list
92098288|NCT01101880|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92098289|NCT01101880|Antimetabolites|antimetabolites|mesh-ancestor
92098290|NCT01101880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098291|NCT01101880|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098292|NCT01101880|Antiviral Agents|antiviral agents|mesh-ancestor
92098293|NCT01101880|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098294|NCT01101880|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098295|NCT01101880|Immunologic Factors|immunologic factors|mesh-ancestor
92098296|NCT01101880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098297|NCT04978038|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92098299|NCT04978038|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098300|NCT03011632|Mometasone Furoate|mometasone furoate|mesh-list
92098301|NCT03011632|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098302|NCT03011632|Dermatologic Agents|dermatologic agents|mesh-ancestor
92098303|NCT03011632|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92098304|NCT01102270|Eszopiclone|eszopiclone|mesh-list
92098305|NCT01102270|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92098306|NCT01102270|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098307|NCT01102270|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098308|NCT01103440|polysaccharide-K|polysaccharide-k|mesh-list
92098309|NCT01103440|Tirofiban|tirofiban|mesh-list
92098310|NCT01103440|Ticlopidine|ticlopidine|mesh-list
92098311|NCT01103440|Abciximab|abciximab|mesh-list
92098312|NCT01103440|Clopidogrel|clopidogrel|mesh-list
92098313|NCT01103440|Prasugrel Hydrochloride|prasugrel hydrochloride|mesh-list
92098314|NCT01103440|Cangrelor|cangrelor|mesh-list
92098315|NCT01103440|Eptifibatide|eptifibatide|mesh-list
92098316|NCT01103440|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92098317|NCT01103440|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92098318|NCT01103440|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92098319|NCT01103440|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92098320|NCT01103440|Purinergic Agents|purinergic agents|mesh-ancestor
92098321|NCT01103440|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098340|NCT01105312|Panobinostat|panobinostat|mesh-list
92098341|NCT01105312|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098342|NCT01105312|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92098343|NCT01105312|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92098344|NCT01105312|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098345|NCT01105312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098346|NCT01105312|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92098347|NCT01105312|Hormone Antagonists|hormone antagonists|mesh-ancestor
92098348|NCT01105312|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098349|NCT01105312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098350|NCT01105312|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92098351|NCT04488978|Amlodipine|amlodipine|mesh-list
92098352|NCT04488978|Irbesartan|irbesartan|mesh-list
92098353|NCT04488978|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92098354|NCT04488978|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92098355|NCT04488978|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098356|NCT04488978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098357|NCT04488978|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92098358|NCT04488978|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098359|NCT04488978|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098360|NCT04488978|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92098361|NCT04488978|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92098362|NCT03460002|Vaccines|vaccines|mesh-list
92098363|NCT03460002|Immunologic Factors|immunologic factors|mesh-ancestor
92098364|NCT03460002|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098365|NCT01105702|Bevacizumab|bevacizumab|mesh-list
92098366|NCT01105702|Temozolomide|temozolomide|mesh-list
92098367|NCT01105702|Lithium Carbonate|lithium carbonate|mesh-list
92098368|NCT01105702|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92098369|NCT01105702|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098370|NCT01105702|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92098371|NCT01105702|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92098372|NCT01105702|Growth Substances|growth substances|mesh-ancestor
92098373|NCT01105702|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098374|NCT01105702|Growth Inhibitors|growth inhibitors|mesh-ancestor
92098375|NCT01105702|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098390|NCT04453332|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098391|NCT04453332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098393|NCT04453332|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92098394|NCT04453332|Contraceptive Agents|contraceptive agents|mesh-ancestor
92098395|NCT04453332|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92098396|NCT04453332|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92098397|NCT04453332|Progestins|progestins|mesh-ancestor
92098398|NCT03456570|Dydrogesterone|dydrogesterone|mesh-list
92098399|NCT03456570|Progestins|progestins|mesh-ancestor
92098400|NCT03456570|Hormones|hormones|mesh-ancestor
92098401|NCT03456570|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098402|NCT03456570|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098403|NCT03468348|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92098404|NCT03468348|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92098518|NCT01153672|Hormone Antagonists|hormone antagonists|mesh-ancestor
92098405|NCT03468348|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92098406|NCT03468348|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098407|NCT03468348|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098408|NCT03468348|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098409|NCT03468348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018478|NCT03050905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018479|NCT03050905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098411|NCT03468348|Sensory System Agents|sensory system agents|mesh-ancestor
92098412|NCT03468348|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098413|NCT03468348|Antidepressive Agents|antidepressive agents|mesh-ancestor
92098414|NCT03468348|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098415|NCT03468348|Dopamine Agents|dopamine agents|mesh-ancestor
92098416|NCT03464682|Atorvastatin|atorvastatin|mesh-list
92098417|NCT03464682|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92098418|NCT03464682|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92098419|NCT03464682|Antimetabolites|antimetabolites|mesh-ancestor
92098420|NCT03464682|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098421|NCT03464682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92098422|NCT03464682|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92098423|NCT03464682|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098424|NCT03464058|Rabeprazole|rabeprazole|mesh-list
92098425|NCT03464058|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92098426|NCT03464058|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098427|NCT03464058|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92098428|NCT03464058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098429|NCT03464058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098430|NCT03451734|Metformin|metformin|mesh-list
92098431|NCT03451734|Antipsychotic Agents|antipsychotic agents|mesh-list
92098432|NCT03451734|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92098433|NCT03451734|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098434|NCT03451734|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92098435|NCT03451734|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098436|NCT03451734|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098460|NCT01106950|Cyclophosphamide|cyclophosphamide|mesh-list
92098462|NCT01106950|Interleukin-2|interleukin-2|mesh-list
92098463|NCT01106950|Denileukin diftitox|denileukin diftitox|mesh-list
92098464|NCT01106950|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098465|NCT01106950|Immunologic Factors|immunologic factors|mesh-ancestor
92098466|NCT01106950|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098467|NCT01106950|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098468|NCT01106950|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098469|NCT01106950|Alkylating Agents|alkylating agents|mesh-ancestor
92098470|NCT01106950|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098471|NCT01106950|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098472|NCT01106950|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92098473|NCT01106950|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098474|NCT01106950|Analgesics|analgesics|mesh-ancestor
92098475|NCT01106950|Sensory System Agents|sensory system agents|mesh-ancestor
92098476|NCT01106950|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098477|NCT03463044|Nangibotide|nangibotide|mesh-list
92098478|NCT03463044|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098479|NCT02522208|Hydralazine|hydralazine|mesh-list
92098480|NCT02522208|Isosorbide|isosorbide|mesh-list
92098481|NCT02522208|Isosorbide Dinitrate|isosorbide dinitrate|mesh-list
92098482|NCT02522208|Isosorbide-5-mononitrate|isosorbide-5-mononitrate|mesh-list
92098483|NCT02522208|Diuretics, Osmotic|diuretics, osmotic|mesh-ancestor
92098484|NCT02522208|Diuretics|diuretics|mesh-ancestor
92098485|NCT02522208|Natriuretic Agents|natriuretic agents|mesh-ancestor
92098486|NCT02522208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098487|NCT02522208|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098501|NCT01200160|Vitamin B Complex|vitamin b complex|mesh-ancestor
92098503|NCT01200160|Micronutrients|micronutrients|mesh-ancestor
92098504|NCT01200160|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098505|NCT04908228|Obinutuzumab|obinutuzumab|mesh-list
92098506|NCT04908228|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92098507|NCT04908228|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098509|NCT01153672|Anastrozole|anastrozole|mesh-list
92098510|NCT01153672|Vorinostat|vorinostat|mesh-list
92098511|NCT01153672|Exemestane|exemestane|mesh-list
92098512|NCT01153672|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098513|NCT01153672|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92098514|NCT01153672|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92098515|NCT01153672|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098516|NCT01153672|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098517|NCT01153672|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92098519|NCT01153672|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018480|NCT03050905|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92018481|NCT03050905|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92018482|NCT03050905|Antiviral Agents|antiviral agents|mesh-ancestor
92018483|NCT03050905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098520|NCT01153672|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098521|NCT01153672|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098522|NCT01153672|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92098523|NCT03010072|Ferric Compounds|ferric compounds|mesh-list
92098524|NCT03010072|Hematinics|hematinics|mesh-ancestor
92098525|NCT03462810|Cabotegravir|cabotegravir|mesh-list
92098526|NCT03462810|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92098527|NCT03462810|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92098528|NCT03462810|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098529|NCT03462810|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098530|NCT03462810|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92098531|NCT03462810|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92098532|NCT03462810|Antiviral Agents|antiviral agents|mesh-ancestor
92098533|NCT03462810|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098534|NCT01219738|Budesonide|budesonide|mesh-list
92098535|NCT01219738|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098536|NCT01219738|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92098537|NCT01219738|Autonomic Agents|autonomic agents|mesh-ancestor
92098538|NCT01219738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098539|NCT01219738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098540|NCT01219738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92098541|NCT01219738|Respiratory System Agents|respiratory system agents|mesh-ancestor
92098542|NCT01219738|Glucocorticoids|glucocorticoids|mesh-ancestor
92098543|NCT01219738|Hormones|hormones|mesh-ancestor
92098544|NCT01219738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098545|NCT03848754|Gemtuzumab|gemtuzumab|mesh-list
92098546|NCT03848754|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92098547|NCT03848754|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098548|NCT03848754|Immunotoxins|immunotoxins|mesh-ancestor
92098549|NCT03848754|Immunoconjugates|immunoconjugates|mesh-ancestor
92098570|NCT04614714|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098571|NCT04614714|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92098572|NCT04614714|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098573|NCT01221298|Ritonavir|ritonavir|mesh-list
92098574|NCT01221298|Ribavirin|ribavirin|mesh-list
92098575|NCT01221298|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92098576|NCT01221298|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92098577|NCT01221298|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098578|NCT01221298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098579|NCT01221298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098580|NCT01221298|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92098581|NCT01221298|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92098582|NCT01221298|Antiviral Agents|antiviral agents|mesh-ancestor
92098583|NCT01221298|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098584|NCT01221298|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92098585|NCT01221298|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92098586|NCT01221298|Antimetabolites|antimetabolites|mesh-ancestor
92098587|NCT01222234|Vitamin D|vitamin d|mesh-list
92098588|NCT01222234|Ergocalciferols|ergocalciferols|mesh-list
92098589|NCT01222234|Cholecalciferol|cholecalciferol|mesh-list
92098590|NCT01222234|Calcitriol|calcitriol|mesh-list
92098591|NCT01222234|Vitamins|vitamins|mesh-list
92098592|NCT01222234|Micronutrients|micronutrients|mesh-ancestor
92098593|NCT01222234|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098594|NCT01222234|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92098595|NCT01222234|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92098596|NCT01222234|Calcium Channel Agonists|calcium channel agonists|mesh-ancestor
92098597|NCT01222234|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098598|NCT01222234|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098599|NCT01222234|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92098600|NCT01203046|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92098601|NCT01203046|Ertapenem|ertapenem|mesh-list
92098602|NCT01203046|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098603|NCT02460588|Prednisolone|prednisolone|mesh-list
92098604|NCT02460588|Cyclophosphamide|cyclophosphamide|mesh-list
92098605|NCT02460588|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098606|NCT02460588|Immunologic Factors|immunologic factors|mesh-ancestor
92098607|NCT02460588|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098641|NCT04155840|Immunologic Factors|immunologic factors|mesh-ancestor
92018484|NCT03050905|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92018485|NCT03050905|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92018486|NCT03050827|Oxybutynin|oxybutynin|mesh-list
92018487|NCT03050827|Parasympatholytics|parasympatholytics|mesh-ancestor
92098642|NCT04155840|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098643|NCT04155840|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098644|NCT04155840|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098645|NCT04155840|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098646|NCT04155840|Alkylating Agents|alkylating agents|mesh-ancestor
92098647|NCT04155840|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098648|NCT03448770|Lactulose|lactulose|mesh-list
92098682|NCT01206478|Amitriptyline|amitriptyline|mesh-list
92098683|NCT01206478|Antidepressive Agents, Tricyclic|antidepressive agents, tricyclic|mesh-ancestor
92098684|NCT01206478|Antidepressive Agents|antidepressive agents|mesh-ancestor
92098685|NCT01206478|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098686|NCT01206478|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098687|NCT01206478|Analgesics|analgesics|mesh-ancestor
92098688|NCT01206478|Sensory System Agents|sensory system agents|mesh-ancestor
92098689|NCT01206478|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098690|NCT01206478|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098705|NCT01206478|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098706|NCT04963530|Lithium Carbonate|lithium carbonate|mesh-list
92098707|NCT04963530|Antidepressive Agents|antidepressive agents|mesh-ancestor
92098708|NCT04963530|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098709|NCT04963530|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098710|NCT04963530|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098711|NCT04963530|Antimanic Agents|antimanic agents|mesh-ancestor
92098712|NCT04963530|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92098713|NCT04963530|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098714|NCT04963530|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098716|NCT01158820|Fentanyl|fentanyl|mesh-list
92098717|NCT01158820|Midazolam|midazolam|mesh-list
92098718|NCT01158820|Dexmedetomidine|dexmedetomidine|mesh-list
92098719|NCT01158820|Ketamine|ketamine|mesh-list
92098720|NCT01158820|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92098721|NCT01158820|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098722|NCT01158820|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098723|NCT01158820|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098724|NCT01158820|Analgesics|analgesics|mesh-ancestor
92098725|NCT01158820|Sensory System Agents|sensory system agents|mesh-ancestor
92098726|NCT01158820|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098727|NCT01158820|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92098728|NCT01158820|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92098729|NCT01158820|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92098730|NCT01158820|Adrenergic Agents|adrenergic agents|mesh-ancestor
92098731|NCT01158820|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098732|NCT01158820|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098733|NCT01158820|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92098734|NCT01158820|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92098735|NCT01158820|Anesthetics, General|anesthetics, general|mesh-ancestor
92098736|NCT01158820|Anesthetics|anesthetics|mesh-ancestor
92098737|NCT01158820|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92098738|NCT01158820|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92098739|NCT01158820|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92098740|NCT01158820|Narcotics|narcotics|mesh-ancestor
92098741|NCT01158820|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92098742|NCT01158820|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92098743|NCT01158820|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92098745|NCT01158820|GABA Modulators|gaba modulators|mesh-ancestor
92098746|NCT01158820|GABA Agents|gaba agents|mesh-ancestor
92098747|NCT01158820|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92098748|NCT01158820|Anesthetics, Local|anesthetics, local|mesh-ancestor
92098749|NCT01158820|Antiemetics|antiemetics|mesh-ancestor
92098778|NCT02521662|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098779|NCT02521662|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92098780|NCT02521662|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92098781|NCT02521662|Cholinergic Agents|cholinergic agents|mesh-ancestor
92098782|NCT02521662|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098783|NCT02521662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018488|NCT03050827|Autonomic Agents|autonomic agents|mesh-ancestor
92018489|NCT03050827|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018490|NCT03050827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098784|NCT03499704|Metformin|metformin|mesh-list
92098785|NCT03499704|Pioglitazone|pioglitazone|mesh-list
92098786|NCT03499704|Dapagliflozin|dapagliflozin|mesh-list
92098787|NCT03499704|Alogliptin|alogliptin|mesh-list
92098788|NCT03499704|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92098789|NCT03499704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098900|NCT01212952|Dexamethasone|dexamethasone|mesh-list
92098790|NCT03499704|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92098791|NCT03499704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098792|NCT03499704|Incretins|incretins|mesh-ancestor
92098793|NCT03499704|Hormones|hormones|mesh-ancestor
92098794|NCT03499704|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098795|NCT03499704|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92098820|NCT01209442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098821|NCT01209442|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92098822|NCT01209442|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92098823|NCT01209442|Growth Substances|growth substances|mesh-ancestor
92098824|NCT01209442|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098825|NCT01209442|Growth Inhibitors|growth inhibitors|mesh-ancestor
92098826|NCT01209442|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098827|NCT01209442|Alkylating Agents|alkylating agents|mesh-ancestor
92098828|NCT01209442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098829|NCT01160380|Modafinil|modafinil|mesh-list
92098830|NCT01160380|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92098831|NCT01160380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098832|NCT01160380|Wakefulness-Promoting Agents|wakefulness-promoting agents|mesh-ancestor
92098833|NCT01160380|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92098834|NCT01160380|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92098835|NCT01160380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098836|NCT04956042|Cytarabine|cytarabine|mesh-list
92098837|NCT04956042|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92098838|NCT04956042|Antimetabolites|antimetabolites|mesh-ancestor
92098839|NCT04956042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098840|NCT04956042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098841|NCT04956042|Antiviral Agents|antiviral agents|mesh-ancestor
92098842|NCT04956042|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098843|NCT04956042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098844|NCT04956042|Immunologic Factors|immunologic factors|mesh-ancestor
92098845|NCT04956042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098846|NCT01228084|Sulforaphane|sulforaphane|mesh-list
92098847|NCT01228084|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92098864|NCT04901208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098865|NCT04901208|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92098866|NCT04901208|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92098867|NCT04901208|Cholinergic Agents|cholinergic agents|mesh-ancestor
92098868|NCT04901208|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098869|NCT04901208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098871|NCT01212484|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92098872|NCT01212484|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92098873|NCT01212484|Dopamine Agents|dopamine agents|mesh-ancestor
92098874|NCT01212484|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098875|NCT01212484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098876|NCT01212484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098877|NCT01212484|Aromatic Amino Acid Decarboxylase Inhibitors|aromatic amino acid decarboxylase inhibitors|mesh-ancestor
92098878|NCT01212484|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098879|NCT03446976|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92098880|NCT03446976|Immunologic Factors|immunologic factors|mesh-ancestor
92098881|NCT03446976|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098882|NCT01212874|Nitroglycerin|nitroglycerin|mesh-list
92098883|NCT01212874|Esmolol|esmolol|mesh-list
92098884|NCT01212874|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098885|NCT01212874|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92098886|NCT01212874|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92098887|NCT01212874|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92098888|NCT01212874|Adrenergic Agents|adrenergic agents|mesh-ancestor
92098889|NCT01212874|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018491|NCT03050827|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92018492|NCT03050827|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92018493|NCT03050827|Cholinergic Agents|cholinergic agents|mesh-ancestor
92098890|NCT01212874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098891|NCT01212874|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098893|NCT01859741|Etoposide|etoposide|mesh-list
92098894|NCT01859741|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098895|NCT01859741|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92098896|NCT01859741|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92098897|NCT01859741|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92098898|NCT01859741|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098899|NCT01859741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098901|NCT01212952|Bortezomib|bortezomib|mesh-list
92098902|NCT01212952|Pomalidomide|pomalidomide|mesh-list
92098903|NCT01212952|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098904|NCT01212952|Antiemetics|antiemetics|mesh-ancestor
92098922|NCT04609865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098923|NCT04609865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098925|NCT04609865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098926|NCT04609865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92098927|NCT04609865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92098928|NCT04609865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92098929|NCT04609865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098930|NCT04609865|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098931|NCT01873859|Metformin|metformin|mesh-list
92098932|NCT01873859|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92098933|NCT01873859|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098934|NCT00493896|Enoxaparin|enoxaparin|mesh-list
92098935|NCT00493896|PENTA|penta|mesh-list
92098936|NCT00493896|Fondaparinux|fondaparinux|mesh-list
92098937|NCT00493896|Anticoagulants|anticoagulants|mesh-ancestor
92098938|NCT00493896|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92098939|NCT00493896|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92098940|NCT00493896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098941|NCT00493896|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92098942|NCT00493896|Antithrombins|antithrombins|mesh-ancestor
92098943|NCT00493896|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92098944|NCT00493896|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098945|NCT00493896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098946|NCT04597619|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-list
92098947|NCT04597619|Analgesics|analgesics|mesh-ancestor
92098948|NCT04597619|Sensory System Agents|sensory system agents|mesh-ancestor
92098949|NCT04597619|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098950|NCT04597619|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098951|NCT03449940|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92098952|NCT03449940|Ceftriaxone|ceftriaxone|mesh-list
92098954|NCT03449940|Lidocaine|lidocaine|mesh-list
92098955|NCT03449940|Analgesics|analgesics|mesh-list
92098956|NCT03449940|Anesthetics, Local|anesthetics, local|mesh-ancestor
92098957|NCT03449940|Anesthetics|anesthetics|mesh-ancestor
92098958|NCT03449940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098959|NCT03449940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098960|NCT03449940|Sensory System Agents|sensory system agents|mesh-ancestor
92098961|NCT03449940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098980|NCT01230424|Hormones|hormones|mesh-ancestor
92098981|NCT01230424|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098982|NCT01230424|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098983|NCT01230424|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92098984|NCT01230424|Immunologic Factors|immunologic factors|mesh-ancestor
92098985|NCT01230424|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098986|NCT01230424|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098987|NCT01230502|Mycophenolic Acid|mycophenolic acid|mesh-list
92098988|NCT01230502|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92098989|NCT01230502|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098990|NCT01230502|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92098991|NCT01230502|Antitubercular Agents|antitubercular agents|mesh-ancestor
92098992|NCT01230502|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92098993|NCT01230502|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098994|NCT01230502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018494|NCT03050827|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018495|NCT03050827|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018496|NCT03050827|Urological Agents|urological agents|mesh-ancestor
92018497|NCT02438787|Golimumab|golimumab|mesh-list
92098995|NCT01230502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098996|NCT03438240|Fentanyl|fentanyl|mesh-list
92098997|NCT03438240|Dexmedetomidine|dexmedetomidine|mesh-list
92098998|NCT03438240|Bupivacaine|bupivacaine|mesh-list
92098999|NCT03438240|Anesthetics, Local|anesthetics, local|mesh-list
92099000|NCT03438240|Anesthetics|anesthetics|mesh-list
92099001|NCT03438240|Sympathomimetics|sympathomimetics|mesh-list
92099002|NCT03438240|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099003|NCT03438240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099004|NCT03438240|Sensory System Agents|sensory system agents|mesh-ancestor
92099005|NCT03438240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099006|NCT03438240|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92099007|NCT03438240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099008|NCT03438240|Analgesics|analgesics|mesh-ancestor
92099009|NCT03438240|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92099010|NCT03438240|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92099011|NCT03438240|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92099012|NCT03438240|Adrenergic Agents|adrenergic agents|mesh-ancestor
92099013|NCT03438240|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099014|NCT03438240|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099015|NCT03438240|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92099032|NCT01213576|Antiplatyhelmintic Agents|antiplatyhelmintic agents|mesh-ancestor
92099033|NCT01213576|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92099034|NCT01213576|Tubulin Modulators|tubulin modulators|mesh-ancestor
92099035|NCT01213576|Antimitotic Agents|antimitotic agents|mesh-ancestor
92099036|NCT01213576|Mitosis Modulators|mitosis modulators|mesh-ancestor
92099037|NCT01213576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099038|NCT01213576|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099039|NCT04452318|Casirivimab and imdevimab drug combination|casirivimab and imdevimab drug combination|mesh-list
92099040|NCT04452318|Antiviral Agents|antiviral agents|mesh-ancestor
92099041|NCT04452318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099043|NCT01161862|Pancrelipase|pancrelipase|mesh-list
92099044|NCT01161862|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099045|NCT01161862|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099046|NCT01161862|Hormones|hormones|mesh-ancestor
92099047|NCT01161862|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099048|NCT01214356|Vitamin D|vitamin d|mesh-list
92099049|NCT01214356|Ergocalciferols|ergocalciferols|mesh-list
92099050|NCT01214356|Cholecalciferol|cholecalciferol|mesh-list
92099051|NCT01214356|Vitamins|vitamins|mesh-list
92099052|NCT01214356|Micronutrients|micronutrients|mesh-ancestor
92099053|NCT01214356|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099054|NCT01214356|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92099055|NCT01214356|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92099056|NCT01232920|Mycophenolic Acid|mycophenolic acid|mesh-list
92099057|NCT01232920|Methotrexate|methotrexate|mesh-list
92099058|NCT01232920|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92099059|NCT01232920|Abortifacient Agents|abortifacient agents|mesh-ancestor
92099060|NCT01232920|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92099061|NCT01232920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099062|NCT01232920|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92099063|NCT01232920|Antimetabolites|antimetabolites|mesh-ancestor
92099064|NCT01232920|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099065|NCT01232920|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099066|NCT01232920|Dermatologic Agents|dermatologic agents|mesh-ancestor
92099067|NCT01232920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099068|NCT01232920|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92099069|NCT01232920|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92099070|NCT01232920|Immunologic Factors|immunologic factors|mesh-ancestor
92099071|NCT01232920|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099072|NCT01232920|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92099073|NCT01232920|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92099074|NCT01232920|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92099075|NCT01232920|Antitubercular Agents|antitubercular agents|mesh-ancestor
92099085|NCT03010540|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099086|NCT03010540|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099088|NCT03010540|Sensory System Agents|sensory system agents|mesh-ancestor
92099089|NCT03010540|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099090|NCT03010540|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92099091|NCT03010540|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92099092|NCT03010540|Anesthetics, General|anesthetics, general|mesh-ancestor
92099093|NCT03010540|Anesthetics|anesthetics|mesh-ancestor
92099094|NCT03445104|Huperzine A|huperzine a|mesh-list
92099095|NCT03445104|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92099096|NCT03445104|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099097|NCT03445104|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099098|NCT03445104|Cholinergic Agents|cholinergic agents|mesh-ancestor
92099099|NCT03445104|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099100|NCT03445104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099101|NCT03445104|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92099102|NCT03445104|Protective Agents|protective agents|mesh-ancestor
92099103|NCT01234714|Liver Extracts|liver extracts|mesh-list
92099104|NCT01234714|Hematinics|hematinics|mesh-ancestor
92099105|NCT03440502|Anesthetics|anesthetics|mesh-list
92099106|NCT03440502|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099107|NCT03440502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099108|NCT01234870|Adenosine|adenosine|mesh-list
92099109|NCT01234870|Analgesics|analgesics|mesh-ancestor
92099110|NCT01234870|Sensory System Agents|sensory system agents|mesh-ancestor
92019390|NCT05526911|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92099111|NCT01234870|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099112|NCT01234870|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099113|NCT01234870|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92099114|NCT01234870|Vasodilator Agents|vasodilator agents|mesh-ancestor
92099115|NCT01234870|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92099116|NCT01234870|Purinergic Agonists|purinergic agonists|mesh-ancestor
92099117|NCT01234870|Purinergic Agents|purinergic agents|mesh-ancestor
92099118|NCT01234870|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099119|NCT01234870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099120|NCT03437460|Ibuprofen|ibuprofen|mesh-list
92099121|NCT03437460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099122|NCT03437460|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099123|NCT03437460|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099124|NCT03437460|Analgesics|analgesics|mesh-ancestor
92099125|NCT03437460|Sensory System Agents|sensory system agents|mesh-ancestor
92099126|NCT03437460|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099127|NCT03437460|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099128|NCT03437460|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099129|NCT03437460|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92099130|NCT03437460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099131|NCT03437460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099132|NCT03444636|Fentanyl|fentanyl|mesh-list
92099133|NCT03444636|Bupivacaine|bupivacaine|mesh-list
92099134|NCT03444636|Ropivacaine|ropivacaine|mesh-list
92099135|NCT03444636|Anesthetics, Local|anesthetics, local|mesh-ancestor
92099136|NCT03444636|Anesthetics|anesthetics|mesh-ancestor
92099137|NCT03444636|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099138|NCT03444636|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099139|NCT03444636|Sensory System Agents|sensory system agents|mesh-ancestor
92099140|NCT03444636|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099141|NCT03444636|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92099142|NCT03444636|Narcotics|narcotics|mesh-ancestor
92099162|NCT01215292|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92099163|NCT01215292|Hormone Antagonists|hormone antagonists|mesh-ancestor
92099164|NCT01215292|Antifungal Agents|antifungal agents|mesh-ancestor
92099165|NCT01215292|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099166|NCT01215292|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92099167|NCT01215292|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92099168|NCT01215292|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92099169|NCT01215292|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92099170|NCT04796454|Gemcitabine|gemcitabine|mesh-list
92099171|NCT04796454|Oxaliplatin|oxaliplatin|mesh-list
92099172|NCT04796454|Temozolomide|temozolomide|mesh-list
92099173|NCT04796454|Pamiparib|pamiparib|mesh-list
92099174|NCT04796454|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099175|NCT04796454|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92099176|NCT04796454|Antimetabolites|antimetabolites|mesh-ancestor
92099177|NCT04796454|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099178|NCT04796454|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92099179|NCT04796454|Alkylating Agents|alkylating agents|mesh-ancestor
92018498|NCT02438787|Ustekinumab|ustekinumab|mesh-list
92018499|NCT02438787|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018500|NCT02438787|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92099180|NCT04796454|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92099181|NCT04796454|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099182|NCT02189668|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92099183|NCT02189668|Amoxicillin-Potassium Clavulanate Combination|amoxicillin-potassium clavulanate combination|mesh-list
92099184|NCT02189668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099185|NCT02189668|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92099186|NCT02189668|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099187|NCT02189668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099188|NCT02981290|Mycophenolic Acid|mycophenolic acid|mesh-list
92099189|NCT02981290|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92099190|NCT02981290|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099191|NCT02981290|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92099192|NCT02981290|Antitubercular Agents|antitubercular agents|mesh-ancestor
92099193|NCT02981290|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92099194|NCT02981290|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099195|NCT02981290|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099196|NCT02981290|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099197|NCT03437226|Simendan|simendan|mesh-list
92099218|NCT01282138|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92099220|NCT01282138|Analgesics|analgesics|mesh-ancestor
92099221|NCT01282138|Sensory System Agents|sensory system agents|mesh-ancestor
92099222|NCT01282138|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099223|NCT01282138|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099224|NCT01282138|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099225|NCT01282138|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92099226|NCT01282138|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92099227|NCT01282138|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92099228|NCT01282138|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92099229|NCT01282138|Histamine Antagonists|histamine antagonists|mesh-ancestor
92099230|NCT01282138|Histamine Agents|histamine agents|mesh-ancestor
92099231|NCT01282138|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099232|NCT01282138|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099233|NCT03444402|Esomeprazole|esomeprazole|mesh-list
92099234|NCT03444402|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92099235|NCT03444402|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099236|NCT03444402|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92099237|NCT03444402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099238|NCT03444402|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099239|NCT01238536|Dexamethasone|dexamethasone|mesh-list
92099240|NCT01238536|Betamethasone|betamethasone|mesh-list
92099241|NCT01238536|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92099243|NCT01238536|Anesthetics, Local|anesthetics, local|mesh-list
92099244|NCT01238536|Anesthetics|anesthetics|mesh-list
92099245|NCT01238536|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92099246|NCT01238536|Antiemetics|antiemetics|mesh-ancestor
92099247|NCT01238536|Autonomic Agents|autonomic agents|mesh-ancestor
92099248|NCT01238536|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099249|NCT01238536|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099250|NCT01238536|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099251|NCT01238536|Glucocorticoids|glucocorticoids|mesh-ancestor
92099259|NCT01238536|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92099260|NCT01238536|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92099261|NCT01238536|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92099262|NCT01238536|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92099263|NCT01238536|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92099264|NCT01238536|Respiratory System Agents|respiratory system agents|mesh-ancestor
92099265|NCT03437070|Doxorubicin|doxorubicin|mesh-list
92099266|NCT03437070|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92099267|NCT03437070|Trabectedin|trabectedin|mesh-list
92099268|NCT03437070|Olaratumab|olaratumab|mesh-list
92099269|NCT03437070|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92099270|NCT03437070|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099271|NCT03437070|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92099272|NCT03437070|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92099273|NCT03437070|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099274|NCT03437070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099275|NCT03437070|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92099276|NCT03437070|Alkylating Agents|alkylating agents|mesh-ancestor
92099277|NCT03128736|Esomeprazole|esomeprazole|mesh-list
92099278|NCT03128736|Dexlansoprazole|dexlansoprazole|mesh-list
92099279|NCT03128736|Lansoprazole|lansoprazole|mesh-list
92099280|NCT03128736|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92099281|NCT03128736|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92099282|NCT03128736|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92099283|NCT03128736|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099284|NCT03128736|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099285|NCT01218958|Naltrexone|naltrexone|mesh-list
92099286|NCT01218958|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92099287|NCT01218958|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92099288|NCT01218958|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099289|NCT01218958|Sensory System Agents|sensory system agents|mesh-ancestor
92099290|NCT01218958|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099291|NCT03440268|Acetylcysteine|acetylcysteine|mesh-list
92099292|NCT03440268|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92099293|NCT03440268|Antiviral Agents|antiviral agents|mesh-ancestor
92099294|NCT03440268|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099295|NCT03440268|Expectorants|expectorants|mesh-ancestor
92099296|NCT03440268|Respiratory System Agents|respiratory system agents|mesh-ancestor
92099297|NCT03440268|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92099298|NCT03440268|Antioxidants|antioxidants|mesh-ancestor
92099299|NCT03440268|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099300|NCT03440268|Protective Agents|protective agents|mesh-ancestor
92099301|NCT03440268|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099302|NCT03440268|Antidotes|antidotes|mesh-ancestor
92099303|NCT03444246|Iodine|iodine|mesh-list
92099304|NCT03444246|Cadexomer iodine|cadexomer iodine|mesh-list
92099305|NCT03444246|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92099306|NCT03444246|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099307|NCT03444246|Trace Elements|trace elements|mesh-ancestor
92099308|NCT03444246|Micronutrients|micronutrients|mesh-ancestor
92099309|NCT03444246|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099310|NCT04369014|Anesthetics|anesthetics|mesh-list
92099311|NCT04369014|Propofol|propofol|mesh-list
92099312|NCT04369014|Etomidate|etomidate|mesh-list
92099313|NCT04369014|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099314|NCT04369014|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099315|NCT04369014|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92099316|NCT04369014|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92099317|NCT04369014|Anesthetics, General|anesthetics, general|mesh-ancestor
92099318|NCT03436836|Lidocaine|lidocaine|mesh-list
92099319|NCT03436836|Nalbuphine|nalbuphine|mesh-list
92099331|NCT03436836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099332|NCT03436836|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92099333|NCT03436836|Narcotics|narcotics|mesh-ancestor
92099334|NCT03436836|Analgesics|analgesics|mesh-ancestor
92099335|NCT03444012|Ticagrelor|ticagrelor|mesh-list
92099336|NCT03444012|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92099337|NCT03444012|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92099338|NCT03444012|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92099339|NCT03444012|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92099340|NCT03444012|Purinergic Agents|purinergic agents|mesh-ancestor
92099341|NCT03444012|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92099342|NCT03444012|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099343|NCT03444012|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099344|NCT03440034|Pioglitazone|pioglitazone|mesh-list
92099345|NCT03440034|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92099346|NCT03440034|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099347|NCT03433326|Grazoprevir|grazoprevir|mesh-list
92099348|NCT03433326|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92099349|NCT03433326|Antiviral Agents|antiviral agents|mesh-ancestor
92099350|NCT03433326|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018501|NCT02438787|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018502|NCT02438787|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018503|NCT02438787|Immunologic Factors|immunologic factors|mesh-ancestor
92018504|NCT02438787|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018505|NCT04901065|Lidocaine|lidocaine|mesh-list
92018506|NCT04901065|Anesthetics, Local|anesthetics, local|mesh-ancestor
92018507|NCT04901065|Anesthetics|anesthetics|mesh-ancestor
92018508|NCT04901065|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018509|NCT04901065|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018510|NCT04901065|Sensory System Agents|sensory system agents|mesh-ancestor
92018511|NCT04901065|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018512|NCT04901065|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92018513|NCT04901065|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92018515|NCT04901065|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018516|NCT04901065|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018517|NCT02493777|Methylphenidate|methylphenidate|mesh-list
92018518|NCT02493777|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92018519|NCT02493777|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018520|NCT02493777|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92018521|NCT02493777|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92018522|NCT02493777|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92018523|NCT02493777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018525|NCT02493777|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018526|NCT04907149|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92018527|NCT04906915|Ketamine|ketamine|mesh-list
92018528|NCT04906915|Analgesics|analgesics|mesh-ancestor
92018529|NCT04906915|Sensory System Agents|sensory system agents|mesh-ancestor
92018530|NCT04906915|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018531|NCT04906915|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018532|NCT04906915|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92018533|NCT04906915|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92018534|NCT04906915|Anesthetics, General|anesthetics, general|mesh-ancestor
92018535|NCT04906915|Anesthetics|anesthetics|mesh-ancestor
92018536|NCT04906915|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018537|NCT04906915|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92018538|NCT04906915|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92018539|NCT04906915|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018540|NCT04906915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018541|NCT04890379|Dimethyl Fumarate|dimethyl fumarate|mesh-list
92018542|NCT04890379|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018543|NCT04890379|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018544|NCT04890379|Immunologic Factors|immunologic factors|mesh-ancestor
92018545|NCT04890379|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018546|NCT04900129|Acetylcysteine|acetylcysteine|mesh-list
92018547|NCT04900129|Diclofenac|diclofenac|mesh-list
92018549|NCT04900129|Methyl salicylate|methyl salicylate|mesh-list
92018551|NCT04900129|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92018552|NCT04900129|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92018553|NCT04900129|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92018554|NCT04900129|Analgesics|analgesics|mesh-ancestor
92018555|NCT04900129|Sensory System Agents|sensory system agents|mesh-ancestor
92018556|NCT04900129|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018557|NCT04900129|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018558|NCT04900129|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018560|NCT04900129|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92018561|NCT04900129|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018562|NCT04900129|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018563|NCT04900129|Antipruritics|antipruritics|mesh-ancestor
92018564|NCT04900129|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018565|NCT04900129|Antiviral Agents|antiviral agents|mesh-ancestor
92018566|NCT04900129|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018567|NCT04900129|Expectorants|expectorants|mesh-ancestor
92018568|NCT04900129|Respiratory System Agents|respiratory system agents|mesh-ancestor
92018569|NCT04900129|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92018570|NCT04900129|Antioxidants|antioxidants|mesh-ancestor
92018571|NCT04900129|Protective Agents|protective agents|mesh-ancestor
92018572|NCT04900129|Antidotes|antidotes|mesh-ancestor
92018573|NCT02616601|Fluorouracil|fluorouracil|mesh-list
92018574|NCT02616601|Antimetabolites|antimetabolites|mesh-ancestor
92018575|NCT02616601|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018576|NCT02616601|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018577|NCT02616601|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018578|NCT02616601|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018579|NCT02616601|Immunologic Factors|immunologic factors|mesh-ancestor
92018580|NCT02616601|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018581|NCT02492997|Glycerol|glycerol|mesh-list
92018583|NCT02492997|Protective Agents|protective agents|mesh-ancestor
92018584|NCT02492997|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018585|NCT04393207|Dexamethasone|dexamethasone|mesh-list
92018586|NCT04393207|Dexamethasone acetate|dexamethasone acetate|mesh-list
92018587|NCT04393207|Methylprednisolone|methylprednisolone|mesh-list
92018588|NCT04393207|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92018589|NCT04393207|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92018590|NCT04393207|Prednisolone|prednisolone|mesh-list
92018591|NCT04393207|Prednisolone acetate|prednisolone acetate|mesh-list
92018592|NCT04393207|Bupivacaine|bupivacaine|mesh-list
92018593|NCT04393207|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92018594|NCT04393207|Prednisolone phosphate|prednisolone phosphate|mesh-list
92018596|NCT04393207|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018597|NCT04393207|Antiemetics|antiemetics|mesh-ancestor
92018598|NCT04393207|Autonomic Agents|autonomic agents|mesh-ancestor
92018599|NCT04393207|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018600|NCT04393207|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018601|NCT04393207|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018604|NCT04393207|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018605|NCT04393207|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92018606|NCT04393207|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018607|NCT04393207|Protease Inhibitors|protease inhibitors|mesh-ancestor
92018608|NCT04393207|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018609|NCT04393207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018610|NCT04393207|Anesthetics, Local|anesthetics, local|mesh-ancestor
92018611|NCT04393207|Anesthetics|anesthetics|mesh-ancestor
92018612|NCT04393207|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92018613|NCT04393207|Sensory System Agents|sensory system agents|mesh-ancestor
92018615|NCT04393207|Protective Agents|protective agents|mesh-ancestor
92018616|NCT02492841|Calcium, Dietary|calcium, dietary|mesh-list
92018617|NCT02492841|Calcium|calcium|mesh-list
92018618|NCT02492841|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92018619|NCT02492841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018620|NCT02492841|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92018621|NCT04814875|Carboplatin|carboplatin|mesh-list
92018622|NCT04814875|Doxorubicin|doxorubicin|mesh-list
92018623|NCT04814875|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92018624|NCT04814875|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018625|NCT04814875|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92018626|NCT04814875|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92018627|NCT04814875|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92018628|NCT04814875|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018629|NCT04814875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018630|NCT04812535|Pembrolizumab|pembrolizumab|mesh-list
92018631|NCT04812535|Vilobelimab|vilobelimab|mesh-list
92018632|NCT04812535|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018633|NCT04812535|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018634|NCT04812535|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92018635|NCT04812535|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018636|NCT04812535|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92018637|NCT04812535|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018638|NCT04812535|Immunologic Factors|immunologic factors|mesh-ancestor
92018639|NCT04812535|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018641|NCT02492763|Liraglutide|liraglutide|mesh-list
92018642|NCT02492763|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92018643|NCT02492763|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018644|NCT02492763|Incretins|incretins|mesh-ancestor
92018645|NCT02492763|Hormones|hormones|mesh-ancestor
92018646|NCT02492763|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018647|NCT04899817|Granisetron|granisetron|mesh-list
92018648|NCT04899817|Antiemetics|antiemetics|mesh-ancestor
92018649|NCT04899817|Autonomic Agents|autonomic agents|mesh-ancestor
92018650|NCT04899817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018651|NCT04899817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018652|NCT04899817|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018653|NCT04899817|Serotonin 5-HT3 Receptor Antagonists|serotonin 5-ht3 receptor antagonists|mesh-ancestor
92018654|NCT04899817|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92018656|NCT04899817|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92081683|NCT01392183|Autonomic Agents|autonomic agents|mesh-ancestor
92018657|NCT04899817|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018659|NCT04905667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018660|NCT04905667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018661|NCT04397107|Aldesleukin|aldesleukin|mesh-list
92018663|NCT04397107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018664|NCT04397107|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92018666|NCT04397107|Sensory System Agents|sensory system agents|mesh-ancestor
92018667|NCT04397107|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018668|NCT04397107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018670|NCT04397107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92018672|NCT04397107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92018673|NCT02453841|Phenylephrine|phenylephrine|mesh-list
92018674|NCT02453841|Oxymetazoline|oxymetazoline|mesh-list
92018675|NCT02453841|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92018676|NCT02453841|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92018677|NCT02453841|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018678|NCT02453841|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018679|NCT02453841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018680|NCT02453841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018682|NCT02453841|Autonomic Agents|autonomic agents|mesh-ancestor
92018683|NCT02453841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018684|NCT02453841|Nasal Decongestants|nasal decongestants|mesh-ancestor
92018687|NCT02453841|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92018688|NCT02453841|Mydriatics|mydriatics|mesh-ancestor
92018689|NCT02453841|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92018690|NCT02453841|Protective Agents|protective agents|mesh-ancestor
92018691|NCT03081689|Paclitaxel|paclitaxel|mesh-list
92018692|NCT03081689|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92018693|NCT03081689|Carboplatin|carboplatin|mesh-list
92018694|NCT03081689|Nivolumab|nivolumab|mesh-list
92018695|NCT03081689|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92018696|NCT03081689|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018697|NCT03081689|Tubulin Modulators|tubulin modulators|mesh-ancestor
92018698|NCT03081689|Antimitotic Agents|antimitotic agents|mesh-ancestor
92018699|NCT03081689|Mitosis Modulators|mitosis modulators|mesh-ancestor
92018700|NCT03081689|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018701|NCT03081689|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018702|NCT03081689|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92018703|NCT04888663|Paclitaxel|paclitaxel|mesh-list
92018704|NCT04888663|Trastuzumab|trastuzumab|mesh-list
92018705|NCT04888663|Ramucirumab|ramucirumab|mesh-list
92018706|NCT04888663|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92018707|NCT04888663|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018708|NCT04888663|Tubulin Modulators|tubulin modulators|mesh-ancestor
92018709|NCT04888663|Antimitotic Agents|antimitotic agents|mesh-ancestor
92019464|NCT04877509|Trace Elements|trace elements|mesh-ancestor
92018711|NCT04888663|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018712|NCT04888663|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018713|NCT04899427|Tislelizumab|tislelizumab|mesh-list
92018714|NCT04899427|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92018715|NCT04899427|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018717|NCT02453685|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92018718|NCT02453685|Insulin Glargine|insulin glargine|mesh-list
92018719|NCT02453685|Insulin Aspart|insulin aspart|mesh-list
92018720|NCT02453685|Insulin, Long-Acting|insulin, long-acting|mesh-list
92018721|NCT02453685|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92018722|NCT02453685|Biphasic Insulins|biphasic insulins|mesh-list
92018723|NCT02453685|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92018724|NCT02453685|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92018725|NCT02453685|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018727|NCT03051841|Bortezomib|bortezomib|mesh-list
92018728|NCT03051841|CKD-581|ckd-581|mesh-list
92018729|NCT03051841|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92018730|NCT03051841|Antiemetics|antiemetics|mesh-ancestor
92018731|NCT03051841|Autonomic Agents|autonomic agents|mesh-ancestor
92018732|NCT03051841|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92018733|NCT03051841|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92018734|NCT03051841|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92018735|NCT03051841|Glucocorticoids|glucocorticoids|mesh-ancestor
92018737|NCT03051841|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92018738|NCT03051841|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92018739|NCT03051841|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018740|NCT03051841|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018741|NCT03051841|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018742|NCT03051841|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92018743|NCT04905043|Acalabrutinib|acalabrutinib|mesh-list
92018744|NCT04905043|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018745|NCT02436759|Phenylephrine|phenylephrine|mesh-list
92018746|NCT02436759|Oxymetazoline|oxymetazoline|mesh-list
92018747|NCT02436759|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92018748|NCT02436759|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92018749|NCT02436759|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92018750|NCT02436759|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92018751|NCT02436759|Adrenergic Agents|adrenergic agents|mesh-ancestor
92018752|NCT02436759|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92018825|NCT03050437|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92018826|NCT03050437|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92018827|NCT02436135|Idelalisib|idelalisib|mesh-list
92018828|NCT02436135|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018897|NCT02419755|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92018898|NCT02419755|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018899|NCT02419755|Antimetabolites|antimetabolites|mesh-ancestor
92018900|NCT02419755|Dermatologic Agents|dermatologic agents|mesh-ancestor
92018901|NCT02419755|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92018902|NCT02419755|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92018966|NCT04897477|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92018967|NCT04897477|Antimetabolites|antimetabolites|mesh-ancestor
92018968|NCT04897477|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92018969|NCT04897477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92018970|NCT04897477|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92018971|NCT04897477|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92019032|NCT03051451|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92019034|NCT02417961|Benralizumab|benralizumab|mesh-list
92019035|NCT02417961|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92019177|NCT04885075|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019178|NCT04885075|Anticonvulsants|anticonvulsants|mesh-ancestor
92019179|NCT04885075|Antiemetics|antiemetics|mesh-ancestor
92019180|NCT04885075|Autonomic Agents|autonomic agents|mesh-ancestor
92019181|NCT04885075|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92019182|NCT04885075|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92019183|NCT04885075|Muscle Relaxants, Central|muscle relaxants, central|mesh-ancestor
92019184|NCT04885075|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92019246|NCT04389073|Alkylating Agents|alkylating agents|mesh-ancestor
92019247|NCT04389073|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019319|NCT05257993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019320|NCT05257993|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019321|NCT05257993|Antimetabolites|antimetabolites|mesh-ancestor
92019322|NCT05533073|Etoricoxib|etoricoxib|mesh-list
92019389|NCT05526911|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019465|NCT04877509|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92019466|NCT03044743|Cyclophosphamide|cyclophosphamide|mesh-list
92019467|NCT03044743|Fludarabine|fludarabine|mesh-list
92019468|NCT03044743|Interleukin-2|interleukin-2|mesh-list
92019469|NCT03044743|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92019470|NCT03044743|Immunologic Factors|immunologic factors|mesh-ancestor
92019471|NCT03044743|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019532|NCT04865185|Lidocaine|lidocaine|mesh-list
92019538|NCT04865185|Anesthetics|anesthetics|mesh-ancestor
92019607|NCT02612077|Bevacizumab|bevacizumab|mesh-list
92019608|NCT02612077|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92019609|NCT02612077|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92019678|NCT05517239|Gemcitabine|gemcitabine|mesh-list
92019679|NCT05517239|Oxaliplatin|oxaliplatin|mesh-list
92019680|NCT05517239|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92019681|NCT05517239|Antimetabolites|antimetabolites|mesh-ancestor
92019749|NCT04873531|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92019750|NCT04873531|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92019821|NCT04872907|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019822|NCT02566031|Glycopyrrolate|glycopyrrolate|mesh-list
92019823|NCT02566031|Tiotropium Bromide|tiotropium bromide|mesh-list
92019893|NCT03048019|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019894|NCT03048019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92019895|NCT05506319|Vasopressins|vasopressins|mesh-list
92019896|NCT05506319|Arginine Vasopressin|arginine vasopressin|mesh-list
92019897|NCT05506319|Norepinephrine|norepinephrine|mesh-list
92019898|NCT05506319|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92019899|NCT05506319|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92019900|NCT05506319|Adrenergic Agents|adrenergic agents|mesh-ancestor
92019901|NCT05506319|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92019902|NCT05506319|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92019920|NCT05505461|Antibodies|antibodies|mesh-list
92019958|NCT04667663|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92020033|NCT02564471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020035|NCT05503667|Bevacizumab|bevacizumab|mesh-list
92020036|NCT05503667|Aflutinib|aflutinib|mesh-list
92020037|NCT05503667|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020038|NCT05503667|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92020041|NCT05503667|Growth Substances|growth substances|mesh-ancestor
92020100|NCT03042325|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020101|NCT03042325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020102|NCT01594333|Methotrexate|methotrexate|mesh-list
92020103|NCT01594333|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92020104|NCT01594333|Abortifacient Agents|abortifacient agents|mesh-ancestor
92020105|NCT01594333|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92020170|NCT03041935|Morphine|morphine|mesh-list
92020171|NCT03041935|Remifentanil|remifentanil|mesh-list
92020172|NCT03041935|Ondansetron|ondansetron|mesh-list
92020173|NCT03041935|Propofol|propofol|mesh-list
92020174|NCT03041935|Ropivacaine|ropivacaine|mesh-list
92020175|NCT03041935|Sevoflurane|sevoflurane|mesh-list
92020176|NCT03041935|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020177|NCT03041935|Antiemetics|antiemetics|mesh-ancestor
92020178|NCT03041935|Autonomic Agents|autonomic agents|mesh-ancestor
92020179|NCT03041935|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020180|NCT03041935|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020181|NCT03041935|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92020182|NCT03041935|Glucocorticoids|glucocorticoids|mesh-ancestor
92020183|NCT03041935|Hormones|hormones|mesh-ancestor
92020235|NCT03045133|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92020236|NCT03045133|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020238|NCT03045133|Sensory System Agents|sensory system agents|mesh-ancestor
92020239|NCT03045133|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020240|NCT03045133|Antitussive Agents|antitussive agents|mesh-ancestor
92020241|NCT03045133|Respiratory System Agents|respiratory system agents|mesh-ancestor
92020302|NCT03041779|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020303|NCT03041779|Antipyretics|antipyretics|mesh-ancestor
92020304|NCT03041779|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92020310|NCT02612779|Dexamethasone|dexamethasone|mesh-list
92020373|NCT04856137|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92020375|NCT04856137|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020446|NCT04847245|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020447|NCT04847245|Anticonvulsants|anticonvulsants|mesh-ancestor
92020448|NCT04847245|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92020449|NCT04847245|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92020515|NCT04838665|Tropicamide|tropicamide|mesh-list
92020516|NCT04838665|Cyclopentolate|cyclopentolate|mesh-list
92020517|NCT04838665|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92020518|NCT04838665|Mydriatics|mydriatics|mesh-ancestor
92020588|NCT04142125|Protease Inhibitors|protease inhibitors|mesh-ancestor
92020589|NCT04142125|Anticoagulants|anticoagulants|mesh-ancestor
92020590|NCT04852315|Caffeine|caffeine|mesh-list
92020591|NCT04852315|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92020659|NCT04850755|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92020660|NCT04850755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020730|NCT04312243|Protective Agents|protective agents|mesh-ancestor
92020731|NCT04841551|Deoxycholic Acid|deoxycholic acid|mesh-list
92020732|NCT04841551|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92020737|NCT03039205|Clopidogrel|clopidogrel|mesh-list
92020801|NCT03036085|Respiratory System Agents|respiratory system agents|mesh-ancestor
92020802|NCT03036085|Mydriatics|mydriatics|mesh-ancestor
92020803|NCT03036085|Sympathomimetics|sympathomimetics|mesh-ancestor
92020804|NCT03036085|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92020805|NCT04831255|Triamcinolone|triamcinolone|mesh-list
92020806|NCT04831255|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92020807|NCT04831255|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92020808|NCT04831255|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92020809|NCT04831255|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020810|NCT04831255|Glucocorticoids|glucocorticoids|mesh-ancestor
92020811|NCT04831255|Hormones|hormones|mesh-ancestor
92020812|NCT04831255|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92020813|NCT04831255|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92020814|NCT04831255|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92020815|NCT04831255|Immunologic Factors|immunologic factors|mesh-ancestor
92020816|NCT04831255|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92020817|NCT04831255|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020821|NCT02413593|Sofosbuvir|sofosbuvir|mesh-list
92020857|NCT02429427|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92020858|NCT02412657|Dexamethasone|dexamethasone|mesh-list
92020859|NCT02412657|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92020860|NCT02412657|Antiemetics|antiemetics|mesh-ancestor
92020861|NCT02412657|Autonomic Agents|autonomic agents|mesh-ancestor
92020862|NCT02412657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020924|NCT04822909|Sensory System Agents|sensory system agents|mesh-ancestor
92020925|NCT04822909|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92020945|NCT04831099|Hormones|hormones|mesh-ancestor
92020998|NCT04835233|Sympatholytics|sympatholytics|mesh-ancestor
92020999|NCT04835233|Autonomic Agents|autonomic agents|mesh-ancestor
92021000|NCT04835233|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021001|NCT04835233|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021070|NCT04820101|Dexmedetomidine|dexmedetomidine|mesh-list
92021071|NCT04820101|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92021144|NCT02603107|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92021145|NCT02603107|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92021146|NCT02603107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92021217|NCT02604199|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021290|NCT04815265|Adrenergic Agents|adrenergic agents|mesh-ancestor
92021291|NCT04815265|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021292|NCT04815265|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021361|NCT04794049|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021434|NCT04802785|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021509|NCT04811911|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021510|NCT04811911|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92021511|NCT04788979|Melatonin|melatonin|mesh-list
92021512|NCT04788979|Antioxidants|antioxidants|mesh-ancestor
92021513|NCT04788979|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021580|NCT04810507|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92021581|NCT04810507|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021582|NCT04810507|Incretins|incretins|mesh-ancestor
92021583|NCT04810507|Hormones|hormones|mesh-ancestor
92021584|NCT04810507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021585|NCT04810507|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92021586|NCT04810507|Protease Inhibitors|protease inhibitors|mesh-ancestor
92021587|NCT04810507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021588|NCT04810507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021590|NCT04810585|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92021591|NCT04810585|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92021592|NCT04810585|Growth Substances|growth substances|mesh-ancestor
92021593|NCT04810585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021594|NCT04810585|Growth Inhibitors|growth inhibitors|mesh-ancestor
92021595|NCT04810585|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021596|NCT04798729|Salicylic Acid|salicylic acid|mesh-list
92021597|NCT04798729|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021598|NCT04798729|Antifungal Agents|antifungal agents|mesh-ancestor
92021599|NCT04798729|Keratolytic Agents|keratolytic agents|mesh-ancestor
92021600|NCT04798729|Dermatologic Agents|dermatologic agents|mesh-ancestor
92021601|NCT04809649|Itraconazole|itraconazole|mesh-list
92021602|NCT04809649|Antifungal Agents|antifungal agents|mesh-ancestor
92021603|NCT04809649|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021604|NCT04809649|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92021605|NCT04809649|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92021606|NCT04809649|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021607|NCT04809649|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021608|NCT04809649|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92021609|NCT04809649|Hormone Antagonists|hormone antagonists|mesh-ancestor
92021610|NCT04809649|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021611|NCT04809649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021612|NCT04809649|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92021613|NCT04786795|Ursodeoxycholic Acid|ursodeoxycholic acid|mesh-list
92021616|NCT04786795|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92021617|NCT04786795|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92021618|NCT02596945|Epoetin Alfa|epoetin alfa|mesh-list
92021619|NCT02596945|Hematinics|hematinics|mesh-ancestor
92021620|NCT04786327|Edetic Acid|edetic acid|mesh-list
92021621|NCT04786327|Mitogens|mitogens|mesh-list
92021622|NCT04786327|Pentetic Acid|pentetic acid|mesh-list
92021623|NCT04786327|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021624|NCT04786327|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021625|NCT04786327|Anticoagulants|anticoagulants|mesh-ancestor
92021626|NCT04786327|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92021628|NCT04786327|Sequestering Agents|sequestering agents|mesh-ancestor
92021629|NCT04786327|Antidotes|antidotes|mesh-ancestor
92021630|NCT04786327|Protective Agents|protective agents|mesh-ancestor
92021631|NCT04786327|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021632|NCT04786327|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92021633|NCT04153435|Calcium|calcium|mesh-list
92021634|NCT04153435|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92021635|NCT04153435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021637|NCT01667419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021638|NCT01667419|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92021639|NCT01667419|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021640|NCT01667419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021641|NCT04808791|Trifluridine|trifluridine|mesh-list
92021642|NCT04808791|Oxaliplatin|oxaliplatin|mesh-list
92021644|NCT04808791|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021645|NCT04808791|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92021646|NCT04808791|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92021647|NCT04808791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021648|NCT04808791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021650|NCT04808791|Antiviral Agents|antiviral agents|mesh-ancestor
92021651|NCT04808791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021653|NCT04023019|Hemostatics|hemostatics|mesh-ancestor
92021654|NCT04023019|Coagulants|coagulants|mesh-ancestor
92021656|NCT04785547|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021657|NCT03938389|Valsartan|valsartan|mesh-list
92021658|NCT03938389|Sacubitril and valsartan sodium hydrate drug combination|sacubitril and valsartan sodium hydrate drug combination|mesh-list
92021659|NCT03938389|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021660|NCT03938389|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92021661|NCT03938389|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92021662|NCT03938389|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021664|NCT03843853|Pemetrexed|pemetrexed|mesh-list
92021665|NCT03843853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021667|NCT03843853|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92021668|NCT03843853|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92021669|NCT03843853|Growth Substances|growth substances|mesh-ancestor
92021670|NCT03843853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021671|NCT03843853|Growth Inhibitors|growth inhibitors|mesh-ancestor
92021672|NCT03843853|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021673|NCT03843853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021674|NCT03843853|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92021675|NCT03843853|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92021676|NCT04784767|Saponin QA-21V1|saponin qa-21v1|mesh-list
92021677|NCT04784767|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92021678|NCT04784767|Immunologic Factors|immunologic factors|mesh-ancestor
92021679|NCT04784767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021680|NCT05054179|Ropivacaine|ropivacaine|mesh-list
92021681|NCT05054179|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92021682|NCT05054179|Anesthetics, Local|anesthetics, local|mesh-ancestor
92021684|NCT05054179|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021685|NCT05054179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021686|NCT05054179|Sensory System Agents|sensory system agents|mesh-ancestor
92021687|NCT05054179|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021689|NCT03497689|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92021691|NCT05611879|Carboplatin|carboplatin|mesh-list
92021693|NCT05611879|Tislelizumab|tislelizumab|mesh-list
92021694|NCT05611879|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92021695|NCT05611879|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021696|NCT05611879|Tubulin Modulators|tubulin modulators|mesh-ancestor
92021697|NCT05611879|Antimitotic Agents|antimitotic agents|mesh-ancestor
92021698|NCT05611879|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021699|NCT05611879|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021700|NCT05611879|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021702|NCT05611879|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92021703|NCT05611879|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021704|NCT04789057|Atorvastatin|atorvastatin|mesh-list
92021705|NCT04789057|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92021706|NCT04789057|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92021707|NCT04789057|Antimetabolites|antimetabolites|mesh-ancestor
92021708|NCT04789057|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021709|NCT04789057|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92021710|NCT04789057|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92021711|NCT04789057|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021713|NCT05613361|Curcumin|curcumin|mesh-list
92021714|NCT05613361|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021715|NCT05613361|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021717|NCT05613361|Sensory System Agents|sensory system agents|mesh-ancestor
92021718|NCT05613361|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021719|NCT05613361|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021720|NCT05613361|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021721|NCT05613361|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021722|NCT05613361|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021723|NCT05613361|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021724|NCT05613361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021726|NCT05613361|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021727|NCT05611645|Bevacizumab|bevacizumab|mesh-list
92021728|NCT05611645|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021729|NCT05611645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021731|NCT05611645|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92021733|NCT05611645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021734|NCT05611645|Growth Inhibitors|growth inhibitors|mesh-ancestor
92021735|NCT03267121|Apatinib|apatinib|mesh-list
92021736|NCT03267121|Tegafur|tegafur|mesh-list
92021737|NCT03267121|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021738|NCT03267121|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92021739|NCT03267121|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021740|NCT03267121|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021741|NCT03267121|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92021743|NCT02835079|Tamoxifen|tamoxifen|mesh-list
92021744|NCT02835079|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92021745|NCT02835079|Hormone Antagonists|hormone antagonists|mesh-ancestor
92021746|NCT02835079|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021747|NCT02835079|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021748|NCT02835079|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92021749|NCT02835079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021750|NCT02835079|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92021751|NCT02835079|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92021752|NCT02835079|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92021753|NCT01667107|Posaconazole|posaconazole|mesh-list
92021754|NCT01667107|Antifungal Agents|antifungal agents|mesh-ancestor
92021755|NCT01667107|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021756|NCT01667107|Trypanocidal Agents|trypanocidal agents|mesh-ancestor
92021757|NCT01667107|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92021759|NCT01667107|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92021760|NCT01667107|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92021761|NCT01667107|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021762|NCT01667107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021763|NCT01667107|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92021764|NCT01667107|Hormone Antagonists|hormone antagonists|mesh-ancestor
92021765|NCT01667107|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92021766|NCT01667107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021768|NCT04589611|Hyaluronic Acid|hyaluronic acid|mesh-list
92021769|NCT04589611|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92021770|NCT04589611|Immunologic Factors|immunologic factors|mesh-ancestor
92021771|NCT04589611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021772|NCT04589611|Viscosupplements|viscosupplements|mesh-ancestor
92021773|NCT04589611|Protective Agents|protective agents|mesh-ancestor
92021774|NCT04589611|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92021775|NCT04589611|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021776|NCT04589611|GABA Modulators|gaba modulators|mesh-ancestor
92021777|NCT04589611|GABA Agents|gaba agents|mesh-ancestor
92021778|NCT04589611|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021779|NCT04589611|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021790|NCT05240131|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92021791|NCT05240131|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021792|NCT05240131|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021793|NCT05240131|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021795|NCT05188339|Citric Acid|citric acid|mesh-list
92021796|NCT05188339|Sodium Citrate|sodium citrate|mesh-list
92021797|NCT05188339|Anticoagulants|anticoagulants|mesh-ancestor
92021798|NCT05188339|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92021799|NCT05188339|Chelating Agents|chelating agents|mesh-ancestor
92021800|NCT05188339|Sequestering Agents|sequestering agents|mesh-ancestor
92021801|NCT05188339|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021802|NCT05188339|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92021803|NCT05188339|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92021804|NCT05614765|Ezetimibe|ezetimibe|mesh-list
92021805|NCT05614765|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92021806|NCT05614765|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92021807|NCT05614765|Antimetabolites|antimetabolites|mesh-ancestor
92021808|NCT05614765|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021809|NCT05614765|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92021811|NCT02590003|Carboplatin|carboplatin|mesh-list
92021812|NCT02590003|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92021813|NCT02590003|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021814|NCT02590003|Tubulin Modulators|tubulin modulators|mesh-ancestor
92021815|NCT02590003|Antimitotic Agents|antimitotic agents|mesh-ancestor
92021816|NCT02590003|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021817|NCT02590003|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021818|NCT04134325|Pembrolizumab|pembrolizumab|mesh-list
92021819|NCT04134325|Nivolumab|nivolumab|mesh-list
92021820|NCT04134325|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021821|NCT04134325|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021822|NCT04134325|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92021823|NCT04134325|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021825|NCT05474053|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92021826|NCT05474053|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92021827|NCT05474053|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92021828|NCT05474053|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92021829|NCT05474053|Purinergic Agents|purinergic agents|mesh-ancestor
92021830|NCT05474053|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021831|NCT05474053|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021832|NCT05474053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021834|NCT05473819|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021835|NCT05473819|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021837|NCT04330729|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92021838|NCT04330729|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92021839|NCT04330729|Analgesics|analgesics|mesh-ancestor
92021840|NCT04330729|Sensory System Agents|sensory system agents|mesh-ancestor
92021841|NCT04330729|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021842|NCT04330729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021843|NCT04330729|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92021844|NCT04330729|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021845|NCT04330729|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92021846|NCT04330729|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92021847|NCT04330729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021848|NCT04330729|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92021849|NCT04330729|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92021850|NCT04330729|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92021851|NCT04330729|Antipyretics|antipyretics|mesh-ancestor
92021852|NCT05473741|Risperidone|risperidone|mesh-list
92021853|NCT05473741|Aripiprazole|aripiprazole|mesh-list
92021854|NCT05473741|Paliperidone Palmitate|paliperidone palmitate|mesh-list
92021855|NCT05473741|Antipsychotic Agents|antipsychotic agents|mesh-list
92021857|NCT05473741|Serotonin Agents|serotonin agents|mesh-ancestor
92021858|NCT05473741|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021859|NCT05473741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021860|NCT05473741|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021861|NCT05473741|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92021862|NCT05473741|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92021863|NCT05473741|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92021864|NCT05473741|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92021865|NCT05473741|Dopamine Agents|dopamine agents|mesh-ancestor
92021866|NCT05473741|Antidepressive Agents|antidepressive agents|mesh-ancestor
92021867|NCT05473741|Dopamine Agonists|dopamine agonists|mesh-ancestor
92021868|NCT05473741|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92021869|NCT05473741|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92021870|NCT05473741|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92021871|NCT05473741|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92021872|NCT03882307|Sofosbuvir|sofosbuvir|mesh-list
92021873|NCT03882307|Antiviral Agents|antiviral agents|mesh-ancestor
92021874|NCT03882307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021875|NCT04762771|Colchicine|colchicine|mesh-list
92021876|NCT04762771|Gout Suppressants|gout suppressants|mesh-ancestor
92021877|NCT04762771|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92021878|NCT04762771|Tubulin Modulators|tubulin modulators|mesh-ancestor
92021879|NCT04762771|Antimitotic Agents|antimitotic agents|mesh-ancestor
92021880|NCT04762771|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021881|NCT04762771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021882|NCT04762771|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021883|NCT04754737|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92021884|NCT04754737|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92021885|NCT04754737|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92021886|NCT04754737|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92021887|NCT04754737|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021888|NCT04754737|Antitubercular Agents|antitubercular agents|mesh-ancestor
92021889|NCT04754737|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92021890|NCT04754737|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92021891|NCT04754737|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021892|NCT04754737|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92021893|NCT04754737|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92021894|NCT04754737|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021895|NCT04754737|Cholinergic Agents|cholinergic agents|mesh-ancestor
92021896|NCT04754737|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92021898|NCT04481035|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92021899|NCT04481035|Antiviral Agents|antiviral agents|mesh-ancestor
92021900|NCT04481035|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92021901|NCT04481035|Expectorants|expectorants|mesh-ancestor
92021902|NCT04481035|Respiratory System Agents|respiratory system agents|mesh-ancestor
92021903|NCT04481035|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92021904|NCT04481035|Antioxidants|antioxidants|mesh-ancestor
92021905|NCT04481035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021906|NCT04481035|Protective Agents|protective agents|mesh-ancestor
92021907|NCT04481035|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021908|NCT04481035|Antidotes|antidotes|mesh-ancestor
92021909|NCT02404311|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92021910|NCT02404311|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92021911|NCT02404311|Immunologic Factors|immunologic factors|mesh-ancestor
92021912|NCT02404311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021913|NCT03032107|Pembrolizumab|pembrolizumab|mesh-list
92021914|NCT03032107|Trastuzumab|trastuzumab|mesh-list
92021915|NCT03032107|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92021916|NCT03032107|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021917|NCT03032107|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021918|NCT03032107|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92021919|NCT03032107|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92021922|NCT03032107|Mitosis Modulators|mitosis modulators|mesh-ancestor
92021923|NCT03032107|Immunotoxins|immunotoxins|mesh-ancestor
92021924|NCT03032107|Immunoconjugates|immunoconjugates|mesh-ancestor
92021925|NCT03032107|Immunologic Factors|immunologic factors|mesh-ancestor
92021926|NCT03032107|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92021927|NCT05388175|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92021928|NCT05388175|Respiratory System Agents|respiratory system agents|mesh-ancestor
92021929|NCT05700955|Pembrolizumab|pembrolizumab|mesh-list
92021930|NCT05700955|Temozolomide|temozolomide|mesh-list
92021931|NCT05700955|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92021932|NCT05700955|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92021933|NCT05700955|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92022080|NCT05548465|Sensory System Agents|sensory system agents|mesh-ancestor
92022154|NCT05540275|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022155|NCT05540275|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022227|NCT02580877|Sympathomimetics|sympathomimetics|mesh-ancestor
92022228|NCT02580877|Autonomic Agents|autonomic agents|mesh-ancestor
92022229|NCT02580877|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022230|NCT02580877|Dopamine Agents|dopamine agents|mesh-ancestor
92022298|NCT05695495|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022299|NCT05695495|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92022300|NCT05461261|Prednisolone|prednisolone|mesh-list
92022370|NCT02582671|Antimetabolites|antimetabolites|mesh-ancestor
92022371|NCT05696977|Cyclosporine|cyclosporine|mesh-list
92022443|NCT02579863|Growth Inhibitors|growth inhibitors|mesh-ancestor
92022444|NCT05677945|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92022445|NCT05677945|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92022446|NCT05677945|Simvastatin|simvastatin|mesh-list
92022515|NCT02343159|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022516|NCT02395653|Fentanyl|fentanyl|mesh-list
92022517|NCT02395653|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92022518|NCT02395653|Narcotics|narcotics|mesh-ancestor
92022519|NCT02395653|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92022520|NCT02395653|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022521|NCT02395653|Analgesics|analgesics|mesh-ancestor
92022522|NCT02395653|Sensory System Agents|sensory system agents|mesh-ancestor
92022523|NCT02395653|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92022524|NCT02395653|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92022525|NCT02395653|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92022526|NCT02395653|Anesthetics, General|anesthetics, general|mesh-ancestor
92022575|NCT05696509|Anesthetics, General|anesthetics, general|mesh-ancestor
92022576|NCT05696509|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92022651|NCT05575219|Adrenergic Agents|adrenergic agents|mesh-ancestor
92022652|NCT05575219|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92022653|NCT05575219|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022655|NCT04341571|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92022656|NCT04341571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022657|NCT05568745|Misoprostol|misoprostol|mesh-list
92022658|NCT05568745|Oxytocin|oxytocin|mesh-list
92022659|NCT05568745|Oxytocics|oxytocics|mesh-ancestor
92022660|NCT05568745|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92022661|NCT05568745|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92022662|NCT05568745|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92022663|NCT05568745|Abortifacient Agents|abortifacient agents|mesh-ancestor
92022664|NCT05568745|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92022665|NCT05568745|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92022711|NCT00352027|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022712|NCT00352027|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92022783|NCT05867030|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92022854|NCT05865990|Patritumab deruxtecan|patritumab deruxtecan|mesh-list
92022855|NCT05865990|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92022856|NCT05865990|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022857|NCT05865925|Irinotecan|irinotecan|mesh-list
92022858|NCT05865925|Floxuridine|floxuridine|mesh-list
92022859|NCT05865925|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92022860|NCT05865925|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92022861|NCT05865925|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022862|NCT05865925|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92022863|NCT05865925|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92022918|NCT05815680|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92022992|NCT05705505|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92022993|NCT05705505|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92022995|NCT05705505|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92023063|NCT05557877|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92023064|NCT05557877|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023065|NCT05557877|Antipyretics|antipyretics|mesh-ancestor
92023134|NCT05379972|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023135|NCT05379972|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92023136|NCT05379972|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023137|NCT05367245|Butyric Acid|butyric acid|mesh-list
92023140|NCT05367245|Histamine Agents|histamine agents|mesh-ancestor
92023204|NCT05068791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023205|NCT05068791|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92023206|NCT05068791|Antitussive Agents|antitussive agents|mesh-ancestor
92023276|NCT04842045|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023278|NCT04754945|Dexamethasone|dexamethasone|mesh-list
92023279|NCT04754945|Dexamethasone acetate|dexamethasone acetate|mesh-list
92023280|NCT04754945|Cyclophosphamide|cyclophosphamide|mesh-list
92023281|NCT04754945|Bortezomib|bortezomib|mesh-list
92023282|NCT04754945|Ichthammol|ichthammol|mesh-list
92023284|NCT04754945|BB 1101|bb 1101|mesh-list
92023346|NCT04582669|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92023347|NCT04582669|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92023348|NCT04582669|Glucocorticoids|glucocorticoids|mesh-ancestor
92023349|NCT04582669|Hormones|hormones|mesh-ancestor
92023350|NCT04582669|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92023351|NCT04582669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023352|NCT04582669|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023353|NCT04582669|Immunologic Factors|immunologic factors|mesh-ancestor
92023354|NCT04582669|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023355|NCT04582669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023356|NCT04580498|Paclitaxel|paclitaxel|mesh-list
92023357|NCT04580498|Carboplatin|carboplatin|mesh-list
92023358|NCT04580498|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023359|NCT04580498|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023360|NCT04580498|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023361|NCT04580498|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023362|NCT04580498|Mitosis Modulators|mitosis modulators|mesh-ancestor
92023363|NCT04580498|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023364|NCT04489719|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92023365|NCT04489719|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023366|NCT04483414|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92023367|NCT04483414|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92023368|NCT04483414|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023370|NCT04428385|Artemisinin|artemisinin|mesh-list
92023371|NCT04428385|Antimalarials|antimalarials|mesh-ancestor
92023393|NCT03997903|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023394|NCT03982212|Glatiramer Acetate|glatiramer acetate|mesh-list
92023395|NCT03982212|(T,G)-A-L|(t,g)-a-l|mesh-list
92023396|NCT03982212|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92023397|NCT03982212|Immunologic Factors|immunologic factors|mesh-ancestor
92023398|NCT03982212|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023399|NCT03982212|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023400|NCT03982212|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92023462|NCT03843528|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023463|NCT03843528|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023464|NCT03843528|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92023466|NCT03779789|Fluvoxamine|fluvoxamine|mesh-list
92023467|NCT03779789|Citalopram|citalopram|mesh-list
92023468|NCT03779789|Fluoxetine|fluoxetine|mesh-list
92023469|NCT03779789|Paroxetine|paroxetine|mesh-list
92023470|NCT03779789|Sertraline|sertraline|mesh-list
92023471|NCT03779789|Escitalopram|escitalopram|mesh-list
92023497|NCT03733132|Metformin|metformin|mesh-list
92023527|NCT03614949|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92023530|NCT03613116|Cholecalciferol|cholecalciferol|mesh-list
92023599|NCT03077542|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92023600|NCT03077542|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92023671|NCT02393625|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92023672|NCT02393625|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92023673|NCT02393625|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023674|NCT02393625|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92023676|NCT02294032|Immunosuppressive Agents|immunosuppressive agents|mesh-list
92023677|NCT02294032|Immunologic Factors|immunologic factors|mesh-ancestor
92023678|NCT02294032|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023679|NCT02168829|Aspirin|aspirin|mesh-list
92023738|NCT00980460|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92023739|NCT00980460|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023740|NCT00980460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023741|NCT00980460|Antimetabolites|antimetabolites|mesh-ancestor
92023742|NCT00980460|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92023743|NCT00980460|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92023744|NCT00980460|Immunologic Factors|immunologic factors|mesh-ancestor
92023745|NCT00980460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92023746|NCT00980460|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92023747|NCT00980460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92023748|NCT00980460|Tubulin Modulators|tubulin modulators|mesh-ancestor
92023749|NCT00980460|Antimitotic Agents|antimitotic agents|mesh-ancestor
92023799|NCT04028401|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92023870|NCT05501821|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023871|NCT05528653|Emtricitabine tenofovir alafenamide|emtricitabine tenofovir alafenamide|mesh-list
92023872|NCT05528653|Antiviral Agents|antiviral agents|mesh-ancestor
92023873|NCT05528653|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92023874|NCT05528653|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92023875|NCT05528653|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92023876|NCT05528653|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92023877|NCT05528653|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92023878|NCT05528653|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92023931|NCT05527795|Sympathomimetics|sympathomimetics|mesh-ancestor
92023932|NCT05527795|Autonomic Agents|autonomic agents|mesh-ancestor
92023933|NCT05527795|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92023934|NCT05527795|Nasal Decongestants|nasal decongestants|mesh-ancestor
92024006|NCT05305651|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024007|NCT05526469|Bupivacaine|bupivacaine|mesh-list
92024008|NCT05526469|Anesthetics, Local|anesthetics, local|mesh-ancestor
92024077|NCT05140525|Enzyme Activators|enzyme activators|mesh-ancestor
92024150|NCT02340975|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024151|NCT02340975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024152|NCT02340975|Immunologic Factors|immunologic factors|mesh-ancestor
92024153|NCT02340975|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024223|NCT05512351|Growth Inhibitors|growth inhibitors|mesh-ancestor
92024224|NCT02569957|Acetylcysteine|acetylcysteine|mesh-list
92024225|NCT02569957|Topotecan|topotecan|mesh-list
92024295|NCT02573311|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024296|NCT02573311|Urological Agents|urological agents|mesh-ancestor
92024297|NCT05520853|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92024298|NCT05520853|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024299|NCT05520853|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024301|NCT05516251|Topiramate|topiramate|mesh-list
92024302|NCT05516251|Anticonvulsants|anticonvulsants|mesh-ancestor
92024303|NCT05516251|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92024304|NCT05516251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024305|NCT05086393|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92024353|NCT02573155|Respiratory System Agents|respiratory system agents|mesh-ancestor
92024354|NCT02573155|Parasympatholytics|parasympatholytics|mesh-ancestor
92024426|NCT05510323|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92024427|NCT05510323|Glucocorticoids|glucocorticoids|mesh-ancestor
92024429|NCT05510323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92024497|NCT04757857|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024498|NCT04757857|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024499|NCT04757857|Anticoagulants|anticoagulants|mesh-ancestor
92024500|NCT04755283|Rivaroxaban|rivaroxaban|mesh-list
92024569|NCT04712851|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024573|NCT02336451|Ceritinib|ceritinib|mesh-list
92024639|NCT04549051|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024640|NCT04549051|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024641|NCT04549051|Sensory System Agents|sensory system agents|mesh-ancestor
92024642|NCT04549051|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024643|NCT05505253|Alfacalcidol|alfacalcidol|mesh-list
92024644|NCT05505253|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92024645|NCT05505253|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92024646|NCT05505253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024647|NCT05505253|Vitamins|vitamins|mesh-ancestor
92024648|NCT05505253|Micronutrients|micronutrients|mesh-ancestor
92024649|NCT04697719|Aspirin|aspirin|mesh-list
92024650|NCT04697719|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92024652|NCT04697719|Analgesics|analgesics|mesh-ancestor
92024702|NCT02334423|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92024774|NCT04411537|Immunologic Factors|immunologic factors|mesh-ancestor
92024775|NCT04411537|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024776|NCT04411537|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92024777|NCT04411537|Antimetabolites|antimetabolites|mesh-ancestor
92024778|NCT04411537|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024779|NCT04411537|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92024780|NCT04411537|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92024781|NCT04411537|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92024782|NCT04411537|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92024783|NCT04630171|Anesthetics|anesthetics|mesh-list
92024784|NCT04630171|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92024785|NCT04630171|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024786|NCT05503147|Nabiximols|nabiximols|mesh-list
92024787|NCT05503147|Analgesics|analgesics|mesh-ancestor
92024788|NCT05503147|Sensory System Agents|sensory system agents|mesh-ancestor
92024789|NCT05503147|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024790|NCT05503147|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92024848|NCT04277845|Antiemetics|antiemetics|mesh-ancestor
92024849|NCT04277845|Autonomic Agents|autonomic agents|mesh-ancestor
92024850|NCT04277845|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92024853|NCT04277845|Glucocorticoids|glucocorticoids|mesh-ancestor
92024920|NCT02556307|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92024921|NCT04352101|Bupropion|bupropion|mesh-list
92024922|NCT04352101|Escitalopram|escitalopram|mesh-list
92024992|NCT04251169|Tubulin Modulators|tubulin modulators|mesh-ancestor
92024993|NCT04251169|Antimitotic Agents|antimitotic agents|mesh-ancestor
92024994|NCT04251169|Mitosis Modulators|mitosis modulators|mesh-ancestor
92024995|NCT04251169|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92024996|NCT04251169|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92024997|NCT04251169|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92024999|NCT04279561|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92025000|NCT04279561|Chelating Agents|chelating agents|mesh-ancestor
92025058|NCT02556775|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92025059|NCT02556775|Immunologic Factors|immunologic factors|mesh-ancestor
92025060|NCT02556775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025061|NCT04080739|Ropivacaine|ropivacaine|mesh-list
92025129|NCT05487469|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025131|NCT05479357|Carbetocin|carbetocin|mesh-list
92025202|NCT05487001|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025203|NCT05487001|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025205|NCT05487001|Glucocorticoids|glucocorticoids|mesh-ancestor
92025275|NCT05472259|Fluorouracil|fluorouracil|mesh-list
92025276|NCT05472259|Oxaliplatin|oxaliplatin|mesh-list
92025277|NCT05472259|Irinotecan|irinotecan|mesh-list
92025278|NCT05472259|Antimetabolites|antimetabolites|mesh-ancestor
92025279|NCT05472259|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025280|NCT05472259|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025281|NCT05472259|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025282|NCT05472259|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025283|NCT05472259|Immunologic Factors|immunologic factors|mesh-ancestor
92025284|NCT05472259|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025339|NCT02370615|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025340|NCT02370615|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92025341|NCT02370615|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92025342|NCT02370615|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92025343|NCT02370615|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92025344|NCT02370615|Anesthetics, General|anesthetics, general|mesh-ancestor
92025345|NCT02370615|Anesthetics|anesthetics|mesh-ancestor
92025346|NCT02370615|GABA Modulators|gaba modulators|mesh-ancestor
92025347|NCT02370615|GABA Agents|gaba agents|mesh-ancestor
92025348|NCT02370615|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025349|NCT02370615|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025350|NCT02370615|Antifungal Agents|antifungal agents|mesh-ancestor
92025351|NCT02370615|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025352|NCT02370615|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92025353|NCT02370615|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92025354|NCT02370615|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025355|NCT02370615|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92025356|NCT02370615|Hormone Antagonists|hormone antagonists|mesh-ancestor
92025357|NCT02370615|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92025358|NCT02370615|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92025359|NCT02370615|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92025360|NCT02370615|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92025361|NCT02370615|Protective Agents|protective agents|mesh-ancestor
92025362|NCT02307513|Apremilast|apremilast|mesh-list
92025363|NCT02307513|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92025364|NCT02307513|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92025385|NCT02305797|Anticonvulsants|anticonvulsants|mesh-ancestor
92025386|NCT02305797|Antiemetics|antiemetics|mesh-ancestor
92025387|NCT02305797|Autonomic Agents|autonomic agents|mesh-ancestor
92025388|NCT02305797|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025389|NCT02305797|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025390|NCT02305797|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92025391|NCT02305797|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92025392|NCT02305797|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025393|NCT02305797|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92025394|NCT02305797|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92025395|NCT02305797|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92025396|NCT02305797|GABA Modulators|gaba modulators|mesh-ancestor
92025397|NCT02305797|GABA Agents|gaba agents|mesh-ancestor
92025398|NCT02305797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92025400|NCT01646073|Adalimumab|adalimumab|mesh-list
92025446|NCT02305563|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025447|NCT02305563|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025448|NCT02305563|Antiviral Agents|antiviral agents|mesh-ancestor
92025449|NCT02305563|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92025460|NCT02553499|Pembrolizumab|pembrolizumab|mesh-list
92025513|NCT05092373|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92025514|NCT05092373|Immunologic Factors|immunologic factors|mesh-ancestor
92025515|NCT05092373|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025517|NCT04532645|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92025518|NCT04532645|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92025519|NCT04532645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025520|NCT04532645|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025521|NCT02560025|Cytarabine|cytarabine|mesh-list
92025522|NCT02560025|Daunorubicin|daunorubicin|mesh-list
92025523|NCT02560025|Idarubicin|idarubicin|mesh-list
92025524|NCT02560025|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92025525|NCT02560025|Antimetabolites|antimetabolites|mesh-ancestor
92025575|NCT05508035|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025576|NCT05508035|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92025577|NCT05508035|Protease Inhibitors|protease inhibitors|mesh-ancestor
92025648|NCT05563571|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025650|NCT02717507|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92025651|NCT02717507|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92025652|NCT02717507|Adrenergic Agents|adrenergic agents|mesh-ancestor
92025719|NCT04085237|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92025720|NCT04085237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025721|NCT04085237|Sensory System Agents|sensory system agents|mesh-ancestor
92025722|NCT04085237|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92025724|NCT04080869|Tretinoin|tretinoin|mesh-list
92025725|NCT04080869|Retinol palmitate|retinol palmitate|mesh-list
92025726|NCT04080869|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92025727|NCT04080869|Keratolytic Agents|keratolytic agents|mesh-ancestor
92025728|NCT04080869|Dermatologic Agents|dermatologic agents|mesh-ancestor
92025729|NCT04080869|Antioxidants|antioxidants|mesh-ancestor
92025730|NCT04080869|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92025731|NCT04080869|Protective Agents|protective agents|mesh-ancestor
92025732|NCT04080869|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025733|NCT04080869|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92025734|NCT04080869|Vitamins|vitamins|mesh-ancestor
92025735|NCT04080869|Micronutrients|micronutrients|mesh-ancestor
92025736|NCT00560495|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92025737|NCT00560495|Technetium Tc 99m Sestamibi|technetium tc 99m sestamibi|mesh-list
92025738|NCT00560495|Chelating Agents|chelating agents|mesh-ancestor
92025739|NCT00560495|Sequestering Agents|sequestering agents|mesh-ancestor
92025773|NCT05491343|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025774|NCT05491343|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92025776|NCT05491343|Contraceptive Agents, Male|contraceptive agents, male|mesh-ancestor
92025845|NCT03209479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92025846|NCT03209479|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92025916|NCT02545933|Antipyretics|antipyretics|mesh-ancestor
92025917|NCT02545933|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92025918|NCT02545933|Purinergic P2 Receptor Antagonists|purinergic p2 receptor antagonists|mesh-ancestor
92025989|NCT05485571|Immunologic Factors|immunologic factors|mesh-ancestor
92026066|NCT05495945|Propofol|propofol|mesh-list
92026139|NCT05482763|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92026140|NCT05482373|Oleuropein|oleuropein|mesh-list
92026144|NCT05482295|Vaccines|vaccines|mesh-list
92026212|NCT05481281|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026213|NCT05481281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026214|NCT05481281|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92026281|NCT05492669|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92026282|NCT05492669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026283|NCT05492591|Valacyclovir|valacyclovir|mesh-list
92026284|NCT05492591|Antiviral Agents|antiviral agents|mesh-ancestor
92026285|NCT05492591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026286|NCT02554721|Aspirin|aspirin|mesh-list
92026287|NCT02554721|Cilostazol|cilostazol|mesh-list
92026349|NCT05479487|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026351|NCT05479487|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92026423|NCT02865551|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026424|NCT02865551|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026425|NCT05478083|Leuprolide|leuprolide|mesh-list
92026426|NCT05478083|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92026427|NCT05478083|Fertility Agents|fertility agents|mesh-ancestor
92026428|NCT05478083|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92026429|NCT05478083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026430|NCT05478083|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92026431|NCT05478083|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026432|NCT02544217|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|6-hydroxy-2,5,7,8-tetramethylchroman-2-carboxylic acid|mesh-list
92026433|NCT02544217|Antioxidants|antioxidants|mesh-ancestor
92026434|NCT02544217|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026435|NCT02544217|Protective Agents|protective agents|mesh-ancestor
92026436|NCT02544217|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026437|NCT05427565|Caffeine|caffeine|mesh-list
92026438|NCT05427565|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92026439|NCT05427565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026479|NCT02551055|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92026480|NCT02551055|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92026482|NCT05470673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92026483|NCT05470673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92026484|NCT05470673|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92026485|NCT05470673|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92026548|NCT02549573|Dopamine Agents|dopamine agents|mesh-ancestor
92026549|NCT02549573|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92026552|NCT05477615|Pemetrexed|pemetrexed|mesh-list
92026620|NCT02301975|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92026621|NCT02301975|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92026622|NCT02301975|Autonomic Agents|autonomic agents|mesh-ancestor
92026691|NCT02366091|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92026692|NCT02366091|Dermatologic Agents|dermatologic agents|mesh-ancestor
92026703|NCT05476679|Celecoxib|celecoxib|mesh-list
92026763|NCT02365233|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92026764|NCT02365233|Pioglitazone|pioglitazone|mesh-list
92026765|NCT02365233|Sitagliptin Phosphate|sitagliptin phosphate|mesh-list
92026766|NCT02365233|Insulin Glargine|insulin glargine|mesh-list
92026835|NCT02320149|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92026909|NCT05451095|Analgesics|analgesics|mesh-ancestor
92026910|NCT05451095|Sensory System Agents|sensory system agents|mesh-ancestor
92026911|NCT05451095|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026980|NCT05398705|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92026991|NCT05415865|Lidocaine|lidocaine|mesh-list
92026992|NCT05415865|Anesthetics, Local|anesthetics, local|mesh-ancestor
92026993|NCT05415865|Anesthetics|anesthetics|mesh-ancestor
92026994|NCT05415865|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92026995|NCT05415865|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92026996|NCT05415865|Sensory System Agents|sensory system agents|mesh-ancestor
92026997|NCT05415865|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92026998|NCT05415865|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92026999|NCT05415865|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92027000|NCT05415865|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92027001|NCT05415865|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027050|NCT01660711|Irinotecan|irinotecan|mesh-list
92027051|NCT01660711|Antimetabolites|antimetabolites|mesh-ancestor
92027052|NCT01660711|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027053|NCT01660711|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92027054|NCT01660711|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027055|NCT01660711|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92027056|NCT01660711|Immunologic Factors|immunologic factors|mesh-ancestor
92027057|NCT01660711|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027058|NCT01660711|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92027059|NCT01660711|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92027060|NCT01660711|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027115|NCT02543801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92027116|NCT02543801|Analgesics|analgesics|mesh-ancestor
92027117|NCT02543801|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92027189|NCT02292771|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92027190|NCT02292771|Oxytocics|oxytocics|mesh-ancestor
92027191|NCT02292771|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92027192|NCT02291913|Tamoxifen|tamoxifen|mesh-list
92027193|NCT02291913|Everolimus|everolimus|mesh-list
92027194|NCT02291913|Letrozole|letrozole|mesh-list
92027260|NCT02389543|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92027262|NCT02389543|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027331|NCT04261075|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027332|NCT05436769|Clarithromycin|clarithromycin|mesh-list
92027333|NCT05436769|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92027334|NCT05436769|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92027335|NCT05436769|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92027336|NCT05436769|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027337|NCT05436769|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027338|NCT05436769|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92027339|NCT05436769|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92027340|NCT05378737|Exatecan|exatecan|mesh-list
92027341|NCT05378737|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92027342|NCT05378737|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92027343|NCT05378737|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027391|NCT05341609|Nirmatrelvir and ritonavir drug combination|nirmatrelvir and ritonavir drug combination|mesh-list
92027392|NCT05341609|HIV Protease Inhibitors|hiv protease inhibitors|mesh-ancestor
92027393|NCT05341609|Viral Protease Inhibitors|viral protease inhibitors|mesh-ancestor
92027394|NCT05341609|Protease Inhibitors|protease inhibitors|mesh-ancestor
92027395|NCT05341609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027396|NCT05341609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027397|NCT05341609|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92027398|NCT05341609|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92027457|NCT05334277|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92027458|NCT05334277|Growth Substances|growth substances|mesh-ancestor
92027459|NCT05334277|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027460|NCT05334277|Growth Inhibitors|growth inhibitors|mesh-ancestor
92027461|NCT05334277|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027462|NCT05334277|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027601|NCT05314621|Autonomic Agents|autonomic agents|mesh-ancestor
92027602|NCT05314621|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92027674|NCT04243837|Analgesics|analgesics|mesh-ancestor
92027675|NCT04243837|Sensory System Agents|sensory system agents|mesh-ancestor
92027699|NCT05218603|Bortezomib|bortezomib|mesh-list
92027746|NCT05248945|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92027821|NCT05205811|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92027822|NCT05205811|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92027823|NCT05205811|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027824|NCT05205811|Dopamine Agents|dopamine agents|mesh-ancestor
92027825|NCT05205811|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92027826|NCT05205811|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92027827|NCT05205811|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92027828|NCT05205811|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92027883|NCT05159245|Dabrafenib|dabrafenib|mesh-list
92027884|NCT05159245|Pralsetinib|pralsetinib|mesh-list
92027885|NCT05159245|Entrectinib|entrectinib|mesh-list
92027886|NCT05159245|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92027887|NCT05159245|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92027888|NCT05159245|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92027889|NCT05159245|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92027890|NCT05159245|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92027891|NCT05159245|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92027954|NCT05186545|Fulvestrant|fulvestrant|mesh-list
92028023|NCT05175781|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92028024|NCT05175781|Adrenergic Agents|adrenergic agents|mesh-ancestor
92028025|NCT05175781|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028026|NCT05175781|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028027|NCT05175781|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92028028|NCT05175781|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92028029|NCT05175781|Anesthetics, General|anesthetics, general|mesh-ancestor
92028031|NCT05175781|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92028088|NCT05082025|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92028089|NCT05082025|Hormone Antagonists|hormone antagonists|mesh-ancestor
92028090|NCT05082025|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028091|NCT05082025|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028092|NCT05081479|Acetylcysteine|acetylcysteine|mesh-list
92028093|NCT05081479|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92028094|NCT05081479|Antiviral Agents|antiviral agents|mesh-ancestor
92028095|NCT05081479|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028096|NCT05081479|Expectorants|expectorants|mesh-ancestor
92028153|NCT01364467|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028226|NCT04216693|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028227|NCT01364389|Prednisone|prednisone|mesh-list
92028228|NCT01364389|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028229|NCT01364389|Glucocorticoids|glucocorticoids|mesh-ancestor
92028230|NCT01364389|Hormones|hormones|mesh-ancestor
92028231|NCT01364389|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92028232|NCT01364389|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028233|NCT01364389|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92028293|NCT02291289|Cetuximab|cetuximab|mesh-list
92028294|NCT02291289|Atezolizumab|atezolizumab|mesh-list
92028295|NCT02291289|Pertuzumab|pertuzumab|mesh-list
92028296|NCT02291289|Capecitabine|capecitabine|mesh-list
92028297|NCT02291289|Fluorouracil|fluorouracil|mesh-list
92028366|NCT02357979|Protective Agents|protective agents|mesh-ancestor
92028367|NCT02357979|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028369|NCT02357901|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92028370|NCT02357901|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92028371|NCT02357901|Narcotics|narcotics|mesh-ancestor
92028435|NCT02289417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92028436|NCT02289417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028506|NCT02504827|Ceftazidime|ceftazidime|mesh-list
92028581|NCT04966585|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028582|NCT04205539|Dexmedetomidine|dexmedetomidine|mesh-list
92028583|NCT04205539|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92028584|NCT04205539|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028585|NCT04205539|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028586|NCT04205539|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92028587|NCT04205539|Analgesics|analgesics|mesh-ancestor
92028588|NCT04205539|Sensory System Agents|sensory system agents|mesh-ancestor
92028589|NCT04205539|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028590|NCT04205539|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92028591|NCT04205539|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92028592|NCT04205539|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92028596|NCT02313909|Aspirin|aspirin|mesh-list
92028643|NCT01646385|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028644|NCT01646385|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92028645|NCT01646385|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92028646|NCT01646385|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92028648|NCT02286843|Trastuzumab|trastuzumab|mesh-list
92028649|NCT02286843|Pertuzumab|pertuzumab|mesh-list
92028650|NCT02286843|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92028651|NCT02286843|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92028652|NCT02281773|BI 409306|bi 409306|mesh-list
92028707|NCT02482129|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92028783|NCT02495077|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92028784|NCT02495077|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028785|NCT02495077|Anesthetics, Local|anesthetics, local|mesh-ancestor
92028786|NCT02495077|Anesthetics|anesthetics|mesh-ancestor
92028787|NCT02495077|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92028788|NCT02495077|Histamine Antagonists|histamine antagonists|mesh-ancestor
92028789|NCT02495077|Histamine Agents|histamine agents|mesh-ancestor
92028790|NCT02495077|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92028791|NCT02495077|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92028792|NCT02495077|Antipruritics|antipruritics|mesh-ancestor
92028803|NCT02494921|Prednisone|prednisone|mesh-list
92028849|NCT02493361|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92028850|NCT02493361|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92028851|NCT04959799|Dalbavancin|dalbavancin|mesh-list
92028852|NCT04959799|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028853|NCT04959799|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92028854|NCT04959331|Fosfomycin|fosfomycin|mesh-list
92028855|NCT04959331|Nitrofurantoin|nitrofurantoin|mesh-list
92028856|NCT04959331|Amdinocillin Pivoxil|amdinocillin pivoxil|mesh-list
92028857|NCT04959331|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92028919|NCT04939987|Sensory System Agents|sensory system agents|mesh-ancestor
92028920|NCT04939987|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92028921|NCT04939987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92028922|NCT04939987|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92028923|NCT04939987|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92028924|NCT04939987|Anesthetics, General|anesthetics, general|mesh-ancestor
92028925|NCT04939987|Anesthetics|anesthetics|mesh-ancestor
92028926|NCT04939987|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92028983|NCT02475733|Meropenem|meropenem|mesh-list
92028984|NCT02475733|Ceftazidime|ceftazidime|mesh-list
92028985|NCT02475733|Avibactam|avibactam|mesh-list
92028986|NCT02475733|Avibactam, ceftazidime drug combination|avibactam, ceftazidime drug combination|mesh-list
92029054|NCT02418949|Histamine Agents|histamine agents|mesh-ancestor
92029055|NCT02418949|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029056|NCT02418949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029124|NCT02469961|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92029125|NCT02469961|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92029126|NCT02469961|Adrenergic Agents|adrenergic agents|mesh-ancestor
92029127|NCT02469961|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029197|NCT01651039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029198|NCT01651039|Immunologic Factors|immunologic factors|mesh-ancestor
92029206|NCT02349633|Palbociclib|palbociclib|mesh-list
92029269|NCT02272803|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92029270|NCT02272803|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029271|NCT02272803|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92029272|NCT02272803|Glucocorticoids|glucocorticoids|mesh-ancestor
92029273|NCT02272803|Hormones|hormones|mesh-ancestor
92029337|NCT02528357|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92029339|NCT04910503|Dexamethasone|dexamethasone|mesh-list
92029413|NCT02462473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029487|NCT05443061|Vasodilator Agents|vasodilator agents|mesh-ancestor
92029488|NCT02537015|Bimatoprost|bimatoprost|mesh-list
92029562|NCT02438371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029563|NCT02438371|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92029564|NCT02438371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029565|NCT02438371|Vasodilator Agents|vasodilator agents|mesh-ancestor
92029566|NCT02438371|Tocolytic Agents|tocolytic agents|mesh-ancestor
92029567|NCT02438371|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92029568|NCT02438371|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92029569|NCT02438371|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92029570|NCT02438371|Analgesics|analgesics|mesh-ancestor
92029633|NCT02436577|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92029634|NCT02436577|Purinergic Agents|purinergic agents|mesh-ancestor
92029635|NCT02436577|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029707|NCT02258529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92029708|NCT02258529|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029709|NCT02258529|Immunologic Factors|immunologic factors|mesh-ancestor
92029710|NCT02258529|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029775|NCT02255565|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92029776|NCT01640301|Aldesleukin|aldesleukin|mesh-list
92029777|NCT01640301|Cyclophosphamide|cyclophosphamide|mesh-list
92029778|NCT01640301|Fludarabine|fludarabine|mesh-list
92029779|NCT01640301|Fludarabine phosphate|fludarabine phosphate|mesh-list
92029780|NCT01640301|Interleukin-2|interleukin-2|mesh-list
92029781|NCT01640301|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92029782|NCT01640301|Immunologic Factors|immunologic factors|mesh-ancestor
92029783|NCT01640301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029784|NCT01640301|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92029785|NCT01640301|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92029786|NCT01640301|Alkylating Agents|alkylating agents|mesh-ancestor
92029787|NCT01640301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92029788|NCT01640301|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029789|NCT01640301|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92029790|NCT01640301|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92029791|NCT01640301|Antimetabolites|antimetabolites|mesh-ancestor
92029792|NCT01640301|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92029793|NCT01640301|Analgesics|analgesics|mesh-ancestor
92029831|NCT05640375|Protective Agents|protective agents|mesh-ancestor
92029832|NCT05640375|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92029833|NCT05640375|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92029834|NCT01641237|Listerine|listerine|mesh-list
92029835|NCT01641237|Fluorides|fluorides|mesh-list
92029836|NCT01641237|Sodium Fluoride|sodium fluoride|mesh-list
92029837|NCT01641237|Cariostatic Agents|cariostatic agents|mesh-ancestor
92029838|NCT01641237|Protective Agents|protective agents|mesh-ancestor
92029901|NCT04853589|Immunologic Factors|immunologic factors|mesh-ancestor
92029902|NCT04853589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92029903|NCT04853589|Viscosupplements|viscosupplements|mesh-ancestor
92029904|NCT04853589|Protective Agents|protective agents|mesh-ancestor
92029905|NCT01638429|Rifaximin|rifaximin|mesh-list
92029971|NCT04586985|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92029972|NCT04586985|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92029979|NCT04586985|Anesthetics|anesthetics|mesh-ancestor
92030044|NCT04850937|Esketamine|esketamine|mesh-list
92030045|NCT04850937|Antidepressive Agents|antidepressive agents|mesh-ancestor
92030046|NCT04850937|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92030047|NCT01363713|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92030048|NCT01363713|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92030049|NCT04411329|Dexamethasone|dexamethasone|mesh-list
92030050|NCT04411329|Dexmedetomidine|dexmedetomidine|mesh-list
92030051|NCT04411329|Bupivacaine|bupivacaine|mesh-list
92030111|NCT04390581|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92030112|NCT04390581|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92030113|NCT04390581|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030123|NCT04183335|Calcineurin Inhibitors|calcineurin inhibitors|mesh-list
92030124|NCT04183335|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030125|NCT04183335|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030126|NCT04254549|Rifaximin|rifaximin|mesh-list
92030127|NCT04254549|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92030128|NCT04254549|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92030129|NCT04254549|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030130|NCT04225767|Calcium|calcium|mesh-list
92030131|NCT04225767|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034604|NCT02476175|Adrenergic Agents|adrenergic agents|mesh-ancestor
92030132|NCT04225767|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030133|NCT04820673|Sarecycline|sarecycline|mesh-list
92030134|NCT04820673|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92030170|NCT03256149|Dexamethasone|dexamethasone|mesh-list
92030171|NCT03256149|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030172|NCT03256149|Antiemetics|antiemetics|mesh-ancestor
92030173|NCT03256149|Autonomic Agents|autonomic agents|mesh-ancestor
92030174|NCT03256149|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030175|NCT03256149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030176|NCT03256149|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92030243|NCT02817633|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030244|NCT02817633|Tubulin Modulators|tubulin modulators|mesh-ancestor
92030245|NCT02817633|Antimitotic Agents|antimitotic agents|mesh-ancestor
92030246|NCT02817633|Mitosis Modulators|mitosis modulators|mesh-ancestor
92030247|NCT02817633|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030248|NCT02817633|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92030249|NCT02817633|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92030250|NCT02817633|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030251|NCT02817633|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92030252|NCT02817633|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92030254|NCT02775435|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92030255|NCT02775435|Carboplatin|carboplatin|mesh-list
92030256|NCT02775435|Pembrolizumab|pembrolizumab|mesh-list
92030304|NCT03905889|Growth Inhibitors|growth inhibitors|mesh-ancestor
92030305|NCT03905889|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92030306|NCT03905889|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030307|NCT03905889|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030308|NCT04804059|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92030310|NCT03846765|Dobutamine|dobutamine|mesh-list
92030311|NCT03846765|Oxymetazoline|oxymetazoline|mesh-list
92030312|NCT03846765|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92030313|NCT03846765|Mydriatics|mydriatics|mesh-ancestor
92030314|NCT03846765|Autonomic Agents|autonomic agents|mesh-ancestor
92030370|NCT04446039|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92030372|NCT04446039|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030440|NCT05031897|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92030441|NCT05031897|Antitubercular Agents|antitubercular agents|mesh-ancestor
92030582|NCT03401073|Immunologic Factors|immunologic factors|mesh-ancestor
92030583|NCT03401073|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030587|NCT02242305|Antiemetics|antiemetics|mesh-ancestor
92030655|NCT02208063|Oxacillin|oxacillin|mesh-list
92030656|NCT02208063|Telavancin|telavancin|mesh-list
92030657|NCT02208063|Nafcillin|nafcillin|mesh-list
92030728|NCT02233647|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92030729|NCT02233647|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92030730|NCT02233647|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92030731|NCT02233647|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92030732|NCT02233647|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030733|NCT02233647|Dopamine Agents|dopamine agents|mesh-ancestor
92030734|NCT02233647|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92030735|NCT01632579|Celecoxib|celecoxib|mesh-list
92030736|NCT01632579|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92030737|NCT01632579|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92030738|NCT01632579|Analgesics|analgesics|mesh-ancestor
92030739|NCT01632579|Sensory System Agents|sensory system agents|mesh-ancestor
92030740|NCT01632579|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030741|NCT01632579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030742|NCT01632579|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92030743|NCT01632579|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92030744|NCT01632579|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92030745|NCT01632579|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92030746|NCT01632579|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92030781|NCT04776369|Magnesium Sulfate|magnesium sulfate|mesh-list
92030782|NCT04776369|Anesthetics, Local|anesthetics, local|mesh-ancestor
92030783|NCT04776369|Anesthetics|anesthetics|mesh-ancestor
92030784|NCT04776369|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92030785|NCT04776369|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92030786|NCT04776369|Sensory System Agents|sensory system agents|mesh-ancestor
92030787|NCT04776369|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92030788|NCT04776369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92030789|NCT04776369|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92030790|NCT04776369|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92030791|NCT04776369|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92030792|NCT04776369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030793|NCT04776369|Analgesics|analgesics|mesh-ancestor
92030837|NCT02202837|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92030910|NCT02224599|Alkylating Agents|alkylating agents|mesh-ancestor
92030911|NCT02224599|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92030912|NCT02224599|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92030913|NCT02224599|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92030914|NCT02224599|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92030915|NCT02224599|Interferon Inducers|interferon inducers|mesh-ancestor
92030917|NCT04763577|Kininogens|kininogens|mesh-list
92030923|NCT02201901|Sofosbuvir|sofosbuvir|mesh-list
92030978|NCT02434081|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92031055|NCT02217501|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92031056|NCT02217501|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92031058|NCT02217501|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92031130|NCT02397889|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92031131|NCT02397889|GABA Modulators|gaba modulators|mesh-ancestor
92031132|NCT02397889|GABA Agents|gaba agents|mesh-ancestor
92031199|NCT02425111|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031200|NCT02393755|Capecitabine|capecitabine|mesh-list
92031270|NCT02384941|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92031271|NCT02384941|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031272|NCT02384941|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92031273|NCT02384941|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031274|NCT02384395|Lamivudine|lamivudine|mesh-list
92031275|NCT02384395|Abacavir|abacavir|mesh-list
92031276|NCT02384395|Dolutegravir|dolutegravir|mesh-list
92031277|NCT02384395|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92031278|NCT02384395|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92031279|NCT02384395|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92031280|NCT02384395|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92031333|NCT02345161|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031334|NCT02345161|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92031408|NCT02250651|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92031482|NCT04886323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92031483|NCT04886323|Hormone Antagonists|hormone antagonists|mesh-ancestor
92031485|NCT04886323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92031554|NCT01618162|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92031627|NCT02339155|Anesthetics, Local|anesthetics, local|mesh-ancestor
92031702|NCT02374099|Cc-486|cc-486|mesh-list
92031703|NCT02374099|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92031704|NCT02374099|Antimetabolites|antimetabolites|mesh-ancestor
92031714|NCT02134977|Leuprolide|leuprolide|mesh-list
92031772|NCT02372383|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92031774|NCT01648699|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92031844|NCT01913470|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92031845|NCT01913470|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92031920|NCT02164929|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92031921|NCT02164929|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92031922|NCT02164929|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92031923|NCT02164929|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92031993|NCT02188719|Antipyretics|antipyretics|mesh-ancestor
92031994|NCT02188719|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92032000|NCT02188719|Hematinics|hematinics|mesh-ancestor
92032066|NCT05269017|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032067|NCT01628913|Everolimus|everolimus|mesh-list
92032068|NCT01628913|Dactolisib|dactolisib|mesh-list
92032136|NCT02531633|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92032137|NCT02531633|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032207|NCT05610371|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032208|NCT02163759|Adalimumab|adalimumab|mesh-list
92032280|NCT05342519|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92032281|NCT05342519|Immunologic Factors|immunologic factors|mesh-ancestor
92032282|NCT05342519|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032283|NCT05342519|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92032284|NCT05342519|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032285|NCT05342519|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032286|NCT05308901|Pembrolizumab|pembrolizumab|mesh-list
92032287|NCT05308901|Lenvatinib|lenvatinib|mesh-list
92032288|NCT05308901|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92032289|NCT05308901|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032344|NCT05529173|Povidone|povidone|mesh-list
92032345|NCT05529173|Plasma Substitutes|plasma substitutes|mesh-ancestor
92032346|NCT05529173|Blood Substitutes|blood substitutes|mesh-ancestor
92032348|NCT05529173|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032416|NCT02525861|Trypsin Inhibitors|trypsin inhibitors|mesh-ancestor
92032417|NCT02525861|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92032487|NCT05359055|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92032488|NCT05359055|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92032556|NCT02525471|RNS60|rns60|mesh-list
92032557|NCT02525471|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92032631|NCT02335411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032639|NCT02161731|Warfarin|warfarin|mesh-list
92032706|NCT02123511|N-monoacetylcystine|n-monoacetylcystine|mesh-list
92032707|NCT02123511|Antiviral Agents|antiviral agents|mesh-ancestor
92032708|NCT02123511|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032779|NCT02120157|Alkylating Agents|alkylating agents|mesh-ancestor
92032780|NCT02120157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92032781|NCT02120157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92032782|NCT02120157|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92032784|NCT02120157|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92032850|NCT05346731|Hormones|hormones|mesh-ancestor
92032852|NCT05346731|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92032924|NCT05205473|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92032932|NCT05253053|Paclitaxel|paclitaxel|mesh-list
92032996|NCT05157971|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92032997|NCT05157971|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92032998|NCT05157971|Tubulin Modulators|tubulin modulators|mesh-ancestor
92032999|NCT05157971|Antimitotic Agents|antimitotic agents|mesh-ancestor
92033068|NCT05248139|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033069|NCT05248139|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92033070|NCT05248139|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92033141|NCT05239091|Sensory System Agents|sensory system agents|mesh-ancestor
92033142|NCT05239091|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033143|NCT05239091|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92033144|NCT05239091|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92033145|NCT05239091|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92033146|NCT05239091|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033147|NCT05239091|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033148|NCT02152371|Metformin|metformin|mesh-list
92033149|NCT02152371|Insulin Glargine|insulin glargine|mesh-list
92033150|NCT02152371|Dulaglutide|dulaglutide|mesh-list
92033151|NCT02152371|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92033152|NCT02152371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033153|NCT02332291|Bupropion|bupropion|mesh-list
92033154|NCT02332291|Escitalopram|escitalopram|mesh-list
92033199|NCT05237687|Immunologic Factors|immunologic factors|mesh-ancestor
92033200|NCT05237687|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033201|NCT01657019|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92033202|NCT01657019|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92033203|NCT01657019|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033273|NCT05228951|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033274|NCT05228951|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033275|NCT05228951|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92033276|NCT05228951|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92033344|NCT02151591|Varenicline|varenicline|mesh-list
92033418|NCT05220293|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033419|NCT05220293|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92033420|NCT05220293|Respiratory System Agents|respiratory system agents|mesh-ancestor
92033421|NCT02297503|Botulinum Toxins|botulinum toxins|mesh-list
92033422|NCT02297503|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92033423|NCT02297503|Hyaluronic Acid|hyaluronic acid|mesh-list
92033424|NCT02297503|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92033425|NCT02297503|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033426|NCT02297503|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033427|NCT02297503|Cholinergic Agents|cholinergic agents|mesh-ancestor
92033428|NCT02297503|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033429|NCT02297503|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033430|NCT02297503|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92033431|NCT02297503|Immunologic Factors|immunologic factors|mesh-ancestor
92033478|NCT02147691|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92033479|NCT02147691|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92033480|NCT02147691|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92033481|NCT02147691|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033482|NCT02147691|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033483|NCT02147691|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033484|NCT02147691|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033544|NCT04751877|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92033545|NCT04751877|Immunologic Factors|immunologic factors|mesh-ancestor
92033546|NCT04751877|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92033547|NCT04751877|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92033548|NCT04751877|Growth Substances|growth substances|mesh-ancestor
92033549|NCT04751877|Growth Inhibitors|growth inhibitors|mesh-ancestor
92033550|NCT02147067|Ranolazine|ranolazine|mesh-list
92033551|NCT02147067|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92033552|NCT02147067|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92033553|NCT02147067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033554|NCT02107131|Ranibizumab|ranibizumab|mesh-list
92033555|NCT02107131|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92033556|NCT02107131|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92033557|NCT02107131|Growth Substances|growth substances|mesh-ancestor
92033558|NCT02107131|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033606|NCT02519231|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92033607|NCT02519231|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92033608|NCT02519231|Analgesics|analgesics|mesh-ancestor
92033609|NCT02519231|Sensory System Agents|sensory system agents|mesh-ancestor
92033610|NCT02519231|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92033611|NCT02519231|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033612|NCT02519231|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92033613|NCT02519231|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92033677|NCT05025605|Adrenergic Agents|adrenergic agents|mesh-ancestor
92033752|NCT05018117|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92033753|NCT05018117|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92033754|NCT05016869|Capecitabine|capecitabine|mesh-list
92033755|NCT05016869|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92033824|NCT04944095|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92033826|NCT02141295|Folic Acid|folic acid|mesh-list
92033827|NCT02141295|Bevacizumab|bevacizumab|mesh-list
92033828|NCT02141295|Oxaliplatin|oxaliplatin|mesh-list
92033829|NCT02141295|Levoleucovorin|levoleucovorin|mesh-list
92033830|NCT02141295|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92033834|NCT02141295|Growth Substances|growth substances|mesh-ancestor
92033900|NCT02511431|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92033901|NCT02511431|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92033902|NCT02511431|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92033903|NCT02137785|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92033975|NCT02507375|Pertuzumab|pertuzumab|mesh-list
92034039|NCT04974281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92034040|NCT04974281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034042|NCT02503865|Orlistat|orlistat|mesh-list
92034109|NCT02046369|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92034180|NCT04734405|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034251|NCT02100657|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92034252|NCT02100657|Glucocorticoids|glucocorticoids|mesh-ancestor
92034254|NCT02100657|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034255|NCT02100657|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92034256|NCT02100657|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034257|NCT02067663|Levonorgestrel|levonorgestrel|mesh-list
92034258|NCT02067663|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92034259|NCT02067663|Contraceptive Agents|contraceptive agents|mesh-ancestor
92034260|NCT02067663|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92034261|NCT02067663|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034262|NCT02067663|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92034263|NCT02067663|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92034264|NCT02067663|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92034309|NCT01878292|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92034310|NCT01878292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034380|NCT01876732|Micronutrients|micronutrients|mesh-ancestor
92034381|NCT01876732|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92034382|NCT01876732|Vitamin B Complex|vitamin b complex|mesh-ancestor
92034383|NCT01876732|Hematinics|hematinics|mesh-ancestor
92034384|NCT01905592|Niraparib|niraparib|mesh-list
92034386|NCT01905592|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92034449|NCT01903252|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92034451|NCT01903252|Analgesics|analgesics|mesh-ancestor
92034521|NCT02499575|Anesthetics, Local|anesthetics, local|mesh-ancestor
92034522|NCT02499575|Anesthetics|anesthetics|mesh-ancestor
92034595|NCT02497391|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92034596|NCT02497391|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92034597|NCT02497391|Antimetabolites|antimetabolites|mesh-ancestor
92034598|NCT02497391|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034601|NCT02476175|Adrenergic beta-3 Receptor Agonists|adrenergic beta-3 receptor agonists|mesh-ancestor
92034602|NCT02476175|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92034603|NCT02476175|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92034605|NCT02476175|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92034606|NCT02476175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034660|NCT02098395|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92034732|NCT01645111|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92034734|NCT02364037|Contraceptive Agents|contraceptive agents|mesh-list
92034806|NCT02293993|Guadecitabine|guadecitabine|mesh-list
92034807|NCT02293993|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92034881|NCT02359435|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92034882|NCT02359435|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92034952|NCT01613326|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92034957|NCT01613326|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92035023|NCT02473913|Silymarin|silymarin|mesh-list
92035024|NCT02473913|Antioxidants|antioxidants|mesh-ancestor
92035025|NCT02473913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035026|NCT02473913|Protective Agents|protective agents|mesh-ancestor
92035096|NCT02060487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035171|NCT04618744|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035242|NCT01896232|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92035244|NCT02460224|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92035248|NCT02058537|Bethanechol|bethanechol|mesh-list
92035312|NCT01857310|Vitamin B Complex|vitamin b complex|mesh-ancestor
92035390|NCT01855828|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035465|NCT02037165|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92035466|NCT02037165|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92035467|NCT02037165|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035533|NCT01622673|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92035535|NCT01622673|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92035608|NCT02485691|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92035681|NCT02451917|Insulin|insulin|mesh-list
92035682|NCT02451917|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92035683|NCT02451917|Insulin Glargine|insulin glargine|mesh-list
92035684|NCT02451917|Insulin, Isophane|insulin, isophane|mesh-list
92035685|NCT02451917|Isophane Insulin, Human|isophane insulin, human|mesh-list
92035686|NCT02451917|Isophane insulin, beef|isophane insulin, beef|mesh-list
92035687|NCT02451917|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035688|NCT02451917|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035689|NCT02349451|Adalimumab|adalimumab|mesh-list
92035690|NCT02349451|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92035691|NCT02349451|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92035692|NCT02349451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92035693|NCT04956263|Dapagliflozin|dapagliflozin|mesh-list
92035694|NCT04956263|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92035695|NCT04956263|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035696|NCT04956263|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92035697|NCT04956263|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035698|NCT02409368|Nivolumab|nivolumab|mesh-list
92035699|NCT02409368|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92035700|NCT02409368|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92035701|NCT02409368|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92035702|NCT02409368|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035703|NCT04891484|Ondansetron|ondansetron|mesh-list
92035704|NCT04891484|Antiemetics|antiemetics|mesh-ancestor
92035705|NCT04891484|Autonomic Agents|autonomic agents|mesh-ancestor
92035706|NCT04891484|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035707|NCT04891484|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035728|NCT01853644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035729|NCT01853254|Ribavirin|ribavirin|mesh-list
92035730|NCT01853254|Peginterferon alfa-2a|peginterferon alfa-2a|mesh-list
92035731|NCT01853254|Antimetabolites|antimetabolites|mesh-ancestor
92035732|NCT01853254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035733|NCT01853254|Antiviral Agents|antiviral agents|mesh-ancestor
92035734|NCT01853254|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92035735|NCT02373098|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92035736|NCT02373098|Sphingosine 1 Phosphate Receptor Modulators|sphingosine 1 phosphate receptor modulators|mesh-ancestor
92035737|NCT02373098|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035738|NCT02373098|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92035739|NCT02373098|Immunologic Factors|immunologic factors|mesh-ancestor
92035740|NCT02373098|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035741|NCT01853176|Bupivacaine|bupivacaine|mesh-list
92035742|NCT01853176|Anesthetics, Local|anesthetics, local|mesh-ancestor
92035743|NCT01853176|Anesthetics|anesthetics|mesh-ancestor
92035744|NCT01853176|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92035745|NCT01853176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92035746|NCT01853176|Sensory System Agents|sensory system agents|mesh-ancestor
92035747|NCT01853176|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035748|NCT01852942|Losartan|losartan|mesh-list
92035749|NCT01852942|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92035750|NCT01852942|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92035751|NCT01852942|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92035752|NCT01852942|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92035753|NCT01852942|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92035847|NCT02369510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035848|NCT02369510|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92035849|NCT02369510|Respiratory System Agents|respiratory system agents|mesh-ancestor
92035850|NCT02369510|Mydriatics|mydriatics|mesh-ancestor
92035851|NCT02369510|Sympathomimetics|sympathomimetics|mesh-ancestor
92035853|NCT01650194|Prednisone|prednisone|mesh-list
92035914|NCT02403674|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92035915|NCT02403674|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92035916|NCT02401256|Efavirenz|efavirenz|mesh-list
92035917|NCT02401256|Bupropion|bupropion|mesh-list
92035984|NCT02400476|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92035985|NCT02400476|Autonomic Agents|autonomic agents|mesh-ancestor
92035986|NCT02400476|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92035987|NCT02400476|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036055|NCT02362412|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92036056|NCT02362412|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92036057|NCT02362412|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92036058|NCT02362412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036059|NCT02347813|Pioglitazone|pioglitazone|mesh-list
92036060|NCT02347813|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036061|NCT02347813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036062|NCT02359994|Hemostatics|hemostatics|mesh-list
92036063|NCT02359994|Coagulants|coagulants|mesh-ancestor
92036064|NCT04905446|Niacinamide|niacinamide|mesh-list
92036065|NCT04905446|Niacin|niacin|mesh-list
92036066|NCT04905446|Nicotinic Acids|nicotinic acids|mesh-list
92036067|NCT04905446|Vitamin B Complex|vitamin b complex|mesh-ancestor
92036068|NCT04905446|Vitamins|vitamins|mesh-ancestor
92036069|NCT04905446|Micronutrients|micronutrients|mesh-ancestor
92036070|NCT04905446|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036071|NCT04905446|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92036072|NCT04905446|Antimetabolites|antimetabolites|mesh-ancestor
92036103|NCT02358668|PAZ320|paz320|mesh-list
92036115|NCT02282527|Protease Inhibitors|protease inhibitors|mesh-ancestor
92036116|NCT02282527|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036118|NCT05650099|Cimetidine|cimetidine|mesh-list
92036187|NCT04876027|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036188|NCT04876027|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036189|NCT02358044|Ribavirin|ribavirin|mesh-list
92036190|NCT02358044|Sofosbuvir|sofosbuvir|mesh-list
92036191|NCT02358044|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92036192|NCT02358044|Grazoprevir|grazoprevir|mesh-list
92036193|NCT02358044|Elbasvir-grazoprevir drug combination|elbasvir-grazoprevir drug combination|mesh-list
92036194|NCT02358044|Antimetabolites|antimetabolites|mesh-ancestor
92036195|NCT02358044|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036196|NCT02358044|Antiviral Agents|antiviral agents|mesh-ancestor
92036197|NCT02358044|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036198|NCT05536219|Antibodies|antibodies|mesh-list
92036199|NCT05536219|Immunologic Factors|immunologic factors|mesh-ancestor
92036201|NCT05649241|Nicotine|nicotine|mesh-list
92036248|NCT04856761|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92036249|NCT04856761|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036250|NCT01832038|Lacosamide|lacosamide|mesh-list
92036251|NCT01832038|Anticonvulsants|anticonvulsants|mesh-ancestor
92036252|NCT01832038|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92036253|NCT01832038|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92036254|NCT01832038|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92036256|NCT01849588|Sorafenib|sorafenib|mesh-list
92036314|NCT05648071|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036315|NCT05648071|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036388|NCT01844830|Sympathomimetics|sympathomimetics|mesh-ancestor
92036389|NCT01844830|Autonomic Agents|autonomic agents|mesh-ancestor
92036390|NCT01844830|Nasal Decongestants|nasal decongestants|mesh-ancestor
92036460|NCT02351960|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92036461|NCT02351960|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92036531|NCT05646199|Metformin|metformin|mesh-list
92036532|NCT05646199|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036533|NCT05646199|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036534|NCT02258659|Paclitaxel|paclitaxel|mesh-list
92036535|NCT02258659|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92036536|NCT02258659|Carboplatin|carboplatin|mesh-list
92036537|NCT02258659|Fluorouracil|fluorouracil|mesh-list
92036539|NCT02258659|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92036540|NCT02258659|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92036541|NCT02258659|Tubulin Modulators|tubulin modulators|mesh-ancestor
92036542|NCT02258659|Antimitotic Agents|antimitotic agents|mesh-ancestor
92036543|NCT02258659|Mitosis Modulators|mitosis modulators|mesh-ancestor
92036545|NCT02258659|Antimetabolites|antimetabolites|mesh-ancestor
92036607|NCT02349386|Estradiol|estradiol|mesh-list
92036608|NCT02349386|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92036678|NCT02034435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036679|NCT02034435|Vasodilator Agents|vasodilator agents|mesh-ancestor
92036680|NCT02033889|Insulin|insulin|mesh-list
92036681|NCT02033889|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92036682|NCT02033889|Metformin|metformin|mesh-list
92036683|NCT02033889|Insulin Glargine|insulin glargine|mesh-list
92036684|NCT02033889|Glimepiride|glimepiride|mesh-list
92036685|NCT02033889|Insulin Detemir|insulin detemir|mesh-list
92036686|NCT02033889|Ertugliflozin|ertugliflozin|mesh-list
92036687|NCT02033889|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92036688|NCT02033889|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92036689|NCT02033889|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92036690|NCT02033889|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92036691|NCT02033889|Immunologic Factors|immunologic factors|mesh-ancestor
92036692|NCT02033889|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92036694|NCT02447003|Pembrolizumab|pembrolizumab|mesh-list
92036741|NCT01843660|Sensory System Agents|sensory system agents|mesh-ancestor
92036744|NCT01843660|Antipyretics|antipyretics|mesh-ancestor
92036816|NCT02419469|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92036818|NCT02419469|Tubulin Modulators|tubulin modulators|mesh-ancestor
92036895|NCT02048241|Guanfacine|guanfacine|mesh-list
92036962|NCT04685577|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037034|NCT04681287|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037036|NCT04681287|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037107|NCT02412761|Hydrochlorothiazide|hydrochlorothiazide|mesh-list
92037108|NCT02412761|Lisinopril|lisinopril|mesh-list
92037109|NCT02412761|Calcium Channel Blockers|calcium channel blockers|mesh-list
92037179|NCT02025621|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92037180|NCT02025621|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037181|NCT02025621|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92037182|NCT02025621|Protective Agents|protective agents|mesh-ancestor
92037183|NCT02025621|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037184|NCT04729023|Temazepam|temazepam|mesh-list
92037185|NCT04729023|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92037186|NCT04729023|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037247|NCT01822756|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92037248|NCT01822756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037249|NCT01822756|Tubulin Modulators|tubulin modulators|mesh-ancestor
92037317|NCT02435069|Glycerol|glycerol|mesh-list
92037318|NCT02435069|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92037319|NCT02435069|Protective Agents|protective agents|mesh-ancestor
92037389|NCT01817530|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92037391|NCT01817530|Hormones|hormones|mesh-ancestor
92037461|NCT02452463|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92037462|NCT02452463|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037533|NCT04926545|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92037534|NCT04926545|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92037602|NCT04902131|Menotropins|menotropins|mesh-list
92037678|NCT01797094|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92037679|NCT01797094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037680|NCT01797094|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92037681|NCT01797094|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037682|NCT02383589|Mycophenolic Acid|mycophenolic acid|mesh-list
92037683|NCT02383589|Rituximab|rituximab|mesh-list
92037684|NCT02383589|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92037685|NCT02383589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037686|NCT02383589|Immunologic Factors|immunologic factors|mesh-ancestor
92037687|NCT02383589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037688|NCT02383589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92037689|NCT02383589|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92037690|NCT02383589|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92037694|NCT02383589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92037737|NCT02404493|Decanoic acid|decanoic acid|mesh-list
92037738|NCT02404493|Antifungal Agents|antifungal agents|mesh-ancestor
92037739|NCT02404493|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92037740|NCT02379221|Lidocaine|lidocaine|mesh-list
92037741|NCT02379221|Epinephrine|epinephrine|mesh-list
92037742|NCT02379221|Benzocaine|benzocaine|mesh-list
92037743|NCT02379221|Anesthetics, Local|anesthetics, local|mesh-ancestor
92037744|NCT02379221|Anesthetics|anesthetics|mesh-ancestor
92037745|NCT02379221|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92037746|NCT02379221|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92037747|NCT02379221|Sensory System Agents|sensory system agents|mesh-ancestor
92037748|NCT02379221|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92037760|NCT02379221|Autonomic Agents|autonomic agents|mesh-ancestor
92037801|NCT04414852|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92037802|NCT04414852|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92037876|NCT01866826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92037877|NCT01865812|Chenodeoxycholic Acid|chenodeoxycholic acid|mesh-list
92037948|NCT01773070|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92037949|NCT01772368|Fluticasone|fluticasone|mesh-list
92037951|NCT01772368|Albuterol|albuterol|mesh-list
92038021|NCT02016183|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92038022|NCT02016183|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038023|NCT02016183|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038026|NCT02421419|Dexamethasone|dexamethasone|mesh-list
92038170|NCT02347085|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038243|NCT02396537|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92038244|NCT02396537|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92038245|NCT02396537|Anesthetics, General|anesthetics, general|mesh-ancestor
92038247|NCT02396537|GABA Agents|gaba agents|mesh-ancestor
92038248|NCT02396537|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92038249|NCT01624467|Necitumumab|necitumumab|mesh-list
92038250|NCT01624467|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038251|NCT01624467|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038252|NCT01624233|Ixekizumab|ixekizumab|mesh-list
92038253|NCT01624233|Dermatologic Agents|dermatologic agents|mesh-ancestor
92038254|NCT01993017|Bupropion|bupropion|mesh-list
92038255|NCT01993017|Sertraline|sertraline|mesh-list
92038256|NCT01993017|Antidepressive Agents|antidepressive agents|mesh-list
92038257|NCT01993017|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92038258|NCT01993017|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92038259|NCT01993017|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92038260|NCT01993017|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92038261|NCT01993017|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92038262|NCT01993017|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038263|NCT01993017|Dopamine Agents|dopamine agents|mesh-ancestor
92038268|NCT01993017|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92038299|NCT02014467|Vitamins|vitamins|mesh-ancestor
92038322|NCT01988103|Apremilast|apremilast|mesh-list
92038373|NCT02078817|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038374|NCT02078817|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038377|NCT02078817|Anesthetics, General|anesthetics, general|mesh-ancestor
92038443|NCT01787188|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92038444|NCT01787188|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038445|NCT01787188|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92038512|NCT01736176|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92038524|NCT01735630|Inositol|inositol|mesh-list
92038584|NCT01766050|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92038658|NCT02338193|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038659|NCT01783444|Capecitabine|capecitabine|mesh-list
92038660|NCT01783444|Everolimus|everolimus|mesh-list
92038729|NCT02337491|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038730|NCT02337491|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92038731|NCT02337491|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038804|NCT01765270|Protease Inhibitors|protease inhibitors|mesh-ancestor
92038875|NCT04887506|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92038876|NCT04887506|Hormone Antagonists|hormone antagonists|mesh-ancestor
92038877|NCT04887506|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92038879|NCT02336165|Durvalumab|durvalumab|mesh-list
92038880|NCT02336165|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92038881|NCT02336165|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92038882|NCT02336165|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92038883|NCT02336165|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92038884|NCT02336165|Growth Substances|growth substances|mesh-ancestor
92038885|NCT02336165|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92038886|NCT02336165|Growth Inhibitors|growth inhibitors|mesh-ancestor
92038936|NCT02281760|Antioxidants|antioxidants|mesh-ancestor
92038937|NCT02390531|Bevacizumab|bevacizumab|mesh-list
92038939|NCT02390531|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92039013|NCT02358863|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92039014|NCT02358863|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92039015|NCT02358863|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039088|NCT04666701|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92039089|NCT04666701|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92039090|NCT04666701|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92039091|NCT04666701|Analgesics|analgesics|mesh-ancestor
92039092|NCT04666701|Sensory System Agents|sensory system agents|mesh-ancestor
92039093|NCT04666701|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039094|NCT04666701|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039095|NCT04666701|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92039096|NCT04666701|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92039097|NCT04666701|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92039098|NCT04666701|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039099|NCT04666701|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039100|NCT04666701|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92039101|NCT04666701|Antiemetics|antiemetics|mesh-ancestor
92039145|NCT04673175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039146|NCT04673175|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92039216|NCT01983969|Dexamethasone|dexamethasone|mesh-list
92039217|NCT01983969|Rituximab|rituximab|mesh-list
92039219|NCT01983969|Azacitidine|azacitidine|mesh-list
92039220|NCT01983969|Melphalan|melphalan|mesh-list
92039290|NCT02310581|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92039291|NCT02310581|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92039292|NCT02310581|Analgesics|analgesics|mesh-ancestor
92039293|NCT02310581|Sensory System Agents|sensory system agents|mesh-ancestor
92039294|NCT02310581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92039295|NCT02310581|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92039296|NCT04892693|Talazoparib|talazoparib|mesh-list
92039298|NCT04892693|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92039357|NCT04672941|Respiratory System Agents|respiratory system agents|mesh-ancestor
92039358|NCT04672941|Parasympatholytics|parasympatholytics|mesh-ancestor
92039359|NCT04672941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92039431|NCT04672005|Folfirinox|folfirinox|mesh-list
92039505|NCT01641367|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92039580|NCT01965327|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92039581|NCT04872595|Cyclophosphamide|cyclophosphamide|mesh-list
92039653|NCT05100199|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92039654|NCT02001987|Methotrexate|methotrexate|mesh-list
92039655|NCT02001987|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92039670|NCT01763164|Dacarbazine|dacarbazine|mesh-list
92039726|NCT05359393|Tislelizumab|tislelizumab|mesh-list
92039799|NCT01637077|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92039800|NCT01637077|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92039801|NCT01637077|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92039870|NCT01999335|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92039871|NCT01999335|Growth Substances|growth substances|mesh-ancestor
92039872|NCT01999335|Growth Inhibitors|growth inhibitors|mesh-ancestor
92040017|NCT01637623|Gout Suppressants|gout suppressants|mesh-ancestor
92040018|NCT01637623|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040019|NCT01637623|Free Radical Scavengers|free radical scavengers|mesh-ancestor
92040090|NCT05226325|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92040091|NCT05226325|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040094|NCT05226325|Analgesics|analgesics|mesh-ancestor
92040159|NCT04796467|Gallium 68 PSMA-11|gallium 68 psma-11|mesh-list
92040160|NCT04796467|Radiopharmaceuticals|radiopharmaceuticals|mesh-ancestor
92040161|NCT04796467|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040232|NCT05813522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92040233|NCT05813522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040234|NCT05813496|Thioctic Acid|thioctic acid|mesh-list
92040235|NCT05813496|Antioxidants|antioxidants|mesh-ancestor
92040237|NCT05813496|Protective Agents|protective agents|mesh-ancestor
92040306|NCT05813106|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040307|NCT05813106|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92040377|NCT05787613|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92040378|NCT05775887|Vaccines|vaccines|mesh-list
92040379|NCT05775887|Immunologic Factors|immunologic factors|mesh-ancestor
92040380|NCT05775887|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040449|NCT05720455|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040450|NCT05720455|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92040451|NCT05720455|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92040452|NCT05720455|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92040453|NCT05720455|Histamine Antagonists|histamine antagonists|mesh-ancestor
92040454|NCT05720455|Histamine Agents|histamine agents|mesh-ancestor
92040455|NCT05715814|Empagliflozin|empagliflozin|mesh-list
92040456|NCT05715814|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92040457|NCT05715814|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040458|NCT05715814|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92040459|NCT05715814|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040460|NCT05690204|Colchicine|colchicine|mesh-list
92040510|NCT05552196|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040511|NCT05552196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040579|NCT05386030|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040580|NCT05324852|Midazolam|midazolam|mesh-list
92040654|NCT05197842|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92040655|NCT05197842|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92040727|NCT05024552|Antimetabolites|antimetabolites|mesh-ancestor
92040728|NCT05024552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040800|NCT04807140|Antimitotic Agents|antimitotic agents|mesh-ancestor
92040801|NCT04807140|Mitosis Modulators|mitosis modulators|mesh-ancestor
92040803|NCT04759248|Trastuzumab|trastuzumab|mesh-list
92040873|NCT04458545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040874|NCT04429516|Morphine|morphine|mesh-list
92040875|NCT04429516|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92040876|NCT04429516|Narcotics|narcotics|mesh-ancestor
92040877|NCT04429516|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92040878|NCT04429516|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040879|NCT04429516|Analgesics|analgesics|mesh-ancestor
92040880|NCT04429516|Sensory System Agents|sensory system agents|mesh-ancestor
92040881|NCT04429516|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92040882|NCT04417452|Adrenergic Agents|adrenergic agents|mesh-list
92040883|NCT04417452|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040884|NCT04417452|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040885|NCT04417452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92040886|NCT04412096|Timolol|timolol|mesh-list
92040887|NCT04412096|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92040888|NCT04412096|Latanoprost|latanoprost|mesh-list
92040889|NCT04412096|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92040890|NCT04412096|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92040891|NCT04412096|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92040892|NCT04412096|Adrenergic Agents|adrenergic agents|mesh-ancestor
92040893|NCT04412096|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92040894|NCT04412096|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92040948|NCT04357951|Cycloserine|cycloserine|mesh-list
92040949|NCT04357951|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92040950|NCT04357951|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92040951|NCT04357951|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92040952|NCT04357951|Antitubercular Agents|antitubercular agents|mesh-ancestor
92040953|NCT04357951|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92040954|NCT04357951|Antimetabolites|antimetabolites|mesh-ancestor
92040957|NCT04285229|Dermatologic Agents|dermatologic agents|mesh-ancestor
92041016|NCT04083898|Glucocorticoids|glucocorticoids|mesh-ancestor
92041017|NCT04083898|Hormones|hormones|mesh-ancestor
92041018|NCT04083898|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041019|NCT04083898|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041020|NCT04083898|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92041021|NCT04083898|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041022|NCT04083898|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92041023|NCT04083898|Alkylating Agents|alkylating agents|mesh-ancestor
92041024|NCT04083898|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041025|NCT04035837|Interferons|interferons|mesh-list
92041026|NCT04035837|Interferon-alpha|interferon-alpha|mesh-list
92041027|NCT04035837|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041028|NCT04035837|Antiviral Agents|antiviral agents|mesh-ancestor
92041030|NCT04035837|Immunologic Factors|immunologic factors|mesh-ancestor
92041032|NCT04023227|Valsartan|valsartan|mesh-list
92041076|NCT03915964|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92041077|NCT03915964|Analgesics|analgesics|mesh-ancestor
92041078|NCT03915964|Sensory System Agents|sensory system agents|mesh-ancestor
92041079|NCT03915964|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041146|NCT03746080|Plerixafor|plerixafor|mesh-list
92041147|NCT03746080|Temozolomide|temozolomide|mesh-list
92041148|NCT03746080|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92041156|NCT03737994|Cisplatin|cisplatin|mesh-list
92041219|NCT03477175|Sorafenib|sorafenib|mesh-list
92041220|NCT03477175|Lenvatinib|lenvatinib|mesh-list
92041221|NCT03477175|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041222|NCT03477175|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92041223|NCT03477175|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041224|NCT03477175|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041225|NCT03461406|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92041226|NCT03461406|Hemostatics|hemostatics|mesh-ancestor
92041227|NCT03461406|Coagulants|coagulants|mesh-ancestor
92041228|NCT03431974|Aminopterin|aminopterin|mesh-list
92041283|NCT03229499|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041284|NCT03179449|Ferrosoferric Oxide|ferrosoferric oxide|mesh-list
92041285|NCT03179449|Hematinics|hematinics|mesh-ancestor
92041286|NCT03179449|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92041287|NCT03179449|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92041288|NCT03132454|Dexamethasone|dexamethasone|mesh-list
92041289|NCT03132454|Dexamethasone acetate|dexamethasone acetate|mesh-list
92041290|NCT03132454|Sorafenib|sorafenib|mesh-list
92041291|NCT03132454|Decitabine|decitabine|mesh-list
92041292|NCT03132454|Palbociclib|palbociclib|mesh-list
92041293|NCT03132454|Ichthammol|ichthammol|mesh-list
92041294|NCT03132454|BB 1101|bb 1101|mesh-list
92041295|NCT03132454|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041296|NCT03132454|Antiemetics|antiemetics|mesh-ancestor
92041297|NCT03132454|Autonomic Agents|autonomic agents|mesh-ancestor
92041298|NCT03132454|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041300|NCT03132454|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92041345|NCT02915744|Antimitotic Agents|antimitotic agents|mesh-ancestor
92041346|NCT02915744|Mitosis Modulators|mitosis modulators|mesh-ancestor
92041347|NCT02915744|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041349|NCT02915744|Antimetabolites|antimetabolites|mesh-ancestor
92041416|NCT02324608|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92041417|NCT02324608|Immunologic Factors|immunologic factors|mesh-ancestor
92041418|NCT02324608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041488|NCT01919086|Lenalidomide|lenalidomide|mesh-list
92041489|NCT01919086|Bortezomib|bortezomib|mesh-list
92041490|NCT01919086|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041491|NCT01919086|Antiemetics|antiemetics|mesh-ancestor
92041562|NCT00565851|Endothelial Growth Factors|endothelial growth factors|mesh-list
92041563|NCT00565851|Antibodies|antibodies|mesh-list
92041564|NCT00565851|Immunoglobulins|immunoglobulins|mesh-list
92041565|NCT00565851|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92041566|NCT00565851|Immunoglobulin G|immunoglobulin g|mesh-list
92041567|NCT00565851|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92041568|NCT00565851|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041569|NCT00565851|Tubulin Modulators|tubulin modulators|mesh-ancestor
92041570|NCT00565851|Antimitotic Agents|antimitotic agents|mesh-ancestor
92041571|NCT00565851|Mitosis Modulators|mitosis modulators|mesh-ancestor
92041572|NCT00565851|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041573|NCT00565851|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92041574|NCT00565851|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92041575|NCT00565851|Growth Substances|growth substances|mesh-ancestor
92041576|NCT00565851|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041577|NCT00565851|Growth Inhibitors|growth inhibitors|mesh-ancestor
92041578|NCT00565851|Immunologic Factors|immunologic factors|mesh-ancestor
92041579|NCT00565851|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92041580|NCT00565851|Antimetabolites|antimetabolites|mesh-ancestor
92041581|NCT00238563|Triamcinolone|triamcinolone|mesh-list
92041582|NCT00238563|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92041583|NCT00238563|Glucocorticoids|glucocorticoids|mesh-ancestor
92041584|NCT00238563|Hormones|hormones|mesh-ancestor
92041585|NCT00238563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041586|NCT00238563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041587|NCT04499677|Ritonavir|ritonavir|mesh-list
92041588|NCT04499677|Lopinavir|lopinavir|mesh-list
92041610|NCT02909335|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92041611|NCT02909335|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92041612|NCT02909335|Prednisolone|prednisolone|mesh-list
92041682|NCT04567108|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92041683|NCT01753570|Interferon-beta|interferon-beta|mesh-list
92041684|NCT01753570|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92041755|NCT01961349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92041757|NCT01961349|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92041758|NCT01961349|Anesthetics, General|anesthetics, general|mesh-ancestor
92041824|NCT01972659|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92041825|NCT01972659|Anticonvulsants|anticonvulsants|mesh-ancestor
92041897|NCT01960413|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92041898|NCT01960413|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92041899|NCT01960413|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92041900|NCT01960413|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92041901|NCT01960413|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92041903|NCT01960413|Antisickling Agents|antisickling agents|mesh-ancestor
92041904|NCT01960413|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92041963|NCT02158507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042037|NCT01938573|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92042038|NCT01938573|Antifungal Agents|antifungal agents|mesh-ancestor
92042109|NCT02740699|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92042110|NCT02740699|Antimetabolites|antimetabolites|mesh-ancestor
92042180|NCT01918371|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042181|NCT01918371|Growth Inhibitors|growth inhibitors|mesh-ancestor
92042182|NCT01918371|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042183|NCT04633551|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-list
92042253|NCT00630565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042254|NCT00630565|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042324|NCT00432679|Rosiglitazone|rosiglitazone|mesh-list
92042325|NCT00432679|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92042326|NCT00432679|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042397|NCT01646177|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042398|NCT01646177|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042399|NCT01646177|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92042400|NCT01646177|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92042401|NCT01646177|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92042402|NCT01646177|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92042403|NCT01646177|Immunologic Factors|immunologic factors|mesh-ancestor
92042466|NCT01957215|Tocolytic Agents|tocolytic agents|mesh-ancestor
92042467|NCT01957215|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92042468|NCT01957215|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92042469|NCT01957215|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042471|NCT01928433|Ciprofloxacin|ciprofloxacin|mesh-list
92042536|NCT02320721|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042537|NCT02320487|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92042538|NCT02320487|Obinutuzumab|obinutuzumab|mesh-list
92042539|NCT02320487|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92042540|NCT02320487|Alkylating Agents|alkylating agents|mesh-ancestor
92042541|NCT02320487|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042542|NCT02320487|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92042544|NCT04197089|Vitamin D|vitamin d|mesh-list
92042605|NCT04892953|Gemcitabine|gemcitabine|mesh-list
92042606|NCT04892953|Pemetrexed|pemetrexed|mesh-list
92042607|NCT04892953|Durvalumab|durvalumab|mesh-list
92042608|NCT04892953|Immunoglobulins|immunoglobulins|mesh-list
92042609|NCT04892953|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92042610|NCT04892953|Immunoglobulin G|immunoglobulin g|mesh-list
92042611|NCT04892953|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92042618|NCT04892953|Antimetabolites|antimetabolites|mesh-ancestor
92042675|NCT02308748|Mexiletine|mexiletine|mesh-list
92042676|NCT02308748|Dofetilide|dofetilide|mesh-list
92042677|NCT02308748|Diltiazem|diltiazem|mesh-list
92042678|NCT02308748|Anesthetics, Local|anesthetics, local|mesh-ancestor
92042679|NCT02308748|Anesthetics|anesthetics|mesh-ancestor
92042680|NCT02308748|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042681|NCT02308748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92042682|NCT02308748|Sensory System Agents|sensory system agents|mesh-ancestor
92042683|NCT02308748|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92042684|NCT02308748|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92042685|NCT02308748|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92042686|NCT02308748|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92042687|NCT02308748|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92042688|NCT02308748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92042689|NCT02308748|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92042690|NCT02308748|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042691|NCT02308748|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92042692|NCT02308748|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92042693|NCT02308748|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92042701|NCT04745689|Etoposide|etoposide|mesh-list
92042734|NCT02275481|Tiotropium Bromide|tiotropium bromide|mesh-list
92042801|NCT02274311|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92042802|NCT02274311|Hormone Antagonists|hormone antagonists|mesh-ancestor
92042803|NCT02274311|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92042871|NCT02203591|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92042872|NCT02203591|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92042943|NCT02275052|Respiratory System Agents|respiratory system agents|mesh-ancestor
92042944|NCT02275052|Tocolytic Agents|tocolytic agents|mesh-ancestor
92042945|NCT02275052|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92042946|NCT02275052|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92043013|NCT01750840|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92043086|NCT01750294|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043087|NCT01750294|Sodium Chloride Symporter Inhibitors|sodium chloride symporter inhibitors|mesh-ancestor
92043159|NCT02273180|Insulin|insulin|mesh-list
92043160|NCT02273180|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92043161|NCT02273180|Insulin Glargine|insulin glargine|mesh-list
92043162|NCT02273180|Insulin Lispro|insulin lispro|mesh-list
92043163|NCT02273180|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92043164|NCT02273180|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043165|NCT01745380|Phenylephrine|phenylephrine|mesh-list
92043166|NCT01745380|Oxymetazoline|oxymetazoline|mesh-list
92043167|NCT01745380|Tetracaine|tetracaine|mesh-list
92043168|NCT01745380|Anesthetics, Local|anesthetics, local|mesh-ancestor
92043169|NCT01745380|Anesthetics|anesthetics|mesh-ancestor
92043170|NCT01745380|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043171|NCT01745380|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043172|NCT01745380|Sensory System Agents|sensory system agents|mesh-ancestor
92043173|NCT01745380|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92043298|NCT02296892|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043299|NCT02296892|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92043300|NCT02296892|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92043369|NCT04875026|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043370|NCT04875026|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92043375|NCT02296112|Trametinib|trametinib|mesh-list
92043442|NCT01927341|Panitumumab|panitumumab|mesh-list
92043443|NCT01927341|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92043514|NCT02196259|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043515|NCT02196259|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92043516|NCT02196259|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92043586|NCT02263079|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92043587|NCT02263079|Antiviral Agents|antiviral agents|mesh-ancestor
92043658|NCT01645280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92043659|NCT01645280|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92043660|NCT01645280|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92043661|NCT01645280|Immunologic Factors|immunologic factors|mesh-ancestor
92043662|NCT01645280|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92043805|NCT01702558|Immunotoxins|immunotoxins|mesh-ancestor
92043806|NCT01702558|Immunoconjugates|immunoconjugates|mesh-ancestor
92043807|NCT01702558|Immunologic Factors|immunologic factors|mesh-ancestor
92043808|NCT01702558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043809|NCT05650775|Methylphenidate|methylphenidate|mesh-list
92043811|NCT05650775|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92043812|NCT05650775|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92043813|NCT05650775|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92043814|NCT05650775|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92043815|NCT05650775|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92043816|NCT05650775|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92043817|NCT05650775|Dopamine Agents|dopamine agents|mesh-ancestor
92043818|NCT05650775|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92043819|NCT02194465|Spironolactone|spironolactone|mesh-list
92043820|NCT02194465|Tadalafil|tadalafil|mesh-list
92043862|NCT05645861|Benzocaine|benzocaine|mesh-list
92043863|NCT05645861|Anesthetics, Local|anesthetics, local|mesh-ancestor
92043864|NCT05645861|Anesthetics|anesthetics|mesh-ancestor
92043865|NCT05645861|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92043869|NCT01719172|Hemostatics|hemostatics|mesh-list
92043932|NCT02287610|Hormones|hormones|mesh-ancestor
92043937|NCT02262728|Sofosbuvir|sofosbuvir|mesh-list
92044009|NCT02260388|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92044010|NCT02260388|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044080|NCT01698814|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044089|NCT01738594|Romidepsin|romidepsin|mesh-list
92044152|NCT01604824|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044153|NCT01604824|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92044220|NCT05642702|Niacin|niacin|mesh-list
92044226|NCT05642702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044227|NCT05642702|Protective Agents|protective agents|mesh-ancestor
92044228|NCT05642702|Vitamin B Complex|vitamin b complex|mesh-ancestor
92044229|NCT05642702|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92044230|NCT05642702|Antimetabolites|antimetabolites|mesh-ancestor
92044231|NCT05642702|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92044232|NCT05642702|Vasodilator Agents|vasodilator agents|mesh-ancestor
92044233|NCT05544734|Acetaminophen|acetaminophen|mesh-list
92044234|NCT05544734|Ibuprofen|ibuprofen|mesh-list
92044235|NCT05544734|Hydrocodone|hydrocodone|mesh-list
92044236|NCT05544734|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044237|NCT05544734|Analgesics|analgesics|mesh-ancestor
92044290|NCT05493566|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044291|NCT05493566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044292|NCT05493566|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92044293|NCT05493566|Analgesics|analgesics|mesh-ancestor
92044294|NCT05493566|Sensory System Agents|sensory system agents|mesh-ancestor
92044361|NCT04848116|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92044362|NCT04848116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044363|NCT05372198|Immunomodulating Agents|immunomodulating agents|mesh-list
92044364|NCT05372198|Immunologic Factors|immunologic factors|mesh-ancestor
92044376|NCT04652960|Nivolumab|nivolumab|mesh-list
92044431|NCT04419662|Mydriatics|mydriatics|mesh-ancestor
92044432|NCT04419662|Autonomic Agents|autonomic agents|mesh-ancestor
92044433|NCT04419662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044435|NCT04419662|Sympathomimetics|sympathomimetics|mesh-ancestor
92044505|NCT04513184|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92044506|NCT04513184|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044576|NCT02191579|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044577|NCT02191579|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92044650|NCT04791566|Glucocorticoids|glucocorticoids|mesh-ancestor
92044651|NCT04791566|Hormones|hormones|mesh-ancestor
92044653|NCT04791566|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92044723|NCT01601132|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92044724|NCT01601132|Autonomic Agents|autonomic agents|mesh-ancestor
92044725|NCT01601132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044726|NCT01601132|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044727|NCT01601132|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044728|NCT01601132|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044729|NCT01601132|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92044730|NCT01601132|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92044731|NCT01601132|Vasodilator Agents|vasodilator agents|mesh-ancestor
92044732|NCT01601132|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92044733|NCT01601132|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92044734|NCT01601132|Purinergic Agents|purinergic agents|mesh-ancestor
92044735|NCT01601132|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044786|NCT05221190|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92044787|NCT05221190|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92044788|NCT05221190|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92044857|NCT03783182|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044858|NCT03783182|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92044859|NCT03783182|Respiratory System Agents|respiratory system agents|mesh-ancestor
92044861|NCT03760484|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92044862|NCT03760484|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92044863|NCT05651750|Fluticasone|fluticasone|mesh-list
92044864|NCT05651750|Xhance|xhance|mesh-list
92044865|NCT05651750|Montelukast|montelukast|mesh-list
92044866|NCT05651750|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92044867|NCT05651750|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92044881|NCT02160145|Tolvaptan|tolvaptan|mesh-list
92044920|NCT02188459|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92044921|NCT02188459|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92044922|NCT02188459|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92044923|NCT02188459|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92044924|NCT02188459|Dopamine Agents|dopamine agents|mesh-ancestor
92044925|NCT02188459|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92044926|NCT02188459|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92044927|NCT02188459|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92044928|NCT02188459|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92044979|NCT01636934|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92045053|NCT02159053|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045054|NCT02158975|Ixazomib|ixazomib|mesh-list
92045055|NCT02158975|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045056|NCT02158975|Protease Inhibitors|protease inhibitors|mesh-ancestor
92045057|NCT02158975|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045058|NCT02158975|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045059|NCT02661464|Smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|smallpox and monkeypox vaccine modified vaccinia ankara-bavarian nordic|mesh-list
92045060|NCT02661464|Antiviral Agents|antiviral agents|mesh-ancestor
92045061|NCT02661464|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92045062|NCT02158039|Ethanol|ethanol|mesh-list
92045063|NCT02158039|Lidocaine|lidocaine|mesh-list
92045064|NCT02158039|Anesthetics, Local|anesthetics, local|mesh-ancestor
92045065|NCT02158039|Anesthetics|anesthetics|mesh-ancestor
92045066|NCT02158039|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92045067|NCT02158039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045068|NCT02158039|Sensory System Agents|sensory system agents|mesh-ancestor
92045069|NCT02158039|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045110|NCT01635764|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92045111|NCT01635764|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045112|NCT01635764|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045125|NCT04810598|Venetoclax|venetoclax|mesh-list
92045126|NCT04810598|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045127|NCT04627064|Belzutifan|belzutifan|mesh-list
92045128|NCT04627064|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045129|NCT04511078|Panitumumab|panitumumab|mesh-list
92045130|NCT04511078|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92045131|NCT04511078|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045132|NCT02158052|Tacrolimus|tacrolimus|mesh-list
92045133|NCT02158052|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92045134|NCT02158052|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92045185|NCT04787744|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045186|NCT04787744|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92045187|NCT04787744|Antiemetics|antiemetics|mesh-ancestor
92045188|NCT04787744|Autonomic Agents|autonomic agents|mesh-ancestor
92045202|NCT04274894|Testosterone|testosterone|mesh-list
92045258|NCT04216784|Diuretics|diuretics|mesh-ancestor
92045259|NCT04216784|Natriuretic Agents|natriuretic agents|mesh-ancestor
92045264|NCT05173298|Bevacizumab|bevacizumab|mesh-list
92045406|NCT02187055|Abortifacient Agents|abortifacient agents|mesh-ancestor
92045407|NCT02187055|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045481|NCT02137369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045482|NCT02137369|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045483|NCT02137369|Serotonin Agents|serotonin agents|mesh-ancestor
92045552|NCT01691482|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92045553|NCT01691482|Autonomic Agents|autonomic agents|mesh-ancestor
92045554|NCT01691482|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045555|NCT01691482|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045556|NCT01691482|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92045557|NCT01691482|Respiratory System Agents|respiratory system agents|mesh-ancestor
92045558|NCT01691482|Tocolytic Agents|tocolytic agents|mesh-ancestor
92045559|NCT01691482|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92045560|NCT01691482|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92045561|NCT01691482|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92045562|NCT01691482|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92045563|NCT01691482|Adrenergic Agents|adrenergic agents|mesh-ancestor
92045564|NCT01691482|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92045614|NCT02134015|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92045686|NCT01709578|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92045760|NCT01709500|Atorvastatin|atorvastatin|mesh-list
92045761|NCT01709500|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92045762|NCT01709500|Simvastatin|simvastatin|mesh-list
92045763|NCT01709500|Alirocumab|alirocumab|mesh-list
92045764|NCT01709500|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92045765|NCT01709500|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92045766|NCT01709500|Antimetabolites|antimetabolites|mesh-ancestor
92045767|NCT01709500|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045768|NCT01709500|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92045769|NCT01709500|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92045770|NCT01709500|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045771|NCT01709500|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92045772|NCT01709500|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92045773|NCT01709500|Protease Inhibitors|protease inhibitors|mesh-ancestor
92045774|NCT01599806|Ciprofloxacin|ciprofloxacin|mesh-list
92045775|NCT01599806|Ceftazidime|ceftazidime|mesh-list
92045776|NCT01599806|Avibactam|avibactam|mesh-list
92045818|NCT01924299|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92045891|NCT02241512|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92045892|NCT02241512|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92045893|NCT02241512|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92045894|NCT02241512|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92045895|NCT02241512|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92045896|NCT02241512|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92045897|NCT02241512|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92045899|NCT01709110|Teriparatide|teriparatide|mesh-list
92045900|NCT01709110|Risedronic Acid|risedronic acid|mesh-list
92045901|NCT01709110|Calcium|calcium|mesh-list
92045902|NCT01709110|Vitamins|vitamins|mesh-ancestor
92045903|NCT01709110|Micronutrients|micronutrients|mesh-ancestor
92045910|NCT02240108|Rifaximin|rifaximin|mesh-list
92045952|NCT02239094|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92045953|NCT02239094|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92046027|NCT01627327|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92046028|NCT01627327|Autonomic Agents|autonomic agents|mesh-ancestor
92046031|NCT01627327|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92046102|NCT02126839|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92046103|NCT02126839|Respiratory System Agents|respiratory system agents|mesh-ancestor
92046174|NCT01568866|Dexamethasone|dexamethasone|mesh-list
92046175|NCT01568866|Bortezomib|bortezomib|mesh-list
92046250|NCT01952145|Liraglutide|liraglutide|mesh-list
92046252|NCT01952145|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92046253|NCT01952145|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046254|NCT01952145|Incretins|incretins|mesh-ancestor
92046321|NCT04769414|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92046324|NCT01922271|Glycopyrrolate|glycopyrrolate|mesh-list
92046395|NCT01641809|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92046396|NCT01641809|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92046397|NCT01641809|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92046398|NCT01641809|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92046399|NCT01641809|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92046401|NCT01632566|Simvastatin|simvastatin|mesh-list
92046402|NCT01632566|LY3031207|ly3031207|mesh-list
92046403|NCT01632566|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92046404|NCT01632566|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92046405|NCT01632566|Antimetabolites|antimetabolites|mesh-ancestor
92046406|NCT01632566|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046432|NCT05650151|Vitamin D|vitamin d|mesh-list
92046459|NCT05638529|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92046461|NCT04859465|Doxorubicin|doxorubicin|mesh-list
92046530|NCT02143843|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92046531|NCT05598905|Pregabalin|pregabalin|mesh-list
92046532|NCT05598905|Lacosamide|lacosamide|mesh-list
92046533|NCT05598905|Oxycodone|oxycodone|mesh-list
92046534|NCT05598905|Analgesics|analgesics|mesh-ancestor
92046535|NCT05598905|Sensory System Agents|sensory system agents|mesh-ancestor
92046536|NCT05598905|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92046537|NCT05598905|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046599|NCT01585168|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046676|NCT04844099|Antimalarials|antimalarials|mesh-ancestor
92046677|NCT04844099|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92046678|NCT04844099|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92046680|NCT04857203|Vitamin D|vitamin d|mesh-list
92046748|NCT02227784|Atorvastatin|atorvastatin|mesh-list
92046749|NCT02227784|Ezetimibe|ezetimibe|mesh-list
92046750|NCT02227784|Evacetrapib|evacetrapib|mesh-list
92046751|NCT02227784|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92046752|NCT02227784|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92046753|NCT02227784|Antimetabolites|antimetabolites|mesh-ancestor
92046754|NCT02227784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046755|NCT02227784|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92046756|NCT02227784|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92046757|NCT02227784|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046758|NCT04577417|Methylphenidate|methylphenidate|mesh-list
92046759|NCT04577417|Amphetamine|amphetamine|mesh-list
92046810|NCT02193776|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92046811|NCT02193776|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92046812|NCT02193776|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92046813|NCT02193776|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92046814|NCT02193776|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92046815|NCT02193776|Cytochrome P-450 CYP2C9 Inducers|cytochrome p-450 cyp2c9 inducers|mesh-ancestor
92046816|NCT02193776|Cytochrome P-450 CYP3A Inducers|cytochrome p-450 cyp3a inducers|mesh-ancestor
92046817|NCT02193776|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92046818|NCT02193776|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92046820|NCT02193776|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92046821|NCT04740697|Tamoxifen|tamoxifen|mesh-list
92046822|NCT04740697|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92046823|NCT04740697|Hormone Antagonists|hormone antagonists|mesh-ancestor
92046824|NCT04740697|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92046825|NCT04740697|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046826|NCT04740697|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92046827|NCT04740697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046828|NCT04740697|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92046829|NCT04740697|Estrogen Receptor Modulators|estrogen receptor modulators|mesh-ancestor
92046830|NCT04740697|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92046831|NCT02170064|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92046832|NCT02170064|Anticonvulsants|anticonvulsants|mesh-ancestor
92046858|NCT02169830|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92046859|NCT02169830|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92046860|NCT02169830|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92046933|NCT02168816|Piperacillin, Tazobactam Drug Combination|piperacillin, tazobactam drug combination|mesh-list
92046935|NCT02168816|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92046936|NCT02168816|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92046937|NCT02168816|Trimethoprim|trimethoprim|mesh-list
92046938|NCT02168816|Sulfamethoxazole|sulfamethoxazole|mesh-list
92046939|NCT02168816|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92046940|NCT02168816|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92046941|NCT02168816|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92046942|NCT02168816|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92046943|NCT02168816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92046944|NCT02168816|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92046945|NCT02168816|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92046946|NCT02168816|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92046947|NCT02168816|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92046948|NCT02168816|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92046989|NCT04745377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92046990|NCT01583530|Belimumab|belimumab|mesh-list
92046991|NCT01583530|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047061|NCT05369039|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047062|NCT05369039|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92047063|NCT05369039|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047065|NCT04373369|Vorolanib|vorolanib|mesh-list
92047066|NCT04373369|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92047067|NCT04373369|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047068|NCT04373369|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047069|NCT04373369|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047070|NCT04373369|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92047071|NCT04373369|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047072|NCT04285853|Oxycodone|oxycodone|mesh-list
92047073|NCT04285853|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92047074|NCT04285853|Narcotics|narcotics|mesh-ancestor
92047075|NCT04285853|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047076|NCT04285853|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047077|NCT04285853|Analgesics|analgesics|mesh-ancestor
92047078|NCT04285853|Sensory System Agents|sensory system agents|mesh-ancestor
92047079|NCT04285853|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92047080|NCT04791059|Sufentanil|sufentanil|mesh-list
92047081|NCT04791059|Dexmedetomidine|dexmedetomidine|mesh-list
92047082|NCT04791059|Ketamine|ketamine|mesh-list
92047083|NCT04791059|Esketamine|esketamine|mesh-list
92047084|NCT04791059|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92047085|NCT04791059|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92047087|NCT04791059|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92047110|NCT05398913|Cannabinoid Receptor Antagonists|cannabinoid receptor antagonists|mesh-ancestor
92047111|NCT05398913|Cannabinoid Receptor Modulators|cannabinoid receptor modulators|mesh-ancestor
92047114|NCT05398913|Hormones|hormones|mesh-ancestor
92047181|NCT03184571|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92047256|NCT02975999|Antidiuretic Agents|antidiuretic agents|mesh-ancestor
92047331|NCT03943901|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92047332|NCT03943901|Glucocorticoids|glucocorticoids|mesh-ancestor
92047408|NCT05355155|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92047483|NCT03774875|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047484|NCT01563172|Listerine|listerine|mesh-list
92047485|NCT01563172|Fluorides|fluorides|mesh-list
92047486|NCT01563172|Sodium Fluoride|sodium fluoride|mesh-list
92047487|NCT01563172|Cariostatic Agents|cariostatic agents|mesh-ancestor
92047488|NCT01563172|Protective Agents|protective agents|mesh-ancestor
92047489|NCT01563172|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047490|NCT01563172|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92047491|NCT01563172|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92047492|NCT04755764|Atenolol|atenolol|mesh-list
92047493|NCT04755764|Labetalol|labetalol|mesh-list
92047494|NCT04755764|Nifedipine|nifedipine|mesh-list
92047495|NCT04755764|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92047496|NCT04755764|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92047497|NCT04755764|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047498|NCT04755764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92047541|NCT02161718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047542|NCT02161718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047543|NCT02161718|Serotonin Agents|serotonin agents|mesh-ancestor
92047613|NCT01580488|Vitamins|vitamins|mesh-ancestor
92047614|NCT01580488|Micronutrients|micronutrients|mesh-ancestor
92047687|NCT03027934|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047688|NCT03027934|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047689|NCT03027934|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047690|NCT01562314|Cannabidiol|cannabidiol|mesh-list
92047691|NCT01562314|Anticonvulsants|anticonvulsants|mesh-ancestor
92047692|NCT01539226|Dapivirine|dapivirine|mesh-list
92047754|NCT01576042|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92047826|NCT03508895|Chelating Agents|chelating agents|mesh-ancestor
92047827|NCT03508895|Sequestering Agents|sequestering agents|mesh-ancestor
92047828|NCT03508895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047829|NCT03507491|Paclitaxel|paclitaxel|mesh-list
92047830|NCT03507491|Gemcitabine|gemcitabine|mesh-list
92047896|NCT01574248|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92047897|NCT01574248|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92047898|NCT01574248|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047899|NCT01574248|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92047900|NCT01574248|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92047901|NCT01574248|Immunologic Factors|immunologic factors|mesh-ancestor
92047902|NCT04761094|Insulin|insulin|mesh-list
92047903|NCT04761094|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92047904|NCT04761094|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047905|NCT01557946|Citalopram|citalopram|mesh-list
92047906|NCT01557946|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92047907|NCT01557946|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92047910|NCT01557946|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92047956|NCT01573000|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92047957|NCT01572844|Sodium thiosulfate|sodium thiosulfate|mesh-list
92047958|NCT01572844|Antidotes|antidotes|mesh-ancestor
92047959|NCT01572844|Protective Agents|protective agents|mesh-ancestor
92047960|NCT01572844|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92047961|NCT01572844|Antioxidants|antioxidants|mesh-ancestor
92047962|NCT01572844|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92047963|NCT01572844|Antitubercular Agents|antitubercular agents|mesh-ancestor
92047964|NCT01572844|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92048024|NCT02217410|Immunologic Factors|immunologic factors|mesh-ancestor
92048025|NCT02217410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048027|NCT02217410|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048097|NCT02180438|Emtricitabine|emtricitabine|mesh-list
92048098|NCT02180438|Cobicistat|cobicistat|mesh-list
92048099|NCT02180438|Elvitegravir, Cobicistat, Emtricitabine, Tenofovir Disoproxil Fumarate Drug Combination|elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate drug combination|mesh-list
92048100|NCT02180438|Elvitegravir|elvitegravir|mesh-list
92048101|NCT02180438|Antiviral Agents|antiviral agents|mesh-ancestor
92048102|NCT02180438|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048103|NCT02180438|Reverse Transcriptase Inhibitors|reverse transcriptase inhibitors|mesh-ancestor
92048104|NCT02180438|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92048105|NCT02180438|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048106|NCT02180438|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048107|NCT02180438|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92048108|NCT02180438|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92048109|NCT02180438|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92048156|NCT01920477|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048158|NCT04641195|Ergocalciferols|ergocalciferols|mesh-list
92048306|NCT02177786|Selonsertib|selonsertib|mesh-list
92048307|NCT02177786|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92048308|NCT02177786|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048310|NCT02153918|Metronidazole|metronidazole|mesh-list
92048380|NCT02136914|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92048381|NCT02136914|Antiviral Agents|antiviral agents|mesh-ancestor
92048382|NCT02136914|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048383|NCT02136914|Dopamine Agents|dopamine agents|mesh-ancestor
92048384|NCT02136914|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92048385|NCT02136914|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92048386|NCT02136914|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048387|NCT02136914|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92048446|NCT01552408|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92048447|NCT01552408|Growth Substances|growth substances|mesh-ancestor
92048448|NCT01552408|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048449|NCT01552408|Growth Inhibitors|growth inhibitors|mesh-ancestor
92048450|NCT01552408|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048451|NCT04099888|Gemcitabine|gemcitabine|mesh-list
92048452|NCT04099888|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92048453|NCT04099888|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92048454|NCT04099888|Antimetabolites|antimetabolites|mesh-ancestor
92048456|NCT02174276|Tenofovir|tenofovir|mesh-list
92048473|NCT01516216|Vitamin D|vitamin d|mesh-list
92048513|NCT01950819|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92048525|NCT01514422|Minocycline|minocycline|mesh-list
92048586|NCT01919229|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92048657|NCT01544920|Antiviral Agents|antiviral agents|mesh-ancestor
92048658|NCT01544920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92048731|NCT01487200|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92048732|NCT01487200|Immunologic Factors|immunologic factors|mesh-ancestor
92048733|NCT01487200|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92048806|NCT01898091|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92048807|NCT01898091|Vitamins|vitamins|mesh-ancestor
92048810|NCT01947855|Empagliflozin|empagliflozin|mesh-list
92048882|NCT01946529|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92048883|NCT01946529|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92048953|NCT01485640|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92048954|NCT01485640|Serotonin Agents|serotonin agents|mesh-ancestor
92049028|NCT01462318|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92049029|NCT01462318|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92049030|NCT01462318|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92049099|NCT02132312|Respiratory System Agents|respiratory system agents|mesh-ancestor
92049100|NCT02132312|Adrenergic alpha-1 Receptor Agonists|adrenergic alpha-1 receptor agonists|mesh-ancestor
92049170|NCT02147132|Autonomic Agents|autonomic agents|mesh-ancestor
92049171|NCT02147132|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049173|NCT02147132|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92049243|NCT02105636|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92049244|NCT02105636|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049245|NCT02105636|Immunologic Factors|immunologic factors|mesh-ancestor
92049318|NCT02125604|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92049319|NCT02125604|Immunologic Factors|immunologic factors|mesh-ancestor
92049390|NCT02139644|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92049391|NCT02139644|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92049392|NCT02139644|Adrenergic Agents|adrenergic agents|mesh-ancestor
92049461|NCT04070573|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92049462|NCT04070573|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049463|NCT04070573|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92049533|NCT02239679|Aminolevulinic Acid|aminolevulinic acid|mesh-list
92049534|NCT02239679|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92049608|NCT02121002|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049610|NCT02121002|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92049682|NCT04732208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92049683|NCT04732208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049684|NCT02068508|Pioglitazone|pioglitazone|mesh-list
92049685|NCT02068508|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92049686|NCT02068508|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92049687|NCT02207231|Adalimumab|adalimumab|mesh-list
92049755|NCT01618305|Raltegravir Potassium|raltegravir potassium|mesh-list
92049827|NCT02203331|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92049828|NCT02203331|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92049829|NCT02203331|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92049830|NCT01893411|Botulinum Toxins|botulinum toxins|mesh-list
92049831|NCT01893411|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92049832|NCT01893411|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92049833|NCT01893411|incobotulinumtoxinA|incobotulinumtoxina|mesh-list
92049834|NCT01893411|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92049835|NCT01893411|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92049836|NCT01893411|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92049837|NCT01893411|Cholinergic Agents|cholinergic agents|mesh-ancestor
92049838|NCT01893411|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92049888|NCT05131555|Histamine H1 Antagonists|histamine h1 antagonists|mesh-list
92049899|NCT02202161|Metformin|metformin|mesh-list
92049968|NCT01483690|Decitabine|decitabine|mesh-list
92050036|NCT01881789|Alkylating Agents|alkylating agents|mesh-ancestor
92050041|NCT01881789|Antiemetics|antiemetics|mesh-ancestor
92050110|NCT01859793|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050187|NCT02229539|Autonomic Agents|autonomic agents|mesh-ancestor
92050188|NCT02229539|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92050189|NCT02229539|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92050199|NCT01835223|Tivozanib|tivozanib|mesh-list
92050260|NCT01833897|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92050261|NCT01833897|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92050264|NCT01833897|Antiemetics|antiemetics|mesh-ancestor
92050333|NCT01459666|Cholinergic Agents|cholinergic agents|mesh-ancestor
92050406|NCT03026842|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050407|NCT03026842|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92050410|NCT03026842|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050476|NCT02224157|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92050477|NCT02224157|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92050478|NCT02224157|Adrenergic Agents|adrenergic agents|mesh-ancestor
92050479|NCT02224157|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92050480|NCT02224157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050481|NCT02224157|Sympathomimetics|sympathomimetics|mesh-ancestor
92050482|NCT02224157|Tocolytic Agents|tocolytic agents|mesh-ancestor
92050483|NCT02224157|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92050485|NCT02196701|Methotrexate|methotrexate|mesh-list
92050486|NCT02196701|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92050541|NCT01623752|Immunologic Factors|immunologic factors|mesh-ancestor
92050542|NCT01623596|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92053246|NCT05741086|Protease Inhibitors|protease inhibitors|mesh-ancestor
92050610|NCT02219009|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92050611|NCT02219009|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92050612|NCT02219009|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92050613|NCT02219009|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92050614|NCT01456936|Bupropion|bupropion|mesh-list
92050615|NCT01456936|Nicotine|nicotine|mesh-list
92050616|NCT01456936|Varenicline|varenicline|mesh-list
92050617|NCT01456936|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92050618|NCT01456936|Autonomic Agents|autonomic agents|mesh-ancestor
92050619|NCT01456936|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050620|NCT01456936|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050674|NCT01454596|Alkylating Agents|alkylating agents|mesh-ancestor
92050675|NCT01454596|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050676|NCT01454596|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92050744|NCT02191397|Autonomic Agents|autonomic agents|mesh-ancestor
92050745|NCT02191397|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92050746|NCT02191397|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92050747|NCT02191397|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92050748|NCT02191397|Cholinergic Agents|cholinergic agents|mesh-ancestor
92050749|NCT02191397|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92050813|NCT02189837|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050814|NCT02189837|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92050815|NCT02189837|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92050816|NCT02189837|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92050817|NCT02189837|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92050818|NCT02189837|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92050819|NCT02189837|Protease Inhibitors|protease inhibitors|mesh-ancestor
92050820|NCT02189837|Immunologic Factors|immunologic factors|mesh-ancestor
92050821|NCT02189837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92050822|NCT02216123|Chloroquine|chloroquine|mesh-list
92050880|NCT04418219|Interferon alpha-2|interferon alpha-2|mesh-list
92050881|NCT04418219|Cyclophosphamide|cyclophosphamide|mesh-list
92050882|NCT04418219|Pembrolizumab|pembrolizumab|mesh-list
92050894|NCT04418219|Antiviral Agents|antiviral agents|mesh-ancestor
92050953|NCT02073565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92050954|NCT02073565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051023|NCT04075240|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92051024|NCT04075240|Analgesics|analgesics|mesh-ancestor
92051095|NCT01473394|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92051168|NCT02111785|Autonomic Agents|autonomic agents|mesh-ancestor
92051169|NCT02111785|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92051170|NCT02111785|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051171|NCT02111785|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92051172|NCT02111785|Glucocorticoids|glucocorticoids|mesh-ancestor
92051173|NCT02111785|Hormones|hormones|mesh-ancestor
92051174|NCT02111785|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92051175|NCT02111785|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92051176|NCT02111785|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92051177|NCT02068495|Amlodipine|amlodipine|mesh-list
92051227|NCT01856907|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051229|NCT02097745|Methotrexate|methotrexate|mesh-list
92051246|NCT02111083|Insulin Lispro|insulin lispro|mesh-list
92051300|NCT04750655|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051374|NCT02109445|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92051375|NCT02109445|Gemcitabine|gemcitabine|mesh-list
92051376|NCT02109445|Nirogacestat|nirogacestat|mesh-list
92051446|NCT04724629|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92051447|NCT04724629|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92051448|NCT04724629|Antiviral Agents|antiviral agents|mesh-ancestor
92051457|NCT02186015|Vitamin D|vitamin d|mesh-list
92051521|NCT01625611|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051592|NCT01625377|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92051593|NCT01625377|Antitubercular Agents|antitubercular agents|mesh-ancestor
92051665|NCT02157935|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92051736|NCT01827267|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92051810|NCT01825941|Dopamine Agents|dopamine agents|mesh-ancestor
92051811|NCT02044159|Hydrocortisone|hydrocortisone|mesh-list
92051846|NCT02155829|Riluzole|riluzole|mesh-list
92051882|NCT01627067|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92051883|NCT01627067|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92051884|NCT01627067|Immunologic Factors|immunologic factors|mesh-ancestor
92051954|NCT01598987|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92051955|NCT01598987|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92051956|NCT01598987|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052026|NCT01824693|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92052027|NCT01824693|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92052028|NCT01824693|Alkylating Agents|alkylating agents|mesh-ancestor
92052029|NCT01824693|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052030|NCT01824693|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052031|NCT01824693|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92052093|NCT02152163|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052168|NCT02118896|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052169|NCT02118896|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92052170|NCT02118896|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052171|NCT02118896|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052172|NCT02124707|Paclitaxel|paclitaxel|mesh-list
92052173|NCT02124707|Carboplatin|carboplatin|mesh-list
92052174|NCT02124707|Cetuximab|cetuximab|mesh-list
92052175|NCT02124707|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052176|NCT02124707|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052233|NCT02124161|Heptavalent Pneumococcal Conjugate Vaccine|heptavalent pneumococcal conjugate vaccine|mesh-list
92052234|NCT02124161|Immunologic Factors|immunologic factors|mesh-ancestor
92052307|NCT02064920|Cholinesterase Inhibitors|cholinesterase inhibitors|mesh-ancestor
92052308|NCT02064920|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052380|NCT02090114|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052381|NCT02090114|Anabolic Agents|anabolic agents|mesh-ancestor
92052382|NCT02090114|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92052383|NCT02090114|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052384|NCT02090114|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052385|NCT02090114|Hormone Antagonists|hormone antagonists|mesh-ancestor
92052386|NCT02090114|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92052387|NCT04742036|Paclitaxel|paclitaxel|mesh-list
92052446|NCT02058836|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92052447|NCT02058836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052448|NCT02107274|Azithromycin|azithromycin|mesh-list
92052449|NCT02107274|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92052450|NCT02107274|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052451|NCT02173769|Tiotropium Bromide|tiotropium bromide|mesh-list
92052453|NCT02173769|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92052454|NCT02173769|Autonomic Agents|autonomic agents|mesh-ancestor
92052512|NCT02147561|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052513|NCT02058368|Tamsulosin|tamsulosin|mesh-list
92052514|NCT02058368|Dutasteride|dutasteride|mesh-list
92052518|NCT02058368|Adrenergic Agents|adrenergic agents|mesh-ancestor
92052581|NCT01625000|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92052582|NCT01625000|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92052583|NCT01625000|Dopamine Agents|dopamine agents|mesh-ancestor
92052584|NCT02057198|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92052585|NCT02057198|Metronidazole|metronidazole|mesh-list
92052586|NCT02057198|Vancomycin|vancomycin|mesh-list
92052587|NCT02057198|Fidaxomicin|fidaxomicin|mesh-list
92052588|NCT02057198|Amebicides|amebicides|mesh-list
92052589|NCT02057198|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052590|NCT02057198|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92052591|NCT02057198|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92052592|NCT02056340|Atorvastatin|atorvastatin|mesh-list
92052593|NCT02056340|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92052594|NCT02056340|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92052646|NCT02080832|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92052647|NCT02080832|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92052648|NCT02080832|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052649|NCT02080832|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052650|NCT02080832|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052651|NCT02080832|Serotonin Agents|serotonin agents|mesh-ancestor
92052652|NCT02080832|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052653|NCT02080832|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92052654|NCT02080832|Antidepressive Agents|antidepressive agents|mesh-ancestor
92052655|NCT02080832|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92052656|NCT02080832|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92052657|NCT02080832|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92052658|NCT02080832|Parasympatholytics|parasympatholytics|mesh-ancestor
92052659|NCT02080832|Autonomic Agents|autonomic agents|mesh-ancestor
92052660|NCT02080832|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052702|NCT02044094|Buprenorphine|buprenorphine|mesh-list
92052703|NCT02044094|Hydromorphone|hydromorphone|mesh-list
92052704|NCT02044094|Naloxone|naloxone|mesh-list
92052706|NCT02044094|Narcotics|narcotics|mesh-ancestor
92052775|NCT01621880|Hormones|hormones|mesh-ancestor
92052776|NCT01621880|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92052777|NCT01621880|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92052778|NCT01621880|Protective Agents|protective agents|mesh-ancestor
92052779|NCT02041429|Paclitaxel|paclitaxel|mesh-list
92052780|NCT02041429|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92052781|NCT02041429|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92052782|NCT02041429|Tubulin Modulators|tubulin modulators|mesh-ancestor
92052783|NCT02041429|Antimitotic Agents|antimitotic agents|mesh-ancestor
92052784|NCT02041429|Mitosis Modulators|mitosis modulators|mesh-ancestor
92052785|NCT02041429|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052786|NCT04699981|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92052787|NCT04699981|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92052788|NCT04699981|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92052789|NCT04699981|Antitubercular Agents|antitubercular agents|mesh-ancestor
92052790|NCT02083783|Amphetamine|amphetamine|mesh-list
92052791|NCT02083783|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92052792|NCT02083783|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92052793|NCT02083783|Sympathomimetics|sympathomimetics|mesh-ancestor
92052794|NCT02083783|Autonomic Agents|autonomic agents|mesh-ancestor
92052795|NCT02083783|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92052796|NCT02083783|Dopamine Agents|dopamine agents|mesh-ancestor
92052797|NCT02083783|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92052798|NCT02083783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052799|NCT02083783|Adrenergic Agents|adrenergic agents|mesh-ancestor
92052800|NCT02083783|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92052801|NCT02083783|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92052802|NCT02083783|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92052803|NCT02083783|Dopamine Uptake Inhibitors|dopamine uptake inhibitors|mesh-ancestor
92052804|NCT02059135|Antithrombins|antithrombins|mesh-list
92052805|NCT02059135|Antithrombin III|antithrombin iii|mesh-list
92052806|NCT02059135|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92052807|NCT02059135|Protease Inhibitors|protease inhibitors|mesh-ancestor
92052808|NCT02059135|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92052809|NCT02059135|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92052810|NCT02059135|Anticoagulants|anticoagulants|mesh-ancestor
92052811|NCT04720105|Halobetasol|halobetasol|mesh-list
92052812|NCT04720105|Tazarotene|tazarotene|mesh-list
92052884|NCT02035267|Cholagogues and Choleretics|cholagogues and choleretics|mesh-ancestor
92052885|NCT02035267|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92052959|NCT05886660|Scopolamine|scopolamine|mesh-list
92052960|NCT05886660|Butylscopolammonium Bromide|butylscopolammonium bromide|mesh-list
92053033|NCT05886088|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053034|NCT05886088|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92053035|NCT05886088|Protease Inhibitors|protease inhibitors|mesh-ancestor
92053036|NCT05886088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053106|NCT05882643|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053117|NCT05877430|Pembrolizumab|pembrolizumab|mesh-list
92053118|NCT05877430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053119|NCT05877430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053120|NCT05877430|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053121|NCT05877430|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053122|NCT05852691|Paclitaxel|paclitaxel|mesh-list
92053123|NCT05852691|Pembrolizumab|pembrolizumab|mesh-list
92053124|NCT05852691|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053125|NCT05852691|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053126|NCT05852691|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053127|NCT05852691|Antimitotic Agents|antimitotic agents|mesh-ancestor
92053181|NCT05789381|Sensory System Agents|sensory system agents|mesh-ancestor
92053182|NCT05789381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053183|NCT05789381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053185|NCT05789381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92053186|NCT05789381|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92053187|NCT05789381|Anticonvulsants|anticonvulsants|mesh-ancestor
92053188|NCT05789381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92053189|NCT05789381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92053190|NCT05789381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053191|NCT05789381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92053192|NCT05789381|Tocolytic Agents|tocolytic agents|mesh-ancestor
92053193|NCT05789381|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92053239|NCT05741086|Antimetabolites|antimetabolites|mesh-ancestor
92053240|NCT05741086|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053241|NCT05741086|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92053242|NCT05741086|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92053243|NCT05741086|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053244|NCT05741086|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92053245|NCT05741086|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92053247|NCT05722262|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol|6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro(isobenzofuran-1(3h),2'-(2h)pyran)-3',4',5'-triol|mesh-list
92053248|NCT05722262|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92053249|NCT05722262|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053250|NCT05722262|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92053251|NCT05722262|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053252|NCT05713994|Bevacizumab|bevacizumab|mesh-list
92053253|NCT05713994|Atezolizumab|atezolizumab|mesh-list
92053254|NCT05713994|Sorafenib|sorafenib|mesh-list
92053255|NCT05713994|Apatinib|apatinib|mesh-list
92053256|NCT05713994|Lenvatinib|lenvatinib|mesh-list
92053257|NCT05713994|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92053258|NCT05713994|Antibodies|antibodies|mesh-list
92053259|NCT05713994|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92053271|NCT05710887|Nitrous Oxide|nitrous oxide|mesh-list
92053308|NCT05657041|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92053309|NCT05657041|Purinergic Agents|purinergic agents|mesh-ancestor
92053313|NCT05656599|Letermovir|letermovir|mesh-list
92053379|NCT05597878|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92053380|NCT05597878|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92053381|NCT05597878|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053453|NCT05535738|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92053454|NCT05535738|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053455|NCT05535738|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92053456|NCT05535738|Respiratory System Agents|respiratory system agents|mesh-ancestor
92053457|NCT05535738|Dermatologic Agents|dermatologic agents|mesh-ancestor
92053458|NCT05535738|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92053459|NCT05535738|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92053460|NCT05535738|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92053461|NCT05535738|Glucocorticoids|glucocorticoids|mesh-ancestor
92053462|NCT05535738|Hormones|hormones|mesh-ancestor
92053463|NCT05535738|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92053464|NCT05535738|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92053465|NCT05535738|Immunologic Factors|immunologic factors|mesh-ancestor
92053466|NCT05535738|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053467|NCT05535738|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053468|NCT05535738|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92053509|NCT05459129|Atezolizumab|atezolizumab|mesh-list
92053510|NCT05459129|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92053511|NCT05459129|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053512|NCT05459129|Tubulin Modulators|tubulin modulators|mesh-ancestor
92053582|NCT05351489|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92053583|NCT05351489|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92053584|NCT05351489|Adrenergic Agents|adrenergic agents|mesh-ancestor
92053652|NCT05169515|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053653|NCT05166239|Lenvatinib|lenvatinib|mesh-list
92053654|NCT05166239|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-list
92053655|NCT05166239|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053656|NCT05166239|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92053657|NCT05166239|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92053658|NCT05166239|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053659|NCT05166239|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053661|NCT05145296|Abatacept|abatacept|mesh-list
92053722|NCT05084222|Respiratory System Agents|respiratory system agents|mesh-ancestor
92053798|NCT05005442|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053799|NCT05005442|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053800|NCT05005442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053801|NCT04931342|Maytansine|maytansine|mesh-list
92053802|NCT04931342|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92053803|NCT04931342|Cyclophosphamide|cyclophosphamide|mesh-list
92053804|NCT04931342|Bevacizumab|bevacizumab|mesh-list
92053805|NCT04931342|Trastuzumab|trastuzumab|mesh-list
92053806|NCT04931342|Atezolizumab|atezolizumab|mesh-list
92053807|NCT04931342|Letrozole|letrozole|mesh-list
92053808|NCT04931342|Olaparib|olaparib|mesh-list
92053809|NCT04931342|Palbociclib|palbociclib|mesh-list
92053863|NCT04902443|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92053864|NCT04902443|Growth Substances|growth substances|mesh-ancestor
92053865|NCT04902443|Growth Inhibitors|growth inhibitors|mesh-ancestor
92053866|NCT04898023|Ascorbic Acid|ascorbic acid|mesh-list
92053867|NCT04898023|Antioxidants|antioxidants|mesh-ancestor
92053868|NCT04898023|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053869|NCT04898023|Protective Agents|protective agents|mesh-ancestor
92053870|NCT04898023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92053871|NCT04898023|Vitamins|vitamins|mesh-ancestor
92053872|NCT04898023|Micronutrients|micronutrients|mesh-ancestor
92053873|NCT04882085|Ceftazidime|ceftazidime|mesh-list
92053874|NCT04882085|Avibactam|avibactam|mesh-list
92053928|NCT04751370|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92053929|NCT04751370|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92053930|NCT04751370|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92053931|NCT04751370|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92053933|NCT04746235|Decitabine and cedazuridine drug combination|decitabine and cedazuridine drug combination|mesh-list
92053934|NCT04746235|Venetoclax|venetoclax|mesh-list
92054002|NCT04254627|Sensory System Agents|sensory system agents|mesh-ancestor
92054003|NCT04254627|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92054004|NCT04254627|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054005|NCT04254627|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92054006|NCT04254627|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054007|NCT04254627|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92054008|NCT04254627|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054075|NCT04091217|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92054077|NCT04081389|Interferons|interferons|mesh-list
92054146|NCT03811847|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054147|NCT03811847|Dopamine Agents|dopamine agents|mesh-ancestor
92054148|NCT03811847|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92054149|NCT03809000|Leuprolide|leuprolide|mesh-list
92054150|NCT03809000|Goserelin|goserelin|mesh-list
92054151|NCT03809000|Bicalutamide|bicalutamide|mesh-list
92054152|NCT03809000|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92054153|NCT03809000|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054164|NCT03653364|Baloxavir|baloxavir|mesh-list
92054218|NCT03564691|Pembrolizumab|pembrolizumab|mesh-list
92054219|NCT03564691|Pemetrexed|pemetrexed|mesh-list
92054220|NCT03564691|Lenvatinib|lenvatinib|mesh-list
92054243|NCT03384238|Antibodies|antibodies|mesh-list
92054291|NCT03101748|Doxorubicin|doxorubicin|mesh-list
92054292|NCT03101748|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92054293|NCT03101748|Trastuzumab|trastuzumab|mesh-list
92054294|NCT03101748|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92054295|NCT03101748|Daunorubicin|daunorubicin|mesh-list
92054296|NCT03101748|Pertuzumab|pertuzumab|mesh-list
92054297|NCT03101748|Trastuzumab biosimilar HLX02|trastuzumab biosimilar hlx02|mesh-list
92054298|NCT03101748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92054299|NCT03101748|Antibodies|antibodies|mesh-list
92054300|NCT03101748|Immunoglobulins|immunoglobulins|mesh-list
92054301|NCT03101748|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92054302|NCT03101748|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92054303|NCT03101748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054304|NCT03101748|Tubulin Modulators|tubulin modulators|mesh-ancestor
92054305|NCT03101748|Antimitotic Agents|antimitotic agents|mesh-ancestor
92054306|NCT03101748|Mitosis Modulators|mitosis modulators|mesh-ancestor
92054307|NCT03101748|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054308|NCT03101748|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054309|NCT03101748|Immunologic Factors|immunologic factors|mesh-ancestor
92054310|NCT03101748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054311|NCT03101748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054312|NCT03101748|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92054313|NCT03101748|Alkylating Agents|alkylating agents|mesh-ancestor
92054314|NCT03101748|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92054315|NCT03101748|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92054341|NCT02979873|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92054342|NCT02979873|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92054343|NCT02979873|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054415|NCT02756000|Dobutamine|dobutamine|mesh-list
92054489|NCT01860170|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92054490|NCT01860170|Immunologic Factors|immunologic factors|mesh-ancestor
92054491|NCT01860170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054492|NCT01860170|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92054493|NCT01860170|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92054494|NCT01860170|Alkylating Agents|alkylating agents|mesh-ancestor
92054495|NCT01860170|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054496|NCT01860170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054497|NCT01860170|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92054498|NCT01847274|Niraparib|niraparib|mesh-list
92054499|NCT01847274|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92054500|NCT01847274|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054501|NCT01847274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054502|NCT01847274|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054503|NCT01697566|Metformin|metformin|mesh-list
92054504|NCT01697566|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92054505|NCT01697566|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054535|NCT01566695|Azacitidine|azacitidine|mesh-list
92054536|NCT01566695|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92054537|NCT01566695|Antimetabolites|antimetabolites|mesh-ancestor
92054538|NCT01566695|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054539|NCT01566695|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054540|NCT01566695|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054541|NCT01471106|Dasatinib|dasatinib|mesh-list
92054542|NCT01471106|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054543|NCT01471106|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92054544|NCT01471106|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054545|NCT01471106|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92054561|NCT00866554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054562|NCT00866554|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92054563|NCT00866554|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92054632|NCT02034565|Protease Inhibitors|protease inhibitors|mesh-ancestor
92054633|NCT02034565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054706|NCT02022007|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054778|NCT01823289|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054853|NCT01821729|Antimetabolites|antimetabolites|mesh-ancestor
92054926|NCT04170465|Alkylating Agents|alkylating agents|mesh-ancestor
92054927|NCT04170465|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92054928|NCT04170465|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92054929|NCT04170465|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92054930|NCT04170465|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92054931|NCT04170465|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92054932|NCT04170465|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92054933|NCT01816893|Hypoglycemic Agents|hypoglycemic agents|mesh-list
92054934|NCT01816893|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92054936|NCT01847313|Glucagon|glucagon|mesh-list
92054937|NCT01847313|Glucagon-Like Peptide 1|glucagon-like peptide 1|mesh-list
92054938|NCT01847313|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92054940|NCT01847313|Incretins|incretins|mesh-ancestor
92054989|NCT01846611|Dexamethasone|dexamethasone|mesh-list
92055061|NCT01844895|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055062|NCT01844895|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055063|NCT01844895|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055133|NCT01844583|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92055134|NCT01844583|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92055205|NCT02030041|Cholecalciferol|cholecalciferol|mesh-list
92055206|NCT02030041|Simvastatin|simvastatin|mesh-list
92055207|NCT02030041|Vitamins|vitamins|mesh-ancestor
92055208|NCT02030041|Micronutrients|micronutrients|mesh-ancestor
92055209|NCT02030041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055213|NCT02030041|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92055273|NCT02018042|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92055274|NCT02018042|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055275|NCT02018042|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92055276|NCT02018042|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055277|NCT02018042|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92055278|NCT02018042|Immunologic Factors|immunologic factors|mesh-ancestor
92055279|NCT02018042|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055280|NCT02018042|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92055281|NCT02017171|Allopurinol|allopurinol|mesh-list
92055282|NCT02017171|Antimetabolites|antimetabolites|mesh-ancestor
92055284|NCT02017171|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055336|NCT02050321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92055337|NCT02050321|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92055338|NCT02050321|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055340|NCT02050321|Keratolytic Agents|keratolytic agents|mesh-ancestor
92055407|NCT02038790|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055408|NCT02038790|Analgesics|analgesics|mesh-ancestor
92055481|NCT01843023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055556|NCT03272139|Anesthetics|anesthetics|mesh-ancestor
92055557|NCT03272139|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92055558|NCT03272139|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055629|NCT01967173|Autonomic Agents|autonomic agents|mesh-ancestor
92055630|NCT01967173|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92055631|NCT01967173|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92055632|NCT01967173|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92055698|NCT01988402|Allopurinol|allopurinol|mesh-list
92055699|NCT01988402|Antimetabolites|antimetabolites|mesh-ancestor
92055701|NCT01988402|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92055769|NCT04691804|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92055844|NCT01964755|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92055919|NCT01962493|Cariostatic Agents|cariostatic agents|mesh-ancestor
92055920|NCT01962493|Protective Agents|protective agents|mesh-ancestor
92055922|NCT01962493|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92055990|NCT02010632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056064|NCT01610037|Autonomic Agents|autonomic agents|mesh-ancestor
92056135|NCT01803711|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92056136|NCT01803711|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92056139|NCT01803711|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056207|NCT01773993|Sensory System Agents|sensory system agents|mesh-ancestor
92056208|NCT01773993|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056279|NCT04177004|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92056353|NCT01961323|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056426|NCT02006641|Serotonin Agents|serotonin agents|mesh-ancestor
92056427|NCT02006641|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92056428|NCT02006641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056498|NCT02111369|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92056499|NCT02111369|Adrenergic Agents|adrenergic agents|mesh-ancestor
92056500|NCT02111369|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92056501|NCT02111369|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92056502|NCT02111369|Vasodilator Agents|vasodilator agents|mesh-ancestor
92056503|NCT02069093|Dexamethasone|dexamethasone|mesh-list
92056504|NCT02069093|Everolimus|everolimus|mesh-list
92056505|NCT02069093|Exemestane|exemestane|mesh-list
92056506|NCT02069093|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92056507|NCT02069093|Antiemetics|antiemetics|mesh-ancestor
92056508|NCT02069093|Autonomic Agents|autonomic agents|mesh-ancestor
92056509|NCT02069093|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056510|NCT02069093|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056511|NCT02069093|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056512|NCT02069093|Glucocorticoids|glucocorticoids|mesh-ancestor
92056513|NCT02069093|Hormones|hormones|mesh-ancestor
92056514|NCT02069093|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056515|NCT02069093|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92056516|NCT02069093|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92056517|NCT02069093|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92056555|NCT01625897|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92056556|NCT01625897|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92056557|NCT01625897|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92056558|NCT01625897|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92056559|NCT01625897|Dopamine Agents|dopamine agents|mesh-ancestor
92056560|NCT02106923|Metformin|metformin|mesh-list
92056561|NCT02106923|Empagliflozin|empagliflozin|mesh-list
92056562|NCT02106923|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92056563|NCT02106923|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92056566|NCT02006732|Tiotropium Bromide|tiotropium bromide|mesh-list
92056622|NCT04417985|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92056623|NCT02106455|Risedronic Acid|risedronic acid|mesh-list
92056624|NCT02106455|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92056625|NCT02106455|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92056689|NCT02005562|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056690|NCT02005562|Glucocorticoids|glucocorticoids|mesh-ancestor
92056692|NCT02005562|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92056693|NCT02005562|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92056761|NCT01471054|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92056762|NCT01471054|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92056764|NCT01471054|Hormones|hormones|mesh-ancestor
92056834|NCT02096003|Hydromorphone|hydromorphone|mesh-list
92056835|NCT02096003|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92056836|NCT02096003|Narcotics|narcotics|mesh-ancestor
92056909|NCT04670666|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92056984|NCT01967576|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92056985|NCT01967576|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92056986|NCT01967576|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057053|NCT01445080|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057054|NCT04709471|Nicotine|nicotine|mesh-list
92057055|NCT04709471|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92057056|NCT04709471|Autonomic Agents|autonomic agents|mesh-ancestor
92057057|NCT04709471|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057058|NCT04709471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057059|NCT04709471|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92057060|NCT04709471|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92057061|NCT04709471|Cholinergic Agents|cholinergic agents|mesh-ancestor
92057062|NCT04709471|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057063|NCT04709471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057064|NCT01959529|Insulin|insulin|mesh-list
92058637|NCT03025906|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92057116|NCT01438060|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057117|NCT01438060|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92057118|NCT01438060|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92057119|NCT01438060|Serotonin Agents|serotonin agents|mesh-ancestor
92057120|NCT01438060|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92057121|NCT01438060|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92057122|NCT01438060|Dopamine D2 Receptor Antagonists|dopamine d2 receptor antagonists|mesh-ancestor
92057123|NCT01438060|Dopamine Antagonists|dopamine antagonists|mesh-ancestor
92057124|NCT01444300|4-Aminopyridine|4-aminopyridine|mesh-list
92057125|NCT01444300|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92057126|NCT01444300|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92057127|NCT01444300|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057175|NCT01958827|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057176|NCT01958827|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057177|NCT04670653|Mometasone Furoate|mometasone furoate|mesh-list
92057178|NCT04670653|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057179|NCT04670653|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057180|NCT04670653|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92057181|NCT01436110|Fluticasone|fluticasone|mesh-list
92057182|NCT01436110|Xhance|xhance|mesh-list
92057192|NCT01619852|Lidocaine|lidocaine|mesh-list
92057242|NCT04666129|Protective Agents|protective agents|mesh-ancestor
92057317|NCT04176055|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057319|NCT04176055|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92057392|NCT01964300|Peginterferon alfa-2b|peginterferon alfa-2b|mesh-list
92057393|NCT01964300|Antiviral Agents|antiviral agents|mesh-ancestor
92057394|NCT01964300|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057463|NCT01996826|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057464|NCT01996826|Growth Inhibitors|growth inhibitors|mesh-ancestor
92057465|NCT01996826|Laxatives|laxatives|mesh-ancestor
92057466|NCT01996826|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92057535|NCT01618214|Insulin aspart, insulin aspart protamine drug combination 30:70|insulin aspart, insulin aspart protamine drug combination 30:70|mesh-list
92057536|NCT01618214|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92057538|NCT01917656|Metformin|metformin|mesh-list
92057605|NCT01915940|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92057612|NCT01914926|Metoprolol|metoprolol|mesh-list
92057679|NCT02029235|Sensory System Agents|sensory system agents|mesh-ancestor
92057680|NCT02029235|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057681|NCT02029235|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057682|NCT02029235|Antipyretics|antipyretics|mesh-ancestor
92057683|NCT02029235|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92057684|NCT02029235|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057685|NCT02029235|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057686|NCT02029235|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92057687|NCT02029235|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057688|NCT02029235|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057743|NCT01937390|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057749|NCT01937390|Anticonvulsants|anticonvulsants|mesh-ancestor
92057815|NCT02013791|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057816|NCT02013791|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057817|NCT02013791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92057818|NCT02013791|Immunologic Factors|immunologic factors|mesh-ancestor
92057819|NCT02013791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057820|NCT02013791|Antifungal Agents|antifungal agents|mesh-ancestor
92057821|NCT02013791|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057822|NCT02013791|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057823|NCT02013791|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057824|NCT02013791|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92057825|NCT02024867|Trimethoprim|trimethoprim|mesh-list
92057826|NCT02024867|Trimethoprim, Sulfamethoxazole Drug Combination|trimethoprim, sulfamethoxazole drug combination|mesh-list
92057827|NCT02024867|Sulfamethoxazole|sulfamethoxazole|mesh-list
92057828|NCT02024867|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92057829|NCT02024867|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92057830|NCT02024867|Antimalarials|antimalarials|mesh-ancestor
92057831|NCT02024867|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92057832|NCT02024867|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92057833|NCT02024867|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92057834|NCT02024867|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057835|NCT02024867|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057836|NCT02024867|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92057837|NCT02024867|Cytochrome P-450 CYP2C8 Inhibitors|cytochrome p-450 cyp2c8 inhibitors|mesh-ancestor
92057838|NCT02024867|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92057839|NCT02024867|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92057840|NCT02023697|Radium Ra 223 dichloride|radium ra 223 dichloride|mesh-list
92057841|NCT02023697|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92057842|NCT01951417|Adapalene|adapalene|mesh-list
92057843|NCT01951417|Benzoyl Peroxide|benzoyl peroxide|mesh-list
92057844|NCT01951417|Dermatologic Agents|dermatologic agents|mesh-ancestor
92057845|NCT01951417|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92057846|NCT01951417|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92057847|NCT01951417|Analgesics|analgesics|mesh-ancestor
92057848|NCT01951417|Sensory System Agents|sensory system agents|mesh-ancestor
92057849|NCT01951417|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92057850|NCT01951417|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057851|NCT01951417|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92057852|NCT01951417|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92057854|NCT02023151|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92057855|NCT02023151|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92057856|NCT02023151|Respiratory System Agents|respiratory system agents|mesh-ancestor
92057857|NCT01979185|Simvastatin|simvastatin|mesh-list
92057858|NCT01979185|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92057859|NCT01979185|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92057860|NCT01979185|Antimetabolites|antimetabolites|mesh-ancestor
92057861|NCT01979185|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057862|NCT01979185|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92057863|NCT01979185|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92057864|NCT01979185|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92057865|NCT01946425|Vaccines|vaccines|mesh-list
92057866|NCT01946425|Immunologic Factors|immunologic factors|mesh-ancestor
92057867|NCT01946425|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057917|NCT01937312|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92057919|NCT01937312|Brinzolamide|brinzolamide|mesh-list
92057920|NCT01937312|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92057921|NCT01937312|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92057922|NCT01937312|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92057923|NCT01937312|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92057924|NCT01937312|Adrenergic Agents|adrenergic agents|mesh-ancestor
92057925|NCT01937312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057926|NCT01937312|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92057927|NCT01937312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92057979|NCT01977937|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92057981|NCT01977937|Antimanic Agents|antimanic agents|mesh-ancestor
92058051|NCT01909466|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058052|NCT01909466|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92058053|NCT01909466|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058054|NCT01909466|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058055|NCT01909466|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058119|NCT01993667|Carbonic Anhydrase Inhibitors|carbonic anhydrase inhibitors|mesh-ancestor
92058120|NCT01993667|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058121|NCT01993667|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058191|NCT01931150|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92058192|NCT01931150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92058193|NCT01931150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92058194|NCT01931150|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058262|NCT01929044|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92058263|NCT01929044|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92058336|NCT04504864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058408|NCT01417078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92058484|NCT01415518|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058485|NCT01415518|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058487|NCT01415518|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058488|NCT01415518|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92058554|NCT01432444|Serotonin Agents|serotonin agents|mesh-ancestor
92058555|NCT01432444|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92058556|NCT01432444|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92058624|NCT01412944|Immunologic Factors|immunologic factors|mesh-ancestor
92058625|NCT01412944|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058626|NCT03025906|Valproic Acid|valproic acid|mesh-list
92058627|NCT03025906|Phenobarbital|phenobarbital|mesh-list
92058628|NCT03025906|Anticonvulsants|anticonvulsants|mesh-ancestor
92058629|NCT03025906|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058630|NCT03025906|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058631|NCT03025906|GABA Agents|gaba agents|mesh-ancestor
92058632|NCT03025906|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058633|NCT03025906|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058634|NCT03025906|Antimanic Agents|antimanic agents|mesh-ancestor
92058635|NCT03025906|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92058636|NCT03025906|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92058638|NCT03025906|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92058639|NCT03025906|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92058640|NCT03025906|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92058641|NCT03025906|GABA Modulators|gaba modulators|mesh-ancestor
92058642|NCT03025906|Cytochrome P-450 CYP2B6 Inducers|cytochrome p-450 cyp2b6 inducers|mesh-ancestor
92058643|NCT03025906|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92058677|NCT01797081|Cholinergic Agents|cholinergic agents|mesh-ancestor
92058678|NCT01797081|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058679|NCT01797081|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058680|NCT01797081|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92058681|NCT01797081|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92058682|NCT01794117|Interleukin 1 Receptor Antagonist Protein|interleukin 1 receptor antagonist protein|mesh-list
92058683|NCT01794117|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058684|NCT01765569|Vemurafenib|vemurafenib|mesh-list
92058685|NCT01765569|Digoxin|digoxin|mesh-list
92058686|NCT01765569|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92058687|NCT01765569|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92058688|NCT01765569|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058689|NCT01765569|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058690|NCT01765569|Protective Agents|protective agents|mesh-ancestor
92058691|NCT01765569|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058692|NCT01765569|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058693|NCT01765569|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92058694|NCT04414605|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92058695|NCT04414605|Immunologic Factors|immunologic factors|mesh-ancestor
92058696|NCT04414605|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058697|NCT01609023|Rituximab|rituximab|mesh-list
92058698|NCT01609023|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058699|NCT01609023|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058700|NCT01609023|Immunologic Factors|immunologic factors|mesh-ancestor
92058701|NCT01609023|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058702|NCT01609023|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92058703|NCT01765179|Methyltestosterone|methyltestosterone|mesh-list
92058704|NCT01765179|Testosterone|testosterone|mesh-list
92058705|NCT01765179|Testosterone undecanoate|testosterone undecanoate|mesh-list
92058706|NCT01765179|Testosterone enanthate|testosterone enanthate|mesh-list
92058707|NCT01765179|Testosterone 17 beta-cypionate|testosterone 17 beta-cypionate|mesh-list
92058708|NCT01765179|Androgens|androgens|mesh-ancestor
92058709|NCT01765179|Hormones|hormones|mesh-ancestor
92058710|NCT01765179|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92058711|NCT01765179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058712|NCT01765179|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92058713|NCT01765179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058715|NCT01793883|Laninamivir|laninamivir|mesh-list
92058716|NCT01793883|Zanamivir|zanamivir|mesh-list
92058717|NCT01793883|Antiviral Agents|antiviral agents|mesh-ancestor
92058718|NCT01793883|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92058719|NCT01793883|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058784|NCT01900730|Anticonvulsants|anticonvulsants|mesh-ancestor
92058785|NCT01900730|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92058786|NCT01900730|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058856|NCT01410448|Immunologic Factors|immunologic factors|mesh-ancestor
92058857|NCT01410448|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058929|NCT01987895|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058930|NCT01618669|Regadenoson|regadenoson|mesh-list
92058931|NCT01618669|Adenosine A2 Receptor Agonists|adenosine a2 receptor agonists|mesh-ancestor
92058932|NCT01618669|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92058933|NCT01618669|Purinergic Agonists|purinergic agonists|mesh-ancestor
92058934|NCT01618669|Purinergic Agents|purinergic agents|mesh-ancestor
92058935|NCT01618669|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92058936|NCT01618669|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92058937|NCT01618669|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92058938|NCT01390948|Bevacizumab|bevacizumab|mesh-list
92058939|NCT01390948|Temozolomide|temozolomide|mesh-list
92058940|NCT01390948|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92058941|NCT01390948|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92058942|NCT01390948|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92058989|NCT01925612|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92058990|NCT01925612|Glucocorticoids|glucocorticoids|mesh-ancestor
92058991|NCT01925612|Hormones|hormones|mesh-ancestor
92058992|NCT01925612|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059061|NCT01390402|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92059062|NCT01390402|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92059063|NCT01390402|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92059064|NCT01390402|Analgesics|analgesics|mesh-ancestor
92059065|NCT01390402|Sensory System Agents|sensory system agents|mesh-ancestor
92059066|NCT01390402|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059067|NCT01390402|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92059068|NCT01390402|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92059069|NCT04661683|Charcoal|charcoal|mesh-list
92059070|NCT04661683|Antidotes|antidotes|mesh-ancestor
92059071|NCT04661683|Protective Agents|protective agents|mesh-ancestor
92059072|NCT04661683|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059073|NCT01428076|Polidocanol|polidocanol|mesh-list
92059122|NCT01940497|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92059123|NCT01940497|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059124|NCT01940497|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059125|NCT01987505|Rituximab|rituximab|mesh-list
92059131|NCT01923896|Cycloserine|cycloserine|mesh-list
92059192|NCT01915303|Dopamine Agonists|dopamine agonists|mesh-ancestor
92059193|NCT01915303|Dopamine Agents|dopamine agents|mesh-ancestor
92059194|NCT01915303|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059195|NCT01915303|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059196|NCT01987427|Phentermine|phentermine|mesh-list
92059197|NCT01987427|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92059198|NCT01987427|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059199|NCT01987427|Appetite Depressants|appetite depressants|mesh-ancestor
92059200|NCT01987427|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92059201|NCT01987427|Sympathomimetics|sympathomimetics|mesh-ancestor
92059202|NCT01987427|Autonomic Agents|autonomic agents|mesh-ancestor
92059203|NCT01987427|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059204|NCT01987427|Adrenergic Agents|adrenergic agents|mesh-ancestor
92059252|NCT01789281|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92059253|NCT01789281|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059254|NCT01789281|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059255|NCT01789281|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92059256|NCT01789281|Immunologic Factors|immunologic factors|mesh-ancestor
92059257|NCT01789281|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059322|NCT01787331|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92059323|NCT01787331|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92059324|NCT01787331|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92059325|NCT01787331|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92059326|NCT01787331|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059327|NCT01787331|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92059328|NCT01787331|Hormone Antagonists|hormone antagonists|mesh-ancestor
92059329|NCT01787331|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92059330|NCT01787331|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059331|NCT01787331|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92059332|NCT01787097|Formoterol Fumarate|formoterol fumarate|mesh-list
92059333|NCT01787097|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92059334|NCT01787097|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92059335|NCT01787097|Autonomic Agents|autonomic agents|mesh-ancestor
92059336|NCT01787097|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059338|NCT01787097|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92059374|NCT04641728|Olaparib|olaparib|mesh-list
92059375|NCT04641728|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92059376|NCT04641728|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059377|NCT04641728|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92059378|NCT04641728|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059440|NCT01912963|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92059513|NCT01427608|Autonomic Agents|autonomic agents|mesh-ancestor
92059514|NCT01427608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059517|NCT01427608|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92059582|NCT01949870|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059583|NCT01922258|Brexpiprazole|brexpiprazole|mesh-list
92059584|NCT01922258|Serotonin Agents|serotonin agents|mesh-ancestor
92059585|NCT01922258|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059586|NCT01922258|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059587|NCT01922258|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059588|NCT01922258|Dopamine Agonists|dopamine agonists|mesh-ancestor
92059589|NCT01922258|Dopamine Agents|dopamine agents|mesh-ancestor
92059590|NCT01406938|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92059593|NCT01405924|Dexamethasone|dexamethasone|mesh-list
92059647|NCT01782495|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92059648|NCT01782495|Antimetabolites|antimetabolites|mesh-ancestor
92059649|NCT01922102|Ranibizumab|ranibizumab|mesh-list
92059650|NCT01922102|Verteporfin|verteporfin|mesh-list
92059651|NCT01922102|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92059713|NCT01403116|Methyltestosterone|methyltestosterone|mesh-list
92059714|NCT01403116|Testosterone|testosterone|mesh-list
92059715|NCT01403116|Testosterone undecanoate|testosterone undecanoate|mesh-list
92059790|NCT01422382|Pitavastatin|pitavastatin|mesh-list
92059791|NCT01422382|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92059861|NCT01387516|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059862|NCT01387516|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92059863|NCT01421134|Lurasidone Hydrochloride|lurasidone hydrochloride|mesh-list
92059864|NCT01421134|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92059865|NCT01421134|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92059866|NCT01421134|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92059867|NCT01421134|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92059868|NCT01421134|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92059869|NCT01421134|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92059870|NCT01421134|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92059871|NCT01421134|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92059872|NCT01421134|Adrenergic Agents|adrenergic agents|mesh-ancestor
92059873|NCT01421134|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92059875|NCT01421134|Serotonin 5-HT2 Receptor Antagonists|serotonin 5-ht2 receptor antagonists|mesh-ancestor
92059920|NCT01780389|Sensory System Agents|sensory system agents|mesh-ancestor
92059921|NCT01780389|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059922|NCT01780389|Antidepressive Agents|antidepressive agents|mesh-ancestor
92059923|NCT01780389|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92059925|NCT01778985|Estrogens, Conjugated (USP)|estrogens, conjugated (usp)|mesh-list
92059926|NCT01778985|Hormones|hormones|mesh-ancestor
92059929|NCT01865084|Tadalafil|tadalafil|mesh-list
92059986|NCT01777581|Sensory System Agents|sensory system agents|mesh-ancestor
92059987|NCT01777581|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92059988|NCT01777581|Antidepressive Agents|antidepressive agents|mesh-ancestor
92060056|NCT01896050|Anastrozole|anastrozole|mesh-list
92060057|NCT01896050|Exemestane|exemestane|mesh-list
92060071|NCT01775787|Menthol|menthol|mesh-list
92060130|NCT01774305|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060131|NCT01774305|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92060132|NCT01774305|Analgesics|analgesics|mesh-ancestor
92060144|NCT01397422|Antiviral Agents|antiviral agents|mesh-ancestor
92060203|NCT01885208|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92060214|NCT01859702|Hormones|hormones|mesh-ancestor
92060276|NCT01383928|Antiemetics|antiemetics|mesh-ancestor
92060352|NCT05892770|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060425|NCT05890118|Ustekinumab|ustekinumab|mesh-list
92060426|NCT05890118|Dermatologic Agents|dermatologic agents|mesh-ancestor
92060427|NCT05889949|Sorafenib|sorafenib|mesh-list
92060428|NCT05889949|Lenvatinib|lenvatinib|mesh-list
92060429|NCT05889949|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060430|NCT05889949|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92060431|NCT05889949|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92060432|NCT05889949|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060433|NCT05887804|Triamcinolone|triamcinolone|mesh-list
92060491|NCT05781711|Carbidopa|carbidopa|mesh-list
92060492|NCT05781711|Carbidopa, levodopa drug combination|carbidopa, levodopa drug combination|mesh-list
92060497|NCT05781711|Dopamine Agents|dopamine agents|mesh-ancestor
92060563|NCT05700045|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060565|NCT05700045|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92060635|NCT05607407|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060637|NCT05600686|Cortisone|cortisone|mesh-list
92060638|NCT05600686|Cyclophosphamide|cyclophosphamide|mesh-list
92060639|NCT05600686|Rituximab|rituximab|mesh-list
92060640|NCT05600686|Doxorubicin|doxorubicin|mesh-list
92060641|NCT05600686|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92060642|NCT05600686|Etoposide|etoposide|mesh-list
92060643|NCT05600686|Vincristine|vincristine|mesh-list
92060644|NCT05600686|Etoposide phosphate|etoposide phosphate|mesh-list
92060700|NCT05545384|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92060702|NCT05536284|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92060703|NCT05536284|Sympatholytics|sympatholytics|mesh-ancestor
92060704|NCT05536284|Autonomic Agents|autonomic agents|mesh-ancestor
92060705|NCT05536284|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92060706|NCT05536284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92060707|NCT05536284|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92060710|NCT05536284|Adrenergic Agents|adrenergic agents|mesh-ancestor
92060767|NCT05394493|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060768|NCT05372354|Dexamethasone|dexamethasone|mesh-list
92060839|NCT05280548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060840|NCT05274477|4-Aminopyridine|4-aminopyridine|mesh-list
92060841|NCT05274477|Potassium Channel Blockers|potassium channel blockers|mesh-ancestor
92060842|NCT05274477|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92060908|NCT05113940|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92060909|NCT05113940|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92060910|NCT05113940|Anesthetics, General|anesthetics, general|mesh-ancestor
92060911|NCT05113940|Anesthetics|anesthetics|mesh-ancestor
92060912|NCT05113940|GABA Modulators|gaba modulators|mesh-ancestor
92060984|NCT04978584|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92060985|NCT04978584|Alkylating Agents|alkylating agents|mesh-ancestor
92060986|NCT04978584|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92060987|NCT04978584|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92060988|NCT04978584|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92060989|NCT04978584|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92060990|NCT04978584|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92060991|NCT04978584|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92061051|NCT04892446|Bortezomib|bortezomib|mesh-list
92061052|NCT04892446|Daratumumab|daratumumab|mesh-list
92061053|NCT04892446|Pomalidomide|pomalidomide|mesh-list
92061125|NCT04702880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92061126|NCT04702880|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92061127|NCT04702880|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92061128|NCT04702880|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92061129|NCT04702880|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92061130|NCT04677816|Vitamin D|vitamin d|mesh-list
92061131|NCT04677816|Cholecalciferol|cholecalciferol|mesh-list
92061132|NCT04677816|Vitamins|vitamins|mesh-ancestor
92061133|NCT04677816|Micronutrients|micronutrients|mesh-ancestor
92061199|NCT04530630|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92061345|NCT04081545|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061418|NCT03826524|Mydriatics|mydriatics|mesh-ancestor
92061419|NCT03826524|Sympathomimetics|sympathomimetics|mesh-ancestor
92061420|NCT03826524|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92061421|NCT03798678|Dexamethasone|dexamethasone|mesh-list
92061489|NCT03554174|Hallucinogens|hallucinogens|mesh-ancestor
92061490|NCT03554174|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061562|NCT03203525|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92061563|NCT03203525|Doxorubicin|doxorubicin|mesh-list
92061564|NCT03203525|Liposomal doxorubicin|liposomal doxorubicin|mesh-list
92061565|NCT03203525|Fluorouracil|fluorouracil|mesh-list
92061566|NCT03203525|Oxaliplatin|oxaliplatin|mesh-list
92061567|NCT03203525|Temsirolimus|temsirolimus|mesh-list
92061568|NCT03203525|MTOR Inhibitors|mtor inhibitors|mesh-list
92061569|NCT03203525|Endothelial Growth Factors|endothelial growth factors|mesh-list
92061571|NCT03203525|Immunoglobulins|immunoglobulins|mesh-list
92061572|NCT03203525|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92061573|NCT03203525|Immunoglobulin G|immunoglobulin g|mesh-list
92061574|NCT03203525|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061575|NCT03203525|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92061576|NCT03203525|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92061577|NCT03203525|Growth Substances|growth substances|mesh-ancestor
92061578|NCT03203525|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061624|NCT03118986|Autonomic Agents|autonomic agents|mesh-ancestor
92061625|NCT03118986|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92061702|NCT02883049|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92061703|NCT02883049|Immunologic Factors|immunologic factors|mesh-ancestor
92061704|NCT02883049|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92061712|NCT02883049|Antiemetics|antiemetics|mesh-ancestor
92061773|NCT02773238|Technetium Tc 99m Aggregated Albumin|technetium tc 99m aggregated albumin|mesh-list
92061923|NCT02157883|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92061924|NCT02157883|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92061996|NCT01869114|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92061997|NCT01869114|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92061998|NCT01869114|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92061999|NCT01869114|Antifungal Agents|antifungal agents|mesh-ancestor
92062000|NCT01869114|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92062001|NCT01869114|Immunologic Factors|immunologic factors|mesh-ancestor
92062002|NCT01869114|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062066|NCT00215813|Antiviral Agents|antiviral agents|mesh-ancestor
92062142|NCT01744197|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062143|NCT01744197|Sensory System Agents|sensory system agents|mesh-ancestor
92062215|NCT00002826|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92062216|NCT00002826|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062290|NCT01739595|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062291|NCT01739595|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062292|NCT01739595|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92062293|NCT01739595|Fertility Agents|fertility agents|mesh-ancestor
92062294|NCT01739595|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92062295|NCT01739595|Selective Estrogen Receptor Modulators|selective estrogen receptor modulators|mesh-ancestor
92062297|NCT01738971|Progestins|progestins|mesh-list
92062354|NCT04609761|Rho(D) Immune Globulin|rho(d) immune globulin|mesh-list
92062355|NCT04609761|Immunologic Factors|immunologic factors|mesh-ancestor
92062428|NCT01875237|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062429|NCT01875237|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92062430|NCT01875237|Antimetabolites|antimetabolites|mesh-ancestor
92062498|NCT01831466|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92062499|NCT01831466|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062570|NCT01853696|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92062571|NCT01853696|Prednisolone acetate|prednisolone acetate|mesh-list
92062572|NCT01853696|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92062641|NCT01705587|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92062642|NCT01705587|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062643|NCT01705587|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92062644|NCT01705509|Ranolazine|ranolazine|mesh-list
92062645|NCT01705509|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92062646|NCT01705509|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062647|NCT01705509|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062648|NCT01853072|Prednisolone|prednisolone|mesh-list
92062649|NCT01853072|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92062650|NCT01853072|Methylprednisolone|methylprednisolone|mesh-list
92062651|NCT01853072|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92062652|NCT01853072|Prednisolone acetate|prednisolone acetate|mesh-list
92062653|NCT01853072|Nepafenac|nepafenac|mesh-list
92062654|NCT01853072|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92062655|NCT01853072|Prednisolone phosphate|prednisolone phosphate|mesh-list
92062656|NCT01853072|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92062657|NCT01853072|Glucocorticoids|glucocorticoids|mesh-ancestor
92062658|NCT01853072|Hormones|hormones|mesh-ancestor
92062662|NCT01853072|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062698|NCT04605393|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062699|NCT01827254|Sunitinib|sunitinib|mesh-list
92062700|NCT01827254|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92062766|NCT01852214|Purinergic Agents|purinergic agents|mesh-ancestor
92062767|NCT01852214|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92062768|NCT01852214|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062839|NCT00210964|Ceftazidime|ceftazidime|mesh-list
92062856|NCT03593434|Xenon|xenon|mesh-list
92062912|NCT03024502|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92062913|NCT03024502|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92062914|NCT03024502|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92062915|NCT03024502|Hormone Antagonists|hormone antagonists|mesh-ancestor
92062916|NCT03024502|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92062917|NCT03024502|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92062918|NCT03024502|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92062919|NCT03024502|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92062974|NCT03978442|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92062975|NCT03978442|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063048|NCT03598192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063057|NCT04003246|Durvalumab|durvalumab|mesh-list
92063123|NCT00213148|Calcium Chelating Agents|calcium chelating agents|mesh-ancestor
92063195|NCT01869699|Antipyretics|antipyretics|mesh-ancestor
92063196|NCT03981796|Paclitaxel|paclitaxel|mesh-list
92063197|NCT03981796|Carboplatin|carboplatin|mesh-list
92063198|NCT03981796|Niraparib|niraparib|mesh-list
92063267|NCT04196998|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063341|NCT03970720|Autonomic Agents|autonomic agents|mesh-ancestor
92063416|NCT04406506|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92063489|NCT02080468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063490|NCT02080468|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92063491|NCT02080468|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92063562|NCT04023760|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92063563|NCT04023760|Protease Inhibitors|protease inhibitors|mesh-ancestor
92063566|NCT04023760|Anticoagulants|anticoagulants|mesh-ancestor
92063635|NCT03022240|Antiemetics|antiemetics|mesh-ancestor
92063636|NCT03022240|Autonomic Agents|autonomic agents|mesh-ancestor
92063637|NCT03022240|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063706|NCT02080780|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92063707|NCT02080780|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92063708|NCT02080780|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92063709|NCT02080780|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063710|NCT02080780|Vasodilator Agents|vasodilator agents|mesh-ancestor
92063711|NCT01871558|Metformin|metformin|mesh-list
92063712|NCT01871558|Vildagliptin|vildagliptin|mesh-list
92063713|NCT01871558|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92063714|NCT01871558|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063715|NCT01871558|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92063716|NCT01871558|Protease Inhibitors|protease inhibitors|mesh-ancestor
92063772|NCT04146532|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92063773|NCT04146532|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063845|NCT04405960|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92063846|NCT04405960|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063849|NCT03945604|Apatinib|apatinib|mesh-list
92063850|NCT03945604|Fluzoparib|fluzoparib|mesh-list
92063851|NCT03945604|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063852|NCT03945604|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92063853|NCT03945604|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063854|NCT03945604|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063855|NCT03945604|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92063856|NCT03944434|Leuprolide|leuprolide|mesh-list
92063857|NCT03944434|Goserelin|goserelin|mesh-list
92063858|NCT03944434|Triptorelin Pamoate|triptorelin pamoate|mesh-list
92063859|NCT03944434|Aromatase Inhibitors|aromatase inhibitors|mesh-list
92063860|NCT03944434|Fertility Agents, Female|fertility agents, female|mesh-ancestor
92063861|NCT03944434|Fertility Agents|fertility agents|mesh-ancestor
92063862|NCT03944434|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92063863|NCT03944434|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92063864|NCT03944434|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92063865|NCT03944434|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92063866|NCT03944434|Luteolytic Agents|luteolytic agents|mesh-ancestor
92063867|NCT03944434|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92063868|NCT03944434|Contraceptive Agents|contraceptive agents|mesh-ancestor
92063869|NCT03944434|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92063870|NCT03944434|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92063871|NCT03944434|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92063872|NCT03944434|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92063873|NCT03944434|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92063874|NCT03944434|Hormone Antagonists|hormone antagonists|mesh-ancestor
92063876|NCT03944356|Trametinib|trametinib|mesh-list
92063889|NCT03920722|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92063894|NCT05580094|Anesthetics|anesthetics|mesh-list
92063965|NCT04144192|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064039|NCT01822496|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92064040|NCT01822496|Keratolytic Agents|keratolytic agents|mesh-ancestor
92064041|NCT01822496|Dermatologic Agents|dermatologic agents|mesh-ancestor
92064042|NCT01867047|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-list
92064043|NCT01867047|Protease Inhibitors|protease inhibitors|mesh-ancestor
92064044|NCT01867047|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92064045|NCT01867047|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064046|NCT03588988|Dexmedetomidine|dexmedetomidine|mesh-list
92064047|NCT03588988|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92064048|NCT03588988|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064104|NCT01866657|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92064180|NCT01846208|Immunomodulating Agents|immunomodulating agents|mesh-list
92064181|NCT01846208|Immunologic Factors|immunologic factors|mesh-ancestor
92064182|NCT01846208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064252|NCT05702398|Nicotinic Acids|nicotinic acids|mesh-list
92064253|NCT05702398|Micronutrients|micronutrients|mesh-ancestor
92064327|NCT03584698|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92064328|NCT03584698|Oxytocics|oxytocics|mesh-ancestor
92064329|NCT03584698|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064397|NCT03584074|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92064398|NCT03584074|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92064399|NCT03584074|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92064400|NCT03584074|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92064401|NCT03584074|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92064402|NCT03584074|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92064403|NCT03584074|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92064404|NCT03584074|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92064405|NCT03584074|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92064406|NCT03584074|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92064463|NCT01818752|Glucocorticoids|glucocorticoids|mesh-ancestor
92064464|NCT01818752|Hormones|hormones|mesh-ancestor
92064466|NCT01818752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92064534|NCT05696626|Fulvestrant|fulvestrant|mesh-list
92064536|NCT05696626|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92064607|NCT01670734|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064608|NCT01670734|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92064609|NCT01670734|Protease Inhibitors|protease inhibitors|mesh-ancestor
92064612|NCT01670890|Cisplatin|cisplatin|mesh-list
92064679|NCT01671904|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92064754|NCT01672450|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92064828|NCT03025594|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92064829|NCT03025594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92064837|NCT03025594|Mydriatics|mydriatics|mesh-ancestor
92064898|NCT02738866|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92064970|NCT04603508|Antimetabolites|antimetabolites|mesh-ancestor
92064972|NCT04603508|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92065042|NCT01675024|Dopamine Agonists|dopamine agonists|mesh-ancestor
92065043|NCT01675024|Dopamine Agents|dopamine agents|mesh-ancestor
92065044|NCT01675024|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065045|NCT01675024|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065116|NCT01675804|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92065122|NCT01675804|Dopamine Agents|dopamine agents|mesh-ancestor
92065187|NCT01696071|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92065260|NCT01590771|Incretins|incretins|mesh-ancestor
92065262|NCT01590771|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92065263|NCT01590771|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92065264|NCT01590771|Protease Inhibitors|protease inhibitors|mesh-ancestor
92065265|NCT01590771|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065266|NCT01590771|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065267|NCT01590771|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92065268|NCT01590771|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92065269|NCT01590771|Immunologic Factors|immunologic factors|mesh-ancestor
92065324|NCT03824938|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065325|NCT03824938|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065396|NCT03806530|Ropinirole|ropinirole|mesh-list
92065397|NCT03806530|Analgesics|analgesics|mesh-ancestor
92065471|NCT03802240|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92065543|NCT00779116|Histamine H1 Antagonists, Non-Sedating|histamine h1 antagonists, non-sedating|mesh-ancestor
92065544|NCT00779116|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92065552|NCT01691781|Lisinopril|lisinopril|mesh-list
92065614|NCT03587740|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065615|NCT03587740|Tubulin Modulators|tubulin modulators|mesh-ancestor
92065684|NCT03774394|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065757|NCT01690299|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92065758|NCT01690299|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92065759|NCT01690299|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92065830|NCT04403776|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92065906|NCT01672762|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92065908|NCT01672762|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065909|NCT03088384|Ketamine|ketamine|mesh-list
92065910|NCT03088384|Analgesics|analgesics|mesh-ancestor
92065911|NCT03088384|Sensory System Agents|sensory system agents|mesh-ancestor
92065912|NCT03088384|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92065913|NCT03088384|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92065914|NCT03088384|Anesthetics, Dissociative|anesthetics, dissociative|mesh-ancestor
92065972|NCT02402920|Pembrolizumab|pembrolizumab|mesh-list
92065973|NCT02402920|Etoposide|etoposide|mesh-list
92065974|NCT02402920|Etoposide phosphate|etoposide phosphate|mesh-list
92065975|NCT02402920|Podophyllotoxin|podophyllotoxin|mesh-list
92066045|NCT03502018|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066048|NCT01689207|Aztreonam|aztreonam|mesh-list
92066120|NCT01688739|Calcitonin Gene-Related Peptide Receptor Antagonists|calcitonin gene-related peptide receptor antagonists|mesh-ancestor
92066194|NCT01558089|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066196|NCT01558089|Dermatologic Agents|dermatologic agents|mesh-ancestor
92066205|NCT01558089|Analgesics|analgesics|mesh-ancestor
92066263|NCT03443128|Tubulin Modulators|tubulin modulators|mesh-ancestor
92066264|NCT03443128|Antimitotic Agents|antimitotic agents|mesh-ancestor
92066265|NCT03443128|Mitosis Modulators|mitosis modulators|mesh-ancestor
92066336|NCT01679080|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066338|NCT03083782|Cyclosporine|cyclosporine|mesh-list
92066412|NCT03087760|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066413|NCT03466294|Azacitidine|azacitidine|mesh-list
92066485|NCT03080350|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92066486|NCT03080350|Narcotics|narcotics|mesh-ancestor
92066558|NCT03366298|Mydriatics|mydriatics|mesh-ancestor
92066559|NCT03366298|Sympathomimetics|sympathomimetics|mesh-ancestor
92066560|NCT03366298|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92066561|NCT05688436|Interferons|interferons|mesh-list
92066632|NCT01931839|Ivacaftor|ivacaftor|mesh-list
92066633|NCT01931839|Chloride Channel Agonists|chloride channel agonists|mesh-ancestor
92069923|NCT01929031|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92066634|NCT01931839|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92066635|NCT01931839|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066636|NCT01842308|Melphalan|melphalan|mesh-list
92066637|NCT01842308|Mechlorethamine|mechlorethamine|mesh-list
92066638|NCT01842308|Nitrogen Mustard Compounds|nitrogen mustard compounds|mesh-list
92066639|NCT01842308|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92066695|NCT04621435|Copper|copper|mesh-list
92066696|NCT04621435|Trace Elements|trace elements|mesh-ancestor
92066697|NCT04621435|Micronutrients|micronutrients|mesh-ancestor
92066698|NCT04621435|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066768|NCT05223088|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92066769|NCT05223088|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92066770|NCT05223088|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92066771|NCT05223088|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92066839|NCT05139004|Mitogens|mitogens|mesh-list
92066840|NCT05139004|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid|mesh-list
92066854|NCT01811186|Oxycodone|oxycodone|mesh-list
92066911|NCT04858360|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92066912|NCT04858360|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92066985|NCT03227926|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92066986|NCT03227926|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067058|NCT03642028|Suvorexant|suvorexant|mesh-list
92067059|NCT03642028|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92067060|NCT03642028|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92067061|NCT03642028|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92067129|NCT03218800|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067130|NCT01802216|Minocycline|minocycline|mesh-list
92067131|NCT01802216|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067202|NCT01770392|Cytochrome P-450 CYP2C8 Inducers|cytochrome p-450 cyp2c8 inducers|mesh-ancestor
92067203|NCT01770392|Cytochrome P-450 CYP2C19 Inducers|cytochrome p-450 cyp2c19 inducers|mesh-ancestor
92067275|NCT01576575|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92067276|NCT01576575|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92067277|NCT01576575|Leprostatic Agents|leprostatic agents|mesh-ancestor
92067278|NCT01576575|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92067344|NCT03226756|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92067345|NCT03226756|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92067346|NCT03226756|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92067352|NCT01807598|Immunotoxins|immunotoxins|mesh-ancestor
92067415|NCT01968967|Antimetabolites|antimetabolites|mesh-ancestor
92067418|NCT01806662|Ustekinumab|ustekinumab|mesh-list
92067491|NCT00002644|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067563|NCT01574703|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92067564|NCT01574703|Autonomic Agents|autonomic agents|mesh-ancestor
92067565|NCT01574703|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067566|NCT01574703|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067567|NCT01574703|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92067568|NCT01574703|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92067569|NCT01574703|Cholinergic Agents|cholinergic agents|mesh-ancestor
92067578|NCT01574703|Dopamine Agents|dopamine agents|mesh-ancestor
92067634|NCT03614494|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92067635|NCT03614494|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92067636|NCT03614494|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92067637|NCT03028155|Oxaliplatin|oxaliplatin|mesh-list
92067705|NCT01572675|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067713|NCT05929937|Analgesics, Opioid|analgesics, opioid|mesh-list
92067779|NCT05929755|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92067780|NCT05929755|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92067851|NCT05928689|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92067852|NCT05928689|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92067926|NCT05919823|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92067927|NCT05907213|Ketamine|ketamine|mesh-list
92067928|NCT05907213|Analgesics|analgesics|mesh-ancestor
92067929|NCT05907213|Sensory System Agents|sensory system agents|mesh-ancestor
92067930|NCT05907213|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92067996|NCT05839366|Remifentanil|remifentanil|mesh-list
92067998|NCT05839366|Esketamine|esketamine|mesh-list
92067999|NCT05839366|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92068000|NCT05839366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068001|NCT05839366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068003|NCT05839366|Anesthetics, General|anesthetics, general|mesh-ancestor
92068004|NCT05839366|Anesthetics|anesthetics|mesh-ancestor
92068005|NCT05839366|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92068006|NCT05839366|Narcotics|narcotics|mesh-ancestor
92068007|NCT05839366|Analgesics|analgesics|mesh-ancestor
92068008|NCT05839366|Sensory System Agents|sensory system agents|mesh-ancestor
92068009|NCT05839366|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92068010|NCT05839366|Antidepressive Agents|antidepressive agents|mesh-ancestor
92068011|NCT05839366|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92068012|NCT05839158|Mupirocin|mupirocin|mesh-list
92068013|NCT05839158|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92068014|NCT05839158|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068015|NCT05839158|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92068018|NCT05827549|Blinatumomab|blinatumomab|mesh-list
92068069|NCT05742607|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92068070|NCT05742607|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068141|NCT05576662|Protease Inhibitors|protease inhibitors|mesh-ancestor
92068142|NCT05576662|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068143|NCT05576662|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068144|NCT05576662|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92068145|NCT05576662|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92068146|NCT05576662|Antiviral Agents|antiviral agents|mesh-ancestor
92068147|NCT05576662|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92068148|NCT05576662|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92068149|NCT05576662|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92068150|NCT05553366|Acetaminophen|acetaminophen|mesh-list
92068151|NCT05553366|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92068152|NCT05553366|Analgesics|analgesics|mesh-ancestor
92068153|NCT05553366|Sensory System Agents|sensory system agents|mesh-ancestor
92068174|NCT05497804|Ichthammol|ichthammol|mesh-list
92068217|NCT05441280|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92068218|NCT05441280|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92068219|NCT05441280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068289|NCT05319587|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068293|NCT05319587|Antiviral Agents|antiviral agents|mesh-ancestor
92068363|NCT05116891|Antimetabolites|antimetabolites|mesh-ancestor
92068364|NCT05116891|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068436|NCT04965155|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92068437|NCT04965155|Glucocorticoids|glucocorticoids|mesh-ancestor
92068508|NCT04724837|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92068509|NCT04724837|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068511|NCT04722822|Immunologic Factors|immunologic factors|mesh-ancestor
92068512|NCT04722822|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068513|NCT04690192|Gemcitabine|gemcitabine|mesh-list
92068514|NCT04690192|Melphalan|melphalan|mesh-list
92068515|NCT04690192|Busulfan|busulfan|mesh-list
92068516|NCT04690192|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92068517|NCT04690192|Antimetabolites|antimetabolites|mesh-ancestor
92068518|NCT04690192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068582|NCT04563507|Letrozole|letrozole|mesh-list
92068583|NCT04563507|Palbociclib|palbociclib|mesh-list
92068584|NCT04563507|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068585|NCT04563507|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92068586|NCT04563507|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92068587|NCT04563507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92068588|NCT04563507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068589|NCT04563507|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92068590|NCT04563507|Hormone Antagonists|hormone antagonists|mesh-ancestor
92068591|NCT04563507|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92068646|NCT04416451|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068648|NCT04416451|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068649|NCT04416451|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92068650|NCT04406649|Dihydroergotamine|dihydroergotamine|mesh-list
92068651|NCT04406649|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92068652|NCT04406649|Dopamine Agonists|dopamine agonists|mesh-ancestor
92068653|NCT04406649|Dopamine Agents|dopamine agents|mesh-ancestor
92068654|NCT04406649|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92068656|NCT04406649|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068713|NCT04206319|Protective Agents|protective agents|mesh-ancestor
92068714|NCT04206319|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068785|NCT03968419|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068786|NCT03968419|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92068787|NCT03968419|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92068788|NCT03924986|Tislelizumab|tislelizumab|mesh-list
92068789|NCT03924986|Gemcitabine|gemcitabine|mesh-list
92068790|NCT03924986|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068791|NCT03924986|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92068854|NCT03816332|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92068856|NCT03816332|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92068928|NCT03682068|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069002|NCT03631199|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92069076|NCT03439293|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069077|NCT03439046|Letrozole|letrozole|mesh-list
92069078|NCT03439046|Fulvestrant|fulvestrant|mesh-list
92069079|NCT03439046|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069080|NCT03439046|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92069081|NCT03439046|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92069082|NCT03439046|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069083|NCT03439046|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069084|NCT03439046|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92069085|NCT03439046|Hormone Antagonists|hormone antagonists|mesh-ancestor
92069086|NCT03439046|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92069087|NCT03439046|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069090|NCT03423979|Paclitaxel|paclitaxel|mesh-list
92069139|NCT03196466|Oxcarbazepine|oxcarbazepine|mesh-list
92069216|NCT03122522|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069217|NCT03122522|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069218|NCT03122522|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92069219|NCT03122522|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069220|NCT03118232|Chlorhexidine|chlorhexidine|mesh-list
92069221|NCT03118232|Chlorhexidine gluconate|chlorhexidine gluconate|mesh-list
92069222|NCT03118232|Povidone-Iodine|povidone-iodine|mesh-list
92069223|NCT03118232|Povidone|povidone|mesh-list
92069224|NCT03118232|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92069225|NCT03118232|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069226|NCT03118232|Disinfectants|disinfectants|mesh-ancestor
92069227|NCT03118232|Dermatologic Agents|dermatologic agents|mesh-ancestor
92069228|NCT03118232|Plasma Substitutes|plasma substitutes|mesh-ancestor
92069229|NCT03118232|Blood Substitutes|blood substitutes|mesh-ancestor
92069288|NCT02775695|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92069363|NCT02344680|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92069364|NCT02338609|Everolimus|everolimus|mesh-list
92069437|NCT01091831|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069438|NCT01091831|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92069439|NCT01091831|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92069440|NCT01091831|Antiemetics|antiemetics|mesh-ancestor
92069508|NCT01549041|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069509|NCT01549041|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92069510|NCT04106115|Durvalumab|durvalumab|mesh-list
92069511|NCT04106115|Monatide (IMS 3015)|monatide (ims 3015)|mesh-list
92069512|NCT04106115|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92069513|NCT04106115|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069514|NCT04106115|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92069515|NCT04106115|Immunologic Factors|immunologic factors|mesh-ancestor
92069516|NCT04106115|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069517|NCT01907815|Trametinib|trametinib|mesh-list
92069573|NCT01518153|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069574|NCT01518153|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069575|NCT01518153|Antimetabolites|antimetabolites|mesh-ancestor
92069577|NCT01518153|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069641|NCT01516749|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92069642|NCT01515423|Soybean oil, phospholipid emulsion|soybean oil, phospholipid emulsion|mesh-list
92069643|NCT01515423|Fat Emulsions, Intravenous|fat emulsions, intravenous|mesh-ancestor
92069644|NCT01515423|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92069645|NCT01515423|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92069646|NCT00637000|Buprenorphine|buprenorphine|mesh-list
92069647|NCT00637000|Buprenorphine, Naloxone Drug Combination|buprenorphine, naloxone drug combination|mesh-list
92069650|NCT00637000|Narcotics|narcotics|mesh-ancestor
92069708|NCT05245786|Immunologic Factors|immunologic factors|mesh-ancestor
92069709|NCT05245786|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069710|NCT05245786|Trace Elements|trace elements|mesh-ancestor
92069711|NCT05245786|Micronutrients|micronutrients|mesh-ancestor
92069713|NCT00634504|Methotrexate|methotrexate|mesh-list
92069714|NCT00634504|Levoleucovorin|levoleucovorin|mesh-list
92069715|NCT00634504|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92069716|NCT00634504|Abortifacient Agents|abortifacient agents|mesh-ancestor
92069717|NCT00634504|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92069718|NCT00634504|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069719|NCT00634504|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92069720|NCT00634504|Antimetabolites|antimetabolites|mesh-ancestor
92069770|NCT03156790|Asparaginase|asparaginase|mesh-list
92069845|NCT01924468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92069917|NCT01929031|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92069919|NCT01929031|Sensory System Agents|sensory system agents|mesh-ancestor
92069920|NCT01929031|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92069921|NCT01929031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92069922|NCT01929031|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92069924|NCT01929031|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92069925|NCT01929031|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92069926|NCT01929031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069927|NCT01929031|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92069928|NCT01929031|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92069929|NCT01929031|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92069930|NCT01929031|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92069931|NCT01929031|Purinergic Agents|purinergic agents|mesh-ancestor
92069932|NCT01929031|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069974|NCT01928719|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92069975|NCT01928719|Cholinergic Agents|cholinergic agents|mesh-ancestor
92069976|NCT01928719|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92069977|NCT01928719|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069978|NCT00986674|Paclitaxel|paclitaxel|mesh-list
92069979|NCT00986674|Carboplatin|carboplatin|mesh-list
92069980|NCT00986674|Cetuximab|cetuximab|mesh-list
92069981|NCT00986674|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92069982|NCT00986674|Antibodies|antibodies|mesh-list
92069983|NCT00986674|Immunoglobulins|immunoglobulins|mesh-list
92069984|NCT00986674|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92069985|NCT00986674|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92069986|NCT00986674|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92069987|NCT00986674|Tubulin Modulators|tubulin modulators|mesh-ancestor
92069988|NCT00986674|Antimitotic Agents|antimitotic agents|mesh-ancestor
92069989|NCT00986674|Mitosis Modulators|mitosis modulators|mesh-ancestor
92069990|NCT00986674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92069993|NCT00986440|Efatutazone|efatutazone|mesh-list
92070033|NCT01925638|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92070034|NCT01925638|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92070036|NCT01925638|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070103|NCT01921582|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070104|NCT01921582|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070105|NCT01921582|Dopamine Agents|dopamine agents|mesh-ancestor
92070176|NCT00984256|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92070177|NCT00984256|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070250|NCT00982930|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92070398|NCT04274608|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070399|NCT04274608|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92070400|NCT04274608|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070401|NCT05607940|Chrysarobin|chrysarobin|mesh-list
92070402|NCT05607940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92070403|NCT05607940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92070404|NCT05607940|Analgesics|analgesics|mesh-ancestor
92070405|NCT05607940|Sensory System Agents|sensory system agents|mesh-ancestor
92070406|NCT05607940|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92070407|NCT05607940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070461|NCT05608642|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92070462|NCT05608642|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92070464|NCT05608642|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070534|NCT03828058|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070535|NCT03828058|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070537|NCT01513551|Immunologic Factors|immunologic factors|mesh-ancestor
92070606|NCT03825250|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070680|NCT03824314|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92070682|NCT03824314|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92070683|NCT03824314|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92070685|NCT03824314|GABA Agents|gaba agents|mesh-ancestor
92070686|NCT03824314|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92070687|NCT03824314|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070688|NCT03824002|Insulin|insulin|mesh-list
92070689|NCT03824002|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92070690|NCT03824002|Metformin|metformin|mesh-list
92070691|NCT03824002|Insulin Glargine|insulin glargine|mesh-list
92070692|NCT03824002|Insulin Aspart|insulin aspart|mesh-list
92070693|NCT03824002|Dulaglutide|dulaglutide|mesh-list
92070694|NCT03824002|Repaglinide|repaglinide|mesh-list
92070695|NCT03824002|Insulin, Long-Acting|insulin, long-acting|mesh-list
92070696|NCT03824002|Insulin degludec, insulin aspart drug combination|insulin degludec, insulin aspart drug combination|mesh-list
92070697|NCT03824002|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92070699|NCT03823846|Flurbiprofen|flurbiprofen|mesh-list
92070738|NCT02810704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92070739|NCT02810704|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92070740|NCT02810704|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92070741|NCT02810704|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92070742|NCT02810704|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92070743|NCT02810704|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92070744|NCT02810704|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92070745|NCT02810704|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92070746|NCT02810704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92070747|NCT02810704|Antipyretics|antipyretics|mesh-ancestor
92070748|NCT02810704|Anticoagulants|anticoagulants|mesh-ancestor
92070749|NCT02810704|Factor Xa Inhibitors|factor xa inhibitors|mesh-ancestor
92070750|NCT02810704|Antithrombins|antithrombins|mesh-ancestor
92070751|NCT02810704|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92070753|NCT02735902|Aspirin|aspirin|mesh-list
92070799|NCT04273282|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92070800|NCT04273282|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92070873|NCT01456468|Dermatologic Agents|dermatologic agents|mesh-ancestor
92070879|NCT01456546|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92070947|NCT02873806|Travoprost|travoprost|mesh-list
92070949|NCT02873806|Antiemetics|antiemetics|mesh-ancestor
92071021|NCT01892332|Narcotics|narcotics|mesh-ancestor
92071022|NCT01892332|Analgesics|analgesics|mesh-ancestor
92071095|NCT01893424|Nabiximols|nabiximols|mesh-list
92071096|NCT01893424|Cannabidiol|cannabidiol|mesh-list
92071097|NCT01893424|Piperine|piperine|mesh-list
92071098|NCT01893424|Anticonvulsants|anticonvulsants|mesh-ancestor
92071099|NCT01893424|Hallucinogens|hallucinogens|mesh-ancestor
92071166|NCT02735122|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92071167|NCT02735122|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92071239|NCT02684032|Hormone Antagonists|hormone antagonists|mesh-ancestor
92071313|NCT05604118|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92071314|NCT05604118|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92071315|NCT05604118|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071316|NCT05604118|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92071317|NCT05604118|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92071318|NCT05604118|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92071319|NCT05604118|Antipyretics|antipyretics|mesh-ancestor
92071320|NCT05603884|Cytarabine|cytarabine|mesh-list
92071321|NCT05603884|Azacitidine|azacitidine|mesh-list
92071322|NCT05603884|Venetoclax|venetoclax|mesh-list
92071323|NCT05603884|Mitoxantrone|mitoxantrone|mesh-list
92071324|NCT05603884|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92071372|NCT04127500|Dexmedetomidine|dexmedetomidine|mesh-list
92071373|NCT04127500|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92071447|NCT03007732|Glucocorticoids|glucocorticoids|mesh-ancestor
92071448|NCT03007732|Hormones|hormones|mesh-ancestor
92071461|NCT03007732|Vitamins|vitamins|mesh-ancestor
92071523|NCT04411069|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92071524|NCT04411069|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071669|NCT01895335|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92071746|NCT02972398|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071747|NCT02972398|Protective Agents|protective agents|mesh-ancestor
92071748|NCT02972398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92071749|NCT02972398|Antidotes|antidotes|mesh-ancestor
92071817|NCT03822520|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92071860|NCT03820180|Xhance|xhance|mesh-list
92071891|NCT01450384|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92071965|NCT01451710|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92072042|NCT01453504|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072043|NCT01453504|Immunologic Factors|immunologic factors|mesh-ancestor
92072117|NCT04840264|Mitosis Modulators|mitosis modulators|mesh-ancestor
92072119|NCT04840264|Antimetabolites|antimetabolites|mesh-ancestor
92072190|NCT04390594|Immunologic Factors|immunologic factors|mesh-ancestor
92072261|NCT02632708|Antimetabolites|antimetabolites|mesh-ancestor
92072262|NCT02632708|Antiviral Agents|antiviral agents|mesh-ancestor
92072263|NCT02632708|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92072264|NCT02632708|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072333|NCT02543944|Antimanic Agents|antimanic agents|mesh-ancestor
92072334|NCT02543944|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92072408|NCT02523976|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92072409|NCT02523976|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92072410|NCT02523976|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92072480|NCT04757506|Sensory System Agents|sensory system agents|mesh-ancestor
92072552|NCT04746040|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92072553|NCT04746040|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92072554|NCT04746040|Autonomic Agents|autonomic agents|mesh-ancestor
92072555|NCT04746040|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92072556|NCT04746040|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072557|NCT04746040|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92072558|NCT04746040|Respiratory System Agents|respiratory system agents|mesh-ancestor
92072559|NCT04746040|Dermatologic Agents|dermatologic agents|mesh-ancestor
92072560|NCT04746040|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92073748|NCT03364348|Immunoglobulin G|immunoglobulin g|mesh-list
92072561|NCT04746040|Adrenergic beta-2 Receptor Agonists|adrenergic beta-2 receptor agonists|mesh-ancestor
92072562|NCT04746040|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92072616|NCT02363374|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072617|NCT02363374|Immunologic Factors|immunologic factors|mesh-ancestor
92072619|NCT02363374|Antidotes|antidotes|mesh-ancestor
92072688|NCT01992952|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92072689|NCT01992952|Hormone Antagonists|hormone antagonists|mesh-ancestor
92072690|NCT01992952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92072691|NCT01992952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072757|NCT01928914|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92072758|NCT01928914|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92072830|NCT02223208|Vincristine|vincristine|mesh-list
92072831|NCT02223208|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92072832|NCT02223208|Immunologic Factors|immunologic factors|mesh-ancestor
92072833|NCT02223208|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072900|NCT01514344|Immunologic Factors|immunologic factors|mesh-ancestor
92072901|NCT01514344|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92072902|NCT01514344|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92072973|NCT01484691|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92072974|NCT01484691|Autonomic Agents|autonomic agents|mesh-ancestor
92072975|NCT01484691|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073045|NCT01810588|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92073046|NCT01810588|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92073047|NCT01810588|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073048|NCT01810588|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92073049|NCT01810588|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92073050|NCT01810588|Antitubercular Agents|antitubercular agents|mesh-ancestor
92073051|NCT01810588|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92073111|NCT01393522|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073112|NCT01393522|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073113|NCT01393522|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92073114|NCT01393522|Analgesics|analgesics|mesh-ancestor
92073115|NCT01393522|Sensory System Agents|sensory system agents|mesh-ancestor
92073116|NCT01393522|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073117|NCT01393522|Antidepressive Agents|antidepressive agents|mesh-ancestor
92073118|NCT01393522|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92073119|NCT02086786|Risperidone|risperidone|mesh-list
92073120|NCT02086786|Serotonin Antagonists|serotonin antagonists|mesh-ancestor
92073121|NCT02086786|Serotonin Agents|serotonin agents|mesh-ancestor
92073122|NCT02086786|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073175|NCT01895998|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073184|NCT01895296|Pasireotide|pasireotide|mesh-list
92073249|NCT01615510|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92073321|NCT00472966|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073395|NCT00425230|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92073396|NCT00425230|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92073397|NCT00425230|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92073399|NCT00425230|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073464|NCT04777552|GABA Modulators|gaba modulators|mesh-ancestor
92073465|NCT04777552|GABA Agents|gaba agents|mesh-ancestor
92073466|NCT04777552|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073467|NCT04777552|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073468|NCT01506609|Paclitaxel|paclitaxel|mesh-list
92073469|NCT01506609|Carboplatin|carboplatin|mesh-list
92073470|NCT01506609|Temozolomide|temozolomide|mesh-list
92073471|NCT01506609|Veliparib|veliparib|mesh-list
92073472|NCT01506609|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92073473|NCT01506609|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073474|NCT01506609|Tubulin Modulators|tubulin modulators|mesh-ancestor
92073475|NCT01506609|Antimitotic Agents|antimitotic agents|mesh-ancestor
92073476|NCT01506609|Mitosis Modulators|mitosis modulators|mesh-ancestor
92073477|NCT01506609|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073478|NCT01506609|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92073479|NCT01506609|Alkylating Agents|alkylating agents|mesh-ancestor
92073480|NCT01506609|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92073481|NCT01506609|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92073520|NCT00199108|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92073521|NCT00199108|Antiemetics|antiemetics|mesh-ancestor
92073596|NCT01479621|Tocolytic Agents|tocolytic agents|mesh-ancestor
92073597|NCT01479621|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92073668|NCT04784104|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073669|NCT04784104|Mydriatics|mydriatics|mesh-ancestor
92073743|NCT03364348|Ado-Trastuzumab Emtansine|ado-trastuzumab emtansine|mesh-list
92073746|NCT03364348|Immunoglobulins|immunoglobulins|mesh-list
92073747|NCT03364348|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92073813|NCT04782310|Dopamine Agents|dopamine agents|mesh-ancestor
92073814|NCT04781998|Liraglutide|liraglutide|mesh-list
92073815|NCT04781998|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92073816|NCT04781998|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073817|NCT04781998|Incretins|incretins|mesh-ancestor
92073818|NCT04781998|Hormones|hormones|mesh-ancestor
92073819|NCT04781998|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92073820|NCT03300544|Leucovorin|leucovorin|mesh-list
92073821|NCT03300544|Fluorouracil|fluorouracil|mesh-list
92073822|NCT03300544|Capecitabine|capecitabine|mesh-list
92073823|NCT03300544|Oxaliplatin|oxaliplatin|mesh-list
92073824|NCT03300544|Talimogene laherparepvec|talimogene laherparepvec|mesh-list
92073825|NCT03300544|Antimetabolites|antimetabolites|mesh-ancestor
92073826|NCT03300544|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073827|NCT03300544|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92073828|NCT03300544|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92073829|NCT03300544|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92073830|NCT03300544|Immunologic Factors|immunologic factors|mesh-ancestor
92073831|NCT03300544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073832|NCT03300544|Antidotes|antidotes|mesh-ancestor
92073833|NCT03300544|Protective Agents|protective agents|mesh-ancestor
92073834|NCT03300544|Vitamin B Complex|vitamin b complex|mesh-ancestor
92073835|NCT03300544|Vitamins|vitamins|mesh-ancestor
92073836|NCT03300544|Micronutrients|micronutrients|mesh-ancestor
92073837|NCT03300544|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92073838|NCT03249844|Methylprednisolone|methylprednisolone|mesh-list
92073839|NCT03249844|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92073840|NCT03249844|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92073841|NCT03249844|Prednisolone|prednisolone|mesh-list
92073842|NCT03249844|Prednisolone acetate|prednisolone acetate|mesh-list
92073844|NCT03249844|Prednisolone phosphate|prednisolone phosphate|mesh-list
92073860|NCT00637624|Antiviral Agents|antiviral agents|mesh-ancestor
92073938|NCT04780984|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92073939|NCT04780984|Respiratory System Agents|respiratory system agents|mesh-ancestor
92073940|NCT04780984|Parasympatholytics|parasympatholytics|mesh-ancestor
92073941|NCT04780984|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92073942|NCT04780984|Cholinergic Agents|cholinergic agents|mesh-ancestor
92073943|NCT04780984|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92073944|NCT04780984|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92073945|NCT04780984|Anticonvulsants|anticonvulsants|mesh-ancestor
92073947|NCT02090374|Poly ICLC|poly iclc|mesh-list
92073948|NCT02090374|Vitamins|vitamins|mesh-ancestor
92073949|NCT02090374|Micronutrients|micronutrients|mesh-ancestor
92073950|NCT02090374|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92073951|NCT02090374|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92073999|NCT04779502|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074072|NCT03026907|Immunologic Factors|immunologic factors|mesh-ancestor
92074100|NCT00063232|Metformin|metformin|mesh-list
92074145|NCT01475721|Xhance|xhance|mesh-list
92074217|NCT00071890|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074218|NCT00071890|Analgesics|analgesics|mesh-ancestor
92074222|NCT00071890|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92074289|NCT00167206|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074290|NCT00167206|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92074358|NCT00078754|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92074359|NCT00078754|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074360|NCT00081328|Metformin|metformin|mesh-list
92074361|NCT00081328|Rosiglitazone|rosiglitazone|mesh-list
92074428|NCT01499277|Aztreonam|aztreonam|mesh-list
92074429|NCT01499277|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92074431|NCT00176800|Tetrathiomolybdate|tetrathiomolybdate|mesh-list
92074500|NCT01527357|Coagulants|coagulants|mesh-ancestor
92074501|NCT00181714|Methylphenidate|methylphenidate|mesh-list
92074502|NCT00181714|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92074508|NCT00181714|Dopamine Agents|dopamine agents|mesh-ancestor
92074574|NCT00185692|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92074575|NCT00185692|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92074576|NCT00185692|Protective Agents|protective agents|mesh-ancestor
92074577|NCT00185692|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92074578|NCT00185692|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92074579|NCT01526733|Insulin|insulin|mesh-list
92074580|NCT01526733|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92074581|NCT01526733|Insulin Aspart|insulin aspart|mesh-list
92074582|NCT01526733|Insulin Lispro|insulin lispro|mesh-list
92074641|NCT02197156|Hydrocodone|hydrocodone|mesh-list
92074642|NCT02197156|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92074643|NCT02197156|Analgesics|analgesics|mesh-ancestor
92074644|NCT02197156|Sensory System Agents|sensory system agents|mesh-ancestor
92074645|NCT02197156|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92074646|NCT02197156|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074647|NCT02197156|Antipyretics|antipyretics|mesh-ancestor
92074648|NCT02197156|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92074649|NCT02197156|Narcotics|narcotics|mesh-ancestor
92074650|NCT02197156|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92074651|NCT02197156|Antitussive Agents|antitussive agents|mesh-ancestor
92074652|NCT02197156|Respiratory System Agents|respiratory system agents|mesh-ancestor
92074653|NCT00187720|Metformin|metformin|mesh-list
92074654|NCT00187720|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92074655|NCT00187720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074704|NCT00189436|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92074705|NCT00189436|Autonomic Agents|autonomic agents|mesh-ancestor
92074711|NCT00189436|Hormones|hormones|mesh-ancestor
92074777|NCT01898416|Photosensitizing Agents|photosensitizing agents|mesh-ancestor
92074778|NCT01898416|Dermatologic Agents|dermatologic agents|mesh-ancestor
92074779|NCT01524783|Everolimus|everolimus|mesh-list
92074780|NCT01524783|MTOR Inhibitors|mtor inhibitors|mesh-ancestor
92074781|NCT01524783|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92074782|NCT01524783|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074783|NCT01524783|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074784|NCT01524783|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92074785|NCT01524783|Immunologic Factors|immunologic factors|mesh-ancestor
92074842|NCT00012298|Rituximab|rituximab|mesh-list
92074843|NCT00012298|Oprelvekin|oprelvekin|mesh-list
92074844|NCT00012298|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92074845|NCT00012298|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92074846|NCT00012298|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074847|NCT00012298|Immunologic Factors|immunologic factors|mesh-ancestor
92074848|NCT00012298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074849|NCT00012298|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074851|NCT00193258|Erlotinib Hydrochloride|erlotinib hydrochloride|mesh-list
92074909|NCT04348474|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92074910|NCT04348474|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92074911|NCT00107536|Lapatinib|lapatinib|mesh-list
92074912|NCT00107536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92074914|NCT00107536|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92074976|NCT00201838|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92074977|NCT00201838|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92074988|NCT00040846|Antibodies|antibodies|mesh-list
92075050|NCT00044044|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92075051|NCT00044044|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92075124|NCT00049036|Etoposide|etoposide|mesh-list
92075125|NCT00049036|Vincristine|vincristine|mesh-list
92075196|NCT00217438|Immunologic Factors|immunologic factors|mesh-ancestor
92075197|NCT00217438|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075198|NCT00217438|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92075199|NCT00217438|Protective Agents|protective agents|mesh-ancestor
92075200|NCT04480450|Rituximab|rituximab|mesh-list
92075201|NCT04480450|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075202|NCT04480450|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075203|NCT04480450|Immunologic Factors|immunologic factors|mesh-ancestor
92075204|NCT04480450|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075205|NCT04480450|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075206|NCT00217594|Alemtuzumab|alemtuzumab|mesh-list
92075207|NCT00217594|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075208|NCT00217594|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075209|NCT00052078|Sertraline|sertraline|mesh-list
92075210|NCT00052078|Antidepressive Agents|antidepressive agents|mesh-ancestor
92075211|NCT00052078|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92075212|NCT00052078|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92075213|NCT00052078|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92075214|NCT00052078|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92075215|NCT00052078|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075216|NCT00052078|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075217|NCT00052078|Serotonin Agents|serotonin agents|mesh-ancestor
92075218|NCT00052078|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075219|NCT05820347|Rocuronium|rocuronium|mesh-list
92075220|NCT05820347|Succinylcholine|succinylcholine|mesh-list
92075221|NCT05820347|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92075222|NCT05820347|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92075223|NCT05820347|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92075224|NCT05820347|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075225|NCT05820347|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075238|NCT05819983|Ivermectin|ivermectin|mesh-list
92075310|NCT05818995|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92075383|NCT05815901|Febuxostat|febuxostat|mesh-list
92075384|NCT05815901|Gout Suppressants|gout suppressants|mesh-ancestor
92075385|NCT05815901|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92075386|NCT05815784|Atropine|atropine|mesh-list
92075387|NCT05815784|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92075388|NCT05815784|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92075389|NCT05815784|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92075390|NCT05815784|Autonomic Agents|autonomic agents|mesh-ancestor
92075391|NCT05815784|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075392|NCT05815784|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075393|NCT05815784|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92075394|NCT05815784|Respiratory System Agents|respiratory system agents|mesh-ancestor
92075395|NCT05815784|Mydriatics|mydriatics|mesh-ancestor
92075396|NCT05815784|Parasympatholytics|parasympatholytics|mesh-ancestor
92075397|NCT05815784|Muscarinic Antagonists|muscarinic antagonists|mesh-ancestor
92075398|NCT05815784|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92075399|NCT05815784|Cholinergic Agents|cholinergic agents|mesh-ancestor
92075400|NCT05815784|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075401|NCT05815784|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075402|NCT05815719|Hormones|hormones|mesh-list
92075403|NCT05815719|Follicle Stimulating Hormone|follicle stimulating hormone|mesh-list
92075404|NCT05815719|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075406|NCT05815654|Analgesics|analgesics|mesh-list
92075433|NCT05815186|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075434|NCT05815186|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075507|NCT05814718|Sensory System Agents|sensory system agents|mesh-ancestor
92075508|NCT05814718|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075509|NCT05814666|Pembrolizumab|pembrolizumab|mesh-list
92075577|NCT05716984|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92075578|NCT05716984|Natriuretic Agents|natriuretic agents|mesh-ancestor
92075579|NCT05716984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075584|NCT05700344|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075585|NCT05700344|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075649|NCT05615844|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92075651|NCT05608005|MF59 oil emulsion|mf59 oil emulsion|mesh-list
92075723|NCT05493501|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92075724|NCT05493501|Carboplatin|carboplatin|mesh-list
92075725|NCT05493501|Gemcitabine|gemcitabine|mesh-list
92075798|NCT05389722|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92075799|NCT05389722|Antimetabolites|antimetabolites|mesh-ancestor
92075800|NCT05389722|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075801|NCT05389722|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92075802|NCT05389722|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92075803|NCT05389722|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075804|NCT05389722|Antifungal Agents|antifungal agents|mesh-ancestor
92075805|NCT05389722|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92075806|NCT05389722|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92075807|NCT05389722|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92075808|NCT05389722|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92075809|NCT05389722|Hormone Antagonists|hormone antagonists|mesh-ancestor
92075810|NCT05389722|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92075811|NCT05389722|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075812|NCT05389722|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92075813|NCT05389722|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92075814|NCT05389722|Antitubercular Agents|antitubercular agents|mesh-ancestor
92075815|NCT05389722|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92075816|NCT05389722|Leprostatic Agents|leprostatic agents|mesh-ancestor
92075827|NCT05383170|Pembrolizumab|pembrolizumab|mesh-list
92075848|NCT05353348|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075849|NCT05353348|Antioxidants|antioxidants|mesh-ancestor
92075920|NCT05144542|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92075922|NCT05144542|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92075923|NCT05144542|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075924|NCT05144542|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92075925|NCT05144542|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92075926|NCT05144542|Cholinergic Agents|cholinergic agents|mesh-ancestor
92075929|NCT05141708|Talazoparib|talazoparib|mesh-list
92075986|NCT05071937|Poly(ADP-ribose) Polymerase Inhibitors|poly(adp-ribose) polymerase inhibitors|mesh-ancestor
92075987|NCT05071937|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92075988|NCT05071937|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075989|NCT05071937|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075990|NCT05063097|Carbon Monoxide|carbon monoxide|mesh-list
92075991|NCT05063097|Antimetabolites|antimetabolites|mesh-ancestor
92075992|NCT05063097|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92075993|NCT05063097|Gasotransmitters|gasotransmitters|mesh-ancestor
92075994|NCT05063097|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92075995|NCT05063097|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92075996|NCT05059470|Pembrolizumab|pembrolizumab|mesh-list
92075997|NCT05059470|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92075998|NCT05059470|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92075999|NCT05059470|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076000|NCT05059470|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076001|NCT05036005|Pertuzumab|pertuzumab|mesh-list
92076002|NCT05036005|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076003|NCT05036005|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076040|NCT04996823|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076041|NCT04996823|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92076113|NCT04941664|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92076114|NCT04933266|Levobupivacaine|levobupivacaine|mesh-list
92076186|NCT04792385|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92076187|NCT04792385|Hormone Antagonists|hormone antagonists|mesh-ancestor
92076188|NCT04792385|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92076189|NCT04792385|Diuretics, Potassium Sparing|diuretics, potassium sparing|mesh-ancestor
92076190|NCT04792385|Diuretics|diuretics|mesh-ancestor
92076191|NCT04792385|Natriuretic Agents|natriuretic agents|mesh-ancestor
92076192|NCT04785651|Tranexamic Acid|tranexamic acid|mesh-list
92076193|NCT04785651|Antifibrinolytic Agents|antifibrinolytic agents|mesh-ancestor
92076252|NCT04669197|Antimalarials|antimalarials|mesh-ancestor
92076253|NCT04669197|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92076254|NCT04669197|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92076255|NCT04669197|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076256|NCT04669197|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076257|NCT04669197|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92076267|NCT04655222|Interferon-beta|interferon-beta|mesh-list
92076268|NCT04655222|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076269|NCT04655222|Antiviral Agents|antiviral agents|mesh-ancestor
92076270|NCT04655222|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076271|NCT04655222|Immunologic Factors|immunologic factors|mesh-ancestor
92076328|NCT04592744|Sympathomimetics|sympathomimetics|mesh-ancestor
92076329|NCT04592744|Vasoconstrictor Agents|vasoconstrictor agents|mesh-ancestor
92076402|NCT04454905|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076403|NCT04454905|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076476|NCT04267978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076477|NCT04267978|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076478|NCT04267978|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92076545|NCT04094961|Ixazomib|ixazomib|mesh-list
92076546|NCT04094961|BB 1101|bb 1101|mesh-list
92076547|NCT04094961|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92076616|NCT03966651|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076617|NCT03946514|Losartan|losartan|mesh-list
92076618|NCT03946514|Amlodipine|amlodipine|mesh-list
92076686|NCT03892785|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92076688|NCT03869034|Fluorouracil|fluorouracil|mesh-list
92076700|NCT03869034|Vitamins|vitamins|mesh-ancestor
92076764|NCT03760575|Pembrolizumab|pembrolizumab|mesh-list
92076832|NCT03629327|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92076833|NCT03629327|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92076835|NCT03628209|Nivolumab|nivolumab|mesh-list
92076904|NCT03458221|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92076980|NCT03204188|Fludarabine|fludarabine|mesh-list
92076981|NCT03204188|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92076982|NCT03204188|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92076983|NCT03204188|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92076984|NCT03204188|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92076986|NCT03194867|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077048|NCT03060434|Anticonvulsants|anticonvulsants|mesh-ancestor
92077049|NCT03060434|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92077050|NCT03060434|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92077120|NCT02779855|Mitosis Modulators|mitosis modulators|mesh-ancestor
92077121|NCT02779855|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077122|NCT02779855|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92077192|NCT02444429|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92077193|NCT02444429|Prednisolone phosphate|prednisolone phosphate|mesh-list
92077264|NCT01726582|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92077342|NCT01531582|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92077343|NCT01531582|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92077345|NCT01531582|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077417|NCT00082706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077492|NCT00218062|Dopamine Agents|dopamine agents|mesh-ancestor
92077494|NCT00218062|Adrenergic Agents|adrenergic agents|mesh-ancestor
92077565|NCT00123604|Adrenergic beta-1 Receptor Antagonists|adrenergic beta-1 receptor antagonists|mesh-ancestor
92077566|NCT00123604|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92077567|NCT00123604|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92077568|NCT00123604|Adrenergic Agents|adrenergic agents|mesh-ancestor
92077569|NCT00123604|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077634|NCT00133978|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077635|NCT00133978|Protective Agents|protective agents|mesh-ancestor
92077706|NCT01469013|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077707|NCT01469013|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077708|NCT01469013|Dermatologic Agents|dermatologic agents|mesh-ancestor
92077709|NCT01469013|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077710|NCT01469013|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92077711|NCT01469013|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92077712|NCT01469013|Immunologic Factors|immunologic factors|mesh-ancestor
92077713|NCT01469013|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92077714|NCT01469013|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92077716|NCT01493427|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92077717|NCT01523457|Folfirinox|folfirinox|mesh-list
92077718|NCT01523457|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92077719|NCT01523301|Rotigotine|rotigotine|mesh-list
92077720|NCT01523301|Dopamine Agonists|dopamine agonists|mesh-ancestor
92077721|NCT01523301|Dopamine Agents|dopamine agents|mesh-ancestor
92077722|NCT01523301|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92077723|NCT01523301|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077724|NCT01523301|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92077725|NCT01766336|Inositol|inositol|mesh-list
92077726|NCT01766336|Vitamin B Complex|vitamin b complex|mesh-ancestor
92077727|NCT01766336|Vitamins|vitamins|mesh-ancestor
92077728|NCT01766336|Micronutrients|micronutrients|mesh-ancestor
92077730|NCT01797302|Vitamin D|vitamin d|mesh-list
92077759|NCT01609478|Mometasone Furoate|mometasone furoate|mesh-list
92077835|NCT01790594|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077836|NCT01790594|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92077907|NCT01733732|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92077908|NCT01733732|Lubricant Eye Drops|lubricant eye drops|mesh-list
92077909|NCT01733732|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92077910|NCT01732796|Ribavirin|ribavirin|mesh-list
92077911|NCT01732796|Antimetabolites|antimetabolites|mesh-ancestor
92077978|NCT00259090|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92077979|NCT00259090|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92077980|NCT00259090|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92077982|NCT00236938|Epoetin Alfa|epoetin alfa|mesh-list
92078052|NCT00242632|Dopamine Agents|dopamine agents|mesh-ancestor
92078053|NCT00242632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078054|NCT00242632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078123|NCT04110340|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92078197|NCT00280384|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92078198|NCT00280384|Botulinum Toxins|botulinum toxins|mesh-list
92078199|NCT00280384|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92078269|NCT04339426|Azithromycin|azithromycin|mesh-list
92078270|NCT04339426|Atovaquone|atovaquone|mesh-list
92078343|NCT01791088|Antifungal Agents|antifungal agents|mesh-ancestor
92078344|NCT01791088|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92078345|NCT01791088|Immunologic Factors|immunologic factors|mesh-ancestor
92078416|NCT00296296|Antifungal Agents|antifungal agents|mesh-ancestor
92078417|NCT00296296|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078420|NCT01791400|Sumatriptan|sumatriptan|mesh-list
92078490|NCT02101918|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92078491|NCT02101918|Growth Substances|growth substances|mesh-ancestor
92078492|NCT02101918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078495|NCT00300742|Topiramate|topiramate|mesh-list
92078561|NCT00147316|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92078562|NCT00147316|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92078634|NCT00326170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92078635|NCT00326170|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92078636|NCT00326170|Keratolytic Agents|keratolytic agents|mesh-ancestor
92078637|NCT00326170|Dermatologic Agents|dermatologic agents|mesh-ancestor
92078638|NCT00326170|Anticonvulsants|anticonvulsants|mesh-ancestor
92078639|NCT00326170|GABA Agents|gaba agents|mesh-ancestor
92078640|NCT00326170|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92078641|NCT00326170|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078642|NCT00326170|Antimanic Agents|antimanic agents|mesh-ancestor
92078643|NCT00326170|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92078644|NCT00326170|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92078645|NCT00326170|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92078699|NCT01608308|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92078700|NCT01608308|Antipyretics|antipyretics|mesh-ancestor
92078702|NCT00332644|Nicotine|nicotine|mesh-list
92078773|NCT00315328|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92078774|NCT01522443|Prednisone|prednisone|mesh-list
92078775|NCT01522443|Mitoxantrone|mitoxantrone|mesh-list
92078776|NCT01522443|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92078777|NCT01522443|Glucocorticoids|glucocorticoids|mesh-ancestor
92078842|NCT01782872|Sensory System Agents|sensory system agents|mesh-ancestor
92078914|NCT01466673|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92078988|NCT01462929|Parasympatholytics|parasympatholytics|mesh-ancestor
92078989|NCT01462929|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92079063|NCT01439373|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079135|NCT01519167|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92079209|NCT00349336|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079210|NCT00349336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92079241|NCT00390364|Everolimus|everolimus|mesh-list
92079281|NCT00392392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079354|NCT01419717|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92079355|NCT01419717|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079356|NCT01458951|Tofacitinib|tofacitinib|mesh-list
92079425|NCT02076321|Acetaminophen|acetaminophen|mesh-list
92079426|NCT02076321|Ibuprofen|ibuprofen|mesh-list
92079427|NCT02076321|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92079428|NCT02076321|Analgesics|analgesics|mesh-ancestor
92079429|NCT02076321|Sensory System Agents|sensory system agents|mesh-ancestor
92079430|NCT02076321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92079432|NCT02076321|Antipyretics|antipyretics|mesh-ancestor
92079495|NCT00398476|Dermatologic Agents|dermatologic agents|mesh-ancestor
92079496|NCT00398476|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92079497|NCT01436643|Fluoxetine|fluoxetine|mesh-list
92079498|NCT01436643|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92079499|NCT01436643|Citalopram|citalopram|mesh-list
92079500|NCT01436643|Fingolimod Hydrochloride|fingolimod hydrochloride|mesh-list
92079501|NCT01436643|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92079564|NCT00366106|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92079565|NCT00366106|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92079566|NCT00366106|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92079634|NCT00408070|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92079635|NCT00408070|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92079636|NCT00408070|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92079637|NCT00408070|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92079638|NCT00408070|Growth Substances|growth substances|mesh-ancestor
92079639|NCT00408070|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079640|NCT00408070|Growth Inhibitors|growth inhibitors|mesh-ancestor
92079641|NCT00408460|Paclitaxel|paclitaxel|mesh-list
92079642|NCT00408460|Imatinib Mesylate|imatinib mesylate|mesh-list
92079643|NCT00408460|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079679|NCT00410488|Ifosfamide|ifosfamide|mesh-list
92079699|NCT00410488|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92079700|NCT00410488|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079701|NCT00410488|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079775|NCT02845882|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92079776|NCT02845882|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92079777|NCT02845882|Protease Inhibitors|protease inhibitors|mesh-ancestor
92079778|NCT02845882|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92079779|NCT02845882|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92079780|NCT02845882|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92079781|NCT02845882|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92079782|NCT02845882|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92079783|NCT02845882|Abortifacient Agents|abortifacient agents|mesh-ancestor
92079784|NCT02845882|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92079785|NCT02845882|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92079786|NCT02845882|Antimetabolites|antimetabolites|mesh-ancestor
92079787|NCT02845882|Dermatologic Agents|dermatologic agents|mesh-ancestor
92079788|NCT02845882|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92079789|NCT02845882|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92079790|NCT02845882|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92079791|NCT02845882|Antiviral Agents|antiviral agents|mesh-ancestor
92079792|NCT02845882|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92079793|NCT02845882|Tubulin Modulators|tubulin modulators|mesh-ancestor
92079794|NCT02845882|Antimitotic Agents|antimitotic agents|mesh-ancestor
92079795|NCT02845882|Mitosis Modulators|mitosis modulators|mesh-ancestor
92079829|NCT01388920|Tesamorelin|tesamorelin|mesh-list
92079900|NCT00427336|Fludarabine phosphate|fludarabine phosphate|mesh-list
92079901|NCT00427336|Thymoglobulin|thymoglobulin|mesh-list
92079902|NCT00427336|Antilymphocyte Serum|antilymphocyte serum|mesh-list
92079903|NCT00427336|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92079904|NCT00427336|Immunologic Factors|immunologic factors|mesh-ancestor
92079905|NCT00427336|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92079906|NCT00427336|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92079907|NCT00427336|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92079908|NCT00427336|Alkylating Agents|alkylating agents|mesh-ancestor
92079966|NCT00431626|Dutasteride|dutasteride|mesh-list
92079967|NCT00431626|5-alpha Reductase Inhibitors|5-alpha reductase inhibitors|mesh-ancestor
92080040|NCT00457366|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92080041|NCT00457366|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92080042|NCT00457366|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080114|NCT00438802|Immunologic Factors|immunologic factors|mesh-ancestor
92080115|NCT00438802|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080117|NCT00377572|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92080118|NCT00377572|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92080119|NCT00377572|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92080120|NCT00377572|Respiratory System Agents|respiratory system agents|mesh-ancestor
92080121|NCT00377572|Immunologic Factors|immunologic factors|mesh-ancestor
92080122|NCT00377572|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080123|NCT00438880|Rituximab|rituximab|mesh-list
92080181|NCT00427804|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92080254|NCT00465088|Vasodilator Agents|vasodilator agents|mesh-ancestor
92080255|NCT00465088|Vitamin B Complex|vitamin b complex|mesh-ancestor
92080256|NCT00465088|Vitamins|vitamins|mesh-ancestor
92080327|NCT00445744|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92080328|NCT00445744|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92080329|NCT00445744|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92080397|NCT00388414|Duloxetine Hydrochloride|duloxetine hydrochloride|mesh-list
92080398|NCT00388414|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92080399|NCT00388414|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92080402|NCT00388414|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92080466|NCT00389818|Antimitotic Agents|antimitotic agents|mesh-ancestor
92080467|NCT00389818|Mitosis Modulators|mitosis modulators|mesh-ancestor
92080468|NCT00452374|Cytarabine|cytarabine|mesh-list
92080469|NCT00452374|Rituximab|rituximab|mesh-list
92080470|NCT00452374|Oxaliplatin|oxaliplatin|mesh-list
92080471|NCT00452374|Fludarabine|fludarabine|mesh-list
92080472|NCT00452374|Fludarabine phosphate|fludarabine phosphate|mesh-list
92080473|NCT00452374|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92080479|NCT00452374|Antimetabolites|antimetabolites|mesh-ancestor
92080534|NCT00453388|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92080535|NCT00453388|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92080536|NCT00453388|Alkylating Agents|alkylating agents|mesh-ancestor
92080606|NCT00528190|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92080607|NCT00528190|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92080678|NCT01452789|Sensory System Agents|sensory system agents|mesh-ancestor
92080679|NCT01452789|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080680|NCT01452789|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92080681|NCT00478192|Conivaptan|conivaptan|mesh-list
92080682|NCT00478192|Antidiuretic Hormone Receptor Antagonists|antidiuretic hormone receptor antagonists|mesh-ancestor
92080683|NCT00478192|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92080684|NCT00478192|Natriuretic Agents|natriuretic agents|mesh-ancestor
92080685|NCT00478192|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080686|NCT01414257|Methotrexate|methotrexate|mesh-list
92080687|NCT01414257|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92080688|NCT01414257|Abortifacient Agents|abortifacient agents|mesh-ancestor
92080689|NCT01414257|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92080690|NCT01414257|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080691|NCT01414257|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92080692|NCT01414257|Antimetabolites|antimetabolites|mesh-ancestor
92080736|NCT00529204|Anti-Obesity Agents|anti-obesity agents|mesh-ancestor
92080737|NCT00529204|Incretins|incretins|mesh-ancestor
92080738|NCT00529204|Hormones|hormones|mesh-ancestor
92080739|NCT00529204|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080740|NCT01451541|Ciclesonide|ciclesonide|mesh-list
92080741|NCT01451541|Glucocorticoids|glucocorticoids|mesh-ancestor
92080742|NCT01451541|Hormones|hormones|mesh-ancestor
92080743|NCT01451541|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080744|NCT01451541|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080745|NCT01451541|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92080746|NCT00530764|Nabiximols|nabiximols|mesh-list
92080747|NCT00530764|Dronabinol|dronabinol|mesh-list
92080748|NCT00530764|Cannabidiol|cannabidiol|mesh-list
92080749|NCT00530764|Analgesics|analgesics|mesh-ancestor
92080750|NCT00530764|Sensory System Agents|sensory system agents|mesh-ancestor
92080751|NCT00530764|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080752|NCT00530764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080753|NCT00530764|Anticonvulsants|anticonvulsants|mesh-ancestor
92080754|NCT00530764|Hallucinogens|hallucinogens|mesh-ancestor
92080755|NCT00530764|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92080756|NCT00530764|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92080789|NCT00483496|Protective Agents|protective agents|mesh-ancestor
92080790|NCT00483496|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080793|NCT00485836|Ranibizumab|ranibizumab|mesh-list
92080860|NCT04075149|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92080861|NCT04075149|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92080932|NCT00540982|Sensory System Agents|sensory system agents|mesh-ancestor
92080933|NCT00540982|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92080934|NCT00540982|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92081004|NCT00498550|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081005|NCT00498550|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92081006|NCT00498550|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92081007|NCT00498550|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081008|NCT00498550|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92081009|NCT00498550|GABA Antagonists|gaba antagonists|mesh-ancestor
92081010|NCT00498550|GABA Agents|gaba agents|mesh-ancestor
92081011|NCT00498628|Quetiapine Fumarate|quetiapine fumarate|mesh-list
92081070|NCT00500656|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92081071|NCT00500656|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92081141|NCT02675452|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92081142|NCT02675452|Antifungal Agents|antifungal agents|mesh-ancestor
92081143|NCT02675452|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92081144|NCT02675452|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92081145|NCT02675452|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92081146|NCT02675452|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92081147|NCT02675452|Hormone Antagonists|hormone antagonists|mesh-ancestor
92081148|NCT02675452|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92081149|NCT02675452|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081150|NCT02675452|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92081151|NCT00509002|Gefitinib|gefitinib|mesh-list
92081201|NCT01445535|Cyclophosphamide|cyclophosphamide|mesh-list
92081202|NCT01445535|Rituximab|rituximab|mesh-list
92081273|NCT01408563|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92081274|NCT01442493|Methadone|methadone|mesh-list
92081275|NCT01442493|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92081276|NCT01442493|Narcotics|narcotics|mesh-ancestor
92081277|NCT01442493|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081278|NCT01442493|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081279|NCT01442493|Analgesics|analgesics|mesh-ancestor
92081280|NCT01442493|Sensory System Agents|sensory system agents|mesh-ancestor
92081281|NCT01442493|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081287|NCT04407975|Hormones|hormones|mesh-ancestor
92081341|NCT00559468|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92081342|NCT00559468|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92081343|NCT00559468|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081344|NCT00559468|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92081345|NCT00559468|Anesthetics, General|anesthetics, general|mesh-ancestor
92081347|NCT00559468|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92081348|NCT00559468|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92081349|NCT00559468|Anticonvulsants|anticonvulsants|mesh-ancestor
92081350|NCT00559468|Neuromuscular Nondepolarizing Agents|neuromuscular nondepolarizing agents|mesh-ancestor
92081351|NCT00559468|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92081352|NCT00559468|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92081403|NCT00520234|Caspofungin|caspofungin|mesh-list
92081404|NCT00520234|Antifungal Agents|antifungal agents|mesh-ancestor
92081476|NCT01441635|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92081733|NCT01402869|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92081734|NCT01402869|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92081804|NCT01422213|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92081805|NCT01422213|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92081877|NCT04033575|Cariostatic Agents|cariostatic agents|mesh-ancestor
92081878|NCT04033575|Protective Agents|protective agents|mesh-ancestor
92081879|NCT04033575|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081952|NCT01880593|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92081953|NCT01880593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92081955|NCT01880593|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92082024|NCT01880437|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082025|NCT01880437|Immunologic Factors|immunologic factors|mesh-ancestor
92082026|NCT01880437|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082027|NCT01861717|Lanreotide|lanreotide|mesh-list
92082028|NCT01861717|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082029|NCT01834729|Alfuzosin|alfuzosin|mesh-list
92082030|NCT01834729|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92082031|NCT01834729|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92082032|NCT01834729|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92082033|NCT01834729|Adrenergic Agents|adrenergic agents|mesh-ancestor
92082034|NCT01834729|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92082035|NCT01834729|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082036|NCT01834729|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082037|NCT01834729|Urological Agents|urological agents|mesh-ancestor
92082038|NCT01860703|Moxifloxacin|moxifloxacin|mesh-list
92082039|NCT01860703|Deferiprone|deferiprone|mesh-list
92082040|NCT01860703|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082041|NCT01860703|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082042|NCT01860703|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92082043|NCT01860703|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92082044|NCT01860703|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082045|NCT01860703|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082046|NCT01860703|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082047|NCT01860703|Iron Chelating Agents|iron chelating agents|mesh-ancestor
92082048|NCT01860703|Chelating Agents|chelating agents|mesh-ancestor
92082049|NCT01860703|Sequestering Agents|sequestering agents|mesh-ancestor
92082050|NCT01399593|Eculizumab|eculizumab|mesh-list
92082051|NCT01399593|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92082052|NCT01399593|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92082053|NCT01399593|Immunologic Factors|immunologic factors|mesh-ancestor
92082054|NCT01399593|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082055|NCT01388985|Vaccines|vaccines|mesh-list
92082056|NCT01388985|Immunologic Factors|immunologic factors|mesh-ancestor
92082057|NCT01388985|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082058|NCT01388361|Insulin|insulin|mesh-list
92082059|NCT01388361|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92082134|NCT01831765|Insulin, Long-Acting|insulin, long-acting|mesh-list
92082136|NCT01831765|Insulin Detemir|insulin detemir|mesh-list
92082206|NCT01383993|Antifungal Agents|antifungal agents|mesh-ancestor
92082207|NCT01383993|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92082208|NCT01383993|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92082209|NCT01383993|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92082210|NCT01383993|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082211|NCT01383993|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082212|NCT01383993|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92082213|NCT01383993|Hormone Antagonists|hormone antagonists|mesh-ancestor
92082217|NCT01396395|Nicorandil|nicorandil|mesh-list
92082271|NCT01396005|Narcotics|narcotics|mesh-ancestor
92082272|NCT01396005|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082273|NCT01396005|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082342|NCT01829425|Urological Agents|urological agents|mesh-ancestor
92082343|NCT01829425|Parasympatholytics|parasympatholytics|mesh-ancestor
92082344|NCT01829425|Autonomic Agents|autonomic agents|mesh-ancestor
92082346|NCT01394991|Epoetin Alfa|epoetin alfa|mesh-list
92082417|NCT01721408|Tigecycline|tigecycline|mesh-list
92082418|NCT01721408|Cilastatin|cilastatin|mesh-list
92082419|NCT01721408|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92082490|NCT03596385|Atenolol|atenolol|mesh-list
92082491|NCT03596385|Carvedilol|carvedilol|mesh-list
92082492|NCT03596385|Bisoprolol|bisoprolol|mesh-list
92082562|NCT00217971|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92082637|NCT00215943|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082638|NCT00215943|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92082713|NCT04199013|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92082714|NCT04199013|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082786|NCT03591471|Dipyridamole|dipyridamole|mesh-list
92082787|NCT03591471|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082788|NCT03591471|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92082789|NCT03591471|Glucocorticoids|glucocorticoids|mesh-ancestor
92082791|NCT03591471|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92082792|NCT03591471|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92082793|NCT03591471|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082794|NCT03591471|Anticoagulants|anticoagulants|mesh-ancestor
92082795|NCT03591471|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92082796|NCT03591471|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92082797|NCT03591471|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082798|NCT03591471|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92082799|NCT03591471|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082845|NCT01825837|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92082846|NCT01825837|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92082848|NCT01854697|Interferons|interferons|mesh-list
92082918|NCT03952299|Oxybutynin|oxybutynin|mesh-list
92082919|NCT03952299|Parasympatholytics|parasympatholytics|mesh-ancestor
92082989|NCT04192617|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92082990|NCT04192617|Abortifacient Agents|abortifacient agents|mesh-ancestor
92082991|NCT04192617|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92082992|NCT04192617|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92082993|NCT04192617|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92082994|NCT04192617|Antimetabolites|antimetabolites|mesh-ancestor
92082995|NCT04192617|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92082996|NCT04192617|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92082997|NCT04192617|Dermatologic Agents|dermatologic agents|mesh-ancestor
92082998|NCT04192617|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92082999|NCT04192617|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92083000|NCT04192617|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083001|NCT04192617|Immunologic Factors|immunologic factors|mesh-ancestor
92083047|NCT04198623|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083048|NCT04198623|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083049|NCT04198623|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92083050|NCT04198623|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92083051|NCT04198623|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083052|NCT01873729|Naltrexone|naltrexone|mesh-list
92083053|NCT01873729|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92083112|NCT04021173|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083113|NCT01852045|Botulinum Toxins|botulinum toxins|mesh-list
92083115|NCT01852045|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92083183|NCT03930771|Capecitabine|capecitabine|mesh-list
92083184|NCT03930771|Temozolomide|temozolomide|mesh-list
92083185|NCT03930771|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92083186|NCT03930771|Antimetabolites|antimetabolites|mesh-ancestor
92083256|NCT04145583|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92083257|NCT04145583|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083258|NCT04145583|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92083259|NCT04022421|Hydroxychloroquine|hydroxychloroquine|mesh-list
92083260|NCT04022421|Antimalarials|antimalarials|mesh-ancestor
92083261|NCT04022421|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92083262|NCT04022421|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92083263|NCT04022421|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083264|NCT04022421|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083265|NCT04022421|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083266|NCT04022421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92083267|NCT04145193|Leucovorin|leucovorin|mesh-list
92083268|NCT04145193|Fluorouracil|fluorouracil|mesh-list
92083269|NCT04145193|Oxaliplatin|oxaliplatin|mesh-list
92083270|NCT04145193|Durvalumab|durvalumab|mesh-list
92083271|NCT04145193|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92083316|NCT01849783|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083317|NCT01849783|Antiemetics|antiemetics|mesh-ancestor
92083318|NCT01849783|Autonomic Agents|autonomic agents|mesh-ancestor
92083387|NCT01870921|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92083388|NCT01870921|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-ancestor
92083458|NCT01846039|Viscosupplements|viscosupplements|mesh-ancestor
92083459|NCT01846039|Protective Agents|protective agents|mesh-ancestor
92083460|NCT01610167|Listerine|listerine|mesh-list
92083532|NCT04148872|Cholinergic Agents|cholinergic agents|mesh-ancestor
92083533|NCT04148872|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92083534|NCT05072236|Lidocaine|lidocaine|mesh-list
92083535|NCT05072236|Anesthetics, Local|anesthetics, local|mesh-ancestor
92083608|NCT01814371|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92083681|NCT03895762|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92083756|NCT01810783|Dopamine Agents|dopamine agents|mesh-ancestor
92083757|NCT01807117|Fluorodeoxyglucose F18|fluorodeoxyglucose f18|mesh-list
92083833|NCT05361772|Antimitotic Agents|antimitotic agents|mesh-ancestor
92083834|NCT05361772|Mitosis Modulators|mitosis modulators|mesh-ancestor
92083835|NCT05361772|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92083836|NCT05361772|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92083837|NCT03031210|Amoxicillin|amoxicillin|mesh-list
92083838|NCT03031210|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92083839|NCT03031210|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92083840|NCT02958514|Tobramycin|tobramycin|mesh-list
92083841|NCT02958514|Dexamethasone|dexamethasone|mesh-list
92083842|NCT02958514|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92083843|NCT02958514|Antiemetics|antiemetics|mesh-ancestor
92083844|NCT02958514|Autonomic Agents|autonomic agents|mesh-ancestor
92083845|NCT02958514|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92083846|NCT02958514|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92083847|NCT02958514|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92083848|NCT02958514|Glucocorticoids|glucocorticoids|mesh-ancestor
92083903|NCT04505566|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92083904|NCT04505566|Lubricant Eye Drops|lubricant eye drops|mesh-list
92083917|NCT05076292|Glucagon|glucagon|mesh-list
92083974|NCT04509622|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92083975|NCT04509622|Immunologic Factors|immunologic factors|mesh-ancestor
92083977|NCT00570700|Dasatinib|dasatinib|mesh-list
92084045|NCT00579280|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92084046|NCT00579280|Anticonvulsants|anticonvulsants|mesh-ancestor
92084047|NCT00579280|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084115|NCT01802437|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084189|NCT00614458|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92084190|NCT00614458|Antiviral Agents|antiviral agents|mesh-ancestor
92084260|NCT00615472|Sensory System Agents|sensory system agents|mesh-ancestor
92084261|NCT00615472|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084551|NCT00629122|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92084624|NCT01799356|Metronidazole|metronidazole|mesh-list
92084625|NCT01799356|Ofloxacin|ofloxacin|mesh-list
92084626|NCT01799356|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92084627|NCT01799356|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084628|NCT01799356|Antitubercular Agents|antitubercular agents|mesh-ancestor
92084629|NCT01799356|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92084630|NCT01799356|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92084631|NCT01799356|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92084632|NCT01799356|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084633|NCT01799356|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084686|NCT00602836|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92084687|NCT00602836|Alkylating Agents|alkylating agents|mesh-ancestor
92084689|NCT00602836|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92084758|NCT00705874|Sunitinib|sunitinib|mesh-list
92084759|NCT00705874|Gemcitabine|gemcitabine|mesh-list
92084833|NCT02143648|Sensory System Agents|sensory system agents|mesh-ancestor
92084834|NCT02143648|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92084835|NCT02997982|Valacyclovir|valacyclovir|mesh-list
92084905|NCT00691600|Trimethoprim|trimethoprim|mesh-list
92084906|NCT00691600|Sulfamethoxazole|sulfamethoxazole|mesh-list
92084907|NCT00691600|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92084908|NCT00691600|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92084978|NCT00656968|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92084983|NCT00657280|Hormones|hormones|mesh-ancestor
92085050|NCT01792102|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085051|NCT02996734|Denosumab|denosumab|mesh-list
92085052|NCT02996734|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92085122|NCT00701896|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92085123|NCT00701896|Autonomic Agents|autonomic agents|mesh-ancestor
92085124|NCT00701896|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92085195|NCT01799941|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92085196|NCT01799941|Cholinergic Agents|cholinergic agents|mesh-ancestor
92085197|NCT01799941|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92085198|NCT01799941|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92085199|NCT01799941|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085200|NCT01799941|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92085201|NCT01799941|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92085202|NCT00702364|Atomoxetine Hydrochloride|atomoxetine hydrochloride|mesh-list
92085203|NCT00702364|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92085204|NCT00702364|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92085205|NCT00702364|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92085206|NCT00702364|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085207|NCT00702364|Adrenergic Agents|adrenergic agents|mesh-ancestor
92085208|NCT00702364|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92085209|NCT00702364|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085211|NCT00713284|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085212|NCT00713284|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085213|NCT00713284|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92085214|NCT00713284|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085215|NCT00713284|Antifungal Agents|antifungal agents|mesh-ancestor
92085216|NCT00713284|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085217|NCT00713284|Immunologic Factors|immunologic factors|mesh-ancestor
92085218|NCT00713284|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085219|NCT00702754|rimabotulinumtoxinB|rimabotulinumtoxinb|mesh-list
92085239|NCT02995720|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085240|NCT02995720|Vasodilator Agents|vasodilator agents|mesh-ancestor
92085312|NCT04270318|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92085313|NCT04270318|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92085314|NCT02999854|Cyclophosphamide|cyclophosphamide|mesh-list
92085383|NCT02995096|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085455|NCT01270750|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085525|NCT00711490|Sirolimus|sirolimus|mesh-list
92085526|NCT00711490|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92085527|NCT00711490|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92085598|NCT01772719|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92085599|NCT01772719|Antimetabolites|antimetabolites|mesh-ancestor
92085670|NCT01272310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92085671|NCT01272310|Immunologic Factors|immunologic factors|mesh-ancestor
92085672|NCT01272310|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085673|NCT01272310|Antimalarials|antimalarials|mesh-ancestor
92085674|NCT01272310|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92085675|NCT01272310|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92085676|NCT01272310|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085677|NCT01272310|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92085678|NCT04386850|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92085736|NCT01273558|Canagliflozin|canagliflozin|mesh-list
92085737|NCT01273558|Sodium-Glucose Transporter 2 Inhibitors|sodium-glucose transporter 2 inhibitors|mesh-ancestor
92085744|NCT00733096|Prednisolone|prednisolone|mesh-list
92085810|NCT01276288|Sodium Potassium Chloride Symporter Inhibitors|sodium potassium chloride symporter inhibitors|mesh-ancestor
92085812|NCT00722566|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085881|NCT00735436|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085882|NCT00735436|Growth Inhibitors|growth inhibitors|mesh-ancestor
92085885|NCT00735436|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92085950|NCT04143477|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92085951|NCT04143477|Immunologic Factors|immunologic factors|mesh-ancestor
92085952|NCT04143477|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92085953|NCT05586009|Cisplatin|cisplatin|mesh-list
92085954|NCT05586009|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92085955|NCT03020979|Apatinib|apatinib|mesh-list
92086021|NCT04149015|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086022|NCT04149015|Antimetabolites|antimetabolites|mesh-ancestor
92086092|NCT05582421|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086093|NCT05582421|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086094|NCT05582421|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086095|NCT05582421|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92086165|NCT02984865|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92086241|NCT03586791|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086243|NCT01795495|Magnesium Sulfate|magnesium sulfate|mesh-list
92086312|NCT01986881|Ertugliflozin|ertugliflozin|mesh-list
92086315|NCT01986881|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92086386|NCT05701995|Dermatologic Agents|dermatologic agents|mesh-ancestor
92086463|NCT03583749|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92086464|NCT03583749|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92086465|NCT03583749|Antitubercular Agents|antitubercular agents|mesh-ancestor
92086529|NCT01274104|Vitamins|vitamins|mesh-ancestor
92086530|NCT01274104|Micronutrients|micronutrients|mesh-ancestor
92086531|NCT01274104|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086599|NCT01274260|Methylprednisolone|methylprednisolone|mesh-list
92086600|NCT01274260|Methylprednisolone Acetate|methylprednisolone acetate|mesh-list
92086601|NCT01274260|Methylprednisolone Hemisuccinate|methylprednisolone hemisuccinate|mesh-list
92086602|NCT01274260|Prednisolone|prednisolone|mesh-list
92086603|NCT01274260|Prednisolone acetate|prednisolone acetate|mesh-list
92086604|NCT01274260|Prednisolone hemisuccinate|prednisolone hemisuccinate|mesh-list
92086605|NCT01274260|Prednisolone phosphate|prednisolone phosphate|mesh-list
92086606|NCT01274260|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92086607|NCT01274260|Antiemetics|antiemetics|mesh-ancestor
92086608|NCT01274260|Autonomic Agents|autonomic agents|mesh-ancestor
92086609|NCT01274260|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92086610|NCT01274260|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086611|NCT01274260|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92086612|NCT01274260|Glucocorticoids|glucocorticoids|mesh-ancestor
92086613|NCT01274260|Hormones|hormones|mesh-ancestor
92086614|NCT01274260|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92086615|NCT01274260|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92086616|NCT01274260|Protective Agents|protective agents|mesh-ancestor
92086617|NCT01274260|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92086618|NCT01274260|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086619|NCT03154983|Docetaxel|docetaxel|mesh-list
92086620|NCT03154983|Apatinib|apatinib|mesh-list
92086621|NCT03154983|Tegafur|tegafur|mesh-list
92086622|NCT03154983|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92086623|NCT03154983|Tubulin Modulators|tubulin modulators|mesh-ancestor
92086624|NCT03154983|Antimitotic Agents|antimitotic agents|mesh-ancestor
92086625|NCT03154983|Mitosis Modulators|mitosis modulators|mesh-ancestor
92086626|NCT03154983|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92086627|NCT03154983|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92086646|NCT03158025|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92086654|NCT01998893|Rituximab|rituximab|mesh-list
92086717|NCT03157479|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92086718|NCT03157479|Anesthetics, General|anesthetics, general|mesh-ancestor
92086792|NCT01275352|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-list
92086793|NCT01275352|Hormone Antagonists|hormone antagonists|mesh-ancestor
92086865|NCT00753142|Parenteral Nutrition Solutions|parenteral nutrition solutions|mesh-ancestor
92086866|NCT00753142|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92086938|NCT01736917|Aprepitant|aprepitant|mesh-list
92086939|NCT01736917|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92087010|NCT00248170|Anastrozole|anastrozole|mesh-list
92087011|NCT00248170|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92087012|NCT00248170|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92087158|NCT03806374|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92087159|NCT03806374|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92087160|NCT03806374|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92087303|NCT00767572|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92087304|NCT00767572|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92087305|NCT00767572|Antimetabolites|antimetabolites|mesh-ancestor
92087310|NCT00780676|Dasatinib|dasatinib|mesh-list
92087375|NCT00758836|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92087376|NCT00758836|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087448|NCT04730999|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92087449|NCT04730999|Growth Inhibitors|growth inhibitors|mesh-ancestor
92087450|NCT04730999|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92087451|NCT04730999|Topoisomerase II Inhibitors|topoisomerase ii inhibitors|mesh-ancestor
92087452|NCT04730999|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92087453|NCT04730999|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92087454|NCT04730999|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087516|NCT01735279|Dermatologic Agents|dermatologic agents|mesh-ancestor
92087517|NCT03802318|Amoxicillin|amoxicillin|mesh-list
92087518|NCT03802318|Rabeprazole|rabeprazole|mesh-list
92087519|NCT03802318|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92087520|NCT03802318|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92087521|NCT03802318|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92087584|NCT03802162|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92087585|NCT03802162|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92087587|NCT01757275|Cimetidine|cimetidine|mesh-list
92087657|NCT01784029|Vitamins|vitamins|mesh-ancestor
92087658|NCT01784029|Micronutrients|micronutrients|mesh-ancestor
92087732|NCT01755637|Mitosis Modulators|mitosis modulators|mesh-ancestor
92087733|NCT01755637|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92087804|NCT01782859|Glucocorticoids|glucocorticoids|mesh-ancestor
92087805|NCT01782859|Hormones|hormones|mesh-ancestor
92087811|NCT01782313|Tivozanib|tivozanib|mesh-list
92087876|NCT00790270|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92087877|NCT00790270|Analgesics|analgesics|mesh-ancestor
92087878|NCT00790270|Sensory System Agents|sensory system agents|mesh-ancestor
92087950|NCT01730053|PCSK9 Inhibitors|pcsk9 inhibitors|mesh-ancestor
92088027|NCT00792142|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92088028|NCT00792142|Glucocorticoids|glucocorticoids|mesh-ancestor
92088029|NCT00792142|Hormones|hormones|mesh-ancestor
92088099|NCT04382170|Sensory System Agents|sensory system agents|mesh-ancestor
92088171|NCT01709084|Efavirenz|efavirenz|mesh-list
92088172|NCT01709084|Rilpivirine|rilpivirine|mesh-list
92088173|NCT01709084|Antiviral Agents|antiviral agents|mesh-ancestor
92088243|NCT01976507|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088244|NCT01976507|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088245|NCT01976507|Anticoagulants|anticoagulants|mesh-ancestor
92088315|NCT03839134|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92088316|NCT03839134|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92088332|NCT03906526|Nivolumab|nivolumab|mesh-list
92088386|NCT01149850|Temozolomide|temozolomide|mesh-list
92088387|NCT01149850|Antibodies|antibodies|mesh-list
92088388|NCT01149850|Immunoglobulins|immunoglobulins|mesh-list
92088389|NCT01149850|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92088390|NCT01149850|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088458|NCT01747915|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92088459|NCT01747915|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088532|NCT01969721|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088533|NCT01969565|Dexamethasone|dexamethasone|mesh-list
92088534|NCT01969565|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92088606|NCT01725529|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92088681|NCT01724359|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92088693|NCT01703221|Incretins|incretins|mesh-ancestor
92088752|NCT01739335|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92088824|NCT01959035|Dopamine Agonists|dopamine agonists|mesh-ancestor
92088825|NCT01959035|Dopamine Agents|dopamine agents|mesh-ancestor
92088826|NCT01959035|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92088896|NCT00830362|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92088897|NCT00830362|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92088898|NCT00830362|Vasodilator Agents|vasodilator agents|mesh-ancestor
92088899|NCT01944839|Ranibizumab|ranibizumab|mesh-list
92088900|NCT01944839|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92088901|NCT01944839|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92088902|NCT01944839|Growth Substances|growth substances|mesh-ancestor
92088903|NCT01944839|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92088904|NCT01944839|Growth Inhibitors|growth inhibitors|mesh-ancestor
92088905|NCT01944839|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088906|NCT01720225|Azacitidine|azacitidine|mesh-list
92088907|NCT01720225|Decitabine|decitabine|mesh-list
92088908|NCT01720225|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92088909|NCT01720225|Antimetabolites|antimetabolites|mesh-ancestor
92088910|NCT01720225|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92088911|NCT01720225|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92088912|NCT01720225|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92088913|NCT01943435|Acetaminophen|acetaminophen|mesh-list
92088955|NCT01943435|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92088956|NCT01943435|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92088957|NCT01943435|Dopamine Agents|dopamine agents|mesh-ancestor
92088958|NCT01943435|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92088959|NCT01943435|Narcotics|narcotics|mesh-ancestor
92088960|NCT01943435|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92088961|NCT01943435|Serotonin Agents|serotonin agents|mesh-ancestor
92088962|NCT01943435|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92088963|NCT01943435|Histamine Antagonists|histamine antagonists|mesh-ancestor
92088964|NCT01943435|Histamine Agents|histamine agents|mesh-ancestor
92088965|NCT01943435|Adrenergic alpha-2 Receptor Antagonists|adrenergic alpha-2 receptor antagonists|mesh-ancestor
92088966|NCT01943435|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92088967|NCT01943435|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92088968|NCT01943435|Adrenergic Agents|adrenergic agents|mesh-ancestor
92088991|NCT00807586|Hormones|hormones|mesh-ancestor
92089013|NCT01941095|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92089030|NCT01941095|Amebicides|amebicides|mesh-ancestor
92089086|NCT00844714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089087|NCT00844714|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92089159|NCT01954121|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089232|NCT00841828|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92089233|NCT00841828|Alkylating Agents|alkylating agents|mesh-ancestor
92089235|NCT00841828|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089303|NCT03696784|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92089304|NCT01682863|Glycopyrrolate|glycopyrrolate|mesh-list
92089305|NCT01682863|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92089377|NCT00890656|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92089378|NCT00890656|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92089452|NCT01857934|Sargramostim|sargramostim|mesh-list
92089453|NCT01857934|Lenograstim|lenograstim|mesh-list
92089526|NCT00863356|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92089527|NCT00863356|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92089600|NCT01935947|Antimetabolites|antimetabolites|mesh-ancestor
92089601|NCT01935947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089602|NCT01935947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92089603|NCT01935947|Tubulin Modulators|tubulin modulators|mesh-ancestor
92089604|NCT01935947|Antimitotic Agents|antimitotic agents|mesh-ancestor
92089605|NCT01935947|Mitosis Modulators|mitosis modulators|mesh-ancestor
92089606|NCT01935947|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92089607|NCT01935947|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92089608|NCT01935947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92089609|NCT01935947|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92089610|NCT01935947|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92089611|NCT01935947|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92089612|NCT02986321|Budesonide|budesonide|mesh-list
92089613|NCT02986321|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92089614|NCT02986321|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92089615|NCT02986321|Autonomic Agents|autonomic agents|mesh-ancestor
92089616|NCT02986321|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92089617|NCT02986321|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089618|NCT02986321|Anti-Asthmatic Agents|anti-asthmatic agents|mesh-ancestor
92089654|NCT00868348|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92089724|NCT01592773|Dopamine Agents|dopamine agents|mesh-ancestor
92089725|NCT01592773|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089726|NCT01592773|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090462|NCT01903031|Estrogens|estrogens|mesh-ancestor
92089727|NCT01592773|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089728|NCT01592773|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92089729|NCT01592773|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92089730|NCT04124965|Rozanolixizumab|rozanolixizumab|mesh-list
92089731|NCT04124965|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92089732|NCT04124965|Immunologic Factors|immunologic factors|mesh-ancestor
92089733|NCT04124965|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089735|NCT01592695|Bupropion|bupropion|mesh-list
92089736|NCT01592695|Nicotine|nicotine|mesh-list
92089737|NCT01592695|Varenicline|varenicline|mesh-list
92089738|NCT01592695|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92089739|NCT01592695|Autonomic Agents|autonomic agents|mesh-ancestor
92089742|NCT01592695|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92089780|NCT04553263|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92089781|NCT04553263|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92089853|NCT01711645|Aluminum phosphate|aluminum phosphate|mesh-list
92089854|NCT01711645|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92089855|NCT01711645|Immunologic Factors|immunologic factors|mesh-ancestor
92089856|NCT01711645|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089858|NCT01711645|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089859|NCT01711645|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92089860|NCT00820534|Penciclovir|penciclovir|mesh-list
92089861|NCT00820534|Antiviral Agents|antiviral agents|mesh-ancestor
92089862|NCT00820534|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92089863|NCT01590433|Exenatide|exenatide|mesh-list
92089864|NCT01590433|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92089865|NCT01590433|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089867|NCT01590433|Incretins|incretins|mesh-ancestor
92089914|NCT01710709|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089915|NCT01710709|Serotonin 5-HT1 Receptor Agonists|serotonin 5-ht1 receptor agonists|mesh-ancestor
92089985|NCT00875836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92089986|NCT00875836|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92089987|NCT00875836|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92089988|NCT00875836|Serotonin Agents|serotonin agents|mesh-ancestor
92089989|NCT00875836|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92089990|NCT00875836|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92089991|NCT00891982|Clindamycin, tretinoin drug combination|clindamycin, tretinoin drug combination|mesh-list
92089992|NCT00891982|Dermatologic Agents|dermatologic agents|mesh-ancestor
92089993|NCT05312398|Irinotecan|irinotecan|mesh-list
92089994|NCT05312398|Cetuximab|cetuximab|mesh-list
92089995|NCT05312398|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92090048|NCT01589497|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92090049|NCT01928381|Pregabalin|pregabalin|mesh-list
92090050|NCT01928381|Analgesics|analgesics|mesh-ancestor
92090051|NCT01928381|Sensory System Agents|sensory system agents|mesh-ancestor
92090052|NCT01928381|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090053|NCT01928381|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090054|NCT01928381|Anticonvulsants|anticonvulsants|mesh-ancestor
92090055|NCT01928381|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92090056|NCT01928381|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090057|NCT01928381|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090058|NCT01928381|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92090059|NCT01928381|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92090060|NCT01928381|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92090061|NCT01928381|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090062|NCT01928381|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92090063|NCT01928225|Vaccines|vaccines|mesh-list
92090064|NCT01928225|Immunologic Factors|immunologic factors|mesh-ancestor
92090065|NCT01928225|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090066|NCT01927757|Etanercept|etanercept|mesh-list
92090067|NCT01927757|Methotrexate|methotrexate|mesh-list
92090073|NCT01927757|Antimetabolites|antimetabolites|mesh-ancestor
92090102|NCT01913639|Vitamin B Complex|vitamin b complex|mesh-ancestor
92090105|NCT01913483|Heparin|heparin|mesh-list
92090179|NCT01910441|Immunologic Factors|immunologic factors|mesh-ancestor
92090252|NCT01905683|Botulinum Toxins|botulinum toxins|mesh-list
92090327|NCT01709227|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090454|NCT01903031|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090455|NCT01903031|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92090456|NCT01903031|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92090457|NCT01903031|Antiviral Agents|antiviral agents|mesh-ancestor
92090458|NCT01903031|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090459|NCT01903031|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92090460|NCT01903031|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92090461|NCT01903031|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92090463|NCT01903031|Hormones|hormones|mesh-ancestor
92090464|NCT01903031|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090465|NCT01903031|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090514|NCT00893074|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090515|NCT00893074|Hormones|hormones|mesh-ancestor
92090516|NCT00893074|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090517|NCT00885742|Fibrinolysin|fibrinolysin|mesh-list
92090518|NCT00885742|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92090521|NCT00887458|Itraconazole|itraconazole|mesh-list
92090580|NCT03837886|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090581|NCT03837886|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92090582|NCT03219970|Osimertinib|osimertinib|mesh-list
92090583|NCT03219970|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090584|NCT03219970|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92090585|NCT03219970|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090586|NCT03219970|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090587|NCT00889330|Alcaftadine|alcaftadine|mesh-list
92090588|NCT00889330|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92090589|NCT00889330|Histamine Antagonists|histamine antagonists|mesh-ancestor
92090590|NCT00889330|Histamine Agents|histamine agents|mesh-ancestor
92090591|NCT00889330|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090594|NCT03219580|Fluorouracil|fluorouracil|mesh-list
92090640|NCT03218254|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92090641|NCT03218254|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090642|NCT03218254|Dopamine Agents|dopamine agents|mesh-ancestor
92090643|NCT03218254|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92090644|NCT03215056|Methoxyflurane|methoxyflurane|mesh-list
92090645|NCT03215056|Anesthetics, Inhalation|anesthetics, inhalation|mesh-ancestor
92090646|NCT03215056|Anesthetics, General|anesthetics, general|mesh-ancestor
92090647|NCT03215056|Anesthetics|anesthetics|mesh-ancestor
92090648|NCT03215056|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090649|NCT03215056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090650|NCT01919801|Icatibant|icatibant|mesh-list
92090651|NCT01919801|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92090652|NCT01919801|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92090653|NCT01919801|Analgesics|analgesics|mesh-ancestor
92090654|NCT01919801|Sensory System Agents|sensory system agents|mesh-ancestor
92090655|NCT01919801|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92090656|NCT01919801|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090697|NCT01901393|Sensory System Agents|sensory system agents|mesh-ancestor
92090770|NCT03214354|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92090771|NCT03214354|Antifungal Agents|antifungal agents|mesh-ancestor
92090772|NCT03214354|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92090773|NCT03214354|Immunologic Factors|immunologic factors|mesh-ancestor
92090842|NCT01738646|Growth Substances|growth substances|mesh-ancestor
92090843|NCT01738646|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090844|NCT01738646|Growth Inhibitors|growth inhibitors|mesh-ancestor
92090845|NCT01738646|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92090846|NCT01738646|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090847|NCT01738646|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090908|NCT01830478|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92090909|NCT01830478|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92090910|NCT01830478|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92090911|NCT01830478|Growth Substances|growth substances|mesh-ancestor
92090912|NCT01830478|Growth Inhibitors|growth inhibitors|mesh-ancestor
92090914|NCT04426695|Antiviral Agents|antiviral agents|mesh-ancestor
92090979|NCT03830398|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090980|NCT03830398|Antipyretics|antipyretics|mesh-ancestor
92090981|NCT04405323|Itraconazole|itraconazole|mesh-list
92090982|NCT04405323|Antifungal Agents|antifungal agents|mesh-ancestor
92090983|NCT04405323|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92090984|NCT04405323|14-alpha Demethylase Inhibitors|14-alpha demethylase inhibitors|mesh-ancestor
92090985|NCT04405323|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92090986|NCT04405323|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92090987|NCT04405323|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92090988|NCT04405323|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92090989|NCT04405323|Hormone Antagonists|hormone antagonists|mesh-ancestor
92090990|NCT04405323|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92090991|NCT04405323|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090992|NCT04405323|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92090993|NCT01720498|Remifentanil|remifentanil|mesh-list
92090994|NCT01720498|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92090995|NCT01720498|Narcotics|narcotics|mesh-ancestor
92090996|NCT01720498|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92090997|NCT01720498|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92090998|NCT01720498|Analgesics|analgesics|mesh-ancestor
92090999|NCT01720498|Sensory System Agents|sensory system agents|mesh-ancestor
92091000|NCT01720498|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091001|NCT01672047|Vitamin D|vitamin d|mesh-list
92091002|NCT01672047|Ergocalciferols|ergocalciferols|mesh-list
92091003|NCT01672047|Vitamins|vitamins|mesh-ancestor
92091004|NCT01672047|Micronutrients|micronutrients|mesh-ancestor
92091005|NCT01672047|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091006|NCT01672047|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92091007|NCT01672047|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92091008|NCT00911326|Dextrans|dextrans|mesh-list
92091010|NCT00911326|Anticoagulants|anticoagulants|mesh-ancestor
92091022|NCT01833676|Anesthetics|anesthetics|mesh-ancestor
92091023|NCT01833676|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091024|NCT01833676|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091025|NCT04380376|Melphalan|melphalan|mesh-list
92091026|NCT04380376|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92091027|NCT04380376|Alkylating Agents|alkylating agents|mesh-ancestor
92091028|NCT04380376|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091029|NCT04380376|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091030|NCT04380376|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92091031|NCT04380376|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92091032|NCT04380376|Immunologic Factors|immunologic factors|mesh-ancestor
92091033|NCT04380376|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091034|NCT04380298|Ketorolac|ketorolac|mesh-list
92091035|NCT04380298|Epinephrine|epinephrine|mesh-list
92091036|NCT04380298|Ropivacaine|ropivacaine|mesh-list
92091037|NCT04380298|Anesthetics, Local|anesthetics, local|mesh-ancestor
92091038|NCT04380298|Anesthetics|anesthetics|mesh-ancestor
92091039|NCT04380298|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92091040|NCT04380298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091041|NCT04380298|Sensory System Agents|sensory system agents|mesh-ancestor
92091042|NCT04380298|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091043|NCT04380298|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92091044|NCT04380298|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92091045|NCT04380298|Adrenergic Agents|adrenergic agents|mesh-ancestor
92091046|NCT04380298|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92091047|NCT04380298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091048|NCT04380298|Adrenergic beta-Agonists|adrenergic beta-agonists|mesh-ancestor
92091070|NCT03210610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92091071|NCT03210610|Tubulin Modulators|tubulin modulators|mesh-ancestor
92091072|NCT03210610|Antimitotic Agents|antimitotic agents|mesh-ancestor
92091073|NCT03210610|Mitosis Modulators|mitosis modulators|mesh-ancestor
92091074|NCT03210610|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091075|NCT03210610|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091076|NCT03152955|Sufentanil|sufentanil|mesh-list
92091137|NCT03210532|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92091138|NCT03210532|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92091139|NCT03210532|Angiotensin II Type 1 Receptor Blockers|angiotensin ii type 1 receptor blockers|mesh-ancestor
92091140|NCT03210532|Angiotensin Receptor Antagonists|angiotensin receptor antagonists|mesh-ancestor
92091141|NCT03152565|Avelumab|avelumab|mesh-list
92091207|NCT01672593|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091208|NCT01722448|Choline|choline|mesh-list
92091209|NCT01722448|Lipotropic Agents|lipotropic agents|mesh-ancestor
92091281|NCT03152409|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92091282|NCT03152409|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091291|NCT03152409|Antipyretics|antipyretics|mesh-ancestor
92091354|NCT01723150|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92091355|NCT01723150|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92091356|NCT01723150|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92091426|NCT01836484|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091427|NCT01726816|Probucol|probucol|mesh-list
92091428|NCT01726816|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92091429|NCT01726816|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92091430|NCT01726816|Antimetabolites|antimetabolites|mesh-ancestor
92091431|NCT01726816|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091432|NCT01726816|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92091433|NCT01726816|Antioxidants|antioxidants|mesh-ancestor
92091434|NCT01726816|Protective Agents|protective agents|mesh-ancestor
92091435|NCT01726816|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091436|NCT00915538|Budesonide|budesonide|mesh-list
92091437|NCT00915538|Budesonide, Formoterol Fumarate Drug Combination|budesonide, formoterol fumarate drug combination|mesh-list
92091438|NCT00915538|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92091446|NCT00915538|Hormones|hormones|mesh-ancestor
92091486|NCT01837108|Mineralocorticoid Receptor Antagonists|mineralocorticoid receptor antagonists|mesh-ancestor
92091487|NCT01837108|Hormone Antagonists|hormone antagonists|mesh-ancestor
92091558|NCT01725412|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091559|NCT01725490|Metformin|metformin|mesh-list
92091560|NCT01725490|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92091561|NCT01725490|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091562|NCT04553666|Vitamins|vitamins|mesh-list
92091563|NCT04553666|Ascorbic Acid|ascorbic acid|mesh-list
92091565|NCT04553666|Micronutrients|micronutrients|mesh-ancestor
92091626|NCT01682720|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091627|NCT01838902|Primaquine|primaquine|mesh-list
92091628|NCT01838902|Antimalarials|antimalarials|mesh-ancestor
92091629|NCT01838902|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92091630|NCT01838902|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92091631|NCT01838902|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091632|NCT01714544|Clocortolone pivalate|clocortolone pivalate|mesh-list
92091633|NCT01714544|Glucocorticoids|glucocorticoids|mesh-ancestor
92091634|NCT01714544|Hormones|hormones|mesh-ancestor
92091635|NCT01714544|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92091636|NCT01714544|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091637|NCT03409432|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92091638|NCT03409432|Brentuximab Vedotin|brentuximab vedotin|mesh-list
92091639|NCT03409432|Lenalidomide|lenalidomide|mesh-list
92091640|NCT03409432|Antibodies|antibodies|mesh-list
92091641|NCT03409432|Immunoglobulins|immunoglobulins|mesh-list
92091642|NCT03409432|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92091643|NCT03409432|Immunoconjugates|immunoconjugates|mesh-list
92091644|NCT03409432|Immunologic Factors|immunologic factors|mesh-ancestor
92091645|NCT03409432|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091646|NCT03409432|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92091647|NCT03409432|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92091648|NCT03409432|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92091649|NCT03409432|Growth Substances|growth substances|mesh-ancestor
92091650|NCT03409432|Growth Inhibitors|growth inhibitors|mesh-ancestor
92091677|NCT01714310|Lisdexamfetamine Dimesylate|lisdexamfetamine dimesylate|mesh-list
92091678|NCT01714310|Fluoxetine|fluoxetine|mesh-list
92091679|NCT01714310|Selective Serotonin Reuptake Inhibitors|selective serotonin reuptake inhibitors|mesh-ancestor
92091680|NCT01714310|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92091681|NCT01714310|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92091748|NCT00915928|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92091750|NCT03407404|Ketamine|ketamine|mesh-list
92091751|NCT03407404|Morphine|morphine|mesh-list
92091823|NCT01047436|Analgesics|analgesics|mesh-ancestor
92091825|NCT03406936|Midazolam|midazolam|mesh-list
92091897|NCT02982694|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92091898|NCT01712984|Fluconazole|fluconazole|mesh-list
92091899|NCT01712984|Vaccines|vaccines|mesh-list
92091900|NCT01712984|Immunologic Factors|immunologic factors|mesh-ancestor
92091901|NCT01712984|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92091902|NCT01712984|Antifungal Agents|antifungal agents|mesh-ancestor
92091903|NCT01712984|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92091964|NCT01593020|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92092040|NCT01592708|Remifentanil|remifentanil|mesh-list
92092041|NCT01592708|Hydrocodone|hydrocodone|mesh-list
92092042|NCT01592708|Ondansetron|ondansetron|mesh-list
92092043|NCT01592708|Antiemetics|antiemetics|mesh-list
92092044|NCT01592708|Propofol|propofol|mesh-list
92092045|NCT01592708|Anesthetics|anesthetics|mesh-ancestor
92092046|NCT01592708|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092047|NCT01592708|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092048|NCT01592708|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92092050|NCT01592708|Anesthetics, General|anesthetics, general|mesh-ancestor
92092108|NCT01042522|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92092109|NCT01042522|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092110|NCT01042522|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92092111|NCT01702844|Paclitaxel|paclitaxel|mesh-list
92092112|NCT01702844|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92092118|NCT01702532|Nicotine|nicotine|mesh-list
92092180|NCT01702298|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092181|NCT01702298|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92092182|NCT01702298|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-ancestor
92092183|NCT01702298|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092185|NCT01702298|Hormones|hormones|mesh-ancestor
92092186|NCT01702298|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92092187|NCT01702298|Dipeptidyl-Peptidase IV Inhibitors|dipeptidyl-peptidase iv inhibitors|mesh-ancestor
92092188|NCT01702298|Protease Inhibitors|protease inhibitors|mesh-ancestor
92092189|NCT03404752|Lenograstim|lenograstim|mesh-list
92092190|NCT03404752|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92092191|NCT03404752|Immunologic Factors|immunologic factors|mesh-ancestor
92092192|NCT03404752|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092193|NCT03401710|Epoetin Alfa|epoetin alfa|mesh-list
92092194|NCT03401710|Hematinics|hematinics|mesh-ancestor
92092195|NCT02242084|Tissue Plasminogen Activator|tissue plasminogen activator|mesh-list
92092196|NCT02242084|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92092197|NCT02242084|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92095884|NCT04021264|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092198|NCT02242084|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092199|NCT01701362|Pregabalin|pregabalin|mesh-list
92092200|NCT01701362|Analgesics|analgesics|mesh-ancestor
92092201|NCT01701362|Sensory System Agents|sensory system agents|mesh-ancestor
92092202|NCT01701362|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092203|NCT01701362|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092213|NCT00919126|Xenon|xenon|mesh-list
92092226|NCT01710020|Janus Kinase Inhibitors|janus kinase inhibitors|mesh-ancestor
92092227|NCT01710020|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92092228|NCT01710020|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092229|NCT01710020|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092230|NCT02982850|Aspirin|aspirin|mesh-list
92092231|NCT02982850|Warfarin|warfarin|mesh-list
92092232|NCT02982850|Dabigatran|dabigatran|mesh-list
92092233|NCT02982850|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92092234|NCT02982850|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92092235|NCT02982850|Analgesics|analgesics|mesh-ancestor
92092236|NCT02982850|Sensory System Agents|sensory system agents|mesh-ancestor
92092237|NCT02982850|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092288|NCT01700192|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92092289|NCT01700192|Epinephrine|epinephrine|mesh-list
92092290|NCT01700192|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92092360|NCT04878315|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92092361|NCT04878315|Protease Inhibitors|protease inhibitors|mesh-ancestor
92092362|NCT04878315|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092363|NCT04878315|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092364|NCT04878315|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092365|NCT04374604|Mitogens|mitogens|mesh-list
92092366|NCT04374604|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092425|NCT01709318|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92092426|NCT01709318|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92092427|NCT01709318|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92092428|NCT02243254|Ibuprofen|ibuprofen|mesh-list
92092429|NCT02243254|Remifentanil|remifentanil|mesh-list
92092493|NCT01699178|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92092494|NCT01699178|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092495|NCT01699178|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92092496|NCT01699178|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092497|NCT01699178|Anabolic Agents|anabolic agents|mesh-ancestor
92092498|NCT02077959|Lenalidomide|lenalidomide|mesh-list
92092499|NCT02077959|Pidilizumab|pidilizumab|mesh-list
92092500|NCT02077959|Immunologic Factors|immunologic factors|mesh-ancestor
92092508|NCT04548518|Vaccines|vaccines|mesh-list
92092558|NCT02243644|Tubulin Modulators|tubulin modulators|mesh-ancestor
92092559|NCT02243644|Antimitotic Agents|antimitotic agents|mesh-ancestor
92092560|NCT02243644|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092561|NCT02243644|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092562|NCT02243644|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092563|NCT01988883|Propranolol|propranolol|mesh-list
92092564|NCT01988883|Modafinil|modafinil|mesh-list
92092565|NCT01988883|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92092566|NCT01988883|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92092624|NCT01698554|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92092625|NCT04404855|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92092626|NCT04404855|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092628|NCT00895791|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92092629|NCT00895791|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92092630|NCT00895791|Immunologic Factors|immunologic factors|mesh-ancestor
92092631|NCT00895791|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092632|NCT01698320|Albuterol|albuterol|mesh-list
92092633|NCT01698320|Bronchodilator Agents|bronchodilator agents|mesh-ancestor
92092634|NCT01698320|Autonomic Agents|autonomic agents|mesh-ancestor
92092635|NCT01698320|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92092636|NCT01698320|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092686|NCT01674933|Sodium Fluoride|sodium fluoride|mesh-list
92092687|NCT01674933|Cariostatic Agents|cariostatic agents|mesh-ancestor
92092688|NCT01674933|Protective Agents|protective agents|mesh-ancestor
92092689|NCT01674933|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092690|NCT01674933|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92092691|NCT01674933|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092692|NCT04373044|Hydroxychloroquine|hydroxychloroquine|mesh-list
92092753|NCT01675947|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92092754|NCT01675947|Immunologic Factors|immunologic factors|mesh-ancestor
92092755|NCT03840915|Paclitaxel|paclitaxel|mesh-list
92092756|NCT03840915|Docetaxel|docetaxel|mesh-list
92092757|NCT03840915|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92092758|NCT03840915|Carboplatin|carboplatin|mesh-list
92092759|NCT03840915|Gemcitabine|gemcitabine|mesh-list
92092760|NCT03840915|Pemetrexed|pemetrexed|mesh-list
92092761|NCT03840915|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92092762|NCT03840915|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092763|NCT03840915|Tubulin Modulators|tubulin modulators|mesh-ancestor
92092764|NCT03840915|Antimitotic Agents|antimitotic agents|mesh-ancestor
92092765|NCT03840915|Mitosis Modulators|mitosis modulators|mesh-ancestor
92092766|NCT03840915|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092767|NCT03840915|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92092768|NCT03840915|Antimetabolites|antimetabolites|mesh-ancestor
92092769|NCT03840915|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92092770|NCT03840915|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92092771|NCT03840915|Nucleic Acid Synthesis Inhibitors|nucleic acid synthesis inhibitors|mesh-ancestor
92092772|NCT03748953|Ixazomib|ixazomib|mesh-list
92092773|NCT03748953|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92092774|NCT03748953|Protease Inhibitors|protease inhibitors|mesh-ancestor
92092806|NCT02083107|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92092807|NCT02083107|Oxytocics|oxytocics|mesh-ancestor
92092808|NCT02335905|Ceftaroline fosamil|ceftaroline fosamil|mesh-list
92092809|NCT02335905|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92092810|NCT02335905|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092811|NCT00925756|Maraviroc|maraviroc|mesh-list
92092812|NCT00925756|HIV Fusion Inhibitors|hiv fusion inhibitors|mesh-ancestor
92092813|NCT00925756|Viral Fusion Protein Inhibitors|viral fusion protein inhibitors|mesh-ancestor
92092814|NCT00925756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92092815|NCT00925756|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92092816|NCT00925756|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92092817|NCT00925756|Antiviral Agents|antiviral agents|mesh-ancestor
92092818|NCT00925756|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92092819|NCT00925756|CCR5 Receptor Antagonists|ccr5 receptor antagonists|mesh-ancestor
92092820|NCT04372732|Autoantibodies|autoantibodies|mesh-list
92092867|NCT02244112|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92092868|NCT02244112|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92092869|NCT02244112|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92092870|NCT02244112|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92092871|NCT02244112|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92092936|NCT03630159|Pembrolizumab|pembrolizumab|mesh-list
92092937|NCT03630159|Tisagenlecleucel|tisagenlecleucel|mesh-list
92092939|NCT03630159|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093008|NCT03627741|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093011|NCT03626337|Vitamins|vitamins|mesh-ancestor
92093084|NCT03705429|Docetaxel|docetaxel|mesh-list
92093085|NCT03705429|Albumin-Bound Paclitaxel|albumin-bound paclitaxel|mesh-list
92093086|NCT03705429|Cyclophosphamide|cyclophosphamide|mesh-list
92093155|NCT05620654|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093226|NCT04370392|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093229|NCT04369222|Acetaminophen|acetaminophen|mesh-list
92093300|NCT04363060|Amoxicillin|amoxicillin|mesh-list
92093301|NCT04363060|Azithromycin|azithromycin|mesh-list
92093373|NCT01696214|Leukotriene Antagonists|leukotriene antagonists|mesh-ancestor
92093374|NCT01696214|Hormone Antagonists|hormone antagonists|mesh-ancestor
92093375|NCT01696214|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92093376|NCT01696214|Cytochrome P-450 CYP1A2 Inducers|cytochrome p-450 cyp1a2 inducers|mesh-ancestor
92093377|NCT01696214|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92093378|NCT01696214|Cholinergic Antagonists|cholinergic antagonists|mesh-ancestor
92093379|NCT01696214|Cholinergic Agents|cholinergic agents|mesh-ancestor
92093380|NCT01696214|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92093381|NCT01696214|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093382|NCT01696214|Vasodilator Agents|vasodilator agents|mesh-ancestor
92093383|NCT01696214|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92093384|NCT01696214|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92093435|NCT05347641|Methotrexate|methotrexate|mesh-list
92093436|NCT05347641|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093437|NCT05347641|Immunologic Factors|immunologic factors|mesh-ancestor
92093438|NCT05347641|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093439|NCT05347641|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093440|NCT05347641|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92093441|NCT05347641|Abortifacient Agents|abortifacient agents|mesh-ancestor
92093442|NCT05347641|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92093443|NCT05347641|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92093444|NCT05347641|Antimetabolites|antimetabolites|mesh-ancestor
92093445|NCT05347641|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093496|NCT03580317|Sensory System Agents|sensory system agents|mesh-ancestor
92093497|NCT03580317|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093498|NCT03580317|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92093567|NCT00938548|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92093568|NCT00938548|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093569|NCT00938548|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92093570|NCT00938548|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92093571|NCT00938548|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92093572|NCT00938548|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093573|NCT00938548|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92093574|NCT00932620|Simvastatin|simvastatin|mesh-list
92093575|NCT00932620|Ezetimibe|ezetimibe|mesh-list
92093576|NCT00932620|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92093577|NCT00932620|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92093578|NCT00932620|Antimetabolites|antimetabolites|mesh-ancestor
92093628|NCT00938704|Cryoprotective Agents|cryoprotective agents|mesh-ancestor
92093629|NCT00938704|Laxatives|laxatives|mesh-ancestor
92093630|NCT00938704|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92093631|NCT03666351|Losartan|losartan|mesh-list
92093632|NCT03666351|Amlodipine|amlodipine|mesh-list
92093633|NCT03666351|Chlorthalidone|chlorthalidone|mesh-list
92093634|NCT03666351|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92093698|NCT03777813|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093774|NCT04366960|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92093775|NCT04366960|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093776|NCT03539445|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92093777|NCT03539445|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92093778|NCT03539445|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92093779|NCT03539445|Protective Agents|protective agents|mesh-ancestor
92093780|NCT03539445|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093781|NCT04360876|Dexamethasone|dexamethasone|mesh-list
92093782|NCT04360876|Dexamethasone acetate|dexamethasone acetate|mesh-list
92093783|NCT04360876|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093784|NCT04360876|Antiemetics|antiemetics|mesh-ancestor
92093785|NCT04360876|Autonomic Agents|autonomic agents|mesh-ancestor
92093786|NCT04360876|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093787|NCT04360876|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093788|NCT04360876|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92093789|NCT04360876|Glucocorticoids|glucocorticoids|mesh-ancestor
92093790|NCT04360876|Hormones|hormones|mesh-ancestor
92093831|NCT04359316|Antimalarials|antimalarials|mesh-ancestor
92093832|NCT04359316|Antiprotozoal Agents|antiprotozoal agents|mesh-ancestor
92093833|NCT04359316|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92093834|NCT04359316|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093835|NCT04359316|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093836|NCT04359316|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093837|NCT03558867|Metformin|metformin|mesh-list
92093838|NCT03558867|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92093839|NCT03558867|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093840|NCT00939874|Raltegravir Potassium|raltegravir potassium|mesh-list
92093841|NCT00939874|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92093842|NCT00939874|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92093843|NCT00939874|Antiviral Agents|antiviral agents|mesh-ancestor
92093844|NCT00939874|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093845|NCT00939874|HIV Integrase Inhibitors|hiv integrase inhibitors|mesh-ancestor
92093846|NCT00939874|Integrase Inhibitors|integrase inhibitors|mesh-ancestor
92093847|NCT00939874|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093848|NCT00939874|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093849|NCT03557385|Adenosine|adenosine|mesh-list
92093850|NCT03557385|Analgesics|analgesics|mesh-ancestor
92093851|NCT03557385|Sensory System Agents|sensory system agents|mesh-ancestor
92093886|NCT04358614|Anti-HIV Agents|anti-hiv agents|mesh-ancestor
92093887|NCT04358614|Anti-Retroviral Agents|anti-retroviral agents|mesh-ancestor
92093888|NCT04358614|Antiviral Agents|antiviral agents|mesh-ancestor
92093889|NCT04358614|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093890|NCT04358614|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92093891|NCT04358614|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92093892|NCT01670409|Cisplatin|cisplatin|mesh-list
92093893|NCT01670409|Fluorouracil|fluorouracil|mesh-list
92093894|NCT01670409|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093895|NCT01670409|Antimetabolites|antimetabolites|mesh-ancestor
92093896|NCT01670409|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093897|NCT01670409|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92093898|NCT01670409|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093947|NCT01670565|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92093948|NCT01670565|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92093949|NCT01670565|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093950|NCT01670565|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093951|NCT01670565|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92093952|NCT01670565|Immunologic Factors|immunologic factors|mesh-ancestor
92093953|NCT01670565|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093954|NCT01670799|Ketorolac|ketorolac|mesh-list
92093955|NCT01670799|Ketorolac Tromethamine|ketorolac tromethamine|mesh-list
92093956|NCT01670799|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92093957|NCT01670799|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92093958|NCT01670799|Analgesics|analgesics|mesh-ancestor
92093959|NCT01670799|Sensory System Agents|sensory system agents|mesh-ancestor
92093960|NCT01670799|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92093961|NCT01670799|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093962|NCT01670799|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92093963|NCT01670799|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093964|NCT01670799|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92093965|NCT01670799|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92093966|NCT01670799|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093967|NCT02404935|Cetuximab|cetuximab|mesh-list
92093968|NCT02404935|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92093969|NCT02404935|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92093970|NCT04320940|Phenobarbital|phenobarbital|mesh-list
92093971|NCT04320940|Anticonvulsants|anticonvulsants|mesh-ancestor
92093972|NCT04320940|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92093973|NCT04320940|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92093974|NCT04320940|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093975|NCT04320940|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92093990|NCT03422523|Immunologic Factors|immunologic factors|mesh-ancestor
92093991|NCT03422523|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92093992|NCT03422523|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92093993|NCT03422523|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92093995|NCT03422523|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92093997|NCT03032536|Tenofovir|tenofovir|mesh-list
92094056|NCT03032458|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92094057|NCT03032458|Narcotics|narcotics|mesh-ancestor
92094059|NCT02245438|Ritonavir|ritonavir|mesh-list
92094132|NCT00948298|Micronutrients|micronutrients|mesh-ancestor
92094133|NCT00948298|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094134|NCT00948298|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92094135|NCT00948610|Infliximab|infliximab|mesh-list
92094136|NCT00948610|Tumor Necrosis Factor Inhibitors|tumor necrosis factor inhibitors|mesh-ancestor
92094137|NCT00948610|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094138|NCT00948610|Dermatologic Agents|dermatologic agents|mesh-ancestor
92094139|NCT00948610|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92094140|NCT00948610|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094141|NCT03031834|Quinapril|quinapril|mesh-list
92094142|NCT03031834|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92094143|NCT03031834|Protease Inhibitors|protease inhibitors|mesh-ancestor
92094144|NCT03031834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094145|NCT03031834|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094146|NCT03031834|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92094148|NCT00944554|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92094149|NCT00944554|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92094150|NCT00944554|Cholinergic Agents|cholinergic agents|mesh-ancestor
92094151|NCT00944554|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094152|NCT00944554|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094153|NCT00944554|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094155|NCT03031756|Glycine Agents|glycine agents|mesh-ancestor
92094156|NCT03031756|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094157|NCT03031756|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094158|NCT03031756|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094159|NCT00944710|Atropine|atropine|mesh-list
92094160|NCT00944710|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92094163|NCT00944710|Autonomic Agents|autonomic agents|mesh-ancestor
92094178|NCT00949078|Respiratory System Agents|respiratory system agents|mesh-ancestor
92094179|NCT00945256|Nitroprusside|nitroprusside|mesh-list
92094180|NCT00945256|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92094181|NCT00945256|Vasodilator Agents|vasodilator agents|mesh-ancestor
92094182|NCT00945256|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92094183|NCT00945256|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094184|NCT03854032|Nivolumab|nivolumab|mesh-list
92094185|NCT03854032|Linrodostat|linrodostat|mesh-list
92094186|NCT03854032|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094187|NCT03854032|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094188|NCT03854032|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92094189|NCT03854032|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094190|NCT03854032|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094191|NCT03031444|Leucovorin|leucovorin|mesh-list
92094192|NCT03031444|Cetuximab|cetuximab|mesh-list
92094193|NCT03031444|Fluorouracil|fluorouracil|mesh-list
92094194|NCT03031444|Oxaliplatin|oxaliplatin|mesh-list
92094195|NCT03031444|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094196|NCT03031444|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094197|NCT03031444|Antimetabolites|antimetabolites|mesh-ancestor
92094198|NCT03031444|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094199|NCT03031444|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92094200|NCT03031444|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094201|NCT03031444|Immunologic Factors|immunologic factors|mesh-ancestor
92094202|NCT03031444|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094229|NCT05153590|Liraglutide|liraglutide|mesh-list
92094230|NCT05153590|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92094231|NCT05153590|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094232|NCT05153590|Incretins|incretins|mesh-ancestor
92094233|NCT05153590|Hormones|hormones|mesh-ancestor
92094234|NCT05153590|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094235|NCT03490864|Melatonin|melatonin|mesh-list
92094298|NCT03030430|Bevacizumab|bevacizumab|mesh-list
92094299|NCT03030430|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094300|NCT03030430|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094301|NCT03030430|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92094302|NCT03030430|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92094303|NCT03030430|Growth Substances|growth substances|mesh-ancestor
92094304|NCT03030430|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094305|NCT03030430|Growth Inhibitors|growth inhibitors|mesh-ancestor
92094306|NCT00089661|Denosumab|denosumab|mesh-list
92094307|NCT00089661|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92094308|NCT00089661|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094309|NCT00941668|Triclosan|triclosan|mesh-list
92094310|NCT00941668|Fluorides|fluorides|mesh-list
92094311|NCT00941668|Fluorophosphate|fluorophosphate|mesh-list
92094312|NCT00941668|Cariostatic Agents|cariostatic agents|mesh-ancestor
92094313|NCT00941668|Protective Agents|protective agents|mesh-ancestor
92094314|NCT00941668|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094315|NCT00941668|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92094316|NCT00941668|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094317|NCT00941668|Fatty Acid Synthesis Inhibitors|fatty acid synthesis inhibitors|mesh-ancestor
92094318|NCT00941668|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92094319|NCT00941668|Antimetabolites|antimetabolites|mesh-ancestor
92094320|NCT00941668|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094321|NCT00941668|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92094322|NCT01597414|Trastuzumab|trastuzumab|mesh-list
92094323|NCT01597414|Pertuzumab|pertuzumab|mesh-list
92094324|NCT01597414|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92094325|NCT01597414|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094326|NCT04984330|Dexamethasone|dexamethasone|mesh-list
92094327|NCT04984330|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094328|NCT04984330|Antiemetics|antiemetics|mesh-ancestor
92094329|NCT04984330|Autonomic Agents|autonomic agents|mesh-ancestor
92094330|NCT04984330|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094331|NCT04984330|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094339|NCT03030196|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92094340|NCT03030196|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094341|NCT00265798|Sorafenib|sorafenib|mesh-list
92094411|NCT00088881|Rituximab|rituximab|mesh-list
92094412|NCT00088881|Doxorubicin|doxorubicin|mesh-list
92094484|NCT00953212|Cytochrome P-450 CYP1A2 Inhibitors|cytochrome p-450 cyp1a2 inhibitors|mesh-ancestor
92094485|NCT00953212|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92094486|NCT00953212|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094487|NCT00953212|Cytochrome P-450 CYP2C9 Inhibitors|cytochrome p-450 cyp2c9 inhibitors|mesh-ancestor
92094488|NCT00953212|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92094489|NCT00953212|Cytochrome P-450 CYP3A Inhibitors|cytochrome p-450 cyp3a inhibitors|mesh-ancestor
92094490|NCT00953212|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92094491|NCT00953212|Sympatholytics|sympatholytics|mesh-ancestor
92094549|NCT03022318|Dopamine Agonists|dopamine agonists|mesh-ancestor
92094550|NCT01677897|Metformin|metformin|mesh-list
92094551|NCT01677897|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92095516|NCT05025033|Antimitotic Agents|antimitotic agents|mesh-ancestor
92094552|NCT01677897|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094553|NCT03483363|Anti-Bacterial Agents|anti-bacterial agents|mesh-list
92094554|NCT03483363|Bacitracin|bacitracin|mesh-list
92094555|NCT03483363|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-list
92094556|NCT03483363|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094557|NCT03483363|Antitubercular Agents|antitubercular agents|mesh-ancestor
92094558|NCT03483363|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92094559|NCT03086733|Metformin|metformin|mesh-list
92094560|NCT03086733|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92094561|NCT03086733|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094562|NCT00086619|Parathyroid Hormone|parathyroid hormone|mesh-list
92094612|NCT00946270|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094613|NCT00946270|Leprostatic Agents|leprostatic agents|mesh-ancestor
92094686|NCT00946348|Cannabinoid Receptor Agonists|cannabinoid receptor agonists|mesh-ancestor
92094757|NCT00080223|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92094758|NCT00080223|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92094759|NCT00080223|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92094760|NCT00080223|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094761|NCT04402359|Meropenem|meropenem|mesh-list
92094762|NCT04402359|Ceftazidime|ceftazidime|mesh-list
92094763|NCT04402359|Avibactam|avibactam|mesh-list
92094764|NCT04402359|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92094765|NCT04402359|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92094766|NCT04402359|beta-Lactamase Inhibitors|beta-lactamase inhibitors|mesh-ancestor
92094767|NCT04402359|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094768|NCT04402359|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094769|NCT00959764|Calcitonin|calcitonin|mesh-list
92094770|NCT00959764|Salmon calcitonin|salmon calcitonin|mesh-list
92094771|NCT00959764|Calcitonin Gene-Related Peptide|calcitonin gene-related peptide|mesh-list
92094772|NCT00959764|Katacalcin|katacalcin|mesh-list
92094773|NCT00959764|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92094774|NCT00959764|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094775|NCT00959764|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92094776|NCT00959764|Vasodilator Agents|vasodilator agents|mesh-ancestor
92094777|NCT01005706|Mycophenolic Acid|mycophenolic acid|mesh-list
92094778|NCT01005706|Sirolimus|sirolimus|mesh-list
92094779|NCT01005706|Temsirolimus|temsirolimus|mesh-list
92094780|NCT01005706|MTOR Inhibitors|mtor inhibitors|mesh-list
92094781|NCT01005706|Tacrolimus|tacrolimus|mesh-list
92094782|NCT01005706|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92094783|NCT01005706|Immunologic Factors|immunologic factors|mesh-ancestor
92094784|NCT01005706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094785|NCT01005706|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92094786|NCT01005706|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094787|NCT01005706|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094788|NCT01005706|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92094789|NCT01005706|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094800|NCT01679691|Anesthetics|anesthetics|mesh-list
92094801|NCT01679691|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92094874|NCT03430947|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92094875|NCT03430947|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92094876|NCT03430947|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094877|NCT03430947|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094878|NCT00960778|Nicotine|nicotine|mesh-list
92094879|NCT00960778|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92094880|NCT00960778|Autonomic Agents|autonomic agents|mesh-ancestor
92094881|NCT00960778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094882|NCT00960778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094883|NCT00960778|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92094884|NCT00960778|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92094885|NCT00960778|Cholinergic Agents|cholinergic agents|mesh-ancestor
92094886|NCT00960778|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92094887|NCT00960778|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094888|NCT03080181|Pasireotide|pasireotide|mesh-list
92094889|NCT03080181|Hormones|hormones|mesh-ancestor
92094890|NCT03080181|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92094891|NCT03080181|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094892|NCT03088293|Infliximab|infliximab|mesh-list
92094893|NCT03088293|Cyclophosphamide|cyclophosphamide|mesh-list
92094925|NCT05688813|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094926|NCT01009918|Carvedilol|carvedilol|mesh-list
92094927|NCT01009918|Lisinopril|lisinopril|mesh-list
92094928|NCT01009918|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92094929|NCT01009918|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92094930|NCT01009918|Adrenergic Agents|adrenergic agents|mesh-ancestor
92094931|NCT01009918|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095517|NCT05025033|Mitosis Modulators|mitosis modulators|mesh-ancestor
92094932|NCT01009918|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92094933|NCT01009918|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094934|NCT01009918|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92094935|NCT01009918|Antioxidants|antioxidants|mesh-ancestor
92094936|NCT01009918|Protective Agents|protective agents|mesh-ancestor
92094937|NCT01009918|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92094938|NCT01009918|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92094939|NCT01009918|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92094940|NCT01009918|Vasodilator Agents|vasodilator agents|mesh-ancestor
92094941|NCT01009918|Adrenergic alpha-1 Receptor Antagonists|adrenergic alpha-1 receptor antagonists|mesh-ancestor
92094942|NCT01009918|Adrenergic alpha-Antagonists|adrenergic alpha-antagonists|mesh-ancestor
92094943|NCT01009918|Angiotensin-Converting Enzyme Inhibitors|angiotensin-converting enzyme inhibitors|mesh-ancestor
92094944|NCT01009918|Protease Inhibitors|protease inhibitors|mesh-ancestor
92094945|NCT01009918|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92094946|NCT01009918|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92094947|NCT04401657|Adenosine|adenosine|mesh-list
92094948|NCT04401657|Analgesics|analgesics|mesh-ancestor
92094949|NCT04401657|Sensory System Agents|sensory system agents|mesh-ancestor
92094950|NCT04401657|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92094951|NCT04401657|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92094952|NCT04401657|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92094953|NCT04401657|Vasodilator Agents|vasodilator agents|mesh-ancestor
92094954|NCT04401657|Purinergic P1 Receptor Agonists|purinergic p1 receptor agonists|mesh-ancestor
92094955|NCT04401657|Purinergic Agonists|purinergic agonists|mesh-ancestor
92094968|NCT03083613|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095040|NCT01012336|Glucocorticoids|glucocorticoids|mesh-ancestor
92095041|NCT01012336|Hormones|hormones|mesh-ancestor
92095042|NCT01012336|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095043|NCT01012336|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92095044|NCT01012336|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095108|NCT00971620|Botulinum Toxins|botulinum toxins|mesh-list
92095109|NCT00971620|Botulinum Toxins, Type A|botulinum toxins, type a|mesh-list
92095110|NCT00971620|abobotulinumtoxinA|abobotulinumtoxina|mesh-list
92095111|NCT00971620|Acetylcholine Release Inhibitors|acetylcholine release inhibitors|mesh-ancestor
92095119|NCT03384537|Chlorhexidine|chlorhexidine|mesh-list
92095177|NCT05687253|Neuromuscular Blocking Agents|neuromuscular blocking agents|mesh-ancestor
92095178|NCT05687253|Neuromuscular Agents|neuromuscular agents|mesh-ancestor
92095179|NCT05687253|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095180|NCT05687253|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095181|NCT02159872|Homoharringtonine|homoharringtonine|mesh-list
92095182|NCT02159872|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92095183|NCT02159872|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095184|NCT02159872|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92095185|NCT02159872|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095186|NCT02159872|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095187|NCT00417664|Midazolam|midazolam|mesh-list
92095240|NCT03358563|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095241|NCT03358563|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095242|NCT03358563|Hematinics|hematinics|mesh-ancestor
92095313|NCT01023724|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92095314|NCT01023724|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92095315|NCT01023724|Analgesics|analgesics|mesh-ancestor
92095316|NCT01023724|Sensory System Agents|sensory system agents|mesh-ancestor
92095385|NCT05686395|Anesthetics, Local|anesthetics, local|mesh-ancestor
92095386|NCT05686395|Anesthetics|anesthetics|mesh-ancestor
92095387|NCT05686395|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92095388|NCT05686395|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095389|NCT05686395|Sensory System Agents|sensory system agents|mesh-ancestor
92095390|NCT05686395|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92095392|NCT01025830|Nevirapine|nevirapine|mesh-list
92095393|NCT01025830|Stavudine|stavudine|mesh-list
92095406|NCT03081039|Carboplatin|carboplatin|mesh-list
92095451|NCT03321981|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92095452|NCT03321981|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095453|NCT03321981|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92095454|NCT03321981|Tubulin Modulators|tubulin modulators|mesh-ancestor
92095455|NCT03321981|Antimitotic Agents|antimitotic agents|mesh-ancestor
92095456|NCT03321981|Mitosis Modulators|mitosis modulators|mesh-ancestor
92095457|NCT03321981|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92095458|NCT03321981|Estrogen Receptor Antagonists|estrogen receptor antagonists|mesh-ancestor
92095459|NCT01027468|Bevacizumab|bevacizumab|mesh-list
92095467|NCT05237349|Oxaliplatin|oxaliplatin|mesh-list
92095515|NCT05025033|Tubulin Modulators|tubulin modulators|mesh-ancestor
92095518|NCT05025033|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095519|NCT05025033|Immunologic Factors|immunologic factors|mesh-ancestor
92095520|NCT05025033|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095521|NCT05025033|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92095522|NCT05025033|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92095523|NCT05025033|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095524|NCT05025033|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92095525|NCT00980746|Eslicarbazepine acetate|eslicarbazepine acetate|mesh-list
92095531|NCT00981214|Pancrelipase|pancrelipase|mesh-list
92095578|NCT01032850|Antimetabolites|antimetabolites|mesh-ancestor
92095579|NCT01032850|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095650|NCT01887353|Ranolazine|ranolazine|mesh-list
92095723|NCT05022394|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095725|NCT01895777|Antithrombins|antithrombins|mesh-ancestor
92095726|NCT01895777|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92095727|NCT01895777|Protease Inhibitors|protease inhibitors|mesh-ancestor
92095728|NCT01895777|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095729|NCT01895777|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095730|NCT01895777|Anticoagulants|anticoagulants|mesh-ancestor
92095732|NCT00992602|Methotrexate|methotrexate|mesh-list
92095733|NCT00992602|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92095734|NCT00992602|Abortifacient Agents|abortifacient agents|mesh-ancestor
92095735|NCT00992602|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92095736|NCT00992602|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095737|NCT00992602|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92095738|NCT00992602|Antimetabolites|antimetabolites|mesh-ancestor
92095739|NCT00992602|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095740|NCT00992602|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095741|NCT00992602|Dermatologic Agents|dermatologic agents|mesh-ancestor
92095742|NCT00992602|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095777|NCT00995722|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92095778|NCT00995722|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095779|NCT00996346|Sirolimus|sirolimus|mesh-list
92095780|NCT00996346|Irinotecan|irinotecan|mesh-list
92095781|NCT00996346|Temsirolimus|temsirolimus|mesh-list
92095782|NCT00996346|MTOR Inhibitors|mtor inhibitors|mesh-list
92095783|NCT00996346|Complement Factor H|complement factor h|mesh-list
92095784|NCT00996346|Topoisomerase I Inhibitors|topoisomerase i inhibitors|mesh-ancestor
92095785|NCT00996346|Topoisomerase Inhibitors|topoisomerase inhibitors|mesh-ancestor
92095786|NCT00996346|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095787|NCT00996346|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095788|NCT00996346|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095839|NCT04606797|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92095840|NCT04606797|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92095841|NCT04606797|Cholinergic Agents|cholinergic agents|mesh-ancestor
92095842|NCT04606797|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92095843|NCT04606797|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095844|NCT02164240|Sunitinib|sunitinib|mesh-list
92095845|NCT02164240|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095846|NCT02164240|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92095847|NCT02164240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92095848|NCT02164240|Growth Substances|growth substances|mesh-ancestor
92095849|NCT02164240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095873|NCT01001806|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095931|NCT04757571|Serotonin Agents|serotonin agents|mesh-ancestor
92095932|NCT04757571|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92095933|NCT04757571|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92095934|NCT04757571|Antidepressive Agents|antidepressive agents|mesh-ancestor
92095935|NCT04757571|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92095936|NCT04757571|Cytochrome P-450 CYP2D6 Inhibitors|cytochrome p-450 cyp2d6 inhibitors|mesh-ancestor
92095937|NCT04757571|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92095938|NCT04757571|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92095939|NCT03232593|Atezolizumab|atezolizumab|mesh-list
92095996|NCT03285321|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92095997|NCT03285321|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92095998|NCT03285321|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92095999|NCT05066698|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92096000|NCT05066698|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92096001|NCT04323748|Rituximab|rituximab|mesh-list
92096002|NCT04323748|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096003|NCT04323748|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096004|NCT04323748|Immunologic Factors|immunologic factors|mesh-ancestor
92096005|NCT04323748|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096006|NCT04323748|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096007|NCT04197310|Nivolumab|nivolumab|mesh-list
92096008|NCT04197310|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92096009|NCT04197310|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096010|NCT04197310|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92096011|NCT04197310|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096012|NCT05320731|Lidocaine|lidocaine|mesh-list
92096013|NCT05320731|Anesthetics, Local|anesthetics, local|mesh-ancestor
92096053|NCT04130698|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92096054|NCT04130698|Autonomic Agents|autonomic agents|mesh-ancestor
92096055|NCT04130698|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096056|NCT04130698|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096057|NCT04130698|Nicotinic Agonists|nicotinic agonists|mesh-ancestor
92096058|NCT04130698|Cholinergic Agonists|cholinergic agonists|mesh-ancestor
92096059|NCT04130698|Cholinergic Agents|cholinergic agents|mesh-ancestor
92096060|NCT04130698|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096061|NCT04130698|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096062|NCT05306223|Levofloxacin|levofloxacin|mesh-list
92096063|NCT05306223|Cycloserine|cycloserine|mesh-list
92096064|NCT05306223|Linezolid|linezolid|mesh-list
92096065|NCT05306223|Pyrazinamide|pyrazinamide|mesh-list
92096066|NCT05306223|Bedaquiline|bedaquiline|mesh-list
92096067|NCT05306223|Clofazimine|clofazimine|mesh-list
92096068|NCT05306223|Prothionamide|prothionamide|mesh-list
92096069|NCT05306223|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92096074|NCT05306223|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096110|NCT03254589|Methotrexate|methotrexate|mesh-list
92096111|NCT03254589|Abortifacient Agents, Nonsteroidal|abortifacient agents, nonsteroidal|mesh-ancestor
92096112|NCT03254589|Abortifacient Agents|abortifacient agents|mesh-ancestor
92096113|NCT03254589|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92096114|NCT03254589|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096115|NCT03254589|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92096116|NCT03254589|Antimetabolites|antimetabolites|mesh-ancestor
92096117|NCT03254589|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096118|NCT03254589|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096119|NCT03254589|Dermatologic Agents|dermatologic agents|mesh-ancestor
92096120|NCT03254589|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096121|NCT03254589|Folic Acid Antagonists|folic acid antagonists|mesh-ancestor
92096122|NCT03254589|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096123|NCT03254589|Immunologic Factors|immunologic factors|mesh-ancestor
92096124|NCT03254589|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096167|NCT04613453|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096169|NCT04613453|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92096170|NCT04613453|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92096171|NCT04613453|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92096172|NCT04613453|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096173|NCT04613453|GABA Modulators|gaba modulators|mesh-ancestor
92096174|NCT04613453|GABA Agents|gaba agents|mesh-ancestor
92096175|NCT02000596|Trastuzumab|trastuzumab|mesh-list
92096233|NCT03015922|Immunologic Factors|immunologic factors|mesh-ancestor
92096234|NCT03015922|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096235|NCT03015922|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92096236|NCT03015922|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92096237|NCT03015922|Growth Substances|growth substances|mesh-ancestor
92096238|NCT03015922|Growth Inhibitors|growth inhibitors|mesh-ancestor
92096239|NCT03015922|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096241|NCT01893827|Alcohol Deterrents|alcohol deterrents|mesh-ancestor
92096242|NCT01893827|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92096243|NCT01893827|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096244|NCT01893827|Sensory System Agents|sensory system agents|mesh-ancestor
92096246|NCT01882907|Pioglitazone|pioglitazone|mesh-list
92096295|NCT05263947|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096296|NCT05263947|Growth Inhibitors|growth inhibitors|mesh-ancestor
92096298|NCT04415567|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096299|NCT04415567|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92096300|NCT04415567|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096301|NCT04415567|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096302|NCT03280251|Methylphenidate|methylphenidate|mesh-list
92096303|NCT03280251|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92096304|NCT03280251|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096360|NCT03014830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096361|NCT03014830|Serine Proteinase Inhibitors|serine proteinase inhibitors|mesh-ancestor
92096362|NCT03014830|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096363|NCT03014830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096364|NCT03014830|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92096365|NCT01055704|Naltrexone|naltrexone|mesh-list
92096366|NCT01055704|Codeine|codeine|mesh-list
92096367|NCT01055704|Methylnaltrexone|methylnaltrexone|mesh-list
92096368|NCT01055704|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92096369|NCT01055704|Narcotics|narcotics|mesh-ancestor
92096370|NCT01055704|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096371|NCT01055704|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096421|NCT01109056|Immunologic Factors|immunologic factors|mesh-ancestor
92096422|NCT01109056|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096423|NCT01109056|Antifungal Agents|antifungal agents|mesh-ancestor
92096424|NCT01109056|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92096425|NCT01109056|Dermatologic Agents|dermatologic agents|mesh-ancestor
92096426|NCT01109056|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096427|NCT01109056|Calcineurin Inhibitors|calcineurin inhibitors|mesh-ancestor
92096428|NCT03870399|Tamoxifen|tamoxifen|mesh-list
92096429|NCT03870399|Estrogen Antagonists|estrogen antagonists|mesh-ancestor
92096430|NCT03870399|Hormone Antagonists|hormone antagonists|mesh-ancestor
92096431|NCT03870399|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096432|NCT03870399|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096438|NCT04333407|Aspirin|aspirin|mesh-list
92096483|NCT01059682|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92096485|NCT04399083|Central Nervous System Stimulants|central nervous system stimulants|mesh-ancestor
92096486|NCT04399083|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096487|NCT04399083|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92096488|NCT04399083|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096489|NCT04399083|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096490|NCT04399083|Purinergic P1 Receptor Antagonists|purinergic p1 receptor antagonists|mesh-ancestor
92096491|NCT04399083|Purinergic Antagonists|purinergic antagonists|mesh-ancestor
92096492|NCT04399083|Purinergic Agents|purinergic agents|mesh-ancestor
92096493|NCT04399083|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096494|NCT01892345|Eculizumab|eculizumab|mesh-list
92096495|NCT01892345|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92096496|NCT01892345|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92096497|NCT01892345|Immunologic Factors|immunologic factors|mesh-ancestor
92096498|NCT01892345|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096516|NCT01892189|Ketamine|ketamine|mesh-list
92096537|NCT01062568|Autonomic Agents|autonomic agents|mesh-ancestor
92096538|NCT01062568|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096539|NCT01062568|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096540|NCT01062568|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92096541|NCT01062568|Glucocorticoids|glucocorticoids|mesh-ancestor
92096542|NCT01062568|Hormones|hormones|mesh-ancestor
92096543|NCT01062568|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92096544|NCT01062568|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92096545|NCT01062568|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096546|NCT01062568|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096547|NCT01062568|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096548|NCT05155137|Amlodipine|amlodipine|mesh-list
92096549|NCT05155137|Valsartan|valsartan|mesh-list
92096550|NCT05155137|Rosuvastatin Calcium|rosuvastatin calcium|mesh-list
92096551|NCT05155137|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92096552|NCT05155137|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92096566|NCT01064284|Factor VIII|factor viii|mesh-list
92096595|NCT01880957|Antimanic Agents|antimanic agents|mesh-ancestor
92096596|NCT01880957|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92096597|NCT01880957|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096598|NCT01880957|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096599|NCT01880957|Anticonvulsants|anticonvulsants|mesh-ancestor
92096600|NCT01880957|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92096601|NCT01880957|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92096602|NCT01880957|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92096603|NCT01880957|Antipsychotic Agents|antipsychotic agents|mesh-ancestor
92096604|NCT01880957|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92096606|NCT01064830|Cyclosporins|cyclosporins|mesh-list
92096607|NCT01064830|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096608|NCT01064830|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096653|NCT01863953|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096654|NCT01068964|Timolol|timolol|mesh-list
92096655|NCT01068964|Bimatoprost|bimatoprost|mesh-list
92096656|NCT01068964|Pharmaceutical Solutions|pharmaceutical solutions|mesh-list
92096657|NCT01068964|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92096658|NCT01068964|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92096659|NCT01068964|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92096660|NCT01068964|Adrenergic Agents|adrenergic agents|mesh-ancestor
92096661|NCT01068964|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096662|NCT01068964|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096663|NCT01068964|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096664|NCT01068964|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92096665|NCT01068964|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92096666|NCT03217162|Pulmonary Surfactants|pulmonary surfactants|mesh-list
92096667|NCT03217162|Respiratory System Agents|respiratory system agents|mesh-ancestor
92096668|NCT02984475|Metformin|metformin|mesh-list
92096669|NCT02984475|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92096709|NCT04276545|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096710|NCT04276545|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92096711|NCT04276545|Anesthetics, General|anesthetics, general|mesh-ancestor
92096712|NCT04276545|Anesthetics|anesthetics|mesh-ancestor
92096713|NCT04276545|GABA Modulators|gaba modulators|mesh-ancestor
92096714|NCT04276545|GABA Agents|gaba agents|mesh-ancestor
92096715|NCT04276545|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096716|NCT04276545|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096717|NCT01117948|Lornoxicam|lornoxicam|mesh-list
92096718|NCT01117948|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92096719|NCT01117948|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92096720|NCT01117948|Analgesics|analgesics|mesh-ancestor
92096721|NCT01117948|Sensory System Agents|sensory system agents|mesh-ancestor
92096722|NCT01117948|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096723|NCT01117948|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096724|NCT01117948|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096725|NCT01117948|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096726|NCT03602157|Fludarabine|fludarabine|mesh-list
92096727|NCT03602157|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92096728|NCT03602157|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096729|NCT03602157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096732|NCT03014440|Cannabidiol|cannabidiol|mesh-list
92096764|NCT01071538|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92096765|NCT01071538|Narcotics|narcotics|mesh-ancestor
92096766|NCT01071538|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096767|NCT01071538|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096768|NCT01071538|Analgesics|analgesics|mesh-ancestor
92096769|NCT01071538|Sensory System Agents|sensory system agents|mesh-ancestor
92096770|NCT01071538|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92096771|NCT01071538|Narcotic Antagonists|narcotic antagonists|mesh-ancestor
92096772|NCT04352686|Buspirone|buspirone|mesh-list
92096773|NCT04352686|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92096774|NCT04352686|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92096775|NCT04352686|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92096776|NCT04352686|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096777|NCT04352686|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92096778|NCT04352686|Serotonin Receptor Agonists|serotonin receptor agonists|mesh-ancestor
92096779|NCT04352686|Serotonin Agents|serotonin agents|mesh-ancestor
92096780|NCT04352686|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92096821|NCT01120834|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096822|NCT01120834|Histone Deacetylase Inhibitors|histone deacetylase inhibitors|mesh-ancestor
92096823|NCT01122160|Omeprazole|omeprazole|mesh-list
92096824|NCT01122160|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92096825|NCT01122160|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92096826|NCT01122160|Proton Pump Inhibitors|proton pump inhibitors|mesh-ancestor
92096827|NCT01122160|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096828|NCT01122160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096829|NCT02623816|Omeprazole|omeprazole|mesh-list
92096830|NCT02623816|Anti-Ulcer Agents|anti-ulcer agents|mesh-ancestor
92096835|NCT01122238|Nicotine|nicotine|mesh-list
92096887|NCT04397913|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92096888|NCT04397913|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92096889|NCT04397913|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92096890|NCT04397913|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92096891|NCT04397913|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096892|NCT04397913|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096893|NCT02176486|Ixazomib|ixazomib|mesh-list
92096894|NCT02176486|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92096895|NCT02176486|Protease Inhibitors|protease inhibitors|mesh-ancestor
92096896|NCT02176486|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92096897|NCT02176486|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096898|NCT01124188|Venlafaxine Hydrochloride|venlafaxine hydrochloride|mesh-list
92096899|NCT01124188|Serotonin and Noradrenaline Reuptake Inhibitors|serotonin and noradrenaline reuptake inhibitors|mesh-ancestor
92096947|NCT02870829|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92096948|NCT02870829|Hemostatics|hemostatics|mesh-ancestor
92096949|NCT02870829|Coagulants|coagulants|mesh-ancestor
92096951|NCT02870829|Micronutrients|micronutrients|mesh-ancestor
92096952|NCT02870829|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92096953|NCT01876823|Memantine|memantine|mesh-list
92096954|NCT01876823|Citalopram|citalopram|mesh-list
92096955|NCT01876823|Escitalopram|escitalopram|mesh-list
92096956|NCT01876823|Antiparkinson Agents|antiparkinson agents|mesh-ancestor
92096957|NCT01876823|Anti-Dyskinesia Agents|anti-dyskinesia agents|mesh-ancestor
92096958|NCT01876823|Dopamine Agents|dopamine agents|mesh-ancestor
92097012|NCT00638157|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92097014|NCT00638157|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097015|NCT00637377|Ranibizumab|ranibizumab|mesh-list
92097016|NCT00637377|Aflibercept|aflibercept|mesh-list
92097017|NCT00637377|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92097018|NCT00637377|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92097019|NCT00637377|Growth Substances|growth substances|mesh-ancestor
92097020|NCT00637377|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097021|NCT00637377|Growth Inhibitors|growth inhibitors|mesh-ancestor
92097022|NCT00637377|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097023|NCT01475110|Imatinib Mesylate|imatinib mesylate|mesh-list
92097024|NCT01475110|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097025|NCT01475110|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097026|NCT01475110|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097027|NCT01475110|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097028|NCT05307718|Anticoagulants|anticoagulants|mesh-list
92097029|NCT05307718|Factor Xa Inhibitors|factor xa inhibitors|mesh-list
92097030|NCT05307718|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-list
92097031|NCT05307718|Hydroxymethylglutaryl-CoA Reductase Inhibitors|hydroxymethylglutaryl-coa reductase inhibitors|mesh-list
92097032|NCT05307718|Purinergic P2Y Receptor Antagonists|purinergic p2y receptor antagonists|mesh-list
92097033|NCT05307718|Anticholesteremic Agents|anticholesteremic agents|mesh-ancestor
92097034|NCT05307718|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92097035|NCT05307718|Antimetabolites|antimetabolites|mesh-ancestor
92097036|NCT05307718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097037|NCT05307718|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097058|NCT01033864|Antitubercular Agents|antitubercular agents|mesh-ancestor
92097059|NCT01033864|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92097060|NCT01033864|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097061|NCT01033864|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097062|NCT01033864|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097064|NCT01082380|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097065|NCT01082380|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92097066|NCT01082380|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097067|NCT01082380|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097068|NCT01083706|Azacitidine|azacitidine|mesh-list
92097069|NCT01083706|Antimetabolites, Antineoplastic|antimetabolites, antineoplastic|mesh-ancestor
92097121|NCT00636441|Immunologic Factors|immunologic factors|mesh-ancestor
92097122|NCT00636441|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097123|NCT00636441|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097124|NCT00636441|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92097125|NCT00636441|Alkylating Agents|alkylating agents|mesh-ancestor
92097126|NCT00636441|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097127|NCT00636441|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097128|NCT00636441|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92097130|NCT00636441|Antimitotic Agents|antimitotic agents|mesh-ancestor
92097183|NCT00636207|Cytochrome P-450 Enzyme Inducers|cytochrome p-450 enzyme inducers|mesh-ancestor
92097184|NCT00636207|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097185|NCT01091116|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2H-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|mesh-list
92097186|NCT01091116|Bradykinin B2 Receptor Antagonists|bradykinin b2 receptor antagonists|mesh-ancestor
92097187|NCT01091116|Bradykinin Receptor Antagonists|bradykinin receptor antagonists|mesh-ancestor
92097188|NCT01091116|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097189|NCT01091116|Complement Inactivating Agents|complement inactivating agents|mesh-ancestor
92097190|NCT01091116|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097191|NCT01091116|Immunologic Factors|immunologic factors|mesh-ancestor
92097192|NCT01091116|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097193|NCT03169881|Darbepoetin alfa|darbepoetin alfa|mesh-list
92097194|NCT03169881|Hematinics|hematinics|mesh-ancestor
92097195|NCT01092676|Ibuprofen|ibuprofen|mesh-list
92097197|NCT01092676|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097236|NCT01041274|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92097237|NCT01041274|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097238|NCT01041274|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097239|NCT01041274|Serotonin Agents|serotonin agents|mesh-ancestor
92097240|NCT01041274|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097241|NCT01041274|Antidepressive Agents, Second-Generation|antidepressive agents, second-generation|mesh-ancestor
92097242|NCT01041274|Antidepressive Agents|antidepressive agents|mesh-ancestor
92097243|NCT01041274|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92097244|NCT00635349|Acetaminophen|acetaminophen|mesh-list
92097245|NCT00635349|Meloxicam|meloxicam|mesh-list
92097246|NCT00635349|Aceclofenac|aceclofenac|mesh-list
92097247|NCT00635349|Tramadol|tramadol|mesh-list
92097248|NCT00635349|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92097249|NCT00635349|Analgesics|analgesics|mesh-ancestor
92097250|NCT00635349|Sensory System Agents|sensory system agents|mesh-ancestor
92097251|NCT00635349|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097252|NCT00635349|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097253|NCT00635349|Antipyretics|antipyretics|mesh-ancestor
92097254|NCT00635349|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92097255|NCT00635349|Narcotics|narcotics|mesh-ancestor
92097256|NCT00635349|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097257|NCT00635349|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92097258|NCT00635349|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92097259|NCT00635349|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097260|NCT00635349|Cyclooxygenase 2 Inhibitors|cyclooxygenase 2 inhibitors|mesh-ancestor
92097261|NCT00635349|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92097262|NCT00635349|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097263|NCT00635349|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097281|NCT01042288|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097282|NCT01043926|Suvorexant|suvorexant|mesh-list
92097283|NCT01043926|Sleep Aids, Pharmaceutical|sleep aids, pharmaceutical|mesh-ancestor
92097284|NCT01043926|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92097285|NCT01043926|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097286|NCT01043926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097287|NCT01043926|Orexin Receptor Antagonists|orexin receptor antagonists|mesh-ancestor
92097288|NCT01043926|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097289|NCT01043926|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097290|NCT01044706|Bicalutamide|bicalutamide|mesh-list
92097291|NCT01044706|Androgen Antagonists|androgen antagonists|mesh-ancestor
92097292|NCT01044706|Hormone Antagonists|hormone antagonists|mesh-ancestor
92097293|NCT01044706|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097294|NCT01044706|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097339|NCT04361656|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92097340|NCT04361656|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097342|NCT01047358|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097343|NCT01047358|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92097344|NCT01047358|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92097345|NCT01047358|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097346|NCT01047358|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097404|NCT02182492|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92097405|NCT02182492|Hormones|hormones|mesh-ancestor
92097406|NCT02182492|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097407|NCT02182492|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097408|NCT01163656|Cobalt|cobalt|mesh-list
92097474|NCT05389176|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097475|NCT05389176|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097476|NCT05389176|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097477|NCT01132846|Dopamine|dopamine|mesh-list
92097478|NCT01132846|Natriuretic Peptide, Brain|natriuretic peptide, brain|mesh-list
92097479|NCT01132846|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92097480|NCT01132846|Sympathomimetics|sympathomimetics|mesh-ancestor
92097481|NCT01132846|Autonomic Agents|autonomic agents|mesh-ancestor
92097482|NCT01132846|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097483|NCT01132846|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097484|NCT01132846|Dopamine Agents|dopamine agents|mesh-ancestor
92097485|NCT01132846|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097535|NCT01134952|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097536|NCT01134952|Antifungal Agents|antifungal agents|mesh-ancestor
92097537|NCT01134952|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097538|NCT01134952|Immunologic Factors|immunologic factors|mesh-ancestor
92097539|NCT01134952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097540|NCT01175902|Timolol|timolol|mesh-list
92097541|NCT01175902|Dorzolamide|dorzolamide|mesh-list
92097542|NCT01175902|Latanoprost|latanoprost|mesh-list
92097543|NCT01175902|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92097544|NCT01175902|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92097545|NCT01175902|Adrenergic Agents|adrenergic agents|mesh-ancestor
92097546|NCT01175902|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097547|NCT01175902|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097548|NCT01175902|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097549|NCT01175902|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92097550|NCT01175902|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92097551|NCT01175902|Ophthalmic Solutions|ophthalmic solutions|mesh-ancestor
92097552|NCT01175902|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92097592|NCT05164770|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92097593|NCT05164770|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92097594|NCT05164770|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92097595|NCT05164770|Tubulin Modulators|tubulin modulators|mesh-ancestor
92097596|NCT05164770|Antimitotic Agents|antimitotic agents|mesh-ancestor
92097597|NCT05164770|Mitosis Modulators|mitosis modulators|mesh-ancestor
92097598|NCT05164770|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92097599|NCT05164770|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92097658|NCT00634179|Immunosuppressive Agents|immunosuppressive agents|mesh-ancestor
92097659|NCT00634179|Immunologic Factors|immunologic factors|mesh-ancestor
92097660|NCT00634179|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097661|NCT00634179|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92097662|NCT00634179|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92097663|NCT00634179|Alkylating Agents|alkylating agents|mesh-ancestor
92097664|NCT00634179|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097665|NCT00634179|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097722|NCT01180894|Hematinics|hematinics|mesh-ancestor
92097723|NCT01181674|Insulin|insulin|mesh-list
92097724|NCT01181674|Insulin, Globin Zinc|insulin, globin zinc|mesh-list
92097725|NCT01181674|Metformin|metformin|mesh-list
92097726|NCT01181674|Insulin Glargine|insulin glargine|mesh-list
92097727|NCT01181674|Acarbose|acarbose|mesh-list
92097728|NCT01181674|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92097729|NCT01181674|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097730|NCT01181674|Glycoside Hydrolase Inhibitors|glycoside hydrolase inhibitors|mesh-ancestor
92097731|NCT01181674|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097732|NCT01181674|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097733|NCT01182376|Dronedarone|dronedarone|mesh-list
92097734|NCT01182376|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92097735|NCT01183312|Flumazenil|flumazenil|mesh-list
92097736|NCT01183312|Antidotes|antidotes|mesh-ancestor
92097737|NCT01183312|Protective Agents|protective agents|mesh-ancestor
92097738|NCT01183312|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097739|NCT01183312|GABA Modulators|gaba modulators|mesh-ancestor
92097740|NCT01183312|GABA Agents|gaba agents|mesh-ancestor
92097741|NCT01183312|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097783|NCT05672550|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92097784|NCT05672550|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92097785|NCT05672550|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097786|NCT01185028|Interferons|interferons|mesh-list
92097787|NCT01185028|Ribavirin|ribavirin|mesh-list
92097788|NCT01185028|Nitazoxanide|nitazoxanide|mesh-list
92097789|NCT01185028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92097790|NCT01185028|Antiviral Agents|antiviral agents|mesh-ancestor
92097791|NCT01185028|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92097792|NCT01185028|Antimetabolites|antimetabolites|mesh-ancestor
92097850|NCT05309460|Labetalol|labetalol|mesh-list
92097851|NCT05309460|Nifedipine|nifedipine|mesh-list
92097852|NCT05309460|Calcium Channel Blockers|calcium channel blockers|mesh-ancestor
92097853|NCT05309460|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92097854|NCT05309460|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097855|NCT05309460|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92097856|NCT05309460|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097857|NCT05309460|Vasodilator Agents|vasodilator agents|mesh-ancestor
92097858|NCT05309460|Tocolytic Agents|tocolytic agents|mesh-ancestor
92097859|NCT05309460|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92097860|NCT05309460|Adrenergic beta-Antagonists|adrenergic beta-antagonists|mesh-ancestor
92097861|NCT05309460|Adrenergic Antagonists|adrenergic antagonists|mesh-ancestor
92097862|NCT05309460|Adrenergic Agents|adrenergic agents|mesh-ancestor
92097863|NCT05309460|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097864|NCT05309460|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92097865|NCT05309460|Sympathomimetics|sympathomimetics|mesh-ancestor
92097908|NCT01143766|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92097909|NCT01143766|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097911|NCT01143766|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92097912|NCT01143766|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92097913|NCT01143766|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92097914|NCT01143766|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92097915|NCT01143766|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92097916|NCT01143766|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92097917|NCT01143766|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92097918|NCT01143766|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92097919|NCT01143766|Antimanic Agents|antimanic agents|mesh-ancestor
92097920|NCT05439408|Dasatinib|dasatinib|mesh-list
92097925|NCT03011476|Donepezil|donepezil|mesh-list
92097967|NCT01189240|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92097968|NCT01189240|Growth Substances|growth substances|mesh-ancestor
92097969|NCT01189240|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92097970|NCT01189240|Growth Inhibitors|growth inhibitors|mesh-ancestor
92097971|NCT01189240|Immunologic Factors|immunologic factors|mesh-ancestor
92097972|NCT01189240|Gamma Secretase Inhibitors and Modulators|gamma secretase inhibitors and modulators|mesh-ancestor
92097973|NCT01189240|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92097975|NCT03467334|Simethicone|simethicone|mesh-list
92098036|NCT03461718|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92098037|NCT03461718|Anesthetics, General|anesthetics, general|mesh-ancestor
92098038|NCT03461718|Anesthetics|anesthetics|mesh-ancestor
92098039|NCT03461718|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098040|NCT03461718|Excitatory Amino Acid Antagonists|excitatory amino acid antagonists|mesh-ancestor
92098041|NCT03461718|Excitatory Amino Acid Agents|excitatory amino acid agents|mesh-ancestor
92098042|NCT03461718|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098043|NCT03461718|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098044|NCT03461718|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92098045|NCT03461718|Narcotics|narcotics|mesh-ancestor
92098046|NCT03461718|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92098047|NCT03461718|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92098048|NCT03461718|Anti-Anxiety Agents|anti-anxiety agents|mesh-ancestor
92098049|NCT03461718|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92098050|NCT03461718|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098052|NCT03461718|GABA Agents|gaba agents|mesh-ancestor
92098053|NCT05431920|Vitamin D|vitamin d|mesh-list
92098054|NCT05431920|Ergocalciferols|ergocalciferols|mesh-list
92098055|NCT05431920|Cholecalciferol|cholecalciferol|mesh-list
92098056|NCT05431920|Hydroxycholecalciferols|hydroxycholecalciferols|mesh-list
92098057|NCT05431920|Calcifediol|calcifediol|mesh-list
92098058|NCT05431920|Vitamins|vitamins|mesh-list
92098059|NCT05431920|Micronutrients|micronutrients|mesh-ancestor
92098060|NCT05431920|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098061|NCT05431920|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92098062|NCT05431920|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92098063|NCT03467022|Ascorbic Acid|ascorbic acid|mesh-list
92098064|NCT03467022|Vitamins|vitamins|mesh-ancestor
92098067|NCT03467022|Antioxidants|antioxidants|mesh-ancestor
92098081|NCT03466632|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098082|NCT03466632|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098083|NCT03466632|Analgesics|analgesics|mesh-ancestor
92098084|NCT03466632|Sensory System Agents|sensory system agents|mesh-ancestor
92098085|NCT03466632|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098086|NCT03466632|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92098087|NCT03466632|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92098088|NCT03466632|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92098089|NCT03466632|Adrenergic Agents|adrenergic agents|mesh-ancestor
92098090|NCT03466632|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098091|NCT03466632|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098092|NCT03466632|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92098093|NCT03466632|Anesthetics, General|anesthetics, general|mesh-ancestor
92098094|NCT03466632|Anesthetics|anesthetics|mesh-ancestor
92098095|NCT05339334|Ritonavir|ritonavir|mesh-list
92098096|NCT05339334|Nirmatrelvir|nirmatrelvir|mesh-list
92098109|NCT03461328|Analgesics|analgesics|mesh-ancestor
92098139|NCT03466320|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92098140|NCT03466242|Dexmedetomidine|dexmedetomidine|mesh-list
92098141|NCT03466242|Ketamine|ketamine|mesh-list
92098142|NCT03466242|Hypnotics and Sedatives|hypnotics and sedatives|mesh-ancestor
92098143|NCT03466242|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098144|NCT03466242|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098145|NCT03466242|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098146|NCT03466242|Analgesics|analgesics|mesh-ancestor
92098147|NCT03466242|Sensory System Agents|sensory system agents|mesh-ancestor
92098151|NCT03466242|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92098202|NCT02522130|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098203|NCT02522130|Gout Suppressants|gout suppressants|mesh-ancestor
92098204|NCT02522130|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92098205|NCT02522130|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098206|NCT01148524|Vaccines|vaccines|mesh-list
92098207|NCT01148524|Immunologic Factors|immunologic factors|mesh-ancestor
92098208|NCT01148524|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098209|NCT03460860|Tocopherols|tocopherols|mesh-list
92098210|NCT03460860|Vitamin E|vitamin e|mesh-list
92098211|NCT03460860|Tocotrienols|tocotrienols|mesh-list
92098212|NCT03460860|alpha-Tocopherol|alpha-tocopherol|mesh-list
92098213|NCT03460860|Lycopene|lycopene|mesh-list
92098214|NCT03460860|Antioxidants|antioxidants|mesh-ancestor
92098215|NCT03460860|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098216|NCT03460860|Protective Agents|protective agents|mesh-ancestor
92098217|NCT03460860|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098218|NCT03460860|Vitamins|vitamins|mesh-ancestor
92098219|NCT03460860|Micronutrients|micronutrients|mesh-ancestor
92098220|NCT03460860|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098221|NCT03460860|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92098222|NCT03460860|Anticarcinogenic Agents|anticarcinogenic agents|mesh-ancestor
92098223|NCT03460860|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098258|NCT01148836|Ubiquinone|ubiquinone|mesh-list
92098259|NCT01148836|Coenzyme Q10|coenzyme q10|mesh-list
92098260|NCT01148836|Micronutrients|micronutrients|mesh-ancestor
92098261|NCT01148836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098262|NCT01148836|Vitamins|vitamins|mesh-ancestor
92098263|NCT01149616|Dexamethasone|dexamethasone|mesh-list
92098264|NCT01149616|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098265|NCT01149616|Antiemetics|antiemetics|mesh-ancestor
92098266|NCT01149616|Autonomic Agents|autonomic agents|mesh-ancestor
92098267|NCT01149616|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098268|NCT01149616|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098269|NCT01149616|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098270|NCT01149616|Glucocorticoids|glucocorticoids|mesh-ancestor
92098322|NCT01103440|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098323|NCT01103440|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098324|NCT01103440|Anticoagulants|anticoagulants|mesh-ancestor
92098325|NCT01103440|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92098326|NCT01103440|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92098327|NCT01103440|Adjuvants, Immunologic|adjuvants, immunologic|mesh-ancestor
92098328|NCT01103440|Immunologic Factors|immunologic factors|mesh-ancestor
92098329|NCT01103440|Antibiotics, Antineoplastic|antibiotics, antineoplastic|mesh-ancestor
92098330|NCT01103440|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098331|NCT01103440|Antiviral Agents|antiviral agents|mesh-ancestor
92098332|NCT01103440|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098333|NCT01103440|Interferon Inducers|interferon inducers|mesh-ancestor
92098334|NCT01103440|Radiation-Protective Agents|radiation-protective agents|mesh-ancestor
92098335|NCT01103440|Protective Agents|protective agents|mesh-ancestor
92098336|NCT01103440|Cytochrome P-450 CYP2C19 Inhibitors|cytochrome p-450 cyp2c19 inhibitors|mesh-ancestor
92098337|NCT01103440|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92098338|NCT01103440|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098339|NCT01105312|Letrozole|letrozole|mesh-list
92098376|NCT01105702|Alkylating Agents|alkylating agents|mesh-ancestor
92098377|NCT01105702|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098378|NCT01105702|Antidepressive Agents|antidepressive agents|mesh-ancestor
92098379|NCT01105702|Psychotropic Drugs|psychotropic drugs|mesh-ancestor
92098380|NCT01105702|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098381|NCT01105702|Antimanic Agents|antimanic agents|mesh-ancestor
92098382|NCT01105702|Tranquilizing Agents|tranquilizing agents|mesh-ancestor
92098383|NCT01105702|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098384|NCT04453332|Estradiol 17 beta-cypionate|estradiol 17 beta-cypionate|mesh-list
92098385|NCT04453332|Estradiol 3-benzoate|estradiol 3-benzoate|mesh-list
92098387|NCT04453332|Estradiol|estradiol|mesh-list
92098388|NCT04453332|Polyestradiol phosphate|polyestradiol phosphate|mesh-list
92098389|NCT04453332|Progesterone|progesterone|mesh-list
92098392|NCT04453332|Estrogens|estrogens|mesh-ancestor
92098438|NCT03130218|Antiemetics|antiemetics|mesh-ancestor
92098439|NCT03130218|Autonomic Agents|autonomic agents|mesh-ancestor
92098440|NCT03130218|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098441|NCT03130218|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098442|NCT03130218|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098443|NCT03130218|Parasympatholytics|parasympatholytics|mesh-ancestor
92098444|NCT01199146|Abiraterone Acetate|abiraterone acetate|mesh-list
92098445|NCT01199146|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098446|NCT01199146|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92098447|NCT01199146|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098448|NCT01199146|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098449|NCT01199146|Hormone Antagonists|hormone antagonists|mesh-ancestor
92098450|NCT01199146|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098451|NCT01199146|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098452|NCT01199146|Cytochrome P-450 Enzyme Inhibitors|cytochrome p-450 enzyme inhibitors|mesh-ancestor
92098453|NCT01199926|Vitamin D|vitamin d|mesh-list
92098454|NCT01199926|Cholecalciferol|cholecalciferol|mesh-list
92098455|NCT01199926|Vitamins|vitamins|mesh-ancestor
92098456|NCT01199926|Micronutrients|micronutrients|mesh-ancestor
92098457|NCT01199926|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098458|NCT01199926|Bone Density Conservation Agents|bone density conservation agents|mesh-ancestor
92098459|NCT01199926|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92098461|NCT01106950|Fludarabine|fludarabine|mesh-list
92098488|NCT02522208|Nitric Oxide Donors|nitric oxide donors|mesh-ancestor
92098489|NCT02522208|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098490|NCT02522208|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92098492|NCT05684172|Fibrinolytic Agents|fibrinolytic agents|mesh-ancestor
92098493|NCT05684172|Fibrin Modulating Agents|fibrin modulating agents|mesh-ancestor
92098494|NCT05684172|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098495|NCT01200160|Niacin|niacin|mesh-list
92098496|NCT01200160|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92098497|NCT01200160|Antimetabolites|antimetabolites|mesh-ancestor
92098498|NCT01200160|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098499|NCT01200160|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92098500|NCT01200160|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098502|NCT01200160|Vitamins|vitamins|mesh-ancestor
92098551|NCT03848754|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098552|NCT01155154|Clindamycin|clindamycin|mesh-list
92098553|NCT01155154|Clindamycin palmitate|clindamycin palmitate|mesh-list
92098554|NCT01155154|Clindamycin phosphate|clindamycin phosphate|mesh-list
92098555|NCT01155154|Cephalexin|cephalexin|mesh-list
92098556|NCT01155154|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92098558|NCT01155154|Protein Synthesis Inhibitors|protein synthesis inhibitors|mesh-ancestor
92098559|NCT01155154|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098560|NCT01155154|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098561|NCT04614714|Niacinamide|niacinamide|mesh-list
92098562|NCT04614714|Niacin|niacin|mesh-list
92098563|NCT04614714|Nicotinic Acids|nicotinic acids|mesh-list
92098564|NCT04614714|Vitamin B Complex|vitamin b complex|mesh-ancestor
92098565|NCT04614714|Vitamins|vitamins|mesh-ancestor
92098566|NCT04614714|Micronutrients|micronutrients|mesh-ancestor
92098567|NCT04614714|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098568|NCT04614714|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92098569|NCT04614714|Antimetabolites|antimetabolites|mesh-ancestor
92098609|NCT02460588|Antineoplastic Agents, Alkylating|antineoplastic agents, alkylating|mesh-ancestor
92098610|NCT02460588|Alkylating Agents|alkylating agents|mesh-ancestor
92098611|NCT02460588|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098612|NCT02460588|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098613|NCT02460588|Myeloablative Agonists|myeloablative agonists|mesh-ancestor
92098614|NCT02460588|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098615|NCT02460588|Glucocorticoids|glucocorticoids|mesh-ancestor
92098616|NCT02460588|Hormones|hormones|mesh-ancestor
92098617|NCT02460588|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098618|NCT02460588|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098619|NCT03449082|Fibrin Tissue Adhesive|fibrin tissue adhesive|mesh-list
92098620|NCT03449082|Hemostatics|hemostatics|mesh-ancestor
92098621|NCT03449082|Coagulants|coagulants|mesh-ancestor
92098622|NCT03413202|3-n-butylphthalide|3-n-butylphthalide|mesh-list
92098623|NCT03413202|Platelet Aggregation Inhibitors|platelet aggregation inhibitors|mesh-ancestor
92098624|NCT03413202|Neuroprotective Agents|neuroprotective agents|mesh-ancestor
92098625|NCT03413202|Protective Agents|protective agents|mesh-ancestor
92098626|NCT03413202|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098627|NCT04169100|Prednisone|prednisone|mesh-list
92098628|NCT04169100|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098629|NCT04169100|Glucocorticoids|glucocorticoids|mesh-ancestor
92098630|NCT04169100|Hormones|hormones|mesh-ancestor
92098631|NCT04169100|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098632|NCT04169100|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098633|NCT04169100|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098634|NCT04169100|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098635|NCT04155840|Rituximab|rituximab|mesh-list
92098636|NCT04155840|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-list
92098637|NCT04155840|Bendamustine Hydrochloride|bendamustine hydrochloride|mesh-list
92098638|NCT04155840|Antibodies|antibodies|mesh-list
92098639|NCT04155840|Immunoglobulins|immunoglobulins|mesh-list
92098640|NCT04155840|Antibodies, Monoclonal|antibodies, monoclonal|mesh-list
92098649|NCT03448770|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098651|NCT03443778|Bupivacaine|bupivacaine|mesh-list
92098652|NCT03443778|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098653|NCT03443778|Antiemetics|antiemetics|mesh-ancestor
92098654|NCT03443778|Autonomic Agents|autonomic agents|mesh-ancestor
92098655|NCT03443778|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098656|NCT03443778|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098657|NCT03443778|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098658|NCT03443778|Glucocorticoids|glucocorticoids|mesh-ancestor
92098659|NCT03443778|Hormones|hormones|mesh-ancestor
92098660|NCT03443778|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098661|NCT03443778|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098662|NCT03443778|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098663|NCT03443778|Anesthetics, Local|anesthetics, local|mesh-ancestor
92098664|NCT03443778|Anesthetics|anesthetics|mesh-ancestor
92098665|NCT03443778|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92098666|NCT03443778|Sensory System Agents|sensory system agents|mesh-ancestor
92098667|NCT03011008|Liraglutide|liraglutide|mesh-list
92098668|NCT03011008|Hypoglycemic Agents|hypoglycemic agents|mesh-ancestor
92098669|NCT03011008|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098670|NCT03011008|Incretins|incretins|mesh-ancestor
92098671|NCT03011008|Hormones|hormones|mesh-ancestor
92098672|NCT03011008|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098673|NCT01157416|Cycloserine|cycloserine|mesh-list
92098674|NCT01157416|Anti-Infective Agents, Urinary|anti-infective agents, urinary|mesh-ancestor
92098675|NCT01157416|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098676|NCT01157416|Antibiotics, Antitubercular|antibiotics, antitubercular|mesh-ancestor
92098677|NCT01157416|Antitubercular Agents|antitubercular agents|mesh-ancestor
92098678|NCT01157416|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92098679|NCT01157416|Antimetabolites|antimetabolites|mesh-ancestor
92098680|NCT01157416|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098691|NCT01206478|Adrenergic Uptake Inhibitors|adrenergic uptake inhibitors|mesh-ancestor
92098692|NCT01206478|Neurotransmitter Uptake Inhibitors|neurotransmitter uptake inhibitors|mesh-ancestor
92098693|NCT01206478|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098694|NCT01206478|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098695|NCT01206478|Adrenergic Agents|adrenergic agents|mesh-ancestor
92098696|NCT01206478|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098697|NCT01206478|Contraceptives, Oral, Hormonal|contraceptives, oral, hormonal|mesh-ancestor
92098698|NCT01206478|Contraceptives, Oral|contraceptives, oral|mesh-ancestor
92098699|NCT01206478|Contraceptive Agents, Female|contraceptive agents, female|mesh-ancestor
92098700|NCT01206478|Contraceptive Agents|contraceptive agents|mesh-ancestor
92098701|NCT01206478|Reproductive Control Agents|reproductive control agents|mesh-ancestor
92098702|NCT01206478|Contraceptive Agents, Hormonal|contraceptive agents, hormonal|mesh-ancestor
92098703|NCT01206478|Contraceptives, Oral, Synthetic|contraceptives, oral, synthetic|mesh-ancestor
92098704|NCT01206478|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098750|NCT01158820|Autonomic Agents|autonomic agents|mesh-ancestor
92098751|NCT01158820|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098752|NCT01158820|Histamine H1 Antagonists|histamine h1 antagonists|mesh-ancestor
92098753|NCT01158820|Histamine Antagonists|histamine antagonists|mesh-ancestor
92098754|NCT01158820|Histamine Agents|histamine agents|mesh-ancestor
92098755|NCT01158820|Anti-Allergic Agents|anti-allergic agents|mesh-ancestor
92098756|NCT03707028|Paclitaxel|paclitaxel|mesh-list
92098757|NCT03707028|Apatinib|apatinib|mesh-list
92098758|NCT03707028|Antineoplastic Agents, Phytogenic|antineoplastic agents, phytogenic|mesh-ancestor
92098759|NCT03707028|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098760|NCT03707028|Tubulin Modulators|tubulin modulators|mesh-ancestor
92098761|NCT03707028|Antimitotic Agents|antimitotic agents|mesh-ancestor
92098762|NCT03707028|Mitosis Modulators|mitosis modulators|mesh-ancestor
92098763|NCT03707028|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098764|NCT03707028|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92098765|NCT03707028|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098766|NCT03447678|Pembrolizumab|pembrolizumab|mesh-list
92098767|NCT03447678|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92098768|NCT03447678|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098769|NCT03447678|Immune Checkpoint Inhibitors|immune checkpoint inhibitors|mesh-ancestor
92098770|NCT03447678|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098771|NCT01225354|Calcium|calcium|mesh-list
92098772|NCT01225354|Calcium-Regulating Hormones and Agents|calcium-regulating hormones and agents|mesh-ancestor
92098773|NCT01225354|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098774|NCT02521662|Nicotine|nicotine|mesh-list
92098775|NCT02521662|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92098776|NCT02521662|Autonomic Agents|autonomic agents|mesh-ancestor
92098777|NCT02521662|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098796|NCT03499704|Protease Inhibitors|protease inhibitors|mesh-ancestor
92098797|NCT03499704|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098798|NCT05183880|Vitamins|vitamins|mesh-list
92098799|NCT05183880|Ascorbic Acid|ascorbic acid|mesh-list
92098800|NCT05183880|Micronutrients|micronutrients|mesh-ancestor
92098801|NCT05183880|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098802|NCT05183880|Antioxidants|antioxidants|mesh-ancestor
92098803|NCT05183880|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098804|NCT05183880|Protective Agents|protective agents|mesh-ancestor
92098805|NCT01159054|Nicotinic Acids|nicotinic acids|mesh-list
92098806|NCT01159054|Niacin|niacin|mesh-list
92098807|NCT01159054|Niacinamide|niacinamide|mesh-list
92098808|NCT01159054|Vitamin B Complex|vitamin b complex|mesh-ancestor
92098809|NCT01159054|Vitamins|vitamins|mesh-ancestor
92098810|NCT01159054|Micronutrients|micronutrients|mesh-ancestor
92098811|NCT01159054|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098812|NCT01159054|Hypolipidemic Agents|hypolipidemic agents|mesh-ancestor
92098813|NCT01159054|Antimetabolites|antimetabolites|mesh-ancestor
92098814|NCT01159054|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098815|NCT01159054|Lipid Regulating Agents|lipid regulating agents|mesh-ancestor
92098816|NCT01159054|Vasodilator Agents|vasodilator agents|mesh-ancestor
92098817|NCT01209442|Bevacizumab|bevacizumab|mesh-list
92098818|NCT01209442|Temozolomide|temozolomide|mesh-list
92098819|NCT01209442|Antineoplastic Agents, Immunological|antineoplastic agents, immunological|mesh-ancestor
92098848|NCT01228084|Protective Agents|protective agents|mesh-ancestor
92098849|NCT01228084|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098850|NCT01228084|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098851|NCT01229410|Brimonidine Tartrate|brimonidine tartrate|mesh-list
92098852|NCT01229410|Antihypertensive Agents|antihypertensive agents|mesh-ancestor
92098853|NCT01229410|Adrenergic alpha-2 Receptor Agonists|adrenergic alpha-2 receptor agonists|mesh-ancestor
92098854|NCT01229410|Adrenergic alpha-Agonists|adrenergic alpha-agonists|mesh-ancestor
92098855|NCT01229410|Adrenergic Agonists|adrenergic agonists|mesh-ancestor
92098856|NCT01229410|Adrenergic Agents|adrenergic agents|mesh-ancestor
92098857|NCT01229410|Neurotransmitter Agents|neurotransmitter agents|mesh-ancestor
92098858|NCT01229410|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098859|NCT01229410|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098860|NCT04901208|Nicotine|nicotine|mesh-list
92098861|NCT04901208|Ganglionic Stimulants|ganglionic stimulants|mesh-ancestor
92098862|NCT04901208|Autonomic Agents|autonomic agents|mesh-ancestor
92098863|NCT04901208|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098870|NCT01212484|Carbidopa|carbidopa|mesh-list
92098906|NCT01212952|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92098907|NCT01212952|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92098908|NCT01212952|Gastrointestinal Agents|gastrointestinal agents|mesh-ancestor
92098909|NCT01212952|Glucocorticoids|glucocorticoids|mesh-ancestor
92098910|NCT01212952|Hormones|hormones|mesh-ancestor
92098911|NCT01212952|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92098912|NCT01212952|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92098913|NCT01212952|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92098914|NCT01212952|Immunologic Factors|immunologic factors|mesh-ancestor
92098915|NCT01212952|Angiogenesis Inhibitors|angiogenesis inhibitors|mesh-ancestor
92098916|NCT01212952|Angiogenesis Modulating Agents|angiogenesis modulating agents|mesh-ancestor
92098917|NCT01212952|Growth Substances|growth substances|mesh-ancestor
92098918|NCT01212952|Growth Inhibitors|growth inhibitors|mesh-ancestor
92098919|NCT04609865|Lidocaine|lidocaine|mesh-list
92098920|NCT04609865|Anesthetics, Local|anesthetics, local|mesh-ancestor
92098921|NCT04609865|Anesthetics|anesthetics|mesh-ancestor
92098924|NCT04609865|Sensory System Agents|sensory system agents|mesh-ancestor
92098963|NCT03449940|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92098964|NCT03449940|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92098965|NCT03449940|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
92098966|NCT03449940|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92098967|NCT03449940|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92098968|NCT03449940|Anti-Inflammatory Agents, Non-Steroidal|anti-inflammatory agents, non-steroidal|mesh-ancestor
92098969|NCT03449940|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92098970|NCT03449940|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098971|NCT03449940|Antirheumatic Agents|antirheumatic agents|mesh-ancestor
92098972|NCT03449940|Cyclooxygenase Inhibitors|cyclooxygenase inhibitors|mesh-ancestor
92098973|NCT03449940|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92098974|NCT01230424|Triamcinolone|triamcinolone|mesh-list
92098975|NCT01230424|Triamcinolone Acetonide|triamcinolone acetonide|mesh-list
92098976|NCT01230424|Triamcinolone hexacetonide|triamcinolone hexacetonide|mesh-list
92098977|NCT01230424|Triamcinolone diacetate|triamcinolone diacetate|mesh-list
92098978|NCT01230424|Anti-Inflammatory Agents|anti-inflammatory agents|mesh-ancestor
92098979|NCT01230424|Glucocorticoids|glucocorticoids|mesh-ancestor
92099016|NCT03438240|Narcotics|narcotics|mesh-ancestor
92099017|NCT03438240|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92099018|NCT03438240|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92099019|NCT03438240|Anesthetics, General|anesthetics, general|mesh-ancestor
92099020|NCT03438240|Autonomic Agents|autonomic agents|mesh-ancestor
92099021|NCT01160848|Ethanol|ethanol|mesh-list
92099022|NCT01160848|Anti-Infective Agents, Local|anti-infective agents, local|mesh-ancestor
92099023|NCT01160848|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099024|NCT01160848|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099025|NCT01160848|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099026|NCT01213576|Ivermectin|ivermectin|mesh-list
92099027|NCT01213576|Albendazole|albendazole|mesh-list
92099028|NCT01213576|Antiparasitic Agents|antiparasitic agents|mesh-ancestor
92099029|NCT01213576|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099030|NCT01213576|Anthelmintics|anthelmintics|mesh-ancestor
92099031|NCT01213576|Anticestodal Agents|anticestodal agents|mesh-ancestor
92099076|NCT01232920|Anti-Bacterial Agents|anti-bacterial agents|mesh-ancestor
92099077|NCT01232920|Anti-Infective Agents|anti-infective agents|mesh-ancestor
92099078|NCT03445182|Anesthetics|anesthetics|mesh-list
92099079|NCT03445182|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099080|NCT03445182|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099081|NCT03010540|Fentanyl|fentanyl|mesh-list
92099082|NCT03010540|Morphine|morphine|mesh-list
92099083|NCT03010540|Analgesics, Opioid|analgesics, opioid|mesh-ancestor
92099084|NCT03010540|Narcotics|narcotics|mesh-ancestor
92099087|NCT03010540|Analgesics|analgesics|mesh-ancestor
92099143|NCT03444636|Analgesics|analgesics|mesh-ancestor
92099144|NCT03444636|Adjuvants, Anesthesia|adjuvants, anesthesia|mesh-ancestor
92099145|NCT03444636|Anesthetics, Intravenous|anesthetics, intravenous|mesh-ancestor
92099146|NCT03444636|Anesthetics, General|anesthetics, general|mesh-ancestor
92099147|NCT01215292|Ketoconazole|ketoconazole|mesh-list
92099148|NCT01215292|Anastrozole|anastrozole|mesh-list
92099149|NCT01215292|Testosterone|testosterone|mesh-list
92099150|NCT01215292|Dutasteride|dutasteride|mesh-list
92099151|NCT01215292|Acyline|acyline|mesh-list
92099152|NCT01215292|Androgens|androgens|mesh-ancestor
92099153|NCT01215292|Hormones|hormones|mesh-ancestor
92099154|NCT01215292|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099155|NCT01215292|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099156|NCT01215292|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099157|NCT01215292|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099158|NCT01215292|Aromatase Inhibitors|aromatase inhibitors|mesh-ancestor
92099159|NCT01215292|Steroid Synthesis Inhibitors|steroid synthesis inhibitors|mesh-ancestor
92099160|NCT01215292|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099161|NCT01215292|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099198|NCT03437226|Cardiotonic Agents|cardiotonic agents|mesh-ancestor
92099199|NCT03437226|Vasodilator Agents|vasodilator agents|mesh-ancestor
92099200|NCT03437226|Phosphodiesterase 3 Inhibitors|phosphodiesterase 3 inhibitors|mesh-ancestor
92099201|NCT03437226|Phosphodiesterase Inhibitors|phosphodiesterase inhibitors|mesh-ancestor
92099202|NCT03437226|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099203|NCT03437226|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099204|NCT03437226|Protective Agents|protective agents|mesh-ancestor
92099205|NCT03437226|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099207|NCT04788420|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099208|NCT04788420|Protein Kinase Inhibitors|protein kinase inhibitors|mesh-ancestor
92099209|NCT04788420|Enzyme Inhibitors|enzyme inhibitors|mesh-ancestor
92099210|NCT04788420|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099211|NCT01282138|Olopatadine Hydrochloride|olopatadine hydrochloride|mesh-list
92099212|NCT01282138|Dextrans|dextrans|mesh-list
92099213|NCT01282138|Ophthalmic Solutions|ophthalmic solutions|mesh-list
92099214|NCT01282138|Pharmaceutical Solutions|pharmaceutical solutions|mesh-ancestor
92099215|NCT01282138|Anticoagulants|anticoagulants|mesh-ancestor
92099216|NCT01282138|Plasma Substitutes|plasma substitutes|mesh-ancestor
92099217|NCT01282138|Blood Substitutes|blood substitutes|mesh-ancestor
92099219|NCT01282138|Analgesics, Non-Narcotic|analgesics, non-narcotic|mesh-ancestor
92099253|NCT01238536|Hormones, Hormone Substitutes, and Hormone Antagonists|hormones, hormone substitutes, and hormone antagonists|mesh-ancestor
92099254|NCT01238536|Antineoplastic Agents, Hormonal|antineoplastic agents, hormonal|mesh-ancestor
92099255|NCT01238536|Antineoplastic Agents|antineoplastic agents|mesh-ancestor
92099256|NCT01238536|Molecular Mechanisms of Pharmacological Action|molecular mechanisms of pharmacological action|mesh-ancestor
92099257|NCT01238536|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099258|NCT01238536|Sensory System Agents|sensory system agents|mesh-ancestor
92099320|NCT03436836|Bupivacaine|bupivacaine|mesh-list
92099321|NCT03436836|Anesthetics, Local|anesthetics, local|mesh-ancestor
92099322|NCT03436836|Anesthetics|anesthetics|mesh-ancestor
92099323|NCT03436836|Central Nervous System Depressants|central nervous system depressants|mesh-ancestor
92099324|NCT03436836|Physiological Effects of Drugs|physiological effects of drugs|mesh-ancestor
92099325|NCT03436836|Sensory System Agents|sensory system agents|mesh-ancestor
92099326|NCT03436836|Peripheral Nervous System Agents|peripheral nervous system agents|mesh-ancestor
92099327|NCT03436836|Anti-Arrhythmia Agents|anti-arrhythmia agents|mesh-ancestor
92099328|NCT03436836|Voltage-Gated Sodium Channel Blockers|voltage-gated sodium channel blockers|mesh-ancestor
92099329|NCT03436836|Sodium Channel Blockers|sodium channel blockers|mesh-ancestor
92099330|NCT03436836|Membrane Transport Modulators|membrane transport modulators|mesh-ancestor
